<SEC-DOCUMENT>0000950170-23-003935.txt : 20230223
<SEC-HEADER>0000950170-23-003935.hdr.sgml : 20230223
<ACCEPTANCE-DATETIME>20230223071625
ACCESSION NUMBER:		0000950170-23-003935
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		161
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230223
DATE AS OF CHANGE:		20230223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kymera Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001815442
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				812992166
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39460
		FILM NUMBER:		23655919

	BUSINESS ADDRESS:	
		STREET 1:		200 ARSENAL YARDS BLVD., SUITE 230
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		857-285-5314

	MAIL ADDRESS:	
		STREET 1:		200 ARSENAL YARDS BLVD., SUITE 230
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>kymr-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-02-22T14:29:13.1441+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:kymr="http://www.kymeratx.com/20221231" xmlns:srt="http://fasb.org/srt/2022" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_59dd5951-129a-4921-a76f-3a77497db12e" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736">http://www.kymeratx.com/20221231#CollaborationRevenuesFromRelatedPartyMember</ix:nonNumeric><ix:nonFraction id="F_15177ffa-26f9-45d3-97f9-2f3f4476600f" name="kymr:FairValueAssetsLevel3ToLevel2TransfersAmount" contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056" unitRef="U_USD" decimals="INF" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction><ix:nonFraction id="F_b87cb352-a683-4457-b6a3-b1e5cbdd4e65" name="kymr:FairValueAssetsLevel3ToLevel1TransfersAmount" contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056" unitRef="U_USD" decimals="INF" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction><ix:nonNumeric id="F_b05166cd-b41a-4edb-ba37-ddead2c7ce38" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" contextRef="C_68eb4b8c-30b8-4277-ae3e-2cf3c48588f6" format="ixt:booleantrue">true</ix:nonNumeric><ix:nonFraction id="F_17c26d05-9f3b-4274-bf66-5ed27d17bc5c" name="kymr:FairValueAssetsLevel2ToLevel3TransfersAmount" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" unitRef="U_USD" decimals="-3" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction><ix:nonFraction id="F_f278db45-7d50-4cc7-9df3-e40961d927bc" name="us-gaap:PaymentsForRepurchaseOfInitialPublicOffering" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_6930f9de-9815-46fa-9020-cd8359eb249c" name="dei:EntityCentralIndexKey" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709">0001815442</ix:nonNumeric><ix:nonNumeric id="F_00a38e07-86ee-4f89-b2df-9c54865fd329" name="dei:DocumentFiscalPeriodFocus" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709">FY</ix:nonNumeric><ix:nonNumeric id="F_744a2776-a92f-4e1a-a3f0-f007a657a324" name="dei:CurrentFiscalYearEndDate" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" format="ixt:datemonthday">12/31</ix:nonNumeric><ix:nonNumeric id="F_33d39829-bb58-4fa6-afba-41c3a06619f4" name="dei:AmendmentFlag" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" format="ixt:booleanfalse">False</ix:nonNumeric><ix:nonNumeric id="F_49320e69-2deb-4571-b75c-f5ce13224fba" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" contextRef="C_34088ddb-035f-4002-9357-123ac90f1d11" format="ixt:booleantrue">true</ix:nonNumeric><ix:nonNumeric id="F_59253975-6be0-4361-b050-c3fcd7cb5491" name="dei:CurrentFiscalYearEndDate" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" format="ixt:datemonthday">12-31</ix:nonNumeric><ix:nonFraction id="F_36542e98-256e-4b6c-9827-dbf2e0c02061" name="kymr:FairValueAssetsLevel2ToLevel3TransfersAmount" contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056" unitRef="U_USD" decimals="INF" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction><ix:nonFraction id="F_da9b41d8-1030-4c51-9b6e-8526848e4757" name="kymr:FairValueAssetsLevel3ToLevel1TransfersAmount" contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49" unitRef="U_USD" decimals="INF" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction><ix:nonNumeric id="F_dc247878-85ea-4ea3-88c3-f656dec50fb8" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709">http://www.kymeratx.com/20221231#CollaborationRevenuesFromRelatedPartyMember</ix:nonNumeric><ix:nonFraction id="F_b12380f5-0b0a-4217-9861-2223af5ef47a" name="kymr:FairValueAssetsLevel1ToLevel3TransfersAmount" contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49" unitRef="U_USD" decimals="INF" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction><ix:nonFraction id="F_23a625d3-cd72-4352-a158-20585e71389c" name="kymr:FairValueAssetsLevel3ToLevel2TransfersAmount" contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49" unitRef="U_USD" decimals="INF" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction><ix:nonFraction id="F_fbb4303c-a232-44f8-b305-22f13b9fd4e0" name="us-gaap:CommitmentsAndContingencies" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_04c71c59-946d-49a4-904b-666ce72c2fa6" name="kymr:FairValueAssetsLevel2ToLevel3TransfersAmount" contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49" unitRef="U_USD" decimals="INF" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction><ix:nonFraction id="F_ae10bbc7-71bf-42d0-a616-ec6d368d4c60" name="us-gaap:PaymentsForRepurchaseOfInitialPublicOffering" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_832519d8-6bb8-4432-a341-503227a48b41" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" contextRef="C_34088ddb-035f-4002-9357-123ac90f1d11" format="ixt:booleantrue">true</ix:nonNumeric><ix:nonFraction id="F_cd7e99d8-1ab4-4cf7-b3ce-eb07021b9806" name="kymr:FairValueAssetsLevel1ToLevel3TransfersAmount" contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056" unitRef="U_USD" decimals="INF" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction><ix:nonNumeric id="F_0a629c5c-447e-4e13-9f0f-f5c8e97606a2" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5">http://www.kymeratx.com/20221231#CollaborationRevenuesFromRelatedPartyMember</ix:nonNumeric><ix:nonNumeric id="F_85f778a6-0d2e-4bfd-85a2-b83f14d4f0bc" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" contextRef="C_68eb4b8c-30b8-4277-ae3e-2cf3c48588f6" format="ixt:booleantrue">true</ix:nonNumeric><ix:nonFraction id="F_d6816af5-4bc5-4791-ba3d-860c44e2a341" name="kymr:FairValueAssetsLevel1ToLevel3TransfersAmount" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" unitRef="U_USD" decimals="-3" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction><ix:nonFraction id="F_cb8b44a8-0a30-4420-9476-09eaa4fdd848" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" contextRef="C_b7c4a6f5-3116-4dfc-94b7-2777489e2b5a" unitRef="U_pure" decimals="0" format="ixt:numdotdecimal">100</ix:nonFraction><ix:nonNumeric id="F_6df59bfa-c32d-4351-8e0b-684185a0ee07" name="kymr:LeaseCommencementDate" contextRef="C_2c4981f1-d2d1-42ff-abb5-fb290d5cfac2">2023-11-30</ix:nonNumeric><ix:nonFraction id="F_a9f2aefd-6d15-4f49-976d-74b2deaa9149" name="us-gaap:CommitmentsAndContingencies" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_edecdabf-262b-4f31-ac10-5d70725bc297" name="kymr:FairValueAssetsLevel3ToLevel1TransfersAmount" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" unitRef="U_USD" decimals="-3" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction><ix:nonFraction id="F_47aa0c7e-13cd-4b61-a6e4-d8d951681874" name="kymr:FairValueAssetsLevel3ToLevel2TransfersAmount" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" unitRef="U_USD" decimals="-3" scale="3" format="ixt:numdotdecimal">0</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="kymr-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_09c6030c-9215-434e-be32-4ed40bf22526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d08b0ba5-abc0-4746-8241-00292ef51a98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7df38be4-2853-4015-a6b5-9f73bad5256f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5e70b6ab-252f-4914-b65d-a19b70d29f38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_588fd5b5-72cb-4b8f-8a09-d3c8c62edc57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_15ff43a4-1a79-4140-833c-62eca307fcca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_22763f63-4293-43da-81e5-a51fcca60bff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_760ee65f-8938-4d70-852d-717a500268f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_97589b7d-a19b-4817-9cb4-54e5513837fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAPreferredUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:CompoundCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-31</xbrli:startDate><xbrli:endDate>2017-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_efe35265-ca7f-48b1-ba12-d45e10f0072e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b43e2e96-8c18-4279-8325-186feb642b24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_79fff542-33ec-47e5-9833-9eb8b9292809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0847ba81-8f44-4437-b8eb-633b0c7d610a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5e41c878-2f37-448f-8041-6169a741fafd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6ad1ca74-8cd0-428a-8420-0ed4140b55c2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-25</xbrli:startDate><xbrli:endDate>2020-08-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b732179f-e38b-4ac0-966a-36f9156f251e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fab1d0dc-259c-4d99-aeaa-b68f059f306d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:UnbilledReceivablesSanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f388feec-ab4d-435a-a116-98c364680e81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1fa761db-d666-44a0-af4c-79d0be38cd5f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dfba4027-fdf3-4f74-b209-0790ae57b570"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_80f9fc1a-bada-456b-a7de-e066beca9a76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a4ff2b85-04a0-48ba-94cb-7f1135555ba1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_540998ce-bee4-4ad6-941f-3538588a5c1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9a28714d-4117-4d6f-a425-e5fffabba86e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21c4c029-6c05-4698-8da3-0afb2df18536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7739607f-6dbd-41a0-9e92-62301ab965ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7bfbb36d-82da-4ad3-994d-90f943b534e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_74aee4f0-c621-4b65-8a33-0e483df74a09"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ffa8f705-3f5f-4262-91ee-9dc0b63d32dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_13c32f2e-7c2d-451d-bddf-0c2c9dd15260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_34088ddb-035f-4002-9357-123ac90f1d11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201912Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_59441261-9496-4c98-982f-a7f3cbd75e89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1f5790c2-3ca6-4592-b151-991462b1693b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6d1928e4-c54d-45cb-bd65-a8ca6a70568a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0a508e8a-8ed4-432c-b50f-3e6ba3cf849e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="kymr:ScenarioPotentialOutcomeAxis">kymr:LesserOfPotentialOutcomeOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d12a3336-c1b4-42ef-b4e8-d151bc4f6073"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5bcbd011-9c2a-4bed-8e4b-8ad966e7a3df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fee29a3a-aedd-47a5-a81d-24177eb305f7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_706ff543-02d9-48e2-ab79-2493d3f2d922"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2e7ba5c8-f99e-4875-a133-bee00f42bf56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAPreferredUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:CompoundCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0a44a408-71c2-4d39-8813-0b78ecef7724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:BilledReceivablesSanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4ab02c5d-c1ed-4254-9c17-05221638469e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ec425b46-47ad-47dc-8171-83d01e53a978"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2349e822-42db-4347-927f-0f4069526a6f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-07</xbrli:startDate><xbrli:endDate>2020-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5848cdd9-12d7-4f30-a785-9342a4c7a6f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:LabEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_136d87f1-3086-4833-98e0-254742d30599"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d7917064-c478-4770-ad01-038576ee96ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cd15099d-d559-460e-9cc6-741a7742e2e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_609eabef-de99-4804-9f3b-bfe0014a08e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6313fdc6-f629-4f9c-b2ab-a0f4799044f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:UnbilledReceivablesSanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_07b901be-39ca-4958-8fa3-0fb35bd13fe8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:PrivateInvestmentInPublicEquityPipeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-09</xbrli:startDate><xbrli:endDate>2019-05-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1af1f196-8f7a-453c-8f26-b468bf9f47e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f8adf4fe-2bfc-43b4-9f31-817a19df61dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e2615d23-21e3-4021-a013-590aec8dff1e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1067d521-9ab9-4291-b211-b3b28cc5875e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_14b69a89-5ece-4633-95eb-269916567868"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e797a856-6bbd-4491-93c3-86302e550709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandEighteenStockOptionAndGrantPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_364f0411-8f1d-481d-848d-0b732287ee1b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStocksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_842a256c-4f35-4914-9766-3edf46028402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_449c3352-cd32-4f01-af2a-4da22097c606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4dc0482d-1972-405a-aca2-c6d2771a5668"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-25</xbrli:startDate><xbrli:endDate>2020-08-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_61237bf4-e312-4023-95fa-e105e4b526af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dc36945d-778f-40c8-b34a-d7b7257091e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-20</xbrli:startDate><xbrli:endDate>2021-12-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bc832249-6262-4522-b906-00d2da961c93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e29716e7-cfe9-40b9-a9c6-244c78e60765"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e838c8dc-9e7e-4afc-9c1b-ef93b8e4bf4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_233f48ad-667b-4b14-9534-dd4453d81c14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a018222a-a47a-445b-bb16-6f9dfa165490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_da066593-343f-4eae-86aa-8434db5d2bc4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-25</xbrli:startDate><xbrli:endDate>2020-08-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e29dbbc6-2913-48f5-ae93-32213dc0a589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1e66e0ff-3fd7-47c3-9d78-6a55c4496d6b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0e8deb54-698e-4ab2-af83-21ba04dff085"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2d89a721-4703-49d1-bd93-8012ab6048ee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5f869677-7ee2-4413-aebc-fa0d38400637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a19a1934-1bfb-4c71-8877-7d13aaae909d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SeriesCPreferredStockPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b259fb45-0841-4caa-af6a-3436ea59b8c5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7a1721f2-1cc5-4103-bee4-aae009ac5e28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a2e3e97a-6104-4a6a-845d-96d26416a456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e4780686-685f-4d62-af29-362e17c976f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_baa1be4a-3f8a-4703-8ce3-1a52e5380d29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5c3de9fd-e34c-40a7-886f-e337a1c4bbf8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_00ea0bf2-b4b5-4c08-b022-561003946977"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:AssetsNotYetInServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5ecfa09f-e84b-4a4a-8989-6581bbb4d5de"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3363a5aa-7bac-47fb-9504-1359994babd8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:RestrictedCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b6180323-5b57-488b-848b-ccefa15e0d49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7ed674cd-4eeb-4640-9889-2c6678deaa43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a3474749-9778-48ea-8068-ff4b03644db1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_27b0ac27-e9ee-48a9-8244-480576173f08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_062f8b1d-9242-4851-af55-d6d0942205c2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-20</xbrli:startDate><xbrli:endDate>2020-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_64fc7649-e229-4be0-9da4-464cbc4ec931"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_393387d1-e62c-4d39-9c26-01748ebd1fc5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b43f0ac9-9dd1-43f0-9c2f-f1e6e998903c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cbe473e2-0c3e-400a-b19a-6ab0d1df53c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e3f5946c-97c3-41b3-9ef5-e15537183ae3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e6afb047-c3cb-439e-93ba-6a0d534e4847"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2975af70-dd29-413c-b9dd-b4bce328cf7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5b5104c9-4084-4a40-bdc7-f2c83bef3744"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0e2b9cb4-93a4-4a46-8ff4-8c907b9948cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:PrivateInvestmentInPublicEquityPipeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8be60b28-58be-4691-8add-44fa167e85d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5bd98592-a6f8-48cb-b2d8-69e2fb37cced"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f905c3a9-aa7b-42be-b38e-38c2c85fc17e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:UnbilledReceivablesSanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_24dbfe2c-9946-41c1-a96a-9697c75159ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_71ee1d85-28a5-45c6-8c2c-1fe698d0852e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d71a034f-8114-4bbc-b37a-9706f02f0795"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_905b1e51-7f5b-485c-9c36-6955cd326bbc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e026c58e-80f9-43a7-892c-915846f96c73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ffaeb917-acaf-403e-b35f-ee9c0815e0fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandEighteenStockOptionAndGrantPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandAndTwentyStockOptionAndGrantPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b3d185f-ca4e-4abd-8e59-83567a508d6b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d4188fce-d0eb-4f3f-bcf3-22439576a842"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3c25311b-f928-4131-a217-3def376fa07e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_234197a7-41c0-49b0-b46a-6e4f533c6f82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a33af802-fd5f-453f-8566-ed374579cd72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:CambridgeMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:FacilitySubleaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_477496b5-689e-4d9f-889f-43f954b285a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f8675fbd-b497-45a1-8f98-17bb97d337a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandAndTwentyStockOptionAndGrantPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bfc05416-87db-404e-9f86-a8b01e216a23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b71771ba-3d9c-4451-8eb3-75b4fdf5da6f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0562b153-f7d2-4919-a735-90f6be837fe7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c311266f-1fb4-45be-8f19-a199951e6b7a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f35c6b15-85ad-422b-890a-5ff664200b70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kymr:VertexPharmaceuticalsIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_31efc25b-97c7-4143-86af-cc79d0a18d8d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c641fd16-c54e-4ea4-bc93-31046365f9ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueSanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fbbcb1bf-5bb2-467d-99d4-b373ccaddd38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_92cf5785-cf06-4620-8a2b-76822df706a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_040be217-5d7c-4430-aeb6-a639e3672c4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c965787c-a43a-4142-aa2d-b72d421bb8bb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_40496514-8b4d-4ab1-ab44-cabf51a7a931"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_68b2899b-3bcc-43f6-ac60-1964d739bcc2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:BilledReceivablesSanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2b3d220a-8dfb-48f9-8630-e9c3cb556015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9f2c591c-cdd0-4e59-b139-60ee5abb1b89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="kymr:ScenarioPotentialOutcomeAxis">kymr:LesserOfPotentialOutcomeTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_322d6f2f-d9c6-4dde-bd2a-00b4fe2d9953"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1d3282a7-0917-49af-8ec3-cef4fee801f9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8d546ca3-b4f9-459e-94ab-382557abce03"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:LabAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_476fbf89-ead5-43aa-a71f-121b8c5b80cd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_22bb0630-1f56-4e08-be75-2de87dfa8f47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dda1079b-6eca-441a-a05b-3722b9bc66cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cfa523b6-c249-44ac-b04c-c2b414d9ace4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_081b7ddc-7d3d-4ad4-aee3-4d90b3c47ad6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4d086ec-121e-41c0-8f9f-29a659fc29f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:AssetsNotYetInServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1df7a9a0-1093-45f8-b738-6e2b781d6256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:PrivateInvestmentInPublicEquityPipeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-18</xbrli:startDate><xbrli:endDate>2022-08-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4b0a689e-0b9b-43f2-8a8d-71565e0e91d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e8aab3b3-a22a-4ff3-bc89-71d92652daea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1c2cea65-c96f-40f3-85ee-3f904357fc50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6a76246b-2b22-46e7-b98f-f3af778c41fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c448089e-36a2-4d25-8667-2eff989ca829"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:PrivateInvestmentInPublicEquityPipeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2c4981f1-d2d1-42ff-abb5-fb290d5cfac2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:FacilitySubleaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-20</xbrli:startDate><xbrli:endDate>2021-12-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_28099439-7f67-4ba5-b139-b21c74762ca3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f04f21d2-40bf-4a93-8a51-d233d78fb6da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueVertexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6fc3eaa2-537c-4116-875f-333d3da37c5c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d26a9a00-5e7d-4d4c-80e3-ac47ef881e7b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueVertexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_835ed024-44c8-4f1f-8d6e-765f4caca866"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a127836f-8972-4634-a63e-075a16b278cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_945eb7b7-5b44-4a38-ac68-221560bd90c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2a30fc5f-816c-4384-aaa2-91ea6a589f09"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_36be0cca-7b17-4bd5-9ff6-6f599abd4d25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:CambridgeMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:FacilitySubleaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_da71e1e6-ad8b-46b6-a6cc-c239a69a2d15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d5e6adf-2cb4-4ff6-abed-16ed9bba1142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-06</xbrli:startDate><xbrli:endDate>2021-07-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_71808508-9486-45a9-a60f-55c647268f87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_08714960-9258-4fdb-9361-563b0b151dda"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_06738e58-f7fd-48f8-91f1-9bb2c730b938"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e4243250-6638-48e7-889c-97b8a1f4c6c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e603dc4a-23d5-4e8a-ba86-53a78b470fd8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b416434c-2e1c-4143-971b-fbbf1771eff0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f2fba413-6548-46dc-aa3b-627f610a3ec7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d991933b-0bbc-4e49-adf6-0e1709f50056"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b6fa59dc-4675-40d7-8994-3d7f6fdb43e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-20</xbrli:startDate><xbrli:endDate>2021-12-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8de70d1d-2b5f-493b-8b0b-26530520a358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ce764760-07d6-464c-9e95-7ae23ffd34e2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c24a6bd6-ab8b-4a23-9222-6e239419ecc3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_611d8018-b7e1-4bc6-a151-16f06fc1c9e5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7b553fef-df42-4c26-baa6-85e17e44d192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:RestrictedCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bc744543-b39d-4939-9a52-727450458e7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueVertexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bef4bf34-693c-41b8-a9a0-8e9c28f7789b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-07</xbrli:startDate><xbrli:endDate>2020-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f90b9a09-ed20-4574-8cf0-a5475c3bafe7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f9e0671b-5bcf-43c6-8613-91b1eee2aa9d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_565059dc-67cf-4057-8152-e525a8f12af2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kymr:IRAK4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-07</xbrli:startDate><xbrli:endDate>2020-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2c23163c-4ca5-41b2-89bd-6f956a18aef8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fd5b0988-24e0-4f79-92bb-866fe46cad5f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5c9218ac-b38f-4b4a-b639-9ec2b585df0c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kymr:VertexPharmaceuticalsIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b519ea9f-6482-4c50-93f0-fae0c804af59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7358d6d6-fbab-43d0-9f78-318ce8621d10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0d3c3a6e-4f6e-4e86-a583-6b94738c1223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-09</xbrli:startDate><xbrli:endDate>2019-05-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b7c4a6f5-3116-4dfc-94b7-2777489e2b5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAPreferredUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:CompoundCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a28bf33d-a98c-4e5d-bf76-7f54880914c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:CambridgeMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d51bc1c7-aa3c-43cd-8c22-e7fed24f7dec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandAndTwentyStockOptionAndGrantPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_46a95b63-fac0-4c7e-886b-297fe0b6508c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">kymr:FederalAndStateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_612b21a6-29b0-4a04-b6c6-2d057f6f698c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2022fb22-d24d-4bbe-bb9f-9dab9e88b500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a36aa140-8b72-464d-955e-145c92e86542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ce893baa-f44c-4ebb-a74e-bff63f53114a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:CambridgeMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f5b3b459-dd6e-414f-b28b-4d450e611a1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueSanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d8fb09f6-e120-4543-92a1-1556cdd15765"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c9486884-24fb-4c2c-83c0-60db6edb5eec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:BilledReceivablesSanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_edc39a4d-75a6-4b3f-af07-3ff0619b84c6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_68eb4b8c-30b8-4277-ae3e-2cf3c48588f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f5672204-3c86-40cf-a340-5ea7293720f7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_92f87a14-6091-4b98-ab40-77d4b06dc412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-25</xbrli:startDate><xbrli:endDate>2020-08-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_76c8ae03-3308-43f1-b225-daad19fb4a85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SeriesCPreferredStockPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d0188f0-21c7-4f50-b44d-994dd494ed83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c6c8d2a8-fc5a-4ae7-a353-aba76870f2db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_74fc36db-9df8-4a3a-b61d-d3906dde152b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eefb7cbc-9caa-4ace-97f5-4dd5fa0c3875"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eec48a46-4598-43e9-a039-7466eaea4546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c2702504-9407-4568-90ec-019c2a2d2ec4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ec1630b7-f419-4a11-a92d-8d8f0402646a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:LabEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c78e13b1-5a22-4766-9c4e-481992abdd5d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0cf55378-3493-4d42-bbac-071bc03a0b45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ceafc2b0-0999-4cab-befa-221a85b5170a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_68a7c495-1305-45e9-99c0-9a0f59885e6b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-07</xbrli:startDate><xbrli:endDate>2020-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bc0e09ba-86f9-40ac-bd79-7819763b03d9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9611dcfe-598d-44f0-becc-70cdcf69b398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-07</xbrli:startDate><xbrli:endDate>2020-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_da156e8f-4b74-46f4-b36a-d8334d9e178c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9c751372-08cb-457c-aad4-5cedac83bf5f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_84f17940-92a7-4e17-be51-01d2d2326192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fad25e8f-82cd-4241-b5a5-deda1a16ec70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5736292d-6714-4a50-bbea-d38622c2466f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e385f6e7-a66f-4abf-a4e6-7cc879be5486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_84cd998d-445c-4b16-bb46-4ea2853490a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1e352199-2021-4cbf-89a6-6b3fb1a9cb86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b9849062-15a8-4157-94eb-425887d7c4d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_568f226b-696c-4f67-8494-4fae12a09dcd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_167de5a4-50cc-4901-9c67-4c426f16265e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandAndTwentyStockOptionAndGrantPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_997b8ca2-0e08-4b7f-bb20-e67b92117eb3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5e341025-329c-4ac7-81f0-c034f045d05a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kymr:VertexPharmaceuticalsIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_87c3d75e-6f9f-4fee-bf73-1e3449016f7a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_353d5cf1-900b-4407-901f-6e88343b6e28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_76aa8dac-964b-4401-9f4a-e42aa52a6fa3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5570ee25-70f9-4703-b517-2f4ecb794156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5441244c-f6a1-4c98-ab13-fd0944167cea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b1c3605d-deb5-4fa5-a122-f271881338b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_502b15a6-ea47-400c-869d-e335729cdbc1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueSanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9d10799d-d7e1-4d27-8675-c80ab8ac70f7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8ff041e4-b315-4e52-b81f-f83d9f3192a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2b8cccc4-67af-4d70-a28f-55b723676bd5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_61d31205-c2b5-4c89-bdaa-f543c2398e40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:LabEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7ce88c48-9db3-4967-b6cf-209b8a85b29a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0ab6f045-1ad1-4153-a9b6-962038299ee7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e683523c-eff3-4658-979d-24ea59364214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kymr:VertexPharmaceuticalsIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_be95bba8-f456-4a90-a5f1-287d343806dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bb8b7969-bb82-4041-994e-9433633910b6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fdb41358-831d-4444-b8f4-0d53bd52e986"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_443e4a77-30f5-47ad-b864-37c3741dcda6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bdb2440e-1e74-443b-8199-85bc8484ff9e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ff725650-2c6a-4920-8877-da2405efe942"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9637e2ee-ccfa-4f69-ae4f-52730c923c29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f62f379d-f310-481c-a34d-1f3d65032cd1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_19cbc32f-ec79-4363-8ead-cd45c0522894"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_02126e7a-b6e0-43d2-9ccf-f5a5b79c8acd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:LabAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a0c7a845-3be7-4f46-849f-63f833e1d24d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b7ba11fe-25ad-4dba-9808-5ea7f213c68e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandEighteenStockOptionAndGrantPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_44015c49-ba45-4506-b30f-8927b0882496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kymr:VertexPharmaceuticalsIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-25</xbrli:startDate><xbrli:endDate>2020-08-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2838053c-edc6-48eb-99f6-f1c1c948532c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0269e2a0-73d4-4767-b9f5-307b464b1430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_efce9fe0-465e-459e-b1a9-4b6162542b7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e35141e7-840c-4c80-868b-75ce55213382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001815442</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>kymr:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_Security"><xbrli:measure>kymr:Security</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="border-top:2.25pt double;padding-top:1.0pt;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fig`</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Washington, D.C. 20549</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9c0f3c0f-72d8-4dde-b1d2-6ec1afdb44c1" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Mark One)</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:2.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:97.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_74a9eb48-4366-4736-abda-2dc46fe33931" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_67fe0723-8ad2-4370-9069-b48264f2e406" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_38e16004-3236-456d-ba04-dbe3780da955" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:DocumentFiscalYearFocus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:11.111%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OR</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:2.037%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:96.963%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c340ebe3-b095-4053-b752-c07b90de7de6" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                    TO</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">                     </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commission File Number </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1904cdd3-1128-4e37-ad37-fbd23727737f" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">001-39460</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:22.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e7d9db36-af14-4699-b7bf-e5902e24d690" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:22.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of Registrant as specified in its Charter)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:50.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0ac3e054-db74-4e0e-881d-c49964424b9f" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4d6e17ab-fcaf-4770-bd9a-baaba55cebc6" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81-2992166</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">incorporation or organization)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(I.R.S. Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_14c5a786-db9c-4071-95a2-6318611b85c1" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">200 Arsenal Yards Blvd.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3c3693df-1412-4aab-a408-c1c4d0bd9009" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Suite 230</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ba5221cc-b4ff-4c0e-8206-0d259ed6dbb7" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Watertown</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_957c9e73-8ede-41b1-b60c-5f3dd6d1c122" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Massachusetts</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_35b99a28-1f46-47d9-bfdb-6f60ac88c4f9" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">02472</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s telephone number, including area code: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_83a88446-b331-4aee-bca7-ee6886b947ee" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">857</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d63c8542-7822-4115-8e40-e5f057e483f9" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">285-5300</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:39.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:20.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:39.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f2efdaf6-22df-434d-b61f-45df836db86d" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_634d82ae-89bf-40b6-99af-28772ee781d3" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMR</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_dd19c61d-cb8b-4bde-bc43-2e7a2163a70a" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Nasdaq Global Market </span></ix:nonNumeric></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f977b396-7852-440d-9c8c-7662083aaa43" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityWellKnownSeasonedIssuer"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746; NO &#9744;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  YES &#9744;  </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7cdcab3c-d847-4744-b6a6-7f16d279a427" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityVoluntaryFilers"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_99dc148c-798b-40ea-b16e-a2cb9e17ae95" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityCurrentReportingStatus"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746; NO &#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).  </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_81c36dd8-87d1-40fc-8076-40fd36f216e4" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityInteractiveDataCurrent"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746; NO &#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:19.12%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:55.657%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:20.324%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.898%;"></td>
   </tr>
   <tr style="height:10.8pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3ce6b900-b5bb-480b-a4a5-241e18c43c77" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Large accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr style="height:2.15pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_80077e83-3b22-4a72-bad7-670b6a6c7ab9" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:2.15pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_75a628f5-745b-40e1-b7e2-ecf326df8d0f" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#x2019;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_15bc09da-ed97-44ad-9d97-e81ecd2982f5" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#x2019;s executiveo&#xfb03;cers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  YES </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_18dd2615-40e6-48ed-bffd-0cc8e5785f3f" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate market value of the registrant&#x2019;s common stock, $</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_133ad779-2f43-45ce-bedb-6b024972af9f" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:EntityListingParValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4">0.0001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> par value per share, held by non-affiliates of the registrant, based on the last sale price of the Common Stock at the close of business on June 30, 2022, was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4dcc504b-b6f8-4f8e-a5eb-c66aefedaf5e" contextRef="C_443e4a77-30f5-47ad-b864-37c3741dcda6" name="dei:EntityPublicFloat" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal">792.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. Shares of common stock held by each executive officer and director and by each other person who may be deemed to be an affiliate of the registrant have been excluded from this computation. The determination of affiliate status for this purpose is not necessarily a conclusive determination for other purposes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The number of shares of Registrant&#x2019;s Common Stock outstanding as of February 17, 2023 was </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e803d908-eb09-40d1-aa16-ac7bdca43fc4" contextRef="C_9a28714d-4117-4d6f-a425-e5fffabba86e" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">55,183,644</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p>
  <div style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1db838d2-d134-4d56-aff7-c1e342774842" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portions of the registrant&#x2019;s Proxy Statement for its 2023 Annual Meeting of Stockholders, which the registrant intends to file with the Securities and Exchange Commission not later</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">than 120 days after the registrant&#x2019;s fiscal year ended December 31, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Table of Contents</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:10.099%;"></td>
    <td style="width:82.817%;"></td>
    <td style="width:7.083%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART I</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#business_section"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Business</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Properties</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART II</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market for Registrant&#x2019;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">116</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 6.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_6_selected_financial_data"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reserved</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">117</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">118</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">131</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 8.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">131</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9C.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9c_disclosure_regarding_foreign"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosure Regarding Foreign Jurisdiction that Prevents Inspections</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART III</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 10.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_10_directors_executive_ficers_corpo"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 11.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Compensation</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 12.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_12_security_ownership_certain_benef"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 13.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_13_certain_relationships_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 14.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_14_principal_accounting_fees_servic"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal Accounting Fees and Services</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART IV</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 15.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits, Financial Statement Schedules</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">136</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 16</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_16_form_10k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form 10-K Summary</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">138</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">i</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SUMMARY OF THE MATERIAL AND OTHER RISKS ASSOCIATED WITH OUR BUSINESS</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:18.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a biopharmaceutical company with a limited operating history and have not generated any revenue to date from drug sales, and may never become profitable.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred significant operating losses in recent periods and anticipate that we will incur continued losses for the foreseeable future.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will need to raise substantial additional funding. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, scale back or discontinue some of our product candidate development programs or future commercialization efforts.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are very early in our development efforts. All of our product candidates are in preclinical or early clinical development. If we are unable to commercialize our product candidates or experience significant delays in doing so, our business will be materially harmed.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our approach to the discovery and development of product candidates based on our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform is novel and unproven, which makes it difficult to predict the time, cost of development and likelihood of successfully developing any products.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Business interruptions resulting from the ongoing coronavirus disease (COVID-19) pandemic, similar public health crises, or geo-political actions could cause a disruption to our supply chain or the development of our product candidates and adversely impact our business.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may not be successful in our efforts to identify or discover additional product candidates or we may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we experience delays or difficulties in the initiation or enrollment of patients in clinical trials, our receipt of necessary regulatory approvals could be delayed or prevented.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current or future product candidates may cause adverse or other undesirable side effects that could delay or prevent their regulatory approval, limit the commercial profile of an approved label, or result in significant negative consequences following marketing approval, if any.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we receive regulatory approval for any of our current or future product candidates, we will be subject to ongoing obligations and continued regulatory review, which may result in significant additional expense.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely, and expect to continue to rely, on third parties to conduct our ongoing and planned preclinical studies and clinical trials for our current and future product candidates. If these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or meet expected deadlines, we may not be able to obtain marketing approval for or commercialize our current and potential future product candidates and our business could be substantially harmed.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are unable to obtain and maintain patent and other intellectual property protection for our technology and product candidates or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and drugs similar or identical to ours, and our ability to successfully commercialize our technology and drugs may be impaired.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ii</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Annual Report on Form 10-K, or Annual Report, contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this Annual Report are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#x201c;may&#x201d;, &#x201c;will&#x201d;, &#x201c;should&#x201d;, &#x201c;expects&#x201d;, &#x201c;intends&#x201d;, &#x201c;plans&#x201d;, &#x201c;anticipates&#x201d;, &#x201c;believes&#x201d;, &#x201c;estimates&#x201d;, &#x201c;predicts&#x201d;, &#x201c;potential&#x201d;, &#x201c;continue&#x201d; or the negative of these terms or other comparable terminology. These statements are not guarantees of future results or performance and involve substantial risks and uncertainties. Forward-looking statements in this Annual Report include, but are not limited to, express or implied statements about:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the initiation, timing, progress, results, and cost of our research and development programs, and our current and future preclinical and future clinical studies, including statements regarding the timing of initiation and completion of studies or trials and related preparatory work, the period during which the results of the trials will become available, and our research and development programs;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to continue to construct Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, our drug discovery platform, and to enable a rational and effective drug discovery and development engine;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing and the success of preclinical and clinical studies under our IRAK4, IRAKIMiD, STAT3 and MDM2 programs;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our plans to submit investigational new drug applications to the FDA for current and future product candidates;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the subsequent initiation of planned clinical trials;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to identify research priorities and apply a risk-mitigated strategy to efficiently discover and develop product candidates, including by applying learnings from one program to other programs and from one modality to our other modalities;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our potential ability to manufacture our drug products, drug substances, delivery vehicles, and product candidates for preclinical use, for clinical trials and on a larger scale for commercial use, if approved;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability and willingness of our third-party strategic collaborators to continue research and development activities relating to our development candidates and product candidates, within expected timeframes, if at all;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain funding for our operations necessary to complete further development and commercialization of our product candidates;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain and maintain regulatory approval of our product candidates;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to commercialize our products, if approved;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the pricing and reimbursement of our product candidates, if approved;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the implementation of our business model, and strategic plans for our business, product candidates, and technology;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">estimates of our future expenses, revenues, capital requirements, and our needs for additional financing;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential benefits of strategic collaboration agreements, our ability to enter into strategic collaborations or arrangements, and our ability to attract collaborators with development, regulatory and commercialization expertise;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">future agreements with third parties in connection with the commercialization of product candidates and any other approved product;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size and growth potential of the markets for our product candidates, and our ability to serve those markets;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our financial performance;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the rate and degree of market acceptance of our product candidates;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory developments in the United States and foreign countries;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to contract with third-party suppliers and manufacturers and their ability to perform adequately;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to produce our products or product candidates with advantages in turnaround times or manufacturing cost;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the success of competing therapies that are or may become available;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to attract and retain key scientific or management personnel;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the impact of laws and regulations;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">developments relating to our competitors and our industry;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the impact of global economic and political developments on our business, including rising inflation and capital market disruptions, the current conflict in Ukraine, economic sanctions and economic slowdowns or recessions that may result from such developments which could harm our research and development efforts as well as the value of our common stock and our ability to access capital markets; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effect of the ongoing COVID-19 pandemic, including mitigation efforts and economic effects, on any of the foregoing or other aspects of our business operations, including but not limited to our preclinical studies and future clinical trials; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other risks and uncertainties, including those listed under the caption &#x201c;Risk Factors.&#x201d;</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any forward-looking statements in this Annual Report reflect our current views with respect to future events and with respect to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, among other things, those described under Part I, Item 1A, &#x201c;Risk Factors&#x201d; and elsewhere in this Annual Report. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All of our forward-looking statements are as of the date of this Annual Report only. In each case, actual results may differ materially from such forward-looking information. We can give no assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of or any material adverse change in one or more of the risk factors or risks and uncertainties referred to in this Annual Report or included in our other public disclosures or our other periodic reports or other documents or filings filed with or furnished to the Securities and Exchange Commission, or the SEC, could materially and adversely affect our business, prospects, financial condition and results of operations. Except as required by law, we do not undertake or plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, estimates or projections or other circumstances affecting such forward-looking statements occurring after the date of this Annual Report, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized. Any public statements or disclosures by us following this Annual Report that modify or impact any of the forward-looking statements contained in this Annual Report will be deemed to modify or supersede such statements in this Annual Report.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may from time to time provide estimates, projections and other information concerning our industry, the general business environment, and the markets for certain diseases, including estimates regarding the potential size of those markets and the estimated incidence and prevalence of certain medical conditions. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties, and actual events, circumstances or numbers, including actual disease prevalence rates and market size, may differ materially from the information reflected in this Annual Report. Unless otherwise expressly stated, we obtained this industry, business information, market data, prevalence information and other data from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data, and similar sources, in some cases applying our own assumptions and analysis that may, in the future, prove not to have been accurate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART I</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="business_section"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1. Business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body&#x2019;s own natural protein degradation system. Our proprietary targeted protein degradation, or TPD, platform, which we refer to as Pegasus&#153;, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have unique advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. We focus on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus&#153; platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and we continue to apply our platform&#x2019;s capabilities to additional therapeutic areas. We have a mission to drug all target classes in human cells using TPD.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our programs exemplify our focus on addressing high impact targets that have been elusive to conventional modalities and that drive the pathogenesis of multiple serious diseases with significant unmet medical needs. Our current clinical stage programs are IRAK4, IRAKIMiD, and STAT3, which each address high impact targets within the interleukin-1 receptor/toll-like receptor, or IL-1R/TLR, and janus kinase/signal transducers and activators of transcription, or JAK/STAT, pathways, providing the opportunity to treat a broad range of immune-inflammatory diseases, hematologic malignancies, and solid tumors. Our fourth clinical program, MDM2, targets both solid and hematologic malignancies.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">With respect to our IRAK4 program, we are collaborating with Sanofi S.A, or Sanofi, on the development of drug candidates targeting IRAK4 outside the oncology and immuno-oncology fields. We are developing KT-474, a highly active and selective, orally bioavailable IRAK4 degrader, for the treatment of IL-1R/TLR-driven immunology-inflammation conditions and diseases with high unmet medical need, including hidradenitis suppurativa, or HS, an inflammatory skin disease, as well as atopic dermatitis, or AD, and potentially other indications. We have completed our Phase 1 trial of KT-474, which included a single ascending dose, or SAD, portion, a multiple ascending dose, or MAD, portion and a single dose, food-effect cohort to establish the dose for the patient cohort, or Part C, in patients with HS and AD. In December 2022, Sanofi notified us of its intent to advance KT-474 into Phase 2 clinical trials. Phase 2 clinical trials of KT-474 will initially investigate its potential in HS and AD, with the clinical trial for the first indication initiating in 2023. With respect to our oncology programs, we are evaluating KT-333, a STAT3 degrader, in a Phase 1 clinical trial in patients with relapsed/refractory liquid and solid tumors, including aggressive lymphomas. Patient enrollment and dosing are ongoing in the Phase 1a portion of the trial, and we expect to provide additional clinical data in 2023. We are also evaluating KT-413, our IRAKIMiD degrader, in a Phase 1 clinical trial in patients with relapsed/refractory B cell lymphomas, including MYD88 mutant diffuse large B cell lymphomas (DLBCL). Patient enrollment and dosing are ongoing in the Phase 1a portion of the trial, and we expect to provide additional clinical data in 2023.  In December 2022, we received FDA clearance for our investigational new drug, or IND, application to evaluate our MDM2 degrader, KT-253, in a Phase 1 clinical trial. KT-253 has been developed to stabilize the tumor suppressor p53 and address a wide variety of p53 wild type tumor types in both solid tumors and hematologic malignancies. We plan to initiate our Phase 1 clinical trial of KT-253 in early 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Strategy</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our mission is to discover, develop and commercialize novel and transformative therapies that improve the lives of patients with serious diseases, and we are committed to the selection of targets that enable a broad impact across multiple clinical indications with high unmet medical need. We believe the unique discovery capabilities of our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform will position us to be a leader in the area of TPD. Our goal is to become a fully integrated biopharmaceutical company with a pipeline of novel degrader medicines targeting disease-causing proteins that were previously intractable. We intend to achieve this goal by pursuing the following strategic objectives.</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Advance the development of our IRAK4, IRAKIMiD</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">STAT3 and MDM2 programs to deliver transformative therapies to patients</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. We maintain a core set of drug development principles which guide our protein target selection and our discovery and development efforts. We are specifically focused on delivering therapeutic solutions that reach previously inaccessible targets, in particular those in which the biological pathways are clinically and genetically well-validated, in order to address significant unmet medical needs within broad patient populations. We believe our IRAK4, IRAKIMiD, STAT3 and MDM2 programs have the potential to treat multiple immune-inflammatory and oncology disease indications that fit these criteria.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further expand the capabilities of our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform to identify the optimal pairing of therapeutic targets with E3 ligases for a range of disease states</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Our TPD platform, Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, enables us to identify an expanded library of E3 ubiquitin ligases, or E3 ligases, to discover highly selective degraders with activity against disease causing proteins throughout the body. Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has the potential to help us better understand not only the optimal pairing of disease-causing protein targets with E3 ligases, but also the degradation profiles across different cell types and tissues, further enabling us to convert our differentiated E3 binders into novel degraders. We believe our ability to identify and utilize previously unliganded E3 ligases, particularly those with selective or restricted expression, may unlock new opportunities across broad therapeutic applications, including using novel E3 ligases to degrade undruggable and non-ligandable high value protein targets using small molecule molecular glues.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Continue to build a broad and diverse pipeline of novel protein degraders</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Guided by our drug development principles and the learnings from our IRAK4, IRAKIMiD, STAT3 and MDM2 programs, we intend to continue to identify therapeutic targets that have disruptive therapeutic potential and are predicted to be well-suited for a TPD approach. Given the unique genetic profiles in some of the patient populations that we aim to serve, we plan to continue to leverage a precision medicine approach to help identify patients with the highest probability of responding to our degrader drug candidates. The capabilities of our discovery platform, such as our expanded toolbox that includes E3 ligases beyond the two predominantly used in the field today, cereblon and von Hippel-Lindau, or VHL, enable us to pursue targets linked to a wider range of indications.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expand and protect our proprietary know-how and intellectual property</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. We have developed a broad patent estate protecting our intellectual property, which we intend to expand to further protect our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform and the drug candidates we develop. Our intellectual property, which includes proprietary know-how as well as a series of patents, applies to not only our invented compounds but also to our E3 Ligase Whole-Body Atlas and our E3 Ligase Binders Toolbox.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursue synergistic collaboration opportunities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. To further our goal of delivering transformative therapies to the broadest possible patient population, we intend to become a fully integrated biopharmaceutical company. As part of this plan, in addition to our ongoing collaborations with Vertex Pharmaceuticals Incorporated, or Vertex, and Sanofi, we expect to leverage additional strategic partnerships that can contribute complementary capabilities in discovery, development and commercialization in disease areas both within and outside of our core areas of therapeutic focus.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Background of Targeted Protein Degradation</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proteins are responsible for the structure, function and regulation of tissues and organs. Cells in the body continuously synthesize and degrade proteins, maintaining an equilibrium called protein homeostasis. Most diseases are the result of aberrant protein behavior driven by activation, mutation, or downregulation of the protein itself, or by the gene responsible for the transcription and translation of that particular protein. With a deepened molecular understanding of various diseases and the characterization of the full human genome, research efforts have increasingly focused on the development of medicines to address malfunctioning proteins responsible for oncologic, auto-immune, cardio-metabolic, neurodegenerative, and rare genetic diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The &#x2018;druggable&#x2019; genome challenge</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Several therapeutic modalities have been developed over the years to address aberrant protein activity. These have included small molecule inhibitors of protein function, therapeutic antibodies, oligo-based therapeutics such as RNA interference therapeutics, antisense oligonucleotides, or ASO, and other genetic therapies.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Some of these modalities have had a tremendous impact on the treatment of diseases and quality of life of patients, and several others, while earlier stage, offer potential. However, these traditional modalities face specific challenges that limit their therapeutic impact and reach. Some of the limitations of existing modalities include the following:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Traditional small molecule therapeutics</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are unable to block the function of proteins without a catalytic or substrate binding site and cannot block proteins with dual function, as such are not effective against transcription factors, scaffolding and adaptor proteins, many of which play a key role in certain diseases.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Therapeutic antibodies</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are generally too large to penetrate cells and are therefore typically limited to protein targets that are extracellular, or outside of the cell, whereas most proteins are inside the cell. They also have to be dosed parenterally and can be costly and complex to develop and manufacture.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Oligo-based therapeutics</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are capable of drugging proteins elusive to small molecules in some cases but have significant drug delivery challenges with dosing and in achieving systemic distribution, greatly limiting the breadth of diseases they are able to address effectively. These therapeutics can also be costly and complex to develop and manufacture.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of these limitations, we believe that only 20% of the full human genome has been effectively drugged to date. New therapeutic modalities which can overcome some of these challenges are necessary to expand the drugged proteome/genome and provide new efficacious medicines to patients in need. We believe that TPD is such a modality.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 1. Expanding the Druggable Human Proteome.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_0.jpg" alt="img254193463_0.jpg" style="width:672px;height:191px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Targeted Protein Degradation</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">One of the methods that cells use to control the balance between the synthesis of new proteins and the degradation and disposal of damaged and/or misfolded proteins, is ubiquitin-proteasome system, or UPS. The discovery of ubiquitin-mediated protein degradation provided important insights into specific processes like cellular division and DNA repair and led to the discovery of UPS&#x2019; critical roles in various cellular pathways, including the cell cycle, signaling pathways, the regulation of gene expression, and responses to oxidative stress. The discovery of the UPS also revealed a new modality to harness this cellular process for the treatment of diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The UPS comprises a series of finely orchestrated enzymatic sequences that ultimately lead to protein polyubiquitination and degradation by the proteasome in cells. Protein ubiquitination is a cellular process involving an enzymatic cascade consisting of ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2), and ubiquitin-protein ligases (E3). In humans, there are two classes of ubiquitin activating E1 enzymes, more than 30 E2 enzymes, and approximately 600 E3 ligases.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As illustrated in the figure below, the E3/E2/ubiquitin ligase complex (shown in blue) binds to a substrate protein (shown in purple) to mediate the transfer of ubiquitin, which leads to degradation of the target protein through the proteasome.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 2. Natural Protein Degradation Through Ubiquitin-Proteasome System.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><img src="img254193463_1.jpg" alt="img254193463_1.jpg" style="width:672px;height:503px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Targeted protein degradation is a new modality that co-opts this innate cellular process. The core of the TPD modality consists of a small molecule (shown in magenta in Figure 3 below) that we refer to as a heterobifunctional degrader. The role of this heterobifunctional degrader molecule is to mediate a &#x201c;new&#x201d; interaction through the formation of a ternary complex between a disease-causing protein and an E3 ligase. The E3 ligase tags the protein target for degradation by attaching a series of ubiquitin, and the proteasome recognizes the tagged protein and degrades it into small peptides.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forming an efficient ternary complex, as shown in step 2 in the figure below, is a critical step in TPD, and its formation, function, and effect on cellular and in vivo systems is vital to the success of the degradation and its impact on disease. In addition, the degrader molecule needs to be able to effect degradation in a variety of different cell types and contexts and have the right pharmaceutical properties to be therapeutically dosed to patients.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As shown in the figure below, after the degrader facilitates the ubiquitination of the target protein, and as the protein is degraded by the proteasome, the molecule separates from the protein, and is able to form another ternary complex to conduct the degradation process again. This iterative mechanism is catalytic, which results in increased potency even at lower concentrations, another key differentiator from other modalities such as small molecule inhibitors and therapeutic antibodies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 3. Overview of Targeted Protein Degradation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><img src="img254193463_2.jpg" alt="img254193463_2.jpg" style="width:672px;height:297px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due to the unique advantages of TPD, this transformative modality is capable of targeting proteins traditionally undrugged by small molecules. Specifically, TPD can target proteins without a catalytic function such as scaffolding proteins and transcription factors, with small molecule-like drug properties that can potentially be dosed orally and distributed systemically unlike oligo-based therapeutics such as RNAi&#x2019;s. TPD molecules also are amenable to existing small molecule manufacturing principles which are less costly than other therapeutic modalities. Because of the catalytic nature of the degradation process, we believe the modality has the potential to be therapeutically effective with smaller amounts of drug substance and less frequent dosing than traditional therapeutics.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The use of small molecules to affect protein homeostasis has been clinically and commercially validated by multiple drugs over the past two decades. Drugs such as bortezomib and fulvestrant have been understood to inhibit the proteasome and target the estrogen receptor for proteasome-dependent degradation, respectively. More recently, immunomodulatory imide drugs such as lenalidomide and pomalidomide have been understood on a post-hoc basis to direct the degradation of a series of transcription factors via the UPS.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These immunomodulatory drugs have validated the concept of using the UPS to degrade proteins and elicit a pharmacological and therapeutic effect in disease settings. However, unlike earlier approaches in this field, TPD takes this proven concept further to prospectively target the degradation of a wider range of proteins through the rational design of heterobifunctional degraders which coordinate the discreet binding of target proteins and E3 ligases to drive the desired protein degradation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">An important factor for the efficiency of a degrader is the specificity and affinity to the targeted E3 ligase. The various E3 ligases have different distribution and cellular localization profiles that are important factors when considering which E3 ligase to use for a particular disease protein target. There are approximately 600 E3 ligases that occur in nature, but to date only a handful of these E3 ligases have been evaluated for therapeutic purposes, leaving a substantial portion of the genome available for targeting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Platform</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our proprietary drug discovery platform, called Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, enables us to rationally design targeted protein degraders that have the potential to drug all target classes in the cell. Our approach is rooted in an understanding of the relationship between E3 ubiquitin ligases and target proteins, which allows us to identify the properties that make a target both ligandable and degradable, and determine how multiple factors impact potency, selectivity, pharmacokinetics, or PK, and pharmacodynamics, or PD. Key components of our platform include our E3 ligase ligand toolbox, our understanding of degradation across healthy and diseased tissue types, our proprietary chemistry and our Center for Molecular Glue Discovery.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expanded E3 Ligase toolbox.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Our E3 ligase Whole-Body Atlas includes the expression profiles of approximately 600 unique E3 ligases. Using this Atlas, we are able to match target proteins with appropriate E3 ubiquitin ligases based on expression, distribution, intracellular localization and biology, a process that is enabled with our machine learning-based algorithms.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Understanding of degradation across tissue types</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Our Quantitative System Pharmacology Model measures and predicts a diverse set of parameters that impact target protein levels, based on an understanding of PK/PD, both in vitro and in vivo, and across healthy and diseased tissues and cell types.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proprietary Chemistry</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Our proprietary chemistry expertise enables the design and optimization of both E3 ligase and target protein binders, with artificial intelligence (AI) enabled insights, allowing for the opportunity to design of targeted protein degraders with optimal pharmaceutical properties.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> &#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Center for Molecular Glue Discovery</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Our Center for Molecular Glue Discovery is focused on identifying novel tissue restricted or selective E3 ligases, beyond traditional cereblon/IMiD interactions, that enable the design of molecules that target both undrugged and un-ligandable proteins through small molecule interactions.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Therapeutic Pipeline</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current clinical-stage programs are IRAK4, IRAKIMiD, STAT3 and MDM2, which each focus on a single critical signaling node within the genetically and clinically validated IL-1R/TLR, JAK/STAT and p53 pathways.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We completed our Phase 1 clinical trial for KT-474 in October 2022. Patient enrollment and dosing are ongoing for our Phase 1 clinical trials for KT-333 and KT-413. In December 2022, we announced we received FDA clearance of our IND to evaluate our MDM2 degrader, KT-253 and we expect to start enrollment in the Phase 1 study in early 2023.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our clinical stage pipeline. We also have multiple programs in earlier stages of development and are exploring targets in therapeutic areas outside of our core areas of focus:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><img src="img254193463_3.jpg" alt="img254193463_3.jpg" style="width:672px;height:228px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our IRAK4, IRAKIMiD, STAT3 and MDM2 Programs</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing KT-474, a highly active and selective, orally bioavailable IRAK4 degrader, for the treatment of IL-1R/TLR-driven immunology-inflammation conditions and diseases with high unmet medical need, including HS, an inflammatory skin disease, as well as AD and RA. We have chosen to pursue IRAK4 degradation due to the well-validated role of the IL-1R/TLR pathway in immunology and inflammation and the potential advantage that drugging a single node of multiple different mediators of inflammation has over other approaches focused on targeting one of many cytokines that stimulate the IRAK4 node. IRAK4 is a critical node in the IL-1R/TLR signaling pathway, which is dependent on both IRAK4&#x2019;s kinase activity and scaffolding function. We have observed through our in vitro and in vivo studies that KT-474 induces IRAK4 degradation, impacting both the kinase and the scaffolding functions, and therefore can efficiently and selectively block IL-1R/TLR-mediated inflammation in a way we believe to be superior to IRAK4 kinase inhibitors. We therefore believe KT-474 has the potential to improve outcomes over current treatment options as well as other drugs currently in development. The dose</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">escalation in the SAD and MAD portions of this Phase 1 trial in healthy volunteers was completed in December 2021. In October 2022, we announced that we had completed the patient cohort, or Part C, of the KT-474 Phase 1 trial, which included hidradenitis suppurativa, or HS, and atopic dermatitis, or AD, patients. We are collaborating with Sanofi on the development of drug candidates targeting IRAK4 outside of oncology and immuno-oncology fields, and in December 2022, Sanofi notified us of its intent to advance KT-474 into Phase 2 clinical trials in patients with HS and AD . See &#x201c;Business&#x2014;Collaborations&#x2014;Collaboration Agreement with Sanofi.&#x201d;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing another group of IRAK4 degraders, which we call IRAKIMiDs, with a unique profile that combines the activity of IRAK4 degradation and immunomodulatory imide drugs, or IMiDs, for the treatment of MYD88-mutated diffuse large B-cell lymphoma, or DLBCL. In oncology, IRAK4 is an obligate protein in MYD88 signaling and this activated mutation is well characterized to drive oncogenesis. IMiDs are a class of drugs that degrade zinc-finger transcription factors, such as Ikaros and Aiolos, resulting in the restoration of Type 1 interferon, or Type 1 IFN, signaling pathway which is relevant in treating lymphoma. Our IRAKIMiDs combine the activity of the IMiDs with IRAK4 degradation in a single agent and address both the IL-1R/TLR and the Type 1 IFN pathways synergistically and in doing so are designed to produce broad activity against MYD88-mutant lymphomas.  In animal models, we have demonstrated that this combination in a single agent is superior to co-administering IRAK4 and IMiD agents. We believe this will be the first precision medicine in lymphoma to target a genetically defined population, which accounts for approximately 25% of DLBCL patients. We have observed that the functional synergy between the degradation of IRAK4 and IMiD activity results in broad activity against MYD88-mutant lymphomas in vitro and in mouse xenograft models, leading to rapid, complete and sustained tumor regressions, even when dosed intermittently. Further, we have seen additive and synergistic activity in vivo combining IRAKIMiD with ibrutinib (BTK), venetoclax (BCL-2 inhibitor), and rituximab (anti-CD20 monoclonal antibody), which are important back-bone therapies in these B cell lymphomas. We are currently evaluating our IRAKIMiD degrader, KT-413, in a Phase 1 clinical trial in patients with relapsed/refractory B cell lymphomas, including MYD88 DLBCL. Patient enrollment and dosing are ongoing in the Phase 1a portion of the trial, and we expect to provide additional clinical data in 2023.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing our selective STAT3 degraders for the treatment of hematological malignancies and solid tumors, as well as autoimmune diseases and fibrosis. STAT3 is a transcription factor activated through a variety of different cytokine and growth factor receptors via janus kinases, or JAKs, as well as through oncogenic fusion proteins and mutations in STAT3 itself. We believe the diverse functions of STAT3 in tumor biology, evasion of immune surveillance by tumor cells, and inflammation and fibrosis provide opportunities to address a wide variety of high unmet need disease indications through the targeting of a single genetically and clinically validated pathway. While the JAK-STAT pathway has been partially addressed with several clinically successful JAK-targeting agents, we believe there are currently no drugs that specifically affect STAT3 broadly across all the relevant cell types. Small molecule STAT3 dimerization inhibitors targeting the SH2 domain have been in development, but significant challenges remain: first, homology of SH2 domains among all STAT family members impacts the ability to achieve specificity for STAT3, and second, inability to block dimerization independent transcriptional activities of STAT3. For these reasons, we believe that STAT3 degraders may provide a transformative solution to the development of targeted and selective drugs to address multiple STAT3 dependent pathologies. We are currently evaluating our STAT3 degrader, KT-333, in a Phase 1 clinical trial in patients with relapsed/refractory liquid and solid tumors, including aggressive lymphomas. Patient enrollment and dosing are ongoing in the Phase 1a portion of the trial, and we expect to provide additional clinical data in 2023.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing degraders that target MDM2 for the treatment of solid tumors and hematological malignancies. MDM2 is the crucial regulator of the most common tumor suppressor, p53, which remains intact (or wild type) in more than 50% of cancers. Unlike small molecule inhibitors, our MDM2 degrader, KT-253, has been shown preclinically to have the ability to overcome the MDM2 feedback loop and rapidly induce apoptosis, even with brief exposures. In December 2022, we announced that we received clearance from the FDA for our IND for KT-253. We plan to initiate a Phase 1 clinical trial of KT-253 in early 2023, which is designed to evaluate the safety, tolerability, PK/PD and clinical activity of KT-253 in adult patients with liquid and solid tumors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Approach to Target Selection</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain a unique approach to target selection within the TPD field focused on targets within three distinct categories, as described below and shown in Figure 4.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inadequately Drugged (ID).</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> We are focused on targets that have been inadequately drugged with other technologies and, importantly, where degradation provides a clear advantage over enzyme inhibition. We have identified and targeted proteins where removal offers superior therapeutic benefit versus inhibition of enzymatic activity or blockade of a binding site. Examples of targets we are pursuing in this category include IRAK4 and MDM2.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Undrugged Targets (UD).</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> We are also exploring targets that are traditionally undrugged using other technologies. In some instances, ligands to these targets may exist and, while inadequate on their own for inhibition, have potential to serve as part of a heterobifunctional targeted protein degraders. In other instances, undrugged targets may have no known ligands and potentially no accessible small molecule binding sites which may make them poor candidates for both inhibitors and current heterobifunctional molecules. In these instances, we are pursuing a molecular glue approach in which a new surface on an E3 ligase is created via a small molecule with potential to engage the protein target of interest through a specific protein-protein interaction. An example of a target we are pursuing in this category is STAT3.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tissue Restricted (TR)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The final category of targets includes targets which can uniquely be accessed using our proprietary human whole body E3 ligase Atlas. Our efforts here are focused on systematically identifying tissue sparing and tissue selective E3 ligases, which enables us to access clinically validated targets where on-target, unwanted pharmacology limits the clinical utility of small molecule inhibitors. We are currently working on several programs, at different stages of development, pursuing tissue restricted or selective degradation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 4. Our Approach to Target Selection</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_4.jpg" alt="img254193463_4.jpg" style="width:667px;height:312px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Programs</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">IRAK4 Degrader for IL-1R/TLR-driven Immunology-inflammation Diseases</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Summary</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing KT-474, a highly active and selective, orally bioavailable IRAK4 degrader, for the treatment of IL-1R/TLR-driven immune-inflammatory conditions and diseases with high unmet medical need, including HS, AD, RA and others. We have chosen to pursue IRAK4 degradation due to the well-validated role of the IL-1R/TLR pathway in immunology and inflammation and the potential advantage that drugging a single node of multiple different mediators of inflammation has over other approaches focused on targeting one of many cytokines that stimulate the IRAK4 node. IRAK4 is a critical node in the IL-1R/TLR signaling pathway, which is dependent on both IRAK4&#x2019;s kinase activity and scaffolding function. We have observed through our in vitro and in vivo studies that KT-474 induces IRAK4 degradation, impacting both the kinase and the scaffolding functions, and therefore can selectively block IL-1R/TLR-mediated inflammation in a way we believe to be superior to IRAK4 kinase inhibitors. We therefore believe KT-474 has the potential to improve outcomes over current treatment options as well as other drugs currently in development. The dose escalation in the SAD and MAD portions of this Phase 1 trial in healthy volunteers was completed in December 2021. In October 2022, we announced that we had completed the patient cohort, or Part C, of the KT-474 Phase 1 trial, which included HS and AD patients. We are collaborating with Sanofi on the development of drug candidates targeting IRAK4 outside of oncology and immuno-oncology fields, and in December 2022, Sanofi notified us of its intent to advance KT-474 into Phase 2 clinical trials in patients with HS and AD initially potentially</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">followed by other indications. See the section entitled &#x201c;Business&#x2014;Collaborations&#x2014;Collaboration Agreement with Sanofi&#x201d; appearing elsewhere in this Annual Report for more information.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Biology and Mechanism of Action of IRAK4 Degrader</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IRAK4 is a key component of the myddosome, a multiprotein complex involved in innate immunity that mediates signaling through TLRs and IL-1Rs. The IRAK4 protein is ubiquitously expressed across multiple different tissue types, including skin, lymphoid tissue, bone marrow, gastrointestinal tract, and lung.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The function of IRAK4 is dependent both on its kinase activity and on its scaffolding function, which are required for the assembly of the myddosome complex following TLR or IL-1R engagement and MYD88 activation. While the kinase function is primarily responsible for the phosphorylation events in the IRAK4-JNK axis, the scaffolding function is primarily responsible for the NF-KB activation and downstream gene traction of several key pro-inflammatory cytokines and chemokines.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe IRAK4 degradation is superior to IRAK4 kinase inhibition as our preclinical data suggests that it is critical to block both the kinase activity and scaffolding functions of the IRAK4 protein, which requires removal, as opposed to just inhibition, of the protein. IL-1 family cytokines, including IL-1a, IL-1&#xdf;, IL-18, IL-36, and IL-33, have been implicated in a variety of different immunology-inflammation conditions and diseases. As both TLRs and IL-1Rs are involved in the production and response to all of these IL-1 family cytokines, IRAK4 targeting with a single small molecule degrader could impact multiple different cytokines and chemokines and thereby provide a transformative approach to the treatment of IL-1R/TLR-driven diseases.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 5. IRAK4 Function is Comprised of Both Kinase-Dependent and -Independent Activity.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_5.jpg" alt="img254193463_5.jpg" style="width:337px;height:354px;" /><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Development Opportunities and Differentiation from IL-1 Family Cytokine Antibodies</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There are numerous cutaneous, rheumatic and gastrointestinal immunology-inflammation disease indications for which pathogenesis involves IL-1 family cytokines as well as TLR stimulation. These present opportunities where we believe a highly efficient and selective IRAK4 degrader would provide significant advantages over both currently approved treatment options and those in clinical development. We are initially prioritizing indications such as HS, AD, and RA where there is clinical proof of concept for targeting cytokines impacted by the IL-1R/TLR pathway but for which there continues to be a high level of unmet need.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 6. IL-1 Family Cytokines</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_6.jpg" alt="img254193463_6.jpg" style="width:380px;height:288px;" />&#160;</p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Hidradenitis Suppurativa</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HS is a chronic, destructive, painful and debilitating inflammatory skin disease affecting up to 1% of both the U.S. and global population. Patients with HS have numerous painful, draining nodules and abscesses, usually within skin folds, that are characterized by inflammation and bacterial colonization. Currently HS is treated symptomatically with corticosteroids, antibiotics and surgery. The only FDA-approved treatment for HS is the anti-TNF antibody adalimumab, which provides some benefit to approximately 50% of patients with moderate-to-severe disease but is not curative. Thus, there remains a high unmet need for better therapies for the treatment of HS.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bacterial activation of TLRs, as well as the production of IL-1a, IL-1&#xdf;, and IL-36 by keratinocytes and inflammatory cells leading to inflammation characterized by high levels of TNF-a, IL-6, and IL-17, are central to the pathogenesis of HS. Monoclonal antibodies targeting individual cytokines such as IL-1a (bermekimab), IL-1a/&#xdf; receptor (anakinra), and IL-17 (secukinumab and bimekizumab) have shown preliminary clinical activity in HS and provide clinical validation for targeting the IL-1R/TLR pathway in HS. As such, an IRAK4 degrader which acts on multiple cytokines as well as TLRs has the potential to offer a significant advantage over the single-cytokine-targeting agents currently being developed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Atopic Dermatitis</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AD is a chronic, pruritic inflammatory skin disease that occurs most frequently in children but also affects adults. In the major global markets, the diagnosed prevalence of AD is estimated over 60 million patients, with approximately 40%, or 24 million, falling into the moderate-to-severe category. AD follows a chronic relapsing course over month to years, with dry skin and severe pruritus as the primary symptoms, sometimes accompanied by skin thickening from chronic scratching and fissuring. AD is treated symptomatically with topical therapies, including emollients, corticosteroids, and phosphodiesterase inhibitors. The lone FDA-approved systemic treatment is the IL-4Ra targeting antibody dupilumab, though only approximately 40% of moderate-to-severe disease patients met the primary endpoint in its Phase 3 trials, leaving a significant percentage of patients who are currently underserved.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, there is evidence that IL-33 and IL-1 are both involved in the generation of inflammation in both AD and other allergic diseases, including eosinophilic asthma and chronic rhinosinusitis. Single-cytokine-targeting monoclonal antibodies against IL-33 (etokimab) and IL-1a(bermekimab) have shown preliminary clinical activity in AD. Thus, we believe the ability of an IRAK4 degrader to impact the production of both IL-33 and IL-1, through complete TLR signaling blockade, and the cellular response to both cytokines, through complete IL-1R signaling blockade, provides a compelling mechanistic rationale for development in AD.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Rheumatoid Arthritis</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RA, an additional potential indication for our IRAK4 degrader, is the most common inflammatory arthritis, affecting approximately 5 million individuals in the 7 major markets worldwide, with a prevalence of 0.7% of the U.S. population. The synovial inflammation characteristic of RA is driven by Th1 and Th17 immune responses with production of TNF-a and IL-1 family cytokines, including IL-1, IL-18 and IL-33, IL-6 and IL-17. Multiple therapies targeting the IL-1R/TLR pathway are approved for RA, and recently an IRAK4 kinase inhibitor (PF-06650833) has shown clinical activity comparable to the JAK inhibitor tofacitinib and a favorable safety profile in a randomized, placebo-controlled Phase 2b study in RA patients with inadequate response to methotrexate. Based on these early signs of activation, we believe a degrader-based approach which impacts both the kinase activity and the scaffolding function of IRAK4 may have the potential for a more transformative effect on the disease.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Studies and Data</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2021, we completed dose escalation in the SAD and MAD portions of the KT-474 Phase 1 trial. The following figure summarizes the trial design of the healthy volunteer portion of the trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 7: KT-474 Healthy Volunteer Study</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><img src="img254193463_7.jpg" alt="img254193463_7.jpg" style="width:376px;height:178px;" /><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"><br /><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The summary of key findings in the healthy volunteer portion of the KT-474 clinical trial included:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IRAK4 was reduced to near the lower limit of quantification using Mass Spectrometry</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Degradation was associated with up to 85% inhibition of multiple disease-relevant cytokines and chemokines in ex vivo TLR stimulation assay at the 100 mg dose level</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dose-dependent IRAK4 degradation in skin exceeded 50%</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KT-474 was generally well tolerated at doses up to 200 mg, with no serious adverse events</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following the healthy volunteer portion of the trial, we completed a single dose, food-effect cohort to establish the dose for the patient cohort, or Part C, of the KT-474 Phase 1 trial, which included HS and AD patients and which was completed in October 2022.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Part C enrolled 21 patients, the demographics of which are shown below in Figure 8.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 8: KT-474 Part C Baseline Demographics</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_8.jpg" alt="img254193463_8.jpg" style="width:454px;height:189px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Part C baseline disease characteristics are shown below in Figure 9. One HS patient withdrew for personal reasons after dose 4, and one AD patient withdrew for personal reasons after dose 5.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 9: KT-474 Part C Baseline Disease Characteristics</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_9.jpg" alt="img254193463_9.jpg" style="width:651px;height:309px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As shown below in Figure 10, the KT-474 plasma PK at the 75 mg once daily (QD) dose (in the fed state) in patients was comparable to healthy volunteers in the MAD portion of the Phase 1 clinical trial who received 100 mg once daily in the fasted state, the MAD cohort which we refer to as MAD3. Additionally, mean Cmax (6-hour post dose concentration) and Ctrough (pre-dose concentration) levels at steady state in Part C were in line with MAD3 levels at Day 14, and the mean half-life of 44 hours was within the range observed in MAD (34-59 hours)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 10: Part C KT-474 Plasma PK</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_10.jpg" alt="img254193463_10.jpg" style="width:562px;height:297px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As shown in Figure 11, KT-474 concentrations in plasma led to a comparable level of IRAK4 degradation in healthy volunteers and HS/AD patients. Specifically, at concentrations above 3 ng/mL degradation was generally above 80% in both populations. Additionally, IRAK4 levels in PBMC in patients with evaluable samples were near the lower limit of quantification at Day 28.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 11: PK/PD Correlation in Plasma/Monocytes (FLOW)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_11.jpg" alt="img254193463_11.jpg" style="width:216px;height:231px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Baseline IRAK4 levels in skin lesions of evaluable HS and AD patients were approximately twice the levels of healthy volunteers. By Day 28 of dosing, the mean IRAK4 in skin lesions of AD and HS patients was reduced to approximately the same level as healthy subjects, as shown below in Figure 12.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 12: IRAK4 Levels in Skin Lesions</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_12.jpg" alt="img254193463_12.jpg" style="width:594px;height:289px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KT-474 was generally well-tolerated. There were no serious adverse events, no drug-related infections, and no adverse events observed leading to dose interruption or discontinuation. The below figure lists adverse events related to study drug occurring in greater than 1 Patient.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 13: KT-474 Part C Adverse Events</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_13.jpg" alt="img254193463_13.jpg" style="width:615px;height:234px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, a modest, non-adverse QTc prolongation, consistent with that observed by Day 7 in the MAD portion of the healthy volunteer study, was also observed in the patient cohort but spontaneously resolved back to baseline with continued dosing during the 28-day dosing period.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A whole blood ex vivo stimulation assay using the TLR ligands LPS or R848 showed broad inhibition of multiple disease-relevant cytokines and chemokines of up to 84-98% in HS and AD patients from Days 14 to 28, comparable or superior to what was observed in the healthy volunteer MAD3 cohort, as shown below in Figure 14.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 14: KT-474 Whole Blood ex vivo stimulation</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_14.jpg" alt="img254193463_14.jpg" style="width:620px;height:282px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To determine whether KT-474 had a systemic anti-inflammatory effect in HS and AD patients, plasma levels of IL-6, CRP, SAA and IL-1b were measured at baseline and at various times during and after the 28-day treatment period. In patients whose baseline levels were greater than the upper limit of normal, the evaluable patients showed suppression of all 4 analytes, with mean maximum reductions through Day 42 ranging from 41 to 63%, as shown below in Figure 15.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 15: Plasma Levels</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_15.jpg" alt="img254193463_15.jpg" style="width:312px;height:272px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Part C also evaluated how systemic IRAK4 degradation in blood and skin would affect the expression of proinflammatory genes known to be relevant to either AD or HS. Figure 16 illustrates select disease-relevant genes downregulated in skin lesions of at least 50% of AD or HS patients at Day 28 compared to baseline. In AD, affected genes included the Th2 cytokine IL-5, the inflammasome NLRP3, as well as CXCL1 and IL-2RB. Genes affected in HS included IL-1 family cytokines IL-1 and IL-36A, mediators of Th1 inflammation such as IFN-g and GZMB, the Th17 cytokine IL-17A, and drivers of innate immunity such as IL-8 and CSF3. The downregulation was substantial with many genes inhibited more than 90% in both diseases.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 16: Disease-relevant biomarkers</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_16.jpg" alt="img254193463_16.jpg" style="width:624px;height:365px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Part C included exploratory clinical endpoints used for HS and AD. The endpoints were chosen in order to assess the effect of KT-474 treatment on the burden of skin disease as well as on symptoms such as pain and pruritus that impact quality of life for HS and AD patients.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In AD patients, as shown in Figure 17, there was a mean 37% reduction in skin lesions as measured using the Eczema Area and Severity Index (EASI) score, with reductions in individual patients of up to 76%. Maximum reduction was seen by Day 28 and was maintained at Day 42.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 17: Mean EASI Score Over Time (n=7)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_17.jpg" alt="img254193463_17.jpg" style="width:325px;height:230px;" /><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As shown in Figure 18, mean peak pruritus in AD patients over the past week or past 24 hours was reduced by 52% and 63%, respectively, with maximum reductions occurring by Day 42. Peak pruritus responders, defined as &#x2265;4 Unit reduction in peak pruritus over the past week or past 24 hours, were seen in 57% and 71% of AD patients, respectively, with responses sustained after Day 28.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 18: Peak Pruritus Numerical Rating Scale in AD patients</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_18.jpg" alt="img254193463_18.jpg" style="width:589px;height:249px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Validated Investigator&#x2019;s Global Assessment (vIGA) of disease severity improved in 2 of 7 AD patients and remained stable in the others out to Day 42, as shown in Figure 19.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 19: vIGA-AD Score Over Time (n=7)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_19.jpg" alt="img254193463_19.jpg" style="width:525px;height:240px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In HS patients, the efficacy analyses were performed in all patients, which included two patients with very severe disease. In addition, efficacy analyses were also performed in a subset of HS patients that only had moderate to severe disease, which was the target population for this study. As shown in Figure 20, the AN count was reduced by up to an average of 46% in all HS patients and of 51% in the moderate to severe subset, with reductions in individual patients of up to 100% and with maximum reduction occurring by Day 42. The proportion of patients achieving an AN count of 0, 1 or 2 at Day 28 was 42% in all HS patients and 50% in those with moderate to severe disease.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 20: AN count over time</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_20.jpg" alt="img254193463_20.jpg" style="width:672px;height:288px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HiSCR50 response is defined as a 50% or greater reduction in AN count and no increase in abscesses or draining fistulas. As shown in Figure 21, at Day 42, the proportion of HiSCR50 responders was 42% in all HS patients and 50% in those with moderate to severe disease.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 21: % of Patients with HiSCR50</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_21.jpg" alt="img254193463_21.jpg" style="width:624px;height:251px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HiSCR75 response, defined as 75% or greater reduction in AN count, was seen in 25% of all HS patients and 30% of those with moderate to severe disease.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Symptoms of pain and pruritus were also measured. As shown in Figure 22, there was a 49 to 55% mean reduction in the Pain Numerical Rating Scale, or NRS, in all HS patients and in those HS patients with moderate to severe disease, respectively, with maximum reduction occurring between Days 28 and 42. Pain NRS30 response is defined as at least a 30% reduction and at least one unit reduction from baseline in Pain NRS. As also shown in Figure 22, the Pain NRS responder rate was 50% in all HS patients and 60% in those HS patients with moderate to severe disease, sustained after Day 28.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 22: Pain Numerical Rating Scale in HS patients</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_22.jpg" alt="img254193463_22.jpg" style="width:628px;height:286px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As shown below in Figure 23, there was a mean reduction in peak pruritus of 62% in all HS patients and 68% in those HS patients with moderate to severe disease, with maximum reduction by Day 42 in all HS patients and by Day 28 in those with moderate to severe disease.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 23: Mean % Change in Peak Pruritus Over Past Week</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_23.jpg" alt="img254193463_23.jpg" style="width:588px;height:252px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Physician&#x2019;s Global Assessment of disease severity improved in 5 HS patients, including clearing of disease in 1 patient with moderate disease at baseline, and remained stable in the other evaluable patients out to Day 42, as shown in Figure 24.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 24: Physician&#x2019;s Global Assessment (HS-PGA)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_24.jpg" alt="img254193463_24.jpg" style="width:600px;height:241px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Development Plan</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> On December 14, 2022, we announced that Sanofi notified us of its commitment to advance KT-474 into Phase 2 clinical trials in 2023. Phase 2 clinical trials of KT-474 will initially investigate its potential in HS and AD with the first clinical trial for the first indication planned for initiation in 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">IRAKIMiD Program in Oncology</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Summary</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing another group of IRAK4 degraders, which we call IRAKIMiDs, with a unique profile that combines the activity of IRAK4 degradation and IMiDs for the treatment of MYD88-mutated DLBCL. In oncology, IRAK4 is an obligate protein in MYD88 signaling and this activated mutation is well characterized to drive oncogenesis. IMiDs are a class of drugs that degrade zinc-finger transcription factors, such as Ikaros and Aiolos, resulting in the restoration of Type 1 IFN signaling pathway which is relevant in treating lymphoma. Our IRAKIMiDs combine the activity of the IMiDs with IRAK4 degradation in a single agent and address both the IL-1R/TLR and the Type 1 IFN pathways synergistically with a goal of demonstrating broad activity against MYD88-mutant lymphomas. We believe this will be the first precision medicine in lymphoma to target a genetically defined population, which accounts for at least 25% of the estimated approximately 150,000 DLBCL patients currently diagnosed in the major global markets. We have observed the degradation of IRAK4 and IMiD activity results in additivity and synergy in vitro. IRAKIMiDs combine both of these mechanisms in a single compound. Our IRAKIMiD degrader, KT-413, has been observed to have broad activity against MYD88-mutant lymphomas in vitro and in mouse xenograft models, leading to rapid, complete and sustained tumor regressions, even when dosed intermittently. We are currently evaluating our IRAKIMiD degrader, KT-413, in a Phase 1 clinical trial in patients with relapsed/refractory B cell lymphomas, including MYD88 mutant DLBCL. Patient enrollment and dosing are ongoing in the Phase 1a portion of the trial, and we expect to provide additional clinical data in 2023.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Target Rationale and Mechanism of Action</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In DLBCL, the activating mutation of MYD88 drives activation of the NF-KB transcription factor and pro-survival mechanisms such as IRF4. MYD88 is a protein that forms a multiprotein signaling complex, known as the myddosome, which transduces receptor agonism from both the TLR and IL-1 b receptors. IRAK4 is an integral component of the myddosome, and both its catalytic kinase activity as well as its scaffolding function are required to drive downstream signals from the myddosome.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The constitutive activation of NF-KB is a hallmark of several B-cell lymphoma subtypes. In DLBCL, NF-KB activation is driven by a range of oncogenic alterations in several upstream pathways and regulators. Multiple co-mutations in these complexes often occur within the same tumor, emphasizing the dependence of these cancers on NF-KB activation. IMiDs such as lenalidomide drive a partial downregulation of NF-KB and IRF4, resulting in the restoration of Type 1 IFN signaling and promoting cell death.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 25. NF-KB is Activated by Complimentary Mechanisms in Diffuse Large B Cell Lymphoma.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><img src="img254193463_25.jpg" alt="img254193463_25.jpg" style="width:439px;height:398px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leveraging knowledge and chemistry expertise derived from the design of our selective IRAK4 degrader program, we have designed a novel class of heterobifunctional IRAK4 degraders, which we call IRAKIMiDs, that utilize an active IMiD as the cereblon binder to simultaneously engage and degrade both IRAK4 and IMiD substrates, such as Ikaros and Aiolos, thus combining the activity of two molecules in a single agent. IRAKIMiDs therefore combine two highly relevant therapeutic mechanisms in a single compound, enabling the functional synergy of NF-kB inhibition and upregulation of the Type 1 IFN response that results in increased and broader single-agent activity in MYD88-mutated DLBCL as compared to either mechanism alone.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 26. IRAKIMiDs (right) Combine Both IRAK4 Degradation and IMiD Activity in a Single Agent.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_26.jpg" alt="img254193463_26.jpg" style="width:672px;height:249px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Development Opportunities and Differentiation of Novel Therapies in MYD88-Mutated DLBCL</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Oncogenic mutations of MYD88, most commonly MYD88L265P, are common in several subsets of DLBCL. In particular, MYD88 is estimated to be mutated in approximately 30-40% of activated B cell DLBCL, or ABC-DLBCL, cases; 30-80% of primary CNS lymphoma cases; and 45-75% of primary extranodal lymphomas cases. In addition, MYD88 is mutated in approximately 90% of Waldenstr&#xf6;m macroglobulinemia cases. The presence of MYD88 mutations in DLBCL is often associated with poorer response to chemotherapy and reduced overall survival compared to other genetic subtypes, supporting the need for more effective therapies targeting MYD88-mutated DLBCL.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Front-line treatment of DLBCL typically involves the R-CHOP treatment regimen of chemotherapy combined with rituximab. While effective in many other patients, front-line chemotherapy has significantly poorer survival rates in DLBCL subsets where MYD88 mutations are prevalent. In additional lines of therapy, several novel targeted therapies have been approved recently, including the combination of polatuzumab, bendamustine and rituximab, as well as CD19-targeting chimeric antigen receptor T-cells. While these agents have some notable activity, many patients fail to respond to or subsequently relapse from these therapies, with no adequate treatment options. Several targeted therapies that impact the NF-kB pathway, such as the Bruton&#x2019;s tyrosine kinase inhibitor ibrutinib, or the IMiD lenalidomide, have shown modest single agent activity, with poor durability of response in MYD88-mutated DLBCL.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on our preclinical data, we believe KT-413, which synergistically combines the activity of both IRAK4 and IMiD substrate degradation to exploit complimentary pathway signaling, will have the potential to improve upon the efficacy of IRAK4 kinase inhibitors and other therapies, including BTK inhibitors and IMiDs, and provide single-agent activity in MYD88-mutated DLBCL.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preclinical Studies and Data</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In support of our preclinical development, we have observed our IRAKIMiD degraders&#x2019; high selectivity and therapeutic potential in both in vitro and in vivo studies.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To assess the activity of our IRAKIMiD degraders in both MYD88-mutated and -wild-type cells lines, we conducted various in vitro studies in a panel of cell lines. MYD-88-mutated cell lines included ABC-DLBCL lines such as OCI-Ly10, SUDHL2, and TMD8 while MYD-88-wild-type cell lines included OCI-Ly19, U2932, and SUDHL6. We have shown that IRAK4 degradation, as opposed to IRAK4 inhibition, shows additivity and synergy when combined with IMiDs in vitro. Specifically, combining an IRAK4 degrader with the IMiD pomalidomide shows additive and synergistic activity in several MYD88-mutated cell lines in vitro, supporting the combined effect of targeting both the MYD88 and IRAK4 pathways together. Notably, we did not see an additive effect when IRAK4 kinase inhibitors were combined with IMiDs, suggesting that the greater activity of IRAK4 degradation is needed for synergistic activity. We believe these data support the development of our unique class of IRAKIMiD degraders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KT-413 is a potent degrader of IRAK4 and the IMiD substrates, Ikaros and Aiolos with single digit nM DC50 values against all three targets with maximal growth inhibition observed with approximately 80% target knockdown. As shown in Figure 27, KT-413 is more potent and more active in MYD88-mutated DLBCL than either an IRAK4-selective degrader compound, or a clinically active IMiD, supporting our hypothesis that simultaneous degradation of IRAK4 and IMiD substrates is more effective than degrading either alone.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 27. KT-413 Potency</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_27.jpg" alt="img254193463_27.jpg" style="width:607px;height:228px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 28 summarizes results of in vivo experiments in xenograft models of MYD88 mutant DLBCL demonstrating profound antitumor activity with durable complete responses in animals treated with KT-413 on intermittent dosing schedules as infrequent as every 2 or 3 weeks. As shown, this level of activity is superior to that of an IRAK4 kinase inhibitor or the clinically active latest generation IMiD compound.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 28. KT-413 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">In vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> xenograft models</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_28.jpg" alt="img254193463_28.jpg" style="width:612px;height:233px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 29 highlights the unique PK/PD properties of KT-413 that result in protracted tumor exposure and robust knockdown of the targets for at least 72 hours, committing tumor cells to apoptosis that leads to tumor regressions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 29. Super Anti-Tumor Activity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_29.jpg" alt="img254193463_29.jpg" style="width:598px;height:272px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to the robust single agent antitumor effects of KT-413, Figure 30 summarizes the combination data with agents used in the treatment of lymphoma. In these experiments conducted in MYD88 mutant DLBCL models, sub-optimal doses of KT-413 combined with ibrutinib (BTK) venetoclax (BCL-2 inhibitor), or rituximab (Rituxan, an anti-CD-20 monoclonal antibody), showed deep and durable regressions highlighting the potential of KT-413 combination to be used in earlier lines of therapy in patients with MYD88 mutant lymphoma.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 30. KT-413 Combination therapy</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_30.jpg" alt="img254193463_30.jpg" style="width:672px;height:180px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Studies and Data</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	In 2022, we initiated our Phase 1 clinical trial of KT-413 to evaluate the safety, tolerability, PK/PD and clinical activity of KT-413 administered as an intravenous, or IV, infusion once every 3 weeks to adult patients with relapsed and/or refractory B-cell non-Hodgkin&#x2019;s lymphomas. Figure 31 below shows the details of the trial design.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 31: KT-413 Phase 1 Clinical Trial Design</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_31.jpg" alt="img254193463_31.jpg" style="width:672px;height:317px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2022, we announced that dose level 1 (0.16 mg/kg) and dose level 2 (0.32 mg/kg) were completed. Patients in both dose cohorts were heavily pretreated, having received multiple prior lines of therapy, and included follicular lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma, which were both wild-type for MYD88. Plasma PK and PD translated as we expected in humans with dose level 1 and dose level 2 showing dose-dependent degradation of IRAK4, Ikaros and Aiolos in PBMC, with up to 95/100% knockdown of Ikaros/Aiolos and 40% knockdown of IRAK4 in dose level 2 as summarized below in Figure 32.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 32: Target Degradation in PBMC by FLOW</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_32.jpg" alt="img254193463_32.jpg" style="width:545px;height:386px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 33 highlights that serial tumor biopsies at Cycle 3/Day 4 in the patient treated at dose level 1 showed comparable knockdown of Ikaros/Aiolos and IRAK4 as in plasma.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 33: Target Knockdown in Tumor by Targeted MS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_33.jpg" alt="img254193463_33.jpg" style="width:378px;height:311px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were no dose limiting toxicities or treatment-related serious adverse events and no neutropenia observed in dose level 1 and dose level 2 patient cohorts.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Development Plan</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Phase 1a dose escalation portion of the trial is ongoing. We currently anticipate dose levels 3 and 4 to be clinically active doses, and we plan to provide additional clinical data in 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">STAT3 Degrader for Cancer and Autoimmune/Fibrotic Diseases</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Summary</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing our selective STAT3 degraders for the treatment of hematological malignancies and solid tumors, as well as autoimmune diseases and fibrosis. STAT3 is a transcription factor activated through a variety of different cytokine and growth factor receptors via JAKs, as well as through oncogenic fusion proteins and mutations in STAT3 itself. We believe the diverse functions of STAT3 in tumor biology, evasion of immune surveillance by tumor cells, and inflammation and fibrosis provide opportunities to address a wide variety of high unmet need disease indications through the targeting of a single genetically and clinically validated pathway. While the JAK-STAT pathway has been partially addressed with several clinically successful JAK-targeting agents, we believe there are currently no drugs that specifically affect STAT3 broadly across all the relevant cell types. Small molecule STAT3 dimerization inhibitors targeting the SH2 domain have been in development, but significant challenges remain: first, homology of SH2 domains among all STAT family members impacts the ability to achieve specificity for STAT3, and second, inability to block dimerization independent transcriptional activities of STAT3. For these reasons, we believe that STAT3 degraders may provide a transformative solution to develop targeted and specific drugs to address multiple STAT3 dependent pathologies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2022, our STAT3 degrader, KT-333, was granted its second orphan drug designation by the FDA for the treatment of cutaneous T-cell lymphoma, following its orphan drug designation for peripheral T-cell lymphoma, earlier that year. We are currently evaluating KT-333 in a Phase 1 clinical trial in patients with relapsed/refractory liquid and solid tumors, including aggressive lymphomas. Patient enrollment and dosing are ongoing in the Phase 1a portion of the trial, and we expect to provide additional clinical data in 2023.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Biology and Mechanism of Action of STAT3 Degrader</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">STAT3 (signal transducer and activator of transcription 3) is a transcription factor and a member of the STAT protein family. In response to cytokines and growth factors, STAT3 is phosphorylated by receptor-associated serine/threonine kinases, and phosphorylated STAT3, or p-STAT3, then forms dimers that translocate into the nucleus, bind to DNA, and regulate transcription of a wide variety of genes involved in oncogenesis, inflammation and fibrosis. STAT3 is frequently mutated and activated in numerous cancers, including clinically aggressive hematologic malignancies with high unmet medical need. Mechanistically, aberrant activation of STAT3 has been directly linked to the promotion of cancer cell survival, proliferation, and metastasis. In addition, STAT3 regulates the crosstalk between tumor, stroma, and immune cells to promote an immunosuppressive tumor microenvironment. STAT3 activation by IL-6 and TGF-&#xdf; is also involved in the pathogenesis of autoimmunity and fibrosis. These various roles of STAT3 in disease pathogenesis make it an attractive target for drug development in cancer and autoimmune and fibrotic diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Differentiation from JAK and IL-6 Inhibitors</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Small molecule inhibitors against JAK family kinases, such as JAK1, JAK2, JAK3, and TYK2, have been approved for the treatment of autoimmune diseases such as RA, psoriatic arthritis, and ulcerative colitis and target the JAK2/STAT5 pathway. In oncology, JAK inhibitors have been approved for hematological malignancies with mutations leading to activation of the JAK2/STAT5 pathway, including primary myelofibrosis and polycythemia vera, and for acute graft versus host disease. JAK inhibitors block signaling of a number of cytokines and growth factors and reduce activation not only of STAT3 but also STAT1 and STAT5 in response to these stimuli. For modulating anti-tumor effects, this broad activity may have conflicting consequences. In particular, the inhibition of STAT1 activity dampens anti-tumor immune responses by cytolytic T cells and antigen presenting cells, thereby counteracting a productive immune response that could be achieved by inhibition of STAT3 alone. As a result, JAK inhibitors have not shown clinical activity in cancer beyond the myeloproliferative neoplasms. The broad activity of JAK inhibitors is also associated with class-specific adverse effects. By targeting STAT3 selectively, these immunosuppressive and safety liabilities associated with broader STAT1 and STAT5 inhibition through JAK inhibition may be avoided while also effectively addressing JAK-dependent and independent activation of STAT3.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Monoclonal antibodies directed against pro-inflammatory cytokines such as IL-6 or their receptors IL-6R have also been approved for select autoimmune diseases. However, autoimmune and fibrotic diseases and certain cancers are often regulated</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">by multiple cytokines. As such, targeting STAT3 has the potential to be more effective since it is involved in signaling by not just IL-6, but also by TGF-&#xdf; and cytokines such as IL-12, IL-2 and IL-15. Consequently, targeting STAT3 directly has the potential to block multiple signaling pathways that converge on STAT3 and reverse pathological processes that contribute to a tumor-permissive microenvironment.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Development Opportunities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The multiple effects of a STAT3 degrader on oncogenesis, tumor cell resistance to tyrosine kinase inhibitors and chemotherapy, and evasion of immune surveillance provide multiple development opportunities in hematologic malignancies and solid tumors. Additionally, the role of STAT3 in chronic inflammation and fibrosis, as also observed in patients with germline STAT3 gain-of-function mutations, informs opportunities in autoimmune and fibrotic diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Hematologic Malignancies</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Oncogenic STAT3 mutations and/or STAT3 pathway activations are highly common in peripheral T-cell lymphoma, or PTCL and cutaneous T-cell lymphoma, or CTCL. PTCL has an estimated prevalence of approximately 40,000 patients in the major global markets and CTCL has an estimated prevalence of approximately 100,000 patients across the major global markets. STAT3 mutations and pathway activations along with responsiveness of PTCL subsets and CTCL to immune checkpoint inhibitors point to a dependency on STAT3 in these indications and therefore the opportunity to develop a STAT3 degrader as a monotherapy. The standard of care for first-line treatment of PTCL is the combination of brentuximab vedotin, a CD30-directed antibody-drug conjugate, and chemotherapy. The majority of PTCL patients, including ALK-ALCL, PTCL-Not Otherwise Specified, AITL and NK/T lymphoma subtypes, eventually progress and die of their disease. For patients with refractory/relapsed disease, current treatment options are limited and approved therapies pralatrexate and romidepsin have shown limited efficacy. High prevalence of STAT3 mutations (approximately 13-38%) and STAT3 pathway activation (up to 90%) is found in these refractory/relapsed PTCL subsets with high unmet need. Given the documented effect of STAT3 downregulation on levels of programmed death-ligand 1, or PD-L1, we expect our STAT3 degrader to have a dual effect in these patients. In CTCL patients with advanced stage disease and the highest levels of STAT3 activation, there are no curative therapies and no standard of care. Antibody-drug conjugates, HDAC inhibitors, and immune checkpoint inhibitors have some activity and are used upfront or in refractory/relapsed patients, but there remains a high unmet need for an effective therapeutic with both tumor-intrinsic as well as immunomodulatory antitumor effects.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">STAT3 pathway activation is also present in virtually all patients with T- and NK-cell large granular lymphocytic leukemia, and up to 70% of patients have oncogenic STAT3 mutations. These findings are highly indicative of STAT3 dependency, which is further supported by the preliminary clinical activity of JAK inhibitors in these patients. STAT3 activation is also commonly observed in AML and in DLBCL even though STAT3 mutations are infrequent. PD-L1 overexpression in DLBCL has been linked to worse disease outcomes and responses to anti-PD-1/PD-L1 drugs have been reported in these patients. Given STAT3 has downstream impact on PD-1/PD-L1, we believe that a STAT3 degrader has the potential to achieve profound clinical effects both as a monotherapy and in combination with other active drugs.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Solid Tumors</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cancers that are responsive to anti-PD-1/PD-L1 immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs), including non-small cell lung cancer, or NSCLC, head and neck squamous cell carcinoma, or HNSCC, breast cancer and colorectal cancer, are compelling development opportunities due to the established role of STAT3 in solid tumor resistance to ICIs and TKIs. Specifically, STAT3 degraders have the potential to improve responses upfront in combination with these modalities or overcome acquired resistance as add-on therapy in second line.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Autoimmune and Fibrotic Diseases</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patients with rare germline STAT3 gain-of-function mutations develop multiple autoimmune and fibrotic diseases, including systemic sclerosis, or SSc, AD, interstitial lung disease, enteropathies, and RA. We believe these manifestations, and their response to JAK inhibitors, provide support for STAT3 degrader development in immunology and inflammation. There are numerous publications that highlight the role of STAT3-mediated IL-6 and TGF-&#xdf; signaling in the pathogenesis of SSc, idiopathic pulmonary fibrosis, or IPF, Crohn&#x2019;s disease, and multiple sclerosis. There remains a high unmet need for drugs that can target both the inflammation and fibrosis in SSc, IPF and other diseases that cause Progressive Fibrosing Interstitial Lung Disease (PF-ILD) and halt or reverse disease progression. A STAT3 degrader has the potential for this dual effect and could therefore provide a transformative approach to treating PF-ILD as well as Crohn&#x2019;s disease and RA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preclinical Studies and Data</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 34 shows the selectivity of our STAT3 degrader as evidenced by proteomic analysis demonstrating that at KT-333 concentrations 10-fold greater than the DC95, STAT3 is the only protein to be degraded among over 10,000 proteins evaluated including other closely related STAT family members.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 34. Change in Protein Levels</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_34.jpg" alt="img254193463_34.jpg" style="width:309px;height:333px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The in vivo activity of KT-333 is summarized in Figure 35, which shows weekly administration resulting in robust antitumor activity with full regressions that are durable in animals bearing STAT3-dependent T cell lymphomas. These regressions were associated with &gt;90% STAT3 knockdown in tumors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 35. KT-333 In vivo activity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_35.jpg" alt="img254193463_35.jpg" style="width:504px;height:276px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While KT-333 single agent leads to profound anti-tumor activity, based on the role of STAT3 in the tumor microenvironment, additional studies were undertaken to explore the potential immune effects of STAT3 degraders on tumors. Figure 36 summarizes results from a mouse syngeneic colorectal cancer model, in which a STAT3 degrader resulted in an IFN-gamma-dependent gene expression signature that has previously been identified as a predictor of response in cancer patients treated with pembrolizumab. These findings are consistent with STAT3&#x2019;s role in remodeling the tumor microenvironment and provide the rationale for combining STAT3 degraders with immune checkpoint inhibitors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 36. Mouse Syngeneic Colorectal Cancer Model</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_36.jpg" alt="img254193463_36.jpg" style="width:672px;height:212px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As shown in Figure 37, a mouse syngeneic CT-26 colorectal cancer model, the addition of KT-333 augmented the activity of a PD-1 inhibitor in a syngeneic mouse model of colorectal cancer (CT-26), resulting in complete regressions in a majority of animals. Furthermore, in the combination group, there was no tumor growth when re-challenged one month after last dose, suggesting development of long-term immune memory. In addition to causing tumor regressions, the combination extended survival relative to either PD-1 inhibitor or STAT3 degrader alone. Collectively, we believe these data suggest that the addition of STAT3 degraders could significantly augment the clinical efficacy of immune checkpoint inhibitors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 37. STAT3 Degradation and Anti-PD-1 Synergy</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_37.jpg" alt="img254193463_37.jpg" style="width:672px;height:256px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Studies and Data</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In 2022, we initiated our Phase 1 clinical trial of KT-333 to evaluate the safety, tolerability, PK/PD and clinical activity of KT-333 dosed weekly on Days 1, 8 and 15 of 28-day cycles in adult patients with relapsed and/or refractory lymphomas, leukemias and solid tumors. Figure 38 below shows the details of the trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 38: KT-333 Phase 1 Clinical Trial Design</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_38.jpg" alt="img254193463_38.jpg" style="width:672px;height:312px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2022 we announced that dose level 1 (0.05 mg/kg) had been completed with a total of four patients enrolled. All patients were heavily pretreated with multiple prior lines of therapy and included three patients with solid tumors and one patient with cutaneous T-cell lymphoma. As summarized in Figure 39, plasma PK and PD translated as we expected in humans with mean maximum STAT3 degradation in PBMC following the first 2 doses averaging 66%, with maximum STAT3 knockdown of up to 86% as measured by mass spectrometry.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 39: Clinical Pharmacodynamics in Peripheral Blood Mononuclear Cells by Mass Spectrometry</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_39.jpg" alt="img254193463_39.jpg" style="width:672px;height:273px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were no dose limiting toxicities or treatment-related serious adverse events observed in dose level 1.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Development Plans</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Phase 1a dose escalation portion of the trial is ongoing. We currently anticipate dose levels 3 and 4 to be clinically active doses, and we expect to provide additional clinical data in 2023.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preclinical Studies and Data in Autoimmunity</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following figures summarize the results of multiple preclinical experiments demonstrating robust antifibrotic and anti-inflammatory activity of STAT3 degraders in mouse models of systemic scleroderma, arthritis, and CNS inflammation. In the Tight Skin model, shown in Figure 40, a spontaneous TGF beta dependent model of fibrosis that is representative of scleroderma, STAT3 degradation resulted in significant reduction in skin thickening and completely inhibited myofibroblast contraction in an in vitro gel contraction assay.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 40. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">In Vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> tight Skin Model (Fibrosis)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_40.jpg" alt="img254193463_40.jpg" style="width:274px;height:256px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the Collagen Induced Arthritis (CIA) model, which is a prototypical model of RA, as shown in Figure 41, STAT3 degradation reduced the clinical signs of disease in a dose dependent manner. The effect of STAT3 degrader is also reflected by the significant reduction in pathology scores and periosteal bone growth.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 41. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">In Vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> CIA Model (RA)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_41.jpg" alt="img254193463_41.jpg" style="width:661px;height:291px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 42 illustrates the effect of STAT3 degradation in the Experimental Autoimmune Encephalomyelitis (or EAE) model representative of MS. In this model STAT3 degradation not only had a profound effect on severity of disease but also greatly reduced the incidence of disease and delayed onset of encephalomyelitis in the animals.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 42. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">In Vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> MS Model</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><img src="img254193463_42.jpg" alt="img254193463_42.jpg" style="width:672px;height:293px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collectively, these findings highlight the pleiotropic effects of STAT3 degraders in fibrosis and inflammation, demonstrating the potential for this approach across a broad spectrum of autoimmune diseases.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">MDM2</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Summary</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing degraders that target MDM2 for the treatment of solid tumors and hematological malignancies. MDM2 is the crucial regulator of the most common tumor suppressor, p53, which remains intact (or wild type) in more than 50% of cancers. Unlike small molecule inhibitors, our MDM2 degrader, KT-253, has been shown preclinically to have the ability to overcome the MDM2 feedback loop and rapidly induce apoptosis, even with brief exposures. In December 2022, we announced that we received clearance from the FDA for our IND for KT-253. We plan to initiate a Phase 1 clinical trial of KT-253 in early 2023, which is designed to evaluate the safety, tolerability, PK/PD and clinical activity of KT-253 in adult patients with liquid and solid tumors.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Target Rational and Mechanism of Action</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MDM2 is the major E3 ligase which controls the tumor suppressor p53. p53 is functional in close to 50% of cancers, both liquid and solid, and many p53 functional cell lines are dependent on MDM2 overexpression for p53 suppression and survival. Stabilization and upregulation of p53 by removal of MDM2 by degradation can cause cells to undergo cell death and/or cell cycle arrest. While MDM2 small molecule inhibitors have shown clinical activity in a variety of tumor types, the activity has been limited as a result of the inhibition of MDM2 leading to a feedback loop, as shown in Figure 43. This feedback loop results in upregulation of MDM2 protein expression, which in turn makes it more difficult for occupancy-driven small molecules to inhibit MDM2. As a result, small molecule inhibitors have had a more modest effect on p53 upregulation which often leads to cell cycle arrest rather than apoptosis, thereby limiting the efficacy of MDM2/p53 small molecule inhibitors. This feedback loop also necessitates more chronic exposure to drug to maintain modest MDM2 inhibition in tumors, potentially leading to toxic effects on normal cells that limits the safety and tolerability of these inhibitors. Degraders have the potential to overcome the MDM2 feedback loop by completely removing the protein in a catalytic manner. This enables the development of highly potent drugs that are able to induce strong p53 upregulation and an irreversible acute apoptotic response in tumor cells with just brief exposures, thereby maximizing efficacy and improving the safety profile by allowing time for the recovery of normal cells.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 43. MDM2 Feedback Loop</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_43.jpg" alt="img254193463_43.jpg" style="width:394px;height:346px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preclinical Data</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KT-253 is designed as a potent and selective degrader of MDM2. Figure 44 displays the sub-nanomolar potency of KT-253 as compared to a small molecule inhibitor currently in clinical trials.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 44. KT-253 Sub-nanomolar Potency</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_44.jpg" alt="img254193463_44.jpg" style="width:428px;height:355px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We observed increased p53 stabilization over small molecule inhibitors, as shown in Figure 45.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 45. p53 Stabilization</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><img src="img254193463_45.jpg" alt="img254193463_45.jpg" style="width:357px;height:268px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result, we believe KT-253 has potential to have stark potency differences versus the inhibitors in cell killing assays in p53 wild type Acute Lymphocytic Leukemia, as shown in Figure 46.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 46. Tumor cell killing (pM range)</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><img src="img254193463_46.jpg" alt="img254193463_46.jpg" style="width:356px;height:363px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As shown in Figure 47, KT-253 is 200-fold more potent in the RS4-11 Acute Lymphocytic Leukemia cell line compared to what has been published, to date, on the most potent MDM2 small molecule in the clinic (DS-3032).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 47. KT-253 Potency in the RS4-11 Acute Lymphocytic Leukemia cell line</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_47.jpg" alt="img254193463_47.jpg" style="width:672px;height:90px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe the potency of KT-253 relative to a MDM2 small molecule inhibitor is the result of its ability to overcome the feedback up-regulation of MDM2, as shown below in Figure 48.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 48. Degrader Overcomes MDM2 Feedback Loop</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><img src="img254193463_48.jpg" alt="img254193463_48.jpg" style="width:672px;height:180px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 49 illustrates that with a single low dose at 1mg/kg, KT-253 induces PD markers of MDM2 inhibition, including brisk p53 upregulation and acute apoptotic readouts such as PUMA. This single low dose sends the established tumor model into deep regression for weeks, while also allowing time for recovery of any normal cells affected. Clinically equivalent exposures of small molecules have not been observed to have significant in vivo activity in this xenograft model.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 49. KT-253 PD markers</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_49.jpg" alt="img254193463_49.jpg" style="width:672px;height:256px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 50 shows that a single dose of KT-253 at 1mg/kg, Q3W achieves in vivo tumor regression in the CTG-2227 AML patient-derived xenograft (PDX) model as measured by reduction of human CD45+ cells in the bone marrow and AML blats in whole blood.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 50. KT-253 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">In Vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> tumor regression</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_50.jpg" alt="img254193463_50.jpg" style="width:631px;height:423px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 51 shows that KT-253 administered once every three weeks in combination with the AML standard of care agent, venetoclax, was more active than either compound alone in the MOLM13 AML CDX model, resulting in sustained tumor regression.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 51. Strong Single Agent and Combinatorial Activity<br /> in Venetoclax Resistant AML Models<br /><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_51.jpg" alt="img254193463_51.jpg" style="width:617px;height:226px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 52 illustrates MDM2 dependency is seen across a large subset of tumor types as shown on the left by genetically knocking out MDM2 across a panel of cell lines and on the right, showing effects on cell lines by pharmacologically removing MDM2 with a degrader. KT-253 shows marked superiority over the SMI DS-3032 in the panel of Acute Lymphocytic Leukemia (ALL), AML, DLBCL and Uveal melanoma cells.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 52. MDM2 Dependency</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_52.jpg" alt="img254193463_52.jpg" style="width:672px;height:309px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Development Opportunities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The large numbers of p53wt cell lines dependent on MDM2, as depicted in Figure 52 above on the left blue, gives a high-level view of the potential breadth of opportunities in oncology for a potent and well tolerated agent for this pathway. These tumor cell types include but are not limited to cancers which have amplification and over expression of MDM2. De-stabilization of p53 by MDM2 enables cells to survive by blocking both cell cycle arrest and apoptosis. While the opportunities are very diverse, we plan to focus our development efforts on tumors which are most susceptible to the acute apoptotic response elicited by our degraders, where we believe we will be able to achieve the greatest therapeutic index and efficacy. Our initial disease areas of interest are AML, Uveal melanoma and lymphomas, in addition to other solid tumors indications where preclinically we see that MDM2 degradation leads to an acute apoptotic response predictive of clinical activity with intermittent dosing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Development Plans</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2022, we announced we received FDA clearance of our IND to evaluate KT-253 and we expect to initiate our Phase 1 trial in solid tumors and hematologic malignancies in early 2023. We have identified AML as an initial hematologic indication for development based on strong pre-clinical KT-253 activity. Preclinical data also support potential development in other hematologic indications, such as ALL and NHL, as well as in select sensitive solid tumors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Platform</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our proprietary drug discovery platform, Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, enables us to rationally design targeted protein degraders that have the potential to drug all target classes in the cell. Our approach is rooted in an understanding of the relationship between E3 ubiquitin ligases and target proteins, which allows us to identify the properties that make a target both ligandable and degradable, and determine how multiple factors impact potency, selectivity, PK and PD. Key components of our platform include our E3 ligase toolbox, our understanding of degradation across healthy and diseased tissue types, our proprietary chemistry and our Center for Molecular Glue Discovery.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have developed a proprietary human whole body E3 Atlas for mapping expression patterns of all known human E3 ubiquitin ligases in both healthy and disease contexts by combining the power of quantitative, high-resolution proteomics with proprietary algorithms. We are refining the characterization of the expression profiles in healthy and diseased tissues of well-established liganded E3 ligases such as cereblon and VHL and, more importantly, of other naturally occurring E3 ligases, which remain unliganded to date. We have established subcellular localization indices for each E3 ligase and  are determining their</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">absolute abundances. We believe our approach is designed to overcome the limitations of relying on publicly available RNA or antibody-based protein expression datasets, which often lead to inaccuracies in determining relative E3 ligase expression levels in different biological contexts.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our proprietary E3 Ligase Whole-Body Atlas enables data-driven, disease-selective protein degradation strategies based on all of the mapped E3 ligases, which we view as a paradigm shift from relying on the limited number of E3 ligases typically exploited for TPD and provides us with a distinct competitive advantage. Using comparative analyses of expression patterns, we can identify selective pairings of E3 ubiquitin ligases with therapeutic targets of interest, including tissue-selective or tissue-restrictive pairings. We believe this approach is central to building out a toolbox of differentiated E3 ubiquitin ligase binders. Furthermore, we are able to use our custom-built Quantitative Systems Pharmacology Models in combination with proprietary data to understand the absolute abundance of E3 ligases and protein targets to predict cellular efficacy. Figure 53 below shows an example of diverse expression profiles, using circle size as a relative abundance measure, for E3 ligases and selected targets across a panel of healthy tissues (on the x-axis), taken from our proprietary E3 Ligase Whole-Body Atlas.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 53. Novel E3 Ligases to Drug a New Generation of Targets</span></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><img src="img254193463_53.jpg" alt="img254193463_53.jpg" style="width:587px;height:465px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As an example of our work in this area, we have identified a tissue-selective E3 ubiquitin ligase that we believe, based on a comprehensive analysis using both proteomics and transcriptomics, is localized to a specific cell type, our target cell, and is not expressed in several other cell types. We believe this profile may allow for the selective degradation of a protein only in our target cells. We have fully characterized this novel tissue selective ligase and, through hit-finding campaigns, have identified unique chemical matter which has affinity for this E3 ligase below 1 uM. We have also shown productive ternary complex formation against the identified therapeutic target. Figure 54 illustrates, on the left, the tissue-selective expression of the E3 ligase and, on the right, the binding affinity of the lead compound and ternary complex formation with the target protein of interest.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 54. Tissue-selective expression and binding affinity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_54.jpg" alt="img254193463_54.jpg" style="width:672px;height:327px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also developing targeted protein degraders directed against a well-validated and high-value oncology target that has known on-target heme toxicity. Utilizing our discovery platform, we have identified an E3 ligase that has very low expression in the target cell responsible for this toxicity, as illustrated in Figure 55 below in the Western Blot analysis.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 55. Western Blot analysis</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><img src="img254193463_55.jpg" alt="img254193463_55.jpg" style="width:378px;height:365px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have developed novel degraders for this oncology target that have demonstrated potent degradation of target type, as shown in the top panel of Figure 56. As illustrated in the middle panel, we have also shown that our degrader does not degrade</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the target in the key blood cell type. Additionally, as shown in the bottom panel, when comparing this novel degrader, versus a well-known small molecule inhibitor, we were able to show that the degrader allows these blood cells to survive while the small molecule inhibitor led to substantial cell death. This is the first in vivo proof-of-concept of selectively degrading this target while avoiding known on target heme toxicity, which we believe is a significant advance that demonstrates the capabilities of our platform.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 56. Degrader profile</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><img src="img254193463_56.jpg" alt="img254193463_56.jpg" style="width:361px;height:363px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As illustrated below in Figure 57, we utilize a broad range of hit finding approaches to develop small molecules against our selected targets. Specifically, we use virtual screening and artificial intelligence enabled iteration to characterize the binding pocket of target proteins and E3 ligases, to evaluate ligandability and to find small molecule ligands. We also use high content screening such as DNA-encoded libraries (DEL), Affinity Selection Mass Spectrometry (ASMS) or traditional high throughput screening (HTS). We use Fragment Based Screening (FBS) and covalent screening for more targeted approaches where protein topology is understood. We also utilize X-ray and cryoEM capabilities to enable not only hit finding, but also ternary complex optimization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 57. Hit finding approaches</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><img src="img254193463_57.jpg" alt="img254193463_57.jpg" style="width:539px;height:239px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As illustrated in Figure 58 below, our proprietary chemistry approach utilizes ternary complex modelling, which leverages cloud computing to evaluate millions of compounds with the objective to design both an optimal linker and to identify the correct vectors to enable efficient binding of both an E3 ligase ligand and protein ligand. We use molecular chameleonicity to accurately design and predict ADME and PK profiles of these complex molecules which is critical to designing molecules with high oral bioavailability. Our experienced chemistry and computational chemistry teams utilize artificial intelligence driven insights to understand those design parameters driving clearance, permeability and efflux.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 58. Proprietary chemistry approach</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><img src="img254193463_58.jpg" alt="img254193463_58.jpg" style="width:557px;height:246px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also utilize a mechanistic modelling process to predict accurately both human PK and PD from preclinical data, an example of which is illustrated in Figure 59. We first applied an indirect PK/PD response model to describe the mechanism of action of TPD. We then accounted for the biodistribution of drug to target tissue and used an Emax exposure-response model to describe the mechanism of action of TPD. A preclinical PK/PD study was conducted in dog to understand the kinetics of protein degradation in tissues at different dose levels, with data used to estimate in vivo degradation potency and protein turnover rate in the target tissue. We then &#x201c;humanize&#x201d; the PK/PD model by applying human PK parameters, adjusting for species&#x2019; differences in potency and protein turnover rate, if necessary, to predict protein degradation in the clinic. As shown in the far right of Figure 59, the model accurately predicted human PD, as measured by predicted IRAK4 reduction, using preclinical PK/PD animal data (orange) to predict human PK/PD data in (blue).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 59. Modeling Approach</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_59.jpg" alt="img254193463_59.jpg" style="width:672px;height:227px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Center for Molecular Glue Discovery is focused on identifying novel E3 ligases, beyond cereblon, that enable the design of molecules that target undrugged and un-ligandable proteins through small molecule interactions. Molecular glues, rather than requiring a defined binding pocket on the undruggable target, leverage a weak preexisting interaction between an E3 ligase and an unligandable protein of interest.&#x202f;Through binding of the molecular glue to the E3 ligase, the protein-protein interaction interface of the E3 ligase is remodeled, leading to enhanced interaction of the two proteins, thus facilitating degradation. Our approach is to move beyond the traditional approach of molecular glues, which mostly utilize cereblon/IMiD based molecular glues. We have established strategic partnerships to advance our molecular glue initiatives. Our work with these groups is focused on identifying and characterizing novel E3 ligase/substrate pairs for molecular glue interactions that exploit natural affinity augmented with small molecules. We are utilizing genetic screening, structural insights, and pathway and computational biology to identify novel matched pairs of E3 ligases and high value undrugged targets.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recently announced the discovery of a novel degron interaction for a target that we believe is undrugged and not ligandable. This finding has led to the identification and characterization of a highly selective novel molecular glue of an &#x2018;undruggable&#x2019; transcription factor, and to the initiation of multiple molecular glue discovery programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Programs</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our focus on key undrugged or inadequately drugged nodes within therapeutically validated pathways combined with the target and disease agnostic features of our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform gives us opportunity to develop new therapies across various therapeutic areas. We are taking advantage of our proprietary E3 Ligase Whole-Body Atlas on the differential expression profile of E3 ligases to pursue targets that can benefit from potentially tissue-restricted degradation as well as programs that can be enabled by novel molecular glue mechanisms. Our early pipeline includes programs in genetically defined oncology and immunology indications. Through our Vertex collaboration, we are engaged in the discovery of additional targets that are able to fully leverage our aforementioned capabilities and expand our impact across several diseases outside of oncology and immunology.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Collaborations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Master Collaboration Agreement with Vertex Pharmaceuticals Incorporated</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On May 9, 2019, we entered into a collaboration agreement with Vertex, focused on the research and development of our small molecule targeted protein degraders against multiple targets in disease areas outside our core strategic focus. The collaboration leverages our expertise in targeted protein degradation and our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform as well as Vertex&#x2019;s scientific, clinical, and regulatory capabilities to accelerate the development of medicines for people with serious diseases. We refer to this agreement as the Vertex Agreement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the Vertex Agreement, we conduct research activities in multiple targets pursuant to an agreed-upon research plan. Upon designation of a clinical development candidate, Vertex has the option to exclusively license molecules against the designated target. We are eligible to receive an aggregate of up to $170 million in potential payments per licensing product based upon the successful achievement of specified research, development, regulatory and commercial milestones, as</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">well as option exercise payments, for up to six (6) programs optioned by Vertex for licensing as part of the collaboration. No milestones have been achieved to date under the Vertex Agreement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, Vertex will pay low single-digit royalties on future net sales on any products that may result from the commercialization of the licensed molecules. Vertex&#x2019;s royalty obligations are on a product-by-product and country-by-country basis and are subject to certain reductions, including (i) in the event that the exploitation of a product is not covered by a valid claim with the licensed patent rights and (ii) in the event of third parties achieving specifically negotiated levels of competitive market share. Such royalty obligations will expire on a country-by-country and product-by-product basis upon the later of (a) the expiration of the last patent which covers a product in such country, (b) the expiration of any exclusivity granted by a regulatory authority and (c) 10 years following the first commercial sale of a product in such country. No additional payments have been made by Vertex under the Vertex Agreement to date.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As initial consideration for the collaboration, Vertex paid us $70 million upfront including an equity investment in us through the purchase of 3,059,695 shares of our Series B-1 preferred stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the Vertex Agreement, the parties established a joint advisory committee, or JAC. The JAC will, among other responsibilities, review and oversee, certain strategic activities performed under the Vertex Agreement, including reviewing the research plan and budget for the research activities and reviewing the research activities performed by each party.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The initial research term of the collaboration is four years, extendable for an additional one-year period upon mutual agreement by the parties and payment by Vertex of certain per-target fees.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Vertex Agreement may be terminated by Vertex either in its entirety or on a target-by-target basis, upon prior written notice to Kymera. Either party may terminate the collaboration agreement upon the other party&#x2019;s material breach, subject to specified notice and cure provisions, or upon the bankruptcy, insolvency, dissolution or winding up of the other party. Kymera also has the right to terminate the agreement with respect to a certain target upon 30 days&#x2019; prior written notice in the event that Vertex ceases all research, development and commercialization activities related to such target for a certain period of time, provided that the cessation is not the result of events outside of Vertex&#x2019;s control.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Collaboration Agreement with Genzyme Corporation</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 7, 2020, we entered into a collaboration agreement, or the Original Sanofi Agreement, with Genzyme Corporation, a subsidiary of Sanofi, to co-develop drug candidates directed to two biological targets. The Original Sanofi Agreement became effective during the third quarter of 2020.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On November 15, 2022, we entered into an Amended and Restated Collaboration and License Agreement with Sanofi, or the Amended Sanofi Agreement, which amended the Original Sanofi Agreement to revise certain research terms and responsibilities set forth under the Original Sanofi Agreement. The Amended Sanofi Agreement also specifies details around the timing and number of Phase 2 trials required under the terms of the collaboration. The Amended Sanofi Agreement became effective on December 5, 2022. The Original Sanofi Agreement, as amended by the Amended Sanofi Agreement, is referred to herein as the Sanofi Agreement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the Sanofi Agreement, Kymera grants to Sanofi a worldwide exclusive license to develop, manufacture and commercialize certain lead compounds generated during the collaboration directed against IRAK4 and one additional undisclosed target in an undisclosed field of use. Such license is exercisable on a collaboration target-by-collaboration target basis only after a specified milestone. For compounds directed against IRAK4, the field of use includes diagnosis, treatment, cure, mitigation or prevention of any diseases, disorders or conditions, excluding oncology and immune-oncology.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the Sanofi Agreement, with respect to both targets we are responsible for discovery and preclinical research and conducting a phase 1 clinical trial for at least one degrader directed against IRAK4 plus up to three back up degraders, the costs of which will be borne by us, except in certain circumstances. With respect to both targets, Sanofi is responsible for development, manufacturing, and commercialization of product candidates after a specified development milestone occurs with respect to each collaboration candidate.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, pursuant to the Sanofi Agreement, Sanofi will grant to us an exclusive option, or Opt-In Right, exercisable, at our sole discretion, on a collaboration target-by-collaboration target basis that will include the right to (i) fund 50% of the United States development costs for collaboration products directed against such target in the applicable field of use and (ii) share equally in the net profits and net losses of commercializing collaboration products directed against such target in the applicable field of use in the United States. In addition, if we exercise our Opt-In Right, Sanofi will grant to us an exclusive</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">option, applicable to each collaboration target, which upon exercise will allow us to conduct certain co-promotion activities in the field in the United States.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In consideration for the exclusive licenses granted to Sanofi under the Sanofi Agreement, Sanofi paid to us an upfront payment of $150.0 million. In addition to the upfront payment, we will also be eligible to receive certain development milestone payments of up to $1.48 billion in the aggregate, of which more than $1.0 billion relates to the IRAK4 program, upon the achievement of certain developmental or regulatory events. We will also be eligible to receive certain commercial milestone payments up to $700.0 million in the aggregate, of which $400.0 million relates to the IRAK4 program, which are payable upon the achievement of certain net sales thresholds. We will further be eligible to receive tiered royalties for each program on net sales ranging from the high single digits to high teens, subject to low-single digits upward adjustments in certain circumstances.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Sanofi Agreement, unless earlier terminated, will expire on a product-by-product basis on the date of expiration of all payment obligations under the Sanofi Agreement with respect to such product. We or Sanofi may terminate the agreement upon the other party&#x2019;s material breach or insolvency or for certain patent challenges. In addition, Sanofi may terminate the agreement for convenience or for a material safety event upon advance prior written notice, and we may terminate the agreement with respect to any collaboration candidate if, following Sanofi&#x2019;s assumption of responsibility for the development, commercialization or manufacturing of collaboration candidates with respect to a particular target, Sanofi ceases to exploit any collaboration candidates directed to such target for a specified period.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, on December 2, 2022, Sanofi provided us with written notice of its intention to advance the collaboration target 1 candidate, KT-474, into Phase 2 clinical trials. We are entitled to receive milestone payments upon the dosing of the first patient(s) in Phase 2 studies per indication up to a specified number of indications as further set forth in the Sanofi Agreement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Manufacturing / Supply Chain</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not own or operate manufacturing facilities for the production of our drug candidates and currently have no plans to build our own clinical or commercial scale manufacturing capabilities. We currently engage with third-party contract manufacturing organizations, or CMOs, for the manufacture of our drug candidates for preclinical studies, and we intend to continue to do so in the future. We rely on and expect to continue to rely on third-party manufacturers for the production of both drug substance and finished drug product. We have engaged third-party manufacturers to supply the drug substances for our drug candidates and a third-party manufacturer to develop and manufacture finished drug products that we are using in our clinical trials. We currently obtain our supplies from these manufacturers on a purchase order basis and do not have long-term supply arrangements in place. Should any of these manufacturers become unavailable to us for any reason, we believe that there are a number of potential replacements, although we may incur some delay in identifying and qualifying such replacements.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All of our drug candidates are organic compounds of low molecular weight, generally called small molecules, but which are larger than traditional small molecule therapeutics. We have selected these compounds not only on the basis of their potential efficacy and safety, but also because we anticipate an ease of synthesis and cost of goods. We have produced drug substances and drug products for use in our clinical trials and continue to refine our production processes. The drug substance and drug product processes are amenable to scale-up and do not require unusual equipment in the manufacturing process. To adequately meet our needs for late-stage clinical and commercial manufacturing, our suppliers will need to scale their production, or we will need to secure alternate suppliers.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Competition</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The biotechnology industry is extremely competitive in the race to develop new products. While we believe we have significant competitive advantages with our years of expertise in targeted protein degradation, clinical development expertise, and intellectual property position, we currently face and will continue to face competition for our development programs from companies that use targeted protein degradation or targeted protein degradation development platforms, and from companies focused on more traditional therapeutic modalities such as small molecules and antibodies. The competition is likely to come from multiple sources, including larger pharmaceutical companies, biotechnology companies, and academia.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competitors in our efforts to develop small molecule protein degraders therapies for patients, include, but are not limited to, Arvinas, Inc., C4 Therapeutics, Inc., Nurix Therapeutics, Inc., and Foghorn Therapeutics, Inc. Further, several large pharmaceutical companies have disclosed preclinical investments in this field. Our competitors will also include companies that are or will be developing other targeted protein degradation methods as well as small molecule, antibody, or gene therapies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for the same indications that we are targeting. In addition to the competitors we face in developing small molecule protein degraders, we will also face competition in the indications we expect to pursue with our IRAK4, IRAKIMiD, STAT3, and MDM2 programs. Many of these indications already have approved standards of care which may include more traditional therapeutic modalities. In order to compete effectively with these existing therapies, we will need to demonstrate that our protein degrader therapies are favorable to existing therapeutics.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Intellectual Property</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our success depends in part on our ability to secure intellectual property protection for our product candidates and future products, as well as our platform protein degradation technologies and any other relevant inventions and improvements that are considered commercially important to our business. Our success also depends on our ability to defend and enforce our intellectual property rights, preserve the confidentiality of our proprietary information, and operate without infringing, misappropriating or otherwise violating the valid and enforceable patents and proprietary rights of third parties.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As with other biotechnology and pharmaceutical companies, our ability to secure and maintain intellectual property protection for our product candidates, future products, and other proprietary technologies will depend on our success in obtaining effective patent coverage and enforcing those patents if granted. However, we cannot guarantee that our pending patent applications, and any patent applications that we may in the future file, will result in the issuance of patents, or that any issued patents we may obtain will provide sufficient proprietary protection from competitors. Any issued patents that we obtain may be challenged, invalidated, or circumvented by third parties.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to patents, we also rely on trade secrets, know-how and continuing technological innovation to develop and maintain our competitive position. We seek to protect our proprietary technology, in part, through confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors and potential collaborators.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent Portfolio</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our intellectual property includes a portfolio of wholly owned patent families covering our platform E3 ligase ligand technology and our novel bifunctional degrader product candidates, including claims to compositions of matter, pharmaceutical compositions, methods of use, methods of treatment, and other related compounds and methods. Our intellectual property portfolio is in its very early stages, and, as of January 20, 2023, included nine granted U.S. patents, about 101 U.S. patent applications, about 20 international patent applications, and about 259 foreign patent applications. Our patent portfolio is generally organized into two categories: (1) platform E3 ligase ligand patent families and (2) protein degrader patent families, including various target-specific degrader patent families.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Platform E3 Ligase Ligand Patent Families</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our platform E3 ligase ligand patent families are wholly owned and include four patent families directed to novel ligands for the cereblon E3 ubiquitin ligase, as well as methods of treatment and other related methods. As of January 20, 2023, our platform E3 ligase ligand patent families included three granted U.S. patents, four U.S. patent applications, and three patent applications in Europe. Any U.S. or foreign patents resulting from these applications, if granted and all appropriate maintenance fees paid, are expected to expire between 2038 and 2040, absent any patent term adjustments or extensions.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Protein Degrader Patent Families</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our protein degrader patent families are wholly owned and are directed to novel bifunctional degrader compounds that are useful in affecting ubiquitination of a target protein, as well as methods of treatment and other related methods. As of January 20, 2023, our protein degrader patent families included one granted U.S. patent, seven U.S. patent applications and about 14 foreign patent applications filed in foreign jurisdictions, such as Australia, Canada, Europe, Israel, Japan, Mexico, New Zealand, and the Russian Federation. Any U.S. or foreign patents resulting from these applications, if granted and all appropriate maintenance fees paid, are expected to expire between 2038 and 2043, absent any patent term adjustments or extensions.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Target-Specific Degrader Patent Families</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our target-specific degrader patent families are wholly owned and focus protection around degrader compounds that are designed to target specific proteins for degradation, as well as methods of treatment and other related methods. Such targets include, for example, IRAK (interleukin-1 receptor-associated kinases) and STAT (signal transducers and activators of transcription). As of January 20, 2023, our target-specific degrader patent families included five granted U.S. patents, about 84</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. patent applications, about 20 international patent applications, and about 241 patent applications filed in foreign jurisdictions, such as Australia, Brazil, Canada, China, Eurasia, Europe, Israel, India, Japan, Mexico, New Zealand, Singapore, South Africa, and Taiwan. Any U.S. or foreign patents resulting from our target-specific degrader patent families, if granted and all appropriate maintenance fees paid, are expected to expire between 2038 and 2044, absent any patent term adjustments or extensions.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">IRAK-Specific Patent Families</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our IRAK-specific patent families are wholly owned and include patent families covering degrader compounds that are designed to specifically target IRAK for degradation and patent families covering novel IRAK ligands. As of January 20, 2023, our IRAK-specific patent families included four granted U.S. patents, about 34 U.S. patent applications, about 9 international patent applications, and about 158 patent applications filed in foreign jurisdictions, such as Australia, Argentina, Brazil, Canada, China, Europe, Eurasia, Gulf Cooperation Council, Israel, India, Japan, Mexico, New Zealand, Singapore, South Africa, and Taiwan. Any U.S. or foreign patents resulting from our IRAK-specific patent families, if granted and all appropriate maintenance fees paid, are expected to expire between 2038 and 2044, absent any patent term adjustments or extensions.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">With respect to the KT-474 product candidate, as of January 20, 2023, we own one granted U.S. patent, 15 pending U.S. patent applications, three pending international patent applications, and about 81 patent applications filed in foreign jurisdictions, such as Australia, Brazil, Canada, China, Europe, Israel, India, Japan, South Korea, Mexico, New Zealand, Singapore, South Africa, and Taiwan, each with claims directed to compositions of matter covering KT-474 and/or methods of making or using KT-474. Any U.S. or foreign patents resulting from these patent families, if granted and all appropriate maintenance fees paid, are expected to expire between 2039 and 2044, absent any patent term adjustments or extensions.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">STAT-Specific Patent Families</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our STAT-specific patent families are wholly owned and focus on degrader compounds that are designed to specifically target signal transducers and activators of transcription (STAT) for degradation. As of January 20, 2023, our STAT-specific patent families included one granted U.S. patent, 14 U.S. patent applications, two international patent applications, and about 33 patent applications filed in foreign jurisdictions, such as Australia, Canada, China, Eurasia, Europe, India, Israel, Japan, South Korea, Mexico, and Taiwan. Any U.S. or foreign patents resulting from our STAT-specific patent families, if granted and all appropriate maintenance fees paid, are expected to expire between 2040 and 2044, absent any patent term adjustments or extensions.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Target-Specific Patent Families</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of January 20, 2023, we own about 36 U.S. patent applications,  nine international patent applications and about 50 patent applications filed in Australia, Argentina, Brazil, Canada, China, Europe, Gulf Cooperation Council, Israel, India, Japan, Mexico, New Zealand, Singapore, South Africa, and Taiwan which focus on degrader compounds designed to specifically target other proteins. Any U.S. or foreign patents resulting from these patent families, if granted and all appropriate maintenance fees paid, are expected to expire between 2040 and 2044, absent any patent term adjustments or extensions.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The term of individual patents may vary based on the countries in which they are obtained. Generally, patents issued from applications filed in the United States are effective for 20 years from the earliest effective non-provisional filing date. In certain cases, a patent term can be extended to recapture a portion of the term effectively lost as a result of the FDA regulatory review period. The Hatch-Waxman Act permits a patent term extension of up to five years beyond the expiration of the patent, though the total patent term, including any extension, must not exceed 14 years following FDA approval. A patent can only be extended once, such that, if a single patent is applicable to multiple products, it can only be extended based on one product.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The duration of patents outside of the United States varies in accordance with provisions of applicable local law, but typically is also 20 years from the earliest effective national filing date.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Similar patent term extension provisions are available in Europe and other foreign jurisdictions to extend the term of a patent covering an approved drug. When possible, we expect to apply for patent term extensions for patents covering our product candidates and their methods of use.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Trademarks</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We intend to file applications for trademark registrations in connection with our product candidates and other technologies in various jurisdictions, including the United States.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have applied to register both the KYMERA mark and the KYMERA THERAPEUTICS mark in the United States, Europe, and Canada. We also filed applications in the same jurisdictions for the mark IRAKIMiD, for pharmaceutical and medical preparations and therapeutics, as well as diagnostic reagents, for the treatment of oncology, autoimmune, immune-oncology and other related diseases. In addition, we filed applications for E3 HUMAN ATLAS and E3 LIGASE WHOLE BODY ATLAS in connection with pharmaceutical research and development and drug development and discovery services.  All of our European Union trademarks in existence as of December 31, 2020 were automatically cloned onto the United Kingdom register due to &#x201c;Brexit.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Most recently, we filed an application for our K &amp; Design mark in the United States, and we plan to file European Union, United Kingdom, and Canada applications based on our U.S. priority date in that application in due course.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government Regulation</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA and other regulatory authorities at federal, state and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring and post-approval reporting of drugs. We, along with our vendors, contract research organizations and contract manufacturers, will be required to navigate the various preclinical, clinical, manufacturing and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval of our product candidates. The process of obtaining regulatory approvals of drugs and ensuring subsequent compliance with appropriate federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., the FDA regulates drug products under the Federal Food, Drug, and Cosmetic Act, or FD&amp;C Act, as amended, its implementing regulations and other laws. If we fail to comply with applicable FDA or other requirements at any time with respect to product development, clinical testing, approval or any other legal requirements relating to product manufacture, processing, handling, storage, quality control, safety, marketing, advertising, promotion, packaging, labeling, export, import, distribution, or sale, we may become subject to administrative or judicial sanctions or other legal consequences. These sanctions or consequences could include, among other things, the FDA&#x2019;s refusal to approve pending applications, issuance of clinical holds for ongoing studies, suspension or revocation of approved applications, warning or untitled letters, product withdrawals or recalls, product seizures, relabeling or repackaging, total or partial suspensions of manufacturing or distribution, injunctions, fines, civil penalties or criminal prosecution.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The process required by the FDA before our product candidates are approved as drugs for therapeutic indications and may be marketed in the U.S. generally involves the following:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">completion of extensive preclinical studies in accordance with applicable regulations, including studies conducted in accordance with good laboratory practice, or GLP, requirements;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">completion of the manufacture, under current Good Manufacturing Practices, or cGMP, conditions, of the drug substance and drug product that the sponsor intends to use in human clinical trials along with required analytical and stability testing; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">submission to the FDA of an IND application, which must become effective before clinical trials may begin;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">approval by an institutional review board, or IRB, or independent ethics committee at each clinical trial site before each trial may be initiated;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">performance of adequate and well-controlled clinical trials in accordance with applicable IND regulations, good clinical practice, or GCP, requirements and other clinical trial-related regulations to establish the safety and efficacy of the investigational product for each proposed indication;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">submission to the FDA of a NDA;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a determination by the FDA within 60 days of its receipt of an NDA, to accept the filing for review;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">satisfactory completion of one or more FDA pre-approval inspections of the manufacturing facility or facilities where the drug will be produced to assess compliance with cGMP requirements to assure that the facilities, methods and controls are adequate to preserve the drug&#x2019;s identity, strength, quality and purity;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential FDA audit of the clinical trial sites that generated the data in support of the NDA;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">payment of user fees for FDA review of the NDA; and</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA review and approval of the NDA, including consideration of the views of any FDA advisory committee, prior to any commercial marketing or sale of the drug in the U.S.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preclinical Studies and Clinical Trials for Drugs</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Before testing any drug in humans, the product candidate must undergo rigorous preclinical testing. Preclinical studies include laboratory evaluations of drug chemistry, formulation and stability, as well as in vitro and animal studies to assess safety and in some cases to establish the rationale for therapeutic use. The conduct of preclinical studies is subject to federal and state regulations and requirements, including GLP requirements for safety/toxicology studies. The results of the preclinical studies, together with manufacturing information and analytical data must be submitted to the FDA as part of an IND. An IND is a request for authorization from the FDA to administer an investigational product to humans and must become effective before clinical trials may begin. Some long-term preclinical testing may continue after the IND is submitted. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA, within the 30-day time period, raises concerns or questions about the conduct of the clinical trial, including concerns that human research patients will be exposed to unreasonable health risks, and imposes a full or partial clinical hold. FDA must notify the sponsor of the grounds for the hold and any identified deficiencies must be resolved before the clinical trial can begin. Submission of an IND may result in the FDA not allowing clinical trials to commence or not allowing clinical trials to commence on the terms originally specified in the IND.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The clinical stage of development involves the administration of the product candidate to healthy volunteers or patients under the supervision of qualified investigators, generally physicians not employed by or under the trial sponsor&#x2019;s control, in accordance with GCP requirements, which include the requirements that all research patients provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria and the parameters and criteria to be used in monitoring safety and evaluating effectiveness. Each protocol, and any subsequent amendments to the protocol, must be submitted to the FDA as part of the IND. Furthermore, each clinical trial must be reviewed and approved by an IRB for each institution at which the clinical trial will be conducted to ensure that the risks to individuals participating in the clinical trials are minimized and are reasonable related to the anticipated benefits. The IRB also approves the informed consent form that must be provided to each clinical trial subject or his or her legal representative and must monitor the clinical trial until completed. The FDA, the IRB or the sponsor may suspend or discontinue a clinical trial at any time on various grounds, including a finding that the patients are being exposed to an unacceptable health risk. There also are requirements governing the reporting of ongoing clinical trials and completed clinical trials to public registries. Information about applicable clinical trials, including clinical trial results, must be submitted within specific timeframes for publication on the www.clinicaltrials.gov website.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A sponsor who wishes to conduct a clinical trial outside of the United States may, but need not, obtain FDA authorization to conduct the clinical trial under an IND. If a foreign clinical trial is not conducted under an IND, FDA will nevertheless accept the results of the study in support of an NDA if the study was conducted in accordance with GCP requirements, and the FDA is able to validate the data through an onsite inspection if deemed necessary.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical trials to evaluate therapeutic indications to support NDAs for marketing approval are typically conducted in three sequential phases, which may overlap.</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Phase</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Phase 1 clinical trials involve initial introduction of the investigational product into healthy human volunteers or patients with the target disease or condition. These studies are typically designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans, excretion the side effects associated with increasing doses, and, if possible, to gain early evidence of effectiveness.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Phase</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Phase 2 clinical trials typically involve administration of the investigational product to a limited patient population with a specified disease or condition to evaluate the drug&#x2019;s potential efficacy, to determine the optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Phase</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Phase 3 clinical trials typically involve administration of the investigational product to an expanded patient population to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval and physician labeling.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2022, the FDA released a final guidance entitled &#x201c;Expansion Cohorts: Use in First-In-Human Clinical Trials to Expedite Development of Oncology Drugs and Biologics,&#x201d; which outlines how drug developers can utilize an adaptive trial design commonly referred to as a seamless trial design in early stages of oncology drug development (i.e., the first-in-human clinical trial) to compress the traditional three phases of trials into one continuous trial called an expansion cohort trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Information to support the design of individual expansion cohorts are included in IND applications and assessed by FDA. Expansion cohort trials can potentially bring efficiency to drug development and reduce development costs and time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-approval trials, sometimes referred to as Phase 4 clinical trials or post-marketing studies, may be conducted after initial marketing approval. These trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication and are commonly intended to generate additional safety data regarding use of the product in a clinical setting. In certain instances, the FDA may mandate the performance of Phase 4 clinical trials as a condition of approval of an NDA.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Progress reports detailing the results of the clinical trials, among other information, must be submitted at least annually to the FDA. Written IND safety reports must be submitted to the FDA and the investigators fifteen days after the trial sponsor determines the information qualifies for reporting for serious and unexpected suspected adverse events, findings from other studies or animal or in vitro testing that suggest a significant risk for human volunteers and any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor must also notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction as soon as possible but in no case later than seven calendar days after the sponsor&#x2019;s initial receipt of the information.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Concurrent with clinical trials, companies usually complete additional animal studies and must also develop additional information about the chemistry and physical characteristics of the product candidate and finalize a process for manufacturing the drug product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and manufacturers must develop, among other things, methods for testing the identity, strength, quality and purity of the final drug product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">U.S. Marketing Approval for Drugs</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assuming successful completion of the required clinical testing, the results of the preclinical studies and clinical trials, together with detailed information relating to the product&#x2019;s chemistry, manufacture, controls and proposed labeling, among other things, are submitted to the FDA as part of an NDA requesting approval to market the product for one or more indications. An NDA is a request for approval to market a new drug for one or more specified indications and must contain proof of the drug&#x2019;s safety and efficacy for the requested indications. The marketing application is required to include both negative and ambiguous results of preclinical studies and clinical trials, as well as positive findings. Data may come from company-sponsored clinical trials intended to test the safety and efficacy of a product&#x2019;s use or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and efficacy of the investigational product to the satisfaction of the FDA. FDA approval of an NDA must be obtained before a drug may be marketed in the U.S.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA reviews all submitted NDAs before it accepts them for filing and may request additional information rather than accepting the NDA for filing. The FDA must make a decision on accepting an NDA for filing within 60 days of receipt, and such decision could include a refusal to file by the FDA. Once the submission is accepted for filing, the FDA begins an in-depth substantive review of the NDA. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective for the indications sought and whether the facility in which it is manufactured, processed, packaged or held meets standards designed to assure the product&#x2019;s continued safety, quality and purity. Under the goals and polices agreed to by the FDA under the Prescription Drug User Fee Act, or PDUFA, the FDA targets ten months, from the filing date, in which to complete its initial review of a new molecular entity NDA and respond to the applicant, and six months from the filing date of a new molecular entity NDA for priority review. The FDA does not always meet its PDUFA goal dates for standard or priority NDAs, and the review process is often extended by FDA requests for additional information or clarification.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, under PDUFA, as amended, each NDA must be accompanied by a user fee. The FDA adjusts the PDUFA user fees on an annual basis. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a non-orphan indication.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA also may require submission of a Risk Evaluation and Mitigation Strategy, or REMS, program if it believes that a risk evaluation and mitigation strategy is necessary to ensure that the benefits of the drug outweigh its risks. The REMS program could include use of risk evaluation and mitigation strategies like medication guides, physician communication plans, assessment plans and/or elements to assure safe use, such as restricted distribution methods, patient registries or other risk-minimization tools.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA may refer an application for a novel drug to an advisory committee. An advisory committee is a panel of independent experts, including clinicians and other scientific experts, which reviews, evaluates and provides a recommendation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Before approving an NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA, the FDA may inspect one or more clinical trial sites to assure compliance with GCP and other requirements and the integrity of the clinical data submitted to the FDA.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After evaluating the NDA and all related information, including the advisory committee recommendation, if any, and inspection reports regarding the manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a complete response letter. A complete response letter generally contains a statement of specific conditions that must be met in order to secure final approval of the NDA and may require additional clinical or preclinical testing in order for the FDA to reconsider the application. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#x2019;s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if the FDA approves a product, depending on the specific risk(s) to be addressed it may limit the approved indications for use of the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase 4 clinical trials, be conducted to further assess a drug&#x2019;s safety after approval, require testing and surveillance programs to monitor the product after commercialization or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a REMS, which can materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes and additional labeling claims, are subject to further testing requirements and FDA review and approval.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Orphan Drug Designation and Exclusivity</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the Orphan Drug Act of 1983, the FDA may grant orphan designation to a drug intended to treat a rare disease or condition, which is a disease or condition that affects fewer than 200,000 individuals in the U.S., or if it affects more than 200,000 individuals in the U.S., there is no reasonable expectation that the cost of developing and making the product available in the U.S. for the disease or condition will be recovered from sales of the product. Orphan designation must be requested before submitting an NDA. Orphan designation does not convey any advantage in or shorten the duration of the regulatory review and approval process, though companies developing orphan products are eligible for certain incentives, including tax credits for qualified clinical testing and waiver of application fees.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If a product that has orphan designation subsequently receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to a seven-year period of marketing exclusivity during which the FDA may not approve any other applications to market the same therapeutic agent for the same indication, except in limited circumstances, such as a subsequent product&#x2019;s showing of clinical superiority over the product with orphan exclusivity or where the original applicant cannot produce sufficient quantities of product. Competitors, however, may receive approval of different therapeutic agents for the indication for which the orphan product has exclusivity or obtain approval for the same therapeutic agent for a different indication than that for which the orphan product has exclusivity. Orphan product exclusivity could block the approval of one of our products for seven years if a competitor obtains approval for the same therapeutic agent for the same indication before we do, unless we are able to demonstrate that our product is clinically superior. If an orphan designated product receives marketing approval for an indication broader than what is designated, it may not be entitled to orphan exclusivity. Further, orphan drug exclusive marketing rights in the U.S. may be lost if the FDA later determines that the request for designation was materially defective or the manufacturer of the approved product is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September of 2022, KT-333, Kymera&#x2019;s STAT3 degrader in development for relapsed and/or refractory lymphomas and solid tumors, was granted its second orphan drug designation by the U.S. Food and Drug Administration for the treatment of cutaneous T-cell lymphoma (CTCL), following its orphan drug designation for peripheral T-cell lymphoma (PTCL) in June of 2022. These designations provide incentives to encourage the development of medicines for rare diseases.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Expedited Development and Review Programs for Drugs</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA maintains several programs intended to facilitate and expedite development and review of new drugs to address unmet medical needs in the treatment of serious or life-threatening diseases or conditions. These programs include Fast Track designation, Breakthrough Therapy designation, Priority Review, Accelerated Approval and platform technology designation and the purpose of these programs is to either expedite the development or review of important new drugs to get them to patients earlier than under standard FDA development and review procedures.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A new drug is eligible for Fast Track designation if it is intended to treat a serious or life-threatening disease or condition and demonstrates the potential to address unmet medical needs for such disease or condition. Fast Track designation provides increased opportunities for sponsor interactions with the FDA during preclinical and clinical development, in addition to the potential for rolling review once a marketing application is filed, meaning that the agency may review portions of the marketing application before the sponsor submits the complete application, as well as Priority Review, discussed below.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, a new drug may be eligible for Breakthrough Therapy designation if it is intended to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Breakthrough Therapy designation provides all the features of Fast Track designation in addition to intensive guidance on an efficient drug development program beginning as early as Phase 1, and FDA organizational commitment to expedited development, including involvement of senior managers and experienced review staff in a cross-disciplinary review, where appropriate.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any product submitted to the FDA for approval, including a product with Fast Track or Breakthrough Therapy designation, may also be eligible for additional FDA programs intended to expedite the review and approval process, including Priority Review designation and Accelerated Approval. A product is eligible for Priority Review if it has the potential to provide a significant improvement in safety or effectiveness in the treatment, diagnosis or prevention of a serious disease or condition. Under priority review, the FDA must review an application in six months compared to ten months for a standard review.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, products are eligible for Accelerated Approval if they can be shown to have an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or an effect on a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality which is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity or prevalence of the condition and the availability or lack of alternative treatments.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accelerated Approval is usually contingent on a sponsor&#x2019;s agreement to conduct additional post-approval studies to verify and describe the product&#x2019;s clinical benefit and, under the Food and Drug Omnibus Reform Act of 2022, or FDORA, the FDA is now permitted to require, as appropriate, that such trials be underway prior to approval or within a specific time period after the date of approval for a product granted accelerated approval. Under FDORA, the FDA has increased authority for expedited procedures to withdraw approval of a drug or indication approved under Accelerated Approval if, for example, the confirmatory trial fails to verify the predicted clinical benefit of the product. In addition, for products being considered for accelerated approval, the FDA generally requires, unless otherwise informed by the Agency, that all advertising and promotional materials that are intended for dissemination or publication within 120 days following marketing approval be submitted to the agency for review during the pre-approval review period, and that after 120 days following marketing approval, all advertising and promotional materials must be submitted at least 30 days prior to the intended time of initial dissemination or publication.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under FDORA, a platform technology incorporated within or utilized by a drug or biological product is eligible for designation as a designated platform technology if (1) the platform technology is incorporated in, or utilized by, a drug approved under an NDA; (2) preliminary evidence submitted by the sponsor of the approved or licensed drug, or a sponsor that has been granted a right of reference to data submitted in the application for such drug, demonstrates that the platform technology has the potential to be incorporated in, or utilized by, more than one drug without an adverse effect on quality, manufacturing, or safety; and (3) data or information submitted by the applicable person indicates that incorporation or utilization of the platform technology has a reasonable likelihood to bring significant efficiencies to the drug development or manufacturing process and to the review process. A sponsor may request the FDA to designate a platform technology as a designated platform technology concurrently with, or at any time after, submission of an IND application for a drug that incorporates or utilizes the platform technology that is the subject of the request. If so designated, the FDA may expedite the development and review of any subsequent original NDA for a drug that uses or incorporates the platform technology.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or the time period for FDA review or approval may not be shortened. Furthermore, Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval do not change the scientific or medical standards for approval or the quality of evidence necessary to support approval but may expedite the development or review process.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pediatric Information and Pediatric Exclusivity</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the Pediatric Research Equity Act, or PREA, as amended, certain NDAs and certain supplements to an NDA must contain data to assess the safety and efficacy of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may grant deferrals for submission of pediatric data or full or partial waivers. The FD&amp;C Act requires that a sponsor who is planning to submit a marketing application for a drug that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration submit an initial Pediatric Study Plan, or PSP, within 60 days of an end-of-Phase 2 meeting or, if there is no such meeting, as early as practicable before the initiation of the Phase 3 or Phase 2/3 trial. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach an agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials and/or other clinical development programs.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A drug can also obtain pediatric market exclusivity in the U.S. Pediatric exclusivity, if granted, adds six months to existing exclusivity periods and patent terms. This six-month exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of a pediatric trial or of multiple pediatric trials in accordance with an FDA-issued &#x201c;Written Request&#x201d; for such trials.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">U.S. Post-Approval Requirements for Drugs</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, tracking and tracing, reporting of adverse experiences with the product, complying with promotion and advertising requirements, which include restrictions on promoting products for unapproved uses or patient populations (known as &#x201c;off-label use&#x201d;) and limitations on industry-sponsored scientific and educational activities. Manufacturers and other parties involved in the drug supply chain for prescription drug products must also comply with product tracking and tracing requirements and for notifying the FDA of counterfeit, diverted, stolen and intentionally adulterated products or products that are otherwise unfit for distribution in the United States. Although physicians may prescribe legally available products for off-label uses, manufacturers and individuals working on behalf of manufacturers may not market or promote such uses. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability, including investigation by federal and state authorities. Prescription drug promotional materials must be submitted to the FDA in conjunction with their first use or first publication. Further, if there are any modifications to the drug, including changes in indications, labeling or manufacturing processes or facilities, the applicant may be required to submit and obtain FDA approval of a new NDA or NDA supplement, which may require the development of additional data or preclinical studies and clinical trials.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-market testing, including Phase 4 clinical trials, and surveillance to further assess and monitor the product&#x2019;s safety and effectiveness after commercialization.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, drug manufacturers and their subcontractors involved in the manufacture and distribution of approved drugs, and those supplying products, ingredients, and components of them, are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with ongoing regulatory requirements, including cGMP, which impose certain procedural and documentation requirements upon us and our contract manufacturers. Failure to comply with statutory and regulatory requirements can subject a manufacturer to possible legal or regulatory action, such as warning letters, suspension of manufacturing, product seizures, injunctions, civil penalties or criminal prosecution. There is also a continuing, annual prescription drug product program user fee.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, requirements for post-market studies or clinical trials to assess new safety risks, or imposition of distribution or other restrictions under a REMS. Other potential consequences include, among other things:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">safety alerts, Dear Healthcare Provider letters, press releases or other communications containing warnings or other safety information about the product;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fines, warning letters or holds on post-approval clinical trials;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">refusal of the FDA to approve applications or supplements to approved applications, or withdrawal of product approvals;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product seizure or detention, or refusal to permit the import or export of products;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs; or mandated modification of promotional materials and labeling and issuance of corrective information.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Regulation of Companion Diagnostics</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Companion diagnostics identify patients who are most likely to benefit from a particular therapeutic product; identify patients likely to be at increased risk for serious side effects as a result of treatment with a particular therapeutic product; or monitor response to treatment with a particular therapeutic product for the purpose of adjusting treatment to achieve improved safety or effectiveness. Companion diagnostics are regulated as medical devices by the FDA. In the U.S., the FD&amp;C Act, and its implementing regulations, and other federal and state statutes and regulations govern, among other things, medical device design and development, preclinical and clinical testing, premarket clearance or approval, registration and listing, manufacturing, labeling, storage, advertising and promotion, sales and distribution, export and import, and post-market surveillance. Unless an exemption or FDA exercise of enforcement discretion applies, diagnostic tests generally require marketing clearance or approval from the FDA prior to commercialization. The two primary types of FDA marketing authorization applicable to a medical device are clearance of a premarket notification, or 510(k), and approval of a premarket approval application, or PMA.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To obtain 510(k) clearance for a medical device, or for certain modifications to devices that have received 510(k) clearance, a manufacturer must submit a premarket notification demonstrating that the proposed device is substantially equivalent to a previously cleared 510(k) device or to a preamendment device that was in commercial distribution before May 28, 1976, or a predicate device, for which the FDA has not yet called for the submission of a PMA. In making a determination that the device is substantially equivalent to a predicate device, the FDA compares the proposed device to the predicate device and assesses whether the subject device is comparable to the predicate device with respect to intended use, technology, design and other features which could affect safety and effectiveness. If the FDA determines that the subject device is substantially equivalent to the predicate device, the subject device may be cleared for marketing. The 510(k) premarket notification pathway generally takes from three to twelve months from the date the application is completed, but can take significantly longer.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A PMA must be supported by valid scientific evidence, which typically requires extensive data, including technical, preclinical, clinical and manufacturing data, to demonstrate to the FDA&#x2019;s satisfaction the safety and effectiveness of the device. For diagnostic tests, a PMA typically includes data regarding analytical and clinical validation studies. As part of its review of the PMA, the FDA will conduct a pre-approval inspection of the manufacturing facility or facilities to ensure compliance with the Quality System Regulation, or QSR, which requires manufacturers to follow design, testing, control, documentation and other quality assurance procedures. The FDA&#x2019;s review of an initial PMA is required by statute to take between six months, although the process typically takes longer, and may require several years to complete. If the FDA evaluations of both the PMA and the manufacturing facilities are favorable, the FDA will either issue an approval letter or an approvable letter, which usually contains a number of conditions that must be met in order to secure the final approval of the PMA. If the FDA&#x2019;s evaluation of the PMA or manufacturing facilities is not favorable, the FDA will deny the approval of the PMA or issue a not approvable letter. A not approvable letter will outline the deficiencies in the application and, where practical, will identify what is necessary to make the PMA approvable. Once granted, PMA approval may be withdrawn by the FDA if compliance with post-approval requirements, conditions of approval or other regulatory standards is not maintained, or problems are identified following initial marketing.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 31, 2014, the FDA issued a final guidance document addressing the development and approval process for &#x201c;In Vitro Companion Diagnostic Devices.&#x201d; According to the guidance document, for novel therapeutic products that depend on the use of a diagnostic test and where the diagnostic device could be essential for the safe and effective use of the corresponding therapeutic product, the premarket application for the companion diagnostic device should be developed and approved or cleared contemporaneously with the therapeutic, although the FDA recognizes that there may be cases when contemporaneous development may not be possible. However, in cases where a drug cannot be used safely or effectively without the companion diagnostic, the FDA&#x2019;s guidance indicates it will generally not approve the drug without the approval or clearance of the diagnostic device. The FDA also issued a draft guidance in July 2016 setting forth the principles for co-development of an in</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">vitro companion diagnostic device with a therapeutic product. The draft guidance describes principles to guide the development and contemporaneous marketing authorization for the therapeutic product and its corresponding in vitro companion diagnostic.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Once cleared or approved, the companion diagnostic device must adhere to post-marketing requirements including the requirements of the FDA&#x2019;s QSR, adverse event reporting, recalls and corrections along with product marketing requirements and limitations. Like drug makers, companion diagnostic makers are subject to unannounced FDA inspections at any time during which the FDA will conduct an audit of the product(s) and our facilities for compliance with its authorities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Regulatory Matters</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing, sales, promotion and other activities of product candidates following product approval, where applicable, or commercialization are also subject to regulation by numerous regulatory authorities in the U.S. in addition to the FDA, which may include the Centers for Medicare &amp; Medicaid Services, or CMS, other divisions of the Department of Health and Human Services, the Department of Justice, the Drug Enforcement Administration, the Consumer Product Safety Commission, the Federal Trade Commission, the Occupational Safety &amp; Health Administration, the Environmental Protection Agency and state and local governments and governmental agencies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Healthcare Laws</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Healthcare providers, physicians, and third-party payors will play a primary role in the recommendation and prescription of any products for which we obtain marketing approval. Our business operations and any current or future arrangements with third-party payors, healthcare providers and physicians may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or financial arrangements and relationships through which we develop, market, sell and distribute any drugs for which we obtain marketing approval. In the United States, these laws include, without limitation, state and federal anti-kickback, false claims, physician transparency, and patient data privacy and security laws and regulations. If our operations are found to be in violation of any of such laws or any other governmental regulations that apply, we may be subject to penalties, including, without limitation, administrative, civil and criminal penalties, damages, fines, disgorgement, the curtailment or restructuring of operations, integrity oversight and reporting obligations, exclusion from participation in federal and state healthcare programs and responsible individuals may be subject to imprisonment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. It is possible that governmental authorities will conclude that our business practices do not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other related governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, imprisonment, disgorgement, exclusion from government funded healthcare programs, such as Medicare and Medicaid, reputational harm, additional oversight and reporting obligations if we become subject to a corporate integrity agreement or similar settlement to resolve allegations of non-compliance with these laws and the curtailment or restructuring of our operations. If any of the physicians or other healthcare providers or entities with whom we expect to do business is found not to be in compliance with applicable laws, they may be subject to similar actions, penalties and sanctions. Ensuring business arrangements comply with applicable healthcare laws, as well as responding to possible investigations by government authorities, can be time- and resource-consuming and can divert a company&#x2019;s attention from its business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Insurance Coverage and Reimbursement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the United States and markets in other countries, patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Thus, even if a product candidate is approved, sales of the product will depend, in part, on the extent to which third-party payors, including government health programs in the United States such as Medicare and Medicaid, commercial health insurers and managed care organizations, provide coverage, and establish adequate reimbursement levels for, the product. In the United States, the principal decisions about reimbursement for new medicines are typically made by the Centers for Medicare &amp; Medicaid Services, or CMS, an agency within the U.S. Department of Health and Human Services. CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare and private payors tend to follow CMS to a substantial degree. No uniform policy of coverage and reimbursement for drug products exists among third-party payors. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. The process for determining whether a third-party payor will provide coverage for a product may be separate from the process for setting the price or reimbursement rate that the payor will pay for the product once coverage is approved. Third-party payors are increasingly challenging the prices charged, examining the medical necessity, reviewing the cost-effectiveness of medical</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">products and services and imposing controls to manage costs. Third-party payors may limit coverage to specific products on an approved list, also known as a formulary, which might not include all of the approved products for a particular indication.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In order to secure coverage and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of the product, which will require additional expenditure above and beyond the costs required to obtain FDA or other comparable regulatory approvals. Additionally, companies may also need to provide discounts to purchasers, private health plans or government healthcare programs. Nonetheless, product candidates may not be considered medically necessary or cost effective. A decision by a third-party payor not to cover a product could reduce physician utilization once the product is approved and have a material adverse effect on sales, our operations and financial condition. Additionally, a third-party payor&#x2019;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#x2019;s determination to provide coverage for a product does not assure that other payors will also provide coverage and reimbursement for the product, and the level of coverage and reimbursement can differ significantly from payor to payor.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The containment of healthcare costs has become a priority of federal, state and foreign governments, and the prices of products have been a focus in this effort. Governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic products. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company&#x2019;s revenue generated from the sale of any approved products. Coverage policies and third-party payor reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which a company or its collaborators receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Current and future healthcare reform legislation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the United States and some foreign jurisdictions, there have been, and likely will continue to be, a number of legislative and regulatory changes and proposed changes regarding the healthcare system directed at broadening the availability of healthcare, improving the quality of healthcare, and containing or lowering the cost of healthcare. For example, in March 2010, the United States Congress enacted the Affordable Care Act, which, among other things, includes changes to the coverage and payment for products under government health care programs. The Affordable Care Act includes provisions of importance to our potential product candidates that:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">created an annual, nondeductible fee on any entity that manufactures or imports specified branded prescription drugs and biologic products, apportioned among these entities according to their market share in certain government healthcare programs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expanded eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to certain individuals with income at or below 133% of the federal poverty level, thereby potentially increasing a manufacturer&#x2019;s Medicaid rebate liability; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expanded manufacturers&#x2019; rebate liability under the Medicaid Drug Rebate Program by increasing the minimum rebate for both branded and generic drugs and revising the definition of &#x201c;average manufacturer price,&#x201d; or AMP, for calculating and reporting Medicaid drug rebates on outpatient prescription drug prices; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expanded the types of entities eligible for the 340B drug discount program; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">established the Medicare Part D coverage gap discount program by requiring manufacturers to provide point-of-sale-discounts off the negotiated price of applicable brand drugs to eligible beneficiaries during their coverage gap period as a condition for the manufacturers&#x2019; outpatient drugs to be covered under Medicare Part D; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since its enactment, there have been numerous judicial, administrative, executive, and legislative challenges to certain aspects of the Affordable Care Act, and we expect there will be additional challenges and amendments to the Affordable Care Act in the future. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court's decision, President Biden issued an Executive Order to initiate a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The Executive Order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how other healthcare reform measures of the Biden administrations or other efforts, if any, to challenge repeal or replace the ACA, will impact our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other legislative changes have been proposed and adopted in the United States since the Affordable Care Act was enacted. In August 2011, the Budget Control Act of 2011, among other things, included aggregate reductions of Medicare payments to providers of 2% per fiscal year, which went into effect in April 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through 2030 unless additional Congressional action is taken. The Coronavirus Aid, Relief and Economic Security Act, or CARES Act, which was signed into law in March 2020 and is designed to provide financial support and resources to individuals and businesses affected by the COVID-19 pandemic, suspended these reductions from May 1, 2020, through March 31, 2022 due to the COVID-19 pandemic. Then, a 1% payment reduction occurred beginning April 1, 2022 through June 30, 2022, and the 2% payment reduction resumed on July 1, 2022. In January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, CMS may develop new payment and delivery models, including bundled payment models. In addition, recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their commercial products, which has resulted in several Congressional inquiries and proposed and enacted state and federal legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for pharmaceutical products. For example, at the federal level, the current administration&#x2019;s budgets for fiscal years 2019 and 2020 contained further drug price control measures that could be enacted in future legislation, including, for example, measures to permit Medicare Part D plans to negotiate the price of certain drugs under Medicare Part B, to allow some states to negotiate drug prices under Medicaid, and to eliminate cost sharing for generic drugs for low-income patients. Additionally, the current administration released a &#x201c;Blueprint&#x201d; to lower drug prices and reduce out of pocket costs of drugs that contains additional proposals to increase drug manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products, and reduce the out-of-pocket costs of drug products paid by consumers. The U.S. Department of Health and Human Services has already started the process of soliciting feedback on some of these measures and, at the same time, is immediately implementing others under its existing authority. For example, in May 2019, CMS issued a final rule to allow Medicare Advantage Plans the option of using step therapy, a type of prior authorization, for Part B drugs beginning January 1, 2020. This final rule codified CMS&#x2019;s policy change that was effective January 1, 2019. Although a number of these and other measures may require additional authorization to become effective, Congress and the current administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs. Individual states in the United States have also increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On May 30, 2018, the Right to Try Act was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational new drug products that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a drug manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2022, the IRA was signed into law. The IRA includes several provisions that may impact our business to varying degrees, including provisions that establish a $2,000 out-of-pocket cap for Medicare Part D beneficiaries, impose new manufacturer financial liability on many drugs reimbursed under Medicare Part D, allow the U.S. government to negotiate Medicare Part B and Part D pricing for certain high-cost drugs and biologics without generic or biosimilar competition, and require companies to pay rebates to Medicare for drug prices that increase faster than inflation. The effect of IRA on our business and the healthcare industry in general is not yet known.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outside the United States, ensuring coverage and adequate payment for a product also involves challenges. Pricing of prescription pharmaceuticals is subject to government control in many countries. Pricing negotiations with government authorities can extend well beyond the receipt of regulatory approval for a product and may require a clinical trial that compares the cost-effectiveness of a product to other available therapies. The conduct of such a clinical trial could be expensive and result in delays in commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the European Union, pricing and reimbursement schemes vary widely from country to country. Some countries provide that products may be marketed only after a reimbursement price has been agreed upon. Some countries may require the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">completion of additional studies that compare the cost-effectiveness of a particular product candidate to currently available therapies or so-called health technology assessments, in order to obtain reimbursement or pricing approval. For example, the European Union provides options for its member states to restrict the range of products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. European Union member states may approve a specific price for a product, or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the product on the market. Other member states allow companies to fix their own prices for products but monitor and control prescription volumes and issue guidance to physicians to limit prescriptions. Recently, many countries in the European Union have increased the amount of discounts required on pharmaceuticals and these efforts could continue as countries attempt to manage healthcare expenditures, especially in light of the severe fiscal and debt crises experienced by many countries in the European Union. The downward pressure on healthcare costs in general, particularly prescription products, has become intense. As a result, increasingly high barriers are being erected to the entry of new products. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various European Union member states, and parallel trade, i.e., arbitrage between low-priced and high-priced member states, can further reduce prices. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any products, if approved in those countries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Compliance with other federal and state laws or requirements; changing legal requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If any products that we may develop are made available to authorized users of the Federal Supply Schedule of the General Services Administration, additional laws and requirements apply. Products must meet applicable child-resistant packaging requirements under the U.S. Poison Prevention Packaging Act. Manufacturing, labeling, packaging, distribution, sales, promotion and other activities also are potentially subject to federal and state consumer protection and unfair competition laws, among other requirements to which we may be subject.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The distribution of pharmaceutical products is subject to additional requirements and regulations, including extensive recordkeeping, licensing, storage and security requirements intended to prevent the unauthorized sale of pharmaceutical products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The failure to comply with any of these laws or regulatory requirements may subject firms to legal or regulatory action. Depending on the circumstances, failure to meet applicable regulatory requirements can result in criminal prosecution, fines or other penalties, injunctions, exclusion from federal healthcare programs, requests for recall, seizure of products, total or partial suspension of production, denial or withdrawal of product approvals, relabeling or repackaging, or refusal to allow a firm to enter into supply contracts, including government contracts. Any claim or action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#x2019;s attention from the operation of our business. Prohibitions or restrictions on marketing, sales or withdrawal of future products marketed by us could materially affect our business in an adverse way.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in regulations, statutes or the interpretation of existing regulations could impact our business in the future by requiring, for example: (i) changes to our manufacturing arrangements; (ii) additions or modifications to product labeling or packaging; (iii) the recall or discontinuation of our products; or (iv) additional recordkeeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other U.S. Environmental, Health and Safety Laws and Regulations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may be subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. From time to time and in the future, our operations may involve the use of hazardous and flammable materials, including chemicals and biological materials, and may also produce hazardous waste products. Even if we contract with third parties for the disposal of these materials and waste products, we cannot completely eliminate the risk of contamination or injury resulting from these materials. In the event of contamination or injury resulting from the use or disposal of our hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain workers&#x2019; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees, but this insurance may not provide adequate coverage against potential liabilities. However, we do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. Current or future environmental laws and regulations may impair our research, development or production efforts. In addition, failure to comply with these laws and regulations may result in substantial fines, penalties or other sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Government Regulation of Drugs Outside of the United States</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To market any product outside of the U.S., we would need to comply with numerous and varying regulatory requirements of other countries regarding safety and efficacy and governing, among other things, clinical trials, marketing authorization or identification of an alternate regulatory pathway, manufacturing, commercial sales and distribution of our products. For instance, in the United Kingdom and the European Economic Area, or the EEA (comprised of the EU Member States plus Iceland, Liechtenstein and Norway), medicinal products must be authorized for marketing by using either the centralized procedure or a national procedure.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Centralized procedure</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;If pursuing marketing authorization of a product candidate for a therapeutic indication under the centralized procedure, following the opining of the European Medicines Agency&#x2019;s Committee for Medicinal Products for Human Use, or CHMP, the European Commission issues a single marketing authorization valid across the EEA. The centralized procedure is compulsory for human medicines derived from biotechnology processes or advanced therapy medicinal products (i.e. gene therapy, somatic cell therapy and tissue engineered products), products that contain a new active substance indicated for the treatment of certain diseases, such as HIV/AIDS, cancer, neurodegenerative disorders, diabetes, autoimmune diseases and other immune dysfunctions, viral diseases, and designated orphan medicinal products. For medicines that do not fall within these categories, an applicant has the option of submitting an application for a centralized marketing authorization to the European Medicines Agency, or EMA, as long as the medicine concerned contains a new active substance not yet authorized in the EU, is a significant therapeutic, scientific or technical innovation, or if its authorization would be in the interest of public health in the EU.  Under the centralized procedure the maximum timeframe for the evaluation of an MAA by the EMA is 210 days, excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the CHMP. Clock stops may extend the timeframe of evaluation of an MAA considerably beyond 210 days. Where the CHMP gives a positive opinion, it provides the opinion together with supporting documentation to the European Commission, who makes the final decision to grant a marketing authorization, which is issued within 67 days of receipt of the EMA&#x2019;s recommendation. Accelerated assessment might be granted by the CHMP in exceptional cases, when a medicinal product is expected to be of a major public health interest, particularly from the point of view of therapeutic innovation. The timeframe for the evaluation of an MAA under the accelerated assessment procedure is 150 days, excluding clock stops, but it is possible that the CHMP can revert to the standard time limit for the centralized procedure if it considers that it is no longer appropriate to conduct an accelerated assessment.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">National procedures</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;There are also two other possible routes to authorize products for therapeutic indications in several countries, which are available for products that fall outside the scope of the centralized procedure:</span></div></div>
  <div style="margin-left:9.065%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.989278055754109%;">o</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Decentralized procedure</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Using the decentralized procedure, an applicant may apply for simultaneous authorization in more than one EU country of medicinal products that have not yet been authorized in any EU country and that do not fall within the mandatory scope of the centralized procedure.</span></div></div>
  <div style="margin-left:9.065%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.989278055754109%;">o</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Mutual recognition procedure</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;In the mutual recognition procedure, a medicine is first authorized in one EU country, in accordance with the national procedures of that country. Following this, additional marketing authorizations can be sought from other EU countries in a procedure whereby the countries concerned recognize the validity of the original, national marketing authorization.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Now that the United Kingdom (which comprises Great Britain and Northern Ireland) has left the European Union, Great Britain is no longer covered by centralized marketing authorizations (under the Northern Ireland Protocol, centralized marketing authorizations will continue to be recognized in Northern Ireland). All medicinal products with a current centralized marketing authorization were automatically converted to Great Britain authorizations on January, 1, 2021. For a period of two years from January 1, 2021, the Medicines and Healthcare products Regulatory Agency, or MHRA, the UK medicines regulator, may rely on a decision taken by the European Commission on the approval of a new marketing authorization  in the centralized procedure, in order to more quickly grant a new Great Britain marketing authorization. A separate application will, however, still be required. The MHRA also has the power to have regard to marketing authorizations approved in EU Member States through decentralized or mutual recognition procedures with a view to more quickly granting a marketing authorization in the United Kingdom or Great Britain.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the EU, innovative medicinal products for therapeutic indications that are authorized for marketing (i.e., reference products) qualify for eight years of data exclusivity and an additional two years of market exclusivity upon marketing authorization. The data exclusivity period prevents generic or biosimilar applicants from referencing the innovator&#x2019;s preclinical and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar marketing authorization in the EU during a period of eight years from the date on which the reference product was first authorized in the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EU. The market exclusivity period prevents a successful generic or biosimilar applicant from commercializing its product in the EU until ten years have elapsed from the initial authorization of the reference product in the EU. The ten-year market exclusivity period can be extended to a maximum of eleven years if, during the first eight years of those ten years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies. There is no guarantee that a product will be considered by the EMA to be an innovative medicinal product, and products may not qualify for data exclusivity. Even if a product is considered to be an innovative medicinal product so that the innovator gains the prescribed period of data exclusivity, another company nevertheless could also market another version of the product if such company obtained marketing authorization based on an MAA with a complete independent data package of pharmaceutical tests, preclinical tests and clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The criteria for designating an &#x201c;orphan medicinal product&#x201d; in the EU are similar in principle to those in the U.S. In the EU a medicinal product may be designated as orphan if: (1) it is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition; (2) either (a) such condition affects no more than five in 10,000 persons in the EU when the application is made, or (b) it is unlikely that the product, without the benefits derived from orphan status, would generate sufficient return in the EU to justify the necessary investment in its development; and (3) there exists no satisfactory method of diagnosis, prevention or treatment of such condition authorized for marketing in the EU or, if such a method exists, the product will be of significant benefit to those affected by that condition. Orphan medicinal products are eligible for financial incentives such as reduction of fees or fee waivers and are, upon grant of a marketing authorization, entitled to ten years of market exclusivity for the approved therapeutic indication. During this ten-year orphan market exclusivity period, no MAA shall be accepted, and no marketing authorization shall be granted for a similar medicinal product for the same therapeutic indication. A &#x201c;similar medicinal product&#x201d; is defined as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal product, and which is intended for the same therapeutic indication. An orphan product can also obtain an additional two years of market exclusivity in the EU where an agreed pediatric investigation plan for pediatric studies has been complied with. No extension to any supplementary protection certificate, or SPC, can be granted on the basis of pediatric studies for orphan indications. The ten-year market exclusivity may be reduced to six years if, at the end of the fifth year, it is established that the product no longer meets the criteria for orphan designation, for example, if the product is sufficiently profitable not to justify maintenance of market exclusivity. Additionally, marketing authorization may be granted to a similar product for the same therapeutic indication at any time if (i) the second applicant can establish that its product, although similar, is safer, more effective or otherwise clinically superior; (ii) the marketing authorization holder for the authorized orphan product consents to a second orphan medicinal product application; or (iii) the marketing authorization holder for the authorized orphan product cannot supply enough orphan medicinal product.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to obtaining a marketing authorization in the EU, applicants must demonstrate compliance with all measures included in an EMA-approved pediatric investigation plan, or PIP, covering all subsets of the pediatric population, unless the EMA has granted a product-specific waiver, a class waiver, or a deferral for one or more of the measures included in the PIP. The respective requirements for all marketing authorization procedures are laid down in Regulation (EC) No 1901/2006, the so-called Pediatric Regulation. This requirement also applies when a company wants to add a new indication, pharmaceutical form or route of administration for a medicine that is already authorized. The Pediatric Committee of the EMA, or PDCO, may grant deferrals for some medicines, allowing a company to delay development of the medicine for children until there is enough information to demonstrate its effectiveness and safety in adults. The PDCO may also grant waivers when development of a medicine for children is not needed or is not appropriate, such as for diseases that only affect the elderly population. Before an MAA can be filed, or an existing marketing authorization can be amended, the EMA determines that companies actually comply with the agreed studies and measures listed in each relevant PIP. If an applicant obtains a marketing authorization in all EU Member States, or a marketing authorization granted in the centralized procedure by the European Commission, and the study results for the pediatric population are included in the product information, even when negative, the medicine is then eligible for an additional six-month period of qualifying patent protection through extension of the term of the SPC, provided an application for such extension is made at the same time as filing the SPC application for the product, or at any point up to 2 years before the SPC expires. In the case of orphan medicinal products, a two year extension of the orphan market exclusivity may be available. This pediatric reward is subject to specific conditions and is not automatically available when data in compliance with the PIP are developed and submitted.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Similar to as in the U.S., the various phases of non-clinical and clinical research in the European Union are subject to significant regulatory controls.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2014, the EU adopted the new Clinical Trials Regulation, (EU) No 536/2014 (Clinical Trials Regulation) which replaced the Clinical Trials Directive 2001/20/EC on January 31, 2022. The Clinical Trials Regulation is directly applicable in all the EU Member States, meaning no national implementing legislation in each EU Member State is required. The extent to which ongoing clinical trials will be governed by the Clinical Trials Regulation will depend on the duration of the individual clinical trial. If a clinical trial continues for more than three years from the day on which the Clinical Trials Regulation became</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">applicable the Clinical Trials Regulation will at that time begin to apply to the clinical trial. The new Clinical Trials Regulation aims to simplify and streamline the approval of clinical trials in the European Union.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The main characteristics of the regulation include: a streamlined application procedure via a single-entry point, the &#x201c;Clinical Trials Information System&#x201d; or CTIS; a single set of documents to be prepared and submitted for the application as well as simplified reporting procedures for clinical trial sponsors; and a harmonized procedure for the assessment of applications for clinical trials, which is divided in two parts. Part I is assessed by coordinated assessment by the competent authorities of all EU Member States in which an application for authorization of a clinical trial has been submitted (Member States concerned) following review by a Reference Member State. Part II is assessed separately by each Member State concerned. Strict deadlines have been established for the assessment of clinical trial applications. The role of the relevant ethics committees in the assessment procedure will continue to be governed by the national law of the concerned EU Member State. However, overall related timelines will be defined by the Clinical Trials Regulation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aforementioned EU rules are generally applicable in the European Economic Area, or EEA, which consists of the EU Member States, plus Norway, Liechtenstein and Iceland.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Government regulation of data collection outside of the United States</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event we conduct clinical trials in the European Union, we will be subject to additional privacy restrictions. The collection and use of personal health data in the EEA is governed by the General Data Protection Regulation, or the GDPR, which became effective on May 25, 2018. The GDPR applies to the processing of personal data by any company established in the EEA and to companies established outside the EEA to the extent they process personal data in connection with the offering of goods or services to data subjects in the EEA or the monitoring of the behavior of data subjects in the EEA. The GDPR enhances data protection obligations for data controllers of personal data, including stringent requirements relating to the consent of data subjects, expanded disclosures about how personal data is used, requirements to conduct privacy impact assessments for &#x201c;high risk&#x201d; processing, limitations on retention of personal data, mandatory data breach notification and &#x201c;privacy by design&#x201d; requirements, and creates direct obligations on service providers acting as processors. The GDPR also imposes strict rules on the transfer of personal data outside of the EEA to countries that do not ensure an adequate level of protection, like the United States. Failure to comply with the requirements of the GDPR and the related national data protection laws of the EEA Member States, which may deviate slightly from the GDPR, may result in fines of up to 4% of a company&#x2019;s global revenues for the preceding financial year, or &#x20ac;20,000,000, whichever is greater. Moreover, the GDPR grants data subjects the right to claim material and non-material damages resulting from infringement of the GDPR. Given the breadth and depth of changes in data protection obligations, maintaining compliance with the GDPR will require significant time, resources and expense, and we may be required to put in place additional controls and processes ensuring compliance with the new data protection rules. There has been limited enforcement of the GDPR to date, particularly in biopharmaceutical development, so we face uncertainty as to the exact interpretation of the new requirements on any future trials and we may be unsuccessful in implementing all measures required by data protection authorities or courts in interpretation of the new law. In addition, further to the United Kingdom&#x2019;s exit from the European Union on January 31, 2020, the GDPR ceased to apply in the United Kingdom at the end of the transition period on December 31, 2020. However, as of January 1, 2021, the United Kingdom&#x2019;s European Union (Withdrawal) Act 2018 incorporated the GDPR (as it existed on December 31, 2020, but subject to certain UK specific amendments) into UK law, referred to as the UK GDPR. The UK GDPR and the UK Data Protection Act 2018 set out the United Kingdom&#x2019;s data protection regime, which is independent from but aligned to the European Union&#x2019;s data protection regime. Non-compliance with the UK GDPR may result in monetary penalties of up to &#163;17.5 million or 4% of worldwide revenue, whichever is higher. Although the UK is regarded as a third country under the European Union&#x2019;s GDPR, the European Commission has now issued a decision recognizing the UK as providing adequate protection under the EU GDPR and, therefore, transfers of personal data originating in the EU to the UK remain unrestricted. Like the EU GDPR, the UK GDPR restricts personal data transfers outside the United Kingdom to countries not regarded by the United Kingdom as providing adequate protection. The UK government has confirmed that personal data transfers from the United Kingdom to the EEA remain free flowing.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is significant uncertainty related to the manner in which data protection authorities will seek to enforce compliance with the GDPR. For example, it is not clear if the authorities will conduct random audits of companies doing business in the EEA, or if the authorities will wait for complaints to be filed by individuals who claim their rights have been violated. Enforcement uncertainty and the costs associated with ensuring GDPR compliance are onerous and may adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Should we utilize third party distributors, compliance with such foreign governmental regulations would generally be the responsibility of such distributors, who may be independent contractors over whom we have limited control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Brexit and the Regulatory Framework in the United Kingdom</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On June 23, 2016, the electorate in the United Kingdom voted in favor of leaving the European Union (commonly referred to as &#x201c;Brexit&#x201d;), and the UK formally left the EU on January 31, 2020. There was a transition period during which EU pharmaceutical laws continued to apply to the UK, which expired on December 31, 2020. However, the EU and the UK have concluded a trade and cooperation agreement, or TCA, which was provisionally applicable since January 1, 2021 and has been formally applicable since May 1, 2021. The TCA includes specific provisions concerning pharmaceuticals, which include the mutual recognition of GMP, inspections of manufacturing facilities for medicinal products and GMP documents issued, but does not foresee wholesale mutual recognition of UK and EU pharmaceutical regulations. At present, Great Britain has implemented EU legislation on the marketing, promotion and sale of medicinal products through the Human Medicines Regulations 2012 (as amended) (under the Northern Ireland Protocol, the EU regulatory framework will continue to apply in Northern Ireland). The regulatory regime in Great Britain therefore largely aligns with current EU regulations, however it is possible that these regimes will diverge in future now that Great Britain&#x2019;s regulatory system is independent from the EU and the TCA does not provide for mutual recognition of UK and EU pharmaceutical legislation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Employees and Human Capital</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had 167 full-time employees, of which 84 have M.D. or Ph.D. degrees. Within our workforce, 134 employees are engaged in research and development and 33 are engaged in business development, finance, legal, and general management and administration. We consider the intellectual capital of our employees to be an essential driver of our business and key to our future prospects. Our workforce expanded during FY22; new employees were hired to support and extend our clinical and preclinical pipeline, with hires in clinical development and operations, research, manufacturing, and general and administrative functions. We expect to continue to add additional employees in 2023 with a focus on expanding increasing expertise and bandwidth in clinical and preclinical research and development. We continually evaluate the business need and opportunity and balance in house expertise and capacity with outsourced expertise and capacity.  Currently, we outsource substantially all clinical trial work to clinical research organizations and certain drug manufacturing to contract manufacturers. Drug development is a complex endeavor which requires deep expertise and experience across a broad array of disciplines.  Pharmaceutical companies, both large and small, compete for a limited number of qualified applicants to fill specialized positions.  We monitor our compensation programs closely and provide what we consider to be a very competitive mix of compensation and insurance benefits for all our employees, as well as participation in our equity programs. To attract qualified applicants, the Company offers a comprehensive benefits package consisting of base salary and cash target bonus, medical and other benefits and equity compensation for every employee.  Bonus opportunity and equity compensation increase as a percentage of total compensation based on level of responsibility. Actual bonus payout is based on performance.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None of our employees is subject to a collective bargaining agreement or represented by a trade or labor union. We consider our relations with our employees to be good.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We support our employees&#x2019; further development with individualized development plans, mentoring, coaching, group training, conference attendance and financial support including tuition reimbursement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Response to COVID-19</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beginning in March 2020, we have supported our employees and government efforts to curb the COVID-19 pandemic through a multifaceted communication, infrastructure, and behavior modification and enforcement effort. Practices that were implemented at different times in 2022 included the following:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Establishing clear and regular COVID-19 policies, safety protocols, and updates to all employees;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Decreasing density and increasing physical distancing in workspaces for employees working onsite by scheduling adjustments and adding work from home flexibility&#x37e;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adjusting attendance policies to encourage those who are sick to stay home&#x37e;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increasing cleaning protocols at our Watertown, MA headquarters&#x37e;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Providing additional personal protective equipment and cleaning supplies&#x37e;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Implementing weekly COVID-19 testing;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Implementing protocols to address actual and suspected COVID-19 cases and potential exposure&#x37e;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prohibiting all domestic and international non-essential travel for all employees&#x37e;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Requiring masks to be worn in all locations.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Facilities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our corporate headquarters are located in Watertown, Massachusetts, where we lease and occupy approximately 34,522 square feet of office and laboratory space. The current term of our Watertown lease expires March 31, 2030, with an option to extend the term five additional years with 12 months&#x2019; notice with rent set at an agreed upon market rate.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On December 20, 2021, we entered into a noncancelable lease for 100,624 square feet of office and laboratory space in Watertown, Massachusetts. This lease has an initial term of 134 months, and we have two consecutive options to extend the term of the lease for five years each at then-market rates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our new facility is expected to be sufficient to meet our current needs. To meet the future needs of our business, we may lease additional or alternate space, and we believe suitable additional or alternative space will be available in the future on commercially reasonable terms.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Corporate Information</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We were incorporated under the laws of Delaware in September 2015 under the name Project HSC, Inc. We are the successor in interest to Kymera Therapeutics, LLC, a limited liability company formed under the laws of the State of Delaware on May 25, 2017 and the former holder of all of our outstanding shares of common stock. Our principal executive offices are located at 200 Arsenal Yards Blvd., Suite 230, Watertown, MA 02472 and our telephone number is (857) 285-5300. Our website address is www.kymeratx.com. References to our website are inactive textual references only and the content of our website should not be deemed incorporated by reference into this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Available Information</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to these reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, are available free of charge on our website located at www.kymeratx.com as soon as reasonably practicable after they are filed with or furnished to the Securities and Exchange Commission, or the SEC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The SEC maintains an Internet website that contains reports, proxy and information statements, and other information regarding us and other issuers that file electronically with the SEC. The SEC&#x2019;s Internet website address is http://www.sec.gov.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A copy of our Corporate Governance Guidelines, Code of Business Conduct and Ethics and the charters of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee are posted on our website, www.kymeratx.com, under &#x201c;Investors&#x201d;.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1A. Ris</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">k Factors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our business involves a high degree of risk. You should carefully consider the material and other risks and uncertainties described and summarized below, as well as the other information in this Annual Report on Form 10-K, including our consolidated financial statements and related notes and the section titled &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; and &#x201c;Special Note Regarding Forward-Looking Statements,&#x201d; before you make an investment decision. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of factors that are described below and elsewhere in this Annual Report on Form 10-K. The risks described below are not the only risks that we face. The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations and prospects. As a result, the market price of our common stock could decline, and you may lose all or part of your investment in our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Financial Position and Need for Additional Capital</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are a biopharmaceutical company with a limited operating history and have not generated any revenue to date from drug sales, and may never become profitable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biopharmaceutical drug development is a highly speculative undertaking and involves a substantial degree of risk. Since our formation in 2015 and our initial funding in 2016, our operations to date have been limited primarily to organizing and staffing our company, business planning, raising capital, researching and developing our drug discovery technology, developing our pipeline, building our intellectual property portfolio, undertaking preclinical studies and conducting Phase 1 clinical trials of our product candidates. We have never generated any revenue from drug sales. We have not obtained regulatory approvals for any of our current product candidates. Typically, it takes many years to develop one new pharmaceutical drug from the time it is discovered to when it is available for treating patients. Consequently, any predictions we make about our future success or viability may not be as accurate as they could be if we had a longer operating history. In addition, as a business with a limited operating history, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors, such as the COVID-19 pandemic. We will need to transition from a company with a research and development focus to a company capable of supporting late-stage development and commercial activities. We may not be successful in such a transition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have incurred significant operating losses since our inception and anticipate that we will incur continued losses for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since inception, we have focused substantially all of our efforts and financial resources on developing our proprietary targeted protein degradation drug discovery platform, or the Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform, and initial product candidates as well as supporting our collaborations and partnerships. To date, we have financed our operations primarily through the issuance and sale of our convertible preferred stock to outside investors and collaborators in private equity financings, upfront payments under our existing collaborations and our initial public offering, follow-on offering and PIPE offering. From our inception through December 31, 2022, we raised an aggregate of approximately $1.03 billion of gross proceeds from such transactions and through our collaborations with Genzyme Corporation, or Sanofi, and Vertex Pharmaceuticals Incorporated, or Vertex. As of December 31, 2022, our cash and cash equivalents and investments were $559.5 million. We have incurred net losses in each year since our inception, and we had an accumulated deficit of $383.8 million as of December 31, 2022. For the years ended December 31, 2022, 2021 and 2020, we reported net losses of $154.8 million, $100.2 million and $45.6 million, respectively. Substantially all of our operating losses have resulted from costs incurred in connection with our research and development programs and from general and administrative costs associated with our operations. We expect to continue to incur significant expenses and increasing operating losses over the next several years and for the foreseeable future. Our prior losses, combined with expected future losses, have had and will continue to have an adverse effect on our stockholders&#x2019; deficit and working capital. We expect our expenses to significantly increase in connection with our ongoing activities, as we:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">initiate and complete preclinical studies and clinical trials for current or future product candidates, including KT-474, KT-413, KT-333 and KT-253; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prepare and submit Investigational New Drug applications, or INDs, with the U.S. Food and Drug Administration, or FDA, for future product candidates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">develop and scale up our capabilities to support our ongoing preclinical activities and clinical trials for our product candidates and commercialization of any of our product candidates for which we may obtain marketing approval; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">secure facilities to support continued growth in our research, development and commercialization efforts;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">advance research and development related activities to expand our product pipeline; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expand and improve the capabilities of our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seek regulatory approval for our product candidates that successfully complete clinical development; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">contract to manufacture our product candidates; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maintain, expand and protect our intellectual property portfolio; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hire additional staff, including clinical, scientific and management personnel; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">incur additional costs associated with continuing to operate as a public company. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, if we obtain marketing approval for our current or future product candidates, we will incur significant expenses relating to sales, marketing, product manufacturing and distribution. Because of the numerous risks and uncertainties associated with developing pharmaceutical drugs, including in light of the ongoing evolution of the COVID-19 pandemic, we are unable to predict the extent of any future losses or when we will become profitable, if at all. Even if we do become profitable, we may not be able to sustain or increase our profitability on a quarterly or annual basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Future Financial Condition</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We will need to raise substantial additional funding. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, scale back or discontinue some of our product candidate development programs or future commercialization efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The development of pharmaceutical drugs is capital-intensive. We have commenced clinical development of KT-474, KT-413, and KT-333, and plan to initiate clinical development of KT-253 this year. We are also currently advancing multiple development candidates through preclinical development across a number of potential indications. We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we continue the research and development of, advance the preclinical and clinical activities of, and seek marketing approval for, our current or future product candidates. In addition, if we obtain marketing approval for any of our current or future product candidates, we expect to incur significant commercialization expenses related to sales, marketing, product manufacturing and distribution to the extent that such sales, marketing, product manufacturing and distribution are not the responsibility of our collaborators. We may also need to raise additional funds sooner if we choose to pursue additional indications and/or geographies for our current or future product candidates or otherwise expand more rapidly than we presently anticipate. Furthermore, we expect to incur additional costs associated with operating as a public company. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, scale back or discontinue the development and commercialization of one or more of our product candidates, and may be unable to expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially affect our business, financial condition and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had approximately $559.5 million of cash and cash equivalents and investments. In August 2020, we completed an IPO of our common stock by issuing 9,987,520 shares of our common stock, including the exercise in full by the underwriters of their option to purchase up to 1,302,720 additional shares of common stock, at a public offering price of $20.00 per share. The aggregate gross proceeds to us from the offering, before deducting underwriting discounts and commissions, and other estimated offering expenses payable by us, were approximately $199.8 million. Concurrent with the IPO, we announced the sale of 676,354 common shares at the public offering price per share in a private placement to Vertex. The aggregate gross proceeds to us from the concurrent private placement were approximately $13.5 million. The concurrent private placement also closed in August 2020. In July 2021, we completed a follow-on offering of our common stock and an additional private placement transaction with Vertex resulting, in the aggregate, in net proceeds of approximately, $243.1 million. In August 2022, we completed a PIPE offering of our common stock and pre-funded warrants resulting in gross proceeds of $150.0 million. We expect that the approximately $559.5 million of cash and cash equivalents and investments at December 31, 2022 will be sufficient to fund our operations into the second half of 2025. We have based this estimate on assumptions that may prove to be wrong, and we could use our capital resources sooner than we currently expect. This estimate also assumes that we do not obtain any additional funding through collaborations or other strategic alliances. Our future capital requirements will depend on, and could increase significantly as a result of, many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, progress, results and costs of drug discovery, preclinical development, laboratory testing and clinical trials for our current or future product candidates, including additional expenses attributable to adjusting our development plans (including any supply related matters) in response to the ongoing COVID-19 pandemic; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, prioritization and number of our research and development programs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs, timing and outcome of regulatory review of our current or future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish and maintain additional collaborations on favorable terms, if at all;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the achievement of milestones or occurrence of other developments that trigger payments under any existing or additional collaboration agreements we obtain; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we are obligated to reimburse, or entitled to reimbursement of, clinical trial costs under future collaboration agreements, if any; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we acquire or in-license other current or future product candidates and technologies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of securing manufacturing arrangements for commercial production; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of establishing or contracting for sales and marketing capabilities if we obtain regulatory clearances to market our current or future product candidates. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Identifying potential product candidates and conducting preclinical studies and clinical trials is a time-consuming, expensive and uncertain process that takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval and achieve drug sales. In addition, our current or future product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of drugs that we do not expect to be commercially available for many years, if at all. Accordingly, we will need to continue to rely on additional funding to achieve our business objectives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize our current or future product candidates. Disruptions in the financial markets in general may make equity and debt financing more difficult to obtain and may have a material adverse effect on our ability to meet our fundraising needs. We cannot guarantee that future financing will be available in sufficient amounts or on terms favorable to us, if at all. Moreover, the terms of any financing may adversely affect the holdings or the rights of our stockholders and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our shares to decline. The sale of additional equity or convertible securities would dilute all of our stockholders. The incurrence of indebtedness would result in increased fixed payment obligations and we may be required to agree to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. We could also be required to seek funds through arrangements with collaborators or otherwise at an earlier stage than otherwise would be desirable and we may be required to relinquish rights to some of our technologies or current or future product candidates or otherwise agree to terms unfavorable to us, any of which may have a material adverse effect on our business, operating results and prospec</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We will continue to incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a public company, we will continue to incur significant legal, accounting and other expenses that we did not incur as a private company. We are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which require, among other things, that we file with the Securities and Exchange Commission, or the SEC, annual, quarterly and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act of 2002, as amended, or Sarbanes-Oxley Act, as well as rules subsequently adopted by the SEC and The Nasdaq Global Market to implement provisions of the Sarbanes-Oxley Act, impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive compensation related provisions in the Dodd-Frank Act that require the SEC to adopt additional rules and regulations in these areas, such as &#x201c;say on pay&#x201d; and proxy access. We were required to implement these requirements beginning in 2022 and incurred unexpected expenses in connection with such implementation. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The rules and regulations applicable to public companies substantially increase our legal and financial compliance costs and make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from other business concerns, they could have a material adverse effect on our business, financial condition and results of operations. The increased costs will decrease our net income or increase our net loss and may require us to reduce costs in other areas of our business. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain the same or similar coverage. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Drug Development and Regulatory Approval</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Preclinical and Clinical Development</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are very early in our development efforts. All of our product candidates are in preclinical or early clinical development. If we are unable to commercialize our product candidates or experience significant delays in doing so, our business will be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to become profitable depends upon our ability to generate revenue. To date, while we have generated collaboration revenue, we have not generated any revenue from our product candidates, and we do not expect to generate any revenue from the sale of drugs in the near future. We do not expect to generate revenue from product sales unless and until we complete the development of, obtain marketing approval for, and begin to sell, one or more of our product candidates. We are also unable to predict when, if ever, we will be able to generate revenue from such product candidates due to the numerous risks and uncertainties associated with drug development, including the uncertainty of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the results of our ongoing or planned clinical trials of our product candidates, including KT-474, KT-413, KT-333 and KT-253;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the results of preclinical studies and timing of IND clearances of future product candidates, and/or clinical trial costs for  current and future product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our successful initiation, enrollment of and completion of clinical trials for current and future product candidates, including our ability to generate positive data from any such clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to receive regulatory approvals from applicable regulatory authorities; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the initiation and successful completion of all safety studies required to obtain U.S. and foreign marketing approval for our product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs associated with the development of any additional development programs we identify in-house or acquire through collaborations or other arrangements; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish and maintain manufacturing capabilities or make arrangements with third-party manufacturers for clinical supply and commercial manufacturing; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining and maintaining patent and trade secret protection or regulatory exclusivity for our product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">launching commercial sales of our product candidates, if and when approved, whether alone or in collaboration with others; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining and maintaining acceptance of our product candidates, if and when approved, by patients, the medical community and third-party payors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">effectively competing with other therapies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining and maintaining healthcare coverage and adequate reimbursement; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the success of our existing collaborations as well as the terms and timing of any additional collaboration, license or other arrangement, including the terms and timing of any payments thereunder; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to enforce and defend intellectual property rights and claims; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to maintain a continued acceptable safety profile of our product candidates following approval. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect to incur significant sales and marketing costs as we prepare to commercialize our current or future product candidates. Even if we initiate and successfully complete pivotal or registration-enabling clinical trials of our current or future product candidates, and our current or future product candidates are approved for commercial sale, and despite expending these costs, our current or future product candidates may not be commercially successful. We may not achieve profitability soon after generating drug sales, if ever. If we are unable to generate revenue, we will not become profitable and may be unable to continue operations without continued funding.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our approach to the discovery and development of product candidates based on our Pegasus platform is novel and unproven, which makes it difficult to predict the time, cost of development and likelihood of successfully developing any products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform utilizes a method known as targeted protein degradation, or TPD, to discover and develop product candidates. Our future success depends on the successful development of this novel therapeutic approach. No product candidate using a heterobifunctional degrader has been approved in the United States or Europe, and the data underlying the feasibility of developing such therapeutic products is both preliminary and limited. In addition, we have not yet succeeded and may not succeed in demonstrating the efficacy and safety of any of our product candidates in clinical trials or in obtaining marketing approval thereafter. In particular, our ability to successfully achieve TPD with a therapeutic result requires the successful development of heterobifunctional molecules that were intentionally designed with a rational drug development process and developing those molecules with the right combination of protein targets and E3 ligases. This is a complex process requiring a number of component parts or biological mechanisms to work in unison to achieve the desired effect. We cannot be certain that we will be able to discover degraders by matching the right target with the ideal E3 ligase and the right linker in a timely manner, or at all. All of our product candidates are in preclinical or early clinical development. As such, there may be adverse effects from treatment with any of our current or future product candidates that we cannot predict at this time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of these factors, it is more difficult for us to predict the time and cost of product candidate development, and we cannot predict whether the application of our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform, or any similar or competitive platforms, will result in the development and marketing approval of any products. Any development problems we experience in the future related to our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform or any of our research programs may cause significant delays or unanticipated costs or may prevent the development of a commercially viable product. Any of these factors may prevent us from completing our preclinical studies and clinical trials or commercializing any product candidates we may develop on a timely or profitable basis, if at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be successful in our efforts to identify or discover additional product candidates or we may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A key element of our strategy is to apply our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform and product pipeline to address a broad array of targets and new therapeutic areas. The therapeutic discovery activities that we are conducting may not be successful in identifying product candidates that are useful in treating oncology, inflammation, immunology or genetic diseases. Our research programs may be unsuccessful in identifying potential product candidates, or our potential product candidates may be shown to have harmful side effects or may have other characteristics that may make the products unmarketable or unlikely to receive marketing approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because we have limited financial and management resources, we focus on a limited number of research programs and product candidates. We are currently focused on our four most advanced development programs, IRAK4, IRAKIMiD, STAT3 and MDM2, which target key signaling pathways implicated in multiple inflammatory and autoimmune diseases as well as numerous cancers. As a result, we may forego or delay pursuit of opportunities with other current or future product candidates or for other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial drugs or profitable market opportunities. Our spending on current and future research and development programs and current or future product candidates for specific indications may not yield any commercially viable drugs. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through future collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We depend heavily on the successful development of our lead programs. We cannot be certain that we will be able to obtain regulatory approval for, or successfully commercialize, any of our current or future product candidates</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently have no product candidates approved for sale and may never be able to develop marketable product candidates. Our business depends heavily on the successful development, regulatory approval and commercialization of our current or future product candidates, including our IRAK4, IRAKIMiD, STAT3 and MDM2 programs. The preclinical studies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and clinical trials of our current or future product candidates are, and the manufacturing and marketing of our current or future product candidates will be, subject to extensive and rigorous review and regulation by numerous government authorities in the U.S. and in other countries where we intend to test or, if approved, market any of our current or future product candidates. Before obtaining regulatory approvals for the commercial sale of any of our current or future product candidates, we must demonstrate through preclinical studies and clinical trials that each product candidate is safe and effective for use in each target indication. Drug development is a long, expensive and uncertain process, and delay or failure can occur at any stage of any of our preclinical studies and clinical trials. This process can take many years and may include post-marketing studies and surveillance, which will require the expenditure of substantial resources. Of the large number of drugs in development in the U.S., only a small percentage will successfully complete the FDA regulatory approval process and will be commercialized, with similarly low rates of success for drugs in development in the European Union obtaining regulatory approval from the European Commission following scientific evaluation by the European Medicines Agency, or EMA. Accordingly, even if we are able to obtain the requisite financing to continue to fund our development and preclinical studies and clinical trials, we cannot assure you that any of our current or future product candidates will be successfully developed or commercialized. For example, in December 2020, we submitted an IND application for KT-474 to initiate a first-in-human Phase 1 randomized, double-blind, placebo-controlled clinical trial in healthy volunteers and patients with hidradenitis suppurativa (HS) or atopic dermatitis (AD). The program was initially placed on partial clinical hold regarding the multiple ascending dose (MAD) portion of the Phase 1 trial, pending FDA review of the interim data in healthy volunteers from the SAD portion of the trial. In June 2021, the FDA lifted the partial clinical hold on the MAD portion of the Phase 1 trial of KT-474 following review of interim SAD results. As a result, in July 2021, we initiated enrollment in the MAD portion of the Phase 1 trial of KT-474, including healthy volunteers. We completed dose escalation in the SAD and MAD portions of this Phase 1 trial in December 2021. We completed a single dose, food-effect cohort to establish the dose for the patient cohort, or Part C, of the KT-474 Phase 1 trial. Part C has completed and included patients with either moderate-to-severe HS or AD.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are not permitted to market our current or future product candidates in the U.S. until we receive approval of a New Drug Application, or an NDA, from the FDA, in the European Union, or EU, until we receive approval of a marketing authorisation application, or an MAA, from the European Commission following scientific evaluation by the EMA, or in any other foreign countries until we receive the requisite approval from such countries. Obtaining approval of an NDA or MAA is a complex, lengthy, expensive and uncertain process, and the FDA or EMA may delay, limit or deny approval of any of our current or future product candidates for many reasons, including, among others:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not be able to demonstrate that our current or future product candidates are safe and effective in treating their target indications to the satisfaction of the FDA or applicable foreign regulatory agency; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the results of our preclinical studies and clinical trials may not meet the level of statistical or clinical significance required by the FDA or applicable foreign regulatory agency for marketing approval; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or applicable foreign regulatory agency may disagree with the number, design, size, conduct or implementation of our preclinical studies and clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or applicable foreign regulatory agency may require that we conduct additional preclinical studies and clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or applicable foreign regulatory agency may not approve the formulation, labeling or specifications of any of our current or future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the contract research organizations, or CROs, that we retain to conduct our preclinical studies and clinical trials may take actions outside of our control that materially adversely impact our preclinical studies and clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or applicable foreign regulatory agency may find the data from preclinical studies and clinical trials insufficient to demonstrate that our current or future product candidates&#x2019; clinical and other benefits outweigh their safety risks; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or applicable foreign regulatory agency may disagree with our interpretation of data from our preclinical studies and clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or applicable foreign regulatory agency may not accept data generated at our preclinical studies and clinical trial sites; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if our NDA, if and when submitted, is reviewed by an advisory committee, the FDA may have difficulties scheduling an advisory committee meeting in a timely manner or the advisory committee may recommend against approval of our application or may recommend that the FDA require, as a condition of approval, additional preclinical studies or clinical trials, limitations on approved labeling or distribution and use restrictions; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA may require development of a Risk Evaluation and Mitigation Strategy, or REMS, as a condition of approval or post-approval; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or the applicable foreign regulatory agency may determine that the manufacturing processes or facilities of third-party manufacturers with which we contract do not conform to applicable requirements, including current Good Manufacturing Practices, or cGMPs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or applicable foreign regulatory agency may be delayed in its review processes due to staffing or other constraints arising from the ongoing COVID-19 pandemic; or </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or applicable foreign regulatory agency may change its approval policies or adopt new regulations.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any of these factors, many of which are beyond our control, could jeopardize our ability to obtain regulatory approval for and successfully market our current or future product candidates. Any such setback in our pursuit of regulatory approval would have a material adverse effect on our business and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we experience delays or difficulties in the initiation or enrollment of patients in clinical trials, our receipt of necessary regulatory approvals could be delayed or prevented.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There may be delays in trial initiation, and we may not be able to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA or similar regulatory authorities outside the U.S. In particular, our ability to open clinical sites and enroll patients may be significantly delayed by the evolving COVID-19 pandemic and we do not know the extent and scope of such disruptions of patient care or delays at this point. Moreover, some of our competitors have ongoing clinical trials for current or future product candidates that treat the same patient populations as our current or future product candidates, and patients who would otherwise be eligible for our clinical trials may instead enroll in clinical trials of our competitors&#x2019; current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patient enrollment may be affected by other factors including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size and nature of the patient population; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">competition with other companies for clinical sites or patients; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the willingness of participants to enroll in our clinical trials in our countries of interest; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the severity of the disease under investigation; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the eligibility criteria for the clinical trial in question; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of an appropriate screening test for the indications we are pursuing; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the perceived risks and benefits of the product candidate under study; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the efforts to facilitate timely enrollment in and completion of clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the patient referral practices of physicians; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to monitor patients adequately during and after treatment; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the proximity and availability of clinical trial sites for prospective patients; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">factors we may not be able to control, such as potential pandemics that may limit subjects, principal investigators or staff or clinical site availability (e.g., the outbreak of COVID-19). </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interim, &#x201c;topline,&#x201d; and preliminary data from our clinical trials that we announce or publish from time to time, including relating to our Phase 1 clinical trials of KT-474, KT-413 and KT-333, may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, we may publicly disclose preliminary or topline data from our preclinical studies and clinical trials, which is based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the topline or preliminary results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline data also remain subject to audit and verification procedures that may result in the final</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">data being materially different from the preliminary data we previously published. As a result, topline data should be viewed with caution until the final data are available. From time to time, we may also disclose interim data from our clinical trials. Interim data from clinical trials that we may complete, including data from of our Phase 1 trials of KT-474, KT-413 and KT-333, are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available or as patients from our clinical trials continue other treatments for their diseases. Adverse differences between preliminary or interim data and final data could significantly harm our business prospects. Further, disclosure of interim data by us or by our competitors could result in volatility in the price of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or product and our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial, including our Phase 1 trials of KT-474, KT-413 and KT-333, is based on what is typically extensive information, and you or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the interim, topline, or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our product candidates may be harmed, which could harm our business, results of operations, prospects or financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Positive results from early preclinical studies and clinical trials of our current or future product candidates are not necessarily predictive of the results of later preclinical studies and clinical trials of our current or future product candidates. If we cannot replicate the positive results from our preclinical studies of our current or future product candidates in our future clinical trials, we may be unable to successfully develop, obtain regulatory approval for and commercialize our current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Positive results from our preclinical studies of our current or future product candidates, and any positive results we may obtain from our early clinical trials of our current or future product candidates, including our Phase 1 trial of KT-474, may not necessarily be predictive of the results from required later preclinical studies and clinical trials. Similarly, even if we are able to complete our planned preclinical studies or clinical trials of our current or future product candidates according to our current development timeline, the positive results from such preclinical studies and clinical trials of our current or future product candidates, including our Phase 1 trial of KT-474, may not be replicated in subsequent preclinical studies or clinical trials. Many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical trials after achieving positive results in early-stage development, and we cannot be certain that we will not face similar setbacks. These setbacks have been caused by, among other things, preclinical findings made while clinical trials were underway or safety or efficacy observations made in preclinical studies and clinical trials, including previously unreported adverse events. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that believed their product candidates performed satisfactorily in preclinical studies and clinical trials nonetheless failed to obtain approval from the FDA or comparable foreign regulatory authority. If we fail to produce positive results in our planned preclinical studies or clinical trials of any of our current or future product candidates, the development timeline and regulatory approval and commercialization prospects for our current or future product candidates, and, correspondingly, our business and financial prospects, would be materially adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, our planned or future clinical trials may utilize an &#x201c;open-label&#x201d; trial design, such as the open-label patient portion of our Phase 1 clinical trials of KT-474, KT-413, KT-333 and KT-253. An &#x201c;open-label&#x201d; clinical trial is one where both the patient and investigator know whether the patient is receiving the investigational product candidate or either an existing approved drug or placebo. Most typically, open-label clinical trials test only the investigational product candidate and sometimes may do so at different dose levels. Open-label clinical trials are subject to various limitations that may exaggerate any therapeutic effect as patients in open-label clinical trials are aware when they are receiving treatment. Open-label clinical trials may be subject to a &#x201c;patient bias&#x201d; where patients perceive their symptoms to have improved merely due to their awareness of receiving an experimental treatment. In addition, open-label clinical trials may be subject to an &#x201c;investigator bias&#x201d; where those assessing and reviewing the physiological outcomes of the clinical trials are aware of which patients have received treatment and may interpret the information of the treated group more favorably given this knowledge. The results from an open-label trial, including our Phase 1 trials of KT-474, KT-413 and KT-333, may not be predictive of future clinical trial results with any of our product candidates for which we include an open-label clinical trial when studied in a controlled environment with a placebo or active control</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The incidence and prevalence for target patient populations of our product candidates have not been established with precision. If the market opportunities for our product candidates are smaller than we estimate or if any approval that we obtain is based on a narrower definition of the patient population, our revenue and ability to achieve profitability will be adversely affected, possibly materially.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The precise incidence and prevalence for the indications being pursued by our current and future product candidates are currently unknown. Our projections of both the number of people who have these diseases, as well as the subset of people with these diseases who have the potential to benefit from treatment with our product candidates, are based on estimates. We are developing KT-474 for the treatment of a broad set of immunology-inflammation diseases, such as HS, an inflammatory skin disease, AD, and rheumatoid arthritis. The total addressable market opportunity for our product candidates will ultimately depend upon, among other things, their proven safety and efficacy, the diagnosis criteria included in the final label for each, whether our product candidates are approved for sale for these indications, acceptance by the medical community and patient access, product pricing and reimbursement. The number of patients for our product candidates in the United States and elsewhere may turn out to be lower than expected, patients may not be otherwise amenable to treatment with our products, or new patients may become increasingly difficult to identify or gain access to, all of which would adversely affect our results of operations and our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">A pandemic, epidemic, or outbreak of an infectious disease, such as COVID-19 or its variants, may materially and adversely affect our business and our financial results and could cause a disruption to the development of our product candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public health crises such as pandemics or similar outbreaks could adversely impact our business. In December 2019, a novel strain of a virus named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), or coronavirus, which causes COVID-19, surfaced in Wuhan, China and has since spread worldwide, including to Eastern Massachusetts where our primary office and laboratory space is located. The pandemic and policies and regulations implemented by governments in response to the pandemic, most of which have been lifted, have had a significant impact, both direct and indirect, on businesses and commerce. The coronavirus pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, travel restrictions and other public health safety measures. The extent to which the coronavirus impacts our operations or those of our third-party partners, including our preclinical studies or clinical trial operations, will also depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information that will emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others. The continued spread of COVID-19 globally, including the ongoing identification of new variants of the virus, could adversely impact our preclinical or clinical trial operations in the U.S. and abroad, including our ability to recruit and retain patients and principal investigators and site staff who, as healthcare providers, may have heightened exposure to COVID-19. For example, similar to other biopharmaceutical companies, we may experience additional delays in enrolling subjects in our clinical trials. COVID-19 may also affect employees of third-party CROs located in affected geographies that we rely upon to carry out our clinical trials. In addition, the patient populations that our lead and other core product candidates target may be particularly susceptible to COVID-19 or its variants, which may make it more difficult for us to identify patients able to enroll in our clinical trials and may impact the ability of enrolled patients to complete any such trials. Any negative impact that the ongoing COVID-19 pandemic has to patient enrollment or treatment, or the execution of our product candidates could cause costly delays to clinical trial activities, which could adversely affect our ability to obtain regulatory approval for and to commercialize our product candidates, increase our operating expenses, and have a material adverse effect on our financial results.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, timely enrollment in clinical trials is dependent upon clinical trial sites which will be adversely affected by global health matters, such as pandemics. We are conducting and plan to conduct clinical trials for our product candidates in geographies which are currently being affected by the coronavirus. Some factors from the coronavirus outbreak that will delay or otherwise adversely affect enrollment in the clinical trials of our product candidates, as well as our business generally, include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential diversion of healthcare resources away from the conduct of clinical trials to focus on pandemic concerns, including the attention of physicians serving as our clinical trial investigators, hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our prospective clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limitations on travel that could interrupt key trial and business activities, such as clinical trial site initiations and monitoring, domestic and international travel by employees, contractors or patients to clinical trial sites, including any government-imposed travel restrictions or quarantines that will impact the ability or willingness of patients, employees or contractors to travel to our clinical trial sites or secure visas or entry permissions, a loss of </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">face-to-face meetings and other interactions with potential partners, any of which could delay or adversely impact the conduct or progress of our clinical trials;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential negative affect on the operations of our third-party manufacturers and the supply chain for our product candidates. For example, in February 2020, one of our vendors for active pharmaceutical ingredient, or API, starting materials based in Wuhan, China ceased its operations for several weeks due to the COVID-19 pandemic, which caused a minor delay in the delivery of API starting materials to a separate vendor who manufactures API; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">interruptions in global shipping affecting the transport of clinical trial materials, such as patient samples, investigational drug product and conditioning drugs and other supplies used in our current and prospective clinical trials; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">business disruptions caused by potential workplace, laboratory and office closures and an increased reliance on employees working from home, disruptions to or delays in ongoing laboratory experiments and operations, staffing shortages, travel limitations or mass transit disruptions, any of which could adversely impact our business operations or delay necessary interactions with local regulators, ethics committees and other important agencies and contractors. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot presently predict the scope and severity of additional planned and potential shutdowns or disruptions of businesses and government agencies, such as the SEC or FDA. For example, since March 2020, the FDA has been working to resume pre-pandemic levels of inspection activities, including routine surveillance, bioresearch monitoring and pre-approval inspections.  Should the FDA determine that an inspection is necessary for approval of any NDAs we may submit and an inspection cannot be completed during the review cycle due to restrictions on travel at that time, and the FDA does not determine a remote interactive evaluation to be adequate, the agency has stated that it generally intends to issue, depending on the circumstances, a complete response letter or defer action on the application until an inspection can be completed. During the COVID-19 public health emergency, a number of companies have announced receipt of complete response letters due to the FDA&#x2019;s inability to complete required inspections for their applications. Regulatory authorities outside the U.S. may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic and may experience delays in their regulatory activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These and other factors arising from the coronavirus could worsen. Any of these factors, and other factors related to any such disruptions that are unforeseen, could have a material adverse effect on our business and our results of operations and financial condition. Further, uncertainty around these and related issues could lead to adverse effects on the economy of the United States and other economies, which could impact our ability to raise the necessary capital needed to develop and commercialize our product candidates. Other global health concerns could also result in social, economic, and labor instability in the countries in which we or the third parties with whom we engage operate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our current or future product candidates may cause adverse or other undesirable side effects that could delay or prevent their regulatory approval, limit the commercial profile of an approved label, or result in significant negative consequences following marketing approval, if any.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All of our product candidates are in preclinical or early clinical development, and there may be adverse effects from treatment with any of our current or future product candidates that we cannot predict at this time. Undesirable side effects caused by our current or future product candidates could cause us to interrupt, delay or halt preclinical studies or could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or other regulatory authorities. As is the case with many treatments for inflammatory and autoimmune diseases, cancer or other diseases, it is likely that there may be adverse side effects associated with the use of our product candidates. Additionally, a potential risk in any protein degradation product is that healthy proteins or proteins not targeted for degradation will be degraded or that the degradation of the targeted protein in itself could cause adverse events, undesirable side effects, or unexpected characteristics. It is possible that healthy proteins or proteins not targeted for degradation could be degraded using our degrader molecules in any of our current or future clinical studies. There is also the potential risk of delayed adverse events following treatment using any of our current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These side effects could arise due to off-target activity, allergic reactions in trial subjects, or unwanted on-target effects in the body. Results of our clinical trials could reveal a high and unacceptable severity and prevalence of these or other side effects. In such an event, our trials could be suspended or terminated and the FDA or comparable foreign regulatory authorities could order us to cease further development of or deny approval of our current or future product candidates for any or all targeted indications. The drug-related side effects could affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims. Any of these occurrences may harm our business, financial condition and prospects significantly.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, our current or future product candidates could cause undesirable side effects in clinical trials related to on-target toxicity. If on-target toxicity is observed, or if our current or future product candidates have characteristics that are unexpected, we may need to abandon their development or limit development to more narrow uses or subpopulations in which the undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective. Many compounds that initially showed promise in early-stage testing for treating cancer or other diseases have later been found to cause side effects that prevented further development of the compound.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, clinical trials by their nature utilize a sample of the potential patient population. With a limited number of patients and limited duration of exposure, rare and severe side effects of our current or future product candidates may only be uncovered with a significantly larger number of patients exposed to the product candidate. If our current or future product candidates receive marketing approval and we or others identify undesirable side effects caused by such current or future product candidates after such approval, a number of potentially significant negative consequences could result, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory authorities may withdraw or limit their approval of such current or future product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory authorities may require the addition of labeling statements, such as a &#x201c;boxed&#x201d; warning or a contraindication; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be required to create a medication guide outlining the risks of such side effects for distribution to patients; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be required to change the way such current or future product candidates are distributed or administered, conduct additional clinical trials or change the labeling of the current or future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory authorities may require a REMS plan to mitigate risks, which could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be subject to regulatory investigations and government enforcement actions; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may decide to remove such current or future product candidates from the marketplace; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we could be sued and held liable for injury caused to individuals exposed to or taking our current or future product candidates; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our reputation may suffer. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that any of these events could prevent us from achieving or maintaining market acceptance of the affected product candidates and could substantially increase the costs of commercializing our current or future product candidates, if approved, and significantly impact our ability to successfully commercialize our current or future product candidates and generate revenues.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Manufacturing our current or future product candidates is complex and we may encounter difficulties in production. If we encounter such difficulties, our ability to provide supply of our current or future product candidates for preclinical studies and clinical trials or for commercial purposes could be delayed or stopped.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The process of manufacturing our current or future product candidates is complex and highly regulated. We do not have our own manufacturing facilities or personnel and currently rely, and expect to continue to rely, on third parties for the manufacture of our current or future product candidates. These third-party contract manufacturing organizations, or CMOs, may not be able to provide adequate resources or capacity to meet our needs and may incorporate their own proprietary processes into our product candidate manufacturing processes. We have limited control and oversight of a third party&#x2019;s proprietary process, and a third party may elect to modify its process without our consent or knowledge. These modifications, such as any impacting the product formulation, could negatively impact our manufacturing, including by resulting in product loss or failure that requires additional manufacturing runs or a change in manufacturer, either of which could significantly increase the cost of and significantly delay the manufacture of our current or future product candidates. Changes in manufacturers often involve changes in manufacturing procedures and processes, which could require that we conduct bridging studies between our prior clinical supply used in our clinical trials and that of any new manufacturer. We may be unsuccessful in demonstrating the comparability of clinical supplies which could require the conduct of additional clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If any CMO with whom we contract fails to perform its obligations, we may be forced to enter into an agreement with a different CMO, which we may not be able to do on reasonable terms, if at all. This could significantly delay our clinical trials supply as we establish alternative supply sources. In some cases, the technical skills required to manufacture our product candidates or products, if approved, may be unique or proprietary to the original CMO and we may have difficulty, or there may be contractual restrictions prohibiting us from, transferring such skills to a back-up or alternate supplier, or we may be</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unable to transfer such skills at all. In addition, if we are required to change CMOs for any reason, we will be required to verify that the new CMO maintains facilities and procedures that comply with quality standards and with all applicable regulations. We will also need to verify, such as through a manufacturing comparability study, that any new manufacturing process will produce our product candidate according to the specifications previously submitted to the FDA or another regulatory authority. The delays associated with the verification of a new CMO could negatively affect our ability to develop product candidates or commercialize our products in a timely manner or within budget. Furthermore, a CMO may possess technology related to the manufacture of our product candidate that such CMO owns independently. This would increase our reliance on such CMO or require us to obtain a license from such CMO in order to have another CMO manufacture our product candidates. In addition, as our current or future product candidates progress through preclinical studies and clinical trials towards potential approval and commercialization, it is expected that various aspects of the manufacturing process will be altered in an effort to optimize processes and results. Such changes may require amendments to be made to regulatory applications which may further delay the timeframes under which modified manufacturing processes can be used for any of our current or future product candidates and additional bridging studies or trials may be required. Any such delay could have a material adverse impact on our business, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Regulatory Approval</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals for our current or future product candidates, we will not be able to commercialize, or will be delayed in commercializing, our current or future product candidates, and our ability to generate revenue will be materially impaired.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current or future product candidates and the activities associated with their development and commercialization, including their design, testing, manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale, distribution, import, and export, are subject to comprehensive regulation by the FDA and other regulatory agencies in the U.S. and by comparable authorities in other countries. Before we can commercialize any of our current and future product candidates, we must obtain marketing approval from the regulatory authorities in the relevant jurisdictions. We have not received approval to market any of our current product candidates from regulatory authorities in any jurisdiction, and it is possible that none of our current product candidates, nor any product candidates we may seek to develop in the future, will ever obtain regulatory approval. As a company, we have only limited experience in filing and supporting the applications necessary to gain regulatory approvals and expect to rely on third-party CROs and/or regulatory consultants to assist us in this process. Securing regulatory approval requires the submission of extensive preclinical and clinical data and supporting information to the various regulatory authorities for each therapeutic indication to establish the product candidate&#x2019;s safety and efficacy. Securing regulatory approval also requires the submission of information about the drug manufacturing process to, and inspection of manufacturing facilities and often clinical sites by, the relevant regulatory authority. Our current or future product candidates may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude our obtaining marketing approval or prevent or limit commercial use.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The process of obtaining regulatory approvals, both in the U.S. and abroad, is expensive, may take many years if additional clinical trials are required, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted NDA or equivalent application type outside the U.S., may cause delays in the approval or rejection of an application. The FDA and comparable authorities in other countries have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional preclinical, clinical or other studies. Our current or future product candidates could be delayed in receiving, or fail to receive, regulatory approval for many reasons, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that a product candidate is safe and effective for its proposed indication; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the results of clinical trials may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for approval; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be unable to demonstrate that a product candidate&#x2019;s clinical and other benefits outweigh its safety risks; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from preclinical studies or clinical trials; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the data collected from clinical trials of our current or future product candidates may not be sufficient to support the submission of an NDA or other submission or to obtain regulatory approval in the U.S. or elsewhere; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or comparable foreign regulatory authorities may find deficiencies with or fail to approve the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we were to obtain approval, regulatory authorities may approve any of our current or future product candidates for fewer or more limited indications than we request, may not approve the price we intend to charge for our drugs, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. Any of the foregoing scenarios could materially harm the commercial prospects for our current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we experience delays in obtaining approval or if we fail to obtain approval of our current or future product candidates, the commercial prospects for our current or future product candidates may be harmed and our ability to generate revenues will be materially impaired.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may seek designation for our Pegasus&#153; discovery platform as a designated platform technology, but we might not receive such designation, and even if we do, such designation may not lead to faster drug development or a faster regulatory review or approval process.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may seek designation for our Pegasus&#153; platform as a designated platform technology. Under the Food and Drug Omnibus Reform Act of 2022, or FDORA, a platform technology incorporated within or utilized by a drug product is eligible for designation as a designated platform technology if (1) the platform technology is incorporated in, or utilized by, a drug approved under an NDA; (2) preliminary evidence submitted by the sponsor of the approved or licensed drug, or a sponsor that has been granted a right of reference to data submitted in the application for such drug, demonstrates that the platform technology has the potential to be incorporated in, or utilized by, more than one drug without an adverse effect on quality, manufacturing, or safety; and (3) data or information submitted by the applicable person indicates that incorporation or utilization of the platform technology has a reasonable likelihood to bring significant efficiencies to the drug development or manufacturing process and to the review process. A sponsor may request the FDA to designate a platform technology as a designated platform technology concurrently with, or at any time after, submission of an IND application for a drug that incorporates or utilizes the platform technology that is the subject of the request. If so designated, the FDA may expedite the development and review of any subsequent original NDA for a drug that uses or incorporates the platform technology. Even if we believe our Pegasus&#153; platform meets the criteria for such designation, the FDA may disagree and instead determine not to grant such designation. In addition, the receipt of such designation for a platform technology does not ensure that a drug will be developed or reviewed more quickly or receive FDA approval. Moreover, the FDA may revoke a designation if the FDA determines that a designated platform technology no longer meets the criteria for such designation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may seek Breakthrough Therapy Designation and/or Fast Track Designation for any of our current or future product candidates.  These designations, even if granted by the FDA, may not lead to a faster development, regulatory review or approval process, and such designations do not increase the likelihood that any of our product candidates will receive marketing approval in the United States.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may seek a Breakthrough Therapy Designation for one or more of our current or future product candidates. A breakthrough therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For drugs that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Drugs designated as breakthrough therapies by the FDA may also be eligible for priority review and accelerated approval. Designation as a breakthrough therapy is within the discretion of the FDA. Accordingly, even if we believe one of our current or future product candidates meets the criteria for designation as a breakthrough therapy, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a Breakthrough Therapy Designation for a current or future product candidate may not result in a faster development process, review or approval compared to therapies considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our current or future product</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">candidates qualify as breakthrough therapies, the FDA may later decide that such product candidates no longer meet the conditions for qualification or decide that the time period for FDA review or approval will not be shortened.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may seek Fast Track Designation for one or more of our current or future product candidates. If a drug is intended for the treatment of a serious or life-threatening condition and the drug demonstrates the potential to address unmet medical needs for this condition, the drug sponsor may apply for Fast Track Designation. The FDA has broad discretion whether or not to grant this designation, so even if we believe a particular current or future product candidate is eligible for this designation, we cannot assure you that the FDA would decide to grant it. Even if we do receive Fast Track Designation for certain current or future product candidates, we may not experience a faster development process, review or approval compared to conventional FDA procedures. The FDA may withdraw Fast Track Designation if it believes that the designation is no longer supported by data from our clinical development program. Fast Track Designation alone does not guarantee qualification for the FDA&#x2019;s priority review procedures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may seek approval of KT-474, KT-413, KT-333, KT-253 or any other future product candidate, where applicable, under the FDA&#x2019;s accelerated approval pathway. This pathway may not lead to a faster development or regulatory review or approval process and it does not increase the likelihood that our product candidates will receive marketing approval.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may seek accelerated approval of KT-474, KT-413, KT-333, KT-253 or future product candidates. A product may be eligible for accelerated approval if it treats a serious or life-threatening condition and generally provides a meaningful advantage over available therapies. In addition, it must demonstrate an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, or IMM, that is reasonably likely to predict an effect on IMM or other clinical benefit. As a condition of accelerated approval, the FDA likely would require that we perform adequate and well-controlled post-marketing clinical trials, and under FDORA the FDA is now permitted to require, as appropriate, that such trials be underway prior to approval or within a specific time period after the date of approval for a product granted accelerated approval. FDORA also gives the FDA increased authority to withdraw approval of a drug or biologic granted accelerated approval on an expedited basis if the sponsor fails to conduct such studies in a timely manner, send the necessary updates to the FDA, or if such post-approval studies fail to verify the drug&#x2019;s predicted clinical benefit. Under FDORA, the FDA is empowered to take action, such as issuing fines, against companies that fail to conduct with due diligence any post-approval confirmatory study or submit timely reports to the agency on their progress. In addition, the FDA currently requires, unless otherwise informed by the Agency, pre-approval of promotional materials for products receiving accelerated approval, which could adversely impact the timing of the commercial launch of the product. Thus, even if we seek to utilize the accelerated approval pathway, we may not be able to obtain accelerated approval and, even if we do, we may not experience a faster development, regulatory review or approval process for that product. In addition, receiving accelerated approval does not assure that the product&#x2019;s accelerated approval will eventually be converted to a traditional approval.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have obtained orphan drug designation for one of our product candidates. We may also seek Orphan Drug Designation for certain of our other current or future product candidates, and we may be unsuccessful or may be unable to maintain the benefits associated with Orphan Drug Designation, including the potential for market exclusivity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA has granted Orphan Drug Designation for KT-333 for the treatment of peripheral T cell lymphoma and cutaneous T cell lymphoma. As part of our business strategy, we may also seek Orphan Drug Designation for certain indications of our other current or future product candidates, and we may be unsuccessful. Regulatory authorities in some jurisdictions, including the U.S. and Europe, may designate drugs for relatively small patient populations as orphan drugs. Under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is a drug intended to treat a rare disease or condition, which is generally defined as a patient population of fewer than 200,000 individuals annually in the U.S., or a patient population greater than 200,000 in the U.S. where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the U.S. In the U.S., Orphan Drug Designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and user-fee waivers.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Similarly, in Europe, the European Commission, upon the recommendation of the EMA&#x2019;s Committee for Orphan Medicinal Products, grants Orphan Drug Designation to promote the development of drugs that are intended for the diagnosis, prevention or treatment of life-threatening or chronically debilitating conditions affecting not more than 5 in 10,000 persons in Europe and for which no satisfactory method of diagnosis, prevention, or treatment has been authorized (or the product would be a significant benefit to those affected). Additionally, designation is granted for drugs intended for the diagnosis, prevention, or treatment of a life-threatening, seriously debilitating or serious and chronic condition and when, without incentives, it is unlikely that sales of the drug in Europe would be sufficient to justify the necessary investment in developing the drug. In Europe, Orphan Drug Designation entitles a party to financial incentives such as reduction of fees or fee waivers</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Generally, if a product with an Orphan Drug Designation subsequently receives the first marketing approval for the indication for which it has such designation, the product is entitled to a period of marketing exclusivity, which precludes the FDA or the EMA from approving another marketing application for the same drug for that time period. The applicable period is seven years in the U.S. and ten years in the European Union. The exclusivity period in the European Union can be reduced to six years if a drug no longer meets the criteria for Orphan Drug Designation or if the drug is sufficiently profitable so that market exclusivity is no longer justified. Orphan Drug exclusivity may be lost if the FDA or EMA determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the drug to meet the needs of patients with the rare disease or condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we obtain Orphan Drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because competing drugs containing a different active ingredient can be approved for the same condition. In addition, even after an orphan drug is approved, the FDA can subsequently approve the same drug for the same condition if the FDA concludes that the later drug is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On August 3, 2017, the U.S. Congress passed the FDA Reauthorization Act of 2017, or FDARA. FDARA, among other things, codified the FDA&#x2019;s pre-existing regulatory interpretation to require that a drug sponsor demonstrate the clinical superiority of an orphan drug that is otherwise the same as a previously approved drug for the same rare disease in order to receive orphan drug exclusivity. The new legislation reverses prior precedent holding that the Orphan Drug Act unambiguously requires that the FDA recognize the orphan exclusivity period regardless of a showing of clinical superiority. Moreover, in the Consolidated Appropriations Act of 2021, Congress did not further change this interpretation when it clarified that the interpretation codified in FDARA would apply in cases where the FDA issued an orphan designation before the enactment of FDARA but where product approval came after the enactment of FDARA. The FDA may further reevaluate the Orphan Drug Act and its regulations and policies. We do not know if, when or how the FDA may change the orphan drug regulations and policies in the future, and it is uncertain how any changes might affect our business. Depending on what changes the FDA may make to its Orphan Drug regulations and policies, our business could be adversely impacted.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if we receive regulatory approval for any of our current or future product candidates, we will be subject to ongoing obligations and continued regulatory review, which may result in significant additional expense. Additionally, our current or future product candidates, if approved, could be subject to labeling and other restrictions and market withdrawal and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our product candidates when and if any of them are approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the FDA or a comparable foreign regulatory authority approves any of our current or future product candidates, the manufacturing processes, labeling, packaging, distribution, tracking and tracing, adverse event reporting, storage, advertising, promotion and recordkeeping for the drug will be subject to extensive and ongoing regulatory requirements. These requirements include submissions of safety and other post-marketing information and reports, registration requirements, and continued compliance with cGMPs and Good Clinical Practices, or GCPs, for any clinical trials that we conduct post-approval. For certain commercial prescription drug products, manufacturers and other parties involved in the supply chain must also meet chain of distribution requirements and build electronic, interoperable systems for product tracking and tracing and for notifying the FDA of counterfeit, diverted, stolen and intentionally adulterated products or other products that are otherwise unfit for distribution in the United States. Any regulatory approvals that we receive for our current or future product candidates may also be subject to limitations on the approved indicated uses for which the drug may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase 4 clinical trials, and surveillance to monitor the safety and efficacy of the drug. Additionally, under FDORA, sponsors of approved drugs and biologics must provide 6 months&#x2019; notice to the FDA of any changes in marketing status, such as the withdrawal of a drug, and failure to do so could result in the FDA placing the product on a list of discontinued products, which would revoke the product&#x2019;s ability to be marketed. The FDA closely regulates the post-approval marketing and promotion of pharmaceutical and biological products to ensure such products are marketed only for the approved indications and in accordance with the provisions of the approved labeling. Later discovery of previously unknown problems with a drug, including adverse events of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in, among other things:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on the marketing or manufacturing of the drug, withdrawal of the drug from the market, or voluntary drug recalls; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fines, warning letters or holds on clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">refusal by the FDA to approve pending applications or supplements to approved applications filed by us, or suspension or revocation of drug license approvals; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">drug seizure or detention, or refusal to permit the import or export of drugs; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA&#x2019;s policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our current or future product candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained, which would adversely affect our business, prospects and ability to achieve or sustain profitability.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Inadequate funding for the FDA, the SEC and other government agencies, including from government shutdowns, or other disruptions to these agencies&#x2019; operations, could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, the ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disruptions at the FDA and other agencies may also slow the time necessary for new product candidates to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Foreign Regulatory Approval and Foreign Markets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if we receive marketing approval for our current or future product candidates in the U.S., we may never receive regulatory approval to market our current or future product candidates outside of the U.S.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We plan to seek regulatory approval of our current or future product candidates outside of the U.S. In order to market any product outside of the U.S., however, we must establish and comply with the numerous and varying safety, efficacy and other regulatory requirements of other countries. Approval procedures vary among countries and can involve additional product candidate testing and additional administrative review periods. The time required to obtain approvals in other countries might differ substantially from that required to obtain FDA approval. The marketing approval processes in other countries generally implicate all of the risks detailed above regarding FDA approval in the U.S. as well as other risks. In particular, in many countries outside of the U.S., products must receive pricing and reimbursement approval before the product can be commercialized. Obtaining this approval can result in substantial delays in bringing products to market in such countries. Marketing approval in one country does not ensure marketing approval in another, but a failure or delay in obtaining marketing approval in one country may have a negative effect on the regulatory process in others. Failure to obtain marketing approval in other countries or any delay or other setback in obtaining such approval would impair our ability to market our current or future product candidates in such foreign markets. Any such impairment would reduce the size of our potential market, which could have a material adverse impact on our business, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our future growth may depend, in part, on our ability to penetrate foreign markets, where we would be subject to additional regulatory burdens and other risks and uncertainties that could materially adversely affect our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are not permitted to market or promote any of our current or future product candidates before we receive regulatory approval from the applicable regulatory authority in that foreign market, and we may never receive such regulatory approval for any of our current or future product candidates. To obtain separate regulatory approval in many other countries we must comply with numerous and varying regulatory requirements of such countries regarding safety and efficacy and governing, among other things, clinical trials and commercial sales, pricing and distribution of our current or future product candidates, and we cannot predict success in these jurisdictions. If we obtain approval of our current or future product candidates and ultimately commercialize our current or future product candidates in foreign markets, we would be subject to additional risks and uncertainties, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">differing regulatory requirements in foreign countries, such that obtaining regulatory approvals outside of the U.S. may take longer and be more costly than obtaining approval in the U.S.; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our customers&#x2019; ability to obtain reimbursement for our current or future product candidates in foreign markets; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the burden of complying with complex and changing foreign regulatory, tax, accounting and legal requirements; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">different medical practices and customs in foreign countries affecting acceptance in the marketplace; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">import or export licensing requirements; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">longer accounts receivable collection times; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">longer lead times for shipping; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">language barriers for technical training; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reduced protection of intellectual property rights in some foreign countries; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the existence of additional potentially relevant third-party intellectual property rights; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">economic weakness, including inflation, or political instability in particular foreign economies and markets; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">foreign taxes, including withholding of payroll taxes; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">difficulties staffing and managing foreign operations; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">workforce uncertainty in countries where labor unrest is more common than in the U.S.; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential liability under the Foreign Corrupt Practices Act of 1977 or comparable foreign regulations; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the interpretation of contractual provisions governed by foreign laws in the event of a contract dispute; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">business interruptions resulting from geo-political actions, including war and terrorism. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign sales of our current or future product candidates could also be adversely affected by the imposition of governmental controls, political and economic instability, trade restrictions and changes in tariffs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may in the future conduct clinical trials for current or future product candidates outside the U.S., and the FDA and comparable foreign regulatory authorities may not accept data from such trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may in the future choose to conduct one or more clinical trials outside the U.S., including in Europe. The acceptance of study data from clinical trials conducted outside the U.S. or another jurisdiction by the FDA or comparable foreign regulatory authority may be subject to certain conditions or may not be accepted at all. In cases where data from foreign clinical trials are intended to serve as the basis for marketing approval in the U.S., the FDA will generally not approve the application on the basis of foreign data alone unless (i) the data are applicable to the U.S. population and U.S. medical practice, (ii) the trials were performed by clinical investigators of recognized competence and (iii) the data may be considered valid without the need for an on-site inspection by the FDA or, if the FDA considers such an inspection to be necessary, the FDA is able to validate the data through an on-site inspection or other appropriate means. Additionally, the FDA&#x2019;s clinical trial requirements, including sufficient size of patient populations and statistical powering, must be met. Many foreign regulatory authorities have similar approval requirements. In addition, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA or any comparable foreign regulatory authority will accept data from trials conducted outside of the U.S. or the applicable jurisdiction. If the FDA or any comparable foreign regulatory authority does not accept such data, it would result in the need for additional trials, which could be costly and time-consuming, and which may result in current or future product candidates that we may develop not receiving approval for commercialization in the applicable jurisdiction.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are subject to certain U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions, and other trade laws and regulations. We can face serious consequences for violations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Among other matters, U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions, and other trade laws and regulations, which we collectively refer to as Trade Laws, prohibit companies and their employees, agents, clinical research organizations, legal counsel, accountants, consultants, contractors, and other partners from authorizing, promising, offering, providing, soliciting, or receiving directly or indirectly, corrupt or improper payments or anything else of value to or from recipients in the public or private sector. Violations of Trade Laws can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Governments outside the United States tend to impose strict price controls, which may adversely affect our revenues, if any.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In some countries, particularly in the European Union, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a drug. To obtain coverage and reimbursement or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product candidate to other available therapies. In addition, many countries outside the U.S. have limited government support programs that provide for reimbursement of drugs such as our product candidates, with an emphasis on private payors for access to commercial products. If reimbursement of our product candidates is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, our business could be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Compliance with Healthcare and Other Regulations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if we are able to commercialize any current or future product candidates, such drugs may become subject to unfavorable pricing regulations or third-party coverage and reimbursement policies, which would harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant uncertainty exists as to the coverage and reimbursement status of any products for which we may obtain regulatory approval. In the U.S. and in other countries, sales of any products for which we may receive regulatory marketing approval for commercial sale will depend, in part, on the availability of coverage and reimbursement from third-party payors. Third-party payors include government healthcare programs (e.g., Medicare and Medicaid), managed care providers, private health insurers, health maintenance organizations and other organizations. These third-party payors decide which medications they will pay for and establish reimbursement levels. The availability of coverage and extent of reimbursement by governmental and other third-party payors is essential for most patients to be able to afford treatments such as targeted protein degradation therapies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the United States and markets in other countries, patients generally rely on third-party payors to reimburse all or part of the costs associated with their treatment. Adequate coverage and reimbursement from governmental healthcare programs, such as Medicare and Medicaid, and commercial payors is critical to new product acceptance. Our ability to successfully commercialize our product candidates will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers and other organizations. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is also significant uncertainty related to the insurance coverage and reimbursement of newly approved products and coverage may be more limited than the purposes for which the medicine is approved by the FDA or comparable foreign regulatory authorities. In the United States, the principal decisions about reimbursement for new medicines are typically made by the Centers for Medicare &amp; Medicaid Services, or CMS, an agency within the U.S. Department of Health and Human Services, or HHS. CMS decides whether and to what extent our products will be covered and reimbursed under Medicare. Private payors tend to follow CMS to a substantial degree. Factors payors consider in determining reimbursement are based on whether the product is:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a covered benefit under its health plan; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">safe, effective and medically necessary; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">appropriate for the specific patient; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cost-effective; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">neither experimental nor investigational. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to commercialize any current or future product candidates successfully also will depend in part on the extent to which coverage and reimbursement for these current or future product candidates and related treatments will be available from government authorities, private health insurers and other organizations. Moreover, a payor&#x2019;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. We cannot be sure that coverage will be available for any product candidate that we commercialize. If coverage is available, but reimbursement is available only to limited levels, we may not be able to successfully commercialize any product candidate for which we obtain marketing approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., no uniform policy exists for coverage and reimbursement for products among third-party payors. Therefore, decisions regarding the extent of coverage and amount of reimbursement to be provided can differ significantly from payor to payor. The process for determining whether a payor will provide coverage for a product may be separate from the process for setting the reimbursement rate a payor will pay for the product. One third-party payor&#x2019;s decision to cover a particular product or service does not ensure that other payors will also provide coverage for the medical product or service. Third-party payors may limit coverage to specific products on an approved list or formulary, which may not include all FDA-approved products for a particular indication. Also, third-party payors may refuse to include a particular branded product on their formularies or otherwise restrict patient access to a branded drug when a less costly generic equivalent or other alternative is available.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, the level of reimbursement.  In addition to their safety and efficacy. In addition, many pharmaceutical manufacturers must calculate and report certain price reporting metrics to the government, such as average sales price, or ASP, and best price. Penalties may apply in some cases when such metrics are not submitted accurately and timely. Further, these prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs. In order to secure coverage and reimbursement for any product that might be approved for sale, we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain FDA or comparable regulatory approvals. Additionally, we may also need to provide discounts to purchasers, private health plans or government healthcare programs. Despite our best efforts, our product candidates may not be considered medically necessary or cost-effective. If third-party payors do not consider a product to be cost-effective compared to other available therapies, they may not cover an approved product as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow us to sell our products at a profit. A decision by a third-party payor not to cover a product could reduce physician utilization once the product is approved and have a material adverse effect on sales, our operations and financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Finally, in some foreign countries, the proposed pricing for a product candidate must be approved before it may be lawfully marketed. The requirements governing product pricing vary widely from country to country. For example, in the EU pricing and reimbursement of pharmaceutical products are regulated at a national level under the individual EU Member States&#x2019; social security systems. Some foreign countries provide options to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and can control the prices of medicinal products for human use. To obtain reimbursement or pricing approval, some of these countries may require the completion of clinical trials that compare the cost effectiveness of a particular product candidate to currently available therapies. A country may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. There can be no assurance that any country that has price controls or reimbursement limitations for products will allow favorable reimbursement and pricing arrangements for any of our product candidates. Even if approved for reimbursement, historically, product candidates launched in some foreign countries, such as some countries in the EU, do not follow price structures of the U.S. and prices generally tend to be significantly lower.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Current and future healthcare legislative reform measures may have a material adverse effect on our business and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in regulations, statutes or the interpretation of existing regulations could impact our business by requiring, for example: (i) changes to our manufacturing arrangements, (ii) additions or modifications to product labeling, (iii) the recall or discontinuation of our products or (iv) additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the United States and in some foreign jurisdictions, there have been, and likely will continue to be, a number of legislative and regulatory changes and proposed changes intended to broaden access to healthcare, improve the quality of healthcare, and contain or lower the cost of healthcare. For example, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or the ACA, was passed, which substantially changed the way healthcare is financed by both governmental and private insurers, and significantly impacted the U.S. pharmaceutical industry. The ACA, among other things, subjects biological products to potential competition by lower-cost biosimilars, expands the types of entities eligible for the 340B drug discount program, addresses a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increases rebates owed by manufacturers under the Medicaid Drug Rebate Program and extends the rebate program to individuals enrolled in Medicaid managed care organizations, establishes annual fees and taxes on manufacturers of certain branded prescription drugs, and creates a new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 50% (increased to 70% pursuant to the Bipartisan Budget Act of 2018, or BBA, effective as of January 2019) point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#x2019;s outpatient drugs to be covered under Medicare Part D; and provided incentives to programs that increase the federal government&#x2019;s comparative effectiveness research.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since its enactment, there have been judicial, administrative, executive and Congressional legislative challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#x2019;s decision, President Biden issued an executive order to initiate a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how other healthcare reform measures of the Biden administration or other efforts, if any, to challenge, repeal or replace the ACA will impact our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. For example:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. Specifically, the Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#x2019;s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of up to 2% per fiscal year, which went into effect in April 2013, and, due to subsequent legislative amendments, will remain in effect through 2030 unless additional Congressional action is taken. However, pursuant to the Coronavirus Aid, Relief and Economic Security Act, or CARES Act, and subsequent legislation, the 2% Medicare sequester reductions were suspended from May 1, 2020 through March 31, 2022, due to the COVID-19 pandemic. Following the temporary suspension, a 1% payment reduction occurred from April 1, 2022 through June 30, 2022, and the 2% payment reduction resumed on July 1, 2022. </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On January 2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. The BBA also amended the ACA, effective January 1, 2019, by increasing the point-of-sale discount that is owed by pharmaceutical manufacturers who participate in Medicare Part D and closing the coverage gap in most Medicare drug plans, commonly referred to as the &#x201c;donut hole.&#x201d; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On April 13, 2017, CMS published a final rule that gives states greater flexibility in setting benchmarks for insurers in the individual and small group marketplaces, which may have the effect of relaxing the essential health benefits required under the ACA for plans sold through such marketplaces. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On May 30, 2018, the Right to Try Act, was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational new drug products that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a pharmaceutical manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act.  </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2022, the Inflation Reduction Act of 2022, or IRA, was signed into law. The IRA includes several provisions that may impact our business to varying degrees, including provisions that establish a $2,000 out-of-pocket cap for Medicare Part D beneficiaries, impose new manufacturer financial liability on many drugs reimbursed under Medicare Part D, allow the U.S. government to negotiate Medicare Part B and Part D pricing for certain high-cost drugs and biologics without generic or biosimilar competition, and require companies to pay rebates to Medicare for drug prices that increase faster than inflation.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, CMS may develop new payment and delivery models, such as bundled payment models. Recently, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products. Such scrutiny has resulted in several recent U.S. Congressional inquiries and has further resulted in proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. For example, at the federal level, the prior administration&#x2019;s budget for fiscal year 2021 includes a $135 billion allowance to support legislative proposals seeking to reduce drug prices, increase competition, lower out-of-pocket drug costs for patients, and increase patient access to lower-cost generic and biosimilar drugs. On March 10, 2020, the prior administration sent &#x201c;principles&#x201d; for drug pricing to Congress, calling for legislation that would, among other things, cap Medicare Part D beneficiary out-of-pocket pharmacy expenses, provide an option to cap Medicare Part D beneficiary monthly out-of-pocket expenses, and place limits on pharmaceutical price increases. Additionally, the prior administration previously released a &#x201c;Blueprint&#x201d; to lower drug prices and reduce out of pocket costs of drugs that contains additional proposals to increase manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out of pocket costs of product candidates paid by consumers. However, it is unclear whether the Biden administration will challenge, reverse, revoke or otherwise modify these executive and administrative actions. HHS has solicited feedback on some of these measures and, at the same time, is immediately implementing others under its existing authority. For example, in May 2019, CMS issued a final rule to allow Medicare Advantage Plans the option of using step therapy, a type of prior authorization, for Part B drugs beginning January 1, 2020. This final rule codified CMS&#x2019;s policy change that was effective January 1, 2019. It is unclear how these developments could affect covered hospitals who might purchase our future products and affect the rates we may charge such facilities for our approved products in the future, if any. On December 20, 2019, former President Trump signed into law the Further Consolidated Appropriations Act (H.R. 1865), which repealed the Cadillac tax, the health insurance provider tax, and the medical device excise tax. It is impossible to determine whether similar taxes could be instated in the future.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, there has been increasing legislative and enforcement interest in the United States with respect to drug pricing practices. Specifically, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, and review the relationship between pricing and manufacturer patient programs. On December 2, 2020, HHS published a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers. Pursuant to court order, the removal and addition of the aforementioned safe harbors were delayed and recent legislation imposed a moratorium on implementation of the rule until January 1, 2026. This deadline was pushed back to January 1, 2027 by the Bipartisan Safer Communities Act. The IRA further delayed implementation of this rule to January 1, 2032. Although a number of these and other proposed measures may require authorization through additional legislation to become effective, and the Biden administration may reverse or otherwise change these measures, both the Biden administration and Congress have indicated that they will continue to seek new legislative measures to control drug costs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the state level, individual states are increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. Legally mandated price controls on payment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">amounts by third-party payors or other restrictions could harm our business, financial condition, results of operations and prospects. In addition, regional health care authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other health care programs. These measures could reduce the ultimate demand for our products, once approved, or put pressure on our product pricing, which could negatively affect our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our current or future product candidates or additional pricing pressures. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action in the United States. If we or any third parties we may engage are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we or such third parties are not able to maintain regulatory compliance, our product candidates may lose any regulatory approval that may have been obtained and we may not achieve or sustain profitability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our relationships with customers, health care providers, physicians, and third-party payors will be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, exclusion from government healthcare programs, contractual damages, reputational harm and diminished future profits and earnings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Healthcare providers, physicians and third-party payors will play a primary role in the recommendation and prescription of any current or future product candidates for which we obtain marketing approval. Our business operations and any current or future arrangements with third-party payors and customers may expose us to broadly applicable federal and state laws relating to fraud and abuse, as well as other healthcare laws and regulations. Pharmaceutical companies are subject to additional healthcare regulation and enforcement by the federal government and by authorities in the states and foreign jurisdictions in which they conduct their business that may constrain the financial arrangements and relationships through which we research, as well as sell, market and distribute any products for which we obtain marketing authorization. Such laws include, without limitation, state and federal anti-kickback, fraud and abuse, false claims, and transparency laws and regulations related to drug pricing and payments and other transfers of value made to physicians and other healthcare providers. If our operations are found to be in violation of any of such laws or any other governmental regulations that apply, we may be subject to penalties, including, without limitation, administrative, civil and criminal penalties, damages, fines, disgorgement, the curtailment or restructuring of operations, integrity oversight and reporting obligations, exclusion from participation in federal and state healthcare programs and responsible individuals may be subject to imprisonment. These laws may impact, among other things, the business or financial arrangements and relationships through which we market, sell and distribute any current or future product candidates for which we obtain marketing approval. Restrictions under applicable federal and state healthcare laws and regulations, include, among others:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the federal Anti-Kickback Statute, which prohibits, among other things, any person or entity from knowingly and willfully soliciting, offering, receiving, providing or paying remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, lease, order or recommendation of, or arranging for, any item, good, facility, or service, for which payment may be made under a federal healthcare program such as Medicare and Medicaid. The federal Anti-Kickback Statute has been interpreted to apply to arrangements between manufacturers on the one hand and prescribers, purchasers, and formulary managers on the other. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. Violations can result in significant civil monetary and criminal penalties for each violation, plus up to three times the amount of remuneration, imprisonment, and exclusion from government healthcare programs. Further, a violation of the federal Anti-Kickback Statute can also form the basis for False Claims Act liability or federal civil monetary penalties; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the federal civil and criminal false claims laws and civil monetary penalty laws, including the federal False Claims Act, which prohibits individuals or entities from knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government. Actions under the False Claims Act may be brought by the Attorney General or as a qui tam action by a private individual  acting as a &#34;whistle blower&#34; in the name of the government permitting the whistleblower to share in any monetary recovery. Violations of the False Claims Act can result in very significant monetary penalties for each false claim and three times the amount of the government&#x2019;s damages. Manufacturers can be held liable under the False Claims Act even when they do not submit claims directly to government payors if they are deemed to &#x201c;cause&#x201d; the submission of false or fraudulent claims. In addition, the government may assert that a claim including items and services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which imposes additional criminal and civil liability for knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private), and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement in connection with the delivery of, or payment for, healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the federal physician payment transparency laws, including the federal Physician Payment Sunshine Act created under the ACA, which requires manufacturers of certain drugs, devices, biologics and medical supplies, among others, to track and disclose payments under Medicare, Medicaid, or the Children&#x2019;s Health Insurance Program (with certain exceptions) and other transfers of value they make to U.S. physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Effective January 1, 2022, these reporting obligations extend to include transfers of value made to certain non-physician providers (physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and anesthesiologist assistants, and certified-nurse midwives). This information is subsequently made publicly available in a searchable format on a CMS website. Failure to disclose required information may result in civil monetary penalties for all payments, transfers of value or ownership or investment interests that are not timely, accurately and completely reported in an annual submission; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and its implementing regulations, including the final omnibus rule published on January 25, 2013, which imposes, among other things, certain requirements relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#x2019;s privacy and security standards directly applicable to &#x201c;business associates,&#x201d; defined as independent contractors or agents of covered entities that create, receive, maintain, transmit, or obtain, protected health information in connection with providing a service for or on behalf of a covered entity. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorney&#x2019;s fees and costs associated with pursuing federal civil actions. In addition, there  may be additional federal, state and non-U.S. laws which govern the privacy and security of health and other personal information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">federal government price reporting laws, which require us to calculate and report complex pricing metrics in an accurate and timely manner to government programs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">analogous state law equivalents of each of the above U.S. federal laws, such as state anti-kickback and false claims laws which may apply to items or services reimbursed by any third-party payor, including commercial insurers or patients; state and local marketing and/or transparency laws applicable to manufacturers that may be broader in scope than the federal requirements; state laws that require the reporting of information related to drug pricing; state laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures and pricing information; state and local laws that require the licensure and/or registration of pharmaceutical sales representatives; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#x2019;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government; and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. In addition, some states have passed laws that require pharmaceutical companies to comply with the April 2003 Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers and/or the Pharmaceutical Research and Manufacturers of America&#x2019;s Code on Interactions with Healthcare Professionals.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to the above, on November 20, 2020, the Office of Inspector General, or OIG, finalized further modifications to the federal Anti-Kickback Statute. Under the final rules, OIG added safe harbor protections under the Anti-Kickback Statute for certain coordinated care and value-based arrangements among clinicians, providers, and others. The final rule (with some exceptions) became effective January 19, 2021. We continue to evaluate what effect, if any, these rules will have on our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Ensuring that our internal operations and future business arrangements with third parties comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices do not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, contractual damages, reputational harm, diminished profits and future earnings, imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or similar settlement to resolve allegations of non-compliance with these laws. Further, defending against any such actions can be costly and time consuming, and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired. If any of the physicians or other providers or entities with whom we expect to do business are found to not be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs and imprisonment.  If any of the above occur, our ability to operate our business and our results of operations could be adversely affected. If any of the physicians or other healthcare providers or entities with whom we expect to do business is found to be not in compliance with applicable laws, they may be subject to similar actions, penalties, and sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is also prohibited in the EU. The provision of benefits or advantages to physicians is governed by the national anti-bribery laws of EU Member States, such as the U.K. Bribery Act 2010. Infringement of these laws could result in substantial fines and imprisonment. Payments made to physicians in certain EU Member States must be publicly disclosed. Moreover, agreements with physicians often must be the subject of prior notification and approval by the physician&#x2019;s employer, his or her competent professional organization and/or the regulatory authorities of the individual EU Member States. These requirements are provided in the national laws, industry codes or professional codes of conduct, applicable in the EU Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological and radioactive materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we maintain workers&#x2019; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological, hazardous or radioactive materials. In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. Current or future environmental laws and regulations may impair our research, development and production efforts, which could harm our business, prospects, financial condition or results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our employees, principal investigators, CROs and consultants may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading laws.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are exposed to the risk that our employees, principal investigators, CROs and consultants may engage in fraudulent conduct or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violate the regulations of the FDA and other regulatory authorities, including those laws requiring the reporting of true, complete and accurate information to such authorities; healthcare fraud and abuse laws and regulations in the U.S. and abroad; or laws that require the reporting of financial information or data accurately. In particular, sales, marketing, patient support and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Other activities subject to these laws include the improper use of information obtained in the course of clinical trials or creating fraudulent data in our preclinical studies or clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. We have adopted a code of conduct applicable to all of our employees, but it is not always possible to identify and deter misconduct by employees and other third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. Additionally, we are subject to the risk that a person could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of our business activities could be subject to challenge under one or more of such laws. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant criminal, civil and administrative sanctions including monetary penalties, damages, fines, disgorgement, individual imprisonment, reputational harm, exclusion from participation in government funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The risk of our being found in violation of these laws is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#x2019;s attention from the operation of our business. The shifting compliance environment and the need to build and maintain robust and expandable systems to comply with multiple jurisdictions with different compliance and/or reporting requirements increases the possibility that a healthcare company may run afoul of one or more of the requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Commercialization</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if we receive marketing approval for our current or future product candidates, our current or future product candidates may not achieve broad market acceptance, which would limit the revenue that we generate from their sales.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The commercial success of our current or future product candidates, if approved by the FDA or other applicable regulatory authorities, will depend upon the awareness and acceptance of our current or future product candidates among the medical community, including physicians, patients and healthcare payors. Market acceptance of our current or future product candidates, if approved, will depend on a number of factors, including, among others:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the efficacy of our current or future product candidates as demonstrated in clinical trials, and, if required by any applicable regulatory authority in connection with the approval for the applicable indications, to provide patients with incremental health benefits, as compared with other available medicines; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limitations or warnings contained in the labeling approved for our current or future product candidates by the FDA or other applicable regulatory authorities; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the clinical indications for which our current or future product candidates are approved; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">availability of alternative treatments already approved or expected to be commercially launched in the near future; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential and perceived advantages of our current or future product candidates over current treatment options or alternative treatments, including future alternative treatments; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the willingness of the target patient population to try new therapies or treatment methods and of physicians to prescribe these therapies or methods; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the need to dose such product candidates in combination with other therapeutic agents, and related costs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the strength of marketing and distribution support and timing of market introduction of competitive products; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">publicity concerning our products or competing products and treatments; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pricing and cost effectiveness; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effectiveness of our sales and marketing strategies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to increase awareness of our current or future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain sufficient third-party coverage or reimbursement; or </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the willingness of patients to pay out-of-pocket in the absence of third-party coverage. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If our current or future product candidates are approved but do not achieve an adequate level of acceptance by patients, physicians and payors, we may not generate sufficient revenue from our current or future product candidates to become or remain profitable. Before granting reimbursement approval, healthcare payors may require us to demonstrate that our current or future product candidates, in addition to treating these target indications, also provide incremental health benefits to patients. Our efforts to educate the medical community, patient organizations and third-party payors about the benefits of our current or future product candidates may require significant resources and may never be successful.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing or commercializing drugs before or more successfully than we do.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The development and commercialization of new drugs is highly competitive. We face and will continue to face competition from third parties that use protein degradation, antibody therapy, inhibitory nucleic acid, gene editing or gene therapy development platforms and from companies focused on more traditional therapeutic modalities, such as small molecule inhibitors. Potential competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization of new drugs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competitors in our efforts to develop small molecule protein degraders therapies for patients, include, but are not limited to, Arvinas, Inc., C4 Therapeutics, Inc., Foghorn Therapeutics Inc. and Nurix Therapeutics, Inc., some of which have entered clinical development. Further, several large pharmaceutical companies have disclosed preclinical and clinical investments in this field. Our competitors will also include companies that are or will be developing other targeted protein degradation methods as well as small molecule, antibody, or gene therapies for the same indications that we are targeting. In addition to the competitors we face in developing small molecule protein degraders, we will also face competition in the indications we expect to pursue with our IRAK4, IRAKIMiD, STAT3 and MDM2 programs. Many of these indications already have approved standards of care which may include more traditional therapeutic modalities. In order to compete effectively with these existing therapies, we will need to demonstrate that our protein degrader therapies are favorable to existing therapeutics.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">    </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of our current or future competitors have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals and reimbursement and marketing approved drugs than we do. Mergers and acquisitions in the pharmaceutical, biotechnology and diagnostic industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific, sales, marketing and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize drugs that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any drugs that we or our collaborators may develop. Our competitors also may obtain FDA or other regulatory approval for their drugs more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we or our collaborators are able to enter the market. The key competitive factors affecting the success of all of our current or future product candidates, if approved, are likely to be their efficacy, safety, convenience, price, the level of generic competition and the availability of reimbursement from government and other third-party payors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product liability lawsuits against us could cause us to incur substantial liabilities and could limit commercialization of any current or future product candidates that we may develop.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> We face an inherent risk of product liability exposure related to the testing of our current or future product candidates in human clinical trials and will face an even greater risk if we commercially sell any current or future product candidates that we may develop. If we cannot successfully defend ourselves against claims that our current or future product candidates caused injuries, we could incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">decreased demand for any current or future product candidates that we may develop; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injury to our reputation and significant negative media attention; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">withdrawal of clinical trial participants; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significant costs to defend the related litigation; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">substantial monetary awards to trial participants or patients; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">loss of revenue; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability to commercialize any current or future product candidates that we may develop. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not yet maintain product liability insurance, and we anticipate that we will need to increase our insurance coverage when we begin clinical trials and if we successfully commercialize any product candidate. Insurance coverage is increasingly expensive. We may not be able to maintain product liability insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If, in the future, we are unable to establish sales and marketing and patient support capabilities or enter into agreements with third parties to sell and market our current or future product candidates, we may not be successful in commercializing our current or future product candidates if and when they are approved, and we may not be able to generate any revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not currently have a sales or marketing infrastructure and have no experience in the sales, marketing, patient support or distribution of drugs. To achieve commercial success for any approved product candidate for which we retain sales and marketing responsibilities, we must build our sales, marketing, patient support, managerial and other non-technical capabilities or make arrangements with third parties to perform these services. In the future, we may choose to build a focused sales and marketing infrastructure to sell, or participate in sales activities with our collaborators for, some of our current or future product candidates if and when they are approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There are risks involved with both establishing our own sales and marketing and patient support capabilities and entering into arrangements with third parties to perform these services. For example, recruiting and training a sales force is expensive and time consuming and could delay any drug launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly, and our investment would be lost if we cannot retain or reposition our sales and marketing personnel.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Factors that may inhibit our efforts to commercialize our current or future product candidates on our own include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to recruit and retain adequate numbers of effective sales and marketing personnel;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability of sales personnel to obtain access to physicians or persuade adequate numbers of physicians to prescribe any future drugs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the lack of complementary drugs to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines; and </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unforeseen costs and expenses associated with creating an independent sales and marketing organization. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we enter into arrangements with third parties to perform sales, marketing, patient support and distribution services, our drug revenues or the profitability of these drug revenues to us are likely to be lower than if we were to market and sell any current or future product candidates that we develop ourselves. In addition, we may not be successful in entering into arrangements with third parties to sell and market our current or future product candidates or may be unable to do so on terms that are favorable to us. We likely will have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market our current or future product candidates effectively. If we do not establish sales and marketing capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing our current or future product candidates. Further, our business, results of operations, financial condition and prospects will be materially adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Dependence on Third Parties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We rely, and expect to continue to rely, on third parties to conduct preclinical studies and clinical trials for our current and future product candidates. If these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or meet expected deadlines, we may not be able to obtain marketing approval for or commercialize our current and potential future product candidates and our business could be substantially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We utilize and depend upon independent investigators and collaborators, such as medical institutions, CROs, contract manufacturing organizations and strategic partners to help conduct our preclinical studies. We do not have the ability to independently conduct clinical trials. We rely on medical institutions, clinical investigators, contract laboratories, and other third parties, including collaboration partners, to conduct or otherwise support clinical trials for our current product candidates, and we expect to rely on such third parties for our future product candidates. We rely heavily on these parties for execution of clinical trials for our product candidates and control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of our clinical trials is conducted in accordance with the applicable protocol, legal and regulatory requirements and scientific standards, and our reliance on CROs will not relieve us of our regulatory responsibilities. For any violations of laws and regulations during the conduct of our preclinical studies or clinical trials, we could be subject to untitled and warning letters or enforcement action that may include civil penalties up to and including criminal prosecution.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We and any third parties that we contract with are required to comply with regulations and requirements, including GCP, for conducting, monitoring, recording and reporting the results of clinical trials to ensure that the data and results are scientifically credible and accurate, and that the trial patients are adequately informed of the potential risks of participating in clinical trials and their rights are protected. These regulations are enforced by the FDA, the Competent Authorities of the Member States of the European Economic Area and comparable foreign regulatory authorities for any drugs in clinical development. The FDA enforces GCP requirements through periodic inspections of clinical trial sponsors, principal investigators and trial sites. If we or the third parties we contract with fail to comply with applicable GCP, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot assure you that, upon inspection, the FDA will determine that any of our clinical trials will comply with GCP. In addition, our clinical trials must be conducted with current or future product candidates produced under cGMP regulations. Our failure or the failure of third parties that we may contract with to comply with these regulations may require us to repeat some aspects of a specific, or an entire, clinical trial, which would delay the marketing approval process and could also subject us to enforcement action. We also are required to register certain ongoing clinical trials and provide certain information, including information relating to the trial&#x2019;s protocol, on a government-sponsored database, ClinicalTrials.gov, within specific timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we designed the Phase 1 trials of KT-474, KT-413, KT-333 and KT 253, and intend to design other clinical trials for our current or future product candidates, or be involved in the design when other parties sponsor the trials, we anticipate that third parties will conduct all of our clinical trials. As a result, many important aspects of our clinical development, including their conduct, timing and response to the ongoing COVID-19 pandemic, will be outside of our direct control. Our reliance on third parties to conduct clinical trials will also result in less direct control over the management of data developed through clinical trials than would be the case if we were relying entirely upon our own staff. Communicating with outside parties can also be challenging, potentially leading to mistakes as well as difficulties in coordinating activities. Outside parties may:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">have staffing difficulties; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fail to comply with contractual obligations; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">experience regulatory compliance issues; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">form relationships with other entities, some of which may be our competitors. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These factors may materially adversely affect the willingness or ability of third parties to conduct our clinical trials and may subject us to unexpected cost increases that are beyond our control. If our CROs do not perform clinical trials in a satisfactory manner, breach their obligations to us or fail to comply with regulatory requirements, the development, marketing approval and commercialization of our current or future product candidates may be delayed, we may not be able to obtain marketing approval and commercialize our current or future product candidates, or our development programs may be materially and irreversibly harmed. If we are unable to rely on clinical data collected by our CROs, we could be required to repeat, extend the duration of, or increase the size of clinical trials we conduct and this could significantly delay commercialization and require significantly greater expenditures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If any of our relationships with these third-party CROs terminate, we may not be able to enter into arrangements with alternative CROs on commercially reasonable terms, or at all. If our CROs do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain are compromised due to the failure to adhere to our clinical protocols, regulatory requirements or for other reasons, any clinical trials such CROs are associated with may be extended, delayed or terminated, and we may not be able to obtain marketing approval for or successfully commercialize our current or future product candidates. As a result, we believe that our financial results and the commercial prospects for our current or future product candidates in the subject indication would be harmed, our costs could increase and our ability to generate revenue could be delayed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The third parties upon whom we rely for the supply of the API, drug product, and starting materials used in our product candidates are limited in number, and the loss of any of these suppliers could significantly harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The drug substance and drug product in our product candidates are supplied to us from a small number of suppliers, and in some cases sole source suppliers. Our ability to successfully develop our current or future product candidates, and to ultimately supply our commercial drugs in quantities sufficient to meet the market demand, depends in part on our ability to obtain the drug product and drug substance for these drugs in accordance with regulatory requirements and in sufficient quantities for commercialization and clinical testing. We do not currently have arrangements in place for a redundant or second-source supply of all drug product or drug substance in the event any of our current suppliers of such drug product and drug substance cease their operations for any reason. Any delays in the delivery of our drug substance, drug product or starting materials could have an adverse effect and potentially harm our business. For example, in February 2020, one of our vendors for API starting materials based in Wuhan, China ceased its operations for several weeks due to the COVID-19 pandemic, which caused a minor delay in the delivery of API starting materials to a separate vendor who manufactures API.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For all of our current or future product candidates, we intend to identify and qualify additional manufacturers to provide such API, drug product and drug substance prior to submission of an NDA to the FDA and/or an MAA to the EMA. We are not certain, however, that our single-source and dual source suppliers will be able to meet our demand for their products, either because of the nature of our agreements with those suppliers, our limited experience with those suppliers or our relative importance as a customer to those suppliers. It may be difficult for us to assess their ability to timely meet our demand in the future based on past performance. While our suppliers have generally met our demand for their products on a timely basis in the past, they may subordinate our needs in the future to their other customers.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Establishing additional or replacement suppliers for the drug product and drug substance used in our current or future product candidates, if required, may not be accomplished quickly. If we are able to find a replacement supplier, such replacement supplier would need to be qualified and may require additional regulatory approval, which could result in further delay. While we seek to maintain adequate inventory of the drug product and drug substance used in our current or future product candidates, any interruption or delay in the supply of components or materials, or our inability to obtain such API, drug product and drug substance from alternate sources at acceptable prices in a timely manner, could impede, delay, limit or prevent our development efforts, which could harm our business, results of operations, financial condition and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our success is dependent on our executive management team&#x2019;s ability to successfully pursue business development, strategic partnerships and investment opportunities as our company matures. We may also form or seek strategic alliances or acquisitions or enter into additional collaboration and licensing arrangements in the future, and we may not realize the benefits of such collaborations, alliances, acquisitions or licensing arrangements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have entered into collaboration and licensing arrangements with Vertex and Sanofi and may in the future form or seek strategic alliances or acquisitions, create joint ventures, or enter into additional collaboration and licensing arrangements with third parties that we believe will complement or augment our development and commercialization efforts with respect to our current product candidates and any future product candidates that we may develop. Any of these relationships may require us to incur non-recurring and other charges, increase our near and long-term expenditures, issue securities that dilute our existing stockholders or disrupt our management and business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we face significant competition in seeking appropriate strategic partners and the negotiation process is time-consuming and complex. Moreover, we may not be successful in our efforts to establish a strategic partnership or acquisition or other alternative arrangements for our current or future product candidates because they may be deemed to be at too early of a stage of development for collaborative effort and third parties may not view our current or future product candidates as having the requisite potential to demonstrate safety, potency, purity and efficacy and obtain marketing approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, collaborations involving our technologies or current or future product candidates are subject to numerous risks, which may include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators have significant discretion in determining the efforts and resources that they will apply to a collaboration; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may not pursue development and commercialization of our current or future product candidates or may elect not to continue or renew development or commercialization of our current or future product candidates based on clinical trial results, changes in their strategic focus due to the acquisition of competitive products, availability of funding or other external factors, such as a business combination that diverts resources or creates competing priorities; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial, stop a clinical trial, abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our current or future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a collaborator with marketing and distribution rights to one or more products may not commit sufficient resources to their marketing and distribution; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disputes may arise between us and a collaborator that cause the delay or termination of the research, development or commercialization of our current or future product candidates, or that result in costly litigation or arbitration that diverts management attention and resources; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable current or future product candidates. For example, the collaboration agreement with Vertex may be terminated by Vertex either in its entirety or on a target-by-target basis, upon one hundred eighty days&#x2019; prior written notice to us, upon our material breach, subject to specified notice and cure provisions, or upon our bankruptcy, insolvency, dissolution or winding up; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may own or co-own intellectual property covering our products that results from our collaborating with them, and in such cases, we would not have the exclusive right to commercialize such intellectual property; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may not pay milestones and royalties due to the company in a timely manner. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result, we may not be able to realize the benefit of our existing collaboration and licensing arrangements or any future strategic partnerships or acquisitions, collaborations or license arrangements we may enter into if we are unable to successfully integrate them with our existing operations and company culture, which could delay our timelines or otherwise adversely affect our business. We also cannot be certain that, following a strategic transaction, license, collaboration or other business development partnership, we will achieve the revenue or specific net income that justifies such transaction. Any delays in entering into new collaborations or strategic partnership agreements related to our current or future product candidates could delay the development and commercialization of our current or future product candidates in certain geographies or for certain indications, which would harm our business prospects, financial condition and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our manufacturing process needs to comply with FDA regulations relating to the quality and reliability of such processes. Any failure to comply with relevant regulations could result in delays in or termination of our preclinical and clinical programs and suspension or withdrawal of any regulatory approvals.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In order to commercially produce our products either at our own facility or at a third party&#x2019;s facility, we will need to comply with the FDA&#x2019;s cGMP regulations and guidelines. We may encounter difficulties in achieving quality control and quality assurance and may experience shortages in qualified personnel. We are subject to inspections by the FDA and comparable foreign regulatory authorities to confirm compliance with applicable regulatory requirements. Any failure to follow cGMP or other regulatory requirements or delay, interruption or other issues that arise in the manufacture, fill-finish, packaging, or storage of our product candidates as a result of a failure of our facilities or the facilities or operations of third parties to comply with regulatory requirements or pass any regulatory authority inspection could significantly impair our ability to develop and commercialize our current or future product candidates, including leading to significant delays in the availability of our product candidates for our clinical trials or the termination of or suspension of a clinical trial, or the delay or prevention of a filing or approval of marketing applications for our current or future product candidates. Significant non-compliance could also result in the imposition of sanctions, including warning or untitled letters, fines, injunctions, civil penalties, failure of regulatory authorities to grant marketing approvals for our current or future product candidates, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of products, operating restrictions and criminal prosecutions, any of which could damage our reputation and our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If our third-party manufacturers use hazardous and biological materials in a manner that causes injury or violates applicable law, we may be liable for damages.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our research and development activities involve the controlled use of potentially hazardous substances, including chemical materials, by our third-party manufacturers. Our manufacturers are subject to federal, state and local laws and regulations in the U.S. governing the use, manufacture, storage, handling and disposal of medical and hazardous materials. Although we believe that our manufacturers&#x2019; procedures for using, handling, storing and disposing of these materials comply with legally prescribed standards, we cannot completely eliminate the risk of contamination or injury resulting from medical or hazardous materials. As a result of any such contamination or injury, we may incur liability or local, city, state or federal authorities may curtail the use of these materials and interrupt our business operations. In the event of an accident, we could be held liable for damages or penalized with fines, and the liability could exceed our resources. We do not have any insurance for liabilities arising from medical or hazardous materials. Compliance with applicable environmental laws and regulations is expensive, and current or future environmental regulations may impair our research, development and production efforts, which could harm our business, prospects, financial condition or results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Intellectual Property</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are unable to obtain and maintain patent and other intellectual property protection for our technology and product candidates or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and drugs similar or identical to ours, and our ability to successfully commercialize our technology and drugs may be impaired, and we may not be able to compete effectively in our market.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial success depends in part on our ability to obtain and maintain patent or other intellectual property protection in the U.S. and other countries for our current or future product candidates and our core technologies, including our proprietary Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform, our initial IRAK4, IRAKIMiD, STAT3 and MDM2 programs, which are our four most advanced development programs, as well as our proprietary compound library and other know-how. We seek to protect our proprietary and intellectual property position by, among other methods, filing patent applications in the U.S. and abroad related to our proprietary technology, inventions and improvements that are important to the development and implementation of our business. We also rely on trade secrets, know-how and continuing technological innovation to develop and maintain our proprietary and intellectual property position.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">97</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We own patent applications and one patent related to our platform E3 ligase ligand technology and our novel bifunctional degrader compounds, including claims to compositions of matter, pharmaceutical compositions, methods of use, methods of treatment, and other related methods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of January 20, 2023, our patent portfolio covering novel compounds, and the methods of making and using thereof, included 77 patent families. Patent term adjustments, supplementary protection certificate filings, or patent term extensions could result in later expiration dates in various countries, while terminal disclaimers could result in earlier expiration dates in the U.S.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent years been the subject of much litigation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The degree of patent protection we require to successfully commercialize our current or future product candidates may be unavailable or severely limited in some cases and may not adequately protect our rights or permit us to gain or keep any competitive advantage. We cannot provide any assurances that any of our pending patent applications that mature into issued patents will include claims with a scope sufficient to protect our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform and our current or future product candidates. In addition, if the breadth or strength of protection provided by our patent applications or any patents we may own or in-license is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the U.S. For example, in jurisdictions outside the U.S., a license may not be enforceable unless all the owners of the intellectual property agree or consent to the license. Accordingly, any actual or purported co-owner of our patent rights could seek monetary or equitable relief requiring us to pay it compensation for, or refrain from, exploiting these patents due to such co-ownership. Furthermore, patents have a limited lifespan. In the U.S., and most other jurisdictions in which we have undertaken patent filings, the natural expiration of a patent is generally twenty years after it is filed, assuming all maintenance fees are paid. Various extensions may be available, on a jurisdiction-by-jurisdiction basis; however, the life of a patent, and thus the protection it affords, is limited. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, patents we may own or in-license may not provide us with adequate and continuing patent protection sufficient to exclude others from commercializing drugs similar or identical to our current or future product candidates, including generic versions of such drugs. Other parties have developed technologies that may be related or competitive to our own, and such parties may have filed or may file patent applications, or may have received or may receive patents, claiming inventions that may overlap or conflict with those claimed in our own patent applications or issued patents, with respect to either the same compounds, methods, formulations or other subject matter, in either case that we may rely upon to dominate our patent position in the market. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the U.S. and other jurisdictions are typically not published until at least 18 months after the earliest priority date of the patent filing, or in some cases not at all. Therefore, we cannot know with certainty whether we were the first to make the inventions claimed in patents we may own or in-license patents or pending patent applications, or that we were the first to file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights cannot be predicted with any certainty.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the patent prosecution process is expensive and time-consuming, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. Further, with respect to certain pending patent applications covering our current or future product candidates or technologies, prosecution has yet to commence. Patent prosecution is a lengthy process, during which the scope of the claims initially submitted for examination by the relevant patent office(s) may be significantly narrowed by the time they issue, if they ever do. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, we may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents, covering technology that we license from or to third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we acquire patent protection that we expect should enable us to establish and/or maintain a competitive advantage, third parties may challenge the validity, enforceability or scope thereof, which may result in such patents being narrowed, invalidated or held unenforceable. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged in the courts or patent offices in the U.S. and abroad. We may become involved in opposition, derivation, reexamination, inter partes review, or post-grant review proceedings challenging our patent rights or the patent rights of others from whom we may in the future obtain licenses to such rights, in the U.S. Patent and Trademark Office, or USPTO, the European Patent Office, or EPO, or in other countries. In addition, we may be subject to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">third-party submissions to the USPTO, the EPO, or elsewhere, that may reduce the scope or preclude the granting of claims from our pending patent applications. Competitors may challenge our issued patents or may file patent applications before we do. Competitors may also claim that we are infringing their patents and that we therefore cannot practice our technology as claimed under our patents or patent applications. Competitors may also contest our patents by showing an administrative patent authority or judge that the invention was not patent-eligible, was not novel, was obvious, and/or lacked inventive step, and/or that the patent application failed to meet relevant requirements relating to description, basis, enablement, and/or support; in litigation, a competitor could assert that our patents are not valid or are unenforceable for a number of reasons. If a court or administrative patent authority agrees, we would lose our protection of those challenged patents.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">An adverse determination in any such submission or proceeding may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical technology and drugs, without payment to us, or could limit the duration of the patent protection covering our technology and current or future product candidates. Such challenges may also result in our inability to manufacture or commercialize our current or future product candidates without infringing third-party patent rights. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we may in the future be subject to claims by our former employees or consultants asserting an ownership right in our patents or patent applications, as a result of the work they performed on our behalf. Although we generally require all of our employees, consultants and advisors and any other third parties who have access to our proprietary know-how, information or technology to assign or grant similar rights to their inventions to us, we cannot be certain that we have executed such agreements with all parties who may have contributed to our intellectual property, nor can we be certain that our agreements with such parties will be upheld in the face of a potential challenge, or that they will not be breached, for which we may not have an adequate remedy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if they are unchallenged, our issued patents and our pending patent applications, if issued, may not provide us with any meaningful protection or prevent competitors from designing around our patent claims to circumvent patents we may own or in-license by developing similar or alternative technologies or drugs in a non-infringing manner. For example, a third party may develop a competitive drug that provides benefits similar to one or more of our current or future product candidates but that has a different composition that falls outside the scope of our patent protection. If the patent protection provided by the patents and patent applications we hold or pursue with respect to our current or future product candidates is not sufficiently broad to impede such competition, our ability to successfully commercialize our current or future product candidates could be negatively affected, which would harm our business. Furthermore, even if we are able to issue patents with claims of valuable scope in one or more jurisdictions, we may not be able to secure such claims in all relevant jurisdictions, or in a sufficient number to meaningfully reduce competition. Our competitors may be able to develop and commercialize their products, including products identical to ours, in any jurisdiction in which we are unable to obtain, maintain, or enforce such patent claims.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will not obtain patent or other intellectual property protection for all current or future product candidates in all jurisdictions throughout the world, and we may not be able to adequately enforce our intellectual property rights even in the jurisdictions where we seek protection.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may not be able to pursue patent coverage of our current or future product candidates, the Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">platform, or other technologies in all countries. Filing, prosecuting and defending patents on current or future product candidates, the Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform, and other technologies in all countries throughout the world would be prohibitively expensive, and intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the U.S. Consequently, we may not be able to prevent third parties from infringing on our inventions in all countries outside the U.S., or from selling or importing products made using our inventions in and into the U.S. or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and further, may export otherwise infringing products to territories where we have patent protection, but where enforcement is not as strong as that in the U.S. These products may compete with our current or future product candidates and in jurisdictions where we do not have any issued patents our patent applications or other intellectual property rights may not be effective or sufficient to prevent them from competing. Much of our patent portfolio is at the very early stage. We will need to decide whether and in which jurisdictions to pursue protection for the various inventions in our portfolio prior to applicable deadlines. Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to pharmaceutical products, which</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">could make it difficult for us to stop the infringement of any patents we may own or in-license or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce any rights we may have in our patent applications or any patents we may own or in-license in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put any patents we may own or in-license at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we are forced to grant a license to third parties with respect to any patents we may own or license that are relevant to our business, our competitive position may be impaired, and our business, financial condition, results of operations, and prospects may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may not obtain or grant licenses or sublicenses to intellectual property rights in all markets on equally or sufficiently favorable terms with third parties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">It may be necessary for us to use the patented or proprietary technology of third parties to commercialize our products, in which case we would be required to obtain a license from these third parties. The licensing of third-party intellectual property rights is a competitive area, and more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. More established companies may have a competitive advantage over us due to their size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. If we are unable to license such technology, or if we are forced to license such technology on unfavorable terms, our business could be materially harmed. If we are unable to obtain a necessary license, we may be unable to develop or commercialize the affected current or future product candidates, which could materially harm our business, and the third parties owning such intellectual property rights could seek either an injunction prohibiting our sales, or, with respect to our sales, an obligation on our part to pay royalties or other forms of compensation. Even if we are able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. Any of the foregoing could harm our competitive position, business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to comply with our obligations in our current or any future agreements under which we may license intellectual property rights from third parties or otherwise experience disruptions to our business relationships with our licensors, we could lose license rights that are important to our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are dependent on patents, know-how and proprietary technology, both our own and in-licensed from Vertex, Sanofi and other collaborators. Our commercial success depends upon our ability to develop, manufacture, market and sell our current or future product candidates and use our and our licensors&#x2019; proprietary technologies without infringing the proprietary rights of third parties. Vertex, Sanofi and other collaborators may have the right to terminate their respective license agreements in full in the event that we materially breach or default in the performance of any of the obligations under such license agreements. Any termination of these licenses, or if the underlying patents fail to provide the intended exclusivity, could result in the loss of significant rights and could harm our ability to commercialize our current or future product candidates, the Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform, or other technologies, competitors or other third parties would have the freedom to seek regulatory approval of, and to market, products identical to ours, and we may be required to cease our development and commercialization of certain of our current or future product candidates. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disputes may also arise between us and our current or future licensors regarding intellectual property subject to a license agreement, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope of rights granted under the license agreement and other interpretation-related issues; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether and the extent to which our technology and processes infringe, misappropriate or otherwise violate intellectual property rights of the licensor that are not subject to the licensing agreement; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our right to sublicense patent and other rights to third parties under collaborative development relationships; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our diligence obligations with respect to the use of the licensed technology in relation to our development and commercialization of our current or future product candidates, and what activities satisfy those diligence obligations; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the priority of invention of any patented technology; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our current or future licensors and us and our partners. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the agreements under which we may license intellectual property or technology from third parties are likely to be complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations and prospects. Moreover, if disputes over intellectual property that we may license prevent or impair our ability to maintain current or future licensing arrangements on acceptable terms, we may be unable to successfully develop and commercialize the affected current or future product candidates or technologies, which could have a material adverse effect on our business, financial conditions, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Intellectual property rights do not guarantee commercial success of current or future product candidates or other business activities. Numerous factors may limit any potential competitive advantage provided by our intellectual property rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The degree of future protection afforded by our intellectual property rights, whether owned or in-licensed, is uncertain because intellectual property rights have limitations, and may not adequately protect our business, provide a barrier to entry against our competitors or potential competitors, or permit us to maintain our competitive advantage. Moreover, if a third party has intellectual property rights that cover the practice of our technology, we may not be able to fully exercise or extract value from our intellectual property rights. The following examples are illustrative:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">patent applications that we own or may in-license may not lead to issued patents; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">patents, should they issue, that we may own or in-license, may not provide us with any competitive advantages, may be narrowed in scope, or may be challenged and held invalid or unenforceable; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">others may be able to develop and/or practice technology, including compounds that are similar to the chemical compositions of our current or future product candidates, that is similar to our technology or aspects of our technology but that is not covered by the claims of any patents we may own or in-license, should any patents issue; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">third parties may compete with us in jurisdictions where we do not pursue and obtain patent protection; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we, or our future licensors or collaborators, might not have been the first to make the inventions covered by a patent application that we own or may in-license; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we, or our future licensors or collaborators, might not have been the first to file patent applications covering a particular invention; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">others may independently develop similar or alternative technologies without infringing, misappropriating or otherwise violating our intellectual property rights; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our competitors might conduct research and development activities in the U.S. and other countries that provide a safe harbor from patent infringement claims for certain research and development activities, as well as in countries where we do not have patent rights, and may then use the information learned from such activities to develop competitive products for sale in our major commercial markets; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not be able to obtain and/or maintain necessary licenses on reasonable terms or at all; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">third parties may assert an ownership interest in our intellectual property and, if successful, such disputes may preclude us from exercising exclusive rights, or any rights at all, over that intellectual property; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may choose not to file a patent in order to maintain certain trade secrets or know-how, and a third party may subsequently file a patent covering such trade secrets or know-how; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not be able to maintain the confidentiality of our trade secrets or other proprietary information; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not develop or in-license additional proprietary technologies that are patentable; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the patents of others may have an adverse effect on our business. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Should any of these events occur, they could significantly harm our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Patent Protection</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Obtaining and maintaining our patent protection, including patent term, depends on compliance with various procedural, document submission, deadlines, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated if we miss a filing deadline for patent protection on these inventions or otherwise fail to comply with these requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The USPTO and foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process and after issuance of any patent. In addition, periodic maintenance fees, renewal fees, annuity fees and/or various other government fees are required to be paid periodically. While an inadvertent lapse can in some cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. In such an event, our competitors might be able to enter the market with similar or identical products or platforms, which could have a material adverse effect on our business prospects and financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depending upon the timing, duration and specifics of FDA marketing approval of our current or future product candidates, one or more of the U.S. patents we own or license may be eligible for limited patent term restoration under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent restoration term of up to five years as compensation for patent term lost during product development and the FDA regulatory review process. Different laws govern the extension of patents on approved pharmaceutical products in Europe and other jurisdictions. However, we may not be granted a patent extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. For example, we may not be granted an extension in the U.S. if all of our patents covering an approved product expire more than fourteen years from the date of NDA approval for a product covered by those patents. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or restoration or the term of any such extension is less than we request, our competitors may obtain approval of competing products following our patent expiration, and our ability to generate revenues could be materially adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in patent law could diminish the value of patents in general, thereby impairing our ability to protect our current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involve both technological and legal complexity and are therefore costly, time consuming and inherently uncertain.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. Additionally, there have been recent proposals for additional changes to the patent laws of the U.S. and other countries that, if adopted, could impact our ability to obtain patent protection for our proprietary technology or our ability to enforce our proprietary technology. Depending on future actions by the U.S. Congress, the U.S. courts, the USPTO and the relevant law-making bodies in other countries, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to our Trademarks, Trade Names and Trade Secrets</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If our trademarks and trade names for our products or company name are not adequately protected in one or more countries where we intend to market our products, we may delay the launch of product brand names, use different or less effective trademarks or tradenames in different countries, or face other potentially adverse consequences to building our product brand recognition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our trademarks or trade name may be challenged, infringed, diluted, circumvented, declared generic, or determined to be infringing on other marks. In such a circumstance, we may not be able to protect our rights to these marks or may be forced to stop using product names, which we need for name recognition by potential partners and customers in our markets of interest.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, during the trademark registration process, we may receive Office Actions from the USPTO or from comparable agencies in foreign jurisdictions refusing registration of our trademarks. For example, in April 2021, the USPTO issued preliminary office action refusals against our applications to register E3 LIGASE WHOLE BODY ATLAS and E3 HUMAN ATLAS. While E3 HUMAN ATLAS has now been approved for publication, we do not yet know whether the USPTO will issue a subsequent office action against our application for E3 LIGASE WHOLE BODY ATLAS, to which we will have to respond, and which we may not ultimately be able to overcome, or if this application will be approved for publication as well.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the USPTO and in comparable agencies in many foreign jurisdictions, third parties are also given an opportunity to oppose pending trademark applications and/or to seek the cancellation of registered trademarks. For example, in November 2019, Novartis AG filed actions in the U.S. and European Union trademark offices opposing our applications to register KYMERA and KYMERA THERAPEUTICS for pharmaceuticals and drug development services on the basis of its claimed rights in the KYMRIAH mark. This dispute was amicably settled in October 2020 and the involved applications for KYMERA and KYMERA THERAPEUTICS are now registered or allowed in the United States and have proceeded to registration in the European Union.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are unable to adequately protect and enforce our trade secrets, our business and competitive position would be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to the protection afforded by patents we may own or in-license, we seek to rely on trade secret protection, confidentiality agreements, and license agreements to protect proprietary know-how that may not be patentable, processes for which patents are difficult to enforce and any other elements of our product discovery and development processes that involve proprietary know-how, information, or technology that may not be covered by patents. Although we require all of our employees, consultants, advisors and any third parties who have access to our proprietary know-how, information, or technology to enter into confidentiality agreements, trade secrets can be difficult to protect and we have limited control over the protection of trade secrets used by our collaborators and suppliers. We cannot be certain that we have or will obtain these agreements in all circumstances and we cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary information.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, any of these parties might breach the agreements and intentionally or inadvertently disclose our trade secret information and we may not be able to obtain adequate remedies for such breaches. In addition, competitors may otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. If we choose to go to court to stop a third party from using any of our trade secrets, we may incur substantial costs. These lawsuits may consume our time and other resources even if we are successful. Furthermore, the laws of some foreign countries do not protect proprietary rights and trade secrets to the same extent or in the same manner as the laws of the U.S. As a result, we may encounter significant problems in protecting and defending our intellectual property both in the U.S. and abroad. If we are unable to prevent unauthorized material disclosure of our intellectual property to third parties, we will not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, financial condition, results of operations and future prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the case of employees, we enter into agreements providing that all inventions conceived by the individual, and which are related to our current or planned business or research and development or made during normal working hours, on our premises or using our equipment or proprietary information, are our exclusive property. Although we require all of our employees to assign their inventions to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Such claims could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Intellectual Property Litigation and Infringement Claims</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may initiate, become a defendant in, or otherwise become party to lawsuits to protect or enforce our intellectual property rights, which could be expensive, time-consuming and unsuccessful.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competitors may infringe any intellectual property we may own or in-license, including our patents and trademarks. In addition, any intellectual property we may own or in-license also may become the subject of a dispute, including those based on inventorship, priority, validity or unenforceability. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. In addition, in an infringement proceeding, a court may decide that any intellectual property we may own or in-license is not valid or is unenforceable or that the other party&#x2019;s use of our technology that may be patented falls under the safe harbor to patent infringement under 35 U.S.C. &#167;271(e)(1). There is also the risk that, even if the validity of these patents is upheld, the court may refuse to stop the other party from using the technology at issue on the grounds that any patents we may own or in-license do not cover the technology in question or that such third party&#x2019;s activities do not infringe our patent applications or any patents we may own or in-license. An adverse result in any litigation or defense proceedings could put one or more of any patents or other intellectual property we may own or in-license at risk of being invalidated, held unenforceable, or interpreted narrowly and could put our own applications at risk of not issuing. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, patient support or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-grant proceedings provoked by third parties or brought by the USPTO may be necessary to determine the validity or priority of inventions with respect to our patent applications or any patents we may own or in-license. These proceedings are expensive and an unfavorable outcome could result in a loss of our current patent rights and could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms. In addition to potential USPTO post-grant proceedings, we may become a party to patent opposition proceedings in the EPO, or similar proceedings in other foreign patent offices or courts where our patents may be challenged. The costs of these proceedings could be substantial, and may result in a loss of scope of some claims or a loss of the entire patent. An unfavorable result in a post-grant challenge proceeding may result in the loss of our right to exclude others from practicing one or more of our inventions in the relevant country or jurisdiction, which could have a material adverse effect on our business. Litigation or post-grant proceedings within patent offices may result in a decision adverse to our interests and, even if we are successful, may result in substantial costs and distract our management and other employees. We may not be able to prevent misappropriation of our trade secrets or confidential information, particularly in countries where the laws may not protect those rights as fully as in the U.S.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may not be able to detect infringement against any intellectual property we may own or in-license. Even if we detect infringement by a third party of any intellectual property we may own or in-license, we may choose not to pursue litigation against or settlement with the third party. If we later sue such third party for infringement, the third party may have certain legal defenses available to it, which otherwise would not be available except for the delay between when the infringement was first detected and when the suit was brought. Such legal defenses may make it impossible for us to enforce any patents or other intellectual property we may own or in-license against such third party.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual property litigation and administrative office challenges in one or more countries could cause us to spend substantial resources and distract our personnel from their normal responsibilities. Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses, and could distract our technical and management personnel from their normal responsibilities. In August 2021, we initiated a US patent office proceeding, a post-grant review, to challenge a third-party patent unrelated to our current product candidates. In response, the owner of the challenged third-party patent disclaimed that patent in full.  We may challenge additional third-party patents in the future. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, patient support or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. As noted above, some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could compromise our ability to compete in the marketplace, including compromising our ability to raise the funds necessary to continue our preclinical studies and future clinical trials, continue our research programs, license necessary technology from third parties, or enter into development collaborations that would help us commercialize our current or future product candidates, if approved. Any of the foregoing events would harm our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be subject to damages or settlement costs resulting from claims that we or our employees have violated the intellectual property rights of third parties, or are in breach of our agreements. We may be accused of, allege or otherwise become party to lawsuits or disputes alleging wrongful disclosure of third-party confidential information by us or by another party, including current or former employees, contractors or consultants. In addition to diverting attention and resources, such disputes could adversely impact our business reputation and/or protection of our proprietary technology.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The intellectual property landscape relevant to our product candidates and programs is crowded, and third parties may initiate legal proceedings alleging that we are infringing, misappropriating or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business. Our commercial success depends upon our ability to develop, manufacture, market and sell our current and future product candidates and use our proprietary technologies without infringing, misappropriating or otherwise violating the intellectual property rights of third parties. There is a substantial amount of litigation involving patents and other intellectual property rights in the biotechnology and pharmaceutical industries, as well as administrative proceedings for challenging patents, including derivation, interference, reexamination, inter partes review and post grant review proceedings before the USPTO or oppositions and other comparable proceedings in foreign jurisdictions. We or any of our current or future licensors or strategic partners may be party to, exposed to, or threatened with, future adversarial proceedings or litigation by third parties having patent or other intellectual property rights alleging that our current or future product candidates and/or proprietary technologies infringe, misappropriate or otherwise violate their intellectual property rights. We cannot assure you that our current or future product candidates, the Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform, and other technologies that we have developed, are developing or may develop in the future do not or will not infringe, misappropriate or otherwise violate existing or future patents or other intellectual property rights owned by third parties. For example, many of our employees were previously employed at other biotechnology or pharmaceutical companies. Although we try to ensure that our employees, consultants and advisors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these individuals have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#x2019;s former employer. We may also be subject to claims that patents and applications we have filed to protect inventions of our employees, consultants and advisors, even those related to one or more of our current or future product candidates, the Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform, or other technologies, are rightfully owned by their former or concurrent employer. Litigation may be necessary to defend against these claims.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While certain activities related to development and preclinical and clinical testing of our current or future product candidates may be subject to safe harbor of patent infringement under 35 U.S.C. &#167;271(e)(1), upon receiving FDA approval for such candidates we or any of our future licensors or strategic partners may immediately become party to, exposed to, or threatened with, future adversarial proceedings or litigation by third parties having patent or other intellectual property rights</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">105</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">alleging that such product candidates infringe, misappropriate or otherwise violate their intellectual property rights. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing our current or future product candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our current or future product candidates may give rise to claims of infringement of the patent rights of others. Moreover, it is not always clear to industry participants, including us, which patents cover various types of drugs, products or their methods of use or manufacture. Thus, because of the large number of patents issued and patent applications filed in our fields, there may be a risk that third parties may allege they have patent rights encompassing our current or future product candidates, technologies or methods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If a third party claims that we infringe, misappropriate or otherwise violate its intellectual property rights, we may face a number of issues, including, but not limited to:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">infringement, misappropriation and other intellectual property claims which, regardless of merit, may be expensive and time-consuming to litigate and may divert our management&#x2019;s attention from our core business and may impact our reputation; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">substantial damages for infringement, misappropriation or other violations, which we may have to pay if a court decides that the product candidate or technology at issue infringes, misappropriates or violates the third party&#x2019;s rights, and, if the court finds that the infringement was willful, we could be ordered to pay treble damages and the patent owner&#x2019;s attorneys&#x2019; fees; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a court prohibiting us from developing, manufacturing, marketing or selling our current or future product candidates, or from using our proprietary technologies, including our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform, unless the third-party licenses its product rights to us, which it is not required to do on commercially reasonable terms or at all; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if a license is available from a third party, we may have to pay substantial royalties, upfront fees and other amounts, and/or grant cross-licenses to intellectual property rights for our products, or the license to us may be non-exclusive, which would permit third parties to use the same intellectual property to compete with us; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">redesigning our current or future product candidates or processes so they do not infringe, misappropriate or violate third-party intellectual property rights, which may not be possible or may require substantial monetary expenditures and time; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and, if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Some of our competitors may be able to sustain the costs of litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations or could otherwise have a material adverse effect on our business, results of operations, financial condition and prospects. The occurrence of any of the foregoing could have a material adverse effect on our business, financial condition, results of operations or prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third parties may assert that we are employing their proprietary technology without authorization. Patents issued in the U.S. by law enjoy a presumption of validity that can be rebutted in U.S. courts only with evidence that is &#x201c;clear and convincing,&#x201d; a heightened standard of proof. There may be issued third-party patents of which we are currently unaware with claims to compositions, formulations, methods of manufacture or methods for treatment related to the use or manufacture of our current or future product candidates. Patent applications can take many years to issue. In addition, because some patent applications in the U.S. may be maintained in secrecy until the patents are issued, patent applications in the U.S. and many foreign jurisdictions are typically not published until 18 months after their earliest priority filing date, and publications in the scientific literature often lag behind actual discoveries, we cannot be certain that others have not filed patent applications covering our current or future product candidates or technology. If any such patent applications issue as patents, and if such patents have priority over our patent applications or patents we may own or in-license, we may be required to obtain rights to such patents owned by third parties which may not be available on commercially reasonable terms or at all, or may only be available on a non-exclusive basis. There may be currently pending third-party patent applications which may later result in issued patents that our current or future product candidates may infringe. It is also possible that patents owned by third parties of which we are aware, but which we do not believe are relevant to our current or future product candidates or other technologies, could be found to be infringed by our current or future product candidates or other technologies. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. Moreover, we may fail to identify relevant patents or incorrectly conclude that a patent is invalid, not enforceable, exhausted, or not infringed by our activities. If any third-party patents were held by a court of competent jurisdiction to cover the manufacturing process of our current or future product</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">candidates, molecules used in or formed during the manufacturing process, or any final product itself, the holders of any such patents may be able to block our ability to commercialize the product candidate unless we obtained a license under the applicable patents, or until such patents expire or they are finally determined to be held invalid or unenforceable. Similarly, if any third-party patent were held by a court of competent jurisdiction to cover aspects of our formulations, processes for manufacture or methods of use, including combination therapy or patient selection methods, the holders of any such patent may be able to block our ability to develop and commercialize the product candidate unless we obtained a license or until such patent expires or is finally determined to be held invalid or unenforceable. In either case, such a license may not be available on commercially reasonable terms or at all. If we are unable to obtain a necessary license to a third-party patent on commercially reasonable terms, or at all, our ability to commercialize our current or future product candidates or Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform may be impaired or delayed, which could in turn significantly harm our business. Even if we obtain a license, it may be nonexclusive, thereby giving our competitors access to the same technologies licensed to us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Parties making claims against us may seek and obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize our current or future product candidates. Defense of these claims, regardless of their merit, could involve substantial litigation expense and would be a substantial diversion of employee resources from our business. In the event of a successful claim of infringement, misappropriation or other violation against us, we may have to pay substantial damages, including treble damages and attorneys&#x2019; fees for willful infringement, obtain one or more licenses from third parties, pay royalties or redesign our infringing products, which may be impossible or require substantial time and monetary expenditure. We cannot predict whether any such license would be available at all or whether it would be available on commercially reasonable terms. Furthermore, even in the absence of litigation, we may need or may choose to obtain licenses from third parties to advance our research or allow commercialization of our current or future product candidates. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all. In that event, we would be unable to further develop and commercialize our current or future product candidates or technologies, which could harm our business significantly.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or expiration of a third-party patent, which might subject us to infringement claims or adversely affect our ability to develop and market our current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot guarantee that any of our or our licensors&#x2019; patent searches or analyses, including the identification of relevant patents, the scope of patent claims or the expiration of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every third-party patent and pending patent application in the U.S. and abroad that is relevant to or necessary for the commercialization of our current or future product candidates in any jurisdiction. For example, U.S. patent applications filed before November 29, 2000 and certain U.S. patent applications filed after that date that will not be filed outside the U.S. remain confidential until patents issue. As mentioned above, patent applications in the U.S. and elsewhere are published approximately 18 months after the earliest filing for which priority is claimed, with such earliest filing date being commonly referred to as the priority date. Therefore, patent applications covering our current or future product candidates could have been filed by third parties without our knowledge. Additionally, pending patent applications that have been published can, subject to certain limitations, be later amended in a manner that could cover our current or future product candidates or the use of our current or future product candidates. The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#x2019;s prosecution history. Our interpretation of the relevance or the scope of a patent or a pending application may be incorrect, which may negatively impact our ability to market our current or future product candidates. We may incorrectly determine that our current or future product candidates are not covered by a third-party patent or may incorrectly predict whether a third party&#x2019;s pending application will issue with claims of relevant scope. Our determination of the expiration date of any patent in the U.S. or abroad that we consider relevant may be incorrect, which may negatively impact our ability to develop and market our current or future product candidates. Our failure to identify and correctly interpret relevant patents may negatively impact our ability to develop and market our current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we fail to identify and correctly interpret relevant patents, we may be subject to infringement claims. We cannot guarantee that we will be able to successfully settle or otherwise resolve such infringement claims. If we fail in any such dispute, in addition to being forced to pay damages, which may be significant, we may be temporarily or permanently prohibited from commercializing any of our current or future product candidates or technologies that are held to be infringing. We might, if possible, also be forced to redesign current or future product candidates so that we no longer infringe the third-party intellectual property rights. Any of these events, even if we were ultimately to prevail, could require us to divert substantial financial and management resources that we would otherwise be able to devote to our business and could adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Employee Matters, Managing Growth and Other Risks Related to Our Business</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Employee Matters and Managing Growth</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our future success depends on our ability to retain key executives and to attract, retain and motivate qualified personnel.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are highly dependent on the research and development, clinical and business development expertise of Nello Mainolfi, Ph.D., our President and Chief Executive Officer, Jared Gollob, M.D., our Chief Medical Officer, Bruce Jacobs, our Chief Financial Officer and Elaine Caughey, our Chief Business Officer, as well as the other principal members of our management, scientific and clinical teams. Although we have entered into employment letter agreements with our executive officers, each of them may terminate their employment with us at any time. We do not maintain &#x201c;key person&#x201d; insurance for any of our executives or other employees. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. If we are unable to continue to attract and retain high quality personnel, our ability to pursue our growth strategy will be limited.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recruiting and retaining qualified scientific, clinical, manufacturing and sales and marketing personnel will also be critical to our success. The loss of the services of our executive officers or other key employees could impede the achievement of our research, development and commercialization objectives and seriously harm our ability to successfully implement our business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, gain regulatory approval of and commercialize drugs. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. Failure to succeed in clinical trials may make it more challenging to recruit and retain qualified scientific personnel.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We will need to develop and expand our company, and we may encounter difficulties in managing this development and expansion, which could disrupt our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had 167 full-time employees, and we will continue to increase our number of employees and the scope of our operations. To manage our anticipated development and expansion, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel. Our management may need to divert a disproportionate amount of its attention away from its day-to-day activities and devote a substantial amount of time to managing these development activities. Due to our limited resources, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. This may result in weaknesses in our infrastructure, give rise to operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. The expansion of our operations may lead to significant costs and may divert financial resources from other projects, such as the development of our current or future product candidates. If our management is unable to effectively manage our expected development and expansion, our expenses may increase more than expected, our ability to generate or increase our revenue could be reduced and we may not be able to implement our business strategy. Our future financial performance and our ability to commercialize our current or future product candidates, if approved, and compete effectively will depend, in part, on our ability to effectively manage the future development and expansion of our company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We or the third parties upon whom we depend may be adversely affected by unforeseen global events, natural disasters, and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unforeseen global events, such as increasing inflation and interest rates and the related U.S. and global economic impact or the 2022 Russian invasion of Ukraine, could adversely impact our business. Such conflicts could lead to sanctions, embargoes, supply shortages, regional instability, geopolitical shifts, cyberattacks, other retaliatory actions, and adverse effects on macroeconomic conditions, currency exchange rates, and financial markets, which could adversely impact our operations and financial results, as well as those of third parties with whom we conduct business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, any unplanned event, such as flood, fire, explosion, earthquake, extreme weather condition, medical epidemics, including any potential effects from the current global spread of COVID-19, power shortage, telecommunication failure or other natural or man-made accidents or incidents that result in us being unable to fully utilize our facilities, or the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">108</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing facilities of our third-party contract manufacturers, may have a material and adverse effect on our ability to operate our business and have significant negative consequences on our financial and operating conditions. Loss of access to these facilities may result in increased costs, delays in the development of our product candidates or interruption of our business operations. Natural disasters or pandemics such as the COVID-19 pandemic could further disrupt our operations, and have a material and adverse effect on our business, financial condition, results of operations and prospects. For example, we have instituted a temporary work from home policy for non-essential office personnel and it is possible that this could have a negative impact on the execution of our business plans and operations. If a natural disaster, power outage or other event occurred that prevented us from using all or a significant portion of our headquarters, that damaged critical infrastructure, such as our research facilities or the manufacturing facilities of our third-party contract manufacturers, or that otherwise disrupted operations, it may be difficult or, in certain cases, impossible, for us to continue our business for a substantial period of time. The disaster recovery and business continuity plans we have in place may prove inadequate in the event of a serious disaster or similar event. We may incur substantial expenses as a result of the limited nature of our disaster recovery and business continuity plans, which could have a material adverse effect on our business. As part of our risk management policy, we maintain insurance coverage at levels that we believe are appropriate for our business. However, in the event of an accident or incident at these facilities, we cannot assure our investors that the amounts of insurance will be sufficient to satisfy any damages and losses. If our facilities or the manufacturing facilities of our third-party contract manufacturers are unable to operate because of an accident or incident or for any other reason, even for a short period of time, any or all of our research and development programs may be harmed. Any business interruption may have a material and adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Data and Privacy</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our internal computer systems, or those of our third-party CROs or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of our current or future product candidates&#x2019; development programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Despite the implementation of security measures, our internal computer systems and those of our third-party CROs and other contractors and consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. While we have not experienced any such system failure, accident, or security breach to date, if such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our programs. For example, the loss of data from preclinical studies or clinical trials for our current or future product candidates could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security breach results in a loss of or damage to our data or applications, other data or applications relating to our technology or current or future product candidates, or inappropriate disclosure of confidential or proprietary information, we could incur liabilities and the further development of our current or future product candidates could be delayed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be unable to adequately protect our information systems from cyberattacks, which could result in the disclosure of confidential or proprietary information, including personal data, damage our reputation, and subject us to significant financial and legal exposure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on information technology systems that we or our third-party providers operate to process, transmit and store electronic information in our day-to-day operations. In connection with our product discovery efforts, we may collect and use a variety of personal data, such as names, mailing addresses, email addresses, phone numbers and clinical trial information. A successful cyberattack could result in the theft or destruction of intellectual property, data or other misappropriation of assets, or otherwise compromise our confidential or proprietary information and disrupt our operations. Cyberattacks are increasing in their frequency, sophistication and intensity, and have become increasingly difficult to detect. Cyberattacks could include wrongful conduct by hostile foreign governments, industrial espionage, wire fraud and other forms of cyber fraud, the deployment of harmful malware, denial-of-service, social engineering fraud or other means to threaten data security, confidentiality, integrity and availability. A successful cyberattack could cause serious negative consequences for us, including, without limitation, the disruption of operations, the misappropriation of confidential business information, including financial information, trade secrets, financial loss and the disclosure of corporate strategic plans. Although we devote resources to protect our information systems, we realize that cyberattacks are a threat, and there can be no assurance that our efforts will prevent information security breaches that would result in business, legal, financial or reputational harm to us, or would have a material adverse effect on our results of operations and financial condition. Any failure to prevent or mitigate security breaches or improper access to, use of, or disclosure of our clinical data or patients&#x2019; personal data could result in significant liability under state (e.g., state breach notification laws), federal (e.g., HIPAA, as amended by HITECH), and international law (e.g., the EU General Data Protection Regulation, or GDPR) and may cause a material adverse impact to our reputation, affect our ability to use collected data, conduct new studies and potentially disrupt our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">109</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on our third-party providers to implement effective security measures and identify and correct for any such failures, deficiencies or breaches. We also rely on our employees and consultants to safeguard their security credentials and follow our policies and procedures regarding use and access of computers and other devices that may contain our sensitive information. If we or our third-party providers fail to maintain or protect our information technology systems and data integrity effectively or fail to anticipate, plan for or manage significant disruptions to our information technology systems, we or our third-party providers could have difficulty preventing, detecting and controlling such cyber-attacks and any such attacks could result in losses described above, as well as disputes with physicians, patients and our partners, regulatory sanctions or penalties, increases in operating expenses, expenses or lost revenues or other adverse consequences, any of which could have a material adverse effect on our business, results of operations, financial condition, prospects and cash flows. Any failure by such third parties to prevent or mitigate security breaches or improper access to or disclosure of such information could have similarly adverse consequences for us. If we are unable to prevent or mitigate the impact of such security or data privacy breaches, we could be exposed to litigation and governmental investigations, which could lead to a potential disruption to our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Common Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The price of our common stock has been and may continue to be volatile and fluctuate substantially, and investors may lose all or part of their investment.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our stock price has been volatile and may continue to be subject to wide fluctuations in response to various factors. The stock market in general and the market for biopharmaceutical companies in particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies, including in connection with developments related to COVID-19, the conflict between Russia and Ukraine and related sanctions against Russia, increasing inflation rates, and interest rate changes, which have resulted in decreased stock prices for many companies notwithstanding the lack of a fundamental change in their underlying business models or prospects. As a result of this volatility, you may lose all or part of your investment. The market price for our common stock may be influenced by many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the success of competitive drugs or technologies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">results of preclinical studies and clinical trials of our current or future product candidates or those of our competitors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory or legal developments in the U.S. and other countries; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">developments or disputes concerning patent applications, issued patents or other proprietary rights; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the recruitment or departure of key personnel; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the level of expenses related to any of our current or future product candidates or clinical development programs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the results of our efforts to discover, develop, acquire or in-license additional current or future product candidates or drugs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">variations in our financial results or those of companies that are perceived to be similar to us;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in the structure of healthcare payment systems; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">market conditions in the pharmaceutical and biotechnology sectors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements regarding our collaboration agreements, including announcements regarding our collaboration agreement with Sanofi;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">general economic, industry and market conditions; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the other factors described in this &#x201c;Risk Factors&#x201d; section. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These and other market and industry factors may cause the market price and demand for shares of our common stock to fluctuate substantially, regardless of our actual operating performance, which may limit or prevent investors from selling their shares at or above the price paid for the shares and may otherwise negatively affect the liquidity of our common stock. The realization of any of the above risks or any of a broad range of other risks, including those described in this section, could have a significant and material adverse impact on the market price of our common stock. The price of our common stock may be disproportionately affected as investors may favor traditional profit-making industries and companies during the times of market uncertainty and instability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Unstable market and economic conditions may have serious adverse consequences on our business, financial condition and stock price.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As widely reported, global credit and financial markets have experienced extreme volatility and disruptions in the past several years, including severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates and uncertainty about economic stability, including most recently in connection with the ongoing COVID-19 pandemic. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. Our general business strategy may be adversely affected by any such economic downturn, volatile business environment or continued unpredictable and unstable market conditions. If the current equity and credit markets deteriorate, or do not improve, it may make any necessary debt or equity financing more difficult, more costly, and more dilutive. Furthermore, our stock price may decline due in part to the volatility of the stock market and the general economic downturn.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay, scale back or discontinue the development and commercialization of one or more of our product candidates or delay our pursuit of potential in-licenses or acquisitions. In addition, there is a risk that one or more of our current service providers, manufacturers and other partners may not survive these difficult economic times, which could directly affect our ability to attain our operating goals on schedule and on budget.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of private and public equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. We do not currently have any committed external source of funds. To the extent that we raise additional capital through the sale of common stock or securities convertible or exchangeable into common stock, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that materially adversely affect your rights as a common stockholder. Debt financing, if available, would increase our fixed payment obligations and may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we raise funds through additional collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our intellectual property, future revenue streams, research programs or current or future product candidates or to grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, scale back or discontinue the development and commercialization of one or more of our product candidates, delay our pursuit of potential in-licenses or acquisitions or grant rights to develop and market current or future product candidates that we would otherwise prefer to develop and market ourselves.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If securities analysts do not publish research or reports about our business or if they publish negative evaluations of our stock, the price of our stock could decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The trading market for our common stock will rely in part on the research and reports that industry or financial analysts publish about us or our business. We do not have control over these analysts. Although we have obtained research coverage from certain analysts, there can be no assurance that analysts will continue to cover us or provide favorable coverage. If one or more of the analysts covering our business downgrade their evaluations of our stock, the price of our stock could decline. In addition, if one or more of these analysts cease to cover our stock, we could lose visibility in the market for our stock, which in turn could cause our stock price to decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">111</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our executive officers, directors, principal stockholders and their affiliates exercise significant influence over our company, which will limit your ability to influence corporate matters and could delay or prevent a change in corporate control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the existing holdings of our executive officers, directors, principal stockholders and their affiliates represent beneficial ownership, in the aggregate, of approximately 31% of our outstanding common stock. As a result, these stockholders, if they act together, will be able to influence our management and affairs and the outcome of matters submitted to our stockholders for approval, including the election of directors and any merger, consolidation or sale of all or substantially all of our assets. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel are in your best interest as one of our stockholders. Some of these persons or entities may have interests different than yours. For example, because many of these stockholders purchased their shares at prices substantially below the current trading price of our stock and have held their shares for a longer period, they may be more interested in selling our Company to an acquirer than other investors or they may want us to pursue strategies that deviate from the interests of other stockholders. Additionally, from time to time, any of our non-affiliated shareholders may accumulate or acquire significant positions in our common stock and may similarly be able to influence our business or matters submitted to our stockholders for approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The concentration of voting power among these stockholders may also have an adverse effect on the price of our common stock by delaying, deferring or preventing a change of control of us; impeding a merger, consolidation, takeover or other business combination involving us; or discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sales of a substantial number of shares of our common stock in the public market could cause our stock price to fall.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales or the perception in the market that the holders of a large number of shares of common stock intend to sell shares, could reduce the market price of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares issued upon the exercise of stock options outstanding under our equity incentive plans or pursuant to future awards granted under those plans will become available for sale in the public market to the extent permitted by the provisions of applicable vesting schedules, any applicable market standoff and lock-up agreements, and Rule 144 and Rule 701 under the Securities Act.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain holders of our common stock have rights, subject to conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. We have also filed registration statements on Form S-8 registering the issuance of shares of common stock issued or reserved for future issuance under our equity compensation plans. Shares registered under this registration statement on Form S-8 can be freely sold in the public market upon issuance and once vested, subject to volume limitations applicable to affiliates. If any of these additional shares are sold, or if it is perceived that they will be sold, in the public market, the market price of our common stock could decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital appreciation, if any, will be investors&#x2019; sole source of gain.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have never declared or paid cash dividends on our capital stock. We currently intend to retain all of our future earnings, if any, to finance the growth and development of our business. As a result, capital appreciation, if any, of our common stock will be investors&#x2019; sole source of gain for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be at an increased risk of securities class action litigation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Historically, securities class action litigation has often been brought against a company following a decline in the market price of its securities. This risk is especially relevant for us because biotechnology and pharmaceutical companies have experienced significant stock price volatility in recent years. If we were to be sued, it could result in substantial costs and a diversion of management&#x2019;s attention and resources, which could harm our business. Additionally, any lawsuit to which we are a party, with or without merit, may result in an unfavorable judgment. We also may decide to settle lawsuits on unfavorable terms. Any such negative outcome could result in payments of substantial damages or fines, damage to our reputation or adverse changes to our business practices. Furthermore, during the course of litigation, there could be negative public announcements of the results of hearings, motions or other interim proceedings or developments, which could have a negative effect on the market price of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Tax</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in tax law may adversely affect us or our investors.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The rules dealing with U.S. federal, state and local income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service, or IRS, and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect us or holders of our common stock. In recent years, many changes have been made and changes are likely to continue to occur in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional changes to U.S. federal income tax law are currently being contemplated, and future changes in tax laws could have a material adverse effect on our business, cash flow, financial condition or results of operations. It cannot be predicted whether, when, in what form, or with what effective dates, new tax laws may be enacted, or regulations and rulings may be enacted, promulgated or issued under existing or new tax laws, which could result in an increase in our or our stockholders&#x2019; tax liability or require changes in the manner in which we operate in order to minimize or mitigate any adverse effects of changes in tax law or in the interpretation thereof. You are urged to consult your tax advisor regarding the implications of potential changes in tax laws on an investment in our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our ability to utilize our net operating loss carryforwards and certain other tax attributes to offset future taxable income may be subject to certain limitations, and, as a result, unavailable to reduce our future tax liability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had federal and state net operating loss carryforwards of $153.9 million and $139.8 million, respectively, which begin to expire in various amounts in 2036 (other than federal net operating loss carryforwards arising in taxable years beginning after December 31, 2017, which are not subject to expiration but the deductibility of such federal NOLs may be limited to 80% of our taxable income annually for tax years beginning after December 31, 2020). As of December 31, 2022, we also had federal and state research and development tax credit carryforwards of $12.7 million and $6.1 million, respectively, which begin to expire in 2036. These net operating loss and tax credit carryforwards could expire unused and be unavailable to offset future income tax liabilities. In addition, in general, under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, or the Code, a corporation that undergoes an &#x201c;ownership change&#x201d; is subject to limitations on its ability to utilize its pre-change net operating losses or tax credits, or NOLs or credits, to offset future taxable income or taxes. For these purposes, an ownership change generally occurs where the aggregate stock ownership of one or more stockholders or groups of stockholders who own at least 5% of a corporation&#x2019;s stock increases by more than 50 percentage points over the lowest ownership percentage of such stockholders or groups of stockholders within a specified testing period. Our existing NOLs or credits may be subject to limitations arising from previous ownership changes. In addition, future changes in our stock ownership, many of which are outside of our control, could result in an ownership change under Sections 382 and 383 of the Code and limit our ability to utilize NOLs or credit. Our NOLs or credits may also be impaired under state law. Accordingly, we may not be able to utilize a material portion of our NOLs or credits. Furthermore, our ability to utilize our NOLs or credits is conditioned upon our attaining profitability and generating U.S. federal and state taxable income. As described above under &#x201c;Risk Factors&#x2014;Risks Related to our Financial Position and Need for Additional Capital,&#x201d; we have incurred significant net losses since our inception and anticipate that we will continue to incur significant losses for the foreseeable future; and therefore, we do not know whether or when we will generate the U.S. federal or state taxable income necessary to utilize our NOLs or credit carryforwards that are subject to limitation by Sections 382 and 383 of the Code.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Controls and Reporting Requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to maintain proper and effective internal control over financial reporting, our operating results and our ability to operate our business could be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ensuring that we have adequate internal financial and accounting controls and procedures in place so that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be re-evaluated frequently. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles. Pursuant to Section 404 of the Sarbanes&#x2011;Oxley Act of 2002, or Section 404, we are required to furnish a report by our management on our internal control over financial reporting, including an attestation report on internal control over financial reporting issued by our independent registered public accounting firm.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">113</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To achieve compliance with Section 404, we have engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will be able to conclude within the prescribed timeframe that our internal control over financial reporting is effective as required by Section 404. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements. In addition, investors&#x2019; perceptions that our internal controls are inadequate or that we are unable to produce accurate financial statements on a timely basis may harm our stock price and make it more difficult for us to effectively market and sell any of our present or future product candidates that may receive regulatory approval.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to certain reporting requirements of the Exchange Act. Our disclosure controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to management, recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements or insufficient disclosures due to error or fraud may occur and not be detected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Charter and Bylaws</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Anti-takeover provisions under our charter documents and Delaware law could delay or prevent a change of control, which could limit the market price of our common stock and may prevent or frustrate attempts by our stockholders to replace or remove our current management.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our fourth amended and restated certificate of incorporation and our second amended and restated bylaws contain provisions that could delay or prevent a change of control of our company or changes in our board of directors that our stockholders might consider favorable. Some of these provisions include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a board of directors divided into three classes serving staggered three-year terms, such that not all members of the board will be elected at one time; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a prohibition on stockholder action through written consent, which requires that all stockholder actions be taken at a meeting of our stockholders; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a requirement that special meetings of stockholders be called only by the board of directors acting pursuant to a resolution approved by the affirmative vote of a majority of the directors then in office; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">advance notice requirements for stockholder proposals and nominations for election to our board of directors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a requirement that no member of our board of directors may be removed from office by our stockholders except for cause and, in addition to any other vote required by law, upon the approval of not less than two-thirds of all outstanding shares of our voting stock then entitled to vote in the election of directors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a requirement of approval of not less than two-thirds of all outstanding shares of our voting stock to amend any bylaws by stockholder action or to amend specific provisions of our certificate of incorporation; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the authority of the board of directors to issue preferred stock on terms determined by the board of directors without stockholder approval and which preferred stock may include rights superior to the rights of the holders of common stock. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporate Law, or DGCL, which may prohibit certain business combinations with stockholders owning 15% or more of our outstanding voting stock. These antitakeover provisions and other provisions in our fourth amended and restated certificate of incorporation and amended and restated bylaws could make it more difficult for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by the then-current board of directors and could</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">114</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">also delay or impede a merger, tender offer or proxy contest involving our company. These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to elect directors of your choosing or cause us to take other corporate actions you desire. Any delay or prevention of a change of control transaction or changes in our board of directors could cause the market price of our common stock to decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our amended and restated bylaws designate specific courts as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders&#x2019; ability to obtain a favorable judicial forum for disputes with us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to our amended and restated bylaws, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware is the sole and exclusive forum for any state law claims for (1) any derivative action or proceeding brought on our behalf; (2) any action asserting a claim of or based on a breach of a fiduciary duty owed by any director, officer or other employee of ours to us or our stockholders; (3) any action asserting a claim pursuant to any provision of the DGCL, our amended and restated certificate of incorporation or our amended and restated bylaws; or (4) any action asserting a claim governed by the internal affairs doctrine, or the Delaware Forum Provision. The Delaware Forum Provision will not apply to any causes of action arising under the Securities Act or the Exchange Act. Our amended and restated bylaws further provide that unless we consent in writing to the selection of an alternative forum, the United States District Court for the District of Massachusetts shall be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, or the Federal Forum Provision. In addition, our amended and restated bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize that the Delaware Forum Provision and the Federal Forum Provision in our amended and restated bylaws may impose additional litigation costs on stockholders in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware or the Commonwealth of Massachusetts, as applicable. Additionally, the forum selection clauses in our amended and restated bylaws may limit our stockholders&#x2019; ability to bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers or employees, which may discourage the filing of lawsuits against us and our directors, officers and employees, even though an action, if successful, might benefit our stockholders. In addition, while the Delaware Supreme Court ruled, and other state courts have upheld the validity of, that federal forum selection provisions purporting to require claims under the Securities Act be brought in federal court, there is uncertainty as to whether other courts will enforce our Federal Forum Provision. If the Federal Forum Provision is found to be unenforceable, we may incur additional costs associated with resolving such matters. The Federal Forum Provision may also impose additional litigation costs on stockholders who assert that the provision is not enforceable or invalid. The Court of Chancery of the State of Delaware and the United States District Court for the District of Massachusetts may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1B. Unresolve</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">d Staff Comments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2. Pro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">perties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently occupy approximately 34,522 rentable square feet of office and laboratory space in Watertown, Massachusetts under a lease that expires in March 2030. We have an option to extend the lease term for five additional years. Additionally, in December 2021 we signed an additional lease for 100,624 square feet of office and laboratory space in Watertown, Massachusetts, which the Company expects to begin occupying in November 2023. We believe that our office and laboratory space is sufficient to meet our current needs and that suitable additional space will be available as and when needed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3. Legal </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceedings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, we may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on our business, financial condition, results of operations and prospects because of defense and settlement costs, diversion of management resources and other factors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4. Mine Saf</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ety Disclosures.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART II</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5. Market for Registrant&#x2019;s Common Equity, Related Stoc</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">kholder Matters and Issuer Purchases of Equity Securities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Information Regarding the Trading of Our Common Stock</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock trades under the symbol &#x201c;KYMR&#x201d; on the Nasdaq Global Select Market and has been publicly traded since August 21, 2020. Prior to this time, there was no public market for our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock Performance Graph</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following graph shows a comparison from August 21, 2020, the first date that shares of our common stock were publicly traded, through December 31, 2022, of the cumulative total return on an assumed investment of $100.00 in cash in our common stock, the NASDAQ Composite Index and the NASDAQ Biotechnology Index for the same period. Such returns are based on historical results and are not intended to suggest future performance. Data for the NASDAQ Composite Index and the NASDAQ Biotechnology Index assume reinvestment of dividends</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comparison of 29 Month Cumulative Total Return*</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Among Kymera Therapeutics, Inc., the NASDAQ Composite Index and the NASDAQ Biotechnology Index</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img254193463_60.jpg" alt="img254193463_60.jpg" style="width:672px;height:377px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:13.6%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*$100 invested on August 21, 2020 in stock and indices, including reinvestment of dividends.</span></p>
  <p style="margin-left:13.6%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ending December 31.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The performance graph in this Item 5 is not deemed to be &#x201c;soliciting material&#x201d; or to be &#x201c;filed&#x201d; with the Securities and Exchange Commission for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities under that Section, and shall not be deemed incorporated by reference into any of our filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent we specifically incorporate it by reference into such a filing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holders of Our Common Stock</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of February 17, 2023, there were approximately 37 holders of record of shares of our common stock. This number does not include stockholders for whom shares are held in &#x201c;nominee&#x201d; or &#x201c;street&#x201d; name.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">116</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Authorized for Issuance Under Equity Compensation Plans</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by Item 5 of Form 10-K regarding equity compensation plans is incorporated herein by reference to Item 12 of Part III of this Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recent Sales of Unregistered Securities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_6_selected_financial_data"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 6. R</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">e</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">served.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not Applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">117</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_7_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7. Management&#x2019;s Discussion and Analysis of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Financial Condition and Results of Operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our audited financial statements and related notes appearing elsewhere in this Annual Report on Form 10-K. Some of the information contained in this discussion and analysis and set forth elsewhere in this Annual Report on Form 10-K, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. You should review the section titled &#x201c;Risk Factors&#x201d; in Part I, Item 1A of this Annual Report on Form 10-K for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body&#x2019;s own natural protein degradation system. Our proprietary targeted protein degradation, or TPD, platform, which we refer to as Pegasus&#153;, allows us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have unique advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. We focus on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or inadequately drugged. To date, we have utilized our Pegasus&#153; platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and we continue to apply our platform&#x2019;s capabilities to additional therapeutic areas. We have a mission to drug all target classes in human cells using TPD. Our current clinical stage programs are IRAK4, IRAKIMiD, and STAT3, which each address high impact targets within the interleukin-1 receptor/toll-like receptor, or IL-1R/TLR, and janus kinase/signal transducers and activators of transcription, or JAK/STAT, pathways, providing the opportunity to treat a broad range of immune-inflammatory diseases, hematologic malignancies, and solid tumors.  Our programs exemplify our focus on addressing high impact targets that have been elusive to conventional modalities and that drive the pathogenesis of multiple serious diseases with significant unmet medical needs. We have completed our Phase 1 trial of KT-474, which included a single ascending dose, or SAD, portion, a multiple ascending dose, or MAD, portion and a single dose, food-effect cohort to establish the dose for the patient cohort, or Part C, in patients with HS and AD. In December 2022, Sanofi notified us of its intent to advance KT-474 into Phase 2 clinical trials. Phase 2 clinical trials of KT-474 will initially investigate its potential in HS and AD, with the clinical trial for the first indication initiating in 2023. With respect to our oncology programs, we are evaluating KT-333, a STAT3 degrader, in a Phase 1 clinical trial in patients with relapsed/refractory liquid and solid tumors, including aggressive lymphomas. Patient enrollment and dosing are ongoing in the Phase 1a portion of the trial, and we expect to provide additional clinical data in 2023. We are also evaluating KT-413, our IRAKIMiD degrader, in a Phase 1 clinical trial in patients with relapsed/refractory B cell lymphomas, including MYD88 mutant diffuse large B cell lymphomas (DLBCL). Patient enrollment and dosing are ongoing in the Phase 1a portion of the trial, and we expect to provide additional clinical data in 2023.  In December 2022, we received FDA clearance for our investigational new drug, or IND, application to evaluate our MDM2 degrader, KT-253, in a Phase 1 clinical trial. KT-253 has been developed to stabilize the tumor suppressor p53 and address a wide variety of p53 wild type tumor types in both solid tumors and hematologic malignancies. We plan to initiate our Phase 1 clinical trial of KT-253 in early 2023.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since our inception in 2015, we have devoted substantially all of our efforts to organizing and staffing our company, research and development activities, business planning, raising capital, building our intellectual property portfolio and providing general and administrative support for these operations. To date, we have received gross proceeds of $1.03 billion from sales of our convertible preferred stock, the sale of common stock including our August 2020 initial public offering, or IPO, and concurrent private placement, our July 2021 follow-on offering and concurrent private placement, our August 2022 private investment in public equity, or PIPE offering, and through our collaborations with Vertex Pharmaceuticals Incorporated, or Vertex, and Sanofi.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred significant operating losses since inception. Our ability to generate product revenue sufficient to achieve profitability will depend heavily on the successful development and eventual commercialization of one or more of our current product candidates or any future product candidates. Our net losses were $154.8 million, $100.2 million and $45.6 million for the years ended December 31, 2022, 2021 and 2020, respectively. In addition, as of December 31, 2022 and 2021 we had an accumulated deficit of $383.8 million and $229.0 million, respectively. We expect that our expense and capital requirements will increase substantially in connection with our ongoing activities, particularly if and as we:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">initiate and complete clinical trials for current or future product candidates, including the ongoing Phase 1 trials of KT-333, KT-413, and KT-253;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">118</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prepare and submit Investigational New Drug applications, or INDs, with the U.S. Food and Drug Administration, or FDA, for current and future product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">initiate and continue research and development activities to support our pre-clinical product candidate pipeline; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacture our drug products, drug substances, delivery vehicles, and product candidates for use in preclinical studies, clinical trials and on a larger scale for commercialization, if approved;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">continue to develop and expand our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform to identify additional product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maintain, expand and protect our intellectual property portfolio; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seek marketing approvals for our product candidates that successfully complete clinical trials, if any; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">acquire or in-license additional product candidates and technologies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expand our infrastructure and facilities to accommodate our growing employee base and ongoing development activity; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">require the manufacture of larger quantities of our product candidates for clinical development and potential commercialization; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">establish a sales, marketing and distribution infrastructure to commercialize any products for which we may obtain marketing approval; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">add operational, financial and management information systems and personnel, including personnel to support our research and development programs, any future commercialization efforts and operating as a public company.  </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, if we obtain marketing approval for any of our lead product candidates, we expect to incur significant commercialization expenses related to product manufacturing, marketing, sales and distribution. As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through the sale of equity, debt financings, or other capital sources, which may include collaborations with other companies or other strategic transactions. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as and when needed, we may have to significantly delay, reduce or eliminate the development and commercialization of one or more of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will not generate revenue from product sales unless and until we successfully complete clinical development and obtain marketing approval for our drug candidates. The lengthy process of securing marketing approvals for new drugs requires the expenditure of substantial resources. Any delay or failure to obtain regulatory approvals would materially adversely affect our product candidate development efforts and our business overall. Because of the numerous risks and uncertainties associated with product development, we are unable to predict the timing or amount of increased expenses or when or if we will be able to achieve or maintain profitability. Even if we are able to generate product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had cash, cash equivalents and marketable securities of $559.5 million. We believe the existing cash, cash equivalents and marketable securities on hand, will enable us to fund our operating expenses and capital expenditure requirements into the second half of 2025 which is expected to take us past the proof-of-concept Phase 2 data for KT-474, as well as early proof-of-concept data for KT-413, KT-333 and KT-253 . We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. See &#x201c;&#x2014;Liquidity and capital resources.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since it was reported to have surfaced in December 2019, a novel strain of coronavirus, Sars-Cov-2 which leads to COVID-19, has spread across the world and has been declared a pandemic by the World Health Organization. Efforts to contain the spread of COVID-19 have intensified and governments around the world, including in the United States, Europe and Asia, have implemented severe travel restrictions, social distancing requirements, stay-at-home orders and have delayed the commencement of non-COVID-19-related clinical trials, among other restrictions. As a result, the current COVID-19 pandemic has presented a substantial public health and economic challenge around the world and is affecting our employees, patients, communities and business operations, as well as contributing to significant volatility and negative pressure on the U.S. economy and in financial markets. We expect that COVID-19 precautions will directly or indirectly impact the timeline for some of our</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">119</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">planned clinical trials and are continuing to assess the potential impact of the COVID-19 pandemic on our current and future business and operations, including our expenses and clinical trials, as well as on our industry and the healthcare system.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of the pandemic, many companies have experienced disruptions in their operations and in markets served. To date, we have initiated some and may take additional temporary precautionary measures intended to help ensure our employees&#x2019; well-being and minimize business disruption. These measures include devising contingency plans and securing additional resources from third-party service providers. For the safety of our employees and their families, we have temporarily reduced the presence of our scientists in our labs and continue to rely on third parties to conduct many of the experiments and studies for our research programs. Certain of our third-party service providers have also experienced shutdowns or other business disruptions. We are continuing to assess the impact of the COVID-19 pandemic on our current and future business and operations, including our expenses and planned clinical trial and other development timelines, as well as on our industry and the healthcare system.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Components of Our Results of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To date, we have not generated any revenue from product sales and do not expect to generate any revenue from the sale of products in the foreseeable future. Our only revenues have been derived from research collaboration arrangements with Vertex and Sanofi. We expect that our revenue for the next several years will be derived primarily from our current collaboration agreements and any additional collaborations that we may enter into in the future. To date, we have not received any royalties under any of the collaboration agreements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Vertex Collaboration Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On May 9, 2019, we entered into a collaboration agreement, or the Vertex Agreement, with Vertex, to advance small molecule protein degradation against up to six targets. Under the Vertex Agreement, Vertex has the exclusive option to license the rights to the product candidates developed through the collaboration at which point Vertex will control development and commercialization. Pursuant to the Vertex Agreement, we are responsible for discovery and preclinical research on the targets, and Vertex is responsible for development, manufacturing, and commercialization of the product candidates after it exercises its option to license.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vertex provided us with a non-refundable upfront payment of $50.0 million and purchased 3,059,695 shares of our Series B-1 Convertible Preferred Stock at $6.54 a share, pursuant to a separate, but simultaneously executed Share Purchase Agreement. We are eligible to receive up to $170.0 million in payments per target, including development, regulatory, and commercial milestones, as well as option exercise payments. In addition, Vertex is obligated to pay us tiered royalties on future net sales on any products that may result from the Vertex Agreement. None of the payments under the Vertex Agreement are refundable. We may also perform follow-on research activities for an optioned target upon Vertex&#x2019;s request and at Vertex&#x2019;s expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sanofi Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 7, 2020, we entered into a collaboration agreement, or the Sanofi Agreement, with Sanofi to co-develop drug candidates directed to two biological targets. Under the Sanofi Agreement, we granted to Sanofi a worldwide exclusive license to develop, manufacture and commercialize certain lead compounds generated during the collaboration directed against IRAK4 and one additional undisclosed target in an undisclosed field of use. Such license is exercisable on a collaboration target-by-collaboration target basis only after a specified milestone. For compounds directed against IRAK4, the field of use includes diagnosis, treatment, cure, mitigation or prevention of any diseases, disorders or conditions, excluding oncology and immuno-oncology. We are responsible for discovery and preclinical research and conducting a phase 1 clinical trial for at least one degrader directed against IRAK4 plus up to three backup degraders. With respect to both targets, Sanofi is responsible for development, manufacturing, and commercialization of product candidates after a specified development milestone occurs with respect to each collaboration candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have an exclusive option, or Opt-In Right, exercisable on a collaboration target-by-collaboration target basis that will include the right to (i) to fund 50% of the United States development costs for collaboration products directed against such target in the applicable field of use and (ii) share equally in the net profits and net losses of commercializing collaboration products directed against such target in the applicable field of use in the United States. In addition, if we exercise the Opt-In Right, Sanofi will grant us an exclusive option, applicable to each collaboration target, which upon exercise will allow us to conduct certain co-promotion activities in the field in the United States.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Sanofi Agreement, unless earlier terminated, will expire on a product-by-product basis on the date of expiration of all payment obligations under the Sanofi Agreement with respect to such product. We or Sanofi may terminate the agreement upon the other party&#x2019;s material breach or insolvency or for certain patent challenges. In addition, Sanofi may terminate the agreement for convenience or for a material safety event upon advance prior written notice, and we may terminate the agreement with respect to any collaboration candidate if, following Sanofi&#x2019;s assumption of responsibility for the development, commercialization or manufacturing of collaboration candidates with respect to a particular target, Sanofi ceases to exploit any collaboration candidates directed to such target for a specified period.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In consideration for the exclusive licenses granted to Sanofi under the Sanofi Agreement, Sanofi made an upfront payment of $150.0 million. In addition to the upfront payment, we are eligible to receive certain development milestone payments of up to $1.48 billion in the aggregate, of which more than $1.0 billion relates to the IRAK4 program, upon the achievement of certain developmental or regulatory events. We will be eligible to receive certain commercial milestone payments up to $700.0 million in the aggregate, of which $400.0 million relates to the IRAK4 program, which are payable upon the achievement of certain net sales thresholds. We will be eligible to receive tiered royalties for each program on net sales ranging from the high single digits to high teens, subject to low-single digits upward adjustments in certain circumstances.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On November 15, 2022, we entered into an Amended and Restated Collaboration and License Agreement with Sanofi, or the Amended Sanofi Agreement, which amended the Original Sanofi Agreement to revise certain research terms and responsibilities set forth under the Original Sanofi Agreement. The Amended Sanofi Agreement also specifies details around the timing and number of Phase 2 trials required under the terms of the collaboration. The Amended Sanofi Agreement became effective on December 5, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally with respect to Sanofi, on December 2, 2022, Sanofi provided the Company with written notice of its intention to advance the collaboration target 1 candidate, KT-474, into Phase 2 clinical trials. The Company is entitled to receive milestone payments upon the dosing of the first Phase 2 patient(s) per indication up to a specified number of indications as further set forth in the Amended Sanofi Agreement. Phase 2 clinical trials of KT-474 will initially investigate its potential in HS and AD with the clinical trial for the first indication expected to be initiated in 2023.<br /><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Operating expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our operating expenses since inception have consisted solely of research and development expenses and general and administrative expenses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and development expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses consist primarily of costs incurred in connection with the discovery and development of targeted protein degradation therapeutics, including those in our initial programs, IRAK4, IRAKIMiD, STAT3 and MDM2. These research efforts and costs, which also support the development of, and enhancements to, our Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> platform, include external research costs, personnel costs, supplies, license fees and facility-related expenses. We expense research and development costs as incurred. These expenses include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">employee-related expenses, including salaries, related benefits and stock-based compensation expense, for employees engaged in research and development functions; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expenses incurred under agreements with organizations that support our platform program development; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">contract manufacturing organizations, or CMOs, that are primarily engaged to provide drug substance and product for our preclinical research and development programs, nonclinical studies and other scientific development services; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost of acquiring and manufacturing nonclinical trial materials, including manufacturing registration and validation batches; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">facilities, depreciation and other expenses, which include direct and allocated expenses for rent and maintenance of facilities and insurance; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">costs related to compliance with quality and regulatory requirements; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">payments made under third-party licensing agreements. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">121</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Advance payments that we make for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered or the services rendered.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. We expect that our research and development expenses will increase substantially in connection with our planned clinical development activities in the near term and in the future. At this time, we cannot accurately estimate or know the nature, timing and costs of the efforts that will be necessary to complete the clinical development of any future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our future clinical development costs may vary significantly based on factors such as:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">per patient trial costs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of trials required for approval; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of sites included in the trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the countries in which the trials are conducted; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the length of time required to enroll eligible patients; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of patients that participate in the trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of doses that patients receive; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the drop-out or discontinuation rates of patients; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential additional safety monitoring requested by regulatory agencies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the duration of patient participation in the trials and follow-up; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost and timing of manufacturing our product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the phase of development of our product candidates; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the efficacy and safety profile of our product candidates. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The successful development and commercialization of product candidates is highly uncertain. This is due to the numerous risks and uncertainties associated with product development and commercialization, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing and progress of nonclinical and clinical development activities; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number and scope of nonclinical and clinical programs we decide to pursue; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to raise necessary additional funds; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the progress of the development efforts of parties with whom we may enter into collaboration arrangements; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to maintain our current development program and to establish new ones; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish new licensing or collaboration arrangements; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the successful initiation and completion of clinical trials with safety, tolerability and efficacy profiles that are satisfactory to the FDA or any comparable foreign regulatory authority; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the receipt and related terms of regulatory approvals from applicable regulatory authorities; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of drug substance and drug product for use in production of our product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish and maintain agreements with third-party manufacturers for clinical supply for our clinical trials and commercial manufacturing, if any of our product candidates are approved; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain and maintain patents, trade secret protection and regulatory exclusivity, both in the United States and internationally; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to protect our rights in our intellectual property portfolio; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain and maintain third-party insurance coverage and adequate reimbursement; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">122</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the acceptance of our product candidates, if approved, by patients, the medical community and third-party payors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the impact of competition with other products; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the impact of any business interruptions to our operations, including the timing and enrollment of patients in our planned clinical trials, or to those of our manufacturers, suppliers, or other vendors resulting from the COVID-19 pandemic or similar public health crisis; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to maintain a continued acceptable safety profile for our therapies following approval. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A change in the outcome of any of these variables with respect to the development of our product candidates could significantly change the costs and timing associated with the development of that product candidate. We may never succeed in obtaining regulatory approval for any of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General and administrative expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative expenses consist primarily of salaries and related costs for personnel in executive, finance,  legal, corporate and business development, and administrative functions. General and administrative expenses also include legal fees relating to patent and corporate matters, professional fees for accounting, auditing, tax and administrative consulting services, insurance costs, administrative travel expenses, marketing expenses and other operating costs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We anticipate that our general and administrative expenses will increase in the future as we increase our headcount to support development of our product candidates and our continued research activities. We also anticipate that we will incur increased accounting, audit, legal, regulatory, compliance and director and officer insurance costs as well as legal, investor and public relations expenses associated with our continued growth as a public comapny.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income (Expense)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest and other income and expense, net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest and other income and expense consists of interest earned on our invested cash balances and interest on our financing leases.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Results of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comparison of years ended December 31, 2022 and 2021</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our results of operations for the years ended December 31, 2022 and 2021:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.254%;"></td>
    <td style="width:1.325%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.798%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.355%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.957%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.355%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.957%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenue&#x2014;from related parties</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46,826</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72,832</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(26,006</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">164,248</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">137,017</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,231</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43,834</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,345</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,489</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">208,082</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">173,362</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,720</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(161,256</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(100,530</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(60,726</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,448</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">313</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,135</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(154,808</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(100,217</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(54,591</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Collaboration revenue</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize revenue under each of the Vertex Agreement and Sanofi Agreement based on our pattern of performance related to the respective identified performance obligation, which is the period over which we will perform research services under each of the Vertex Agreement and Sanofi Agreement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">123</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration revenues were $46.8 million for the year ended December 31, 2022, of which $10.8 million and $36.0 million were attributable to our collaboration agreements with Vertex and Sanofi, respectively. Collaboration revenues were $72.8 million for the year ended December 31, 2021, of which $18.5 million and $54.3 million were attributable to our collaboration agreements with Vertex and Sanofi, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and development expenses</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our research and development expenses for each period presented (program expenses are not disclosed prior to formal development cadidate nomination):</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.271%;"></td>
    <td style="width:1.384%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.614999999999998%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.394%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.971%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.394%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.971%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">External research and development costs:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IRAK4</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,850</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,368</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(9,518</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IRAKIMiD</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,914</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,847</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(5,933</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">STAT3</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,332</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,081</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1,749</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MDM2</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,823</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,823</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46,474</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35,909</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,565</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Internal research and development costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74,855</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52,812</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,043</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total research and development expenses</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">164,248</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">137,017</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,231</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses were $164.2 million for the year ended December 31, 2022, compared to $137.0 million for the year ended December 31, 2021. The increase of $27.2 million was primarily due to an increase of $22.4 million related to IND-enabling studies for our MDM2 program and increased investment in our other pipeline programs and platform, as well an additional $22.0 million increase in personnel, stock-based compensation and occupancy costs due to increases in employee headcount in the research and development functions. These increases were primarily offset by a $17.2 million reduction in direct expenses related to our activities for our IRAK4, IRAKIMiD and STAT3 programs due to changes in the stage of development of these respective programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General and administrative expenses</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative expenses were $43.8 million for the year ended December 31, 2022, compared to $36.3 million for the year ended December 31, 2021. The $7.5 million increase was primarily due to a $6.5 million increase in G&amp;A employee compensation due to an increase in employee headcount, and a $1.0M increase in legal and professional services expenses to support our growth as a public compamy.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income, Net</span></p>
  <p style="text-indent:5.147%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income, net was $6.4 million for the year ended December 31, 2022, compared to $0.3 million for the year ended December 31, 2021. The $6.1 million increase was primarily due to the prevailing interest rates in the respective periods.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">124</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Results of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comparison of years ended December 31, 2021 and 2020</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our results of operations for the years ended December 31, 2021 and 2020</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.147%;"></td>
    <td style="width:1.381%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.804%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.391%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.942%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.391%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.942%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenue&#x2014;from related parties</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72,832</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,034</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38,798</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">137,017</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62,105</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74,912</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,345</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,233</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,112</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">173,362</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80,338</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93,024</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(100,530</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(46,304</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(54,226</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">313</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">711</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(398</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(100,217</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(45,593</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(54,624</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Collaboration revenue</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize revenue under each of the Vertex Agreement and Sanofi Agreement based on our pattern of performance related to the respective identified performance obligation, which is the period over which we will perform research services under each of the Vertex Agreement and Sanofi Agreement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration revenues were $72.8 million for the year ended December 31, 2021, of which $18.5 million and $54.3 million were attributable to our collaboration agreements with Vertex and Sanofi, respectively. Collaboration revenues were $34.0 million for the year ended December 31, 2020, of which $15.2 million and $18.8 million were attributable to our collaboration agreements with Vertex and Sanofi, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and development expenses</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our research and development expenses for each period presented (program expenses are not disclosed prior to formal development cadidate nomination):</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.271%;"></td>
    <td style="width:1.384%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.614999999999998%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.394%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.971%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.394%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.971%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">External research and development costs:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IRAK4</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,368</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,016</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,352</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IRAKIMiD</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,847</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,170</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,677</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">STAT3</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,081</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,674</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,407</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35,909</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,579</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,330</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Internal research and development costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52,812</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,666</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,146</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total research and development expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">137,017</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62,105</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74,912</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses were $137.0 million for the year ended December 31, 2021, compared to $62.1 million for the year ended December 31, 2020. The increase of $74.9 million was primarily due to higher direct expenses related to IND-enabling studies and clinical activities for our IRAK4, IRAKIMiD, and STAT3 programs of $21.5 million, as well  as increased expenses related to the investment in our platform, exploratory programs, and Vertex collaboration of $23.3 million. We also had a $30.1 million increase in personnel, stock-based compensation, occupancy costs due to increases in employee headcount in the research and development functions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General and administrative expenses</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative expenses were $36.3 million for the year ended December 31, 2021, compared to $18.2 million for the year ended December 31, 2020. The $18.1 million increase was primarily due to an increase in legal and professional service fees and an increase in personnel, facility, occupancy and other expenses stemming from an increase in headcount to support our growth as a public company as well as increased stock-based compensation expense also attributable to our headcount.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income, Net</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income, net was $0.3 million for the year ended December 31, 2021, compared to $0.7 million for the year ended December 31, 2020. The $0.4 million decrease was primarily due to the prevailing interest rates in the respective periods.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liquidity and capital resources</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have not yet generated any revenue from any product sales, and we have incurred significant operating losses since our inception. We have not yet commercialized any products and we do not expect to generate revenue from sales of products for several years, if at all. To date, we have received gross proceeds of $1.03 billion from sales of our convertible preferred stock, the sale of common stock including our August 2020 IPO and concurrent private placement, our July 2021 follow-on offering and concurrent private placement, our August 2022 PIPE offering, and through our collaborations with Vertex and Sanofi. As of December 31, 2022 we had cash and cash equivalents and marketable securities of $559.5 million.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2021, we entered into a sales agreement, or Sales Agreement, with Cowen and Company, LLC, or Cowen, pursuant to which we may offer and sell shares of our common stock having aggregate gross proceeds of up to $250.0 million from time to time in &#x201c;at-the-market&#x201d; offerings through Cowen, as our sales agent. We agreed to pay Cowen a commission of up to 3.0% of the gross proceeds of any shares sold by Cowen under the Sales Agreement. There have been no shares of our common stock sold under the Sales Agreement as of December 31, 2022.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash flows</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our sources and uses of cash for each of the periods presented:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:56.574%;"></td>
    <td style="width:1.332%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.158999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.332%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.158999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.332%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.11%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash (used in) provided by operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(153,085</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(128,946</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88,130</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash provided by (used in) investing activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,519</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(99,835</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(422,588</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">152,999</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">250,280</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">289,262</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net increase (decrease) in cash, cash equivalents and restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,433</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,499</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(45,196</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flows (Used in) provided by Operating Activities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, operating activities used $153.1 million of cash, primarily resulting from our net loss of $154.8 million during the period and a $37.8 million decrease in deferred revenue under our Sanofi and Vertex collaboration agreements. These were offset by adjustments for non-cash items of $39.3 million (primarily consisting of stock-based compensation, depreciation and amortization and premiums and discounts on available sale-securities) and a $0.2 million net increase in operating assets and liabilities primarily driven by changes in accounts payable and accrued expenses partially offset by changes in prepaid expenses and other operating assets and liabilities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2021, operating activities used $128.9 million of cash, primarily resulting from our net loss of $100.2 million during the period and a $69.4 million decrease in deferred revenue under our Sanofi and Vertex collaboration agreements. These were offset by adjustments for non-cash items of $33.2 million (primarily consisting of stock-based compensation, depreciation and amortization and premiums and discounts on available sale-securities) and a $7.5 million net increase in operating assets and liabilities primarily driven by changes in accounts payable and accrued expenses partially offset by changes in prepaid expenses and other operating assets and liabilities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2020, operating activities provided $88.1 million of cash, primarily resulting from $150.0 million of proceeds received under our collaboration agreement with Sanofi executed in July 2020. Cash provided by operating activities also included an increase of accounts payable and accruals of $6.7 million, an increase in net operating assets and liabilities of $0.7 million, offset by our net loss of $45.6 million adjusted for net non-cash items of $8.9 million (primarily stock-based compensation, depreciation expense and amortization of premiums and discounts on securities).</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flow provided by (used in) Investing Activities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, cash provided by investing activities was $20.5 million comprised of  maturities of marketable securities of $469.3 million partially offset by purchases of marketable securities of $446.0 million and purchases of property and equipment of $2.8 million.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2021, cash used in investing activities was $99.8 million comprised of purchases of marketable securities of $456.4 million and purchases of property and equipment of $1.6 million offset by maturities of marketable securities of $358.2 million.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2020, cash used in investing activities was $422.6 million comprised of purchases of marketable securities of $529.4 million and purchases of property and equipment of $9.1 million offset by maturities of marketable securities of $115.9 million.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flow from Financing Activities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, net cash provided by financing activities was $153.0 million, primarily consisting of $149.8 million of net proceeds received in our August 2022 PIPE offering, $3.2 million in proceeds from the exercise of employee stock options, $1.1 million in proceeds from the issuance of shares under our employee stock purchase partially offset by finance lease payments of $1.1 million.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2021, net cash provided by financing activities was $250.3 million, primarily consisting of $240.8 million of net proceeds received in our July 2021 follow on offering, $2.3 million from our July 2021 concurrent private placement, $7.6 million in proceeds from the exercise of employee stock options, $0.8 million in proceeds from the issuance of shares under our employee stock purchase plan offset by the payment of $0.4 million in offering costs related to our August 2020 IPO and finance lease payments of $0.8 million.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2020, net cash provided by financing activities was $289.3 million, primarily consisting of $183.1 million of net proceeds received in our August 2020 IPO, $13.5 million from our August 2020 concurrent private placement, $88.2 million of proceeds from our issuances of Series C convertible preferred stock in March 2020, net of issuance costs, and $4.8 million of proceeds from the second closing of our Series B convertible preferred stock financing in January 2020, net of issuance costs.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Future funding requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we advance the later-stage clinical development of our product candidates. In addition, we expect to incur additional costs associated with our growth as a public company.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because of the numerous risks and uncertainties associated with the development of our product candidates and programs and because the extent to which we may enter into collaborations with third parties for development of our product candidates is unknown, we are unable to estimate the timing and amounts of increased capital outlays and operating expenses associated with completing the research and development of our product candidates. The timing and amount of our operating expenditures will depend largely on:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the initiation, progress, timing, costs and results of nonclinical studies and clinical trials for our product candidates or any future product candidates we may develop; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to maintain our relationships with Sanofi, Vertex and other key collaborators; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">127</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the outcome, timing and cost of seeking and obtaining regulatory approvals from the FDA and comparable foreign regulatory authorities, including the potential for such authorities to require that we perform more nonclinical studies or clinical trials than those that we currently expect or change their requirements on studies that had previously been agreed to; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost to establish, maintain, expand, enforce and defend the scope of our intellectual property portfolio, including the amount and timing of any payments we may be required to make, or that we may receive, in connection with licensing, preparing, filing, prosecuting, defending and enforcing any patents or other intellectual property rights; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effect of competing technological and market developments; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of continuing to grow our business, including hiring key personnel and maintaining or acquiring operating space; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the degree of market acceptance of any approved product candidates, including product pricing, as well as product coverage and the adequacy of reimbursement by third-party payors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost of acquiring, licensing or investing in additional businesses, products, product candidates and technologies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost and timing of selecting, auditing and potentially validating a manufacturing site for commercial-scale manufacturing; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost of establishing sales, marketing and distribution capabilities for any product candidates for which we may receive regulatory approval and that we determine to commercialize; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our need to implement additional internal systems and infrastructure, including financial and reporting systems. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe the existing cash, cash equivalents and marketable securities of $559.5 million as of December 31, 2022, will enable us to fund our operating expenses and capital expenditure requirements into the second half of 2025. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. We expect that we will require additional funding to continue the clinical development of our IRAK4, IRAKIMiD, STAT3 and MDM2 programs, commercialize our product candidates if we receive regulatory approval, and pursue in-licenses or acquisitions of other product candidates. If we receive regulatory approval for any of our product candidates, we expect to incur significant commercialization expenses related to product manufacturing, sales, marketing and distribution, depending on where we choose to commercialize our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Identifying potential product candidates and conducting preclinical studies and clinical trials is a time consuming, expensive and uncertain process that takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, our product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that we do not expect to be commercially available for many years, if ever. Accordingly, we will need to obtain substantial additional funds to achieve our business objectives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances, and marketing, distribution or licensing arrangements with third parties. However, we may be unable to raise additional funds or enter into such other arrangements when needed on favorable terms or at all. Market volatility resulting from the COVID-19 pandemic or other factors could also adversely impact our ability to access capital as and when needed. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interests of our existing stockholders may be materially diluted, and the terms of such securities could include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and preferred equity financing, if available, may involve agreements that include restrictive covenants that limit our ability to take specified actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, reduce or eliminate our product development or future commercialization</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">128</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contractual Obligations and Other Commitments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have entered into arrangements that contractually obligate us to make payments that will affect our liquidity and cash flows in future periods. Such arrangements primarily include those related to our lease commitments.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Lease Commitments</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our lease commitments reflect payments due for our two lease agreements for laboratory and office space in Watertown, Massachusetts that expire in March, 2030 and December, 2034, respectively. As of December 31, 2022, our contractual commitments for our leases were $137.1 million, which will be paid over the term of such leases. The amount of lease commitments reflects payments due for one of our leases that had not commenced under Accounting Standards Codification (ASC) Topic 842, Leases (ASC 842), as of December 31, 2022, and as a result, these leases are not reflected within the consolidated balance sheets. We expect this lease to commence in 2023. For additional information on our leases and timing of future payments, please read Note 7, Leases, to the consolidated financial statements included in this Form 10-K.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Obligations</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We enter into contracts in the normal course of business with various third parties for clinical trials, preclinical research studies, and testing, manufacturing, and other services and products for operating purposes. These contracts provide for termination upon notice. Payments due upon cancellation generally consist only of payments for services provided or expenses incurred, including non-cancellable obligations of our service providers, up to the date of cancellation. These payments have not been included separately within these contractual and other obligations disclosures.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Critical Accounting Policies and Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our management&#x2019;s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles, or GAAP, in the United States. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, costs and expenses, and the disclosure of contingent assets and liabilities in our consolidated financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements appearing at the end of this Annual Report, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, we perform the following five steps: (i) identification of the contract(s) with the customer, (ii) identification of the promised goods or services in the contract and determination of whether the promised goods or services are performance obligations, (iii) measurement of the transaction price, (iv) allocation of the transaction price to the performance obligations, and (v) recognition of revenue when (or as) we satisfy each performance obligation. We only apply the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">129</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">When optional goods or services are offered, we assess the options to determine whether the options grant the customer a material right. This determination includes whether the option is priced at an amount that the customer would not have received without entering into the contract. If we conclude the option conveys a material right, it is accounted for as a separate performance obligation. In identifying performance obligations in a contract, we identify those promises that are distinct. Promised goods or services are considered distinct when the customer can benefit from the goods or services on their own, or together with readily available resources, and the goods or services are separately identifiable from other promises in the contract. If a promise is not distinct, it is combined with other promises in the contract until the combined group of promises is capable of being distinct.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We estimate the transaction price based on the amount of consideration we expect to receive for transferring the promised goods or services in the contract. The consideration may include both fixed consideration and variable consideration. At the inception of each arrangement that includes variable consideration, we evaluate the amount of the potential payments and the likelihood that the payments will be received. If it is probable that a significant revenue reversal would not occur, the variable consideration is included in the transaction price. For contracts that include sales-based royalties for licensed compounds, we recognize revenue at the date when the related sales occur. Finally, we determine whether the contract contains a significant financing component by analyzing the promised consideration relative to the standalone selling price of the promised goods and services and the timing of payment relative to the transfer of the promised goods and services. At each reporting date, we reassess the transaction price and probability of achievement of the performance obligations and the associated constraints on transaction price. If necessary, we adjust the transaction price, recording a cumulative catch-up based on progress for the amount that was previously constrained.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenue is recognized when (or as) control of a performance obligation is transferred to the customer. When combined performance obligations contain a promised license and related services or other promises, management judgment is required to determine the appropriate timing of revenue recognition. In doing so, we must identify the predominant promise or promises in the contract to determine whether revenue is recognized at a point in time or over time. If over time, we must determine the appropriate measure of progress. If a license is deemed to be the predominant promise in a performance obligation, we must determine the nature of the license, whether functional or symbolic intellectual property, to conclude whether point-in-time or over-time revenue recognition is most appropriate. The determination of functional or symbolic intellectual property requires an assessment of whether the customer is able to exploit and benefit from the license in its current condition, or if the utility of the license is dependent on or influenced by our ongoing activities or being associated with us.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At each reporting date, we calculate the measure of progress for the performance obligations transferred over time. The calculation generally uses an input measure based on costs incurred to-date relative to estimated total costs to complete the transfer of the performance obligation. The measurement of progress is then used to calculate the total revenue earned, including any cumulative catch-up adjustment.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Contract Costs and Accruals</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As part of the process of preparing our consolidated financial statements, we are required to estimate our accrued research and development expenses. This process involves reviewing open contracts and purchase orders, communicating with our applicable personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of actual costs. The majority of our service providers invoice us in arrears for services performed, on a pre-determined schedule or when contractual milestones are met; however, some require advance payments. We make estimates of our accrued expenses as of each balance sheet date in the consolidated financial statements based on facts and circumstances known to us at that time. We periodically confirm the accuracy of these estimates with the service providers and make adjustments, if necessary. Examples of estimated accrued research and development expenses include fees paid to:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">vendors, including research laboratories, in connection with preclinical development activities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CROs and investigative sites in connection with our clinical trials and preclinical studies; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CMOs in connection with drug substance and drug product formulation of preclinical studies.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.587%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We base the expense recorded related to external research and development on our estimates of the services received and efforts expended pursuant to quotes and contracts with multiple CMOs and CROs that supply, conduct and manage nonclinical studies on our behalf. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the expense. In accruing service fees, we estimate the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, we adjust the accrual or the amount of prepaid expenses accordingly. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may result in reporting amounts that are too high or too low in any particular period. To date, there have not been any material adjustments to our prior estimates of accrued research and development expenses.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">130</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equity-Based Compensation Expense</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure equity-based awards granted to employees, directors, and nonemployees based on their fair value on the date of the grant and recognize compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. The equity-based payments include stock options and grants of common stock, including common stock subject to vesting. The measurement date for equity awards is the date of grant, and equity-based compensation costs are recognized as expense over the requisite service period, which is the vesting period, on a straight-line basis. We have issued stock options and restricted stock with performance-based vesting conditions and record the expense for these awards if we conclude that it is probable that the performance condition will be achieved. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model, which requires inputs based on certain subjective assumptions, including the expected stock price volatility, the expected term of the option, the risk-free interest rate for a period that approximates the expected term of the option, and our expected dividend yield. Expected volatility is calculated based on reported volatility data for a representative group of publicly traded companies for which historical information is available. We select companies with comparable characteristics to us with historical share price information that approximates the expected term of the equity-based awards. We compute the historical volatility data using the daily closing prices for the selected companies&#x2019; shares during the equivalent period that approximates the calculated expected term of our stock options. We will continue to apply this method until a sufficient amount of historical information regarding the volatility of our stock price becomes available. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant commensurate with the expected term assumption. We use the simplified method, under which the expected term is presumed to be the midpoint between the vesting date and the end of the contractual term. We utilize this method due to lack of historical exercise data. The expected dividend yield is assumed to be zero as we have no current plans to pay any dividends on common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7A. Quantitative and Qualitat</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ive Disclosures About Market Risk.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are exposed to market risk related to changes in interest rates. Our primary exposure to market risk is interest rate sensitivity, which is affected by changes in the general level of U.S. interest rates, particularly because our investments, including cash equivalents, are in the form of money market funds and marketable securities and are invested in U.S. treasury or government obligations and corporate securities. However, because of the short-term nature of the duration of our portfolio and the low-risk profile of our investments, we believe an immediate 10% change in market interest rates would not be expected to have a material impact on the fair market value of our investments portfolio or on our financial condition or results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also exposed to market risk related to changes in foreign currency exchange rates. We contract with vendors that are located in Asia and Europe and certain invoices are denominated in foreign currencies. We are subject to fluctuations in foreign currency rates in connection with these arrangements. We do not currently hedge our foreign currency exchange rate risk. As of December 31, 2022, we had no significant liabilities denominated in foreign currencies.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inflation generally affects us by increasing our cost of labor and clinical trial costs. The global macroeconomic environment has experienced, and continues to experience, extraordinary challenges, including the highest rates of inflation in 40 years. These macroeconomic factors have contributed, and we expect will continue to contribute, to increased costs, among other concerns. We cannot predict how long these inflationary pressures will continue, or how they may change over time, but we expect to see continued impacts on the global economy, our industry and our company. During 2022, we experienced increases in interest income and costs across our business. If inflationary pressures continue to persist, they may continue to have an adverse impact on our consolidated financial position, results of operations and/or cash flows.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 8. Financial Statement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">s and Supplementary Data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">131</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:92.917%;"></td>
    <td style="width:7.083%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#report_of_independent_registered_public"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (Public Company Accounting Oversight Board ID: </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_972257f9-441a-448a-bea8-6f5daf3c9803" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:AuditorFirmId"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Balance Sheets as of December 31, 2022 and 2021</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Operations and Comprehensive Loss for the Years ended December 31, 2022, 2021 and 2020</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_equity"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#x2019; Equity for the Years ended</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></a></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_equity"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Cash Flows for the Years ended December 31, 2022, 2021 and 2020</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#notes_to_consolidated_financial_statemen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="report_of_independent_registered_public"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Report of Independent Registered Public Accounting F</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">irm</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the Stockholders and the Board of Directors of Kymera Therapeutics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opinion on the Financial Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of Kymera Therapeutics, Inc. (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive loss, convertible preferred stock and stockholders&#x2019; equity (deficit) and cash flows for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the &#x201c;consolidated financial statements&#x201d;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 23, 2023 expressed an unqualified opinion thereon.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#x2019;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Critical Audit Matter</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:15.218%;"></td>
    <td style="width:2.54%;"></td>
    <td style="width:82.242%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Collaboration Arrangements</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Description of the Matter</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As discussed in Note 5 to the consolidated financial statements, the Company recognizes revenue associated with each performance obligation as the research and development services are provided using an input method, according to costs incurred as related to the research and development activities for each individual program and the costs expected to be incurred in the future to satisfy that individual performance obligation. The amounts received that have not yet been recognized as revenue are deferred as a contract liability on the Company&#x2019;s consolidated balance sheet. For the year ended December 31, 2022, the Company has recognized $46.8 million in collaboration revenue.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auditing the Company's accounting for revenues from collaboration arrangements was complex and required significant judgments primarily in evaluating estimates of the total expected costs under the input method for revenue recognized over time.  Auditing the progress toward completion of collaboration agreements was especially challenging because it involves subjective management assumptions used in estimating the remaining research and development costs necessary to satisfy the performance obligation. The calculation of the total remaining estimated research and development cost includes forecasted costs associated with internal employee efforts, materials costs, and third-party contract costs. The recognition of revenue pursuant to collaboration arrangements is subject to these judgments made and estimates developed by management and is sensitive to changes in these assumptions.</span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:165.15pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">How We Addressed the Matter in Our Audit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We evaluated and tested the design and operating effectiveness of internal controls over the Company&#x2019;s process for developing the estimate, including controls to assess the completeness and accuracy of the data that supports management&#x2019;s estimates.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To test the Company&#x2019;s collaboration revenue, we performed audit procedures that included, among others, reading the collaboration agreements and testing the accuracy and completeness of the underlying data used in evaluating the estimates and significant judgments described above. To assess the reasonableness of the Company's significant estimates and judgments, we compared cost estimates to costs previously incurred for similar activities, evaluated the remaining estimated level of effort required to complete the services, and inspected evidence of actual costs incurred. We also discussed the basis for key assumptions with the Company's research and development personnel, who oversee the completion of the collaboration arrangements.</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fc49d4bf-9d2a-4199-a8da-56ddfdf2b0e9" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:AuditorName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ernst &amp; Young LLP</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have served as the Company&#x2019;s auditor since 2018.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_969277fd-1cdc-44f5-afa0-44c80c912cd3" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="dei:AuditorLocation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Boston, Massachusetts</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Ba</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">lance Sheets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands, except share and per share amounts)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:70.018%;"></td>
    <td style="width:1.551%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.285%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.541%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.603%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current assets:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_835360e6-cfa6-465c-a0e2-fd3bce327ac1" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">68,395</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_053c4942-9549-4fe6-89d3-52f6413738b7" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">47,976</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (Note 4)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c65ad31-d5e2-4364-aaa3-01245dc22be7" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">338,771</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_335e4e97-fc8f-455a-b743-f48f8a6816d8" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">394,442</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contract assets&#x2014;due from related party</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5f53df31-0f3f-49b8-a06e-ef596a9482ee" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:ContractWithCustomerAssetNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,537</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e67fefb8-5c50-4f43-a4e8-3727ed2cea03" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:ContractWithCustomerAssetNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">135</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ef169ebc-1f79-44a0-a64e-5c499604a546" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,713</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c8ee96f0-4959-49f9-b533-53986de4813e" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,720</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_429a31fd-9a57-44a7-b3a5-207f744cc40a" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">419,416</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1d9cfc54-082e-4232-a373-b3e0a3030c55" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">451,273</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, non-current (Note 4)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_da1fec79-40c9-42c3-a90a-5e78379623e5" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">152,328</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e7944113-354e-4f56-8cd6-56ca3ca54137" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">125,187</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net (Note 6)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_39be2817-9e10-48ee-8712-078dff5dac49" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,334</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e114d67e-a7d8-46b5-a87e-3f6a00a3e0e4" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,881</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets, operating leases</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24602630-7fd0-4dfb-9e2c-d98d33871e81" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,909</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1e341f52-c81e-4a5a-9eb0-9281f2381d5e" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,426</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other non-current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eecc86be-ef1b-45ee-96d7-1a25500b336f" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,017</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a2c2159-db07-4859-98c6-721681bc4706" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,022</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fb0f4632-1949-4db1-8a34-c58007ce07c0" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,130</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_25c87401-446b-40e5-b318-28a1db3472b4" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,116</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_596016a7-d4d5-4657-b1e5-cba6162c7594" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">603,134</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_414d1ac1-f4c2-41fe-ae60-a9a3ff21f1ed" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">605,905</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities and Stockholders&#x2019; Equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_36c5e100-d30d-4cc5-be6b-6f5c29f4c6e9" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,335</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e57b3999-5c14-4208-8e5d-9d5e897054af" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,005</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses (Note 8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_035b58f1-e482-47c3-8845-24f5cb9bfc27" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,502</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_674167db-e9e7-47f3-b432-3b3e76dedb29" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,971</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4ddaf04c-9c02-4e35-90b5-a0ae6d1e8180" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:ContractWithCustomerLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35,260</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b7ecfa6-b1ec-4e3a-9b25-0f975fb7df82" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:ContractWithCustomerLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">61,739</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4cc67d80-e6dd-4e6d-be97-749572ea77e3" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,535</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ecfb414b-6cea-478e-81b3-5ce7f97cc0ea" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,461</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Finance lease liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3b6b4cd7-434c-41e2-b58c-c106c61640b9" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,408</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_30e1827a-5873-440e-a6d1-2a9e8d2ea780" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,138</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_810e7d9e-e79f-460b-a5f8-c63866bdbfe4" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">303</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d8a07115-f1e2-4f71-ab20-ec3f55fd5b49" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">228</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f6323d9-6e73-407f-b6ca-ca09e305549b" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">71,343</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b60a2b3-1b97-4d8c-8db3-ef0e0ab7e2e0" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">92,542</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue, net of current portion</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f8f13765-4852-4490-b8a4-0d66e5dc5ebe" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21ca6add-3cef-4546-9d58-350a44e1dfc2" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,295</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9f79d15-191c-4d13-9daf-bce9cf6b06d2" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,146</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dabadda0-a9e9-4d9f-b3a8-d35dabd57006" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,224</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Finance lease liabilities, net of current portion</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d7f8aaea-e161-4509-a81c-a4178f196f43" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,246</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5a9db3ff-97f5-4816-8eb2-0b01f28285f8" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,140</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other non-current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eb624179-3277-4237-9a62-91033cd64366" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">248</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f6eda52b-de2e-42c7-83c0-2a2c2fa4c621" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">66</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_208c28d8-ea84-47b8-b7f9-95c6bfb13a36" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">112,983</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b1309252-e11c-45c8-9fc1-6845e32cbd3b" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">146,267</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commitments and contingencies (Note 9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="-sec-ix-hidden:F_a9f2aefd-6d15-4f49-976d-74b2deaa9149;"><span style="-sec-ix-hidden:F_fbb4303c-a232-44f8-b305-22f13b9fd4e0;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stockholders&#x2019; equity:</span></span></span></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock, $</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_09a742b8-dc4c-4b0d-aa3d-68990a3962d8" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_3fd411cf-257a-462c-8f14-aa406fbd18f4" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value; </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_189e4a16-c949-46af-a759-9a656ef96030" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_1783c4cd-f597-4f8a-b574-f8a061a2bf4b" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">150,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares authorized at December 31, 2022 <br />&#160;&#160;&#160;and 2021, </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a7e84c30-5a66-4dfc-a93b-f3486dfeb048" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">55,039,380</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0aef9346-3827-4b0c-985b-61db0d567845" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">51,573,924</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares issued at December 31, 2022 and 2021,<br />&#160;&#160;&#160;respectively; </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_43173008-a82e-435e-9364-56b49570690b" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">55,039,380</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73fe7456-ca81-475d-b6cb-6ecacf266dc7" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">51,536,181</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares outstanding at December 31, 2022 and <br />&#160;&#160;&#160;2021, respectively</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21a33c41-fd8b-47b2-91ff-fa603ac16585" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_95237b43-26c8-49e0-827e-e844aadfb902" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a03e194-f0b9-474a-8983-63cea930583c" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">878,884</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_84515f0d-5b31-410a-91bb-c9dddbca8f81" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">689,275</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b0a95125-f7e1-48ac-b147-cc46eee1966e" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">383,790</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_db941c40-bbc8-4706-8ab3-61904c0353b0" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">228,982</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated other comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_756c1d81-28e7-4b27-9915-b456261ed5ed" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">4,949</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6e17b04-abcf-4871-aa3b-9c643b62bff0" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">660</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stockholders&#x2019; equity</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_266e0737-ee21-403d-a023-51069475831f" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">490,151</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16a3ebbc-552b-4501-82da-552c8f5198af" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">459,638</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities and stockholders&#x2019; equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_294ff13e-9428-4ded-8a2b-4d7460e3a1cd" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">603,134</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_401d7b85-fd32-4c71-b29f-e5b2cca12871" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">605,905</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Stateme</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">nts of Operations and Comprehensive Loss</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands, except share and per share amounts)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.22%;"></td>
    <td style="width:1.393%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.821000000000002%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.393%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.821000000000002%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.393%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.96%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Statement of Operations Data:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_dc247878-85ea-4ea3-88c3-f656dec50fb8;"><span style="-sec-ix-hidden:F_59dd5951-129a-4921-a76f-3a77497db12e;"><span style="-sec-ix-hidden:F_0a629c5c-447e-4e13-9f0f-f5c8e97606a2;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration</span></span></span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Revenue&#x2014;from related parties</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2f960aa8-0158-43f4-b0bf-76c9a35309bb" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">46,826</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_af528321-129f-4726-a0ea-209d02e0a2dc" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">72,832</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ea131961-fac9-4cdd-b159-a5310380e842" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">34,034</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e0691037-6cfb-4bf4-b3d5-54f6f53f7bb3" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">164,248</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_826edae5-6585-40e2-be15-9c0603e75d59" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">137,017</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_51b3854f-63e6-471f-975d-f7b51f8a1bcf" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62,105</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e4b0bde4-0e84-4904-ba8d-385538993b28" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">43,834</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_670ebc72-92bd-4470-b0cf-8752a6c56e06" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,345</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_27caed2e-5f62-4dc1-aad6-a3bbddbafcb3" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,233</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_778714b9-bbb0-4123-8baa-07b6c7b3cf5b" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">208,082</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c60b7640-1e41-4831-9edc-f973db95d779" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">173,362</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cc397617-73c1-4a21-bf9f-cfe4e2f2cc79" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">80,338</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93d3ea10-c591-47a9-ad7b-0257c7b1c964" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">161,256</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_20dc8f94-0b70-46c6-8cf7-195d92f30a98" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">100,530</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_62a2c52a-62cb-46c1-a114-c397e7ca5d11" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">46,304</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense):</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest and other income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_856c600d-6d0a-4786-9769-1e4431811811" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:OtherNonoperatingIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,624</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90044248-5ee7-4273-b262-3e75d77a1dd1" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:OtherNonoperatingIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">488</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_668eec40-67d7-457a-848d-3e073450b2fc" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:OtherNonoperatingIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">826</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest and other expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b9bb0776-9048-450b-8403-079404bbbb09" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:OtherNonoperatingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">176</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2d65e1ba-537c-4a72-bc2c-fc73e67cd26f" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:OtherNonoperatingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">175</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_62555f12-85b0-4dd2-86bd-1cc718f8be5a" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:OtherNonoperatingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">115</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total other income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ee1e8e70-4ec9-4e58-98ad-146d9a97f659" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,448</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_389f2071-3a1a-4501-9fda-f6d9ea2bff11" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">313</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9ec6ff3c-c03b-43dd-9a57-2193267e0a43" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">711</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cca690e4-9326-4cfc-9d33-45e6186eda91" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">154,808</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2c953ad5-1aaa-4030-a2e8-7a5ee1ee2472" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">100,217</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d056b228-4f47-4882-94ee-0b1df49cb84e" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">45,593</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive loss:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized loss on marketable securities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_25a38056-50f8-4913-aac5-878e9a6d7904" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">4,289</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_05cc9588-5749-43a4-95de-3a2b38d7bc1c" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">532</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9b6e5a96-76b3-485c-aa5c-88daf1596a03" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">134</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_088a0c37-135d-4aa7-89b9-e43cac1b5a8e" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">159,097</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_191a1ea4-c387-4285-bd4e-2751749d28a2" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">100,749</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_07ea3046-de16-44eb-9825-bb1729957521" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">45,727</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reconciliation of net loss to net loss attributable to common <br />&#160;&#160;&#160;stockholders:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net Loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e7340d10-5346-42a0-9b36-18751ce5bbd9" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">154,808</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b5dab053-992f-40b0-b1d7-8604794d02db" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">100,217</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9e5185f1-9a6d-4474-9d3f-f6fa65a2880c" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">45,593</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deemed dividend from exchange of convertible preferred stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b33b8a2f-f4df-4e9e-bcb3-a3b51cc11647" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:TemporaryEquityDividendsAdjustment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_34b76745-8a6b-4f18-aa8f-9aca81f3890e" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:TemporaryEquityDividendsAdjustment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_72f68393-0e12-4d8b-8cbb-8af9e4b9f2b1" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:TemporaryEquityDividendsAdjustment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,050</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss attributable to common stockholders</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_80c21a62-a4ff-4ff1-9e93-639b17d3fb0b" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">154,808</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d42b094a-9d14-407b-b148-bb49534848dd" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">100,217</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dbb5b03f-a771-48c0-b2a7-37ecf929552c" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">54,643</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share attributable to common stockholders, basic<br />&#160;&#160;&#160;and diluted</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_db160915-dba5-43bd-938c-cd35d19ed175" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_8b70b499-83a6-49dc-ad08-bc489e1d87e1" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">2.87</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dec51d82-a455-46b5-9144-daa946847807" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_adc3ef73-36a8-4646-9731-05970ef4d016" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">2.09</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_12de0623-d3e9-498a-92d6-4a9a51279674" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_dc46e217-b280-42bb-9d9b-0499cc92aa04" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">3.15</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average common stocks outstanding, basic and<br />&#160;&#160;&#160;diluted</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a613bc6b-892a-43bf-a678-bfcfacc6ebb4" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_aa7db214-a26d-4d0d-a95e-477a854180ca" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">53,933,229</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fd0cb5bc-e3e6-44ec-a715-7ed78c72960e" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_853630fd-2a3a-40fb-bb92-f65520321374" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">47,989,023</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_31372fb9-c071-4253-a2e7-eff8a1f6a7b3" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_abfac52e-e155-440a-ac4d-d080197b32e1" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">17,349,582</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_equity"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#x2019; Equity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the years ended December 31 2022, 2021 and 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:16.223%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:3.346%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.746%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:3.8710000000000004%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.271%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:3.8710000000000004%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.271%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:3.346%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.271%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:3.8710000000000004%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.796%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.094%;"></td>
    <td style="width:1.103%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:3.4069999999999996%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.5269999999999997%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.9099999999999997%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:3.417%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.599%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.0649999999999995%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series Seed<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series A<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B-1<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional<br />Paid in</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated<br />Other<br />Comprehensive</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total<br />Stockholders'<br />(Deficit)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain/(Loss)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2019</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f5e6d807-e609-4c74-90ff-24a17b75346e" contextRef="C_588fd5b5-72cb-4b8f-8a09-d3c8c62edc57" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,000,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_18b25778-f886-4d9c-97a4-0c5ced41b23a" contextRef="C_588fd5b5-72cb-4b8f-8a09-d3c8c62edc57" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,900</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_215a7826-4d59-4e16-b6e3-16a4cfdcda8c" contextRef="C_74aee4f0-c621-4b65-8a33-0e483df74a09" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">14,720,126</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cfa57289-1eee-4305-9d8e-db6ec48203f7" contextRef="C_74aee4f0-c621-4b65-8a33-0e483df74a09" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,237</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24568c58-2f4e-42cc-9896-188b2d28b7c7" contextRef="C_b732179f-e38b-4ac0-966a-36f9156f251e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">14,827,580</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c515f105-a84f-4ca7-baf7-d5c0a1b8c49a" contextRef="C_b732179f-e38b-4ac0-966a-36f9156f251e" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,918</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_677a0a63-794e-484e-838c-d0682ce0a3bd" contextRef="C_2b8cccc4-67af-4d70-a28f-55b723676bd5" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,059,695</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b1aff938-a11b-4cec-8fd8-eb31b438ef55" contextRef="C_2b8cccc4-67af-4d70-a28f-55b723676bd5" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,025</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_745bd010-346d-4e47-a578-35065d43d6a5" contextRef="C_4ab02c5d-c1ed-4254-9c17-05221638469e" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,929,516</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ff56b46e-d86f-4bc8-bc50-30bde868fb17" contextRef="C_e4243250-6638-48e7-889c-97b8a1f4c6c0" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,044</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_edf36df7-ab13-406e-8266-0aaeb6ae7735" contextRef="C_c78e13b1-5a22-4766-9c4e-481992abdd5d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">76,456</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e878d985-6b63-4653-b72e-16f4d0253f8e" contextRef="C_ceafc2b0-0999-4cab-befa-221a85b5170a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6f17d8f-d318-4ab5-a787-222d291e04dd" contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">74,406</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vesting of Series A Preferred Stock<br />&#160;&#160;&#160;in connection with collaboration <br />&#160;&#160;&#160;arrangement (Note 5)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_450beeba-b74d-4818-9298-0574074ff16c" contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0" name="kymr:TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">110,788</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_89958644-3b7c-40e1-b2a8-1224508b0ac2" contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0" name="kymr:TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">222</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of Series B Preferred Stock,<br />&#160;&#160;&#160;net of issuance costs of $</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d01442d8-3f31-404c-a64b-839dbe6b8914" contextRef="C_364f0411-8f1d-481d-848d-0b732287ee1b" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf7b72cc-c8d1-4974-9bd3-efe19b0a2a70" contextRef="C_5bd98592-a6f8-48cb-b2d8-69e2fb37cced" name="kymr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,182,265</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c08fb58-62ca-40af-af97-14e5573577d2" contextRef="C_5bd98592-a6f8-48cb-b2d8-69e2fb37cced" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,800</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of Series C Preferred Stock,<br />&#160;&#160;&#160;net of issuance costs of $</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_91fbd8f3-7fa8-45ba-a7b9-d09f77a1df30" contextRef="C_dda1079b-6eca-441a-a05b-3722b9bc66cf" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">320</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b38de459-c152-4bb3-9940-a85290e61411" contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46" name="kymr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">13,539,141</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1a1755f5-6e89-495a-923b-663fa0441cb5" contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">88,180</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exchange of Series A Convertible<br />&#160;&#160;&#160;Preferred Stock for Series C <br />&#160;&#160;&#160;Preferred Convertible Preferred <br />&#160;&#160;&#160;Stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e5c59759-2e2d-4fdb-93fc-3a71ce10251d" contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0" name="kymr:TemporaryEquityExchangeOfConvertiblePreferredStockShares" unitRef="U_shares" decimals="0" sign="-" format="ixt:numdotdecimal">1,988,802</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f190249-5c4e-451d-8080-6e327fb4e5e1" contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0" name="kymr:TemporaryEquityExchangeOfConvertiblePreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">3,950</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_89433764-0bcd-40cc-9d6e-2e59dd95da13" contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46" name="kymr:TemporaryEquityExchangeOfConvertiblePreferredStockShares" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,988,802</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4d2f3ac7-4fa5-4ced-8015-ef678f96a404" contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46" name="kymr:TemporaryEquityExchangeOfConvertiblePreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3ab0a57e-4e42-4d8b-b76b-617f37d64e3d" contextRef="C_477496b5-689e-4d9f-889f-43f954b285a8" name="kymr:ExchangeOfConvertiblePreferredStockImpactOnEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,334</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cdc35004-9de4-4b0b-b3ed-7da01d4bb7f2" contextRef="C_449c3352-cd32-4f01-af2a-4da22097c606" name="kymr:ExchangeOfConvertiblePreferredStockImpactOnEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">6,716</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c1ad69d9-ca94-4377-aa98-f228c94d54d8" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:ExchangeOfConvertiblePreferredStockImpactOnEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">9,050</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise of Stock Options</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_05cc5c3e-7924-4fd2-b394-5c09e1854250" contextRef="C_a36aa140-8b72-464d-955e-145c92e86542" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">78,852</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_beae3b34-6807-414a-8cfb-5ed92fcfb946" contextRef="C_477496b5-689e-4d9f-889f-43f954b285a8" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">162</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90dad999-a743-4de2-ac58-aa0a1dec696c" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">162</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vesting Restricted Stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5b50d48e-c680-41ae-9648-c2becf12c79a" contextRef="C_a36aa140-8b72-464d-955e-145c92e86542" name="kymr:StockIssuedDuringPeriodSharesRestrictedStockVested" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">184,410</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f11f87a6-6492-4188-8380-ac6e09ecd63c" contextRef="C_477496b5-689e-4d9f-889f-43f954b285a8" name="kymr:StockIssuedDuringPeriodValueRestrictedStockVested" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">112</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7bef61be-abb5-4d87-8c49-585c328a2383" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:StockIssuedDuringPeriodValueRestrictedStockVested" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">112</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_523e4af8-deb7-4b19-a48d-f310aba7f9fa" contextRef="C_477496b5-689e-4d9f-889f-43f954b285a8" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,190</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_55ad978a-c6d6-47af-87c0-890aae23fde7" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,190</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized loss on marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_29855007-e3b4-4c48-a39e-cb8490bdaa55" contextRef="C_c24a6bd6-ab8b-4a23-9222-6e239419ecc3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">134</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_48e8e356-6245-47d6-a6a6-9334ca2bffdc" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">134</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of shares in connection<br />&#160;&#160;&#160;with initial public offering net<br />&#160;&#160;&#160;of underwriting discounts and<br />&#160;&#160;&#160;offering costs of $</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_272fbd1f-68b0-4a00-8e3e-7d5108887605" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,003</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11b2cd20-8bec-4233-b6f7-fe20a8d10529" contextRef="C_be95bba8-f456-4a90-a5f1-287d343806dd" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">9,987,520</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3f8b6b40-5c6b-4cf9-bd15-344d01993649" contextRef="C_be95bba8-f456-4a90-a5f1-287d343806dd" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a46ab95-6f37-4402-9341-dad1c1c00f59" contextRef="C_ff725650-2c6a-4920-8877-da2405efe942" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">182,747</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6ad210b2-60a9-479c-81bf-37afb3d5500b" contextRef="C_21c4c029-6c05-4698-8da3-0afb2df18536" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">182,748</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Conversion of convertible preferred<br />&#160;&#160;&#160;stock into common stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_db686747-1bd1-4efb-bf96-1bc745a9d9cd" contextRef="C_b416434c-2e1c-4143-971b-fbbf1771eff0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="0" sign="-" format="ixt:numdotdecimal">3,000,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9f82769-6e45-4603-aeba-4811659ffe8b" contextRef="C_b416434c-2e1c-4143-971b-fbbf1771eff0" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5,900</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_65363f92-772e-4281-bf89-4e59020813a4" contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="0" sign="-" format="ixt:numdotdecimal">12,842,112</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_78c210ee-7a63-4d12-9e68-2b0cab8435c9" contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">25,509</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_906bb213-a9dc-4878-84ab-3b939d982890" contextRef="C_5bd98592-a6f8-48cb-b2d8-69e2fb37cced" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="0" sign="-" format="ixt:numdotdecimal">16,009,845</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_de43a1da-2f21-49ad-acfd-cf56dfb5fa20" contextRef="C_5bd98592-a6f8-48cb-b2d8-69e2fb37cced" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">64,718</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_380e99ac-d9bb-485d-9132-75010b8fb535" contextRef="C_d4188fce-d0eb-4f3f-bcf3-22439576a842" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="0" sign="-" format="ixt:numdotdecimal">3,059,695</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e314324b-cb39-4d7b-b5d3-2580d6e7eb71" contextRef="C_d4188fce-d0eb-4f3f-bcf3-22439576a842" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">14,025</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad8dc84d-e1eb-435c-ba62-a4c4a730100c" contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="0" sign="-" format="ixt:numdotdecimal">15,527,943</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b03aa15d-fc0c-4780-8741-afefee09f50f" contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">101,180</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_425368ad-b3f0-4074-86b8-82f005672737" contextRef="C_a36aa140-8b72-464d-955e-145c92e86542" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">31,625,534</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad0c51a9-178b-4b42-aea6-503540748a33" contextRef="C_a36aa140-8b72-464d-955e-145c92e86542" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4e3e7c28-3eed-4368-9e4f-b2dc5ff7d907" contextRef="C_477496b5-689e-4d9f-889f-43f954b285a8" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">211,329</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6dabae08-a4b3-4817-8929-3aac5b8efe55" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">211,332</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of shares in concurrent<br />&#160;&#160;&#160;private placement</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9ffe31de-7438-47d5-ba45-a6660c1617b4" contextRef="C_7358d6d6-fbab-43d0-9f78-318ce8621d10" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">676,354</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9bbe60af-95a7-417a-8a42-2eadf00c0c54" contextRef="C_84f17940-92a7-4e17-be51-01d2d2326192" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,527</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_96cb27df-ca0e-46a7-90b8-57822827eec8" contextRef="C_f62f379d-f310-481c-a34d-1f3d65032cd1" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,527</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net Loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_789ec107-379f-40f5-bfd2-d75e882c2d8a" contextRef="C_449c3352-cd32-4f01-af2a-4da22097c606" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">45,593</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c70387f5-2077-45ec-8867-0cd8c36893fa" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">45,593</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb9359bf-fe2e-4424-8a04-4cf20299b66e" contextRef="C_0562b153-f7d2-4919-a735-90f6be837fe7" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">44,482,186</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_723bae4a-832e-4da5-bd56-fbcce78041f6" contextRef="C_0562b153-f7d2-4919-a735-90f6be837fe7" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_108871af-46fe-486f-880e-9345e7f73f2e" contextRef="C_5441244c-f6a1-4c98-ab13-fd0944167cea" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">412,777</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bdc3a149-c290-4442-a304-736cd2d16e79" contextRef="C_997b8ca2-0e08-4b7f-bb20-e67b92117eb3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">128,765</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8c2604f4-0fbc-44ff-b654-710f8fea50ad" contextRef="C_c311266f-1fb4-45be-8f19-a199951e6b7a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">128</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_270b12a0-635f-407c-85b7-835c2abc7b69" contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">283,888</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#x2019; Equity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the years ended December 31 2022, 2021 and 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20.214%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.5279999999999996%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.249%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.508%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.963%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.508%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.963%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.508%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.963%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.508%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.963%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.538%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.137%;"></td>
    <td style="width:0.137%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:5.686999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.533%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.07%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.817%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:5.389%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.817%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series Seed<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series A<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B-1<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional<br />Paid in</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated<br />Other<br />Comprehensive</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">'Total<br />Stockholders'</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain/(Loss)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_713a16ec-84aa-4645-9d5b-3be81fa2e3b9" contextRef="C_0562b153-f7d2-4919-a735-90f6be837fe7" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">44,482,186</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_883f27fe-cf9c-427e-bedd-344026371cea" contextRef="C_0562b153-f7d2-4919-a735-90f6be837fe7" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_88c50c8b-ab8b-44d5-b5ba-6698a300fc42" contextRef="C_5441244c-f6a1-4c98-ab13-fd0944167cea" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">412,777</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_719fc714-fb3e-4e4f-ac1d-33c22e0c11a2" contextRef="C_997b8ca2-0e08-4b7f-bb20-e67b92117eb3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">128,765</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90745e04-e242-4e7f-b607-32bcda2f172d" contextRef="C_c311266f-1fb4-45be-8f19-a199951e6b7a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">128</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_29494918-ae34-4f4d-ac05-36883528a24a" contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">283,888</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise of stock options</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6241033e-4b10-46c4-93e3-790bedee101e" contextRef="C_0269e2a0-73d4-4767-b9f5-307b464b1430" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,431,271</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_45629e0a-1234-48da-ba29-549cddb10f7d" contextRef="C_0269e2a0-73d4-4767-b9f5-307b464b1430" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5cf1b9d4-9838-43b1-a8c7-f006056c19b0" contextRef="C_a0c7a845-3be7-4f46-849f-63f833e1d24d" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,632</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bd00fd25-223a-4202-8cfe-7ad7f42fc824" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,633</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vesting restricted stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c5ed8181-3411-4207-9a4d-428aebe2c9e8" contextRef="C_0269e2a0-73d4-4767-b9f5-307b464b1430" name="kymr:StockIssuedDuringPeriodSharesRestrictedStockVested" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">72,359</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of shares under employee <br />&#160;&#160;stock purchase plan</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b75d7c4-d531-49e3-9163-3cdcd5de7828" contextRef="C_0269e2a0-73d4-4767-b9f5-307b464b1430" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">19,687</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b406984-c2ed-4c02-82e5-c28c66ee38d6" contextRef="C_a0c7a845-3be7-4f46-849f-63f833e1d24d" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">788</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2c421039-7b31-4ad5-8246-222960e53720" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">788</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of vested restricted stock to consultants</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_84fa9065-dea7-41a4-a1d7-5456abe5c7b8" contextRef="C_0269e2a0-73d4-4767-b9f5-307b464b1430" name="kymr:IssuanceOfVestedRestrictedStockToConsultants" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">12,500</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation<br />&#160;&#160;&#160;expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aec7271f-b52b-4e09-8353-1b0093d62a3f" contextRef="C_a0c7a845-3be7-4f46-849f-63f833e1d24d" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,972</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6d5fa9a4-5ae7-4ee2-a49b-717aad24122a" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,972</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized loss on marketable<br />&#160;&#160;&#160;securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5f79b46d-5b42-4040-ae62-c3e714e93b0b" contextRef="C_f9e0671b-5bcf-43c6-8613-91b1eee2aa9d" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">532</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0907c118-b834-4bc0-9dc9-fafad156c7dc" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">532</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of shares in connection with<br />&#160;&#160;&#160;public offering net of underwriting <br />&#160;&#160;discounts and costs of $</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b79b2f2-a980-476a-95c3-1f70c5efce7b" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,207</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2d63be7a-0a25-4f60-a0b5-4a4b4e3e6fe4" contextRef="C_e3f5946c-97c3-41b3-9ef5-e15537183ae3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">5,468,250</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_800ab9d3-3dca-4e02-990f-30dbb5ed6b44" contextRef="C_b43f0ac9-9dd1-43f0-9c2f-f1e6e998903c" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">240,760</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8c578900-cd0f-4f60-9a17-93bea0998cef" contextRef="C_1d3282a7-0917-49af-8ec3-cef4fee801f9" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">240,760</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of shares in concurrent <br />&#160;&#160;private placement</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08658a02-65b0-4f5e-9cd0-9ec2ebb1995a" contextRef="C_9b3d185f-ca4e-4abd-8e59-83567a508d6b" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">49,928</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_500847f6-4f9e-4379-bd1d-7489dab126ab" contextRef="C_476fbf89-ead5-43aa-a71f-121b8c5b80cd" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,346</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bbfbfb4a-abbf-4532-ba77-ca1ef97bea00" contextRef="C_a3474749-9778-48ea-8068-ff4b03644db1" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,346</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net Loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d08debb1-7948-46a5-bab5-80d156d65653" contextRef="C_d7917064-c478-4770-ad01-038576ee96ad" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">100,217</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba97e0fb-073c-4622-a58b-804208dc202c" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">100,217</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_89b66aaa-d55e-4dc6-b683-bd268473674a" contextRef="C_06738e58-f7fd-48f8-91f1-9bb2c730b938" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">51,536,181</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d3adf2d4-9b57-4865-8bed-b4c731aa201a" contextRef="C_06738e58-f7fd-48f8-91f1-9bb2c730b938" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ca3e8d26-f96b-45d6-ad69-f3024900a044" contextRef="C_fad25e8f-82cd-4241-b5a5-deda1a16ec70" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">689,275</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d140092a-6789-439f-9aef-b9e95dc40943" contextRef="C_1af1f196-8f7a-453c-8f26-b468bf9f47e8" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">228,982</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_38d0b899-ddd5-489e-8ebe-d0eddd2916ee" contextRef="C_b519ea9f-6482-4c50-93f0-fae0c804af59" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">660</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b44c9753-6329-474b-9b9a-9c4cd32751b1" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">459,638</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#x2019; Equity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the years ended December 31 2022, 2021 and 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:21.502%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.309%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.112%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.76%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.661%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.549%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.4730000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.549%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.4730000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.549%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.4730000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.549%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.137%;"></td>
    <td style="width:0.137%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:5.721%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.9610000000000003%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:6.271%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:6.646%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:6.297%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:6.8709999999999996%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series Seed<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series A<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B-1<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional<br />Paid in</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated<br />Other<br />Comprehensive</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">'Total<br />Stockholders'</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain/(Loss)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d72ea4f4-bdad-46b3-9ddc-61b4765a36f5" contextRef="C_06738e58-f7fd-48f8-91f1-9bb2c730b938" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">51,536,181</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e35eb16b-60a7-42d5-961c-dad5298d442b" contextRef="C_06738e58-f7fd-48f8-91f1-9bb2c730b938" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0758fef9-0aa9-4f8a-91e4-834a5055e7e9" contextRef="C_fad25e8f-82cd-4241-b5a5-deda1a16ec70" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">689,275</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b166f82-fe02-41bd-b6a1-34b55929868f" contextRef="C_1af1f196-8f7a-453c-8f26-b468bf9f47e8" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">228,982</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0103a076-7416-4b10-ac5f-cdbfa61614fe" contextRef="C_b519ea9f-6482-4c50-93f0-fae0c804af59" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">660</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c8720668-7a58-49ce-a997-bb7e8456e578" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">459,638</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance cost of $</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a1dd06bd-628b-4a21-a020-4c297199d4b8" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">174</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2ce2e539-40e7-4ce9-82a0-89e609748a2f" contextRef="C_08714960-9258-4fdb-9361-563b0b151dda" name="kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">2,769,228</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_12efa25b-d07e-411c-a117-fe5633a9c8d5" contextRef="C_08714960-9258-4fdb-9361-563b0b151dda" name="kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8381726e-1d59-4cbd-ba54-f7504b2757d2" contextRef="C_76aa8dac-964b-4401-9f4a-e42aa52a6fa3" name="kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">149,825</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d8b5b95-b9d4-4b53-98e1-a2489277516a" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">149,826</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3b907cbd-ca56-42e8-8317-671b5bc8f9da" contextRef="C_08714960-9258-4fdb-9361-563b0b151dda" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">601,594</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d3bf8e9-f7a1-4da4-8d04-6d76eff6863f" contextRef="C_76aa8dac-964b-4401-9f4a-e42aa52a6fa3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,154</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3424af99-57aa-430b-ad4e-773cb3e59298" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,154</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vesting restricted stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_87de8cf5-008e-4f0b-bd68-880d61a1bf44" contextRef="C_08714960-9258-4fdb-9361-563b0b151dda" name="kymr:StockIssuedDuringPeriodSharesRestrictedStockVested" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">36,866</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of shares under ESPP</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ec43a0f9-d6dc-469a-9a32-4edab0059358" contextRef="C_08714960-9258-4fdb-9361-563b0b151dda" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">95,511</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f77a3455-2928-4962-9a38-32f0a22a476b" contextRef="C_76aa8dac-964b-4401-9f4a-e42aa52a6fa3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,150</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f93d5f92-93bc-4871-b5d7-4440f75b9db3" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,150</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation<br />&#160;&#160;&#160;expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e27d764d-00b3-49cb-b6b6-6201224e5cc7" contextRef="C_76aa8dac-964b-4401-9f4a-e42aa52a6fa3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35,480</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4fbf7b61-4d74-4c70-a7b7-3ee0d35fa4f5" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35,480</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized loss on marketable<br />&#160;&#160;&#160;securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aa81b784-cd95-4c03-9ecb-cc6db07e17ae" contextRef="C_24dbfe2c-9946-41c1-a96a-9697c75159ef" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">4,289</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_30cd2373-a236-4e69-bd31-9637fcb37d61" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">4,289</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net Loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f0ec5c57-0e95-4844-8aef-39fe7868c00b" contextRef="C_0cf55378-3493-4d42-bbac-071bc03a0b45" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">154,808</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_01c9498a-a2e5-4784-9930-3feb92c3be66" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">154,808</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a68621b-7173-45eb-b351-a00cfbc08f38" contextRef="C_611d8018-b7e1-4bc6-a151-16f06fc1c9e5" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">55,039,380</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_06e4d779-112a-4072-afa2-88be22b48c87" contextRef="C_611d8018-b7e1-4bc6-a151-16f06fc1c9e5" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c468b551-d90f-42f9-9cd4-ca617a8a4b23" contextRef="C_2022fb22-d24d-4bbe-bb9f-9dab9e88b500" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">878,884</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8400f894-7a13-4b76-8a6b-7e39dadb78f3" contextRef="C_ec425b46-47ad-47dc-8171-83d01e53a978" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">383,790</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b6e3ad64-f501-4cb3-a997-844687a3e39e" contextRef="C_71ee1d85-28a5-45c6-8c2c-1fe698d0852e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">4,949</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e94b38be-066c-4417-af2b-32362105bac9" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">490,151</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statem</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ents of Cash Flows</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.493%;"></td>
    <td style="width:1.339%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.754%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.339%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.754%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.339%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.982%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f0787a8d-9ce9-4700-a7ec-e9b0e00a83a8" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">154,808</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cd62e68f-54a6-441c-a596-5ac6adaeea63" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">100,217</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2cdc89f7-28d2-46c3-8207-364972057474" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">45,593</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_63a71a96-d7b8-444e-86aa-8bded771e32c" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35,480</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c1b61339-232d-4874-9109-59dc44683189" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,972</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc85d13d-2efa-4815-aeac-03e7ec09ed93" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,190</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation and amortization</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_560319a8-b280-49c8-8724-a0c1457c681b" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,977</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3cda8756-6c81-4698-8469-0ffa71417c2b" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,397</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_41905981-8aa8-4efb-8d92-326a94dc749e" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,763</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Premiums and discounts on available for sale marketable securities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_72d4cf00-ecf6-41d7-b130-4585cfdb8945" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">889</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_124d2b36-93c1-4eb2-9cff-8a122a4e59e4" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,807</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_df1f5e37-9b31-4c9a-9834-c66048fede70" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,571</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss on disposal of property and equipment</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b708601e-2f8d-491c-91cc-1e96cb1690b9" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5c03560c-c0fd-4dad-835c-efbd0fb05fdd" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d09617ac-9a45-4330-b0dc-37b78a260462" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-cash research and development expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b182d274-89dd-4deb-a2c4-0ceebd94d41b" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:NonCashResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ffa3648f-fcb9-4b49-81d8-d4eee2d956fe" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:NonCashResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_58d09b00-85e0-4174-8183-0d84522c1d8b" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:NonCashResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">332</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ae3e35fb-995e-4aa2-a7db-6dde22280f73" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">992</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d93733bf-eb44-46c2-a4c8-f6b8cfd52156" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,016</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a013ed40-460c-412a-9b93-0aed26652543" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,816</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable&#x2014;due from related party</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f7b3a3b-fcf5-4aec-98f2-42fad0b36b46" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_065b9f0b-729a-4139-beaf-84a96d1a0edb" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">577</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be8f945f-6abd-44cb-82f6-14ede3f9cfd1" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">577</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contract asset&#x2014;due from related party</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24a16876-c65a-48e9-a67f-6e5978e2ebc3" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:IncreaseDecreaseInContractWithCustomerAssetRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,401</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ab4fc6a2-94d2-45b2-93e5-6cde131c63aa" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:IncreaseDecreaseInContractWithCustomerAssetRelatedParties" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">721</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4e921b6b-f156-43de-bee7-d30021c0586c" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:IncreaseDecreaseInContractWithCustomerAssetRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">856</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bbfc2ec4-45f5-4acd-aacc-45baa964a863" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">253</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_04ddb500-c36d-4459-a326-83493fe10a8d" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">54</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2d2817ef-ccc8-45eb-a315-b99a8b67cdaf" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">990</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7f95d109-cb75-4544-ae35-3c064ab93962" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,519</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6783b8bb-e12b-4f6f-9d5c-6d08a0ac2d88" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,599</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5b18b577-5d39-44d3-9bb5-4dc4d0fac268" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,754</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d295edc9-1279-4799-b321-b6a975c2eb91" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">37,774</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bffbd4c4-2541-442c-b4b2-4047fba11730" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">69,356</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_478613c5-6160-475f-8fff-0bacb7ecc8ec" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">117,400</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6fda8602-329c-4a65-b9f9-762d1884186c" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">517</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8562c00a-c46a-47e6-8781-a71cc785fd3b" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">419</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_059dc094-44b2-4198-809b-24500c30ee72" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">8,444</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad7960b9-cdf2-430e-bfd8-b9edd6460d47" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:IncreaseDecreaseInOperatingLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,004</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e77ba10-c3f6-454e-a58a-dbcdbb173bbc" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:IncreaseDecreaseInOperatingLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,015</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73600f29-d694-4a42-8e5c-a067e0e1f0c0" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:IncreaseDecreaseInOperatingLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,647</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other non-current assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_229462e1-afbe-4779-9b80-65243bafdc2a" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">998</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_939c4ef7-63a2-4daf-baac-e492ef34c380" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,992</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b6a41340-713c-4e77-b809-c71511353e99" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other non-current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1e81cb9e-69e9-4445-8242-08623e3f2fcb" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">257</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_55ccca88-b801-4d2c-a093-aa0cccb21ba2" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">86</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_38a06638-5d4f-4387-a9fe-91cfa67e5ff7" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">205</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash (used in) provided by operating activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2abc022-755b-4767-8b82-5eaccb1c8f3e" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">153,085</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9771d5ab-0c4f-4dfc-810c-2fb7a61b625f" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">128,946</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8d352143-23aa-4dfc-9835-cd1be3ee0c42" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">88,130</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase of property and equipment, net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_52293e25-0dad-412d-87ad-d36a5efe569c" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,836</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a8318ad8-4d9d-4943-a1b0-b52f589d2e5e" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,597</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_46253423-df6d-4389-999a-ebe6bed01e34" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,096</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase of marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8782dd9f-f05a-4969-887c-9ec0d2211e85" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">445,972</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e46bb837-e381-4243-aa33-07567a43b327" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">456,404</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8975738f-fe1a-4c98-859d-c92f7619a85c" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">529,382</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maturities of marketable securities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a53af20f-941b-4dac-9a39-2663704270f3" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">469,327</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_da4997e7-14c8-4ed5-a3d9-49726dde5f27" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">358,166</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a04eb27-fa93-4ea9-938c-fc5a5c2b23a1" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">115,890</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by (used in) investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_180f4b80-d80b-4da5-8efc-91c8aca4c962" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,519</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f7439f45-fb47-42dc-8954-14db0a97c0ad" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">99,835</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_85840b20-4dd5-4b75-a333-60f02e824a37" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">422,588</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuance of common stock and accompanying <br />pre-funded warrants from private placement, net of issuance costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7fd19ac6-10b3-447f-a520-4d2b0da28858" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">149,825</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2f3a7d47-236f-49cc-8d56-7d7f7dea9f47" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_67ad4c45-2a22-47bb-ba58-c5169f42110c" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from the issuance of Series B-1 Convertible Preferred Stock, net of<br />&#160;&#160;&#160;issuance costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_57cb3838-25e8-4b48-bba0-755ae717340b" contextRef="C_842a256c-4f35-4914-9766-3edf46028402" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1a3d6d9f-ddfe-4b77-ba10-a07ee267d2e2" contextRef="C_8ff041e4-b315-4e52-b81f-f83d9f3192a0" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6f54714d-7fb9-4fca-be78-d560cc7e0520" contextRef="C_d4188fce-d0eb-4f3f-bcf3-22439576a842" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,800</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from the issuance of Series C Convertible Preferred Stock, net of<br />&#160;&#160;&#160;issuance costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83234beb-de59-436e-a58d-a9282947052e" contextRef="C_cd15099d-d559-460e-9cc6-741a7742e2e1" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_475ab3ff-ce7f-4ab4-8f2c-22a30efd96ed" contextRef="C_1c2cea65-c96f-40f3-85ee-3f904357fc50" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f9a394fc-6969-439a-9fa8-cb32eb797441" contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">88,181</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from stock option exercises</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8d9eff06-f573-490c-b31b-a4e664e6d9d2" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,154</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1bb7b655-b669-4e02-a535-7e3c9702c57e" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,632</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2d532037-2fb4-4452-acd6-6e5f02de6de2" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">162</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from employee stock purchase plan</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fbccc1a5-5d11-4d02-9127-487cc1a1d8e3" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ProceedsFromStockPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,150</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0a397653-a3eb-4e1f-a488-bf8dc6a0d4b5" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ProceedsFromStockPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">788</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e818f6d8-dab6-4266-9983-858cfcaf7956" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ProceedsFromStockPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payments of offering costs in connection with initial public offering</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_ae10bbc7-71bf-42d0-a616-ec6d368d4c60;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_087a8caf-302b-47af-bef5-aeeefc020ce4" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:PaymentsForRepurchaseOfInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">397</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_f278db45-7d50-4cc7-9df3-e40961d927bc;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payments on financing leases</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cccddf49-49d5-48ec-9e06-410caa6a8d1f" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:PaymentsOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,130</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bfd86429-d1a2-49a7-92c1-1d036805bb33" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:PaymentsOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">849</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_36941ce6-d132-49c8-bf17-7f9f4c62599f" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:PaymentsOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">554</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from follow-on public offering, net of underwriting discounts and<br />&#160;&#160;&#160;offering costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1c6010d8-5b06-4ec6-97d2-ef89d0d9747d" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f58e4a97-1da2-4038-a757-25aa2de8cc53" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">240,760</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6bfd09fa-5807-4c0e-9386-40e255ab41a1" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from initial public offering, net of underwriting discounts and<br />&#160;&#160;&#160;offering costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_19c02132-69c1-4cd2-8a5b-61655a12ec87" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7db4ee79-e2f8-4a4d-a59b-d166f517c655" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_84b1d69a-3862-4ab2-9fe0-104f80dda151" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">183,146</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from concurrent private placement</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_369c0779-1400-41e9-84fd-c5ea44cb79a4" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:ProceedsFromConcurrentPrivatePlacement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_30af8697-e6c8-4878-8e48-b4fa62dddc32" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:ProceedsFromConcurrentPrivatePlacement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,346</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ac5c43e4-0632-45ac-9f38-a8dcbb8565cf" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:ProceedsFromConcurrentPrivatePlacement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,527</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0d8f7533-fa7c-47b9-ba5b-d5a95a1859b1" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">152,999</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e284464d-c6e5-41f4-833c-3ab12f29e3fd" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">250,280</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cc91d3c6-b883-4a8a-b66f-ec8353039b84" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">289,262</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net increase (decrease) in cash, cash equivalents and restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_10eb537a-2a53-47c5-a4b5-1ec470e83bc4" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,433</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3fed6930-dd90-44c3-825b-60b58a3e280d" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,499</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_adeb8231-80b3-442d-ada8-f77f989260ee" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">45,196</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash, cash equivalents and restricted cash at beginning of period</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_926a730d-552a-4f07-b6c3-d6ad8078c639" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">54,092</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d7703966-05a7-4260-b411-0690fc9af333" contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,593</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5adce1b3-11de-4876-b734-e37e7ac2861b" contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">77,789</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash, cash equivalents and restricted cash at end of period</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0062067f-b483-4c09-acb1-466a6f5d6640" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">74,525</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc705fb0-ca14-4dae-b11e-dafbc53dd750" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">54,092</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b296904e-46a3-4001-813e-a2f3456f5dad" contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,593</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental disclosure of cash flow activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash paid for interest</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ae99998-f59f-4d23-b743-097f4db541b5" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">179</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6f959998-2555-4848-a4fb-b404bb05832d" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_acbd6fa7-b154-44b2-a465-20707d965300" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">115</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental disclosure of noncash investing and financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of property and equipment through finance and lease liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a4ee04b4-4365-4a1d-9be8-a1ced803addb" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,506</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1873985d-8e10-4e56-9f80-7b5d1b072ef7" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,918</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e555732b-92f8-4c9e-bce2-bcee11f2522a" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment purchases included in accounts payable and<br />&#160;&#160;&#160;accrued expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_49f6808b-934d-4dc3-b1a2-5e70c94ba148" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">87</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b92b5f18-1792-42b9-9995-d99cf6ddd5ff" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_55505d5b-7124-449c-8f05-3024fbd8d662" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Offering costs included in accounts payable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_773c8dd4-8185-4b24-b1e8-e84bb6bc1f93" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:OfferingCostsIncludedInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9b5bf58c-8e58-42f7-abe5-03b1239ced7c" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:OfferingCostsIncludedInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_53d1825f-bfd0-418b-b082-e8f859bcda04" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:OfferingCostsIncludedInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">397</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental disclosure of noncash operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reduction of right-of-use asset and liability due to lease modification</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b609a507-8c20-4bc3-a531-9baae9e46b4d" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf96bd1b-449e-40ba-bb7d-9f91b883cbe1" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_62b207c3-4c86-41b1-96b2-9d950cb39a54" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,161</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of each of the periods shown above:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:56.751%;"></td>
    <td style="width:1.396%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.964%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.383%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.964%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.383%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.16%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a41ea73f-e9ec-4ec2-bcf1-47030704673c" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">68,395</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c7276c28-0801-4afe-bdbb-a6eef56b1eb2" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">47,976</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f40fa797-17ea-4d8f-828e-b393a640f874" contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,004</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5f876f2d-a33e-4083-b2cc-070a7a1cc0ed" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,130</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_95a2bf4f-a5c4-4b1c-a5ff-4e264975f84e" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,116</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d7d9a90b-80e3-4241-a5fc-1a2eec16bf13" contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,589</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash, cash equivalents, and restricted cash</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bdcfb40f-cb09-455f-951e-2f5b9a808d66" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">74,525</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4525c74a-0914-4fbc-838d-fc977586520a" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">54,092</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aa0ff114-6248-46b7-b819-892b3f33b8d4" contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,593</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="notes_to_consolidated_financial_statemen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notes to Consolidated</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Financial Statements</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1fdb58f2-0e8e-4843-9165-18c9403019f3" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 1. Description of Business and Summary of Significant Accounting Policies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Therapeutics, Inc., together with its subsidiary Kymera Securities Corporation, is referred to on a consolidated basis as the &#x201c;Company&#x201d;. The Company is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body&#x2019;s own natural cellular process, a method known as targeted protein degradation. The Company has devoted its efforts principally to research and development since formation. The Company has not yet completed product development, filed for or obtained regulatory approvals for any products, nor verified the market acceptance and demand for such products. As a result, the Company is subject to a number of risks common to emerging companies in the biotech industry. Principal among these risks are the uncertainties of the product discovery and development process, dependence on key individuals, development of the same or similar technological innovations by the Company&#x2019;s competitors, protection of proprietary technology, compliance with government regulations and approval requirements, the Company&#x2019;s ability to access capital and uncertainty of market acceptance of products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has hi</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">storical net losses and anticipates that it will continue to incur losses for the foreseeable future and had an accumulated deficit of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2a47f0e6-89d1-4aa8-99c4-752bd8bf2bc7" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:numdotdecimal">383.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as o</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">f December 31, 2022. The Company has funded these losses principally through issuance of preferred stock, convertible notes, common stock, including its initial public offering and concurrent private placement completed in August 2020 (&#x201c;IPO&#x201d;), follow-on offering and concurrent private placement completed in July 2021 (&#34;Follow-on Offering&#34;), August 2022 Private Investment in Public Equity (&#34;PIPE&#34;) offering, and from cash proceeds received in connection with the Company&#x2019;s collaboration agreements with Vertex Pharmaceuticals Incorporated (&#x201c;Vertex&#x201d;) and Genzyme Corporation (&#x201c;Sanofi&#x201d;) (see Note 5). The Company expects to continue to incur operating losses and negative cash flows until such time as it generates a level of revenue that is sufficient to support its cost structure.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company had cash, cash equivalents and marketable securit</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ies of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e0ba7c9d-61b0-4809-8ea9-083aa0f8f5f7" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:InvestmentsAndCash" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">559.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million. The Company believes these cash, cash equivalents and marketable securities will be sufficient to fund its operations and capital expenditure requirements through at least twelve months from the issuance of these consolidated financial statements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company expects to finance the future research and development costs of its product portfolio with its existing cash, cash equivalents and marketable securities, or through strategic financing opportunities that could include, but are not limited to future offerings of its equity, collaboration agreements, or the incurrence of debt. However, there is no guarantee that any of these strategic or financing opportunities will be executed or realized on favorable terms, if at all, and some could be dilutive to existing stockholders. If the Company fails to obtain additional future capital, it may be unable to complete its planned preclinical studies and clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reverse Stock Split</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4f6f802e-f915-4a3c-982d-2712f95cdab7" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:StockholdersEquityReverseStockSplit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On August 20, 2020, the Board approved a 1-for-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_04931b77-5108-435c-bdc7-0bbdcbacdc18" contextRef="C_062f8b1d-9242-4851-af55-d6d0942205c2" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" unitRef="U_pure" scale="0" decimals="4" format="ixt:numdotdecimal">1.5949</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reverse stock split of the Company&#x2019;s issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each of the Company&#x2019;s outstanding series of preferred stock.  All share and per share amounts in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to this reverse stock split, including reclassifying an amount equal to the reduction in par value of common stock to additional paid-in capital.</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Initial Public Offering</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On August 20, 2020, the Company&#x2019;s registration statement on Form S-1 relating to its initial public offering of its common stock was declared effective by the Securities and Exchange Commission (&#x201c;SEC&#x201d;). In the IPO, which closed on August 25, 2020, the Company issued and sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_54db873c-c191-4735-b58e-9a5f0b595ecb" contextRef="C_6ad1ca74-8cd0-428a-8420-0ed4140b55c2" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">9,987,520</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, including full exercise of the underwriters&#x2019; over-allotment option to purchase an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b1eaf5b-ba19-4652-82c7-fd1b84017e85" contextRef="C_4dc0482d-1972-405a-aca2-c6d2771a5668" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,302,720</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares, at a public offering price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8e309425-9da7-4ac6-ba9c-c21c5b93de74" contextRef="C_dfba4027-fdf3-4f74-b209-0790ae57b570" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">20.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share and the aggregate gross proceeds before deducting before deducting underwriting discounts and commissions, and other estimated offering expenses payable by the Company, were approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6fdd3417-98f5-40dc-8508-723d0b13e410" contextRef="C_6ad1ca74-8cd0-428a-8420-0ed4140b55c2" name="kymr:ProceedsFromIssuanceInitialPublicOfferingGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">199.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. Concurrent with the IPO, the Company issued and sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a07e227-9e44-472f-a3e1-20a5d9af0551" contextRef="C_44015c49-ba45-4506-b30f-8927b0882496" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">676,354</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock at $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0e269459-0b21-4914-83e6-3730a5a0f5e0" contextRef="C_e683523c-eff3-4658-979d-24ea59364214" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">20.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share in a private placement to Vertex and the aggregate proceeds were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bac12e17-b309-46ee-a441-b1d67c654eca" contextRef="C_44015c49-ba45-4506-b30f-8927b0882496" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">13.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Follow-on Public Offering</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 6, 2021, the Company completed a follow-on offering of its common stock and issued and sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4cde095e-28c6-46dd-b2d6-8e9c59618043" contextRef="C_3d5e6adf-2cb4-4ff6-abed-16ed9bba1142" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">5,468,250</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, including full exercise of the underwriters&#x2019; over-allotment option to purchase an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11266c42-27a9-4630-a0fd-2ded12b07d17" contextRef="C_e6afb047-c3cb-439e-93ba-6a0d534e4847" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">713,250</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares, at a public offering price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2fe9fff1-7894-4d4b-aa13-377b4792f8a1" contextRef="C_f8adf4fe-2bfc-43b4-9f31-817a19df61dc" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">47.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. The aggregate gross proceeds before deducting underwriting discounts and commissions, and other estimated offering expenses payable by the Company were approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e82998e3-dda4-48f6-bcbe-c30c625a9df3" contextRef="C_3d5e6adf-2cb4-4ff6-abed-16ed9bba1142" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">257.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. Concurrent with the follow-on offering, the Company issued and sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba13c6cd-4fac-4e7c-bc7a-7a93fdf40c61" contextRef="C_f35c6b15-85ad-422b-890a-5ff664200b70" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">49,928</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock at $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fa261d1d-d832-446d-ba5b-0f8d10355769" contextRef="C_5e341025-329c-4ac7-81f0-c034f045d05a" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">47.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share in a private placement to Vertex and the aggregate proceeds were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a5ac945-0d9f-4ed9-943e-da15ac8e9e3e" contextRef="C_f35c6b15-85ad-422b-890a-5ff664200b70" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Private Investment in Public Equity &#34;PIPE&#34; offering</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On August 18, 2022, the Company and certain accredited investors entered into a securities purchase agreement pursuant to which the Company agreed to sell and issue to such investors in a private placement (i) an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a4a829b1-8ab3-4022-a9bd-26796137d10c" contextRef="C_1df7a9a0-1093-45f8-b738-6e2b781d6256" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,769,228</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#x2019;s common stock at a purchase price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83ab486b-6837-4291-8a1b-70c85f3ee247" contextRef="C_0e2b9cb4-93a4-4a46-8ff4-8c907b9948cb" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">26.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, and (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e0260c5e-0d59-4de1-b718-20548d671729" contextRef="C_0e2b9cb4-93a4-4a46-8ff4-8c907b9948cb" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Pre-Funded Warrants to purchase common stock, at a purchase price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c6a8ad5-5b79-464c-8a00-24fedd574c1f" contextRef="C_0e2b9cb4-93a4-4a46-8ff4-8c907b9948cb" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:numdotdecimal">25.9999</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per pre-funded warrant, (the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;Pre-Funded Warrants&#x201d;)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Pre-Funded Warrants will have an exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8e4613a4-ed8e-43db-a2f4-b4013b92042d" contextRef="C_1df7a9a0-1093-45f8-b738-6e2b781d6256" name="us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share of common stock. The offering closed on August 22, 2022, resulting in net proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_222763ac-5fa2-4a3e-9c68-bd8d470be123" contextRef="C_0e2b9cb4-93a4-4a46-8ff4-8c907b9948cb" name="us-gaap:GeneralPartnersOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">149.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million after offering expenses.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As the Pre-Funded Warrants are indexed to the Company&#x2019;s common stock (and otherwise meet the requirements to be classified in equity), the Company recorded the consideration received from the issuance of the Pre-Funded Warrants as additional paid-in capital on the Company&#x2019;s consolidated balance sheets. The Pre-Funded Warrants are exercisable at any time. The holders of Pre-Funded Warrants may not exercise the warrant if the holder, together with its affiliates, would beneficially own more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_64040601-ad05-4fff-b96f-dd18a57dcff2" contextRef="C_1df7a9a0-1093-45f8-b738-6e2b781d6256" name="kymr:MinimumPreFundedWarrantsExercise" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">4.99</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the number of shares of the Common Stock outstanding immediately after giving effect to such exercise. The holders of Pre-Funded Warrants may increase or decrease such percentages not in excess of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b30ad824-758e-4a38-a7d1-2bff15ba54d2" contextRef="C_1df7a9a0-1093-45f8-b738-6e2b781d6256" name="kymr:IncreaseOrDecreasePreFundedWarrants" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">19.99</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% by providing at least </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c995c9c9-e340-4cec-84d8-dfbd5b831e07" contextRef="C_1df7a9a0-1093-45f8-b738-6e2b781d6256" name="kymr:PriorNoticePeriod" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> days&#x2019; prior notice to the Company.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the twelve months ended December 31, 2022, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0fed3bff-f6b3-4625-afa6-f46bdfbcf96c" contextRef="C_c448089e-36a2-4d25-8667-2eff989ca829" name="us-gaap:PaymentsForRepurchaseOfWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Pre-Funded Warrants were exercised. As of December 31, 2022, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_65c9099f-e547-45ad-8607-aeb6e508e6a2" contextRef="C_07b901be-39ca-4958-8fa3-0fb35bd13fe8" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> pre-funded warrants outstanding.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_0d021c53-d9d4-4c12-9559-f7c39059c0ba" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 2. Summary of Significant Accounting Policies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note, and elsewhere in the accompanying consolidated financial statements and notes.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d5ec9a6f-547d-433e-b700-73553821dd3c" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ConsolidationPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary Kymera Securities Corporation. All intercompany transactions and balances have been eliminated in consolidation.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d5999ae1-8ed2-456c-8cad-134ce4850acc" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Update (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_384a006d-f81a-4fe4-8e4b-e1c3404d384c" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:UseOfEstimates" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amounts of expenses during the reporting period. Management&#x2019;s estimates and judgments are derived and continually evaluated based on available information, historical experience and various other assumptions that are believed to be reasonable under the circumstances. Because the use of estimates is inherent in the financial reporting process, actual results could differ from those estimates. In recording transactions and balances resulting from business operations, management makes estimates based on the best information available at the time the estimate is made. Significant estimates relied upon in preparing these financial statements include revenue recognized under our collaboration agreement with Sanofi and Vertex, accrual for research and development expenses, equity-based compensation expense, and the valuation of equity prior to the Company's initial public offering. As better information becomes available or actual amounts are determinable, the recorded estimates are revised. Consequently, operating results can be affected by revisions to prior estimates.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3f4f4815-2d0a-4703-85fc-2c2d8ad05c9a" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:SegmentAndGeographicInformationPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Segment and Geographic Information</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company&#x2019;s chief operating decision maker is the Chief Executive Officer. The Company views its operations and manages its business in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_852db266-1a87-4a12-853e-d6be88244715" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:NumberOfOperatingSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> operating segment.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fb22c044-6983-4180-8690-53a574837677" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents are highly liquid investments that are readily convertible into cash with original maturities of three months or less when purchased. These assets include investments in money market funds that invest in U.S. Treasury obligations and corporate bonds. The Company maintains its bank accounts at major financial institutions.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_88f9c374-07ed-4f67-9d1b-b5d18d2dff9b" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:RestrictedCashPolicyPolicyTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash represents the cash held to secure letters of credit associated with the Company&#x2019;s facility leases.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1282176f-0225-4863-926e-093f5aaf8a28" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:MarketableSecuritiesPolicy" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company classifies marketable securities with a remaining maturity of greater than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2eda4071-56fa-4387-9b72-827104aa6977" contextRef="C_1e66e0ff-3fd7-47c3-9d78-6a55c4496d6b" name="kymr:MarketableSecuritiesRemainingMaturityPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three months</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> when purchased as available-for-sale. The Company classifies investments available to fund current operations as current assets on its balance sheets. Marketable securities with a remaining maturity date greater than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_04f271e2-0f41-4af1-babf-f47aac5a0931" contextRef="C_1e66e0ff-3fd7-47c3-9d78-6a55c4496d6b" name="kymr:MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are classified as non-current. Available-for-sale securities are maintained by investment managers and consist of U.S. Treasury securities and corporate bonds. Available-for-sale securities are carried at fair value with the unrealized gains and losses included in other comprehensive income (loss) as a component of stockholders&#x2019; equity until realized. Any premium or discount arising at purchase is amortized and/or accreted to interest income and/or expense over the life of the instrument. Realized gains and losses are determined using the specific identification method and are included in other (expense) income, net.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company&#x2019;s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer&#x2019;s industry, and any significant deterioration in economic conditions.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d6f1014c-dbed-4f2d-939e-8d17f00944d8" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 1&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted prices in active markets for identical assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 2&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar asset, or other inputs that are observable or can be corroborated by observable market data.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 3&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets, including pricing models, discounted cash flow methodologies and similar techniques.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The carrying values of the Company&#x2019;s cash equivalents, prepaid expenses, accounts payable, and certain accruals approximate their fair value due to their short-term nature.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_09068e9e-4471-4f78-8d63-4cf4d1d6bf41" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Leases that are economically similar to the purchase of assets are generally classified as finance leases; otherwise the leases are classified as operating leases. The Company has elected not to recognize leases with an original term of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_817b1cf3-b36c-4b93-a4c0-68592fbc4ff0" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or less on the balance sheet. Options to renew a lease are not included in the Company&#x2019;s assessment unless there is reasonable certainty that the Company will renew. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets, lease liabilities and, if applicable, long-term lease liabilities. Lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. However, certain adjustments to the right-of-use asset may be required for items such as incentives received. The Company has elected as an accounting policy to combine lease and non- lease components, such as common area maintenance, for all classes of underlying assets. The interest rate implicit in lease contracts has not historically been readily determinable. As a result, the Company utilizes its incremental borrowing rates, which are the rates incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. To estimate its incremental borrowing rate, a credit rating applicable to the Company is estimated using synthetic credit rating analysis since the Company does not currently have a rating agency-based credit rating.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_80cc2636-2a21-4f3d-87e6-8f048203edc7" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment are recorded at cost, net of accumulated depreciation. Major additions and betterments are capitalized; maintenance and repairs, which do not improve or extend the life of the respective assets, are charged to operations as incurred. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3b3bb647-359d-4e00-8726-3dc30a85251b" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock" escape="true" continuedAt="F_3b3bb647-359d-4e00-8726-3dc30a85251b_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset as follows:</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_3b3bb647-359d-4e00-8726-3dc30a85251b_1"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:62.619%;"></td>
          <td style="width:0.208%;"></td>
          <td style="width:37.173%;"></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated Useful Life</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in years)</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1a16c0dd-4345-4635-b95e-493f2dfd1e3d" contextRef="C_ec1630b7-f419-4a11-a92d-8d8f0402646a" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_603b2c22-cd7a-4f61-ace0-7df0b0196bb7" contextRef="C_d08b0ba5-abc0-4746-8241-00292ef51a98" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Office equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_69b28a9d-4ca4-484b-aa8f-8e6ef3f7e6ca" contextRef="C_5bcbd011-9c2a-4bed-8e4b-8ad966e7a3df" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_08adf91b-bf68-431e-94bb-7b708fb41fab" contextRef="C_e4780686-685f-4d62-af29-362e17c976f3" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 years</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_21f20880-8b56-4194-9437-b4961cf211e5" contextRef="C_6fc3eaa2-537c-4116-875f-333d3da37c5c" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shorter of life of lease or remaining lease term</span></ix:nonNumeric></span></p></td>
         </tr>
        </table></ix:continuation></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon retirement or sale, the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction-in-progress is stated at cost, which includes direct costs attributable to the setup or construction of the related asset. Depreciation expense is not recorded on construction-in-progress until the relevant assets are completed and put into use.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_794d381d-bcfd-4c01-98bd-08b153e186bd" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Long-lived assets (including right-of-use assets) to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value, determined based on discounted cash flows. The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a06f0aef-5341-4320-ba92-838f9206418f" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_96586e3b-de96-4eb3-85f5-90d83f81d9d2" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_a36b2bce-9c49-43f2-8bee-95f0e4408a5a" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t record any impairment losses on long-lived assets during the years ended December 31, 2022, 2021 and 2020.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9664691c-1517-4589-a192-caed682f492e" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:ConvertiblePreferredStockPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company classified convertible preferred stock as temporary equity in the accompanying consolidated statement of Convertible Preferred Stock and Stockholders&#x2019; Equity due to terms that allow for redemption of the shares in cash upon certain change in control events that are outside of the Company&#x2019;s control, including the sale or transfer of the Company as holders of the convertible preferred stock which could trigger redemption of the shares. The Company did not accrete the value of the convertible preferred stock to the redemption values since a liquidation event was not considered probable prior to the conversion date. In connection with the Company&#x2019;s initial public offering on August 25, 2020, all outstanding shares of convertible preferred stock converted to common stock.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Warrants</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determines the accounting classification of warrants that are issued, as either liability or equity, by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and then in accordance with ASC 815-40, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#x2019;s Own Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Under ASC 480-10, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate the issuer to settle the warrants or the underlying shares by paying cash or other assets, or must or may require settlement by issuing variable number of shares.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If warrants do not meet liability classification under ASC 480-10, the Company assesses the requirements under ASC 815-40, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature. If the warrants do not require liability classification under ASC 815-40, in order to conclude equity classification, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable U.S. GAAP. After all relevant assessments are made, the Company concludes whether the warrants are classified as liability or equity. Liability classified warrants are required to be accounted for at fair value both on the date of issuance and on subsequent accounting period ending dates, with all changes in fair value after the issuance date recorded in the statements of operations as a gain or loss. Equity classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d19e7589-84e1-4e8a-bca9-0d3dad5451f0" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Costs</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development costs consist primarily of costs incurred in connection with the discovery and development of targeted protein degradation therapeutics, including those in the Company&#x2019;s most advanced development programs, IRAK4, IRAKIMiD, STAT3 and MDM2. These research efforts and costs, which also support the development of, and enhancements to, the Company&#x2019;s Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> targeted protein degradation platform, include external research costs, personnel costs, supplies, license fees and facility related expenses. The Company expenses research and development costs as incurred.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8732c8a3-c37a-4869-a235-df3c7e41f12a" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:PatentCostsPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent Costs</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recoverability of the expenditure. Amounts incurred are classified as general and administrative expenses.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1581888a-8ca9-427a-8826-6849ebf175f8" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:FinancingCostsPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Costs</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Costs incurred in connection with the issuance of equity units and shares are recorded as a reduction of proceeds to the equity carrying value. The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process financings as deferred offering costs until such financings are consummated. After consummation of the financing, these costs are recorded as a reduction of the proceeds received from the financing. If a planned financing is abandoned, the deferred offering costs are expensed immediately as a charge to operating expenses in the consolidated statement of operations and comprehensive loss. There was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_204fc2e3-edd8-4fd2-b2c7-5c3b60033c13" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_9d156514-a9af-4f8f-ba27-feed255e2f25" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> deferred offering costs on the Company&#x2019;s consolidated balance sheet at December 31, 2022 and December 31, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0a4f5a5d-ef1a-43db-9b4b-8fa379ca93fd" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:RevenueRecognitionPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under ASC 606, Topic 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,  the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the contract(s) with the customer; (ii) identification of the promised goods or services in the contract and determination of whether the promised goods or services are performance obligations; (iii) measurement of the transaction price; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As part of the accounting for these arrangements, the Company must use significant judgment to determine: a) the number of performance obligations based on the determination under step (ii) above and whether those performance obligations are distinct from other performance obligations in the contract; b) the transaction price under step (iii) above; and c) the standalone selling price for each performance obligation identified in the contract for the allocation of transaction price in step (iv) above. The Company uses judgment to determine whether milestones or other variable consideration, except for royalties, should be included in the transaction price as described further below. The transaction price is allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. In determining the stand-alone selling price of a license to the Company&#x2019;s proprietary technology or a material right provided by a customer option, the Company considers market conditions as well as entity-specific factors, including those factors contemplated in negotiating the agreements as well as internally developed estimates that include assumptions related to the market opportunity, estimated development costs, probability of success and the time needed to commercialize a product candidate pursuant to the license. In validating its estimated stand-alone selling prices, the Company evaluates whether changes in the key assumptions used to determine its estimated stand-alone selling prices will have a significant effect on the allocation of arrangement consideration between performance obligations.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the transaction price based on the amount of consideration the Company expects to be received for transferring the promised goods or services in the contract. The consideration may include both fixed consideration and variable consideration. At the inception of each arrangement that includes variable consideration, the Company evaluates the amount of the potential payments and the likelihood that the payments will be received. The Company utilizes either the most likely amount method or expected value method to estimate the transaction price based on which method better predicts the amount of consideration expected to be received. If it is probable that a significant revenue reversal would not occur, the variable consideration is included in the transaction price.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer. Promised goods or services are considered distinct when: (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on their own and whether the required expertise is readily available.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation in order to determine whether the combined performance obligation is satisfied over time or at a point in time. The Company receives payments from customers based on billing schedules established in each contract. Up-front payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional. Amounts recognized as revenue, but not yet received or invoiced are generally recognized as contract assets.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Exclusive Licenses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;If the license granted in the arrangement is determined to be distinct from the other promises or performance obligations identified in the arrangement, which generally include research and development services, the Company recognizes revenue from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. In assessing whether a license is distinct from the other promises, the Company considers relevant facts and circumstances of each arrangement, including the research and development capabilities of the collaboration partner and the availability of the associated expertise in the general marketplace. In addition, the Company considers whether the collaboration partner can benefit from the license for its intended purpose without the receipt of the remaining promise, whether the value of the license is dependent on the unsatisfied promise, whether there are other vendors that could provide the remaining promise, and whether it is separately identifiable from the remaining promise. For licenses that are combined with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition based on estimated remaining research and development costs. The calculation of the total remaining estimated research and development costs includes forecasted costs associated with internal employee efforts, materials costs, and third-party contract costs, as well as the assumed timing and duration of these activities. The recognition of revenue pursuant to collaboration arrangements is subject to these judgments made and estimates developed by management and is sensitive to changes in these assumptions. Therefore, the measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the arrangement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Services</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;The promises under the Company&#x2019;s collaboration and license agreements generally include research and development services to be performed by the Company on behalf of the collaboration partner. For performance obligations that include research and development services, the Company generally recognizes revenue allocated to such performance obligations based on an appropriate measure of progress. The Company utilizes judgment to determine the appropriate method of measuring progress for purposes of recognizing revenue, which is generally an input measure, such as costs incurred. The Company evaluates the measure of progress each reporting period as described under Exclusive Licenses above. Reimbursements from the partner that are the result of a collaborative relationship with the partner, instead of a customer relationship, such as co-development activities, are generally recorded as a reduction to research and development expense.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Customer Options</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;The Company&#x2019;s arrangements may provide a collaborator with the right to certain optional purchases, such as the right to license a target either at the inception of the arrangement or within a pre-defined option period. Under these agreements, fees may be due to the Company at the inception of the arrangement as an upfront fee or payment or upon the exercise of an option to acquire a license. If an arrangement is determined to contain customer options that allow the customer to acquire additional goods or services, the goods and services underlying the customer options are not considered to be performance obligations at the outset of the arrangement, as they are contingent upon option exercise. The Company evaluates the customer options for material rights, or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the inception of the arrangement. The Company allocates the transaction price to material rights based on the relative stand-alone selling price, which is determined based on the identified discount, and the probability that the customer will exercise the option. Amounts allocated to a material right are not recognized as revenue until, at the earliest, the option is exercised or expires.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Milestone Payments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;At the inception of each arrangement that includes milestone payments based on certain events, the Company evaluates whether the milestones are considered probable of being achieved and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The Company evaluates factors such as the scientific, clinical, regulatory, commercial, and other risks that must be overcome to achieve the particular milestone in making this assessment. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. At the end of each subsequent reporting period, the Company reevaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. If a milestone or other variable consideration relates specifically to the Company&#x2019;s efforts to satisfy a single performance obligation or to a specific outcome from satisfying the performance obligation, the Company generally allocates the milestone amount entirely to that performance obligation once it is probable that a significant revenue reversal would not occur.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Royalties</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;For arrangements that include sales-based royalties, including milestone payments based on a level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue resulting from any of its licensing arrangements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Collaboration revenue&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company analyzes its collaboration arrangements to assess whether they are within the scope of ASC 808,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Collaborative Arrangements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (&#x201c;ASC 808&#x201d;) to determine whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and those that are more reflective of a vendor-customer relationship and therefore within the scope of Topic 606. For elements of collaboration arrangements that are accounted for pursuant to ASC 808, an appropriate recognition method is determined and applied consistently, generally by analogy to Topic 606. For those elements of the arrangement that are accounted for pursuant to Topic 606, the Company applies the five-step model described above.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9602139d-a917-4d66-a4f9-03508962a04d" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Costs associated with License and Collaborative Arrangements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Costs associated with licenses of technology acquired as part of collaborative arrangements are expensed as incurred and are generally included in research and development expense in the consolidated statements of operations.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2febf10e-32db-4ef6-b827-a055eca92b5f" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounts Receivable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company extends credit to customers based on its evaluation of the customer&#x2019;s financial condition. The Company records receivables for all billings when amounts are due under standard terms. Accounts receivable are stated at amounts due net of applicable prompt pay discounts and other contractual adjustments as well as an allowance for doubtful accounts. The Company assesses the need for an allowance for doubtful accounts by considering a number of factors, including the length of time trade accounts receivable are past due, the customer&#x2019;s ability to pay its obligation and the condition of the general economy and the industry as a whole. The Company will write off accounts receivable when the Company determines that they are uncollectible. In general, the Company has experienced no significant collection issues with its customers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8f7f2a70-c62d-42db-84bd-8fde7c37f2cd" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for all stock-based awards granted to employees, directors, and nonemployees based on their fair value on the date of the grant and recognize compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. Stock-based payments include stock options and grants of common stock, including common stock subject to vesting. The measurement date for stock awards is the date of grant, and stock-based compensation costs are recognized as expense over the requisite service period, which is the vesting period, on a straight-line basis. The Company has issued stock options and restricted stock with performance-based vesting conditions and records the expense for these awards if the Company concludes that it is probable that the performance condition will be achieved. Stock-based compensation is classified in the accompanying consolidated statements of operations and comprehensive loss based on the function to which the related services are provided. The Company recognizes stock-based compensation expense for the portion of awards that have vested. Forfeitures are accounted for as they occur.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes options-pricing model, which requires inputs based on certain subjective assumptions, including the expected stock price volatility, the expected term of the option, the risk-free interest rate for a period that approximates the expected term of the option, and the Company&#x2019;s expected dividend yield. Prior to the IPO, as there was no active market for the Company&#x2019;s common stock, the Company estimated the fair value of common stock on the date of grant based on the then current facts and circumstances. Upon becoming a public company, the fair value of the underlying common shares equals the closing price of the Company&#x2019;s stock on the date of grant. As the Company&#x2019;s IPO was in 2020, the Company  lacks a sufficient period of company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of guideline companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#x2019;s stock options has been determined utilizing the &#x201c;simplified&#x201d; method for awards that qualify as &#x201c;plain-vanilla&#x201d; options. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#x2019;s common stock on that same date.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compensation expense for discounted purchases under the employee stock purchase plan is measured using the Black-Scholes model to compute the fair value of the lookback provision plus the purchase discount and is recognized as compensation expense over the offering period.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c84a7fd7-5ceb-4118-a35f-d32f6f177727" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company records income taxes in accordance with FASB Accounting Standards Codification Topic 740, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (&#x201c;ASC 740&#x201d;), which provides for deferred taxes using an asset and liability approach. Under this method, deferred income tax assets and liabilities are recognized based on future income tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities, and their respective income tax basis. Deferred income tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of changes in income tax rates on deferred income tax assets and liabilities is recognized as income or expense in the period that a valuation allowance for any income tax benefits of which future realization is not more likely than not.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company provides reserves for potential payments of tax to various tax authorities related to uncertain tax positions. The tax benefits recorded are based on a determination of whether and how much of a tax benefit taken by the Company in its tax filings or positions is &#x201c;more likely than not&#x201d; to be realized following resolution of any uncertainty related to the tax benefit, assuming that the matter in question will be raised by the tax authorities.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_20d86663-48f2-4f36-aad7-caf83f610850" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Off Balance Sheet Risk and Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has no significant off-balance sheet risk such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and restricted cash. The Company&#x2019;s cash, cash equivalents, and restricted cash are deposited in accounts at large financial institutions. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash, cash equivalents and restricted cash are held. The Company maintains its cash equivalents in money market funds that invest in U.S. Treasury securities and U.S. Treasury obligations and corporate bonds. The Company&#x2019;s marketable securities primarily consist of corporate bonds and U.S. Treasury securities paper, and potentially subject the Company to concentrations of credit risk. The Company has adopted an investment policy that limits the amounts the Company may invest in any one type of investment. The Company has not experienced any credit losses and does not believe it is exposed to any significant credit risk on these funds.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4bf50c60-90f7-476a-a838-c7ca44f9b564" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss includes net loss as well as unrealized gains and losses on marketable securities and other changes in stockholders&#x2019; equity (deficit) that result from transactions and economic events other than those with stockholders.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_69b937ab-2553-46f4-89ad-8acccadb7d28" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net Loss Per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company applies the two-class method to compute basic and diluted net income (loss) per share attributable to common stockholders when it has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income (loss) available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to share in the earnings as if all income (loss) for the period had been distributed. The Company&#x2019;s convertible preferred stock participates in any dividends declared by the Company and are therefore considered to be participating securities. The participating securities are not required to participate in the losses of the Company, and therefore during periods of loss there is no allocation required under the two-class method.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including the pre-funded warrants given their nominal exercise price. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) per share attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including potential dilutive common shares. For purpose of this calculation, outstanding options to purchase common stock, unvested restricted stock awards, and shares of convertible preferred stock are considered potential dilutive common shares. The Company has generated a net loss in all periods presented, and therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9c342bfe-6dff-4559-89c9-fa51c4b07e85" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Standards</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The Company adopted ASU 2020-06 effective as of January 1, 2022. The adoption of ASU 2020-06 did not have an impact on the Company&#x2019;s financial statements.</span></p></ix:nonNumeric></div></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1cd41eda-05a0-4ae4-ae5c-9f6a14efe449" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:FairValueDisclosuresTextBlock" escape="true" continuedAt="F_1cd41eda-05a0-4ae4-ae5c-9f6a14efe449_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 3. Fair Value Measurements</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b9d7a26e-9bc0-4a97-8210-254489c0d160" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents information about the Company&#x2019;s financial assets measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values as of December 31, 2022 and December 31, 2021 (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.798%;"></td>
        <td style="width:1.049%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.212000000000002%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.049%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.212000000000002%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.06%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.223%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.06%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.335%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements at<br />December 31, 2022:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_015901c7-d106-496a-a1dd-f37220105617" contextRef="C_92cf5785-cf06-4620-8a2b-76822df706a4" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,551</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_31e465c3-ddcb-452c-a05a-e555c65abd42" contextRef="C_a4ff2b85-04a0-48ba-94cb-7f1135555ba1" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,551</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e4a61929-e08c-40c8-a322-dde6f772b870" contextRef="C_cbe473e2-0c3e-400a-b19a-6ab0d1df53c3" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">74,045</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9ff8b754-c57b-44ad-ab4a-07f82c42cfa2" contextRef="C_bdb2440e-1e74-443b-8199-85bc8484ff9e" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">74,045</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6009f366-82d1-4e09-a4b5-0be8134d2b68" contextRef="C_fdb41358-831d-4444-b8f4-0d53bd52e986" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">120,467</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_590fdb52-4c53-4811-b8c0-c3d5326fda38" contextRef="C_353d5cf1-900b-4407-901f-6e88343b6e28" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">120,467</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4aa22648-d36e-4237-b14d-0d5ab9d57c22" contextRef="C_f5672204-3c86-40cf-a340-5ea7293720f7" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">144,259</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e42b00b2-d2f7-41c1-ba30-bb48232d80d7" contextRef="C_1e352199-2021-4cbf-89a6-6b3fb1a9cb86" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">144,259</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, non-current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b5cd3cf9-d340-4f02-93cd-d9131093bdb3" contextRef="C_cbe473e2-0c3e-400a-b19a-6ab0d1df53c3" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,804</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c0dd1629-dfea-48eb-93de-1517f2d22fd4" contextRef="C_bdb2440e-1e74-443b-8199-85bc8484ff9e" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,804</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f86f57da-cb00-4664-8066-27f8ed14a1b3" contextRef="C_fdb41358-831d-4444-b8f4-0d53bd52e986" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,653</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b87adaec-fa72-45eb-9de7-f54a44b2407c" contextRef="C_353d5cf1-900b-4407-901f-6e88343b6e28" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,653</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_82a7443a-45ec-43e8-9eeb-e1d9b8e0fb89" contextRef="C_f5672204-3c86-40cf-a340-5ea7293720f7" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">73,871</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d9d4541-e04b-4f47-8319-b144bf82ab74" contextRef="C_1e352199-2021-4cbf-89a6-6b3fb1a9cb86" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">73,871</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_64c0b1a3-d934-4732-8194-43715b892dfd" contextRef="C_7ed674cd-4eeb-4640-9889-2c6678deaa43" name="kymr:RestrictedCashFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,130</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21a65e7d-bdb9-4ea2-93b0-ee58537291d7" contextRef="C_b1c3605d-deb5-4fa5-a122-f271881338b2" name="kymr:RestrictedCashFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,130</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f146951-67ab-4798-9db8-b62e4ed1f3ef" contextRef="C_7ed674cd-4eeb-4640-9889-2c6678deaa43" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">150,530</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_582993b7-0c5b-4928-aae6-04229588b7b9" contextRef="C_760ee65f-8938-4d70-852d-717a500268f2" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">397,250</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a9ad4ef-f0f0-49d6-bb6c-2a207a3beb55" contextRef="C_b1c3605d-deb5-4fa5-a122-f271881338b2" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">547,780</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.735%;"></td>
        <td style="width:1.058%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.218%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.07%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.218%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.07%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.218%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.07%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.341%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements at<br />December 31, 2021:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_769fd769-d67c-433e-a834-0beb1b812cb0" contextRef="C_5e41c878-2f37-448f-8041-6169a741fafd" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">43,182</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ae2ad5ca-4bb6-4d6f-978b-17f1728971aa" contextRef="C_22763f63-4293-43da-81e5-a51fcca60bff" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">43,182</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad818ff4-3d88-4bd9-b5a9-a6a9d98ad087" contextRef="C_6d1928e4-c54d-45cb-bd65-a8ca6a70568a" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">169,481</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8be088f7-7778-4f4f-95f9-94f3b78fa58e" contextRef="C_eefb7cbc-9caa-4ace-97f5-4dd5fa0c3875" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">169,481</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c41df630-10b3-401f-a1a3-8ee880aa9b00" contextRef="C_f2fba413-6548-46dc-aa3b-627f610a3ec7" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,170</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a62e689e-656d-42e5-b9ed-0e497ebe1b95" contextRef="C_2a30fc5f-816c-4384-aaa2-91ea6a589f09" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,170</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_82528739-4ec9-4819-9334-a484af3c90f0" contextRef="C_568f226b-696c-4f67-8494-4fae12a09dcd" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">192,791</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6f107061-ee6f-4a9e-997a-4a9443fb2515" contextRef="C_9637e2ee-ccfa-4f69-ae4f-52730c923c29" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">192,791</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, non-current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be252ef4-4a10-4181-8bf2-4b3ea5f11a3e" contextRef="C_6d1928e4-c54d-45cb-bd65-a8ca6a70568a" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,172</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5b81dc23-fc48-436b-90bb-d11a32c98392" contextRef="C_eefb7cbc-9caa-4ace-97f5-4dd5fa0c3875" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,172</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d402c4a3-b3f8-4697-8219-7bdb67f44d9f" contextRef="C_f2fba413-6548-46dc-aa3b-627f610a3ec7" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">47,363</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6340e663-8979-44d1-8c47-906ecc75d66a" contextRef="C_f2fba413-6548-46dc-aa3b-627f610a3ec7" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">47,363</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e25096c6-3870-4f24-87a9-ec2adbd4b607" contextRef="C_568f226b-696c-4f67-8494-4fae12a09dcd" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60,652</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f7c65528-bfbe-4f95-940e-c2de4e11a95a" contextRef="C_9637e2ee-ccfa-4f69-ae4f-52730c923c29" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60,652</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7273c13a-a81a-4ef6-93da-639ec8d24b5c" contextRef="C_a018222a-a47a-445b-bb16-6f9dfa165490" name="kymr:RestrictedCashFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,116</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_55756549-5476-4af1-afca-8f8582d6cc1e" contextRef="C_e026c58e-80f9-43a7-892c-915846f96c73" name="kymr:RestrictedCashFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,116</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2e7dab8-cdb3-4300-b616-a21b9e0c4a9f" contextRef="C_a018222a-a47a-445b-bb16-6f9dfa165490" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">315,484</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e092b0bf-c77a-4e88-87d0-b26096d813e7" contextRef="C_bb8b7969-bb82-4041-994e-9433633910b6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">253,443</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1cbdee96-dee3-46c4-8e86-c08e9dc99625" contextRef="C_e026c58e-80f9-43a7-892c-915846f96c73" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">568,927</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span><ix:continuation id="F_1cd41eda-05a0-4ae4-ae5c-9f6a14efe449_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the years ended December 31, 2022 and 2021, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5fb562a6-5a25-4b2f-8f9c-893ea418964d" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="kymr:FairValueAssetsLevel1ToLevel3TransfersAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_81a9c3df-a0d1-47bc-b67b-a727b54e19eb" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="kymr:FairValueAssetsLevel3ToLevel1TransfersAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_26f35c82-b63d-448a-9fec-5bd2ffcec78a" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="kymr:FairValueAssetsLevel3ToLevel2TransfersAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_3c3942f3-80a1-4c09-b3c3-067c0ce4b839" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="kymr:FairValueAssetsLevel2ToLevel3TransfersAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_d6816af5-4bc5-4791-ba3d-860c44e2a341;"><span style="-sec-ix-hidden:F_edecdabf-262b-4f31-ac10-5d70725bc297;"><span style="-sec-ix-hidden:F_47aa0c7e-13cd-4b61-a6e4-d8d951681874;"><span style="-sec-ix-hidden:F_17c26d05-9f3b-4274-bf66-5ed27d17bc5c;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> tr</span></span></span></span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ansfers in or out of Level 3.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_311264bf-96b5-4130-87d1-91d2b5008d19" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 4. Marketable Securities</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a4ff26bf-f392-4864-b27d-747fe3ae2ac1" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the available-for-sale debt securities held at December 31, 2022 and 2021 and (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.234%;"></td>
        <td style="width:1.208%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.502%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.195%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.49%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.195%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.49%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.195%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.49%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br />Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br />Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br />Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br />Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5c1d50c5-2c23-4571-97d7-199c2a95f23a" contextRef="C_e2615d23-21e3-4021-a013-590aec8dff1e" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">94,958</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f4800ba9-47fe-463e-988c-87d502649b9e" contextRef="C_e2615d23-21e3-4021-a013-590aec8dff1e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_09e65be0-ea88-42a2-bea2-0ad37e1d425e" contextRef="C_e2615d23-21e3-4021-a013-590aec8dff1e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,111</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_694b365f-69f0-4bad-8914-7169851c8fde" contextRef="C_e2615d23-21e3-4021-a013-590aec8dff1e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">93,850</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agency securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1648eb6d-271c-4920-b30f-78ab0b63941a" contextRef="C_5b5104c9-4084-4a40-bdc7-f2c83bef3744" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">180,967</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_705f966d-5ff5-4f22-9481-9272bb762322" contextRef="C_5b5104c9-4084-4a40-bdc7-f2c83bef3744" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8546a093-35a1-42ff-99d6-c4b02a429f24" contextRef="C_5b5104c9-4084-4a40-bdc7-f2c83bef3744" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,873</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_638b25b8-e2a6-4e1e-9612-6181bd7c4bfb" contextRef="C_5b5104c9-4084-4a40-bdc7-f2c83bef3744" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">179,119</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_de83686b-8d0a-4f68-946a-7aa72936dad9" contextRef="C_ce764760-07d6-464c-9e95-7ae23ffd34e2" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">220,119</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b73fb4a-a567-46e9-a4bd-69a5223736d8" contextRef="C_ce764760-07d6-464c-9e95-7ae23ffd34e2" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9afa4c6f-4b97-4584-b39a-a4d8d4e2e8e1" contextRef="C_ce764760-07d6-464c-9e95-7ae23ffd34e2" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,014</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a014cac7-3b88-468d-aa04-799c8158093f" contextRef="C_ce764760-07d6-464c-9e95-7ae23ffd34e2" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">218,130</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4eb991d8-0b4e-4d87-99cd-18b69fdae0b7" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">496,044</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ce6bbed7-c4cc-4fa2-8ffa-a621ebd19145" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">53</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11e6ce24-7a2c-441e-b9e4-4a0091be17cc" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,998</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f0e3caa4-2d99-43ac-98e6-4ed188b8b8ca" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">491,099</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.135%;"></td>
        <td style="width:1.208%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.494%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.195%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.468%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.283%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.468%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.283%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.468%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br />Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br />Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br />Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br />Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2fc57c8-2aa2-4a2d-beaf-c5e37e36a839" contextRef="C_efe35265-ca7f-48b1-ba12-d45e10f0072e" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">186,700</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_386dcbc8-abf5-4d63-b0fd-01f8358f041c" contextRef="C_efe35265-ca7f-48b1-ba12-d45e10f0072e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a905583-fed4-4f05-a54b-f21f5593e5c1" contextRef="C_efe35265-ca7f-48b1-ba12-d45e10f0072e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ab2ca967-1ac3-4212-8207-5647e3cb16e0" contextRef="C_efe35265-ca7f-48b1-ba12-d45e10f0072e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">186,655</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agency securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_97a36501-a21d-4e98-92d8-486e6d2feb5f" contextRef="C_28099439-7f67-4ba5-b139-b21c74762ca3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">79,657</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fb17698b-66c1-4d78-8225-4921d92b067e" contextRef="C_28099439-7f67-4ba5-b139-b21c74762ca3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0561c1f2-80e0-410e-b115-494bd4ebb749" contextRef="C_28099439-7f67-4ba5-b139-b21c74762ca3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">125</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_18349183-1de8-4696-ad54-61cdde769386" contextRef="C_28099439-7f67-4ba5-b139-b21c74762ca3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">79,532</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6e8867e1-915c-44af-b92c-812fa38d9cc5" contextRef="C_393387d1-e62c-4d39-9c26-01748ebd1fc5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">253,929</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c316295f-d5ab-4aca-8cf2-8badeed8ccb2" contextRef="C_393387d1-e62c-4d39-9c26-01748ebd1fc5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7cef362d-c872-4913-bba9-aad1ecfbe21e" contextRef="C_393387d1-e62c-4d39-9c26-01748ebd1fc5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">488</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e4ee229f-d316-4773-87ac-7279f955b039" contextRef="C_393387d1-e62c-4d39-9c26-01748ebd1fc5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">253,442</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_66dcc2c5-239a-4a6e-9219-a7df8751e610" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">520,286</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b06839f7-f899-42de-bc18-efb902bc108a" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_65240b2f-3fc6-40ef-8246-ffa8634489d0" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">658</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_add1ddd4-b6ef-4ba2-bdf7-9f0464ba136d" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">519,629</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company held </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7b98637b-473d-4bb8-86a8-575714ac6320" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" unitRef="U_Security" decimals="0" format="ixt:numdotdecimal">149</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities that had been in an unrealized loss position for less than 12 months with an aggregate fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2b60ce3-4fb2-4e42-8bc6-ab059c40a45e" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">330.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. As of December 31, 2021, the Company held </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c11fdf9b-de5a-4f92-ac37-ea0648e2b4cb" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" unitRef="U_Security" decimals="0" format="ixt:numdotdecimal">113</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities that had been in an unrealized loss position for less than 12 months with an aggregate fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b40c617f-b2b9-46a4-8680-1604a73fda2b" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">515.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. As of December 31, 2022, the Company held </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fbc1bae1-ba58-457d-8a4b-9311c1d47a2d" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="kymr:DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions" unitRef="U_Security" decimals="0" format="ixt:numdotdecimal">36</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities that had been in an unrealized loss position for greater than 12 months with an aggregate fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b4875846-6a82-4c8c-8306-8e73fd446f0d" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="kymr:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">115.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. As of December 31, 2021, the Company did not hold any securities that had been in an unrealized loss position for greater than 12 months.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of  December 31, 2022 the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e0359f81-244a-4387-911e-2a4438dfd197" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities" unitRef="U_Security" decimals="0" format="ixt:numdotdecimal">118</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities with a fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_414c2f9d-bc2e-4afc-8a3d-302072e7a1cb" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="kymr:FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">338.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million with a contractual maturity of less than 12 months and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_14eb44e6-866f-4029-b870-e180da8ed574" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities" unitRef="U_Security" decimals="0" format="ixt:numdotdecimal">81</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities with a fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_99123f4e-6b68-4a8b-ade7-4dfeb2e150f1" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">152.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million with a contractual maturity of greater than 12 months. As of December 31, 2021, the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_17c4ef78-42f3-478c-92f9-0755d61c319c" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities" unitRef="U_Security" decimals="0" format="ixt:numdotdecimal">79</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities with a fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb880007-d3f4-4612-84d3-13d613babe05" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="kymr:FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">394.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million with a contractual maturity of less than 12 months and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e7e2e64-5382-42f2-bc3f-0ddc2e279b77" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities" unitRef="U_Security" decimals="0" format="ixt:numdotdecimal">37</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities with a fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0e23e11a-2eed-43e8-a894-1eef4933d09d" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">125.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million with a contractual maturity of greater than 12 months.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company evaluates securities for other-than-temporary impairments based on quantitative and qualitative factors, and considered the decline in market value for the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a5248b11-e610-4341-8c41-e638f8bebac7" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities" unitRef="U_Security" decimals="0" format="ixt:numdotdecimal">185</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities in an unrealized loss position as of  December 31, 2022, to be primarily attributable to the then current economic and market conditions. The Company neither intends to sell these investments nor concludes that it is more-likely-than-not that the Company will have to sell them before recovery of their carrying values. The Company also believe that it will be able to collect both principal and interest amounts due at maturity.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_128886fa-6582-49fe-8de9-466df0b7f2f3" contextRef="C_4b0a689e-0b9b-43f2-8a8d-71565e0e91d0" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 5. Collaborations</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sanofi Collaboration Arrangement</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Agreement Terms</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 7, 2020, the Company entered into a collaboration agreement, or the Sanofi Agreement, with Sanofi, to co-develop drug candidates directed to two biological targets. Under the Sanofi Agreement, the Company granted to Sanofi a worldwide exclusive license to develop, manufacture and commercialize certain lead compounds generated during the collaboration directed against IRAK4, or Collaboration Target 1, and one additional undisclosed target in an undisclosed field of use, or Collaboration Target 2. Such license is exercisable on a collaboration target-by-collaboration target basis only after specified milestones. For compounds directed against IRAK4, the field of use includes diagnosis, treatment, cure, mitigation or prevention of any diseases, disorders or conditions, excluding oncology and immuno-oncology.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the Sanofi Agreement, the Company is responsible for discovery and preclinical research and conducting a Phase 1 clinical trial for at least one degrader directed against IRAK4 plus up to three backup degraders. With respect to both targets, Sanofi is responsible for development, manufacturing, and commercialization of product candidates after a specified development milestone occurs with respect to each collaboration candidate.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, pursuant to the Sanofi Agreement, Sanofi will grant to the Company an exclusive option, or Opt-In Right, exercisable on a collaboration target-by-collaboration target basis that will include the right to (i) fund 50% of the United States development costs for collaboration products directed against such target in the applicable field of use and (ii) share equally in the net profits and net losses of commercializing collaboration products directed against such target in the applicable field of use in the United States. In addition, if the Company exercises the Opt-In Right, Sanofi will grant to the Company an exclusive option, applicable to each collaboration target, which upon exercise will allow the Company to conduct certain co-promotion activities in the field in the United States.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Sanofi Agreement, unless earlier terminated, will expire on a product-by-product basis on the date of expiration of all payment obligations under the Sanofi Agreement with respect to such product. The Company or Sanofi may terminate the agreement upon the other party&#x2019;s material breach or insolvency or for certain patent challenges. In addition, Sanofi may terminate the Sanofi Agreement for convenience or for a material safety event upon advance prior written notice, and the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company may terminate the Sanofi Agreement with respect to any collaboration candidate if, following Sanofi&#x2019;s assumption of responsibility for the development, commercialization or manufacturing of collaboration candidates with respect to a particular target, Sanofi ceases to exploit any collaboration candidates directed to such target for a specified period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In consideration for the exclusive licenses granted to Sanofi under the Sanofi Agreement, Sanofi paid to the Company an upfront payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_db77341e-6a29-4ce3-ad75-d16b02d35d02" contextRef="C_bef4bf34-693c-41b8-a9a0-8e9c28f7789b" name="kymr:UpfrontPayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">150.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. The Company will also be reimbursed for certain research activities for a certain backup degrader under the IRAK4 program as well as contract manufacturing costs for the lead 474 program, unless certain criteria are not met for an initial IRAK4 degrader. In addition to the upfront payment and the reimbursements, the Company is eligible to receive certain development milestone payments of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f9aaba43-0db0-4a34-824f-33871772319b" contextRef="C_68a7c495-1305-45e9-99c0-9a0f59885e6b" name="kymr:DevelopmentMilestonePayments" unitRef="U_USD" scale="9" decimals="-7" format="ixt:numdotdecimal">1.48</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> billion in the aggregate, of which more than $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b64508b6-e70b-4baf-9539-07611fbca6d4" contextRef="C_565059dc-67cf-4057-8152-e525a8f12af2" name="kymr:DevelopmentMilestonePayments" unitRef="U_USD" scale="9" decimals="-8" format="ixt:numdotdecimal">1.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> billion relates to the IRAK4 program, upon the achievement of certain developmental or regulatory events. The Company will be eligible to receive certain commercial milestone payments up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_09aa89b3-f08c-47b9-bb5e-cf03526aec1f" contextRef="C_68a7c495-1305-45e9-99c0-9a0f59885e6b" name="kymr:CommercialMilestonePayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">700.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in the aggregate, of which $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_adafa589-3960-46b0-a936-20acdd3acdfd" contextRef="C_565059dc-67cf-4057-8152-e525a8f12af2" name="kymr:CommercialMilestonePayments" unitRef="U_USD" scale="6" decimals="-6" format="ixt:numdotdecimal">400</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million relates to the IRAK4 program, which are payable upon the achievement of certain net sales thresholds. The Company will be eligible to receive tiered royalties for each program on net sales ranging from the high single digits to high teens, subject to low-single digits upward adjustments in certain circumstances.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On November 15, 2022, we entered into an Amended and Restated Collaboration and License Agreement with Sanofi, or the Amended Sanofi Agreement, which amended the Original Sanofi Agreement to revise certain research terms and responsibilities set forth under the Original Sanofi Agreement. The Amended Sanofi Agreement also specifies details around the timing and number of Phase 2 trials required under the terms of the collaboration. The Amended Sanofi Agreement became effective on December 5, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally with respect to Sanofi, on December 2, 2022, Sanofi provided the Company with written notice of its intention to advance the collaboration target 1 candidate, KT-474, into Phase 2 clinical trials. The Company is entitled to receive milestone payments upon the dosing of the first Phase 2 patient(s) per indication up to a specified number of indications as further set forth in the Amended Sanofi Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting Treatment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company analyzed the discovery and pre-clinical research activities as well as the exclusive license grants under the Sanofi Agreement and concluded that the arrangement was indicative of a vendor-customer relationship and would be accounted for under ASC 606.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company identified the following material promises under the arrangement: (1) research services for Collaboration Target 1, (2) research license for Collaboration Target 1, (3) exclusive license for Collaboration Target 1, (4) research services for Collaboration Target 2, (5) research license for Collaboration Target 2, (6) exclusive license for Collaboration Target 2, (7) option to extend the research term, and (8) optional research services during the development period.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determined that Collaboration Targets 1 and 2 are distinct from each other. The research associated with degraders directed to each target is at different stages and the licensed field, should development activities be successful, are different from each other. As such, all promises associated with each target are considered distinct from promises associated with the other target.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The research and development services for each collaboration target were determined not to be distinct from the research license and the exclusive license and have been combined into a single performance obligation for each collaboration target. That is, two performance obligations were identified, the combined research services, research license and exclusive license for Collaboration Target 1 and the combined research services, research license and exclusive license for Collaboration Target 2. The exclusive license for each target is not distinct from the pre-clinical and clinical research and development services under the Sanofi Agreement, primarily due to the highly specialized nature of the research and novel technology involved with developing protein degraders &#x2013; the pre-clinical activities and studies and first phase 1 clinical trial could not be conducted by another party in the manner required.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The option to extend the research term and optional research services during the development period were evaluated as material rights. The fees associated with each option are at or above the standalone selling price. As such, the underlying options are not performance obligations and fees associated with each option are excluded from the transaction price until the underlying option is exercised.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determined the total transaction price to be $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3bb071a9-84c0-4fd6-beaf-f9f2fd9d2c36" contextRef="C_bef4bf34-693c-41b8-a9a0-8e9c28f7789b" name="kymr:CollaborationAgreementTransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">150.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which consists solely of the upfront payment. All milestone payments and option payments are constrained as the achievement of such milestones are contingent upon the success of the underlying research and development activities and are generally outside the control of the Company. The reimbursement of costs for the IRAK4 backup degrader is also treated as constrained variable consideration as the criteria for reimbursement may not always be met, under which circumstances the Company would be responsible for the costs related to the backup degrader. Upon becoming unconstrained, the reimbursement consideration will be added to the transaction price and allocated to Collaboration Target 1.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company allocated the upfront payment to each performance obligation based on the relative standalone selling price, as follows:</span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 1: $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ce07cbec-ed54-4042-8379-5fc91064d32d" contextRef="C_9611dcfe-598d-44f0-becc-70cdcf69b398" name="kymr:CollaborationAgreementTransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">120.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span></div></div><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 2: $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c73223b-d8f9-4bda-8e46-9a66e4f68cd2" contextRef="C_2349e822-42db-4347-927f-0f4069526a6f" name="kymr:CollaborationAgreementTransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">30.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span></div></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determined the allocation of the $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6894c0d4-0870-40ae-a932-f2d8087f635c" contextRef="C_bef4bf34-693c-41b8-a9a0-8e9c28f7789b" name="kymr:CollaborationAgreementTransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">150.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million transaction price between Collaboration Target 1 and Collaboration Target 2 based on the value of the research and development for the programs from projected research and development costs for each collaboration target plus a developer&#x2019;s profit and the total potential milestones for each collaboration target.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes revenue associated with each performance obligation as the research and development services are provided using an input method, according to costs incurred as related to the research and development activities for each individual program and the costs expected to be incurred in the future to satisfy that individual performance obligation. The transfer of control occurs over this time period and, in management&#x2019;s judgment, is the best measure of progress towards satisfying each performance obligation. The amounts received that have not yet been recognized as revenue are deferred as a contract liability on the Company&#x2019;s consolidated balance sheet and will be recognized over the remaining research and development period until the performance obligation is satisfied. Reimbursement consideration added to the transaction price will be recognized as revenue on the same pattern as Collaboration Target 1, with a cumulative catch-up upon becoming unconstrained. Pursuant to the November 15, 2022 amendment to the Sanofi Agreement, the Company reevaluated its rights and obligations under the Agreement as amended. As part of this reevaluation, the Company reassessed its accounting pursuant to the arrangement concluding that the amendment had no impact on the performance obligations nor revenue recognized in the periods presented</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The performance obligations have not been fully satisfied as of December 31, 2022. During the year ended December 31, 2022, the Company recognized $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1f9a1ac7-41b7-4e6a-be25-aff69bb965a5" contextRef="C_081b7ddc-7d3d-4ad4-aee3-4d90b3c47ad6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">36.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in revenue under the Sanofi Agreement, of which $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6d975936-af1d-406b-bf68-d11c4c1c607a" contextRef="C_bfc05416-87db-404e-9f86-a8b01e216a23" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">19.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 1 and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77945896-117f-466c-b24c-5206303e8bc6" contextRef="C_b9849062-15a8-4157-94eb-425887d7c4d5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">16.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 2. Of the $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9073b50f-e5ae-435c-8918-dd29b6bcdc4d" contextRef="C_081b7ddc-7d3d-4ad4-aee3-4d90b3c47ad6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">36.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of revenue recognized in the year ended December 31, 2022, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b1fe2a3b-e2bd-4d5d-9634-d6d230bf40ca" contextRef="C_0ab6f045-1ad1-4153-a9b6-962038299ee7" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">30.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was recognized from amounts that were recorded in deferred revenue as of December 31, 2021. The aggregate amount of the transaction price allocated to the Company&#x2019;s unsatisfied performance obligations and recorded in deferred revenue at December 31, 2022 is $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc9447ab-8257-47e5-908b-414d09e3525c" contextRef="C_612b21a6-29b0-4a04-b6c6-2d057f6f698c" name="us-gaap:RevenueRemainingPerformanceObligation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">54.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. During the year ended December 31, 2021, the Company recognized $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_562d0209-ea7b-457f-82b5-512ee7c7c42b" contextRef="C_0ab6f045-1ad1-4153-a9b6-962038299ee7" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">54.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in revenue under the Sanofi Agreement, of which $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0adcd55c-0836-4bef-b25b-d99e86d8ef6c" contextRef="C_d12a3336-c1b4-42ef-b4e8-d151bc4f6073" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">45.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 1 and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cde49a3b-1497-460e-ba18-76a9f34fc3d5" contextRef="C_e603dc4a-23d5-4e8a-ba86-53a78b470fd8" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">8.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 2. The aggregate amount of the transaction price allocated to the Company&#x2019;s unsatisfied performance obligations and recorded in deferred revenue at December 31, 2021 is $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cd87510c-8d5f-4dae-b54e-1f722c48c5e5" contextRef="C_14b69a89-5ece-4633-95eb-269916567868" name="us-gaap:RevenueRemainingPerformanceObligation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">81.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. During the year ended December 31, 2020, the Company recognized $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5dc337d0-477d-4bf2-941f-e4d1143da482" contextRef="C_8be60b28-58be-4691-8add-44fa167e85d8" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">18.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in revenue under the Sanofi Agreement, of which $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f24df0ac-7c4f-400f-8c47-ee5c679b8ec4" contextRef="C_eec48a46-4598-43e9-a039-7466eaea4546" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">16.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 1 and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d0cd681e-6b11-484f-b184-888b4ae377fb" contextRef="C_59441261-9496-4c98-982f-a7f3cbd75e89" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 2. During the years ended December 31, 2022 and 2021, the Company received $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6fdf3672-7d69-46d8-aa4f-c61bca08a82e" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:CostReimbursementPaymentReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">6.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ec7a9492-44f9-4832-a660-9c016f8f8289" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:CostReimbursementPaymentReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">4.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, in in cost reimbursement payments under the Sanofi Agreement. The Company recorded $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1d972867-75c3-480f-b902-e5974c13e97e" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:UnbilledContractsReceivable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7cdbbecb-ceba-4387-b161-c90ba1ce75ed" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:UnbilledContractsReceivable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of unbilled accounts receivable related to reimbursable research and development costs under the Sanofi Agreement as of December 31, 2022 and December 31, 2021, respectively. The Company will recognize the deferred revenue related to the performance obligations based on a cost input method, as described, over the remaining research term, which as a result of the amended agreement, is a maximum of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_66a8d438-228c-4ad0-96aa-849997cec134" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:RemainingResearchTermOfCollaboration" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.0</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years as of December 31, 2022.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any consideration related to performance-based milestones will be recognized when the risk of probable reversal is resolved, at which point the Company shall adjust the transaction price determined for the agreement accordingly and recognize revenue on a cumulative-catch up basis, reallocating the revised arrangement consideration to the performance obligations. Any consideration related to sales milestone payments and royalties will be recognized when the related milestone events or sales occur and therefore are recognized at the later of when the related sales occur or the relevant performance obligation is satisfied. As part of its evaluation of constraining the milestones, the Company considered numerous factors, including the fact that the achievement of the research and development milestones are contingent upon the results of the underlying research and development activities and are thus outside of the control of the Company.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi participated in the Company&#x2019;s Series B Convertible Preferred Stock offering and as a result of this, was considered a related party during the year ended December 31, 2020 but no longer are considered a related party in any other periods presented.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Vertex Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On May 9, 2019 (the &#x201c;Effective Date&#x201d;), the Company entered into a collaboration agreement (the &#x201c;Vertex Agreement&#x201d;) with Vertex to advance small molecule protein degraders against up to six targets. Under the Vertex Agreement, Vertex has the exclusive option to license the rights to the product candidates developed for the designated targets at which point Vertex will control development and commercialization. Pursuant to the Vertex Agreement, the Company is only responsible for discovery and preclinical research on the targets, and Vertex is responsible for development, manufacturing, and commercialization of the product candidates after it exercises its option to license. The initial research term of the collaboration is four (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_68ef6269-362d-4567-a64c-779ac696559a" contextRef="C_0d3c3a6e-4f6e-4e86-a583-6b94738c1223" name="kymr:InitialResearchTermOfCollaboration" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) years, extendable for an additional one (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ba9d1493-668e-4535-94dc-2c2a0bf9b93e" contextRef="C_0d3c3a6e-4f6e-4e86-a583-6b94738c1223" name="kymr:ExtendedResearchTermOfCollaboration" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) year period upon mutual agreement by the parties and payment by Vertex of certain per-target fees.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vertex provided the Company with a non-refundable upfront payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be898d62-52d7-4285-9d1b-48ec0c3f8664" contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac" name="kymr:NonRefundableUpfrontPaymentReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">50.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and purchased </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d419e17e-c6f1-4bba-882f-fb1dfc36f110" contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,059,695</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#x2019;s Series B-1 Convertible Preferred Stock (&#x201c;Series B-1&#x201d;) at $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a3e101a-f15f-4d53-b843-c690459b8776" contextRef="C_b259fb45-0841-4caa-af6a-3436ea59b8c5" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">6.54</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> a share, pursuant to a separate, but simultaneously executed Share Purchase Agreement. The shares were purchased at a premium of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_667259d6-a221-42db-9a5a-56cb2e65dfa3" contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac" name="kymr:PreferredStockIssuancePremium" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which was included in the transaction price and will be recognized as revenue over the period of performance. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vertex additionally purchased shares of the Company&#x2019;s common stock in a private placement concurrent with the Company&#x2019;s follow-on offering in which the Company received proceeds from Vertex</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77a8b8f2-e159-4505-94eb-338add0e3445" contextRef="C_5c9218ac-b38f-4b4a-b639-9ec2b585df0c" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. As a result of this purchase, Vertex is considered a related party.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is eligible to receive up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_424ac5dc-54d9-4ce5-ba86-708c8a29a833" contextRef="C_d8fb09f6-e120-4543-92a1-1556cdd15765" name="kymr:PotentialReceivableMilestonePayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">170.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in payments per target, including development, regulatory and commercial milestones as well as option exercise payments. In addition, Vertex is obligated to pay the Company tiered royalties on future net sales on any products that may result from the Vertex Agreement. None of the payments under the Vertex Agreement are refundable. The Company may also perform follow-on research for an optioned target upon Vertex&#x2019;s request and at Vertex&#x2019;s expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The term of the Vertex Agreement began on the Effective Date and expires upon the expiration of all payment obligations from Vertex to Company under the Vertex Agreement or, if Vertex does not exercise any of its options, the lapse of all Vertex&#x2019;s option rights under the Vertex Agreement. Vertex also has the ability to terminate for convenience with prior written notice to the Company, and either party may terminate for an uncured material breach.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting Treatment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company analyzed the joint research activities required under the Vertex Agreement and concluded that the arrangement was indicative of a vendor-customer relationship and would be accounted for under ASC 606.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company identified the following material promises under the arrangement: (1) the non-exclusive, royalty-free research license; (2) the research and development services to be performed on up to six targets; and (3) the option to license each of the targets for development, manufacturing, and commercialization efforts. The research and development services were determined not to be distinct from the research and development license and have been combined into a single performance obligation. The Company determined that the option to license the targets in the future was not priced at a discount, and that the option exercise fee for each target is at or above the standalone selling price for research at this stage of development; as such, the options and the underlying licenses are excluded from the performance obligation and the option exercise fees are excluded from the transaction price until the underlying option is exercised.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As part of its evaluation of constraining the research and development milestones, the Company considered numerous factors, including the fact that the achievement of the research and development milestones are contingent upon the results of the underlying research and development activities and are thus outside of the control of the Company.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the commencement of the arrangement, two units of accounting were identified, the issuance of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_faad8266-5ee9-45c9-83cb-043eb03adacf" contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,059,695</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#x2019;s Series B-1 and the research activities the Company will perform over the Research Term. The Company determined the total transaction price to be $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f465294f-5404-46e1-b292-25836d05a883" contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac" name="kymr:CollaborationAgreementTransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">55.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which consists of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5645e48-0e99-4498-95c4-8f96e68ddfc2" contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac" name="kymr:PreferredStockIssuancePremium" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million attributed to the premium from the Series B-1 shares sold to Vertex and the $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_36d89d65-603b-428c-93a0-9982392382d9" contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac" name="kymr:NonRefundableUpfrontPaymentReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">50.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million upfront payment. To determine the fair value of the Series B-1 issued to Vertex, the Company performed a valuation of the shares of the Company&#x2019;s common and preferred stock, which took into consideration recent financings, and the Company&#x2019;s recent development and future exit strategies, as well as a discount for lack of marketability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company recognizes revenue associated with the performance obligation as the research and development services are provided using an input method, according to the costs incurred as related to the research and development activities on each program and the costs expected to be incurred in the future to satisfy the performance obligation. The transfer of control</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">occurs </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">over this time period and, in management&#x2019;s judgment, is the best measure of progress towards satisfying the performance obligation. The amounts received that have not yet been recognized as revenue are deferred as a contract liability on the Company&#x2019;s consolidated balance sheet and will be recognized over the remaining research and development period until the performance obligation is satisfied. The performance obligation has not been fully satisfied as of December 31, 2022. During the years ended December 31, 2022, 2021 and 2020, the Company recognized $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1df43815-9f14-4d06-8fdd-554706f38e15" contextRef="C_5570ee25-70f9-4703-b517-2f4ecb794156" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">10.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c3cf7777-fe11-4d88-9255-fb701fe97dc4" contextRef="C_22bb0630-1f56-4e08-be75-2de87dfa8f47" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">18.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8e388fc0-e0d9-47d6-828e-6a8b9c5e6b27" contextRef="C_e385f6e7-a66f-4abf-a4e6-7cc879be5486" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">15.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, in revenue under the Vertex Agreement. All $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f11046bc-74ca-40d1-a1c1-49987edfdb29" contextRef="C_5570ee25-70f9-4703-b517-2f4ecb794156" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">10.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million revenue recognized during the year ended December 31, 2022 was recognized from amounts that were recorded in deferred revenue as of December 31, 2021. The aggregate amount of the transaction price allocated to the Company&#x2019;s unsatisfied performance obligation and recorded in deferred revenue at December 31, 2022 and 2021 is $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba8e9458-7337-4e09-aeae-d657925b63e8" contextRef="C_40496514-8b4d-4ab1-ab44-cabf51a7a931" name="us-gaap:RevenueRemainingPerformanceObligation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">8.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b4e55ad1-fc3a-4256-a2f8-e2b49fc105bf" contextRef="C_1067d521-9ab9-4291-b211-b3b28cc5875e" name="us-gaap:RevenueRemainingPerformanceObligation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">19.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. The Company will recognize the deferred revenue related to the research and development services based on a cost input method, over the remaining research term, which is a maximum of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c354de59-efd3-4800-a2f2-5b363ef6befd" contextRef="C_baa1be4a-3f8a-4703-8ce3-1a52e5380d29" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.5</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> year as of December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any consideration related to sales milestone payments (including royalties) will be recognized when the related milestone events or sales occur and therefore are recognized at the later of when the related sales occur or the relevant performance obligation is satisfied.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Compound Collaboration</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2017, the Company entered into a collaboration agreement (the &#x201c;Collaboration&#x201d;) with a pharmaceutical company to jointly identify, research and conduct preclinical development of collaboration compounds against specified collaboration targets to identify drug candidates. Under the terms of the Collaboration, both parties provided one another with a non-exclusive, royalty-free, sub-licensable research and development license to each party&#x2019;s intellectual property to develop five agreed-upon collaboration targets, as well as an exclusive, royalty-bearing development and commercialization license to sell any licensed products that stem from such research. The parties also have the ability to nominate additional collaboration targets if agreed-upon, as long as there are no more than five targets at any given time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In exchange for the non-exclusive license rights, the Company provided the pharmaceutical company with an equity grant and is required to make tiered royalty payments based on net sales of all products licensed under the agreement in the low single-digit percentages. In conjunction with the Collaboration, the Company initially issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_37325020-5bf8-409d-899a-d7d87d2fd7f7" contextRef="C_97589b7d-a19b-4817-9cb4-54e5513837fe" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">886,305</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Series A Preferred Units (&#x201c;Series A Preferred Units&#x201d;) to the pharmaceutical company. On November 1, 2018, these Series A Preferred Units were exchanged on a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_cb8b44a8-0a30-4420-9476-09eaa4fdd848;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one-for-one</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> basis for shares of Series A Convertible Preferred Stock (the &#x201c;Series A Preferred Stock&#x201d;). These shares vested in equal installments over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e550f697-70fe-4de0-917a-2cbb2cd51f40" contextRef="C_b7c4a6f5-3116-4dfc-94b7-2777489e2b5a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company recorded expense over the vesting period based on the fair value of the shares under the Collaboration. The Company recorded $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c114254d-ef1b-4f71-b6ef-fb64abbf550f" contextRef="C_2e7ba5c8-f99e-4875-a133-bee00f42bf56" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million to research and development expense related to the vesting of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_51a65bbc-cde6-4b26-844d-443e5c1c8cac" contextRef="C_2e7ba5c8-f99e-4875-a133-bee00f42bf56" name="kymr:TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">166,183</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series A Preferred Stock during the year ended December 31, 2020. As of December 31, 2020, all shares under the Collaboration were fully vested and all expense had been recognized.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The royalty payments are contingent and as such are not being recorded until incurred. The Company determined that the license is representative of an in-process research and development asset, with no future alternative use. As such, the Company records the expense related to the vesting of shares as research and development expense in the Company&#x2019;s consolidated statements of operations and comprehensive loss.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Collaboration was terminated by the parties effective </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_90f7cf53-030c-4200-9388-007e37a990db" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:CollaborationTerminationDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">April 27, 2022</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9cdb71a0-363d-4171-9973-196cab6fa41e" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents the changes in accounts receivable, contract assets and liabilities for the year ended December 31, 2022 (in thousands)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.959%;"></td>
        <td style="width:1.15%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.102%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.15%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.117999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.15%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.117999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.15%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.102%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at<br />December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deductions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at<br />December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable and contract assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Billed receivables &#x2013; Sanofi</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_12187f06-ebd3-4d7b-9263-88231e1b39a3" contextRef="C_0a44a408-71c2-4d39-8813-0b78ecef7724" name="us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1287db8b-4fab-4bd0-aad9-c1911eec7e7f" contextRef="C_c9486884-24fb-4c2c-83c0-60db6edb5eec" name="kymr:ContractWithCustomerAssetNetAdditions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,650</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6facf4b4-cb4b-4278-b9fa-e17e0445f91b" contextRef="C_c9486884-24fb-4c2c-83c0-60db6edb5eec" name="kymr:ContractWithCustomerAssetNetDeductions" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">6,650</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d07b07cc-69dc-48ed-92fb-1bf045dba7dd" contextRef="C_68b2899b-3bcc-43f6-ac60-1964d739bcc2" name="us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unbilled receivables &#x2013; Sanofi</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0e62c1f3-b7ae-4b95-8654-655639afbce1" contextRef="C_f905c3a9-aa7b-42be-b38e-38c2c85fc17e" name="us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">135</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_efcbd2b0-e89c-4971-988f-0621b00179ec" contextRef="C_6313fdc6-f629-4f9c-b2ab-a0f4799044f4" name="kymr:ContractWithCustomerAssetNetAdditions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,052</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be121822-bf5f-4271-9393-a011bedece77" contextRef="C_6313fdc6-f629-4f9c-b2ab-a0f4799044f4" name="kymr:ContractWithCustomerAssetNetDeductions" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">6,650</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e862a115-6e4b-4a5e-9347-6fe29b2d95f8" contextRef="C_fab1d0dc-259c-4d99-aeaa-b68f059f306d" name="us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,537</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accounts receivable and contract assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_35c30d9d-0c82-458a-ac52-9f259de91af3" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">135</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_98d36b7b-7ba3-48d7-ada2-0ff12a560aeb" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:ContractWithCustomerAssetNetAdditions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,702</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f160b201-3f61-45d1-8b31-e804cc0f4f6b" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:ContractWithCustomerAssetNetDeductions" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">13,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b4447c1c-94d1-4499-ad2c-3f2203664846" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,537</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contract Liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred Revenue &#x2013; Vertex</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_94a2aac7-f5f3-4f56-abaf-21d42371b230" contextRef="C_d26a9a00-5e7d-4d4c-80e3-ac47ef881e7b" name="us-gaap:ContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,212</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5fb20c08-4d30-4dba-ac8c-a9ea91140f03" contextRef="C_f04f21d2-40bf-4a93-8a51-d233d78fb6da" name="kymr:ContractWithCustomerLiabilityAdditions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_39af6a98-91a5-4989-9138-6fd3052cd14d" contextRef="C_f04f21d2-40bf-4a93-8a51-d233d78fb6da" name="kymr:ContractWithCustomerLiabilityDeductions" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">10,813</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c08430a7-5d06-476a-b6f0-2f7c922c5ea3" contextRef="C_bc744543-b39d-4939-9a52-727450458e7f" name="us-gaap:ContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,399</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred Revenue &#x2013; Sanofi</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e8934131-3f43-4432-b169-0390e60d89b9" contextRef="C_f5b3b459-dd6e-414f-b28b-4d450e611a1a" name="us-gaap:ContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">81,822</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a84d6e2-3dc1-49f5-b274-c170172620e4" contextRef="C_c641fd16-c54e-4ea4-bc93-31046365f9ac" name="kymr:ContractWithCustomerLiabilityAdditions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,052</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_567abf42-5bfb-44c9-bd0f-546336c554b9" contextRef="C_c641fd16-c54e-4ea4-bc93-31046365f9ac" name="kymr:ContractWithCustomerLiabilityDeductions" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,013</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f476e999-6a25-444d-b810-1719e8648905" contextRef="C_502b15a6-ea47-400c-869d-e335729cdbc1" name="us-gaap:ContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">54,861</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total contract liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f33c2664-d975-4e7d-a866-90791b81ac46" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:ContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">101,034</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b51c7b71-e941-4d28-a585-31e64e1b28a8" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:ContractWithCustomerLiabilityAdditions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,052</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c6d3ca84-4470-4520-915d-ca437a7c1fb9" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:ContractWithCustomerLiabilityDeductions" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">46,826</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a88e530-c5fd-4d08-8921-12e3340ba196" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:ContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">63,260</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_888d7bc9-bd8d-422d-9cde-d925e840d11f" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 6. Property and equipment</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_82ee2c70-871b-402a-8371-ec14030fb8ba" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment consists of the following as of December 31, 2022 and 2021 (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.73%;"></td>
        <td style="width:1.696%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.439%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.696%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.439%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lab and office equipment under and financing<br />&#160;&#160;&#160;right-of-use asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4f4bce94-e45d-40b1-9184-9fcb06d82b7f" contextRef="C_8d546ca3-b4f9-459e-94ab-382557abce03" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,475</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b7b0f7af-25ff-419d-b9bf-471c20fb2bde" contextRef="C_02126e7a-b6e0-43d2-9ccf-f5a5b79c8acd" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,969</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lab equipment</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9f1530ce-2695-42c5-8da6-b0a53eab075f" contextRef="C_61d31205-c2b5-4c89-bdaa-f543c2398e40" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,383</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f98e56ca-d0db-40a2-a87f-8eb26ef31c44" contextRef="C_5848cdd9-12d7-4f30-a785-9342a4c7a6f5" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,805</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e95f48bb-1dfa-4e01-9864-c26c6b1f4287" contextRef="C_fbbcb1bf-5bb2-467d-99d4-b373ccaddd38" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">357</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d864d122-0619-4065-a62b-bdcbe93875c3" contextRef="C_c965787c-a43a-4142-aa2d-b72d421bb8bb" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">273</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture &amp; fixtures</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7011fad6-b13b-4918-b4b5-1d792e74e169" contextRef="C_31efc25b-97c7-4143-86af-cc79d0a18d8d" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,064</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7ba0e2a5-a9dd-4b3e-bc76-9d7b8281a9e1" contextRef="C_2d89a721-4703-49d1-bd93-8012ab6048ee" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">943</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ae5d43c1-99ab-4da9-af00-050c6ce30af0" contextRef="C_87c3d75e-6f9f-4fee-bf73-1e3449016f7a" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,802</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3f7dd602-febf-4d25-a92a-bce2643bc413" contextRef="C_7739607f-6dbd-41a0-9e92-62301ab965ac" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,741</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets not yet in service</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3365580d-6932-42ff-9c74-40044cc3e7ee" contextRef="C_c4d086ec-121e-41c0-8f9f-29a659fc29f6" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,146</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_462362a5-aa92-4eca-84af-710f7caa1aa6" contextRef="C_00ea0bf2-b4b5-4c08-b022-561003946977" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">66</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21ec3d0b-ab04-46e4-b1d8-bf4b1624fd22" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,227</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c1e1e7a7-f89a-432e-89c3-a25aaff78e57" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,797</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less accumulated depreciation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5c631c4a-bc55-49fe-96ca-6e5664ba3625" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,893</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4146edee-5944-44cd-917e-829d5a0e8499" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,916</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6659efb1-ec32-4342-aff9-d6102e955533" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,334</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8aa254a3-f89f-4d6a-b846-daea861c2129" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,881</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation expense for the years ended December 31, 2022, 2021 and 2020 was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bc4e1e2c-1373-4bd5-981e-2ff3f312e87e" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">3.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3aee5568-002a-4f1e-8bd8-2db204b09b0e" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_683943ba-8d17-400f-af9f-55dc1d6863ca" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in property and equipment is lab and office equipment right-of-use assets under financing leases with a cost basis of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f85dc815-c0da-4daf-8211-fbfc918f5063" contextRef="C_8d546ca3-b4f9-459e-94ab-382557abce03" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_94debb26-c5af-4a0a-a3df-a1f2910ea033" contextRef="C_02126e7a-b6e0-43d2-9ccf-f5a5b79c8acd" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">4.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and accumulated amortization expense of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_995b3da2-6fc5-498f-9858-8a496ff18679" contextRef="C_8d546ca3-b4f9-459e-94ab-382557abce03" name="kymr:AccumulatedAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_07b69d3e-dd1e-4a86-9422-449744ba03f0" contextRef="C_02126e7a-b6e0-43d2-9ccf-f5a5b79c8acd" name="kymr:AccumulatedAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as of December 31, 2022 and 2021, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization expense related to right-of-use assets was</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c17b10e9-d80e-4abd-8ce3-3886c77e56d2" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a47b51bd-6a3b-4f2e-ada6-04ef34942639" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16e44404-fb6f-46c1-92a3-861593467a2c" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million the years ended December 31, 2022, 2021 and 2020 and is included in depreciation expense.</span></p></ix:nonNumeric></div>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fbae3e92-95d1-4640-8f13-d6c540ba26aa" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:LesseeOperatingAndFinanceLeasesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 7. Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2018, the Company entered into a noncancelable facility lease agreement (the &#x201c;Lease&#x201d;) for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cc5985d8-6470-4d6b-92a4-e36256a39069" contextRef="C_ce893baa-f44c-4ebb-a74e-bff63f53114a" name="us-gaap:AreaOfRealEstateProperty" unitRef="U_sqft" decimals="INF" format="ixt:numdotdecimal">9,836</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> square feet of research and development and office space in Cambridge, Massachusetts. In March 2020, the Company signed a termination agreement for this lease which was determined to be a lease modification that resulted in a reduction of the right-of-use asset and liability of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fcc87e29-1eb9-4d5c-96e1-899d83f59401" contextRef="C_a28bf33d-a98c-4e5d-bf76-7f54880914c1" name="us-gaap:ImpairmentOfLeasehold" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. The lease termination was effective </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_73133e46-97e5-4f9f-b0b1-4a78a743db13" contextRef="C_a28bf33d-a98c-4e5d-bf76-7f54880914c1" name="kymr:LeaseTerminationDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 31, 2020</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the Company no longer has any obligations under the Lease.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2019, the Company entered into a facility sublease agreement (the &#x201c;Sublease&#x201d;) for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8016c0c4-bef3-405a-ae1d-0e166f3648b9" contextRef="C_a33af802-fd5f-453f-8566-ed374579cd72" name="us-gaap:AreaOfRealEstateProperty" unitRef="U_sqft" decimals="INF" format="ixt:numdotdecimal">1,471</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> square feet of office space in Cambridge, Massachusetts. The term of the lease began on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5ff67c10-1160-4563-a603-5895d4fa1dd1" contextRef="C_36be0cca-7b17-4bd5-9ff6-6f599abd4d25" name="kymr:LeaseCommencementDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 24, 2019</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and terminated on June 30, 2020, and following termination, the Company had no further obligations under the Sublease. The Sublease required the Company to share in prorated operating expenses and property taxes based upon actual amounts incurred; those amounts were considered variable lease costs and, therefore, are not included in the measurement of the lease and are instead recognized to expense as incurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2019, the Company entered into a noncancelable facility lease agreement (the &#x201c;the 2019 Lease&#x201d;) for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6bb96fa3-9004-43bc-90f6-8c58d341faac" contextRef="C_64fc7649-e229-4be0-9da4-464cbc4ec931" name="us-gaap:AreaOfRealEstateProperty" unitRef="U_sqft" decimals="INF" format="ixt:numdotdecimal">34,522</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> square feet of research and development and office space in Watertown, Massachusetts. The term of the 2019 Lease is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3616caf3-8268-47ec-bffd-ac63de6b06b2" contextRef="C_2c23163c-4ca5-41b2-89bd-6f956a18aef8" name="kymr:LeaseTerm" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months and expires on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1e664fab-37aa-4374-82ff-f39ec83c0f35" contextRef="C_2c23163c-4ca5-41b2-89bd-6f956a18aef8" name="us-gaap:LeaseExpirationDate1" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2030</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The 2019 Lease has an option to be extended for an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e1487928-fe71-4734-99fb-45196d35730e" contextRef="C_2c23163c-4ca5-41b2-89bd-6f956a18aef8" name="kymr:LeaseAdditionalTerm" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">s. The lease is not reasonably certain to be extended and as such the additional term is not included in the measurement of the lease. The 2019 Lease includes a rent escalation clause, and rent expense is being recorded on a straight-line basis. The Company received a tenant incentive allowance of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb56c9c1-1c41-4602-9884-f67e7160d49f" contextRef="C_27b0ac27-e9ee-48a9-8244-480576173f08" name="kymr:TenantIncentiveAllowanceReceivable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in 2020 as the tenant improvements were completed all of which has been collected from its landlord as of December 31, 2022. In accordance with the lease agreement, the Company is required to maintain a security deposit and provided a letter of credit to the landlord for $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9607e4e7-dfc1-44ba-805f-7e7115683897" contextRef="C_7b553fef-df42-4c26-baa6-85e17e44d192" name="us-gaap:SecurityDeposit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which is recorded in restricted cash as of December 31, 2022 and 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2021, the Company entered into a noncancelable lease (the &#34;2021 Lease&#34;) for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_72571eb5-4d3a-42be-aacc-1118234d5294" contextRef="C_905b1e51-7f5b-485c-9c36-6955cd326bbc" name="us-gaap:AreaOfRealEstateProperty" unitRef="U_sqft" decimals="0" format="ixt:numdotdecimal">100,624</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> square feet of office and laboratory space in Watertown, Massachusetts, which the Company expects to begin occupying in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_6df59bfa-c32d-4351-8e0b-684185a0ee07;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 2023</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The  2021 Lease is subject to base rent of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3286953b-cf39-4909-ae3d-7c9017eb40d1" contextRef="C_b6fa59dc-4675-40d7-8994-3d7f6fdb43e3" name="kymr:RentalAndLeaseExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million per month beginning two months after the commencement date, plus the Company&#x2019;s ratable share of taxes, maintenance and other operating expenses. Base rent is subject to a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a9219a03-ff32-455c-aa89-69516acd5f21" contextRef="C_b6fa59dc-4675-40d7-8994-3d7f6fdb43e3" name="kymr:BaseRentAnnualIncreaseOverTheLeaseTerm" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% annual increase over the lease term of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c8927dc8-16ec-4582-a643-746558da2b74" contextRef="C_dc36945d-778f-40c8-b34a-d7b7257091e7" name="kymr:LeaseTerm" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">following the commencement date. The Company also has two consecutive options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">extend the term of the lease for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8a7a679e-8f4a-4ba3-91be-b5c89e0b7945" contextRef="C_b6fa59dc-4675-40d7-8994-3d7f6fdb43e3" name="kymr:LeaseAdditionalTerm" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> each at then-market rates. The 2021 Lease also includes a tenant improvement allowance of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_43090138-1834-446a-be23-684356236cf3" contextRef="C_905b1e51-7f5b-485c-9c36-6955cd326bbc" name="kymr:TenantIncentiveAllowanceReceivable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">20.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. In connection with the signing of the 2021 Lease, the Company issued a letter of credit for $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f78c535-798f-49a2-ae95-e7e9baf472d9" contextRef="C_3363a5aa-7bac-47fb-9504-1359994babd8" name="us-gaap:SecurityDeposit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">4.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million which is classified as restricted cash as of December 31, 2022. The Company also paid first month&#x2019;s rent of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f21f5f41-b007-46a0-a575-2089bf359f34" contextRef="C_edc39a4d-75a6-4b3f-af07-3ff0619b84c6" name="us-gaap:PaymentsForRent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million upon execution of the 2021 Lease in December 2021 which is classified as other non-current assets as of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. As of December 31, 2022, the Company has not taken control of the space associated with the 2021 Lease and therefore, the Company has not recorded a right of use asset or lease liability related to the space as of December 31, 2022.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s financing lease obligations consist of certain property and equipment financed through capital leases.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_59bb90b7-e53c-48b1-bb0d-eb2305e93287" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of the lease costs for the years ended December 31, 2022 and 2021 (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.685%;"></td>
        <td style="width:1.613%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.902000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.613%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.188%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_34e6b9ae-7c58-441d-9993-1be2ea9e61f8" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,095</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fb3749b0-1b3e-48ce-b7cd-c273649781ff" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,095</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing lease costs:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of right-to-use assets, financing<br />&#160;&#160;&#160;leases</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_37f42830-2488-4da7-8ccf-d3b5080f00a3" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,184</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b9c836e3-f585-450d-999d-e93e10b6619a" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">906</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense for financing lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_884aebd3-d3a9-436c-b3f5-582f098bc0ca" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:FinanceLeaseInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">179</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b370a7a-5b93-473e-b69f-51c4e0e2d93e" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:FinanceLeaseInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dbb7a537-ab89-4776-8fb9-35ebeb185a9b" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,192</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3aed6c8b-4a9d-44a8-aa0e-95aea18daf35" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,015</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2c3fa6ca-8b1b-4956-9f85-96e8d725f1b8" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,650</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aaaba36b-0b9c-479e-ad4c-201bae3f31cd" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,174</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8ace5db2-03a2-4872-ad5b-9a8728929622" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:SupplementalCashFlowInformationRelatingToLeasesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental cash flow information relating to the Company&#x2019;s leases for the years ended December 31, 2022 and 2021 were as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.02%;"></td>
        <td style="width:1.578%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.364%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.592%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.448%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash paid for amounts included in the measurement<br />&#160;&#160;&#160;of lease liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating cash flows used in operating leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c496e6eb-6e09-4f6a-846d-7c8e8bd7d5a6" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:OperatingLeasePaymentsProceeds" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,581</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0484180e-8da5-43f6-9b62-fc86b3281cfc" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:OperatingLeasePaymentsProceeds" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,691</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating cash flows used in finance leases</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2dd7d7b8-02d2-495f-aeee-d4e4cb3e4f67" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,130</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9ec52508-c161-4855-b477-4f22051254ae" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">933</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing cash flows used in finance leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_44d0c0c4-68ed-460e-b898-896537748935" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:FinanceLeasePrincipalPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">179</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f132a7e6-95c0-40e8-a705-8f8d5e9f2c2b" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:FinanceLeasePrincipalPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b153a933-2bc4-495e-a525-8a3df1992718" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average remaining lease terms and discount rates as of December 31, 2022 and 2021 were as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.844%;"></td>
        <td style="width:1.139%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.696%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.139%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.183%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining lease term:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8e07e18e-a6a3-4ef8-a665-9058f5de3f40" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.3</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8efed8e1-b350-49b9-bcbe-b931718d760e" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.3 </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing lease</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_611e1205-8ff6-4aea-8fef-94f3cea9b2f9" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2d7856a6-e2ee-4400-91c4-902f03e698bf" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4 </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Discount Rate:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c2575c1a-fe95-4e24-8f59-231965327edf" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">10.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a7313397-724e-48ae-9204-7133c220bcbb" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">10.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing lease</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2462fe41-fd66-4e6d-b9ac-192dca9a3c27" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">8.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f3c8267-e62d-42e7-a68f-31c13dde0bdb" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">8.8</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d53fd60a-c095-4191-8902-27e7aa50edd5" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The undiscounted future lease payments for operating and finance leases as of December 31, 2022, were as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.274%;"></td>
        <td style="width:1.572%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.79%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.572%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.79%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal Year</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating<br />Leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing<br />Leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16786e11-cc96-423f-8324-18ea2114a74c" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,659</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_63b547d1-444d-4c1a-bc0f-8963677ed23e" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,463</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e0a63a4b-4596-40a1-9c3e-2524ef887c0a" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,732</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eb487bf1-55e6-4cce-8300-d8d333785749" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">839</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b133da59-b8b0-43fb-9398-9f3b08ab7ab9" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,814</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1eb8dc9b-eaeb-49dc-bc46-0f6e5238f729" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">402</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7c7f7b46-80b3-4b02-85cd-296b523f0ba9" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,898</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_264053e0-ebf6-42cf-b0af-cbb3ea6b1118" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">133</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1763db65-2e1f-4447-bafa-3da9888317e6" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,985</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e90a5c97-3475-4838-b25d-9ae4922dcb84" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">99</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cbf785ff-a771-47bc-8778-bcf30d27277c" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,041</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5f40c78-7ada-4ac8-9c68-38481fa2dbbd" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6be3edd4-428f-42dd-b3cc-5a77d0fe0c6d" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,129</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9e32516-14b0-47c4-b6ae-81f251c54d21" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,936</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less amounts representing interest or imputed interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_457f7908-663e-4ad5-ada3-dfb3aaf270ae" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,448</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16f7f007-58ab-4224-b3c3-a2e800661846" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">282</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Present value of lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f7155e11-f59f-4171-b5d9-28b7c5144678" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,681</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ce910980-b5c7-4776-8df9-3b3aa6fc0a70" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:FinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,654</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excluded from the table above are all future payments related to the 2021 Lease.</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_daad84ce-4d48-478d-89ff-36dfeb6a526d" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 8. Accrued Expenses</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fa885460-4a40-4ecc-96e4-444741c25466" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consist of the following as of December 31, 2022 and 2021 (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.015%;"></td>
        <td style="width:1.592%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.359%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.592%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.441999999999998%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08396ef1-5745-4653-acb1-776e3fa71f11" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="kymr:AccruedResearchAndDevelopmentExpensesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,975</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d238f93f-e958-4471-87d8-6245a52d9fcf" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="kymr:AccruedResearchAndDevelopmentExpensesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,169</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payroll and payroll-related</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_62a5f5ab-b563-4f68-a84a-ba350d76ac76" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AccruedSalariesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,149</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_96e09e22-ab2e-43ca-a22d-56f08279b366" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AccruedSalariesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,033</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Professional fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_64e34b30-91df-4d30-93d9-3ba9807df253" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,971</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bed8b37a-1695-4c6c-a586-fd5db53a8950" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,417</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4dae4093-eb90-454a-a995-d8cbf2b05248" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">407</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_982dc80d-25b2-42a0-bee6-26c3740c5994" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">352</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_263a404e-32e1-4ecc-b5ac-507a65c97f81" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,502</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d75b8ba4-1cb9-428b-a413-e0bde1eadfe1" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,971</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7df802b7-e348-441d-9337-86267b0f2781" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 9. Other Commitments and Contingencies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Legal Proceedings</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the ordinary course of business, the Company may be subject to legal proceedings, claims and litigation as the Company operates in an industry susceptible to patent legal claims. The Company accounts for estimated losses with respect to legal proceedings and claims when such losses are probable and estimable. Legal costs associated with these matters are expensed when incurred. The Company is not currently a party to any legal proceedings.</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Indemnification Arrangements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As permitted under Delaware law, the Company has agreements whereby it indemnifies its investors, employees, officers, and directors (collectively, the &#x201c;Indemnified Parties&#x201d;) for certain events or occurrences while the Indemnified Parties are, or were serving, at its request in such capacity. The term of the indemnification period is for the Indemnified Parties&#x2019; lifetime. The Company believes the estimated fair value of these indemnification agreements is minimal. The Company enters into standard indemnification agreements in the ordinary course of business. Pursuant to these agreements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally the Company&#x2019;s business partners or customers, in connection with any U.S. patent or any copyright or other intellectual property infringement claim by any third party with respect to the Company&#x2019;s products. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. The Company is not aware of any claims under indemnification arrangements, and it has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ca79d3d1-7175-4cd5-9ae2-85c3383fdd2b" contextRef="C_e35141e7-840c-4c80-868b-75ce55213382" name="us-gaap:LossContingencyAccrualAtCarryingValue" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_4f8a1a70-a946-4767-a3b3-38f099d5b10d" contextRef="C_a2e3e97a-6104-4a6a-845d-96d26416a456" name="us-gaap:LossContingencyAccrualAtCarryingValue" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_109a1f30-7d69-4ce6-8450-ade3093c15dc" contextRef="C_80f9fc1a-bada-456b-a7de-e066beca9a76" name="us-gaap:LossContingencyAccrualAtCarryingValue" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t accrued any liabilities related to such obligations as of December 31, 2022, 2021 or 2020.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5d64159f-64f7-456a-8978-a9fe5f9a24e8" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:PreferredStockTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 10. Convertible Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Immediately prior to the IPO, the Company&#x2019;s Certificate of Incorporation authorized a total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4c2d91d8-b582-4a2a-875f-401545ed282b" contextRef="C_c6c8d2a8-fc5a-4ae7-a353-aba76870f2db" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">52,483,788</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of convertible preferred stock with a par value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_19b713b1-db3c-4061-95d8-8a6146cfc121" contextRef="C_c6c8d2a8-fc5a-4ae7-a353-aba76870f2db" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, of which </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c5130fe3-fb75-4967-9f99-6bea878bde02" contextRef="C_0e8deb54-698e-4ab2-af83-21ba04dff085" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares were designated as Series Seed Preferred Stock, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_921ee0b3-7fab-45fb-8423-d916e25a0a06" contextRef="C_9d10799d-d7e1-4d27-8675-c80ab8ac70f7" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">14,886,305</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares were designated as Series A Preferred Stock, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3354daab-e335-4bdf-9538-9735dce44074" contextRef="C_e8aab3b3-a22a-4ff3-bc89-71d92652daea" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">16,009,845</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares were designated as Series B Preferred Stock, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1997928f-75d2-466c-9129-fc77b60ff8d2" contextRef="C_3c25311b-f928-4131-a217-3def376fa07e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,059,695</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares were designated as Series B-1 Preferred Stock and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_170890d4-79c5-40ae-a50f-79a8ac52971b" contextRef="C_79fff542-33ec-47e5-9833-9eb8b9292809" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,527,943</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares were designated as Series C Preferred Stock. The Series A, Series B, Series B-1 and Series C convertible preferred stocks will be collectively referred to as the Convertible Preferred Stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2020, the Company issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ddf22eb2-dd6a-448b-9d15-ee9e6d13f76b" contextRef="C_609eabef-de99-4804-9f3b-bfe0014a08e4" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,182,265</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series B Preferred Stock at $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ec441e8-93ad-400b-82cd-b4c9fe0044bc" contextRef="C_609eabef-de99-4804-9f3b-bfe0014a08e4" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">4.06</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share to complete the second closing of the Series B Preferred Stock issuance for total proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_41837cd5-15f3-4a32-9e9f-e27fe31bf37d" contextRef="C_f90b9a09-ed20-4574-8cf0-a5475c3bafe7" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">4.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. The issuance costs related to the second tranche were insignificant.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2020, the Company executed a Series C Preferred Stock Purchase Agreement (the &#x201c;Series C SPA&#x201d;) to issue </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9b2ad80f-178f-4b57-ae42-e5d14ec8740c" contextRef="C_a19a1934-1bfb-4c71-8877-7d13aaae909d" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,539,141</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C Preferred Stock at a purchase price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ffd2422a-64e0-413f-97a1-fa7818c5085b" contextRef="C_a19a1934-1bfb-4c71-8877-7d13aaae909d" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">6.5366</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share for a total consideration of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9ebc2bae-d82e-463b-bc5e-69d0e3850268" contextRef="C_76c8ae03-3308-43f1-b225-daad19fb4a85" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">88.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, net of issuance costs of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b5400ebf-f257-4ba1-abbd-b3826f0f29d8" contextRef="C_76c8ae03-3308-43f1-b225-daad19fb4a85" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. In conjunction with the Series C SPA, the Company exchanged </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d2b3dfd1-3748-40d1-a71e-3d9d1f9b2362" contextRef="C_2975af70-dd29-413c-b9dd-b4bce328cf7f" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,988,802</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series A Preferred Stock for an equal number of shares of Series C Preferred Stock related to a transaction amongst investors. This resulted in a total issuance of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_595b4aa3-1c7d-4d63-bf83-b0365025af6e" contextRef="C_2975af70-dd29-413c-b9dd-b4bce328cf7f" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,527,943</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C Preferred Stock. The fair value of the shares of Series C Preferred Stock issued exceeded the carrying value of the shares of Series A Preferred Stock exchanged by $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7a085488-1e1e-409e-b869-cf2e50c7c5c1" contextRef="C_cd15099d-d559-460e-9cc6-741a7742e2e1" name="us-gaap:TemporaryEquityDividendsAdjustment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">9.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">which was</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">recognized </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">as a deemed dividend through a reduction of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_94844da5-3c52-4ca3-b48e-dea50b1f349e" contextRef="C_cd15099d-d559-460e-9cc6-741a7742e2e1" name="kymr:AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million to additional paid-in capital and an increase of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_33cc8238-4a4e-41f5-8ec5-22ddf057dd8f" contextRef="C_cd15099d-d559-460e-9cc6-741a7742e2e1" name="kymr:IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">6.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million to the accumulated deficit. The $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d9ec379c-c81c-45e7-9fb8-d2747d379f95" contextRef="C_cd15099d-d559-460e-9cc6-741a7742e2e1" name="us-gaap:TemporaryEquityDividendsAdjustment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">9.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million deemed dividend increased the net loss for the year ending December 31, 2020 to arrive at net loss attributable to common stockholders in the calculation of earnings per share.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Company&#x2019;s August 25, 2020 IPO all issued and outstanding Convertible Preferred Stock of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_63e6c213-e4a0-4645-87db-4e4bf1083daf" contextRef="C_da066593-343f-4eae-86aa-8434db5d2bc4" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">50,439,595</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> were converted to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_18aa396a-e5e0-4ecf-baa3-2788e546f49e" contextRef="C_92f87a14-6091-4b98-ab40-77d4b06dc412" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">31,625,534</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#x2019;s common stock and were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_67470dfb-c976-4208-8c16-4ea04c5a6946" contextRef="C_6a76246b-2b22-46e7-b98f-f3af778c41fa" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_2d1ead5e-6b14-4225-a118-2f9387ecbce2" contextRef="C_6a76246b-2b22-46e7-b98f-f3af778c41fa" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> longer issued or outstanding as of December 31, 2020.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_4e71da36-154c-4162-b4f2-6022486c5fc0" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 11. Equity-Based Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2018 Stock Option and Grant Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In November 2018, the Company adopted, and its stockholders approved, the 2018 Stock Option and Grant Plan (the &#x201c;2018 Plan&#x201d;), which provides for the granting of stock options and other equity-based awards at the discretion of the Board of Directors or any subcommittee of the Board of Directors to the Company's employees, officers, directors, and independent contractors. No further grants will be made under the 2018 Plan. However, the 2018 Plan will continue to govern outstanding equity awards granted thereunder. To the extent outstanding options granted under the 2018 Plan are cancelled, forfeited or otherwise terminated without being exercised and would otherwise have been returned to the share reserve under the 2018 Plan, the number of shares underlying such awards will be available for future grant under the 2020 Stock Option and Incentive Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2020 Stock Option and Incentive Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the Company and its stockholders approved the 2020 Stock Option and Incentive Plan (the &#x201c;2020 Plan&#x201d;), which became effective on August 20, 2020. The 2020 Plan replaced the 2018 Plan as the Company&#x2019;s Board of Directors has determined not to make additional awards under the 2018 Plan following the closing of the Company&#x2019;s IPO. The 2020 Plan allows the Company to make equity-based and cash-based incentive awards to its officers, employees, directors and consultants. The Company has initially reserved </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_80f83e9a-ba4e-4d8f-bdbf-285b9f343681" contextRef="C_cfa523b6-c249-44ac-b04c-c2b414d9ace4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">4,457,370</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock for the issuance of awards under the 2020 Plan, which includes the shares of common stock remaining available for issuance under its 2018 Plan as of the business day immediately prior to the effective date of the registration statement. The 2020 Plan provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2021 and each January 1 thereafter, by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f7fa5b9-8646-4a59-8b57-924acc6b4713" contextRef="C_09c6030c-9215-434e-be32-4ed40bf22526" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Company&#x2019;s outstanding number of shares of common stock on the immediately preceding December 31, or such lesser number of shares as determined by the Company&#x2019;s compensation committee. These limits are subject to adjustment in the event of a stock split, stock dividend or other change in the Company&#x2019;s capitalization. As of December 31, 2022, there were an aggrega</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">te of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6bac0e5f-3a30-4420-ba8a-d4ba22e472cd" contextRef="C_5c3de9fd-e34c-40a7-886f-e337a1c4bbf8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,744,415</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> remaining available for future grants.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2020 Employee Stock Purchase Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the Company and its stockholders approved the 2020 Employee Stock Purchase Plan (the &#x201c;2020 ESPP&#x201d;), which became effective August 20, 2020. The 2020 ESPP initially reserves and authorizes the issuance of up to a total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b2a74cf5-b05f-4bc1-9223-2c33a1c6276f" contextRef="C_f388feec-ab4d-435a-a116-98c364680e81" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">445,653</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock to participating employees. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_da7ed364-633a-42c3-81ef-3efdb01ac995" contextRef="C_5e70b6ab-252f-4914-b65d-a19b70d29f38" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2020 ESPP provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2021 and each January 1 thereafter through January 1, 2030, by the lessor of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a063ed09-8bf5-4448-8917-465923cf83ea" contextRef="C_0a508e8a-8ed4-432c-b50f-3e6ba3cf849e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">438,898</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c5db524d-ba30-4bbb-825b-dc405756d1a4" contextRef="C_9f2c591c-cdd0-4e59-b139-60ee5abb1b89" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Company&#x2019;s outstanding number of shares of common stock on the immediately preceding December 31 or (iii) such lesser number of shares of common stock as determined by the administrator of the 2020 ESPP.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The number of shares reserved under the 2020 ESPP is subject to adjustment in the event of a stock split, stock dividend or other change in the Company&#x2019;s capitalization. As of December 31, 2022, there were an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d8449f1-9e8d-4bf2-84f4-a1660a254bf3" contextRef="C_2b3d220a-8dfb-48f9-8630-e9c3cb556015" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,208,252</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares remaining available for future grants.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock Options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_547463f6-cd33-470c-9c18-0bfa6ecf2dbb" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of stock option activity under the 2020 Plan during the year ended December 31, 2022 is as follows (in thousands except share and per share data):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.337%;"></td>
        <td style="width:0.856%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.870000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.008%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.295%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.856%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.144%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.091%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.543%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br />Options<br />Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br />Average<br />Strike<br />Price per<br />Option</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br />Average<br />Remaining<br />Contractual<br />Term<br />(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br />Intrinsic<br />Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_80f9bf21-e5b0-4290-b1c3-b53b09274ac7" contextRef="C_d51bc1c7-aa3c-43cd-8c22-e7fed24f7dec" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,239,182</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_418edc58-074f-433d-88e8-828441272dbe" contextRef="C_d51bc1c7-aa3c-43cd-8c22-e7fed24f7dec" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">23.91</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a165097e-058e-4448-b025-c24462a1a066" contextRef="C_f8675fbd-b497-45a1-8f98-17bb97d337a6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.56</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b31ab616-5c90-41be-953d-b032b57ae1ef" contextRef="C_d51bc1c7-aa3c-43cd-8c22-e7fed24f7dec" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">246,933</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2182f700-a895-4c5e-8152-0cafcab4d0eb" contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,761,441</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_154a154a-79f9-4478-9fbd-c0e6b489452d" contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">35.33</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1abf4073-ee48-412f-b27a-b817d0970b6d" contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">601,594</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7f7ecd2c-37b6-4aa4-aed8-740046355973" contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">5.24</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_738ba2a7-d4d1-46ad-973f-512bcfd9d214" contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">641,740</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fdc6a054-91d2-48fa-aa1c-de2299d4545c" contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">33.89</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_95cb2ca9-00b5-40e4-b073-b09dcb7a7047" contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,757,289</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f076cf74-2ce8-48a9-8586-c67f23157513" contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">27.60</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_929c170f-4699-4a2d-bbb6-0bc4c39d1e29" contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.01</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_872dc47c-805e-43cb-bf47-b7105db5abe3" contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">55,934</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercisable at December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6bf0c47e-5522-45c5-bb8f-72856898d3f3" contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,505,520</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_958a315c-2cfa-4672-b17a-b9aec1702b5a" contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">23.27</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fa0d96bf-a73b-4d12-b8ab-c5c578f87981" contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.61</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_06de5af0-b693-4f13-97e4-9f7eea2e22c7" contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">38,500</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The intrinsic value of stock options exercised during the years ended December 31, 2022, 2021 and 2020 wa</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">s $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_203ce7bd-408c-46a0-a119-ba52670b0873" contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">15.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_319a5e9e-777a-473f-9d0a-53a2e71ff650" contextRef="C_2838053c-edc6-48eb-99f6-f1c1c948532c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">67.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_527a1980-68a3-4a63-86f7-caf9c41689fe" contextRef="C_540998ce-bee4-4ad6-941f-3538588a5c1a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average fair value of options granted during the years ended December 31, 2022, 2021 and 2020 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c873cafc-25ee-462c-8e30-c89031528678" contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">20.18</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b018f610-445f-4664-b2a3-91db3fd6b4e5" contextRef="C_2838053c-edc6-48eb-99f6-f1c1c948532c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">29.95</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a5451bc-002a-4a36-b2e0-2e45a60d450e" contextRef="C_540998ce-bee4-4ad6-941f-3538588a5c1a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">8.35</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the total unrecognized stock-based compensation expense for unvested stock options was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_986b420c-7d73-4b9c-9913-b840ddb35950" contextRef="C_a127836f-8972-4634-a63e-075a16b278cb" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">57.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which is expected to be recognized over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6b04b6e8-2fea-4aea-afa2-fb27b3e3c371" contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c146e781-d80b-4d8b-975d-e1321fc0c26f" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table outlines equity-based compensation expense for stock options for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.541%;"></td>
        <td style="width:1.374%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.654%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.374%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.654%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.374%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.654%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.374%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0adae75b-cc63-49bd-a4d5-84a7bcd3cd63" contextRef="C_74fc36db-9df8-4a3a-b61d-d3906dde152b" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,388</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c4cf721-2723-4694-bb17-7542993fc21e" contextRef="C_5736292d-6714-4a50-bbea-d38622c2466f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,161</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eb275342-c0f0-4fc0-b139-ba8b62196dc1" contextRef="C_fee29a3a-aedd-47a5-a81d-24177eb305f7" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,084</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f226f95-2125-41c5-8b8c-e9001fe2ec29" contextRef="C_bc832249-6262-4522-b906-00d2da961c93" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,941</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba4c427e-15cb-453d-9f29-0f48a46befa4" contextRef="C_71808508-9486-45a9-a60f-55c647268f87" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,628</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fb42f8f7-941c-4901-945f-325521ef95ee" contextRef="C_efce9fe0-465e-459e-b1a9-4b6162542b7f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,864</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c2c271dc-94f3-4bfb-b9f5-66fea33bc4d1" contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,329</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_70ae4294-a344-49c7-967d-a573809c3d6f" contextRef="C_2838053c-edc6-48eb-99f6-f1c1c948532c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,789</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f5e35aec-70eb-43df-b64d-cbe3a7f0b77e" contextRef="C_540998ce-bee4-4ad6-941f-3538588a5c1a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,948</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_56e24e63-ffaf-46bb-b23e-df4d761ac047" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average assumptions that the Company used in the Black-Scholes option pricing model to determine the grant date fair value of stock options granted to employees and non-employees for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.193%;"></td>
        <td style="width:1.052%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.535%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.052%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.657%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.052%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.457%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_822a7ffa-0f26-42e8-bbbb-3f13062fb64c" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.86</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2dcbf6e8-92f1-4ec8-9c9b-e23eb8072ca6" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.87</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5a40c7be-5425-4e94-9619-5ea5bd64efc4" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.09</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a57eb23-c3fa-4306-a5f2-aa80ca4d448f" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">62</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4851a4d0-8f1d-48da-bd04-f23a42d64201" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">66</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d322dd41-1ad7-43f6-ada3-7cbe3a7e06f6" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">70</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f05b0629-974c-4630-b38f-aa314a40405e" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">2.1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d63cf188-f3d4-46dc-976a-a85d5facdbe3" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cdbd9836-0eb0-476c-bd49-3a4647d80fb8" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1d5886f5-05df-4bca-b028-bbd61a2cbccd" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c1f70585-5804-4450-8da4-2786b20c1dd6" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6459ae7-decc-4a93-9a34-13f52e6a3a50" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Common Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has granted shares of restricted common stock with service-based and performance-based vesting conditions. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f5d281ac-916b-4c27-867b-168e45887a7a" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" escape="true" continuedAt="F_f5d281ac-916b-4c27-867b-168e45887a7a_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of restricted stock activity under the 2018 Plan during the year ended December 31, 2022 is as follows: </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_f5d281ac-916b-4c27-867b-168e45887a7a_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.152%;"></td>
        <td style="width:1.123%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.443%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.607%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.676%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br />Units<br />Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grant Date<br />Fair Value<br />per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_74ec480c-5e90-47d7-a257-cd2185b2d554" contextRef="C_b7ba11fe-25ad-4dba-9808-5ea7f213c68e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">37,745</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eaf9c9ca-89fa-4be0-bd4b-e9f1dcca64d8" contextRef="C_b7ba11fe-25ad-4dba-9808-5ea7f213c68e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.60</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ea2d3a90-809f-4373-b743-e1fd9e46e561" contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">295,892</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b29ed6c9-0927-4497-9b09-da5658dda8c5" contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">24.01</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fae34e71-d1bb-4f59-9881-cac8bba2f236" contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">36,866</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1e6a6a05-6935-410c-9f26-6853ca86ef33" contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.60</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_423ef196-df01-40e1-85df-569cbb9bd4cb" contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">14,928</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_60a0ae4b-8191-4e56-8bbd-af1326418d25" contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">29.93</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bea3f12b-5ebc-41d3-a71c-664eadd1118e" contextRef="C_ffaeb917-acaf-403e-b35f-ee9c0815e0fd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">281,843</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1c326fc4-883b-4b1d-ab4c-42bd69392abf" contextRef="C_ffaeb917-acaf-403e-b35f-ee9c0815e0fd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">23.64</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company granted </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e670228a-7b4a-43cd-ae9d-a6deded1a9b8" contextRef="C_7df38be4-2853-4015-a6b5-9f73bad5256f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">295,892</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9dcf1827-5e0c-443b-84db-4eb56a360518" contextRef="C_13c32f2e-7c2d-451d-bddf-0c2c9dd15260" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">12,500</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of restricted stock during the years ended December 31, 2022 and December 31, 2021, respectively. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6a48db5-043a-4ab3-bd96-04291bbc8920" contextRef="C_0847ba81-8f44-4437-b8eb-633b0c7d610a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> grants of restricted stock for the year ended December 31, 2020. The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_746c743e-b51a-437f-82b1-681c04832290" contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t grant any restricted stock to consultants for the year ended December 31, 2022 and granted </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1387361b-725f-45f7-9d15-66f679aec95e" contextRef="C_2838053c-edc6-48eb-99f6-f1c1c948532c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">12,500</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of restricted common stock to consultants which were fully vested at the time of grant during the year ended December 31, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the total unrecognized stock-based compensation expense for unvested restricted stock was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ef11f991-ad22-462e-a604-d51e148b4b4e" contextRef="C_fd5b0988-24e0-4f79-92bb-866fe46cad5f" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  million, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">which is expected to be recognized ov</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">er </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0c88729e-cd3c-4a80-bf4f-f7257ce03b41" contextRef="C_7df38be4-2853-4015-a6b5-9f73bad5256f" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the years ended December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company recorded stock-based compensation expense for restricted stock of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b235c2d-a378-4e16-987b-d9711a3dfe1e" contextRef="C_7df38be4-2853-4015-a6b5-9f73bad5256f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1309da40-b70d-432c-8fb8-3bd662fbd6de" contextRef="C_13c32f2e-7c2d-451d-bddf-0c2c9dd15260" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e5e5ecea-3361-4fc3-955b-b061b876c01f" contextRef="C_0847ba81-8f44-4437-b8eb-633b0c7d610a" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. During the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company recorded stock-based compensation expense of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aa5c54f3-a72e-40ed-a6da-e71cd1efe107" contextRef="C_234197a7-41c0-49b0-b46a-6e4f533c6f82" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_761c0304-5626-4640-a68b-b3f87aeb491a" contextRef="C_e838c8dc-9e7e-4afc-9c1b-ef93b8e4bf4d" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a521b227-5123-481e-81eb-5cf463407869" contextRef="C_7bfbb36d-82da-4ad3-994d-90f943b534e8" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, within research and development.  During the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company recorded stock-based compensation expense of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bfef20f6-bcce-4d38-9bb2-0b5bd9f8ebce" contextRef="C_ffa8f705-3f5f-4262-91ee-9dc0b63d32dc" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e4fccfa4-02f4-4ff0-91cd-ee2166cd4dcd" contextRef="C_9c751372-08cb-457c-aad4-5cedac83bf5f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, and an immaterial amount, respectively, within general and administrative.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">      </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equity-Based Compensation Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_585a5c9a-34ad-4f58-9f1e-76cc9c8d44c8" contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation expense recorded as research and development and general and administrative expenses for employees, directors, and non-employees during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020 is as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.442%;"></td>
        <td style="width:1.473%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.621%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.473%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.621%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.374%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.621%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.374%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Years ending December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c849d81b-d913-476f-a153-34140322772b" contextRef="C_233f48ad-667b-4b14-9534-dd4453d81c14" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,008</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a408c82-1472-417d-8c70-1921a64b0972" contextRef="C_19cbc32f-ec79-4363-8ead-cd45c0522894" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,731</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bdd940d9-b6bc-4850-b24f-b59cf5f1e15b" contextRef="C_1fa761db-d666-44a0-af4c-79d0be38cd5f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,305</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5641dbfe-73a7-4c33-b7c6-2a714278ff80" contextRef="C_8de70d1d-2b5f-493b-8b0b-26530520a358" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,472</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2c23d4ea-895f-4bb6-aeae-1f2de325f58e" contextRef="C_e29716e7-cfe9-40b9-a9c6-244c78e60765" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,241</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_49063940-a94d-4e43-a35d-a97888e89cf8" contextRef="C_136d87f1-3086-4833-98e0-254742d30599" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,885</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7011d727-275e-4194-9c61-a50ff03dac0c" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35,480</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e586fc8d-455d-4ebb-9a9d-a9a2c369a1c2" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,972</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_def59aa5-1052-411d-a085-bf55b6e2dbb1" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,190</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_856a7ae9-8dc3-45fc-a849-89c93ec7dfc8" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 12. Related-Party Transactions</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to the collaboration discussed in Note 5, the Company had the following related party transactions for the periods presented in the accompanying consolidated financial statements, which has not otherwise been discussed in these notes to the consolidated financial statement. The Company made payments of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a5703c8e-f525-4afa-ac1b-07008ab50d40" contextRef="C_5f869677-7ee2-4413-aebc-fa0d38400637" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million to an investor for rent expenses for the year ended December 31, 2020. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cd6d4e17-7a25-4b19-8311-42f7decce3ba" contextRef="C_da71e1e6-ad8b-46b6-a6cc-c239a69a2d15" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" unitRef="U_USD" scale="6" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_78915df7-19b1-4f01-ba4c-560b23cee7a6" contextRef="C_b43e2e96-8c18-4279-8325-186feb642b24" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" unitRef="U_USD" scale="6" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> payments were made to related parties during the years ended December 31, 2022 and 2021.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_1bd7efef-3580-45be-be25-95b08954cc7d" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 13. Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company records income tax expense related to profits realized by its U.S. operating subsidiaries. For the years ended December 31, 2022, 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">021 and 2020, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f3d6b906-5a7c-43ed-83ef-9a6bd5702dd2" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_48401829-1817-4f42-9a21-ccdb61fb65fa" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f4d4ecda-67dc-42a6-a6d4-648038a4a2c7" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> income tax expense was recorded due the group&#x2019;s net operating loss (&#x201c;NOL&#x201d;) and full valuation allowance.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_019a4ee2-65b0-4f17-a57f-53333e77dab6" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The rate reconciliation of the U.S. statutory income tax rate to the Company&#x2019;s effective tax rate for the years ended December 31, 2022, 2021 and 2020 are as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.06%;"></td>
        <td style="width:1.327%;"></td>
        <td style="width:12.443%;"></td>
        <td style="width:1.996%;"></td>
        <td style="width:1.327%;"></td>
        <td style="width:12.443%;"></td>
        <td style="width:2.008%;"></td>
        <td style="width:10.399%;"></td>
        <td style="width:1.996%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax effect at statutory rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2625f12c-903c-4cda-9259-b0e1f5433465" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_52270832-6c1e-4387-902e-56752143d583" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fafa4090-5a8b-4a5b-a763-d0b063707729" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State taxes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c612822-3b15-4954-99fe-6a8bf230fa2d" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">6.4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_040d0ba8-cc03-479a-bf47-d23196b2f982" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">10.6</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2d383e25-1c85-439b-8449-b4d6b87bb6e5" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">5.8</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_68ab4b7f-f76e-430b-8b52-37745c039998" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c35fd6a3-47b0-4bda-ae4e-70e1229eaaba" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">9.6</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4ba02abb-8a0d-4f7c-9fe5-bbd15d37e084" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permanent differences</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7f9636c2-42bb-4f00-949c-bbb60397fe6d" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:EffectiveIncomeTaxRateReconciliationPermanentDifferences" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ae447f21-b680-4230-95d4-f2656065347e" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="kymr:EffectiveIncomeTaxRateReconciliationPermanentDifferences" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cc292aa4-4198-4ba3-8c9e-69de7e396145" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="kymr:EffectiveIncomeTaxRateReconciliationPermanentDifferences" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal research and development credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_799b91ac-bc3f-4f2e-a590-8887d1959087" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a29157cb-2cfa-4cd8-a40a-823cf75671e5" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">7.7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f7fbedf-0aeb-44d4-acdf-75e5f2fa2859" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">3.6</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_87e60cf1-b4f5-465e-9381-eb7ca9b92e59" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">1.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_34c15cc0-0da2-45b1-b426-fcfa4918171f" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">5.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_147a53c3-211f-4124-b1b8-e3dd14522cc8" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6ebcbbc2-d98b-49ba-9dd8-4ee2f7dbdfec" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">27.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8cec631e-88eb-4199-93fa-2c093f263b4e" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">43.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_65e17f8e-46a7-47c2-bfe9-1e2534b5842a" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">28.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_af35ac95-efa2-49b2-913f-266781eadbc8" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_57e8ccd5-d9bb-4e5a-9111-5478857b7540" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f56de057-33d7-41ba-974e-f8ece66c2d8f" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_07bf1015-9676-4e0e-b42e-3262c93eb226" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true" continuedAt="F_07bf1015-9676-4e0e-b42e-3262c93eb226_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of the Company&#x2019;s net deferred income taxes are as follows (in thousands):</span></ix:nonNumeric></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_07bf1015-9676-4e0e-b42e-3262c93eb226_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.612%;"></td>
        <td style="width:1.565%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.36%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.551%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.36%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.551%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="8" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Deferred Tax Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dee2c3ac-8a90-48ea-b8ad-406ead9c10c8" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,320</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6097d72f-27b3-464b-b7d3-412780759a22" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,957</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bda5bd98-d9da-42f5-8178-1db0d8ec703d" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,835</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3f87eb2a-343c-4a92-9c8c-7afeb719c2fc" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,651</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development credit carryforwards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f91d3838-0e29-406d-9008-fcccd10f3913" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,581</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_588cd87e-13fa-45e3-bcc1-7415fb48c6de" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,611</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bba678c0-45f6-40b7-b89b-cff8bd2030d4" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="kymr:DeferredTaxAssetsLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,011</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f586b735-4d0c-47d1-b2bb-c02ec3b87968" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="kymr:DeferredTaxAssetsLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,285</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90d4324b-4279-4e38-b57d-8050e688d3a0" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredTaxAssetsDeferredIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,315</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4d39d083-4ffa-4d56-a134-6ce79055065f" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredTaxAssetsDeferredIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,130</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accruals and reserves, stock and other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1148f447-c36f-472d-aec7-c2fcfea0240b" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredTaxAssetsTaxDeferredExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,350</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b170a74a-2fb6-40f8-ba5c-91ef55dee394" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredTaxAssetsTaxDeferredExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,156</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized Research and Development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_74666ebf-0574-47a3-a70c-efeb1854b283" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,435</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6de0204f-0726-499c-be54-32c16cbc8021" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a9cc296-b879-4de7-84a6-528efa445a19" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">125,847</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b8bc63d-5fd4-4fd5-b319-94a9f0e81da8" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">83,790</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5f7a5c3-c802-482b-85c5-1a98b7404294" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">120,096</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4d01d015-3d28-4bfe-a169-13eae040689e" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">77,990</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_250fae1f-8a56-4dde-86f0-51e742b8713e" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,751</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9f4b232f-d2b0-437f-b139-80022d95a0fa" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,800</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fixed and intangible assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cbfdf665-b8fa-48c7-806c-5224409997b8" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,187</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6308a0d3-abe5-4f8d-97f9-86ea3497c2d7" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,941</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a784a8d3-e05f-4a6f-a5ed-76f2a442b618" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="kymr:DeferredTaxLiabilitiesRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,564</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bdead8dd-a8f1-4577-bd7e-2c2fd54512b6" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="kymr:DeferredTaxLiabilitiesRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,859</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred tax asset</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4330ca86-81dc-4c14-a08f-69c7234c5140" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7aeadab3-b283-479b-ab2c-2773af94eeb6" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As required by ASC 740, management of the Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets, which are composed principally of NOL carryforwards and research and development credit carryforwards. Management has determined that it is more likely than not that the Company will not recognize the benefits of its federal and state deferred tax assets, and, as a result, a valuation allowance of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_755b92fc-1c39-446d-b863-647be95a6485" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:ValuationAllowancesAndReservesBalance" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">120.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8848236d-f437-4788-80fd-31e606b8e3b2" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:ValuationAllowancesAndReservesBalance" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">78.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million has been established at December 31, 2022 and 2021, respectively. During 2022, the valuation allowance increased by $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f156f24b-e19d-4f6c-bc76-b18ce9e7f380" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">42.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million primarily due to the increase in the Company&#x2019;s NOL during the period.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beginning in 2022, Tax Cuts and Jobs Act (TCJA) amended Section 174 and now requires U.S.-based and non-U.S-based research and experimental (R&amp;E) expenditures to be capitalized and amortized over a period of five or 15 years, respectively, for amounts paid in tax years starting after December 31, 2021. Prior to the TCJA amendment, Section 174 allowed taxpayers to immediately deduct R&amp;E expenditures in the year paid or incurred.   The Company has applied this required change in accounting method beginning in 2022 and the computation may be adjusted pending future IRS guidance.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has incurred NOLs from inception. At December 31, 2022 and 2021, the Company has federal NOL carryforwards of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d7abf093-7371-46b5-8d61-1af7d2c76d7c" contextRef="C_706ff543-02d9-48e2-ab79-2493d3f2d922" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">153.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6ab4c74a-d022-411b-9ec7-a63039f999e5" contextRef="C_da156e8f-4b74-46f4-b36a-d8334d9e178c" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">123.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, and state NOL carryforwards of approximately</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb75f35c-7788-445e-a443-0081e7be4745" contextRef="C_15ff43a4-1a79-4140-833c-62eca307fcca" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">139.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_50825821-22cf-43fb-a961-67c900047c1a" contextRef="C_e29dbbc6-2913-48f5-ae93-32213dc0a589" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">105.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. Of the federal net operating loss carryovers, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6d175ec7-299b-4a8a-826b-00f54e9125db" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="kymr:FederalNetOperatingLossCarryoversNotSubjectToExpiration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">144.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million is not subject to expiration and the remaining federal and state NOLs begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9844ba1b-964a-4f65-aa1e-48d52dffc029" contextRef="C_46a95b63-fac0-4c7e-886b-297fe0b6508c" name="kymr:NetOperatingLossBeginToExpireYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2036</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. These loss carryforwards are subject to review and possible adjustment by the appropriate taxing authorities.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Utilization of net operating loss and research and development credit carryforwards may generally be subject to limitation under Sections 382 and 383 of the Internal Revenue Code due to ownership changes that have occurred previously, or that could occur in the future. These ownership changes may limit the amount of net operating loss and research and development credit carryforwards that can be utilized annually to offset any post-ownership change taxable income and tax, respectively. The latest Section 382 study was performed through December 31, 2022, noting that historic ownership changes have likely occurred. Nonetheless, the Company has determined that as of December 31, 2022 the prospective utilization of all net operating loss and tax credit carryforwards generated from inception through December 31, 2022, and therefore the corresponding Federal and Massachusetts deferred tax assets, should not be restricted by Sections 382 and 383, although ownership changes after December 31, 2022 could impact the Company&#x2019;s ability to utilize these tax attributes in the future.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At December 31, 2022 and 2021 the Company had federal research and development credit carryforwards of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1755e9d8-0dc2-49c7-907c-0c97d1b0c4b3" contextRef="C_5ecfa09f-e84b-4a4a-8989-6581bbb4d5de" name="kymr:ResearchAndDevelopmentCreditCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">12.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_edd56dc7-f997-41d3-9b6d-07b1465273eb" contextRef="C_c2702504-9407-4568-90ec-019c2a2d2ec4" name="kymr:ResearchAndDevelopmentCreditCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">10.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, and state research and development credit carryforwards of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c34b0cf6-d978-4cd0-82d8-dcc42389d9bc" contextRef="C_1f5790c2-3ca6-4592-b151-991462b1693b" name="kymr:ResearchAndDevelopmentCreditCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">6.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d480e11e-4704-4f9c-8519-b322be788727" contextRef="C_d71a034f-8114-4bbc-b37a-9706f02f0795" name="kymr:ResearchAndDevelopmentCreditCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. These carryforwards begin to expire in 2031.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company follows the provisions of ASC 740-10, &#x201c;Accounting for Uncertainty in Income Taxes,&#x201d; which specifies how tax benefits for uncertain tax positions are to be recognized, measured, and recorded in financial statements; requires certain disclosures of uncertain tax matters; specifies how reserves for uncertain tax positions should be classified on the balance sheet; and provides transition and interim period guidance, among other provisions. As of December 31, 2022, and 2020, the Company has not recorded any amounts for uncertain tax positions. The Company&#x2019;s policy is to recognize interest and penalties accrued on any uncertain tax positions as a component of income tax expense, if any, in its statements of income. As of December 31, 2022 and 2021, the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_19569389-f934-4671-9307-2583716224ea" contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_707f1476-b8f6-431f-80d4-0431b8a9519d" contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reserves for uncertain tax positions. For the years ended December 31, 2022 and 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_420e5f67-76cb-4a99-b2d6-2b618a5e8b69" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_b4769a13-5efa-482a-8890-48ee5177a9db" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> estimated interest or penalties were recognized on uncertain tax positions.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has not conducted a study of its research and development credit carryforwards. This study may result in an adjustment to research and development credit carryforwards; however, until a study is completed, and any adjustment is known, no amounts are being presented as an uncertain tax position. A full valuation allowance has been provided against the Company&#x2019;s research and development credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the balance sheets or statements of operations if an adjustment were required.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company's tax returns for the years ended</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> December 31, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2dca4dfe-4b7a-456c-bb1e-85444d57220b" contextRef="C_3d0188f0-21c7-4f50-b44d-994dd494ed83" name="us-gaap:OpenTaxYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2019</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to December 31, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_bdad85f0-7bbc-4132-8203-4d060855b091" contextRef="C_7a1721f2-1cc5-4103-bee4-aae009ac5e28" name="us-gaap:OpenTaxYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> remain open and subject to examination by the Internal Revenue Service and state taxing authorities.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_0049115f-e844-4bd9-b0f1-ab0c16e5d212" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 14. Net Loss per Share</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net Loss per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic and diluted loss per share is computed by dividing net loss by the weighted-average common shares outstanding for the period, including the pre-funded warrants given their nominal exercise price (in thousands, except for share and per share data):</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_24c6ab7f-6faa-4f1a-9c90-dac4d0f357e7" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;">&#160;</p>
      <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:56.524%;"></td>
        <td style="width:1.385%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.662%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.375%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.652000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.375%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.652000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.375%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9e5efd74-f7d7-45b0-8b95-859e94af3f95" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">154,808</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2ca4154b-8e4c-44cd-90c4-2e8a1d9b1409" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">100,217</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cc7a3bca-e96f-469b-90a1-3dccbfea109b" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">45,593</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deemed dividend from exchange of convertible<br />&#160;&#160;&#160;preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f1966a96-ccc3-4951-9d5e-bc962831a1e3" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:TemporaryEquityDividendsAdjustment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7116b64b-5b67-49f1-843c-142c80e17359" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:TemporaryEquityDividendsAdjustment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_46b078b3-6127-4d7b-b6a8-3d3bd8152ac5" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:TemporaryEquityDividendsAdjustment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,050</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss attributable to common stockholders</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fad8a508-eb33-4574-9922-4a71a4602aca" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">154,808</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d9340975-23a2-4b65-9e85-b124ddf74827" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">100,217</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_708b74c3-e4ff-4a67-9d56-3e64807fe3c4" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">54,643</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Denominator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average common shares outstanding, basic<br />&#160;&#160;&#160;and diluted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bede1706-e543-4c8b-8d8c-6bf57763a136" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_68d17092-676f-478c-9091-bb42e8016b58" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">53,933,229</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e71aaece-cc06-464d-ba93-e8854d6f602b" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_c2746def-758a-43aa-b07d-46e1c40f5703" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">47,989,023</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_31c4a46c-788a-4c92-852e-1acca1170820" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_cd18809c-9a04-4bca-8b85-675c4270cf84" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">17,349,582</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e7db484b-39d4-4566-8d37-2b65eeae02e7" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_57726b23-af45-4480-a93d-f13040936b84" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">2.87</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5873a8c4-97b1-4c6a-a1f0-4ca0f481089c" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_a4e71e49-daab-43ae-9874-476b776fdfc9" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">2.09</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c5ad7141-643a-4b24-b72f-10cf690dc119" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_653c87e8-8f38-4718-9160-8580c310cd2e" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">3.15</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s potentially dilutive securities, which include convertible preferred stock, restricted stock, and stock options, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_03e8b339-e2fe-47c3-a35d-e4a64a18cd36" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true" continuedAt="F_03e8b339-e2fe-47c3-a35d-e4a64a18cd36_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders at December 31, 2022, 2021 and 2020 because including them would have had an anti-dilutive effect:</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_03e8b339-e2fe-47c3-a35d-e4a64a18cd36_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:57.826%;"></td>
        <td style="width:1.014%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.541%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.024%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.541%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.024%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.622%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.409%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested Restricted Stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_795d10f1-39cb-482e-a2ed-148c088ced2f" contextRef="C_945eb7b7-5b44-4a38-ac68-221560bd90c3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">281,843</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3c2b876d-ccda-4f30-8342-fdce9540b739" contextRef="C_322d6f2f-d9c6-4dde-bd2a-00b4fe2d9953" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">37,745</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8cd54650-801f-4394-8211-dea25a7d6df4" contextRef="C_bc0e09ba-86f9-40ac-bd79-7819763b03d9" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">110,104</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options to purchase Common Stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_feeed76c-3995-4a2e-97b1-8772bdf471bf" contextRef="C_835ed024-44c8-4f1f-8d6e-765f4caca866" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">6,757,289</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ea5866c1-5930-4b44-815a-57f921f44b0c" contextRef="C_7ce88c48-9db3-4967-b6cf-209b8a85b29a" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">6,239,182</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5a5b7ec0-c27f-465d-91fe-45e390a1c4a0" contextRef="C_b71771ba-3d9c-4451-8eb3-75b4fdf5da6f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,580,924</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3ad2b9d1-2ba7-4bd4-a6ba-219f61fedbb8" contextRef="C_e797a856-6bbd-4491-93c3-86302e550709" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">7,039,132</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f77ff08-166c-478e-8231-ca727a3b12e4" contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">6,276,927</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b52c0307-69ea-4b79-a660-e10a84782abe" contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,691,028</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9. Changes in and Disagreements With Acco</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">untants on Accounting and Financial Disclosure.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9A. Controls</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and Procedures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Management&#x2019;s Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain &#x201c;disclosure controls and procedures,&#x201d; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the SEC&#x2019;s rules and forms and (2) accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their control objectives.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our management, with the participation of our Chief Executive Officer, who serves as our principal executive officer, and our Chief Financial Officer, who serves as our principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2022, the end of the period covered by this Annual Report on Form 10-K. Based upon such evaluation, our chief executive officer and chief financial officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of such date.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Management&#x2019;s Report on Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act as a process designed by, or under the supervision of, a company&#x2019;s principal executive officer and principal financial officer, or persons performing similar functions, and effected by a company&#x2019;s board of directors, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of a company&#x2019;s assets;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that a company&#x2019;s receipts and expenditures are being made only in accordance with authorizations of the company&#x2019;s management and directors; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the supervision of and with the participation of our principal executive officer and principal financial officer, our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2022 based on the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control&#x2014;Integrated Framework (2013 framework). Based on this assessment, management concluded that our internal control over financial reporting was effective as of December 31, 2022.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our independent registered public accounting firm has issued an attestation report of our internal control over financial reporting.  This report appears below.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Report of</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Independent Registered Public Accounting Firm</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the Stockholders and the Board of Directors of Kymera Therapeutics, Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opinion on Internal Control over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have audited Kymera Therapeutics, Inc.&#x2019;s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control&#x2014;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Kymera Therapeutics, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on the COSO criteria.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive loss, convertible preferred stock and stockholders&#x2019; equity (deficit) and cash flows for each of the three years in the period ended December 31, 2022, and the related notes and our report dated February 23, 2023 expressed an unqualified opinion thereon.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#x2019;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#x2019;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Definition and Limitations of Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A company&#x2019;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#x2019;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#x2019;s assets that could have a material effect on the financial statements.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> /s/ Ernst &amp; Young LLP</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Boston, Massachusetts</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the three months ended December 31, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9B. Other</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Information.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_9c_disclosure_regarding_foreign"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART III</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_10_directors_executive_ficers_corpo"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 10. Directors, Executive Off</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">icers and Corporate Governance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 10 will be included in our definitive proxy statement to be filed with the SEC with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 11. Executiv</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">e Compensation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 11 will be included in our definitive proxy statement to be filed with the SEC with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_12_security_ownership_certain_benef"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 12. Security Ownership of Certain Beneficial Own</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ers and Management and Related Stockholder Matters.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 12 will be included in our definitive proxy statement to be filed with the SEC with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_13_certain_relationships_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 13. Certain Relationships and Related </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transactions, and Director Independence.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 13 will be included in our definitive proxy statement to be filed with the SEC with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;" id="item_14_principal_accounting_fees_servic"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 14. Principal Accoun</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ting Fees and Services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 14 will be included in our definitive proxy statement to be filed with the SEC with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART IV</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 15. Exhibits, Financi</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">al Statement Schedules.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(a)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Statements </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For a list of the consolidated financial statements included herein, see Index to the Consolidated Financial Statements on page F-1 of this Annual Report on Form 10-K, which is incorporated into this Item by reference.</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:18.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(b)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Exhibits</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.185%;"></td>
    <td style="width:1.478%;"></td>
    <td style="width:90.337%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;3.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1815442/000119312520229873/d45025dex31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fourth Amended and Restated Certificate of Incorporation of Kymera Therapeutics, Inc. (Incorporated by reference to Exhibit 3.1 to the Registrant&#x2019;s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 25, 2020).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;3.2</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1815442/000119312520229873/d45025dex32.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amended and Restated Bylaws of Kymera Therapeutics, Inc. (Incorporated by reference to Exhibit 3.2 to the Registrant&#x2019;s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 25, 2020).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1773427/000114420419040443/tv525698_ex4-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specimen Common Stock Certificate (Incorporated by reference to Exhibit 4.1 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-240264) filed with the Securities and Exchange Commission on August 17, 2020).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.2</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1815442/000119312520206645/d940105dex42.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amended and Restated Investors&#x2019; Rights Agreement among the Registrant and certain of its stockholders, effective as of March 11, 2020 (Incorporated by reference to Exhibit 4.2 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-240264) filed with the Securities and Exchange Commission on July 31, 2020).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.3</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1815442/000156459021012240/kymr-ex43_735.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Securities (Incorporated by reference to Exhibit 4.3 to the Registrant&#x2019;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 11, 2021).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.4</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1815442/000119312522224656/d247240dex41.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Pre-Funded Warrant (Incorporated by reference to Exhibit 4.1 to the Registrant&#x2019;s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 19, 2022).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001815442/000119312520206645/d940105dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2018 Stock Option and Grant Plan, and form of award agreements thereunder (Incorporated by reference to Exhibit 10.1 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-240264) filed with the Securities and Exchange Commission on July 31, 2020).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001815442/000119312520221618/d940105dex102.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020 Stock Option and Incentive Plan, and form of award agreements thereunder (Incorporated by reference to Exhibit 10.2 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-240264) filed with the Securities and Exchange Commission on August 17, 2020).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kymr-ex10_3.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated Non-Employee Director Compensation Policy dated January 17, 2022.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.4#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001815442/000119312520218412/d940105dex104.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Senior Executive Cash Incentive Bonus Plan (Incorporated by reference to Exhibit 10.4 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-240264) filed with the Securities and Exchange Commission on August 13, 2020).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001815442/000156459020050872/kymr-ex101_540.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated 2020 Employee Stock Purchase Plan (Incorporated by reference to Exhibit 10.1 to the Registrant&#x2019;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2020).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001815442/000119312520221618/d940105dex106.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Incorporated by reference to Exhibit 10.6 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-240264) filed with the Securities and Exchange Commission on August 17, 2020).</span></a><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.7</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001815442/000119312520206645/d940105dex108.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease between the Registrant and Arsenal Yards Holding LLC, dated as of August 15, 2019 (Incorporated by reference to Exhibit 10.8 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-240264) filed with the Securities and Exchange Commission on July 31, 2020).</span></a></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">136</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.185%;"></td>
    <td style="width:1.478%;"></td>
    <td style="width:90.337%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001815442/000119312520218412/d940105dex109.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Amended and Restated Employment Agreement (Incorporated by reference to Exhibit 10.9 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-240264) filed with the Securities and Exchange Commission on August 13, 2020).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.9&#134;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1815442/000119312520206645/d940105dex1011.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Master Collaboration Agreement between the Registrant and Vertex Pharmaceuticals Incorporated, dated as of May 9, 2019 (Incorporated by reference to Exhibit 10.11 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-240264) filed with the Securities and Exchange Commission on July 31, 2020).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.10&#134;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kymr-ex10_10.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated Collaboration and License Agreement between the Registrant and Genzyme Corporation, dated as of November 15, 2022.<br /><br /></span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.11</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001815442/000156459020050872/kymr-ex103_542.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Amendment to Master Collaboration Agreement between the Registrant and Vertex Pharmaceuticals Incorporated, dated as of August 27, 2020 (Incorporated by reference to Exhibit 10.3 to the Registrant&#x2019;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2020).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.12&#134;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kymr-ex10_12.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amendment to Master Collaboration Agreement between the Registrant and Vertex Pharmaceuticals Incorporated, dated as of October 21, 2021.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.13</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kymr-ex10_13.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease between the Registrant and ARE-MA REGION NO. 75, LLC dated as of December 20, 2021.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.14</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1815442/000119312522224656/d247240dex101.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Purchase Agreement, dated August 18, 2022, by and among the Registrant and the persons party thereto (Incorporated by reference to Exhibit 10.1 to the Registrant&#x2019;s Current Report on form 8-K filed with the Securities and Exchange Commission on August 19, 2022).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.15</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1815442/000119312522224656/d247240dex102.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Rights Agreement, dated August 18, 2022, by and among the Registrant and the persons party thereto (Incorporated by reference to Exhibit 10.2 to the Registrant&#x2019;s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 19, 2022).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kymr-ex21_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">List of Subsidiaries of Registrant.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kymr-ex23_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consent of Ernst &amp; Young LLP, independent registered public accounting firm.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Power of Attorney (included on signature page to this Annual Report on Form 10-K).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kymr-ex31_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.2</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kymr-ex31_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;text-decoration:line-through;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kymr-ex32_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;text-decoration:line-through;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="kymr-ex32_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.INS</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Instance Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.SCH</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.CAL</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.DEF</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.LAB</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.PRE</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101).</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:73.333%;text-align:justify;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:73.333%;text-align:justify;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">+ </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This certification will not be deemed &#x201c;filed&#x201d; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, except to the extent specifically incorporated by reference into such filing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"># Indicates a management contract or any compensatory plan, contract or arrangement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#134; Portions of this exhibit (indicated by asterisks) were omitted in accordance with the rules of the Securities and Exchange Commission.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">137</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:18.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statement Schedules</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No financial statements have been submitted because they are not required or are not applicable or because the information required is included in the consolidated financial statements or the notes thereto.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_16_form_10k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 16. Form </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K Summary</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not Applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">138</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:5.0%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:42.996%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Therapeutics, Inc.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: February 23, 2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Nello Mainolfi, Ph.D.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nello Mainolfi, Ph.D</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President and Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each person whose individual signature appears below hereby constitutes and appoints Nello Mainolfi, Ph.D. and Bruce Jacobs, CFA, MBA and each of them, with full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:32.996%;"></td>
    <td style="width:1.042%;"></td>
    <td style="width:43.304%;"></td>
    <td style="width:1.042%;"></td>
    <td style="width:21.617%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Nello Mainolfi, Ph.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President and Chief Executive Officer</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nello Mainolfi, Ph.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;(Principal Executive Officer)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Bruce Jacobs, CFA, MBA</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bruce Jacobs, CFA, MBA</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;(Principal Financial and Accounting Officer)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Bruce Booth, DPhil</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chair of the Board of Directors</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bruce Booth, DPhil</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Jeff Albers, MBA</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jeff Albers, MBA</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Pamela Esposito, PhD</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pamela Esposito, PhD</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Joanna Horobin, MB, ChB</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joanna Horobin, MB, ChB</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Gorjan Hrustanovic, PhD</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gorjan Hrustanovic, PhD</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ John M. Maraganore, PhD</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">John M. Maraganore, PhD</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Leigh Morgan</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leigh Morgan</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Elena, Ridloff, CFA</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Elena Ridloff, CFA</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Victor Sandor</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Victor Sandor</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">139</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>2
<FILENAME>kymr-ex10_3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMENDED AND RESTATED</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NON-EMPLOYEE DIRECTOR COMPENSATION POLICY</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The purpose of this Non-Employee Director Compensation Policy (the &#x201c;Policy&#x201d;) of Kymera Therapeutics, Inc. (the &#x201c;Company&#x201d;) is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high-caliber directors who are not employees or officers of the Company or its subsidiary (&#x201c;Outside Directors&#x201d;). This Policy will become effective as of the effective time of the registration statement for the Company&#x2019;s initial public offering of equity securities (the &#x201c;Effective Date&#x201d;). In furtherance of the purpose stated above, all Outside Directors shall be paid compensation for services provided to the Company as set forth below:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash Retainers</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annual Retainer for Board Membership</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: $40,000 for general availability and participation in meetings and conference calls of our Board of Directors, to be paid quarterly in arrears, pro-rated based on the number of actual days served by the director during such calendar quarter. No additional compensation will be paid for attending individual meetings of the Board of Directors.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:88.985%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:8.002%;"></td>
    <td style="width:1.004%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional Annual Retainer for Chairperson of the Board:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$30,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:5.75pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional Annual Retainers for Committee Membership:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:5.75pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Audit Committee Chair:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$15,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:5.75pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Audit Committee member:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$7,500</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:5.75pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compensation Committee Chair:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$10,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:5.75pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compensation Committee member:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$5,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:5.75pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nominating and Corporate Governance Committee Chair:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$10,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:5.75pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:1.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nominating and Corporate Governance Committee member:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$5,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.003in;word-break:break-word;white-space:pre-wrap;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chair and committee member retainers are in addition to retainers for members of the Board of Directors. No additional compensation will be paid for attending individual committee meetings of the Board of Directors.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity Retainers</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Award</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: An initial, one-time stock option award (the &#x201c;Initial Award&#x201d;) to purchase 24,000 shares will be granted to each new Outside Director upon his or her election to the Board of Directors, which shall vest in 36 equal monthly installments over three years from the date of grant, provided, however, that all vesting shall cease if the director resigns from the Board of Directors or otherwise ceases to serve as a director of the Company. The Initial Award shall expire ten years from the date of grant, and shall have a per share exercise price equal to the Fair Market Value (as defined in the Company&#x2019;s 2020 Stock Option and Incentive Plan) of the Company&#x2019;s common stock on the date of grant. This Initial Award applies only to Outside Directors who are first elected to the Board of Directors subsequent to the Effective Date.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annual Award</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: On each date of each Annual Meeting of Stockholders of the Company following the Effective Date (the &#x201c;Annual Meeting&#x201d;), each continuing Outside Director, other than a director receiving an Initial Award, will receive an annual stock option award (the &#x201c;Annual Award&#x201d;) to purchase 12,000 shares, which shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the director resigns from the Board of Directors or otherwise ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting. Such Annual Award shall expire ten years from the date of grant, and shall have a per share exercise price equal to the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114548327.2</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Market Value (as defined in the Company&#x2019;s 2020 Stock Option and Incentive Plan) of the Company&#x2019;s common stock on the date of grant.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: For purposes of this Policy, &#x201c;Value&#x201d; means with respect to (i) any stock option award, the grant date fair value of the option (i.e., Black-Scholes Value) determined in accordance with the reasonable assumptions and methodologies employed by the Company for calculating the fair value of options under Financial Accounting Standard Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 718; and (ii) any award of restricted stock or restricted stock units the product of (A) the average closing market price on Nasdaq Global Market (or such other market on which the Company&#x2019;s common stock is then principally listed) of one share of the Company&#x2019;s common stock over the trailing 30-day period ending on the last day of the month immediately prior to the month of the grant date, and (B) the aggregate number of shares of common stock underlying such award.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sale Event Acceleration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: All outstanding Initial Awards and Annual Awards held by an Outside Director shall become fully vested and exercisable upon a Sale Event (as defined in the Company&#x2019;s 2020 Stock Option and Incentive Plan).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expenses</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company will reimburse all reasonable out-of-pocket expenses incurred by non-employee directors in attending meetings of the Board of Directors or any committee thereof.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maximum Annual Compensation</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate amount of compensation, including both equity compensation and cash compensation, paid by the Company to any Outside Director in a calendar year for services as an Outside Director period shall not exceed $750,000; provided, however, that such amount shall be $1,000,000 for the calendar year in which the applicable Outside Director is initially elected or appointed to the Board of Directors; (or such other limits as may be set forth in Section 3(b) of the Company&#x2019;s 2020 Stock Option and Incentive Plan or any similar provision of a successor plan). For this purpose, the &#x201c;amount&#x201d; of equity compensation paid in a calendar year shall be determined based on the grant date fair value thereof, as determined in accordance with FASB ASC Topic 718 or its successor provision, but excluding the impact of estimated forfeitures related to service-based vesting conditions.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adopted August 11, 2020, subject to the effectiveness of the Company&#x2019;s Registration Statement on Form S-1.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated on January 17, 2022.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114548327.2</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>3
<FILENAME>kymr-ex10_10.htm
<DESCRIPTION>EX-10.10
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder identified by the mark &#x201c;[***]&#x201d;.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	AMENDED AND RESTATED	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">COLLABORATION AND LICENSE AGREEMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">BETWEEN</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GENZYME CORPORATION</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AND</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 15, 2022</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TABLE OF CONTENTS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:95.498%;"></td>
    <td style="width:4.502%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 1 DEFINITIONS</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 2 Research</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 3 EARLY DEVELOPMENT</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 4 SANOFI PARTICIPATION ELECTION RIGHT</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 5 DEVELOPMENT AFTER SANOFI PARTICIPATION ELECTION</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 6 Commercialization</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 7 Regulatory Matters</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 8 Manufacturing</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 9 GOVERNANCE</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 10 LICENSE GRANTS; EXCLUSIVITY</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">109</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 11 FINANCIAL PROVISIONS</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 12 INTELLECTUAL PROPERTY</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">144</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 13 REPRESENTATIONS AND WARRANTIES</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">162</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 14 INDEMNIFICATION; INSURANCE; LIMITATIONS</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">169</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 15 TERM; TERMINATION</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">171</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16 CONFIDENTIALITY</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">184</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 17 GOVERNMENTAL APPROVALS</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">188</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 18 MISCELLANEOUS</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">189</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:5.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SCHEDULES AND EXHIBITS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedules</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.16		        Approved Third Party Contractors</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.157	        [***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.167	        Initial Collaboration Target 1 Degrader</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.187 	        [***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.188	        [***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.189	        [***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.193	        [***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.214	        [***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.229	        M2 Criteria</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.259 	        Opt-In Data Package</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.268	        Participation Data Package</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.275	        Patent Resolution Procedures</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.286	        Phase 1 Patient Data Package</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.287 	        Phase 1 Ready Criteria</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.294	        Phase 2 Ready Criteria</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.318 	        Qualified Third Parties</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.367 	        Screening Criteria</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 2.3.1		Research Plan</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1.1(d)	        [***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.2.1		Early Development Plan</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 5.3.1 	        Late Development Plan</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 8.4		        CMOs</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 9.9.2(b)(iii) 	Expert Disputes</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 9.9.2(b)(iv)	Arbitration</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 9.9.2(b)(v)	&#x201c;Baseball&#x201d; Arbitration</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A 	Terms and Conditions of Development Cost Sharing</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B 	Terms and Conditions of Co-Promotion Agreement</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C 	Terms and Conditions of Cost/Profit Sharing Agreement</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit D	Kymera Press Release</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit E	        Sanofi&#x2019;s form of Phase 2 Election Notice</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMENDED AND RESTATED</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">COLLABORATION AND LICENSE AGREEMENT</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Amended and Restated Collaboration and License Agreement (this &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is executed as of November 15, 2022 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restatement Execution Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and is by and between Genzyme Corporation, a corporation organized under the laws of the Commonwealth of Massachusetts (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and Kymera Therapeutics, Inc., a corporation organized under the laws of the State of Delaware (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Sanofi and Kymera each may be referred to herein individually as a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or collectively as the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RECITALS</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHEREAS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera controls certain Patents and Know-How, technology and expertise relating to ubiquitin-mediated protein degradation therapeutics;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHEREAS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Sanofi is a global biopharmaceutical company that has expertise in the development and commercialization of pharmaceutical products;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHEREAS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Parties entered into that certain Collaboration and License Agreement dated as of Original Agreement Execution Date (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Original Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), pursuant to which the Parties established a strategic collaboration focused on the research, development and commercialization of ubiquitin-mediated protein degradation therapeutics Directed Against the Collaboration Targets for use in the applicable Field; and</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHEREAS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Parties now desire to amend and restate the Original Agreement in its entirety and replace the Original Agreement with this Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOW, THEREFORE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, in consideration of the respective covenants, representations, warranties and agreements set forth herein, the Parties hereto agree as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 1<br>DEFINITIONS</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For purposes of this Agreement, the following capitalized terms will have the following meanings:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.1	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A&amp;R FAD Research Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.2	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounting Standards</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a Party or its Affiliate or Sublicensee, GAAP or IFRS, as such Party, Affiliate or Sublicensee uses for its financial reporting obligations, in each case, consistently applied.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.3	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.8.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.4	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquirer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.44</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.5	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquiring Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.8.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.6	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquisition Transaction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.7.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.7	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Actions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.8	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Affiliate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, as of any point in time and for so long as such relationship continues to exist with respect to any Person, any other Person that controls, is controlled by or is under common control with such Person.  A Person will be regarded as in control of another Person if it (a) owns or controls, directly or indirectly, more than fifty percent (50%) of the equity securities of the subject Person entitled to vote in the election of directors (or, in the case of a Person that is not a corporation, for the election of the corresponding managing authority), or (b) possesses, directly or indirectly, the power to direct or cause the direction of the management or policies of such Person (whether through ownership of securities or other ownership interests, by contract or otherwise).</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.9	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in the Preamble.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.10	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alliance Manager</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.12.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.11	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Allocation Methodology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.12	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Allowable Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.13	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annual Net Sales</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.14	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Applicable Law</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all applicable laws, statutes, rules, regulations and other pronouncements having the effect of law of any federal, national, multinational, state, provincial, county, city or other political subdivision, agency or other body, domestic or foreign, including any applicable rules, regulations, guidelines, or other requirements of the Regulatory Authorities that may be in effect from time to time, including the United States Federal Food, Drug, and Cosmetic Act, as amended, GCP, GLP and GMP, anti-bribery laws, such as the United States Anti-Kickback Statute, Foreign Corrupt Practices Act and UK Bribery Act, as well as all applicable data protection and privacy laws, rules and regulations, including the United States Department of Health and Human Services privacy rules under the Health Insurance Portability and Accountability Act, as amended, and the Health Information Technology for Economic and Clinical Health Act and the EU General Data Protection Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC, along with other country-level data protection laws, as may be applicable.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.15	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Approval Application</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an NDA or similar application or submission for a pharmaceutical product to a Regulatory Authority in a country or group of countries to obtain Marketing Approval for such pharmaceutical product in that country or group of countries, including any amendment thereof.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.16	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Approved Third Party Contractors</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) the Third Party contractors set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and (b) any Subcontractor approved by the JRDC (such approval not to be unreasonably withheld, conditioned or delayed by either Party&#x2019;s representatives on the JRDC).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.17	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Arbitrator</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) with respect to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 9.9.2(b)(iv)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an individual who (i) is a qualified attorney in private practice or a retired judge, each admitted to practice law in the United States, with expertise in intellectual property matters in the pharmaceutical or biotechnology industry, (ii) is professionally fluent in English, (iii) is not from academia, (iv) has not worked for or been engaged by either Party or its Affiliates, or any other portfolio companies of its material investors, in the [***] period immediately prior to selection of such individual, or (v) does not own equity or debt in either Party or its Affiliates (other than equity or debt owned through a broad based mutual fund or exchange trade fund) and, (b) with respect to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 9.9.2(b)(v)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, an individual who (i) is a qualified attorney in private practice or a retired judge, each admitted to practice law the United States, with relevant experience in financial disputes pertaining the pharmaceutical products, (ii) is professionally fluent in English, (iii) is not from academia, (iv) has not worked for or been engaged by either Party or its Affiliates, or any other portfolio companies of its material investors, in the [***] period immediately prior to selection of such individual, or (v) does not own equity or debt in either Party or its Affiliates (other than equity or debt owned through a broad based mutual fund or exchange trade fund).</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.18	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Audited Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.19	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auditing Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.20	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Authorized Generic</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an authorized generic version of a Licensed Product that is Manufactured by or on behalf of Sanofi, its Affiliate or its Sublicensee or a Third Party designated by Sanofi or its Affiliate or Sublicensee.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.21	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Degrader Criteria</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.22	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) for Collaboration Target 1, the Backup Degraders for CT1, and (b) for Collaboration Target 2, the Backup Degraders for CT2.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.23	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Degraders for CT1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***]. Notwithstanding the foregoing exclusion, [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.24	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Degraders for CT2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.25	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Research</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.26	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Research Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.27	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Research Budget Excession</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.28	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Research Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.29	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Research Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.30	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balancing Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.31	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bankrupt Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.32	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bankruptcy Code</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.33	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Blocking Third Party Intellectual Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a Collaboration Candidate or Licensed Product in any country, Patents or Know-How in such country owned or controlled by a Third Party (but not then included in Licensed Technology) that [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.34	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Blocking Third Party Intellectual Property Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.35	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Branding Strategy</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.9.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.36	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Breaching Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Party that is believed by the other Party to be in material breach of this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.37	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Business Day</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a day, other than a Saturday or Sunday, on which national banks in each of the following locations are open for commercial banking business:  Paris, France, Boston, Massachusetts, U.S. and Bridgewater, New Jersey, U.S.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.38	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calendar Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.39	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calendar Quarter</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the respective periods of three (3) consecutive calendar months ending on March 31, June 30, September 30 or December 31, during the Term, or the applicable part thereof during the first or last calendar quarter of the Term.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.40	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calendar Year</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any year commencing on January 1 and ending on December 31, or the applicable part thereof during the first or last year of the Term.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.41	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calendar Year Net Sales</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Licensed Product-by-Licensed Product basis, the total Net Sales by Sanofi, its Affiliates and Sublicensees in the Territory of such Licensed Product in a particular Calendar Year.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.42	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CDA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.76</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.43	&#x201c;[***]&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.44	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change of Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a Party, (a) a merger or consolidation of such Party with an Acquirer that results in the voting securities of such Party outstanding immediately prior thereto, or any securities into which such voting securities have been converted or exchanged, ceasing to represent more than fifty percent (50%) of the combined voting power of the surviving entity or the parent of the surviving entity immediately after such merger or consolidation, (b) a transaction or series of related transactions in which an Acquirer, together with its Affiliates, becomes the beneficial owner of more than fifty percent (50%) of the combined voting power of the outstanding securities of such Party, or (c) the sale or other transfer to an Acquirer of all or substantially all of such Party&#x2019;s business to which the subject matter of this Agreement relates.  Notwithstanding the foregoing, with respect to Kymera, the term &#x201c;Change of Control&#x201d; will not include any sale of shares of capital stock of Kymera, in a single transaction or series of related transactions in which Kymera issues new securities to institutional investors for cash or the cancellation or conversion of indebtedness or a combination thereof where such</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">transaction(s) are conducted primarily for </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">bona fide</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> equity financing purposes.  &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquirer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, in the context of a Change of Control, a Third Party or its Affiliates.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.45	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a study in humans that is required to be conducted in accordance with GCP and is designed to generate data in support of an Approval Application.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.46	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CMC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means chemistry, manufacturing and controls.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.47	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CMC Transfer Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 8.1.1(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.48	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CMO</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any Third Party contract manufacturer.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.49	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Commercialization Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.3.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.50	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Commercialization Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Collaboration Target-by-Collaboration Target basis, the [***] comprehensive plan for the Commercialization of the Opt-In Products Directed Against such Collaboration Target in [***], which will include the following:</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.50.1	[***]</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.50.2	[***]</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.50.3	[***]</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.50.4	[***]</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.50.5	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.51	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Promote</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Collaboration Target-by-Collaboration Target basis, with respect to the Opt-In Products Directed Against such Collaboration Target for which Kymera exercises the Kymera Co-Promote Right for such Collaboration Target in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.2.2(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Detailing activities with respect to such Opt-In Products undertaken by or on behalf of either Party in the United States pursuant to the terms set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Promotion</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Promoting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; will have a correlative meaning.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.52	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Promote Opt-Out Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.53	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Promote Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Collaboration Target-by-Collaboration Target basis, the period of time from the Kymera Co-Promote Effective Date (if any) until the termination or expiration of the Co-Promotion Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.54	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Promotion Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.55	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Promotion Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.56	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Promotion Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.57	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Promotion Wind-Down Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.11(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.58	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Candidates</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.59	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Compounds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, (a) for Collaboration Target 1, the Collaboration Target 1 Degraders, and (b) for Collaboration Target 2, the Collaboration Target 2 Degraders.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.60	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration In-License</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.5.1(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.61	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration In-License Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.62	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Collaboration Target 1 or Collaboration Target 2, as the context requires.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.63	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.64	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 1 Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***]. For clarity, the Collaboration Target 1 Degraders exclude [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.65	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.66	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 2 Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) the Initial Collaboration Target 2 Degraders, and (b) the Backup Degraders for CT2.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.67	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Combination Product</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.250(j)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.68	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial Milestone Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.69	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial Milestone Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.70	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercialize</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercializing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, in respect of a Licensed Product, to (a) market, advertise, promote, Detail, distribute, offer for sale, sell, have sold, import, have imported, export, have exported or otherwise exploit, (b) conduct activities, other than Research, Development and Manufacturing, in preparation for the foregoing activities, including obtaining Price Approval or (c) conduct post-Marketing Approval commitments or studies (including Phase 4 Clinical Trials).  When used as a noun, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercialization</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any activities involved in Commercializing.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.71	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercially Reasonable Efforts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.72	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Committee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means each of the JSC and each Subcommittee.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.73	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competing Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.7.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.74	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competing Product</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.7.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.75	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competitive Infringement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.76	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Confidential Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to each Party, all Know-How or other information, including proprietary information (whether or not patentable) regarding or embodying such Party&#x2019;s technology, products, business information or objectives, that is communicated in any way or form by or on behalf of the Disclosing Party to the Receiving Party or its permitted recipients, pursuant to this Agreement or that certain Confidentiality Agreement between Sanofi and Kymera dated July 31, 2018, as amended or restated from time to time (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CDA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), whether or not such Know-How or other information is identified as confidential at the time of disclosure.  For clarity, the Degrader Platform will be the Confidential Information of Kymera.  Notwithstanding the foregoing, Confidential Information does not include any Know-How or information that:  (a) was already known by the Receiving Party (other than under an obligation of confidentiality to the Disclosing Party) at the time of disclosure by or on behalf of the Disclosing Party; (b) was generally available to the public or otherwise part of the public domain at the time of its disclosure to the Receiving Party; (c) became generally available to the public or otherwise part of the public domain after its disclosure to the Receiving Party, other than through any act or omission of the Receiving Party in breach of its obligations under this Agreement; (d) was disclosed to the Receiving Party, other than under an obligation of confidentiality, by a Third Party who had no obligation to the Disclosing Party not to disclose such information to the Receiving Party; or (e) was independently discovered or developed by or on behalf of the Receiving Party without the use of any Confidential Information belonging to the Disclosing Party.  Confidential Information disclosed to the Receiving Party hereunder will not be deemed to fall within the foregoing exceptions merely because broader or related information falls within such exceptions, nor will combinations of elements or principles be considered to fall within the foregoing exceptions merely because individual elements of such combinations fall within such exceptions.  Without limiting the foregoing, and notwithstanding clauses (a), (d) and (e) of the preceding sentence:  [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.77	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Controlled</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means with respect to a Party any Know-How, Patent or Materials, possession of the ability by such Party or its Affiliate (whether by sole or joint ownership, license or otherwise), other than pursuant to this Agreement, to grant, without violating the terms of any agreement with a Third Party, a license, access or other right in, to or under such Know-How, Patent or Materials.  Notwithstanding anything in this Agreement to the contrary, a Party and its Affiliates will be deemed to not Control any Know-How, Patents or Materials that are owned or controlled by a Third Party described in the definition of &#x201c;Change of Control,&#x201d; or such Third Party&#x2019;s Affiliates (other than an Affiliate of such Party prior to the Change of Control), (a) prior to the closing of such Change of Control, except to the extent that any such Know-How, Patents or Materials were developed by such Third Party prior to such Change of Control using or incorporating such Party&#x2019;s or its pre-existing Affiliate&#x2019;s Know-How, Patents or Materials, or (b) after such Change of Control to the extent that such Know-How, Patents or Materials are developed or conceived by such Third Party or its Affiliates (other than such Party) after such Change of Control without using or incorporating such Party&#x2019;s or its pre-existing Affiliate&#x2019;s Know-How, Patents or Materials.  Kymera and its Affiliates will not be deemed to Control any Patents or Know-How licensed to Kymera pursuant to a Potential In-License entered into after the Original Agreement Execution Date unless such Potential In-License becomes a Collaboration In-License Agreement in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 11.5.1(b)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.78	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corrective Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.79	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost/Profit</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Share</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.80	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost/Profit Sharing Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.81	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Counterparty</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.399</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.82	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Covering</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Covers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) as to a compound or product (or [***]) and a Patent, that, in the absence of a license granted under, or ownership of, such Patent, the making, using, selling, offering for sale or importation of such compound or product (or [***]) would infringe such Patent or, as to a pending claim included in such Patent, the making, using, selling, offering for sale or importation of such compound or product (or [***]) would infringe such Patent if such pending claim were to issue in an issued patent without modification, (b) as to Know-How and a Patent, that, in the absence of a license granted under, or ownership of, such Patent, the use or practice of such Know-How would infringe such Patent or, as to a pending claim included in such Patent, the use or practice of such Know-How would infringe such Patent if such pending claim were to issue in an issued patent without modification and (c) as to a compound, product or technology and Know-How, that the exploitation of such compound, product or technology incorporates, uses, employs, embodies, or practices such Know-How.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.83	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CTA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.161</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.84	&#x201c;[***]&#x201d; means, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.85	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Defending Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.86	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.87	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Degrader</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.88	&#x201c;[***]&#x201d; means, [***].  For clarity, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.89	&#x201c;[***]&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(iv)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.90	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Degrader Platform</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Kymera&#x2019;s proprietary Know-How with respect to the identification, development, synthesis, manufacture and optimization of Degraders, including any such proprietary Know-How with respect to [***], together with any and all Patents Controlled by Kymera or its Affiliates that Cover any of the foregoing Know-How; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***].  For clarity, Know-How of Kymera will be considered proprietary if [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.91	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designated Sales Force</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.92	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Detail</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Detailing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to an Opt-In Product in the Field in [***], a person-to-person (including, for clarity, e-details) contact between a sales representative and a physician or other medical professional licensed or authorized to prescribe drugs (including a nurse practitioner or physician assistant with prescribing authority) (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Healthcare Prescriber</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), during which a primary position detail or a secondary position detail is made to</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such person, in each case as measured by each Party&#x2019;s internal recording of such activity in accordance with the Co-Promotion Agreement; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such meeting is consistent with, and in accordance with, the requirements of Applicable Law, Exhibit B and the applicable Co-Promotion Agreement.  For the avoidance of doubt, the following activities will not constitute a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Detail</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;: sample drops; activities conducted at conventions, exhibit booths, speaker meetings or similar gatherings; a delivery of savings cards or coupons without discussion with a Healthcare Prescriber or other office staff member involved in the prescribing or reimbursement of an Opt-In Product; and activities of medical science liaisons and activities conducted by market development specialists, managed care account directors and other personnel not performing person-to-person sales calls or not specifically trained with respect to an Opt-In Product.  The definition of &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Detail</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; may be further refined in the applicable Co-Promotion Agreement.  When used as a verb, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Detail</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Detailing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means to engage in a Detail.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.93	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a Collaboration Compound, Collaboration Candidate or Licensed Product, all (a) non-clinical and pre-clinical research and development activities and optimization completed prior to filing an IND with respect to such Collaboration Compound, Collaboration Candidate or Licensed Product, including animal and toxicology studies (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-Clinical Development</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and (b) clinical and non-clinical research and development activities conducted after filing of an IND with respect to such Collaboration Compound, Collaboration Candidate or Licensed Product, including toxicology, pharmacology test method development and stability testing, process development, formulation development, delivery system development, quality assurance and quality control development, statistical analysis, Clinical Trials (other than Phase 4 Clinical Trials), regulatory affairs, pharmacovigilance, Clinical Trial regulatory activities and obtaining and maintaining Marketing Approval.  When used as a verb, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Develop</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Developing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means to engage in Development.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.94	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.95	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Milestone Events</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.96	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Milestone Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.97	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Different</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; with respect to two (2) Indications means that [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.98	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Directed Against</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a Degrader and a Target, that such Degrader [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.99	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclose</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosed</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, as to a compound or product and a Patent, that, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.100	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosing Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.101	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dispute</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.102	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Distinct Indication</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) with respect to Collaboration Target 1, an Indication with a diagnosed prevalence in humans in [***] of no less [***] and (b) with respect to Collaboration Target 2, an Indication with a diagnosed prevalence in human [***] of no less than [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.103	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Distribution Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.104	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Distributor</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a Person who distributes, markets, and sells Licensed Products in the Territory (with or without packaging rights), in circumstances where the Person purchases its requirements of Products from Sanofi or its Affiliates or Sublicensees pursuant to a written agreement but does not otherwise make any royalty or other payment to Sanofi or its Affiliates with respect to its intellectual property or other proprietary rights.  The term &#x201c;packaging rights&#x201d; in this Section means the right for the Distributor to package and label Licensed Products supplied in unpackaged bulk form into individual ready-for-sale packs.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.105	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Divest</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a Competing Product, the sale, exclusive license or other transfer by the applicable Party and its Affiliates of all of their development and commercialization rights with respect to such Competing Product to a Third Party without the retention or reservation of any development or commercialization obligation, interest or participation rights (other than solely an economic interest or the right to enforce customary terms contained in the relevant agreements effectuating such transaction).</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.106	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Activities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1.1(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.107	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Milestone Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.108	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Milestone Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.109	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.110	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EMA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the European Medicines Agency and any successor entity thereto.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.111	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">European Commission</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the European Commission or any successor entity that is responsible for granting marketing approvals authorizing the sale of pharmaceuticals in the European Union.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.112	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">European Union</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EU</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the European Union and all its then-current member countries but including in any case France, Germany, Italy, Spain and the United Kingdom regardless of whether they are then-current member countries.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.113	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excepted Matter</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.114	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excluded Compounds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.115	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excluded Field</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, solely with respect to Collaboration Target 1, diagnosis, treatment, cure, mitigation or prevention of any diseases, disorders or conditions in Oncology.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.116	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exclusions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.117	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exclusive Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.1.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.118	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Officers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.119	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expert Dispute</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.120	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FAD Permitted Overrun</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.121	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FAD Research Budget Excession</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.122	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FAD Term Extension</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.123	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Falsified Medicine</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.13.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.124	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FD&amp;C Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the United States Federal Food, Drug, and Cosmetic Act, as amended, and the rules and regulations promulgated thereunder.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.125	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the United States Food and Drug Administration and any successor entity thereto.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.126	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Field</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) for Collaboration Target 1, diagnosis, treatment, cure, mitigation or prevention of any diseases, disorders or conditions, excluding the Excluded Field or (b) for Collaboration Target 2, diagnosis, treatment, cure, mitigation or prevention of any diseases, disorders or conditions.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.127	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Final Balancing Report</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.128	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Finance Dispute</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(v)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.129	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Additional Degrader Criteria</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a given Degrader, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.130	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.131	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.132	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.133	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Additional Degrader Research Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.134	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Additional Degrader Research Term&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.135	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Additional Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for Collaboration Target 1 [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.136	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Commercial Sale</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means with respect to a Licensed Product, [***]; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that the following will not constitute a First Commercial Sale:  [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.137	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Force Majeure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a condition, the occurrence and continuation of which is beyond the reasonable control of a Party, including an act of God, governmental acts or</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions, war, civil commotion, labor strike or lock-out, epidemic, pandemic (including, [***]), flood, failure or default of public utilities or common carriers, or destruction of production facilities or materials by fire, earthquake, storm or like catastrophe.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.138	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreground Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.140</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.139	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreground Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.140</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.140	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreground Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) any and all Know-How discovered, developed, invented or created solely by a Party or its Affiliates or Third Parties acting on its or their behalf, or jointly by both Parties or their respective Affiliates or Third Parties acting on their behalf, in each case, in the performance of activities under this Agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreground Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and (b) any and all Patents that Cover any such Know-How described in clause (a) (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreground Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.141	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FTE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***], which number of hours will be pro-rated based on the number of days when used for [***], devoted to or in support of (a) the Research activities, Pre-Clinical Development, Clinical Development, other Development activities or Backup Research that is carried out by one or more qualified scientific or technical employees (excluding Third Party contractors) of a Party or its Affiliates or (b) the Late Development Plan, Manufacturing activities or Commercialization activities that is carried out by one or more qualified scientific or technical employees (excluding Third Party contractors) of a Party or its Affiliates, as applicable.  Notwithstanding the foregoing, the time of a single individual will not account for more than [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.142	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FTE Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for any period, the FTE Rate multiplied by the number of FTEs who perform a specified activity under this Agreement.  FTEs will be pro-rated on a daily basis if necessary.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.143	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FTE Rate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to [***]; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">each such rate will increase or decrease on January 1 of each Calendar Year (starting with January 1, 2021) in accordance with the percentage year-over-year increase or decrease in the Producer Price Index (PPI) for Pharmaceutical and Medicine Manufacturing (NAICS 325400) over the twelve (12)-month period preceding each such January 1.  The FTE Rate includes (a) all wages and salaries, employee benefits, bonus, travel and entertainment, supplies and other direct expenses and (b) indirect allocations, including all general and administrative expenses, human resources, finance, occupancy and depreciation, in each case ((a) and (b)), expended in connection with relevant activities.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.144	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Funding Failure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.145	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GAAP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means United States generally accepted accounting principles, consistently applied.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.146	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GCP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means good clinical practices, which are the then-current standards for Clinical Trials for pharmaceuticals, as set forth in the FD&amp;C Act, ICH Guideline Q7A, or other Applicable Law, and such standards of good clinical practice as are required by the Regulatory Authorities of the European Union and other organizations and governmental authorities in</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">countries for which the applicable Collaboration Compound, Collaboration Candidate or Licensed Product is intended to be Developed, to the extent such standards are not less stringent than United States standards or ICH Guidelines.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.147	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Generic Product</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a particular Licensed Product in a particular country, a product on the market in such country commercialized by any Third Party that is not a Sublicensee and that did not purchase such product in a chain of distribution that included any of Sanofi or its Affiliates or Sublicensees, that (a) is approved by the applicable Regulatory Authority, under any then-existing Applicable Laws pertaining to approval of generic products, which approval is based on all or part of the clinical data referenced in any Regulatory Approval for the Licensed Product or which otherwise relies on the Regulatory Authority&#x2019;s finding of safety or effectiveness for the Licensed Product, or (b) is otherwise recognized as an &#x201c;substitution&#x201d; product by the applicable Regulatory Authority.  For clarity, Authorized Generics will not be classified as Generic Products for purposes of this Agreement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.148	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GLP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the then-current good laboratory practice standards promulgated or endorsed by the FDA as defined in 21 C.F.R. Part 58, or the successor thereto, or comparable regulatory standards in jurisdictions outside of the United States as they may be updated from time to time, to the extent such standards are not less stringent than United States standards.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.149	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GLP Toxicology Study</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a toxicology study of the relationship between dose and its effects on an exposed animal, where the study is to be conducted in accordance with GLP.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.150	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GMP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the then-current Good Manufacturing Practices as specified in Applicable Law, including the United States Code of Federal Regulations, ICH Guideline Q7A, or equivalent laws, rules or regulations of an applicable Regulatory Authority at the time of manufacture.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.151	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Governmental Authority</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any court, agency, department, authority or other instrumentality of any national, state, county, city or other political subdivision, including any relevant Regulatory Authority.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.152	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Healthcare Prescriber</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.91</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.153	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HEOR Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.154	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HSR Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.155	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ICH</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the International Council on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.156	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IFRS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means International Financial Reporting Standards, consistently applied.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.157	[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.158	[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.159	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.160	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In-License Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.161	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IND</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any Investigational New Drug application (including any amendment or supplement thereto) filed with the FDA pursuant to Part 312 of Title 21 of the U.S. Code of Federal Regulations, including any amendments thereto or if applicable, a comparable application or submission filed with a Regulatory Authority outside the U.S. for the investigation of any product in any other country or group of countries (such as a Clinical Trial Application in the EU) (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CTA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.162	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 14.1.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.163	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnifying Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 14.1.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.164	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Independent Third Party Patent Counsel</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an independent Third Party patent counsel (i) with expertise in the relevant matter at issue, (ii) who has not worked for or been engaged by either Party or its Affiliates, or any other portfolio companies of its material investors, in the [***] period immediately prior to selection of such individual, and (iii) who does not own equity or debt in either Party or its Affiliates (other than equity or debt owned through a broad based mutual fund or exchange traded fund).</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.165	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indication</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a specific disease or medical condition in humans that is approved by a Regulatory Authority to be included as a discrete claim (as opposed to a variant or subdivision or subset of a claim) in the labeling of a Licensed Product based on the results of a separate Registrational Study(ies) sufficient to support Marketing Approval of such claim; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, [***].  For clarity, the following will be part of the same Indication:  [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.166	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Balancing Report</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.167	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Collaboration Target 1 Degrader</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.168	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Collaboration Target 2 Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.169	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initiation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initiate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to any Clinical Trial, dosing of the first human subject in such Clinical Trial.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.170	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Insolvency Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.171	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JAMS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the JAMS Comprehensive Arbitration Rules and Procedures.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.172	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JCC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.6.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.173	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JFC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.7.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.174	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JMC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.4.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.175	[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.176	[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.177	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Foreground Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any Foreground Know-How jointly owned by the Parties pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.1.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.178	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Foreground Patent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any Foreground Patent jointly owned by the Parties pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.1.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.179	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Foreground Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all Joint Foreground Know-How and Joint Foreground Patents.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.180	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.181	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JPC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.182	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JRDC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.183	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JSC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.1.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.184	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JTT</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.5.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.185	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all proprietary data, results, pre-clinical and clinical protocols and data from studies and Clinical Trials, chemical structures, chemical sequences, materials, information, inventions, know-how, formulas, trade secrets, techniques, methods, processes, procedures, technology, practices, knowledge and developments, whether or not patentable; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Know-How does not include Patents.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.186	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Knowledge</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to Kymera (i) as of the Original Agreement Execution Date and the Restatement Execution Date, as applicable, the actual knowledge, following reasonable inquiry of Kymera personnel and advisors (including [***] and other external patent counsels as appropriate) that would reasonably be anticipated to have knowledge of the facts relating to the relevant subject matter, of [***], and (ii) as of the Original Agreement Effective Date and during the Term, the actual knowledge, following reasonable inquiry of Kymera personnel and advisors (including internal and external patent counsel) that would reasonably be anticipated to have knowledge of the facts relating to the relevant subject matter, of the Chief Executive Officer, the Chief Financial Officer, and the Chief Medical Officer.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.187	[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.188	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.189	[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.190	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in the Preamble.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.191	[***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.192	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Background Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Collaboration Target-by-Collaboration Target basis, any Know-How, other than Kymera Foreground Know-How or Joint Foreground Know-How, that [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.193	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Background Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Collaboration Target-by-Collaboration Target basis, any Patent (including any further Patent claiming priority thereto), other than [***] that [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.194	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Background Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all Kymera Background Know-How and Kymera Background Patents.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.195	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Co-Promote</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.196	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Co-Promote Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.197	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Co-Promote Right Deadline</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.198	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Co-Promote Right Exercise Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.199	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Co-Promotion Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.200	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Competitor</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.3.1(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.201	[***] means [***].</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.202	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Existing Phase 1 Clinical Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Phase 1 Clinical Trial that is currently being conducted by or on behalf of Kymera for KT-474 under ClinicalTrials.gov Identifier: NCT04772885.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.203	[***] means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.204	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Foreground Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.205	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Foreground Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.206	[***] means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.207	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 14.1.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.208	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Safety Event Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7.6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.209	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera&#x2019;s Nonexclusive Negotiation Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(e)(iv)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.210	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Opt-In Deadline</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.211	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Opt-In Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.212	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Opt-In Exercise Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.213	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Opt-In Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.214	[***] means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.215	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Phase 1 Clinical Trials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Phase 1 Clinical Trials to be conducted by or on behalf of Kymera for the Collaboration Candidates and Licensed Products Directed Against Collaboration Target 1 for the first Indication in Field in the Territory in accordance with the Early Development Plan.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.216	[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.217	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.218	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Late Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.219	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Launch Window</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.220	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LCM Development</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.221	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LCM Development Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.222	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 14.1.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.223	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Licensed Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Kymera Background Know-How, the Kymera Foreground Know-How and Kymera&#x2019;s interest in the Joint Foreground Know-How.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.224	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Licensed Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Kymera Background Patents, the Kymera Foreground Patents and Kymera&#x2019;s interest in the Joint Foreground Patents.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.225	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Licensed</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any pharmaceutical preparation in final form or other product, including any Combination Product, that contains a Collaboration Candidate, in all forms, presentations, strengths, doses and formulations thereof.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.226	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Licensed Product Mark</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.227	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Licensed Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Licensed Patents and Licensed Know-How.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.228	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ligand</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.86</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.229	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">M2 Criteria</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) for Collaboration Target 1, the criteria set forth on part (1) of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.229</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and (b) for Collaboration Target 2, the criteria set forth on part (2) of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.229</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, in each case as may be amended by the JRDC.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.230	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MAD Data Package</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; [***]:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	[***]</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	[***]</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.231	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.232	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Major Indication</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.233	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.234	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacture</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufactured</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means activities directed to making, having made, producing, manufacturing, processing, formulating, filling, finishing, packaging, labeling, quality control testing and quality assurance release, shipping or storage of a Collaboration Compound, Collaboration Candidate or Licensed Product by or on behalf of a Party or its Affiliate or (sub)licensee.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.235	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.236	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market Researcher</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.237	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketing Approval</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a product in a particular country or jurisdiction, all approvals (including approvals resulting from any priority review, breakthrough therapy, accelerated approval or fast track designation, application or submission), licenses, registrations or authorizations necessary for the Commercialization of such product in such country or jurisdiction, including, (a) with respect to the United States, approval of an Approval Application for such product by the FDA and with respect to the European Union, approval of an Approval Application for such product by the European Medicines Agency or the applicable Regulatory Authority in any particular country in the EU, (b) where applicable, Price Approval in such country or jurisdiction, (c) where applicable, pre- and post-approval marketing authorizations (including any prerequisite Manufacturing approval or authorization related thereto), and (d) where applicable, labeling approval.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.238	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Communication</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.239	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Safety Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an event occurring after the Original Agreement Effective Date that is caused by a Licensed Product, or based on objective scientific or clinical evidence, is reasonably likely to be caused by a Licensed Product, and results in [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.240	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Submissions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.241	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all biological materials, chemical compounds and other materials arising out of a Party&#x2019;s activities under this Agreement and (i) provided by such Party to the other Party for use by the other Party or (ii) otherwise provided by a Party for use by the other Party, in each case, to conduct activities pursuant to this Agreement, including Collaboration Compounds, Collaboration Candidates, Clinical Trial samples, cell lines, compounds, lipids, assays, viruses and vectors.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.242	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maturity Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.243	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Medical Affairs Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.244	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Events</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.245	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.246	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MTA Development Studies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.4.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.247	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MTA Research Studies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.8.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.248	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NDA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a new drug application that is submitted to the FDA for marketing approval for a Licensed Product, pursuant to 21 USC &#167; 355.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.249	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net Profits and Net Losses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.250	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net Sales</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a Licensed Product for any period, the aggregate gross amount billed or invoiced by Sanofi, its Affiliates or its or their Sublicensees for the sale of a Licensed Product to Third Parties (including Distributors) in bona fide arm&#x2019;s-length transactions commencing with the First Commercial Sale of such Licensed Product less the following deductions determined in accordance with Accounting Standards as consistently applied from such gross amounts which are actually incurred, allowed, accrued or specifically allocated to the Licensed Product:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the purposes of calculating Net Sales, all Net Sales will be converted into Dollars.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to the above, Net Sales will be calculated in accordance with the standard internal policies and procedures of such Sanofi, its Affiliates or its or their Sublicensees, which must be in accordance with applicable Accounting Standards and applied consistently across their respective businesses.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As used herein, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Combination Product</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***] (such other active ingredients, devices or other items of value described in the foregoing provisos (a) and (b), &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Items</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.251	&#x201c;[***]&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(e)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.252	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Approval Studies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any surveys, registries and Clinical Trials not intended to gain Marketing Approval or any additional labeled Indications, excluding any open label extension studies of a Collaboration Candidate or Licensed Product.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.253	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Bankrupt Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.254	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Breaching Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Party that believes the other Party is in material breach of this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.255	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Defending Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.256	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Disclosing Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16.6.1(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.257	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.258	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Oncology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, the diagnosis, treatment, cure, mitigation or prevention of an Indication characterized by abnormal cellular proliferation, including solid or liquid malignancies (including primary and metastatic tumors), lymphoid and myeloid proliferative disorders (including myelodysplastic syndrome and myelofibrosis), and hematopoietic control or dysregulations.  For clarity, &#x201c;Oncology&#x201d; also includes all cancer immunotherapy and immuno-oncology indications.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.259	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opt-In Data Package</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the data package described on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.259</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.260	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opt-In Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Collaboration Target-by-Collaboration Target basis, the period of time from the Kymera Opt-In Effective Date (if any) until the termination or expiration of the Cost/Profit Sharing Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.261	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opt-In Products</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Collaboration Target-by-Collaboration Target basis, during the Opt-In Period, any and all Collaboration Candidates or Licensed Products Directed Against a given Collaboration Target.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.262	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opt-Out Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.263	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Original Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in the Recitals.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.264	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Original Agreement Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means August 10, 2020.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.265	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Original Agreement Execution Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means July 7, 2020.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.266	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Items</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.250</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.267	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Out-of-Pocket Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a Party, costs and expenses paid by such Party or its Affiliates to Third Parties (or payable to Third Parties and accrued in accordance with Accounting Standards), other than employees of such Party or its Affiliates.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.268	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Participation Data Package</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, (a) with respect to a given Collaboration Target, a data package containing the information set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.268</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> with respect to all Collaboration Candidates and Licensed Products Directed Against such Collaboration Target that exist as of the date of delivery of such Participation Data Package and (b) with respect to Collaboration Target 2, in addition to the information in clause (a), [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.269	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in the Preamble.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.270	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent and Trademark Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.271	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent and Trademark Recoveries</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.272	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent Challenge</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.273	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent Family</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a group of Patents that share any priority relationship.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.274	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent Filing Jurisdictions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.275	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent Resolution Procedures</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means those procedures set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.275</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.276	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the rights and interests in and to issued patents and pending patent applications in any country, jurisdiction or region (including inventor&#x2019;s certificates and utility models), including all provisionals, non-provisionals, substitutions, continuations, continuations-in-part, divisionals, renewals and all patents granted thereon, and all reissues, reexaminations, extensions, confirmations, revalidations, registrations and patents of addition thereof, including patent term extensions and supplementary protection certificates, international patent applications filed under the Patent Cooperation Treaty (PCT) and any foreign equivalents to any of the foregoing.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.277	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patient Assistance Program Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.278	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PDE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.279	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PDE Cost</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.280	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PDE Requirement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.281	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permitted Backup Research Overrun</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.282	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permitted U.S. Budget Overrun</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.283	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Person</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an individual, sole proprietorship, partnership, limited partnership, limited liability partnership, corporation, limited liability company, business trust, joint stock company, trust, incorporated association, joint venture or similar entity or organization, including a government or political subdivision or department or agency of a government.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.284	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pharmacovigilance Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7.6.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.285	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 1 Clinical Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any Clinical Trial as described in 21 C.F.R. &#167;312.21(a), or, with respect to a jurisdiction other than the United States, a similar Clinical Trial; [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.286	&#x201c;Phase 1 Patient Data Package&#x201d; [***]</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:19.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	[***] (such patients, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining Patients</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;):</font></p>
  <p style="margin-left:19.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.287	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 1 Ready Criteria</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for Collaboration Target 2, the criteria applicable to a Licensed Product Directed Against Collaboration Target 2, as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.286</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as may be discussed by the JRDC and amended by the JSC in accordance with this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.288	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 Activities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in Section 3.1.1(f).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.289	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 Clinical Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means: either (a) a Phase 2a Clinical Trial, (b) a Phase 2b Clinical Trial or (c) any other Clinical Trial as described in 21 C.F.R. &#167;312.21(b), or, with respect to a jurisdiction other than the United States, a similar Clinical Trial.  [***].</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.290	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2a Clinical Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.291	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2b Clinical Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.292	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1.1(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.293	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 Protocol</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1.1(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.294	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 Ready Criteria</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for Collaboration Target 1, the criteria applicable to a Licensed Product Directed Against Collaboration Target 1, as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.294</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as may be discussed by the JRDC and amended by the JSC in accordance with this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.295	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 Trigger Point</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in Section 1.403.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.296	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 3 Clinical Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any Clinical Trial as described in 21 C.F.R. &#167;312.21(c), or, with respect to a jurisdiction other than the United States, a similar Clinical Trial.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.297	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 4 Clinical Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any (i) Clinical Trial of a product conducted in accordance with ICH and local standards, which is not required for receipt of Marketing Approval in the United States and which is principally intended to support the marketing and Commercialization of a product, including any investigator or institution initiated trial, or clinical experience trial, study conducted to fulfill local commitments made as a condition of any Marketing Approval and (ii) health and economic outcomes research and other reviews/analyses/studies relating to value and access issues.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.298	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PIR</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.299	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Platform Foreground Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.1.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.300	&#x201c;[***]&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.1.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.301	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Platform Foreground Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.1.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.302	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Platform In-License</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.5.1(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.303	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PMDA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Pharmaceuticals and Medical Devices Agency and any successor entity thereto.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.304	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-POC Milestone Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.305	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-POC Milestone Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.306	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Potential In-License</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.5.1(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.307	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-Clinical Development</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.93</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.308	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-Clinical and SAD/MAD Data Package</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.309	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-Existing Restriction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.310	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestone Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.311	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestone Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.312	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preexisting Affiliate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a Party that is subject to a Change of Control, any Affiliate of such Party following such Change of Control that was an Affiliate of such Party prior to such Change of Control.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.313	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Price Approval</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, in any country where a Governmental Authority authorizes reimbursement for, or approves or determines pricing for, pharmaceutical products, receipt (or, if required to make such authorization, approval or determination effective, publication) of any government approval, agreement determination or decision establishing such reimbursement authorization or pricing approval or determination.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.314	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeding</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any action, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), prosecution, contest, hearing, inquiry, inquest, audit, examination or investigation that is, has been or may in the future be commenced, brought, conducted or heard at law or in equity or before any Governmental Authority, excluding all administrative proceedings before any patent office.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.315	&#x201c;[***]&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.316	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Promotional Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.317	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prosecution and Maintenance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prosecute and Maintain</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with regard to a Patent, the preparing, filing, prosecuting and maintenance of such Patent, as well as handling re-examinations and reissues with respect to such Patent, together with the conduct of interferences, derivation proceedings, pre- and post-grant opposition proceedings, post-grant patent proceedings (such as inter partes review and post grant review) and other similar proceedings with respect to the particular Patent. For clarification, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prosecution and Maintenance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prosecute and Maintain</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; will not include any enforcement actions taken with respect to a Patent.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.318	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Qualified Third Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Third Parties set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.318</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.319	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">R&amp;D Expert</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an individual with sufficient experience for the relevant matter at issue, who (i) has both relevant scientific and business expertise in the research and development of human therapeutic products (and more specifically, if relevant to the matter at issue and if available, expertise in ubiquitin-mediated protein degradation therapeutics), (ii) has not worked for or been engaged by either Party or its Affiliates in the [***] period immediately prior to selection of such individual, and (iii) does not own equity or debt in either Party or its Affiliates (other than equity or debt owned through a broad based mutual fund or exchange trade fund).</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.320	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Receiving Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.321	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrational Study</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a Clinical Trial that is intended to establish that a product is safe and efficacious for its intended use in the target population, and to determine warnings, precautions, and adverse reactions that may be associated with such pharmaceutical product in the dosage range to be prescribed, which clinical trial is a registration trial intended to enable submission of an Approval Application for such product, as and to the extent defined for the United States in 21 C.F.R. &#167; 312.21(c) or 21 C.F.R. Part 314 Subpart H, or its successor regulations, or, with respect to a jurisdiction other than the United States, a similar Clinical Trial.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.322	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Authority</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a country in the Territory, any national (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">e.g.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the FDA), supra-national (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">e.g.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the European Commission, the Council of the European Union, or the EMA), regional, state or local regulatory agency, department, bureau, board, commission, council or other Governmental Authority that holds responsibility for development, commercialization or manufacturing of, and the granting of Marketing Approval for a pharmaceutical product in such country or region.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.323	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Exclusivity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a Licensed Product in a country, any data exclusivity rights, market exclusivity rights, or other exclusive right, other than a Patent, granted, conferred or afforded by any Regulatory Authority in such country or otherwise under Applicable Law with respect to such Licensed Product in such country, which either confers exclusive marketing rights with respect to a product or prevents another party from using or otherwise relying on the data supporting the approval of the Marketing Approval for a product without the prior written authorization of the Marketing Approval holder, as applicable, such as new chemical entity exclusivity, exclusivity associated with new Clinical Trials necessary to approval of a change (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">e.g.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, new indication or use), orphan drug exclusivity, non-patent-related pediatric exclusivity, or any other applicable marketing or data exclusivity, including any such periods under national implementations in the EU of Article 10 of Directive 2001/83/EC, Article 14(11) of Parliament and Council Regulation (EC) No 726/2004, Parliament and Council Regulation (EC) No 141/2000 on orphan medicines, Parliament and Council Regulation (EC) No 1901/2006 on medicinal products for pediatric use and all international equivalents.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.324	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.325	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Filings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, collectively:  (a) all INDs, Approval Applications, establishment license applications, Drug Master Files, applications for designation (including as</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an &#x201c;Orphan Product(s)&#x201d; under the Orphan Drug Act, for &#x201c;Fast Track&#x201d; status under Section 506 of the FD&amp;C Act (21 U.S.C. &#167; 356) or for a Special Protocol Assessment under Section 505(b)(4)(B) and (C) of the FD&amp;C Act (21 U.S.C. &#167; 355(b)(4)(B))) and all other similar filings (including counterparts of any of the foregoing in any country or region in the Territory); (b) any applications for Marketing Approval or Price Approval and other applications, filings, dossiers or similar documents submitted to a Regulatory Authority in any country for the purpose of obtaining Marketing Approval or Price Approval from that Regulatory Authority; (c) any Patent-related filings with any Regulatory Authority; (d) all supplements and amendments to any of the foregoing and submissions made related to any of the foregoing; (e) all documents referenced in the complete regulatory chronology for each Marketing Approval; (f) confirmed meeting requests and meeting minutes; (g) foreign equivalents of any of the foregoing; and (h) all data and other information contained in, and correspondence with any Regulatory Authority relating to, any of the foregoing.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.326	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Lead</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, unless otherwise agreed by the Parties: [***] on a Collaboration Target-by-Collaboration Target basis, during the Sanofi Participation Term with respect to such Collaboration Target (if any), Sanofi for all Collaboration Candidates and Licensed Products Directed Against such Collaboration Target.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.327	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining Patient Data Package</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:&#x201d; [***]</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.328	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining Patients</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; as the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.286(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.329	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reporting Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) a reporting company under the United States Securities and Exchange Act of 1934, or (b) a company that has publicly filed with the Securities and Exchange Commission, and has not withdrawn, a Form S-1.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.330	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means conducting research activities to discover, design, optimize, deliver and advance Collaboration Compounds, Collaboration Candidates or Licensed Products, but (a) specifically excluding Development, Manufacture and Commercialization, and (b) [***].  When used as a verb, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Researching</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means to engage in Research.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.331	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.332	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Collaboration Target-by-Collaboration Target basis, the period commencing on the Original Agreement Effective Date and ending upon the earliest to occur of (i) the Sanofi Participation Election Deadline without Sanofi&#x2019;s exercise of the Sanofi Participation Election Right with respect to such Collaboration Target, (ii) the Sanofi Participation Election Effective Date with respect to such Collaboration Target, or (iii) the effective date of termination of this Agreement (with respect to such Collaboration Target or in its entirety). For the avoidance of doubt, (a) the expiration of the Research Term pursuant to clause (ii) shall not result in the expiration of the First Additional Degrader Research Term or Second Additional Degrader Research Term, which shall only expire in accordance with the terms thereof, and (b) the expiration of the Research Term with respect to Collaboration Target 1 pursuant to clause (i) or (iii) of this definition shall result in the contemporaneously expiration of both the First Additional Degrader Research Term and the Second Additional Degrader Research Term on such the effective date of expiration of the Research Term.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.333	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rest of World</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.334	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restatement Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 17.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.335	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restatement Execution Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in the Preamble.</font></p>
  <p style="margin-left:0.667%;text-indent:5.879%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.336	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reversion Compound Data</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any data that is generated by or on behalf of the Parties under this Agreement for any Reversion Compounds.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.337	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reversion Compounds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.6.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.338	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reversion Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.6.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.339	&#x201c;[***]&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(e)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.340	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Licensed Product-by-Licensed Product and country-by-country basis, the period commencing on the First Commercial Sale of such Licensed Product in such country and ending upon the latest of:  (a) the date on which the use or sale of such Licensed Product is no longer Covered by a Valid Claim of [***] that Cover [***]; (b) the [***] of the First Commercial Sale of such Licensed Product in such country; or (c) expiration of Regulatory Exclusivity in such country with respect to such Licensed Product.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.341	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SAD Permitted Overrun</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.342	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SAD Research Budget Excession</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.343	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SAD Term Commencement Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.344	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SAD Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(f)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.345	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Safety Concern</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to any compound or product, (a) any safety concern required to be reported under 21 C.F.R. &#167; 312.32 if an IND with respect to such product was open at the time of the observation (or that would be so reportable to a Regulatory Authority if an IND was not open at such time), or (b) a toxicity or drug safety issue or a Serious Adverse Event reasonably related to or observed in connection with development or commercialization activities with respect to a product, as determined by (i) prior to a Sanofi Participation Election Effective Date (if any), either Party, in accordance with its standard operating procedures and (ii) on or after a Sanofi Participation Election Effective Date (if any), Sanofi, in accordance with its standard operating procedures.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.346	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Safety Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.347	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales and Marketing Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.348	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in the Preamble.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.349	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Background Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Collaboration Target-by-Collaboration Target basis, [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.350	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Background Patent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Collaboration Target-by-Collaboration Target basis, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.351	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Background Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Sanofi Background Know-How and the Sanofi Background Patents.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.352	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Foreground Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.353	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Foreground Patent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.354	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Foreground Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all Sanofi Foreground Know-How and Sanofi Foreground Patents.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.355	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 14.1.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.356	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Safety Event Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7.6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.357	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Election Deadline</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.358	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.359	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Election Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.360	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Election Right Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.361	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Election Right Exercise Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.362	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, on a Collaboration Target-by-Collaboration Target basis, the period commencing on the Sanofi Participation Election Effective Date (if any) with respect to such Collaboration Target and ending upon the effective date of expiration or termination of this Agreement with respect to such Collaboration Target.  On a Collaboration Target-by-Collaboration Target basis, the Backup Research Term (if any) for a given Collaboration Target will be considered part of the applicable Sanofi Participation Term for such Collaboration Target.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.363	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Phase 2 Election Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a written notice delivered by Sanofi by Kymera in the format set forth on Exhibit E.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.364	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Reversion Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a Terminated Target, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.365	&#x201c;S</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">anofi Safety Review Committee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.366	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Sanofi Background Technology, the Sanofi Foreground Technology and Sanofi&#x2019;s interest in the Joint Foreground Technology.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.367	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Screening Criteria</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the criteria set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.367</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as may be reviewed and discussed by the JRDC and amended by the JSC.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.368	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Additional Degrader Criteria</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a given Degrader, such Degrader meets all of the following criteria: [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.369	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;Second Additional Degrader Research Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.370	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;Second Additional Degrader Research Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.371	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Additional Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.372	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series 2 Permitted Overrun</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.373	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series 2 Research Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.374	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series 2 Research Budget Excession</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.375	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series 2 Research Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.376	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Serious Adverse Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an adverse drug experience or circumstance that results in any of the following outcomes (a) death, (b) life threatening condition, (c) inpatient hospitalization or a prolongation of existing hospitalization, (d) persistent or significant disability or incapacity or substantial disruption of the ability to conduct normal life functions, (e) or a congenital anomaly/birth defect, (f) significant intervention required to prevent permanent impairment or damage, or (g) a medical event that may not result in death, be life threatening, or require hospitalization but, based on appropriate medical judgment, that may jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the outcomes described in clauses (a) through (f).</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.377	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SOPs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.378	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specifically Claim</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specifically Claims</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, as to a compound, product or [***] and a Patent, that, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.379	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specifically Disclose</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specifically Disclosed</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specifically Discloses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specifically Disclosing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, as to a [***], compound or product and a Patent, that [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.380	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Standard Cost</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.381	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Step-In Activities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.382	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Step-In Triggers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.383	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subcommittee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means JCC, JFC, JMC, JPC, JRDC, JTT and any other subcommittee formed by the JSC in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.1.2(s)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.384	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subcontractor</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a consultant, subcontractor, contract researcher, contract manufacturer, academic researcher or other vendor engaged by a Party to conduct activities on behalf of such Party or its Affiliate under this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.385	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sublicense</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, directly or indirectly, to sublicense, grant any other right with respect to, or agree not to assert, the rights granted to Sanofi hereunder.  When used as a noun, &#x201c;Sublicense&#x201d; means any agreement to Sublicense.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.386	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sublicense Revenues</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.387	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sublicensee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an Affiliate or Third Party, other than a Distributor, to whom Sanofi (or a Sublicensee or Affiliate) sublicenses any of the rights granted to Sanofi hereunder during the Term.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.388	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successful Completion</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, (a) with respect to a Licensed Product containing a First Additional Degrader or Second Additional Degrader, [***], (b) with respect to a Licensed Product Directed Against Collaboration Target 2, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.389	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Target</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a specific protein that is associated with an ENSEMBL GENE ID (as listed in the database available at https://www.genenames.org or any successor website) (together with any and all naturally occurring mutations, variants and alternative sequences thereof).</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.390	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Target Binding Moiety</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 1.86</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.391	[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.392	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.393	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.394	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terminated Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(f)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.395	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terminated Products</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.396	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terminated Target</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any Collaboration Target with respect to which this Agreement has been terminated in accordance with any of the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 15.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 15.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  For clarity, (a) if Sanofi fails to timely exercise the Sanofi Participation Election Right with respect to a Collaboration Target prior to the Sanofi Participation Election Deadline in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, this Agreement will automatically terminate with respect to such Collaboration Target in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and such Collaboration Target will become a Terminated Target and (b) if this Agreement is terminated in its entirety, all Collaboration Targets will be Terminated Targets.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.397	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Territory</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means worldwide.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.398	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any Person other than Sanofi, Kymera or their respective Affiliates.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.399	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Party Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.400	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third-Party Infringement Claim</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.401	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Party Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.402	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trigger End Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, (a) in respect of Collaboration Target 1, [***], and (b) in respect of Collaboration Target 2, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.403	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trigger Point</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) for Collaboration Target 1, [***], and (b) for Collaboration Target 2, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.404	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">United States</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the United States of America and its territories, possessions and districts.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.405	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Budget Excession</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.406	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Development Activities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.3.3(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.407	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Development Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.3.3(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.408	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Development Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.409	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valid Claim</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a claim (a) of any issued, unexpired United States or foreign Patent, which has not, in the country of issuance, been irrevocably donated to the public, disclaimed, held invalid or unenforceable by a court of competent jurisdiction in an unappealed or unappealable decision, or (b) of any United States or foreign patent application, which has not, in the country in question, been finally cancelled, withdrawn, or abandoned; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, for purposes of this clause (b), (i) notwithstanding the foregoing, on a country-by-country basis, a patent application pending beyond the [***] will not be considered to have any Valid Claim for purposes of this Agreement unless and until a patent that meets the criteria set forth in clause (a) above with respect to such application issues, and (ii) a patent application filed after the date of the First Commercial Sale of a Licensed Product in a country will not be included in clause (b) of the definition of Valid Claim for such Licensed Product in such country unless and until (A) a patent that meets the criteria set forth in clause (a) above with respect to such application issues, or (B) Sanofi consents to the filing of such patent application (evidence of such consent may be given to the JPC).</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.410	&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Withholding Action</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 2<br>Research</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Generally</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to the terms and conditions of this Agreement, on a Collaboration Target-by-Collaboration Target basis, during the Research Term, Kymera will be responsible for conducting certain Research activities for the Collaboration Compounds and Collaboration Candidates (but not, for clarity, Excluded Compounds) Directed Against such</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target in the Field (and not, for clarity, in the Excluded Field) in the Territory in accordance with the Research Plan, as further set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior Research</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2.1	The Parties acknowledge that Kymera has performed certain Research Activities with respect to Collaboration Target 1 prior to the Original Agreement Execution Date, and agree that for purposes of this Agreement, [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2.2	Under the Original Agreement, Kymera provided Sanofi (via the JRDC) a list of [***], for discussion by the JRDC.  Kymera will provide a list of [***] to the JRDC at the first JRDC meeting after the Restatement Effective Date.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2.3	[***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.3.1	On a Collaboration Target-by-Collaboration Target basis, during the Research Term, Kymera will conduct the Research activities under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the Collaboration Compounds and Collaboration Candidates Directed Against each Collaboration Target in the Field in accordance with a written plan (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) that includes (a) [***] (b) [***] (c) [***] (d) [***] (e) [***] (f) [***];</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, an updated draft of each such budget will be provided by Kymera every [***]. A copy of the current Research Plan as of the Restatement Execution Date is attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 2.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, [***]. In the event Sanofi provides notice to Kymera under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that Sanofi desires to have Kymera conduct new Research activities with respect to Second Additional Degraders, Kymera will prepare an amendment to the Research Plan to include such new Research Activities no later than [***] from the date of Kymera&#x2019;s receipt of written notice thereof [***]. [***]. Any amendments to the Research Plan will be subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.3.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.2.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event of any inconsistency between the Research Plan and this Agreement, the terms of this Agreement will prevail.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.3.2	Kymera may propose amendments to the Research Plan at any time to reflect any material developments or adjustments to the applicable Research activities, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that (a) any such amended Research Plan will at all times meet the requirements set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.3.1[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***] through [***], and (b) in no event will Sanofi conduct any activities under the Research Plan except as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or as mutually agreed by the Parties. Kymera will promptly provide any such proposed amendment to the Research Plan to the JRDC for review and discussion.  No update or material amendment to the Research Plan will be effective unless and until approved by the JRDC in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.2.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Additional Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4.1	For Collaboration Target 1, in addition to the Research activities relating to the Initial Collaboration Target 1 Degrader and the Second Additional Degraders (as set forth more fully in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> below), Kymera will conduct Research activities, in accordance with the Research Plan during the First Additional Degrader Research Term with the goal of</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">identifying one (1) new Collaboration Compound that satisfies the First Additional Degrader Criteria. For clarity, a &#x201c;new Collaboration Compound&#x201d;, as used in the prior sentence, may be a Degrader which was identified or synthesized prior to the Original Agreement Effective Date, so long as it has not previously been designated as the Initial Collaboration Target 1 Degrader or a Second Additional Degrader.  Without limiting the foregoing, Kymera shall assign personnel under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in accordance with the Research Plan.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4.2	Kymera will conduct the Research activities under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> during the period commencing on the Original Agreement Effective Date and ending on the earliest to occur of the following:  (a) the date of selection of the First Additional Degrader</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, (b) [***], and (c) the effective date of termination of this Agreement with respect to Collaboration Target 1 or in its entirety (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A&amp;R FAD Research Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); provided that,  as long as the A&amp;R FAD Research Term has not otherwise expired or terminated, Sanofi will [***] have the one-time right upon written notice to Kymera to extend the term of Kymera&#x2019;s Research activities under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> until the [***] (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FAD Term Extension</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, and with the A&amp;R FAD Research Term, collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Additional Degrader Research Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4.3	[***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4.4	[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:8.040000000000001pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4.5	[***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4.6	During the First Additional Degrader Research Term, Kymera will use the screening assays in accordance with the procedures set forth in the Research Plan to determine whether a given Degrader that is Researched under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> satisfies the Screening Criteria or the First Additional Degrader Criteria.  All Degraders that meet the Screening Criteria during the First Additional Degrader Research Term will be Collaboration Compounds under this Agreement, subject to the reversion rights set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding anything herein to the contrary, any Degraders that are Researched by or on behalf of Kymera under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that do not meet the Screening Criteria will be classified as Excluded Compounds, unless [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4.7	During the First Additional Degrader Research Term, within [***] after Kymera reasonably believes that it has identified a Collaboration Compound that has satisfied all of the First Additional Degrader Criteria, Kymera will present a written report to Sanofi that identifies [***]. In addition, Sanofi may, in its discretion and through the JRDC, request that Kymera provide additional information, results or data in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.11.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Within [***] after the delivery of such report (or such longer period of time as may be reasonably determined by the JRDC, but in no event longer than [***]), the JRDC will (a) meet, discuss and review the report and associated material data, results and information and (b) determine whether such Collaboration Compound satisfies the First Additional Degrader Criteria.  If the JRDC determines that such Collaboration Compound satisfies the First Additional Degrader Criteria, then (i) such Collaboration Compound will be classified as a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Additional Degrader</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; under this Agreement, (ii) the First Additional Degrader Research Term will expire, (iii) Kymera will perform Early Development Activities with</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">respect to such First Additional Degrader in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the Early Development Plan, and (iv) Kymera will have no further obligation to conduct any further additional Research activities under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If the JRDC does not believe that such Collaboration Compound satisfies the First Additional Degrader Criteria, then Kymera will use diligent efforts during the remainder of the First Additional Degrader Research Term to conduct additional Research activities in accordance with the Research Plan, and thereafter present a report to the JRDC as and to the extent applicable in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event that the JRDC does not agree on whether such Collaboration Compound satisfies the First Additional Degrader Criteria, then such dispute will be resolved in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding the foregoing, Sanofi may determine [***].  Any selection of a Collaboration Compound as a First Additional Degrader by the JRDC, by the R&amp;D Expert in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or by Sanofi pursuant to the preceding sentence, will be recorded in the minutes of the JRDC.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Additional Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5.1	Under the Original Agreement, Research activities relating to [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5.2	During the period commencing on the Restatement Effective Date and ending on [***], Sanofi will have the right to provide written notice to Kymera that Sanofi desires to have Kymera conduct new Research activities in accordance with the Research Plan during the Second Additional Degrader Research Term with the goal of identifying one (1) new Collaboration Compound that satisfies the Second Additional Degrader Criteria.  For clarity, a &#x201c;new Collaboration Compound&#x201d;, as used in the prior sentence, may be a Degrader which was identified or synthesized by or on behalf of Kymera or its Affiliates prior to the Restatement Effective Date, so long as such Degrader has not previously been identified by the Parties pursuant to this Agreement as the Initial Collaboration Target 1 Degrader or a First Additional Degrader. In addition, in the event that the Sanofi provides written notice to Kymera in accordance with the first sentence of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Degraders to be researched under the Research Plan during the Second Additional Degrader Research Term may include all [***] that the Parties believe in good faith, as of the date of such written notice to Kymera, would have [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5.3	In the event that Sanofi provides written notice to Kymera in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera provide the JRDC with an amendment to the Research Plan in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. [***] Kymera will conduct new Research activities under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> pursuant to the amended Research Plan during the period commencing [***] after the date of [***] (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SAD Term Commencement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and ending on the earliest to occur of the following: (i) the date of selection of the Second Additional Degrader</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, (ii) [***] (iii) the effective date of termination of this Agreement with respect to Collaboration Target 1 or in its entirety or (iv) the effective date of termination of the SAD Termination.  The period of time during which Kymera conducts new Research activities under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (if any) will be the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Additional Degrader Research Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5.4	During the Second Additional Degrader Research Term (if any), Sanofi will reimburse Kymera in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for [***] actually incurred by or on</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">behalf of Kymera or its Affiliates (a) in accordance with the Second Additional Degrader Research Budget, and (b) in connection with conducting Research activities under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in accordance with the Research Plan.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5.5	During the Second Additional Degrader Research Term (if any), Kymera will use Commercially Reasonable Efforts to ensure that [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5.6	During the Second Additional Degrader Research Term (if any), Kymera will use the screening assays in accordance with the procedures set forth in the Research Plan to determine whether a given Degrader that is Researched under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> satisfies the Screening Criteria or the Second Additional Degrader Criteria.  All Degraders that meet the Screening Criteria during the Second Additional Degrader Research Term will be Collaboration Compounds under this Agreement, subject to the reversion rights set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding anything herein to the contrary, any Degraders that are Researched by or on behalf of Kymera under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that do not meet the Screening Criteria will be classified as Excluded Compounds, unless [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5.7	During the Second Additional Degrader Research Term (if any), within [***] after Kymera reasonably believes that it has identified a Collaboration Compound that has satisfied all of the Second Additional Degrader Criteria, Kymera will present a written report to Sanofi [***].  In addition, Sanofi may, in its discretion and through the JRDC, request that Kymera provide additional information, results or data in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.11.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Within [***] after the delivery of such report (or such longer period of time as may be reasonably determined by the JRDC, but in no event longer than [***]), the JRDC will (a) meet, discuss and review the report and associated material data, results and information, and (b) determine whether such Collaboration Compound satisfies the Second Additional Degrader Criteria.  If the JRDC determines that such Collaboration Compound satisfies the Second Additional Degrader Criteria, then (i) such Collaboration Compound will be classified as a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Additional Degrader</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; under this Agreement, (ii) the Second Additional Degrader Research Term will expire, (iii) Kymera will perform Early Development Activities with respect to such Second Additional Degrader in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the Early Development Plan, and (iv) Kymera will have no further obligation to conduct any further additional Research activities under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If the JRDC does not believe that such Collaboration Compound satisfies the Second Additional Degrader Criteria, then Kymera will use diligent efforts during the remainder of the Second Additional Degrader Research Term to conduct additional Research activities in accordance with the Research Plan, and thereafter present a report to the JRDC as and to the extent applicable in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event that the JRDC does not agree on whether such Collaboration Compound satisfies the Second Additional Degrader Criteria, then such dispute will be resolved in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding the foregoing, [***].  Any selection of a Collaboration Compound as a Second Additional Degrader by the JRDC, by the R&amp;D Expert in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or by Sanofi pursuant to the preceding sentence, will be recorded in the minutes of the JRDC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Collaboration Target 2 Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.6.1	For Collaboration Target 2, during the Research Term, Kymera will, at its cost and expense, conduct Research activities in accordance with the Research Plan with the goal of advancing [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.6.2	In the event that the first Collaboration Candidate Directed Against Collaboration Target 2 is designated in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera will [***] continue to conduct any applicable Research activities with respect to such first Collaboration Candidate in accordance with the Research Plan or Development activities with respect to such Collaboration Candidate in accordance with the Early Development Plan, as applicable.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.6.3	In addition, from and after the designation of the first Collaboration Candidate Directed Against Collaboration Target 2 in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera will continue to conduct Research activities in accordance with the Research Plan in order to [***].  Kymera will conduct activities under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> until the earliest of (a) the date that the JRDC or the R&amp;D Expert determines that a second Collaboration Compound Directed Against Collaboration Target 2 satisfies [***] and is classified as a Collaboration Candidate, (b) the Sanofi Participation Election Effective Date for Collaboration Target 2, (c) the date that the JRDC determines such Research Activities should be discontinued, or (d) the expiration or termination of the Research Term with respect to Collaboration Target 2 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series 2 Research Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  During the Series 2 Research Term, Sanofi will reimburse Kymera in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for Kymera&#x2019;s [***] actually incurred by or on behalf of Kymera or its Affiliates in connection with conducting Research activities under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that if [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.6.4	[***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.6.5	During the Research Term, within [***] after Kymera reasonably believes that it has identified a Collaboration Compound Directed Against Collaboration Target 2 that has satisfied [***], Kymera will present a written report to Sanofi that [***]. Sanofi may, in its discretion and through the JRDC, request any other information, results or data with respect to such Collaboration Compound as set forth more fully in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.11.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Within [***] after the delivery of such report (or such longer period of time as may be reasonably determined by the JRDC, but in no event longer than [***]), the JRDC will (a) meet, discuss and review the report and associated material data, results and information, and (b) determine whether such Collaboration Compound satisfies [***].  If the JRDC determines that such Collaboration Compound satisfies [***], then such Collaboration Compound will be classified as a Collaboration Candidate.  If the JRDC does not believe that such Collaboration Compound satisfies [***], then Kymera will use diligent efforts during the remainder of the Research Term to conduct additional Research activities in accordance with the Research Plan, and thereafter present a report to the JRDC as and to the extent applicable in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event that the JRDC does not agree on whether such Collaboration Compound satisfies [***], then such dispute will be resolved in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any designation of a Collaboration Compound as a Collaboration Candidate by the JRDC, by the R&amp;D Expert in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be recorded in the minutes of the JRDC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.6.6	If the JRDC designates [***] Collaboration Candidates under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, then Kymera will have no further obligation to conduct any further additional Research activities under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diligence; Decision-Making</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.7.1	On a Collaboration Target-by-Collaboration Target basis, during the Research Term, Kymera, directly or through its Affiliates or Subcontractors, will [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.7.2	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 2.4.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.9.2(b)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, on a Collaboration Target-by-Collaboration Target basis, during the Research Term, Kymera will have the final decision-making authority with respect to the Research activities for the Collaboration Compounds, Collaboration Candidates and Licensed Products Directed Against such Collaboration Target under this Agreement prior to the Sanofi Participation Election Right Exercise (if any) with respect to such Collaboration Target, including the prioritization of the Research activities and allocation of resources among the Research activities;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that any such decision is consistent with the terms and conditions of this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.8	[***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.8.1	Sanofi shall be entitled to conduct [***]. Sanofi also may, with Kymera&#x2019;s prior agreement, conduct additional Research activities (including [***]) under the Research Plan.  Sanofi will obtain prior written consent from Kymera prior to [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.8.2	Any and all [***] constitutes &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MTA Research Studies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,&#x201d; and all such MTA Research Studies will be documented in the applicable Research Plan or the relevant JRDC minutes.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.9	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer of Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.9.1	To facilitate the conduct of activities under each Research Plan:  (a) Sanofi may, at its election, provide Materials to Kymera to facilitate Kymera&#x2019;s Research activities under the Research Plan (in which case the transfer of such Materials shall be specified in the Research Plan or the minutes of the JRDC), and (b) Kymera will provide to Sanofi reasonable quantities of such Materials as are reasonably necessary to permit Sanofi to [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.9.2	All Materials transferred pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (a) will remain the sole property of the supplying Party (it being understood that jointly-owned Materials will remain jointly-owned, notwithstanding any physical transfer between the Parties), (b) will be used only in the fulfillment of the receiving Party&#x2019;s obligations or exercise of rights under this Agreement, (c) will remain solely under the control of the receiving Party, (d) will not be used or delivered by the receiving Party to or for the benefit of any Third Party (other than a permitted Subcontractor or Sublicensee) without the prior written consent of the supplying Party, and (e) will not be used in research or testing involving human subjects, unless expressly agreed in writing.  The receiving Party will use the Materials in compliance with Applicable Laws and the terms and conditions of this Agreement, and will not reverse engineer or chemically analyze such Materials, except as specified in the Research Plan.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.9.3	Any intellectual property generated by or on behalf of either Party in connection with the use of Materials transferred pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be governed by the following:</font></p>
  <p style="margin-left:4.173%;text-indent:15.653%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Subject to the licenses granted under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the supplying Party will solely own all right, title and interest in and to any data, information, results and reports generated by or on behalf of either Party directly from the use of any transferred Materials that comprise Collaboration Compounds, Collaboration Candidates or Licensed Products, solely within any MTA Research Studies permitted and conducted under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (including [***]), and such data, information, results and reports will be shared with the supplying Party via the JRDC,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:15.653%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Except as set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.9.3(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, all</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">intellectual property created, conceived or generated by or on behalf of either Party using Collaboration Compounds, Collaboration Candidates or Licensed Products under this Agreement in connection with the MTA Research Studies will be governed by the provisions of this Agreement, including </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.9.4	All Materials supplied under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are supplied &#x201c;as is&#x201d;, with no warranties of fitness for a particular purpose and must be used with prudence and appropriate caution in any experimental work, as not all of their characteristics may be known.  The receiving Party assumes all liability for damages that may arise from its use, storage or disposal of the Materials.  Except as otherwise set forth in this Agreement, the supplying Party will not be liable to the receiving Party for any loss, claim or demand made by the receiving Party, or made against the receiving Party by any Third Party, due to or arising from the use of the Materials under this Agreement, except to the extent such loss, claim or demand is caused by the gross negligence or willful misconduct of the supplying Party.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.9.5	For clarity, the transfer of any material owned or Controlled by Sanofi other than Materials will be governed by a to-be-negotiated material transfer agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.10	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subcontracting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During the Research Term, Kymera may engage Approved Third Party Contractors to perform Research activities hereunder; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that (a) each contract between Kymera and an Approved Third Party Contractor entered into after the Original Agreement Execution Date will include confidentiality and non-use provisions that are substantially similar to those set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (or such other terms as are otherwise agreed by Sanofi) (but of duration customary in confidentiality agreements entered into for a similar purpose, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that the duration of confidentiality for any information which constitutes a trade secret will be for as long as such information remains a trade secret under Applicable Law), (b) Kymera will remain at all times fully liable for the acts and omissions by such Approved Third Party Contractors under this Agreement as if they were acts or omissions by Kymera, (c) subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera will be responsible for the effective and timely management of and payment of its Approved Third Party Contractors hereunder and (d) each contract between Kymera and an Approved Third Party Contractor entered into after the Original Agreement Execution Date will provide that [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Records; Reporting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11.1	Each Party will maintain, and [***] to maintain, records of the Research activities under this Agreement in sufficient detail and in good scientific manner appropriate for scientific, patent and regulatory purposes, which will be complete and accurate in all material respects and will fully and properly reflect all work done, data and developments made, and results achieved.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11.2	Each Party will furnish to the JRDC, within [***] after the end of each Calendar Quarter, to the extent applicable to such Party, an update on such Party&#x2019;s progress under the Research Plan for the applicable Collaboration Target (including with respect to any MTA Research Studies or other activities governed by a separate material transfer agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> during the relevant Calendar Quarter, including a summary of any results and data generated by such Party under such Research Plan and an overview of the resources (including a summary of all expenditures incurred by such Party in connection with such Research activities and reasonable documentation relating thereto, and an overview of FTEs used by such Party for such Research activities) allocated to activities under such Research Plan during the relevant Calendar Quarter.  Such Party will provide the JRDC with such other information, results and data with respect to the Research activities under the Research Plan as any member of the JRDC may reasonably request that are in such Party&#x2019;s possession or control.  Kymera will provide Sanofi a reasonable opportunity via the JRDC to discuss and provide input with respect to Kymera&#x2019;s Research activities under the Research Plan, including with respect to the prioritization of Research activities for Collaboration Compounds.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11.3	In addition to, and without limiting, the reporting requirements in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.11.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, during the First Additional Degrader Research Term, Kymera will furnish to the JRDC, within [***], a written report on Kymera&#x2019;s Research activities with respect to Collaboration Compounds that are Researched under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and have the potential to be classified as First Additional Degraders.  Such reports will [***].  Kymera will provide the JRDC with such other information, results and data with respect to the Research activities under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as any member of the JRDC may reasonably request that are in Kymera&#x2019;s possession or control.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11.4	In addition to, and without limiting, the reporting requirements in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.11.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, during the Second Additional Degrader Research Term, Kymera will furnish to the JRDC, within [***], a written report on Kymera&#x2019;s Research activities with respect to Collaboration Compounds that are Researched under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and have the potential to be classified as Second Additional Degraders.  Such reports will [***].  Kymera will provide the JRDC with such other information, results and data with respect to the Research activities under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as any member of the JRDC may reasonably request that are in Kymera&#x2019;s possession or control.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11.5	In the event that Sanofi has provided written notice to Kymera that [***], then, within [***] of the date of receipt of such written notice, Kymera will permit Sanofi to examine the relevant books and records of Kymera and its Affiliates, as may be reasonably necessary to verify the reports provided by Kymera in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.11.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; provided that such examination will be subject to customary and reasonable</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">due diligence procedures to preserve the confidential nature of any books or records.  An examination by Sanofi under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.11.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (a) will occur not more than [***], (b) will be limited to the pertinent books and records for any Calendar Year ending not more than [***]before the date of the written notice, (c) will be conducted in such a manner to minimize, to the extent reasonably possible, the period of examination and in no case shall such period exceed [***], and (d) will be conducted by the minimum number of Sanofi employees as necessary to provide requisite subject matter expertise and conduct the review in the allotted timeframe, each of whom shall have appropriate experience in the Research of small molecule compounds and candidates; provided, that if any examination by Sanofi under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.11.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reveals any material discrepancy, Kymera will permit Sanofi to conduct additional examination of pertinent books and records for Calendar Years ending not more than [***] before the date of the written notice, during a period limited to minimize the days of examination as much as possible and in no case more than [***].  Sanofi will be provided access to such books and records at Kymera&#x2019;s facility or facilities where such books and records are normally kept and such examination will be conducted during Kymera&#x2019;s normal business hours.  Upon completion of the examination, Sanofi will provide Kymera and the JRDC a written report disclosing the reason(s) for the difference between the relevant report provided by Kymera and the results and data that should have been generated and the activities that should have been conducted by Kymera during the relevant time.  The costs and fees of any examination conducted by Sanofi under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.11.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be borne by Sanofi.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 3<br>EARLY DEVELOPMENT</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Activities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1.1	With respect to Collaboration Target 1, during the Research Term prior to Sanofi&#x2019;s exercise of the Sanofi Participation Election Right with respect to Collaboration Target 1, the terms and conditions set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will apply.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Kymera will be solely responsible for (a) conducting all Pre-Clinical Development of Collaboration Candidates and Licensed Products that are Directed Against Collaboration Target 1 in the Field in the Territory, (b) filing all INDs for all Collaboration Candidates and Licensed Products Directed Against Collaboration Target 1 in the Field in the Territory, and (c) for conducting the Kymera Phase 1 Clinical Trials therefor, in each case ((a)-(c)) in accordance with the Early Development Plan (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Activities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, following the Restatement Effective Date, Kymera will only be required to conduct [***]. For example, Kymera may conduct the [***], but shall not be required to [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	[***], and subject to the last sentence of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1.1(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Sanofi will be solely responsible for [***], to conduct [***] pursuant to the Phase 2 Development Plan; provided that, subject to any [***], (i) Sanofi shall use Commercially Reasonable Efforts to [***], (ii) [***] Sanofi shall use Commercially Reasonable Efforts to [***] and (iii) Sanofi must [***].  The Parties acknowledge and agree that [***] to determine whether the applicable [***] that are conducted by Sanofi under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1.1(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are designed as [***]; provided, for clarity, that all [***] will be determined in accordance with, and as defined by, Applicable Law and the definitions set forth herein.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	No later than [***] prior to the expected submission of a clinical trial protocol for each Phase 2 Clinical Trial sponsored by Sanofi pursuant to the Phase 2 Development Plan, Sanofi shall provide Kymera with such protocol for each such trial, and within [***] of receipt of such protocol, Kymera may provide Sanofi with comments to such protocol, which Sanofi shall consider in good faith (each such protocol, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 Protocol</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); provided that, [***]. [***] shall be permitted to make amendments to the Phase 2 Protocol; provided that, it shall promptly notify [***] of any material changes to any Phase 2 Protocol.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	The initial Phase 2 Development Plan as agreed by the Parties as of the Restatement Execution Date is attached as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1.1(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and sets forth the high-level details with respect to the [***] (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Each Party may propose amendments to the Phase 2 Development Plan at any time.  Such Party will promptly provide any such proposed amendment to the Phase 2 Development Plan to the JRDC for review and discussion.  No update or amendment to the Phase 2 Development Plan will be effective unless and until approved by the JRDC in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.2.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; provided that, [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	The Parties acknowledge that pursuant to the Original Agreement any Phase 2 Clinical Trial with respect to [***] would have constituted an activity occurring during the Sanofi Participation Term under the Late Development Plan. However, pursuant to this Agreement, any such Phase 2 Clinical Trials for [***] conducted prior to Sanofi&#x2019;s Participant Election Deadline shall be deemed activities occurring during the Research Term. [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	All Development activities conducted under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1.1(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the Phase 2 Clinical Trials for [***] by or on behalf of Sanofi pursuant to the Phase 2 Development Plan will be the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 Activities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.&#x201d;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	The Parties will be responsible for the costs and expenses of the Development activities contemplated in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1.2	With respect to Collaboration Target 2, during the Research Term prior to Sanofi&#x2019;s exercise of the Sanofi Participation Election Right with respect to Collaboration Target 2, Kymera will be solely responsible, at its cost and expense and in accordance with the applicable Early Development Plan, for (a) conducting all Pre-Clinical Development of Collaboration Candidates and Licensed Products Directed Against Collaboration Target 2 in the Field in the Territory, and (b) filing the first IND therefor for the first Indication in the Field in the first Major Market Country, in each case ((a)-(b)) in accordance with the Early Development Plan.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.2.1	On a Collaboration Target-by-Collaboration Target basis, during the Research Term, Kymera will conduct its Development activities under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the Collaboration Candidates and Licensed Products Directed Against each Collaboration Target in the Field in accordance with a written plan (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) that includes [***].  A copy of the current Early Development Plan as of the Restatement Execution Date is attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any amendments to the Early Development Plan will</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">be subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.2.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event of any inconsistency between the Early Development Plan and this Agreement, the terms of this Agreement will prevail.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.2.2	Kymera may propose amendments to the Early Development Plan at any time to reflect any material developments or adjustments to the applicable Development activities, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that (a) any such amended Early Development Plan will at all times meet the requirements set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and (b) in no event will Sanofi conduct any activities under the Early Development Plan except as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or as otherwise mutually agreed by the Parties.  Kymera will promptly provide any such proposed amendment to the Early Development Plan to the JRDC for review and discussion.  No update or material amendment to the Early Development Plan will be effective unless and until approved by the JRDC in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.2.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.2.3	Sanofi may propose amendments to the Early Development Plan at any time to include [***] to be conducted by or on behalf of Sanofi [***].  Sanofi will promptly provide any such proposed amendment to the Early Development Plan to the JRDC for review and discussion.  No update or material amendment to the Early Development Plan will be effective unless and until approved by the JRDC in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.2.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; provided that, Sanofi shall have final decision-making authority in the event that such [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diligence; Decision-Making</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.3.1	On a Collaboration Target-by-Collaboration Target basis, during the Research Term, Kymera, directly or through its Affiliates or Subcontractors, will (a) [***] (b) use Commercially Reasonable Efforts to Research and Develop one (1) Collaboration Candidate that achieves Successful Completion for Collaboration Target 2, (c) use Commercially Reasonable Efforts to Research and Develop one (1) Collaboration Candidate that achieves Successful Completion for Collaboration Target 1, and (d) use Commercially Reasonable Efforts to conduct the Kymera Existing Phase 1 Clinical Trial.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.3.2	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, on a Collaboration Target-by-Collaboration Target basis, during the Research Term, Kymera will have the final decision-making authority with respect to its Development activities for the Collaboration Candidates and Licensed Products Directed Against such Collaboration Target under this Agreement prior to the Sanofi Participation Election Right Exercise (if any) with respect to such Collaboration Target, including the prioritization of its Development activities and the allocation of resources among the Development activities;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that any such decision is consistent with the terms and conditions of this Agreement.  In the event that a Material Safety Event occurs in connection with any Clinical Trials conducted by or on behalf of Kymera, then Kymera will have the right, at its sole election, to wind-down such Clinical Trials in accordance with Applicable Law.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.3.3	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, during the Research Term, Sanofi will have the final decision-making authority with respect to [***];</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that any such decision is consistent with the terms and conditions of this Agreement.  In the event that a Material Safety Event occurs in connection with any Phase 2 Clinical Trial that Sanofi is</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">conducting for [***], then Sanofi will have the right, at its sole election, to wind-down such Phase 2 Clinical Trial in accordance with Applicable Law.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.4	[***]</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.4.1	Sanofi shall be entitled to conduct [***]. Sanofi also may, with Kymera&#x2019;s prior agreement, conduct additional Development activities (including [***]) under the Early Development Plan; provided that, for the avoidance of doubt, no such consent shall be required for Sanofi to perform the Phase 2 Activities. Sanofi will obtain prior written consent from Kymera prior to [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.4.2	Any and all [***] permitted and conducted under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.4.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, collectively, constitute &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MTA Development Studies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,&#x201d; and all such MTA Development Studies will be documented in the applicable Early Development Plan or the relevant JRDC minutes.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer of Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5.1	To facilitate the conduct of activities under each Early Development Plan:  (a) Sanofi may, at its election, provide Materials to Kymera to facilitate Kymera&#x2019;s Development activities under the Early Development Plan (in which case the transfer of such Materials shall be specified in the Early Development Plan or the minutes of the JRDC), and (b) Kymera will provide to Sanofi reasonable quantities of such Materials as are reasonably necessary to permit Sanofi to conduct [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5.2	All Materials transferred pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (a) will remain the sole property of the supplying Party (it being understood that jointly-owned Materials will remain jointly-owned, notwithstanding any physical transfer between the Parties), (b) will be used only in the fulfillment of the receiving Party&#x2019;s obligations or exercise of rights under this Agreement, (c) will remain solely under the control of the receiving Party, (d) will not be used or delivered by the receiving Party to or for the benefit of any Third Party (other than a permitted Subcontractor or Sublicensee) without the prior written consent of the supplying Party, and (e) will not be used in research or testing involving human subjects, unless expressly agreed in writing.  The receiving Party will use the Materials in compliance with Applicable Laws and the terms and conditions of this Agreement, and will not reverse engineer or chemically analyze such Materials, except as specified in the Early Development Plan.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5.3	Any intellectual property generated by or on behalf of either Party in connection with the use of Materials transferred pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be governed by the following:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Subject to the licenses granted under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the supplying Party will solely own all right, title and interest in and to any data, information, results and reports generated by or on behalf of either Party directly from the use of any transferred Materials that comprise Collaboration Compounds, Collaboration Candidates or Licensed Products, solely within any MTA Development Studies permitted and conducted under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.5.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and such data, information, results and reports will be shared with the supplying Party via the JRDC;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Except as set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.5.3(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, all</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">intellectual property created, conceived or generated by or on behalf of either Party using Collaboration Compounds, Collaboration Candidates or Licensed Products under this Agreement in connection with the MTA Development Studies will be governed by the provisions of this Agreement, including </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5.4	All Materials supplied under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are supplied &#x201c;as is&#x201d;, with no warranties of fitness for a particular purpose and must be used with prudence and appropriate caution in any experimental work, as not all of their characteristics may be known.  The receiving Party assumes all liability for damages that may arise from its use, storage or disposal of the Materials.  Except as otherwise set forth in this Agreement, the supplying Party will not be liable to the receiving Party for any loss, claim or demand made by the receiving Party, or made against the receiving Party by any Third Party, due to or arising from the use of the Materials under this Agreement, except to the extent such loss, claim or demand is caused by the gross negligence or willful misconduct of the supplying Party.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5.5	For clarity, the transfer of any material owned or Controlled by Sanofi other than Materials will be governed by a to-be-negotiated material transfer agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subcontracting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During the Research Term, Kymera may engage Approved Third Party Contractors to perform Development activities hereunder; (a) each contract between Kymera and an Approved Third Party Contractor entered into after the Original Agreement Execution Date will be consistent with the provisions of this Agreement, including </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and will include confidentiality provisions that are at least as restrictive as those described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, (b) Kymera will remain at all times fully liable for the acts and omissions such Approved Third Party Contractors under this Agreement as if they were acts or omissions by Kymera, and (c) Kymera will be responsible for the effective and timely management of and payment of its Approved Third Party Contractors hereunder.  The engagement of any Approved Third Party Contractor in compliance with this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will not relieve Kymera of its obligations under this Agreement.  Additionally, Sanofi may engage Third Party contractors to perform the Phase 2 Activities; provided that, (a) each contract between Sanofi and a Third Party contractor entered into after the Restatement Execution Date will be consistent with the provisions of this Agreement, including </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and will include confidentiality provisions that are at least as restrictive as those described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, (b) Sanofi will remain at all times fully liable for the acts and omissions such Third Party contractors under this Agreement as if they were acts or omissions by Sanofi, (c) Sanofi will be responsible for the effective and timely management of and payment of its Third Party contractors hereunder and (d) the engagement of any Approved Third Party Contractor in compliance with this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will not relieve Sanofi of its obligations under this Agreement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Records; Reporting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.7.1	Each Party will maintain, and [***] to maintain, records of the Development activities under this Agreement in sufficient detail and in good scientific manner appropriate for scientific, patent and regulatory purposes, which will be complete and accurate in all material respects and will fully and properly reflect all work done, data and developments made, and results achieved.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	The Parties acknowledge and agree that, prior to the Restatement Effective Date, Kymera provided to Sanofi the Pre-Clinical and SAD/MAD Data Package for the Kymera Existing Phase 1 Clinical Trial, the MAD Data Package, the Phase 1 Patient Data Package for the Kymera Existing Phase 1 Clinical Trial and the Remaining Patient Data Package. [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.7.2	Each Party will furnish to the JRDC, within [***], to the extent applicable to such Party, an update on such Party&#x2019;s progress under the Early Development Plan or the Phase 2 Development Plan (as applicable) for the applicable Collaboration Target (including with respect to any MTA Development Studies or other activities governed by a separate material transfer agreement) during the relevant Calendar Quarter, including a summary of any results and data generated by such Party under such Early Development Plan or the Phase 2 Development Plan (as applicable) and an overview of the resources (including a summary of all expenditures incurred by such Party in connection with such Development activities and reasonable documentation relating thereto, and an overview of FTEs used by such Party for such Development activities), allocated to activities under such Early Development Plan or the Phase 2 Development Plan (as applicable) during the relevant Calendar Quarter. Such Party will provide the JRDC with such other information, results and data with respect to the Development activities under the Early Development Plan or the Phase 2 Development Plan (as applicable) as any member of the JRDC may reasonably request that are in such Party&#x2019;s possession or control.  Each Party will provide the other Party a reasonable opportunity via the JRDC to discuss and provide input with respect to such Party&#x2019;s Development activities under the Early Development Plan or the Phase 2 Development Plan (as applicable), including with respect to the prioritization of Development activities for Collaboration Candidates and Licensed Products.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.7.3	In the event that Sanofi has </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> written notice to Kymera (including via the JRDC) that [***], then, within [***] of the date of receipt of such written notice, Kymera will permit Sanofi to examine the relevant books and records of Kymera and its Affiliates, as may be reasonably necessary to verify the Research updates and progress reports submitted by Kymera in accordance with this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such examination will be subject to customary and reasonable due diligence procedures to preserve the confidential nature of any books or records.  An examination by Sanofi under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.7.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (a) will occur not more than [***], (b) will be limited to the pertinent books and records for any Calendar Year ending not more than [***] before the date of the written notice, (c) will be conducted in a such a manner to minimize, to the extent reasonably possible, the period of examination and in no case shall such period exceed [***], and (d) will be conducted by the minimum number of Sanofi employees as necessary to provide requisite subject matter expertise and conduct the review in the allotted timeframe, each of whom shall have appropriate experience in the Development of small molecule compounds and candidates; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that if any examination by Sanofi under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.7.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reveals any material discrepancy, Kymera will permit Sanofi to conduct additional examination of pertinent books and records for Calendar Years ending not more than [***] before the date of the written notice, during a period limited to minimize the days of examination as much as possible and in no case more than [***].  Sanofi will be </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> access to such books and records at Kymera&#x2019;s facility or facilities where such books and records are normally kept and such examination will be conducted during Kymera&#x2019;s normal business hours.  Upon completion of the examination, Sanofi will provide Kymera and the JRDC a written report disclosing the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reason(s) for the difference between the relevant report provided by Kymera and the results and data that should have been generated and the activities that should have been conducted by Kymera during the relevant time.  The costs and fees of any examination conducted by Sanofi under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.7.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be borne by Sanofi.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 4<br>SANOFI PARTICIPATION ELECTION RIGHT</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Election Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, during the Research Term, Kymera hereby grants to Sanofi an exclusive right, exercisable in Sanofi&#x2019;s sole discretion, to continue, in collaboration with Kymera as specified herein, the Research, Development, Manufacture and Commercialization of Collaboration Candidates and Licensed Products Directed Against such Collaboration Target (each a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Election Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Participation Data Package</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except in the case of a Phase 2 Trigger Point, on a Collaboration Target-by-Collaboration Target basis, within [***] after the Trigger Point for a given Collaboration Target, Kymera will provide Sanofi with the Participation Data Package with respect to such Collaboration Target, and Sanofi will use such Participation Data Package (and any additional information provided by Kymera pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) solely to determine whether to exercise the corresponding Sanofi Participation Election Right with respect to such Collaboration Target.  Additionally, Kymera will make all data within the Participation Data Package for such Collaboration Target available to Sanofi through an electronic data room.  [***]  For clarity, Kymera will not be required to provide Sanofi with the Participation Data Package in the event of a Phase 2 Trigger Point.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Incomplete Participation Data Package</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, if such Participation Data Package for a given Collaboration Target is incomplete, Sanofi may notify Kymera of the incomplete status of such Participation Data Package in writing including any items that, in Sanofi&#x2019;s reasonable determination made in good faith, should have been included in the Participation Data Package but were not included therein within [***] after receipt thereof.  Following receipt of such notice, Kymera will promptly deliver to Sanofi the additional information requested by Sanofi to complete such Participation Data Package.  For clarity, delivery of such incomplete Participation Data Package will not trigger the [***] period after which the Sanofi Participation Election Deadline would occur pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, but such [***] period after which the Sanofi Participation Election Deadline would occur pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will thereafter be triggered on the date of Sanofi&#x2019;s receipt of the additional information requested by Sanofi to complete such Participation Data Package.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.2.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due Diligence Following Participation Data Package</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, following the date of delivery of the Participation Data Package for a given Collaboration Target, to assist Sanofi in conducting thorough due diligence to decide whether to exercise the corresponding Sanofi Participation Election Right with respect to such Collaboration Target, Kymera will afford to Sanofi and its representatives reasonable access during normal business hours to Kymera&#x2019;s personnel, records and data, offices, laboratories, and manufacturing and supplier sites that Sanofi may reasonably request regarding such Collaboration Target and Collaboration Candidates and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Licensed Products Directed Against such Collaboration Target; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such obligation to supply such records, data and information will be limited to those records, data and information then available to Kymera and will be subject to customary and reasonable due diligence procedures to preserve the confidential nature of any such information.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise of Participation Election Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, during the Research Term, Sanofi will have the right, in its sole discretion, to exercise the Sanofi Participation Election Right (each such exercise, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Election Right Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) for a given Collaboration Target by delivering to Kymera written notice of such exercise (each such notice, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Election Right Exercise Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) within [***] after either the date of delivery of the Participation Data Package with respect to such Collaboration Target or the date of the Phase 2 Trigger Point, as applicable (the end of such [***] period, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Election Deadline</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  If Sanofi provides the Sanofi Participation Election Right Exercise Notice prior to the Sanofi Participation Election Deadline with respect to such Collaboration Target, then the date of receipt of such Sanofi Participation Election Right Exercise Notice will be the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; with respect to such Collaboration Target.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Participation Election Right Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, if Sanofi declines to exercise its Sanofi Participation Election Right or fails to provide a Sanofi Participation Election Right Exercise Notice in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> with respect to a Collaboration Target, in each case, prior to the Sanofi Participation Election Deadline for such Sanofi Participation Election Right, then (a) the Sanofi Participation Election Right will expire and be of no further force or effect with respect to such Collaboration Target, (b) such Collaboration Target will no longer be a Collaboration Target and this Agreement will automatically terminate with respect to such Collaboration Target in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> with such Collaboration Target becoming a Terminated Target, and (c) except as set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.6.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera will retain all right, title and interest in and to such Collaboration Target, including with respect to all Collaboration Compounds, Collaboration Candidates and Licensed Products Directed Against such Collaboration Target. For the avoidance of doubt, [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 5<br>DEVELOPMENT AFTER SANOFI PARTICIPATION ELECTION</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Generally</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, during the Sanofi Participation Term (if any) with respect to a Collaboration Target and subject to Kymera&#x2019;s obligations under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the Kymera Opt-In Right, Sanofi will be solely responsible for all further Research and Development of Collaboration Candidates and Licensed Products (but not, for clarity, Excluded Compounds) Directed Against such Collaboration Target in the Field (but not, for clarity, in the Excluded Field) in the Territory in accordance with the terms and conditions of this Agreement.  For clarity, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. To the extent not already completed pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.7.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2.1	On a Collaboration Target-by-Collaboration Target basis, Kymera will promptly (but no later than [***]) following the Sanofi Participation Election Effective Date with respect to a Collaboration Target (if any), transfer to Sanofi or its designated Affiliate a</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">copy of all Licensed Know-How and Regulatory Filings (if applicable) related to Collaboration Candidates and Licensed Products Directed Against such Collaboration Target in its possession or control as of such Sanofi Participation Election Effective Date, including any documentation (whether held in paper or electronic format) or similar removable media (including e-mails, documents, spreadsheets, copies of standard operating procedures or technical specifications); </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that any documentation transferred electronically will be in an electronic format reasonably acceptable to Sanofi.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2.2	During the Sanofi Participation Term (if any), on a Collaboration Target-by-Collaboration Target basis, (a) Kymera shall disclose to Sanofi on a [***] basis any Licensed Know-How created, generated, invented or developed by or on behalf of Kymera under this Agreement and not previously transferred to Sanofi pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and (b) in the event that Sanofi or Kymera reasonably believes additional Licensed Know-How is necessary for the continued Research, Development or Commercialization of the Collaboration Candidates or Licensed Products Directed Against such Collaboration Target, Sanofi may reasonably request a copy of such additional Licensed Know-How from Kymera.  Sanofi and Kymera will discuss in good faith and Kymera will transfer to Sanofi a copy of such additional Licensed Know-How in Kymera&#x2019;s possession or control, including any documentation (whether held in paper or electronic format) or similar removable media (including e-mails, documents, spreadsheets, copies of standard operating procedures or technical specifications), following mutual agreement by the Parties; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that any documentation transferred electronically will be in an electronic format reasonably acceptable to Sanofi.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2.3	To assist with the transfer of Licensed Know-How (excluding CMC) under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and Sanofi&#x2019;s exploitation thereof in accordance with the terms of this Agreement, for [***] after the Sanofi Participation Election Effective Date with respect to a Collaboration Target (if any), Kymera will make its personnel reasonably available to Sanofi during normal business hours to transfer such Licensed Know-How to Sanofi and respond to Sanofi&#x2019;s reasonable inquiries with respect thereto; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that if Kymera fails to timely and fully complete the technology transfer set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the JRDC will agree on a reasonable extension of time during which Kymera will make its personnel reasonably available.  Following such [***] period with respect to such Collaboration Target (as it may be extended by the JRDC), upon Sanofi&#x2019;s request, Kymera will make up to [***] of its personnel that worked on the applicable Collaboration Target reasonably available to Sanofi during normal business hours at a mutually agreeable date and time to transfer such Licensed Know-How (excluding CMC) to Sanofi and respond to Sanofi&#x2019;s reasonable inquiries with respect thereto, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, following such period with respect to a Collaboration Target, such assistance with respect to such Collaboration Target will not exceed [***] of time provided by Kymera employees unless otherwise agreed by Kymera.  All assistance provided pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be at [***] sole cost and expense; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2.4	[***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2.5	On a Collaboration Target-by-Collaboration Target basis, at Sanofi&#x2019;s reasonable request following the Sanofi Participation Election Effective Date with respect to a Collaboration Target (if any), Kymera will use Commercially Reasonable Efforts to</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">facilitate the establishment of a business relationship between Sanofi and any Approved Third Party Contractor that Kymera has engaged in the Research or Development activities of Collaboration Candidates or Licensed Products Directed Against the applicable Collaboration Target, including by facilitating introductions with such Approved Third Party Contractors, and use Commercially Reasonable Efforts to assign to Sanofi any agreements with any such Approved Third Party Contractor that are exclusively related to such Collaboration Target in the Field.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2.6	On a Collaboration Target-by-Collaboration Target basis, if the Sanofi Participation Election Right was triggered by a Trigger End Date for such Collaboration Target, the following additional provisions will apply:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	If Kymera is performing ongoing Research activities under the relevant Research Plan, then Kymera will, at Sanofi&#x2019;s election, either (i) complete those Research activities remaining under the relevant Research Plan at Sanofi&#x2019;s expense, or (ii) transfer such activities to Sanofi, which such transfer will include any support necessary for Sanofi to complete the remainder of such activities without unnecessary delay in timelines or unnecessary incremental expense.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	If Kymera is performing ongoing Development activities under the Early Development Plan, then Kymera will (i) with respect to Clinical Trials, complete those Clinical Trials ongoing as of the Sanofi Participation Election Effective Date at Sanofi&#x2019;s expense, and (ii) with respect to Pre-Clinical Development activities, (A) if such activities can be completed within [***] after the Sanofi Participation Election Effective Date, complete such activities, or (B) if such activities cannot be completed within [***] after the Sanofi Participation Election Effective Date, transfer such activities to Sanofi, which transfer will include any transfer support necessary for Sanofi to complete the remainder of the Early Development Plan without unnecessary delay in timelines or unnecessary incremental expense.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Sanofi will reimburse Kymera for all reasonable and documented [***] incurred by or on behalf of Kymera or its Affiliates in the performance of its obligations in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.2.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Late Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.3.1	During the Sanofi Participation Term (if any), on a Collaboration Target-by-Collaboration Target basis, Sanofi will Research and Develop Collaboration Candidates and Licensed Products Directed Against such Collaboration Target in the Field in the Territory in accordance with a written plan (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Late Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) that [***].  An initial draft of the Late Development Plan is attached as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 5.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.3.2	Sanofi will promptly (but no later than [***]) following the Sanofi Participation Election Effective Date with respect to a Collaboration Target (if any) prepare, in consultation with Kymera through the JSC, an updated Late Development Plan for JSC review and approval in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.3.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.3.3	During the Opt-In Period, on a Collaboration Target-by-Collaboration Target basis:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	The Late Development Plan will contain a plan for Development activities to be undertaken by the Parties until [***] (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Development Activities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), which plan will include an anticipated [***] budget of U.S. Development Costs for all activities conducted by the Parties in connection therewith (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Development Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  On or before [***] during the Opt-In Period, Sanofi will provide to the JSC the then-current Late Development Plan (if any) for the Opt-In Products Directed Against such Collaboration Target, which will include a rolling [***] year U.S. Development Budget.  The [***] of the initial U.S. Development Budget will be binding, and [***] of the U.S. Development Budget will be binding only to the extent that Sanofi provides such budget to Kymera after it has completed all necessary internal approvals, otherwise such [***] in such initial U.S. Development Budget will be non-binding.  Subsequent Calendar Years of the U.S. Development Budget will be non-binding.  The U.S. Development Budget, and each update thereto, will be prepared by the Parties based on each Party&#x2019;s good faith estimation, consistent with its standard internal practices, of the probable Development activities to be conducted during the relevant U.S. Development Budget period for the United States, and based on and consistent with the documents and information related to the Licensed Products prepared by such Party for its internal use and reference in the budgeting process.  Upon request by a Party, the JSC will discuss the appropriate level of detail to include in the U.S. Development Budget for the applicable Development activities to be performed during the period covered by such U.S. Development Budget.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	The Parties will (i) review the Late Development Plan at least annually during the period covered by such Late Development Plan for the purpose of considering appropriate amendments thereto to be proposed to the JSC and (ii) then no later than [***] of the then-current Calendar Year beginning with the first full Calendar Year of the Late Development Plan, provide the JSC with a proposed updated Late Development Plan for the JSC&#x2019;s review and discussion.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Annual updates to the U.S. Development Budget will contain a proposed U.S. Development Budget covering [***], in accordance with the requirements set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.3.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The annual updates to the U.S. Development Budget for the United States will further contain any proposed Development activities that were not previously included as Development activities in the then-current Late Development Plan (including any new Indications).</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	In addition to the annual updates, either Party, through its representatives on the JSC, may propose amendments to any Late Development Plan at any time until such time as no further Development activities are occurring or expected to occur under such Late Development Plan, including amendments to add Development activities to such Late Development Plan (including new Indications).  In addition, at least [***], Sanofi will prepare an updated Late Development Plan (including an updated U.S. Development Budget) for JSC review in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.1.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(ii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, during the applicable Opt-In Period, no annual update or material amendment to the Late Development Plan will be effective unless and until approved by the JSC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(ii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, during the applicable Opt-In Period, any additional amendments to the Late Development Plan will be subject to JSC approval in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 5.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.1.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event of any inconsistency between the Late Development Plan and this Agreement, the terms of this Agreement will prevail.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diligence</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, during the Sanofi Participation Term, Sanofi will (a) [***], and (b) use Commercially Reasonable Efforts to (i) Develop and (ii) seek Marketing Approval for, in each case ((i)-(ii)), at least one (1) Licensed Product Directed Against such Collaboration Target in at least one (1) Indication in the Field in [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.1	If, [***], Kymera will, upon Sanofi&#x2019;s written request [***], perform additional Research activities, including to identify and synthesize Backup Degraders (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Research</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), in accordance with this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that Sanofi will not have a right to request such Backup Research with respect to a Collaboration Target after the first Marketing Approval of a Licensed Product Directed Against such Collaboration Target.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.2	Prior to Kymera commencing any Backup Research for such Collaboration Target, Kymera will notify Sanofi of any Reversion Compounds which are subject to any Pre-Existing Restrictions, and the Parties will mutually agree (such agreement not to be unreasonably withheld, conditioned or delayed) upon a reasonable written plan for such Backup Research (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Research Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), which will include [***] (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Research Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Sanofi may only include in the Backup Research Plan any Reversion Compounds which are not subject to Pre-Existing Restrictions at the time the Backup Research Plan is prepared; thereafter, any such Reversion Compound will no longer be classified as a &#x201c;Reversion Compound&#x201d; and instead will be classified as a &#x201c;Collaboration Compound&#x201d; under the Backup Research Plan.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.3	During the Backup Research Term, either Party may, at any time, propose updates or amendments to any Backup Research Plan, which updates or amendments will only become effective by mutual agreement of the Parties.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.4	Following the Parties&#x2019; agreement on a Backup Research Plan, during the Backup Research Term, Kymera, directly or through its Affiliates or Subcontractors, will use diligent efforts to perform the Backup Research in accordance with such Backup Research Plan, in a professional and timely manner and in accordance with all Applicable Laws.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.5	Sanofi will reimburse Kymera in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for Kymera&#x2019;s [***] actually incurred by or on behalf of Kymera or its Affiliates (a) during the Backup Research Term, (b) in accordance with the Backup Research Budget, and (c) in connection with conducting Backup Research activities under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in accordance with the Backup Research Plan.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.6	[***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.7	During the Backup Research Term, Kymera will use the screening assays in accordance with the procedures set forth in the Backup Research Plan to determine whether a given Degrader that is Researched under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> satisfies the Screening Criteria or the Backup Degrader Criteria.  All Degraders that meet the Screening Criteria during the Backup Research Term will be Collaboration Compounds under this Agreement, subject to the reversion rights set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding anything herein to the contrary, any Degraders that are Researched by or on behalf of Kymera under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that do not meet the Screening Criteria will be classified as Excluded Compounds, unless [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.8	During the Backup Research Term, Kymera will furnish to the JRDC, within [***], an update on Kymera&#x2019;s progress under the Backup Research Plan for the applicable Collaboration Target during the relevant Calendar Quarter, including a summary of any results and data generated by Kymera under such Backup Research Plan and an overview of the resources (including an overview of FTEs used by such Party for such Backup Research activities) allocated to activities under such Backup Research Plan during the relevant Calendar Quarter.  Kymera will provide the JRDC with such other information, results and data with respect to the Backup Research activities under the Backup Research Plan as any member of the JRDC may reasonably request that are in Kymera&#x2019;s possession or control.  Kymera will provide Sanofi a reasonable opportunity via the JRDC to discuss and provide input with respect to Kymera&#x2019;s Backup Research activities under the Backup Research Plan, including with respect to the prioritization of Backup Research activities.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.9	In addition to, and without limiting, the reporting requirements in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, during the Backup Research Term, Kymera will furnish to the JRDC, within [***], a written report on Kymera&#x2019;s Backup Research activities with respect to Collaboration Compounds that are Researched under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and have the potential to be classified as Backup Degraders.  Such reports will [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.10	During the Backup Research Term, within [***] after Kymera reasonably believes that it has identified a Collaboration Compound that satisfies all of the Backup Degrader Criteria, Kymera will present a written report to Sanofi that identifies such Collaboration Compound [***]. Sanofi may, in its discretion and through the JRDC, request any other information, results or data with respect to such Collaboration Compound as set forth more fully in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.9.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Within [***] after the delivery of such report (or such longer period of time as may be reasonably determined by the JRDC, but in no event longer than [***]), the JRDC will (a) meet, discuss and review the report and associated data, results and information and (b) determine whether such Collaboration Compound satisfies the Backup Degrader Criteria.  If the JRDC determines that such Collaboration Compound satisfies the Backup Degrader Criteria, then such Collaboration Compound will be classified as a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Backup Degrader</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; under this Agreement.  If the JRDC does not believe that such Collaboration Compound satisfies the Backup Degrader Criteria, then Kymera will use diligent efforts to conduct additional Research activities during the remainder of the Backup Research Term in accordance with the Backup Research Plan, and thereafter present a report to the JRDC as and to the extent applicable in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event that the JRDC does not agree on whether such Collaboration Compound satisfies the Backup Degrader Criteria, then such dispute will be resolved in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding the foregoing, Sanofi may determine, in its sole discretion, that a Collaboration Compound that satisfies at</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">least certain of the Backup Degrader Criteria during the Backup Research Term will be selected as a &#x201c;Backup Degrader&#x201d; notwithstanding that it does not satisfy all of the Backup Degrader Criteria.  Any selection of a Collaboration Compound as a Backup Degrader by the JRDC, by the R&amp;D Expert in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or by Sanofi pursuant to the preceding sentence, will be recorded in the minutes of the JRDC.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.11	In the event that Sanofi has </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> written notice to Kymera (including via the JRDC) that [***], then, within [***] of the date of receipt of such written notice, Kymera will permit Sanofi to examine the relevant books and records of Kymera and its Affiliates, as may be reasonably necessary to verify the Backup Research updates and progress reports submitted by Kymera in accordance with this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such examination will be subject to customary and reasonable due diligence procedures to preserve the confidential nature of any books or records.  An examination by Sanofi under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (a) will occur not more than [***], (b) will be limited to the pertinent books and records for any Calendar Year ending not more than [***] before the date of the written notice, (c) will be conducted in such a manner to minimize, to the extent reasonably possible, the period of examination and in no case shall such period exceed [***], and (d) will be conducted by the minimum number of Sanofi employees as necessary to provide requisite subject matter expertise and conduct the review in the allotted timeframe, each of whom shall have appropriate experience in the Research of small molecule compounds and candidates; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that if any examination by Sanofi under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reveals any material discrepancy, Kymera will permit Sanofi to conduct additional examination of pertinent books and records for Calendar Years ending not more than [***] before the date of the written notice, during a period limited to minimize the days of examination as much as possible and in no case more than an additional [***].  Sanofi will be </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> access to such books and records at Kymera&#x2019;s facility or facilities where such books and records are normally kept and such examination will be conducted during Kymera&#x2019;s normal business hours.  Upon completion of the examination, Sanofi will provide Kymera and the JRDC a written report disclosing the reason(s) for the difference between the relevant report provided by Kymera and the results and data that should have been generated and the activities that should have been conducted by Kymera during the relevant time.  The costs and fees of any examination conducted by Sanofi under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be borne by Sanofi.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5.12	Notwithstanding anything herein to the contrary, in no event will Kymera be required to conduct any Development activities for any Backup Degraders.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reversion Compounds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.6.1	Effective as of the effective date of expiration of the First Additional Degrader Research Term, all Collaboration Compounds and Collaboration Candidates Directed Against Collaboration Target 1, that were Researched by or on behalf of Kymera under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> but are (a) [***], or (b) [***], will, in each case ((a)-(b)) cease to be Collaboration Compounds, Collaboration Candidates or Licensed Products and will be classified as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reversion Compounds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; as of such date [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.6.2	Effective as of the effective date of expiration of the Second Additional Degrader Research Term, all Collaboration Compounds and Collaboration Candidates</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Directed Against Collaboration Target 1 that were Researched by or on behalf of Kymera under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> but are (a) [***], or (b) [***], will, in each case ((a)-(b)) cease to be Collaboration Compounds, Collaboration Candidates or Licensed Products and will be classified as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reversion Compounds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; as of such date [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.6.3	Effective as of the expiration of the Backup Research Term (if any), all Collaboration Compounds and Collaboration Candidates Directed Against Collaboration Target 1 that were Researched by or on behalf of Kymera under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> but are (a) [***], or (b) [***], will, in each case ((a)-(b)) cease to be Collaboration Compounds, Collaboration Candidates or Licensed Products and will be classified as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reversion Compounds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; as of such date.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.6.4	Each of the applicable dates for reversion referenced in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 5.6.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be referred to in this Agreement as the applicable &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reversion Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.6.5	In addition to the foregoing, if at any time prior to the applicable Reversion Dates, [***], then the Parties will promptly meet and discuss the same in good faith through the JRDC and JPC.  In the event that both Parties, through the JRDC and JPC working together, agree to proceed with an early reversion of any such Collaboration Compounds or Collaboration Candidates to Kymera, then the JRDC will identify the applicable Collaboration Compounds or Collaboration Candidates as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reversion Compounds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and the applicable &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reversion Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; in the minutes of the JRDC.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.6.6	From and after each applicable Reversion Date, subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, (a) Kymera will retain all right, title and interest in and to all corresponding Reversion Compounds, (b) Sanofi&#x2019;s licenses and rights under this Agreement will terminate with respect to all corresponding Reversion Compounds, and (c) Kymera will grant a license to Sanofi with respect to the corresponding Reversion Compound Data in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.1.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.6.7	Notwithstanding anything to the contrary, and for the avoidance of doubt, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Opt-In Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.1	Subject to the remainder of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, on a Collaboration Target-by-Collaboration Target basis, Sanofi hereby grants to Kymera an exclusive option, exercisable in Kymera&#x2019;s sole discretion one (1) time per Collaboration Target, to fund fifty percent (50%) of the U.S. Development Costs for Opt-In Products Directed Against a given Collaboration Target in the Field in the United States and share equally (50:50) in the Net Profits and Net Losses of Commercializing Opt-In Products Directed Against such Collaboration Target in the Field in the United States (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Opt-In Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.2	On a Collaboration Target-by-Collaboration Target basis, on the later of (a) the date that is reasonably anticipated to be [***] of a Licensed Product Directed Against the relevant Collaboration Target or (b) [***] after the Sanofi Participation Election Effective Date, Sanofi will provide Kymera with the Opt-In Data Package with respect to such</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target, and Kymera will use such Opt-In Data Package (and any additional information provided by Sanofi pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) solely to determine whether to exercise the corresponding Kymera Opt-In Right with respect to such Collaboration Target.  Additionally, Sanofi will make all material data within the Opt-In Data Package for a Collaboration Target available to Kymera through an electronic data room.  Notwithstanding anything herein to the contrary, Sanofi shall not be permitted to [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.3	On a Collaboration Target-by-Collaboration Target basis, if such Opt-In Data Package for a given Collaboration Target is incomplete, Kymera may notify Sanofi of the incomplete status of such Opt-In Data Package in writing including any items that, in Kymera&#x2019;s reasonable determination made in good faith, should have been included in the Opt-In Data Package but were not included therein within [***] after receipt thereof.  Following receipt of such notice, Sanofi will promptly deliver to Kymera the additional information requested by Kymera to complete such Opt-In Data Package. For clarity, delivery of such incomplete Opt-In Data Package will not trigger the [***] period after which the Kymera Opt-In Deadline would occur pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, but such [***] period after which the Kymera Opt-In Deadline would occur pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will thereafter be triggered on the date of Kymera&#x2019;s receipt of the additional information requested by Kymera to complete such Opt-In Data Package (such date of receipt in no event to exceed the [***] period described above).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.4	Following delivery of the complete Opt-In Data Package, and prior to the Kymera Opt-In Deadline, Kymera will be entitled to request, through the Alliance Managers and with reasonable advanced notice, [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.5	On a Collaboration Target-by-Collaboration Target basis, Kymera will have the right, in its sole discretion, to exercise the Kymera Opt-In Right for a given Collaboration Target by delivering to Sanofi the following within [***] after the delivery of the Opt-In Data Package with respect to such Collaboration Target (the end of such [***] period, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Opt-In Deadline</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;):  (a) written notice of exercise (each such notice, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Opt-In Exercise Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and (b) reasonable documentation demonstrating that Kymera has enough cash to cover its allocation of costs and expenses according to the proposed budget for the first year of Development and Commercialization of Licensed Products contemplated by the relevant Opt-In Data Package, and a reasonable plan to cover its allocation of costs and expenses according to the proposed budget for the subsequent [***] of Development and Commercialization of Licensed Products contemplated by the relevant Opt-In Data Package.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.6	On a Collaboration Target-by-Collaboration Target basis, if Kymera provides a Kymera Opt-In Exercise Notice for a given Collaboration Target in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, then (a) Kymera will have exercised the Kymera Opt-In Right with respect to such Collaboration Target, and (b) the date of receipt of such Kymera Opt-In Exercise Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">will be the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Opt-In Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; with respect to such Collaboration Target.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.7	On a Collaboration Target-by-Collaboration Target basis, if Kymera fails to provide a Kymera Opt-In Exercise Notice in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> with</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">respect to a Collaboration Target prior to the Kymera Opt-In Deadline for such Kymera Opt-In Right, the Kymera Opt-In Right will expire and be of no further force or effect with respect to such Collaboration Target.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.8	On a Collaboration Target-by-Collaboration Target basis, if Kymera exercises the Kymera Opt-In Right with respect to a Collaboration Target, the Parties will negotiate in good faith the terms of a cost and profit sharing agreement which will include the terms set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost/Profit Sharing Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), within [***] of Sanofi&#x2019;s receipt of the Kymera Opt-In Exercise Notice with respect to such Collaboration Target</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> provided </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that the terms of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall govern until such Cost/Profit Sharing Agreement is executed.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.9	On a Collaboration Target-by-Collaboration Target basis, the Cost/Profit Sharing Agreement will provide that each of Kymera and Sanofi will be entitled to and bear fifty percent (50%) of all Net Profits and Net Losses incurred in each Calendar Quarter that the Cost/Profit Sharing Agreement is in effect with respect to all Opt-In Products being sold in the United States by or on behalf of the Parties or their Affiliates or (sub)licensees, pursuant to the terms of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost/Profit Share</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  On a Collaboration Target-by-Collaboration Target basis, the Cost/Profit Share will commence on the Kymera Opt-In Effective Date and immediately terminate on the earliest to occur of (w) [***] of Kymera providing written notice that is terminating the Cost/Profit Share (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opt-Out Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), (x) [***] (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opt-In Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  If the Opt-In Period for a Collaboration Target terminates pursuant to clauses (w) or (x) in the immediately preceding sentence, then the Royalty Term will apply with respect to such Collaboration Target.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.10	If Kymera fails to pay amounts owed under the Opt-In Period for U.S. Development Costs or the Cost/Profit Share (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Funding Failure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), then, subject to the cure period set forth in the Cost/Profit Sharing Agreement, Sanofi will be entitled, in its sole discretion, to [***]. The remedies set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be Sanofi&#x2019;s sole and exclusive remedy with respect to such Funding Failure.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.11	Notwithstanding anything to the contrary:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	if the Opt-In Period terminates pursuant to clause (w) of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, then the Co-Promote Period will terminate on the [***];</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> provided </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that if [***];</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	if the Opt-In Period terminates pursuant to clauses (x) or (z) of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, then the Co-Promote Period will terminate on the [***] (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Promotion Wind-Down Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> if [***]; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	if the Opt-In Period terminates pursuant to clause (y) of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, then the Co-Promote Period will terminate on the effective date of termination of the Opt-In Period.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7.12	For clarity, the terms of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are on a Collaboration Target-by-Collaboration Target basis, and the application of such terms for a given Collaboration Target have no effect on the other Collaboration Target.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.8	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.8.1	On a Collaboration Target-by-Collaboration Target basis, unless and until Kymera exercises the Kymera Opt-In Right for a given Collaboration Target, during the Sanofi Participation Term with respect to such Collaboration Target, Sanofi will be solely responsible for all costs and expenses incurred in connection with the Development of Collaboration Compounds, Collaboration Candidates and Licensed Products Directed Against such Collaboration Target in the Field in the Territory.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.8.2	On a Collaboration Target-by-Collaboration Target basis, if Kymera exercises the Kymera Opt-In Right for a given Collaboration Target, then during the applicable Opt-In Period, (a) the Parties will share all U.S. Development Costs for all Development activities for Opt-In Products Directed Against such Collaboration Target in the Field in the United States in accordance with the applicable Cost/Profit Sharing Agreement, and (b) Sanofi will be solely responsible for all costs and expenses incurred in connection with the Development of Collaboration Compounds, Collaboration Candidates and Licensed Products Directed Against such Collaboration Target in the Field in the Rest of the World.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.9	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Records; Reporting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.9.1	Each Party will maintain, and [***] to maintain, records of the Development activities under this Agreement in sufficient detail and in good scientific manner appropriate for scientific, patent and regulatory purposes, which will be complete and accurate in all material respects and will fully and properly reflect all work done, data and developments made, and results achieved.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.9.2	Each Party will furnish to the JSC, (a) prior to any Kymera Opt-In Effective Date, on a semi-annual basis, to the extent applicable to such Party, and (b) during the applicable Opt-In Period, within [***], to the extent applicable to such Party, in each case ((a)-(b)), an update on such Party&#x2019;s progress under the Late Development Plan for the applicable Collaboration Target during the relevant period, including a summary of any results and data generated by such Party under such Late Development Plan and an overview of the resources (including an overview of FTEs used by such Party for such Development activities), allocated to activities under such Late Development Plan during the relevant period. Such Party will provide the JSC with such other material information, results and data with respect to the Development activities under the Late Development Plan as any member of the JSC may reasonably request that are in such Party&#x2019;s possession or control. In the event Kymera is a Reporting Company, Sanofi will provide Kymera such information regarding its Development activities under the Late Development Plan that is necessary for Kymera to comply with Applicable Law (including the rules and regulations promulgated by the United States Securities and Exchange Commission).</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.9.3	On a Collaboration Target-by-Collaboration Target basis, [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 6<br>Commercialization</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to the terms and conditions set forth in this Agreement, on a Collaboration Target-by-Collaboration Target basis, during the Sanofi Participation Term, the Parties will conduct Commercialization activities for the Licensed Products Directed Against such Collaboration Target in the Field in the Territory as further set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, during the Sanofi Participation Term, Sanofi will be solely responsible for all Commercialization activities relating to the Licensed Products Directed Against such Collaboration Target in the Field in the Territory, including the booking of all sales of such Licensed Products, subject to Kymera&#x2019;s right to perform certain Co-Promotion activities (with Sanofi) in the Field in the United States for Opt-In Products Directed Against such Collaboration Target as specified in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Co-Promote Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to the remainder of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, on a Collaboration Target-by-Collaboration Target basis, Sanofi hereby grants to Kymera an exclusive option, exercisable in Kymera&#x2019;s sole discretion one (1) time per Collaboration Target, to conduct between [***] and [***] of all Co-Promotion activities for Opt-In Products Directed Against such Collaboration Target in the Field in the United States (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Co-Promote Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such Kymera Co-Promote Right will expire immediately with respect to such Collaboration Target if Kymera did not exercise the Kymera Opt-In Right prior to the corresponding Kymera Opt-In Deadline or the corresponding Cost/Profit Share has been terminated.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2.1	On a Collaboration Target-by-Collaboration Target basis, on or about the date is reasonably anticipated to be [***], Sanofi will provide Kymera with the Co-Commercialization Plan with respect to such Collaboration Target, and Kymera will use such Co-Commercialization Plan (and any additional information provided by Sanofi pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) solely to determine whether to exercise the corresponding Kymera Co-Promote Right with respect to such Collaboration Target.  Additionally, Sanofi will make all material data within the Co-Commercialization Plan for a Collaboration Target available to Kymera through an electronic data room.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2.2	On a Collaboration Target-by-Collaboration Target basis, if such Co-Commercialization Plan for a given Collaboration Target is incomplete with respect to related Co-Promotion activities, Kymera may notify Sanofi of the incomplete status of such Co-Commercialization Plan in writing including any items that, in Kymera&#x2019;s reasonable determination made in good faith, should have been included in the Co-Commercialization Plan but were not included therein within [***] after receipt thereof.  [***].  For clarity, delivery of such incomplete Co-Commercialization Plan will not trigger the [***] period after which the Kymera Co-Promote Right Deadline would occur pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, but such [***] period after which the Kymera Co-Promote Right Deadline would occur pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will thereafter be triggered on the date of Kymera&#x2019;s receipt of the additional information requested by Kymera to complete such Co-Commercialization Plan.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2.3	Following delivery of the complete Co-Commercialization Plan, and prior to the Kymera Co-Promote Right Deadline, Kymera will be entitled to request, through the Alliance Managers and with reasonable advanced notice, [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2.4	On a Collaboration Target-by-Collaboration Target basis, Kymera will have the right, in its sole discretion, to exercise the Kymera Co-Promote Right for a given Collaboration Target by delivering to Sanofi the following within [***] after the delivery of the Co-Commercialization Plan with respect to such Collaboration Target (the end of such [***] period, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Co-Promote Right Deadline</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;):  (a) written notice of exercise (each such notice, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Co-Promote Right Exercise Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and (b) reasonable documentation demonstrating that Kymera has (i) the necessary sales force in place to Co-Promote the Licensed Products Directed Against such Collaboration Target in the Field in the United States or (ii) a plan reasonably designed to build such sales force to Co-Promote the Licensed Products Licensed Products Directed Against such Collaboration Target in the Field in the United States at least [***] before the anticipated First Commercial Sale of the first Licensed Product Directed Against such Collaboration Target in the Field in the United States; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, Kymera will not be entitled to use in such sales force any field personnel who are responsible for promoting Collaboration Target 1 Degraders in the Excluded Field.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2.5	On a Collaboration Target-by-Collaboration Target basis, if Kymera provides a Kymera Co-Promote Right Exercise Notice for a given Collaboration Target in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, then (a) Kymera will have exercised the Kymera Co-Promote Right with respect to such Collaboration Target, and (b) the date of such Kymera Co-Promote Right Exercise Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">will be the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Co-Promote</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; with respect to such Collaboration Target.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2.6	On a Collaboration Target-by-Collaboration Target basis, if Kymera fails to provide a Kymera Co-Promote Right Exercise Notice in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> with respect to a Collaboration Target prior to the Kymera Co-Promote Right Deadline for such Kymera Co-Promote Right, the Kymera Co-Promote Right will expire and be of no further force or effect with respect to such Collaboration Target.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2.7	On a Collaboration Target-by-Collaboration Target basis, if Kymera exercises the Kymera Co-Promote Right with respect to a Collaboration Target, the Parties will negotiate in good faith the terms of a definitive Co-Promotion Agreement covering the Co-Promotion activities for Licensed Products Directed Against such Collaboration Target in the Field in the United States which will include the terms set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Promotion Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), within [***] of Sanofi&#x2019;s receipt of the Kymera Co-Promote Exercise Notice with respect to such Collaboration Target; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, the terms of Exhibit B shall govern until such Co-Promotion Agreement is executed.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2.8	For clarity, the terms of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are on a Collaboration Target-by-Collaboration Target basis, and the application of such terms for a given Collaboration Target have no effect on the other Collaboration Target.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Commercialization Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, but only during the Co-Promote Period:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.3.1	The Commercialization of the Opt-In Products Directed Against such Collaboration Target in the United States will be conducted pursuant to the Co-Commercialization Plan, which will at a minimum include a reasonably detailed plan for the Commercialization of the Opt-In Products Directed Against such Collaboration Target in the United States.  At least [***] prior to the anticipated date of First Commercial Sale of the first Opt-In Product Directed Against such Collaboration Target in the United States (or such other time as may be mutually agreed by the Parties), Sanofi will prepare, in consultation with Kymera via the JCC, a proposed initial Co-Commercialization Plan for the JCC&#x2019;s review, discussion and approval.  The JCC will endeavor to approve the initial Co-Commercialization Plan at least [***] prior to anticipated date of First Commercial Sale of an Opt-In Product Directed Against such Collaboration Target in the United States.  The initial Co-Commercialization Plan for a given Collaboration Target will not be effective unless and until approved by the JCC.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.3.2	On a Collaboration Target-by-Collaboration Target basis, the Co-Commercialization Plan for a given Collaboration Target will contain a [***] rolling budget for the probable Allowed Expenses for the Commercialization activities to be performed for the United States during the then-current Calendar Year (broken down by Calendar Quarter) and the [***] of the Co-Commercialization Plan, and will be updated by Sanofi annually on a rolling [***] period basis.  Such initial Co-Commercialization Plan will include a budget for the then-current Calendar Year commencing as of the date of such initial Co-Commercialization Plan and ending [***] of such Calendar Year and [***] thereafter [***] (each such budget, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Commercialization Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  The [***] of the initial Co-Commercialization Budget will be binding.  [***].  The initial Co-Commercialization Budget for the Co-Commercialization Plan, and each update thereto, will be prepared by Sanofi based on Sanofi&#x2019;s good faith estimation, consistent with its standard internal practices, of the probable Commercialization activities to be conducted in the United States during the relevant Co-Commercialization Budget period, and based on and consistent with the documents and information related to the Opt-In Products Directed Against such Collaboration Target prepared by Sanofi for its internal use and reference in the budgeting process.  Upon request by a Party, the JCC will discuss the appropriate level of detail to include in a Co-Commercialization Budget for the applicable Commercialization activities to be performed during the period covered by such Co-Commercialization Budget.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.3.3	On a Collaboration Target-by-Collaboration Target basis, Sanofi, in consultation with Kymera via the JCC, will (a) review the Co-Commercialization Plan for a given Collaboration Target at least annually for the purpose of considering appropriate amendments thereto to be proposed to the JCC and (b) then no later than [***] of the then-current Calendar Year beginning with the first full Calendar Year of the initial Co-Commercialization Plan, provide the JCC with a proposed updated Co-Commercialization Plan for the JCC&#x2019;s review, discussion and approval.  The JCC will endeavor to approve such updated Co-Commercialization Plan for such Collaboration Target no later than [***] of the then-current Calendar Year.  Annual updates to the Co-Commercialization Budget for such Collaboration Target will contain a proposed Co-Commercialization Budget covering (i) the next Calendar Year, broken down by Calendar Quarter, and (ii) each of the [***], in each case ((i) and (ii)), in accordance with the requirements set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.3.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In addition to the annual update, either Party, through its representatives on the JCC, may propose amendments</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to the Co-Commercialization Plan for such Collaboration Target at any time.  No update or amendment to the Co-Commercialization Plan for such Collaboration Target will be effective unless and until approved by the JCC.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercialization Activities in the United States</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.4.1	On a Collaboration Target-by-Collaboration Target basis, during the applicable Co-Promote Period, for each Opt-In Product Directed Against such Collaboration Target in the United States, Sanofi will be solely responsible for all Commercialization activities for each Opt-In Product Directed Against such Collaboration Target in the Field in the United States, including handling all returns, recalls, order processing, invoicing and collection, booking of sales, inventory and receivables, and managed and government pricing programs, other than Kymera&#x2019;s Co-Promotion activities with respect to such Opt-In Product Directed Against such Collaboration Target as set forth in the Co-Promotion Agreement.  Kymera will not accept orders for any Opt-In Product Directed Against such Collaboration Target or make sales for its own account or for Sanofi&#x2019;s account, and if Kymera receives any order for an Opt-In Product Directed Against such Collaboration Target in the United States, then it will refer such orders to Sanofi for acceptance or rejection.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.4.2	On a Collaboration Target-by-Collaboration Target basis, if Kymera does not exercise the Kymera Co-Promote Right with respect to a given Collaboration Target (or thereafter exercises the corresponding Kymera Co-Promote Opt-Out Right for such Collaboration Target), then Sanofi will be solely responsible for all Commercialization activities for each Licensed Product Directed Against such Collaboration Target in the Field in the United States, including development and implementation of a promotional strategy, handling all returns, recalls, order processing, invoicing and collection, booking of sales, inventory and receivables, and managed and government pricing programs.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercialization Activities in the Rest of World</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, Sanofi will be solely responsible for all Commercialization activities for each Licensed Product Directed Against such Collaboration Target in the Field in the Rest of World including development and implementation of a promotional strategy, handling all returns, recalls, order processing, invoicing and collection, booking of sales, inventory and receivables, and managed and government pricing programs.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Commercialization Activities in the Excluded Field</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  For clarity, in no event will any of the Commercialization activities under this Agreement be conducted in the Excluded Field.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diligence</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.7.1	On a Collaboration Target-by-Collaboration Target basis, during the applicable Co-Promote Period (if any), Kymera will use diligent efforts to perform its Co-Promotion activities for the Opt-In Products Directed Against such Collaboration Target in the Field in the United States in accordance with the Co-Commercialization Plan and the Co-Promotion Agreement for such Collaboration Target.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.7.2	On a Collaboration Target-by-Collaboration Target basis, Sanofi will use diligent efforts to perform its Commercialization activities for the Opt-In Products Directed Against such Collaboration Target in the Field in the United States in accordance with the Co-Commercialization Plan and the Co-Promotion Agreement (if any) for such Collaboration Target.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.7.3	On a Collaboration Target-by-Collaboration Target basis, during the Sanofi Participation Term for a given Collaboration Target, [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.8	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reports</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. During the Co-Promote Period (if any):</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.8.1	On a Collaboration Target-by-Collaboration Target basis, [***], each Party will provide to the JCC during the applicable Co-Promote Period (if any), a summary of material Commercialization activities undertaken by or on behalf of such Party in the Field in the Territory during such Calendar Quarter with respect to Licensed Products Directed Against such Collaboration Target, and an overview of the resources, including an overview of FTEs, allocated to activities under the Co-Commercialization Plan during the relevant Calendar Quarter.  Such Party will provide the JCC with such other information with respect to the Commercialization activities as any member of the JCC may reasonably request that are in such Party&#x2019;s Control.  Each Party will maintain records relating to its sales force and account management.  Kymera&#x2019;s obligations under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.8.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will only apply during the Co-Promote Period for a particular Collaboration Target.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.8.2	Sanofi will be responsible for the creation, preparation, production, reproduction, review (medical, legal, and regulatory), and filing with the applicable Regulatory Authorities, of promotional materials relating to each Licensed Product in the Field in the Territory.  All such promotional materials will be compliant with Applicable Law.  Unless prohibited under Applicable Law, Sanofi will include a reference in such promotional materials to such Licensed Product as being marketed by Sanofi and Kymera in the Field in the Territory.  Sanofi will own all rights, title, and interest, in and to any and all promotional materials for any Licensed Product in the Field in the Territory.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.8.3	On a Collaboration Target-by-Collaboration Target basis, [***].</font></p>
  <p style="margin-left:0.8%;text-indent:6.72%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.9	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Advertising and Promotional Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.9.1	Sanofi, in its reasonable discretion, will lead and develop (and thereafter modify and update) a branding strategy (including positioning, messages, logo, colors, and other visual branding elements) (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Branding Strategy</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) for each Licensed Product in the Field in the Territory.  During the Research Term, Kymera, in its reasonable discretion, will lead and develop the International Nonproprietary Name (INN) submission request process for Licensed Products Directed Against Collaboration Target 1; provided that (i) Kymera shall provide a draft of the INN submission to Sanofi prior to its submission, (ii) Sanofi shall have [***] to review such submission and provide comments to Kymera and (iii) Kymera shall consider any such comments provided by Sanofi in good faith;  provided further that, in the event that Applicable Law requires Sanofi to be the filing party for such INN submission, Kymera shall continue to lead and develop the INN submission request process, and Sanofi</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">shall be responsible for filing the INN.  During the Sanofi Participation Term (if any), Sanofi, in its reasonable discretion, will lead and develop the INN submission request process for Licensed Products Directed Against Collaboration Target 1; provided that, (i) Sanofi shall provide such INN submission to Kymera prior to its submission, (ii) Kymera shall have [***] to review such submission and provide comments to Sanofi and (iii) Sanofi shall consider any such comments provided by Kymera in good faith.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.9.2	Sanofi will be responsible for the creation, preparation, production, reproduction, review (medical, legal, and regulatory), and filing with the applicable Regulatory Authorities, of Promotional Materials relating to each Licensed Product.  All such Promotional Materials will be compliant with Applicable Law. During the Co-Promote Period and in respect of materials for the U.S., (i) all Promotional Materials will be consistent in all material respects with the Co-Commercialization Plan for such Licensed Product and (ii) unless prohibited under Applicable Law, Sanofi will include a reference in such Promotional Materials to such Licensed Product as being marketed by Sanofi and Kymera in the approved Indication in the Field in the Territory.  Sanofi will own all rights, title, and interest, in and to any and all Promotional Materials for any Licensed Product.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.9.3	Sanofi will develop and approve packaging and labeling for each Licensed Product, which in all cases will be in accordance with Applicable Law. During the Co-Promote Period, such activities further will be consistent with the Co-Commercialization Plan.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.9.4	Sanofi will have the sole right to determine and own the trademarks used in connection with the Development, Manufacture and Commercialization of the Licensed Products on a worldwide basis.  Subject to any pre-existing trademarks a Party may have, neither Party will, directly or indirectly:  (a) use in their respective businesses, any trademark that is confusingly similar to, misleading, or deceptive with respect to or that dilutes any trademark for a Licensed Product; and (b) do any act which endangers, destroys, or similarly affects, in any material respect, the value of the goodwill pertaining to the trademarks for any Licensed Product.  Each Party agrees to conform to the customary industry standards for the protection of trademarks for Licensed Products and such guidelines of Sanofi with respect to manner of use (in the case of Kymera, as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in writing by Sanofi) of the trademarks for Licensed Products.  Without limiting any pre-existing trademarks a Party may have, neither Party will, directly or indirectly, attack, dispute, or contest the validity of or ownership of such trademark anywhere in the Territory or any registrations issued or issuing with respect thereto.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.10	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales and Distribution</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding anything to the contrary contained in this Agreement, Sanofi and its Affiliates will, as between the Parties, have the sole right to book sales, warehouse and distribute Licensed Products in the Field in the Territory.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.11	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recalls, Market Withdrawals or Corrective Actions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event that any Regulatory Authority issues or requests a recall or takes a similar action in connection with a Licensed Product in the Field in the Territory, Sanofi will, as between the Parties, have the sole right to decide whether to conduct a recall and the manner in which any such recall will be conducted.  Without limiting any indemnification obligation Kymera may have under this</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement, (a) during the applicable Opt-In Period, [***], (b) during any time other than the applicable Opt-In Period, [***], and (c) [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.12	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pricing Approvals and Combination Product Decisions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  For all Licensed Products, Sanofi will exclusively control without coordination by the JCC (a) all Price Approvals and (b) all decisions with respect to Commercialization of such Licensed Products as Combination Products.  Kymera will provide Sanofi with reasonable assistance and cooperation with respect to obtaining pricing and reimbursement approvals for all such Licensed Products, at Sanofi&#x2019;s request and expense, subject to the Cost/Profit Share, if applicable.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.13	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subcontracts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to any applicable Cost/Profit Sharing Agreement or Co-Promote Agreement, each Party will be entitled to utilize the services of Third Parties to perform Commercialization activities under this Agreement, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that (a) such Party will require that such Third Party perform its obligations in a manner consistent with the terms of this Agreement, (b) if such Party is Kymera, (i) Sanofi will have the right to conduct customary reviews and audits of Kymera and its Affiliates and (ii) Kymera will use diligent efforts to obtain for Sanofi the right to conduct customary reviews and audits of its Approved Third Party Contractors, in each case ((i) and (ii)), upon [***] prior written notice, to confirm such Parties&#x2019; compliance with the Co-Promotion Agreement and (c) such Party will remain at all times fully liable for its responsibilities. Each Party will require that any such Third Party agreement entered into by such Party pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.13</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [***].  For clarity, [***].  In each agreement with a Third Party that relates solely to Collaboration Compounds, Collaboration Candidates or Licensed Products, the subcontracting Party will use Commercially Reasonable Efforts to require that such agreement is freely assignable.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 7<br>Regulatory Matters</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Lead Responsibilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, on a Collaboration Target-by-Collaboration Target basis, the Regulatory Lead will be solely responsible for all regulatory matters in the Territory relating to the Collaboration Candidates and Licensed Products Directed Against such Collaboration Target for which such Party is the Regulatory Lead.  The Regulatory Lead will own all INDs, NDAs, Marketing Approvals, Regulatory Filings, Price Approvals and related regulatory documents in the Territory with respect to such Collaboration Candidates and Licensed Products Directed Against such Collaboration Target, including any drug master files maintained by such Regulatory Lead solely with respect thereto in the Territory.  The role of Regulatory Lead may transition from one Party to the other Party as contemplated by the definition of such term, and the Parties will document such transition in writing.  On a Collaboration Target-by-Collaboration Target basis, the Regulatory Lead will be the sole point of contact with Regulatory Authorities with respect to the Collaboration Candidates and Licensed Products Directed Against such Collaboration Target.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assignment of Regulatory Filings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  To the extent not already completed pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1.1(e)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, On a Collaboration Target-by-Collaboration Target basis, within [***] following Sanofi Participation Election Effective Date for a given Collaboration Target (if any), Kymera will transfer and assign to Sanofi Kymera&#x2019;s entire right, title, and interest in and to all INDs, other Regulatory Filings, and other regulatory documentation in the Territory with respect</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to all Collaboration Candidates and Licensed Products Directed Against such Collaboration Target that is in the possession and control of Kymera, excluding any drug master files maintained by Kymera or a Third Party solely with respect thereto.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Communications with Regulatory Authorities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.3.1	On a Collaboration Target-by-Collaboration Target basis, (a) Kymera, as Regulatory Lead, with respect to Material Communications with a Regulatory Authority in the Territory, and (b) Sanofi, as Regulatory Lead prior to and during the Opt-In Period, with respect to Material Communications with a Regulatory Authority in the Major Market Countries, as applicable, will:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	provide the JSC (or a Committee or Subcommittee to which the JSC has delegated responsibility) for its review and discussion with a brief description in English of the principal issues raised in each Material Communication with Regulatory Authorities with respect to any Collaboration Candidates or Licensed Products Directed Against such Collaboration Target for which such Party is the Regulatory Lead, including any communications with a Regulatory Authority with respect to any audit or inspection of such Party or any of its Affiliates or Subcontractors conducted by a Regulatory Authority and related findings thereunder to the extent such audit or inspection relates to the activities conducted under this Agreement;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	provide such descriptions of such Material Communications to the JSC as part of the quarterly updates regarding Development and Commercialization activities with respect to such Collaboration Target, if related to any Collaboration Candidates or Licensed Products Directed Against such Collaboration Target (except, solely with respect to the U.S., within [***] after receipt thereof), if related to any Collaboration Candidates or Licensed Products Directed Against such Collaboration Target; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	allow the other Party a reasonable opportunity to review and comment on such Regulatory Lead&#x2019;s proposed response to such Material Communication in advance of the transmission of such response, and the Regulatory Lead will reasonably consider all comments timely provided by such other Party in connection therewith; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that Sanofi will not be obligated to provide Kymera the right to review or comment on Sanofi&#x2019;s proposed response to a Material Communication to a Major Market Country other than the U.S., even during the Opt-In Period.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.3.2	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Sanofi, as Regulatory Lead, will keep Kymera reasonably informed of its progress with Regulatory Authorities with respect to Collaboration Candidates and Licensed Products pursuant to the Late Development Plan and JSC as part of the quarterly updates regarding Development and Commercialization activities with respect to such Collaboration Candidates and Licensed Products.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Meetings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, (a) Kymera, as Regulatory Lead, with respect to meetings with a Governmental Authority in the Territory, and (b) Sanofi, as Regulatory Lead both prior to and during the Opt-In Period, with respect to meetings with a Governmental Authority in the U.S., as applicable, will provide the other Party with reasonable advance notice of all meetings with Governmental Authorities</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pertaining to any Collaboration Candidates or Licensed Products Directed Against such Collaboration Target for which such Party is the Regulatory Lead, or with as much advance notice as practicable under the circumstances.  To the extent permitted by the applicable Government Authority, the non-Regulatory Lead may have up to [***] attend all such meetings.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Submissions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. On a Collaboration Target-by-Collaboration Target basis, (a) Kymera, as Regulatory Lead, with respect to submissions to a Governmental Authority in the Territory, and (b) Sanofi, as Regulatory Lead prior to and during the Opt-In Period, with respect to meetings with a Governmental Authority in Major Market Countries, as applicable, will provide the non-Regulatory Lead, through the JSC, with written notice of each of the following events with regard to any Collaboration Candidates or Licensed Products Directed Against such Collaboration Target for which such Party is the Regulatory Lead (a) within a reasonable period of time following the occurrence thereof (but in any event no later than [***] thereafter), to the extent notice was not previously </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pharmacovigilance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.6.1	On a Collaboration Target-by-Collaboration Target basis, prior to the Initiation of the first Clinical Trial for a Licensed Product or earlier upon the written request of either Party, the Parties will enter into a pharmacovigilance agreement setting forth the worldwide pharmacovigilance procedures for the Parties with respect to the Licensed Products, such as safety data sharing, adverse events reporting and safety profile monitoring with respect to Licensed Products Directed Against such Collaboration Target (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pharmacovigilance Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Such procedures will be in accordance with, and enable the Parties to fulfill, local and national regulatory reporting obligations under Applicable Law.  Each Party will be responsible for reporting quality complaints, adverse events and safety data related to the Licensed Products to the applicable Regulatory Authorities in its territory, as well as responding to safety issues and to all requests of Regulatory Authorities related to the Licensed Products in its territory, in each case at its own cost.  The initial global safety database will be established by Kymera using its Approved Third Party Contractors, and Kymera will, at Kymera&#x2019;s sole cost and expense, transfer such global safety database to Sanofi upon Sanofi&#x2019;s written request reasonably in advance of the desired transfer date, which transfer date will be no later than [***] and in the form requested by Sanofi.  Prior to such transfer Kymera shall provide to Sanofi all safety information obtained by Kymera for the Licensed Products prior to Sanofi&#x2019;s assumption and implementation of the global safety database in accordance with the Pharmacovigilance Agreement.  Each Party agrees to comply with its respective obligations under the Pharmacovigilance Agreement and to [***] comply with such obligations.  Among other things, the Pharmacovigilance Agreement will provide the right for each Party to cross-reference all relevant safety data of the other Party.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.6.2	Without limiting the foregoing, (a) if a Material Safety Event occurs during the Sanofi Participation Term, and [***], Sanofi will provide written notice thereof to Kymera (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Safety Event Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and (b) if a Party, in accordance with such Party&#x2019;s internal operating procedures consistently applied across its own pharmaceutical products, determines that a Material Safety Event has occurred with respect to a Clinical Trial conducted by or on behalf of Kymera under this Agreement, such Party will provide written</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">notice thereof to the other Party (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Material Safety Event Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Any such notice issued by a Party under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7.6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will include [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right of Reference</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  To the extent necessary or useful to exercise Sanofi&#x2019;s rights under the Exclusive Licenses, Kymera hereby grants, and shall ensure that its Affiliates grant, to Sanofi and its permitted Sublicensees a &#x201c;right of reference or use&#x201d; (as that term is defined in 21 C.F.R. &#167;314.3(b), as amended from time to time, and any foreign equivalent thereto), to any drug master files maintained by Kymera or a Third Party solely with respect to all INDs, other Regulatory Filings, and other regulatory documentation in the Territory with respect to all Collaboration Candidates and Licensed Products Directed Against such Collaboration Target that is in the possession and control of Kymera, and Kymera shall provide appropriate notification of Sanofi&#x2019;s access and reference rights to the applicable Regulatory Authorities requested by Sanofi.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 8<br>Manufacturing</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Technology Transfer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.1.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer Timing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Under the Original Agreement, Kymera conducted a technology transfer of CMC information for [***] to Sanofi or its designated CMO.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:19.173%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Kymera will conduct a technology transfer of CMC information for the [***] to be completed (i) if such transfer occurs upon the achievement of [***], at least <br>[***] prior to the anticipated transfer of Development responsibility to Sanofi for the applicable Degrader Directed Against Collaboration Target 1, (ii) if such transfer occurs after the achievement of [***] for the applicable Degrader Directed Against Collaboration Target 1 [***], and (iii) at least [***] prior to the anticipated transfer of Development responsibility to Sanofi for the applicable Degrader Directed Against Collaboration Target 2. Such transfer will be conducted pursuant to a transfer plan to be agreed upon by the Parties and approved by the JMC (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CMC Transfer Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) in accordance with the timelines set forth in this clause (b).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.1.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Process of Transfer to CMO</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. On a Collaboration Candidate-by-Collaboration Candidate basis, the CMC Transfer Plan will require that Kymera initiate a technology transfer of the relevant CMC information to Sanofi or its designated CMO.  Such transfer will include a transfer of Kymera Background Know-How that is necessary for the Manufacture of the relevant Collaboration Candidates.  Kymera will make available its personnel on a reasonable basis to consult with Sanofi or such CMO with respect thereto.  Except as set forth in the previous sentence, Sanofi will bear the costs of conducting each CMC Transfer Plan.  For each Collaboration Candidate, Kymera will not be required to perform technology transfer to more than one (1) CMO for each stage of such the relevant supply chain (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">i.e.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, non-GMP starting material, bulk drug substance, bulk drug product and finished product).  Promptly after Sanofi&#x2019;s written request, Kymera will use diligent efforts to assign to Sanofi any manufacturing agreement between Kymera and a CMO that is solely related to the manufacture of relevant Collaboration Candidates.  Subject to applicable confidentiality obligations, Kymera will promptly provide to Sanofi a copy of any such</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing agreement and, to the extent permitted by such manufacturing agreement, reasonable access to personnel from such CMO.  Such assignment will be subject to the terms and conditions of such agreement, including any required consents of such CMO and Sanofi&#x2019;s written agreement to assume all the obligations of Kymera under such agreement to be undertaken after such assignment, but Kymera will remain solely responsible for its obligations under such agreement arising prior to such assignment. Except as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in the immediately preceding sentence, Sanofi will be solely responsible for contracting with such CMO (and any other CMO to whom a technology transfer has been or will be conducted as set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 8.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) for the supply of relevant Collaboration Candidates and Licensed Products and Kymera will have no obligations under such agreement between Sanofi and such CMO.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research Term Supply</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.2.1	On a Collaboration Target-by-Collaboration Target basis, Kymera (through itself, its Affiliates or CMOs) will be solely responsible, [***], for Manufacturing all Collaboration Compounds, Collaboration Candidates and Licensed Products required to conduct Kymera&#x2019;s activities under the Research Plan or Early Development Plan.  Notwithstanding the foregoing, Sanofi (through itself, its Affiliates or CMOs) will be responsible, [***], for (a) the CMC process development of such Collaboration Candidates and Licensed Products Directed Against the relevant Collaboration Target in accordance with the Research Plan or Early Development Plan (as applicable), and (b) Manufacturing all Collaboration Compounds, Collaboration Candidates and Licensed Products required to conduct the Phase 2 Activities or Sanofi&#x2019;s activities under the Early Development Plan (if any) or Late Development Plan (if any).</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.2.2	Under the Original Agreement, [***]. Sanofi is responsible for completing Manufacturing of [***] using such delivered starting materials at Sanofi&#x2019;s cost and expense.  If Sanofi provides a written notice to Kymera with a request to [***], Kymera will, within [***] of a request from Sanofi, authorize the applicable CMOs to accept orders for starting materials and for Manufacturing of active ingredients from Sanofi, Sanofi may engage the applicable CMOs for such purposes, and all such starting materials and Manufacturing will be obtained at Sanofi&#x2019;s cost and expense.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.2.3	Under the Original Agreement, Kymera supplied to Sanofi or its designated CMO quantities of [***] as set forth in the then-current Research Plan to enable Sanofi to execute its comparability protocol as set forth in the Research Plan. To the extent required by Sanofi, the Parties will enter into an agreement that details the quality assurance obligations of each Party.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.2.4	The JMC, in consultation with the JRDC, will be responsible for monitoring Kymera&#x2019;s progress under the Early Development Plan to anticipate, and plan for, the transition of Manufacturing activities to Sanofi based on the anticipated Development timelines set forth in the Early Development Plan and the Late Development Plan.  With respect to [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Participation Term Supply</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.3.1	On a Collaboration Target-by-Collaboration Target basis, Sanofi (through itself, its Affiliates or CMOs) will be responsible, at its cost and expense, for Manufacturing (including CMC process development) for Sanofi use in the Development and Commercialization of Collaboration Candidates and Licensed Products Directed Against such Collaboration Target.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.3.2	Notwithstanding </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 8.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, on a Collaboration Target-by-Collaboration Target basis, if Kymera exercises the Kymera Opt-In Right with respect to a Collaboration Target, Sanofi&#x2019;s fully burdened manufacturing cost for all Collaboration Compounds, Collaboration Candidates and Licensed Products Directed Against the relevant Collaboration Target will be shared by the Parties in accordance with the relevant Cost/Profit Sharing Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CMOs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Party will be entitled to utilize the services of CMOs to perform Manufacturing activities under this Agreement, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that: (a) such Party will require that each such CMO perform its obligations in a manner consistent with the terms of this Agreement; (b) such Party will remain at all times fully liable for its responsibilities; (c) in the case of Kymera, such CMO(s) (and specified manufacturing site(s)) shall be as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 8.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (as such schedule may be updated from time to time solely by prior written agreement of the Parties), </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that for [***], Kymera may continue to use its existing CMO; and (d) in the case of Sanofi, such CMO(s) will be selected in accordance with its internal standard operating procedures for the selection of CMOs.  Each Party will require that any such CMO agreement entered into by such Party pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 8.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> entered into after the Original Agreement Execution Date [***].  The subcontracting Party will be solely responsible for direction of and communications with such CMO.  In each CMO agreement entered into after the Original Agreement Execution Date that relates solely to Collaboration Compounds, Collaboration Candidates or Licensed Products, the subcontracting Party will use Commercially Reasonable Efforts to require that such agreement is freely assignable.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cGMP Compliance and QA Audits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Following the Effective Date, when negotiating a CMO agreement for the Manufacture of Collaboration Compounds or Collaboration Candidates, Kymera will use Commercially Reasonable Efforts to obtain the right for Sanofi to, upon no less than [***] advance written notice to Kymera, and subject to the terms of any relevant CMO agreement, have representatives visit the locations at which Manufacturing activities are undertaken by the relevant CMO, in each case, during normal business hours to review and inspect records and reports pertinent to the Manufacture, disposition or transport of Collaboration Compounds or Collaboration Candidates.  Such visits will occur no more than [***], except in the case of audits by Sanofi that are required by Applicable Laws. In addition, upon [***] written notice to Kymera, Kymera will permit Sanofi to conduct on-site visits to the relevant Kymera premises during normal business hours to review and inspect such premises, and Kymera&#x2019;s reports and records, regarding (a) Kymera&#x2019;s oversight of manufacturing, quality control procedures, release, and (b) the Manufacture, disposition or transport of materials supplied by Kymera to Sanofi, in each case ((a) and (b)) to confirm Kymera&#x2019;s compliance with Applicable Law; such visits to be subject to customary and reasonable due diligence procedures to preserve the confidentiality of any information obtained by Sanofi.  Such visits will (a) occur no more than</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***], (b) will be conducted in such a manner to minimize, to the extent reasonably possible, the period of such visit and in no case shall such period exceed [***], and (c) will be conducted by the minimum number of Sanofi employees as necessary to provide requisite subject matter expertise and conduct the review in the allotted timeframe, each of whom shall have appropriate experience in the Manufacture, quality and cGMP compliance of small molecule compounds and candidates.  Upon completion of any such visit, Sanofi will provide Kymera and the JMC of Sanofi&#x2019;s findings from each such visits.  [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quality Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Parties will enter into one or more quality agreements to govern the transfer of materials, Collaboration Candidates and Licensed Products contemplated under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 9<br>GOVERNANCE</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Steering Committee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.1.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Formation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Pursuant to the Original Agreement, the Parties established a joint steering committee (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JSC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to act as a forum to review, discuss and oversee activities under this Agreement.  The JSC will be comprised of [***] from each Party.  Each Party&#x2019;s representatives on the JSC will be of the seniority and experience appropriate in light of the functions and responsibilities of the JSC.  In addition, each Party may invite a reasonable number of additional subject matter experts or relevant personnel of such Party to participate in discussions and meetings of the JSC; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such individuals will have no decision-making authority.  Each Party&#x2019;s representatives on the JSC and all other individuals attending or participating in discussions and meetings of the JSC on behalf of a Party will be bound under written confidentiality and non-use obligations with respect to information disclosed at such meeting that are no less restrictive than the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Party may replace its representatives on the JSC at any time by providing notice in writing to the other Party.  Each Party will appoint one of its representatives on the JSC to act as a co-chairperson of the JSC.  The co-chairpersons of the JSC will be responsible for setting the agenda for meetings of the JSC with input from the other members, and for conducting the meetings of the JSC.  The JSC will conduct its responsibilities hereunder in good faith and with reasonable care and diligence.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.1.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Responsibilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The JSC will be responsible for overseeing the collaboration and approving strategy, plans and budgets with respect to (i) Collaboration Compounds, Collaboration Candidates and Licensed Product activities before the expiration or termination of Kymera&#x2019;s Opt-In Right with respect to a given Collaboration Target, and (ii) during the applicable Opt-In Period, Collaboration Candidates and Licensed Products activities as to which Kymera has exercised the Kymera Opt-In Right for a given Collaboration Target. Any failure of the Parties to agree on matters within the purview of the JSC as set forth this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.1.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be resolved in accordance with the decision-making and escalation procedures set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Without limiting the first sentence of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.1.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the JSC will:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	discuss and approve changes to the Screening Criteria, M2 Criteria, Phase 1 Ready Criteria or Phase 2 Ready Criteria;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	review, discuss and approve each Late Development Plan;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	be responsible for overseeing the Parties&#x2019; performance of their respective activities under the Late Development Plan and provide support to each Party with respect to such Party&#x2019;s activities thereunder;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	solely during the applicable Opt-In Period, upon request by a Party, discuss the appropriate level of detail to include in the U.S. Development Budget required for the United States for the applicable Development activities to be performed during the period covered by such U.S. Development Budget for the United States;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	solely during the applicable Opt-In Period, review, discuss and approve proposed updates and amendments to each Late Development Plan;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	review and discuss reports provided by a Party pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.9.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	review and discuss materials provided by a Party pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	solely with respect to (i) Collaboration Compounds, Collaboration Candidates and Licensed Product activities before expiration or termination of the Kymera Opt-In Right for a given Collaboration Target, and (ii) during the applicable Opt-In Period, Collaboration Candidates and Licensed Products as to which Kymera has exercised the Kymera Opt-In Right for a given Collaboration Target, in each case review, discuss and approve annual budgets and any updates or amendments thereto;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	discuss and approve extensions to timelines pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(j)	review and discuss the rationale of obtaining any Potential In-License;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(k)	in coordination with the JPC, review and discuss Potential In-Licenses (including related proposed economics);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(l)	identify a Party to lead negotiations with the applicable Third Party licensor for any Potential In-License;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(m)	on receipt of a substantially finalized draft Potential In-License, determine whether to approve such Potential In-License as a Collaboration In-License Agreement for the applicable Collaboration Target;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n)	solely during the applicable Opt-In Period, review, discuss and agree on the Late Development Budget;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(o)	solely during the applicable Opt-In Period, review, discuss and determine whether an overspend is a Permitted U.S. Budget Overrun;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(p)	solely during the applicable Opt-In Period, review, discuss and determine whether an U.S. Budget Excession was caused by circumstances within Sanofi&#x2019;s reasonable control or whether to otherwise approve an U.S. Budget Excession;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(q)	solely during the applicable Opt-In Period, review and discuss expense reports with respect to U.S. Development Costs;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(r)	review, discuss and approve any decisions or disputes submitted by a Committee to the JSC;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(s)	establish, but not delegate decision making authority to, such additional Subcommittees as it deems necessary to achieve the objective and intent of this Agreement; and perform such other duties as are specifically assigned to the JSC under this Agreement or as may be otherwise mutually agreed by the Parties from time to time; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(t)	perform such other functions as are set forth in this Agreement, or as the Parties may mutually agree in writing, except where in conflict with any provision of this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Research and Development Committee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.2.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Formation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Pursuant to the Original Agreement, the Parties established a joint research and development committee (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JRDC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to act as a forum to review, discuss and oversee research activities under this Agreement on a Collaboration Target-by-Collaboration Target basis prior to the applicable Sanofi Participation Election Effective Date.  The JRDC will be comprised of [***] from each Party.  Each Party&#x2019;s representatives on the JRDC will be of the seniority and experience appropriate in light of the functions and responsibilities of the JRDC In addition, each Party may invite a reasonable number of additional subject matter experts or relevant personnel of such Party to participate in discussions and meetings of the JRDC; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such individuals will have no decision-making authority.  Each Party&#x2019;s representatives on the JRDC and all other individuals attending or participating in discussions and meetings of the JRDC on behalf of a Party will be bound under written confidentiality and non-use obligations with respect to information disclosed at such meeting that are no less restrictive than the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Each Party may replace its representatives on the JRDC at any time by providing notice in writing to the other Party.  Until Sanofi&#x2019;s first exercise of the Sanofi Participation Election Right, Kymera will designate the chairperson of the JRDC; thereafter, Sanofi will designate the chairperson of the JRDC.  The chairperson of the JRDC will be responsible for setting the agenda for meetings of the JRDC with input from the other members, and for conducting the meetings of the JRDC.  The JRDC will conduct its responsibilities hereunder in good faith and with reasonable care and diligence.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.2.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specific Responsibilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The JRDC will, subject to the escalation, final decision-making authority and dispute resolution procedures in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	be responsible for overseeing the Parties&#x2019; performance of their respective activities under the Research Plan and Early Development Plan and provide support to each Party with respect to such Party&#x2019;s activities thereunder;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	review and discuss (i) each amended Research Plan and Early Development Plan and approve updates or material amendments to the Research Plan and the Early Development Plan and (ii) the Phase 2 Development Plan and approve updates or material amendments to the Phase 2 Development Plan;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	discuss and determine whether a Degrader that is Researched under this Agreement meets the Screening Criteria, M2 Criteria, Phase 1 Ready Criteria or Phase 2 Ready Criteria;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	review, discuss and approve changes to the Screening Criteria, M2 Criteria, Phase 1 Ready Criteria or Phase 2 Ready Criteria;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	discuss and determine whether Successful Completion has been achieved;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	review and discuss the list of Degraders provided by Kymera pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	review and discuss reports and data provided by Kymera pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> within [***] after the delivery of each such report, and determine if a relevant Degrader satisfies the First Additional Degrader Criteria;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	cause the minutes of the JRDC to reflect any selection of a Degrader as a First Additional Degrader, whether by the JRDC, the R&amp;D Expert in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or by Sanofi in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	review, discuss and determine whether a Collaboration Candidate or Licensed Product Directed Against Collaboration Target 2 satisfies the Phase 1 Ready Criteria;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(j)	review and discuss reports and data provided by Kymera pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> within [***] after the delivery of each such report, and determine if a relevant Degrader satisfies the Second Additional Degrader Criteria;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(k)	cause the minutes of the JRDC to reflect any selection of a Degrader as a Second Additional Degrader, whether by the JRDC or the R&amp;D Expert or by Sanofi in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(l)	review and discuss reports and data provided by Kymera pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> within [***] after the delivery of each such report, and determine if a relevant Degrader satisfies the M2 Criteria;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(m)	cause the minutes of the JRDC to reflect any selection of a Collaboration Compound as a Collaboration Candidate, whether by the JRDC or the R&amp;D Expert;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n)	review and discuss information provided by Kymera pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 2.4.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 2.5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and whether to approve any related overspend as a FAD Permitted Overrun or SAD Permitted Overrun;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(o)	review, discuss and approve a FAD Research Budget Excession or SAD Research Budget Excession in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 2.4.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 2.5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, including whether any such FAD Research Budget Excession or SAD Research Budget Excession was in Kymera&#x2019;s reasonable control;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(p)	review, discuss and determine whether Research Activities under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> should be discontinued;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(q)	review and discuss information provided by Kymera pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and whether to approve any related overspend as a Series 2 Permitted Overrun;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(r)	review, discuss and approve Series 2 Research Budget Excession in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.6.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, including whether any such Series 2 Research Budget Excession was in Kymera&#x2019;s reasonable control;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(s)	discuss and approve a transfer of Materials from one Party to the other Party in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and discuss information provided by a Party with respect to MTA Research Studies;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(t)	during the Research Term prior to Sanofi&#x2019;s exercise of the Sanofi Participation Election Right with respect to Collaboration Target 2, determine the first Indication for which the first IND will be filed with respect to a Licensed Product;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(u)	discuss and approve a transfer of Materials from one Party to the other Party in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and discuss information provided by a Party with respect to MTA Development Studies;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	review and discuss reports provided by a Party pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">    </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(w)	to the extent contemplated by </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, review, discussion and approve an extension of time during which Kymera will make its personnel reasonably available;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(x)	review and discuss information provided by Kymera pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and whether to approve any related overspend as a Permitted Backup Research Overrun;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(y)	review, discuss and determine, in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, whether any Backup Research Budget Excession was in Kymera&#x2019;s reasonable control;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(z)	review and discuss reports and data provided by Kymera pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> within [***] after the delivery of each such report, and determine if a relevant Degrader satisfies the Backup Degrader Criteria;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(aa)	cause the minutes of the JRDC to reflect any selection of a Degrader as a Backup Degrader, whether by the JRDC, the R&amp;D Expert in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or by Sanofi in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(bb)	in coordination with the JPC, review and discuss any requests by Kymera pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.6.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> regarding a potential reversion of any Collaboration Compounds or Collaboration Candidates Directed Against Collaboration Target 1 that were Researched by or on behalf of Kymera under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> but have not been selected as the First Additional Degraders, Second Additional Degraders or Backup Degraders;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(cc)	review and discuss reports provided by Sanofi in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(dd)	in coordination with the JMC, monitor Kymera&#x2019;s progress under the Early Development Plan to anticipate, and plan for, the transition of Manufacturing activities to Sanofi based on the anticipated Development timelines set forth in the Early Development Plan and the Late Development Plan;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ee)	in coordination with the JMC, determine whether it is reasonably foreseeable that [***];</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ff)	discuss, review and approve, in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.3.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, grants of Sublicenses by Kymera of any of the licenses granted to Kymera in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.1.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to additional Third Party contractors other than Approved Third Party Contractors, such approval not to be unreasonably withheld, conditioned or delayed;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(gg)	review and discuss information provided by Sanofi pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and whether to approve any related overspend as a Permitted U.S. Budget Overrun;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(hh)	 review, discuss and determine, in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, whether any Research Budget Excession was in Kymera&#x2019;s reasonable control;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	review, discuss and approve any U.S. Budget Excession in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, including whether any U.S. Budget Excession was in Sanofi&#x2019;s reasonable control;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(jj)	review, discuss and approve additional Third Party contractors as Approved Third Party Contractors;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(kk)	determine reasonable expenses pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ll)	perform such other functions as are set forth in this Agreement, or as the Parties may mutually agree in writing, except where in conflict with any provision of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any failure of the Parties to agree on matters within the purview of the JRDC as set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be resolved in accordance with the decision-making and escalation procedures set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Patent Committee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.3.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Formation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Pursuant to the Original Agreement, the Parties established a joint patent committee (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JPC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to coordinate the Prosecution and Maintenance and enforcement of [***].  The JPC will be comprised of up to [***] representing each Party.  Each Party&#x2019;s representative(s) on the JPC will be of the seniority and experience appropriate in light of the functions and responsibilities of the JPC.  In addition, each Party may invite a reasonable number of additional subject matter experts, outside counsel or relevant personnel of such Party to participate in discussions and meetings of the JPC on an ad-hoc basis.  Each Party may replace its representative(s) on the JPC at any time by providing notice in writing to the other Party.  The JPC will conduct its responsibilities hereunder in good faith and with reasonable care and diligence.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.3.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specific Responsibilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The JPC will, subject to the escalation, final decision-making authority and dispute resolution procedures in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	in coordination with the JSC, review and discuss Potential In-Licenses (including related proposed economics);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	in coordination with the JRDC, review and discuss any requests by Kymera pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> regarding a potential reversion of any Collaboration Compounds or Collaboration Candidates Directed Against Collaboration Target 1 that were Researched by or on behalf of Kymera under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> but have not been selected as the First Additional Degraders, Second Additional Degraders or Backup Degraders;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	review, discuss and determine [***];</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	coordinate the Prosecution and Maintenance activities under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	consider matters raised to the JPC pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16.6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	perform such other functions as are set forth in this Agreement, or as the Parties may mutually agree in writing, except where in conflict with any provision of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any failure of the Parties to agree on matters within the purview of the JPC as set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.3.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be resolved in accordance with the decision-making and escalation procedures set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Manufacturing Committee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.4.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Formation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Pursuant to the Original Agreement, the Parties established a joint manufacturing committee (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JMC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to act as a forum to review, discuss and oversee Manufacturing activities under this Agreement.  The JMC will be comprised of [***] from each Party.  Each Party&#x2019;s representatives on the JMC will be of the seniority and experience appropriate in light of the functions and responsibilities of the JMC.  In addition, each Party may invite a reasonable number of additional subject matter experts or relevant personnel of such Party to participate in discussions and meetings of the JMC; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such individuals will have no decision-making authority.  Each Party&#x2019;s representatives on the JMC and all other individuals attending or participating in discussions and meetings of the JMC on</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">behalf of a Party will be bound under written confidentiality and non-use obligations with respect to information disclosed at such meeting that are no less restrictive than the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Party may replace its representatives on the JMC at any time by providing notice in writing to the other Party.  Prior to the Sanofi Participation Election Effective Date, each Party will appoint one of its representatives on the JMC to act as a co-chairperson of the JMC; thereafter, Sanofi will designate the chairperson of the JMC.  The chairperson of the JMC will be responsible for setting the agenda for meetings of the JMC with input from the other members, and for conducting the meetings of the JMC.  The JMC will conduct its responsibilities hereunder in good faith and with reasonable care and diligence.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.4.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specific Responsibilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The JMC will, subject to the escalation, final decision-making authority and dispute resolution procedures in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	work with the JSC to be responsible for overseeing Manufacturing activities under this Agreement;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	review, discuss and approve the CMC Transfer Plans;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	determine the timeline for technology transfer of CMC information for a Degrader Directed Against Collaboration Target 1 for which transfer will occur after the achievement of the relevant [***];</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	in coordination with the JRDC, monitor Kymera&#x2019;s progress under the Research Plan and the Early Development Plan to anticipate, and plan for, the transition of Manufacturing activities to Sanofi based on the anticipated Development timelines set forth in the Research Plan, the Early Development Plan and the Late Development Plan;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	in coordination with the JRDC, (i) determine whether it is reasonably foreseeable that [***];</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	discuss and approve changes to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 8.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	discuss, review and oversee the transfer of Manufacturing activities to Sanofi or its CMO(s); and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	perform such other functions as are set forth herein or as the Parties may mutually agree in writing, except where in conflict with any provision of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any failure of the Parties to agree on matters within the purview of the JMC as set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be resolved in accordance with the decision-making and escalation procedures set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Transition Team</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.5.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Formation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  On a Collaboration Target-by-Collaboration Target basis, within [***] after the relevant Sanofi Participation Election Effective Date for such Collaboration Target, the Parties will establish a joint transition team (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JTT</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to coordinate the transition of the relevant Collaboration Compounds, Collaboration Candidates</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and Licensed Products Directed Against such Collaboration Target.  The JTT will be comprised of [***] from each Party.  Without limiting the foregoing, but subject to the escalation, final decision-making authority and dispute resolution procedures in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the JTT will be responsible for (a) finalizing and approving a transition plan, including transition activities that either Party will be obligated to perform under such transition plan and (b) performing such other activities as the Parties agree in writing will be the responsibility of the JTT with respect to such Collaboration Target.  Each Party&#x2019;s representatives on the JTT will be of the seniority and experience appropriate in light of the functions and responsibilities of the JTT.  In addition, each Party may invite a reasonable number of additional subject matter experts or relevant personnel of such Party to participate in discussions and meetings of the JTT; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such individuals will have no decision-making authority.  Each Party&#x2019;s representatives on the JTT and all other individuals attending or participating in discussions and meetings of the JTT on behalf of a Party will be bound under written confidentiality and non-use obligations with respect to information disclosed at such meeting that are no less restrictive than the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Party may replace its representatives on the JTT at any time by providing notice in writing to the other Party.  Sanofi will designate the chairperson of the JTT.  The chairperson of the JTT will be responsible for setting the agenda for meetings of the JTT with input from the other members, and for conducting the meetings of the JTT.  The JTT will conduct its responsibilities hereunder in good faith and with reasonable care and diligence. Any failure of the Parties to agree on matters within the purview of the JTT as set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be resolved in accordance with the decision-making and escalation procedures set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Commercialization Committee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.6.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Formation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  The Parties will establish a joint commercialization committee (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JCC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) at least [***] to act as a forum to review, discuss and oversee Co-Promotion activities for Licensed Products Directed Against Collaboration Targets for which Kymera has exercised the Kymera Opt-In Right.  The JCC will be comprised of [***] from each Party.  Each Party&#x2019;s representatives on the JCC will be of the seniority and experience appropriate in light of the functions and responsibilities of the JCC.  In addition, each Party may invite a reasonable number of additional subject matter experts or relevant personnel of such Party to participate in discussions and meetings of the JCC; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such individuals will have no decision-making authority.  Each Party&#x2019;s representatives on the JCC and all other individuals attending or participating in discussions and meetings of the JCC on behalf of a Party will be bound under written confidentiality and non-use obligations with respect to information disclosed at such meeting that are no less restrictive than the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Party may replace its representatives on the JCC at any time by providing notice in writing to the other Party.  Sanofi will designate the chairperson of the JCC.  The chairperson of the JCC will be responsible for setting the agenda for meetings of the JCC with input from the other members, and for conducting the meetings of the JCC.  The JCC will conduct its responsibilities hereunder in good faith and with reasonable care and diligence.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.6.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specific Responsibilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The JCC will, subject to the escalation, final decision-making authority and dispute resolution procedures in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	review, discuss and approve the FTE Rate with respect to Co-Promote activities;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	ensure that each Co-Promotion Plan allocates to the Designated Sales Force a </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">pro rata</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> portion of centers of excellence and high prescribing physicians for the Opt-In Product(s);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	upon request of a Party, discuss the appropriate level of detail to include in a Co-Commercialization Budget;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	review, discuss and approve each proposed Co-Commercialization Plan; while endeavoring to approve each such Co-Commercialization Plan no later than [***] of each relevant Calendar Year;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	review, discuss and approve proposed updates or amendments to a Co-Commercialization Plan;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	review and discuss reports provided pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 6.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or a Co-Promotion Agreement;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	review, discuss and provide comments with respect to any promotional materials for the Co-Promotion of Opt-In Products;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	discuss notification from Kymera that Kymera wishes to decrease its then-allocated percentage of Detailing;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	oversee the Parties&#x2019; joint promotional efforts;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(j)	specify which commercial functional area experts (other than managed care) of Sanofi the Designated Sales Force will have access to;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(k)	review and discuss the engagement by Sanofi of a commercial advertising agency to be used in connection with Detailing of the Opt-In Products, including the identity of such agency and the material terms of such engagement;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(l)	establish the value of secondary position details, consistent with Sanofi&#x2019;s then-current standard operating procedures;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(m)	establish benchmarks for the content and effectiveness of the principal promotional messages that are used by the Parties to promote the relevant Opt-In Product(s);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n)	develop a Corrective Plan in the event market research indicates that a Party&#x2019;s delivery of the principal promotional messages for an Opt-In Product set forth in the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">applicable Co-Promotion Plan is not effective and not conveying the corresponding underlying promotional message;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(o)	establish the PDE Cost;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(p)	determine the anticipated commercial launch date of each Opt-In Product; and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(q)	perform such other functions as are set forth in this Agreement, or as the Parties may mutually agree in writing, except where in conflict with any provision of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any failure of the Parties to agree on matters within the purview of the JCC as set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be resolved in accordance with the decision-making and escalation procedures set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Finance Committee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.7.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Formation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Within [***], the Parties will establish a joint finance committee (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JFC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to coordinate the financial reporting by the Parties with respect to the funding of U.S. Development Costs for Opt-In Products pursuant to the Cost/Profit Sharing Agreement and to discuss and resolve financial disputes in connection therewith.  The JFC will be comprised of [***] from each Party.  Each Party&#x2019;s representatives on the JFC will be of the seniority and experience appropriate in light of the functions and responsibilities of the JFC.  In addition, each Party may invite a reasonable number of additional subject matter experts or relevant personnel of such Party to participate in discussions and meetings of the JFC; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such individuals will have no decision-making authority.  Each Party&#x2019;s representatives on the JFC and all other individuals attending or participating in discussions and meetings of the JFC on behalf of a Party will be bound under written confidentiality and non-use obligations with respect to information disclosed at such meeting that are no less restrictive than the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Party may replace its representatives on the JFC at any time by providing notice in writing to the other Party.  Sanofi will designate the chairperson of the JFC.  The chairperson of the JFC will be responsible for setting the agenda for meetings of the JFC with input from the other members, and for conducting the meetings of the JFC.  The JFC will conduct its responsibilities hereunder in good faith and with reasonable care and diligence.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.7.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specific Responsibilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The JFC will, subject to the escalation, final decision-making authority and dispute resolution procedures in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	facilitate, in coordination with the JSC and JCC, the creation of U.S. Development Budget and Co-Commercialization Budget, including the annual updates thereto;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	reconcile financial and accounting matters between the Parties;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	initiate and execute an effective and efficient revenue and cost sharing process (cross-charges);</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	cooperate to ensure that the U.S. Development Budget and Co-Commercialization Budget agreed to for a Calendar Year (or any other given period) can be interpreted for the purposes of both Parties&#x2019; internal financial and audit reporting requirements, including each Party&#x2019;s fiscal year reporting;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	monitor the budget, expense and revenue reporting requirements between the Parties related to each Cost/Profit Sharing Agreement to ensure that each Party is able to comply with its respective internal financial and audit reporting requirements and, as appropriate, recommending to the JSC for approval, changes to the reporting requirements under this Agreement; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	undertake such other tasks with respect to the calculation, implementation and reporting for the Parties&#x2019; sharing of U.S. Development Costs, Allowable Expenses, Net Profits or Net Losses as the Parties mutually agree.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any failure of the Parties to agree on matters within the purview of the JFC as set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be resolved in accordance with the decision-making and escalation procedures set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.8	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Meetings; Minutes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.8.1	Each Committee will meet in person or by teleconference at least [***] following the formation thereof on such dates and at such times and places as agreed to by the members of the such Committee; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that (i) at least [***] such meeting of each Committee per Calendar Year will be in person unless the Parties agree otherwise and (ii) the first meeting of the JCC will occur within [***] of the date on which Sanofi proposes the initial Co-Commercialization Plan to the JCC.  Each Party will be responsible for its own expenses relating to attendance at, or participation in, Committee meetings.  Upon [***] prior written notice, either Party may convene a special meeting of a Committee for the purpose of discussing any urgent matter within the scope of the authority and responsibility of such Committee.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.8.2	The responsibility for preparing the minutes will alternate between the Alliance Managers or their respective designees on a meeting-by-meeting basis.  The Alliance Manager or its designee responsible for the minutes will provide the other Alliance Manager and the members of such Committee with draft written minutes for the Committee&#x2019;s approval from each meeting within [***] after each such meeting setting forth, among other things, a description, in reasonable detail, of the discussions at the meeting and a list of any actions, decisions, or determinations approved by the Committee.  Such minutes will be effective only after being approved by both Parties.  If the minutes of any meeting of the Committee are not approved by the Committee (with each Party&#x2019;s representatives on the Committee collectively having one (1) vote) within [***] after the meeting, the objecting Party will append a notice of objection with the specific details of the objection to the proposed minutes.  Should a decision be made by a Committee outside of a meeting, such decision may be made by a written resolution unanimously agreed to by the Parties; notwithstanding anything herein to the contrary, such written agreement may be by email.  Notwithstanding the foregoing, no minutes will be prepared for meetings of the JPC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.9	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Decisions; Disputes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.9.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Decisions and Disputes within Committees other than the JSC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">With respect to decisions of all Committees other than the JSC, the representatives of each Party will have collectively one (1) vote on behalf of such Party.  For each meeting of such Committee, at least [***] of each Party will constitute a quorum and each Party will use Commercially Reasonable Efforts to have its representative(s) participate in each Committee meeting.  Action on any matter may be taken at a meeting, by teleconference, videoconference or by written agreement.  Each such Committee will attempt to resolve any and all matters before it for decision by consensus.  If a Committee other than the JSC is unable to resolve a matter by consensus during a period of [***], then (a) with [***] with respect to all other matters not discussed in the foregoing clauses (a)-(d), such matter(s) will be escalated to the JSC.  Any action of any Committee taken pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be recorded in meeting minutes in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.8.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding anything to the contrary set forth in this Agreement, without the other Party&#x2019;s prior written consent, no exercise of a Party&#x2019;s decision-making authority on any such matters may, without the other Party&#x2019;s prior written consent, (i) conflict with any of the express terms of this Agreement or any Co-Promotion Agreement or Cost/Profit Sharing Agreement, (ii) impose any requirements that the other Party take or decline to take any action that would result in a violation of any Law or any Collaboration In-License Agreement or (iii) otherwise conflict with this Agreement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.9.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JSC Decisions and Disputes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  With respect to decisions of the JSC, the representatives of each Party will have collectively one (1) vote on behalf of such Party.  For each meeting of the JSC, at least [***] of each Party will constitute a quorum and each Party will use Commercially Reasonable Efforts to have its representative(s) participate in each JSC meeting.  Action on any matter may be taken at a meeting, by teleconference, videoconference or by written agreement.  The JSC will attempt to resolve any and all matters before it for decision by consensus.  If a dispute is escalated to the JSC by any Subcommittee, then at the next meeting of the JSC each Party will provide analysis to support its position with respect to the dispute.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	If the JSC is unable to reach a consensus with respect to a matter before the JSC within [***], then the dispute will be submitted to a senior executive of each of Kymera and Sanofi to be designated by Kymera and Sanofi, respectively, for resolution.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	If such escalated dispute cannot be resolved by the senior executives during a period of [***], then</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	On a Collaboration Target-by-Collaboration Target basis, prior to the Sanofi Participation Election Effective Date (if any), except as set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,  (A) Kymera will have final decision-making authority on all matters, except as to the following matters: [***]; (B) subject to the terms and obligations set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, each Party will have final decision-making authority with respect to matters concerning [***]; and (C) Sanofi shall have final decision making authority on [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	On a Collaboration Target-by-Collaboration Target basis, following the Sanofi Participation Election Effective Date (if any), except as set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,  Sanofi will have final decision-making authority on all matters, except as to the following matters:  [***].  Following the Sanofi Participation Election Effective Date (if any), Sanofi will have final decision making authority with respect to matters concerning [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	If the dispute arises out of any of [***] (each of the foregoing, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expert Dispute</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) the Parties will submit such matter for resolution in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and the determination of the R&amp;D Expert will be binding on the Parties.  For avoidance of doubt, the Parties will be bound by the determination of such R&amp;D Expert and neither Party nor the JSC will have authority to modify or amend the finding of the R&amp;D Expert.</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	If the dispute is related to [***], then the Parties will submit their respective proposals to arbitration in accordance with the provisions set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 9.9.2(b)(iv)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	If the dispute is related to the calculation, sharing, or payment of amounts owed with respect to U.S. Development Costs, Allowable Expenses or Net Profits and Net Losses during the Opt-In Period in accordance with this Agreement or the Cost/Profit Sharing Agreement (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Finance Dispute</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), then such dispute will be resolved by &#x201c;Baseball&#x201d; arbitration in accordance with the provisions set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 9.9.2(b)(v)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(vi)	If the dispute relates to a Party&#x2019;s request that Kymera suspend or cease Development activities due to a Safety Concern prior to the Sanofi Participation Election Effective Date (if any), Kymera will suspend or cease such Development activities unless and until the Parties mutually agree to re-start such Development activities.</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(vii)	For all other disputes, a Party may institute dispute resolution procedures pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (excluding </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">).</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	The JSC will conduct its activities in good faith and will not have the power to (i) amend or modify the Parties&#x2019; respective rights and obligations under this Agreement or (ii) resolve any dispute between the Parties regarding such rights and obligations.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	Where this Agreement or any Co-Promotion or Cost/Profit Sharing Agreement refers to a decision or determination or similar action by a Committee and the relevant matter is decided pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, such decision, determination or similar action will be deemed to have been made by the relevant Committee.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.10	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Discontinuation of the Committees</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The JSC and JPC will remain in existence throughout the Term, unless the Parties mutually agree to terminate the responsibilities of such Committee with respect to each Collaboration Target.  The JRDC will disband and terminate on the effective date of expiration of the latest to expire Sanofi Participation Election with respect to the Collaboration Candidates.  The JMC will disband and terminate upon completion of technology transfer pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 8.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The JTT will disband and terminate upon the completion of all transitions of the relevant Collaboration Compounds, Collaboration Candidates and Licensed Products Directed Against each Collaboration Target.  The JCC and JFC will disband and terminate on the effective date of termination or expiration of the Opt-In Period or, with respect to the JCC, termination of Kymera&#x2019;s Co-Promotion activities pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.8.3(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or the Co-Promotion Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.11	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Establishment of Sub-Committees</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Committee may establish sub-committees or working groups to interact on a more frequent basis on specific projects and tasks assigned to them by such Committee; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that the authority of such sub-committees or working groups will not expand beyond the authority of the applicable Committee.  Any such sub-committees or working groups will have no decision-making authority, but will make recommendations to the applicable Committee for its review and approval.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.12	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alliance Managers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.12.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Appointment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Party will appoint a representative of such Party to act as its alliance manager under this Agreement (each, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alliance Manager</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Each Party may replace its Alliance Manager at any time upon notice to the other Party.  The Alliance Managers as of the Restatement Effective Date will be:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For Sanofi:  [***]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For Kymera:  [***]</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.12.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specific Responsibilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Alliance Managers will attend all meetings of each Committee (other than the JPC) but may not be members of any Committee.  The Alliance Managers will serve as the primary contact point between the Parties for the purpose of providing each Party with information regarding the other Party&#x2019;s activities pursuant to this Agreement and will have the following responsibilities:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	schedule meetings of each Committee and circulate draft written minutes as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	oversee and facilitate the flow of information and otherwise promote communication, coordination and collaboration between the Parties;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	provide a single point of communication for seeking consensus both internally within the respective Party&#x2019;s organization and between the Parties regarding key strategy and planning issues; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	perform such other functions as requested by the JSC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 10<br>LICENSE GRANTS; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXCLUSIVITY</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">License Grants to Sanofi</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1.1	Subject to the terms of this Agreement, on a Collaboration Target-by-Collaboration Target basis, during the period commencing on the Original Agreement Execution Date and expiring on the Original Agreement Effective Date, Kymera hereby grants to Sanofi a non-exclusive, non-royalty bearing license, including the right to grant Sublicenses in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, under the Licensed Technology to perform CMC process development activities and Manufacturing of [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1.2	Subject to the terms of this Agreement, on a Collaboration Target-by-Collaboration Target basis, during the Research Term, solely to the extent that Sanofi has any Step-In Activities, CMC activities, Manufacturing activities, or other activities under the Research Plan, Early Development Plan and Phase 2 Activities, Kymera hereby grants to Sanofi a non-exclusive, non-royalty bearing license, including the right to grant Sublicenses in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, under the Licensed Technology to perform such Step-In Activities, CMC activities, Manufacturing activities, or other activities under the Research Plan,  Early Development Plan or Phase 2 Activities, as applicable.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1.3	Subject to the terms of this Agreement, on a Collaboration Target-by-Collaboration Target basis, Kymera hereby grants to Sanofi (a) an exclusive license (even as to Kymera), including the right to grant Sublicenses in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, under the Licensed Technology to Research, Develop and Manufacture Collaboration Compounds, Collaboration Candidates and Licensed Products Directed Against such Collaboration Target in the applicable Field in the Territory, and (b) an exclusive (even as to Kymera) royalty-bearing license under the Licensed Technology to Commercialize Licensed Products Directed Against such Collaboration Target in the applicable Field in the Territory (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exclusive Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); [***], and (ii) such Exclusive Licenses are subject to immediate termination (and without any further action) as set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1.4	[***]</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">License Grant to Kymera</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to the terms and conditions of this Agreement, including </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 8.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, on a Collaboration Target-by-Collaboration Target basis during the Term, Sanofi hereby grants to Kymera a non-exclusive license under (i) the Sanofi Technology, and (ii) the Exclusive Licenses under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.1.3,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> each including the right to grant Sublicenses in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, solely to perform Kymera&#x2019;s obligations under this Agreement.  The foregoing license to Kymera and its Affiliates includes, on a Collaboration Target-by-Collaboration Target basis, a license to Kymera and its Affiliates to (a) perform activities under the Research Plan, Early Development Plan and Backup Research Plan for a given Collaboration Target, (b) if Kymera exercises the Kymera Co-Promote Right for a Collaboration Target, to perform Co-Promotion activities for  Opt-In Products Directed Against such Collaboration Target in the applicable Field in the United States, and (c) perform Manufacturing activities for Collaboration  Compounds, Collaboration Candidates and Licensed Products Directed Against such Collaboration Target as set forth in this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sublicensing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By Sanofi</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Sanofi may grant Sublicenses (through multiple tiers) to its Affiliates and Third Party Subcontractors (including CMOs) of any of the licenses granted to Sanofi in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> without the prior consent of Kymera.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.3.1(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Sanofi may grant Sublicenses (through multiple tiers) to [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	[***].  As used herein, &#x201c;[***]&#x201d; means [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By Kymera</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Kymera may grant Sublicenses to its Affiliates and to Approved Third Party Contractors of any of the licenses granted to Kymera in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> without the prior consent of Sanofi.  In addition, Kymera may grant Sublicenses to additional Third Party contractors [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Generally</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Except as expressly set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.3.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, prior to granting a Sublicense of the licenses granted in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 10.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the sublicensing Party will obtain the prior written consent of the other Party. For clarity, Sanofi has no licenses or other rights with respect the Excluded Compounds except with as expressly provided in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.1.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Each such Sublicense will be consistent with, the terms of this Agreement and will require such Sublicensee to comply with all applicable terms of this Agreement.  The sublicensing Party will, as soon as reasonably practicable thereafter (and in any event within [***]), provide the other Party with a copy of an executed Sublicense with a Third Party Sublicensee (which copy may be redacted to remove provisions which are not necessary to monitor compliance with this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">), </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that a Party will have no obligation to provide the other Party with any copy of any Subcontractor agreement.  Each Sublicense will contain the following provisions:  [***].  Notwithstanding any Sublicense, the Party that grants a Sublicense will remain liable to the other Party for the performance of the granting Party&#x2019;s obligations hereunder, and will be responsible for all actions and omissions of each Sublicensee of such Party, as if such Sublicensee were such Party hereunder.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Implied Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except as expressly provided in this Agreement, no Party will be deemed by estoppel, implication or otherwise to have granted the other Party any licenses or other right with respect to any intellectual property.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bankruptcy</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All rights and licenses granted under or pursuant to this Agreement by a Party to the other are and will otherwise be deemed to be, for purposes of Section 365(n) of the Bankruptcy Code, licenses of rights to &#x201c;intellectual property&#x201d; as defined under Section 101 of the Bankruptcy Code.  The Parties agree that the Parties will retain and may fully exercise all of their rights and elections under the Bankruptcy Code and any foreign equivalent thereto.  The Parties further agree that if (x) a bankruptcy proceeding by or against a Party (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bankrupt Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is commenced under the Bankruptcy Code, (y) this Agreement is rejected as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in the Bankruptcy Code, and (z) the other Party (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Bankrupt Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) elects to retain its rights hereunder as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in Section 365(n) of the Bankruptcy Code, the Non-Bankrupt Party will be entitled to a complete duplicate of, and complete access to (as the Non-Bankrupt Party deems appropriate), all such intellectual property and all embodiments of such intellectual property.  Upon such occurrence, such intellectual property and all embodiments of such intellectual property will be promptly delivered to the Non-Bankrupt Party.  The Bankrupt Party (in any capacity, including debtor-in-possession) and its successors and assigns (including any trustee) agrees not to interfere with the exercise by the Non-Bankrupt Party of its rights and licenses to such intellectual property and such embodiments of intellectual property in accordance with this Agreement, and agrees to assist the Non-Bankrupt Party and its Affiliates in obtaining such intellectual property and such embodiments of intellectual property in the possession or control of Third Parties.  The foregoing provisions are without prejudice to any rights the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Bankrupt Party may have arising under the Bankruptcy Code or other Applicable Law.  As used herein, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bankruptcy Code</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Title 11, United States Code, as from time to time in effect.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exclusivity Covenants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6.1	From and after the Original Agreement Effective Date and [***], on a Collaboration Target-by-Collaboration Target basis, except as expressly permitted under this Agreement, each Party and its Affiliates will not [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6.2	From and after the Original Agreement Effective Date and [***], for Collaboration Target 1, each Party and its Affiliates will not, itself or through any Affiliate or Third Party [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6.3	From and after the Original Agreement Effective Date and [***], for Collaboration Target 1 [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6.4	From and after the Original Agreement Effective Date and [***], with respect to Collaboration Target 1, Kymera and its Affiliates will [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6.5	The Parties hereby acknowledge and agree that neither Party&#x2019;s obligations under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will apply to any activities intended by such Party or any of its Affiliates to ensure its compliance with this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">e.g.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, using screening assays for compounds).  In addition, notwithstanding the foregoing, the rights and licenses granted to the Counterparty pursuant to the Third Party Agreement, and the Counterparty&#x2019;s practice of such rights and licenses, did not and will not constitute a breach of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquisition of Competing Product</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.7.1	Notwithstanding the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, if a Party or any of its Affiliates (such Party, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competing Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) acquires rights to research, develop, manufacture, or commercialize a product in the applicable Field as the result of a merger, acquisition or combination with or of a Third Party other than a Change of Control of such Party (each, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquisition Transaction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and, on the date of the closing of such Acquisition Transaction, such product is being researched, developed, manufactured or commercialized and such activities would, but for the provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, constitute a breach of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (such product, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competing Product</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), the Competing Party or such Affiliate will, within [***] notify the other Party in writing of such acquisition and either:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	[***];</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	[***]; or</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	[***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.7.2	During the discussion period under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.7.1(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, prior to the time of divestiture pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.7.1(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or prior to the termination of activities pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.7.1(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as applicable, the Competing Party and its Affiliates will [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change of Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8.1	Each Party will notify the other Party in writing promptly (and in any event within [***]) following the closing of a Change of Control of such Party (the Party subject to the Change of Control, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8.2	On a Collaboration Target-by-Collaboration Target basis, if, as of the closing of the Change of Control, the acquirer or its Affiliates (other than the Acquired Party and its Preexisting Affiliates) (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquiring Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) possess rights to research, develop, manufacture, or commercialize a Competing Product Directed Against a given Collaboration Target in the applicable Field on the closing of the Change of Control transaction, [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8.3	If the Acquired Party is Kymera and the Acquiring Parties possess rights to research, develop, manufacture, or commercialize a Competing Product in the applicable Field as permitted pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.8.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as of the closing of the Change of Control transaction, then:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	[***]; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	on a Collaboration Target-by-Collaboration Target basis, Sanofi may, in its sole discretion, within [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 11<br>FINANCIAL PROVISIONS</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Up-Front Fee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Under the Original Agreement, Sanofi paid Kymera a one-time, non-refundable, non-creditable, up-front fee of One Hundred Fifty Million Dollars ($150,000,000) that is not subject to set-off.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Milestones</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, Sanofi will pay to Kymera the milestone payments (each an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Milestone Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> upon the [***] (each an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Milestone Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) with respect to a Licensed Product Directed Against such Collaboration Target, as applicable, in each case, subject to reductions pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:14.097%;"></td>
    <td style="width:61.359%;"></td>
    <td style="width:24.544%;"></td>
   </tr>
   <tr style="height:23.75pt;">
    <td colspan="3" style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.45pt;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.45pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 1 &#x2013; Early Development Milestones</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Number</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Milestone Event</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Milestone Payment</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:97.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:17.409%;"></td>
    <td style="width:58.115%;"></td>
    <td style="width:24.476%;"></td>
   </tr>
   <tr style="height:23.75pt;">
    <td colspan="3" style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 2 &#x2013; Early Development Milestones</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Number</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Milestone Event</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Milestone Payment</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On a Collaboration Target-by-Collaboration Target basis, each of the Early Development Milestone Payments [***].  Further, in no event will the Early Development Milestone Payments with respect to [***] exceed [***], will the Early Development Milestone Payments with respect to [***] exceed [***], nor will the total Early Development Milestone Payments exceed [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestones</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, Sanofi will pay to Kymera the milestone payments (each a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestone Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> upon the [***] (each a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestone Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) with respect to a Licensed Product Directed Against such Collaboration Target in each case, subject to reductions pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each of the Pre-POC Milestone Payments for each Collaboration Target is payable [***], and no such Pre-POC Milestone Payment will be payable for [***].  Further, for the avoidance of doubt, with respect to [***], the Pre-POC Milestone Payments will be paid [***] under one of the following </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 11.2.2(a)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.2(a)(ii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.2(a)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> based on the nature of [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestones for </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	If the first Clinical Trial for a Licensed Product [***] conducted after the Initiation of the Kymera Existing Phase 1 Clinical Trial (A) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">does not</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> contain [***] and (B) is a [***], then the following Pre-POC Milestone Payments shall be paid.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.198%;"></td>
    <td style="width:38.524%;"></td>
    <td style="width:28.278%;"></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Event</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestone Event</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestone Payment</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	If the first Clinical Trial for a Licensed Product [***] conducted after the Initiation of the Kymera Existing Phase 1 Clinical Trial (A) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">does </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">contain [***] and (B) is a [***], then the following Pre-POC Milestone Payments shall be paid.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:21.594%;"></td>
    <td style="width:25.882%;"></td>
    <td style="width:25.882%;"></td>
    <td style="width:26.642%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(231,230,230,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(231,230,230,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First person dosed in the first </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;that </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">does</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;contain </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Column 1)</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(231,230,230,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First person dosed in a second </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;that </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">does</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;contain </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Column 2)</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(231,230,230,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First person dosed in the first </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***] </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">does </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">not</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;contain </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Column 3)</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(231,230,230,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Row 1)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(231,230,230,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(231,230,230,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(231,230,230,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	If the [***] (A) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">does </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">contain [***] and (B) is any type of [***], then the following Pre-POC Milestone Payments shall be paid.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.198%;"></td>
    <td style="width:38.524%;"></td>
    <td style="width:28.278%;"></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Event</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestone Event</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestone Payment</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	The maximum payment for the Pre-POC Milestone Event 1 for [***] shall be: (a) [***] or (b) [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	In no event will the Pre-POC Milestone Payments associated with [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestones for </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:14.097%;"></td>
    <td style="width:61.359%;"></td>
    <td style="width:24.544%;"></td>
   </tr>
   <tr style="height:23.75pt;">
    <td colspan="3" style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#x2013; Pre-POC Milestones</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Number</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestone Event</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-POC Milestone Payment</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	In no event will the Pre-POC Milestone Payments with respect to [***] exceed [***], nor will the [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional Provisions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	For [***].  By way of example, [***].  As an alternative example, [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	For the avoidance of doubt, (I) [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	[***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-POC Milestones</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, to the extent indicated below, on a Licensed Product-by-Licensed Product basis, Sanofi will pay to Kymera the milestone payments (each a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-POC Milestone Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, and together with the Early Development Milestone Payments and the Pre-POC Milestone Payments, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Milestone Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> upon the [***] (each a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-POC Milestone Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, and together with the Early Development Milestone Events and the Pre-POC Milestone Events, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Events</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) with respect to a Licensed Product Directed Against each Collaboration Target, in each case, subject to reductions forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:13.016%;"></td>
    <td style="width:35.861%;"></td>
    <td style="width:25.604%;"></td>
    <td style="width:25.519%;"></td>
   </tr>
   <tr style="height:23.75pt;">
    <td colspan="4" style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 1 &#x2013; Post-POC Milestones</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Number</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-POC Milestone Event</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Column A:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Column B:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For [***]; provided that, for the avoidance of doubt, (I) [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For clarity, the amounts in Columns A and B with respect to [***].  For further clarity, as indicated in the table above, certain Milestone Events are achievable with respect to [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each of the Post-POC Milestone Payments for Collaboration Target 1 are [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For illustration purposes only:  If a Licensed Product [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Post-POC Milestone Payment associated with the [***] Post-POC Milestone Event with respect to Collaboration Target 1 is due in addition to the Post-POC Milestone Payments associated with the [***] Post-POC Milestone Event with respect to Collaboration Target 1, and will occur in connection with the [***].  For clarity, the [***] Post-POC Milestone Event with respect to Collaboration Target 1 is payable [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the avoidance of doubt, [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the avoidance of doubt, [***]. Further, in no event will the Post-POC Milestone Payments associated with Collaboration Target 1 exceed [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:86.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:15.122%;"></td>
    <td style="width:62.89%;"></td>
    <td style="width:21.987%;"></td>
   </tr>
   <tr style="height:23.75pt;">
    <td colspan="3" style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 2 &#x2013; Post-POC Milestones</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Number</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-POC Milestone Event</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;text-indent:1.5pt;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="margin-left:1.5pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-POC Milestone Payment</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For Collaboration Target 2, if [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For illustration purposes only:  [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the avoidance of doubt, if [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Post-POC Milestones Events with respect to each Collaboration Target that are achieved outside of the corresponding Opt-In Period will be paid at [***] of the amounts set forth above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each of the Post-POC Milestone Payments for Collaboration Target 2 is payable [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In no event will the Post-POC Milestone Payments associated with Collaboration Target 2 exceed [***] nor will the total Post-POC Milestone Payments exceed [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On a Collaboration Target-by-Collaboration Target basis, if a Licensed Product is not required to undergo the Post-POC Milestone Event associated with any such Post-POC Milestone Payment, such skipped Post-POC Milestone Event will be deemed to have been achieved upon the achievement by such Licensed Product of the next successive Post-POC Milestone Event.  Payment for any such skipped Post-POC Milestone Event that is owed in accordance with the provisions of the foregoing sentence with respect to a given Licensed Product will be due concurrently with the payment for the next successive Post-POC Milestone Event by such a Licensed Product.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial Milestones</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, Sanofi will pay Kymera the milestone payments (each a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, and, together with the Development Milestone Payments, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in accordance with the procedure set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> upon the [***] (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial Milestone Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, and, together with the Development Milestone Events, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Events</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) with respect to [***], in each case, subject to reductions pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:76.92%;"></td>
    <td style="width:23.08%;"></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial Milestone Event for Collaboration Target 1</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial Milestone Payment for all Licensed Products Directed Against Collaboration Target 1</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:76.92%;"></td>
    <td style="width:23.08%;"></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial Milestone Event for Collaboration Target 2</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial Milestone Payment for a Licensed Product Directed Against Collaboration Target 2</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:23.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each of the Commercial Milestone Payments for Collaboration Target 1 is payable [***].  Each of the Commercial Milestone Payments for Collaboration Target 2 is payable [***].  Further, in no event will the Commercial Milestone Payments associated with Collaboration Target 1 exceed [***], nor will the Commercial Milestone Payments associated with any particular Licensed Product Directed Against Collaboration Target 2 exceed [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notwithstanding anything herein to the contrary, for purposes of the Commercial Milestone Events, on a Collaboration Target-by-Collaboration Target basis, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Annual Net Sales</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On a Collaboration Target-by-Collaboration Target basis, the Commercial Milestone Payments in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are [***], such that if more than [***]Commercial Milestone Event specified in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> is achieved in the same [***] with respect to a particular Collaboration Target, then [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opt-In Period, Opt-Out</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	During the Opt-In Period (if any) for any Collaboration Target, (i) Kymera may [***] and (ii) except as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in clauses (b) and (c) below, Kymera will [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	[***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	[***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice; Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Milestone Payment will be deemed earned upon achievement of the corresponding Milestone Event, and Sanofi will provide Kymera with written notice upon the achievement of each of the Milestone Events set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 11.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, such written notice to be </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (i) with respect to any Milestone Event under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, within [***] and (ii) with respect to any Milestone Event under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [***] for the Calendar Quarter in which such Milestone Event is first achieved.  Following receipt of such written notice, Kymera will</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">promptly invoice Sanofi for the applicable milestone and Sanofi will make the appropriate Milestone Payment within [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General Right to Reconcile Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Sanofi will have the right to offset [***], against any payments owed by Sanofi to Kymera under this Agreement.  Such offsets will be in addition to any other rights or remedies available under this Agreement and Applicable Law.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty Rates</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 11.3.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, on a Collaboration Target-by-Collaboration Target, Licensed Product-by-Licensed Product and country-by-country basis, Sanofi will pay Kymera royalties based on the aggregate Net Sales of the applicable Licensed Product sold by Sanofi, its Affiliates or Sublicensees in the applicable Field during a Calendar Year at the rates set forth in the applicable table below.  The obligation to pay royalties will be imposed only once with respect to the same unit of a Licensed Product.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:75.155%;"></td>
    <td style="width:24.845%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td colspan="2" style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 1</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calendar Year Net Sales (in U.S. Dollars) for such Licensed Products</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty Rates as a Percentage (%) of Net Sales</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:75.155%;"></td>
    <td style="width:24.845%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td colspan="2" style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 2</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calendar Year Net Sales (in U.S. Dollars) for such Licensed Products</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty Rates as a Percentage (%) of Net Sales</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The applicable royalty rate set forth in the applicable table above will apply only to that portion of the Net Sales of a given Licensed Product during a given Calendar Year that falls within the indicated range.  By way of example and without limitation of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, if Calendar Year Net Sales by Sanofi, its Affiliates and Sublicensees of a given Licensed Product Directed Against Collaboration Target 2 were [***], then the royalties payable with respect to such Calendar Year Net Sales for such Licensed Product for such Calendar Year, subject to adjustment as set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, would be:  [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notwithstanding the foregoing, on a Collaboration Target-by-Collaboration Target basis, in the event that Kymera exercised the Kymera Opt-In Right and later exercises the Kymera Opt-Out Right, the royalty rates will be as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:26.995%;"></td>
    <td style="width:36.0%;"></td>
    <td style="width:37.005%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td colspan="3" style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 1</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calendar Year Net Sales (in U.S. Dollars) for such Licensed Products</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty Rates as a Percentage (%) of Net Sales if Kymera has borne U.S. Development Expenses at least equal to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;but less than </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty Rates as a Percentage (%) of Net Sales if Kymera has borne U.S. Development Expenses at least equal to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">97</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:26.995%;"></td>
    <td style="width:36.0%;"></td>
    <td style="width:37.005%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td colspan="3" style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 2</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calendar Year Net Sales (in U.S. Dollars) for such Licensed Products</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty Rates as a Percentage (%) of Net Sales if Kymera has borne U.S. Development Expenses at least equal to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;but less than </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty Rates as a Percentage (%) of Net Sales if Kymera has borne U.S. Development Expenses at least equal to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***] up to and including [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portion of Calendar Year Net Sales that exceeds [***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Sanofi will pay royalties to Kymera under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> on a Licensed Product-by-Licensed Product and a country-by-country basis during the Royalty Term for such Licensed Product in such country.  Upon the expiration of the Royalty Term for a given Licensed Product in a given country, the Exclusive License granted to Sanofi under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will become fully-paid, perpetual, irrevocable and royalty free with respect to such Licensed Product.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reduction for Lack of Patent Coverage</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If during any period within the applicable Royalty Term for a country, no Valid Claim of any Patent within the Licensed Technology (which includes, for clarity, the Joint Foreground Patents) exists that Covers the sale or use of such Licensed Product in such country, then the royalty rate applied to Net Sales of such Licensed Product in such country will be reduced by [***] for purposes of calculating the royalty owed under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the remainder of the Royalty Term for such Licensed Product in such country.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reduction for Competition</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Following the First Commercial Sale of a Generic Product in a given country, if during any Calendar Quarter during the Royalty Term for a Licensed Product in such country, the average quarterly Net Sales of Licensed Product sold [***] declines [***] or more when compared to the average quarterly Net Sales of such Licensed Product in such country during the [***] immediately prior to the First Commercial Sale of such Generic Product, then the royalty rate with respect to Net Sales of such Licensed Product in such country will automatically be reduced to [***] of the royalty rate otherwise applicable with respect to such Licensed Product in such country for such Calendar Quarter.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Further, following the First Commercial Sale of a Generic Product in a given country, if during any Calendar Quarter during the Royalty Term for a Licensed Product in such country, the average quarterly Net Sales of Licensed Product sold [***] declines [***] or more when compared to the average quarterly Net Sales of such Licensed Product in such country during the [***] immediately prior to the First Commercial Sale of such Generic Product, then the royalty rate with respect to Net Sales of such Licensed Product will automatically be reduced [***] with respect to such Licensed Product in such country.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Party Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Sanofi may deduct from the royalties payable to Kymera under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [***] of any Blocking Third Party Intellectual Property Costs and In-License Costs paid by Sanofi prior to or during such Calendar Quarter; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that in no event will the royalties that would otherwise be payable to Kymera with respect to Net Sales of Licensed Products, after any applicable reduction to such Net Sales under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.3.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, be reduced by more than [***] in any given Calendar Quarter.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate Limitation on Deductions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 11.3.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.4(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, in no event will the combined effect of all reductions to the royalties payable to Kymera under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 11.3.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.4(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reduce the royalty amounts payable by Sanofi to Kymera under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for any Licensed Product in any country during a Calendar Quarter to less than [***] of the amount that would otherwise be due under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, but for such deductions </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that Sanofi will be entitled to [***]; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that notwithstanding the foregoing, on a Collaboration Target-by-Collaboration Target basis, [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opt-In Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding anything to the contrary in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, on a Collaboration Target-by-Collaboration Target basis, if Kymera has exercised the Kymera Opt-In Right with respect to a given Collaboration Target, then, during the applicable Opt-In Period, (a) the Parties will share costs and profits in the United States with respect to Licensed Products Directed Against such Collaboration Target in accordance with the applicable Cost/Profit Sharing Agreement and (b) the terms of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 11.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> through </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will apply to sales of Licensed Products Directed Against such Collaboration Target in the Rest of World.  For clarity, in the event Kymera exercises the Kymera Opt-In Right with respect to a given Collaboration Target and later exercises the Kymera Opt-Out Right with respect to such Collaboration Target, then the terms of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 11.3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> through </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will apply to sales of Licensed Products Directed Against</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such Collaboration Target throughout the Territory.  Further, any relevant Blocking Third Party Intellectual Property Costs paid by Sanofi will be subject to the relevant Cost/Profit Sharing Agreement.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.8	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty Reports</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Following the First Commercial Sale of a Licensed Product and continuing for the remainder of the Royalty Term for such Licensed Product, within [***] after the end of each Calendar Quarter, Sanofi will deliver a report to Kymera specifying on a Licensed Product-by-Licensed Product basis: (a) Net Sales in the relevant Calendar Quarter, (b) to the extent such Net Sales include sales not denoted in U.S. Dollars, a summary of the then-current exchange rate methodology then in use by Sanofi and used to convert Net Sales to U.S. Dollars, and (c) royalties payable on such Net Sales.  All royalty payments due under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for each Calendar Quarter will be due and payable within [***] after the end of each Calendar Quarter.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Invoicing for Additional Amounts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  With respect to any amounts owed under this Agreement by one Party to the other Party for which no other invoicing and payment procedure is specified elsewhere in this Agreement, within [***] after the end of each Calendar Quarter, the applicable Party will provide an invoice, together with reasonable supporting documentation, to the other Party for such amounts owed.  The owing Party will pay any undisputed amounts within [***] of receipt of the invoice, and any disputed amounts owed by the owing Party will be paid within [***] of resolution of the Dispute.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In-License Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.5.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Potential In-Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	On a Collaboration Target-by-Collaboration Target basis, a Party may notify the JSC that the Research, Development, Manufacture or Commercialization of Collaboration Compounds, Collaboration Candidates or Licensed Products Directed Against a given Collaboration Target may require or benefit from a grant of rights under additional Patents or Know-How of Third Parties, whether by license or acquisition (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Potential In-License</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	If the Third Party Know-How or Patents that are the subject of the Potential In-License would constitute [***], then [***], in which case such Potential In-License will be deemed to be a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration In-License</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; upon the execution of such agreement, or (ii) follow the procedures set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	 Except as set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.5.1(b)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, if the Third Party Know-How or Patents that are subject to the Potential In-License either (x) [***] or (y) [***], the Parties will, through the JSC (in coordination with the JPC), review, discuss, and determine whether to negotiate the terms of such Potential In-License for use by the Parties pursuant to this Agreement with respect to the Research, Development, Manufacture or Commercialization of Collaboration Compounds, Collaboration Candidates or Licensed Products Directed Against such Collaboration Target to which such Potential In-License relates. In connection therewith, except as otherwise expressly agreed by the Parties, the JSC will:</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	[***];</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	[***];</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	[***]; and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	If the Potential In-License relates to Patents or Know-How of Third Parties that are not otherwise covered in clause (b) or (c) above, then either Party will have the right, but not the obligation, to negotiate and enter into the applicable Potential In-License.  Promptly after execution of any such Potential In-License, (i) the Parties will enter into a common interest agreement, and (ii) the applicable licensing Party will bring such Potential In-License to the attention of the JSC in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	Notwithstanding anything to the contrary set forth in this Agreement, neither Party in its role as &#x201c;lead negotiator&#x201d; will negotiate for or agree to economic terms in any such Potential In-License in a manner [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.5.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration In-License Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If a Potential In-License is brought to the attention of the JSC pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, then the Parties will, through the JSC, [***].  The JSC will review and discuss the rationale of including such Potential In-License for use by the Parties with respect to the applicable Collaboration Compounds, Collaboration Candidates or Licensed Products Directed Against a given Licensed Target pursuant to this Agreement and the proposed (or agreed) economics associated with doing so (including related royalty or milestone obligations), and determine whether to approve such Potential In-License as a Collaboration In-License Agreement for the applicable Collaboration Target.  For any Potential In-License that the JSC approves for use by the Parties pursuant to this Agreement, (a) such Potential In-License will be deemed to be a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration In-License Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; hereunder on the date such agreement is executed by the applicable Party and Third Party, and (b) as of such execution date, the Patents and Know-How in-licensed under such Collaboration In-License Agreement will be deemed &#x201c;Controlled&#x201d; under this Agreement as Licensed Technology or Sanofi Technology for purposes of the Research, Development, Manufacture and Commercialization of Collaboration Compounds, Collaboration Candidates and Licensed Products Directed Against the applicable Collaboration Target.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.5.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Costs for Collaboration In-Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Any upfront payments, milestone payments, similar payments or royalties incurred under a Collaboration In-License that are specific to the Collaboration Compounds, Collaboration Candidates or Licensed Products Directed Against the applicable Collaboration Target will be allocated between the Parties as follows:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.5.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Approved Potential In-Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If the JSC does not approve a Potential In-License as a Collaboration In-License Agreement pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.5.1(c)(iv)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, then (a) such Potential In-License will not be a Collaboration In-License Agreement hereunder, and (b) the Patents and Know-How which would have been in-licensed under such Potential In-License will not be included as Licensed Technology or Sanofi</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Technology and will not be &#x201c;Controlled&#x201d; by the Party to the Potential In-License for purposes of this Agreement.  For clarity, if the JSC does not approve a Potential In-License, then (a) each Party will be entitled to, at its discretion, independently in-license such Third Party Know-How or Patents </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such independently-obtained license would not block the other Party from seeking its own direct license to such Intellectual Property for use in connection with the Research, Development, Manufacture or Commercialization of Collaboration Compounds, Collaboration Candidates or Licensed Products, and (b) the other Party will have no obligation to reimburse the other Party for any costs or expenses incurred or payments due with respect to any licenses between such Party and such Third Party.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.5.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Party Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding the foregoing, the Parties acknowledge and agree that (a) the Third Party Agreement has been terminated in accordance with its terms prior to the Restatement Execution Date; (b) no (sub)license or other right with respect to any Know-How or Patents owned by Kymera (whether solely or jointly with the Counterparty) pursuant to the Third Party Agreement is granted to Sanofi pursuant to this Agreement; and (c) any Know-How or Patents co-owned by Kymera and the Counterparty under the Third Party Agreement will not be Controlled by Kymera or its Affiliates for purposes of this Agreement except as provided in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event that the Parties wish to use or incorporate any of the Know-How or Patents co-owned by Kymera and the Counterparty into or under this Agreement, then the Parties may amend this Agreement to incorporate such rights, licenses and other obligations as the Parties may mutually agree in writing.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:6.957%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.5.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compliance with Collaboration In-License Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All licenses and other rights granted under this Agreement will be subject to the rights and obligations under the applicable Collaboration In-License Agreements. Each Party will comply with all applicable provisions of the Collaboration In-License Agreements, and will perform and take such actions as may be required to allow the other Party to comply with its obligations thereunder, including obligations relating to sublicensing, patent matters, confidentiality, reporting, audit rights, indemnification and diligence.  Without limiting the foregoing, each Party will prepare and deliver to the other Party any additional reports required under the applicable Collaboration In-License Agreements and reasonably requested by the other Party, in each case, sufficiently in advance to enable the other Party to comply with its obligations under the applicable Collaboration In-License Agreements. For clarity, as of the Restatement Execution Date, there are no Collaboration In-License Agreements, and the Third Party Agreement will not be deemed a Collaboration In-License Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and Development Funding Reimbursement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.6.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research Costs </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***].  Sanofi will reimburse Kymera for [***] actually incurred by Kymera or its Affiliates for the Research activities conducted under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.4.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> with respect [***].  Any payments to be made to Kymera by Sanofi pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be made [***] pursuant to invoices submitted by Kymera to Sanofi within [***]; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera will provide a good faith estimate of any costs for which reimbursement is due under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> within [***].  Each such invoice will be accompanied by reasonable supporting documentation evidencing the expenses incurred for</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such Research activities (such expenses to be itemized) [***].  Undisputed payments will be due within [***] after Sanofi receives such an invoice from Kymera.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.6.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research Costs </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***].  Sanofi will reimburse Kymera for its [***] actually incurred by Kymera or its Affiliates for the Research activities conducted under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.5.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in accordance with the Research Plan and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 2.5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.6.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any payments to be made to Kymera by Sanofi pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be made [***] pursuant to invoices submitted by Kymera to Sanofi within [***]; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera will provide a good faith estimate of any costs for which reimbursement is due under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> within [***].  Each such invoice will be accompanied by reasonable supporting documentation evidencing the expenses incurred for such Research activities (such expenses to be itemized) [***].  Undisputed payments will be due within [***] after Sanofi receives such an invoice from Kymera.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.6.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research Costs </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***].  Sanofi will reimburse Kymera for its [***] actually incurred by Kymera or its Affiliates for [***] performed in accordance with the applicable Backup Research Plan, subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any payments to be made to Kymera by Sanofi pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be made [***] pursuant to invoices submitted by Kymera to Sanofi within [***]; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera will provide a good faith estimate of any costs for which reimbursement is due under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> within [***].  Each such invoice will be accompanied by reasonable supporting documentation evidencing the expenses incurred for the Backup Research (such expenses to be itemized) [***].  Undisputed payments will be due within [***] after Sanofi receives such an invoice from Kymera.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.6.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Development Funding Reimbursement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Funding for </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***].  Kymera will pay for [***] incurred by or on behalf of Kymera for the Kymera Existing Phase 1 Clinical Trial [***].  Sanofi will pay for [***] incurred during the period commencing [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Funding for </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]. Kymera will pay for [***] incurred by or on behalf of Kymera during the period commencing on the Restatement Effective Date and continuing for the remainder of the Research Term for: [***].  Sanofi will reimburse Kymera for [***] incurred by or on behalf of Kymera or its Affiliates with respect to [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Funding </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]. Sanofi will reimburse Kymera for [***] actually incurred by or on behalf of Kymera or its Affiliates for all Early Development Activities for Licensed Products containing [***] conducted under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 3.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, including Development, regulatory Manufacturing activities related thereto.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.6.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any payments to be made to one Party by the other Party pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be made [***] in arrears pursuant to invoices submitted by Kymera to Sanofi within [***] following the end of the applicable [***]; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera will provide a good faith estimate of any costs for which reimbursement is due under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> within [***] after each [***].  Each such invoice will be accompanied by reasonable supporting documentation evidencing the expenses incurred for</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such Research activities (such expenses to be itemized) during such [***].  Undisputed payments will be due within [***] after Sanofi receives such an invoice from Kymera.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payment Terms</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.7.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Currency; Payment Method</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All payments under this Agreement are expressed in U.S. Dollars and will be paid in U.S. Dollars, by wire transfer or Automated Clearing House (ACH) payment to an account designated by Kymera (which account Kymera may update from time to time in writing).</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.7.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exchange</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If any amounts that are relevant to the determination of amounts to be paid under this Agreement or any calculations to be performed under this Agreement are denoted in a currency other than U.S. Dollars, such amounts will be converted to their U.S. Dollar equivalent using Sanofi&#x2019;s then-current standard procedures and methodology, including its then-current standard exchange rate methodology for the translation of foreign currency expenses into U.S. Dollars or, in the case of Sublicensees, such similar methodology, consistently applied. Calculation of Net Sales will exclude hedging and foreign exchange gain or loss realized through a hedging program.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.7.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Invoices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except as otherwise set forth in this Agreement, Kymera will deliver an invoice to Sanofi for all payments owed by Sanofi to Kymera in accordance with Sanofi&#x2019;s reasonable instructions.  Sanofi will pay all undisputed payments owed to Kymera within [***] after receipt of the invoice for such owed amount, except where a different timeframe is expressly </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in another Section of this Agreement, and any disputed amounts owed by Sanofi will be paid within [***] of resolution of the Dispute.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.8	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Withholding Tax</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Where any sum due to be paid to Kymera hereunder is subject to any withholding or similar tax, Sanofi will pay such withholding or similar tax to the appropriate Governmental Authority and deduct the amount paid from the amount then due to Kymera.  Sanofi will timely transmit to Kymera an official tax certificate or other evidence of such withholding sufficient to enable Kymera to claim such payment of taxes.  The Parties will cooperate with one another and use reasonable efforts to reduce or eliminate tax withholding or similar obligations in respect of royalties, Milestone Payments, and other payments made by Sanofi to Kymera under this Agreement.  Kymera will provide Sanofi any tax forms that may be reasonably necessary in order for Sanofi not to withhold tax or to withhold tax at a reduced rate under an applicable bilateral income tax treaty.  Each Party will provide the other with reasonable assistance to enable the recovery, as permitted by Applicable Laws, of withholding taxes, value added taxes, or similar obligations resulting from payments made under this Agreement, such recovery to be for the benefit of the Party bearing such withholding tax or value added tax. Notwithstanding this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, if, as a result of a Withholding Action by Sanofi (including any assignee or successor), withholding is required by Applicable Law and the amount of such withholding exceeds the amount of withholding that would have been required if Sanofi had not committed the Withholding Action, then Sanofi shall pay an additional amount to Kymera such that, after withholding from the payment contemplated by this Agreement and such additional amount, Kymera receives the same amount as it would have received from Sanofi absent such Withholding Action by Sanofi.  For the avoidance of doubt, if as a result of a Withholding Action by Kymera (including any assignee or successor) the amount of withholding under the law of the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">applicable jurisdiction exceeds the amount of such withholding that would have been required in the absence of such Withholding Action by Kymera, Sanofi shall be required to pay any additional amount only to the extent that Sanofi would be required to pay any additional amount to Kymera pursuant to the preceding sentence if Kymera had not committed such Withholding Action.  For purposes of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Withholding Action</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; by a Party means (i) a permitted assignment or sublicense of this Agreement (in whole or in part) by such Party to an Affiliate or a Third Party outside of the United States; (ii) the exercise by such Party of its rights under this Agreement (in whole or in part) through an Affiliate or Third Party outside of the United States (or the direct exercise of such rights by an Affiliate of such Party outside of the United States); (iii) a redomiciliation of such Party, an assignee or a successor to a jurisdiction outside the United States; and (iv) any action by such Party that causes this Agreement or any payment contemplated by this Agreement to become subject to Tax in a jurisdiction outside of the United States or subject any payment contemplated by this Agreement to withholding in any jurisdiction that would not have been required absent such Withholding Action.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.9	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Records; Audits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Sanofi will keep and maintain accurate and complete records regarding Net Sales during the [***].  Kymera will keep accurate and complete records regarding all [***] incurred in connection with the (i) Research activities relating to [***], in each case, in sufficient detail to confirm the accuracy of any payments required under this Agreement, covering the [***].  Upon [***] prior written notice from the other Party (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auditing Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), the Party required to maintain such records (as applicable, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Audited Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) will permit an independent certified public accounting firm of internationally recognized standing, selected by the Auditing Party and reasonably acceptable to the Audited Party, to examine the relevant books and records of the Audited Party and its Affiliates, as may be reasonably necessary to verify the royalty reports submitted by Sanofi in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.3.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or [***] reported by Kymera in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as applicable.  An examination by the Auditing Party under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will occur not more than once in any Calendar Year and will be limited to the pertinent books and records for any Calendar Year ending not more than [***] before the date of the request.  No records will be audited more than once.  The accounting firm will be </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> access to such books and records at the Audited Party&#x2019;s facility or facilities where such books and records are normally kept and such examination will be conducted during the Audited Party&#x2019;s normal business hours.  The Audited Party may require the accounting firm to sign a customary non-disclosure agreement before providing the accounting firm access to its facilities or records.  Upon completion of the audit, the accounting firm will provide both Parties a written report disclosing whether the reports submitted by Sanofi or [***] submitted by Kymera, as applicable, are correct or incorrect and the specific details concerning any discrepancies.  No other information will be </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to the Auditing Party.  If the report or information submitted by the Audited Party results in an underpayment or overpayment, (a) the Party owing the underpaid or overpaid amount will promptly pay the amount of such underpayment to the other Party, and (b) any such overpayment will be creditable against future payments to the other Party hereunder.  The costs and fees of any audit conducted by the Auditing Party under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 11.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be borne by the Auditing Party, unless such audit reveals an underpayment of amounts owed to the Auditing Party of more than [***] of the amount that was owed by the Audited Party with respect to the relevant period, in which case, the Audited Party will reimburse the Auditing Party for the reasonable expense incurred by the Auditing Party in connection with the audit.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">105</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.10	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Late Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any undisputed payment under this Agreement that is not paid on or before the date such undisputed payment is due will bear interest, to the extent permitted by Applicable Law, at [***] above [***], as reported by Reuters from time to time, calculated on the number of days such undisputed payment is overdue, compounded annually and computed on the basis of a three hundred sixty-five (365) day year.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 12<br>INTELLECTUAL PROPERTY</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ownership; Assignment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.1.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Background Technology and Sanofi Background Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  As between the Parties, Kymera will own and retain all of its rights, title and interest in and to the Kymera Background Technology and Sanofi will own and retain all of its rights, title and interest in and to any Sanofi Background Technology, subject to any rights or licenses expressly granted by one Party to the other Party under this Agreement.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.1.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreground Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	For purposes of determining inventorship under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, inventorship will be determined in accordance with United States patent laws (regardless of where the applicable activities occurred).</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	As between the Parties, Kymera will be the sole owner of any Foreground Know-How that [***], and will own and retain all rights, title and interest thereto, subject to any rights or licenses expressly granted by Kymera to Sanofi under this Agreement.  For clarity, [***].  Any dispute of whether any [***] will be governed by </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.9.2(b)(iv)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Except as expressly set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.1.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as between the Parties, each Party will be the sole owner of any Foreground Know-How discovered, developed, invented or created solely by such Party, its Affiliates, or Third Parties acting on its or their behalf, and all Patents that Cover any of the foregoing.  The Parties will jointly own, on an equal and undivided basis any Foreground Know-How discovered, developed, invented or created jointly by both (i) Sanofi, its Affiliates, or Third Parties acting on behalf of Sanofi or its Affiliates and (ii) Kymera, its Affiliates, or Third Parties acting on behalf of Kymera or its Affiliates, and all Patents, including [***], that claim or encompass any of the foregoing [***]. [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.9.2(b)(iv)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for any dispute of whether any Foreground Technology is Platform Foreground Technology, [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	Promptly following receipt by Kymera or any of its Affiliates of an invention disclosure with respect to any invention discovered, developed, invented or created, solely or jointly, by Kymera, its Affiliates, or Third Parties acting on its or their behalf that constitutes Foreground Technology, Kymera will promptly disclose to Sanofi in writing, and will cause its Affiliates to so disclose, the discovery, development, invention or creation of such Foreground Technology.  Promptly following receipt by Sanofi or any of its Affiliates of an invention disclosure with respect to any invention that is discovered, developed, invented or</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">created, solely or jointly, by Sanofi, its Affiliates, or Third Parties acting on its or their behalf that constitutes Foreground Technology, Sanofi will promptly disclose to Kymera in writing, and will cause its Affiliates to so disclose, the discovery, development, invention or creation of such Foreground Technology.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prosecution and Maintenance of Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.1	[***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Except as expressly set forth in this Agreement, Kymera will control, be responsible for and have the sole right for (but not the obligation), at its own expense, all aspects of the Prosecution and Maintenance of [***].  Kymera&#x2019;s interest in [***] is addressed in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Kymera&#x2019;s interest in all other [***] is addressed in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 12.2.5,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.6(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Each Party&#x2019;s rights in respect of [***] are addressed in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.1(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. For clarity, Kymera will control, be responsible for and have the sole right for (but not the obligation), at its own expense, all aspects of the Prosecution and Maintenance of all Patents that [***] and Sanofi will have no right to review and comment on the Prosecution and Maintenance of such Patents that [***].  [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 12.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera will have the exclusive right, but not the obligation, to Prosecute and Maintain all Patents that [***].  Without the prior consent of Sanofi, Kymera will not [***].  Kymera will not [***].  If [***], Kymera will not [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 12.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera will have the exclusive right, but not the obligation, to Prosecute and Maintain all Patents that [***].  Without the prior consent of Sanofi, Kymera will not [***]. Kymera will not [***].  If [***], Kymera will not [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 12.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera will have the exclusive right, but not the obligation, to Prosecute and Maintain all Patents that [***].  Without the prior consent of Sanofi, Kymera will not [***].  If [***], Kymera will not [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 12.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera will have the exclusive right, but not the obligation, to Prosecute and Maintain all Patents that [***], and will not [***].  If [***], Kymera will not [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.2	[***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to the Sanofi Participation Election Effective Date (if any) for Collaboration Target 1, [***] will use Commercially Reasonable Efforts to Prosecute and Maintain, at its own expense [***]. Without the prior consent of [***] will not [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the [***], and [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of the [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	[***].  Prior to the Sanofi Participation Election Effective Date (if any) for Collaboration Target 1, [***] will have the first right (but not the obligation) to</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prosecute and Maintain the [***], subject to the [***] backup rights described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  [***] will have the right to review and comment on the Prosecution and Maintenance of the [***], and [***].  Without the prior consent of [***], [***] will [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of the [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to the Sanofi Participation Election Effective Date (if any) for Collaboration Target 1, [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***], subject to the [***] backup rights described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].  If the Parties cannot agree on a particular action with respect to the [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to the Sanofi Participation Election Effective Date (if any) for Collaboration Target 1, [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***], subject to the [***] backup rights described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  [***] will have the right to review and comment on the Prosecution and Maintenance of the [***], and [***].  Without the prior consent of [***], [***] will not [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of the [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to the Sanofi Participation Election Effective Date (if any) for Collaboration Target 1, Kymera will have the first right (but not the obligation) to Prosecute and Maintain the [***], subject to the [***] backup rights described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  [***] will have the right to review and comment on the Prosecution and Maintenance of the [***], and [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of the [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the Sanofi Participation Term (if any) for Collaboration Target 1, [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***].  [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the Sanofi Participation Term (if any) for Collaboration Target 1, [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***].  [***] will have the right to review and comment on the Prosecution and Maintenance of the [***], and [***].  Without the prior consent of [***], [***] will not [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of the [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">108</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the Sanofi Participation Term (if any) for the Collaboration Target 1, [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***].  [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the Sanofi Participation Term (if any) for Collaboration Target 1, [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***].  [***] will have the right to review and comment on the Prosecution and Maintenance of the [***], and [***].  Without the prior consent of [***], [***] will not [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of the [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the Sanofi Participation Term (if any) for Collaboration Target 1, [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***].  [***] will have the right to review and comment on the Prosecution and Maintenance of the [***] and [***]. If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of the [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Kymera Background Patents relevant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]. In the event that any [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.4	[***].  Prior to the Sanofi Participation Election Right Exercise (if any) for [***] and prior to the filing of any new Patent application that Covers [***], the JPC will meet and in good faith discuss [***].  The Parties, through the JPC, will use good faith efforts to agree on such strategy, with the goal of maximizing the value of the Parties&#x2019; respective patent portfolios.  For clarity, [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Prior to the Sanofi Participation Election Effective Date (if any) for  [***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***], subject to the [***] backup rights described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that (i) [***] will not [***], and (ii) [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the [***], and [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of the [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During the Sanofi Participation Term (if any) for [***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***].  [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.5	[***].  Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Parties will divide responsibility for the Prosecution and Maintenance of [***], other than [***], as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">109</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Prior to the Sanofi Participation Election Effective Date (if any) for [***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***], subject to the [***] backup rights described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  [***] will have the right to review and comment on the Prosecution and Maintenance of such [***], and [***].  In any [***], without the prior consent of [***], [***] will not [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of such [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During the Sanofi Participation Term (if any) for [***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***], other than [***].  [***] will have the right to review and comment on the Prosecution and Maintenance of such [***] and [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of such [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.6	[***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	[***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to the Sanofi Participation Election Effective Date (if any) for [***] will use Commercially Reasonable Efforts to Prosecute and Maintain, at its own expense, [***].  [***] will have the right to review and comment on the Prosecution and Maintenance of [***], and [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of any [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  During the Sanofi Participation Term (if any) for [***], [***] will have the first right (but not the obligation) to Prosecute and Maintain all [***].  [***] will have the right to review and comment on the Prosecution and Maintenance of such [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	[***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to the Sanofi Participation Election Effective Date (if any) for [***], [***] will have the first right (but not the obligation) to Prosecute and Maintain all [***], subject to the [***] backup rights described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  [***] will have the right to review and comment on the Prosecution and Maintenance of such [***], and [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of such [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the Sanofi Participation Term (if any) [***], [***] will have the first right (but not the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obligation) to Prosecute and Maintain [***].  [***] will have the right to review and comment on the Prosecution and Maintenance of such [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	[***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Prior to the Sanofi Participation Election Effective Date (if any) for [***], [***] will have the first right (but not the obligation) to Prosecute and Maintain all [***], subject to the [***] backup rights described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  [***] will have the right to review and comment on the Prosecution and Maintenance of such [***], and [***].  If the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of such [***], then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the Sanofi Participation Term (if any) for [***], [***] will have the first right (but not the obligation) to Prosecute and Maintain all [***].  [***] will have the right to review and comment on the Prosecution and Maintenance of such [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.7	[***].  Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 12.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.6(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Parties will divide responsibility for the Prosecution and Maintenance of [***], other than [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.8	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Sanofi will control, be responsible for, and have the sole right (but not the obligation) for, at its own expense, all aspects of the Prosecution and Maintenance of all Sanofi Background Patents and Sanofi Foreground Patents.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2.9	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Matters Pertaining to Prosecution and Maintenance of Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	During the Term, each Party will keep the other Party informed (through the JPC, or directly if the JPC is disbanded) as to material developments with respect to the Prosecution and Maintenance of the [***] for which such Party has responsibility for Prosecution and Maintenance pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, including by providing (i) copies of any office actions or office action responses or other correspondence that such Party provides to or receives from any patent office, including notice of all interferences, reissues, re-examinations, or oppositions, and all patent-related filings; and (ii) drafts of any material filings or responses to be made to any patent office sufficiently in advance of submitting such filings or responses so as to provide the other Party the timely opportunity to have reasonable input into the strategic aspects of such Prosecution and Maintenance.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	If, during the Term, Sanofi intends to abandon patent applications for any [***], then Sanofi will so notify Kymera of such intention at least [***] before such Patent will become abandoned, and Kymera will have the right, but not the obligation, to assume responsibility for the Prosecution and Maintenance thereof at its own expense with counsel of its own choice, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, [***]; and (iii) if the Parties cannot agree on the reasonableness of any other strategic purpose, then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">111</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	If, during the Term, Kymera intends to abandon any [***] that Kymera is responsible for Prosecuting and Maintaining in a particular country, then Kymera will notify Sanofi of such intention at least [***] before such Patent will become abandoned, and Sanofi will have the right, but not the obligation, to assume responsibility for the Prosecution and Maintenance thereof at its own expense with counsel of its own choice.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Defense of Claims Brought by Third Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If any Third Party brings a claim or otherwise asserts that a Licensed Product or Collaboration Compound infringes such Third Party&#x2019;s Patent or misappropriates such Third Party&#x2019;s Know-How (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third-Party Infringement Claim</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), the Party first having notice of the claim or assertion will promptly notify the other Party in writing.  Prior to the Sanofi Participation Election Effective Date (if any) with respect to the applicable Collaboration Target, [***] will have the sole right to undertake and control the defense or settlement of any Third-Party Infringement Claim using counsel of its choice, at its cost and expense and, following the Sanofi Participation Election Effective Date (if any) with respect to the applicable Collaboration Target, [***] will have the sole right to undertake and control the defense or settlement of any Third-Party Infringement Claim using counsel of its choice, at its cost and expense (such Party having the right to control such defense, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Defending Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  If the Party not having the right to control such defense in accordance with the preceding sentence (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Defending Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is named as a defendant in such suit, the Non-Defending Party will have the right to participate in such defense and settlement with its own counsel, at its cost.  The Defending Party will not enter into any settlement of any Third-Party Infringement Claim that is instituted or threatened to be instituted against the Non-Defending Party without the Non-Defending Party&#x2019;s prior written consent, which will not be unreasonably withheld, conditioned or delayed;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> except that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, such consent will not be required if such settlement includes a release of all liability in favor of the Non-Defending Party or an assumption of any unreleased liability by the Defending Party.  As requested by the Defending Party, the Non-Defending Party will provide reasonable cooperation and assistance to the Defending Party in connection with the Defending Party&#x2019;s control of the defense or settlement of a Third-Party Infringement Claim.  Such cooperation and assistance will include executing all necessary and proper documents and taking such actions as will be appropriate to allow the Defending Party to control the defense and settlement of such Third-Party Infringement Claim.  The Defending Party will reimburse the Non-Defending Party for the reasonable Out-of-Pocket Costs incurred by the Non-Defending Party in providing such assistance and cooperation; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">except that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> the Defending Party will have no obligation to reimburse the Non-Defending Party for any costs or expenses incurred if the Non-Defending Party exercises its right to participate in the defense and settlement of a Third-Party Infringement Claim with its own counsel.  The Defending Party will keep the Non-Defending Party reasonably informed of the progress of any Third-Party Infringement Claim.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Enforcement of Patents Against Competitive Infringement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Duty to Notify of Competitive Infringement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During the Term, if either Party learns of an infringement, unauthorized use, misappropriation or threatened infringement by a Third Party with respect to [***] (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competitive Infringement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), such Party will promptly notify the other Party in writing and will provide such other Party with available information regarding such Competitive Infringement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4.2	[***].  As between the Parties, Kymera will have the sole right, but not the obligation, to institute, prosecute and control any action or proceeding with respect to any infringement of any [***], by counsel of its own choice, in Kymera&#x2019;s own name and under Kymera&#x2019;s direction and control.  For clarity, the enforcement of [***] are addressed in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 12.4.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.5.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4.3	[***].  For clarity, the provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are applicable to [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  As between the Parties, for any Competitive Infringement with respect to [***], [***] will have the first right, but not the obligation to institute, prosecute, and control a Proceeding to enforce any [***] against such Competitive Infringement by counsel of its own choice.  [***] will have the right to engage counsel of its own choice in connection with such Proceeding at its own expense.  [***] will provide [***] with prompt written notice of the commencement of any such Proceeding, and [***] will keep [***] apprised of the progress of such Proceeding and will reasonably consult with [***] with respect to such Proceeding.  If [***] fails to initiate such Proceeding within a period of [***] after written notice of such Competitive Infringement is first provided by a Party under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, [***] will have the right to initiate and control a Proceeding to enforce the [***] against such Competitive Infringement by counsel of its own choice, and [***] will have the right to be represented in any such action by counsel of its own choice at its own expense; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  As between the Parties, for any Competitive Infringement with respect to [***], [***] will have the first right, but not the obligation, to institute, prosecute, and control a Proceeding to enforce the [***] against such Competitive Infringement by counsel of its own choice at its own expense, and [***] will have the right, at its own expense, to be represented in that action by counsel of its own choice.  If [***] fails to initiate such Proceeding within a period of [***] after written notice of such Competitive Infringement is first provided by a Party under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, [***] will have the right to initiate and control a Proceeding to enforce the [***] against such Competitive Infringement by counsel of its own choice, and [***] will have the right to be represented in any such action by counsel of its own choice at its own expense; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4.4	[***].  For clarity, the provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are applicable to [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  As between the Parties, for any Competitive Infringement with respect to [***], [***] will have the first right, but not the obligation to institute, prosecute, and control a Proceeding to enforce any [***] against such Competitive Infringement by counsel of its own choice.  [***] will have the right to engage counsel of its own choice in connection with such Proceeding at its own expense.  [***] will provide [***] with prompt written notice of the commencement of any such Proceeding, and [***] will keep [***] apprised of the progress of such Proceeding and will reasonably consult with [***] with respect to such Proceeding.  If [***] fails to initiate such Proceeding within a period of [***] after written notice of such Competitive Infringement is first provided by a Party under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, [***] will have the right to initiate and control a Proceeding to enforce the [***] against</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">113</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such Competitive Infringement by counsel of its own choice, and [***] will have the right to be represented in any such action by counsel of its own choice at its own expense; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  As between the Parties, for any Competitive Infringement with respect to [***], [***] will have the first right, but not the obligation, to institute, prosecute, and control a Proceeding to enforce the [***] against such Competitive Infringement by counsel of its own choice at its own expense, and [***] will have the right, at its own expense, to be represented in that action by counsel of its own choice.  If [***] fails to initiate such Proceeding within a period of [***] after written notice of such Competitive Infringement is first provided by a Party under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, [***] will have the right to initiate and control a Proceeding to enforce the [***] against such Competitive Infringement by counsel of its own choice, and [***] will have the right to be represented in any such action by counsel of its own choice at its own expense; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4.5	[***].  For clarity, the provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are applicable to [***].  As between the Parties, for any Competitive Infringement with respect to a [***], [***] will have the first right, but not the obligation, to institute, prosecute, and control a Proceeding to enforce any [***] against such Competitive Infringement by counsel of its own choice at its own expense, and [***] will have the right, at its own expense, to be represented in that action by counsel of its own choice.  If [***] fails to initiate such Proceeding within a period of [***] after written notice of such Competitive Infringement is first provided by a Party under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, [***] will have the right to initiate and control a Proceeding to enforce the [***] against such Competitive Infringement by counsel of its own choice, and [***] will have the right to be represented in any such action by counsel of its own choice at its own expense; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joinder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	If a Party initiates a Proceeding in accordance with this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the other Party agrees to be joined as a party plaintiff where necessary and to give the first Party reasonable assistance and authority to file and prosecute the Proceeding.  Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 12.4.7 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the costs and expenses of each Party incurred pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.6(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be borne by the Party initiating such Proceeding.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	If one Party initiates a Proceeding in accordance with this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the other Party may join such Proceeding as a party plaintiff where necessary for such other Party to seek lost profits with respect to such infringement.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Share of Recoveries Prior to Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any damages or other monetary awards recovered, prior to Sanofi&#x2019;s exercise of the applicable Sanofi Participation Election Right, with respect to a Proceeding brought pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be shared as follows:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	[***]; then</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	[***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">114</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4.8	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Share of Recoveries Following Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Any damages or other monetary awards recovered, following Sanofi&#x2019;s exercise of the applicable Sanofi Participation Election Right, with respect to a Proceeding brought pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be shared as follows:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	[***]; then</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	[***]; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	[***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4.9	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Settlement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding anything to the contrary under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, neither Party may enter a settlement, consent judgment or other voluntary final disposition of a suit under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that disclaims, limits the scope of, admits the invalidity or unenforceability of, or grants a license, covenant not to sue or similar immunity under, or take any other action in a manner that materially diminishes the rights or interest of a Patent Controlled by the other Party or its Affiliates (including take any action that would reasonably be expected to materially adversely affect the scope, term, validity or enforceability of any claim of [***]) without first obtaining the written consent of the Party that owns or controls the relevant Patent, such consent not to be unreasonably withheld, delayed or conditioned; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> the foregoing restriction will not apply with respect to any Sublicense granted by Sanofi.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Infringement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.5.1	[***].  With respect to the infringement of a [***] that is not a Competitive Infringement, [***].  Any damages or other monetary awards recovered with respect to a Proceeding brought pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.5.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be shared as follows: [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.5.2	[***].  Kymera will retain all rights to pursue an infringement of any [***] that is not a Competitive Infringement and Kymera will [***]; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.5.3	[***].  Sanofi will retain all rights to pursue an infringement of [***] and Sanofi will [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent Listing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Following the Sanofi Participation Election Effective Date (if any) for a Collaboration Target, Sanofi will have the sole right, but not the obligation, to submit to all applicable Regulatory Authorities patent information pertaining to each applicable Licensed Product pursuant to 21 U.S.C. &#167; 355(b)(1)(G), any similar statutory or regulatory requirement enacted in the future, or any similar statutory or regulatory requirement in any non-U.S. country or other regulatory jurisdiction.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Interest</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All information exchanged between the Parties&#x2019; representatives regarding the Prosecution and Maintenance, or enforcement of Patents under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be deemed Confidential Information.  In addition, the Parties acknowledge and agree that, with regard to such Prosecution and Maintenance, and enforcement of the Patents under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the interests of the Parties as collaborators and licensor and licensee are to</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain the strongest patent protection possible, and as such, are aligned and are legal in nature.  The Parties agree and acknowledge that they have not waived, and nothing in this Agreement constitutes a waiver of, any legal privilege concerning the Patents under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, including privilege under the common interest doctrine and similar or related doctrines.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.8	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Research Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Parties intend that this Agreement is and will be understood to be a &#x201c;joint research agreement&#x201d; (as that term is defined in 35 U.S.C. &#167; 100(h) and used in 35 U.S.C. &#167; 102(c)), entered into for the purposes of researching, identifying and Developing Collaboration Compounds, Collaboration Candidates and Licensed Products.  The Parties will coordinate their activities with respect to any submissions, filings or other activities in support thereof.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.9	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent Term Extension</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, following the Sanofi Participation Election Effective Date (if any) with respect to such Collaboration Target and solely with respect to [***], as between the Parties, Sanofi will be solely responsible for obtaining patent term restoration in any country in the Territory under any statute or regulation equivalent or similar to 35 U.S.C. &#167; 156, where applicable to a Licensed Product Directed Against the applicable Collaboration Target.  In exercising the foregoing responsibility with respect to a Collaboration Target following the Sanofi Participation Election Effective Date (if any) with respect to such Collaboration Target, Sanofi will determine which relevant [***] will be extended (including, by filing supplementary protection certificates and any other extensions that are now or in the future become available).  Kymera will abide by Sanofi&#x2019;s determination and cooperate, as reasonably requested by Sanofi, in connection with the foregoing (including by providing appropriate information and executing appropriate documents), at Sanofi&#x2019;s cost.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.10	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recording</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If Sanofi deems it necessary or desirable to register or record this Agreement or evidence of this Agreement with any patent office or other appropriate Governmental Authority in one or more jurisdictions in the Territory, Kymera will reasonably cooperate to execute and deliver to Sanofi any documents accurately reflecting or evidencing this Agreement that are necessary or desirable, in Sanofi&#x2019;s reasonable judgment, to complete such registration or recordation.  Sanofi will reimburse Kymera for all reasonable Out-of-Pocket Costs, including attorneys&#x2019; fees, incurred by Kymera in complying with the provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.11	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unitary Patent System</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Sanofi will have the exclusive right to opt-in or opt-out of the EU Unitary Patent System for [***].  For clarity, &#x201c;to opt-in or opt-out&#x201d; refers to both the right to have or not have a European patent application or an issued European patent registered to have unitary effect within the meaning of Regulation (EU) No 1257/2012 of December 17, 2012 as well as the Agreement on a Unified Patent Court as of February 19, 2013; and to the right to opt-in or opt-out from the exclusive competence of the Unified Patent Court in accordance with Article 83 (3) of that Agreement on a Unified Patent Court.  Without limiting the generality of the foregoing, unless a Party or its Affiliate has expressly opted into the EU Unitary Patent System with respect to a given Patent, the other Party will not initiate any action under the EU Unitary Patent System without such Party&#x2019;s prior written approval, such approval to be granted or withheld in such Party&#x2019;s sole discretion.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">116</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.12	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trademarks</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Following the Sanofi Participation Election Effective Date (if any) with respect to a Collaboration Target, Sanofi will have the sole and exclusive right, but not the obligation, to brand and promote the Licensed Products using trademarks, designs, copyrights, domain names, trade dress and trade names it determines appropriate in its sole discretion for the Licensed Products, which may vary within the Territory (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Licensed Product Mark</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Sanofi will own all rights, title and interests in and to the Licensed Product Marks, and all goodwill in the Licensed Product Marks will inure to the benefit of Sanofi.  Sanofi will have the sole and exclusive right and responsibility to register, maintain, defend and enforce the Licensed Product Marks to the extent it determines reasonably necessary.  Except as otherwise agreed in writing by both Parties, Sanofi does not grant to Kymera, by implication, estoppel or otherwise, any license to any Licensed Product Mark.  For the avoidance of doubt, trademarks, designs, trade dress and trade names evaluated for use as Licensed Products but not actually used in the Commercialization of a Licensed Product will not be a Licensed Product Mark and will remain property of Sanofi after termination or expiration of this Agreement.  In any event, any trademarks, service marks, names or logos that include any corporate name or logo of the Parties or their Affiliates will not be a Licensed Product Mark and will remain the property of each respective Party.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.13	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Falsified Medicines</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Without limiting either Party&#x2019;s rights or obligations under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.13</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">:</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.13.1	  Each Party will promptly notify the other Party in writing if it becomes aware of any Third Party&#x2019;s manufacturing, sale, offer for sale, distribution or contribution to the manufacturing, shipment or commercialization of a medical product purporting to be a Licensed Product which deliberately or fraudulently misrepresents its identity, composition or source (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Falsified Medicine</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); and</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.13.2	  Sanofi will have the sole and exclusive right, but not the obligation, to lead any detection program, investigation or collaboration with any Governmental Authority and the sole and exclusive right, but not the obligation, to file or threaten to file a claim or lawsuit to enforce any rights against any Third Party manufacturing, selling, offering for sale or distributing Falsified Medicines or contributing to any of these actions.  If requested by Sanofi, Kymera will reasonably cooperate with Sanofi with respect to any suspected Falsified Medicines to provide complementary information related to the applicable Licensed Product when necessary or requested by any Governmental Authority.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 13<br>REPRESENTATIONS AND WARRANTIES</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representations and Warranties of Sanofi</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Sanofi hereby represents and warrants to Kymera, as of the Original Agreement Execution Date and the Restatement Execution Date, that:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Sanofi is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Sanofi (i) has the requisite power and authority and the legal right to enter into this Agreement and to perform its obligations hereunder and (ii) has taken all requisite</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">117</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">action on its part to authorize the execution and delivery of this Agreement and the performance of its obligations hereunder;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	this Agreement has been duly executed and delivered on behalf of Sanofi, and constitutes a legal, valid and binding obligation, enforceable against Sanofi in accordance with the terms hereof, except to the extent that enforcement of the rights and remedies created hereby is subject to (i) bankruptcy, insolvency, reorganization, moratorium and other similar laws of general application affecting the rights and remedies of creditors, or (ii) laws governing specific performance, injunctive relief and other equitable remedies;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	the execution, delivery and performance of this Agreement by Sanofi will not constitute a default under or conflict with any agreement, instrument or understanding, oral or written, to which it is a party or by which it is bound, or violate any Applicable Law of any governmental body or administrative or other agency having jurisdiction over Sanofi;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	Sanofi has obtained all necessary consents, approvals and authorizations of all Governmental Authorities and other Persons or entities required to be obtained by it as of the Original Agreement Execution Date in connection with the execution and delivery of this Agreement; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	Sanofi has not employed (and, to the best of its knowledge, has not used a contractor or consultant that has employed) any Person debarred by the FDA (or subject to a similar sanction of EMA or foreign equivalent), or any Person that is the subject of an FDA debarment investigation or proceeding (or similar proceeding of EMA or foreign equivalent), in any capacity in connection with this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representations and Warranties of Kymera</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Kymera hereby represents and warrants to Sanofi, as of the Original Agreement Execution Date and the Restatement Execution Date, that:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Kymera is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Kymera (i) has the requisite power and authority and the legal right to enter into this Agreement and to perform its obligations hereunder and (ii) has taken all requisite action on its part to authorize the execution and delivery of this Agreement and the performance of its obligations hereunder;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	this Agreement has been duly executed and delivered on behalf of Kymera, and constitutes a legal, valid and binding obligation, enforceable against Kymera in accordance with the terms hereof, except to the extent that enforcement of the rights and remedies created hereby is subject to (i) bankruptcy, insolvency, reorganization, moratorium and other similar laws of general application affecting the rights and remedies of creditors, or (ii) laws governing specific performance, injunctive relief and other equitable remedies;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	the execution, delivery and performance of this Agreement by Kymera will not constitute a default under or conflict with any agreement, instrument or understanding,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">118</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">oral or written, to which it is a party or by which it is bound, or violate any Applicable Law of any governmental body or administrative or other agency having jurisdiction over Kymera;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	Kymera has obtained all necessary consents, approvals and authorizations of all Governmental Authorities and other Persons or entities required to be obtained by it as of the Original Agreement Execution Date in connection with the execution and delivery of this Agreement;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	(i) all Kymera Background Technology is owned solely by Kymera, and the Kymera Background Technology does not include any Patents and Know-How that are in-licensed from a Third Party; (ii) all Kymera Background Technology is free and clear of any liens, charges and encumbrances; and (iii) to Kymera&#x2019;s Knowledge, no license granted by any Third Party to Kymera or its Affiliates, or by Kymera or its Affiliates to any Third Party, conflicts with the rights and licenses granted to Sanofi hereunder;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	Kymera is entitled to grant all rights, options and licenses under the Kymera Background Technology that it purports to grant or that are anticipated to be granted to Sanofi under this Agreement;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.193</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> sets forth a true, correct and complete list of all Kymera Background Patents as of (i) the Original Agreement Execution Date and (ii) the Restatement Execution Date and, except as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.193</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, each such Patent is owned solely by Kymera. To the extent any Kymera Background Patent is not owned by Kymera, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.193</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> identifies the licensor or sublicensor from which the Patent is licensed;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	to Kymera&#x2019;s Knowledge, all Kymera Background Patents have been Prosecuted and Maintained from the respective patent offices in accordance with Applicable Law.  Kymera has not received any written claims, nor to Kymera&#x2019;s Knowledge, is there any ongoing claim or threatened claim, by any Third Party (i) challenging the scope, validity or enforceability of any issued Kymera Background Patents, (ii) asserting the misuse or non-infringement of any of the Kymera Background Technology, or (iii) challenging Kymera&#x2019;s Control of any of the Kymera Background Technology;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(j)	with respect to the Kymera Background Patents that exist as of the Original Agreement Execution Date and the Restatement Execution Date, as applicable, (i) Kymera has obtained valid and enforceable assignments from the inventors of all inventorship rights relating to such Patents, and all such assignments of inventorship rights relating to such Patents have been properly executed and recorded in the relevant U.S. and foreign patent offices, (ii) to Kymera&#x2019;s Knowledge, no current officer, employee, agent, advisor, consultant or representative of Kymera or any of its Affiliates is in violation of any term of any such assignment or other agreement with Kymera or such Affiliate regarding the protection of any Kymera Background Technology, and (iii) to Kymera&#x2019;s Knowledge, no Person who claims to be an inventor of an invention claimed in a Kymera Patent is not identified as an inventor of such invention in the filed Patent documents for such Kymera Patent;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(k)	(i) all employees of Kymera performing activities on behalf of Kymera are subject to a present obligation to assign to Kymera all right, title and interest in and to any</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">119</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">inventions developed by them in the conduct of such activities, whether or not patentable; and (ii) all Subcontractors of Kymera performing activities on behalf of Kymera are subject to a written contract that provides that Kymera will obtain ownership of, or a fully sublicensable license (any expenses of which will be borne by Kymera) under and to, any Know-How and Patents that are discovered, developed, invented or created by such Subcontractor in the performance of such agreement and are necessary or reasonably useful to Research, Develop, Manufacture or Commercialize Collaboration Compounds, Collaboration Candidates or Licensed Products in the Field in the Territory; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that the foregoing requirement to obtain ownership of, or a fully sublicensable license will not apply to any improvements to the proprietary core or platform technology owned or in-licensed by any such Subcontractor or its Affiliates unless such improvements are necessary or reasonably useful to Research, Develop, Manufacture or Commercialize those Collaboration Compounds, Collaboration Candidates or Licensed Products with respect to which such Subcontractor or its Affiliate conducted its activities under such contract;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(l)	with respect to the Kymera Background Patents that exist as of the Original Agreement Execution Date and the Restatement Execution Date, as applicable, (i) Kymera and its Affiliates have materially complied with all applicable disclosure requirements of the applicable Governmental Authority, in connection with the Prosecution and Maintenance of such Kymera Background Patents, (ii) the pending applications included in Kymera Background Patents are being diligently prosecuted in the respective patent offices in the Territory in which Kymera has chosen to file in accordance with Applicable Law, (iii) to Kymera&#x2019;s Knowledge, Kymera has presented all relevant references, documents and information of which it and the inventors are aware to the relevant patent examiner at the relevant patent office, and (iv) it has timely paid all filing and renewal fees payable with respect to any such Kymera Background Patents;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(m)	Kymera and its Affiliates have taken commercially reasonable measures consistent with industry practices to protect the secrecy, confidentiality and value of all Kymera Background Know-How that exists as of the Original Agreement Execution Date and the Restatement Execution Date, as applicable, that constitutes confidential information or trade secrets under Applicable Law (including requiring all employees, consultants and independent contractors to execute binding and enforceable agreements requiring all such employees, consultants and independent contractors to maintain the confidentiality of such Kymera Background Know-How) and, to Kymera&#x2019;s Knowledge, such Kymera Background Know-How has not been used, disclosed to or discovered by any Third Party except pursuant to such confidentiality agreements and to Kymera&#x2019;s Knowledge there has not been a breach by any party to such confidentiality agreements;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n)	to Kymera&#x2019;s Knowledge, [***];</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(o)	no inventions Covered by the Kymera Background Technology (i) were conceived, discovered, developed or otherwise made in connection with any research activities funded, in whole or in part, by the federal government of the United States or any agency thereof; (ii) are a &#x201c;subject invention&#x201d; as that term is described in 35 U.S.C. &#167;201(e); (iii) are otherwise subject to the provisions of the Patent and Trademark Law Amendments Act of 1980, as amended, codified at 35 U.S.C. &#167;&#167;200-212, as amended, or any regulations promulgated pursuant thereto,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">including in 37 C.F.R. Part 401; and (iv) are the subject of any licenses, options or other rights of any Governmental Authority, within or outside the United States;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(p)	there are no judgments or settlements against Kymera or any of its Affiliates, or, to Kymera&#x2019;s Knowledge, pending or threatened claims or litigation, in each case, in connection with the Kymera Background Technology that exists as of the Original Agreement Execution Date or the Restatement Execution Date, as applicable, or relating to the transactions contemplated by this Agreement;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(q)	to Kymera&#x2019;s Knowledge, the use, practice or application by Kymera (or its Affiliates) of any Kymera Background Technology as contemplated under this Agreement does not infringe any Valid Claim of any issued and unexpired Patents of a Third Party;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(r)	Kymera has not misappropriated any trade secret or other Know-How of a Third Party in development of the Kymera Background Technology;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(s)	Kymera has not employed (and, to its Knowledge, has not used a contractor or consultant that has employed) any Person debarred by the FDA (or subject to a similar sanction of EMA or foreign equivalent), or any Person that is the subject of an FDA debarment investigation or proceeding (or similar proceeding of EMA or foreign equivalent), in any capacity in connection with this Agreement; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(t)	Kymera has [***], and neither Kymera, nor, to Kymera&#x2019;s Knowledge, any of its Subcontractors, are in possession of [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Updated Information Regarding Representations and Warranties of Kymera</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a Collaboration Target-by-Collaboration Target basis, within [***] after the delivery of the Participation Data Package with respect to such Collaboration Targets, Kymera shall provide written notice to Sanofi stating any exceptions to the veracity of the representations and warranties set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 13.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as of the date of such notice of which Kymera has Knowledge (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">).</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Covenants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Sanofi hereby covenants to Kymera that, except as otherwise expressly permitted under this Agreement:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Sanofi will, and will require its Affiliates and Subcontractors to comply with all Applicable Law in its and their conduct of activities pursuant to this Agreement, including where appropriate GMP, GCP and GLP (or similar standards);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	all employees of Sanofi or its Affiliates or Third Party subcontractors and Sublicensees working under this Agreement will be under appropriate confidentiality provisions at least as protective as those contained in this Agreement;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	all employees and Subcontractors of Sanofi performing activities hereunder on behalf of Sanofi will be obligated to assign to Sanofi all right, title and interest in and to any inventions developed by them in the conduct of such activities, whether or not patentable;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">121</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	where this Agreement refers to an action or obligation to be undertaken by Sanofi&#x2019;s Affiliates, Sanofi will cause such Affiliates to undertake such obligations or other actions, and Sanofi will be responsible and liable for any acts or omissions by its Affiliates;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	Sanofi will not, and will [***] not to, engage directly or indirectly, in any capacity in connection with this Agreement any Person who either has been debarred by the FDA, is the subject of a conviction described in Section 306 of the FD&amp;C Act or is subject to any such similar sanction; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	Sanofi will inform Kymera in writing promptly if it or any Person engaged by Sanofi or any of its Affiliates or Subcontractors who is performing services under this Agreement or any Co-Promotion Agreement or Cost/Profit Sharing Agreement is debarred or is the subject of a conviction described in Section 306 of the FD&amp;C Act, or if any action, suit, claim, investigation or legal or administrative proceeding is pending or, to Sanofi&#x2019;s knowledge, is threatened, relating to the debarment or conviction of Sanofi, any of its Affiliates or any such Person performing services hereunder or thereunder.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Covenants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Kymera hereby covenants to Sanofi that, except as otherwise expressly permitted under this Agreement:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Kymera will, and will require its Affiliates and Subcontractors to, comply with all Applicable Law in its and their conduct of activities pursuant to this Agreement, including where appropriate GMP, GCP and GLP (or similar standards);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	all employees of Kymera or its Affiliates or Third Party subcontractors and Sublicensees working under this Agreement will be under appropriate confidentiality provisions at least as protective as those contained in this Agreement;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Kymera will use Commercially Reasonable Efforts to maintain and not breach any Collaboration In-License Agreement in a manner that would reasonably be expected to give rise to a termination right of the licensor party, and will cause its Affiliates to maintain and not breach in a manner that would reasonably be expected to give rise to a termination right of the licensor party;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	Kymera will promptly notify Sanofi in writing of any material breach by Kymera or its Affiliate or a Third Party of any Collaboration In-License Agreement;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	Kymera will not, and will cause its Affiliates not to, amend, modify or terminate any Collaboration In-License Agreement in a manner that would adversely affect Sanofi&#x2019;s rights hereunder without first obtaining Sanofi&#x2019;s written consent;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	Kymera will not, and will cause its Affiliates not to (i) license, sell, assign or otherwise transfer to any Person any Licensed Technology (or agree to do any of the foregoing) or (ii) incur or permit to exist, with respect to any Licensed Technology, any lien, encumbrance, charge, security interest, mortgage, liability, grant of license to Third Parties or other restriction (including in connection with any indebtedness), in each case, that would conflict with, limit, impair or restrict the rights and licenses (or sublicenses, as the case may be) granted to Sanofi</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">122</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hereunder; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that nothing herein will restrict Kymera from effectuating an assignment in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	Kymera will not, during the Term, enter into any material agreements or contracts that would be inconsistent with its obligations under this Agreement;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	during the Term, (i) all employees of Kymera performing activities hereunder on behalf of Kymera will be subject to a present obligation to assign to Kymera all right, title and interest in and to any inventions developed by them in the conduct of such activities, whether or not patentable, and (ii) all Subcontractors of Kymera performing activities on behalf of Kymera pursuant to an agreement entered into after the Execution Agreement will be subject to a written contract that provides that Kymera will obtain ownership of, or a fully sublicensable license (any expenses of which will be borne by Kymera) under and to, any Know-How and Patents that are discovered, developed, invented or created by such Subcontractor in the performance of such agreement and are necessary or reasonably useful to Research, Develop, Manufacture or Commercialize Collaboration Compounds, Collaboration Candidates or Licensed Products in the Field in the Territory; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that Kymera will use Commercially Reasonable Efforts to obtain (x) ownership of any such Know-How and Patents rather than a license to such Know-How or Patents or, (y) if Kymera cannot so obtain ownership using Commercially Reasonable Efforts, an exclusive license to any such Know-How and Patents; and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">further provided </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that the foregoing requirement to obtain ownership of, or a fully sublicensable license will not apply to any improvements to the proprietary core or platform technology owned or in-licensed by any such Subcontractor or its Affiliates unless such improvements are necessary or reasonably useful to Research, Develop, Manufacture or Commercialize those Collaboration Compounds, Collaboration Candidates or Licensed Products with respect to which such Subcontractor or its Affiliate conducted its activities under such contract;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	where this Agreement refers to an action or obligation to be undertaken by Kymera&#x2019;s Affiliates, Kymera will cause such Affiliates to undertake such obligations or other actions, and Kymera will be responsible and liable for any acts or omissions by its Affiliates;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(j)	Kymera will not, and will cause its Affiliates and Subcontractors not to, engage directly or indirectly, in any capacity in connection with this Agreement any Person who either has been debarred by the FDA, is the subject of a conviction described in Section 306 of the FD&amp;C Act or is subject to any such similar sanction; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(k)	Kymera will inform Sanofi in writing promptly if it or any Person engaged by Kymera or any of its Affiliates or Subcontractors who is performing services under this Agreement or any Co-Promotion Agreement or Cost/Profit Sharing Agreement is debarred or is the subject of a conviction described in Section 306 of the FD&amp;C Act, or if any action, suit, claim, investigation or legal or administrative proceeding is pending or, to Kymera&#x2019;s knowledge, is threatened, relating to the debarment or conviction of Kymera, any of its Affiliates or any such Person performing services hereunder or thereunder.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclaimer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  WITHOUT LIMITING THE RESPECTIVE RIGHTS AND OBLIGATIONS OF THE PARTIES EXPRESSLY SET FORTH HEREIN, EACH PARTY SPECIFICALLY DISCLAIMS ANY GUARANTEE THAT THE ACTIVITIES CONDUCTED</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">123</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HEREUNDER OR ANY COLLABORATION COMPOUND</font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Collaboration Candidate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> OR LICENSED PRODUCT WILL BE SUCCESSFUL, IN WHOLE OR IN PART.  EXCEPT AS OTHERWISE EXPRESSLY </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">PROVIDED</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> IN THIS AGREEMENT, NEITHER PARTY MAKES ANY REPRESENTATIONS OR EXTENDS ANY WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED (AND EACH PARTY HEREBY EXPRESSLY DISCLAIMS ANY AND ALL REPRESENTATIONS AND WARRANTIES NOT EXPRESSLY </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">PROVIDED</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> IN THIS AGREEMENT), INCLUDING WITH RESPECT TO ANY PATENTS OR KNOW-HOW, OR MATERIALS, INCLUDING WARRANTIES OF VALIDITY OR ENFORCEABILITY OF ANY PATENTS, TITLE, QUALITY, COMPLETENESS, ACCURACY, MERCHANTABILITY, FITNESS FOR A PARTICULAR USE OR PURPOSE, PERFORMANCE, AND NONINFRINGEMENT OF ANY THIRD PARTY PATENTS OR OTHER INTELLECTUAL PROPERTY RIGHTS.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 14<br>INDEMNIFICATION; INSURANCE; LIMITATIONS</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.1.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnification by Sanofi</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Sanofi will indemnify, defend and hold harmless Kymera, its Affiliates, and its and its Affiliates&#x2019; employees, officers, directors and agents and their respective successors, heirs and assigns (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) from and against any liability, loss, damage or expense (including reasonable attorneys&#x2019; fees and expenses) (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) arising out of any Third Party suit, investigation, claim or demand in connection with:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	the Research, Development, Manufacture, Commercialization or use of any Collaboration Compound, Collaboration Candidate or Licensed Product by, on behalf of, or under the authority of, Sanofi or any of its Affiliates (other than by a Kymera Indemnified Party);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	the breach by Sanofi of any of its representations, warranties or covenants set forth in this Agreement; or</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	the negligence, recklessness or willful misconduct of Sanofi or any Sanofi Indemnified Party in connection with the performance of its obligations hereunder; and except, in each case ((a)&#x2013;(c)), to the extent such claims fall within the scope of Kymera&#x2019;s indemnification obligations under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 14.1.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (or would have had the Third Party claim been made against Sanofi under this Agreement) as to which Liability each Party will indemnify the other to the extent of their respective liability.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.1.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnification by Kymera</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Kymera will indemnify, defend and hold harmless Sanofi, its Affiliates and its and its Affiliates&#x2019; employees, officers, directors and agents and their respective successors, heirs and assigns (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) from and against any Liability arising out of any Third Party suit, investigation, claim or demand in connection with:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	the Research, Development, Manufacture or Commercialization of any Collaboration Compound, Collaboration Candidate or Licensed Product by, on behalf of, or under the authority of, Kymera or any of its Affiliates (other than by a Sanofi Indemnified Party);</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">124</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	the breach by Kymera of any of its representations, warranties or covenants set forth in this Agreement;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	the negligence, recklessness or willful misconduct of Kymera or any Kymera Indemnified Party in connection with the performance of its obligations hereunder;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	[***]; or</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	following the grant of the license set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.2(f)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the research, development, manufacture, and commercialization by or on behalf of Kymera or its Affiliates, sublicensees, subcontractors, agents or consultants of any (i) Terminated Product and (ii) Degrader that constitutes an improvement, modification or derivative of such Terminated Product, in each case Covered by such license; and except, in each case ((a)&#x2013;(c)), to the extent such claims fall within the scope of Sanofi&#x2019;s indemnification obligations under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 14.1.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (or would have had the Third Party claim been made against Kymera under this Agreement) as to which Liability each Party will indemnify the other to the extent of their respective liability.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.1.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Procedure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Party will notify the other Party in writing if it becomes aware of a claim for which such Party may seek indemnification hereunder.  If any Proceeding (including any governmental investigation) is instituted against a Party with respect to which indemnity may be sought pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 14.1.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.1.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as applicable, such Party (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">will give prompt written notice of the indemnity claim to the other Party (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnifying Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and provide the Indemnifying Party with a copy of any complaint, summons or other written notice that the Indemnified Party receives in connection with any such claim.  An Indemnified Party&#x2019;s failure to deliver such written notice will relieve the Indemnifying Party of liability to the Indemnified Party under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 14.1.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.1.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as applicable, only to the extent such delay is prejudicial to the Indemnifying Party&#x2019;s ability to defend such claim and allow the Indemnifying Party to assume the defense of claim.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Provided that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> the Indemnifying Party is not contesting the indemnity obligation, the Indemnified Party will permit the Indemnifying Party to control any litigation relating to such claim and the disposition of such claim by negotiated settlement or otherwise (subject to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 14.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) and any failure to contest such obligation prior to assuming control will be deemed to be an admission of the obligation to indemnify.  The Indemnifying Party will act reasonably and in good faith with respect to all matters relating to such claim and will not settle or otherwise resolve such claim without the Indemnified Party&#x2019;s prior written consent, which will not be unreasonably withheld, conditioned or delayed; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such consent will not be required with respect to any settlement involving only the payment of monetary awards for which the Indemnifying Party will be fully responsible.  The Indemnified Party will cooperate with the Indemnifying Party in the Indemnifying Party&#x2019;s defense of any claim for which indemnity is sought under this Agreement, at the Indemnifying Party&#x2019;s cost and expense.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Insurance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Kymera and Sanofi will respectively, at their own cost and expense, obtain and maintain commercially reasonable insurance coverage from insurance carriers licensed to do business under the laws of the country, state, commonwealth, province, or territory in which such Party&#x2019;s obligations are provided, with insurers that carry a rating of at least an A- VII or better from A.M. Best.  Each Party will furnish to the other Party evidence of such insurance upon</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">request.  Notwithstanding the foregoing, Sanofi may self-insure to the extent that it self-insures other activities.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Limitation of Consequential Damages</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except for (a) claims of a Third Party that are subject to indemnification under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 14</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, (b) claims arising out of a Party&#x2019;s fraud or willful misconduct or (c) a Party&#x2019;s breach of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, neither Party nor any of its Affiliates will be liable to the other Party or its Affiliates for any incidental, special, punitive or other indirect damages or lost or imputed profits or royalties, lost data or cost of procurement of substitute goods or services, which are not probable and reasonably foreseeable, whether liability is asserted in contract, tort (including negligence and strict product liability), indemnity or contribution, and irrespective of whether that Party or any representative of that Party has been advised of, or otherwise might have anticipated the possibility of, any such loss or damage.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 15<br>TERM; TERMINATION</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Term; Expiration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to the Closing as set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 17.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the term of this Agreement will begin as of the Original Agreement Effective Date and, unless earlier terminated pursuant to the other provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 15</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, will expire on the latest of (such period, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;):</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	on an Opt-In Product-by-Opt-In Product basis, the date on which neither Party is Developing or Commercializing such Opt-In Product in the U.S.;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	with respect to a Licensed Product that is not an Opt-In Product, on a country-by-country and Licensed Product-by-Licensed Product basis, on the date of expiration of all payment obligations under this Agreement with respect to such Licensed Product in such country; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	in its entirety upon the expiration of all payment obligations under this Agreement with respect to all Licensed Products in all countries pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination of the Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Automatic Termination of Collaboration Target</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If Sanofi fails to timely exercise the Sanofi Participation Election Right with respect to a Collaboration Target in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> prior to the applicable Sanofi Participation Election Deadline, this Agreement will automatically terminate with respect to such Collaboration Target, and, for clarity, such Collaboration Target will become a Terminated Target, with no further action by the Parties.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi&#x2019;s Termination for Convenience</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Sanofi may terminate this Agreement, either (i) in its entirety, or (ii) on a Collaboration Target-by-Collaboration Target basis, in each case ((i)-(ii)), for convenience by providing written notice of its intent to terminate to Kymera, in which case, such termination will be effective [***] after Kymera&#x2019;s receipt of such written notice, and, for clarity, any such Collaboration Target, or each</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target to the extent this Agreement is terminated in its entirety, will become a Terminated Target.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination under Certain Circumstances</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi&#x2019;s Right to Terminate for Material Breach</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(a)(ii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> below, if Sanofi believes that Kymera is in material breach of this Agreement, Sanofi may deliver written notice of such material breach to Kymera.  If the breach is curable, Kymera will have [***] following its receipt of such written notice to cure such breach (except to the extent such breach involves the failure to make a payment when due, which breach must be cured within [***] following its receipt of such written notice).  If Kymera fails to cure, or fails to dispute, such breach within such [***] period or [***] period, as applicable, or the breach is not subject to cure, Sanofi may terminate this Agreement in its entirety or with respect to the particular Collaboration Target to which the breach relates by providing written notice to Kymera, in which case, this Agreement will terminate in its entirety or with respect to such Collaboration Target, as applicable, on the date on which Kymera receives such written notice; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that if (A) the relevant breach is curable, but not reasonably curable within [***], and (B) Kymera is making a </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">bona fide</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> effort to cure such breach, Sanofi&#x2019;s right to terminate this Agreement on account of such breach will be suspended for so long as Kymera is continuing to make such </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">bona fide</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> effort to cure such breach and if such breach is successfully cured, Sanofi will no longer have the right to terminate this Agreement on account of such breach.</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	If Sanofi believes that Kymera is in material breach of this Agreement and such breach constitutes a Step-In Trigger, as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Sanofi may deliver written notice of such material breach to Kymera.  If the breach is curable, Kymera will have [***] following its receipt of such written notice to cure such breach.  If Kymera fails to cure, or fails to dispute, such breach within such [***] period, or the breach is not subject to cure, Sanofi may elect to exercise the alternate remedy provision set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If Sanofi does not exercise the alternate remedy provision, this Agreement will terminate [***] after the date on which Kymera received written notice of the material breach.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi&#x2019;s Right to Terminate for Material Safety Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event a Material Safety Event has occurred and notice has been provided pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7.6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Sanofi may: (i) in the event of a Sanofi Material Safety Event Notice or a Kymera Material Safety Event Notice issued by Sanofi, include in such notice (or within [***] after the date of such Sanofi Material Safety Event Notice or Kymera Material Safety Event Notice, as applicable) a written notice of termination of this Agreement, or (ii) in the event of a Kymera Material Safety Event Notice, provide Kymera a written notice of termination of this Agreement within [***] after the date of such Kymera Material Safety Event Notice (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Safety Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), which termination notice will be effective as of the date of its issuance.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera&#x2019;s Right to Terminate for Material Breach</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If Kymera believes that Sanofi is in material breach of this Agreement, Kymera may deliver written notice of such material breach to Sanofi.  If the breach is curable, Sanofi will have [***] following its receipt of such written notice to cure such breach (except to the extent such breach involves the failure to</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">127</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">make a payment when due, which breach must be cured within [***] following its receipt of such written notice).  If Sanofi fails to cure, or fails to dispute, such breach within such [***] period or [***] period, as applicable, or the breach is not subject to cure, Kymera may terminate this Agreement in its entirety or solely with respect to the particular Collaboration Target to which the breach relates, by providing written notice to Sanofi, in which case, this Agreement will terminate in its entirety or with respect to such Collaboration Target, as applicable, on the date on which Sanofi receives such written notice; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that if (A) the relevant breach (1) does not involve Sanofi&#x2019;s failure to make a payment when due and (2) is curable, but not reasonably curable within [***], and (B) Sanofi is making a </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">bona fide</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> effort to cure such breach, Kymera&#x2019;s right to terminate this Agreement on account of such breach will be suspended for so long as Sanofi is continuing to make such </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">bona fide</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> effort to cure such breach and if such breach is successfully cured, Kymera will no longer have the right to terminate this Agreement on account of such breach.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Party&#x2019;s Right to Terminate for a Patent Challenge</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If a Party or its Affiliates (A) commences or actively and voluntarily participates in any legal action or administrative proceeding (including any patent opposition or re-examination proceeding) challenging or denying the validity or enforceability of any claim of any Patent that is licensed to it by the other Party under this Agreement, or (B) actively and voluntarily assists, or directs or supports any other Person in bringing or prosecuting any legal action or administrative proceeding (including any patent opposition or re-examination proceeding) challenging or denying the validity or enforceability of any claim of any Patent that is licensed to it by the other Party under this Agreement (each of (A) and (B), a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent Challenge</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), then, to the extent permitted by Applicable Law, the challenged Party will have the right, in its sole discretion, to terminate this Agreement with respect to any Collaboration Target to which such Patent relates, upon written notice to the challenging Party, [***] following such notice, and, unless the challenging Party withdraws or causes to be withdrawn all such challenge(s) (or in the case of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">ex-parte</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> proceedings, multi-party proceedings, or other Patent Challenges that the challenging Party does not have the power to unilaterally withdraw or cause to be withdrawn, the challenging Party ceases assisting any other party to such Patent Challenge and, to the extent the challenging Party is a party to such Patent Challenge, it withdraws from such Patent Challenge within such [***] period), this Agreement will automatically terminate with respect to any Collaboration Target to which such Patent relates.  Notwithstanding the foregoing, (a) the challenged Party will not have the right to terminate this Agreement under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> if the challenging Party challenges the validity of any Patents of the challenged Party licensed to such challenging Party under this Agreement in defense of claims of patent infringement filed by the challenged Party against such Party or its Affiliate, as the case may be, and (b) the termination provisions under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will not apply with respect to any administrative proceeding that is filed, after consultation with the challenged Party, in a good-faith effort to correct, reinforce the patentability, validity or enforceability of, or expand the claim scope of, a challenged licensed Patent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera&#x2019;s Right to Terminate for Shelving</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	On a Collaboration Target-by-Collaboration Target basis, following the Sanofi Participation Election Exercise, if Sanofi and its Affiliates and Sublicensees cease all Research, Development, Manufacturing and Commercialization activities with respect to Collaboration Compounds, Collaboration Candidates and Licensed Products Directed Against such Collaboration Target for a period of not less than [***], and such cessation is not due to a</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">128</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requirement of a Regulatory Authority, a Force Majeure, a delay by a supplier or other vendor or any similar event outside of Sanofi&#x2019;s or its Affiliates&#x2019; or Sublicensees&#x2019; reasonable control, Kymera will have the right to terminate this Agreement with respect to such Collaboration Target upon [***] written notice thereof to Sanofi.</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	Notwithstanding the foregoing clause (i), in the event Kymera terminates this Agreement under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(e)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> with respect to a given Collaboration Target after completion of all Backup Research in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, if [***], then for a period of [***] following the effective date of termination of this Agreement with respect to such Collaboration Target, Kymera will not, and will cause its Affiliates not to, [***]; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that the foregoing will not prohibit Kymera or its Affiliates from [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	On a Collaboration Target by Collaboration Target basis, if (a) Kymera terminates this Agreement pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(e)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> with respect to such Collaboration Target, (b) the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(e)(ii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> apply, and (c) prior to the [***].</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;" id="docxtextref1413"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	If either </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Y</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) Sanofi does not provide a [***] within such [***] period, or (Z) [***], then, in each case ((Y) and </font><font id="docxtextref1414"></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Z)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">), [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi&#x2019;s Right to Terminate the SAD for Convenience</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Sanofi may terminate this Agreement solely with respect to the Second Additional Degraders (such termination, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SAD Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and such terminated Second Additional Degraders, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Terminated Degraders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), for convenience by providing written notice of its intent to terminate to Kymera, in which case, such termination will be effective (i) [***] after Kymera&#x2019;s receipt of such written notice, if such notice is provided during the Second Additional Degrader Research Term, or (ii) [***] after Kymera&#x2019;s receipt of such written notice, if such notice is provided after expiration of the Second Additional Degrader Research Term.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remedy in Lieu of Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event that [***], in lieu of terminating this Agreement pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Sanofi may elect by written notice to Kymera, at Sanofi&#x2019;s cost, to [***], in which case [***].  For clarity, [***].  In the event that Sanofi elects [***] pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, then [***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disputes Regarding Material Breach</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding the foregoing, if the Breaching Party in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> disputes in good faith the existence, materiality, or failure to cure of any breach, and provides written notice to the Non-Breaching Party of such dispute within the relevant cure period, the Non-Breaching Party will not have the right to terminate this Agreement in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or the right to exercise the alternative remedy provision of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as applicable, unless and until the relevant dispute has been resolved pursuant to the dispute resolution provisions in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During the pendency of such dispute, all the terms of this Agreement will remain in effect and the Parties will continue to perform all of their respective obligations hereunder.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination for Insolvency</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If, at any time during the Term, either Party makes an assignment for the benefit of creditors, appoints or suffers appointment of a receiver or trustee over all or substantially all of its property, files a petition under any bankruptcy or insolvency act or has any such petition filed against it that is not discharged</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">129</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">within [***] after the filing thereof (each, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Insolvency Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), the other Party may terminate this Agreement in its entirety by providing written notice of its intent to terminate this Agreement to such Party, in which case, this Agreement will terminate on the date on which such Party receives such written notice.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consequences of Expiration or Termination of the Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In General</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If this Agreement expires or is terminated in its entirety or with respect to one or more Collaboration Targets (or, in the event of a SAD Termination, the Second Additional Degraders) by a Party pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the following terms will apply to this Agreement, either in its entirety or, on a Terminated Target-by-Terminated Target basis, with respect to the Terminated Targets (or, if applicable, Second Additional Degraders) that are the subject of such termination, as the case may be:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	except in the case of Kymera for any Confidential Information of Sanofi that is Sanofi Reversion Technology, each Party will take all action required under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	termination or expiration of this Agreement for any reason will be without prejudice to any rights or financial compensation that will have accrued to the benefit of a Party prior to such expiration or termination.  Such expiration or termination will not relieve a Party from obligations that are expressly indicated to survive the termination or expiration of this Agreement;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	if this Agreement expires or is terminated in its entirety, all Committees will automatically be dissolved as of the effective date of such termination;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	as of the effective date of expiration or termination, as to Prosecution and Maintenance matters:</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	Kymera will control, be responsible for, and have the sole right (but not the obligation) for, at its own expense, all aspects of the Prosecution and Maintenance of all (i) Kymera Background Patents solely applicable to the Terminated Target, and (ii) all Kymera Foreground Patents solely applicable to the Terminated Target. For clarity, in the event that this Agreement is terminated in its entirety, Kymera will control, be responsible for, and have the sole right (but not the obligation) for, at its own expense, all aspects of the Prosecution and Maintenance of all Kymera Background Patents and all Kymera Foreground Patents;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	Subject to the Sanofi backup rights described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.9(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera will control, be responsible for, and have the sole right (but not the obligation) for, at its own expense, all aspects of the Prosecution and Maintenance of (i) all Joint Foreground Patents solely applicable to the Terminated Target, and (ii) all Joint Foreground Patents applicable to both the Terminated Target and another Target that is not a Collaboration Target. Notwithstanding the foregoing, in each case ((i) and (ii)), (x) Sanofi will have the right to review and comment on the Prosecution and Maintenance of each such Joint Foreground Patent, and (y) Kymera will incorporate all reasonable comments from Sanofi in respect thereof, and (z) if the Parties cannot agree on a particular action with respect to the Prosecution and Maintenance of such</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">130</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Foreground Patent, then either Party may refer such dispute to an Independent Third Party Patent Counsel for resolution in accordance with the Patent Resolution Procedures.  [***]; and</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	For any Joint Foreground Patent that is applicable to both a Terminated Target and a Collaboration Target, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.2.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall apply (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) as to such Collaboration Target;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	as of the effective date of expiration or termination, as to Patent enforcement matters:</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	Kymera will control, be responsible for, and have the sole right (but not the obligation) for, at its own expense, enforcing (1) all Kymera Background Patents solely applicable to the Terminated Target, and (2) all Kymera Foreground Patents solely applicable to the Terminated Target, and in each case ((1) and (2)), Kymera will retain all recoveries associated therewith. For clarity, in the event that this Agreement is terminated in its entirety, Kymera will control, be responsible for, and have the sole right (but not the obligation) for, at its own expense, enforcing (x) all Kymera Background Patents, and (y) all Kymera Foreground Patents, and in each case ((x) and (y)), Kymera will retain all recoveries associated therewith;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	For any Competitive Infringement (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) with respect to a particular Terminated Product against any Joint Foreground Patent that is (i) solely applicable to the Terminated Target or (ii) applicable to both the Terminated Target and another Target that is not a Collaboration Target, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall apply (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">). For any other infringement against such Joint Foreground Patent that is not a Competitive Infringement (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) with respect to a particular Terminated Product, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.5.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall apply;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	For the infringement of any Joint Foreground Patent that is applicable to both the Terminated Target and a Collaboration Target, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 12.4.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.5.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall apply;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall apply in respect of any damages or other monetary awards recovered with respect to any Proceeding governed by this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.1(e)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">); and</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 12.4.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall apply in respect of any settlement, consent judgment or other voluntary final disposition of any Proceeding governed by this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.1(e)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">);</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	Kymera and Sanofi will respectively, at their own cost and expense, continue to maintain commercially reasonable insurance coverage from insurance carriers licensed to do business under the laws of the country, state, commonwealth, province, or territory in which such Party&#x2019;s obligations are provided, with insurers that carry a rating of at least an A- VII or better from A.M. Best, for a period of [***] after the termination or expiration of this Agreement in the entirety; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that if Kymera clinically Develops or Commercializes a Terminated Product, it shall continue to maintain such insurance coverage until the date [***].  Each Party will furnish to the other Party evidence of such insurance upon request.  Notwithstanding the foregoing, Sanofi may self-insure to the extent that it self-insures other activities; and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">131</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	the following provisions of this Agreement will survive the expiration or termination of this Agreement:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 2.9.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.9.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.9.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.9.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.6.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.13</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.14</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.15</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effects of Termination for Automatic Termination, by Sanofi for Convenience, or by Kymera for Material Breach, Patent Challenge, Shelving or Insolvency</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If this Agreement is terminated in its entirety or with respect to one or more Collaboration Targets pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Automatic Termination), by Sanofi pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Convenience) or by Kymera pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Material Breach), </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2.3(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Patent Challenge), </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2.3(e)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Shelving) or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Insolvency), or if a Collaboration Target otherwise becomes a Terminated Target, the following terms will apply with respect to any Collaboration Candidates or Collaboration Targets that are the subject of such termination, as the case may be:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	if such termination occurs prior to exercise of the Sanofi Participation Election Right, such Sanofi Participation Election Right with respect to the Terminated Target(s) will terminate;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	except as set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the licenses and rights granted to Sanofi under this Agreement with respect to all Collaboration Compounds, Collaboration Candidates and Licensed Products Directed Against the Terminated Target(s) will terminate;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	except as set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, each Parties&#x2019; rights and obligations under this Agreement with respect to the Terminated Target(s) will automatically cease;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	any permitted Sublicense of Sanofi with respect to the Terminated Targets will, at the Sublicensee&#x2019;s option, survive such termination on the condition that the relevant Sublicensee is not in material breach of any of its obligations under such Sublicense.  In order to effect this provision, at the request of the Sublicensee, Kymera will enter into a direct license with the Sublicensee on terms that are substantially the same terms as the applicable terms (including economic terms) of this Agreement; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that (i) Kymera will not be required to undertake obligations in addition to those required by this Agreement, (ii) Kymera&#x2019;s right under such direct license will be consistent with its rights under this Agreement, taking into account the scope of the license granted under such direct license, (iii) the license grant by Kymera to such Sublicensee will only include the Licensed Technology in existence as of the effective date of termination and subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.2(f)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Sanofi Reversion Technology with respect to Terminated Products Directed Against a Terminated Target (as applicable) and (iv) Kymera will not be required to grant to such Sublicensee any then-unexercised rights granted to Sanofi, including under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 4.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	subject to patient safety and other ethical considerations, Sanofi will wind-down any ongoing Clinical Trials for any Licensed Product Directed Against the Terminated Target(s) in accordance with Applicable Law:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	if Kymera terminated this Agreement, all such wind-down costs will be borne by Sanofi; otherwise</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	all such wind-down costs will be allocated between the Parties&#x2019; in accordance with the then-applicable terms of this Agreement with respect to Development cost sharing;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	solely in the event that Kymera provides Sanofi with written notice within [***] following the effective date of such termination that Kymera desires to receive a license under the Sanofi Reversion Technology, then effective as of the date of Sanofi&#x2019;s receipt of such notice:</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	Sanofi hereby grants to Kymera [***], and (B) if the grant of such license to Kymera with respect to any Know-How or Patent included in the Sanofi Reversion Technology or Kymera&#x2019;s exercise of such license would trigger a royalty or other payment to a Third Party or would require compliance with any provision of any license between Sanofi and a Third Party, Sanofi will so notify Kymera in writing and such Know-How or Patent will only be included in the foregoing license if, following receipt of such notice, Kymera agrees in writing to reimburse Sanofi for all such payments to such Third Party and comply with any such provision;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	On a Terminated Target-by-Terminated Target, Terminated Product-by-Terminated Product and country-by-country basis, Kymera will pay Sanofi royalties based on the [***] at the rates set forth in the table below, with the stage of development determined as of the effective date of termination with respect to the relevant Terminated Product.  The obligation to pay royalties will be imposed only once with respect to the same unit of a Terminated Product:</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:72.62%;"></td>
    <td style="width:27.38%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;for Terminated Products Directed Against the relevant Terminated Target</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(217,217,217,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Applicable Royalty Rates</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The terms of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 11.3.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will apply with respect to Kymera&#x2019;s payment of such royalty (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">); and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	Sanofi will, as promptly as practicable:</font></p>
  <p style="text-indent:33.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1)	no later than [***] (or such other period as may be agreed by the Parties) following such termination, transfer to Kymera or its designee (A) a copy of any Know-How that constitutes Sanofi Reversion Technology and is included in Sanofi&#x2019;s submissions or filings with Regulatory Authorities, including any documentation (whether held in paper or electronic format) or similar removable media (including e-mails, documents, spreadsheets, copies of standard operating procedures or technical specifications), in Sanofi&#x2019;s possession or control,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that Sanofi shall have no obligation to transfer to Kymera any such Know-How to the extent (x) Kymera already is in possession or control of such Know-How, or (y) Sanofi previously transferred such Know-How to Kymera prior to the effective date of termination, and (B) any Materials transferred by Kymera to Sanofi in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 2.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that relate to such Terminated Target, to the extent in Sanofi&#x2019;s possession or control;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:33.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2)	promptly transfer and assign to Kymera all of Sanofi&#x2019;s and its Affiliates&#x2019; rights, title, and interests in and to any trademarks (if any) exclusively used in connection with the Terminated Products (but not any Sanofi house marks or any trademark containing the word &#x201c;Sanofi&#x201d;) owned by Sanofi and used for the Terminated Products in the Territory, if applicable;</font></p>
  <p style="text-indent:33.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(3)	if Sanofi or its Affiliate or Sublicensee is the sole source Manufacturer of finished product with respect to Terminated Products on the effective date of termination of this Agreement, then at Kymera&#x2019;s reasonable request, Sanofi or its Affiliate will, and Sanofi will use Commercially Reasonable Efforts to cause its Sublicensee to (A) negotiate in good faith to enter into a commercially reasonable supply agreement pursuant to which Sanofi or such Affiliate or Sublicensee would supply such finished product to Kymera for a reasonable period of time, not to exceed [***], at a price equal to [***] of Sanofi&#x2019;s (or Affiliate&#x2019;s) cost for such Terminated Product, on customary supply terms to be negotiated by Kymera and Sanofi and (B) at Kymera&#x2019;s sole cost and expense and for a period not to exceed [***], conduct a technology transfer to enable Kymera or the applicable Third Parties designated by Kymera to Manufacture the Terminated Products and, if Clinical Trials for such Terminated Product(s) have begun, such transferred Manufacturing process shall be in accordance with GMP and comparable under Applicable Law to the Manufacturing process used by Sanofi as of the effective date of termination; and</font></p>
  <p style="text-indent:33.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(4)	transfer to Kymera any inventory (including materials and work-in-progress) of the Terminated Products (if any) in the possession or control of Sanofi or its Affiliates as of the effective date of termination, at Kymera&#x2019;s cost for both the transport of the same and reimbursement of [***] of Sanofi&#x2019;s (or Affiliate&#x2019;s or Sublicensee&#x2019;s) Manufacturing Cost (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) for such inventory;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	Sanofi will, as promptly as practicable:</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	assign and transfer to Kymera or its designee ownership of all Marketing Approvals, Regulatory Filings and Price Approvals solely relating to the Research, Development, Manufacture or Commercialization of any Terminated Product;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	transfer to Kymera or its designee copies of all material correspondence and conversation logs with Regulatory Authorities in Sanofi&#x2019;s possession or control related to any Terminated Product in the Territory and all material data, reports, records and other sales and marketing related information in Sanofi&#x2019;s possession or control that relate solely to the Research, Development, Manufacture, Commercialization of the Terminated Products in the Territory, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, [***] Sanofi shall have no obligation to transfer to Kymera any such materials to the extent (x) Kymera already is in possession or control of such</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Know-How, or (y) Sanofi previously transferred such materials to Kymera prior to the effective date of termination;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	at Kymera&#x2019;s request, appoint Kymera as Sanofi&#x2019;s or Sanofi&#x2019;s Affiliates&#x2019; or Sublicensees&#x2019; agent for all Terminated Product related matters in the Territory involving Regulatory Authorities until all Marketing Approvals, Regulatory Filings and Price Approvals in the Territory have been assigned to Kymera or its designee and in the event of a failure to obtain assignment, Sanofi will consent and grant Kymera the right to access and reference (without any further action on the part of Sanofi) any Marketing Approvals, Regulatory Filings or Price Approvals;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	if the effective date of termination is after the First Commercial Sale of a Terminated Product, then at Kymera&#x2019;s request, to the extent permitted by Applicable Law, Sanofi or its Affiliate will, and Sanofi will use Commercially Reasonable Efforts to cause its Sublicensee, if applicable, to, appoint Kymera as its exclusive distributor of such Terminated Product in the Territory and grant Kymera the right to appoint sub-distributors, until such time as all Regulatory Filings, Marketing Approvals and Price Approvals in the Territory have been transferred to Kymera or its designee;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	at Kymera&#x2019;s reasonable request, use Commercially Reasonable Efforts to facilitate the establishment of a business relationship between Kymera and any Third Party Subcontractor that Sanofi has engaged in the Research, Development, Manufacture or Commercialization of a Terminated Product, including by facilitating introductions with such Subcontractors, and use Commercially Reasonable Efforts to assign to Kymera any agreements with any such Third Party Subcontractor that are exclusively related to a Terminated Product; and</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(vi)	if Kymera does not elect to receive a license under the Sanofi Reversion Technology pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.2(f)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Sanofi will destroy any inventory (including materials and work-in-progress) of the Terminated Products (if any) in the possession or control of Sanofi or its Affiliates as of the effective date of termination;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	notwithstanding anything to the contrary above in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (including, for the avoidance of doubt, clauses </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.2(g)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.2(f)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">), Sanofi will:</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	[***], and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	[***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effects of Termination for SAD Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If this Agreement is terminated by Sanofi with respect to the Second Additional Degraders pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(f)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the following terms will apply with respect to the Terminated Degraders:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall apply, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that (i) all references to &#x201c;Collaboration Compounds, Collaboration Candidates and Licensed Products Directed Against the Terminated Targets&#x201d; will be deemed references to &#x201c;Terminated Degraders&#x201d; (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">); and (ii) all wind-down costs incurred pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.2(e)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be borne by Sanofi; and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Sanofi shall remain subject to the exclusivity covenants of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in respect of the Terminated Degraders and shall not, during the Term of this Agreement, Research, Develop, Manufacture or Commercialize the Terminated Degraders in violation of the restrictions set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.6.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effects of Termination due to Kymera&#x2019;s Breach, Patent Challenge or Insolvency</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If this Agreement is terminated in its entirety or with respect to one or more Collaboration Targets by Sanofi pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the following terms will apply with respect to any Collaboration Candidates or Licensed Products Directed Against such Collaboration Targets that are the subject of such termination, as the case may be:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 15.3.2(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(h)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall apply  (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 15.3.2(g)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(g)(ii),</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(g)(iv)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(g)(v)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (each at Kymera&#x2019;s cost) shall apply (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">);</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.3.2(f)(iii)(3)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall apply in Sanofi&#x2019;s sole discretion and at Kymera&#x2019;s cost (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	subject to patient safety and other ethical considerations, Sanofi will wind-down any ongoing Clinical Trials for any Licensed Product Directed Against the Terminated Target(s) in accordance with Applicable Law and such wind-down costs will be borne by Kymera; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	If requested by Kymera, Sanofi will transfer to Kymera any inventory of the Terminated Products (if any) in the possession or control of Sanofi or its Affiliates as of the effective date of termination, at Kymera&#x2019;s cost for both the transport of the same and reimbursement of Sanofi&#x2019;s (or Affiliate&#x2019;s or Sublicensee&#x2019;s) Manufacturing Costs.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effects of Termination due to a Material Safety Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If this Agreement is terminated in its entirety or with respect to one or more Collaboration Targets by Sanofi pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 15.2.3(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the following terms will apply with respect to any Collaboration Candidates or Licensed Products Directed Against such Collaboration Targets that are the subject of such termination, as the case may be:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 15.3.2(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(h)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shall apply (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 15.3.2(g)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(g)(ii),</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(g)(iv)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.3.2(g)(v)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,  (each at Kymera&#x2019;s cost) shall apply (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">);</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	subject to patient safety and other ethical considerations, Sanofi will wind-down any ongoing Clinical Trials for any Licensed Product Directed Against the Terminated Target(s) in accordance with Applicable Law and such wind-down costs will be borne by Sanofi; and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">136</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	prior to the Initiation of a relevant Clinical Trial, Kymera will obtain and maintain, to the extent it does not already, insurance coverage at commercially reasonable levels for the conduct of Clinical Trials.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16<br>CONFIDENTIALITY</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Confidentiality</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During the Term and for [***] thereafter, each Party (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Receiving Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) receiving any Confidential Information of the other Party (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosing Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) hereunder will: (a) keep the Disclosing Party&#x2019;s Confidential Information confidential; (b) not publish, or allow to be published, and not otherwise disclose, or permit the disclosure of, the Disclosing Party&#x2019;s Confidential Information; and (c) not use, or permit to be used, the Disclosing Party&#x2019;s Confidential Information for any purpose, except, in each case, to the extent expressly permitted under this Agreement or otherwise agreed in writing.  Without limiting the generality of the foregoing, to the extent that either Party provides the other Party any Confidential Information owned by any Third Party, the Receiving Party will handle such Confidential Information in accordance with the terms of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 16</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> applicable to a Receiving Party.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Authorized Disclosure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, each Party may disclose the other Party&#x2019;s Confidential Information to the extent such disclosure is reasonably necessary to:</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.2.1	file or prosecute patent applications as contemplated by this Agreement;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.2.2	prosecute or defend litigation;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.2.3	allow its Affiliates and actual or potential Sublicensees and actual or potential Subcontractors, in each case, to exercise its rights or perform its obligations under this Agreement; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such disclosure is covered by terms of confidentiality at least as restrictive as those set forth herein;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.2.4	subject to the remainder of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, share with its advisors (including financial advisors, attorneys and accountants), actual or potential acquisition partners, financing sources or investors and underwriters on a need to know basis; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such disclosure is covered by terms of confidentiality similar to those set forth herein (which may include professional ethical obligations); or</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.2.5	comply with Applicable Law (including to obtain and maintain Marketing Approvals for a Licensed Product); </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that with respect to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 16.2.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or 16.2.4, the Receiving Party will notify the Disclosing Party of the Receiving Party&#x2019;s intent to make any disclosure pursuant thereto sufficiently prior to making such disclosure so as to allow the Disclosing Party adequate time to take whatever action it may deem appropriate to protect the confidentiality of the information to be disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notwithstanding anything to the contrary contained herein, in no event may Kymera disclose Sanofi&#x2019;s Confidential Information to any Third Party (including any of Kymera&#x2019;s investors, collaborators or licensees) engaged in the research, development, manufacture or</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">137</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">commercialization of pharmaceutical products, other than to actual or potential Subcontractors.  Notwithstanding anything to the contrary contained herein, in no event may Sanofi disclose Kymera&#x2019;s Confidential Information to any Third Party (including any of Sanofi&#x2019;s investors, collaborators or licensees) engaged in the research, development, manufacture or commercialization of pharmaceutical products, other than to actual or potential Subcontractors or Sublicensees.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expiration or Termination of this Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Following the expiration or termination of this Agreement, if requested by the Disclosing Party, at the Receiving Party&#x2019;s election, the Receiving Party will use diligent efforts to return or destroy, all data, files, records and other materials containing or comprising the Disclosing Party&#x2019;s Confidential Information, except to the extent such Confidential Information is necessary or reasonably useful to conduct surviving obligations or exercise surviving rights.  Notwithstanding the foregoing, (a) the Receiving Party will be permitted to retain one copy of such data, files, records, and other materials for archival and legal compliance purposes and (b) the Receiving Party will not be required to return or destroy electronically stored information that is commercially impractical to access, segregate or destroy, including any electronic back-up tapes or other electronic back-up files that have been created solely by the Receiving Party&#x2019;s automatic or routine archiving and back-up procedures, to the extent created and retained in a manner consistent with its or their standard archiving and back-up procedures.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SEC Filings and Other Disclosures</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Either Party may disclose the terms of this Agreement to the extent required to comply with Applicable Law, including the rules and regulations promulgated by the United States Securities and Exchange Commission or any equivalent governmental agency in any country in the Territory; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> such Party will provide the other Party a reasonable opportunity to review such disclosure and reasonably consider the other Party&#x2019;s comments regarding confidential treatment sought for such disclosure.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public Announcements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  On a date to be determined mutually by the Parties, Kymera will issue a press release regarding the signing of this Agreement in substantially the form attached hereto as Exhibit D.  Except (a) as set forth in the preceding sentence and (b) as required to comply with Applicable Law (including the rules and regulations promulgated by the United States Securities and Exchange Commission or any equivalent governmental agency in any country in the Territory in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">), and (c) as may be expressly permitted under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, neither Party will make any public announcement regarding this Agreement without the prior written approval of the other Party.  Notwithstanding the foregoing, subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and any requirements as a result of Applicable Law or Regulatory Authority, Kymera may make public announcements on or after the Restatement Effective Date with respect to (1) (i) a summary of data and results provided by Kymera in the Pre-Clinical and SAD/MAD Data Package, the MAD Data Package, the Phase 1 Patient Data Package and the Remaining Patients Data Package of the Kymera Existing Phase 1 Clinical Trial, and (ii) a statement that Sanofi will be conducting Phase 2 Clinical Trials with respect to KT-474 (for clarity, without any other additional details on any such Phase 2 Clinical Trials), (2) Sanofi&#x2019;s exercise of a Sanofi Participation Election Right, and (3) the receipt of any milestone payments hereunder; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, in each case ((1) - (3)), prior to making any such public announcement, Kymera will (A) consult with Sanofi with respect to the timing of the relevant announcement, (B)</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">138</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide Sanofi with a copy of the proposed announcement, and (C) in good faith coordinate the timing of such announcements with Sanofi&#x2019;s disclosures of the same subject matter.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Publications</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.6.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Publications Prior to the Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During the Term prior to the Sanofi Participation Election Effective Date (if any) with respect to [***]:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	[***].</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	[***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	[***].</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.6.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Publications Following Sanofi Participation Election Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  During the Term following the Sanofi Participation Election Effective Date (if any) with respect to a Collaboration Candidate, each Disclosing Party will submit to the Non-Disclosing Party for review any proposed academic, scientific or medical publication or academic, scientific and medical public presentation related to such Collaboration Candidate or related Licensed Product Directed Against such Collaboration Target in the applicable Field or any activities conducted pursuant to this Agreement with respect to such Collaboration Candidate or such related Licensed Product; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, no such academic, scientific or medical publication or academic, scientific and medical public presentation will occur without Sanofi&#x2019;s prior written consent.  The Non-Disclosing Party will review such publication or presentation for purposes of (a) determining whether any portion of the proposed publication or presentation contains the Non-Disclosing Party&#x2019;s Confidential Information, (b) preserving the value of the Licensed Technology and the rights granted to each Party hereunder, or (c) obtaining Patent protection. The Disclosing Party shall give any such comments due consideration and shall not unreasonably reject such comments.  Written copies of such proposed publication or presentation will be submitted to the Non-Disclosing Party no later than [***] before submission for publication or presentation.  The Non-Disclosing Party will provide its comments with respect to such publications and presentations within [***] after its receipt of such written copy.  The review period may be extended for an additional [***] if the Non-Disclosing Party reasonably requests such extension, including requests to permit the Non-Disclosing Party to prepare and file patent applications.  The Non-Disclosing Party may require that the other Party redact the Non-Disclosing Party&#x2019;s Confidential Information from any such proposed publication or presentation.  Each Party will comply with standard academic practice regarding authorship of scientific publications and recognition of contribution of other parties in any publication. Disputes concerning publication shall be resolved by the JSC.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.6.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Publications Regarding Degrader Platform</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding anything to the contrary in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 16.6.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Kymera may, at any time during the Term, make academic, scientific or medical publications or academic, scientific or medical public presentations specific to the Degrader Platform and containing no information specific to a Collaboration Target, any Collaboration Compound, Collaboration Candidate or Licensed</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">139</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product Directed Against such Collaboration Target in the applicable Field or any activities conducted pursuant to this Agreement with respect to such Collaboration Target; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, if such publication or presentation could reasonably be expected to adversely impact Sanofi&#x2019;s ability to Prosecute and Maintain the Sanofi Foreground Patents, then at least [***] prior to any such publication or presentation, Kymera will convene a meeting of the JPC to discuss the matter and implement an appropriate course of action, and upon Sanofi&#x2019;s request, Kymera will delay such publication or presentation to allow for at least [***] for Sanofi to prepare and file patent applications.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 17<br>GOVERNMENTAL APPROVALS; CLOSING CONDITION</font><font style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HSR Clearance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Parties acknowledge and agree that (a) the Parties filed their respective pre-merger notification and report forms with respect to the Original Agreement with the United States Federal Trade Commission and the United States Department of Justice pursuant to the HSR Act, and (b) the waiting period under the HSR Act expired as of 11:59 pm on August 10, 2020.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing Condition</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Upon the terms and conditions set forth herein, at the Closing, the Original Agreement is amended and restated in its entirety and replaced with, and superseded by, this Agreement; provided that any activities conducted under the Original Agreement shall be deemed to have been conducted under this Agreement.  The closing of this Agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) will take place on the first Business Day after Kymera&#x2019;s receipt of Sanofi&#x2019;s Phase 2 Election Notice attached hereto as Exhibit E (such date, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restatement Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  In furtherance of the foregoing, during the period between the Restatement Execution Date and the Restatement Effective Date, the Original Agreement will continue to govern the Parties&#x2019; relationship in accordance with its terms.  [***].  [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Article 18<br>MISCELLANEOUS</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assignment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement will not be assignable by either Party to any Third Party without the written consent of the non-assigning Party.  Notwithstanding the foregoing, either Party may, subject to the terms of this Agreement (including </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 10.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">), assign this Agreement or its rights and obligations under this Agreement, without the written consent of the other Party, to an Affiliate that agrees in writing to be bound by the terms of this Agreement or to a Third Party that acquires all or substantially all of the business or assets of such Party to which this Agreement relates (whether by merger, reorganization, acquisition, sale or otherwise), and agrees in writing to be bound by the terms of this Agreement; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, in the case of an assignment to an Affiliate, the assigning Party shall remain fully liable for the performance of its obligations under this Agreement by such Affiliate.  The assigning Party will promptly notify the other Party in writing of any permitted assignment or transfer under the provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement will be binding upon the successors and permitted assigns of the Parties and the name of a Party appearing herein will be deemed to include the names of such Party&#x2019;s successors and permitted assigns to the extent necessary to carry out the intent of this Agreement.  Any assignment not in accordance with this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will be null and void.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">140</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.8%;text-indent:6.72%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Force Majeure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.2.1	Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.2.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, each Party will be excused from the performance of its obligations under this Agreement to the extent that such performance is prevented by Force Majeure and the nonperforming Party promptly provides written notice of the Force Majeure to the other Party.  Such excuse will continue for so long as the condition constituting a Force Majeure continues, on the condition that the nonperforming Party continues to use Commercially Reasonable Efforts to remove or mitigate the Force Majeure and resume performance of its obligations under this Agreement.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.2.2	For clarity, Sanofi and Kymera acknowledge and agree that either Party&#x2019;s ability to perform its obligations under this Agreement may be affected by [***].</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representation by Legal Counsel</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Party represents that it has been represented by legal counsel in connection with this Agreement and acknowledges that it has participated in the drafting hereof.  In interpreting and applying the terms and provisions of this Agreement, no presumption will exist or be implied against the Party that drafted such terms and provisions.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  All written notices which are required or permitted hereunder will be in writing and sufficient if delivered personally or sent by nationally-recognized overnight courier, addressed as follows:</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If to Sanofi:</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Genzyme Corporation<br>450 Water Street<br>Cambridge, MA 02141<br>Attention:  [***], Global Business Development &#149; Sanofi Partnering<br>Email:  [***]@sanofi.com</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">with a copy (which will not constitute notice) to:</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">450 Water Street<br>Cambridge, MA 02141<br>Attention:  [***], Head of Legal Global Functions<br>Email (to each of the following):  [***]@sanofi.com;<br>[***]@sanofi.com</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If to Kymera:</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Therapeutics, Inc.<br>Attn:  Chief Executive Officer<br>200 Arsenal Yards Blvd<br>Watertown, MA 02472</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">141</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">with a copy (which will not constitute notice) to:</font></p>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Goodwin Procter LLP<br>Attn:  Sarah Solomon<br>100 Northern Avenue<br>Boston, MA 02210</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or to such other address as the Party to whom written notice is to be given may have furnished to the other Party in writing in accordance herewith.  In addition, each Party will deliver a courtesy copy to the other Party&#x2019;s Alliance Manager concurrently with such notice.  Any such written notice will be deemed to have been given and received by the other Party:  (a) when delivered if personally delivered; or (b) on receipt if sent by overnight courier.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amendment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No amendment, modification or supplement of any provision of this Agreement will be valid or effective unless made in writing and signed by a duly authorized officer of each of Sanofi and Kymera.  For clarity, references in this Agreement to a &#x201c;written acknowledgement&#x201d; will not be deemed to be an amendment, modification or supplement of this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Waiver</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No provision of this Agreement will be waived by any act, omission or knowledge of a Party or its agents or employees except by an instrument in writing expressly waiving such provision and signed by a duly authorized officer of the waiving Party.  The waiver by either Party of any breach of any provision hereof by the other Party will not be construed to be a waiver of any succeeding breach of such provision or a waiver of the provision itself.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.7	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If any clause or portion thereof in this Agreement is for any reason held to be invalid, illegal or unenforceable, the same will not affect any other portion of this Agreement, as it is the intent of the Parties that this Agreement will be construed in such fashion as to maintain its existence, validity and enforceability to the greatest extent possible.  In any such event, this Agreement will be construed as if such clause of portion thereof had never been contained in this Agreement, and there will be deemed substituted therefor such provision as will most nearly carry out the intent of the Parties as expressed in this Agreement to the fullest extent permitted by Applicable Law.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.8	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Descriptive Headings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The descriptive headings of this Agreement are for convenience only and will be of no force or effect in construing or interpreting any of the provisions of this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.9	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Export Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement is made subject to any restrictions concerning the export of products or technical information from the United States of America or other countries that may be imposed upon or related to Kymera or Sanofi from time to time.  Each Party agrees that it will not export, directly or indirectly, any technical information acquired from the other Party under this Agreement or any products using such technical information to a location or in a manner that at the time of export requires an export license or other governmental approval, without first obtaining the written consent to do so from the appropriate Governmental Authority.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">142</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.10	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Governing Law</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement, and all claims arising under or in connection therewith, will be governed by and interpreted in accordance with the substantive laws of The State of New York, without regard to conflict of law principles thereof.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.11	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jurisdiction; Venue; Service of Process</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except as otherwise </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, (a) each Party irrevocably submits to the exclusive jurisdiction of (i) the courts of the State of New York located in New York, NY, or (ii) the United States District Court for the Southern District of New York, for the purposes of any actions, suits and proceedings (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Actions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) arising out of this Agreement (except for government agency actions to adjudicate registered intellectual property rights, e.g., post-grant proceedings at the United States Patent and Trademark Office or other foreign equivalent proceedings), (b) each Party agrees to commence any such Action either in the United States District Court for the Southern District of New York or if such Action may not be brought in such court for jurisdictional reasons, in the courts of the State of New York located in New York, NY, and (c) each Party irrevocably and unconditionally waives any objection to the laying of venue of any Action arising out of this Agreement in (i) the courts of the State of New York located in New York, NY, or (ii) the United States District Court for the Southern District of New York, and hereby and thereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such Action brought in any such court has been brought in an inconvenient forum.  Each of the Parties agrees that process may be served upon it in the manner specified in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and irrevocably waives and covenants not to assert or plead any objection which it might otherwise have to such jurisdiction, or to such manner of service of process.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.12	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dispute Resolution</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If a dispute arises between the Parties in connection with or relating to this Agreement or any document or instrument delivered in connection herewith (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dispute</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), it will be resolved pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as applicable.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.12.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Informal Dispute Resolution; Escalation to Executive Officers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event of any Dispute, the Parties will first attempt in good faith to resolve such Dispute by negotiation and consultation between themselves.  If, after [***] from receipt of the written notice of a Dispute, such Dispute has not been resolved on an informal basis, either Party may refer any Dispute to the Executive Officers of the Parties by delivering written notice to the other Party, who will confer in good faith on the resolution of the issue for a [***] period following receipt of such written notice.  If any Dispute is not resolved within such [***] period by the Executive Officers, each Party may, at its sole discretion, seek resolution of such Dispute in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding the foregoing, a matter that was subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will not also be subject to this Section but will otherwise be subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and all other provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.12.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jury Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  EXCEPT AS LIMITED BY LAWS, EACH PARTY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF ANY PARTY HERETO IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT HEREOF.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">143</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.12.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equitable Relief</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding the foregoing in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, nothing contained in this Agreement will in any way limit or preclude a Party from, at any time, seeking or obtaining equitable relief hereunder, whether preliminary or permanent, including a temporary or permanent restraining order, preliminary or permanent injunction, specific performance or any other form of equitable relief, from any United States court of competent jurisdiction if necessary to protect the interests of such Party.  Each Party agrees that its unauthorized release of the other Party&#x2019;s Confidential Information or its breach of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 10.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of this Agreement will cause irreparable damage to the other Party for which recovery of damages would be inadequate, and that such other Party will be entitled to obtain timely injunctive relief with respect to such breach, without the need to show irreparable harm or the inadequacy of monetary damages as a remedy, and without the requirement of having to post bond or other security, as well as any further relief that may be granted by a court of competent jurisdiction.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.12.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tolling</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Parties agree that all applicable statutes of limitation and time-based defenses (such as estoppel and laches), as well as all time periods in which a Party must exercise rights or perform obligation hereunder, will be tolled once the dispute resolution procedures set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> have been initiated and for so long as they are pending, and the Parties will cooperate in taking all actions reasonably necessary to achieve such a result.  Further, with respect to any time periods that have run during the pendency of the Dispute, the applicable Party will have a reasonable period of time or any specific timeframe established by the tribunal&#x2019;s decision to exercise any rights or perform any obligations affected by the running of such time periods.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.12.5	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain IP Disputes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  In the event that a Dispute arises with respect to the validity, scope, enforceability, inventorship or ownership of any Patent, trademark or other intellectual property rights and such Dispute cannot be resolved in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, unless otherwise agreed by the Parties in writing, either Party may initiate litigation in a court of competent jurisdiction in the relevant jurisdiction, notwithstanding </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sections 18.10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:4.173%;text-indent:13.914%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.12.6	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Dispute Resolution Mechanisms</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding anything to the contrary herein, this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 18.12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will not apply with respect to (a) disputes arising under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that are expressly subject to the R&amp;D Expert dispute resolution procedures set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 9.9.2(b)(iii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, (b) disputes arising under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(iv)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that are expressly subject to the arbitration set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 9.9.2(b)(iv)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and (c) disputes arising under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 9.9.2(b)(v)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that are expressly subject to the &#x201c;baseball&#x201d; arbitration set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 9.9.2(b)(v)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.13	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Entire Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 17.2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as of the Closing, this Agreement (together with all schedules and exhibits attached hereto) constitutes and contains the complete, final and exclusive understanding and agreement of the Parties and cancels and supersedes all prior negotiations, correspondence, understandings and agreements, whether oral or written, between the Parties respecting the subject matter hereof, including the Original Agreement and the CDA (which, with respect to the CDA, was superseded and replaced in its entirety as of the Original Agreement Effective Date).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">144</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.14	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Independent Contractors</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Both Parties are independent contractors under this Agreement.  Nothing contained herein will be deemed to create an employment, agency, joint venture or partnership relationship between the Parties or any of their agents or employees, including for U.S. federal income and other applicable tax purposes, or any other legal arrangement that would impose liability upon one Party for the act or failure to act of the other Party.  Neither Party will have any express or implied power to enter into any contracts or commitments or to incur any liabilities in the name of, or on behalf of, the other Party, or to bind the other Party in any respect whatsoever.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.15	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interpretation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Except where the context expressly requires otherwise, (a) the use of any gender herein will be deemed to encompass references to either or both genders, and the use of the singular will be deemed to include the plural (and vice versa), (b) the words &#x201c;include,&#x201d; &#x201c;includes&#x201d; and &#x201c;including&#x201d; will be deemed to be followed by the phrase &#x201c;without limitation,&#x201d; (c) the word &#x201c;will&#x201d; will be construed to have the same meaning and effect as the word &#x201c;shall,&#x201d; (d) any definition of or reference to any agreement, instrument or other document herein will be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein), (e) any reference herein to any Person will be construed to include the Person&#x2019;s successors and assigns, (f) the words &#x201c;herein,&#x201d; &#x201c;hereof&#x201d; and &#x201c;hereunder,&#x201d; and words of similar import, will be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (g) all references herein to Articles, Sections or Schedules will be construed to refer to Articles, Sections or Schedules of this Agreement, and references to this Agreement include all Schedules hereto, (h) except as otherwise expressly set forth herein, provisions that require that a Party, the Parties or any committee hereunder &#x201c;agree,&#x201d; &#x201c;consent&#x201d; or &#x201c;approve&#x201d; or the like will require that such agreement, consent or approval be specific and in writing, whether by written agreement, letter, approved minutes or otherwise (but excluding e-mail and instant messaging), (i) references to any specific law, rule or regulation, or article, section or other division thereof, will be deemed to include the then-current amendments thereto or any replacement or successor law, rule or regulation thereof, (j) any action or occurrence deemed to be effective as of a particular date will be deemed to be effective as of 11:59 PM ET on such date and (k) the term &#x201c;or&#x201d; will be interpreted in the inclusive sense commonly associated with the term &#x201c;or&#x201d; (and/or).  Unless otherwise specified, deadlines within which any payment is to be made or act is to be done within or following a specified time period after a date will be calculated by excluding the day, Business Day, month or year of such date, as applicable, and including the day, Business Day, month or year of the date on which the period ends.  Whenever any payment is to be made or action to be taken under this Agreement is required to be made or taken on a day other than a Business Day, such payment will be made or action taken on the next Business Day following such day to make such payment or do such act.  The preamble to this Agreement and the descriptive headings of Articles and Sections are inserted solely for convenience of reference and are not intended as complete or accurate descriptions of the content of this Agreement or of such Articles or Sections.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.16	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Third Party Rights or Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No provision of this Agreement will be deemed or construed in any way to result in the creation of any rights or obligations in any Person not a Party to this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">145</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.17	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further Actions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Each Party agrees to execute, acknowledge and deliver such further instruments, and to do all such other acts, as may be necessary or appropriate in order to carry out the purposes and intent of this Agreement.</font></p>
  <p style="margin-left:0.667%;text-indent:6.711%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.18	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Counterparts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement may be executed in two (2) counterparts, each of which will be an original and both of which will constitute together the same document.  Counterparts may be signed and delivered by digital transmission (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">e.g.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, .pdf), each of which will be binding when received by the applicable Party.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[Signature Page Follows]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">146</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Parties have caused this Agreement to be executed by their representatives thereunto duly authorized as of the Restatement Execution Date.</font></p>
  <table style="margin-left:0.167%;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:54.22%;"></td>
    <td style="width:45.78%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GENZYME CORPORATION</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:_</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;______________________</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">___________________________</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:</font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:</font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title:</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terms and Conditions of Development Cost Sharing</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terms and Conditions of Co-Promotion Agreement</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Terms and Conditions of Cost/Profit Sharing Agreement</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit D</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Press Release</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit E</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi&#x2019;s Form of Phase 2 Election Notice</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: [______]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To:  Kymera Therapeutics, Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Attn:  Chief Executive Officer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">200 Arsenal Yards Blvd</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Watertown, MA 02472</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">with a copy (which will not constitute notice) to:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Goodwin Procter LLP</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Attn:  Sarah Solomon</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100 Northern Avenue</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Boston, MA 02210</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By [Email]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Re: Sanofi Phase 2 Election Notice</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dear Ladies and Gentleman,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sincerely,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Genzyme Corporation</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">____________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:[ ]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title: [ ]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>4
<FILENAME>kymr-ex10_12.htm
<DESCRIPTION>EX-10.12
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain identified information, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MARKED BY &#x201c;[***]&#x201d;,</font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.12</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECOND AMENDMENT TO MASTER COLLABORATION AGREEMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Second Amendment to Master Collaboration Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (this &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amendment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is made and entered into as of October 21, 2021 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amendment Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), by and between and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vertex Pharmaceuticals Incorporated</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vertex</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Therapeutics, Inc</font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and amends that certain Master Collaboration Agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), dated as of May 9, 2019 by and between Vertex and Company, as amended by that certain First Amendment to Master Collaboration Agreement, dated as of August 27, 2020. All capitalized terms used, but not otherwise defined, in this Second Amendment shall have the meaning given to them in the Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Whereas</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, pursuant to Section 13.6 of the Agreement, the Parties wish to amend the Agreement in accordance with the terms and conditions set forth herein.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Now, Therefore,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in consideration of the foregoing premises and the mutual covenants set forth below, and for other good and valuable consideration, the receipt of which is hereby acknowledged, Vertex and Company hereby agree as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.984988947906702%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amendments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.246527777777779%;">a.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to Section 2.3.1 of the Agreement, the Parties agree to substitute the Reserved Target, [***], for the Collaboration Target, [***], as a Collaboration Target. As of the Second Amendment Effective Date, (a) [***] shall be a Collaboration Target and cease to be a Reserved Target, and (b) [***] shall be a Terminated Target and cease to be a Collaboration Target. As such, Schedule 1.35 and Schedule 1.178 shall be deleted and replaced in their entirety with such schedules as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.246527777777779%;">b.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A new Section 2.11 is hereby added following Section 2.10 as follows:</font></div></div>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Early Research for [***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="margin-left:3.333%;text-indent:13.793%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11.1.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***] Initial Research</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Notwithstanding anything to the contrary in this Agreement, the initial purpose of the Collaboration Program for the Collaboration Target, [***], shall be the generation of a Collaboration Compound directed against [***] that meets the criteria set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***] Degrader</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). Following the Second Amendment Effective Date, Company shall promptly prepare and provide to Vertex an initial Research Plan for [***]; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that, notwithstanding the requirements of Research Plans as set forth in Section 2.3.1, such initial Research Plan for [***] shall be limited to a high-level description of the activities Company anticipates are reasonably necessary to generate a [***] Degrader within [***] months of the Second Amendment Effective Date rather than the activities to identify a Candidate Drug (such Research Plan, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***] Early Research Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). Vertex shall provide one or more Vertex Components for use in the Collaboration Program for [***].</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.12</font></p>
  <p style="margin-left:3.333%;text-indent:13.793%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11.2	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Target Validation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Company identifies a [***] Degrader in connection with the activities contemplated by the [***] Early Research Plan, it shall promptly provide notice to Vertex and provide any supporting data regarding such [***] Degrader reasonably requested by Vertex and in the possession and control of Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">; provided that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Company shall in no event be required to conduct any new or additional Research or other activities to generate any such additional information or records. Thereafter, Vertex shall prepare and provide to Company a work plan for its conduct of a target validation experiment in [***] using such [***]Degrader and shall consider any comments from Company on such work plan in good faith (such experiment, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Validation Experiment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and such work plan, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Validation Experiment Work Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). Vertex will use Commercially Reasonable Efforts to perform the Validation Experiment in accordance with the Validation Experiment Work Plan. Company shall provide Vertex with the [***] Degrader in such quantities as reasonably necessary for the Validation Experiment as set forth in the Validation Experiment Work Plan. Upon completion of the Validation Experiment, Vertex will provide a summary of the results to Company including an assessment of whether such results have achieved the success criteria set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(such achievement, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Target Validation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). If Target Validation is achieved, (a) the purpose of the Collaboration Program for [***] shall be for the generation of Candidate Drug(s) directed against [***], (b) Company shall promptly prepare and provide to Vertex a Research Plan for [***] meeting the criteria set forth in Section 2.2.1, including, for clarity, a high-level description of the activities Company anticipates are reasonably necessary to identify a Candidate Drug directed against [***] during the Research Term and shall consider any comments from Vertex on such Research Plan in good faith and (c) Company shall promptly commence the Collaboration Program for [***] in accordance with the terms of the Agreement.</font></p>
  <p style="margin-left:3.333%;text-indent:13.793%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11.3	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Failure to Identify [***] Degrader or Achieve Target Validation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If (a) Company fails to identify a [***] Degrader within [***] months of the date hereof (or such later date as the Parties may mutually agree) or (b) Target Validation is not achieved by the results of the Validation Experiment, (i) Company shall cease all activities under the Collaboration Program for [***] and (ii) upon mutual agreement of the Parties, the Parties shall substitute a Reserved Target, or another mutually-agreed Target, for [***] as a Collaboration Target.</font></p>
  <p style="margin-left:3.333%;text-indent:13.793%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.11.4	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]-Related Activities and Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. For the avoidance of doubt, all activities performed by the Parties under the [***] Early Research Plan and Validation Experiment Work Plan shall be deemed activities performed under this Agreement. In consideration for the activities to be performed by Company under the [***] Early Research Plan, Vertex will pay to Company the payments as set forth in Section 7.14 of this Agreement.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.246527777777779%;">c.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A new Section 7.14 is hereby added following Section 7.13 as follows:</font></div></div>
  <p style="margin-left:3.333%;text-indent:11.214%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.14	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]-Related Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Notwithstanding anything to the contrary in the Agreement, (a) Development Milestone Number 1 ([***]) as set forth in Section 7.5.1 of this Agreement shall not be payable with respect to [***] and (b) in addition to the amounts that may become payable by Vertex to Company pursuant to Sections 7.4, 7.5 and 7.6 under this Agreement for the [***] Collaboration Program, Vertex will pay to Company the following:</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.12</font></p>
  <p style="margin-left:3.333%;text-indent:13.793%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.14.1	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional [***] Milestone Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In addition to the Development Milestones set forth in Section 7.5.1 of this Agreement (excluding Development Milestone Number 1), Vertex will pay to Company the following one-time milestone payments set forth in this Section 7.14.1 upon the achievement of the relevant milestone events with respect to the Collaboration Target, [***].</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:6.667%;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:79.203%;"></td>
    <td style="width:20.797%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(191,191,191,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***] Milestone Event</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(191,191,191,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Payment</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:right;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.984988947906702%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Miscellaneous</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Except to the extent expressly amended hereby, the terms and provisions of the Agreement shall remain in full force and effect. Sections 13.11 and 13.19 of the Agreement are hereby incorporated herein by reference.  This Second Amendment, together with the Agreement as amended hereby, constitutes and contains the complete, final and exclusive understanding and agreement of the Parties and cancels and supersedes all prior negotiations, correspondence, understandings and agreements, whether oral or written, between the Parties respecting the subject matter hereof.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Signature Page Follows</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.12</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Witness Whereof,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> the Parties have by duly authorized persons executed this Second Amendment to Master Collaboration Agreement as of the Second Amendment Effective Date.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-87.501%;padding-left:46.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		 &#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:50.0%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">VERTEX PHARMACEUTICALS INCORPORATED</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;/s/ Mark Bunnage</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;/s/ Nello Mainolfi</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:  Mark Bunnage</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:  Nello Mainolfi</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title:  SVP Head of Research</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title:  CEO</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain identified information, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MARKED BY &#x201c;[***]&#x201d;,</font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.12</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Targets and Reserved Targets</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.35</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Targets</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.775%;"></td>
    <td style="width:50.225%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(191,191,191,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name</font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(191,191,191,1);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ENSEMBL GENE ID</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1.178</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reserved Targets</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:49.797%;"></td>
    <td style="width:50.203%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(191,191,191,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name</font></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(191,191,191,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ENSEMBL GENE ID</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain identified information, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MARKED BY &#x201c;[***]&#x201d;,</font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.12</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Degrader Criteria</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></div></div>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:36.667%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:5.262659277154091%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Target Validation Success Criteria</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>5
<FILENAME>kymr-ex10_13.htm
<DESCRIPTION>EX-10.13
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">LEASE AGREEMENT</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">THIS LEASE AGREEMENT (this &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lease</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) is made as of this 20</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> day of December, 2021, between </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ARE-MA REGION NO. 75, LLC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, a Delaware limited liability company (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), and </font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Kymera therapeutics, Inc.</font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">a Delaware corporation (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:-20.0%;padding-left:16.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Building:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	The to-be-constructed building in the Project to be located at The Arsenal on the Charles, Watertown, Massachusetts 02472 (also known as Building 1), in which the Premises are located.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:-20.0%;padding-left:16.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Premises:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	That portion of the Project, consisting of (i) the entire rentable area of the second, third and fourth floors of the Building (inclusive of the fourth floor terrace) (but exclusive of Common Areas), (ii) certain storage space on the first floor of the Building and (iii) certain mechanical space on the penthouse floor of the Building, and containing in the aggregate approximately 100,624 rentable square feet, as determined by Landlord, as shown on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, consisting of (a) approximately 33,074 rentable square feet on the second floor of the Building, (b) approximately 33,074 rentable square feet on the third floor of the Building, (c) approximately 32,647 rentable square feet on the fourth floor of the Building (inclusive of the fourth floor terrace), (d) approximately 1,588 rentable square feet of storage space on the first floor of the Building, and (e) approximately 241 rentable square feet of mechanical space on the penthouse floor of the Building, subject to adjustment from time to time in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sections 5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">45(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:-20.0%;padding-left:16.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Project:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	The real property on which the Building in which the Premises are located, together with all improvements thereon and appurtenances thereto as described on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:-37.926%;padding-left:27.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rentable Area of Premises:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">    100,624 sq. ft., subject to adjustment from time to time in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sections 5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">45(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:-37.926%;padding-left:27.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant acknowledges that the rentable square footage amounts set forth on the first page of this Lease are based on initial estimates from Landlord utilizing the BOMA Modified measurement standard. Accordingly, within sixty (60) days following the Commencement Date, Landlord may, but shall not be obligated to, calculate the rentable square footage of the Premises and Building pursuant to BOMA Modified (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Initial Remeasurement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), and deliver to Tenant (A) a statement setting forth any changes to the (i) rentable square footage of the Premises, the Building, or the Project, (ii) the Base Rent, (iii) the Building&#x2019;s Share of the Project, (iv) the Tenant Improvement Allowance and the Supplemental Tenant Improvement Allowance, and (v) Tenant&#x2019;s Share of Operating Expenses, resulting from such changes to or remeasurement of the Premises, the Building, or the other buildings with the Project, and (B) back-up calculations showing any changes to the rentable square footage of the Premises, the Building, or the Project. Tenant shall execute and return an acknowledgement prepared by Landlord of: (1) the rentable square footage of the Premises, the Building, or the Project, (2) the Base Rent, (3) the Building&#x2019;s Share of the Project, (4) the Tenant Improvement Allowance and the Supplemental Tenant Improvement Allowance, and (5) Tenant&#x2019;s Share of Operating Expenses, resulting from Landlord&#x2019;s Initial Remeasurement within 7 business days following Landlord&#x2019;s request. The failure of Tenant to do so shall be deemed Tenant&#x2019;s unconditional and irrevocable acknowledgement and agreement of the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_0.jpg" alt="img10132136_0.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> IF &#34; DOCVARIABLE &#34;SWDocIDLocation&#34; 1&#34; = &#34;1&#34; &#34; DOCPROPERTY &#34;SWDocID&#34; ACTIVEUS 187586682v.10&#34; &#34;&#34; ACTIVEUS 187586682v.10</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:27.507%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">facts contained therein.  If there is any disagreement with respect to the facts contained in such acknowledgement of Landlord&#x2019;s Initial Remeasurement, then Tenant must raise the same by written notice to Landlord within 7 business days of receipt of the statement in clause (A) or Tenant will have irrevocably waived the right to object.  Following Landlord&#x2019;s timely receipt of such objection notice, the parties shall reasonably and in good faith discuss such matters; provided that any dispute will be resolved by Landlord&#x2019;s architect, whose determination of the rentable square footage of the Premises, the Building and the Project shall be conclusive, final and binding on Landlord and Tenant.  Notwithstanding the foregoing, in no event shall the rentable square footage of the Premises be increased or decreased by more than 10,000 rentable square feet from that specified above (i.e., above 110,624 rentable square feet or below 90,624 rentable square feet) in connection with the Initial Remeasurement, unless such increase is the result of an implemented Change Request (as defined in the Work Letter) in which event the foregoing cap shall not apply.  The Initial Remeasurement by Landlord shall not be considered in lieu of or a waiver of Landlord&#x2019;s other rights of remeasurement set forth in this Lease.</font></p>
  <p style="text-indent:-37.926%;padding-left:27.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rentable Area of Building:	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">120,454</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">sq. ft.,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">subject to adjustment from time to time in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sections 5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">45(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof and in accordance with the definition of Rentable Area of Premises.</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rentable Area of Project:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	1,132,958 sq. ft.,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">subject to adjustment from time to time in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sections 5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">45(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof and in accordance with the definition of Rentable Area of Premises.	</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Building&#x2019;s Share of Project:	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">10.63%,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">subject to adjustment from time to time in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sections 5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">45(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof and in accordance with the definition of Rentable Area of Premises.</font></p>
  <p style="text-indent:-57.895%;padding-left:36.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant&#x2019;s Share of Operating Expenses:	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">83.54%, subject to adjustment from time to time in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sections 5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">45(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof and in accordance with the definition of Rentable Area of Premises.</font></p>
  <p style="text-indent:-20.0%;padding-left:16.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Base Rent:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	$754,680 per month [initially based on $90/RSF annually], subject to adjustment pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:-20.0%;padding-left:16.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rent Adjustment Percentage:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  Three percent (3%)</font></p>
  <p style="text-indent:-20.0%;padding-left:16.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Base Rent Commencement Date:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  2 months following the Commencement Date.</font></p>
  <p style="text-indent:-20.0%;padding-left:16.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Security Deposit:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  $4,528,080</font></p>
  <p style="text-indent:-20.0%;padding-left:16.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Target Commencement Date:  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">November 30, 2023</font></p>
  <p style="text-indent:-20.0%;padding-left:16.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Base Term:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Beginning on the Commencement Date and ending 134 months from the first day of the first full month of the Term (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">) hereof.</font></p>
  <p style="text-indent:-20.0%;padding-left:16.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Permitted Use:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> 	General office, laboratory, small-scale assembly in support of laboratory and life science research and development, and life sciences research and development uses</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:16.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">consistent with the character of the Project and otherwise in compliance with the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:-20.0%;padding-left:16.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall not permit (a) the second floor of the Premises to contain less than 35% of lab space or use nor less than 35% of office space or use, (b) the fourth floor of the Premises to contain less than 20% lab space and use, or (c) the third and fourth floors of the Premises, in the aggregate, to contain less than 35% lab space and use.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Address for Rent Payment:	Landlord&#x2019;s Notice Address:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ARE-MA Region No. 75, LLC	c/o Alexandria Real Estate Equities, Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">JP Morgan Chase	26 North Euclid Avenue</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">P.O. Box 975383	Pasadena, CA  91101</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Dallas, TX  75397-5383	Attention:  Corporate Secretary</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant&#x2019;s Notice Address:	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">Before the Commencement Date:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">200 Arsenal Yards Blvd., Suite 230</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Watertown, MA 02472</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Attention:  Bruce N. Jacobs, CFO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">After the Commencement Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">KYMERA THERAPEUTICS, INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The Arsenal on the Charles, Building 1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Watertown, MA 02472</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Attention:  Bruce N. Jacobs, CFO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">And with a copy to:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Goodwin Procter LLP</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">100 Northern Avenue<br>Boston, MA 02210</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Attention:  William D. Collins, Esq.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The following Exhibits and Addenda are attached hereto and incorporated herein by this reference:</font></p>
  <p style="text-indent:-73.211%;padding-left:42.267%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> - PREMISES DESCRIPTION</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	 </font></p>
  <p style="text-indent:-73.211%;padding-left:42.267%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> - DESCRIPTION OF PROJECT</font></p>
  <p style="text-indent:-73.211%;padding-left:42.267%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> - WORK LETTER</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	 </font></p>
  <p style="text-indent:-73.211%;padding-left:42.267%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT D</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> - ACKNOWLEDGEMENT OF COMMENCEMENT DATE</font></p>
  <p style="text-indent:-73.211%;padding-left:42.267%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT E</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> - RULES AND REGULATIONS</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	 </font></p>
  <p style="text-indent:-73.211%;padding-left:42.267%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT F</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> - TENANT&#x2019;S PERSONAL PROPERTY</font></p>
  <p style="text-indent:-73.211%;padding-left:42.267%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT G</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> &#x2013; CONTROL AREAS</font></p>
  <p style="text-indent:-73.211%;padding-left:42.267%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT H &#x2013;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> DESIGNATED ROOFTOP AREA</font></p>
  <p style="text-indent:-73.211%;padding-left:42.267%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-73.211%;padding-left:42.267%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lease of Premises</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Upon and subject to all of the terms and conditions hereof, Landlord hereby leases the Premises to Tenant and Tenant hereby leases the Premises from Landlord.  Landlord and Tenant are each a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; and collectively the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.&#x201d;</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The portions of the Project which from time to time are for the non-exclusive use of Tenant and one or more other tenants of the Project or other third parties are collectively referred to herein as the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Common Areas</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.&#x201d;  The Common Areas include, without limitation, to the extent any exist from time to time and are generally available to all tenants: (a) the common lobbies, hallways, stairways, and elevators providing access to the Premises, (b) the common chases and conduits, mechanical and utility rooms, and trash enclosures located within the Building,(c) the common loading areas located in and serving the Building, and (d) pedestrian sidewalks, and landscaped areas serving the Project.  The Common Areas include, without limitation, the various amenities, amenities facilities, and buildings or other improvements containing the same located in, on or otherwise serving the Project, if any, as may exist from time to time and be available for use by Tenant and one or more other tenants of the Project or other third parties (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Amenities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  Amenities may include, by way of example, things such as business centers, conference centers, restaurants, or gyms and other athletic facilities.  It is understood that Landlord may contract with or arrange for affiliates or third parties to provide Amenities rather than providing the same itself.  In either case, the cost thereof will be included in Operating Expenses (or paid by Tenant to such affiliates or third parties).  Notwithstanding anything contained in this Lease to the contrary and for the avoidance of doubt, however, Landlord has no obligation to provide, and if provided has no obligation to continue to provide, any Amenities or other Common Areas, other than reasonable access to the Premises and any parking required by the terms of this Lease to be available to Tenant.   Tenant shall have access to the Premises and the Building twenty-four (24) hours per day during the Term of this Lease, except in the case of emergencies or Force Majeure (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 34</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below), as the result of governmental action or Legal Requirements, the performance by Landlord of any installation, maintenance or repairs, or other work, any other temporary interruptions, and otherwise subject to the terms of this Lease.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Delivery; Acceptance of Premises; Commencement Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall use reasonable efforts to deliver the Premises to Tenant on or before the Target Commencement Date, with Landlord&#x2019;s Work Substantially Completed (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Delivery</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Deliver</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  If Landlord fails to timely Deliver the Premises, Landlord shall not be liable to Tenant for any loss or damage resulting therefrom, and this Lease shall not be void or voidable except as provided herein.  If Landlord does not Deliver the Premises within 60 days following the Target Commencement Date for any reason other than Force Majeure delays and Tenant Delays, then Tenant shall be entitled to a day for day abatement of Base Rent for each day that the delay in delivery continues from and including the 60th day after the Target Commencement Date (as such Target Commencement Date is extended for Force Majeure delays and Tenant Delays) through the earlier of Delivery or the 120th day after the Target Commencement Date (as such Target Commencement Date is extended for Force Majeure delays and Tenant Delays).  If Landlord does not Deliver the Premises within 120 days following the Target Commencement Date for any reason other than Force Majeure delays and Tenant Delays, then Tenant shall be entitled to an abatement of Base Rent for two days for each day that the delay in delivery continues for the period from the 120th day after the Target Commencement Date (as such Target Commencement Date is extended for Force Majeure delays and Tenant Delays) until the earlier of Delivery or the 195</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">th </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">day after the Target Commencement Date (as such Targe Commencement Date is extended for Force Majeure delays and Tenant Delays).  If Landlord does not Deliver the Premises within 195 days of the Target Commencement Date for any reason other than Force Majeure delays and Tenant Delays, then this Lease may be terminated by Tenant by written notice (given no later than 10 business days after the expiration of the 195 day period (as so extended)) to Landlord, and if so terminated by Tenant: (a) the Security Deposit, or any balance thereof (i.e., after deducting therefrom all amounts to which Landlord is entitled under the provisions of this Lease), and any prepaid Base Rent shall be returned to Tenant, and (b) neither Landlord nor Tenant shall have any further rights, duties or obligations under this Lease, except with respect to provisions which expressly survive termination of this Lease.   As used herein, the terms &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord&#x2019;s Work</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant&#x2019;s Work</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,&#x201d; &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant Delays</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Substantially Completed</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; shall have the meanings set forth for such terms in the Work Letter.  If Tenant does not elect to void this Lease within 5 business days of the lapse of such 195-day period, such right to void this Lease shall be waived </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">5</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and this Lease shall remain in full force and effect.  Notwithstanding anything to the contrary contained herein and for the avoidance of any doubt, the termination rights provided for in this paragraph shall terminate on the Commencement Date.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Commencement Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; shall be the earliest of:  (i) the date Landlord Delivers the Premises to Tenant; (ii) the date Landlord could have Delivered the Premises but for Tenant Delays; and (iii) the date Tenant conducts any business in the Premises or any part thereof. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Upon request of Landlord, Tenant shall execute and deliver a written acknowledgment of the Commencement Date, the Base Rent Commencement Date, and the expiration date of the Term when such are established in the form of the &#x201c;Acknowledgement of Commencement Date&#x201d; attached to this Lease as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit D</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, Tenant&#x2019;s failure to execute and deliver such acknowledgment shall not affect Landlord&#x2019;s rights hereunder.  The &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; of this Lease shall be the Base Term, as defined above on the first page of this Lease, and (if timely and properly exercised) the Extension Term that Tenant may elect pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 40</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Subject to the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> of the Work Letter, Landlord shall permit Tenant access to the Premises at such times set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> of the Work Letter prior to the Commencement Date for Tenant&#x2019;s installation and setup of furniture, fixtures and equipment (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">FF&amp;E Installation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), provided that such FF&amp;E Installation is coordinated with Landlord, and Tenant complies with this Lease and all other reasonable restrictions and conditions Landlord may impose.  All such access shall be during normal business hours.  Any access to the Premises by Tenant before the Commencement Date shall be subject to all of the terms and conditions of this Lease, excluding the obligation to pay Base Rent or Operating Expenses (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Except as set forth in the next paragraph, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 13</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof, or the Work Letter:  (i) Tenant shall accept the Premises in their condition as of the Commencement Date; (ii) Landlord shall have no obligation for any defects in the Premises; and (iii) Tenant&#x2019;s taking possession of the Premises shall be conclusive evidence that Tenant accepts the Premises and that the Premises were in good condition at the time possession was taken.  Any occupancy of the Premises by Tenant before the Commencement Date shall be subject to all of the terms and conditions of this Lease, including the obligation to pay Base Rent and Operating Expenses.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">For the period of twelve months after the Commencement Date, Landlord shall, at its sole cost and expense (which shall not constitute an Operating Expense), be responsible for any repairs that are required to be made to the Building or Building Systems (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 13</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">), unless Tenant or any Tenant Party was responsible for the cause of such repair, in which case Tenant shall pay the cost of such repair.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant agrees and acknowledges that neither Landlord nor any agent of Landlord has made any representation or warranty with respect to the condition of all or any portion of the Premises or the Project, and/or the suitability of the Premises or the Project for the conduct of Tenant&#x2019;s business, and Tenant waives any implied warranty that the Premises or the Project are suitable for the Permitted Use.  This Lease constitutes the complete agreement of Landlord and Tenant with respect to the subject matter hereof and supersedes any and all prior representations, inducements, promises, agreements, understandings and negotiations which are not contained herein.  Landlord in executing this Lease does so in reliance upon Tenant&#x2019;s representations, warranties, acknowledgments and agreements contained herein.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Base Rent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The first month&#x2019;s Base Rent (i.e., the Base Rent due for the first full month following the Base Rent Commencement Date) and the Security Deposit shall be due and payable on delivery of an executed copy of this Lease to Landlord.  Commencing on the Base Rent Commencement Date, Tenant shall pay to Landlord in advance, without demand, abatement, deduction or set-off, monthly installments of Base Rent on or before the first day of each calendar month during the Term hereof, in lawful money of the United States of America, at the office of Landlord for payment of Rent set forth above, or to such other person or at such other place as Landlord may from time to time designate in writing.  Payments of Base </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">6</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rent for any fractional calendar month shall be prorated.  The obligation of Tenant to pay Base Rent and other sums to Landlord and the obligations of Landlord under this Lease are independent obligations.  Tenant shall have no right at any time to abate, reduce, or set-off any Rent (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">) due hereunder except for any abatement as may be expressly provided in this Lease.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	In addition to the Tenant Improvement Allowance (as defined in the Work Letter), Landlord shall, if Tenant so requests in writing and subject to the terms of the Work Letter, make available to Tenant the Supplemental Tenant Improvement Allowance (as defined in the Work Letter). Commencing on the Commencement Date and continuing thereafter on the first day of each month during the Base Term, Tenant shall pay the amount necessary to fully amortize the portion of the Supplemental Tenant Improvement Allowance actually funded by Landlord, if any, as Additional Rent in equal monthly payments with interest at a rate of 8% per annum over the Base Term, which interest shall begin to accrue on the Commencement Date. Any of the Supplemental Tenant Improvement Allowance and applicable interest remaining unpaid as of the expiration or earlier termination of the Lease shall be paid to Landlord in a lump sum at the expiration or earlier termination of this Lease.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Additional Rent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  In addition to Base Rent, commencing on the Commencement Date, Tenant agrees to pay to Landlord as additional rent (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Additional Rent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;):  (i) Tenant&#x2019;s Share of Operating Expenses and (ii) any and all other amounts Tenant assumes or agrees to pay under the provisions of this Lease, including, without limitation, any and all other sums that may become due by reason of any default of Tenant or failure to comply with the agreements, terms, covenants and conditions of this Lease to be performed by Tenant, after any applicable notice and cure period.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Base Rent Adjustments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Base Rent shall be increased on each annual anniversary of the Base Rent Commencement Date during the Term of this Lease (each an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Adjustment Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) by multiplying the Base Rent payable immediately before such Adjustment Date by the Rent Adjustment Percentage and adding the resulting amount to such Base Rent payable immediately before such Adjustment Date.  Base Rent, as so adjusted, shall thereafter be due as provided herein.  Base Rent adjustments for any fractional calendar month shall be prorated.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Operating Expense Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall deliver to Tenant a written estimate of Operating Expenses for each calendar year during the Term (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Annual Estimate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), which may be revised by Landlord from time to time during such calendar year.  During each month of the Term, on the same date that Base Rent is due, Tenant shall pay Landlord an amount equal to 1/12th of Tenant&#x2019;s Share of Operating Expenses of the Annual Estimate.  Payments for any fractional calendar month shall be prorated.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Operating Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; means:  (A) all costs and expenses of any kind or description whatsoever incurred or accrued each calendar year by Landlord with respect to the use, ownership, operation, management, maintenance and repair of the Building, including, without duplication, Taxes (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">), capital repairs, improvements and replacements amortized over the lesser of 10 years and the useful life of such capital items, the costs of Landlord&#x2019;s third-party property manager (not to exceed 3% of the then-applicable Base Rent (which, during the period between the Commencement Date and the Base Rent Commencement Date will be calculated based on the Base Rent rate payable on the Base Rent Commencement Date, and thereafter will be calculated based on the actual Base Rent)), or if there is no third-party property manager (or Landlord elects not to pass through the cost of the third-party property manager), administrative rent in the amount of 3% of the then-applicable Base Rent (which, during the period between the Commencement Date and the Base Rent Commencement Date will be calculated based on the Base Rent rate payable on the Base Rent Commencement Date, and thereafter will be calculated based on the actual Base Rent)), and the cost of upgrades to the Building or enhanced services provided at the Building that are intended to encourage social distancing (also referred to as physical distancing), promote and protect health and physical well-being, and/or prevent or limit the spread or transmission of communicable diseases and/or viruses of any kind or nature, including, without limitation, COVID-19 (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Infectious Conditions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), and (B) the Building&#x2019;s Share of Project of all costs and expenses of any kind or description whatsoever incurred or accrued each calendar year by Landlord with</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">7</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">respect to the Project (other than those costs and expenses specific to the Building or any other building not containing Amenities), including, without duplication, costs and expenses related to the use, ownership, operation, management, maintenance, and repair of the Amenities and other Common Areas (including for the avoidance of doubt, payment or reimbursement by Landlord to affiliates of Landlord or third parties for market rent paid by such affiliates or third parties to Landlord for Amenity space and reduced rent or other concessions or subsidies provided to restaurants or others providing Amenities), Taxes, capital repairs, improvements and replacements amortized over the lesser of 10 years and the useful life of such capital items, and the cost of upgrades to the Project or enhanced services provided at the Project that are intended to encourage social distancing (also referred to as physical distancing), promote and protect health and physical well-being, and/or prevent or limit the spread or transmission of Infectious Conditions.  The only Amenities for which a separate use fee may be charged to Tenant in addition to inclusion of the costs and expenses thereof in Operating Expenses are related to the use of any conference facility or fitness center (if a conference facility or fitness center is created and available).  Landlord or its affiliates or third parties retained by Landlord may charge standard rates for usage of any conference facilities and services thereto.  No membership fee will be charged for any fitness facility (or for basic offerings normally included in a membership fee), but Landlord or its affiliates or third parties retained by Landlord may charge a separate fee for additional services, if available, such as personal trainers or wellness clinics.  Operating Expenses shall exclude only:</font></p>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">the original construction costs of the Project (including the construction of any Common Areas and Amenities) and renovation prior to the date of this Lease and costs of correcting defects in such original construction or renovation;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">capital expenditures for expansion of the Project or capital improvements that are not includable as set forth above;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">interest, principal payments of Mortgage (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 27</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">) debts of Landlord, financing costs and amortization of funds borrowed by Landlord, whether secured or unsecured and all payments of base rent (but not taxes or operating expenses (unless otherwise excluded under this Lease)) under any ground lease or other underlying lease of all or any portion of the Project;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(iv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">depreciation of the Project (except for capital improvements, the cost of which are  includable in Operating Expenses as provided above in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">);</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(v)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">advertising, legal and space planning expenses and leasing commissions and other costs and expenses incurred in procuring and leasing space to tenants for the Project, including any leasing office maintained in the Project, free rent and construction allowances for tenants;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(vi)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">legal and other expenses incurred in the negotiation or enforcement of leases;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(vii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">costs of completing, fixturing, improving, renovating, painting, redecorating or other work, which Landlord pays for or performs for other tenants within their premises, and costs of correcting defects in such work;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(viii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">costs to be reimbursed by other tenants of the Project or Taxes to be paid directly by Tenant or other tenants of the Project, whether or not actually paid;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(ix)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">salaries, wages, benefits and other compensation paid to officers and employees of Landlord who are not assigned in whole or in part to the operation, management, maintenance or repair of the Project;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">8</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(x)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">general organizational, administrative and overhead costs relating to maintaining Landlord&#x2019;s existence, either as a corporation, partnership, or other entity, including general corporate, legal and accounting expenses;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xi)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">costs (including attorneys&#x2019; fees and costs of settlement, judgments and payments in lieu thereof) incurred in connection with disputes with tenants, other occupants, or prospective tenants, and costs and expenses, including legal fees, incurred in connection with negotiations or disputes with employees, consultants, management agents, leasing agents, purchasers or mortgagees of the Building;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">costs incurred by Landlord due to the violation by Landlord, its employees, agents or contractors or any tenant of the terms and conditions of any lease of space in the Project or any Legal Requirement (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 7</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">);</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xiii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">penalties, fines or interest incurred as a result of Landlord&#x2019;s inability or failure  to make payment of Taxes and/or to file any tax or informational returns when due, or from Landlord&#x2019;s failure to make any payment of Taxes required to be made by Landlord hereunder before delinquency;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xiv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">overhead and profit increment paid to Landlord or to subsidiaries or affiliates of Landlord for goods and/or services in or to the Project to the extent the same exceeds the costs of such goods and/or services rendered by unaffiliated third parties on a competitive basis;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">costs of Landlord&#x2019;s charitable or political contributions, or of fine art maintained at the Project;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xvi)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">costs in connection with services (including electricity), items or other benefits of a type which are not standard for the Project and which are not available to Tenant without specific charges therefor, but which are provided to another tenant or occupant of the Project, whether or not such other tenant or occupant is specifically charged therefor by Landlord;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xvii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">costs incurred in the sale or refinancing of the Project; </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xviii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">net income taxes of Landlord or the owner of any interest in the Project, franchise, capital stock, gift, estate or inheritance taxes or any federal, state or local documentary taxes imposed against the Project or any portion thereof or interest therein;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xix)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">reserves for future expenditures;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xx)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">costs or expense occasioned by condemnation that are recovered by Landlord in any condemnation award;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xxi)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">costs reimbursed to Landlord under any warranty held by Landlord for the Building or the Project;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xxii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">costs arising from the gross negligence or willful misconduct of Landlord or its employees; and </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xxiii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">any cost incurred to remove, test, or remediate the presence of Hazardous Materials (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 30</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">) in, on or about the Building or the Project for which Tenant is not responsible under this Lease. </font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant&#x2019;s Share of Operating Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; shall be the percentage set forth on the first page of this Lease as Tenant&#x2019;s Share of Operating Expenses as reasonably adjusted by Landlord from time to time</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">9</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">following changes to or remeasurement of the Premises, the Building or other buildings within the Project occurring from time to time.  Any such remeasurement of a building within the Project shall be performed by Landlord in accordance with the Standard Method for Measuring Floor Area in Office Buildings as adopted by the Building Owners and Managers Association International (ANSI/BOMA Z65.1-2017), as customarily modified by Landlord for laboratory properties in the Cambridge/Watertown market, which includes, for the avoidance of doubt, a portion of the floor area for the Acid Neutralization System (as defined below) within the rentable square footage of the Premises (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">BOMA Modified</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  Landlord may equitably increase Tenant&#x2019;s Share of Operating Expenses for any item of expense or cost reimbursable by Tenant that relates to a repair, replacement, or service that benefits only the Premises or only a portion of the Project that includes the Premises or that varies with occupancy or use.  Base Rent, Tenant&#x2019;s Share of Operating Expenses, and all other amounts payable by Tenant to Landlord hereunder are collectively referred to herein as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.&#x201d;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Within 90 days after the end of each calendar year (or such longer period as may be reasonably required), Landlord shall furnish to Tenant a statement (an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Annual Statement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) showing in reasonable detail:  (a) the total of actual Operating Expenses and resulting Tenant&#x2019;s Share of Operating Expenses for the previous calendar year, and (b) the total of Tenant&#x2019;s payments in respect of Operating Expenses for such year.  If the actual Tenant&#x2019;s Share of Operating Expenses for such year exceeds Tenant&#x2019;s payments of Operating Expenses for such year, the excess shall be due and payable by Tenant to Landlord as Rent within 30 days after delivery of such Annual Statement to Tenant.  If, however, Tenant&#x2019;s payments of Operating Expenses for such year exceed the actual Tenant&#x2019;s Share of Operating Expenses for such year, Landlord shall pay the excess to Tenant within 30 days after delivery of such Annual Statement, except that after the expiration, or earlier termination of the Term or if Tenant is delinquent in its obligation to pay Rent, Landlord shall pay the excess to Tenant after deducting all other amounts due to Landlord.  Landlord&#x2019;s and Tenant&#x2019;s obligations to pay any overpayments or deficiencies due pursuant to this paragraph shall survive the expiration or earlier termination of this Lease.  The Annual Statement shall be final and binding upon Tenant unless Tenant, within 90 days after Tenant&#x2019;s receipt thereof, shall contest any item therein by giving written notice to Landlord, specifying each item contested and the reason therefor.  If, during such 90-day period, Tenant reasonably and in good faith questions or contests the accuracy of Landlord&#x2019;s statement of Tenant&#x2019;s Share of Operating Expenses, Landlord will provide Tenant with access to Landlord&#x2019;s books and records relating to the operation of the Project and such information as Landlord reasonably determines to be responsive to Tenant&#x2019;s questions about the accuracy of such statement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Expense Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  If after Tenant&#x2019;s review of such Expense Information, Landlord and Tenant cannot agree upon the amount of Tenant&#x2019;s Share of Operating Expenses, then Tenant shall have the right to have a nationally or regionally recognized independent public accounting firm, selected by Tenant, working pursuant to a fee arrangement other than a contingent fee (at Tenant&#x2019;s sole cost and expense) and approved by Landlord (which approval shall not be unreasonably withheld or delayed) (the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201c;Independent Accountant&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">), audit and/or review (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Independent Review</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) of the Expense Information for the year in question.  The results of any such Independent Review shall be binding on Landlord and Tenant.  If the Independent Review shows that the payments actually made by Tenant with respect to Operating Expenses for the calendar year in question exceeded Tenant&#x2019;s Share of Operating Expenses for such calendar year, Landlord shall at Landlord&#x2019;s option either (i) credit the excess amount to the next succeeding installments of estimated Operating Expenses or (ii) pay the excess to Tenant within 30 days after delivery of such statement, except that after the expiration or earlier termination of this Lease or if Tenant is delinquent in its obligation to pay Rent, Landlord shall pay the excess to Tenant after deducting all other amounts due to Landlord.  If the Independent Review shows that Tenant&#x2019;s payments with respect to Operating Expenses for such calendar year were less than Tenant&#x2019;s Share of Operating Expenses for the calendar year, Tenant shall pay the deficiency to Landlord within 30 days after delivery of such statement.  If the Independent Review shows that Tenant has overpaid with respect to Operating Expenses by more than 5%, then Landlord shall reimburse Tenant for all costs incurred by Tenant for the Independent Review.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Operating Expenses for the calendar years in which Tenant&#x2019;s obligation to share therein begins and ends shall be prorated.  Notwithstanding anything set forth herein to the contrary, if the Project is not at least 95% occupied on average during any year of the Term, any component of Operating Expenses that varies based upon occupancy for such year shall be computed as though the Project had been 95% occupied on average</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">during such year.  Following the date that is 24 months after Landlord&#x2019;s delivery of an Annual Statement to Tenant, Tenant shall not be responsible for the payment of items of Operating Expenses not reflected in such Annual Statement, except for Taxes and Utilities for which Tenant is responsible under this Lease.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">6.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Security Deposit</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall deposit with Landlord, upon delivery of an executed copy of this Lease to Landlord, a security deposit (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Security Deposit</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) for the performance of all of Tenant&#x2019;s obligations hereunder in the amount set forth on page 2 of this Lease, which Security Deposit shall be in the form of an unconditional and irrevocable letter of credit (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Letter of Credit</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;):  (i) in form and substance satisfactory to Landlord, (ii) naming Landlord as beneficiary, (iii) expressly allowing Landlord to draw upon it at any time from time to time by delivering to the issuer notice that Landlord is entitled to draw thereunder, (iv) issued by an FDIC-insured financial institution satisfactory to Landlord (Landlord acknowledging that Silicon Valley Bank is an approved issuer), and (v) redeemable by presentation of a sight draft in the Commonwealth of Massachusetts, by overnight delivery or by facsimile.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">If Tenant does not provide Landlord with a substitute or extended Letter of Credit complying with all of the requirements hereof at least 10 business days before the stated expiration date of any then current Letter of Credit, Landlord shall have the right to draw the full amount of the current Letter of Credit and hold the funds drawn in cash without obligation for interest thereon as the Security Deposit.  Any cash proceeds of the Letter of Credit following a draw by the Landlord (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Cash Proceeds</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) are property of the Landlord, and Tenant shall have no right in the Security Deposit or the Letter of Credit other than the right to a return of the Letter of Credit when both this Lease has terminated and Tenant&#x2019;s obligations under this Lease have been completely fulfilled as set forth herein.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	The Security Deposit and the Letter of Credit and Cash Proceeds shall be held by Landlord without obligation for interest thereon as security for the performance of all of Tenant&#x2019;s obligations under this Lease.  The Security Deposit and the Letter of Credit and the Cash Proceeds are not an advance rental deposit or a measure of Landlord&#x2019;s damages in case of Tenant&#x2019;s default.  Upon each occurrence of Default (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 20</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">), Landlord may use and apply all or part of the Security Deposit and the Letter of Credit and the Cash Proceeds, without notice to or any action by Tenant or any other person or entity, to pay delinquent payments due under this Lease, and the cost of any damage, injury, expense or liability caused by such Default, without prejudice to any other remedy provided herein or provided by law.  Upon such use or application, Tenant shall have no right whatsoever to any amount so used or applied.  Landlord's right to use and apply the Security Deposit and the Letter of Credit and the Cash Proceeds under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> includes the right to use and apply the Security Deposit and the Letter of Credit and the Cash Proceeds to pay future rent damages following the termination of this Lease pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 21(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below.  Upon any use or application of all or any portion of the Security Deposit and the Letter of Credit or the Cash Proceeds permitted under this Lease, Tenant shall, within 5 business days following Landlord&#x2019;s written demand, pay Landlord the amount, or provide Landlord a replacement Letter of Credit meeting the foregoing criteria, that will restore the Security Deposit to its original amount.  Upon bankruptcy or other debtor-creditor proceedings against Tenant, the Security Deposit and the Letter of Credit and the Cash Proceeds shall be deemed to be applied first to the obligations of Tenant arising for periods prior to the filing of such proceedings.  Tenant hereby waives the provisions of any law, now or hereafter in force, which provide that Landlord may claim from a security deposit only those sums reasonably necessary to remedy defaults in the payment of Rent, to repair damage caused by Tenant or to clean the Premises, it being agreed that Landlord may, in addition, claim those sums reasonably necessary to compensate Landlord for any other loss or damage, foreseeable or unforeseeable, caused by the act or omission of Tenant or any officer, employee, agent or invitee of Tenant.  The Security Deposit and the Letter of Credit and the Cash Proceeds, after deducting therefrom all amounts to which Landlord has used or applied in accordance with this Lease, or to which Landlord is entitled under the provisions of this Lease, shall be returned to Tenant (or, at Landlord&#x2019;s option, to the last assignee of Tenant&#x2019;s interest hereunder) within 90 days after the expiration or earlier termination of this Lease. For the avoidance of doubt, no portion of the Security Deposit and the Letter of Credit and the Cash Proceeds shall be returned to Tenant until both this Lease has terminated and Tenant&#x2019;s obligations under this Lease have been completely fulfilled as set forth herein.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">11</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">If Landlord transfers its interest in the Project or this Lease, Landlord shall either, at Landlord&#x2019;s election in its sole discretion and expense (other than any transfer or processing fees, which shall be paid by Tenant), (a) transfer any Security Deposit and the Letter of Credit and the Cash Proceeds then held by Landlord to a person or entity assuming Landlord&#x2019;s obligations under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> after deducting therefrom all amounts to which Landlord has used or applied in accordance with this Lease, or to which Landlord is entitled under the provisions of this Lease, or (b) return to Tenant any Security Deposit and the Letter of Credit and the Cash Proceeds  then held by Landlord and remaining after the deductions permitted herein.  Upon such transfer to such transferee or the return of the Security Deposit and the Letter of Credit and the Cash Proceeds to Tenant, Landlord shall have no further obligation with respect to the Security Deposit and the Letter of Credit and the Cash Proceeds, and, in the event of a transfer, Tenant&#x2019;s right to the return of the Security Deposit and the Letter of Credit and the Cash Proceeds shall apply solely against Landlord&#x2019;s transferee.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">On the 3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">rd</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> anniversary of the Base Rent Commencement Date (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Reduction Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), provided (i) this Lease shall be in full force and effect, (ii) Tenant is not in Default or monetary default under this Lease and (iii) no more than two Defaults have occurred since the date of this Lease, the Security Deposit shall be reduced to an amount equal to $3,018,720 (the &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Reduced Security Deposit</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;).  Subject to the foregoing conditions, on the Reduction Date, if Tenant provides Landlord with a replacement Letter of Credit in the amount of the Reduced Security Deposit and otherwise in accordance with the requirements of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, then Landlord shall return the original Letter of Credit then held by Landlord to Tenant promptly after Landlord&#x2019;s receipt of the original replacement Letter of Credit (or reasonably cooperate to amend the existing Letter of Credit pursuant to the foregoing provisions).  If Landlord returns to Tenant any portion of the Security Deposit in accordance with this Section, then from and after the date such monies are returned to Tenant, the &#34;Security Deposit&#34; shall be deemed to be the Reduced Security Deposit for all purposes of this Lease. In no event shall any such return be construed or deemed as an admission by Landlord that Tenant has performed all of its covenants and obligations hereunder.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">7.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Use</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The Premises shall be used solely for the Permitted Use set forth in the basic lease provisions on page 2 of this Lease, and in compliance with all laws, orders, judgments, ordinances, regulations, codes, directives, permits, licenses, covenants, requirements and restrictions now or hereafter applicable to the Premises, and to the use and occupancy thereof (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Legal Requirements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; and each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Legal Requirement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), including, without limitation, (i) the Americans With Disabilities Act, 42 U.S.C. &#167; 12101, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">et seq.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> (together with the regulations promulgated pursuant thereto, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ADA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), and (ii) all restrictions, requirements and provisions set forth in the record documents identified in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 44</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> and/or imposed by Governmental Authorities (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">) having jurisdiction, including, without limitation, those related to the historical significance of, and historical activity on, the Project.  Tenant shall, upon 5 days&#x2019; written notice from Landlord, discontinue any use of the Premises which is declared by any Governmental Authority having jurisdiction to be a violation of a Legal Requirement.  Tenant will not use or permit the Premises to be used for any purpose or in any manner that would void Tenant&#x2019;s or Landlord&#x2019;s insurance, increase the insurance risk, or cause the disallowance of any sprinkler or other credits.  Tenant shall not permit any part of the Premises to be used as a &#x201c;place of public accommodation&#x201d;, as defined in the ADA or any similar legal requirement.  Tenant shall reimburse Landlord within 10 days following written demand for any additional premium charged for any such insurance policy by reason of Tenant&#x2019;s failure to comply with the provisions of this Section or otherwise caused by Tenant&#x2019;s use and/or occupancy of the Premises.  Tenant will use the Premises in a careful, safe and proper manner and will not commit or permit waste, overload the floor or structure of the Premises, subject the Premises to use that would damage the Premises or obstruct or interfere with the rights of Landlord or other tenants or occupants of the Project, including conducting or giving notice of any auction, liquidation, or going out of business sale on the Premises, or using or allowing the Premises to be used for any unlawful purpose.  Tenant shall cause any equipment or machinery to be installed in the Premises so as to reasonably prevent sounds or vibrations from the Premises from extending into Common Areas or other space in the Project.  Tenant shall not place any machinery or equipment weighing 500 pounds or more in or upon the Premises or transport or move such items through the Common Areas of the Project or in the Project elevators without the prior written consent of Landlord, and then in accordance with Landlord&#x2019;s reasonable rules and regulations therefor.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">12</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Except as may be provided under the Work Letter, Tenant shall not, without the prior written consent of Landlord, use the Premises in any manner which will require ventilation, air exchange, heating, gas, steam, electricity or water beyond the existing capacity of the Project as proportionately allocated to the Premises based upon Tenant&#x2019;s Share of Operating Expenses as usually furnished for the Permitted Use.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord shall, as an Operating Expense (except the same shall be at Tenant&#x2019;s expense to the extent such Legal Requirement is applicable by reason of Tenant&#x2019;s particular use of the Premises (as opposed to office and lab use generally)), make any alterations or modifications to the Common Areas or the exterior of the Building that are required by Legal Requirements, including the ADA, to the extent such Legal Requirements are enacted subsequent to the date of this Lease (provided Landlord shall not be in default for failing to do so if such non-compliance does not have a material adverse effect on Tenant).   Tenant, at Tenant&#x2019;s sole cost and expense, shall make any alterations or modifications to the Premises (in a manner approved by Landlord) that are required by Legal Requirements (including, without limitation, compliance of the Premises with the ADA). Notwithstanding any other provision herein to the contrary, Tenant shall be responsible for any and all Claims arising out of or in connection with Legal Requirements to the extent arising from or related to Tenant&#x2019;s use or occupancy of the Premises  or Tenant&#x2019;s Alterations, and Tenant shall indemnify, defend, hold and save Landlord and the Landlord Indemnified Parties (as defined below) harmless from and against any and all claims arising out of or in connection with the failure of the Premises to comply with any Legal Requirements to the extent arising out of Tenant&#x2019;s use or occupancy of the Premises, the Tenant Improvements, or the Tenant&#x2019;s Alterations.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant acknowledges that Landlord may, but shall not be obligated to, seek to obtain Leadership in Energy and Environmental Design (LEED), WELL Building Standard, or other similar &#x201c;green&#x201d; certification (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Green Standards</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) with respect to the Project and/or the Premises, and Tenant agrees to reasonably cooperate with Landlord, and to provide such information and/or documentation as Landlord may reasonably request, in connection therewith (provided such cooperation does not materially increase Tenant&#x2019;s obligations or responsibilities or Tenant&#x2019;s rights pursuant to this Lease).  Tenant agreeing however that such cooperation may include, Tenant complying with certain standards (i.e. to satisfy or meet the Green Standards) pertaining to the purchase of materials used in connection with any approved Alterations undertaken by Tenant in the Premises, the sharing of documentation pertaining to any such Alterations undertaken by Tenant in the Premises with Landlord, the sharing of information regarding utility consumption, the sharing of Tenant&#x2019;s billing information pertaining to trash removal and recycling related to Tenant&#x2019;s operations at the Project.  Tenant shall have no responsibility for costs or expenses incurred by Landlord to initially obtain Green Standards, but Tenant hereby acknowledges that Landlord&#x2019;s costs or expenses incurred to maintain any obtained Green Standards shall be included as part of Operating Expenses.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">8.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Holding Over</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If, with Landlord&#x2019;s express written consent, Tenant retains possession of the Premises after the termination of the Term, (i) unless otherwise agreed in such written consent, such possession shall be subject to immediate termination by Landlord at any time, (ii) all of the other terms and provisions of this Lease (including, without limitation, the adjustment of Base Rent pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof) shall remain in full force and effect (excluding any expansion or renewal option or other similar right or option) during such holdover period, (iii) Tenant shall continue to pay Base Rent in the amount payable upon the date of the expiration or earlier termination of this Lease or such other amount as Landlord may indicate, in Landlord&#x2019;s sole and absolute discretion, but not more than 150% of the Base Rent due for the last month of the Term, in such written consent, and (iv) all other payments shall continue under the terms of this Lease.  If Tenant remains in possession of the Premises after the expiration or earlier termination of the Term without the express written consent of Landlord, (A) Tenant shall become a tenant at sufferance upon the terms of this Lease, including the obligation to pay 100% of all Additional Rent due under this Lease, except that the monthly Base Rent shall be equal to 150% of the Base Rent in effect during the last 30 days of the Term, and (B) Tenant shall be responsible for all damages suffered by Landlord resulting from or occasioned by Tenant&#x2019;s holding over, including consequential damages; provided that, unless Landlord gave written notice to Tenant at least 30 days before the expiration of the Term that a subsequent tenant would be leasing the Premises or any part thereof and that Landlord reasonably anticipates holding </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">over, even for less than 30 days, is reasonably likely to impact Landlord&#x2019;s delivery schedule to such new tenant, Tenant shall be responsible for consequential damages only once Tenant&#x2019;s holding over exceeds 30 days.  No holding over by Tenant, whether with or without consent of Landlord, shall operate to extend this Lease except as otherwise expressly provided, and this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> shall not be construed as consent for Tenant to retain possession of the Premises.  Acceptance by Landlord of Rent after the expiration of the Term or earlier termination of this Lease shall not result in a renewal or reinstatement of this Lease.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">9.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Taxes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Except as set forth below in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 9</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, Landlord shall pay, as part of Operating Expenses, all taxes, levies, fees, assessments and governmental charges of any kind, existing as of the Commencement Date or thereafter enacted (collectively referred to as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Taxes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), imposed by any federal, state, regional, municipal, local or other governmental authority or agency, including, without limitation, quasi-public agencies (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Governmental Authority</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) during the Term, including, without limitation, all Taxes:  (i) imposed on or measured by or based, in whole or in part, on rent payable to (or gross receipts received by) Landlord under this Lease and/or from the rental by Landlord of the Project or any portion thereof, or (ii) based on the square footage, assessed value or other measure or evaluation of any kind of the Premises or the Project, or (iii) assessed or imposed by or on the operation or maintenance of any portion of the Premises or the Project, including parking, or (iv) assessed or imposed by, or at the direction of, or resulting from Legal Requirements, or interpretations thereof, promulgated by any Governmental Authority, or (v) imposed as a license or other fee, charge, tax, or assessment on Landlord&#x2019;s business or occupation of leasing space in the Project.  Landlord may contest by appropriate legal proceedings the amount, validity, or application of any Taxes or liens securing Taxes.  Taxes shall not include any net income taxes imposed on Landlord except to the extent such net income taxes are in substitution for any Taxes payable hereunder, or any estate, inheritance, succession, gift, franchise, transfer, documentary, mortgage recording, or capital stock taxes; except to the extent the same, however denominated are imposed in substitution for or addition to any Taxes payable hereunder as a result of any change in the manner of taxation of the ownership, operation, or leasing of real estate, in which case the same shall be deemed to be included within the definition of the term &#x201c;Taxes.&#x201d;  If any such Tax is levied or assessed directly against Tenant, then Tenant shall be responsible for and shall pay the same at such times and in such manner as the taxing authority shall require.  Tenant shall pay, prior to delinquency, any and all Taxes levied or assessed against any personal property or trade fixtures placed by Tenant in the Premises, whether levied or assessed against Landlord or Tenant.  If any Taxes on Tenant&#x2019;s personal property or trade fixtures are levied against Landlord or Landlord&#x2019;s property, or if the assessed valuation of the Project is increased by a value attributable to improvements in or alterations to the Premises, whether owned by Landlord or Tenant and whether or not affixed to the real property so as to become a part thereof, higher than the base valuation on which Landlord from time-to-time allocates Taxes to all tenants in the Project, Landlord shall have the right, but not the obligation, to pay such Taxes.  Landlord&#x2019;s determination of any excess assessed valuation shall be binding and conclusive, absent manifest error.  The amount of any such payment by Landlord shall constitute Additional Rent due from Tenant to Landlord within 30 days following written demand from Landlord.  As of the date of this Lease, the Building is not a standalone tax parcel. Landlord shall allocate any Taxes applicable to a taxable lot among all buildings, including the Building, located on the assessors&#x2019; lot on which the Building is located in a fair and equitable manner, as determined by Landlord.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">10.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Parking</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Subject to all applicable Legal Requirements, Force Majeure, a Taking (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 19</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below) and the exercise by Landlord of its rights hereunder (including, without limitation Landlord&#x2019;s rights set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 45(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">), Tenant shall have the right to park, at a rate of 2.0 cars per 1,000 rentable square feet of the Premises, in those areas of the Project designated by Landlord for non-reserved parking, subject to Landlord&#x2019;s rules and regulations but in any event free of charge to Tenant other than the inclusion of costs and expenses as Operating Expenses.  Such parking shall be on a first-come-first-served, non-exclusive basis.  Landlord shall not be responsible for enforcing Tenant&#x2019;s parking rights against any third parties, including other tenants of the Project.  Landlord reserves the right, but not the obligation, to dictate specific locations of the Project that Tenant is permitted to use for its parking rights under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If, at any time during the Term, the Project is subject to a transportation demand management plan (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TDMP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) setting forth requirements related to the Project, Tenant (at its sole </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">14</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">cost and expense) shall comply with such TDMP.  As of the date hereof, the Project is subject to that certain Transportation Demand Management Program dated June 2021 (as amended from time to time, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Existing TDMP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  Tenant shall, at Tenant&#x2019;s sole cost and expense, for as long as the Existing TDMP remains applicable to the Project, comply with the Existing TDMP as applicable to the Project, including without limitation,: (i) offer a subsidized transportation benefit to all employees in accordance with the terms of the Existing TDMP; (ii) offer a subsidy to a bike share service to all employees in accordance with the terms of the Existing TDMP; (iii) implement a Commuter Choice Program and the MBTA&#x2019;s &#x201c;Perq for Work&#x201d; program (formerly known as the Corporate Pass Plan); (iv) discourage single-occupant vehicle (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SOV</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) use by its employees; (v) promote alternative modes of transportation and use of alternative work hours; (vi) at Landlord&#x2019;s request, meet with Landlord and/or its representatives to discuss transportation programs and initiatives; (vii) participate in annual surveys, monitoring transportation programs and initiatives at the Project; (viii) cooperate with Landlord in connection with transportation programs and initiatives promulgated pursuant to the Existing TDMP; (ix) provide alternative work programs (such as telecommuting, flex-time and compressed work weeks) to its employees in order to reduce traffic impacts in Watertown during peak commuter hours; (x) offer an emergency ride home (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ERH</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) through the Transportation Demand Management Coordinator and Watertown Transportation Management Association (as defined in the Existing TDMP), or have its own ERH program, for all employees who commute by non-SOV mode at least 3 days a week; and (xi) otherwise cooperate with Landlord in encouraging employees to seek alternate modes of transportation.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">11.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Utilities, Services</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Utilities, Janitorial Services</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall provide, subject to the terms of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 11</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, (i) facilities for tepid water, electricity, heat, light, power, sewer, and other utilities (including natural gas and fire sprinklers to the extent the Project is plumbed for such services) (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Utilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), and (ii) refuse and trash collection and janitorial services for the Common Areas and, at Landlord&#x2019;s election, the Premises (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Janitorial Services</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  The Utilities will be installed as set forth in the Work Letter.  Landlord shall pay (except as otherwise expressly set forth herein), subject to Tenant&#x2019;s reimbursement obligation or inclusion of such costs as Operating Expenses, for all Utilities used on the Premises, all maintenance charges for Utilities, and any storm sewer charges or other similar charges for Utilities imposed by any Governmental Authority or Utility provider, and any taxes, penalties, surcharges or similar charges thereon, as well as the cost for Janitorial Services.  If any Utilities are not separately metered or check-metered as part of the Tenant Improvements, Landlord may cause such Utilities to be separately metered or check-metered at Landlord&#x2019;s expense.  Landlord may cause any Utilities separately metered or check-metered to be charged directly to Tenant by the provider.  Tenant shall pay directly to the Utility provider, prior to delinquency, any separately metered Utilities and services which may be furnished to Tenant or the Premises during the Term.  Landlord may cause, at Tenant&#x2019;s expense, the Janitorial Services to be separately charged or charged directly to Tenant by the provider, in which case, Tenant shall pay directly to the Janitorial Services provider, prior to delinquency, any separately charged Janitorial Services.  Tenant shall pay, as part of Operating Expenses, its share of all charges for jointly metered or check-metered Utilities based upon consumption and all charges for Janitorial Services that are not separately charged, as reasonably determined by Landlord.  No interruption or failure of Utilities or Janitorial Services, from any cause whatsoever other than Landlord&#x2019;s willful misconduct, shall result in eviction or constructive eviction of Tenant, termination of this Lease or the abatement of Rent.  Tenant agrees to limit use of water and sewer with respect to Common Areas to normal restroom use.  To the extent such services are not provided by Landlord, Tenant shall be responsible for obtaining and paying for its own janitorial services for the Premises.  Utilities shall be available to the Premises 24 hours per day, 7 days per week, except in the case of emergencies, as the result of Legal Requirements, the failure of any Utility provider to provide such Utilities, the performance by Landlord or any Utility provider of any installation, maintenance or repairs, or any other temporary interruptions.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Service Interruptions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Notwithstanding anything to the contrary set forth herein, if (i) a stoppage of an Essential Service (as defined below) to the Premises shall occur and such stoppage is due solely to the gross negligence or willful misconduct of Landlord and not due in any part to any act or </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">15</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">omission on the part of Tenant or any Tenant Party or any matter beyond Landlord&#x2019;s reasonable control (any such stoppage of an Essential Service being hereinafter referred to as a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Service Interruption</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), and (ii) such Service Interruption continues for more than 5 consecutive business days after Landlord shall have received written notice thereof from Tenant, and (iii) as a result of such Service Interruption, the conduct of Tenant&#x2019;s normal operations in the Premises are materially and adversely affected, then there shall be an abatement of one day&#x2019;s Base Rent for each day during which such Service Interruption continues after such 5 business day period; provided, however, that if any part of the Premises is reasonably useable for Tenant&#x2019;s normal business operations or if Tenant conducts all or any part of its operations in any portion of the Premises notwithstanding such Service Interruption, then the amount of each daily abatement of Base Rent shall only be proportionate to the nature and extent of the interruption of Tenant&#x2019;s normal operations or ability to use the Premises.  The rights granted to Tenant under this paragraph shall be Tenant&#x2019;s sole and exclusive remedy resulting from a failure of Landlord to provide services, and Landlord shall not otherwise be liable for any loss or damage suffered or sustained by Tenant resulting from any failure or cessation of services.  For purposes hereof, the term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Essential Services</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; shall mean the following services:  HVAC service, water, sewer (but excluding the Acid Neutralization System), electricity, and access to the Premises, but in each case only to the extent that Landlord has an obligation to provide same to Tenant under this Lease.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">    </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Emergency Generators</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord&#x2019;s sole obligation for either providing emergency generators or providing emergency back-up power to Tenant shall be: (i) to provide an emergency generator designed to provide approximately 4 watts per RSF of the Premises based on customary diversity measures (Tenant acknowledging that such generator(s) may serve both Tenant and other tenants, and one or more other generators may be designated for the exclusive use of others from time to time during the Term), and (ii) to contract with a third party to maintain the emergency generators as per the manufacturer&#x2019;s standard maintenance guidelines.  Except as otherwise provided in the immediately preceding sentence, Landlord shall have no obligation to provide Tenant with operational emergency generators or back-up power or to supervise, oversee or confirm that the third party maintaining the emergency generators is maintaining the generators as per the manufacturer&#x2019;s standard guidelines or otherwise.  During any period of replacement, repair or maintenance of the emergency generators when the emergency generators are not operational, including any delays thereto due to the inability to obtain parts or replacement equipment, Landlord shall have no obligation to provide Tenant with an alternative back-up generator or generators or alternative sources of back-up power.  Tenant acknowledges and agrees that (x) in connection with the proper verification of loads and maintenance of the emergency generators, that power will need to be transferred during routine testing, and (y) Tenant is responsible for cooperating with Landlord or Landlord&#x2019;s third party contractor with respect to scheduling such routine tests and checking its own equipment loads as it operates during load transfer periods, provided Tenant&#x2019;s obligation to cooperate pursuant to this subsection (y) is conditioned upon Landlord delivering reasonable advance notice to Tenant of such routine tests and checks (except in the case of emergencies in which case no such notice shall be required and such tests and other activities may be at any time; provided that notice is made as soon as practicable given the circumstances).</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant expressly acknowledges and agrees that Landlord does not guaranty that such emergency generators will be operational at all times or that emergency power will be available to the Premises when needed.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Usage Data</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant agrees to provide Landlord with access to Tenant&#x2019;s water and/or energy usage data on a monthly basis, either by providing Tenant&#x2019;s applicable utility login credentials to Landlord&#x2019;s designated online portal, or by another delivery method reasonably agreed to by Landlord and Tenant. The reasonable third-party, out-of-pocket costs and expenses incurred by Landlord in connection with receiving and analyzing such water and/or energy usage data (including, without limitation, as may be required pursuant to applicable Legal Requirements) shall be included as part of Operating Expenses.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Acid Neutralization System</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall provide Tenant with access to an acid neutralization system (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Acid Neutralization System</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) pursuant to the terms and conditions of this Lease.  Tenant acknowledges and agrees that the Acid Neutralization System may be shared with other tenants of the Building, if any, and/or the Project, as applicable.  Tenant shall pay its share of ongoing operation costs </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">16</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">of the Acid Neutralization System as an Operating Expense, as allocated by Landlord among Tenant and other user tenants, if any, on a pro rata basis, with Tenant&#x2019;s share based on the ratio of the rentable square footage of the Premises to the sum of the rentable square footages of the Premises and the premises of all other user tenants, if any.  Landlord&#x2019;s sole obligations for providing the Acid Neutralization System, or any acid neutralization system facilities, to Tenant shall be (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Acid Neutralization Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) to (i) use reasonable efforts to obtain and maintain the permit required from the Massachusetts Water Resources Authority for discharge through the Acid Neutralization System (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Discharge Permit</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), provided that Tenant cooperates with Landlord and provides all information and documents necessary in connection with the Discharge Permit; and (ii) contract with a third party to maintain the Acid Neutralization System as operating as per the manufacturer&#x2019;s standard maintenance guidelines.  Notwithstanding anything herein to the contrary, if the Acid Neutralization System must be replaced and the cost thereof is not included in such third party maintenance contract, then, Landlord shall replace the Acid Neutralization System, it being acknowledged, however, that Tenant shall be responsible for its share of all costs incurred in connection therewith as an Operating Expense.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall be solely responsible for the use of the Acid Neutralization System by Tenant and all Tenant Parties or any party other than Landlord or Landlord&#x2019;s contractors, and Tenant shall be jointly and severally responsible for the use of the Acid Neutralization System with the other user tenants, if any.  Tenant shall use, and cause other parties under its control or for which it is responsible to use, the Acid Neutralization System in accordance with this Lease and in accordance with all applicable Legal Requirements, the Discharge Permit and any permits and approvals from Governmental Authorities for or applicable to Tenant&#x2019;s use of the Acid Neutralization System.  Tenant shall not take any action or make any omission that would result in a violation of the Discharge Permit or any other permit or Legal Requirements applicable to the Acid Neutralization System.  The scope of the Decommissioning and HazMat Closure Plan (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 28</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> of this Lease) shall include all actions for the proper cleaning, decommissioning and cessation of Tenant&#x2019;s use of the Acid Neutralization System, and all requirements under this Lease for the surrender of the Premises shall also apply to Tenant&#x2019;s cessation of use of the Acid Neutralization System, in each case whether at Lease expiration, termination or prior thereto (but Tenant shall not be required to complete the decommissioning of the Acid Neutralization System if other tenants or occupants will continue to use the same after the expiration or earlier termination of this Lease, nor shall Tenant be responsible for or bear any costs of decommissioning arising from the use of the Acid Neutralization System by any party, if any, other than Tenant and the Tenant Parties; it being agreed that if multiple tenants use the Acid Neutralization System, then Landlord shall be responsible for completing the decommissioning thereof, and Tenant shall pay to Landlord within thirty (30) days after invoice therefor Tenant&#x2019;s share of the reasonable, actual costs of decommissioning based on the ratio of the rentable square footage of the Premises to the rentable square footage of the Premises and the premises of all other user tenants, if any).  The obligations of Tenant under this Lease with respect to the Acid Neutralization System shall be joint and several with such other tenants as aforesaid, except in the event that Tenant can prove to Landlord&#x2019;s reasonable satisfaction that neither Tenant nor any Tenant Party caused, contributed to or exacerbated the matter for which Tenant would otherwise be responsible but for this exception.  Without in any way limiting the Acid Neutralization Obligations, Landlord shall have no obligation to provide Tenant with operational emergency or back-up acid neutralization facilities or to supervise, oversee or confirm that the third party maintaining the Acid Neutralization System is maintaining such system as per the manufacturer&#x2019;s standard guidelines or otherwise.  During any period of replacement, repair or maintenance of the Acid Neutralization System when such system is not operational, including any delays thereto due to the inability to obtain parts or replacement equipment, Landlord shall have no obligation to provide Tenant with an alternative back-up system or facilities.  Tenant expressly acknowledges and agrees that Landlord does not guaranty that such Acid Neutralization System will be operational at all times or that such system will be available to the Premises when needed.  Without in any way limiting the Acid Neutralization Obligations, in no event shall Landlord be liable to Tenant or any other party for any damages of any type, whether actual or consequential, suffered by Tenant or any such other person in the event that the Acid Neutralization System or back-up system, if any, or any replacement thereof fails or does not operate in a manner that meets Tenant&#x2019;s requirements.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">17</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">12.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Alterations and Tenant&#x2019;s Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Any alterations, additions, or improvements made to the Premises by or on behalf of Tenant, including additional locks or bolts of any kind or nature upon any doors or windows in the Premises, but excluding installation, removal or realignment of furniture systems (other than removal of furniture systems owned or paid for by Landlord) not involving any modifications to the structure or connections (other than by ordinary plugs or jacks) to Building Systems (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 13</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">) (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Alterations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) and excluding Notice-Only Alterations (as defined below )shall be subject to Landlord&#x2019;s prior written consent, which may be given or withheld in Landlord&#x2019;s sole discretion if any such Alteration could reasonably be expected to affect Structural Items or Building Systems but shall not otherwise be unreasonably withheld, conditioned or delayed. Notwithstanding the foregoing, Landlord shall have the right to disapprove in its sole discretion any proposed Alterations which could reasonably be expect to: (a) affect structure, Common Areas or the exterior of the Building or exterior of the Project; (b) affect Building Systems (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 13</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">); (c) affect other tenant space in the Building, if any; (d) not be in conformance with any special permits or other Project entitlements; or (e) reduce or enlarge the square footage of the Building.  If Landlord approves any Alterations, Landlord may impose such conditions on Tenant in connection with the commencement, performance and completion of such Alterations as Landlord may deem appropriate in Landlord&#x2019;s sole and absolute discretion.  Any request for approval shall be in writing, delivered not less than 15 business days in advance of any proposed work, and accompanied by plans, specifications, bid proposals, work contracts and such other information concerning the nature and cost of the alterations as may be reasonably requested by Landlord, including the identities and mailing addresses of all contractors, subcontractors, or others performing work or supplying materials.  Landlord&#x2019;s right to review plans and specifications and to monitor construction shall be solely for its own benefit, and Landlord shall have no duty to ensure that such plans and specifications or construction comply with applicable Legal Requirements.  Tenant shall cause, at its sole cost and expense, all Alterations to comply with insurance requirements and with applicable Legal Requirements and shall implement at its sole cost and expense any alteration or modification required by applicable Legal Requirements as a result of any Alterations.  Tenant shall pay to Landlord, as Additional Rent, within 30 days following written demand, an amount equal to (a) 5% of all charges incurred by Tenant or its contractors or agents in connection with any Alteration to cover Landlord&#x2019;s overhead and expenses for plan review, coordination, scheduling and supervision, and (b) the reasonable out-of-pocket costs incurred by Landlord with respect to each Alteration.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Before Tenant begins any Alteration, Landlord may post on and about the Premises notices of non-responsibility pursuant to applicable law.  Tenant shall reimburse Landlord for, and indemnify and hold Landlord harmless from, any expense incurred by Landlord by reason of faulty work done by Tenant or its contractors, delays caused by such work, or inadequate cleanup.  &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Notice Only Alterations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; means non-structural Alterations in Premises (which could not reasonably be excepted to affect Structural Items or Building Systems) that do not exceed $250,000 in the aggregate over any 12-month period; provided Tenant notifies Landlord in writing of such intended Notice-Only Alteration, and such notice shall be accompanied by plans, specifications, work contracts and such other information concerning the nature and cost of the Notice-Only Alteration as may be reasonably requested by Landlord, which notice and accompanying materials shall be delivered to Landlord not less than 15 days in advance of any proposed work.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall make arrangements satisfactory to Landlord (which may include furnishing security if the cost of the Alterations will exceed $200,000 for any one project or series of related projects) to assure payment for the completion of all Alterations work free and clear of liens, and shall provide (and cause each contractor or subcontractor to provide) certificates of insurance for workers&#x2019; compensation and other coverage, including commercial general liability insurance, in amounts and from an insurance company satisfactory to Landlord to protect Landlord against liability for personal injury or property damage during construction and shall include Landlord as an additional insured thereunder.  Upon completion of any Alterations, Tenant shall deliver or cause to be delivered to Landlord:  (i) sworn statements setting forth the names of all contractors and subcontractors who did the work and final lien waivers from all such contractors and subcontractors; and (ii) &#x201c;as built&#x201d; plans for any such Alteration.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Except for Removable Installations (as hereinafter defined), all Installations (as hereinafter defined) shall be and shall remain the property of Landlord during the Term and following the expiration or earlier</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">18</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">termination of the Term, shall not be removed by Tenant at any time during the Term, and shall remain upon and be surrendered with the Premises as a part thereof.  Notwithstanding the foregoing, Landlord may, at the time of its approval of any such Installation is requested, notify Tenant that Landlord requires that Tenant remove such Installation upon the expiration or earlier termination of the Term, in which event Tenant shall remove such Installation in accordance with the immediately succeeding sentence.  Upon the expiration or earlier termination of the Term, Tenant shall remove (i) all wires, cables or similar equipment which Tenant has installed in the Premises or in the risers or plenums of the Building, (ii) any Installations for which Landlord has given Tenant notice of removal in accordance with the immediately preceding sentence, and (iii) all of Tenant&#x2019;s Property (as hereinafter defined), and Tenant shall restore and repair any damage caused by or occasioned as a result of such removal, including, without limitation, capping off all such connections behind the walls of the Premises and repairing any holes.  During any restoration period beyond the expiration or earlier termination of the Term, Tenant shall pay Rent to Landlord as provided herein as if said space were otherwise occupied by Tenant.  If Landlord is requested by Tenant or any lender, lessor or other person or entity claiming an interest in any of Tenant's Property to waive any lien Landlord may have against any of Tenant's Property, and Landlord consents to such waiver, then Landlord shall be entitled to be paid as administrative rent a fee of $1,000 per occurrence for its time and effort in preparing and negotiating such a waiver of lien.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	For purposes of this Lease, (x) &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Removable Installations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; means any items listed on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit F</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> attached hereto and any items agreed by Landlord in writing to be included on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit F</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> in the future, (y) &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant&#x2019;s Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; means Removable Installations and, other than Installations, any personal property or equipment of Tenant that may be removed without material damage to the Premises, and (z) &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Installations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; means all property of any kind paid for with the TI Fund (as defined in the Work Letter), all Alterations, all fixtures, and all partitions, hardware, built-in machinery, built-in casework and cabinets and other similar additions, equipment, property and improvements built into the Premises so as to become an integral part of the Premises, including, without limitation, fume hoods which penetrate the roof or plenum area, built-in cold rooms, built-in warm rooms, walk-in cold rooms, walk-in warm rooms, deionized water systems, glass washing equipment, autoclaves, chillers, built-in plumbing, electrical and mechanical equipment and systems, and any power generator and transfer switch.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">13.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord&#x2019;s Repairs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall, at Landlord's sole expense (and not as an Operating Expense), be responsible for capital repairs and replacements of the roof (not including the roof membrane), exterior walls and foundation of the Building (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Structural Items</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), unless the need for such repairs or replacements is caused by Tenant or any Tenant Parties, in which case Tenant shall bear the full cost to repair or replace such Structural Items.  Landlord shall (with all related costs included as an Operating Expense) be responsible for the routine maintenance and repair of such Structural Items.  Landlord shall (with all related costs included as an Operating Expense) maintain, repair and replace the roof membrane and all of the exterior, parking and other Common Areas of the Project, including HVAC, plumbing, fire sprinklers and all other building systems serving the Premises and other portions of the Project (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Building Systems</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) but excluding those exclusively serving the Premises, reasonable wear and tear and uninsured losses and damages caused by Tenant, or by any of Tenant, or by any of Tenant&#x2019;s assignees, sublessees, licensees, agents, servants, employees, invitees, vendors and contractors (or any of Tenant&#x2019;s assignees, sublessees and/or licensees respective agents, servants, employees, invitees, vendors, and contractors) (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) excluded.  Losses and damages caused by Tenant or any Tenant Party shall be repaired by Landlord, to the extent not covered by insurance, at Tenant&#x2019;s sole cost and expense.  Landlord reserves the right to stop Building Systems services when necessary (i) by reason of accident or emergency, or (ii) for planned repairs, alterations or improvements, which are, in the judgment of Landlord, desirable or necessary to be made, until said repairs, alterations or improvements shall have been completed.  Landlord shall have no responsibility or liability for failure to supply Building Systems services during any such period of interruption; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, that Landlord shall, except in case of emergency, make a commercially reasonable effort to give Tenant 48 hours advance notice of any planned stoppage of Building Systems services for routine maintenance, repairs, alterations or improvements.  Landlord shall use commercially reasonable efforts (at no cost to Landlord) to minimize interruption with Tenant&#x2019;s operations in the Premises or access thereto in connection with any planned and scheduled stoppage of </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">19</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Building Systems pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 13</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall promptly give Landlord written notice of any repair required by Landlord pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">13</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, after which Landlord shall make a commercially reasonable effort to effect such repair.  Landlord shall not be liable for any failure to make any repairs or to perform any maintenance unless such failure shall persist for an unreasonable time after Tenant&#x2019;s written notice of the need for such repairs or maintenance.  Tenant waives its rights under any state or local law to terminate this Lease or to make such repairs at Landlord&#x2019;s expense and agrees that the parties&#x2019; respective rights with respect to such matters shall be solely as set forth herein.  Repairs required as the result of fire, earthquake, flood, hurricane, sinkhole, tornado, vandalism, war, or similar cause of damage or destruction shall be controlled by </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 18</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.]</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">14.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant&#x2019;s Repairs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 13</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof and the Work Letter, Tenant, at its expense, shall repair, replace and maintain in good condition all portions of the Premises, the building systems exclusively serving the Premises, and systems installed by Tenant, including, without limitation, entries, doors, ceilings, interior windows, interior walls, and the interior side of demising walls, reasonable wear and tear, damage and casualty not caused by Tenant or any Tenant Party excepted.  Such repair and replacement may include capital expenditures and repairs whose benefit may extend beyond the Term.  Should Tenant fail to make any such repair or replacement or fail to maintain the Premises, Landlord shall give Tenant notice of such failure.  If Tenant fails to commence cure of such failure within 10 days following Landlord&#x2019;s written notice, and thereafter diligently prosecute such cure to completion (not to exceed 45 days following Landlord&#x2019;s written notice), Landlord may perform such work and shall be reimbursed by Tenant within 30 days after demand therefor; provided, however, that if such failure by Tenant creates or could create an emergency, Landlord may immediately commence cure of such failure and shall thereafter be entitled to recover the costs of such cure from Tenant.  Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sections 17</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">18</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, Tenant shall bear the full uninsured cost of any repair or replacement to any part of the Project that results from damage caused by Tenant or any Tenant Party and any repair that benefits only the Premises.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">15.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Mechanic&#x2019;s Liens</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall discharge, by bond or otherwise, any mechanic&#x2019;s lien filed against the Premises or against the Project for work claimed to have been done for, or materials claimed to have been furnished to, Tenant within 10 days after Tenant receives notice or should have been aware of the filing thereof, at Tenant&#x2019;s sole cost, and shall otherwise keep the Premises and the Project free from any liens arising out of work performed, materials furnished or obligations incurred by Tenant.  Should Tenant fail to discharge any lien described herein, Landlord shall have the right, but not the obligation, to pay such claim or post a bond or otherwise provide security to eliminate the lien as a claim against title to the Project and the cost thereof shall be immediately due from Tenant as Additional Rent.  If Tenant shall lease or finance the acquisition of office or lab equipment, furnishings, or other personal property of a removable nature utilized by Tenant in the operation of Tenant&#x2019;s business, Tenant warrants that any Uniform Commercial Code Financing Statement filed as a matter of public record by any lessor or creditor of Tenant will upon its face or by exhibit thereto indicate that such Financing Statement is applicable only to removable personal property of Tenant located within the Premises.  In no event shall the address of the Project be furnished on the statement without qualifying language as to applicability of the lien only to removable personal property located within the Premises.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">16.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Indemnification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Subject to the waiver of subrogation contained in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 17</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof, Tenant hereby indemnifies and agrees to defend, save and hold Landlord, its officers, directors, employees, managers, agents, sub-agents, constituent entities, affiliates, and lease signatory(ies) (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord Indemnified Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) harmless from and against any and all actions (including, without limitation, administrative or judicial proceedings, and orders or judgments arising out of or resulting therefrom), costs, claims, damages (including, without limitation, with respect to Hazardous Materials or holding over, consequential damages and damages based upon diminution in value of the Premises or the Project, or the loss of, or restriction on, use of the Premises, or any portion of the Project; provided this parenthetical shall only apply with respect to Hazardous Materials and/or holding over), expenses (including, without limitation, reasonable attorneys&#x2019; fees, and consultants&#x2019; and experts&#x2019; fees, court costs and amounts paid in settlement of any claims or actions), fines, forfeitures or other civil, administrative or criminal penalties, injunctive or other relief (whether or not based upon personal injury, death to persons or </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">20</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">property damage occurring within or about the Premises), liabilities or losses (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Claims</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), to the extent arising directly or indirectly out of Tenant&#x2019;s (or any party claiming by, through or under Tenant) use or occupancy of the Premises or a breach or default by Tenant (or any party claiming by, through or under Tenant) in the performance of any of its obligations hereunder, except to the extent caused by the willful misconduct or negligence of Landlord Indemnified Parties.  Landlord Indemnified Parties shall not be liable to Tenant for, and Tenant assumes all risk of damage to, personal property (including, without limitation, loss of records kept within the Premises). Tenant further waives any and all Claims for injury to Tenant's business or loss of income relating to any such damage or destruction of personal property (including, without limitation, any loss of records).  Landlord Indemnified Parties shall not be liable for any damages arising from any act, omission or neglect of any tenant in the Project or of any other third party.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">17.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Insurance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall maintain all risk property and, if applicable, sprinkler damage insurance covering the full replacement cost of the Project.  Landlord shall further procure and maintain commercial general liability insurance with a single loss limit of not less than $2,000,000 for bodily injury and property damage with respect to the Project.  Landlord may, but is not obligated to, maintain such other insurance and additional coverages as it may deem necessary, including, but not limited to, flood, environmental hazard and earthquake, loss or failure of building equipment, errors and omissions, rental loss during the period of repair or rebuilding, workers&#x2019; compensation insurance and fidelity bonds for employees employed to perform services and insurance for any improvements installed by Tenant or which are in addition to the standard improvements customarily furnished by Landlord without regard to whether or not such are made a part of the Project.  All such insurance shall be included as part of the Operating Expenses.  The Project may be included in a blanket policy (in which case the cost of such insurance allocable to the Project will be determined by Landlord based upon the insurer&#x2019;s cost calculations).  Tenant shall also reimburse Landlord for any increased premiums or additional insurance which Landlord reasonably deems necessary as a result of Tenant&#x2019;s use of the Premises.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant, at its sole cost and expense, shall maintain during the Term:  all risk property insurance with business interruption and extra expense coverage, covering the full replacement cost of all property and improvements installed or placed in the Premises by Tenant, at Tenant&#x2019;s expense; workers&#x2019; compensation insurance with no less than the minimum limits required by law; employer&#x2019;s liability insurance with employers liability limits of $1,000,000 bodily injury by accident &#x2013; each accident, $1,000,000 bodily injury by disease &#x2013; policy limit, and $1,000,000 bodily injury by disease &#x2013; each employee; and commercial general liability insurance, with a minimum limit of not less than $2,000,000 per occurrence for bodily injury and property damage with respect to the Premises.  The commercial general liability insurance maintained by Tenant shall name Alexandria Real Estate Equities, Inc., and Landlord, its officers, directors, employees, managers, agents, sub-agents, constituent entities, affiliates and lease signatory(ies) (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord Insured Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), as additional insureds; insure on an occurrence and not a claims-made basis; be issued by insurance companies which have a rating of not less than policyholder rating of A and financial category rating of at least Class X in &#x201c;Best&#x2019;s Insurance Guide&#x201d;; shall not be cancelable for nonpayment of premium unless 10 days prior written notice shall have been given to Landlord from the insurer; not contain a hostile fire exclusion; contain a contractual liability endorsement; and provide primary coverage to Landlord Insured Parties (any policy issued to Landlord Insured Parties providing duplicate or similar coverage shall be deemed excess over Tenant&#x2019;s policies, regardless of limits). Copies of such policies (if requested  by Landlord), or certificates of insurance showing the limits of coverage required hereunder and showing Landlord as an additional insured, along with reasonable evidence of the payment of premiums for the applicable period, shall be delivered to Landlord by Tenant prior to (i) the earlier to occur of (x) the Commencement Date, or (y) the date that Tenant accesses the Premises under this Lease, and (ii) each renewal of said insurance.  Tenant&#x2019;s policy may be a &#x201c;blanket policy&#x201d; with an aggregate per location endorsement which specifically provides that the amount of insurance shall not be prejudiced by other losses covered by the policy.  Tenant shall, at least 5 days prior to the expiration of such policies, furnish Landlord with renewal certificates.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">   </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">In each instance where insurance is to name Landlord as an additional insured, Tenant shall within 5 business days following written request of Landlord also designate and furnish certificates so evidencing</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">21</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord as additional insured to:  (i) any lender of Landlord holding a security interest in the Project or any portion thereof, (ii) the landlord under any lease wherein Landlord is tenant of the real property on which the Project is located, if the interest of Landlord is or shall become that of a tenant under a ground or other underlying lease rather than that of a fee owner, and/or (iii) any management company retained by Landlord to manage the Project.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The property insurance obtained by Landlord and Tenant shall include a waiver of subrogation by the insurers and all rights based upon an assignment from its insured, against Landlord or Tenant, and their respective officers, directors, employees, managers, agents, invitees and contractors (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Related Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), in connection with any loss or damage thereby insured against.  Neither party nor its respective Related Parties shall be liable to the other for loss or damage caused by any risk insured against under property insurance required to be maintained hereunder, and each party waives any claims against the other party, and its respective Related Parties, for such loss or damage.  The failure of a party to insure its property shall not void this waiver.  Landlord and its respective Related Parties shall not be liable for, and Tenant hereby waives all claims against such parties for, business interruption and losses occasioned thereby sustained by Tenant or any person claiming through Tenant resulting from any accident or occurrence in or upon the Premises or the Project from any cause whatsoever.  If the foregoing waivers shall contravene any law with respect to exculpatory agreements, the liability of Landlord or Tenant shall be deemed not released but shall be secondary to the other&#x2019;s insurer.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord may require insurance policy limits to be raised to conform with requirements of Landlord&#x2019;s lender and/or to bring coverage limits to levels then being generally required of new office/lab tenants within the Project.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">18.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Restoration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If, at any time during the Term, the Project or the Premises are damaged or destroyed by a fire or other insured casualty, Landlord shall notify Tenant within 60 days after discovery of such damage (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Restoration Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) as to the amount of time Landlord reasonably estimates it will take to restore the Project or the Premises, as applicable (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Restoration Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  If the Restoration Period is estimated to exceed 12 months (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Maximum Restoration Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), Landlord may, in such notice, elect to terminate this Lease as of the date that is 75 days after the date of discovery of such damage or destruction; provided however, notwithstanding Landlord&#x2019;s election to restore, Tenant may elect to terminate this Lease by written notice delivered to Landlord within 10 business days following receipt of Landlord&#x2019;s estimate of the Restoration Notice if it specifies a Restoration Period for the Premises longer than the Maximum Restoration Period.  Unless Landlord or Tenant so elects to terminate this Lease, Landlord shall, subject to receipt of sufficient insurance proceeds (with any deductible to be treated as a current Operating Expense), promptly restore the Premises (excluding the improvements installed by Tenant or by Landlord and paid for by Tenant unless covered by the insurance Landlord maintains as an Operating Expense under this Lease, in which case such improvements shall be included, to the extent such insurance proceeds are actually received, in Landlord&#x2019;s restoration), subject to delays arising from the collection of insurance proceeds (provided that any such delay is not the result of Landlord&#x2019;s failure to maintain the insurance policies required to be maintained by Landlord under this Lease), from Force Majeure events or as needed to obtain any license, clearance or other authorization of any kind required to enter into and restore the Premises issued by any Governmental Authority having jurisdiction over the use, storage, handling, treatment, generation, release, disposal, removal or remediation of Hazardous Materials (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 30</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">) in, on or about the Premises (collectively referred to herein as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Hazardous Materials Clearances</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;); </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, that if repair or restoration of the Premises is not substantially complete as of the end of the Maximum Restoration Period or, if longer, the Restoration Period, Landlord may, in its sole and absolute discretion, elect not to proceed with such repair and restoration, in which event Landlord shall be relieved of its obligation to make such repairs or restoration and this Lease shall terminate as of the date that is 75 days after the later of:  (i) discovery of such damage or destruction, or (ii) the date all required Hazardous Materials Clearances are obtained, but Landlord shall retain any Rent paid and the right to any Rent payable by Tenant prior to such election by Landlord or Tenant.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">22</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant, at its expense, shall promptly perform, subject to delays arising from the collection of insurance proceeds, from Force Majeure events or to obtain Hazardous Material Clearances, all repairs or restoration not required to be done by Landlord and shall promptly re-enter the Premises and commence doing business in accordance with this Lease.  Notwithstanding the foregoing, (i) either Party may terminate this Lease if the Premises are damaged during the last 12 months</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">of the Term and Landlord reasonably estimates that it will take more than 4 months</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">to repair such damage, or (ii) Landlord may terminate this Lease if the Premises are damaged and insurance proceeds are not available for such restoration.  Rent shall be abated from the date of the casualty, provided that if Hazardous Materials Clearances are required as a condition for the repair or restoration, then Rent shall be abated from the date all required Hazardous Material Clearances are obtained, and in either case, such abatement shall be until the Premises are repaired and restored, and shall be in the proportion which the area of the Premises, if any, which is not usable by Tenant bears to the total area of the Premises, unless Landlord provides Tenant with other space during the period of repair that is suitable for the temporary conduct of Tenant&#x2019;s business.  Such abatement shall be the sole remedy of Tenant, and except as provided in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 18</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, Tenant waives any right to terminate this Lease by reason of damage or casualty loss.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The provisions of this Lease, including this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 18</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, constitute an express agreement between Landlord and Tenant with respect to any and all damage to, or destruction of, all or any part of the Premises, or any other portion of the Project, and any statute or regulation which is now or may hereafter be in effect shall have no application to this Lease or any damage or destruction to all or any part of the Premises or any other portion of the Project, the Parties hereto expressly agreeing that this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 18</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> sets forth their entire understanding and agreement with respect to such matters.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">19.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Condemnation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If the whole or any material part of the Premises or the Project is taken for any public or quasi-public use under governmental law, ordinance, or regulation, or by right of eminent domain, or by private purchase in lieu thereof (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Taking</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Taken</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), and the Taking would in Landlord&#x2019;s reasonable judgment, either prevent or materially interfere with Tenant&#x2019;s use of the Premises or materially interfere with or impair Landlord&#x2019;s ownership or operation of the Project, then upon written notice by either Party this Lease shall terminate and Rent shall be apportioned as of said date.  If part of the Premises shall be Taken, and this Lease is not terminated as provided above, Landlord shall promptly restore the Premises and the Project as nearly as is commercially reasonable under the circumstances to their condition prior to such partial Taking and the rentable square footage of the Building, the rentable square footage of the Premises, Tenant&#x2019;s Share of Operating Expenses and the Rent payable hereunder during the unexpired Term shall be reduced to such extent as Landlord determines may be fair and reasonable under the circumstances.  Upon any such Taking, Landlord shall be entitled to receive the entire price or award from any such Taking without any payment to Tenant, and Tenant hereby assigns to Landlord Tenant&#x2019;s interest, if any, in such award.  Tenant shall have the right, to the extent that same shall not diminish Landlord&#x2019;s award, to make a separate claim against the condemning authority (but not Landlord) for such compensation as may be separately awarded or recoverable by Tenant for moving expenses and damage to Tenant&#x2019;s trade fixtures, if a separate award for such items is made to Tenant.  Tenant hereby waives any and all rights it might otherwise have pursuant to any provision of state law to terminate this Lease upon a partial Taking of the Premises or the Project.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">20.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Events of Default</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Each of the following events shall be a default (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Default</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) by Tenant under this Lease:</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Payment Defaults</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall fail to pay any installment of Rent or any other payment hereunder when due; provided, that for the first instance within a 12-month period of Tenant&#x2019;s failure to pay any amounts due hereunder when due, Tenant shall be in Default only if such failure continues for 5 days from the date when due.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Insurance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Any insurance required to be maintained by Tenant pursuant to this Lease shall be canceled or terminated or shall expire or shall be reduced or materially changed, or Landlord shall receive </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">23</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">a notice of nonrenewal of any such insurance and Tenant shall fail to obtain replacement insurance at least 10 business days before the expiration of the current coverage.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Abandonment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall abandon the Premises, provided, however, that Tenant shall not be deemed to have abandoned the Premises if: (i) prior to vacating the Premises Tenant provides Landlord with prior notice and complies with the requirements pertaining to a Decommissioning and HazMat Closure Plan as set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 28</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">; (ii) Tenant has obtained the release of the Premises of all Hazardous Materials Clearances and the Premises are free from any residual impact from the Tenant HazMat Operations and Tenant provides reasonably detailed documentation to Landlord confirming such matters, (iii) prior to or at the time of vacating the Premises, Tenant has made reasonable arrangements for the security of the Premises for the balance of the Term, and Tenant has notified Landlord of such arrangements, (iv) Tenant continues to maintain in full force and effect any permits and approvals as may be required by any Governmental Authority for the Premises, and (v) Tenant continues during the balance of the Term to satisfy all of its obligations under the Lease as they come due, including without limitation the obligation to pay Rent.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Improper Transfer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall assign, sublease or otherwise transfer or attempt to transfer all or any portion of Tenant&#x2019;s interest in this Lease or the Premises except as expressly permitted herein, or Tenant&#x2019;s interest in this Lease shall be attached, executed upon, or otherwise judicially seized and such action is not released within 90 days of the action.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Liens</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall fail to discharge or otherwise obtain the release of any lien placed upon the Premises in violation of this Lease within the time period required pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 12</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> of this Lease.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Insolvency Events</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant or any guarantor or surety of Tenant&#x2019;s obligations hereunder shall:  (A) make a general assignment for the benefit of creditors; (B) commence any case, proceeding or other action seeking to have an order for relief entered on its behalf as a debtor or to adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, liquidation, dissolution or composition of it or its debts or seeking appointment of a receiver, trustee, custodian or other similar official for it or for all or of any substantial part of its property (collectively a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Proceeding for Relief</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;); (C) become the subject of any Proceeding for Relief which is not dismissed within 90 days of its filing or entry; or (D) die or suffer a legal disability (if Tenant, guarantor, or surety is an individual) or be dissolved or otherwise fail to maintain its legal existence (if Tenant, guarantor or surety is a corporation, partnership or other entity).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Estoppel Certificate or Subordination Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant fails to execute any document required from Tenant under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sections 23</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">27</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> within the time periods set forth in such applicable Section.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(h)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Other Defaults</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall fail to comply with any provision of this Lease other than those specifically referred to in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 20</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, and, except as otherwise expressly provided herein, such failure shall continue for a period of 30 days after written notice thereof from Landlord to Tenant or Tenant shall not have commenced such cure within 10 days of Landlord&#x2019;s notice.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Any notice given under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 20(h)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof shall:  (i) specify the alleged default, (ii) demand that Tenant cure such default, (iii) be in lieu of, and not in addition to, or shall be deemed to be, any notice required under any provision of applicable law, and (iv) not be deemed a forfeiture or a termination of this Lease unless Landlord elects otherwise in such notice; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> that if the nature of Tenant&#x2019;s default pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 20(h)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> is such that it cannot be cured by the payment of money and reasonably requires more than 30 days to cure, then Tenant shall not be deemed to be in default if Tenant commences such cure within said initial 10-day period and thereafter diligently prosecutes the same to completion; provided, however, that such cure shall be completed no later than 90 days from the date of Landlord&#x2019;s notice.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">24</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">21.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord&#x2019;s Remedies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Performance; Payment; Interest</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If default by Tenant shall occur in the keeping, observance or performance of any covenant, agreement, term, provision or condition herein contained, Landlord, without thereby waiving such default, may perform the same for the account and at the expense of Tenant (a) immediately or at any time thereafter and with only such notice as may be practicable under the circumstances in the case of an emergency or in case such default will result in a violation of any Legal Requirement or insurance requirements, or in the imposition of any lien against all or any portion of the Premises or the Project not discharged, released or bonded over to Landlord&#x2019;s satisfaction by Tenant within the time period required pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 15</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> of this Lease, and (b) in any other case if such default continues after any applicable notice and cure period provided in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 20</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  All reasonable costs and expenses incurred by Landlord in connection with any such performance by it for the account of Tenant and also all reasonable costs and expenses, including reasonable attorneys&#x2019; fees and disbursements incurred by Landlord in any action or proceeding (including any summary dispossess proceeding) brought by Landlord to enforce any obligation of Tenant under this Lease and/or right of Landlord in or to the Premises, together with interest thereon, from the date such sums were paid or incurred, at the annual rate equal to 12% per annum or the highest rate permitted by law (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Default Rate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), whichever is less, shall be paid by Tenant to Landlord on demand as Additional Rent.  Nothing herein shall be construed to create or impose a duty on Landlord to mitigate any damages resulting from Tenant&#x2019;s default hereunder.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Late Payment Rent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Late payment by Tenant to Landlord of Rent and other sums due will cause Landlord to incur costs not contemplated by this Lease, the exact amount of which will be extremely difficult and impracticable to ascertain.  Such costs include, but are not limited to, processing and accounting charges and late charges which may be imposed on Landlord under any Mortgage covering the Premises.  Therefore, if any installment of Rent due from Tenant is not received by Landlord within 5 days after the date such payment is due, Tenant shall pay to Landlord an additional sum of 5% of the overdue Rent as a late charge.  Notwithstanding the foregoing, before assessing a late charge for the first delinquency in any calendar year, Landlord shall provide Tenant with written notice of the delinquency and will waive the right to assess a late charge on such delinquency if Tenant pays such delinquency within 5 business days after Landlord&#x2019;s notice.  The Parties agree that this late charge represents a fair and reasonable estimate of the costs Landlord will incur by reason of late payment by Tenant.  In addition to the late charge, Rent not paid when due shall bear interest at the Default Rate from the 5th day after the date due until paid.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Additional Remedies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Upon the occurrence of a Default, Landlord, at its option, without further notice or demand to Tenant, shall have in addition to all other rights and remedies provided in this Lease, at law or in equity, the option to pursue any one or more of the following remedies, each and all of which shall be cumulative and nonexclusive, without any notice or demand whatsoever (except as otherwise expressly provided in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 21(c)(v)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> with respect to Landlord&#x2019;s Lump Sum Election).  No cure in whole or in part of such Default by Tenant after Landlord has taken any action beyond giving Tenant notice of such Default to pursue any remedy provided for herein (including retaining counsel to file an action or otherwise pursue any remedies) shall in any way affect Landlord&#x2019;s right to pursue such remedy or any other remedy provided Landlord herein or under law or in equity, unless Landlord, in its sole discretion, elects to waive such Default.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">This Lease and the Term and estate hereby granted are subject to the limitation that whenever a Default shall have happened and be continuing, Landlord shall have the right, at its election, then or thereafter while any such Default shall continue and notwithstanding the fact that Landlord may have some other remedy hereunder or at law or in equity, to give Tenant written notice of Landlord&#x2019;s intention to terminate this Lease on a date specified in such notice, which date shall be not less than 5 days after the giving of such notice, and upon the date so specified, this Lease and the estate hereby granted shall expire and terminate with the same force and effect as if the date specified in such notice were the date hereinbefore fixed for the expiration of this Lease, and all rights of Tenant hereunder shall expire and terminate, and Tenant shall be liable as </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">25</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">hereinafter in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 21(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> provided.  If any such notice is given, Landlord shall have, on such date so specified, the right of re-entry and possession of the Premises and the right to remove all persons and property therefrom and to store such property in a warehouse or elsewhere at the risk and expense, and for the account, of Tenant.  Should Landlord elect to re-enter as herein provided or should Landlord take possession pursuant to legal proceedings or pursuant to any notice provided for by law, Landlord may, subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 21(c)(ii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> from time to time re-let the Premises or any part thereof for such term or terms and at such rental or rentals and upon such terms and conditions as Landlord may deem advisable, with the right to make commercially reasonable alterations in and repairs to the Premises.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord shall be deemed to have satisfied any obligation to mitigate its damages by hiring an experienced commercial real estate broker to market the Premises and directing such broker to advertise and show the Premises to prospective tenants.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">In the event of any termination of this Lease as in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 21</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> provided or as required or permitted by law or in equity, Tenant shall forthwith quit and surrender the Premises to Landlord, and Landlord may, without further notice, enter upon, re-enter, possess and repossess the same by summary proceedings, ejectment or otherwise, and again have, repossess and enjoy the same free of any rights of Tenant, and in any such event Tenant and no person claiming through or under Tenant by virtue of any law or an order of any court shall be entitled to possession or to remain in possession of the Premises.  </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(iv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">If this Lease is terminated or if Landlord shall re-enter the Premises as aforesaid, or in the event of the termination of this Lease, or of re-entry, by or under any proceeding or action or any provision of law by reason of a Default by Tenant, Tenant covenants and agrees forthwith to pay and be liable for, on the days originally fixed in this Lease for the payment thereof, amounts equal to the installments of Base Rent and all Additional Rent as they would, under the terms of this Lease become due if this Lease had not been terminated or if Landlord had not entered or re-entered, as aforesaid, and whether the Premises be relet or remain vacant, in whole or in part, or for a period less than the remainder of the Term, or for the whole thereof, but in the event that the Premises be relet by Landlord, Tenant shall be entitled to a credit in the net amount of rent and other charges received by Landlord in reletting, after deduction of all of Landlord&#x2019;s expenses incurred in reletting the Premises (including, without limitation, tenant improvement, demising and remodeling costs, brokerage fees and the like), and in collecting the rent in connection therewith, in the following manner:  Amounts received by Landlord after reletting, if any, shall first be applied against such Landlord&#x2019;s expenses, until the same are recovered, and until such recovery, Tenant shall pay, as of each day when a payment would fall due under this Lease, the amount which Tenant is obligated to pay under the terms of this Lease (Tenant&#x2019;s liability prior to any such reletting and such recovery by Landlord no in any way to be diminished as a result of the fact that such reletting might be for a rent higher than the rent provided for in this Lease); when and if such expenses have been completely recovered by Landlord, the amounts received from reletting by Landlord as have not previously been applied shall be credited against Tenant&#x2019;s obligations as of each day when a payment would fall due under this Lease, and only the net amount thereof shall be payable by Tenant.  Further, Tenant shall not be entitled to any credit of any kind for any period after the date when the Term of this Lease is scheduled to expire according to its terms.</font></div></div>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Actions, proceedings or suits for the recovery of damages, whether liquidated or other damages, under this Lease, or any installments thereof, may be brought by Landlord from time to time at its election, and nothing contained herein shall be deemed to require Landlord to postpone suit until the date when the Term of this Lease would have expired if it had not been terminated hereunder.</font></p>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(v)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">In addition, Landlord, at its election, notwithstanding any other provision of this Lease, by written notice to Tenant (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lump Sum Election</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), shall be entitled to recover from Tenant, as </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">26</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and for liquidated damages, at any time following any termination of this Lease, a lump sum payment representing, at the time of Landlord&#x2019;s written notice of its Lump Sum Election, the sum of:</font></div></div>
  <div style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.692662720527998%;">(A)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">the then present value (calculated in accordance with accepted financial practice using as the discount rate the yield to maturity on United States Treasury Notes as set forth below) of the amount of unpaid Base Rent and Additional Rent that would have been payable pursuant to this Lease for the remainder of the Term following Landlord&#x2019;s Lump Sum Election if this Lease had not been terminated, and</font></div></div>
  <div style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.692662720527998%;">(B)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">all other damages and expenses (including reasonable attorneys&#x2019; fees and expenses), if any, which Landlord shall have sustained by reason of the breach of any provision of this Lease; less </font></div></div>
  <div style="margin-left:13.333%;text-indent:7.692%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.692662720527998%;">(C)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">the net rental revenue that Landlord may expect to obtain for the Premises for the balance of the Term, calculated based on the then present value (calculated in accordance with accepted financial practice using as the discount rate the yield to maturity on United States Treasury Notes as set forth below) of the aggregate net fair market rent plus additional charges payable for the Premises (if less than the then present value of Base Rent and Additional Rent that would have been payable pursuant to this Lease) for the remainder of the Term following Landlord&#x2019;s Lump Sum Election, calculated as of the date of Landlord&#x2019;s Lump Sum Election, and taking into account reasonable estimates of the length of time until the space will be leased and rent will commence to be paid, and future costs to relet any then vacant portions of the Premises (except to the extent that Tenant has actually paid such costs pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 21</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">).  </font></div></div>
  <p style="margin-left:6.667%;text-indent:7.143%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord&#x2019;s recovery under its Lump Sum Election shall be in addition to Tenant&#x2019;s obligations to pay Base Rent and Additional Rent due and costs incurred prior to the date of Landlord&#x2019;s Lump Sum Election, and in lieu of any Base Rent and Additional Rent which would otherwise have been due under this Section from and after the date of Landlord&#x2019;s Lump Sum Election.  The yield to maturity on United States Treasury Notes having a maturity date that is nearest the date that would have been the last day of the Term of this Lease, as reported in </font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The Wall Street Journal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> or a comparable publication if it ceases to publish such yields, shall be used in calculating present values for purposes of Landlord&#x2019;s Lump Sum Election.  For the purposes of this Section, if Landlord makes the Lump Sum Election to recover liquidated damages in accordance with this Section, the total Additional Rent shall be computed based upon Landlord&#x2019;s reasonable estimate of Tenant&#x2019;s Share of Operating Expenses and other Additional Rent for each 12-month period in what would have been the remainder of the Term of this Lease and any part thereof at the end of such remainder of the Term, but in no event less than the amounts therefor payable for the twelve (12) calendar months (or if less than twelve (12) calendar months have elapsed since the date hereof, the partial year increased to be on an annualized basis) immediately preceding the date of Landlord&#x2019;s Lump Sum Election.  Amounts of Tenant&#x2019;s Share of Operating Expenses and any other Additional Rent for any partial year at the beginning of the Term, for the month in which the Lump Sum Election is made, or at the end of what would have been the remainder of the Term shall be prorated.</font></p>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(vi)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Nothing herein contained shall limit or prejudice the right of Landlord, in any bankruptcy or insolvency proceeding, to prove for and obtain as liquidated damages by reason of such termination an amount equal to the maximum allowed by any bankruptcy or insolvency proceedings, or to prove for and obtain as liquidated damages by reason of such termination, an amount equal to the maximum allowed by any statute or rule of law, whether such amount shall be greater or less than the excess referred to above.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">27</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(vii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Nothing in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 21</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> shall be deemed to affect the right of either party to indemnifications pursuant to this Lease, which shall be in addition to the remedies set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 21</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(viii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">If Landlord terminates this Lease upon the occurrence of a Default, Tenant will quit and surrender the Premises to Landlord or its agents, and Landlord may, without further notice, enter upon, re-enter and repossess the Premises by summary proceedings, ejectment or otherwise.  The words &#x201c;enter&#x201d;, &#x201c;re-enter&#x201d;, and &#x201c;re-entry&#x201d; are not restricted to their technical legal meanings.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(ix)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">If Tenant shall be in default in the observance or performance of any provision of this Lease, and an action shall be brought for the enforcement thereof in which it shall be determined that Tenant was in default, Tenant shall pay to Landlord all reasonable, out of pocket fees, costs and other expenses which may become payable as a result thereof or in connection therewith, including reasonable attorneys&#x2019; fees and expenses.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(x)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Independent of the exercise of any other remedy of Landlord hereunder or under applicable law, Landlord may conduct an environmental test of the Premises as generally described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 30(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(xi)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">In the event that Tenant is in breach or Default under this Lease, whether or not Landlord exercises its right to terminate or any other remedy, Tenant shall reimburse Landlord upon demand for any out of pocket costs and expenses that Landlord may incur in connection with any such breach or Default, as provided in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 21(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. Such costs shall include legal fees and costs incurred for the negotiation of a settlement, enforcement of rights or otherwise.  Tenant shall also indemnify Landlord against and hold Landlord harmless from all costs, expenses, demands and liability, including without limitation, legal fees and costs Landlord shall incur if Landlord shall become or be made a party to any claim or action instituted by Tenant against any third party, by any third party against Tenant or by or against any person holding any interest under or using the Premises by license of or agreement with Tenant.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">(d)	Except as otherwise provided in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 21</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, no right or remedy herein conferred upon or reserved to Landlord is intended to be exclusive of any other right or remedy, and every right and remedy shall be cumulative and in addition to any other legal or equitable right or remedy given hereunder, or now or hereafter existing.  No waiver by Landlord of any provision of this Lease shall be deemed to have been made unless expressly so made in writing by Landlord expressly waiving such provision.  Landlord shall be entitled, to the extent permitted by law, to seek injunctive relief in case of the violation, or attempted or threatened violation, of any provision of this Lease, or to seek a decree compelling observance or performance of any provision of this Lease, or to seek any other legal or equitable remedy.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">22.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Assignment and Subletting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">General Prohibition</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Without Landlord&#x2019;s prior written consent subject to and on the conditions described in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 22</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, Tenant shall not, directly or indirectly, voluntarily or by operation of law, assign this Lease or sublease the Premises or any part thereof or mortgage, pledge, or hypothecate its leasehold interest or grant any concession or license within the Premises or any part thereof, and any attempt to do any of the foregoing shall be void and of no effect. If Tenant is a corporation, partnership (limited, general or other) or limited liability company (or other business associations), the shares or other ownership interests thereof which are not actively traded upon a stock exchange or in the over-the-counter market, a transfer or series of transfers whereby 50% or more of the issued and outstanding shares or other ownership interests of such corporation, partnership (limited, general or other) or limited liability company (or other business associations) are, or voting control is, transferred (but excepting transfers upon deaths of individual owners) from a person or persons or entity or entities (or other business associations) which were owners thereof at time of execution of this Lease to persons or entities (or other business associations) who were not owners of shares or other ownership interests of the corporation, partnership or limited liability </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">28</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">company (or other business associations) at time of execution of this Lease, shall be deemed an assignment of this Lease requiring the consent of Landlord as provided in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 22</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Notwithstanding anything in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 22</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> to the contrary, any public offering of shares or other ownership interest in Tenant on a nationally recognized stock exchange shall not be deemed an assignment requiring consent of the Landlord.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Permitted Transfers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If Tenant desires to assign, sublease, hypothecate or otherwise transfer this Lease or sublet the Premises other than pursuant to a Permitted Assignment (as defined below), then at least 15 business days, but not more than 60 days, before the date Tenant desires the assignment or sublease to be effective (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Assignment Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), Tenant shall give Landlord a notice (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Assignment Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) containing such information about the proposed assignee or sublessee, including the proposed use of the Premises and any Hazardous Materials proposed to be used, stored handled, treated, generated in or released or disposed of from the Premises, the Assignment Date, any relationship between Tenant and the proposed assignee or sublessee, and all material terms and conditions of the proposed assignment or sublease, including a copy of any proposed assignment or sublease in its final form, and such other information as Landlord may deem reasonably necessary or appropriate to its consideration whether to grant its consent. Landlord may, by giving written notice to Tenant within 15 business days after receipt of the Assignment Notice:  (i) grant such consent, (ii) refuse such consent; provided Landlord will not unreasonably withhold, condition or delay consent (provided that, in the case of a sublease, Landlord shall further have the right to review and approve or disapprove the proposed form of sublease prior to the effective date of any such subletting), or (iii) terminate this Lease with respect to the space described in the Assignment Notice as of the Assignment Date (an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Assignment Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  Without limiting the other grounds upon which it may be reasonable for Landlord to refuse consent, it shall be deemed reasonable for Landlord to refuse consent if (1) the proposed assignee or subtenant is a governmental agency; (2) in Landlord&#x2019;s reasonable judgment, the use of the Premises by the proposed assignee or subtenant would require increased services by Landlord; (3) the proposed assignee or subtenant is engaged in areas of scientific research or other business concerns that are controversial such that Landlord reasonably determines the same could reasonably be expected to (A) attract or cause negative publicity for or about the Building or the Project, (B) negatively affect the reputation of the Building, the Project or Landlord, (C) attract protestors to the Building or the Project, or (D) lessen the attractiveness of the Building or the Project to any tenants or prospective tenants, purchasers or lenders; (4) in Landlord&#x2019;s reasonable judgment, the proposed assignee or subtenant lacks the creditworthiness to support the financial obligations it will incur under the proposed assignment or sublease; (5) in Landlord&#x2019;s reasonable judgment, the character, reputation, or business of the proposed assignee or subtenant is inconsistent with the desired tenant-mix or the quality of other tenancies in the Project or is inconsistent with the type and quality of the nature of the Building; (6) Landlord has received from any prior landlord to the proposed assignee or subtenant a negative report concerning such prior landlord&#x2019;s experience with the proposed assignee or subtenant; (7) Landlord has experienced previous defaults by or is in litigation with the proposed assignee or subtenant; (8) the use of the Premises by the proposed assignee or subtenant will violate any applicable Legal Requirement; (9) the proposed assignee or subtenant, or any entity that, directly or indirectly, controls, is controlled by, or is under common control with the proposed assignee or subtenant, is then an occupant of the Project and the Landlord has available space of substantially similar size and use at the Project; (10) the proposed assignee or subtenant is an entity with whom Landlord is actively negotiating (e.g., a proposal being shared and responded to) to lease space in the Project; (11) the proposed assignee or subtenant (or such party&#x2019;s affiliates, principals or predecessors) has been requested to take remedial action in connection with Hazardous Materials contamination or Landlord otherwise determines the proposed assignee&#x2019;s or subtenant&#x2019;s use of the Premises presents a risk associated with Hazardous Materials or is not compatible with the Project; or (12) the assignment or sublease is prohibited by Landlord&#x2019;s lender.  If Landlord delivers notice of its election to exercise an Assignment Termination, Tenant shall have the right to withdraw such Assignment Notice by written notice to Landlord of such election within 5 business days after Landlord&#x2019;s notice electing to exercise the Assignment Termination.  If Tenant withdraws such Assignment Notice, this Lease shall continue in full force and effect.  If Tenant does not withdraw such Assignment Notice, this Lease, and the term and estate herein granted, shall terminate as of the Assignment Date with respect to the space described in such Assignment Notice.  No failure of Landlord to exercise any such option to </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">29</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">terminate this Lease, or to deliver a timely notice in response to the Assignment Notice, shall be deemed to be Landlord&#x2019;s consent to the proposed assignment, sublease or other transfer.  Tenant shall pay to Landlord a fee equal to Two Thousand Five Hundred Dollars ($2,500) in connection with its consideration of any Assignment Notice and/or its preparation or review of any consent documents.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">In addition, Tenant shall have the right to assign this Lease, upon 30 days prior written notice to Landlord (except to the extent (a) prohibited by applicable securities or other laws or regulations, in which case such notice shall be provided as soon as permitted, or (b) prohibited by confidentiality requirements, in which case such notice shall be provided as soon as permitted but in no event later than 10 days before such transaction) but without obtaining Landlord&#x2019;s prior written consent, to a corporation or other entity which is a successor-in-interest to Tenant, by way of merger, consolidation or corporate reorganization, or by the purchase of all or substantially all of the assets or the ownership interests of Tenant provided that (i) such merger or consolidation, or such acquisition or assumption, as the case may be, is for a good business purpose and not principally for the purpose of transferring this Lease, and (ii) the net worth (as determined in accordance with generally accepted accounting principles (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">GAAP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;)) of the assignee is not less than the net worth (as determined in accordance with GAAP) of Tenant as of the Commencement Date, and (iii) such assignee shall agree in writing to assume all of the terms, covenants and conditions of this Lease (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Permitted Assignment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Additional Conditions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  As a condition to any such assignment or subletting, whether or not Landlord&#x2019;s consent is required, Landlord may require:</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">that any assignee or subtenant agree, in writing at the time of such assignment or subletting, that if Landlord gives such party notice that Tenant is in default under this Lease, such party shall thereafter make all payments otherwise due Tenant directly to Landlord, which payments will be received by Landlord without any liability except to credit such payment against those due under this Lease, and any such third party shall agree to attorn to Landlord or its successors and assigns should this Lease be terminated for any reason; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, in no event shall Landlord or its successors or assigns be obligated to accept such attornment; and</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">A list of Hazardous Materials, certified by the proposed assignee or sublessee to be true and correct, which the proposed assignee or sublessee intends to use, store, handle, treat, generate in or release or dispose of from the Premises, together with copies of all documents relating to such use, storage, handling, treatment, generation, release or disposal of Hazardous Materials by the proposed assignee or subtenant in the Premises or on the Project, prior to the proposed assignment or subletting, including, without limitation:  permits; approvals; reports and correspondence; storage and management plans; plans relating to the installation of any storage tanks to be installed in or under the Project (provided, said installation of tanks shall only be permitted after Landlord has given its written consent to do so, which consent may be withheld in Landlord&#x2019;s sole and absolute discretion); and all closure plans or any other documents required by any and all federal, state and local Governmental Authorities for any storage tanks installed in, on or under the Project for the closure of any such tanks.  Neither Tenant nor any such proposed assignee or subtenant is required, however, to provide Landlord with any portion(s) of the such documents containing information of a proprietary nature which, in and of themselves, do not contain a reference to any Hazardous Materials or hazardous activities.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No Release of Tenant, Sharing of Excess Rents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Notwithstanding any assignment or subletting, Tenant shall at all times remain fully and primarily responsible and liable for the payment of Rent and for compliance with all of Tenant&#x2019;s other obligations under this Lease.  If the Rent due and payable by a sublessee or assignee (or a combination of the rental payable under such sublease or assignment plus any bonus or other consideration therefor or incident thereto in any form) exceeds the sum of the rental payable under this Lease (excluding however, any Rent payable under this Section) and actual and reasonable brokerage fees, legal costs and any design or construction fees directly related to and required pursuant to the terms of any such sublease or market concessions (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Excess Rent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), then Tenant shall be </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">30</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">bound and obligated to pay Landlord as Additional Rent hereunder 50% of such Excess Rent within 30 days following receipt thereof by Tenant.  If Tenant shall sublet the Premises or any part thereof, Tenant hereby immediately and irrevocably assigns to Landlord, as security for Tenant&#x2019;s obligations under this Lease, all rent from any such subletting, and Landlord as assignee and as attorney-in-fact for Tenant solely for the limited purpose of receiving such rent from subletting, or a receiver for Tenant appointed on Landlord&#x2019;s application, may collect such rent and apply it toward Tenant&#x2019;s obligations under this Lease; except that, until the occurrence of a Default, Tenant shall have the right to collect such rent.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No Waiver</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The consent by Landlord to an assignment or subletting shall not relieve Tenant or any assignees of this Lease or any sublessees of the Premises from obtaining the consent of Landlord to any further assignment or subletting nor shall it release Tenant or any assignee or sublessee of Tenant from full and primary liability under this Lease.  The acceptance of Rent hereunder, or the acceptance of performance of any other term, covenant, or condition thereof, from any other person or entity shall not be deemed to be a waiver of any of the provisions of this Lease or a consent to any subletting, assignment or other transfer of the Premises.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Prior Conduct of Proposed Transferee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Notwithstanding any other provision of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 22</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, if (i) the proposed assignee or sublessee of Tenant has been required by any prior landlord, lender or Governmental Authority to take remedial action in connection with Hazardous Materials contaminating a property, where the contamination resulted from such party&#x2019;s action or use of the property in question, (ii) the proposed assignee or sublessee is subject to an enforcement order issued by any Governmental Authority in connection with the use, storage, handling, treatment, generation, release or disposal of Hazardous Materials (including, without limitation, any order related to the failure to make a required reporting to any Governmental Authority), or (iii) because of the existence of a pre-existing environmental condition in the vicinity of or underlying the Project, the risk that Landlord would be targeted as a responsible party in connection with the remediation of such pre-existing environmental condition would be materially increased or exacerbated by the proposed use of Hazardous Materials by such proposed assignee or sublessee, Landlord shall have the absolute right to refuse to consent to any assignment or subletting to any such party</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">23.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Estoppel Certificate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall, within 10 business days of written notice from Landlord, execute, acknowledge and deliver a statement in writing in any form reasonably requested by a proposed lender or purchaser, (i) certifying that this Lease is unmodified and in full force and effect (or, if modified, stating the nature of such modification and certifying that this Lease as so modified is in full force and effect) and the dates to which the rental and other charges are paid in advance, if any, (ii) acknowledging that there are not any uncured defaults on the part of Landlord hereunder, or specifying such defaults if any are claimed, and (iii) setting forth such further information with respect to the status of this Lease or the Premises as may be requested thereon.  Any such statement may be relied upon by any prospective purchaser or encumbrancer of all or any portion of the real property of which the Premises are a part.  Tenant&#x2019;s failure to deliver such statement within such time shall be conclusive upon Tenant that this Lease is in full force and effect and without modification except as may be represented by Landlord in any certificate prepared by Landlord and delivered to Tenant for execution. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">24.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Quiet Enjoyment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  So long as Tenant is not in Default under this Lease, Tenant shall, subject to the terms of this Lease, at all times during the Term, have peaceful and quiet enjoyment of the Premises against any person claiming by, through or under Landlord.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">25.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Prorations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  All prorations required or permitted to be made hereunder shall be made on the basis of a 360-day year and 30-day months.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">26.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rules and Regulations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant and any and all Tenant Parties shall, at all times during the Term and any extension thereof, comply with all reasonable rules and regulations at any time or from time to time established, modified or amended by Landlord covering use of the Premises and the Project.  The current rules and regulations are attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit E</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If there is any conflict between said </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">31</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">rules and regulations and other provisions of this Lease, the terms and provisions of this Lease shall control.  Landlord shall not have any liability or obligation for the breach of any rules or regulations by other tenants in the Project.  Landlord shall not enforce such rules and regulations in a discriminatory manner.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">In addition to the foregoing, Landlord shall have the right to institute, modify or amend at any time or from time to time reasonable rules and regulations related to Tenant&#x2019;s use of the Amenities, including by way of example but not limitation, requirements related to reservation systems for conference facilities, designation of permitted caterers or restaurants that may serve any conference facilities, reasonable fees for the use of conference facilities, liability waivers for individuals using gyms, and access card entry requirements.  Tenant and any and all Tenant Parties shall comply with all such rules and regulations, provided notice of such modified or amended rules and regulations are delivered in writing to Tenant.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall cause all Tenant Parties to comply with all rules and regulations established from time to time by Landlord pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 26</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant will reimburse Landlord for all damages caused by Tenant&#x2019;s or any Tenant Party&#x2019;s failure to comply with the provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 26</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> and will also pay to Landlord, as Additional Rent, an amount equal to any increase in insurance premiums caused by such failure to comply.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">27.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Subordination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  This Lease and Tenant&#x2019;s interest and rights hereunder are hereby made and shall be subject and subordinate at all times to the lien of any Mortgage now existing or hereafter created on or against the Project, the Building, or the Premises, and all amendments, restatements, renewals, modifications, consolidations, refinancing, assignments and extensions thereof, without the necessity of any further instrument or act on the part of Tenant; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> that so long as there is no Default hereunder, Tenant&#x2019;s right to possession of the Premises shall not be disturbed by the Holder of any such Mortgage.  Tenant agrees, at the election of the Holder of any such Mortgage, to attorn to any such Holder.  Tenant agrees within 5 business days following demand to execute, acknowledge and deliver such commercially customary instruments, confirming such subordination, and such instruments of attornment as shall be requested by any such Holder, provided any such instruments contain appropriate non-disturbance provisions assuring Tenant&#x2019;s quiet enjoyment of the Premises as set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 24</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof.  Notwithstanding the foregoing, any such Holder may at any time subordinate its Mortgage to this Lease, without Tenant&#x2019;s consent, by notice in writing to Tenant, and thereupon this Lease shall be deemed prior to such Mortgage without regard to their respective dates of execution, delivery or recording and in that event such Holder shall have the same rights with respect to this Lease as though this Lease had been executed prior to the execution, delivery and recording of such Mortgage and had been assigned to such Holder.  The term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Mortgage</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; whenever used in this Lease shall be deemed to include mortgages, deeds of trust, security assignments and any other encumbrances, and any reference to the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Holder</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; of a Mortgage shall be deemed to include the mortgagee or beneficiary under a deed of trust.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">As of the date of this Lease, Landlord represents there is no existing Mortgage encumbering the Project.  If during the Term there is a Mortgage encumbering the Project, Landlord agrees to use reasonable efforts to cause the Holder of the then-current Mortgage to enter into a subordination, non-disturbance and attornment agreement (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SNDA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) with Tenant with respect to this Lease.  The SNDA shall be on the commercially customary form proscribed by the Holder, and Landlord shall request that Holder make any commercially reasonable changes to the SNDA requested by Tenant.  Landlord&#x2019;s failure to cause the Holder to enter into the SNDA with Tenant (or make any of the changes requested by Tenant) shall not be a default by Landlord under this Lease.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">28.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Surrender</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Upon the expiration of the Term or earlier termination of Tenant&#x2019;s right of possession, Tenant shall surrender the Premises to Landlord in the same condition as received, subject to any Alterations or Installations permitted by Landlord to remain in the Premises, free of Hazardous Materials brought upon, kept, used, stored, handled, treated, generated in, or released or disposed of from, the Premises by any person other than a Landlord Party (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant HazMat Operations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) and released of all Hazardous Materials Clearances, broom clean, ordinary wear and tear, Landlord&#x2019;s repair and maintenance obligations, and casualty loss and condemnation covered by </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sections 18</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">19</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">32</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> excepted.  At least 3 months prior to the surrender of the Premises or such earlier date as Tenant may elect to cease operations at the Premises, Tenant shall deliver to Landlord a narrative description of the actions proposed (or required by any Governmental Authority) to be taken by Tenant in order to surrender the Premises (including any Installations permitted by Landlord to remain in the Premises) at the expiration or earlier termination of the Term, free from any residual impact from the Tenant HazMat Operations and otherwise released for unrestricted use and occupancy (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Decommissioning and</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">HazMat Closure Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  Such Decommissioning and HazMat Closure Plan shall be accompanied by a current listing of (i) all Hazardous Materials licenses and permits held by or on behalf of any Tenant Party with respect to the Premises, and (ii) all Hazardous Materials used, stored, handled, treated, generated, released or disposed of from the Premises, and shall be subject to the review and approval of Landlord&#x2019;s environmental consultant.  In connection with the review and approval of the Decommissioning and HazMat Closure Plan, upon the request of Landlord, Tenant shall deliver to Landlord or its consultant such additional non-proprietary information concerning Tenant HazMat Operations as Landlord shall request.  On or before such surrender, Tenant shall deliver to Landlord evidence that the approved Decommissioning and HazMat Closure Plan shall have been satisfactorily completed and Landlord shall have the right, subject to reimbursement at Tenant&#x2019;s expense as set forth below, to cause Landlord&#x2019;s environmental consultant to inspect the Premises and perform such additional procedures as may be deemed reasonably necessary to confirm that the Premises are, as of the effective date of such surrender or early termination of this Lease, free from any residual impact from Tenant HazMat Operations.  Tenant shall reimburse Landlord, as Additional Rent, for the actual out-of-pocket expense incurred by Landlord for Landlord&#x2019;s environmental consultant to review and approve the Decommissioning and HazMat Closure Plan and to visit the Premises and verify satisfactory completion of the same, which cost shall not exceed $5,000.  Landlord shall have the unrestricted right to deliver such Decommissioning and HazMat Closure Plan and any report by Landlord&#x2019;s environmental consultant with respect to the surrender of the Premises to third parties.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">If Tenant shall fail to prepare or submit a Decommissioning and HazMat Closure Plan approved by Landlord, or if Tenant shall fail to complete the approved Decommissioning and HazMat Closure Plan, or if such Decommissioning and HazMat Closure Plan, whether or not approved by Landlord, shall fail to adequately address any residual effect of Tenant HazMat Operations in, on or about the Premises, then following written notice to Tenant of such failure and Tenant&#x2019;s failure to commence a cure within 10 days of the delivery of such notice and to complete such cure within 30 days of the delivery of such notice (except in the case of emergencies in which case no such notice or cure period is required), Landlord shall have the right to take such actions as Landlord may deem reasonable or appropriate to assure that the Premises and the Project are surrendered free from any residual impact from Tenant HazMat Operations, the cost of which actions shall be reimbursed by Tenant as Additional Rent, without regard to the limitation set forth in the first paragraph of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 28</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Upon the expiration or earlier termination of the Term, Tenant shall immediately return to Landlord all keys and/or access cards to parking, the Project, restrooms or all or any portion of the Premises furnished to or otherwise procured by Tenant.  If any such access card or key is lost, Tenant shall pay to Landlord, at Landlord&#x2019;s election, either the cost of replacing such lost access card or key or the cost of reprogramming the access security system in which such access card was used or changing the lock or locks opened by such lost key.  Any Tenant&#x2019;s Property, Alterations and property not so removed by Tenant as permitted or required herein shall be deemed abandoned and may be stored, removed, and disposed of by Landlord at Tenant&#x2019;s expense, and Tenant waives all claims against Landlord for any damages resulting from Landlord&#x2019;s retention and/or disposition of such property.  All obligations of Tenant hereunder not fully performed as of the termination of the Term, including the obligations of Tenant under </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 30</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof, shall survive the expiration or earlier termination of the Term, including, without limitation, indemnity obligations, payment obligations with respect to Rent and obligations concerning the condition and repair of the Premises.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">29.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Waiver of Jury Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  TO THE EXTENT PERMITTED BY LAW, TENANT AND LANDLORD WAIVE ANY RIGHT TO TRIAL BY JURY OR TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT, TORT, OR OTHERWISE, </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">33</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">BETWEEN LANDLORD AND TENANT ARISING OUT OF THIS LEASE OR ANY OTHER INSTRUMENT, DOCUMENT, OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS RELATED HERETO.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">30.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Environmental Requirements. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Prohibition/Compliance/Indemnity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall not cause or permit any Hazardous Materials (as hereinafter defined) to be brought upon, kept, used, stored, handled, treated, generated  in or about, or released or disposed of from, the Premises or the Project in violation of applicable Environmental Requirements (as hereinafter defined) by Tenant or any Tenant Party.  If Tenant breaches the obligation stated in the preceding sentence, or if the presence of Hazardous Materials in the Premises during the Term or any holding over results in contamination of the Premises, the Building, the Project and/or any adjacent property or if contamination of the Premises, the Building, the Project and/or any adjacent property by Hazardous Materials brought into, kept, used, stored, handled, treated, generated in or about, or released or disposed of from, the Premises by anyone other than Landlord and Landlord&#x2019;s employees, agents, and contractors otherwise occurs during the Term or any holding over, Tenant hereby indemnifies and shall defend and hold Landlord, its officers, directors, employees, managers, agents, sub-agents, affiliates and contractors harmless from any and all actions (including, without limitation, remedial or enforcement actions of any kind, administrative or judicial proceedings, and orders or judgments arising out of or resulting therefrom), costs, claims, damages (including, without limitation, punitive damages and damages based upon diminution in value of the Premises, Building, or the Project, the loss of, or restriction on, use of the Premises, the Building, or any portion of the Project), expenses (including, without limitation, reasonable attorneys&#x2019; fees, and consultants&#x2019; and experts&#x2019; fees, court costs and amounts paid in settlement of any claims or actions), fines, forfeitures or other civil, administrative or criminal penalties, injunctive or other relief (whether or not based upon personal injury, property damage, or contamination of, or adverse effects upon, the environment, water tables or natural resources), liabilities or losses (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Environmental Claims</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) which arise during or after the Term as a result of such contamination.  This indemnification of Landlord by Tenant includes, without limitation, costs incurred in connection with any investigation of site conditions or any cleanup, treatment, remedial, removal, or restoration work required by any federal, state or local Governmental Authority because of Hazardous Materials present in the air, soil or ground water above, on, or under the Premises, the Building, the Project or any other adjacent property.  Without limiting the foregoing, if the presence of any Hazardous Materials in, on or under the Premises, the Building, the Project or any adjacent property caused or permitted by Tenant or any Tenant Party results in any contamination, Tenant shall promptly take all actions at its sole expense and in accordance with applicable Environmental Requirements as are necessary to return the Premises, the Building, the Project and/or any adjacent property to the condition existing prior to the time of such contamination, provided that Landlord&#x2019;s approval of such action shall first be obtained, which approval shall not unreasonably be withheld so long as such actions would not potentially have any material adverse long-term or short-term effect on the Premises, the Building or the Project.  Notwithstanding the foregoing, Tenant shall not be responsible for the clean-up or remediation of, and the indemnification and hold harmless obligation set forth in this paragraph shall not apply to (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Excluded Matters</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), (i) contamination in the Premises that Tenant demonstrates to Landlord was present in the Premises prior to the date of Substantial Completion of the Tenant Improvements (or any earlier date of entry onto the Premises by Tenant or any Tenant Parties during which early entry Tenant or the Tenant Parties utilize or introduce Hazardous Materials), (ii) contamination on the Project (including the Premises) that Tenant demonstrates to Landlord was not introduced by, or caused by an act or omission, of Tenant or any of the Tenant Parties, or (iii) any environmental condition that Tenant demonstrates to Landlord resulted from the presence of any Hazardous Material that migrates into the Premises from outside the Premises, except, in any case of clauses (i) &#x2013; (iii), to the extent Tenant and/or any of the Tenant Parties have exacerbated or contributed to such contamination or migration. If Tenant encounters any pre-existing Hazardous Materials in connection with any Alterations, it shall promptly notify Landlord and cease any action that may disturb such Hazardous Materials until Landlord has the opportunity to remediate the same if required by law.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">34</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Business</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord acknowledges that it is not the intent of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 30</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> to prohibit Tenant from using the Premises for the Permitted Use.  Tenant may operate its business according to prudent industry practices so long as the use or presence of Hazardous Materials is strictly and properly monitored according to all then applicable Environmental Requirements.  As a material inducement to Landlord to allow Tenant to use Hazardous Materials in connection with its business, Tenant agrees to deliver to Landlord prior to the Commencement Date a list identifying each type of Hazardous Materials to be brought upon, kept, used, stored, handled, treated, generated on, or released or disposed of from, the Premises and setting forth any and all governmental approvals or permits required in connection with the presence, use, storage, handling, treatment, generation, release or disposal of such Hazardous Materials on or from the Premises (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Hazardous Materials List</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  Upon Landlord&#x2019;s request, or any time that Tenant is required to deliver a Hazardous Materials List to any Governmental Authority (e.g., the fire department) in connection with Tenant&#x2019;s use or occupancy of the Premises, Tenant shall deliver to Landlord a copy of such Hazardous Materials List.  Tenant shall deliver to Landlord true and correct copies of the following documents (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Haz Mat Documents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) relating to the use, storage, handling, treatment, generation, release or disposal of Hazardous Materials prior to the Commencement Date, or if unavailable at that time, concurrent with the receipt from or submission to a Governmental Authority:  permits; approvals; reports and correspondence; storage and management plans, notice of violations of any Legal Requirements; plans relating to the installation of any storage tanks to be installed in or under the Project (provided, said installation of tanks shall only be permitted after Landlord has given Tenant its written consent to do so, which consent may be withheld in Landlord&#x2019;s sole and absolute discretion); all closure plans or any other documents required by any and all federal, state and local Governmental Authorities for any storage tanks installed in, on or under the Project for the closure of any such tanks; and a Decommissioning and HazMat Closure Plan (to the extent surrender in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 28</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> cannot be accomplished in 3 months).  Tenant is not required, however, to provide Landlord with any portion(s) of the Haz Mat Documents containing information of a proprietary nature which, in and of themselves, do not contain a reference to any Hazardous Materials or hazardous activities.  It is not the intent of this Section to provide Landlord with information which could be detrimental to Tenant&#x2019;s business should such information become possessed by Tenant&#x2019;s competitors.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant Representation and Warranty</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant hereby represents and warrants to Landlord that (i) neither Tenant nor any of its legal predecessors has been required by any prior landlord, lender or Governmental Authority at any time to take remedial action in connection with Hazardous Materials contaminating a property which contamination was permitted by Tenant of such predecessor or resulted from Tenant&#x2019;s or such predecessor&#x2019;s action or use of the property in question, and (ii) Tenant is not subject to any enforcement order issued by any Governmental Authority in connection with the use, storage, handling, treatment, generation, release or disposal of Hazardous Materials (including, without limitation, any order related to the failure to make a required reporting to any Governmental Authority).  If Landlord determines that this representation and warranty was not true as of the date of this Lease, Landlord shall have the right to terminate this Lease in Landlord&#x2019;s sole and absolute discretion.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Testing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall have the right but not the obligation to conduct annual tests of the Premises to determine whether any contamination of the Premises, the Building, or the Project has occurred as a result of Tenant&#x2019;s use.  Tenant shall be required to pay the cost of such annual test of the Premises; provided, however, that if Tenant conducts its own tests of the Premises using third party contractors and test procedures acceptable to Landlord which tests are certified to Landlord, Landlord shall accept such tests in lieu of the annual tests to be paid for by Tenant.  In addition, at any time, and from time to time, prior to the expiration or earlier termination of the Term, Landlord shall have the right to conduct additional appropriate tests of the Premises, the Building, and the Project to determine if contamination has occurred as a result of Tenant&#x2019;s use of the Premises.  In connection with such testing, upon the request of Landlord, Tenant shall deliver to Landlord or its consultant such non-proprietary information concerning the use of Hazardous Materials in or about the Premises by Tenant or any Tenant Party.  If contamination has occurred for which Tenant is liable under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 30</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, Tenant shall pay all costs to conduct such tests.  If no such contamination is found, Landlord shall pay the costs of such tests (which shall not constitute an Operating Expense).  Landlord shall provide Tenant with a copy of all third party, non-confidential reports and tests of the Premises made by or on behalf of Landlord during the Term without representation or </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">35</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">warranty and subject to a confidentiality agreement.  Tenant shall, at its sole cost and expense, promptly and satisfactorily remediate any environmental conditions identified by such testing in accordance with all Environmental Requirements.  Landlord&#x2019;s receipt of or satisfaction with any environmental assessment in no way waives any rights which Landlord may have against Tenant.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Control Areas</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall be allowed to utilize up to its pro rata share of the Hazardous Materials inventory within any control area or zone (located within the areas of the Premises designated on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit G</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">), as designated by the applicable building code, for chemical use or storage.  As used in the preceding sentence, Tenant's pro rata share of any control areas or zones located within the Premises shall be determined based on the rentable square footage that Tenant leases within the applicable control area or zone.  For purposes of example only, if a control area or zone contains 10,000 rentable square feet and 2,000 rentable square feet of a tenant's premises are located within such control area or zone (while such premises as a whole contains 5,000 rentable square feet), the applicable tenant's pro rata share of such control area or zone would be 20%.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Underground Tanks</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall have no right to install any underground or other storage tanks at the Project. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant&#x2019;s Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant&#x2019;s obligations under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 30</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> shall survive the expiration or earlier termination of this Lease.  During any period of time after the expiration or earlier termination of this Lease required by Tenant or Landlord to complete the removal from the Premises of any Hazardous Materials (including, without limitation, the release and termination of any licenses or permits restricting the use of the Premises and the completion of the approved Decommissioning and HazMat Closure Plan), Tenant shall continue to pay the full Rent in accordance with this Lease for any portion of the Premises not relet by Landlord in Landlord&#x2019;s sole discretion, which Rent shall be prorated daily.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(h)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Definitions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  As used herein, the term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Environmental Requirements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; means all applicable present and future statutes, regulations, ordinances, rules, codes, judgments, orders or other similar enactments of any Governmental Authority regulating or relating to health, safety, or environmental conditions on, under, or about the Premises or the Project, or the environment, including without limitation, the following:  the Comprehensive Environmental Response, Compensation and Liability Act; the Resource Conservation and Recovery Act; and all state and local counterparts thereto, and any regulations or policies promulgated or issued thereunder.  As used herein, the term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Hazardous Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; means and includes any substance, material, waste, pollutant, or contaminant listed or defined as hazardous or toxic, or regulated by reason of its impact or potential impact on humans, animals and/or the environment under any Environmental Requirements, asbestos and petroleum, including crude oil or any fraction thereof, natural gas liquids, liquefied natural gas, or synthetic gas usable for fuel (or mixtures of natural gas and such synthetic gas).  As defined in Environmental Requirements, Tenant is and shall be deemed to be the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">operator</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; of Tenant&#x2019;s &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">facility</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; and the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">owner</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; of all Hazardous Materials brought on the Premises by Tenant or any Tenant Party, and the wastes, by-products, or residues generated, resulting, or produced therefrom.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">31.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant&#x2019;s Remedies/Limitation of Liability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Notice of Landlord&#x2019;s Default</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall not be in default hereunder unless Landlord fails to perform any of its obligations hereunder within 30 days after written notice from Tenant specifying such failure (unless such performance will, due to the nature of the obligation, require a period of time in excess of 30 days, then after such period of time as is reasonably necessary).  Upon any default by Landlord, Tenant shall give notice by registered or certified mail to any Holder of a Mortgage covering the Premises and to any landlord of any lease of property in or on which the Premises are located and Tenant shall offer such Holder and/or landlord a reasonable opportunity to cure the default, including time to obtain possession of the Project by power of sale or a judicial action if such should prove necessary to effect a cure; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> Landlord shall have furnished to Tenant in writing the names and addresses of all such persons who are to receive such notices.  All obligations of Landlord hereunder shall be construed as </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">36</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">covenants, not conditions; and, except as may be otherwise expressly provided in this Lease, Tenant may not terminate this Lease for breach of Landlord&#x2019;s obligations hereunder.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant&#x2019;s Right to Cure.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  Notwithstanding the foregoing, if, at any time after the Commencement Date, any claimed Landlord default hereunder will immediately, materially and adversely affect Tenant&#x2019;s ability to conduct its business in the Premises (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Material Landlord Default</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), Tenant shall, as soon as reasonably possible, but in any event within 2 business days of obtaining knowledge of such claimed Material Landlord Default, give Landlord written notice of such claim (which notice shall specifically state that a Material Landlord Default exists and shall specify that Tenant intends to exercise its self help rights under this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 31(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">) and telephonic notice to Tenant&#x2019;s principal contact with Landlord.  Landlord shall then have the right within 5 business days after receipt of both written notice and telephonic notice to commence cure of such claimed Material Landlord Default and if commenced shall diligently prosecute such cure to completion.  If such claimed Material Landlord Default is not a default by Landlord hereunder, Landlord shall be entitled to recover from Tenant, as Additional Rent, any costs incurred by Landlord in connection with such cure.  If Landlord fails to commence cure of any claimed Material Landlord Default as provided above, then Tenant may commence and prosecute such cure to completion; provided that Tenant&#x2019;s cure efforts do not affect (i) any Building Systems affecting other tenants or areas outside the Premises, (ii) the Building exterior, structure and structural components, (iii) Common Areas, or (iv) any other tenant&#x2019;s use and enjoyment of their premises or the Project.  Tenant shall be entitled to recover the costs of such cure (but not any consequential or other damages) from Landlord by way of reimbursement from Landlord within 30 days after invoice with no right to offset against Rent, to the extent of Landlord&#x2019;s obligation to cure such claimed Material Landlord Default hereunder, subject to the limitations set forth in the immediately preceding sentence of this paragraph and the other provisions of this Lease.  Tenant, at its option, may elect to pursue any and all other rights and remedies expressly provided in this Lease.  In no event shall the provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 31(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> benefit any subtenant or be exercisable by subtenants against Landlord.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Limitation of Liability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  All obligations of Landlord under this Lease will be binding upon Landlord only during the period of its ownership of the Premises and not thereafter.  The term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; in this Lease shall mean only the fee owner for the time being of the Premises.  Upon the transfer by such owner of its interest in the Premises, such owner shall thereupon be released and discharged from all obligations of Landlord thereafter accruing, but such obligations shall be binding during the Term upon each new owner for the duration of such owner&#x2019;s ownership.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">32.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Inspection and Access</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord and its agents, representatives, and contractors may enter the Premises at any reasonable time on not less than 48 hours advance written notice (except in the case of emergencies in which case no such notice shall be required and such entry may be at any time) to inspect the Premises and to make such repairs as may be required or permitted pursuant to this Lease and for any other business purpose.  Landlord and Landlord&#x2019;s representatives may enter the Premises during business hours on not less than 48 hours advance written notice (except in the case of emergencies in which case no such notice shall be required and such entry may be at any time) for the purpose of effecting any such repairs, inspecting the Premises, showing the Premises to prospective purchasers and, during the last 18 months of the Term, to prospective tenants or for any other business purpose, provided that Landlord shall use commercially reasonable efforts to minimize any interference with Tenant&#x2019;s use of the Premises for the Permitted Use as a result of such entry.  During the last 18 months of the Term, Landlord may erect a suitable sign on the Building exterior or the property adjacent thereto stating the Premises are available to let, and at any time during the Term Landlord may erect suitable signage on the Project stating that the Project is available for sale.  Landlord may grant easements, make public dedications, designate Common Areas and create restrictions on or about the Premises, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> that no such easement, dedication, or restriction materially, adversely affects Tenant&#x2019;s use or occupancy of the Premises for the Permitted Use or access nor materially increases Tenant&#x2019;s obligations as provided in this Lease.  At Landlord&#x2019;s request, Tenant shall execute such instruments as may be reasonably necessary for such easements, dedications or restrictions.  Tenant shall at all times, except in the case of emergencies, have the right to escort Landlord or its agents, representatives, contractors or guests while the same are in the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">37</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Premises, provided such escort does not materially and adversely affect Landlord&#x2019;s access rights hereunder and Landlord shall not be required to reschedule its access more than once if Tenant&#x2019;s escort is unavailable.   To the extent that the access requirements set forth in this section prevent or delay Landlord&#x2019;s performance of its obligations under this Lease, then Landlord&#x2019;s failure to perform shall be excused and extended until such access is granted.   Landlord and its employees shall, and shall use commercially reasonable efforts to cause Landlord&#x2019;s agents and contractors to, cooperate and comply with Tenant&#x2019;s reasonable security protocols and measures (provided that such security protocols and measures have been previously provided in writing by Tenant to Landlord).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">33.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Security</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant acknowledges and agrees that security devices and services, if any, while intended to deter crime may not in given instances prevent theft or other criminal acts and that Landlord is not providing any security services with respect to the Premises.  Tenant agrees that Landlord shall not be liable to Tenant for, and Tenant waives any claim against Landlord with respect to, any loss by theft or any other damage suffered or incurred by Tenant in connection with any unauthorized entry into the Premises or any other breach of security with respect to the Premises.  Tenant shall be solely responsible for the personal safety of Tenant&#x2019;s officers, employees, agents, contractors, guests and invitees while any such person is in, on or about the Premises and/or the Project.  Tenant shall at Tenant&#x2019;s cost obtain insurance coverage to the extent Tenant desires protection against such criminal acts.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">34.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Force Majeure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Except for Tenant&#x2019;s obligation to timely pay Rent or either party&#x2019;s obligation to make any other payment due hereunder (which such obligation shall not under any circumstance be delayed or excused), neither Landlord nor Tenant shall be responsible or liable for delays in the performance of its obligations hereunder when such delay in performance is caused by, related to or arises out of acts of God, sinkholes or subsidence, strikes, labor stoppages, lockouts, or other labor disputes, embargoes, quarantines, declared states of emergency or public health emergencies, pandemics, epidemics, infectious disease, weather, national, regional, or local disasters, calamities, or catastrophes, inability to obtain labor or materials (or reasonable substitutes therefor) at reasonable costs or failure of, or inability to obtain, utilities necessary for performance, governmental decrees, laws, actions, restrictions, orders, limitations, regulations, or controls, regional, state, local, or national emergencies, delay in inspection by federal, state or local inspectors, officials or other applicable Governmental Authorities, delay in issuance or revocation of permits, approvals, certificates of occupancy, or entitlements, enemy or hostile governmental action, terrorism, insurrection, riots, civil disturbance or commotion, fire or other casualty, and any other causes or events beyond the reasonable control of the obligated party (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Force Majeure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">35.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Brokers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord and Tenant each represents and warrants that, other than Cushman &amp; Wakefield and CBRE (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Brokers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), it has not dealt with any broker, agent or other person entitled to a commission, compensation or fee in connection with this transaction.  Landlord and Tenant each hereby agree to indemnify and hold the other harmless from and against any claims by any broker, agent or other person or entity, other than the Brokers, claiming a commission or other form of compensation by virtue of having dealt with Tenant or Landlord, as applicable, with regard to this leasing transaction.  Landlord shall be responsible for all commissions due to the Brokers arising out of the execution of this Lease subject to and in accordance with the terms of a separate agreement(s) with the Brokers. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">36.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Limitation on Landlord&#x2019;s Liability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  NOTWITHSTANDING ANYTHING SET FORTH HEREIN OR IN ANY OTHER AGREEMENT BETWEEN LANDLORD AND TENANT TO THE CONTRARY:  (A) LANDLORD SHALL NOT BE LIABLE TO TENANT OR ANY OTHER PERSON FOR (AND TENANT AND EACH SUCH OTHER PERSON ASSUME ALL RISK OF) LOSS, DAMAGE OR INJURY, WHETHER ACTUAL OR CONSEQUENTIAL TO:  TENANT&#x2019;S PERSONAL PROPERTY OF EVERY KIND AND DESCRIPTION, INCLUDING, WITHOUT LIMITATION, TRADE FIXTURES, EQUIPMENT, INVENTORY, SCIENTIFIC RESEARCH, SCIENTIFIC EXPERIMENTS, LABORATORY ANIMALS, PRODUCT, SPECIMENS, SAMPLES, AND/OR SCIENTIFIC, BUSINESS, ACCOUNTING AND OTHER RECORDS OF EVERY KIND AND DESCRIPTION KEPT AT THE PREMISES AND ANY AND ALL INCOME DERIVED OR DERIVABLE THEREFROM; (B) THERE SHALL BE NO PERSONAL RECOURSE TO LANDLORD FOR ANY ACT OR OCCURRENCE IN, ON OR ABOUT THE PREMISES OR ARISING IN ANY WAY </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">38</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">UNDER THIS LEASE OR ANY OTHER AGREEMENT BETWEEN LANDLORD AND TENANT WITH RESPECT TO THE SUBJECT MATTER HEREOF AND ANY LIABILITY OF LANDLORD HEREUNDER SHALL BE STRICTLY LIMITED SOLELY TO LANDLORD&#x2019;S INTEREST IN THE PROJECT OR ANY PROCEEDS FROM SALE OR CONDEMNATION THEREOF AND ANY INSURANCE PROCEEDS PAYABLE IN RESPECT OF LANDLORD&#x2019;S INTEREST IN THE PROJECT OR IN CONNECTION WITH ANY SUCH LOSS; AND (C) IN NO EVENT SHALL ANY PERSONAL LIABILITY BE ASSERTED AGAINST LANDLORD IN CONNECTION WITH THIS LEASE NOR SHALL ANY RECOURSE BE HAD TO ANY OTHER PROPERTY OR ASSETS OF LANDLORD OR ANY OF LANDLORD&#x2019;S OFFICERS, DIRECTORS, EMPLOYEES, MANAGERS, AFFILIATES, AGENTS OR CONTRACTORS.  UNDER NO CIRCUMSTANCES SHALL LANDLORD OR ANY OF LANDLORD&#x2019;S OFFICERS, DIRECTORS, EMPLOYEES, MANAGERS, AFFILIATES, AGENTS OR CONTRACTORS BE LIABLE FOR INJURY TO TENANT&#x2019;S BUSINESS OR FOR ANY LOSS OF INCOME OR PROFIT THEREFROM</font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant acknowledges and agrees that ANY measures and/or services implemented at the Project, if any, intended to encourage social distancing (also referred to as physical distancing), promote and protect health and physical well-being and/or prevent or limit the spread or transmission of Infectious Conditions, may not prevent or limit the spread or transmission of such Infectious Conditions (IT BEING UNDERSTOOD AND AGREED THAT LANDLORD HAS NO OBLIGATION TO UNDERTAKE ANY SUCH MEASURES OR SERVICES AND HAS MADE NO REPRESENTATION THAT IT WILL UNDERTAKE (OR IF UNDERTAKEN, ENFORCE) ANY SUCH MEASURES OR SERVICES, NOR AS TO THE SUFFICIENCY OF ANY MEASURES OR SERVICES UNDERTAKEN BY LANDLORD IF LANDLORD UNDERTAKES ANY MEASURES OR SERVICES, AND TENANT WILL NOT RELY ON ANY MEASURES OR SERVICES UNDERTAKEN BY LANDLORD IF LANDLORD UNDERTAKES ANY MEASURES OR SERVICES).  Neither Landlord nor any Landlord Indemnified Parties shall have any liability and Tenant irrevocably releases and waives any claims against Landlord and the Landlord Indemnified Parties with respect to any loss, damage, injury or death in connection with (x) the implementation, MANNER OF IMPLEMENTATION, or failure of Landlord or any Landlord Indemnified Parties to implement OR ENFORCE, any measures and/or services at the Project intended to encourage social distancing (also referred to as physical distancing), promote and protect health and physical well-being and/or prevent or limit the spread or transmission of Infectious Conditions, or (y) the failure of any measures and/or services implemented at the Project, if any, to prevent or limit the spread or transmission of any Infectious Conditions.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">IN NO EVENT SHALL ANY PERSONAL LIABILITY BE ASSERTED AGAINST ANY OF TENANT&#x2019;S OFFICERS, DIRECTORS, EMPLOYEES ON ACCOUNT OF A DEFAULT BY TENANT.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">37.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Severability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If any clause or provision of this Lease is illegal, invalid or unenforceable under present or future laws, then and in that event, it is the intention of the Parties hereto that the remainder of this Lease shall not be affected thereby.  It is also the intention of the Parties to this Lease that in lieu of each clause or provision of this Lease that is illegal, invalid or unenforceable, there be added, as a part of this Lease, a clause or provision as similar in effect to such illegal, invalid or unenforceable clause or provision as shall be legal, valid and enforceable.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">38.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Signs; Exterior Appearance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Except as expressly provided in this Section 38, Tenant shall not, without the prior written consent of Landlord, which may be granted or withheld in Landlord&#x2019;s sole discretion:  (i) attach any awnings, exterior lights, decorations, balloons, flags, pennants, banners, painting or other projection to any outside wall of the Project, (ii) use any curtains, blinds, shades or screens other than Landlord&#x2019;s standard window coverings, (iii) coat or otherwise sunscreen the interior or exterior of any windows, (iv) place any bottles, parcels, or other articles on the window sills, (v) place any equipment, furniture or other items of personal property on any exterior balcony or terrace (including, without limitation, any terraces contained within the Premises), or (vi) paint, affix or exhibit on any part of the Premises or the Project any signs, notices, window or door lettering, graphics, placards, decorations, or advertising media </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">39</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">of any type which can be viewed from the exterior of the Premises.  At Tenant&#x2019;s election, to the extent permitted by Legal Requirements, and subject to Landlord&#x2019;s prior written approval of size, location and design (such approval not to be unreasonably withheld, conditioned or delayed), Landlord shall cause to be installed (at Tenant&#x2019;s sole cost and expense) the following signage:  (i) suite-entry signage on the entryway or immediately adjacent to such entryway of the Premises, (ii) Tenant&#x2019;s pro rata share (as reasonably determined by Landlord) of non-exclusive signage bearing Tenant&#x2019;s name and logo on the multi-tenant monument sign serving the Building, and (iii) Tenant&#x2019;s pro rata share (as reasonable determined by Landlord) of non-exclusive signage bearing Tenant&#x2019;s name and logo on the lobby multi-tenant signage of the Building, if any.  Tenant shall provide Landlord with the applicable signs and/or placards to be installed pursuant to the foregoing sentence.  All costs associated with the design, permitting, approval, fabrication, installation, maintenance, and removal (and associated repairs of damage to the Building and/or the monument sign due to Tenant&#x2019;s signage removal), shall be borne exclusively by Tenant. Tenant understands that light pollution from the interior of the Building would be a serious issue.  Accordingly, Tenant acknowledges and agrees that:  (x) all lighting in in Exterior Rooms must be controlled (at Tenant&#x2019;s expense) by switches with motion detectors that automatically turn off when the area is unoccupied, and Tenant will not override such switches; and (y) for any period from dusk to dawn that Tenant&#x2019;s lights are on in an Exterior Room, Tenant will use commercially reasonable efforts to keep its blinds closed in such Exterior Room unless there is a reasonable reason to keep them the blinds open.  If either (a) Tenant complies with the foregoing clauses (x) and (y) but the neighbors or City complain in writing to Landlord about light escaping from the Tenant&#x2019;s windows (an email being considered to be a writing for these purposes, and Landlord agreeing to share such written complaint with Tenant), or (b) Tenant does not comply with the foregoing clauses (i) and (ii) (either (a) or (b), a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lighting Issue</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), then Landlord will have the following rights (without derogation of Landlord&#x2019;s other rights and remedies set forth in this Lease).  The first (and any subsequent) time Landlord notifies Tenant of a Lighting Issue, Tenant will promptly propose and implement a plan to address the same, such plan being subject to Landlord&#x2019;s approval.  The second (and any subsequent) time Landlord notifies Tenant of a Lighting Issue, Landlord shall have the right (but not the obligation) to install powered blinds in some or all Exterior Rooms, as Landlord may elect, and at Tenant&#x2019;s expense.  The third (and any subsequent) time Landlord notifies Tenant of a Lighting Issue, Landlord shall have the right (but not the obligation) to program or reprogram any powered blinds installed by Landlord or Tenant to be closed from dusk to dawn (or any shorter period as Landlord may elect), and Tenant will not override the same.  The foregoing Landlord rights are cumulative and not alternative, meaning, by way of example, the third time Landlord notifies Tenant of a Lighting Issue, the Tenant must come up with and implement a remediation plan, Landlord may install powered blinds where it has not already done so already (if any windows remain), and Landlord may program or reprogram the powered blinds (if any).  For the purposes of the foregoing provisions, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exterior Room</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; shall mean any office, room and other area with a window visible from the exterior of the Building.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">39.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Right to Expand</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Expansion in the Building</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall have the right, but not the obligation, to expand the Premises (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Expansion Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) to include any Available Space upon the terms and conditions in this Section.  For purposes of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 39(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Available Space</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; shall mean any space in the Building, which after the initial lease-up of such space is not occupied by a tenant or which is occupied by an existing tenant whose lease is expiring within 6 months or less and such tenant does not wish to renew (whether or not such tenant has a right to renew) its occupancy of such space.  If there is any Available Space in the Building, Landlord shall, at such time as Landlord shall elect so long as Tenant&#x2019;s rights hereunder are preserved, deliver to Tenant written notice (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Expansion Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) of such Available Space, together with the terms and conditions on which Landlord is prepared to lease Tenant such Available Space (provided in the event there are at least five (5) years remaining on the Term as of the date of Landlord&#x2019;s delivery of the Expansion Notice, the Expansion Notice for such Available Space shall be for a term that is co-terminus with the existing Term). Tenant shall have 10 business days following delivery of the Expansion Notice to deliver to Landlord written notification of Tenant&#x2019;s exercise of the Expansion Right.  Provided that no right to expand is exercised by any tenant with superior rights, Tenant shall be entitled to lease such Available Space upon the terms and conditions set forth in the Expansion Notice.  Notwithstanding the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">40</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">foregoing, nothing herein shall prevent Landlord from keeping space vacant or from using space for Amenities or for Landlord&#x2019;s other purpose (or from leasing the space to affiliates of Landlord in connection therewith), and in any such case, Landlord shall not be required to give an Expansion Notice, Tenant shall not have an Expansion Right with respect thereto and such space shall not be considered Available Space.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Amended Lease</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If: (i) Tenant fails to timely deliver notice accepting the terms of an Expansion Notice, or (ii) after the expiration of a period of 30 days from the date Tenant gives notice accepting Landlord&#x2019;s offer to lease such Available Space, no lease amendment or lease agreement for the Available Space has been executed, and Landlord tenders to Tenant an amendment to this Lease setting forth the terms for the rental of the Available Space consistent with those set forth in the Expansion Notice and otherwise consistent with the terms of this Lease and Tenant fails to execute such Lease amendment within 10 business days following such tender, Tenant shall be deemed to have waived its right to lease such Available Space; provided that in the case of clause (i) Landlord shall again be required to deliver an Expansion Notice prior to leasing the Available Space (or a portion thereof) to a third party if Landlord does not enter into lease(s) for the subject Available Space or portion thereof, as applicable, within 12 months of the original Expansion Notice to a third party(ies) for at least 92.5% of the Net Effective Rental Rate offered to Tenant.  For purposes of this paragraph, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Net Effective Rental Rate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; shall mean the annual net rental rate payable to Landlord under a lease net of all tenant inducements (e.g., tenant improvement allowances, rental abatements, moving allowances), operating expense, and taxes, with the cost of such tenant inducements, together with interest thereon at a rate of eight percent (8%) per annum, amortized over the term of such lease.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exceptions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Notwithstanding the above, the Expansion Right shall, at Landlord&#x2019;s option, not be in effect and may not be exercised by Tenant:</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">if Tenant is not then occupying at least 67% of the Premises;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">during the final 24 months of the Term (unless Tenant then has the right to and validly concurrently exercises its right to extend the term in accordance with the requirements set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 40</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof);</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">during any period of time that Tenant is in Default under any provision of this Lease; or</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(iv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">if Tenant has been in Default under any provision of this Lease 3 or more times, whether or not the Defaults are cured, during any 12 month period prior to the date on which Tenant seeks to exercise the Expansion Right, whether or not the Defaults are cured. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The Expansion Right shall, at Landlord&#x2019;s option, terminate and be of no further force or effect even after Tenant&#x2019;s due and timely exercise of the Expansion Right, if, after such exercise, but prior to the commencement date of the lease of such Available Space, Tenant fails to timely cure any default by Tenant under this Lease.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Subordinate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant&#x2019;s Expansion Rights granted pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 39(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> above are and shall remain subject and subordinate to the right of Landlord and/or Landlord&#x2019;s affiliates (and/or any of their respective affiliates, successors and/or assigns) (i) to occupy all or a portion of the Available Space for its own purposes as a management and/or marketing office, or for common amenities serving the Project, or (ii) to elect to lease all or a portion of the Available Space to an affiliate of or third party to Landlord in connection with providing one or more of Alexandria Real Estate Equities, Inc.&#x2019;s proprietary products (such as, by way of example, LaunchLabs&#174; and GradLabs&#174;);</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rights Personal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Expansion Rights are personal to Kymera Therapeutics, Inc. and any assignee of this Lease under a Permitted Assignment (but not a subtenant) and otherwise are not </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">41</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">assignable without Landlord&#x2019;s consent, which may be granted or withheld in Landlord&#x2019;s sole discretion separate and apart from any consent by Landlord to an assignment of Tenant&#x2019;s interest in this Lease.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No Extensions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The period of time within which any Expansion Rights may be exercised shall not be extended or enlarged by reason of Tenant&#x2019;s inability to exercise the Expansion Rights.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">40.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Right to Extend Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. Tenant shall have the right to extend the Term of this Lease upon the following terms and conditions:</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Extension Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall have 2 consecutive rights (each, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Extension Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) to extend the term of this Lease for 5 years each (each, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Extension Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) on the same terms and conditions as this Lease (other than with respect to Base Rent, which shall be determined as set forth below, and the Work Letter, which shall not be applicable) by giving Landlord written notice (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Extension Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) of its election to exercise each Extension Right at least 12 months prior (but no earlier than 18 months prior) to the expiration of the Base Term of this Lease or the expiration of the then-current Extension Term.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Base Rent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Upon the commencement of any Extension Term, Base Rent shall be payable at the Market Rate (as defined below).  Base Rent shall thereafter be adjusted on each annual anniversary of the commencement of such Extension Term by a percentage as determined by Landlord and agreed to by Tenant at the time the Market Rate is determined or determined by arbitration as provided below.  As used herein, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Market Rate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; shall mean the rate that comparable landlords of comparable buildings have accepted in current transactions from non-equity (i.e., not being offered equity in the buildings) and nonaffiliated tenants of similar financial strength for space of comparable size, quality (including all Tenant Improvements, Alterations and other improvements) and floor height in Class A laboratory/office buildings in the Project and in the Watertown, Allston, Brighton and West Cambridge markets for a comparable term, with the determination of the Market Rate to take into account all relevant factors, including, without limitation, tenant inducements, views, available amenities (including, without limitation, the Amenities), age of the Building, age of mechanical systems serving the Premises, parking availability, leasing commissions, and allowances or concessions, if any.  Notwithstanding the foregoing, the Market Rate shall in no event be less than 95% of the Base Rent payable as of the date immediately preceding the commencement of the Extension Term increased by the Rent Adjustment Percentage multiplied by such Base Rent.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">If Tenant gives a valid Extension Notice, then Landlord shall deliver to Tenant Landlord&#x2019;s determination of the Market Rate no later than the later of (x) 30 days after delivery of Tenant&#x2019;s Extension Notice or (y) 11 months prior to the expiration of the Term.  If, on or before the date which is 180 days prior to the expiration of the Base Term of this Lease, Tenant has not agreed with Landlord&#x2019;s determination of the Market Rate and the rent escalations during the Extension Term after negotiating in good faith, Tenant shall be deemed to have elected arbitration as described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 40(c)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant acknowledges and agrees that, if Tenant has elected to exercise the Extension Right by delivering notice to Landlord as required in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 40(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, Tenant shall have no right thereafter to rescind or elect not to extend the term of this Lease for the Extension Term.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Arbitration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Within 10 business days of Tenant&#x2019;s deemed election to arbitrate Market Rate and escalations, each party shall deliver to the other a proposal containing the Market Rate and escalations that the submitting party believes to be correct (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Extension Proposal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  If Landlord fails to timely submit an Extension Proposal, Landlord&#x2019;s original submission will be used for this purpose.  If Tenant fails to timely submit an Extension Proposal, Landlord&#x2019;s submitted proposal shall determine the Base Rent and escalations for the Extension Term.  If both Parties submit Extension Proposals, then Landlord and Tenant shall meet within 7 business days after delivery of the last Extension Proposal and make a good faith attempt to mutually appoint a single Arbitrator (defined below) to determine the Market Rate and escalations.  If Landlord and Tenant are unable </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">42</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">to agree upon a single Arbitrator, then each shall, by written notice delivered to the other within 10 business days after the meeting, select an Arbitrator.  If either Party fails to timely give notice of its selection for an Arbitrator, the other party&#x2019;s submitted proposal shall determine the Base Rent for the Extension Term.  The 2 Arbitrators so appointed shall, within 5 business days after their appointment, appoint a third Arbitrator.  If the 2 Arbitrators so selected cannot agree on the selection of the third Arbitrator within the time above specified, then either Party, on behalf of both Parties, may request such appointment of such third Arbitrator by application to any state court of general jurisdiction in the jurisdiction in which the Premises are located, upon 10 days prior written notice to the other party of such intent.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The decision of the Arbitrator(s) shall be made within 30 days after the appointment of a single Arbitrator or the third Arbitrator, as applicable.  The decision of the single Arbitrator shall be final and binding upon the Parties.  The average of the two closest Arbitrators in a three Arbitrator panel shall be final and binding upon the Parties.  Each Party shall pay the fees and expenses of the Arbitrator appointed by or on behalf of such party and the fees and expenses of the third Arbitrator shall be borne equally by both Parties.  If the Market Rate and escalations are not determined by the first day of the Extension Term, then Tenant shall pay Landlord Base Rent in an amount equal to the Base Rent in effect immediately prior to the Extension Term and increased by the Rent Adjustment Percentage until such determination is made.  After the determination of the Market Rate and escalations, the Parties shall make any necessary adjustments to such payments made by Tenant.  Landlord and Tenant shall then execute an amendment recognizing the Market Rate and escalations for the Extension Term.</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">An &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Arbitrator</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; shall be any person appointed by or on behalf of either party or appointed pursuant to the provisions hereof and:  (i) shall be (A) a member of the American Institute of Real Estate Appraisers with not less than 10 years of experience in the appraisal of improved office and high tech industrial real estate in Greater Boston, or (B) a licensed commercial real estate broker with not less than 15 years&#x2019; experience representing landlords and/or tenants in the leasing of high tech or life sciences space in Greater Boston, (ii) devoting substantially all of their time to professional appraisal or brokerage work, as applicable, at the time of appointment and (iii) be in all respects impartial and disinterested.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rights Personal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Extension Rights are personal to Kymera Therapeutics, Inc. and any assignee of this Lease under a Permitted Assignment (but not a subtenant) and otherwise are not assignable without Landlord&#x2019;s consent, which may be granted or withheld in Landlord&#x2019;s sole discretion separate and apart from any consent by Landlord to an assignment of Tenant&#x2019;s interest in this Lease.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exceptions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Notwithstanding anything set forth above to the contrary, Extension Rights shall, at Landlord&#x2019;s option, not be in effect and Tenant may not exercise any of the Extension Rights:</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">if Tenant is not then occupying at least 67% of the Premises;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">during any period of time that Tenant is in Default under any provision of this Lease; or </font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">if Tenant has been in Default under any provision of this Lease 3 or more times, whether or not the Defaults are cured, during any 12 month period prior to the date that Tenant intends to exercise the Extension Right, whether or not the Defaults are cured. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No Extensions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The period of time within which any Extension Rights may be exercised shall not be extended or enlarged by reason of Tenant&#x2019;s inability to exercise the Extension Rights.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The Extension Rights shall, at Landlord&#x2019;s option, terminate and be of no further force or effect even after Tenant&#x2019;s due and timely exercise of an Extension Right, if, after such exercise, </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">43</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">but prior to the commencement date of an Extension Term, Tenant fails to timely cure any default by Tenant under this Lease.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">41.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shuttle Service</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  During the Term, Landlord may provide or otherwise arrange for (but shall not be obligated to provide or otherwise arrange for) Shuttle Service to and from the Project on weekdays (subject to weather conditions, holidays, Force Majeure), and Tenant&#x2019;s employees shall, subject to seating availability, have the right to use such Shuttle Service at all times that such Shuttle Service is in operation and available for use by tenants of the Project.  &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shuttle Service</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; shall mean shuttle bus service provided or contracted for by Landlord between the Project and various commuting locations in the Watertown/Cambridge/Boston area, as determined by Landlord from time to time. Landlord shall have the right to adjust the schedule, frequency, and route(s) of the Shuttle Service as it determines based upon usage. No fee shall be charged to any passenger that utilizes the Shuttle Service, provided that all costs of such Shuttle Service shall be included as part of Operating Expenses.  Tenant&#x2019;s use of the Shuttle Service shall be at Tenant&#x2019;s sole risk, and Tenant hereby acknowledges that Landlord shall have no liability with respect thereto.  Tenant shall indemnify, defend and hold Landlord harmless from and against any Claims by any of Tenant&#x2019;s employees or invitees related to the Shuttle Service or any personal injury or property damage related thereto or arising therefrom. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">42.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Roof Equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  As long as Tenant is not in Default under this Lease, Tenant shall have the right, at its sole cost and expense, subject to compliance with all Legal Requirements, to install, maintain, and remove on the area on the top of the roof of the Building shown on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit H</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> attached hereto, an emergency generator, rooftop condensers, and other comparable laboratory equipment as Tenant may request from time-to-time to the extent compatible with and space is available on core dunnage structural support previously erected by Landlord (if any) or otherwise on core dunnage structural support to be erected by Tenant in accordance with this Lease and subject to Landlord approval of the size and weight capacity thereof and plans and specifications therefor (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Roof Equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;). </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Requirements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall submit to Landlord for Landlord&#x2019;s approval (i) the plans and specifications for the installation of the Roof Equipment, (ii) copies of all required governmental, quasi-governmental and other permits, licenses, and authorizations that Tenant will and must obtain at its own expense, with the cooperation of Landlord, for the installation and operation of the Roof Equipment, and (iii) an insurance policy or certificate of insurance evidencing insurance coverage as required by this Lease and any other insurance as reasonably required by Landlord for the installation and operation of the Roof Equipment.  Landlord shall not unreasonably withhold or delay its approval for the installation and operation of the Roof Equipment; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, that Landlord may reasonably withhold its approval if the installation or operation of the Roof Equipment (A) may damage the structural integrity of the Building, (B) may void, terminate, or invalidate any applicable roof warranty, (C) may interfere with any service provided by Landlord or any tenant of the Building, (D) may reduce the leasable space in the Building, or (E) is not properly screened from the viewing public.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No Damage to Roof</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If installation of the Roof Equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">requires Tenant to make any roof cuts or perform any other roofing work, such cuts shall only be made to the roof area of the Building allocated to Tenant by Landlord and only in the manner designated in writing by Landlord; and any such installation work (including any roof cuts or other roofing work) shall be performed by Tenant, at Tenant&#x2019;s sole cost and expense by a roofing contractor designated by Landlord.  If Tenant or its agents shall cause any damage to the roof during the installation, operation, and removal of the Roof Equipment,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">such damage shall be repaired promptly at Tenant&#x2019;s expense and the roof shall be restored in the same condition it was in before the damage.  Landlord shall not charge Tenant Additional Rent for the installation and use of the Roof Equipment.  If, however, Landlord&#x2019;s insurance premium or Tax assessment increases as a result of the Roof Equipment, Tenant shall pay such increase as Additional Rent within ten (10) days after receipt of a reasonably detailed invoice from Landlord.  Tenant shall not be entitled to any abatement or reduction in the amount of Rent payable under this Lease if for any reason Tenant is unable to use the Roof Equipment.  In no event whatsoever shall the installation, operation, maintenance, or removal of the Roof Equipment by Tenant or its agents void, terminate, or invalidate any applicable roof warranty.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">44</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Protection</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The installation, operation, and removal of the Roof Equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">shall be at Tenant&#x2019;s sole risk.  Tenant shall indemnify, defend, and hold Landlord harmless from and against any and all claims, costs, damages, liabilities and expenses (including, but not limited to, attorneys&#x2019; fees) of every kind and description that may arise out of or be connected in any way with Tenant&#x2019;s installation, operation, or removal of the Roof Equipment.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Removal</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  At the expiration or earlier termination of this Lease or the discontinuance of the use of the Roof Equipment by Tenant, Tenant shall, at its sole cost and expense, remove the Roof Equipment from the Building.  Tenant shall leave the portion of the roof where the Roof Equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">was located in good order and repair, reasonable wear and tear excepted.  If Tenant does not so remove the Roof Equipment, Tenant hereby authorizes Landlord to remove and dispose of the Roof Equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and charge Tenant as Additional Rent for all costs and expenses incurred by Landlord in such removal and disposal.  Tenant agrees that Landlord shall not be liable for any Roof Equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">or related property disposed of or removed by Landlord.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No Interference</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall not permit the Roof Equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">to interfere with the proper functioning of any devices or equipment that have been installed or will be installed by Landlord or for any other tenant or future tenant of the Building.    </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Relocation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall have the right, at its expense and after 60 days prior notice to Tenant, to relocate the Roof Equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">to another site on the roof of the Building as long as such site reasonably meets Tenant&#x2019;s sight line and interference requirements and does not unreasonably interfere with Tenant&#x2019;s use and operation of the Roof Equipment.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Access</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord grants to Tenant the right of ingress and egress on a 24-hour 7-day per week basis to install, operate, and maintain the Roof Equipment.  Before receiving access to the roof of the Building, Tenant shall give Landlord at least 24 hours&#x2019; advance written or oral notice, except in emergency situations, in which case 2 hours&#x2019; advance oral notice shall be given by Tenant.  Landlord shall supply Tenant with the name and telephone number of the contact individual(s) responsible for providing access during emergencies.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(h)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Appearance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If permissible by Legal Requirements, the Roof Equipment shall be painted the same color as the Building so as to render the Roof Equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">virtually invisible from ground level.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No Assignment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The right of Tenant to use and operate the Roof Equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">shall be personal solely to Kymera Therapeutics, Inc., and its assignee or successor by virtue of a Permitted Assignment and (i) no other person or entity shall have any right to use or operate the Roof Equipment, and (ii) Tenant shall not assign, convey, or otherwise transfer to any person or entity any right, title, or interest in all or any portion of the Roof Equipment or the use and operation thereof.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(j)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Acknowledgement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant hereby acknowledges that (i) the Project is listed as a historic district on the National Register of Historic Places, and is subject to historic preservation restrictions by the instruments identified in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 44</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below, as well as local, state and federal requirements, (ii) as part of Tenant&#x2019;s obligation to comply with Legal Requirements, the Rooftop Equipment must comply with all such restrictions, and (iii) as a result, Tenant&#x2019;s ability to utilize the Rooftop Equipment may be frustrated.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">43.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Intentionally Omitted</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">44.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Disclosure of Encumbrances</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Acknowledgement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant hereby acknowledges that the Project is a historic site listed on the National Register of Historic Places that was formerly owned and operated by the United States Army for research and production of military weapons and related materials dating back to the mid-1800s, and </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">45</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">that such uses included those that impacted the environmental condition of the Project.  Accordingly, the Project is subject to various restrictions related to the historical significance of certain aspects of the Project and environmental contamination of other aspects of the Project.  Tenant has been given the opportunity to review all such matters to its satisfaction and Landlord makes no representations, warranties or assurances with respect thereto.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Deed</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Notwithstanding anything contained in this Lease to the contrary, the Premises (and Tenant&#x2019;s rights therein) are subject to all easements, restrictions and encumbrances now or hereafter of record so long as the same may be in force and effect, including without limitation all easements, restrictions and covenants contained in that certain Quitclaim Deed dated August 20, 1998, recorded with the Middlesex Southern District Registry of Deeds at Book 29012, Page 420, from the United States of America, acting by and through the Secretary of the Army (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Army</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), to the Watertown Arsenal Development Corporation, with respect to the Premises (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Army Deed</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), which Army Deed is incorporated by reference and includes, without limitation, (i) covenants in Part IV of the Army Deed associated with the Army&#x2019;s obligations under the Federal Facility Agreement between the Army and the United States Environmental Protection Agency and (ii) covenants in Part XI associated with certain historical resources at the Premises.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Environmental Grant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Notice is hereby given that a Grant of Environmental Restriction and Easement, dated August 11, 1998, pursuant to Massachusetts General Laws Chapter 21E, has been recorded by the Army with the Middlesex Southern District Registry of Deeds at Book 28978, Page 549; as amended by a First Amendment to Grant of Environmental Restriction and Easement, dated February 5, 1999, recorded at Book 29779, Page 359; as affected by a Subordination Agreement, dated March 16, 1999, recorded at Book 29957, Page 104; as further affected by a Subordination Agreement, dated March 24, 1999, recorded at Book 29985, Page 151; as further amended by a Second Amendment to Grant of Environmental Restriction and Easement, dated April 15, 1999, recorded at Book 30066, Page 116; as further affected by a Partial Release of Environmental Restriction and Easement, dated June 10, 1999, recorded at Book 30278, Page 511; as further amended by a Third Amendment to Grant of Environmental Restriction and Easement, dated June 7, 1999, recorded at Book 30278, Page 513; as further amended by a Fourth Amendment to Grant of Environmental Restriction and Easement, dated July 22, 2000, recorded at Book 31682, Page 99; as further amended by a Fifth Amendment to Grant of Environmental Restriction and Easement dated July 14, 2004, and recorded with said Registry of Deeds in Book 44119, Page 1; as affected by a plan entitled &#x201c;Plan Showing Excavation Areas B, E, and G in Watertown, Massachusetts,&#x201d; dated February 20, 2002, as revised on September 25, 2002, prepared by Dunn McKenzie, Inc., recorded as Plan No. 1348 of 2004; as further amended by a Sixth Amendment to Grant of Environmental Restriction and Easement dated March 21, 2005, and recorded with said Registry of Deeds in Book 45129, Page 1; as further affected by a plan entitled &#x201c;Plan Showing Commercial Reuse Area in Watertown, Massachusetts,&#x201d; dated October 25, 2004, as revised on March 16, 2005, prepared by Dunn McKenzie, Inc., recorded as Plan No. 523 of 2005; as further amended by a Seventh Amendment to Grant of Environmental Restriction and Easement dated August 9, 2006, and recorded with said Registry of Deeds in Book 48562, Page 187; and as further affected by a plan entitled &#x201c;Plan Showing Commercial Reuse Area in Watertown, Massachusetts,&#x201d; dated August 16, 2004, as revised on March 16, 2005 and February 10, 2006, prepared by Dunn McKenzie, Inc., recorded as Plan No. 1480 of 2006 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Grant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  This restriction on the activities conducted on the Premises and use limitations contained in the Grant are hereby incorporated by reference and shall be independently enforceable by the Army under the Grant as a restrictive covenant and equitable servitude.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Activity and Use Limitations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Notice is hereby further given that the following three (3) Notices of Activity and Use Limitations, pursuant to Massachusetts General Laws Chapter 21E, have been recorded with the Middlesex Southern District Registry of Deeds:  (i) dated August 11, 1998, recorded at Book 28959, Page 92; (ii) dated August 11, 1998, recorded at Book 28959, Page 190, as amended by a First Amendment to Notice of Activity and Use Limitations, dated October 26, 1999, recorded at Book 30801, Page 319, as further amended by a Second Amendment to Notice of Activity and Use Limitations, dated December 9, 2019, recorded at Book 73807, Page 226; and (iii) dated February 4, 1999, recorded at Book 29766, Page </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">46</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">17, as amended by a First Amendment to Notice of Activity and Use Limitations, dated August 19th, 2004, recorded at Book 43589, Page 438, and as further amended by a Second Amendment to Notice of Activity and Use Limitation, dated February 28, 2005, recorded at Book 44737, Page 453 (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Notices of AULs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;). The restriction on activities conducted on the Premises and use limitations contained in the Notices of AULs are hereby incorporated by reference and shall be independently enforceable by the Army as a restrictive covenant and equitable servitude.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">45.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Miscellaneous</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  All notices or other communications between the Parties shall be in writing and shall be deemed duly given upon delivery or refusal to accept delivery by the addressee thereof if delivered in person, or upon actual receipt if delivered by reputable overnight guaranty courier, addressed and sent to the Parties at their addresses set forth above.  Landlord and Tenant may from time to time by written notice to the other designate another address for receipt of future notices.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Joint and Several Liability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If and when included within the term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,&#x201d; as used in this instrument, there is more than one person or entity, each shall be jointly and severally liable for the obligations of Tenant.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Financial Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall furnish Landlord  with true and complete copies of (i) Tenant&#x2019;s most recent audited annual financial statements within 90 days of the end of each of Tenant&#x2019;s fiscal years during the Term, (ii) Tenant&#x2019;s most recent unaudited quarterly financial statements within 45 days of the end of each of Tenant&#x2019;s fiscal quarters during each of Tenant&#x2019;s fiscal years during the Term, (iii) at Landlord&#x2019;s request from time to time, updated business plans, including cash flow projections and/or pro forma balance sheets and income statements, all of which shall be treated by Landlord as confidential information belonging to Tenant, (iv) corporate brochures and/or profiles prepared by Tenant for prospective investors, and (v) any other financial information or summaries that Tenant typically provides to its lenders or shareholders.  So long as Tenant is a &#x201c;public company&#x201d; and its financial information is publicly available, then the foregoing delivery requirements of this Section 45(c) shall not apply.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Recordation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Except as expressly set forth herein, neither this Lease nor a notice of lease shall be filed by or on behalf of Tenant in any public record. This Lease shall not be filed by or on behalf of Tenant in any public record, except as required by law in connection with Tenant&#x2019;s SEC obligations (if any).   At the request of either party, Landlord shall prepare, and Tenant will execute, a notice of lease in the statutory form containing only the minimum information required by law, which Tenant shall then cause to have recorded in the applicable public record at Tenant&#x2019;s expense.  If a notice of lease shall be filed, prior to the expiration or earlier termination of this Lease and as a condition to satisfaction of Tenant&#x2019;s requirements to surrender the Premises, Tenant shall execute and deliver to Landlord a duly executed and acknowledged notice of expiration or termination of lease in a mutually acceptable form (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Notice of Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), acknowledging the expiration or termination of this Lease. For the avoidance of doubt, at Landlord&#x2019;s election, Tenant will be considered to be holding over in the Premises and subject to Landlord&#x2019;s rights and remedies for a holdover unless and until Tenant has executed and delivered to Landlord such a Notice of Termination, whether or not a subsequent tenant is then in occupancy.  This Section 45(d) shall survive the expiration or earlier termination of this Lease. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Interpretation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Lease or any exhibits or amendments hereto.  Words of any gender used in this Lease shall be held and construed to include any other gender, and words in the singular number shall be held to include the plural, unless the context otherwise requires.  The captions inserted in this Lease are for convenience only and in no way define, limit or otherwise describe the scope or intent of this Lease, or any provision hereof, or in any way affect the interpretation of this Lease.  Each term and provision of this Lease to be performed and observed by Tenant shall be construed to be both a covenant and a condition.  Tenant&#x2019;s covenants contained in this Lease are independent and not dependent, and Tenant hereby waives the benefit of any statute or judicial law to the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">47</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">contrary. Tenant&#x2019;s obligation to pay Rent shall not be discharged or otherwise affected by any law or regulation now or hereafter applicable to the Premises, or any other restriction on Tenant&#x2019;s use, or (except as expressly provided in this Lease) any casualty or taking, or any failure by Landlord to perform any covenant contained herein, or any other occurrence; and no termination or abatement remedy that is not expressly provided for in this Lease for any breach or failure by Landlord to perform any obligation under this Lease shall be implied or applicable as a matter of law.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Not Binding Until Executed</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The submission by Landlord to Tenant of this Lease shall have no binding force or effect, shall not constitute an option for the leasing of the Premises, nor confer any right or impose any obligations upon either party until execution of this Lease by both Parties.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Limitations on Interest</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  It is expressly the intent of Landlord and Tenant at all times to comply with applicable law governing the maximum rate or amount of any interest payable on or in connection with this Lease.  If applicable law is ever judicially interpreted so as to render usurious any interest called for under this Lease, or contracted for, charged, taken, reserved, or received with respect to this Lease, then it is Landlord&#x2019;s and Tenant&#x2019;s express intent that all excess amounts theretofore collected by Landlord be credited on the applicable obligation (or, if the obligation has been or would thereby be paid in full, refunded to Tenant), and the provisions of this Lease immediately shall be deemed reformed and the amounts thereafter collectible hereunder reduced, without the necessity of the execution of any new document, so as to comply with the applicable law, but so as to permit the recovery of the fullest amount otherwise called for hereunder.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(h)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Choice of Law</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Construction and interpretation of this Lease shall be governed by the internal laws of the Commonwealth of Massachusetts, excluding any principles of conflicts of laws.  Each of Landlord and Tenant acknowledges and agrees that all disputes arising, directly or indirectly, out of or relating to this Lease shall be dealt with by application of the laws of the Commonwealth of Massachusetts and adjudicated in the state courts of the Commonwealth of Massachusetts sitting in Middlesex County or the United States District Court for the District of Massachusetts; and hereby expressly and irrevocably submits to the jurisdiction of such courts in any suit, action or proceeding arising, directly or indirectly, out of or relating to this Lease.  So far as is permitted under the applicable law, this consent to personal jurisdiction shall be self-operative and no further instrument or action, other than service of process in one of the manners permitted by law, shall be necessary in order to confer jurisdiction upon either party in any such court.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Time</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Time is of the essence as to the performance of Tenant&#x2019;s obligations under this Lease.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(j)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">OFAC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant and all beneficial owners of Tenant are currently (a) in compliance with and shall at all times during the Term of this Lease remain in compliance with the regulations of the Office of Foreign Assets Control (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">OFAC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) of the U.S. Department of Treasury and any statute, executive order, or regulation relating thereto (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">OFAC Rules</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), (b) not listed on, and shall not during the Term of this Lease be listed on, the Specially Designated Nationals and Blocked Persons List, Foreign Sanctions Evaders List, or the Sectoral Sanctions Identification List, which are all maintained by OFAC and/or on any other similar list maintained by OFAC or other governmental authority pursuant to any authorizing statute, executive order, or regulation, and (c) not a person or entity with whom a U.S. person is prohibited from conducting business under the OFAC Rules.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord and all beneficial owners of Landlord are currently (a) in compliance with and shall at all times during the Term of this Lease remain in compliance with the regulations of the Office of Foreign Assets Control (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">OFAC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) of the U.S. Department of Treasury and any statute, executive order, or regulation relating thereto (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">OFAC Rules</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), (b) not listed on, and shall not during the Term of this Lease be listed on, the Specially Designated Nationals and Blocked Persons List, Foreign Sanctions Evaders List, or the Sectoral Sanctions Identification List, which are all maintained by OFAC and/or on any other similar list maintained by OFAC or other governmental authority pursuant to any authorizing statute,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">48</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">executive order, or regulation, and (c) not a person or entity with whom a U.S. person is prohibited from conducting business under the OFAC Rules.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The provisions of this subsection (j) shall not apply to any interests in Tenant or Landlord held as shares publicly traded on a nationally recognized U.S. stock exchange.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(k)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Incorporation by Reference</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  All exhibits and addenda attached hereto are hereby incorporated into this Lease and made a part hereof.  If there is any conflict between such exhibits or addenda and the terms of this Lease, such exhibits or addenda shall control.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(l)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Entire Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  This Lease, including the exhibits attached hereto, constitutes the entire agreement between Landlord and Tenant pertaining to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, letters of intent, negotiations and discussions, whether oral or written, of the Parties, and there are no warranties, representations or other agreements, express or implied, made to either party by the other party in connection with the subject matter hereof except as specifically set forth herein.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(m)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No Accord and Satisfaction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  No payment by Tenant or receipt by Landlord of a lesser amount than the monthly installment of Base Rent or any Additional Rent will be other than on account of the earliest stipulated Base Rent and Additional Rent, nor will any endorsement or statement on any check or letter accompanying a check for payment of any Base Rent or Additional Rent be an accord and satisfaction.  Landlord may accept such check or payment without prejudice to Landlord&#x2019;s right to recover the balance of such Rent or to pursue any other remedy provided in this Lease.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(n)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Hazardous Activities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Notwithstanding any other provision of this Lease, Landlord, for itself and its employees, agents and contractors, reserves the right to refuse to perform any repairs or services in any portion of the Premises which, pursuant to Tenant&#x2019;s routine safety guidelines, practices or custom or prudent industry practices, require any form of protective clothing or equipment other than safety glasses.  In any such case, Tenant shall contract with parties who are acceptable to Landlord, in Landlord&#x2019;s reasonable discretion, for all such repairs and services, and Landlord shall, to the extent required, equitably adjust Tenant&#x2019;s Share of Operating Expenses in respect of such repairs or services to reflect that Landlord is not providing such repairs or services to Tenant.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(o)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Redevelopment of Project</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant acknowledges that Landlord intends to undertake significant renovations and/or construction at the Project, including, without limitation, for lab, office and retail uses, and including, without limitation, the creation of one or more Amenities or Amenity buildings or centers.  Landlord expressly reserves the right, in its sole discretion, from time to time to expand, develop, renovate, redevelop, alter, improve, maintain, construct, demolish, relocate and/or reconfigure the Project (or portions thereof) and buildings, Common Areas (including parking and site drives) and other improvements therein, as the same may exist from time to time and, in connection therewith or in addition thereto, as the case may be, from time to time without limitation:  (a) change the shape, size, location, number and/or extent or existence of any improvements, buildings, structures, lobbies, hallways, entrances, exits, parking and/or parking areas; (b) modify, eliminate and/or add any buildings, improvements, and parking structure(s) either above or below grade, from or to the Project, the Amenities or other Common Areas and/or any other portion of the Project and/or make any other changes thereto affecting the same; (c) amend any existing land use and zoning approvals for the Project (including, without limitation, any special permit applicable to the Project) and seek additional approvals, relief or zoning amendments in connection with any future expansion, development, renovation, redevelopment, alteration, demolition, relocation, improvement, operation, maintenance or repair of the Project (including, without limitation, the Common Areas); and (d) make any other changes, additions and/or deletions in any way affecting the Project and/or any portion thereof as Landlord may elect from time to time, including without limitation, creation and/or elimination of, and/or additions to and/or deletions from, the land comprising the Project, the Amenities or other Common Areas and/or any other portion of the Project.  Landlord shall have the right, in connection with such contemplated activities, to subject the Project and its appurtenant rights to </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">49</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">easements for the construction, reconstruction, alteration, demolition, relocation, improvement, operation, repair or maintenance of elements thereof, for access and egress, for parking, for the installation, maintenance, repair, replacement or relocation of utilities serving the Project, and to subject the Project to such other rights, agreements, and covenants for such purposes as Landlord may determine; provided that such rights, agreements, and covenants do not (i) change Tenant&#x2019;s Permitted Use of the Premises, (ii) materially increase any of Tenant&#x2019;s obligations pursuant  to this Lease, or (iii) materially reduce any of Tenant&#x2019;s express rights pursuant to this Lease.  This Lease shall be subject and subordinate to all such matters.  For the avoidance of doubt, however, Landlord shall have no obligation to undertake any action described in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 45(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, and Tenant is not entering into this Lease in reliance of Landlord making any alteration to the Project (other than construction of the Building) or any other action described in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 45(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant hereby agrees that this Lease shall be subject and subordinate to any expansion, development, renovation, redevelopment, alteration, improvement, maintenance, demolition, relocation and/or reconfiguration activity, or any other matter set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 45(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, and, in connection with such activity or matter.  Landlord may, from time to time, cause the rentable square footage of the Premises, the Building and/or the Project to be remeasured by Landlord&#x2019;s architect. Neither Tenant nor any affiliate of Tenant shall take any action, directly or indirectly, to oppose any of the foregoing activities by Landlord or its affiliates. Landlord and its agents, employees, licensees and contractors shall also have the right to undertake work pursuant to any actions contemplated above; to shore up the foundations and/or walls of the Building (or any other structures within the Project); to erect scaffolding and protective barricades around, within or adjacent to the Building (or any other structures within the Project); to close off Common Areas; and to do any other act necessary for the safety of the Building (or any other structures within the Project) or the expeditious completion of such work.  Tenant acknowledges that construction noise, vibrations and dust, and alterations of traffic patterns or parking, associated with construction activities are to be expected during the course of such construction.  Notwithstanding anything to the contrary contained in this Lease, Tenant shall have no right to cancel or terminate this Lease and Landlord shall not be liable to Tenant for any damages, compensation or reduction of Rent by reason of (i) inconvenience or annoyance or for loss of business resulting from any act by Landlord pursuant to this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 45(o)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, or (ii) any changes, expansion, renovation or reconfiguration of the Project; nor shall Tenant have the right to restrict, inhibit or prohibit any such changes, expansion, renovation or reconfiguration.  Landlord shall not change Tenant&#x2019;s Permitted Use of the Premises, and Landlord shall use commercially reasonable efforts to mitigate the impacts of Landlord&#x2019;s construction activities on the Premises.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">   </font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(p)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Discontinued Use.  E</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">xcept as set forth below in this subsection (p), if, at any time following the Commencement Date, Tenant does not continuously operate its business in the Premises for a period of 90 consecutive days, Landlord may, but is not obligated to, elect to terminate this Lease upon 30 days&#x2019; written notice to Tenant, whereupon this Lease shall terminate 30 days after Landlord&#x2019;s delivery of such written notice (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Termination Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), and Tenant shall vacate the Premises and deliver possession thereof to Landlord in the condition required by the terms of this Lease on or before the Termination Date and Tenant shall have no further obligations under this Lease except for those accruing prior to the Termination Date and those which, pursuant to the terms of this Lease, survive the expiration or early termination of this Lease; provided, however, that such termination notice shall be null and void and the Term shall continue if Tenant in good faith resumes full operations in the Premises prior to the Termination Date and timely certifies to Landlord the same in writing. Further, and notwithstanding the foregoing, Landlord shall not have such termination right if Tenant provides Landlord with reasonable advance notice prior to stopping operations and, at the time of stopping operations, (i) Tenant completes Tenant&#x2019;s obligations under the Decommissioning and HazMat Closure Plan in compliance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 28</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, (ii) Tenant has obtained the release of the Premises of all Hazardous Materials Clearances and the Premises are free from any residual impact from the Tenant HazMat Operations, and Tenant provides reasonably detailed documentation to Landlord confirming such matters, (iii) Tenant has made reasonable arrangements with Landlord for the security of the Premises for the balance of the Term, and (iv) Tenant continues during the balance of the Term to satisfy and perform all of Tenant&#x2019;s obligations under this Lease as they come due; provided that, </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. - Page </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">50</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">for reasonable periods due to casualty, alterations, Tenant shall only be required to comply with clauses (i), (iii), and (iv).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(q)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Counterparts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  This Lease may be executed in 2 or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature process complying with the U.S. federal ESIGN Act of 2000) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.  Electronic signatures shall be deemed original signatures for purposes of this Lease and all matters related thereto, with such electronic signatures having the same legal effect as original signatures.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(r)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Non-Disclosure of Terms</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant acknowledges and agrees that the terms of this Lease are confidential and constitute proprietary information of Landlord.  Disclosure of such terms may adversely affect the ability of Landlord and its affiliates to negotiate, manage, and administer other leases and impair Landlord&#x2019;s relationship with other tenants. Accordingly, as a material inducement for Landlord to enter into this Lease, Tenant, on behalf of itself and its partners, managers, members, officers, directors, employees, agents, and attorneys, agrees that it shall not disclose the terms and conditions of this Lease to any publication or other media or any tenant or apparent prospective tenant of the Building or other portion of the Project, or real estate agent or broker, either directly or indirectly.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(s)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Prevailing Party&#x2019;s Fees</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  In the event that either party should bring suit or commence any suit or proceeding related to this Lease, then all reasonable out of pocket fees, costs and expenses, including reasonable attorneys&#x2019; fees and expert fees, incurred by the prevailing party relating to such legal action shall be paid by the other party, which obligation on the part of the other party shall be deemed to have accrued on the date of the commencement of such action and shall be enforceable whether or not the action is prosecuted to judgment.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">[ Signatures on next page ]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">IN WITNESS WHEREOF, Landlord and Tenant have executed this Lease as of the day and year first above written.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TENANT</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">:</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Kymera THERAPEUTICS, INC.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">a Delaware corporation</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">By:       </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">/s/ Bruce Jacobs	</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Name: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Bruce Jacobs	</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Title:    </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">CFO	</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> I hereby certify that the signature, name, and</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">title above are my signature, name and title.</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">LANDLORD</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">:</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ARE-MA Region No. 75, LLC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">a Delaware limited liability company</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">By:  Alexandria Real Estate Equities, L.P.,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">                                                                                     a Delaware limited partnership,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:43.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> managing member</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">                                                                                     &#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">                                                                                     By:  ARE-QRS Corp.,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">                                                                                            a Maryland corporation,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:47.507%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">general partner</font></p>
  <p style="margin-left:40.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">             By:        </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">/s/ Allison Grochola	</font></p>
  <p style="margin-left:40.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">             Name:   </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Allison Grochola	</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">               Title:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">     </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SVP &#x2013; Real Estate Legal Affairs	</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#xf078;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> I hereby certify that the signature, name, and</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">title above are my signature, name and title.</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_0.jpg" alt="img10132136_0.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> IF &#34; DOCVARIABLE &#34;SWDocIDLocation&#34; 1&#34; = &#34;1&#34; &#34; DOCPROPERTY &#34;SWDocID&#34; ACTIVEUS 187586682v.10&#34; &#34;&#34; ACTIVEUS 187586682v.10</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT A</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">DESCRIPTION OF PREMISES</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><img src="img10132136_2.jpg" alt="img10132136_2.jpg" style="width:91px;height:37px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">AOTC Building 1, Floor 1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img10132136_3.jpg" alt="img10132136_3.jpg" style="width:624px;height:302px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">AOTC Building 1, Floor 2 &#x2013; Suite 201</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img10132136_4.jpg" alt="img10132136_4.jpg" style="width:624px;height:290px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">AOTC Building 1, Floor 3 &#x2013; Suite 301</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img10132136_5.jpg" alt="img10132136_5.jpg" style="width:571px;height:277px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">AOTC Building 1, Floor 4 &#x2013; Suite 401</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img10132136_6.jpg" alt="img10132136_6.jpg" style="width:590px;height:267px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">AOTC Building 1, Penthouse</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img10132136_7.jpg" alt="img10132136_7.jpg" style="width:593px;height:166px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. B</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT B</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:18.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">DESCRIPTION OF PROJECT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">A certain parcel of land with the buildings thereon situated on the Southerly side of Arsenal Street in Watertown, Middlesex County, Massachusetts and being shown as Lot 1 on a plan entitled &#x201c;Plan of Land in Watertown, Massachusetts&#x201d; dated June 19, 1997, prepared by Dunn-McKenzie, Inc. and recorded with the Middlesex South Registry of Deeds on August 5, 1998 as Plan No. 832 in Book 28930, Page 478, bounded and described as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Beginning on the southerly sideline of Arsenal Street at the Northwesterly corner of Arsenal Associates Land being the Northeasterly corner of Lot 1 on the easterly sideline of Talcott Street (a private road); thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SOUTH 13&deg; 53&#x2019;-39&#x201d; WEST	a distance of 737.70 feet by Arsenal Associates and Town of Watertown land to an angle in said property; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SOUTH 11&deg; 42&#x2019;-25&#x201d; EAST	a distance of 2.67 feet to a corner of Lot 2; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">NORTH 76&deg; 03&#x2019;-07&#x201d; WEST	a distance of 438.96 feet through a granite bound to a Hex-rod (set) for a corner; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SOUTH 19&deg; 17&#x2019;-48&#x201d; WEST	a distance of 125.38 feet to an Iron Rod (set) for a corner; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SOUTH 50&deg; 21&#x2019;-36&#x201d; WEST	a distance of 163.25 feet to an Iron Rod (set) at North Beacon Street on curve for a corner; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">NORTHWESTERLY	on a curve to the right having a radius of 586.00 feet, an arc distance of 160.79 feet to the point of tangency; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">NORTH 20&deg; 36&#x2019;-23&#x201d; WEST	a distance of 292.07 feet to the point of curvature; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">NORTHWESTERLY	on a curve to the left having a radius of 627.44 feet, an arc distance of 465.40 feet to the point of tangency; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">NORTH 63&deg; 06&#x2019;-20&#x201d; WEST	a distance of 707.76 feet to a slight angle break; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">NORTH 63&deg; 43&#x2019;50&#x201d; WEST	a distance of 101.12 feet to a corner of land of Burnham Manning Post #1105-Veterans of Foreign Wars of U.S.A., Inc. the last five courses being by North Beacon Street; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">NORTH 25&deg; 59&#x2019;-00&#x201d; EAST	a distance of 435.94 feet to a corner of Arsenal Street; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SOUTH 69&deg; 39&#x2019;-19&#x201d; EAST	a distance of 1455.13 feet to a Stone Bound at a slight angle break; thence</font></p>
  <p style="text-indent:-36.364%;padding-left:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SOUTH 68&deg; 05&#x2019;-21&#x201d; EAST	a distance of 451.60 feet to a corner at the point and place of beginning, the last two courses being by Arsenal Street.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lot 1 contains 1,281,841 square feet (29.42 Acres) more or less.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT C</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">WORK LETTER</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">This WORK LETTER (this &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Work Letter</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) is incorporated into that certain Lease Agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lease</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) dated as of December 20, 2021, by and between ARE-MA REGION NO. 75, LLC, a Delaware corporation (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;), and </font><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Kymera Therapeutics, Inc.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, a Delaware corporation (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;).  Any initially capitalized terms used but not defined herein shall have the meanings given them in the Lease.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">General Requirements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's Authorized Representative</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant designates Kevin Dushney and Bruce Jacobs (either such individual acting alone, &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's Representative</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) as the only persons authorized to act for Tenant pursuant to this Work Letter.  Landlord shall not be obligated to respond to or act upon any request, approval, inquiry or other communication (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Communication</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) from or on behalf of Tenant in connection with this Work Letter unless such Communication is in writing from Tenant's Representative.  Tenant may change either Tenant's Representative at any time upon not less than 5 business days advance written notice to Landlord.  Neither Tenant nor Tenant's Representative shall be authorized to direct Landlord's contractors in the performance of Landlord's Work (as hereinafter defined).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord's Authorized Representative</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord designates Suzie Markin and Dante Angelucci (either such individual acting alone, &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord's Representative</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) as the only persons authorized to act for Landlord pursuant to this Work Letter.  Tenant shall not be obligated to respond to or act upon any request, approval, inquiry or other Communication from or on behalf of Landlord in connection with this Work Letter unless such Communication is in writing from Landlord's Representative.  Landlord may change either Landlord's Representative at any time upon not less than 5 business days advance written notice to Tenant. Landlord's Representative shall be the sole persons authorized to direct Landlord's contractors in the performance of Landlord's Work.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Architects, Consultants and Contractors</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord and Tenant hereby acknowledge and agree that: (i) AECOM Tishman shall be the general contractor, (ii) any subcontractors for the Tenant Improvements shall be selected by Landlord, (iii) OTJ Architects shall be the architect (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TI Architect</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) for the Tenant Improvements, and (iv) BR+A Consulting Engineers shall be the MEP/FP engineer for the Tenant Improvements.   Tenant shall contract directly with the TI Architect and BR+A Consulting Engineer.  Landlord shall be named a third party beneficiary of any contract entered into by Tenant with the TI Architect, BR+A Consulting Engineers, and any other consultant providing design or engineering services for the Tenant Improvements, including any warranty made by any of the foregoing.  Tenant shall deliver copies of all such contracts to Landlord.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Improvements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Base Building</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  All aspects of the design, permitting and construction of the Building shall be determined by Landlord in its sole and absolute discretion (other than certain aspects of the Tenant Improvements (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 2(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below) within the interior of the Premises, which shall be subject to the input of Tenant to the extent expressly set forth herein below). </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant Improvements Defined</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  As used herein, &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant Improvements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34; shall mean all improvements to the Premises of a fixed and permanent nature as shown on the TI Construction Drawings, as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 2(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below.  Other than Landlord's Work (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 3(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below), Landlord shall not have any obligation whatsoever with respect to the finishing of the Building or the Premises for Tenant's use and occupancy. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's Space Plans</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant has delivered to Landlord and the TI Architect, and Landlord has approved, the schematic drawings and outline specifications attached to this Work Letter as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> (the &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TI Design Drawings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) detailing Tenant's requirements for the Tenant Improvements. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Working Drawings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Not later than June 28, 2022, Tenant shall cause the TI Architect to prepare and deliver to Landlord for review and comment or approval construction plans, specifications and drawings for the Tenant </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Improvements (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Proposed TI Construction Drawings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;), which Proposed TI Construction Drawings shall be prepared substantially in accordance with the TI Design Drawings.  Tenant shall be solely responsible for ensuring that the Proposed TI Construction Drawings reflect Tenant's requirements for the Tenant Improvements.  Landlord shall deliver its written comments on the Proposed TI Construction Drawings to Tenant not later than 14 days after Landlord's receipt of the same; provided, however, that Landlord may not disapprove any matter that is consistent with the TI Design Drawings previously approved in writing by Landlord (provided it does not affect the base Building, structural components of the Building, Building systems or the project schedule).  Tenant shall resubmit revised Proposed TI Construction Drawings to Landlord addressing Landlord&#x2019;s comments for Landlord&#x2019;s review, comment or approval, and the foregoing process will be repeated until Landlord approves the  Proposed TI Construction Drawings, which shall then be referred to as the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TI Construction Drawings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.&#x201d;  Any disputes in connection with such comments shall be resolved in accordance with </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 2(e)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof.  Once approved by Landlord, subject to the provisions of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below, Tenant shall not materially modify the TI Construction Drawings except as may be reasonably required in connection with the issuance of the TI Permit (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 3(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Approval and Completion</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  It is hereby acknowledged by Landlord and Tenant that the TI Construction Drawings must be completed and approved by Landlord and Tenant not later than July 26, 2022, in order for the Landlord's Work to be Substantially Complete by the Target Commencement Date (as defined in the Lease), and it shall be a Tenant Delay, without further notice from Landlord, if the TI Construction Drawings are not completed and approved by Landlord and Tenant by such date.  Upon any dispute regarding the design of the Tenant Improvements, which is not settled within 14 days after delivery of written notice of such dispute is delivered by one party to the other, Tenant may make the final decision regarding the design of the Tenant Improvements, provided (i) Tenant acts reasonably and such final decision is either consistent with or a compromise between Landlord's and Tenant's positions with respect to such dispute, (ii) that all costs and expenses resulting from any such decision by Tenant shall be payable out of the TI Fund (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 5(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below), and (iii) Tenant's decision will not affect the base Building, structural components of the Building, any Building systems, or the project schedule.  Any changes to the TI Construction Drawings following Landlord's and Tenant's approval of same requested by Tenant shall be processed as provided in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> hereof.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Performance of Landlord's Work</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Definition of Landlord's Work</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  As used herein, &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord's Work</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34; shall mean (a) the work of constructing the Tenant Improvements and (b) the work of completing the improvements identified as &#x201c;Base Building Delivery Condition&#x201d; on the matrix attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Schedule 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Base Building Work</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;).  Tenant shall be solely responsible for ensuring that the design and specifications for Landlord&#x2019;s Work are consistent with Tenant&#x2019;s requirements.  Landlord shall be responsible for obtaining all permits, approvals and entitlements necessary for Landlord&#x2019;s Work, but shall have no obligation to, and shall not, secure any permits, approvals or entitlements related to Tenant&#x2019;s specific use of the Premises or Tenant&#x2019;s business operations therein, all of which Tenant shall be obligated to obtain.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Commencement and Permitting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall commence construction of the Tenant Improvements upon obtaining a building permit (the &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TI Permit</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) authorizing the construction of the Tenant Improvements consistent with the TI Construction Drawings approved by Landlord.  The cost of obtaining the TI Permit shall be payable from the TI Fund.  Tenant shall reasonably assist Landlord in obtaining the TI Permit.  If any Governmental Authority having jurisdiction over the construction of Landlord's Work or any portion thereof shall impose terms or conditions upon the construction thereof that:  (i) are inconsistent with Landlord's obligations hereunder, (ii) increase the cost of constructing Landlord's Work, or (iii) will materially delay the construction of Landlord's Work, Landlord and Tenant shall reasonably and in good faith seek means by which to mitigate or eliminate any such adverse terms and conditions.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Completion of Base Building Work</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall, at Landlord&#x2019;s sole cost and expense, substantially complete or cause to be substantially completed the Base Building Work in a good and workmanlike manner pursuant to Landlord&#x2019;s plans and specifications therefor, as Landlord may revise the same from time to time, provided such revisions do not have a material adverse effect on the functionality of the Premises for its intended use. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Completion of Tenant Improvements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall substantially complete or cause to be substantially completed the Tenant Improvements in a good and workmanlike manner, in accordance with the TI Permit subject, in each case, to Minor Variations and normal &#34;punch list&#34; items of a non-material nature that do not interfere with the use </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">of the Premises as determined by Landlord&#x2019;s Authorized Representative and Tenant&#x2019;s Authorized Representative (and in the event of any disagreement between Landlord&#x2019;s Authorized Representative and Tenant&#x2019;s Authorized Representative, the determination of Landlord&#x2019;s architect shall be final, binding and conclusive) (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Substantial Completion</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34; or &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Substantially Complete</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;).  It shall be a condition of such Substantial Completion that a certificate of occupancy permitting lawful occupancy (temporary or permanent) or a signed building card from the city inspectors has been issued or obtained permitting lawful occupancy of the space unless the same cannot be obtained due to work or other activities of Tenant.  In the event a permanent certificate of occupancy is not issued, Landlord agrees to use commercially reasonable efforts to obtain the same following Substantial Completion.  Upon Substantial Completion of Landlord's Work, Tenant shall require the TI Architect and Landlord shall require the general contractor to execute and deliver, for the benefit of Tenant and Landlord, a Certificate of Substantial Completion in the form of the American Institute of Architects (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">AIA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) document G704. For purposes of this Work Letter, &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Minor Variations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34; shall mean any modifications reasonably required:  (i) to comply with all applicable Legal Requirements and/or to obtain or to comply with any required permit (including the TI Permit); (ii) to comply with any request by Tenant for modifications to Landlord's Work; (iii) to comport with good design, engineering, and construction practices that are not material; or (iv) to make reasonable adjustments for field deviations, conditions encountered during the construction of Landlord's Work, or changes to the base Building.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">    </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Selection of Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Where more than one type of material or structure is indicated on the TI Construction Drawings approved by Landlord and Tenant, the option will be selected at Landlord's sole and absolute subjective discretion.  As to all building materials and equipment that Landlord is obligated to supply under this Work Letter, Landlord shall select the manufacturer thereof in its sole and absolute subjective discretion.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Delivery of the Premises</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  When Landlord's Work is Substantially Complete, subject to the remaining terms and provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 3(f)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, Tenant shall accept the Premises.  Tenant's taking possession and acceptance of the Premises shall not constitute a waiver of:  (i) any warranty with respect to workmanship (including installation of equipment) or material (exclusive of equipment provided directly by manufacturers), (ii) any non-compliance of Landlord's Work with applicable Legal Requirements, or (iii) any claim that Landlord's Work was not completed substantially in accordance with the TI Construction Drawings (subject to Minor Variations and such other changes as are permitted hereunder) (collectively, a &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Construction Defect</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;).  Tenant shall have one year after Substantial Completion within which to notify Landlord of any such Construction Defect in the Base Building Work or the Tenant Improvements discovered by Tenant, and Landlord shall use reasonable efforts to remedy or cause the responsible contractor to remedy any such Construction Defect in the Base Building Work or the Tenant Improvements within 30 days thereafter.  Notwithstanding the foregoing, Landlord shall not be in default under the Lease if the applicable contractor, despite Landlord's reasonable efforts, fails to remedy such Construction Defect of the Base Building Work or the Tenant Improvements within such 30-day period, in which case Landlord shall have no further obligation with respect to such Construction Defect of the Base Building Work or the Tenant Improvements other than to cooperate, at no cost to Landlord, with Tenant should Tenant elect to pursue a claim against such contractor for the Base Building Work or the Tenant Improvements, provided that Tenant shall defend with counsel reasonably acceptable to Landlord, indemnify and hold Landlord harmless from and against any claims arising out of or in connection with any such claim.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall be entitled to receive the benefit of all construction warranties and manufacturer's equipment warranties relating to equipment installed in the Premises, and Landlord shall use commercially reasonable efforts to enforce such warranties at Tenant&#x2019;s request and, at Tenant&#x2019;s request, shall reasonably cooperate with Tenant to enforce such warranties, in each case, at no cost or expense to Landlord.  If requested by Tenant, Landlord shall attempt to obtain extended warranties from manufacturers and suppliers of such equipment, but the cost of any such extended warranties shall be borne solely out of the TI Fund.  Landlord shall promptly undertake and complete, or cause to be completed, all punch list items.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Commencement Date Delay</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Except as otherwise provided in the Lease, Delivery of the Premises shall occur when Landlord's Work has been Substantially Completed, except to the extent that completion of Landlord's Work shall have been actually delayed by any one or more of the following causes (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant Delay</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;):</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's Representative was not available to give or receive any Communication or to take any other action required to be taken by Tenant hereunder within 2 business days following receipt of Communication (whether verbal or otherwise) with respect thereto;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's request for Change Requests (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 4(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below) whether or not any such Change Requests are actually performed provided that Landlord delivers to Tenant notice of its estimate of a delay caused to address such Change Request (it being acknowledged the actual Tenant Delay is not limited to such estimate);</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Construction of any Change Requests provided that Landlord delivers to Tenant notice of its estimate of a delay caused to address such Change Request (it being acknowledged the actual Tenant Delay is not limited to such estimate);</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(iv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's request for materials, finishes or installations requiring unusually long lead times, provided Landlord delivers notice (which may be informal via email or verbal) of such long lead time (or anticipated lead time);</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(v)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's delay in reviewing, revising or approving plans and specifications beyond the periods set forth herein;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(vi)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's delay in providing information identified by Landlord as critical to the normal progression of the Project beyond the periods set forth herein (or if no period is specified herein, then the period specified by Landlord in its request to Tenant for such information).  Tenant shall provide such critical information as soon as reasonably possible, but in no event longer than one week after receipt of any request for such information from Landlord;</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(vii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's delay in making payments to Landlord for Excess TI Costs (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 5(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> below) beyond the period set forth herein; or</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(viii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Any other act or omission (where Tenant has a duty to act) by Tenant or any Tenant Party (as defined in the Lease), or persons employed by any of such persons which continues for 2 business days after notice (which may be verbal and shall be deemed given if discussed in a construction or design meeting of which Tenant was notified in advance and entitled to attend).</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">If Delivery is delayed for any of the foregoing reasons, then Landlord shall cause the Landlord&#x2019;s architect to certify the date on which the Tenant Improvements would have been Substantially Completed but for such Tenant Delay and such certified date shall be the date of Delivery.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Changes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Any changes requested by Tenant to the Tenant Improvements after the delivery and approval by Landlord of the TI Design Drawings shall be requested and instituted in accordance with the provisions of this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 4</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> and shall be subject to the written approval of Landlord, such approval not to be unreasonably withheld, conditioned or delayed (except where Landlord would have sole discretion approval rights if the work relating to such change were an Alteration under the Lease or would delay the project schedule). </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's Request For Changes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If Tenant shall request changes to the Tenant Improvements (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Changes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;), Tenant shall request such Changes by notifying Landlord in writing in substantially the same form as the AIA standard change order form (a &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Change Request</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;), which Change Request shall detail the nature and extent of any such Change.  Such Change Request must be signed by Tenant's Representative.  Landlord shall, before proceeding with any Change, use commercially reasonable efforts to respond to Tenant as soon as is reasonably possible with an estimate of:  (i) the time it will take, and (ii) the architectural and engineering fees and costs that will be incurred, to analyze such Change Request (which costs shall be paid from the TI Fund to the extent actually incurred, whether or not such change is implemented).  Landlord shall thereafter submit to Tenant in writing, within 5 business days of receipt of the Change Request (or such longer period of time as is reasonably required depending on the extent of the Change Request), an analysis of the additional cost or savings involved, including, without limitation, architectural and engineering costs and the period of time, if any, that the Change will extend the date on which Landlord's Work will be Substantially Complete; provided Tenant shall be responsible for estimating its own architectural and engineering costs and delay.  Any delay in the completion of Landlord's Work caused by a Change (whether longer or shorter than the estimates), including any suspension of Landlord's Work while any such Change is being evaluated and/or designed, shall be Tenant Delay.  No deduction from the rentable square footage of the Premises for purposes of determination </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">of the Base Rent payable under the Lease, which would otherwise apply under the Lease, shall be made as a result of any vertical penetrations or other modifications required by or as a part of such Change.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Implementation of Changes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  If Tenant: (i) approves in writing the cost or savings and the estimated extension in the time for completion of Landlord's Work, if any, and (ii) deposits with Landlord any Excess TI Costs required in connection with such Change, Landlord shall cause the approved Change to be instituted.  Notwithstanding any approval or disapproval by Tenant of any estimate of the delay caused by such proposed Change, the Landlord&#x2019;s architect&#x2019;s determination of the amount of Tenant Delay in connection with such Change shall be final and binding on Landlord and Tenant.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Budget For Tenant Improvements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Before the commencement of construction of the Tenant Improvements, Landlord shall obtain a detailed breakdown by trade of the costs incurred or that will be incurred in connection with the design and construction of the Tenant Improvements (the &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;).  The Budget shall be based upon the TI Construction Drawings approved by Landlord and Tenant and shall include a payment to Landlord of administrative rent (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Administrative Rent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) equal to 3% of the total hard and soft costs of the Tenant Improvements and Changes for monitoring and inspecting the construction of the Tenant Improvements and Changes, which sum shall be payable from the TI Fund (as defined in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 5(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">).  In addition, Administrative Rent also shall include, without limitation, all reasonable and actual out-of-pocket costs, expenses and fees incurred by or on behalf of Landlord arising from, out of, or in connection with monitoring the construction of the Tenant Improvements and Changes, and shall be payable out of the TI Fund.  If the Budget is greater than the TI Allowance, Tenant shall deposit with Landlord the difference, in cash, prior to the commencement of construction of the Tenant Improvements or Changes, for disbursement by Landlord as described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 5(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Any and all costs to inspect, monitor, supervise, remediate, contain or encapsulate any Hazardous Materials as part of Landlord&#x2019;s Work shall be paid at Landlord&#x2019;s sole cost and expense.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TI Allowance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall provide to Tenant a tenant improvement allowance (collectively, the &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TI Allowance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) as follows:</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant Improvement Allowance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; in the maximum amount of $200.00 per rentable square foot of the Premises, being $20,124,800 in the aggregate (subject to adjustment as set forth in the definition of Rentable Area of Premises), which is included in the Base Rent set forth in the Lease; and</font></div></div>
  <div style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:7.14323979728499%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Supplemental Tenant Improvement Allowance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d; in the maximum amount of $50.00 per rentable square foot of the Premises, being $5,031,200 in the aggregate, which shall, to the extent used (subject to adjustment as set forth in the definition of Rentable Area of Premises), result in the adjustment to the Base Rent as set forth in the Lease.  </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Before Landlord commences Landlord&#x2019;s Work, Tenant shall notify Landlord in writing whether and how much of the Supplemental Tenant Improvement Allowance Tenant has elected to receive from Landlord.  Such election shall be final and binding on Tenant, and may not thereafter be modified without Landlord&#x2019;s consent, which may be granted or withheld in Landlord&#x2019;s sole and absolute discretion.  The TI Allowance shall be disbursed in accordance with this Work Letter.  Any unused portion of the TI Allowance shall be forfeited and shall cease to be available to Tenant after a period of 18 months following the Commencement Date.  Tenant shall have the right to use and apply the TI Allowance only toward hard and soft construction costs of the Tenant Improvements described in the TI Construction Drawings approved pursuant to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 2(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, including, but not limited to, any architectural and engineering fees, design, permits, electrical power and other utilities, the cost of preparing the TI Design Drawings and the TI Construction Drawings, costs resulting from Tenant Delays and the cost of Changes, costs set forth in the Budget, including Landlord's Administrative Rent, and Landlord's out-of-pocket expenses (collectively, &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TI Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;); provided, however, Tenant shall have no right to the use or benefit of any portion of the TI Allowance for any other purpose (including the reduction or payment of Base Rent, the cost of any personal property or other non-Building system materials or equipment, including, but not limited to, non-ducted biological safety cabinets and other scientific equipment not incorporated into the Tenant Improvements).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">In addition to the TI Allowance, Tenant shall be entitled to an allowance of $0.12 per rentable square foot of the Premises, being $12,074.88 in the aggregate (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Space Planning Allowance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;) to be used and applied only for the costs and expenses of preparing the TI Design Drawings.  Following completion and approval of the TI Design Drawings and receipt by Landlord receipts evidencing payment by Tenant to the architect for the TI Design Drawings and such other certificates or materials as Landlord may reasonably require, Landlord will reimburse to Tenant the lesser of the amount of such paid receipts or the unused amount of the Space Planning Allowance.  As of the date of the Lease, Tenant acknowledges that Landlord has disbursed the entire Space Planning Allowance to Tenant and has no further obligation hereunder.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Costs Includable in TI Fund.  </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The TI Fund shall be used solely for the payment of TI Costs.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Excess TI Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord shall have no obligation to bear any portion of the cost of any of the Tenant Improvements except to the extent of the TI Allowance.  If at any time the remaining TI Costs under the Budget exceed the remaining unexpended TI Allowance, Tenant shall be responsible for 100% of the TI Costs in excess of the TI Allowance (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Excess TI Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) as set forth below.  In connection with each of Landlord&#x2019;s payments to the general contractor or others for the Tenant Improvements, Tenant shall promptly (but in no event later than 10 business days after requisition from Landlord) pay Landlord for the portion of such payment attributable to Excess TI Costs, being the amount of such payment multiplied by a fraction, the numerator of which is the total remaining Excess TI Costs and the denominator of which is the total remaining TI Allowance.  If Tenant fails to timely pay Landlord any installment of any Excess TI Costs, Landlord shall have all of the rights and remedies set forth in the Lease for nonpayment of Rent (including, but not limited to, the right to interest at the Default Rate and the right to assess a late charge).  For purposes of any litigation instituted with regard to such amounts, those amounts will be deemed Rent under the Lease.  The TI Allowance and Excess TI Costs are herein referred to as the &#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TI Fund</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.&#34;  Installments of funds due and deposited by Tenant shall be the first disbursed to pay Excess TI Costs.  Notwithstanding anything to the contrary set forth in this </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Section 5(d)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, Tenant shall be fully and solely liable for TI Costs and the cost of Minor Variations in excess of the TI Allowance.  If upon completion of the Tenant Improvements and the payment of all sums due in connection therewith there remains any undisbursed portion of the TI Fund, then Tenant shall be entitled to such undisbursed TI Fund solely to the extent of any Excess TI Costs deposit Tenant has actually made with Landlord.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">6.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant Access</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's Access Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Landlord hereby agrees to permit Tenant access, at Tenant's sole risk and expense, to the Building (i) in advance of the Commencement Date as indicated on Landlord&#x2019;s project schedule to perform any work (&#34;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant's Work</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34;) required by Tenant other than Landlord's Work, provided that such Tenant's Work is coordinated with the TI Architect and the general contractor, and complies with the Lease and all other reasonable restrictions and conditions Landlord may impose, and (ii) prior to the completion of Landlord's Work, to inspect and observe work in process; all such access shall be during normal business hours or at such other times as are reasonably designated by Landlord.  Notwithstanding the foregoing, Tenant shall have no right to enter onto the Premises or the Project unless and until Tenant shall deliver to Landlord evidence reasonably satisfactory to Landlord demonstrating that any insurance reasonably required by Landlord in connection with such pre-commencement access (including, but not limited to, any insurance that Landlord may require pursuant to the Lease) is in full force and effect.  Any entry by Tenant shall comply with all established safety practices of Landlord's contractor and Landlord until completion of Landlord's Work and acceptance thereof by Tenant.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No Interference</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Neither Tenant nor any Tenant Party (as defined in the Lease) shall interfere with the performance of Landlord's Work, nor with any inspections or issuance of final approvals by applicable Governmental Authorities, and upon any such interference, Landlord shall have the right to exclude Tenant and any Tenant Party from the Premises and the Project until Substantial Completion of Landlord's Work.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No Acceptance of Premises</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  The fact that Tenant may, with Landlord's consent, enter into the Project prior to the date Landlord's Work is Substantially Complete for the purpose of performing Tenant's Work shall not be deemed an acceptance by Tenant of possession of the Premises, but in such event Tenant shall defend with counsel reasonably acceptable by Landlord, indemnify and hold Landlord harmless from and against any loss of or damage to Tenant's property, completed work, fixtures, equipment, materials or merchandise, and from liability for death of, or injury to, any person, caused by the act or omission of Tenant or any Tenant Party.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">7.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Miscellaneous</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Miscellaneous Charges</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Tenant shall not be charged for freight elevators, security, access to loading docks, parking, utilities, or temporary HVAC during construction of the Tenant Improvements or Tenant&#x2019;s move into the Building, provided that said activities occur during normal Building hours.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Consents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  Whenever consent or approval of either party is required under this Work Letter, that party shall not unreasonably withhold, condition or delay such consent or approval, unless expressly set forth herein to the contrary.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Modification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  No modification, waiver or amendment of this Work Letter or of any of its conditions or provisions shall be binding upon Landlord or Tenant unless in writing signed by Landlord and Tenant.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No Default Funding</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.  In no event shall Landlord have any obligation to fund any portion of the TI Allowance or to perform any Landlord&#x2019;s Work during any period that Tenant is in Default under the Lease.</font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">[Remainder of page left blank]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SCHEDULE 1</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Approved TI Design Drawings</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">AOTC Building 1, 2nd floor</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img10132136_8.jpg" alt="img10132136_8.jpg" style="width:624px;height:330px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">AOTC Building 1, 3rd floor</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img10132136_9.jpg" alt="img10132136_9.jpg" style="width:624px;height:355px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">AOTC Building 1, 4th floor</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img10132136_10.jpg" alt="img10132136_10.jpg" style="width:624px;height:373px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SCHEDULE 2</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Work Matrix</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">[Attached]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:1.231%;border-spacing:0;table-layout:fixed;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:68.171%;"></td>
    <td style="width:8.545%;"></td>
    <td style="width:6.705%;"></td>
    <td style="width:16.58%;"></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:85.3pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:85.3pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARSENAL ON </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">THE </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CHARLES - BUILDING NO</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:5.15pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:5.15pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Landlord</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:4.8pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:4.8pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tenant</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:2.7pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:2.7pt;text-indent:0.0pt;font-size:8.5pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Landlord (at Tenant's Expense)</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:68.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:68.05pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.9180555555555555in;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LANDLORD/TENANT RESPONSIBILITY MATRIX - DRAFI'</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.3pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.3pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">GENERAL</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The Core &amp; Shell shall be certified by the USGBC at a minimum of LEED Gold</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:30.25pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The Tenant Improvements shall be certified by the USGBC at a minimum of LEED Silver</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.35pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">At grade parking spaces at a ratio of 2</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">0 cars per 1,000 RSF leased</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Changes to the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell scope to meet FM Global (or equal) requirements</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.5215277777777777in;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
   </tr>
   <tr style="height:19.45pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The Core &amp; Shell third-party commissioning to meet LEED Enhanced Commissioning requirements</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The Tenant third-party commissioning to meet LEED Enhanced Commissioning requirements</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:3.85pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.45pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.45pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SITEWORK</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Perimeter sidewalks</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">street curbs</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">miscellaneous site furnishings</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and landscaping</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Telephone service, from local exchange carrier, to the Core &amp; Shell main demarcation room for Core &amp;</font></p><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell and Tenant Premises connections</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Domestic sanitary sewer connection to the Core &amp; Shell</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Roof storm drainage</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Electrical service for the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell and anticipated Tenant Premises loads</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Natural gas service for the Core &amp; Shell needs</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Natural gas service for the Tenant Premises needs</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Domestic water service to the Core &amp; Shell</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Fire protection water service to the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.35pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">LANDSCAPING</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Complete site and civil improvements package</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">including design and installation</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Site landscaping, including design and installation</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.45pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.45pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">STRUCTURE</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Reinforced composite concrete slabs-on-metal deck with 100 psf live load capacity in the Tenant</font></p><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.25pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:23.05pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Reinforced composite concrete slabs-on-metal deck with 100 psf live load capacity in the Core &amp; Shell</font></p><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Common Areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:6.35pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Reinforced composite concrete slabs-on-metal deck with 150 psf loading capacity in the Core &amp; Shell</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">mechanical penthouse</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.2pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">100 PSF load capacity at the penthouse roof at areas designated for Tenant roof top equipment</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.35pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">250 PSF load capacity at the loading dock</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Concrete containment curbs at mechanical penthouse walls and shafts</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Containment curbs in Tenant Premises to support Tenant program</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Structural enhancements for specific Tenant Premises and program load requirements</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.5215277777777777in;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Structural floor designed to meet peak vibration criterion of 8</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">000 micro inches per second at 75 spm</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Structural reinforcing to meet vibration criterion required by Tenant</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.5215277777777777in;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Typical Floor to floor height of</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">:</font></p></td>
    <td rowspan="4" style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:5.95pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td rowspan="4" style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td rowspan="4" style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">20'-0&#34; at Level 1</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">15'-0&#34; at Levels 2-4</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">20'-0&#34; at Penthouse</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Proposed column bay spacing</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">: </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">33'-0&#34; N-S and 30'-0&#34; + 50'-4 1/2&#34; E-W</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">typical</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Structural framing dunnage above the roof for the Core &amp; Shell equipment</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.15pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Structural framing dunnage above the roof for Tenant equipment</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">subject to Landlord review and approval</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:4.4pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.5215277777777777in;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Framed openings for the Core &amp; Shell utility risers</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Framed openings</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">within pre-allocated Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell areas</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">for Tenant utility risers</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Framed openings, beyond what the Core &amp; Shell is providing within pre-allocated Core &amp; Shell areas</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font></p><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">for the Tenant, subject to Landlord review and approval</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:4.6pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.5215277777777777in;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Miscellaneous metals and/or concrete pads for the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell equipment</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Miscellaneous metals items and/or concrete pads for the Tenant equipment</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.35pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ROOFING</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Single-ply TPO roofing system with protection board, rigid insulation, AVB, and 20 year warranty</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.65pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Roofing penetrations for the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell equipment</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Roofing penetrations for the Tenant equipment, installed by Core &amp; Shell roofing subcontractor.</font></p><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Penetrations subject to Landlord review and approval.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:4.7pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.5215277777777777in;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:1.231%;border-spacing:0;table-layout:fixed;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:68.171%;"></td>
    <td style="width:8.545%;"></td>
    <td style="width:6.705%;"></td>
    <td style="width:16.58%;"></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Walkway pads to the Core &amp; Shell equipment</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Walkway pads to the Tenant equipment</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.5215277777777777in;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Roofing alterations driven by approved Tenant requested modifications to the Core &amp; Shell</font><font style="background-color:rgba(0,0,0,0);color:rgba(66,66,66,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">installed</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">by the Core &amp; Shell roofing subcontractor</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:4.6pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.5215277777777777in;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:1.231%;border-spacing:0;table-layout:fixed;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:68.171%;"></td>
    <td style="width:8.545%;"></td>
    <td style="width:6.705%;"></td>
    <td style="width:16.58%;"></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:85.3pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:85.3pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARSENAL ON </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">THE </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CHARLES - BUILDING NO</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:5.15pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:5.15pt;text-indent:0.0pt;font-size:8.5pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Landlord</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:4.8pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:4.8pt;text-indent:0.0pt;font-size:8.5pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tenant</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:2.65pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.65pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Landlord (at Tenant's</font></p><p style="margin-left:2.35pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expense)</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:68.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:68.05pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.9180555555555555in;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LANDLORD/TENANT RESPONSIBILITY MATRIX - DRAFI'</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.35pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXTERIOR</font></p></td>
   </tr>
   <tr style="height:28.8pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The Core &amp; Shell exterior (note: the Core &amp; Shell fac;:ade is currently being designed and will be</font></p><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">consistent with a Class A building typical to the local market and sustainability goals)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The Core &amp; Shell accessible entrances</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:28.8pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Building mounted signage and/or ground mounted exterior signage in accordance with City of</font></p><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Watertown rules and regulations and the Lease</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">subject to Landlord review and approval.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Penthouse enclosure for tenant equipment</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Penthouse enclosure for Core Shell equipment</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rooftop Screen for Core and Shell rooftop equipment</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rooftop Screen for the Tenant rooftop equipment</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.35pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">COMMON AREAS</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Accessible Core &amp; Shell entrances</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Egress corridors on multi-tenant floors</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">First floor finished lobby, consistent with a Class A building typical to the local market</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Toilet rooms in Building Core</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">consistent with a Class A building typical to the local market</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Finishes in the Core &amp; Shell Common areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Code required interior signage for the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Maintenance closets in the Core &amp; Shell areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Electrical rooms in the Core &amp; Shell areas for Core &amp; Shell equipment and Tenant sub meters</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The Core &amp; Shell Tel Data Demarcation room (MPOE)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Pathway from the Core &amp; Shell demarcation room to the Core &amp; Shell lDF rooms on each floor</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant IDF rooms within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant low voltage infrastructure from the Core &amp; Shell Demarcation room (MPOE) to Tenant IDF</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">rooms and distribution to Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.15pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Doors, frames, and hardware at the Core &amp; Shell areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Doors</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">frames</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and hardware at the Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.35pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ELEVATORS</font></p></td>
   </tr>
   <tr style="height:14.4pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Two (2) passenger elevators</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">serving levels 1-4</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The elevator will have 3</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">500 lb</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">capacity</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">350 FPM</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font></p><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and 3'6&#34; wide opening</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:7.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">One (1) service elevator serving every floor including the penthouse</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Elevator will have 5,000 lb.</font></p><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">capacity, 350 FPM, 4</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">'</font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">-6</font><font style="background-color:rgba(0,0,0,0);color:rgba(38,38,38,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#34; </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">wide door opening</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.35pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Modifications to the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell elevators to accommodate Tenant requirements</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.5215277777777777in;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.45pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.45pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">WINDOW TREATMENT</font></p></td>
   </tr>
   <tr style="height:20.15pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Furnish and install the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell automated window treatment standard</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">including associated</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.2pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">supports and blocking</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">in Tenant Premises</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">; </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">the standard window treatment is currently TBD</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Solid surface window sills as applicable in Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.3pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.3pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TENANT PREMISES</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Drywall and finishes at inside face of exterior walls</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Finishes at inside face at Tenant side of core partitions</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Toilet rooms within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Finishes in Tenant Mechanical rooms</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Electrical closets for Tenant program</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tel/data rooms for Tenant program</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant kitchen areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Modifications to the Core &amp; Shell to accommodate Tenant requirements</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.5215277777777777in;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Moisture mitigation measures at slabs in Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Partitions, ceilings</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">flooring, painting</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">finishes, doors, frames, hardware, millwork, casework, and</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">buildout in Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.6pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Fixed or movable casework in Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Laboratory equipment including</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">but not limited to</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">biosafety cabinets, autoclaves</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">glasswashers</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">bioreactors in Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.6pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Chemical fume hoods</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">bench fume hood</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">lab casework in Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shaft enclosures for Core &amp; Shell risers</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shaft enclosures for Tenant risers within allocated space in the main vertical Core &amp; Shell shafts</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shaft enclosures for Tenant risers outside of the allocated space in the main vertical Core &amp; Shell</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">shafts, subject to Landlord approval.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:1.231%;border-spacing:0;table-layout:fixed;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:68.171%;"></td>
    <td style="width:8.545%;"></td>
    <td style="width:6.705%;"></td>
    <td style="width:16.58%;"></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">All interior signage for Tenant Premises</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sound attenuation upgrades (interior and / or exterior) in order to comply with City of Watertown's</font></p><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">acoustical criteria and design of Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.75pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Upgrades to Tenant Mechanical rooms (solid partition enclosures; wall</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ceiling and floor finishes;</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.35pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">doors</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">frames and hardware)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.65pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:1.231%;border-spacing:0;table-layout:fixed;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:68.171%;"></td>
    <td style="width:8.545%;"></td>
    <td style="width:6.705%;"></td>
    <td style="width:16.58%;"></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:85.3pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:85.3pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARSENAL ON </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">THE </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CHARLES - BUILDING NO</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:5.15pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:5.15pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Landlord</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:4.8pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:4.8pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tenant</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:2.7pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:2.7pt;text-indent:0.0pt;font-size:8.5pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Landlord (at Tenant's Expense)</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:68.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:68.05pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.9180555555555555in;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LANDLORD/TENANT RESPONSIBILITY MATRIX - DRAFI'</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.35pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">FIRE PROTECTION</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Fire service entrance including fire department connection, alarm valve</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and back flow protection</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:3.9pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Primary distribution and sprinkler heads adequate to support ordinary hazard (with upturned heads)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:3.8pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">All run outs</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">drop heads</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and related equipment within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Modification to the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell Fire Protection system</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">including sprinkler piping and head locations</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font></p><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.2pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">to suit Tenant layout and hazard index</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:3.85pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Specialized extinguishing systems</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Preaction dry-pipe systems (if required) within Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Preaction dry-pipe systems (if required) within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Fire extinguisher cabinets within Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Fire extinguisher cabinets within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Standpipes</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">distribution and hose connections within building common areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Additional hose connections within Tenant Premises</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">including distribution piping</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Fire Pump</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">if required</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.35pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">PLUMBING</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Domestic water service with backflow prevention and Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell risers</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Domestic water distribution within Tenant Premises</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">including reduced pressure backflow preventer</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.15pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Non-potable water risers for the Tenant use</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">including water booster system and reduced pressure</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">backflow preventer</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Non-potable water distribution within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Core &amp; Shell restroom plumbing fixtures compliant with accessibility requirements</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant restroom plumbing fixtures compliant with accessibility requirements</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Wall hydrants within the Core &amp; Shell areas (where required by code)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant metering and sub-metering at Tenant connection</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Storm drainage system</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sanitary waste and vent service for the Core &amp; Shell areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sanitary waste and vent service for the Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sanitary ejector for Core &amp; Shell fixtures that cannot drain by gravity</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Hot water generation for the Core &amp; Shell restrooms</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Potable hot water generation for tenant spaces</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Laboratory waste system and risers</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lab waste and vent lines will be capped at each floor for Tenant</font></p><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">connections</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.25pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">PH adjustment system</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lab waste ejector system for 1st floor tenant or recessed pH adjustment system</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11.5pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tempered hot water distribution piping to pH neutralization system area eyewash/shower unit.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lab waste and vent pipe distribution serving Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.1pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sampling ports at laboratory waste lines prior to connection to building riser. Sampling port locations subject to Landlord's approval.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Non-potable hot water generation for Tenant use</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Air compressor</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">risers</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and pipe distribution</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lab vacuum system</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">risers, and pipe distribution</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tepid water generator and risers</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tepid water pipe distribution and emergency fixtures for Tenant design including open end drain</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">RO/DI water generator</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">risers pipe distribution</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and reject routing to the point of connection</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.4pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">DI water generator, risers, pipe distribution wand reject routing to the point of connection</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Manifolds</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">piping</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and other requirements including cylinders</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">not specifically mentioned above</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">OED at janitor closets for clear water waste</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.35pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">NATURAL GAS</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Natural gas service to the Core &amp; Shell</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Natural gas service</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">pressure regulator</font><font style="background-color:rgba(0,0,0,0);color:rgba(77,77,77,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">and meter for Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell gas needs</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Natural gas service</font><font style="background-color:rgba(0,0,0,0);color:rgba(52,52,52,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">pressure regulator, and meter for Tenant gas needs</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Natural gas piping from Tenant meter to Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Natural gas meter serving Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Natural gas pipe distribution within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.35pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">HEATING, VENTILATION, AIR CONDITIONING</font></p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">An air handling system sized to provide 100% outside air based on 1.4 CFM/USF for tenant areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.6pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:1.231%;border-spacing:0;table-layout:fixed;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:68.171%;"></td>
    <td style="width:8.545%;"></td>
    <td style="width:6.705%;"></td>
    <td style="width:16.58%;"></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant fitout areas to utilize fan coils or chilled beams for space conditioning</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Humidification</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Gas fired condensing boilers to support the 100% outside air handling units and reheat coils</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.75pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(8,8,8,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:1.231%;border-spacing:0;table-layout:fixed;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:68.171%;"></td>
    <td style="width:8.545%;"></td>
    <td style="width:6.705%;"></td>
    <td style="width:16.58%;"></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:85.3pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:85.3pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARSENAL ON THE CHARLES </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">- </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">BUILDING NO</font><font style="background-color:rgba(0,0,0,0);color:rgba(73,73,73,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:5.15pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:5.15pt;text-indent:0.0pt;font-size:8.5pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Landlord</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:4.8pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:4.8pt;text-indent:0.0pt;font-size:8.5pt;margin-top:3.6pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tenant</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:2.65pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.65pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Landlord (at Tenant's</font></p><p style="margin-left:2.35pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expense)</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:68.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:68.05pt;text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.9194444444444445in;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LANDLORD/TENANT RESPONSIBILITY MATRIX </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">- </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DRAFI'</font></p></td>
   </tr>
   <tr style="height:28.8pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Chiller plant to provide chilled water for AHUs and terminal units (fan coils or chilled beams) on the</font></p><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">floors</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.25pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Chilled water to floors sized for 500 SF/ton</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.45pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.45pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Vertical supply air duct distribution with horizontal take off through a smoke/fire damper at the Tenant</font></p><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">connection point</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Air flow monitoring via building management system</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Supply and exhaust air duct distribution within Core &amp; Shell areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Supply and exhaust air duct distribution with Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.45pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.45pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Vertical exhaust air duct risers at the Tenant connection point</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhaust air duct distribution within Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhaust air duct distribution within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Specialty exhaust system for Tenant program</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Restroom exhaust for Core &amp; Shell toilet rooms</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Restroom exhaust for bathrooms within the Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Hot water pipe risers</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Hot water pipe distribution within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Hot water BTU meter within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Building Management System (BMS) for the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">BMS (compatible with Landlord</font><font style="background-color:rgba(0,0,0,0);color:rgba(73,73,73,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">'</font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">s system and subject to Landlord review and approval) within Tenant</font></p><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Premises monitoring Tenant infrastructure</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Cooling system for the Core &amp; Shell electrical closets</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Cooling system for electrical closets within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sound attenuation for the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell infrastructure to comply with Watertown Noise Ordinance</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sound attenuation for Tenant equipment to comply with Watertown Noise Ordinance</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Additional/ dedicated cooling equipment for Tenant requirements</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Chilled water pipe risers for Tenant use</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Chilled water pipe distribution within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.35pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ELECTRICAL</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Normal Power with capacity for Tenant Premises based on 12 watts/USF lab and 4 watts/USF of office</font></p><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">area</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.2pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Standby Power (generator) with capacity for Tenant Premises based on </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">4 </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">watts/RSF based on</font></p><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">customary diversity measures</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.35pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Life Safety Power with battery back-up for all Core &amp; Shell area emergency lighting/exit signage</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.25pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Life Safety Power with battery back-up for all Tenant area emergency lighting/exit signage</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Future standby generators for Tenant use (in addition to what is provided by the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Normal and standby power distribution within Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:28.8pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.1pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.07222222222222223in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Sound attenuation for the Core &amp; Shell generator to comply with Watertown Noise Ordinance</font><font style="background-color:rgba(0,0,0,0);color:rgba(73,73,73,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Core &amp; Shell generator provided with fuel tanks to support 12 hours of run time with a local agreement  for 8 hour fuel service</font><font style="background-color:rgba(0,0,0,0);color:rgba(73,73,73,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">480V normal power distribution for Tenant connection</font><font style="background-color:rgba(0,0,0,0);color:rgba(73,73,73,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">unmetered</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Switchgear and panels for standby and life safety power on each floor are available for Tenant power</font></p><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">connections.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.4pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Switchgear and busway for Tenant tie-in with bus plug and check meter</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lighting and power distribution for the Core &amp; Shell areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lighting and power distribution for Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lighting in Tenant Premises to be programmed to turn lights off at a certain time (time to be</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">determined by Landlord)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant distribution panels</font><font style="background-color:rgba(0,0,0,0);color:rgba(73,73,73,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">transformers</font><font style="background-color:rgba(0,0,0,0);color:rgba(73,73,73,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">etc</font><font style="background-color:rgba(0,0,0,0);color:rgba(49,49,49,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">in Tenant Premises to serve Tenant loads</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Electronic check metering for Tenant normal and standby power including reporting to the Core &amp; Shell</font></p><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">BMS system</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.6pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.2pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.2pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lightning Protection System for the Tenant Premises (proper surge protection on Tenant equipment</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">including protecting any circuits that extend up through the roof)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Grounding Riser network and copper grounding bar on each level within the Core &amp; Shell electrical</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">room</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.65pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Grounding extension to and within the Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.35pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.35pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">FIRE ALARM</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Fire alarm system with devices within the Core &amp; Shell areas</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Fire alarm expansion sub panels and devices for Tenant Premises with integration into the Core &amp;</font></p><p style="margin-left:1.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell system</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:1.231%;border-spacing:0;table-layout:fixed;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:68.171%;"></td>
    <td style="width:8.545%;"></td>
    <td style="width:6.705%;"></td>
    <td style="width:16.58%;"></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Alteration/reprogramming to fire alarm system to facilitate Tenant program</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="border-top:0.75pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.3pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.3pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TELEPHONE/DAT A</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Underground local exchange carrier service to the Core &amp; Shell demarcation room (MPOE)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.5pt;margin-top:4.6pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant tel/data rooms</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(7,7,7,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. C</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:68.178%;"></td>
    <td style="width:8.542%;"></td>
    <td style="width:6.699%;"></td>
    <td style="width:16.581%;"></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:85.3pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:85.3pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ARSENAL ON THE CHARLES - BUILDING NO</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:4.8pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:4.8pt;text-indent:0.0pt;font-size:7.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:4.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:4.9pt;text-indent:0.0pt;font-size:7.0pt;margin-top:5.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant</font></p></td>
    <td rowspan="2" style="border-top:1pt solid rgba(0,0,0,1);background-color:rgba(216,228,188,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:2.4pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:2.4pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord (at Tenant's Expense)</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(216,228,188,1);border-right:0.75pt solid rgba(0,0,0,1);text-indent:68.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:68.05pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.9180555555555555in;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LANDLORD/TENANT RESPONSIBILITY MATRIX - DRAFI'</font></p></td>
   </tr>
   <tr style="height:19.45pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Pathways from the Core &amp; Shell demarcation room (MPOE) to Core &amp; Shell tel/data rooms</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Pathway from Core &amp; Shell tel/data rooms to Tenant tel/data rooms</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tel/Data cabling from demarcation room to intermediate distribution frame rooms</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tel/Data cabling from demarcation room and/ or intermediate distribution frame rooms to Tenant</font></p><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">tel/data room</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:4.4pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.05pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tel/data infrastructure including</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">but not limited to</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">servers</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">computers</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">phone systems</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">switches</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">routers</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">MUX panels</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">equipment racks</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ladder racks</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">etc</font><font style="background-color:rgba(0,0,0,0);color:rgba(75,75,75,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Provisioning of circuits and service from service providers</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.25pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Audio visual systems and support</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Cabling from Tenant tel/data room to all Tenant Premises</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.15pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.15pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Distributed Antenna System (DAS) for enhanced cellular coverage in Tenant Premises (Tenant DAS</font></p><p style="margin-left:1.25pt;text-indent:0.0pt;font-size:7.0pt;margin-top:1.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">prescribed by Landlord)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:4.35pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td colspan="4" style="background-color:rgba(223,223,223,1);border-right:1.5pt solid rgba(0,0,0,1);text-indent:1.45pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.45pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">SECURITY</font></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Card access at the Core </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&amp; </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Shell entries</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:2.9pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:2.9pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:18.7pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.1pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="margin-left:1.1pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Card access into or within Tenant Premises on separate Tenant installed and managed system</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:4.6pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:19.45pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:1.45pt;word-break:break-word;white-space:pre-wrap;border-left:1.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:1.5pt solid rgba(0,0,0,1);"><p style="margin-left:1.45pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Video camera coverage of Tenant Premises on separate Tenant installed and managed system</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:1.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.75pt solid rgba(0,0,0,1);text-indent:3.05pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:1.5pt solid rgba(0,0,0,1);text-align:left;"><p style="margin-left:3.05pt;text-indent:0.0pt;font-size:7.0pt;margin-top:4.75pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">X</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:1.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:1.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.35pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:13.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-0.013%;padding-left:0.013%;font-size:10.0pt;margin-top:4.8pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">Disclaimer: For the avoidance of doubt, it is understood  that all wattages, pressures,  volumes and other capacities  referenced  or specified </font><font style="background-color:rgba(0,0,0,0);color:rgba(5,5,5,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">in this Landlord/Tenant Matrix are included only to specify the capacities for which the applicable systems are designed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. D</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT D</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ACKNOWLEDGEMENT OF COMMENCEMENT DATE</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">This ACKNOWLEDGMENT OF COMMENCEMENT DATE is made as of this _____ day of ______________, 202_, between ARE-MA REGION NO. 75, LLC, a Delaware limited liability company (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), and ______________________, a _______________ (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), and is attached to and made a part of that certain Lease Agreement dated as of ______________, 202_ (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Lease</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201d;), by and between Landlord and Tenant.  Any initially capitalized terms used but not defined herein shall have the meanings given them in the Lease.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord and Tenant hereby acknowledge and agree, for all purposes of the Lease, that the Commencement Date of the Base Term of the Lease is ______________, 20__, the expiration date of the Base Term of the Lease shall be at 11:59 p.m. on ______________, 20__, and the Base Rent Commencement Date is _______________, 20__.  In case of a conflict between the terms of the Lease and the terms of this Acknowledgment of Commencement Date, this Acknowledgment of Commencement Date shall control for all purposes.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">IN WITNESS WHEREOF, Landlord and Tenant have executed this ACKNOWLEDGMENT OF COMMENCEMENT DATE to be effective on the date first above written.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TENANT:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">a </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">By: ___________________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Name: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Title: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">LANDLORD:</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">ARE-MA Region No. 75, LLC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">a Delaware limited liability company</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">By:  Alexandria Real Estate Equities, L.P.,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">       a Delaware limited partnership, managing member</font></p>
  <p style="margin-left:40.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">       By:  ARE-QRS Corp.,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:18.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">              a Maryland corporation, general partner</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">              By: ______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">              Name: ____________________________</font></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> Title: ______________________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. E</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT E</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Rules and Regulations</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The sidewalk, entries, and driveways of the Project shall not be obstructed by Tenant, or any Tenant Party, or used by them for any purpose other than ingress and egress to and from the Premises.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">8.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall not place any objects, including antennas, outdoor furniture, etc., in the parking areas, landscaped areas or other areas outside of its Premises, or on the roof of the Project (except as permitted by the terms of this Lease).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">9.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Except for animals assisting the disabled, no animals shall be allowed in the offices, halls, or corridors in the Building without Landlord&#x2019;s express written consent.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">10.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall not disturb the occupants of the Project or adjoining buildings by the use of any radio or musical instrument or by the making of loud or improper noises.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">11.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">If Tenant desires telegraphic, telephonic or other electric connections in the Premises, Landlord or its agent will direct the electrician as to where and how the wires may be introduced; and, without such direction, no boring or cutting of wires will be permitted.  Any such installation or connection shall be made at Tenant&#x2019;s expense.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">12.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall not install or operate any steam or gas engine or boiler, or other mechanical apparatus in the Premises, except as specifically approved in the Lease.  The use of oil, gas or inflammable liquids for heating, lighting or any other purpose is expressly prohibited.  Explosives or other articles deemed extra hazardous shall not be brought into the Project.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">13.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Parking any type of recreational vehicles is specifically prohibited on or about the Project.  Except for the overnight parking of operative vehicles, no vehicle of any type shall be stored in the parking areas at any time.  In the event that a vehicle is disabled, it shall be removed within 48 hours.  There shall be no &#x201c;For Sale&#x201d; or other advertising signs on or about any parked vehicle.  All vehicles shall be parked in the designated parking areas in conformity with all signs and other markings.  All parking will be open parking, and no reserved parking, numbering or lettering of individual spaces will be permitted except as specified by Landlord.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">14.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall maintain the Premises free from rodents, insects and other pests. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">15.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Landlord reserves the right to exclude or expel from the Project any person who, in the judgment of Landlord, is intoxicated or under the influence of liquor or drugs or who shall in any manner do any act in violation of the Rules and Regulations of the Project.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">16.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall not cause any unnecessary labor by reason of Tenant&#x2019;s carelessness or indifference in the preservation of good order and cleanliness.  Landlord shall not be responsible to Tenant for any loss of property on the Premises, however occurring, or for any damage done to the effects of Tenant by the janitors or any other employee or person.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">17.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall give Landlord prompt notice of any defects in the water, lawn sprinkler, sewage, gas pipes, electrical lights and fixtures, heating apparatus, or any other service equipment affecting the Premises.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">18.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall not permit storage outside the Premises, including without limitation, outside storage of trucks and other vehicles, or dumping of waste or refuse or permit any harmful materials to be placed in any drainage system or sanitary system in or about the Premises.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. E</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">19.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">All moveable trash receptacles provided by the trash disposal firm for the Premises must be kept in the trash enclosure areas, if any, provided for that purpose.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">20.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No auction, public or private, will be permitted on the Premises or the Project.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">21.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">No awnings shall be placed over the windows in the Premises except with the prior written consent of Landlord.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">22.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The Premises shall not be used for lodging, sleeping or cooking or for any immoral or illegal purposes or for any purpose other than that specified in the Lease.  No gaming devices shall be operated in the Premises.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">23.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall ascertain from Landlord the maximum amount of electrical current which can safely be used in the Premises, taking into account the capacity of the electrical wiring in the Project and the Premises and the needs of other tenants, and shall not use more than such safe capacity.  Landlord&#x2019;s consent to the installation of electric equipment shall not relieve Tenant from the obligation not to use more electricity than such safe capacity.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">24.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant assumes full responsibility for protecting the Premises from theft, robbery and pilferage.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">25.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall not install or operate on the Premises any machinery or mechanical devices of a nature not directly related to Tenant&#x2019;s ordinary use of the Premises and shall keep all such machinery free of vibration, noise and air waves which may be transmitted beyond the Premises.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">26.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall cause any vendors and other service providers hired by Tenant to perform services at the Premises or the Project to maintain in effect workers&#x2019; compensation insurance as required by Legal Requirements and commercial general liability insurance with coverage amounts reasonably acceptable to Landlord.  Tenant shall cause such vendors and service providers to name Landlord and Alexandria Real Estate Equities, Inc. as additional insureds under such policies and shall provide Landlord with certificates of insurance evidencing the required coverages (and showing Landlord and Alexandria Real Estate Equities, Inc. as additional insureds under such policies) prior to the applicable vendor or service provider providing any services to Tenant at the Project.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">27.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Neither Tenant nor any of the Tenant Parties shall have the right to photograph, videotape, film, digitally record or by any other means record, transmit and/or distribute any images, pictures or videos of all or any portion of the Premises or the Project, except to the extent such images, pictures or videos satisfy all of the following:  (a) they are taken wholly within the Premises, (b) they do not show any identifiable buildings or signs located in the Project, (c) they do not show people other than Tenant&#x2019;s employees or others who have consented thereto, and (d) if such images, pictures or videos will be used for advertising and/or marketing purposes, then, prior to such use, they will be delivered to Landlord, and, at Landlord&#x2019;s request, will include a recognition or attribution to Landlord or a Landlord affiliate designed by Landlord (e.g., a statement on the image reading &#x201c;Courtesy of Alexandria Real Estate Equities, Inc.&#x201d;).  Such recognition or attribution will be subject to Landlord&#x2019;s reasonable approval.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">28.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Tenant shall regularly review the guidelines published by the Centers for Disease Control (CDC) and any federal, state and/or local governmental agencies, and will implement the practices and procedures suggested thereby, as well as industry standard best practices, to limit or prevent the spread or transmission of Infectious Conditions.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:6.667%;">29.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Without limiting Landlord&#x2019;s general right to amend, update, and implement new rules and regulations, Tenant acknowledges that Landlord has the right, but has no obligation, to implement additional rules and regulations relating to access to the Premises, the Building and/or the Project (including, without </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. E</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">limitation, the Amenities) that are intended to promote and protect health and physical well-being and/or prevent or limit the spread or transmission of Infectious Conditions.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. F</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT F</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">TENANT&#x2019;S PERSONAL PROPERTY</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">None</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. G</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT G</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">CONTROL AREAS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">[Attached]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. G</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img10132136_11.jpg" alt="img10132136_11.jpg" style="width:624px;height:396px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">	Building 1 (AOTC) / Kymera Therapeutics, Inc. &#x2013; Ex. H</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 10.13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT H</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">DESIGNATED ROOFTOP AREA</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img10132136_12.jpg" alt="img10132136_12.jpg" style="width:243px;height:76px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">AOTC Building 1, Penthouse Level</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img10132136_13.jpg" alt="img10132136_13.jpg" style="width:624px;height:174px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">AOTC Building 1, High Roof</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img10132136_14.jpg" alt="img10132136_14.jpg" style="width:624px;height:180px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		</font><img src="img10132136_1.jpg" alt="img10132136_1.jpg" style="width:283px;height:48px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>6
<FILENAME>kymr-ex21_1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html>
 <head>
  <title>EX-21</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 21.1</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SUBSIDIARIES</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:36.966%;"></td>
    <td style="width:1.015%;"></td>
    <td style="width:25.983%;"></td>
    <td style="width:1.058%;"></td>
    <td style="width:34.979%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subsidiary</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jurisdiction of Incorporation</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Securities Corporation</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Massachusetts</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">ACTIVE/107610297.1</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>7
<FILENAME>kymr-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;" id="exhibit_23_1"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 23.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We consent to the incorporation by reference in the following Registration Statements:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-8 No. 333-248249) pertaining to the Kymera Therapeutics, Inc. 2018 Stock Option and Grant Plan, Kymera Therapeutics, Inc. 2020 Stock Option and Incentive Plan, and Kymera Therapeutics, Inc. 2020 Employee Stock Purchase Plan,</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-8 No. 333-254122) pertaining to the Kymera Therapeutics, Inc. 2020 Stock Option and Incentive Plan and Amended and Restated Kymera Therapeutics, Inc. 2020 Employee Stock Purchase Plan,</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(3)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-3 No. 333-259955) of Kymera Therapeutics, Inc., and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:11.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(4)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-8 No. 333-262947) pertaining to the Kymera Therapeutics, Inc. 2020 Stock Option and Incentive Plan and the Kymera Therapeutics, Inc. Amended and Restated  2020 Employee Stock Purchase Plan;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of our reports dated February 23, 2023, with respect to the consolidated financial statements of Kymera Therapeutics, Inc. and the effectiveness of internal control over financial reporting of Kymera Therapeutics, Inc. included in this Annual Report (Form 10-K) of Kymera Therapeutics, Inc. for the year ended December 31, 2022.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Ernst &amp; Young LLP</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Boston, Massachusetts</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 23, 2023</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>8
<FILENAME>kymr-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 31.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, Nello Mainolfi, Ph.D., certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of Kymera Therapeutics, Inc.;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.466%;"></td>
    <td style="width:5.04%;"></td>
    <td style="width:3.036%;"></td>
    <td style="width:46.458%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: February 23, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Nello Mainolfi, Ph.D.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nello Mainolfi, Ph.D</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President and Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>9
<FILENAME>kymr-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 31.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, Bruce Jacobs, CFA, MBA, certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of Kymera Therapeutics, Inc.:</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.466%;"></td>
    <td style="width:5.04%;"></td>
    <td style="width:3.036%;"></td>
    <td style="width:46.458%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: February 23, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Bruce Jacobs, CFA, MBA</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bruce Jacobs, CFA, MBA</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Financial Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>10
<FILENAME>kymr-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 32.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Annual Report of Kymera Therapeutics, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the period ending December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:47.669%;"></td>
    <td style="width:1.657%;"></td>
    <td style="width:3.016%;"></td>
    <td style="width:47.659%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: February 23, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Nello Mainolfi, Ph.D.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nello Mainolfi, Ph.D</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>11
<FILENAME>kymr-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 32.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Annual Report of Kymera Therapeutics, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the period ending December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:47.669%;"></td>
    <td style="width:1.657%;"></td>
    <td style="width:3.016%;"></td>
    <td style="width:47.659%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: February 23, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Bruce Jacobs, CFA, MBA</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bruce Jacobs, CFA, MBA</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Financial Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img10132136_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #P!$,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGQCXEO/"FD2ZLNE+>V4 4RD7/ENN6 ^[M((Y'>NFKC/BQ_R2_7?^N2?^C%H
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M#_U]2_S%>DT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%<=XS\;#P_);Z5IEK_ &AX@ON+6S7H/]M_11^N/3)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_B*ZRB@#!TG2-:L;PRW_ (FN=2AVE?)DM88QGURB@U?UPA= U$G@"UDY_P"
MFK]4]1TNQU>U-IJ-K%<VY.XQRKN4GZ4 >;_ F6./X<S,\BJJWTNYB0 /E2L_
MXCZC_P + U'3_!GAN1;S;<B>^NHOFB@4 KRPX.,DG'? ZUZ!_P *^\'_ /0L
MZ7_X#+_A6S8Z;8Z7!Y&GV5O:0YSY<$:QKGZ  4 >6K$GA;X\VOVA/*L-1TM+
M.RD;[H90H"Y['*8_X$/6KGQ.M?[3\9>"+"U3??+?FX.WDQPJ4+L?0?+^E>@:
MKHNFZY:?9=3LH;N'.X+*N<'U!Z@^XJ/2_#NDZ-+)-8V21SR*%>9F9Y"!T&]B
M3CVSB@#5KB='EC/Q<\2H'&\6%GE<C/\ '_B/SKM" P(/(/!K%MO!_AVSOUO[
M;1K**[4[A,D0#Y^O6@#SOXD^%K_0-83X@>%U\N[MCOOH$'RRIW<@=01PWY^I
MK-\0Z?=:A^SEHYM8V?[,D4\JKR=@+ G\,YKW!E#J59<J>"#T-5[*PM-.L8[&
MT@2*UC7:D2CY0/0>U '.:OKFG:K\+[_5_,C-E<Z9(W48RR$;?KDXQZUY9J5G
M/HWP2\&IJ&82-9CN&#<;$;S6&?3@YKUV+P+X8AF\R/1[=1YGF^5\WE;_ .]Y
M>=F??%:NJ:3I^MV+6>IVD5U;,03'*,C(Z&@"6VO;:\\S[-<13>4VQ_+<-M;
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M^!"?XU<CE2:,/&ZNAZ,IR#7B7PFT+2+_ ,3^.(;O2[*YB@NTCA2:!75%WS<
M$<#Y1^5:7CSPNW@>Q?Q=X.D;3);:1#=VD1/D3H2%R4Z=2/PYX- 'J=]J-CID
M GU"]M[2(L$$D\@123T&3@9JW7FVN>)_!>O> ]*U'Q6N;6Y"7*6P$A82@,I
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MY;1ET5%A.=RCJW]U?5CTH [.BN.\#^+3KOA2"_U'SXIT@\ZYGEMFAAQD\HY
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MRVM[W4;VUC$EQ#91!S"I&1N)(&3V .?:B+QMH,WAD>(A>XTSG,OEL2I&<@J
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M-G#>6<Z36TRAXY4.58'N* +%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 445Y;JNO7EM\2+/7!-_P 2.*[.@2KVWNH<O[ 2;5)_V* /4J**I:K;
MPW6E74%Q$DL31-N1AD'B@"[17$?":-%^&NCS!%$DL;M(V/F8^8W)/>NWH **
M\W^),&G_ /"0^$9;]+=8)+]H[B27"J8]N<,3VSZUU'AVR\/6\E[/X?DM625E
M686LBNBLH.!QT.&SB@#H**9)&DL;(ZAD8%65AD$5Y;-./AAXQNRMI+-I&N)N
MLTB!9H[I>D(] ^>/_K&@#U6BN;\)^'!H5@\URD1U2\=I[R2-<*&8YV)Z(O0#
M\:Z2@ HKR[Q!KUY9_$&TUQ9O^))I]TFC7 '3=,NYW)]%;R0?=:]1H **R?%/
M_(H:U_UX3_\ HMJXCP9XEU'0+JQ\+>*9M[7,2R:5J+'Y;A"!^[8]G&<<]?RR
M >FT5Q=_96W_  M;1I?(CWOIUR[-M&2RM&%/U 8\UVE !17G/CG3+.Z\>^#%
MGMHW6YGN$F!'$JB($!O7!Z9K2USP#:R6CW'AR671M7C7=!-:2LB,PZ*Z?=93
MTY% ':45S'@+Q'+XJ\(VFI7,:QW66BN$7A?,0D''UZUJ>((8KCP]J*31I(GV
M:0[7 (SM- &G17BPTBWA^"NFZ[8;K7788HY+>Z@)6264R!0IQ]_=G&#FO8[7
MSC:Q&X"B;RU\P+TW8YQ^- $U%4]4ABN-+NHIHUDC:)@R,,@\5RGPFC0?#72)
M0H\R5':1^[-YC<D]Z .WHHKRWQKKMY9>,+36;>3_ (E7AV:*&_ S@_:00Y]]
MB^4?J] 'J5%("&&1R#T-+0 4444 %>)^"B/#'QQ\1:3?_NVU-I);5VZ/N?>H
M![_*6_%<5[97.>*/!6B^+HXO[2@D6Y@Y@NX'V31<_P +?T.10!T=>3_%S4(&
MNO"C/.DFEQ:RHO=K!E#*5^5O?:7X-=+%X(U#R_L]YXSUZXM  /+#HCL/1I N
M\Y]B#6I>>#M"OO#;:!+81KIV/EBCRI4YSN!Z[L\Y[]\T 8OQ=M+:[^&>K&XV
MCR0DL;'LX<8_/./QKB=9\^>Z^#WVT,TS8,@E').(.OO7?GP''=65KIVJ:UJ6
MHZ;;,K):W'EA7V_=$C*H9P/0GGO7+?%BVCN_&O@"U>22)9+R1-\+['7+0X*G
ML<]* )OC5:+-9^&WMDSJO]K11VQ7[V"#G'_ @E+\5K2?1=0T;QYI\;-/I<RQ
M72KQO@8D<^V25_X'75V?@V&/78=9U+4[_5;RV5EMFNV0+ ",$JB*J[B.IQ6+
MXS\9Z%>:7JWABTN$O=:G!L4L@C9,K_*.<8PN=Q(/&WUH O>#IX_$.K:MXL0[
M[:X9;*P8C'[B+.YA_O2%_P#OD5O>(WN8O"^K2661=I9S- 1UWA#M_6G:%I,.
MA:#8Z7;_ .KM(5B!QC<0.3^)YK3H \]^"LD$GPPT\1;?,26838Z[O,8\^^TK
M7'>'K=K*Q^+EE;+C3(4N1$@^ZC;9<A?H, _05Z);>!(-*O[VXT+5K_28KT[Y
MK:W$31;S_$BNC;3].*G_ .$(TZ+PO-X>L[B\L[:YW_:IH2C37&\$/O9U;);/
M) !],4 9WPGM8/\ A66AMY2;@LC@[!D-YC\_6NYK!\+^%X?">EKIMKJ-_=6D
M>?*CNFC;R\DDX*HIZGOFM6[@DN;9X8KJ:U=A@30A"Z_3>K+^8- 'E/P;_P"1
MN\?_ /7^G_HR>M[XPZW!I?@"]M&<&ZU#;;V\7=B6&XX]A^N/6GZ7\++/1;F\
MN-.\2^(;>:](:X=9X<R,"3DYBZY8_G6GIWP_T2QU8:M/]JU+4EQLNM0G,SIC
M^[G@?@.* /.O&6C3:#^SUING72;;B*2)Y$/56=F8CZC=BNX\?^'+K7I=*DT?
M5%L=?L&DN+$R?<D'RAP>#ZKV/TK1\7>"[7QG:)9ZAJ6H0VBL',%LT:JS#.&)
M9&/?IG'M3KWPE]M.F2OK>J+>:;O\F[1H@[;@ =XV;6&!TQ0!S'A#Q7?:GJ6M
M:-XBTE;'Q+;60,LB?=GB0MM/<<&3/&0=WX5:^"F#\+[ =?WLP/\ W\:NBTKP
MM:Z=J=YJD]Q<7^HWB+%+<7&W(C'1%50%"_ASWK'T/X:6/AW[0FFZSK,,;,SP
M)YZLMLS=2BLI4G'RY8'CWYH P?@3:P2?#Z4O"C$ZA(QW*#DA4P?PJ[8?\G#:
MI_V E_\ 1D=;_A#P3:>"K:2UT[4]1EM'8N8+DQ,H8@?,"$#=O7%10^ K>#Q>
M_B<:WJ[:BZ"-R6AV-&,?)M$73@=.?>@#G/"*J?CAXT8JNX11 -W VK3;2Q6U
M_:(NWL%VQS:7YMX%Z;B0.?<D(?UKI[KP+;-XBN->TS5-0TK4;H!;A[=D=)0
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M[2GSLANFC)A);=E&5%(.XYY)JEHOPJTO29(1-JVKZA9V[AX+&[N=UNC Y!V
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MJD%4+>5T!&?7WQ4NH?#[2=6\+VF@ZC/>745F%%M=,Z+/" ,##*H'08Y!SWH
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MJ-2T_5?'?A3PUICZ)=Z==6]Q!-<W%PBQI"J*0Q3G))R,+CZXQ5WXB1:-X>\
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MC1L(I"H#C<NXA<(<$'#8([U)?_$;PEINH?8;O6X8Y]P0[4=T#'L74%0?J>*
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M*089#T(H ([B&5W2.5'>,[756!*GT/I4U>5?!F"*VG\76\";(HM5=$0= H+
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MY5FCNH %8. 1G'3H:Q[WX8+?76F7T_B75WU*P;<EXSJS$<<!2-J].N#G/.:
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M1PKY+@\\CU[Y]2?I3X_ UU#HUWHL?B*Y_LN[,HEB:!&=5D)+JC_P@[CU!ZT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH Y6Z^''@^]O6O+C0+1IV)9B 0"3W*@X/Y5T5I9VUA:QVUG;Q6\$8
MPD4*!$4>P'%6** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#.U71[+6K-K._C>2V?[T:S.@8>C;2,CV/%1:'X=TSPY;
M-;:5;FVMV.[RA*[J#Z@,2![XZUK44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img10132136_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #P!$,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGQCXEO/"FD2ZLNE+>V4 4RD7/ENN6 ^[M((Y'>NFKC/BQ_R2_7?^N2?^C%H
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M#_U]2_S%>DT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%<=XS\;#P_);Z5IEK_ &AX@ON+6S7H/]M_11^N/3)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_B*ZRB@#!TG2-:L;PRW_ (FN=2AVE?)DM88QGURB@U?UPA= U$G@"UDY_P"
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M>=F??%:NJ:3I^MV+6>IVD5U;,03'*,C(Z&@"6VO;:\\S[-<13>4VQ_+<-M;
M.#CO@@U9JII^G66E64=EI]K%;6T?"Q1(%4?A5N@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "N#\7>$=1&L1^+/"<D<&NP
MILFADXCOHQ_ _OV!/MR, CO** /G+4;;3O'WB6VGUO5M1TS78XQ%<V0TW)B*
MDD! &W$<\<,?6K]Q\(],O-5NKVYU/7A;W$CNK#1GW%B23PH+  GNBCTKU_Q%
MX.T+Q5"J:MI\4SJ,),,K(GT<<X]NE<5>?"C5XBHTKQA>2VR?<L]6C%U&OH1G
MA2.Q"Y'K0!QB_!G3U@ECDU#7A=D_N$&CL5(SQDABO/NZX[XH/P8L&MXECU'7
M#=KS.AT=@ .^"6"\?[+-GMFNN_X0KQ^"NZ]\/7#KG9<SO<M-#G_GFQ)*_@12
MP_#+Q5=W"SW_ (P^QN/OOIL++,X]#,2'(]B2* .+U;PSX<\,Z_I^KW/B/5(Y
M+7R6BC?2O+D=H0H0!7*D_<'.TKZFNXT/0-?\=ZE9:[XSB6WTVS.^QTOR]ID;
MM+*I)_[Y_0#KTOA_X=>'O#UU]MBMWO-2SDWM\_FRY]03P#[@9KKZ "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ ICNL:%W(55&23P *?7C5Y<3?$OXJW
M7AV:65/#NC;C<01N5%S(K8(;'^T<?13T)H ]3@U[1KF<06^KV$LQX$<=RC,?
MP!S5V&:.=2T+HZ@E25((W D$?4$8K"O? _AF_P!,.G2Z'8K;E2J^5 J,F1C*
ML!D'WK,\*V4'P\\#/!J]TD-K93S$3R,#OC,C;#QW((XZYXH [6BN5/C_ $:&
MZLX;]+[3UO#BWEO;5XHW)Z#<>%/UQ4VN^.O#WAS4(+#4[[R+F<@*I1L 'N6Q
M@#\: .DHKC=-^)OAW4M>71@UY:W<N/(^UVS1";/3;GGGMD#-7X_&FCS>)V\.
MJ;K^U%Y:(VS@;?[VXC&WWH Z.BLF77[*+Q#%H;";[;+$9U A8KL!P6+= ,\<
M]ZUJ "BN8N/'6D1->?9TO;Z.R)6ZEL[9I4B8=06'!([XSCO4_P#PFGAW_A'A
MKPU2(Z83M\\*S8;T*@9!]L4 =!44TT5O$99I$CC7JSL% _$UQUI\4O"]_J&F
MV=M<S/+J+;(?W#8#$X 8]B?Y$9Q792Q1SQM'*BO&PPR, 010!4_MO2?^@I9?
M^!"?XU<CE2:,/&ZNAZ,IR#7B7PFT+2+_ ,3^.(;O2[*YB@NTCA2:!75%WS<
M$<#Y1^5:7CSPNW@>Q?Q=X.D;3);:1#=VD1/D3H2%R4Z=2/PYX- 'J=]J-CID
M GU"]M[2(L$$D\@123T&3@9JW7FVN>)_!>O> ]*U'Q6N;6Y"7*6P$A82@,I
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MY;1ET5%A.=RCJW]U?5CTH [.BN.\#^+3KOA2"_U'SXIT@\ZYGEMFAAQD\HY
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MRVM[W4;VUC$EQ#91!S"I&1N)(&3V .?:B+QMH,WAD>(A>XTSG,OEL2I&<@J
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M-G#>6<Z36TRAXY4.58'N* +%%%% !1110 4444 %%%% !1110 4444 %%%%
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M_:(NWL%VQS:7YMX%Z;B0.?<D(?UKI[KP+;-XBN->TS5-0TK4;H!;A[=D=)0
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M[2GSLANFC)A);=E&5%(.XYY)JEHOPJTO29(1-JVKZA9V[AX+&[N=UNC Y!V
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MJD%4+>5T!&?7WQ4NH?#[2=6\+VF@ZC/>745F%%M=,Z+/" ,##*H'08Y!SWH
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MJ-2T_5?'?A3PUICZ)=Z==6]Q!-<W%PBQI"J*0Q3G))R,+CZXQ5WXB1:-X>\
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MC1L(I"H#C<NXA<(<$'#8([U)?_$;PEINH?8;O6X8Y]P0[4=T#'L74%0?J>*
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M*089#T(H ([B&5W2.5'>,[756!*GT/I4U>5?!F"*VG\76\";(HM5=$0= H+
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MY5FCNH %8. 1G'3H:Q[WX8+?76F7T_B75WU*P;<EXSJS$<<!2-J].N#G/.:
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M1PKY+@\\CU[Y]2?I3X_ UU#HUWHL?B*Y_LN[,HEB:!&=5D)+JC_P@[CU!ZT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH Y6Z^''@^]O6O+C0+1IV)9B 0"3W*@X/Y5T5I9VUA:QVUG;Q6\$8
MPD4*!$4>P'%6** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#.U71[+6K-K._C>2V?[T:S.@8>C;2,CV/%1:'X=TSPY;
M-;:5;FVMV.[RA*[J#Z@,2![XZUK44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img10132136_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_2.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Z (\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BL3Q;=W
M-GH!DM+J:UE>ZM8?.AC61T62XC1MJLK G:QQ\I^E<SYVHYU7_BK/$O\ HI_=
M?\2N#G]V&^;_ $7U)].* /0:*\^$VH_\2K_BK/$O^E'][_Q*X./W;-\O^B^H
M'KQ^=)/-J,=IJ\J^+/$NZTW>5G2X,'$2O\W^B^I/IQCZT >A45P<S7Z:C90+
MXL\3^7,LA<G2X,@J!C'^B^]5WN-26PU><>+/$F^T:01 Z7!@[4##=_HOJ?;B
M@#T2BN&<7JZG!;CQ;XH\MX9'8G2X-V5* 8_T3I\QS^%1Z1?:B-8TX2>(-8NX
MY=1GMI(;NQBCC:-8IBIW+ A#913PWKQ0!WM%%% !1110 4444 %%%% !1110
M!@^,!(="B$3*LG]HV&TL,@'[7#C(R,_G6?Y>L9\1_P"EV/7YO]&?G]PO3]YQ
MQ5WQL(SX<42QM)&;^QW(H)+#[7%D #DUSWDZ-G7_ /B3WO!^7_19?E_<KU].
M: -01ZQ_Q3G^EV/7Y?\ 1GX_</U_><\4V\CUC^S?$V;NQQ\^_%L_/^CIT_><
M<?6LT0Z-_P 2#_B3WO)^;_19?F_<MT]>:;=PZ-_9_B+&D7H(W[#]FE^7_1TZ
M^G/- &[<Q:S_ &YI6;NPW>7-@_97P.%_Z:52ECU?^QO$O^E6.W?-O'V9\G]T
MO3]YQ4%Q#HO]LZ9C1[X+Y<NX?99<GA:I21:-_9'B+_B47NX/-L/V:7Y?W2]?
M2@#IY8M:_M^S_P!+L-WV6?!^ROC&Z+_II]*R;--074M)-S/;/%_;=U\L<+*V
M[R;CG)8\=>,4LL.B?VY:8T:^V_9ILC[++DG=%C^OYU1TJ/3UUG23;6%S!+_;
M-T-\D+J-ODW'&3QGIQ0!7U*&RL=*M9K?P_HU[J&I>(+FS\R^MU(^:><[F8*2
M<; *FMH;*P\36NB^(_"7AN+[;!+-;75E$K)^Z +JZL@*\'.>14>NZ;)JNBZ'
M;(MUL_X2N=I7M69'C3S[G+;EY7&1SD=:Z$>#M,TN.^U"'[==Z@;.2!)KV\EN
M752"2J;V.,G'2@"*-/A[+:7%W'!X<:VMD22>410[8U<90L<8&1R*?%;> 9],
M?4H;/P\]E&XC>=8(2B,2  3C@Y(X/J*X^[T6YL?AMX$^S1O8PV;VUS?[;0RF
M)S"?WCQ<%L2,"?3KVJM>:=<:QH7BF^2YN=7COI-/A,@TXP1W&R9261<DL K8
M+8 X[XH ZO\ M#X7>1)/YGA4Q1N$9@D& Q!('3T!_(U<72_#$NL6T,.C^''L
MIK%[M7$,9D8!D 91MP8\-RV>NWUIJ:5$?BK/=&P7R?["CA64Q?+GSGRF<8Z8
MX],5Q>AZ7<+HNCQWNEW\D(\&W=O/#%&5D)+Q9C&>CD X!]* .XTNU\ :W+-%
MI5MX<O9(?]8EO%#(5]R .GO26-OX U.^DLK"U\.W-U'G=%%#"S#!P> .QZ^E
M<=I\E]?I/I^C7<6L%M%N;:VOSIQM9[%MH$<3OPIRV.  05SBF^&K>>^NO"=G
M%JES*=*82-:IHYMS9A8F5DE<MQG.W')8\]!F@#L[>W^']YJKZ7;6_AN;4(\[
MK:..!I!CK\H&>._I6IX9MX;71V@MX8X88[R[5(XU"JH^T2< #@5YUX=G6UU'
M1+'3BU]!%>MG2[[32EUI6X.7?SEP.,D9(.X'@GBO2= _Y!TO_7[=_P#I1)0!
M5\8!SH<0C95D.HV&UF7< ?M</49&?S%4?*U7/B/_ $VRX/S?Z(W/[A>G[SC]
M:M^-0A\.J'A,Z?VA8[H@H.\?:XN,'@Y]ZPO*T_/B#_BEGZ_+_HL/R?N5_P!K
MCUXH TA%JO\ Q3G^FV7)^7_1&X_</U_><_I3;R+5?[-\39O;/ W[O]$;G_1D
MZ?O../K6>(M/_P"*?_XI9^OS?Z+#\_[EO]KGUYIMW%I_]G>(\>%W!&_:?LL/
M[O\ T=/]KCUX]: -NYBU;^W-*S>V6[RYL'[(_'"_]-:I2Q:I_8WB;_3+/ >;
M</LC<_NEZ?O./UJ*XBT[^VM,QX5D \N7*_98?FX7_:JE)'I_]D>(O^*7<$/-
MM;[+%\G[I?\ :XQUXH Z6:'5O[?L_P#3;+=]EGP?L;XQNB_Z:_2LFT2^74=)
M,]Q;R1_VY=#;' R'=Y-QSDN>/;'XT^6+3O[=M/\ BE) /LTV5^RP\_-%S][M
M_6J&EI:+K&DF'16M'_MFZ_?&&->/)N/ERIS^'3B@#H-$ODL;*X@N+>^207UV
MV!93,"&N)&4@A<$$$$$>M:/]LVO_ #ROO_ "?_XBM"B@#/\ [9M?^>5]_P"
M$_\ \11_;-K_ ,\K[_P G_\ B*T** ,_^V;7_GE??^ $_P#\11_;-K_SROO_
M   G_P#B*T** ,_^V;7_ )Y7W_@!/_\ $4?VS:_\\K[_ , )_P#XBM"B@#/_
M +9M?^>5]_X 3_\ Q%1^']W]ENS1RQ[[NY<++&R-M,\A!VL 1D$'\:U** ,?
MQ-I][J>B-;Z<T"W:W%O/&9V*I^[F20Y(!/1#V-<[_97CG.H_O=&_TP\_OWX^
M0)_SQ]J[JB@#A?[*\<_\2[][HW^AGC]^_/R%/^>/O1-I/CF6VU*$RZ,!>YR?
M/?C,:I_SQ_V:[JB@#B9-/\=27MK<^9HV8%=0/M#\[@/^F/M4+:/XY:SU*W\W
M1L7I<D^>_&Y O_/'VKO** .,>R\=-?PW7F:-F.)X\?:'_B*'_GC_ +%-TK1/
M%2:M82:G)IALX+V:[<0S.SDO'*H !C'>3UKM:* "BBB@ HHHH **** "BBB@
' HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img10132136_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_3.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (*!#<# 2(  A$! Q$!_\0
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MZ[#_ - 6N?\ %/\ R%T_ZX1_^CUKH-/_ ./[4O\ KL/_ $!:Y_Q3_P A=/\
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M*N/4T 3T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M M%<]:^*H)M1AMIUMX5FB:17^T XP0,,,#!YJSJ?B*RL+>.2.:WG=Y5B"B<
M#<<9)YP!0!L45@?\)&?72_\ P8?_ &%'_"1GUTO_ ,&'_P!A0!OT5@?\)&?7
M2_\ P8?_ &%'_"1GUTO_ ,&'_P!A0!OT5@?\)&?72_\ P8?_ &%'_"1GUTO_
M ,&'_P!A0!OT5@?\)&?72_\ P8?_ &%'_"1GUTO_ ,&'_P!A0!OT5@?\)&?7
M2_\ P8?_ &%'_"1GUTO_ ,&'_P!A0!OT5@?\)&?72_\ P8?_ &%'_"1GUTO_
M ,&'_P!A0!OT5@?\)&?72_\ P8?_ &%'_"1GUTO_ ,&'_P!A0!OT5@CQ"S,
M/[,)/ ']H?\ V%:5A>R7;7$<T"Q2P2!&"R;P<J&R#@>M %RBBB@ HHJ"2Y,=
MY#;^1*PD!/F*/E7'J: )Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"":\M;=]LUS#$Q&<.X4_K4?]J:?_S_ %M_W^7_ !J6QE>VNM;GA2#S
MRME$CRQ"38'E*D@'V-=Y_P (G??]!>#_ ,%L5 'GW]J:?_S_ %M_W^7_ !H_
MM33_ /G^MO\ O\O^->@_\(G??]!>#_P6Q4?\(G??]!>#_P %L5 'GW]J:?\
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M$3OO^@O!_P""V*C_ (1.^_Z"\'_@MBH \^_M33_^?ZV_[_+_ (T?VII__/\
M6W_?Y?\ &O0?^$3OO^@O!_X+8J/^$3OO^@O!_P""V*@#S[^U-/\ ^?ZV_P"_
MR_XT?VII_P#S_6W_ '^7_&O0?^$3OO\ H+P?^"V*C_A$[[_H+P?^"V*@#S[^
MU-/_ .?ZV_[_ "_XT?VII_\ S_6W_?Y?\:]!_P"$3OO^@O!_X+8J/^$3OO\
MH+P?^"V*@#S[^U-/_P"?ZV_[_+_C1_:FG_\ /];?]_E_QKT'_A$[[_H+P?\
M@MBH_P"$3OO^@O!_X+8J //O[4T__G^MO^_R_P"-']J:?_S_ %M_W^7_ !KT
M'_A$[[_H+P?^"V*C_A$[[_H+P?\ @MBH \^_M33_ /G^MO\ O\O^-']J:?\
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M6-#U'3[#[0NJV\A\Q$PVG1?Q,!_6@#Y9\#+(_CG14B#%FNXQA>IYK[%\,?\
M(*F_Z_[O_P!*)*\0G/C*'XC0:)::3#-;6NK"YANY+,Q*[8/+,HX7D]*]*\-W
MGC%-*<)I.E2?Z7<EF^V.H+&9\X&P\9S0!WU%8V@ZGJ-^][#J5E!;36LBI^XF
M,BME<]2!R,C\ZV: "BBB@ HHHH **** /E+X_P#_ "4R3_KTB_K7OO@S_60_
M]@BS_P#9ZLZ]\//"OB?4?[0UC24N;K8(_,,CJ=HZ?=(]:LZ;;Q6GB>\MH$"0
MQ6-LB*.P!D % &Y(0(V)Z &O)OAD]Q'-:Q-)-Y323N%&I0E,%F(_<@;_ -:]
M9D&Z-P>X(KR;X9+<R2VLC6]V(EDG02?88A%@,P'[S._MZ4 ==XXEFB@M?)DF
M4DMGRM0BM>W?S =WX5Y!X)T_4]$O=;LY7F27SHY&\B\M,$,NX?-)][@]5XKU
M_P <1SR06OD07<N"V?L]G%/CCOO(Q^%>.^#+V[UFZUR^OK%[J5941G&C)<;5
M5<#." G ' H [/S]1_Y[W_\ X':=7&6;2/\ $G43,TC/L7)DDC<_ZM>\?R_E
M71:8);XPV\FD6J7LQ_=HNB1["""RY<L ,KR?3D5DMHE[H?Q&GCOULUEGMEF"
M6<>Q%&-N,>ORF@#HZ*** "BBB@#A_#D:)XF215"O-#<-*P'+D38!/K7<5YOI
M6NV&G>*98KZ=;?[&LT+LYX9FDW#'X5U/_":^'?\ H*0?F: +'BG_ )%75?\
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MSR#D'\Z:+: ,&$*;@YDSM'WB,9^N* /&+;X:>$9+.V=M(4L^GW$S'S9.75L
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MA_JL;.OO[T =+X_6W,%GYZ6S#<V//L)+KMVV'C\:Y?0/"GA'4;!_%TY*VTP
M6U ^SQ!HQL.$!R<E2<$]Z[?Q9I6H:I#;K81)(R$[MU]+;8_[X!S^->>_#CX<
MZM&UZ_B8ZA:FVN/] 2*\.T*22Q&.Q..>] "V?B"(3VNISR*->A#VT+O;2",0
MN-P)C R2F-G'K[US$&J7^J?$>]?4+Y;R2*)8UD2 PJ%VAL!3R.6/6O>M2T6T
MU3#R^;%<*AC2Y@<I*BD@D!AR,X%>&W5BNF_%W6+5)[B=42/]Y<2F1SF)3RQZ
MT ='1110 4444 >=^'].LM4\;>)$OK:*X6.8[!(N[;\QZ5UO_"*Z#_T"+3_O
MT*YOPGNC\9ZU*Z$)?,\L!R.55R#GTYKNZ .1\4>'-&MO#&H3P:9;1RI"2KK&
M 0:TO!W_ "*&E_\ 7!:7Q?\ \BEJ?_7!J3P=_P BAI?_ %P6@#<IDW^ID_W3
M_*GTR;_4R?[I_E0!D_!/Q7H^@^']4M]1NO)D>^9U&TG(P/2O3O\ A8_A?_H(
MC_OVW^%>'_"S1['4]!\1&6RMYK\WT$%K++$':,NQ!(R/3)_"O4?"6C:/:^)[
M-K/3;6$3Z1OE"1#YGW@$GWZT ;__  L?PO\ ]!'_ ,AM_A6QHGB#3?$-M+<:
M9<>='%)Y3G:1AL XY]B*M_8+/_GT@_[]C_"LM%BT36IW9%BLK[80ZKA4E Q@
M^F1C'N* ':QXKT?0;R&TU"Z,<\L;2H@0M\H(!/ XZUG?\+'\+_\ 01_\AM_A
M7!?%0*_C.RR 04MA^!E>O8/L%G_SZ0?]^Q_A0!3TKQ!IVO:8;[2+B.\3!(5&
MP<^A!Z'CO61?_$#1],OIK&\8PWD48=X6Y*D\J"1D9(YX/%8'@">UTYM1FF:.
M&(&7)Z9/VF; ]S78Z5IR2_:;^\M(Q/>2^9LD0%D0 *JGWP.?<F@#$B^)FB3*
M"F_=@L4ZD#/?&>W-,?XHZ$FWYF?)Q\IZ<#DYQ[_E2?$2TMHM)TXQV\2$WZ@E
M4 R/+DXKL/L%G_SZ0?\ ?L?X4 <M;_$WPY+N\VX>$J<#<N0WN,?UK9T7Q1I'
MB&6>/3+KSG@"F0;2, YQU^AK0^P6?_/I!_W['^%9=S#%H^L)J21+':RQ>3.4
M3&P@Y5CCMR03[B@"?6?$>F: ;8:C<&)KEF6(!"Q8J,GIZ"ET;Q#IGB".9]-N
M1,L)"O\ *1@GIUKS;XR2*;K0Y$8LICG(,?)(VCI71> ;^6XU[Q/9_P"EI:VL
MUN((KM-LB;H\MGC/)YH [:Y=H[661?O*A(^H%>%3>,M57RS=>-[^UN6O"DUN
MEC$RQ09.'!V<G&WCWKW6Y1I+69%&69& 'OBO/M(\(ZRNC6$L!L[&_AEN-ZWE
MMYVY'?(Z,.< =Z ."O/["OO"NJ6BZM=ZA>7.HFX#R$Q"8$*6<H,*#P>W:K_A
M?X4:1XE%W?W%Y> )=+Y:[\AE\M2._P#M?I5S4= UOPYX@\'6UQ>Z-<HMQ<"'
M?:F)0?*8DN=QSUX]ZZ7X1.1X<U-I&3B_<L4/RCY$Z>U %9O@IH#J5:>8J>""
M6_\ BJ7_ (4MH('_ !\3_FW_ ,57H+:E9)*D;7,8=SA5W=> ?ZC\Z8-6T\O$
M@NXBTK;$&[[S>@H \XB^!6@Q1A/M]XV">2Y'\C7G)T:#0_$%[9P-*S66JQ0Q
MRM*Q+(S$$$9QVQ7TU7SOKG_(YZY_V&8/_0VH ZBBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH K6W^MUC_KIIO_I17M->+6W^MUC_ *Z:;_Z4
M5[30 4444 9VO\^'M1_Z]I/_ $$UXCHWCO58]/$&BZ%J,]C S1HZQQMT//.W
MWKV[7O\ D7]1_P"O:3_T$UYG\'_$.E:;X+DM[NXV2_;93C8QXX]!0!F0?$CQ
M4[21PZ#JF8VVNJQQ\'&?[M*GQ+\62321)H>JF2+&]0D>5ST_AKM=#\5Z+%J>
MN,]W@2789?W;<C8OM1I7BO14\2:Y(UWA)&AVGRVYPI]J .*7XE^+&N'@&AZJ
M944,R[(\@'I_#[53O?'/B74M4TV*Z\/ZI(MG=1WCPE5!8+G&,+ZUZ#:>*]%7
MQCJ4QN_W;6L(!\MNH+Y[4+XKT7_A-9)OM?[LV*KGRVZ[S[4 <[J_Q+GU:RGT
M>Y\%:N!=1,"JN-VWN1\M6&^*UW&L=DW@G5070JB[QD@#GM6W<>*]$/C*SF%W
M^[6TD4GRVZ[A[4FH>*]%?Q3I$JW?R(DVX^6W<#VH \[TGQWXLT33+/37T34Q
MMS'$%C3D D@<KGI5^7XE^+("@ET/55,C!%RD?)/;[M=MK7BO19-7T1TN\K'<
M,6_=MP-A]J3Q#XKT6:722EWG9?1LW[MN!S[4 <5-\2_%EN@>;0]512P4$I'U
M)P!]VB?XE^++:(RS:'JJ(,98I'C_ -!KM?%/BO19]-@6.[R1=P,?W;= XSVI
M?%OBO19_#EQ'%=Y<LF!Y;?WQ[4 <'#\4M6GMKEQI>HL;=S]H"P1,$(SU..N0
M>U6W^(GB2.%IGT;5Q&HW%C;Q\#UZ53\/ZYIT.G>/5DGP;FY=HOD/S#<_MQ7H
M>J^+-$?PO=Q+=Y<VC*!Y;==OTIL2.'/Q#\1>2+@Z)JWEA=X?[/'P.N>E=1HU
M[XIUG2;;4[-0L%T@E7<8@2#Z_+5UO%FB'P@\/VO]Y]A*X\MNNSZ5J^!;8VG@
M71(2VXK:1G.,=1FCH!FB/QH!@%?^^X__ (FCR_&G]Y?^_D?_ ,379T4AGF_A
M[2?'&E:68)3&)7FDF?9)'C+.3W7WJQ:Z1XKM-1O;Z+B:\*&4F6/'RC Q\OI7
MH%% 'F\VC^-G\3VNJJ8_W=M);N3)'G!8$8^7U%:OE^-/[R_]_(__ (FNSHH
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MXJ32V:]), D0G9)'G.X8_A]<5Z+6%XO_ .1=E_ZZQ?\ H:T >=Z'JNK^,X]
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MVEBQP,JCJ/\ T,_E7=:?K,.E?%*+36V-')YULLGF !0S>:GUX(6O$?#GP_\
M%OB"RN[K2-,1TD8 M),J%,_,, D=N]=3H?P\URQ\4:1;^(((K F6-U*2"3S!
M'O<DX/!X _*@#Z/OM0L],M6NKZYBMH%(!DE8*H)X')J9DBN(2K*DD3CH>0PK
MC_$MU:Z]X:N[6\LE,;I%/&LF&#H7&"?0^WO72ZE>)I&EM-'"&$>V..,':,DA
M5'L.10!YA\7_  ]IVG>&X+K3[<6US+=Q1>9&S?*OS$8&<#!.>,5)?:(8/#3B
MWUO7UUA0\;(=3D*QL@RSD?W<8(]=P]:?\3I=0U6PL-%OK>&RGGN5>&6&<R@$
M!AD@JO0D5Y#K/B;Q/I7B"^TZ;Q,DEV6,,DI@^:12,8^Z0!C'% 'M?PBT33W\
M'VFL2VXFU&627?<2L7;B1NF2<?A7H$.HV4][/90W4+W4 !EA5P63/3([5PGP
M[OUTOP)I]M# TS!KF0KNQA%E;)]SSP*TX9;'3M:\0:Y!9QM-)!:MN "L^X-@
M$_E^5 $/Q0N(K3P]97$S;8HKY7<XS@".2IS\3/#8A\XR7XBV[M_]GS;<>N=O
M2N5^+.J7W_".PV6I64%NSR-*C0W!E&%C?.<JN.M0MXT\./HTF@C7+/\ LT G
MS3*.4V9\GU^]Q_N\4 >G:'KNG^(M.6_TR8RVS' 8H5[ ]#ST(JQ?W]EIUMYV
MH7,-O S!-TS!5)/ '/K7G?P<U2%/!C03*\"6_E$S2_*C;HDQ@_A75>-K>PN]
M ACOXX)(3>VQ FP1_K5!Z^Q/X9H Y7XH:!I%IX=34K:U6&=9<+)#G #*Q)"]
M,G [59^',RW'BGQC*EU=7*M-:XENHO+D;]UW7 Q^56?BF\;>"$:&11&)UVNF
M" -C<BH?A[+YWBWQE)]O-]F:U_T@QA-_[GT'IT_"@#T*BBB@#S[XB6QO/$_@
MV!;*VO2UU<8@NCB-_P!R>IP?KTIGPAC \-ZG$T2(!?NIC3E1\B<#VJ3XEZ?-
M<W?AV^71YM6M;.YE:>VB^\0T94?K1\(X#;>';^,QB/\ TS<(\_<!C0[3[C.*
M .CA\,Q0O XN9&>(MEF'+9/&?H !]!4MCH"68AW3M(89VF0;< 97;CV'>MBB
M@ KYWUS_ )'/7/\ L,P?^AM7J^L>(/$'_"62:)H=K92-';)<,URS+PQ8=1]*
M\!O?$UQ-XSO8;I+=+J?48Y)$4MC>K'@''3GO0!Z?12*=R@^HS2T %%%% !11
M10 4444 %%%% !1110 4444 %%%<9_PG\/\ ;7]F>1'Y_G>3C>W7./[N* .S
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **1VVHS=<#-<9:_$&WN=633
MU@3S&DV$!V_^)Q0!VE%%% !1110 4444 %%%% %:V_UNL?\ 733?_2BO::\6
MMO\ 6ZQ_UTTW_P!**]IH **** ,[7O\ D7]1_P"O:3_T$UYK\'=9TBQ\%20W
MEY;Q2_;93MD(SCBO2M>_Y%_4?^O:3_T$UYO\'+C2(_!,BWDEHLOVV7B4KG''
MK0!T>A>(="34]<9]0M0'O 5)8<CRUHTKQ#H2>)===M0M0CM#M)88.%.:=H5U
MH0U/72\UCM-X-N2O3RUZ4:5=:$/$NNEIK#86AVY*X^Z<XH ;:>(="'C+4I#J
M%KY;6L 5MPP2"^:%\0Z%_P )M)+_ &A:^7]A5=VX8SO-.M+K0O\ A,]2)FL/
M+-K!MY7&<OFA+K0O^$VD/G6'E?85&<KC.\T -N/$.A'QG92#4+7RQ:2 MN&,
M[A1J/B'0F\5:/(NH6I14FW$,,#@8IUQ=:%_PF=D1-8>7]DDR<KC.X4:C=:$?
M%6CE9K#8$FW8*XZ#K0 W6_$.A/K&ALFH6I5+ABQ##@;#1XB\0Z%)+I/EZA:G
M;?QLV&' IVMW6A'6-#*36.T7+;L%>FP]:/$5UH1ETCRYK#B_CW8*].>M #?%
M7B'0I=,MUBU"U8B\@) 8= XS1XN\0Z%-X;N$BU"U9RR8 89^^*=XJNM".F6_
ME36!;[9!G:5Z>8,T>+KK0F\-W BFL"^Y,;2N?OB@#S_P]JNF1:;X_$EU IGN
MG:')^^-S]*]%U;Q%H+^%KN-=0M"YM&  89SMKSSP]/I@TWQ_YDEJ"UTYAW$<
MC<_W:]%U:[T$^%KL)-8;_LC8P5SG;38D1-XAT'_A#WC_ +0M/,^PE<;AG.RN
M;\&>,=0F\$Z7)_:.A1,D&SRIQ(' 4E1G#=3BNF:ZT'_A#W'G6'F?82.JYSLK
M&^&MSHL?PUTU;B6R681R9#E<_?:CH'4GT_QKJ=_8QW)U'P["7!^1C)D<_6I-
M-\;WE]9&9K[08W#LFQGDYP<9Z]ZN^%;K05\-6@EFL ^&SN*Y^\:9X4NM"71W
M$LU@&^T2_>*YQO-(91L?'6HWJS'[3X?C\J5HL--)\V.XXZ4^Q\=7MU<7<<EQ
MH2"WD\O/GN-_ .1QTYJUX<O-"CMM3:26QXOI2 2O(XZ5RG@+XA^'==\4ZO8&
MQ2V\UVN%DFV[0%"KM^N>: .@B\>WLU]=6R/H8%N5&][MP'R,\?+21^/K^349
MK/.@@Q(KES>OM;=G@?)UXJ[I-UH0\2:Z6FL=A:'9DKC[ASBBSNM"_P"$RU,F
M:P\LVL&TDKC.7S0!5D^(-PM\]HD>C,ZQ>:7-^P4C.,9\OKQ74>&+QM0\+Z7>
M,H5I[9)"%.0,C-<\]UH7_"7W1\ZQ\O\ L\ <KC.XUM>"\'P5HN,8^QQXQ_NB
M@#=K@?'#-_PFG@]<#;]I8^^=\5=]7 ^./^1T\'_]?+?^AQ4T!WU<1\2[^?2]
M,TR^BD 6#4('>)CM63YUP&;!(&>>*[>O._BU?1VVG:-;RA=MQJ,0)8\ *ZDT
M*U]1,;J?CO4;6)+G=HPBC8>9'#?EF<$@<9BXHU/Q[?VELUPJ:<4AR[B/40Q=
M<]!F/\*TO%UUH3>')Q%-8%]\>-I7/WQ4GBJZT%O"NI"*:P+F XVE<YI#,J;Q
MW>16DMTXL0B1EMD>H*S'@^L?N./:JK^/M6:WDGCCLUC9 Z WT99>YXV\_2NB
MU>[T$^%;P)-8;_LC8P5SG;3H[O0?^$84&:PW_9/5<YV4 947Q)D;3(;A--@F
MD9 Q!U"-/Z<4SP[XRMM9UB75M1BMM.@-HL,2O=I*7(=B>@XK4T*ZT$>%K,/-
M8;_LXSDKG.*;X5NM!7PU9B6:P#[3G<5SU- $7A3Q#H46C,LNH6JM]HE."PZ;
MS7,:UK&E3^#-4@ANX'GDUB,HBD9(\Z/I74^%+K0ET9A+-8!OM$OWBN<;S7+Z
MU<:4W@S5%ADM#.=8CV!"N['G1]* .^_M74?^$A^P_91]G,A7S2IZ;0V?RX^H
MJQ;:F\NJSQ.ZK"F=B>6<L,*0V[IU8C'M5 >,+<^*/['^S/Y7F>1]JWC'G8W;
M-O7IWJ!_'^F(\"FTOC]H :(^6,,IZ'KP#[XH Y+2;Z>P^)WC%X=HW21!G92P
M&(\@8'J0!^-=K)JFLECY=HP#7$<2C:.%*;F/)['CFN7\"7'VKXF^,YC#)%N:
M'Y)1AA\O>O3* .8&N7YEN%=%C:,R".,Q$F4*7 (/0?=7\Z;K=Q)=>#/.FSYC
M21Y! X_>#TK;UK4?[(T6]U'R_,^S0M+LSC=@9QFO(%^,=MXO8:/#8+&TCHQ<
M2L< ,.Q44 2>!G\OP=X<;T\0R?\ HN2O2O!W_( /_7Y=_P#I1)7AO@WQOI8M
M=%\-;+@7T6M/.6V#9M*NHYSG.2.U>X^##GP]GUO+K_T?)0!T%%%% !1110 4
M444 %%%-E;9$[_W5)H ^-=4O8--^,-Q?7+%8+?5S)(0,X429/%;_ (MG\!^(
M?$5_KI\370DFD,JP)8/GV&20,_E51_A_J.MWXOIN9M2GEE3?<JIV\N&.5Z8[
MYJ_8_!36;N*&Y6V!AD?"AKV-2^.P^7V- '5VGQ<^']M9PP-:^)&:- I9;AU!
M('H)L"NWM_$/@BYMHITN-9"R*& ,EX>OT.*X]_AYHD5S%:'P'$\SG&!KG3MS
M\O'/&*W!X;N;*U(&@7$$$ "D?\)'A8_0?=XZB@#9_MKP7_S\ZQ_WW>?XT?VU
MX+_Y^=8_[[O/\:Q;;1[VYMS.GA^]5!R2_B(J0.Q(*\ ^]-ETJZANTMFT*\,K
M*6*CQ%]Q1U9OEX% &Y_;7@O_ )^=8_[[O/\ &O+?''B3PY9>.(YH_P"T9+,V
M:C)>4/NRW=V#8Z>U=Z_A^_C5F?0KI0J;R3XCZ+Z_=Z5EMX*MM>,=U=^"WNG=
M/W37&O99D!ZCY<XY_6@#G/#VJ:'XEDG2R74%:$ MYMQ(.OIAS6]_8MGZW/\
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M <=JUGXT\2WEK)KK:=-! '41V\%S'N# J03L/8UJ/H.A0:?/!;^%-/LS(/\
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M+>W6S6$:@$=O*F;>YX^52 PR?K717/PILWV+#X)2%D99)"VN YC!Y_AXR.]
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M/B)3+-X&0I;$KYAUT@8]>5/''6LZZ^&^C6DB12>!@97^[&NN MCU/R<#W/%
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M?^!$_P#\771Z7X(MM&6?[-X'B4\>;NU\C;Z9P!BK4&G+<R7"Q>"8RMN<2/\
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M3T&-G4T <U+\4O!SZ_;WJ^'91;QP-&R>7%DL2"#]ZBZ^*7@Z;6;&[C\.RK#
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MC#4PL<AE0!GPKG.6'S]>3S[U%X&O;2?3?!,$-U#)-''<;XTD!9?E[@<BO5*
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M,MX05)SR/S/YFO1:* //9?A)I\\/DS:_K\D7F&78UZQ&\YRV/7D\^]/'PGL
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MA?>S_P#"9^(-[1^4S?:.2G]WZ>U=9_PA>B"[-V(KK[25V^;]NGW8],[\U/\
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MJNUY1.P_M"7YI 0=Q^;KD#GVK-_X1?QQ_P!#O_Y*+2_\(MXX_P"AV_\ )1:
M(M>\ Z-IOAG4I+6744.T2E?MTNUF7&"1GGH*X'X=>"]1\97=WKNK^(KZ;3TN
MI[22T,TFZ0*,#+[NGS?I6]KO_"4Z?>1V5YXB;4K)RR7*B%8UR$:39D#))"\^
MF15;X/\ BW2]*\,ZA:W?VH3'4YY/W5K)(N#M_B52.W2@#:\5?"G4-3NXYM \
M47^F PF&X$D\LIE7/ SNZ#)X]ZN^%_A9%I.D);ZKK.HWUV@:,3174D2K$?X
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M6ZV4T<<Y8%W('3'8=Q7JU !1110 4444 %%%% !1110 4444 %%%% !1110
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M06[0[I;P7);A6_U@ !^]C\* /9**** "BBB@#R&Y%Q:?'RR9+J0PWLDT,L+
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M8S&^D,B[@=GW%([Y.>*W/"@%]=ZMK9 *W5P8(".GDQ?*,>Q;>?QH Z:BBB@
MHHHH **** "BBB@ HHHH *CN/^/:7_</\JDJ.X_X]I?]P_RH \T\/M!_:'@=
M?+D^T"PE._S/EV[>FW/!SWQ^->GUY9X8L[>VU#P9+&EUYLUI,TCL28C\O_H7
M\A7J= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;L1+IQN\<+T (V=/O4 =AK?@J?1[5M4AU[4I'@146..*V'< '#*%X'KS6/\
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M0HY!6VA;_EDA[G_:/?TX%2ZG8R7 2YM2$O8,F)CT8=T;V/\ ]>N=_LKX@?\
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M1:E1$MT0L8(S&,MA6X'(&*]"KG_#UG;6.J:W!:6\4$*SQ[4B0*H_=KV%=!0
M4444 %>;_%F:TO-/T[31=Q+<_;5<KO&Y,1N0Q'IG&?:O1V(52QZ 9KYGN98O
M$_Q1MWL',IN+J:86]T2$,81MP+ 'KM(QCTYH [%-$OH]9.K+XJT#[:93*7QW
M.[/&>GSG]*@G\,W5TEFL_BO0W%G%Y4.>,#GKSR>:H>&H_"=PFIW&K^&KB]F:
M]58EAM9)%BCVKP&48PN3QUKO/"'A'PS=Q:G.OAV%;5[P_9A=6I5MGEIT#C(&
M[=0!R]WH-]?)/'<^+-"D2>99G7IEEC\H=#D?+^M*NAZ@B*B>+="5%AF@"@#
M65][?KTKM-<\/>#[73[N&/3M)COA [1HJ(),A2<@=?>J7A31?"=WH&G?VA9:
M7)J,\6]A,J&1\D\\\F@#E[30+VPC,5KXJT&-#-%.0.<O&Y=>2?4_E3TT6^37
M/[87Q5H/VWS?-WXXSSVSC')KTG_A"?"__0 T[_P'7_"C_A"/"_\ T -._P#
M=?\ "@#B--EU_2K5K>V\7^'_ "S*\IW)D[G8L>_J35S^U_$__0X>'?\ OW_]
M>NK_ .$(\+_] #3O_ =?\*/^$(\+_P#0 T[_ ,!U_P * /-M7T:_UN^%[?>*
MM >=4V*P& HP1TS[FNF^'K3R:WKCW-S%<SLR%YX1B-SSROM_@:Z/_A"/"_\
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M?U4OM-L]214N[=)=IRI/#*?4$<C\*XO_ (5BW_0V:]_X$4?\*Q;_ *&S7O\
MP(H R?#FH:[I.IZ]%I6B7&LPM?.#)+J 4Q;79 @W@D_*H[UUGAKQ9>:SK-_I
M6HZ,=-N[.-)&3[0)<ANG( K'3X5QQ$F+Q+K,9;EC'*%W').3@<G)/)YK;\,>
M"[;PS>7=XM_>7MS=*J/)=.&.%Z4 =-1110!SWBWQ-)X:MK%H-/-]<7MTMK%"
M)1'EF!QR0?2N UO1=<U62R>V\ QV#P7;7,CPZA&#+E2&7@#&<CFNM^(>BS:_
M!HUC;72VL[7Q:.9D+;&$4A!X(.>/6N4O/AUXIL[*>YD\9MLB0N?EE[#/_/2@
M#I/A8NS1-44P"W(U%\P@Y\L^7'E<]\=,U-XHL[J_\;>';>UU>[LQLGDGBA?
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MX5Y#_P!!W6?_  +;_&@#LZ*XS_A7D/\ T'=9_P# MO\ &C_A7D/_ $'=9_\
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M3WM9M,U!DDCV,"8?3_KI79^%=4&L>&K*[\Q7D,867#AB& Y!()&: -FBBB@
MHHIKNL:,[D*JC))["@".\@-S8W$"D RQL@)[9&*Y_1O#VH0:+8Z9J=Y$]M:P
MI$8K="!+M&/F)Y(]ABK%IXU\-WUY':6VL6TL\C;412<L?3I6]0 @ 4    <
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MZJ?\)%H?_09T_P#\"D_QH TJ*S?^$BT/_H,Z?_X%)_C1_P )%H?_ $&=/_\
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MU:);>,I'JURB!ESA0V ,FNL^Q6O_ #[0_P#?L5SG@7_CTUK_ +#%U_Z'754
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M9(V8="4!VG&?2I/".G2:7X7LH)V9[ET\Z=V.2TCG<Q)^I-;= !1110 4444
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 97B;_ )%?5/\
MKUD_]!-<3\$/^1*N?^OUO_1<==MXF_Y%?5/^O63_ -!-<3\$/^1*N?\ K];_
M -%QT >ET444 %%%% !1110 445'<3QVMO)/,VV.,;F;T% $E%4+K6;&R>59
MYMGE*6<[20,#.,^N.<5 GB32GD6-;@[BA?&P].?;K\K?E0!K45%;7,-W")H'
M#QDD!AT.#CBI: "BBB@#C=+_ .2J:W_UY1?SK7\+?\@^\_["5Y_Z/>LC2_\
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M57W<@'TS794 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^HJ^7/B42/C!, ,@RQY.>G- 'TQI?_()LO\ K@G_ *"*MU4TO_D$V7_7!/\
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M_K78UR'P\G%SIFK3JDB"35KE@LBE6&6[@]#77T %%%% !1110 4444 %%%%
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M#!^5>?:D_P"$)O\ _H8;S_O[+_\ '*[.B@#C/^$)O_\ H8;S_O[+_P#'*/\
MA";_ /Z&&\_[^R__ !RNSHH XS_A";__ *&&\_[^R_\ QRC_ (0F_P#^AAO/
M^_LO_P <KLZ* .'N/"%W:VTMQ+XCO%CB0NQ\V7@ 9/\ RTKA= T":_T:.]U&
M"-KOQ#>(ENX8NQ@/+,V>>$0XY.-U>@?$R[G3PFVF68W7NK3)8PKNQG>?FY[?
M*#S4?A[3H$\20VT%HEK;Z-9!/)1@RI/-RW/J%4?]]4 =F(HQ$(MB^6!@*1QB
MD@MX;6(16\211@D[44*,GD\"I** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *^7?B3_R5ZX_ZZQ_S-?45?+GQ*8#XP3*>IECQ^= 'TQI?_()L
MO^N"?^@BK=5-+_Y!-E_UP3_T$5;H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRSXM31P7EA)+(J(
M('RS' ^\*]3K \2>#=&\5^3_ &M!)+Y.=FV0K_*@#-O?%WA"^L57_A(+!+B-
M=T,HE&Z-P."#_G-=#H>I+J^AV6H(583Q*^5Z$XYQ6 /AQH@&!/JH _ZB$O\
MC2?#WS([+6K1KB>:.TU>XMX3/*9&5%Q@9/- '84444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1160_BG04NY+1M7LQ<1$AXS*,J1US0!I7,ZVUK+
M._W8D+GZ 9KCM%\9>%8[5;RZUW3S?W #S.91D9Z*/0#IBMV;Q7X>AC+3:Q9*
MG3+2C'-4O^$I\&?]!32?^^DH J_#RYAO-+U:YMI5EAEU:Z='4Y# MP1785Q_
MP[E@FTK59;5D:!]6N6C9/NE2W!'M784 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 1S_\>\G^X?Y5Y#\)?^1DO_\ KVC_ /0$KUZ?
M_CWD_P!P_P J\A^$O_(R7_\ U[1_^@)5+9BZGL5%%%2,**** "BBB@ HHHH
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M^'/%%W#&/NVNH#[3%] 3\P_ UFCXCZEHNLS:/XBTB.2YA17:339"X96S@A&
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MJW532_\ D$V7_7!/_015N@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+,J31NNX1LQP'7/3YB,_GVH E\,Z:UK?7,]G?7TFDE0D$-U(9 6SRREOFV]
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M@C';UK8_X9^M_P#H)0?]^&_^*H ]7_X2;0/^@YIO_@7'_C1_PDV@?]!S3?\
MP+C_ ,:\G;]GRV92#J4.#_TP;_XJE_X9^MP/^0E#_P!^&_\ BJ /5_\ A)M
M_P"@YIO_ (%Q_P"-'_"3:!_T'--_\"X_\:\H_P"&?K?_ *"4'_?AO_BJ0?L^
M6P8M_:4.3_TQ;_XJ@#UC_A)M _Z#FF_^!<?^-'_"3:!_T'--_P# N/\ QKRC
M_AGZW_Z"4'_?AO\ XJD;]GRV92#J4.#_ -,&_P#BJ /6/^$FT#_H.:;_ .!<
M?^-'_"3:!_T'--_\"X_\:\H_X9^M_P#H)0_]^&_^*H_X9^M_^@E!_P!^&_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M** "LS4O#ND:NN+ZPAE;&-^W:X^C#!K3HH \JUOX&Z)>[Y--G>SD/(4C*^W
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MA9ZE )[&[AN8CT>)PP_2@"S1110 4444 %%%% !1110 4444 %%%% !1110
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M&/Q8GDD^I)R:M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 54OM+L-3B,=]9P7">DB X^GI5NB@#SK7/@UX;U4O);+)9S-G
MYD.>O7GJ?Q)K@+_X0>+/#TK77A[4I-X.0]NY4]>X&#T[8:OH2B@#YZL_B=X_
M\+RK;ZU8?;E'&)H]LA^C+_4<5VVA_'+PQJ05=06?393U,@WQ_P#?2]/Q KT>
M[L;2_A,5Y;0SQGJLJ!A^M<3KOPA\,:T&86[6TI_B0YY_'G]<4 =EIVKZ=JT
MFTZ^M[J,_P 4,@;'UQTJY7@&H_!;Q#HLYN_#^HLS+RIBD*./0=0?U8GTJM#\
M0/B/X/D$&J6CZA&IVA;B+YFYQPPP<^V#0!]$45Y5HGQVT"](BU:UN--F'#''
MF(#]1R/Q%>B:7KVDZW")=,U&VNEQG]U("1]1U% &C1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5\Z^/[V#Q3\6K71Y+F..U6X2!V=P%"K]XG/'=Q7ONL:@FDZ->:A(1M
MMX6D.?85\[_#'2O^$F\=27EW&)45_,?> 1UW'(/<D(/HQIH1[Y<ZKHQMQ:(T
M%Z2NQ+6'$I8=,8Z ?6CPYH4&AVL_E6\-N]U*9I(H!B-#@ *H] !^)S6I#:V]
ML,001Q#_ &% _E4M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME^!NA_9-%GU-T >; 4^Q ;&?]W9^=>M4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !01D8-%% &)JOA'0M95_MFG0LSC#.J[2?K
MCK]#FO.=>^ NF7F7TN[:!@VX(_ S]1P/R->PT4 ?/']@?$WP,<Z=>W,MJO\
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M6Q1THH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'_?&5_6GRL5T6OB'K7]@>!-5O58++Y)BBS_??Y1_.N$^!&AM;Z3-J<Z_O9
M#C'7'_LH4_\  A4'QPUA-0CT/0+.=9%NI?/9HF!!'W5QV/5C^%>E^#=+72/"
MME;A C,GF,H&,%N0/P&!]!2&;U%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** *FI:98ZQ926>H6L5S;R##1R+D?\ UC[TNFZ=;:1IMOI]
MG'Y=M;H$C7.< 5:HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img10132136_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_4.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (*!&(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "N:\?\>"[XXS\\/_ *-2NEKFO'W_ ")E[_OP_P#HY* /G_X8N7O=
M?=E*%ID)4]1R]>BUY[\-?^0EXB_Z[K_-Z]"H **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ JKJ/_ "#+G_KDW\JM55U+_D&7/_7)
MOY4 <Y9^&+748/M,D\L99F&R-4"@ X&/E]JG_P"$*LO^?NY_)/\ XFM30O\
MD%K_ +[_ /H1K2H \YU_PL@TS5T@DN)9($C,:!5)8GD]%SVH^"T,D'C*QCE1
MD=;L@JPP0?)DKMK3_D+ZA](OY&L#P!_R5R;_ +";_P#HJ2@#Z/HHHH ****
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M5I70DJ&X+'UKZNF8I!(XZJI(_*OB7Q;JEQJWB>:ZNWWSNX=V  !+?-P!TZT
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M6M_U_P */^$T\.?]!:W_ %_PH WJ*P?^$T\.?]!:W_7_  H_X33PY_T%K?\
M7_"@#>HK!_X33PY_T%K?]?\ "C_A-/#G_06M_P!?\* -ZBL'_A-/#G_06M_U
M_P */^$T\.?]!:W_ %_PH WJ*PAXS\.$X_M:W_,_X4LGB[01$Y35K7=M./G[
MT ;E%>*:7\0-<?5[1;N_46S3*)24 &W//Z5ZC_PEWA__ *"UK_WW0!M45B_\
M)=X?_P"@M:_]]T?\)=X?_P"@M:_]]T ;5%8O_"7>'_\ H+6O_?='_"7>'_\
MH+6O_?= &U16+_PEWA__ *"UK_WW2-XO\/*,G5K;\&S0!MT5B+XP\/.,C5K;
M\6Q2_P#"7>'_ /H+6O\ WW0!M45B_P#"7>'_ /H+6O\ WW1_PEWA_P#Z"UK_
M -]T ;5%8O\ PEWA_P#Z"UK_ -]T?\)=X?\ ^@M:_P#?= &U16+_ ,)=X?\
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M#=HK"_X3/PY_T%K?\S_A1_PF?AS_ *"UO^9_PH W:*PO^$S\.?\ 06M_S/\
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M8KHO@S>F#QOI\8C#+YX;.<$$J4_]FH ^M:*** "BBB@ HHHH **** "BBB@
MHHHH **** (KG_CUF_W#_*OA;6I%?5Y9(W##"8(.1PHK[IN?^/6;_<;^5?/;
M>%_#6D:?HEGJLD]I+<6?V@7*2H!<%@I49<$+C)S].M 'CJZO?W%PNU(9)G8
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M[^YL[_Q#J%G+$IERZVVW;@$*"%Y;!H XC_A"/"7_ #XS_P#D6F'P+X4\T/\
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MX2_Y\9__ "+7'>,/",-E):C0=/O)E?>92(G;'3 Z?6O?/^$R\/\ V99SX\N
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MA-MN"CKO.S 8YX7V_*KJGQ!TV*RMVTKQ==WES<H9%0+;?NE&,EP5'//"YR:
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M./;@5W:?$/1[]G@T_P 87XG5=V^YA@CC4=^2G)]AUK6C\6:&S0(?'D^Z6 S
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M[L9QQZT66E^&SXPU5&L-*,0@@*@PQX!^;..*=I/A[07\1Z\CZ;9%$EA" QC
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MR61;<E66,9!H K_!Y5_X0&' &/.?''O7?;5]!^5<%\'@!X!A & )GQ^==]0
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M31! 8Q@?NEZ4EAX>T%O%VK1MIMD8UA@*@QC SNS1=A9%:/0/"P\93P_8=/\
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MH]:9XH\)Z;!I]JR-=Y-[;J<W3G@R >M+XL\)Z;!X<N)$:[W!XAS=.1S(H]:
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M99,8+,03^G3\*\S^)XD.B>%5C*#*Q;B[[!@;"<MVZ=17K.K?\@>]_P"N#_\
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M=9I+*!+9YPN-\A 9L#L NP =LUUM9/AR%X]&BFE&)KIFN9/JYW8_ $#\*UJ
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MN6 X<TOA?0+N7PW:NNO:A&"K?*I7 Y/M2>%M NY=%W+KVH1CSY1M4KC[Y]J
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MPU,K8Z<9?LT.Y3<-@#+8P=M G\2_\)JQ^PZ=YWV$?+]H;&-Y[[: $N$\3_\
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M^&GW&FR0Z+:02/=J@:/4)<G(/&<<?45:\0>$;^WL8=UFJK+<Q0L/[5G8,&8
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M=\4D^M:F?&5I)_PCUT'%HX"><F2-PYZT:CK6IMXHTASX>NE95EPAF3+<#WH
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M^&*9XKUK5)?#\JOX>NHU\V$[C,A_Y:+[T[Q3K6J2>%K]'\/74:F+ES,F!^M
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MRG8G'6C2=:U-?$.O,OAZZ9FEB+*)D^7]V/>@ L=0U\>+M59=#B,A@@W+]K'
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M #B9,'CKUH 9X8U#7U\-6BQ:'$Z!#AC=@9Y/;%-\*ZAKZ:(!%H<3KYTOS&[
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M;J'B&=<B]O"X!.<1QX;'_?1B'_ : /:=(LCIVDVMJ>7CC <^K=2?SS5VBB@
MHHHH **** "BBB@ HHHH \:^,W_(M:_QG_2[+^1KJ3XAF_X081?V'J6/[."[
M]B[?]7UZ]*Y;XS''AG7SC.+NR_D:ZD^*+7_A!A#]BU'=_9P7/V9L?ZO'7TH
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MU)2DSD*47+?(>G-'B#Q#-)<:.3H>I)MOD8;D7YOE;@<]:-7\4VLFNZ(XLM1
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M)8!C^_\ ?E(_X&V/^ 5P/C_5+?Q9\3-'L4@G6VL(3/=":,KP/G((ZC("C/\
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MQ&6;=]DV_P"H?KM^E-T'Q=I$7ABRB>6;<MN <0.>WTJ6W\5:"/#$<9U&#?\
M9-N/?;3= \5:%%X7LHWU& .MN 0>QQ0!!X7\6Z1!X<MHWDFW#=G$#G^(^U)X
M6\6Z1!H[(\DV?M$QX@<\%S[5)X6\4Z%#X;MHY-1@5QNR#_O&D\*^*="AT=DD
MU&!6^T3'!]"YH C\-^+=)ACU'?+-\U]*PQ QX)^E&@^+=(BO]<9I9L27VY<0
M,>/+0>GM3_#7BG0H8]2\S48%W7\K#/<$T:!XIT**_P!<9]1@ >^W*3W'EH*
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M$LLVYK5E'[A^NWZ4WQ3XIT*;PKJ$<>HP,[0D #O4NK^*M!?PQ>1KJ,!<VC
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M K+G_6+3_%.K:"_A74%BN[$N83@*RYI/%T&ACPW.8H=/#^9#C:J9_P!8M/\
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M+Z55Y/ &/>ET+PIH<NHZXKZ?&1'>[5&3P/+0^M #]+\/Z"WB;74?3;(HC0[
M8UP,QC.*+3P_H)\8ZG&=-LC&MM"57RUP"2V:9I?A30W\3:[&VGQE(VAVC)XS
M&">]%IX4T-O&.IPG3XS&MM"57)X)+9[T /\ ^$?T'_A-C%_9MEY7V -M\M<9
MWFBX\/Z"/&5E&--LO+-I(2OEKC.13/\ A%-"_P"$V,/]GQ^7]A#;<GKO/O27
M'A30AXRLH1I\?EM:2,5R>N1[T 2:GX?T%?$VC(NFV01O-W 1K@_+WHUOP_H*
M:QH:IIMD%>Y8,!&O(V'K4>I^%-#3Q-HT:Z?&$?S=PR><+]:-:\*:''K&B(FG
MQA9+E@PR>1L/O0!)XC\/Z#&VE>7IMDNZ_C5L1KR,&CQ3X?T&+3K8Q:;9*QO;
M<';&O0R#-1^(_"FAPMI7EZ?&N^^C5N3R,'WH\4^%-#@TZV:/3XU)O;=203T,
M@![T 2^+?#^@Q>&[EXM-LE</%@K&N?\ 6+3O$_A_0(O"NH21:;9+(L!(*QKD
M&H?%GA/0H/#=Q)%I\:N'BP03WD4>M/\ $_A/0H/"NH2QZ?&KK 2#D\'\Z +&
MI^'M 7PS=NNFV(<6C$$1KG.VDMO#V@'PO&YTVQ\S[(#GRUSG;3=3\):"GAF[
MD73H@XM&8')Z[?K26WA+03X8CE.G1;S:!LY/7;]: %\/^'] D\+V+R:;8M(;
M<$DQKDG%1^%?#^@R^&[=Y=-LF<[LEHUS]XTOA_PGH4OABRE?3HB[6X).3R<?
M6H_"WA/0I_#EO))I\;.=V22?[Q]Z '>%?#^@RZ0[2Z;9,WVF89:->F\XH\->
M']!D34_,TVR;;?RJN8UX&>E,\*^%-"GTAWET^-F^TS#))Z!S[TGAOPIH<R:E
MYFGQMMOY57D\ 'ZT 2:#X?T&34==$FFV1"7V$S&O \M.E&E^']!;Q-KJ/IMD
M41X=@,:X'[L9Q4>@^%-"EU'7%?3XR([W:HR>!Y:'U]Z72_"FAOXEUV-M/C*1
MO#M&3QF,$]Z 'V?A_03XQU.,Z;9&-;: JOEK@$ELT#P_H/\ PFS1?V;9>5]A
M#;?+7&=YIEGX4T-O&.IPG3XS&EM"57)X)+9[T#PIH?\ PFK0_P!GQ^7]A#;<
MGKO/O0 ^X\/Z"/&=G&--LO+-I(2OEKC.X4:EX?T%?$^CHNFV01A+N C7!X'6
MF7'A30QXRLX1I\?EM:2,5R>N1[TFI>%-#3Q/H\2Z?&$<2[AD\X ]Z )-:\/Z
M"FLZ&J:;9!7N&# 1KR-AZT>(_#^@QOI/EZ;9+NOXU;$:\C!J/6O"FAQZSHB)
MI\862X8,,GD;#[T>(O"FAPOI/EZ?&N^^C5N3R,'WH D\4^']!BT^U,6FV2DW
MUN#MC7H9!FE\6^']!B\-W#Q:;9*XDBP5C7/^L6HO%'A30X-/M6CT^-2;ZW4X
M)Z&0 ]Z7Q9X3T*#PY<21:?&KAX@"">\BCUH F\4>'] B\*ZA)%IMDL@@)!6-
M<@U+JOA[0$\,W;KIMB'%HQ!$:YSMJOXH\)Z%!X5U"6/3XE=8"0<GC]:EU3PE
MH*>&;N5=.B#BT9@<GKM^M #K?P]H!\,1N=-L=_V3.?+7.=M-T#P_H$GA>R>3
M3;$R&W!),:Y)Q26_A+03X8CE.G1;_LF[.3UV_6FZ!X3T*7PQ92OIT1=K<$G)
MZX^M ">%O#^@R^&[9Y=-LF<[LEHUS]XTGA7P_H,NCLTNFV3-]HF&6C7IO.*;
MX6\)Z%/X;MI)-/C9SNR23_>/O2>%?"FA3Z.SR:?&S?:)ADD] Y]Z '^&O#^@
MR1ZEYFFV3;;^55W1KP,T:!X?T&2_UT2:;9$)?83,:\#RTZ5'X:\*:'-'J7F:
M?&VV_E5<D\ 'ZT:#X4T*6_UQ7T^,B.^VJ,G@>6A]?>@"32O#^@MXEUY'TVR*
M(\.P&-<#]V,XHL_#^@MXPU2,Z;9&-;> J/+7 )W9J/2O"FAOXEUV-M/C*1O"
M%&3QF,$]Z+/PIH;>,-4A.GQF-+> J,G@G=GO0!(/#^@_\)L\?]FV7E?85;;Y
M:XSO-$_A_01XSLXQIMEY9M)"5\M<9W"F#PIH?_":O#_9\?E_85;;D]=Y]Z)_
M"FACQG9PC3X_+-I(Q7)Z[A[T /U+P_H*^*-'1=-L@C++N C7!X%&L^']!36M
M#5--L@KW#!@(UY&P]:9J/A30D\4:/$NGQA'67<,GG 'O1K/A30X]:T1$T^,+
M)<,&&3R-A]Z '^(O#^@QRZ1Y>FV2[K]%;$:\C!H\4^']!BL+0Q:;9*3?6ZG;
M&O0R#-1^(O"FAPRZ2(]/C7??(K<GD8/O1XH\*:'!86C1Z?&I-];J<$]#( >]
M $GBWP_H,7AR=XM-LE<20X*QKG_6+3_%/A_0(O"NH21:;9+(L)(*QKD5#XM\
M*:%!X<GDBT^-7$D0!!/>11ZT[Q1X3T*#PKJ$L>GQJZPD@@GC]: +.K>'M 3P
MQ>.NFV(D%HQ!$:Y!VTD'A[0#X81SIMCO^R9SY:YSMIFK>$M!3PQ>2KIT0=;1
MF!R>NWZT0^$M!/AA)3IT6_[)NSD]=OUH =H/A[0)/"]D\FFV)<VX))C7).*C
M\+>']!E\-6KRZ;9,Y#9+1KG[QHT'PEH4OABRE?3HB[6X).3R<?6H_"WA/0I_
M#=M))I\;.0V22?[Q]Z '^%?#^@RZ,6ETVR9OM$PRT:]-YI/#7A_09(M1\S3;
M)MM_,J[HUX&>E,\*^$]"GT8O+I\;-]HF&23T#GWH\->%-"FBU$R:?&VV^E4<
MG@ _6@!^@>']!DOM<$FFV1"7Y5,QKP/+3@4:3X?T%O$FO(^FV11)(=@,:X'[
ML9Q4>@>%-#EOM<5]/C(COBJ\G@>6A]?>C2?"FAR>)->C;3XRD<D(49/&8P?6
M@"2R\/Z"WC#58VTVR,:V\!53&N 3NS0OA_0?^$VDB_LVR\K["K;?+7&=YJ.R
M\*:&WC#5(3I\9C2W@*C)X)W9[T+X4T/_ (3:2'^SX_+^PJVW)Z[S[T 23^']
M!'C.TC&FV7EFSD)7RUQG<*-1\/Z"OBG2$73;(1LLNX"-<'@5'/X4T,>,[2$:
M?'Y9LY&*Y/7</>EU'PIH:>*-(B73XPCK+N&3S@#WH ?K/A_04UO0U33;(*\[
MAP(UP1L/6CQ%X?T&.;2!'IMDH:_16Q&O(P:9K/A30X];T1$T^,+).X89/(V'
MWI/$/A30XIM($>GQKOOD5N3R,'WH D\4>']!BL;,Q:;9*3?VZG;&O(,@R*/%
MOA_08O#LSQ:;9*XEA&5C7/\ K5S4?BCPIH4%C9M'I\:EK^W4X)Z&0 ]Z7Q;X
M4T*#P[-)%I\:N)81D$]Y%'K0!+XI\/Z#%X5U"2+3;)9!"2"L:Y%3:OX>T!/#
M%ZZ:;8AQ:,01&N0=M5O%/A/0H/"VH2QZ?&KK"2#D\?K4NK^$M!C\,7DJZ=$'
M6U9@<GKM^M #XO#V@?\ ",*YTVQW_9,Y\M<YVTFA>'M ?PO9.^FV)D-N"28U
MR3BFQ>$M!/AA93IT6_[)NSD]=OUINA>$M"E\,64KZ=$7:W!)R>3CZT 'A;P_
MH,OAJU>73;)G*MDM&N>II/"OA_09=%W2Z;9,WGS#+1KG&\XIGA?PGH4_AJUD
MDT^-G*MDDGU/O2>%?">A3Z+ODT^-F\^49)/0.?>@!_AGP_H,D.H^9IMDQ6_F
M4;HUX&>!1H'A_09+W7!)IMD0E^53,:\#RTX%,\->%-#FAU R:?&VV^F49)X
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M2ZIX1TI/#-W*!<[A:,PS<OC.WZU%XG\+P0^%M0D&H:DQ6$G#73$'\*EU3PM
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M;-]&%Q:XP>>>M+XHL?$2Z=;&75[5U^VVX %KC!\P8/6D\11^)PVE>;<:8?\
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MX3291K%MYOV)"6^R\8W'C&:);'Q%_P )G;J=8MO-^QN0WV7C&X<8S0D7B?\
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M%2^%9W@=IM3,DGDA@%9E503GL!N/X5[QX/LDM="21%VBX;S%!ZA,!4'X(JT
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M2O\ Q ?$NCLVBP"0>;M7[6#GY>>=O%&M7_B!M7T0OHL"L+EM@%V#N.P_[/%
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M;Q,=:T3S+/30XG;8!.V"=AZ_+1J-_P"(#XGTAFT6 2!9=J_:QSP,\[:-9O\
MQ =9T0OHL"L+AM@%V#N.P_[/% !XBF\3&72?-L]-&+Y-NV=CDX/7Y:/%$WB8
MV%IYUGIRK]NM\;9V//F#'\-'B&_\0-)I/F:+ F+Y"N+L')P>/NT>*+_Q UA:
M"718$'VZW((NP<GS!@?=H 7Q9-XF/AV<366FK'YD62L[$_ZQ<?P^M.\43>)C
MX6U 366FK'Y)W%9V)Q_WS3?%E_X@?P[.)M%@1/,BRPNP?^6BXXVT[Q1?^(6\
M+:@LNB0)&83N878.!]-M $NJS>)SX9O ]EIHC^R-DB=\XV_[M$,_B?\ X1A
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MO6EU/Q%<-X9NT.@ZDH-HPW%%P/EZ]:2V\17 \,1Q_P!@ZD1]D W!%Q]WKUH
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M%5?E_=IP>>M !I6LZJOB+767P]<,S21;E$R?+^['O19:SJH\7:JX\/7!=H(
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MOJ#6CI/BFV7Q%KLOV'42LDD) 6V)(Q&.M=-J/AG1=4TE]+NM-MVLF.[RE0(
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MQ&HYHT#Q;I45WK9=Y\27Y9<0.>-B>WM1I/BW2H_$.O2,\^V26(K^X?M&H]*
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M']@U+/V3;G[,<?=I-%\4VT?ABSC-AJ1(M@,BV)'2G+XNTG_A&!%OGW?9-O\
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M+-(5C&#UY8G\*]J\"Z9%I^B9B \MB(HB/^>48V+CV."W_ J .HHHHH ****
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M:O%;Z7!8NPQN@C&#]1W_ $/O3]+^%WA>VTZ*'4-"TJZN4R&F6V"[QG@D>N*
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M]=PI\>LZ%_PFTS_;++R_L* '<N,[VHEUG0O^$UMW%Y9>6+-P3N7&=PH 9?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_E^3!MR$Q_%G%,TC0M!?Q#KZ/IUB42:((#&N!^Z7I18:%H+>+M6C;3K$QK#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)!I=W<79<0:A9^4S?*H[G'48QGM73:+:Z[/KVN-!KEJW[V+<ZVP8-^[&,<T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
J**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img10132136_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_5.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (=!%X# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "O+];8+\4F+$#-FXY]?+:O4*\OUM5?XI,& (%F
MY&?41M0!]3Z;_P @NT_ZXI_Z"*LU6TW_ )!=I_UQ3_T$59H **** "BBB@ H
MHHH **** "BBB@ ILCK%&TCG"J"Q/L*=5>__ .0==?\ 7)_Y&@#SWQCXOTO7
M?"=U96 NI)93&R$V[*I =6)R?8&N&TR_M;.Y(N)TC+65L1N[_?K@_&FK:A9Z
MGI4%M>SPQ-9QDHCD DD]14]GXQT2.Z$=_I\L[I%';@[0<%2V>_3D4 >D_P!M
MZ;_S^1?G2+KFF,,B]B(/O34T32G17%C#AAD?+6/X=TK37T9Y9[6([9Y@68=
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MYI5#'*@\+G)ZTMSK,%K>26SH^]$1P>S;CCCZ4 :-%9AU<O(T5O:R32(SAE!
MP%;&>??M6D#E0<$9'0T +1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>7ZV
MP7XIG/5K1U ]28V %>H5XSX_N)K7QS+-!*T<JVXVNIP1P: /JC1_$NBW%O96
MD.IV[7#1H@C#\EMO3ZUO5\S_  EOKJ_ELWN[B2=UU2(*TC;B!7TQ0 4444 %
M%%% !1110 4444 %%%% !3)HA-!)$20'4J2/<4^B@#XJ\<+-;^.[S3I9S,FG
MS_98F*@'8IXSBMIOAZ+CQ*UM'J'EAHA<@F+.,D\=?:J/Q+LKBT^*>L_:(FC\
MV^:5-W\2,<@CZUZ-;?\ (Y#_ +!\?\VH O/'JMM:LPN[5A&F<>0W.!_O5'I>
MD6RV<4A:5TD_?>4[Y16;YCQWY/>M*]_X\;C_ *YM_*N9\/>)I]1M+:&&S@9A
M IVK=@M@ #D8XH ZVBN=U3Q'<Z65$UE;H64L!)=A2<>G!JWIOB/3K_3;:[DN
MK:!IHPYB>=<IGL: ->N?\1?\?^D?]? _]"2M/^V-+_Z"5G_W_7_&L?6[F"ZO
M-)>WGCF07(!:-PPSN3TH Z6BBB@ HHHH \OTN]\9>(KK4#8:K%%';3E-KJ!W
M.,<>U:7]D?$#_H-6OY?_ &-'PT_UFO?]??\ \57?4 >9ZNGCK1=+FU"XUB!H
MH0"P103R0/3WJOI7PV_M*WM-6?52#.%G*>3W/.,YKK_B!_R)&H_[J?\ H:U>
M\+?\BKI?_7LG\J ->BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *U[9_;(X
MP)6B:-]ZLH!YP1T/UJ"724G,;RS2-+$H$;\#:0<Y&.YK0HH S)]&CG!4SRA&
M9BZ<$'+;N_3D]15J:RCF^T[F8>>@1L=@,]/SJS10!G+HMLLT,N7+1[^_W@V<
M@_F:6STI+2X\[SGD*IY:!@/E7TR!D_C6A10!G-I$9NQ,)7"B3S1'@8#^H.,^
M^*C'A^S6(HFY=T?EN1U?G.3[Y_G6K10!G'1;5CM8$P^:91#@;0Q&/\3^-12:
M#"]NL"S2(@C\IA@'<HZ#D=O6M:B@#/ATOR+UIXKAU5B"T>U2#A0O7&>@HO=(
MM[]R\I8-N1@5/(*D_P \UH44 9K:.@=GAN)87<ON9<9(8Y(]N:T54*H49P!C
MDYI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP5ZA7EGPAGBNM3\430G*/<QD<8_@%>IT %%%% !1110 4444 %%%% !1110
M444R61887E;[J*6./04 >!?$'Q-:>'?BM>FYAFD\ZVB0>6!P>.N321L&\<.P
MZ&Q0_P#CS5P7Q3UZU\1^/CJ%HKK&RQ+M?&X$>N*NGQ]96OBEYVM9F5(5ML C
M.03S^M 'I-__ ,@ZY_ZY-_*J7AK_ )%G3?\ KW3^5-N=5CN+&54MKO,D9"_N
M&[BL#2]?U73]*M;-O#=Z[0Q*A8,,' H [:BN5_X2O5/^A8OO^^A1_P )7JG_
M $+%]_WT* .JKS]?^0]/_P!A<_SCK6_X2O5/^A8OO^^A61;)=&]CNKJTDM6N
M=3\U8Y.H&8Z /0:*** "D?[C?2EH(R"/6@#S#X8?\AW6_K_[,:]/KR?1H/$O
MAG4]1EM- DN!<2'#.>-N21C!K;_X2CQG_P!"L/S/^- &K\0_^1*O?JG_ *$*
MUO#W_(N:=_U[I_*N#UW4?%^NZ1-I\OAMHTEQEE)R,'/K4NE?$BRLK6TTV6QN
M/-B"PL<CJ.* /2:*** "BBB@ HHHH **"< FN#_X6CI_V_[+]AN,^9Y><CUQ
M0!WE%%% !1110 4444 %%%% !1110 4444 %%%% !12.P1&8] ,UPUK\3M/N
MM2BLULK@-)*(PQ(XR<9H [JBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2T/@[4VF9=^T:A$=H]3^\XJ63X9^%H8FDD\(:DB(,LQU*+ '_?R@#,^R6?\
MT$Y__ FC[)9_]!.?_P ":T+?X;>%KJW2:/P;JH1QE=VH1@X^ADIK?#KPFMXE
MI_PA^J&9E+[5U&,[1ZG]YQ0!1^R6?_03G_\  FL77(+:.\TP+?2N'G ):?.W
MYEZ>E=;)\,O"T4;22>$-25%&68ZE%@#_ +^4VU^'/A>YMTFB\&ZJ$?E=VH1@
M_7'F4 9WV2T_Z"<__@31]DL_^@G/_P"!-7Y/AYX4%ZEJ?!^J-,ZEL#48S@>I
M_><5(_PR\+Q1M(_A#4E11DL=2BP!_P!_* ,S[)9_]!.?_P ":/LEG_T$Y_\
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M8'BG_GI=?^#+_P"QKU2^T?3]-@$UUH6LQJS!5SJ466)Z ?O.:GC\-VLJ!H]
MUEU/0KJ41_\ :E '@FMZEJGA^ZCMKZ:_65TW@+?%L#..NVLW_A,)O^>^H_\
M@8?_ (FO=Y_ WA_7;N1KCPCJUU) ?+,C7\1&?[H/F<X[^E5;KX:>$K.(23>"
M=2&Y@BJ+^(EF/8#S.30!YSIEGXAU6PAO;5[LP2KE6;4<=\=-M7/["\4?WKG_
M ,&7_P!C7JUKX.LK.V2WMO#&LQ0H,*BZC$ /_(E)!H=G<S31Q>']<;R6VNPU
M"+:&],[^M 'E0T/Q02?^/H?]Q/K^E']A>*/6Y_\ !E_]C7JMWH=G91>9/X?U
ML D*H&HQ$L3T &_DU./"\)&?^$=UOIG_ )",7_Q= 'D8T+Q0<Y^U#_N)_P#U
MJ/["\4>MS_X,O_L:]5@T.SN9YHH?#^N.8CAV&H1;<^F=_6BZT*SLX1)-X?UL
M D*H&HQ$L3T &_DT >">);R_THG3M1>\WS1;BGVTNN"2.>.>E<U8ZA#8WB7$
M,<L;IG#13%6Y&.N*^EKWX=:)JDJSWO@_59Y-NT,^H19QZ?ZRLZ'X:>$KB>6*
M+P3J;&([787T6T-Z9\SK0!YWIUEXAU2QAO+9KLP2KN5FU''Z;:M?V%XH_O7/
M_@R_^QKU!O#.F:/8HB^&]9A@3"1QIJ$7)/0 ;^35L>&(2,_\([K8^NHQ?_%T
M >1C0O%!)S]J'_<3Z_I2_P!A>*/[US_X,O\ [&O5(=#LY[B:&+P_KC&' D8:
MA%M!],[^M+=:'96<!FFT#6PN0 !J,1+$] !OY- 'E0T+Q0>OVH?]Q+_[&C^P
MO%'K<_\ @R_^QKUL>&(2 ?\ A'-;&1G!U&+_ .+J&'0[.>XE@B\/ZX[18WD:
MA%M!],[^OM0!X%XGO=0TPMIE_)=B66(,5-X9% )/7CGI63X;U/3M'OUO9VNS
M(H8;8,+U]Z^@M8\!^'IO]-U/PCJLSX"*S7\3,WHH DY//2L&\^".E7=T\\&D
M:]:Q/C;"EU:D+QT^9B: .)_X6)I7_//5O^_XJS8>.=*OKZ&V_P")I&97"!FG
M&!GUKI;'X-:3]O:,6'B*=8&'FH;FU"$_W<@]<>G/-;-W\+_"ME;M-/X1UA5!
M  &HQ$DGH -_)/I0!4^R6?\ T$Y__ FC[)9_]!.?_P ":TU^%/AXJ#_PA^LC
MC.#J,7'_ (_4$7PT\,37,UO'X2UEFAQYA&H1;5)[9W]?:@"AY6GCKJ\O_@6*
M/*T__H+R_P#@6*OW7PP\+65NTT_A'6%0?]1"(DD] !OY)]*F7X3^'&4'_A#M
M8&1G!U"+/_H= &;]DM/^@G/_ .!-8OB2&UCM(=E_)(Q<Y5I]V!L;G_Z]=7!\
M.O"\ES+;0^#=69XL;R-0CP">V?,ZXYQ[BDO?AMX7M[=IY_"&K*@&,KJ,9+9X
M  \SDGIB@#) TO _XG;?^!@I<:7_ -!MO_ P5J+\)/#3*&_X0[61GL=1BS_Z
M'4,?PO\ "LMU-;Q^$=99XL>81J,6%)[9W]?;W% &3?)ISV,ZQZPSN4.U3=CD
MXZ=:Q1J:6<#[9F=5W.-MVR=23C&T@?G78W7PM\*V5NT\_A+6%1>/^0C$22>@
M W\D^E0:G\./!VCZ7+J.H>%=8@MHEW.S:A%D9[8W]?:@#R_4?&FGZKI-Q93Q
M:C$T@P")_,7\B!7+I-IUM;72PR7+R31; '0*!R#Z^U?3=K\&O =_I7GV$,KB
M:/,<HNBX4D<=#CBN'_X9VU#O>VS'U^T$9_\ (5 '$_!W_D?K#_KK'_Z&*^OJ
M\6\&_!B_\,>([34C<VS1Q2*S@3,QP#G@;!_.O:: "BBB@ HHHH **** "BBB
M@ HHHH *KW__ "#KG_KD_P#(U8JO?_\ (/N?^N3?R- 'F6G^&['QCK%N-:L&
M$%OI$'V?+_,P).21VZ=*E\/?#'PQ>6]XTUK(QCO)HU^?HH; JWH^F'4/$$6R
M\N[-ET6VRT$@&_D]0<XQ^%6_#/AZ66VOB-<U-,7TRX61><-UZ=: ,G0_AAX8
MNKG5Q+:2'R+UHD^?HH13C]31IGPP\,7&MZU;RVDAC@EC6,;^@,:D_J:UO#_A
MZ62ZUH#6]339?LN5D7YOD3D\=:-(\/2OK^O(-;U-2DT0+"1<M^Z7KQ0!DV7P
MQ\,2^)M3M&M9###%"R#?T)#9_E1'\,/#!\736AM)/)6S20#?W+$5JV'AZ5O%
MFK1_VWJ8*Q0'>)%RV0W7BB/P]+_PFD\7]N:GD62-O\Q<_>;CI0!E2?##PP/%
MD-E]ED\AK1G*[^^X"B\^&/AB+Q-IMJEK((98Y2XW]2,8K5D\/2CQI!%_;>IY
M-FQW^8N?O#CI1?\ AZ5?%>E1_P!MZF2T4IWF1<CITXH RM3^&'AB#7-(ACM)
M D\CK(-_4!"1^M&N?##PQ:W&DI%:2!9[Q8Y!OZJ58X_2M75O#TJ:_HB'7-38
MO+(-QD7*_(>G%&O^'I8[K1@=;U-]U\JY:1?E^5N1QUH RO$/PP\,65O9-!:R
M*9+V")OG_A9P"*/$WPP\,6.BO<06DBR":%<[^QD4']":UO$WAZ6*VL"=<U-\
MW]NN&D7C+CGIUH\5^'I8=!=SK>IR?OX1M>1<<RJ/2@#+\2_##PQ9>'+RY@M)
M%D1,J=_N*DU?X7>%[;P[=W,5I(LD=NSJ=_0@5I>*O#TL7AB^D.N:FX$8^5I%
MP>1[5)K?AV9/#-[(=<U1@+9CM:1<'Y>GW: ,D_"WPM_PCQNOLDGF_9M^[?WV
MYHTOX7>%[CP[;7,EI(97MP['?U.*UV\.S?\ ",&3^W=4Q]DSM\Q<?=Z?=I-'
M\.S/X8M)!KFJ*#; [1(N!\O3[M &+X=^%_AB\\.VMS-:2&1T))W^YIOAKX8>
M&+[1DN)[21I#)(N=_8.0/Y5L>&/#TTOAFS<:YJ: QGY5D7 Y/M3?"OAZ670D
M<:YJ:?O91M61<??;VH R?#WPP\,7MK>-/:R,4O)HU^?^$-@"C0_AAX8NI]66
M6UD(@O6BC&_HH53C]36KX9\/2RVMZ1KFIIB^F7"R+SANO3K2^'_#TLESK0&N
M:FFS4&7Y9%^;Y$Y/'6@#)TOX8>&+C7-:ADM)"EO-&L8W] 8U)_4T67PQ\,2^
M)M4M7M9###'"4&_IN!S_ "K6TCP]*^OZ\@UO4UV3Q@L)%RW[I3SQ26'AZ5O%
M>KQ_VWJ8*Q0'<)%RV0W7B@#*B^&'A@^+9[+[+)Y"VB2!=_<L1_2A_AAX8'BZ
M*T%I)Y+6C.1O[[@*UHO#TI\9W$7]N:GD62'?YBY/S-QTI)/#TH\:0Q?VWJ>3
M9,=_F+G[PXZ4 95Y\,?#$?B;3K1;63R98I6==_4C&*-3^&'ABWUO1[>.UD$<
M\CJXW]0$)%:M]X>E7Q9I<?\ ;>IDM#*=YD7(Z=.*-6\/2IX@T1#KFIL7DD&X
MR+E?D/3B@#*UOX8>&+6[TE8K20">\$;_ #]5VL<?I1XA^&/ABS@L6AM9%,E]
M#$WS]59@"*U=?\/31W>C ZYJ;[[Y5RTB_+\K<CCK1XF\/2Q6^GDZWJ;[M0@7
MYI%XRXYZ=: ,KQ+\,/#%AHK36]I(KB:%<[^QD4']#3O$OPO\+V/AZ\NH+219
M8T!5M_3D5J>*_#TL.A,YUS4Y!Y\ VM(N.95'I2^*O#TL7AB]D.N:FX"#Y6D7
M!Y'M0!G:S\+O"]MX=O+F*TD$J6[.IW]\4-\+?"R^'3<BTD$@MM^=_?;FM;7/
M#LR>&;YSKNJ,!;,=K2+@\=/NTK^'9O\ A&&D_MW5,?9,[?,7'W>GW: ,C3/A
M;X6G\/6UU):2&5K8.6W]\9J/P]\+_#%[X=M;F>TD:5X\L=_6MK2?#LS^&+60
M:YJB@VH.T2+@?+TZ5'X9\/32^&+.0:YJ: QGY5D7 Y/M0!D>&OAAX8O=$CGG
MM)&<R2+G?V#D#]!2>'?AAX8O;6[>>TD9H[R:-3OZ*&P!6MX5\/32Z#&XUS4T
M'FRC:LBX^^WM2>&/#TLMG>D:YJ:8OIUPLB\X8\].M ' :19K]@M=*$]V]LUX
M!;Q&\,4<3F289)",3G:HQTYKMU\&:TL<D:R$)),+A@-6<9D!!#?ZC_9'Y5S?
M@VQBOI;.SG+.CD@MGYOO7'.?7O7LRC"@9SCN: /.9? ^KS/=O(2SW94SM_:S
MY?;C;_RPXQ@=*J^(?#^J6>BZG>ZB\DMN\(%PBZN^957.%_U(YYQ[YKU&L;Q1
M917N@W/G;BL*-*%!X+!3C/T//U H \6BT*_TGQ1&UAI.H6RZH-D<7VB%6EB\
MH97< =O()SCG%=&=+UNVOXY#HVK"ZDA^S+_Q.4),?]W&SI[UOZP[IXG\'M&H
M9Q&=JDXR?*? KNK>$HBO+M:X*@.X7&?_ *U(I)6NSRP:#KS6\$1T75A'!&8H
MU.L+\J'&5^YR.!2QZ%K]K':+#HNJJMF2;=5U=/W>1@X^3T->L44K/N7[2/\
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M?HUC([>*=,\E,NS3;G(_$IFN5UNZ\477@ZZU#7]1:=8+N:W^SC:FR58WPW"
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MM3?#'AZ66QNR-<U-,7LZX61><.>>G6@"CH'P_P!'N?[2ADGU+R[74'6%5OI
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M#7P_TJ]T.UN)KW6/,5Y-NW490%^9AQSQQ3/#?P]TB[T^9I+O5AY5]-L"ZA*
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MEVM]E7CIGB@!=6T74UU_1%/B*\9FED 8Q1Y7Y#T^6C7]%U-+K1@WB*\<M?*
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M$UR-7$\6]OLJG<?*7\J+#3O$!\5ZNJZY&)!%!N;[*O/#8XH (M%U,^-+B/\
MX2*\WBR0[_*CR1N;C[M$FBZG_P )I#'_ ,)%>;S9,=_E1YQN''W:(M.\0?\
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M\3)XBO(U\R3Y5BCQ]]O]FF^&-%U.2QNRGB*\C O9P0(H^3O//W:7PKIWB!]
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M)H(_^$BO-_V+/F>5'G&[I]VEN]%U,>+].0^(KPL;>4A_*CR.1Q]VD.G>(/\
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M:!B<[VSWIWAF3Q0/#-GY,.F&/RS@LSYZFF^%9/$XT)/)ATPIYLOWF?.=[9H
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M:=)XI_X1FW"0Z9Y?V48)9\XVU'X<D\4#PQ9>5#IAC\G@LSYQ0 WPK!XG/AZ
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MQ1_PC$I-_IWE_93D?9VSC;_O4MA;^*#X9@*W^G"/[*, V[9QM_WJ2[D\4_\
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MSBQW#&WLH(%>G_#GX7W'A'79M2O18+B Q01VCR.%+'+,2XSG@#\Z /4****
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MS<YQ18:OJX\6:LX\/REVB@W)YZ?+PU$>KZQ_PFD[_P#"/R[S9(-GGIP-S<T
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MJT?V888W."1M^E*=8UC_ (1@I_PCTVW[)C=YZ=-O6DT?5]87PQ:(OAZ9E%L
M&\].1MZT 1^&;WQ&OAFS$6DVK1^6<,;G!/)]J3PK>^(ET)!#I-JZ>;+R;G'.
M]L]J7PSJ^L)X9LU3P_+(HC.&$Z#/)I/"NKZQ'H2+'X?ED7S9?F$Z#^-J $\,
MWOB);6]\K2;5@;Z8G-SC!W<CI1X?O?$0N=:\O2;5B=08OFYQ@[$XZ4>&=7U>
M.UO0GA^60&^F)(G08.[I1X?U?6$N=:*>'Y7+:@Q8"=!M.Q.* #2+WQ$->UXI
MI-J7,\6\&YZ'RE]O2BPO?$0\5ZN5TFU,ABAW+]IX'#8[4:1J^L+K^O,OA^5F
M:>(LOGI\O[I:+#5]7'BO5W'A^4NT4&Y//3Y>&H (KWQ%_P )G<,-)M?-^Q("
MOVGC&YN<XHDO?$7_  FD+'2;7S?L3 +]IXQN'.<41:OK \9W#_\ "/R[S9("
MGGIP-S<T2:OJY\9PO_PC\N\63#9YZ=-PYH +Z]\1'Q9I9;2;42"&7:OVG@CC
M/:C5KWQ$?$&B%])M0XDDV 7/7Y#[47VKZN?%FEN?#\H<0RX3STYZ4:MJ^L-X
M@T1F\/RJRR2;5\]/F^0T &OWOB(W>C>9I-JI%\I3%SG)VMQTH\2WOB)K?3_-
MTFU4#4("N+G.3O&!THU_5]8>[T8OX?E0K?*5!G0[CM;BCQ+J^L26^GA_#\L8
M&H0$$SH<G>,"@ \5WOB)M!83:3:HGGP<BYSSYJX[>M.\57OB-O#%Z)M)M4C*
M#+"YR1R/:F^*]7UB30F63P_+&OGP'<9T/_+5:=XJU?6)/#%ZDGA^6-2@RQG0
MXY% $NN7OB,^&;X2:1:K&;9LL+G) Q]*'O?$G_",,/[(M?+^R?>^T\XV_2C7
M-8UAO#-\C>'ID4VS L9TX&.M#ZQK'_",,G_"/3;?LF-WGITV]: #2;WQ&/#-
MJ$TBU,?V888W/)&WZ5%X9O?$:^&;,1:3:M'Y9PQN<$\GVJ72=7UA?#%JB^'I
MF46P ?STY&WK47AG5]83PS9HGA^611&<,)T&>30 GA6]\1+H,8ATFU=/-EY-
MSC^-L]JIZ7>^($\/:QMTJV*>?=%V-ST.3GM5SPKJ^L1Z#&L?A^61?-E^83H/
MXVJA9:OJR>%]< T*4H9KHL_GI\N2<_E0!B_#;[^A_P#7&/\ E/7JPOP^L-8)
M'N\N$2R/G[N3A1CWP?RKROX<_++HGM"G\IZ]:AM(8)YYXU_>3L&D8G.<# _#
M%.6[$MB8].!6)=7ZZCX4OYO+,;K%+')&3DHRY!'YBMRLC5K6&VT75Y(EVM<1
M.[\\%MF,_D!2&>6_%R-Y+/PQL&=K0L2690 .I)7D#W%,^VVG_/\ Z=_X-[[_
M .)KK]4E\OQ/X0&POO0+C'JAKN2L0(!5 3VP*G6YK:"BF^IXKX*_>_&=)XFC
MEA.D.OF0SRS+G>.-T@!S[5V-O_R7.^_[ D7_ *,:NKU'28M0:"1+J:UEAW;9
M+=@#@XR.0>.!61'X*MX]7?5DU?4C?-$(&F,JEB@)(7IZDT78-4VDTSJ:^?/#
M4FH)9Z^UG:1S1B\@#L\FTJ?M+$#\:]DFT@VT9DG\2:A&G]YY44#\2M>7V,<^
MC)XGM;"PDNK4:G;!9O-7M(",^N<_K3N)P5FTSMO%5[XC;PS>B;2;5(]@RPN<
MD<CVJ37;WQ&?#-\)-(M5C-LV6%SD@8^E1^*M7UB3PS>I)X?EC4H,L9T..14F
MNZQK#^&;Y'\/3(IMF!8SIP,=:9F+)>^)/^$88'2+7R_LGWOM/.-OTHTJ]\1C
MPS:A-(M3']E&&-SR1M^E$NL:Q_PC#)_PCTVW[)C=YZ=-O6C2M8UA?#-JB^'I
MF46H ?STY&WK0!POPVW?\)IH;.H5VTN_+ >OVJO5_$.KS:-8I<06_P!I<OL\
MA?OMGNOTZGV!KR3X4+'%K=SJ^H7,H%K9S"-'(VQ*TYW 8ZY('XU[7!<QSA 0
M$F*"0PN1O4'U% "VDAFLX9&DCD+H&+Q_=/T]J\HUT(WAK51(%9#XANMRL,AA
MY4G%>IW5Y!IZP^:-D3OLW ?*A/3/H.V?>O+=;C2;P]J44@RC^([E6'J#&] &
M7;Z=X7O)/+MOA]--)C.V.9&./7 -6O\ A&]&_P"B8WWYBO0=!\ ^'/#6H&_T
MJQ\BX,9CW^8S?*2"1R?85TN1G&>30!XPWAW154D_#&^  R>16>L?@Q_]7X(+
MCU$Z#^>*]SG_ ./>7_</\J\O\)> ?#GB+1QJ.IV/G7(F= _F,. V1P#0!F_\
M(YHQY_X5C??FM'_"-Z-_T3&^_,5[(H2)%0855  &>U.R#T- 'ANJZ!I,&DW4
ML?P^N[)TC8K<O@K$<?>(]!6];W>NCP9X85=,MS"LUKY3_:,%N1C(QQFNX\9?
M\B7K/_7I)_Z#7#V^IZH/!?AB-=$E:-)K79)YRX?!&..V: -GQ7>^(FT/$VDV
MJ)]H@Y%SGGS5QV]:=XJO?$;>&;P3:3:I'M&6%SDCD>U-\5ZOK$FA[9/#\L:_
M:(#N,Z'GS5P*=XJU?6)/#-XLGA^6-2HRQG0XY% $FO7OB,^&+X2:1:K&;9LL
M+G) Q]*6:]\2?\(PX.D6OE_9#\WVGG&WZ4FO:QK#^&;Y'\/3(IMF!8SH<#'6
MEFUC6#X8=#X>F"?9"-WGITV]: /.](UCQ%=Z78!O&45DD[R0M;F%6^SJNX#)
MQR#M'YUKVL.K6-I':P?$BU2%%PJ^0O _*O'_  _$\_CW3?,L_.4WC/-;JH9G
MC7+-D=Q@'\J]X^'NC:%J]CJUQ-I-C<(-0=83-;*Q6/:I"C(X STIM6$G<Q[.
M'5K"V6WM_B1:I$I) \A3R3D]O4TEI!JMC&\=O\2+5%>1I&'D*<LQR3TKTG_A
M$O#?_0 TO_P$C_PK.U[X=^'-<T>;3QIMK9>;M_?VMO&DBX(/!Q[8I#.'M8-5
MLS.T'Q(M5\^4RR'R%Y8@#/3V%$$&JVUQ<SQ?$FU62Y</*?(7D@ #MZ 5G7'P
MUM?#&O6>EZ.[7TUPOFB._C22-B X^8?*. <CW%;UIX1U^U@$1\->&)3DG<^G
MIG_T90!2B@U6&\GNT^)-J)IPHD;R%YV].U"P:JM^]Z/B3:^>Z"-F\A>5!R.W
MO5>+X;Z[%=1S_P!FZ2^R3S/+>W0H>>A&_I6I=^$-?NHT4>'/#$6UMV4T].?;
M_64 9OAO7/$<GQ&-L+I=79+!\/(1&K@2D;EP.G KK;R]\1'Q=IK-I-J)1!+M
M7[3P1QGG%<+X4:\TGXJRPPZ>D]U'I\BR6]N%B1#YQSM&2,?CWKNKS5]7/BW3
M7/A^4.()0$\].>E-B0:I>^(CXCT0OI-J'#R[%%SU^0^U&O7OB(W^B>9I-JK"
M]!0"YSD[&XZ4:IJ^L-XCT1F\/S*RO+M7ST^;Y#1KVKZN]_HA?P_*A6]!4&=/
MF.QN*0P\2WOB)HM-\W2;50-0@*XN<Y;=P.E'BN]\1-H@$VDVJ)]I@Y%SGGS5
MQVH\2ZOK$D6F[_#\J8U" C,Z')W=*/%>KZQ)H@63P_+&OVF [C.AY\U<"@!?
M%5[XC;PU>";2;5(]JY87.2/F'M4_PR,C>&KDRH$D.H7&Y0<@'=ZU!XJU?6)/
M#5VLGA^6-2JY8SH<?,*G^&3N_AJY=XS&YU"X)0G.T[NE '9T444 %<'X;U'6
MPVM06&G6\\$&K7*!GGV')?=C&/\ :KO*\X\,ZEJ%EKWBBVM-*DO%.HM,6655
MP6)'?_<H N>%[WQ$MA=>5I-JP^VSDDW.,'><CI1X=O?$2R:QY6DVK9U!RV;G
M&&VKQTH\,:OK$=A=!/#\L@-[.21.@P=YR*/#NKZPDFL;/#\K[M0D+8G0;3M7
MB@#DO$\^JS/J"7EC##$VL6WF,DVXJ?+& ..>*Z/PKX&$?A?3/L^MWL4+6ZL(
MUCB(7(SU*$]ZYWQ+?W\\M\EQI;VZ-K-LS.95;8?+&!Q77Z-K.IQZ>]C&+56M
M[=&MR8BP9=HX(##GGVZ=ZEK4UA*T7;?0P/&WPUNKFQ^W6=U>:GJ,<<L,4<@C
M0*KHRD_*HSR16_X>U?5=(\.:=IT_A;56EM;=(79/+P2H )'S]*TKKQ!J%O+<
MQ+:!S&Z)')Y;!9.SD<]C27.O:E;Z#]L:"%+D3M&RNN % )R06'7'KW'THMYA
M[1-).*.&U.6\O_C%H-_<:9<V$9M_*5;C;N8B13D;2>.:]%T=U34M?=R%5;P$
MD]AY,=<KJ]^NH>,?#LOF0%A,1Y:,"R#*?>QTR<\>U=-IB0SZAX@MIMI66Z"E
M"<;AY,>::)G:^AIZ7>/J&G17;Q>4)<LB]]F?E)]R,'\:35;XZ;8F[\K?&CKY
MOJJ$X+?@.?PJVB+'&J(H55   ["DFBCGA>&50\;J593T(/6F0<EXZP8+4C!!
MBN.?^V=<=8W.KIX'UN.WL(9+7^T9OWK38;/F#MBNN\;")+:TAB(Q'%.NT'.W
M]WQ7(V-_J$7@?6X(=*DF@_M&8^>)5 _U@['F@#J_$%[XC;PQ?"32+58S;MEA
M<Y(&/I3KF]\2?\(Q*#I%J(_LIRWVGG&WZ4WQ!J^L/X8OD?P],BFW8%C.AQQU
MIUSK&L'PQ*A\/3!?LA&_STZ;>M !IU[XD'AFW"Z1:F/[*,,;GG&WZ5'X;O?$
M:^&+(1:1:M'Y/#&YP2/RJ33M8UA?#-N@\/3,HM0 WGIR-O6H_#FKZPGABR1/
M#\SH(>'$Z#- #?"M[XC7P] (=)M73?)@FYQ_&WM2>%[WQ$NGW(BTFU9?MLY)
M-SCG><CI2^%=7UB/P] L?A^:1=\GS"=!GYVI/"^KZQ'I]R$\/RR WLY)$Z#!
MWGB@ \.WOB)7U?RM)M6SJ$A;-SC!VKQTHT:]\1#6M=*:3:LQN4W@W.-I\M?:
MCP[J^L(^K[/#\K[M0D+8G0;3M7BC1M7UA=:UYE\/RLS7*%E$Z?*?+7B@ TV]
M\1#Q1K)72;4R%8=ZFYX'RG':BWO?$7_"97C#2;7S?LD>5^T\ ;FYSBC3=7U=
M?%&LNOA^5G98=R>>GR_*:+?5]7'C*\<>'Y2YM(P4\].!N;F@ -[XB_X30-_9
M-KYOV+&W[3QC=USBB[O?$1\7:<QTFU$HMY=J_:>",C/.*#J^L?\ ":!_^$?E
MW_8L;//3INZT7>KZN?%^G.?#\H<6\H">>G(R.: #4[WQ$?$FBE])M0X:78HN
M>#\ASVHUV]\1'4=$,FDVJL+S* 7.<G8W'2C4]7UAO$FBLWA^565I=J^>GS?(
M:-=U?6'U'1"_A^5"MYE09T^8[&XH /$E[XB9=,\W2;5<:A"5Q<YR=W Z4>*K
MWQ$VCJ)M)M47[5!R+G//F+CM1XCU?6'73-_A^5,:A"1F=#D[NE'BK5]8DT=5
MD\/RQK]J@.XSH>?,7 H 7Q7>^(V\-W0FTFU2/Y<L+G)'S#VJ3Q#>^(V\,7PD
MTBU6,VYRPN<D#'TJ/Q7J^L2>&[I9/#\L:G;EC.AQ\PJ3Q#J^L/X8OD?P],B&
MW(+&=#CCK0 Z[O?$A\,2AM(M1']E.6^T\XV_2EL+WQ(/#, 72+4Q_91AOM/.
M-OTI+O6-8/AB5#X>F"?92-_GITV]:6PUC6!X9MT'AZ8K]E W>>G(V]: (O#E
M[XC7PQ9"+2+5H_)X8W."1^5-\*WOB-?#T ATFU=-TF";G'\;>U/\.:OK">&+
M)$\/S.@AX<3H,TSPKJ^L1^'H%C\/RR*&DPPG09^=J $\+WOB)=.N1%I-JR_;
M)R2;G'.\Y'2CP[>^(E;5O*TFU;.H2%LW.,':O'2CPOJ^KQZ=<B/P_+(#>3DD
M3H,'><BCP[J^L(VK;/#\K[M0D+8G0;3M7B@ T6]\1#6-=*:3:LQNDW@W.-I\
MM?:C3;WQ$/$^LE=)M3(1#O4W/ ^4X[4:+J^L+K&NLOA^5F:Z0LHG3Y3Y:\4:
M;J^KKXGUEU\/RL["'<GGI\ORF@ M[WQ%_P )E>L-)M?-^RQY7[3P!EN^*/MO
MB+_A--W]DVOF_8L;?M/&-W7.*+?5]7'C*]<>'Y2YM(@4\].!EN:/[7UC_A--
M_P#PC\N_[%C9YZ=-W6@ N[WQ%_PE^GL=)M1*+:7:OVG@C(SSBN/^,&N:W9:3
M:"[LH+;S_,A#1S[CAEPW;TS787>KZN?%^GN?#\H<6TH">>G(R.:X3QE<7/CC
MXJ>'_#MQ9O;):.'FC\P-P?G8Y''W5 P?6@#TWX<Z'_PC_@33+-TVSO'Y\_'.
M]_F.?ID#\*ZFD "J% P , "EH **** "BBB@ KR_X]';\.XSZ:A#_P"S5ZA7
MF'QZX^'D7_80A_\ 9J -2]UZ[;P5+&=!U *;';O(7'W.O6I_^$@O/^$8V?\
M"/ZCC[)C=A<?=Z]:AO?$T3>"I81IFI@FQV[C:MC[G7/I4_\ PD\7_",>7_9F
MJ9^R8S]E;'W?6@!NC:_>)X8M$&@:BP%L!N 7!XZ]:C\,:_=Q>&;1%T#49 $/
MS*%P>3[U+HWB>*/PQ:1G3-4)%L!D6K$=*C\,>)HH?#-I&=,U-B$/*VK$=30
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M(P8_[,U3/V3&?LK8^[ZTFC^)XD\,6D9TS5"1; 9%JQ'W: (O#.OW<?AFS1=
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MP>F/,Y'-4M=N_%EWK-DHUW4;99@R;(-)9 , G(&\Y- 'I7C+_D2]9_Z])/\
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MO[6>UN+&-+K6R)Y_+;?9$'&TGCGD\4:E:SV:VICNM;/FW"1-YED1PQP<<]:
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M<ULP&;.0#[OKMJ/Q5XLT.?PO?117P9VC  \M_4>U2ZWXMT*3PQ?1I? NULP
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M^F89<<@MQ4GA.XT(:"HEFT\-YTOWF3/WVI/#%QH0M;_S)M/!^WSXW,G3=Q0
MSP]X@T".ZULR:C9@/J#,N7'(V)THTCQ!H">(->=]1LPCS1%"7&"/*7I3_#UQ
MH0NM;WS:> =0;;N9.FQ.E&CW&A#Q#KY>;3]AFBV99,?ZI>E #+#Q!H"^+=7D
M;4;,1M% %)<8. V:(_$&@#QK/)_:-GY1LD ;>,9W-3["XT+_ (2[5RTVG^68
MH-N63'1LXHCN-"_X3:<^=I_E_84P=R8SN:@".3Q!H!\:02C4;/RA9,"V\8SN
M%+?^(- ;Q9I4BZC9F-8I@Q#C Z8I\MQH7_";0$3:?Y?V)\G<F,[A1?W&A?\
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M7\V4X9QG[[5+X7N-"'A>S$DVGA_+.=S)GJ:;X3N-"&@()9M/#>;+]YDS]]J
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MDT1TU&S*(TN\AQ@?(>M/O+C0O^$PTTB;3_+^SR[B&3&>*-5N-"/B70RLVG[
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M))J-FKB'!!<9JQIUSH(\+VX:;3]_V49RR9SMJ/PU<:$/"UD))M/#^3SN9,T
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MQ:@$%QG.VG7=SH/_  BTP$VG[_LA_B3.=M+I]SH/_"+VX:;3]_V09RR9SMH
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M#RS9,VWG&=P]Z+[PSH2^+=+B%A (VAE+#GG&/>@!VK:7H2^(M#5+6Q"-))N
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M[C^-O>E\-^%;.;PQ92-=Z@"T6<+=,!^5)X5\+6<_A^&1KO4 2\@PMTP'WVH
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M3OT\M3ZTGAWPM9ROJ^Z[U ;-0D4;;IAD;5Z^]&B^%K.36M>0W>H 1W* $73
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M#2?VWJF/LF=OFC'W>G2DUS1-23PS?.WB.^=1;,2ACCP>.GW:5]#U+_A&&?\
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M5'I2>)=%U&.#3BWB*]DSJ$  :./@[QS]VE\5Z)J,>A%G\17L@^T0#:T<>/\
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MZ "8X_E.QN1\M'B71-1CATXMXBO9,ZA !F./@[NOW: %\5^'9(=#WG6M3?\
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MC H6*WB6) !P !BK- !1110 4444 %%%% !1110 5Y?\>N/AW'SC_B80\_\
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ML+?Q,?%FK!=0T\2B*#<3;M@C#8QS1';^)O\ A-)P-0L/.^Q)EOL[8QN;MF@
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M="8S:AI[)Y\'"V[ Y\U<=_6G>*K;Q,/#%Z9M0T]H]@R%MV!/(_VJ )=<TWQ
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M&VH+V\\1GP7*K:5:"+[#@M]IYQLZXQ4_VSQ+_P (QC^R;3R_LGWOM/.-OTH
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MV_\ "/R;/LF-WVA.FWK4%[KUZW@J6,Z!J 7[#C>=F/N=>M3_ -OWO_",;/\
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MM%!N3[0GR\-1'JVL_P#":3O_ &!)O-D@*?:$X&YN<T6&O7J^+-6D&@7Y9HH
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MHN@:A(HC/S+LP>3[T )X5U;68]!C6/0))%\V7YA<(/XVI/#&K:REG>B/0))
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MIMV!<[,#CKUIUSK]Z?#$J?\ "/Z@%^R$;_DQ]WKUH -.U?6AX9MT7P_(R"U
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M^]+X8\5:=#97BM%?$M?3L-MG(>"Y]J/#WBK3HIM9+17WSZ@[#%G(>-J=>.*
M#1_$J1Z[KSG2]4/F7$9P+8DC]THY]*33_$J+XJUB7^R]4(>.$;1;'(P#U%+H
M_BK3X]=UYVBOL27$9&+.0G_5*.>.*-/\5:>GBK6)3%?;7CA  LY,\ ]1CB@
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MR0K=+=23W"0%K=U7<[D#DC ZU!^S_HI@\/7NMR(P>\D$,98<E4ZGW^9CS[4
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MN6'(V)1I'B+04\0:\[ZC:!'FB*$L,$>4HXH 98>+-$7Q;J\K7F$>* *?*?G
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M=SM& !Y3CN/:I=;\6Z')X8OHDO<NULP \I^NWZ4WQ7XBT"7PO?1Q:C:,YC&
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MXTBF^V?NQ9,N?*?KN'M1>^+-$;Q;I<HO,HD,H8^4_&<>U/?Q%H/_  FL4O\
M:-IY0LF!;<,9W"DOO$6@MXMTN1=1M#&L,H8[A@'C% #=6\6:))XAT21;S*QR
M2%CY3\?(?:DU_P 6:)+>Z*4O,A+X,W[I^!L;VI^K>(M!?Q%HCIJ-H4223>0P
MP/D-'B#Q%H,E[HACU&T(2^#-AAP-C4 -\3>+-$F@TX1WF2NH0,?W3C #C/:C
MQ7XLT2?0BD=YN;[1 <>4XX$JD]J=XF\1:#+!IPBU&T8KJ$#'##@!QDTOBSQ%
MH$NA%(M1M&;[1 <*PZ"5<T )XJ\6:'/X8O8H[W<[(,#RG'<>U2:[XMT.7PQ?
M1)>Y=K9@!Y3]<?2F^*_$6@2^&+U(M1M&<H, ,,]14NN^(_#\GAB^1-1LRYMF
M  89)Q0 V7Q;H9\,-%]M^?[)MQY3]=OTHTKQ;H:>&+6)KW#BU (\I^NWZ4^7
MQ'X?/A=H_P"T;/?]DQC<,YVT:5XC\/IX8M8WU&S#BU (+#.=M $'AGQ9H</A
MBSBDO<.L6"/*<^OM3?"OBS1(- BCDO=K"24X\ISU=O:I/#/B+0(O#%G'+J-H
MKB+!!89[TGA3Q%H$7A^))=1M%<22G!89^^U $?A?Q9HD%E>+)>8+7T[#]TYX
M+G':CP[XLT2&?62]Y@/J#LO[I^1M3VIWA?Q%H,5E>"74;12;Z=AEAT+G%'AW
MQ%H,<^LF34;0!M0=ERPY&Q.: &Z/XLT2/7=>=[S"R7$94^4_(\I1Z4:?XLT1
M/%6L2M>81XX0I\I^< Y[4_1_$6@)KNON^HV@5[B,H2PP1Y2]*33O$6@KXKUB
M1M1M!&T<.TEA@X!S0 V'Q9H@\9W4QO/W9LXU!\I^NYO:AO%FB?\ ":1S?;/W
M8LBN?*?KN'M3X?$6@#QI=2G4;3RS9Q@-N&,[FH;Q%H/_  FL<O\ :-IY7V(K
MNW#&=PH 9>^+-$;Q=IDHO/D2"4,?*?C./:C5?%FB2>(M$D6\RD;RECY3\?(?
M:GWOB+06\7:9(NHVAC6"4,=PP#Q2:KXBT%_$6B.FHVA1'EW$,,#Y#0 W7_%F
MB2WVB,EYD1WH9OW3\#8WM1XE\6:)-#IHCO,E=0@8_NGX ;GM3M?\1:#)?:(8
M]1M"$O@S88<#8U'B;Q%H,L.FB+4;1BNH0,V&' #<F@!OBOQ9HD^A[([S<WVB
M X\IQP)5)[4[Q7XLT.?PS>1QWFYV48'E..X]J7Q9XBT"70]D6HVC-]H@.%8=
M!*N:7Q7XBT"7PS>)%J-HSE1@!AGJ* ':]XMT.7PQ?1)>Y=K9@!Y3]<?2EF\6
MZ&?"[Q"]^?[(5QY3]=OTIVO>(] D\,7T<>HV9<VS  ,,DXI9O$?A\^%WC&HV
M?F?9",;AG.V@!FE^+=#3PQ;1->X<6H4CRGZ[?I4?AKQ;H</ABRBDO<.L6"/*
M?_"I]+\1Z GABVC;4;,2"U (+#.=M1^&O$6@1>%[*.34;-7$6""PS0!%X5\6
M:)!X?BCDO=K"24X\ISU=O:D\+^+-$@L;M9+S!-[.P_=.>"YQVJ3PIXBT"+P_
M$DNHVBN))>"PS]]J;X7\1:#%8W8EU&T4F]G898="YQ0 WP[XLT2&763)>8WZ
M@[+^Z?D;4]J-&\6:)'KFO.]YA9+F,J?*?D>4H]*=X=\1:#'+K/F:C: -J#LN
M6'(VIS1HWB+04US7V?4;0*]S&4)8<CREZ4 -T[Q9HB>*M8E:\PCI#M/E/S@'
M/:B'Q9H@\9W<QO/W9LXU!\I^NYO:G:=XBT%?%6LR-J-H(V2':2PP< YI8?$6
M@CQG=RG4;3RS9Q@-N&,[FH 8WBS1/^$T2;[9^[^Q%<^4_7=]*+SQ9HC>+M-F
M%Y^[6"4$^4_!./:GMXBT#_A-4E_M&T\K[$5W;AC.ZB\\1:"WB[3)!J-H8U@E
M#'<, \4 ,U3Q9HC^(]$D6\RD;R[CY3\90^U&O>+-$EO]$9+S(2]#-^Z?@;&]
MJ?JOB+0'\1Z(ZZC:%$>7<0PP/D-)KWB+0)+_ $0QZC:$)>AFPPX&QJ &>)?%
MFB31::([S.W4(&/[I^ &Y[4OBOQ9HD^B!(KS<WVF X\IQP)5)[4[Q-XBT&6+
M3/*U&T;;J,#-AAP W)H\6>(M ET0+%J-HS?:8#A6'02KF@!/%?BS1)_#-Y%%
M>[G8+@>4X_B'M4NO^+=#E\,7T27N7:V8 >4_7'TIOBOQ%H$OAF\2+4;1G*K@
M!AG[PJ77_$>@2>&+Z./4;,N;9@ &&2<4 -N/%NAGPO)$+WYS:%<>4_7;]*--
M\6Z&GABVB:]PXM0I'E/UV_2GW'B/P^?"\D8U&SW_ &0C&X9SMHTWQ'X?7PQ;
M(VI68<6H!!89SMH @\-^+=#A\,644E[AUBP1Y3_X4WPKXLT2#P]#')>;6#R'
M'E.>KM[5+X:\1:!%X7LHY-1LU<18(+#--\*>(M B\/0I+J-HKAY."PS]]J (
M_"_BS1(+"Z62\P3>SL/W3G@N<=J/#OBS1(9-8,EYC?J$C+^Z?D;5]J=X7\1:
M!%870EU&T4F]G898="YQ1X<\1:#')K'F:C:#=J,C+EAR-J\T -T;Q9HD>MZ\
M[WF%DN4*GRGY'E*/2C3O%FB)XIUF5KS".L.T^4_. <]J=HOB+04UO7F?4;0*
M]RA0EAR/*7I1IOB+05\4ZS(VHV@C98=I+#!P#F@!L'BS1!XSNYC>?NVM(U!\
MI^NYO:@^+-$_X359OMG[O[$5SY3]=WTIT'B+01XSO)3J-IY9LXP&W#&=S4'Q
M%H/_  FJR_VC:>5]B*[MPQG=0 V\\6:(WB_39A>?NUMY03Y3\$X]J-4\6:(_
MB31)%O,I&TNX^4_&4/M3[SQ%H+>+]-D&HVAC6WE#'<, \4:IXBT!_$FB.FHV
MA1&EW$,,#Y#0 S7O%FB2ZAHC)>9$=[N;]T_ V-[4>)?%FB31Z9Y=YG9J$#-^
MZ?@!N>U.U[Q%H,FH:(8]1M"$O=S88<#8U'B7Q%H,B:9Y>HVC;=1@9L,. &Y-
M #?%?BS1)]%5([S<WVF X\IQP)5)[4OBOQ9HD_AJ[CCO=SD+@>4X_B'M3O%?
MB+0)=%58M1M&;[5 <*PZ"5<TOBOQ%H$OAF[2+4;1G(7 5AG[PH 7Q!XMT.7P
MO?1)>Y=K=@!Y3]<?2G7/BW0SX7EB%[\YM"N/*?KM^E+X@\1Z!)X7OXX]1LS(
M;=@ &&2<4ZY\1^'SX7EC&HV>_P"R$8W#.=M #-.\6Z&GAFWB:]PXM0I'E/UV
M_2H_#?BW0X?"]E%)>X=8<$>4Y_I4^G>(_#Z^&+=&U&S#BU (+#.=M1^&_$6@
M1>%[*.34;-7$.""PS0!%X5\6:)!X>@CDO=K!Y,CRG/\ &WM2>%_%FB0:?<K)
M>8)O9V'[ISP7..U2>%/$6@1>'H$EU&T5P\F06&?OM2>%_$6@1:?=++J-HI-[
M.1EAT+G% #/#GBS1(7U?S+S&_4)&7]T_(VK[4:+XLT2/6M>=[S"R7*%3Y3\C
MRE'I3_#GB+0(WU?S-1M%W:C(RY8<C:O-)HOB+0$UK7F?4;0*]TA0EAR/*7I0
M W3?%FB)XHUF5KS".L.T^4_.%/M1;^+-$'C.]F-Y^[:TC4'RGZ[F]J=IOB+0
M5\4:S(VHV@C=8=I+#!PIS1;^(M!'C.]E.HVGEFTC ;<,9W-0 T^+-$_X343?
M;/W?V+;GRGZ[OI1=^+-$;Q?ITPO/W:V\H)\I^I(]J<?$6@_\)J)?[1M/*^Q;
M=VX8SNI;OQ%H!\7Z=(-1M#&MO*&.X8!R* &:IXLT1_$FBR+>92-I=Q\I^,I]
M*-=\6:)+J.ALEYD1WNYOW3\#8WM3]4\1: WB71'74;0HC2[B&&!\AI-=\1:!
M)J.AE-1M"J7N7PPX&QJ &^)/%FB3+I?EWF=FH0LW[I^ &Y[4>*O%FB3Z,B1W
MFYOM4#8\IQP)%)[4_P 2>(M D72_+U&T;;J$#-AAP W)H\5^(M ET9%BU&T9
MOM4!P&'02KF@!OBOQ9HD_AJZCCO=SG;@>4X_B'M4GB'Q;H<WA>^B2]R[6Y '
ME/UQ]*3Q7XBT"7PU=)%J-HSG;@!AG[PJ3Q#XCT"3PO?QQZC9M(UNP ##).*
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M&5GT_8'EW89,?</6C7[O0CJ&A[)]/(%\"V&3IL;K2:KIVA#Q)HBK;6.PO+N
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MPFJK]FL?*^Q$XVKC.Z@!;R[T+_A,--(GT_RQ;R[B&3&>*-5N]"/B70RL^G[
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MG0O%(F?R]&\0"/\ A#V\K'^0H]SS#WCWS0-5^'T.@VT=YY*W(0APUO+G.?\
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M>U7X?P:.B7ODK/YDA(:WES@N<?P^F*30-4^'\-M="\\E7:[E9-UO+]PM\O\
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M'7M$&DM92!GD\R)LHP^0XR#7HFJZ!I&N0F'5--MKM,8_>Q@D?0]1^%><Z_\
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MGT#G%-\*^$]'G\/0220R%B\G2=Q_&WO2>%_">CSZ?<M)#(2+V=1B=QP'..]
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M*75/#K)XCT1/[9U1M[R_,9AE?D/3BDU[PXT=_H@_MG5&WWH7+3#Y?D;D<=:
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MMXCOW46[$H4CP>.GW:B\5:;KR>&KMI=?$B +E?LJ#/S#O4NOZ9KZ^&+YI/$
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M-Q]VC3=-UX^*-95=?"N%AW-]E3YOE..*+?3=>/C*\0:^!(+2,E_LJ<C<W&*
M Z)J'_":"/\ X2*_W?8L[]D><;NGW:\UU6SF\4_':RT2:^FO[?3F7S'E ^4+
M\[CY0,<[5^IKT#4H]9TSQ#<WD_B #[/IKRM(;5/N@YQ7+? G39M1U+6_%EYE
MYKAS$LA&"68[W_\ 91CVH ]NHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&56
M4JP!!Z@BEHH X_6_AAX2UTL\VE1V\S?\M;7]T?Q X/XBO/-1^!>J:7="]\*^
M(&CE0Y"RDQ28]-Z<'/N*]SHH ^==1USXI>%;FUN-7M'NX[(L4FDA$B\C!)=.
MW/>I8OB]/K%WIAU"Z@L&@N@Y=[8M&ORD9RK'UZ8KZ%(R,&N6UWX<^%/$67OM
M'@$Q.?.@'E/GKG*XS0!SNHZEJ.LV>F36/B'2+V,ZA!M,$6=K;N,C=^E:'BNV
M\2KH@,VHV#)]I@X6V(.?-7'?UKC-6^ DMO,+KPYK;Q2J0RK< JP/7(D3\,9%
M8>KWGQ6\-V(M=3M9=0L4D1S(R"8#:P8?.OS8XY)% 'J'BJV\2KX:NS-J5@T>
M%R%MB#]X>]2Z_:^)AX8OC)J5@T?V=MP%L02,?[U>77GQLN]9TF>QO;&WM6D
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M)YWG/>E\*MXH_P"$>@\E-,\O?)C<7S]]J3PN?$_]GW/DKIFW[;/G<7Z[SF@
M\.VWB4OJ_E:C8+C4) ^;8G+;5Y'S4:-;>)3K6O"/4; .+E-Y-L2"?+7ISZ4>
M'3XGWZOY2Z9_R$)-^[?][:O3VHT8^)_[:UWRUTS?]I3?NWXSY:]/PH --MO$
MI\4:R$U&P$@6'>3;'!^4XQS1;VWB7_A,KP#4;#S?LD>6^S'!&YNV:--;Q/\
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MP36>K:#(9S/)*YA?:06.2"C#(Q73^"_B+%J<FHK96D4DMQ>-,L3W21O@JO\
M"W)Z4 ;FC7?B0:WKQCTRS+FY3>#<$8/E+TX]*-.N_$@\4:P5TRS,A6'>#<'
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MOKG3Y%.0CGS8R?Q^8?GQ7K=% 'S\GA7XH^ Y9)M(N6OH&(9Q$_G*V!U*/\W
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH JW^F6&J0&"_LX+J(_P31AA^M>>ZY\#O"FJDR6BSZ=*/N^2^
MZ,<?W&R,?3%>F44 ?/UU\*_'?A:6.X\/ZJ;V*W?S(HXY2I! Z^6_RY.3T-5[
MSXJ>*M.FL;+Q7HAW6]U'.9!$87;8<GK\I^HKZ)J&ZL[6^@:"[MH;B)NJ2H&4
M_@: /*-7^,/A36=$2'SKFUN?M$#F*>$@@"12>1QT%=!XE\8Z5?\ A:Z^S+>2
M*X4JXM)-I^8=\8J+6_@SX2U8,T%M+ITI_BM7PO\ WR<C]*\_U+X-^,-"5CX=
MUD7-L>7A1S$S=_N$E#TH ]-\0>*]/E\,7T2P:@&:W8 M92 =/7%.N?%>GGPQ
M+'Y&H;C:%<_8I,?=]<5Y5??$KQQHNG3Z3XGT8.LL9B$LL1A8<=F'R-@5V%I\
M8_"FH>');2YFFL+G[,4"7$9PQVXX(R* .ET[Q7IZ>&;>,P:AN%J!D64A'W?7
M%1^&_%=A#X8LHF@U LL."5LI"/SQ2Z3XT\/2>%[=$U%786H4[8G/.WV%'AOQ
M;HD/A>RBDO"'6'!'DN?_ &6@!GA7Q580>'H(V@OR0\GW;*0C[[=P*3POXJL(
M=/N5:"_)-[.WRV4AX+GVIWA7Q9HD'AZ".2\(8/)QY+G^-O\ 9K,M/'.G:3X6
MU*6UF66]-W-]GB>)PKNTAVY..G-"5] ;L:/AWQ580OJ^Z#4#OU"1AMLI#QM7
MKQQ1HOBJPCUK7G,%^1)<H1BRD)_U:CGCBN>\,_$=-*2Z?7],N;>*\N3<+=P1
MEX<, /J.E;7AWQSX;GU?7)8M31TFN49"L;G($:CICU!IM-"3N9'B'QQ::9#X
MKNH$NUGEMXXX/,MG4!RI SD<=:W_ (1Z(VB_#VQ,JXN+W-W+_P "^Z.>>% _
M6O.O'>H1>+?&]MX;TV0R17]U TIV,/E52.<X. "Q_"O>X8D@A2&,81%"J/0#
MBD,?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1SP0W,+0SQ
M1RQ,,,DBA@1[@UP^N?!_P?K;-*+ V-P<_O;-MF">^W[OZ5WE% '@E]\$_$FA
M2O<>%];$@_N;S Y]CC*MQ]*I6GCSQYX#ABL-<T W%F@V*\T.P@=AYBY4GZU]
M$4UT21"CJ&4C!##(- 'D7@KXN>%DTF&QU0R6$RLYWRQ[HSEB>&7/K6/K.NV6
MMZ?:Z3I=S%/YFHSSN8CG[SE8_P#T(M^%>BZW\+?"6N;GDTM+69N?-M#Y1SCC
M@<'\17%0?!U_"6N)K6FW\U[;1*W^C&(!QD8W''#XR>P-5!\KN3)75CH](T2Z
MU6*Y6TO$M[>T*V\:/"'20A06ST/<#@^M<K=>'X9/$5Y9MH%S#>V:J[7^E$JN
M#R.1@_AC\ZTO#WB37]"\NSF_LRXM+F:5X-SF-N6)PS@8!Y[@#G&:V)9QIEAJ
MT%EH^KVFIZH=H$F9XR[83<'!(  .><<"I*.8\":=%=?$6U\02ZA<ZA'+!-!;
M27405U9,#.1UXWCH*]KKR'1[2+P]XL_L^*2X9++5$55=<1JDJ8PIQZR<UZ]0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% '+^(O"46HI+<62JEPX/F1$X27_P");W_.N<T?Q%<^&)OL5XDATF%50B=R
MT\#]^O5?Q^E>EUQ7Q#\"?\)E80^1<^1=0;L#HLRD8*L1R/8\X]*=Q6['G?Q&
M\81Z5XCFN])D6_BEC@D98V^6)U((9L#(S\HZCK7M&@ZF=:\/Z?JAB\HW=NDQ
MCSG;N .,U\WZGI]_HBS:1>6;VSM&B2;@9&F <-N&3@#"@DKQP 0.E?1'A*+R
M/!^C1=-EG$/_ !T4AFS1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% &?K&AZ9K]G]EU.SCN8LY&X<J?4'J/PJ[%$
MD$*11J%C10JJ.P'2GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img10132136_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_6.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (,!%4# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.F2*M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 451U>YEM-,FFA_UBX ^7/4
M@=*H76I7=AIT5P[&1F<H4EC"-ST.!V'4^U &[16!=ZG?1RR11,K",KED0,V-
MN20N>1GTJREQ=RZE:A+I/L\L/FE1&.<8Z'KWH UJ*YN#7KHW(CF5 DC0K&X'
M\3$;@?P.1]*MV^HSO>P^9(HCGE>-8Q&>-N?XO7Y>AH V:*Q[_4)X;F79(J10
M;-R^66+;L]<=!QUIK:RPU>YM1CRTC8(=I_UBC)YZ=#^AH VJ*Y^VUBX6UNY)
MF+^5&C#=%L;>W0 =QTYI\>JW%S:6H1Q%,ZN96\O/S)P0%/J?TH W:*Y]-4N[
MF[M4B=O+>$2.8X<Y.<'.>0*M:KJ<NGW,9"J;?RV,C'JIZ*?IGK]: -:BL/\
MM*[FO%M$=(RX0B0KG&5)/'K_ /7K7MG:2VC9W1WQRT?W2?:@"6BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *RKB=;75Y[AP2L5EO('7 8FM
M6L+6/]?J'_8.;^;4 <K;:_'XV\:Z-:Z3:W G!=2LA !&,^O;!KZF' %?*/P'
MTN6^^)-O=1NBI9122R!LY((V\?BPKZOH **** "BBB@ HHHH **** "BBB@
MHHHH ^=OVD@3K&A =?(E_P#0EJGI0*IX1!ZBW/\ Z :[#XJJK_$OPFK*&!@G
MX(]JQ=4 'B;10   9.!_NF@#E_B+_P C+X=_ZZ'_ -"6H-,@1[:1C&A/GR\G
M3&F_C/\ $#S5KXAQN_B3PZ51F D/(&?XEJIILZ);R*9K13Y\O$D\ZG[Y[+Q^
M5 %W[,G_ #QC_P#!*W^-8>D0PO>:@LL5NX67Y1+#,NWENBH?E^AK:^TQ_P#/
M>P_\";JL?0I5%[J1,Z*#+QMU!H >6Z9!+?C0!J?9+/\ Y];#_OU=?XUB)'''
M\1M(6*.)%RIQ$L@'4_W^:Z/SD_Y^E_\ !V?_ (FN4U;4!IWC*QU#:UPENBLP
M2Z\_/)XW8X^E 'M=%>=K\586&1H\_P#W\%!^*L (!TB<9_Z:#_"@#T2BO/O^
M%I6^,_V8_P#W^'^%1GXL6X./[)G_  D'^% &CIG_ ".H_P!Z\_\ 0TKM*\9L
M?&\5IXGN=5:SGDCD#>5"'_U98@M^>!70?\+9M_\ H$7'_?8_PH ZWQ9_R*>J
M?]>[_P JR?AI_P B9!_UT?\ G7-ZM\28=5TFZL$TR:-KB,QAV<8&>YXKIOAN
MA3P;;Y[R/_Z$: .MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 %%%% !1110 5GC_D86_P"O4?\ H9K0K U*]N++7E-O:&X+6HR,D8^8^@-
M&KX _P"2S:G_ -@M?_0A7M5>$?"N_.H_%K4YRBI_Q+%&%8L.JD=0.Q]*]WH
M**** "BBB@ HHHH **** "BBB@ HHHH \$^/6JS:+XL\.:A J-)%!-@/TY('
M]:SH[U]2OO#-[(%#SQL[!>@)0USGQI\2S:_XD2WGCCC^P^9&@12,J6QR23D_
M+Z"N=N/%VI:=+I<<'E8L[9/*W)G[R#.?SH ]QK"\(?\ ( 7_ *[S?^C&JGI?
MB>XN]*M;B8Z<))(PS;KHJ<_38<?G61:2:[I\+06FL:*L'F.ZJ[%B-S$]<>]
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M"P\P<'%2?V[I/_01MO\ OX* -"BL_P#MW2?^@C;?]_!1_;ND_P#01MO^_@H
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M_P"W=)_Z"-M_W\%>7GXF:W_:GE9MO(\[;GR_X<^OTH ]@HK.&O:40,ZC;?\
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M&WBWZ3'N8CU&_CH:+N[O()1#%XW\.2R^<(G_ .)5&%3)').__:'^<T >*_\
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MBDG_ #[7'_@QB_\ B:/^$4D_Y]KC_P &,7_Q->\>1?\ ER.?''AT+%,('/\
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MR ?>/;--\+>%=.GTR9G>]R+J4?+=R#HQ]Z (/#O@;PS<#4_-TB!O+OI$7)/
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MX6\*:=/X<M9'>]W'=]V[D ^\>V:;X6\*Z=/I,CN][G[3*/ENY!T<^] %'0_
M&AWZ7YGC),-X\28CB'RC&/X*32? &A7E_J\,T1*6UR(X\1Q#C8IY^3GDU?\
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MC]*V:*0&-_PB7AO_ * &E]<_\>D?^%<!IF@Z,WQ9U&T?2K$VJ)(5A:!-@.R
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M7(R][MC:'&+N0'E#U.>:+3PKIS>,=2A+WNU;:$C_ $N3/)?OF@"BGPX\'_\
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MD<KT-!T&\_X341_V_J.[[#NWY3/W^G2B[T&\'B_3XSK^HEFMI2')3(Y7C[M
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M^[0 WPKX9CF\.VTAU35%R6X2Z('WC3?"WAJ.;3)F.J:HN+J886Z('#&G>%=
MO)?#MLZZ_J,8.[Y5*8'S'_9IOA;0;R73)F77]1C NI1A2G]X\_=H /#GAJ.4
M:GG5-47;?2+\MT1G@<GWI=$\-1R:MKBG5-479=*,K=$$_NUZ^M)X<T&\D&I[
M=?U%-M](IVE.>!R>*-$T&\?5M<4:_J*%+I02"F6_=KR?EH H>&[(6'Q?UN%9
MYY@+*+YYWWM^==W/8NVL6M_"ZJ41HIE/\:'D?B"/U-<-X:M)+/XLZW'+=373
M"VC_ 'LN-QX'H/>NWU'5HK":*!PX:8':X PI_'J?:@#1JA96+PZA?7D[JTEP
MZA-O\$:CY1^98GZUS<?C=)])M40A=2GNTL2"ORK(?O-CT Y_$5NV>O17T%O-
M;P2/'-*8@P9>" 3SSZ T <_\2(Q+8Z2A)&Z_49'4?*U=2+"46YB^WW.XMGS,
MC</;ITKF?B)_Q[:/_P!?Z_\ H+5:U+79HM:CFM+A)-,LU_T[;A@-QQU]5ZGV
MS2:3+5225EL;KV,KI$HOKE2@P2",O]>*<;20W8G^USA1C]UD;>GTS6?I,U[J
M@AU.:Z$5K("T-K&H&5.<%V/)..<# K:HY4/VDBG'92IYN;ZX?>"!N(^3W'%>
M8^(=)\SQ5XH62_O"T>B12963;N^:3@X'(KUJO*/%EI)=>-O$WEWD]N(] B8B
M+'S_ #R<'(Z460G4D]&=)J'AB-/#%Q)_:FJG%H3M-T<?=I;3PQ&WAF&3^U-5
M!-H#@71Q]VFZAX?O%\,7#GQ!J+ 6A.TE,'Y>GW:6T\/WA\,PN/$&H@&T!V@I
MC[O3[M,@9X?\,QR^%[*0ZIJBDP [5NB ./2F>%?#,<WARVD.J:HN=W"W1 ^\
M:=X?T"\D\+V3KX@U% 8 =BE,#C_=IOA;0+R7PY;.NOZC&#N^52F!\Q]J /$_
MB5%+HZZ7+:WUYYCM>KN:8D@;L''U[U]*Z" /#VF@=/LL?_H(KYY\7>%;[6]5
MTK38=0:1V2_EW7)&%"$YZ#O7T)H#JWAW3&R.;6/O_LB@#2KR0_\ (L^,_P#K
MNW_I1-7K6X>HKR4_\BSXS_Z[M_Z434 2> _#\=RML3J&HQYTBU?]W<%<9W<?
M3VK='AJ/_A-6A_M35,?80V[[4=WW^F?2L+P'HMU.EKMUJ^ASI%J_R%> =WR]
M.@K<&@W?_":M'_;^H[OL(;?E,_?Z=* %N?#48\8V,7]J:H0UK(=QNCD<CO2:
MCX:C3Q/H\?\ :FJ'>LOS&Z.1@#H:+G0;P>,;&/\ M_42QM9"'RF1R..E&HZ#
M>+XGT=#K^HL667#$IE>!TXH -;\-1QZKHB_VIJC;[DC+71)'R'I1XB\-1Q/I
M6-4U1MU]&OS71./<>]&MZ#=IJNB*=?U%B]R0"2F5^0\CBCQ%H-Y&^E;M?U%]
MU]&HW%/E]QQ0 >*?#4<.EPL-3U1LW< P]T2.9!2^+?#,</ANZD&J:H^"G#W1
M(^\*3Q3H-W%I<+-K^HR#[7 ,,4QS(.>E'BW0+R+PW=.VOZC( 4^5BF#\P]J
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MCDU+6U_M35%V7@7*W1!/R+UH\-:#>20ZCMU_44VWTJG:4YZ<]*-"T"\?4M;
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M+^..WA:\_?*S[E4 ,#S@9''I5'5O$%O=:M:7NF6EPFEV,91K=M.F N4;AP@
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M_&]EK6K2:;;6YM;K44NT8NA)"S&0=6&.HXJ_K%M\1]4TV2T:UML,RG_ED.C
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M\[[#UV/C&_\ G1;S^)O^$SOB+'3_ #?L<.Y?/; &Y\=OK1Y_B;_A-<_8=/\
M.^P_=\]L8W_2@!+J/Q/_ ,)AIX:;3/-^S2[2$?&,KFC4H_$__"3:/OFTSS,2
M["$?'W><TMU/XF_X3#3R;'3_ #?LTNT>>V",KGM1J4_B8^)M'+V.GB0"78!.
MV#\O.>* #7(_$_\ :>B^9-II;[4=FU'QG:>M'B-/$X.E^;-IA_TZ+;M1^N>,
M^U&N3^)CJ>B^98Z>&%T=@$[<G:>O%'B*?Q,?[+\VQT\?Z=%MVSL<G/&>* #Q
M3'XG&DQ^=-IA3[5#]U'SGS!BCQ;'XG'AF[\^;3#'A<A$?/WA1XIG\3'28Q-8
MZ>J_:H>5G8G/F#':CQ;/XF/AF[$]CIZQX7)6=B?O#VH E\31^*!X7U+SIM,,
M?V9]P5'SC':G7\?BG_A&;C=/IGE_9#D!'SC;3?$UQXG/A?4A-8Z<L?V9]Q6=
MB0,?2G7]QXG_ .$9N UAIPC^R')$[9QM^E !91^*?^$9@VSZ9Y?V08!1\XVU
M'X>C\4'PO9>5-I@C\@8#(^<8J6RN/$__  C, 6QTXQ_9!@F=LXV_2HO#UQXG
M'A>R$5CIYC\@8+3L#C'TH ;X5C\3GP[;>3-I@C^;&Y'S]XTGA:/Q.=,F\F;3
M OVJ7.Y'SG<<TOA6?Q,/#ML(;'3VCRV"T[ _>/M2>%Y_$PTR;R;'3V7[5+DM
M.PYW'/:@!/#B>)R-3\J;3!_ITF[<C]<#I[4NB1^)_P"UM<\N;3 WVI=^Y'QG
MRUZ4>')_$P&I^58Z>W^G2;MT[#!P/:C1)_$PU;7/+L=/+&Z7>#.V ?+7IQ0!
M#X86['Q!U9KYHFN-S!C$"%XC@Z9KK[B[F;7;6Q@.$5&FN#C/R]%7\22?^ UQ
M_A>:X;QIJLM\D44XFF\P1ME1A(.YKO+:>&Z@2YA(9)5!5L8R.U $U9MA=S'4
M[^QN2"\3"6$XQNB;I^1!'Y5I5!<W%O9Q&YG8(@PI<CIDX'X9- 'GGQLLY=0\
M(6]I  99KH(H/J5-0VFC:[#:0Q/_ ,)("D:K\K6F,@=N^/K6S\2EW6&D@'!^
MWKS_ ,!:NFN]8@M#:81I5N6VJZ$;1TZD_6IUN:KE4$[7=_\ AOU/++WP[K+>
M,/#.J7(U%;6RO,ROJ#P +D<;?+^G>M_Q'<03_%SP88IHY J762C X_=FNGGU
MBRN$AM]2L"JSSM$L<P1P2O&3R1UP![D52T=O#=_J#QVNB6D4B+YGF?9XP>W/
M'(Z]Z-0O3:71_P!>9U6Y<XW#/IFO!;O[:?B+X\-D\ S;'S/-!.5V+TQWKUJ/
M5M D87R6\;7;NR@)!OF8C@]!G!'<^M>9ZU,S>+M:FT:TMDBFT<[XV'E[0"0V
M0!][(IW9+4;73.YU"/Q3_P (Q<;Y],\O[(<@(^<;:6TC\4_\(S#MGTSR_L@P
M"CYQMI-0N/$__",7 >PTX1_9#DB=LXV_2EM+CQ/_ ,(S"%L-.\O[(,$SMG&W
MZ4R"/P_'XH/A>R\J;3!'Y VAD?.,4WPM'XG/ARV\F;3!'\V-R/G[QIWA^X\3
MCPO9"*QT\Q^0,%IV!QCZ4WPM<>)AX<MA#8Z>T?S8+3L#]X^U '@OQ.%\+JP^
MVM Q NMOE C^,YSGWKZCT+_D7]._Z]8__017@.J2E/%-O<ZUID5S'#:WI$46
M),DL5SAL=":]5T#Q9='1=$AA\.ZA<+<6J^5-%)$4(51R3NX_&@#N:\F3'_"/
M>,=P)7[2<@?]?,M=AJ7C"XTB&*6^T"\A26588\SP_,[=%'S]37&P^8WA/Q5+
M+&8FF99O+)!9-\TK!3CN >1ZT 0:.;R\DMM/M+[2!.PV+&]@I(VKG!;R\$X]
MZZ/_ (13Q/\ \_.A_P#@$G_Q%==H2K_8.GG:,_9TYQ_LBEU;7--T*&&;4[N.
MVCFE6&-G/WG/04 <A_PBGB?_ )^=#_\  )/_ (BN8;4KV.[N+>YN=*MWMW>-
MF:P5P[*S*<;8R0/E[^M>S @@$'(-<7X*53K/B4D _P"FOU'_ $UEH S[?PYX
MCN[:*XBNM$,<BAU/V).A_P" 5+_PBGB?_GYT/_P"3_XBN_  & ,"B@#SR;PK
MXF$$A:XT0@*2<62>G^Y6!I::X/A2/L\EBMD)'"JZL7_UY[CCK7KMS_QZS?[A
M_E7D>F2ZX/A5MAM;-K/S7VNTI#_Z\]L>M '5>)X_% \+ZD9IM,,?V=MP5'SC
M':GZE'XI_P"$8N=\^F>7]D;("/G&VF>)[CQ.?"^I":QTY8_L[;BL[$@8^E/U
M*X\3GPQ<A[#3A']D;)$[9QM^E "VL?BG_A&8L3Z9Y?V08!1\XVU'H$?B@^%[
M/RIM,$?V<8#(^<8J2UN/$_\ PC,0%CIWE_9!@^>V<;?I4>@7'B<>%[,1V.G&
M/[.,%IV!QCZ4 >?Z+\2+_3 ^DW=XD3PRF.)8H$8$'GDLP/4UM:5XGU:TCDM+
M)=1D97:21!8QLR%OFY&_C.>*\:GCGN?&<=NY"7,U_&H&3Y8;(Y)_&O?/A[>2
MWOBKQ*\R(DL<B0,$)*DHJID9]=N:IJPD[F;8ZYX@T\3B&UU?]],TS;M.C/S'
MK_'[4VWU_7=.DO;H6^JK]H?SI6?3X\ A0/[_  ,"O58Y)&D=6@9%#8#%@=P]
M>#43/)-$\<MD^UCL*EUY4]3UZ?K4C/(;3QS<17M[>075T\MP$9U6TA;./E7:
M _4YJW:^)-;DU*XU&&VU@S21I$X;3$  7)'!;W-:_CC0-.M?[*M].M(;%KJY
M6$R6Z;"N70!N,<C.:G_X0F^TR$L/%FJ;7=5)9RW)( ZGWH YB7QK>6^M/=S3
MW<=V(Q R/:PC SGD&3KS5N?Q#K@OH]4DMM7#Q1&,$::A&UB.V^H&\+:3?W<4
MTVK32SW18B22U1F+*0.3Z]Q[5U<O@34IH#"_BO4MA&,*=OZ@T <C:>*/$6L>
M-](A1EC<M*B)>VOE,/W98D@'IQQ75:U'XG_M;1/,FTPM]I;9M1\9V'K7&-87
MF@_%72-.M;AM1O5WR++>2-E@8F&">>F#CZUV>M3^)CJVB&2QT\,+EM@$[8)V
M'KQ0 GB*/Q.)-*\V;3#_ *='MVH_7W]J/%*>)QID'G3:85^UP8VH^<^8,4OB
M&?Q,9-*\VQT]<7T>W;.QR??BD\4S^)CID/G6.GJOVN#!6=CSY@QVH 7Q;'XG
M'ARY\^;3#'E,A$?/WA4GB>/Q0/"^I&:;3#']G;<%1\XQVJ/Q;/XF/ANY$UCI
MZQY3)6=B?O#VJ3Q/<>)SX7U(36.G+']G;<5G8D#'TH ?J<?BC_A&+K?/IGE_
M9&R CYQMK)^%(G%]XE^TE#+Y\&XIT_U=:VIW'B<^&+H/8Z<(_LC9(G;.-OTK
M)^%)G:^\2FX5%E\^#<$.1_JZ /2J*** "O-].75F^)WBK^RY+5>(-_V@,?\
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MW_"969-CI_F_9),#SVQC</:@ U"/Q/\ \)3I.Z;3/,V3;"$?'09S1K,?B?\
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M>]MG.T],#K]:3&CH/$6H:^TFE>9H<:8OHRO^E*<GTI/%.H:^^F0"70XT7[7
M01=*>?,&!7/ZY;>(@^F^9/X@.;Q-N][;K[8'7ZT>(K7Q$-/B,L_B K]IAQYD
MEMC.\8Z#K2&=#XMU'Q _ANY670XXTRF6%TIQ\PJ3Q/J/B!O"^I++H4:1FW;<
MPNE.!CTKFO$MKXB&@SF:?Q"4RN?-DM]OWAZ#-2>(;7Q$/#U^99_$1C$+;A))
M;;<8[X&: .DU/4?$!\,72OH4:QFT8%OM:\#;UQ6#\,M2AMK_ ,1G49H+.5YH
M"$DF4?\ +/L3UJ/4+;Q*/#UP3/X@\O[,<[VMBN-O?C.*P!X)U.:P-\T.KR/)
M'YK,SQ@9VC^ZPXX%-)/<3;Z'LJZ]H[KN75;%AZBX0_UI?[<TG_H*67_?]?\
M&O$]%^'TS:+#.+;7-LBF7$4T2J,\\9/2K&B>!A?:;'=S6/B&9I,Y\N]15X)'
M'S4[+N%WV/8SKVCA@IU6Q!/0?:$Y_6N#TC4+W_A9/BF;2+2+4(W$&76=5 P@
MZ'O7-:'X&L;ZV^U7.AZ_<31RR(LBZB!M ;&/O>U='X&CET1=2>T\/:E*[7+1
M%I+I7(5>B_,W;)J1FGH>H:^NIZX8]#C9C=@N/M2C:=B\>]&E:AKX\2:XR:'&
MSDP[U^U*-ORG'UHT+6M234]<*^'KQRUV"0)(_E.Q>#\U&E:UJ:^)-<<>'KQF
M8PY421Y7Y3U^:@"!]0U[_A(M:/\ 8D>\V$8=?M2_*/GYJ;P!X@T>R\%:?;W>
MJV-O.N_?%+<*K+\[=0321:KJ,OBO50?#UX3+9Q(R"6/(&7Y^][UQ\?A2=-=.
MGI;>)%A6V$@B74%!'S$?WL8I@>FW&M>$[K;YVK:6VW./]*08S]#4.C_V;JNK
MW$MD\$]E8E5B,3[U,K#+-G)R0,#VYKSJ7PM<IKT%F(/$H1X6<H=07<2".0=W
M2K<.D:EHNK6UG80^(($O"\DJFZB9Y& '.23V]:.6-[C=2?+RWT]1OQ1E$/BE
M3YR1,;-65G&1@>9DX[XR*Z#PKXJLM6CM]7U;7;&:X2)D2&"(H(2QYSR<G 'I
M7.Z[H5]/K&ER3V_B S.S0AS=1ARA&2H*D=P#S4&I^&+JR>R$</B9!-<K&V[4
M5^8'L,-UHLNY-V>I_P#"5:'_ -!*']?\*/\ A*M#_P"@E#^O^%>6ZQX9N[&T
MCECB\3(6GCC)?401AF QPW7FC6_#-WI^E2W,<7B:-E*@-)J((&2!V:BR#4ZW
MQOXETQ/#TU_I][%+?VB,T,8!/F;@593[$'\P*Y;PYJ&K#1_%:0:02OR^:)9E
M1X_W"CD?K3=8\+W5CH]U=1P^)T>*,L&DU%2H^HW5H6FCW'A_2M5O(-)UF1[N
MS99FN+F-P>"0QYR2,T:!J=+#J/B'_A&D4:%&8_LF-WVM>FWK3-"U'Q OA>S6
M/0HVC%N,-]J49&/2I(=;U,>&43_A';PK]DQO\V/&-O7[U,T+6M33PO9HOAV\
M=1;@!Q)'@\=?O4AD?A;4?$"^&[18M#C= &PQNE&?F--\+:CKZ:0XBT.-U^T2
M\FZ4<[S3_"VM:G'X;M$3P[>2* V&62/!^8_[5-\*ZUJ4>D.J>'KR0?:)3N62
M/^^>/O4 )X:U#7UAU'RM#C?-]*6S=*,'CBC0M0U]=1ULQZ'&S&[!<?:E&T[%
MX]Z7PUK6I1PZCM\/7DF;Z4G$D?!XX^]2:%K6IIJ6ME?#UXY:\!($D?RG8O!^
M:@ TK4-?'B/7"FAQLY:'>OVI1M^0X^M%IJ&OCQCJ3#0XS(;:$,GVI>!E\'-&
ME:UJ2^(]<<>'KQF9H=RB2/*_(>OS46FM:D/&.I2#P]>%FMH04\R/(Y?G[U
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MV6HD.(, 6C$C"GJ.U%MXIM5\97\WV/4=K6<*@?9&SPS]OQH 4>(9?^$U,O\
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MC8(ER,,_/6@>(9?^$U:7^P]4S]A"[/*7=]_KUZ4EKXIM5\9:A-]CU':UI"H
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M'/6D3Q3:_P#":RS?8M1VFQ5<?9&S]\]J+CQ3:GQE9S?8M1VBT=<?9&S]X=J
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M=SP6/M4GA3Q1H4/AV!);^%7#/D$'^\?:D\+>)]"ATVX62_A4F[F(R#T+'VH
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MB#S[C:%?^/=^NWZ46'BW2$\,V\1DGW"T"G_1WZ[?I3[[Q3H+>&)XQJ$)<VA
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MK[4:7XGT-/$VN2-?PA'\C:<'G"G/:@!MKXLTE?&6H3%Y]C6D*C_1WSD,_;%
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M,.TX/.%.>U%KXGT)?&6HRF_A\MK2$!L'D@OGM0 U?%FD_P#":O-OGV?80O\
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M2//N: @9MW']*3Q;XGT*?P[/'%?PLY>/  /]\>U2>*?%&A3>%M1CCOX6=H"
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M@ HHHH **** "BBB@ KF?B'_ ,D\U[_KSD_E735S'Q%S_P *[U_'7[%)C\J
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M@NVE>7=V1Q?Q%L,O S1XJU;07TF(17=D6^U0'Y67IYBYIWB2+0@VE>7'I_\
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M"67!^4YQ3M"BT(ZMKN^/3]OVM=N0G3RUZ4:5%H1\3ZZ&CT_9^XVY"8^Z<XH
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M;<0RX' IUQ%H7_":60$>G^7]DDSPF,[A1J,6A?\ "5Z.%CT_9LFW8"8Z#K0
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M'?\ 9,8W+G.RC6(M!_X16\*1Z?O^R-C 3.=M.BBT'_A&%/EZ?O\ LGHF<[*
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M?"IC@@_G5+X069DT"_\ $,D2QRZU>R7"A1@",':@ [=#^E 'HE%%% !1110
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MFAQZQHB)8J%DN&##>W(V'WH\1>%=#BETD1V*C??1JWSMR.?>@!_BG0=!BTR
MQ6%FK&\@!PHZ%QFCQ=H.@1>&[AXK"S5PR8*J,_?%,\4^%=#@TV!H[%5)O(%/
MSMT+C/>CQ;X4T.#PY<216*JX9,'>W]\>] $_BG0= C\+:D\6GV2R+ Q4A1D&
MGZKH'A]?"]VZ:?9"06C$$*,YVU#XI\*:%!X6U*6.Q576!B#YC<'\Z?JOA/0D
M\+W<JV*AQ:,P/F-UV_6@"6'0/#Y\,HYT^RW_ &3.=HSG94>@Z!H#^%[-WT^R
M,AMP22HSG%+#X3T(^&4E-@N_[)NSYC==OUJ/0?">A2^%[.5[%2[6X)/F-UQ]
M: %\*Z#H$OAJT>6PLF<ALEE&?O&F>%=!T"71W:6PLV;[1*,LHZ;S1X5\*:'/
MX;M))+%6<ALGS&_O'WIOA7PIH<^CN\EBK-]HE&=[= Y]Z '>&M!T&2'4?,L+
M,XOI0N5' XHT+0= ?4M<$EA9D+> ("HX&Q>E,\->%-#FAU$R6*MMOI5'SMP!
MCWHT+PKH<NI:XKV*D1W@5?G;@;%]Z 'Z3H.@MXCUU'L+,HC0[ 5&!\ASBBTT
M'03XRU.,V%GY:VL!4;1@$E\TS2O"FAOXCUR-K%2D;0[1O;C*'/>BT\*Z&WC+
M4X38J8UM8"HWMP27SWH >F@Z#_PFTL?V"S\K["IQM&,[S1<:#H(\9V<8L+/R
MS:2$C:,9W"F)X5T/_A-98?L*^6+%6V[VZ[S[TMQX4T,>,K.$6*^6UI(Q&]NN
MX>] #M0T'05\5:0BV%F(V2;< HP>!BC6M!T!-9T-4L+,*UPP8!1R-AZTS4/"
MNAIXJTB);%0CI-N&]N< >]&M>%-#CUG1$2Q4+)<,&&]N1L/O0 _Q#H.@QS:0
M(["S&Z^C#84<CFCQ3H.@1Z=;F*PLU)O( 2%'0N,TSQ#X4T.*;2!'8J-]]&K?
M.W(Y]Z/%/A30X-.MVCL54F\@4_.W0N,]Z '^+=!T"+PY.\5A9JX>/!51G[XJ
M3Q3H.@1>%M2>*PLED6!B"JC(-0>+?"FAP>'9Y(K%5</'@[V_OCWJ3Q3X4T*#
MPMJ,L=BJNL!(/F-Q^M $NKZ!H">%KQTT^R$@M&((49SMI\>@>'SX95SI]EO^
MR9SM&<[*BU?PGH4?A:\E2Q4.MHS ^8W7;]:=%X3T(^&5E^P+O^R;L^8W79]:
M $T+0- ?PO9N^GV1<VX))49SBF^%=!T"7PU9O+863.5.2RC/WC1H7A/0I?"]
MG*]BI<VX)/F-UQ]:9X5\*:'/X:LY)+%6<J<GS&]3[T 'A30= ET9FEL+-F^T
M2C+*.F\T>&=!T&2#4#)869(OI0,J.G%-\*^%-#GT9GEL59OM$HSO;H'/O2>&
MO"FAS0:@9+%6*WTJCYVX Q[T /T'0=!?4=;$EA9D+>87*C@;%Z4:3H.@MXBU
MU'L+,HCP[ 5&!\G:F:#X5T.74=;5[%2$O-J_.W V+[T:3X5T.3Q%KD;6*E(W
MAVC>W&4^M #[/0=!/C'5(VL+/RUMH"HVC )+YHCT'0?^$VGC^P6?E"Q0@;1C
M.\TRS\*Z&WC'4X38J8UMH"HWMP26SWHC\*Z&?&LT/V%?+%BC!=[==Y]Z .-^
M+%EIUG);6&EV-LMWJ<0M(?+3.&9P">/;->O:1IT6D:-9:=",16L*1*/91BO,
M#H6FZA\<K*VL+8);:':?:)R"6!E;[@Y/!'7\*]<H **** "BBB@ HHHH ***
M* "N9^(A ^'>O$]/L<G\JZ:N9^(G/P\UX'_GSD_E0!Y[\(-!L-3^'5Q=3-<;
M_M,^/+N'1<?0'%=CX;\*:9-X7LI6-YN:$$XNY /RS7'?"'0HK[X=W$YO;Z$B
MYG 2"X*+Q["NQ\-^&(9?"]E(=2U12T(.%NV 'X4 -\*^%-,G\/02.;S<6?[M
MW(!]X^])X7\*:;/IT[.;O(NI5XNY!P&/O2^%?#,,WAZ!SJ6J*2S\+=L!]XTG
MA?PS#-IT['4M37%U,,+=,.C&@ \.>%--F.J;FO/DOI%&+N0<8'O1HOA339-8
MUU&-WB.Y0+B[D'_+-3SSS1X=\,PRG5,ZEJB[;Z1?ENF&>!U]Z-%\,PR:QKB'
M4M3&RY0 BZ8$_NUZ^M !IOA337\4:W$3=[46#&+N0'E6ZG/-%OX4TP^-+Z'-
MWL6RA8?Z7)G)9^^?:DTWPS"_BC6X_P"TM3 18,$739.5;J>]+;^&83XTOH?[
M2U/"V4+;OM39.6?O0 'PIIG_  FHAS=[/L.[_C[DSG?ZYHN_"FFKXOTZ$&[V
MM;2D_P"ER9X*]\TA\,P_\)J(?[2U/'V'=N^U-G[_ *^E%WX9A7Q?IT7]I:F0
MUM*=QNFR.5Z&@!=3\*::GB71HP;O:_FYS=R$\+ZYHUSPIIL6I:*JF[P]T5.;
MN0_PGWXI-3\,PIXET:,:EJ9#^;DFZ;(^7L:-<\,PQZEHJC4M4.^Z():Z8X^4
M]* %\1^%--A&F;3>?-?1*<W<AX)^M'BKPIIL&D(Z&[S]IA'S7<AZR*/6CQ'X
M9AB&F8U+5&W7T2_-=,<9/4>])XJ\,PPZ0CC4M4;_ $F$8:Z8CF04 +XM\*:9
M!X8O)4-WN4+C==R$?>'8FIO$OA/3(?"^IRH;S<MLY&;N0CIZ9J'Q;X9A@\,7
MD@U+4V("\/=,0?F':I?$OAB&'POJ<@U+5&*VSG#7;$'CN* 'WOA/3%\,SR!K
MS<+0M_Q]R8SM],T6'A/3&\,6\I-YN-H&XNY,9V^F:2]\+PKX9GD_M+5"1:$X
M-VV/N^E%AX7A;PQ;R?VEJ@)M V!=MC[OI0!'X<\)Z9-X7LI6:\W- "<7<@'Y
M9I/"OA33)_#MO(YO-Q+_ ';N0#[Q]Z7PYX8AE\+V4AU+5%+0 X6[8 ?A3?"O
MAF&;P[;R'4M44DOPMVP'WC0 GA?PIIL^FSLYO,BZE7B[D' 8^]'ASPIILW]J
M;C>?)?2*,7<@XP/>D\+^&89M-G8ZEJ:XNI1A;I@.&-'ASPS#+_:F=2U1=M](
MORW3#/ Y/O0 NB>%--DU?748W>([I0N+N0?\LU///-&F>%-,?Q/K<1-WMC$&
M,7<@/*MU.>:31/#,,FKZXIU+4QLNE *W3 G]VO7UI=,\,POXGUN/^TM3 00<
MBZ;)RK=3WH +?PIII\9W\)-WL6SA8?Z7)G)9^^?:C_A%--_X37R<W>S[#N_X
M^Y,YW^N:2W\,PGQG?P_VEJ>%LX6W"Z;)RS]Z/^$9A_X37R?[2U3'V'=N^U-G
M[_KZ4 +=>%--7QAI\(-YM:VE)_TN3/!7OFC4_"FFIXFT>,&[VOYN<W<F>%]<
MTEUX9A7QAI\7]I:F0UM*=QNFR.5[T:GX9A3Q-H\8U+4R'$N2;ILCY>QH 77/
M"FFQ:GHJJUWA[HJ<W<A_A/3GBCQ'X4TV$Z7M-W\]]$IS=R'@GZTFN>&88]3T
M51J6IG?=$$M=,2/E/3TH\1^&88CI>-2U-MU]$OS73''/4>] "^*O"FFP:1&Z
M&[S]J@'S7<AZR >M'BWPIIL'AF[E0W>Y0N-UW(1]X=B:3Q5X9AATF-AJ6IM_
MI4 PUTQ',@I?%OAF&#PS=R#4M38@+P]TQ'WAVH E\3>$],A\+ZE*AO-RVSD9
MNY".GIFGW_A/3%\,W$@:\W"T+<W<F,[?3-,\3>&(8?"^I2#4M48K;.<-=L0>
M.XIU_P"%X5\,W$G]I:H2+0G!NVQ]WTH 6R\)Z8WAF"4F\W&T#?\ 'W)C.WTS
M4?A[PGIDWA>RE9KS<T )Q=R =/3-/LO"\+>&8)/[2U0$V@; NVQ]VH_#WAB&
M7PO92'4M44M #A;M@!QZ4 )X5\*:9/X=MI'-YN);[MW(!]X^]-\+>%--GTR9
MG-WD74H^6[D'1C[TOA7PS#-X=MI#J6J*26X6[8#[QIOA;PS#-IDS'4M37%U*
M,+=,!PQH 7PWX4TV8:GN-Y\E](HQ=R#C ]Z-$\*:;)JVN(QN\1W2JN+N0?\
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M.\.Z/J[^%[)T\0SHA@!""!#C]*;X5T?5Y/#MNT?B">-27PH@0X^8^U ">%]
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M]'U=O$NMHOB"=67R-S>2GS?*?:@ MM NCXRU"/\ M[40RVD)+[ER?F?CI0-
MNO\ A-6B_M[4=WV$-OW+G[_3I1;:/JY\9:@@\03AQ:0DOY*9(W/QTH&CZO\
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MRM8MUQ?2!LVP.3QSUH\+1>)SI<ODW&FA?M,N=R/G.\YH\-Q>)RNI^5<::/\
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MXS1I47B?_A(]<"7&FB3=#O)1\'Y#C%):1>)_^$QU(+<:;YOV:'<2CXQE\8H
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MXGUMET2(R$0;U^U ;?E;'..: "WG\3?\)G?$6>G>;]CAW#SFQC<^.WUI//\
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MCID/G6>G*OVN#&V9CSY@QVI?$6H>(&DTKS-$B3%]&5Q=*<GTZ4GBG4/$#:9
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M =QEC/\ RT''6E\6ZSJDOAF[1_#UU&I"Y=I8R!\P]#2>*O$$\ND1J="U./\
MTJ Y:-<<2#C[U+XM\0SS>&;M#H6IQ@A?F>-<#YA_M4 2^)M:U23POJ2/X=NX
MU-LX+F6/ XZ]:=?ZUJI\,W"'P[=A3:$;S+'@#;UZTWQ-XAGE\+ZE&=!U1 UL
MXW-&N!QU/S4Z_P#$4[>&;A/[!U0 VA&XQK@?+U^]0 66M:J/#,"#P[=E?L@&
M_P V/!&WKUJ/P]K6J)X7LD7P[=NH@ #B6/!X^M267B*=?#,"?V#JA M -PC7
M'W>OWJC\/>(9X_"]E&-"U1P( -RQK@\?[U #?"NLZI'X=ME3P]=2*"WS"6,
M_,?>F^%M9U2/3)@GAZZD'VJ4Y$L8YW'CK3O"OB&>+P[;(-"U.0 M\RQK@_,?
M]JF^%O$,\6F3*-"U.3-U*<K&N/O'C[U !X<UG5(QJ>SP]=/NOI"<2Q_*<#CK
M1HFLZHFK:X5\/73EKI2P$L?RGRUX/-'ASQ!-$-3QH6IONOI&^6->.!P?FZTN
MB>(9TU;7&&A:FV^Z4D+&N5_=KP?FH 33-9U1?$VMN/#UTS,(-R"6/*_*>O-%
MMK.J#QE?R#P]=%S9P@IYL>0-S\]:73/$,Z^)M;D_L+4V+B#*B-<KA3U^:DMO
M$$X\97\O]A:F2UG"-GEKD89^?O4  UG5/^$U,G_"/76_[#CR_-CSC?UZT76L
MZH?&%@Y\/7086LH">;'D\KSUH'B"?_A-3+_86IY^P[=GEKG[_7[W2BZ\0SGQ
MA82?V%J8(M91L,:Y/*\_>H -2UG5&\3Z.Y\/72LHEPAECRWR_6C6]9U1]4T0
MMX>ND*W1*@RQ_,=AXZT:EX@G;Q/H[G0M34J)<*8URWR]OFHUOQ!.^J:(QT+4
MUV71(#1KEOD/ ^:@ \1:SJDC:7O\/72;;Z(C,L?S'/3K1XIUG5)-*B5_#UU&
M/M4!R98S_P M!QUH\1>(9Y&TO.A:FFV^B;YHUYYZ#YNM'BGQ!/+I42G0M3C_
M -*@.6C7'$@X^]0 OBW6=4E\-7:/X>NHU.W+M+&0/F'H:D\3:UJDGA?4D?P[
M=QJ;=P7,L>!QUZU'XM\0SS>&KM#H6IQ@[?F>-<#YA_M5+XF\0SR^%]2C.A:H
M@:W<;FC7 X[_ #4 .U#6M5;PQ<(?#MVJFT(WF6/ &WKUHM-:U4>&84'AV[*_
M9 -_FQXQMZ]:-0\13MX8N(SH.J &T(W&-<#Y>OWJ6T\13CPS"G]@ZH0+0#<(
MUQ]WK]Z@"/P_K6J)X7LD7P[=NH@ #B6/!X^M,\+:SJD?ARV1/#UU(HW882Q@
M'YC[T_P_XAGC\+V48T+5' @ W+&N#Q_O4SPKXAGB\.6R#0M3D W?,L:X/S'_
M &J &^%M9U2/2Y0GAZZD'VF4Y$L8_C/'6CPWK.J1KJ>SP]=29OI"<2Q\'CCK
M1X6\03Q:7*HT+4Y/])E.5C7'WSQ]ZCPWXAGC74\:%J;[KZ1OEC7CIP?FZT &
MB:SJB:KKA7P]=.6NE+ 2Q_*?+7@\T:7K.J+XEUMQX>NF9O(W()8\K\I]Z-$\
M03QZKKC#0M3;?=*2%C7*_NUX/S4:7X@G3Q+K;_V%J;%_(RHC7*X4]?FH +76
M=4'C+4)!X>NBYM(04\V/(&Y^>M UG5/^$U:3_A'KK?\ 80/+\V/.-_7K1:^(
M)QXRU"7^PM3):TA&P1KD89^?O4#Q#/\ \)JTO]A:GG["%V>6N?O]?O=* "YU
MG5#XQL9#X>N@XM9 $\V/)&1SUHU'6=4;Q/H[GP]=*RK+A#+'EN![T7/B&<^,
M;&3^PM3!%K(-AC7)Y'/WJ-1\0SMXGT=SH6I@JLN%,:Y;@=/FH -;UG5'U71&
M;P]=(5N25!EC^8[#QUH\1:SJDCZ5N\/72;;Z,C,L?S'TZT:WX@F?5=$8Z%J:
M[+DD!HURWR'@?-1XB\0SR/I6="U--M]&WS1KS[#YNM !XIUG5)-+A#^'KJ,?
M:X#DRQ]?,''6E\6ZSJDOANZ1_#UU&I*99I8R!\P]Z3Q3X@GETN%3H6IQXNX#
MEHUQQ(./O4OBWQ#/-X;ND.A:G&"4^9XUP/F'^U0!)XGUK5)/"^I(_AV[C4V[
M N98\#CKUI^I:UJK>&+E#X=NU4VC N98\ ;>O6F>)_$,\OA?4HSH6J(&MV&Y
MHUP.._S4_4O$4[>&+F/^P=44&T8;C&N!\O7[U "VNM:J/#,2#PY=E?L@&_S8
M\8V]>M1Z!K6J)X7LT7P[=NHMP XECP>.O6I+7Q%./#,2?V#JA'V0#<(UQ]WK
M]ZH] \0SQ^%[.,:%JC@6X&Y8UP>/]Z@!OA;6=4C\.6J)X>NY%&[#"6, _,?>
MF>%M9U2/2I%3P]=2#[3*<B6,?QGCK3_"WB&>+PY:H-"U.0#=\RQK@_,?]JF^
M%O$,\6E2*-"U.3_293E8UQ]\\?>H 3PWK.J1IJ6SP]=29OI"<2Q\'CCK1H>L
MZHFJ:X5\/73EKL%@)8_E/EKP>:/#?B&>)-2QH6IONOI&^6->.G!^;K1H?B&>
M/5-<8:%J;;[L$A8URO[M>#\U !I>LZHOB77''AZZ9F,.Y1+'E?E/O1:ZSJ@\
M8ZC(/#UT7-I""GFQY R_/6C2_$,Z^)=<?^PM38N8<J(URN%/7YJ6U\0SCQEJ
M,G]A:F2UI"-@C7(P7Y^]0 BZSJG_  FKR?\ "/76_P"P@>7YL><;SSUHN=9U
M0^,;*0^'KH.+60!/-CR1N'/6E7Q!/_PFKR_V%J>?L(79Y:Y^^>?O=*2Y\03G
MQC92?V%J8(M9!L,:Y/S#G[U !J.LZHWBC2'/AZZ5E67"&6/+<#WHUK6=4?5M
M$9O#UTA6Y8JIEC^;Y#QUHU'Q!.WBC2)#H6I@JLN%,:Y;@=/FHUKQ!.^K:(QT
M+4UV7+$!HURWR'@?-0 >(M9U1Y-*W>'KI-M]&1F6/YCZ=:/%.LZI)ID ?P]=
M1@7<!R98^3Y@XZT>(O$,\DFE9T+4TVWT;?-&O/L/FZT>*?$$\NF0*="U-,7<
M!RT:XXD''WJ %\6ZSJDGANY1_#UU&I*99I8R!\P]#4GB?6M4D\+ZDC^';N-3
M;L"YECP..O6H_%OB&>;PW<H="U.,$I\SQK@?,/\ :J3Q/XAGE\+ZE&="U1 U
MNPW-&N!QW^:@!VIZUJC>&+I#X=NU4VC N98\ ;>O6G6^M:J/#,:#PY=E?L@&
M_P V/&-O7K3=3\13MX8NHSH.J*#:,-QC7 ^7K]ZG6_B*<>&8T_L'5"/L@&[R
MUQ]WK]Z@"/0=:U1/"]FB^';MU%N '$L>#QUZTWPMK.J1^&[1$\.W<B@-AA+&
M ?F/O3M!\0SQ^%[.,:%JC@6X&Y8UP>/]ZF^%O$,\7ANT0:%J<@ ;YEC7!^8_
M[5 #/"VLZI'I+JGAZZD'VF4[A+&/XSQUH\-ZSJD<6H[/#UU)F^D)Q+'P>..M
M+X6\03Q:2ZC0M3D'VF4Y6-<??/'WJ3PWXAGCCU'&A:F^Z^E;Y8UXZ<'YNM !
MH6LZHFIZX5\/73EKL%@)8_E.Q>#S1I6LZHOB37''AZZ9F,.Y1+'E?E/O1H?B
M">/4]<8:%J;;[L$A8UROR+P?FHTKQ#.GB37'_L+4V+F'*B-<KA3U^:@ M-9U
M0>,=2<>'KHN;6$%/-CR!E^>M"ZSJG_":R2?\(]=;_L*CR_-CSC>>>M%IXAG'
MC'4I/["U,EK6$;!&N1@OR?FH7Q!/_P )K)+_ &%J>?L*KL\M<_?//WNE "W&
MLZH?&-G(?#UT'%I( GFQY(W#GK2:AK.J-XITASX>NE94EPAECRW ]Z6X\0SG
MQC9R?V%J8(M)!L\M<GYAS]ZC4/$$[>*=(D_L+4P52;"F-<MP.GS4 )K6LZH^
MKZ(S>'KI"MPQ53+'\WR'CK1XAUG5'ETG=X>NDVWT9&98_F//'6EUKQ#.^KZ(
MQT+4UV7#$!HURWR'@?-2>(?$$\DNDYT+4TVWT;?-&O/L/FZT 'BG6=4DTV /
MX>NHP+N Y,L?)WCCK1XMUG5)?#EPC^'KJ-2R?,TL9 ^<>]'BGQ!/+IL"G0M3
M3%W <M&N.'''WJ7Q;XAGF\.7"'0M3C!9/F>-<#YQ_M4 /\4:UJDGA?44?P[=
MQJ8&!<RQD#]:?JNM:HWA>[1O#MVJFU8%S+'@#;UZTSQ1XAGE\+ZE&="U1 T#
M#<T:X'U^:GZKXBG?PO=QG0=44&U8;C&N!\O7[U #H=:U4>&43_A';LK]DQO\
MV/&-O7K4>A:UJB>&+-%\.W;J+< .)8\'CKUJ2'Q%./#*)_8.J$?9,;O+7'W>
MOWJCT+Q#/'X7LXQH6J.!;@;EC7!X_P!Z@!OA;6=4C\-VB)X=NY% ;#"6, _,
M?>F^%=9U2/2&5/#UU(/M$IW"6,?QGCK3O"WB&>+PW:(-"U20 -\RQK@_,?\
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MED7(7 5ES]X4 .\3^*="F\+:G''?Q,[6SA0%/)Q]*=?^*M";PQ<1K?Q%S:$
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M\LO+-I"%.Y<9W/F@:QH7_";-)]LLO*^P@9W+C.^@!ESXHT,^,K&47\7EK:R
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MVX[3QD#VI]QK&@GQG9.+RR\L6D@)W+C.X4:CK&A-XJT=UO+(HJ3;B&7 X&*
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MTCDOXE<!L@J?[Q]J;X5\4:'#H[))?Q*WVB4X*GH7/M4OA76=!C\-6BRWED'
M;(9ES]XTSPIK&@QZ.XEO+(-]HE/S,O3>: &>&O%&AQ0ZB)+^)=U]*PRIY''M
M1H7BC0X]2UQGOX@'O RG:>1L7VI_AG6-!2'4?,O+(9OI2N67IQ1H6L:"FI:X
M7O+(!KP%<LO(V+TH 9I/BC0T\1Z[(U_$$=H=IVGG"'/:BT\4:&OC+4Y3?Q"-
MK6 *=IY(+Y[4_2=8T%?$FNLUY9!&:'82RX/R'.*+/6-"'C+4W-Y9>6;6 *=R
MXSE\T ,3Q1H8\;2S?;XO+-BJ[MIZ[S[47'BC0SXSLY1?Q>6+212VT]=P]J>F
ML:%_PFTLGVRR\K["HSN7&=YHN-8T$^,[-Q>67EBSD!.Y<9W"@!FH>*-#;Q5I
M$BW\11$FW':>,@>U&M>*-#DUG0W2_B*I<,6.T\#8?:GZAK&A-XJTAUO+(HJ3
M;B&7 X%&M:QH3:SH;)>615;ABV&7@;#UH 9XA\4:'+-I!2_B.R^C9OE/ Y]J
M/%/BC0YM.MUCOXF(O(&("GH'&>U/\0ZQH+S:1Y=Y9';?1EL,O YH\4ZQH,FG
M6XBO+(D7D!.UEZ;QF@!GBWQ1H<_AV>.*_B9R\> %/]\>U2>*?%.A3>%M1CCO
MXF=H"  IY/Y4GB[6-!D\.3K%>63/OCP%9<_?%2>*M9T&3PMJ217ED7,# !67
M.: #5_%.A2>%KR-;^(N;1@!M/7;]*='XJT(>&5C-_%O^R;<;3UV?2EU?6=!;
MPM>(E[9%S:,  RYSMIT>LZ!_PC"J;VRW_9,8W+G.R@"'0O%.A1^%[.-[^(.+
M< C:>N/I3/"OBG0X?#5G')?Q*X4Y!4^I]JET+6=!3PO9H]Y9!Q;@$%ESG%-\
M*ZSH,?AJS66\L@X4Y#,N>IH B\*>*-#AT9DDOXE;[1*<%3T+GVI/#?BK0H+?
M43+?Q*#?2N,J>G'/2G^%-8T&/1F66\L@WVB4X9EZ;S7+:_XITK2OA_XB:WN+
M9KN>[EBA52-WSX&1]!D_A0 GPHC7Q%XU\3^,2O[J64V]LQ&/ESD_7@)7K]<C
M\,M"_P"$>\ :9:NFR>5/M$PQ@[WYP?H,#\*ZZ@ HHHH **** "BBB@ HHHH
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M/3M#\?\ @2U.H&Y:$>;=O)'FUS\A QVINF?$'P%:ZGJTMR\"Q3SJT.ZUZKL
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M=K<HH-K@[MN.N/6O+G^!OCS>?+MK94[ WV<4D?P-\=I,)&LM/EQ_#+=!@:-
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M#_&SMNM["U@!_P"6:W^5'TSS_.HXO@=X[CG$CV.GS8ZK+=!@:- U/3-/\?\
M@./7M5N9&A^SSB'R3]ER#A3GM21?$+P#%XIO+J62!;:2VB1";;C<"V>,>XKS
M>?X'^-W.8+&U@']Q;_*CZ9Y_G3(O@=X[CG$CV.GS#NLMT&!HT#4],'C_ ,!G
MQ3]L#0FT-IY8/V7C=NSTQZ4VZ^(?@#_A*+*Y,MNMLEO(CDVN!N)&.,5YQ/\
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M,F/'W3G%?.,6@0"[)ETR7[.1]V.ZP0?;.>/SJP^@Z:$;RM*NMQ&/WETI'^-
M'T/:OX>/C/4,MIOE?9(=OW,9W/G%.4Z ?&[8_L[ROL _N8SOKYSMO#]@(1]I
MTNZ,O<QW:X/YBGOH.FA&\K2KK<1C]Y=*1^G(H ^B;K^P?^$SL,?V=Y?V23/W
M,9R*-2_L'_A*=&VC3MFV7=C9C[HZU\YVWA^P$*_:=+NC*.ICNUQ^HIMUH%KL
M_P!#TZ=7P01-<!@?3!&"* /H[7!H/]K:'L&G;?M1W8"8QL/6CQ&-!WZ3Y8T[
M_C_CW;0G3WKY]\/Z+X6NHBFN+JMG*CE&EM_WL>0?8[OTKOM.^$?@[7+9VT7Q
M,+J0KPC/DJ>Q(R&7F@#T7Q6-"_LJ'RAI^[[7!G:$SCS!FE\7KH7_  C-UY2Z
M?ORF-H3/WA7F]M\$WL0KWZW<A5L[[&?S,8/!*MC],UTG_"+6USI[Z;:ZI837
M# 8AU*R$,W!SPPP?QP: .H\4+H7_  BNI^6NG[_L[8VA,YQ3]370?^$6NMJZ
M?O\ LC8P$SG;6-KUG9)X>OXKGPF;>X:!@DD$0F0G'8KR/Q%7[G3_  M=>%;J
M6TM].D=;5N4"DJVWOZ&@"W:KH/\ PB\65T[?]D'9,YV5'X>70O\ A%;+>NG[
M_LXSN"9SBEM="\/GPQ$YL+'?]D!SL7.=M1^']#T!_"UD\EA9%S;@DE%SG% "
M^%%T+_A&K7S%T_?\V=P3/WC3/"BZ%_9,GFKI^[[3-]X)G&\T>%=#T"3PW:O+
M863.=V2R+G[QIGA70]!DTF1I;"R9OM,PRR+TWF@!_AE="V:GYBZ?_P ?\FW<
M$Z<4:$NA?VKKN]=/V_:QMR$Z>6O2F>&M#T&1-3\RPLCB_D"Y1>!Q1H>AZ"^J
MZZ'L;(JMV @*+P/+7I0 _2ET+_A)M=W+I^S,&W(3'W3G%%JNA?\ "::CE=/\
MO[)#C(3&<OFF:5H>@MXEUQ&L+(HI@V HN!\ISBBUT/03XSU&,V%EY8M(2HV+
M@'+YH >JZ%_PF[_+I_E_81V3&=YHN5T+_A,['"Z?Y?V23/"8SN%,70]!_P"$
MV>/[!9>5]A!QL7&=YHN=#T$>,K&,6%EY9M)"1L7&=PH ?J2Z%_PE6C[5T_9M
MFW8"8Z#K1KBZ%_:^A[%T_;]I;=@)C&P]:9J.AZ"OBG1T6PL@C+-N 1<'@4:W
MH>@IJ^AJEA9!6N6# *O(V'K0 _Q&NA>9I/EKI_\ Q_Q[MH3I[T>*UT/^RX/*
M73]WVR#.T)T\P9IGB+0]!CDTGR["R&Z_C#81>11XJT/08]+@,5A9*QNX 2J+
MT\P9H D\7KH7_"-7/E+I^_*8VA,_>%2>*5T+_A%=2\M=/W_9VQM"9SBH/%VA
MZ#%X;N7BL+)7!3!55S]X5)XHT/0(_"VI/%862R"W8J51<@XH FU1=!_X1:ZV
MKIV_[(V,!,YVTMNN@_\ ",1Y73M_V0=DSG946J:%H"^%[IUL+(2"T8@A%SG;
M3K?0O#Y\,QN;"QW_ &0'.Q<YV4 )X?70O^$6LMZZ?O\ LXSD)G.*;X470O\
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M#A/^%0^%/^>5]_X&2?XT?\*A\*?\\K[_ ,#)/\:[NB@#A/\ A4/A3_GE??\
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MNN/K2P^$M*/AE)2+K=]DW?\ 'U)C.WZTS0O">ER^%[.5A=;FMP3BZD Z>F:
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MS'^>/PKHZ  !@<"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWOSC\!@?A0!U%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8U5?$>N,OAZY9F:'<HFC^7Y#[T6FL:J/&.I./#UR7-M""GG1Y R_/6@ 2_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ZKY4P'MG(_(CZ4 5H?$-R/#*)_8&ID?9,;MJ8^[U^]4>A>(;E/"]F@T#4W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#L^ZGZ#/XUW=065I%86%O9PJ%B@C6-0!C@#%3T %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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G "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img10132136_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_7.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %!!%$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)A*JRBWAL%\O!]?W@R?T]J.5AS(MKXQN!9VXMX-1$%V&D%Y/+$TDP&,^4F[
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MWF[,!3_AS_R)T/\ U\7'_HUJ .KHHHH *Y/XA_\ (M+_ -?"?R-=97)_$/\
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M -&M73T %%%% !1110 5QD7_ "523_KT/\EKLZXR+_DJDG_7H?Y+0!V=%%%
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MWMI;R(=MRS(LF> P&0#]0#^5.Z%J<A9ZA::CXMU26SG29%TC:60Y .]N*O\
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M75SG;T_USUTE<SX"R/#1R #]KN<A>@_>MTKIJ "BBB@ HHHH **** "BBB@
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MQ@YKJ==_U&D_]?\ !4OBG_D5M3_Z]VJ+7?\ 4:3_ -?\% &Y1110 5E>)O\
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M444 %%%% !7"^!?^1I\9?]?X_F]=U7"^!?\ D:?&7_7^/YO0!W5<YX6M()M
M1I$R3+*#R?\ GHU='6%X0_Y%Z/\ ZZR_^C&H U!%- /W+[T'\$AY'T/^-.2Z
M1FV.#')_=?C\O6IZ:\:2+M=0P]"* .2\3RNNMB&&P:_FFTV94MP=H?YEZL>
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M+]>O*]/2I[G^Q[42@Q71CF!,D8DPAW%@2><9X(_*@#>$^GZ]9S6H8RPRPJ7
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M )P#M'.,9W5Z#7'?#:Q$'AEM09</J4[7(SU$?W8Q]-@'YUV- !1110 4444
M%%%5[^\BT_3[B\F.(H(VD;Z 9H \WU.5?$OQILK#AK/0H/M$I/02'D?C]W\,
MU?\ L,VK6Z3WAS_;%]N@@'\,0YW-[^6G'H3[USW@2WN)O#^MZ[,<W^O7OV:)
MO]DMCCV&YOR->BVD22^)&5!^XTVV6!/9WP3_ ..JOYT ;@ 4  8 X I:** "
MBBB@#C?$_P#Q-_&/AW0AS%$[:E=#_9CX0'ZNW3VKLJXWPE_Q-O$_B+Q >8VG
M&GVQ_P"F<7WB/J[-S[5V5 'GOC#_ (G_ ,0/#?AP#?!;L=1NUQD;4^[G\>/Q
MKT*O/? 0_MSQ7XE\4MAHY)Q8VK<'$<?7'<9)!KT*@ HHHH **** "N%\"_\
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M10 57B_X_KC_ '4_K5BJ\7_']<?[J?UH L5QFL_\CUI_^_#_ "FKLZXS6?\
MD>M/_P!^'^4U '9T444 %<MXY_X\+#_KY?\ ])YJZFN6\<_\>%A_U\O_ .D\
MU &_IG_(*L_^N"?^@BK54]/=8](M&=@JB!.2?]D4_P ^2;_CWC^7_GH_ _ =
M30!89E12S$ #N:K_ &EI>+>/</[[<+_]>E6U4L'F8RN/[W0?058H KBUWD-.
MYE/H>%'X58 P,#I110 5QEY_R4>W_P"V/_HN>NSKC+W_ )*-;_\ ;'_T7/0!
MV=%%% !1110 4444 0R6R.V]<QR?WTX/X^M,\R>'_6IYJ?WXQS^(_P *LT4
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M!ZX/YT =;;6-M9[_ +/$(PY)(7IDG)X^IJQ7!_\ "SK8ZD;$:3<F41>:2'7
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M'0XKM;L86&8!GC 5 ,Y&.S=* .[BOK'3];M;>RNK=[6^9D\B.13Y<H4MD =
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MR_Z_Q_-Z .ZK"\(?\B]'_P!=9?\ T8U;M87A#_D7H_\ KK+_ .C&H W:***
M.9UR86^N-*UVMH$TN8_:&7<(_G7G'>L'X<^*Y=0M[+2Y&LY8TLS()H9"6X?;
M\ZXPI.<XKI-=T>>\U*VO8YU6&.-HY8F4E7!((SCMD<BJ,GA2T@CEN%TS1LX+
M$K;$9[^M &S-K@AU1;(:??2 LH^T)&IB&>^<]!WXK-\6>*)= ^QBW6S<SF3<
MUS*45=JY R >356W\'0VD#M+;Z9(6)=G>$]^P&>![5B^&9+;1_$OBY;VWC6%
M+JQB2*./*J9$"C /3)89H ] TJ\;4=)L[UH_+:>%)"G]TD XJT0",$9![4H
M   P!T%% &!XEOW\/:4+ZU"*3/%$RRMB,!W"ECZ8SFL*_P!:;7O#EG=>2J@W
MLB!HSN1MHD7(/X5W3HDBE7564]0PR*YSQ@B1Z79K&H51=<!1@?ZMZ -;0_\
MD7]-_P"O6+_T$5?K(T6VQH.G/"YB<VL1..5/RCJ*O?:'BXN(\#_GHG*_CZ4
M6:*165U#*P8'N#2T %5XO^/ZX_W4_K5BJ\7_ !_7'^ZG]: +%<9K/_(]:?\
M[\/\IJ[.N,UG_D>M/_WX?Y34 =G13))8X5W2,%'OWJ'S)YO]4GEI_?D'/X#_
M !H GDD2)=SL%'J37*>,YO-LK$^4XC^T/AFXR?L\W:NGCMD1M[$R2?WWY/X>
ME<YXY_X\+#_KY?\ ])YJ -G2[:/^SK21\R-Y*8+G..!T%:%5=,_Y!5G_ -<$
M_P#015J@ HHHH **** "N,O?^2C6_P#VQ_\ 1<]=G7&7O_)1K;ZP_P#HNXH
M[.BBB@ HHHH **** "BBB@ HHK@?$OC>]TKQ@^BPM;01)9I<>;+;2S%BS,,8
MC'&-O?UH [F6WCE.6&&'1EX(_&H_](AZCST_)O\  UYU-\0-1B@DD%_8,54M
MC^R[L9P/7%:WPW\8W_C'1UOKZ%(6=20D<$BJ,,1P[?*W3M0!L)X6\+W#,1H]
MEOSE@80"#[BI/^$-\-_] 2R_[]"LKQ5KUYINN:7:V]IY\=S<PPR'[/)F-78@
ML)!\HQQQUKJ,7$/0^>GH>&_/H: ,S_A#?#?_ $!++_OT*/\ A#?#?_0$LO\
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MR_WHN2/JO6@#/_X0WPW_ - 2R_[]"C_A#?#?_0$LO^_0K9CFCF&8W#?3M3Z
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MSPHUP-!C$<<;+YLO);!_UC>U '1T56WWG_/&+_OL_P"%&^\_YXQ?]]G_  H
MLU1O$>&TF$:EHV4_*!DJ?;VJ7?>?\\8O^^S_ (4;[S_GC%_WV?\ "@!8T:4K
M)*, ?<0]O<^]>:WG_(S>,?\ L)Z1_-*])WWG_/&+_OL_X5YE<&4^)_%_F*H'
M]HZ5G#9Y^3% 'JU%5M]Y_P \8O\ OL_X4;[S_GC%_P!]G_"@"S7-^,_^0;:?
M]?7_ +3>MO?>?\\8O^^S_A6!XM:9K"T$R(J_:>JMGGRWH V=#_Y%_3?^O6+_
M - %7ZR-%>Z&@Z=MBC*_9H\$N>FT>U7M]Y_SQB_[[/\ A0 YK5=V^)C$_JO0
M_44WSY8?]?'E?^>D?(_$=11OO/\ GC%_WV?\*-]Y_P \8O\ OL_X4 3I(DB[
MD8,OJ#4,7_']<?[J?UJG<&2-]P2..4]/+<Y;\,<U66?4_/E+0JN0N\J<D#GM
M_P#KH V99XX1\[ 9Z#N?PKC-79IO&E@0'B8R0@9 STFYKI[;S,;XHH7)ZN9"
M3^>*YC5S*?&E@611)OAPH;CI-WH [&.VCC;?RS_WV.34U5M]Y_SQB_[[/^%&
M^\_YXQ?]]G_"@"S7+>.?^/"P_P"OE_\ TGFKH-]Y_P \8O\ OL_X5S?C-IFL
MK'SD15^T/@JV>?L\U '1Z9_R"K/_ *X)_P"@BK59NG/=?V9:;8HR/)3!+G^Z
M/:K.^\_YXQ?]]G_"@"S15;?>?\\8O^^S_A1OO/\ GC%_WV?\* +-%5M]Y_SQ
MB_[[/^%&^\_YXQ?]]G_"@"S7&7W_ "46V^L/_HNXKJM]Y_SQB_[[/^%<C>&7
M_A/K<LJB7,.%!X_U<_?\Z .WHJMOO/\ GC%_WV?\*-]Y_P \8O\ OL_X4 6:
M*K;[S_GC%_WV?\*-]Y_SQB_[[/\ A0!9HJMOO/\ GC%_WV?\*-]Y_P \8O\
MOL_X4 6:*K;[S_GC%_WV?\*-]Y_SQB_[[/\ A0!9KR'QC#J$GQ.NQ8Q7+22:
M3"H,-S)!C]Y)SE!@@=>2!7JN^\_YXQ?]]G_"N0\4^*+V*\G\/:;I@NM4EM@S
M%9TC$:.2H(+D;CD'@4 <WI>B3WFN'1)]8U$Z?#;_ &EKV+4Y#YT38VC'W0/O
M G_9[5:^$$5K;07=K:O"T<#R1IMNY'<J)6 )0_*OU'6L&^L?$UKHPTRYT:_A
MTZU1W21KFV!;(X1L_*0#N( &>16A\#C=IX8A1-[1B-L))=H5!WG.(PNY?Q-
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M^[ VGH<4 >6>&I5D\6VNV:23;=62G>N-I\J;@<#(]^?K7N=>&>&I/,\6VO\
MI FVW5D.%QL_=3?+[X]:]SH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "LGQ1_R*^I?]<&_E6M63XH_Y%?4O^N#?RH @\&_\BEI
MW_7/^IK=K"\&_P#(I:=_US_J:W: "BBB@ HHHH **** "BBB@ KRGXG(9-5V
M"**8LEH/+E.%;]\W!]J]6KRGXG)YFJE/LXN,I:#R2<!_WS<9H Z[P",>&F&T
M+B\N>!T'[UJZBN7\ C'AIAMV_P"F7'R^G[UN*ZBFQ(****0PHHHH **** "B
MBB@ HHK'\5:P- \+ZCJA^];P,R#U;HH'OG% '-^&%FUCQIXC\0QLC112#3;;
M>.JQ\N01T^9OQP*[/[2\?^N@=1_>3YA^G/Z5@^"M+O-$\(:=9-#%YWE>9,=Y
M^:1_F8]/4FM[?>?\\8O^^S_A0!+'/%-_JY%;V!J.^_X]C_O+_,5%)%-+R]K
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M\U &_IG_ ""K/_K@G_H(JU573/\ D%6?_7!/_015J@ HHHH **** "N,OO\
MDHEK]8?_ $7<5V=<9?\ _)1+7_>A_P#1=Q0!V=%%% !1110 4444 %%%% !7
M#Z[H]G_PL#3]56*6:[>-(G LO/6-5<D-NR/+.2>>?TKN*\UU[3S%\7+/4+E8
M?(FM88H&D,F?,61B<!.,_,/O<4 =/XW5#X==GMC<*D@8H++[5T!YV9'Y]JX_
MX,S-=:3)<B&9(IC)(FZS2-,&1C@.#EOH>E=9X]%JWAIEO#"(3( 3+YF!P?\
MGGS_ $KC_@M#;0Z=/';&!D3>J.EO(K,HD;!,A^5ACTY]: -3QKI5[JGC#0A:
MP3NMO=V]P["U38%5B6S+G<#C^'&*]#KS/QY>R:?XW\/S0&%':\MXY'^S.7\M
MF8,/,^X!STZUZ'Y\LW^HCPO_ #TDX'X#J: +#,J*69@ .Y-5_M#R\6\>1_ST
M?A?P]:<MJNX/*QE<=VZ#Z"IZ *XM0Q#3N96]#PH^@I+WBU_X$O\ Z$*LU7OO
M^/4_[R_^A"@"9XTE7:ZAAZ$5!Y,L/^HDW+_<D.?R-6:* ($NEW;)5,3^C=#]
M#WJ>FNBR*5=0P/8BH/(DAYMY/E_YYOR/P[B@"S15=;I0VV93$W^UT/T-6* "
MBBB@ HHHH **** "BBB@ JEJ_P#R!;__ *]Y/_035VJ6K_\ (%O_ /KWD_\
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M_:[@&ZN2>IDD.YL_3./PJ_XEU9-"\-:AJ;G'V>!G7_>QQ^M:@ 50   . !7
M?$QFU6?0?"D1R=3O%:< 9Q"GS-D>G&?PH U/AOI+Z3X'L5G4BYN@;N?.<[Y.
M<<^@P/PKK*:B+&BH@PJ@  =A3J "BBB@ HHHH **** "N%\"_P#(T^,O^O\
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MH X'Q1J%GIGC?1$O52[>>>&)$:^<.C,S /Y(^4@$=:]#KBOB*B;/#4FQ=_\
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MNJX7P+_R-/C+_K_'\WH [JL+PA_R+T?_ %UE_P#1C5NUA>$/^1>C_P"NLO\
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MZB@"Q15;SY(>)X_E_P">B<C\1U%3HZR*&1@RGN#0 ZJ6K_\ (%O_ /KWD_\
M035VJ6K_ /(%O_\ KWD_]!- 'C'AF,)XMM<0R1;KNR/SONW_ +J;YAR<#VKW
M2O"O#&/^$MML"Y'^EV?^OSS^ZF^[_L^E>ZT %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !63XH_Y%?4O^N#?RK6K)\4?\BOJ7_7!
MOY4 0>#?^12T[_KG_4UNUA>#?^12T[_KG_4UNT %%%% !1110 4444 %%%%
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MB@#N7C21=KJ&'H17%WZ>3X[M4B7+"2$KN8_\\[CCZ5%]H\7_ -VX_P"^5_\
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M-%5OML?_ #RN/^_+?X4?;8_^>5Q_WY;_  H LT56^VQ_\\KC_ORW^%'VV/\
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MF@#O$18XUC0850 !Z 4ZJWVV/_GE<?\ ?EO\*/ML?_/*X_[\M_A0!895=2K
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M 9FK^']-UT0C4(&D\G=L*RLA&X8/*D=15ZWMXK2VBMX%V11($1?0 8 J6B@
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MV[1[D;.",CD<&K,^O:1;3-#/J=G%*APR/,H(/N,T :%%9?\ PDNA?]!BP_\
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M67_PDNA?]!BP_P# A?\ &C_A)="_Z#%A_P"!"_XT :E%9?\ PDNA?]!BP_\
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MAV[B9E .1G@YYH W:*R_^$DT/_H+V/\ X$+_ (T?\))H?_07L?\ P(7_ !H
MU**R_P#A)-#_ .@O8_\ @0O^-'_"2:'_ -!>Q_\  A?\: -2BLO_ (230_\
MH+V/_@0O^-'_  DFA_\ 07L?_ A?\: -2BLO_A)-#_Z"]C_X$+_C1_PDFA_]
M!>Q_\"%_QH U**R_^$DT/_H+V/\ X$+_ (T?\))H?_07L?\ P(7_ !H U**R
M_P#A)-#_ .@O8_\ @0O^-(WB70U4DZO8\#/^O7_&@#5HKG+/QYX:OI($BU:V
M#30^<-T@&!G&#SP>>E7_ /A)-#_Z"]C_ .!"_P"- &I167_PDFA_]!>Q_P#
MA?\ &C_A)-#_ .@O8_\ @0O^- &I63XH_P"17U+_ *X-_*G?\))H?_07L?\
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MXT?VYI/_ $$[/_O^O^- %^BJ']N:3_T$[/\ [_K_ (T?VYI/_03L_P#O^O\
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M?:S>/,ISG$:G:H'MP?PQ7>U2TC3HM(T>STZ$8CMH5B7\!BKM !1110 4444
M%%%% !1110 4444 %<+X%_Y&GQE_U_C^;UW5<)X$96\5>--I!QJ !QV/ST =
MW6%X0_Y%Z/\ ZZR_^C&K=KB_#WBG0M-TD6E[JUK;W$<TH>*20*R_.W44 =I1
M6!_PF_A?_H/6'_?X4?\ ";^%_P#H/6'_ '^% &_16!_PF_A?_H/6'_?X4?\
M";^%_P#H/6'_ '^% &_16!_PF_A?_H/6'_?X4?\ ";^%_P#H/6'_ '^% &_1
M6!_PF_A?_H/6'_?X4?\ ";^%_P#H/6'_ '^% &_16!_PF_A?_H/6'_?X4?\
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MA=SNN/$%C*?[OF@*/P_QH WS=>8=MNAD/][HH_'_  H^S-)S</O_ -@<+_\
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M +_"@#?HK _X3?PO_P!!VP_[_"C_ (3?PO\ ]!VP_P"_PH WZ*P/^$W\+_\
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M7_/G=?\ @ ?\*[[ ]!1@>@H X'_A97A+_GSNO_  _P"%'_"RO"7_ #YW7_@
M?\*[[ ]!1@>@H X'_A97A+_GSNO_   /^%'_  LKPE_SYW7_ ( '_"N^P/04
M8'H* .!_X65X2_Y\[K_P /\ A1_PLKPE_P ^=U_X '_"N^P/048'H* .!_X6
M5X2_Y\[K_P  #_A1_P +*\)?\^=U_P" !_PKOL#T%&!Z"@#@?^%E>$O^?.Z_
M\ #_ (4?\+)\)?\ /G=?^ !_PKOL#T%&!Z"@#@?^%E>$O^?.Z_\   _X4?\
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M)?\ /G=_^ !_PKOL#T%&!Z"@#@?^%E>$O^?.[_\   _X4?\ "RO"7_/G=_\
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M_P ^=W_X '_"N^P/048'H* .!_X65X2_Y\[K_P  #_A1_P +*\)?\^=W_P"
M!_PKOL#T%&!Z"@#@?^%E>$O^?.[_ /  _P"%'_"RO"7_ #YW?_@ ?\*[[ ]!
M1@>@H X'_A97A+_GSNO_   /^%'_  LKPE_SYW?_ ( '_"N^P/048'H* .!_
MX65X2_Y\[O\ \ #_ (4?\+*\)?\ /G=_^ !_PKOL#T%&!Z"@#@?^%E>$O^?.
M[_\   _X4?\ "RO"7_/G=_\ @ ?\*[[ ]!1@>@H X'_A97A+_GSN_P#P /\
MA1_PLKPE_P ^=W_X '_"N^P/048'H* .!_X65X2_Y\[O_P  #_A1_P +*\)?
M\^=W_P" !_PKOL#T%&!Z"@#@?^%E>$O^?.[_ /  _P"%'_"RO"7_ #YW?_@
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M7_/G=?\ @ ?\*[[ ]!1@>@H X'_A97A+_GSNO_  _P"%'_"RO"7_ #YW7_@
M?\*[[ ]!1@>@H X'_A97A+_GSNO_   /^%'_  LKPE_SYW7_ ( '_"N^P/04
M8'H* .!_X65X2_Y\[K_P /\ A1_PLKPE_P ^=U_X '_"N^P/048'H* .!_X6
M5X2_Y\[K_P  #_A3A\3O"H&!;7@'_7BW^%=Y@>@HP/04 >5^*_B#IFJ>&[S3
MM#L[Q]1NU\B'-H5 +'!.<<8!KT/P_I4>A^'[#3(AA;:!8_J0.3^>:T<#TI:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img10132136_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_8.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (Y!#,# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU7=AL33Q--5*3NCCKT*E"?LZBLPHHHK<Q"BBB@ HHHH **** "BBB@ HHHH
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M_P"T?>L6HR?"3PN&49[MW]"LTQ,<1B.:&R5@HHHKU#S@HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !17N/_  SM_P!33_Y3_P#[;1_PSM_U-/\
MY3__ +;4>UCW-?8S['AU%>X_\,[?]33_ .4__P"VT?\ #.W_ %-/_E/_ /MM
M'M8]P]C/L>'45[C_ ,,[?]33_P"4_P#^VT?\,[?]33_Y3_\ [;1[6/</8S['
MAU%>X_\ #.W_ %-/_E/_ /MM'_#.W_4T_P#E/_\ MM'M8]P]C/L>'45[C_PS
MM_U-/_E/_P#MM'_#.W_4T_\ E/\ _MM'M8]P]C/L>'45[C_PSM_U-/\ Y3__
M +;1_P ,[?\ 4T_^4_\ ^VT>UCW#V,^QX=17N/\ PSM_U-/_ )3_ /[;1_PS
MM_U-/_E/_P#MM'M8]P]C/L>'45[C_P ,[?\ 4T_^4_\ ^VT?\,[?]33_ .4_
M_P"VT>UCW#V,^QX=17N/_#.W_4T_^4__ .VT?\,[?]33_P"4_P#^VT>UCW#V
M,^QX=17N/_#.W_4T_P#E/_\ MM'_  SM_P!33_Y3_P#[;1[6/</8S['AU%>X
M_P##.W_4T_\ E/\ _MM'_#.W_4T_^4__ .VT>UCW#V,^QX=17N/_  SM_P!3
M3_Y3_P#[;1_PSM_U-/\ Y3__ +;1[6/</8S['AU%>X_\,[?]33_Y3_\ [;1_
MPSM_U-/_ )3_ /[;1[6/</8S['AU%>X_\,[?]33_ .4__P"VT?\ #.W_ %-/
M_E/_ /MM'M8]P]C/L>'45[C_ ,,[?]33_P"4_P#^VT?\,[?]33_Y3_\ [;1[
M6/</8S['AU%>X_\ #.W_ %-/_E/_ /MM'_#.W_4T_P#E/_\ MM'M8]P]C/L>
M'45[C_PSM_U-/_E/_P#MM'_#.W_4T_\ E/\ _MM'M8]P]C/L>'45[C_PSM_U
M-/\ Y3__ +;1_P ,[?\ 4T_^4_\ ^VT>UCW#V,^QX=17N/\ PSM_U-/_ )3_
M /[;1_PSM_U-/_E/_P#MM'M8]P]C/L>'45[C_P ,[?\ 4T_^4_\ ^VT?\,[?
M]33_ .4__P"VT>UCW#V,^QX=17N/_#.W_4T_^4__ .VT?\,[?]33_P"4_P#^
MVT>UCW#V,^QX=17N/_#.W_4T_P#E/_\ MM'_  SM_P!33_Y3_P#[;1[6/</8
MS['AU%>X_P##.W_4T_\ E/\ _MM'_#.W_4T_^4__ .VT>UCW#V,^QX=17N/_
M  SM_P!33_Y3_P#[;1_PSM_U-/\ Y3__ +;1[6/</8S['AU%>X_\,[?]33_Y
M3_\ [;1_PSM_U-/_ )3_ /[;1[6/</8S['AU%>X_\,[?]33_ .4__P"VT?\
M#.W_ %-/_E/_ /MM'M8]P]C/L>'45[C_ ,,[?]33_P"4_P#^VT?\,[?]33_Y
M3_\ [;1[6/</8S['AU%>X_\ #.W_ %-/_E/_ /MM'_#.W_4T_P#E/_\ MM'M
M8]P]C/L>'45[C_PSM_U-/_E/_P#MM'_#.W_4T_\ E/\ _MM'M8]P]C/L>'45
M[C_PSM_U-/\ Y3__ +;1_P ,[?\ 4T_^4_\ ^VT>UCW#V,^QX=17N/\ PSM_
MU-/_ )3_ /[;1_PSM_U-/_E/_P#MM'M8]P]C/L>'45[C_P ,[?\ 4T_^4_\
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MN/\ PSM_U-/_ )3_ /[;1_PSM_U-/_E/_P#MM'M8]P]C/L>'45[C_P ,[?\
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MW_4T_P#E/_\ MM'M8]P]C/L>'45[C_PSM_U-/_E/_P#MM'_#.W_4T_\ E/\
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MT_\ E/\ _MM'M8]P]C/L>'45[C_PSM_U-/\ Y3__ +;1_P ,[?\ 4T_^4_\
M^VT>UCW#V,^QX=17N/\ PSM_U-/_ )3_ /[;1_PSM_U-/_E/_P#MM'M8]P]C
M/L>'45[C_P ,[?\ 4T_^4_\ ^VT4>UCW#V,^Q[C1117(=P4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\4;M(-KR-N*YSM&  /R H LT444 %%%% !1110!#<3^2%"H7D<[40=S_ (5
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M55871>&"*1090TSR#&",''N>@H TZ*** "BBB@ HI%96&5(.#C@TM !1110
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M+O.%:-LC/8'TS5NLBWB6YD$D*S;'=7DDEXSL/  ^M:] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %74O^/%_]Y?_
M $(5:JKJ7_'B_P#O+_Z$*M4 5;C_ (_[/ZO_ .@U:JK<?\?]G]7_ /0:M4 %
M%%% !1110 4444 %5;'_ )>/^N[5:JK8_P#+Q_UW>@"U1110 4444 %%%% !
M1110 55N/^/^S^K_ /H-6JJW'_'_ &?U?_T&@"U1110 4444 %%%% %74O\
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M%=[7*V#:OI=M]GT[PCI=I!DMY=O?+&N3WPL0&:M?VGXE_P"A=M/_  9__:Z
M.@HKGO[5\28S_P (]9X]?[3'_P ;I?[4\2_]"[:?^#/_ .UT =!56Q_Y>/\
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M(!R<?Y[U-7-#4=?><S#0K4N@\MD.H@!>_!\OG/'Y5(=4\2@9/AZS _["8_\
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M-O$T$>2^5DB48D8<;U]_UJ7[!;?WIO\ P(?_ !H MT50ND0"&WB5WDYV#SF
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M1;2!(%<C&X*H ./PHJ[10 C*KH5=0RD8((R"*K_V=8_\^=O_ -^E_P *LT4
M5O[.L?\ GSM_^_2_X4][.VD1$>WA9$X52@(7Z>E344 0R6EM,09;>)RHP-R
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MI&ES,S.QP% M+C))KA)BT4\4F^-(ON2;L DG 7!^O&/>NVA\!S5?B+?GS?\
M/63_ +Z-/T[9=>*-*CD8/+','!90Q"G@@$],_J :@JSX<WOK]I(VQ@URHC*<
M_+GCG\ZV,CGXI;Q_B3XG@M]2ELB+B..$PV\#LS,  FZ0$JOR]N!CIDBNOET/
MQ'IND7%Y=^,'>2-"VTV4(0?4A"?R%8VC7&C6?Q!\;C5#@OL,@\MGVHN=Q.T'
M:!\O)]JTM:^(FBP:'(DL37RW4A@M%1&V7(]2S8Z'@\]<>M9W3;NSKY)QA%PA
MYWM?Y=O7S&V&B:CJMT)1XF47:6J2I<+80/(H9Y5(!:,87Y/KG=QC&>=\5)KO
MA6%KD^(<ZO,\<:SM8VJ(T;,!N=]NX 8''/3T!QNZ?XZL--UJ/3+KP]?:=J%Q
M:(MO$T)#2L'E(0?,3C)X.,Y9AV%4?'.M^'-3\$74K3)++<7=O'=-$L@&]"I:
M-79< A<\?4XY-#:6S",*D[J</+:UG\E;UOT^\Z30?&.@R>#8C>^)]+_M@11B
M9I$M]PDSAMH8J&!]:U5\3>#&UFUG:_\ #3LML UT\EJ&#$-\N[?N'N ,<]3S
M6'X(T71K[P?ITT^GV5V?)4*9[=9&C7'";F'./;CFN@_X1CP__P! '2__  "C
M_P#B:ZG1L]SSH5KJ[11L_%&B6UG+.)? BW\]SF41:C#&'CQPS'DE\D\>_6K5
M_P"+]#-X\=MJ'A$VX"F"3^THBSOC[K*.BYSSFI/^$8\/_P#0!TO_ , H_P#X
MFLOQ#HNB:=I'VR'2]-M6AN+=S.MM&AC F3)W8XX[TG3:5RE4NRU%XH\+PFSN
MI;GPLM_<-LO9+6:U. " ,LT@., >O3I1;>)/!-F^L2G7]"A\R;>&ABM@V-QY
M&TDR=>I&?SKA(/AK8ZCH=E<Z8SVU[J5M'+)=R(L\(("L1L*_+GJ&!]1WK?N/
MAAX=N+V"VFM+N96<W$L@,<:!@ ,?*@SG'W0<=361H+XT\1^$WU#PS,=9MI-(
M>Y/VM[.8@N@B;[PB^;[Q3([$C-<Y?/X*U7QU8CPG-+)!)9S&]:.6X0NX*[-S
M,03@9K.T:U@B\,^ YTMXTD>^N 9 @#-S*.3WZ#\A7=5+9I"-]3+B\.:7 &$,
M,\8=B[!+N9=S'J3A^2?6G_V'8_\ 3W_X&S__ !=:-%3<VY5V,E/#.DQSRSQV
M\J32_P"LD6ZF#/\ 4[\G\:QM9T[1_#<6CR1^?8Z?_:L NQ#<3!?)))DRJMZ#
ML,\5U]%%Q.*:.>MI=%US5[A=+O)I]-B#F )=3*5!?C.6#=CC=^%7H_#FE01;
M(;:2)6)9O+N)5WDGDMAOF/N<UITIZ"G<2BDK'&Z9I]U8^*=6T[1-4GTJSAA@
M<0QHLRY8-D@29QT[=:W?LGB+_H;;K_P!M_\ XFJ6G?\ (]Z]_P!>UK_)JZ&B
M[!13,/PYI^J7&I^)+(^(&BBL(H9 L=A;)YKS*^6;"#)!4'W[U5\/CQ!?>'K"
MZ7Q--;K+"&$,5A;A4]@-G2M2X\.Z1>WTE[<V,<ES)&8VD+-DJ5VXZ^G%7;6U
M@LK6*UMHQ'!$NU$'11Z<T7)4-=2A]D\1?]#;=?\ @#;_ /Q--@TS5H+:6W_X
M2!S"ZD",:?;JJDG). N#WZ]<\UK4IX _.B[*Y(F/%I^NP1)%#XIN(XT&%1+"
MW 4>@ 3BG&QU^0%'\67+*PVL#8VY!![?=K5HI78<D>QPCRP7GPCN[FX\;VD5
MX8Y0=%2*UB+8E( "J PR &X]:Z6U9HK2".-BB+&H55. !CH!69XPTC3(?".J
MS1:;9I*L.1(D"!@<CD'&:TH?]1%_N#^5$G<(1LV2.[2(R.S,C JRL<@@]015
M<V=JUFMFUM";53D0&,; >O"].YJ>BI-+(?YLG_/1_P#OHTETJW-NL,X$L3I\
MR2#<K<GJ#UZ4VGN01'@]%_J:!61SOAY%OM-O[>[5;B"+49DCBF&]452 H /
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M;3K5FB0L84))49)VBN!M'6")UFD4/]CFC+-A=[F)OU)KT+3_ /D&VG_7!/\
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M*SMH)YIX;>&.:<@S2(@#2$# +$=<#UJ:@ HHHH **** "BBB@ HHHH ****
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M>.M=KHJ-%HUI$U@+#RXP@M0X<1 < 9'7@"LY1229HF[V,/PC_P A#5_]]O\
MTJNZZJN5\(_\A#5_]]O_ $JNZMWVE>('GNI=.\0+!YS@QQSVPD2)0,$#H>>M
M%3XA0^$WZY'X@?\ 'KX=_P"Q@LO_ $(UJV%EKT5[YE]JUO/;8_U4=ML.?KGI
M65\0/^/7P[_V,%E_Z$:(JTD-NZ.NHKG;O2?$4ES>-:Z^L4,\@:)'@W&%<#A3
M]?7UI\NF>(3?>?#KL:QF-5,+6^Y0P'+#GN:E)=QW\CH%^\/K7->!C;GPXWV?
M&1>W(EQG_6>:V>OX4L-CXM75(-^L63V2N'D/V;#LN1E,=N,_-G\*D\&JJ^&X
M]JA=UQ<,<#&3YK\U5O=%?WC5.I6 O'LS>VXN44,\)E&]0>A(SG%3K+&[;4D1
MCC. P/%<IXDL+C4A<Q3^&8-30L!"'EV @8.6.[V[ =.].T/319ZO%/'X56P+
M1M"US]I#%% 4@;<G@D?ABDHJUP;=QOCC_C]\)?\ 8?M__07KJ+J[MK&W:XN[
MB*"!/O22N%4?4FN7\<?\?OA+_L/V_P#Z"];^K_:38,MM:K<LS -&QZKW[C^=
M#V0+=EE+NVD0.EQ"R$9#!P01ZU/&064@Y!(Y%>?KX>A,MPA\"P"&4  BZ W
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MR/6G5%R['*^%N;[5?)X;>=V_D'_2;KIC'?=^&/0YZ<^9O&TIM[Y!S7,>$?\
MD(:O_OM_Z57==5CC-74?O$P7ND9$^3AH\=LJ?\:Y7QS@6V@_:?F']N6FSR^,
M/N."<YR/4=?>NNKD?B!_QZ^'?^Q@LO\ T(TH/WAR6AUG[SS.J;/3!S32)\G#
M1X_W3_C4E%1<=AB";S%RT>,C.%/^-8/@Q_,\/)L>-D2XN%8#DAA*_%=$OWA]
M:YGP(T+>')/)C*%;ZZ$F1]Y_-;)_E5)^ZQ6U1T)$^>&BQ_NG_&@";(W-'COA
M3_C4F**5QV./\;^9]O\ ">2NW^WX,8!S]UZZO$_]Z+_OD_XURWCC_C]\)?\
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M/_*S:_\ Q58'B+PCXJ\13))+X8N+?;$866+6+,AU+!N<GU _*E_X1'P]_P!
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M-'?!6\Q5C;RR5.#M;&.<@@9S@U?T+PUIWAV">&Q%PPGD$DC7$[2L2 %'+<]
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M (3C6_+Z;_M,>/SVT\:-JC*"OC/7B#T(G0@_^.T<DNP<R[G:0:!IMK?Q7EO
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MO5+NVBN+?QSKTL,JAXY$O$(92,@@^7TI\OAG4[>VEGN/'/B"*.)2[,UTFU5
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M_P"W_P 1748%JBH2UUO0"&$J0-Q,IR#WP-O/Z?A22/=AR(X(63L6F()_#::
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MC-;2':5R4.W(![$ &O/[>&"]U"75+._CTO4%=EB@U(/YN4.UF:1\X)X! !7
M'4\BZ-7\2&_O-,@T*:WU+4UC8S@YMT(&R282#(QL\O"_>S^= &GKMP/$.H0Z
M?'(OV0W'D1@-S-(N?-?'=8U!'NQ/H,]HB+&BH@ 50  .PK*T30+?1XE8MY]W
ML$;3L.0HZ*H_A7V[]3DUKT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!YQ\=/^23ZG_P!=8/\ T:M='IO_ "";'_KWC_\ 017.?'3_ ))/J?\
MUU@_]&K71Z;_ ,@FQ_Z]X_\ T$5$BHEL?=D_W#5=/]8OU%6!]V3_ '#5=/\
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MA3^)&D]F4--\0ZO!XMN8D\/W;"XOYFDB\RV+$BVM^ 3)QCJ<'&"/<#4\)?\
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M"%7&>.&QWK;L/^0=:?\ 7!/_ $$55;H33ZF?XJ9D\.7#*AD998"$4@%CYT?
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M88(Q%:H]]&?LH#HP\OCCF-?RKN?^$$\)_P#0N:;_ -^!1_P@GA/_ *%S3?\
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MMU:T6)D>'<90&\T]EV^^:L^%9HIOB)K;Q2I(O]G6XW(P8?>;N*W?^$$\)_\
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M)?C)IFFR3P7=KH<)NI9[8%8VD(&W*DG!!*]SWKV6M(1Y41)W844459(4444
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M;G.,^]7+[Q7H":LHDDW2R6=XT=QMD&Q6,/R[=O.[@Y/39[UK3^%&<MR[X?\
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MI<;9 2LT9)^15+'..W4Y.>>HHMZHVA=(ZJR\=QW]G(\]C)Y*Y62YLV$\0(8
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M5PMO;M&DFG2&.3>Q&7920<;5VX#-P31>IX:E-[?M/%%?1KYR"7-C-$.25WH
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MG*>,H8(-3\+/J$\DUPT0$Q"'RHD.Y0V0-JJ1[YJ_H^E_$2T=M M[OPP1I=M
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MT<S-=R@R&!T;IY7&?+QUXS5JZAU'6M<L;[5[+3$ALX)DC2*5IB7=HSGYD4#
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M:-B)+KYO+:09^Z!U_P ,UZ77'^//$ECIVDWNCR+<O>WMA*T2PPEP%P5+,1P
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MU=9'B>2"=XUC )PJ*#C9C!Y!SU/-3:KX/N;^6*==3W7,6=ES)"$N%] LL6W
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M3K^ ISIRG%<O84*BC)W,SQ?JM[IWQ2NK:.]E6UU"\BA,5OJ,T$D;B"#YRJ,
MP(8 <9^4\\5-H",GQ6N ]Q=3G^PA\US</,P_?] 7)('MTI]S;VZZG=^(-9-G
M-?S2*WVA+;84 1455!+'^'/7J:J>%[^*_P#BQ?>7',AAT98W65-ISYP8<>F&
M%+V?)#WMPY^:6FQZ4."*XOX:^'[[P_X_U%+ZUME-S%=7$5S%)N:1&DA 4YY
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M)J'-)V92BWJCU/Q_JQTCP=>R1\SS@6\*CJS/QT[\5VW@_1%\.^$-+TI0-UO
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MH,!0* $L+*+3K&&TA+F.)<!G;+-ZDGN3UJS110 4444 %%%% !1110 4444
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M)Z45%<_\>LO^X?Y5+5"$9%<8901[BL_5Y;JTTW-A'$TQECC597VIAG"DD]>
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M$;X8:5H?PMN6@U#498]*S+:Q2F' 9Y &W%8PS=>[>E5AXZ\+X'_$ZM^GH_\
MA7/^,=:\;WG@JYLM4N[UDC#?;YI5M_(N%\P;!&$0.O\ ">3V]Z['3=2TO585
MDL+BWG7&?E'..F<'GK104HWZ#K.,K'/W^I:6WB>&W@\11VX,BQW.G_.5DD#J
MRG ^4MD8RV<=>M/A\2:#)>Z<]KJL<UOIR1/<2G=E(UNK3YFX]%)XJ9X=-B\7
M3/KFES7<DSQ?V7+'*%$+CJ2,@G!Y/J!C!KM/BF(+<Z;(PCBC5278X  %S:Y)
M/I6;DU>-MRU&]I7V///%WC/PQ=^-M7U&"+1]8AN;&*W@DNRP\EP&RZY0G/(Y
M&#P*M:5XQ\.66DVEM/KUM)+%$JNP5N3_ -\U'<2ZAXBUZYL=$U:PMK>"P%[#
M,639(58;@S<\=L<=>:V-"U>WU?P]!JLT*6RLI\SS,!01P2#_ '<]#6M&*C)J
M+U_KS,ZK<HIM'.-?66M_$'3-5TV]@N+:RMGBD.9ER[K( H,:E\XR>!VKM+G1
M[2'PGX1NXVNV>:[&Z.6]GEBYMYVXCD8J#D#G -<9K)^V_$;PW#8271,L$K@6
MBN2<+)@J$>,D_>YW#CU&0>SN-%MK'PKX/NU:^\]KK:RSWDSJ,V\Y.(W=E7H.
M@XK)N];YFBTI?(Y_1[Q]8\2BU9HX(I+O[+!#$T8ESL+"1HRA9DXP6!7%;MI\
M_FB:*+[1!/)!(R+PS(Q!(/H:?%#<6AF-AJ%S9B5]Y\H(=A/WBI93MW=\<=P
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M1+"2H4X7!8MG#$]0.-O?I2K=3V.HL\-M]AOI6S+82N/)NS_>B?H'('MGN.]
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M!Z5?-*Q/*KF?9&.QL8+1!#MA0)\LJ@<5G>,)YSX/OQ:B3S9HS$&A7S&4'@D
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M*]^* .ML=0#:G?7S&(F1EA16G0;53KCZDDUJ7[VUR_V"Z@MYHI<!DED7G/\
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MOPNOH8<;Y7A*^8?+'$BGDM@#\<5:@E6+1X4:8P,MJH,P7<(_D'S9Z''7TXK
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M.!M^4'()4+T'0'WK7F:6FQGRIO4MIXKTJTF:TU"9=/EA^5OM4B*"1UQ\V?S
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M*:.TRL04R,6 (.05/R]#UQ4<\KE\L;'7:[XF;1Y[2&#2[C4)+A9&V12(C*$
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M.>:J:QX U>"9;W0==O9)]Q,L=W=$>:#CC.THH&,C" ]>>:]&HHYGW"R.2N/
MD=S"8I/$&MLI(./M"+G!R,E$5L<<X(S65H?@S5$N+NWO-=O?L438MY+>8;B<
MG<&#HQXXP=QZ^U>A55L?^7C_ *[O1=A9'%ZU\/M0D476D^)=46^B'R"XF&P]
M>,*H7G<>2I/3IBM&'P7)):1_:=?UF.9HQYJQSQ$*Q'(!\L'&>]=;11S/N%D>
M?67@'4[+67C&O:@=(DBR-MSF1)!M _UBOD,,DX( (Z<U:U3X>M>6[>1XBU<7
M*HRQ/+/A4)Q\V(PN2,#KD=>.:[>BB["R.*TGP;J3:?&=6U[4TO06#_9YXRC
M$X89BXR,'';.*H/\/M4L=5MY-,\0:@U@Y"74<UT3)C)^<,X8;AD\ *#QZ5Z)
M11S/N%D<=?> !>6CP_\ "1ZVI/(/GJHS[[%4_J*K:-X*U9;:6/6/$6HM*DFV
M*2WECQ)'@8)!CX.<CJ>@/>NZHHYGW"R/.M9^'VK1R?;M#U^_>[#;FCNKD@2#
M;MV\ HH[_<SGG-:L_@R&6$6MQKFM%YQ@$3H"I')PRHI[8^GI7855N/\ C_L_
MJ_\ Z#1=A9'$:5X%UFTU"YM[OQ!?-IN"]O)#.-Z$MG80Z,2.202Q["GZQ\/+
MV8"YTKQ+J<=\F-K7$V4(';:H"\Y/)4]O2N^HHNPLCD+/P;</8P->:]J\=TT:
MF9(IXF17Q\P4F+D YP:R['X?ZMI^K"%?$>HRZ.Z$G-P#-&X  Y=6W XYY&#R
M!SBO0Z*.9]PLCB=5^'C7UJ5B\1:P)@K",R7&U02,9_=A"2.V20/2F:+X-U9K
M'&M:[J"7:N5S:SQE'4=&P8A@GTYQZUW-%',^X61YQ>>!-2TO4(KVPUN]GL-^
M;V"YN26>/=EF!(89 +8"A<\#WK6O? "7D&QO$.M;@=R;IPJ[L$<^6$)'/3(K
MI]2_Y!=W_P!<7_D:M47861P6A^"-7B@F@U?Q#J#>4X6WEMYD^>/ QN#1Y!'3
MJ<]:Y3Q5X074;^_MQ=ZG<Q6<UO\ :'OM:6"%Q\DA7RQ'MSMX!_O8/:O:*SY]
M(TUKJ743I]J;XQ[3<F%?,P!TW8SBB["R.-\++=7.M6EL=.GBL+4SWKW#SF0/
M</M55+;%!PKR=,XP.XKT*H++_CPM_P#KDO\ (5/2&%%%% !1110 4444 %%%
M% $$?E_;9]N[S-B;L],<XQ^M3U5B_P"0G<_]<X__ &:K5 !1110!1U31M,UN
MV^SZII]M>1<X6>(/CW&>A]Q7!ZK\(=$U&R\K1KVYTQ%=OW:'S8F/0AE;DCCU
MQ7HMS-Y%M)+C)5>!ZGL/SHMH?(MHXLY*CD^I[G\Z /GN7X4^+?">J1:IIMI;
M:H;<JRFW?:S;7#C,;<'E0< CI6Q!XU1X5_X29KC1M;N)C/$TMLP\K! 5=I^;
M'!SQC!ZU[C67-IUCJDM[;:A9P7<!9"8YXPZYV]<&FG835S@9YDUB&*2;6[>>
M:_QIZ3V[J%C5B6.W/\0 8\^@%>;?$AQJ&NW-KJ7B..2.TC\JVV6N)'D3<(U(
M4[<%FD^8$=N,5ZEJWP4\,WDOVC3'N])N -H-O(63'<%6['TSBN"U#X-^(]'U
M"#4+6VL=:2!U?RXV^SL^U@0I4_*1QT!%-M,$K'<:+;0>&O!-K#,VXV< DF(/
M)D^\V??=26^MW%EJ-E:ZK=VTOV^Q-\GV>!P8%RHP^,C;\WWCCD>XK(B\>VLT
MOV3Q!HU_H]WAG9;J$X*+RQ!QDC /0&H['Q+H_AW5I[O0QI\4$A6)YY(SY)C$
M9; =.$8OA K8]<5HY6U1FH]R77=;O=)O9;W3FNY+:\D1C<Z:J22&-8BJQAB&
M  DPY]0YQTJ]IDNIFQO-2N!LN[Y+>%4$6P2W&T(TH4\C<2!@]0@/>DAOO#][
MXMN=3U&REAEN8/)CO+ _NHA"1YK-(AY!>5!D@CA1VI\D5E<W,]WJ7BNXM=/L
M;S.GHFP3S,L8^;H2_P Q?"[><9J5)7N4XNUBGJ<%WX6U&STJ?5Y-2TVP2*=+
M5H]C>:S[(E# $<89@I.>!6?XX\=W^@>*+?2]/A\X>0-X*95IG;$:EOX>A/OD
M4:19W^L>+8KO4"S2M.+ZZ)+*1&J;+8.%8Q.2 &Z!@5/XUM.TC6[KQXTFH6\T
M=M-?27TY(!3;& D"9'&>A]<8]*<;\HG:YZ:A?8A< 28&X#H#WKE_!-IHGAGQ
MIJME'J_D09#065TP \^4!GV,V"QVA.,G[U0_$6]U2RT&WDTY[F&(W:?;;JV3
M=);P?Q.!WK?M;4Z1\*F^U_Z?=W,1<&\B5FEEE.(PZXP2-R#IT6G5?05-=33T
M2[A_XG_B>Z;9;O*Z(_7%O;@KD8[%A*WT(KSOP+XFN]?\4:P(+S[9IC*MVSO%
MM,,\AR8E.!E5^[R/X?2MKQ3IFB^ _"^GQKJ%]I\$CQ6TRQ.\D+J.7+(0P (!
MSMQUKHX)H;BWCGMY$D@D4/&Z'*LI&00>XQ2IK6XZCTL8^O\ B_1/#$L$>K79
MA>=6:-1&S9 ZG@5PWB+P%K/VBS\42-:7=VLD<;64HR&DD<,(RK<, 9,'D<#T
M%='XDT:T_P"$ST35I-8%B\[BRECG*^5)#]]@-WW2<!??-=A.5U+QE9V*X>&T
MD?4)".1G8J1_^A,?PI5&[V""5KGB%EX2UI_B/:P:GIHLK&6Y>X^Q-%^X5  6
M"(P*')P/E)(!KW&N,\;^+Y[?XE:98:9<V]Q+',EE/8LN7 D =I >V!M^M=7?
M7<>GV%Q>2D^7!&TC8&3@#/2KI[$U-SS?Q49]6\91E+::XLK"1$E\H#(*_/C!
M(R"VWD>AJ[/:2:ZR1WUJT-@C"3RI&&^5ATW;3\H!YZ\D"H_#US&^E/*LL4UW
M*SSRQH^3N))QSR >HSZUG6FOWYDAFO[N&+34\M[ZZ%I)&T!?(,(5A\Y5BN6'
M6NA.,(W?4Q:<I670UX](DTU,Z3J5U9*H'[L-O3 .<8/ SW/)]ZZ3PCJ%_JF@
M1WFH/"\DCML:)=H9,\&O/C>ZC!<:_ISZB^H1+<QVMI))&(9&+KEL# YQG QU
M%>K6-HMC806J8Q$@7(&,GN?Q.34-Q=G$I*2NI'/:]XSL+#4W\/PFX?5YHPL0
MCA)1'<83<W;)(]>M7M;C\1:;H^G^&Y+>UU&"[D2WWVK>5,T2#?)E&^7)16&<
MCEAZUFVFCZ;IOQ3BO9-9\C[>AN9[2Y==LKH=L81CR,%B=H_N5VUJ1J?CF[N0
M=T.EVPM8_3S9</(?^^5B'XFN:HVW9F\$K7.9\4ZMJ'B9[;1]$>72KN)7N+I=
M0M&&U2#&@QT;)9B"I(!CIWAS1(/#'AS3M+!WFV4[FB7'F/@EC@^O-<\OC*34
MOBV]GIMW!>6=RKQSQE"&M1#D AN^X@G'^U75:UJUCH=FNH:E<"WM8W >0J6P
M2"!P 3U-:4TK7)G>]CD_A]=ZSXS\22/J]S ]C8RSFXTR2UVM$?NQ*X;KD,Y_
MX!74VOA.QO\ Q+J[:5-=:3:V7EVR+8R;8FFQOD/ED%. T:\ =#4>BZEJEGIV
MH^*+:RLK[3+MC.A$AAF\B-<*?F&&! + '!^8U%9>)!IO@F2VE2XLO$%\KRHE
MU;LBR3S,3\K_ '6P6Z YP.E9-NY:2L+X?U-=3LIF?48+XPWCPK)  #A6PNX
M\$@9_&MVN(\*^$;W1M;U'6=5:Q:]O#%$GV-"BHB_>R.Y)"\]?ESWJ#Q#XCUB
M?QL?#&DW=E:@VJ%OM,9+S.[8VQ\C.%(.1G'/I6RE979E:[T.Y62.9E*,' &X
M,IR.:EK'U+PWIR2Z-9Z.LNF75W<%?-L9"@\E 2S%/N9.!R1U:G@WFF>)AHMS
MJMM?9M3<_,@CG4;MHR <$'YN<=J(U$]!R@T7-0O[?2[":]NWV01 %FQGJ0!^
MI I]GX=N=8B6_N]2FM@ZGR[6V9'C"G_GID$.3[8 Z5-UJ@=+LH)#/;J]G-NW
M%[1S$68\98+PQ_W@:<DWLR8M+<HW/AA['5=&LIKI9;"XF:)9U=]T3!2P5%+%
M5R P!'*\XQFNHU/4X]&B@T;2(8Q=F/\ =ICY((^F]OZ#J3^-<]J=IK=S9Q06
MNI6Q,$\<]N;F DQ,C9ZJ1NR,CGL:O6UJ+=9&:1I9Y3OFF?[TC>I]!Z#H!6:I
MMO4T<TEH5[+3[.QLIFB3F<>9/+CYY3CJ3[#@#L.!5PSPB<0&5/.*[_+W#=MS
MC..N,]ZB_P"89_VQ_P#9:YC6]'LIKG5-3U"SU3[9''BSGLP)1M5.%"X)4EB>
M@_$5HW9:(A*[+VMZ/J$^N6VK6(M)S!:2VYM;M<HY;D'.#CI@\=*DT*Q?PMX2
M$=Y*A:W62:3;Q&F26*KZ**P;)=1\/V>EJ/$<.H0A3+=/*WF,D:)OD R<\-A<
MD\9%7O"<-[XCT.UUQ_#37$DTC2!YM:EC5R'./W0!7:,8QCG'(J.=+WBN5O0Q
M/^$1FFOHY=]G'-;78BC,4'E3R7$BAI0TL>"ZIN(Y(SSGM7=Z1X,U<"Y35]>O
M1ME/D-9RH%:,C/*M&2"#D=3G&:L^$=$N[!@^KQQM?.9)-JMN$6Y]Q.>Y9N_H
MJCM78UE=FED>>ZU\/]3#+>:+K^H->(X8K=71 < %2HP-@!![H3D9S6M-X&6>
M!XI/$.N;77:<3QJ?S5 1^!%=911S/N%D>?:;X%UFUU>X@GUV\_LEE:2%H;C]
MY&^1\F)%<D8W')8XX%3:M\/+BXB,^G^)-5COU"^7)//E5P<CY5 7G/.Y6R.*
M[NBB["R//+CX?KK.B?9]5N9I=72U+'S?)F1'<$!59HLA<KV //TQI_#[PA'X
M3TZZ46,%G)<2 F**3S-J@=W(!/S%R,] 0.U=,G_(4G_ZXQ_^A/5JD,**** "
MBBB@ KSWQ=I-U+K-VL3.@N[<7$$IGD \Z$$^6%4@$G"GYLC@\$UZ%5/4].BU
M2Q>VD8H<AHY%^]&XZ,/<?KT[T 9OFKJ^OV04![>S@%T3U_>."$_\=W'/O200
MK9:G>:1(,VE^KSVX/12?]8@_$[O^!&LOPL+SPOI*66MV=P9^!)>6X,T)"@(@
MX^<?*JYR, YYK9O)+77]+^T:1>6UQ<6TGFV\D4@91*O\)(Z Y*D>A- &+I/A
MT'0[*ZLUM3,856YM9H@UO+(O#D#&4.X'IQZBH9)-!@FCTNWT"TLM<N"2EJ8Q
M$O\ M2%TP&0>W).!@=KNA:]:PZ#=310MQ?2QP6ZXWR2N=Y08[AV8'TVL3P*2
M:XT?3X)TUMX=1U*Y*M/;QQ^<5R<(H7^%03@%L#/.<F@#GK_PE#H.HZ1IFGI(
M(M3:=;B=.-DWER,)!Z$L5P.?N^V:]"TB_P#[3TFVO,*&D0;U4Y"N.&7/LP(_
M"O.-1O'M/$FG1S&YL=/L;A+IH7G-RX)# #/.TX8Y3<3C!4&NMLM9L=+M]6F>
M=6L(O],BD0[@T;]E Z_.&'U- $OB_57L]+DM+10]Y/&2OR[O+7INQW))"J.[
M$>AK0T/2H](TJVM@JF5(P)).[MW.>_.:Y[0K6ZUV:+5;I%2"25;AF(SYVW/E
MHOI&A(;/\3#(XZ]G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 07BQM:L)7*)E<D#/<8J>H+QD2U9I$WKE<
MKGW%3T 02K&;JW+.0XW;5QUXYJ>H)6075NK)EFW;6S]WCFIZ "BBB@ HHHH
M**** "H+98U\[RW+9E8MQT/<5/4%JR-YVQ-N)6!YZGUH GHHHH **** "BBB
M@ HHHH *@E6,W5N6<AP6VKCKQS4]02L@NK=63+,6VMG[O'- $]%%% !1110
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M*8B$B@K&ZJ><GE",[C\Y6LZ'Q7J7A_Q(MCX7N=16QNROE&9 C2.W!^490XX
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MH_PWDE=HTU2^1I"9" OVB=B><]@7Q]%KG_ .MMKGA>.5K)+7[-(UH!$<QN$
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MF0QH&7'09;!_G^53U K(;Z50F'$:$MGJ"6P/PP?SJ>@ HHHH **** "BBB@
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M 55L?^7C_KN]6JK6:,GG[E(S,Q&1U% %FBBB@ HHHH **** "BBB@ JK<?\
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M!9UC>1<L3E7>-"-@9<)@=/F(X[@'1Z/KVIW%Y%#K&EIIXND+6H64N25^\K9
MP2.0,= <X/%=%7(SP:KK>C[K#4[.[V'="\T30RQS*>-Q7(7!X(V="15Y_$D^
MGR6T&KZ3=0R3# EM0+B(L!D@;?G_ #4<"@#H**I66KZ?J+,MG>0S.OWD5QN7
MZCJ*NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%,E?RXG?&=JDX]:
M .>\>"?_ (1"\EBEF2*';+=)"VUY;=2#*@;JI*;N1Z8[UQ,%XT.G?V9X5M;4
M:@9TNY00SB!\@I$ O4A  Q)"C)YYQ6EKEMXB\6:=;6,VI06"ZG&LB6=BA9DC
MR&+RRMU '& HR3C/<87PYT?3-+TKSK^QCE*3O;W]RQ.^&<'J^#RC9&#VH ;-
M:>,[/6O^)Q>",W>W9/:3H)">ICWL%V]/NK^&:V8M(T.X<07$5G'?,K#S+Z>X
M2X]R&;G\N*O^/=,T5=#-D]M;I ZFYN';@"*,@_>[$ML ]LUC:1JV@6EXVA:[
M]EN[4#_1[R5"N^,_=+YX8<@;AG!ZXR#0!S.K:*WA?Q;H^FC42=/=9)XV@MS*
ML!;$84 DAMS-'GO[C.:Z33?#OB6[\^Z DLKNWO$_T>.\WQ,L>"@,;<KD9Z2'
M[QJ&]T/2V\9VNE6RQ1:3J,\T#Q1-@1,D(.X<\;FV8QW%=!H/B%M/DUL:E\U]
M90+]JQR9I8\H& _VE\L\=VH Z+P]K]UJ]Q?6=]I4MA>6+*LP\U)8V+#(VLIZ
MXP2"!C(K>KC?AK]LE\/7-]J&/M-[>RSL>#U.!@CJ, 8/IBNRH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "J]]="RM&F(S@@ >Y.*L5!>6RW=N8
MB<<@@D=P<B@#)DO@#'=&Y:8QY;RS 5!&""0<=AGDYK<1@Z*PZ,,BLHZ<98_)
M-I!"#]YU<GCO@8]SU_6M55"(%7H!@4 +1110 4444 %%%% !1110!!>2-%:N
M4_UC?*G^\>!_.I(8EAA2)?NHH4?A4<ACDN4A9260>:/0=OZU/0 4444 %%%%
M !1110 4444 %5;;]Y<W$YZ;A$OT7K^I/Y5/(ZQQLS,% 'WCT%-MX1;VZ1 Y
MVCDGN?6@"6J&IZ+I>M0&#4]/MKN,C&)HPV/H>U7Z* /,M8^#NCQQS7>@:E?Z
M%.,O_H\A>//^X3_(BJMY:?$30I6EAL;/6]/^\JQR;9U7'0@XR3[;OI7I]Y&\
MR)$H.UG&\^BCG^E6*:DUL)I/<\:M_B-HYO?L6LV-]HUX!\WVJ$JH/INZ_F!7
M6V-Y;7T8DL[Z*ZB(R"CAOU%==?Z;8ZI;FWO[."ZB/\$T88?K7":G\'- F=[C
M1)[O0[SJLEI(=F['&4/&/IBK53N0Z?8AT[P[I_BK5-5U74'F,5NR6D)MYG4H
MT9RW3'\6/J*DN?">HR+):Z?J\.K1>62(=47.%+<KO3#=. /89JUX2NY?!T-O
MX8\0@),7;[/J63Y5X22>2?NOC'!_/U[%8(KO?)+ JMO(5APQ .,YJ.9WN796
M//?AKH]_:^+O%-[K%JEM?;XH8HHW#(L(&5V_D/RKT2\_>-!;_P#/1\M_NKR?
MUP/QKGK>-[+X@7<22@FZT]'02$L24<@D_@0*W0SI-]IG7)"^7MAR^T]2>F?3
MM2&7J*BBNH)_]7*K'TSS^52T %%%% !1110 4444 %%%8WB:\GM-+58?,19Y
M5AEN$!/V>,_>?@'H._0$C.* .:\8RKJND7M\YW:?92)';H%W>?,)%W. .3MP
M54#J=Q]*H^'[_4_$T,T&GP"#11*7M[>YN/)F:%@#\P4,VS).U1C*X!:M7PQ=
M6=SK$UE?;%O+)RMC"O, @_@>(_Q,1U)YSG'%:FF:/;7_ (=L-P:&Y@0K%/"=
MLD1!(X/I['@T 6+?2=36".%]2BM84X6&PMA&H7L,L6/XC%9%MH"77B:\N+?4
M+Y);"-;=+EK@R-YCXD=65N" /+XZ?-VQ6C/KS^'H7/B)XDMD!*Z@@Q&P SAU
M_@;\P>V.E+X<O;2+1(99[VV^T7):YFQ.K .Y+%<]P,[1[ 4 9U\]YI5W]MG6
M*TNSA3=H#]DNNP$HY,;=@W./4]*T9;E/$.ER1VP^SZG;%9DAE(S'(.5.1P5/
M(W#(()K3?5--*$/>VI4C!!D4Y%<KJFEZ>)$O-!UFWL+R+)C1G!BYZC'\(/<#
M(]C0!+OT;5M2EOKJWCQ+IRW+,PVR1^6Q# L,$%3D$9ZBNAT!+B/P_8"[=VN#
M K2[WW$,1DC)ZX)Q^%>80:]+<^)YM#N;98+O4XR@B#;HF#.GG&-AD%67+ =0
M=V>N:]@ P,"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDREX)$7JRD
M#/TI]% '">$=46QLV&J6%]'J:%;:Y<0^8L01<*HV%BJ8Y!.,Y)[UC>'=/T6;
M7]4>*3=#>:C-!YT,I1DE($@&1V92PP?[M;_B*"XLO$%SJFGR_9KL6*DRM\T<
MBA]I5E[X#;@>Q]B17%WUG;:-:6\]I-<?VCJ,8N'=%W;93)OA>?)P,Y')YRO'
M7% &_9Z$MMJ=[<Z@MUJ^C6[FSC64 FV4#)8J /,0%B >2OH>2)K;3[?7M3DT
M^YN(YI(+-5MKAE$A;:QVR9.=P*LH8'K@YZU-X8\17;Z'*LDND6DMH2USON7F
M8,Y+;L!5X))Q@GL.O%4(-!U<:XWB6'4-.TR9(GB6)H#"+A&()8JSMY7('/)/
M4@=* (]#T1-.UC4M#AAMH&N%$QL9U)C?&-WER??49VLI&=N<8R,URGCEM1T?
MQ%I5Y=VUSY[DVCR28_TB,\KRORM(A"D'OA3C.16_XIUV.8:;Y6L7"^(([I?L
MT2I '48.\AP-IC*Y!/(Y!(XQ5;1#'8^*9)+]-2\3Z@L"-'(L99=[X!";\!43
M'!]&)H ]/\+P);^&K!8VW1M'YB'_ &6.X?H16O63X:@OK;0+:#4(5AGC!41B
M0.43)V@D #(&!QQQU-:U !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1169)J(EN'A2ZA@VL4&Y=S,1P3UX&>
M* +EM*9_,DVJ!O*J1U(''\\U/5#2[A'@,"LK&$!=R'(8=C5^@ HHHH ****
M"BBB@ HHHH @G\J22.W<,2QW@#_9P>?;.*GJK;_O;RXF[+B)?PY/ZG'X5:H
M***;(ZQ1M(QPJ@D_2@",*QNFDW@H$VA0>^><_I4U5K%"MHK.,/)F1_J>:LT
M%%%% &?K=G;7^DS6UU!'.D@VJCC(W'@'\S7'7.K:G\/;NULKB*[UG1KDLMNT
M2[KBVQ@[6[,H!XYS@=Z[>=3+>6Z8.U,R$]L]!_.I+JU@O;=[>YA26)QAD<9!
MH \P36X/$_Q'M-:T^2XAL],A6UD=T:)G:1F9D92 < 1_0YS7J%O&L<7R[CO)
M<ENO/-<S=Z!=+?Z?;QWWF6 N1,R2\R@*K#;O_C3YOXN1QR1P.KH BEMH)_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%% !1110 4444 %%%% !1110 4444 (RAAA@"/<4M%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 (R*XPRAA[C-*  , 8
M%%% !1110!4NK^&W20;MTBJ3M )Y]\=*DLT6.SB56#@*/F!^\>YK%LAJGV=P
MCA2"VX93[V>=V1^5:.D;_L\I8DJ96*$XY'X<=<]* - D 9/2H+21YK9)7&"^
M6 QV)X_3%8SWT,S-]I25_,9E5!)L50,^XYP.OX5>TJ[\[SH/G*Q$;&;&=O8'
MWX/O0!I4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!!
M+9VTS[Y8(W;U*U, %    '0"EHH IM9,LC-!*J*YW,KQ[AGN1R,5-;6R6R,%
M)9F.YW/5CZU-10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
( !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img10132136_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_9.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (/ YX# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH*5).ZN='KWAVSTB]TV.%YI%N9"KB1@> 5Z8 ]36AXF\.:9INBR7-K R2AU
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MI1G7RVG[-7MO^)PU>A^ 6!T6X7N+@G\U7_"O/*ZGP5JT=C?R6D[A([C&UB>
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MI7#%<\A1W_/%?,T/J\,PI_46VGO^N_D?05O;SP53ZXDGT_3;S//****^R/E
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ JS;ZA>VD9CMKRXA0G)6.4J"?7 -5J*4HQDK25RHR<7=.PZ22
M2:1I)79W8Y9F.23[FD5F1@R,58'((."*2BG96L*[O<U$\2:RB!1J$V!QR<G\
MS52YU&]O 1<W<\H/9W)'Y56HK*.'HP?-&"3]$:2KU9*TI-KU+EMJVH6:A;>]
MGC4=%#G;^72IYO$.KSQE'U"?:>H5MO\ *LRBD\/1E+F<%?T0*O52Y5)V]0ZF
MK]IK6I6,7E6UY+''V4'('T!Z50HJYTX5%RS2:\R83E!WB[,GN[VZOI1)=3R3
M.!@%VS@>WI4%%%5&*BK15D*4G)W;NRU_:=_Y'D?;KGR=NSR_-;;MQC&,XQCM
M56BBE&$8_"K!*4I;L569&#*2K Y!!P0:LSZE?7,1CGO;F6,\E9)68?D356BA
MPBVFUJ@4I)63)(+B:UF$L$KQ2+T9#@U=GU_5;F%HI;Z9HV&&7.,CT.*SJ*F5
M&G.2E**;7D5&K.*Y8R:04445H9FC!K^K6T8CBOY@@Z MG'YU6NKZ[OF#75S+
M,1TWL3CZ>E5Z*RC0I1ES1BD^]C25:I*/*Y-KU"BBBM3,**** +<FJ:A-$8I;
MZY>,C!1IF((^F:J445,81CI%6*E*4OB=QR.\<BR1LRNI!5E."".X-3W&H7MW
M&([F\N)D!R%DE+ 'UP35:BAPBW=K4%*25D]!\4TL$@DAD>-QT9&((_$5HMXC
MUAHRAU"?!&.#@_GUK+HJ9T:=1WG%/U14*M2"M&37S%9F=BSL68G)).2:DM[F
M>UE$MO,\4@_B1B#45%6XIJS6A";3NC3D\1:O+&8WU";:>N#C]16822<DY)HH
MJ*=*G3^"*7HK%3J3G\;;]2U_:=_Y'D?;KGR=NSR_-;;MQC&,XQCM56BBJC",
M?A5A2E*6["K%O?7=F?\ 1KF:+G.$<@57HIRBI*TE<(R<7=.QJGQ+K)7:=0FQ
M[$ _G6;)+)-(TDKM([=68Y)_&F45%.C3I_!%+T5BIU:D_CDWZL****T,PHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /5?\ A0/BK_H(:-_W^E_^-T?\*!\5?]!#1O\ O]+_ /&Z
M^C:*Y?:R.WV$#YR_X4#XJ_Z"&C?]_I?_ (W1_P *!\5?]!#1O^_TO_QNOHVB
MCVL@]A ^<O\ A0/BK_H(:-_W^E_^-T?\*!\5?]!#1O\ O]+_ /&Z^C:*/:R#
MV$#YR_X4#XJ_Z"&C?]_I?_C='_"@?%7_ $$-&_[_ $O_ ,;KZ-HH]K(/80/G
M+_A0/BK_ *"&C?\ ?Z7_ .-T?\*!\5?]!#1O^_TO_P ;KZ-HH]K(/80/G+_A
M0/BK_H(:-_W^E_\ C='_  H'Q5_T$-&_[_2__&Z^C:*/:R#V$#YR_P"% ^*O
M^@AHW_?Z7_XW1_PH'Q5_T$-&_P"_TO\ \;KZ-HH]K(/80/G+_A0/BK_H(:-_
MW^E_^-T?\*!\5?\ 00T;_O\ 2_\ QNOHVBCVL@]A ^<O^% ^*O\ H(:-_P!_
MI?\ XW1_PH'Q5_T$-&_[_2__ !NOHVBCVL@]A ^<O^% ^*O^@AHW_?Z7_P"-
MT?\ "@?%7_00T;_O]+_\;KZ-HH]K(/80/G+_ (4#XJ_Z"&C?]_I?_C='_"@?
M%7_00T;_ +_2_P#QNOHVBCVL@]A ^<O^% ^*O^@AHW_?Z7_XW1_PH'Q5_P!!
M#1O^_P!+_P#&Z^C:*/:R#V$#YR_X4#XJ_P"@AHW_ '^E_P#C='_"@?%7_00T
M;_O]+_\ &Z^C:*/:R#V$#YR_X4#XJ_Z"&C?]_I?_ (W1_P *!\5?]!#1O^_T
MO_QNOHVBCVL@]A ^<O\ A0/BK_H(:-_W^E_^-T?\*!\5?]!#1O\ O]+_ /&Z
M^C:*/:R#V$#YR_X4#XJ_Z"&C?]_I?_C='_"@?%7_ $$-&_[_ $O_ ,;KZ-HH
M]K(/80/G+_A0/BK_ *"&C?\ ?Z7_ .-T?\*!\5?]!#1O^_TO_P ;KZ-HH]K(
M/80/G+_A0/BK_H(:-_W^E_\ C='_  H'Q5_T$-&_[_2__&Z^C:*/:R#V$#YR
M_P"% ^*O^@AHW_?Z7_XW1_PH'Q5_T$-&_P"_TO\ \;KZ-HH]K(/80/G+_A0/
MBK_H(:-_W^E_^-T?\*!\5?\ 00T;_O\ 2_\ QNOHVBCVL@]A ^<O^% ^*O\
MH(:-_P!_I?\ XW1_PH'Q5_T$-&_[_2__ !NOHVBCVL@]A ^<O^% ^*O^@AHW
M_?Z7_P"-T?\ "@?%7_00T;_O]+_\;KZ-HH]K(/80/G+_ (4#XJ_Z"&C?]_I?
M_C='_"@?%7_00T;_ +_2_P#QNOHVBCVL@]A ^<O^% ^*O^@AHW_?Z7_XW1_P
MH'Q5_P!!#1O^_P!+_P#&Z^C:*/:R#V$#YR_X4#XJ_P"@AHW_ '^E_P#C='_"
M@?%7_00T;_O]+_\ &Z^C:*/:R#V$#YR_X4#XJ_Z"&C?]_I?_ (W1_P *!\5?
M]!#1O^_TO_QNOHVBCVL@]A ^<O\ A0/BK_H(:-_W^E_^-T?\*!\5?]!#1O\
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M^% ^*O\ H(:-_P!_I?\ XW1_PH'Q5_T$-&_[_2__ !NOHVBCVL@]A ^<O^%
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MTO\ \;KZ-HH]K(/80/G+_A0/BK_H(:-_W^E_^-T?\*!\5?\ 00T;_O\ 2_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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METT2FY<O()=BE6D!R&);(&>^!G\ZL:JB/ILV]5; R,C-6U544*JA5'0 8 H
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MND^?:2,DY]P:L69$DUQ,@_=.PVG^]@8)I-2BC>",O&K$31 $C/\ &M7>@P*
M"BBB@ HHJM<LQGMX4)&YMS8_NC_(H LT444 %%%% %2^^5896!,<<H9QC/&"
M,_@2#^%5)68Q72O,LXN#B"-6R?\ ZWK6M5*TBC2^O2D:*=R\A0/X10!<4$*
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M./,W[FP<DY5AZ\59LCYEQ/,G,;!5#=F89R1^8'X4:C'')]FWHK?OU'S#-70
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MXQFK% !1110 4444 %5=3_Y!=U_UR;^56JKWY0:?<&12R>6=P!P2,4 -O_\
MCW3_ *[Q?^C%JU5>\*"%=ZDCS8^ <<[QC]<58H **** "BBB@ HHHH ****
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M (6CIO\ T /$_P#X*)* .YHKAO\ A:.F_P#0 \3_ /@HDH_X6CIO_0 \3_\
M@HDH [(2 W[Q;%R(E;=W/)X_2IZX,?$C3Q<&[_L3Q'M91&$&E2;P02<D>GS<
M'V/I3_\ A:.F_P#0 \3_ /@HDH [FBN&_P"%HZ;_ - #Q/\ ^"B2C_A:.F_]
M #Q/_P""B2@#N:*X;_A:.F_] #Q/_P""B2C_ (6CIO\ T /$_P#X*)* .YJ"
M]D$5G)(45P!]UNAKC?\ A:.F_P#0 \3_ /@HDIDWQ'T^]A:W71/$<9DX#RZ7
M(JCZGM0!WE%<-_PM'3?^@!XG_P#!1)1_PM'3?^@!XG_\%$E ';N<1L<9P#Q3
M+5Q):0N%"AHU.T=!D=*XIOB?IKJ5_L'Q,,C&3I$G%)%\2M/M84MVT/Q([1*$
M+1Z5(RL1QD'N/>@#NZ*X;_A:.F_] #Q/_P""B2C_ (6CIO\ T /$_P#X*)*
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M  M'3?\ H >)_P#P424 =S17#?\ "T=-_P"@!XG_ /!1)1_PM'3?^@!XG_\
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M0$NFNN#UR<]!VSZU'%\3-+AB6-- \3[5Z?\ $IEH [RBN&_X6CIO_0 \3_\
M@HDH_P"%HZ;_ - #Q/\ ^"B2@#N:*X;_ (6CIO\ T /$_P#X*)*/^%HZ;_T
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M/I9?^E2UZ)0 4444 %%%% %2^_Y=O^NZU;J"YD$?DY17W2JHSV]ZGH ****
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MQGJ<^KV-HT5E]GN!,LBM$Q.5B9U(.[U7D8.<]J+H3@UJ=#_PFNA?\_%S_P"
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M[IA2,'!Y%,5F>@Q>,-!AC$?FW"8S\HM)FZG/4*:?_P )KH7_ #\7/_@#/_\
M$5R$'Q%U@ZQ>:=#X9U.>2WCC=H(+-,QA\D$L9N<X/8=#UJ]_PG7B+_H2=>_\
M!8__ ([0(Z'_ (370O\ GXN?_ &?_P"(J)_%NC&[BF:YG\I4.W%G,26)YR-G
M''KZUSY\<>)_M"L/!VMB$*0R&RCW%NQW>=P/;'XTQ/&'B>VO;ACX3UF:&0[E
M"V* @\?Q&;D8[8'U- '4?\)KH7_/Q<_^ ,__ ,11_P )KH7_ #\7/_@#/_\
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M<O\ -G;G[HZ^U--,3BX[FA_PFNA?\_%S_P" ,_\ \11_PFNA?\_%S_X S_\
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MDR[O;)48ID.I:PLTS37-F\3']TBVK*4'N?,.[MV%4]<\37^F:;YYBM[@/-#
M8S&1D22*G][_ &NG>A5H-V3!TY+4OR>,=!E4+YMP^&5L?9)EZ$'/*]L9QWQC
MFG_\)KH7_/Q<_P#@#/\ _$5Q\GC[Q+)-*5\+:@(A&6BBN+)5'F+R,N)CU(P!
MMZD<UT.D:WKMQ9&>_P#LT;R2.4B-HT;1H&(7<#(<D@ ]NM4ZD5NQ*$GT+_\
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MHUN5@^)'0^)/#$8=2XNY25SR/W9[5O5SXK^(=>$_AA1117.=04444 %1S_\
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M=M\3+R&;X::TGFQ^;&88I%#?=?S$.T9]N?I2^%;VT?6PJW=NS&VN@ )5)/\
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M _E^9_8&G;,XW8.,_G7+4AS2;1UTJG)'EL8_VFW_ .?B'_OX*/M-O_S\0_\
M?P5K?\()X$_Z 6F_K_C3E\ >!V5F70-.*K]X@'C]:CV7F:>W\C),T(+ RQ@K
M][YQQ]:;]IM_^?B'_OX*Z*3PCX3F^V7#Z18M]KXN7Q_K/F#<\_W@#^%4_P#A
M!/ G_0"TW]?\:/9>8>W\C)^TV_\ S\0_]_!3)[FW^SR_Z1#]QO\ EH/2MM?
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M#S&P'7R6*$]ADDX)XYQ@:IX9U2'XHVPM=+V0K-!AB_G0CY5ZR-'@CURAQ[T
M=/XC:R/AG4]@M=QM9-NW1[R,_=/1FE*CZD$4SPNN/"&DG)^:#_V8TFK:;?II
MFK:.@TB6ZBLGF\J(0-*4;.-I%L"6^A!Y'3(JQX<M+B+PKI4$D$B2QPD.C*05
M.X]10!-=!U59HHDDE0@#<<':2-V#]/Y5/"ICLH@Z(DLO[V4)TW&F7-F]S)%;
M26TS1L=[.!A1M((!^I_E2V\11GM(X)4%N?+0/R2@'!^E &CI5L/[0L[OS'W?
M;H8MF?EQLF.<>M=O)J=A#=_9);VW2XQGRFD ;'KBN/TQ2K6H8$%-2A=L]@(Y
M02?;D?G70:AH?A[5;L75_96EQ.  )'Y. <@5R5U>:.BB_=9H2:G81*C27MNJ
MNX129!@L1D#ZXJ6.Y@F.(IHY".R.#6,OAGPW'9-;QZ?:QV[L,A3@;@NT'KU
MXJSI^BZ)HKF6PL[>U:3)+)QNSC)]^@K"R-;LY33M=TG1OB/XQ&IZE:V9E-EY
M?GRA-^(3G&>N,C\Z;:W6C>)?BS*UO-9ZE;#0-C%"LBAOM&<9['!'YU;TFPM)
MO'WBZYO[.WEAE-GY$EQ$K*V(B&VDCUQG%=3;6&E6,SWEK:6EO)(@C:6*-4W*
M"2!Q[D_Y%6].G0E:G+ZAXH_X0[4X-+O(99K"6XB5;V67:EK%)N WL>N"CX]A
MR1QF/Q9X@\/:_HBZ59Z[9RSW-Y:HJVUPIDQYZ9*^X&3^%=C>165[;+%>I#-
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M^"_B&MGIFBV2Z?J26ENZ0%8&24F<A@,;2, YSSP!4JH4X'=4UI8U.&D4'T+
M5G^(=73P_P"'[_5GA,ZVD1D,:MM+<@8SVZUE^!-+MO$4.L:EXCT#2GU"6]C;
M:85FV(;6 JNYAGH<D>I-5*5A1C<Z/SHB<>:F?]X4^N,/AS1A\'!>0:+I@O\
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MN.2OS0<?K^E9ED%E;:)J$CQVV@6;,@RP.U>,X[Q#/3M5W^P+#_H7++_ON/\
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M ,_MS^:__$U)';M&'S<S/N&/F(X]QQ4]% $"6S+&Z&YF8MT8D97Z<5']B?\
MY_;G\U_^)JW10!!%;M&6S<S/D8^<CCWX%>-^$;>VU7QE\0M/N;2$Q+?HKL =
MTOS2\MDD9X[ 5[77SI$UZFM?$YK&:6&0:K!YC0MB3R_-DWA/]HC. .351W%+
M8]4TKPYINAPO%ID)M4<Y81X^8^Y(SW/YFK%_I%IJEC-8Z@ANK69</%+@@\Y!
MZ=017+>!I)#JNLQ02:N=-00^0FKY6=6(.[Y3@@=.< '\#6A\0;;6+OP1?P:#
M]H_M)C'Y7V>38^/,4M@Y'\.>]:JUKF3WL-\-1W^CZ%JNE:)H49TVVO)XXW%Z
M$( //#*Q_7\JRYTO=1\ :?:WNDH=.NAIT5POVL%51I(E&%"ANA&/FXXSG'.[
M\,(!;?#RY@^S36ICGN%:&<Y=&_BR?7.3^-4]86TF^#=K%<64MU$8-*6>"(_-
M.ID@RJ\]2..W6L>IL;.BZ!IWA[3_ +!I<)M[;)8(#G!/4Y/.?K7.ZKX?LH=:
MT;7+/3EFUIM2\H2B7RF==DO!.".PY()XQ4_PWL=3T_PLUOJD-Y"ZW4GV>*[E
M\QT@XV+GV'&*P6L-1/QGTR^NK6_.FFZ"64IGS#&WER^8-N>"Q'Z&M);&:W.J
MU&Z\1#Q)HJOH_P"]/G^7G44)^X,X/EX'X@_A5-="MM9\<7E]KVC1#4;*VMC;
MO)/YQ7<TO/ "_P (QD<=>_'7ZM_R.'ASZ7/_ *+%>=>.-/U.[^+UC-I-M?F2
M&*T-U<6]QY:+!OFW(W/.2 <8/0UG'<N6QW%[IEOJ6GW%A>[Y[:X79(CD?,/3
M@5@>%=.NM DUK2_#FCC^SX+X8VWHC^9K>%CD,K$GYNN>F!CCG1\7PZA<>$=4
MATGSO[0>'$'D/L?=D?=;(P<9JM\'K2*P\/ZK:Q6%S8^7J"AX+IMT@?[-!O)/
M?+9/T-74(@97VK6'^%3K-HD1T^6PV-NO045#P2$"AOPW5TND>'=,\.V+V&DV
M_P!EMRY<A#DD],Y/7H.M9]P$/P)D$B-(ATPAD7JP[@>YK-^&=CJNGZ'>Q:G;
MWUNINR;6&\EWLD6Q< <G SGBBGN.9S/CV3R_BEH%H8A*9;//G'SO-3#N<*83
MNZC/ )_"M3^Q[1/"?AC4 UT9;C4F#QO=SM$-J7##$;L<'*J>1G([<U%XLLX+
MSXL:>)P_[K1C)&\<C1NC"?AE92"#R>A[UR6[5+37=+TJS:_GOIY)W2WU&XD-
MK:E=V)(AO.[Y"Q.1DYXJG"WO="5+[/4W5UN23Q5+;3(6MX)HH(K-7*271=PK
ME,#YBH;=C('%;FH6;27&KZ1,\4OD3>6DA3Y2" R[ESR1D9'?\:JZ3?SS7E^;
M2ZN]+U&VE^S7T=NZ.A<>Y#*W'1@ >QJ::6/2[<!%EGGFD.U2VZ2:0\DEC^9)
MZ ?05T0@W)R;T,)222BEJ8/C<ZC?G1K_ %6>&2:+4+:&-85( !?)Y/T':M+Q
M,^G0V<-S?,JSPRAK(["[>=_"%0$%C[=ZP?%5U?\ VG3+2[%N$-[:S!8LDJ?-
MVX)/7CVKJ=7TYK^W1H&CCO;=_-MIG7(C?U]?RJE!)-10G)W3DSJO!6G1>(M
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M3Q03>#=3MXV;YIVNX#M'N!7;T4.$7T$I-'!'7_$Y4#_A!=5&.XO8.:IZA?\
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MM""NUJ[1HOVJ<%<_,"N6^O%++;M(01<S1X&,(1S[\BIZ* *GV)_^?VY_-?\
MXFI'MF>-%%S,I7JRD9;Z\5/10 455_LRQ_Y\X/\ O@4^.RM8@PCMXTWC:VU0
M,CT- $]%0+96J1O&EO$J/]Y0HP?K3/[,L?\ GS@_[X% %JOGC3KY=+\8^/\
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MK/V2V_YX1_\ ?(IR6\,>=D2+D8.!U%))(+DE9ATBXCO;NYLM;U*R^UR"66*
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M!XKTI#NC5CU(!KPKXAZ!<S^%GF;4=]OIY\U$DBS(<D+M+YY SU(S[FO=(O\
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M.".V:YCQC;O<?"RW"P1<I<I]IDDV"(F_AP"20H!QR3TV]1S6@?&MIG_CV_\
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M "*FC?\ 7A;_ /HM:K:HER_BG11:6=G=RB"[/EWDA1,?NLG(1^?P_&K/AO\
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M5Q3D[F_:WUY+<W]GJ5I;Q7%G/"A^SSM(C;PK Y*J>,],5JYSUK+#E/%7B(@
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MI>_%GPCIUI#=7=U>Q03,R12/I\ZJ[*<, 2@R0>M<;X^NT\4);:-I4$<EPBW
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MP>PR<5+N;<IV]9/BBX^R>%=5N/L\-QY=L[&&92R/QT8#DCZ5J(Z2QK)&P9&
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M%M=QA0K:Q 7 ;NJN".,\X5^*I>(]$N;C7])T>U>:XLPQN_WH%Y&L:8QD$B0
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MW1K&P9U=K:WCA+J,!BJ@9QVSBG!Z"FCF?$6F66L^-=*T[4;=+BTG$0DB?.&
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MBZ@NQ=B&9[=IPA42%3PV"!U4J3[DU[]&W)'T/(J_$_4Q_BK_ ,B8G_80M?\
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MCYE0;2 C8[L2#CT!/IG-M?AEX2CM8$GT:&65459'$L@WL!R?O=S74VUK;V4
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M-+%/XAL'GN'D9%0G+'.2,#@<9'-:/A74=.GU&06=YJ=P9E(*W4; (R !LD\
MD;>..GO7DNFN7;4]#FUW%\4';XL\/$]F_P#:\%=)<W]GIMNLE[<) IYW/W/^
M36-K3VT?BK2/M,)D#Q/'&P_@D,T&T_H:T]:L)]0LUCMFMEE5PP:XB\Q0._'K
MCO3FUR03_K5BBO?D_P"MB3^V-,,@C&H6Q<X 42@GGD58@NK>Z5FMYXY0IVL4
M8'!]*Y(>%]3-S-*8M"4.1@+:]0,8#<9.!N[]ZWO#]K<6FGD7EI:VURTC%UM@
M K#/!X]JSE&*5TRXRDWJB+P[_J=3_P"PE<?S%61KNDEI5_M&V!BQOW2!=N?K
M5/PLDD=IJ*2R^;(-3N,OM"Y^8=A6=J'AK4+IKA4319(99=P6>TR0F02I]23W
MJIJ+J2YA1;4%8Z)-5T^39LO8#O;8OSCD],"L'Q/_ ,C3X/\ ^OV;_P!%&FV>
MA:E;7]D;BTTJ>+<6N)4A"NK#.&'3/..@[4[Q/_R-/@__ *_9O_11HC%*6CZ/
M\F#;:U\OS.BNKRWL8#-=3+%&/XFZ5 NM:6ZAEU&V8'&,2 ]>E&KVD]]ILD%L
M\"3$@HT\?F("#U*]ZYYO#&HFX+I%HJ(_#[;;EADGGCOFHA&+6K*DVMCJ8+NV
MNMWV>XBEV<-Y;AL?7%<OX+)-WXG4?]!ZY)_[Y2M7P]87-C%<K=6=E;L9,(;1
M HD4#@D?XU!X7M[>"36S%(CR2:K.TVTYVL2"!]=NW-:1M%2L0[MHTFUK3$FD
MB>_@1X_OAWVXY([_ $-*-7TTC(O[;&=N?,'6L?5= O[RZNFA&E/!,P(2XMMQ
M'&"2?XB:IKX>U6&YB=K/1KB+S0NT0!6BC]CQT_$U*A!K<;E)/8V=9YU+P\1_
MT$?_ &WFK?;(4[1DXX!KG-?BD>_\.)!+Y175%.0H;*B&4E<>X!&>V<UT$[!;
M>1B&("DD+UZ=JT7\-?,7VF80UW64<++X9NB&;@QR*0!C^+..X_459M-7U">\
MC@FT.ZA0DAYBR[%Z\^I'3\ZXZ :1#8(J3^*(%'!CA+$YR>ZC]16MI=UIEKJ$
M,#W>M/+<S Q"])9<J",#(X]<5LX+L9<S[F_XF_Y%/6O^O"?_ -%M5_PS_P @
MF;_L(7W_ *52U0\3?\BGK7_7A/\ ^BVJ_P"&?^03-_V$+[_TJEKLR_J<V,Z&
M+\3O^14M_P#L)VG_ *,%:+??/UK.^)W_ "*EO_V$[3_T8*T7^\<=2<"O5IZ7
M/.GT.8U/6CJLLFB>'[JY?55D!G:RMQ,UM$KJ')#8!.&Z5!INLWGAX2V?BZ>Z
MA+SR&QN[RV$7G0C8.0F0K9<<'U%2?!]]6E\1+)=&-M)>WU Z?(=OG'_28?-$
MF.^[!&?7TJU\=!J.W3S9W$<=K]ANOMR,5#20>9;;E4M_$3MQC!XK#VLN:YM[
M*-K&Q>_\@^Y_ZXO_ .@FN9T ^*CIFH0:(Z+9SH(RP2,NDOEC+ LZXX*_WAQT
M]>C2-9M(6*V!"/;!8@_4 IA<_I7-^$];\0+HK'1O#D-Y']H=)FFOUA99$ 0C
M&#D?+U'K58GF=N4FA;6YZ#HUM+9:%IUI.%$T%K%$X4Y 94 .#WY%07_VZVUO
M3=2LK$W@MXKB.2-9DC(W^7@_-P?N&L'^WO''_0FV7_@W3_XFJ=[XP\:V4]O;
M_P#"#1W$TX=DCM]1$C87&XD!>!\P_.N%4ZD7>QV>T@]+DL?_  G$.HQWT-M!
M'>R06L=WO,,GFB-'#L!N4 %V! &#QVZ'?\+6NHV6C-!JD86<7,T@;<"75W,F
MXX) .YV&,G@#FN5C\;>+Y3,J?#^X;4(2JR6PN?F6-@2K'Y>A((_"K-AXK\::
MC:"YA\&6RJ7>,K+JBHRLCE&!!7@AE(IN-2>EA)PCK<[Q3A@?>N1W^*(O"6G:
M'!HN%@L6M+AC=P[9?W)12,\@;L'L<"HQKOCDG'_"&V7_ (-T_P#B:Q5^(7C-
M]-&HK\.[AK(Q>>)Q=?*8\9W?<Z8YH4*D.@.4)=2QI.C>+8]+T#1-2D1;#3KJ
M-@ D0,D<;$JK,KDY QT4<CDGJ?0Z\];QEXL%O8W,G@EXY;B?R%22[VHF[;L+
M,5X+$X K0_M[QQ_T)ME_X-T_^)H<*D^@*<(]3?U5+U+_ $>^LK/[6;*Z:62(
M2K&2K0RQ\%N.KBO.KX:]?_%/1[B^M?*U"QT>5W^:)U=&D=">&4#"R8XYR <&
MMJ_\7^--/-LK^"(9I+F0Q11P:D)&9@K.> O]U6/X5@Q:SXNN_B&FI77@:Z@V
M::+2>(SY\N)Y2WFD[?\ 888]CS3BIQT:$W&6J9V6DV^N_P!JZC=ZPB*+F:"4
M,I4$L,)M"*S84  Y)Y)-=57%6_B'Q-=YF'A>WVD8D#ZB%:*=1Q$1MS][:"?<
M^E/_ +>\<?\ 0FV7_@W3_P")I.G4EK8:G!=31$WB'3$U.#3]*\W[3J2727 N
M8@#%F/>NUN02J,.G<&N,TO0?B#8>!)_# %LENUJT$8C$1(W%RV7+@X.X G!]
M@,<[Z^)/&;S/"GA/3FECP7C&M(67/3(VY%'_  DOC/SQ!_PB>G><5W"/^VDW
M8]<;<X]ZI1JI;$\U/N6/B4C'X::T@&6,"# [GS$KKK%G>SC=R<L,@>@[#\J\
M^U75_%%]9G3M1\+V=NEU\L;+J2R$NI#*-NWGY@,^@YKTA 0B@@ @#(':I47%
M693DI.Z*^JWL6FZ+=7TY BMU,K$G' 4FN/M=<9[[2+33]<L-4OKZ,,\4_P"Z
M*)M+E@5[$C:!MSTK9\9P07^B0Z7=SRV]M?7*QRRQIG"JI;'((&2 ,D8YKC/"
M/@V_7Q;KFIVE^DEND@MH+F".*:(!45RK1L,GI&OR$?,IYQ51BGN)R:V.\DOY
MK,?\3+3KJU]75?-C_P"^DS_*K%O=6]XA>VN(IE!P3&X;!]#CH:QIM=U;1+.[
MOKF!9$F)/G17# JZC) MYB-O Y5&/<^]9GAV31FTB./5X(3K<C-*QC9K2Z)D
M;<Q!8J>IZ*QSBDZ2Z#51]3K1_P ?C_\ 7-?YM4M<[JT]QH^NV-A9:FDTU[(J
M+#J8"[5VLYPZ@<  #D,<N!FM62ZO+($ZCIEQ"HZRP_OH\>N5Y ^HK.4)(I23
M.6^*=\UMX0:TAM_M%WJ$R6L,84$DD]@?P'_ J](T#28M"\/V&E0X*6D"1;@,
M;B!RWXG)_&O,O,A\6_%[1[2!UFL=%A-]*<''F'[@]CDJ<'^[7KU;4U:)G-W8
M44459(4444 %%%% !1110 4444 %%%% !7B_@#_DHWQ&_P"PBG_H4U>T5XOX
M _Y*-\1O^PBG_H4U5#XB9;'H]>7_ !(T*^GUXZR=*-]IL.EM"6^U!/L\VYB)
M=G\6T=O?U%>H5PWC[Q1%:07OAR/3K^YNKG3GG:6W0%(8B2I=CG( /4@=ZUE:
MVIG'<[W7_P#D,>%_^PH__I)<UY9\7M"U;Q-XPBLM&L?-NH+2&3SQ.(O*3?+N
M!R1G=Q]-OO7;ZWX7MHM5\.*-1UDB3460EM3F)'^BSG();@\=1V)'>N6\4>(K
M+X>>,Y9+J#5;VUEL8(S-YAG:-C)(0&9VS@X.!GL:Q5KZFKVT.P\16MQ?^&]6
ML[,9N;BSFBA&[;\[(0O/;DCFL/X/Z3)H::MI\UN\4\26WG,\HD,LA5BS9';.
M5 ]%]ZZ74+V'3-.N[^XW>3:PO-)M&3M4$G ^@KFO!T,'BS5=6U$MJUE$\-J\
M2QW3P>8CJSAB$;!^]C/J#6E0B!K'_DEGB3_N+_\ H^>N;^'FA7^DWVN75QI7
M]EV5[)$]I:_:1+L #;NAXR3G\<5</ARW/PW\07'V_5MR?VIA3J,VP[9IP,KN
MP<XYSUYSUJ[X7\51>()+VS.FWVGW>G^6D\-Y&%(+ D8P3V&><=:F%KCGL<O\
M1]%O[KQ!I.K1Z>;K3[5529A=;?+<RKM;8>N/USSTKTOQ9_QZZ5_V%;3_ -&"
MN)\?>(X;..+P_P#8K^>YU!5=7MUPL:+*FYBV1C'MTXZ5M^)O#%M#;::1J&LG
M?J5LA#ZG,V,R#IEN#[T3W'#8Y_XS:+J&OZAHMCI=@;F\^S7#QR?:!%Y.);?<
MV<^F5_X%GM7:VR-':PHXPRQJK#=NP0!GGO\ 6N0\9:A9_#[Q!IFI3)K-_;/9
M7,<I-PUQY.9;<!OG;@9P..I(KL8I5F@CF3.V10ZY&#@C(XJJ>Q,Q]<EJNO&7
MQ+<:/:V4LDUG%')-*SJL:J^2,<Y/0\8J_J_B5M/UB'2;33KB_OGMFNVCBX"1
M!MI8G![\?_KKSZ#5M0UKQ]J6I:*+-;.>RLWN1>APZIAON;>,]>O'2K4K/0AQ
MNM31UZQCM-"DEOI)IM0N;N%D>U&'\_.(UCSTQT'?\<5U?PT_M87WB/\ MK[7
M]M\R#=]J(+;=AQC'\/IWZUYE<ZKK7BB ::NK^#I)'<&,0SSB17'0K[UT'AX?
M$?P\]]*+S0+^:\96EEO7N';Y1@ 8 P,=J51.3]U!3:BO>9E>"O%>CZ1X,T:R
MO;AXY?*+,1$S(@:5P"S 84$^M=4GBK1Y-:_LA+EVN_,,(Q$VPR 9*[\8R!VS
M47PS\!:'KOPMT^2^^W,+^(BYC2]E2.0)*^T%0V,"NPB^&7AV"+RH3J<<?VDW
M95=1F ,QZO\ >^\?6A5VE8;HIZG):7XMT76;[['8W3O,0S)NB95D"G#%"1AL
M>U$JW>A1W5Q!&MSIRAYS"&VR0\%FVD\,IY..,>_0:?B+P=I7AVWT.XTYKU&M
MKV.WA62\DD2..3(=0K$C!P/RJ'6_^1?U/_KSF_\ 0#6U.;G&[,IQY78W]#U(
M:KI27(MY+<AWB:*0J65D8J>5)'4=C6C7G^D>*7TZUO+.UTJZOGM9[JXN&BX"
M+Y[_ )G'/;K]<=Q87L.HZ?;WL!/DSQB1,CG!%8J5S5JQP?Q1T#5-8DT:ZLM/
M%_:61F>\@-QY65.PCN,_=;UQ79W/_)/_  [SG]_I//\ VW@K'\9^++?PY#;V
M3V%[>7&I)+' EJBL<@ '.2/[XZ9I+CPW;KX&T*8:AJQ,DVF C^T9MHW3P@X&
M[ QGC'3C'2LYVN7#8I?&#3[K6M0TS3+/2Q?W+V5R8<3B$POOA'F;CZ>GO74:
M+;3V?A_3K6Y&+B&TBCD&[=\X0 \]^1UKF?&%W#X(\2Z9?"WU?4X$L+II@)FN
M)(EW0Y;+MPHQSSU(KK;"\CU#3;6^B5UBN84F17&& 8 C/OS54["F</\ ";0]
M2T'Q9JUOJMCY-S+;F;SA<^<)D,IV_3'(]3WKT'3/^1VU_P#Z][3_ -JUQ/AG
M4[/Q[XPNY88]8LK>TLS"LJS-;>:PE.[&QLD#T/3TK;T_PQ;/XOUN$ZCK($<%
MJ01J<P8Y\SJ=V3T_"LWOH6MCC_"6AZFOQ(U;7!8FWTQYKV%I#<Y\Z7[5)\VP
M'TPO/]W/>M?XAZ'?ZU;Z.+/33J45M>B6YM!<^3YD>,8SGUIGA#Q);#6;WPH;
M74$NK>YO)DGN!N6:/[5+\V_)).<@D]2#S6WXC\3Q>&4L6>PO;Z:\G\B&"S0,
M[/C/0D>E:I+E,W?F(HO^2(:;\NW_ (E]K\OIRG%)\6-/75=/T:Q:V>X\Z\D
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MZ=<9/:LC6M)TSQWX@DBU"WU/9':12&*56M96(>0*60@ J,M@]>3VKO\ 7_\
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M[*POEUN&&*UGD:.XMGM&F DA^4$J R@A2><@A,<$UU<*2168C7SLH J[MA;
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MIU@-)TBWT^T6X6&V41QJQ1F"@>I//\ZYOX@:%?>(-"MX(K>*<P72SE;R3RU
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MJD*,D]<5#H]2E5Z'/1^ DAFF@OM/O_\ 0TCEO9+34II6C!C8D*N06RV", X
M.><5ST&B:1/?Z+9W)9KBXE<I<17MP\=PFT_-;MDC((VMDX]^P]&T5[T^)K2;
M0=8EDDU"*87)U/?,/W6P %,J58;S_45R-]I[6'CS1XIE@,L6K7"!X+.>-%4Q
M%]J.S%-N6/R+R*E02E9E.3<;HT9/ FA0H7EFU-%'4MJ#@?\ H50:=X2\,:M9
MM<6-UJ,\:R-&66_DR&4X(Z_YZUI^,;&2XLK&]A@6YEL+R.46SOM$ZDA"F?4[
M@ >QJ[=^&]7\)S:AK:06EU#J,T1?3K)3%Y#[=H*EVPV3C<>.>?:M90IQE9K0
MR4IRC=,SO^$(THV8MMVH^6)/,&+U]V<8Y.>GM7(V6F^#;:\U.VO]4^RS17TD
M81-1EC8@8Y?<1ELYR1D<=:]!T?59=0:YAN-,N[">V8+(EQMY))^Z5)S@J16'
MX/\ A_:>*9?&=U/>O";C5I[.11;Q2?( K J74E6^<\CT%$XP44TAPE)MILHP
M:#X+N;XZ?#J]Q)>9($*ZJY<D<D ;JTS\/]%VC#:IGOB_D_\ BJO:S\+;;PQX
M.6:PU21GT9S>VGFVT(9I020)'";F7+'C/IZ"G^'M6O-2&HP:A#:QW>GWC6LI
MM'+1.0 <J6YQSW]**:IRT:";G'6YR^H^#8+/48%M5F9)XI(K=I]2G#BY*.1T
MR-FP,#T/)P>QT3X'T6WTX3WTU_$T<>^=QJ,@1<#+');[HYZ]JT_$=L+J\\/(
M9'CVZJDF4."=L4K8^AQ@^Q-9^M7>I:SK%YX<MA:0Z>#:6]]/(Q,Y2YE$9\I<
M;<@-W^M4Z=.-VT)3G*R1C?8_ !AWCQ!+A3@_\39\_P#H5/72_ SRPQ+KLY>?
M'EJ-6;+9.!CYO7BN^?X/6#ZY;:N=3<7-M%Y4:BQMA%MP1RFS!/)Y-55^"&EQ
MZ;J-BNKW/DW\GFS$VL!<'.?D;9E!["L;Q_E-;2[G-:GX'T6VT:]G+W^8H)'_
M 'U]*4X4GY@#DKZXYQ7;>'+2.UTV[DM%</=:E=S3^60<R>:R$_/T/R#('&<X
MXK@K;Q!J.I^&M8L=5CLS=+H?VP36DA9626(D!@1\K]R.G/%>C>&?^03-_P!A
M"^_]*I:T:C=.)FG*SYCGKWX=:->WTMY/%JDDTMQYY0W?[LR%LYV[L8SVJ])X
M?TJ0N\NE0-*6RS%>2>_?%=7'O-Y;@?<WC<?Z5YO\-YG\=7.HOJ.N:@9;:--T
M-J_D)&QEG!Z ;OD2,YY^\1VX7NQ>H_>EL;;>'=&VKC1[?..<+_\ 7IO_  CN
MD?\ 0'A_[Y'_ ,56 ^JS:7\51X9@UBYN;4S2[X;H;V11;Q.F)",G+M)QGC:/
M7EOB'6[E/B#IWA\ZK-9VEU%;L%@0!W=K@(R[\$J/+W'MR/?%5>-N8GWKV.C?
MP[H[0%/[*A!.0<#G'_?6*J1>'[33M/$%I<ZM:PPY9A:W+;F)YR0#\Q[<>E1?
M$JW7P1H]IJ-EKVJ13/+*@6>0SHY$$C*"I!ZNJ#/;)/O6SI4SWMG8/*,N\,4S
MNK[3NVJV<#D\_A23B]AM26Y:M8;BUM8H3+=2LBX,DA1F8^I))-<IX=T&X\,>
M/Q<&YB2UU 74ZJB*LBR$QYRSL0001P".1T%=T.M<)X3UF3QI\0)+?4],T]M.
MT]KRVB1U\QG=3'EF##&,=,>IHJ))!!MLZRPU!!XSUMUN6!:VM,R*\.3_ *S@
MY./R-<UHVD7-QX@?7&^R-##->0VS6Z'S"&G<MN8MM)W9Z+C^Z<8SU6FZ)H[^
M-M>L6T?3S;QP6LB1FV3:K$2 D#&.PKCO#^MWUEXN/AM[?3ETZ:;4)K4V[,)(
MU2YD&UE^Z.<X [ 5G"U]32=[:&WXCT2;7+"U1%B:XMKE;B+[3'N7<O(R%9>,
M^Y^E3QW=N?AQ9)Y\ BBT3GRG C^:+&/F._& 1P-W/K6T#@@^E>0:=\+;VPO;
M:^@\56),&[RHKFQ65 &))&UFQR235SA?8B$K;GH?BF5[[PI8VD$\,CRS6Z1I
M<[&C)) '"-N/7C.!ZXI^A:3_ &%X>M--@7:( 1B)0!U)/#,?7U)K@=$^%+:=
MXNM-<?Q#9S/%<BX:&&U$88YZ##<?E7JU.$+;BG*^QQ.G:'=^'_',>H2WUL]I
MJ6H27"AH@D\4OD2_*&)VD;2WWL#TYQGJQK#-KNHPR70>,6<3!"T6\_-*#G^'
M'R\;<GKGC%<=9:O<>(_B!%I]_::6VCZ=JLMMMDR\KR"VF*EE.5*\$_7%=BNC
M:7:>+]2?^S+*1[?2;61"]NO#"2<9Z<=!^0]*RE:^AI&]M3CX= FOO&\_B/[3
M:O;6UW)%'&D692YR"Q?.W.7Z#*]/3([63S?EV^9TYVA?ZUPMMKUSHWQ!F\-Q
M66GKIEW?S-#Y;;9(\ Y^3IC*'H.,C/6O0*UA:VAG.]]2MF?_ *;?E'5#7;T6
MFF1QRL0]U(+=0ZY#,QP <=,],^]17NJFXUHZ+:7T-K-&@DGD8@N >BHI[^I[
M?6KEKX?WZC;W,VHW<XMSO$<K!@3S[<?_ %A3F[1;%%7:-6."2TL[>" 3!8XP
MIVA#S[[CU^E4M3>9X[>SD,^+J7#*WE@F-/G?&.^ .N :VZS=6MI)+RUDM[N2
M"=$*8VAT8$ACE3] ,CGK7%=+<ZK7.5O]3W^+2]]#*;+3HA;3N]B)T$LN)9/F
M!VQD#RN6'0D<5K0S:1;Z:=4M_MD%M"#YGV*X2>$C&=Y4$X'7L/Y4_2XKO18[
MC[3IZWDUS)+)/?6#B.9B[EON,1P,@#YB<*.*Q/%=KHNJQ6-AIS0KJEY,L$AN
M4>WN63.68L-I( !&2&!S5WC(FS1KZ'+XAU.RMKS%I=6LZ;S-;.J;?0!6SNXZ
MDE?I5B76;>"1+:XFFM;IG*HES&(FDQR=N[ 8>XI)=&UFVFM8([EIT4"94O(S
M)&C@?=$\>UQP.KJ0<CKTK BU^XU;QA)=W\0DTRPB\MQ%%_:%NK2D%R&C 8?(
MJ@%EP-S9]TZ:8U-G5N[M,#%O.8P2R;#GD^O]*Y&_"^(?B1I6C-^^;3$^WRQ'
M*R(005*X_=L-WE\,?7BMRW;0[N"ZO[*5K.*#!\S2IC.K#D99 #P!@D;>/UK*
M^#D,VJ2Z_P"*[J1IGOKGR()6 &Z).X Z9)Z#CBE&%F.4KH]'E^U?9XMOVG?S
MNVB+=^.3C\J6X^U8B\O[3G;\VP1=??<>OTXJ[16A!E_Z=_T_?]\P?XU/)]J^
MRQ;?M/F9.[:(MWXY./RJ[10!0F^U_N]GVO[@W;!%U]\GK].*B_T[_I^_[Y@_
MQK4HH SW^U^1%M^U[^=V!#GKQG)Q^7XT^Y^U;T\K[3C:,^6(L9]]QZ_3BKM%
M &7_ *=_T_?]\P?XU-+]J\B'9]IWX.[:(L_CDX_*KU% %7S;[_GTA_[_ )_^
M)I\;W+!O,@C7 ^7$N<GTZ<4S^SK;TE_[_/\ XT^.SAB#!-_S#!S(QX_$\4 "
M27)C<M!&KC[JB7(/XXXIGFWW_/I#_P!_S_\ $T];.%(WC7?M?KF1B?SSQ3/[
M.MO27_O\_P#C0 ^*2Y8MYL$: #C;+NR?3H*\B\#+$OCSQ^\,C27#7Z&6)DVK
M&=TO ;)W=^<#I74^*?&UEX-U&2":WC$(AB+3W%Y(H+2&7"@!'.<0L<\=JX+P
M-XHTA_$/BBYOM<TB*VO)8I[<"<1[06ERI=U1G8?+D\]1SS50W)EL>H[[C_G@
MG_?S_P"M574[*75=(O=/E_<I<PM'O1\D9&.XQ67_ ,)7X4\S']L0^7YGE?:/
M-?[/OV[]OG?ZO=MYQNS4O_"4^$XU8CQ%I6-IS_Q,$/'_ 'U6MS,BU:'6(K5-
M4U'Q*T::6S7:L+.,A<1NC$X&3\KOQCTK(T'Q7I>H^(XIUUO^T-0U*W^SP9@:
M$2+&6<_P  C)ZXZ59U;Q)X>U+PQJ5G9:]IT%S/;R1Q)?3B(AROR[DEPP'(/(
MP1ZUS%OK5U_:?AZ;5+S0_L.FPRO<2:;-)=.R+%L+_(IV*#MR1M SCMBH>C5B
M]UJ>JJTQ#;HE!QQA\Y/Y5YYXKNK&T:>VCN[JSEO\)JHLH?-7[,9"I>9L?NN"
M5#=2.QKJ5\4^%$#!?$>D_,,'.HH?_9JYVXN=)CUJY">)[73=-U) ]Y;W$*Q_
M:E' :*=P ZMQNP6XXXJI:DQT,VZ;PSHNI+:Z)KSQ:;<6PCU*&SNC=Q")2%4R
M28/DCDKGT/:O2K5/)MHX8K>**"- L2QOE0 . ..!BN&U:;P\\8C\.^(]-M;B
MXC%F\%HBW9EB(/"Q1Y8D#.."H[BMG2O$GA"TTNUAM_$>F^4D"(OFWB(VT  9
M4D;3[8&/04HJPY.YL:I93:II-Q9L?(:3;M=&#$$,&!Y&.H'%9][IOB+4$A6X
MUYB(9DG3%M$/G0Y7^'UIB^+O"NYHQK$ B+^7]H,CB N%W;1,?DW8(. V:63Q
M3X2CC+_V_I[X_ABO1([>P56+,?8 FFTF)-HMV]CJAU9-1U'43>20V\D$2>6D
M8 =D9L[1_P!,U_6K5_J<.E:=+?7[Q6\,6-S/)QR<#MUR<  <UEIXI\,))-%+
MJ\%I,AV20WTK6T@R ?N2[6Q@CG%4M7\0>%;RP>U3Q @91]H$]@QN6MMA'[PE
M0P0 D<M@<]:>RT#=ZFA/XNTJVTRVU&:]M%M+EQ'#+YQ(=CV "YX[^G?%1ZEX
MLTBUCC@N+M UXBBW:%7E20N6"_.JE1DJV,GL?2N"N]4TSP]J-[?-J.F:_8);
M%;14U&W\^&=E_>2[>,EF]#G'8TS1]3DM[7P^+6XT?[5%!&\T=[(;997_ -)C
M;R\*!*")ACRSC*GUS4.3&HH].T37K/Q%I?\ :&ER)/;ERBL-R@D=1\R@C\JO
M;[C_ )X)_P!_/_K5Q/A37=-T_2)+;4]7TRYU"[O9I1;Z3*;DX;+ !8@6. #D
MX[<FMJ+Q5X1FB25/$6F;74,-VH*IP?4%L@^QYJTR;&AJ&N6&CQ>9JMY9V2D'
M9YUP%WD=AG&?PS4:>(;&71[;4X9DF@NL&W\K<YESV50I8GK\N,C%>:^*+NS?
MQ?'X@L/[%UC3HX#:>5?*P@\XC/%P5,9.#P"_'UK6T'Q)HNBZ5IE_J5YHV^))
MS/96%_%NMA(Y=?+"L,[5PI Y/OWGF97*CN;75DNX998T5!#_ *U9BT31\9^9
M74%>.>15;1_%.D:\A_LS4;*YDV[A%'."^/4J0&';J*P+OQ-H>K2ZNRW\&DR?
M9&M(X-5F$$[2%2RNZ2'(3##&<@@GBN#L6L[[Q)X?U2Y@T#1X=*#2W/\ 9LAN
M&EY4;Y#""L:YQ@L1]XT<S#E1[B&F\LDQ+OSPN_C\\4W?<?\ /!/^_G_UJQQX
MH\*[#&/$>DX)S_R$8_Y[JA3Q7X68Q>9JBVZ3(9(9;LRV\<J@@$H\@57ZC[I/
M6JN38W94EGM9XG0)YD;)\KYZ@CTXK";0]<?2;73CK[^3;/ 8E^S19_=,K(2<
M>J+GUJ0>*O#*LL-OJ]O=RS':L-E(UU(V 2<)'N;& 3G&*(?%GA.2)3_;^GHI
M.2DMX(W4CC!5B&4^Q H:3W&KHP+;Q=IDWB:SGO/$/VV]2273(%^S-$#*[)E.
M$QD%5YZ<GFNZ#3;6S$@/8>9U_2O'TO[D365G)JOAW^SH==%S)>I.2NS+2",O
MM\I7*%B#D-D=<DUZ))XL\)6]O+(WB+3"BJ68)?*[8'/ #$D^PY-3%CD4O&5\
M=+MX[^TEN;;6V1XXOL47GR/%C+93NJ_>S_#Z\URYC\-:);://X5UV5=093"3
M93F]E:)QN<M#@[#GG@<'L:UM3N=#GUQ-3T[Q59Z/J")]DNTOCY4OE9W<+*5=
M&&>#C!SR#3K^^\+6=I%)X?US3[?4+:-C'+:1_:@L8Y?S%A!8)W)^49YI25W<
M:=M#K=&^S+HMN=.6-K0H'A992PD#?,6+$9R2223W-7EDF5=PC7>#PN_C'UQ7
M(^'=3\*Z%H,.FGQ5I%PRY,DHNX8MY))X52 .N./3FK\?B_PLZB,ZQ!%$Y8I+
M/(T4<NUMK>7(^%?!X^4FKN18@/A[6O[ CT0:XXL(XTB1/(BW!5QMYV\]!5NX
MT_5KB6"ZU/5VN19LTD40@1 69&3D@9Z.:C;Q/X5&U8]:M+B1V")%:7)N)')Z
M )&68_@*6'Q5X6GM\0:WI\AE'$+78$A]MK'<#[$ U/*BKLW2T^W/E+NST\SM
M]<4W?<?\\$_[^?\ UJPF\7^$UE%O_;MF02#YBW!:)20V TH.Q20C84L"<=*<
M?$_A)5)/B+2\ 9XU%3_[-57)L6]:\1VGAW3Q=:K,MK#+((8R"[[G8$@?*I(X
M![50TWQ!9>(Y;>UT^X$ZZ?/YEXAWJ%,(!"DD#^/8>,CY36;KH?Q/I^GW/A=X
MI;C3=2ANY$OA+"I41L0/G7/(<$$#H<@\5'X6TN\>36[Z\2VCO=9U**TB%N[E
M%B1<OC(!/R!^3GG YJ)-EQ1(_P -;KQ"_P#;;ZYJMM-?,UPT<=R43:YR@V$?
M*0NT?A3E^#TQC8MXHUD..BBYR#^/:O2QIML  !* .@$S_P"-2+9PI$\8W[7Z
MYD8G\\Y%9EGER_!N<(S_ /"5:V9&/W#=< >QQ2?\*?NO^AEU?_P+/^%>I?8X
M?)\GY]F<_P"L;.?KG-,_LZV])?\ O\_^- 'F4?P<F$1W>*=:W*/E!N<[OJ>U
M))\&YF@7'BK6Q(3RJW6,#Z__ %J]12SA2-T7?M?KF1B?SSQ0;2%H5B._8IR/
MWC9_/.: /+?^%/W7_0RZO_X%G_"G#X.3%"Y\4ZT)!P$%SP>G.:]-_LZV])?^
M_P _^-/%I"(6B&_8QR?WC9_/.: /,#\'IO*##Q1K)DSROVG@#Z__ %J8/AEJ
MUA%<P:=XEU%;^X0/!/<7)=8"C#.!CD$,01]#VKU(VD)A$)W[ <C]XV<_7.:K
M-96@NXHS'*69&(;SGX *Y'7OD?E1<#R3Q3X;\<MI=K9ZFG]KV\$BW2WNF(!/
M;RIG:0A(+]??Z5QFI>-KE;K4'U/4;R/4)+46TD#Z<45SNY<QEAMPN5()&<YK
MZ76SA6%HAOVL<G,C$_GG(JE?>'-&U2.--0TZWO!&24^T+YA7Z%LT[L5CQGPI
MK-GH6@_VQ!IZ>?J\IB$EO$L<:>4O+,N\A5P&/#<XSCUU/">G'1_$EU9ZGK":
MCJ&GP--;1P)MA@BGD+/R,\[AWZ BNEUSX4:;J!D?3+MM-9^3$MM%)$3CC*LN
M?UKBYO!?CSPMI-Y9:?8Z3J<-P@1KFT@2*8C.3N0X##^'&>E-2$T=YJ'B72]+
MAC>[O;2-Y" L?G99LG V@ EN?04^UU2-])DU*(PRVP$DKRI+D?+G<.G48(Q[
M5XY:ZY?:5JTM\MO/IUT5*WFDO$T,-O$0J(80W(((R>,')KI-0UNVT'X7VQNY
MK:2XN9C PTIU90&9F.U<;<[>2".I-6I-DN*.FT3Q]H?B5X?L%RJW"?.T$^8R
M%(P#DC!Y..":ZH/+Y898U+>F_C\\5XU\/7@>?5]7DTMKO1FB8)"JQJSC)$0=
M %7("RDG/\8]J])M)C9Z;::?;:=>:A/'"KR1VFQ?+SQ@DLH'.1@'M1&5]PE'
ML:#V"/()!91(X9GS'*5RQ&"3@8)X'7-1I872+@2*VU %#G))SU+8],]NM12:
MC9KHZZC%!<R[V6-( Y61I"VT)@L &W''6H!XI\/QWS:5=7PL;W(W6UVQC<'C
MC<3@GD=":I.Q-KE>[>^&FSQ00RP3OOB@GV>8N[:2'XSA0?[VWD>]<G+_ &=>
MVXBTV34);2Y%O=W'VNTN+B&XE0G(DVIEMP(X7*Y4<UZ7#'!-;(44A.2N'/KZ
MYIKZ;:.2WEE9"NWS%8[@/K2:<MQII;'">'- U+3XX+ZTO&L;A6DV(;<$*CXR
M-K$X'RJ!GG  -4-7TI[+QAH>H:AJKSW-U?RN%\D*I;RL<X;"\#L*]"?2Y W[
MJ<%&D4E9 ?E7'(!!Z_6LR721J.HV-OJ>CI+;K%,[.Y61(G^4)@GDL>3TXJK)
M"NWH<]XJMDN1:OJ4EVFBP;IKI+,X>0@97+#D*#ST/([5/97^N^)M)CGN=8NX
M[9W,EDIM4BE51]QWZ[F[]@>#BKU]X-U:.7SM&\37,1'2WO8UEB_0 BJ*VGCS
MRMO]G:$\H)#/]MD [8P-O!_^M0[-W8E=*R*NGFYTVUU66.]GU%HC)-->WF""
MRY+(H7&<'=GMDD>N,'P_=ZM%?^(I=,O-:>TN+N<B*Q6*-8;HA3N.]\LN-O'&
M<5Z%!X?O/^$7%I*\*WQM"C!1E/-*G/;D;CZ?A7*Z3H/C[2TN5^PZ#-Y\[39^
MTLFW( Q\JC/3J>:)).RZ!%M7?4BN5\4ZB\&C7<^LS6<DY^W7<]Q%Y4MO@YB$
M8YY^4;L^O%='*]EH=J#!9Q0K)(%6"UC53(YZ   9/]!Z"J7V7Q_C']E:!C_K
M]E_^)JUI>D>)[K5XI=<M],M[2")]@M9FD8R$J ?F QA=XX/\55'ECL3+FEN9
MVHW<DGB72K2;:A2=9XT5"22T5PN&;./X6/ [>_$^N^&[350;]+=8M9@4-:7B
M?ZR*13N0CH#A@.#]*;XG\-^)'UJRN]%EL1;Q>6TAN#AF93)\G0D*P< D'CG'
M?+OLOC_&/[*T#'_7[+_\31S+5,+/2QEP:CXQ;5+:6:3Q&FFV\2I<Q"Y@,UW(
M0077G$:@X.,GBGFX\7?9KV(ZKX@6>YD#V4[-!LLX]WW91N^<A>I'_P!:M$VO
MC\@#^RM X_Z?9?\ XFH;G3O'UQ;20_V;H*;UVEA>2$@?BN*CDA_7_#%\TS)U
M%[;3/!&H/INGP6FEBT\AKHQ@R3*1Y8<*,;NN=S'GKCU]"\/[ETF3R0)#]OO-
MVX[<'[3+D=\X.1GOUXZ5G>)?#=[?^&+VQTR2 7<B*(A,HV A@><@C& >U7M!
MCN9- 8W=LT%S]INF$.XC;F>3;R,;AC'S8YZ]Z<MQ1V-2SDN6N?,$*',@ !EP
M.#CT]<UPWP6$D9U8VUM$T/D1>7*R")IO](NLL<%NAW+DX.$7CO7=V]E$K1*0
M_! /[QA_6L.#1["QOC<V<!MI=OE_N)'C4KEC@JI"GEF.2/XC4N#D5SJ)R&IB
M8_'#?/:Q0L)IO)=%#><39P;U9L@C8-A'R\EV]Z9K";OBQI3^6CSBWM<JT081
MK]L7#!RP()?"<*>&-=?'HNG1ZA+J MMUY*Q=IW=G?)&"06)VY  XQP .PJ9M
M.LWN5N6MHVN% "RD9< '< &Z\, ?KS5>S?+8GVBYKE+XRK)-X2M//MHB/.GW
MC8)B@^S3989*_=7<^>N47 -3>'F1M*MGMT$A2"*(NP*' 1?TYI]UIEI=RO/<
MPO=.5*[)YF=#QC[K':,C(SCH3ZFMBS@B6W2!X/FA15.]B2.!QD$=.GX5*BXL
MIR4D1;Y_^>*_]_/_ *U<GJ^H:1X'\2V7B1]*"R26]S'<&T3YI!NBP3T'4GDX
MR3U)(![GR+?_ )X+_P!]-_C5>\TG2]1B2*^TNSND0ED$\7F;2>N,YQ52NU82
MLG<XT?$JPTF6;QG<V4YT[6H8X[5(F#2*(2X8N. I).  3TS])_!]KI5S:2^(
M=,L(&EU*YN9S=L-LCAIY"!R"1@''&,XSCM6^?#?APD6Q\.:5Y8&\+]E7&>F<
M>OO5^WT^PM($@MK&""%/NQQ JJ]^ #@5$8M.Y4FFBA<7Z0(^^2!'0H'#2CY-
MYPI/ID@@>N*X+X=:3%?^+=2-]X5L1"6O6MVN8D)G_P!(4,6^\ 4.%&!CD\\5
MWLVCVTVJ3S+'&#)%&KA@S [6)&06P>IP<9':J%MX'L+&62:RU'6+661G=WBN
M^6+'+=5.,GDXQD]>@IR3D*+43F+K2[:R^*B&#0+:*-+\B.2WMT"I)]CC)3=N
M& !B3[F<DXSS7?EI-@(C7=W&[^N*I0>%[6&YCN)+W4+F9)?.WSS*Q9MH4Y(4
M'[H ]<#&<5LF*$H%\A,#GJW^-."<584K-G#^(6T+PUK6F>*+G3HQ=Q2N9&A3
M]Y*/*DXSP.IW%CV4U9_X3FPO+(>+(H)FL]8CCTN*(8\R-T:8EF'0+\WKGCWX
MZ&?3--U7>M_IMK=0HP$:3Q[U!&><'OR>:K-X9\-6H-Q'X<TI7C^8,ELH((]#
MVJ)1;=RHM)6.?\/QZ-JYO?$]A:P37%[?EQ<L@WJ/E 4-STR1QCO75LT@QMC4
M\<Y;&/TI\=EI^GV:VUKIUM!;B08BA38H)(&< U9:*%L9@3@8&"P_K6BT5B7J
M8U_IMMJD7EW^F6URHZ>9@D?0XR/PKG_#^NKH<5]&-.U"6P2Y:/SP3(D!4;F5
MFYP &4=?I7:R6\)C8)"@8C"DLW7\ZR/AJ$OM*UQI4";-<ND B)087:HZ'KA<
MGWS6=37<JGH:.FZ]8ZN$.GSP3ML$CQ&0HZ ^JD;AWZ@4_P ^XEGD/D(<'G]Y
MW//I7(:MX@\-W7BS1(;)TL;>>-YWN)K=[;[5@ *H:15WYR#D'/2M(>)O"\$)
M,FN6+2EOFBBN_,D+$XVA%)9CR!@ FN6:Z'3%G0EI=@(B4MW7?T_'%0W5NEY
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MTNYN)5,5XT):$$ $+GN <@X//-=+;>*(==0:Y)J&G/'8VTCI%:2-(S<?,<,
MP'RC P:TB^A$D:C>)M)AGGBNKG[((93"9;I3%$S  _+(?E/7USP>*U8Y$EC6
M2)U=&&593D$>QKR;X@F^M/#NF>&-2U#3K6Y=#.\A=P#+(3N)SG& T@QGHW:J
M'PVTH:/#JUW>ZI<6ZPQ22Q?9)U"7!!PNP<HQ.",$9R:2J!R'M+,$1F;HHR:;
M$H5/ESR2W/7GFLA=2@AMK6QOK^%KX+$MRWW1O('7L"3T'O5V\U;3]/GC@N[E
M87D1G7>#@*N 26QA1R.I'6M+D6+M%<\/&^@OXACT6.[\VYDC,BR1 /$0%W$;
M@>N"#^(I-:\:Z1H<D$<ZWEP\RLRBSMFE("XR3CI]X4^EPZV.BHKG-!\<Z#XC
M6X-E<2H]NP66*XB,;KGH<>G!_*JVJ?$30])OI;6:+4IFBP&DMK-I(\D XW>O
M-'2X=;'43.8T4KC)=5_,@5)6/;:[8:KHMOJ5M(WD3;95#H0V W.1Z\&L-?B?
MHKJ&73M>92,@C3'((I =I17&?\+,T?\ Z!FO_P#@L>M70/&&D^([F>UM6N8+
MF!0[PWENT3[3T8 ]J+@;U9,&BK:$QVVH7B1O+-,T>]2 96+$CY<\,21G/7G-
M:K/"C*KW,"ESA07QN/H/6HX=CS32&6,8.P9)Z#K^O\J&!2&DS"((-;U0,%"B
M3?%NR&+;O]7C/..G0#C/-(VC%I'?^T[\;I1+M#1X &?D'R?=.>>_ YK4^3_G
MM%^9_P *,)_SVB_,_P"% &4-%(4K_:FH')<Y+1Y&X #^#^'&1[DYS37T'>''
M]K:D-T:QY#QC:01\P^3[QQSVY/ XQ3C\;Z$VH&WDO!#;DE8KZ566WE<=460C
M&X<\>Q]*VK+4-.U*$S6&I6=U$#M+P2AP#Z9%"86*+:#&\FZ2_OG3S8Y?+9TV
M_+_#]W.TG!(SV'([Z2.6FE4]%(Q^(S4OR?\ /:+\S_A4,6S[1<?OH^J\Y_V1
M0!+168?$>B+(B2:K;P[\[&G#Q(V#@X9E"GIV-:@\L@$3Q$'D'<>?THO<+$6\
M_:?+XV[-WXYJ2HOD^V_ZZ/\ U77)]:BU.]MM.TV>[GNX8HHERTA)PH]>G;K1
M<">(LRDN,'<<#V[4^JMCJ>F:BI^PZK8W>P#=Y,X?'UQ5OY/^>T7YG_"@!*:[
MB-"[= ,T_P"3_GM%^9_PJ.0IYD<>^)@V<\] ._3UQ0 L:".,*N<>_6FW#F.W
MD=<;E4D9J7Y/^>T7YG_"H;S9]CFQ-&?D/ )_PHZ A9W,: KC)=5Y]"P%5DU?
M3GU"2P%Y#]KC.&A9L-TSQGKU'3.,U8NMGEK^]C/[Q.Y_O#VKA]=\.1S:)=PW
M.E-)J%Y/MEU'3Y3S&\F&9TR,[8^Q!Y'%)MK8:2>YW+A'F12W*?/C]*XCP3K-
MFOA[Q%I4&HVPU2\UV\B@@69?-P[@;PN<D 9;/^S6?J5R/#EC>?V3XBQ:6>GR
M'RYU'F!V 6+J." &(4!1Q]:[#0-!\52^#-/MY]?MK:22Q1& TW]Y#N3IN\P?
M,N<9QU%9RE<TBK'-:7X:T[5;^"?28(8YFNGFAD,2SQ6EHIV1@1OD#S#&7RNT
M\]:T)_@U;W.L+J4FH60=<;(8M)CBC4C!R A!SD9SGN:[/PUHRZ%;C3XI3*(8
MU624H%\QL8''8*H  [#%;U04>?WGPT%Y%*K7&BI))G,Z:! 9,GOEB>?<YJEI
M'P@MM&63R;O3IVE!5VN=)23<,YP1NVXS[5Z;10!YCJOP>M]6,'FWFFVZ1-NV
M6FBPQ!SQ]X@Y(XZ9'4U?B^&D<4$4.[0W2)0B>=H<<A51VRSDXKOZ* /*K/X0
M6MKJMQ*M_;-=L#)YITU%50X9"JHC* ,9ZYSGVKM_"WAF+PS8O )Q/-)L#RB(
M1[@B!%^4$C.%&3W-:B?\A:;_ *X)_P"A-5J@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ J"*16NKA BJ4*Y8=6R.]3U!%*SW5Q&0,1E<
M$=3D9YH GJ"TD66#<J!!O<8'LQ&?QQFIZ@M)6F@WL #O=>/9B/Z4 3T444 %
M%%% !1110 5!>2"*RGD9 ZK&Q*-T;CI4]07DI@LIY5 +)&S 'IP* )Z*** "
MBBB@ HHHH **** "BBB@" 2*;]X]B[A$K;^Y&3Q^GZU/4 E8WSPX&T1*V>^2
M2/Z5/0 4444 %%%% !4%[(L5G([(K@#E6Z&IZ@O)6@M))5 )4< ]* )Z***
M&N<1L2,X!XIEJXDM(75 @:-2%'0<=*>YVHQ'8$TRUD,UI#(P +QJQ Z<B@"6
MBBB@ HHHH **** "BBB@ J!Y%%[#&4!9HW(?N,%>/QS^E3U \K+>PQ #:Z.Q
M/?@K_C0!/1110 5!=2*L:HR;Q*PCV^N>OZ9J>H!*S7S1 #8B!F/?)/'\C0!,
M %  & . *6BB@"":14N+92@8NY 8]5^4G(_+%3U!-*T=Q;( ")'(.>V%)X_*
MIZ "BBB@"I"D%]8;9;>(Q/N!C90RD9(/%<=K/P?\(:LK&"Q;3)3SOL&\M?;Y
M.4_3/O7:V<K3VRR, "2>!TX)%3T ?/\ XK^"?BNX<26>NKK2+PJ7SE9%^7 P
M6)''U_"F:/KMQX+T*VT#Q)X;O=/07233WJQ[XF55  !'0DJO?U]:^@Z9,(S"
M_G!3&!E@PR,4 >46>J6^JZ;?Z9IS07?]I&8Q7'VA$&R4GYRA^8LG0;<YVCWJ
MWK%Y=V6E:Q=@0-#+'_9B3.V"C '>5XYSDY]#'6WJWPS\+>)(H[F;3WLKDQ@+
M+9R&)D!YQ@?*>2>H-<-KWPE\76VF_9="\3M?V<<AE2RO3MPQ.3@\CG)Z;>II
MW%8XRVMAX>U/2M<N[;9;".Z>=[:,,L88#:/E[9+8/IBI3XK;4/M>IVES;YD:
M.TALVC?=Y3@DN91\J'=P0?[H]LSZ]<>)-#TNTL;_ ,.&R2TGC<.T;2VTBQD'
M#%#P,@=SFJEIJB>)_&T5U,NE6P<F4BR.-Z\85PP!(X/OENU;J3TC!F+BM921
M>T@R:!KVNM):W#J;>T(E<83*QG<6<\<$\FM&-K?4HM.L(+J.Y-_=&6XDC+ '
M!W,!W4CJ,_W*FUR&^UU]0T[3M3LH/L$4<US#<@*7W;BH5B?]D'&WTSD'%94>
MGZS=V.NZG9M)-JDX"F1)$WLQ($FT*%4,%!VX ^]6CG9\B(4+KF9IQ^(8].T>
MRT9K6]CN9TN0&6W)VA"[':O4G&,?45TFDZUHUS9645A?P%'B401&0"3:!@#:
M3G/%/\!^'-!N?#<M_!!>>;)<^1&UW<9N[2/<J%0Z$,F>6P#U-97BCX2Z=X:\
M+7,^B@W3K/#(%N8A)=$^8H$<,RX*9Z=#UZBLE6:9HZ2:.HW$<DG%<WX,GQI_
MB#Q9=%I([J>1XMJY/V>$$#;ZYP>/6J^O>*+:?P3=7^G2N9+AC9PJ5*.L[';M
MP>0PY./:NJL_[,\*Z%I^GW5W;6T4,2PJ97"!R ,D9]2<_C6TW=F459&!X >[
M^(,"WWB./1KRRCMR\5M#&?W<C,5 D#$X;"DC'(R#WK>TWP]=W=_J\FEZU/9V
M]I*EK''*//@9T0&5MK'<!N8#Y6 !4\52TO41X8T2_P!4E\/,ME>3/J"SV!1A
M(@XCW*,,,X4YP?O=:NQ:Y9VGP\.G:==PW.MS1%&MV?R9'N)26D.",CYF<YQQ
M7)=W.FRL6=#OGU+2(+N22WD9]WSV[91@&(!&>1D8..V<5?90ZE&&588(]JX[
MP#X<OM#;6;F^M(;#[==;X;&"4/'#&!Q@CC/..@^[[U%K/BK4+GQ7<>%M(L;>
M?9%&MU-+/Y;)YI"X08^8@.I_/TK?FLKLQY;NR.3T_P 4:1;ZG!9'4[FYLM+O
M6NK;3[NU 0_,=SB49SP6(! '/:MSQ-XFT[4-<&IO<W^BZ5]BREU8,&^T3JQV
M))LR /F/RD@G/I6WJGPRT;0]>T:3PK-/I&LW,C1"5<3QB,(3(S1R9'08X(&6
M%<[X:^&-_P"%?B')+?7]O>PB![C,0*Y+,57>AX&?G/&>5K!:LV>B.Y\-37]Q
MX;L)M3S]L>(-)N7:?Q'8UR'CRWUF\\2:7;VTVI0:9*C0%]/F,;-<OQ&)".B9
MV<X/\5>A22+%$\CG"HI8GV%<KX?UB3Q_?6CZ3+>:9%;*UV)WA1@Q!,: J<@@
M_.<<'@=ZVGI&QE#5G5>(M/@_L;1O"RKYT=W-%;OYN"3!&-\A/U5-I]WKF?%=
MQX;\$>)M*""?2[:<.]P8"XMLGA R#*+D[CD 'BM.WN_$0\9W-S<6,.K0Z9!]
ME#V1$+!GP[-L<G)P$! ;M6#JFB3>/-8&K3ZA=6VEQ7B,-,FMAB7R3CYLG(^;
M>#U%8P3OH:RM;4[#<//V[1G9G/X]*X?XFWTW]G6>DV8MI+J[E\WR;E@$>.+Y
MV# D9!V@8[YQ7<@L9]@&1LST]Z\@\=Z[?7'B.WMY-'AFT=I1$MU?6SHL3!]K
M2),O*#(ZCTZ5M-Z&4%J>@:_I6A^'/A>E[KFG6L-ZD0+RVT05XKB5LL8V'(PS
M,0,] !5+X>7M]J>A7%]<:E+?64MU(NGO/&JR^0C%07(QEC@]L^YSQQ.J^+[N
M_NF\+W?B&YMYE)1"8XM0@=G3:H$P ;&'')!(/?BO5-!TY](\/:=ITAC,EK;1
MPL8\[254 D9YQGUJ*:U*J/0H^,O$)\+^%[K54C626/:L:-T+,<#/M4_AO17U
M[0Y-2\3^4ETI^2;3[B2-450?F5E;)')]1UJ75Y]->RN+*]>TE,D>/LLS*2^>
MGR'D\U1U/6(M \%0^'+BPO=->4)8QSR)OB(;AF#KG^'<<'G IU6PIHCM;?7K
M#PD?$#:Q!<6WEM.+>_AVL(LG8/,3N5QU4\FMYG86>^6,!_+!=,Y ..1GO65X
M\O;?4_"EEH^A6=OK<4[ M;Q701?*B /+#T8Q\=^:K>#=,O=!\$6-G?R/)=Q1
MEG$C;MA))V ^@H@VUJ$TNANW5U;VWE">6-3(X5 [ ;CU.,^@!/X5@30Z0+74
MEU#3YIO$+.YLYQ$2_3]WY4@X11QGD=\YS5C5)-6M/$-O?0:?:WNGQ6LD;)("
M6WL>0 #W"J,[3U/X\Q8:E8QZ-J$JQ:AH>K7MT5LX5;,*2,=L2"-LKC/).T'D
M^U$WK9A!:7)O%42ZYXL\+>$6"GSIEN;P!3@H@R1GW 8?\"KVLG S7E'PZ@.N
M?$#Q!XCD/F1V@73K9R,9QRY_0?G7J5QYOE@0_?+ 9]!GD_E6<G=EQ5D1V"G[
M/YK@AYF,A![9Z#\L"K-%%24%%%% !1110! LBF_DCV ,(E8OW();C]/UJ>H%
ME8WTD.!M6-6![Y)8?TJ>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ JI;_\ '_>?5/\ T&K=010LES/(2,2%<8]AB@">JNG?\>A_ZZR?
M^AM5JH;6%H(-C$$[W;CW8G^M $U%%% !1110 4444 %5=2_Y!=W_ -<6_E5J
MH;N%KBSFA4@-(A4$],D4 34444 %%%% !1110 4444 %%%% %5?^0M)_UP7_
M -":K50B%A?-/D;3&$QWR"3_ %J:@ HHHH **** "JFI_P#(.F^G]:MU!>0M
M<6DD2D!F& 3TH GHHHH ;+_JG_W34-A_R#K;_KDG\A4SC<C*.I&*9;1F&UAB
M8@LB*I(Z<"@"6BBB@ HHHH **** "BBB@ JK+_R%+;_KE)_-*M5"\+->13 C
M:B.I'?DK_A0!-1110 55L,O$]P>LSEQ_N]%_0 _C4MP\B19B7<Y( 'U/6I0
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M5&:M9F9?ZO9Z=\4C;'2$C6_C^RVMU;[26:/)DWH.5&XD;N^SVKI;HA;24DX
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3*0?KC/XL *Z)L:K9(VFZM'M++)'/'ME'!R/8CBNRU/1M,UJ#R-3T^VO(\$
M3Q!L9],]/PKB+SX5:3/%GP]J-]HTD4K,# Y92V,8()R1QZU?M.Y/)V&2WWB1
M=<TZ\U&PMM2M;$2,#:/Y4A=AC=M<[20,]Q]ZLCQ)HTOQ%O;F;^T=0T[3?+CM
MC:20JI?:=['Z9(&02#MIT^G?$KPTC.8[+Q':H,GR_P!W-CO\IQG\#5:V^(VE
M&9+?7]/O=$OBH)2ZA8?EP&/Y8]Z:4&Q-R.FUV:YT_P ,W\NFV\DUU%;,((H1
M\V[&!@>W7'M5/X3HVL:++J=]JD^K,\:PRBZC $4F 9(P,#ID YZ_3%:>GWUI
M?Q>=8W\5U#TRCAL'T)'3Z5GS7?B72]"OK*TL[.ZCE238\<ICF5WR68Y!#'))
MQQ55$VM"8-+<=H_A[2ETG5O$UM+<:4MQ-+/$]@_EJ((QM3Y/ND$(7Z=7-1^$
MKFSU+0+>]AO(M0E<L\MR% ;S&)+9'53\W2B_UR*_\+VGAG14GT[4&\N%8[VU
M8JL:#<Q)4[3PO0-GFF^$/#<OAO3KJ.ZNENKR[NGN9YD3:K,V.@[< 5-).]RJ
MC5CH"0.I K 4Z3</J9U;5);35X9W6SC6<QLJ?\LS&F0'W=^#SD<51UW6H!XA
MMX#IL6JV]E&\D\2R_/'(WRJ0JY;(7?VQSU&*HZ9XGTU]+U'4X=2N;-([B1+:
MUO!O15"X50YSEF8'C<3S]*<Y=!0CU(/'$*:E=Z%X9@CCCU'6IH_M3QQ ,8EZ
MEN^ 2S>VRO;(8HX(8X8D"1QJ%11T4 8 KR;P;!)XA^+&HZM<JI71+5;2,J/E
M$SCYRI],;_\ ONO5[@J(2IDV%_D5AU!/ K.;NRXJR&V\11YI&(+2/D$>G85/
M38XUBB2-!A44*/H*=4E!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A_;TNF
ME\V6Y1<E=L0 "KG&2>IK<K..G&*1C!%;.K,6'FKRI/7D=: ':7<F:)X2"#"0
MHRN"5(R./I5^JUE9I9QL!MWN=S%5P/P'I5F@ HHHH **** "BBB@ HHI&8(A
M8] ,F@"JG[W49'_AA4(/J>3_ $JW4-L0T"R"/RS)\Y7OD^OO4U !1110 444
M4 %%%% !1110!%<S"WMI)2,[%)QZ^U):PF"UCC/W@/F/J3R?US23JDKQPLQ!
MR),#OM(/\\5/0 56OM.L=4MC;ZA9V]W >3'/&'7\B*LT4 ><ZE\)?#4>I6M]
MI2W.FWBN5C$$I,8R#DE2?T! K+ET+XD^'<FVN+'Q#:KDA9/W4V.P]/UKU)HG
M>^21@/+C0[?]X_\ UOYU8IIM;":3W/&$^(UG!<"V\2Z+J&BW 8J&N(CM..I5
MNX^F:ZBSUG3;NSFN+'4(;E(TWL!(&*C&>1U'XUW-S:V][;O!=6\4\+C#1RH&
M5A[@\&N \0?!CPMJ\+FPBDTFY)W!K1R$S[IT _W<5:J/J2Z:':#X2T35?#2:
MEJNE_:;B_G^UM+L*2KDY3."#P ./7MS4$_@9;L&/2=5#M;3+)$FI*9FW*0P.
M<AA@C@?SK:T3Q%/ICQ:!XAMTL[Y%\NUF0_N;M0.-I/1L=5/?\*Z@0+<6\?VJ
M)&? )RO0^U1=E6.*^$^D2:/X>OX;LHVHOJ$S73IT9LX!_+%=E+^]U"&/M$ID
M/U/ _K7.^'U:W\1>)-/@N%5UN(K@*PW;5=,8/.>=IYK?C<Q%K@(T_F_>:+MC
MC !_&D,O45!%>02MM60!_P"XWRM^1J>@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ J"YE9/*2/&^20*,^G4_H#3-0NS9
MVX=5W.S;5XSCJ2<>P!-9LE[Y4L=R999FC#9C:';\N1DCT_'- &Y10#D9%% !
M1110 4444 %%%% !114<THA@DE;HBDF@!D31S3RR*GS(?+W>N.?ZU/4%G$8;
M2-7^_C<WU/)J>@ H) &2< 455OR3;>2IPTS",?0]?TS0!);)M1WW[_,<OGV/
M3],5-2 !0 .@XI: "BBB@#*UW3K75[:+3[N%98Y9 3D<J%YW#T/3GWKD&U[7
M?!>KKHUU9W6N:>Z![2YC($ZKG!C.<!RN">#G&.#V[M$9]0DE8$*B!$SWSR3_
M "_*G7EE;:A;-;W<*30MU5A^OL?>@#S;PS,VH>.+_P 3RV]U;)>NUK#%(K1L
M\<2JH+(<<[G/Y5Z;%&L,2QH,*HP*Y^+19X_$EG)+?R7-M:0R&))<EUWE>&;/
MS_=X)&>N2:Z.@".6"*==LL:.OHPS3'@<(BP3-$$X P&!^N>?UJ>B@""6::)^
M+<R1XZHPR/PI([ZWD;;OV/\ W)!M/ZU8IKQI*NV1%8>C#- #J*B:#,RR++(N
M."H;Y2/H?Z5&\EU&['R4ECSQL;# ?0\?K0!9HJM'?0NX1BT;GHLB[35F@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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1;H **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>img10132136_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_10.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (] [\# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;_D.Z?\ ]?,?_H0KW)U.:BZD>UU]QY$86JJ$N]OQ.W_X0+2O^?B\_P"^U_\
MB:/^$"TK_GXO/^^U_P#B:=XZD>/1(2CLI^TJ,J<?PM7GOVJX_P">\O\ WV:^
M<P%+'8NC[55VOD>[C:F#PM7V;HI_,Z:T\/V(\93Z7());:./<-S8;.U3U&/4
MU!XOTFSTFXM4LXRBR(Q;+$YP?>JGARQ75]8\F>>= 8RQ>-\-QCN<UHZWH%O9
MZUIEHMQ<R1W+A7,C@D L!QQ[UV\[I8V$)U6VHZJVCLGKO\SDY%4PDI0II7EH
M^JNUIL5;;P?J%UIR7J36HB=/, 9FSC_OFN?KV6VL8K73DLD9S$B>6"Q&<5PO
MB;PS9:+IL=S;2W#.TPC(D8$8()[ >E8Y=G/MJTJ=5[OW=/7<UQV5>RI*I36R
M][4Y2M/1M#N]:G*0 +&GWY6Z+_B:S*]2\-6Z:?X8@D5<LZ&9\#EB>?Y8%=^:
MXV6$H<T/B;LCCRW"1Q-:T_A2NS*3X?VP0>9?3%NY5 !_6LG7?"/]D6+WB7GF
M(I V,F#R<=<TEQ'XKU"5K@QWJ!CD(K% H] ,BLF^NM61&L[^:[VY!,<[,>G3
MK7+A88QU$WB%+NE;YG1B9850:5!KL]3/HHHKW3Q@J_HEC%J6L6]I,SK'(2"4
M(!X!/?Z50K9\*?\ (S67^\W_ *":PQ<G##SE'=)_D;X:*E6A&6S:_,ZS_A M
M*_Y^+S_OM?\ XFC_ (0+2O\ GXO/^^U_^)J'Q[(\=K9%'927;[IQV%<+]JN/
M^>\O_?9KY_ T,=BJ"K*NU?R/;Q=;!X:LZ3HIV\SI=(T*QG\57VG3J\L$",4R
MV#D,HY(QZFJ?BW3+72M5B@M(RD;0!R"Q/.YAW^@JYX#8MKT[,22;9LD_[RTG
MCW_D.P?]>R_^A-73"K5CF:HRDVN7Y7MO8YITZ;R]U5%)\WSM?:YRU%=MHO@F
M*:TCN=2DD#.-PB0XVCW-7Y?!6CW,1^S2R1L.C*^X9]P:WJ9YA(3<+MVZI:&4
M,GQ,X*5DK]+ZGG5%6]1TZ?3=1DLY1EU. 0/O ]"*['3/ ULELLNI2NTI&3&K
M;53ZGO73B<QP^'IQJ3>DMK=3GH8&O7FX16JWOT.#HKT.Y\$:7<P$V<TD3_PL
M'WJ3[_\ ZZXN+36778M-N@4)N%B?:><%@,C\ZG"YGA\2I.#UCNGN5B,OK8=I
M36^S6Q0HKO;GP#:GRQ:74R_-\YE(;Y?8 #FL7Q3H5KH<=DMNTCM+OWLYZXVX
M^G4U-#-L+7J1ITWJ[].Q5;+,11A*I-:(YRK^CZ8^KZE':(^P,"6?&=H ZX_S
MUJA7>> M/V6]Q?NO+GRD..PY/ZX_*M,RQ7U;#2J+?9>K_JYG@,/]8Q$8/;KZ
M&'K_ (:CT*WBD-_YTDC86/RMO ZG[Q]OSKGZZCQ&+W7M:G%E;R3PVO[H%!D
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MV<X]_:O2Q5:-#,Z5:MHN7_,\_#4I5LOJ4J6KYO\ (\NJ]HW_ "'=/_Z^8_\
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M*$*QV#H>AZ&NWT+74UR*9T@:(1,!AFSG-<SXWU=)YCI8B8/!(KF3/!RN>G_
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M2:Y6] HHHJB0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* /5?^% ^*O^@AHW_?Z7_P"-T?\ "@?%7_00T;_O]+_\;KZ-HKE]K([?80/G
M+_A0/BK_ *"&C?\ ?Z7_ .-T?\*!\5?]!#1O^_TO_P ;KZ-HH]K(/80/G+_A
M0/BK_H(:-_W^E_\ C='_  H'Q5_T$-&_[_2__&Z^C:*/:R#V$#YR_P"% ^*O
M^@AHW_?Z7_XW1_PH'Q5_T$-&_P"_TO\ \;KZ-HH]K(/80/G+_A0/BK_H(:-_
MW^E_^-T?\*!\5?\ 00T;_O\ 2_\ QNOHVBCVL@]A ^<O^% ^*O\ H(:-_P!_
MI?\ XW1_PH'Q5_T$-&_[_2__ !NOHVBCVL@]A ^<O^% ^*O^@AHW_?Z7_P"-
MT?\ "@?%7_00T;_O]+_\;KZ-HH]K(/80/G+_ (4#XJ_Z"&C?]_I?_C='_"@?
M%7_00T;_ +_2_P#QNOHVBCVL@]A ^<O^% ^*O^@AHW_?Z7_XW1_PH'Q5_P!!
M#1O^_P!+_P#&Z^C:*/:R#V$#YR_X4#XJ_P"@AHW_ '^E_P#C='_"@?%7_00T
M;_O]+_\ &Z^C:*/:R#V$#YR_X4#XJ_Z"&C?]_I?_ (W1_P *!\5?]!#1O^_T
MO_QNOHVBCVL@]A ^<O\ A0/BK_H(:-_W^E_^-T?\*!\5?]!#1O\ O]+_ /&Z
M^C:*/:R#V$#YR_X4#XJ_Z"&C?]_I?_C='_"@?%7_ $$-&_[_ $O_ ,;KZ-HH
M]K(/80/G+_A0/BK_ *"&C?\ ?Z7_ .-T?\*!\5?]!#1O^_TO_P ;KZ-HH]K(
M/80/G+_A0/BK_H(:-_W^E_\ C='_  H'Q5_T$-&_[_2__&Z^C:*/:R#V$#YR
M_P"% ^*O^@AHW_?Z7_XW1_PH'Q5_T$-&_P"_TO\ \;KZ-HH]K(/80/G+_A0/
MBK_H(:-_W^E_^-T?\*!\5?\ 00T;_O\ 2_\ QNOHVBCVL@]A ^<O^% ^*O\
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M]!#1O^_TO_QNOHVBCVL@]A ^<O\ A0/BK_H(:-_W^E_^-T?\*!\5?]!#1O\
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M^% ^*O\ H(:-_P!_I?\ XW1_PH'Q5_T$-&_[_2__ !NOHVBCVL@]A ^<O^%
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MTO\ \;KZ-HH]K(/80/G+_A0/BK_H(:-_W^E_^-T?\*!\5?\ 00T;_O\ 2_\
MQNOHVBCVL@]A ^<O^% ^*O\ H(:-_P!_I?\ XW1_PH'Q5_T$-&_[_2__ !NO
MHVBCVL@]A ^<O^% ^*O^@AHW_?Z7_P"-T?\ "@?%7_00T;_O]+_\;KZ-HH]K
M(/80/G+_ (4#XJ_Z"&C?]_I?_C='_"@?%7_00T;_ +_2_P#QNOHVBCVL@]A
M^<O^% ^*O^@AHW_?Z7_XW1_PH'Q5_P!!#1O^_P!+_P#&Z^C:*/:R#V$#YR_X
M4#XJ_P"@AHW_ '^E_P#C='_"@?%7_00T;_O]+_\ &Z^C:*/:R#V$#YR_X4#X
MJ_Z"&C?]_I?_ (W1_P *!\5?]!#1O^_TO_QNOHVBCVL@]A ^<O\ A0/BK_H(
M:-_W^E_^-T?\*!\5?]!#1O\ O]+_ /&Z^C:*/:R#V$ HHHK,V"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK=0TKA03@>I/M0!)144-S#.66-\LO52,$?A4M !1110 4444 %%%% !1110
M456;4+56(,HP#@L < _6K(((!!R#0 4444 %%%% !1110 4444 %%1S3Q6ZA
MI7"@G ]2?:FPW,,Y98WRR]5(P1^% $U%%-DD2)"\C!5'4DT .HJ".]@E<(K_
M #'D!@1GZ9J>@ HHHH **** "BBJS:A:JQ!E&%."P!P#]: +-%5AJ%JS "48
M)P&(."?KTJS0 4444 %%%% !1110 445'-/% H:1PN>!ZGZ4 245%#<PSEA&
M^67JI&"/PJ6@ HHHH ***1F5%+,P51R2>U "T57COK>1U59.6^[D$;OI5B@
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M6J@8Q_;H@5/F^6^T]MN5S_2@">BBB@ HHHH **** *LG_(4M_P#KC)_-*M5
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MM(3!:QQMRX&6/JQY/ZYJ:JVG&9M,M#<2F:<PH9)#"8B[;1D[#RN3_">G2K-
M!1110 4444 02NBW=NIC!9MVUO[O%3U4G_Y"%I_P/^56Z "BBB@"H_[W4HT_
MAA3>?J>!_6K=0VSF5#*T80LQQQR0"0"?P_G4U !17#W=YXD7XE16D6HW"Z(P
M#/$-&=D4A4^3S\8^;+-NZ+C:>:[B@ HHHH *@LG22SB=(Q&I7(4=JGJKIG_(
M-M_]P4 6J*** *B7$<=K<2A @C=\CU()Y_&IX/,^SQF4YD*@M]:I0>7(CP29
M_>7$AP/0-GGVZ?G6C0 4444 %%,EW"%]K;6VG!V[L'Z=ZX[P#>>(KM]3_MZ_
MN+D1R!;<2Z0]E\N3\X+#YMW''5<<]: .TJ!W07L*% 7*.0_H 5R/QR/RJ>JL
MO_(4MO\ KE)_-* 'AT^WNGEC>(E)?U&3Q_GUJ>JJ_P#(6D_ZX+_Z$U6J "BB
MN'UR]\21>/M-MK'4+B/2)"IN(TT9YE7#+\IF' W@L,_P8R: .XHHHH ****
M"BBB@#G=-\2)<^*'\/I9>4L.FPWHE$F1AV*A-N.V.N?PKHJ\]T'_ )*S=?\
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M((E,6[./;.*:=7\4#_F86_\  *+_  J84Y35XE2J1CN=E_PF_A7_ *&'3/\
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M+_;OB<D?\5 W_@'%_A1=!R2.S;QCX6:9)O[<L"$!7S!<+M7..#SU../H:?\
M\)OX5_Z&'3/_  )3_&O.-'\7^(]8MI;L:RT30SRVXS:0L?E;!.=O? XK0_M[
MQ/\ ]# W_@'%_A1="4),[?\ X3?PK_T,.F?^!*?XT?\ ";^%?^AATS_P)3_&
MN(_M[Q/G_D8&Q_UYQ?X4O]O>)O\ H8&_\ XO\*+H?)([;_A-_"O_ $,.F?\
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M"FX1"#$LF%QTS@;L?CFI9+*WED+M'\QZE21GZXJ9(TB0(BA5'0 =* '4444
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M[L9S[U:?X?\ @JYG:232+:6:0Y9FGD9F/J3NR335^''@=R0NAVA(Y.)7X_\
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M'R9=P7RWR>0-IJB+.03?VA]GO-Y;84V'[N=HX]._XTB37TG_ )#5A_U\Q_\
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M#.C7L0C&IZG; $Y-OJ\P+#T.YSQ71"2BK&,DY.YMR_$KPM#=K:27=XMTQ"B
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M8#LUO)&,DD8!=1G!4@XSBMJN3\ Z!;^%?#O]FG4+>[NM[37$T3<,>!N())'
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M"RN8$FB\ >'C&XRI^WW _K5@_P#)0E_[!)_]'5OT<S$J:.<_LFV_Z)_X>_\
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M:K6.CV5V\4FF:C%!<@,UZ]C.8)%8G.6AYC/'4E<GKGFL2,:O>>/-Z))/+I\
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M6VMXH9UCE\QI]B@8S@ *<<]\<4:GI.J0:)J.EZ7%!<VES;RQ0QR2>6T!=2,
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M!Z J:]773[)&#+:0*P.01&,@UY?X^GE@^+W@Z"*5XX;B.<SQHQ"RX4XW#O\
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M@\E3$(HDN(YP>IV':P//4,,CM63JE_K-E81:)B&.2_8)&\%V6?9)PQ,<OSJ
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M[X4TW4ENMK07]U)"#"H@1,$N,J RL?QKT"LCQ#:3W%K;2Q6OVN.WN4FEM?\
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MWAC_ *#=K^9_PKII22;NSGJ)NUCIM#^)V@Z)X=LM+U"*_@N]-TZ 7*/!C;A
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M'2M#L]&6<6<,@:=]\LDCL[R-ZEB2369<>';"UM9KF62,10HTCD:99'"@9/\
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MDY YZ87:OX5V=6E96(>H4444P"BBB@ HHHH **** "BBB@ HHHH **** "O
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M(MO;*-S&4J#M Y/-7/%PB;4M(6>4Q0EE#R+(8RB_;+/)W @K@=\C%;%YX:\
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MG!%;^GZ#:2W::G:ZAJ:0&[>\^PM-^Y6<Y5R4(R&SGO2^(_\ D/>%_P#K_?\
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MHUSJ^LW6K6\!MI9?(LS=1F/>D *+LE/R8+!SG(QQ5S6IXM#\/)J.GZG/;R3
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MC7+6WD=+FVU@!OE52J''/&1Z<<DD]>*&F":.OG;!90N&90 WU./_ *]3 !5
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M%%% !15*ZU%8)3&OE[AC<TDFQ03V[Y/M3[2]6Z)7"AP,_*VY6'J#0!:HHHH
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M4M_%=VUO9R#-NLJ,7*C(W%MV #C(XZ$9%5=-CN;JSDFN)5N$DE+0,/W9\K
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MQ;J=]XE;1M*MK*!8[Y[)KF\=I&++!YI(A7:0O( ;=^%&KT ZF6*9I8_+!"
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MU&(8Y$%O&H4128E^\.N ,@\XXJK)I7QBE;=)?>%7;&,M$2?_ $73?[%^+_\
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M>2.HJDE8#H['7[^Z-S;7>F2V,\2"1O,C+1L#T"2 X8^N!5B[EOX;!GMS;2W
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M?P+U /!>A6DMI;6]O<Q0?,!&E].J@ 9  #\"NJJK<?\ '_9_\#_E0!AO\/\
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M10 5#:O)):0O,-LK(I<8Q@XYXJ:J]C(TNGVTCMN=HE9CZDB@"Q1110 4444
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M@H 6(2^=,TA^0D;%]!BI:BMHC!;1QDY91\Q]3W/YU+0 4444 %%%% !1110
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MI1/%"B;X]C.Z[BN[';(%58)_)OH?)@2%9&".$8X?KR!CMCK0!O4444 %%%%
M!1110 4444 %1SRB"WDE/\*DU)56\_>206XZ.^YO]U>?YX'XT 3P[_)0R8WD
M MCUI]%% !4%TT9189 Q$QV +UZ$G] :GJJ/WNI$_P ,"8_X$W_U@/SH M
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M '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $,]N
ML^T[F1T.5=>HIL=J1*LLTSRNOW<@ +] .]6** "BBB@ HHHH **** "BBB@
MJ*-I&GEW*!&N AQR>,D_R'X4Z600PO(W15)IEH'%K'YC%G(RQ/J: )J*** $
M)"J6)P ,DU%;!#&94# 2G>=W7FBYE\M%7:&,CA I[YZ_IFI0 H  P!P!0 M%
M%% !4%PL<I2!V(+'?@=PI!_+I4]5(/WM]/+_  IB)?YG]3^E %NHKB1XX28T
MWN2% ^IQS[5+5<R.U^L2G"(A9_<DX'\C0!. %    '0"EHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5!<W*VP3(+.YVH@(RQ_&IZS-6LOM+P2MYACCW
M!Q'][!QS^E "QW!.I*\ZJ@9-D15PPSG)_/ _*M%F"J68@ =2:PX["&2XB^S,
M[X=6=S&%50OX=?8?6KFK>9MMPNW89,,&Z$X.W/X_KB@!WVJ&[OX8HIE81@R-
M@]3T ]^I/X5?KGKH:D(5:0$2"3]V<)G/\(&/7C-= N=HW8W8YQ0 M%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !371)$*.H93U!'6G44 0165O#('2/YAP"23CZ9J>BB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>img10132136_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_11.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -W!70# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MII]E\[6NC%82M&2DGUEIVO>S_'5'*:;XAUE9M.N?MEW>^?(!<P-:%8U4GJK
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MB@ HHHH **** "BBJUU?06;PI*2#-((TP,Y8]* +-%%(K!T##H1D4 +1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]KMK?48IIUC,VXPR!V9BC,.A(Q@^HJQX<EN[SQ/JEU<S6\V(8XMUKDQ(<D[
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MT75M1CO+O4#;&Y%E-;VMO;$[077!)9L<G@>E7_"5A=:7X7L[.[B\NXCW[DW
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M0TGPS,0JK:^?)(K9!Q(&VX'_  (5=O-"N_\ A(;C4X(K"Z$Z(@%YG,&T8RN
M>#UQQSWKI**F6(DY.7?]7<J&$A&"AVM^"M^1R=CX;O[:SM()9(7>#53=LZDC
M<F&&<8X.3T_6MJ*PF3Q'<7Y*^3);1Q*,\[E9B?PY%:5%3*M*5[EPP\())=/\
MK&;H5A-INFFWG*E_.E?Y3D89RP_0UI445G*3DVV:PBH145T"BBBD4%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %<]XF)673"#@B\CP?SKH:Y[Q,I>73%'
M4WD8'ZT /O/$%G;)+;/=LMRLPB)\ML E@ "P&!P1^=6H+V(QK']LCVK&#OWK
MDY'3]/Y5Q$FC?;/B$\YDD=DEWF'C8[+&A!/N"V1_NBN_>*4EW"_?79L!Z#L?
M3/)S^'I0!GVGBC2Y;*"0W$K[XU;<+>0@Y'7[M:5EJ-KJ*.UK(7"-M8,A4@XS
MT(![UEVWA;3X[6&-K.U4J@! @7C I=*\,6^DRW3Q3RL9VW@<*(SN9OEP.F&
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M1_V,ZLIRHYW7@ &7'?UH3Q3K;7D=H=<TE;B26")4_L5SDRJ64@B\(( !R?\
M$4 >AT5P4FN^*5N;NW2]T^22V=591HQ4L"Q7< UZ#MR.I SD$9&<-F\0>);>
M(RSZEIL<>YHU9M'.&=6VNH/VW (.1S@?*<$T =_17G<7BS69?)QKVD S6K72
M?\29SE06P!B\.2P1F&,@A<YZ9E7Q#XC-_!9/JNDI/+,T.UM*^ZP*@@XO>?OC
M@9/7B@#OZ*Y/4KGQ5HT5M=W&IZ-<P->VMO)%'I<L3%99XXB0QN& (#YZ'I76
M4 %%%% !1110 4444 %%%% !1110 4444 %87B#_ (^M)_Z_8OYFMVL+Q#_Q
M]:3_ -?L?\S0!DV7_(_S?[[_ /HJ.NSKB[+_ )'^;_??_P!%1UVE !5>]N&M
M[?,2AYG.R)3T+'IGV[GV!JQ6;&_VBY>](W)&3%;KZG.&;\2,9] 3T- $T%LL
M:); [E3YI&Z%G/.?KG)_*FO:212>9;N0QZX[GW'0_H?>K<4?EICJ3RQ]323.
M43Y<;SPH]Z *R:C$C1QW+I$\C^6AW<.W]T9Z-U^7K^1J[7/^*0D&B!D>!+Q9
MD,$DL*O\^?F.#ZIO!/8$TWP=ILMCHZS7#%I[A59CC&1C[Q'8MDL?J!VH Z*B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-'$YVX&W&05P3G"C*Y%.GO=.EDL=3L]!CO[F;SVBEWLTI6*1%!4[226VH>2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)?7L^L708L6*Q@] >C8]@/E'_ O7-=14=O!';6\<$2[8XU"J/0"I* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY=Q5COT68Y(! _Y>O0D?0FD?P[X@D$H?4O#Q$JNKC^Q9OF#@*P_X^NX49^E
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?W@#!GVA1Z]#2:3!#-H]C+LQOMXV_-0: &_VR?\ GTEI&UAR,"UE!R/YU?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&TB$ZUKDNHR*!;0,!&FWOU0'W .X^[+_ ':ZV@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTLX<7)SO\R, @;N.-OH!0!9FU+3;IC%-ODC"G<JS-'SD8.0?8TVVU#2;9/\
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M-^SSCN],4#Q/I;%@)CE>O%<KX>TRSN+S41Y,^U3'@7D(#C@GI@<5O?V%9?\
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MKCC\J+!<Z'6,?V)?YX'V>3_T$U2L"IMW*#"^?+CC'_+1JPM5\0:_<Z3=0Q:
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MN0+9=2>='\I_F\Q70?-C;U*^_P WL:[/Q+JEG:V,UI--LGFA;RUVDY[=<8%
M&GIG_(*L_P#K@G_H(JU7&MXVL["WTRW@B:Y#(B3.ORB'YHU).1SA6=N,_<QW
MS6Q_PEFA_P#/^/\ OV_^% &U16+_ ,)9H?\ S_C_ +]O_A1_PEFA_P#/^/\
MOV_^% &U16+_ ,)9H?\ S_C_ +]O_A1_PEFA_P#/^/\ OV_^% &U16+_ ,);
MH?\ S_C_ +]O_A6C9W]K?VZ3VTP>-R0IP1G!P>#SVH LT5FWNOZ9IUS]GN[H
M1R[0VW8QX.?0>U5_^$LT/_G_ !_W[?\ PH VJ*Q?^$LT/_G_ !_W[?\ PH_X
M2S0_^?\ '_?M_P#"@#:KCO$MI;_V]:SVMK&=11&F\X_WOECB5O\ 9+L#]4^M
M:_\ PEFA_P#/^/\ OV_^%96F7,>NZ^]W$V^V,Q97'0I#\B*1[R-(XX_A% '4
M6=K'964%K%GRX45%SUP!CFIZ** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#E/&@'GZ!_V$HOYUM=.U8OC/_7Z#SC_B91?SK:K2
M!$A"JGJ!^55K?3K.UN9KF"WCCGF_UDBCE^2>?7DFK5%:""BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *;)_JG_W33J;)_JG_P!TT,"GX7+#1X]H
M!)(SGTR<UNMN!4J!C.&^E<=HFN6>FVBPW%S$K!<%"_(.2>< ^HK4/BS2R"/M
M4//^V?\ "L#0IBRBN?'KR2!&:.Q("LN<YE_^L*LW]G+%?SF*S9XY[,P[H$4
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M>2[0.D8#I@G!QZ@5IW.I+?Z'=WZ3$6L:,5V9RVWJ?4]^W.*Q-2QX<W?V#9;
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M;/\ ZX)_Z"*YK7?%^@7.@7\,.IQ/(\#JJ@-R2#[5TNF?\@FS_P"N"?\ H(H
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M0J)M4445F4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^+/\
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M(JW1PBE%RBG'W01C& "!G@G-&H&E_P )OX3_ .AHT7_P81?_ !5'_";^$_\
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M7PGS$XZ\MZ\>F446"YYO!%I$,]U(1K$OFW;3QF3P_>%HU-LL"IGRN=NT'/\
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M I:C/:Z9IMS?3QCRK>)I&P.2 ,X'O65X6@VQ2R,N&C"P,W9Y.7D8?5W(_P"
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M\[_H,?C2;L@1H>$+%[/0(3/_ ,?$V99B>N]B68'Z$D?0"MZF1)Y<2IZ#%/K
MT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q9_R*.K?
M]>DG_H)K8K&\6?\ (HZO_P!>DG_H)H K:!_R+FF?]>D7_H K1K.T#_D7-+_Z
M](O_ $ 5HUNMC,****8!1110 4444 %%%% !1110 4444 %%%% !UIGE1_\
M/-/^^13Z* &>5'_SS3_OD4&*/'^K3_OD4^@]*+ )I$:-:.2H)+L#D=JR]0@6
M+QIH3!F.X3#YCT 1O\:UM'_X\V_ZZ&L3Q-:O>>(]#@CGFA9O.P\+[6&$SP:Y
MRUL=717-)H5S:RQSMJ^ILJ2*2KW.Y2-PSD8Z5K&24.S^;+Y)7"DJO7UZ=/\
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M#W(JS);:N^H7V9;GRF5FAVN%53E=H'KQNYXQT(/!HNPLBS_PE_AG_H8M(_\
M V/_ .*H_P"$O\,_]#%I'_@;'_\ %54N(=:-TT5N;D#S5#2.ZF,PY&-N#NW8
MZD_[7^S4!7Q2L)\H O$DL8#N/G9BVUAP<A?W>"2#C=D9/!S,+(TO^$O\,_\
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M+XT_U^@<C_D)1?SK:K2F1(****T$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7"Z'J4>E1:I::BNN?O+^\*PQ:1<LL:M<S,&22.
M,YW*ZG(8XXQBNZHH \T-_J$UHD,^HZD!'9R01FV\.WT;!BH WL\;A^GW@J'N
M!S@+)=.-*U>WAFU@W%[8S0PN=&O4\F5MVTY6#)'S#YCR-O&<\>E44K!<\UBN
MI8+Y)4N=7:&&X:94;0[T"8,%4AE6$*F%5@  P)8M@'I9_M.**^M)8+?4A%'-
M*\B_V+=C(:7<N,VS<A>."N.@->@T46"YYO;:C+'I<\+)J<3M':@11:3?LKM&
MV92S& 8$BX0X7@#/)-,N=1DDV+;VFHP[RI,@T[42;8!V8H@,'S!@=I.5P">,
M +7I=%%@N><V-U%;^6ES_:UU'$ZB,RZ+?,XC$++M),/)WE3GN%!//6I%<36E
MLJ :I?$1J&CFTJ^B4OY>TGY+?L<G.,G=S@J"?4:*+!<X*TUV:WT.ZT]O[5,[
MEA'=_P!D7Q;#-RQ'D<$ Y R02,9'6LZ6:4V^U+C5R\<?DQC^Q+Y05PX!+&%G
M! 9>YSMY/.:].HHL!YQ;:G=)-9R.=1C%HP8(FBWI$VX@/NVP(!\HP,JW+'T%
M-O;Z635)+NWDUCREF!AA;2M05?+R)6#8A/)E51WPF?4@^DT46"YYO::G=6+F
M/=J=W"89(]\FD:A&RE]A+8\ELG(<]1][ P*M+KA?6[*]EM-41(XPDH73+YQP
M&Z VX.3D=P.N0<"N^HHL!@_\)?IO_/MK7_@CO/\ XU1_PE^F_P#/MK7_ (([
MS_XU6]13 P?^$OTW_GVUK_P1WG_QJC_A+]-_Y]M:_P#!'>?_ !JMZB@#GO"\
MINKSQ#>+!=10W.HJ\/VFVD@9U%K A(610V-RL,X[&NAHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L6R1=2\:3SY#1Z?"(%'
M^VV';\0/+_,_CK7$\=M;R3RMMCC4NQ] *I>#;1H=%^U2@>?>NUS(1ZN<@?@"
M%_X#43?0J)T5%%%9%!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-H90 &&5.#\HKK:* *FEV$>E:39Z="[O%:0) C/]XA5"@G'?BK=%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %9NH:!I6J-ON[&)Y>TJC;(/HZX8?G6E10!S<GAW4;0
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M HHHH **** "JUWI]G?1F.ZMHID/4.@-6:* .6G\#V2L7TVZN=/;^[$^8_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !45S;07<#0W$2R1L,%6&:EHH XG5+*/PJ)K
MZ8O+HS$&==V&4GA<DD?Q$<@\]P3@U6\*>(K34?&FH0Z;')+97,1D6Y(*C<I!
M*X/.096KN;NSMK^V>VN[>*X@?&Z.5 RM@Y&0?<"L'2?!MIHOB%M2LIY!"UN8
M1;/EMA+*<JQ.0..ASUZT =)1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF;_Y%H^V>,/^@%H?_@YF_P#D6@#H**Y_[9XP_P"@%H?_ (.9O_D6C[9XP_Z
M6A_^#F;_ .1: .@HKG_MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.9O\ Y%H
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MF;_Y%H^V>,/^@%H?_@YF_P#D6@#H**Y_[9XP_P"@%H?_ (.9O_D6C[9XP_Z
M6A_^#F;_ .1: .@HKG_MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.9O\ Y%H
MZ"BN?^V>,/\ H!:'_P"#F;_Y%H^V>,/^@%H?_@YF_P#D6@#H**Y_[9XP_P"@
M%H?_ (.9O_D6C[9XP_Z 6A_^#F;_ .1: .@HKG_MGC#_ * 6A_\ @YF_^1:/
MMGC#_H!:'_X.9O\ Y%H Z"BN?^V>,/\ H!:'_P"#F;_Y%H^V>,/^@%H?_@YF
M_P#D6@#H**Y_[9XP_P"@%H?_ (.9O_D6C[9XP_Z 6A_^#F;_ .1: .@HKG_M
MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.9O\ Y%H Z"BN?^V>,/\ H!:'_P"#
MF;_Y%H^V>,/^@%H?_@YF_P#D6@#H**Y_[9XP_P"@%H?_ (.9O_D6C[9XP_Z
M6A_^#F;_ .1: .@HKG_MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.9O\ Y%H
MZ"BN?^V>,/\ H!:'_P"#F;_Y%H^V>,/^@%H?_@YF_P#D6@#H**Y_[9XP_P"@
M%H?_ (.9O_D6C[9XP_Z 6A_^#F;_ .1: .@HKG_MGC#_ * 6A_\ @YF_^1:/
MMGC#_H!:'_X.9O\ Y%H Z"BN?^V>,/\ H!:'_P"#F;_Y%H^V>,/^@%H?_@YF
M_P#D6@#H**Y_[9XP_P"@%H?_ (.9O_D6C[9XP_Z 6A_^#F;_ .1: .@HKG_M
MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.9O\ Y%H Z"BN?^V>,/\ H!:'_P"#
MF;_Y%KH* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q[K69Y+Z
M73](M4N[F J+B267RX8"<':S $E]IW;0.A&2H()2:\UVRQ++I]M>0#_6"TE(
ME4>JJPPWTW ^F:9X;*Q^%HKB1Q%)*LD]Q(3G;(S%G))]#D>V,=JS/ NKVFL1
MWTMAK"W]JK)Y:O>">9>#EW&28]Y!(0] .@Z  WY-<T^+2HM3:XS:2O%&DBJ3
MEI'6-1C&1\S '/3OC%7FD1&56=0S'"@GD_2O/M1L->U&;7M*T>UTQK*+5K:Y
M62YO7C*.OD7#H$6%AAF!.=W5R?:L[5H]:UK4(=7DG\-+$T2PP;-:)CW)+N+*
MQMB<Y(!P1RJ^E 'J+31(A=I$"@;BQ88QZU1?6K.*_OK29C']BM([R:5\",1N
M90#G/;R6)X[CKV\U_P"$?\1/J+6SR: TPN0(+==68F*%-\GD;3;$$CS0<X!P
ML>0<9.QIFF^+?#SW%W]C\/X:Q@LT,NJRA4,;S,I/^C\@^<!M&/N]>> #L]/U
MNQU.TFN87DC2'_6BXA>%H_E#997 (&T@]*CT[Q!I^J2R16[3JR1B7]_;20AT
M)(W*74;AQU'3(]1GBWAUNV\,W^GZG!X>D_M9)8[F[EUR1&F9DV,1_HV. , #
MH !5B:#QSK6G6ZF#PQ-:$0L1%?S;)2DJNV?W!^5@I7&<#/.[I0!WGGQ?)^]3
MY\;?F'S9]/6H+74[*]A26WN8W1RP4YQG:2#P?<&O.V\'>)I//,NC^&V=I-\!
M%_+BW_TAIOD'V<XZ@9&.1GC.!#;>!O$MM-/(-)\-GS((H% OI!M5;B29A_Q[
M\AQ)L(XX'O@ 'H[:K;C5K33EW/)=6TMS&ZX*;(VC4\YZDRKCZ'\4M-:T^^O+
M^TM[@--8.J7 (*A"1D<G@C@C([@CJ#7'6&B>+M/UN/48]+T +&EVJP)J<JJO
MGO"_'^C\8\GGU+D\=*S(_!GC".QD@,6D2-<6\D5UOU)RDKO)YC.%%KD?.7."
MQ^^1[T >GK/"YPDJ,2N_A@?E]?I4%YJ=G8Z5=:G-.OV.VB>:61/G 1 2QXZX
M / KSFX\&>*IKB]FCT_0(_M+R$1F^9D57A\G:1]E^8 8X/RX &.,U+%X4\6P
M:%XGTI++1-FN"3$AU.0>3O@6$D@6P#'Y=W&WKCB@#M[/Q#87TDD40NEEC9 T
M<MK)&V'.%8!E&5_VAP,'-: N8&1G$\956VL0XP#Z'WK@[W1O&U]?+<R6'A\>
M5%%'$JZC-\NV0.Q.8.<[5'08P>N>.:;PEXLT&ZAO!H^DW\'[B-[:.Y=D'EPS
M)O:-+=1@F10-J_+M7C'S* >PM=6Z9W3Q#"[CEQP/7Z4&X@&W,T8W#<,L.1C.
M?RKRW1_!WBRVT"PMGTG05F2.V$DDEZQEV1Q*NSFW8*=P!."<<@=FHL_ /B&W
M6$W&C^&[F2)X"KO?RY"1,[;!FW. =^/P[T >K*P90RD%2,@CH:6N1T>+Q?I.
MEPV(T?0I%B+;6_M>50 6)  ^S'  ('X5>^V>,/\ H!:'_P"#F;_Y%H Z"BN?
M^V>,/^@%H?\ X.9O_D6C[9XP_P"@%H?_ (.9O_D6@#H**Y_[9XP_Z 6A_P#@
MYF_^1:/MGC#_ * 6A_\ @YF_^1: .@HKG_MGC#_H!:'_ .#F;_Y%H^V>,/\
MH!:'_P"#F;_Y%H Z"BN?^V>,/^@%H?\ X.9O_D6C[9XP_P"@%H?_ (.9O_D6
M@#H**Y_[9XP_Z 6A_P#@YF_^1:/MGC#_ * 6A_\ @YF_^1: .@HKG_MGC#_H
M!:'_ .#F;_Y%H^V>,/\ H!:'_P"#F;_Y%H Z"BN?^V>,/^@%H?\ X.9O_D6C
M[9XP_P"@%H?_ (.9O_D6@#H**Y_[9XP_Z 6A_P#@YF_^1:/MGC#_ * 6A_\
M@YF_^1: .@HKG_MGC#_H!:'_ .#F;_Y%H^V>,/\ H!:'_P"#F;_Y%H Z"BN?
M^V>,/^@%H?\ X.9O_D6C[9XP_P"@%H?_ (.9O_D6@#H**Y_[9XP_Z 6A_P#@
MYF_^1:/MGC#_ * 6A_\ @YF_^1: .@HKG_MGC#_H!:'_ .#F;_Y%H^V>,/\
MH!:'_P"#F;_Y%H Z"BN?^V>,/^@%H?\ X.9O_D6C[9XP_P"@%H?_ (.9O_D6
M@#H**Y_[9XP_Z 6A_P#@YF_^1:/MGC#_ * 6A_\ @YF_^1: .@HKG_MGC#_H
M!:'_ .#F;_Y%H^V>,/\ H!:'_P"#F;_Y%H Z"BN?^V>,/^@%H?\ X.9O_D6C
M[9XP_P"@%H?_ (.9O_D6@#H**Y_[9XP_Z 6A_P#@YF_^1:/MGC#_ * 6A_\
M@YF_^1: .@HKG_MGC#_H!:'_ .#F;_Y%H^V>,/\ H!:'_P"#F;_Y%H Z"BN?
M^V>,/^@%H?\ X.9O_D6C[9XP_P"@%H?_ (.9O_D6@#H**Y_[9XP_Z 6A_P#@
MYF_^1:/MGC#_ * 6A_\ @YF_^1: .@HKG_MGC#_H!:'_ .#F;_Y%H^V>,/\
MH!:'_P"#F;_Y%H Z"BN?^V>,/^@%H?\ X.9O_D6C[9XP_P"@%H?_ (.9O_D6
M@#H**Y_[9XP_Z 6A_P#@YF_^1:/MGC#_ * 6A_\ @YF_^1: .@HKG_MGC#_H
M!:'_ .#F;_Y%K<@,S6\37$<<<Y0&1(W+JK8Y 8@$C/? SZ"@"2BBB@ HHHH
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M22.1LES&6(4AB<E6(Y).><4]K[5)E:'3=#>UE<?\?%ZT:QI[[48LQ'7' /\
M>%;M% %+3--33-/%LLKRR$L\L\F-TDC'+,>W)[= , <"L"Y\#QW9D>;4)3*6
M#1LJ8$1PX8J,\$A_7@J.W%=910!BZ+X:M-%NM0GB9IGO+K[5NE +1L8T0X/7
MG9DGWI\/AVRM=)FTZ ;8I7WY95.&XYX ]!6O10!S,O@NUE\1SZPU]>2><JH;
M.9P]O$H:-F$28^3>T2%NN3FNDCC2) D:*B#HJC %.HH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_M!^>WE''_H5=-11R(+LYC^R]7"L/[2DR>YB;C_QZC^R]6V!?[1DZ]?*.?\
MT*NGHI\B"[.-33?$S:G()+Y!8@?NRJ-O)PN,C=Z[^_I5P:9JP<M_:#\]O*;
M_P#'JZ:BCD079QMY9:O"J(-4G#,?,)1"&"(-QQEN22 O_ J[ZV65;6)9W#S!
M '8="V.37/QM)>>(/+5,PQ,$9B<8V@2,1Z_,81^==+63W*6P4444AA1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!1UI0^A:@IS@VT
M@^4X/W3T-<A%I6K[YBFKW>SSY0H<%B!O/&0P'^%=CJ__ "!;['_/O)_Z":HV
M((@DW$$^?+D@8_Y:-515V)LYX:1K00K_ &Q<9]?+;_XJJFH:5XH\J,6&JL6W
M?/YH<?+@]"#UZ5VM%7R(F[.6_LG62P)U>XP.P1N?_'J/[)UK=G^U[CZ>6W7_
M +ZKJ:*?(@NSE1I&LC=_Q.+GG_8;CK_M>]5[+2?$9MV%WJTXE\U\$(>4W?+T
M;^[7944N1!=G*G2-9.,:O<#'^PW/_CU+_9.L[]W]KW&/38W_ ,574T4^1!=G
M*_V1K6TC^V+C)&/]6W_Q5+_9.L[0/[7N,^NQO_BJZFBCD079RW]DZSQ_Q-[C
MC_8;_P"*H&DZU\V=8N#GI^[;@?\ ?5=311R(+LY7^R=9V$?VO<9/?8W_ ,55
M:WTGQ(;BY$^K3K"' @(0Y9=HSGYNN[/X5V=%'(@NSEO[)UDMG^U[CZ;&_P#B
MJ!I.LC.=7N#G_8;C_P >KJ:*.1!=G*_V3K6TC^V+C)[^6?\ XJAM)U@ ?\3B
MX"CK\C=/KNKJJ;)_JG_W32Y$%V<EIECJ^HPB7^V)U.,X$;$8R1_>J[_8&L D
MG6KC!_Z9M_\ %?6M/PN2-'B(&>@/TR:W7)&T 9R<'V%9%GE:Q^*8M6GLS?W,
MR.#) S80A1@=-WKG@]@/4UJKI'BQU7$LR >LXR1_WU6_YB1>+V9U)_T4XP/]
MNM<:A'S^[<?E_C0,\_OK;Q391232SS*$4MGS01T/HWZ59L+;4[RVCF&LW ,L
M:R;>/E!YQ_K,]ZZG6;N*;1;U3&^?(?&<<':>>M8-AX5TR;3K65[6%G>%&8E.
M22!3BKB;L0K8:FT+,-:N3MY)"!CT[ /^E*;#4C$'_MBZ"@XY0H?U<5>_X1'2
MO^?.#_OBN8U;P]]E\26[PV0_LP1;92I&W?\ -U7.3_#VIN-A)FR]AJ<;!CK-
MQSR!@?\ QRN?V>+;6+5O.U49LMTG[XD,4P2H&UB,X'<]:Z34/"=E!I=RXLK=
M=D;,&$9R.#WS2>&=!TV>XN!+96\BI%;L \0;DIDGGIFI&4O[$\8[0!J]OUSG
M][_C2_V+XRR/^)M;]/\ IK_C7HU% 'F5W8^+;)4EEU:W(>5(P,R<%F ]?<4R
MQL?%U]!))'JT&$E>+)\SJC;3W]C^=>C7UA#J$/DW"))'W1T# _@:DM;2"RMD
MM[:&.*)>B(H4#\!0!YK/;>*K:[BMI+_SFD5F"P.RG ZY+,!W%%S_ ,));0R7
M,SW2Q1KN;$JG@?\  _K7:3*&\86P(!'V:3K]5K0U'3XK^QDM70;) 5;!VY!'
MJ* /,=-_X3*4W"7;R&XA<(PBF&T913W;KS5\6_B@*1FZY[F9?_BZ[K2](M],
MAD5/,=Y7WR/+(TC$X ZL2>@%7_+3^XOY4 >;?9_%.W&ZZSZ^<G_Q=0W7_"1V
MEL9II+M8TQN;SE/'3^_ZUZ?Y:?W%_*JFI:=%J-B]JZ#8_P![!*\?4<T <'80
M:]=WES%-?SP-!L^7EL[@3SAL5>&D:R-V=8N#G_8;C_QZK^C6BV6L:M LDL@4
MQ?-+*TC=#W8DUMUI&*:(;=SE/[(ULC_D,W'_ '[/_P 566]KXHL[6:>^U,@+
M(JQ"/?\ ,"P'S9/6N_K'\2_\@<_]=8__ $,4W%6"[*W]@:SNS_;5QTZ>6?\
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M#@'TP3G_  K&6Y:V,?Q00NGL6("B2$DG_KH*UYY(854/@;R% QW)Q_,BN?\
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MFQEVD[0Q%PQQGMT]#^-8&AW=%<1_PG\O_0-M_P#P,;_XU2?\+ ESC^S;?/\
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M<1QJCR$2!=H"D^G/>NEKD+J]&H67BBX@1UC,&#YBX8?NVKKZU@R)!6/XE_Y
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MG=-_Y#FK_P"^G_LU:]9&F?\ (<U?_?3_ -FK7K:.Q#W"BBBJ$%%%% !1110
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M-=8. !7,Z>&O_&-U.>8-/MQ"GH9)"&8_4*JC_@1KIJQD[LM;!1114C"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH YSQ@<1Z-T_Y"L';_>K2K-\7
MAC%HVW/_ "%(,X]/FK2K2F1(****T$%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4V7_5/_ +IIU-<%D8#J010!1\*D-ID:$9PH;/IRU;[@%>0#
MCD"N1&@RJ,)=W<:CHJ3;0/P%+_8<_P#S_P!]_P"!!K+D97,B6TU.UF\82^3<
M12!+8K*$<$QMOZ,!T/M73%8I "55ACC/-<3'X12*ZFNDN]0$\QS(_P!L?)X
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MQ6]6%H_ABSTK4[C4T$AO+A-DCN^XL-V[)]3FMVM8JR)84444P"BBB@ HHHH
M**** "BBB@ HHHH ***9+(D,3RN<(BEF/H!0!F66-0\9S/UCTRW"#_KK)R?Q
M"J!_P*NGK"\(PD:(+UU(EU"1KM\^CGY1[80**W:P;NS1!1112 **** "BBB@
M HHHH **** "BBB@ HHHH *Y+PD,>'H1_MO_ .A&NMKDO"0QX>A_WW_]"-7#
M<F6QN51O=5@L;FV@D25GGD6,;%R%W$@%N>!GC\15ZDVKNW;1GIG%:DBT444
M%%%% !1110!2U'4X=-6 S*[>=*L*[2H^9NG4CTJ[37C23&]%;!R,C.#3J "B
MBB@ HHHH *IWFIVUA-;13EPURXCCVH6YR!SCIU'-7*0@'J : %HHHH ****
M"BBB@"C>ZM:6%W:VL[.);DXC"H6!^9%Y(Z<NO6KU(0#U%+0 4444 %%%% !5
M*[U:ULKR"UF9Q+/C8 A(Y8+R1P.6'6KM)@'M0 M%%% !1110 4444 9\NLV<
M.L0Z4[/]JF 9 $)7!$AZ]!Q$U:%)@9S@9]:6@ HHHH **** "J#ZQ:)JZ:62
M_P!I< @;#MP0Q^]TZ(:OTFT9S@9]<4 +1110 4444 %%%% %./48I=6FTX*W
MG0Q+*QRN,,2!WSV/;^E7*:$0.7"KO(P6QS3J "BBB@ HHHH *H/JT2:Y%I)B
MD,LD)F$@*[0 <$'YMV>1VQSUZU?IGE1^9YFQ=_3=CG\Z 'T444 %%%% !111
M0!0BUBTGU>;2T9_M4()<%"%P AX/0\2+5^DP,YP,^M+0 4R65((7ED("(I9B
M>P%/K%\2EI[&'2XSB349EMN#@A#RY'T0,:3=D"+WA*W:/04NI5Q/?.UW)GKE
MSE1^"[1^%;M(JJB!% "J, #L*6L#0**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH YOQ@,Q:-[:K!_[-6G69XP&8M&Z?\A6#O_O5IUI3(D%9
MEAKEOJ.IWEC%%.KVIPSNH"/R0=ISS@@CM6G2*JK]U0/H*T$+1110 4444 %%
M%% %)-4@DUF72U#>?%"LS'(QM8D#OGL>W]*NTW8H<OM&XC&<<TZ@ HHHH **
M** "J=GJEM?7-S;P,YDMSB0,A 'S,O!/7E&Z5<I, =!0 M%%% !1110 4444
M 4K+5;6_N;FW@9S);'$FY" #N9>">O*-TJ[2  =!2T %%%% !1110 52TO5;
M75[=I[1G9%8*=Z%>2JMW]F%7:  .@ H **** "BBB@ HHHH HZ5J]IK-LUQ9
ML[1JP4[T*G)57Z'V85>H  Z "B@ HHHH **** "J.GZM::HTZVS.3 VU]R%>
M>>F>O3K5ZD  Z"@!:*** "BBB@ HHHH IZ=J4.IQS/ & BF:%MQ'WE.#T)JY
M2*BIG:H&3DX%+0 4444 %%%% #)95AB,C=!5/1]6@UO3([^V21(I"P DVYX.
M.Q([>M7F4,,, 1Z&D1%C7:BA5'8# H =1110 4444 %,FE6W@DF?.R-2[8]
M,T^CK0!3TW4K;5;4W-J7,88I\Z%3D>QYJY2  = !]*6@ K'\2?O].CTU6(?4
M)DM<J<$*Q^<CZ(&-;%9-N%U'QFO&Z/2[<MUZ2R\#_P <#?\ ?53)V0UN=+'&
MD,21QJ%1%"JHZ #H*=116)84444 %%%% !1110 4444 %%%% !1110 4444
M%<EX2_Y%Z'_??_T(UUM<EX2Q_P (_%@DC>_4?[1JX;DRV-RBBBM20HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **RO$FJ7&B^'KS4+6V%U<0J#' 6QYC%@ ,_C6-JOC>.TM?#4]E;?:1K5S
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M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_7_>-=;7)>$O^1>A_P!]_P#T(U<-R9;&Y1116I(4444 %%%% !1110 4444
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MA"$CV^9)\@4#&<DL^, 9QD\U#)?0KHR8TW34L$2-VMG@PL3M)Y;C!P 5;=U
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ME?:#P"UI<DX].2371U@:\H76/"JJ  -3< #M_H=S6_0@"BBBF 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4C,%4LQP ,DTM9'B260:0U
MK VVXO76UB/H7.,_@,G\*3=D!/X1C$NG3ZJ1^\U&=I\]?D!VQCZ;0#^)KH:B
MMK>*TM8;:! D4*+&BCHJ@8 J6L#0**** "BBB@ HHHH **** "BBB@ HHHH
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M_.M?^#R\_P#CM'_"(:;_ ,_.M?\ @\O/_CM;U%.P&#_PB&F_\_.M?^#R\_\
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M&,82%Y"0N,G" X^\.OK6%X/N(F\-V[B0 ,SL-W!P6)'!JX;DRV.@HIGG1?\
M/1/^^A5"[NKM;J,6HB>$E-[&51@;QNP,<_+]/SK2Y)I44SSHO^>B?]]"CSHO
M^>B?]]"F ^BF>=%_ST3_ +Z%'G1?\]$_[Z% #Z*9YT7_ #T3_OH4>=%_ST3_
M +Z% #Z*RM3N[^,C^STBE^0YW3*N#AL8R#DYV^WO6EYT7_/1/^^A2N ^BF>=
M%_ST3_OH4>=%_P ]$_[Z%,!]%,\Z+_GHG_?0H\Z+_GHG_?0H ?13/.B_YZ)_
MWT*I7ES=+=VHM!#)"2?/+2A=HRO(X.3C=QQ]>E%P-"BF>=%_ST3_ +Z%'G1?
M\]$_[Z% #Z*9YT7_ #T3_OH4>=%_ST3_ +Z% #Z*9YT7_/1/^^A2&:+'^L3_
M +Z% &0?$L)N)X8K"_F,+E&:.)2I.2O&6]0:C7Q?8;BDEM?QN&VL#:LVTY8<
ME<@?=;OVKG4N+^TO3=6DK?9([EVNXTBC;>@>0CECGJ,?+D_-[<]CX-LWMM&,
MDIW2S2$LQZG "DG/J5+?\"K+G97*BI_PE6F_W;O_ ,!G_P */^$JTWTN_P#P
M&?\ PKK**.=ARHY/_A*]-_NW?_@,_P#A1_PE>F^EW_X#/_A7644<[#E1R?\
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MS>I<=B>BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 'X?_"C_ (2[1?\ GY?_ +\/_A1=!8W**P_^$OT7_GY?_OP_^%'_  EVB_\
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MQU./F P?SI^E>)K?5)A$;2YM"T9EC-P8\2)QR-CMC[PX.#1=!8VZ*C^T0?\
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MR7X8Z"]K)!$]U;E_^6L3(''T)4XST/J*Z^W@CM;:*WA4+%$@1%'8 8 J2B@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH@HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!BZKX3T/6I/-OM.B>;.3*F4<]!R5P3P.]<CJ?PEM9 SZ9J$
MD3=1'.H=?ID8(_6O2** /"+SPAXK\.R-/;03EE'$UBY;^7S8^HJUIWQ*\0Z<
M?*NFCO%7@K.F''XC'ZYKVVL[4M!TK5Q_I]A!.V,!V7YA]&'- '):=\3="O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH AN;
M6"\@:"XC$D;=0?T/L?>O(O'6CZMI44UO)=N^A2R V\<; ,)-I&&/4=2?E&#C
MGDD@HH ]<LE*6%NK$EA$H))R2<5/110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!%<VMO>0F&Z@BGB/5)$# _@:Y/4_AGX?ORTD$4EE*>\#?
M*?\ @)R/RQ110!Q6L_#'5=-5I[&XBNXE/3/EN,\=#Q^M9_@/2VOO'$,=SDFU
M+7#ACDDJ>.?]XBBB@#W:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
(H **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>img10132136_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_12.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !, /,# 2(  A$! Q$!_\0
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M77^U_#_S#_C^?O\ ].\U '&/\:+6-&=_"'BE4499FL< #U/-*/C/;, 1X/\
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I44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>img10132136_13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_13.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %U!3T# 2(  A$! Q$!_\0
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MPF7AW_H*P?K_ (4 ;M%87_"9>'?^@K!^O^%'_"9>'?\ H*P?K_A0!NT5A?\
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M!^O^%'_"9>'?^@M!^O\ A0!NT5A?\)EX=_Z"T'Z_X4?\)EX=_P"@M;_F?\*
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MB8ZI*IC:-&P/LI(&0/7FO2_!>FV;>'8+6[T^V>>V54,CP+EU*AE;..>"/Q%
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MSUW9QGM4O_"OM9^T2S_\)R-\B!&'V"/&!GH-W!Y/-;WVCX?_ //UH7_?Z/\
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M'F%/+_X\XL8SGINQGWJ$>!;H6\, ^(<>R*02*?LT><@YY.[D<]*]-_L;2_\
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MW=8\2#4_"&KHVGPAY8MF#D*6,;-SN4$D*HY (.1@U6^&31W-WJ*M;QJH4G8
M"H(N9\8^A'% 'I=%%% !1110 4444 %1W'_'M+_N'^525'<?\>TO^X?Y4 <I
MX _X\+__ *[1?^D\5=?7(> /^/"__P"NT7_I/%77T %%%% !1110 4444 9'
MBG_D4]6_Z])?_0347A+_ ) *_P#7>7_T,U+XI_Y%/5O^O27_ -!-1>$O^0"O
M_7>7_P!#- &Y1110 4444 %%%% !1110 4444 %%%% 'G,W_ "5BU_Z^I?\
MTEBKT:O.9O\ DK%K_P!?4O\ Z2Q5Z-0 4444 %%%% !7AOBK2FU/XI:WLN&A
M>..T0<MM_>-'&20I&2-V>O:O<J\=U61$^*FO[W5<_P!G8R<?\MH: -+_ (5'
M/_T,+?\ ?F3_ ..T?\*CG_Z&%O\ OS)_\=KTHW=NK.IGB!3E@7'R_6G+/"Z;
MUE0KC.0PQB@#R&_\$KX=U;2H[NZEU2*^E>$01^9$VX(6&")#W'Y9JAJ.DR:%
M)>VD,TKRB]B7#2LRC_CW<*-Q/ 9CBN^\9WKVNL>'9K2$7=S'-.\=NKA3(1"W
M&3TK@9]7N=<DGO[NP:QFDU*/-NSABN!; <CUQFACB[-,]E6[N?LAE-A)Y@;'
ME;UR1ZYZ4?:[G[*)?L$GF;L>5O7./7.<5<HI6?<OGC_*OQ_S*;7=R+59182&
M0G!BWKD#USG%,N;JZ%AOCL9#*ZD%-ZY3W/:K]-D_U;_0T6?<%./\J_'_ #/.
MO F__A =6\W_ %G\7U^SQYKM;"YAM=$TTS.$$D44:DCJQ48%<;X*_P"1(UK_
M 'C_ .B(ZTKR^>33+327A589;*-DN,G(D"%EQ@8R"H/)'MG%,AN[N=E17'Q^
M.8QHPO)K9HY (05ES'N9E+-C<.P!QZ\58N=?U.9=773K:V?[+&3"[O(-YV@Y
MSLV]#V)H$:FI74-WX?U%X'#JL4J$@?Q $$?G7E/BK=\VRY%LWVK2L3$ A/W4
MO.#Q7I,$$EMX#,4RQK(+)BWEL6!)4DG) ZUYOXI&[(^S"YS=:5^Y.,/^ZEXY
MXH [[P#G^R;[<X<_;I,L!C=TYKJZY/P!_P @F^^3R_\ 3I/D_N\#BNLH :Z+
M(I5U#*>Q%0>1)%S;R<?\\WY'X'J*LT4 5UNE#!)E,3'INZ'Z&K%(RJZE6 (/
M4$57^SO%S;R;1_<;E3_A0!9HJN+H(0LZ&(]B>5/XU8SD9% !1110 5PGQ>G$
M/P^N(SC$]S!%@]_WBG^E=W7E7QVOHT\+Z=8+,!/-J,+;01N"C/./J10!Z%_P
MC>A?] 73O_ 5/\*X_P"&>A:1<^#(Y)]*L97^V70W/;HQP)W Y(]*ZG^Q]3_Z
M&;4/^_%O_P#&ZY'X:Z9?S>#8WBUZ]@7[7=#8D4!&1.^3\R$\]: -VS\/Z*?%
M>JQG2+ HMM;%5-LF 29<X&/84:WX?T5+W0PNCZ>H;4-K 6R#(\F4X/'L*BL]
M)U$^*M54>(KX,+:V)?R8,MS+Q_J\<?UHUK2=16\T0-XBOG+7^ 3#!\I\F7D8
MC_GZT 1^.] T:#P!X@EATFPCD2PF972V0%3L/(('%:6B>'=$?0=.9M&T]F-K
M$23:H23M'M6/XZTK4(_ 6OO)XAOI46PF)C:& !AL/!Q&#^1K3T72-2;0M/9?
M$=^@-M&0HAM\#Y1QS'0!B>!-"TB>;Q3YNE6,GEZ[<(F^W0[5 3 '' ]JI>/[
M71]&^UO%I5@LLNFF&$"W0?O'E50>G4 D_A5CP+I=_+-XH\O7KV+9KMPK%8H#
MO.$^8YC//TP*RO%FF3S_ !(T*UN]6FO;:WMI+RZ69(UV(A!'W%'!Y'/K0!4;
M18I[[2=+DB62TT,69F1U!5IYITR".GW=WYUZ5J7AW0UTN[9=&T\$0N01:IQ\
MI]JXC3])OKGPQ_;K:I=6\NKZI;W31+'$0%,Z"/ED)X7:<9QFNQU'2-2&EW9/
MB2_8"%^#!;\_*?\ IG52>HH[&3\/-!T>X^'7A^:;2;&25[&(L[VR$L=O4DCF
MJWAK0M(D\?>,XI-*L6CBEM!&C6Z$)F')P,<5)\/=+U"7X>>'Y(]?O84:QB*Q
MI# 0HV] 3&3^9JMX;TN_?QYXR1=>O4=);3=((H"9,P\9!CP,=. *D9N7WA_1
M5\4:.@TBP"-%<%E%LF#@)C/%'BKP_HL7A35)(](L$=;9R&6V0$''TJ&^TG41
MXGTA3XBOBQBN,,88,KPG3]WBE\4Z3J*>%=49_$5](HMG)1H8 &XZ<1YH W?^
M$;T+_H"Z=_X"I_A7'_#+0M(N?!44D^E6,LAN[H;GMT8X$[@<D>E=3_8^I_\
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MTL!HO,9V4]2C#UX +8Z=ZM17\<&+:+2(TNXYI%,2N-JDH'9@?<,/Q-5)-?\
M#TN[?87+;M^[,/7?][OWJYHRZ#K^F.UE#(8HKAT?>65Q(.&R<YZ8'7I0!SGB
MG7]);PSJ\(TSGR(HTZ D.F0?^ ;Q^='P]L;9=7OG6(!H0ZI@D8'VB:M3QO;:
M'I^@3":T7[1=J;6V"+R9"H"CV'R+^54OAZ0VIZF001\_(.1_Q\34 >@4444
M%%%% !1110 5'<?\>TO^X?Y5)4=Q_P >TO\ N'^5 '*> /\ CPO_ /KM%_Z3
MQ5U]<AX _P"/"_\ ^NT7_I/%77T %%%% !1110 4444 9'BG_D4]6_Z])?\
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MH/\ "N>\9^";3QI:PA[N6WEASLEB;@C(.".A&5!_"FE<3*_]L?$#_H4]+_\
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M._)^X?RJSX>_Y%K2O^O.'_T 4SQ/_P BKJ__ %YS?^@&G^'O^1:TK_KSA_\
M0!0!I4444 %%%9^JZI_9B0;;=[B6>3RTC1@,G!/4\=!0!H45RY\8 $C["G_@
M;#_\51_PF(_Y\4_\#8?_ (J@#J**Y?\ X3$?\^*?^!L/_P 51_PF(_Y\4_\
M V'_ .*H ZBBN7_X3$?\^*?^!L/_ ,51_P )B/\ GQ3_ ,#8?_BJ -\?\A)O
M^N0_G5FN3_X2O_2#-]CCP4VX^VQ>N?[U2?\ "8C_ )\4_P# V'_XJ@#J**Y<
M>,,G L4S_P!?L/\ \53YO%<EO*8IM-$<@ZJ]Y$"/UH Z6BN7_P"$Q'_/BG_@
M;#_\51_PF(_Y\4_\#8?_ (J@#J**Y?\ X3$?\^*?^!L/_P 51_PF(_Y\4_\
M V'_ .*H ZBBN;E\52P%1-IOEEE#*&O(AD'OUJ/_ (3$?\^*?^!L/_Q5 '44
M5R__  F(_P"?%/\ P-A_^*H_X3$?\^*?^!L/_P 50!T4ELCMO&4D_OIP?_KT
MSS)X?]:GF)_?0<_B/\*P/^$Q'_/BG_@;#_\ %4?\)B/^?%/_  -A_P#BJ .E
MCE25=T;!A[4^N1D\41NV\6*I)_?2^A!_]"YI\7B]PC>;:PL0>,7D0)^OS4 =
M717+_P#"8C_GQ3_P-A_^*JWI_B/[;?06SV31"</Y<JS)(I*C)'RF@#=HHHH
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M!\G_ ($2?_%5%IW@O5]*L(;&R\7WL=M"NV-/LL)P/J5JU_PC?B'_ *'.]_\
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MA_3>!_QZQ?\ H J34M'TW6+<P:E8V]U$1C;-&&_+TKD+SX8VJ3?:-&U.\LW
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M0%'YD5Y/HIC:ZD,5ZUXAU:;$S,"3_HK>G%>R:*8Y-$T]<JS);Q$CJ5.P8^E
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MO_(6\0?]?R?^D\55O"MC%ILVLV<!8QQ7BJI8Y)_<1=35G1?^0MX@_P"OY/\
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M:C<OIMHY2-.+J=3]P'^!3_>(_(?45I0PQV\"0PHJ1H JJHX H > %    '
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MMG%O)_I4WW3Z>GTJY4<__'O+_N'^5 '(^#HS+YVV1X\6MK]S']P^M=3]E?\
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MIZ-<+':WEM$LJ[D#>8A('WE/&#0!VE1W'_'M+_N'^5<A]E\:_P#/XW_?</\
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M^$BTKRA8.F_[6F-WF*<9SUJIH$W@86EUY[>']WVZY*[Q#G;YK;<9[8QBAIO
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M/2/^@79?^ Z?X4?V'I'_ $"[+_P'3_"K]% %#^P](_Z!=E_X#I_A1_8>D?\
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M6E?]></_ * *9XG_ .15U?\ Z\YO_0#3_#W_ "+6E?\ 7G#_ .@"@#2HHHH
M*Y[Q5UTW_KNW_HIZZ&N>\5==-_Z[M_Z*>@"_X>_Y%K2O^O.'_P! %:59OA[_
M )%K2O\ KSA_] %:5 !1110 4444 5A_R$F_ZY#^=6:K#_D)-_UR'\ZLT 9G
MB+_D6M4_Z])?_035+PK]S4?^OG_VFE7?$7_(M:I_UZ2_^@FJ7A7[FH_]?/\
M[32@#H**** "HY_^/>7_ '#_ "J2HY_^/>7_ '#_ "H Y3P1_P MO^O2U_\
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M5KH7LVC:FX>\@SMD_P">@&#_ "(.??U!H T_[!T?_H$V/_@.G^%']@Z/_P!
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M^KW;R@G_ )Y@D#Z9.X_C7?T %%%% !1110 4444 <-\4/^0+IO\ V$8?YUW
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M-9V4X5S# D3<<$JH']* +M%5O(EAY@DRO_/-^1^!ZBG+=+N"2J8G/0-T/T-
M$]<]XJZZ;_UW;_T4]=#7/>*NNF_]=V_]%/0!?\/?\BUI7_7G#_Z *TJS?#W_
M "+6E?\ 7G#_ .@"M*@ HHHH **** *P_P"0DW_7(?SJS58?\A)O^N0_G5F@
M#,\1?\BUJG_7I+_Z":I>%?N:C_U\_P#M-*N^(O\ D6M4_P"O27_T$U2\*_<U
M'_KY_P#::4 =!1110 5'/_Q[R_[A_E4E1S_\>\O^X?Y4 <IX(_Y;?]>EK_Z
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M^VF'^R=%\KR]WF_VA)C=G[OKGO0![%D>HHR/45XP-6C^S0R?V'HWF/*$>/\
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M'_QZC^U_%W_0,/\ X"C_ ./4 =G17&?VOXN_Z!A_\!1_\>H_M?Q=_P! P_\
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M3"1 ^XC"UZU7F_PHA-ZFL^()$V_;+GRH1C&V-!P/UQ_P&O2*& 4444 %%%%
M!1110 5#=W4=E9SW4S!8H4:1R>P R:FKB_B9/<3>'X-!LG"WNM7"V<9(SM0\
MNQ'H%!S]: .<\%M>IX3UGQ/M7[=K=TQC5\@_,VQ /Q/Z5U,.D06%YH^D>9YL
MB?Z3<2MU<1C"#V&X@@?[-3VVFQV=QH6A1 >1I\/GOCIE1L7]68_@*MZ9$FHZ
MGJ=_(H9/,%K#G^[']XCZN6_(4 ;E%5O*GA_U3^8G]R0\_@?\:<ETC-L<&.3^
MZ_&?IZT 3T444 %<5%_Q._BM-)]ZWT*S$8]//FY/XA0/S-=A=7$=G:37,K!8
MXD+L3V &:Y3X;VTA\-/K%P,7.L7$E\^>H5C\@_!0.* .PKA_BIJ$MOX2.G6N
M3=:G*MK&H&203SQ^0_&NXKSG4O\ BHOC%I]CC?:Z) ;F7C(\T_=!]#R#^% '
M<Z/IT>D:-9Z=#_J[:%8A^ Q5VBB@ HHHH **** "BBB@#AOBA_R!=-_[",/\
MZ[@?='TKA_BA_P @73?^PC#_ #KN!]T?2@"EK7_(#O\ _KWD_P#034UA_P @
MZU_ZY)_(5#K7_(#O_P#KWD_]!-36'_(.M?\ KDG\A0!8HHHH CN/^/:7_</\
MJ\QUW4VTSP_X/FM]6MXKP?9O+LKF15C<%""[<;L#/8XKT^52\+J.K*0*X*U\
M."^TJWMM>T07\UM&D*X=0L048&W)SSU)[_2@#?\ !^NW6OZ3-<7BVHFAN9("
MUJY:-MIQD$U,/$@.J?8?['U8'S-GGFV'E?7=GI[UAC0;73[0PV.A74&<B.-;
MPHFX^H5JEM=#,-NJ36&IS2]6<WQ&3[#=P* -+QCKEUH&D0W-F+7SIKJ.W#73
M%8UW'J2*/!^N76O:3-<7BVPFBN9("UJQ:-MIQD$URNA+;R_$'7;.]B<Z=%I\
M,OD7LGG(I#'+?,2/QKT.S@M+>U1;&*&*W8;E$*A5.><C''- $](RJZE64,#U
M!%+10!Q_B77KK0-9TVRLY+..*ZCFD=KR4JJ[-OW??GIFH;C5VUO1- OVB,;7
M!,O ^7F)^E=;=Z;8W^S[996]SLSM\Z)7V_3(XK$\2QQP)I4<2+'&D[!508 '
ME/T% &EX>_Y%K2O^O.'_ - %:58V@P./#NF/#*58VD1*MRI.P?E6B+HQG%PA
MC/\ >ZJ?Q[?C0!8HI 01D'(I: "BBB@"L/\ D)-_UR'\ZLU6'_(2;_KD/YU9
MH S/$7_(M:I_UZ2_^@FJ7A7[FH_]?/\ [32KOB+_ )%K5/\ KTE_]!-4O"OW
M-1_Z^?\ VFE '044A( R2 /4U ;DR<6Z&3_:/"_GW_"@"P3@9-4[BZ#PRK I
ME.TY(^Z./6I/LQDYN'\S_8'"C\._XT^8!;60   (>!]* .2\'0I-YH8L5%K:
M\9QGY#UKL5544*JA0.@ KD?!'_+;_KTM?_0#77T %%%% !1110 4444 %<9;
M_P#(\M_U_2_^DL==G7&0?\CRW_7]+_Z2QT =G1110 4444 %%%% !1110 44
M44 %%%<G=>,Y4\1:CH]EHL]W)8"(RR">.-?G7<,;C0!U3HLBE74,I[$5!Y$D
M/,$GR_\ /-^1^!ZBN>_X2K5O^A8G_P# V'_&JFA?$$Z]K-_ID6C2036$RQ7!
MEN8\ MGI@_-T[4 =-,EG=LB7]I$7'W?.C##\":7^QM*_Z!EG_P!^%_PJQ=OY
M=I*XB64JN=C,%#>V3P*YWP]KXUJ^U2SMX'M9M.D6.6-Y!(C;AD;2* -K^Q=*
M_P"@99_]^%_PH_L72O\ H&6?_?A?\*F%T%(6=#$QZ$\J?QJP#D9% %'^Q=*_
MZ!EG_P!^%_PH_L72O^@99_\ ?A?\*O44 4?[%TK_ *!EG_WX7_"JZ:/I9OYA
M_9MG@1I@>0OJWM6M5>/_ )"$_P#US3^;4 0_V+I7_0,L_P#OPO\ A1_8NE?]
M RS_ ._"_P"%7J* */\ 8NE?] RS_P"_"_X4?V+I7_0,L_\ OPO^%720H))
M ZDU6:X:0$PX6,=97Z?AZT 5Y=+T>$#=IMGD]%%NI)^@Q41T/3YAF73K.*+^
MZ(5R?J<59B/)-NAE<]9I. ?\^U3"U#G=<.93Z'A1^% &6^EZ6\D)MM)M9$C)
MW%8$ /'J1S4#Z%;D2JNEVRI(2<&WC)&?0UT8&!@44 82Z181RQ,VBP>6B%2?
M)0D].<5+_8VAW3;DLK19!QE85!'U&*V*CD@BF_UB*WH<<B@#,_L>SA^]I5E,
MOJMN@;\L5)%INC3$A=.L]PZJ;=01^&*M?9Y8_P#4SL!_=D^8?XU'*2P_TFU)
MQ_''SC^M "?V+I7_ $#+/_OPO^%']BZ5_P! RS_[\+_A2Q2-_P N\ZS*/X'/
MS#\?\:F6[3<$D!B<]G[_ $/0T 0?V+I7_0,L_P#OPO\ A1_8NE?] RS_ ._"
M_P"%7J* */\ 8NE?] RS_P"_"_X4?V+I7_0,L_\ OPO^%7J* .2\9Z7I]OX=
M:6&PMHW%S;X9(5!'[Y.A K@_!Z0Q^(+=8+5[:/\ MR3$3C!'^CM[UZ/XX_Y%
ME^<?Z3;<_P#;9*\Z\)%CXCM]]VMT?[=D_>J  ?\ 1V].* /9Z*** "BBB@ H
MHHH **** "BBB@#"\;?\B+KW_7A-_P"@&GV.HV]AX<TPROF1K6(1Q+R[G8.
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MHHHH **** "BBB@ HHHH *\B\>B1M9OA#.L$G]I:;ME9=P7Y)N<5Z[7D'Q
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M/\^2;B"/Y?\ GH_ _ =30!5\1?\ (M:F/6UD _[Y-9OAIY0NH+%&"3<YW,<
M?(M6]?M@/#NIR2NTCBUD()Z#Y3T%0^%?N:C_ -?/_M-* -@6N\[IW,I]#PH_
M"K&,# HHH *CG_X]Y?\ </\ *I*CG_X]Y?\ </\ *@#E/!'_ "V_Z]+7_P!
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M8 C< %9NQ_2LGP]XLU#Q%\0M6F::XM8X);>V"6FG-,LB@L?G9US']X\X'Z4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N,\2_\ (YZ)]!_Z,6NSKC/$O_(YZ)]!_P"C%H [.BBB@ HHHH **** "BBB
M@ HHHH **** "O'_ (@E%U74#)=&U3^T=-S."!L^2;G)XKV"O(?'WF?VQ?>3
M"D\G]I:;MC<X5CLFX)H G^&EYJ,4=X+73OMB>5'B7[0J;AYL^&Z=^?RK0\4W
MVJMXQ\&M)HVQUO)RB?:E.\^0V1GMQS7/^ /'/A[0OML&IWWV:4(B%!#(X#"6
M<D953TW"KGB7XB^%;SQ7X2NH-3+PVEW,\[?9Y1M!A91P5YY/:@#HO'-_J[^
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MR3^0H 3[#!_=;_OLT?88/[K?]]FK-% %;[#!_=;_ +[-'V&#^ZW_ 'V:LT4
M5OL,']UO^^S1]A@_NM_WV:LT4 >7ZC;QQ^.?&!4'Y-!5EY/7#5V^@VD,GAW3
M'93N:TB)^8CG8*XW5 ?^$W\9G!Q_PCZ\_@U=SX>_Y%K2O^O.'_T 4 6?L,']
MUO\ OLT?88/[K?\ ?9JS10!6^PP?W6_[[-87B2WC@?3FC!!,[#DD_P#+-ZZ:
MN>\5==-_Z[M_Z*>@"QH-G"_AW3'96RUI$3\Q_N"M#[#!_=;_ +[-5O#W_(M:
M5_UYP_\ H K2H K?88/[K?\ ?9H^PP?W6_[[-3231PKF1PH_G4/F3S?ZI/*3
M^^XY_ ?XT -DM;2)=TA*CU+FH?LPF_U,3(O]^1C^@S5N.VC1M[9DD_OOR?\
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MFCSIH?\ 71[E_OQC/YBIXY$E7<C!AZ@T 0?88/[K?]]FC[#!_=;_ +[-6:*
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MUV=<9XE_Y'/1/H/_ $8M '9T444 %%%% !1110 4444 %%%% !1110 5X_\
M$)X8]4U!KB62*(:CIVYXR=P&R;ICG\J]@KR/QWY_]MWOV;R_._M+3=GF9VYV
M3=<4 :OPHV-;791BZF&,AFZD>=<<FM3Q<!_PFW@CC_E]N/\ T0]<7X"\%:5K
M;7TU^;T2E%=O(OI8UW&6<' 5AQ\H_7UJWXE^'^AVGBOPG;1-J7EW=W,DF[4)
MF.!"S#:2V5Y':@#N?'X'_"O/$7'_ ##I_P#T U%=:@=+^',5U&,S"PB2(>LC
M*%4?F17,>,OAUH-AX*UN[A;4S+#92R)OU*=UR%)&06P1[&H--\':3#K7A..U
M-ZTOD"_N!+>2R)A4&WY68@?.P/3M0!Z!H^A6^EZ-9V(#$P1*A.X\G')_/-7?
ML,']UO\ OLU9HH K?88/[K?]]FC[#!_=;_OLU9HH K?88/[K?]]FC[#!_=;_
M +[-6:* *WV&#^ZW_?9H^PP?W6_[[-6:* *WV&#^ZW_?9H^PV_\ =;_OLU9K
MG_&^LG0?!NIWZ?ZY82D(]9&^51^9% '/>![6+6]?\1^)'5C%+<_8K,[C_JHN
M"1[%B?Q!KN/L,']UO^^S69X/T8>'_"6F:9CYX8%\PGJ7/+$^^2:W* *WV&#^
MZW_?9H^PP?W6_P"^S5FB@"L;"W(P4)'NQH&GVRC 0@>@8U9HH K?88/[K?\
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ML/\ D'6O_7)/Y"H=:_Y =_\ ]>\G_H)J:P_Y!UK_ -<D_D* +%%%% !1110
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M@#EOB'J,MAX/NHK4D7E\RV5L!UWR';Q]!D_A6[I.G1:1H]GIT  BMH5B4#T
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M_P"O27_T$U2\*_<U'_KY_P#::5=\1?\ (M:I_P!>DO\ Z":I>%?N:C_U\_\
MM-* .@HHHH *CG_X]Y?]P_RJ2HY_^/>7_</\J .0\&PI,)=X.1:6N"#@CY#T
M-=5_I$'_ $W3WX8?T-<SX(_Y;?\ 7I:_^@&NOH BBN(Y20IPPZJPP1^%2U'+
M!',!O4$CH>X_&HMMQ!]QO.3^ZW##\>] %FBH8[F.1MN2KCJC#!J:@ HHHH *
MXR+_ )'E_P#K_?\ ])(Z[.N,B_Y'E_\ L(/_ .DD= '9T444 %%%% !1110
M4444 %%%0R7*(VQ<R2?W$Y/X^E $U>>:;8QR?%3Q3<23W:,GV)XXK>4J)/W9
M^\!P1QWKNO+GF_UK^4G]Q#S^)_PKEO#\D$?Q%\6Q)A-B62X)ZG8Q_K0!TES:
MSZA;/#)+);1N,9@?$G_?7;\*Y_3_ (;Z!INI2:C!]O\ M<LHEED:]DS(P.1N
M&<'\:ZXD 9)P*8)HB<"1"3V#"@".\M8[VSEM92XCE7:QC<HV/8CD5PGP^L8=
M-\7^,[2!I3%'<P;?-D:1O]6>K,237H)(49) 'J:X;P8P;QYXW*D$?:K?D?\
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M9KK[*HU+3<S<?)\DW//'YT /^&_B?P_I4=Y#?:M863")$$4]PB%2)9R5P3U
M(_,5?\4>,/#5QXO\'SPZ_ILD5O>3M,Z72$1@P, 6.>.>*R?AY/X61;T:K-I+
M2^6GS7(CRS>;/D\]\;?TJ]XFN/!S>+/"+6SZ(;=;N8W!C$6T+Y+8W8XQG'7O
M0!O:QKVD>*;S2]#TK4[.^$UTLUT+:99-L4?SG=@\ L%%=O7%^&K?2[[Q?JFK
M:7!:+9VL264,ELBA78_/(05Z]5'X&NTH **** "HI;>.4@LN&'1AP1^-2T4
M5O\ 2(?^FZ?DP_H:DBN(Y<A6^8=5/!'X5+4<L$<V-ZY(Z$<$?C0!)15;;<0?
M=/G)Z-PP_'O4D5Q'*=H)5QU1A@B@#-\4:I_8OA?4]1 RT%N[(,XRV/E'YXJK
MX&T<Z'X-TVR?/G^5YLQ/4R/\S'\R:X?QEXQCU7Q'8^%FLW-C)JT<,DR.&,WE
M[6=-G4#<5&?8UZS0 4444 %%%% !1110 4444 %%%% !1110 45"]TBML0&2
M3^ZG./KZ4SRYYO\ 6OY:?W(SS^)_PH ?)<QQML&7D_N(,G_ZU,*SR@M*XAC
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MO27_ -!-4O"OW-1_Z^?_ &FE7?$7_(M:I_UZ2_\ H)JEX5^YJ/\ U\_^TTH
MZ"BBB@ J.?\ X]Y?]P_RJ2HY_P#CWE_W#_*@#E/!'_+;_KTM?_0#77UR'@C_
M );?]>EK_P"@&NOH **** &211S+B10WI[5#Y<\/^K?S4_N.>1]#_C5FB@"&
M.Y1VV-F.3^X_!_#UJ:FR1I*NUU##WJ#RIH?]2^]?[DA_D: +-<9%_P CR_\
MV$'_ /22.NL2Z0L$D!BD_NOW^A[UR<7_ "/#_P#80;_TDCH [.BBB@ HHHH
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MC@$4_P V/_GHOYT *B+&H5%"J.P%.IGFQ_\ /1?SH\V/_GHOYT /HIGFQ_\
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MHOYT>;'_ ,]%_.@!]%,\V/\ YZ+^='FQ_P#/1?SH ?13/-C_ .>B_G1YL?\
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MS^5 ';> MW]EW^\ /]NEW =,\5U=<CX!>)=(O0&POVV3 <\XP.N>:ZOS8_\
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M"C[);?\ /O%_WP*FHH HBUM_[0(\B+'E#C8/6K'V2V_Y]XO^^!3!_P A)O\
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MT_FU #OLEM_S[Q?]\"C[);?\^\7_ 'P*FHH A^R6W_/O%_WP*/LEM_S[Q?\
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M_ILE>?\ A82#Q-!YLZ3/_;CY=%V@_P"CMVR: /9:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N,\2_\ (YZ)
M]!_Z,6NSKC/$O_(YZ)]!_P"C%H [.BBB@ HHHH **** "BBB@ HHHH ****
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M .@% $?V2V_Y]XO^^!1]DMO^?>+_ +X%344 0_9+;_GWB_[X%'V2V_Y]XO\
MO@5-2,ZHI9V"J.I)H B^R6W_ #[Q?]\"H;JVMEM)6\B(80\[!3_M$DO%O'D?
M\]'X7\.YI1:AB&G8RM_M?='T% &;>:=IVI-;3RW4L4\*%5DM[AHVP<9!*GV%
M)%96&F:;=16\[2&=S)(TTQD9V( Y).>@%;'DQ?\ /-/^^11Y,7_/)/\ OD4
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M=E#=POF":-948\94C(/Y4W[?9_\ /W!_W\'^-<-;_$+P]9Z7!IIT[7'@CA6
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MOL_^?N#_ +^#_&O-/[9^'_\ T)UW_P""9O\ "C^V?A__ -"==_\ @F;_  H
M]+^WV?\ S]P?]_!_C1]OL_\ G[@_[^#_ !KS4ZO\/P ?^$.N^1G_ ) S?X4G
M]L_#_P#Z$Z[_ /!,W^% 'I?V^S_Y^X/^_@_QJNTMAN+Q7L,3^JR+@_4=Z\]&
MK^ #G'@Z[X&?^0,W^%)_;/P__P"A.N__  3-_A0!Z%_:T$/^OG@*_P#/2.0$
M?B,Y%61J%F55A=P;6&0?,'(KS3^V/A__ -"==_\ @F;_  HN=9\"SJJMX6U
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MAA]@.XMQC'R=.M,'A^U^RD&'Q%]H\W(/]GG;LW=/N==OZT ?2OVZT_Y^H/\
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ML>2?QJ6@"*.VCB;=@L_=V.34M%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5#);1NV]<QR?WTX/\ ]>IJ* *WF3P_ZQ/-7^^@
MY_$?X5-'+',NZ-@P]NU/J&2VCD;?@J_]]3@T 3456W7$/WU\Y/[RC#?EWJ6*
M:.891@<=1W'X4 24444 %5H_^0A/_P!<T_FU6:KQ_P#(0G_ZYI_-J +%%%%
M!1144MQ'$=I)9ST11DF@"6HI9XX<!F^8]%')/X5'BXG^\?)3T'+'\>U2Q01P
MYV+@GJQY)_&@"+_2)_\ I@GYL?Z"I(K>.(DJN6/5CR3^-2T4 %%%% !1110
M4444 %%%% !1110!C>)O^/"U_P"OZV_]&K3/"O\ R#;K_K_N?_1K4_Q-_P >
M%K_U_6W_ *-6F>%?^0;=?]?]S_Z-:@#<HHHH **** "BBB@ HHHH **** "B
MD9U7[S ?4U U[;*<><I/HO)_2@"Q15;[7N_U<$[_ / -O\\4>;=-]VW5?]]_
M\* +-%5MEVW6:)/]U"?U)H^RLW^LN9F^A"_RH L$@#D@5$]W;QG#3(#Z;J:+
M&WZF/<?5B3_.I4BCC^XBK_NC% $/VU#]R.5_]V,_S-9.IZ=+JFE26;121$SB
M97VJX!5PXRI.#TZ5OT4 <QI6BW-AJIU"X8SR"$PJL=O'" "023@\]*V;:9K>
MW6.6WF4C.2%W#K[5>HH KB^MB<&55/HWRG]:F5T?[K _0TI4,,$ CT-0M9VS
M=84!]AB@">BJWV-1]R69/HY(_(T>3<K]VZ#?]=(P?Y8H LT56W7B]8XG_P!U
MB/YBC[3(OW[64>ZX;^M %FBJWVZW'WW,9_VU*_SJ99HG^Y(K?0T /HHHH **
M** "BBB@ HHHH **** &O]QOH:XSPG_Q^:5_V"6_]&BNS?[C?0UQGA/_ (_=
M*_[!+?\ HT4 =K1110 445%)<1QMMR6?LBC)H EJ*6>.(@,<L>B@9)_"H]MQ
M-]X^2GHO+'\>U2Q01P@[% )ZGJ3^- $7^D3_ /3!/S8_T%216\<1)5<L>K'D
MG\:EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK/UW5(]%
MT&^U.8X2U@:4_@.* .9T ?VU\1M>UD_-!IR+IEL>VX?-*1^) _ 5VU<Q\/\
M2Y-+\&6(N!_I=R#=W![F20[C^6<?A73T >??%2XDN]/TOPW;L?/U>\2(XSP@
M.2>/P/\ P&N]MX([6VBMXAB.) BCT &!7GUF#XB^,EU=XW6NA6WDQG''G/P2
M#Z_>'X5Z+0 4444 %%%% !1110 4444 %%%% !1110 4444 <-\4/^0+IO\
MV$8?YUW ^Z/I7!_%6>.'1]*#G&_4H0#^9KLQJ%E@?Z9;_P#?U?\ &@"/6O\
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M:?\ 0*US_P %DO\ A4;^*]/D^_HVLM]=+E_PH Z?K17*?\)+IO\ #I.NH?\
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M'17.?\)E:?\ 0+UO_P %LO\ A1_PF5I_T"];_P#!;+_A0!T=%<Y_PF5I_P!
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M^$/^?Z3_ +]&C_A;?A#_ )_I/^_1KK_[.LO^?.W_ ._2_P"%']G67_/G;_\
M?I?\* .0_P"%M^$/^?Z3_OT:/^%M^$/^?Z3_ +]&NO\ [.LO^?.W_P"_2_X4
M?V=9?\^=O_WZ7_"@#D/^%M^$/^?Z3_OT:/\ A;?A#_G^D_[]&NO_ +.LO^?.
MW_[]+_A1_9UE_P ^=O\ ]^E_PH Y#_A;?A#_ )_I/^_1H_X6WX0_Y_I/^_1K
MK_[.LO\ GSM_^_2_X4?V=9?\^=O_ -^E_P * .0_X6WX0_Y_I/\ OT:/^%M^
M$/\ G^D_[]&NO_LZR_Y\[?\ []+_ (4?V=9?\^=O_P!^E_PH Y#_ (6WX0_Y
M_I/^_1H_X6WX0_Y_I/\ OT:Z_P#LZR_Y\[?_ +]+_A1_9UE_SYV__?I?\* .
M0_X6WX0_Y_I/^_1H_P"%M^$/^?Z3_OT:Z_\ LZR_Y\[?_OTO^%']G67_ #YV
M_P#WZ7_"@#D/^%M^$/\ G^D_[]&C_A;?A#_G^D_[]&NO_LZR_P"?.W_[]+_A
M1_9UE_SYV_\ WZ7_  H Y#_A;?A#_G^D_P"_1H_X6WX0_P"?Z3_OT:Z_^SK+
M_GSM_P#OTO\ A1_9UE_SYV__ 'Z7_"@#D/\ A;?A#_G^D_[]&C_A;?A#_G^D
M_P"_1KK_ .SK+_GSM_\ OTO^%']G67_/G;_]^E_PH Y#_A;?A#_G^D_[]&C_
M (6WX0_Y_I/^_1KK_P"SK+_GSM_^_2_X4?V=9?\ /G;_ /?I?\* .0_X6WX0
M_P"?Z3_OT:/^%M^$/^?Z3_OT:Z_^SK+_ )\[?_OTO^%']G67_/G;_P#?I?\
M"@#D/^%M^$/^?Z3_ +]&C_A;?A#_ )_I/^_1KK_[.LO^?.W_ ._2_P"%']G6
M7_/G;_\ ?I?\* .0_P"%M^$/^?Z3_OT:/^%M^$?^?Z3_ +]&NO\ [.LO^?.W
M_P"_2_X4?V=9?\^=O_WZ7_"@#D/^%M^$/^?Z3_OT:/\ A;?A#_G^D_[]&NO_
M +.LO^?.W_[]+_A1_9UE_P ^=O\ ]^E_PH Y#_A;?A#_ )_I/^_1H_X6WX0_
MY_I/^_1KK_[.LO\ GSM_^_2_X4?V=9?\^=O_ -^E_P * .0_X6WX0_Y_I/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
F444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>img10132136_14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img10132136_14.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %0!(T# 2(  A$! Q$!_\0
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MX2! ^W/D_P"Q_P#7I?\ A;'A+_G^;_OG_P"O0!V]%<1_PMCPE_S_ #?]\_\
MUZ/^%L>$O^?YO^^?_KT =O17#CXM>$CG%\_!Q]S_ .O0/BUX2)(%\_'^Q_\
M7H [BBN'/Q:\)*,F^?\ [X_^O0?BUX249-Z__?'_ ->@#N**XC_A;/A/_G]?
M_OD?XT?\+9\)?\_K_P#?(_QH [>BN'_X6UX2W;?MKYZ_<_\ KT?\+:\);L?;
M7S_N?_7H [BBN'_X6UX2W8^VOG_<_P#KTO\ PMGPE_S^M_WR/\: .WHKAQ\6
MO"1&?MKX_P!S_P"O0/BUX289%Z^/]S_Z] '<45Q'_"V?"7_/Z_\ WR/\:/\
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MA+_G];_OD?XT =O17#CXM>$F&1>OC_='^- ^+7A)AD7SX_W?_KT =Q17$?\
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MEC-.D/BJ^61%M"L?V*.3/FJA8Y"=MQP*]KU?_D"WW_7N_P#Z":\I@_Y"4O\
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M_0[ZC_X*1_\ &Z[SX??\@R]_Z^(__2>*NNI*2_E7X_Y@XOO^7^1XK_;FN?\
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M_P"_IKH**0SG_P#A#=)_NS?]_31_PAND_P!V;_OZ:Z"B@#G_ /A#=)_NS?\
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M2OY05I3W?H_R(J;?-?F>QT445F6%%%% !1110 4444 %%%% !1110 5%<_\
M'K+_ +A_E4M17/\ QZR_[A_E0!RWP^_Y!E[_ -?$?_I/%775R/P^_P"09>_]
M?$?_ *3Q5UU !1110 4444 %%%% !1110 4444 %1W'_ ![2_P"X?Y5)4=Q_
MQ[2_[A_E0!RGP^_Y!M]_U\1_^D\-=?7(?#[_ )!M]_U\1_\ I/#77T %%%%
M!1110 4444 %%%% 'AGCW_D8?&/_ %[0_P#HHUZYIW_(,M/^N*?^@BO(_'O_
M ",/C'_KVA_]%&O7-._Y!EI_UQ3_ -!% %FBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /%?$/_ "-'BO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&1Y#_P#H)KRB'']IS8&!YNE_R@K2GN_1_D14V^:_,]CHHHK,L**** "BBB@
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M\\U_*CRH_P#GFOY4 )]HA_YZI_WU1]HA_P">J?\ ?5#+"B[F5%'J0*A_UO\
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M?Y$5-OFOS/8Z***S+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /#/'O\
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MP/Q/>IE147:JA1Z"EHH *@MNL_\ UU/\A4]06W6?_KJ?Y"@">HG@1VW#*/\
MWEX-2T4 0;YHO]8OF+_>0<_B*E21)%RC CVIU1/ CMN&4?\ O+P: ):*@WS1
M?ZQ?,7^\@Y_$5*DB2+E&!'M0 ZBBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BD9U1=S,%'J:A\V27_ %*87^^_3\!0!*SJB[F8*/4U%YLD
MO^I3"_WWX'X"E6W4-O<F1_5NWT':IJ (5MU#;W)D?U;M]!VJ:BB@""\_X]S_
M +R_SJ>H+S_CW/\ O+_.IZ $90P(8 @]C4/D-'S ^!_<;E?_ *U3T4 0K< ,
M%E4QMVST/T-34C*&!# $'L:A\AHN8'P/[C<K^'I0!/14*W !VRJ8V]^A^AJ:
M@ HHHH **** "BBB@ HHHH **** "BBB@#Q7Q#_R-'BO_KYM_P#T6E>[K]T?
M2O"/$/\ R-'BO_KYM_\ T6E>[K]T?2@!:*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBH;NZBLK*>ZF.(H8VD<^P&30!X]\4;V75=:.DVQ)DG>+3(@,\
M%R'D/Y>6*]>T^SBT[3K:RA4+%;Q+&@'8 8KQ_P '6DFO_$Z.XN5R-+@:[GR.
M!<S'./\ @(./^ "O::N>EH]B(:W84445!84444 %%%% !1110 4444 %%%%
M%+5_^0+??]>[_P#H)KRF#_D)2_\ 772OY05ZMJ__ "!;[_KW?_T$UY3!_P A
M*7_KKI7\H*TI[OT?Y$5-OFOS/8Z***S+"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /#/'O_(P^,?^O:'_ -%&O7-._P"09:?]<4_]!%>2>.H+EO'&MVTM
MI>K9WL<.;B*V=P5"8(4J#S[]JH)+=QHJ)K?BU548 "S<#_OB@#W.BO#?/O?^
M@[XN_*;_ .(H\^]_Z#OB[\IO_B* /;7C96,D7WOXE[-_]>FO<#R"Z?>^Z%/7
M=Z5XH;B\4$G7O%P ZG$W_P 14GAO4=33QGH<ZZSJ-U87K2*L5W.7\P!"0V#T
MYZ=Z /:XHQ%$J#L.OK3+I=UK*/\ 9-21R"1 R_B#U%*PW*5]1B@!$;=&K>H!
MIU0VAW6D1_V0*FH **** "BBH6N%W%(P9']%[?4T 35"UPNXI&#(_HO;ZGM2
M>3)+_KGPO]Q.!^)[U,JJB[54 #L* (?)DE_USX7^XG _$]ZF5%1=JJ !V%+1
M0 4444 %%%% !4%MUG_ZZG^0J>H+;K/_ -=3_(4 3T444 %%%% !43P([;AE
M'_O+P:EHH @WS1?ZQ?,7^\@Y_*I4D21<HP(]J=7-^-HR?#S>7++ \MS;Q-)"
MY1]K2HK#(]02* .DHKF$^%VAQ$E+S6%)]-0D_P :)/A?HDN-]YK#8Z9U"3_&
M@#IZ*YB/X7Z'%G9>:PN>N-0D_P :1_A=H<I!>\UAB/74)/\ &@#J**\/\?Z.
MOA6_:TTR_P!22)XXV.^\=B"?-S@Y_P!D?E7>WWPXT-=$GN_-U,S);,X8ZA+U
M"Y_O>M.VEQ7UL=G17)Z;\.-#DTNUE:;5-TD*.V-0E') )_BJGIOP[T2]OM72
M>74V%O>"*/\ XF$O"^5&V/O>K&D,[BBO-Y_!6FP?$73M&CNM36QFTV:X>/[?
M+RZR( <[L]&-,\?>!=)T7PK/J%E/J27*SP(&:_E;AI44\%O0F@#TNBN<'PTT
M%0 )M5 '_41E_P#BJR?#_P .=#U#P_8WES+J;330J[M]OE&2?^!4 =S17%6G
M@#2)=?U*T:XU0PP10-&O]H2\%M^?XO\ 9%9.N^!-)L?&'A>P@GU);>_EN%N%
M-_*2P2(LO.[CF@#TIG5%W,P4>IJ'S9)?]2F%_OOT_ 5PWC7P)I.E>"M9U&UN
M-36YM;226)FOY6 8+D'!:M'3_AGH$VGVL[R:GYCQ(Y(U"7J0#_>H ZE;=0P=
MR9']6[?0=JFKBM$^'^CW]A.]Q<:HS"[N(A_Q,)1\J3.JC[WH!3$^'6AKXH-H
M)=3$(LQ*!]OESNWD9SN]* .XHKS?QCX*TW3#H"VMSJ:K>:O!:S W\IW1MNR/
MO<=!6QJ/PUT&STN\N8)=366*!W4_VA+P0I(_BH ["BN!\)> ])UKP9HU_?7&
MIR7%S9Q2RM]OE +%02<!JFTCX=Z)->:LCS:GBWO/)CQJ$HPOE1MC[WJQH [&
M\_X]S_O+_.IZXB]^'FB_\)!IUF9M3,$T,[NIOY3DJ8\?Q?[1K,\<^"-+\/\
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M@8EM>!/ NSC_ +_/7T:OW1]*;W$A:***0PHHHH **** "BBB@ HHHH ****
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M8_\ XBG?\);J_P#T-]Y_X 1__&Z /9/]+'_/$_F*-]T/^649_P"!X_I7C?\
MPENK_P#0WWG_ ( 1_P#QNC_A+=7_ .AOO/\ P C_ /C= 'LGFW ZV_Y.*/M$
M@ZVLOX%3_6O&_P#A+=7_ .AOO/\ P C_ /C='_"6ZO\ ]#?>?^ $?_QN@#V3
M[4!UAF'_  #/\J/M<7<2#ZQL/Z5XW_PENK_]#?>?^ $?_P ;H_X2W5_^AOO/
M_ "/_P"-T >R?;+?O*!]>*<+J ])D_.O&?\ A+=7_P"AON__   C_P#C=-/B
MK5#U\6W1_P"W"/\ ^-T >U":,])$/_ J<"#T(->(GQ+J)Z^*KC_P7Q?_ !NF
MGQ%?GKXJN?\ P C_ /B* /<:*\-_X2'4.WBV]'TLT'_LE*/$FJ+T\9:A_P"
MJ_\ Q% 'N-06W6?_ *ZG^0KQE?%6K+T\87OXV49_]DH7Q5JJ[MOB^\&XY/\
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M/X@TZ.&YNK=H9&N% D A4$J<\X/% &!H5[>W_P"T8\^H:9)IMP=.(-O)*LA
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MZK^</_QNC^PKK_H8=5_.'_XW0!L[%_NC\J-B_P!T?E6-_85U_P!##JOYP_\
MQNC^PKK_ *&'5?SA_P#C= &SL7^Z/RHV+_='Y5C?V%=?]##JOYP__&Z/["NO
M^AAU7\X?_C= &SL7^Z/RHV+_ '1^59GARYGN] M)[F4RS,I#.0 6P2,G'%:E
M ";%_NC\J\2\4 #X@ZM@8_T[3OYI7MU>)>*/^2A:M_U_:=_-* /;:*** "BB
MB@#Q+XQ@'6P",@P0_P#M:O3[_2=-'AJY8:?:!A9N<^2N?N'VKS#XR#=K0!SS
M!$.#C_GM7H=]X;LU\.7+BZU3(M&.#J4Y'W#VWU3^%$K=FEI6D::VCV1.GVA)
MMXR285_NCVJEHFE:<VH:\&L+4A=0 7,*\#R(N.E+I?AJS?2;)C=:H"8$/&I3
M@?=';?5+1?#EF]_K@-UJ8V7X48U&<9_<1'GY^3SUJ2BG>:98#XNZ5$+&V$9T
M>X8IY2X)\V/G&*3XGZ980^!KAXK&V1_M-J-RQ*#S.GM5:\T"U7XLZ7;BYU'8
MVD7#EC?S%@1)'T;=D#GIG%)\2] M;7P3/*EQJ+,+FV&)+^9UYG0="Q% '=_V
M/IG_ $#K3_OPO^%8_A32M.?PII;/I]JS&W4DF%23Q]*M_P#",67_ #]ZK_X,
M[C_XNLGPMX<M)?"VF2-=:F"UNI(749U'3L ^!0!;L=)TX^*M84Z?:E1#;8'D
MK@?ZSVK'\3Z9IZ>/?!2+8VRH\]WN41* V(#C/'-7;+PY:-XGU:,W6IX6&W((
MU&<'GS.IWY/2LCQ+H%K%XZ\&Q+<ZB5EFN@Q:_F9AB$G@ELK^% &K\0]+T^+X
M=>(9(["U1UL)2K+"H(.T]#BMK2](TUM(LB=.M"3 A),*_P!T>U<U\0/#UI;_
M  ^U^9+G4F9+&5@)-0G=3\IZ@N01[&MG3/#5F^E6;&ZU0$P(<#4IP/NCMOH
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M2,#'\2AN1[4 >LZ%_P B_IO_ %ZQ_P#H(K0K/T+_ )%_3?\ KUC_ /016A0
M45S\PO[_ ,17MK#J<UI!;P0LJQ1H<EB^22P/]T5/_8^I?]#%>_\ ?F+_ .)H
M V:*QO['U+_H8KW_ +\Q?_$T?V/J7_0Q7O\ WYB_^)H V:*Q-)>\AUJ_L+F]
MDNTBBBD1Y$56!8L"/E _NBMN@#&\4?\ ((C_ .ORV_\ 1R5LUC>*/^01'_U^
M6W_HY*V: "BBB@ HHHH **** "BBB@ HHHH **** ,;PG_R+-G_NM_Z$:V:Q
MO"?_ "+-G_NM_P"A&MF@ KQ+Q1_R4+5O^O[3OYI7MM>)>*/^2A:M_P!?VG?S
M2@#VVBBB@ HHHH \.^,YF_MZ/R@A'D19W$_]-<?UKT>^_P"$C_X1RYW?V5L^
MR-G'F9QL->=_&5MFL[L%L01'"C)/^NZ5UE[X^WZ!<1?\(GXH7=:LN]M/PH^7
M&2=W2J?PHE;LWM+_ .$D_LBRV_V3M\A,9\S.-HJEHO\ PD7V_7=G]EY^WC?N
M\SKY$73VQBJ>F^/_ "]+M(_^$2\4MMA0;ET[(.%'(^;I532/'GDWVLM_PBGB
M=_-O0^$T_)3]S$,-\W!XSCT(J2A;S^WO^%LZ7G^S?M']D7&W'F;-OF1YSWST
MI/B7_;W_  A,_P!I_LWROM-MGRO,W9\],=??%9=UXUW_ !/TV^_X1GQ$/+TN
M>+R#8_O6S(AW!=W*C&"?<4?$/QK_ &AX.GM_^$9\16V;BW;S+FQV(,3(<9W=
M3C ]R* /0_\ BIO^H1_Y$K(\+?\ "1?\(MIGE?V7Y?V==N[S,XQWIG_"PO\
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M?-?F>QT445F6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_G)6S0!C>*/^01'_ -?EM_Z.2MFL;Q1_R"(_^ORV_P#1R5LT %%%% !1110
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M"\)?\):UO_PC>F>3]A#[/LRXW>81G&.N* &^/M3T^63PMY=];/MU^V9MLJG
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M (1_P5I>GL )5A$DV.[M\S?J<?A71TI.[N$596"BBBD,**** "BBB@ HHHH
M**** "BBB@ HHHH **** *>K_P#(&OO^N#_^@FO*(/\ D)2_]==*_E!7JVK_
M /(%OO\ KW?_ -!->4P?\A*7_KKI7\H*TI[OT?Y$5-OFOS/8Z***S+"BBB@
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M0!C>*/\ D$1_]?EM_P"CDK9K&\4?\@B/_K\MO_1R5LT %%%% !1110 4444
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M#/\ "G_(LV?T;_T(ULUB^$R#X8LB#D%20?\ @1K:H *\)\>_\A[QG_UPB_\
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M% !1110 4444 4]7_P"0-??]>[_^@FO*(/\ D)2_]==*_E!7JVK_ /(%OO\
MKW?_ -!->._VI:V_B1+"1G%Q<2:68P(V(.!#U8# Z'K6E/=^C_(B>WS7YGM]
M%%%9EA1110 45C2>*M'BN[BU^U%YK=]DJQQ,^QL9P2!UYI/^$JTG_GK-_P"
M\G_Q- &U16+_ ,)5I/\ SUF_\!Y/_B:/^$JTG_GK-_X#R?\ Q- &U16+_P )
M5I/_ #UF_P# >3_XFC_A*M)_YZS?^ \G_P 30!M45B_\)5I/_/6;_P !Y/\
MXFC_ (2K2?\ GK-_X#R?_$T ;5%8O_"5:3_SUF_\!Y/_ (FC_A*M)_YZS?\
M@/)_\30!M45B_P#"5:3_ ,]9O_ >3_XFC_A*M)_YZS?^ \G_ ,30!M45B_\
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MI:T** &111PQ+%$BI&HPJJ, "GT44 %>$^/?^0]XS_ZX1?\ HJO=J\)\>_\
M(>\9_P#7"+_T50!Z_IW_ "#+3_KBG_H(JS5;3O\ D&6G_7%/_015F@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /%?$/\ R-'BO_KYM_\
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M*KW:O"?'O_(>\9_]<(O_ $50!Z_IW_(,M/\ KBG_ *"*LU6T[_D&6G_7%/\
MT$59H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q7Q#_R-
M'BO_ *^;?_T6E>[K]T?2O"/$/_(T>*_^OFW_ /1:5[NOW1]* %HHHH ****
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M_P 1+)X;U:\CN[\W$,UK&K(5**.I8>E:G_";7G_0G>(?^_"?_%5UU% '(_\
M";7G_0G>(?\ OPG_ ,51_P )M>?]"=XA_P"_"?\ Q5==10!R/_";7G_0G>(?
M^_"?_%4?\)M>?]"=XA_[\)_\57744 <C_P )M>?]"=XA_P"_"?\ Q5'_  FU
MY_T)WB'_ +\)_P#%5UU% '(_\)M>?]"=XA_[\)_\51_PFUY_T)WB'_OPG_Q5
M==10!R/_  FUY_T)WB'_ +\)_P#%4?\ ";7G_0G>(?\ OPG_ ,57744 <C_P
MFUY_T)WB'_OPG_Q5'_";7G_0G>(?^_"?_%5UU% '(_\ ";7G_0G>(?\ OPG_
M ,51_P )M>?]"=XA_P"_"?\ Q5==10!R/_";7G_0G>(?^_"?_%4?\)M>?]"=
MXA_[\)_\57744 <C_P )M>?]"=XA_P"_"?\ Q5'_  FUY_T)WB'_ +\)_P#%
M5UU% '(_\)M>?]"=XA_[\)_\51_PFUY_T)WB'_OPG_Q5==10!R/_  FUY_T)
MWB'_ +\)_P#%4?\ ";7G_0G>(?\ OPG_ ,57744 <C_PFUY_T)WB'_OPG_Q5
M'_";7G_0G>(?^_"?_%5UU% '(_\ ";7G_0G>(?\ OPG_ ,51_P )M>?]"=XA
M_P"_"?\ Q5==10!R/_";7G_0G>(?^_"?_%4?\)M>?]"=XA_[\)_\57744 <C
M_P )M>?]"=XA_P"_"?\ Q5'_  FUY_T)WB'_ +\)_P#%5UU% '(_\)M>?]"=
MXA_[\)_\51_PFUY_T)WB'_OPG_Q5==10!R/_  FUY_T)WB'_ +\)_P#%4?\
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M +]Q?_%UTM% '-?\)7>?]"IKG_?N+_XNC_A*[S_H5-<_[]Q?_%UTM% '-?\
M"5WG_0J:Y_W[B_\ BZ/^$KO/^A4US_OW%_\ %UTM% '-?\)7>?\ 0J:Y_P!^
MXO\ XNC_ (2N\_Z%37/^_<7_ ,772T4 <U_PE=Y_T*FN?]^XO_BZ/^$KO/\
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M !VL3_A'M(_Z$[Q!_P"!H_\ C]+_ ,([I&,_\(?X@_\  T?_ !^JO3[/[_\
M@"M/NOZ^9M?\)NG_ $!-1_[[@_\ CM4H/B987'D^5I&IMYSNB?ZD9*'#?\M.
M.E4?^$>TC_H3O$'_ (&C_P"/U$GA30$*;?!.N+L)9<78X)ZX_?\ >E>'9_?_
M , +3[K^OF=!_P )NG_0$U'_ +[@_P#CM'_";I_T!-1_[[@_^.UB?\(]I'_0
MG>(/_ T?_'Z/^$>TC_H3O$'_ (&C_P"/T[T^S^__ ( 6GW7]?,V_^$W3_H":
MC_WW!_\ ':/^$W3_ * FH_\ ?<'_ ,=K%/AW2!_S)_B _P#;Z/\ X_2?\(]I
M'_0G>(/_  -'_P ?HO3[/[_^ %I]U_7S-O\ X3=/^@)J/_?<'_QVC_A-T_Z
MFH_]]P?_ !VL4>'=(P3_ ,(?K_';[:.?_(])_P (]I'_ $)WB#_P-'_Q^B]/
ML_O_ . %I]U_7S-O_A-T_P"@)J/_ 'W!_P#':/\ A-T_Z FH_P#?<'_QVL0>
M'M()_P"1/\0?^!H_^/TI\.Z0"1_PA_B ^XO1_P#'Z+T^S^__ ( 6GW7]?,VO
M^$W3_H":C_WW!_\ ':@N_B%;64'G3Z-J2Q[E3(: \L0HZ2>I%9?_  CVD?\
M0G>(/_ T?_'Z;)X9T26/;)X,UYUSG:UX#R.0?]?1>GV?W_\  "T^Z_KYFM!\
M0[:YEN(HM'U(O;OY<@+0##8!_P">G/!%3_\ ";I_T!-1_P"^X/\ X[6"GAG1
M(V=D\%Z\I<Y8B\ W'U/[^GCP]I!_YD_Q!_X&C_X_1>GV?W_\ +3[K^OF;?\
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M]P?_ !VL0^'M(!_Y$_Q!_P"!H_\ C]'_  CVD?\ 0G>(/_ T?_'Z=Z?9_?\
M\ +3[K^OF;?_  FZ?] 34?\ ON#_ ..T?\)NG_0$U'_ON#_X[6)_PCVD8S_P
MA_B#_P #1_\ 'Z/^$>TC_H3O$'_@:/\ X_1>GV?W_P# "T^Z_KYFW_PFZ?\
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M\#1_\?HO3[/[_P#@!:?=?U\S;_X3=/\ H":C_P!]P?\ QVC_ (3=/^@)J/\
MWW!_\=K$/AW2 <?\(?X@/_;Z/_C]'_"/:1_T)WB#_P #1_\ 'Z+T^S^__@!:
M?=?U\S;_ .$W3_H":C_WW!_\=H_X3=/^@)J/_?<'_P =K$_X1[2,9_X0_P 0
M?^!H_P#C]'_"/:1_T)WB#_P-'_Q^B]/L_O\ ^ %I]U_7S-O_ (3=/^@)J/\
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M /@!:?=?U\S;_P"$W3_H":C_ -]P?_':/^$W3_H":C_WW!_\=K$/A[2 <?\
M"'^(#_V^C_X_1_PCVD?]"=X@_P# T?\ Q^B]/L_O_P" %I]U_7S-O_A-T_Z
MFH_]]P?_ !VO*_%MTU_>>+KTVTL"RV\95)"I; C(_A)';UKN?^$>TC'_ ")_
MB#_P-'_Q^N:U[PE<S)J<6E>#M5Q=0(L3S7X&QQG=N'FG<"".])N%M$-<W4[?
MP_XLTK4Y+'3;*<3S&S$S%""$QM&#Z'FNEKQ!/#7C:%E>'PY(CJNP$7##"^G_
M !\58_L;Q]_T [K_ ,"V_P#DBH*/9Z*\7&C>/\G.AW..W^EO_P#)%']C>/\
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MO_DBC^QO'W_0#NO_  +;_P"2* /9Z*\7&C>/\G.AW/7C%V__ ,D4O]C>/O\
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M7_PCVD?]"=X@_P# T?\ Q^FS>&=&DC>)O!NNR*01AKT;6^O[_I1>GV?W_P#
M"T^Z_KYG-_#.UN]>\=3:G>VYB71X#%AI Q:XE)9GX_WF_,>E>UUS7@KPK;>%
MM$6)(0MY/B2[?>6+/Z9/89Q72U,G=W*BK*P4445(PHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
3 HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>img254193463_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_0.jpg
M_]C_X  02D9)1@ ! 0$#O@.^  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" :T%Y4# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!IZTJBBB@
M!:*B:XB3[S@5&=1MEZS*/QH LU!/>PV_WVQ5*]\06EK&3YJD_6O,?&GCI85<
MH_ZU2C<5STJ;Q5I]N</+BJ<WCW2HP?WP/XU\D>+/B==1R/LD/YUP5Q\5+]I<
M"1OSK54S-U#Z^\9>.[6^A=4<8QQS7S'\3K4ZLLNP9S572/%UYJ> S,<UW>C^
M&GUM5WKG-6ERDWYCY(NOAO<W&I[A&V,^E?2'P)\&SZ?+#N0C!':O6-)^"<=P
MRN8OTKTCPS\-TT=E(C Q[4Y5+JPHT[.YV_AN,Q:7&I]*U:@LX?L\(3TJ>N4Z
M IE/I,"@!%IU)BEI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ****0!1113 *3-+2;10 M%)4<UREN,L
M<4 2T5CW'BBRMOON!^-4)?'^FQ_\M%_.G9B.DED$*%CTKG]2\70Z?G)7BN9U
M[XE6K1,(Y5_ UXUXT\<23!_+D/YU<8DN5CV2\^,%I:L077]*Q=0^-MM(I595
M'T-?(_B+Q)J$DS;&?%8EMJVJ33 $OUK54T9\Y]*>)?B(=25]DF<^]>2>)KB\
MU#=L+'-6O"FFW>H%!(&.:]@\-_#1=05=\><^HIZ1%K(^6Y-#U26;(#]?>NF\
M-^%;^29=ZM7UM9_!.T*@M$H^M;-G\)K.T8$(O%3[0:IGDG@GP&TP3S(_TKV+
M1OAS9K"K2QK^5;^F^&(=/QM51BMQ5"J .E8N5S51.>C\#:9'TB'Y5=M_#MG;
M_<3]*U:*11'%"L*X48J2BBD 4444 %%%% !29H;I3: '9I:93EZ4 +1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4RGTE "+3J** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI#0 M%-W4HH
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MM^SO!,HYHL!=HI*6D 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6%%Z(!^%/HJ1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)1F@!:*** "BBDS
MB@!:*C:8+2K(&I@/IK8 IU17#[(S2 8]P$[U6DU(+WK*U+41'GFN=N]:VY^:
MJL*YU[:PJG[U+'K"L?O5YI>>(O+8_-4%OXI_>?>JN4+GK*ZDK#[U03ZJ%4_-
M7%V>O^:H^:IIKXR+P:?**Y=U/5MV<&N2U#4&+'FK=W(S9YK#NCDFJL3<NV6I
MLKCFNST75LA037F?FF-JW=%U ^8HS4,:/6[.X\Y1S5NL#09_,5:WZS+"BBDS
M0 M%)FEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBFT .HIJTZ@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **3=2T %%%% !1110 4444 %%%% !1110 W%&VG4E
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MEW+FM?1F/FK]:.42E=GK?AMLHM=37)>%V^1:ZVN=FJ$IM/I-M(8VG+THVT4
M+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %(32TUJ #=3J;3J "F[:=10 @%+29HW4 +1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 -W4H-)@TJT +24M%
M#=M+2T4 %%4=3U!+*$DM@UYUX@^)*Z<6Q)C'O32N*]CU+-0W5Y%;1EF< _6O
MG34OCT+5R/._6L.\^.QO 5$WZU?(R.='L7BSQLEBK[7Z5XSXD^,<MJ[A9/UK
MGM4\8S:X& <G=7):AX4O-68D*QS6L8KJ2Y=C9N?CM<M(5\T_G35^(]SK'&\G
M-<LGPFOY) WE/^5=KX7^%EU"Z;HV_*K]U$:LA70[C7^Q.:FC^"4]\=WEDY]J
M]R\%^ U@5-\?Z5ZOI^@VMK&O[I2<>E92GV-% ^3M)^!,MO,"8C^5>H>%?AF;
M'9NCZ>U>W"QMQTA7\J>L$:]$4?A4.;8U!&1H6AQ6,(R@R*VNG2CI1FLS06BD
MI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@!H%.HHI %%%%, HHHH ***KSW C'6@"<
ML!U--\Q?6L.\U<1_Q5G-XA"G[U.PCK@X/>EW#UKDT\0K_>_6G-XC0+]_]:+#
M.DEN%C'6J4NI*O>N8NO$:X.'K%NO$7^U5J#(<K'?IJB_WJIZEJR>6<-VKSJ;
MQ7Y>?G_6J%QXO\SC?^M/E!2-C6]1WL<&N7N)#(W6F3:I]H;.:A%P#3 ;,I"D
MU@:M<-'GFM^:8;#7,ZPQ;-5&+$Y(YRZU219#S1#JLC?Q55NK=GD/%6;'37;M
M6NQEN7HIGFJ[#:M)VJQ8:4<#(K=M]/"@<470^4PUTLMVJU;Z?M(XK<6U5>U'
ME!36<IE1B06\6RBZ!V&K"J*9<<J:A2;+Y4CC]4W;C3--R9!FKVI1 L:BT^/;
M(*W1C?4Z&UC_ '8K8TE2)5^M4+-=R"M[2;7=(#429:1Z%X88A5KL5^Z*Y;P[
M!M5:ZI>@KF9JA:***0PHHHH **** "BBB@!NZE!I*5: %HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &M24^B@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%)5>:^CAZF@3:6Y9HJ@NKPDXW"K
M,=U')T84 I)[$U%)FEH&%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKL:*CF9?*D,BC$2!0,"GTE)NJ2AU%(*6@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI,TM !11
M24 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !129I: "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ1112.H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFM0 ZDI,FG4 ,
MIR]*-HI: &M24ZD- #J*9FG4 +1110 4444 %%%% !1110 44E-S0 ^BD'2E
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "DI:* &4Y>E&T4M !1110 4444 %%%% !12,P7J<5!)?01_>D44 3T53;
M6+->LR_G69JGBRTMX6"2 GZTP-*ZU:"USO;]:R;CQUI]N<,X_.O)_&GCWRUD
M\N3]:\(\4_$J\21MDC?G6BA<S<['V!=?$S3HU.V1<_6N#\5?$:.X5_+D_(U\
MF-\2=1FDQYC=?6NCT/6+S5BH8L<U?L[&?/<Z#QCXJN;C?Y;,?QKRO4-8U-YS
M@OUKW/1_ ;ZPJ[T)S[5U-G\!4N,,8?TJN9(?*V?..C2:C=2J&WFO7/"'A2;4
M-GF*3]17J&G_  +CM7!\K]*[O0? ,>F[?DQCVI.:%R,X_0_A+#=(I>(?E72P
M?!RQCP=B9^E>A6=JMK$%48J>L7)LU44<=8_#NTLR"%7CVKI+'3([( *.E7:*
MDJR"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :W6A:7%&* %HHHH
M **** "BBB@ HHHH *:U.I* &T^DP*6@ HHHH **** &LP4<UF7VH"-3S4NH
MW7EH>>U<5K&JE21FKBA,FU76L;L-7):AK+;CS3+R^,F>:Q+N3)/-:6(+AUME
M;[U#:\<<M^M8$\GO69=W;1CK5)!<Z.ZU%9^^:S)(1*V16!'JC&3!-=!I\PD4
M$UNE8YV6+:W$?45+-(%7 J&ZN1$O%4!=&9L9HN*Q'>2G)JFKEFK3:T,BYQ4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% ";: ,4M% "4FVG44 %%%% !1110 4G2EJ&ZD$<+$
MT 4=3U);>,G->>>(?&J6K,/,Q^-/\;^(A:QOAJ^<?''CIEFD ?U[UK"-SY[,
M<9[%:'KQ^(R^=CS/UKJ_#_C)+K;\^?QKXS'CIS<C]X>OK7IG@GQL69,O72Z>
MA\OA\WDZEFS['TG4$N8A\W:M*O'/#'C1?*7+UU1\;1A?OC\ZY91:9]M1QM.4
M4VSN:AN+E($))KAG\>1J#^\_6L+5O'R>6V)/UJ5%LJ>-IQ5[FOXP\2)!&^'Q
M^-?/?COQF=T@$GZUJ^,O&OG*^'_6O"O%NN/<._S9KNIT^Y\#FV8N;M%E3Q!X
ML:1G^?\ 6N$U'Q 6<Y:HM5NW8MS7):A<-N-:-6/F(7J:LZ6/6P6^]6I9ZP&[
MUYO'>/NZUM:?=MQS303I([[^UMJ\&J%YKCJIPU9<=P67K52[8M39A&/*.DUN
M9I?OG\ZZ[PGXFD@F3+GKZUYXRD-FK5GJ!MY%YJ#5-Q=T?9_PS\9;O*!D_6OI
M3PGK*W4"_-GBOSZ^'?BMH9HANKZQ^&OBHS1Q@MZ5SU(GWN3XS9,]_!R,BEK.
MTN\^T1J<]JT:Y#[J+YE=!1110,*;NIU-P:0"@TM-44ZF 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %-:G4UA0 E/IN#3J "BDW44 +2'FEHH ;MIU%% !1129H 6BDW4;J
M%HI-U% "T444 %-VTZB@!N<4H-)@TJT +1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%)NH 6BDS2T %%%% !1110 4444 -W4HI-II5H 6BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHYI +1110 4444 %%%% !32U.II%  &IU- IU !1110 4444 %%%% !1110
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MY-;5Q'A36#?OMS0V"5BNLF&K0M7W8K"\_P";K6I8R9Q18#?MVX%2228%58Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !24M% #*<.*6HY)ECZT#)**S;C7+>W^\U4V\7V:G!8?G63JTX[LT5*<MD;
MU%8L?BFTEZ,/SJY#JL4WW31&I"6S$Z<X[HO4UJ1) XXI]:F8RBGT4 -%.I&.
MT9JM-?QP_>-)M+<:3>Q:HK)D\1VT75A^=5V\862G&X?G63K4UNS54:CV1O45
MCP^)K6;[K#\ZT8;I)QE3FJC4C+9D2A*.Z)Z***T("BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *:W6G44 -6G444 %%%% !1110 45#-=)"#NK/E\16T/WF
M'YU$IQCNRXPE+9&M16'_ ,)99C^(?G1_PEMG_>'YUG[:G_,7[&IV-RBL/_A+
M;/\ O#\Z/^$ML_[P_.CV]/\ F#V-3L;E%8?_  EMG_>'YT?\);9_WA^='MZ?
M\P>QJ=C<HK#_ .$LL_[P_.GKXHM&_B'YT_;4^X>QJ=C9HK/CUNWEZ-^M6X[A
M)>AK12C+9F;C);HEHHHJB0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ I*6F4 .I::M.H **** "BBB@ HIK,%&34?VI,XS2ND.S)J*:L@
M;I3J8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HJI<:C%:_?.*R;KQI8VN0SC\Z8'0U7N[I;6/<QKEKCXEZ;
M$O#KGZUR'B7XF03QL$E'3UIJ+)<CKM4\?0:?G+J,5S%Y\;+:V8@R*/QKP[QC
MXOFN/,\MR?H:\?US6-2DF.TO6RIHR<V?6NJ?&Z&X4JLP_.O._$WCI]45MCYS
M[UX-ITVISR -OKU'P?X>N;\IYBD_6JY5$.9LY+7K6^U!V*[CFN:C\*:G)-G:
M^,U];^&_A;'>1H7B!^HKLK?X.6**"T: _2CVB0<MSY.\*^#+UI$WHWY5[MX*
M\ AUC\R/\Q7I]G\-+.T((1?RKH[#0X;$#:!Q64IW*4#&TWP#80QJ9(USCIBM
M*/PCIT?(A _"MJBLS2R*,.CVUO\ <3%7%4(, 8%.HI#"DR*6B@!*6BB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **1FVTPS*O6BP$E(QPI-0M>1KWJI=ZDBJ0#0!'?7PC[U@7>J=<
M&HM4U#=G!K!FF9F/-:1B2V:3ZD?6HFU8K_%68['%9M]>&)3S5-"-]M?\L_>J
M)O%P7C?^M>>:IKWEY^:N;N/$CESAS5J-R).QZ]<>*]ZG#UBWWB0X/S?K7GT.
MNLW5JK:AK1VGYJI1)YSJKSQ!YC$;JSVNC/T.:XY=6,DA&ZNFT=O.VYIM6%<F
MDMV936'J$)CS7>K9JT/2N:UVU"AN*2*L<AYVUZT;6ZZ<UF3QD2&IH5*UJ9,W
M5G#+3)&W5028K5B*3<:3*18AB+,*WM-C*XK-LHPQ%=%8V_ K)W*5KFC;L0O%
M1W4S!35R&VXZ5%>6AV]*S-M#GKN\([U46\^;K4NI6Y7-8K.8VK6)C(Z2UN-W
M>MFUD'%<9;7FWO6U:7V<<U3C<$['4QR"G[N*R;>X+8J_$Q8"LFK&B9.&J>-Q
MBJV*=R*DH6Z8%37,:LVT-703,<5@ZI'O4TT)G,RW6V3K6CI^H<CFLF\M7WGB
MDM5>-A6W0P<K';0WFY>M#R;JR;*0X%:2<BLFC6+N,DJ+FIV6F[:"QJYS4Z&F
MJE3+'3)L12#(JG-&3FM0PU$UO3Y42V9/EG-31@K5MH144B;:AEK8B:;:M0F[
M [U%=$C-9DTQ7-4HW)<K&PVH!0>:JS:XJ_Q5S]W?,JGFN<U#5F0GFM53,W,[
MJ76T93\PK U34MV<&N0;Q"5;&ZI%U3[2.N:;B+F);C5)(Y.#6QH/B*1)%&ZN
M>N(=_-%E^YE'UJ.4:D>W:+XB9HQEJMZCK6Z,_-7G>D:EL1>:T+K4BZXS4<I?
M,3:AJWS'FL]=6!;DUEW4S.36;)(\;=:+%IGH^BZHFY>:],\.ZP@V\U\]Z7J#
MHP&:]#\.ZH_R\U+0SW[3]65E'-:2WBMWKS+2]58*,M70V^J%@.:SL,ZMKP ]
M:<MXK=ZY:34C_>ID.K8;DTK!<[-6##(IU8ECJJL!DUIK>QMWJ1EBBH?M*>M/
M60-TH ?1110 44A8+UJ)KE%ZF@":BJWVY/6G+=(W0T 3T4BG<,TM !1110 4
MRGT4 -6G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNM#U,6^T9K:,3",DI7/I'P;K"QB,;J]H\.ZD)XUYKY1\+^(L2(-W>O<O!OB
M%$RU8U:9]YE6,6D3U^BL >)8XX02PK*O/'D4+$;P/QKS^5GV+Q%-*[9VE%>?
M?\+"C)_UGZU-%XYC?_EH/SHY69_6Z7<[NBN,C\81NWWQ^=;&GZTMT1\V:5F:
M1KPGHF;=%(IW*#2TCH"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[!/\1B&_UGZU+;_$3D9D_6O$6N)Y.06I5NYXB,DUY7]K5KGIO*Z5K'TKHOQ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 44E-S0 ^BF9IRT +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!#
M=#=$17%Z]:E]W%=PR[EQ69J&F^:I.*N+)9Y1>695SQ53E:[35M*V[CBN1OXS
M"QK7<1#YN*:TA:J_F9-688B^*I:&;U9'Y>34JMY:U*T6P5GWEQY:GFH>K-5H
M)?:F(E(S7(ZQJ0FR,T:SJ1YP:Y::Z:23K6L492D65MA<29Q72:3I(P/EK'TB
M,NPKM]-AV(.*<I$I7(VTU0O2JKZ>N>E;-Q*$6LYK@,V*SNS2Q!'IZGM5N'2U
M/:I(6W8K0MZ13V,VXTA2GW:Y37M'.UL+7I'E[UK-U#2Q-&>*OFL9.)\[>)M+
MD7?@5YMJ^F.6;BOI+Q'X=#;_ ):\TUKP^JNWRUK&5S-JQXQ<::\9SBJ$MQ);
M=\5Z3J6CJJGY:XK6=-"[N*8C"_MA]V"U30ZI\WWJPK_]PYYJM#??-UI >J>'
M->\F1/FKV3P?XQ5-@+U\PV6IF/!S72Z3XN:U8?/^M5<#[(L?%D<T(&_M6?K6
MIBXC;#=J\%T/XA?=!D_6NTLO%:7B<OG\:3&B/7RSLU</J4;;C7<7TR7"D@YK
MGKJQ\U^!69LC!L8V\RN_\-,Z;:Q;#1SNSBNKTVU%NHH2)9W>CWWEH,FNACU,
M;>M>=)J0@7&:M6^N;CC=0X I6.WDN@_>J5TPVFLJWU R#K4LEP66GRV);N03
M3;7ZU>L9=V.:QY6RU7;&7;WI- CJ+=N!4_F5FV]R-HYJPLNZH-+%M7S4Z.:J
M19+"K>WY:AHI$GVG:.M,:XW=ZHW,A6J\=P=U,#54!J1EJ*&3(I[-1S!8I7BC
M'2L"\7!-;UT2:QKQ>M:1,Y&<LNQJ2;4/+7K5:[D\O-8=[=DYYJ[&=R]>:T%8
M_-6+>:XK#!:L?5;IUR<UQVH:P\;$9-,#I]0U)7S@U@SWP5^M9']J-(.M9M_J
M!CR<TQ['=:7J"LR\UZ)X=N5;;S7@6E:[B8#=WKU7PIJV]4YJ&-,]IT^X'ECF
MK<\PQ7+:7?[HQS6I]H+K22L.]R9IOFXH^V%>]5QEJBF4@5$C2,2TU]N[U2NI
M/-4U6+$-4\/SU)1SNI6K-G K!GT]F8\5Z&^G"7M5>30Q_=IWN+8\[DT]E[4V
M%'A85VUSHN,\5E7&EA.U:1,Y":7>%",FNLL=0#*,FN)">2U6HM2,7&:4HA&5
MCN6O4*]:JM<(S5RC:T<#FB/5BQ^]69J=8LB5!=7$:KUKGI-7*KUK)O-<9LC=
M346Q7-'4KI68X-4K>$S2#O5&*1[A_6N@TVVV@$U:@9RD:NF680 D5O0S+$N,
MUBB\6W3K6==Z\J\!J<HB4CI[B^3'6LR2[7/!KG&UAI#P:?#</(:SY33F.C@U
M!D/!K2AUV5 /F-8MC;F0<UJ+I_R9K111#E<O+XFD3JU6;7Q@P;EZY7483"#6
M!)>M#)UI2C<2;/;]-\6;U&7_ %K0D\1[EX:O%-,UYEP-U=+:ZN9%'S5GRV-4
MSKKSQ$V[[U3Z7X@9Y1EJXJXN"W>K&DSD3#FI91[EH.H><JY-=(K;J\^\+7!V
MK7=V[$J*R:&B>D;I2TC=*0QM.7I3:<O2@!:*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &2-M4
MFN2\2:Y]BB8[L5U%XVV$UX]\2M0>&WE(/8TT<F)J.$&T<)X[^)WV/S!YN/QK
MPKQ)\8&>9P)OUKG/BWXDN8YI0&;O7SMJOB:ZDNF!9NM=4('YOC,=4=3E/?Y/
MBE(S?ZT_G2_\+"DN%QYA/XU\_P!IJT\C#+&NJT>:6;;DFMU%'GO$3MJ=_J6M
MO?*?FS7)ZA:-,Q-;]C8M(HR*LS::%7D5LK(Y>>[N<0-/*<XJI?*54UU]U:JJ
MGBN;U2,<U,F=-.2.2NR=QJKNVU=OAM8UF225A8[E'F)EN#NQ6I8IYV*P(_F>
MNET=>F:8Y044;5KIH90<5>6Q5.U36;*JBBXN%5:9YTF[D#1*M4KB,8HFOAN(
M!J+SM]'*-&?<P@YXK,FA [5M7&,&LFZ8#-.QU03,RX&VJ#M\U7+I^M9[-\U)
MG;&.A:MVW&M>UAW8XK'LQEA73:?#N4<5".:HVF"P[1TI&FVU>FAVH:Q+N3:Q
MKI6QC'WC0ANANK:L;@-CFN-CN"&ZUL6%YC'-0]R:E/0[2W8-BK\:_+7.65]T
MYK=M+@2 5K&1YLB*\4[36',S*]=3-")%K&O+/!)Q5W*C8JV]PP[U9:=V'!JE
MM\MJL1.&ZUFY&$X7=R";>W>EMX7W#-7A&&[5/#"..*CF)2L26JLJU,UPR#K4
MD:@#BDD@W UK%B9!#>.).O>NX\*ZH\<R?-WKB$MB),XK>T67R9%JWJ8+W7='
MU7\,M8+F(%J^E?#4PFM ?:OC;X9ZP(Y(@6KZK\#ZLDEN@W=J\RLM3]+R*MS*
MS9V](1FD5PZY!S3JY3[43;2T44 -VTM+10 A-(&H84 4 .HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<#DLJBYFCY?&YQ&#LCP&;P+(L9.P_E7+:UX9FM\_*:^N9O!2&/'E_I7%>*/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5#=RTK!1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKR^W_P"/T?6OP_'?QS]JP'\$]N^&?WHOPKZG\$_\>Z?2OEGX8_>BKZG\%?\
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M "SKV\E^)'BYSLSW#0C^Y'TK6K)T'_4K]*UJ_6J7P(_*ZGQL****U,@HHHH
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MV/)_'MBJQR<5\Z^,(PLCU](>/WS')]*^<?&1_>25\'GD4F['W.2MV1YC>?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG%:45KD=*J6O:M>$C:*"D49K;:.E49#Y;5L73#::Q;GD\4B)(LVMSAA6Y:W
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MO S'"?578]_+\5]95R/23^\'UKV#P+_K(Z\<T=LR+7LG@/\ UD=7E?QH69?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAJZ'3KMY)%YK"2.B.Q[7H&K&X8<UVUNVZ)37EO@_<2F:]0M?]0M9,HFHHHI
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MT4BL&&12TC0**** "BDHS0 M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(32TUJ %
MW4M,I] "-]TUROBK_CW>NJ;[IKE?%7_'N_TKEQ/\-G5A_C1\V?$I?FEKP35E
M_P!*_&O?/B4?FEKP/5C_ *4?K7XAG/\ %9^SY/\ PD=1X/\ ]8E?1?P^^[%7
MSIX/_P!8E?1?P^^[%7L9'NCR,[V9[=HG^J6MBL?1/]6M;%?K=+X$?E53XF%%
M%%;&16OO^/=J\F\=?ZMZ]9O_ /CW:O)O'7^K>O%S+^&SV<M_B(^>/&G^L>O*
MM0_X^?QKU7QI_K'KRK4/^/G\:_%<Q^,_9,!\"/0OAW_KH_K7UM\.?^/>/Z"O
MDGX=_P"NC^M?6OPY_P"/>/Z5]OPUT/BN(^IZ-7.^)(]T#?2NCK)UJW\VW?CM
M7Z-65X,_/J+M-,^;/B-&5\VOGGQ-_KV^M?2WQ.M3&)>*^:?$V?M3#'>OQ;/$
MXS9^PY*U*"+O@]MLZ?6OISX:7BJL7-?+/AV;R9%/3FO:?!/BA;5HP7Q5Y)75
M&2N3G5"56+L?6VDS+):K@YJ[7E?AOQW'Y:@R?K71MX[A49WBOUREC*4H)W/R
MBI@ZL9M6.AUF=8;0DG%>%_$+6P/, :NG\7?$"-H6"R=O6O _&7BHW4CX;-?,
MYQF$.7EBSZ3*<!/FYI(X[Q9=?:))#G-<5;Q_Z9^-;FH7)G))K*MU_P!)'UK\
MIQ$_:5+GZE0CR0L>R?#0?-'7U+X)_P"/=/I7RW\-_OQU]2>"?^/9/I7ZAP[\
M*/S3/_B9U<W^K->=^-O]2_TKT2;_ %9KSOQM_J7^E?5X[^$SY7!_Q$?-GC_[
MTE>,W_\ Q]_C7LWC_P"])7C-_P#\??XU^'9I_$/VG*_X9Z9\-?\ 71?6OK;X
M?G_1X_I7R3\-?]?%7UK\/_\ CWC^E?=<-;(^+XBW9Z!2445^DGYT><^/O]7)
M]*^:/''^NDKZ7\??ZN3Z5\T>./\ 725^<9]NS]#R+9'G%U]\_6NE\'?\?*?6
MN:NOOGZUTO@[_CY3ZU\%A_XR/N,1_"9]0?#7_5Q?A7KZ_='TKR#X:_ZN+\*]
M?7[H^E?MN6?P$?C69?QF+7.^-/\ D&M]*Z*N=\:?\@UOH:[\1_"D<%#^)$^0
M/BM_KY*\=M?^/S\:]A^*Q_?RUX]:G_3/QK\#S3_>3]SRW_=T>J>"3^\C_"OI
M/X?\QI7S7X*_UD=?2GP]^XE?9Y#NCX[/-F>B7[;+,_2O"OB5J#Q^8 :]TU!=
MUF?I7@GQ,MS^\XKZG-VU1T/G,HM[74\#\07CRS-D]ZYR%?,N%SZUNZ]&4F?C
MO6';MMN!]:_':]W4U/URC\&A[)\,]-CFECW"OJCPCHMO;V"/L!.*^4OAWJBV
MLD>3BOI/POXPB2R52XZ5^F9!.E&'O'YMGL*LIZ'?"-5Z*!^%#!=IR!BN=;Q?
M"JYRM8.O?$*."!@' X[5]C/%4::NV?)0PM6H[)'(?%J:)5FP1WKY.\6S;KQ_
MK7LOQ"\:"^,@#Y_&O"=:N#<7+'KS7Y!GV*C6J/E/UO(\+*C37,7-!^:1:]J\
M!CYXZ\6T#AUS7L_@5AOCKGRI^^C7-/A9]%^#?]6E=I7$>#3^[2NWK]GPG\)'
MX_BOXC/)?BI_J9?QKY!\>_\ 'T_UKZ]^*G^IE_&OD+Q[_P ?3_6OS+B;XF?H
MW#?PHPO#O_'POUKW7P!]Z.O"?#_^O7ZU[KX!/S1UX.3_ !H]_-O@9]#>$_\
M4I7<1_<%<-X1_P!2E=U']P5^U8/^&C\;Q?QCJSM=_P"0?)]*T:SM=_Y!\GTK
MJJ? SEA\2/ECXN?>F_&OGF\_X_#]:^AOBY]Z;\:^>;S_ (_#]:_"\Z_WAG[=
MDO\  .U\)_?CKZ#\ _P?A7SYX3^_'7T'X!_@_"O9R7XD>/G/PL]PT'_4K]*U
MJR=!_P!2OTK6K]:I? C\KJ?&PHHHK4R"BBDS0 M%%% ' ?$+_4O]*^6_'?\
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M?2^I_P#'G)]*^:/BW_RU_&OF,_\ X!]'DG\8^;]6;_36^M;_ (=^\M<_JO\
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MW$<9.:]'L<A!FOO,+5=6-V?"XFDJ4K%JBBBO0.$**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/@E;54.S'X5]/E.42E-3:/F,TS2,8N"9T'@W2?(MX\C'%=HB!.E5=/LQ:Q@
M8JY7ZQ1IJG!11^75JCJ3;"BBBMS **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNEHJ;LJR(+6T2U7"BIZ**0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ I*6F2-M0F@"CJ%Z+=22:\_\2>,%LPW
MS_K6SXLU$P0O@U\Y_$3Q/+$9,,:UA&Y\[F.,]A'0ZC6/B<(V8>;^M<AJ?Q2S
MG$OZUX=KWBRX:9AN/6N?FU^>4?>-=D:>A\%4S>I*32/7]9^)[$'][^M<%K7Q
M*D?</-_6N$U#4IG4\FN5U"ZE9CR:3BC'ZY.>YV6H>-Y)V/[P_G5%?$3R');]
M:XCSI"W)J[;R-32L93DY;G:1:TVW&ZF7&JF0=:YZ*1JL+N:MD<C5B2ZF,O-4
M&4]:O^26IDEOQTIN)49&%>9P:QYU.ZNCNK?.:RI[?%82T.Z%C-\OBHV@JZRA
M:9Q4W-D[%/[/4<B;:T=M5YH^M4CKILRY<U$%.:MR1TP(!29M?0(DJ8**C#;:
M/.J+F18"[J1HZ6)]U6-NY:N(TR@S%:EM9"T@HGAI+.,B05M8U=K'6Z3#O45K
M3+Y,=5=!CR@K0U--L)Q5)'FR=Y'/75X0V,U2D8R"HKQCYAJ>U7>!2:'/1%46
MYW=*V=+MCQ38K3)'%;%A;E<<5%C@J3T-2RM>!6E'9CCBH[*,\<5K0V[-CBM4
MCRIU;,?I>D_:) ,5Z#H?@4W*J=F?PK.\(:69KA 5[U]&>"O"Z-;QDIV]*527
M*CW,MI?67J>1S?#H10Y,?Z5QNO>'UL=WRXKZG\2:1#9VC':!Q7SG\0KI(GE
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)Q0!C:YI?VY6&,UYUK/PW%Y(Q\O.?:O7N#VI-J_W1^5<%?!T\1\9VT,74H?
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MP%3Y>/PKO-%\*I9A?DQCVKJUB1>B@?A3L>U>M1P%*C\*/*K8ZK6W9'!;K"H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5A,YOQ)(-K5Y7XAE^=J[WQ)JBD/S7F6L70ED;FMX1N92>A@S1F9R*EATG?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB@ HHHH **** "BBB@ HHHH *2EIAH =2TU:=2 ****8!1110 4444 %%%%
M!1110 F:6BB@ HHHH 2C(I&I* 'T444 %)2TUJ %R*6F4^@ HHHH ***1NE
M!D4M,IU, HS2-0O6@!U%%%( I,TM-;K0 N:6FKUIU !1110 444A- "T4W=3
MJ "BBB@!*,BD:DH ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI1FEHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?UKZ[^"L'S0\>E-DH^S_ (;QA;6/Z5WM<3\/UVVL?TKMJYF;(****0PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH J7D_EJ:YR^U+YB,UJ:U(54UPU_='
MS#S6D42RS=:@>3NKG]4\0^0AR]0ZIJ0AB))KR7QIXR%KO&_'XUHD3)FUXB\7
M+EAOKBKCQ(LDOWZ\QU[Q_P"9*P\SOZUEVOBHS2#Y\_C73'0YGJ>[:=K2G'S5
MT=CKB<?-7A^F^(#M'S5LP^*C&!\V/QJKDV/;(M61P/FJQ'=(_0UXQ#XV"G[_
M .M;-AXX1B/G_6D"/689 >]5K^/S%..:Y33_ !;')CY_UK=MM62XQ\U/89S>
ML:4SDG%<XVF^6_(KTJZC29":YC4K4*QP*0C.L(@N*V%N/+CK.@0K4=]<>7$>
M:H96UK5MBMAJ\^UK6FW-AJTM=U [F&:XN^F,C&F9O0LV^JLT@RW>NS\/7^YE
MR:\]M(2S5UVB*RLM)H<9'L>ALDRK73PVB%<XK@O#MPRA<UVMO??N^M9.)OS$
MEPJQ#TK-DO%5NM,U74-JGFN3N=8VR'FDD2V=O;70;'-6F.X5R6D:AYI'-=5#
M\T8-2S1"(OS5=C Q555^:IN56L^4OF17U*-6C-><^*-.617XKO-1NMJD9KBM
M<N@RM6\4<\GJ>+>)M( D<A:YRU4VLP[<UZ-KL2R%JXN_M?+8D"F4M3K_  KK
MYAVC=7J&CZ_YJK\U>!:7<-"X'O7H?AW4&(7FEN5L>MQ:EN4<U,E^/6N3M;PF
M,<U/]N*]ZEHM2.QAOE]:G:Z7'6N*CU8JW6K/]K_+]ZL[%7-?4+P8/-<QJ%QN
MS1>:INSS65-=>83S6U[(S97N/F:I[&/<PS4>W=5ZSBPPXJ;BY35ALT:/D5BZ
M]H\<D;?+6]$2JU4OFWK@TT2SQKQ)X560L=E<'>^'5@<G;BO>=4LQ(IXK@/$.
MGA-Q K0@\RN&%GTXJ?2]<VS ;JJ>(U,;-BN>L966X'UJ66>^>%-6WJA)KT6S
MU@)&/FKPSPG?%57FN\AU)O+'- '6:AK!D! :L"2<R/U[U5%RTAZU/$N:8/49
M<*-AS7+ZL5W&NFOB0AKD=2W-(:=R+&8REFXI5C(JW:VI;K3KM!"M Q]G"&Q6
MW#8_*"!6!I]R/- KM-/59(Q]*!%.WA,<@KK=%N @&36#<*L>:2WU#RNAK-R-
M$=S-=HT?6L.\Q(QJ@NJ%^,U/"YEHL.Q4N+7<.E94]FV[I761V^]>E13Z>.N*
M:(.35&C.:E_M@VO\6*OWUL(P>*Y35E;YL53 V&\:F'C?BK=CXV,C#]Y^M>5Z
MDTT;'K46GZA)'( 2>M96-$SZ$TWQ-Y@!WULKXE"K]_\ 6O'=&U1M@YK5DU9_
M6FXC4CTW_A(!*,;JR]2NC,IP:Y33M0>1N3710H9HQ61IN8TA;S*U+&;RU!-2
M?V66;.*<]BT2=*TB92T)_P"UA&W6M?2]85V W5Y_J4KPL:9INMM#(,M6CC=&
M:>I[A9W"R*.:M;0U<'H?B 2!1N_6NNM+T3*.:PY;'1%IC[N(%37+:I:[B<"N
MME^9:S+BTW]J19QZV1#]*T[2T)QQ6@UAANE6[6UVTR2HMF<=*J75OMSQ72-"
MNVL>_49-:1,I&!-'AJ(_EJQ+'560[*N6Q*)9+G8*CAO-S=:RKR\QGFF6-P7E
M%1%%O0[C35\W%=%;VXVBL+P^NY5-=7%#\HIR=B$N8B\E:C954U/)E:HS,16?
M-<M1L2[AFI!S5-&):KD*UBS:XC+4,GW35IDXJ"5#M-.(&!J<>X&N6N[<[C77
M:@, YKGY]I:NA'-):E2QC.ZNITV LHK(L(0S"NMTR !12D7$469V#BJ5Q&8V
MKI!"-E95]#S61L6_#LI\Y>:]I\*-F-*\3T0;)UKUSPU?+'&O-1(2.VDD$:Y-
M95UJPBSS574-958S\U<5JVNG<<-4V'<[,:^N[&ZKUKJBRXYKR+^WFW_>[UTF
MAZP9"O-%@/2XI/,6I*S=+G\Q!6E4C"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %)2T4 -VFE6EHH **** "BBB@ HH
MHH **** "BBB@!"<4FZAJ2@!=U.IE/IL HHHI %%%% !1112 ****8!1110
MW!I5I:* "BBB@ IN#3J* $6@TM(U ";J=3*?0 W!I5I:* "BBB@ HHHH 3=1
MNI&ZT+UH 4TFTTZB@!!2T44 %%%% !1110 4444 %%%% #=U*#FFTJT .HHH
MH *3=2TR@!V:&I%IU #=IIU%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 W=2BFTY: %HHHH **** "BBB@ I*6DH ;3EIM.6@
M8M%%% @HHHH *1A2T4 -P:=110 4444 %%%% !1110 4444 %%%% !1110 4
M444 )2;33J* $6EHHH **** "BBB@ HHHH **** "BBB@!&I-IIU% !1110
M4444 %%%% !1110 4444 %)NI:90 X'-+35IU "4FZE;I3: '4M(O2EH *0T
MM% #=II12T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%(: %HI!2T %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 44F110 M%)1D4 +1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !15>\NEM8RQ.*X[6/B#%IV<R 8]Z=F([FF22+$A9C@"O'+WXX0
M6S$><OYUB:A\<HKI2HF!_&J4&+F1Z5XD\7)IZMA^GO7E.O\ QH^PR,!)C'O7
M(^(O'3ZL&"/G/O7EVO:??:E(Q0,<ULH+J0Y=CU&Z_:!=F*B7]:S;GXIRZPI
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M-XYP3ZUZOX(D$OEJ37-ZGX8>Q3=L(_"E\+ZP;&]52<8-*3[ M]3Z?\'>$TU
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M ***:W6@!U%-7K3J "BBB@ HHHH **** "BBB@ HHHH *93Z3 H ;2K2XHH
M6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *93Z3:* !:6DI: &L
M@;K56;38INHJY10)I/<PKCPO!-GY5_*J,G@F!C]Q:ZNBF8RH4Y;HY&3P+!Y9
M^1:XKQ9X&187Q&/RKV.LO6K$74+<9XIJ33.2O@Z=2#21\3_$3PVUMYN$Q7A>
MKPO#<,,=Z^UOB1X3$T<I"5\Q>,/"QM[ASM[UZ-*=S\US'">PDVD<;I1+8S6G
M<*NRJ]K:_9V(Q5R2%I%XKI/G+MLP[B,9-4I%VUO2Z9)UQ6;>6QB!R*G0Z(J1
MBW$F%Q6->MD'FM*^DVYK$NI P-*QVP@95TPYJEN!-2WLF,UG>=\U9M'I0AH:
M"H#BK$,?S57M?FQ6I;Q=#69C-<I:M4XJ^J],54B^6KUNN_%"1S2D30J<BM2T
M0\4RUM<XXK1C@V"MDCDE,=)@1FJEJV;E1[T^Z<JN*K6+_P"D+GUK6QRMNY[C
M\,[19)(R17U+X+CAM[>,D#I7RA\/=52U\OFO:]/\=+:VX ?MZUQU(W/M,LJP
MIJ\CZ&M];MX8PI(J9=>MFZ']:^<)OB=\V!)^M6K'XBF1AF3]:P]DSZAYK3CH
M?1<>IPR=#4WVI.N:\4TWQ^O&9*WH_'D7E_ZP?G6;@T=E/'4YJ]ST>;4HH1R:
MI2^);>//(_.O*=:^("(K8D_6N#U3XF%7($GZT*#9SULSA3ZGT@GBBW?HPJY#
MJT4W0BOF/2_B,TT@_>?K7I'AGQ4;K;\V?QINFT94,TC6=D>P)(LG2GUCZ3=^
M<@.:V*R/>C+F5PHHHI%D<R>9&5KSWQAX96\C<[<UZ-5*_LQ/&>,U2=CGKT56
MCRL^1/''@?:SD1_I7B^OZ*UG(WRXP:^W/%GA9;E7^2O O'7@=E,A"?I7?3J:
M'YEFF5N,G**/FW4[@PJPKD+ZX\R0UZ3XL\,RV[-\IKSR[TUXY#D5MS7/"IQ=
M+1E>UCW-6@+?Y>E1VMN5/2M-8\+4-7-W*YG"W.:<T/%7F4+5:XF55-3RB1GS
M1A34#2*M,O;T+GFL>?4?FZU:@;Q39>NKD8XK#O+@Y/-$EYO[U7D^>DU8Z8KE
M(?-.[K5NWE/%55BYJW;P]*S,ZD]"_#\V*TK6WW,.*IVL?2MRPBRPK1,X)2-S
M1+7YEXKUWP7;#='Q7F6EJ%*UZAX,G DC'O73%:'#&?[Q(^@/ UGPG%>X>';?
MRXUKQWX?LK+'7MVB_P"J6O-K;GZME$?W:9KTM%%<A].%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHI %%)FEI@%%%% !2&EI* ,#7-1^RJQ
MSBO-=?\ '0M6(\S'XUTWCV\,,+\U\Q^/O$KPS/ASUKZ+ 855MSY_'8ETMCU_
M3_B())@#+W]:]+\+^(UO57Y\U\1:3XPD6Z'SGKZU[Q\-_%QD\L%_UKOQF7J$
M;I'G83,'*5F?3$<@D4$4^L/0=2%U"G/:MROD91Y78^NA+FC<****@L*3;2T4
M )MH-+2&@!,FE%)M-** %HHI"<4 +13=U.H **** "BBB@ HHHH :6H!H(H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBF[J0#J*0
M4M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FY-.INTT *M+2
M+2T (U)DTII-IH 6EI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@!*;3Z* $7I2T44 (U-I]% !1110 4444 %)D44V@!]%(O2EH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4GW7%2;U_O#\ZZ+G.+BEI-P]:6F(**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3- "T4F:6@ HHHH ****
M "BBB@ HHHH **** "BBB@ HI,T9H 6BBB@ HHHH **** "BBB@ HHJ"XNE@
M7DTFTM6-*Y/17/W?B6.W_B%8]UX_BAS^\'YURRQ5*&[.F.&J3V1VS,%&2<"L
MZ^U:. 'YJ\ZU'XG1 $"4?G7(:M\25D!Q)^M>;6S2C!:,]*CE=:;U1ZE?>+DA
MS\_ZU@7GQ"2'/[S]:\:U;QX9-V)/UKCM4\8R-NPY_.OF\1GG+\+/HL/DG-\2
M/?+SXI*G_+7]:P+[XK!L_O?UKY\OO%,[9^<_G6/-X@G8GYC7S]7B"KLF?04L
MAIK5H]\OOB9YF<2_K6!?>/6DS^\_6O'/[9F;^(TIU*1NI->;/.*E3=GI0RFG
M#H>AWGC!Y,_O/UK#O/$<LF?G/YUS'VMV[TGG%NM<$\9.?4[(X2$-D:%UK$S=
M&-9DVH3-GYC3_O4>6*XY2E+J=D8QCT*IO)R?O&@74WJ?SJUY(H\H5GRR[FEX
M]BO]IE]31]HD]35CRQ2^6*=GW#F78K^?)ZFE\Z3U-3^6/2CRQZ4<K"Z(/.?U
MI?-?WJ;RQ1L%.S%=$/FO[T>:_O4VP4;!19A=$#32#UI//D]:G9!1L'I19CYD
M0^?)ZFF>?+5KRQ2>6*5GW%=%<7$OJ::UU-ZFK7EBD:-?2E9]Q\R[%1KN;^\:
M?'>3@CYC4_D@]J<(5II274?-'L36^I3+CYC6I;:[*A'S&LCRP*:S;36L:DH]
M3"5.,NAV5IXHD3'SUMV?C1X\9D_6O,O/9:/MSKT-=D,=.'4Y)X*$^A[79?$$
MQX_>?K6_8_$_R\?O?UKYU_M25?XC2C7)E_B-=]/.*L.IQ3R>G/H?5%C\5UX_
M>_K6]9_$Y9<?O?UKY!M_$4ZG[QK?TWQ9,A&7/YUZM'B"ILV>56R"GND?7UCX
MZ2;'[S]:Z&Q\2)-CYQ7R?I7C9TVY?]:[+2?B%Y>W,GZU]'AL[4OB9\[B,E<?
MA1]-VUXDRC#"K->&Z7\3$7;F7]:ZJQ^),4F/W@_.OHZ6949K<^>JY;6IO8](
MHKD;7QI%/CYP:VK/6([C&&%=\*\)[,X)49PW1J44U6#+D4ZMS **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDR* %HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%%( HHHI@%%%% !4%W<+;0EF.*2\NEM8RQ.*\P\>^/X[&%P),?C32;%<O\
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M)$X[U[#HO_'J*SD4:%%%%2 4444 %%%% !1110 4444 %%%% !1110 4444
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M5)W<UT1BS2UR/4O$!W$;JQ)M8+G[U8-]?%I#S5(W1]:Z5H4HG4+J6[O3UO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1*,>U=GH_AF/3<84#%0Y]BXQMN<OI?PGLO+4R1J/J*UH?AGIL+9"+^5=B!M
M%+63DR[(Q+/PK:V>-BC\JUX85A7:HXJ2BI&%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#SW%?HK\&=2W6< SVK.1:/?9T$T=8&IZ:)%/%;UI)YD(I9( ]9HH\KUKPT)
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M4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !112;J %HI <T4 +13=U.H ***0G% "T4FZEH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"H$:[L>E9.=MC11[GS)IOP",+ ^5^E>@^&?A:-.*YCQCVKV;RT_N+^5.V@=
M/RK-S;+Y496BZ/'81#Y1D5K44F>:@H6BBB@ HHI-U "T4FZEH *;DTZF[30
MJTM(M+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7KVKYQ\7>#)K*20!".?2OU-\9>!8-2C8K&#D>E?.?Q ^#(D:0K!^E7&9#B?
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MDT\,O2IM,.;<5<K"YJ8+:.&/2I[?2UC/2M:EHN(ACA$:]*?3Z;MI#%ZB@#%
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M5WNC_#61MN8_TI<Z0?5:E79'.>#[299DX-?2/P]AE CSGM7*^&?AV870F/\
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M+1115$A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;&?;^%["%<>2I/TJRFBV<?W85%7J*S+(H[6*+[J 5+110 4444 -)H'6G44
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M[=5N(N?2L[4-'C8DXI%'GGAWPZ(Y 66O3=&LH+>-20!6 ZI99/2J-SXI%N"
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MIJVX&!5^BLSTXTH0V0U5VBG444C8****8!1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&'2MW.>E?/OA?X@A50&3]:]+T7Q@ETJ_/FO.E%IGZAA<=3JQ2N=Q15&UU 7
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M10 4444 %%%% !1110 44F12T %%%% !1110 4444 %%%% !129%+0 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4^7%8G@OP<FGPQ_N\$#TKT*&(0QA17+)W.A*P]5VC I:**@8A.*3=2M3<<T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!X:^'\FY<Q_I7KOAOX<QE4)C_2N_T_P/#;*IV ?A7VV"R%Z2DCXO&9]O&+.
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M%JF64TD-G":U,$9JY6^U585/-=%XDC90QKR7Q1JC6H?G%:&5R77/%8B+ /\
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M+VOFJG%#".YT&GVY51D5?9EC'-78M/V0@XK!UB5H=V*E&H7E\B]#6-/J19L
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M-^S0KQBMFDCQM&WI3J\\_1H14%9!1112+"BBB@ HHHH **** "BBB@ HHHH
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MZ1L,:Y.21Y),DU^5YAF<Z\FD]#]0P&60H13:+5Y</<-DG-0(II\?:I=M?/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4AI:0T )NI:3;2T +1110 E&VEHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ I,BBD'- #J**KW-XELI+&DW;<:3>B"ZNEMDR3BN)\3>+TMHW&
M_''K5;Q?XN2W1P'Q^->#>-/'#2,X$GZU\SF69QH1:3/I<NRR5=IM&EXV\=%]
MX63]:\7U[Q!)=2-\Q-1ZQKKW4C?,36,O[ULFORK&8Z>(D]3]1P6!AAXK08LC
M2/DFK*H.*180M/KS$NYZ;?8%I],I"VVF2.;K4;-2--2Q(9FP!2WT16VY'YA+
M5H6.F/>,/E)J_IGAR2[=<*37J'@_P"\C(6C_ $KT<+@JE>25CSL5C:="-[G-
M^&_ ;W#*?+/Y5[%X1^'_ ).PM'^E=KX3\#QQ1H3&.GI7?6>BPVJC &:_2,OR
M6--*4D?G6/SJ51N,69.@^&8;>-24 Q[5T<=O'& %4"GJH1<#I3J^QITXTU9(
M^0J5)5'=L****U,AO-*M+10 4444 %)D4M,H =2TU:=0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !29]J6B@ IK1JW49IU% &7J>BPW<3?(,UY=XL\#+/OQ'^E>R56N-/BN =
MPK@Q&$AB%9H[\/BIX>5TSX_\4?#UXV<B/]*\TU;P^]C(<J1BON'Q!X/BN(W(
M0'\*\4\:> "=Y6/]*_/\SR7DO*"/OLNSKGM&3/FV1C&V*<DFZNKU[PE+:R-\
MF/PKF9K9K?((KX.I1G2=I'V].M"JKQ$I<5"):>K;JS3-K#J0QBG8I*87L5Y,
MQ]*NZ7J\EK*"&(J!EW5$\>SD5*<H.Z!I35F>Q>"_'#0L@:3]:]Y\(^-%N%0%
M\_C7Q;I^J/:R#!Q7I_@[QH\,B R8_&OL<KS:5)J,F?(YGE,:B<HH^S+'4%NU
M!!S5ZO(/!WC19U0%_P!:]0L-42ZC4@Y-?J&%Q4:\;IGYEBL+*A*S1?IM+2UW
MG (M+110 4444 -I5I:*0PHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJ-]JD5D#N(XKGKSXAV=
MF2&9?SIV Z^J]Y=+:Q%B<&N"G^+^GQY D0'ZURWB#XKP74;!)0?H:I19-T=A
MKGQ!CTW/[P#'O7$WWQTBMF(\X?G7DGC#Q3-?;_+<G->2ZQ_:5Q,Q7?UK94T9
M<Y],7WQV2ZRHFSGWKC]<\=2:NK;7)S7AVFZ9J<DXW!\5ZIX0\*W-SL\Q6I\J
M0N9LY?7-)O=59BH8YK C^'FHRR9V/^5?6?A7X:QW"H9(Q^5=Y:_##3XE&Y%S
M]*GGL/EN?(OA/X=7BR)OC;KZ5[OX+\!A1'OC_2O5+;P+86Q!5%_*MBUTF"TQ
ML7I42G<I0L9FF^$;*WA7?$"?I6DNBV2=(%J#5M9735.2!BN;;XC0QR%2ZU'*
MS31'9)9P1_=B45!J%\EC'U KF&^($#1DAUKBO%GC]?+;$GZTU%W%='2ZQX^%
MJY'F8_&J-K\2E;CS?UKYY\5>.F:9\2?K7/V?CJ17_P!8?SKJ]GH8.I9GT'XS
M\?!K5\2=O6OF/Q_\0I%FDQ)^M7_$7C1IK5@7/3UKPCQIK33RR'=0HV)E+F.C
MC^(TWF_ZT]?6MZQ\?RRK_K#^=>"QWS>:>:ZC1;QVQS6L2);'J>H>)9;J,_,3
M7)7\TMPQ))-6;-O,3FK'V=>]:&-V<U-9M(#D5GR:4V[@5V+0)4?V>/VI6*YC
MEX;22'IFFSZA/;=&(KJ9(8@O:N>U:-,'%*P)L98^*IXI -Y_.NLT_P <31H/
MWA_.O-2H63BKB7!2/K2T+N>N:7\0I?-4&4_G7L7@/QH]S(@,F?QKY!M=2:.8
M'=7K/P^\3^3-'E_UK.2+@S[U\$ZA]JBCRV:]#7[H^E?.WPU\81M'%E_UKW#3
M_$,,UNI+ G'K7')'6F;=-9PO4XK'O/$D-O&2& /UKCM:^(,-MN_> ?C2Y6%S
MT)KZ-3U%/CN$DZ&O";CXKPK+M\X?G71^'?B%'>2*!+G\:?*%T>LT51TO4%O(
M00<U>J!A1144MPL74T 2T566^C8XS4ZL&Z&@!U)2TUJ #=2YJ.E6@![5&W>I
M:8: (]M*!BG[?:D88H ;NI-U(W>F[: )=U%,VTZ@!:*5>E+0 RDW4I4XI-M
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M?X:>L2KT%/I-U(84M-S2T +1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRYK!OKHKGFM-C+<O:IJY>,C=7G^M_P"D,QK7NKAI,\UGS6[2=14&L3FXK/\
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M HHHH **** "F4^DVT (M.I,8I: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ I#TI:2@!-U.I-M+0 4444 9NI77E*:XW5-3^8C-=1K2DJ:X'4D;S#6
MD1,IWTWF@USU["6)XK<VD]:@N(1C-:HRDKG*R6/))%0R,EMR>*T=4NDMT8Y
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M#%7JXF[GV]&G[*/*%%%%2;A1110 4444 %%%% !1110 4444 %%%% !1110
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M219.AI](!,TM%% !1124 +124M !129I: "BDHR*  TFVER*,T -HI=II,4
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M-H ?12+2T %%%% !1110 4444 %%%% !1110 C4VGTE "TUNM.I* $6G444
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M"S8!%>8^+/%!LV8;L5S&G>.#)<@>9W]:\"KFD:<^0]VGEDJD.<^@H;U9NE6
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MBTM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8FO:Y'8Q-AQD4 ;+3(O5U'XTS[7".LJ_G7B/BCXG?V?OVR]/>O,M4^/$L$Q
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MDB8-MQ1#<4MCA5F^SMC.*OP:MM_BK&U!]LAQ6;+>E,\UO>QA8[9=<Q_%0WB
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MJ]:",4#K0 ZBBB@ HHHH **** "BBB@ HHHH **** &2G;&Q]J\E^(FJ&!)
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M:W1MV!%>B^"?%#131C=^M>8S UHZ'?FVF4YQS73AL1*C431S8FA&M3=S[/\
M ?B0311Y;]:]+M[@3*"#FOE+P#XP\HQ@OC\:^@O"FNB\B3YLU^PY7CHUH*-S
M\BS3 RHS<K'944@.0#2U](?.!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG\:]HT#7EU"-<'.:P:L:W.AHI*6I&%%%% !2$9I:* &[:=110 4444 %%%%
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M>:[6L;0]/^RQJ,5LUYLG=GZOAX.%-)B?Q4M%(:DZ!:*;DTHH 6BBB@ HHHH
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MHV;6/Z5\F^%3NU%,>M?6/PS_ ./6.N/AOXSLXA^ ]"I*6BOTD_.AE/I-M+3
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MO%>DT5ES,TY48>E^&HM/QA0*VU&T #I2T5)04444 )FFT[;1MH 1:=28Q2T
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M/A7P,&5<I^E=FW@-/)^Y^E(9XMHNEO;NN17IOAWY544FH>%_L;<+5C1;5DF
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M.*[>&$0J *X*DN8_3LOP:HQ3L.50@P*4FEI*Q/=#=11BEH ;MI:6B@ HHHH
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M*MUK6Y+C<ZR&X62K]O;J^#BN1LKT[AS74:;=!L<TXG%431LVL0C(K=L;PI@
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M_K76MXN4)G?7SEIOB*2!1\QK5;Q=(8\;C7V-'-G"%CY&OE7-.YZ1XJ\=;8V
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M"OCQ=0C0>9G/O7/*-C52/2**JV=X+I :M5!053U5_+LI#[5<JIJD9DLW7VH
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M#/I2FBH,^]=#D\S38S6A7/>#;KSM+CY[5T-<IL%%%%( HHHI@%%%% !1110
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MQ-D**U[6T%NH %>C@<O6$=SAQN/>*5F6:*92K7NGB"M3:?24 +1110 4444
M%%%% !1110 4444 5-2MQ<6[#%>0>.O"?VA9&V5[21N&*R-9TE+JV?@$UY^,
MPRQ$&F>A@\2\/--'Q/XP\/\ V.1SMQ7GMQ^[E(KZ7^)7A<CS2$_2OG_7-):W
MN&X[U^-9IA'0J.R/V#+,4J]-79F)]TTM-R%X-.5LUXJ9[374=3/+[T^@TPN,
MANC;R#!KU/X>^(FCFC!;O7DLB?,#72^&;[[)*ISBNO!UI4JJ9Q8RBJM)H^UO
M ^O+/;("V>*[:.42#(KYQ^'_ (KP(UW_ *U[KX=U 7<2G.>*_:,NQ:KTTC\<
MS'".A-LW:***]L\4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHJ.6985RQQ0!)169-X@M+?[[@?C5.3QIIL?64?G3L!NN
MP123TK$U#Q1!89W$<5@:Y\0K1866.1?SKQOQOXZ:17\N3\C5QC<ER/8+OXK6
M5JQ!9:R;SXT6A5E611]*^0_$GB[4'F;8[?G7.V_B+4YIL%GQ6OLS-S/J'Q-\
M2%OE;RY,Y]Z\<\5ZG=WS/Y98YIGAN"\U#;OW'->K>'/AS_:2KOCSGVIZ1)UD
M?-D^G:G-(<!\5N^'?#^H2S)O5CS7UEI_P/MF4%HE_*MFQ^#MK:,"(U%+VB#D
M/(O!?@=[C9YB5['H?PSM6A5I(U'X5TFE^$8=/QM4#%=#'&(T"CH*Q<KFRB<Q
M%\/--CZ1C/TK0M?"MG:XV+C\*VJ*F['8B@MDMUPHJ6BBD,**** "BBFMUH =
M135IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML:7,>:U(J!;<[NE='/9C'2JZ68W=*5AC]'MR&&:[6Q(6,5SUG"(\5H_:O+7
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M;&WC!&,"N*^$_@I+>VB.S]*]CM+%;50!7+)FZ+=%%%0,**** "BBB@ HHHH
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ME6@!:;)'O%/HH Q;[1UN,Y%<_>>'8[;,A7%=S61XD7&GL0.<5<96)<;G$?\
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M@^0UZ/X?\!O=*O[O/X5Z!H?PN?<I\K]*CFL>C0P<ZQY]X;\(/(J_N_TKJY/
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MB**D"A>@Q2TFZG9"NPH(SUI%ZTZF(884;JN:8;6%NL:FIJ*5D.[*_P!AM_\
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M>&X?)TR,>U:M<9N@HHI*0Q:*2EH **** "BBB@ HHHH **** "BBB@ HHHH
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ML\U%UHDSFA17X)B*KJU6V?V3@\/&A0BD**6BBL-CIW"JER">E3EN:EAMOM#
M 4?%HA_#JRYX8L3<7"C'>OI'X;^%Q(L1*_I7DO@7PZSW"';WKZB^'ND"WACR
MO:ON\AP7-).2/B,^QG+%J+.OT735LX5XQQ6M2*-HP*/XJ_48Q4%9'Y=*3D[L
M6BBBK)"BBB@ HHHH **** "BBB@ HHHH **** "HIKE(1EC3;JZ6W0DFO/O%
MOBY+.-\/BN6OB(T(WD=-"A*M*R.JU+Q1!:J<,!^-<=JGCR)6.)!^=>,^*/B-
M)YCJLGZUQ4WBZYNF.'8U\5B\^2?+$^QPV1NW-(]^;Q\F[_6?K5JU\?1[AF0?
MG7SFNL7;<Y:C_A(+J%OO-7FK.IK4]'^QH/0^M-)\;PR8S(/SKJ;/6H+I1AAF
MOC73?'<]NXRY%>F^#_B$9F16D_6O=P>>1J/ED>+C,EE37-$^C%<.,@YIU<]X
M:UI+Z%?FSFN@# ]#7U].HJD>9'R52#IRY6+1116IF%%%% !124M !1110 44
M44 %)2T4 %%)2T %-:G4F,T -I])MI: "BBDR/6@!:*** "BBB@ HHHH ***
M* "HGN$3J:+B3RX68UP?B#Q,+1F^;%<U:M&BKLZ*-%UG9';'4H5_BI\=ZDG0
MUXNWCK=-CS._K75>'_$!NF7YLUP4\PC4ERH[JF G3C=GHJMN&:6J]E)YD(-6
M*]=.ZN>4]'8*2EHIB$I:** "DI:* $I:** "BBB@!-M&*6DH 6BBB@"O>3>3
M$6KC=4\5):R$%L?C72>(Y#'8L1Z5\Z>.M<GAN'"L>M>%F>,^JQNCV\NPBQ+L
MSV"Q\81SO@./SKJK"^%PH(.:^8?"OB"XEN@"QZU[YX0N'FA0GTKER['O$G3F
M&!6'.V5P%R:B>^BCZM5#4KT6MN3G'%><:YXT%O,PWXKV<1BHT%J>30PLJ[T/
M5!J,3< U+',).E>0Z3XQ^TR ;\UZ!HFH_:%7FLZ&,C6V+K825'<Z.BD4Y -+
M7I'G!1110 44G.:6@ HHHH *:U.I,4 -I])MI: "BBB@ HHHH **** "BBB@
M HHHH ***;0 ZBD6EH YKQ=I_P!JMVXSQ7SA\0/"YWR-M_2OJR\MQ<1X(KR_
MQYX=#PR-M[5\UFV#5>#D?1Y5C'0FD?'FKV/V21ABL@29;%=[X\TLV\TF%Q7G
M@!64BOQW%4W1J<I^P86I[:FI%VBD4_+2U@;$4R[A18+Y<P/O4C#--'R'-3UN
M/I8]5\"Z]]E>,;L5]%^"_$'VJ.,;LU\:Z+JQM[A1NQS7T'\,==\PQ M7W>28
MZTE"Y\/G6#3BYV/I&W;=$IJ2J6E7"S6:$&KM?J<7=)GY?)6;044451(4444
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ML.M1S1F04ZUA+8K6BL=R]*!;'*75L5:J>W8U=7?:?\IXKG;RW*L>*3+3'6K
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M?^(_B%HUE ;]:^8_&_B":223#'K7QF.S'EDXIGU>$R]3BFT:VO>-HY)&^?\
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M #R7\J@NM)M[B,CRP#7U\LBHM61\I'/*R=V?$?B/PC/IK,=I&*S-#U673KH
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M84^[&HJ'4;+Y487AWP[%8PKE!P/2NA50HP  *4 +P!BBLBQ:*3/M10 M%%%
M!1110 4444 %%%% !1110 4GI2TA[4 +3)I!&I)I]9>O77V6U9LXXI@<]XI\
M4)IT+DMC'O7SO\1OC&MD)0)L?C6A\7_'!LXY0),?C7Q!\5?B%---,!(>_>M5
M$SN=IXV^.;22R 3_ *UYC??&*1IB?./YUX7X@\57$UPWSG\ZYV;7)F.=QI[#
M/JK0_C5)"RDSG\Z]0\,?M!&';FX_6O@B'Q!/'C#&M:Q\97,)&)&'XTAGZ5:7
M^T8NQ?\ 2/\ QZM-OVC$V?\ 'Q_X]7YR6?Q$ND4?O6_.KC?$FZV_ZT_G2L!]
M]W7[1R\_Z1_X]5=?VD%W#_2/_'J_/VX^(=VW_+5OSJO_ ,+ N]P_>M^=*P'Z
M9>'?VA$N95!N/_'J]J\%_%.'40F90<^]?D9X7^)MS#.A,I_.OHKX:_&AX#'N
MG].].P'ZBZ5K4%]"I#C/UK3SGIS7R%X(^.,<D<8,X_.O;?#'Q,BU!5'F@Y]Z
MEQ&>HT5G:=JT=XH(8&M&H&%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 )2;J6FT .%+2+2T %%%% !1110 4444 ,>-9!AE!KC?&WAF*\L
MW(0'(]*[6JU];BXMV4C--,#X3^,'@/YYBL?KVKY5\5>&WL[A_EQ@U^E?Q(\&
MK>)(=F>#VKY-^)'P],;2L(O7M71%F,D?)EZK1,1BJ$K&O0/$OA=[>5OD(KB;
M^S:'.15F2W,J0U"S5*RG=BE^SLW.*DU*,C=JJNNXU?GMBM5=N&J1E8VI:I(;
M/D<5<0"K$2#BA(5Q]E:[<<5M0PC;5.WP,5IPX*UJB6S.O;<,IXKGKNQW'I78
M7$.5K-DM0QJ6@3.3DTT^E4+JU9%KMI+-3VK+OK ;3Q4.):9PEU&58U#'(\;<
M&MO4+/:QXK):/:W2LK%EZUO).!FMNQ8NPS6!;KR*WM.^\*M S;AC^6H;I<"K
MMLN5%17B5H9=3$?.ZI8H2V*5X_FJ]9PAL4%$#6OR]*SKNW*YXKK%LPR]*R]0
ML\ \5-@4CE6X-7+7.13;BW*L>*=;*P8<4BF:L(-3;#2V-N\G\-:7]GR;<[35
MID&8RE15:2X\OO5N^1X<\8KGKJX;)H;&C0_M+;WIZZIGO6 &9FJW#"QQ4%6.
M@M;S<16G]J7RLUS,68\476I&.(C-4C-E^2]5KC&>]>H_#731J$T8QGD5\_1Z
MJ\E\!GO7T[\ ;4WES!D9Y%9R9I%'T]\._ANMY;QGRL\>E=_??"%9+<_N>WI7
MHGP?\,QM80ED["O5;[0;>. Y Z5BMRS\_P#XC?"$0K(PA_2OFKQEX1_LV23Y
M,8K]*/BKI=JMO+@+T-?#_P 7+:))9]N.];IBL?-5T/+N-OO7<>"]+^VS1\9Y
MKC=4C_TXX]:]/^&6P31;O451#/J/X(>#AYL#%/3M7V;X;M4TO3%[8%?,WP=O
MH+=(22!P*]WO_%44.F$*XZ>M9R*1POQJ\7"VM9E#XX]:^"OBAXP-Q=3#?GD]
MZ^@OCKXR+I. _P"M?$/C377GOI/F[U41,J7NH-<7!Y[UTGAW2C?LH SFO/H+
MHM,,GO7MWPELTOKF%2.IIW%8['PC\+9=29#Y1.?:O:/#OP#::)28/TKUKX,_
M#R"\AA8Q@\>E?1>D>";2SA7=&/RK-R+L?'=Q^SN&MR?L_;^[7G'B[X FW5R+
M?_QVOTB;0+)H]OE"N.\6?#^UNH7(C4\>E),9^5?B+X8OIDC'RL8/I7)W%A]A
MR",8K[A^+7P]BM$F81@?A7QW\0K<:?<2 <8)K>+,9(XZXF!8C-$)&ZL4W^Z8
MC-6DN@%SFK(-L,-M03,*S#J04=:;]O\ ,/6BX[%BXFVUD7U]\IYJY-EUK"U+
M*YJ&58P]6N#(QYK :,ER:U[K)8U4\OGI69:'V@VUHK)Q5*%*LJ#04),VZHH[
M<NW2IUCW-6E8VH;'%58D33[,J172V?[M14%O:A0#4DD@C%.UB#1CD!.,U>CC
M#K7.1WH5NM;5E>JP'-6A,2\@8#BL6:Q>9O6NDED604ZUM5D;I0*Y@6NA$G)%
M;5KI_D@<5O062A<XJ*ZB"]*M1)YKF:T@C%+'=\U%/&68TV*!LBI T%N.*BF;
M</PI!&5%1NU5<"C<*2:CC0YJXZYJ%L+FLRT6(.!4SR#%9YN-E,-R6JR;%B22
MH6F-1ERU)M)J2K#9&+ U77/G U<\JF"']X/K185ST/P!J @GCR>]?8WP>UU6
M$(W>E?$/AAFCF3'K7U/\&[M_,A&:B1<3[L\'7/GVJGVKIJX?X<R%[-,^E=Q6
M#-0HHHI %%%% !1110 4E+10 W;2BEHH **** "BBDH 6BDW#UHS0 M%%% #
M67<I%<KXJT%;RSE^7/%=94<\0FB9"."* /A_XS>#?]<1'Z]J^/?&7AYK>\?Y
M.]?IE\5?":W,4Q"9Z]J^+OBAX1^SSRG9W/:NN$C"1X=HMTVGS+SC!KZ&^$OC
M5HYH5\SOZU\YZS&;2=@..:[3X::L\5W%SWK1HF+L?IG\*]?%[##EL\5ZI7S#
M\$_$'RP MV%?2UG=+<PJP.>*XY+4W3N>/?%V^>&.<KGO7R#XT\:7%A>O\Y&#
MZU]L_$GPZVH0S$+G(KXZ^*'P\N/.E98V[]JJ G<Q/#/Q@EMI5#2G\Z]V\"?&
M07'EAIOUKXOU70[S29F.UA@U<\.^-+K29E#.PP:N2)3/T]\+^.H=05,R@Y]Z
M[JWNH[F,,C U^?G@+XS/"8U:;]:^B/!OQ=2XC0&;]:Q:-+GT 1G@C-8^M:##
MJ$1_=C/TJAH?BZ/457+@YKIHY!(H93D4AGAGC3X6I>I(5A'/M7S]XV^"KKYC
M+#^E?>,MO',N'0,*Y[6O!EIJ$38C'Y52D)GY>>)OAQ=:;,Q$;#!]*P['4+K0
M9ADLN*^]/'WPH@D60B(=^U?*'Q4\!'3&E9$QCVK9.YG:QB6_Q/E,/EF4^G6I
M=+U"36[Q3DMDUY$8+B.^V -UKWGX/^%Y+Z:%F0GGTHV%>Y[[\'/#C;H69?2O
MJ;0]/%M:Q\=J\V^&?A<6=O$2F.!7KL2>7&JCL*QDS5#Z***@84444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -+
M4!J#UH'6@!U(W2EI#TH B84*M*U :@!&%-IY/-,VF@ HW4NVDH >K4X-^%1@
MT;J )=WO2Y%1;J7=0!)NHIF:<K4 .HI :6@ HI,TM !1129H 6BDW4M !2&E
MHH QM3M_,!KF+RQ()XKN)H0XK-NM/5E/%:IDM'GU]+]E4D\5R&L^)UMU;YJZ
M?QTPLX9#G%?.?B[Q4T<[J'[XK1:D'9W'C#S)\!N]=+X<UA[AEYKQ+0;F34;@
M')/->R^$=-=$0D50CTNQNBL0.:L+JYC;K6;"I6'%5I@V[BI'<W)M8++UKG=2
MU%F)YJ4AMM4KJW+=JT21E*Y46_(;K5N/4..M9TEJRT+&RT#BV:,EX6%4+F9C
MG%3)$33OL9;M35@9DFX=6JW:ZP\)'-32::3VJE-IK@\"DV3J=#;>+6C &ZK/
M_"3_ &@8+5Q;6<JGO3XDD3UI\J*YF=/<W$=P#GFLB[C3G ID<K>M.96DID6N
M8]U'DG JIY)S6^;$MVIAT_':BX6,J.'VJ9H/EZ5H+8D=JD^Q_+TH PI+0,W2
MIK>S7<.*T9+7;S5:200TAW-*T585JAK4@:,@55?5-O&:JS77GYYS56 Y>^M#
M).3CO6OHL/DXJQ]A\SG%6(K?RJH@VH;K:F,U!<W6X'FJ?F$"HFD-2"(YF)JC
M.3MJ\1NJ"XA^7I0BS%E;#5-:WGEGK4-\I3-9$ETR-5$G8QZCN7@U(LY>N8L;
MLMWKH+4Y6D MTQVFL&\.YJWKK_5UBO"6DZ50$5MIIN&QBM1?")FB)V?I6OX?
MT[>RY%>B6.CQ_9N5[5C)V-%&Y\R^.O"YMX9#M[5\R>/(?L\SBON;XI:<D=K+
M@=J^)/BG'Y=S+@=S23!H\WAGVS5UNAZLT++BN+LHS-<8]Z](\,^%I+S80I-%
MPL=GHOB%O+ )J/7M2^T1&K]MX-FMX<["*Q=:L7@W BK1)SEDV+X'WKWKX:ZH
M(UC!:O 0WDS9/K7=^$?$HM64;L?C28T?43S1W5CU[5X]\0[!-DA K=TGQDDE
ML 7'3UKF/&FL)<0OA@>*E+4;V/G_ ,40[;IOK6EX)F\FX0GUJGXDQ)<,?>G^
M'6\N8?6M#(^H/!7B9;.U3YL8%7?%'Q&V6[*).WK7E>BZ@ZVX ;M6=X@N)9L\
MFIL7&0:_XLDU&9@&)R?6L%-(FU*0'!.:=IVFO-< MZUZ1X=T>-54L*"F8WAK
MP2V]24_2O5]#\+K#&N5_2G:/#;PXZ5U5O)$$&"*=R+,YO6M"B%LWRCI7@WC[
M2UCE<@=Z^CM:N$\AN1TKP3XA2*TCX-&XSD?!8\G4$^M?6'P]U+R;&/)[5\G>
M&7VWRX]:^@_">I-#8KSVI<H<UCUC4/$8C7&^J5OXF5GQOKS+7O$CQY^:N?M_
M&+K)][O5\I/,?26EZPDH'S5HW4D<T1YKPW0O&Q^4%_UKM[/Q6)XP-^:CEU*Y
MC,\<Z:MQ&^!7@?B+PH9+AB$[^E?1.H2B^4]\US-YX8%PQ.S/X5>PCR'PWX9,
M,P^3OZ5ZWH&CE47Y:ET_PL(I/N8_"NZT+0?NC;2<BR/2=+*A>*ZK3[!N.*U]
M*\-_*/EKH[70=N/EK%R+43*L=/+8XK<MM'#*.*T;72_+QQ6S:V851Q639I8Y
MS^PAQQ5JUTD1L.*Z+[.GI2B%1VJ+E$-K;B-15JD Q2U("4%J1J8: 'YH XIB
MU(O2@ VTA6G4F: &%: M/W4;J  +2TW=2YH 6BBB@ HHHH *3=2TUJ %W4M-
M'6ES0 M%-W4;J '44@.:6@ HHHH **** "BBB@ HHHH *AGN%@4DFI&8*,FN
M,\7>(EL8G.[%:4X.<K$2ERJY4\7>*%MHW ?'XU\]^//&A=I!YGZU/\0/B$%:
M0>9^M>">)_&'VB1_GS7VF P-DFT?+XS$W=D2^)-;^U.WS9K@-4D#,3FEN]:\
MQCS61=7V[/-?50ARGAM\VK,_4'ZUSU\_6MF\DWYK$O$/-=42&9,QJ#-33J<F
MH47)K5(SNQ5C+59AAQ4MO;[A4[Q[%Z5+-$V,$(85#+9Y[5-')AJMKM9:RE$V
MC,Q?LY5NE6;>,U8DC&ZIK6$9J8JQ4W=$]O"3VJS]G.VK%M&,5:VBM;G$S&EM
MCZ52FM3Z5T+Q!JJS6WR]*?-8I',30[344:GS*UKNVP3Q5%8]KTT[FJ9TWAWB
M1:],T<AHQ7E^CS")EKNM+U154<USU$4=)=0*T9K'6!4N ?>K;:@)$ZU6+;FR
M*P5S-[GJ7P[U!+::/)QR*^K?A]KT;0Q#=7PWH>K/9S+SCFO?_AGXN8M$I;]:
M\#,,*YQYCUL'74969]@6-P)X00<U:KE?!NJ"[MUR>U=37P52/+)H^PA)2C="
MT445F:!1110 4444 %%%% !1110 4444 %%%% !1110 4A&ZEHH I76FI<*0
M16/-X0AFDR4%=+16BJ2CLR'"+W.?C\(VJ+C:OY5A>(_!<4EN^U >/2N]J*XB
M$T94C-7&M.+O<F5.+5K'QI\4O ?$NV/]*^6?&/A"2&X?Y,<^E?I)XX\)K?(_
MR9S7SMXV^%YED<B+]*^TR[&JR4F?(9A@W>\3X_LM'>&3E:Z6PL>!D5Z/J7PY
M>U=CY>/PK&DT0V9Y7%?3JI&>Q\O*,H.S,)M/!7I63>:2&SQ743L(P16?,ZG-
M.PXRL<?/HW7Y:JMI07M763E.>E9\VWM3*YSG9+ >E5GT_/:N@:+=VIRV>[M4
MN)2F<U_9Q]*5;$CM74KIX]*9)8A>U3RE^TN8$-KM[5H6ZA:FD@"]J@=MHK78
MS>IIPW2Q]ZF_M%3WKF9[ME/%117;LW6F+E.G:ZW]#4MKND85GZ>C3$5U.EZ8
M6QQ3,BQ8V1D49%7)-&#+TK8L-/$:CBKK6XV]*SYB#DAHJ[ONUJ6>D+Q\M:+6
MXW=*U=+L3(Z\4F[*Y+DWH:GA/1AYR?+WKZ,^'NF^6L?%>7>#="+2(=M>_>#-
M)\E$XKYC,JRLT>_E=-N5ST#28]D*UI5!:Q^7"!4]?#2=V?H,%:(4445)8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>ZM5N%P15BB@6YSMYX7
MCN,Y0&LJ3P1$6_U8_*NWHJN9F$J%.6Z.0M?!\4)R$'Y5OV.FK:@8&*T**.9E
M1I1AL@JI>V:W*'BK=%2:M)JS/+?&7A,7,3X3/X5\X_$'P*5:0B/]*^T]0L5N
M8R,5YAXU\&K<PR$)^E=,)GRV99>JJ;1\">(=$:QF;Y<5QU],8V(KZ5^(G@5H
MWD(C]>U>$:]X:DAN&^4CFNR+3/SNMAY496.2,N35RS3SN.M3?V*^>E=#X=\-
MR32+\M;:'"^9NR)O#WAUKJ1?E_2O;O ?@E]T9\O]*;X!\"F1HR4KZ,\&^"%A
MC0[*YZE0^CRW+I5))M$W@;P\;../Y<5ZQ8KLMP*I:=HZ6L:\8K35=JXKSY.[
M/TW#4?8PL.HHHJ#L"BBD+!>M  :Y#Q=>^7"XSBN@U#4DMXSS7E7C;Q(FQQNK
MQ\PQ*I0:N>E@Z+J31Y!\2-2W-*,U\^^(V\Z1Z]8\<ZJ+B23!S7D&L2;I#7Y7
M7K2J5;GZ7AZ2C3L<5JD'S$UCM\IK>U1AS7/S2 -UKTJ.QE..I9A:K"+NQ6=%
M,*OVK[L5I(RV+L%ONK6M;,^E16,>[%=#:VHV=*Y)2-%(IHHAJAJ6I+$IYYJ]
MJ[>1&>U><Z]JS*S#-:TJ7.S"I5L3ZGK&YCAJI6^H,[CFN>:^,TG6M/3U+,*]
M'V:BCEC4<F==I\Y.*V8[DJ!S6'IR=*VHH2PKRZB5ST8,T-/U!DD'-=_X=UQH
M]OS5YY:V3;@<5T^D1,,"O.KQ70[(R74]=T?Q2RE1O_6O4/"?B!IV3YJ\+T&Q
MEF=< U[+X'T>560D'M1@:=;VFAY^-E2Y3V[P[<&:-376P_<KE_#=F8X5R.U=
M3&,+7ZW@8R4%<_.<4USZ#J;3Z2O5.(1:=24M !1110 C*&4@UP?C3P^+R.3Y
M<YKO:K75HMPI!%!E4IJHK,^2O&7PU-Q*Y$7?TKC(?A2_G?ZGOZ5]E7GA&*Z;
M)4537P#"K9V+6JG8^>J93&<KV/ _"/PS\EDS%^E>Q^'O!,<,:YC'Y5UMCX7B
MM<845LPVRPC %2Y'HX? PI+5&-'X5@$>"HS]*PM:\$Q2*V$'Y5WE->,2+@TN
M9G9+#TY*UCYQ\7?#D2;\1_I7BWBGX;NC.1%^E?<6H:#'=*?E!KA?$7@..96Q
M'^E:QJ'S.-RE5$W%'PAJ'@V2"0_)^E58_"\A/W#^5?4?B#X;CS&Q'^E8MO\
M#?YO]77;&IH?$U,JG&=K'S\WA>15SL_2LN\TEH<_+7TU>?#G;$<1_I7!^(/
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MSPW:_9[,<=JV:@LXO)A J>OU:G'EBD?EDY<TFPHHHK0@**** "BBB@ HHHH
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M3XE&Z-<_2K\/@S3X>50#\*WZ*SN:%.WTN"UQL7%7***0!1110 4444 %%%%
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M-V3/X5].>!_#*Z?$GRX_"BIH3#5G4Z'I:V5N@QC K6I%4* !TI:YCH"BBBD
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MQ&"#7Q_\-?%W,8W_ *U],^#]6%U#'\V>*^!S##.G)L^HP&)Y]#L:*2EKPCZ
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MU&T 4M%%>2>X%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !5'4-/2ZC8;<\5>HH$TI*S/&/&_@A;I7/E_I7@?
MBSX:GS7(B[^E?:>I:<ETA^6N)UGP7'<D_NQ^5;1J-'SF.RV-75(^+V^';^;C
MRC^5=EX3^')61"8OTKWX_#E/,SY7Z5NZ1X)2VVGRQ^5:>V=CPZ.3OGNT<WX+
M\&K:A,Q_I7K>EZ>EM$/EQ3-.TI+91A0*U -O K"4N8^RPV&C1C9(6BBBH.X*
M*** "JE[-Y:$U;K&UR79"U8U9<L;FE./-*QPWC#Q$;>-_FQ7S_XV\9G>XW_K
M7H?Q%OF5).:^8?'6JNLDGS&OSG,\3*<N4^XR_"J*4ANM>(A<.WS5Q^HWP?/-
M<]>ZX_F$;C50ZFTO>O%IT+^\SW_:J/NB:M=<FN;N+KYJT]0D+*:YVZ;YC7K4
MHJQG*=S0M[C..:U[&;+"N8MY.16S8R\BJG$RW.VTR;I746<H\NN%T^YVXYKI
M+*^&SK7F5(ZEV&^(G_=MBO(_$3'S&KU#6KC?&>:\Q\0+EVKOPIY]?1F':??K
MI]+7D5RT!*R5TFER<BNVJM#.D=?I^.*Z338A)BN5LI<8KIM)N!N7FO%JIGI1
M.IM=/!4'%;FCZ?NF48JAIUPC(!73Z&H,ZFO)<GSI,Z/LGJ'@/PNMR8R5S7O/
MASPDD$*D)7F'PZN(XO+SBO>M%O(I+=0".E?H>4TJ4HIL^)S&I4C(GL[(6Z@8
MQ5RBEK[",5%61\XY.3NPHHHJB0HHHH **** "BBB@ HHHH ***0B@ S2TT"G
M4 %13P+,I!%2T4 <Y?\ AN.X;.S/X53C\(QK_!^E=?15<S.9X>G)W:.0N/"<
M;KC9^E<SJWP^CGS^[_2O5::T:MU4&CF9C/!4I[H\(G^%Z,Y_=?I5K3OAC'&X
M/E?I7M#6<3'.T4Y;:-.BBJYV<RRNBG>QQ.C^#8[7;^[Q^%==96"VZ@8Q5S '
M04M0W<]&G1A35HA1112-PHHHH **** "BBD(H *6F_=HW4 .HHHH **** (I
MH1(M<WX@T5)(6)6NIK-UR0);'/I33,*T(RB[G@OB[0XU9SMKRS6M/2-FXKV+
MQM>J&>O(M9F\UFQ7;"Y^:9E&"D['GVLPA<\5QFI)AC7H6J6;29XKDM3TUAGC
M%;\Q\SRZW.6W;32O,-M/O(?)S6/=7FP=:S9K$BU*8<\US%[\Q-7[R^W9YK(F
MFR3S4,[(Q*%PN":SKAJOW+YS65<-2N=E-6*-RN[-9LJ[6K3F:J,JYI-GJ4Y:
M%=&Q5J-LU6V\U/%FIN7*UBPHJ11BDC^[4FVHN<4A5:IXSFJW2I8VJ[F$HHMK
M3MW:HE?BG9S6L3&P[=3EIBYJ1:IF;0\-TJ16-1J*M00[L4D9,GMV8&MVPF88
MJG8V!DQQ71:?HS-CBKY;G/4:+^FS$L*[/33NC%<_I^BNK#Y:ZS3=-<*!BM(J
MQYTF^AD:Y;[HVP*\UUC3W:0X'>O;[C0GN%QMK"NO \DC9\O]*)21V4:4I*YY
M5INDNS#@UZ#X9T%Y'7Y36_I/@.3S%_=?I7J/A'P"VY,Q_I4J21O'"SJ2LD4O
M"?A%I=F4X^E>O>'? (D5"8_TK?\ "?@D1*A,?Z5ZGHN@I;QK\M93K=C['+\I
M5KS1RV@^"4M]IV?I7>:;IXM5 QBKL<*QK@"I*XI2<C[*CAX45:*"BBBH.H*R
MM9L1=1$8S6K364,I!H)E'F5F>&>-O!PN%<[*\/\ $'@=EF;$??TK[(U;1TNE
M/RYKA=4\#+<2$^6/RK>$['R6894JKND?+EKX%=F'[O\ 2K-UX%=8_P#5_I7T
ME:_#]5;_ %?Z5)=^ U9"/+_2MO:GBK)&H['R%J7@^16/R'\JGT'P?(TZY0]?
M2OH_4/AR'8_N_P!*72_AV(90?+[^E7[70\_^Q9^TO8QOA]X/V>63'^E>]^'M
M)6TA3Y<<5D^&O#JV:K\N*[*.,1J *XYR<F??Y?@U0@A]%%%9GM",H92#TKF]
M:\/K>*?ES72TG6@B<%-69Y#J7P[2:0MY?Z4:;\/4AD!\O]*];:%&ZJ*%@C7H
MHK3G9YW]GT>;FL<]HOA]+-5^7%=%'&(U  IW3I2U#9Z$(*FK(BN(1,A!%<WK
M'AE+J-_DKJ:3K2"=.-16D?./CSP6L:R$)Z]J^<O&VB_99'^7%?<'CK3EEADP
MOK7RS\2M%/F2$+772D?GV<X*,6W%'SCJ:>6YJA I=N*Z76M)E\YOEI-&\.RS
M2#Y*[M#X)Q?-RHBTG3VED48KU?P?X9:?9\GZ57\,^"WDD0F/]*]V\#>"_+$>
M4_2LY32/:P. E5DKHRM+\"[H0?+_ $J+5/ Y53B/]*]]TOPPB0 ;/THO_"B2
MJ?D_2N3VKN?:_P!CQ<-CY;D\&NLWW._I77^%?!A\Q<I^E>L2>!U\S/E_I6WH
MWA9;5A\F*KVNAA0R51G=HI>&_"JQ1IE/TKIF\.HT>-E;-K:K;H !4[,%&37.
MYO<^NIX6$8\MCROQEX3C6W9MG:OF[QY8+:2R #%?6GC?4(ULV&>U?*7Q*NED
MFEP>]?!<0XIJ%D?<</9;#VG-8\LED_?$5(O.*JN<S&K:#Y17Y3S.;NS]=4%3
M22'444UCBGL DGS"BQM3)<+QWI8_G;%=-X=T@W$R?+GFKITW5DDC.I4]G%L]
M.^%ND[FBROI7T[X=T\0V<9QBO&_AMHOD^6=M>[Z>GEVJ#VK]AR/#^SI79^0Y
MU7=2KH6 ,4M%%?5'S 4444 %%%% !1110 4444 %%%% !1110 4444 %9&NV
M^^U;CM6O5>\C\V!A[5G4CS1:+A+EDF?+OQ2M"KR<5Y-IDP@U 9/>OH#XJ:26
M64A:^==2C>SOB<8YK\?S:#HXCF/UK*9JK0Y3Z0^&^J)Y<8S7MVDW FA&/2OD
M;P!XE,#QJ6Q7TAX+U^.XC0%^OO7VN2XR-2"C<^.SC"2A-R.XHIJNK+D$$56O
M+Z*VC8EQFOK7))79\HDV[(YOQQ>+#;L">@KYB^(&H+)-( :]A^)'BA!&X#_K
M7S?XDU)KRZ;!SS7YSGV+4GRH_0LCPKBE)C?#EN9M04^]?3GP]M3'8KQVKP3P
M%I#3W4;%<\U].>$]-^SZ>O':HR&@[\Y>>UE;E."^*C8MY*^=S&'U3G^]7T-\
M6/EAD%?.S3"/4_QKS<Z_WA7/0R;_ '=V/?/A?:J%C./2O?\ 2E"VJ@"OGGX7
MZ@FV,$U]!Z1<)):KAATK[C)7'V*L?&9PG[5W(/$D:OI[9&:^6?BA;J+B0@=Z
M^H/%5]'#8L"PS7RO\3+Y9+B3!SS7!Q#*/L[';D"E[0YCP<2M^N/6OH#1YC_9
MJ\]J\ \%QM)J"D#O7T'H]J?[-'':O!R9/E=CW,X:YE<\Z\=-N9Q7G=G K7@/
MO7HOCQ?++UYM:706\'UKS\=95M3T<#?V.A[W\,854Q\5[O#_ *I/H*\#^&%X
MA,>37O<#!X4*G(Q7Z'D[7L-#\^S:_M]3G?'B!M).1V-?)/CJ(#4'QZU]8?$"
M\CATPJ6&<5\E>-[H2:@^#WKP.)&M#WN'HO5DOA-RK#!KL;RZ?[/U[5R/A&%I
M&&!FNWNM-<V_2O"PBDZ6A[N)LJNIYYK3&20Y/>M;P7;K]K0GUK-\06[02'(Q
MS5GP??".\0$XYKB@U&NN8ZZFM!\I]6> 4"V' _AKK*XKX=WT<MF%W#)%=HS!
M5)/ K]<PC3HQL?E&*35:5SROXEQJZR<5\T^*(0ETV..:^B_B9J,:B3#5\X>(
M;C[1=L!SS7YYGTH^TL??Y'&2IHZ/X=R,MS'S7T78L6TH9]*\ ^'5@[7$9Q7T
M';0F+2^G\->CDJ?LF>=G,DZJ2/ _BM_KI*\_\*6PDOUX[UWWQ4;_ $B3ZUQO
M@W_C^7ZU\MC%S8P^GPC<<&?1WP]M52&,X[5ZW#_J4QZ5YAX%4?9X\>E>G6_^
MI6OU#+5:DD?FF8/FJLKZNP73YB?2OEOXI,&N9?J:^H->_P"0;)7RS\3L_:9/
MK7C\0/\ ='K9"OWMSA_#C?Z<OUKZ3^'3?N8^*^:?#K 7RY]:^D_AS(GDQ\BO
MGLB_B'OYVO</2=2/^A'_ ':\%^)!_P!;^->\:@RM9GGM7@OQ*!_>8]Z^HSC^
M$?-91_%/((_^/[\:]Q^%Z_-%7@ZR;=0Y]:]Y^%,Z;HLFOCLGUQ!];FR:H'O5
MM_Q[I]*\X^*C?N)/I7I$3*85(/RXKRKXK7R>7* :_1<PDHX9GY_@(N6(1\R:
M]SJ)_P!ZO2?AJOW*\RUB0/J)Y_BKT_X:CE*_,,"[XH_2\=IACVM?^/'\*\9^
M)7_+3\:]G4?Z#^%>,?$S^/\ &OJ\T_@'RF6?QSRO25W:D/\ >KZ@^$\*^7"<
M5\PZ-C^TQ_O5]2?"C_4Q?2O(X?\ XQ[&?-JB>H-]UOI7AGQ6(8R\>M>Y3?ZE
M_I7A/Q0/,OXU]EG#_<6/D,I_CG@DT?\ IQ^M>O?#7(:.O)IL?;OQKUOX;_>2
MOS[+/]X/N\Q?[@]BO/\ D&'_ ':^;_B=_P ?,GUKZ0OO^08?]VOFWXG-_I3_
M %KZ7/?X"/G\D_C,Y[P6O^G+]:^IOA\P%K']*^6/!3#[:OUKZD\ _P#'HGTK
MAX>W.O/]BQ\09!]A?Z5\F>,C_P 3)_K7U7\0<_87^E?*/C#_ )"3_6EQ$_>1
M7#RT9V7PS;]]'7TWX7DS;(/:OF'X9NHDCR>]?2_A25#"G->CD#]Q'GYZO?-_
M4+47$+ C/%>#_%#0]J2,%KZ"ZUYQ\2M)$UJY"]J][-*"JT6SQ,MKNE62/E&%
MC9ZIZ?-7NO@?Q L=BH+=J\6\36+6>H,V,<UH:)XF:S@V[\5^;8/$?5*K3/T3
M&4/K=)-'<_$;Q )58!Z\ST6,WNH#OS3/$6O-?R8W9K<^'NFFXNT)&>:BI6>,
MQ*L:TZ2PF&=SVKP#H.V*-MO:O7M-@$,(%<[X/TL0V2''85UBKM7 K]0P%!4J
M:/S#'5G5J,=12$T UZIYH-3:<>:3;0 ZBBB@ HHHH **** "BBB@ HHHH *3
M I:* $I:** "BBJ]U>1VT;%G ./6@"5I%7[S 5S>N6]I=;MQ4USOBCQJED&V
MR?K7DWB+XMM:EOWG3WJ9T%67*RH5G1?,CT^X\/Z=N)(6LC4H=/L4)!05\^ZY
M^T(;/=F;'XUYIXD_::#!A]H_\>KGAD]).]CIGFU5JUSZ-\1>.[72=^V11CWK
MRWQ-\?DT]7"S@8]Z^9O%GQZ:^WXG)S[UX[XH^)$]]OVRM^=>K2PD:6QY53%2
MJ;GT[XJ_:DD3>HN?_'J\<\2?M)SWDK+]I//^U7SIK>MW5T[?O&_.N4F:ZDGR
M6;K7>HHX7)GU!I?Q(EURX :4G)]:]Y^&6AC7&B+?-G%?#O@O4I+.XC+L:^UO
MV?O%D7G6ZLPZBLJBML;4W?<^P/AS\)$DCC?R^WI7M.@>!DT[;E.GM4'PDOH;
MS2XRN-VVO1*\Z4G<[XQ1#:VZV\051BIJ*2LRQ:*3FB@!:*** "BBB@ HHHH
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M*** "DVTM% "4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTJJ\UC'-U%=%&JZ3NCGJTE55F?-^K?#?S9"?+_2J$/PO^;_5?I7TG)H$$AY
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ML%%%%26%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<A9DKB)/!\IO"=AZ^E>H^ =!>U*97%?!Y;0J1KW:/MLQKTY4;(],OB?[*/\
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MM"H+-?+MU6IZ_6H+EBD?E4G>38UJ%IU%62%%%)0 ;J*;3EZ4 +1110 4444
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M* "BBB@ HHHH **** "BBB@ I*6DH 8U1U(U1T %%%% !1110 4444 %%%%
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MDY[UQMO]XU^&XZHYUF?MN"IJ%%%NG445Q([!K&D"^9Q22-BK%@GFN!BA>\[
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MIM/I-M  O2EI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *5:2C-
M#J;2[J2@ HHHH *%ZT44 .IIZTNZDH *5:2E6@!:**3=0 E%%% !1110!-MI
M:6DW4 +129I: "HKK_4M4M,F7=&13 \G^(*G[/)]*^0_BE,8Y9:^SO'MB7M9
M,"OCCXO6#I)-QZU]?E,E='S^/@['@=]?'[0>>]1RW9\OK534HY%NFX/6H)-X
MCK[OET1\G:S,W5KH\\U@K^^FQUJWJ[.-W%4-&W27B@CO6EK*Y47J=5H_AIKQ
M00F:GU7PN]K&3LQ7J_PY\,?;K="4SQZ5N>-/!7D63L$QQZ5XDL3:IRGMQHWA
M<^6+Y#!*138@7K<\4:6;>\88QS6?:VU>O#6-SR*FDBLT-5Y!LK6EC"BLVZ7K
M6%2)T4IE"24YI@;FED7FF8P:Y-4ST4TT7(/FJX(=RU1MFYK6A(VBNJ+NCAJ>
MZS-N(-N:HNQ6MRZCR*PKQ=N:YJGNNYV4)<RL*MUCO4GVK<.M9#2E6J6*8\5C
M&L[G4Z*:N:T4A9JV],D(85SMNW2MG3Y-K"O2IRYD>96A8[S1YB=O-=WHOS%<
MUYWHDFYEKO-*N!'M.:*B.$]M^'D*M/'FOK'X<VJ>1%Q7QS\/=75;B,9[U]=?
M#'4TDABY[5\7FR:1[V76N>J?='%8.KZPMGG+8K<DD"Q%L\8KQ_XBZ_\ 8Q(0
MV*^7P]/VDK'T567)&YT$GC6-'QY@_.M/3?%$=P1\]?*FK?$0PW1'F=_6ND\*
M?$3S&7,GZU[LLM:A<\3Z]:5CZNL[Q+A1@\U9KR_PKXO6X5/GS^->@6.H"X4<
MYKP:M&5-GL4JT:B-"BDI:YCI"BBB@ HHHH **** "BBB@ HHHH **** $W4;
MJ0]:!UH =1110 4444 %(:6D/2@!-U**;3ATH 6BDW4;J %HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI* %HI-
MU+0 4444 %%%% !1110 4444 %%%% #=U*#24+0 II-M.HH 2EHHH *0TM%
M#=M+2T4 %%%% !1110 4444 %5;Y-T3?2K51S+NC(J)KFC8J+L[GBWQ&MV\F
M6OE;Q]&5G>OLCX@:?NMY#CM7R7\3+,PR2<5^:YQ1:D??9357*>-W3[6.36/>
M.&SS4FM7WV>1AG%<S<:T,GYJ\O#TG:Y[%:5V27VWFN?O) N:GO-4#9YK!O+W
M=GFO6IP9PRE8;<7'7FL^2Y]Z;-,6JHQKNC&QSRD3&:F-,?6H&;%1M)6G*2F7
M8[DKWJY%>'UK%\S%2Q3'-'*/FL;?VHXZTGV@YZU2C8L*EP>*SY0O<UK6Z.1S
M6Q#<%EZUSEJIS6U:]!FL9Q1I$N-EJLV2L)!4"GBKUD/G%<LMC>*.QT#=\M=K
M:D[17(: .E=G8INVUX.(>IZ$-C:TVU:=UXKT_P '^'6E9#MKCO#-F'D3(KW/
MP38QJL>0*YL/252HKF.(JN$78[/PAX?\I4^6O2]/M?)0#%8>A^5&JXKIHYD(
M&#7ZKEM&%."L?GN,K3G-W)J*3K2U[YY8444FZ@!:0T9I: &[:=110 4444 %
M%%% !1110 4444 (:3;3J* $%+110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4W=3J:>M #JS]2L5N(SQFK]! ;@TT[$RBI*S/+O$7A
M);G?\F:\J\5>!4C5V\O]*^F[JR2122*\W\<6L45O)TK>-0^>QN!A*+D?(GBS
M1DLF?Y<5Y5K4RQNPKV7XH720R2@$5\^:YJ&Z9@#76I71^=8FFJ<[(S=2D#9K
MFK_'-:MU-NS6->-FL)&M$Q[AL,:KALU/<+DU L9K.QZ5U8?MW4>34L:5.(^*
MTL8N=F4O)I1'5PQ4WRJ.4B51D"KBI8Z=Y=21Q?,*=CG;[EZSCW$5O6=J..*S
M-/CZ5O0$1J*V43%EF&U&.E7[2SW,,"J45P,CFNDT&W^T3*,9K3EL<U1,V/#N
MB-+,GR]Z^B/ACX9^:(E*XGP+X6^T-&=F?PKZ4\ ^%?LZQG;7/4EH>YE>#E.:
MD=]X5T5+>U0[:ZA5"C %06, M[<**LUPGZA3CR02"D)Q2;J":1J&ZG4VG4 %
M%%% !1110 4444 %(32TUJ #=3J;3J "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R]6NO)A;FO$/B+
MJFZ.0;J]6\5WGDQ/SVKY[\?:IN,@S7R><5^6#B?5Y/0YIIGC?BR3S+A_K7.V
MZ_,:V=<D\R9C63"N#7X_6UJ-GZY2]VFD6:***D97N&Q6GX?C\R=1[UDW9K=\
M(QF2Z0>].BKU4@K>[2;/=?A[I/F>6<5[_P"'+$0PIQVKR_X8Z;NCB..U>UV-
MN(8P*_9\GP_+24C\;S:OS57$LCI2T45],?-A1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4V091A[4ZB@#ROQ
MUX;.H;_ESFO-(?AV5N]WE]_2OI"[TY+CJ*H_\(_%NSMKYW$97"M4YV?0X?,Y
MT*?(CB_"7ATV:J-N*]'L(_+C J&WT]8> *NQKMKUL/05&-D>5B*[K2NQ]%%%
M=AQA6=K,'VB KCM6C3)(_,7%3)<RL5%\KN>->)O"1NW8[,US%KX!,=QGR^_I
M7OD^DI-U%0+H48.=H_*OGJF5QJ3YCWJ>9SA'E.1\)Z#]CV?+BO185VQ*/:JE
MO8K#C JZO  KV,/15&/*CR<16=:7,Q:***ZSE"BBB@!":0&AJ2@8^BF\T<T"
M'4E S2T -VFEI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#D/%UFUQ&X%>'^*/"<M
MQ(V%)YKZ0O;43Y!K N_#<<S'*5\_CL L3N>[@<<\.?-5O\/I9).8S7;>&?AS
MY;*3'^E>NVOA.)6^X/RK>L]'AMU'RUYV&R.$)<S/0Q&=3G&R,/PWX?6PC7Y<
M5UHX %(J!> ,4ZOK*=-4H\L3Y>I4=27,PI.:6BM3(2EHJIJ%ZMG"6)P: +=%
M><Z]\0DT\M\_3WK@=4^.B6;$>;^M4HMD\R/H)Y%C&68 >]<GXE\31V:OM<<>
M]>&W/Q^68;1-^M8&I?$I]7!"R9S[U:@R>='9>)_BHUD7VR]/>O.-2^.\\,A
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MM,O@=N:8K:ER'5!N S5];KS%ZUR D9)*UK*ZW8&:06+MQ&9,U7^RGTK1@42
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M44 %(W2EHH 93J*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWD W^E8R1:/T&\.E6T],5K5Q7@/5_M5E&,YXKM <UD6+1112 **** "BBB@
MHHHH **** "BBB@ HHHH **** $;[IKE/$&@)?@Y7-=94;0ANM 'B6J?#"&Z
MD),0//I5K0OAO%8R*1$!CVKUYK&-NHI5LT7M0!1T&Q%C % QQBM:F*OETY:
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M_*N^I"<#)X%:1K3CLR>2)A:7HD6F1GY<8%>2_&36(X+.90>U>F>*O%$6FPN
MX&!ZU\G?&3QVMP)E$F?QKTL%1G5J*3./$5%"-CYH^+&KB6\EP>]>,74AED-=
MKX\U+[5<R'.>:X4'YJ_0J4>2"1\M.7,[EBUM]U7&M1MZ55@F"58^U UMH<^M
MRG<P;>E8]TA4FNC*^=5&\L3@G%<U2+.ZC)7U.>W$5;MY,8J&XA\LFF1R;:Y4
MVF=\HJ2-V&ZVK1-=!L\UB-=%>](+PGO6ZJ&*HEV7#&HV4"H?M&>](TN:3:-%
M!EA&P:T;&3YA6,LG-7[.3YA6M.>IC6IW1W&CS?=KJ[7YU%<+I4V,5VND2>8%
MKOO='D./*S8M5*,#70:?JS6V/FK)CC&S-0W$A3I6+5Q'8GQ8X3&^LC4-<:YR
M"V:YKSG;/-*&8U"I13N/G9;9?.?-;NCV>YAQ6+9J21FNKTC"E:<MC)GHO@JS
M59$-?2?P_NH[>.,$U\S:#J2VVTYQ7IGAOQH("HW_ *U\[C:$JJT/2PN(C2>I
M]5V=]'-$N#SBK0(/2O)_"_B_[2$&_P#6O1M,O/M" YKXRMAY4GJ?54<1&JM#
M3HHHKD.L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI* %HIN
MZEH 6BBB@ HHHH 9FG+2;:/NTP'44T-3J0!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %(U+2$9H 2G4E+0 4444 %(U+10
M S-.HP*6@ I.:6DR* #FEHHH **2EH 3%&VEHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MINZG4 %%%% !1110 4444 %%%% !1110 E%+10 4444 %%%% !1110 4444
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MQ7T9X;@\NV3Z5\-FDH\VA]=ED9<NIMT445\X?2!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %(W2EI&Z4 -IR]*;3EZ4 +1110 4444 %--.HH
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M+.P4445U& 4F:6FM0 NZEIJ]:=0 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBBB@ HHHH **** "BBB@ HHHH **** $W49IM*M "M2;:=10 E+110 4444
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MQ>FG;BNFL+H+CFMWJ<GPLZR%OEIDTFVJUK=!EZT^8[LU@60-=%6ZUIZ:QN&
M'-8,R-NXKJ?!]F9KA 1WHEI&X6YG8[+P]X=DO"ORYKU'PQX'?<C&/]*UOAOX
M52X2,E/3M7NVB>#4CC0A!^5?,8K'^S;B>K1P//J87@OPW]E"?+BO6=-A\FW
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M 4C4M)0 VG4;:6@ HHHH 2EHHH **** "BBB@ HHHH 913MM&T4 (M.I,4M
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MD(%2T.Y6L1MG!'K7MOPOU%H+J'![BO&=-A+S#ZU[3\,M'DENHL ]:20C[Y^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !115:^O$M8&8MSB@#(\0:XE
MC"V6Q7A?Q!\6?:ED57S^-;/Q*\6^7O57_6O&A=RZQ>;<DY-:)$GE_P 0+&YU
M)Y"@8YKRS^P;VSN=Y5AS7VQHWPK_ +8B#-%NR/2JGB7X$K#"S" =/2AL9X!\
M/?%L^CS1AW*XKZK^'?Q.2=8E:7T[U\R^*? <^BS,40C!]*@\,^(KK2;I59F
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MZY&[8W5\_P DCWN9&S14%O<K,!@YJ>HV*"BBBD 4444 %%%% !1110 4444
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M10 4444 (1FDVTZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HI*-U "T444 %%4=4OA9PEB<5YUKGQ.CTV8J90/QII7$>IT5YCX?\
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M]J\I^$L<8LH?H*]CCQL&/2L)&R'T44FZI&+12;J,B@!:*;NI-U #Z*8&I=U
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MT"BBDW4 )MI0,44M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !112;J
M%HI-U% "T444 %%%% !1110 444V1Q&I)H CNIA!"SDXXKR_QMXT2TCD0/C\
M:Z+QEXC6SL9!OP<&OE#XC>/&:\D02=_6G9@:7B76&UBZ8*V<FMCP/X6>:X1R
MO&?2N%\"W/\ ;%ZFX[LFOJ?P%X7B^S1OM'2JO81T_@_1X[.Q4E!G'I6OJ6F1
M7UNRL@SCTJU!"MO&$6I*@9X?XZ^&4=]'(PC_ $KYY\6?#UM*G=PF,>U?=&K>
M2+5_-V]*^=/BK+:K'+MV]ZI,#P/3]>?0[@ MC!KV+P)\4E&Q3+^M?,GCK61;
M73E&QS6!H/Q!DLKA?WN!GUK:US)NQ^FOA;QG#?QKEP<^]=E'>0R*"KBO@SP+
M\:/L\:!I_P!:]9TCXX1R*JF?]:R<2T[GT^K!NA!I:\A\._$Z*^VCS@<^]>C:
M3KD=\@.X'-04;%%(#GFEH **** "BBB@!NVE'%+10 4444 %-W4ZF4 .H)H'
M2AJ $W4ZFTZ@ HHHH **** "DI:* &XH IU% Q*3;3J*!"4M%% !1110 TK3
M-M2TW;0 BK1M]J<*6@!FWVI"*DIAH 92Y-!%+MI *K4C-2$4F*8";J-U&VDQ
M2$Q=U+2=/>@506%XI>*0]*;FD(EHJ/=2@T!8=NHW4W-(30%A^X4;J9N-&:!#
M]U ;D4VDW4#)Z\E^-7A_^V+&4;<Y%>KB2L?7M,74(6!&::=F$C\M_BQ\-I+/
M4)IEB(P<]*Y3PCXTN?"-TJABNTU]Y?%'X5)J,<Q6')/M7R/XZ^#%U;W3M'"P
MY]*]",U)69R2BT]#T?PK^T1/]C5#,>!ZUSGQ ^/5Q+"^V8_G7F%CX)U"Q8KL
M<4S4O .H:E@>6QI<L;BN[$NC_$R]U;4@-[')]:^A? UK<:Q:H6R<BO'OAW\%
M[L7D;O"W7TK[)^&/P]-G:Q!X\<>E34:Z%03ZGC_C3P-)]C=MAZ>E?*WQ(T>;
M3[A\*1@U^GWB;P*EQ8.!'GCTKY6^*GP?>ZED98?TJ:<QSB?'_ANZN5N@.0,U
MZ(U_/%:@DGI6Y;_"F6QO,F$CGTKH&^'\MQ#L$9_*MW)&44S"^'>N2'58P?[U
M?8_A^1KGPSG'\']*^>_ /PEN$U"-_*;KZ5]7>'?"KV>A"-E_AKGFT=$8GY^?
MM/6<JZE(0#UJ/]E^*5=6AW _?KW'X[?#%]7O'(BSSZ54^!OPPDTG4(V,6WYO
M2M>9<ICR^\>Z^-58^$C_ -<_Z5\)>,(Y?^$H;@_?K]%?$OA]KCP\8]N?EKY3
M\3?"V2;7&D\D_>STJ*<DBYQ-?X7;UT=,_P!VN(^+$TOV@@>M>X>"_![V.FJI
M3'RUQGQ"\$R7EP3Y>>?2ES+F+MH87P#:1M0C#?WA7W'8^'UOM!CRN=RU\L?!
MWP9)87T9,9'/I7VCX>A$>DP(1VK*H]2H(^2?CQ\-O+BED2/MGI7Q+XI:Y\.Z
MH^T%=K5^M/Q,\*QZYI[80$E<=*^(_BQ\"Y;JZF>. GDGI6U.?<RG'70\U^%W
MQFNM-DC1I",>]>^P_'IIM/VM+V]:^:D^$]]I-P2(F&#Z5J1^'=0C39AZIQBP
MBVD3?&#XFMJ"2[6R37S[INL7-_K QGEJ]IU3X:WVL<&-CFM7P3^S[<&^21K=
MNOI5Q:BB'=L[3X1:3->646Y3T]*[/QEX%>6S9MG;TKU+X7?"PZ9:Q!HL8'I7
MI&L^ 4N;(KY>>/2N:4M3=1T/S0\<^&Y]/G<A"/PKCM/N[F"X"\CFOM;XF?"
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M'JD4G0C\ZLI<*_2NQ3C+9G.XM;DM%)2U9(4444 %%%% !1110 4444 %%%%
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M44 %%%% !1110 4444 %%%% !1110 E-I])0 VG+12T %%%% !1110 4444
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M'Y%F[]]FI1117TQ\T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5<')E6Z^,U]?7I59F.3ZUZ-X%\87]TR,SMBO*?A[\,+C6=00["<GTKZT\%_
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M*6B@ HHHH **** "BBB@ HHI* %HI,CUHH 6BBB@ I,4M% "8I:3(]:-P]:
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M HHHH **** "BF[J44 +1110 4444 %%%% "4;12T4 %)SZTM% !136D5>K
M53N=2BA!^:@"[N'K2>8O]X5S%YXBCCS\WZUCS^+E7/S_ *U5@.^\U/[PH\Q/
M[PKSC_A,ES]_]:FA\8*S??\ UHL!Z%N'K2UR5GXD23'SUN6>J1RX^:E8#1*T
MVE616Z'-+2 ;1110 4444 +NH)I** $:DW&E-)MH =13<FE% "T444 %%%%
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M,OA9\K*+CN.HHHK4@***2@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2C=0W2FT /HI*6@ H
MHHH **** "BDHH 6BBB@ HHHH *0TM% #=IIU%% #2*%%.HH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !2;:6B@!.]+110!R'C73WO() HSQ7R3\7OA]>7WG%$8]>U?;\UL
MDXPPS7.:SX&M-25LHI)]JTC+E(E'F/R=\1_"[4H;MFV/U]#6WX*T>ZT>9#(K
M#![U][>*O@O:S;BL"_E7E/B#X1_92YCAQ]!72JMT<WL[,QO!OCB/3(XPYQBO
M2[/XP6<<*@LOYUX;JG@F_M6.Q&&/:L23P]JRM@"3'XU/*F4FT?4=E\7;20C#
MK^==5I/Q(@N-N''YU\AZ?I>J0D%@]=EHNH7EEMWEABI<$7S,^O\ 2?%4=UM^
M?K72PS+-&&4YKY9T;QXUGMWOC'O7::;\9(;90&E_6LG!EJ1[M17CZ_'.TXS*
MOYU;M_C1:S=)%J>5E<R/5:*X:P^)%O>8PZ\UT-CK\=WC# YI68[FQ1358,H(
MZ4ZD,**** "BBB@ KPG]IC_D"R_[G]*]VKP_]I"$R:-+QGY/Z5<-Q2V/RL\?
M,1XHD_WZ^KOV4[A5DM\G'2OD[XJ$V?B*5B,8>O4?@'\3H]$FBW2;<8[UZ,M8
MG"G:1^M&DS(VFP,&& O->._&CQ,EI;S@/V/>N!TG]HRW32U3[0,[?6O'/BO\
M8UUE9527=N]ZX8P=SJ<U8\[^(7B@WE\Z!L\UE>&=+>]F5MN<FL2QMY_$&J @
M%MQKZ&^'GPY=K6-S%V]*ZF^5',M68]CIIMK/E>U>=^+;=9+K!'>OH'Q)X?.F
MVC?+CBO _%1/V\C'>E%W&U8]2^ ^AV\EY"60=?2OMC3-#M(]#!5%SM]*^,/@
M9(T=U#]:^U-)=Y-%7_=KGJ;F],^8/CM"L+3!1ZU\L0R#^W #_>K[ ^.^CNT4
MS[>Q-?%'B"__ +)UDLW&&K6&J,YZ,^XO@&L;6*<CI2?M#;(]*FP1]TUXM\&_
MC%#IUNJ-*!QZU/\ &GXKQ:MITBK+G*^M1ROF*YERGSS;W"_\),?]_P#K7TCX
M;8MH Q_=KY4T.Z:\\0AQSEZ^N?A_I[7FCHF,_+6L]#*!\Z?%9IAJ$G!QFM/X
M,LIU&+S1W'6O2?B1\-'NF>01?I7G6CZ>_AB^#$;=IJHNZ"UF?H+\)EL&TN+<
M%SMK@_VD([+^R;C:%^[7F7@'XN?8;=8S-C QUKFOC9\4/[0TN4>;G*^M8*#Y
MC?F7*?(GB2./_A+&V#^.OK'X-QG^P$Q_=KXW_M'^T/%&[.?GK[D^!.G_ &G0
MXEQGY1714T1C#<\#_:+DE2:3@]:ROV;62378O,'\7>O9_CY\-Y+Y)'$>>_2O
M'?AWI[^$]8#,-@4T)WB*5U*Y^HG@&&P'AN,L%SL_I7A?Q\:S6.?:%[UA>'?C
M4MGI*P^=C"XZUY=\4_B(=7CE(DSGWKGC%W-)25CQ+Q-Y;:LQ4?Q5Z9\-RZP+
MM]*\:FO3>:IUSEJ^COA'H)N[5#MSQ6\MC.&K.0^*DDALV!STKQGPSI(OM:4%
M>K5]/?%KP>ZV+ML[>E?/&DRC1=<&_P"7#U4'H3..I]"^'?AK'>:.I\L'Y?2O
M/O%7PH6'4,B/OZ5ZAX/^)EE;Z6J-(H.WUJOJ'BRRU:^&UE/-1=IE631%\/?!
M;V-F-J8P/2O-OC];7%K:R !N]?5GP]T^&\LEV@'(KS_X\?#DWUG*RQ9X)Z5*
ME[VI;C[I\/\ PSW/XE02#C?_ %K]3?V==/LGTBW+A2=HK\V[?PV_AO7?,*;=
MKYZ5]3_"GXU)H-I%$9MNT8ZU=5<RT(IOE>I]:?%JSLDT60[5#;>U?F;\=Q$N
ML3;,?>-?4OCOXXKJVFNHFSQZU\4_%#Q$=4U9SG.6J*,6BZDDSTW]G%C_ &Q!
M_O"OU \#_P#(MVOTK\QOV:H2VJ6YQW%?IWX+7;X=M1[5%;<NEL7]8_X\)*^6
M?C;_ ,>\_P"-?4NM'&GR5\I_&Z;%O/\ C6,-RYGYZ_&S_CYG^IKYKU#_ (^S
M]:^C_C1)NNIOJ:^<-0_X^V^M>K#8\V>Y:M_NU-4-O]VIJHD@N_\ 5GZ5E:7_
M ,A-/K6I>?ZLUEZ7_P A-/K3Z"/NG]E9?](M?J*_4KX9KC1(_P#=%?ES^RHN
M;BU^HK]2_APNW0H_]T5YM;<]"CL=91117*=(4444 %%%)F@!:3=2TUNM #J*
M** .:\6Z]_8]NSYQ@5\\^-/VC/[!GD7SL;?>O9/BM:RW%C*(P<X[5^??QO\
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M,A;CUIN*L"D[V/L.XUI(;7S"V.*YY?'$1N?+\P=?6O-?&WCT:5I!S)@A?6O
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M44 %(:6FM0 W(I,&DI] $1HI6I* "BBB@ I0U)10 NZC=244 .!I]1K3UZ4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***2@ W44VG+TH 6BBB@
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MM?2QAD^;''K7S3\4O'G[V15D_6NL^)WC?[)'* _KWKY)\>>.'N;QQO)YK2*
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MZDQ16Y M%,S3EHL M(W2EHH 913MHHVB@ I&IU)0 VGTF!2T %%%% !1110
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MM,UZ***^H/F HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZT444 %%%% !1110 4444 %.IM&30 K4E%% !12K0U "44TFE6@!:D5JCIU
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MCWB#PK)*[86L"/P3,S?</Y5],#P:EX<[,YK2LOABLA!\K]*R=2QO&G<^8H_
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MZU\;?$SX@31Z]*BR'[_K74_#O6+O5H5PS-FNCDT(4SZ$U;XG2+<<2''UKK?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN:  C%)2M24 (:3;3MII=M  %HVTM% #2,44K48- !MI*=3: "BBB@ HI**
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M4#"BBB@ HHHH *;MIU% "#BEHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% $5U_Q[O]*\.^)D6Y9*]RN/]2_TKQOXB0[EDKP\UCS43VLK
MERUD?,/B:';</]:YB2NV\66^V9_K7$7'RL:_&,5'EFS]EPLN:"%C[TZF1T^N
M0ZNHVK5G)ME7ZU5--CEVRBA.S"2NCVWX;W&9HAFOJ+P@VZQ'TKY)^&EUFXBY
MKZR\%-NL!]*_5N'I<T3\KX@CRR.DHHI!WK[@^*%HHHH **** "BBB@ HHHH
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MG_#>K+=6R\YXK?5MPR*Y#H%HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#BJ]O#TXK7MH>*YZDC: D,/S=*Z;18^E9$4/S"NAT>/!%<-26AT(T;BW+PG
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ2 <6J,TII.*0Q*3)]*<*7;0!'2K3J* N*!2TW=2Y% A::U+NI,T )13EI:
M&44XTV@I!1110(**<!2T ,HI]-H$)BC%+Q10.XE%%**!B44[%+0(:M.444JT
M .I&&X8I:* ,/7K$2V[<=J\#\>>'R\S$+WKZ3N8A-$5-<3KGA47C$[,U<969
M$E<\1\&:&8;Q,KW]*^C_  S;(FGKE>U<CI/@X6TP;9CFN_T^#[/;A153E<45
M8KWVDQ76?E%<[J'@>*Y!_=C\J[.BLS0\AU;X3PW ;]T/RKA=:^",4F[]R/RK
MZ7J*6UBF&&0?E34A6/BCQ!\#57=B']*\VU_X,/&&Q$?RK]!-2\,PW&?D!KDM
M4^'L5SG]T/RJU,7*? NF_"N:"^'[L]?2OI?X1^$7L8XB5(QCM7H2_"J,3[O)
M'7TKM?#_ (173T "8Q[4.5Q)6,_4M0.EZ?UQ@5XEXP^*#6-PX\W&/>O6_B+&
M\5FX7TKXS^*372W$I7=WIQ5Q29Z$GQL*2<S_ *UO:/\ &Q7D&9_UKXQU+5+Z
MWD/+=:K6?B^^MW^^U7R@F?HYH_Q>@FA :8'\:@\0>+K/5(&RZG(]:^$]-^*%
MY;8!D8?C70V_Q?G9<-*?SJ.49ZUXXM[2X:1AM->*^(K6&-FQCK4NH_$AKM3F
M3-<;K'B8W&X[JZ(.VYSS1H:=(D-R"#WKVSX<^)!:R1#?CGUKYGCUW9+G=7<^
M#_%1CN(QO[U<M4$%8_0WX>>)OM$<8W9XKV&QD\VW#5\D_!WQ";CR1OSTKZLT
M&3S-/0UP25CJ1I4445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBD- "TR6,2+@BEW4Z@#$O]$2=3\M<7KGA-65
MB$_2O3ZJWEFLZGBM(R:,Y13/G'Q!X5*;L)^E<!JVBR1,?EKZEU;PRLZGY:\X
M\3^%4A5CLKMA6.6=(\ N+-H\YK/FB/K79^(K5+5V'2N/G)9CCFNF,N8Y>1Q9
MCW5EYE55T<,W2MIH6[BEC7;UH<4QJ31S>H:")(S@5QVI:"UM(6 KU=E5@<BL
M#6[-61L"N:5,Z8U#A]/\42Z&PPY7'O746GQMEMXPOGG\Z\X\56;HS[1BO.=0
MFN(9#R:Q<3=3N>]ZW\:)9XV_?'\Z\J\3?$"6^9OWI.?>N NM0G.06-9DTDLG
M>HL-LTM0U1KIF)8_G66RECUIJPRL> 35^QTFXN' "$U0C/6V>1L+S6QI/AN>
MZD7Y2<^U=IX9\ SWDB9B)S[5[KX#^#;7#1EH/TI-E)'"_#3X9R74T1:(G\*^
MO_AI\(T\F,M#^E:GP[^$:6?E,8?TKZ \.Z#%I<(P@! ]*R<C0XK_ (5;##:\
M1#IZ5Y_XM\"BV5RL>/PKZ1Z\&N<\0^'TOE;"9S4J06/C+6EFTF<[01@U=\._
M$":RF4,Y'->L^-/AJ9][+'^E>,^(?!,^ER,RH1BNA-,R:9[]X(^)23A \G/U
MKUO2_$=O?QJ=XS]:^$-,U^ZT>< E@ :]8\%_$J3**\GZUG*):9]6+(C<A@:2
M2=(U)9J\WT;QS'-"I:3MZU7\0>/([>!L2 ?C6?*RS8\:^+(K6V<!AP/6OF+X
MA>,/M$D@#9J_XZ^(AN&D19<_C7D>H7DFI3$YS71"-C"4K[%:93J$Q)YR:T=/
MT':P.VI]'TT[@2*ZVTL0JCBM'(%$H6>F[5 Q6M;V?S#BK4-L%[5=AA]JR+2(
MH;?':K:0U-'#[582&I-"!8ZE6.IUAJ18:9)76.I%CXJ814NS%(2(MHI=M*RX
MI*"PV4WRZDIR#UI(FQ79-O-4M0NECC/-7KZ98T-</XBU@(K -3#8Q?$VL;=P
M!KSZ\OFGD(S6AK5\UPY&:R([<L^:T2,I7&M:F7FB.U\HYK6@M_EZ4VXAVJ>*
M8BWH]YY4@&:]-\-W?F[>:\<MY#',*]+\&W&YD!J65%GJUA!YB@UKVMKTXJGH
MJAX5^E=!;0].*@T)[.';BM!1BHXH]M/D;;30B.:0*M95Y<=:L74V >:Q[J;)
M-2V,K7$N6-4V.:DD;)J*I&%(:?MI#0@(FZ5#)4[=*ADJQ%"X[UBZE_JVK;GK
M&U/_ %;?2@#S[5O^/@_6NS^'S;;A/K7':M_KS]:ZSP&W^D)]:OH3U/JGP/-_
MH\?TKNT.5%><^!W_ -'C^E>B0G]V*YF:$E%%%( HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]8OYU'*Q\R/6Z*X+3_B5#>8PZFNCL?$$=WC!%*S'<VJ*:C!U!'2G4AA1112
M*3O2T4P"J]W<"!,DXJQ6#XHNOL]JQSVH \.^.VO!;&X7=V-?ES^T#>_:+RXY
M[FOOKX\>(#Y-P-W8]Z_.?XQ7GVF[FYSR:[Z*.*LSPQ5_TP_6MJ(?**S%3_2"
M:U8_NBNPXD.JI?'Y:MU2U%MJ4%$_AOY[Y![U]C_ /2_.D@./2OC?P@WF:E&/
M]JOOG]FO2/M!@.WTK.IHC2FKL^W?A'I?E6D)QVKW2V7;"@]J\_\ A[H_V?3X
M3MQQ7H:C:H%>7+<])+0=1114%!1110 4444 %%%% !1110 444V201H6/04
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MZ#%>&^&-=)9!FO6M O#.B\U\_/ K#;'TE#'_ %G<Z"BBBN8] **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ I*6HIVVI2;LKC(KBZ$:]:QKS5@O\
M55]8U#RP>:XS4-9.X\U\]B\9R:(]7#X7FU.DFUP+_%2V^O#=]ZN N-4;UJ*+
M5F5OO5Y,<;*YZ;PBL>NV6L*^/FK7BO%D[UY+IVN$$?-75Z;K6[&37L8?'J6C
M/-K8-K5';*VZG5EV=\)%'-:*2!J]N%136AY<HN.X^F4^DP*U($6G4E+0 444
M4 %%%% "9HHQ10!'<#=&17G/C:SWPOQ7I+#<IKD/%]KNMG..U>;CJ?/3._"3
MY9GR5\1K)5DDX]:\/U:W7SFKZ ^*4!CDE_&OGS6&(G8>]?E>*BX5#])PK4J=
MS"OH0JG%<W?#YC727C_*:YJ^D )KKH;&<]'H94R]:H3/Y=6[F<+GFL:\N!ZU
MZ4(LXY3)_M^SO4BZKT^:L":XYZU6:\*]ZZ?9W,><ZO\ M7WI\>I9[UR:7Q]:
MN6]P3WJ'2L-2.TL-0(8'-=GH7BAK5EP^*\OLYSZUMV4[%A@UQU(6U1O%\VY]
M$>%_B!*&0>8?SKVCP;XLENF3YR:^4_"*/)+'R:^COAOI[MY5>-S5?:61O*G3
MY+L^C?"MZ]PB9.:] L\[17#>#]/*QQY%=_#'L45^E99&?LTY'P>.<>>R):**
M;7O'E#J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO>0B2!Q[58I&&Y
M2*35U8:=F> ?%2TVI+Q7RWXG7;=-]:^O/BM:[HY:^4/%MJ5NW^M?D/$5.U0_
M6N'ZG-31A6?2K3=:KP+M J>OCH['USW"J\BY:K%,9>:)#B;&@R>7(IZ5[?X!
MU+#1C->"6,OEL#7J/@34OWR#-?0975Y*B1X.9T>>FV?5GA6;S84Y[5TM<3X$
MN/-AC^E=M7[+A9<U),_'<3'EJ-!11176<H4444 %%%% !1110 4444 %%%%
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M$,O4"K]% &'-X6MINJK^5</\0? <#6$CK&#QZ5ZI6+XL42:3(,9X--"/S?\
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MIU&T4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>M>$VLBV4Q2YKEN)P5G)-"P.XUUVA^))K-E.\_G6#=VI@)&.E46G=.E MCZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKQVKP'X8:=Y:Q<5]&: NVT ]J^MRN,6KGQV92?-8TZ6BBOI#P HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4,B_G71ZSKEEK$&-RG(J-4S32Q\M^%_"MSI^L*0I #5]*Z-=SVNA@,3]VH-
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M$QW%HI,TM,84444A!@T4E+0%PHHHH'S!11138KA1113&%%%%( HHHI %%%%
M!1110 4444 %%%% !1110 +UJ1:8M/6@!]+24M !36IU% ""EJ&:X2'EJS+K
MQ19VN=[ ?C0!LT5S:>.M/D;:'7/UK8LM4AO@#&<TP+E(U+2'FD VG4;:6@ I
MK4ZB@!HZTZD:D9@@YH =14'VN/UIXG1N] $E%5IKZ.$9)K-N/%5K;G#,/SH
MVZ*P8?%]G.V%8?G6O;7272Y4T 2F-3VHV*.U.HH *:U.HH 2EHHH :U)3Z*
M"BBB@!E*M.HH **** $S2TFT4#B@!:*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **:\@C&2:R[_7HK-6^84["+6H:@MG&23@XKQSXF?$!+2UE D[5+X\^(
M26T,F)0.O>OE/XG?$=KII567/XUI&)#D<;\6OB(]Q<2@29Y]:\?L_%#37GS-
MGFK'B)YM6G8\G)K#AT.:&8-M-;Q5C*3YCV/PWJJR1KSS7<V*M<J *\:\.7+V
MK*&S7LG@V\CGV FNB,CE<6;$/AN2ZQ\N:V=.\"2.R_(:]"\(Z'%?*GR@YKUG
M0_ 4;HI\NHE5L:QI7/&-#^'K,5S'7H>B_#M"J[H_TKU*Q\'0VZCY5%;-OI44
M'0"N652YT*G8\_M/A[ J_P"K'Y5J6O@V*%AA!7;K"J]!2^6OI6-V;:&59:+'
M%& 1BJVL>%X+V!AM!KH** /F/XG?#V%4E81C\J^2_B%X4$,D@5/6OT0^(6C_
M &JWDPN<BOE+XA>$&::0E/TK6)+/CG5/#+,[?+7/W/AMD)^6OH75O"RQNV4_
M2N4U#P^GS86M&B#P^ZTTP9R*S))#"U>J:QX9+;L)7&:EX:>-B2AJ0Y3(L]9E
MMV!!(KT#PCXUEAF3+\9KSR:Q\GJ,4ZTNC:MD'%58%H?7_@_QY') @=^?K6_J
MWB."ZA.&!KY,T?QG-:[0)"/QKL].\</,H#29_&A:";N=IK]X'D8@\5SOF&1L
M9JI<ZXLRY+5'8ZDAF&2.M:7,;'<>&]+::13BO8O"N@!50D5YAX3U*%=I)%>M
M:#KT"*N&%3)FL4=M::6L<8P*LK#MJK8ZPDZ##"M.+$F,5D:D:QU/%%4RP59A
MM^:8A;>WK7M8,8J*VM^E:<,>T5(R6*/%2TBTQSB@EA(X JA<38%27$VWO67<
MS47&B.XFSFL^1\YI\LF34.-V:FPP6JFH3".,FIYI/+!-<UKVJB.-AFJ!',>)
MM6V;@#7G>H7QN)#S6KXBU$S2, :YN(&23GUK1(ALGM[<LP.*V[.#:HJO9P#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHUYKHHSN45YWX2NS(B9->@V[;HQ7PN(AR2L?HF$J>TA<EHHHKE.X**** $-
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MQBO#_#%X0R\UZYX=N"R+7MX*IK8\'&4[:G544B_=%+7T)XP4444 %(:6B@!
M:6BB@ HHHH *X7QMI_VF&3C-=U67JMB+B-N.U<6+I^UIN)U8:I[.HI'R#\0O
M#Y5I#MKP3Q19>2[C%?9/Q*\/_NY"%KY6\>:6T=Q(,5^6XO#/#U&S]%PN(]M!
M(\;U*'<S5@7&FM(W2N[DTII)",5=M/";3]$S^%:4JVATU(GFT>BM_=JTNEE5
MY%>H#P1(%SY=4KKPI)&?N&G*NUJ91@F>?KHY8_=K3L?"LDQ&$S79Z7X5>64
MI7JOA'X<FZV9CS^%%.LZNB+FE35V>3:#X%F:13Y9_*O9O!/@N2)HR8_TKU3P
M[\)5VJ3%^E>CZ+\.5M0O[O'X5W4\MJ5'S'EULQA%6,_P)HIMUCRM>QZ2GEVX
M'M6%I.@BTP N*Z6WC\M,5]I@,.Z,;,^0QE95G=$U%%%>P>8%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5L,87%:>FW G@![U<KZV,N:-SY.4>5V&IQ@>U+1BEJA#,TX=*3;2T +1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "L?Q!;^= 1[5L57O(O-C(]JSJ1YHM%PERR
M3/G;X@:+DR';7@GB2T^SROQCFOKCQUHNZ!VV]J^8?'UIY$TG'>ORS/<-[-N1
M^GY'B?:)1//=WSU8'2J6[]\:NK]T5\+!GW4A:BN.5J6F2?,*J6Q*W&Z6VRX4
M^]>X_#G5?):,;L5X?;C9(#7<^$]9^SS(-U>EEM;V-1,\W,:7MJ;2/L3PKJPF
M@0;J["-MR@UXG\/M;^T+&-V:]GLFW6Z&OVK 5O;4TS\:QU'V51HGHHHKTSS
MHHHH **** "BDR** %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4A&:6B@#G/%UB);!CC
M/%?*7Q/TLK-+QWKZ_P!<C\RR88KYY^)&A&5I3MKY#/L/[2GH?69'7]G4LSYC
MDMS'.W%3+]VMS7-+^SS-QBL%FVMBOR*I#V<FC]:IS]I%,DIE.7E:6I*(\;1F
MK6FWQAN%YJ"1?DJM#\LXI*7+)-%<O,G<^C?A;JVYH@3Z5]+:)=":QCY[5\<?
M#G5/L\D>6KZ<\'ZX)K:-=U?K.0XI.GRL_*<]PS53F1WM%1PR>8F:DK[8^,"B
MBB@04444 ,I5I<"B@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0G%+4-U)Y
M<)-)NRN-&?KM\L-FW.*^:_BEJVYI0&KU[QIX@$,+KNQ7S=X]U874DGS9S7PV
M?8M<G*F?;9'A7SJ3/,=5NS)=-SWJ.+YE%17:[IB?>IHAA:_)[MR;9^IZ1BDA
M](>E+2-TJA#<U:L;,SS+QGFJ"/F0#WKL_"NF_:I4XS6U"'M)6,ZT_9PN>@_#
M;1<31G;7U!X3M1#9+QVKR'X?Z!Y8C;;7MVDQ>3; >U?K^2X?V,+L_(\ZQ'M9
MV+]-7K3J:U?5GRPZBFKUIU !1110 4444 %%%% !1110 4444 %%%% !1110
M AZ4VGTE  O2EHHH *1NE+10 RG+THVBEH **** "BBB@ I#3:<M  *6BB@
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M%"<$BJ^K3&.-B*\N\3>)'M)&^;%4E<#UB'7(96P"/SK0CD$BY%?/NE^/0MP
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M:A1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^"_C%9Q:*JM(O"^M?.'[3GQ$M]7AF"N#G-80OS&LK<I\J>"+Y[+Q)M4X ?\
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MF&([,?A7MPZ"N.;NSI@K(6BBBLRPHHHH **** "BBB@ HHHH **** "BBB@
MHHHH *0C=P:6B@""2SBD^\N:B_LFVSGRQFKE% $,=I%%]U *FHHH *:RAQ@C
M-.HH JR:9;R_>C!J+^P[/KY0J_10!472[9.D8J1;.)>BXJ>B@!GE+C&.*@DT
MVWF^]&#5JB@"I'I=M&<K&!5@1*!C'%/HH JS:;;S_?C!JJWAK3V.3 ,UJ44
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** &44NVC;0 E*O6C;2[: %HHHH **** *>I7@M;=CWQ7SG\8M<W0
MSC/K7NWB:7;"_P!*^8/BY<;EF&:]C+Z:E-,Y*\K*Q\C_ !,O#-=2\]Z\S529
M":]%\=1^9<2?6N'6W*D\5^F4+*"/"EN0^:8A3)-4*]Z2\&T&L6ZD.371:YBS
M775B6^]6MI]V)".:XCSBK=:V-+OMK+S3<=#*4$ST6S4.HJXUM[5C:/?*RCFN
MCBD6117*]&<,HV*BV^*<T V\U;8J!5"ZNQ'GFG>Y$8NY1OHU4&N:OKCRR<=*
MT]1U$'/-<U?3>9GFKBCTZ=TAK7QSUIRW6>]93DYI4D85ORFMS8\P-2>7NJI#
M(:NQ'.*S:L,18>:G6$%>E.5>!3]P%3<=BE<6@93Q69-9E6Z5T2@/44UJ".E"
MD484,.W%;&G@ C-5I(MAJ6U;:PJWJB3J;+&T5?;[M9-C)P*TMWRUS- 8^I+N
M!KG)K;]YTKJ;L;LUF/;Y;\:UC*P&?!#MITAVU=\G;5.XJT[C*K-352C^*K4,
M>ZJ8K$2QGBG&.KBP<4DD86I0%%H^*JRI5^3 %4IC5DE7'-!45'(^VHA<>]%S
M1(61:CR:F#;J/+S2&0\M2_9]U6(X:LI&*=K@Y%..R^;I6A:P".GQJ*F' J>5
M$<S9HV<@7 K>L8?.(%<K;2$2"NY\+PB:50?6L:GNH<5=FUI7AE[IEPA/X5Z%
MX<^'4EP5S$?RKJ?AWX32^,65S^%?1WA'X;QB!6\H?E7S>*S#V>AWTZ%SRSP3
M\,O+:,F+]*^@O!OAA;&./Y,8%:ND^$H[3;\F/PKI[6T6!0 *^3Q.+=4]*G34
M2>)!'& *?117E'0%%%% !112$T +13=U.H *2EHH 8T2MVJA?:2EPC#:#Q6E
M15*31/*F> _%'P6)H)B(\_A7Q;\4_ <@FEQ&>I[5^EOBG2%OK=QMSD5\^^//
MAF+UI"(LY]J]S!8KD>IY.+P_/L?G+?>#98YF)0CGTJG_ &&T)Y6OKOQ)\(C%
MO(A_2O)O$W@62S9\1XQ[5]13Q$:A\W4P\J9Y MIY?:GJ@6MK4-)D@D(VU3%B
M[<8KK.-RZ%>-C6OI<9DD%1VNBRR8PI-=9X;\,S23+E#U]*1/,=%X9TEYE7"U
MV!\-R-%]PUUW@#P.\R1YC_2O4O\ A7O^CY\OMZ5S2Q,8NS-5AY25T?,&H>&W
M#'Y/TK+?PZ_]TU]%:KX!/F']W^E97_"OV8_ZO]*KVT=S)TY+0\/M_#;EONUN
MZ;X=?</EKUR#X?$'_5_I6I:>!2K#]W^E+ZQ$S=&;//\ 2?#)8K\GZ5Z1X7\)
M_,OR?I70Z3X.*LN8_P!*]"\.^&1'MRGZ5QXC&12T-:&%G*6I5T'PH/+7*?I7
M3)X/1U^Y^E=3I.DK$@^6MI+=%7&*^6K8N3EH?98?"14?>//AX)C_ .>?Z4O_
M  A<:_\ +/\ 2O0_+7TI/+7TK#ZU4[G3+"4V>=MX21?X/TIT'AM8V!V?I7?M
M;(W:H_L:^E5]:D8?487O8Q--TP0X^6MZ% BBA80O:I5KFG/FU.^G35-:"YHQ
M1BEK(V"BBB@ HHHH YSQ!'NC:O)?$T.UFKV'7L>6U>2^*F&YJ^8S!:GO8$\Z
MU*3;NKD=4<MFNKU7EFKF+Z'.:\BF>S(Y2\3YC63.V*W]0CVYKG;PD9KNB<[*
MS28[T@EJN['--5ZVL)HL-)FH_,J-I.*B:2JL9WLRSYQ%21W1!ZUG^9S4L>2:
M?*5<V;>Z/K6C!>'N:PX*N19XK%Q*1U%A=;F'-=KH-R%*\UYQ8R%6%=3IM]Y>
MWFL)*S*>J/;?#>J*FWFO2]&U8,J\U\\Z+K11E^:O1/#^N%MOS5O3Q'LV<-2A
MS'M%O="11S5C-<CI.J>8J_-726T_F <U]!0Q"J(\6K2<&6Z*2EKM.<**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:* *EW9B9&
MX[5XA\3]$^64A:]ZK@/'6D_:HI,#/%>3F-!5:+/5R^LZ59,^)O%&FM'=/QCF
ML6%2@YKUWQQX9,<LC;._I7EU_;_9V(Z5^*8R@Z-1G[/@\0JU-6(<T]:K1R9-
M3JU<2.UZ"L.]5IF*'BK)/%5YX]U3+8<=SI/".I-#<)SWKZ<^&_B(>7&"U?)&
MF2&WD!SCFO6_ OB@PR1KO[U]/DV,]A-)L^:SC!^W@VC["T^\6YC4@YJY7 ^"
M=>%W%&-V>*[T'(!K]AH556@I(_(J])T9N+!J6D(S2UT'.%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BDI,F@!U)B@4M "8I:0T4 <WX\E:+1W*]<&O@KXW7UW-=3
MJI;&37Z >*+/[=I[1@9XKYI\<?"5M5NY&\K.3Z5M3:3,JBNCXHT?P5<:[?@/
M&S9/I7OWP]_9U2_6-GM\YQVKU+P;\%19W*LT/?TKZ(\&^%8-*MT_=@$#TK65
M7L9QAW/%M/\ V8;9;>,_9AT_NUS_ ,1OV;(+?0G9;<9P>U?7%4=:L4U#3I87
M7<"*PYW<UY$?C-\3/A+/H^L2&.%AAO2NJ^%]O>Z;&%(8<5]J_$3X)1ZQ=R2"
M ')]*Y/2O@4;%CB''X5U^T36IR^S:9\N?$^.\OK<C#'BJ'P1\-W*Z_"S(WW_
M $KZMU[X'->\&'/X5J> ?@A_9-\DGD8P<]*?M%8OE;=SV'P!:M#X;12,'9_2
MO"OCEI4MQ--M4U]4:#H?V/31%C'%<)XY\ _VL[GR\Y]JY8RL[FTEI8^'-)\/
MW"Z@#L;K7OO@/09?LRY4]*ZJS^$'EW ;R>_I7I7AKP&+6(#9C\*TE(SC ^:?
MC%H$ITV7:IZ5\>W&GWEGX@R%8?/_ %K]1?'GPY&I6CKY><CTKYWU;X L^I&0
M0?Q>E5":L*46V<_\,-:NX=)1"6^[7._$Z.ZU*1N&.:][\*_"5[*W5?*QQZ5:
MU;X/M>-DQ9_"CF5[CY78^:/ASX:N%O%9D;KZ5[-J6ARMI1&T_=KT3PS\(?L,
M@/DX_"NSN?A^'M=GE]O2HE/4:BT?GY\0O#ERMQ(51NM<3IOV_3+@$!ABOO/Q
M'\$QJ$C'R<Y]JXV\_9S;DBW_ /':VC45B'%G@FC_ !"U&UM=F]AQZUQGC;6+
M_7I"I+-FOI"Z^ <T+$"$_E3M/_9]DN)UW09_"CF6Y/*]CQCX'^!;BXU.*1XV
MZ@]*^XM+\ ";PZ%:/G9Z51^&OP5716C8P@8]J]\T_1$@LA%M[8K&=2[-H1L?
MG3\<?A.\=W+(D)Z]A7C>DR7WA:<[ R;37Z:_$#X91ZW'(?*!S[5\[>+?V?FD
MD<I!^E:QJ*UF9RAKH?.C_%[5(V51*_''6LZZUR_\4/ARS;J]<F_9WG:X_P!0
M>OI7:^$/V?7AD0M!^E7S1(49'E_PP^$[ZC>12/"3DYZ5]5Z7\,5L-#P(L';Z
M5UOP_P#A;'I*QDP@$>U>I3:'']B,87MBN:52[.F,;(_-?X_>$[BWN)3&AX)[
M5XOX3U+4-&O^-RX-?H_\3O@^NO&0B'=GVKP?4/V='@N69;?'/I6\9IJQC*#O
M<\@U+QYJ$VG[-[=/6O+=6;4-3O"2&.37UC'\!99%V^1^E:=A^S>2P8V_Z4U*
M*)<6SP_X/Z%=+?0,RMU':OO_ .$]NT6FQAAVKS/PC\%?[)F0^3C'M7O/AK2D
MTFU4$8P*PJ2YC:$>4Y'XMZ"E]I<V5S\M?FI^T!X<_L^\G95QR:_3SXAZQ MA
M*I8=*_/K]H:W34)9]G/)JZ-R*B/F'P7=2_VND>3][^M?H9^SCX=^W0VS,F>G
M:OAOP'X/FEUY&V$C=_6OTU_9G\._9=/MRZ8PHK2L]":2/?-!T=;&VCPN.*VZ
M11M  Z4M>>=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,'UKZ&\ _$@72QAY?UJ7$+GT#2UDZ+K4-_;KAQG'K6KD'O690M%%% !1110
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MFE.TKGM8>5T=K2T45\X=X@ZTM%% !1110 4A&:6B@!NVG444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M('I7L5C9+9QA5&*YYRYC>$;%JBDS1FL346BBB@ HHHH **** "BBB@ HHHH
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MRZVKC-8%Y<EF/-6+NZSFLF:3<U)C(Y)"QI 31168QPHI,FCF@H2D.:=MHVT
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJW!S7['@<5'$05C\=QF%>'F[E^BBBO4/-"BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***90 ^D:A:6@!E/I,"EH **** "
MBBB@ HHIM #J:U*M% "9IU(13: 'T4B]*6@ HHI&Z4 +13*<O2@!:*** "BB
MB@ HHHH **** "F4^DP* $6G4E+0 E)NIU)M% !]X51NM)CNAA@*OT4 <I=?
M#^RNV)95_*BS^']C:,&55_*NKHIW8K(JV=A'9J @JU112&-;K0O6EQ1B@!:*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "L_5]06QA+$XXJY+.D*DL<5Y?\2O&
M"6UO(%?''K30'$?%7XB):V\JB3MZU\E^)O'HN]28>9D;O6NB^*GBB>_FF5')
MY]:\1DTV[N+DOACSFMDK&;/IKX1:U!<31;V%?7_@VXMFM(]NWI7YS^!-8N-%
MGCW$C!KZB^'7Q2 CB1Y?UJ7J4CZG4AE!'2EKD_#OC.VOX5!<'CUKIX;J.<91
MLUF42T44E(""ZLTNEPPKC_$G@2"^C8A <^U=Q2,H92#TI@?,'C3X:B+>4B_2
MO/K7PS<6-Z-JD &OL/6/#L=^I^4&N0G^',9FW>7W]*KF%8P?AG#+'Y8;->T1
M_P"K7Z5R^@^&5TW;A<8KJE&% J6,6F-(%ZTYNE9&IWPMU))Q4@:?VA.F:D5@
MW2O/[CQ?'!*07_6M32?&$%P0-X_.JL!UM%5[>]BN%!5JL4@$9MHR:XSQA,DD
M+@^E=1J=Q]GMRU>0^-/$HC+C=5Q5Q,\<^)&FQSM*0*\#US3A!,Q KW/Q1JPN
MM_.:\@\2J&=L5UK8YGN<'>NPX%7M!M7GF7(SS3UT_P"T3 8SS7=>%?#/S*=M
M '5^#=#RB$K7I5C8B&,8%9/A[3A;1KQ74(!MK%LW6P^ =!6K9KTK/A7I6E"=
MM(#220*M0W%QQUJ%IN.M5)IMU#&$TVZJ[=:,TE3<04445-B@IRT@7UIX7BG8
M&"TM%(QIB&/WJ)J>QIN*0T-IRB@+4FV@8Y6VJ:YOQ+)^Z;Z5OR/M4UR/B6?]
MV_-.)+/*O$;;IF^M9-BN6K3UP[IF^M4["/YJW1D:D*_+5R-?:HH8^!5J-*AF
MA-&M6%7%1(VWK45Q?I&IYI 6)+@1CFLZZU98U/S5D:GK04-AJY/4-<8YPU4D
M*YOZGKP .&KDM2UPMG#5G76H/(>M4G5I*8AUQJ3OGFJOVEF[U*+,FG+9FJN!
M79BU1LM7C:FH9(=M(#/ECS3K&WW2"IS'DUI:79;I!Q5$,Z#0K/ 4XKK;=6B4
M&J>B6/RKQ6^UIB.HN4EH):ZHT+#FNKT3Q 0RY:N$FC*M5FQNC"XYHL(]NTW6
M!+&.:OR3B1:\TT76L8&ZNRLK[SD'-38T3+DIZU3FDZU8F;Y:R+JXVYIHEE/4
MKC:#S6&TAFDQUJY?3>;D"ET?36N)UXSS5DFWX8T,W$R';WKW7P7HGV=4.VN6
M\#^&_P#5DK7L6DZ:MO"O&*QG(J*-&%=D:BI**:U8&HZBDI: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M #=M*.*6B@ HHHH *;DTZF[30 HI:1:6@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'3DXL****U,@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHI %%)2TP"J&K7JVD))/.*LW$PA0DFO/?''B1887 ;MZUR
M8BLJ,&V=6'HNM-)',^//& 2-U#_K7SIXRUMKR9_FS6]XZ\4-+*X#]_6O,[J\
M:XD))S7Y%FV8.O-QN?K&4Y>J,5)HIEBTA)J=>@I@7FI*^8B?4!113)&VK3D(
M5CQ45K;M)< #UHA8RMBNP\+^'VO)D.W/-71INM))&=6HJ,6V=;\//#[7$D9*
MYZ5]+>#_  VL%NAV8X]*X3X=^%?)$9*?I7N&G6PM[=5 K]>R7 JG3O)'Y1G.
M.=2=HLEMXA#& *EHHKZS8^2"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&I,F
ME:DVF@!U)MI:* &49I<4E QU+24M @HHHH **** "F4^F[: !:=2 8I: $I-
MM.HH 2EHHH *2EHH ;MI:6B@ HHHH **** "BBB@ I#2TAH 3)I12;32B@!:
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI#2;J '4444 %(U+2-0 F
M33J;M-.H *1F"J2>!0S!5)/05R'B;Q0FGPR?/CCUH R?'?C!--CD DQUKYM\
M;^-GU.9T63.?>K?Q2\<M<22*C]_6O+]%2?5M0&<D$UM&)+9H6?@V7Q!<9*%M
MQKL;'X&[K?<8.<>E>L?"WP2LD,;O'V]*]JM?#=M';A2@SCTI2D)(^%O%'PQD
MTG<RQ$8]JXJ+5+O0KH#+*%-?='C7P'%?1N%C!_"OG/QI\)9?.D9(C^5$64RK
MX&^*4T3(KRD?C7T7X)\>)>1Q[I,_C7QQ-X9NM$FSM9<5U'ASQU-I!56<C!]:
MIJY)]VV>IPW<8*N,U<SGI7S)X1^+7FLBM+^M>S>&_&$>H*OSCGWK)Q*N=M14
M<,RS(&4YJ2I&%)2T4 )2T44 (WW:X;QI<M#"Y%=R>E<KXHTLWD3@#- 'S5XN
M\47%I</ACUK-\/\ Q&F2X :0]?6NP\;> )KAI&"'\J\KN_"=SILY;:1@UT*Q
MEJ?2?@SQTMTJ;I/UKU73]4ANX58.,XKXLT7Q+-I#J"Q&*](T/XL>7&JM)^M2
MXAS'N?BS5(X;4J&[5\V?$#7")I,-WKJ-8^(2WT)_>9S[UX_XRU7[078-FKA$
M4I'/WVM>8S M7*ZI)]H8XYJKJ&H,LIY[U)IJM>2#O6S,BWH>EF6925[UZWX9
MT<)&N5K \-:#PC%:]'TNU$*@8J&S2*+-O (QTJVE)MJ2->E9,U+$-6PW%58_
MEJ7?20QSR=:A9LTK-3:38A<9H(Q2K0U2 VEVFC;3]M-##;3U6A5J55JA#-M1
MN*F;BH6-("$KS1MIQ%&VI&(*E5>*8%Z5.J_+TH S[YMBFN$\1W'RL,UVFK2;
M5->=>()_F:M(DLXC5/FF/UIMBGS4ZZ&^0_6I[./&*U>QDC1A7Y15E65157S
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M>E*<K"BF;?AG1EMHT^7%=6HV@ 5%;VXA4 "IJY6S=!2$9I:*0PHHHH ****
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M'K'A.*ZC;Y :Z*>.E&6Y#I)H_.WQ7\+'69\1'\JYVQ^%\K7 _='KZ5]V:_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 RE6EVT 8H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD:P1H1H(U %.HHK U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY?CXXB"5S\ES# RP\V['5T4U6#J"*=7NGAA1110 FZC--I5I@.HHHI %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@\UAWEQNSS4][<=:Q9YCNZUT1B3L2;LFK$+[<8JA')DU95JT$:T%X5[U?AU
M\<U@(^.]6(YJS<0W.CCO-W>K"RAA6##<'UJY'<&LFBS0?!J"0"F"?.*"VZDA
M#X3\U7MN8ZIP#YNE6VXCI/<9AZLHYKF+HXD-=/JF3FN5O/E8UTP>@,2-OFK2
MM),5BK+@UH6LW3FK:)1T=K<8[UL6T^5%<S:N>*V;1CBN:2"QMVK;I!7JGP_C
M5IH\UY':R?O :])\$ZB()DY[UQ5XWB5!V9]A?#6WC\J/CTKW/28PD"D>E?-/
MPS\1#;&-WI7T1X=U1+BW49[5^?8Z#4CWZ$DT;U%(&#=#2UY!UA1110 4444
M%%%% !1110 4444 %%%% #*<M-IRT +1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !29H:FT %*M I: "FT^DH ;3ATHVBEH :U"]:6
MC% "T444 ,I5I:6@ I*6B@!E.7I1M%+0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444UJ '
M44U>M.H 1E#*0:YWQ'H$=Y;L=N>*Z.FR*)%*GO6=2FJD>5FE.;IRYD?+7Q$\
M%E?,94_2O"]:T5[2=LKBON3Q9X96]A<[,\5\]^/O!)A:1@GZ5^99SE3BW.*/
MTK)\TYDH29X7YGE\&GJ^X5/K&F/:S,,8YJE$VWK7P$DX2LS[I6E&Z)FH'2@,
M&I:I AC1!JA9C"<BK-1RQ[Z3\BD^YO>&_$4EI,OS5[QX!\=85 TGZU\RJIA.
M172^'?$CV<JC?@5[.7YA/#35V>-F& CB8NR/N;P_XD2ZC4;@:Z:.02+D5\R^
M!?'6?+!D_6O<O#OB2.ZC7YP<U^M8#,(8B*U/RG'8">'D]#JJ*9'*LB@J:?7N
M'B!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%,04444 %%%% !1110 444FZ@!:*3=2T %%%)NH 6BF[J4&@!:*** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44AI-U #J**3=0 M
M%(#FEH **** "BDW4 YH 6BBJU[="VC))Q0!7UJ^6QLW8G!Q7SI\3O&NWS$#
M^M>A?$3Q@L-FZB3G'K7REXTU^34+YPK9YK6,2).QR_BKS=:F?!)R:X>?P).T
MN_8>M>U>#/##ZK,NY,Y/I7K4'PB6:U5O)_2M).Q"U/D_2H;C1&!P1BO5O!/Q
M*GL9(U9R!]:ZWQ1\'FC5BD)_*O+]4\'7.CS$A&&VLT:GU;X%^(RWBQAY,_C7
ML&F:S!>0KAQFO@3PYXON-'D568C'O7M/@SXK&3RU:7]:'$+GU(&!Z'-+7!^'
M?&"WZ)\^<^]=K:W GC!!S60R>BBB@"&>V2=2".:Y_4/#:3L3LKIJ* .0M?#(
MAD!"XKI;&W^SQXJS2T %(W )I:ANGV0L: *EUJ*09R:AAUZ!FP7%>;^./%#:
M?OPV,5Y@?BH\-UM,G?UJN45SZIBN(YAE6!J6O%/"/Q&%X%!DS^->J:/K$=[&
M/F'-*P7->BBBD,*RO$%Y';6+;L9Q5R\NA;QDDXKRWXA>*Q#!( _:FE<#S#XG
M:S&S2@$5\]ZQ;_;;IB/6NO\ '/B8W%S( V>:YK2?]*F&>:ZH*QSSD6?#VB%)
M%.*],TFW$<8XK(TFP554XKI;6/:HJFR8HM11UH6ZU5A6M"%:AFI/&M3JO%,C
M6I5K,L%7FG;:%7FG;30(;MIZK2;33A04B55I],1JDQFF#$I,4[;1MI"&-3&I
M[5&S=:0#:7;24^@0S;[4NVG[:7;3&-5:G1:8J]*F4A:0%>XF\M37*>(-7"(P
MS6SKEX(8VP:\K\2:P2S#=5Q5R&[&5X@U(S2, :YU5,TE2R3&XD]:MVEK\V<5
MM:QG>[%AL-R]*IZAIV$/%=1:6PQTHO--\Q.E(L\JO[0JYXJ.SA.X5V&H:*2Q
M.VJ,.DF-ONT[7)"QM20.*TTM=HZ58L;+:!D5>DA"K5;$W,Z./!K0ME JF[!6
MJ2.X"CK0(UUF$8J*>^"J1FLV6^XZUFW5_P!>:"2;4M0X/-<;K%T7SS5Z^OB<
M\U@W#F8F@M&=&IDFKL/#UCG!(K&T^PW.#CO7<:+9B-1Q4,:-NSMQ'&.*L-*%
M7K432;$JC)<%FP*25RKDMQ,35/:TK5:@A:?M6YINAF3'RU>Q.YFZ?I32L,BN
MMTO0]H!(K0TW0Q'MRM=!!:+&HXK.4BU$HV]B(E'%1W6%6M2;"CBL6^?K4&AS
MNM-E6KF+>/\ TP?6NCU1MP-8UG#NNAQWIHB1[+\,8OFCXKZ(TE=MFGTKP7X9
MP;3'Q7ONFKMM$^E8R942U1114%A2$9I:* $VTM%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** *6H6*W41!%>7>-/!JW$;D)^E>O51U#3DNH6&.:
MX<3AHUXM-'=AL3*A)-,^+O&G@UK>1R$_2O,;RQ>SE(((Q7V9XT\%K<+(0GZ5
M\_\ C+P:UO)(0GZ5^5YIE<J4G**/U/*\TC5BHR9Y8MQSBK"MN%-OM/:UF((J
M*.;;Q7R6L79GU6DE=%BBD5MU+3(&E >U0,QC;(JS3)(PU)^129I:3KDEJZ_,
M17JW@[QPT+("_P"M>)[?+Y%:%CJSVK AJ]#"8R>'EN<&*PD,1'8^S_"?CI)D
M4&3]:]#TW5$O5&#FOBWPKXVDAD4&3OZU[GX+\>*RH&D_6OTW+,WC52C)GYIF
M642I-RBCV^BL?3O$$5Y&IR"36LC!UR*^OC.,U='R4HN+LQU%%%60%)2TUJ %
MR*6F4^@ IK=:=10 U>M.HHH *93Z* &4JTZB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHI %%%% !1113 **** "BBB@ HHH
MH 2C-(U H =1110 4R201J6/%5[K4([8'<:Y#Q%XSCMXV <#\:YZM>%)7;.B
ME0G5=DC3UOQ1'9(WSXKQWQM\0AMD D_6L+QMX^/[P+)^M>+:]XHENI7^<G\:
M_/LTSK>,6??97DVTI(T?%'BJ2[D;#D_C7'R7CS,<FD:8SG)-((P*_/JM6=:7
M,V?>TJ,:,;( -U/5:%%.K,V"BBF,^* %9N*C1B\F!3H\S' YKH-#\.O>3+A<
MTX4Y5':),ZD::O(-#T%[Z1?ES^%>U> _ 9S&QC_2G> _ A/EEH_TKWOPWX9B
MLX%)4#BOT'*,GNU.:/@,VS:UX08OA?P['90J2N,"NE50HP!BB.,1K@=*=7Z/
M3IJG%11^=U)NI)R84445J9A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "-
M3:?10 4UNM.HI@-6G444@"BBB@!E*M.HH *XKQ[KBZ?;/\V,"NGU+44LX6).
M#BOG_P"+GB[=%*JOV/>JBKL3/+?B+X\,TTD8DSSCK7":+9OK5X#@G)K*U-IM
M5U,\D@M7L_PF\#M<-&S)G\*Z?A1A\3.]^%O@P1^4S)^E>^V>DP06Z(4!XK%\
M+^'5T^%/EQBNIKGD[FR5C%U3PW;7T9^0 _2O(/'?PWCF20I&/RKWFJ5]I<5X
MI# <U)1\(>+? <]C([)&1SZ5R^G7%UI-T =PP:^U_%WP\ANH7(C!_"O!?%GP
MU,-PY2/OZ5JF38L^ ?&SJT:LY[=Z^AO"GB(74*\YXKY@\/\ ABXL[E?E88->
MZ^";>6)$!S42&CUV"7S5S4M4]-SY(SZ5<J!A1110 4444 %07B[K=A[5/367
M<N#0!X5\2M%FN%E*@U\Y^(-'N[6Z8[6 S7W-K'AV*_C;*@YKRCQ?\-XY-Y6/
MGZ5I&0FCY]\.^))]+90S$8KV#PA\4!'L5I/UKSOQ-X'ELW8HA'X5RD,=WILW
M\0 K:R9GJC[*T+QY'?(HWY_&NQM+Y+B,-N%?'GACQK+9,H=R/QKU;1OBE$EN
M THSCUK*42TSTKQEJZVMNY#=J^8OB1XN9GD4/^M=QXP^(27T#A9,\>M>"^*+
ME]0N&.<@FKA$4F<K?3/?7!/7FN@\.V)5E)%5]-TO+ L*Z_2[%8\<5T&&YO:;
M%M1:V(5Z5GV:XQ6M!'TK,M%F%*OQ+4$$=7(UQ429:'@4]1TI!4BUF4.5:7;3
MEIU B/;1MJ3'M3E6F,8HJ5:3;3@M "TE+36IV C8U&>M/:DV^U(8W;3]M.51
M3MOM2)&4]114BCI0 X1_+5&^N1;J>:O22!(S7'^)M4$2-@T[#,3Q-K@VN-U>
M8ZM=&>0X]:T=<U9II&&:R88_/;-;11A)W%L(2Q&:WK>#IQ56SM=N.*V;6WW8
MIR!(MV%ONQQ6NFF>8@XS2Z78DXXKJK'3MRCBB(-G$W7AW=GY:S)O#WE\[:]5
MDTD,.E96I:6JH>*U1FV>9S6HM^U9EU<!<BNBU^/R=V*X74+HJQYI,$/FN,DG
M-0FZQ6?)>>]0-=U!J7IKOWK/N+H\\U%)<Y[U1GN.O-,AD-Y/D]:AM_WC4R5M
MYJ[IMON<50[FWI=J.#BNDMOW:U3TNQ)4<5NPZ8S8XJ;!<@^:3BK%OI;2L.*U
M]/T1F(RM=5IN@#C*U+E8:5S!TG03P2M=CIND+&!D5H6>EK$HXJ]Y8CZ"LW(U
M4;$ M5C7I4<GRBK$C54F:H**=PW7FL;4&X-:\_>L/4FP#5","_;.:ATF#?<+
M]:==-N8UJ^';/S)UX[U:V,V>P?#FWV^7Q7MMFNVW0>U>5> ;/RU3BO6(1MA4
M>U<\MS6))1114%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "'FLZ^TE;Q2",Y
MK2HIIVV \H\=?#V.ZM7(C!)'I7R/\5OAD\;S%8O7M7Z$W5NMU"R,,YKROQ]\
M/XKZVD?RP>O:O:P6.E2E9G+5I*1^6_B3PC+:S/E",>U<;>6)A;D5]@?%7P''
M8M,0@&,]J^9/%5FMO<.,=Z_0\+B?;1/%J4^4XXKM-3V[8-5[AMK&HXY\5Z)S
MV9O1RC;52\S(#5>&YSWJ]&OFBI+M8YRXMVW<"KVEQE6%:<FGAN<5):V8C8<5
MR23N;*2L:UJQ\H56O/F8U;CPL=59\,:UCH<TM64XH^:T;>*H84J['A:J4AH=
MC:*K7$FW-3R2#%9]Q(,&I2+*=U.>:RIICNJ[<'-9LR\T-&D6A\<QS5^";I62
MO!JS'(:UBB)RU-J.:I]VZLB&;U-78YJ&B$R?^*M"SDVXK+\SI5B&;%2T(W/M
MF%ZTV.\RPYK-\_-2V_+"HL!T5I/D"K+3#;6;:\**ED8UE;4":.?]X/K7IG@%
M#--&,=Q7EUG;M).OUKW#X6Z*TDT61W%<F*:C"Y=._,?1WPTTO='$2M>]Z'8B
M.%>.U>>_#71/+MXB5["O5[>(11@ 5^=8RIS2:1]#1C9$@&.E+117FFX4444@
M"BBBF 44C4F30 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_K7H^GZE%=QC##-??4,5"NKIGP=?#3H.S1>I*,@]*6NPXQ-HI:** "BBFEJ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI:0=*6@!",TFVG44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %,I])3 1:=112 **** "BBB@ HHHH CF@69<,*Y;Q%X
M5BNX6(7/%=;3742*0:QJ4HU%:2-J=65*5TSYC\;> .9"J?I7C&N^$Y+61CLK
M[EU;PS'?1ME0>*\C\:?#]=KD1_I7P6:9+S7G%'W66YU9J$F?*-Q;FWX(J!9J
M]$\4>#9(9&PAZ^E<+>:3);L<J17YW7P\Z,K6/T*AB(5HW3(5?=3JA7]V>:D$
M@-<R?<Z&NPZD(S2T51(PQ"A?W?(I]*R[J5NQ5R6UUR2U88:NOT#QM+&Z@O\
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M:@#D5>''%+17TT8J*LCYIR<G=A13*5:HD=1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 %%%% !1110 4444 %%%% !1110 444F?:@!:*2EH **** "BBD9@HR3@4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT(.&4?C6,J]..[-8T*DMD=+)((U))Q63>:ZEOGYA7%ZM\0HMK8D'YUP6O?$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4SS$_O#\Z/-3^\/SHN@LQ]%,\Q/[P_.E\Q?[P_.F ZBF>8G]X?G1YB?WA^=
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1>"=)/F(<5[IH-N(;4?2N(\*:)Y2H=M>B6D?EP@5RS=V;Q5D3T445F4%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^M+_ ,+07_GI^M?,2^*)_P"^?SI?^$IF_OG\ZT_M^IW,_P"P8=CZ<_X6BO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1]-,\P.*]A\%Z3Y00D43>@0W.ZT>Q$,*'%:P&T8IENGEPJ/:I*XSI"BBDR*
M%HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F4^B@!JTZB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F[C3J2@ !I:**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>%%+1161H%,I]% #5IU%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ I*6B@!-M+110 TFC)H(HVT "TZD I
M: "DVTM% "8Q2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1124
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFN/NO^/P_6NS\+_>2ORG"_Q3]0Q.E,]P\"Z:DOEY&:]Q\/\ A^#R5)45XYX
M/^KKW?P^W^C@>U?L.40C*"NC\DS:I)2T9,VAVQ&-OZ5#_P ([;Y^Z*UZ*^G]
ME#L?-JI-=3,CT."/HHJ]#;I"N *EHJHPC'9$RG*6[,W7_P#D'O7RS\6#^\E_
M&OJ;7O\ D'O7RO\ %G_63?C7R'$/\(^JR#^*> W?_'X?K70:&H9E^M<]=_\
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M^>?Z5*OP_/\ SS_2A91/L3_:T.YX<OAUS_":FC\,NW\->Y1^ /\ IG^E6H?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q/%'_ !Y'Z5\J_%7[\U?5
M7BC_ (\C]*^5?BK]^:OBN(OX;/LN'_XAX+=?\?A^M=GX7^\E<9=?\?A^M=EX
M7^\GUK\GPO\ $/U+%?PSWSP#_P LZ]W\/?ZD?2O"/ /_ "SKW?P]_J5^E?L6
M3_"C\AS;XF;5%%%?5GS(4444 9NO?\@]Z^6?BQ_K)?QKZFU[_D'O7RS\6/\
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M_@Q/PS%?QI!11178<@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M(>E ";J=3*=0
M M%%% !1129% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC;3J*!C2M)C!I]-:@!56I8TID8JPJXH*#[M,>G,U0NU FQI-1LW3FE8U$S4
M#-4;/2,U1,U  [U6F>G2-52:3K5(ED-Q-C-9%Y-GO3[^ZVYJA&QN& K1(R;'
MVMNTT@XKO/#.A^8RDK6=X=T0S,IVUZEH&C"!5^6HE*Q48W+VCZ8(8UXK>7Y5
M IL<(C0"D:N9NYT;#RU)N]Z914@/W>]*&J.G+VH ?12;J3=0 ZDW4F[BF$YI
M@2[J0TU:?2 93MU-I-U #MU&[WIAHH 5C3>]+10 ]33J93Z $:DI6Z4W(H <
M&I=WO3-PI-U #RU.6H]PIRM0!)12 TM !1110 4444 %%%% !1110 4444 %
M%%% !1249H 6F[:=10 W;2CBEHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG[/D_P#!1=TW_6+7L?P[_P!9'7CFF_ZQ:]D^'?\ K(Z65?Q$5F?\-GTOX/\
M^/5?I725SG@]<6J_2NCK]IP_\-'XWB/XC"BBDKI.<6J&L?\ 'D_TJ_6=KT@C
ML'J*GPLTI_$CYX^)DVQI:\#UF?=,U>S?%*]P\HSZUX+?W6^X;GO7XMG-7]\T
M?L&3T_W292F3=**](^&L!^TQ<=ZX.WM_.D7BO6?ASINV>,[:\W+:;E63/2S"
MHHT6CZ?^'R[;)/\ =KL:Y?P3'Y=FOTKJ*_=,*K48H_$\2[U9,**:U)74<H^B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EIE Q
MU+3*?0(**** "BBB@ HHHH **** "BBB@ HHHH **** $;I3:?24 %+110 4
M444 %%%% !1136H =13*?0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%(: "F4K&FT '6G+2JM.H 3%%+10 RBGTR@!RTM,S1N]Z %:F%L&@G-,-
M$@.ZHKFS693Q3UJ6@#A?$&@B0-A:\\U3P^RLV%KW6XLUF!R*P-2\/+)DA:VC
M.QFXW/$9+%H>U,$ACZUZ%JWAW;G"UR.H:.Z,<+70FF8-.)F_;MM/6_\ >JDN
MGRJW0U']CD'K3Y4%V:7V_P!Z;]O'K5#[/)Z4&U?T-*P^8N'4/>F&^'K5/[')
MZ&GQZ?*QZ&FHB;+'VG?3TB,E26VDR,W2NCTO06?&5I.R!79QNH:6[H>*Y#5-
M(?<>*]WG\-CRCE:Y#6M!6-C\M"D#B>40:.3)]VNFTG1QQD5H'35C8\5I6,(0
MCBAL447=/TU54<5L0P","J]M\JBKJ&LF;DJ\ 5*#3%IXI(H6BE6E-,D;1114
M %+BDJ15J@%C6I2:3&%IC-0,9(U1,U+(U0LW6I&*S>]0L:':HRU4(&/6H7:G
M.U5)I=O>F(;-)UK+NKL+D9J2YNA@\UC7$ADDP*T2,I,;<,;AL#FMC0=&::12
M13=&TIKB1<C(KTWP[X="JIVTY2Y4.,;E[PQH8C5"5KMH+40J,56T^T%NJC%:
M&ZN.3NSH6@QC4=/8TRI&%%%%.X@I5I**0Q6-)12[>:!B8-+M-/VT;:!#!2TX
MC%-:@ R*;1M-.VT -I=M+BG*O2@!FVDJ4BF'O0 4[=4=-W4 2,>M-I :6@ H
MHHH *53244 /5JDW"H!3]U $M%,IU "T444 %%%% !136ZTE #Z*:O6G4 %%
M%% #6H%#4TT /R*,BH]U+NH DHIJTZ@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,3Q1_QY'Z5\J_%
M7[\U?57BC_CR;Z5\J_%7[\U?%<1?PV?9</\ \0\%NO\ C\/UKL_"_P!Y*XRZ
M_P"/P_6NS\+?>2OR?"_Q3]2Q7\,][\ _\LZ]W\/#]ROTKPCP#QY=>[^'3^Y7
MZ5^R9/\  C\AS?XF;5%%%?4GS(4444 9NO?\@]Z^6/BU_K)?QKZGU\_\2]Z^
M5_BU_K)?QKX[B'^$?6Y!_%/ +O\ X_#]:Z/0?O)7.W?_ !^'ZUT.A?>3ZU^1
M4/XA^KU_X9[I\.W :*OHSPW(K6*@=<5\V?#_ ._'7T3X4_X]E^E?K^1R]RQ^
M29S'WKG0T445]>?+!1110 4444 %%%% !6=KG_'@_P!*T:SM<_X\'^E9U/@9
MI3^)'S)\5/ORUX#J _TIOK7OWQ4/SRUX#J'_ !]'ZU^)9S_&9^S9/_!1;TW_
M %BU[+\.F_>1_6O&=//[Q?K7K7@*Z$<D>34Y6U&HBLR5Z;/J7PBP-F![5T-<
M'X3UB-;=06[5TK:U&/XA^=?LN'JQ]FM3\@Q%*7M'H:])FL0ZY'_>%5YO$,:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %-VTZB@!N,44I&:3;0,=1110(**** "BBB@!F:<M)
MMI10 M%%% !1110 4444 %%%% !1110 4444 %%%% !28I:* $VTM%% !111
M0 4444 %%%% !36IU(10 E.INVG4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:,BB@ Q2T44 %)NHS4;-0 YFIC&D+4?>H 2G+VI-M*.U $BTZFK3J "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3=2TR@
M!V:6FK3J "BBB@#$\4?\>1^E?*GQ5/[R:OJOQ3_QXM]*^4?BPVV2;\:^)XB_
MAL^SX>_BG@]T?],/UKL_"Y^9*X:ZF_TP_6NU\*R99*_)L*_WI^J8I?NSZ!\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5SHC$1%"KQ2-2;J2LR@HIK=:5:!6%HHHH&%%%)0 M%%%, HHHH =D4C4E%(
MHHHH 7=2TVG9%,!Q-,:@FDI -Q3]M(.M.H ***;0 ZE S3%ZU(M !MHVT^B@
M!H7BEVTZDS0  8I:3=1F@!#3*DIC T -I:-M(W2@!=U&ZF44 /W4JM4=% $N
MZEW5#NHW>] $A;K3":;N]Z6@ H%&*7;0 N:4"FJM/'2@!ZTM%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2T4 %%%%
M !1110!D>(HS)9L!Z5\S_$WP])=/+A2:^I[R'SXRM<9K7@E=0+93.?:OG\TP
M3Q<>5'O99C%A)79\-W'@J=KLGRVZ^E=?X9\)31LF4/Y5]'O\)XVDSY(_*M"R
M^&J6Y'[O]*^,H\.3A/F/L:W$,)PM<Y#P/H[P;,KBO:=#C,<0S67IOA=;3'RX
MKHK6#R0!7W>!PKP\;,^&QN*5>5T6:93Z3;7L'DB+3J3%+0!GZTIDL7 KYL^)
MV@274DN%)KZ=N8_.C*UQVM>#5U!FRF<^U>#FF#>+ARH]O+,6L+/F9\07G@N=
MKHGRSU]*W=%\(3(R_(?RKZ;D^%*-)GRA^56K;X8I#C]T/RKXFGPY.,KV/M*G
M$,)1L>>>!=#D@:/*FO>O#,)BMU!]*R=+\(K9D?)C%=39V_V=<8K[?+\&\,K,
M^+S#%K$.Z+5%%%>Z>(%%%% !1110 4444 %4-:7?8N*O5#<1^=&5J9+FBT5%
MVDF?-GQ*T*2ZDD(4FO$;_P 'SM<,=AZ^E?:FL>$%U G*9_"N:F^%J2/GRA^5
M?G^.R.6(J<R/O,#G4</#E9\E?\(;/_</Y4I\%3M_ ?RKZR_X56G_ #R'Y4?\
M*M3_ )Y#\J\S_5N?8]+_ %BAW/DEO T_]P_E3?\ A!9O^>9_*OKK_A5J?\\A
M^5'_  JU/^>0_*E_JU+L/_6*/<^1U\"S?W&_*K$/@6;(_=G\J^L!\+4_YY#\
MJ>OPP1?^60_*A<-2["?$4>Y\QV/@67C,9_*NPT/P$S,N8_TKW>'X<I'_ ,LA
M^5:]CX-2W(^0?E7IX?(.1ZH\ZOGO,M&>>^'/AZBE28_TKTW1?"L=FJ_)C\*V
M;'3$ME'R@5?KZ[#8"G06Q\GB<=4K/<9#"(5P*DHHKU-CS HHHI@%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP/2@"2EI%I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH 0&EIN#2YH 6BDW4;J %HHHH **** "BBB
M@ HHHH **3-&Z@!:**3(H 6BDI: "BBB@ HHHH **3-&Z@ H"TM% !1110 4
M4E&?:@!:*3/M10 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+24 )NI13>:<M "T
M444 %%%% !2$TM(U ";J::7!I&'% #=WO2AJ8>M.5: ';J-U!6DH =3Z93Z
M"F,*?36H ;MI:*,T -W4F[WHIA.* )-U*#FHE;FI%- #J3=2TT]: #=[TUFI
M** '*W-.W4Q:6@!=U-)-.VTFV@ 5J>&J,<9HW4 2;O>F;O>DW4E #]WO1N]Z
MCW4 YH <6I*** 'YI^ZF8IV#0 [=2,U)36:@ W>]-W4E% "$4 4M% !1110
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M[1RJQ'VC]:K+^T=_TW_6M/9LGG1]RPZU;2?\M!5N.XCD^ZZG\:^$XOVF?*<
MW'ZUVOA?]HY+R1%-P.?>DZ;#G1]=U#-((QDUYQX/^)$>M1KB4'/O72:]K8@L
M6D#=LUG:S+N;!U:&-L,PJQ#J$$WW7%?+7CGXU)HMTZF8+@^M'@?X]1:I<JGV
M@'GUJ^1[D\R/JWAO>J\T@CZUB>%?$4>K6J,'!R*3Q5J@L+=GSCBL[%7-3^U(
MEZM3EU"*3HPKYZ\0_%A;"Z9/-QSZUH^%?B>NI2*/-S^-5RL.9'O0D#]#4@6N
M<T/5OMB*<YS73K]T5 R*29(1ECBH&U:W4X+@?C7&_$+Q8FAV\C%]N!ZU\W>(
M_P!HA-/O2GV@#GUK2,'(B4DC['CU""7[K@U*SJW0YKY:\"?'2+6)$'G@Y]Z]
M[\.^(4U.%&#YR*4HV&I)G2M4,ETD74U)(V(2U>;>-/%O]DJYWXQ22N4=_P#V
MM#NQN%6(KA9NAS7S1_PMX?;-GF]_6O6_ 7B@:PB'=G/O5.-B5*YZ'M^6FU-C
MY14;+S690@:GAJCP:* 'EJ8>:** !14@/%,6ER* #=[TA:DHH **** "BBB@
M HHHH **** "BBB@ HHHH *<O:FTY>U $BTZFK3J "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:U)
M2K0,2BG44"%HHHH **** "BBB@ HHHH :U"]:=24 +3*?3* '+2TBTM !111
M0 4444 -:DIU% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 E%(U)0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *2AJ;0 ^BDI: "BBB@ HHHH **** "D:EHH CV\TY:7%(>M  U)12KU
MH 2GT44 %,;O2EO>HV[T &:,TVB@!U1M3J* &K4BTBBE/2@!VZD-,R:* "E6
ME7I10 4M-:DH DR*6H]U.R: $;O3:=2-0 E%%% #*5:6EH *5:%I: 'KVI]1
M+UJ1: &MWJ-J<U,H **** $S13:5: '44JTM #:=3:* '4&D6G+0 W;25)M%
M-H ;3J*1J $;K3*?2;10 4^BB@ HHHH **** "BBB@ H;I110 VG"BB@!=U1
M36XD4Y%24[=3 YC5M'$BG KA]5T%MQPM>MO")!R*S[K14ESQ6JE8SE&YXE/H
MSHQ^6JQLW3M7K5[X<7GY:P;SP[C.%K3FN1RG M&RT>6U=5+H)S]VF#03G[M5
M<GE9RWV=F[4HT]W/2NPAT G'RUJVGAL'&5I<P<MS@X-$D8]*U;3P^Y8?+7H-
MIX:3CY:U(= 1,?+42J%JF<?I?AW[N5KJ]/T-$ ^6M.'3UB[5;1?+K)RN:*)#
M#8+'CBK&W:*7?36;-04&^D'6DHH ?3:,TE #D^]4E1I]ZI* /"_CAJC6=K/@
MXX-?GQ\5O%]T;Z55=NO8U][?'Z,M:S_C7Y^^/]/635)-WK771.6H<+ITVHZI
M/A2YR:[C2_!6K74(8*YS71?#/0+*2XC\P+UKZM\%^$=(DM$W!.E;2G8B,;GP
M]KO@S6+++;9!CZUD:7X@U'0KI1([C:?6OO3QQX'T@V;E53I7R/\ $WPM!:W4
MGD@=>U*,^;0)1L>R_ WXHR330QO*>H[U]0:QKQO/#K.K9^3^E? 7P<MYX-6B
M SC=7VUIRO)X7PW]RLIK4VIMM'PK^TKXRNM+OIRLC !CWKR3X6?'">WUJ-'G
M;[WK7I7[6>FAIKDCU-?%^AS36.O@J2,/79"*<3CFVI'[8_L^_%!=8L;<&7.0
M.]>L_$34#)HSNI_AK\__ -EWQI+;1VP=SCBOL/7O%T5YX?(+Y)3UKBG&TCLC
M*\3Y/^*?BJXM-6D =A\WK6_\(?%4]U=1 N3SZUPWQ2C6\U:0KS\U=3\&]/V7
MD/UK5_"9*_,?<7P_N&FM8R3VKT.XU!+6W))Z+7 ?#RVVV"'VIOQ#\2?V392?
M-C"UQVNSJV1XG^T5XV,-I<!),'![U^;?Q-^(5[#JDA61L;CWKZU^+WBG^W+B
M:(/NR2*^8O&GPSFU,23!"<\UWTXI;G'4;EL:'P5^+EPFH0K),W7UK](/@=XS
M_M:W@'F;L@=Z_)7P_H5QX=UA,@KAJ^_/V8O%#?Z.C/Z=Z5:*M="I2=[,^^E7
MS+#(ZE<U\X?&R26&.?:3WKZ$T?4$N-+B;/.VO#OC)'',LV:XH[G;+8^2OM]U
M_;&,MC=7UE\")I9(H=^>U?-WV.#^UNWWJ^GO@K$B1Q;?:MJFQC#<]\7[HIC_
M 'J>OW144A^8URG0%-HS10 4444 %)FAJ;0 ^BDI: "BBB@ HHHH **** "B
MBB@ HHHH **** "G+VIM.7M0!(M.IJTZ@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $VT4M% !1110
M 4444 %%%% !1110 4444 %%%% !2;12T4 )2T44 %%%% !1110 4444 %%%
M% !1110 C4W-.-)MH 6EI*6@ HHHH **** "BBB@ I*6DH ;FG+2;:44 &*-
MM+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "
M4;112;J '4UJ-U)0 A;FC=2-33VH EW4;JCW4NXT /W&E6FBE6@!U%%% !24
MM)NH ,"BDW4;J #=3=U+3*  M2#G-)@TJT !%)3C3=IH **-IHVF@!5I:1:6
M@!-M)3J;M- #EZ4C4HI&H 2BC::-IH **-IHVF@ R:*-IHVF@!*;FG[32;:
M =*6C;1M-  O6GCK30*=0 [%)FDW44 -8TE*12;30 4[:*3!I: $VTF.:=2,
M* $I<FDVFEP: %VBDVTM% #E%+TINZC=0 NZFT44 )DTE+@TFTT "TZD44M
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MOU-44J_,*XCJ&T4;31M- !11M-&TT (>:3;3MII=M "44;31M- !11M-&TT
M%%&TT;30 T]:3-.VT;: $'6G4FVEVF@ HHVFC:: "BC::-IH *<O:F[33A0!
M(M.I@-+NH =12 TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI** (]M&VI** (]M&VI** (]M&VI** (]M&VI*2@!N**?10 U:=110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 <%X\T3^THW&W->&:O\,!-=%O*[^E?4EY8BY4@C-9$GAE';.S
M]*TC*Q+C<\9\&^ _[/D0^7C'M7MWA^'[/"JX[46^@I#C"BM.WM_)Z4G*X)6*
M&N:''JENZE0217SQ\2/@['>22,(03]*^GJS=4T>._4Y4$T1E8&KGQMX>^%9T
MS4 PBQ@^E>W:7H++I?ED=J[O_A"8Q)N$8_*M.#P^L<>W;5.=R>4^7?&WPO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>img254193463_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_1.jpg
M_]C_X  02D9)1@ ! 0$#O@.^  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"!&I%Y4# 2(  A$! Q$!_\0
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MBB@ HHHH **** "BBB@ HHHH :U)3L48% "T444 %%%% !1110 4UNM.I,4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **9FG+0
M M%%% !1110 4444 %(W2EI* (VIU(U-YH =FD6DP<]*7::9)(.E&:9VHW5+
M&244Q6IRTQBT4E-S0 ^BDI: "D;I2T4 ,IU&T4M !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 (32!J&HZ4 .HI-U+0 4A-+330 !J=30*=0 W=
M2BFTX=* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **3-&10 M%)2T %%%% #=M*!BEHH 0FDW4K4F#0 ZBBB@ HI** %I,
M]:6HY&V@T .W"DWKZUEWNHK;@G=BN;O_ !=';L1O_6@M1N=SN7U%+N'K7FT?
MCR,MCS/UK9T_Q3'<8^?]:"O9LZ\X[4TBJEG>+,HYJ]P:#/88M.6EQ1TH$+3=
MM&ZES0 M%)1F@!:*2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *2EIE AV:&IM+S0%Q*?3*7)H"XZBFY-)F@+CZ*910,?1110 4444 %%%% !
M1110 4444 %%%% !12$TFXT"'44W-)0,?29I":;ZTQ#]U&ZH\FE!ZT["N244
MW-(:DH?135IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M "49IM% #LT$\4VD/2I ,BEIE.7I0 Y:7--I&H&/W4FZHRQQ15$LEI::M#4#
M'44RE7K0 ZDW4F3323F@5Q2W-%1DTY:!$@JGJ4WDQDU<K$\43&.U8CTH-(J[
ML<#XN\3"U5_GQ7BWB3Q\R2-B3]:U/B7KS0^:-U?//B+Q$S3/\QIV/8I4;H]*
MA^(+^>/WGZUWGAGQX69<R?K7RQ#KC><#NKK]!\4-"5^?]:KE.KZNK'V?X?\
M&2R(N7_6NQL_$B38^>OD?0?'1C"CS/UKT7P]XX\UD'F?K18XZF&/HZVOA,HY
MJSU&:X'PSKWVE5^;-=Q:R>9&*FQY<X<K)*=05I"#FD9!NHW4F#24P)%-+FF+
M2TACLT9IM% #LT4VE6@!U%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3&:>Q8"^M.HHJ"AI-)113 ****!";:-M+10,5:=2+2T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,-/I-M "**=
M244 +3*=NIM !1114@%%+M- 6G<!U%%%, HHHH **** "DI:* &X/K1@TZB@
M!O-+2T4 -:DIS4@% "44K<4W=28"T4FZES2"P<TF*<M+5"L)MI*?3=M P6G4
M@&*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBDH 6BDI: "BBDS0 M%%% !1129H 6BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HI,TM !1110 4444 %%%% !1110 4444 %%%% !1129H 6
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** $I"U*W2HFH ?N]Z"U19-/49H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 444E ";J-U-:FT 2[J*C5J>M "T+2-QS566[$7>@+%RBLEM9521N
MJ2/55D[T%<K- BD/%11S>9CFI>M!-K!N]Z7=3#Q0O6@8_=2AJ:12#B@1)29H
M5LT'O0 AP*BFN5B4\U6OKP0*>:Y#7/$X@5OF_6@TC3<MC6UCQ ENK?-^M>4>
M,O%2R*XW_K6?XF\:?> ?]:\H\0>*FD9OG_6KBCT*5%F=XPN1>,_.>:\PU+3P
MSL<5TNI:V)"V6KG[B_1V/-:(]2$;(P9-/^;I4L%C@CBKID5VJ>%15V.E,DL[
M7&.*Z'3<1E:R(6"U;CN-I'-%BWL>A:'JWV<CFO0]'\:"WC7+_K7A,6J>6.M.
ME\5/"O#U#..I"Y]#W'Q*6-,>;^M9$WQ07?\ ZW]:^<]0\<2C/[P_G6)+XUE+
M??/YU-CC]B?8&A_$A9I%'F_K7J7AOQ*MX%^?-?"'A?QK)YR9D[^M?0OP\\8F
M3RP7].]0T93HZ'U):S"2,$&IFKE?#>L"ZA3YLUU2-N4&I/,G&S&DT FA^M-I
MF-B0-2TSO3UZ4AH6BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 444E "TTBC=24 %-:G4G5J3*&,N:=&F
M.M2!:HZGJ26,+%CBG%";&:EJR6,9).,5X]\1OB?%I]O+B4# ]:J?$[XE1:?#
M+B0#'O7Q1\8/C,TC3JLWKWKMITSAG4-7XP?'%MTJI<'\Z^2_&7Q+GU*Y<&5C
MD^M9_B_QE+JUP_[PG)]:X::!YI"Q->A&%CBE(N75TU\Q+'.:ACL\U);V^P#-
M6T7 I\I/,01V^RI@,4^F-3)W#/O1D4S-&ZJ4@Y22F9]Z*0\5JB+"[J,TVDJ6
M/8?NIPJ,4_-9,0ZBBBLD]2PHHHJQA1DT44 %%%% !28I:*JXA-M+112YB>4*
M***.8JPQH]U5WMMU6Z2H&4TM?+.:U=+\02:;,I5R,&JK51FMRS9IQUT#8][^
M'_Q=FL9(P9B,>]?7WPA^- N/)#3YZ=Z_,NSNI+.0$,17K_PX^(DFFS1 RD8(
M[TJE%6-8S=S]DO OCB'5((P9 <CUKOHIEF7*G-?G_P#!SXS!O(5IO3O7U_X%
M\<1:I"GS@Y%>34CRL]*G*Z/1,"BD219%!4Y!IU9&PRG+THQ2T %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4UNM.I,4 (M.I,4M !3*?2;
M10 +2TE+0 C=*;3Z3% !2T44 %%%% !113,T /HI%I: "BBB@ HHHH *1J6D
MH ;3J-M+0 44VA: '4444 %%%% !1110 4444 %%%% "-3:=1MH *6BB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HIK4#K0 ZBBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *2EIE #Z1J%I&H :U"KFDIZ\+2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M-;K0 NZ
MEIE.7I0,6BBB@04444 %%%)F@!:*2EI %%%)FBX"T4W<:53F@ :FT^BF RBG
MT4 ,I<&G44 -VFC!IU% !1110 4444 %%%% !36IU% #*?249H 6BDW44 +1
M110 4444 )2-24JT )3Z2EH **** "BBB@ HI,TM !1110 4E+10 RG+2T4
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MPL6VMT0B(6JT]80O:I1Q10QMC-HI:5J2D9BKUI::*?5(!E.7I12U)84JTE%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?,A.*\5\,V@:5,CO7TA\,;=8S%2>AA6V/I7P#:>7;IQVKT2-=JBN(\&R*L*
M5VP8,HQ6#/FZNXX]*1:7M2B@YAK4E/:F4BT2+3J:M.H$%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,4M% #=M+2T4
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MJ>M "TFZD,BGH:;N]* '[J<IZ5#DU*M #Z*** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@UJ1)V&[O5_PGJTDDZY;O3L',CZ2TFY^TQ@YS6G7->#Y?,M@2>U=+2 ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 )1@4R1]N>:I7&H+%WQ04HMFAQ2U@/X@1&^\/SI%\2)_>H*=.
M1OTM82^(4/\ %4ZZXC#J*".5F=XNQY+_ $KYT\?2%6?FO=?%&JK)"_S5\_\
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M12;J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M13 K32>5STKL?AWKC0:A%\V.:XR^7*FKOA.8PWR'..:SGJ@O8_3+]G/Q3F.
M%_2OMKPWJ2W=C&<YXK\Q/@'XI^RM "WIWK[W^&WB87=G$-V>!7G5(V/1HU+G
MK><\TC4RV;S(E:I66N8[1*<O2FTM,0ZBFY-&32 =1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1132: !J2EZTNT4 +1110 4C4M-:@!***=M% !2T44 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+I\R5Y_I<1W#BO0?#D@C*YH$WH>L^'6\M5->A:+JAC9>:\LT?4%51S76Z3J
M9EYK.2..I3N>TZ'J)D5>:ZF"3<HKS7PW>9"\UWUA*7C%8'BUJ?*7N:!]ZE"F
MD+A>M,\]CU6G;:C^T(.II/M4?]ZD6D2@8H-1BX1NAI?.6@8[;2U']H3UH^T)
MZTA#^>:2D$@;O0#3 <O6G4U>M.H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDR**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>O38V\V,,*^,/@/XZ^V1P*9,].]?87A^Z%UIT; YXKRZD;,]"G+0O,M/6E-
MK$U%HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU?&4Q:S;Z5\Z>+&_TQOK7T5XP7-FWTKYZ\50DW3?6IB:5-R;P>?](3ZU](>
M_P#4I7SEX1A/VA/K7T;X$7;"E$C2!VU%%)_%69J+1110 RE6G44 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDW5.IXJ:ZTYK-B",8JLC5OS&3B24JTWBEJ9:C2'T4U>M.K(H****8@HHI5H
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MO.?:O,[CX--]IW"+OZ4DPL7?!/BRYN(U#,W3UJ/XA02ZI;.<$Y%=/X7^'KV
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_".@<[:C?31;YXI#*[R8CQ7/:HVXFMB[?;D5@7S%LTBT9,BY:IK>.F,/FJQ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3;CSH5.<\5\4? O7OW4 W>E?8'A.Z^T6J'.>*\RM&QWT97.CHHHKE.P****
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M9IFZEH ?29HI&H 7=2TRGT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1129H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *2EHH C:D6G&E45)70:U,'>I6%, ^:J(')3Z:M.I#,
MOQ ,Z>_TKXB_:07]U<_C7W!KR[M/D^AKXH_:/A/DW/'8UT4MS"KL?FU\25_X
MF4OUKE;'[M=C\3(\:E+]:X^S&!7K1V/)>Y>IK=:%I: $S3J**0AU-/6C)HIC
M"BBB@ HHHH **** "BBB@ HIU-;K0 4444 %%%% #6^[4/\ %4C]ZB7[U &U
MH?\ Q\I]:^Q?V=/^/BW^HKXZT+_CZ3ZU]C_LY_\ 'Q;_ %%<M78UIO4_0GP3
M_P @B/\ W:\H^.G_ ![3?0UZUX)_Y!$?^[7DWQT_X]9OI7!'XCTG\)^=?QD_
MX^I_K7SM?_\ 'T?K7T3\9/\ CXG^M?.U_P#\?1^M>M3/+J;EF#[GX5.M00_<
MJ13S70R(DRT-35)I:R!A1112N 4444P"BBB@ HHHH$%%%% PI&Z4M-:@!*9<
M_<-/J.X_U9IA8HV/_'X/K7TM\$4W7$'U%?-%A_Q_#ZU]0_ F'?/!]16%38N)
M^@7P<A_T:'Z"OHS2%VVPKP7X/VNVUA^@KW[35VVXKS9L].EL6Z93Z:HK(W$I
M5H:A:!=1U%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M *93Z2@!,FE6FTJT .HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHI*  FHJD:F$4#!.:>P^4TV,4Y_NFG<1SNO:A]FB8YKPKX@
M>,3;^9A\?C7J_C29EA?'I7RS\4+V7=+@FFD>GAZ:D<IX@^(KI.V)._K5+3?B
M:ZMS+^M>2^)K^7[0_)ZUBV^IRJ>IK6Q[/L58^G+;XKLL8'F_K6?J_P 2C<1D
M>9G\:^?UUZ9?XC0VN2R<%C1RF/L5%G>ZYXD-VS?-UKD;R;SF)J@+QY.IIRR%
MJ=CJB-857D.*LM56:@Z+:#[>X*2 BN\\+:P8&7YJ\Z7(8&MK3;TPL.:+&,D?
M0.C^*V6%?G_6NAL?%S^8/G[^M>':7K#,H&ZNLTN^9BIS2,7$^C?"7BPLR O^
MM>R>'-96X1,M7R3X=UAK=T^:O8O"/BP(J O6;/,K4;GT"K!E!'2H;RX6WA)8
MUQMKXQC\@?./SK#\3>.D2%L2=O6ERGF^RE<L>+?%:6J/\^/QKQ/Q1\1-LC@2
M?K6/X^^(!/F 2?K7A'B#Q?)-,WSFK43U:-$]:D\>F67_ %GZU;M_&!)!W_K7
MS_;^(I/,SN-;UEXA<@?-5'JJGH?1.B^-"C+\_P"M>G>&_&JR;1YGZU\B6?B5
MH\'?7<^%O&C+*@,GZTK'DXBD?9>DZPMTH^;-;\9W+FO$_ GB<7"IE\U[%I=T
MLT*\U#/&E3:9?5>*S-6O/LL9.<5JUQOCJ\-M;N0>U2$5J<?XH\:BSWC?C'O7
MG-]\3,2D>;^M<5\2O%<D,LH#D?C7C5UXNE:9OG/6G8]FC0YD?4ND_$@22#,G
MZUZ-X?\ &B3A<OG\:^(=,\9212 F0_G7HWAOXC&,KF7]:=C2IAK(^U--UJ.=
M1\U:Z3))T-?.'A?XCK($!E_6O5-!\6)=*OSY_&AH\JI1<3O33-U5[.\2=0<U
M;X]:1R.+N,!IVZE(%-:D,7=[T4FVGT@&T;O>G-3&H -WO2TBC-/X% #:0S(O
M4U!>7"PH3FN/UKQ0EIGY\4%QBV=M]IC_ +U+YZ'H:\AD^(2+)CS/UK7TOQFM
MR1\]58T]DST?S :<&K%TW41<*.<UL1L"!4F3C8<:2EI*" IU-IU Q:*** $-
M)NI6I-IH 6EI*6@ HHHH 2DW4M)M-  !FEQ0*6@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M ***3=0 M%)FEH 0\TTBGTUJ $I0:;FE'44R4/KS_P"*$FRQD_W:] KS?XL/
MMT^3_=IQW%+8^"/CM>D33\]S7QWXNF\RXD^M?5OQXF/VB?ZFODCQ(VZX?ZUZ
M-,\JIN<L5_>&KD8XJOC]X:L+]VNU;'/U'4445!84444 %%%%!(444NV@H2BC
M&** "BBB@ HHHI@(:3=2MTIM2P"G"FYHI1$28S2'B@-2_>K<C<9NJ"Z;Y>*)
MI-E0QAKA@H&:SEH4D+ID+W%P% [U[_\ "/P.]]=0L8\\CM7G_P /?!LNH7D?
M[LG)]*^Z?@3\+=JV[M#Z=JYJDSJIQ/8_@;X&%A;0L8\8 [5[GK6H)I>EL,XP
M*K^&-%AT335) 7 KS+XO>.(]/M95$@&!ZUQVYF=G-RH\'^/OC-6^T*']>]?"
M/Q%U3[9<R\YY->R_&CQZ;JXG DSSZU\W:OJ!O)F).>:[Z<>4XIRNS!5/WQ^M
M:"+\HJ!8OFS5A>@KIYM#GZC]M+3=U.K,IA1110(**** "BBB@ HHHH$ I=M(
M*7=0,8U1L>*D:F,.*!HJM]^M_09=DR5@M]ZM72'Q,M SZO\ @;?'[3 ,]Q7Z
M,?!J;?90_05^:'P-F/VN'ZBOTC^"<F;*#Z"O.K,[:![-32U.IIZUQG< :G4T
M"G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M +129%&: %HI,T9H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IE/HH
M :M.HHH *:U.IK4 ,["G+VIO84Y>U5T)0^O,OBX?]!E_W37IM>9_%M<V,O\
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MK\W?@;'_ *7!]:_23X)+BQ@^@KSZR/0HH]FIO\5.IO\ %7&=@ZBBB@ HHHH
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MI*;N]Z=N% #:<M+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!,T;J&IM,0^BBB@ HI** %HHI,T +1110 4444 %%%% !1110 4444 %%%%
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M( <U/09V"BBDS0 M%)NHS0 M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC% !3:?2;10 4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIU-%.H$(U-IS4V@8ZEI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>9&O/:L6>)B('7J=V*4U' VY0:>S4CRWN.'-.J-6I^Z@0-3:4FDH&.I:2EH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *2EI* &-0G>E-,S0 Z:/S8V7UKROXB>"5U2WE^3/'I7JJ
MMGBH+RQ2ZB92,DBJB[,EJY^9OQS^%_DF=EB]>U?%?C;P_)I]TXV$8/I7[!_&
M+X=KJ$$Y$6<@]J^"/C'\*7M9IF$) R>U>E3F<-2!\EPDQ\&K4<FZM+Q#HC:;
M,X*XP:PX)<-BNQ,XI(OK2TQ9 U/J'N3<!2EJ;FDR:TC$ -(O6BBJ<2;CJ7%-
M6I*Q8QM%*U)06%%%% !1110 4444 %%%"]: &[:2I33",T"L-I0*7H:6@>PE
M-I])BA(3&TJTE*M:(D4TW%.HR*&AC:***@H*::=05H128T=:?G%)C;4,TNT5
MK8B6H^63Y34-FK37 4#O1"WVAMHYKN?!?@R34KI,1DY/I64F)1.G^&_@E]4N
M8CY><GTK[D^"/PK^SB!S%CIVK@_@;\)SN@9H?3M7W%\/O!<>G6L?[L# ':N*
MI,[J43HO!FAKIMD@VX(%=.>!4<<:PJ%'2E9LUY[=V>B"TM"4YNE #13Z93Z0
M!1110 4444 %%%% #3UH6G4C4 %-HHH *<M,R*>M "T444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ5[SX;T(6T:?+BIDSY[$RN;FEVWE1+Q6FK4D<8C4"FY^:LCS20MTI<BHZ=2
M?36IU-:@!*?3*?3 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>$YH&=#IDA?'-=#!#YBBN>TM=N*Z>S<;15%H>NGANU6HM/ [5)'(*L1RBEL
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !3=M.HH BQ2K3MM&V@0+2]: ,4M(8W;S0M.I/XJ8 RAE(/0UY3\3O!B:
MI;RG9G(->KU4O[%+R)E89)%7&7*R)KF1^8?QQ^%QMVN'$/KVKXU\:Z2^FW3K
MMQ@U^O\ \:OAZEY:SE8\G![5^=_QJ^&\EK<S,(CU/:O0A4N>7.G9GS+:RL7Y
MK1W<4W4--?3YF!7&#52.XRV*[H2,)(NT4B\@4M:MF04JT8-+BLF4AP-!:DHJ
M#0**** "BBB@ HHHH **3-%2 M%%%, HHQ29H 6BDI: "BBB@ IN#3J* $6B
MEI5H$-"T\=**;0 -UHI*6@KH%%%&TT""BBBF UNM&VG,.M5)KC82*M&3;N0W
MCE>E;'A>Q>_N%4+GFJ5K9MJ$@ &:]Q^$?PXDO+J)C$3R.U<]25C:)ZC\$OAN
MUW) QBSSZ5]]?"?P0NFV\),>.!VKSGX(?#-;6" M%C@=J^H=%TA+&W0  8%>
M=.=ST:<#3AC$,2J!@ 4DGWJDJ)^M<^YUB+UJ5:8O:I%HL M%%% !1110 444
M4 %%%% !129%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3&-/J-J!#<
MTNT,.:;MI1FF@N5[BQ293D5F3>'XI/X16[U%*J#'-#+4V<E/X9B;/R"N7\1>
M&(DA8[!7IMWMC4FO/O&6M1P0N"PZ4D=-.;N?/OC_ $]+7S,#%> >*+@1S.,]
MZ]K^)/B!)&D :OG?Q-?>;,V#WK='MT7<Y[4+DLQYK+R6-69LO4<<56=XZ$=*
MNQU D>*G44Q7)UJ:.JZ]JL1]J-Q%E*EJNK4_=4@2T8S35IZTP(76JTC;:MR5
MGW+;14@5YY.*Q[V3=FK=U-MK+FDW&G<3,^X4EJK&$FK[*&-"Q>U!)26U]JE6
MWV]JN>6!36%("#&VFL<U(U1X-("C<K65,.:VKB/-9L\?6J0RH.*;4I7;3-N:
M!B+3]NZG1QU9CAI#*OETNTU>-OQTIC0>U-!<J;35B'(Q4BV_M4JPXH$RQ ^W
M%75E-48UQ5B/-(DT+=B6%;VGX.*YVW/S"M[3VZ55@1NQQC:.*LQKMIEFFY14
M\R[%H-"O=?,IKF=2LO,R<5OS3#.*@:$2#I0P:.1^P[6Z5H6<.&'%:4UESTIU
MM:G>.*DRL:&G6I?'%=3INBF3'RU3T2Q+,O%>B:'I>X+\M,B6A'H'ALR.HV5Z
M_P"#_!(DV$Q_I67X7T4-(GRU[OX*T--B?+4MG%5G8/#O@M(8T_=X_"NWL?#\
M4:CY16Q9V"0QKQ5H1A>E9-GD3J7>AFKH\7]VIX]+B7^&KFVG5)CS,BCMTCZ"
MJVJ3>3;MCCBKU96M*6@?'I0);GA/Q2U=HXI0#7R3X\U9Y+AQN[U]1?%>!_+F
MXKY(\;JRW+_6KBCU<.<LTAE8Y-(L?-10M\U65KHZ'O0V%5:F5,TQ5JY:P[V'
M%9LB0^WA)[5L6=FS8XJSI.DM,1A<UW.B^$7FV_)1<GVJB<M:Z2TF/EK6A\,M
M(OW*])TKP&[;?W?Z5U]CX!_=<Q_I2N82K)GSQJ7A8HK$I7&:GHOENWRU].^)
MO"(MXF^7M7CGB+2Q',PQ0F9)\S/*KC2L9XK,N+#:3Q7H-QIP.>*PM0L-N>*T
M/0CL<9);[2:8L=:EY%Y9/%4,C<:5P$5.*;(M3KS39$R*8&=)FEA0FIVAYIT:
M!<5)(Y(:;)!@595P!UIKL&IC,R2.H]M:#P[JKR1;:1)1D&!529L5>F^45EW#
M<T#())#3-Q:FMEJEACH&.ACRU:=K%C%0015=0A:9)=CPM2JU4?/%30R[C067
MDYQ4RU'#S4N*+ +NIK24UFJ!I.:!DV_=4T8S52,\U?@7@59E)$D4=;&EQ9D7
MCO5&&*MC35VR"LV.)Z?X+@'F1U[]X/4*B8KP3P?(%9*]Z\&_.J5#,:ST/5]"
MF(VUW.GL645Q.@6Q(4UW%C'L45#/GJSU+U-[YIU(U2<P;J6F4Z@!:*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBDH 6BF4Y: %HHHH 2FTZFT""HV-24QA4 -HI=M&VF4*K
M[:D5@U0T^/BJ HZEH<&H(P=1R/2O)?'GPDM[Z.0B$'(]*]LS45S;K<QE&&::
M9$HIGYR?%;X'?ZXI!Z]J^4_''PCGLY),0D<^E?L5XG^'D.J*^8@<^U>!_$+X
M$QS+(1 /RKLIS.&I3/R@OO"4UB[;D(Q[5E21FW;!&*^TOB+\$7M3+L@Q^%?.
M_BKX:W-K*^(C^5=\9(XSS/[8!3UN U6;_P +7-LYRC#'M5/[#)#]X&MM!%I9
M,BG9JLK"/K3OM"^M9L"Q147GKQ@T[S!2%<?13/,%&\>M.P7'4M1[A3E:BPKC
MJ*2@FBP7%HIF[WI5:GRCN2+THIGF8I/.%'*%QU1FCSEJ-IU]:$ [-'F &HC,
MI/6E"^9TK3F5@L2-<JM1M<AC3ETN6X8;5)K8TOP9=73KB-C^%<\F"1D+8/=X
M &:W]!\ W%]*N(R?PKT[P3\)[B\>/="3GVKZ6^&_P'\PQE[?]*YY3L;QBSQ'
MX;_!F:>2,M">H[5]>_"[X(QHL)>#]*]-\"_!:&RCC8P =.U>U>'_  I%ID:@
M(!CVKFE5.N%,Y_PE\.;?384/E 8]J[BWL5LU 48JZJA5 ' I&Z5RR=SJ44B/
MSC2!\T%:0+4%)CJ6E4=*<5I@)N]Z,TUNM*M4 ]:6D7I2T %%%% !1110 UJ2
MG44 +36ZTZF&F 4QN*EJ*X8*I-+J)[%6:Z$6>:SKC7$BS\U9/B#6!:JWS8KR
M[7_'0@9AYGZUWTJ#GL>;6Q"IGKJ^)(RV-U:=GJR38^:OFZ'XA!I?]9W]:[+P
M_P".5D909/UKHJ8.26QRTL=%RLV>WK*) *>!7*Z/XB2X4?-72V]TLJC!KRI4
MY1>I[,*D9K0GIV132V>E)NJ34DHI@-.6@0M)2-24#'T4W=2;L4$CJ6H]U*#Z
M4#'T4E(30 ZBF44 /HIF:,T /HIE.7I0 M%(U-H 4&G4RGT@"BBF,>M,!V:6
MH]U.I@.HHIIZU(#J*:M.I@%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(W2EIK4 )3EZ5
M'2KTH DHI%Z4M !124V@!]%,I>: '44W<:-QH =13** '&FLU!--^]0(9):B
M93D5YYXZ\/JUO(=O:O2-P5>37'>-]0C%K(,]JI'11D[GQ[\2]+6WDDP*\+UB
M3RY&KZ"^*UTK22XKYQ\1S?O7K5'TM&6ASNI7V&/-9+W._O2:A,2YJBLAW4SH
MD6W^9:IR1_-5M&#+3'4&FS.Q67Y:9,_%/D.T5GW%QC/-(!9&J!VQ437(]:CD
MFR*=AV'O<;:K/=56FFY-0!BQH&6_/+4])#44$):KD=H?2@0U9*7SCVI_V5O2
MD-J?2F,B\\GO4T;$TS[.1VJ55VT@+4;;:L1WGEXYJB7J*20TQ&Y#J&6'-:,,
MV]:Y2"8[A6U9W'R@9I :,QJNK$MBI"VZDC7YJ0MS6TR/<1720Q 1U@:<0N*V
MUFQ'5%I&9JRA5-<=J"[F-=5JTVY3S7+W7S-1<5S$EBY-0LAK1DCJNT-%PN46
M4TJ1YJUY!]*<L.* N+!'5Q5&*@C&VI=V*DD1E'-5Y%&*G9JB;FF/8JLM21*:
M=Y6ZK$,-,J^A-;J:OQ+TJ"&/&*M+P*D@E4"E>F(:FV[A0,S[AC57SB&ZUHSP
MYS5&2##&@19M;HC%:]K>D8YK C7;5V%RM '46^H>]7X[[WKE89CZU?AN#QS3
MN-,Z6.^&[K6QI\PE8"N*6=L\&NET!V:1:+E'IWANP\UDXKV/P?I>TH<5YKX)
M@W>7D5[CX5LP G%)LQF]#T?PM$8D2O0["3]V!7$Z+#M1:Z_3\X%8,^?Q%KFF
MU)BG+TIK&D<(C4VBE6@84ZDVTM #Z*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHI#0 M%-W4QFQ2N!SGB_1%U*W<%<Y%?)/QH^$ZW,<SB']*^V
M6C$R$$9KA_''A./4;5QL!R/2M(2LS*I"Y^.GQ2^'+Z;<3$1XP3VKQ&ZLFL[@
M@@C!K]+_ (U?"7SA.RP^O:OBCXA?#N73KB4B,C!]*].G,\R<&CRN.X'3O5A?
MF JI>6;VLQ# BIK>8!1S74Y7.9Z,GHI P;I2UF6@HI5I:H8VBDIN:0#Z*9FE
MR:8#J0GTI-U&:!"4Y:,"BBP7%I5I**+"N*U,;K3J3%.P[@M+24M*P!1112&%
M%%,- #Z5:CI10!)3:1:6@04444 *M+3:,FF%PI"<4,P6HI)AMZT6 5YQS518
M6N)@ ,\U)!"US( M>A>"_ DVI7$?[LG)]*ERL-1N:GPS\#/J5U%F/.2.U?=/
MP2^$JQI"YB].U<-\%/A*R/ S0^G:OM_X;^#TTZUCS&!@>E<-69U4Z>IN^"_#
M*:7;QC;C ]*['IQ38HQ"@4#%+NKA;/12L@:HZ=ZTBT(H%IZTE%,74?12+2TA
MA1110 444UNM #J1NE(O6G4 ,IR]*-HI: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *CI[5&U !Q0:04HH6@["C-.W!1S1MJ"Z;:IQ3$D8/BC5Q:P.0<8
M%?./Q*\<&+S0'Q^->N?$#4&CMY>>U?(OQ0U9O,E^;UH/2H4[G%^+/%S74SC?
MGFO/;Z\\Z0G-1ZG?&2X;GO5$R;C6B/:IPY2P%#5(L=0QM5B.K.@>JU(J=*5%
MZ59CCIDD2QU.L=31P^U2K#UXIHL@V^U-JVT.*B:/%*X#8STJ2F*M*:=R+C)&
MK-O&ZU=E-9UT?EH&8UY)UK.9OFK0NUW9K.9?FJ2!5J9142J3BK<,.:H!GEDT
MUH3Z5HI;^U.:W%(JQD-"?2F^3BM1X0N:JS87-%AF;-%Q6=/#UXK7E854D4-F
MD2S(>.F+%S6@\.:C\GF@+D4<=6HU IFS;2-)MH$6.*85!JOYQ-2IEJ )0!3N
M*:(V.*7R7H <K#-2JPJ%86STI_EL!0!:MY?FKH-,^;%<U;1L7%=;HEJ3MR*J
MXXG4:;#E!3M1&Q#5NRC\N/FJ6K2?*:$:'-S3_OL5H6?SK66T9:;\:W=.M2RC
MB@BY!-'[59T^V\R0<59_LUG;I70:#X>DEE7Y:9+FC7\.:,963"UZGX?\,LRK
M\M-\%>$&;9E/TKV[PSX."QIE/TJ&SEJ5$<]X<\.M&Z';7KWABS,"+Q3=/\-K
M#CY?TKH[*R$*CBL),\BM.YI1_<%(6I.@J,]:1P$P;I3JB7M4BTK@+5>[A$D+
M#VJQ36Y4TP/$OB7H/VB&7Y<U\D_$+PNT<TAV]Z^]O$FD"\B<;<U\]_$CP5E9
M&"?I6L&>E0=CXXN[0VLA!&*ACDKM?&/A]K6:3Y<<UQ26S+(1BM['NTY:%J/E
MA71Z+8_:)$XK)L-->:1<#->H>"_"TDTD9V?I6+"I-6-_P?X4-PR?)^E>U^%O
M H*H3'^E+X"\'[5C)3]*]IT/04MXU.T5%SPZU;4YC3_!*1QJ=GZ5H3:-%:PG
MY0*Z^=H[:W.<#%>?>+?$\=K&XW8I&$).3. \>>6L<@&*^?/%"AIFQZUZ7XR\
M6+,T@WYKRG5KP7#DYS5I'LTHLPY(0<UBZE:Y!XK?ZYJM>6^Y2<5JCM3/-M8A
MV,:YV23:QKMM?ML9.*X6^^20TF(M0R[JL+AA63!,<BM".3Y:0Q9*J2S!:DN)
M=H-9%U<=>: 99DOL=Z?!>;FZU@RSG=UJ>SF.X<TQ'41L&6H[A14-K)\M.N)*
M8V9UP.369<(<UKR+NJI-!GM4DF6L56H8NE2K;G-6HK<T -5=HJ.23;5IHBJ]
M*H7"D9IC&FXYZU:M9^1S64P.ZK5KD&D(Z>TDW"KNS<*R;!CQ6Y"NY:HHHRKB
MJC9S6G<*,&J#CFF6$7WA6E;GI5")>E7805I7(D:D+ "M"SEVN*Q8Y-M6[:?Y
MAS4B2/3/"^H".1.:^@/A_J2R[!FOES1;HK(N#7N_PSO':2/FI9Q5WH?5OA>(
M2PH:ZU(PM<CX'8O;Q_2NQK)G@5'J%%%%(R"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\"D,#3:=1BF VEW4E% !NII-/VTUEIH0VGJ:3;3MM# 6D;K2[J3K4V&"TZD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDH7;1M_"G44 ,HIV!2;:! M.I ,4M PHHHH *:>M.IIZT"!:=35IU PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@!#S2%:=29% #-M+C%/IK=:!#JK
M7:[E-3;J1UW"@:9Y-\0[-I+>7 [&OD'XH:1,TLI /4U]V>)])^UPN,9KP/QY
M\/\ [4SD1Y_"@]7#S2/AW4-)F6X;@]:K?8'7M7T!KGPU:.1CY7?TKD[SP.\;
M']V?RJXGM0J)H\QCLV]*N16I':NQD\+/'_!^E5VT-X_X?TK9#<S CMS5J.WK
M2_LUU_AJ6/3WS]VD3S(JPVV:M+9\=*OV^GMQQ5Y+$XZ4&L9&!):G%59+<^E=
M0]C[57DL1Z4#D^QS?D'TIDD1%;SV0':JD]KUI&:.?E0U1N(S6]-:GTJA/;=>
M*"[G-W$/6J#6YS7136OM5;[%N;I2),R"S+$<5HPV6.U:ECIO3BM+^SPJ]*OH
M4<_Y.VH)C@5K74.VLNX2D!G7$VW-9=Q='FM*ZB/-9-Q >:=Q%9[@YH63=44D
M16F+E:0F6U7=4@A!J&%N:O1?-0(J/!UXJG-":W1!N[5#+99[4P,)(3NK1L[7
M=BIUL?FZ5J6-G\PXH*$MM+WXXJZNB\=*U[&U&!Q6F+=0O2F.QR4FD;>U0MIO
MM74W$:U3\D%NE%A6,JSTK+CBNLTO3_+4<5!9VXR.*W+8!5%0/8?)^[2L:]W2
M9%;WD^;P*?'HC3-]VBY$IHYJSTEII!\M=IHOAMY /EK;\/\ A)IG7Y/TKUSP
MMX!\P+^[_2BYS2JI'FFF^"7F8?)^E>D>$_AV=R$Q_I7I^C?#U5VDQ_I7?:'X
M1CM]OR?I4.1YM2OJ<YX5\%K;JN4_2O1],TE+=0,5=L]/2%1@5<50M1<XI56Q
MBPJO05)M%.HI&%VQA6F[:>S4W(H$ 6G9I** '4'I0#1F@"O-;B1""*\Z\=:
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ML.%+FH^12[C1<5A:5324W-4(DI:8O:GT %%%% !1110 4444 %%%% !1110
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MC*YZ$_W37GOC:Z\F&3![5*_Q#@>(_O!^=<#XR\71W$,F'[>M-(UI47?4\?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME !2TRC=[T /HIJM2YI +1113 2D/6DHH 5>M.IJTZ@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAZY'4-89F/S5C7&LF1CS5-[KS.]>C3H**,JE1U'=FU;ZPZN.:Z72]?=<?-7
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH-35S6L=E[[!1249% Q:*;NHW4 .HINZDW4 /HI-U+0 4444 %%%% !1110
M4444 %%)D4;J %HINZEW4 +1110 4444 %%%% !124;J %HINZC=0 ZBBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M$IM/I-HH %Z4M%% "4;12T4 )@4M%% !1110 4444 %%%% "4;12T4 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%:V-JT!=F?J'*FN4U*#+&NIOFZU@WD>[-(I,P!!\U7;6VW4];?+=*U+.UZ4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4QRB:&DZTT3*-U=WH>N%MOS5Y3$K1O71Z/?-&1S0<\J=SV_1]8!V_-7:Z5J
MDQS7ANE:R5*_-7?^']8+;?FJ&CSZU+0]7MI RBK7%8&DWOF*.:W(VW8K,\22
MLQU)WI66D6D0+112K03U%I:**"@HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU?Z5\Y_%N,*DM>]ELOWAX.9+W#Y+\5L5NG^M<T)JZ/QDV+J3ZUR'F8K]-H_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]8CN/M%EDGM7S=X.U0PRIDU['IOB%?L8!;M7SF)H/FNCT(UE8X_XD+M63%>
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M[6G*Z#::-IIU%06-VFE44M*O6J$.HHHH **2B@!:*** "BBB@ HHHH ****
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MS7.64.W%=!9/Y>*I%([72PK8%;C6:R1]*Y+3+S81S7565X)% S3$<_K&ECG
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&H6ANE("":0
M1J37*ZUXB2S#?-BMC6KKR86YKP?XB^*6M1)A\5Z.%H>TE8Y*];D1TFJ?$*.)
MB/,_6JEG\0$D?_65\Q^(?B!(MPP\SOZU'I/CV1F'[S]:^JCEONW/G:F.=S[/
MT7Q@DV!OKK;36%F48:OD?PSX^;<@,E>L^'?'*R!<R?K7CXK+W'5(ZJ&.N]3W
M"*428YJ7;7%:7XLB=1\XKH;76XYP,-7@2P\HO8]R&(C-;F@R4!:(Y!(,BI-M
M9\MC?<:*7'%%%%T%AU+24[)I6*$I,TK9IK4; #4E&#2[324A"44NTTQA57$#
M4W<*&J-J8KC]U2*W2JXS4L=%A<Q:6G4R.GT%!1110 4444 %%%% !1110 44
M4T]: '44BT-0 Q^]5I,U8:HV7-5>Q+5R)<[JL*>*AV4N_963=V6E9$K+N0UY
ME\1+<?9Y/I7H,VH+&IR:\U\?:HCP2#/:O0PD9<ZL<&*J04'<^1_B?&5GE^M>
M+W3D3-7N'Q)Q--+CUKQN\LSYIXK]+PB?(KGYSBY*4W8S=Q-3P@\5(+/VJ9+?
M;BN^QP),U]'NC;L#G%=C9^(&6, -7 PY6M"&=EQS7-.FF7SLZ/5M0-RAR:X/
M6HPVXUN3WGRG)KG-4N@P/-53A8U@SBM7&&-4;&/S)1]:T-4(9C3-+A_?"NSH
M=%[H[/P[IX8*2*[BQM$C4<5R^@C:BUTBW!517+:[.2I[IM10IMJ9;.-AT%8T
M5\1WJTFI[>]2XLQC,FNM.C49Q7,:Q&L*G%;-UJXVGFN7UB]\U3S3BF=$=3D=
M7O3&S8-<[-?,S'FMC5(S(QK#DMRI)K0Z8Q*UQ)N!K(NFZUI72E<UBW#'<:SE
M(Z(QN19J:&4J>M5@:DC%97-W%6-RUO"O>K3:@<=:Q8F(Q4IDXZUI?0YG&S+C
M:B<]:DCU,^M9#M1&W/6BY+B= -0)7K5>>^/K52/)'%17&<&M$1&.I-_:!5NM
M:%EJQSUKFF)W=:LVLA5J4C9Q._L-2W@9-:7VD,N<UQ=C=%<<UK+?';UI)&3-
M&YO-G0U1;5CNZU0NKO=WK/\ ..[K6\8G/)'2QZH3CFKMOJ6"#FN6BFX'-6XY
MCGK2D8-'<6>L;<?-6M#K?3YJ\_AN&K2M[IO6G%7,N4]!M=:Z<UL6NN'CYJ\X
MM[P\<XK9L;PG'-$H(-CT.WU<MCFM.UU'>PR:XBUN#M'-:UE='S!S7+**'S6/
M1=/VS+3[V$(N16?H=QN45?U!\QUR;2,ZGO(J6DW[T"NYT(;E6O.;>;9<=:[S
MP[>KM49K#%)N.AEAXVEJ=UIZE66NUT,GBN+TN99"O-=OHN,+7R.(BUN?:X'H
M=GIS?**UHVK'T_[HK6BKP:CU/M**]TGHIO-&:A&HZBF4M4(>#3JBW4[)H *5
M:2B@!]%-7K3J "BBB@ HHHH **** "BBB@ I&I:2@"-C@TPSA>],O)A"I)XK
MDM8\3):9R^*"XQN=9)J"1C)-9=_XCCA1OF KS;4_B%''G$OZUPNO?$D;6Q+^
MM.QU0HMGHWB3QPD(;#_K7D7BCX@$L^)/UKA_$?CYIBV)/UKSW5/$CW#'Y\UH
MHGI4Z-CJM>\9/<;AO_6O/M8U5KAFYJO<7S29R:R;J7.>:JQZ4(6*L\VZ7.>]
M=5X5O3',O-<5))\];V@W&R1>:+!..A]2?#76#F(9KZ%T/4A]E4Y[5\C?#W6!
M$T?S5[UI7BA([0?/VJ9(\NK2NSH/&WB06]J_S=J^4_B=XN,C2C?7IWQ%\6@P
MN _;UKY<\<:V;B:3YJFQ5.C8X_Q!KC27#'=WK)&K$+]ZJ.I3;I"<UG/-M7K3
ML=\(FQ)KA7^*FQZXV[[U<U-<>]-AN#NZU9;.\LM:9L<UMV^H&1>M<+IKEB.:
MZJPS@52"*+UP?,4DU@Z@H7-;4S;5K!U.3K3+9B74VUJSY+H^M3W;;F-9LN<U
M)F2/<DT1R;C51LU-">: -6V4&M2W4"LBWDK1BFH UH7"U=BN=O>L2.?WJU#(
M6-44CI+6]*XYKI]'OBS*,UQ-FI;%=3H:'S%IC/2=.C\Z$9]*S/$%J$B8XK7T
M7B$9]*S_ !.W[EOI04CR'Q"VUVKDK@G<:ZCQ"_[YA7+S<FD*0R%SFM*";IS6
M8@JW#GBI(1KQR9Q5F/FL^')Q6C N304684Z5>BCZ5!"G2KL:]* '1QU?LX<N
M*JQ+R*V-/CRPIDMG4^'8=K+7M'@H[3'7DFAQ[2M>J^#V(9*1A/5'NOAF0^6E
M=S:_-&*X/PKS&E>@6B?(*R9X&(6I+MI5;%.QQ3,?-2N<-M1LUN)Q@BL+4O"L
M5V#E0:Z-:7(J352:/)=>^'L4BL1&/RKRGQ-\-@6;$?Z5]3W5NLRD8K!OO#*7
M))V"JN;1JM'RA#\-&\S_ %?Z5>G\ &WASY>/PKZ8A\$1#)V"L;Q-X9CM[=\(
M!Q5<QTPKNY\=>+M%-JKC;BO'?$$161A7TK\2K-8C* *^??$5N&F:M#UZ4N9'
M!O&?,JY; KBII+/]YTJ1+?:.E4CM6A9AFVXK=T74O*D4YKG-I%/CG:'D&E(R
MD?0/@?Q,D+)EJ^B/!7C*+RXQO%?"6C^)7M9!\Q%>K>#OB!(CHID_6LVCS:L;
MGWAI.O1W4:\@UL+)YG(Z5X!X!\:&Z6,%\U[9HE^+J%3FHL>1.-F:?*TC+O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\<T8+]_6O'Q& CRW2.VAB9QDC[H\/:PEW&IW9KHMP9017AGP_P#%@FCC!?\
M6O7M/U%;B,?-VKX3%T73EH?98:NIQ-)FQ3?.4=ZK7%TJ+G-8EYK2Q$_-7F0I
MSDSMG5C%'1FZ1<\TS[<GK7#77BA4S\_ZUGR>+@&^_P#K7K0PLFCRIX^$7JST
ML7J-WIXF5N]>9P^+@S??_6MJR\2+)CYOUK"IAY(TIXZ$^IVJL.*?N'K7/0ZT
MA7[U2_VT@_BK!49'5]8@;>X4UJR(]81C]ZKL-VDG>J=-HN-6,B=A[4W9UJ0,
M#14&NC(O+IRBG4J]J=Q<I+'3Z:E.I %%%)0 M%)NHH 0F@&EVT4 +1110 4U
MJ=28S0 S-+FD9>:$H &6F=#4W%032+'G)I/4I S#!-9>H7ZPJ>:;J&K)"A^:
MN"\1>*%0, ]=5'#NHS@Q6*C3B6]:\2+"K8:O*O&'B;S4<;OUJOX@\4[F;#_K
M7G6NZT9MWS5]?@\"HV;/@,;CIR;2.9\5W7VIWYK@[BUW/G%=1J5QYC')K'D0
M,QKZF$>161XD).3NS)-H!VJ*2$**TYL+65=S[<U2;.YM6&*!NJ<?*M9JW/S5
M/]J^6KW,%&[(;^ZV*>:Y?4+[)/-:FJ3$@URU[(2QJTK&R5BO<3;VJ[I?^L%9
M#M\U:FEM\RT^;0TB>@:+RBUT"Q[E%<YHC_*M=1$PV"N?J14C=$++M%4KJZ\O
M/-6KRX"J:YZ^N\L>:HY(Q%N+XL>M499#)FHMQ=JLQQTSICH95S;[L\5E75N%
MS717>%4US>HW07/-3<W3,/4%'-<]=)R:V+RY#,>:SI%\RLY(ZJ<K&>J&IXXS
M5F.USVJW'9^HJ+&KD5$C/%.935\6OM0UM[47.=LRF4TZ&%BW2M%;3=VJ[;Z=
MR.*";D%K;%EZ4MQ9DKTK<M[,+CBK/]GAEZ5LGH4F<--9,&Z4L-LRGI782:*&
M[5"=(V]JEL'(R;6(KUJ[]U:L-:^7FJL[[:%(S*EP]50WS4MQ+S4$;?-70I$.
M-S2M\MBM*WMRV.*I6*;B*Z73[7=CBI;,)*Q%;V1..*NQ6;>E;5IIX('%:$>F
MCTIQE8Q,&&W;TK7L;=N.*OQ:6,]*V=.T@L1\M4Y&4KD-G;.5'%:]E9OO'%;F
MF>'RP7Y:Z&S\,[2#M_2N651(SU9#H=NRJ*U+Z/\ =UH6FD^2O2H-1CVJ17 Z
MB<AJ+.1N)#%(36QH^LF-AS6-J2_,:IPRM$W6NGE4UJ:*%M4>S^'M<#%<M7I^
M@:HC*O-?->CZX8&7+5Z-X?\ %6W;\_ZUX6,PMUH>GA<8J3LSZ)TN\1E'-;<,
MZMWKQ_1_%0*K\_ZUU^G>(A)CYJ^0JX629]SA<PA.-CM]XQ2[MU8]KJ(D'6M&
M.8-WKE<.4]6-12V+&:*8K"G YJ"PI]-VT[M0,3=0#3:5:D0]>M.IJ]:=5 %%
M%% PHHHH **** "BBFDT .HI :6@#GO%5W]FMV.>U?.7Q%\;&S:0;\?C7O?C
MZ0K9R8]*^+_C%?2I)+@FM(H[Z$4S$UCXF,9&'F_K7.7GC=[K/[PG\:\MU34Y
MOM+?,>M):WTC$9)K;E/;ITT=[<:N]QSNJE),S=ZRK:Y)49J22ZQGF@Z^5(M/
M<;>]4KBX]ZJ7%]UYJA)>;J+!S6+$DWS=:OZ?>>6PYK!\[<W6K5O*012,G*YZ
MUX4U\P,GS5ZC9^,&%L!O[>M?/FB715AS7>Z?>.T0&:&39&GXR\0/<HPW5XMK
MS232-U->G:I"UPI[URUWH?F,>*@JR1Y=>6K\\5DW$#CL:]/N_#N<_+6-=>'N
MORU5@/.I87]*9#"VZNWD\._[-56T/8WW:JP[,KZ/"=R\5UMHH51639V?DXXK
M0:X$:T]BDK#[R8*M<_?2;B:LWE[NSS6=(V^H$]2A)'N-5)H:T77%5W7-!)ER
M1TL:[:M215%Y>#3 FA;;5V.2J48JS#G-(3-&%2U:MG;DD<51L8]V*W[.(+BF
M5$OV-MTKI]'C"NM<[#,(\5K:;? 2#FJ*/2]+8"$?2LKQ-EHFJ71[T-&!FEUB
M/SH30%SQCQ"I$CUS$C?-7>>)=/.YCBN&NX3'(:0GJ)"NZKD*55MZOPU(%NW3
MI6I;Q]*S[<<UK6J]*H9;ABJXD=10K5I13 (U^:M?3R%=:R.C5>LY/G%(SD=]
MH9W%:]4\)X5D->1^'Y.5KTK1-0$"J<UFQ\MT>\>%[U$5!FO1+"\21!@U\[:3
MXK$) WX_&N^T'QDLFT;_ -:AH\;$TSUH,&Z4UEK#TO65N%'S5MQ/O7-2>1L+
M13Z3%(0BTZDI:!A7'>.KY(;5QGH*ZNYF$,9).*\A^)6LB.&7YNU-&U-:GSY\
M3]55I)1GO7ANI2":9OK7<_$;6#)<2C=WKS1;GS)36I]#AUH,DMLGI2-:^U:"
MH& IWD@UK$ZY,R#:GTJ.2U.VMO[/2_9-W:FT9[G/)9NK9%=!H<DEO,O)ZU*E
MB/2K5O:[&!Q6=C.4+GLWP[\0&!HLM^M?2O@WQ,DD* O7QAH.IFSD7G%>Q^"_
M&178"_ZU+1Q5*!]7VM^LRC!JZ&S7FGA7Q']J1/FS7H%G<>:@-8,\JI3Y66Z<
MM-HW4SG!L'-5I8%;/%6&INW<:"2E]A3KBK4,,<(Y %3,H5>:Y[7-:2RC8[L8
MH*NS6NM6@M5.6%9G_"3V_F8WC\Z\;\9?$<69<"7'XUYTWQ>VW&/.[^M4D=4*
M+D?75OK$$P^^*EDU.!!]\5\S:3\7@4'[W]:L7GQ@4*?WWZT<K*^KL]RUS5;9
MH6^8=*\'^(\UO(LN".]8&J?&$,I'F_K7G?B3XB"^##S,Y]ZM1.JG2:.%\:0H
MTTF*\YO(0K&NSUK51=LQSFN4OOFS5\IZL(V,.1MN:K22;JFNSM8U0:3FJ-R.
M;%5QRU2S-4"MS2)+$:BB1@M-$FT55FFYH&.>:G1S<BJ6\L:FBS3%<UH)JMQS
M5E19JW$303<T8Y*N0?-6="*TK<4BC1MUJZL=5;;M6A#SB@!JQ&KMID,*:L?%
M3PIBJ")O:5EF6N^T"V+LM<%I/#BO3?"J;W3BH9=1Z'J'@VQ(V5[;X:@*1I7F
M/@RU!5.*]?T2';&M92/GL1+4VU&%IU)14'FBT444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2;:6DR* $
MZ4 T=:4+0 M%%% !1110 AYI-M.HH **** "BBB@ HHHH *0FEI",T (&IU)
MMI: "BBB@ HHHH 1JC;O3VJ)FI-707 &G2']V33%Y(ITW$+?2L$G<MG"^+KO
MRXWY[5\_>-M4RSC=7M'CZZ,<<G/:OFGQMJA$K\U]OE=.Z/B,TD[LXO7;HNS<
MUCV-RR3 Y[TS4]0W,W-9UO>8?K7V,8^[8^3MK<]:\+ZT8=OS5Z;IGB'=$/F_
M6O -'U(HPYKMM-UPJH^:O.JX=29JL0XZ'J<VI"53S6'J%PO/-<[_ ,)&%7EJ
MRM2\3#:?F_6LH4.5F$XNKJ:.I:@B \URNH:L-Q&:RM4\1;\@-7/R:F9I.N:]
M"-/05.+I;F^UQYS5/#&.M9%E(6P:T6N1''UHY;'7[925A;RX6%#S7$Z]JVS=
M@UI:UJP4-@UYYKNI%RW-:QBR>6Y7U+6CN/S5D/JY+=:R[VZ9F/-9[3G-;K0?
M(CIEU8\<T_\ M0^M<RDQXYJ7SSZUH2X]C?\ [2]Z3^T#ZU@^<34BN35Z$\IN
MKJ1W=:M0Z@3WKG%D-689CZU#-(Z'2+=;N]0R2$U1AFSBK*DM2*W%\TKWJ>.X
MJ PGTJ-R8Z0G$T?M'O6CIM]Y;#FN7-T0<5-#?%>] N4]=T'Q#Y>T;J[_ $GQ
M-NV_/7S[IVK,K#YJ[/0]:8E?FK&=)2.2<3Z TS7MRCYOUK<CUPJOWJ\IT/4R
MRKS72?V@1'UKSI4(W.=U)QV-O6/$)"G#5YWK^N/(6^:KNIWS/D9KFKR,S$UT
M4J48F'/4D]3(FNGFD.3FK=DAW TY;'YLFKL,(CKHE)+8]&E%-:FE:R>6M4]6
MU#;&>:CFNA$O6N:UG4L@C-9Q5PG#70Y[Q%>>8S<UQ-]%YC&N@U*8R,:RVAW4
MFF=E'0YFYM3NSBHXH2K5O75KFJ?V7FB+:.J4E8+9BN*MBY('6F1VYQ2M ?2N
MN,M#S)QNQLET:J2W)I\Z%:R[B4KWKFG)W.RG35BZMQ\PK0M;@<<UR_VS#=:O
MV=YN[T1FR90.PMI=U:EKR17/:?-NQ716*YQ71&1PU(,Z326V[:[32[S;MYKB
M+$[<5MVMV4QS42BI&#BTCUKP[K0B9?FKUGPSXH50HWU\S6.M-$1\U=EH/BID
M9?G_ %KQ<5A541Z6"Q#I,^J]-\1+(J_-6S'JZLOWJ\'T'Q865?GKJ;?Q1P/F
M_6ODZN!:9]93S)=6>LPWZR'K6A&P85YOI&O^:P^:NVTV\\Y1S7F5*+@>[A\4
MJJ-:G*.E,4[L5(*Y+GHCU%.IJTZF2%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444E "T4FZEH 3;3
M-O-/I*  ?=K&UJS^T1L,9K9_AICQB13F@J+L>"^.O#A*R,%_2OGSQ9I[6\K\
M=Z^S?%NCK-;O\O:OF[XB:!Y;RD+6L3V,/5/#I/O$&LZ_954UJZTOV21NU<9J
MVK!<C-;W/5C.Y'=WH1C53^U!GK6%?:GECS5..]+-UI7+.I^W[^]03R;EK.MY
M"<5-)-A:.8EW,^_7K6#<+\QK8O;CKS6-,^YJS9"5R+;4L7RFFBE6@NS-*WFV
MXJ^MQD=:QHV(JU'*:"B^TF>]5Y'-,\P^M(S4BD,+&G*Q]:8:3?[4T'-8G4\U
M9@7+"J4;?-6E9KN(JBN9,Z+0UPZUZ'I,Q6->:X+2EV[378:;-C%%AZ&Q=NSI
MP:P+R-SFNDA03+45QIX8'BF+0X6\A:LUK=]W2NYFT?<W2J_]@9_AI,BYRB1/
MCI3)+=F[5V T'':FMH?'W:D.8XAK,]<55GM2.U=S+HN%^[6/J&FF//%(+W.*
MN8#SQ5$PG/2NBN;4[CQ5==/W<XH(:,RW@.X5HV\/3BIUL]K=*LQ0XJRHDMJ-
MM6_,PM0*NVD=J"@DDW40KN(J'=FK5KC-,9J6%J&8<5VVA:>K,N17(64RQL.:
MZO2-42-AS02>C:/8(JK7;:+&JLM>:6'B)$4?-73Z+XD5I5&ZLB9VL>Y^&HP0
MM>AZ;'MC%>5>#=62;;S7J^ES+)$#[5#9\]B-S33Y13LTF/EHZ5)YPZD)I::U
M PW4;J2@4 %%.HS0!&<TJU)24 ,-.7-+BEH ANEW1UYWXSM"]O)QVKTB3&TY
MKB_%A3[/)]*:-J>Y\E?$ZS96DXKYWU^%OM#_ %KZB^)\2MYF*^<O$5N!</\
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MTWQ$T++\_P"M>@>&_&A5U&_]:R.&K0T/J.QU!9E!SFK^[=7EOA;Q0MPJ_/\
MK7HNGW0FC!S2/)G3Y2SFE%.V[J3;0<['K3UZ5&M/5J!#J*2EH*"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKX;TWR8UXKL;9=J@5!\U7=V6=U"TVGTCD"BBB@84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT6#S5M6"BJ8KM&7<6?7BJ#6N#TK;N&%9\F*BPKMD4-OTXJPUEE>E+ P!J\K
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MLQCNS0CMBR:&8AJUK.X.X5B)UJ_:MM851IH=79S%E%6Y&^4FLG3YNE7+B?\
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MMF(T7BM-5VU':* @J9J1\Y)W8JTM(M+00%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 )3:?3=M "4JT;:4#% A:***!A36HW4E #6I*<U-H 8:;4A&: M8R!:
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M<7T%6GTU:=3("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI,T &:-U(U
M)0 ^BF;J-] #Z3-)NI&:@!VZC=3:* ';J*;FG+0 M%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEX%>#*1];3I\J)%P*5J8#3JS-@HHHI[@*O6G4RBD ^BBB@ I&I:* &4^DI:
M&MUI*#12&PIRTVBF05]0&8S7EWCFUWPOQ7J=T-R5Y_XRMRT#\4T=-)ZGR=\1
M+,!Y>*\/U>';,WUKZ'^)%MM:7BO M=4+,WUKH6Q[M&1S\L>16+J4/RFMR60
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M*?24M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ@N<'XDN#&6YKA[F^;>>:[+Q1AMU<!=+B0U+ E%T6/6KMM)NK(C%:5O\H%-
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MM2&$0X&,5)Q3J<Q-#"(U J3UIH:BD<X4Y:;2K3$2+TI:1>E+0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 444R@!]%,I5H =1110 4UNM.I* &TC4XTQJ!C<F@9I
M=N:?MIB!5.*7;2&0*.:;]H3UI /VTC<4T3JW2E9MPH ;4BU%BI%[4 /HHHH
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M@^$_!:LB'9^E>BZ?X76W4?)^E/\ ",,0A3@=*Z[:,8Q6#9\_6J.]C.M;(0J
M!5S[HQ4NT4UEJ3D>I%WIXZ4;*=MJB+"9-*M&T48I%"TJTE. I"%HHHH&%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@!*1J&ZTE !12@9I<4"$VF@TZDH&-IRTFVE)P*8D9>K3>5&>:\G\:ZWY2N
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI&Z4M(W2D0-IU-IU "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2/B7MZUXGXH^*3>8ZB;OZUY9XF^($MPK8D)_&JL>C3HW.^\??%=IO, E_6O
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M7LFW-;:Q_NZQ=2B/)Q3*9G1SGS*WM+NBI'-<VH(>MG32<BI,SL+>^*KUHDU
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!KYZI1=-GU5'%1JK0U :6HE;=3UKF;.TDH-"T-0# 4M(O2EH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=U/%,Q@TY:!CJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:P_,*U)'<'UJ&2:LCAJIS,.:@:Z..M5IKDMWH"PZ5AS58MDTC2YI%^8TP+4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/NK6]"H*URRO<WI6L9$&D#=TKJ-!TW;(O%00QKFNBT4*LBTI2?*<=5KF/4/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*A7I3T7)IHFQ:CDJ7<:CBC-3>7@4BA!)BI5FJLU&XT#+ZR9J3;NJ@LN*L1W
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*R9X5:5V/6EHIE(YA]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "DP*6DW4 &*1J7-!% #-U)NH(I* &%OFIZ\T
MW;3U7%)B)#PIKS+XD7!6VE^E>DS2!8VS7EGQ&D$EO(,UVX5>^CDQ,K0/D/XH
MW#-/+]37A^H1F21J]V^)%GYEQ+CU->07UAMD/%?IF$T@CX>M*\SD;BUZ\5A:
MG'MS77WT8137(ZPV,UZ463$P\;I*U;"WW8XK+A^:3\:Z*Q4*HIR\B[V)]H1:
MR=0;K6C>3;5-85Y<9SS1'0S?O&?)]\U<LXMQ%46;YZU=+7<PK2YEU-".U^7.
M*KW.8ZWH+;='TK,U*W(SQ2N58R?M)!ZU/#=$U4:W.X\5+# WI3$6)9MRFL^X
M)R:O/&0IJA.",T 1*Q44Y9CNZU"QIH;YJ=PB;=G.<CFMVSDW**Y.VE.16_I\
MW2LY(V.BABW 5;CL\GI5;3VW 5OVD(;%8-V&5X;/:.E)/F)36]'9C9TJC?V?
MRG K/F%8XS5)F;/-<S=0&1CQ797^GEF/%94FFG=G%=4=B;&!%9>U2^3LQ6NU
MIM'2JUQ#@=*JXFM#*D8C-5)')J]<1GFJ3QXJR$5VR:B9:LLO%1E?QI'0B-:L
M1DTQ8ZF6.F1(L0N>*O0DU1A0UH6\9I,DNP]JN1FJL4?2K*<5DRBRE7((=Q%5
M(?FQ6SI\.[%9C+-G8[L<5N6MD%QQ3+.$*HJ_Y@45SRDRAW$:UEWTF[-6Y9MP
MJC,A<T11+9D31EGJ]IMKN8<5(EF6/2MG3+ JPXK1O0?-H:6FV(VCBM>.,)BD
MM;<I'TILK,K5BM6<-:5C7L;<38XKH+71PP!VUBZ"K.RC%>A:78EXQQ652IR'
MBU(N;,^QT?+#Y:W(]!W1YVUM:3HY=Q\M=?;Z#^Y'RUXM7&<K/1PN#E+4\>U?
M1?+4_+7%ZE8[6/%>Y^(M#VHWRUYGJ^DL)#\M=V&KJ:+Q%%T]#S^2SRW2KEEI
MI8CBMAM*;?TK;TG12S+\M>E*HDKGC2NY6(=%T4N5^6O1_#WAG=LRE.\-^'<[
M/EKU'P_H(C5/EKYO&8SET1]+@,$ZEFR'P_X96-5)2NXT_35A4<5/I]@L:#BM
M#RPJU\A7KNHS[W#894TAL6%XHF/RFCO1*-RFO-LVSTSBO%=P5A?Z5\W?$B]/
M[SFOI;Q59EX'^E?-GQ+T]AYIQ7T^6NS1\QF4;H^?->F,D[?6N?FCW*370Z]#
MY=PWUK$D(VFOOJ:O$^$G&TCF]0C*YKF+^0KFNOU)0V:Y;4+<MGBMK6-H[&#-
M<'/6H_/YZT^ZMRI-4]I#4&R-"&:K)F)6LZW!S5V-214%%6[^;-9<JX-;<\7!
MK*N8\9K.1I%ZE%GQFA9*;(#FB.,M7.[W.U<MBU&YJ=2:9;PDU=6W^7I5HYI-
M7T,Z;IS6=-WK7NH]HK(GZFN>9W42K(M1^7FI]NZGQP[JPL=_-RHJB$GM4J6W
MM6A':^U3"WQ5*!S2K%..WJU'&%IQ7943S!:O1'/=R)]P6HVFJNTU-W;J.8:@
M^I/]HI&NO>JDC&J[2G/6H<CHC3N::W&>]6X9JPXY3FK]O)1&9$Z=C9BEJU')
M67"U78FKIB<<B\OS58C&,55A:K2&K1A)%ZVE*]ZV;.?..:P(LUHVLA4BM8F4
MHG66F&6I9XQM)K+L[S:!S5XW =:Z$S!HRKUBI-5[>X99.M7;J(R9-4EMV#=*
MNYC)'5:/J!7;S736^J?*/FK@[$E,5N6TIP*KE.8Z*2\\SO6;=,7IT&6JTEKO
MJ79%1U,R&%FDKHM,M#M!IEKI_P W2MVS@"**S<QU(Z%O3\Q.M>G>#+PJZ#->
M:1L%<5VGA6Z$<B\UYV+7- C"7C41](>$[K=&G-=_9MN45Y-X,U!66/FO5-+D
M$D8Q7Y[BH6DS]4P4KP1H4JT=J%ZUP7/0'4444 %)MI:* $Q2TA-&Z@!:***
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M4BTH^E;$=JL>.*N0HE;.3-(F+#IS+VK7LU:+%7DA1J=]G'85FY7-4BQ!=84
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M M<Q=W'SFM74+C*5S-U/^\Z]Z9#1JV<A8CFNNT,D,M<)8W04CFNLTO4%7'-
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $:FT^B@ HHHH
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*6BB@ HHHH
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M@>I6I-R>.]?47Q,T([I3MKP35M)VW)X[UI'4]V@S#L;7"CBM:"S+8XJU9V/
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M "TVG4G% "KTI:;FC)H =131UIU !1110 4444 %%%% !1110 4444 %%%%
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MM,A#*!7%Z?, PKL='N!E>:9+->321/'TKE-<\/E=QVUZ+92(T?-5-6LTFC;
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M 6BDW4M !1110 44W=1NH =1110 4444 %%%% !1110 4444 %%%% !1110
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M;M6G:6 DQQ71Z7H1D8?+42J**U//E)R=D<[#H32#[M2GPNS#[GZ5ZAI7A7S
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5Z4D@CA&3T%9,^:J[DNVC;5*358HS@D4BZM$QX(I&'*7J1N5J%+I9.E2!MU
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM5$DBM3MPJ(45)0LBANU9]QIR2YXK0'-2;1Z4%*31A+H:;@=M7(-/2+^&M'
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MBB@ HHHH **** "BBB@ HHHH **** "BBD)H 6BDW4M !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-R34<UNLRX-2'K2AJBS0;JQS.L>'([F-OES7COCKP6FUR$_2OHIHPPP:\_\
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M>WW?Q"VY_>?K56+XD?,/WGZUX!J'BQ^?G_6LQ?%\@D^^?SI\IH\,F?6^B_$
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M;C]U&ZH\FE6@H?D49%-I 3F@"2BD7I2T %%%% !1110 4444 %%%% !1110
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M[*5HV[>M;9M0RYK*OE\H'M4J7,0IE*5E45D7UX(\TE]>E6(S7/:C>%@>:WA
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M :.O>?#<8\E/I4-GB8AG0PKM45)3>E)FLSR1]%(M+0(**** "BBB@!*6BB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BDIN: 'T4@Z4-0 M%-R:=0 4444 %%%%
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MSQ]:@52&H*-. [@*L-;AEJE:L1BM2%LK3&95U9>U9<UMM;I73SJ&6LBZBZT
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M,TY:!"T444 %%%% !1110 4444 %%%% !1110 4444 -:A>M#4+UH =1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M06PA3;BM"WZBH8X:M1IBI,S0@:I^M5(FQ5N/YJ ()(\YJ#R3FM3R<U#)#MH
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M U&[:44M% !1110 4FZC(I#UH -U&ZDHH 7=1NI** '"EI!TI: $-)NI6IM
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MCJ6I/*>XW;2@8IVVDH&% HI0* '4FZEIE #@<TM-6G4 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 0 \>:^CO!5Q''&G(KYK,:DN5I'3@Z,54/2](L_+A7BM5?EJCI]XC1#!JX)
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M%ETD;1<U]/\ AN]2:R49[5S2/'Q5S9V@#BF9-2?>%-\OWJ#S!%IR]:7;1MH
M*6BBD 4444P"BBB@!,44QIE7K4)U"(<9H'8LX%(144=TDG0U+NR*!"4^F4Z@
M!:*3-+0 4444 %)BEI"P7K0 ;::PQBHYKM(AUK'OO$$<.?F%!:BV;>X4JG..
M:XU_%T2MC?\ K5VS\31S8^84#<&=115*UU!9AP<U;# C-!%AU(:3=1NH$(1V
MINRGY]J2JN*PW;2,P1<YQ1)(%!K(U'5%A4\TBXP;+5UJ2P]36/<>)XXS]_\
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M+0 U:=12-0 M%,S3J %HHHH *3-(U)0 ^BBB@ HHHH **1NE-H *5:4=*6@
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M+$2-S35V1CZ5=J&&/:M2,U9GE,7-+3%-+NH$.HINZG4#"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0T !IA7-.W4**
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MY#_$*\XO_&2PY_>?K6:/B F<>9^M%@]C(]8:XC7JPJ-M0A7JXKR:Y^(2*O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)L [4^DQ2T$C6H6EHH 6BBB@ HHHH ***0T +13<FEH 6BBB@!*;3CTIM2T
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MTK*UB!<' JTCFMJ<2T.UJL0H.*=<1[7-1K)MQ0:E^.,&I1;CTJM#/5^&0-0
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M"BG4;12,Q%IU)TI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.U8\AO[5%=5-31I4BPU8BA]JVC&Q$JET$,/(K4M8>14,,.*NQ,%K8Y6S0MX
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M'\-+Y07I57#VE]R.$;5 I^ZC;1MI,ACMWO3@:9MIRTB1U%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7NKT+'UKF=2N@['FE&)=SG+Z(LQJG$A5ZUI%$E-2UW-Q6U@N6]-)P*TIM/\
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MGY.[&$T;C2XHQ09#@:6DZ4M!0F!1BEHH 2EHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/]*Z#4O Z_9S^[[>E>EZ+X?2W1?EK2O-*22,C;VK.YR/$:GR+XS\%LK/B/\
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MZQD;3/O<%*\"9JBQFI6J/BN-'HCE'2GTP&G T +1113 **** "BBB@ HHHH
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M:&NY5KJ[>$[17+^%")=E>BVMB&A!]JL#G+Q2J]*YZ^!YKK]6A$>:YB\CW9H
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MEN-M.Y%CEIK4[JDM[?YNE:LUO\W2B&W&102TT1Q6YQTI[VI8=*T(815V.S#
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MF_V?[4['3H92LRU(L[<"KCV)]*B^RD'I1RDMEJSD+$5OV:[E%85K&5:M^Q.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+GI7!^+/$0M8W^:NLURX\N)N:\*^(NLE%E :O'Q.)4$=^&H.HSBO'7Q!:%I
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%%, HHHH
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MH-%*QY5JG@&.9B?+_2L=OAQ&#_JQ^5>SO;*W:H6L4]!3-%5:/&V^'B _ZO\
M2M+3O Z1L/W?Z5Z:VGH?X:?'8JI^[3N;>V=C TGP^MN%^6NDMX?)Q4T<87'%
M*U2<LI7'AJ4C(Q4?:G[J""G=6*S*>*\_\7>'Q)')\M>F]:QM<LQ-&W':KBS>
MG4<6?(GC[PYM:3Y:\0UW1=DK96OL'QSX;\[?A:\%\5^%VCD<[?TK4]:C4N>+
M/8!&Z4$"$5T.IZ6T#-Q7-ZAF/-!ZL-2I>7G!&:P[N0R-4]Q(68U7V;J13*R*
M=U7;=>E-$-6(4Y JR%'4LQPYJ=;4-VIUNF36W8Z:9\<4C;H4++3RS# KO/">
MBNTR';WJ30?"CSR+\A/X5ZYX.\#LK(2GZ5+9P5I([SX7Z>T(B.*^A-)XM%%>
M;>#_  _]D1/EQ7I=BOEQ@5F]CY^M+4M&@4FZG5!S"-3:=C-&*!C:?110 5$U
M/W4E $39J%I_+4Y-62M8FL7'D1MVK&M*T;CBKNQ@^*M86.)^:^>_'VJB9I!F
MO0O&^N&-7&ZO!O%&K--(_-?GV98EQ;1]GEN'V9P_B"V%Q(YZUQ6H:2%8G%=Q
M</YA:N?U9< U\I&JYR/M5!0B<-?6XCSBLAY"K<5O:GRQK$DAYKVZ*TU/#Q%:
MSL/MY":NQMD50C7;5E7Q6DC.G4;+++4,D=2*V:>5S65SKC(K+'S5VWCZ5&J<
MU;ACZ5,F:W+$*=*N1QTRWA/'%:,-O7))A<@6$U=M5VD9I5C"YS4,UXL(ZU"5
MV8R+\UPL<9YKE-:U8)NP:;JFN!5(W5Q.K:P9&;FO2HTKG)*5BY/K1+GYJM6>
MI%V'-<9]I+2=:V=-D/%=,Z22+IS.[LKK('-:D=U@5S6GN=HK65CMKRIQ5STH
M:HTSJ!7O21ZL5?K63+(?6H5D.[K4\I=^4] T35R67FO1=$U3Y5^:O&M'D*LO
M-=_HUV55>:\K$0['53DI:'JVGZP4Q\U=/IWB/9CYJ\JMM0VJ.:OPZUMZ-7)2
MJSHNZ(KX>-1'N>D^*1\HW_K7<:/K@F"_-7SCI.N,TBX:O4/">I/(4YK[C+<S
ME)J+/B\?@HP39[/:S"115GL:QM%D+QC-;:K7Z!1ES13/CY:2L%.6@CBA:[40
M+3*?0%H 93EHQ25 $BTM1J:>M" #TIC-3Z8RU0#-U.DC$D>#2;>:>K<4#.7\
M0:$MU$_RYXKY]^)G@T;)"$]>U?4TT8DC((KS7QWH(NH7PN>*=SMHU+'Y_>-O
M#;QW#@+^E<5#X;EDD^[7U7XO^'YN+AR(^_I7/Z=\+RT@S%^E4>G&MH>'Z;X.
MF=Q\A_*O2/"O@65F3,9_*O7]#^%8+*3%^E>E>'_AHD(4^5^E-A+$'&>"/ Q4
M)NC].U>Q:/X,00KE/TK7T7PLEFJ_)BNJM8%A4#%3<\ZIB&SC+CP3&W\ _*JT
MG@6/;]P?E7H9 /:CRU/&*=SE]LSQ;7O *M&V(_TKQSQEX!*[\1_I7V!>::DZ
MD8KBO$'@Y+I6^3/X4*1U0K,^#?$G@^6%V^3]*XJYT5X6.5K[*\7?#<-O(C_2
MO'?$GP_>%G(C_2G<[J=6YX:+,J>E2"+;VKL;_P ,O YRM9,FE%6QBF=\97,E
M4J3R2:UHM)9OX:NPZ"[8^7]*N)LFCFC:D]J1K4XZ5UO]AE1RM5YM,VCI5A<Y
M=K<^E4;JW/-=--:!>U9US;CGBIL!RTUN=U$-OCM6R]H":<EE[4[%!I:_O%%>
ME^%=*%VR#;FN"TVR/G+@=Z]L^&^CF22/*U+.:I4Y3LO#7@(72*?+_2NUMOAB
MNS_5?I7<>"?#Z^0A*]O2O0[?18PH^45DV>54Q+/GO4OAT(T.(_TKBM6\%-&6
MQ'^E?6&H>'HY%/RBN.UCP<DF["?I3N9QQ)\N3>&7CD^[^E:.GZ"V1\M>O:CX
M*VN?D_2FV/A':X^3]*=SLC7NCC=,\*M-M^3]*N:CX \R GR^WI7KFA^%57;E
M/TKHI/"\;Q8V=O2ES'+/$:GQ7XP^'KJSXC_2O-Y_!$RS']V>OI7W9XA^'T=U
MN_=@_A7!7GPL3S"?*_2CF-(8D^9=-\%R\?(?RKK])\"R/M_=_I7M]G\-51A^
MZ_2NLTCX>HN/W?Z4N8U>)/&M%^';,5S'^E>C>'?AV(RA,?Z5ZAIO@N.+'[O]
M*Z2ST)+<#"T^8XZF);,+P]X52VA'R?I5G6]"5[=@%[5U,,8B7 IEU$)E(QFH
MN<+J-NY\Z>,/!QED<A/TKSF\\%NKGY/TKZLU/PZEUGY<USMQX'1V/R?I5J1V
MTZVA\YV_@^3=]S]*V+/P8^X?)^E>X1^!45O]7^E7[?P:BX^3]*5RY5CSOPQX
M1,;*2GZ5ZYX>T<01K\M/L?#ZVY'RUOVL(B4 "@X9U&R>.,(M.;H:*1ONFH,3
MF?$-V8HVYKQ'QQK!7S.:]D\3QEHWQ7@WCJU<F2K1Z&'6IY'XDU'SI'YKD+R/
MSLUT6N6SK*V:QO)]:T/I*;7*<CJEAP>*X_4;4QMTKT^_M ZGBN.U?322<"@B
M6YSUA-Y3CFNGM]3VQ]:YW["\;]*LJKJM6AQ-.XU(LW6DM[PLPYK'8,6J]9QG
M@T[%G26ES\HYK123<O6L2VRJBM&&3B@D;>#Y2:YO4G"YKH+R3Y37*ZK)UI,9
MC7DW)K*FERQJ>ZD.XUGR2?-2$R96R:D+"JT;TYG^6A$D<KXS4!GVTRYDVU0D
MN,=Z0MRY)=<=:J27&2>:IR77O5=KC-,=B_YFXU/">:S8Y>:N0R=*0V:L3#BI
M&E&*H+<;1UIDES[TR2Q-(#55CFH7N,]Z%DW4@)0:GC-0H,U81: +$;5+N%5\
M[:0RT 2N-U0214Y9,T\?-0!1:'K2I'TJV8\TJQ>U #%7BG[:?MXHH 3;3XX^
M:%%6(5H MV2885UVCR;=M<I;_*PK?TV?:1S5(I'<6O[Q!5+5].WQL<5+I5P&
M YK3N@LD-,9Y/K%B8Y&X[UG6T/S5V&O66YFP*PX;%M_2@5@CMP4'%(UMZ"M6
M&Q;:.*>UB<=*!F#)#C/%4YEK=N;4K6/=)M)J;"9F2K4/E_-4\GWC2(OS46(+
MVGP985V6CV><5S.FQ_,*[?0T'RT@-[3[/@<5N0P[4Z4S3[<;15^1 BT&B,74
M -IK N(=S=*W-0?DBJ$<'F2"@B9L^$K'?.G'>OI3X;Z2=L1Q7BO@;22\T?RU
M]/\ P[TG9%'\M2V>16E8](T&U\F%>.U= IR*K6=N(XEX[5/G;61Y,G=C]PH!
MS49.:5:1F+*-T9%<)XLTX30R<5WC?=KG?$$.Z!^.U,VINS/E7XD:2$\SBOG;
MQ1;^7,_UKZN^)EG\LO%?,GB^U/VA^.]:H]VA)LX0<&K,/:E:V()I8XRN*I'H
MHF5 U2+ *2-35A15 ,^SCCBI(X!Q3_PJ2-NE,"6"'%7D7:M5XC4C24 $TVVJ
M$TS,W%232;FJUIVGFZD Q64A.IREC0[.2YE48)KV#PCX1>YV93]*SO W@TS2
M1G9^E?1G@GP6L:1Y3]*CF/-K5SC;3P!^Y&8_TK-U3P08U.$_2OHR'PVB1@;.
MU96I>%TD4_)2N<*Q#/E?4/"\D;'Y/TK,FT.1,_+7T;J/@=6)/E_I7-:AX(VY
MPGZ5:9O'$'@EUI[1YXK$O%,>:]BUSPFT*L=GZ5YKX@TMK=FXQ6B/1A+F.1FG
MVMUYI(;CYAS5>^!20BH(9-K51UQ2.FM9L]ZU+>3WKG+*;/>NAT^!IL8K-D32
M-K3[AD88-=UH.I2+MYKFM(T%YF7Y:[[1O##A%^4TCR:J1T.G:\\:#+&H-7\7
M&*,_-^M.DT9X8^ :X?Q3;S1JV,T'-&*;,;Q5XX+;QO\ UKR[6/$!NG;YLU9\
M2";>^<UQTJON.:9ZE&")II/,8FJ5P1BI&)&*J7#?+5H[N4RKQNM9<C\UI70+
M9K-DC.ZF8O08M(V:ECB/%.:$^E(N)GR,5S2),:LRVIYJ-;0TF47+.X.171:?
M(6 K"L[,Y'%=%I]L5Q0(U88MXJ7["6[5;L;?.*V(;,>E &!%I9]*UK/3=N.*
MTH[15[5;AC5:0#+6RV@<5HPV^!20LJU:C8'I57$5Y(15&:$>E;!A+]!4$FGN
MW:F%T8K0CTJ%T%:TU@ZYXK.N(RF<T@316+;:B>:F2OUJ')8B@)3T+]JVYJZ3
M2[8R$5@:9;F1A7HOAG1C,R?+29A[2Q8TO16EQ\M=CI'AEB5.S]*W?#OAG<JD
MK^E=_I?AQ8U7Y:R;.>KB-#%\/Z#Y.WY:]!TNU\I!Q4-GIHAQQ6I"NRHW/#J5
M.9DXXI:0&EI& 4444 1[J56IE&[FH8R23_5M]*\N^(6FM=028&>*].9LJ:P-
M:TT74; C-=6'J<LKG-6CS1L?#'Q2\+R^9*P0]Z^;O%.CSP2O\IZU^BWCCP"+
MX/B//X5X'XL^#;32.1%W]*^_P..A%),^4KX:5SXRDL9]_P!TT+9RYY!KZ.OO
M@Q)#D^3^E<SJGPUDM-W[O]*]Z.,A+8\_V3CN>/QVK+U%2F' KK-3\.O:L?DQ
MBN?N;=XV^[73&2D$KV*L,)W5NZ99EF'%4+&!F8<5V&BV.<9%$I6/,J1=R_IV
MFY09%6+K31LZ5M6=J$0<5)<0@J:XI3=SLHOE6IP=U8[6/%49X0@-=5J$ &37
M,ZE((\UK&1M-WV,2Z8+5 N,]:;J%YM8\UF?;ANZUKS)$*#9M1U#<J=M1VD^^
MK;Q[EI<UQ6L<[=*=U5US6M>6YSTK.D3;FG<H:K8IPFP:C:FGK2YB^1&O8S_,
M*Z&UDW+S7+6.=PKH;5MJBF*R1-=*&4USM^N,UN74^%/-<[?3;B:4I6145=F9
M(WS4L<A6HW;+4JUS<]V=G)H:-K=%2.:U8[X[1S6!'GBK:$UTQ..HDB]<7&X=
M:H,W-/;-0MQ6QSK<D5\4&;WJ!FJ,M4.1U1CH322$TP-S3-U/452E<F2:+-O]
MZM[3K@QXYK!AXJ_#(5Q5[G*V>@:+?9P,UVMCB9!7E.CWA61>:]&T&^#!>:XZ
MD03-IK,DC K7TN KBG65N)@#6]9Z;A<XKCE*PFC+OES":X+7K<%FXKTC5+<Q
MQFO/M>;:S5I29)QL\.UC38/E:I+R7YC5$3_-UKK.F,M#IM/NMA7FNKTO5MF/
MFKSNVNCD<UMV-Z>.:R<3.K!31[%H.M99?FKU3PMJ6YDYKYZT'4"&7FO6?">I
MX*<UY^(I\T6>6J?LYW1]&^&;[Y4YKT/3;C>@YKQ3POJF=G->J:#=>8J\U\'C
M:/+)GW>6U[QL=5NJ-VIT?*TR1:\5GT3%#^]2*W'6H*>M-#1(S4S=S2TTBK&2
M!N.M/W5#NIVZL^H,DI::IR*=5B$I-U+2;30 ;J44FTTJT +1110 4444 %%%
M% !1110 4444 %%%% !3=U.INTT **6D6EH **** "FD4ZB@! M%+10 F!1M
M%+10 PK32M2TA&:5AD:K3]M&VG46L(9MI-M244P(BE(8ZFHI6&5]E+MJ5EIG
M\5388WRZ)E_=FIEI)!E30H*]Q-GGGB_3S<1OQ7SSX\\.L6D.VOJW5+ 7"GBO
M-O%7A$7*O\F:^BP.(]DT?.8[#.HKGQKK&D212-\IK-M]/D9L%37T#KWP[9Y&
M(C_2L6W^'3+)_J_TK[&GCH..Y\?4P<U(\LBT!Y5^Y^E1W'A:3;]S]*]ZT_X>
M' S'^E:,GPWW)_J_TK&680B]SIA@9M;'S!)X=E5ON&H9-$E13\I_*OI63X6E
MB?W7Z5G:A\+BJ']U^E7',8/J)X"?8^9;RSDBSD5G2.8\YKVCQ/X">U5SLQ7E
M.O:6UFS<8KMIXF,]C"6%E$Y^ZNL9YK)N)MQ/-+?S%6(JI&Q=J[(NYC)<J-&Q
MMS,PKMM T%IF7"YK%\,V/GR*,9KW7P+X4%QY?RUAB*RIQ,J2<Y6,C2?!KR1@
M^7^E:4WA$Q)]S]*]RT3P*OV<'93-;\)"&-ODKYY8^\['N_4WR7/G:ZT'8V-M
M10Z&"WW:]&UC1?+D;Y:QFM!#U&*]JG5YD?/5HN$K&+;Z&JKG%.FLUA4X%:<U
MTL:UC7U\&! -7JR5+0S[J0*>*SY&W&I+B4LU5]QK9*QC*[9=L?E8&NGL;L(H
M&:Y&&3;5ZWO#N%3)7%RV.FN9/.7BL"^T]I&) K7L&\[%;,>E^<H.*CFY3%G"
M1Z4V[I6WI^ED8R*Z/^P]O\-2QV7E=JF52Y49<I3M]-QCBK'V$XZ5HPQ^U7XK
M(R=JY95.7<IU7+1'-M9GGBLK4+%V4X%>@KHY;^&J]QX?+@_+4+%1N$83>YX_
M>:9)N/%%KIS*W2O2;KPR>?EJFOATJ?NUUJNFC91[F-HUJRRIQ7LO@965DKA]
M,T0K(OR]Z]3\'Z849.*\G'5ERG=@:+]JF>M>&R?)7Z5U,;?**YW0;?9&M=%&
MN *^"J2YI'ZC05J:!EI M/;I3:R-A5]*-M"BG4 )1MI:3(H ,8I:2EH ****
M "BBB@ HHHH **** "BBB@ HHHH *0K2T4 - I32TAH 3=2BDVFE% "T444
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M'44C4E>?'<[6*U)2-2**ZC&^I*M2+TJ-:D7I4EBT444 %%%% !1110 4444
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M'9QQC@5-N%&ZI.=NXPC;TI*<>:,4"!:<*!TI: "BBB@ HHHH **** "BBB@
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MBQ6:,@BO,?'GAE98I,+VKUA>5K#U[3Q=1L,4CHIS<6?%GC;PJRS283O7"?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *3%+10 F*6BB@ HHHH *1J6D- #<FGTT<
MTZ@ IK4ZFM0 TFDR32M2J118!NTT8-24FY?6H:&,VFCFG>8@[BFM-&O5A4ZA
M<.:<IJ%[R)?XA5:75HE_B%-18N9&CN%-,BCO6!<>((HP?G%9%WXNBCS^\'YU
MI[.1',CM/M$8ZM3?MD7=J\RN_',<>?WGZUCW/Q$1/^6GZUT1P\V2ZB1[)]NA
M_OBD.H0?WQ7A-Q\3E3_EK^M9=Q\6 N?WV/QK;ZK(R==(^AFU:V7JXJ-M<M5_
MC_6OFBX^+VW_ );?K6;/\8C_ ,]OUK18.3)^L(^HI/$ELO\ $/SJK)XL@7^,
M#\:^5Y_C$?\ GM^M9\WQA;_GM^M:+ R#ZPCZLG\8P ??'YUF77C:%?XQ^=?+
M,GQ>9O\ EM^M4YOBHTF?WWZUT1P+,)8A'T[<>/(USB0?G65<_$)%S^\_6OFB
MX^)CMG][^M9T_P 0W;_EK^M;++V8_63Z4N/B0J_\M/UJE)\2P,_O/UKYIE\=
M2-_RT_6JC^-9&_Y:'\ZT_L]]A_6#Z8?XF#_GK^M0M\3O^FGZU\T-XRD_YZ'\
MZB;Q?(?^6A_.MXY?Y$_6&?2DWQ0/_/7]:IR?%(C_ ):_K7SDWBN5OXS4+>)9
M6_C-;1R]$2Q#/HMOBHW_ #U_6F_\+4;_ )Z_K7SB?$4O]\_G33XBE_OFG_9\
M>Q'UAGTA_P +4;_GK^M(?BH?^>OZU\X#Q'+_ 'S^=(WB*7^^?SH_L]=A?6&?
M2(^*A_YZ_K3U^*A_YZ_K7S2OB.7/WS4J^))?[Y_.G]0B'UAGTJOQ4/\ SU_6
MIH_BD<_ZW]:^9O\ A))?[]/7Q/(/XS4?4$:QQ#/J&+XH$_\ +7]:M1_$[_IK
M^M?+<?BR1?XS^=64\82#_EI^M9O+UV*^L,^HT^)8/_+7]:L1_$@<?O?UKY:7
MQE(/^6A_.I5\;R+_ ,M#^=8O+_(KZP?6-K\1%;'[S]:U;?Q_&P_UGZU\BP>/
MG7_EI^M:$/Q'=?\ EK^M1_9S#ZP?7UKXYB;'[P?G6K;>,X6Q^\'YU\=0?%!U
M_P"6OZUH0?%AE_Y;?K64LND:QKGV+%XN@_OC\ZMQ^*K=OXE_.OCN/XP,O_+;
M]:N0_&,\?OOUK%Y;(V5='V!'XBMG_B'YU,NLVS?QC\Z^2K;XQ'C]]^M:EO\
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MMA[:H]S)\0[\K/55&5%+BH;>3?&#4U?')6/N;W%HHHJ@"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK'K3J
M:5H ;NI:-OM16=RA<FHV)IV:;6B(8VG+32*533=B=2857O%W0D5*&ILGS+BH
ML7T/+?&ND^<C\5\^>-O#K;W(6OK76=,%PC<5YCXG\'BXW82OI<#B53LF?+X[
M#.;N?'FL:+(LC?*:R?[*D_NFOH37O !WL1'^E<]_P@;;_P#5_I7V%/&1L?)U
M,+),\ACT223^$TZ3PS(P^Z?RKW+3_AX7QF/]*VX_AKE?]5^E3/,(1+A@IL^8
M;KPI)S\A_*LR3PG+N^X?RKZHNOAG_P!,OTK/;X8Y_P"67Z5G_:$;;FT<'*]C
MYF7PS+'_  FE;37A'(KZ*O?AJ8U/[K]*XGQ!X,:V5OW>/PK:GC%-[DUL,XH\
M>GS'FJOVHKWKH=<TMH&;C%<E<*8V->I"2DCR^6S-%+[WJ>.X\RN?,Q5NM:VE
M_O67ZTV=:^$V+2U,S#BNBT_1PV,BFZ/8@J"1726\:P@5A(X9SLRK'H:[>E1R
M:.H_AK=AF4C%/:,.*SU01=SE_P"S &Z5-'IR^E:\UN%R<55=ME--LUN4SIJ>
ME20Z6FX<5*LPJQ!<+NZU6I#DC8TG2U7'%=-#IX,? K$TFX#,M=SHUK]H"\9K
MCJ2Y=60USZ(Y2\T9FS@5DW&AN,\5[+%X7\Y<[*IWWA+:I^3]*YUC(WL-86:U
M/%IM+9.U4WMVC[5ZC?>&6Y^2L&Z\-MG[E=<:T9$RC*.AR4!96%=/H:L[BEB\
M-/N^[75^'_#;JZ_+4UJT8Q,HTISD=1X4LBS)Q7LOAFSV1IQ7%^%=#\O9E:]/
MTBS\I!Q7Q&.K\SLC[O*L*XV;-J ;8P*<PI5&%%+C-?/;GV6R&$9IM2[?:F[:
M(QL(:%IQ6EQ2UJ38:M2+3,4\<5(Q:*** "BBB@ HHHH **** "BBB@ HHHH
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M*TFV@!5-/W4T+2[:H!=U.6F4]: '4444 %%%% !1110 4444 %%%% !1110
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M5/4=*3;2CBK$/HINZC)J0N.I-M+10,3%+110 4444 %%%% !1110!!MI:**
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%.KH7=5N_M#$FL8QC=G%3/(6ZTS(KU())6/-E*['*Q7I5VUU!X6&#5$,*/,
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)2 #0*,TM,
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M<U65<M3'GR:DAD!-,YF]2>.W+5'/"5%:-M@@47$(9:#HCL<])\K57D;-7[J
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M4BTM:@%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLV3PZC,3M_2NJ.-G'J<DL%!]#RK0_!_E,OR5Z9H.BBW5?EJ_;Z*L)'RUK6T
MCP,5E4Q,JBU-J.%C!Z$]O#L4#%3GI2+TIU>:U=GJ+1$9C![4GD"I**86&K&!
M2[:=10/8B9?:E"T_:*6@=QM+BEHH)"F,M/I*!C-M.7K2TM !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !36ZTZFMUH %ZTZFKUIU
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M0 4444 %%%% !1110 4444 %%%% !1110 RBG8HH 1:=110 4444 %)BEHH
M3 I:1J3)H =1110 44UJ!UH =1110 RE6EP** %HHHH **** "BBB@ HHHH
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M !1110 4444 %(W2EHH 93EZ4;12T %%%% !1110 4444 %%%% !2;:6B@!
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MBZ<CZ^E5]I&Z)UIU(M+5(U"BBBF 4444 %%%% !1110 4444 %%%% !1110
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MCIZT(&)(NZN5\56P:W?CM76&L#Q)'_HS_2NBD[21A55XGRU\4+8*93BOG7Q
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MRT@6I_EHPM7S$V1&O:G&E.!2%J=[AL-J1:C6I%H"XZBDS1NH 6BBB@ HHHH
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M%)NI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 0\TFVG44 %%%% "$9HVTM% !1110 4444 %%%% !1110 4444 %%%%
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M1110 4444 %%%% !1110 4444 %%%% !2$TM(U ";J=3=IIU !1110 4444
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MK1M9MI%1)&C/7/"_B,V[)\U>X>"_&VW8#)^M?*&GZD86'.*[WPWXH:%E^?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIK$TM0'^9[4[<*AYIVTTP'[Q1O%,P:*8#]XHW4RB@!^ZC=3** )-U&ZF+2T
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MH HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3
M-+3*5: '4C=*6B@!E.7I2T4 %%%% !1110 4444 %%%%( HHHI@07%LDT; C
MM7E7C[P6E]#*=F?PKUIJI:AIZW4+9':H4FF,_/\ ^*7P\%NTC"/'X5\\:YI9
ML;AAMQS7Z#?%SPVGDRG:.E?&'Q!T;R;R3"]Z^DP4VSS*\4<+IDFU@*Z&V;<*
MP;:V,<G2MNTR*^LI2=CQYJ[-!5R*:RBI%^Z*:U;\Q"C89BEVT;:"=M4D5N#+
MP:I[<S"K/F YJ>QLS-.O&>:<M$9^RN=W\/\ 2?M4\?RYKZQ^&OA=5BC.RO!_
MA7H1::([?2OKSP'I8AM8^.U?'YC6>R/4P] Z2QLQ;0@ 8XK'\21E[=OI74LG
MRX%9FJV@DA;BOBL33=1,^EPLE3DCYI^(%BQ:3CUKPS7K4K,W'>OJ7QYI(*R'
M'K7SUXNL?*E?BORS,Z$HS/T3 XA.-CSB]7"FN>N8]S'%;^K2",FN=DNU#')K
MAH71Z,I<P+;FH+J':IJ;[<BCK6??Z@N#S7I1YF>=45C,O%5<UC74@7-2:AJ0
MR>:P;G4,YYKNIP81EH37%P*SKBYZU%-=[N]9\UP?6NV,3&8ZXFSWJFSFAI-U
M,8UT)'-*5AWF>]'F&HF:F%J?+<7,6/,]Z3S*K&2D\RCE N+-5J.XY'-97F4]
M9J.6XTS;6XSWIKS5GQ7&:LJVY:SE&Q=P:0TSS#FG.M18YH1=RU#,:TK.<[L$
MUDQKTK2LD^:HEL,Z.T.Y14DT?%1V(PHJW-C;7"]S:+,QH_FJS;ITJ*1AFK%J
MPW"J>QJ;VEV^YEKM-+M<**Y;1L%EKO-*C!45Y->1I$M0QE0*GC.6%2^3QQ3H
M;<EQ7DR.^G8N6=OYF.*[/0-'\UE^6LC1=/,C+Q7J?A/02Q0[:5*/--(C$U5"
M)L>%_#.[:=E>JZ#H(A5?EJ#PSH81%^6NXM;$1QCBOTK+,!"45)H_/<=BVVU<
M;9VXC45<Z4BQD4XH:^KC35-61\_S<SU =:D0U'@[J>M:%6):1J%Z4M AE.I:
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!?GS7K.C7WVB-3G-?&XC#>R9]CA<1[1&Y124W=7">@/HIH:G4#"BFEJ3=[T
M/HIH:G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% ";112T4 %-:G4UJE@-W4M)CFEI)@-;K0M.H JP%6G4G
M2DW4F 9-&ZDHH0"[C1UI*5>M,!=HHVBEHH 3%%+10 E&T4M% !1110 4444
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M,JXL,>!5E8Z(X^*G"<5 B#RZ794VRD9*8$>VFE:EVTOETQ(@V4FRK/ETACI
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@$-)M-.HH ;M-&VG44 -VT 4ZB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0KX+,6KNQ]UE*ERJYK-]VHZD;H:C-?/Q=SZ@%ZU(M,6I%%:"'4M%%( HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(U)5I#T%(#15HACEI:1:#TJ@%HIF:<.E "T444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNZE%-IRU**8Y:6@#%+5"&[:6EHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBDH 6BDW4M !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9M'DXBDXL[.FM4=O+YB@U(RYJ3SP4TZHQQ3E- #J*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *1NE+10 RBG4V@ HHHH **** "BBB@ I5I*5: '4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOT?"55.)\%5CRR'FE44U>M2+7HLP%'2EHHI#"D:EHH 93Z** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*0T +13=U+0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *8QZTI:D- ";J6FXIU !3:<:B:@5Q^ZC?3-V*ADN%7O4<R1:B
MV6U;=Q23/M7-4X[Y/6H-0U-$C/S5C4K1C'<TC3;=C/UG5?LZMS7G6N>+O)=L
M/5KQ;KX57 :O'?$&N-)(V&KXC,<Q=-Z,^DP6%4MSOH?'!\S[];5KXT#+]^O
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSN>I&*9:?6&W?>JS9ZTRL/FKGN6:I4R@S5>Q6P_9Q.YM?$QC4?-4[>+?]O\
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M$5H2\5^CTY<T;GQ-320]&J2H(JG7I6I(M%)FEH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,L=5%F@J]*DINVG58@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC5R[54@D#**N1 =:Y9*X_:%N, 4V>=54\U!-,4%8U]?E2>:QC3;8_:6+5W=
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MH **** "BBB@ HHHH **** "BBB@ HHHH ;MHIU-P: !:6D44Z@!NVC;3J*
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M M%%% !1110 4444 %%%% !1110 44UFIN^@"2BFAJ-U #J*86I-]*X$E)3
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M110 4444 %%%% !1110 444QGH ?14/FTOF4 2T4P-3LT +1244 +129I-U
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:U.I"* &8]Z>*;3EH&
M&*0TZD(I"$%+M%(!3JH!!3)O]6:DIDW^K:H \V\=S!+:7Z5\;?&:42&4#WK[
M%\?0,UO+CTKX[^+UFVZ7BOJLIW1XF-T1\C^+(<W3_6L2WCVUU/BR';<OQWKG
M47%?HJBN0^7<_>(V6F-)MJ22J-Q)C-<%3W=3LH^\R22X]ZK2356DFJ/>37#*
M=SUHT[(L>9FFM3%IQ-9[CY2-S\M5)I*L2'@U4FJ6;1(6;FCS#3329-8LWL.W
M&G>8:B]::QQ2N/E+0DW4-S519,5,']ZJY/**5YI"*7-&:6@,8>U.7[U)MZ4]
M5H&3QC.*M1K4$*U:CK5&,BS;?>%=%I^-HKFX6PU;=E-@"NFF<%6+:-IWVIQ6
M?-<88\U(TVY:HS$DUVW9Y_)J2>>6J6/YJH(:N0R8 KIILRG!(N1G;6C:W6T]
M:QC,!2K=;6K9R1CR7.XT_4,$<UT^GZD..:\PM=0*L.:WK'5MN.:SDDS"5XGJ
M-MJ"[1S5M=07UKSZWUKY1\U7%UG_ &JQ]F9<S.[M]0'F#FNU\-:KMD3YOUKQ
M>WUKYQ\U=EX;UG]XGS5A5IZ%1>I]6> ]8W>7\U>\>&[Q9(5R>U?)O@/6@I3+
M5[OX?\41PVZ_/V]:^(Q^';>A]3@:RBM3UO<!W%,\Z/\ OBO,]2^(4=O'_K?U
MKFIOBM&LA'F_K7DQP521ZLL9")[EYR'^(4NX=C7CVE_$B.Y8#S?UKN-)\1)>
M*,-G-<]7#5*>Y<,3">QU!:D4U7BF\P @U/7&M'8[4TT.S2@TQ:>!6@AU%%%
M!1110 4444 %%%% !1110 44W=1NH =12"EH **** "BBB@ HHHH ***3=0
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M @P*T N%Q47/,G+F8QCS1DTNWFC;0S,6ER:-IHVFD JTM(M+0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4RGT4 -6EI:2@!IIE.;I3: %Q12KTH:I ;3@BLO(S36Z4J/M%.X&#X
MFT"+4+=OESQ7S%\6/ABMPLS"+]*^NI1YBD5R'BKPRE];OE,Y'I7;1J.+1C.*
MDC\L_B'\.6M)I"(R.?2O&=5T)[>8C:1^%?I#\2?A6+KS2L/Z5\Y^)O@W*;AB
M(#U]*^QPV*CRZL\2I2?-H?,=OI+R<;:U+7PG)<=$/Y5[II_P;G\P9@/Y5WF@
M_!ERJY@_2MY8R,>I?+)(^6)/ \JKGRS^58>H:')9YRIK[>OO@P5MS^X[>E>4
M^-OA+);JY$)'X5E'%QF[&$G)'S%N*-@U;A;=UKH_$'A*33YFRA&*YMO]';!K
MTJ:YM4*]R5H]PJE<0CTJXDH:HIAD5I..AK"5C*DC]JA*\U<F7K55ASTKB:L=
M5[BK4RM4'2E5JFX6)F-15(&S2;?FJA!&NZM*UAZ55@3I6C"P45K!'/4;)PNW
MI5>:<K4DEP-M4)Y,]*TG+30RA#6['-,6II;-5]WO3PWO6%V=-B4&GBHE:G[J
MM,9*M3+5=>M3+6\3&1-4B=:B6I5K2.YC+5%A#4E0JU2*U=\&>?4B/1?FK;TT
M=*QX\;JU+.8+6QPN]SH$(V56F?!J#[9\O6J\ESNI(6Q>CDZ5H6TGO6'%-6A;
MR\BFT*YT%N_2KL?-9-K)G%:<+<=:Q:&B_!C(KIM#E"2+7*QO6SI,Q\Q:R9$S
MVKPM?[57!KT73]681KS7C_AF8[4YKO[*ZVH,FO-JTU(\BI>+NCT&PU9S_%5J
M\U1_+/S5RFFWH)'-;$C>;'ZUX56BHR.VE6DX6N8^HZ[)'(?F-/TGQ0XE&6K+
MUBV/S&L.&1H9NO>O2IT82@>//$U*=2]SWKPWKYFV_-7I&E77F(#FOG[PEJ)W
M(,U[1X;NM\:\]J^7Q]!0>A]]E6*=1*YV:-E13Z@MVW**GKPCZT:W6A:=13 *
M3(H;I3:0#Z*2EH **** "BBBE8 HHHI@1R5#N^:IY*AV\T@)%I6I%I6I@,)I
MII33D7-0]1C%XZUF:QJ0M(F).*U9/E!KSKXB:J;.SD.<<&MZ-.\K$2V.4\8_
M$=-/WCS,8]Z\>U[XU(K,!-^M>8_&;XAR6DTP$A'7O7S+J_Q-FFNG'FGKZU]M
M@\N52-VCS*LVCZRU/XR>9G$WZUPOB+XBF^5AYF<^]?/J^,YIN3(?SJ>/Q!),
M.7KZ&E@8T^AY$Y.3.OUC4Q>2,2<UGV^W=FL9;XOR34\=[M[UUN.ED5%(Z2%E
M&"*TK34'@88.*Y:'4 <<UHV]TK8YK!P[E2/2O#OBZ:V8?.1^-=NOQ$D2VQYG
M;UKQ&WO!'@@U)<ZTPC(#5SRH1D]C-2:.J\7?$*67<!(?SKS*\\2274QRV<U6
MUB^:<MS7/Y;S,UVTZ,8H?,V==9W@D8$FNET]ED45YY9W)1AS75:-J'0$TJD2
MD=/)8[ESBL74+79GBNAM;I)(QS5;4+<2*<5RQ=GJ-HX:Y7#'BJZKS6[>6!#'
MBJ'V4J>E=:EH189".E7H)-IJ)(>*E2/I0R+&M9ZD\)&#706/B:6'&&/YUR<:
M58W;16$HH=V=Q'XVF7^,_G5RU\?31L,R'\Z\Y:;WJ%KQE/!J/8PET%S,^B?"
M?Q%<R(#)^M>_>!_&PN%C!DS^-?".A:V\,B_-BO;? /C,Q-$#)^M>3C,'&4=#
MIIU&F?<>CZH+J-?FS6XJ[ES7B'@GQJLB("_ZUZSI6M1W,:_,#7P.)PTH2/=H
MU$T:<BU'4JL).E+Y-<D;H[.9-#%S3^:79BEQ5L@5>U24Q:DIH HHHIB"BBB@
M IA'6GTE $3 T 4XXS3B,"@!O\- Q6??:BMJIR<5AS>+HHVQO'YT =<<5&U<
MU:^*(YV #BMJTO!<=#F@"T/>GKTI&'RFL75-<2P!W-B@#=VBF2#:*XZ/QQ"T
MFWS!^=:#>)(Y8]P:@#6DN K=:='> ]ZX;4O%20M]^H+'Q8LK@!Z /28Y@U25
M@Z3J'VE5P<UO+T% "TUJ=4<[;8R?2@"*23;WIGG#UKGM6UY+5R"V*S[?Q0DD
M@&^@#M V[O4@K)L;]9E!S6M"VX4 /6G444 %%%% !1110 4444 %%%% "$XI
MC3!>])<OY<1;TKD-6\4)9L07Q0!UOG!CUH'S8KBM/\6)<R8#BNFM=15E!S0!
MHB&CR\52;5XUXW"G1ZDDK8#4 6^E,:3;WJ13N7-9&J7HMLY.* -$3CUIXE![
MUQ,OBA(Y,;ZOV'B!+@CYLT =6**ALYA,H(JS0 U:=110 4444 %%%% !24M%
M "8I"OI3J* &4[:#2T4 8WB"Q2:U8X[5\[_$S1X\2G'K7T7X@G\FT;Z5\Y?%
M#6%42C/K5([<.FV?,_C*S2&9\#%>=W&%F-=UXTU19)I,&O.IKC=,>:M'TE&.
MAI0FK&>*HVLF15MF^6J1O)">=M:KMK=>]8DLN&I\-T1WJS&.YTR7NT]:T['5
M"K#FN,^VD=ZL6^I;6'-!4HW/;/"VO&-U^:O9_"OBO:J?/^M?*VAZWY;+\U>C
M:%XH,:K\]0<DZ5SZGTWQ8&5?GKIK'Q(KJ/F_6OF;3_&17;^\KJ--\<[0N9/U
MJ7$XI8>Y]"KKJ8^]^M.76E;^*O$H_'8('[S]:OV?C/>P_>4<IRRPS/:K>^$F
M.:O1L&KS'2?%"OMR]=98Z\C@?-4N)S2HM'2;:;ZU5AU!95ZU-OW=*@PY6B56
MHIBDU(M!("EI&H6@!U%%% !1110 4444 %%%% !24M-:@!<BEIE/H **** "
MBBB@ I,BBFT .I:1:6@ HHHH **** "BBB@ IE/HH 913Z* &KUIU%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4V3[IIU-:@#C/%UCYUM)QVKY+^,FE;5E.VOL_6K7SK=AC/%?.WQ6\+
M-=1RX3->]EU10DCR\7!R1^>WC>V,=U)QWKBCE:^@?'W@&7[1(?+/7TKRK4_"
MLEKNRA%?I%&M&4$?'U:;C(XZ1ZSKALYK:O;,PY!%8UP.36-=7V.W"[ZE"3.Z
MA5-3&/K2A/:O+Y6CW+JPU>*0U)M]J3RZ8KD#*3FHI(ZN>73'CJ7$KF,UXZC*
MU>>.J[IBL^6QJF5ZC<U(]1-FH:-4QA-*K4FWVI<>U9W&2*]2*V:KYIZM5"+"
MC-3*M01GBIU/%,QDR:,5,O%5U:IMW2M(LR)HV^:M6T8UDQ<L*V+->E=='5F%
M:R1>4_+4<E2_PU7D:N^UCS;W(Z>),5"S4F^G&5A.+D3--3/.J%GJ-FYK.4]3
M:-+0O1W!4]:T+>^*]ZPU:K$<F*UA,YZM%'3V^I'CFK\-\6[URMO-TK5M)NE=
M:L>;*G8Z*WNFW"NIT34S"ZG-<=:G=BM2*8Q@8-1)7(Y3VSPSXQ%GM^?]:[VW
M^* BA $OZU\NKKSV_1B*7_A+INF\_G7F5,(JCNSLIU''8^A]:^*+2*P$OZUQ
M\_Q"E:;B0_G7DW_"123=6-+%J#.X.:UIX6$%L95)2DSZ!\+^/I/-3,A_.O?O
M 7C W'E@O^M?%OAV]82)@U]!_#.^D,D7)[5Y&88>'*VD=F%E)2/K[0;W[5$I
MSFMXCBN)\#R%[>/-=S_#BOSJK'EFS[2E\"(EZU**A'WC4JU)H.HHHIC"BBB@
M HHHH **** "DI:* &44^B@!%I:** "BBB@ HHHH **** "F-WI],;O0!$]-
M&:<W6CI42B Y5JK?7BVJDDU%>:HEK&26Q7FOC3QW':QN!(!^-;X>C*H[&=2H
MHHZ74O&L=FQ!<#'O6;'\2(G?;Y@_.OFWQC\3]LC[9?UKC+'XH2-=?ZWOZU]+
M#+.:-SS)8C4^X-.\4)>XPX_.NAMY/.4&OESP'\0?/,>Z3/XU[[X9\0)>0I\V
M>*\;$X1TF==+$)G6!<5)&<&FP$2+FGM'CI7ENYW<R:(-2G$=NQ]J\'^)VO""
M.0;J]?\ $U[Y%J_/:OE'XQ>(BGFC?7N9=1<YW//Q$[(\;\?Z\+B:0;N]>2:E
MB>0FM+Q-KAFNG^;O6*LWF<U^B48<D4>)*7,QL4.VM*PN##("*I*U3(P'-:/4
MC8]#T'Q4]GM^?'XUT,WQ%E2/'F?K7DD=X4'!IDVH,PZUSNA&3U#F9Z/-\1IO
M,_UA_.NL\(_$>0S)F3OZU\]SWC9ZUK:!K36\RG=WI2PT''8J+E<^_/A[XV^T
M+&"_ZU[?H^I+=0K\V:^#/AWXZ\AHP9,?C7TOX)\?)+'&#(/SKXS'8)IW2/5H
M5+;GN6S=SFF>7S6/I?B*.ZB'S UJ+=JY&#7R\Z<HL]2,TR=4Q2GBHO/'K3MV
M[I2NQCP:6FKFG U7,,*C8\5(:B>CF C+<U)'452Q4[W"Y/2T450@IE/IE "K
M3J:M.H 2FTZFT .6EIJT-0 -4=/HV^U)C&4^BBDM!-C&[TBK4E)BAJX7&L*C
MR<U-BF^7S51T(>H)27$PCB))IL\@A7.:Y/Q)XE2TA8;\5SUJT8HTI4W)G/>.
MM?%M%)\W:OF/X@^+BS2 /^M=Q\2/&ZL)0)/UKYL\6>(#=3/\V>:^(QU?F>A]
MOE^'LE<R/$6NO*['=7&76L,&/S5>U";S-W-<IJ,A5C7C4XN3U/I6E%:%BXUA
MBW6J3:HS'K69)(6:E3)->@J:1SN3+S7C-WIJW#9J)4R*E6&GHC&4KD\<Q.*D
MW%J;%#TXJ]#:[NU9-HR*B(<BM;3PP(J2'3]W:M2ST_;CBL930N5EFUE*K2W%
MY@5.+4JO2L^\MWK!6;%9E"[NP<\UCW%US5NZB9<YK(N,BNR$43>Q,M\0>M7[
M.^SCFN<:0JW6IK>Y*MUK5P5CHC,[)+@,M4KPALUG0WQQUI9;O(ZUSJ%F$F12
M*-U,VBHI+H>M1?:QZUMRLS+JX%6X)=M9(N@>]31W'O4.)JCI+:\VXYJ\NI[>
M]<HMWM[TK:@1WK!T;L#J6UC;WJ>TUDLWWJXEKXMWJW8W3;AS5>S21I&I8]-L
M=2W*.:TK>^^8<UQ6FW1VCFMF&YZ<UYU2.IT*7,>G^&=6*.G->N>&_%'DJN6K
MYYT>_P#+V\UUUIXB,*CYL5$*GLGH<M7#>T1].Z-XU7Y1O_6NTTSQ0MQCYJ^2
MM-\9.L@&_P#6O1_"OBXRLH+U[=#,G%I-GB5LMZV/I6ROQ,HYK21MRYKSWPQJ
M_P!H1?FS7>6<F^,&ON\'7]K"Y\KB*/LY6+"]:=117H'&%%%.7I0 QNE-J5NE
M-J1AFG+3:?5 )1FD:A>M A:;3Z* &4X=*6FM0 -36Z4O>B@8U:>%%)1F@0C0
MAABJ-UI:3*<KFKY:D9JPJ04EJ:1DXZH\_P!>\*QR*WR?I7F^N>#,LV$_2O?+
MJW$O45BW6@I,3\N:\BMA8R5K'I4\5*/4^?5\%MYGW/TK2M_!I5/N?I7L?_"+
MINSLJ?\ X1U%7[M>#6RCF=['IPS5QTN>#:IX6**<+^E<O<>&WW_=_2OHC5/#
M2N#\E8+>#PTGW*\>IDK;V/;HYPK:GCUGX3>0CY/TKJ]%\%G<N4_2O2M/\(*N
M,I72V/AM(L?+7HX7)>5ZHX<5FW,M#E-!\,B +\M=WIMF(57C%3Q:<L/08JQ&
MFVOKL/@511\I6Q3JLM1G Q4G6H$)J937J(Y!K1!NM4KS34D4\5HTUNXJ)4XR
MW*4G'8XC5/#ZR;L+7.W'A@;C\M>H36XD[54DTP,I.*\3%8&,UL=]/%2CU/']
M5T7[.C<5Y[K\GV<MVKW+Q38B.)^*\(\; QN]?GF88/V;>A];E^(=3<X;5M4P
M6YKBM8U7[W-:6MW15FYKAM8NBV[FO#HP]X^EEL8VO:T5S@UR<VNMYAYJYK1:
M1C7-M:.S]*^IH0CRGCU.:YTVGZD9B.:VXU,J5S6CVC*R\5V-G#MCYI5+)Z&U
M.YA:E:D*3BN2U&/:QKO]50>6U</JH&YJ=*1T2V.?FZTU32W!^8U'&U>BMCDZ
MER#[U:MKG(K+MVYK2@D"XYK":*-JV)XK4MY-N*Q(+@>M:,%P..:X9Q*1MP3'
M(J:=@T9^E9D,WO4[397%*G&S%/8YG78MS-7/1PL):Z_4(/-SQ6:MB _2N[G5
MK'(XES25.T5U%KD**P[&,1XK=MY!MKSJNIK%%V.[:'G-;6B^)##,HW5SDW*'
M%9Z2O'.,'O6,=S6Q]5?#CQ1YC1#=^M?2GA/4!/;ISVKX6^'>MO!-$"U?5?@#
MQ*&AC!>OJ\OK*&Y\QF%&Y[6HW8I_EUC6&K+(@.ZKK:@N.M?4PQ4.Y\UR2N6L
M4TU72Z$G>IU^;O74I*>PN5H2I1TH"TM4HV) -Q3U-0U(M6(DHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3&:8UNC=5J2
MB@"LVGPMU6F?V5!_=JY10.[*BZ9 IR%J9;=$Z"I:*!"  4M%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK60OQ("R<R_K0![FLR-T84ZO+]%\>17+*#*/SKO-+U9+Q%PP.:0&K124@/-
M#J*** "BBB@ HHHH YGQI*8[)B/2OD3XM:HZM,,^M?7GC2+S+!OI7R#\7-/)
M>7CN::/0PNY\V^(=0:6=\GO7.>86DK?\06ACN'^M8(CQ)6A]/2-&U;BK;/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1110 UJ2G$9I-M "4^DVTM !1110 44C4F30 ZBBDS0 M%%% !1110 4444
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M3<FE% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU=' SS0!/H^KS.PP3712>*I]/BR6(Q5OPCX%DN-IV9JQXV\#36]DQ5"./2@
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M#14?2G*U:IF#1(.M2JQXJ->:E45:$T/ZU(B4B+TJQ''71"-SBJU.4=&E:-K
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M;\<:U%'I[Y(Z4 ?'/BKP;%:ZDY" ?-6EHS?8;? XXJUXTUR&74' 8=:I6/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH Q2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDW4T:,DDDJI(QJ5FS4>P^E0[CC9$EO*5(K6M;CCK61'&=PK1MU-4D1(TO/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:!TH:O5D<T1:7%-':EI(&Q]%%%, HHHH **** "BBB@ HHHH **** "BBB@
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MD;K0M #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI[)X2M3':ID=JZBJ&D6PAME&.U:%? U)<TKGN4U9!11161H)BC%+10 4444
M%%%% "8%+110 4444 %%%% !1110 4444 %%%% !1110 444E "$TN:-HIM
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK3J3% "+UIU)BEH **** "FM3J0C- #:?2;:6@ HHHH *1NE+24 -IU)MIU
M"8HQ2T4 (W2FTZC;0 4M%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 44W=2@T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]E]3EDD?+'BRV(D?CO7#7$15C7KOC#22LC_+WKSG4+$J6XK\[YN65C]'H2O
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M* "DI::U "Y%&:CW4;J '[J7=4.ZG*U #]U+NIM*O6@!U%%% ";J :1NM"T
M.HHI#0 9%&13-U&Z@!^11FFYH7K0 ^BBB@!E*M%"T .HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT /6G4E+0 4444 %%%% !1110 4444 %1M4E1/0 WDTOEFH_.$?4T"^CZ9%
M#S&:<HIHN%?H:>O2@!Z]*6FK3J "BBB@ HHI&H 6HR:6F4 )_%3U6FY"\TTW
M:+P30!(RXH6H_M2OP#3EYH EI:1>E+0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:-4[DJTZD Q2UHB@HHHI@,HI]%,!E*O6AJ%ZT@'4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5YU-,WVC\:].\21^<K5Y[=VOES$XQS7L4VG$Y&]3H/#N3MS7H>EGY!7FVBW
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M_P"6GZU\[>*/B<5O&02]_6L8>+KB^C)5R<^] 'TJOQ8B\S'F?K6[I7CR*_P
M^?QKX[GUR\BDW;FQ74>%?'<MM*@>0C\: /L>SOEN%!!S5O&>E>3^"_&R7B1C
MS,GZUZE83BXA#=: )?NT]339!2I0!)1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHH **** "BBDH 6BFY-&30 ZBHRU*K4 .VBEHIN32 =13<FC)I@.HIN329-
M :3=3))-N:IS7RQ]34.26Y2BV7=W(J3&:QO[8CW?>J_;ZA%(H^:A5(OJ)P:(
M-7<QPL?:O#?B5?$QR#->Q^(M1C6W;#=J^?/B-J2MY@S7C9A-<K/6P$.::/G?
MQPOG7$GUKBX;<*Y)KL?%<P:5SFN&NK\1,>:_.:LG*H?H]*GRT[ERZN5A3K7.
MWVK;2<&H-3UC((S7-75\9&/-=5.EU.2<M3=75CG[U7[?5O>N.6X/K4HOBHZU
MLZ=Q0TW.P;6L?Q4JZW_M5Q,FI'UHCU(^M"I&TI:'>?VQN'WJ='JG(YKC(]08
M]ZM1WA]:RE1N9([_ $_5_F'-==I>I;E7FO)=.NVWCFNXT:Y.Q>:X:M*Q;U/1
M+?5_+ ^:M>QU(7'!:O/FNF4=:T]'U(K(.:X'%F+BSM[S3UFCR!S7%:UIYC8X
M%=I9WPFC -4=4LUF!-))C5SSK:RM5J%2U:-YIXC8FJD>(VIREH;Q9*NG^8O
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5?$2JN*^EPV#5'8^;KXAU&01?NUQ3O,YI[1TSRZ]E.R/-=[C)/W@-9EUIBW
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M ,>\/TKY-TMO^)QU_B_K7UE\(LFWA^E 'NUC_J12WW_'G-_NFDLL^2OTHO\
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M]*^=_'"M_;+?[U>X_ %&\R'\* /K2,_Z$#_L5\^_&+4FM_.P<5]!1C_00/\
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M$<1*9H L^%_AF79&,?IVKV30/ XM+7[F./2NJT/PNEO$A*=O2NFCM4CCVXH
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M)JI\*YI9-6C)/\5 (^_='UMKG0PV[/R5\_?%#Q0]KJ3 -CYJ]B\+Y_X1U?\
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M%7IOQDUZW"R[2*\D\#ZXK:VN#_%0!]N^&<?\(ZO^Y7SQ\7L?VHW^]7N'A75
MWAU>?X*^?_BY?;M3;'K0!W_P-^\M>B?%;']CO_NUYG\")2S)7HOQ:D*Z,_\
MNT ?,5FBGQ#_ ,"K[?\ @-&HT^/ _A_I7PE9W1_X2+_@5?<OP!E+V$7^[_2@
M#V#40&L9P>FPU\6_'E56ZF^M?:&J'&G7'^X:^)/CY<%;N;ZT <1\,?\ D,1_
M[U?=_P .?^0.G^Z*^!OA;.6UB+_>K[X^&_\ R!D_W10!UQZ4T+3J%H %I:**
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***90 ^BFK3J74 H
MHHI@%-:DHH **** "FT9-)0P0M.4TRH)[M85))J(ZL;+;,%ZFJMQ?+&IP:YS
M5O%45J&^<#\:XW4/B#$K$>8/SKNIT)2..==1+OQ"U<K:28/:OB#XV:RYEG^;
MUKZ9\8>,(KJUD^?MZU\C_%Z[6YDF(-?3Y;1<9:H\+%5N8^=]:OVDNVR>]01L
M644[5(?]*8^]$,>%K[N&B/&TD&VCH*E$>:4PGM5LSE&Q#NI5;D4OV=C4L-FS
M'I6-]2+ERSK45OEJI:V;+VJVR%%J[E1*5U+BJ1F]ZFO&Z_6J.[FJ++2S4K2U
M3\RCS*8F60W-6[>2L]<MBKUO$>*=SG9KVK;L5I00[JSK.$\5MVT>T"LF4A\=
MN,5,L86G*<4QY M1N2)(P6J<MQM[TZ:8<\UG32YJBBQ]JR3S2K<>]9^^G>=C
MO3L!I"XQWJ1;W;WK%DNMO>HA=$MUJDA<O,=/#J1R.:UK6\+KUKD+.0LPKH[
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MQ[8U^E?GF*^,^CI?".44E2 8IIKD-A%Z4Y:2G4 (U"]:2B@!]%)2T""BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M S"U71O)T4H%_AKX^^,/AF:2^E94/4U]\ZMIHDM2F.U>*>-_ATNH,[>7G\*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3P<54M)MRBK=>Y%W1Y+W M2;J&I-IK5 .I<T;:-M,!*5>M)2CK0 ZF[:=10
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M4]=+0X)6M'BG"@"E'9I'T&*<UNKC!%6'[TQ,4 0+I\><[:GCC$?3BIATIK4
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M5>M<Q]H*4QM2*]Z^TR_A]RDI21\GC,[BHN*9OW=\&!YK&N9]V:IOJ!;O41N
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MZ@H**** "BBB@!#TIM/HH 2D:G4UJ $#4NZF4E R7--I!2TF["%6ER*;123
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MP8BEV^U&WVH ;+\R$5S>L:$MX22N:Z;K2-"&H X:U\)QPR!@@_*NKTZU%LH
M&*N?9UI^S;0 XF@&FT4 /IK4+2F@"(YHQ3]OM2A>* $4>E*0:6EH B9>*09J
M5AQ3=OM0 *3BC-.4<=** (VINXU(W>F4 +FGY-)3Z &-FDVT_%&* &!:=DTM
M+0 WFDI]-;K0 AYI-M.6EP* &J,4NXTM-H -QQ1D\4JT-0 A)XI/XJ<*7;0
MQ<T$4M. XH :.*7)H:DH 3%+3J,4 %(S4-UI* &%C3MQH9?:D6@ HW4\+Q36
M% #3DTBBGJOM3]M #%-.P:2G4 ,9:.E/I&% #=QHVTM.Q0!'MIZTNT4M !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!GZK!YT1&.
MU>*?$?03-'*=O8U[Q*GF+BN/\6:(+BW?CM75AY\LT<F(AS1/@3XC>'GCEE.W
MN:\4U.W-O,V:^R?BCX3XE(3UKY5\;:6;29^,5^E8"LIP2/CL5#E9PMS<#IFJ
MAD#57O92LQ%1I(<5[G+H>3%7D664&J<ZU-YU5YI*1Z'0J24B+EJ5N34L,>34
M6U,G(TM/CY%=# NU161I\>,5M1K\M.XAC/M:K-O-529:9'+M-3N)FT<2+6+J
MEKE36C!= KUIET!(II-"N<+?6Y5SQ51(R*Z/4+/+'BLIK8J3Q34;E\[(8X\G
MI5^WA]JCAA.>E:5O#5;$ZLLVL?2K^=JU#"F*F;[M2!!)<%<U+;7Y##FJLZ57
M7*M3&=;9W^<#-;$4HD6N)M;HJPYK>L[[IS64HD7+]]:B13@5R6K:>><"NRCF
M$PJM?:>)E/%0I<IV0/++JU:-S26^5:NHU72-I) K!>U,;'BNCFN=L#2LYMH'
M-:UK<=*YZ%BO%:-K+TK)Q.DVY9-R5S^J1[LUK"3*U0O4W THZ".4N8OF-566
MM>ZAZUFS1[:Z$(CC.*OVDOS"LX U<M%.X4V,Z*S.X"K_ )?%4-/7I6J/NUSO
M<"C+'5?RZTGCW5']G]J7,2T5%2G[>*LK!3Q;Y[4"L42M C/I6@MI[5,EH*39
M:10CA*U(S!%JU)&(Q65>3[<\TEJ,@O+K;GFL.ZNBQ/-3W4Q;-9TBEJZ(H"M-
M*:8C'=4DD)I8[<^E.Q7,K$T>34JJ:=#;GCBK2V]7=6,7J0QK5A*>L&.U.\O%
M9LJQ&5J-EJ5ZA_BIHBPGE9IRV_M4L:YJQY=/8I(J>7BI$&*D=*:JU%QD\=#2
M;:3I56>3;4VN-$S3>])]HQ5!IOFZTGG5JD,T3<9[U&S!JI>::<LO2BQD78^U
M:-O63%)5V"?'>ID4D;49&VDFA,O JI#/N8"NN\-Z.=0D4;<YKEG/D5V:)'$7
MF@SS9VJ:R6\'W<C_ '&_*OJKP[\*?[0C4F+.?:NOL_@='N!,/Z5Y<LTC3=CK
M5&Z/C[2?A]=R.I\MORKO]$\ 3PJI:,_E7UEH_P $8(U!,(_*KU_\,8+"$D1@
M8]JY)9HIO0)T=#Y=?0&M8^5Q6%J,/EL:]J\9:/'8AP!BO%_$#B.1@*Z*>(4S
MQ*U-&+)UJ,DK35DW,:>PR*ZKQ>QY4J=M2*2:J,\YYYJW*M4+A#S4F92N)B<U
M1DDJS,AJG(M,TB5Y&J!\U9,='DY[4[FA0933!'5]K>F-#MJ&:HACAJ80^U)]
MVI4DJ1D+05+#&5-3*NZI8XZF12)(5-3^3FEA4<5=CC!J"RF8<=JK3+C-:\D/
M'2J4T76IL)HRF3YJDA3I4S0\U)%#CM6\="2Q;)TK6MUK/MTYK6MDIRD<\I%A
M(OEJ.:'&>*MKA5YJ*9P:X:DSIH0YV9,D)9JGM+ LW2K*1!VK8T^S&1Q7YMGV
M-G1B[,_2\DP,9VNB73++9CBM^%=JBH+:WV@<5<5>*_):N(G6;;9^C0PT:>R*
MTS$"LZ64\UIS1YJA-;GFLHZ;F]W'8B24M4@!:HXX3NJ]%!Q3E+L5%.1'&@'6
MEDF6,=:;=2>2M<[?ZIMSS7OY=E<\6T['R^98[ZL[7-J34 O0U+;WQ9AS7(1W
M[2,.:W]+RV*_5<NX?IQ2YT?"8K.I_99UEE<$XK42?Y>M8EM\BBII+O:O6OKH
M93AH+8^3Q&:UI/<T)KH>M9T]YUYK/N-1]ZSIK_=WJGA8T_A/,^M3J;FP;[GK
M3DOO>N>^V>]2QW1]:W@FC.SD=3#>#UI\MX,=:YM;[;WIDNJ>]=%R' W3>#=U
MK6TG4 )%YK@VU/YNM7M/U;:P.<4T9<A[EH6H)L7FMNXOE\O@UY)H_B3RU W5
MT"^(A(N-U+E(Y3=N]0(8X-9-WJ[*I^:JIOA-WJG>_,IYJ6:15B&Z\0."?FI+
M/6V:0?-6!J"-N-0V<A20<U<8HRDGN>O>'=7(9/FKU[PKK9"I\U?/7AZ\^9.:
M]5\-W^U5YKEQ%%21K1KNFSW_ $?6QM7+5T<&KHV/FKQO3]:\M1\U:</B@J1\
MU?,UL&VSZ2CFG+HSV&'45;O5R.X#5Y=IGB7S&'S5UNFZKY@'->54H.![E'&1
MJ['5JVZDSS52WN-ZU9#5S6/13N/IR^M1TY6J&78DHIN[I2[J8A:*;DT9- #J
M*1:6@ HHHH *:U.I,4 ,VT;:?10 VG4VEW4@%HI-U&ZG8!3TIM*6I* &X-%/
M44-20$34BBI"M&,9K0FPBU7O/E0U8#;:IW\PV&N6I)6-::U.6U:[,>>:YN?4
MCN/-:NN2;B:Y.X8AB:\'$370]VC'0LS7V[J:HRS;N]5)I]O>JC77S=:\66YW
M(OM)4#FHEGW4C24K&@CFHFDIKR5 [T<I5RQYQSUJU:W15NM92OS5F%JSDM27
MJ==I>H$8YKL-+ORV.:\WL9B"*[#1YB=M>M@Y.YYU>*L=]9S;@.:OKTK&TUOE
M%;,?2OJH.\3PYK48U"U(RTW;3L9"K3EZTT#%.7K5(!U%%%, HHHH **** $I
MC4^F-0 W^*BBDR:R>XK#LU&U.S2XX-7%W*B5Y%W\5E:II(FC;Y<UM[?FI\L8
M,9KFQ%)5(LU4G%H\'\<>'5$<AVU\[>-M+$;OQ7USXXM0T4G%?-/CZS_>2<5^
M69E1]E/0^[RI^TCJ>%:A:XD-9[6H9370ZQ#MD:L-I-N17!3D['T<H6.>U6P!
M4\5R&H6.UCQ7H%[AU-<MJD/WJ]>A-GFU#D)K<+4!A6KU\=I-9S35ZD3EZC)8
M_2LZXASVK3'S4-9[JVC+E'R<QSS6YS33":WVT_VJ%K&M?:F$J)A^2:M6\)W"
MK_V'VJU!8^U3*H0J#'6-N2170V-OC%4K.WVXK:LX^E<%21UPA8L1H>,5Z)\/
M(V-Y'QW%<A8Z>967BO5OAWHO^DQG'>N%5%SCJP]P^K/A#;_N(LCL*^@;&,+;
MKQVKQ?X6V?DP1<=A7MEN1Y*_2ON\OLXIGPF,OSCMW:DS4;-S2JU>[;0\R^H^
MEH6D;]*RZECEIU,5J?5@%%%% !2;:6B@!*6BDH 6BFY-&30 ZBD%+0 4E+10
M 4444 %%%% !1110 4444 %%%% #*5:7:** %HHHH **** "BBB@ HHHH **
M** &M24ZC:* %HHHH **** "BBB@ I*6B@!*6BB@ I*6B@ HHHH **** "BB
MB@ I#2TC=* $R:6FTZ@ HI:* $;I3:?2;10 44F:44 %+110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %-:G4UJ $HHHI %(U+2-3$B!Z>%#+S0W>FC-9M6+,S5=(C
MNHV&W->%_%#P6C0RD1_I7T6J;EP:X_QMH:W5K)\N<BO1PF(=.:/.Q%'F1^;G
MQ.\--;3RX3'X5XO>6;1S-D=Z^UOBQX(+-*0GZ5\R>*/#9LYWRN*_3L%B%4@C
MY"O3<)'F\D//2I+:'YNE7+JVV2$8I]O#R.*]0YUJ7;&'I6ND?RBJ5JNT5;\X
M*M9LKE&31BJ31C=4UQ<CGFJ;7 ]:$2S1M9/+K42_VKC-<TMWM[T[[<?6DU<F
MYMW-]NSS69-('JHUP6[TJL32Y;&+9+M%.X6A1FAA5%)#3-MI/M&3UJ*0&H>:
M=C5%]9-U/VYJC')MJW')FE:Q=QWD\T]8ZD3%/&*5Q$04K3XI"K5+Y=-\O!H,
MS:TO4#&PYKM-)U8;1DUYK$Y0UL6.H-'CFLI1YAW/2GO%E3K7-:VJLK8JM;ZM
ME>33+RZ\U3S6"A9E1>IQVJ1?,:R!%\W2NDU"'>36<+7YNE;GI4R&&USVK1M;
M?;VIT$0JR,**QE(["S&P5:AN&#5!)<[<U USN[T11-Q7A!J/R0*D63-.;I5@
M0_=IH^8TXKS3HT^:D(>L7%1RX05.S;5K&U*^$8/-!21)+=*O>J[7P]:Y^YU3
MYNM0_P!H%N];QB*5SHFU$>M1'4O>L%KHFH3<MGK5\A%SIUU#=WHDN"P/-<_;
MW1R.:TH9-PK-QY2D.F8FL^X&<UILNY:JR0YIE&0T)9JLV]GDCBKL=IR*OP6H
M7M5N6A-BE';[1TI^ *N2QA:HN^&J%J6685S5Z&.LZWDZ5HPR5+$RVL((J.2W
M%3QR#%17$@&>:@10D@%5Y+8>E6'F&ZD#!JTU0&:]O@TZ.WJXT8S0JA:KF'8B
M$( J&90*M.V!5&XDJ4)D+ 9I0M5VFYJ2.85I8FXDRU5\KYJO'#4]+?=3V'8K
M0V^[M5V&U'I4T<&VIUPM1S!86&V'I5V.S#+TJM',-U:5K,N*SDV4C.NK'"GB
ML&\C,;&NTF42*:QK[3]^<"B$NY3.:CD.[%;>GL3BJW]ELK=*T+2W,>*TDTR;
MG0V<NU.M+=7VU3S5!9]BU5N9"XK%1NP(;S4#N/-51>,W>HYH6;M3%A*]:WY4
MC-ZEZ&X)[UJV=P5/6L)&V5:AN=O>LVKA8[*QO]A'-=OX?U,,R\UY);WQ##FN
ML\/ZB5=>:YJD- :/?=#OEV#FNSTO5!&Z\UY%X?U+<J\UV%K?E5!S7D5:=Q1W
M/>O"OB(+L!?]:]7T76DFB'SU\B6'C V4@!;]:]/\'>/Q-M7S/UKYO%8-OWD>
MU1J<J/<M4O@(R0:\K\8:\8=X#5T4FN"ZM<[NU>7^-K@MO(->73HM3L&(KKET
M.(\2^)7)?YZ\WU;7V9F^;]:T/%%X59^:\ZU34?F;FON,+%1@?"XAN4R?4-:;
M=]ZJD.O,CCYJYZ]OMQZU26[.[K79*TD<ZBXZGLWA?Q8T4B?/7M?A'QUM"@R?
MK7R5I.I-&RG.*[W0O%#P%?G_ %KSJV%YSNI8ATS[,TCQJDBKF3]:Z:S\3))C
MYQ7R;H_CPQA?WGZUU^F_$3&/WGZUX]7+_(]JEF!]-VNLI+CYA6I#=*_>O ]#
M\>+*R_/^M>A:/XH695^>O)J85Q/7HXZ,MV=_N7UH:15'6L!-:4K][]:@NM>6
M-3\WZUY[P\FSN>*C8W;J\5(VYKS/QOJP6-\-5O5O%2HK#=^M>4>-/%0='^;]
M:];"85\RN>3BL2G&R.&\8:TWG28;O7"R:P^X_-3O$6L>?,W/>L*)S(U?:4:*
MC$^/JWG(VO[7?UIDFM,!]ZL]HSBJ=P& KKBT<SI(NSZVW/S4MIKC!OO5SEQN
MS1;[E85K))HF,%%GINE:\V!\U;JZP\D?WJ\XTR=EQ73VDQ917Q6;8/VD78^O
MRNO&FU<T+V8S USUY;A\UM.W%9UP17XYC\KES-V/U7"X^'*E<Y^XLQS69<6Z
MC/%;=[(%S7/WEX 37S%3"2IL]_#XB,F4+B 5GS6XYXJ^UP).],=-PK!7CN>U
M921SUY",&N=U!,9KKKZ+Y37,:E'UKOHL\ZI2.<FZFHE7+59GCY--C3FO1OH<
MZIV)(HZ5TXJQ$G%),O%1U-49K+\U.5.*)/O&G*W%:%HAFCXJE*N#6F_(JG+'
M5Q935RM&F:T;>WW57CCK3ML+4RD3RD\%J*O0VX':HH9!5V-@17+)L.414VU/
M&U)MS3TCK%LU2+ENU:=K)@BLJ(%:OV['-<\M35'3:?/TYKJ=-DW8KB]/;D5U
M>ER?=->/7B;+5'<Z0^,5UNGCS0!UKAM-N-N.:[+0[@,P&:Y8/4RFK(NWFC":
M/.*X;Q%H016.VO78HT:'FN.\50IM>NU,X5)WL>!:]I^QFXKA=2MRK'BO6]?M
M0S/Q7"ZGIFYC@5W4:B1HTV<E;!E85TVDY.*I+II5NE;.EVI#"M:LTT:4TS8M
M[<LHJS]E*]JT--L]R#BKLUGM7I7F2D=L8W,,(5-6[=B,420_-TJS;V^['%<T
M]3T805C7TNX=&'->A>'-2=67FN&TNR+$<5W.@Z>V]>*\]TY2EH>;BHQLSUCP
MU?-(J5Z1H[%E%>;^%;%EV9%>H:/;E56ON,IIRC8_/L=:^AM6_:K50PKC%35^
MEX?X3P6.W4M,I]=;,]@IPZ4VG+TI"*]^=MNQKQ?XC7ACCDY]:]GU#_CV:O$/
MB7'NAE_&FCHI*[/F+X@:RRRR?-WKR'4-4,DC<UZ)\2%*32?6O%]0NBDQY[UJ
M?148V1=O;@,IKEKZ8!C5ZXOOW9YKG[RXW,::-Y%J.84LMT .M9L<Q]:260U2
M,XDTESD]:6&;)ZUFO)S3X9\-0S9F_"]2G[M9EO<<UHQMN6@DC9B*6.3FED7B
MJSL5I :L,PJW%,O%<\MT1WJS%='UIW!,Z-)%:D=0U9<-WTYJTMQGO2++4<8K
M2M,+BLE;@#O5J&\'K3$=9ILP4BNKT_4 J@9KSJUOL8YK;LM2/'- 'H*Z@&7K
M44EZ/6N;AU [>M$NH>],#=:]SWIIGW=ZYY=0RW6K]O<;N],"Z[FHN<U(HW4]
M(^10,DMH2Q%=#IL1CQFJ>FVN['%;/E^2GI0):BWEYY<1YKSWQ-J6[<,UO:YJ
M7EJPS7G6M7QE8\T@,2^F\R1JSFBR:MM\ST[RJ5QE(14GEU?\FFM!UXI 4QD5
M,K4/'BF?=H E9ZJ3O3FDJM,] %6XD/-49&-6I>:JLIID#,FGKS0J<U*JT(!%
MCS4BPU+''FK"QT6&D5UAH:'BKGETUDXIE6*9CIC+5B3Y:JR24"$V9IRP9IJ-
MNJW#C%22-CMO:M"VM1QQ4"D"KUK(,BJ+L;FDV>=O%=GI=EA1Q7.:+ABM=_H]
MJ&5>*+B;+VEVVUAQ7=Z/#B,<5B:9IWS#BNPT^RVQU BO>R>7&:X_5;K<S#-=
M;K*[4->?:M*5D/UICL.A4225UFAVJ_+Q7$6=WM8<UV?AVZ#E1FD8R/0]%MP"
MN!7H_AV(X6N)\-VIFV<5ZEH&F%54XJ9'GUIZ'2Z7&=@K:3BJEC;^6HXJ]C%9
MGB2=V-;I2]:0FE7M2$.%(U.I&H C_BIZTE.6@8M%%% @HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2"'VK06SYZ5(MF?2F49?D^U0S187I6P]KM[52N8L+4L:,2;AJ;$U37$7S&H
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MBBB@ HHHH **** "BBB@ I-U+33UH 4&EIJTZ@ HHHH **** "BBB@ HHHH
M*0TM% #=M+2T4 %%%% !1110 W;2BEHH **2C(H 6BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@!&I@&33FH6DQE#4K421G(KROQQH\3PR9
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBF4 *U)2K2T +1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;>*[>Q7"CZ5]%@X:'S=?<M?=%(S4YNE,/->VMCC &G+UIH%.7K6?4!U%%%6
M4444 %%%% !4;"I*3;0 S;13L4F*$/H,I=M.V^U+MIL0T4[)HVT;:FP"]JKW
M"[E-3-P*C;YJ;5T3?4\Z\;Z?YL,F!VKYA^(6@LTLF%K[%US3A<QL,9KQOQKX
M/$V\[/TKXO-:#=VCZ++ZJBU<^1[C1628Y%,.ECIBO3O$/ADVTC?)7+?V<WG
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M_P#<]>U<'HMWTYK9NKXB$\UR_$SSZL-3-\0WZ_-S7#7VH+N;FK?B75"K-S7
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MG9IFXT"D8$E%%% #:5:6BF 4444@"BBB@ HHHH **** "BBB@ HHHH ****
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MS:_V7&I8=* ,QOA!;<_NA^526OPK@MV!$0_*NJ_X3BU9L!EK2L]>AN@,$'-
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MNQ3^]9*L:F20BDX@;4<@:IEP:RH9S5N.XK-IE&A'5R-0<5E17 S5^WG!Q6;
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEHW%80FFTM)5(M"@9IK**=FD/-1)BM<C5>M6$Z5&J\U*M3$+"T4458!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ***2@!#UJ-EIS&D-3) -SCBG;J:U"K7.]!HD
M6L[6[D0VK<]JOLVQ:XOQKJOV>U?GM770CSR2(J/0\?\ BEXB\E90']:^2_'W
MB%III!OSS7K?Q>\4%6F&[UKY>\1:Z;BZ?GO7Z-EV'Y8W/!K2U,S4KQGD)S5-
M+IL<FFS2^9S5=LU]"NQP_$7!=9/6IX9LUE[C4L,I4TV@-F,;ZTK2USCBLNQ;
M<PKIM/C! K"6A+U#[/M6J<PVM6[)$-M8UY\K&E#5G%5T$M^:T$C&VLN"7#"M
M.*;*5I)'*I:F7JL>%:N)U5=K&NZU+YE-<=JEN68\5I!EV,%,[JT[/-5TM3NK
M3M;?&.*UD,FCSMJ1<YJ58,"E\JLS-CHC5E3NJOMVT]7P13,R22W#BLRZM=N2
M!6NC@BH+B/<II7+2.=D7:U/A:K-Q;_-TJ!(]IJF=E,NPBK"U7A/%3UB=T1^Z
MFL,TY5-2K'NI%%4QFHVC-:0MJ/LM*X^4R6C/I4D4)S6D+.IX[(57,.Q5AC-7
M84IZVNVIXH:R;$"I4<_"U?$/RU0O/E4U*=V48U\W6LJ1?FJ_>2<FJ!?YJZ(Z
M(8Z-*L*HJ"-JF5Z";"O'52:/K5UFJM,W!H3%RF7-'42KS5B;J:B'6MKBL2Q)
M5E(:CA%78USCBH+0)'4@A-688=U6X[4>E9N0%&*"KT:[5J7[.%J.1@HJ21)'
MJNS9ILDF2:15+4P)%^:GA:=''2R$**"B"0;:I38YJ6XN .]9\UQG/-.P#9#5
M&XDQ4TDV<U1N'X-:H1!)/CO3%N*K3-S42OUIW-%&YIK<>]2B3=6;&QXJU&U,
MEZ$[+NJ%DQ5F/D4K19ID%!^*A9JN30FJK1TQI#%:I*%CJ98333$R!LT],U-Y
M'M3UMZKF))+=:TH5X%588\5;4[163=RBTF%J3>*I>=BE6;GK6=AE[AJ:T8Q4
M4<E65.14O0+%*9.M5),UJR1[JK/;U46#1ER U$(R36H;7/:G1V?/2KYB+$5C
M&=PKJM-X49K)M;7:1Q6S;KMQ6$G<"](-RUF7$/)K37D56N5ZUFF4C.V[:N6?
M^L%4)6(:K.GEFD'%:BEL=KH_W5KH5<J@K$T*W9U7BNF%@QCSBN2HSR,04EDR
M:>R;EI)K=HCTIGG;>#7%RZGF1>I0OH<9K NX\9KIY_W@K#OH#SQ6B1U)Z'/7
M"]:SYH>O%;4T)W=*KM9ENU58I,P9+<GM5>2U/I71_P!GMZ4R73SM^[2:-$SD
M[B(KFLNY!R:Z>^LRN>*P+J [NE18NYFB/<U6H;7=VI\4!+=*U;6UW8XHY2N8
MHQV/M5R&S([5JPZ?GM5M;#':E8CF,7R]M5+ACS6[<6IP>*R;JW(SQ5"<C(EZ
MTU15B:,KFH=M9R*BP9?E-9UXO6M3;Q5.YAS69HC!ESNJQ9D[JEDM26Z5-;V^
MWM6=B[Z&E:Y*U--'E:9;C:*L_>K4S,2ZM\YJI]E.>E="UKN[4S[![4K#N9,,
M&VK*KBK<EJ4!XJK)\M(0]:GCJFLE3)-0!?10:?LXJM#-TJTK96@!A6E4T24Q
M:UB9R9-NHVTB+G%2B.E(29&$IPCJ3;S3U6H1H5_+J2-=I%2%:;_%6J,V:EC'
MNQ6J+,,O2LO3G^85T,&&04$&!>6FW/%9_DX;I73W4 :LN2S.[(%43L58%JSM
M^44BQ%:5FXJ@W&YVUKZ3-AUK$W$FM725)D%42T>E>'[CY5KK(Y-R"N0\.PDJ
MM=G;P$1BH6YSL:I.>M6%D([U$PVM3TYKIB]#GJ1T-/3I&WBO1O"KMO2N TF#
M<PXKTOPM:X9>*\[%R]T,-I-'L7A-CL3->C63?NQ7GOA=-J)7H%E_JQ7P.*UD
M?I>!U@6FHW4'FDKD/1'"EI%I: "BBB@ IDG2GU'-]PTGL!G7DFU37):S<##5
MM:Q=>6IYK@]8U/EAFO#Q4SU<-$R-4D!8UA2N-U6;Z\W9YK)EF]Z^=G*[/=CL
M6-XIKX-4C<8[T>?GO6]-F<HZE@J/2F/(%J(R55FFQGFMG(.46XN<=ZS+BZSG
MFDNICSS69-,:29 EQ+N-4Y#3I),U'UKHBR15YJQ$M0K4\1JKDEN):NQ&J<)J
MW'6,F!;CD-7[:0UFQK5RWR#6,0-&1MRUS^J=36V[_*:PM1?)-=D4484D6YZM
MV=KN(IG\5:=BH.*F6PC1T^WV@<5LQ_*M4[50%JY_#7#,TB*9CVJ[8W!\P<U1
M\LL:MVL95A6*EJ:3CH=]X?N#\O->@:;-F,5Y?HLWEXKO-)NLJ*]O"S/$KTSI
MMU .:@A?< :EKZ&+T/,<1Q.*%--IRTR22BDI:H HI,BB@!:*** "BBB@ HHH
MH **** "BBB@!&]:9MI[4S-*PQ:3%&ZEH0@%+G%)29I@/W4VBBD NV@C%+D4
MC5* 2EVT#K2_C5 -V^U-:GEJC9J+@*.:-M(&IW-3N, ,4^F\T^J2$%%%%, H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *1ONFEI&^Z: .$\?-_H,GTKXJ^*ZHU_(#ZU]J>/U_P!!E^E?$?Q=W1WL
MA]S0!8^$NDV]QJ$>X#K7VGX3\(V<NDQ?*O2O@SX:^)/[/U!,MC!KZ^\'_$Z.
M/3HU,F./6@#T_P#X1.SAY"+4\%E!:G"X%>?77Q0B[2C\ZCM?B%'<2 >9U]Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&I:* (V
MIM2[:8PH&-/2G"FTY>E82!*Q'<9\LXKS3X@QNUK+CTKTYEW+7*>+-*%S;R#&
M>*[,-)1DC*IL?!_Q@AE\R;KWKYLU:-UNFSZU]R?%+P(UTTI$>>O:OG+Q!\,Y
MOM#$1'KZ5^EX'$0Y$KG@UHML\CC4XZ4XQ]>*]!_X5Y<+_P LC^5(_@&X5?\
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M9A*1S$T6W-9\G>NCO+$\\5E261W=*Z8QN3&12BC+5T&BV_[P54M[+IQ6_I,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_?%/T2S+*N16]):JD?2J%<Q[>$1GFM:UN$CQS6!J5\MKDYQ7.7GBP0D_/^M
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M%IZK35-.4T"'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2;<5!!K31@QU@WT/S&M\-N454FM?,S0-G.&$BH70[JZ!M-)[55ETUO2@+&9
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 )2;:=10 @I:** "BBB@ HHHH
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M<[17,:/IYCQQ776,>U169\]6DF7E^Z*6D%&:1PBT444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_#]5_P"6?Z5=;P&NW_5_I7K4>F1)V%2&PB/:H>-D7'+X'B\G@-=W^K_2I(/
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M9?!Q7,HFT49,5J<9Q39H<"NC.EE%Z52N+(\\4W WV.;=2#4T(-6IK7:>E1H
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M>N3!V;FMC6-6W9YKE+JX,S'G-.Y/*9<D9:0U-'& M3K;[N:<T97-21:Q4F4
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M&VN=RU/%J5M3Q:[\#K#&?W?Z5YWXLT46JO\ +BOIG7+%%B;"]J\-^(5N%63
MJD;T:MSYO\5/Y+,.E>=:E?MN8 UZ'XTC)D>O-[RR9V;BK/8A,YZ\N&D8\U7C
M7<:OW6GNI)Q500M&>10;\Q:AC 6F3*HJ)KC8/2JDU][TR&R.[QS6-==35V>Z
MW=ZSIGW4C,I3'DU5D>K,W)JG+30T,:2D7YFIII\0YK30"W!'S5]%VU!;KQ5A
MCM6LV(&?%0,],>0YIF2U(0YI*C,I]:5E-,V4 2))4ZOQ55>#4L>:8T3;J<JT
MD:Y-68XZ0A(U-7(5-,CCJW#'TIV"Q-"AK1MXSQ4-O#6E;Q=*8TB_I<?[Q:]
MT3"H*XO3XMK UU5A<>6@YIE,V;^8",USLD@DD-3:CJ'RD9K%6\'F=:0D7;RW
M#1GBN$\06N&;BNXEO 8CS7(ZTPD9J0CBGM_G/'>G+:^U:?V<,U6(K/=VH"QG
M0VI&.*U+6W;TJ]:Z9N(XK7M])P.E4:+0BTNW.X<5Z)X7L2TB<5S6FZ=B1>*]
M*\(Z:6D3BLV1-Z'I7@O3CM3BO7-'TTM&O':N4\$Z/N6/Y:]?T71QY:\=JAL\
MFK5L9]CI9##BNMTRU\M1Q3X=-"=L5?AA""H;/+G/F)UX%.6F@TY:1SCJ***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR;9(R"FE<4YFI*1SC0*>M)10 [=2TRGT %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 6BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %-?[IIU-D^X:3V YW69=JM7G6O7@#-S7=^(,[6KS#Q!N
MW/7@XH]7#'/7UWEJSFFW4MT&W&H%C->(]SW8K0@N&+9K.FZUK20FJ,T/M73!
MJQSRO<RY%R:B\G=5QX^:6./-#*B5H[3=VJS'9>U7H;?VJTL(7M5(=C*:SP.E
M5YK?;6Q-A5-9]PP.<5HC-F5)'@U6D7K6A+'NS5=K<FF9LSY(=V>*K-;>U;(M
M32-:^HJHL:,9;0^E6([/IQ6AY 6I4C%;<VAH58K7IQ5V&VQVJ6*,5:5 !TK%
MLFQ%''MQ5RW?!%5V.#4MNI9ABIM<:.BTV/SBHKL-*T8RX.VL+PW8F1TXKUGP
M_I(V+E:TA2YF85*BB9MAH.W'RUT=CI83'%;,.FJJCBK,=L%[5Z=.@CS)UKD%
MK;B,=*NKQ2;-M&#7?"FHHX92N/-)2<T#O5B%S2J:8U*M $E%)2TP"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS"I2L<U1'H&AQ[F4UZ1H*B-5->;>'Y@-N:[O3[X(@YKFJKF-J:Y4=[;W V
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MN>:R0'O4(A^;I717EAM8\556Q)/2@11M8RK"NIT>;9MK+BL3D<5K65JRL.*
M.MLY=R@>U7EAW<UFZ7"W%=+;VOR]*!EOP\ICN%^M?0?PYN OE5X+I<6R9:]E
M\ W!1HZAG%61]):%,&@7Z5N1]JX_PS<%X4KL8?N"LF>%55F.:FM4E,H,!E.6
MEQ0M #J6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;,9JBL'M3N8ZT6AFW<WUON.M5;BZW9K+^U$=Z&F+5:9F232;J@QFE)S24R4
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M-3<&D<XNZE5N:92CK2&2;J6F4^@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *3=2TV@!0<TM(M+0 C'%,X/6G-43=JS>XT9^K:>
MEU$01FO)?&G@9+Q7(CS^%>UE-PQ5&\TI+A3D9KNP]=TF8U*:D?%WB?X5EYFQ
M%W]*YF'X3MYP_==_2OL[5/!\4[$^6*RH_ L2R9\L5[\<S:5KG#]6U/$O OPU
M^RR1DQX_"OHSP;HZV,2#&.*-,\,Q6V,(!71VMN(,8%>/B\5*L=M.FH&A24Q6
MIU>8C<7%+128JA"T444 %(U+2-0!&W6DH;O3%ZU+'8<PQS5"]U!;=22V*NW+
M;8B:\U\;>(A8Q/\ -BMZ,/:.QC4J<B'>)/&Z62O^\QCWKQKQ=\5%7>/-_6N-
M^('Q"96E42_K7@GBCQE-<,^)"?QK['!Y<MV>5/$7/1?%OQ"6\WC?G\:\9\2:
MJ+QW(.:Q;S7IIF.6-4&N6EZG-?2TJ"I;''*7,5+A<R$U&6XJ:853=J[D96L2
M9IM-W<4WS*0R;BH)*=YF:CD;-6A,@D;FH_,ITE0L:LDF$E.W>]5-]2*QICN3
M%J3--ZU+''4A<L6^<BM6U:LV)<5<A;:16;0S45N*CF8TR)\U96'S*RV$8MPI
M.:H/&<]*Z>33]PZ57;2R>U6I(HY[RS44BD5T3Z60.E4+BQV]JT4D(Q\D4[S,
M5+-"5[55?(J[DV+"S5)YG%4-QS4L<A)I#)F8EJLV^2PJ*"'>PXK5L[/IQ2;0
MF:>F@C%;:KN2LVTBV8K1BDKEEJ",S4+3=GBL&XL?FZ5V$RAZSYK,-VJHRL:7
M.<BL_FZ5?CMQQQ5LVVTGBHV.TU?-<D06?F8 %=IX'T S74?RYYK$T6S:ZD Q
MGFO=?AGX3,DL3%._I7#B*WLX,J$=3VGX2^$%>*+*=AVKW-?!<36P'E]O2L3X
M9Z"MK#'E<<"O5U554#%?G.*Q3]H['NTJ2<=3Q;Q!\-H[C=B/]*\XU;X.B5R1
M%^E?5<EK'-]Y15630[>3J@_*II8^<2OJ\6?)/_"F>?\ 4_I5JW^#@5A^Z_2O
MJ8^';?\ N"D_L"W4_<%;2S2:W']7CT/FT_"98X3^Z_2O-/'WP]^SQ28C[>E?
M;=SHL#0D!17FGC;P6EY&X"9XK?#9DW+5G/.B?FWXS\-RV\SX0]?2N$N-/FCS
M\IK[8\9?")KB1R(<_A7G%]\%I=Q_<'\J^SHX^FXZLXY46?.%A9S/*!M->C^%
M/#,MVRY0G\*]%TWX+2K,"8#U]*]9\%_"4P,F8<?A2KX^"6C)5)G">&OARTR(
M3'^E>C:-\+=VW]U^E>P^&_ ,=O&N8_TKN]-\+PQ@?(/RKY>OF>NC.B- \:T?
MX7!,$Q?I7=Z+X#2VV_N_TKTRVT6&,#Y15U;.->@KQZF.E4.N.'2,#2=&2U5?
MEQ6_#A%Q2M$%IG?%<$IN1U1BHDC-1313JE(U$VU(HIE/7M3)8^BBB@04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MW;3J* $I:** "BBB@ HHHH *0C-+10 W;3J** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!K=:%ZTM% "T444 )FEIE*M
M "M3:?10 PTPM4C?=JLYI-@2_>IK6P;M3$DJ=9,U*D!&MJJ]J?Y84<"I.:8W
M2K&0NM-5?F%.+4JJ6K-EZ,EW?+BN5\4:.+Z%QC-=1M-,>V$RD&M*<N5W(E$^
M1/BE\._.64B//X5\G^/O!$EG-*=GZ5^G/BSPG'>Q/\F?PKYJ^*/PO$BRE8O7
MM7V>79ARV39Y=:F? -Y"UG*01C%1)J'/6O5/'GP\EM)I"(R.?2O++O19;68@
MJ17V5.O&HCQ))Q9:6YW"H+B3BDCB9>#3GA+5OH7$S99.::K<U/-:MZ5$(2M7
M<HD1ZL))TJHRE:?&QXH9)>5LTIJ*,U-4; 0M3DI[)2;<4R2134BGFH5%2J#4
M%D\9J];S;35!<BI%<K2L(Z.SOMN.:VK>Z$B\FN)BNMN.:U;.^/'-8RB,Z6:)
M)%S6;/:KZ4^.\++4<EQNK-70;B10JK5>CB7%9OG8[U-'=8[TW<&+>V:LIXKE
MM2TX[CQ78+)Y@JG>68D!XJH3Y02.!:S*MTJS;6>>U;-Q8A6/%)# %KHY@L5X
M[,>E3QV@]*L[0*D3'%1<FPV"S&1Q5M;/CI3X,9%78U#5DV,QYK7':J_DE370
MO9[NU59+$CM0I#,M05J17*U8:U.>E-:W/I5I@2VTA+ 5MVT>].E9%G;DL*Z2
MQM3LZ5E,:*%U!BJ'D;FK<O+<CM5.&#+5">@K&;):[1TJC(H3-=)<PA8S7+:E
M-Y;&KB[C)5F45*LRYKG6U#:QYIT>I?-]ZM>4#JH&#8JT0 M8%C?[L<UI_:MR
M=:QE%H&)<3!,UGS7PYYIMY*6K+;<S5K"-P)IKDR-Q4EMDL*B@MRW:M6UM<8X
MJY>Z06;: OCBNL\.:.9IEXS61IUN"PXKTSP7IZM,F17#5G9&D3T?X=^%-S1$
MK7TMX+T06L:?+BO-_A[I:!8^*]TT*U$<2X%?#YAB&W8]*A Z*Q7;"!5AJBA^
M5:D:OFK\QZT4,9L4@:E-"K67)J4.7+4UK=7ZBI%Z4M;QT)*;:9$W:F_V7&.@
M%7J3<*N[%RHIC3D'84O]GKZ5;S2T78N5%(Z:A["JMQHJ2 _+6MN%-+\4^=H7
MLTSC-1\*QR@_)7,:AX'1B?D_2O5F0-4$EBK]JWCB91.2IA8R/%+KP&.<1_I6
M#J/@3Y3B/]*^@)-'1_X:HW'AU)%/R5VT\?)=3AG@$]CY/\2> 6VMB/\ 2O,=
M:\"2*[8C_2OMO5O!J3*?D_2N'UCX=I)N_=?I7JT\?H>74R]]#X[D\(RQY^0_
ME4/_  C<F?NU]/7WPU'.(OTK$E^'.&_U7Z5T_7O,\Z67RN>"V_A5Y&'R?I73
MZ1\/VN,?N_TKUZQ^'F''[O\ 2O0/#/@%%QF/]*SGC=-S:CE\KGS;JWPQ=;=C
MY7;TKQ;QQX->S9_DQ^%?HWJWP_C:T8>6.GI7SO\ %+X;_P"M*Q?I44L;S.QZ
M,\&XQ/ARZL6AF((J6U3YA7I'B;P/);W#XC(_"L"W\+R+*/D->Q&I%H\F=.42
M#3;7=CBNFLK7: <59TSPX\:C*5J/IQA7IBK4DSG::,NX8)&?I7):ROF9Q73:
MEE<BN?N8_,8U7*F6I-')S6!9CQ43Z<0O2NI%F">E-ELU"]*?L^IJJAQLMF5[
M5";<CM733V8)Z54DL/:G:P^8QA%QTJ&:*M:2V*CI5.:.I8^8RF0YH Q5J2.H
M)..*@!M/4&H=_O4BR47"PCBJTF:N-\PJ"2+FD4BH6.:FA8YI/)YJ>"'FFBI6
ML7[8GBKZ_=JI;QXQ6A&M="D<[*TG%4IG(K3ECR*H30GGBDQ%02'-68)CNZU'
MY/M4T4/2D4:%O.:T(;@^M9<*[:N1M02T:L<VZGF,M5>U.YJV+>#<O2@SL91C
M*U)'6G+8'&<55^RF-J"'H-QP*:5YJ7[M(<5JA(B(%-IS4Y5S57*;)8&^:MO3
MY.E8T49':M6QX(H,6=38@L!6Q#$<"LK25W8KI[>UW(#BES$6*J_)UIRW6T]:
M6\7RQZ5EM-\U7'4B3.@M;PY'-;=I=GCFN2L7W,*Z&S^Z*VL<LHW.PT>]/F+S
M7J?A6^)V\UX[I&?,6O4?"O\ !7CXR*L=6'O&1[%HMV2B\UU=C/N YK@M'FVH
MM=7I]UT&:^-K1U/M,+4T.HA?(JTM9EK-D"KZ-7GR1[E.5Q9K<2K@BL+4?#,=
MT#E<UT6ZBLSH4FCSNZ^'\+L3Y8_*HD^'\.?]6/RKT@H&[4GEKZ4T7[1G$6?@
M6&-@=@_*MZS\.QV^,*!6V !2TR7-D$-L(NE3T44&84VG44 ,IK4]NM)0 BT^
MFKUI] !1110 444C4 &:6F4Z@!::U.I* &T^DI: "F4^DH CVT]:7;10 C1A
MNM1&S1NHJ;=1F@#.O]'BN(6 7FO&/B)X5#1R$)^E>\-]TUR'B?21>1O\N:#>
MG)IGP[XU\/M!,Y"UYEJ$+0N1BOK7QUX(,V\B/]*\,\2>!Y(Y'Q&?RK1:'KTJ
MQYC&U3QR+FM6Z\-RPY^4_E6:VG2(W0UHF>E&:99BE&T4RXD&TTD=JX'0U'=1
MLJT;FFACWS#FL*\[UK7SX)S61<$-2&K&3,3FJOF'=6I);[^U0?V>2W2@I)#[
M/YL5IK!\O2F:?IYXR*U_LA5.E,TY58QI(L4B1U9N8]IJ!:HP9/$ *T+=@,5F
MHU6X'Y% C57YA1Y6:2URV*N>5Q0%RON$:YJM<ZJ(5X-.OF*1FN4U.Z8$\T,E
MEN_U\MD!JS!JC2-UK+=FE:M"QT]I,<5 C7L[AFQ6Y9S8Q6=9Z:RJ.*TEMS'0
M@-NTO-N.:T8]4PHYKEO.*4X7AZ9IB.OCU;WJ0ZEN7K7*V]R6/6M>UC:;'%!4
M7RFM;WQ9Q@UV?ABZ<S)CUKE=+T629E^4UZ1X5\.LKH2IJ#&K-25CV/X?2.RQ
MYKW;0\_9U)]*\7\&6PM53/%>N:/J*+$HSVJ6>!6AJ;Y%-J);H2=#4F[-0<=A
M&HHVFE6@!:?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?3&J@0F>M/5NE1=ZD7M6=R;DM%%)5C#-+3*<M "T444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M17PY\'A?*)3]*\X^&^DK</&<>E?4?@71%CAC.VOF\QQ'*K'H4(7.M\,Z*EM
MOR@<5TWEJB\"H[.$11 "I9*^*E)R=V>W"/*B)Z04I6D/RYJ&[&]Q::>>*3.:
M5:%,SW$\NCRZ?36-#28[#E%/6HUJ2A6"X\&EIG-+5 .HW4S=2;J3$*W2DHS1
M4IH=QPHHIVVK$Q%I<48HH$-I,4I--W>](8*M.44BFE#4K"'T4@-+5#$VT4M%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM-Q2K6EQCJ*44NVFF(6BBBF 44C4W- #Z*9FGT %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKMQQ75J@$0Q65IMN(\5LJ!MIF=S,N$.:@6,J:TI(Q4$B@4%7'VLNUAS6W:W
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!",TFVG
M44 -VTZBB@ HHHH **** "BBB@ HHHH 2DVTZB@!!2T44 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4QN]/IC
MTF S(IVX5'3Z40%[T,W%)4;9HD4BOJ$/F0-]*\!^+6DEX9>.QKZ$N) (3GTK
MQGXH21M;RYQT->E@)OG1PXC1'PM\0M+,=W)QWKSUE\EC7L?Q*\O[1)CU->/Z
M@PWMBOTN@VX(^?YKR*4TWS41S53D?YC3XWKKMH63W,IVFL.ZD.ZM68[EK)NE
M^8U422HTV*C:>HYCC-5FDK>PBZLV:L1L*REE.:MP3=*0<IIKBG5#&^ZIUYK,
M+$B5*!38UJ4#%($@5:MP<57!%31M6;+:1J6\G JSYF5K,CDZ5:CDJ+$7+#5$
MT>:<K9%+2+1 T=$?RFIF6F[:11;M93D5L6_[Q:Q;?[PK;LR-M1(+%:^M?E)Q
M7+ZA"58UW%Q'O4USFI6>2>*<&0T<O,^VL^XDW5KWEF1GBLV2U/I75%H@RY8R
MV:JR0D5LM;U5N8@N:U3'8R7XI\38:F7'!J.-N:HNQN6DV,5J0S>]<Y;S8[UJ
M6\_O6<HA8UUDJ3S*HQR5,C5G8EHM*^:NV62PJE"N[%:^GVQWBHD*QUV@QY5:
MZ-IO)CK&T:/RT%2ZM>>5">:X7JS1%'5M6"Y&:Y>]U#S&/-4]8U0^81FLH79D
M[UTQA9"9IK<;C5NWN>1S6,DE689<-UK3E).NT^028KIK&%64&N(TVZVXR:Z:
MSU+:HYKEJ19)LW**L9KD]8DV[L5LS:AYBD9K$U*,S*:4--QW.1O+I@YYJJEZ
M=W6KFH6A#$UF+"5DKM5K%(Z/3)#)BNBACS&*YS1Q@BNKM\&.N:H58Q=2^537
M*WLGS&NRU6'<IQ7)7UJ0QK2!#,^-OFK1MVSBJ(A*M5ZU7I6Q!;Q\M26\S0MD
M4^./*U(MONK,:.L\+:^\%P@W$<^M?3OPI\0--Y(+>E?*.@V+-<I@=Z^E_A%9
MNK0\=Q7AYA&/(ST:.Y]=^%I?-M5/M6[7/>$%*V2?2NA/2OSRI\3/:CL,:E7M
M114%#J6FKUIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5[N
M3RX]U6*S-=E\NS<Y[4 <7XH\9)I8;<^,>]>:ZA\8H8Y2OG#\ZY#XU^*I+$3;
M7QU[U\MWOC:\NM1*J['GUH ^S8_BQ'-R)?UJ3_A:*#_EK^M?-7AJ2_O(5;YC
M6_):W^/XJ /?;;XH))(!YGZUW7AOQ<M]MPV:^2]/BOA<#.ZO;_AVMP%CWYH
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M@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!:=17.VY;F\8J.PW91MIU%38L;LI=H%+119"$I-M.HI@-VT;:=10 FVBEHH
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M/'2F[>:=02&*,4M% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]9_#_P "I9V\9* $#TH Z[P+I_V#353&.*Z>J]K;BUC"@5-NH 7;0!BC=10
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ IC=Z?3&[T ,I],I] "K2M]TTF:-U(#AO&5B;BWDP
M.U?*7Q:\,R2";"GO7VKJ6GBYC8$9KR;QQX%6]CD_=Y_"O;P.)5.2.:K#F1^:
MOC+PW+%<2':>M<8UF8<@C%?8/Q(^&)B:5A%Z]J^=O%7AIK&1QLQ7Z#AL2JD=
M#Q*D'%GG<B_,:NV*X(I)K4K(1BK%NNPBO0;T.>QO6?W14TRY%5;.3@5>;#+7
M/U*,.^3K6)<*<UT5\O6L2XCYK>)+*'\56K?K4++\U31<5J2C4MZM[<BJ$#5=
MC:L)&HC1T+#4ZC-/5:D5B-8:1H>*N1XI)%&*5P,R5=M59'"U9O6VYK"NKDKG
MFK3*4;E_SE%/%T!WKGVOCZTW[<?6I<C10.FCO!5N*X#5R4=\?6M"WOO>C<'$
MZ99ABC[1\U9$=YN'6G_:/FI\IDSHK*?+"NOT4B3;7GMC<?,.:[/0[K&WFL*D
M01WMK;JR#BJ6I68VGBK&GW0914UYB1:X;ZE6.&OX]C&L:9AN-='K";=QKDKN
M;:YYKM@0R7RU:GK;IZ5GK>8[U*M][U=F07Q:(W:G-I:,O2JD=]TYK1M[P-WJ
M=2DS"U'1AM.%KF;S2BK'BO29(UF7FLJ\TL-GBKA.PS@!9E3TJ6.$K70W&F[3
MTJNMC[5OS$D5GE6%=7I-WY>.:P$LRN*MQ,T..U9R]X:T.VCO@T8&:S[Y1+FL
M>WU+;@9J\MT)!UKGY>4;9GW%K6?):G=TK?DVL*KF$%NE:)B,N&S+$<5H6]@>
M.*T[*Q#L.*UH]/"KTJ',$8:6NWK4BPBM&X@\NJ;-M-1>XR6"$<<5K6D2K61#
M)MJ[%=8[TB6SI+614Q5N2]V)P:YN&_\ >IY+O>O6LN4BQIQ7OFR 9KOO!^BB
M^D3*YKS#2U:2Y7ZU[]\+]-,C1DBN/$R]G$ZJ<4SU'P3X-5%C.S]*]6TWPTGE
M@%*K>%-.$=NAV]J[*W41C&*^!Q>)DY'L4Z2.>E\&Q2'.P?E4D'@V&+!V"NF4
MTZN:-:;6YT^SBC*M]'2WQA:NHNQ:GIF*SE)O<T22&TY:-M+620#J1J,FDK5
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M<?:8P<UH,M "*U.!J.GI0 ]>M.I *6@ J-JDI-M #%I^T4;:6D FVC:*6BF
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGKTI',+1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM2T4"!NE5;J+S(S5ENM,89%!:/-_&&@_:HW^7->$>+O +32.1'^E?5]YIXN
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 UJ94E-- [B+2,!1NINZE<0UA29VTZFM1=%I#U7S.#5
M2^TB.Y4Y -7(:DD;:C'VIIM:HB4;GE7C;PK!]GD.P=/2OD/XP:/%;F;"CO7V
M1\0-4$-O(,]J^,?C)JPE:89]:^LRMS;5SP\3&Q\K^*F$=TX]ZP%DRM:OBR8M
M=.?>N?CDK]!A\*/.C&Y99Z8S&FJV:6K+Y=2-FI5FVTQFJ.L9,Z(QT->SFW$5
MM6T885SUAG<*Z.U.(Q2N8R5B22!<50DMU9JN7$VT52\[YJFUS/F9-:VX5JUH
MV"K65',%J3[71RA<MW#9K/D^]3FN=W>H6DJTF2/7[U7(1FL[S,$5<M9-U-EQ
M-.$8I\D@45&IPN:IW=QMS611'=R YK/==S4DMUDTQ9-U:6T))47;22-Q2[N*
MKSR4TAE:=LYJO3I7J'=2;*L..*2DSFG+5Q,V.%.S1MHK0DECDQ5V&?%96[!J
M:.8U+1:9L+<>M#7  K-\ZFO,:FQ,KFM'=<]:OP7&Y>M<S'<?-6C:W6*EH(LV
M)6W U2DA+&I(Y@U3(0U1L$A;&W.X<5T%M 0E9]DHW"MV!0R5E-BBC/N 5JLC
MX:M:XM2W:J#VI4]*E2#E=R2&;:170:2WG,HZUR_*M75^%X3-,G'>HGHKFJB>
ML> ]'$TT9VYKZD^'>A+''&=O85X?\--%+&([:^H/!>G^3$G%?(9C6Z'?0IZG
M:6-D(X5XJVJXXI\0 C%)WXKXZ4;NY[,=$.HHHJAA3EH7I2T (W2FT^B@!*6B
MB@ HHI&H ,TM,IU "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %-R:=3* '#I4<E2"HY*F2N-$7>E%)WIZ]*Y^5C9(E$O^K;Z4JTDO\
MJV^E=$58D\:^)VJ/;0S8.*^-?BAXDE:64;SU-?8OQ4L&FAEP*^+/BGI+QS2G
M'K7V65J+L<.(EH>(ZWJCR3,2QZUFP:HZ_P 5&O9AF8&L-9C7W4(+E/$EN=+_
M &PW=JCDU;/>N=:<^M1M<'UJN5$&Y+J&[O59KO)ZUE^>?6CS318.5FG]HI?.
M%9@FIZR^]43RE]9<M6UIL>\BN;B;YJZ71V&X5,MBCHH;4>7TJCJ$?E@ULPR+
MY?6LC5CE3BN5;EG.7<VW/-9<EQ\U6-08JQK(DD.ZNN*T%<OQS<U862LN.2IU
MFIV N2,,5GW W9J1IJA9MV:+ 5VC^:GK%4RINJ98J5AW(4CJ?;@4X1T&F9VN
M0L:CWU*ZFH&4U8#O.([U/#.<CFJFTFIH4/%24:*S%A44N32Q*:D*5%A7*:Q_
M-6A:K4:Q58B7;38C3MXP16A#;JV*R8KC9WJ_:W@)%8V9=S8MK,,1Q6Q;:8"O
M2J6FR"3%=79PC8*Y)R:&M3(?3PJ]*S[BW52:Z/4,1H:Y:]NP&/-*+;+V*\D8
MIOETZ.02596/-;7L9,J[34T><U((<FM+3]+:X8 +4RD$5<CLT=L8K0>TD:/I
M74Z'X/DFQ\A_*NKB\!2-'_J^WI7!4KQBS;V;9X=>Z?(S'@U8T7099KA?E/6O
M79?AW(TG^K/Y5TWA?X9L9D)C_2D\;"*(]F[E?X<>#W9HB8_3M7U!X%\,"WBC
M)2L/P/X%%JL9,?Z5[%HVF+:Q*,8KY3'8SGT1ZE"CW+FGVZVZ 8J^P5EP>:A*
MA>E.S7S4I:GJJ.A3NM/292-HKF=4\(QW6?W8_*NUH"@]13C6E%Z$<D3RUOAW
M&7SY0_*M;3?!D=K@^7^E=[Y:^E&Q?2MWB)M:CY8F78Z>MNH 7%7^@Q4A J-A
M7%.3D-(:IJ0-4>W%.6B*8V24ZF"I*V$(U)2D9I-M #J*** "BBB@ HHHH **
M** $H!S2TE "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3:=3=
MM "K2T@&*6@ HHHH **** "BBB@ I-HI:* $I:** "BBB@ HHHH *2EHH 3;
M2T44 )BC%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %-:G4A% "4ZF[:=0 4444 )BFGBGTUJ &4N >U&.*6@+D4
MENK]JH7FCI,I^6M9>E+04I-'G>L>$DD#'97G?B#14T_<=N,5[UJ(7RSQ7C7Q
M$F6..3'O5([*4FSAK?Q(+"<#=C%>@^&/&\;*H,GZU\V>)M>-K=-AL<^M1Z+\
M06MF \S'XU=CIE2<D?:EKXLA:,?./SJ9_%$(4_.*^5K/XID*!YGZU:D^*AVG
M]Y^M2<GU=W/H#5O&D<:MAQ^=>5>,_'"R1N!)^M><:E\2#,#^\_6N)UKQ8USN
M^?\ 6G8[J5"Q-XLUW[5(_P V:XKS/,ES3+[4#,QR<U6AF^>M#THQL;]H@.*V
MK6/I6#8S#CFMVUF'%!H;MA#NP*[7P]I8E=/EKCM*<;A7I?A7;N2@Y*DCT3PK
MX?4A#MKTW2])6&,?+7->%%78M=];J/+&*QD>/5FPB01CI4U-*]Z2I.)CMPHW
M5&: :8KDM(U"F@]*0QF*>M-IR]* %HI":-U "T444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !3&/6G9IA.>* &-4=3[:C9:SD T<TM 4BG=%K/6Y:
M8JR!>IJIJFJ16MNQ+#.*S=9U5;-&.[%>0^./B*MK'(OF8_&O1H8>55V,Y342
MG\4O%4:QR /^M?'/Q-UP7,TOS9ZUZ'X^\?\ VPR 29_&OG[Q;JQN)'.:^]R_
M"^S2N>'B)*3//O$!\R9C6'TK6U*3<QK(<U]-?E1RPB/5L4K/4&ZC=FL74-U$
M5FS3XUR:$CW59BAQ515Q2E8M6,?2MN%L)65:KMQ6DA^6M+'*]2&[DXJCYOS5
M:NJS9&PU"1!:^T8'6F-<'UJH6-* :NQ5BTLY]:F6:J:J:<&P*9)9:3FKMC)S
M64K9:KUJVW%0]BT;JO\ NZR-08\U>23*U5NX]V:SB@9B22'FECFI]Q;E<U4(
M*UJ-%[[1\M022YJ#?[TUFS3'8;(]-5J0YIRU/+J:$BBGJM"+5B./.*K8PD1!
M:=Y9Q5I;>G-#BBXC/9*1%-6WBJ/9S1<8VFLM2A:&7B@;6A!]UJL0R;<<U784
MBL0:5C(U8[CCK5F.Z]ZR8B35E0:+%W-VTOMI'-=+I5R)B!7!*[+TKK/"*O<7
M"#KS6%2*M<J.YWUCH;7B\+FK,W@F9ER(S^5>J?#;P<=2CCRF?PKV6U^$8FMP
M?*[>E?-5L?&E*QZ$*/,KGQE-X+G$@_=G\J[;P5X-F$Z9C/7TKZ1D^#(+_P"I
M_2MK0_A6MG(#Y6,>U85,TCRVN6J+N5?AOX7,,<1*5[MHUB+>)>*Q/#OAY;%%
M&W&*ZZ% BBOD<5BN>1WTZ?*6%;BDW4T=*5:\Y2N=G0E6G;135I]:$!1110 4
M444 %%%% !24M% ";:6BB@ HHHH **** "BBB@ HHI#0 M%-W4M "T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !3=IIU% !4;#BI*8W>@:(MN#3A114.0,>K"E?[A^E,7K2
MGH:A2 \\\=60FMY.,U\?_&+35C\XX]:^U_%EOOMGX[5\A?'"'RXYSCUKZK*Y
M^\CS\0M#XO\ &3>5=./>N4BFW$UL_$"\\N^D'O7)V5YO:OTNG\"/#=[FN[&H
M3FG*=V*F6'<*92*_(I"QJY]F]JBD@(J!HK[S4T;;JBV%34\*TKENUBQ%6S87
M'EXYK+C2IE8K5;F',==:ZAN4#-/N/WRUS-M=%2.:VK>\#* 36$HVU!&9J5F>
M>*P+FW*M7;31B9:QK[3\\@5<9%6.:Y!IP:K-Q:&,]*K;=K5L,7<:0'FE%-QS
M0268:N1K5&'BK<<@%2P)?+IGE\T[S:%;+>M1J,9Y6:C>&KJ '%/\G--,EF6(
M:LPPU9^S^U210X:FV"$2'CI2F/%6E3BAXZGF*Y2H%IU/VTY8RU!! Q-36LA#
M5+]EW5/;V9W#BB^@SH-%D.5KOM-&Z(5P>E0E6%=GI]P(XADUY];78UCH)K0Q
M&:X#49BLQKMM8N@T;<UPVH<R'ZU5%"FR6SF]:V(&!%<];L5K5LYMQ'-:21DM
M37MX?,D Q7I/@GPY]LD3Y<_A7$:#:&XF7C/-?1/PL\/B22(E:\S$U?9Q.BG&
M[.N\'_#L20H?+_2N[C^'J+'CR_TKT#P?X?CCM$)4=/2NH;2XL<"OB*^,E*1[
M=*DK:GBG_"O$W?ZK]*Z'0_!,=NR_NQ^5>D?V3'Z"GI8K'T%<CQ$I(;HJY0TS
M1X[=5PM:RQA ,4P?(*=O-<<Y-G1&-ALG6H]].;YJA8&N?4T)UDIX:JZBI1D5
M<8D-DNZER:C&:>*UL*X'-)3J1JGE*N,:@=:6EJTA"K3]U-P:*0#LTM-6G4 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME.I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ]*DQ2+2TE(BPM.IE+5<Q5AU%*M+VIWN(;1113 ?13<FEH 6BD:DH =1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$B"I*PM$U 7,*<YXK=%?'R34K'JQVN,I5H-*!BM(["'CBEI-U%4 $9HVTM%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !3*?10 U:=110 C=*;3Z* $7I2T4UNM
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M110 4UJ=10 RGT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!3&IU1L>M  "<U)42U+0!S_BZX,-FQ'I7R1\8O$$D?G -ZU];>,83+8MCTKX
M]^,VCRN9R >]>YEB7/J<>(O;0^2O'6K-/<29:O-YKS;,3FN[\<:5/'/)\IZU
MYE>6LXF/RFOT^A%<NAX$KWU-R+6-J@;JF_M0R=#7-QV5PV,*:Z/0] N+IE&P
MU;48ZC4;LW_#L,EY.@Y/-?0/P]\!MJ CS'G/M7'_  W^'\LTT1:,]?2OL+X6
M^ Q;QQ%H_3M7S688U4E9,[Z=%LYO3?A LEH"8>WI7%^-OA/Y,,FV']*^TM/\
M.Q1VBC8.GI7->)O!<=]&X" Y]J^5IYH^?<Z'0T/S&\9^!9[69\1D?A7"MH\]
MN^"K<&OT"\;?!P7#.1#^E>'^*_A"]FSD0X_"OL,-F$*D4KG#.DT?.D,++C(J
MPV%%=7KWA=]/9OEQCVKDKI3&Y!KUHR4M48[$;3;:%FW57=J(^M:)$,T8%WFM
M&.SW+TJE8C)%=#9P[E'%92=@B8ES:E0>*H>65:NV?16F7A:SKCP[*O.P_E4Q
MFALQK5>E:<,?RU']A: \BIU8(O-)@M090M(!FF/,/6EAD7=UI%6-&UAW8K8M
MXP@!K*M9E6K37P5>M9.Y)<N9AMQGM7-ZE$)LU9N=0W=ZJ-<!ZN*: R'T\;LX
MIR6>.U7V(IFX5I=A8CCM@M3K&%%,\S;3?.IB)O2I5JLLFZK,=!(IBS4,EM[5
M?1<XIWE UF697V7VJYI]MB0<59^SU8M8=K"ALFYW'@]_*FCKZ6^&NH*OEC/I
M7RYH-QY4B_6O:_ NOBW:/YJ\7&4^>)O3GJ?8/AN^62W49[5T&\%:\@\'>*%D
MC0;^U>EZ??"X4$'-?#5J+A(]FC.Z-,]*;3OX:;7$SJ%IU-'6G4ABY-,)YIU-
MJ@'+VI],7M3Z "BBB@ HHHH ****0!1113 **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:U.I
M",T )3J3;2T %%%% !1110 4444 %4[JW$JXQ5RHV- [V.3U;PK'>HV4SFO+
M/&'PT21'(B_2OH!2I%9NJ:?'=1D;0:I,WA5:/A?QG\.VA9]L?Z5Y/JO@^6.1
MOD/7TK[W\3^!4O-V(_TKS'5_A6))&_=?I5J1Z-/$'R''X9F5ON'\JT[?P_*H
MY4U]'M\)]ISY7Z53N_AJ85/[O]*U4CT:=='A,>DLO5:E73\=J]-U+P>UOGY/
MTKG+S2&@/W:?,=7.F<R+'CI2'3_:MCR]IP13EC5J1%S":SV]J3:5K<DM0R\5
M2FM2O:A 5(VQ5VWDR151H2IJ>!2&IE6-B!0V*F,-5[9L 5=#<4F3(B2/:U:5
MHP4BL]F"TGVOR^]2*)VFEW*J1S7<:'J2JR\UX_::MM8<UU&CZT=R_-4CE'0^
M@_#VK#"\UZ#I=\)%7FO _#>M?=^:O5O#NI>8%YK-GBXB!Z#$VX5+52QDWH*M
MU)Y(4444"$/2FYIU)MH 44M-W4H.: %HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBBB@ HHHH **** (]M*JBG4G>@!=M)MH!IU #=M&P4ZBD F,4M%%, I*6BD
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M7IMI&(H0 *H:?9+:Q* ,5>63'%?#UZSG(]&$4B5XQ)P15.?28Y^H%7%D%.W
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MF+X6Z]YWE#=Z5])Z#-YUBIK\_P 3'ED>[2E=&E1117&;A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0TM(:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M110 4444 %%%% !1110 RE6G44 %%%% !5;4(_-M9%QVJS3)ANC8>U 'R_\
M&C0_.68[:^,/'>C&WO)#M[U^AGQ,T?[3#*=N:^-OBIX?\F:4[:]*A4.:I$\,
MMW\J3%=+I<VY17+WZF"X(]ZV=&G^45];@Y'C54=$_P!VJ*K^^%6E;<M1"/\
M>9KV[<R.2YZ-\/[[[/-'SWKZL^'&N;HXANKXR\.WGV>9.<<U]$?#+7,M"-U?
M.8^EHV=E">I]9Z1<>=$#FM)NE<SX/NO/MUY[5T]?%R^)GOQV1&/O&G+24J]:
M@H=1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=M&VD +3J0#%+3 ;24[;1MH 1:=28Q2T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC;3 ;3Z3;2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2T4 -V
MT;:=10 W;1MIU% #=M&VG44 -VT;:=10 W;1MIU% #=M&TTZBIL W;1MIU%4
M W;1MIU% #=M&VG44 -VT;:=10 W;1MIU% #=M&VG44 -VT;:=10 W;1MIU%
M #=M+MI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ I#S2T4 )M'I2;%]*=10 W8OI2[0.U+10
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-VTZB@!NVC;3J* $V
MTFVG44 -VT;:=10 W;1MIU% #=M+2T4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 FZD!YI*%^]0,61=R$5XW\5-)$T,N!V->S5PGCBQ%Q!)QGBK@]2);'P!\4
MM#,<TIV]Z\6ND\B8CIS7UA\7- V^<=OK7RYXFA^SW3#IS7TN#EL>36B6-)FS
MCFNA7YEKCM'N/F%=;;R;E%?3TI:'FR*UP/FKL? ]R8[B/GO7)S)DUN^&I/)F
M0^]765X&<=SZ^^%^J?NXAFO?=%N?-A7FOD[X::OM,8W5],^#[OSX4YKX+&PM
M)GN8:5SLMORTRI1T%1FO(/4'+VI],7M3LBJ)#-&ZD:DH =NI::O6G4 %%%%
M!24M(U !NI:93J %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F
MMUIU1LU #L]*=40;FI*2&>=?%"Q$MG)QVKX9^,&CD7$IV]S7Z ^.K7S[-N.U
M?'?Q?T/<TIVUV4969S5$?(]Q"8+ANW-:NF3?,!2^)+/[/<OQCFL_39MLH%?6
M825SR:B.RA.4%1SM@TEI)F,4VY:OH%JC@D=1X-N-ETG/>OK?X3:A^[AY]*^-
M_#$WEW2_6OJ#X5:EM$(SZ5X&80T.[#/4^K]+N/,MTY[5>'S<US/AN\\V"/GM
M73+]T5\3-69[T=AK<4M# TFZH0Q:5:;NIRTP'4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 E1-WJ:F8H B%3KTJ,BI%Z4KC9D^(+?S[=AC
M/%?-GQ9T'='*=M?4-W'YB$5Y%\3M%\RUE.WM6M-ZF<EH?GK\0M/^SW4O'>N!
MLY=MQCWKV;XNZ;Y-Q-QWKQ*/*71^M?4X)GE5D=K839C%69OFK*TV3Y!6J/F4
M5]5"6AY<B_HC^7.I]Z]\^&NJ>6T0S7S_ &'R2 UZGX#U+RYHQGO7F8V/-$VH
M2LS[1\$7_G0Q\]J]&C^XOTKQ/X:ZCYJ1<^E>TVS;H4/M7P5:/+(^AIRYD/:H
MZ?(>E,KG-0IZ]J93U[4P'T444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -H
M6EVT 8H 6BBB@ I,4M% #"M.6B@<4F %<UQ?Q!L!)8.<=J[6L+Q=#YNFMQVJ
MX[B9^?\ \;-+VSSG%?-MU#Y5X?K7V'\;-+W/.<5\I:]9^3>/QWKZ;!RT/,K(
METU\ "MZ'YEKF=/DPPKI[/YHQ7TU*6AY,T6(_EKKO"5[Y=RG/>N0?Y5K4\.7
M!6Z3GO2K+FB9K1GV+\)]0W+%SZ5]$Z7)YEJI]J^5OA#=Y\KGTKZ@T"3?9K]*
M^%QD;2/H,,]#0DZT@I[KR.*;7E'H!3E[4RGJ*H@?1110,**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M124 +12;J-U ";J4&FTH-,!U%)NI:0!1110 44A.*3=0 ZBFY-&Z@!2:,TVB
M@D?24FZC=0,-U&ZDS2;J!CMU*#3-U*K4 /HI-U&Z@!:*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "F[J=3* ' T4BTM  O2BD!I:0&#XJ
MM_,L7X[5\:_'*Q_UW'K7VSK4/FV+_2ODWXW:;N68X]:[*$M3&9\.^(+?R[YO
MK5G26VJ*T/%UGY=ZYQWK*L6VL*^KPKV/,JHZB!LQBK%NW[P52LVW1BKL?W@:
M^CC\)Y<MSO/"%ULGCY[U]._#&\W"/FODWPW<>7<)SWKZ4^%=[DQ\U\UF$=#O
MP\M3ZDT1MUFOTK1K&\-R;[-?I6PW2OC9;L]V.PF?:E6F;J<M2ACJ*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***1NE "T4RBD ZEI
ME.6BX"TF:&Z4VF ^BDI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;
MI2TC=* &T444 %%-I5H <.M+FFTNVH&+D4M)M%+3L(:U)3Z*H!E&TTZEH&)2
M-3J*!#**=10*Q%14FT4;!0!'2K2E*!UH&+1110 ZEI*1J '44RB@!]%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4UJ4G%-- #:2
MG;:,5("KTHIR]*6BP#**?3:8#J*3=0*8"T44C4 +13<FEH 6BBB@ HHHH **
M** "BBB@ HHHH **** "BD:DR: '4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5)Z%FE7K010O6L$;CJ***8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2/-(.M.IH^\:XNIU#J***8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGK24N*2@0"G;J;10*X^BF4;O>@H?13-U&ZD ^BF9HI@/HIE% "L>*;NH:DJ
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M"=*28$M%%%4 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !36IU% "+TI:** $/2F-UJ2F-WI,!%^]3ST-1K]X5)
M3 \@^*T.ZWE^AKXF^*=MMN)N.]?<OQ,CW02_0U\6_%:WVS3<5Z6&>ISU#P"Z
M7;.:U=);I6;J7RSM]:NZ2W2OIZ+V/&KG0QUN:.VV9?K6#%U%;.EMME7ZU[2^
M Y:>Y] ?#&;]Y%^%?5_@=MULGTKY$^&$G[Z+ZU];> VS;)]*^*S->\>[A]CL
MZ3-+35ZUX)W#J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHI#0 M%-R:6@!:**1J %HIN31NH =1110 4E%1R-M% "O(%K
M)U&^"*W-/O+O:#S7+ZMJ!^;FM81N1)V,[7-6P&YKSO7-4+,W-;NM7A;=S7!Z
MQ,2QYKOIQ.*I(R-0NR['FLF20L:ENI,L:IL]=L4>?(EW<4UI*B,M1M)6W-8S
MY;E@29J:-JI*QS5J&HN7RV+\)K1MFK.MQ6A#5HEHUK63&*V+.7I7/V[8(K6L
MYNE)H21U5C)TK?L9.E<G8S=*W[*XZ<US21T1.IM9.E:]O,*YBUN< <UIPW@'
M>N"43JC(Z*.;BI1<"L1+T8ZT-?#UK'E.CF-LW0IC7(]:PFU#GK^M.CO=W>ER
M"4S;6?-3QR5CPW'2KL4U0XV-5*YIHV:DJI'+[U.K5F:C]HI&I:1C0,8>M.4&
M@8I=P%,!U,I&F J)K@>M("?=2,U5Q./6GA]U $@-*::M&[K2 0FF[Z220+52
M6X [UGS6-(Q+/G4"6LYKP>M(+L>M2YHT<=#4$@I?,%9JW7OS4L=QN[U/M#'E
M9?W9IRU#$VX5,*V3N(<.:-M"TZJL(**;NHW4[ .HI!2T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ/']*^/S-:GLX>1Z'35IU(M?.'I#J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB7?GBO,J1.ZE,]A;[M1_6FVDWG1YJ20?+6!V#<TX=*C6I5[4 /HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO_Q[Q_2OE<TW/3PQZ32#O2T5\N>N%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!/0Y!<T_=4=/IB'TA-&ZD-  #3J:O6G4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(:6D:@!K-2;J&I
MHH D4T2-M1CZ"A.]5M4F$%G(Q..* 9YK\2/% L;.4;\<&O@CX^>,OM7VA1)G
MKWKZ0^/'B[[)%< /CKWK\^_BIXN:\NI5WYY/>NVG#0X:D^AXWXQN6NKYSG/-
M9NGJ=M6-0;[1*6-):KMKLBK''(L,*CI^:;MK=&(E/INVG5+*"BBBI!A1113
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU%(*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^A_P?U+[5:0\YX%?E+\$M8*WT W=Q7Z9? ;4O-LX.>PKSZL3MHR/?Z8PIPY
M-(W6N!G> I=HI%ZTZ@!K4M(U+3%U%HHHH&%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 44C4F30 ZBBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4W=2TV@!PI:1:6@!&I-IIU% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%%38 HHHIV 3^*EIN[YJ=0!C
M:W_J6^E?-GQB;]S/]*^DM=_U#_2OF?XQR?N9J[*.YG/8^*OB)S>2?6N4TE?W
ME=1\0)-UY(/>N9T?YFKZ3#]#PZVYUMD.!6U9+\ZUCV8X%;NG+F1:^CC\!SH]
MB^&$?[^+ZU]A_#M=MM']*^1OAA'^^BKZ]^'Z_P"C1U\;F6YZF&.Z;I3%I[=*
M8.]?/GJDE%%% @HI,BEH **2C(H 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<.M=AF.HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9,8]Z][T?]H2*WMU7[1V]:YIIFL6CZX;3].ST2A;'3E;HE?*W_#1D1_Y>/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !12;J-U "T4F:6@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ I&Z4M(: &T[</6HI6VBLVZU$0YR<4 :^X>M+7+-XC2-L
M%ZLQ^(XF7[X_.@9#XID'DO\ 2OECXQ3#RYJ^BO$^M1- _P P/%?+WQ<U!9$F
MP:[,/N9U-CY2\;-F\?ZUC:./G%:7B]C)=O\ 6J6AQ'<.*^JP^R/$J[G3V?\
M#75:''NE6N<LX>5KLO#MOF1,U[J?N'*>V?#. ^9%Q7U1X)0K;I]*^;?AG;C?
M%7U!X1C5;5<>E?$9D_>/5PQT1IHI])7AGIBTE+24 )NI12;:44 +1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "49I&H7K0 ZBBB@!*
M6F4JT .IK&G5&U $<E5I&J>1JJRGK6,F:I%>5JIRO4\S52F:N>1M&)#(]59'
MI\TF*HS3XK)HT03-5*63FB:XZU1FN.36#B:Q)6FIGF54:?WI/.K)Q-+%P34\
M251$E2*QH:&6_,IZMS592:FCH&3@4M*M.IW&.6I4:H*4-BLQ%U6J0-BJ:RTY
MIL"D)QN7EFQWJ=+FL8W'O3TNO>J3(]F;J7-3QW%8<=Q5N*3I6\9$2IZ&PDWO
M5F.6LN)C5Z&NJ,CCE$THFZ592J,7:K<==,9&3)J*1:*VN2&:,TVBF ^BD6EH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?#Z W2JDM6Y.E5):\J4N8]6,>4K,:C8T]JC:L.4VYB-ZA8&IV%)Y=;1=C&1
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHI%I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI&I-QH =13=U.H
M**** "BBB@ HHHH **** "BBB@ HHI": %HINZDW>] !12;J3=0 ZBBB@ I]
M-'TIU !13<FE6@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ***1J %HIN33J "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0TF30 ZBDI
M: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FM1DTW=0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTE.6D M%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>Q(YKT8:G%+0N;:3'-/IIZUHXF-]1**0T#I631T1'TM)ZTM0(**** "BBB@
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M"Q%G9J ,<5T+'BO-D[L].$;(86H'2D'-/VU%C06DP:=13)$ Q2T44#"BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:1S3J*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>PZ3<":%3FFM3\OQV'EAI\IHK3Z:!3JU/."FM2DTV@04^F4^F,***1J0"TE
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM% #LTM-6G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFFEJ8AYH6F@TJU-@'4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#;I;KA!BGELTX]*0"L#H$"]*?112 ****8!1136H =13*?0 44RE6@!U%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M(: &TW-*
M33<TP'9ZTF:3-(QH10%J3=3>M+L)IV,WH+N]Z7S*3RC3?+:BP<PXM43R!<YJ
M7;Q6)K5]]DC;)Q3T013J2LB[+JT< Y(K USQC##"P#@?C7G?BSQP+/>!)C\:
M\A\1?$QF9@)?UKAK5U%'U> R.I6:=CM/'WBQ;@2 /Z]Z^=?&-T+J20YS6IK'
MC(W9;+Y_&N&UC5!)N.:^=Q&(YC]:RG+7A4KHYC4+-&D)Q6;-9H!TJY>WHW'F
MLR:]]Z\B3;9^@0E'EL0M:H*FMX0&JJUUNIT-UM:I=SFDE>Z.ELXQ@5)<VNY>
M!6;9Z@!CFM>&Y65>M9:EQ9RNI6)R>*R4LR7Z5VM];K(M9<=D/-Z5U4]S"O"\
M;C]%T,W##Y<UW%CX*:2('9G\*;X3LT\Q<BO9]!TR%K5<@9Q7L0IJ2/B,1BI4
M9G@NO>&&LXV.W%>;ZM,;64CIS7TS\0--BCMY, =*^9?&"^7=.!ZUQU*:BSV<
M)B95HW90&H$]ZB>]/K6;'(:4R5FH(Z)U7<TDU!E[TDNJ-ZUG>8*:QW57*9NJ
M[:$TFH,S=:2.Y+'K4'DEC4\<!%/0PYIMFA;R]*T([C;WK(CRM/:X*BL91YCT
MJ=7D6IJMJ&WO56753SS65-==>:IR7.<\T1IF=3$W-IM4)[TJZ@6[UAK-Q5B&
M3YNM7RV,(UKLWH9#)CFKL<&[K6;8L.*UXY %ZUS2N>K1:8JPA:9)-L%$LP]:
MS[B8G-)1N=,ZG*M!\MUSUI8KLYZUG2.<T*YK?DT/+E-MW-R.ZXZTK7-9*34X
MS<=:R<-3LIU^5&K'<\]:O0WAQUK AEYZUHV[;A2?NERJ<YHM>'UJ2'4-IZUG
MN#MJOO*FEN7&5CJ8+SS%ZT7,/F#-8^GW!R.:W8VW1\TU$B:N84\/EM5[2KPP
MR#FHK\<FLU9C&]/8*;6S/7_#/BHVS)\^/QKVGP;\1/)V R_K7R78ZJT9'S8K
MJ=,\7/:[?GQ^-=E'$.#/,QV6PQ4=C[S\-_$J-E3,H_.N[L/'D-P -X/XU\ :
M7\3GM]O[TC\:[_PO\6&DD0&8_G7MT<7S'Y9F/#;@W)(^W[36H[I1AA5]9/,6
MO#_ ?C+[>L?SYS[U['I,WGPJ>O%>K"7,? 8G"O#RLR]3J-M%:GGC:4&F\FEV
MFF2+FFTUV*BJ-SJ"P Y-(KE<MC0W>]-\VN7O/%44&<N!68WCB'=CS!^=*Z.B
M.%JRZ'?*VZI:XVQ\6Q3,,.#^-=';ZQ#)%NW4R)49PW1F^++S[+;,<XXKYJ^)
M7C@VK2@28Z]Z]G^(_B!%M9 K=J^-?BGKC27$H#>M8U'RGWO#V7_6&G)'.>(?
MB+-YSXD/7UJGH?Q*F6Z7,IZ^M>=:I*TTC9.:S[%GCN 03UKF]HS]-KY3!4[6
M/MKX<_$(S)'ND_6O69?&B_8B=_;UKXM\"^(GM=GS$8]Z]-D\;,;/&_MZUTJI
MH? SR3FK7L;GQ&\9>89 '_6OG/Q=JINI'.[-=+XL\0O<NWS9KS?5+@S$Y-<E
M1\Q^E99@UAJ:T.?NVW.:JGEJL7*_,:KXYK#E/4J3N[">7N-:.GW'V5@0<526
MFS2;%XHC*S$TG'4]G^'?C!H+J)=_?UK[#^&/B7[3;1Y?/'K7YV^$]6,%\AW8
MYKZR^%OC);>VC!D["O2I2/S#/<)[1^ZCZ8\1^(EMK%B&[5\R_$KX@-')*%D_
M6NN\8>.EDL6 D[>M?,OCK7&O+B3YB<U<YV/.R7+;3O)&?KOCV>29L2'KZU#I
M/C2XWC]X?SKD983/)D\UIZ;8[<5RNH?KU'"TO9V:/5-)\;3JJYD/YUO#QW-L
M_P!8?SKS"V7R\5=$QV]:CG9Q5,NHR=['7WWC2:3(\P_G7.WNORW&<L36;))G
MO55Y%'6I;;-:.$I4MD2SW#2]35*92<U(TZCO43W">M1RGJ*<4K&?<6Y:J1L3
MGI6R9$;O4;,E5RD.HC/C@V4DS;5-3S3(N:R[NZ&#@T<J,93N4[ZXZ\UEF\(;
MK4EW)NS5+RBSUF]#DN[FS97!?'-;=O&&7FL+3;<Y%=%!$52CF.B/F.\E!1M1
M>U0SNRU6:9JOF1KHRQ,$P>*S;B,'.*E=V:F!"U'.CGJ0?0R[BW)SBLZ:%U.:
MZM+0/U%1W6FKM)Q5;G#.$CCS,T=0R7A/4U=U2W$1.*YZ:4JQYI<AR2J..C+4
MUQGO4'G<U4>?WJ'[1[UI&F<,JVIKQW&.]68[K'>L(7'O3DNN>M.4;%1KV.HM
M[K+#FNETEO,Q7!V=P68<UV.A38VYK!GL8>MS'?:;;AE%:Z6PK&TN\55'-:RW
MJ^M2>RGS(L?95]*FCM5]*JB\'K4\=V,]:=S.29/]C!'2LK4M/W*<"MF*X#=Z
M)MCK1<YI<VQYKJNDMD\5SUQIS)GBO4[ZU1@:YN_L%YP*.8P]F[W.(BMRD@R*
M[OPC?+;2)DUS=U9[&) J&&^:SD'.*CGLS24/:1Y6?6_P[\61P>6-X_.OHCPC
MXPCEC0!Q^=?GKX:\</:NHWX_&O>?A[\0C,T8,GZUU4Z]]#\_SC)U9S1]JV>J
M"Z08.:O+\U>;^!];^W11_-GBO2X5S&#7?%W/R+%4O93Y1HS2T[;0V*9RH;DY
MIZM4984WS*=S30L;J-U0!Z<#18FY+NI:9NHJ0'T44QC0 [=0,U'N]Z>K4!8D
M6FTY>E+28"+0W2EHH2 913J;3 <O2EI%I: "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M I*6D- $;U7DJP]5I#30BK)5:0U8E:J4SUH0QDDE49I.M22R53F:M49LK325
M3DD-6)A5.05HC-D4LF<U2F.<U9DJK-5$%&:J4E7)JI24R"N],W&G2&F5=PL+
MNHW4E%2F%@9J3=0U)M-,H7=4BM46VI%H![$RM3PU5\U(K5HF<]KLG#4Y6J):
M>*JY:5A^ZE5JCW4JMS6<BT3JW2EJ-34@KD:NS:+L.6I5J):?FLI1.I3)*=42
MFI5YKBJ*QK'46I(Z:%J6-:X),[J:)HZE6F*M2!:YI,[HDJ5.E5UJQ'7-U*EL
M6(ZM1&JT8JS'7?2C<\^I(OP]JO0UGPGI5V-J].%,X9R+J&I5:JRR<=:<)/>N
MI0.;F+BR5)YE4?-IPF]ZIQ*4B]YE+NJHLU2+)4V'<LAJ<&J%6]ZD4U)2)!2T
MBTM(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 444E "TQA2[J1N: *EP
MO!K%OEX-;LZ\5CWR]:TBR9(YF\7K7.ZBO6NFOEZUSFHCK77!G)(Y/4EZUSEY
M#G-=3?1Y)K%GM]Q/%=L96.-HYJ:WSGBJS6WM7126>>U0-9>U:<QFT8'V?VIR
MV_M6PUG[4HLCZ5HI$F6D'M4OEXK0^R[>U1/#BJYB&5@M!6GXVYIK&K(&]#3D
M)J/=3XZ0%N(UH0U1A6KD;8Q0(M;MM5IYL"DDFP.M49ILT#"2;<U/A;FJF[+5
M+&^#0P-6%NE7H&Z5DPR5H6[=*YW#4OFLC8MVZ5IV_:L>W;I6K:GIS3Y#+G-F
MU[5OV/&*PK->E;EJ=H%<LX&L):FY;M\HJY&W-94,G2M&W;+"N*43TH2-.'UJ
M[&O%4[?I5Y!Q7,SMB.HHHI%D;CK4#K5BFLM1(I%*2*H_)JZR4WRZY^6[-.8J
MB&I8X:F"4\+6GLPYB-8ZE5:*<M6HD-BJM.Q2+3JH@*;DTZF[:H!5I:0#%+0
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M28S2T4 )MI:** $VT8Q2T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M85NE:=I&J@9JRZ=!/<RUT/(Z4Y=#^;I72Q[-M/Q'4,U]@C+L-*VD<5T=G8C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFZ+%+35/2G4AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4FZEH **** "BBDH 6BDR*3</6@!U%-\Q?44NX>M "T4TL!WI-^: 'T4E+0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BD-)DT .HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH :U025,W>HV7- %.1:KM'5YHZB9:JXK%!HZKRI6@
MRU6E2K(:,V1?:JLBU?F6JDBU5R2E(OM521:O351F/6M8F<F4Y15*=>M7)6JG
M*U6C(SKA>M9\U:4RYS5.2.J&4FS0O:I_)H6*J 15J15I56G5(#<8I*5C43-0
M!)2;JCWT%JI(FQ)NHW5'3U6K$/I\8Z4BK4B\8J;@2)4BGWJ(&GJ>*AE11,K4
M\-4 -.5JY):G9$G6G**8K<4N_%<W)<V4K$RG%2"3%5/,H\RM84493J,N>;2^
M950/S3U:NZ-)')*HRT&I&:H@]#/6Z7*<[E<E#4GF&H3)36DJ[F=KDYDIOF9J
MMYI]:59*'J)1L7%:I _-5%DJ16YK.UB^A=CDJ[#)67&U6X7J+W,S6ADJW')6
M7%)5N-^:31<6:<,G2K<;5F0MTJ]$W2N>2.V$D7HS5N-NE48VJU&U<[.F)=3M
M3ZBC:I:DH0FF[N:<U,V\T /!H)Q0M(U !NI=U-HH ?1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2T
MC=* $W4E%% #&7VJK+'FKK+4;1YIH'J9,D'M5=[?VK8:"H7@J^8GE,62W]JK
M205MR6]0M:^U/G*Y3%^R]>*3[. .E;)M>O%0O;X'2M(S.62,AX:KR05K20U
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M:Y=;XY/-6(KHN16S@CSXXMWL;$ET6Z&J[;FJ2SMVFQ6Q#I)8=*S=D=D8RJ&
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M1110 AI-M.HH 2EHI-U "T4F:6@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 -R:-U&VFF@!6J"2GL
MU0R-0!7D%59C5ES5:0=:N)$BE-5*1*TI%JK(E6(SI(ZKM'5^5:IR\5M$PD59
M%X-4YL5:F;K5&9NM:&=BK,V*J2-5B3)J!H\UHC-Q*[-439-6FB--\DYZ59/*
M46C)IGDUH_9Z/L_M3#E,]8:=Y=7!#2^30%BEMIP6K/D^U*L)J)&I $I=N*L>
M2:1HJA 5Z*E\NF^7[4P(FZTW/-2F/FFM'0 S=3]U)Y=.V4T)A2YQ1BF,U:<I
MGS$FZEWU7WT>9026A)2[JJJ]/5J5Q\I.: ,U&K4]35"';:3;3A3MM (:*>JT
M;?:E%(8]:E3FH:>C4$EE:>K5 &XIZFFF2R[#UJ[#6=#UK1M^U-DER(5;A%00
MQ]*O0Q>U<TC2*;+5OVK2MUJE;QUI0ICM7+)G93C8L1K4ZK3(UJ6L#K04444#
M"FM3J:U "4444 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ I-M+10 RE%+MHQ0 ;:*6B@ HH
MHH C:HB,U,RTW;[4)A8KM'5*Z6M&0<51N.:M,RDC#O$K&NH>M;]U'UK,FB]J
MZHLYI1.?N(:SKB'K70S09JA+;9[5JF<[1@26V3TI%M/:MDVOM2?9<=JW4B.4
MROL?M3)+3VK9-OQTJ-K?VJN8B43#:U]J5;/VK7^RY[4];7VJN8YW$RQ:\4R6
M':#Q6RT&VJ-Q'BKC(RE$QY(^32QP\U;,.6Z58AM>1Q70I:')*(MG!TXK<L[?
MI5>UM>E;=G;].*PJ3-:<+LM6</2MVSBZ53M8>G%;%K#TKS*DCVZ,+%R!,8JR
M.*;&O2G&N&1Z<=!]%)2T#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 VDS2[:-M  M.I *6@ HHHH **** "BBB@
M HHHH **** "DVTM% "4M%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)FC=0
M M%)2T %%%)NH 6BDW4M !1110 44F<4F\4 .HI,TM !12;A2;J '44TM3=U
M $E%(#2T %%%% !1110 44FZC=0 M%)2T %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %(U+24 1MUI5HVTN,4 .J*
M0C%.+8J"1^M581#(W6JDK5-(V<U6D7=5$,JS$\U7=<U=:/--\FJ(,YH>O%1_
M9\GI6IY% MZ+@9RVOM2_9?:M-8/:AH:KF$T97V?VIK0UIM#UIGDT^8$C-\FF
M-#[5J>13/L]/F%RF6T%)]GK5^S^U(;;IQ2YA\IG+;T_[/[5H""G"&GS$\IE-
M![4PP^U:S6]1/![5?,*QF>3Q4;0UHM#UIOD4B;&9Y!]*3[/6M]F]J8UO[4<P
M<IEF&HVA]JTVBQ4#QT7*L9DD>*JR1UJ21U5DCK0EHRY(<U7DM_:M5H:C:&G<
MFQC/;^U,\BMAK>HFMMO:G<BQG>21VI?+J\8::8:!7971:L1I0L)JS#">*8K#
M5CZ5*L-6XK7I5I;/VI7'8S?L_2GB"M$VO'2FF&A,$BAY-.2'VJZL/-31VN<4
M[CY2I';>U7H+7IQ5N&SZ<5HPV?M6;D+E*MO:]*TH;?VJ:&UQVJY%!63D;Q@,
MAAJY&FVECBQ4JK6#D="0HI],I=U26.HI!2TAA24M% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %)2T4 )12T4 )12T4 )12T4 )2T44 )MICK4E)0!3DCJI)#
M6HR5 T=/F%8RVM_:F?9O:M)HJ;Y7M34F+E10,'M430>U:1CJ-HZI29#B930T
MQH?:M)H>M,\FM%)F4HF8\-5I8_:M:2+BJ<T5;1D<LH&5)#FH#!R>*TFCIGDU
MLF<[B45M_:KEO;^U2QV]7K>WJ)2+A$?:V^,<5IPP[<4RWAZ5>C2N:4COA$DB
M2K"K38UJ2L&SH2&44[ HVBD4"]*6BB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-:G4UJ &M29-*1F@
M+S0 M/I-M(30 K5&QZTK-1MH 1:<7VBFD[16=?:@(5/- TKEZ2\5.M5IM61
M>:X[5/$RPY^;'XUR]]XR"Y^?]:KE.N-!L](N/$"+_%53_A)$W??%>/WWC8@G
MY_UK,;QQ\WW_ -:.4Z5ASW^VUY)/XJTX;X2#@UX1I'C3>R_/^M>@Z%XB6=5^
M:BQSU*+1WN_<.M(*IV=VLRCFKRC(J3B<6F)D^E S4FRC90 @I] %+0 4444
M%,I],H ;DTH-&VE5: %6G4F,4F30 ZBF\THH 6BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:M9,]&%TA_F>]/6XQWJFTE,9S2L-S-2.\YJRMP'6L)&.:OVV6H:+4KDUQ")
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI:1:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!E*M.HH **** "BBB@!*8T=24AH J21U T1J\RU&R\U?,3
MRE3R:/*-6]M'ET<Q/*5TCJ94]J>JT\"B]PL-"U(O I=ORTUJ@L?2TQ>U/H&%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MACQ%]HV?-FO2-,NA+&.:D\Z<'$TJ*2EI&(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "DI:1J #(HS3:* ';::RTZAJ (F6
MF&.I\&DV^U $'ETY8ZEV^U% #53I3PM*M+0 W::-IIU% ";J*;3EH 6DS0U-
MH ?1124 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !24M(U !NI,4E.H 9MHQS3Z1J !:=3*?0 4TBG44 -VF@"G44@"BBBF
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7!I*=0 FTT8-.HH 913Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0]*;3Z*
M $'2EHHH **** "BBB@!&IM*U)0(**** L%%%% 6"BBB@+#Z***!A2-2T4 ,
MHI](>E #:1J6BF,92;J<PSFDVTA$B?=JOJ S;-5A>E0WO_'NU T>)?$6W+)(
M:^9O&R&.1Z^IOB%M$<E?+OQ 8>9)BM4>MAT>2ZK=%9"/>L]+G=3M88^<?K5*
M$FF>[#8TXY-U3QJ352W-7(VK0),N0';6C#)[UB&?;4T-[[TPW-6X;*UB7O4F
MK_G[UJI<H6H&F8[_ 'JDAN-M+-"1FJS K0#D;5OJ13'-:=OK9&/FKD&F*TZ.
M^VGK0F3S'H,&O,/XJTK7Q(RL/GKSB'4^.M6$U;;WILS:N>RZ3XR:-A^\_6NY
MT?Q]MQ^\_6OFN#7S'CYJU[+Q4RL/FJ+$.FCZUT;Q^&V_O/UKJ(O&BS1@;_UK
MY/T7Q<^Y?G_6N]T?Q0\FWYJ31DZ2/8-3U870/.:Y;4;?SPU5+/5#,!SFM-9%
M=.:"H1Y3A=:T;<&.VO/=>T;;N^6O:-45-IK@]<MTD+4';S61Y)=::58\5J^&
M]/;[2O'>MV;21(W [UN>&]!_?K\O>@Y*DCUOX7Z?@1<5]$Z';B.V7CM7D'P\
MTORECXKVO3T$=NH%929X-=D[4%J4BFE>*@X1IZTE+BC% P7K3J0+3L&@!**,
M&B@!5IU-6G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )12T4 %%%% !
M1110 4RGTFT4 (M.I*6@ HHHH 2EHHH :U)3J,"@!:93Z3;0 BTZDQBEH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2EHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1129H
M6BDW4M !1110 4444 %%%% !2$TM(1F@ !H:@#%(U)@,;K2K2'K2K04.(Z4U
MJ<>E)5$$;5&6XJ5A3-HH9#(F;FDW&I_+'UIWEK4W)17%. J?8M5;B9(<\T^9
M(VW1*N*;=.(XB:H1ZHF[&ZDU._3[&Q#=J4JD4C)1?-8XCQIXF%E$_P V*^:_
MB%X\+-(HD_6O0?BSKQ@67#5\D>-O$SR74@W'K7A8O$:61^P<,X.$K2DB+Q)X
MDDNIFPYZ^M95AJTJR9W&N<EU(S2<FK,%T%6OEI5)<US]F^JTG3LD>IZ%XPDM
M=OSD8]Z["W^(C^6!YGZUX#_:K1MP:MV^MR?WC7?2Q$HG@5LIIS=['N5QX]>1
M#^\_6N)\2>)'NE;YL_C7*1ZH\B_>-1W$S2 Y-.IB')%4<MA3=TCGM<9KB0FL
M-+4[JZ6ZAW52-L >E<"GJ>O&DDK$5K#MQ5ML*M-5=M1SM2NVS3EY45+J6J6_
MYJFGR:K[>:W6QS3;N6X6Z4^22JRR;:;)/[U%M1\]D$TWO5":XI9YNO-9ES<8
MSS73&)Y]:M8=/<>]4))_>HIKKWJHUQ[ULHGCSKW9=^U'UJ":7S*J^;FI8?F8
M9K=:'!*?,6K.U\QAQ74:;IXP.*R=-C&175Z<%XKFJS.O#T]2S;VFWMBK2Y2K
M,,8:IC9[ATKS92YF>Y"G9%'SR*<LFZI)+(CM3%A*]:=[&BI79-&HJ7>$6H=^
MVJMQ=;1UI?$=L8*"+%Q=!>]8EY=9SS3+J^]ZRI[K<>M:1IF%:HDB5I2S=:L0
MM[UD-=!>](NI!>]='*<$<0HLZ)9!CK44TM9$>I!OXJF6Y\SO4<IT_6%):#Y)
M*K2-4S?-4$@XK2)R3D0LU*LE1N<4Q9*LY>;4TH9>E7XI,BL:&3I5V&7BLY1N
M>A1J%^0YJI(O-2>;3-P8U*T.B4DR'RZ3RZMK'Q2F*GS$\A4V4;?:K#1XJ)N*
M+W$XD++435*S5$QJS!CE8TK'-0^9BD,U!',D.=,T^&+FH?.JQ#(":>I,7%LO
MPKM%2228%1QL,5',_%8]3T+VB,DDSWJ!FS4<DV#4/G>]:I'+*9*U0M3PVZC9
MFJ,)/F(.:>%J3RZ3%!G:PUNE1LU/:H)*I"E(7S*<K57+'-.5J=C/F+BM0QS5
M;S<=Z7SO>I+YM".X6LV?BK\T@(K.N&ZUM$XZC*DCU6:XVMUI\SUG3R<UJHGA
MUJG*S5MKSD<UMV=T&'6N+2X*M6E::CMQS2E!FN'QB3LSM8Y PZTKX-8%OJG3
MFKT=\'[US.+1[L,1&2)Y5ZU685-Y@84S;FJ0W[PU5J>..FHO-6HUI,N$41^7
MBHY%J[L%021^U2F:2@4<?-3U/-.:.D5:T.>VI/&U3*U0)4ZBH9T1+,4E:5K+
M60M6X9-M9R1VPE8TIG&VLBX8;JL2W''6LZ:3+5$0JR3+$+59\O<*I0-S5^-O
MEJS):H@DAVU7:7RZOR]#61>$KFKB<E30=)>=LTV&?<_6LB:8AJ?;W6&K2QRJ
MIJ=WI-P%QDUT(99H\5Y_8ZAMQS71Z?J@( )J#JA*X[5-.#AL"N1U+3RA/%>@
M>8MPOK6;?:8)<D"GL:2IW1YO)"R-TJ+<5ZUU.H:3LR<5SMY 8R:I'G3CRD0F
MIZRUGR3%33H[BKY3D=4Z'3SN85UVGI^[%<3I<WS"NSTV8>6*[*,;'J82I<M7
M*_+5'.&-7KB3(J@W6NJQZLA9).*S[B;WJQ.Q -9%U(:F3L<E6I8E,W-21RYQ
M6<K$FKUO&6Q6*;9SQDY%C)-0RYJ_%;%ATITEB2.E;\NANXNQ@R,W-0/(:U;B
MQ*YXK-N(2F:S4-3AFFBI)+[U7::G39YJG(Q%:<IPSE8L>?4D=QTYK/\ ,-21
MO5)&*J:FU;S5HPS=*P(9<5>CG]ZMQT.ZE5-CSQ36F%9OVCWIIN/>L>4Z76+[
M3=:C:;WJG]HJ)[CWJTF1[8MM<>]1-<^]4I)_>H'GYK2-SFG6- W%6+>X^85B
M><:M6LQR*YJJ"G5NSJK6?Y:LM=87K6+;S?+4DDYQUKFD]#U(U-"Y)=9SS4#7
M'O5$ST>=[UPRNV/VA;-P?6D\PM556W5;A0M4V-8RN/53FI56I8X?:GM'MI<M
MC=1(&45!(VVIY&P*I3OQ5(RF[#'FVU']H^;K56:3K4'G?-5HX95+,U8YZL)/
M6*MQCO4WVK ZU7**-8W(IQZU:60,*YV*\YZUHV]UN[U,J9W4ZZ+LF:8K%2*D
M5MRBF2#%9<KB=-[ZEF&:K*X>LCS=IJU;W'S#FNBFR)2T+DEN",U2F79GBM%)
M0ZU7N(=PKJYC@G'FV,PL&XIK0!J?+&8V-0FX"U7,<_+;<BDM!40M?:K2S!JE
MC7=4W1I&"9##:^U7H[0;:?#%5E<+5(W]EH4Y-/##I6;=Z4#GBM_S!C!ICX>C
M0PG33.*NM+P3Q6>UB5;I7<W%F&SQ67-8@-TI-GG2PUV8UK8Y8<5N6>GA<<4V
M"$(W2M*%@HJ.9'?0H*)+;VX6KT8"@5468"G?:/>L9R1[=.T2]O%,:053-Q[T
MWS_>N1LZ?:(N>9BCS\52\[WI?,J+D\R9?^T&E^T>]4@U+N--2 M-+3?,JOOI
MRUK%W#0N02#-27$Z^6:H[MM4[R\VJ1FNN!SU))(S=9F&XXKG6G^?K5S4[K<Q
MYK#DF^8UT\MSY:O6]XVH;S'>KD=][US:W!'>IENCZUDXF<<38Z+[=[U&UYN[
MUBK<GUIXG/K4V-XXBYI-/FJD\^*C\VH)FS6\*=SGK8CE0UYBS4J(7IB1[FK3
MM;?(%=\*1X%;%E/[(6J-],+=JZ&*U'I5J.Q5NU=:I'BU:W,<3+I)':J,UDT?
M:O2#HXD7.*RM2T/:I.VIE3.>+U.!=2IIGS5N76FD2$8JQ8Z$TW\-8.F=\*AS
MBQN3TJ_9V+R$<5U]KX/9L?)^E;=CX0*X^2A4F:\R.5L=#:3'RUI?\(ZVW[M=
M_I_AL+C*UL1^'%=1\M:^Q-(54F>-7.CO%_#5/R&C;I7LVH>$<QDA*X+7M#:U
M9OEK"=%GK4:Z.>ADVU<1R1Q63(7CEQBMS2+1[K:,5R>Q/6C720T*[=!3_)EV
M]#7>:'X,DO-OR9_"NJ7X8OY.?*_2M(T+FL<5$\6\IU;D5M:*0LRY]:ZS7/!+
MV08[,?A7&S!K&XQC'-*5+E-:=>,I'T=\);E%FAS7VG\-[V,6\7T%?GU\*]99
M;F(9[U]H_#G6"+.,D]A6]+<^2SZGSQ/?9M52.(<]JQ-0\3)$I^>N*UCQ5]GB
M/S]O6N"UCQMDL/,_6O8C'0_,_8>\>@ZQXV$9.'_6N;E\>G?_ *S]:\MU3Q0T
MS'Y_UK#DUN3=]XT-'2J!] :;XWWL,O\ K79:5XH63'S?K7R]IOB)XV'SG\Z[
M?1?%I7;\_P"M*P/#GT?:ZTKJ/FK4M[Y9.]>(Z9XP!V_/^M=AI/B828^>BQS3
MP]CTA9 W>@R+]:YVVUI64?-4DFL*O\52<OLF;_F"C<*YI==3/WJO6VIK+WI$
MNFT:_K24R&0-SFI:#*PFTT9QQ3J:>M !FA>M)2KUH =1110 4444 %%%% !3
M=M.HH 0#%+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% #6IAJ6DVB@1'S1S4FVC H CYIXI:*8#6
M)IN34F*3;2 2EW4E% QPH;I0.E(30 TTBT]<4N* (\FC-248H$,V\5!<2;%-
M6ZR]6G6.-N>U!<5=G%^+]2\N-\&OG[QMJ[M)( U>N^,K\,K@&O$/$R&:1_K5
MQ/;P],\^U*X>9VR:P;J L>:ZNXL?F-9MS:A:U2/5C&QS#VOM3/LHK6N(PN:H
MRR*M67S%">W&VL2\BQFMZ:8-Q5*2 2TF(YF2$EJLVL)#"M1M.^;.*6.U$=(1
M);?*HJSYX7O50MY8JM-<X[U0&@][QUJG-> \9K.ENCSS5.6Z/K0,MW%P.>:S
MYIP<U7FNO>JCW%(BY<8[J0)FJT<V:NP_-0#$6.I%&&JPD5#18-,DTM);#+7H
M&@R_=KS[3>'%=MI$NP"D#.Z@E_=CFJM^^4/-9G]J"-.M4+S7%*D;JD"CJS'Y
MJY._9@QK=N[X3$\UD74?F9H&4+69U<<UUFC7C\<US,=N0W2NAT>/YA00SM;&
M=V .:UK>ZDC8<FJ&D0[E7BMDVHVYQ02HF_H.NO$ZY:O4?#OB0A5RWZUXC:[H
M9 :ZK2=3:(+S2:%.FI(][T_Q*&Q\U=%8:XL@'S5X18^("N/FKI=,\4;<9>LK
M'F5,,>W6UXLF.:MJP:O.]'\1B3;\]=AI^H"91S29YTZ3B:M.IB-NJ2D8A2-1
M0: &TZDVTM "T444 %%%% !1110 4AI:1J $W4ZF4^@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCS'M \0(?XJ5M>3'WJ\.C\>;C_K/UJ9O'&5_UGZTK,M8=GL,WB:-,_,*K?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#WJ^6QS>T3%9:$8K2;QZTUFIF?H7X9S5OS?EK'ADYJXLGRTN4UC48L]SM[U
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MV"*I,M2QMMI,=-\C.CMYOEJRLF[%84%UMK0@N <<UDXGLTZR9KPU/L&*HPW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'W=\[2')JK]L.[K5Z^M,,>*S&MSNJX^\=W.H[%E;PU-'='.:AM[-F[5<73V
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M*D93N;?:E<MJR8+<5U=U<*RD"N>U"'S,T$,Y28$,:CC8[JT+BU(8U76 [NE
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M21!4BU 6Q2":I&3L:B9JB::HVEH <^*A:E\S=3@N: "-L5=MV)JJL=6X%P:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ***2@!:*;NI-U Q]%-W4A:@0^D--WTN[- !NIU,I<
MT .HIFZFM)0(EHJ 3<U*K;J=@N.HI,TTM0#:0^BH_,]Z3S!FBPE),EHJ'S/>
ME\SBD6/)]*4&H&DI5DZ4K@3T4S=[T;O>F%A]-;%-+8IHD%,3'U7NI/+A-6*I
M:FP6!N>U1+17%'='E7Q#UDV\4F#7RK\0/%3^?(-_ZU]"_%2XVQRX/K7R!X^N
M6^U2<]Z^8QU5H_8^&,/&5FS%NM6:X<Y;-49)OFS6?#,=QS3IKC;7R4FYL_9(
MTU3CH:"3"K,9#5@+>8;K5N"^"]ZTC&Q49&A<0!E-8EY:E<UJ"^5@>:@N&$BU
MKL83DS .8VJY:WVTCFHKR+J167+,8VZUI'4P52VYVUCJ@&.:TEU)9%ZUYO'J
MQC[UHVNM'CYJOE:*E4BT=%JT8FC->=:]IQW-@5VRZ@)EP36??68N,\5=.?*]
M3Q,52E4V/-X[%EDZ5T.FVY7%:3:,%;.VI8[7R>U;RJ)HPP^%G!W9/;C:M2LP
MJLTGEBH)+SWKD=V?14Y*FK,M28(JA=*.:=]JSWJ*27=513152I&2,RY7K6=,
MM:MPN:IM#N-=<6>'5AJ4$AW-TK2M+,MVJ:TL=S#BNAL]- 7I3E(SA1[F-]G\
MM:;QTK6U"W\M>E8$DNV0THZERM'0O)"'JS%8C(XJO9R;L5K0L,5$FS>G&XL-
MJ%Q4S6*R"F&X5:ECOE'>I1M**M8S+S10V>*Q+O1@O:NOFNT9:RKJ9&-=,9'!
M4P\6<LVE!6Z5(EKM[5K2%:K,16Z9QO#Q6Q2>UW5 VG[CTK650U3+$M#!4$RC
M96 5AQ71V,*JHXJC&JK5I+@*.M<=0[:%&,30;:!59V%5Y+SCK562Z]ZYE%GI
MWBBW(XJC< -3&N?>HVFW5M$PJ.+1G7UN&S6!>6O)XKJ92&%4)K425T1E8\#$
M4>?8Y5H2#TIPB:N@_LO=CBG_ -D^U="FCROJ4SF]K+2K.T=;LVEX[5F7-@5S
MQ0Y)D2HU*9+;WQXYJ]'>[AUKGV#1M4L=T:R<2Z==QT9N-<9[U7DDS5/[1QUI
MK34XQ.WVR:)RU2Q252\VGK+6CV(Y]35CDZ<U85ZR8Y_>K<<U8<IV4ZER_FE:
MH(Y*DWTMCJYB*4549:N2&J[+5HRDR-5I[)30<4K24C(K2K4&WVJPS;JC JC-
MV9)".E7X>U4XQTJY#VI,U@B5AQ47W6J1FXJN[9:I-Y-%R&3%/:3(JC&QJRN3
M18<9!WJ:&H\8J6$U,BEN:$*\5*RX%,MSQ4L@XK$]2"]TIS-6=,QK0F6J;1$F
MM(G'5N5/+W5(MO5N&USVJT+?:O2J;,8TS&FCVK63=<5T%XFU36!>+R:TB>=B
ME8H[CNJS"QJJV=U6;==V*U/(BI7+(<TQY#5B.WW"FRVQQTJ;G8HR2*$DAJLS
M$FK,T16HDA+-31Q5.9LK,I84T0DGI6M'9[ATI_V'VJ^9"C0E+<S[>'YNE;5D
M@7%5E@VU9A?;429Z5&GR&U 1@5,6JC;RYQ5U?FKED>Y3>@W=M-6(9L5"T=(J
MXHT*9KQR!EJK>P"13389-HJ5I PK2,CEJ4^8YJ]L1N/%5H;7:W2NAN(0U4Q;
M@-TK;F1Y_L'<+>U!6H+RSZX%:MNH %/FMP_:I<S:.'N<PMJ5;I6M8J% J5[/
MYNE.CB*]JQ<CIIT7$OQX9<56O+4.IXJ6'/%6F4,M1S'0Z=T<??6NS/%9,@VM
M75ZI",'BN8NUVL:WB[GBUZ?*R&G+5=I,4+-[U?*>?SHM 9I=M11R9JP@S31O
M#WAH2I4C-3Q0[NU:%M8[L<4W&^QV0IW,]8S4@C-;B:7\O2F3:=M[5+@SI]DT
MC)44K9JT]MM/2ECM2QZ5'*P$LU.X5N6V5456M+';@XK1$.Q:ZZ=)[G72T$>X
M*]ZC%P6-13YJ.-26KKCH:\SN:$,F<5)(WRU7C^4"B22M6U8UYK(AE;+4V-"U
M-^\U7K.'=CBN=:LF*YF+#:[NU7([/ Z5:A@ 45(VU171%(ZHTTBDT8453NF'
M-7+B8<\UEW4N<\U3(J2449UTW6LR9NO-7+ECFLV9CS69XE66I7F>FQG<13)J
M6'AA5).YYDI:EWR_EJC<J>:T8^5J*:W+=JZ8Z&4ESK0Q^=U6(?O"I&M".U1[
M?+-:-W1A&+B]38L<<5N6Y&WBN8M+C!'-;UG/N45X^(4CZ+"U(ER5<U1F4BM#
M<&%5IE%>-JGJ>G42DBAYA6GK,:;(M1[:ZHR/-E%W+&^E$O-0;JC:2J<@7NFE
M'/TYJTDV:Q$FJS'<5%SIA4-1FS5>3'-0BXXZTC35<364D,D6HMM*TM,\RDSE
M;0C+3%6I,[JDCCR:CJ5&*D$<>:MI"33H8:NQPBGS(ZH4F4C;TWR:OLHQ41Q4
MRDK&GL[$*0BG-"-M2JPI'<8J(/4MI6,NZAZUE7%GN)XK;G8<U48"O1A-6/ Q
M5/F9C?8?FZ5;MK7!%6_+%31( 11*2,L/1Y66;.$#%:48 6J,3;14_G>]<<F>
M_3M%$DQJA,>M66DR*JS=Z2BV34:*DK<FJ^[FI)CUJN6YJ^5H\^5BPKU*K54C
M;)JU&,T+0F(CYJ!JN-'Q43QT[CE!E1C43,:LR+563BKB8/0"U5KCFG-+BJLT
MW7FNN)QU)(HW0-01Q%F%6V7S#6GIVF&1EXK>)YOLW.6A%I^FF3'%=%::'N ^
M6M/2]'"J,K6_#9K&!Q4<NI[U#"^Z<T?#XVYVUEWVB^7G KT'RTVD5FW]HK \
M5TPBD.MA-#S"\LBA/%55MSNZ5V&I:>-Q.*QY+7:3Q71I8\:6%:95M8<8XK4@
M7:!4,,56XTK"4COHT[%B-L5:CDJFJU*N:A.YWQNB\DU2>=5$,:1I,5M8OVEB
M:>:LZ:3WITTU4Y),U/(SFG5'[^:FA:J0;FK$+4U!F'M-31A-6D-486Z5>BK!
MIIGITO>18CSBI&3(I88\U9$5--G8H7,>XAS6?-;^U=%-;^U4)K?VIW.:K1,,
MPXJ6/Y:LR0U"5JXRU/*K4;JQ,K96F-"&I%XIX>NQ5$?-U,&[D8MQ4\<(]*0-
M4JR5I[1'#4P<F(81BH67;5EI,BH6YJU,\ZI@I+4C5L5-'+TJ%EI%^6M4SS7#
MD=C028U:ADY%9D;5<A;FKN!KV[]*OH:R;>3I6C#)Q3N42L*:%IV[-.04QDL(
MJ[&*KPK5R-:8#2E,*U,W2JTCXI6+Y208IL@J'SP.],:XH$-E%4Y*FDFJI)+2
M(O8:U0E>:5I*%-4/F1+"=IJ_'=;!6>IQ2/(:0KFHVH>]5IK[/>LN28U$9#ZT
MA7-!KHDTZ.X.>M9P8M5B,&@.8U([HXZU.MP3WK,4XJ59:07-19-U2H,UGQ2U
M=CE'K3&6T7%2;N*KK)09:0B0R?-3UFJKYE(TN*0TR\MQM[U+'>8[UC-<8[T@
MNO>J&=-!>$]ZFEN-RUSUO=<BKOVC<O6J'9$%\V2:SS5RX^;-4VX-,5B*3K5J
MQD*R"JI.34]O\K"D!WWA[4#'MYKU/POK15DYKQ/29BN.:[_P_>%63FLIBE&Z
M/I3PEKN0N6KUSP_J@D1?FKYB\+ZR8ROS5ZWX:\1@!?FK)'F5Z=SVZWF$B#FI
MJY71=:695^:NEAF$BY!H/$G%Q8\T;J6C%!D'WJ3;2\44#$W4ZF4[(H 1NM"]
M:&H7K0 ZBBB@ HHHH **** "BDW4;J0"TE)NI&:F*X[=2+S4;/Q2QO3"X2<5
MAZQ>>5&W-;<[?*:Y'Q+(5B;%(VIJ[/.?&'B Q*_S8KQ#Q5XF9I'^>NZ\?7C1
M^9S7@?B;4F\UAFMHGLT8E?6-:>0M\U<Q<7S,QYHN;EI,U46-G:M#VJ:219M[
MEMXYK?L;@[16';VISG%:]NOEK3,YK70M7=Q^[ZUQ^M3_ 'N:W;^XVJ>:Y#59
MRS-S09&#>-N8U5CC^:K$PW,:=#%DU([$MO&<BNATM>E9]K:[L<5MV=OY>.*:
M!(UX#A*JWS'!J5),<5',OF4RWL<_>,QS6)<;]U=9<6>X'BLJXT_GI09):F3:
MW#QL.375:+JSKCYJYQK7:W2KUCE6%!V1M8]"M]4,D8R:S=7E$BFJ-K,54<U!
MJ%R0IYIG/)',ZPH5FKE;R3YC70:M<;F;FN7NGW,:BY)7=ZAWTYZA:D _?4;/
M2$U'F@"5&JW#\U4XUZ5=A&* +,:5-&O-1(U/$F*: T;=MN*L&7BLV*:K'FYH
M8%I93NK5L9,$5AQDDUIVLFVF4CIH;K"CFJ]Y=?*>:HK<?+UJ&XGW TBBI>3%
MF/-9DTAJW/\ ,:HS+02R%I*BDDHDXJK+)BD21S3'=5BQ;=(*S)I/FJS9W&UA
M0!Z#H>%VUU\-PJQCZ5Y[H]^!MYKIX+S<O6J++&J2!E-<U=8R:U;VXR#S6%=3
M<FI @DQFG1Q[L5 9>:L6[ XIH#3L8>172V(VXKG[%NE;]HU,HT67*5C:A&1G
M%;:<K5:YM?-[4P,6QSY@KMM)AWQBL&STW;(.*Z[2[?8JU!#'O9>U$<)C-:ZQ
M*RTU[<>E!FRK'<%!5>\NBRU:DMZI7$!H!7.=U!BV:S44[JW[FR+9XJHMB0W2
MK0-D^F+\PKL]*<*%KEK. Q]JV[68QXIL:DSKH568 5T&AZ2LDJG'>N2TNZW,
M,FO0O#<R97)J"):H]1\&Z<L*IQ7J%BR1QCZ5Y?H6I)$J\UTR>(%5!AJR:/'J
MTI29W7VE-O6N=\1ZBJQ-@]JQ)/% 53\]<SKOB3S58;JGE.:.'E<Y'QMJ99G
M->2ZC*\TQY[UV_B.\-PS'.:XV2/,G3O5V/5I4VB?1X6WBNTL<I&.:YG3<+BM
MQ;P+'C-58]*,58OSZD81]ZH[?Q(T<GW_ -:Y_4+XMG!K&DO'#$YH%*":/;O#
MOBK<R@O^M>FZ)JWVA5^;-?,'A_5W69>:]K\%ZBTH3FHD>#B*=CUVWDW*#3SU
MJKIS;H15DUF>8.W4M1YYIXH 6BBDH 6BDR*6@!NZE!I*5: %HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ:%VG%9VDV@XXKJK.,1J*L]_"856NS0MH5C6EF;'2HOM&WBF^9N/6@]J,%$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7*W"^8U7I6\QN343(HJK'7&-BI%"%J2281K45Q<K&#S6'J.K!5/-45<EU/5
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M13ZBM^5%2$XK,\1BT^H]U/!S0(&IM.(S2$8H 2GTRGT %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !2-2T4 ,9>*;MJ1NE-H 7;2%>:=VIK-0(3I36:@M0$W4BD(OWJ?Q2;-
MO.:S=1U);122<5+E8KEYM$6;R=(5)SBN-\2>*H[.%QY@Z5B>*_'D=I&X\P#'
MO7@_CCXG!MZB7]:XJN*4=#Z'+,IGB)IM%OXF>-!.L@$F>O>OE_QIJ37$TASF
MNG\2>+FOI&^?/XUP.K3?:-QKYK$5>=G[9EN7K"4T['+W$QW'-5?/YJQ=)\W%
M5UM2W:N%(].I6;=@^T4HNR*5K-@.E59D,>:TY4.-2VYJVU\<]:W;&^/'-<5'
M=;36UIMYDCFN><&M3H5>)V]KJ$@Q@ULZ?J4WF+\QZUS.FR"0"NHTZ-<J:FG4
M<6:NI"<;6/6/ ^LRQ[,L:]&N/$Q2T^_VKQWP_<"W4<ULZAK16W(W=J]>.(?*
M?$8[ JI4ND9/CGQ(TC2#?7D6K7QGD.3FNB\5:B9&?FN!O+X!CDUYU>3DSZ+*
MZ:HI#FQN-1RS!%-47U$>M5IKS?TKDC39]'4Q"V1+<R>9D5FR::9V/%7(/WC>
MU:]I"O>NA2Y#S*B=0Y:302!G;6;=:>8<\5Z)<1(%Z5R^L*HSBNBG4<CS:E'E
M.6W>6:>9_EZU4OIO+<U1^V_-UKJL<GME'0UC)NJ1<M56QS.172V&D-,!Q4R=
MC:#Y]C)6(U8AC-=(OAUL9VT'12G:N=S1WTZ+N9ENIXJ\JBAK0P]L5&TFRL[W
MV.ZW*A)EP*S9GVU>DF#+6?<?,:N*.2H^PZ"3=5]?N_A6=;1G<*T57"TY&])N
MQ!/WJA,:NW'>LV:3%5%&565AZ-@U>MY>E8WG8/6IX;GWJI1N<T*O*S?6;BFO
M)G-9\5QNQ5E&W5ERV/0C5YD/!):K$*U'&M68\+6;.B,>I,O"U#/)M!ITDNT5
MGW$]$4$[)$%U-5"20DU+,VZJ^TUTQ/+J2U%!S3&7/:I8XZL+:ENU7H9J',BM
M -K"M".08J,69'.*1HS'1S&3ARA-AJIM&*EFDVU3DN.:O<SE9$H J:,BL_[0
M,]:FCFS4#A)&DC5*K55A^:KT-N6Q4,[HAL#=J1H:T8;$GM5C^SSCI4&W+<P&
MB-0O&>>*WIK'':J4UMM[52,I0,=HCZ4UH2>U7VBYI1#GM5<QS<AA7%N<&LBZ
MC*UULUOG/%9%U8[B>*UC(X,13?0YMLYJ2.-FK2.FDMTJ[::6>.*TYD>5[&4F
M9,-BTA'%:]GH9?\ AK;L='''%=%8Z6J 9%8RJ6.JGA6<W#X;+ ?+5F/PP?[E
M=M;VL8QP*OPV<9[5SNJ=L<.S@E\,$?PTR3PYM!^6O2UT]".E07.FKMZ5+JFZ
MPYY7/HI4_=IMOH^6'%=S?:<H)XJE%:JC4*K<VCARAI^@A@/EK=M=#"X^6K=F
M40"KOVI%6CG-O9<I673TC7I4-Q"B@U)<Z@J@X-9-UJ&X\&H=Q62(+V%6SQ7.
M:C9]>*WFG\S/-0S6XD'2JBV<5:-S@[RU*L>*S^4:NSOM,W9P*Y^[TTJQXKKC
M*YYTHN)02X(J3[0<4QK4JU*+=F'2M+$*3'I.<UHV<YW"J*VK5;MXBK4[&D9M
M,W[68E14\C;JIVB]*N[3BN>2/=I5KQ*CQ[CTH6'':K*I3V4 5#+M<A4[:D\V
MHGZ\4G-0:$5P]9-P>36K,I(-95T-M;0.&LF1PMAJUK63BL#S=K5>M+CWK26J
M,*4[,WU8'%29Q5."3<!4['"USM'K0EI<2:3"UEW4E69G/K6=<-5Q1RUJA5FD
M]ZK-+2S-51WKH1Y%25B222JLC4K-FHVJTCCG*Z(9*CW&GN::JEJL\Z7O,DAY
M85L64.[%4K.U+L.*ZC3=-)QQ64V>IA:+DQ+># Z5;5#6I%I9V]*5M/*]JY7,
M^DC3Y49GET>76@UOMJ!XZGF-'$J%*:T.ZK7ET]8ZKF,G$H_9CZ4X6^.U:"QB
MG&(4N8<:9FM'47E_-6DT-1F&GS#=-A9_+6@6W)5*./;5ZW7=6D9:@XNQC:A;
M%LFL">,QL:[JYL]T9XKE]4L]K'BO5I2L>-B*3O<I6LV"*W+6X&T5S:J4:K<=
MP5QS7>FFCDC&QTANE9>M4KE@V:S?MA]:/M.[O63IW.E3021Y:G1+M:F>9FI$
M:DJ:129<C-2[O>JT;5,.:LZHDJMFI(UJ-%-3)5(T1,N*&;'2F[N*C:2ME+0T
MN,D:FH<4CMQ4+28K%[F<G8U(9@JBFS7&:S1<^]'G;J9'M"ZK;FJ];Q[JHVJ[
ML5N6</RBIL==)W!(]HJ*X;:#5Z10HK)OGQFHEH=4I<J,Z[FZUGO-S4ERY)-4
MI":YV>74GJ2M-P:K2R4K$XJO)WJT<4I$;2TJR\]:@DIBR8JTF<_.:,=QMJQ'
M>>]8YFJ6&0L15[%1JZFR+DMWJ&;<XHMXRV*N+!FN>I,Z?>DC GM78TR'3W+#
MBNH33P_:K46EJ,<5C&IJ9K"2F[F'9Z>>,BM)+4+VK2%J(QTJ.1<54ZNAV0PW
M(9D\84<5FW"GFMF5-V:JR6A;M7!\3*E'0Q,$4]6-79;0KGBJK1[>U4XV.7E:
M ,:D63%18HYJ!W+:258CDK.5C4RRXIFD9EXR"J\DP&:KR3X%4IKKWK:*"596
M+<ER/6JS7&>]4)+@^M,68UH<,JQ9EDJE,V:>9,U$W-6MCEG+F*\@J+<:M.N:
MB\NDI:G#*+N2VTA!%;MC=;<<U@QKMJ[#)MQ6RD=%*Z.ICO=R]:4S;JQ89CQ5
MQ9N*QFSV:<[(O>94,CBJ[W&WO5=[KK7,:RJ7))35=J/.W4Y1FJYC#<2-:MPU
M$JU+'6;+CH6T7BB1:?$.*=(G%0=MKHH2K562.KLB[:AV;JVBSAG$IK'S6E96
MY..*+>S+,.*W+*QV@<5U05RZ--MDUC#M K0)55J';Y:U7DF/K6UK'L1M%#+P
M@YKG]0C# UKS,6K.NHRU7$\O$0YCDKZW^8\5!;VIWCBM^:SW-THM['#=*KE/
M!>']XN:-"5Q76VC[4%8=C"$ K5C;:M0]#Z+"7@K%J67WJ-)1NZU7D<GO38V.
M:BYZBF:T4GR]:SM6?Y35J#.*AOH#(IXKKCJCFKZQ.%U*0^8:J0DLPK>O]-)8
M\52AL2K#BFD[GS<XOF+-C;E\5T%KII91Q5+380I&:Z[3X5*BF]#T:%,R?[/*
M=J?"&B:ND:S5EZ5FW5GLSBH/6C"R);.Z/&:T))!)'7/K(8VJ\EUN7K6L2)Q,
M3Q!&"&KA;V/]X:[S5_G4UQU]#\QIGBUHZF7MIC)5AABHC5H\V<4RL69>E21W
M3KWI63-($&:I2./V*N3K<LW>IH6+8JLJ\U:A%1([:<4C4M.U:UN*R+4XK4@>
MIV/8HF@F!3STJ%)*>3Q6+/5C+08U-I'>H_,H,9,F5:>%J))*?NJ6RHV&3**9
M&OS4]S35;!K2#./%1O$N*ORU5NHNM3"8 56N+@8/->E#8_-LPI^\S-FCPU-C
MZTL\P]:A689K92/GU$V+7'%:MO(%ZUS4=Z(\<T\ZTL?\55S&T8G81W@C'7%2
MKJZK_%7!R>(!_>_6JK>(/]JCF-;'J$&N*/XJ;>:^%0_-7F:>(B/XJANO$19?
MO4<VAM32ZG5:AXB^8_-5.'6?,?[U<'<ZP68\U/I^IGS!S6?,=DE&QZQIESYF
M.:W8\%17":'J0;;S78V=P)%'-5<\^<4RWCYJ>D&[M3H8MYK1AM]O6@Y?9-E)
M=-W]J/[)QVK8CVKUJ3>A%,J.'E)F1%8^615Z%A#BDGF5>]95UJ 4G!J.8^BP
MF ;6QU^FL)V"]:[_ ,/>%#J&T[,YKR_PC=&XND'7FOJ;X6Z*MTL1*T*1Q9E1
M=&)3T'X9[MA\K]*]1\._#U(8US'^E>@:)X9BCA1BH_*NBAL8H5 "T.1^?U*C
MYCPOQWX1CALY,1]O2OD+XH:'Y-Q+A<<U^@WC;2A<V[X':OE+XI^#V9IFV?I3
MB=V&JGR+<6YBD/%-5JZ;Q1I)LIG^7%<EYA$F*T/6YBWN.*CW$TY%+XK6T_2'
MN6'RT!S&2J,>U6(XF]*[?3_!,DR@B,_E5V;P/)"N?+/Y4#4CS_RSW%&VN@U+
M17M<Y6L&7Y'Q07>Y+'#NK2M;8<<5G02UIV]P!3+L;%G"%Q6M#",5BVUT,BM:
M"Z&VF.PZ=1'63=70C[U<O[KY3S7)ZG?$,>:!%^;4!ZU7:[#=^]<[-J!W=:?#
M?;N] 7-OS2S=:UM-8\<USMO.&85T&FR+Q18=SI;64JHYI\UZ5'6J\+!E&*9.
MI(H&FAXU)MW6M;3=2.X<US3(5:KMG(5IE71Z-I.N&-E^:O5/!OB0ET&ZOGZS
MNF#"O2O!5P[2)6$SS,0KGU3X7U;SHTYKM(9/,45Y7X)9C&F:]-L?N+]*S/#J
M1L7=M*.***#G%I,BC--H *5:2G+0 M)D49%-SB@0[;44E2;J:_S4,:9AZTQ6
M%OI7AOQ"OGC63!KWG5K<O"U>*^/]':59.*:9VTGJ?-GB;5I?/?D]:P(]0E9N
MIKK_ !/H++,Y*URKV?DL<BM5J>W3M8N6]Z^WDU))>>IK.\X1U4N;P<\U1T(T
MVU$+WJE=:T%'WJQKB\/.#6/>W3G/-4:6-'4-<Z_-7-:AK!;/S52O[IN:P;N[
M//-,YY%J\ORS'FLZ2XW=ZKR3ECUJ/?4W+B]"QOI5YJ%6YJQ%1N42PQ\BM.U^
M7%4H15V$9Q3V&:,;<42%J2W7-:$5F9.U!15M%8M7264&Y1Q4%EI9W#BMVWL_
M+4<4(1GW%F"O2LB[LPN>*Z.ZD""N?OKE>:&@,&ZB"UD73[:U+Z<'-85Y)2 H
MSW!R>:JM<'/6EGJO@TC-DZS&K4;9JFBFK,:XQ0,LU%(.*?NQ4;-F@"I(G6F*
MG-667.:B8;30!)%3Y3Q44;4LAXH S[I^M4'EQ5J\SS6=,QIH:)EN]N.:M1:C
MTYK!FF*U&MT0>M '6)>!N].W>97/07AP.:U+2Z#8YI :$=MN(XK1M;,\<4EB
MHDQ706=F, TD EC9].*W+>S&!Q4-O$$K1MV'%,HEMK$<<5N6=FH4<50@8 5;
M%\(QUIH"W+:IMZ51DLE/:DDU0>M1#4%/>J ;+9A0>*RKR';6I)?*5/-9-Y=*
MV>:D#%OEK"O&P36W>2!LU@7HZTA,SYI>:;')S22*=U+'&:"31M).:UXIOEK%
MA&W%6Q<;5ZTP)[J7WK+DF^:GW%UGO6=+-2 T([CWJW#<>]8*W%6([@^M &\M
MT/6D-V/6L@7.>](UQ5!<U&N0>]1235G+-FIE?<*D=Q[3$$T+=,.],VYI/+JB
M66DNV]:D^T,W>JR+[5*%I"'&0M3U8TU4IVW%/<+DT<A%78;G;WK.Z4]6J0-N
M&]/K4CWA;O6.DU3+)DU1HBT\Q;-"M42\U+'BD,MV_P!ZM[30=PK$M5^85TNE
MPYQ3L!T6FY&VNST.0JRURMC'M KHM)DVLM,1Z]X2NCN3FO:/"\Q9%[UX/X1E
MW.E>Y^$?F1*QF>3B3T&U_P!6*D:FVHQ$*>]9'B,;3U:HZ<.E A]#=*%Z4-TH
M ;3Z93Z "DS2TUJ %W4M-6G4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?>N0N)&:0G/>OFZE5U'<_6\#EU/"P5T=*-6,[<MFGR2>8E<Y;2E>];-M)N4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ5F=YXK-\C;U%=OJFGCDXKF+V'R\U:B>+5C9F5-\IJ)9OFI+F3YC57S/FIG
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MJ34@(T@C0DUY;\2=03[-+SV-=CK6L"VC;YJ\,^(WB8/'(-WK51.VA3;9\_\
MQ,N1)<2X->,Z@NYVKTKQM??:)G.>]>=7:Y+5L>_3CRHPV^62MK2?F9:R)E_>
M5J:/GS%I'2CT?P_&/EKV'P.P61*\?T!ONUZQX/8JZ4NARUMCZ3\%W \I.:]"
MADW1BO*/!DY")7IMB^Z,5EU/G:T=2ZH^:IEIB+4E#.5(****104444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %)NHS3&H 7=3LU&!DT\<#
M-, ;IFO*OB9JWV.WE(;%>D:AJ"V\+Y..*^=?C)XC AF ?U[UQXBKRQL>MEN&
M=:NM#YY^*/C%C-*H?U[U\_\ B#5'NI'.<\UUOQ#UAIKR3YNYKSR23S<YKY&O
M-RD?T1EF%C0H)V,B:9EDS3H=296 S27<?S&JD<#-(*(6MJ98JH^:R.MTNZ,V
M 3726^FBX3.*Y;182I6N[TMU5!FG*2(I4/:;F=-H2KSMJL]N+4Y'%=/=7"!#
M7*ZQ>*N>:PZG7]2BMQW]NO;<!L5GWWBB9U(WG\ZP+S4/F/-9TEUYAZUNF[$>
MSITR[>:I),QR2:HR7#-3HU\RK,=D7[5#9C.KT1CW!)!K'?>LV<5V;:07'2JD
MV@G.=M7&:1PU(RJ(V? _B!["1/FQBO7[?XAR+9[?-[>M>#06[6;9 Q5Y=9>-
M<%JW]L^AQ1R]2ES21V7BCQA/<R-B0G\:XFX\07#,?G-07&H>=U-49)%-9<SD
M>Q&G3A&UB>;6IFZL:KMJ+MU-5G8&HF:GRF$G%;%S[26[TQYO>JGFTOF9JK$^
MT8LLAJLTAR:G*[J;]G+=JK8SE=D*S'-6(Y3430%:%R&H,XMFC!)TJ_"U9,+5
M?CDQ6;5SMIR+_F"HFD JNTU5Y)CZTN4UE4+XE&:LPR"L+[00:M07!J7$SC+4
MZ"%QQ6A"<XK#M9"<5KV[?+7/+0]:A9EX<+5:>2GM)\M4+B;KS415SLG9(@N)
M.35-FI\TE5F:NE1/-G+4>IYJQ#<&,BJ>ZFM)BGRD*=CJ=-ON1S746,GG**\\
ML;@JPKK](O.F36;C8Z8^\C:NK'SEZ5SFJ>']V3MKLK659%&:M2V*31]*%*QG
M.G<\9OM(,#'Y:RY%,?%>GZYI PQ K@M4L3&YXK:,KGF5(<IE#YJFABW$4D<)
MW8K3L[7<1Q52E8=-<S)+6W..E2S+M4UHPVFU:KWD>U37/>[/6Y.6)@W$A5C4
M2R;J=>?>-0P@YYK=;'G2=V7K=2U:<*LJU5LU'%:D8&VHOJ7RM*Y4N VVL*^A
M9LUU31AA6?=6H;-:1.6?-+0XR6U9FZ5-:V/S#(K9FM0#TIL<:K5\QA&AK=D]
MC;!<<5N6^U5K(CD"XJ=;K /-<\M3V*/+!&G-. IK-N+CWJ&6ZZ\U2DN/>HC$
MTJ5B^LU68YP*Q1<8[TOVW'>M.4P5;E-J2X&WK6==7'7FJ;:A[U6ENMW>KC$R
MJ8A,AO9SS6/),=QK0F_>52DMSS6R1XE>3D/M;PJW6MNSU#IS7-;"AJ>"X*D4
MY*Z.2G5E"1W-K>[@.:OK*66N5TVX+8KI;,>8HKCE&Q]#0K.:$F!.:I21FMO[
M+N6H)+/VJ%([7!F-M-2H2M738D]J8]J5K3F1"T*LLV%JA-<'<:N7"%0:R9\Y
M-7$RJ2+,5T0PYJ]#='CFL-6(-789.E4XD4Y&FTY854D;=2B3BHW85*1M)W&[
MJ?'US41(J2-AQ39DMS9L<#%:J3!5ZU@03;:L->87K7+*-V=<*BB7Y[SKS5&:
MXSGFJ,UU[U";@MWJXP&ZMRVUQBH'N">]0;BU.CA+U?*D8.38UI"U1/DBKZV9
M]*5K,U2DC-QDS(D4]:J2)6Z]G562R]JM2,)19C[#4\,&[M5P61STJU#:8QQ3
MYB8TVR&WM/:M&&WVBI(H0M3=!6,F=L:?*1XVTQFI9&JNS5"-!S-FHF-+N]ZC
MD;;6AC-D%U)\IKGM0;)-:UU/P:P[R3<QK:"/#Q4KF;(/FIT8H;[U/05TGB<M
MV2JO%31K3(ZGC%9LZX01>LVVD5T.GN>*Y^V7D5N6)QBLVD>MA[IG3V,@P.:T
M1,-M8-O-M JVMS[UQR/KL/426I->-N!K#NV/-:<TVY:Q[R0<TXHG$2C8IM(=
MW6M&PO"C#FLAI!D\U)%-MQ6]CQ^;4[O3K[=@9K5XD3-<5IMV0PYKI[6\R@KG
MD=4=2.\CVDU5CDV'K5F[F#9YK,DEQFLSLC%(TUOMHZT&^W=ZP)KPK59=2PW6
MM(H4ZD8HZ&XF##.:QKN<*QYJ-M1W+UK(OK[D\UTQ1XM>HF:*W2U86\55ZURW
MVX[NM._M XZT^4PA5L='+?C'6J$U][UC27Y/>H6NRW>G8OVYL?;#ZU#)=D]Z
MSA<<5&]S[T^4EURZTV[O4T$G(YK&^U59ANNE/E,U65SHH9L**F2ZVMUK'BN,
M@<U*LW-9<IZ$*^AU=AJ!7'-:+ZCE>M<E;7!7O5IKWY>M9N)VQK:&A=7W/6J1
MO#NZUGS71]:@^T&CE,Y5M3?AO,]ZOPS!N]<Q!<\]:U+6X]Z6Q<*G,=+;QA\5
MHPV*MVK%L[G&.:WK*Z&!S4.9U1BFKE6^TL;#@5QVKZ<5SQ7I$A61*Y[5K(,#
MQ3IO4Y:T+H\YDM2K=*I75OP>*ZJ\L<,>*SI;'=GBO:I5.4^>K4&SC[BW*GI4
M/*5T]UIG!XK'N;(J3Q7=&JF>7.C*)3CE.:N0W&WO5-HBE0M,4-=5U8YXU'!G
M10W?O5I+H>M<O'?;<<U:CU#WKEG(]&GBCHOM(QUJ)IMW>LE;S=WJW:L9&KDE
M,[HU?:;%Z.W\PYK1MK,+@XI+&'(&:T2H5:4979V4Z5M05O+%037&>]1S38S5
M9I"U:RE8Z7+HA[2;JGAZU57FK<-1&5QPW+\/W:=)R*CB-28S3G>QZ$=44Y%J
M+RZNLE1,O6N-.S,Y0*DB_*:RKQ>M;$QX-9=U@@UZ%.5SQ\4K(QF'S4]6VBB?
M"YJI)/MS7<MCYV53E9)/-6;<7/7FB>XR#S6;-(>:RD<\ZS'R2[C4UK%O8<53
MC^9JVM.AY%<TI6)I)SD:>GV^,<5M0_**JVL>U1Q5AFVUYU25SZG#QY4BQO\
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MR^6&,\UP?BCQ(L4;#?\ K21O"#DS \::]Y:2 -7SSXXUYI&<;J[7QGXF\SS
M&KQ3Q-J1F9CFM4>W0I\IR.NW1ED;FN8G.<UJ:E-ECS6'-+R>:L]+H5WBW-6C
MIL>V05G+,,]:NV=R%<4 CT7P_P E17KO@V'<R5XQX:N@TB<U[IX!02-'6;,*
MNQ[=X/MCMCXKTW3X]L8KC/!]J/+3BN_@C"QBLV?.5GJ2CI2T@XHI',+1124
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3W#*RFJBC.<G8XN]M]K'BJ94+6YJ2C)K NIMN<5J>?)ZE>X>J,CFI9)-QZU
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M6FK3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBFM0 ZBFCK3J "BBB@ HI&IN
M: 'T4S-/H **** "BD:FYH ?1110 4444 %%%% !1110 4444 %%%% !112-
M0 M%,S3Z "BBB@ HHHH **** "BBB@ HI#TIN: 'T4@Z4M !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !12-24 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5A\U/4TQCS3EJF>$B2BBBD4%%%% !1110 F,T;:6B@!-M+110 4UJ7=2&@!
MO-*12"E)H$-S2J:1J9NH!(E8!E(-<WKVB)>1M\N:Z)6S3FC5A@B@N,K'SGXV
M\ B82$1_I7S]XV\$M;LYV8_"ONS7M%CGC;Y<\5X5\1O"Z;)"$_2J3/1HU^A\
M4ZSI;6LC<5B!BCUZGXXT80S286O.)K,B4\59[E.7,B..0U;AF([U#]G*]J<B
M[:M&[T->SO#&0<UI_P!L,L?WJYQ&VTDUP54\U1&Y/JFK.^?FK(6Z=I*BN)BS
M'FFV_+4"Y38AN#CK4ZWA7O5%!\M1R,13&M#5^W9[TUI]W>LGSC4D=Q2L/<O1
MKND%>C>!KA898\^M>:V\GS UU6AZE]G93G%%C*<;H^O_ (>:Y%''&"PKV;3=
M>A:(?,*^+O#'CC['L_>8_&O1=-^*85 /-_6H<3Q*U-MGT9J?B&*.,X?]:\^\
M1>+UC5@'_6O.[SXE">,@2_K7&:[XR,RM^\_6L^4THX=LO>-_%7G!QOS^->&^
M)-0\Z1^:V_$&NM,S?-7!ZE=&0GFM$>K&GR(J33\FJ<LF<TR27D\U&OS4&B(G
MY:KMB"K"F);[NU7[6WQB@&=1H<GW:[;3VW*.:X#3Y/)Q71V6L", 9ID\IU,D
M.Y:I/;LK9%01:ZK <U8COEE[T&CAH:&FS/!(O->K^"=6?<@S7EEC&)&%>F>"
M[,^8E)GBXA'T'X5N#-&F?2NIKEO",>V%/I74U@>.]Q.YJI=3"->M32R!<U@Z
MK?!%;F@N,;L2[U@0D\U@ZGXE 0C=6%KFL;2V&KB=4UYOF^:J1W4Z%RYXJUOS
MD?#5XIXMD:5GYKM-4U,S!N:XO64,V[BM#TZ=$\OU6-O,/UK,7<IKKM2TXLQX
MK"FL=IZ5:.V,>4BMFY%7RH9*I1Q[&JY&V15EW,/5+7=GBN<FL3N/%=W-;B7M
M51M(#=JD@XU;,@<BH+BW !XKKY]+"#I6'J%OY>>*D9R=W;CFLR6(+6W>C#&L
M>XR6IB*,PQ5-JNS*351HSFD2-44Y5YZ4*IJ5$YH L6Z5=51MJ"W7%63C;3$5
MY6"U2FF J>Z;K63<2'-($222!JKR885"9#4BM3+L5+B#=GBL^:SZG%;XC#4U
MK4-VH YIK/VJ,VI]*Z*2S'I4#68]*0C!,)%1M&:VI+7':JS6WM029JJ0U7+=
MBM/^RT]8"M [%V&;Y:=)-\M5ERM,DD-,HAN&SFLZ53FKKG=4+1YI$E3FG+FI
M/*/I2K'0 B,16E:SE6JDL-3QH5:@#IM/N>G-;T,FY:Y"P8@BNCM9#M%44T6;
MAAS69,WS5=F;BL^8?-4DBQMR*N(W%4(^#5E9* )V:D62HM]*O- %Z&4U?@F-
M9<?%6XVH&:\-P<BKT=R?6L2*3I5V&3I5(M&O'.:L1W!]:SXC4ZMB@#2CG/K5
MF.3-9D+Y-7K>D#-"-JMV\A5A5.%,U=BB-"$;VGW^S S726UX)8ZXNW4JU=%I
MK?*,FJ$0:_"&C)Q7E'B2+;(V!BO7]44-":\P\46V6;B@$<2DFV3\:VM-D#,.
M:Q)HS'(>*N:;/MD&:"CO]-C#**UFM=R]*Q-#N RKS75VZK(HH$8<UEUXIUO:
M$=JVY+4'M1'; =J N16UK@=*EDA [5>BAPM0W2A:";BZ?A9%KU#P7)&)$S7D
M<=QY<G6NU\+:OY<B?-BHD-PNCZH\%S1>6G2O3;.1&C&*^>_!GB'Y4&ZO8-$U
M831K\U9,\+$4SKUP11MJ"UDWJ#5FH/*:L-VTE/INV@ 6G4@&*6@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@WWJ<M)WIPH.:X^BBB@8E&10U-H ?1110 4444 %%%% #6ZTE/HH 9S13Z*
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M/GJL>5DU%%-;K2,!U%-6G4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 -:DIV,T;: %HHHH 1NE1M4C4PB@1'01BG 4.O%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5XC9_&2%EQYP_.I;KXK1R*<2_K3Y0YCV'^T8]V-PJQ'.D@X85\]W'Q56-O\
M6_K6AI'Q:CFD"^=^M'*"D>[Y'K2;JY'P_P"*$U15P^<UUB?,@-06.W4NX5%T
M:GYI /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 1J:U*QIC4 "T[&X4RI%^[0!4NOW:DURFL>(5L]WS8Q71Z]-Y-
MLQ]J^?/B/XK-F9 'Q^-2V>M@,(\1.QU=]\1UAD(\S]:O:-\0$N& \S]:^2=9
M\>R&Z;$G?UK4\._$!XG7,GZUGS'W_P#J[S4KV/K^\\0)/:DANWK7B_Q&U9O+
MDVMZU2TOX@"XA"F3/'K6/XHOA?PL<YXIR=T>=ALMEA:RNCPWQ=JDWVA^3UK
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MX/-9%U-YF:V@F<5:2:,:Y7YC5=(SNK1>'?FG1VG/2NN,3QI4^9A9P^U;%O&
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MVT#I4V"YY[X5\93P7R*SGK7T3X9\7;M.4E_X:^4EB6VU3Y3CFO6?#^I2+IH
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MYK?4[ES7FW@_4#-&O->C6K;H@:R9\_66HYJ:*>PI%%!S(5>U/IJTZD4%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2,M1-\M,:Z'K5>2Z'K5<IC*JB_'+M(K1MYO>N:^UX/6KMM?>]*4!1K*YT32
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MO.,4JU5V+Z_=%+12-6A\R&ZEIE*M [#J1J6B@0RG4M% !1110 4444 %%%%
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M^Z\LCFNMTG4?NC-4(ZM;<-6SI-GOD Q6-97 DQS78>&X!),GUJ&#E9'>>#]
M$NP[:]I\,^'UC1/EKB_!-B-J<5[!I%N%C7BLI'BXB1?L[188QQ5J@<#%#5!X
M[8C4TK2T[@T"&CM3FZ4M% QE/HHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6.=*[*OASX/Q+&I\K]*[/3_AW%9X/ECCVKM+ *+9=HQ5FL6[G2HZ&+9Z2MF
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&I:2@!N:=1MI: "D:EIK4
M&329HHJ0%W4;J2BJ%J!- IK-437 3J:3=BDBSD4QIE7J:SI]6CCSEA6#JGB>
M*%3\^*YY5E$T5-LZPWD8XS2K<HW0UY5-XV7S2!)W]:W]#\1"Z(^;-91KW93I
M-'<AMU+S4%K,)$!J?=77&29BU87 I:*1JL0QJ%H-*JT .I:** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQB6****DT"BBDR* %HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M('6H=.XEB%$Z!M0'K4]O>!B.:XYM2.>M7['4#N'-)TM#IIXA29WEFP;%:B8
MKF=-O,@<UM+=#;UKGEH>S2M)%B22J^X9J"6Z]ZJ2WFWG-9:FL[)&M'(O%3>6
ML@KG/[2VMUK0M=2W8R:?*T>=*Q9N+,8/%9=S#MK5DO RUGW$@;---F5E<HH/
MFJ_$PVU3W#-+]HVBM#=)6'7C#!K$N(]S&K\TV[-5=NYJM,Y9PYF5%M=U2K8Y
M[5=AAJXMN,=*:J6,?JKD<_-I_'2J,UCC/%=3/ ,=*S+B$;CQ6L:ER'@['.M:
M>U(+7VK6:#VI1;^U:\^@HX=(S4M\8JQ'$.*MM#@5'C::A/4N5)(GCMPR]*I7
MUF,'BM&%ZCNB&!K3GL<LJ*9REQ:G<>*:MN16O-"&;I35MA2YCG^KF<JE:M0R
M%:G:W]J;Y.*5S>%-Q'^<:A>0U86&AK;CI2N:N,F46D-,\[WJ::W*U492M,XI
MN423SJ435"M+31FILU+,[F%;5O#E:P=//S"NEM/NTI(]O"^\1R0XJN5 J_-T
MJA*X%9'5.-ARL*<7%4FN,4PW%,RYTBU)(*K22"HFFJ"2:G8QE,F+"DQEJJ^;
M4\))Q3(4KE^V7FM:#&VLRWJ\C[5K*1VTRYD4NX52:;!IRS9[UG8ZHR'3_-FJ
M$T18UH?>H\D-VJEH1./,9D=N=U6EM_EJY';@5/Y'%*3,'1,"ZMNO%9<EL=W2
MNJN+<'/%9\EH,]*N$CFE09B)"16A: @BIOL@':I88-O:K;,O9-%J-OEJC?38
M!J[Y9VUF7T9YJ43.\49-Q<')YJE)(6JU+;DD\5']E-;JQY\N:93VEJ55JY]E
MQVIIAVT&:IM:D:\8J0-1MHVTBM4+YF*<)O>HV0TW8:92DRSYM)OS42J:?B@O
MF;'J>:E0U&BU,JTC:*8_?BF-)0RFF$4BY-H3S*EBD^85$J&GK&:9E[2QO:;=
M!2.:W$U!=@YKCH9#'STJ?^T"%QFN:5.[/4H8_P!G&QJ:G>!L\US%Y+DFK-Q=
MF3O6=,2U:PC8\_$UO:NXQ'^85L6+YQS6*JX85J63[<5MRGGTYN,CH[?[HS4S
M8Q5"&Z"J.:D:Z![UDXGOT:Z:L),F:I/'S5WS PJ*11BIV+EKJ,ADV$5IV]X.
M.:Q)&*FF+=%3UI-7%&M[,ZA;@-WIDC!JQ8;[WJY'=;L<U/)8ZXUU)#YEJA,M
M79)-PJK+0C*=I&;*N,U#NP:MS+UJI)P:V1PR)$DQ4ZS5G;]M!F-.US-5.4TC
M,*K32#FJOV@^M,:;-%B)UKC9FYJJQYJ1VS41ZTSADQK-3&:E8&HR#5(Y9MD4
MC579N:FD0U RG-;(X9MW!3S5RW'2JD:G-7[=.E3(VHW9IV:UJP*-HK,M_EQ6
MA#)BL&?0T=$756GXQ5=9J=YU9G=%I%I6"]Z=YPJBTU1M/4\HW4-+S0:>K UD
MK<^]3QW7O3L-54:J 5,L8Q6='=<]:MQW QUJ>4Z(R4B5E"U5FF$=.GN0%/-8
M6H7VW.#5QB95JRIHT'U)5[TT:HO]ZN2N-1;/6HX]08]ZW]D>#+,7S61VG]H*
MW>G"<-7+0WC,1S6O9REL5G*-CNI8IS->-JD:;:M00Y*TDV:R.[FT(+BZ//-5
M5N26IMQGFHXE):K.1W;-VPDR1FM^WVLM<Q:,5Q6W:7'%3U.F*T)=00;37'ZH
MVTFNKO)LH:X[6&^8UV4V>=B'RF4TOS4]6S5,M\U3*U=J5T>5[34LK3UJ!7IP
MDK'E-XS1:4U8C[5222K,<E9.)UP:+L8JQ'56.45820<5'*=<;%I:F6JRO4R-
M4\IVQDBR$S4,T=2+-44LF:IZ%RLT4I82V:J361.>*UHU#&K!M@R]*A2//G2N
M<C-:E6/%.@RK"MJ\M!SQ67+'Y>:+7.7DY&7;>Z"CDUH1WP]:YF2X*=Z([X@]
M:EQ-HXKET.QCN0V.:N1$&N5L[TL1S6]:3%@*SY3UZ%=2-1<4,14/F<5&\U5R
MG:ZB)MPJ.3O4'VCWI1)N[T<IG[1,AF%5)*T&7=566*HL8314:F;C4K)S496F
M<K$]*&%+BG8XK2+,64YEZU39>:T95JJT>35W,91(43<:N0P^U,BAK0MX:RE)
MFU*G<2.$TLD>!5Q4&*CGQBB";9URBHHQ;L8S6/<#YJV;TCFLB;EJ]*GHCP,1
M:X^QCRPKJ=.7Y17-V(^85U6GXVBM[G1@TKEF1?EK/FC)S6HXR*K-#NKEE>Y[
M4US(QY(":B^RGTK;^R9[4OV/VJXLY'1N8\=K@U=@BVXJU]FQVIZQ;:MJY4:7
M*26_%7HV%9ADVT+>8/6ERG;&JHFNS+BJEQ(*K_:MPZU%)(6K2.A,ZO-L5[F3
M.:SI6.:T)(R:JRP]:V3/,J79G32%:K-<[6ZU8NEQFLJ4G=2DSRJDG%FI#>'/
M6M&"ZSWKG(7.ZM*W<\5*+IU&;0FW4QU+4RW&[%:$-ONHDCU(7F9ZVI8U:AM,
M8XK0CM1Z4]HP@K*QU1HVU*Z1*@YIV]5J"XFVUGR73>M:IF<IJ)KB1:D21:Q$
MN&-3QW!HO8<:R-5Y1BL^ZD&#4+W+55FF+5K=6,:E2Y5NSG-9%PI)-:<V6JI)
M'FN><CR:D>8S"IJ6&IS :582M<,G=F4:=BS;MR*U[68#O6(AVXJS'<;3UI1T
M.ZG4Y3I(9@<<U;B85SD-YTYK1AN_>E)<QZE.LF;:,*<:H1W&:LI+FL' ].%1
M,L*.E/ID;5)[UBXG4M1*7RP:2G@U!7*0-#2K'MJ?;2-BNF+T,W314F.W-9\T
MAJ_=&J#)N-1*1Q5%J)&QJ["Q6HH8*E;]V*N*N3\*N75NMJ]:SM0OOE/-5;B]
MV=ZQKN^+9YKIC$Y*N(LK#+ZYW,>:H&8^M)-)O-0[<U<CQ9U&V3K,:MP2DU0C
MCJ_;1]*YY,VIW9JVC$XK7MSTK,LX^!6M;QUESL][#Q+.?EJI<59[5!(I:DFV
M=D[6,N9:@\NM&2'.>*B,!J9)GGR@5TCJS'#GM3HXNE7;:')%9WLS:%.XR&W/
M'%7HTVK5J&U&WI4=QB-37H4Y:&DJ5D86K+N!KFS;EI.E=)?.';%16>G^<XP*
MWY>9GE3H-RNR/3;8@#BMJ% H%:.G^'V91A:NR>&YE7.PUU1CH=M.=.GN9\+*
M*L17024?6FMI<L75338].D>4<&J46>Y3K4^2]SV7X57V;J'GO7VY\+Y3):Q?
M05\1_"G1Y5NH3M/6OM[X7VYBM8LCL*]"E='XMQ54C.3L>HD?NQ1'2M]P41]*
MW9^6VT)J***1(4RGTF!0 BTZDQ2T %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 1/4634[+46VD4 R:BGM_.&,585:
MDVTTR3F-0\/)<@Y7]*YC4? <<V[]V/RKTUE&*B>%6[55S2,W$\*U;X;HV[$?
MZ5YYXF^'?DJQ$?Z5]7S:7',.@KD_%GAB-K9B$[>E',>C2Q7+H?#OBCPX;5G^
M7'X5YMJUIM9N*^E_B5HBV[2X7'6OGSQ)&(Y'X[UT+8]>G/G. U"W&XXK+:W^
M:MR].YC5+R]U)F]BHD''2G&&KBPTDD?RU2&C.D&VJ<S]:OW$9Q5"6,YJ60R#
M)+5*L>ZB./FK<,/2D(BCM]QZ5;BL_:K$,'3BM&&W'I5%)&:MC[58AL>1Q6FM
MN/2K4-IGM18LKVNG[L<5HII)9>E:%E9].*W;:S7N*"3D)-#8_P -0-H#>GZ5
MZ&MBC+TIS:4C+TH \SDTDQ]JIRVIC/2O1K[1Q@X6N;O]**D\4P1RKIBJLBYK
M:GLRO:J$T&VE<9FM'3-N*MR+MJO)B@1&QP*KL].FDJG))\U2)EE9.:M025EK
M)S5VW;D4$HV;?YL5-)!N6J]HW2M.,!E%-&AA7%B3VJN+%E/2NI^S*U-:S7TJ
MB;7.<%N5[4\+MK2N(0M4)!@TAK0%[4_%,7M4JU($3+3:G9:@D^6@!N_%*):K
MR/30_2G8AFC#)NP*T;5=U9-JI8BNBTVT9\<4AIEVVAXJ:0;5J];V15<XJO?1
M[%- 7,.\FVYK%NILYJ[J+')K&FD):F.Y#)\U5FCJUUH*#%!)2^[3)).M2S?+
MFLZ:7DTV LDE-4\U"7S4D?6I LQU86HHEJ=10 QN!5>1L5-(W%4YFH 8TE-0
MEF%,'S-BM'3[(S..* +-A:M(PXKK-+TIVV\4_0]#W;?EKOM)T-54?+5%&5I^
MG&/'%;"KY:5K?V:(UZ5GWR>6IIC,B^N,*:P+J;)-7M2F(S6#/<?-UJ0)Q\QI
MS1Y6JT,V:N*=RT@*%PFW-5/,VFM*YCRIK*N%*YJFP+,<V:2;YA5)9,&IUEW5
M*$9EY;YSQ6/<1[<UTEPNZL:\CZTQ,PYGVU1DFYJ]=1GFL]HSFA%(C+$T G-3
M+#GM3Q;T,&)$QS5^W8\57C@-6HH\4$EV/E:)%I(^*=(U(12D&#313Y:BW4 2
MJU6(STJJ@W5<A3I0(D7I2^;BE9=HJK(VV@9:66IHFW&LU9><59AFYJT6D;EH
M!D5T%A'NQ7,V<O(KI]+D!Q2D9R=C>M8?E%7,;:9:XVBGS&E<(L@D>J<TE6&4
ML<4^/3'GZ*:+EMV,:9CVJA< ^E=M#X3FF_@/Y5,W@29E_P!6?RJ7(S59'FK(
M=W2K=F"&%=G-X#G4_P"K/Y4D'@N96_U9_*ES&JJIE;2&(9:]3\(,VY*Y;2?"
M,JLOR'\J]3\'^%G5DRAI<QC4DK'J?@<O^[KVSP_GRUKS7P?H9A6/Y:]6TFV\
MI5%0V>'B&NAKCH*6DHJ3SA:*93Z "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7U&WD&_J*M1,W*YPLVI,^N<-_%7UI\!Y6>"+)[5\1:#JAO\ 6E)YRU?;GP+
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M** "BBB@ HHHH **** "BBB@!K4E.:FT6 *?3*?0 AI :&I .: 'UF>(-O\
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MJA.N10!!;KNE%=KX=T_S&3C-<A8QYF'UKT[PC;@[,TQ'6Z-IHC4';7368$8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7@&WL[>4J@QCCBLU+4T<=#XH\(6;6^L(&'\5?;GPCO!;Z;&<]J^3%T];/7<
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M\&PV>FLP4# KY<^*5U]ANG13CFDM29Z&=KVO3ZHS*C$US)\(ZA?2%PKD5O\
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M\4:LUVS'=FO/;X%I&-:GKTX\J*0;<U:5KT%9BK\U:=GVI7.M,WK'!(KHK.,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/>H/AOIZRWB<=Z/B6^=0D_WJO?"Y@+R//K3N'4^H_ ^F+':1G':NEU35$T^
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M%\-SE9$Q7M_@B\<[*\7\(V1N'3BO>O!>CE50X]*^HR^C)23/#Q<E8]3T5BT
MSZ5HU2TN'RHL5=;[M?>P^%'S$MQGK3E%,IRM5DCZ*** "F-3Z8:8#*7-#48S
M0PL)2^92-P*JO(0:$B92L69'W"LO58/,@;Z5:60L:DGB\R$U5K%TJEF?,OQ@
MTXF&8X[5\1?$FRV74GU-?H)\7--+VTQ [&OAOXIZ:ZW,IV]S7'6/U[A^7-%6
M/$F7RV-1;]S8J]=VKJY&*33=)EN+@ *>M<"A=GVM:3IJ[8EGI,EXP"@FNW\/
M_#^>ZVGRR?PKM/AW\.I-0>/=%G/M7T_X'^#*M;HQ@_2N^%.Q\;C,VC1=KGRE
M<?#F2&W),9''I7$:YH+64A&W%??'BKX6K:VC8AQQZ5\S?$CP>;6:3"8_"LJR
MLCLRS,HXB25SQ"UCVGFK_P!U:EFL3;RD$=ZADZ5X-:HT?HE.FI1NB&2Y\NJE
MQJA7O2W*FL:\W#-<L9MG%6;CL3S:H3WID>HY/6L69RM0QW#!NM:ZL\QXAIG6
MPW(DQS5C 9:YVSNCQS6W;2;@*RE$]"C5Y@F3%9UQWK8D7*YK)O!MS6E/0RQ"
M,J;FH-F6J:4_-2PIN:M6[GEVNQT,/3BM"" T^TM=V.*UH+/VJHQN=M*E<KV]
MOR*V[.';BJ\-OM/2M*W7;BNZG&QZU*GRE^W4!14LCA:@63:*@N+CBM)2L>@M
M$.DN.:@DD#"J4L_-1_::B-0YY31)-&&S59H:E\[=3L@K6BU..=F49)#'2P7Q
MW8S1>)D5F[BKT[V9P3O$Z6.82+5.ZA#54M[O:.M3M<;JZ=XF=[D"QA6JRK8
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M2<PM%-W&C)IBN.HINZC- R1:&I%[4IYH ;3Z;MHR: %Q10*6@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** *.M#=ILOTKXO^.T;K<3,
M!W-?:FH+YEHZ^HKYR^*W@=]5:4A,YSVJHF<X\R/D_P +>)Y-)U13G&&KZ/\
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M/2O7=!<I^<+B"3JV;/S*\5>#9+"1ODQ^%<->6LD!(Q7VS\2/A?\ /(5B_2O
M/$GP]DAD<",]?2O%JX=IZ'WV78^%:*;9Y%IOF-<*,5[/\/[1I6C&*YG2O TG
MVI?W9Z^E>Y_#?P/()(_W9_*M*-%G;F.+IPIW3.^\)^$1?0I\F<UTT_PG%Q'G
MROTKT7P#X1$<,>Y.U>JVGAR!8P&45[$*>A^0XK.)4ZGNL^2KCX-[9/\ 5?I6
MKI?PBVX_=?I7T_+X6MV;[H_*IK?PW;Q?PC\JW44A/B&JXVN?/,/PG''[K]*U
M;'X6K&P)B_2O?%TFV7^"GKIL"]$JK'G5,YK3ZGFNA>!TM"OR?I7=Z;IJVT8
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MWIO@M=JY3]*['1?#*QJORUTD.EK"!Q7W.%P"Y5='.ZK.'M_ L38S&/RK5L_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$9YJD8R&K>N[7&>*S9(<,:0B"(8-:-N,XJDJ;35VW.*92-6W45M:2NZ516)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&X-95R_6D:%9F^:F,U(S?-2=: $8T^-J;MIT:\T"+L/:I&4TVWC)Q5Q;<M2
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M8Q[5Q%W;M$Q&*9UIW,R];K6!=L=U;MX#M-8-RI+4RBNDG-3JQJ)(C5A8\5(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1124 +129%+0 4444 %%)1D4 +1110 4444 %
M%%% !129%% "T44F:0"T444P"BBB@ HHHH **3-&10 M%)2T %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *3-+36H 7=2TT=:=0 4444 %%%%
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MBB@ HHHH **** "BFM24 /HIE/H **** "BBD;I0 M%,IR]* %HHHH ****
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M*** "BBB@!&IM/I* "EHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFSW%O$,9Z,*@N/$"*OWJ\9@\:%S]_P#6I;KQ6QB)W]J.4A43T'4/%Z1$_/\
MK68OC=&?&_\ 6O%O$'C!U9OGKG+?QM)YP^?O1RV-XT#ZGTWQ.DV/FS7366J+
M,!S7S;X<\7M)L^?]:]1\/:^9=OS5#(J4#U-9-W0T[WK&T^^\Q1S6M')N J#S
MY1L.I],HIF0^BF4X=*"A:*** "BBB@ HIE*M #J*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** $Q1MI:* $VTM%% !32:=32*  &EI/
MNTNZ@ VT4M% !1110 4444 %%%% !129HW4 +124M !129HW4 +129I: &MQ
M4+72+U.*2^E\J$FN!U[Q0+-F^:N2M55-79+E8[Y;R+^\*5KR-1G->11^/5+X
M\S]:NMXT5D^_^M>9+,816Y<6I'6Z]JB>6W->,>.KP3)( :W=5\3B;/SY_&O/
M_$=]YRMSFOGL3FBD[)G'B-4>/^++3SIG..]<Q9VGE7 ..]=IKQ!=ZYM0/-XK
MR95I5#X_$*TCL_#4P78*]B\'W"MLKP[1I"C+7J7A.^,;)S6-.;C/4]; KF/H
M+P]L:-:ZN,#:*\W\,ZL-JC-=Y9W0E0<U]_E]12BCZ>,;(O#O3:<O/-)7NO83
M'4NXTS)IU9H0[=2TRG+5@+112;J0!W-)(WRTO>FR=*8SG=>4M;O]*^</BI9R
M2"3 />OIK5(?,C85Y1XR\+F^W?)FO+Q,>9'GXB',CXVU#P_/<7Q^4GFO0? _
M@EY/+)CKT9?AL7NL^7W]*]%\*>!UM53*8_"O(CA7*5V>33PO-+4Q/"_@L0A2
M8_TKU70='%JB_+BKFGZ*D"CY:V[>W"*,"O:H4% ]RC04"2W7:N*<TBKU-.V[
M5KGM<U+[(C'.*]!NR.N4E%&VVH1)U85!-J\*@_,*\AUSQ]]ED8;\?C7//\30
MQQYGZUYU3%*)Y\L9&#/8]2\0)&IPU<7K7C(0AOGQ^-<'>>._.4_O/UKC->\4
M-(K8?]:\NICNQYU;'*VAUNO?$ C</,_6O/\ 5O&K3,?WGZUQVL:W)(Q^8U@M
M>/(W6O'JXJ4CY^KC92T.OG\0/,3\U4I-29R?FK$B9R*>HD+]*\^[DSB]I*3-
M-%>X88.:[CPAHTDDJ'!K \,Z6]S(F5KW+P3X8^X2GZ5Z.'H-RN>MAL.YNYUO
M@G26CC3(KTZQM_+0<5D:%I8MXUXKHU4*HK['#PY8GUE&GR1'KTHQ2*:"U=;1
MUBY%+4>ZG;J$!)VI::&HW4Q#J*3-+0 44FZC=0 M%)FC- "T4E#'%  >U(S!
M1DU!-<"/J:RK[6$B4_-652HH(<5S%ZZODB!YK!OO$"1D_-7,>(/%B0AL/^M>
M;ZUXXPYP_P"M>!6QJ3/4I89R/88_$J,V-];NFZ@)\$'-?/&D>+FGF'S_ *UZ
MYX1U W"KS54,5S,*M#D1Z(#N6L/6M%^V1MQFMNWY05,0&'/2O;5JD;,\J:OH
M?./Q!\'E5D(2OG;Q5HTD$S@+CFON+QGHZW,3X7->">*/ IN+A\1_I7SV+P,5
MJCRZV'YCYRATZ9F^Z:U;/0YF8?*:]>L?AJ2W,?Z5TUA\-@,?N_TKYR6"E*5D
M<'U1W/)='T69&7Y37KW@BQEC9,@UN67P_$>/D_2NOT'PLMJR_+BO5PN7N#39
MVT:'*SJ_#,)6),^E=-C K.TN%+>,"K[R#L:^NI6C&QZR5D&ZGAOEJ#=3U:NG
M<#*U?3Q=(1BN(U#P<LTA.S]*],*AE.:B:U1CTKFJT8S)<.8\@O?!JQQGY/TK
MSCQ3X9*[L)^E?3-YIJ2(1BN+USPJ+C=A*\+$9>I;'-4HH^5[K0)%N/NGK78^
M$="<R)E:]#NO 692?+[^E;6@^$OLTB_)C\*\NGEO+.YQQHM2-GPCH>V-"5KO
M[:U$*CC%5=%L5MXU&.E:CD5]90HJ$;'K0C9"@X%)3 U/4BNNQ88]J<!09$7O
M49N$'\5+01+1UJ-9T;O3PP;H:H+"$8H'-.I5H 3;2],4ZFL:8A'^85F:AI_G
M1MQ6AOYJ3@K@TQQDXO0\%^(OAT-'*=M?+/CS15@FD.VOM7XD>7';RGVKX\^)
MUXBS2X/K7F8B)^J\-UG*R/%]280,P%<Q?:A\QYK7UNZW.V#WKD+QRS&O!J(_
M6>9\I,UZ2>M(9BU454EJTK6WW=:P1C%RD4IU;:367<L5ZUU4E@2G2L+4;(KG
MBM%$YZR:1BF8^M/23I4,T;*W2FQDT^4\OFU+RRTC7&.]19^6H)F--1+<[(F:
M\P>M*M]\W6LR20U$LC;JNQS.LTSHX;O=CFK<>'%<_:S'BMBUFK6*.NE4<MR6
M>'Y<UDW4>TUN-AEJC/;[^U;J%RJD;[&*(RS8JU;699AQ5Z'3RS=*W-/TK..*
M.7E,(T6ROING'CBNDM;,*HXJ>ST\(H.*NB,**KF2/1I45$HR0[15612*UC%N
MH-CN%<\JAWQ5CGY&(JK(U;=W8[<\5BW492JB^84VRE-54_>J:9C4 R6K2QY\
M]R[:L<BMBW;Y161:Q\ULVZ?+5H[*+8LE49FQFM*1?EK.N%'-)LNI(B63!JU'
M+QUK/;BG+-BIYK(PC4+\DG%5)7I#-Q5::7K7E5GS,PJ2&S2#%56^8TR2:FH^
M6K.*:,XLD\G-02Q[:MAAMJI=25:;N7-*UR%<;JDW<56#_-4JMQ6AS*0R3K5<
MU/)S4 IF<@V[JD6/VS4L,><59\GBIN5&)FR_**H328K3NUPIK'N/O&J1QUI<
MNPGF9H+5$&H9ZLX^=DFZES4.ZI%H%>[)4.:E"[JACJQ&:#J@-:+(JK-;^U:/
M6CR=U*]BY4U)&-]E^:K5O#M[5>^R^U'E;:?-<QC1Y7<GM?EQ6M;MG%9$>5J[
M!-MK*2N>E2ERFLJAJC=0*CCN..M$DV:RV._F5A=U*R[EJNK9:KL0!6J.>5I&
M5=(5!Q65-G-=#=Q UE2V_P W2KB<<X&6R%NU1F$^E:PM<TY;/VK7F.?V1CBW
M-2QVQK5%G[5/'9CTJ7(TC0,R.W-.:/;6M]E"K5*Z7;FE%ZERI\J,R04Q4S2R
M/\U20\UNY:'!&SD/2+VILD=6UCXI&CK&YW<FA'9Q_,*Z"S7"BLBVCPU:T+[5
MJ)'515B2X;"FL:\FZ\U?NI?E-8EY(>:(H6(J610NIN3S6;+*<U9N"2QJE(#6
MZ1\Q6FVR:WF.:W+&;IS7/0YW5KV;XQ1(VPLW<Z2"7Y:L;N*RH):NQR96L&CZ
M6$TT)-WK/DDVU=G;K61=2;:J)S5I\I9285828<<U@FZVGK4T5[TYJG$XXXA7
M-LR\=:89?>J"W6[O4BR9J>4ZHU.;8M>9[TGF5#N]Z-U%BU(LK)2[LU3\VE6:
ME8.9%EFIGF5 \U0M-5&3J6-*.058C<5CI<5<AG]ZF43:%1&HK<5'*U,CDR*)
M/FK)'4Y712N&ZU39^:N7"GGBJ,BD5NCSJEQV[CK5"\^9:M%JJ7'S"M8GG57H
M94R_-354U-+&=W2GP0$L.*NYYG+=DEK"6(KH+"'@54L;/IQ6[:V^T"N>;/:P
MM.VXX0_+TJ,PFM%(QCI3_L]8\Q['LN9&?#":T;>'@4+#M-6%PM0W<<:/*&T+
M3&D"T32"J,TV,T)&E^4EFN *IR77O56XN:I-<'-:QB8RK&@UQGO5:6;WJKYW
MO4;R9[U?*<\JMR5YO>HFDJ%GIA:KL<DIDC-NJ)N])NIZKNJC!RYBO(I/2J\D
M9K76UW=J;)9<=*FYG*DVC( Q4BR8[U+/!LJFS%:K<Y&^1FC!+TK6MI*YZWD.
M16O:R=.:EH]"A4N:AD^6J5Q)UJ7=\M5YANS4([Y2=BE,W6JWWJMR1DTP0FJ/
M/E%MZD*19-7[>"FPP\UHP1T^AK2I:BQ@J!2M+4IC]J@:(YK,[MANXM3ES3UA
MXIRQTR;,3DBJ5TAYK7C@W"H+RW^4U*.>I!M'.2(=U2PK4LT?S4L:XK6YA"GK
MJ/1<5<A8+5/=BGK)4LW5HFM'-@4\R!A64LY%2QW%1RF_/H37,885CW4.,UL>
M8&%5+B/=5Q/.K1YC$VE6K3T]^1526'#=*FMOEJF84URF^C!EJG<@$FD6;:O6
MJ\UQ4J)TN2L# 56F;%#W/O5667=5V,') TV&ZU8MYLUG,3FIH'*D46(C/4WK
M<!L5.;<&J-K-TK3BD#8K-GK4VI(B^R^U.\G%754-4<V%%(ZE%)%";Y:J%_FJ
M6ZFZ\U0,F35''4G9FG;R5>1_EK(MY.E:$;<5+.BE+0DE:J<G4U9D:JST(<W<
MCQ3"U/R*C8U1B+N%/5ZKLW-()*+"YBWN]ZCDYS4?F4A>@3E<BD%1KUJ1N:15
MS5'/RZEJU;D5K6[?+63#\N*T;=^E9R/1HZ%WM36H5J1FJ#KD]!N>:GBEVU68
M\T]<TB(MDEQ<?+UK%O)LL:OW&=IK%NG^8U<4<E>5B%WJ/FDW4J@UJ>4Y7%6I
MHQFF)'5F*/I0;4XLFA6KD<?M4,*XJW'4,]"*T&^73XTYI3VJ:)>14]#H@KEV
MR3I6KM.S\*I6:]*T2ORUSR9Z,(Z&-=)\U%L=K5/=+\QJ&-=IJ[Z&?+J7ED^6
MDSFH@V!2J]0:(MP_>JZCA5K,23%2?:/>ERFW/9$]S/UK*N&\S-332[LU0FDV
MUT0T/-KSYC.OK?=FN>O+,\\5TLTF[-0?8_./2O1IL\"M1YV<C]C;=TJY;6K
MCBNG71-P^[0VD^7VJZFQ-'"M.YFV\'M6A%'BGI;[>U2[0M<:/6Y.4;]VHI9M
MHZT32;<U0GFZUI8F4N5!<3^]9TTF:DDDS5:1N:9Y]25R-LXI 30S4W=18Y2Q
M&]3H]5%-2*]58TC(O1M5N.L^&3I5V-N*R.V#+*]JFC;;58/3_,J#H3-BSO\
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M)'4U11KBI>M)EQ5D)DTZF[:=2*$VT4M% !1110 4444 %%%% !1110 4444
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M7O"NM#"9:OGS3;IX6%=YH&O/%MYK.03IIH^F=%UI65?FKK[&^$BC!KY_\/\
MB8_*-U>G:!K@E5?FK$\6O1['HT;;A3L5FV-ZKH.:OK,K#K5'EN+0_FEIN]?6
MEW#UH)%HI*6@ HI*6@!-M'2EII- #J*;NI=U "T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4E+2-0 9%&:;10 [-%-HH 5J2BBHOJ,=NI
M:93JL0M%%% !1110 4444 -:DI6I*.@!2[J2@&H 4TE%%4 JTZFJ>*@GNA;J
M232<D!7UQMMH>><5X!\0-0>&23#5ZKXH\41Q0LN\?G7@'CK74NF?#9KYW,ZO
MNZ'/53Z'*2>*)(9S\_ZUH0^,'*@;_P!:X"^F+3$CUIUO,_%?GU:I+74FG='H
M\>OM<'[V:AU"X,D9-<_I;LV*V9T)A/TKS8\TI:F5:6AP^O2?,U85O\THK=\0
M1_.:Q+/_ %PKW**Y4?)5W>1TNEQ_=KN=!<QE:XW3"/EKM=#7>RXKCJS:EH?1
MY;%6/3?#-XWRC->H:)<%XUR:\P\,V1.TXKT_1;<QHO%?6Y75F['TDMCIHONT
MI6DA^Z*DK[B#T.9D>VG4NVEIB&4JTE)NHN,>>E-HS15*Q([=36YI:,&LI,HK
M2P[\UEW6C)/U6MW:*-@J.3FW(:N<U'X9BW9V?I6M:Z2D*\"M **?VIJFHB44
MBOY(7I3E7%/:FULD: W^K-<!XV=EA?%=\_W37(^)[/[1&PQFN>MI'0YZUW'0
M^7?'-]/'-)@FO.FUR>.3EC7MOCOPT6\QMOZ5X?X@L_L<C<8KX_%<USX[&1E%
MW+L7B"1ARU17>IF93S7(_P!J".3&:OVMV)\#->)*4CQ/:2;L-O)&9J9:*7;&
M*UXM+-T.%S6UI/A.2213L_2M*<929K&C*;(-)T=KG'RUU-CX(>9@?+_2NP\)
M^"VRF4_2O6]!\%IM7*?I7NX?"7U9[V&P-]SSKPCX%,3(3'^E>T>&]"6UC7Y<
M?A6GIOAJ.W"G:!6Q':B'@"OHJ6'44?2T<.J:%AC$8Z5/NXJ+G-.7-=L=#J'
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M2!A&F?2O&_!>GJTD9Q7OWA"U$<:<=J^ORZDY)-GS.,J).R.S@&(EJ0-2JN$
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MHVTP&TY:*6D(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGH^H"1%YJ&>#7@=)MXI*2)MRT[;4GFM"49I#TH/6@2'+2M2#K2MTI%#:***
M'4M)2T (U)3J* "BBB@!*S-4OA;PMS6FWW37"^,-0,$+\]J:-:<>:1YY\0=>
M&V0;J^=?%FJ&2=^>]>C>/-:+-(-U>)Z]?;I&.:V/>HT^74IW%UNSDUE7%T%8
MU7NK[;GFL2\U+&>:1ZD7I8VFO@.]4[K4/E/-8+:IN8\U+'(UQ[U5S.4;:D5]
M?GFLS[>V[K6[_8DEQ_#4;>%9LYV&I;,O:V(=-U([AS7::3>[E'-<K;^'Y86!
MVFMRQA>W'(Q34BU-,Z=IMR=:Q=0DY-2F\VKC-95]> YJBTT5)IMK58T^]'F
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MVM6W8+DBJ TK: MBM2VM<8.*2PASBM58PJT"L11Q;:L1MM-5Y9A'5=KX!NM
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MWL+A5;4Q]&\*I;*OR5UEE9K"HXJVL*QJ.*48KW(4U$]Z--16A(K "D9LTS-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4E#4V@84V:/>A%.I=W:@5S
MBO$^A"YC;Y<\5X)X\\+^7YAVU]47=L)HSD5Y1\0-%#12$+5(]"C4/C'Q99FU
M9QC%>=WMP58U[9\0M%99),+W->-ZII[)(W%6>W2G=&.;@LW6GCYZ8UL5:ID7
M;5Q.BY1NX>#66T?S5MW'(-43%EJI@);QU:5<40QX%.D8+0@N/5JMPW 6LAK@
M+WI!>>] [G1_;,CK5"^DW*:HQWGO39KC<IYH8S"U5L$US\LOS&MW4OFS6!/$
M=QJ#)@)*>DG2JZQM4\=NYQQ3$7(VJU#&6Q4-I8R2,.*Z72=$>0C*T(96L;!G
M8<5TFGZ.[8XK=T7PSNVY2NUTOPRHQE:H#D]-T5^.*ZBPT<ICBNEL]"2/'RUI
M_88XUZ4F28$49MUJ&XU$QCK6EJ"A5.*Y749"":DWB75U@[^M;NDZT59?FKSU
MK@JW6K]CJ!3'-,F4;GO7AGQ+L9/FKUKPUXI5@@W5\JZ1KQB9?FKO-!\8&-E^
M>DT<-2D?6FEZXDT:_-6Q'=JXS7@7AWQMN"@R?K7H6E^*%D49?M6;1X]2B[G>
M>8#TJ1>:Y^SUA)2/FK:M[I9 .:DYI0Y2S2-THS0W2D9C:;2M35ZT")%IU-6E
M)H&+12 TM !1110 C?=/TKS7QU"S1OBO2CT-<QXBTO[5&W&>*9O1=I'R;XYM
M7$DF:\;UV-E9J^I/'7A5F\PA/6O!O$WA>59'PAK1,]^%16/*+S/-8EQ"TC'@
MUZ#<>%9FS\AIMIX)FED&8S^5%SI56*.!M=%EN)  #7<>'/!,UP5RA_*O1/"W
MPR>:1,Q9_"O:?"?PL5%3,/Z4KG/4Q"/(-#^&;RHN8_TKHE^%65_U7Z5]&:1X
M!CA4?NQ^5;0\'1@?ZL?E1<\R=<^2K[X6F,$B+]*Y?4O 4MOG$?Z5]IW?@F.1
M3^['Y5S6J?#5)58^5^E9D1Q!\4WWAF>,GY36+<^')V_A-?76K_"L;CB+]*P&
M^%(:3'D_I5J1TK$GS+8>#9[B0?(:[G0?AU+A28S^5>^Z+\)T5E)A_2NWL_A[
M#:P_ZL#BJY@^L'SLOA)[.'[N,>U<_K%C(JD8KZ+\1:!#;HP"@5YCK&DQO(1@
M529O3J<S/#=2TF620\&FV&@R>8"5->N_\(O'*<[14R>%HXE!"U9Z5]#B-/TD
MQH,BI+NT*CI76W&GBW7@5DW<(.:8CFHX#OYJ]%&JJ,TVZVPY-95UJXCXW4#-
M>215J%G#=*P/[:#,/FJY;7ZN>M F7)(MU9MU:G::U!.A'6F2;&!H%<Y&\A*Y
MK+FN##75:A"N#7(ZI'@G% P36#&>M7[?7=V,FN/N&96ID=VR-UJ!GH"ZHLB]
M:&N ]<=#J3>M:5O?%L<TT!TD,@S6Q82 $5RUO,3BM:UN"N*H#MK.Y"J.:M2:
M@%7K7*PZ@57K45UJV%/-(1J7VK!<\UD2:U\WWJY_4-6SGYJR7U([NM!1WEOK
M&>]7EU;WKSVWU0@CFM&+4BV/FIB.U76BN/FJU!XA(/WJX=;PMWJ:.Z(/6@FQ
MZ-;^(#Q\U7DU[=WKSB&^([U>BU$^M ['<MK.[O4?]M8[UR:WY(ZT[[63WH Z
M^/7B.]3KKQ/>N*6Z]ZG6[(QS295CK)-9+#K5&;53ZUAM>>]5I+OWJ0:-W^U2
M.]/_ +:*_P 5<PUW[U7FOB!]Z@AHZJ3Q&5_BJNWBQE_CKB[K4#SS6;)?-GK0
M8\IZ1'XQ;^_5B/QHZG[]>6+?-ZU(M\WK0"I7/8;/QP^X?/\ K7;^&_'!9ER]
M?.4&H,I'S5UOAW6&1U^:@J5'0^OO"_B83JOS5Z+I]X)HUYS7S+X(UYF9!NKW
MCPK?&:-.:R:/"Q%.S.U496@_>%+'_JQ]*&7I4'GA3Z93J %HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH 2DS2GI3:!H=NIK&E'6D84P&4Y<4QFQ5&\OA
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "$9IM/H
MH 8>*;GFE:DH)).HKD/%FGBXA?BNO'2LG5(1)&V:9M"5F?+?Q#\-[FD.VO ?
M$FC^3(W%?87C[3%,<AQ7S5XXLECE?BM$>U1D>1RV>'/%5)HO+K?N(@KM6-J.
M%S5GIQU,F:H549IL\WS&FQS#UH-"SPJU1NIL5-)+\M9=Y+UJB&0S7')YJ(7'
M/6JLLAJ(R4B35CNO>I6GW+61',>*T(,R8I#(IU,G%0KIIE/2MJ&Q\S'%;5AH
M^[&13L%CDTT-C_#6C8^'C(P^6NSCT9<#BM+3]*56'%.P[&3HW@[S,?+^E=QI
M?@T1J#M_2M?0[.--O KJH5B2/C% 6,"VT=+51QBK\,R0\5+>2#M6+/(=QP:8
MF;?]I(O>JLVM+@C-8<LS^M9\LSYZU)FC8NM0$@/-8%\^[-.\XXYJG=3<&D;Q
M,NZDVL:ACO=AZU#?3XS63)=[6ZT&AUMKJA7'S5NZ;K+*P^:O/+:].>M;NGW9
MR*#.6IZ_H/B1X]OS5Z%H_C J%R_ZUX-IMZRXKI++5I(\<FE8XI4[GT;HOC ,
M1E_UKO\ 1_$22JOSU\L:3XD>)A\U=_H'C$KMR_ZU#B<TZ%SZ3M=0251\U7DD
M##@UY#HOC$/M&_\ 6NYTK7%N%'S5F>;4HN)TK4P=:9#,)5%2$4'%:S'J:1FI
M,\4O6@8BM3MU&V@4 .HI*6@!I:H+B,2(014Q%(5IH+V.*\0>'%O%;Y>M>:ZU
M\-?M$C'R\Y]J]]:W1^HJ)M-@?JM%S>-5H^:S\)\G_5?I5W3_ (3A7!,7Z5]"
M?V1;_P!RI5TZ!.B"D6Z[/,- \ QVA7,>/PKT#2]%BMHQ\HK4%NB]%Q2]*9SR
MJ28JQJO08I<#TI,FDW&@BX[:/2FM"C]5%+NJ*:;:.M(:*=WI,$F<J*S7T.W5
ML[15B^U=8 <M7+:IXPCAS\_ZT&T8-G0%+6T_NBL36O$EO;0L PZ5PFN>/PH;
M$GZUYIXF\?.RMB3]:M(ZXT6=3XP\:1;G <?G7F5YXLC>8_-7#>)?&$DCM\_Z
MUQ<WB:3S,[C6B.ZE#E9[M8^(XF_B%:JZU#(N,BO ;/Q4ZX^?]:VK7Q@>,O\
MK6B/42T/4=0NXW!P:YG4+U8PQS7/R>+ Z_?_ %K&U'Q#YBMAJ +.L:N!D UQ
MNH:L=QPU1ZCJ1D8\US]U<%B:0&K'JQW#YJU+/6L?Q5Q?G$&I8KQE[TP/18];
M^7[U3?VVO=J\_34F7O3VU1O6@5CM;C55D'6LFZ(FS6$FIMQDU=M[P/WH&17%
MCNSQ6=-8LN>*Z2+;)4O]GK(.E)@<FD#JU:UC"3BM%M) .<5)#;B*I N6=MN4
M5IK;[5JG;S+'5IKQ=O6J =(Q1:R+ZZ(SS5NXN@5/-8]W)NS3 R[RX//-9S7!
MW=:MW2YS6>\?-2,M0W1W5JVMR>*PXE/%:%NVVD(WH9L@5:CDK*MY:O1250&C
M'(:L),:H1R5.LF>] B^DY'>I?M7O6=YE#2U0&DMY[U*+WWK#:;FC[5CO4LK8
MVFOO>J\E][UDO=^]5I+L^M2,UI-0]ZJ2WQ/>LTW!--9RU,">:Y+9YJJTQ]:1
MB:@=\5)%B?S:D66J'G5-#)N-,Z(6+\<QR*Z/0Y&:1<5SUO"7(XKMO"VFF21.
M*0ZC5CU/P(KF2.OHOP6K"-,UX_X!T$_NSM_2O>?#>G^3$G&*F1\UBI'6Q?ZM
M?I2M1']T4K=JR/)&TZDVFEH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ I&Z4M% $9&:2GM24"'?PUG:@V%:M&LO5%/EF@N.YY7X\E'E25\T>.FW2
M/7T;XZ5O+DKYQ\:Q,9'S6J1[- \QO/O-7.:LQ -=1?1[6-<MK'W6JSVH;'+W
M4^US44=U[U!J#;7-45F.:I()&TUQNJG<MNIL+EZL?9C)VH>A!D25"_6M>33V
M]*JR69':I)*T*_-6UI\>[%48;8[NE;6GP$,.*I#1MZ?:@XXKH+2%8U%9EBFU
M15]I]BTRV: =>*LV\@!XKGOMAW5;M[S/>@E'9Z?>;<<UN0WC..M<7I]UTYKH
M[&Z7CF@IHU2K256EM^]68[I O6JUS>)@\T&93EC'2JDEN*=+?+NZTS[6K=ZF
MP[%*ZCV*:P=0N/+SS70WD@*&N,UR?;NI"V,R^O-Q/-9LDFXU5N+O=(>:?%)N
MH*N:5CEF%=;H]BTC#BN9TJ/=(*].\+V"OLR*";EW3=';:#BME-)95Z5TNEZ6
MGECBM)M-0+TIE1B<.87@/I5RSU1[=AS6IJ%BJ@\5S]S'Y9-)FCBCMM#\3.KJ
M-]>K>%?$F_;EZ^=;&Z,4@YKOO#>O>2R_-6;1PU::9]/Z+J0FC7FNAC;>M>/^
M%_$RLJ#=7I6DZLLRCFHL>'6I-,V&6F[@HJ.6Z55K%O\ 6DASS2..S-IK@#O3
MHY0QZUQ$WBI ^-]6K+Q-'(P^:@KE9V8I:S;/5$F4<UH+(&Z4"::%H:EIK&@0
M;J-XIF:2@"7=1NIM%,0I:FYH--:@=B48-1R-MIR&H;QMB$T@17NKX0@Y-<WJ
MWB5(4/SU2\2ZU]F5N<5X_P"*O&1CW@/5I'53IW.E\3>.!&&Q)^M>5^(/'CLS
MXD/YUROB'Q<\S,-_ZUQ-]J[3,?FK1(]6E2.GU+QA)-GY_P!:Y75->>7.6S69
M)=[L\U0NI-PZU5COC2,W5KXNQYKG9KH[NM:>H]ZPIS\U%BO9\I9%^R <TX:P
MZ_Q5F,]1,U,I,W%UU^?F-._M9I.IK 4U(LVWO1<9J2W6[O521]U56N?>F?:.
M>M 7)R*C+;:3SA5>::@"9IQGK1]H]ZSVFYIOG>]*XKFF+KGK5NWOMO>L'SJF
MCN,'K1<9V-AJ'(YKHK.Z5E'-><V]Z5QS6S:ZN54<TP.VDF3;6?/< $X-8O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHI* $W4M-IP- "T4W=2;Z 'T4@-+0 4444 %%)3=U #
MZ3;2;J-U "TUFI=U124K@030B3((K)N]%2;/R@UMJNXU*L8Q6<H*6Y-CCO\
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MZ]R^$FD>3<0[E[BL#3?"Y;:=GZ5Z[\/= ,,L?R]ZX8UGS'RF8YM>FXIGTCX
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M** "BBB@ HHHH *3%+10 TBDIQYI-M "4W)IU,H 6G[>*8!3VX0T2V&9>HW
MA4UY_P")?$ MU?YJZ3Q1>F&-N:\+\;:\X:0!J^<QU=PB["D/U?QD5D(#_K52
MQ\5F60?/^M>8ZAJCR2'YJFTO4&5QS7YYB,5*4SFYM3WW1=>W;<M7?Z/JPD4?
M-7SYHNK,I7YJ]'\-ZL[%>:]?+\8XM)FL9GLEK<;U'-6MV17.Z/=&1%S70Q_,
MM??X>?M(W-!RT]:3;Q3E[5Z"T =BEHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *0G%&ZD)S0 ;J-U)2[: &[J-WXT;:.* %YHI"P]:3>/6@8AI!UH
M9@:;F@I(?1G'6CS%456FO43O4.5C-Z%O<.U5KB8(IJO_ &E'_>%9^I:HBQGY
MJEU%8ERT*FK:R+=3\U<;J'C%8WQO_6L[QAX@$2OAZ\4\2>,6BE;Y_P!:\FOB
M>5GE8C$\I[?)XP26,CS!^=>:^/-8$T4F&S^->>1^/GW8\S]:IZIXF-]&1NS7
MEUL5>)Y53&*2L<GKU])]I8@GK56WU";;U-:4E@;Z3.,UL:?X1>51\E>"ZCJ2
ML>2^:J]#FX%EN) #DUZ!X/\ #K7$B97-6=)\#OYBDQUZQX-\)>2R93]*]C"X
M7F=V==#"N^IM>#/"XC6,E/TKUK1=/%NBC;5#0-)6&-?EKJ((PBU]-3HJFCZW
M#TU%$J*% I^324NVNU'8**6D%!JA"T4W=3J "D-+36- ",U-HH K+J4.HHHS
M6BU)"EINZDW4[ /W49IN:?N% AA:@<T$B@50QPQ033<TFZI%<=3EZ4VG4K%
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MC3PL"<"MB.X%P<=:LKIHE7.*214GV.3FC91TK$U!V7-=U?:9L4\5RFJ6)^;
MKMA$\NO>QR<\I9JDMOO"GW5FRL>*2",J15R/)BGS&W8]!6Q#T%8UGG K223
M%8W/<HZ(M,V*KO,!WIKR$U6D8^M!LY$K7%,$V:K$DT^-2:1DY-LNQMNJU'$#
M5:!:N1L%H.FGYBB >E/$(]*3S0*;Y_O3.B\298@*4@5!]H'K4;7/O0/FB32*
M*K20[J/M ]:D5]U(QDU(K^3BI8_EJ5EXJ%\BNNG&Z.&4U3D7X'&,5M:-;K-<
M*#ZUS$<NVM_P[>!;I,GO4<GO'H_6$Z>A]$?#/PG'>>7\N:]XL?AI')9Y$7;T
MKR;X.:I$&A!(KZU\+R6]U9*.#Q7M8>"L?C^=8^K2JW1\K?$7X>FW23;'CCTK
MY@\<>&9K>:3"$<^E?IAXP\'QZE&VU <CTKYT^(?PA,GFL(?TK:K2YD:99GFJ
M4F?"SV4L4AR#4>UA*!7M'BCX;R64CXBQ^%<,WA*;[4!Y9Z^E>!/#/F/TS#YA
M3E"]S9^'MBUQ<QC'<5]B_"7P_P#NXB5KP3X6^#9/M$1,?IVK[.^&?AO[/;Q9
M3''I7KX6GRGY]Q!F5TU%GHOANR6WA3CM70-]TU!:VHAC Z5.W2O81^159.I*
M[(57FI56FK4E$A15@J1:9BI%J306BBB@04444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444C' H 9-*
M(D)-<)XP\1K;V[C=CBMWQ#J8MK=N<<5\\_$KQAY*RC?^M,Z*,>9G$?%+Q6)?
M- >OF;Q1J1FN'.>]=EXT\4FZF<;\UYAJ5P9G8YK1'TU"/*BG)+NS5.1LU)(V
M,U5=N:HVF1R<TS%.)IK-BJ,5N2AJDC:J334Z.;WI%LTE:AFXJO')FIP-PIB*
MLQJA,U:<R<&LNZ&W-(JQ3D:HL9I)&^:A6YJD"';:5FQ4FWY:KSY&:0NHC38I
MRS51=CNI5<TRK&I'-5F.2LB.2K<,G3FI(->.6K"S'UK,CDJ=)* -%9O>K4,W
M2LI9/>K4,G2F!L1/N%2=:H0S8[U:6:F6AS+BF;B,U)NS4;K2L4'F4Z-LL*AJ
M2'[PI$FQ8Q[L5T%G;!@.*P]/[5T5I(%452 NQVJ^E2K;KGI4'VP+WIOV\>M,
M#3@M5R.*VK*W1<5S<.I*#UK0AU=1WH).ICE6-:K75Z,'FL4ZL&'6J\E_NSS0
M)C=3E\S.*Y>\MV=CBNA9A+3XM-$V.*@2..73W+=*T;/36XXKK8?#X.#MJ_;Z
M&%Q\M!JCFH=(+#[M;NAZ*%F4E:V8M-55Z5<M52W8&@SF>A>"88[783Q7KNGZ
M_';6X&X=*\!L/$"VHQNQ6B_C;:F/,_6@\]T^9GJ7B+Q0LD;#?7D7B35!+(QS
MFL_4O&!E!^?]:Y34=<\YB=U%K'53HV);V]&X\UD3WW/6J5UJ&[/-9-Q?'GF@
MZXJQK37_  >:Q=1O-P/-5I+PMWJC=3%J"GL8^J3DEN:YJ\E/-=!?*6S6'>0'
MGBD<[*5JQ,PKT?PGQMS7GEM$5F%=]X;?;MJT7T/3;6Z$4(K+U;6-N?FJ-;@^
M3U[5S>M3,=U,217U+6_F/S5G)K&6ZUBZA(^XU3CD;=UI%'<VNJ;N]7UG$JUQ
MUI,PQS6S;76T#)H NW-BLP/%95QHZDGY:V([M6'6DEE7!H&SF)M/$>>*S+R,
M+FNDOI!SBN;OVZU))AW1ZUGR5H72\FJ3+025F4U!(IQ5TK4,B4(:*#*:8P-6
MV3VJ/RZHJXR-?FJS$M,6.K4:5)+'HM3(,4BK4BK0(>E.D7-(M28W8H I20U%
MY)K5$&ZE-KTH'8QFA/-*J[:TI+7CI59X<=J0%??BF"3FGR1FH2NVF(MQ35=B
MFK'5\&K4,M &S',*D,_O6<DE/\R@1<\_+5;M7W,*RX^:TK%?F%!2-^R3.*TU
MPHJA8]!5UVXJD:(E6;D5I6.785C0@NV*Z+2H.AHN3)&[968902*EN+55!XJ6
MW?RXQ56^O  >:3.>VI3:-=U:NF*JLM8'VO,G6M73Y\LM3<VZ'L/@695DCKZ/
M\#WB>5'7RQX/N"LB5] >";X[4YK.1X^(B>U1N'4$4ZLO3;@R1+6FO2H/'>@M
M)36--YH$2T4BTM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 W::9MJ6FGK2N T4LG^K-)W%
M+U7%$M@.&\80L\;XKY]\<6D@9S@U]/ZS8BX1AC->3^+_  IYX<A,U\[CJ#G%
MV%(^9;[?'(V14FFS$R 5V^N^#)%D;"5F:=X7DCG'R&OSROA9J>QS\IN>'[=Y
MF7 ->J^&-+<;3BL#PCX=.Y,K7L.@Z&L<:_+7M8# RD[FL8%O1[<QJN170QGY
M:@BM1&.!4WW:^^P\/9QL:$V[-*O2HU[5*O:NS<8^BBBJ$%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU8E#9I]1*"*D'W3702-8TBFAJ%H&2#I2T@Z4M !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYA74:?"54<5GZ38F1AQFN[T?PZTZC"YJ1MI+4PI=RK61>-(V>*]57P++*O\
MJS^54;OX?R+D^6?RJ;G*ZBN>61Q.TG2M_2[=LKQ72+X+>.3E/TK;TSPFV5^2
MH9?M$6O"5NV].*]W\%PMA*X7POX59&3Y*]C\+Z/Y*I\M9GGUY([31T(C&?2M
MH=!5.QA$<8^E7:#Q);C&%+MIU%!(E+110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!(&4<T3+N%<B/IXR]W0K/=%>]"WOO56ZRM49)BM;<J.*I4<6=##? XYK0AN
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M4+#%6<TH6(9(]P-4I;<^E::C-.\@-5W."I3N8GDD&I4B/'%:3VH%,6$9H(C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML,[35>30Y(>JU])6/PO:2 'RCT]*PO$'PW>W5B(B/PJKCE-,\'6$Q-R*OV[
MK6_K7A>2UD/R'\JQX].D5L8-*XE(23&VL74&"YKIO[+ED7@&LO4/#\S*2%-3
M<.9''75P U01W )ZUHWV@3JQ^4U2319@?NFG<.=%B"8-6I!)Q5.VT>;CY36C
M'I\B#D&@.:XR8[EK-GCRU:SPE>M5)(>:5QE%8JE6/I5A8:>L/M3*L0JG2I52
MIEAJ3RZ"2%%JPBT+'4JK3 %6IXXZ15JQ&M,!57%*QQ4FVHIJ"AA?D5+%)5)G
M(-/CDJ0N:T4W2K]O<=*PXY*NP2T :[3?+UJE/-S2-,<=:J3-S5C'&3=3!EC3
M5!)JW;VY8]*0T+#;EB*TK?36;M5K3['=C(KJM-TI6QQ2%<YRUTE^.*W;#3VC
MQQ73VNAIM^[5QM+6%>!2$4;%?+49J^9U"]:S;R86X-8EUKGEL1NH(.BFF1B>
M:I3JK9Q7.MKW^U4D>LAOXJ"K%B[M@V<"LJ;368GBMB&Z66M"WMDDIEG)KH[^
ME7K?3&3J*["+38\=*CN+:.):DBYSK0^6M9=](!FM34[A8\X-<MJ%\.>:=B;D
M%Q*%:B&Y -8]Q??-UI+>Z+-P:DLZF&??226IEZ"H-,4R8KJK"P$BC(JBCETT
MI]W2MK3M/=,<5T<.DIUQ5V.QCC7I5(1DK&8TJK<2=JT[UEC4USUU=KN/- BO
M>-G-8ETW)K3FF#9K+NJ"C,N)MM9MQ<5<NN]95QUH$123?-35GP>M029J'S*"
M#56;*TDC;A5&.:IQ)NI7*0C#.:C9:F%(R^E.P,JLE)Y=6O*I?)H)*+I562M.
M2*J,T?6I$S.DJ U=DCJ!HC3&B.-CNJ]!)TJFL>#4BMMH U8YJ1KD =:SA<>]
M127'O0Q%Z2\]ZKF^[9JA),?6H?-R:5BK&U'=[N]7H9=U8$$G-:=O)0%C4R"*
M8R!JB66GB2@1&T&ZH7M\5>4[J)(\BJ R)$VU&&YJ[<0]:J-"=QH0BQ _2M6U
MDK)@C*XK2ME-!21OV<M;MC)EA7,VA-;5C(=ZT%GI/A>$22)Q7NG@C04N-F5K
MPCPC<A9(\FOHKX=:@F8^14R9PUY-(]1T?P/'-"IV#IZ5+J/P[CV'$?Z5V/A>
MX22%.E='- LL?3-97/%G5:9X!>> 0LA_=_I4NG^"=KCY._I7L<^CI(WW?TI(
M=%1#]W]*FX_;NQR>B^%EAV_+^E=?8Z>+<#BKD-JL?05-BD<TZCD.A&U<5,M1
M+UJ1:#)#J***!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZIS7?VK QBOIL+B%-%(L#UHW4HZ4E>LM1CJ*3-+4-V$%%&:3--2 6BBEVTV
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MJ<!LE(Z&J\@E]*]FM_AC+)&#Y9_*J=[\,Y8\_NS^51*A(R_M2DW:YY+#'([
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P !:@9X8^:]+C.Z-?I7CGPS9O(CS[5[##_J5^E8L^?J;DF!14:MSUI^XTC
M1E%,V4^G4@(U7%/S2D4F#0,-U.IM.H *0FEIK4  :G4T=:=0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%(U !FC--HH ?13<FDJ;@.;I3:*1JI +6;J:DQM]*T%JM?*/
M+:N>O\(T>5^+HF <UXIXHN7AD?FO>O%S(J/DUX%XTE3S'Q7P>8WU)D<1=ZLY
MDQNKH/#.H-YBDFN,NF!F/UK?T*<(5YKY&-249F*/H3P;K 54!:O4]-U021KS
M7SKX9U(JR@&O6O#=\TBKDU]KEU9NQT)GI<$PD6IJS=-8L@-::U]Q2=X@,I*<
MU-K22N(*5>M&TTHHY0%I],I<FBP"Y%(:2BF,****GF$/HHHJ@"BBB@ HHHH
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M16JP+@#%2J]!:MK6/*E4E/=C=V*.M)BG*M"9F)2TZBBXQN*44X"EI#%HHHH
M**** "D;I2T4 ,IR]**6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &M3#WI[=:8W6
M@!5DI)$\S@TFVGK2&49M'BFSD"H/^$<M\YVC\JU]U&13'S,S8]$ACZ**LQVX
MBQ@58+ 4QFW4"NP\PT9\SBF@9J0<4A$4EFDG457;1X6_A'Y5?W49%,+E./2X
MX^@%3K;JO:I=U)NI@1M:HW6F?8(_2K&ZC<*07*[6$3#&*R]2\.Q74;?*#6RT
M@I0V:=@YK'AGCCX>I<1R$1#\J^;?'WPX,+R$1?I7WMJ&EK>1MD9KROQQX#2Y
MCD(C'3TH.^E7:/SQUSPR]I(WR8_"N>:S*-C%?47C?X<,))-L??TKRZ^^'\RR
M']V?RK2YZT*UT>4RP'TJI) ?2O3YO 4__/,_E63?>#I8024/Y51?.FSA%A]J
ME6&MJXT=H6(*U6:U*YXJT;(S&CQ3!5V:/&:J,,47&2+2LU1;L5&TE,0YFI%J
M'=EJFCI,"15S4T8I$2G_ '14FB$DDVK55KCYJ2ZFQFL_S_GZT!S&_:7'2M..
MXX'-<]92=*TQ)Q5#-5;S;WJW;ZA[US4EQM[T1WVUNM '9K?97K4$]V6[UB6^
MH;L<U.;D-WHN,G>8M569L@TIDJ"1J-P*5SWK-FK1GR:SIEI$,KEL4AEH=:;M
MSBD(7S":86-6(;4OVJT--9NU4!C2,<54DDZUMW&EL!TK.N+%ESQ4@4(Y/G%=
M3H,VUEKES&4:M;2[CRV'- 'IEC=?NQS45]<'!YK(L+[Y!S5BYFW+UJBS,OKD
MC/-8%U=9)YK1U*3K7/7$G)J26,FGYZU!Y]1S-4.ZG8#4M[DKWK9M-0Z#-<M'
M)MJS#=%3UH$=DESYB]:CF7<*R;.]R,$UI+,&'6J15RK,E0^75QEW4GE]*3$5
M?)J-EQ5UE%5Y%Q20K$"MBK$4G-5FI\6<T,#7M?FQ6U9P;L5B69Z5T.GR 8H2
M-$:MOIX91Q4%]8!%/%:UG.OE]:K:G*&0XJA,XO4%$;&L2XF'-:FM2$,<5RMY
M=%2:@EDD\PYJE(P8U UUN/6@2;J L!7FE5,T9IZTA$BPBI?*%-1@*<THI@)M
M%.6H6FI4DSB@"?;[4X1YHC^;%68X\T )##R*O0P$4^WM\XK2M[/=VIHI(H>2
M<4^.,UJBQXZ4OV/':J**\,9XJ]##TI8;?VJ]%#@=*0A((NE7X+<L14$9"GFM
M/3V5I!3*L:VDZ&URR_+7L'@'P@PEC.S]*YWP3IZ7$D>17T;X%\/Q[8SM%9R9
MYF(E9'8>!=*-K#&,8XKT>/\ U8%8^DV @C7 K9'W:Q/GIN[(QUJ3=3!UI:;$
MA].J*GBI ?12+2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%(.M*:&,B:F[:D(H K-MH=Q%6I5IJK3\5462&T4M%%4 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 F:1FH:FM0 ;J6F[33J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ$5H6Z9Q56WA/%:EK#TKGDSV:47H6;>(\5;52!3[>'@<58\CCI6+9[4*>A6
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MDTX4 &VEHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI
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MC48J[9:+'"!A16K#;B/&!7T=&C[-'T=&BJ:'1)M%34#BEP:[SJ #-&VE6BD
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M-24#'T444 -W4H-)0M #J*** "F[J7=3: ' TM(M+0 4444 %%%% !24M)0
MFZE%-IPZ4 +1110 4444 %%%% "&DVTZB@ HHHH 0C-&VBC- "T444 %%%%
M!2&EHH ;MI12T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 FVF=#FI*8RT *&K.U2S%S&PQFM +2[0>M T>4^)/!*WN[]WFO(_%GPMW!R
M(OTKZMDLXY,Y%8VK^'(;J-L*#3N=4*S1^?WB[X>/:[R(OTKR#Q!X=DMY&^0B
MOT)\9_#M+B-R(_TKY\\<?#4Q-(1'^E:)G?3KW/DB\L6C8Y%5?*Q7IGBGPNUF
MS?)C'M7!7D'DL>*H[HSYBK&M6H_EJK&U6%:JN;V+BM\M-D>H1)1YE ]@W'-2
MK+Q4'WJD"D"FP)"VX5'M!I&;;3/-%!1*(Q2-"*%E'K3VDXZT@*<D>*C4[6JQ
M*>M56^]02:UC/M(YK;AN 5'-<E#,4:M""^X S04CI5D!I9&^6LF"\#=ZNI)O
MJAE>Y3=FJ#VQ8]*V?*W4Y;/)Z4 8@TXMVJ.;2CCI76V^GANU6)=*!7I2%8\W
MNM.*YXJA):E>U=_?:2.>*Q+G2\9XH8CEQ&5-3Q @U=GLBIZ4R.W.>E2!+;YJ
MRS?+38H=H%+*,+0,S;UNM8T[=:U[OG-9%PN":!%":JK+5F:JQ-,!8UJ];-BJ
MBU:A7YA0.QKV\G2KJR5F6^>*NCI2)+D<U61-\O6LV-NE3[J8[DDDU1I/\U5Y
MF-0JQW4"-VUEW8K4@QQ6#9D\5L0R?**92+^\**A>["=ZJS7&T'FLVXNR328V
MS6DU7:"-U8NH:B9 >:J2SLW>JLF6I&=S-OG+L:SV6M2>/)JJ\7-46B"..K4:
M411<U:CAH&.AJTK?**B6/;2,VT5)!*T@IJODU5>:G0R9:@1J0KFI'0T68W8K
M0%MN H&4(82S#BMJQM>F14=M9_,*UH8Q&M,I#XU$>*5[X1]ZI7EX(P>:P+S4
MSD\TT,ZC^V@K?>J:/6L_Q5P#:DQ;K5FWU!N.:&0=ZNI[^].-T&'6N4M[X^M6
MUO\ WIEHUYY :R;MMU(UYGO5:2;=2!E*=>:@5#FK;KNS3HX-W:D:10R%#Q5^
M&,^E/M[,MCBM*WL3QQ4V)>Y#;QG<.*W-.5MRXJ&WL3N'%=/HNCF5U^6I!O0[
MOX>>9Y\77K7UM\-=WDQ9KYX^'WATB2,[:^G? >GF").*AGA8EGI4/^K7Z4^F
M1C" 4^I/'"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M798^M5VCYJKG%*]R2WZBMFT&<5D0QG=Q70Z/8R3,H -0US'53C979?L[)IF
M KI-/\)RW2_<)_"MWPAX0DO'3,9/X5[[X,^%_GQIF+]*VAA92/,QF80P^[/F
MV\\ S;<^6?RK';P).9,>6?RK[D;X.K)#_J>WI69_PI=?,SY'Z5T?4Y'S%3/Z
M>USY)TSX=3/MS&?RK=7X=2K'_JS^5?6VF_!U$4?N/TK4;X2)L_U/Z5K'!OJ<
MU'/HQE>Y\/:EX%F7I&?RK*C\#SM)_JSU]*^W;[X-K)G]S^E48O@JOF9\COZ4
MI8-GKRXAIN.Y\Q>'?AQ+.R9C/Y5[+X+^%/S1DQ?I7LF@_"=+<KF']*]'T+P9
M%:!?W8'X5I2PC3U/F<7GS::BSC?"/@%;-4_=X_"O3=-TL6L8 %:UKID<*C"X
MJR80.@KVZ=/E1\+BL9/$2NR&([5Q4P;BFK&=U2;:T.!#=U/6C;3@M4 QFINZ
MGLM-"\TP%INVI0M&V@!JTM+MHVT )12[:-M "44NVC;0 E*O6C;2[: %HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **2DW4 .HI!
M2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVEV5,E<9%3E[4_93<8Q2A$0]:=35H:M1"TM-7K3J &4H44E.7I0 ;:6BD:@
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MIM #Z*1:6@ HHHH **** "BBB@ HHI,T +1110 4444 %)NI:;0 N:6D6EH
M**** "BBB@ HHHH **** "BBB@!*;3Z* $'2EHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **3-+0 4444 %)D4M,H =2TW^&DS0(R-:TQ;R-AC->.>./ 0NU<B//X
M5[UL##FLW4-%CNE.5S0=%.IRL^#O'GPU:/S"(OTKPGQ)X9>QD?Y,5^C/CCP+
M'-#(1'V]*^7?B5X$\EI2(_TIH]FE6NCY4FC,4F,59M3TK=\0Z&UK<-\I'-8J
M1M&V,5HCM4RQ)G96+?AN>*ZBSLVN% QFKG_"(R7/(0G\*>P>T1YI(KY/%(BO
MG[M>D?\ " RLW^K/Y5<L_AM-(W^J/Y4A>V1YY:0NQ'RUU6CZ*]TRC97>Z;\)
MYF*_N3^5>C>$_A/(LB9A/Y4$2Q"2/--+\ R7"@^6?RK3F^'\D,>?+/Y5].^'
M?A:JQ+F+]*T-6^&BK;G$7;TK/J<BK)L^,-3\/O:D_+BLZ"Q._&*]_P#&7@,P
ML^(_TKS2XT V\QRN.:T1Z%.=T9=CIO0XK4C@$=6X;81KTILR59J]2)MNVJ-U
MC%6),BJ<_P!VF8\NIDWG>L"^/6M^[4\UC7<);-,W2.;O&/-9LC'FM^XLBW:L
MV:Q([4B&C);)-,"G-7VM2O:D%OSTI"*?E;J#9%^U:4=MN[5<CM1Z52&C _LH
MMVIW]DGTKI%@5:&5 *11S?\ 9^WM3DM]M:\RK55E H9!59=M9]U(16I+WK,N
M(]V: ,R20FH&S5V2V.:C^SFBQ94\O=3UM\]JMK;U,L( YJ@*B0;6JW&NVE90
MM1M)MI6 F)&*JSC-.,U)G?B@>Q0E4\U78D5J/;;JK36I%(EE$R5&TM/FC*YJ
MLW6D231MS5R,;JHQ]15^WYQ30T31QU<@CZ4V&.K<<>*0V31\59B:JZBIHU-!
M)?C&ZK*19JK#VJ_"::! L-/4^74VWBJMQE<TBB1KK;3/M.[O6?)(<T^%B30*
MYHJOF4[[#O[4MFN[%;MG9^9VIE(Y_P#LSVH_L\CM77?V7E>E)_9.6Z4<H['.
MVNGDD<5T>FZ6>.*NVFD?,/EK?L]/\M1\M+E)Y2/3]/VXXKI=-C"NM9JE8:EM
M]0"2#FJM87(>V_#UE\R.OIGP9L,"?2OD/P/K0CECYKZ0\#^(@T<8W5C(\;%P
M:/6L#TI/+%4[2^\^,'.:N9K,\BPGECTI=N*0-2Y/I0(,4;:2GT"0@I:**!A1
M110 4F:6FM0 NZEIJ]:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !112$T +13=U&Z@!<TAZTW=2TP$:DYIU(QH&&VC;
M2;Z7(IC 4UN].R*,9J22(DTJ9I^RE5:0AZ]*6BBF,**** "BBB@ HHIIZT .
MI&Z4W-% @S11330#'4NVH]^*<)AWHNAH<!2TWS%]:"V: '9I:8*5:!CJ2EHH
M$%%%% "44M% !1110 4444 %%%% !124F32 =12"@TP*EY8K=*01FO+_ !WX
M/6XC<[,\>E>MYK*UFS6ZC(QFN2O2YT:0ERL^*/&G@-_.DVQ_I7 MX%F#G]V?
MRK[.UKP0EX['96$/A@C-GR_TKYJOE[FSUJ>(Y4?)4W@>8*3Y9_*N=U7PW):9
MRI'X5]KW7PL3R2?+_2O)?B!\/_LL<A$>./2LE@?9*YTQQ',SY>EF-G)Z5?L=
M>9<#<:F\5:&]O<, ,<UB6M@ZMTKQ\34<=$>S2M)';:?K$DQ W9KM-!MY;IU/
M)KAO#=AOF0'UKWOP!X96X\OY:\RE3G5EH8XA)(W/!VBRY0D&O;?"]BT2H"*J
M>&?!ZQQ(=M=Q8:6+?M7WN P\HI7/EJTE<T+-=J"K-1HNT"I*^CM9'$%%%% "
M4VGTFV@ 7I0U%!H 8U-\P+1(>*S+Z^$ /-95)J"N.QJ><*7=NKE#XB19,;JT
MK764E7[U<4,7%NURN4V-V.M,:Z"]ZRKO5DC4_-6!>>)41B-U54Q,4/E.Q%T&
M[U*K;L5Q%GXB65Q\U=1IUX)E'-*EB5)ARFHM+2*<BEKT$[F8E+2-3<TP'TRG
MTFV@!%I6Z48Q2T ,HI])MI@-IC5+BFLM9L9%3AVI=N*2IY0';:6DP:-U:;!8
M=MHP:89A2K,#2YD(6C-'6BJN@'4M1[J4-0 YJ;FANE,J1CZ5:8.M/6J$#\*:
M\^\9ZB;>-^>U=_<'$+?2O(_B).5CDQZ5Q8J?+$Z*,>:1XUXS\0'S)!NKRW5=
M3,C$YKH/&5X?.?GO7GUU=;F/-?GV-JN3:/JL/3LBVMQN;K5J',G%9-J=[5T6
MDVWF.!7BTE:5V>FY)(ACTR2:08%>@^"=%F2:,[36CX7\*B\*?+FO8O"_@-8U
M1ME?2X7#^T::/ Q-2QL>";=XXDR*]&M1\HK(TO119JO&*VH_W:U]IAZ3A$\"
MH^9DS?=K+U"U\Y2*T!)367=73.-S)'F?B3PJ+W=\N<^U<)-\+TFFR8N_I7O<
MUB),\5 NEINSMKAEAU)FCE8\IT7X6Q1XS$/RKL-/^'L,.#Y8_*NVM;9(OX:L
M[A713PZB+VDC#LO#45JO"@4FH,+.-L<5NLP"DUQOBS4%AC?G%;U'&$;G+6D[
M7."\:>(?*63YL5XMKGBAO.;Y^_K71^/->&Z0;J\:U?4O,F;!KXO&XAR=D?'X
MO$N,CT#1O%A5Q\_ZUWNE>-@NT>9^M?.UIJ31MUK7M_$4D9&&KRZ.(E3E<PIX
MYH^I]%\;+)M_>?K79Z;XB68#YJ^3]#\62!E&^O5_"?B,S;,M7TM#'N>A[>&Q
M?.SU;79C=V[ <\5X3X^\+27S2$)FO<=,_P!.C ZU)>>#DO%.5S7;*#K(^HHU
M;*Y\5WWPYE:X)\L]?2I+7X?RH1^[/Y5];3?#.-FSY?Z5&/AK&I_U?Z5PRR[F
M/4ABK'@WA?P*^]-T?Z5[3X5\!IM0F,=/2NDT[P2EJP.S&*[#2[%;4 8KLP^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4XK-TM3#"H/I5W=7T\8J*LCY^H[NY(U.I@YI]40%%%% !112;J %I*6D;H:
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M7^E36/PS"N,Q?I1]3LS>7$EHZ,\(T/X8M,RYB_2O7O!?PS^SLA,6/PKT_1/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:3=3J!!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2;13J*!$?ET>74E% #0M&VG44 -"T;:=13 ;MHVTZBD W;1MIU%,!-M+112
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MAES^- 'U,MTG7/%4[_Q!;V:G+ &N,_X2@+IOF;^V:\5^(7Q;_L^:1!-CMUH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHR:5J;0,&)Q3*?@T4#0*M.I%ZTZ@04444 %%%% "9HW4C4E #Z*** "BBB@
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M[M"TT')IP[U1 IZ5&U.IM(0+3UIBT]:8QU%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 44F:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8C!_JQT]*AR/,EB;,^2[SP8]OGY#^59QT%U/W:^FM;\!JQ;$?Z5RTO@ [_\
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M(<87%:MO9+#CBKK,*2MJ=",1\PY1MQ3Z:M.KI("BBB@0444F: %HHHH 2EI
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MGK0 [X<:LD=U&,]Z^M/ >I![-"#VKX0\*ZF^GZDH8D8:OJGX=^,HDL4W..E
M'H_CS5ECL9 3VKX[^*5\MQ=2 'O7N?Q$\;1R6[JKCIZU\V>(IGU6\..<F@0G
M@*W+:@I]Z^AXV\G1>?[M>5_#GPO(TR.4[U[%K&G-;Z.>/X:!GSWXPU!5U8\_
MQ5[9\#=0#"+!KYS\>R/#J[$_WJ]8^!OB*.W>(,V.: /J_P 1$R:.W^[7QC\;
ME:.24U]@RZO#?:3@,#\M?+OQMT4W/FE1F@#Y(FOG74< ]Z];\!374T:[<UYX
MWAQ_[6^9>-U?17PE\,P-''O H I3:;>7"X(8UHZ-X#FO&#-&3^%>TV_A6RV+
MPM=7H?AJTCCX"T >"7GAW^PH2Y7;BN$UOXB/I[M&LF,<=:]^^*VEK%8R>6.U
M?&WC"SG;5''.-U '<Z?XNN-6G #L<FN^TVSGN+7+ ]*\[^&>CJTT9DKZ)TW3
M+:/3NV<4 ?,_Q,L6AWY%<U\.9A'JR#_:%>D?&2W0>;L]Z\H\$[HM:3TW4 ?=
M_P ,K-;[2XP1G(K0\7?#F&\C9O*!/TK#^$.K+#I\.X]A7IU]KUO(F"10!\V>
M)?AV;%69(\?A7COBB.\TV9MNX8-?9VLK9WT+9VUXKXZ\)VMQYA % 'B/ASQQ
M=V%PH9V&/>O2%^(CW5EM:3/'K7GNK>%Q;SL8QWJ.UT^X^Z,T :&K7_VZZ+9S
MS7??#B\2VN(R3W%<'#H4^-Q4UJZ3>/I=PN>,&@#[0\#ZPDEF@![5-XRU()9N
M<\8KQ_X=^.$6)%:3]:VO'7C*)M/?:_./6@#S#QMK"273C/>N(N%^T*2.:HZ]
MK3WVI, <Y-=/H.BO=VH8KVH \^U"(Q3'-;GA2Z"W"_6I_%&@O;L3MJAX;MG6
MZ48[T"/J;X7WO[N/FNW\;76[27^E>>?"^,K''7<>-,G27_W:!GR#\2K@?VH_
M^]6_\)KK%U%CUKF/B1;NVIR8'\5=!\)[=ENHL^M 'V1X3N/,TM >PKROXY7?
M^BS?0UZ7X2&W31]*\H^."LUK-CT- 'R>EP&U_P#X'7T'X7.[0Q_NU\ZPVS_\
M)!G_ &Z^C_!]JSZ(!C^&@1\U?'K(GEQZUY7X#N94U)=I/WJ]U^-WAN6YFD(4
MUYOX!\*F+4E+K_%0,]J\.W]W]A4*6Z4FJ6=YJ&00QS7?^#?#]LUG&&QG%=G;
M^%+-L'"T"/"="^'LD]TKM&>OI7T5\-/"_P#9JQ?+C%6M+\.6L+KA5KO-$LHX
M57:*!G3V@VVZBE;[QIL?RKBG#K0 +UJ1:9BGT +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>*^%_ =S:R*60U[7X3TE[6- PH [5%^44?=-/3A12,O-  *?30.E.H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUK+S6+IS8C6M>%^*^\H_">NGH2XI,FG4FVMR@%+24M !1110 4QNM.-1LU
M>M)3&;F@-^=*X#Z*4<T%:8T-+TW<*#'2;,4%W0Y<4_:#VINVG+UHL0QNT4;:
MDQ330(2EI**"AXHH44[%!)$U,S4C+367VH %I:%6G;: 0+5+5&*PG'I5T'%4
M]07S(R/:I>P2/*/&6H/#OP:\;USQ/);S'+'\Z]R\8:.TT<A KYZ\<:++"[D
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M6"P]5IV*C5O>I :H0M%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?_5BN+\-P[%6NSA_U=?I.%ORJY[,=B3;2=Z7-)7HECLBEIE.H ,T;J1J%ZT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "FL:=44G2@"-FI/,J-^M-S2);9*9*3S*B.:;S5Q
M)N6E(:G^6K=LU45CFIXY#Q0TB]2;[/'_ '!36MHO[HIPD-(TE1H-MC?(0=!B
MEV@=*8TAINXDUI8RNR4TS;S0.:?2N,%IS&DHZU):&DTJ]J7;3L4#'+2TE+0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW!ZTSPOX5ENKA-R$\U\[B(>\>_3:A$IZ+X5ENE7"$UWWAOP/*DR-Y9_*O4O
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MKGA]+Q6^6MV&\$G>K:1++UKNBXUD92C<\BNO *O)D1_I6KHOA 6K#"8KTO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%)NH 6BDS2T %-W4ZF[30 ;J4'-)M-*
MM "T444 %%%% "$T;J1A0!0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BDW44 +1110 4444 %%%% !1110 444
M4 %)MI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZVS;<HKS#PG>;E3FO2M-DW*.:_0LOGS)7+YC2%+24M?1"$IM/HH 1>E+110
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MBBB@ HHHH **** &4Y:6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNJUFOEQ@58W5]=3TB>1+<?CBD-&ZEQ6A VBAJ8S46)$DYK*U+3UN%/%:9:C
M:LY4U(N,CSK5/!JW3$[/TK)7X=INSY?Z5ZW]G1NHI?LJ?W17-+#19NJAYI:^
M!4C_ (/TK:L_"JQ8^3]*[-84':G^6GI6:PL4#J&%:Z.L>/EK2AMA&!Q5K:!T
MI#75&E&)FY7!<#M3A3*<M;62)',*B:I6:H\9J62*HJ1>E-5:=0K@+124A:K
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=E?0U_I(G/(K%N/"JR?P5\KBL#[65R7J?,=[X-=6)$?Z50;0Y+=ONFOI&_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1136H =13*?0 444UNM #J*:O6G4 (W2HVJ1NE1M4R&A*5:2E]*S5
MQL=11BH;B80KD\5;E9$DQ84C2#UKG-0\1);9RV*PY_'$2G&\?G7#4Q48=32,
M;G<27"KWK,O-66$<M7(2>-HW7B0?G7.:UXN&UL/^M>/7S)16C-U3.[G\5)&<
M;Z2'Q2DA WUX5J7C!UD/S_K3])\8,\@&_O7B_P!L6E:X.FSZ'M=4$V,&M.)]
MXKR[PWKOG[<M7HFFW'F(.:]_"8WVQDX6--5IU*G2AJ^BCM<Q"GKUJ.I%I\UP
M%:FT^BF 444RE<!]%(M#47 1J8:=14O4!E.&>]+12L JTM(M.JD RBGTFT50
MQ%IU%% @HI&Z4V@!]%)2T %%%% !1110 4444 %%%% !3:=10 U:=110 444
M4 %%%% !112-0 VBFMUI5J4@'4K?=-+44TH1#]*;V Y'Q5=&")^:\!\>:^5:
M0;J]A\=:@%ADYKYE\?:IF63GO7R^/J=#AQ#T.0UK5/.E;)[UF6K@R@UFW-X7
MF/-6;$EF%?'U%=W/G:NYV^CS!=O->@Z#JHAV\UY98S&/%;-OKGV?'S8K!5G!
MG1A;\Q[YHWB0*H^:NRTWQ )<?-7S=IGBS# ;_P!:]$\,:\;AE^:O?P6,=S[>
MC3]RY[SIMYYP'-;*_=%<9X;N#(B<UVD/^K%?<4*G/$Y:BLQK=:7-#4VNHR1*
M.E+3%-/I %%%% !1110 4UJ6FM\JT 1R-C/-4KF\$.>:KZEJ(MT))Q7":]XN
M6'<-_P"M<->NJ9K"FY,Z?4/$B6^<MBN<N_'"*Q&^O-M<\9%MV'_6N'OO%$K2
M'#FO"Q68*,=&>Q3P?,CW^U\:)(P&_P#6NETW7!<8^:OF?1_$4K3+EC7K'A'5
M6EV9:N#"8UU)V)K87D5SV&VD\P U9VXK+T:0R1K6QZ5]K3UBF>-)68+UIU-6
MG5J2%%%% !124M "&HWZ5(W2F-TH C J1:9Q2AJ=Q<I6U*/S(6%>-_$#0&NE
MD^7M7MLB[UQ7.:UHJ7$;96N'$4^9&56ESQ/C#Q3X5>.9SM[UQ\UB;?((KZ9\
M<^'8XUD.VO!?%$"V\C >M?&8FARL^,QF&Y7<P;:01M71Z3K'V=EPU<8TQ#'!
MJS;7#;NM>8O=9Y4:CI['L^B^+"@7Y_UKKK+QAP/GKPBPOW3'-=!9ZI)Q\U>C
M3Q+BK7/2I8R1] Z#XG\Z11N[UZ%:W?VBW'.>*^>?!]Y(\R<GK7NOAMC);KGT
MKZ/ U7,^FP=9S6IRGCR%C"YKYI\=*RR/FOK7QC8A[5SCM7R_\2K,1R28%3CZ
M7,AXK$.EJ>%ZM)F8BM/PW"))5^M8^L9^U,/>MSPPVV1<^M?&2I<LC3"9O;2Y
M[9X+T=)U3(KU73?!D<T:G97F?@._53&":^@?"<L<\<?3I7T&"IJ5CVHY@JG4
MQ;?P*J8(2NET?PR+=E^6NSM[&-HP<"IULUC;@5]-##)%2Q',B/3[%84'%7'7
MTIJG9Q2[MU=<8J)RM\PWFG+0!3E[5I<5AU+112 **** "D;I2T4 ,IU+10 U
MJ%IU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFP9I<FDHJA#EI::M.H 2FYI]-VT *M+2#BEH *1J6FM2 8:%ZTUC3E;#5*W
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M,3ZU[MX;AVP+]*\*\'7@\Q.:]T\,SAH4^E?49:SZ_ VL-\5QYM7X[5\P_$Z
M[I.*^I_$VTVK9]*^:/B@J[I*]/&.T3+,HKEN?-FLP_Z4?K5W1W\K;46O8%TW
MUI=-^;&*^,J:R/B/:N$M#TWPCJQBD3FOH3P)KF5C&ZOF?PS _F+BO=? Z.OE
MUZN!GRR/H,#5E)ZGT1I.HB6$<UK*VZN0\/L?*7-=9!]VOLH2NCZZG=H>U)3F
MHVTV;C:>O:DVTY12"XZBBBJ$%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUSP ;@L?+S^%?.8S!NH2SY=32YEG^Z>M=7H>FR,R@@UZ9+\-2LF?*_2M32_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK=:=36H %ZTZF49I /IE&
M:*8!1114<H!11156 ?2-3:*8!1110 ^BBB@ HHHH **** "BBDS0 M%)FC-
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MZTK4#M7:87'K4E,2GT@0QN],I[=ZC:D4@+<TTKNXHQ2CBGN,@FTU+CJ*K?\
M".P[LX%:JMZT[</6ERV%<IP::EOT%6?N\4XL*C9J:L#;8R0\]*BVU+1BK;1%
MB,+3Q0:;65RW+0E!I:8O2EILE#J44RG5F:#EI:**T,PHHI1UH&)36ZU)3&H
MC;K2;:=U:C;18=A%6I5[4S%/7M18!]%%%,04444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)BE
MHH 3;2;:=14V ;MI=M+13 ;MI=M+29I@&T4;:-U+0 W;2[:6BDP$VT;:6BA
M%%%%, I#2TC4 )NHW4E%,!-U-WTM1M64K@/#4NZF+3^,4X>8"@T[=35I:<F
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C=*6DH
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M2W?A]KAON_I5X&C)R6AUJJDCR/3?!!NYA\F>?2NYT_X8GRU/E?I7H7A;P?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!-U+28I: &M24XBDVT
M  ZTZFXQ2[J %J&XC62,@BI3434I14E89QFN>'5O"?ES^%<_%X)"RY"=_2O4
M?LZOU%+]CC]*X)X2,F%SE])T7[*J_+72VT>Q:F6!5Z4N,5K2H*F 4TC%/ I&
M6NIB$W4[)IFVG[34H VTM+15@)C-&VEHH **** "BBB@!*3=2FDVF@!U%)2T
M )BC HS1NH 6BF[J=0 4F,TM% ";112T4 )@4M%% "'O7-:]??9U;G%=*S;5
M)-<'XPN L;X-<]::A&X[G)ZMXM^SN1O_ %K NO'6 1O_ %KDO%VJ&&1L-7GE
M[X@?<1NK\]S''3BWRF,I'J\_C0R,</\ K5C3]>:>0?-7C^GZE)<2@;C7I'A6
MT>9D->%A\95J3L*,KGK?ANX:3::]'TQLQBN#\,Z>R(A(KOK!=L8K],R]R<%<
MW6Q</-+117MB&M0#0PH H =3<FG4W:: %6EI%I: "DI:2@!-QI12;32K0 M%
M%% !1110 4444 %%(:3=0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH 1NE-I]% "5&W>I:C:I<K (M2U$M/6DI7 =3*?3*L!RT-3:*
M "GTRGT@"BBBF E&12-24 /HHHH **** "BBB@ HHHH :U)3Z* &4^BB@ HH
MHH **** "BBD/0T 9>J:A]GC;FO(O&_B98UD&ZO0_%#-Y;X]*\"\>"9C)C-?
M.YA4E:R!GG'C+Q,))'PU<)_:)N)>#6AXBLYI)3P:@T30Y))ERM?$U*4JLM3G
MDCJO"=HT\R<=Z]\\$Z-\J$K7 ^!?"[;HR5]*]Z\+Z+]GC7*UZ^!RO7F:%%6.
MCT?3Q'$.*VHTVU':1B./%3Y%?<4:*IJQT(?12+2UTC"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH 1J;3Z* "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "HVJ2F&LY*X#13J *7;1&-@'4RER:2M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11128!1113 **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1J;
M3FIM #J6DI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>img254193463_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_2.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $I J # 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BHY9/+
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MZF_TJ)X9?WIY5@@./3_5K^OK3O$+2+BV4'A_1KDZ18!V4-+Y0<[I6QW8Y).
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M10K@%C[]*\I\>>.+36=/%II89ECDW-(\?7'H"./K51C<Y<5B8T8/7WNB.?\
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M@ISQCC_]=8LB21@(%P%'''6NQ\+ZL-.EM'FA22U4_,Q/W2<@C'KSD=JZ[6O
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M533_ !1I6HK'Y=P$DD.%CD&"><5GRO<].6)HQERRDDS9HHHI&P4444 %%%%
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MU#P[IMY-())9[6.1W";0Q*@DX[4#0-&5)472; )*09%%LF'(.1GCG!K0 "@
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M%="5QC)'7G@\5KKV,=.YFW7AS7WEDG:UO'DDBND54D3R]QG5U+KG!W+DYYY
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M;26,0::EY]K=UQ'O0LHVG.3P0>U6KOQQ:V^GV]Y#:2W$5W*T=HP; G51EI.
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ME:V<-J9IY&Q'QP#CU["O4=2^#,LEX[V&HPI \SN$F0G8AQM4=<XY_2NF\/\
MPTT_0=9BU%+N6<P@^4C*%VDC&<CKU/YU]!/,L/&',I7=M%9_B<2P\V[6-WPK
MHQT+P]:V3ES*%#2!I"X5B.0">WTK:HHKY>I-U)N<MV>C&*BK(S]5T33];CAC
MU"W\T0OYD9#LA1L$9!4@]"1^-06/AC2--U%]0M+5H[I_OOYSG?\ *%Y!;!.
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M** "BBB@""YZ+]:KU8N>B_6H,'T-8SW-8["44N#Z&C!]#4%"44N#Z&C!]#0
ME%+@^AHP?0T )^ ]*,#T%+@^AHP?0T )@>@_*C\!2X/H:,'T- "8&,8&/I1Q
MZ#KFEP?0T8/H: $_ 44N#Z&C!]#0 E%+@^AHP?0T )12X/H:,'T- "44N#Z&
MC!]#0 E%+@^AHP?0T )12X/H:,'T- "44N#Z&C!]#0 E/A_UJTW!]#3X@?-7
M@TUN)[%NBBBN@Q"BBB@ HHHH **** "BBB@ HHHH **** (+[[/]@N/M8!MQ
M&QE!&?EQS^E>16T%I=SO)83&XM0Y".5(./<>M>O7EL+RRGMF=T$T;1ET.&7(
MQD>]>;67P@6U=Q_;UTL2G]UY2[3[[N>37+BL!1Q<5SNS6S/4R_$4Z49<\K7*
M%YX@D\+:C9[;=L/RT@/4=P!WKTW2M7BU.QAN0K1B5 P#C%<;I_P\_LK7EO[B
M^EOHHUQ )1DJ?>NSAA  XITZ<*$8TZ?S??Y!C:E"HER:ON:%%,C7:*?70CRP
MHHHI@%%%% !1110 4444 %%%% !1110 52U/48M.TZZNF9285^[G^(]!^.15
MVO)?$M[)/KVH*)&\HS %0>"4& ?YUY^8XSZK2YDM7I^!V8+#?6*EGLC,-S,6
M+,Y+$Y)]Z[WP#%(UI=7<G1W$:?0=?YUP$$,ES/'!"I:21@JJ.Y->QZ58)I>F
M6]FG/EK@GU;J3^=>)DE&4ZSJ/:/YL]7-:D84N1;O\BY1117U9\\%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 A8+U('UI/,3^^OYU#=?=7ZU6H
MO^8G]]?SH\Q/[Z_G5"BF(O\ F)_?7\Z/,3^^OYU0HH O^8G]]?SH\Q/[Z_G5
M"B@"_P"8G]]?SH\Q/[Z_G5"B@"_YB?WU_.CS$_OK^=4** +_ )B?WU_.CS$_
MOK^=<MJWBW0-"O%M-4U.*UN&C$H1U8G821G@' R#6M;3PWEK%<VLJ302J'CD
MC.58'N#18+HT_,3^^OYT>8G]]?SJA@XSCBEP1VH&7O,3^^OYT>8G]]?SK%@U
M.TN=2O=/BD)NK(1F="I&W>"5YZ'(!Z5GWWC#PYINHG3[W6;2"Z! :-F/R$]
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MHH **** "BBB@ HHHH **** "BBB@"O=?=7ZU6JS=?=7ZU6IB"BBB@ HHHH
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M5Z!_:]LI*W-Q%&WF,JC?NR <9Z<<_E4=UK<5O<?9XG21PLA<;]H3:N>3C_\
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M<]_K6GI:SRZO900%X)Y755FV%C&<@ X'6JC5ELCS,7DV#Q=5U:RN[>9Z5?\
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MV-O<33RP6NEOI>PX'F1MMRQ(Z-\HZ41>#SY5BEYKNHWWV*[BN83<;./+! 3
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MS/[B2$9QTX.>*^=) S7(9TPH&7!R=PZ?C7U7J]A#?Z:=.ET]+JTE&V2(OL4
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M>:I** (_LZ?WFH^SI_>:I** (_LZ?WFH^SI_>:I** (_LZ?WFH^SI_>:I**
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(J-U,HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>img254193463_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_3.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'F!9H# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT3QAXC\(?$E+'7=:U"YM;>Z-M=)<W+R(4)QOPQ[9# U]+.ZQQL[L%102Q/0
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M-&: "BC-&: "BC-&: "BC-&: "BC-&: "BC-&: "BC-&: "BC-&: "BC-&:
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M&C>%;26UT6S^RPROYCKYKOEL 9RQ)Z 4N9<G*5R/GYCYL^''_)7-,_Z^I?\
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M3C_@->J:GI6GZS:&TU*R@NX#SLF0,,^HST/O7+I\)O R3^<- C+9SAIY2O\
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M4KAI[C0(!(QR?)=X03]$8"M;1/"F@^'-W]D:5;VK,,,Z+ER/0L<G'XT.4-[
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M;10 [-&:;10 [-&:;10 [-&:;10 [-&:;10 [-&:;10 [-&:;10 [-&:;10
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M0 [-&:;FC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT9IN:,T .S1FFYHS0
M[-&:;FC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT9IN:,T .S1FFYHS0 [-
M&:;FC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT9IN:,T .S1FFYHS0 [-&:
M;FC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT9IN:,T .S1FFYHS0 [-&:;F
MC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT9IN:,T .S1FFYHS0 [-&:;FC-
M #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #
MLT9IN:,T .S1FFYHS0 [-&:;FC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT
M9IN:,T .S1FFYHS0 [-&:;FC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT9I
MN:,T .S1FFYHS0 [-&:;FC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT9IN:
M,T .S1FFYHS0 [-&:;FC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT9IN:,T
M .S1FFYHS0 [-&:;FC- #LT9IN:,T .S1FFYHS0 [-&:;FC- #LT9IN:,T .
MS1FFYHS0 W#?W3^5&&_NG\JL44 5\-_=/Y48;^Z?RJQ10!7PW]T_E1AO[I_*
MK%% %?#?W3^5&&_NG\JL44 5\-_=/Y48;^Z?RJQ10!7PW]T_E1AO[I_*K%%
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MK%% %?#?W3^5&&_NG\JL44 5\-_=/Y48;^Z?RJQ10!7PW]T_E1AO[I_*K%%
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MIH%N5@AMI9I&C8L P5%)(RK9].^,BI)/$VC1Z-;ZL;Y&LKDA8'16<RL> JJ
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MV<>6 CJS$@=F(&3C'-.S"Z.UHKD]*\0O'J_B@:G?-]@TZ6V6%I8PC('@C8Y
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M$$<BG<7*<;HI:Z\3W<'B6TNEU34=/\E4EMXHX7MHV.Y0(YI><R\[F[C %5/
M.G7LNK2C4&$L'AM9-)L9,Y\P[LL_U$8A3ZAJ[33?#^FZ5<-<6T4S7#)Y9GN;
MF2>39G.T/(S$+D X!Q5C3M,L])M/LME#Y41D>0@L6+,[%F)))))))Y-%PL6Z
M***DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *165U#*P8'N#FEJMI__ !Y1_C_,T 6:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ILDB11EW.%'4TZJVH?\>,G
MX?S% %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $9E7&Y
M@,G R>II:K7O2#_KLM6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *3<N[;N&[&<9YQ2U6_YBG_;'^M %FBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM
MI_\ QY)]3_,U9JMI_P#QYK]3_.@"S1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %5K__ (\9/P_F*LU6O_\ CRE^@_G0!8'04M(OW1]*6@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** *U[T@_Z[+5FJU[]V'_KJM6:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K'_ )"8_P"N/]:L
MU6/_ "$U_P"N7]: +-%%% !1110 4444 97B3Q!:>%M NM9OHYI+:VV;U@4%
MSN<*, D#JP[U-HVL66OZ1;:GI\OFVUPFY3W'J".Q!X(KE?C#_P DKUK_ +8?
M^CXZX'PYJ%W\*M7TY;QGD\+:[#'.LAY^SRLH)_+//JN#U&*T4;QOU,Y3M*SV
M/6?#GBRP\3RZE'90W,9T^Y-M+YRJ-S#/*X)R..^*WJ\5\%^(8_#6@_$#6R@F
M6WU)F10>'9F*J,^A+"LL?%C4[*VMM5;Q=9ZC.S*9]%72WB5%/W@LQ498>YQ]
M>XZ;;T$JJ2U/?JCN)XK6VEN)W$<,2%W=NBJ!DD_A7G/B'QCJG@KQ;%>ZK/+=
M>%M0@)@ A4/;3!<[<@ G..,D]?\ 9-96JS>,-4^$FK:YJ6K?8_M:M,EDMLA"
MVK @1[L!@6#9W$DXQW)I*!3FM3UBSO+?4+*&\M)5FMYD#QR+T93T(J>N%^%M
MAJUMX1T^XOM:^VV<UG$;:U^RI']F&.F\'+]ASZ5W52U9V*B[JX4444AA1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!QWQ*\5W_@WPLNJ:=%;2SFY2+;<*S+@AB?ND'/'K6#JGC3QMX2L[
M75?$>FZ+=:3*Z+(^F/*LD6[H2'Z_Y&1FE^.__)/8_P#K^C_]!>JFM:?XW\>Z
M)9Z'/H%OHFFEHWGNI+Y)V=5Z;53IZX/MR*UBE97,9-\S2/5H9H[B".:)MT<B
MAU;U!&0:?7B.L^&%UWXS2Z M_=6=B=)C2<P, \D2[<)DC'4*>G:KDFAP:Q\1
M[7P)=W%RWA_1M+5UMC,4-RPVC+E<9/SCIC[IQCFER+N5SOL>Q45Y%HJWGA3X
MBZUX1T.:9["736NK.WF<N+>;;Q@GMDG]/2O.IK/0]>\+P6D$6I7?CZ6Z*7"O
MYCD_.0=Q/RA0,>X/7BA4[B=2W0^HJ*\/\2>$H9OBMH'A:QN[BQL3HHA=X7_>
M&(/,Q4$YZX[UM^)]'\&>'['1/#^J7.M7R6\3^1I5K(6:Y!8G<ZH%S@YP<COU
MI<BTU'SO70]5HKP'0+]QX8^(NCP17]OIEM;&2UM+\$2VP8,"I!)QT'&>WN:K
MZEH4.C_"31/%]C=7L6N(8@+K[0Q(0Y4(!G 4 #H*?L_,7M-+V/H:BO%[W1+;
MP3X\\$7.C27*/JSM%?>9.S^?]P;FR>OSD^F0*]HJ9*Q<97"BBBI*"BBB@ HH
MHH *Y?XA>)+SPGX/N=7L(H)+B)XU59U)3#, <@$'OZUU%>??&G_DF5]_UUA_
M]#%5%7DB9NT6SM-'O)-0T/3[V4*LMQ;1RN$& "R@G'MS5VO$?$MDNHZW\,[)
MYIX4GLA&[P/L?:40$ ]LC(_&M'3["V\"_&2'2-&$T6EWVEM<36QE9UWKOY&X
MGG]V/S-5R$\YZIJ-P]IIEW<QA2\,+R*&Z$@$C->=6OCWQ7J/PWT_Q!INAP7^
MI7%X898((W*)&&8;@NXGL!G.!G-<[X4\.VWC?PKK/B_7;BYFU:1YO(DBN&3[
M,%7("@''X'(QBL"^_P"3<--_["9_]"DJE!;$.;W\CZ-0LR*67:Q )7.<'TIU
M>4:I9KXX^,5]X>UB69M'TJR65;-)619G8(=S8()^_C\!ZFM?7="\,>$O!<MA
M>:KJMEIDMT&58KIVD8_\\4ZG:<'CZG/>HY33FW/0*P])\36VL>(M<T>")P^D
MM$LDI(VN74GCZ;2*\F\+3Z?9?%33M,T'3-8TO1]4LY4N;34 Z"8A'/F*&8G^
M$#.?7I5KX>>#= N/B#XK\ZP+_P!C:A"UAF:3]R0\A_O?-RB_>STI\B5[DJ;;
M5CT3PGK7B#5K[6HM;T;^SX;6Y\NS?:P\Y.>>3\W0'<.#N]JZ>O!(=;O/#^F_
M%*_L',=U_:_E)(.J;YI%+#W )Q[XJ]XA\&V?ACX<0^+M,O+R/Q! EO<27PN'
M8SEV12""<8^;T[<YIN&H*;L>VTUW6-&=V"JHR2>PKQ;5;:/Q?\5_"Z7QGAAU
M#P]'+<1PR&,L#YKE"1SC/!%);0?\(KXK\=^&]':9--30I;R"W:1G$<@C7[N3
MG^,]\]/2ER#]IY'>_#_Q!J7BG3]0UBZV+837CKIZ!<,(5XR3WR<_D?:NBU?[
M<=&O?[,=%O\ R7-N77</,Q\N1]:\M;3M9OO@!I-MX>21IV1&FB@?:\D>YBX!
M]22#^?TJ]\,9_"D>L7EII.GZIHVJ+!_I&FWLCE< C+@,>3TY.#STQ0X[M"4M
MDSK? GB-O%/@^QU.; NBICN5 QB53AN.V>N/>NDKSGX1EEM/$\(7$,>N7 3C
M@<+D#\A^=>C5,E9EP=XH****DH**** "BBB@#S*3QAXSU/X@ZSX;T&'0533U
M#A[]9@64A>Z-URWH*OV7C?6-)\2VF@^,M.M+66^.VTOK*0F"5NFW#<@YP.?4
M<=ZQ_"7_ "7GQ?\ ]>R_^TZ;\<"9+7PW;6Y'V^341Y"C[W3''XE?TK6R;43&
M[2<KG8PZUX@?XAW&COHVW0DMA(E_M;YGP.-V=O4D;>O&>E=/7E4JSO\ 'W4%
MMF"W!T0B)FZ!L+@G\:Y;PM#I6BZ[81>,]+UO3O$C7>Y=4:=_*N6+\*2#C;T!
MQD'N12Y+CY['OU%>/:!HMK\2O%GB>\\2-/<0Z?=FTL[19F185!8;L*1SP/QS
M4_C"S>WUGPAX"M[^]CTFZ+&YD>X8RS(IR$+^G48Z<CT%+DUL/GTO8]:HKR&Y
MTRW^'WQ-\/6.@^='I>L*\-U8O(TD9(P-PW$\\@_@>QJEI6MGX<V?CG0'<J;$
M_:]-!/59<*N/H6C_ %HY.P>TMN>UT5X+K-IJ?A?P/X.\,VD4S3ZU<--?1Q3B
M&2=B4/E>81\N=X7/^SWK<\)>'/$FB^-;&YL/"DVA:,Z/'?PMJZ722<':^,Y#
M9QTS^'-/DTO<%4=[6/7J*\'^%_@>V\403:IJ=]=FWT[56^SV<; 1EQM=BP(.
M0<J.,' ZU)8:_)\.M+\:^%WD836K&;2\]667"@CZ;D;Z[J.36R8E4TNT>Z45
MS?@+P]_PC'@S3M-=<7 C\VX]Y6Y;\LX_"NDJ'N:+5!5:P_X]!]3_ #JS5:P_
MX]1_O'^=(8:C</::9=W,84O#"\BANA(!(S7G%M\1]8F^#UYXN:VL1J$$PC6,
M(_E$>:B<C=GHQ[UZ%K?_ " =1_Z]9?\ T$UX;8?\FR:I_P!?2_\ I1'6D$G]
MYE-M/3LSUKP+XRM/&OA^.^AVQW4>$NH ?]6^.W^R>H/^!K"T7QYJFI:%XTOI
MH+-9=#>X6V"(P5_+5B-^6Y^Z,XQ7&7]A??#Q]%\=:+&SZ=>6L"ZI:K]TLR#+
M>VX\Y[-_O8J3P5=17W@3XEW<!)BG^U2(2,$JT3D?H:KE6Z)YWHGN='X=\1_$
MKQ)X=M]=LK7PNUM.'*0-YZ2G:Q4CJ5'*GO73>#/&D7BJ.[MY[1[#5K"3RKRS
MD;)1NF0>XR#_ )P3G_![_DE>B_\ ;?\ ]'R5@^&,S?M!>*YK4@VJ6:QRE>GF
M8A&/KE7_ "-2TFVNQ2;2B[[G3?$KQ7?^#?"RZIIT5M+.;E(MMPK,N"&)^Z0<
M\>M0V$GQ,FDM9;@>$A:N4:3R_M._8<9QGC./PS61\=_^2>Q_]?T?_H+UO^&O
M^$Z\^T_MG_A'?[,\KG['Y_G?=^7[WR]<9HM[MPN^>QU]%>+:-X7T[Q5\4/&M
MKJWGRV<4T;_9TF:-';D!FVD$D<X^IIOA74+*W\">*-)UW6KZSTO3M1:W@GAF
M(F5,\1J<$G.T\8[GI1R#]IY'M=<=X1\5W^O^*?%6EW45LD&D7*10-$K!F!,@
M.[)()^0= .]>;:->:;H_Q,\.KX7TW6M+LK_=%=+?JZI=C'#KN8YP3R>,''O6
MAX9\)Z;XJ\?^/(=5-Q):Q7J_Z/',T:.Q:3#-M(R5P<=N33Y$D[BYVVK'H7Q"
M\27GA/P?<ZO81027$3QJJSJ2F&8 Y (/?UJO+XB\1'Q)X>M+;15GTJ_M1->7
MBHV(7()P#G"XXZYSG KR.ZNKE/A9XOT.6YDN;;2=6C@MI9&W'9YF, ^GRY_X
M%77ZK_R4WX=?]>)_] -'(D+G;?W?F>NT5XEX2\'Z5XN\5>.8]8^TS6\&K2^7
M D[(@=GD^? (RPP,9X]JR[75=:F^"%RJ7=T\-AK'V6YEC<^:+0*I(!_WG ^G
MM2Y/,?M.MCZ!JO??\>4OT'\Z\,\/^&?"7B#XE:9/X6M+N31;2'S[N1O,"+,O
M*#<_.<XR.G!QQFO<[[_CRE^G]:F4;%QES$Z_='TI:1/N+]*6I*"BBB@#E_B%
MXDO/"?@^YU>PB@DN(GC55G4E,,P!R 0>_K7*WGC3QWH&@6OB/5M,T*[TB18Y
M)%L'E26-'Q@G?D?Q <9Y_.M'XT_\DROO^NL/_H8K N+?QQXQ\#:?X=B\/6^E
MZ?-;P+)?S7Z2[XE"D$(O(S@'!SZ5K%*UV8S;YFD=/:>.;B_^(MAHEK';MI5Y
MI:WZ2E&$IW D<[L8QCM7<UXG>>%;*X^,.E>'II;C[#;Z''$PBE,;2J@(PQ7G
M!QSBM#PFEMX7\>>,O#4=Y-:Z#;6:W*[IC_HV44LRL<D??//L.M)Q70<9M;GK
ME%?-OB&^\/Z/9VFM^$K?Q$=0@NE+:U=!_*N1SE68G!)QTVC.#76?$2PE3QS)
MJ7B71-2U?PNMLJPBRD8"V?C<[!2.<[NI Y'/&*/9A[0]FHKP_P 5:VMSH?@[
M0O"\E[?:5J+ON1KORIK@(P'E-(WW>21^7M6MX+\.^(M%\;6TUKX7FT'0I(72
M\@;5DNT+;25<#.0=P4=^O:ER:7'[36R1Z;JVK6.AZ7/J6HW"P6L"Y=V_( >I
M)X KA? GQ(OO&7B[4K!]/CM+"&W$\ 96\X@E=I8YQ@AL\#N.37H5S;6]Y;O;
MW4$4\#C#QRH&5A[@\&O-?#H"_'[Q8J@ "P@  [?)#1&UF.5TT>GT445!8444
M4 5KW[D7_75:LU6OO]7'_P!=%JS0 4444 %<-\2?&&J^$X-)_LF&RDFOKGR#
M]K5BHX&#\K ]3[UW->3?'%I$@\-/%'YLBZAE(]VW<<# SVS505Y$5':+:+]]
MXU\6>$=2TY?%VGZ3)IU[,(!=:8\G[IC_ '@_)[GZ _0[/AKQ9?ZSXW\2Z+<0
MVRVVENBPM&K!VSG.XDD'IV KG=;T7QA\0KW3+36-$@T+2+2Y%Q,#>K<22D<8
M&S@<$CGUK)T7PMIOBGXI^-8-5$\EM%*A,$<[1HY.<%MI!..W/>KLK:D7E?0]
MIHKQCP??VMOX%\5:5K6LWEII6FW[6\5S%,5FCCSPBG!/)'3!^\:R-/O=*T?X
M@^%Y/"NG:WIMM?3&"Z>_5UCO5)4;EW$[B-QSTQ\N*7L]RO:;'OU%>":_9P:=
MXQUF\\>Z3K$]K/<YT_5;25MEK%D[0,$ <8X.3P>.YO>,+Z[\1>.=-T"QL)];
MTB+3DN4LDU#[,+H,,AVD;EN"..O4^M'(+VGD>VURWC;Q9+X8M+&*QLOMNJ:C
M<"VM("<*6/4L?09'Y_4U@?#?1_$6BZSJ<-WHTNDZ#+&KVMI)J"70AD& 0K Y
MP1D\CL*] OKZUTRQFO;V=(+:%2\DCG 45-DGW+NW'L<1I_C#Q#IGB^Q\/>+;
M+34?449K2YTYG*;AU1@_.??W'X=_7DOAA+SXB^/T\97$#V^B:8&ATZ-Q@S-R
M-WZDGW '.#7K5.:L*#;04445!856;_D)K_UR/\ZLU6;_ )"2?]<S_.@"S111
M0 4453T_5M.U:)Y=-U"UO8T;:SVTRR!3UP2I/- %RBH+R]M-.M7NKZZAM;=,
M;I9Y B+DX&2>!S4+:OIB6]M<-J-HL%TP6WE,ZA9B>@0YPQ/;% 7,'XDZ/?Z_
MX U/3-,@\^\G\KRX]ZKNVRHQY8@= >]/N_"5OKWP_M?#^K1;'6SB3(()AE5
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M]I]E^R^3TZ?-OW>W3%1>)? _]L:W;:]I>JS:1K-NGE"YBB6173GAT/#=3_\
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MW5&+KT+R DO^/OZUZ!11S,.1'#7_ ,/KI/$5YK/AOQ'/HDU_S>1K;K,DI_O
M,1M/).>>2<=:GU7X?1:MHNF6TVL7YU33',EMJKD-,')R<^HZ<>PYKLJ*.9AR
M(XO1O <]OXCC\0:_KLVMZE!&8[9W@6%(0002$4D9Y//O3/%OPVL_%GB;3-8F
MNS +4*EQ"(MPN45]P4G(QW['K[5V]%',[W#D5K'/>+O"-GXOTV*VN)I;:XMY
M1-;74)P\+CN/\^E4M$\*:[9:O#J&L>,;W5! A2.W6W6",@C'SJI.X^_6NNHI
M<SM8.57N<QX&\(?\(9I-W8_;OMGVB\>ZW^3Y>W<JC;C<<_=Z^]<=XBTFQ\5?
M'#2K:.$-_9-L+B_DQP<-NC0^^2/P/M7K%%-2=[B<%:P4445)856L/^/;_@3?
MSJS56P_X]S_OM_.@!][;?;+"XM=^SSHFCW8SC((SC\:X:W^&7D?#&Z\&_P!K
M[O/E$GVO[-C;^\5\;-_/W<=>]>@44U)K83BGN9L&C6X\.0Z)=A;JW6U6VDW+
M@2*%"DX[9Q7*^'OAI%X=\->(=$@U1I(M621$=H,& ,A09^;Y\9]LX[5WE%',
MT)Q3/-M*^'7BG1M'BTBQ\?R0:?%N"Q1Z5&& 9BQPY8L#DGG-=7X4\):=X1T^
M2VL?-EEG?S+FYF;=),_JQ_/CW]S6]13<FP4$MCF/'GA#_A-O#RZ5]N^Q8G6;
MS?)\SH",8W#U]:H67A?QI:S6_F^/_.MHF7=#_8T*[T!&5W9R,CC-=M11S.U@
M<5>YR^@^#_[$\6:]KOV[SO[696\GR=OE8S_%N.[KZ"N=E^$4%QI&L64VL2;[
M[4?[1AF2#;Y#C=@$;CN&&([5Z511S,.2)P2?#N_GU[1]:U;Q1<:C>Z=*6R]J
MB(R8^ZJJ1M/<GG-1?\*WU2TUK6]5T?Q=<:=<:I.9'5+-715Y.TAFY(W'##&.
M?6O0J*.=BY(GG\WPLL_^$ N/"]KJ$D<ES.MQ/?2Q>8\CA@22,CTQU_.M&Z\#
M_:?$WAS6?[1V_P!C0>3Y/D9\[Y<9SN^7\C77T4<S'R1.8\+>$/\ A&M6\07W
MV[[3_:]X;K9Y.SRLLQVYW'=][KQTKSSQ1X,G\)^ AI/F3ZAI]WK2W=]=6]N5
MDM8B%!*J&.<;3R>.>G0U[510IM.XG!-6/$M'OY+CQ?HL?@KQ3XCUNU,X.I#4
M&=X8H01GEE7!QG''7'->RWW_ !Y2_2K%5[W_ (\Y?I1*5QQC8F3_ %:_04ZF
MQ_ZM?H*=4E!1110!S_C7PQ_PF'AF?1OMGV3S71O.\KS,;6!Z9'IZUJZ79?V;
MI-G8^9YGV:!(=^W&[:H&<=NE6Z*=]+"LKW.7?P?O^(L?BW[=C9:?9?LOD]>O
MS;]WOTQ5&[^'5O?^)?$>JW5^[0ZU9K:M;I%M,6%0;@^3D_)G&.]=M13YF+E1
MY==?"2_U#PRFA7WC"YGM;;:+.,6:(D6#_$ V7.,@9;C-=%KWA/7=3U*YN-.\
M8WFG6US&(Y;4VR3(!C!V9(V$^HYS77T4<[%R1.(N_AAI$WA33-$MKBXM9=,?
MS;2^C(\U)"<LQ]<GG''0>E7-"\+:W8:NFHZQXNO-5:.(QI (%@BP<<LJD[CQ
MUZUU=%',Q\J*VH0W5SIUQ#97?V.Z="L5QY8D\INS;3P<>AKSZT^&_B6S\27.
MOQ^.O^)A=JL=Q+_9$?[Q%V@#&[ X4<@=J]*HI*36P.*>X4444B@HHHH K7W^
MJ3_KHM6:K7W^I3_KHM6: "BBB@ KE/&O@O\ X3#^RO\ B8?9/L%R+C_4^9YG
M3C[PQTZ\UU=%-.VJ$TFK,*Y?0?!_]B>+->UW[=YW]K,K>3Y.WRL9_BW'=U]!
M74447!I,\WD^$EM<:)KNFW&JNW]IW_VZ.1(-I@?)P,;CN'S$=JLGX<ZA=ZMH
MVJ:OXKN=1O-,N%E0O:HB%!C*A5/!) RQ)Z#BN_HI\\B>2)P6K_#_ %C6'O;6
M;QI?_P!CWDIDFLGMT=L$YV+)U5?0 8JUKGP]MK^;3+W1]0FT;4M,@%O;7,*!
MQY0& K*<;@![]SUKLZ*.9CY$<[X;\.ZGH]S=W6J^([S6+FY"J?,C6*) ,_=C
M&0IY[5G_ ! \#W?CBUM;--<;3[2%B\D(M_,$S<;2?G7ISQ[UV5%+F=[ARIJQ
MQ6B^$_%6D364;>-(Y=-MBH-DFCPQ*T8_@# Y7CO7:T44-W&DEL%%%%(856;_
M )"4?_7,_P ZLU6?_D(Q_P#7,T 6:*** "OF[X0:S<>&=;LVN6QI.N.UKN/1
M)T(VY_[Z _X'[5](UX7X%\++XN^"=Y8)A;Q+Z2:TDZ;955<<]L\@_6M(-6=S
M*HGS*Q;^,NIW6MWC>&-/8B'3K5]2U!QT&U<HI_,?BZ^E-UH:6OPU^'[ZE8SW
M0\R!(Q#<^3M)7G/RMD<#@8/N*O6_A74=$^&'BW5/$!WZ]J=O+)<L6#%% (5<
MCCU/''(':LGQ/_R2_P"'?_7S;?\ H!JU;1(AWU;.BT26.#X]>,9I7"1QZ?"S
ML>@ CA)-6S\4+V2PEUJT\(WT_AR)CNU#[0BL4!P76(C)''K]<5CK8/JOQ>^(
M&G1,%DN]&$"L>@+0Q*#^M<EH-G\/M-T46'BWP_?#Q+;LR26Z_:-]P=QVE K!
M>F!VZ9I63W\@YFMO,]7UKX@I:76D6.AZ7)K-_JL'VFWA2985\K&=Q=@0. >/
M:N>^(/BS7_\ A6EQ.?#MUIDLSFWN'DN5!ML,F&7'+ALE01C&,],9@\96_@:*
MUT.#5(]8T-H;)6L;V&*3,"]HF.&)8>G49ZC-9%V/$>L_ K5FU$W5YLNU:TEG
M0B:6W5U^=AU/<\\\&A):,<I/57.YL?&=SHO@9M8\3Z.^FQ6\<20*MTD[W65&
M",8P3Z'W/:J\?Q+O+*ZL#XC\+76CZ?J#B.WO&N%E&3TWJ "GX^_I7/\ BFYC
M\>_">V;PX);R72IK>6:'R6!?;&0R@$?-C<>G]TX[5#XW\3V?Q+TG3O#?AV&Z
MFU":Z22Y5H&46B@$'>2 .,]O0_2DHI[H;DUL_P#@G5ZA\1+Z'QEJ7AC3/#$^
MI7MHD;H8[E45PR*Q+%AA -P'4Y/I5O0?B)8ZGH>K:AJ-K+I<VCN4OK>1MYC(
MST( W9((Z=16%X<79\??%:[BV+" 98Y)^2'K7,PZ-=>()?BSIMDNZYENH&C7
M^\4ED?;^.W'XT<L?R#FE^9V ^)U];VUMJNI^$KRR\/W+*$U!KE&90WW6:,#(
M4YZY_.M#6O'EU:^)G\/Z#H$NM7\, N+@+<K L:'&,%@<GD<>]>9:1#\+VTJR
MM;[PUJ4OB#:D5S8QBY\WS. S8W!0,\XSGVK?^(?_  A\7B":2>[UG1-?M[=!
M;7=K%(%N#M^500/FQP,_+TQGBGRJ^PN:5KW/5M(OIM2TJWO+BQGL9I5R]M/C
M?&<XP<?G^-7:YKP!/K5UX(TV?7P_]H.A+>8N'*[CM+#UVX__ %UTM9/1FR=U
M<****0PHHHH **** "BBB@#E/"O@L>&M=\1ZD;_[2-:N?M'E>3L\GYI&VYW'
M=_K,9P.GO6;8?#4Z4/$MK8:OY6E:W!+&+(VV1;.ZE=RG?R!D\8&1@9XKO:*K
MF9/(CQ3Q?H'_  C>F>#M&U"XO5T33Y)9+C6+&)EEA?DK@#=LY(YY/''0BKO@
MN]N[KQ];KX<U_7=:\-B!S>SZH695?:=H1F4'.[;Q@=^M>O44^?2Q/L];HX[P
MOX#_ .$;\$7WAO\ M+[1]J\[_2/(V;=Z!?N[CG&,]:IO\,K>?X96_@Z?4F8V
M[M)'>+#C#&1G!V;CQAR.M=[12YF5R1V.-D\)>))=(@@;QQ>C4()C*MVEJBJP
M*@;6CSA@.3R>I^E6O"O@[_A'[W4=4O=2EU35]0*_:+MXA&"%& %0< ?X#TKJ
M**7,PY5N%%%%(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "JMA_Q[G_ 'V_G5JJUC_J&_WV_G0!9HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "H+W_ (\Y?]VIZ@O/^/.7_=H EC_U2?[HIU,B_P!4G^Z*
M?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %6^_P!0O^^O\ZM5
M6OO]0/\ ?7^=6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K
M/_R$8O\ <-6:JR?\A&'_ '#0!:HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "JTM_;07]M922;;BY5VB3!^8)C=S[;A5FLV^
MT6"^UC3-3>69)]/,GE!" K;U"L&XYX%-"=^AI45Q^D^.+'[!J\NJWL$<VGWU
MQ!Y8(#NJM\@5>I)! XZFMG1CJ]SI4EQJ3+;W5R3)% %!^S*?NH3_ !,.I]R0
M*))I!&2>QKT5C?VM-)8I%&JC4GD\@H>0CC[S?[H'/XBI=9N[NRM+=K8AY3*%
M8$?? !)'U.*YOK,.5S6R_JWJ;>QES*/<U**SM0U QZ6L]H0TLX @STR1G/X#
M)_"I(;F1]%2Z)'FFW$A..^W-7[:/,XKM<7LY6OYV+M%8UC<27$=L[:Q$SR*K
M&(*F22,D>M6M4GFABMQ!((VEG2,L5!P#[&I5=.#G;3Y?YC=)J7+?\R_1669+
MNTOK2.2Z6=)V9"IC"D84G(Q]/UJQJ=S):V1:''GR,L<0(_B8X'^/X4_;+EE)
MJUO^'%[-W274N451TVXFD^T6]RP:>WDVE@,;E/*G'T/Z4NKP276CWD$,7FR2
M0LJIYS0[B1TWKROU%:4YJ:NB)1<78LPW$%P9!#-'(8G,<FQ@=C#JIQT/(X]Z
MDKS/P!X<\2Z7K][<:Q/)<P>?*H9YY$VOA<R!2,2AN!N/(VUZ95R5F1%W0444
M4B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ&UE:>V
M21@ 3G./K0!-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 >;_P#"P-5_Y][+_OAO_BJ/^%@:K_S[V7_?#?\ Q5<I17PW]HXK
M^=GUGU+#_P B.K_X6!JO_/O9?]\-_P#%4?\ "P-5_P"?>R_[X;_XJN4HH_M'
M%?SL/J6'_D1U?_"P-5_Y][+_ +X;_P"*H_X6!JO_ #[V7_?#?_%5RE%']HXK
M^=A]2P_\B.K_ .%@:K_S[V7_ 'PW_P 51_PL#5?^?>R_[X;_ .*KE**/[1Q7
M\[#ZEA_Y$=7_ ,+ U7_GWLO^^&_^*H_X6!JO_/O9?]\-_P#%5RE%']HXK^=A
M]2P_\B.K_P"%@:K_ ,^]E_WPW_Q5'_"P-5_Y][+_ +X;_P"*KE**/[1Q7\[#
MZEA_Y$=7_P + U7_ )][+_OAO_BJ/^%@:K_S[V7_ 'PW_P 57*44?VCBOYV'
MU+#_ ,B.K_X6!JO_ #[V7_?#?_%4?\+ U7_GWLO^^&_^*KE**/[1Q7\[#ZEA
M_P"1'5_\+ U7_GWLO^^&_P#BJ/\ A8&J_P#/O9?]\-_\57*44?VCBOYV'U+#
M_P B.K_X6!JO_/O9?]\-_P#%4?\ "P-5_P"?>R_[X;_XJN4HH_M'%?SL/J6'
M_D1U?_"P-5_Y][+_ +X;_P"*H_X6!JO_ #[V7_?#?_%5RE%']HXK^=A]2P_\
MB/<Z**K:A?0Z=8S7<Y^2-<X[D]@/K7W$I**<GLCY1)R=D-U'4[32K<SW<PC7
ML.I8^@'>N)O_ (@7+N5L+:.)/[TOS,?P' _6N:U35+G5[U[FX;)/"KV0>@JE
M7R>,SBK4DU1?+'\6?18;+*<%>IJ_P-YO&6O$\7H7V$*?X4G_  F.O?\ /_\
M^08__B:PJ*\_ZYB?^?DOO9V?5:'\B^Y&[_PF.O?\_P#_ .08_P#XFC_A,=>_
MY_\ _P @Q_\ Q-85%'US$_\ /R7WL/JU#^1?<C=_X3'7O^?_ /\ (,?_ ,31
M_P )CKW_ #__ /D&/_XFL*BCZYB?^?DOO8?5J'\B^Y&[_P )CKW_ #__ /D&
M/_XFC_A,=>_Y_P#_ ,@Q_P#Q-85%'US$_P#/R7WL/JU#^1?<C=_X3'7O^?\
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M /\ (,?_ ,36%11]<Q/_ #\E][#ZM0_D7W(W?^$QU[_G_P#_ "#'_P#$T?\
M"8Z]_P __P#Y!C_^)K"HH^N8G_GY+[V'U:A_(ON1N_\ "8Z]_P __P#Y!C_^
M)IK^+M=D0HU]E3P1Y2?_ !-8E%'US$_\_)?>P^K4/Y%]R-P>,->4 "^X' _<
MI_\ $TO_  F.O?\ /_\ ^08__B:PJ*/KF)_Y^2^]A]6H?R+[D;O_  F.O?\
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M /$T?\)CKW_/_P#^08__ (FL*BL?KF)_Y^2^]FOU:A_(ON1N_P#"8Z]_S_\
M_D&/_P")H_X3'7O^?_\ \@Q__$UA44?7,3_S\E][#ZM0_D7W(W?^$QU[_G__
M /(,?_Q-'_"8Z]_S_P#_ )!C_P#B:PJ*/KF)_P"?DOO8?5J'\B^Y&[_PF.O?
M\_\ _P"08_\ XFC_ (3'7O\ G_\ _(,?_P 36%11]<Q/_/R7WL/JU#^1?<C=
M_P"$QU[_ )__ /R#'_\ $T?\)CKW_/\ _P#D&/\ ^)K"HH^N8G_GY+[V'U:A
M_(ON1NCQCKV?^/[/_;%/_B:NVGCW5(6'VB.&X7OE=K?F./TKE:*J./Q,7=5'
M]]_S%+"4)*S@ON/6]&\26&M#9"QCN ,F%^OX>HK8KP^*62&598G9)$.593@@
MUZIX7UW^V].)EP+J'"R@#&?1OQKZ++<T^L/V53XOS_X)XF.P'L5SP^'\C<HH
MHKV3S HHHH *S;W6H+'6--TR2.5Y]0,@B**"J[%#,6.>.#6E5:6PMI[^VO9(
M]UQ;*ZQ/D_*'QNX]]HIH3OT.7TGP-8?8=7CU:Q@DGO[ZXG\T*#(BLWR%7ZJ0
M #QT-;N@IJD-@;75B)9[=S&ER"/](0?=<CLV."/4''6M2BAR;W$HI;%!+';K
MLM[Y:X:!4#]\Y.?TQ3[ZWDGDLS& 1%.';GH-I']:N45C[&/*X]W?]37VCNG\
MC$M]+N4N9$<+]F@606OS<DOZ^F!Q^-7H+:5-$CMF $HMQ&1GOMQ5VBIAAX0V
M_K_AMBI5I2W,>QCG@BMHWTA%9%56D#IQ@8)]:LZI9M>Q6\81719T=U;IM'6K
M]%"H14'3;NOE_D#JOFYEN9::6EGJD5S:6\:QLACE  &WN&'\C_\ 6I]]8R7U
M_;!RRVT(9RR.58OT'3G@9K1J.6>&!=TTL<8]78#^='U>'*XVT;O87M97YNI0
M@TY[+5A- TCPRQE)C)(6((Y4\_4BM.H5N[9XC*MQ$T8X+AP1^=2JRNH92&4]
M"#G-:4Z2IIJ.Q,IN6K%HHHJR0HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *K:?\ \>2?C_,U9JMI_P#QYI]3_.@"S1110 4444 %
M%%% !1110!6_M"R\J27[9;^7$=LC^8,(>F"<\&BWU"RNW*6UY;S,.2(Y58_H
M:X0?\BIXC_Z_!_Z&M6=+A^U^(-.C^PP:;):PB4[2"UP"!R,  _\ ZZ\F.8S<
MHQY=[=^K:].E]3T7@HJ,G?:_Y)_J=M/=6]ML\^>*+>=J^8X7<?09ZT3W,%J@
M>XFCB0G:&D8*"?3FN'\1W]A?ZQ=V]W=>4EI 4@PK',QY)X'&, 5+KFH_VGX*
ML;H?-(9T5QG^, @_X_C5RS%)U%&SY=M>VCN3'!-J#=]=_GL=G-=6]N4$\\41
M<[4#N%W'T&>M$]S!:Q^9<31PQYQND8*,_4US&C.=1\2W4VJH8K^W&(+5N1&G
MJI[GW]_RPM?UFTUF&\DDN"C1$):6VULGYAN=CC&2,\9HJYBH4G4TZV3TVWO_
M );[!3P3E44/2[]>W^9Z314-K=0WMM'<V[[XI!E6P1D?0U-7I)IJZ.%IIV84
M444Q!1110 4444 >&4445^<GVP45J^&_^1CL/^NHK=TZUA7Q\\HO[=G^U3'R
M0LF[^+CE<<?6NNAA7547>UY6_P"#O^!SU<1[-M6V5SC:*[BP>SGCO;.+4CIN
MH&]=O,SCS!DX&>,CVS7+:W!=6VLW,5Y()+A6^9U& V0"#^6**V%]G34T[I_U
M;>]_D%+$<\W!JW]>GZE"BNE\*6LL:7NKQP/,]M&5@14+%I&XZ#G@=?K6J+'[
M/X]T^[6)HXKU3,%88*L4.X$>N>?QJZ6!E.$9WW:6W1NU_O(GBU&<HVV3^]*]
MON.%HKK=-O;B_P#%,VF7DC75G/+*C13$L% W$%<_=(QVKE[F)8;J:)&W*CLH
M;U .,UA5HJ$5.+NKM?-?\.:TZKE+E:L[)_>145W>FQW4WAW08;74!:.TLN<E
MOW@#,<8'!^AQ5:PABOO%^H:C#:.(+/,GDA/F:0# &T=R0373]0?N6E\5NG=7
M?7I\C#ZXO>NMK_@[+[SC:*Z7Q9:RN;/5G@>%KN,"9&4J5D7@\'U[?2LK1=,.
MK:I%:;_+1LL[XSA0,FN>IAI1K>Q6KZ>=]C>%>,J7M'HNORW,^BMS^S=.GTF?
M4K870CMIE22.21<NI. 00O!]L&NFB6UC\=7L4<,B,ML0[;P5(V)T7 Q^9K:E
M@7.UY)7:_&_^3,JF+4;V6U_PM_F>>T5T]EX;M=5@L;BTDGACFE>.42LKE0H)
MR" .N/3O21:#IMS-;+'<F,R7'E-#]JBE<H>C IT^A!J5@:S2:V>WGM_F4\73
M3:[?U^AS-%=5!X?TF\U"ZL[2>ZDFME8&-W1#*X.,*<' '.<CTK!U2T^PZA+;
MB&:$)CY)B"PX]1P:SJX6=*/.]KV+IUX5)<JW*=%%%<YL>YUQ'Q"O2L5I8J>&
M)E<?3@?UKMZ\Z^(*G^V;9OX3;@#_ +Z:OL\WFXX25NMCYC+8J6(5SD:***^,
M/IPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *U;_
M $1K.RTR=)3,]^I*QA,%3\O'7G[U95>B0ZC8Z=9>&WO( Q>%E2<M_J>%R<=#
MG(Y[5VX.A3K*:F[6MKVU2.7$U9TW'D5]].^C.:N?#]CIUQ#;ZAJX@F:/?(JV
MYD$9XP,@\GKV[?2I[GPUI=G;VUQ/K^R*Y4M$WV-CN QZ'CJ.M9_B/3[JPUB8
M7+M+YIWI,W_+0'O_ $K1\2?\B[X=_P"N#_R2M^6E'VMZ2]W:[?=+74RYJC]G
M:I\7:W9OL<TX578*VY0<!L8R/6M70= FUVY=%D\F&,?/*5S@GH ,C)-,']A'
M3P,ZB+[9U^3RM_\ /'ZUV=A;P07.F6>GZGI[6T+&295G!DGDP>=H[>V?Y5&#
MPD:E1.;36FB??I_F5B<3*$+1T>NK78XVWT[3C/<PWNK?96AD*+_H[/O .,\'
MBI]4T*UL=(AU"WU(W*3/LC'V<QYZY/)SCCTHN-(DNO%;V$<T4IFF+%XFW!02
M2<^X'45<U66TU3Q-;:<9UM].M/W =C@ */FY/KC&?84U2AR24H*]^5.[WOZV
MT7EV!U)<\6I.UKO;;[KZE*P\-S7FB76J22B&*)&:-2N3)M'/?@=L\UB5Z1Y/
MVO\ M-8M0TW[(+,P01Q7&1$O]YN./<UYU*GE2O'N5]K%=R'(..X/I48W#1HQ
MARKO=]V/"UY57+F_X891117 =@4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 =)X/O&BO)[7/[N9 V/]I2/Z$UZ?7DGAD$ZY$1V5B?
MRKUNOK\DDWA;/HV?-YK%+$775(****]<\T**** "BBB@ HHHH **** "BBB@
M HHHH **** "JTO_ "$(/]UJLU6E_P"/^W^C?RH 9JUW]@TBZNA]Z.,E?][M
M^N*\9)+,6))).237K'BU2WA>^"]=JG_QX5Y-7RV?3;K1CTM^O_ /H,HBO9RE
MUN:>DZ'/J\=S)%/;PI;A3(T[E0 <]\'T-78_"=U]OLX9+B V]T2$N8#YBY )
M]O2K?A/R/[&U[[3YGD>4F_RL;L?/TSQFKFCZO93:GI&EZ=#,EM#(\A><C>S;
M&]..YK'#X;#RA3=3>7GO[UMNUC6M7K*<U#9>7]V_YG'7%N8;R6V4EV20QC Y
M;!QTK8F\):C#;RR&2U:6*/S)+=)<RJOJ1C^M;-W>7&I:#K/FX:2TNT%ML0 I
M\X'&._Z\U7%EJ6C6<]R]O=76J7D15G",XA0]2S=VX'TQ^<K!TTVVFXVO?:VZ
M\[NZT&\3-I:I.]K=]GY:6>ISFF:9<ZM=_9K8+N"EV9SA54=S^E6;O0;BUDM4
M6XM+D73^7&UO+N!;(']:?X=.H)>326%FMV!"5GB8 AHSC(KH[6T@L+_2+^"W
M?3IKN8PRVLAW?+ZC<,CM^8K/#X6%6DFT[WW\KI::6?WW+KUYTZC2>G_ ;UZK
M[CB;F![6ZFMY,;XG9&QTR#@U%7H:+KL^KZE-),+>.%BD,C6GF2"/><;% R1Q
MUYJQ<8M-4U&X18VE_LD3,3'@.X+<E?P'%:_V8G[RDTK]5Z^?D9_7[:-)NW1^
MGEYGGL-A//87-X@'DVY4.2>[' Q3M-TVYU6[%M;*I?!8EC@*!W)KL-,UC6;W
MPQ?W,,K2WR3($*1*3CY<\ 8Z9[5R>DVE]?7GV6P9U>52LA5B!L[[L=JYZF'I
MQ=/EO+F7:U]>F_\ 7J;0K3DI\UE;Y]/D6+SPY>V@MF1X+I+A_+C>VDW*6],\
M5)>^%[ZRM99S+:S>1CSDADW-'G^\,<5O6SMI>J:3IWV>>.Q@G.ZYFB*"65E(
MXST'/%165C=Z;<>(;F_C9;9H)5R_ E9C\N/7_P"O75]3I/9/L_[ME?YJ_P"1
MA]9J+JO\];?E^9DP>$M1G@C<26J2R1^9';O+B5E]ABH-/\.WE_;F?S+>VBW^
M6K7+[-[>@XZUL:?8ZEI\4>LW,%W>7Q0K:P[7<H,8W.>PP>!5;3;&_*V]U=V$
MNIVCR,HMUD8>5)NY++T'?KQZU"PU.\?<?_ TLW9?@O(KV\[2]Y?U?1:_GYF#
M?64^G7LMI<*%EC.& .1Z@_E6MX.O6L_$<"Y^2?,3#Z]/U IGBY-GB6[S,9"V
MUB2!E?E'''H,54T)2WB#3P.OVB,_DPKFBO88RT.DOU-Y/VN&O+JOT/8Z***^
MZ/D@HHHH *IZIJMCHUA+?:C<QV]M&,M(YP!5RO'?VA['4KOPE826<<LEM#<%
MKD("<#'RDCTSF@#7_P"%[^!OM/D_;+GKC?\ 9SM_.NZT;7=,\06 OM*O(KFW
M/&]#T/H?2OG?PKJ7PCU+0[?3=9TMK&_V!9+EL\MZ[ATKT36+33OA_P#!C43X
M8N/-BD4E+D-N)+G&<CT% &[KGQ<\':!>M9W6I^9.APZVZ&3:?0XJYX=^)'A;
MQ1<K:Z9J:-<M]V&0%7/T%>5_!GX;>'_$/A:37-;MA>SS3.BK(QPH'?ZFL31=
M(LM"_:.CT[3XO*M8;@A$SG VT >Z>(_B#X9\*3_9]6U)(KC ;R5!9\>N*Q=.
M^-/@C4KM+9-2>%W. T\11<_6O*?B!IUMJW[0MI87D?F6T[0I(F<9&#6Q\:?A
MWX;\/>$(]4TBP6TG2=8SY9.&!]: /?/.B\GSO,7RMN[?GC'KFN"U#XT>"-.O
MFM)-3:5U.UFAC+J#]:X#Q!XBO[3]G'2#',XFNE6!Y,\[,G(S6I\,_A/X7U/P
M%9:CJEF+NZOHS(79C\@/  ]* /6-#\0Z5XDL1>Z3>Q7,)X)0\J?0CM7S7X[U
M:S\0_&&[LO$NHS6VBV<AB CR< #L/4^M:OPY$O@[XXWWANUF=[%W>$J3UP,J
M?J*K:?HVGZ_^T3JMAJEJES:O-*6C?H2 ,4 =@MEX!M/A8PL=7N8=(>\S]H92
MS&3T(]*],\%#3QX1T_\ LNY>YLS&/+E<8+#Z=J\T^-6@Z9X=^%L=CI-I':VW
MVU7\M.F3U-=I\(_^28:)_P!<*U=>HZ:I7]U.]O,KGER\O0[:BBBLB0HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K6'_ !Z+]3_.
MK-5K#_CU'^\?YT 6:*** "BBB@ HHHH **** ,7_ (1FR_L^]LO-N/+O)!+(
M=PR#D'CCIQ5BXT2VN'LI/,ECEL\"*2,@,1C&#D<BM*BL/JU)*W+_ %>_YFOM
MZE[W_K8I:9I<&E0R1PM(YED,CO(069C] *HR^%K&6">#S;A8I;@7!16&%;GI
MQTY_05MT4WAZ3BHN.B!5JBDY)ZLS[W2+>]O;>\+R17,!^62(@$CT.0<BI=2T
M^+5=/ELIV=8Y,9*$ \$'N#Z5;HJG2@U)6^+?S)]I+1WVV"BBBM" HHHH ***
M* "BBB@#PRBBBOSD^V+%C>26%[#=Q!3)$VY0PXS[U/!J]Q;ZV=51(C.9'DVD
M';ELYXSGOZU0HJXU9QLD]G?YDRIQE>ZWT^1IC6<C][IUC*WFM+O>-MVXG/)#
M#(]CFEN-66[L;O[5$DM[<3A_.\L HH'(!].@QBLNBK^L5+6;)]C"][%R34II
M-)BTW9&L$<AERH.YF/<G/H<5;LO$5W8P6D210.+21I(F=22-P((X(XYS6112
MC7J1?,GKM]P.E"2LT:W]OS1M/):VMM:SSYWS1!B_/7!9CC\*K75U;S:?8P10
M(DT(?S9 @!?)XR>^ .OO5*BB5><DTW_5[@J44[HT&UBY;3[*S78BV;F2)U!W
M9)SSSCK[58U#Q'=ZA:S0/#;1"=UDE:)2"Y P,Y)]!6/13^L5;-<VCT_"WY:!
M[&G>]OZW-;3-9^R0QV=S!#-9^>)F$D>\@]#@9 Y%58M0DM=5-_9A87$C.B@9
M"@YX^F#BJ=%+VT[)7VV#V4+MVWW-&XUF6:R>SBM[>V@D?S)%@4C>??)/'L.*
MM?\ "3W7]H-?BVM1<O&8W?:WS@@#D;O0#I6)15+$U4[I_P!+_AQ.A3>EC4M=
M>O;.TM[>#RT%O,9D?:=V2""#SC&">U*FN-%<13P:?8PR1R^:"B-R?0Y;I[#
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M'O7+?\-!0YS_ ,(BF<D_\?P[]?\ EEWI/^&@8?\ H4(^W_+\.W3_ )9=J/[
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MJO=?<=3_ ,(/?XS]NT[&"V?-;H."?NTO_""ZAG'VW3\Y"X\UNIY ^[7*?\-
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MZ9_UG6F_\+V\1XQ_9.A8QMQ]FDZ=<?ZSI1_8>%_D_%_YA_;%?^;\%_D>K?\
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M/_'O)U'3_EIVH_L/"_R?B_\ ,/[8K_S?@O\ (]4_X0*'&?[;CQ@G/DCH.O\
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MF),#!'^T!]:]($$!7B*,J01]T8P>OYU#R?"+>'XO_,TCF>(EM/\ !?Y'#_\
M" 19Q_;29R!CR1U/0??I/^$"@QG^VX\8+9\D=!P3]^NZ\B+.?*3.0<[1U'0T
MGV>#&/)CQ@KC:.AY(J?[(P?\GXO_ #*_M'$_S?@O\CA_^$ BSC^VDSD+CR1U
M/('WZ3_A H-N[^VX\8W9\D=.F?OUW?DQ9SY29R&SM'4< TW[-!MV^3'C&W&T
M=.N*/[(P?\GXO_,/[1Q/\WX+_(X?_A (MVW^V4SNVX\D=>N/O]:0> H-N[^V
MX]NW=GRATZ9^_P!*[OR8MV[RTSNW9VCKTS]:;]F@V[?)CV[=N-HZ=<?2C^R<
M'_)^+_S#^T<3_-^"_P CE[+P3I$$@-Q<M<L&V["P49ZXP.<_C72PM9VT"QP-
M!'$JY"H0  3U_.I?)BW;O+3.=V=HZ],_6F_9H,8\F/&-N-HZ=<?2NNCAJ-!?
MNXI'-5KU*OQNY7U":(V<B^8F[(7&X9R""15G[1!C/G1XP#G<.AX!JMJ$,7V.
M1A&F[.[.T9R2 35C[/!MQY,>, 8VCH.0*W,A?/BSCS4SDC&X=1UH^T0XSYT>
M, YW#H>GYT>1%G/E)G).=HZGK1]GAQCR8\8 QM'0=/RH //ASCS4SDC[P[=?
MRH^T0_\ /:/M_$._3\Z/(ASGRDSDG[H[]?SH^SP_\\8^W\([=/RH //A_P">
ML??^(=NOY4>?#_SUC[?Q#OT_.CR(?^>4??\ A'?K^='D0_\ /*/M_".W3\J
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M^1ZK_P (##_T&H^W_+$=^G\?>D_X0&'&?[:CQ@G_ %([=?X^U>5_\+W\2?\
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M%% !1110 4444 %%%% !1110 4444 %%%% 'TC\ RY\ W0;.!J,@7/IY<?\
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M<-17<_\ "GO'G_0"_P#)N#_XNC_A3WCS_H!?^3<'_P 71SQ[AR2['#45W/\
MPI[QY_T O_)N#_XNC_A3WCS_ * 7_DW!_P#%T<\>X<DNQPU%=S_PI[QY_P!
M+_R;@_\ BZ/^%/>//^@%_P"3<'_Q='/'N')+L<-17<_\*>\>?] +_P FX/\
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M<-17<_\ "GO'G_0"_P#)N#_XNC_A3WCS_H!?^3<'_P 71SQ[AR2['#45W/\
MPI[QY_T O_)N#_XNC_A3WCS_ * 7_DW!_P#%T<\>X<DNQPU%=S_PI[QY_P!
M+_R;@_\ BZ/^%/>//^@%_P"3<'_Q='/'N')+L<-17<_\*>\>?] +_P FX/\
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MH_C@ND /_?94_I74JD6<DJ4ET//:*[G_ (4]X\_Z 7_DW!_\71_PI[QY_P!
M+_R;@_\ BZ?/'N3R2['#5ZD?%'P[;PK!X?CB\46MJ"'N3:I;JUT_K(2Q) [#
M@#TX%8W_  I[QY_T O\ R;@_^+H_X4]X\_Z 7_DW!_\ %TFXOJ4E-="U9>+/
M"5]X>M-#\26&K3V^EW$CZ?/;.GF-$S9\N3) '8';Z#&,5IV?Q%\,7?B^]\1Z
MYI^H_:0JPZ;';1Q2+:Q@8#?.P!?.3R"!FL+_ (4]X\_Z 7_DW!_\71_PI[QY
M_P! +_R;@_\ BZ7N=Q^_V'OKW@J#Q-'J"V.LZO:W*2IJ U<Q&3+8P\90_>'/
M7\,4NN^+O#T7@I_"_ABTU,6T]R+B:;4G4LN.0J!20.@_+OG-1_\ "GO'G_0"
M_P#)N#_XNC_A3WCS_H!?^3<'_P 71[G</?['#45W/_"GO'G_ $ O_)N#_P"+
MH_X4]X\_Z 7_ )-P?_%U7/'N1R2['#45W(^#WCPG_D!X_P"WN#_XNMK2?@/X
MFO)%.HW%GI\6?F^?S7Q[!>/_ !ZASCW&J<GT/,[.SN=0O(;2TA>>XF8)'&@R
M6)["OJGX:^"%\%>'?*FVMJ5T1)=NIR 1T0'T&3^)-3^#_AYH7@R/?90M->L,
M/=SX+GV'91[#\<UUE<]2IS:(Z:5+EU>X4445D;!1110 4444 %%%% !1110
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MN;,_9Y\]<Y_U?6G_ /"V/ >_=_PDDWWR^/LT^.F,?ZOI7RW11[&(>WD?4/\
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ML_B'HPSLB_B_[:=NWI7SS11[&(>WF?0W_"]?"N<_9O$'53C9%V[?ZSOWI/\
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MQLB_B_[:=NU'_"]/"N/^/?Q#T4?<B_A_[:=^_K7SS11[&(>WF?0Q^.GA4_\
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M+^+_ +:=NU?/-%'L8A[>9]#?\+T\*X_X]_$/11]R+^'_ +:=^_K0?CIX5/\
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MK%% %?[+SGSY^K'&_P#O?X=J/LG'_'Q/T4??_N_X]_6K%% %<VN?^7B?^/\
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M,L,2LT);[IRGW5Y7ECGJ#UQ7AE.,KBE&P44451(4444 %%%% !1110 4444
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M110 4444 %%%% !1110 4444 %5K/K<?]=FJS5:S^]<?]=C0!9HHHH ****
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MTN^NHRYC#P6[N-P&2N0.H!!QZ5Z59ZA::E;^ KC3]9L;"WT8A;^">[6!HW#
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MS^&.E._TO=_RQV[F]<XQ\OXYZUS'4<]XS\!:/XVLU2_1HKN,8ANX@/,3V/\
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M>/XNF.M'M9=@]C'N?+O_  A?BK_H6=9_\ )?_B:/^$+\5?\ 0LZS_P" $O\
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MXOSI?^$TT#/_ ",WA_&5_P"7^/I_%_%^5'M9=@]C'N?+G_"%^*O^A9UG_P
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MT\/[_P#D9M V[C_R_P >=N./XNN:/:R[![&/<^6_^$+\5?\ 0LZS_P" $O\
M\31_PA?BK_H6=9_\ )?_ (FOJFV\3Z;>X6TUS19Y"JC$5VK?-GGH>F.E:_\
MI>[_ )8[=S>N<8^7\<]:7MGV'["/<^/_ /A"_%7_ $+.L_\ @!+_ /$T?\(7
MXJ_Z%G6?_ "7_P")KZ__ --V_P#+ONVKZXS_ !?AZ4?Z7G_EAC+>O3^'_P"O
M1[=]@^KKN?('_"%^*O\ H6=9_P# "7_XFC_A"_%7_0LZS_X 2_\ Q-?7_P#I
MF.?(Z+Z]?XO_ *U!^V=O(_C]?^ __7H]N^P?5UW/D#_A"_%7_0LZS_X 2_\
MQ-2P> _%MQ($3PUJH)_YZ6CH/S8 5]=?Z9G_ )8?P^O_  +_ .M1_IF./(SA
MO7K_  __ %Z/;OL'U==SY^\,_ G6;Z5)M?GCTZVX+11L))F]N/E7ZY/TKWC0
M]"TWPYI<>G:7;+!;IS@<ECW9CW)]:M?Z7G_EAC*^O3^+_P"M3?\ 3=O_ "[[
MMK?WL9S\OX8ZUG*;EN:PIQCL6:*@_P!+W_\ +';N7USMQ\WXYZ4W_3=O_+ON
MVG^]C=GC\,=:@LLT5!_I6_\ Y8[=X]<[<<_CFF_Z=L_Y=]^P_P![&[/'X8H
MLT5#_I6__ECLW^^=N/YYIG^G>7_R[[]G^UC=G^6* +-%0?Z5O_Y8[-Y]<[<?
MSS3?].V?\N^[8/[V-V>?PQ0!)=?\>DO^X?Y4L'_'O%_N#^55[G[5Y$N?)V?-
MZYVXX_'-$/VS[+'L\C_5IC.>O?\ #'ZT 7**@_TO=_RQV[F]<XQ\OXYZTG^F
M[?\ EWW;5]<9_B_#TH L457_ -+S_P L,9;UZ?P__7H_TS'/D=%]>O\ %_\
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MTT'MXF\/_P ?_+_'_P !_B_.J]K+L3[&/<^7/^$+\5?]"SK/_@!+_P#$T?\
M"%^*O^A9UG_P E_^)KZC_P"$TT#/_(S>'_X?^7^/_@7\7Y4G_"::#CCQ-X>S
MAO\ E_3K_#_%^='M9=@]C'N?+O\ PA?BK_H6=9_\ )?_ (FC_A"_%7_0LZS_
M . $O_Q-?4?_  FF@9_Y&;P_C*_\O\?3^+^+\J3_ (330MO_ ",WA[=M;_E_
M3&<_+_%TQUH]K+L'L8]SY=_X0OQ5_P!"SK/_ ( 2_P#Q-'_"%^*O^A9UG_P
ME_\ B:^H_P#A-/#^_P#Y&;P_MW+_ ,O\>=N/F_BZYZ4G_"::%M_Y&;P]NVG_
M )?TQNSQ_%TQUH]K+L'L8]SY=_X0OQ5_T+.L_P#@!+_\31_PA?BK_H6=9_\
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M[[]G^UC=G^6*=_I6_P#Y8[-Y]<[<?SS0!/14,7VG<OG>5MV<[,_>S[]L5-0
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MS;>%'?2]*2.[U8#YRQS';_[V.K>WY^E?/NM>)-9\17!FU;4;BZ8G(5W^1?\
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M6+_<'\J+C_CUE_W#_*BV_P"/6'_<'\J ):*** "BBB@ HHHH **** "BBB@
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M'B^2XAN/"]Y(6\A#/9D]ES\Z?@2"/J?2L*M-6NCII57?E9[71117.=(4444
M%%%027MO#>P6<DH6XG5VB0]6"XW?EN'YT 3T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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METF](.V6S,0..Z.2?_0Q7-2^(ZZWP'C]%%%=9Q!1110 4444 %%%% !1110
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MX](O]P4 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:]Z0?\
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M_,M3_P ?_+Q/_#_VT[]O6O0:*KGEW)Y(]CS[_A5'@//_ "+4_P##_P O$_\
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MG_A&KC[JG'VB?//;_6=1WKT&BCGEW#DCV//_ /A5'@/./^$;GZL,_:9_X?\
MMIW[4G_"J? >/^1:GZ*?^/B?^+_MIV[^E>@T4<\NX<D>QY\?A1X#'_,M3_Q_
M\O$_\/\ VT[]O6C_ (51X#S_ ,BU/_#_ ,O$_P#%_P!M.W?TKT&BCGEW#DCV
M//O^%4^ \9_X1J?HQQ]HG_A_[:=^WK2_\*H\!YQ_PC<_51G[3/W[_P"L[=Z]
M HHYY=PY(]CS[_A5/@/;N_X1JX^ZS8^T3YX/3_6=3VI?^%4> ]^W_A&YOO*N
M?M,^.1G/^LZ#O7H%%'/+N')'L>>_\*J\![=W_",W'W2V/M$^>#C'^LZGM3O^
M%3^ ]^W_ (1N;[X7/VF?'(SG_6=.U>@44<\NX<D>QY[_ ,*J\![-W_",W'W"
M^/M$^>N,?ZSKWI__  J?P'OV_P#".3??V9^TSXZ9S]_I7?T4<\NX<D>QY[_P
MJKP'Y>__ (1FX^YOQ]HGSUQC_6=:?_PJ?P'OV_\ "-S??*9^TSXZ9S_K.E=_
M11SR[AR1['GO_"JO >S=_P (S<?<#X^T3YY.,?ZSKWIW_"I_ >_;_P (W-]X
MKG[3/C@9S_K.E>@44<\NX<D>QPEO\-/ ]J1+'X79B%5]LC22=3C&&8C([CTK
MK+.*STZ$6UCIWV:$,P"0P!%X'7 ]>U7Z*3;>XU%+9%?[7\N?L]Q]U3C9SSV^
MH[T?:N<>1/U89V?W?\>U6**0RO\ :^/^/>?HI^Y_>_P[^E!NL?\ +O/_ !_P
M?W?\>WK5BB@"O]JY_P"/>?\ A_@_O?X=_2C[7QG[//T8XV?W?\>WK5BB@"#[
M5SCR)^JC.SU[_AWIOVOY=WV>X^ZS8V<\'I]3VJS10!!]I^?;Y$WWE7.SCD9S
M]!WIOVSY=WV:X^Z6QLYX.,?4]JLT4 0?:?GV^1-]\+G9QR,Y^G:F_;/DW?9K
MC[A?&SGKC'U[U9HH A^T_/M\F;[^S.WCIG/TIGVS]WO^S7'W-^/+YZXQ]:LT
M4 0?:?GV^3-]\IG;QTSGZ4W[9\F[[-<?<#XV<\G&/KWJS10!6DN"RO&()LDL
M@.WC@9S]*C@N#%:H&MY\JBD@)ZG&/J.IJ[10!!]J^;'D3?>9<[..!G/T/:D^
MU_+G[/<?=4XV<\]OJ.]6** *_P!JYQY$_5AG9_=_Q[4?:^/^/>?HI^Y_>_P[
M^E6** *YNL?\N\_\?\']W_'MZT?:N?\ CWG_ (?X/[W^'?TJQ10!7^U\9^SS
M]&.-G]W_ ![>M+]JYQY$_51G9Z]_P[U/10!6^U_+N^SW'W6;&SG@]/J>U.^T
M_/M\B;[RKG9QR,Y^@[U/10!6^V?+N^S7'W2V-G/!QCZGM3OM/S[?(F^^%SLX
MY&<_3M4]% %;[9\F[[-<?<+XV<]<8^O>G_:?GV^3-]_9G;QTSGZ5-10!6^V?
MN]_V:X^YOQY?/7&/K3OM/S[?)F^^4SMXZ9S]*GHH K?;/DW?9KC[@?&SGDXQ
M]>]1W,C3;46&48EQDKQP,Y^A[5=HH K?;/DW?9[C[JMC9SR<8^H[T[[5\V/(
MF^\RYV<<#.?H>U3T4 5C= IS;3X*J<%/[W&/P[UDS^'O#EU*7N/#%C,^6&^2
MPC8\>Y'?MZUOT47"USFO^$5\*X_Y%'3>BG_D&Q?Q?AV[^E*?"OA4?\RCIO\
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MUJ:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW^KW-RT)M8BEJFI16YF$V&<AP&&T#[O4=>?2M:_OVM);:"&$37-RQ6-&?8N
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MMIIGC\[4$O%B'G6UX[$CU8!L]_3CVKH* "BBB@ HHHH **** "BBB@ HHHH
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M)/<]R:U** ,ZTTZ=-0-]=W2SSB'R4\N+RU"YR>,G)) K1HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>img254193463_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_4.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &% T # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME5@<'D"CEEV#GCW.YHK/T?7-,\06"WNE7D=U;DXW(>A]"#R#[&M"I*"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#E+?GXE7>
M[J+-=OZ5Y/\ M#&3_A(-(_N?8Y-OUW<_TKU?53_9GCK3;YN(;J,V[MV#=OYB
MN5^.OAR34_"]OK%NA:737)E '/E-P3^! /YUSX)VG.+WYG^.IT8Q7C"2_E7X
M:'?^%A$/"6C^1CROL4.W'3&P5Q%SLU_XAJBR&6W$H7(_NH,G'MD&JWP5\8V^
MJ^'5\.7<JB_L5*Q*Q_UL/8CU(Z'\*?KFD7?A+5([VQGVPNS>2_&Y<CE2._%<
MF;*2C%M7BG=G3E;BW))VDU9&OXOO_B/;>9_PCVE:7+ /NR"8O+C_ '6VC/YU
MX3XIU_QY)(T?B.ZU:W4G_5.IAC_ * #7T+X&U74-1ANUOFEE",&29QQSU&:G
M\:^,M$\(Z=&^L(TXN"4CMXT#L^!SP3T]Z]##8A5J:G%;G#B:#I3<)/8^1!@D
ML.2>I]:[GX0EQ\3]*V=Q*#]-AKV.S\%>!O'_ (?M=:BT1+47:%@UN?*=#D@@
M[>,@CTJCX*^'6B:!X\N+W3-2N[@V4;1-#/&"%9N,AQC.!D8Q6\JT%[KW9A&E
M)ZK9'JE%%%9FAXWI=UXAM?BGXR.@:9:7S-)'YHN)_+VC'&/6NG\9ZKKV@:+I
M?B;SU@^RL@U+35=6CE5L A6(SN!/'K^%.N?AU.?$>I:SIWB;4-.EU!@TJ0(N
M.!@#FKG_  @SW;Z4-8UR\U.'3YFN!'.B@32?PE\=0O85JVKIF2C*S1RDOB77
MKOX<>(/&4>IO#YS :?;1[2+:-9%7GCESSG-37FI^)O#E_P"%]6O->:_M]7N(
M[>XLO(5$3> 04QSQ5GQ5X&ET[PCXJCT1[FX34RDJ:<D88))O4L4QSR >/\*O
MZ-X <W.CZAK.LW]^NGQH]K9W"J%@?:.I ^8CMGTHO&UQ6E>QS7C/Q/?:1<:C
M>V7C5Y[RTF!33;>S#0HFX#9(P!YQGDFM*;5?$&O_ !!&CV6MR:993Z1%>,(X
ME=E)(SM)Z'D<^E79/A:CV.I:8OB"_CTF]E><VB(@VNQSDMC+ $#CCI6[I_@Z
MWT_Q1'KJW<KRIIZ6'E%1C:N/FSZ\4<T;!RRN<"OCS7[+P1J4#W2SZM!K']E0
M7KQ@<'HY'3( /Z5-=:5J6D_%;P?%J.MSZJS1SE7FC52AV\@$=0??I73/\,]-
MFT;6-.FN[AEU&]-\)0 K02=BOT_K3K'X?/#KNEZUJ'B"_P!1OK#>JM,%"LI&
M  HZ=SGJ:.:/0.674XH^+M?B^'-_J,.HE;V/Q ;9)#&N!'D?*1CD?K71P7OB
M#P]\1-)TN^UQ]5M=6MY79)(5C$3J,_+CH/:KI^&5F?#-QHG]HS^7-J7]H&38
M,AN/EQZ<5LZIX82^\2:9KRW#BXTV*1(H<#;(6&.3U%#E$%&7Y'EY\3^)KX'[
M-X@O8_$;Z@;9M(BM%:.&/=C.2O8<[B:]9UBVO/\ A%+F"+4I8KM+8_Z6J*6)
M49)QC'.#^=>/6>E^(+&PEM["'Q;9>(9)WD,,*K]@#L^<[CGY<=\U[?#!++I4
M=O?E7F> ).4X#,5PV/QS1.RM8*=W>YX=!8W</[/=U>2ZI--;S1*([1D4+"1<
M<D$#)S[^M=3%=>(O#6O^$EN-=:_M-8Q!+:M J)%\BX*8Y&,_I6G!\,!#X6O_
M  X_B"]ETVX $,3QI_HX#[^/4DUNZEX2@U*[\/W#W4B'1I!)& H/F< <^G2A
MR0*#7X'G!\7>(]>FU:_LKO6+<VUP\-C:V6GB:%MG:5L<D]_2O6-#O+O4- LK
MN^M6M;N6%6F@88*/CD8^M<U<?#Z2+4KRYT3Q#?Z/!?.9;FV@565G/5E)^Z37
M86EO]ELX;;S99O*0)YDK;G? QECW-3)I[%04D]3SWX-J'\,ZNK $'5I\@CV6
MN92[F\/Z[\24T*4V]M;VRSIY0&V*?C.!T'5OR]JZJR^&%WIB7$.G^,-5M+>X
MF:9XH50#<W7G\JV(/A]I-EX1U#P_9M+&M^I%Q=.=\LC'^(GN:KF5VR>65DNQ
MQ>JZCXMTOX=?\)+<^(F>YO1:F*&*%56 ,PS@]R1U_&NH\1:SJ-G\0?!^GV]T
M\=I>B?[1$ ,2;4!&>.U:VH>#K+4_!2>&+F64VZ0I$LRX#@IC:WIG(K*L_A]+
M%K.EZQ?^(;_4;W3=_E><JJA4KMVX'3U)Y)I73'RR7X'#W?BCQ+=-?>1KU[!X
MC34#;0Z-#:*T8CW 9R5/8YW$UL^)M;U33O$JZ1J7B6[TNTBT]9;>Y@ME9[R;
MHV["G'/&T 5SL.F:]8P7\=M!XLLO$$]S+,L-FH^PEF;@[CGY<8R2:U=:TS5T
M\6"_UJ'Q DO]GP01WGA]=WFN!F3?Z?-T& *O2YG=V-2WU#78O %C>^(?%;:/
M=W<Q9WEM$\WR^0J(H'WB,'H3S7-W?B2]U/P1XXTBZU";48;%(6M[N>'RI&5G
M&0RX'3%=+I'@W7M>T;3[W6M4O;+5;"[DEL)ID22586P )5Z%N,^U:;?#*WDM
MM=CFUB]GEUF*)+B:55+ H<Y& !SZ=J5XHJTFM#GY+WQ'X2B\):E+KK7MGJ$D
M%I-8^0JHBLHQLQSD =366OB2Z\+6_CN\L5!NY=:6WB8KN"%MWS8[X /'KBNX
MM/ATJ:IIUSJ&NW^HVFF$-96DX4+&P& 20/FQCBIO^%=:9+;:_;W<TT\6L7(N
M7X"F%QT*GU!I<T1\LNAA^&]6\1V_BBQM7DUO4M.N4874FH:>(?(<#(96 ^Z3
MQ@U)\;&*>#K-PI8KJ,)"CJ>&XKH-#\*:EI=_%<WOBK4M1C@0I%;R!43!&/GQ
MRQ]ZM>+O"T/BW2X+&>YDMUBN$G#(H))7/'/UI<RYDQ\KY&CBKZ#7/'7BK0+C
M_A'+G1[32Y_M$MU=E0[XP=B@<]OUIGAC5?$^I6NIZ_>ZXW]G:1=W(%FD*[K@
M("<,W8#( Q[UZN.!7/\ ASPI;>'M,O[ 3/=0WES+<2"10/OX!7CMQ1S*P^1W
MN>?_ -I^+QX$_P"$]_X2']Y_K_[-\E?(\K?MV^N??-)=1:CKOQ5T:>WUR[LQ
M>Z1]KAVQ1DP*W)C&1@@XZGFN@_X59%]G_LO_ (2#4?\ A'_,\S^S/EV]=VW?
MUVY[5JZYX'74]:T_5M/U6YTJZLX/LRFW16#1?W<'I3YD3RR.+OO%.N:QXDUN
MVMK_ %BSM],E^S0+IU@)P\BY!:4D="1T]*NS^*O$^IQ^%-".[1M5U99&O)VA
M^>-8\YVJ>A8#-=#J'@.1]:N=4T;7[W2)[P 78A1768C^+!Z-[BI]4\"V^I:=
MID9U2^34M-.ZVU,N&F!/7=QA@?2CFB'++4Y2Y\0:]X<U'Q#X<NM5DOVBTB2_
MLKUXU66,@?=;'!YYS[5FRZUXOL](\+:L/$AEDUUDM7ADMDV0[QPZXZL.O/4U
MVMI\/8$@U>2_U2ZU#4]3MC:RWTRJ"D9&,(HX _PJ2?P#:SZ1X<T\WTP31)DE
MC?:,RE>Q]*.:(<LCGK/Q+K/A?7?$^EZCJ$FL1:=IPOX))D5'SQ\IV]LG]*Q]
M*\3>+9+?3-7BGUK4+BYD1KBR;30MKY3'G8X&1@=\\UZ+_P (?9OXJU+6YY6F
M&H68LY;9E&S9QGGKSBLO3?A_=Z5)!;VWBO5DTFWD#Q62[1@ YVE\9*^U'-$.
M61H^/Y=4MO!=_>:-<O;WMJHG5D )*J<L,$'MFN,U#Q_J4WB31;W3YL:)#%:G
M4E !!:XR!GC^'@]>]>K31)/!)#*H:.12K*>X(P17%:7\,=+TOPCJGA];F>6/
M4&W/.X&],8V8_P!W&14Q:MJ5)2;T.5USQ3KDOACQ?KEMJ#I:PZ@EI8+L4JJH
MP5V&1SN)[U-KMCJE_P#%7PXD>O7-LUQI\DD3I$A,'R?,%R.=V.<^M=7-\/+*
M7X?IX26[F2 $,UP%!=FW;B2/<U)KW@C^U]0TO4;35[K3;[3XC"D\*JQ9",$8
M/?K^=5S(EQEU\CC;/2]5U'XH>,(+#7)=.9(;8R31PJSR$)QUX SDG%=E\-]=
MOO$/@V"[U)UDNXY9()) N-^UL!L#VJ[I?A6+3/$FK:V+N66;4HXTD1E "[%Q
MD8]:D\)^&H?"FB_V;!<27"><\N]U .6.<<5,I)HJ,6G]YR?Q(51XM\"84<ZF
M>WNE1_&IO)\-:2Z1ERNJQ,$0<L0K<#WKK?$'A:'Q!JFBWTMS)"VE7'VA%501
M(>.#Z=*3Q9X5A\665I;3W,EN+:Z2Y#(H.XKGCGZTU)*P2BWS>9QMS!K?C?QG
MX?O3X=N='L]*F\^6YNRHDDY!V #MQ^M6/A* S^+ 0"#K$O!KTJO/8/AE=6-U
M?RZ;XMU.QCO9VGECA1 -S'UHYDU83BT[K4I>&(X[#XU^)++30$L7M4EGCCX1
M9?E[= >3^9KT^L'PQX1TWPI:S1V7FRSW#;[BZG;?+,WJQ_/CWK>J9.[+@K+4
M****DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R?
M$>C_ -LZ1) AVSH?,A;T<=/\*J^'M7CUS39+*^1?MD2F*Z@D'WAT)QZ'O705
MSVN>''NKI=3TN;[+J<?1A]V0>C5RU83A/VU-7[KNO\T=5*<9P]E4=NS[/_)G
MBWC?X4ZQX6U,ZUX5%Q+9(_F(MN3Y]J?;'++[CGUJG#\8[^YLDL/$FE0:F(FR
M)5D,$H(XYP",_@*]LM/&'V606FOVLEC<CCS-I,;>X_R:LW>D^$O$1\ZZL]*O
M6/\ &RH6_/K6L<30KQY96?D]_FC*6'K4)<RT\UM\F>.WOQ\O([%;71M"MK,*
MH1&FF,FT>P &:Q]!\$^+/B;K0U769;B*S<CS+VX7!*_W8E_R!7ND'AOP5HC^
M?%IND6SKR'*)D?3--N_&44LGV30[:2_NCP"JD1K[D_Y^M54Q5&BK7M^?R1,,
M-5JN]K_E]XMW)IW@CPW!IFE0*C!?+M8%Y+,?XCZ\\D]S5[PQH[:1I0$YW7<[
M>;.W?<>WX55T7P[-'>G5M9E%SJ+?='\,0]![UTE<]*$ZD_;5%;LNWF_-_@;U
M90A#V5-W[OOY+R04445UG*%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 17%M!=Q&.XACE0_P +J"*P
MY_!.@S-N^QF,_P#3-R!70T5E4HTZGQQ3-(5JE/X)-'.P^"-!B;<;1I#_ --)
M&(K<MK2VLXA';01PI_=10*FHHIT*5/X(I?()UJE3XY-A1116IF%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !117GOQ%^*%IX-7[#:(EUJ[KD1D_)"#T+X_0?RII-NR%*2BKL]"HK
MY!U?X@>*=;F9[O6;H*3Q'"YC0>P"XJK8>,?$>F3"6TUN^C8'/,S,#]0<@UM[
M!]S#ZPNQ]D45X]\/?C,-7NHM)\1B.&ZD(2&[0;4D;L&'8GU''TKV&LI1<79F
MT9*2N@HHHJ2CBI_%D^G^/=:L[V8#2+#2EO"JQY93NY.>IX[5H:9X\T'5K]+.
MVN)A))$9H6EMW19D RQ0D?-CVK \0^%-7U#Q'XHN[>W1H+_0_L=NQD4;I<],
M9X^IXJ2Z\-:YY_A">TAB$VEV4T<K.XQ'*8=J_4;O2M+1,KR3-W2_'&B:OJ/V
M&"2XCF:-I8C<6[Q+,B]60L!N KG-4^(<-]K7AZVT&XN/)N=3$$TK6S".>/D'
M8[#!Y]*S+/PEXJU35M-NM82Z1X[:Y@N9KB]27#R1[=T:+PJ9[=?7I4ECX<\5
M/;>$M.N='@@@T&]1I)UNU;SD4$;E7L,=<\Y/2G:*%S29V4GCG0H]4:Q,\QV3
M"W>X$#F!)3QL,F-H;/&,U!J?Q#\/:3=WEO<SW#?8^+B6*V=XXF[(6 P&]JY"
MV\"7UC>W.G7&@OJEG+?-<)=?VL\,01GW?/$#RP]@<U1\5:9KWAWPAXOL6TZ&
M;3KRY:\74/M !"NR_*4^\6X^E"C&X.<DKGI\?B;3);V_M%D?SK"W2YG&PX",
MI8$>O Z5G7/Q!T*VL+.\)O)(KJ#[0GDVKN5BZ;VP/E'UK N-%\06VNZC>Z9I
ML-[;:SI<-OYC7*Q_9W5"N6!Y(Y[507PWXRAT;3-'$,YLDTL0-';7R0A+CD,9
M3R67!'"TN6(W*1T6H_$.SM?$VCZ=;0S75K?6[3M-#;O(2"!L*8'(Y.?3O6E-
MXYT*#4WLGGF/ES""6X6!S!'*>B-)C:#SZURECX:\1:+-X.O8=,2[DTZQDM+J
M 7*H4+8^;)X(Z]*J1^!+ZSOKVPFT%]4L[J]:X2Y&K/!$J,P.)(@>6'L#FBT0
MYIF_HOC+RM:U>UUBZ;8=9-A9'R_E7Y%(4D=,DG!-=5:ZU97NKWVF6[L]Q8A/
M/PIVJ6&0,],XYQ7 :MX:>U\,>-I]5*6L<MZ;^SGW!MI15*-QR#N&,=>:Z7X?
MZ7<V'AE+O4/FU/4G-[=L1@[WY _ 8%*25KCBY7LS"M;[QAK_ (G\1VVFZ[:V
M=OIETL444MD)-P*YY;((Z>]7M)^(=O#I5VWB8)8WNGWHL;HQ@M'O.=KCN%(!
M^E4K.T\6>'_$WB2ZL?#T5]!J5TLL,K7J1@ +CD'GO52X\ ZPVB>;-Y-UJ]]K
M4&H7H1@L:(I/RKNZ@ _C5:=2?>6QV6E>,=)UB^BL[5K@3RV[7*++ R9C#%<\
M^XJM_P )_H3:?:W<3W,_VJ22."&&W=Y7,9PY" 9P,=:IZ]IFMVWCNT\0:5IR
M:A$U@UE+$9UB,9W[@V3U'/;FO/[C2]3\/V_AK3)W@LM5B>]G:3[8+<>6S<*L
MV".<YVXSQVI**8W*2/3%^(&@2:;#>PR74R3S-#!%':NTDKJ,L%7&3CN>@I8O
M'_A^;2FU%)YS")Q;JOV=]\DO]Q5QEF]0.E>:7.I17.C>&8-*MDTN:UO;E$F>
M^V*X5?G9+@@@[BW<'.#5^UT=_$WAVRDTG3")-$U.0RPK?G%Z6'SLDXQ\V3UX
M[BGR(2G)['H#>.="319M4DN9(XH9A!)#)"RS+*>B>61NW'TQ69X3\4S^(/&?
MB"W6286%M%;F""> Q/&S [L@@'J.]84WA#4VL+?4]/T 6E_:ZI%>FSN-1,[W
M2HN/F=B0K<G'-=!X6TO6H_&&NZWJMA'9QZA#;B*-)Q(5V!@02._3VYXS2:BD
MQIR;5SLZ***S-0HHHH **** "BL#7/$T6F,8( );GOGHOU]ZY"X\0:G<.6:[
MD4>B':!^5=-/"SFK[(X*^8TJ,N7=^1Z=17F5OXAU2V8%;IV']USN'ZUV.A^(
MX=5Q#*!%<_W>S?2E4PTX*^Z##YC2K2Y=GYFY1117.=X4444 %%<]XP\1R^&=
M-M+J*W2=I[V*V*NQ& Y(S^E'B;Q'+H-[H4$=NDPU*_2T8LQ&P$=1ZFG9B<DC
MH:*RCXFT);J.U.L6(N)',:1^>NXL#@C&>N:H>+/%]AX;TJ]?[99_VE%;M-#:
MRR@-(0,@8SFBS!R25SI**P[7Q1IG]FV<^H7]I:W$]O%,T3RA2/,'& 3GDY J
MZ=;TM;-[PZA;"V23R6E\P;0^<;<^N>,46871?HK*N_$VAZ?>FSO-7LH+D#)B
MDG56 ^A-%UXGT*QN([>ZUBQAFD0.J23J"5(R#UZ46871JT5F77B+1;$V_P!J
MU6SA^T@-#YDRCS >A'/(INL>(-,T6#-WJ%I!-(C-"DTH7S"!QC)YHLPNC5HK
MF="U[5-=\!6NM6MI;-J-Q#O2!G*QEMQ&,\D<"L'2O%_C'4_$%]I*Z%I:R:>\
M:W3?;&X#\Y7Y>> :?*Q<ZT/1**S8O$&CS:HVF1:I9O?+G-NLREQCKQFA/$6C
M2S^0FJV;2A78H)ER APQ//0=Z5F.Z-*BLJP\3:'JDOE6.KV5S)S\D4RL>.O&
M:(O$VA7$=T\&KV4JVJEI]DZGRP.YYXHLPNC5HKFM$\=:'K&@?VN;ZVMHD_UR
MRS+F+YB!N],XR*W;*^M-2M4NK*YBN+=_NR1.&4_B*&F@33V+%%%%(84444 %
M%%% !1110 45S?B_QGIWA"P$MSF6ZE!\BW4_,_N?0>]>(:Q\3_%&K3,4OC90
MGI%;?* /KU/YTTFSHHX:=576B/I.BOEFV\;>)K2421:W>9]&E+ _@>*]*\&?
M%_[7<1V'B)8XW<A4NT&%)_VQV^HXIN++J8*I%76IZY10"",@Y%%2<AQ^O>*M
M4'B-?#?ANP@NM26'S[B6Z<K# AX&<<DGTJG?^)_%&D6^E+JNGV$%S=:K%9LT
M$AD22-@264'!4Y&.:CU:WU7POX^N/$EGI5QJFGZA;)#<QVH!EA=.C!<\@BJ^
MO3ZQXIBT.X3P[?V<5MK<$@6<#S#$ =SLH^Z ?6M$EH9-O4Z'2_%426=U<:YJ
M&EP(M_+:PO#,=GR]%8MT; .:9JGB^VF\.2ZEX?U+2YS'/'$SW$I$:Y8 @XY!
MYXKBX?#FJ/9VL4VESLO_  ESW3H\61Y!)^<C^[[TGB?P[JLU_P",/LFEW#17
M5SI[P>7'Q)L*[R,=<<YI\JN+FE8](U#Q1H>D7<5IJ.JVEM<R $1R2 '![^P]
MS22>*] AU==)DU:T6_8A1 9!NR>@^OMUKD8DN_#WC#Q!+>>';W58]5DBDMI[
M>%9!M"X,;DD;0#SSQ6#XG@\3:U/?6W]D7<)BU&.2.&VL8_+>-67$K39W,W7A
M?Y4E%%.;1N7?CS58+R\B6*V*P^(8=,7*'/E.!D]?O5VO_"1:/_9,FJ_VC!]A
MC8H\^[Y58';@^^>,5YG>^']8DO[]TTVY(?Q7;W2D1GF( 9<?[(]:L2>'YI/B
M=-X?A9&T.2=-<N(@?N. 5V$>C. V/;VIN*9*E)'9>+/$EQX:72[T0QR:;-=+
M!>2-G=$K\*X]@>N:37?$EQ9>)]$T+3X8I9[YFEG:3.(8%'+<=ST%:7B/1HO$
M/AV_TJ;[MS"4!_NMU4_@<&N(\!:5X@+:GX@UVQ*ZK':K86D,O&Y(UY//9V[U
M*M:Y;;O8["V\6:'J-Q<VFG:K:7-W"C,8HY 3QUQZ_A6!X6\7:IK:^'7N&TU%
MU"WGDGCW,LI*,0/+7N.!G/O7+Z79^(M1\2>'KZ[TR\A%M]H2>,6"6\-N6C.%
M0CYF&>YXZ>M.\.^&]:C_ .$3C>QN+9X-,OX99'0@0N[-LW>A.0:KE2(YI-_U
MY'5:UX_L8=6TK3M'O[*ZN)]2CM+F,-N*(<@D8[@_6M]?%6@MK/\ 9"ZM:'4-
MVWR!(-V[^[]?;K7F.FZ;JATOPAI'_",7UO-I&IQ/>7+1*$QN.64@Y8'J3T%+
MJEOXFUC4;<2Z3=P-;:U',T$%BBPK&'QYGF_>=B#DXXZYHY4"F]SO-$\=Z/K>
MLZEIL-S"KVDFU#YH/G*%!9AZ <C\*T],\3:)K,TT6G:I:W,D(S(L<@) ]?I[
M]*X";1M4GF\=:''IEW%-JKM/:7GE@0,NP?*7SP3@C'O52R\/W6JVC0QV7B2#
M4X-+FM8WOA%'!&S)MV*5 + ]NPZTN5#YY'4W/C^RN?%.AZ7HM_9WD=W<2Q76
MP[F0*A(Q^(Z\BI?'&M^)O#UE<:IIEOI<NG6T(>7[0S^:6SC@#C'(KE]*M=0N
M]2\#HGAB^L$T@O%=S2Q*JAO*(XP<E21G=TR:[3X@V=SJ'@+6+2S@DGN)8,)%
M&N68[AT%%DF@3;BV0Z-KVJVVCOJOBV72+&S>.-X'@D;^(9PV[OTP![UJ1>*M
M!FTV/48]6M39R2B%9O, 7?\ W3Z'ZU@>(9-7L?!NC1V.G&>0&!+D_9A/);*%
MY=8S]Y@?RKB5\-:S=VE^ESI=]-'<^(+2Y(GMU0R1;?G=D3Y0/7'3O0HIZ@Y-
M:'ILOC;PS#:6]U)K=FL%P6\IR_W\'!(]@>_2IKCQ;X?M=.BU";6+-;29BL<O
MF AR.H&.N*X'QC!.GCDP:';39&DF&]6RBB=EC9S@;'P%[G(]>E4C9K</X;U_
M18-;;0X=.>Q462(US ZMC)5@00<$$BCD0<[O8[K6O'^B:-<Z1&]Y;R1:BV1,
M)1M2+!/F=\C(Q]:TV\5:"NIQ::=6M1>RA2D/F#<=PR/Q(/ KSZ?1YM)LO"=_
M9:)K$UM9W\\T]M*B27*B0'!*K@ 9.<=LU8EM=3M?''GZ#8:K$+R]CDOH+RU1
MK5DQ\TJR9RK =ASFCE0<TCU"BBBLS4**** "BBB@#-\0ZO'H/AZ_U60;EM86
MD"_WB!P/Q.!7R9I*MXK\<V::K+)(=1O56=U.&.YN<>E?2'Q921_AIJ_EYX1"
MV/0.N:^<? G_ "/V@?\ 7]%_Z%7127NMG-6?O)'5_P#"!:1_PN;_ (1+?<_V
M=MSGS!YG^KW=<>OM5G4=$^%%AJ]SI-QJ&N6]S!*89)2NY%8<9SCI6^?^3G3_
M +@_]$5Y9X[_ .1^U_\ Z_I?YTU=O?H*5HJ]NI?\;^!9_!\UK<P7:WVDWHWV
MMY&,;N,X..^.?>O??A3XED\2^![:6Y<O=VK&VF8GEBH&&/U!'XYKS+7U:V_9
MUT.&_!%Q)<JULK_>"[G(_P#'?T-='^SXD@\/:NYSY;72A?J%Y_F*4]8:]!P]
MV>G4]AHHHKG.D\^UCQ/H7AOQ \]QX7U3[4T_E)>1VN5FD;LK9YS78:-JIUBP
M^U&PO+'YRGE7D7EOQWQZ5R?Q1_X]?#?_ &'+;^9IGQ!O=-?4].TJ\AEEFDBD
MF42:B;.W"C )9ARS#L!FM+72,[M-GH%%>&Z(;KQ(?!%C?ZC>^5/!?13&*=E:
M5$884MU/0#/6D\0?9SXLU;1IM5CMIHYK=+6]N=1D@-K#M7**G\?&>>Y/6CV>
MMA>TTO8]SJC->Z?-J7]C3%)+B2 SF!TW QA@,GMU(KR+7OM%QXKUFSNM3L[.
M&SMXAILEYJ$T/EQ[/];'MX<YZDYJ_!9:<OQ1T^;6;U&GFT6*9+@7#HDUQO R
MO(R"!G;T]J.0?.>M@     #L*6O)_ \R6/C&*RN;B/5;R[CFE35+34'E610<
MGS8B<(>0!^E3>-;B_P!&\6W%K:23@>);-+6':21'.'5"P]/W;$_A2Y-;!SZ7
M/3Y9/*B>3:S;5+;5&2<=@/6LBS\365S8Z9<W$5S9/J,AB@M[J(I)N&>".W"D
M_E7GOAR6_O=>AT6XGG8>%K>Z6=V8_O7)*Q$^OR<UB"WL;OP]\.;S6)Y/(DFF
MCN)I+ET&WYB,MD8.>_6GR"=1]#UVPUNRUW5-8TDVK$Z;*D<OFJ"KEAN! ]L=
MZTKV]MM-L9KR[F6&V@0O)(W 4"O'+W2;2ZN/B+?K/<K)IZQRVC0W+J%80Y5N
M#\QX')S72^,X=0UOX.0RQ*]S.8+>YG1>LJC:SCW]?PH<5=#4W9C-.U3P?JU]
M;QKX7U".&\?;!>363B*4GI@YX!]371^"Y=%U#3)-3TC3OL2R2/"P(^8[&([$
M\9ING>/O"M[!81VFJP&2Z*Q0VR@F0,1PI4#*X]^*\IM+B[&A>'K-IX8=)GO[
M[SS<3O#"\@<[%=TY ZX'0FG:Y/,EYGOU075E:7T8CN[6&X0'(6:,. ?H:\C-
MW:PZ)8Z3J-]%JJ7%_/\ 9!;:J\5O$BJ"8Y9S@L%)X')K+TNXNM8L?"VGS:C=
M+ ^L7EH6@N6+>2%&$W]2,'&>N#2Y!^T/;IM/LKBV6VFL[>6!?NQ/$I4?0$8J
M:*&*")8H8TCC485$4 #Z 5%864.FV$%E;[_)@0(F]RQP/4GDU8K,U"BBB@ H
MHHH *1F"(6/0#)I:CG_X]Y/]P_RH >C!T5AT89%4]5O/L.GO,#AB0B_4G%6;
M?_CVB_W!_*L7Q9N_LR$CH+A-WTYK2E%2FDS'$3<*4I+>QR7B'3AIFI"(3/,7
M3S"SCG))_P *2VTE)_#]SJ1E8/"VT( ,'I_C5_QJ#_;,1[& 8_,TZPX\"Z@3
MT,G'_CM>BIR]G%WWL> Z,/K%2-M$G^1#:Z%8-HL&HWE_) LAQPF0#D_X4Y-"
M1T-UHNHBYDA^8QXVN/I4EY_R(-C_ -=1_-JI^%#(/$, CS@JP?'IC_\ 52O/
MEE*^UQ\M)3A3Y=TM=;W9WFF7GV_3H;CHS+\P]&'!_6K=4-*55CNA']S[2^W'
MUY_7-7Z\V:2D['T%)MP3>X4445)H<E\1='OM9\+@:;%YUW:745VD.<>9L.2H
M]\$U@W5]?>.O$?AU;;0]2L;;3+L7EW-?0F(*5'"+G[QSZ5WNHZ;_ &B(_P#3
M;RVV9_X]IMF[Z^M4?^$:'_0:UG_P+/\ A5J5D0XW9YK-X=N3\/\ Q0PT>4ZC
M)K;2PG[.?-9/-0AEXR1C=R/>G:S8W<'_  FUC<Z!?7U_JG[VRNH[7S%,>P8&
M_P#A*D'CKZ5Z1_PC(_Z#6L_^!9_PK:C3RXU3<S;0!ECDGZT^<GV9YIH7A_[1
MX\L;G4=*,D,'AZV1))X,JDH/(&1C<!^(KG[^VU.'PCJGAK^Q-4DO1K)N?,CM
MF:(Q&4,&#=#QV'->VT4N<?L]#P[5?(.N>(WNX+UO#BZHD]S<6]FL_P Z!2P\
MW(*KG (P<#C-+KP@N==\39@O'\/22P27D]K9K.5*(K$!R08P!C(P<<]*]0N/
M!'ARZU![Z;3(VFD?S)!O8([?WF0':3]12WG@GP[J%^][<Z9&\TA#2X=E60CN
MR@[6_$57.B?9L\ZU;3G_ .$EU6]GCU5]*U>TA%F^GZ>EP&BV >40RDQGN.@Y
MS5D:;+HOB&Y^V:'J6I6]WHT%KI[M;"9HRJ89)#T0YQD]*]:551 JJ%51@ #
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M0MR.]PHHHKK.<**** (+W_CRF_W#4DD:31/$XW(ZE6'J#4=[_P >4W^X:GH
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M;)@8&1Z^];%%%V%D9>C^'-'\/K*NE:?#:^:07*#EL=,D\UJ444MQI6"BBB@
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M8BZS1>0OS%."P!Z8Z&H1;V;Z%::7:Z=]J54N0]Q-92L8[@MS$(P<JPR,,QX
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M,8;T['(JQ'K;1221R1RW#M-*J"-0,!,<=??K39_$"RV;O LL#%%EB=T!WH6
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M-J)I+9UB:4-M*B0C;G(QUKH*\Y\/Z!?ZUIMY;7-\D6E?VQ<2O;+;D22;;@L
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MCZM2_E#V]3N-1!'&J#HH %.HHK<R"BBB@ HHHH **** "BBB@ HHHH ****
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M6%IEY>6.F6EG<Z5.9X8K>.0VZ+Y>6&#MYZ+CG],UJV=RUU"TC6TUN1(R;)@
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTF1A=-'_ *M5#&5?XDY[D>G?%=310!D^&;2_LO#6GV^IS^?>I HF?:  V.@
M].GX5K444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%8]_K\=O<?8[.%KV]_YY1]%_WCVK
M.I5A35YLN%.4W:*-BHI+B"'_ %LT:?[S 5B#2]8U'YM1U$VT9_Y86G'YM4T7
MA31X^7M3,W]Z5RQ/ZUC[6M+X(67F[?@KFOLZ4?BE?T5_Q=C0&I6).!>6Y/\
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ME0V_OKG4[U]*TM]@3_CYNA_RS']T?[5:>G:9:Z7;^3;1[<\LQY9SZDUYW?\
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ME>]:A;_:].N+?O)&RCZXXKQ+R8[2\R'E663(8*,D?X5UY7)1QDHO[45^#_\
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M#@CCWKA-1>VEFT"6+Q+/<6R:@RR70ECPI,38!8+CKQ_P+%5K?6=3TS2;>6W
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MX[..^>2 (%$+@D'YF'.%/'6HX_!]S8PQ+IFKFV=K&*RN6:W#^8L8(5U&1M8
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MPK$J<$'#8JX_A=WU1+K[<IBDL18W<)@ $J L<K@C9]X]C5*/P3,NCW.ER:C
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M@M(8YS"DDLZ8DX!!&#QP>AYK%U/PW?R:C>WEI%;L#+8S11%]N\PLQ8'CC@@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
40 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>img254193463_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_5.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +Q LX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8_B]\8K5QC=1L8J4^5RN>I6MU!?6D5U;2K+!*H='4\,#4>IWG]G:7=WNS?\
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M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF,2(3UP15N@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKB-+^'45IX[N?%E]J+WMW(6,4;1A5BSP,<]EXKMZ*:;6PFD]PHHHI#"BBB@
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MA==TF*_2VFMPY(\N8888.*TJ\XN]?U*'3?#EO>:H]A#>6_FW6H; 6W8R%SC
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M[.(E(Y5,GY1]*N>#/#K>%_#L>G/*9'\UY3ERP3<V=H)Y(% 'FNB_\BI\4/\
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M 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK(Z?2CI0!LI>122! 3SW-6*Y\$J?I6O9W(F3:?OC]: +-%%% !1110 4444
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M']*!@8!QZ&NCZW5[FWUBIW.>O/"@NH'0W)5N@.WC-9MAX"-C%(/MQ=B?E^3
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M9GDD6$ O H*O]T?-C!]P#7KG_"/2 @_8$R$V].OO1_PCK[MQL(SM39C'7WH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?3[.,1V]N@C11V JIX>\.Z;X8TF/3M,@$4*#YF_B<^K'N:U: "BBB@ HHHH
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M#7%R.DD@^[]!73T452BDK(QJ59U9<TW=A1113,PHHHH **** "BBB@ HHHH
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ]Y<BWA.#\YX%
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MK_"WPG>>)-;E\=^(LR/)(6M8W'4_WL>@Z"O;:BM[>&TMH[>WC6.&)0B(HP%
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MMV"]J]5T+0[#PYI$&F:="([>%<>['NQ/<FM*B@ HHHH **** "BBB@ HHHH
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MI/7FM"'X9:%!<12+/J3)!.L]O"]T6C@(.<(IZ"K.L^ M*UG47O\ [3J-C/*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %9>K)AT?U&*U*K7\7F6K<<KR* ,*FR9$;$=<4ZCK4SCS
M1<>X'+>*)RWA751GK;/_ "KE;J:]#^"3IXA:Z6V.P3$A/]4,YQ79:[IANK&Z
MM"Y2.XC9-X&=N160NAHLVCR?:&_XED9C4;1^\^7;D^E?*4TL->G4W3?XQLC"
M47<Q-5O]<U35+?P[KGV.QM;HAUFARPGVG.P$]#5OQK?--<:9HL5K<7:-()[B
M"W&6:-.@_/%:NN:1%KE@+>1VBD1Q)%,HRT;#N*99:2;;5I]2FNFN)Y8EB&5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+#(4<="IKT+POXI755%K=$"Z X;^_P#_ %ZYS^P_#D>I_P!BSZA=+?CY'N<
M0))C[I]O>N86672]4(613);RXW(V0<'J#6-6,*\;=>A$DIH]RHJO8W(O+""Y
M'_+1 U6*\5JVARA1110 4444  &36[90>1  1\S<FJ6G6OF-YKCY5/'N:UJ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+^XTR^AO;1]D\+;D;&<'Z5+A*6KT?^06;.KTF[AT_P  7;W6G0WH&H!3%,2
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MN\7E[BZG;S8;>7GZ,W]!5?X:^![OQ1J9\:^+-UPTK>9;0RCASV8C^Z.PKW
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M8?@GP@U@5U*_3$Y'[J,_P^Y]Z[JBBO5ITXTX\L3Y^O7G6GSR"BBBK,0HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)89VA@3CUH T,E&##[I[8S3UD=<H&([@YJO%/!*SQI(N ,BI%.]"1@E.Y.:
M+<5]*L9!^8KZC^M3C45V@LG!ZX.<5G%MK"1>0>O:C 5BO 5N10!M)-')C:PR
M>W>I*P 3COE3GDU.EU)&ZL&.T]1U% &Q15*/4%8D.I&.XZ5:CD25=R,"* 'T
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YM\9_%)T
M/PD=/MY,7NHDQJ >1'_$?Z5Z356;3;&XNTNI[*WEN$&U)7B#,H] 3R* /DGP
MIX8O=8U>RAN],U272FE'G-;1G@'N"1BOJ/0_!OA[P]$$TS2K>(XYD*[G/U8\
MUN]** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HIDDB1*6<X JA/>2
M2+F([5]NM %Z2=(CAC\W8#K5&34'+% -@/0XYJJ3YW.2'[G/]:0$/\KX!_0T
M *7;)#G<I[]:;@QG*\J?3O2&18SY<S84],_TK&U#Q3INE,\=Q.N .G)(_ 4
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M.M7XY4D&5;/M6)P21GAN10KLFUANRI[&@#>HK.@O7$FR3D>O<5?21)!E&!H
M=1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4UG5!EF 'O4-S=+ ,#E_3TK,>9I6RQR:\C
M'YM3PSY(+FE^7J!H/?(/N+N^M0F\E8\8 ^E513P<5XD\QQ57>5EY:!S(F\Z8
MC[YH$LP_C-0^9BD\[%9?6*G6;^]CYD61<SKW!^HJ1;X='3'N*I><*:9 :VAF
M->G\,[^NHN9&Q',D@^5@:?6%YFTY!P:O6M^'(20C/8UZV#SF%67)5T?X?\ 5
MTR_1117MC"BBB@ HHHH **** "BBB@ HHIDLJ0H7<\4 /JG/>JI,:'YO[U5K
MFXDF(*'Y1S@?UJ $3<-Q)VH &=U8[\L#UI,%?GC.5/:DWB/"2D;>@-86L>*;
M/0YQ&TJ%Y%.T$@$XH VY'C$9E# $>O:N9UWQK8:?:!EW/+T&WGGU)]*XJ_\
M%6JW<UX& MT4C"==PQGK]*R+54:YNX4)*2JLA#<I%M&YE/MVH V=;\5ZGJ$$
MWE#RGCPRKC[Z\9.?7)K)FAC-ZA3,GVG8H/WD9L9//;GC\*2"V^U1X+$S["V
M=H8$Y0<]\\D5N:?X:N+RRC;RC#%'$T+A>,9.21[GO0!B6L<OVV)6V@M$5=1R
M9$&?E]B3R/:K>GZ7-,J!+9I"V9N1O4.?X?H.OUKM+7PU;*\#C-S(@&?EVXQV
MS6^+);/]Z9([=6&"L?84 </IOA6>2UB-Q(BM;N2I/?(Y&/Y&MFW\+67V2-46
M65EZH1\JCV-:5[K>DZ-,H.V5F..H)!^E<_<?$"?[7*L%KB!) DA8XV^^!0!U
M"::L3+<1PPQ;>NXY)]S3I39V6)I[P()2 =N%!)KS:ZU[6+R&[B:Z:#%QM&"
M-O4\_2LBYN0ULR274H5)UD!9B6 [\>F.E 'J4OB#P_:W1C,ZL.F"^1D_2J$G
MCG2;=;H+;,RPMM.V//\ D>]<%=1E9[DI %? D8]L9P,>^.<4JB1!?.850R2(
M%!^;S6 ^X0/3J30!U]W\0EAL)#%9,&C9=Q?"@ ]_PIESX_O1.%CL01&H?[^-
MP/3''%<?<0RM 526-O-"I&7&1NSR/<9[U8GB:ZGDCW2896$8 VDN,;F]EH Z
M(^/=1;5956"/RDA$BC<?F![Y_2BW\>ZH$D:6VC&^,NHW$'(&<8KFXHY7:1D=
MI% 2(1J@0!NH;/8#L*C:%TMC*)7+.AC+,O+/G[V.W]: .@N_B3?6VA+*]LI>
M2%G5PW ]\?6N2^&.K+I-W<7DULTT]\Y ;O@<G'KS6;XSFGM],M[,.W[Q@CY
M!E*@<@=0,\5K:3;?8;6WB5UVQ6^S,:DN96.3M_7)H ](M?'.DW=SB2W9%;(!
M:/@D=>E7+7Q#H%W$S><(OFPA+;3D?6O-/WT>TE4V*C.R18 0CHN??T]:1+;R
M[6QMOL[>;M\XP[LMNZG=Z<8P* /7$-I.B745Z&+#'S@,#4<NC)(SJ]O!/OP5
M8'D'VKR2"82364<,XC0L\Y0$[MH'\ZV+/Q'JMI<HS:@)%\T($D(; /09'4T
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M-TS5RL C!8<9ZU9@NGB=03E&[?X4 :U%,CE25<J<T^@ HHHH **** "BBB@
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MGA[F:,&9T(+^7N(0=%6L>X62T7S3]HE2((57</,GDZ8^E>[7F@@LKV^UPO\
MRSDY%<9J7A2+SY9?+\F9%(12.!GN#0!PUG->:/(BVMR4NY&#SO(P].FWJ?3\
M*[72?'-LUKY.IXC=WVJQY5S_ $KDM3T6:R257B6 /M/G$%F\L'L?SK,"16Y,
M]S#:I%&0+6,$@[2?O,O7).* /9&LXIX=]OLD29,-$XS^1KD[_P ,Q@/=6[F.
MY/RD=&0>Q^E8&A>(Y]'N8TFN?.4YD:/=@(/8'H!7H6EZOI_B6V>:)RK#D$C!
M!^E 'EMU8S1F38C+<&4!IYW&$4>N>^,FJEHK77[V*2XM[.V<EI)!F2=L_P .
M.V!Q7J6KZ'%J+_Z6  <$.!PY'8UQ&HZ4;:Z19UN'CW;PJ287(Z*!0!O>&O&S
M3B*ROHFBW-B*1OE##MGT-=X'1V.PD@CK7@S-/'<)%([R7D@;[/;A0R1\\,[>
MM=7X=\62:'=BRU&=K@D'?)]X1'T/MB@#T\-@JV3Z'-7;6\*+LD.1G&?2LRVN
M([JT6>-P4;E2.X]:F_O8QZYH WP<C(HK.M+S:$C?ICKZ5H@@C(.10 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C
M*&4JP!!Z@BEHH Q[OPW97)+(&A;_ &>GY5D3^$[E3F&:-QZ'@UU]%<M3!4)Z
MN(K(X&3P[JD>?]'W8_NL#4*Z+JC,!]BE'N0/\:]$HK!Y70\Q<J.&B\,:DY^:
M-$'JSBM&V\)8(-Q<#Z(/\:ZBBKAEV'CTN'*BG9Z7:6('DQ#=_>;DU<HHKLC&
M,5:*L4%%%%4 4444 %%%4KZX=!MC/U(_E0 R[NE+&'H.Y]ZI%&0[E.0?UI?,
M67B08:H;JX&G0-/(P,2@L?H* "XN($@=Y75"HY).*\L\1>*Y-:%Q:(!)9Q[D
ME7.&<#."#^%'BSQ%+K$[QZ?<- $XPR_+.,9QGMTK# 2ZBAO$EVQM)&I*(!AL
M#()[KU_.@!MA%&TESIJ,[>7N>/<<&1=H^7WSTK=T#0FU%$CD\M;;RPN9,Y3!
MR1GOS5G2?#\NHQK=7$(A\AB>'XY.< 5WUM9*L"3S1!8D'"#J?<T 5]'TD0VA
M@0*ENIR6/!:JNM>)+'3[62RA>*.Z (13TSVR:R_%GBUHH]FBLDDJ$>:H/(3O
MCU-<&_[S_2 LKBZ*-)N;=C(.3GUR>GM0!+->WNJRM=7?F/>VS^7@'Y<[<].P
MSWJ%;1Y[99T5VV[6\@@<DX!##Z#.?>KMCIC3W8VAY8KR-DE96!(SP"OIP!Q7
M?:%X8%K)L,"7$Y0 R 8"GU_*@#"TSPP)B+VX#>5+()%3/S@XP0/;TKO=+\/*
MNYE5H(& &SJS#W-:^G:3#8QJ<;I1U)[?2M"@"*"VAMDVPQA1[=34M%% !111
M0 4444 %%%% !112,RJ,L0!2;25V M%5GO8UX4;JA-Y(WW0!^%>?5S7"TW;F
MN_+4=B_16?\ :)C_ !8^E+]HG'<?E62SFAV?W?\ !"Q?HJD+QQ]Y014R743\
M9VGWKII9AAZKLI6?GH%B>BBBNT04444 %%%% !1110 5'-!%<1E)4#*1CFI*
M* .:U3PX)H@ //A!YC;J![5Q.K>'7\R2ZLT&8F!9& W8Z#KZ5ZW5*]TR"\#%
MAMD(QO% 'S]-:N)&CDF\FU:8FYDD0$SD_P *X&0*2/4!:RK>P3&S2,%84'RA
MN<'W;FO4=:\.^8$A=5A8@A9E''U/O7GFK:7=VTVU01<K&56=CE(%SR0._% '
M;:%XOM]0:/3+D;;D+\P'*_GZ^U:VI:>KVIA4^9 &R..4SWKR0K''!Y,$TB8V
MO<77EX,A)]3TYKK_  OXT2"(Q:A<;XW;9#,>=W;&/;UH I:KH;:.C-8R$1GD
MLB@F0GUST KFI_,@WQ+,4M4C'FW5TIVAL]!CK7LLUJDL!FB".DR$/&1GCVKA
M-:\-'8UTI$B' 2-\E4(_O+0!0\.^);C35(99!I"'Y97Y+#/4>WM7J5K>6]\B
M2V[*Z,N05.1]:\5O9<+'-=O T(=4BAC'/H2%/K6IX>\3?\(W<'[6)8H)P2EN
M4^=<'&[T ]J /7%.,<XP<5>LKG9NC<\9X]JRK*Y6\LDN(R-KX8 ^E6#U;Z=J
M -^BJ%G=981-G!Z$U?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #TXZUX?>>-O%?P^\>7"^
M)MUWH]])NC9!\JKV*>A ZBO<*RO$/A[3O$VDRZ;J< EA<<'^)#V8'L: +>G:
MC9ZMI\-]83I/;3*&21#D$5:KYYM[GQ#\$_$1M[E9+[P[<OD$="/4?W7'IWKW
M/0?$&F>)=,2_TNY6>%ASC[RGT8=C0!IT45'-*(8RY_"@".YN5B&S.&(Z^E99
M,D;$D[E_E3G9;ABV<-Z&HV9K<9;.P=: $D:(Q,Y(4@=#7F/B7Q3)>ZDNBR+(
MMO*X03(V%D4\8S]:T/%_B,SD6VEC=@CS9%< !#P1[GFN(@M_ML2V<<\B1K(J
MG^)HV#$@\]B* %6)X76*1"(DC+;"<N"O0C'4?-73:!H($TEUL(T^8C=&(\*>
M!G IOAG2OM_E/>Q^0UOD"1>"RYZ$>_%>B6-EY=J"[86/_5H?X??ZT );6=O;
ML))D\I/X(^P],UQOBKQ<\<XTZU9C;SGRS<QD$*V<%<^M)XL\5_;C-I%E<)'.
M@/F-SD;><#ZXKBHH?MGF01OY9R ^T9!).0P!Z]#^= "QQO#(J,7!B#$2R#&#
MD@*?S'-;.B:#-</]@;*Q1R>;%,V#T&/F]>,U8T'1)-6BB>Z3RS#%LE#\AQG(
M_'->EZ-H4?DPF2!8H4'"@8+^YH IZ'X>1;;RHX$CB#<RXY;V%==;V\5M&(XE
MVJ/S-2*JHH50 HZ 4M !1110 4444 %%%% !1110 444=!F@"&XN%@3)Y)Z"
MLN2=Y6RQJ"[O/,N&.>!4 N0.I%?%YCCZF)J."=H+\?,ES[%T4[=BLB#7]-N;
MAK:WOK>6=?O1I("P_"K!O*Y+<FC1/.7_ #<4GGUS'B;6[C2O#M[?6VTS0Q[D
MW#(SFK$6IQNMNDDR">:(2!,\G@9('I5/VG)SK;_(.=F]YX--,@/>L0ZG;B>2
M$W$8EC7>Z;N57U/M58>(=,:6.(:C;&2091?-&6'M46J2Z"YF=3!?-$<$Y7TK
M6CD65 RG(-<8;GWK3T;4/])$+'A^!7K95CZE.:HU'>+V\BE+N=%1117U1844
M44 %%%% !1166/$6DG7I-#-[$NI(BR>0QPQ4]"/6@#4HHHH 9+$DR%)%#*>Q
MKF-9T)5M90(Q+ QR01\R_CZ5U5! (P>10!X=X@T)K7<FZ6Y@DD#B.-L!SZ'Z
M5SX(BD:6[G2YOPQ2% A"0CKC Z_6O=M2T9&#S6Z*<J0T9'!^E>;:[HDEK$;J
M"8K$R,K*HRT?X'UH A\*^)+C3[B&QO9_.M@-P?KY8[9]%KO9(HM03[3;A)%!
MRRCD.*\7CL8UW1R[;73T0.<D">4CH6]LFNF\.^*+G2G^SW$:II[L%C)?)3MD
MGTH M:YHLJ77G:=$J@2$G>,B,FN42"TL"RLDEU<R2':US&2% [C_ &<U[)=1
M)-"TL'S%T&]>SUPOB#239;[B"=Q#)'ABB_,I_N@&@"EX:U^ZTFY2VO;E6MIV
MRN%SL)_D*]162.7#1G@KU'->&P6$HD>.VA6RM H#74I_?,/<9[FNJ\&^)8M+
MN_[*E:>2(C"3R*0"<\CGMZ4 >EJQ#(0<G%:EG<^:@5^&[>]92G?%&X^ZW2G*
MVP@J2"#0!O45%!,LR9'4=14M !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %/4]+L=9L);'4+:
M.XMI1AD<9'_UC7AFN>#O$GPKU5M>\*S2W&E9S+"?FVKZ..X]Z]_I&4.I5@"I
M&""."* ..\$?$?2/&=H!$XMM01<RVLC<_5?45MW-Q(92?X?3T%>9>-OA-#)>
M/JWA&;[%J2-O^SJVU6;_ &#_  G]*R_#7Q9N],NAH_C6UE@G0[/M13!!]7'?
MZB@#UP*DO3Y6]*Y/Q=XDETRV-G 8WNI@?*#-QGU-:>JZU81:.+ZWO8C&XPDB
MME<GI7DKW5S?ZC(-26$7I8-%(P)609QQCIVH J.!;77VVWM2R2!UNHL[E (!
MW?2NDTK0S?W330GS+1</&ZG:4P,8-4=(L9IKA;4 ,L3O'(LWWE!P/RZUZ9HV
MC06N;>%LP #.!@,?\* +%E:0P+#.8%BBC7Y%Q_X\:Y[QEX@DC*VVGB0F3 D9
M.RMQD'UJ[XK\2_V7;-91()+AUS&HZ$=_TS7EB&&"^&7G$%R2K>82?((;ID=O
M2@!6%Q*D-S"ZR20;OWIX8J%(*Y]>_-=/HVAC4F-Z%)M<JX!.UD8#&!Z]Z9HF
MARO=M(RF*W#$EXL;74]_KQ7J&BZ+%&OF%"L(.8XSW]S0 _2=%B4K.]N(HPH"
M1?U-;_2BB@ HHHH **** "BBB@ HHHH **** "D8;E(]1BEHH X>X9H;AXVS
ME3CFL+Q9=31^%=1:!F#^4>5/('?]*[;7M*:;-U ,N/OJ._O7*N RM'(H*D89
M2."*^.KX9X6OJKI.Z\T9270Y]+3PU8V6B7/EK%)N06LMN</(Y'<C[P]<UJ'5
MM8&I-$VC8M Q'V@3C[OKMJI9>&-'T^]%W;6865<[,L2$S_=!X'X5K[JFK.#?
M67KT]+/^NQ*1SGB'6K?5O %_=P$K&ZF,*W4,&QCZTLL@3QIX?WD*QL'49[G"
M\58/A;1#?F]-F/-+^85W'9N]=O3-6=5TC3]8C1+Z#?Y9RC!BK+]".E:PG27N
M0O;WOE=6[ZV^0<K9@R3I)XW\0E&5BNF*C8.<'!XK,DTK3XOA.+E+6,7/V=9A
M-CYP^X<@UU=KH&EV,DKVUMY;31>3(0Q.Y??W]ZD?2K)]'_LDQ'[%L$?E[OX1
MVS6JQ48N/)>R<?\ R56%RERSN&?3[9F.6,2DG\*TM(+RZI JD_>%9<481$BC
M'RJ JCVKL?#FD-;+]KG&)&'R@]A6>#P[JUU;:]S1(Z&BBBOK30**** ./^*6
MIWNC_#?5[_3KF2VNX40QRQG#+F10<?@37R__ ,+3\<_]#-?_ /?8_P *^E?C
M)_R2?7?]R/\ ]&)7S!\/],M-8\>:1I]_$);6><)(A.-PH M?\+3\<_\ 0S7_
M /WV/\*P]1\0ZQJVJKJE]J-Q/?* %N&;#@#I@BOK'_A3G@3_ * <?_?;?XUQ
MVH? '3]0\:-<1,MAH"1IB")B9)'_ (N3]T4 5O@_\5/$.N7D6A:G83:BJ#'V
M^-?FC'_33L?KUKW6LW0] TOPWIR6&DV<=M;KV0<L?4GN:TJ "BBB@ K)U/2$
MN<2Q(I<<LA'RO]:UJ* /(-?T!E=KN&!&19,21N,D>G_ 17#NK+= KYDUY([[
M%ASY4&>F]>GO7T!K.DK=PO)$O[W'S#^\*\TU[1_L2&2P\R*/.YPG!R?[WJ!0
M!!X3\2G2-0%GJM\)I)3A<OG9QC!^M=W<VT5S']J5%DB8$,IZ$>H]Z\;E$D+>
M6A58% !N;SY"6)Y"^IKM_!_BMKEET^=)/*4A8[B0XW^V/I0!F:_H8259Y+<S
M03$MG=@MCMGTKEIYGBF$=W<1Q!B7CMT7=(1V^<< U['JFG13QF+<?LSDABO\
M.>XKSK4M*&CW@6UBMU?D1LZYW'^]GM0!T_@[Q'<7P2TU"$P,"1%O)W.H[\UV
M1Z'#9YKPN2Z$6IF074K:C$XVE2SH6([8X ]J]9\.ZS'J6F()"!=@#S8RP)4T
M =#!,T#D@=_SK95@Z!AT(S6 > PR?I5^RN2K%'/R]C0!HT444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5%/,(8BQ_"I:RKJZWR%6'R#I0!"Z"0EE;.:YWQ5X=T77M/==;M0VU25
MG48>/WS_ $KH1&"=T3<UQ'C7Q%-!$FGVYA\Y^3N?^$<GCU- 'BU]IU_H33-I
ME[]NTQ)=JC.1[$KV-7[#7-,U7,5T1970R8F8G$;$@\'T/H:UT66PN6NK2%#;
M.N;F#=UPW5<]00:UX/AWI/B&UGNBTD+R-F,@?,&/;W% ';>'-/86@#A99I%!
M,XP<)]:U=>U2UTK22R2I#)]R,$X 8],_C7E$GASQ]\-2UUI%Y]NT[J\8.X?B
MA_F*P]0^(K:]<B348$MV6,J%5=P+>I_&@#:>XNM6NY?MD<0O@V00Q.Y2",J:
MOZ%I;:L8[9@LD3H \S':<AB3N K+TN*UUN:&2QE"WJ[6CV$EE!)RO':O6_#V
MBJZ!'@"L&W3R 8W'TH O>'=%$=LJMC[/&WRC'WSZFNIZ4U$6- B !0, "G4
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M8=",T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 5[R1D@.S[QK+\U7)WK@U+=32&8M_#Z5"98V_P!;
M\I]30!0UJ[_LS3Y+A)%#;?E![GM7C<MY+J6I2_VA%%!?%MT;N"0Z\J<>G6NE
M\;7YOKT6")OM48>8S2;5#$<8]<5RT4-KJ$<*W<+1LY81D@Y1\=5^M &OHFFS
MO>);?O8E@9@R.-Q9">H->H:99VT;>9&FR(#$>?U-8GAO2KFSM4MYBS/(@)9N
MJK_2K_BC6[/2='9G+*^-BH@Y_#Z=<T <SXV\1R+.-,MKHI@[G8*3C'.W-<!=
M:+#>3QW;6<,T3 +*B*07Y(#J1TXQFK0O-M]]FO[QI([EM\,YXQSAE;CZ5U'A
MG0W%PLUS ?)A.-L9_=R*22,8H P(?A+=S"&]\.:K):W3G*PRD@K_ ,#'3\JO
MPZK\5_ X\NZL?[1M5.<E/-!_X$O->U:18"TA:1HPLDG. /NCTK2H \=TOX^6
M&\0:[H]U93#[S1?,,_[IP1^M=GIWQ0\'ZF!Y6LPQL?X9@4/ZUN:CX=T;5TVZ
MAI=I<C_IK"IKC-2^"7@Z_+-#;W%D[<Y@E./R.10!?UCXI>'M%UVRT^XN%DM[
MJ,O]KA<.D9S@!@/YUV5M=07ENEQ;3)-#(,JZ-D$?6OF77_A'K$7BR;2O#]I=
M7=I&JDW,X"("1G&[H<>U>I?#7P!XC\'L6O=<5K5Q\]BB[TSZ@GH?I0!Z;4%W
M<?9+22<J6V#.!4]17,7GVLL7]]2*:W&K7U,W0=5;4HYQ*R&2.3&%]*UZ\M@@
MNK+5"D<C))O*CG!5JWW\4W]E+%'?1JBHW[TE>6'L/6NF>';UB=U3!N3O3?R.
MHU.\&GZ;/=$$^6A( [GM7F4V9].$CG+-*78GN>IK0AOM<\6:M+#&C1:>/[_
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M&O,]1T^.WOVCBTZWG=>40C!_WB>A^E '7^!]<M[K2QIZ3"2:' )VE<CM77'
MW#D'TKQW2M5N-.UB"]7R?LP=ED2)-O7KGU.:]?AF-Q;B?'#\C- &GI\_)B8_
M2M"L%&V,"#T:MQ&#H&'0B@!U%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** *.K_P#(.?ZBO);G_D99O^N)HHH YRP_U>F?]=O_
M &:O9;S_ )!</T'\Z** .'U7_D-K]&_E6';_ /(+MOQ_F:** /4;#_CUA_ZY
BC^56C]]?K110!N0_ZE/]T4^BB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>img254193463_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_6.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '0 F4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ***Y2+QU:2S^)HA9S@Z"I,IRO[W@GY?\ OGOZ
MTTFQ-I;G5T5F>'M:B\1:!9ZM#$\4=TF]4<@D#)'./I6G2V&G<**X^;XCZ*/&
M-GX:M3)=W,\AC>6'!CB8 G:3W/'0=*D\5^.$\,:KIVFKI-YJ%U?JYBCML9.W
MJ,&JY63S+<ZRBN7\->-[/Q#J%SIDEE>:;JELN^2TO$VMM_O#U'(_.K&J>)7L
MO$EIHMK9-=SR6TMW-M?!CC3@8&.2S?*!Q2Y7>P^96N=!17G%Q\59[74;;3Y_
M!NMQW=T"8(650TF.N!WQ6M=^/5T^PT>XO]$O[674[S[(MO-M5XSG 9O:GR,7
M/$[&BLSQ#K47AW0+S5YHGECM4WLB$9(R!QGZUR5I\5+9I+)M4T'5=,L[TJL%
MY/&#$Q;[N2.QSUI*+>J!R2T9Z!1112*"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *\<L_^0A\5_P#<;_T!Z]CK(3POHL<FJR+8J&U4
M8O3O;]\,$>O'4],5478F4;V,;X9W$(^'6AQF:,/Y&-NX9^\:MZ*OC0:Q(=<?
M1#IN&\L6@D\W.?ESNXZ9S56T^%W@RQO(;NWT1$GA<21MY\IVL#D'!;'6NOH;
M5]!13LKGF7BJVT_3_B+X*CLXK:W3[5<R2K$%4;BH)+8[GWJI\2#J+?$GP:=&
M:U^WE9_(-SDQ9P/O;><8STKJ[[X9>#]3OY[Z\T9);F=S)(_GR#<QZG ;%:S>
M&-&>[TRZ:R4SZ6GEV;;V_=+C&.O/ [YJN9*Q+@W<X3X>/+J7C'7=5\17")XD
MME^RR6BQ[$AA&"&7))8''7_&MWP(#K%]K/BR3)&HS^1:9[6T1*J1_O'<:VM2
M\)Z/JE_)J$UN\=_);M;&Z@D:-_+8$$<'!X/<&M+3["VTK3K>PLXQ';6\8CC7
MT4# I.2948M;GGWB[_DLG@G_ ')__031\6B!=>$"2 !K$>2?PKN;O0=,OM8L
MM6N;427UD&%O+N8;,]> <'\14.O>&-'\3V\4&LV0NHH7WHI=EP<8S\I%"DKH
M3@[/S,;XE3Q2_#?71'*CD6_(5@?XA7FZMK5\G@_0_%EQ:6OAVX2&6VFM(S^]
M95&R.1F/RD@]AW_+T^S^'/A/3[>\M[72$CBO(O)G7SI#O3(..6XY Z5I7WAC
M1=2T.+1;RP273X558X69OD"C"X.<C [YIJ22L)P<G<UZ*9%$L$*1)G8BA5W,
M2<#W/)I]9FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%>>^%_B \_A_P 0ZOX@EAB@TR^D@0Q)@LH
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MV,%<_0UV-<%XM_Y*EX#_ -Z]_P#10KO:I[(F.["BBBI*"BBB@ HHHH ****
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M-7J3EK<:CI8\CN+/QO:^*=:UVY\,0:B[H\%I,;]$6WMQG[J]<D<D]>OK6O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.$_X07Q!_P!#_J__ '[2C_A!?$'_ $/^K_\ ?M*[NBCG8<B.$_X07Q!_T/\
MJ_\ W[2C_A!?$'_0_P"K_P#?M*[NBCG8<B/-I_A7?W.KVVJS>--3>_ME*0SF
M)=R Y! Y]S^=7O\ A!?$'_0_ZO\ ]^TKNZ*.=A[.)PG_  @OB#_H?]7_ ._:
M4?\ ""^(/^A_U?\ []I7=T4<[#D1PG_""^(/^A_U?_OVE'_""^(/^A_U?_OV
ME=W11SL.1'"?\(+X@_Z'_5_^_:4?\(+X@_Z'_5_^_:5W=%'.PY$<)_P@OB#_
M *'_ %?_ +]I1_P@OB#_ *'_ %?_ +]I7=T4<[#D1PG_  @OB#_H?]7_ ._:
M4?\ ""^(/^A_U?\ []I7=T4<[#D1PG_""^(/^A_U?_OVE'_""^(/^A_U?_OV
ME=W11SL.1'"?\(+X@_Z'_5_^_:4V3P/X@CB=_P#A/]7^52?]6E=[45S_ ,>L
MW^X?Y4<[#D1R_P ,M2O=6^'NEWVH7+W-U+YN^60\MB1@/T %=;7$?"'_ ))?
MH_TE_P#1KUV]$OB8X?"@HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK,UG1AK,449U
M+4;'RV+;K&X\HM[$XY% ,TZ*Y3_A!A_T-'B;_P &)_PH_P"$&'_0T>)O_!B?
M\*=EW)N^QU=%<I_P@P_Z&CQ-_P"#$_X4?\(,/^AH\3?^#$_X467<+OL=717*
M?\(,/^AH\3?^#$_X4?\ "##_ *&CQ-_X,3_A19=PN^QU=%<I_P (,/\ H:/$
MW_@Q/^%'_"##_H:/$W_@Q/\ A19=PN^QU=%<I_P@P_Z&CQ-_X,3_ (4?\(,/
M^AH\3?\ @Q/^%%EW"[['5."R,JL5)& PZCWYKQ;X=V7B=/BQXB^W7"A8V'V^
M00J!.?\ EF%_NY!W<=A7?_\ "##_ *&CQ-_X,3_A35\!1*[.OB3Q(KOC<PO\
M%L=,G;S5)I)HF2;:?8ZVBN4_X08?]#1XF_\ !B?\*/\ A!A_T-'B;_P8G_"I
MLNY5WV.KHKE/^$&'_0T>)O\ P8G_  H_X08?]#1XF_\ !B?\*++N%WV.KHKE
M/^$&'_0T>)O_  8G_"C_ (09?^AH\3?^#$_X467<+OL=717)GP.H&3XH\3#_
M +B)_P *C'@Z KN'BWQ&1G&1J?\ ]:G9!=]CL**Y,>"$(R/%/B8_]Q(_X4O_
M  @P_P"AH\3?^#$_X4K+N%WV.KHKE/\ A!A_T-'B;_P8G_"NCLK7[%90VWGS
MS^4NWS9WWNWNQ[FAV&FRQ1112&%%%% !1110 45S^I^%1J=_)=_V[KEKOQ^Y
MM;TQQK@8X7''3-5/^$&'_0T>)O\ P8G_  IV0KOL=717*?\ "##_ *&CQ-_X
M,3_A1_P@P_Z&CQ-_X,3_ (467<5WV.KHKE/^$&'_ $-'B;_P8G_"C_A!A_T-
M'B;_ ,&)_P *++N%WV.KHKE/^$&'_0T>)O\ P8G_  H_X08?]#1XF_\ !B?\
M*++N%WV.KHKE/^$&'_0T>)O_  8G_"C_ (08?]#1XF_\&)_PHLNX7?8ZNL;Q
M6NK-X8OSH<RQZBD9>+<@??CDK@]R,C\:S?\ A!A_T-'B;_P8G_"C_A!A_P!#
M1XF_\&)_PIJP.[Z'/?!%-7'@A7OY1]AWLEE#Y8!50S%F)ZG+$CG^[7IE<A#X
M AMXEBA\2>)8XUX55U @#]*D_P"$&'_0T>)O_!B?\*<K-W%%.*L=717*?\(,
M/^AH\3?^#$_X4?\ "##_ *&CQ-_X,3_A4V7<=WV.KHKE/^$&'_0T>)O_  8G
M_"C_ (08?]#1XF_\&)_PHLNX7?8ZNBN4_P"$&'_0T>)O_!B?\*/^$&'_ $-'
MB;_P8G_"BR[A=]CJZ*Y3_A!A_P!#1XF_\&)_PH_X08?]#1XF_P#!B?\ "BR[
MA=]CJZ*Y3_A!A_T-'B;_ ,&)_P *LZ?X2&GWT5U_;^O7'EG/E7-\7C;C^)<<
MT67<+OL=%1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHH)P,F@!&954LQ  ZDFLNXU<JV((PP!QDGAJKWER;VZ\L-FW1AC
M'&X]_P *2*)491GOG)JDAE@WMRXR'5,CHJ]/Q-(LMT%)\_(/KCBE"JW.<-UR
M12E0#G@$?K0 HU"X7&Y48=R :OP7$=PN4/(Z@\$5F_Q#TJ-T975E. ._?-%@
M-NBJUI=>>"KX$@Z@59J1!139)$B0N[!5 R2:RO[1FD<^40$)XR.:=@->D) &
M20*Q$BD0G][(S$Y)=_6D:%W(82R *>F_K3L.QNT5E?;I[<AI,/ !\S8^:M**
M5)HPZ'*FDU80^BBHKF=;:!I7Y Z#U/84@":XB@&9'"\9YK-DNYKA\KA$QQD<
MBJ^'F9I9.78Y&>=@[591<+C<22,9Q56L,:8=SAI-Q(7^)LTNWC!P!Z#I575=
M1CTC3)KZ8.T<(&53J<FN2UGX@6ZVRQ6$3FX.#('&#&,9/_ZZNG"527+'<TC2
MG)<R6AW!1]P;+8QC&:EAOW1PDR_+T\P?U%>.KXEE(CC_ +0-N2VX2;F<BNS\
M)^*!JZM9W<T,EUSM=" 9 #W6MJF'E!78YT7%7._5@RAE.01D4M95M<_9FV/G
MRF.!_LG_  K5KE:L8A1112 **** "BBB@ HHHH **** "BD) !). .IK+N+J
M2X)6)BL73W;_ .M32N!<N+Z* [0&DD/1$&?S]*K"^GE7*Q!.V2,_E4<<>!Z#
MT%1G4+(2%#=P;P.5WCBJ4;[!HBRES= <E6^JT^._(($\17/\2\@?6F*RN,JP
M9<<$&FLN2:+(9HHZR('0@J>A%.K*5WMSO7)YY4=ZTXW61 ZG*GI4M6$.HHHI
M (2 ,D@#WJO-?0PML#!Y/[H/3Z^E9VH:O$U\NF1!C,PWEL<8'O352,-\Q523
MRS=ZKE[CL74O9GF8%46,< \DYJ-I[O)8.O&>%7J.W%06EW:W?F-;SK*J.4<J
M<X8=J=<7=M8F/SIDB$K;4#'[Q]*=M;6 CM-<BFO+JUBD$MQ;X\V,DC;DXZ_T
MJ\-25L#80Q&<'VZUFZA/9:3:7>IS0* B[I6C0!FYQSCD]:2TFBO]/@NX 1%.
M@D /O3LFKA8Z$'(S16=I6JV^H(RQ3I,R'!9.G_ZZT:AIK1B"BBBD 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6=JMRT<0
MCC)#DXZX%:-9&L<W-L#TPQ/Z4UN!4MDV*JD$@# S_%WJSM7=G 8GU%,C&%%9
M'BC6QH>DF5/^/B4[(O8]S^'\ZN,7.2BBHQ<G9%Z^UFPTQMMQ, _]P#)_^M6/
M-XVMO)9X;1W?&0AD _I7G+:G(TQE?#LW)#$M@?C3_MS8RJ*@)XP.GX5ZL<#"
M.DM6=RPL5HST2T\;64RD74#P,.NP[Q_0UT,$L-Q DMO(KQ.,@J<BO$9KTAN#
MSU+5T'A+Q!)97\43RE;25\21GH"?XO;FLJV#CRN5,BIAU:\#U&.;R+I#SQ]X
M8Z@UK%U5-Y("]<UC3?ZLGOBM#491#I\C9QQ@"O-9QF9=S&\O2J,3$IP >G'4
MXJ14V]NAY/>HH%^7/ZUD^)M<_LNS,<+ 7,@X((R@]<4-V-:-*5::IPW9I7FJ
M6-BRK/,H8G;M!R0?4^E1#Q!I1'-T,'OL;_"O,X+KS9BTF9&+9*N?O4Z:]\J+
MA3N)Z#IBHYSWO[%@DDY.YZRDD5Q$)(W61&'#*<@T1R_8Y/,&1'_$OMZUY7I>
MO7.E70FAD9E8?-$WW6'^>]>F6EY!J.G1W<!S'*N<=QZ@^X-4G<\G&X*>%G9Z
MKN= "&4$'(/2LB^NEN+T6ZD[8#F0$=R.*OV+E[5<DD@[>>U938?4;IP"!O"D
MGO@4T<1-PJGLH&36?H^NV.N+.]C([K"P5MR;>O2K4]]:VC8GN(XV(R%9N<?3
MK2V(L_+=K(0;&;+F$  MZG'>AI[]"E;E=UJ4UUA[CQ%+I#Z;((ECW&X9/D/
M_ CFO-/'\VG#7FFTV<23*W^DQB,E4<<9SC';'7K7IJ3:R?$,D3V\0T@1964/
M\Q;Z?7-%[IVB6MO?7=U9V\<<R_Z5(5Y<?XYQT[U=&JZ4N9&\)J$E9=%L>&-.
M\SJ9Y3,2P4@C.U.IP3T.*W/ &HV=EXJ4W)6&'#[)&/(R#P:TX]"T#5/%"Z=I
MUY<_O8VD641 JHQG;U].,^M+XC\(6&@W&E^7([^:S+*[# 8#&.!TX)KT?:PK
MODIO?R.F5I2]G?<[G0Y-7N%N9=2:WDMW.;=H6!R/48[?7FNHL7W6P7))3@DG
MK6/IYT^.RAM],>-[6+]VGEMN QVS6EIYVR3)SV(S7E+X3@JN\GI8OT444C,*
M*** "BBB@ HHHH **** ,^^FE&(?E ?/3J157?'!'))(V(XUW.QZ  5-J#9N
MT7."%X'?KS_2L#Q9?FSTCRU S<MY9^F,GC]*VI0<Y**ZBE)1BVS!U#Q-<7^Y
M(W,=NQX2-QDKZ$^M5!)'!&'+*1G)QP1VZUE?:(XSN&WYN%&,#-*M[F!9'C!&
M<,O7%?21HPI1M%'ENI*;NS7MM6G@9GAN)5;<#@'CWSGK78Z-KL6JQ%3A;A!D
MH#]X>HKRZ2ZE+[ANXYX &%SWK5TB[:"]M;A648<'@XX[_G7-B,-"K!M+5&M*
MJX2L]CU'[PS_ #%/M)!%.T9'ROR#[TTXSBHP=MU&<CEQ@5X)Z)K55O[K[);%
MQ]]B%3ZFK58FH?O]45';]W$ P^IJ4(S(]2ABUS^S&@G#&'S#<,O[L #)Y[?G
MWK.\1S:+J5I]EN;V57B??&UN2<-@CKT/YUR_BCQ-J,<ESIMZ#"8Y 8XH,D.,
M@C><\@C^=<Q<7T\SK,Y^93\I]!5RERM-'JX;+G5CS7U_KJ=PVO1>'=&MK?0X
M&.U]UR\\66ESU?C/^<8K>TSPQ;-&;B_NY]42247-O]I!4Q''IGKR,Y]!Q7D'
MV^YBR5E?<,;6+'*C/05Z!;^(]*2'2=>U&_NI+V$&W:WA?<A//S,/H?Q.*J,I
M2T1GBL)[&W*[G5:S.EU>0:'=6%S);:@AWSID!,'.,@<=.]3V]WIFG36NA1S!
M;A8P(H3DG9@XR?H#6&FL+H%Y?6,0U+4Y95-XA?+#!&0B\= /UXJ"VU!?%R2V
M\=H=.U;[,LB7NP,57<. >HR#TSW-5R::['#8Z:TTVUTF%8K"%8(Q)YI )Z^Y
MKH(9!-$L@&,CIZ5R6G:Q'+JDVBGSY9K.-?,N&7Y9" ,]/K6[8W"PSO ^0&^9
M6[5G)/J2T:=%%%9B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *R-7Q]IMSUZ@X]\5KU0U.T-S$K(I,B'((--;@4D(88';B
MO+?'UZUWXG-IO(BMD50,< GDG]:]/MY!( ZC!(R1ZUY?X^LO*\5-,%.+A%<$
MG&<#!_E7=@+>W5SJPEO:JYR1?]Z<CZ4\S%02305'/3CCVI)$66-!TD7.3CJ*
M]F<=3T91U*[2$MSG\ZT+9B"K-TQC ZFJ'EG=@G'I6A!&7P%(P"!4P6CN**WN
M>P:%>?VAX?LWR691Y;YZDJ<?RQ70ZP,V(7U=1^M<[X1TR2'2[>WE(.?WSJ>J
MYZ?TKJ+^+?9,HZ#!_*OGJEE-V/(G;F=C-CZ5Y?XTGED\1W (.(\(H/I@5Z?&
M2,=SZ>W>N(\<Z6R7:ZBB_NY0%=AV8>OX?R-936AZV1U(PQ=I=4TO4XF*9HFQ
M@YXP,]:)I1Y@9YBV#RNTX^@J3R/NGN.A]:CECBD4<$-GL.:R/KIT[:K<@CNO
M-NBY&%')P.!Z5ZOX*9F\,(&SQ*XZ>]>;P6:G8!$<9S@]SVKU;0[-M.T.&&3B
M3!D<>A/:KAN?/YW[M&,9/5NYT&G?\>S^N\UPFOS:Y8ROJ-C*GV:%7:2(X^9L
MX!YZCD5W]E$8K50<9//YUROBZ5[/3KQ$LWN?M&46- 21D'GCGJ*T5F_>V/G:
M+:FK(\C?5+RZF:>:ZDDNYFP5SP,^]/T+Q!<6'B"U*W4C0^8H;)(W"DOM"U/2
MS$]Q:NA=00P7(R>?SQVJA&D-OJ%O,\9WQON*\8S]*]2HXQC>3O%^70])PY_A
MV/<_$%E?:AIODZ;>BUGWAMQXWK_=R.G4'\*L-:1OHRV>INEPAB$<[N<!SCD_
MG63):V]U=:=XEO+J:Q6&($V\C87)SC/IU_'BN3\>^)97U--/M9<6\2JQ9&^^
M2,Y_(BO.H4O:SY3BC&4K03_#KZ]3L;76?#>G1K:VT\$(A&T!8SD#//..>:Y/
MQIK^G7U_I@L[D7 C9A*BYV\E<9]>AK@Y)I&8NI&#][COZT_1[=;GQ'IZ2 ^5
M-<*&"'EN17:J2HRYDGH:RIQIR4T[GN6E:19:-9M;V".L3OO^=MQ)( _E6GI^
M6G9ARH&"<U%*PC5F/ '-6-,C*PL^T*KG(]_>O/M9'%*3D[O<O4445)(4444
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M'J3UKMO!?A>^MY1J\UFS16ZM) C8#2-@X ';ZUU&B^!=,T>7S9V6]D7F,2H
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MBT445 @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUQ'BSX>)XH\5:5KC:DUN;#9B(1;M^U]_7(QZ4H2M*['.+<;(Z^__ .0==?\
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MRY8X^8=EY /'>AS5[W!0;5FBAH#J?@E;D,,#1W&<^B&N<^#W_)*=6_Z[3_\
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ME^$GA.6]DN/LMPD4C[Y+2.X986/NH_EFNYHI<S'RQ?0;'&D,211J%1%"JHZ
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M7B.&TTC4IC+(C6^^6//4+GC.#C/L*3:=T-)JS.)M-6U+_AGV[O/[0NOM2ZB
M)O.;>!N3C=G-7O$MOK?A>T\/ZY9>)]3EO]8VP7!N'#(/,0'*IT&,\?05TB?"
MZ]B^&-SX374;<S27GGI.4;;MRIP1Z\5K>*O UWX@T?P[90WD$3Z7+%)(SJ</
MM4 XQ]*KF5R>25OD<VEI?>"/BKH.FVNM:A>V6JQ-]HCO)C)E@#\P].<'\Z;X
MW&B?VMJ1O_'.J_V@JEK6QLBQ6V(&0&" ]_7!YKL==\(W.K>.]!\01W,20Z:'
M#Q,#N?.>G;O6#8_#WQ'I&HZO%I>N6<&F:I,TLLKVV^Y0-G(4GCN>3]<5*DM[
ME.+VL<OJU[>>*/@'%J^H7UT;JU8QMY<FU9QY@4>8/XN,?CS6GJ4MQX ^%4.H
M:5J%_+>ZG';1*UU-YBVY*$DQ@C"\9'Y>E=#8_#B2'X77'A"XOT,DC.R7"(<
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M7V8'H:+- FF6****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BB@D $DX ZDT %%(K*ZAD8,IZ$'
M(-+0 4457OKVWTVPN+ZZD$=O;QM+(Q[*!DT 6**\XTP^-/&]JNL1:TOA[39L
MM:6\5LLTKIV9RW3/7 K=M[_6/"OAS4K[Q5>VM[%9+OBN+>,H\JXZ,O0,3@#%
M4XDJ5]3JJ*\[L;+QWXILX]6E\01Z!%.HDM[*WM5E*J>1O9NY';_]57_#GB+5
M[;Q+)X5\3>0]_P"3Y]I>0*52ZCSS\O9AZ>Q_$Y04CM:*\OT$^*_%&I>()(/%
MDMBECJ4MM##]CCD7:.1G.#WQ5NS\6:TWA_Q=8Z@\ UG0HGQ=6ZX20%"R/M/0
M\<CI3Y!*9Z+17FGA[2?&NL>'=/UA/'3I)=0+,()-.C9 2,X)SDUN^%/$]_>:
MO?>'-?@AAUFQ19"\!/EW$1Z.H/([9'O2<04[G74445)84444 %%%% !1110
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M(QC)]2>I/N:&UK8$F[)]"]1114&@4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVIIY>ZV &\8FR?TYKUJBA3:$X)D,%O%"BE(41MH!VJ!4U%%26%%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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-%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>img254193463_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_7.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $3 D4# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(8Q*2-P&<8!/]*WY_"VC6T[V\WB!(YEX*N@&#[\U2\/6SV7C."VD'SQ2NA_
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M_P!!-O\ OR/_ (JC^R,9_)^*_P P_M+#?S?@_P#(X2BN[_X5TG_03;_OR/\
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M,9_)^*_S#^TL-_-^#_R.$HKN_P#A72?]!-O^_(_^*H_X5TG_ $$V_P"_(_\
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M\WX/_(X2BN[_ .%=)_T$V_[\C_XJC_A72?\ 03;_ +\C_P"*H_LC&?R?BO\
M,/[2PW\WX/\ R.$HKN_^%=)_T$V_[\C_ .*H_P"%=)_T$V_[\C_XJC^R,9_)
M^*_S#^TL-_-^#_R.$HKN_P#A72?]!-O^_(_^*H_X5TG_ $$V_P"_(_\ BJ/[
M(QG\GXK_ ##^TL-_-^#_ ,CA**[O_A72?]!-O^_(_P#BJ/\ A72?]!-O^_(_
M^*H_LC&?R?BO\P_M+#?S?@_\CA**[O\ X5TG_03;_OR/_BJ/^%=)_P!!-O\
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M6W)WMV5N]NINY04E6T225O5W_0V(]2_M'PA)>HQ5VMFW$'!# $']:Q]#\/\
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M?_-^GF;<U2I!]E_PR]3"/@62]756UC5C=7%_:"T\VWME@V(#N#$ G<^>Y],
M"I4\(7T]TUWJFNM>7#:?-896U6-0LFWYMH)Y^7GGGVK9FU*:X6#^R8X[D2EL
MSLW[M,=<D<YSQBGZ1J3:C!-YL:QS03-#(%.5+#N#Z5:Q$7+E3_R^3,W0:CS-
M'.1>&;S2A8WE[J-SJ]OHT/\ H5C!;(CE]FS<3NPYQG'3&>]5M$\&W\7AK0Y!
M=#3-:L[=XG+1+.A1VW%'7(S@X.01@YKI_P#A)M$^W/9?VI:BYC\PO&9 "FS[
M^[TQ[U':^+- O;*ZO;;5[22VM2!/(LG$>>F?0'UK>[,K1*-UX6OY3I]Y!KC0
MZQ9K)']K-JA25'(+(T0(&,@8YR,=33KWPS?W5QH]ZFN.NHZ?Y@:X>V1A,LF-
MPV@@+T&#V[YK2TSQ'HVLR7$>G:G;73V_^M$<@.WW^G'7I6,OC6QU#Q1I&FZ-
MJ%G>0SM.MSY;;F78FY<$'IGOS2U#W2=O#%Y<^(K74K_5_M$%G*\MM"+58W4L
M",-(#EE )XP,\9SBH_%6EZGJ&L^'I--D:!K>XF=[D1B01 PL 64D9!) X]>U
M:=MXGT*\U5M+MM5M);Y<@P)("V1U ]2.X%,'BWP^;HVW]L68F =BAE ("$AL
M^F,'\J-1Z&6/!&^PF-QJDDFKRWBWQU 0J-LJKM4"/D; OR[2>A/-3OX8OKNS
M@BU+6%N)8;Z"[#16:Q*!&P;:%!)Y]234MYXDM+SPZ^I:)K&G;%G2(W$Y+1J2
MZ@J0,$,0<#W(J27QGX<@U3^S)=7MDO?-$/DDG=O)P%^M'O"M$U[NUBO;.>TG
M7=#/&T<B^JD8(_(USEGX3O%TV72-3UR2_P!)-LUJD!MUC?81@%W&2S =" OJ
M<UI1^*=!FU&;3XM6M'NX59I(ED!("_>_+OZ5A6WCRRUW1Y[C2=2L+:XANEB;
M[269?+,VP'C'+C[ONPH28VXENR\*7PO[.XU77)-02P5A9Q_9UBVL5V;W()WM
MM)'8<DXI\'@]8=&\.Z=]N8C19XYA)Y?^NVJRX(SQG=[]*T+WQ/H>FZC'I][J
MMK!=R8VQ22 'GIGTSVS3-2\6:!I%RUOJ&KVEM,I4-')( PR,@D>GOTHO(+1,
M=O TQA.E_P!LR#P^9_..G^0N_P"_O\OS<YV;NV,XXS6SI^@I91ZPC7#2+J=U
M)<-\NTQ[D5=H]?N]?>FC59XO%D6GR-$]E>6AFM74<[T(W@GN"&4CZ&I;V^EM
M]>T^W^V6<4$L4SR02 ^;)M"X*'I@9YSZBB[!)$?AG1KK0-'BTVXU'[=' JQP
M-Y B*1J  #@G)XY/Z5LUCV'BS0-4OELK'5[2XN63S%CCD!++C/'KQ3T\2Z)+
MJ[:1'JEJ^H*2#;B0%LCJ/K[=:33&FC5HKG?"GB(:QH>E2WTT*ZC>P--Y2#;N
M56P2!SP,C\ZO7'B/1K73YK^XU*VCM89F@>5GP!(#@I]<C&*+/8$U:YJ45Q5I
MXMGU-[Z2TU'34M8M6@M8)I%8K+&Z(2H(/WR6(';VK;D\7>'HM173Y-8LUNVE
M,(A,@W;P<;3Z'/K1RL%)&U163>^*-"TW45T^]U:SM[IAN\N64*0.V<]/QK41
MUD171@R, 593D$>HI6'<=1110 4444 4-6L)M2LGM8KH0)(I60F+>2#Z<C%4
M[O1+R\T9-.;5-@!PSI!C<@& I&?_ -=%_JMQ'XEL=,MM@C\B2[O&9<D1+\J@
M>Y8_DIJ&'7[MH;2^EM8EL+N41IM<F1=QPI(QC\!7)7C14OWE_>7GM\MCHHRJ
MM>YT?EN:&EV%W8*4N-0^TQA0L:"!8PF/3%9>K^&+S6=3B>XUC_B71SQW M?L
MJ>8K(00%ESE02.>,\D9P:U;K4F\IUTZ-;NX241,@; C)[MZ 5'INHW%Q?7=C
M=Q1K<6P5BT3$HP8<=>0:TIU*=-JG']7^+)G"<TYR_P OP,"]\"W-U'J=G'KT
ML.F7]P;IK;[,K,LA8,?GSG:2,XQGGK4U_P"#[^YO-7DL]?>S@U9U-S&MLKL%
M$8C(1B?E) ZX/7IWK;N/$.D6NHII\^H01WCNL:P%OG+,,J,>]16?BC0M0N[B
MUL]6M)Y[=2\J1R E5'4^X'M73>1S6B<U;^%QJFK:Y;36-S9:2;&VTZW9F4.Q
MA9R'3!/ RI!/7'2M4^%KV^TV^L-;UG[9!<Q>4OD6B6Y0YR'R"26! ]![5?T_
MQ5H.JWWV*PU:TN;DIY@CCD!)7 .1Z]1]*RM<\;6%M>6VGZ9J-G-?G4(+:>#=
MN95=P&Z'[P'Y4_>;"T4B>3PSJ6H:)J.F:SK[WB7=N8%:.U2+RQ_>/)W-^('L
M*9?>&M;OM'CL)?$41S&T5P6TU&213T*J6^5@.,Y(]JT[CQ1H5KJR:5/JMI'?
M.0H@:0!LGH/8GTI;CQ-H=I?BQN-4M8KHRB+RGD ;>0"!CW!'YTKL=HF;XHT:
M4_#F]T;38Y9Y%LA!"I;+O@ #D]3Q38_"$MY>RW.O:HVI VDEG#&(!"L<<F Y
M."<N0 ,\>PJ\?$NFZAIVJ/I.K6,D]E$Y=V;<D+ $AG YV\=O0U6D\:Z#IEO;
M1ZOK=C'=/;QRN5)",&&=RY_A/:C47NC+#PSJ=M ]I<Z]]ILQ;M!$GV)$?!7:
M"[@_,0/0+GO6UH^GC2=%L=.$IE%I;QP>85QNVJ%SCMG%5I/%&A1:I#IDFJVJ
MWL^WRX#(-QW#(&.Q(Z UC?\ ">:9?7&NZ=8ZA9PWM@C^5).2R$K'N9V  ^53
MD'GL:-6/W46HO#-_9:M<SZ;KCVMA=W'VF>T-LKG><;MCD_*&QR,'J<8JI<^!
MYI4NM/AUJ6'0KR9II[$0*6.YMSHLF<JK'/&">3@UJW/B?2-(L;)]8U:RAEN(
ME8-NVK)P,LHZ[?<U-J'B;0]*2-K[5+6!98_-C+2#YTR!E?4<CI1>06B4IO"J
MRVOB2 794:V",^7_ *C]R(N.?F^[GM5>3PG>V]Q]HT;6VL)I;:*WN2ULLJR^
M6,*X!(VM@D9Y'3CBK5UK^V]T.ZM)X+C2-1=H#*GS?.R[HV!'8E64CU(KH*+M
M!9,YW2/"5MHNHV-Q:W$ABM+!K)8W&2^Z0.7+>I(/;O4NF:!<:7K^I7L6I%K*
M^E,[VC0#*RE54G?G.,+TQWZUNT4KL?*@HHHI#"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!DW^HD_P!T_P J\/[5[A-_J)/]T_RKP_M7S?$&]/Y_H>YD
M^T_E^H4445\Z>T%=C\//^0G>_P#7$?SKCJ['X>?\A.]_ZXC^==^5_P"]P_KH
M<F/_ -VG_74]"HHHK[<^4.-,$[ZWXLTR-MES>10W4!)QO0QB,@?0IC_@0J>Q
ML/\ B9Z?)8Z9-8K;H1=,Z[ XQ@+_ +7/>MN]U#2[&[1[N6%+C80K%<LJ$C/(
M&0,@>W%7T=9$5T8,K#((.017+4I4ZU7FOJK=NFOR-Z=2=*G:VCO^/YG-7VH7
M\.DPQ:=H]S;/,S!A'$"85W<D <;CU%:.@")-.\F&QN;18VQBY7#.>I8\\YJ7
M3=<TW6);F/3[M+@VS[)2@.T-SP&Q@]#TS6A50P[C4YW*^EMD$JRE#E2ZW.'L
MK74M+\/^+)[;2%GOIM2N988)DXN$)&#C^(8S@=\8KE]0TO7]4AUVZEM;ZZ%W
MI*0Q>98+;LS+-G9Y8)/ )(W<X]J]@JG-J=K;ZK::;(S"YNDDDB4*2"$V[LGM
M]X5UJ1RN*.0\4:%?WVOW$>FV[1K+X>N;1)E&U%<NNQ">W&<>G-5H([S5]3\-
M"VT*_P!+CL;>XMY9)X0@A9H=H"X/*Y'7H>*]$JO>WUKIME+>7LZ06T2[GD<X
M"BES XK<\\LK2_GTCPYX<70+NTO-+NH))[MXP($$9R[I)GYBXR,#GYSG%._L
M*[;P[90MIDAD'B=KJ1#%SY?VASO/MM(Y]*[!_%>B1V]C.]^JI?MMM@4;=)SC
MA<9 SW(K9I\S!11YMKVCZC--XN$%A.R7-[ITD.Q.)-ICWL/7&#D^U:,NIS7O
MC8#4-&U<VEC-Y5B%LF:%I#P9V;I@9(7T&3W&.XJ.&XAN YAE201N8WV,#M8=
M0?<>E+F#E/,[9/$FJZ_HD]Y83VT=GJ)::U2P6.* %9!N67<6D!R,D#!SVXH6
MRU-O!MUHITF_6ZMM82<DQ?)(C7GF91L_, O)]*]0HI\P<AYS?6][8VOBC1GT
M"[O[C6+B62VN(HPT4BR* HD<GY-G3GLH(JYIVAWEO>>)1=6S322:7:VR3LF?
M/98G#A2>OS8R/<5UR:G:R:Q-I:LWVJ&%)W7:<!&+ '/3JIJY2Y@Y4<%H$4YO
MO!UA+&\=SIND-+=(XPT994C53Z$D-Q_LUIZ]974_C+1+B&WDD@BM+U))%7*H
MS*FT$^^#CZ5TZPQ),\RQHLL@ =PH!8#ID]\9/YTBW$+7#VZRH9D4.T88;E4Y
MP2/0X/Y4<VMQ\NEC@+'1;R#P[\/XETZ2.6SN(VN5$>#"# X8MZ?,1GW-7/!\
MESI-G;^'KO0;X7<,TAEO!$I@?+,?.\S/)8$<?>R>E=O10Y7!1L>9:+;:EH%M
MX3O[C1[^9(+&XM+B*"+=+"[NK*2G7!VGGMQ3+>QU2Q;3M7NM$O)8K76;Z>:S
MC022H)2?+D"C[V,]O[V1TKU"BGS"Y#S*33=3NI+RY&DW4 G\2V=VD;H-WE!8
M]SG'3H<^G>I-0T2]?P5XOACTV4W=UJLDT*B/YY5\Q"K#U& <'VKTFBES!R'D
M>O;WUKQ*YBOY?#PGC?4!9+;L&:-$+[FD8.I&!PH.0.#DUZO;S1W%M%/%GRY$
M#ID8X(R..U9UUX7T&^U)=1NM(LIKQ<$3/"I;CID]ZUJ&[CBK,****DH****
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M3DYXXQ6>/ $\^D2)<S:>+S[<+Z&!+;=9Q,%V;!&QSM89STY.1TH]T/>+<?Q
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MQ'=[88R[O&\2JNU1R>48?6J7A36;/6]>.IWTD_\ :T\12WM#:3*EI#]XIO9
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M?J%%%%?.GM!78_#S_D)WO_7$?SKCJ['X>?\ (3O?^N(_G7?E?^]P_KH<F/\
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M=$O=&NM/2+0[JSGL[8"%1:R*ZQ@#A>#QQ6E7(RP067Q/TX64:1/<Z9,+I(U
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MO[N&WVF*WO+V6:)2OW3L9BO&..*NZMX6TW6;H7-R;M)-GEO]GNY(A*G]UPK
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MX2G0_P#H)0_K_A7D=%']O5_Y5^/^8?V12_F?X?Y'KG_"4Z'_ -!*']?\*/\
MA*=#_P"@E#^O^%>1T4?V]7_E7X_YA_9%+^9_A_D>N?\ "4Z'_P!!*']?\*/^
M$IT/_H)0_K_A7D=%']O5_P"5?C_F']D4OYG^'^1ZY_PE.A_]!*']?\*/^$IT
M/_H)0_K_ (5Y'11_;U?^5?C_ )A_9%+^9_A_D>N?\)3H?_02A_7_  H_X2G0
M_P#H)0_K_A7D=%']O5_Y5^/^8?V12_F?X?Y'KG_"4Z'_ -!*']?\*/\ A*=#
M_P"@E#^O^%>1T4?V]7_E7X_YA_9%+^9_A_D>N?\ "4Z'_P!!*']?\*/^$IT/
M_H)0_K_A7D=%']O5_P"5?C_F']D4OYG^'^1ZY_PE.A_]!*']?\*/^$IT/_H)
M0_K_ (5Y'11_;U?^5?C_ )A_9%+^9_A_D>N?\)3H?_02A_7_  H_X2G0_P#H
M)0_K_A7D=%']O5_Y5^/^8?V12_F?X?Y'KG_"4Z'_ -!*']?\*/\ A*=#_P"@
ME#^O^%>1T4?V]7_E7X_YA_9%+^9_A_D>N?\ "4Z'_P!!*']?\*/^$IT/_H)0
M_K_A7D=%']O5_P"5?C_F']D4OYG^'^1ZY_PE.A_]!*']?\*/^$IT/_H)0_K_
M (5Y'11_;U?^5?C_ )A_9%+^9_A_D>N?\)3H?_02A_7_  H_X2G0_P#H)0_K
M_A7D=%']O5_Y5^/^8?V12_F?X?Y'KG_"4Z'_ -!*']?\*/\ A*=#_P"@E#^O
M^%>1T4?V]7_E7X_YA_9%+^9_A_D>N?\ "4Z'_P!!*']?\*/^$IT/_H)0_K_A
M7D=%']O5_P"5?C_F']D4OYG^'^1ZY_PE.A_]!*']?\*/^$IT/_H)0_K_ (5Y
M'11_;U?^5?C_ )A_9%+^9_A_D>N?\)3H?_02A_7_  H_X2G0_P#H)0_K_A7D
M=%']O5_Y5^/^8?V12_F?X?Y'KG_"4Z'_ -!*']?\*/\ A*=#_P"@E#^O^%>1
MT4?V]7_E7X_YA_9%+^9_A_D>N?\ "4Z'_P!!*']?\*/^$IT/_H)0_K_A7D=%
M']O5_P"5?C_F']D4OYG^'^1ZY_PE.A_]!*']?\*/^$IT/_H)0_K_ (5Y'11_
M;U?^5?C_ )A_9%+^9_A_D>N?\)3H?_02A_7_  H_X2G0_P#H)0_K_A7D=%']
MO5_Y5^/^8?V12_F?X?Y'KG_"4Z'_ -!*']?\*/\ A*=#_P"@E#^O^%>1T4?V
M]7_E7X_YA_9%+^9_A_D>N?\ "4Z'_P!!*']?\*/^$IT/_H)0_K_A7D=%']O5
M_P"5?C_F']D4OYG^'^1ZY_PE.A_]!*']?\*3_A*=#_Z"4/Z_X5Y)11_;U?\
ME7X_YA_9%+^9_A_D=GXF\8QWMJ]CIV[RWXDF88R/0#^M<9117EXG$U,3/GJ,
M[Z%"%"/+ ****YS86BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
<0 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>img254193463_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_8.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $G L4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCF069)14?GP_\]4_[Z%'GP_\]4_[Z%',@LR2BH_/A_YZI_WT*//A_P">J?\
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MN5?[-L/^?*V_[]+_ (4?V;8?\^5M_P!^E_PJU11[.'9!SR[E7^S;#_GRMO\
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M[M4@!1GMD4/DN7(V,NW//6O7AG SUJY*R1$&VV+1114%A1110 4444 %%%%
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MZGXD\+V%W&)+>XDNXY%/<&W:L&ZTW7+[2[ZWUZ-OLOA^QN%AF;I>RF-@DO\
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MI'O62%1RH]B!UI\@<YZ]17CFE:MX@MM&\&^()]?O+IM3O4M+BUE"^48VW#@
M9W?+U]ZD^W^)=8\1WEI9:KJBWT6KFW<VYB^QPVH//7^,#VSFCD%[3R/7ZSK#
M6K/4=1U&PA9Q<Z?(L<Z.N#\R[@1Z@CO[5YE<ZKXMUC6?$']ERZ@)-+N?L]JD
M,L*0KM&<S*_+;O7IZ5TNG/*/BPY=0DL^A127:*<A9!)@<_BPHY;#Y[G<T445
M!84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX Z#/<CK78ZSJ.N65S FE:"NI1./WLAO$A\LY]&'/%*VBL/F=W<AUKQMX?\
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M_C4]% $'GR_\^K_]]+_C1Y\O_/J__?2_XU/10!!Y\O\ SZO_ -]+_C1Y\O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\N)[#?IK2;G@@8271:,H7D=B3NYSBK<?@V=/"&E:(;R,R65W'<-+L.&"RE\
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *1MVP[,;L<9Z9I:* .?\)^&W\/6=VUU<B[U&^N&N;JX"X#L3P .P X%
M=!113;N)*RL%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M2$!@01D'@TM% 'G+?#G53IK>&QK<(\+M,9#!]G_TC87W^7OSC&>^,UZ*B*B*
MBC"J, >U+13;;W$HI;!1112&%%%% !1110 4444 %%%% !1110 4444 %%%%
M '-:WJM[I7BW0%,O_$KOVDM)4*CY9BNZ-L]><%<>]9NG^*KZX^(-Q92E?[&F
M:2TM#@9-Q" TG/7G+#_@-:_C/1[K6O#<L-AM&HP2)<V;,< 2HP9>??D?C6)J
M7A'4D^']C9Z:Z#7;%UNXI2P -P23(<GUWO\ I5JUC-WOH9S>+=2:YL=2>YF.
MGW6O2VL,,,08O D;J  !EMSKG\JW=0\5VM[H\\D%W>Z5<6MY!!.DEJ#*A=EV
MJ5;C# CD=C3?^$5N+.T\'V=FBF+2;@/<'=CCRG4D>N6;]:IZWX6U6^O]?E@B
MC*7MWI\L),@&5A*[\^F,'ZT_=8O>2-2P\7&X\4ZSID]K<QVUBR 3M 51/D+,
M78G ![>U6]/\7:?J-W;P)#>0K= FUFN("D=P ,_(3[<C.,CFLJ70M2DU[Q);
M-:@Z=K<*J+Q9@#"1$4(*=3S@\>M0>'/#]S:7&FQ7WAN&.2Q7'V[[>9%W!=H9
M$ZC(/?&,FE9#O(ZW5]1CTC2+O4)1E8(R^T=6/8#W)P/QJ#3Q?6WAN,W\QDOQ
M 7E? X<@D@>P/ ^E5]<L[C5-2TJR$1-@DWVJZD['R^43WRY!^BUKW2-+:31K
M]YD91]2*GH7U.*\#>+K[5=(6SUO:FK_9?M4,@ "W4)Z.HZ9!X8=N/6K6B^+E
MC\):#<:B;B\U/4+82"&UAW22$#+-M&  ..>!S4*>#[J;P+I%IYBVFNZ9"#;7
M"G<(Y,8*D]T8<$?X55TSP[K>A0>'+^&SCN[JQTTV%U:"8(>2K;D8\'!7D>AJ
MWRLA<R-YO&VCIIL-\S7&R6[^Q&+R&\R.;GY&3J#Q_*KFC^(+369;J"**YM[F
MT*B:WNHO+D0,,J<>A .#[5R\?A;6)9;?4)X88[F?7X]2G@27(@B6,H!G^)L8
MSCUK77PX;KQ3KMQJ%M'+IM];VT:*6^\T>\G('(QD4FD-.0WQ7KLNBZQX;7[9
M';6=U>/'=-)M"E1&Q )/3D"H=2\5P2^)_#MEI.JVL\=S<2K<QPR)(2HC)&<9
M(YIVK^%5DO\ PS'I]G"-/T^[DEFB8C"JT;#H>OS&IM6\.F7Q'X>O=/L[>.*S
MN)'N&150A3&5'UY-"L#YB#3O%-M:Z>OFW5]JES/>W$,,:6H$K>6QW*%!QM7'
MWB>>*OW/BZRM9K:W:TU![NYMS<16R6Q,A4$ @KV(SWKG4\+W<.A?9KO13>S#
M4;JYC>WO1#+ '<E&1LCJ#R,_@:JP?V]I7BS04N(?[4U--'G$R^>%8CS5Q\Q&
M&(X!/&>33LF+F:.MC\6V%QH\>HVL%[<B24P_9X;=FF61<[E9?X2,'.<"HCXV
MTA=.MKQOM0%Q=-9B+R&,B3 '*,O4'Y2/RK"BT+Q+96$;1JV;[49[W4;6SN1'
M(H<?(BR'' (&[&">U,T[PGJ]O]A,D*+Y7B!]0<&Y,A6$Q%1ECRS9.*5HA>1J
M:EXLM;O0[V2"[OM*N+.X@BG$EJ#-'O==HV-QA@>N>F:TKGQ590ZK+I\5M?7<
ML!5;A[6W,B0%N0&([X.<#.!7/Z_X6U6_NO$<EO%&RWTFGM!F0#(B;+Y],#\Z
MO6EIKN@:QJRV>F17]GJ%W]KCF-RL9B9@ RN",D#&1C/I196"[N=?7-^"M4O-
M6TJ]FO9O-DCU&Y@0[0,(DA"CCT%:6EZA<WUQJ,<]H(4MKDPQ.'W"5=H.[IQR
M2,>U<OX<A\2^'EN[$^'UN()M0GG%PM\B_))(6!VD9X!Z4DM"F]4;C^++&+5H
M[&:VOXEDG^S1W4ELRPO+S\H8^N#@XP?6L6/QC+?#Q1;O'>V2:?YBQW:VF?*"
MQ!B3DX+9)(!ZC%4+GP_XGU*XMC?1RR3P:HEPTQO0(#"LF0(XAT(7'WN<@\G-
M79=#UI'\86,=C');ZN));>Y\]0 S0A A4\YR.O2JLB;R-(>,;*T6"RV:AJ%Z
M+**Z(M[7<SHP^^0.!R.1[\58D\8Z5]BT^XMOM%ZVH(9+:"VA+RNH^\2O8#H<
MXYXJIH.A7]AXB%Y<(BP?V/;6F0X)\Q"VX8].>M8VC>&]=\/#2-1BLHKNYM[>
MXM+BU$ZH=KS&175CP>V0?6E9!>1VND:Q9ZW9FYLV?:KM'(DB%'C=>"K*>015
M^N>\*Z3>6"ZG>Z@L<5UJ5XUTT$;[EA&T*JY[G"C)]370U+W+5[:A1112&%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17,DL5K+)##YTJ
MH2D6X+O..!D],U+37++&Q1=S $A<XR?3- '!>"-<\1ZAXP\0Z?X@>%'M8X'2
MVAP4@W@G;NZL<8R?6N_KSWPY8^)[;Q]JNL7V@16]KJJQ(Y6^1S (U(S@#YL_
MABO0JJ6Y$-@HHHJ2PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MF2RK#"\K\*BEC]!S3Z;+&LT3QN,HZE6'L: /)?\ A)/%9\)'Q^-47['YY;^R
M?(79]G\S9]_[V[OFO68I%FA25/NNH8?0UY9_PB'BH>&CX&%M:_V-Y_\ R%/M
M W>1OW[?+QG=VSTKU2.-8HDC085%"@>PJYVZ&<+]1U%%%0:!1110 4444 %%
M%% !1110 4444 %%%% !1110 45S?B?6M2T[4=%T_2TM3/J4TD6^Y#%4VH7Z
M+SVK(O?&&L:;I_B2"\M;+^TM)M$N4E@+-#('S@$'!4_*>,^E4HMDN21W=%9%
MQXFT>PDM[>_U.UM[F9%81O( ?FZ9] 3ZU+J>OZ1HSQIJ.H6]L\H)19'P2!U.
M/3WZ4K,=T:5%<[:^(M_B'7+:YEMX]/T^""9)\XX=6+%FSC'%;\,T=Q!'-$X>
M.10RL.A!Z&AJP)W'T5DZ5J<VIZCJFU4%C:S"WB8 [G=1^\/T!.W\#45AK<UW
MXMUC2&B18;&*!TD&=S&0,3GZ8HL%S;HKE+SQ->I?>);2'[! =+BMWAFNW98R
M9 2=Y'0#'&*UY?$&E6EY#8W>HVL=[(%Q%OYR>GTSVSUHLPYD:E%9$_BG0;:X
M%O/J]I'*93#M:4 AP<%3Z')QS3[_ ,1Z+I=W':WVIVUO.^"L<D@!P3@$^@)[
MFBS"Z-2BLO4/$FBZ5(\=_J=M;R( S(\@# '.#CKC@\^U,_M1Y==L8+:YL'LK
MBU>;'F$S/@C#(!P5YY/N*+,+HUZ:8HS*)2B^8!M#XY ],UG67B+1M1OGLK/4
MK:>Y3.8XY 3QP<>N/:H_%.K2Z#X7U'58(TDEM83(J/G!(]<46=[!=6N:]%5T
MNXUTY+RX=(H_*$CLS851C)))[5FKXLT2;3+V_MM2MIX;--\I1_N\<9^O8T6"
MZ-JBN8L_%2ZM::+=:=<Z<$O)56XCEE.]24W%$QU<>A["M!/%6@27<5JFKV;3
MS,4C02C+,"1M^N0>/:BS#F1KT444AA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 445GZ[J\&@:%>ZK< M%:Q
M&0J.K8Z ?4X% ;&A17!:?XN\16NIZ,OB+3[&*SUH[;9K5V+P.1N5),\'([BN
M]IM6$FF%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 45PMMXYO[SXB6VA+I,EKITJ3;9[E2LDS1]2J]ESQSUKNJ;36XDT]@HHHI#"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#A?B#:+/JGAJ>XL;N[L8+J5K
M@6T;NR@QD _)SUQ6!<Z5<R:-XK30]*U"VT>YT_$=O<HWF37.>616RV-N <]^
ME>LT52E9$.%W<\S\5OJ][;:UI,5G/$&L%CMU@L/-:\)CYW2'A0IXQU'6KEBT
MV@>(+F]U/3+VYCOM/M8X)8+<S%"B$/"0.5))SSP<UZ!11S:6#EUN>8:OHFJ7
MGBC5=5M[.>2U@6RG_LV1 ([P*K93_?7J!TR!FNYU36#:^&9=3MH)6E:$&"%D
M(<NW"J5Z@Y(SZ<UK44.5QJ-C.T'3!HVB6EANWO&G[Q_[[GEF_%B37+#PO;:M
M\0]>N=4L)9+<V]J()"[HK$!MP!4C..*[JBDFQN*9Y9J7AN6Q@\>6FFZ=.(+B
MWM/LR@,_F, =VTDDG!K2U6.\T_Q%)<:&E^;^Z>W%S:2VF^VN0-JEO,Q\FU<\
MYZCI7H-%/F)Y#R?STETCQGI$6D75W>W^J744)CMRT;L=H&Z3HNWKSC':K?B1
M=9DLM5T,03[AIJPPO!8^:U\WEG):0\* W&.O>O1+/3[33_M'V6%8OM$S7$N"
M?FD;JWXX%6:?,'(</X>TR=?%=Q<W5F^TZ+:0B21.K#=N7)[],BL'1M#U9K31
MK=;6>WE&B7]L'=2HB=I!L!/;CI["O5J*7,'(<;X;UB"QT"SLI-#U""XTZQ_?
MI]DPJ%$^8*QX8L0<8)SWJQXM=]=^&>HRV%O-(UY8[XHMGSG< 0,>M=1)&DT3
M1R*'1P596&00>U*JA5"J  !@ =J+ZW';2QQDGBF2?P[<0:?H>HS7L-H"L-W9
M.D;D8!'/WNI..^*R+.RU/4O$&J7!6YN(;C07MHYI;/[,K2;SA0O7C/>O2Z*.
M:VP<M]SSFQ6>^T[P2L6G7L3:?=)'=":W:/85@92>>HSQGI5<:+=K\,&MUTZ0
M7IU;SM@B^<_Z9G=Z_=YSZ5Z=11S"Y HHHJ2PHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P?&FBR^(?!NJ:7
M;D>?/"1'DX!8$,!^8%;U%-.VHFKJQY>DNI^+M1\*V1T2_L%TB=;F_ENH]B!T
M7:%0_P 63GIVKU"BBANXHJP4444B@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#S+6=4E_X6KI6H)HVKO:V$,UM+*EHQ4LW *GNOO7IM%%
M-NY*5KA1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#!\1>(WT.YT
MVU@TZ6_N=0E:**..14Y5=QR6XZ U0E\<I;:;K$MWI5S:W^E0"XELY74ET;.T
MJZD@@X/TK.^(;PQZ[X2:XU%M.B%W-NNE95,?[H]V!'/3GUKF=1FA;3/&JV-^
M=8M)-,5Y-3D^9ED!($.\85@!\V .,GUK1131E*339Z^DZ-'$S,J&4 JI/)XZ
M4]Y$CQO=5R<#)QDUY/XTNM.N8=91;.R34;&Q3%S=3L)BWE[D\A!SQ_>&!GKT
MJ\)=(NO$MP_C"2$Q'3;9[#[8V(RI0F5ESQOW=<<XQ2Y2N?6QW%IK2W?B#4])
M\DH;%(G,A;A_,!/3MC%::L&4,I!!Z$=Z\FU@SGQ-KDEL6?0EBL6U".#/G-;[
M&^Z>NT=6'4C.*]&NM4L=+\-/J<!C:RAM_,A$7W67'RA?KP!]:3B$97W)+'55
MO]2U"UBB;R[)UB:;/#2%=Q4?0%<_6J,7BRP?QC<>&9-T5['"LT9;&V8$9(7W
M'I4_AK39=,T*"*Y.;N3,]RWK*YW-^IQ] *Y:YT./7_%WBBW$I@NX5LYK2Z4?
M-!*$;:P_D1W&10DM0;=D==::Q'=Z]J6E+"ZO8I"S2$C#^8"1CZ;:T%D1P2KJ
MP!P<'.*\B.H:U>6WCB5[::UU6*"RAND@SG"[A(T>.<%,D=\&M1/[#C\2V(\)
M/";=K"X.H"T;,?E[/W9?MOW=,\]:;B)3/21(C-M#J6QNP#SCUJOJ=\NF:3>:
M@Z,Z6L#S,B]6"J3@?E7F.EZ;:6'ASP!JMM%Y=_<75O'-<!B7D1XVW*Q[C@<=
ML"NNURWU>'PSXB?4-0MKFW:PN/*CCMC&4^1NIW'/'L*7+J-2NC4?78D\)G7_
M "',0L_M?E9&[&S=MSTS2V.L2W]Q:!-/E6VN;);H7!==JDXQ&1G.<'.>E<1-
MH5T/A6US_P )#JA3^Q]_D9CV8\K.W[F<=NN::$2?4;.&2\:RCD\(;6N%/^J!
M9!N_"GRH7,STM98V4LLBD X)![^E*KHY8*RL5.#@YP:\<O;B"V\'Z]I\4&G*
M;>.T9]1TESY<P,H S_=<8)X)Z]:V?M&B:?XIN+O0$6;3H='GDU-+%BP<@J8P
M2#_K"-_O1R!SGI2R1MNVNIVG#8/3ZT"1&;:'4MC. ><>M>16,UM%KR'38=.M
M;>ZT6Z,D5A.TN<*I7S&Q@N,]>O)JYIVG6FFZ=\/M2M(O*O;J6*.><,2\JO Q
M*L>XR!P>F!BCD!3/1=-OY;RP^TW5H]BP=U,<KJQ #$ Y!QSC/XU=!# %2"#R
M"*\ATY[5M/\ #J:RX_L)M0U 7!E8B(S>:WE"3MM^]C/&<5Z'I&H^';>.TL-*
MN;98[EI?LT41RKE>7V]L#VXI2C8<97)UUR-O%+Z#Y+^:EF+OS<C;@OMV^N:T
MWD2/&]U7)P-QQDUPM]K&FZ-\6)9=2OH+2-]&55:9PH)\XG S5+Q9JFAZU>21
M);Z;=,NG^;'=WEP0A5BP A49W-D=1@CBGRAS6.]GU2VMM4M=.D8BXND=XQCC
M"8SG_OH4W3[Z:\-R+BRDM/*N&AC\QU;S5'1Q@\ ^AYKS*S33+B_\#ZCKZP-]
MHTAE>>Z_CE C*@D_Q=<?C3Y88[N2*VF+-#+XQE1U#D97RVXX[>U'*+G/5D=9
M%W(P9?4'(H1TD&496&<94YKRK5K8:5<>*M/TY9+?3$FT^2YAMLCRX7SYQ4#I
MD 9QVS6SH8TI/'T2^%FA.FG3V-\+1LPA]R^43CC?C=[XZT<H^?4[ZBBBH+"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDTJP023
M/PD:EF^@&:?5/5I+6+1[Q[TNMJ(7\XH"6"8.< <YQZ4 <]X;\8ZAXCEMI%\,
M7MMIUPA=+V69"NW&0=H.>?ZUUM>1: VDVOC/0K;P-JEW>63QO_:,+3O)#'$%
M^0G=]UL]!7KM5-69$&VM0HHHJ2PHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBHKJ)I[2:)6VLZ,H/H2,4 <5_PLVVWF[_ +(O?[!%S]E_M;*^
M7OSMSMSNVYXW5W0.1D=*\+&IVZ_"(^"-C'Q'YQLOL&P^9O\ .W;L?W<<YKV^
MVC:&TAB8Y9$52?4@5<TD9PDV2T445!H%%%% !1110 4444 %%%% !1110 44
M44 %%%% #)(HY0!)&K@=F&:!%&L?EK&@0_PA1C\JJZKJ]AHEBU[J-REO I"[
MFR2Q/0 #DD^@K/TOQ?I&JWPL8I9H+ME+I!=0/"TBCJ5W ;OPIV8KJ]C9:WA:
M42M#&9 -H<J,@>F:)((90HDBC<*<KN4'!]JJW6KV5I:ZA.\P9=/C,ERJ<L@"
M[^GKCFK%I<QWMG!=0Y\J:-9$R,'!&1_.D&A+L7).T9;J<=:CDMH)H1#+#&\0
M((1E! (.1Q[$5+45Q<16EO)<3MLBC&YFP3@>O% R6D"J&+  $]3CK5'2-8LM
M<L%O;"7S8&. PZ9],]#^%7Z $"@,6 &3U..M,C@BA#".)$#'+;5 R?>I** &
M^6F%&Q<+]T8Z?2E(# @@$'J#2T4 )M7;MVC;C&,<8I/+3^XO3;T[>E.HH R]
M6T&SU;1Y=,=?(@E96;R0%.58-Z>HK1CABB#".)$#')VJ!DT^BBX6(H[>"%=L
M4,:+R<*H YZT_8F%&U<+]WCI]*=10 QH8GB,31(T9ZJ5!!_"H6L+9KFWN#&-
M]N&$0' 3=P<#Z<59HH CD@AE.9(D<^K*#2&V@+1L8(]T?W#L&5^GI4M% $;P
M0R!0\2,%.5!4'!]J=Y:?W%Z[NG?UIU% ";5R3M&3U..M-BAB@4K%&D:DY(10
M!FGT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 444R::.W@DFF=8XHU+.[' 4#DDT )%!##N\J)(]QRVQ0,GWJ2N:T;QY
MX?U[41865U)Y[J6A\V%HQ.HZE"1\PKI:;36XDT]@HHHI#"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** &>3%YWG>4GFXQOVC=CZT^L8^*M'
M_P"$G3PZMV'U-D9S$@SL &?F/0'':MFBPDT%%%% PHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH XOQ2\=OXZ\*7-^573E>=%=_N+<%!Y9/8'&X#WH^($D
M3MH%M 0VJMJD#VJK]\*#F1O9=F[/:NLOK"TU.SDM+ZVBN+>08:.50RG\#6?I
M/A70M"G:?3=-A@F8;3+RS8] 220/:J31#B]3AVL=J?$:X:\O',0E41O,2A!M
M@>1WQG ]JM67VW0IO",D.I7UTNH6SI/;S2;HVVVY==JXPI!4#CL:[&?PUHUS
MJ%Q?S:?$]U<1&&:3GYT(VD$=#QQGK5DZ58EK)C;)FQ_X]C_SR^7;Q_P'BGS"
MY&<#X9E\2ZE;:1K:SRL;J57NC+?@PLC$[D6+;\I7H,<Y'.:TO!EE/K.G3ZCJ
MFI7MX'GN+<6TDG[D1K*P&5[GCJ?I701>%="@U/\ M&+3($NMYD#@' 8]6"]
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M ]![#%;-.3OL**:W"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /,Y],TO1_C%H*6$$%NLMK=RS%3RSMU+'KFO3*YVX\">&+O4'OY
M]'@>[=_,:4ELELYSUKHJJ3O8F*M<****DH**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>img254193463_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_9.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'C _D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBH;F[MK- ]S/'"
MI. 78 $TFTE=C2;=D344@((!!R#T-0Q7EM-.\$4\;RQ_?16!*_44.26[!)LG
MHJM=:C961 NKJ&$GH'< FI89X;F,202I*AZ,C BDIQ;Y4]1\LDKVT)**9-*D
M$+RRL%C12S$]@*CL[N&^M8[FW;=$XR"1CVHYH\W+?47*[<W0GHHHJA!112$A
M5+,0 .23VH 6BHK>Z@NXS);S1RH#@LC C-)<W=M9Q[[F>.%>Q=@,U//&W-?0
M?*[VMJ345#!=6]U%YEO-'*G]Y&!'Z5'8ZA;:E 9K63>@8J3C'(HYXMI7W'R2
MLW;8M44451(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%06]]:W
M;.MO<12LGW@C@XIT]Q#:Q&6XE2*,'&YS@5//%KFOH/E=[6U):*HKK6ENV%U"
MU)_ZZK_C5U6#*&4@@]".]$9QE\+N.491W0M%%5;;4;6[N;BWADW26[!9!CH?
M\@_E0Y132;W$HMIM+8M44450@HHI&944LQ 4#))/ H 6BJL&IV%U*8H+R"60
M?PI(":'U&VCU&.P:3%Q(A=5QU'U_ _E4>UA:]UV+Y)7M8M44459 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M23T_#Y?UK>\:_P#(N2?]=%_G61K]CXAN]-+WB67EV_[S,).X #G'^>U3:SJ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BCM6?Y>K_\ /Q9?]^6_^*J92<>ERHQOUL:%%9_EZO\ \_%E_P!^6_\
MBJ/+U?\ Y^++_ORW_P 54>T?\K_#_,KD7\R-"JFH:9::I$L5Y%YB*VX#<1S^
M%1>7J_\ S\67_?EO_BJ/+U?_ )^++_ORW_Q53*2FN64&U\O\QQ3B[QE9_,OJ
MH10JC  P*J6^EV=K>37<,6V>;.]MQ.<G)XJ/R]7_ .?BR_[\M_\ %4>7J_\
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M7_?EO_BJ/+U?_GXLO^_+?_%4>T?\K_#_ ##D7\R-"BL_R]7_ .?BR_[\M_\
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M/+U?_GXLO^_+?_%4>T?\K_#_ ##D7\R-"BL_R]7_ .?BR_[\M_\ %4>7J_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-JPD[ENBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'#;*V$9@.69@5X&!R?2M;Q/X.?Q-I=A;S:D\=W;';)=)& 98V7;*F!P X_+
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M6/4QL I/7FGRASGI=%>2W8U)M$T:YNY!$GB'5&N+U;B9HT5&0F"%F7E5PJ#
MZGCO3M9TV]TCP]J<,6H6UO ][8>5;6%R[FT<S ,P+<J&&#CID&CD%S^1ZQ17
MFWB+2(]/UK0M!LTB32KK[1-)%=W4HCN)P%P'?DDXW,%Z$CVKI/!UA<Z;:WUM
M+>6LT"W),$%O.THMAM&8]S<]<D ]-U)K2Y2EK8Z6BBBI*"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** .&OOB9:6DMY-%HVI76E6,_V>ZU&)%\M'! . 3E@">2*[:&6.>&.:)@\
M<BAE8="",@UYEXH\1:;XHU&;PC9ZG8V.EQN#JM[),D>[!SY463RQ(Y/05Z5:
MK EG EJ5-NL:B+8<KMQQ@^F*N221$6VV34445!84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44V3?Y;>7MWX.
MW=TSVS7,6J>/!I]Z+N?P\;PA/LABCF\L'/S;\G/3ICO32$W8ZFBL[1!K"Z<!
MKKV37NXY-DK"/;V^]SFM&D,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O<6%I=7%O/<6T4LULQ>%W0
M$QDC!*GMQ27^G66J6C6M_:PW5NW)CF0,I/K@U9HH SH- TBUMH+:#3+2*""4
M3Q1I$ $D'1Q_M>_6HM>T7^W8K.VDG"6D5TEQ/%LSYX0[E3V&X*3],5K44[L5
MEL%9=UX:T.]U%=0NM(L9KQ<$3R0*S\=.2.U:E%(=KE'4]%TS6HDBU.PMKM$.
MY!-&&VGVSTIS:3ISZ8=,:QMC8%=OV;RAY>.N-O2KE%%Q61!<V5K>V;VEU;13
M6SC:T4B!E(],'BJ5OX;T2ULC9V^DV<5LSK(T20J 64Y5CZD$#!K4HHN%D5;_
M $VRU6U-KJ%I#=0$Y,<R!ESZX/>BPTVRTJU%MI]I!:P Y$<*!1GUP.]6J*!V
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#GF\">$W8LWAS3"Q.23;+R?RK=AABMH(X((
MUCBC4(B*,!5 P !Z5)13NV))+8****0PHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***YV^\=^%M
M,O9;*]UNUAN86VR1N3E3Z'BFDWL)M+<Z*BJ]C?6VI645Y9S+-;3+NCD3HP]:
MEDFBAV^;(B;F"+N8#+'H![TACZ*** "BFR2)%&TDCJB*"69C@ >I-*K*ZAE8
M,I&00<@B@!:**S=7\0:3H*0MJE_#:B9MD0D/+GV Y/44!>QI455U#4;/2;"6
M^O[A+>UB +RN>%R0!^I%9>F^-?#6KW2VMAK=G/</]V-9 &;Z ]:=F*ZV-ZBJ
M)UG3AK0T<W<?]HF'SQ;_ ,6S.,U>I#"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BCM6?_9*?\_E]_P"!+5$G)?"K
ME147NS0HK/\ [(3_ )_+[_P):C^R$_Y_+[_P):IYJG\OXE<L._X&A16'J8TW
M1;%KW4M6N[:V4A6DDN6 !)P*LQZ;#-$DL=_>O&ZAE9;IB"#T(HYJG\OXA:'\
MWX&G16#IK:5K N#IVL7-R+>0Q2F.Z8A7'45>_LA/^?R^_P# EJ.:I_+^(6A_
M-^!H45G_ -D)_P _E]_X$M1_9"?\_E]_X$M1S5/Y?Q#EAW_ T**R;JRMK*TF
MNKC4+V."%#)([7+850,DU'IT%IJNFVVH6E_J#6]S&LL;-.ZDJ1D<'FCFJ?R_
MB%H?S?@;5%9_]D)_S^7W_@2U4+-]+U"^O;*TUBZFN;)@MS&MRV8R>F?R/Y4<
MU3^7\0M#^;\#?HK/_LA/^?R^_P# EJ/[(3_G\OO_  ):CFJ?R_B'+#O^!H45
MG_V0G_/Y??\ @2U']D)_S^7W_@2U'-4_E_$.6'?\#0HK/_LA/^?R^_\  EJ/
M[(3_ )_+[_P):CFJ?R_B'+#O^!H45@:0=.UW3UOM/U*_D@9F3)G=2&4D$$'D
M'([U?_LA/^?R^_\  EJ.:I_+^(6A_-^!H45G_P!D)_S^7W_@2U']D)_S^7W_
M ($M1S5/Y?Q#EAW_  -"BL_^R$_Y_+[_ ,"6H_LA/^?R^_\  EJ.:I_+^(<L
M._X&A16?_9"?\_E]_P"!+4?V0G_/Y??^!+4<U3^7\0Y8=_P-"BL_^R$_Y_+[
M_P "6H_LA/\ G\OO_ EJ.:I_+^(<L._X&A16?_9"?\_E]_X$M1_9"?\ /Y??
M^!+4<U3^7\0Y8=_P-"BL_P#LA/\ G\OO_ EJ/[(3_G\OO_ EJ.:I_+^(<L._
MX&A16?\ V0G_ #^7W_@2U']D)_S^7W_@2U'-4_E_$.6'?\#0HK/_ +(3_G\O
MO_ EJ/[(3_G\OO\ P):CFJ?R_B'+#O\ @:%%9_\ 9"?\_E]_X$M1_9"?\_E]
M_P"!+4<U3^7\0Y8=_P #0HK/_LA/^?R^_P# EJ/[(3_G\OO_  ):CFJ?R_B'
M+#O^!H45G_V0G_/Y??\ @2U']D)_S^7W_@2U'-4_E_$.6'?\#0HK/_LA/^?R
M^_\  EJ/[(3_ )_+[_P):CFJ?R_B'+#O^!H45G_V0G_/Y??^!+4?V0G_ #^7
MW_@2U'-4_E_$.6'?\#0HK/\ [(3_ )_+[_P):C^R$_Y_+[_P):CFJ?R_B'+#
MO^!H45G_ -D)_P _E]_X$M1_9"?\_E]_X$M1S5/Y?Q#EAW_ T**S_P"R$_Y_
M+[_P):C^R$_Y_+[_ ,"6HYJG\OXARP[_ (&A16?_ &0G_/Y??^!+4?V0G_/Y
M??\ @2U'-4_E_$.6'?\  T**S_[(3_G\OO\ P):J]];V6F64M[>ZG>06T*[I
M)'N6PHHYJG\OXARP_F_ V**R;2SM+ZTBN[74KR:WF4/'(ETQ#*>A%5K-]*U"
M^N[*SUFYGN;-@MQ&ETQ,9.< _D?RHYJG\OXBM#^;\#?HK/\ [(3_ )_+[_P)
M:C^R$_Y_+[_P):CFJ?R_B/EAW_ T**S_ .R$_P"?R^_\"6I&TJ-5+->WP &2
M3<MQ1S5/Y?Q#EAW_  -&BL'1SI^NZ9%J.GZCJ$MK*6".9G7=ABI.#VR#5[^R
M$_Y_+[_P):CFJ?R_B%H?S?@:%%8,3:7/K$^DQ:O=-?V\8DE@%RVY%.,$_F/S
M%7O[(3_G\OO_  ):CFJ?R_B%H?S?@:%%9_\ 9"?\_E]_X$M1_9"?\_E]_P"!
M+4<U3^7\0Y8=_P #0HK/_LA/^?R^_P# EJ/[(3_G\OO_  ):CFJ?R_B'+#O^
M!H45G_V0G_/Y??\ @2U4-,;3M8%U]BU*_<VEP]M,#.ZE)%ZC!_GWHYJG\OXA
M:'\WX&_16?\ V0G_ #^7W_@2U']D)_S^7W_@2U'-4_E_$.6'?\#0HK/_ +(3
M_G\OO_ EJ/[(3_G\OO\ P):CFJ?R_B'+#O\ @:%%9_\ 9"?\_E]_X$M1_9"?
M\_E]_P"!+4<U3^7\0Y8=_P #0HK/_LA/^?R^_P# EJ/[(3_G\OO_  ):CFJ?
MR_B'+#O^!H45G_V0G_/Y??\ @2U']D)_S^7W_@2U'-4_E_$.6'?\#0HK/_LA
M/^?R^_\  EJ/[(3_ )_+[_P):CFJ?R_B'+#O^!H45G_V0G_/Y??^!+4?V0G_
M #^7W_@2U'-4_E_$.6'?\#0HK/\ [(3_ )_+[_P):KOE#^\__?55%R>Z):BM
MF/KQ_2YM8B^(/C,:7X<M-7!NHO,,]RL7E_*<8W YSS^5>P5Q5U\.8Y=;U#5+
M/Q%K>G2W\@DF2TF5%) P/X?K^=;1:5[F4TW:Q4\:^*=0\"W6GZFPCET:>-H)
M+! JO',%+*R'J5XP?3KWKG_$T?B.ZL_ SWNN0FYO-2BES#;(R12')1E_O!0<
M8/7KFNZB\%63ZA;7FI7=WJDEM:&TB6\8, &X=SQR[ X)]*IO\.;!O#MGHZZE
MJ*)877VFRN%D7S;<YX4''(&3UIJ442XR9SVK>*?$/_"2W>@6M_>1G3+>+SKJ
MTTG[2UQ*Z[LLHX1?8>_-22>)_%M]=^$+ ,FCWNK07(NTGM=QC:/HP4D$$@$@
M$X^;G-='?>!+>YNX;ZWUC5;+4%MUMYKNWF4/<(.GF97!/O@&K2>#K-=3T._:
M[O99M'CE2%II=YD\P8)=B,D_E1S1#ED>?ZUK.O7W@'QGIU[J:27&D7'D/<K;
MJIN86&-I7HIYZC_Z]>C^$K:]M?#5DE]?B]=HD9'$(BV(5&%P.N/6JA\#Z8\'
MB&&62XDCUR3S+@%@-AQQMXX]><UI:!HQT'2DL/[0O+X(?EENW#,!@ *, < "
ME)IJR'&+3NS@#XD\5ZIHFM^*K#4[6TL=-FE6'3GM0_G)%]XNY.02/2JMU)J7
MB'XE>&+^UU(6@O=)-U"KVJR?9P5!91GKGU[5U5[\-=+N[F\\O4-3M;"^E\Z[
MT^WG"PS.>I(QD9[X(K7;PM8_\)'IVLQM)%)86K6L,*8$80^V,\?6GS);"Y9/
M<R/BQ_R3'6O]R/\ ]&+6=XUT72)?A7->36L$5Q;6*307"H%=) !MPPYY.!^-
M=AXCT*W\2Z!=:1=R2QP7( 9XB PPP;C(([5S</PQT]W@&JZQK.KVT!!CM;VZ
MW0@CIE0!G%*+20Y1;;,*P\0ZY)K=ELM8+C46\)"\5&@7S)+C/ +_ 'L'^[G&
M:?H/CB]AT35[_4-8:]U"RL3/-I-QI_V:2&0>A'WDR<9_'CI79WGA*TO/$$NL
M_:KN"YDT\Z?^X<)L0MNW*<9# ]ZK:=X&L;:ZNKO4;V]U>YN;4V3R7SJ<0$Y*
M *!U/4]:?-$7+(Y?PSXG\57.J:1)<B^OK6_ ^U(VDM!%:AERK))_$H.!SU'-
M5KSQOJ6F^([%H_$MKJL$^I+:365O8%8HD9L9$W.6'IFNNT?P-#H]S 8]<UF:
MSM@1!8S7.84!!&"  6 !X!)Q5&W^%VFV]O:VG]JZJ]E972W5I:M,OEPL'W=-
MOS9R1SGJ<4[QN'+.QF#Q1K*>/IM/U;5SHT/VT165K+I^Z&\AS@$39X=OR'Z5
MG7?C?Q/J.H:S-I/VQ$T^[>VMK.#2C<).4Z^9*.5)]!C'%=G<^!X+[5DN[[5]
M4NK6.Z%Y'8S3 Q)*#D8XW;1GA<XIEYX!M9M4N[VRU?5M+%\^^[AL;@(DS=VY
M!*D]R"*5X@XR.EL9Y+K3[:XF@:"66)7>)^L9(!*GW'2K%-CC$421@L0JA06.
M2<>I[FG5F:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 <)\7XUE\ 31N"4>ZMU8 ]C(*YH:_J7AO2;WP!$SR:VLZVFE2G^.
MWESMD)_V%W ^F!Z5Z3XD\/VWB;2#IMW++'$9$DW1$!LJP8=0?2K<NE6$VJP:
MG):1/?0(8XIROSHIZ@'\_P SZU:DDK,S<6W='CFB:C+\/O"_B:WTQ3-/'K:V
M,#R*6PQ4#>5'7H>/7%=7H&O^(UU"]M;^6ZEL19/.FI:EI9LU@E!^ZPR RXYZ
M@\8]ZW7\!Z1-9ZU:7)FFBU:Z-W+E@#')Q@H0.,8]ZCA\"PFSOK74M;UC4XKN
MW-LRW5SD(G7*@ #=Q]XY--RBQ*,D<SX=\8ZB_C2QTM]?CUNTO[>5S(M@;=87
M1=WR-_&IZ=ZR[3QAXO7P3IWB^XU>VEA-V+>2Q%FJ^8GF%"2^<AN.P KN-,\
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M PE"\A\?Q=>M#2M<:D[V.PHHHJ"PHHHH **** "BBB@ HHHH **** "BBB@
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MFSQJWVA9,!(M^\X'?D8[4N5CYD=/Y:>9YFQ=_3=CG\Z5D5L;E!P<C(Z&O/\
MQUKGVS1_$&F)$\3Z;<Z>#*'_ -9YDL;<#MCI6[K_ (EU'0_M5R- EN--LT$D
M]U]H1#MQEBB<EL#KG;TXS1RL.9'1LJNI5U#*>Q&1044]5!YSTJM-?11:7)J
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVQVY)Q[8K5J7N7%604444AA1110 4444 %%%% !1110 4444 %%%% !1110
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M>60WW2-V#Q[5<U'0HK3Q7X+@T_3MFG6)NLB./*0YB^4D]B3W/>M--C-<V_\
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MHHH **** "BBB@ HHHH **** "BBB@"GJ]\-,T:^OV( MK>28Y_V5)_I7"^
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M'@CN87FC^_&K@LOU'45PO@^6/[%XA\):;J$9-DSG3[B*0.$AF!*<@G)1BP_
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M((((R>WK72TFK#3OJ%%%%(84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% $-U:6]]:RVMU"DT$JE9(Y!E
M6![$5*   !P!2U!>7<5A93W<Y80P1M(Y52QP!DX Y/T% #S!$UPLYC4S*I17
M(Y ."0#^ _*I*Y=/B#X?DTF74UEN_LL4JPL?L<N[<02/EVY(XZUNZ7J5MK&F
MPW]F7-O,"4+QE#P2.00".E-IK<2:>Q;I&571D8 JPP0>XI:*0R*VMH+*UBM;
M:)(8(D"1QH,*JC@ "I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF&TD=<,6_6K*213JWENCJ"5;:<X(ZCZUP<]_%H/A[1/"FEWD-I?W-JNZXD<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKHJ*+L=D4-7M=0N[,)INI?8+A7#"0P+*K#^ZRGL?8@\=:R+/PUJ$#ZAJ-QK
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MO_X$G_XFC[1JO_/A;_\ @2?_ (FCVT>S^Y_Y![-^7WHT**S_ +1JO_/A;_\
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M ($G_P")H]M'L_N?^0>S?E]Z-"BL_P"T:K_SX6__ ($G_P")H^T:K_SX6_\
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MLU\Q?WBLN >O'XXJ[IO4BS2T\SHM3\:Z?8RV5O:VUYJEW>0?:8;>QBWOY/\
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MM7(+H>HZI\1SK.I0B/3=,A\K34+AC)(X^>7 Z<?*,^QJHNQ$U=%W6[^X\+>
M;J[DG:YN[&Q_US]9)0N Q^K<UQ.J7%]X?TOPCI5_KMYINEW$#-?:DCYE,Q7>
M$WD$J"2?P^E=UXVTN76O!6KZ? NZ::V;RU_O,.0/Q( KC&@U#6Y/"_C/3--B
MUB"+3S!+822K&T<AX9UW?+D'*GZ?E4=B9WN58?$_B)?AIK=_9WLMW%;7S0V>
MIR1@R-:A@&DV\;B.><?RJQX;O9-8\0ZAH6F>)+[6M$FTPF>[F;Y[:9B5 1P%
M/(R<=OPJO)X!UZ]\.:O(;:UM+B]U.._32!+F+8F<QLPXRV<G'' _#3L[+4E\
M6?\ "7:IHT/A[3]-T^1)8DG21YQC.3LXV@=,\\#\*=M;$KFTN=!\/-3N=4\%
MV3WK;KNW+VLS$Y+-&Q3)]R #745R/PUM)[;P1:S72>7->R27C(>PD<L/_'2*
MZZLI;LUC\*"BBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 4[S5K"PN[2UN[N*&>\<I;QN<&1AU _,?G5RO'/$^
MI:=KNN^()Y;QHKK38TMM(*PR/B>-A([@JI RX5/H#733^)]1UM_"']CWJ64>
MM13M.QA$A0I&&( /\0(8>GJ#5N!"GJ=U++'!$TLTB1QJ,L[L  /<FJT^J6-M
MJ5KITURB7EV',$1ZR!1EL?05YCXIO]8E\(^+M)NM4,SZ5<6ZBY\A%:>*4(0K
M # (+=1C.*ZR:XU/3?%GAG3+B_%X+E+QII7MT5FVJA4# ^7&3TZ]Z7*'.='I
MFIV>LZ=%?V$PFM9<[' (S@D'@\]0:+35+*_N+NWM;E)9;23RYT7K&V,X->6:
M%=ZYH/PML?$%MJB&UM7).GFW7;)&9RK O][=R2""!T&*W;WQ/J5D_B"*W,'V
MDZS;Z=:.\0VQ>:D?S-C&[&XGD^@I\FN@E/34]!JC?:SINFZ9)J5Y>PQ64;;7
MF+94'=MQD>_%<VMSK>D^)[/0[O66OH]4MIF@N'MXUDMY8P"3A0%92&Z$=1UK
ME-(N=6TKX/7&K+J?G$R-Y4,EM&5C8W9#'I\V<D\],\4*(W,]=!!&1T-%<?\
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M5'X  ?A74TFK,I.ZN%%%%(84444 %%%% !1110 4444 %%%% !1110 4444
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MB3^-:E97AO5_[>\.V6I&/RY)H_WL?]R0$JZ_@P(K5J7OJ4K6T"BBBD,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \
MZ\.:[8>!;>Z\/^(I6L6BNII;:XDC8QW,3N6!5@,;AG!'7BGZWJUC?ZSX:UZ[
M@G_X1^)KA6DN+=@B2D 1RLI&0I 8!B.,CIFO02 >H!^M+UJN97N1RNUCQW75
MBO/#_CF^TJ)AHMT;,0&.,JDTH91(Z# X^Z"1U(KH_'>GZ5I-IX<G^PVT%A::
MO"T[+"-L<>UP2V!TSMSGVKO\#&,<4$ C!&13Y@Y#S+6HI]1UKQ#_ &$"6N/#
M$0M#$-NX%Y,!>F"1TK0M=0T+4O#,NG>&%BCU==,ECMT2 K);MLQM9L?(=V.I
M&2.]=[1@#.!UI<P<IY.D^CWVC>%=,T&VV:W:75LSQ+ 4EM0O^N,IQP,;@<_>
M)[U;CN(-'\7_ &?2KJTU1;[52USI\UL?M-J['YY5?^ZN,_,,8X!Z5Z;@9SCF
MDP,YP,^M/F#D/*;2*+^S/'6B:?&D.OR7=X]M"D>V0Q,J[=IQP#R!S5G0%T>^
MU#1S;:WONK*)_+LHM/$+QKY95HY2!\H]CU(%>G8&<XYI,#)..O6CF#D/)K#1
M0/@9:-8V!:XEAB>[6%/WTT0E!D7/4Y4'CTXK9BN])UCQUX?G\,+&R6D4XOIK
M>$HB0E $C<X'._!"]1@\"O0>E  '04<P<AXYI!@LM%\#WVK)C1K>:^\YI$)C
MBF+MY3.,<?Q $]":G\K1M3N_%D[73:98/>V-Q;77V8^7O5,ARA&&0L.<\'KF
MO6\#&,<4N :.<7(<KX'U.?4K._,T=FZQ7.Q+ZSB,<5X-J_. >X^Z3DCC@UU5
M &!@=**EN[+2L@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "@C((HHH \4L]67PYX"UGP1=VET===[BWM;=(
M&;[2LI.UU(&,?-Z]J]5\,:;+H_A72M.G(,UM:QQ28_O!0#^M:V.<T54I7(C&
MP444U71R0K*Q7J <XJ2QU%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5P,:OXM^)S3,K'2/#@*QDCY9;MNI]]H_(CWKO
MJ,8Z4T[":N<YX]MY;KP%K<4*EG^R.P4=3M&2/R%<YXJN=.U'6/#\^KSO;^''
MM&N(;N$E/WYQM!E7E!L)/!&3]*]%(# @@$'@@U5TW3+32=-AT^SCV6L(VQH6
M+;1G..>W--2L)QN>5_OE\&ZS:Z='--X9;5(T6Y,&^5K5L&=QD9?#9PY!..<\
M5K>&3I4'C=#X7NI;W37LG_M&>:1I5B*D>4!*^2"<ME<XP,XKTFH+NSAOK&>S
MF4^3/&T<@5BI*L,'D<CK3YB>0YWX>Y?PE'<@$1W5U<W$6?[CS.RG\00?QKJ:
MBMK>&SM8K:WC6.&%!'&B]%4#  _"I:EN[N6E96"BBBD,**** "BBB@ HHHH
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MID@FM^LCPOH:>&_#-AHZ2>9]EBVL^,;F)RQ_$DUKU+M?0J-[:A1112&%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% %+4M7TW1X!-J=_;6<;'"M/*$!/H,]:DL=0L]3MEN;"[@NH&Z20R!U/XB
MN.\/6EMK?C/Q-?:I!'<75E=+9VR3*&$$(0,"H/3<23FHKRV_L3XC16^A>39G
M4]-FDN(UCS&KQD;)2@QSR5[9JN5;$<SW.UN]1L[&W6XN;B.*%Y%C5R>"S' '
MXGBK5>-6Z:I_PI[1YI;NWG$MW9M;1F$IY9\\??8$[LG'0"NKN?$VK^&=4U&V
MUB:WU"*+29-3B:"#R2I1@ICQDY!W#!Z]:;AV!3[G=45P>C>(M?DU/31<E[N&
M]R+B--,E@6S)0L&$C<,N1M.>>0?:KO@34O$&OZ3:ZWJEU:"VN(2$M8("&W!L
M;RY/?!^4#C(YI.-AJ29T6HZQINCQI)J6H6UFCG:C7$JH&/H,GFFV^MZ5=V,M
M];:E:36D(+2S1S*R( ,DD@X'%<GX^>:/Q#X1>"Q%]*+R;;;%U7S/W+=VX'KS
MZ5DI,UKXA\27MWI,6DWK:&[1:<RK+%<JFXF5RORL02%V]<?6FHW0G+6QZ;;W
M$-U;QW%O*DL,JAXY$.593R"#W%1W=_:V A-W.D(GF6"+><;I&X51[FN-L=:U
M;59-(T;2I;33F_LB&_N9_L^]5WC"QQQY  R&/L !6;J>LW>JV>FVVH+$+[3O
M%-K:3/""$EP0RN <XR&'&3@YI<H<^AZ917$_VMXCUE]:O=(NK*UM=,N9+:*W
MGMS(;EXQ\Y9MPV@G@8'O52Z\:7%\-%DBU"VT*RO].-Y]JNHO-#29&81D@< Y
M/<C&*.5CYT=S/?VEM<V]M/<Q13W)*P1NX#2$#)"CO@58KS[3=;U:\D\&3:M;
MV;7.HSW!)-J5:)!$Q4IN)*D[0<^AQ6EX<U'Q!XDA@UV.]L[?3)IF\NR-L68P
MJQ7)DW##G&>F![T.-@4KG7T5P^C>)-1O/%$EEJ6HV]A.)Y$329K-E9XE)VO'
M*6PY(PW (Z\5W%)JPT[A1112&%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 5;G4K&SN;>VN;N"&>Y;9!&[@-(?11WJ
MU7EOBOP];Z?\1?#.K?:+FXN[W5,%II,B*,+Q&@Z!0<GUYKT;5[E[+1;ZZC&9
M(;>21?J%)'\JIK:Q*EO<C&NZ4;*XO3?P):V\K0RS2/L174X89.!P>*9_PD.C
MG2QJ:ZC;R6/F+'Y\;AT#,P4 D9QR0/;-<#<VZ6GA7P'#9PB^OPT=S#8/]VZ8
MQ%I&9CPNW>7W'//;FI].MAJ5SXWMM5LQIUW>6J&33U(9%C\ME68..&8G.2 ,
M;13Y43SL[+6O$NG>'RAO_M*J^,/%:R2*,G !*J0#GL:UHY!+$DBA@&4, PP>
M?4=J\YET)_%FB^%=4U"W%[:O9P"\A6-/-)(5@X=AG;G[R@@D'/L?1D1(HUCC
M4*B@*JJ,  = *3212;8ZBBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *S;[Q#HVEW<=K?ZK96MQ+]R*:=48_@36
ME7E7AO2=/\06WCR\UBUAGN7U&XMV>506BC1?D"D],>H]!Z522>Y,FUHCU4$$
M9'(HKD_AE=3WGPXT2:Y9FD\@IECDE58JOZ 5UE)JSL-.ZN%%%%(84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M <[J_A-;W5#JVFZG=Z3J3((Y9[8*RS*.@=&!5B.QZBI-$\+0:1<7-[/=W.HZ
ME=*$FO+H@L4'1%  "KWP!6]13N]A<JO<X^V\!K;Z"FBMJ]U-8P7$4UJCHF85
MC?>%R!ELGC)K5O\ PS9ZGK9U&Z9I%?3Y-/DMR/E>-V!.>^>,5MT4<S#E1SVE
M>&[S3)8$?Q#J%S8VRE8;:58QQC #N%W/@=/ISFKOAW1(O#GA^TTB&9YH[92J
MR. &;))YQ]:U**&VP22,#Q)X;?7IM.N(-3GT^ZL)6EAFAC5SEE*GA@1T)JK#
MX*1OMT^HZM>:A?W=F]E]IF"+Y43#D(B@*.><]\5U-%',PY4<Q)X.6-=-FT[4
M[FQO[&S6R%S&B/YL0 ^5U8$'D9'H2:$\$626%I;BZN&EBU)-3FN'P7N)E.26
MXP >!P!@ 8KIZ*.9BY4<O>>#3+<WYL=9O=/M-18O>6T 0AV(PS*S E"P')%8
MVN:%+9ZYIYMK35HM,LK 6UK)H[*9%.X95PW\.%3! ZYR:]!HIJ3!Q1Q^B:#J
M=XFDZAKMU.;K3KJ>6V60(9#$ZE%$I7Y=P4Y.VK=CX3ETN[VV&MWMOI?GFX&G
MJL956+;BH<KN"$DG;GN>:Z6BES,.5'.'PM+<:K:W6H:Q=7MO9W!N;:WDCC79
M)@@$LH!8 ,<#Z9S71T44-W&E8****0PHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#C?$'@6YU[6H=1;Q+?VWV:42VL
M,<<96!MH!(R,G/OZUU45KC3DM+F5KG]T(I)' !DXP2<<9-6**;;8DDM3C+#P
MA=2:!IEI=W4MGJ.BR/'87UNRLQBY525(((9, J?2G7GA2_M])UB6VOI=0US5
M(5M7N[G:@BCSM^55  "AF; Y)KL:*?,Q<J(+&TBT^PMK* 8AMXEB0>BJ !^@
MJ>BBI*"BBB@ HHHH **** "BBB@ HHHH ***8LL;NR*ZET^\H/(^M #Z***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *XS5?AW;7^I7]U::OJ.G1:EC[?;VK
MJ$GXP3R#M)'7'6NSHIIM;":3W*VGV%MI>G6]A9QB.VMXQ'&@[*!BK-%%(844
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4UV"(SG)"C/%.HH JP:A;SVZS;_+# ';)\I&3@9!Z9-2&[ME<(9XPQ)4#<
M.H.,?GQ52_TI;ZY24R;5"%77&=QZJ?\ @))-0_V*X@,7VA3YL2QSL4Y)#%BP
MYX)+']* +_V^SW,HNH2RMM8!QD'T/Y4D-_;3Q2RI*-D3,CD\8(.#5.31R;=$
MCD5)5E>03*"K+N8GC!YZXYR#4PT\FSN;9S'(DLC.H8'^)MV#@^O<4 6!>6Q9
M%$\>YQE1NY(IIU"S6(RM=0B,'!8N  ?K5.+2IHTE1KGS%GC\N5G!+#J!@Y]#
MW]*%TEVGAFFEC9HC'PJ8!"!L<9ZY;]* -%+B&21HTE1G7JH.2*8MY;,Q59XR
M0P7 8=3P!^=5;+3!:3LV59<OL8[MPW')'7'Y"H5T5O($;3K^[@\F%E3!'((8
M\\D%1^OK0!HF[MPX4SQ[BQ4#<.H."/SXI%O;5TD=;F(I&<.P<84^A]*H#10K
MQ-O63$:I)OS\Q#%BW![DGK[4Z739(]$-G#L>3>&R1@'YPQ)H N_;K78C?:(M
MKG:IW#D^E1RZE:0LBM,N6D$8P<X;GK^1JE-I%Q-%,GVI4$[,\@53C)P!CGT'
MXYS3ETB5'+QS*JB82I%\Q0'YL\$\9W=N.* -)KB%7VM*@;<%P6&<GH/J::+N
MW9U03QEF^Z PY_S@_E5*^TC[9=-.LWEGR\ ;<XD'W'_#)J-=#5)!\X9"B*P.
M005&,C!Q[\]#0!=;4+?=&$D63?)Y>4((4[2>?; -6$=9$5T8,K#((/!%8W_"
M/J]O'#)(,1X7<N[<RA6 ZDX^]G'3KZUL0JZPHLK*S@ ,RC )^G:@!]0R7<$5
MPD#RJLKJ653U('4U-33&C,&**6 P"1S0!%!>072JT#[T9=RN =I&<=:FW# .
M1@]*R[[3'N)OW2QB+8JE>@XD5CQ] :9'ILT5R',,4L(>3;$6P$#$$,./8_G0
M!IP7$5S")8FW(20#C'0X_F*4SQBX$&[]X5+X]@0/ZBL.'2+R$%,1D/)&Y._[
MH60L>W.0:0Z-=,A7$:,(BC2!N93YBMSQW ([]: .@W#CD<]/>HYKB*W3?*V!
MN5?7DG _4UEIIDT=Q;2QC:58EP[*RA2<D ;>#Z$8I7TV=EE3RHB[7 E$Q;EE
MWAL=.P&/P% &K'(LB*PR PR PP?R-(9XA<"#=^\*E\>PP#_,5CPZ/.B*6$9E
M46X5L\C8V6P<>GYTV/2[J(@B&W9A$T;,QSYI+@[B,>@/7O0!N[AQR.:,C&<\
M5@PZ+. ?.$3'='MYZ*)68@<<?*<8_"G'2YUGM8Q@1,T@G &5\L.70>W4#'H3
M0!M/*J%0<DE@OR@G'U]*?D'H:QXM.G5(4,<0>.?>\P;F49;D\=>:2WTRXM8"
ML<<!8VB1,I/RLX)R3Z\'K0!L;AQR.>E,>XB2:.%FQ))G:/7 S6$-$N62?>(B
MS1N(N?N$MN'0<?A5J'3IDU..=DC(265VEW?,X8<#IVZ?A0!I2W$4)02. 78(
M/K@G^E'VB(W#0;OWBH'(]B2 <_@:RDTJ4QP12PPL8YQ))*3DRCYNO'7D=:C3
M2+F.2%V6.1(U4&(MPP#.0.G8,I'TH VIYX[:%II6VHHR3C-/W#&<C'K6 VA2
MO!-YBQ/*8!'$22=GS,2![8(&?:I9](E:9R@7R/-9A"K!1AD49Y! .0?SS0!L
M22+%&7;<0/[H)/Y"F37<,#A')WLI8*JDD@=>!]:QI='NFFE=/+*. JJSD[2-
MOSYQR6Q@_A[TLVD7,ADVI$&*SCS=W+[SE<\=NGX4 ;N03C//I2@@C(.16#<:
M+<2B0QLD<CRRL7!P2C#@9Q]*T]/MC;0,I4J6<MM+ XZ=,  =* +=%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6//9/;W)N#B4RW$
M8&06VKOSTZ#'J/K6Q67]KO8Y[\F+S!$ 88L@%L]\^G^!H J)?:@MO&[NQ\R)
M7=C%_JOG ) QV4YP?2E6XDAUGS1(SVSA%DE9.",28[>N.E:27Z"PMKF8%3.$
MPJ@M\S#@"E&I6Y2-QYFUVVY\LX5L[<'T.>* ,;[5=W4%N+AW5B;=@@CQORX+
M$\<8_#&/>I!?:D;5Y&DB608W1MP5.[H#MP...<U=AUF*2))I 88VC+[7!W<,
M%^G>I#K%FO5GX!+80G8 <$GTQF@"AJ4T<\=K&RNES/$/WDHQY"\$MZ;O3'?V
MJ74KZX@O'B@E(80*\<83/F/N(Q^-7$U.(BZ:1)(TMY?+9F'!Z<C\ZBEU.T7S
M)8F0S*6C+,IXVD9!('3G]: *#75W:K<%)G<K=/NC; <KC@)D8_#O[5:U"[OK
M>["0(61D$H.S. ARZ_4C 'XT_P#MD&94%M+CSWA/RY)VJ3D ?2K+:E:K&LAD
M^1X3,K8."HQG^8XH R)9;F1/.=GB+"WD+HF"%,C<'CLN*L6+W$5XJ[G:*:XG
MRK)P,'(.?\]:MOK-E&)"\A C!W':>W4?44^+4K:7 !D5RXCV,A5@2,C@^W/X
M4 9K7VI!)1M(\AUBD<I@-EN7'!X"X[$9)]*>LNJ3O)Y=R@\N#>F(P5D8LV,D
M@=@,XQ5\ZI:A6;<Q D\H$+]YN<@>_!_*FC4[*:,_O-RL53!4\[A_+K^1]* *
MZ7EU/H[7J,L9E8/$L@QM3(X)P>2,\G/6H(;S4+F8(&^S[E78LJ_,05Y; &"<
M^X''3FK@UFQ2)-A?!*JB)&26!!*X '3 /Y5/!J-M<RM'')D@$@XP" <$CZ&@
M#*_M'4)(HY2I@C>3RV++C857D]#P6R.G0#UI6NM35993*-JR1QE5CPJ@JI9\
MD$]21TXJT-862X"1)B,K&RR."-VY]HQQ^1J;^U[0Q+(&8JY(3"GY\=2/:@"I
M/<W(M;823!5D$F^:-,YQ]T<CO].W'6J<-Q=VUFK1KMVK"&&W:[CRAP"003GL
M?I6Q)JMI$ SNP0IO5RIVL, \'OU%*=3MEE2)F97;;D%?N[CA<^F30!GK?W@:
M9IGV ,RF-5RZ#< I'&.G)))'/M42ZEJ6T$(96*R!(P &+ O@L,<@X'((_6M2
M75;6*>6%F??%@-A#C)Q@9Z9.1Q2IJ=M*0(V9N,MA3\G)'S>G(/Y4 5["ZFD:
M,374;!VPH"DEOER1G  QUZ>U:E9QU>V?RVC8'G/*G<5*L05X[[34C:K:+@"0
ML2%*A5)W9!(Q^ S0!=HK.?5X3) MN#*))%0N =HW#/7UQCCWIS:K#$9!*22K
M.,1HQP%QDGCMD4 7Z*R)=99;B1$A!C21(P[9YW#.?I@BI6UB!;<G>/.\KS-N
MUL8V[MW3.WW_  ZT :5%4'U>UC=D8R%E)!VQD@D#)Q] <TE[JT5K [JK,PCW
MIE2%?C/![\4 :%%5TO8I(Y659"T3;738=P/!Z?0BH5U:T=E56<YV@G8<*6)
M!].010!>HK/CU1)KORH4+1^4\@D((!VD#CU'-,@U=)[>W;'ERR"(E'4CA^..
M.><B@#3HJA'K%G(5VM)AMI!,9 PQP#]">*9-K-LH'ENK?O%4EN!MWA20?;-
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MW?\ :)LY(2H9YR(D*?P@_>)...,_C52"&XMWM+=DEBCMKAE41DE=C(2@)QR
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M [0 /<YK/U.6ZF2:"%+J2-HF1@Z=?DR"!CU]_7BGWUM,^I7$GDDP9@WLJ$N
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MA+D!HRP^5QE0<?\ ?5+?ZH;.]@A"H8SAIV8X**3M4C\3^0-#Z'9R2,Y\SG.
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MY56SCIN&0,=>G\Z:VM)Y2/%;S,6:(;2 #M<\-U^M2QZ5;PC;&TBJ4",H;[P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
8* "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>img254193463_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_10.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %/ GD# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M -8_[YKIZX\/>I5G5_[=7RW_ !_(ZJSA"G&FD^^_?Y=BI)J4$=DETR7)C<X
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M6/O4;ATC%M^MFE^IWX-PA:5M922WZ7OV]!?"%XEH;K1I%F,L-PP4B)BH&.[
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M+/&KF?\ ?,'7.2>G7VQ5?Q<[7"6.E1GY[N<!L?W1_P#7(/X5T:(L<:H@PJ@
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MO94HP[?GU_$*U3VE1R,'Q;9M<:.;F'B>T83(1U&.O^/X5J:=>+J&G6]VG25
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MDJV!S^5=?14^SC:QNL954KW_ *;O^:.4U'P9$D-G-HTMQ'?6,R26PNKZ>2(
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M>2\.)&Z=%SSU_2M"D9@JEF("@9))X KK.8YR*ST^T\+VL,FE7MW;I-YB6\L
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MEE<R[\M\XVL2,Y&#\M=Y7,ZGJFM^';;^T=1DL+W3XV47!M[=X9(E) W@%W#
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MW,_1+6>RT:VMKA566-2&"G(ZG'Z5H445-."A!06RT'.3G)R?4****LD****
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M11B4RB-1(1@OCDCZT^BBBP!1110 4444 %%%% !1110 4444 %%%% !1110
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M+]7^(4445V',%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %,2&*/=LC1=QRV% S]:?118+G)7,<GA/4S>P*S:5<MB:,?\ +)O4?Y]O
M2NJBECGB26)P\;@,K#H123PQW,#PS('C<;64]"*Y>RFE\+ZF--NF+:;.Q-M,
MW\!_NG_/OZUP?[I.W_+M_P#DK_R?X,[/]XC_ 'U^*_S7XHZRBBBN\XPHHHH
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M_O\ O_C1_9\?_/>Z_P"_[_XT 6Z*SIK B6 1S76TN1)^_;IM/OZXJ;^SX_\
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MT/7C<_;[;<PEM%Q%>VS @ER/N D ,N1SP,@UUUAI]MI=HMI9Q^7;H24CW$A
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M4;/*SAA(&'._.,'C&/K6)I<FC7?B?2[KPS"D!,4@U**&+RPD8!"K*HX$@D
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>img254193463_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_11.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %I 5$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH *K7BAS;JP#*90"#T/!KDKW7-60:IK$5TB6>G7ZVOV+R@1*@**[%NH;+DC
M'' ZYKJ;N=1=6T6U]WF@YV''0]Z;5A)W)OL=K_S[Q?\ ? J,067F,GEV^1VP
M,UA>-M6N+#28X[9FC>X?87'!"@9.*\T#LKAU9@X.=V><UX^-S58:I[-1N^IZ
M>%RYUZ?.Y6/;/L=K_P ^\7_? KG;;PS=1?$&]UJ2:%M+FL4MX[7)^60-DMMZ
M=._6K/A749;S35$Q9B$5@>O7(Q^E06UKKR_$2]O9II#H#V"1P1>9D"8-\QV]
MN.]>G1J*K!374X*E-TYN#Z&_]CMMY'V>+I_<%+]CM?\ GWB_[X%/WCS#P>GI
M3MX]&_*M""+[':_\^\7_ 'P*3[';;\?9XNG]P5-O'HWY4W>/,Z'IZ4 ,^QVO
M_/O%_P!\"C[':_\ /O%_WP*EWCT;\J-X]&_*@"$V=MO4?9XN<_P"E^QVO_/O
M%_WP*>7&]>#W[4[>/1ORH B^QVO_ #[Q?]\"D-G;;E'V>+G_ &!4V\>C?E36
M<;EX/7TH 9]CM?\ GWB_[X%'V.U_Y]XO^^!4N\>C?E1O'HWY4 0-9VPV_P"C
MQ=?[@IWV.U_Y]XO^^!3W<?+P>OI3MX]&_*@"+[':_P#/O%_WP*1K2V '^CQ=
M1_ *FWCT;\J:[C X/4=J &?8[7_GWB_[X%'V.U_Y]XO^^!4N\>C?E1O'HWY4
M 0O9VP4D6\7_ 'P*7[':_P#/O%_WP*>[@H>#^5.WCT;\J (OL=K_ ,^\7_?
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MJQ5>Z^_;?]=A_P"@FBXK6,[Q/I]OJ&CO'.6#JP,3*.0_05P8\(W_ )F&DAV
M\L"?Y5Z-JT32VRE/O(X90>Y';^=9'VQ%<ADD5NZ%3N'X5Y6-P=&M4YJB/2PN
M)JTX<L&:'A^UBM=.V(/WBG8_H".@'M_C6?;7'B _$>^MYHY!X?6P1H',8VF?
M=\PW=<X[5L:5 \-H6D&'E8OM_NCL/RK&MM;U67XCWVB26H&E0Z>D\<_EL"TA
M;!7=T/':O0HQY::5CBJRYIMG2_\ +0_2G4T?ZP_2G5J9A3?^6GX4ZF_\M/PH
M =1110 T_P"L7Z&G4T_ZQ?H:=0 4UOOI]?Z4ZFM]]/K_ $H =1110 U_X?\
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M% #J*** &G_6+]#3J:?]8OT-.H *:WWT^O\ 2G4UOOI]?Z4 .HHHH :_\/\
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M]C>&]1T4$IY@O(F3S>N,98].?SJSXO\ %_\ PC3HEKI;ZA>?9WN757""*!"
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M-.H *:_W&^E.IK_<;Z4 .[44=J* $;[I^E"_='TH;[I^E"_='TH 6CM11VH
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MF84UOOI]?Z4ZFM]]/K_2@!U%%% #7_A_WJ=37_A_WJ=0 4U^@^HIU-?H/J*
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M>)N0.1FJ&K*!=6I &T;LCH-V./ZUKPV^%)E +-V]*9>6J7$)B\L,,9V],_\
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MY<=>V*]#H:L*+N5O[.M/^?=/RH_LZS_Y]T_*K-%(H@^QVW_/"/\ [YHJ>B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHIOF1^;Y6]?,QNVYYQZXH =14$E
MY:Q,RR7,*,IP0T@!%$=[:S.$BN87<_PK(": )Z**B:Y@5&=IXPB':S%QA3Z'
MWH EHJ"*]M9G"17,,CG^%9 34ID19%C+J';.U2>3CT% #J**CBN(9P3#-')C
MKL8''Y4 24444 %%%% !137D2)=TCJBYQEC@9IU !130Z%R@9=X&2N>0*=0
M444W>GF>7N7?C.W/./7% #J**:9$$@C+J'(R%SR1]* '4444 %%%% !1110
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@0 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>img254193463_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_12.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '# Z # 2(  A$! Q$!_\0
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ME_8NF?\ /C!_WP*/[%TS_GQ@_P"^!5W?_LM^5&__ &6_*@"E_8NF?\^,'_?
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M>98T+,K8'HI-1?;X?27_ +]-_A3LV)M+<@_L73-^/L,'3^X*7^Q=,_Y\8/\
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M_/C!_P!\"KN__9;\J-_^RWY4 4O[%TS_ )\8/^^!1_8NF?\ /C!_WP*N[_\
M9;\J-_\ LM^5 %+^Q=,_Y\8/^^!1_8NF?\^,'_? J[O_ -EORHW_ .RWY4 4
MAH^FO\S6,!)ZG8*/[%TS_GQ@_P"^!5Q&^0?*WY4N_P#V6_*@"E_8NF?\^,'_
M 'P*/[%TS_GQ@_[X%7=_^RWY4;_]EORH I?V+IG_ #XP?]\"C^Q=,_Y\8/\
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MI_8NF?\ /C!_WP*/[%TS_GQ@_P"^!5W?_LM^5&__ &6_*@"E_8NF?\^,'_?
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MBB@ HHHH **** &R?ZMOI3J;)_JV^E.H **** "BBB@ HHHH **** "BBB@
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M *__ #$O^V/]:L57_P"8E_VQ_K5BFR8]0HHHI%!1110 4444 %%%% !1110
M4444 %%%% !1VHH[4 -3[@IU-3[@IU !1110 4444 %%%% !1110 4444 %%
M%% !1110 4UOO+3J:WWEH =1110 4444 %%%% !1110 4444 %4;W_D(:?\
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M HHHH **** "BBJ.H:@;$Q!8?-:0D ;L=*BI4C3CSSV!*Y>HK&_MR;_GP/\
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MF_/_ +-'S_[- #J*;\_^S1\_^S0 ZBF_/_LT?/\ [- #J*;\_P#LT?/_ +-
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M@!U':F_/_LT'?C^&@ 3[@IU1IOV#[M.^?_9H =13?G_V:/G_ -F@!U%-^?\
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M&AB3C:1[G%.HHI@% ZT4#K3$:NA_\@P?[[?SK2K-T/\ Y!@_WV_G6E7M8/\
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M444 %%%% !1110 4444 %%%% !5&]_Y"&G_]=&_] -7JHWO_ "$-/_ZZ-_Z
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MV%3'?0N7PNYP.H>/?AK/X.EM(;:%M]N4BL5LR'#8P!G& 0?XLUV_P^L[RP\
MZ+;7ZLMREN-ROU4$DJ#] 0*\^B/CL7@U&#X:Z!%<M\PE,:"0=^3OR#^M>JZ#
M/J=SH=K-K-K':ZBZDSPQG*H<GIR>V.]5/1:$0NW=_D:-%%%9FH4444 %%%%
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M]!-4F9RBDO\ @C?)G_Y^F_[X6I(D= =\IDSTR ,?E4E%*Y2BD%%%%(H****
M"BBB@ HHHH *HWO_ "$-/_ZZ-_Z :O51O?\ C_T__KHW_H!H O4444 %%%%
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MVX9?G.#Q3)M.2#Q'#?":5FN&VF-C\JX0]*VZHWO_ "$-/_ZZ-_Z : +U%%%
M!1110 4444 %%%% !39%1HV60*4((8-T([YIU1SP1W-O+!*NZ.5"CC/4$8-
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MC?\ X^;+_KZC_G3]I_O&HW!^TV7S'_CZC_G36Y,MCNJ*;L/]]J38?[[5YA]
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M,V'^^U&P_P!]J]4@?13=A_OM2;#_ 'VH ?13=A_OM1L/]]J .-G_ .0MJ/\
MUW_H*3)]:)U/]K:C\Q_U_P#04FT_WC7I=O1?D>#U?J_S%R?6C)]:3!_O&C:?
M[QH 7)]:8Y.^/G^(_P J=M/]XU&X.^/YC]X_RH0F2Y/K1D^M)M/]XT;3_>-
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MH_\ R$Y_^N2_SK2C_&AZ_HP>QNT445] 9A1110 4444 <7/_ ,A;4?\ KO\
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M#K3 U=#_ .08/]]OYUI5FZ'_ ,@P?[[?SK2KVL'_ +O#T1$MPHHHKI$%%%%
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M*M*@ HHHH */XI/]X?RHH_BD_P!X?RH **** "BBB@"]X/\ ^2JZ'_UYW?\
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MW^KM/^NX_D:SJ\/%?QY?+\C1;!1117. 4444 (.@I:0=!2T %%%% !5K1_\
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M_D<UO7^\OYT;U_O+^==+_8.E?\^$/_?-']@Z5_SX0_\ ?-'MX>8?4ZWE^/\
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M-_Z :O;%]*HW@ O]/P/^6C?^@&@"_1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 4-6.R""0JQ5)T9MJDD 'K@4G]LV?_ $W_
M / =_P#"M"B@#/\ [9L_^F__ (#O_A1_;-G_ --__ =_\*T** ,_^V;/_IO_
M . [_P"%']LV?_3?_P !W_PK0HH S_[9L_\ IO\ ^ [_ .%']LV?_3?_ ,!W
M_P *T** ,_\ MFS_ .F__@._^%']LV?_ $W_ / =_P#"M"B@#/\ [9L_^F__
M (#O_A3(]:LO,EPTQ(;D"!^./I6G3$B1'=E4!G.6([G&/Z4 4O[9L_\ IO\
M^ [_ .%']LV?_3?_ ,!W_P *T** ,_\ MFS_ .F__@._^%']LV?_ $W_ / =
M_P#"M"B@#/\ [9L_^F__ (#O_A1_;-G_ --__ =_\*T** ,_^V;/_IO_ . [
M_P"%']LV?_3?_P !W_PK0HH S_[9L_\ IO\ ^ [_ .%']LV?_3?_ ,!W_P *
MT** ,_\ MFS_ .F__@._^%']LV?_ $W_ / =_P#"M"B@#/\ [9L_^F__ (#O
M_A1_;-G_ --__ =_\*T** ,_^V;/_IO_ . [_P"%']LV?_3?_P !W_PK0HH
MS9=:LEB8LTR@#DF!P!^E._MFS_Z;_P#@._\ A5Z2-)HVCD4,C#!![TZ@#/\
M[9L_^F__ (#O_A1_;-G_ --__ =_\*T** ,_^V;/_IO_ . [_P"%']LV?_3?
M_P !W_PK0HH S_[9L_\ IO\ ^ [_ .%']LV?_3?_ ,!W_P *T** ,_\ MFS_
M .F__@._^%']LV?_ $W_ / =_P#"M"B@#/\ [9L_^F__ (#O_A1_;-G_ --_
M_ =_\*T** ,_^V;/_IO_ . [_P"%']LV?_3?_P !W_PK0HH S_[9L_\ IO\
M^ [_ .%']LV?_3?_ ,!W_P *T** ,_\ MFS_ .F__@._^%']LV?_ $W_ / =
M_P#"M"B@#-_MJR\W;NFW;<X\A\X_*G?VS9_]-_\ P'?_  J]Y:>;YNT>9MV[
MN^/2G4 9_P#;-G_TW_\  =_\*/[9L_\ IO\ ^ [_ .%:%% &?_;-G_TW_P#
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M_P#A1_;-G_TW_P# =_\ "M"B@#/_ +9L_P#IO_X#O_A1_;-G_P!-_P#P'?\
MPK0HH S_ .V;/_IO_P" [_X4?VS9_P#3?_P'?_"M"B@#/_MFS_Z;_P#@._\
MA2'6;+<N6E'H#"XS]..:T::T:.R,R@E#E3Z'I0!1_MFS_P"F_P#X#O\ X4?V
MS9_]-_\ P'?_  K0HH S_P"V;/\ Z;_^ [_X4?VS9_\ 3?\ \!W_ ,*T** ,
M_P#MFS_Z;_\ @._^%']LV?\ TW_\!W_PK0HH S_[9L_^F_\ X#O_ (4?VS9_
M]-__  '?_"M"B@#/_MFS_P"F_P#X#O\ X4?VS9_]-_\ P'?_  K0HH S_P"V
M;/\ Z;_^ [_X5"]Y%>ZC9"!93L=F8M$R@#:1U(K6HH *9+*L,32-G"C)Q3Z:
MZ*ZE6&5/44 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP,6''KDGFE=7'RNQQ-I'>^%] CM[C5K306N[RXN4M5A^U21(S96*-1P0,Y.
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M)./4FI[#PK9VFH1ZA<75[J-Y""(9;V;?Y(/78  H)]<9]Z=T39F5\19/)M-
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M 7K7;:=#-+XUMHI)C<-I&DK!<3_WYI2I_/;'N_X$*;M82;N==11169H%%%%
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M=%_Z",'YT?6:/\Z^]!["K_*_N9HP016T$<$$210QJ%2.-0JJ!T  Z"I*RO\
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M4^BBR"[&>3%_SS3_ +Y%'DQ?\\T_[Y%/HHL@NQGDQ?\ /-/^^11Y,7_/-/\
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MG_?(I]%%D%V,\F+_ )YI_P!\BCR8O^>:?]\BGT46078SR8O^>:?]\BCR8O\
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MBJO]HV7_ #]1?]]4?VC9?\_47_?5 %JBJO\ :-E_S]1?]]4?VC9?\_47_?5
M%JBJO]HV7_/U%_WU1_:-E_S]1?\ ?5 %JBJO]HV7_/U%_P!]4?VC9?\ /U%_
MWU0!G>+(-7N_#=W9Z)Y8OKE?)621]HB5N&;Z@9Q[U=T;2;;0M&M-+M%Q!;1"
M-?4XZD^Y.2?K4G]HV7_/U%_WU1_:-E_S]1?]]4[Z6%;6Y:HJK_:-E_S]1?\
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M[Q+XJUO8RV]Q=QVL!88W"!=K,/8L3^5=C112;N-*R"BBBD,*S]=TJ/7=!O\
M2I7*)=P-%O SMR.#^!YK0HH \YM?#OBC5IO#^G:Y:V5OI^ARI,;F&X\QKQXU
MQ'A<#:.YS717-WXF;PY.W]AVTNHO*\2VR7@5?*.0'WD=<8X_E72453E<E1L<
M5X)M_$>A>"?[-O-$B6[L(MMLBWBD7)R3R0/D[#G-4_!]KXKTB?7WO/#T$8OK
MB;4(MM^K?O&"A8N!TX^]^E>@T4<VX<NVNQYIX9L?%]MXEDU77/#D-S>W3B-[
M[^T4Q:P9^Y''@X ZGG)K:\:!K+6O"^N;6,%E?-#.5&=B3)LW'V#;?SKL:.M'
M-K<.6RL<#J.D^+[GQ)!JD6EZ QL_.CMR]S(-R.1RXV=<*._<UN^*?#\OBCP=
M<:5(\=O=RQHRLN2B2J0P]]N1CZ5T-%','*M3@K;2?%&M^(],U77;"SLUT:*7
MR(8KGS/M,[KMW$X^5>.G6B]TOQ.=5TGQ9;Z;9OJ\5J]I>Z<;G:K(6RI23!&0
M>>:[VBCF#D. L- \5Z3I=[J=H]@=;O\ 4/MEU:.28FBQ@0J_8@?Q8ZUGK8:C
MX>L?$_B>]TRUTL7-D((-+LG\P&3E59MH +$L!P.E>GT=:.87(C(\+:;)H_A3
M2M.F_P!;;6L<<G^\%&?US6O114LM*P4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
L0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>img254193463_13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_13.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %N \$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_=_UU-J*-(8DB081%"J/0"GT45[B5M#R=PHHHH **** "BBB@ HHHH ****
M"BBB@ K&U_04UN&(B4PW$))C<?R/Y5LUBZUIVJ7,\5SIM^89(ACRF^ZWO_\
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MDVG&3Z?JOYFL:U94DM+MM)?/^KFM*G[1O6UDV=)17&7D^JWGB^XTZUU%[>,
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M18[61L[9%RR?0X/]*ZL52;K1J.'/%)JVF_?7[CGP]1*G*"ERMM:Z[=M"EX=
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MLNNNQTNG$G3+0MU\E,_]\BK-(BA$5%&%48 I:]V*M%(\B3NVPHHHJA!1110
M4444 %%%% !1110 4444 49-4CBD9#:WK%3C*VS$'Z'%,_MB/_GTO_\ P%?_
M  K1HK)QJ?S?A_P33FAV_$SO[8C_ .?2_P#_  %?_"C^V(_^?2__ / 5_P#"
MM&BCEJ?S?A_P0YH=OQ,[^V(_^?2__P# 5_\ "D.K0D@FROB1R";1^/TK2HHY
M:G\WX?\ !#FAV_$SO[8C_P"?2_\ _ 5_\*/[8C_Y]+__ ,!7_P *T:*.6I_-
M^'_!#FAV_$SO[8C_ .?2_P#_  %?_"C^V(_^?2__ / 5_P#"M&BCEJ?S?A_P
M0YH=OQ,[^V(_^?2__P# 5_\ "C^V(_\ GTO_ /P%?_"M&BCEJ?S?A_P0YH=O
MQ,[^V(_^?2__ / 5_P#"C^V(_P#GTO\ _P !7_PK1HHY:G\WX?\ !#FAV_$S
MO[8C_P"?2_\ _ 5_\*/[8C_Y]+__ ,!7_P *T:*.6I_-^'_!#FAV_$SO[8C_
M .?2_P#_  %?_"C^V(_^?2__ / 5_P#"M&BCEJ?S?A_P0YH=OQ,[^V(_^?2_
M_P# 5_\ "C^V(_\ GTO_ /P%?_"M&BCEJ?S?A_P0YH=OQ,[^V(_^?2__ / 5
M_P#"C^V(_P#GTO\ _P !7_PK1HHY:G\WX?\ !#FAV_$SO[8C_P"?2_\ _ 5_
M\*/[8C_Y]+__ ,!7_P *T:*.6I_-^'_!#FAV_$SO[8C_ .?2_P#_  %?_"C^
MV(_^?2__ / 5_P#"M&BCEJ?S?A_P0YH=OQ,[^V(_^?2__P# 5_\ "C^V(_\
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M_;$?_/I?_P#@*_\ A6C11RU/YOP_X(<T.WXF=_;$?_/I?_\ @*_^%']L1_\
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MZ7__ ("O_A1_;$?_ #Z7_P#X"O\ X5HT4<M3^;\/^"'-#M^)G?VQ'_SZ7_\
MX"O_ (4AU6$L&-E?$CH?LC\?I6E11RU/YOP_X(<T.WXF=_;$?_/I?_\ @*_^
M%']L1_\ /I?_ /@*_P#A6C11RU/YOP_X(<T.WXF=_;$?_/I?_P#@*_\ A1_;
M$?\ SZ7_ /X"O_A6C11RU/YOP_X(<T.WXF=_;$?_ #Z7_P#X"O\ X4?VQ'_S
MZ7__ ("O_A6C11RU/YOP_P""'-#M^)G?VQ'_ ,^E_P#^ K_X4?VQ'_SZ7_\
MX"O_ (5HT4<M3^;\/^"'-#M^)G?VQ'_SZ7__ ("O_A1_:\?_ #Z7_P#X"O\
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M(Z'[(_'Z5I44<M3^;\/^"'-#M^)G?VQ'_P ^E_\ ^ K_ .%']L1_\^E__P"
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MS1Y*[HV##(.",CT/%2T %%1?:8!="U,T?V@IY@BW#<5SC=CKC/&:EH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HH!!&0<BD) ZGK0 M%%% !1110 44R
M26.&-I)76-%Y+,< ?C3E974,K!E89!!R"* %HHHH **9+-'!$TLTB1QKU9V
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M I!)!!R!Z>M=113YF')'L<K9> M,L];L=:>ZO[K4[3?_ *3<S[VE#+MPW&,
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M/:NOHHH;N-*P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4569;S>=DD 7/ *'/\Z3;??\ /6W_ ._9_P : +5%5=M]
M_P ];?\ []G_ !HVWW_/6W_[]G_&@"U157;??\];?_OV?\:-M]_SUM_^_9_Q
MH M455VWW_/6W_[]G_&C;??\];?_ +]G_&@"U157;??\];?_ +]G_&C;??\
M/6W_ ._9_P : +5%5=M]_P ];?\ []G_ !HVWW_/6W_[]G_&@"U157;??\];
M?_OV?\:-M]_SUM_^_9_QH M455VWW_/6W_[]G_&C;??\];?_ +]G_&@"U157
M;??\];?_ +]G_&C;??\ /6W_ ._9_P : +5%5=M]_P ];?\ []G_ !HVWW_/
M6W_[]G_&@"U157;??\];?_OV?\:-M]_SUM_^_9_QH M455VWW_/6W_[]G_&C
M;??\];?_ +]G_&@"U157;??\];?_ +]G_&C;??\ /6W_ ._9_P : +5%5=M]
M_P ];?\ []G_ !HVWW_/6W_[]G_&@"U157;??\];?_OV?\:-M]_SUM_^_9_Q
MH M455VWW_/6W_[]G_&C;??\];?_ +]G_&@"U157;??\];?_ +]G_&C;??\
M/6W_ ._9_P : +5%5=M__P ];?\ []G_ !HVWW_/6W_[]G_&@"U157;??\];
M?_OV?\:-M]_SUM_^_9_QH M455VWW_/6W_[]G_&C;??\];?_ +]G_&@"U157
M;??\];?_ +]G_&C;??\ /6W_ ._9_P : +5%5=M]_P ];?\ []G_ !HVWW_/
M6W_[]G_&@"U157;??\];?_OV?\:-M]_SUM_^_9_QH M455VWW_/6W_[]G_&C
M;??\];?_ +]G_&@"U157;??\];?_ +]G_&C;??\ /6W_ ._9_P : +5%5=M]
M_P ];?\ []G_ !HVWW_/6W_[]G_&@"U157;??\];?_OV?\:-M]_SUM_^_9_Q
MH M455VWW_/6W_[]G_&C;??\];?_ +]G_&@"U157;??\];?_ +]G_&C;??\
M/6W_ ._9_P : +5%5=M]_P ];?\ []G_ !HVWW_/6W_[]G_&@"U157;??\];
M?_OV?\:-M]_SUM_^_9_QH M455VWW_/6W_[]G_&C;??\];?_ +]G_&@"U157
M;??\];?_ +]G_&C;??\ /6W_ ._9_P : +5%5=M]_P ];?\ []G_ !HVWW_/
M6W_[]G_&@"U157;??\];?_OV?\:-M]_SUM_^_9_QH M455VWW_/6W_[]G_&C
M;??\];?_ +]G_&@"U157;??\];?_ +]G_&C;??\ /6W_ ._9_P : +5%5=M]
M_P ];?\ []G_ !HVWW_/6W_[]G_&@"U157;??\];?_OV?\:-M]_SUM_^_9_Q
MH M455VWW_/6W_[]G_&C;??\];?_ +]G_&@"U157;??\];?_ +]G_&C;??\
M/6W_ ._9_P : +5%5=M]_P ];?\ []G_ !HVWW_/6W_[]G_&@"U157;??\];
M?_OV?\:-M]_SUM_^_9_QH M455VWW_/6W_[]G_&C;??\];?_ +]G_&@"U157
M;??\];?_ +]G_&C;??\ /6W_ ._9_P : +5%5=M]_P ];?\ []G_ !HVWW_/
M6W_[]G_&@"U157;??\];?_OV?\:-M]_SUM_^_9_QH M455VWW_/6W_[]G_&C
M;??\];?_ +]G_&@"U157;??\];?_ +]G_&C;??\ /6W_ ._9_P : +5%5=M]
M_P ];?\ []G_ !HVWW_/6W_[]G_&@"U157;??\];?_OV?\:-M]_SUM_^_9_Q
MH M455VWW_/6W_[]G_&C;??\];?_ +]G_&@"U157;??\];?_ +]G_&C;??\
M/6W_ ._9_P : +5%5=M]_P ];?\ []G_ !HVWW_/6W_[]G_&@"U157;??\];
M?_OV?\:-M]_SUM_^_9_QH M455VWW_/6W_[]G_&C;??\];?_ +]G_&@"U157
M;??\];?_ +]G_&C;??\ /6W_ ._9_P : +5%5=M]_P ];?\ []G_ !HVWW_/
M6W_[]G_&@"U157;??\];?_OV?\:-M]_SUM_^_9_QH M455VWW_/6W_[]G_&E
M5;W<-TD&W/.$.<?G0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#"C_ &5!P!5QC?<B4K:(]>HHHJ"PHHHH **** "BBB@ HHHH **** "BBB@
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M5\DL(7[T,:YW2$]A_P#7]*N*3T(DY+4]&HHHJ"PHHHH **** "BBB@ HHHH
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MM?\ 'EWI'_"06^E:0NGM'Y\6GR/)]I>+&0=X^4,1R!BCE8<Z/0**X'7/B/\
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MWCD5Z]-:6US"(9[>*6(8^21 R\>QIRV\"",)#&OE#$>% V?3THYU83@VS@O
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M'38G6WM N$61N/,S[+QC'O6[2;TL4D[ML****DH**** "BBB@ HHHH ****
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>img254193463_14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_14.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &Y \@# 2(  A$! Q$!_\0
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MD*FHH A\]O\ GC)^0H\YO^>,GY"IJ* (?/.<>3)^0H\]O^>,GY"I#]]?QIU
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MU $/GM_SQD_(4Z&99X]Z@@9(Y]14E5+#_CW?_KHW\Z +=%%% !1110 4444
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M!+^NIVQW.]NY952+$THRW.'/I4=O++]J@'G2D&1007/K3KS[L7^__0U';_\
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MY&+2/^OQ/ZU[<?\ 6&O(S&4E-6?0N)16]NV!)NI>I[BM+1YYYKJ5)9Y'4("
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MI;FX2"5EGD! )'->5> ?^1SC_P"O.;^:5ZC/_P >TW^Z?Y5X^+E)8E)/L-_
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MC_Z_(OZUY!WKF.\]9\#ZGJ%_X3AGO+Z>>;S95,CD9(#D#MZ5M7=W<J\86YE
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MO*;SB?G!0_=QTQ74U,MQQV04444BAO\ RT_"N ^+O_(N:?\ ]A!/_0'KO_\
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MTH <.@KQ#XE?\CY-_P!>D7]:]O'05XA\2O\ D?)O^O2+^M &!I'_ ",6D?\
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MWG_'NO\ OK_.O(_YCUZK]":W\&7H5NU=+I/_ ""[?_=_J:YKM72Z3_R"[?\
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M*\G"?[_\W^3,\5_ ?R_,KR?<-=FGW%^E<9)]PUV:?<7Z5[^(V1R8+>7R//\
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M *\YOYI7J,__ ![3?[I_E7EO@$C_ (3./G_ESF_FE>HSD?9IN?X3_*O&Q?\
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MOA?_ )%+1_\ KU2K-S_Q]G_<'\ZK>&"/^$2T?G_EU2K%R1]K//\  *\K+/\
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MKZ+KYUU[_D:=;_["$W_H5<1ZYI^ ?^1SC_Z\YOYI7J4__'M-_NG^5>7> ?\
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M1Y-/_>/FS?HHHKG/4.>;JW^\?YUHZ7]V;_>'\JSFZM_O'^=:.E_=F_WA_*O
MP7\>/S_(TEL:%%%%>^9GS)'T;_KHW_H1KT[X=?\ (I'_ *^YO_0S7F,?1O\
MKHW_ *$:].^'7_(I'_K[F_\ 0S7!F/\ "7J5'<Z"Z_X^A_N#^9JSH_\ R%%_
MZYM_2JUU_P ?0_W!_,U9T?\ Y"B_]<V_I7I8/_=(^AY<_P#>?F=)7SGK7_(R
M:Q_U^R_SKZ,KYSUK_D9-8_Z_9?YU!Z1V7PS_ .0;JW_7TO\ Z#777IQ+%GT-
M<C\,_P#D&ZM_U]+_ .@UZ#9PQ37>)8U<!3@,,UY$*BIX_F??]!5J;J4W%&=I
MY!U.WY_B/\JZJH4M+>-PZ01*PZ$( :FKVZDU-W1C0I.G%IGSIKO_ "-&M_\
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M@BN#$_P9>AZ"W/5;S_CW_P"!C^=57^XWT-6KS_CW_P"!C^=57^XWT-5D_P#
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M(F]7SKKW_(TZW_V$)O\ T*OHJOG77O\ D:=;_P"PA-_Z%7$>N:G@'_D<X_\
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MZ'ZG^5<U\./^15E_Z_9OYBNEO?O0_4_RKR<-_OZ]7^I&)_@OY?F5I/\ 5O\
M[IKL(/\ CWC_ -P?RKCY/]6_^Z:["#_CWC_W!_*O?Q&R.+!?%(XGXL_\B='_
M -?D7]:\@[U[MXV\.W/B;0!86D\4,RSI*&E!*_+GCCZUP'_"J/$'_00TW\G_
M ,*YCT#8^'G_ ")D/_7>;_T8:WKW_6Q?0_TJEX9T6?P_H2:;<RQRS1RR,SQ@
M[?F8GC/UJ[>_ZV+Z'^E>1@VGCDUW?Y,SQ7\%_+\RO)]PUV:?<7Z5QDGW#79I
M]Q?I7T&(V1R8+>7R//\ XN_\BY8?]?T?\C7DLG^JD_W3_*O6OB[_ ,BY8?\
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M,=S0?_7S?[_]!6EH7_'Y-_US'\ZS'SY\W3[_ /05I:%N^V38 _U8_G7LT_\
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M '5>K/,Q7\?[CKZ\$\<?\CYK'^_'_P"BUKWG+^B_G7@OCC/_  GFL=/OQ_\
MHM:9Z1:^'G_(VS?]>+?^AK7I%[]R+_?_ *5YO\/,_P#"6S?]>+?^AK7H]YG9
M%_O_ -*\W_F81^7Y$8C^#(KMT_$?SKLQTKBVSCIW'\Z[$%\=%_.O;Q'0X\%]
MKY?J>+?$W_D>F_Z\T_F:S?!G_([:=_N3?^@BM'XFY_X3EN!_QYQ_S-9O@S/_
M  FVG=/N3?\ H(K@Q/\ !EZ'H+<]6O/^/?\ X&/YU5?[C?0U:NPQM\!23O'
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M7O\ D:=;_P"PA-_Z%7T1N;^X?SKYVUXG_A*=;X_Y?YO_ $*J+-7P#_R.<?\
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M-W2M[1M*O[;2(!)<M:2-*\\L"*KCYFSLR1V]O>FTA)MG0CH*\0^)7_(^3?\
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M9Q\_\N<W\TKU&<'[--S_  G^5>-B_P#>5\AOX&4AT%;N@?\ 'K-_UU/\A6"
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M@ V$'^'M7255L+JPO(&GTZ>WFA=SNDMV#*6[Y([U:I/<I;!1112&-_Y:?A7
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M%-?[AH 4 "EH[44 %%%% &+?_P#'W+]!4FG?\?G_   U'?\ _'W+]!4FG?\
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M?%_SU3_OH4 .W-_<_6FH6V#Y?UH\^+_GJG_?0IJ31;!^]3_OH4 5]7WMHM^
MA)-O)@#_ '37E/PR\<:9H/A'3]%OK;4%O/,*X%JQ4%FXY_&O8/.A_P">J?\
M?0IN^W_O1?F*I-6LR6G>Z/']'\)'Q!\1/&1N;K4[*(7(Q]FD,0E!]3WKK=9M
MO#W@OPG!I<GAZXO-&DD*S)%%YVS/)=^YY[UVHEA!)$D>3_M"@S0D8,D9'^\*
M;E<2@D>3?#VTMU\>WESX6M[^#PT;3$JW 98VGR,; WH,UZWN;^Y^M1QRPJI
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M^RWY4ZB@!N__ &6_*C?_ ++?E3J* &[^/NM^5-1OD'RMT]*DIJ?<7Z4 &_\
MV6_*C?\ [+?E3J* &[_]EORHW_[+?E3J* (W;Y#\K=/2E#\#Y6_*E?[A^E*.
M@H 3?_LM^5&__9;\J=10 W?_ ++?E1O_ -EORIU% $;M\A^5ORIV_P#V6_*B
M3[AIU #=_P#LM^5&_G[K?E3J* /!H/ \WB>Z\<R1-=V]_'?9M?G9(Y>"2K+T
M8'&,U>U747UGP%H$0TFZM=*M+L0:W86T)#(J^@')7/.17M0 &< #-&U>>!SU
M]ZTYS/V9XQHMBM[XMOH? 7VG3M'N-/:.YN7A81"?HI4-@D@9J'7?"7B;P]H.
M@Z;'J5E-;QZI"8_*LF#"4DGS'.3NYZU[6550H4 #=VIQ /4 TN=W#V:L>/>)
M(;1/'\C^/(+B[TM;)%L98H7,/F8_><+D@D],UT?PI2^@\/WB2PW,6F?;'_LR
M.X7$BV_;(/.,YZUWS*K## $>]+0Y75AJ%G<J:?\ ZJ7_ *ZO_.BBP_U4O_75
M_P"=%066Z*** "BBB@ HHHH **** &M&CXW*#]12>3%_SS3\J?10 SR8O^>:
M?E4']GV_VW[5L_>>7Y>.V,YZ5:HH 9Y,7_/-/RI/)B_YYI^5244 ,\F+_GFG
MY4>3%_SS3\J?10!5DT^WDNX;DI\\(8*!T^;KD=ZF\F+_ )YI^5244 ,\F+_G
MFGY4>3%_SS3\J?10 SR8O^>:?E4$^GV]Q) [I@P/YBXXYP1SZ]35JB@!GDQ?
M\\T_*D\F+_GFGY5)10 SR8O^>:?E2>3%_P \T_*I** *MUI]O=QJDB8"NKC;
MQR#D5/Y,7_/-/RI]% $?DQ?\\T_*E\F+_GFGY4^B@!GDQ?\ /-/RJ&ZL+>[M
M9+>1 $D&"5X/YU9HH C$$0 'EKQ[4>3%_P \T_*I** &>3%_SS3\J3R8O^>:
M?E4E% %6[L+>\M9+>1,)(,$KP?SJ;R(O^>:_E4E% $?D1?\ /-/RI?)B_P">
M:?E3Z* &>3%_SS3\J9+:0S0R1-& KJ5.!@X(Q4U% $$-I!!!'$L8*HH49&3@
M4_R8O^>:?E4E% #/)B_YYI^5'DQ?\\T_*GT4 1^1$1_JU_*HK6PM[.V2"-,H
MN<;N3R<]?QJS10 SR8O^>:?E2>1%_P \T_*I** &>3%_SS3\J/)B_P">:?E3
MZ* *MMI]O:HZQID/(TAW<\L<G\*G\F+_ )YI^5/HH 9Y,7_/-/RI5147"J /
M04Z@]* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I" 00>AI:* (/L<
M'_//]:/L<'_//]34]% $'V.#_GG^M0KID0O7GW,4:,((L_*""3GZG/Z5=HH
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M% $'V.#_ )Y_J:/L<'_//]:GHH IW.FQ3VTD2%HF=<"1#RON*>EC J*I7<0
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MW_*JE(S!$9F.%4$DGL!0!<WCW_*C>/?\JQ3KFE#2XM3-_ +&9E6.XW?(Q)P
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M,\Z(SQ.@MXOWL*!LEAG[S# _6J>G#4H]$O(+9+OS;^]*174Z[9"C#YI6 Z8
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MYENF^U*RYMFLPIP![],8YSFGVS0:T;J]FM+^TEAA5+2&.$HT2*V5P>A<GMT
M-5RHCF9UT-_:7#0K#<)(9H_-C"G[R?WOI5BN0\/V>J:1J26TD:/'(JB0L"7"
M[<@ANF%/RX[G)KKZ35BD[DD/WQ]:*(?OCZT4ADLWW!]?Z56J>X)"#",_/11[
M55W/_P ^\W_?(_QH R_%-K+?>$]6M8 3+):N% [G&:Y"30K_ %O5&US2T%O,
MNG6DFFW,G">:N=R,.N,'!KT/<_\ S[S?]\C_ !H!8# MY0/0*/\ &J4K$N-V
M><CPWK>AR:HVFVLES=7FFI"UR"/GN'DS(QR<X4'/T IMWX1UK2(I[:R5;^WO
M-)>PD$"!-C(O[MCD\Y)(S7I&Y_\ GWF_[Y'^-&Y_^?>;_OD?XT^=BY$<2;'4
M]<M/#NG-I5W81:=)%/<3W05>8UQM0*3G)[\<4_&I3>*K+6KO3+FRCL89OMAG
MD#P*F.#  >IQDG KL]S_ //O-_WR/\:"7(P;>4@]BH_QI<P^4P_!5O+;>#].
M292CNADV'JH8D@?D:WZ9N?\ Y]YO^^1_C1N?_GWF_P"^1_C2;NQI65A^<=**
M9N?_ )]YO^^1_C1N?_GWF_[Y'^-(8_-%,W/_ ,^\W_?(_P :-S_\^\W_ 'R/
M\: 'T4S<_P#S[S?]\C_&EW/_ ,^\W_?(_P : '9/K13=S_\ /O-_WR/\:3<_
M_/O-_P!\C_&@!]%,W/\ \^\W_?(_QI=S_P#/O-_WR/\ &@!U%,W/_P ^\W_?
M(_QHW/\ \^\W_?(_QH ?13=S_P#/O-_WR/\ &C<__/O-_P!\C_&@!U )'2F[
MG_Y]YO\ OD?XTFY_^?>;_OD?XT 29.<Y-)3=S_\ /O-_WR/\:-S_ //O-_WR
M/\: '44W<_\ S[S?]\C_ !I-S_\ /O-_WR/\: 'T9IFY_P#GWF_[Y'^-&Y_^
M?>;_ +Y'^- #Z*9N?_GWF_[Y'^-&Y_\ GWF_[Y'^- #Z*;N?_GWF_P"^1_C2
M;G_Y]YO^^1_C0 _K13=S_P#/O-_WR/\ &C<__/O-_P!\C_&@!U%,W/\ \^\W
M_?(_QHW/_P ^\W_?(_QH ?1D^M,W/_S[S?\ ?(_QHW/_ ,^\W_?(_P : 'T4
MS<__ #[S?]\C_&C<_P#S[S?]\C_&@!]%,W/_ ,^\W_?(_P :-S_\^\W_ 'R/
M\: 'T4S<_P#S[S?]\C_&C<__ #[S?]\C_&@!]%,W/_S[S?\ ?(_QHW/_ ,^\
MW_?(_P : 'T=*9N?_GWF_P"^1_C1N?\ Y]YO^^1_C0 _)HS3-S_\^\W_ 'R/
M\:-S_P#/O-_WR/\ &@!]30?>_/\ I5;<_P#S[S?]\C_&IK=F+X,4B\'E@,4
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M'&1D \9J]#*L\*2IG8ZAERI!P?8\BD.X^BBJU_J%MIEJ;F[D*1@A>%+%B>
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MBB@ HHHH **** "BBB@ HHHH **** "H+V:2WL9YH8FFE2-F2-1RY X%3T4
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M:_XT?:IO^?.7\U_QJU10!5^U3?\ /G+^:_XT?:IO^?.7\U_QJU10!5^U3?\
M/G+^:_XT?:IO^?.7\U_QJU10!5^U3?\ /G+^:_XT?:IO^?.7\U_QJU10!5^U
M3?\ /G+^:_XT?:IO^?.7\U_QJU10!5^U3?\ /G+^:_XT?:IO^?.7\U_QJU10
M!5^U3?\ /G+^:_XT?:IO^?.7\U_QJU10!5^U3?\ /G+^:_XT?:IO^?.7\U_Q
MJU10!5^U3?\ /G+^:_XT?:IO^?.7\U_QJU10!5^U3?\ /G+^:_XT?:IO^?.7
M\U_QJU10!5^U3?\ /G+^:_XT?:IO^?.7\U_QJU10!5^U3?\ /G+^:_XT?:IO
M^?.7\U_QJU10!5^U3?\ /G+^:_XT?:IO^?.7\U_QJU10!5^U3?\ /G+^:_XT
M?:IO^?.7\U_QJU10!5^U3?\ /G+^:_XT?:IO^?.7\U_QJU10!5^U3?\ /G+^
M:_XT?:IO^?.7\U_QJU10!5^U3?\ /G+^:_XT?:IO^?.7\U_QJU10!5^U3?\
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M$<D>O44AE&/Q79/8R7CVM_#"I41^;;,IF+?=$8ZL32+XNTQHX6Q<AGD,<B&
M[H"" ?,'\(R0,^]<[#X?OXF%U8:7)9VMK-#-'ITESO\ ,=<[BI)(7@X'KBK#
M^&[G53/=75C]GN+VZ#C$O-O$ !SC@L<9QV//:KLB+R.OM;Z&],WD%F6)S&SX
M^4L.N#WQTJS6!X9M-3L8I+>\?,* !%* ;&YR%QU7&.3WS6_4LI;!2,RHI9B%
M51DDG  I:P=5T/4+ZVN8H=58)/*K&.:,% @.2@QS@\9]J$#%7Q;IDNFP7ULM
MS<QSNZ1)! S.^PD,0OH,=:D@\3Z9<7,,44DA2:/S%G\L^7]TMM+= VT$X]*P
MH+#6['0I;.[L5O4GGN-PLY/)DC5G)4K['],BHI_"=W/962^1&M[!:#S)-_RR
M2 85,=#QU;N..]59$WD=K:74=[:1W,0<1R#<N]=I([''OUJ:L[1%ODT_;?2-
M(X<['=0KE.VX#@'K6C4,M!1152^M)KM8A#>RVI1PS&, [QZ'/:@"M'KD,VK/
MI\5K>N8VV/.L!\E6QDC?TS4<WB;38I[Z!6EFFLBBRQPQEB6;HJ_WF]A6-<Z-
M=R^(VGTRPDTV<RNTU]YV])E*D#]WG!).#T&,57L_#&I6CWL5XL%Y:FU146(&
M-Y)0Q.[=G(.>2?>KLB+LZJSUFSOWA2W9W:6'SL;"-B]!N]">>/8U?KD=#T35
M-%U&.))<VIP95VC:1MY^;KD-P!_=KKJEKL4F^H4444AA1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 445FW<MY::-<S22IYZ!F5D7@#MP: -*BL/^TKNWOUCDS)#("(MZ
MA"Q+* 3QP.3VJ7^UIS<,%MMRI"[,BMEBRL!@<<T :]%9[ZH%T^.[6(NK'#;<
MX0>IXS^E5H]8DC1VFC#H6?RV5NN"..GOUH V:*R9M:\@LCVQ,@R JOG<PYP#
MCTYJ1M6S;I+%!O#NRKE\ @ G/3VH TJ*R?[:.%7[,?,8C:H8D8*[NH%1W.K3
ME%>.,Q1AF5LD;LA"V,$<<B@#:HK*EUCR94B$0D+ ;2'[DJ.>,#[U3#46:./$
M \UY6B"%^ 5R3SCT'I0!?HK,M+^:[O)B%"PI"K!<\[B6SV_V:KQZM=+Y<LL2
M&/R=[JK=/FQD<<_2@#;HK/M]3^T>:P@81H&(8YYVG&.GM[U#%K+.R![<(K;,
MMYF<;QD=O;F@#6HK(.NA7"M!R9!&"'X)(R.H''O1'J\FV-1"9"0,LS@'EB!T
M'M0!KT5EKK(9"Q@(("9&[NS;?3M34UEF*EK7"%48D29(#-M'&/6@#6HK,N[^
M<1S&"-0(Y4CW,W))901C'3GK0^K^6BL\*Y\TQNH?)'S;<CCD?E0!IT5DC66\
ME9&ML%T1T ?.0QQSQ_C4D&J22S)$UHZ.0N\ D[-WX?X4 :5%8Z:G=)(P>%9-
M\SJH#@!%49)Z<T_^V&_= 6WSRA60>9QM;U..#[4 :M%9$FJRR:?<2QQB*1(U
M=?FW=3]*?+JYA5]\*[HWVNHDSQQR..>M &I160=<P_E_97\[<P$9SG &>>/Y
M9'O4<>K3++/O4OM?:J$A0,OM&3C- &W166NL%IA"+9C("0X!)QABO!QST/I3
M)-6>UFN3.F^%)2BE3R,)NQC'L: ->BLK^T[F26 1VP <MD,Q&<+GC(J,>(8B
MC.('*!=X.>J[22?P(Q]: -FBLLZPP=8_LC^8P+ <X(&.GR^]20:DT[[3#L#*
MY1M^3\IQR,<4 :%%8T5]<106<TLZR"<'<K@*!@$YR!3TUL.XC-N1(S%$&[AF
M!Y'3TYH UJ*I6M[]MBFX,#QG:P/5?<Y'^(IFGW$LD)DFD9Q*Y\G,>,*.F<#O
M[T :%%8IO[R*PGW'S+CSWC5TC.U .Y STJ5]2:&SMIVW.6A9V& NX@#VXH U
M:*RY[^=["[,2K#<1%5!SO )P0>GH:A35II+J#($4$>Y;G</XPI. ?08Z^] &
MU17/Q:I=R6[*\ACF::)D)BVD1NP&,$<D<C-6I+BY$MQ MP2T(#JP5=SY!^7G
MCC&: -:BJ:79_LR&Y8HSO&IY.T$D=N*IQ:Z) '^SD1 JK-OY!.>V/:@#8HK*
MCU"XE6YDVK&JVXEC .[&03D\?I3([VX@6T,DHF\^'>0^%VG /4#OF@#8HK)B
MUKS2B"V;S9!N1-W+ 9R>G8C'XU9@NY+VP>2$+%+RN'!.T^X(% %VBL&75;I-
M/LV4GS'5'EE\HD$%@"!@8R>?I5^_NS';EXYFC(.T*(_F=NRC- %^BL>*]NSJ
M"1R$!/-$;  ;<[,X]<Y_#%2/J<D=Q<1K$92C,?F<+@*JGCC_ &J -2BLB\O+
MDW6RU=LF 21QA 0S$]SV%..L2?:?L\=LLDA8!<2X4CGG./;WH U:*RAJ-Q_8
MLMVR(LBLP&#D<,1FM"%'0'?.TN?4 8_(4 2T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2"-6!SD* ?\ /-3T4 1I!$BLJ1JJN26 '!)HBMX8,^3$B9Z[1C-244 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>img254193463_15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_15.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &I >@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ&,*.B_A5VNVA"44^;=MO\3EK24FK=$D%%%%;F04444 %%%% !1110 4444
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M  _S#V:_F7X_Y&E16;Y>L_\ /S9?]^6_^*H\O6?^?FR_[\M_\51[5_RO\/\
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M\V7_ 'Y;_P"*H\O6?^?FR_[\M_\ %4>U?\K_  _S#V:_F7X_Y&E16;Y>L_\
M/S9?]^6_^*H\O6?^?FR_[\M_\51[5_RO\/\ ,/9K^9?C_D:5%9OEZS_S\V7_
M 'Y;_P"*H\O6?^?FR_[\M_\ %4>U?\K_  _S#V:_F7X_Y&E16;Y>L_\ /S9?
M]^6_^*H\O6?^?FR_[\M_\51[5_RO\/\ ,/9K^9?C_D:5%9OEZS_S\V7_ 'Y;
M_P"*H\O6?^?FR_[\M_\ %4>U?\K_  _S#V:_F7X_Y&E16;Y>L_\ /S9?]^6_
M^*H\O6?^?FR_[\M_\51[5_RO\/\ ,/9K^9?C_D:5%9OEZS_S\V7_ 'Y;_P"*
MH\O6?^?FR_[\M_\ %4>U?\K_  _S#V:_F7X_Y&E16;Y>L_\ /S9?]^6_^*H\
MO6?^?FR_[\M_\51[5_RO\/\ ,/9K^9?C_D:5%9OEZS_S\V7_ 'Y;_P"*H\O6
M?^?FR_[\M_\ %4>U?\K_  _S#V:_F7X_Y&E16;Y>L_\ /S9?]^6_^*H\O6?^
M?FR_[\M_\51[5_RO\/\ ,/9K^9?C_D:5%9OEZS_S\V7_ 'Y;_P"*H\O6?^?F
MR_[\M_\ %4>U?\K_  _S#V:_F7X_Y&E16;Y>L_\ /S9?]^6_^*H\O6?^?FR_
M[\M_\51[5_RO\/\ ,/9K^9?C_D:5%9OEZS_S\V7_ 'Y;_P"*H\O6?^?FR_[\
MM_\ %4>U?\K_  _S#V:_F7X_Y&E16;Y>L_\ /S9?]^6_^*H\O6?^?FR_[\M_
M\51[5_RO\/\ ,/9K^9?C_D:5%9OEZS_S\V7_ 'Y;_P"*H\O6?^?FR_[\M_\
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M2K*2\4Y$[VZEP?\ >QFM"J<KB4+!1114%A1110 4444 %%%% !1110 4444
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M]9T"+4O#5QHEI*-.@F01$V\8&U"1N4#H,C(_&M.VMXK2UAMH$"0PH(XT'15
MP!^5)NX1C9DM%%%26%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 5C<S D"SE(]=R_XTGVF?_GRE_[Z7_&K5% %7[3/_P ^4O\
MWTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %
M7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GR
ME_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\
MWTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %
M7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GR
ME_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\
MWTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %
M7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GR
ME_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\
MWTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %
M7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GR
ME_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\
MWTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %
M7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GR
ME_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\
MWTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %
M7[3/_P ^4O\ WTO^-'VF?_GRE_[Z7_&K5% %7[3/_P ^4O\ WTO^-'VF?_GR
ME_[Z7_&K5% %9;B9F -I(H)Y)9>/UHJS10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 8GB?Q/9^%]/2XN$EGGGD$-M;
M0C,D\AZ*H_K6$OB3QO %NKSP6AM"1NBMKY7N$'KMP Q]@:K^+62'XH^"Y[S
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ML#M/TKIJ*.9BY4<E/H,OACP5J%IX<@FN]2N Q\V60&269\*978XSC.?H*W-
MTF/0?#]AI41W+:PK'N_O$#D_B<G\:T:*&[C22"BBBD,**** "BBB@ HHR*,C
MUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(
M]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]:
M"BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C
M(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HH
MR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6
M@ HHR/6C(]: "BC-% %8Z?:,23 A)I/[.L_^?=/RJU10!5_LZS_Y]T_*C^SK
M/_GW3\JM44 5?[.L_P#GW3\J/[.L_P#GW3\JM44 5?[.L_\ GW3\J/[.L_\
MGW3\JM44 5?[.L_^?=/RH_LZS_Y]T_*K5% %7^SK/_GW3\J/[.L_^?=/RJU1
M0!5_LZS_ .?=/RH_LZS_ .?=/RJU10!5_LZS_P"?=/RH_LZS_P"?=/RJU10!
M5_LZS_Y]T_*C^SK/_GW3\JM44 5?[.L_^?=/RH_LZS_Y]T_*K5% %7^SK/\
MY]T_*C^SK/\ Y]T_*K5% %7^SK/_ )]T_*C^SK/_ )]T_*K5% %7^SK/_GW3
M\J/[.L_^?=/RJU10!5_LZS_Y]T_*C^SK/_GW3\JM44 5?[.L_P#GW3\J/[.L
M_P#GW3\JM44 5?[.L_\ GW3\J/[.L_\ GW3\JM44 5?[.L_^?=/RH_LZS_Y]
MT_*K5% %7^SK/_GW3\J/[.L_^?=/RJU10!5_LZS_ .?=/RH_LZS_ .?=/RJU
M10!5_LZS_P"?=/RH_LZS_P"?=/RJU10!5_LZS_Y]T_*C^SK/_GW3\JM44 5?
M[.L_^?=/RH_LZS_Y]T_*K5% %7^SK/\ Y]T_*C^SK/\ Y]T_*K5% %7^SK/_
M )]T_*C^SK/_ )]T_*K5% %7^SK/_GW3\J/[.L_^?=/RJU10!5_LZS_Y]T_*
MC^SK/_GW3\JM44 5?[.L_P#GW3\J/[.L_P#GW3\JM44 5?[.L_\ GW3\J/[.
ML_\ GW3\JM44 5?[.L_^?=/RH_LZS_Y]T_*K5% %7^SK/_GW3\J/[.L_^?=/
MRJU10!76PM48,L"!@<@T58HH **** "BBB@ HHHH **@EO;6"Z@M9;F*.XGS
MY,3. TF!D[1WP*$O;62\ELTN(FN8E#20AP70'H2.HS0!/1110 45!#>VMQ<3
MV\%S%)- 0)HT<%HR>@8=J=-<P6RAIYHX@3@&1@N3^- $M% ((R.110 4444
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M   ')Y(I-2UC3-'B674]0M;-'.%:XE5 Q]LGFBPKEVBL^\US3+#2#JT]Y$+
M;?\ 2$.]/F8*#D9XR1S6@"",CD4#"BBB@ HHHH **** "BBB@ HHHH ****
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M]PI6=HC-(IZAI&+D?^/42ZCANCIJ***S- HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9NJV*2V5Y)#
M&N98MF0.6'I6E5+SY8[VY,TD0MHXP^,'*]<D_E0!F2Z1<!T5L26]M*AM4'50
M7!8G_=&0/:F31WTMQ,T5M/%O5@,.>) Z[&))QCJ>.,<5<L]:9[266\B\N1'3
M"1@DE7QL_'G!]P:LG5(A;O-Y4^(V99%"<IM&3GGTH AMX9#H[+=1S-<(Q9]I
MY9P<[E] 3T]!4.FVUW9WOELF4<9=L9 &.,-UX/&/J>]2P:U$7NA/A1$79"HX
M9%"D_C\PXI\FK1F*8Q;E,3*KLR9"L2!@@'.>: *4]E>'[7.IGWM<@;=Y(,/&
M0JY'?\>M0W-I<M:RQNEU/&UM((5 *[7)/!&?3&,GI6S'J4$BW#J',<&[>^!C
M*YR.N>U1_P!LVH0LXD0[495=<%@QPN/Q]>E %$QWJSB()/S>+(&!^41[ ,=>
MF>U1O9M+IT EM;EYXI8FGW$DL0WS%>>>_3M6@-;MVD2.*.:61@QVHF=N#@Y/
M0<U':ZSNLH9;B-_,DB\]DC3[B>IYZ?J?2@" PW/G$W$5S);>;,=B,<\XV'KG
M&-WT-1I::AL>2;SFN4%OM(<XR"-^!G'3.:OMK5L)9$5)W"%5+K'E26QM /<G
M<*<NLVIW%_,C50Y+.N "GWA]10!GW=@[WM]MMY"9I(&#J3@J&7=SG@\4Y;"X
M>]CB<7"VB3RL )"!MPI7)!SC.>*O+K%L^%19&E+!1$ "QR,YZXQ@'OVI+75/
M,T^VGEC/FSL56.,<D@GU]AS0!EO:ZB]HR1K.MQY#B=BQP[Y&W:<_7IVXI;R2
MX:XE8K*D<UPGEI*=H91&<]QCGW'-:;:W:JNX+,RB/S'(3[BY*G/T(/'M4::K
M"TEW%=JH$+.5^7(94"D_C\U &;#9R-;23VHN'988!#(S$,S*S;B>>?\  UHA
MI+;5;]S:S2+*L>S:N0V 01GH/QJU-J4-O@,DN1'YKA5_U:>I_7\C35U6W>X\
MH"3!E\H2;?EW;=P&?I0!DQ65Y']CM3%*HC"Q2R([8*%#G'.  3CUXS5S21>7
M%G-/)*/.(\F)C\RD)D;\>YR?RJW_ &I +@PE9!B7R2Y7Y=Y&0,_B*@GUA8-J
M):S%_,C0H5"G:Q(##GV- %.&WNM+^UO]D%T?+C*A <RR9;YB3[G)/Y5HZ3"T
M5JYD+M/)(9)69"N6..@/8# 'TIG]KPQ;Q*VY_,=555P<+C/4\XR/KGI3UU>V
M>0*@D92ZQB0+\NYE# 9]P10!?HK+MM:2:&%I()$DF=U2/C)"G!/7Z>]3SZI;
M6\K1RE@RR)&?E[OT/TZ\^U %VBLBYUI85GDB0RK&F0FW!)#E2<YQC(J1-6Q>
MS0S0NB+*D:L%X!900&YZY../:@#3HJHVHP+*T1W^8LJQ;=O)+#(/TQW]C52Z
MUI860")T(D'F+(N#L*L<C_OF@#6HJB^KVL8^8L/D1P,==Y(4?7BDBU:VGFCA
MCW-(^<J,97!P<\^OIF@"_15:YOH;-T$^Y$<X$A'R@]@3VJG+JDR:=J%P$3?;
M2LB#G! QU_.@#5HK/2_E:VU&3:F;9W5.N#A01G\Z@L]9>Z^R(T:QSNY2>,]4
M.PL"/8X!!]* ->BL^]U5+-)LPRETC=T!& ^T9.#_ )[TMU?R06EM,L)S+*B%
M",D!C['K0!?HJ@=6@6W,WES;$9EDPG^KVGG=_P#6I#K%J$D?YMB2>7NXPSYQ
M@<^OKB@#0HK'.L^9=QQPE!$P&2RDD-Y@0KP??K_.K"ZS:%2[^9'&%=P[K@$(
M<-B@#0HJM:7T-YO$>0R8W*<9&>1TJS0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %5KNUAO()(';:),*Y7&6'7;^(S^9JS7.7#+
M%K+R2$*@OXR6;@#]P>] &E+HUJ\PDC'DY"AEC  ;:P89X[$?J:9/HT%SYP,T
MFV1W9UX(RP /!'48X/;-37MU<)9336J)(!&2CJV[GUQCG'7KVJKI,\=NTEKY
MR21;P(I@,&5R"S ^IXSGW]J "318"T"!\JESY[[CR?EQM'L<#-33Z-#<W,D\
MCMO8!05500,@X) Y^Z.O3FLV[*QZS)(Y"H+V ECP!^Z;O6XSF96VE?L[(?WR
M2<CZ<?KF@"L^F(S7<R.#-/$T6<  9]<#G'J>:C314:!1<3-),$C57P/DV<C
MQSSGKUK,A:WCTR""*1! -0=2"=PVY<C=SR. >>M7X;G[-HD>Z25<2&-9%P=P
MW'!!;@*>Q/04 78M/2.;SC(S/Y1B/  P3GH!4)TB)8HHTGDCVP"W)&,NGIR.
MON/4UF1ZC?R6LTYF=3#$C!?+'SGS&!SQW"CI4WGO/JUKYLQ,B7<B^3M&$4(P
M4],\C!SWS0!?_LZUC4PB0H'F255R."FW 'M\HIATNSF+1M*7^:5F3</^6G6H
M;8VJ3W8OPGV@W!(\Q<EES\FWU&,=.^:H6J,MU$TL:)&;JXVRJOS,^6 5CZ$$
MGWP* -:/3XV$;1W1,D+95T5..,$$ 8.0:>FEQQVUO%'+(KV[%HY#@GG.<\8/
M4U1T.SD\BPNBD<*I:A-J=9,XY;@=,>_4U!<:I=--(EK/)A^ SQJ=A\Q5X Y'
M!/!^M &D-%MQ%+&)),2PF)CD9.6+%NG7+&F3Z-%-*F&RHNOM$F3S]W&T>QP,
MYJ&.XOEU(V[W"8C=%'F$ RKM&6P%Y).>A &*:[3P:I=RQ2, ;N!&3:"&#*H/
M;/?]* -"YT^.[=I%F=/,C\J39@ATR>.>_)Y]Z1=,@&-CM@7 G !'!"[<?3BL
M;[;="&&)+@6P*,Q94557]X02W&,8%6K!YH;J,+(QBFO+A60J,  L0<XSU'ZT
M 6DTIFN9I)IF,;7'GI&N,9"@ DXSU&?RIJ:%"@)6>3S#Y9#X7.4)()XY//.:
MISZC>Q37$8</B0?O$8%(X]^#GC*L!ZY'4TKW=_MEQ=@B.UDF5H@&#$-QDXY]
M#C&: +SZ3"&\WS65P[OO8*1\V,C!&.PJ0Z;""29'&Z=)NP^90 !T]JRKV_N<
MW4;[9%:/<BJ%94^[PZD9SR<'H:<&=+N=3*SL=10;' ;:I48(XX^OM0!=DT>%
MK3[-),Q@\PL%95XR<X!QD').#UYJ:ZTJWN[HW$A<,86AP#Q@]_J.<?6LLWEY
M-!(LP!^S/'#)NC!$DGF#YAD?W<'_ (%[4BW<^GP75SYLDRPWC^="<%MA) QQ
MGJ0?I0!HG1+<V_D^9)C[.(,Y&< YW?7-2'3$8NSRNS/+'*QX&63&/Y50U"^N
MK*SB5II#>"(R,%5=K'/(YZ^F!SWJ.6_O5:Y031[U<$/YBA-NXC:"1\KXXYST
MH U9=-AEU!;TLXD6,IA3@?[WU ) /N:J+X?M@07ED<_+NZ#=@,.<#K\QR:K'
M4IYY;=+>6=&E(C82HGR$QD@XZDYQST[4TZC?S6#7>X0J'$9C)"DE0=^TD$9W
M=,]E]Z +W]B1%3YD\KMMC520OR["2O&.>O.>M22:5'-Y EDW"%@X_=J.0<C!
M R/P[5<@?S+>-\,-R@X<8(R._O4E $3VT,DZ3/&K2(/E)YV_2JLNE12M,/-D
M6&9P\L0QACQWZC.!FK]% %#^S,&Z47$@BN69G3:.I7!P<>U*=)MOMEI=?,)K
M9-BL#]X8QAO7K5ZB@#,DT2":>26261BXD';(#C!&<9P.WI5B:Q\^UAA>=]T3
MJZR #.5Z<8Q5NB@#)FT&">(H\TI#[S(3CYBW5NF ?IVI\NBP3323.[&5L;6"
MJ,8.1GCYO3GM6G10!GG2(GFCE>5RZ!1P% .'#C@#U%(VC6[P)"[.R*LBXR.0
MYR:T:* (+6V^S(5,A<GOL5?Y 5/110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !2%58@D E3D>U+10 4444 1RP1S-&77
M)C?>O/0X(_J:DHHH **** "BBB@ HHHH **** ()K*WGD\R6(,V-I.3R/0^H
M^M3T44 %%%% !1110 4R2*.90LBA@&# 'U!R*?10 4444 %,BBC@B6*) J+T
M [4^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
>**** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>img254193463_16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_16.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (Z \\# 2(  A$! Q$!_\0
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M.1,C YWCGKWYKKK. VME;V[2O,8HU0R/]Y\#&3[GK2=NA2OU)J***D84444
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M7_09L?\ OQ-_A1_PM30O^@S8_P#?B;_"OGFBCD0?4J?=GT-_PM30O^@S8_\
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M_P#03U__ ,!(O_BJ/LW@?_H)Z_\ ^ D7_P 57-45=CMY'W9TOV;P/_T$]?\
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M?MS*,7 \\7(8S$>=\F#GCY<?>R?7FNPI;,N,FFI(\E_X43I__0=O/^_*4?\
M"B=/_P"@[>?]^4KUJBCF9M]9J]SR7_A1.G_]!V\_[\I1_P *)T__ *#MY_WY
M2O6J*.9A]9J]SR7_ (43I_\ T';S_ORE'_"B=/\ ^@[>?]^4KUJBCF8?6:O<
M\E_X43I__0=O/^_*4?\ "B=/_P"@[>?]^4KUJBCF8?6:O<^=?$GA3PIX6U<Z
M9?ZMK+SB-9,PVL97!SCDD>E9'V;P/_T$]?\ _ 2+_P"*K:^,G_(_M_UZ1?\
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MQ5>^:Y6PN#9(KW0C;R5<X!?'&3Z9KSI?!VN6L-K:7-K;ZM;022R &Y,>6EC
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MCI6]%HFM6OA46DTR:A(ML4^PNVU'8DX4R_>V@8'N![U5EW)N^QO:M_QZP_\
M7Q%_Z&*OUR-GI5]8:!H\,L[VX@F3SK8A'#DR9X;^$#/ '08%==4E!1110 44
M44 %%%% !1110!R7B'X<Z#XGU4ZEJ(NOM!C6/]U-M&!G'&/>LK_A3'A/TO\
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MG^%>HT4[LV5>HE9,\M/P.T, G^U-0X]T_P *\P<>"4D="GB$E6*GYH>QQ7U
MWW#]*^/KC_CZG_ZZO_Z$:J+N=F%G*I?F9O[O!/\ SS\0_P#?4-&[P3_SS\0_
M]]0USE%78Z^3S9T>[P3_ ,\_$/\ WU#2%O!.#^[\1?\ ?4-<[2'H:+!R>;/J
MSPA]F_X0_2?L8E%M]E3R_.QOVXXSCC-;=<_X%_Y$71/^O./^5=!6+/$G\3"B
MBB@D**** "BBB@ HHHH S]&_Y!J_]=9?_1C5H5GZ-_R#5_ZZR_\ HQJT* "B
MBB@ HHHH .E%>=:EX8\275SJUT5MYDU(@/:^<5VI'(IC&3QR@8' 'WN<UN:+
MHNJV5G,#,+2!YWE33T(D"1D#$8<_=Y!/' W<55EW%<W=6_Y ][_UP?\ D:LP
M_P"IC_W1_*N*TW1=3LO">H)(O]DRO(\S01,L\>S9C8N>@P!D]2<GO7:Q?ZE/
M]T5+&A]%%% 'E_Q7T;0+6*/Q%J=E=W<[NEKLANO* &&(/0UY9_:'@_\ Z%S4
MO_!E_P#8UZS\;?\ D2[;_K^3_P!!:O ZTCL>KA5S4[M_B=$VH^#MC9\.:ET_
MZ"?_ -C7TMHAC;0=.:%&2(VT91&;<5&T8!/>OD5_N-]#7UOX?_Y%O2_^O.+_
M - %*1EC8V2-&BBBH//"BBB@ HHHH **** "BBB@ HHHH 1_N-]*IZ1_R![/
M_KDO\JN/]QOI5/2/^0/9_P#7)?Y4 7:*** ,W7=<LO#NDRZE?LRP1D A!EB2
M<  4F@Z]8^)-)CU+3V<P.Q7#KAE(.""*XCQW(?$?C70O"<?S0K(+N\ Z;1V/
M_ 0W_?0I/!;_ /"->/\ 7/"S_);7#?:[,=L'G _X"?\ QRG;0Z/8KV=^N_R-
M[7/B+HGA_6)-+O$O&N456(BB##!&1WI-)^)?AG5[Q;1+N2WN'.%2YC*;CZ9Z
M9_&N= !_: ?(S_HG_M(5M?$W0;#4/!U]=R01K=6B>=%,% 88(R,^A':G9%>S
MIIQB[ZI:^IVU<?\ %+_DG6J_]LO_ $8M6OA]J4^K>!],NKEB\WEF-G;JVUBH
M/Y 55^*7_).M5_[9?^C%I+<SIQY:RB^C_4=\,/\ DG6D_P"[)_Z,>NNKD?AA
M_P DZTG_ '9/_1CUUU#W)K?Q)>K"J<NJZ=!$DLNH6L<;L45WF4!F'! .>2*D
MODN9;"XCLY$CN6C98G?HK$<$X]*X6#P!J.FK!#:76GW=O"TC*EY"0 9(PCG"
M\'D;O<L:$EU,FV>@LZJA=F 4#)8G@"L^_D2;^S9(W5XWN5964Y!!5N0:R'\'
MLWAY-)&M7P001P-NVLC*H&1M(Z'&#ST.*6#19-,MO#\<U[-)+:>7;E4.V)\(
MPSL]?2C0#IZ***0PHHHH *S-9\.Z1XACA35K&.[6$EHP^?E)X/0UIT4#3:=T
M<K_PK;P=_P! &V_-O\:XCXCZ3X<\&V>GS6/AC39VN961A/YF  ,\885[#7DG
MQW(&EZ+D@?Z1)U_W:I/4Z,/.4JB3;/./^$HT[_H3M#_\B_\ Q=6+'Q-ISZC:
M*/"&B*6GC 8>;E?F'(^:N1WK_>'YU9TYU_M6R^8?\?$??_;%78]1TU;_ (<^
MOZ***R/""BBB@ HHHH **** "J.L?\@UO^ND?_H:U>JCK'_(-;_KI'_Z&M %
MZBBB@ HHHH ***9+YGDOY.WS=IV;^F>V?:@"";4]/MXFEFOK:.-9#$SO*H <
M=5))Z^U2RW5O#;&YEGB2 +N,K. H'KGIBN#MO FJZ=Y)@OK*\Q<+>2I=1%5:
M?8Z.?E!SG>#SS\M;NG^&;C2]#2T@U!Y)XX&1$D'^C[SD@[,$X!/ ST JFEW)
MNS0O[F"[T^WFMIHYHFN8L/&P93\X[BM2N:DT&'2],TJ"&XN%6TEB78C[4E8N
M"S.O<DDGZFNEJ2@HHHH **** "BBB@ HHHH **** ,O6?#FC^(5A75K"*[$)
M)C#Y^4GKT/L*R?\ A6W@[_H VWYM_C75447+5225DSE?^%;>#O\ H VWYM_C
M7COB?4](T/Q/J.EV_A'1Y(;:78C2>;N(P#SAO>OHROESXA,H^(.N L/^/GU_
MV15QU9UX1N<FI-L7_A*-._Z$[0__ "+_ /%U[A\,+R*_\$P3PV%M8H9I!Y%O
MNV##=?F)/-?-.]?[P_.OHOX.D'X>VY!S^_E_]"IR6AKC(I4].YWM%%%9GF%'
M6/\ D#W?_7(U='052UC_ ) ]W_UR-71T% "T444 %%%% !2$@$ D GH/6EKF
M->T+5-3URRU"UN8(TT_:\$;@DNY;Y\D= 4&WO]XTT)NQTB2QRY\N17VG!VG.
M#2AU+E PW 9*YY%<=H7A;4M/>)O.AL&BMV@:2VP[3DON#L&7' X'4\GFKRZ!
M>-XEFO\ ?%;HULT)GA/[V1FVX<@K@,-I]1TP!S19"3?8UM&_X\#_ -=Y?_1C
M5?K,T"-HM)6-I7E99909'QN;]XW)QQFM.D4%%%%  1D8KB&^$O@]W9SI\N6)
M8_Z0_4_C7;T47*C.4?A=CQWQ[X3\)^#='M[Z'0C=-+.(BCWDB@#!.>#[5Y[_
M &WX<_Z$^+_P8RUZK\<3CPG8_P#7ZO\ Z U>#Y'J*TCJCU,,G.G>3?WLZ/\
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M%_Z *J1V8V*25C2HHHJ#SPHHHH **** "BBB@ HHHH **** $?[C?2J>D?\
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MJ- U.BHHHI#"BBB@ HHHH *KW5C:7RJMW:P7 4Y42QA\'VS5BB@#._L#1O\
MH$V'_@,G^%*-"T=6#+I5B"#D$6Z<'\JT**!\S[A1110(**** "BBB@ HHHH
M*HZQ_P @UO\ KI'_ .AK5ZJ.L?\ (-;_ *Z1_P#H:T 7J*** "BBB@ HHIDJ
MN\+K&^QRI"OC.T]CCO0!ER^*-%A@>9M0C,<=RUHQ0%B)E&2F "<@ FKHU&R.
MF_VB+J(V7E^;Y^X;-F,YSZ5RMMX ;3F@?3M9GCDB=)29XA*&D570MC(QD.>/
M85KV/A6STW3T@MW=KA(FC$TI+ ELDL4R%/))QBJ=A*Y8N[J"^TJSN[602V\T
MT$D;KT92X(-:M<P?#\&G:1H\4[_:;C3Y(HHI\%.-X'W0<=*Z>I&%%%% !111
M0 4444 %%%% !1110 4444 %49M&TNXE:6;3;.21SEG>!22?<D5>HH&FUL>&
M_$G7[KPYXN-AI=KID5M]G23:UA$YW$G/)7VKT'X8:G<:MX*@N[H0"5II%(AA
M6)<!O[JC%>7?&*WGD\>EHX)77[)%RD9(ZMZ"O1_A"CQ_#^W61'1O/EX92#][
MWJWL=M5+ZO%]=#NZ***@X2CK'_('N_\ KD:NCH*I:Q_R![O_ *Y&KHZ"@!:*
M** "BBB@ JO/?6MM<6]O/<1QS7+%849L&0@9('KP,U8KG]8\,?VOJL.H'4)H
M9+94^S*B@JC!PQ8YZYP!VX'O37F)WZ&E8:SINJ,ZV-Y%.R#+!#SC.,^XR",T
MY-5L9-2;3EN%^UA2QBY!P,9/OU'YUB:;X/%H8?M.H2RBW@:W@\@&$JK/N.6#
M9)X [#CIS6E_8<4E[=W%Q-)*)H%MT7<5,48Y(# YR3R3UX'I0["5R;1_^/ _
M]=Y?_1C5?K,T"%+?2$ACW;(Y957<Q8X$C=2>3^-:=(H**** "BBB@"GJ.E:?
MJ\"PZC9P742MN5)D# 'UYK-_X0GPO_T -._\!U_PK>HH*4I+9GG'Q"TG1?#/
MA.74M.T#2?M"RQH/-M59<$X/%>1GQC-C_D ^'O\ P7K_ (U[+\8O^2>S_P#7
MQ%_Z%7SL<X/!_*M(['I81*5.\NY]6>$+@W?@_2;@Q11&2U1MD*;47CH!V%;=
M<_X%_P"1%T3_ *\X_P"5=!6;/-G\3"BBB@D**** "BBB@ HHHH S]&_Y!J_]
M=9?_ $8U:%9^C?\ (-7_ *ZR_P#HQJT* "BBB@ HHHH S+GQ#I-H]ZD]]$CV
M*HURO),8?A,@>M6+/4[+4+(WEI.LL"E@S*#E2.H(Z@CTZUR]SX $TUS<IJ]P
MEU=.S3.R!D;,BNH"YXVE%'7IGUK7T[PQ;VCO<W,TEU?27!N7FR8U+D <(IQ@
M!0,'/2JT%J.?6+#6-$U)["?S1%&\<GR,I5MN<$$ ]"#^-:\/^IC_ -T?RKG[
MKP[:0^&+BWNBUW(IDN7F<E2\IR2QP?? 'H *Z"+F%/\ =%2QCZ*** "FR1I+
M&T<B*Z,,,K#((]"*=10!G?V!HW_0(L/_  &3_"M!$6-%1%"JHP% P /2EHH&
MVWN%%%% @HHHH **** "BBB@ HHHH **** $?[C?2J>D?\@>S_ZY+_*KC_<;
MZ53TC_D#V?\ UR7^5 %VBBB@ HHHH **** "N/\ BE_R3K5?^V7_ *,6NPKC
M_BE_R3K5?^V7_HQ::W-*/\2/JAWPP_Y)UI/^[)_Z,>NNKD?AA_R3K2?]V3_T
M8]==0]PK?Q)>K$) !). .]<X/'&DRVEO<6Z7EPL\DL:)#;DO^[Y8D=<8P1Z@
MC%;M[:K?6-Q:.\D:3QM&S1G# $8.#V-<Z/ 6E02*]A<7U@%.0MO-P,H$.-P.
M,J /P%"MU,G?H;#ZY9#3%O[=GNXG17C2V7>[AL8PO7OWZ54DU6RU*+1Y[:=2
M+F5)HT8X<J5;G:>:+GPIIDND-IUO&UDC0K 9K7"RF,8^7>0200,'UIUQIT%I
M_9 "K)+!,D2SNB[]H5N,@# ]A@4:!J;5%%%(84444 %%%% !1110 56U)VCT
MN[=&*NL+E6'4':>:LU6U)&DTN[1%+.T+A5'4G::!K<^7E\;>*MH_XJ+4NG_/
M8TO_  FWBK_H8M2_[_&D7P3XJVC_ (I[4>G_ #Q-+_PA7BG_ *%[4?\ OR:U
MT/:_=>7X!_PFWBK_ *&+4O\ O\:/^$V\5?\ 0Q:E_P!_C1_PA7BG_H7M1_[\
MFC_A"O%/_0O:C_WY-&@?NO+\#L_A=XFUW4_',%K?ZQ>7-N8)6,<LFY20.#BO
M=J\(^%WAG7=,\<P75_I%Y;6X@E!DEB*J"1P,U[O42W/.Q?+[3W>P4445)RA5
M'6/^0:W_ %TC_P#0UJ]5'6/^0:W_ %TC_P#0UH O4444 %%%% !113)4\V%X
MP[)N4KN4X*Y[CWH P3XSTMH6>!;JY87C60CAA)9I I;('=<*2#T.*TK;6].N
M]-74(KI/LQC,FYCM*J.N0>1C!S]*Q(_ &DVODFPGO;)XMA#0S DLBLH8[@><
M.P/UK13PIHBZ:EBVGPR1*@0M(,NPSNY?J23SUJG8E7(9-9L=5TC3[JWEVK=3
M1-"DOR.P$@!^4\UOUS[Z'8:1I5C;VT(86]RGE/+\[KND!.&//>N@J64%%%%
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M_3+GI_SV;_&E^VWG_/Y<_P#?YO\ &NE7X:^)PH!M[+I_S_Q?XTO_  K7Q/\
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M<PLQDCPJR D_.M3(X<9.,K<KN:M%%%0<04444 %%%,EC2:)XI!E'4JPSC(-
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M_P!_F_QH^VWG_/Y<_P#?YO\ &NF_X5KXG_Y][+_P.B_QH_X5KXG_ .?>R_\
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MO;BVCN8+<)(@G5@#]0:V-'YT:S/_ $Q7^59,\>H[S=B[11100%%%% !1110
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M2F]@JY'4#)ZFM 75N611<1%G7>HWCYE]1ZB@ ^R6W_/O%_WP*/LEM_S[Q?\
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MX4G]GV7_ #YV_P#W['^%6:* &HB1H$1551T51@"G444 %%%% !1110 4444
M! (P1D&JTT5E;PO--%!'$@W,S*  /6K-% '+0WNF6^N0I:6'VB#5I-WVI&1E
MWJF#A>NT!!D] 2/6NC^R6W_/O%_WP*J2:%I\NM1ZNT4GVV./RUD65P-O7&T'
M!&3Z5HTV)$/V2V_Y]XO^^!1]DMO^?>+_ +X%344AF=JDUCI.EW.H3VR-%;QF
M1@L8R<=A5+PRME-I MX]/^SM9R-;212[79&7G[PX/!!S[U>URYL+72)FU-=]
MG)MAD7;NW;V" 8^K"C3X-,TBSD@M'BBAB<F4M+N(8]2[$DY/N:?074M?9+;_
M )]XO^^!1]DMO^?>+_O@5E3^+-'MM4_L^6X828YD\MC$&VE]N_&W=M!.,]!3
MK#Q3I6HS-%#,RLD$<\GFKL$8D&4#$\!B.<46871I_9+;_GWB_P"^!6+XK2TM
MO#\\DNF_:(@0TBQLD955.[.X_P"[T[D@=ZMS^(M-MEU-II]@TW'V@L,8RF\!
M?[QV^E1:Q#HVLZ1 VI$M:D"ZB7S6C8E1N!&""2.N*$NX&A!%;7%O%,+14\Q
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M,$\4OEMM?8X;:WH<=#0!+16<^OZ-'Y6_5K!?.&8]UP@WC...>>1BM$'(R.E
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M_AQ;W$%GK#2Q2&*;4&EBN7MS;_: 44%A$?N $8]\9KM:I_VI;_W;C_P&D_\
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MRS,S^U-1_P"@C>?]_P!O\:/[4U'_ *"-Y_W_ &_QK3_X1.Z_Z">C?^!Z4?\
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M$_$7_0$OO^_1HY:/E^ 7J^99_P"$Y\1?\_Z?^ \?_P 31_PG/B+_ )_T_P#
M>/\ ^)JM_P (GXB_Z E]_P!^C1_PB?B+_H"7W_?HT<M'R_ +U?,L_P#"<^(O
M^?\ 3_P'C_\ B:/^$Y\1?\_Z?^ \?_Q-5O\ A$_$7_0$OO\ OT:/^$3\1?\
M0$OO^_1HY:/E^ 7J^9=@\;^(7N84:^0JTB@C[/'R"1_LU[W]CMO^?>'_ +X%
M?/=OX4\0K=0,VBWP D4DF(\#(KZ*KCQ:@K<MCJPSD[\Q#]CMO^?>'_O@4?8[
M;_GWA_[X%345QG40_8[;_GWA_P"^!1]CMO\ GWA_[X%344 0_8[;_GWA_P"^
M!1]CMO\ GWA_[X%344 5WM+;8W^CP]/[@J+1^-&LP/\ GBO\JN/]QOI5/2/^
M0/9_]<E_E0!=HHHH **** "BBB@ KGO''_(GWW_ /_0UKH:Y[QQ_R)]]_P
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M:@[GT#1117B'K!1110 4444 %%%% %#2_NW?_7U)_.K]4-+^[=_]?4G\ZOT
M%%%% !1110!E:WK<6B"Q:>-FCNKD6Y9024RK'. "3]W'XUBZ7X[BO[F'SK,V
MEK+ TJ32LV9-I((0!?FQCD9!&>G>NIGM(+EX7FB5V@D\R(D?<;!&1[X)_.J=
MKX?TFRO%N[:PBCG52JNH^Z"<G'H3D\TU86I3B\2K/XB@TY+8K:SP^9#=2;E$
MS8)*H-N"0!DY(/M4]A?07NO7P@9SY,21ONC9<-N?ID#/U'%6_P"RK'^U/[2-
MLAO FP2GD@>WI]:9'_R';C_KWC_]">A@B_7-?$!F3P-JC(S*P1<%3@_?%=+6
M+XLTNXUKPQ?:=:;//F4!-YP.&!Y/X55-I33?<4TW%I'SQ]JN?^?F?_OZW^-'
MVJY_Y^9_^_K?XUTFH> ]0TEHUU#4=*M6D!*"6X*[L=<<53_X1H?]![0__ O_
M .M7KJ<'JCRW"2W,?[5<_P#/S/\ ]_6_QH^U7/\ S\S_ /?UO\:V/^$:'_0>
MT/\ \"__ *U'_"-#_H/:'_X%_P#UJ?/$.61C_:KG_GYG_P"_K?XT?:KG_GYG
M_P"_K?XUL?\ "-#_ *#VA_\ @7_]:C_A&A_T'M#_ / O_P"M1SQ#ED8_VJY_
MY^9_^_K?XT?:KG_GYG_[^M_C6Q_PC0_Z#VA_^!?_ -:C_A&A_P!![0__  +_
M /K4<\0Y9&9;75S]L@_TF?\ UJ?\M6]1[U].5\]6_AL+=0G^W=$.)%.!=<GD
M>U?0M<.,:=K'7A4U>X4445Q'6%%%% !1110 C_<;Z53TC_D#V?\ UR7^57'^
MXWTJGI'_ "![/_KDO\J +M%%% !1110 4444 %<]XX_Y$^^_X!_Z&M=#7/>.
M/^1/OO\ @'_H:U4?B1,_A8[P3_R*%A]'_P#0VK?K \$_\BA8?1__ $-JWZ)?
M$PA\*"N.\4KXF-_>'1B_D?V:-HYYE\P_<QT?;Z^U=C36DC0D,ZK@9.3C ]:2
M=AM7.1T#_A(UGU)2CR+]H!2?4"Z;E.[(5!D#' R.#QWS4WAYM3>_UMF_M"-"
M^+9-14E2PW9<$=%)( 4= H/4UTZ2QR,ZI(C,APP5@2I]#Z4)-%*[K'(CLAPX
M5@2I]_2BX6,[0?M LI?M1B-Q]HE\PQ A,[CTSSBM2J&E?ZNZ_P"OJ7_T*K](
M85\^>/?^1YU7_KHO_H KZ#KF-2^'_A_5M1FO[NWF:XF(+E9F )QCH/I71AZL
M:<FY&->FZD;(\ HKW3_A5_A?_GUG_P# AO\ &N*\8:9X:\*:I!9KH<MT)8?-
MWF]=,<D8QSZ5W0Q,9NT4SCE0E%7;. HK>_M3PY_T*[_^#%_\*/[4\.?]"N__
M (,7_P *UYGV?X?YF7*N_P"?^1@T5O?VIX<_Z%=__!B_^%']J>'/^A7?_P &
M+_X4<S[/\/\ ,.5=_P _\C!HK>_M3PY_T*[_ /@Q?_"C^U/#G_0KO_X,7_PH
MYGV?X?YARKO^?^1J_"W_ )'>+_KWD_I7N=>0_#R^T>X\6QQV6B-:3>1(1*;Q
MI,#C(P17KU>;BW>IL=^&5H!1117,= 4444 %4=8_Y!K?]=(__0UJ]5'6/^0:
MW_72/_T-: +U%%% !1110 4444 <OXH7Q"UZO]BDB/\ L^YW;L[?,^39C'\?
M7'XU0\/_ /"3)>WP=)I24C99=09D13CE HR#C^\,9[\UVK2(IPSJ#@GD]AU-
M(DT4CLB2HSK@LH8$C/3-.^@K:G,Z6-6_X2[4"XO19F#'^D']T)MW'E_[.WIC
M!ZYYQ6GH8N@+[[:8#<?:3N, (3[BXQGFM-98W=T5U9T^\H.2OUJGIW_'SJ/_
M %\_^R+0P2+]<K\1_P#D1-1^B?\ H8KJJI:MI5KK6FRV%ZC-;RXW!6*G@YZC
MZ54)*,DV*:O%I'S-17NG_"K_  O_ ,^L_P#X$-_C1_PJ_P +_P#/K/\ ^!#?
MXUZ/URGYG#]5F>%T5[I_PJ_PO_SZS_\ @0W^-<!XG@\-^'=?GTQ= DN!$JMY
MAOG7.1GIBJAB8S=HID3H2@KR9Q5%;W]J>'/^A7?_ ,&+_P"%']J>'/\ H5W_
M /!B_P#A6O,^S_#_ #,^5=_S_P C!HK>_M3PY_T*[_\ @Q?_  H_M3PY_P!"
MN_\ X,7_ ,*.9]G^'^8<J[_G_D8-%;W]J>'/^A7?_P &+_X4?VIX<_Z%=_\
MP8O_ (4<S[/\/\PY5W_/_(P:1_N-]*W_ .U/#G_0KO\ ^#%_\*1M5\.;3_Q2
M[]/^@B_^%/F?9_A_F'*N_P"?^1[YHW_(#T__ *]H_P#T$5=JII;(VD631IL0
MP(53.=HVC SWJW7B/<]9;!1112&4=8_Y ]W_ -<C5T=!5+6/^0/=_P#7(U='
M04 +1110 4444 %9'B@:@?#=X-*\S[=M7R?+ZYW#^F:UZ1F5%+,P51U).*$!
MY^X\5KXA1YA=31B_P(8-R0&(K'\V[.0%^?Y6!!YQSBK6N_\ "5G5M),*,(UD
MS*+)F,;#>G#9QCY=_P![(_'%=FT\*L%:6,,S;0"PR3Z?6GLRKC<P&3@9/4U7
M,38R9Q>?\)-:&1H/LFR3RPH/F;L#.3TQ6O5"Z_Y#&G_27^0J_4E!1110 444
M4 ?,.H?\A.\_Z[R?^A&J]>[R_#/PS--)*]M.7=BS?OVZDY/>O--:D\-Z1K=Y
MIP\.22BVE,?F&_<;L=\8KUJ>(C/2*9YDZ+AK)G)T5O?VIX<_Z%=__!B_^%']
MJ>'/^A7?_P &+_X5KS/L_P /\S/E7?\ /_(P:M:7_P A>Q_Z^8__ $(5J?VI
MX<_Z%=__  8O_A5G3]3\/-J=FJ>&G1S.@5O[0<[3N&#C'-)R=MG^'^8U%7W_
M #_R/?Z***\4]8**** "BBB@ HHHH H:7]V[_P"OJ3^=7ZH:7]V[_P"OJ3^=
M7Z "BBB@ HHHH Q?$.IWNFMI?V*#SVN+U89(^ 2A1SP3P.5'-<SH7B[6+S5;
M>*[C$IEMW=;6W1=X96;.\DC;P!@_=/UKT"DP <X&:=]!6.5?7K[_ (3#3K#<
ML<4Z-Y]FT8,D.$+!BP)!R1C(X'0\D5J6,UQ-KU]Y]HUOLB14S(K>8NY_FXZ?
M0UKX&<XYJA'_ ,AZX_Z]X_\ T)Z&"+]%%%(9Y+\8_P#C^TG_ *YR?S6O,Z]]
M\6^"8?%D]K++?2VWV=64!$#;LX]?I7F_B'PIX?\ #-]'9WVJZFTDD?F PVR$
M8R1W8>E>GAJT>10ZG!7I2YG+H<516]]G\)?]!+6?_ 2/_P"*H^S^$O\ H):S
M_P" D?\ \571SKL_N.?E,&BM[[/X2_Z"6L_^ D?_ ,51]G\)?]!+6?\ P$C_
M /BJ.==G]P<I@T5O?9_"7_02UG_P$C_^*H^S^$O^@EK/_@)'_P#%4<Z[/[@Y
M3&M?^/RW_P"NJ?\ H0KZAKY[M[?PG]JAVZCK!;S%QFTCQG(_VJ^A*X<8[\IV
M856N%%%%<1UA1110 4444 (_W&^E4](_Y ]G_P!<E_E5Q_N-]*IZ1_R![/\
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MJ?M(V/F/<O\ >'YT;E_O#\Z^F/[#TG_H%V7_ (#K_A1_8>D_] NR_P# =?\
M"NOZZNQS?5'W/F?<O]X?G1N7^\/SKZ8_L/2?^@79?^ Z_P"%']AZ3_T"[+_P
M'7_"CZZNP?5'W/F?<O\ >'YT;E_O#\Z[GQ;X@N]*\57]C9V^G);PN BFQC.!
MM!ZD>]8O_"7ZI_SRTW_P B_PKIC*4DFE^/\ P#G<8IVN8&Y?[P_.FNR[&^8=
M/6NA_P"$OU3_ )Y:;_X 1?X4C>,-4"G]UIO3_GPB_P *J\NWX_\  %:/<]\T
M;_D!Z?\ ]>T?_H(J[532Y&ETBRD;&YX$8[1@9*CH.U6Z\1[GK+8****0RCK'
M_('N_P#KD:NCH*I:Q_R![O\ ZY&KHZ"@!:*** "BBB@ K)\3:7-K/AV\T^W=
M8YIE4*[' &&!S^E:U5[V]M].LY+N[D$<$>-SD$XR<#I[FA SBCX+U./Q M_'
M<Q3'[;YPN;A@SB,K&&!39M)^0X(VD<<GD5K:IH%[/<Z//'(+V6RO?/,UTX1D
M3:5*J%7!//?TK3;Q%I:ZD-.^TEKOS#&8DC9B" IYP.!\R\GCFI=0UFPTN:WB
MO)_+>X;;'\C$=0.2!@#) R>Y%5=DV17GMF3Q+:7)NIV61)%$#$>6F .0,9S^
M-:]9]T?^)QI_TE_D*T*DH**** "BBB@ KYS\9,O_  FFL<C_ (^6[_2OHRJ4
MFD:9-*TLNG6CR,<LS0J23[G%;T*RI-MHQK4G422/F7<O]X?G1N7^\/SKZ8_L
M/2?^@79?^ Z_X4?V'I/_ $"[+_P'7_"NKZZNQS_5'W/F?<O]X?G5K2V7^V+'
MYA_Q\Q]_]H5[?XTMK31_"E[?6.GV,=Q$%V,;5&QE@#P1Z&O+M/\ %NIR:G9Q
MM'I^UIXU.+&('!8=\5M"LZD6TC*=)0DDV>_T445Y!Z84444 %%%% !1110!0
MTO[MW_U]2?SJ_5#2_NW?_7U)_.K] !1110 4444 8OB&+596TO\ LI]CK>JT
MS')41['SN ()&<<>N*YC0;3Q3!JMNUR+F20V[K(]TY\F)MS;2H5_FSQP1D<<
M]J[]Y$C*AW52YVJ"<;CZ"HDOK22984NH&E92RHL@+$ X) ],TT]!-'*1V_B3
M_A/H)Y_,-@(@)/*8B$C8<D M_>QQC/?..*V[%;M=>O?M<L,@,2&+RHRNU-S\
M').3[\5I&Y@%R+8SQ_:"N\1;QN*^N.N*JQ_\AZX_Z]X__0GH;N"5B_1112&%
M>,_%W_D9[/\ Z]!_Z&U>S5B:QX2T77[I+G4K3SI438K>8RX&<]C[UM0J*G/F
M9E6@YQLCYTHKWO\ X5MX5_Z!I_[_ #_XT?\ "MO"O_0-/_?Y_P#&NWZ[3[,Y
M/JL_(\$HKU'QOH/AWPI96D]OH<=P9Y3&1)<2   9[&N+_MG1O^A6M/\ P+E_
MQK:%7G7-%?D92I\KLV85%;O]LZ-_T*UI_P"!<O\ C1_;.C?]"M:?^!<O^-5S
M/M^7^9/*N_YF/:_\?EO_ -=4_P#0A7U#7SU;ZSHYNH0/"]J"9% /VJ7CD<]:
M^A:X<8V^6Z.S"I*^H4445Q'6%%%% !1110 C_<;Z53TC_D#V?_7)?Y5<?[C?
M2J>D?\@>S_ZY+_*@"[1110 4444 %%%% !7/>./^1/OO^ ?^AK70USWCC_D3
M[[_@'_H:U4?B1,_A8[P3_P BA8?1_P#T-JWZP/!/_(H6'T?_ -#:M^B7Q,(?
M"@KG==\'V/B"ZFN+IV#O:?9EP!^[^?=N'O6SJ%XNGZ;=WKH76WA>4JO4A5)P
M/RKF)/B'8$$VUN\Z!H5:7>%C0R*S?,QX7&W'/4D"DK]!NW4O6/@^SMY[N6YD
M:Y^T3"4(%\I$89Y"I@;CGD]\"IM+\*V&DSW[0M/)%>J%DAFD+KU8GKSSN-+J
M'BBQL[)KFW#7P2>."46[ ^47;;EN> *=:Z^LVHZC:7%I+;"R02-*S!E9"3@G
M;G:?ES@\X(/>GJ&A+H-M#9V4UM;Q+%#'<2JB*,!1N/ K4K+T&YAO+&6YMW$D
M,MQ*R,!U&XUJ5(PHHHH **** "BBB@#R?XKZ=?7NMZ>]I97$ZK;,&:*(L =W
M3BN!_L'6?^@3??\ @.W^%?2U8'C:62'P7JLD4CQNL!*LC$$<CH1791Q+24$C
MEJX=-N=SPG^P-:_Z!%__ . [?X4?V!K7_0(O_P#P';_"HO[7U/\ Z"5Y_P"!
M#_XT?VOJ?_02O/\ P(?_ !KT/?.+W3LOAMI.I6?C&.:YT^Z@B$$@WR0LHSQW
M(KVBO%/AGJ%[<>,XHY[RYE3[/(=LDK,.W8FO:Z\W%W]IJ=^&MR:!1117*= 4
M444 %4=8_P"0:W_72/\ ]#6KU4=8_P"0:W_72/\ ]#6@"]1110 4444 %,E3
MS8GC)P&4KD=LT^B@#C#\.=/2R^S6TYA!M(K9R85??L)._GHW/4=,<5J77A2T
MET:[L+>62&2ZA$,MRQ\QV'0D[CC)]:=KOBJQ\/3K%>Y7?;37"MD -Y>WY?J=
MW'TJOIWC.QO);H7*?88X-G-Q(JLVX9!V]<'L>AJO>W)TV+5AH$UMK-UJ%UJ+
M7AGA$(C>%5$:C'"D= >21W)]A4NAV=M8"^MK2%(8$N3M1!@#**33+#Q+8:EJ
MM_8V[Y-F!N<GA_[VT=PO )]3BGZ'>6]^+ZYM91+"]R=K@$9PB@]:3\QKR-:B
MBBD,**** "BBB@ HHHH **** /"?&^CZI<^--3E@TV\EB9UVND+,#\HZ$"L#
M^P-:_P"@1?\ _@.W^%>F_%R[N;6TTHVUQ-"6EDW>5(5SP.N*\M_M?4_^@E>?
M^!#_ .->M0E*5--'F58QC-HE_L#6O^@1?_\ @.W^%-;0-:V'_B47_3_GW?\
MPIG]KZG_ -!*\_\  A_\:1M7U/8W_$RO>G_/P_\ C6WOF?NGT?I*,FC6*.I5
MEMXP5(P0=HJY5/2&9]%L68EF-O&22<DG:*N5XCW/66P4444AE'6/^0/=_P#7
M(U='052UC_D#W?\ UR-71T% "T444 %%%% !5#6]*BUS1[G39G9(IP%9E'.
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M%&@_\))H<FF_:/L^]U;S-F[&#GID5P4GP?$43R-KAVH"QQ;=A_P*O5J@O?\
MCPN/^N3?R-:TZTX*T69SI0D[M'D_P\M=$B\6QO8:M<W,_D28CDL_+&.,G.XU
MZ_7A?PL_Y':+_KWD_I7NE:XM6J&>&=X!1117*= 4444 %4=8_P"0:W_72/\
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MEPU1R]WL:=%%%<1UA1110 4444 4-+^[=_\ 7U)_.K]4-+^[=_\ 7U)_.K]
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M97/3([53T[_CYU'_ *^?_9%K)TKPNUAXEU/53.VRX79$H(+9;#.[''4D# Y
M ..N*OZ';M:B^A>YFN66Y/[V8@L?D7K@ ?I0P1K4444AA1110 4444 %%%%
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M )_8?_ =:1OB;XJ"DB]AZ?\ /NM87]@ZS_T"+_\ \!W_ ,*1M!UG8W_$HO\
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M3W2&I5%U9O?\+,\5?\_L/_@.M'_"S/%7_/[#_P" ZU@_V#K/_0(O_P#P'?\
MPH_L'6?^@1?_ /@._P#A1[.EV0^>IW9O?\+,\5?\_L/_ (#K7I7P\UW4/$&@
MS76I2K),MPT8*H%^4 'H/K7B_P#8.L_] B__ / =_P#"O7?A7:7-GX9N([JV
MF@<W3$+*A4D;5YP:Y\3"FJ=XI&V'E-SU9U6E_=N_^OJ3^=7ZH:7]V[_Z^I/Y
MU?KSCN"BBB@ HHHH :\D<90.ZJ7.U0QQN/H/?BH4OK.2988[J!Y64LJ+("Q
M."0/3-9^OZ+)K/\ 9P2X: 6MV+AF0X? 1EPI['YORS7/:+X(O]+OX7%]'%&L
M+QS2PDF64DL5/S A2-WWAUZ$4[*PKL[$W]FMX+,W< NB,B$R#>>_W>M01_\
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M+,&4@^@]!CT%-6$[ER'2]/G@CE6"4*ZA@&D<$9]1GBG_ -C6/_/)_P#OZ_\
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M/ER?]_7_ ,:Q#X*1]#72)=4N9+49#;HHBS9)W$DK]XY/S=>]=.B".-47.U0
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MSBY[SP]()-1-Q=1VM@?+N+9TE'FF0J(SM/)&>G'.:[""59X(Y55E5U# ,,$
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M:U':0VYLO)63=<+<(2SID'8K#E02!GUQBM^B[[A8SDTN2.,1QZA<H@& JK&
M/H-M7+:!+6VB@0DI&H4%CS@5+12&%%%% ',:]K5[8>)=)LK=U6"Y8"0%02?F
M ZUNZE.]MI=W/$0)(X7=21GD D5QGC6.:7Q5HD=O-Y,S'"2;<[3N&#BK>I:/
MXDCTN[>7Q&)(UA<NGV91N&#D9K7E5D9<SNQ^G^*;A/!4FL7@$TZR%% &T$Y
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M&FW;S0O"+B^N)XXG7!5&D.,CMGK^-;U%#E<%&P4445)04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!YM>^&?$ZW]Z]DSI'/=SS0>5=^4(I
M&9"LS@??&T,-O/TYXS-/7Q%=76LF/3;J_O1(3;"^?$$)\UL.5?CS N,!>, >
M]>N457,3RGE\?@ZZ>:TL#I\\4,8L)07F'R+%))YBEUX+?.&P/7CI2IX6\72R
MP^=*=T,\<CR37?FK),K.?.13]P %1MX^G&3Z?11SL.5'G.D^&_$EMHVO;1):
MZC>6]ND<DE[YKO(BD2'?SMW9./3/:G#PQK7]JIJ=I!<6<D:VB1QR:@9#M65S
M*KG)W#8W&<]>*]$HHYF'*CS.T\->++F5TOI+BWM))_-:*+4&)7]U(" VXMC>
M8SU'K@5D6MKXONM3OK)I]3341:F-)3*PB#A(]Q8_=P<.$9>[$FO8Z*.<.4XG
MPUI>IVNOVSWD=V!!8S*\EPX<_/*"D>X$YVA6/4XR.:[:BBDW<:5@HHHI#"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :_,;8ZX->5:9JGBK1M,L
M8##/!#;6R$QS6I:/RO+9I))).H96 &W([<'.1ZO2$!@00"#P0::=A-7/&I-7
MN_$GAY!J']HWM^TVQ#!;OMT\,BDRN(@ []2F,XR/<U?N;;5YM;GNK 7$]W9W
M5Y-Y3IE7D6&/[/OSTRIX]\UZE;VT%I%Y5M!'#'G.R- HS]!4@4 D@ $]3CK5
M<PN4\KN+WQ7)=1ZA##?7'V:*=+>YDLO+D*L(=Q,7 )4^9M&.=O?O?LI]=T_P
MNTD/]H(9]9F:>Y:SW3K S,1((L=SM[< DXKT:BES>0<IYG!<>)-)N]1NH8]0
MFM;FYN7,(M 7&(4*2+GN6R-IXZ\4D.L^-Y+42E;A/LZ.^&LAFXQ.JJ&X&,QD
MG@#IFO3:*.;R#E\SR.S\8>*-1M;E[6],KB=-RQVFYH8"9!YJ@*<J2J@#YB!D
MFNO\'274FH:R]P02QMVFVH57[085\S"GD?P9'K73P6MO:[_L]O%%O;<_EH%W
M'U..IJ4*JYP ,G)P.IH<D"0M%%%24%%%% !1110 4444 8FJ^'O[3UK3]1^T
M^7]D(.S9G=SGKGBM2]M_M=C<6V[;YT;1[L9QD8S4]%.[%9'-P>$8X_#?]CR7
MDN!(9!+&-ISVX[U4'@R[N6CBU37+B[LXR"(<$9QZDDUU]%5SR)Y(B*JHBHH
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<]XX_Y$^^_P"
M?^AK70USWCC_ )$^^_X!_P"AK51^)$S^%CO!/_(H6'T?_P!#:M^L#P3_ ,BA
M8?1__0VK?HE\3"'PH*JOJ-E$SK)=PH4D$3!G VN1D*??'-6JY#4O! U#4;J]
M-W\TUY'<^6X8Q[5B"%63(!SZTE;J-WZ'36NH6=]:?:K6ZBFM^?WJ."O'7FDM
M;^TU&T-Q8W,5Q%R \3AAD=LBL72?#$]CI:6\^I3/)'O\M$=O)13T0JQ)=1_M
M$^E+IGAMK31KVUO;DL]U<-<.;5FA"D@<*<[L?+Z]\=!1H&I)%96R>'1>-&SS
M+;>:2TK_ #,%SSS7E2_$>^*@_P!EV/(_OR__ !=>MH,>#<#/%@1_XY7SDBML
M7Y&Z?W379A*<)I\R.7$SE%KE9V7_  L:^_Z!=E_WW+_\71_PL:^_Z!=E_P!]
MR_\ Q=<=M;^XW_?)HVM_<;_ODUU_5Z78YO;5.YV/_"QK[_H%V7_?<O\ \71_
MPL:^_P"@79?]]R__ !=<=M;^XW_?)HVM_<;_ +Y-'U>EV#VU3N=C_P +&OO^
M@79?]]R__%T?\+&OO^@79?\ ?<O_ ,77';6_N-_WR:-K?W&_[Y-'U>EV#VU3
MN=C_ ,+&OO\ H%V7_?<O_P 71_PL:^_Z!=E_WW+_ /%UQVUO[C?]\FC:W]QO
M^^31]7I=@]M4[G8_\+&OO^@79?\ ?<O_ ,71_P +&OO^@79?]]R__%UQVUO[
MC?\ ?)HVM_<;_ODT?5Z78/;5.YV/_"QK[_H%V7_?<O\ \71_PL:^_P"@79?]
M]R__ !=<=M;^XW_?)HVM_<;_ +Y-'U>EV#VU3N=C_P +&OO^@79?]]R__%UN
M^$/%DWB'Q)!IMU86T<4B.Q:*27=P,CJU>8[6_N-_WR:Z[X9JP\=6F58?NI>H
M_P!FHJT*:@VD73JS<TFSVG^Q['_GD_\ W]?_ !H_L>Q_YY/_ -_7_P :O45Y
M1Z)1_L>Q_P">3_\ ?U_\:KRV4%GJ%@T ="TK*W[QB"-C'&"?:M:J-]_Q^Z=_
MUV;_ - :@"]1110 4444 %%%% $$UY;6[[)IXXV\MI<,P!V+C<WT&1D^]1VN
MIV-[/+#:WD$TL0!=(W#%0>F<5D>(O"XU^Z69KIX0MG/; (S*<R;<$D$9 V].
M]5=)\'S6$]SYFHO';RJF(K-GBRXZR'YC@GH0N >N,T[*PM;G1PZA9W-U-:P7
M4,EQ!_K8T<%D^H[51@LH+R\OWN [LL^U?WC# V+Q@'WK/T;PF^E^(-1U)[SS
M4N@ZA0"&^9MV2<X!'3Y0,]3S6CH=I'9"^MXFE9%N3@RR%VY1>K'DT,$>9:[X
MWNM*U^_L(=.M&BMYC&K/)+D@>OS5G?\ "QK[_H%V7_?<O_Q=9'C!6/C+6,*Q
M_P!*;L:Q=K?W&_[Y->K"A3<4VCSI5JBD]3L?^%C7W_0+LO\ ON7_ .+H_P"%
MC7W_ $"[+_ON7_XNN.VM_<;_ +Y-&UO[C?\ ?)JOJ]+L3[:IW.Q_X6-??] N
MR_[[E_\ BZ/^%C7W_0+LO^^Y?_BZX[:W]QO^^31M;^XW_?)H^KTNP>VJ=SL?
M^%C7W_0+LO\ ON7_ .+H_P"%C7W_ $"[+_ON7_XNN.VM_<;_ +Y-&UO[C?\
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M_0.?_P #Y:X+>O\ >'YT;U_O#\Z/JU+L'MZG<[W_ (6;<_\ 0.?_ ,#Y:/\
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MQT [4.P:EO2,'1;+H08$_'BL/Q]=3:9X0NKJQ?[/.K(%D0#(RP!K<T<8T:R
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M<?DO^%'_  F7B/\ Z"]Q^2_X4?\ "'>(O^@3/^:_XT?\(=XB_P"@3/\ FO\
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M )&K1_\ R+_\37;SQ_I''R,]N\(?\B?I'_7JG\JVJR?#$2P>%],B2>.=4MT
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M% !7/>./^1/OO^ ?^AK70USWCC_D3[[_ (!_Z&M5'XD3/X6.\$_\BA8?1_\
MT-JWZP/!/_(H6'T?_P!#:M^B7Q,(?"@KAM6U_P 0VVIWL%M"HM8]0BA2X:/<
M$1H0Q!4#+#<?O#Z5W-%).PVCE?#.LZM?Z1 \]N]PQ=TENW9%0$?Q*  63T.
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M?:LG4-A<@_*!@$GW ]:NV\US)XHG6>U$,:6^(G\T-Y@W]<?PULUG_P#,Q_\
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M_P"1HL?^0?;?]<E_D*-0_P"0;=?]<7_D:+'_ )!]M_UR7^0H L4444 %%%%
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M<9).,Y '-:5O=K<^*)XA#.AAMMI:2(JK_/U4G[P]Q2=^HU;H;-%%%(84444
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M;\_ND0!>>O%);6-IIUFUO96T5O",G9$H49/?BN?U76M2M+[13,4L(KB:2.>
MIYQ($;%6W#@ ,!QWSUIGAS6-2U#P[=W:-_:4@G98%F46SE,#[XVX4]2!CH0#
MSFBSM<+JYT&D?\@>S_ZXK_*KM4M'S_8MED8/D)D>G J[2&%%%% !1110 444
M4 %%%% !1110 4444 %5=1U*STFS:\O[A8+=2 TC= 3P*M5QWQ/_ .1&N_\
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M *2_R%7ZQYY;IO$UI$]JJVRI(4G\T$N<#(VXX^N:V*DH**** "BBB@ HHHH
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M6/HO_(A6?_8/'_H%;%C_ ,@^V_ZY+_(5Y4E9M'HQ=TF6****0PHHHH ****
M"N>\<?\ (GWW_ /_ $-:Z&N>\<?\B???\ _]#6JC\2)G\+'>"?\ D4+#Z/\
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M2M&B@"CLU7_GO9_]^F_^*HV:K_SWL_\ OTW_ ,55ZB@"CLU7_GO9_P#?IO\
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M-QYLMR%\IE1<,$4 _P 3  GTS30F;6S5?^>]G_WZ;_XJC9JO_/>S_P"_3?\
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MS;Y-ZX8L<D?.Q8@$[FRV.V<9K?IL2*'V;4O^@C%_X#?_ &5'V;4O^@C%_P"
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M9BUC3I]2;3HKR)KU8A,T /SJAZ$CMU%37-]:V;P+<SI$UQ*(8@QQO<@D*/?
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M:U?_ (2"UDCN[V[O;FQC:&QAWQI!(8"Q9T*['0MWW @X%/V#[B]HCU*BO+O
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M_>Z;OM];(M69Y)5*84Y8;4SCUYS4UY!<1SW2Q)-]F'V<%4SS&"V\+^&,XYH
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//K3J* "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>img254193463_17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_17.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %H ?P# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *Q=9\3V>BW @DM[VYE$1GD6T@,ABB!QO;T'!]2<' XK:KD_%F
MK3).FD166I"&YC/VJ]M;*2;9'TV(5!^<\\_PCGKBFE=BD[(MWOC/2[-@0MU<
MPK"D\T]M"7C@C<95W/8$9/&3CG%= "&4,IR",@BN#\2NUUI']D6>CZO$!!&^
MG&WC/E2G;A8YP1A54X#*_;\J[J$.(8Q(%#[1NV],XYQ3:T$F[F7??\C/I'_7
M.X_DE:]8EU&4\4:43([[H[C ;'R\)TP*VZ3&%%%%(84444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDE6=9M].NM'NH=6,8T]D_?F20HNT<G+9&!Z\U6OO^1GTC_KG<?R2M9E5E*L
M0>H(ZTQ'B]E>V;_#6QAL[BW06^O;FN$(=+!?M#LDKJ.-N   <#G-='X2N;&X
MAU_3KO4%F.JW\L46H1?(MZ6A&XQ@< J!C(R,C.:]#6&)%95B10W4!0,THC10
MH"* O0 =*IRN0H6/-_!>GWUWXFAE-[;W.E>'K5M-MKF"W,7VASM# _,=P4*
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M-UCX8^'-3G^UVT$FE7XR5NM.?R6!]<#C]*S?LWQ&\+\VUS:^)[%?^6<_[FY
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MM'_[!UW_ .AP5T5-B74****0PHHHH **** ,7QA_R).O?]@ZX_\ 1;5I:?\
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MIX?M-;MUZSZ9+LDQZ[#U/L!6?+?9FG,UNCT*BN(T_P"*WAFYF%M?RW&D7?\
M%#J,)B(_'I^9KL;:[MKV$36MQ%/$W1XG#*?Q%)IK<I23V)J***0PHHHH ***
M* "BBB@ HHHH **** .=\$?\BR/^OR\_]*9*Z*N=\$?\BR/^OR\_]*9*Z*G+
M<4=D%%%%(84444 %%%% '.WO_)0M'_[!UW_Z'!715SM[_P E"T?_ +!UW_Z'
M!714V)=0HKE/^$BU;_A84&B2Z?';Z;+;S/'*[!I)F3;\P .%7YL<\GGI5;_A
M(=<M?%MAIMX=.;[=+(!80AC-!  Q69GS@YV\C Z\=*?*Q<R.THKC_%GC.+1M
M8T[1;>[LK>]NF$DTUX^([>$'ECR,LW11GK77J0RAE(((R".])JPTTW86BBBD
M,Q?&'_(DZ]_V#KC_ -%M6EI__(-M?^N*?R%9OC#_ )$G7O\ L'7'_HMJTM/_
M .0;:_\ 7%/Y"GT%U+%%%%(84444 8LFM1OXN_X1N2U#A]/-X96(((\S9M*X
M]\UPEU9^%1#H_BW0K*[L);K5(K7-I)Y 8F4HV].5*Y4\#&0:ZGQ%X-N=9UZ'
M6+'7[O2KF.U^RDVZ [DW;N2??'Y5BV/PKGLUL('\5:A/8V=VEVEH\2["ZOO_
M %)/YUHK+J9R4F]CT1Y$BC:21U1%&69C@ >I-*K*ZAE8,K#((.016-XPMY;O
MP7K=O!&TLTMC,B(@R68H0 !ZUYO%XLU6+4/"\J>%?$RV^E6LD-U&MJ0)28U5
M2!G! *D\^M2HW'*5F>GZ+?7U]!<M?VD-M)%<R1(D4XER@/#$CH3Z=15NYL+.
M]*FZM()RH(4RQAL9ZXR*Y3X<"Y?3=9N[FPNK$WFKW%RD-U'L<(P4C(_STKLZ
M3T8XZH@-E:F2*0VT)DA&V)O+&4'HI[?A4]%%(HR+[_D9](_ZYW'\DK7K(OO^
M1GTC_KG<?R2M>FQ(****0PHHHH **** "BBB@ HHHH **** "BBB@ KF]%_Y
M';Q1_P!NG_HLUTE<WHO_ ".WBC_MT_\ 19IK9B>Z.DHHHI#*FH:5I^JP&#4+
M*WNHC_#/&''ZUQUS\*-$2=KG0[O4-#N2<[[&X8*3[J?Y#%=Y134FMA.*>YY[
M]E^)>@?ZB]TWQ';+GY)T\B<CZCC\R:<GQ3@T]Q#XGT'5-$DX!DDB,L/X.O7\
MJ] ILD:2HR2(KHPP589!I\R>Z)Y6MF9ND^(]%UU ^EZI:W7^S'("P^J]1^5:
ME<CJWPR\)ZM)YQTQ;2YSD3V3&%@?7Y>/TK+_ .$1\::$,^'_ !<UY"H^6UU>
M/S!]-XY_E1:+V87DMT>A45Y[_P )UXFT3CQ-X.N?*7K=Z6PG3'KMZ@?4UM:/
M\1/"NN$):ZQ DQ./)N/W3Y],-C/X9H<6-31U%%("& (((/((I:DH**** "BB
MB@#G?!'_ "+(_P"OR\_]*9*KZ7XJO=0\8:CI$VDR6MO;6HGA,I_>S#>5W8S@
M*2#C//&>]6/!'_(LC_K\O/\ TIDJHFD^(4\>7.N>3IGV62S%FJ_:)-^U69E8
MC9C)+ $9X]35Z79&MD)IWB76AXCT_2]9T^UMSJ4$L\44$A>2V"8XE/0Y!ZCC
M((YJ+4/%MU'XTDT*"[TBU6)8?^/XN))F?)(3! X 'XFJ^@Z#XJTZ^U#4K^/2
M+O5KM&'VPW,I"  ^7$J;/EC!QG!R>O)JYX@T3Q!XCM'TJY.E1:?.86EGC+F9
M-I5F"J1@DD'#9& >F:-+BUL=?1114&@444C,%4LQ  ZD]J .>O?^2A:/_P!@
MZ[_]#@KHJ\%USXU11>.H;RRTL3V=DDUJ&>7#2J[(2PXX_P!7QUZU[;I&J6^M
MZ/::G:$F"ZB65-PP0#V/N.E7*+25R(34F[&'?Z'KESXVLM:BN-.6UM(WA6)T
M<NR/M+Y(.-WR\=N>:@;PMK5WJ5@VHZO!<VFG737=L_D;9W;#!5=@<;1N[ 9
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M_KBG\A6;XP_Y$G7O^P=<?^BVK2T__D&VO_7%/Y"GT%U+%%%%(84444 %%%%
M!1110 4444 %%<7XST+3+Z>"-;=SJ^IRB".59I 8U R\F P'RH#^)7UKL88E
M@ACB3.Q%"KDY. ,=:;6@D]2"7_D)6W_7.3_V6K54C(SZG"#$Z;4?!;'S?=Z8
M-7:0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ J&[N19VDMPT4THC&2D,9=V^BCDFIJ* .5\"
M7,C:/):36%_:RQ7$\I^U6S1!EDFD=<$]>",^F:ZJBBFW=B2LK!1112&%%%%
M!1110 4444 %%%% !1110 4444 8OC#_ )$G7O\ L'7'_HMJTM/_ .0;:_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
B%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>img254193463_18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_18.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &% YD# 2(  A$! Q$!_\0
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M9I>C3Q<HR -<9QM"DYQGO3KOXDZ?:WURGV*X>QM+@6US>*R;8Y,@$!<[F )
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M3Z1>64E\DDD)G*Y*)@[B!TSGI0XM IIG545Q$OQ*LH[*&X&FWDIEU*73DCB
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M<<@UU'BK7F\/:-]JA@%Q=2RI!;P9QYDCM@#^9_"J&G>.;"\\9W_A>:,V]];
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M<KC4;$E%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,EFBA7=+(D8]
M68"B*:*89BE20>J,#7G_ (MT'P[IKC4=5TZ^U^^OKD16UK+,7^<Y.U%R%4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2Y)6YH[/^K#J***T("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>%;/<^PJW5=?^/\ D_ZYK_,U8J2@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N6\&_=O?^NS_^AM74
MURW@W[M[_P!=G_\ 0VJ)_9]?T9<.OI^J.IHJ&ZFD@@:2*!IW&,1J0"?SK-37
ME^RW4\]G/$;=MA3ABS8S@8J9UH0=I,<:<I*\38HJ&TN!=VD-PJE1*@< ]1D5
M-6B::NB&FG9A1113$8?C+_D3-8_Z])/Y5N5A^,O^1,UC_KTD_E6Y3Z"ZA111
M2&%%%% !1110!RWC;[FA_P#837_T5+74CH*Y;QK]S0_^PFO_ **EJXJ7BZ[%
M;QZE-*BJ99D95VJO\*\#/)_05SU*G)4VO>R_%FT(<T-[6O\ DC=HK*TN:\;4
M=0AO)5<QLA4(,*H(S@=ZU:UIS4X\R7?\-")PY'8****L@YKQIHU]JMC93:;'
M!-=6%VETEO<'$<V 05)[=<CW%4/#FEZW=^*9/$&L:;:Z5LM/LL=M!('9\MN+
M.1QQCBNNBO+::2:..>-W@;;* W*'&<'TK/\ [1O/^$I_LXQ6HLS:^<K^?^^+
M;L?<_N^]4F[6):5[DM[%=QRS7:2RW,*PD#3E2/$C?[QYR?<XKEX+;5);B#6I
M]'O!?Q7 DG@=HAN0H5"Q8<CY<_Q$9R37<T4D[#:N9'AVTN+33I#=1B*:XN9;
M@Q @^6'<L%R.,X/..^:N;"NHJ2[-E#P>W-6ZKO\ \?\ '_N'^=(:T+%%%% !
M1110 4444 %%%% !1110!S_C'PK:^+] ET^?"3#Y[><#F*0="/ZUQWPX\675
MO<3>%?$&8M1LV\OYSU]"/8_YZUZC7G?Q,\'SZC#'XCT5=NLV"Y*J/]?&.JGU
M([5G4@Y*\?B6W^3\G_P2H247KL]_\_5?\ ]$HKCOA_XR@\4:/&&?%U&N&5NI
MQUS[BNQHIU%4C=?\,^PYP<'8****T("BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M \V^($$6K>(+;3['0;W4-6AMO-:>UO/LOE1%B I;^+)!XK?^'\EA_P (Z]M9
M:;-ILEM</%<VT[[W67@L2W\6<@YK$\<0:>VM7%_+KVJZ;-I^GAY?L2@ QLY"
MKGNQ;H*7X=Z-")9M5MM:UJ3]ZZW-CJ& 1*0,EQZXQ@UH_A,E\9Z)11169J%(
M2!U(%+7.>+[>SDT]3);+/?2M]GM 6(^=N_!Z#K^%-";LCH\CUHKSN]L[2T&J
MVEY>RQMI=A%]@)G92/D),BC/S,7&._0"N\L9)I=.MI)UQ.T2LZ^C$#(_.AJP
M)W!?^/\ D_ZYK_,U8JI 9&O9?,0*=B\ Y[FK=(84444 %%%% !1110 4444
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M2.MJN_\ Q_Q_[A_G5?1M2;4[ S20^3/'(\,T8;<%=&*G![CC(]C4Y96U! K
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M% !1110 4444 %%%% !1110 4444 %8</_(]7?\ V#8?_1DE;E8</_(]7?\
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M'D_3TKJ:*F[*:3*.D::-*L?(,S32-(\LLK  N[,68X'3D]*D**NH(54 E#G
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MK=B[>;=2G=-,>K'_  K4KSS^R_BI_P!!_0?^_#?_ !-']E_%3_H/Z#_WX?\
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MU=O=?X?YK\2_)X9T&7[^C:>?^W9/\*IR^!/"DW^L\/Z>?^V(I]KXE19A:ZK
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MZOP2]&73^-%B+_4I_NBGTR+_ %*?[HI]6MB7N%%%%,04444 %<M<#_BX4?\
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MB2L5(/-^VR^;LW>6OW,^I]:MU77_ (_Y/^N:_P S5BD4%%%% !1110 4444
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MCV,9/FDV%%%%42<WXM@:YDT&%&52VIKRPXXAE-=)VK#\0_\ '_X>_P"PF/\
MT1-6Y1RJ]PN]@HHHH **** .8\;7]O866GE]*?4[R2]064"-L_?#)!W=L &L
MCP?I-U#XHO-2N_"S:7)/&Q\TWWFH"6!*HG\.3R?I5.X\+V'BWQ7K,']M^(8S
M83QNVRY40I*1N C&,C:,?G5_PYI\.A>.+C2GU;7+N?[&)X_MUP)(I$+8)4
M@@\?C6FRL9;RN=W11169J%5W_P"/^/\ W#_.K%5W_P"/^/\ W#_.@"Q1110
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M\U+&MBW1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>R^:5)V+]T8[FK=5U_X_Y/\ KFO\S5BD4%%%% !1110 4444 %%%% !1102
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS"85.&D#C:/J:S-2>J[_ /'_ !_[A_G4ZLKJ&5@RD9!!R#4#_P#'_'_N'^=
M%BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7CW>D:<+:=TV,_G2/E>N,,Q':NAHI\SVN+E5[V,/Q"VI_P!GZ@L-K%-:&T?
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MH?R--+W,;Q[_ "V5G"G:#D>]6JS9]=TZWOKBSEN LUM;_:9A@G8F<9/O[=:
M-*BJ&EZQ:ZLLIM_-5XB!)'-&4=<C(.#V(J_0 4444 %%%% !1110 4444 <!
MKOE1W'B.SN+=WU#4#']@Q&29,(H7:W;:P)/3'6M?X@@CX;ZX'.6%DV?KBNHI
MLD4<T;1RHKQL,,K#((]Q5<VQ/+N?#^#7TYH7ACQ9-X>TV6#Q[/#"]K$R1#38
M6"*4&%R>N.F:Z6.3PK+J9TY+:Q-R&*;?LHVEAU4-MVEAZ YKH%541410JJ,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6\5I:Q6T"A(HD"(H[ # %2U#W-%L%%%%(84444 %%%% !1110 4444 %%%%
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M)]!3F95(W,!DX&3U- "T4A90P4L-QY SR:%96)"L#M.#@]#0 M%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
6HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>img254193463_19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_19.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #P @T# 2(  A$! Q$!_\0
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M*L9NR.;%9=7PL5.JM'IN;-%1;)O^>P_[XHV3?\]A_P!\5H<!+146R;_GL/\
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MJX62C5W9+146R;_GL/\ OBC9-_SV'_?%6<I+146R;_GL/^^*-DW_ #V'_?%
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MM.Q@#ZUTE-IH2:84444AA1110!Y%\7_^0QIG_7N__H0KSJO1?B__ ,AC3/\
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M/X*?J_T+=%%%=I\J%%%% !1110!\^^./^1WU;_KL/_017/UT'CC_ )'?5O\
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M 2!GVJ/S7_YX/^8_QJ"R6BHO-?\ YX/^8_QH\U_^>#_F/\: .#^(?_(1LO\
MKDW\ZXVNP^(+%M0LLH5_=-UQZUQ]?$9I_O<_ZZ'U> _W:']=0HHHK@.L*]<\
M+?\ (L6'_7/^IKR.O6/#$C#PU8 1,P\OJ"/4^]>YD/\ 'EZ?JCRLW_A1]?T-
MNBHO-?\ YX/^8_QH\U_^>#_F/\:^J/GB6BHO-?\ YX/^8_QH\U_^>#_F/\:
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MO:/%K^BW.F37%Q;QSKM,MN^QUYSP?P_$5HT4 <!X=\)ZSX5\1Q201Z9=Z9)
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M2GA$M%1?9H?[@_.C[-#_ '!^= $M%1?9H?[@_.C[-#_<'YT >4>*/^1FO_\
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MW7_?TT?VUJG_ $$;K_OZ:/\ 5JK_ ,_%]P?ZP4_Y']Y]!>"P?^$HM^/X'_\
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M_P!<F_D: /B(=*6D'2EKO/-"BBB@#O\ X+_\E0T__KE/_P"BS7U)7RW\%_\
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MYZI_WT*/.B_YZI_WT* /DSXG_P#)3->_Z^!_Z M<E76_$\@_$O7B#D?:!_Z
MM<E7;'X4>?/XF%%:5GHEQ?:9<WT,UMBW1I'@,G[THN-S!?0;AU(SVS6;57%8
MLZ=_R%;+_KXC_P#0A7VU7Q+IW_(4L_\ KXC_ /0A7VOYT7_/1/\ OH5SU^AT
MX?9CZ*9YT7_/5/\ OH4>=%_SU3_OH5@= ^BF>=%_SU3_ +Z%'G1?\]4_[Z%
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MS6DUS?X;CT5=/MHT23S3.A<22/ZM\VT\<#C@=.M9-%%.P-W.D^'O/Q$\/_\
M7['_ #KZ^V+_ '1^5?(7P]_Y*)X?_P"OV/\ G7U]7-6W.JA\(FQ?[H_*C8O]
MT?E2T5B;B;%_NC\J-B_W1^5+10 FQ?[H_*J]\B_8+GY1_JF[>QJS4%]_R#[G
M_KDW\C0!\1#I2T@Z4M=YYH4444 =_P#!< _$_3\_\\IO_19KZCV+_='Y5\N?
M!?\ Y*AI_P#URG_]%FOJ2N6M\1V4/A$V+_='Y4;%_NC\J6BLC8  !@#%%%%
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M24GH;THN*LQ]%,VR?\]!_P!\T;9/^>@_[YK.QH/HIFV3_GH/^^:-LG_/0?\
M?-%@'U!??\@^Y_ZY-_(U)MD_YZ#_ +YIDL+S0O$TGRNI4X7UHL!\0CI2U]&?
M\* \,_\ 00U3_OXG_P 31_PH'PS_ -!#5/\ OXG_ ,375[6/<Y/8S/G.BOHS
M_A0/AG_H(:I_W\3_ .)H_P"% ^&?^@AJG_?Q/_B:/:Q[A[&9YE\%_P#DJ&G_
M /7*?_T6:^I*\_\ #/PCT7PIKT.KV-Y?/<1*RJLS*5PPP> !ZUWNV3_GH/\
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M1@@]ZK)IEA'"84L;98B0Q18E"DCH<8IH31G:=XD@U1I4AB:-HH?-D,I 6,$
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1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>img254193463_20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_20.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )E!94# 2(  A$! Q$!_\0
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MLMI(;E;@K"98!"[)CG*@#@'H<<^]=K4M6=BT[JX4444AA1110 4444 %%%%
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MXR;=FCHF940LS!549))P *\$T_XM:_-X[@N9[G_BEKC4'M40PH %X );;NR
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MWSC<1U8_[(R/S KD;>/XSZI:KJ27^F:>K@.MC)$@;'IRC$?0L#]*S/B/^_\
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MX(\0R^*O"%CK4\"027/F9C0D@;9&3O\ [M>5RK)XQ^ BZEJEY=-=:5YNQUD
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MV@$,""1W]*47>S94ERW2,"^T;3=%\6Z%HW@GQCJ,T&IS+'=FSO 3$"RC=F/
M/!8X/3;6Q\2->9_&%AX/O]>N=/T.T@C^V76&>29MF<MM!+$C Z8R235*TNM>
M^&$T>KZA\/\ 2;2W=_*,\,[/(,YR YEDVY /:NK\9Z%KMOXMTSX@>%;0WKF!
M?/M"/G*E<9QWRIQQR" >>SOJB;:.QQFE:MH?A'QMH@\%>(KW4=/O)U@O;2X1
MUP&8*#RB@_>)&!D$>]?1M>;Z'XR\<Z_K=I$/!ATO3U<?:Y;YG4[>^S*KS[8/
MX=:](K.HS:FM-#QKX/?\CWXV_P"O@_\ HV2N3^%_@9/'.C7L.HZO?0Z=:3YC
MM;=@ 9&7ESD$= .WXBNY^%>D:GIWC3Q?/?:==VT,\^89)X&19!YCG*DC!X(Z
M>M+\"](U/2-%U:/4M.N[)WN$*+<P-&6&WJ P&:MRM=KR,XQORI^96^#=W?6&
MO>)?"MQ=O<VVFS%86<_=*NR''H#@''M[U[!7E'PZTC4['XG>,[N[TZ[M[:XN
M)3#-+ R)*#,Q!5B,'CGBO5ZSJ?$:4_A/%?B;_P EH\%?]=;;_P!**]3\4:PV
M@>%]2U5$#O:V[2(IZ%L<9]LXKSGXAZ-JE[\6_"-[::;>7%I!);F:>*!G2/$^
M3N8# P.>>U>F:]I$6O:!?:5,Y1+N%HBXZJ2.#^!P:;M:(HWO(\:\)?#E_B'H
M(\3^(M=U%[RZ=S;F-UP@5BN3D'^)3P,8 %7? 3WGB2T\2_#W7]2NI5L9=B74
M4N)0J2X8!B#QE1USP2/2H?#VK>//AYIC>')/!UQJL<3N;6XMRS(H8YY*J01D
MDX.T\G-=-\+/"&K:/+JVOZ^@BU/5I2[0 _<!8L2<=R3T[ 5<GH[_ "(BE=6^
M9YU\(_ &E>+(+K4K^XO8YK&YC\I8'4*>-W.5)ZCL17?^,/ %IK6O7.H^*/&$
MUOI3 ?9K4RI"L6!SRWR]>>F?4US/@%?%O@+6+S0O^$2O+RWN;M";M<A%0'!8
M-C:?EYZBGQZ1=V/Q!UV[\6>$-5\1&>3.GS0P>?"J98@')"@8*CGI@\<TY-\U
M[BBDHI6+_P '-4GMO$>O^%TU+^T=-M"9+2;?N7:'VY4@D8((.!QQQ[G[/?\
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MR0L(VR1LVL1@DD(<#T-=+\1=(U.^^)W@R[M-.N[BVM[B(S310,Z1 3*268#
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA,XKUJT:<DK-^?\ F>OB,MI4J4IQ;NO3_(](HHHKZ0\,**** "BBB@ HHHH
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MHHHJ2BO9?ZAO^NLG_H;58JO9?ZAO^NLG_H;58H **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M10 4444 %%%% !1110!YS\4/%&NZ1I=_96/AV[FLY;0YU2"<KY!.025"DC&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"9VC)W-WXKM**:;0.*84444AE>R_U#?]=9/_ $-JL57LO]0W_763_P!#:K%
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M* *]E_J&_P"NLG_H;58JO9?ZAO\ KK)_Z&U6* "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCOL%CAFT9(KBTF0#*NC+SG_:Y!]<U7*3S'?44R&3S8(Y-I7>H;![9%)+.D1
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M[1_^PE#_ %K=K"\2_>T?_L)0_P!:YL7_  7\OS-\-_%7]=#=HHHKI, HHHH
MYZ?Q=IB^-(?"1266\FMVF8JFY$&,[6],@']/6N/U?X(>$YKB:_1M2MHP&D>V
MM74J>IP@*DCZ9]ABL^WU"V\,_M ZL^L2+#'J=JBVMQ*<+R$P,GH,HR_4"O5-
M2U?3]'TZ2_U"[BM[5%W&1VX(]O4^PZUIK&UC-6E?F.;^&=]X?O?!\7_".VKV
MEM%(T<L$AS(LG&2Y[DC!S^'&,5V->4_!%9+BU\1ZLL316E[J!:!2,#C)./\
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MS+=HA!"E"H"9VC)W-WXKM**?,Q<J"BBBI**]E_J&_P"NLG_H;58JO9?ZAO\
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MM'^('BCX<:C'H?C.TGN;+I%.3N=4'&4;I(OL>1[=*KE4M8D\[CI/[SI/&O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^Q:;_P!+&KU6L,+_ +O3_P *_(TK_P :I_B?YA1116YF%%%% !1110 4444
M%<UXTMOMEA86OGS6_G7J1^= ^R2/(8;E/9AU!]:Z6L'Q/TTC_L(Q?UKFQ?\
M!?R_,WP_\1?UT)?",\MSX+T*>>5Y9I=.MWDDD8LSL8U)))Y))[ULUA^"_P#D
M1/#W_8,MO_12UN5U/<YUL%%%%(9@^*O%^D>#]--YJ<^&(/E0)S)*?11_7H*\
MVL=!\1?%F^BU;Q*9--\.(VZVT^,D-*.Q_P#LC^ %;'BOX.KXJ\1W.L3^(;B)
MI2NR+R=XB  & 2W3O^-4[CX3WEG;M/<_$35((4&6DD<JJCW)DP*UCRI:/4QE
MS-ZK0]2L+"TTNQBLK&WCM[:)=J11K@**LUY_\,8K"W_M>"Q\57/B#8\8DEE#
M;8SAN%))SGVXXKT"LY*S-8NZ.#^)/A;^WH;&\F\5#0;6P8R>8R<>9_"P;>NU
MAR!]:X+^RXO^BYS_ /?Y_P#X_77_ !(LK._\7^#[;6U=]#GGFBD16*J9RH\L
M,1SR>/SK@/$^A^%/#6K^+K"\M8[:X6&WNM%)#,#Q\R@$D$;A@YSQGIBMH;6,
M)[MGOVE*%T>R479O +>,?:2?]=\H^?J>O7J>M6ZI:/+]HT2PF\A;?S+:-_)0
M86/*@[0.P'2KM8,W05G6,VLR7+KJ%A806X4[7M[UYF)R, J8D &,\Y/T[UHU
M#=VL5[9SVEPI:&>-HY%#%2588/(P1P>HYH&<%>W3?$;7%TNP_P"1;TVY5[^Z
M[7<J'(A3U4$ L?\ ZV='PEF#QCXRMIO^/@WD4XS_ !1-$ I'L-I'X5?L_ ^B
M:?;);67]IVUO']R*'5KI$7Z*),5?U+P[IFJW*7-U XN%3RQ-!/)#(4_NED8$
MK[$XJVUL0HO=[F#X('G:UXNO(O\ CUEU4I&1T9D15<C_ (%Q^%=BY8(=@!;L
M"<#\Z@L;"UTRSCL[*WC@MXQA(T& *L5+=V4E9%-3,=1B\U(U_=/C8Y;/*>PJ
MY5=_^0C#_P!<I/YI5BD,**** "BBB@ HHHH **** "BBB@ HHHH *JZAI]MJ
M=HUM=1AXV_-3Z@]C5JBIE%23C)73'&3B[K<\\234?!&H^7)NN--E;CT/N/1O
M;O7=V5[;ZA:I<VT@DB<<$=O8^AI;RSM[^U>VN8Q)$XY!_F/0UPDD6H^"-1\V
M+=<:;*V#GH?8^C>_>O*]_ 2[TG]\?^!_7KZ'NXQ=JG_I7_!_KT]"HJKIVHVV
MJ6BW-K)O0]1W4^A'8U:KU8R4DI1=TSSY1<79[A7(_$[2FU?X>:O!%;B:XCB$
MT0V!F!5@QV^^ 1QZUUU%6G9W):NK'PY75?#KQ%:^%O&MGJE\THM$61)?*7<2
M&4@<9Z9P?PKT#QQX&T(^+8C!;M;+=:U96<D<!"J$F1BY Q@'*CIQUXKT^T^&
M_A&TT?\ LL:);2P$Y9YEW2,?7?U!^A%:QQ$*D+KS7W.S.=X><)V?D_O5S2T/
MQ5H7B2$2:1J=O<G&3&K8D7ZH<,/Q%;%>/:Y\![0R_:_#.JS6%PIW)'.2R@^S
MCYE_\>K&_P"$D^*/P]^76;-M5TY.LT@\T8]?-7D?\#_*IY$_A9ISN/Q(]ZHK
MS;P]\:_"^L;8KYI-*N#VN/FC)]G']0*]$M[F"[@2>VFCFA<962-@RL/8BH<6
MMRU)2V):***104444 %%%% !1110 4444 %%%% !1110 4444 <-\2NOA#_L
M9;/_ -GKN:X;XE=?"'_8RV?_ +/7<U3V1*^)A1114E!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !5+5]6LM"TFXU/4)O)M+==TCXSWP !W)) _&K4TBPPR2L"512QQUP!7AGC
M?XN>&/%7A.[TJ&SU5)Y-CQ&6&/9N5@P#8DS@XP?K51BY,B<U%&V_[0/AX.P3
M2M390>"1&,_ANKN_!WBVU\9Z(VJ6=O-!$)FAV38W9 !SP3ZUPEK\??#"6D*R
M:7JD3J@#1Q11%%..BG>./3@5WWA+Q78>,M&.J:=%<Q0"5HMMPJJV0 3]TD8Y
M]:J4;+:Q,)7>]S4O]0L]+LWN[^ZAM;=/O2S.%4?B:X.\^-?A&WG:*V:_OV&?
M^/6VR#]-Q6M7XC1^&XO#T>I^)].FOK2RG5UCA^]N8[>FY01SR":Y&R^-W@?3
M8!!8Z)J5K$  $AM84''L)*(QNKVN.4K.U[&U9?&KPA=3K#<R7VGL?^?NWP!]
M=I;%=Y8W]IJ5HEW8W,-S;N,K)$X93^(KRNY^-/@C656SOM$U&ZCD;:$N+6%U
MYX[R&O1= \,:/X8@N(='LUMHYY/-D4,6RV,=R>/:E))=+!"3?6YKU6OM0LM,
MMC<ZA>6]I "%,MQ*L:Y/09) JS7.^*]-U347T=M-BMY1:7ZW4J3S&(,%1@HR
M%;^(@].U2MRWL:FG:UI6L>9_9FIV=[Y6/,^S3K)LSG&=I.,X/Y40:UI5S?/8
MV^IV<MXF=]O'.K2+]5!R*XSQ/XRNX?"OB>UEM#I^LV%HK;8Y?-5DD^42(^ 3
M@YZ@$$4_QII%KHGPQWV"QPS:,D5Q:3(!E71EYS_M<@^N:KE)YCOJ*9#)YL$<
MFTKO4-@]LBDEG2(@,LAS_<C9OY"H+([+_4-_UUD_]#:K%5K%@UL6&<&60\C!
M^^W:K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'<2F"!Y1%)
M*5&=D8RQ^E244GMH-;F%>N^KW.GQV]K<(L-PMQ))-$T80+GY>1R3G'%-L'ET
M1;NTDM+F5/.>6W:*,N'5N=I(Z$'/7%;]%<_U=\WM+^\;>V]WDMH9F@V,MAI2
M1SC$\C-+( <X9CG'\JN7-[:6>W[5=0P;\[?-D"YQUQGZU/7#?$7_ )AO_;7_
M -DK/$U/J>&<H*_+;\TBZ$/K-?ED[7O_ )F!X_GAO/&OA>XM94GAAU"T>62)
M@RQJ'<DL1P ,C)->HVU[:7F[[+=0S[,;O*D#8STSCZ5XG72>%/$%IH7VO[5'
M,_G;-OE*#C&[.<D>M>1@\XO4Y*B23;=ST<3EEH<T&VTDK'I]%<I_PL#2O^?>
M]_[X7_XJC_A8&E?\^][_ -\+_P#%5Z_]HX7^='G?4L1_(SJZ*Y3_ (6!I7_/
MO>_]\+_\51_PL#2O^?>]_P"^%_\ BJ/[1PO\Z#ZEB/Y&=717*?\ "P-*_P"?
M>]_[X7_XJC_A8&E?\^][_P!\+_\ %4?VCA?YT'U+$?R,ZNBN4_X6!I7_ #[W
MO_?"_P#Q5'_"P-*_Y][W_OA?_BJ/[1PO\Z#ZEB/Y&=75*35],C=XY-1M%=25
M96G4$$=B,U@_\+ TK_GWO?\ OA?_ (JN U&X2[U.[N8PP2:9Y%#=0"21FN/&
M9O3I13HM2.G#9;.HW[5.)I>$YX;;XA6US/*D5N/#[0F5V"J)/M3-MR>-V.<=
M<<UZLCI+&LD;*Z, RLIR"#T(->'5[+HG_(!T[_KUB_\ 011E..E77LFK<J7^
M09AA(T7[1._,V7J***]D\P**** "BBB@ HHHH *P?$_32/\ L(Q?UK>K!\3]
M-(_[",7]:YL7_!?R_,WPW\5?UT'>"_\ D1/#W_8,MO\ T4M;E8?@O_D1/#W_
M &#+;_T4M;E=3W.>.P4444AGD7C#XIZO:^++CPOHEM86T\3!&O;^<*F2 <@'
M '7OGZ5A:]X(U:;4?#=QXL\1/JYU+4H[=X(6(B1""3L/ _)17KVO^#O#_B:,
MC5M,@GD(P)@-LB_1Q@UYOJ/P<U729[>[\)Z])MM)Q<P65\<HL@/!!'&>3U7\
M:VC*/30PG&774]/T+PWH_AFT:UT>PBM8V(+[<EG(Z%F.2?Q-:M<GX'U?Q1J$
M5[;^*M)2QN[5D"21CY)@<\CD@XQV/?M765D[WU-HVMH<EXV\2SZ,VFZ?IFEK
MJ>MW\K?8X'QM3:/FD8]@ ?;OR,5R4FN3ZYX OO$VN^&M)O\ 5M&O)(?*V'8B
MHR[R,ELXR3C..,UTOCO1-;FO-*\1>&TBEU72C(!;2G"SQN &7J.>/4=?I7G>
MDZ;\0M5TG4?#2Z&NF66I7LL]W>7&045R"RKD\],< Y]NM:12L92;O8]RL[J.
M^L;>[BSY4\:RIGT89'\ZGJ"RM(["PM[.+/E01+$F>N%  _E4]9&P4444 %%%
M% !1110!7?\ Y",/_7*3^:58JN__ "$8?^N4G\TJQ0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %1SP174#P3QK)$XPRL."*DHI-)JS!.VJ//;VQO\
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MWBG0S?MIDVF[96B$$IYP .>@XY_2G*-EL3"5WN/\::S:^'_"6H:I=VT5RD"
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M7LO]0W_763_T-JL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME(QO8  M^)YJ>BBL3H"BBB@ HHHH **** *[_P#(1A_ZY2?S2K%5W_Y",/\
MURD_FE6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1E5U*L
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MZ8&9@?4%X3@^XYKI?[!^,W_0VZ-_WZ7_ .,5VT/B[3I]1T2RC2=GUBV:ZMG
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M K&\4Z9J>L:#+8Z1J;:;=R,N+I<Y1006QCG./I6S6-XJ\0P^%?#EUK$T+3"
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ML%CAFT9(KBTF0#*NC+SG_:Y!]<U7*B>9V.^HID,GFP1R;2N]0V#VR*26=(B
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MO!=W<T[W,\RC +N><?D*J6VY$%KL4OBI<7=M\.-6>S9T8JB2O']Y8F=0^/\
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M)^M:>[#S9G[T_)' ^"O@UI^CNFI>(774]3)W^6W,4;=<\_?/N>/;O7J0
MP!VHHK.4G+5EQBHJR/*_B/\ \C[X1_["=G_Z,>O5*\K^(_\ R/OA'_L)V?\
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MXZ5[S5/4]*L-9L7LM2M(KJV?[T<JY&?4>A]QS34^DM273UO'1E;0/$FD>)K
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M/YI5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MPM*_Y&K7_P#MW_\ 0#6[6%I7_(U:_P#]N_\ Z :W:YL+_#?^*7_I3-\1\:](
M_P#I*"BBBNDP"BBB@ HHHH Y_7_"EKK ::+;!>=?, X?_>']:P].\1ZAX?N1
MIVN12-$.$DZLH]0?XA^O\J[RJFHZ9::K;&"[B#KV/=3Z@]J\^O@GS^VP[Y9_
M@_4[*6*7+[.LN:/XKT)[>XANH%F@D62)QE64Y!J2O/9K/5_!ER;BT<W%@Q^8
M$<?\"'8^X_\ K5UVC:]9ZW#N@;;*H^>%OO+_ (CWJL/C54E[*JN6?;OZ=Q5L
M*X1]I3?-'O\ YFI1117<<@4444 %%%% !1110 4444 <-\2NOA#_ +&6S_\
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M?TKV'P9XC;Q1H7VXZ7+INR4PBWEZ@ #GH..?3M5S6AG3=WN=#11161L%%%%
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M4ZZ&%YU[2H^6/?\ R'WVLZEXKNFT[28VCM?XW)P2/5CV'MWKIM"\-VFB1!E
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M<?X*^%^B>#T2XV"]U3'S7<RCY3_L+_#]>OO7<445#;>K-$DE9!1112&%%%%
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M]#:K%5[+_4-_UUD_]#:K% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)N\RZ\A8?,RQ(^1>!@$#\,UAA]I?XF:UK\R]$7J***W,@HHHH ***0D*"20
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M#T9&!!_$4^O93OJCR]@JEJ>CZ;K5L;;4[&WNX?[LT8;'N,]#[BKM% 'DVO\
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MM**.87*@HHHI%%>R_P!0W_763_T-JL57LO\ 4-_UUD_]#:K% !1110 4444
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M10!7LO\ 4-_UUD_]#:K%5[+_ %#?]=9/_0VJQ0 4444 %%%% !1110 4444
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M'?\ ON>68_5B3^-:E2REMJ%%%% PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ K)\1>)-)\+Z<M[K-W]FMY)!"K^6[Y<@D#"@GHI_*M:BA _(P_!?_ "(G
MA[_L&6W_ **6MRBBAB2L@HHHH&4]6U*#1](O-2N<^3:PM,X7J0HS@>]>277Q
M&^)&-/N8/#&FPVFJRK%8"=B7D+#*@_O%QD=R *]:U?38M9T:]TR<D17<#PL1
MU 8$9'N,UY]?:)->^"],\,+XBTN;Q9H\D=Q:JLR[M\1.T%<[N$XR1U&35PMU
M,YWZ&[X \0>(=?MM2/B&VL+6XM+G[/Y%L&#(P'S;\LWJI!!P178UQ'P[T?6+
M(ZUJFO7%J^HZC=!I8K5PRQ;%QM..AYZ<]!7;TI6OH5"]M0HHHJ2@HHHH ***
M* "BBB@ HHHH KO_ ,A&'_KE)_-*L57?_D(P_P#7*3^:58H **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#'-IK4$DTZZHMT KF.V:W5 3@[1NSG@XKDKV#5+'1]
MEWI9666Z266Y:Y1C(^>!@=!7HM1S00W"!)XHY5!#!74,,COS7!7P*J1]V33U
MZWW];O[CKHXMP>L4_P -O2QS.MP-;I'KQN7TV^\ORWB4++O/9?0GW_PJ;1HX
M_#VD/?:M.4GNY \K."2">B\=^M;TUK;W#H\T$4C1G*,Z E3[9Z4Z:"&YC\N>
M*.5,YVNH89^AJEA'&HZL7KTWWZMK:[\K"^L7@J;VZ^G1+_@G&W<&FWGBN_\
M[<F"1+$AM@TA1&7')!SZ]O7-:7@UI#I]THD>2S2X9;9WZE/\/_KUNW%E:W>W
M[3;0S;>GF1AL?G4J(L:!$4*JC 51@"II8-PK>TNNOJ[]_3H54Q*G2Y+=O16[
M>HZBBBN\XS"_YGP_]@S_ -JUNUA?\SX?^P9_[5K=KFPWV_\ $S>O]GT04445
MTF 4444 %%%% !1110 5Y5\34NO^$N\/W5KI][?_ &*YMKJ6&SA,LGEH[DD
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M^'_L&?\ M6MVL+_F?#_V#/\ VK6[7-AOM_XF;U_L^B"BBBNDP"BBB@ HHHH
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M*S1>;&&\N02\.N>C#/!'-=)6.'VE_B9K66L?1!111708A1110 4444 %%%%
M!1110 5P^K_"O0=7U2YOS<ZE9F[;?=0VESLBG8]2RD'KWQBNXHIIM;":3W*V
MGV%MI>GP6-E$(K:!!'&@_A I+'3;+3%F2RMH[=)I3-(L8P"YQDX]\"K5%(=@
MHHHH **** "JFH1ZA) HTVZMK>;=EGN;=IE*X/&U70@YQSG\/2W10!ROAWPA
M/I'A8^&]1OK74-,$#0!5M&B<AB2=S&1@>IZ 4S_A#KNXLK/2M2UDW>CVCHRP
M?9@LLH0@HLLFXA@"!T5<XYKK:*?,R>5!1112**]E_J&_ZZR?^AM5BJ]E_J&_
MZZR?^AM5B@ HHHH **** "BBL;5O$VG:0"DDOFSC_EC'R?Q[#\:SJ584H\TW
M9%PIRJ/E@KLV:P=7\6Z;I6Z,/]HN!_RSB/0^YZ"N,UGQ5>WML9KR\@TG33QN
MDDVAO8?Q.?91^%<-+\0+*"Y6S\+:-+J^H,<)<7,1*Y_V(5Y/U8_A7"L1B,5I
MA8VC_,_T74ZI4J&'UQ$KO^5?J>BW%QK?B*![BZGCT[2E&6DE?RXPOJ2>6_E]
M*Y6_^(O@_P *DQZ/;OKNHKP)V^6%3[$]?P!^M5[;X:>-_'-PE[XQU:2TM\[E
M@8AF _V8UPJ?S]J],\,_#KPUX5"26-@LMTO_ "]7/[R3/J#T7_@(%=%'+Z-*
M7M*KYY]W^G8PJXVM47)37)$\N_L_XG?$T[KR1M(TB3^!@84*_P"Y]]_^!<>]
M=OX9^#/AG02DUY&VJW:\[[E1Y8/M'T_/->BT5VNH]EH<JII:O4:B)%&J1JJ(
MHPJJ, #T%.HHJ#0**** "BBB@ HHHH #T->5>#?^2EVG_8M-_P"EC5ZJ>AKR
MKP;_ ,E+M/\ L6F_]+&K!_[S'_#+\XFO_+A_XH_E(]5HHHK<R"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .*\
M7?#'0_%<S7N'L-5X*WMOP21T++T;&!SP?>N/?7/$WPV=(?%FG6VLZ,6V1ZC
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M^_@H L457^WV?_/W!_W\%'V^S_Y^X/\ OX* +%%5_M]G_P _<'_?P4?;[/\
MY^X/^_@H L457^WV?_/W!_W\%'V^S_Y^X/\ OX* +%%5_M]G_P _<'_?P4?;
M[/\ Y^X/^_@H L457^WV?_/W!_W\%'V^S_Y^X/\ OX* +%%5_M]G_P _<'_?
MP4?;[/\ Y^X/^_@H L457^WV?_/W!_W\%'V^S_Y^X/\ OX* +%%5_M]G_P _
M<'_?P4?;[/\ Y^X/^_@H L457^WV?_/W!_W\%'V^S_Y^X/\ OX* +%%5_M]G
M_P _<'_?P4?;[/\ Y^X/^_@H L457^WV?_/W!_W\%'V^S_Y^X/\ OX* +%%5
M_M]G_P _<'_?P4?;[/\ Y^X/^_@H L457^WV?_/W!_W\%'V^S_Y^X/\ OX*
M+%%5_M]G_P _<'_?P4?;[/\ Y^X/^_@H L457^WV?_/W!_W\%'V^S_Y^X/\
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MUA_45+10 4444 %%%% !1110 4444 %%%% $4T;/+;L.B2%C]-K#^HJ6BB@
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MQ?W)_P#OP_\ A0!8HJO]MB_N3_\ ?A_\*/ML7]R?_OP_^% %BBJ_VV+^Y/\
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M[D__ 'X?_"@"Q15?[;%_<G_[\/\ X4?;8O[D_P#WX?\ PH L457^VQ?W)_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M45R.I_$_P=H^I3Z??ZQY-U;MLEC^S3-M/ID(0?PII-[";2W.NHKGM#\=>&/$
MD_D:3K$$\_)$3!HW/T5P"?PKH:&FMP33V"BBBD,**** "BBB@ HHHH ****
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M*IPP#%5(89'!7H:KZ9H6KZ!H;1Z=/8W&I7-Y)>7K7*LD<CR$EPFW)3G !(/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<I/X,-[\0;?Q
M3>ZAYT=I"8K6R\G B)'+%MQR>6[#MZ5U=%-.PFD]PHHHI#"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&CS,5C5F +D G '<X!/X4 24444 %%%% !1110 4444 %%%% !1110 4444
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MTVVT?2K73;--EM;1+%&#UP!CGU/K5NBG?2PK:W"BBBD,**** "BBB@ HHHH
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M*6Y=0YR8Y#*0P"G."-W':M>QT2\@\>66I#3H+2PCT(VA2!U,<4IE5O+4<$@
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MO/) DL;2Q@%XPP+(#G&1VS@X^E $E%%% !1110 4444 %%%% !1110 4444
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M[7=,TV<PWEVL,@C$NU@>5)QQQSR#QUIUAK6G:I!)/9W221Q?ZPG*[?J#C H
MOT5D6OBC1;R\6TM[]'F8X5=K $^Q(P:S9_&-A:^))K6>["6D4)5CY3$^<&P1
MP,]/PH ZFBLNU:U&N7R)?W,EPJJTEO(Q,<0(X*C&!GZU$OBS0FNQ;#48_-+;
M>C;<_P"]C'ZT ;-%9=[XBTG3IY(;N\6*2,*64JQ//3&!S^%-;Q)I9TB74HKI
M7@0[<A6^]V!&,B@#6HK \,>(H-9LXHGN!)J"Q[YD$94#G'ICN.E;] !1110
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M>_X'32^K<O[WFOY6_4YJZ\?7Z7<RVT5H\ D81LR/EESP3\P[5H:+XYCG\_\
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M;AH8S,@VK(5&X#T!ZTS[#:?:OM7V6#[3_P ]O+&_\^M &/XW_P"10OO^V?\
MZ,6H=2?3K37I;Q-4M[6_$ 62.Y7*.O;'0Y^A_"NBG@AN86AN(HY8F^\DBAE/
M?D&H[FPL[QE:ZM()ROW3+&&Q],B@"IX?OAJ6BV]TML+</G]VH^7@D9'L>M8>
MGW=GIOBO6?[4ECAN)'5H99B!F/'0,?PX_P *ZY55%"JH55&  , "H+FPL[PJ
M;JT@G*_=\V,-C\Z .0UJXL)+_1;V*;RM)#2IYT42[4D/?#*1U[X]35U$TJXU
M2:XAUB2]ODM7!V^65*8[E$ /;J:Z5K>![?[.\,;0XQY94%<>F.E,@L+.U1DM
M[2"%7X98XPH/UQ0!RFE6L'_"LYF\E-SVLSL=O)8;L$^XP*>@TY;70+F;48K*
M_CLD,33 %&78,YS@?J#75):V\=K]E2WB6W*E?*" )@]1CICFFRZ?93P)!-:6
M\D,8 2-XP54#T!'% '$W^I)J6EVUU+;Q_8;;4P+EX5/ERJ/X\=<<]ZNZ[>Z=
MJ-UHT6ES037JW4;(T.#Y<8SG..@]JZU;>!+?R$AC6'&/+"@+CTQTJ*WTZRLW
M+VUG;P,>K11*I/Y"@#!T"&-O%7B"8HIE65%5B.0"#G^0K.M)+>U\1ZRE_J;Z
M?.\V]&818DC(XY=#V[9KM([>"&222.&-))2#(RJ 7(]3WJ.YL+.\*FZM()RO
M3S8PV/SH X>^CTRWLM.FM[F2YTHZF9+EW4;0Q '0*!MX/08Y-7]3O=/O?%&@
M_8989FCD8.T6" "ORC(X['BNL-K;FV^S&"(P8QY10;<?3I4<>G6,(C$5G;H(
MV+(%B4;">I''!H =>?\ 'C<?]<V_E7')'-+\*-D"LS^63A>N!+EOTS7;LH92
MK $$8(/>F0P16T*PP1)%$OW410H'T H X[7M3T*Z\)_9K%X'D<*MM @S(K9'
M;J#5R&WW^.;3[6H>:'25;+<X?S,$_J:WX],T^&?SXK&V2;.?,6%0WYXJ;R(?
MM'VCRH_/V;/,VC=MSG&>N,\XH DKC_#^H65EK/B!;N\MX"UX2HEE5<\GIDUV
M%49-&TN:5I)=-LWD<Y9F@4DGU)Q0!SU]>P^(O$.EVVFMYT5G-]HGG4?(N.@S
MWSBF7%^=0T?5YX8].L[/,D;B6/=)*X!Y." &)Z9R?K76P6\%K'Y=O#'#'UVQ
MJ%'Y"HCIE@;@W!L;8S-UD\I=Q_'&: .2DCEC\(Z+K,.6GT]%<\_>B/#+^6/P
MS6MX;7[=<7VNN#_I<FR#(Y$2\#\SS^%7M6T^:?1)-/TWR;?S%$?/RJB'K@ >
MG'XU>MK>.TM8K:$8CB0(H]@,4 4]7U>/1XH)IXG:W>41R2KTBSW(ZXKF9VTN
M'Q-87&@7/F7EW<YNDA?S%:-N7)ZX/?VKM9(TEC9)$5T88*L,@U!;:?96;,UK
M9V\!;@F*(+G\A0!C7DWA26_NS?&R-TOR3>>N&X&.,]>/2F>"T*Z?>-"'6P>Z
M<VBOG/E^V>W_ ->MRXTZQNY!)<V5O,XZ-)$K$?B15A55%"J J@8  P * ,35
M+UO[<L["WMK5KMHVE2>Y'"#.,+CDD^Q%<XS!HO&.)H)1Y4.7MTVH3M.<#)[]
M>>N:[BYLK2]"BZM89PO*B6,-CZ9I!86821!:0;)%"NOEC# = ?4"@#E=;M8(
MOAJGEPHNV&!QA<88E,GZG)J4W%G9>/KN34I(XM]LGV:28@* .N">!SG]:Z>2
MUMY;;[-);Q/;X \ID!7 Z#'3C I+FQM+S;]JM8)]OW?-C#8^F: .>\-S6USX
MCU^:SV_9W-N4*K@'Y6!(_'-'CLA=&M68@ 7D9)/;AJZ2.W@AD>2*&-'< ,RJ
M 6 X /KCM3;FUM[R+R[JWBGC!SME0,,^N#0!G7?BC1K.!I3J%O*0.$AD#LQ]
M,"N>T]I-+T.UCNK*%[G4[UI8TN1\D).,%N.N!P!ZUU<.D:9;R"2'3K2.1>0R
M0*"/Q JQ<6T%W%Y5S!'-'G.R1 P_(T <K;M-_P + B$T]K),;)A+]F0J!\W1
MLL<GIUQVXJA.EQ9SW?A2$,$O+A7MVP?DA;)?\MN/Q-=M#86=NR-#:01E 0I2
M,#:#U QTJE#IDS>(Y]3N6C*+$(;9%))5>K$\=2?TH T8XE@MTAA 58T"(.P
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M)= LK2.XC>XCB+/&K991N/7TKHJKV]C:6C,UM:P0L_WC'&%+?7%6* "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4F:,T +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HS0
MM%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T
M +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC
M- "T4F:* $HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>img254193463_21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_21.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #[ G # 2(  A$! Q$!_\0
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MHH S=9UB+1K>*65"WF/L7+JB@X+<LQ ' /U.!5.W\4V]S=0JEK<"VE=(1<.
M LK('"%<YZ$<XQDXJ[JVD)JJP%IFBD@<NC!589*E3E6!!X)JC:>%+6RG@,5S
M<FVA=91;NP*M*J; Y.,YP!QG&1FFK=27?H;Q8#&2!GIDTM0W2@V[$@$CIQTJ
M:D4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !16;KMU/8Z5+=P3Q0^2-S>9$9-_HH 8<DX K'M=>
MU474 O([3RQ=1V,Z1AMWFF,.64YQM!.,8Z<YII7$W8Z6Y_X]WJ6H+MPL# YR
M>G%3TAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD.Q%<_\ 'N]2U%<_\>[U+0 4444 %%%% !1110 4444 %%%% !1110 4444
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MY^1KBL'[&:7,M5Z>1LT5C;?$G_/72_\ OB3_ !HV^)/^>NE_]\2?XUV>W?\
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M&WB2*->BHN!6=ZM3;W5^/W;+YW]#2U.&_O/\/^#_ %J9']E7^I_-J]WLA/\
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MO4JW4IWZ'07/_'N]2U!=HK0$D<CIS4]24%%%% !1110 4444 %%%% !1110
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M!(!/3)ZU-2&%%%% !1110 4444 %%%% !1110 4444 %%%-=TC0N[*JCJS'
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MB?\ @P?_ .(KLJ*+^06\SC?[2^(7_0O:)_X,'_\ B*/[2^(7_0O:)_X,'_\
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M_JH/^OB/_P!"%4_"O_(M6?T;_P!"-1'XI?+]2GLOG^AL44459(4444 %%%%
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M$;M5>&:%TW*R31LC [B>A'O6U1222NP;;"BBBF 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<E)J]V/$I
MB%Z0XOUMA887!@,>XR8QNSG)W9QQBFE=V$W97.HN?^/=ZEK@_'=_=VNI6L=O
M=31(T)+*CE03NJ'P^OB#6K"41:P\-N)<.Y^>7.!P"3P*\W^T$\0\/&+;7H=W
MU)J@JSE9,[>]U.QTV,O>744*@9^9N?RZUQEY\3K:>9K7P]IUWJUP./\ 1XBZ
MCZD<#\2*T8/ FD++YU]:S:G-G.Z]FWC/^Y]W]*Z2",6L*PV]FD42_=2/:H'X
M"NKEJR^)V]/\W_E\SGYH1^%7]?\ )?YGGK:=\0_$AS=O9Z/:M_!*_FOC_<3"
M_FQK1M/A?II0#6=1O]5]8GD\F#_OW'@?F37:^9+_ ,\/_'A1YDO_ #P_\>%:
M0I0@[Q6O?=_>]2)3E-6D].W3[MBOINCZ;H\ @TVPMK2+^[!$$S]<=:NU%YDO
M_/#_ ,>%'F2_\\/_ !X59)+147F2_P#/#_QX4>9+_P \/_'A0!+147F2_P#/
M#_QX4>9+_P \/_'A0!+14'G2%ROD'( /WA3O,E_YX?\ CPH EHJ+S)?^>'_C
MPH\R7_GA_P"/"@"6BHO,E_YX?^/"CS)?^>'_ (\* ):*B\R7_GA_X\*/,E_Y
MX?\ CPH EHJ+S)?^>'_CPH\R7_GA_P"/"@"6BHO,E_YX?^/"D,LJJ28#@#/W
MA0!-14*RRLH(@.",_>%+YDO_ #P_\>% $M%1>9+_ ,\/_'A1YDO_ #P_\>%
M$M%1>9+_ ,\/_'A1YDO_ #P_\>% $M%1>9+_ ,\/_'A1YDO_ #P_\>% $M%1
M>9+_ ,\/_'A1YDO_ #P_\>% $M%1>9+_ ,\/_'A3?.D#A?(.2"?O#_/>@">B
MHO,E_P">'_CPH\R7_GA_X\* ):*B\R7_ )X?^/"CS)?^>'_CPH EHJ+S)?\
MGA_X\*/,E_YX?^/"@"6BHO,E_P">'_CPH\R7_GA_X\* ):*B\R7_ )X?^/"C
MS)?^>'_CPH EHJ+S)?\ GA_X\*:D\CH&$!P?]H4 3T5%YDO_ #P_\>%'F2_\
M\/\ QX4 2T5%YDO_ #P_\>%'F2_\\/\ QX4 2T5%YDO_ #P_\>%'F2_\\/\
MQX4 2T5%YDO_ #P_\>%'F2_\\/\ QX4 2T5%YDO_ #P_\>%'F2_\\/\ QX4
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M&HRW,%W<O&\(C\J5]V#O9BV>I)+=_>MJAVZ K]0HHHI#"BBB@ HHHH ****
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MXL[&%(XXI83NW 8+Y#8W8X&1P,^N:Z*F[=!*_4****0PHHHH **** "BBB@
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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LH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>img254193463_22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_22.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &_ ]4# 2(  A$! Q$!_\0
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MVQUFVLI)=0U!S;VNG!OG><,5*Y_N@@DMZ?6NOM#<M9PF\6-+DH#*L1)4-CD
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MO7S ,[<\X^E#2QJ6#2*"HRV3T'J:0Q]%(K*ZAD8,IY!!R#2T %%%% !1110
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MG02W&3_8VD3C[/T/4$DL1UX Z>E>BWUA::G9R6=];17-M)C?%*H96P<C(/N
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M&JZ==>;]GO[6;R?]9Y<RML^N#Q61X8\8:?XG%Y]G:.-[>[DMUC,RLTJIC]X
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MJ&F7A_X257MDM)6>"VRI/E9Z@ ]NO-"@KH)3=F>ZO>6L=U':O<PK<2 LD+.
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M\*W=S<1ZN8Y7[FR7][N_'K^57]1L;J_^+&KV,L&A2);6D26-OK ?REAVC/E
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M3L /S-5_[5T[_G_M?^_R_P"-2YQCHV4HR>R+=%(K!E#*001D$=Z6J)"BBB@
MHHHH *HZKH^GZY9?8]3M([JWW!_+D&1D=#5ZB@!%4*H4#  P!6#/X)\,W6JR
M:G<:)9RWDN=\CQYW$C!)'3/OC-;]%--H32>YE0^&]&@GL)XM/A673XS%:L!S
M"I&"!^9I]MX?TFSM+VUM["&."]9WN44<2EAAB?J*TJ*+L+(KV%A:Z98Q65E
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MUX?TF]%B+BPAD^P$-:DCF$C&-I[=!^5:5%%V%D%%%%(84444 %%%% !1110
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MI_0CL1Z&O7P]55(=FM&NS_K;N>;6@X3\GJGW1=HHHK<R"BBB@ HHHH ****
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MJ"RS1110!G:QI$&KVGE2?)*O,4HZH?\ "O.]:\--KU\@,YTKQ=98-K?H<"X
MZ!\=>._IZ\BO5:R]:T6+5[8#/EW,?,,PZJ?\*Y*U*<)^WH_%U7\R[>O9G13G
M"4?95?AZ/L_ZW.6\(^/I;O43X;\40#3O$4/R[6X2Y]&0],GT[]O0=[7GVIZ)
M8^-;4Z-KJ&UUNTYM[Q.'!'((/?U([]1[4]!\9ZIX7U:/PQXZ(5VXLM6_Y9W"
M]@Q['W/X^IZ:-6%>'/3^:['/4A*C+DG]YT>F73W?CZ_:2+RI(]/BB9 ^X<2.
M<Y_$_E[UU5<?H[+_ ,+&U@;ADVD>!G_;:NPJ:3;@G)W+J)*3LK!16%>7KZ[I
MU[:Z-J$ME<1L$DGDM'!09.=F\ $X!P1D"N4T[Q;/I/PLT.YEN#)J5\@ABGNF
M+*K$G,DC?W5'/J>!WK91;,G)(](HKBOAMJ@N_#EZ)=6DU)[6^N$:YE8LS('.
MT^P(&0*S?#?B>\O_ !#!J^JV]]!8ZPQM]( E!@5 "PWH#D.^TG)'0 "CEW#G
M6AZ/1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &?KGG_V!J'V5YTN
M/L[^4UN@>0-M.-H/4YZ"O/=$\1WMKH5KI]]\.M4>4;#<-'9H$EE&/WA&!R2
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M@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N-^(>GW>I:=ILFFZ9'JEQ9:C'.;9Y41& 5LA]QQT/UR0:[*O.
MO&?A[PKI>F3-=Z5>W\VJZDLJ6MO.X>:X*L!CG@8+'T_2JCN3/8T/#NHZ_<:S
M%'?^![32K<AMUW'>PR,G!P-JC//3\:[6O&_ %OHL7BZR>T\'WNES.MP(KJ?4
M#(N8\I(H4]2"<8[=>U>R4YJS%!W04445!84444 %%%% !5:W_P"/V[_WE_\
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M,Z-F"*6.<#T&:J6<BRW-TZ9VEEQD$?P^]7*K6_\ Q^W?^\O_ *"*@LLT444
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MM7T#4--27RGNK:2%9/[I92,_K7FDUIXGUKP_;>#I/"=M8"'RHY=0%RC1QJC
M^8BCG<0O'UK2&QE/<]:HH' HK,U"BBB@"*>W@NHC%<0QS1DY*2*&'Y&B6UM[
MB$0S0121#&$= 5XZ<&I:*  # P.E5KW_ %<7_79/_0A5FJU[_JXO^NR?^A"@
M"S1110 4444 %%%% !1110 4444 %%%% !1110 445334[62]-HIE\X=087
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M-)-MW3.WSC;]W&  ,>PJQ9V$=FTL@>26:8@R2R$%FP, < # IWVZS_Y^H/\
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MU3XIT-/XUR+F)??J3Q_O?45I9/8GF<?B/4Z*YGPQX]T#Q6@6PO ET!\]I/\
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M4?4L-_S[C]R#ZU7_ )W][,/_ (1#1/\ GU?_ +_/_C1_PB&B?\^K_P#?Y_\
M&MRBCZEAO^?<?N0?6J_\[^]G#>)/"("V_P#8]F['YO,_>$^F/O'ZUS^A:5>S
M:VGEP%C9W$?GC(^3D'^0KUFN/\'?\A[Q+_U\Q_\ H)KAJ930E7YE==;*UM+>
M1UPS&K&CRO7I=WOK<["BBBO8/-"BBB@ KE?'.K7^FV.FV^FBU6ZU"^CLTGNE
MW1P[@3N([GC ^M=57,>-]6ETS3;&.VTJ'4KR\O8X+:*<@1K)RRL2>F-O'O3C
MN3+8Y'PEK>O'Q;8V>KZU97"337ELUM!9HDB20Y^\0,@%1N!^@[UZK7 ^']'\
M0KXP_MC5O#WA^V>5&6>\M9',WW>, \<D $^E=]3GN*%[:GFFI)=>'?&6LW]S
MX2N->M]3,36]Q;1+*T05 IC8'[HR,Y]ZZ'X?Z3>:3X=D6\M5LFN;N:ZCLE;(
MM4=LK'QQQ_6NJK,T/5I-9L9+F33;RP99GB\J[3:S!3]X#T-#E= HI,TZ**HW
MNG->7-M.M_>6_D-GRX) $DY'#@@Y''MU-2602Z]:Q^(8-%"R/<2HSLZCY(\#
M(#'U(Y ]/PJG9^+[2\N[9!9W<=G=RM#:WSJOE3N,\#G<,[3@D ''':L:#PKK
MECKNE/\ VP+JW66>6XE-FJL2X&=QW<EN@.. !V%-L-,U=K/0M FTUXDTJY22
M:]+J8I$BSLV8.XLWRY! QS5V1%V=Y5:W_P"/V[_WE_\ 015AE#*5)(!]#@U4
MM$$=S=("Q 9>6))^[ZFH++E%%% !1110 4444 %%%% !114,]RMNT:F.9]YP
M#'&6 ^N.E)M)78TFW9$U%<Y=Q"UU.RGCFF8376'N3+N4YR/*V@].@Z<4RVU*
M674H]2N(6-I--]EMBLGW.2,E?4D'GM7(\6E+EDM;_AW_ !]/,Z/JS:YD_P"N
MQT%U:07UNUO<QB2)L94DC.#GM7$R:18#Q_;Z>+<?96M97:/<<%AY>#USW/YU
MWE<C(/\ BZ%K_P!><W_M*KK4:<YQ<XI^J\F33JSA"2C)K_AT6+GP]<Z;,;S0
M)3&V/GMG.4?\_P"OYBKFE>(H+Z7[+<H;2^4X,,G&3[?X5M5G:KHMGJT>)TVR
MC[DJ<,O^/TK)X:=%\V'_ / >C].S_#R+5>-1<M;[^OS[_F:-%<JFHZGX<=8=
M45KNQSA+I!EE_P![_P"O^9KI+:Z@O(%GMI5DC;HRFMJ.)C5?+M);I[_\-YHS
MJT)4_>W3ZK8Y?Q/\.= \3.;F2!K/40=RWMH=D@;L3V;\>?>N:_M#Q[X ^74H
M#XFT5/\ EYAXN(U_VAU/XY^HKU.BNI2>S.9P6ZT9XCXI^+OA^YO--N+"*ZN?
M+DAFD0IL*;'+%3GJ?IQ[UZIX7\4Z9XNT==2TR1BF[9)&XP\;?W6%?.?Q)\%:
MMI'C.]E2TEN+:^G::"2%"V=[$[2!T()(QWKK_ OAKXC>#M(?4=-L+.5+LAIM
M-N6VRX7.#VVDY/&<],BK]G!1]UF?M*CE:2/<;JU@OK66UNH4F@E4I)&XRK ]
M0156^T+2=2:!K[3;6Y:W_P!498@VSV&>W XKB;+XNV$%PMGXGTJ_T&[Z'SXR
MT9^C 9Q^&/>N[T[5=/U:V%QIU[!=0G^.&0,/TZ5#31JI1D6Z***DH*YKQU(C
M>$[Z .IF;RRL8/S']XO0=:Z6N.^(J*N@+,J@2B9 ' ^8#/KUJ)R<4FNZ_,J,
M5*Z?9G8T4CL$1G;HHR<#-<3XD\<V:6-M:Z;?"VN-0=HEN[F)XDMD4 O(=X&2
M 0%'<D=@:T2;(;2W.WHKR>Q\4ZI>> =!TO1[B>^UK4O-C>X$H,D4<;9D?<QQ
MOVLH&3U(]*[_ ,+ZG;:IH43VPNE\AFMI4NVW2I(AVL'.3DY'7/--Q:$I)FS1
M114E'.^.F5/!VH,S!5$9R2<"L+6/%DVG^$K.UT&2";5#IOVDR9#);PQI\TC>
MIR-JCN?8&MWQTJOX.U$,H9?+.01D557P?H6M^%K>.;3;(3S:>L*W(MT+QY3@
M@X[$D_6IA;VCOY?J.=^16\_T*FLZMK$/AFTUK^V(;"T&GK-(ZVOG22SE00I7
M& GTY]Q6M-J6L2> 3J5O:*VLR6 E2"'#KYQ7@#G! )]:KR>$+B&QM;32M:GL
M(8K,6<D2PJ\;KW<(>%<DGYN>O(-6+?PU/I]HEGIFLW5I:PV4=K;Q^6C^6RG/
MF?,.21P1T_IKH9ZE/P5J5[=F_MM4U:>[O[<IYEO<6"VKP!@2#A20P;L<]JZV
ML71= ;3;Z]U&[O7O=1O BRS&,1J$0$*JJ.@Y)ZG)-;52]RHWMJ%9^MJK:-=9
M .$[BM"J&M?\@:Z_W*QK_P *7HS6C_$CZHSO Y)\%:22<GR/ZFN@KG_ W_(D
MZ3_UP_J:Z"MI;LRCL@HHHI#"BBB@ HHHH \^^)$FB07.G3W%_J5EK2A_LDNF
M(7FV?Q;E[I]?\:X^WO\ 1M1UBTAU[Q;KFMZ8L\>V0VGE61E."JR,#S@D<8XK
MT;6](NO^$UT?6M-O+-+I8VM9K:Z.#- 6#,8\<[EZ_P _?%\2Z5I]Y;P^"=$O
MM*LX[JZ\Z_A>XS.J[Q)\B9R6)'X#VK6+5K&,D[MGHM<HOCNR.D:M/):SPZCI
M<+RW&FR\2X4$Y']Y3_>&175 8  [5XT-0NO&/B.PM[RY@CU(SRIY%K:O'=:4
M%#89I#PZG #*1AMW%1%7W+G)K8[?PMXMO=6UB73-0ATXR_95NXY=.NO.C"%L
M;7.!AOT//I77UR'@ZWNM(NKK2+[0[.TN OFB_P!/@6."\7.,D ?*_/*GZCBN
MOHEOH.-[:E'5-8L-%@2?4+@0QN^Q#M+%FP3@  GH#^507/B71[33[>_N+Y([
M>X_U)96#/ZX7&[CZ<50\6#21]AEU/5KK3&B=V@F@?9\Q7!!.TCH>!WK!T_4Y
MK'4='UKQ([Q12:=-;K<SQ;-K^:"I< ?(SQA3CCD$>U"6@G*S.^M[B&[MX[BW
ME26&10R2(V58'H0:BO?]7%_UV3_T(5D>"H9(O#49:%X(Y9YYH8G7:4B>5F0$
M=OE(..V:T[Q9-T;>:/+\U/DV_P"T.])Z,I.Z+M%%%(84444 %%%% !1110 4
M444 %%%% %"]TQKYG5[R=;>0 20KMP0.P.,C/?FHKG0X;B68K/+%%<!1/$F,
M2!>!VR....U:E%8RH4Y7NM_Z_5FBJSCLR"XN(+"T::8[(8P,D#.!TZ"N&U'7
MM.G\::1J,4Q:UMT<2OL88RC@<8R>6%=5XG('AR]R0/D'\Q7D>#Z&O(S3,*N&
MJQC!+:^OS7<]+ 8.G7IRE-O>WY,]&"7OBR4.^^UTA3D+T:;_ #^7UKI[>VAM
M(%@MXUCC48"J*I>'_P#D 6/_ %R%:5>EA*2455EK*25W^GDO(XL14;DZ:TBM
ME_74*"0!DG %8_B+Q/I'A;3S>:M=K"AX1.KR'T5>IKSX)XL^*9S)YWA_PLW\
M(_X^+I?\#^7^]7:HWUZ'(Y6T6YJZ_P#$IYM1;0?!EI_;&KG*M*O,$'N6Z''U
MQ[]J?X<^&HCU :[XMNSK.MM@_O.88?0*O?'TP.P%=9H'AS2O#.GBRTFT2WBZ
ML1RTA]6;J36K3<K:1$HWUD%<A/\ \E%L?K<?^B8JZ^N0G_Y*+8_6X_\ 1,58
M3^./J_R9M'X9?UU1U=Q*8+:64(SE$+!%&2V!G K@?#_BO7+C3[^?49K1]0@T
M\W:Z4;.2UD5L9&6D.&7(VD@8SWKOKA)9+:5()1%*RD)(5W;#C@X[X]*Y2?P9
M<:P][/KVI)-/<:>^G(;2#RECC8@LV"S98D#OCCIS6T;=3*5^A5\&^++OQ%J+
MV<\EM>VS6,=T\T5L\(A=SCR2&)W<<AAZ&K.M_##PEKI:2;2TMIR<^=:'RFSZ
MX'!_$&K.C^&;VUUR+5M3U**YFM[+[# EO;^2NS()9OF.6.!TP!V%=/0W9^Z)
M1NK2/,?^$*\<>&QN\,^*S>VZ]+/5%W<>@;G]-M*/B7KF@'R_&'A*[M4!P;RR
M_>Q?7K@?]]&O3:0@,"" 0>H-/FON@Y+?"SG]#\<^&O$04:=J]N\K?\L7;RY/
M^^6P3^%<I%XR\.VGQ4O5GU:W0-;?9PY/R>9N7Y2W0=#WK4\9?#?0=<TB_FMM
M(MX]5\EVMY8?W1,@!VYQ@'G'6OEB2":*X:!XG696V&,J0P;IC'K3C2C-W[$3
MJS@K6W/MX$$ @Y!Z$4M>1^'_  1X^?P]I[-XVN+#,"XM&M]YA&.%)SV&/I6E
M_P (-X\_Z*+-_P" @_\ BJ7*NY:F^QZ517FO_"#>//\ HHLW_@(/_BJ/^$&\
M>?\ 119O_ 0?_%4<J[AS/L>E45YK_P (-X\_Z*+-_P" @_\ BJ/^$&\>?]%%
MF_\  0?_ !5'*NX<S['I5>9Z5XT\-P?$"^@EU>W5I(O(5B3L+_:)6V[NG1E[
MXYJIJ_@?X@+H]Z8_'4]XXA?%LMOL,O'W0V[@GI7SOY,OG^1Y;^=NV;-IW;LX
MQCUIQHQD^:^Q$ZTHJUC[?HKR?1_ _C]M%LC)XYGLV,"9MFM]YBX^Z3NY(Z5>
M_P"$&\>?]%%F_P# 0?\ Q5+E7<OG?8]*HKS7_A!O'G_119O_  $'_P 51_P@
MWCS_ **+-_X"#_XJCE7<.9]CTJBO-?\ A!O'G_119O\ P$'_ ,51_P (-X\_
MZ*+-_P" @_\ BJ.5=PYGV/2'=8T9W8*B@EF8X 'J:\V\%^,/#TOBO6[1-5MS
M-=W*?9P20)< @[6/!Y_/M6+XO\%^/(?"FHR-XQN-4C6+,EFMOL,J9&X @GMD
MX[XQ7A-E;75U?0V]G'))=.X6-(Q\Q;/&/>JC1C)\U_+\O\B)UI17+;^OZ9]M
MT57T]+B/3;5+MM]RL*"5L]7P,G\\U8K(V"BBB@ KR_\ X1+2?%WB/6[<:[XH
M_P! NU:3%X! LIRVV,$'!0_EQ7J%>;SCQ#X&\2:O=V.ARZUH^JS_ &HK:M^^
M@E(PP(YR#BKCY$3Z7)=*T>S\-^/['3I-:\2W4\UK)-!]MO1);RXR&7;C.X [
MORK4^*4LD'PVUF6&1XY%1,.C%2/WB]Q69H=OK_BKQI:>)-8TE](L=-ADCL[:
M5LRR/(,,S>@Q[5W=XUJEG*]Z81:JI:4S8V!1SDYXQ0W9H25XM'F3_%?0!XPL
M"FO'^QUL'$X\B3'G;EVY&W.<9]JW/A=?C4M U.[6X>>*35KEHG8D_(2"N,\@
M8/2MK4KCPKH]G%=ZA_95M;S$"*21$ ?(SQQSQS3O"?VPZ+YEXVF-YDKO"^FC
M]TT1/RGW-#:MH@2?-JS<HHHJ#0**** "JUO_ ,?MW_O+_P"@BK-5K?\ X_;O
M_>7_ -!% %FBBB@ HHHH **** "BBB@ HHHH I)I-BER+A8 ) Q<?,=H8]PN
M< ^^*5-*LDN?M"P 2!BX^8[0QZD+G /OBKE%9^QI_P J^XOVD^["N>DT/3-4
M\37%U>V<<T]J(C!(V<Q]3Q^('Y5T-9UI_P AO4O]V'^1I5/BAZ_HQP^&7I^J
M-&BBBM3,1T61"CJ&4C!!&0:YNYT"ZTR=KW09?+8\O:L<H_T_S^(KI:*PK8>%
M9>]NMFMUZ,UI5I4WIL]UT9C:5XBM[^3[-<(;6]4X:&3C)]O\*V:S=5T2SU:/
M]\FV9?N3)PR_XUCKJ>I>'&$.JHUU9=$NDZCV/_U_S-8>WJ8?2OK'^9?JNGKM
MZ&WLH5M:.C[?Y/KZ;D7BL_\ $YTK_K[M/_1IKKZ\[UWQ!8ZAJ-C- 9-D-Q!(
M^Y0.$DW'OZ5WEE>17]G'=0;O+DSMW#!X./Z5IAL31JWC"2;NV17H5*=G.+2T
M"\L+34;=K>]M8;F%NL<R!U/X&N%U#X0Z,;DWN@7E[H-[G(>SE.S/NI/3V!%>
MA45UJ36QRN*>YYC]I^)_A3B>WM/$]BO\<7[N?'T[G\&K1TGXN>'+V?[)J1N-
M&O1PT-_&4 /^]T'XXKO:SM6T'2==@\G5-.M[M.WFH"1]#U'X57,GNA<K6S+L
M%Q#=0K-;S1S1-RKQL&4_0BN4^(__ "+2_P#79/YUB7'PF_LR9KKP?K]_HLQY
M\DN9(6]B#S^>:\B^(_B'Q;)J[:#X@OHW:QP"+8;(Y21D.>F3@CMQ2=+GLD^S
M^YA[5PUDN_Y'U/17SO\ #/QMXYEM[C1](LDUCR@)%:[EQY"],;B1D'TS]*[X
M6OQ;U$GS+_0]+0]HT+L/S#?SJG3L[-BC4NKI'5#P;I*:786,/VF 6!;[+/%.
MRRQ[L[@''.#GD'^E:.GV&GZ!IJ6EL%@MT).9'R68G)9F)R222237"?\ "O/%
ME^/^)M\0=0(/5+2/RP?Q##^5/C^"WAYV#ZE?:MJ+]S<7/!_(9_6EIU8*_1'5
M7OC3PQI^1=:]IR,/X1<*Q_('-<_=_&3P7:MMCU":Z;T@MW.?Q( K0L_ACX,L
M0/+T"V<CO-NE_P#0B:Z"TT?3+  6>G6EN!_SRA5?Y"CW1^^?.OQ3^(=SXHGM
MK.RBOK+253<8YT\LSOD_,0#R!QCWS3?A)X\/AO6S8ZKJ#1Z-.AR)-S+%)V(Q
MG&>A^OM7L?Q/\.Z9K?A::>^M]T]JI:"53AD]1GT.!Q2^$?A[X9TKP]&J:9%<
MF\A1YWNE$I;*YQR, <]JI58-.-C-TI\RE<ZC3M7TW5X!-IU_;7<?7=#('Q]<
M=*NUY]J/P>\-W$QN=+>\T:ZZK)93$ 'Z'^F*H3:%\3-"ADBLM8M/$-FRE3#>
M QRE3V#9!SCONJ>5/9FG-);H[?Q+KZZ!IOFQPFYOIB8[2U4X::3&?P4 $D]@
M#7.W'CRY32/#]R(K"T?5;4W#7%[,4MXB%#;,@9+'/'T/6N'N=>TZR:)?$WAO
MQ!H-U#"\,5U#=RR1@.<GYB<D$XSC/2MCPU!875KH$FAZ[I&J7=A8-:26=_,^
MTE]I+("-RX(QC;]WCBJY4EJ1SMO0[NV\3/<>!1XD&FS[S:&Y^Q_QG )P#COC
M@XZ=JP]-\72Z_;ZE92K93>79QW(N=/E,D2[R1Y;$CAQC/T/:I5\':Q_PAX\,
M-JL/V-[&2*2X"MYJS,^Y=O./+ )7'7&*2+P_J5I/?:M?_8+<?V<MFMK8;O+?
M#;O,;('/8#!P">36%?E]C/T9O1YO:Q]4;'@;_D2=)_ZX?U-=!7/^!O\ D2=)
M_P"N']3705<MV3'9!1112&%%%% !1110!PGB^#5M-\8:9XEL-'DUB&WM);8V
M\3 /$['(< ^H^4X[5R=SX'O;?P&MW<:49?%NHZDEPUT@W/:,T@;)?^%0HY[
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MKT&E/<<-@HHHJ2PJM>_ZN+_KLG_H0JS5:]_U<7_79/\ T(4 6:*** "BBB@
MHHHH *9YT6_9YB;_ .[N&:?63]F@/BAI##&7^RJV[8,YW$9SZUG4DXVMU9<(
MIWN:U%%%:$!1110 4A( ))P!U)I:YG6KR?5;X:%I[8S_ ,?4PZ(O<?Y^GK6-
M>LJ,+[MZ)=V:T:3J2MLNK[(A<OXLU7RU)&D6K?,1_P MF_S^GUJKJEC:1_$#
M0[=+6%8723?&(P%;$<G4=#T'Y5UUE9P:?9QVT"[8XQ^?J3[U\_>*?C!,WC>&
M_P!'LX&M]/9HXVFR?.X92W!& 0QQ^'TK*A@VVI3UDW=_<]%Y+_@E5L4DN6.D
M>GWK7U/H=$2&,(BJB*. !@ 5Y]X@^)1?43H/@ZT_MC66RI=.8(/4LW0X^N/?
MM7/V-YXG^,$3%)ET/PRK>7,()-TT[  E<\<<^PY_BKTWP_X:TGPOIXLM)M$@
MCZNW5Y#ZLW4FN[E4-SDYG/;8Y/P[\-0-0&N^+[O^V=:;#!9.88#Z*O?'TQZ#
MO7H5%%2VWN6HI;!1112&%<?*RO\ $2R*$,%-QG!SC]S%785S5_%';^-]!\F-
M(_-BNS)L&W?@)C..O4U$HMRBUT_R:*4DHM/K_FCI:***LD**** "BBB@ KA[
M6PLI?BO>S26=N\JV0=9&B4L&W(,@XZX[UW%<A8_\E1O_ /KP_P#9DJ)?%'^N
MC*7PO^NJ-&[\7:?::X=(%O?W%TAC$AMK1Y$C+_=W,!A>.>>U$_C#1[?5&L'E
MERDRV\DXA8PQS-C$;28P&.1^8KG/$%H)-;DDT'3M6MO$#WD!:Z"RK;R1J5#,
MQSY;+L!&.N>U9M_I6I?V1KOA==.NVNM1UDW4%RL1,(A>5)/,,G0%0",'G(&!
MS6RBC%R9ZG1114&@4444 %<1HVGV3_$'4+EK.W,ZVV\2F)=P;[1,,YQG. !G
MVKMZY'1/^1XU'_KT_P#;F>H?\1>C_0K[#]5^IUU%%>8VT&H>%_$*2ZO'+=7]
M_P#;)+6>'497CW*K2!&A("@;> 1GI6B5S-NQZ=17F&A37-F_@G4DO[J>YUQ6
M&H++.SK+NB,FX*3A=A&!M XXKT^AJP1=PHHHI%!7G&A7GA_P]KWB#4-2:QLB
MUVD<<\B*I)*$D XSSU->CUY(4T5O$VJRZGKDNE7-O.9+61"N"3'M;AE8$XZ#
MJ><5*_BI>3_-#E_#;\U^3/1;CQ/H=KIUM?SZI;1VER,P2L^!(/4>HK4BECFB
M26)UDC=0RNIR&!Z$'N*\PTO59[;6]$USQ8B6<<^A/#YDL>Q%E\W<01_"S)M.
M/8@>E=3\.K:YM/ >EPW4;Q/M=EC<89(V=B@([84KQ6CC9&<979U%%%%26%4+
M/6M.OY;V*WND:6RD,=S&>&C(]0>WH>AJ_7E'BC44O]>EU"PTY[&2QNUTXZU%
M<)O\PE5V/ 1F6++ ')SCD545<F4K'8:/XYL-9U&WM4LM0MH[M6:RN;F#9'=!
M1D[#G/3D9 R.:G\;Z-=>(?!FIZ79.JW,\0$>XX!(8-@GMG&/QKE?!VGZ=I?B
M6*PU6SN;+7(8W^QPO<O+:,A'S-;;N%XZKU XKTJAZ/04;R6IYEI.A:KXI\56
MVJ>)?#L=AIFEV7D6MA*RRAY3C+ =,8&!]%K=^&VFWFF>%Y4N[1[)9KV>:"T<
M8-O$S?*F.W<_C6_J.MVFEWVG6=QYGFZA,88-JY&X#//H,"M&AR;0**3N%%%4
M;VUOI[JVDM=1^S0QMF:+R%?S1D<9/*]^GK4EE>#Q#:7.JOI\,%Z[QR-$\PM7
M\D,!R/,QM]NO7BF6OBK2;S45LH9Y"\CO'%*86$4KKG<J2$;6(P> >Q]*Y^*&
M$>)[?^PX=7@G:\D?45G$RV_EL&W'#_)DMM*[.?PS533H[F73/#?A[^S[J.^T
MR[C>Z=X66*-(MV7$F-K;^,8)/S'.,&KY41S,]$JM;_\ '[=_[R_^@BK#@E2%
M;:>QQG%5+-76YN@[[VW+EL8S\M067**** "BBB@ HHHH **** "BBB@ HHHH
M *R;.4_VY?9@N%638%=HB%.T'//2M:BHG!R:=]BXRLFNX44459 4444 %9VO
MC.@7_P#UP;^5:-(5#*58 @]0:BI#G@X]T5"7+)2['AVUL_=/Y5WV@>)$T[2[
M6VO[2:&'!$<X&5;D_P#U^F:B\93V&GZKI;7$MM;1M=6V3(RH"!*=W7VZUVK0
MPRP>6T<;PL/NE05(^E>+@\KJX>3J0J:[;?\ !/5Q./IUDH3AION-MKJWO(A+
M;3)*A[H<U-7/7/A6))C<Z5<R6,_HA)0_A_D>U0_VUJVD$+K%D9H1_P O-OR/
MQ'3^5>A]:G3TQ$;>:U7^:^?WG%]7C/\ @ROY/1_Y,Z>BJ=AJMEJ2;K6X1SC)
M7HP^HZU<KKA.,US1=T<\HRB[25F%>9?%SPCI.KZ?#JDT31WT;K%YT1P63/0C
MH>O%>FUR'Q'_ .1:7_KLG\Z)2<;-=U^:$HJ5T^S_ "+_ (3\&Z1X-T][72XG
MS(0TLTIW/(1TR?Z#BN@HHJV[ZLE)+1!113)9HH(S)-(D:#JSL *EM+5C2N/H
MK N?%NGQOY5HLM[-V6%21^?^&:A\SQ-JGW(X=-A/=OF?_/X"N5XVE>U.\GY:
M_CM^)TK"U+7G[J\]/PW_  .<\4>)+F[^WZ.\4(AWO%O4'=@$CUQ70>#-9FU*
MU>UDCC5+2.-$*@Y(P1SS_LUQ^MZ!J=B]U>7,;O C,S7!8?,,_>QG//6M;PUX
M7O)XGN)IKBS5T1X7B<?.#D\X.?3TZUXF'KX[ZUK%M:Z;=[:GJ5Z6$]AHTGW^
M[H>A45S?]C^(+8YMM<\P#HLR?U.:!<>*[;/F6=I= ?\ /-L']2/Y5[7UN4?C
MIR7RO^39Y?U=/X9I_A^=CHI(TEC:.1%=&&"K#(-<AK/PN\(ZT6DDTI+68G/F
MV9\HY]<#C\Q5S_A)[RW'^FZ'=Q^IC^8?R _6IHO&.D2-M>26%O22,\?EFJCF
M%!/X[>NGYV%+!56OAOZ:_D<C_P ()XR\/?-X8\82SPK]VTU-=Z_3=S^@%<OX
MU^)'C;0M+.D:QH]G97MROR7D3[U=!U*KDX/3J?PKV>#6=,N#B*^MR?0N ?R-
M>>?%*QT3Q/;BQF>>+4;,[H+A$5D^8 E3SD@\?0BMI8S#QCS59+E,5A:S?+23
MN<=\)OB3JJ:Y9>'-1D%S8W!\J%BH#0MU'(Z@].?6OH*O$/A1X#T^PU]=0O;E
MKF_@C9X8T3$<9X!)).2>>. *]OK15J5;WZ3NB%2J4O=JJS"BBB@84444 %%%
M% '$^-M,O;Z_MGM?!NF:ZJQ8,UY,B-&<GY0&[=ZX W0B\30:$OPST"346(9H
M[>9)/)&>KE00OKS7>_$.^\8QV\5AX4TR27SU)GO(W4-$,XVJ&(PV._:L/PQ/
MK?A>S%K8_#F]WR-NN+J74(VEF;NS''/?CI6L?A,9+WO^ >HROY4+R;&;8I;:
M@R3CL!W->+QVW@K43/;2^+M3TJWBE::#2KQOL_V.<DD, PYP22!FO:ZJW>F6
M%_C[98VUQCIYT2O_ #%1&5BY1N><>&-7T33?$;2/XCN_%6N7BI;>;;6^Y8(0
MV?X?E"Y.2<]NE>HU!;6=K91F.UMH8$/\,2!1^0J>E)W'%61RWB[7$LC#IC27
M-LMTC--=102/Y<8X(4JIP[=!Z#)["L+17@\3?\(_IUS-<2:>FC><8_,DB,LR
ME$)8\,VW\LMGGBO16 92IZ$8-95UX:TF\L[2UEMF$=FFRW:.5T>-<;<!U(;!
M  (SSWIIJPG%ME?P=<S7'AU/.G>X,-Q/ D[G+2(DK(I)[G '/?%:-Y(=T4?E
MOCSD^? V]14]I:6]A:16EI"D-O"H2.-!@*!VIE[_ *N+_KLG_H0I/<I:(LT4
M44AA1110 4444 %9;2)'XC8R.J V@^\<?QFM2N(\9V-I?:WI"7=K#<)]JMEV
MRQAA@N^1SZUG45W'U+@[*7H=O10  , 8 HK0@***H:OJL.D6+7$O+'B-,\NW
MI43G&G%SD[)%0@YR48[LI^(-7>R2.RLQOU"Y^6-1_"/[W^?Z58T32(](LMF=
M]Q(=TTAZLW^%4_#^E3(\FJZC\U_<<X(_U:^GM_D5;\0^(-/\,:/-J>I3>7#&
M,!1]Z1NRJ.Y-<V'IRJS]O46O1=E_F^OW&]:<:<?90>G5]W_DO^"1>*/$NF^%
M-$EU+4I,1@;4C'WI6[*H]?Y5\T?\*X\17^H60AL([;^U-TMO!+, T:?,1NSR
M/E!/K_*O8/#/A[4/&VM1>,?%D)2W3YM+TQN5C7J'8=R>#[]>F!71:O\ \E(T
M#_<D_P#1<E=SFZ;277_)G%R*HFWTV^]%CP%X27P9X7BTLS":<NTT\B_=+G .
M/8  ?A7.?$/QI/9B[TS1M2@M+BQ1)KR9G7?\S#;$@/5B/F)QP![UZ361KOAO
M3?$&G7%G>0*// #3(B^8,$'@D'TH4M;L;C[MHG.>,[O4;2W;4K#791+.(X](
ML+1$(N)3R=V<[U/M@!037;Q&0PH90HDVC>%Z9[XKEM5\"0:GKPU=-;U>QN$B
M$$2VDJ*D2<9"@H<9QDUU,2&*%(R[.54+O?JV.Y]Z':PTG=W'T445)05SNJ_\
MCOX=_P"N-W_Z#'715S&L75O'XZ\/(]Q$K+%= JS@$96/%-"EL=/1112&%%%%
M !1110 5R%C_ ,E1O_\ KP_]F2NOKD+'_DJ-_P#]>'_LR5G+XH_UT9<?AE_7
M5'7T445H0%%%% !1110 5R.B?\CQJ/\ UZ?^W,]==7(Z)_R/&H_]>G_MS/6;
M_B+T?Z%_8?JOU.N(R,5C:?X5TG3+Q;NW@E:9%9(C/.\HB5OO! Y.T'OBMFBM
M+F=C%T[PGHVE7PO+.T*2H&6(-*S)"&.6$:DD)D]=H%;5%%#=P2ML%%%% PKC
M_!X!UWQ+D XN8SS_ +IKL*X_P=_R'O$O_7S'_P"@FL_^7B]'^:+^Q\U^3.O(
M!&" ?K2T45H0%%%% !6+/X6\/OK0UR?2[0Z@A#?:67D$=&/;(]>M;5<)\5(X
MY="TU;F&\N;(:C&;JUM$9FGBPV1\O3'7G'3UQ3CO8F6BN=BMS874\82>VFE0
MDIAU9@<8)'X9IFK2:C%ITDFE003WBX*13N45QGD;AG!QG'O7GW@__A"?^$EM
MO[&\*:I87VU_+N+BUD1%&TYR2Q R,C\:].IM681=T<)/XJT6;4+'_A+-*NM%
MOK.4R6\EX"8 Y&"5E4[#QZXKMX)X;F%9H)4EB<95XV#*1[$5Q6K?$3P['KUC
MI,E_ID]C<"=;UY) 1"4 VJ1TY)(Y]*Z+P]I>B6%DUQH,,,5G>$3#[.3Y;9'W
ME'09'IBB2T%%Z[FO1114EA1110 56M_^/V[_ -Y?_015FJUO_P ?MW_O+_Z"
M* +-%%% !1110 4444 %%%% !1110 4444 %%%% !37;8C-M+8&<*.3]*=10
M!@ZMJ$LT"6Z07D$4H8S2^2Q95'\(QG!/KV%4?+L9_"5E=W5NT\R0K'"K%E+.
M> .",\]ZZM@&4J1D$8(J 6%J$MT$*[;<YB'93C%<53"RG)R;3NK:KT^7GZG5
M"O&,4DK6=]/F5;.P^PZ(NGQS 3B%AO)S\QZGZ9-4-"M4TS4I=/:"(3_9UD,T
M;,0PSCD$\'//%;4UE;7$A>:%'8H8R6'53U%):V%K9!A;0K'N^\>I/IR>:KZO
M[\&DK1V]/N)]M[LDWO\ F4Y(HYO$8$L:.!:<!E!_CK4K._YF3_MS_P#9ZT:V
MI?:]69U.GH%!&1@]***U,S$O_"]A=OYT(:TN!R)(#MY^G_ZJI^?XAT7BXB&I
MVH_C3B0#W_R?K73T5R3P<+\U-\K\OU6S.F.)E;EG[R\_T>Z,K3?$.G:GA(IO
M+FZ&*7Y6S_7\*YWQ_?VEWH BMKJ&:03*2D;ACU]!72ZCH.G:GEIX )3_ ,M4
M^5OS[_C7D,HV2LH)(![UYV.QN(PBBII._75;6Z?\$[,+A:.(YG%M>7K?J>T1
MW]G+ T\=U T2G#.) 5!^M9-UXMTZ%_*MS)>3'HD"YS^/?\,USG@_0;/5;*6>
M[,KA)=HC#87H#GUKN;6QM;)-EM;QQ#_87&?J>]=5"MB<334U:*?S?W:?J85J
M="A-Q=Y-?(PO/\2ZG_J8(M.A/\4G+X_S["GQ>$H))!-J5W<7TO\ ML0O^/ZU
MT72L5/$ELPOY/+?[/:('$@_Y: DC@>F1P>]5/#T(M.O)R?GMIKMM^!,:U62?
ML5RKR_SW-.VL[:S39;01Q+Z(H&:GJA::B\UXUI<6Q@G$8E"[PP*DXZCOGM45
MWJ\EI([/92?94D6-IBP!); RJ]QDBNE5:4876B]/ZL8.G.4K/?U*7CC_ )%#
M4/\ KF?Y5IZ+_P @'3O^O:/_ -!%9GCC_D4-0_ZYG^5:>B_\@'3O^O:/_P!!
M%7'XY?+]2'\*^?Z%ZBF32I!!)-(VV.-2S'T Y-4HM9LI+>6X+O'#$ 6>2-E&
M#TQD<_A3E4A%VD[,%"4E=(T*BFM;>X&)H(I!_MH#_.HK2_M[TR+$7$D>-\<B
M%&7/3(/K41UBR%U]G\T[O,\K=L.S?_=W8QGVJ74IN*;:LRE":=DG=$$_AG1Y
MP0UC&G_7,E/Y5YQXCL8=/URXMK=6$2;< G/50?ZUZ[6?K0']CW1P,[*\_,,N
MI5:3<$HM:WMY;'9@\;4IU+2;:>FYQ'@ ?\3N;_KW;_T):]'KGO P'_"%:4<<
M^1U_$UT-=6#POU6E[*]]3GQ.(^L5/:6L%%%%=9SA1110 4444 17-Q#:6TMS
M<2+'#$A>1V. J@9)-<0OQ=\-2.!#'J<R,<+)'9,5;W%=#XEEL;G1]0TB:YLU
MN+FRE(AN)Q'E-I!8]PH[GM7G^E^)/%MA96=BNM^!)(X$2$,;YMS  #L<9Q5Q
MBFC.4FGH>MT4#I14&@4444 %%9&NW>I6L<1L/L4,7S-<7EZ^(H%&,94$$DD^
MH P?85C6OB75]7CTRVT^VM(+ZYM7NIGN-[1(BOL4J!@MO/(Z8'/-.PG)(["J
MU[_JXO\ KLG_ *$*JZ!JKZQI$=U+"()P[Q31!MP21&*, >XR#CVJQ>R1_NH]
MZ[_.3Y<\_>':D-:ENBBB@ HHHH **0D $D@ =2:@@OK2Z5V@N8I0GWBC@[?K
M2<DG9L:3:NBQ7'^*?^0]I/\ U^6O_H;UU5O>6UVK&VGCE"G#%&!Q7*^*?^0]
MI/\ U^6O_H;UG)J7*UW+2:4D^QV%%%!.!D]*U,R*YN(K2VDN)W"1QC+$US>E
MVTOB#4AK-]&5MHSBTA;_ -"/^>OTIDS-XKU7[/$S#2;5LR./^6K>@_STY[BM
MW5-4T_P]I$M]?2I;V=NG)_D .Y[ 5P1_VNI?[$7I_>??T73NSKE_L\+?;>_D
MO\W^0W7-;L/#NDSZGJ4XAMH1DGNQ[*H[D^E>>^']%O\ XB:U%XL\30&+2H3G
M2],;H1VD<=\\'W^@&8M%TJ_^)^M1>)/$$+P>'K=LZ;IK_P#+;_IHX[C^?3IU
M]7 "@   #@ =J]+X=%N<"]_5["UR.K_\E(T#_<D_]%R5UU<CJ_\ R4C0/]R3
M_P!%R5A/XH^OZ,WC\,OZZHZZBBBM" HHHH **** "J,^BZ5=77VJXTRRFN,@
M^;) K/QTY(SQ5ZB@ HHHH **** "BBB@ /3TKE+.U:U^(DGF3M/)+IAD9V4+
M_P M ,8'':NKKG3_ ,E('_8(/_HX4N12:;Z#YFE9=3HJ***8@HHHH **** $
M8$J0#@D<'TKF-+MOL?CB^A:0S.VGQR^8P /S32DC XZY/XUU%<_%_P E#O/^
MP3!_Z-EI<B;YNJ'S-*W<Z"BBBF(**** "BBB@!DJL\3*CF-B,!@ <?G7->&;
M=;3Q#XBM]Q=TEA+2G@N6CST' Z]JZBN=T7_D;_$__72V_P#1(I<B;YNJ'S-+
MEZ'14444Q!1110 5R?CV_P!2M+#3+?3;PV/V[4(K2:\$8<P(V>0#QDD 9]ZZ
MRN8\;:O>Z98Z?;V$MO;W&H7R6BW5PFY(,@MNQW/RX /<TX[DRV.)\(ZCJ-OX
MZL]-O_$VH:A<>=>6]Q8RX'E&//ER-ZJR\CW(ZUZ9K>L1:%IK7T]M=W$2, ZV
ML1D90?XB!V'>N&\-:_<7&L>%FG^Q7%[JEK<K>S) BS#RS\CDCD*=NW'2O2JJ
M>Y,-M#S:;6/A[JNLZ9K0UG2H5M%FWV\D2H93( /F# '(QZ=ZZ;P_XOT;7;Q[
M'1$GFMX$_P"/F.W*VXP0-@8XY]@.QK6FT;2[F4RSZ;9RR'^-X%8_F15M$2-
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M\.O'XC?6?[8OV=U$;0$1>7Y8+$)]S. 6/.<^];E%%Q-7"BBB@84444 %%%%
M!6;IFC)IM[J%W]JGN)KZ422&;;\H4855V@< <<Y/O6E10%@HHHH **** "O)
M_%_CN=M:N?"FI>#H[JWE<K";N[$*7 !X9688!],'->L5Y_XT\8^'7DD\-MI\
M6NZBQ(-F2JQQMZO(W"8]N1[5<-]B)[;E3P'I5QHNL^7%\/ET:"96$MZ=1%PP
M &0O.3@D#I7I=<%\.--N-%MI[>\U^UN?/.ZWTV"X\Y;51D[59B6/'X<5WM*>
MX0^$****DL**** (5L[5+IKI;:%;AQM:8( [#T)ZT):6T=R]REO$MQ(,/*J
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M_P"E4M"^'VJ^*6@OO%^ZSTU&WP:-"Q&3_>E/7/Z_3I6?-/%:4W:'675^4?\
M/[BK1P^LU>?;MYO_ "*=C>ZSXNDETSP6LEGIC';>:_<*5>7U$8ZCZ#GU(KT;
MPGX*T?P?:&.PA+W,@_?7<O,LI]SV'L*W;6UM[*UCMK6&.&")=J1QJ%51Z "I
M:[(1C3@H4U9(YI.4Y<\W=A7'^*?^0]I/_7Y:_P#H;UV%<;XED2;Q)I<4;J\B
M7=L613DJ SDY'T(_.LZC2<;]S2";4K=CLJ***U,PHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC[?;^LG_ 'Z;_"@"S15;[?;^LG_?IO\ "C[?;^LG_?IO\* +-%5OM]OZR?\
M?IO\*/M]OZR?]^F_PH LT4U'65%=#E6&0:=0 4444 %%%% !1110 4444 %%
M%% !1110 445SVK7NI7&OV^B:7<Q6CFV:ZFN9(?-(4,%557('))R3V'O32N)
MNQT-5KW_ %<7_79/_0A5/PYJ<^K:.D]U&B74<DD$ZQYV[XW*$C/8[<_C7$ZS
MXGU:+5;JW2ZQ'%.P0>6O&UN.WM7'C,93PB3J)Z]CIPV&GB6U![=ST:YN8;.W
M>>XD6.)!DL:\M\0^*-7\4ZDVB>&[8RR#[V3B.(?WY6[>R_SJ:#^T?%\PBO\
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M2WEK%IILH(3)-)=7#HRXR3@*C9X]Z$KB;L;=%4]*N;F\TFTN;RV%M<S1*\D
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MX5N[:?38KO5!<Z=I1+6<(@VN3M*KYC9(;:I(& ,]37444[B:3"BBBD,****
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M%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%!( R3@#O10 4444
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M\-Z5=WZWTML1.-H)CE>-7V_=WJI ;';(-68])L(M4N-32V07EQ&L4LO=U7.
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M[-FK.GZ8EC<7UQYADFO)O-=B,8 4*JCV '\Z+Z HN]R]1114EA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7"ZQJ?Q)AU>YCTC0-)FL%?
M$,LL_P S+ZGYQ@_A7=44T[":N?+?C#Q/X\C\9LNHW%W87\;+Y5K:.PC7IC8
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M3_(#V JU2925D%%%%(84444 %%%% !102 ,FHWGAB"F26- W3<P&: )****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH 9+$D\+Q2#*."K#U%9B6ZV-[)NMWE
MMS D<(5-^T#.5_'(]ORK6HH Y^TMM1MTC5C,/*,(5 V5"DG</? ./PJQ9F^2
MWG>YE?S!$=RE" 'YY!SC\N.E;%% '/VTMW);*X%W)%)%%EF)4[\$L>!G;]WI
MW_&FVT5\)/,E2?SI#;,^>1Q@/[#O71=!@44 8$2:FR1B66<.9$$RJI&/F.2#
MZ8].V*ELX;@:E;RW G.(I8]Q)QP_R[OJO<]:VJ* ,2U%^D]H7$C*=P=""NWY
MF^;(X/&.#[8I9OMVRZV?://\WC .SRMP^[[[?QSFMJB@#!=-1VNR2W#[(MT>
M 5RV\\$'D\>O:GDWXNI%;SWM_.!:1-P;;EOE"^QV\KU%;=% '/\ EZL\<D@D
MG62. >4G&&)9NOJVW;^-)<QWLEK+&S7,D3PRA B,IWD# .>2.O7_  KH:* ,
M6ZMKH71GMUD$BV6Q"#QNSTQTSC^E(L5Y-=Q(LEW':>:3N)(<@)T)/.-W^<5M
MT4 8<\+L-5@^S2-)<./*.PXSL4!MW08(_2HIYM0A::<"=(X4,A$C<.RL..F!
MN7.,>H[UT-! (P1D4 4 LB:=$;F)YY"P=P &*$G/ [[?Z5GI!<16JM&DXO 9
M/*.SY6#/GYQT7/!/3%;]% &7JDEV)(UM8YBPPVY3\OWAD$=^,]<545=22%3N
MN27CS+W(_>#.WT.TG_\ 76_10!@FVE_LB[40S$M=AU5@2S+O4Y]>@I]P)FO)
M;B""=8I$6,[<H2PW'<0!G X&<=_05MT4 8E@^H/>PP7#O@1)<2DGD,5V[#^(
M+4MQ9W)UB*[EC29 SJ"I.8X]AXQCJ3^? K:P,YQR:* ,G2D=S/</"]NSJJ1P
MF,CRT7.WV+<DGTX%4L:I]G8 3%UCD"R@$%SA,'#<J>O'3K71T4 8S+=QW+1N
MUT;02M\R$E\;%(YZXSN_'':I+-;UKV3[1)(%W.-NP[2N?EP<X'&.G/7-:M%
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MR)<+.\D329'R%1& ^>V>/SQ5ZXDN)KJTE@\TP2*-T>&3:#_%GU ['\.:U:*
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M<,,$?44ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
ABB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>img254193463_23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_23.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $% F$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#ZU;M[B&[MTN+::.:&0;DDC8,K#U!'6L34/#LDBV2:=<"WCM[S[6XFW2EV]
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M **** "BBB@ HHHH **** "BBB@ HHHH Q/%DT<'ARY>5;AERJ[;>X\AR2P
M ?(QS69X,T[4;.XOY;JVO[6WD$8BBOK[[2^X9W$')"CD?K5;XA7LDELFBJVG
M)%<P23S&^G:)71"OR*5(.XD_ABM+P;#HJZ?]HTBZ>4SQQO+&]ZUP8CC@<L<=
M_KBKVB1O(Z6BD) QD@9Z4M06133K"H&Y/,;/EHS!2YQT%<Z/$MXTT]M':V\D
M\.]F=9#Y9"*"R@XY8$@>E=)+$DT91QP01D'!&?0CD5F1^&M*BLHK-('$$0(1
M?.?*@C!&<YP>X[TU;J)WZ%^UNDNK*&Z'R)*BN QZ9&:?;_ZA:<D:1QK&B@(H
M 50. !3;?_4+2&24444 %%%% %2_TRTU*+R[J$/C[K=&4^H/:LO_ (FVB?WM
M2L1_W^C'_LW\ZWZ*QG0C)\T=)=U^O?YFL*KBN5ZKM_6Q4L-3M-3B\RUF#X^\
MIX93Z$=15NLR_P!#MKR7[3$SVMX/NW$/#?CZCZU4&JWVDD1ZS#OAZ"]@7*_\
M"7^'^51[:5/2LM.ZV^?;\O,KV49ZTW\NOR[_ )^1L7-K;WD#0W4$4\3<,DJ!
ME/X&O$/BO\-84>"]\.64%NB1L]S K%5/S* RCH/O8P,5[C#/%<1++#(LD;#(
M93D&N7\;?\@^Y_Z]#_Z-CKH]HXV<7NT8.FI74NS.;\*>#/'7ACP[;6EEK^GJ
M1EFM+FW,D<9)S@."#6U_:_C^P_X^_#>G:A&O5[*\V,?^ N/ZUVU%6Y7W)4+;
M,XG_ (6,MIQJ_AG7M//<_9?.4?\  D)J]9?$;PC?R"./7+6.7O'.3$P^N[%=
M15&]T;2]20I?:=:7*GM-"K?S%%T%I=RQ;7EK>)OM;F&=/[T3AA^E35R%S\,?
M"4[^9%IALY1T>SF>''T"G'Z5#_P@NIV?_((\::U;@=$NF6Y4?@PHLNX7EV.U
MHKB?LWQ&L/\ 5W^B:I&.TT+P2-^*G;1_PEGBNQXU/P1<R#^]IUTDP_(X-'+V
M#F[G;45Q:?%#0(VV:C%J.F/_ !?;+)T4?\"P16UI_B[P[JJ@V.MV$V>@6=<_
MD:7*T-23(]7_ .1H\._]=9__ $4U7M4O)+6(@!HXVC<O=G;LM\#[S GG_P"M
M7,^(O%>@6/C#0(+G5K6.2.24N"^=@:,JN3VR>*[4A77! 92/J"*'T$NIY</&
M.H1:="]KJ27MK)</,EQ)+&LKPH$_=C QYCLV0N,[?>NGO=?SXET 0:M!'9WA
MD1[4[0SL%.,DG/!&,#O72&&UB7!CA0 [ON@<^M1/<::K!I)K0,O(+,N13NNP
MK-=2Y15!]<TE/OZI9+];A!_6JTOBOP]#_K-<TX?]O*?XTK,JZ-BBN;D^('A&
M'[_B+3A_VV%5F^)W@E3C_A([$GT5B?Y"CE?8.9=SK:*XYOBEX0'W-4,G_7."
M1OZ5&?BIX:_@_M*3_KGI\S?^RT^5]A<\>YVM86G?\CEKG_7O:_\ M6L5OBAI
M)C8P:7KLK $@#390#^8KS3PO\8K^?X@-+J4%I!8:BZ02=0857=L.XG_:.<_I
M34).Y,IQ31['XAUAK*TNAY\FG+!M9KR2$,C _P ,?/+GH!6#9>+M3?7]!TV]
MVQ-*-EWB!B)9&B9EV, 5P,#.#U)["NUE@M-1ME$L<-S V&7< ZGT([4^.V@B
M2)(X8U2+_5JJ@!."./3@G\Z2:L4T[[DM%%%24%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!B^([/2I++[;J>CIJ2V_(7R!*ZJ2,D _GQZ55\*SZ%<&[D\/Z6MO:
M':/M4=N(H[@\_=Z%@/7IS4/C71[.ZT\ZA):/<7406.(>?)&B[F RP0Y(&<GO
M63\-HS:W.KV3VEM;26[HCI;O,RJ06&#YC'!XSQV(J_LD7]XS_%5AI=CKBV?E
M:0UQ-";E[K7;Z4%LL1M3'3&/;J*[KPW9I9:%;)'.)E==^Y9VF09[(S<[?2N9
M\>65_=7B-!.(D2!3$D<<+2SOO^=!Y@))"<@#C/6NKT 3#P]I_P!H7;-]G3>.
M.N!Z<?E0_A017O,NRS+$N3@L0=J9 +'T&>]80\3DRS6XLBUU#O,B+(" JJ&;
MGUY QZ]\<UN3V\=PA610>" W=<C&0>QK*;PU;.[RO<7#7+@H\^X;F0KMVGC&
M,?CGFI5NI3OT-2WN8[FUBN4.(Y4#KGT(S3K?_4+1%!'#!' B 1QJ%5?0#I1;
M_P"H6D,DHHHH **** "BBB@ I" P((!!Z@UAZM--N@1S+!,SD(8G+(HR/F;@
M<^WO1I_VN#4KAKB21HMWE[\LP=R<@@8^7 P/2N9XA<_)8W]@^7FN.FT)[:9K
MG1I_LDIY:$C,4GU7M]17#ZSXBO=1>:TNXH(Q@P.8\\#>I)Y/JHKO]$D9H;E'
MEEE*SMAY002.U<WX@\*B2Z*Z1;Q->2HTN;B=E0$.O/ ;L3QCO7!B*%6<8RPK
MY;O57T.NC5IQE*.(7-I\SL+6^MKR-7@N(I<C^!@:L5DR^'-+N0'>S2*8@9:%
MBI!^HQ4/]B7UM_QX:S<*!T2X42J/ZUW\]:/Q1OZ/]';\SDY*4OAE;U7^5_R-
MRBL3[5X@M/\ 76-M>(/XK>38WY-_2E'B>TC8+>P75DW_ $VB./S&13^M4U\?
MN^JM^.POJ\W\.OIK_P $VJ*K6VH6=XNZVNH91_L.#5FMXR4E=.YDTT[,****
M8AKQI(NV1%9?1AD5B:AX,\-:HVZ]T.PE?^^85##\1S6[11>PFDSY[\4_!^2;
MQO';:-/!;V%Y)M5968F(A-S>N1@'%>EQ?"GPZL,<<\NISE5 );4)1G\ W%:%
M[_R.NE?]?$O_ *3FNIHC4E*.K[_F)TXJ3LNWY'&+\*_"*];"=_\ ?O)F_FU3
M+\,O!R]=#@?_ 'V9OYFNMHJN:7<.2/8YA?AUX-3IX:TT_P"] #_.K4?@KPO#
M_J_#^FK]+9/\*W:*5V/E1FQ^'M%A_P!7I-BOTMU_PJRNG6*?=LK=?I$H_I5F
MBE<+(B6V@7[L,8^BBI  !@ #Z4M% PKS[P_X3\/R^(]8>71[-V>W@+;X@1ES
M)OX/K@9^E>@]JY?PW_R']5_Z]K7^<M1=J:]'^:&TG'YK\F9[^!;[0Y&N/!NK
MR:>,Y.GW69;5_8 \I^%+!X_?2YEM/&&ERZ-,3A;H?O+60^T@^[]&_.NWJ.>"
M&YA:&>))8G&&1U# CW!K7FON1RVV"WN(;N!9[>9)8G&5>-@P(^HJ2N(N/A^=
M,G:\\(:G+HLY.6ML>9:R'WC/W?JN*:GCC4-!=8/&6D/9+G U&TS+:M[G'S)^
M-'+?8.:VYW-%5[*_M-2M4NK&YBN8'&5DB<,I_$58J2@HHHH ***",C!H **Y
MWPA:06EC?) A1!?3  L6P V .2:Z*FQ)W04444AA1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '.>-M1@L?#\D;ZC#9
MS3D)'YD_E&7G+*&_A)&1GMFJO@>SUB"S,FJ0-;+Y$<,<3W(F9MN[,A8<<@J.
MI^[FG^*O#VK:M?6]SI=SIT12WEMY%O;<R@ARIRN",'Y:M^%M/U[3++[+K-]9
M74<2)';_ &:%HRH P=V2<]JK3E(UYCB?%&L6.K^*%DTF\)U#3CY,\4NF2S^7
M@MRNT<9W'/8X%>B:#!';:!800M(T<<"*K2(48@#NIZ?3M7GOB:[O=8\18_X1
M_5M/CLI,)J=G:[[F8 ]$8$!5/OGZ5Z;:3_:;.&?RY8]Z!MDR[77V8=C3ELA1
MW9-TK#7Q7I\J2M#'<2^7(Z82,?,$4,SC)Y7##GOVK4N[*WOHC%<(S(000'9<
M@C!S@^E8W_")6T+S/97$MLTA8<?/A"BH5&3_ +(.:E6ZEN_0WH9DN((YHFW1
MR*&4^H-);_ZA:;!;1V]I%;(#Y<:A%YYP!2V_^H2D,EHHHH **** "BBB@ HH
MHH *HO\ \AV'_KVD_P#0DJ]6?(Z#7X%+ ,;9\#//WDK.KLO5?F:4]WZ,T***
M*T,PI&4,I5@"#U!I:* ,RY\/:5=-O>SC63L\?R,/Q%5O["N[;FPUBYC Z1SX
ME7]>?UK<HK"6&I-WM9^6GY&RKU$K7NO/7\S#\_Q#:?ZVTM;U!WA?RV/X'BE'
MB:VB.V^M;NR/K+$2OYC-;=! (P1D&E[&I'X)_?K_ )/\1^T@_BC]VG^:_ JV
MNI65Z,VUW#+[*X)_*K59MUH&E79W2V46[^\@VG\Q6=>Z%/:V%PUCJEZBB)CY
M3MY@;@\#/(_"DZE>"O**?H_T?^8*%*3LI6]5_E_D07O_ ".NE?\ 7Q+_ .DY
MKJJ\AT;[?_;UELW"X\SY/.SC.#G/X5Z'CQ+ZZ=_X]7+@\?[:#?(]&_/S.C$X
M/V4[<ZU_X8VZ*Q,>)?73O_'J,>)?73O_ !ZNOZQ_<E]QS>Q_O+[S;HK$QXE]
M=._\>HQXE]=._P#'J/K']R7W!['^\OO-NBL3'B7UT[_QZC'B7UT[_P >H^L?
MW)?<'L?[R^\VZ*Q,>)?73O\ QZC'B7UT[_QZCZQ_<E]P>Q_O+[S;/2N7\-_\
MA_5?^O:U_G+5+Q0->_L?_2#;[/-7_CVW;\\_I63X/U)-,U"ZDO!,(VB56?:2
M$YX+>@ZUQ3S%1Q*IRBTK;O3^MCJC@G*@YJ5W?9?UYGI=%1P7$-S$LL$J21MT
M9#D5)7J)IJZ//:MHPIKHDJ,DBJZ,,,K#((IU%,#C+WX>VL-T^H>&;V;0;]CN
M;[-S!(?]N(\'\,5 /%^N^&R(_%^CEK8<?VKIJF2+'JZ?>3]17=4$ C!&0:KF
M[D\O8IZ9JVGZS:+=Z;>0W4#='B<,/H?0^QJY7(ZG\/M-GNVU'1YY]#U,\_:+
M$[5<_P"VGW6'X52_X2/Q1X7^3Q+I7]I6*_\ ,2TM"2!ZO%U'U&11:^P<S6YW
M=%9NC:_I7B"T^TZ5?0W4??8W*^Q'4?C6E4E;F)X8_P"/6^_Z_P"?_P!"K;K$
M\,?\>M]_U_S_ /H59'C'4O$,6F3PV6FW42;F_P!+M'61PBC(^4D;23QWP,U5
MKLF]D=E17G.CZ[J*>,)VOGO5M#YBF*16.S[@3<H&%!).""<YYK6\&ZOJFHZA
MJ*ZC&26(E! <"WY*B$AAC<  21US0XM I)G84445)04444 %%%% %+6)Y[71
MKRXMF19HH6="XR,@9Y%.TI[B72K66ZD22=XE=V1=H)(SP*BUW_D7]1_Z]I/_
M $$U+I?_ "";+_K@G_H(I]!=2W1112&%%%% !1110 4444 %%%% !1110 44
M44 %%%% '->-;U(] NK6*\CBNV0/Y9NA S1[@&^<_=!Z9K/\ 26,GV_[%;>3
MC9N_XFOVS/7'<[?Z_A6_K\MC9:;+>W=A'=L (UC**2Y9@ N6X )QUXJGX8U+
M3[X,MGID=C*UO%/(L:I_$6 !*]P5-5]DC[1AZMXD\2^'M6DCOFT/[%)Q:RW5
MYY!<[CVP>0" >W'O7;V4LTUC!+<+&LKH&<1/N4$CL>X]ZP/$'A_4;[4UU#3)
M[!96M_LLJ7UN95V9)RN",'D^QXK;TJQ73-)M+%)#(MO$L8<C&[ QFAVL-7N6
MF(52S'  R2:S#KUFMK'<.)D24%D#1G+*!DMC^Z!SFKT\ F .6#+G W$*3C^(
M \CV-<^/#,Z2RW$$L$$DBO'Y**?*1&4 D#UR ??I[TE8;OT.DCD66-9$8,C
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MESZL\L22&4?Z.F"^\.I(YR 0>.A!IMMI,>B[;*.0R -!(S%0N6:<DX X ST
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M_P#4+45E!+;Z;;0/)F6.)59NN2!S4EO_ *A*0R6BBB@ HHHH **** "BBB@
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M$CA@,<X/;BN,0ZB(3)<&XBL7$H@$;,Q,BKA6)/(W-D@>N/6FE<3=CO*CM_\
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M2?E2"?+%?+DR/:@"6BH_-/\ SRD_*CS3_P \I/RH DHJ/S3_ ,\I/RH\T_\
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MT^QQ0#'V5PUW8P7+0M"94#^6^,KD9P<5/110 4444 %%%% !1110 4444 9
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M !65<Z[##JW]FQV\UQ,(FE8Q@$*1@A?]XYSBM6LJY\/6,UTUW$AMKLB3]_"
M&W. "W(/( XIJW43OT)]-U)=12?]TT4D$IAD0L&PPQW'!ZU>JEI6FQ:381V<
M,CO&G0OC<?4D@#))YS5VDP04444#"BBB@ HHHH **** "BBB@ HHHH ****
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M#8R <'(S110 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/%%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>img254193463_24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_24.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %X ZD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M**XSPEXEO=5\2^++&_GB\C3KU8;8!0I"D$G)[TTA7.SHKS:7QYJ5CJOCMI%C
MNK71(8I+2%5 )++DY8=1G]*N^#;SQ;JK66IW.NZ)J&EW,>^>&VA*O 2N0JD$
MY(/!W>]/E8E),[RBLWQ%>3:=X:U2]MB%GM[666,D9 95)''U%>8IXO\ &VD>
M"].\97]]INH:=<>4TUG]F,4BJYQ\K X)&?2A1;!R2/8**\[N_$WB7Q-XIO\
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MSTTW2[?3]2N)[74;:\D:"S=T\M2<X8#!/M225]!MNVIU?B>3Q/)<6-AX<2"
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M !1110 4444 %%%% !12;AN"Y&2,XI$D23=L=6VG:=IS@^E #J*** "BBB@
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M )"%'D7?_/[_ .0A5JBNT^5*OD7?_/[_ .0A1Y%W_P _O_D(5:HH J^1=_\
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M J^1=_\ /[_Y"%'D7?\ S^_^0A5JB@"KY%W_ ,_O_D(4>1=_\_O_ )"%6J*
M*OD7?_/[_P"0A1Y%W_S^_P#D(5:HH J^1=_\_O\ Y"%'D76?^/S_ ,A"K5%
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MK-% &?>RWUI8W%R)8&,432;3&1G )Q]ZO,#\7-5!Q_9UG^;?XUZEK'_($O\
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M:NIKA/BQ_P BK;_]?B_^@/456U!M'7@*<:F)A":NFSF_^%NZK_T#K/\ -O\
M&C_A;NJ_] ZS_-O\:\\K5;28!X9&JK>B2?[0L+VZH<1@AB,D]_EZ#UK@5:H^
MI]A++,#&UZ>^G7_,Z[_A;NJ_] ZS_-O\:[/P=XDU#Q3I\]RZ6UN8I?+"JK-G
M@'/6O":]@^$?_(!OO^OG_P!E%:T*LY3LV<&:Y?AJ.%<Z<+/3OW.YV7O_ #W@
M_P"_1_\ BJ-E[_SW@_[]'_XJK-%=I\F5ME[_ ,]X/^_1_P#BJ-E[_P ]X/\
MOT?_ (JK-% %;9>_\]X/^_1_^*KRN3XM:JDC+_9UF<''5O\ &O7:^89_^/B3
M_>-<V(G*%N5GO9'A*.(<_:QO:WZG?_\ "W=5_P"@=9_FW^-'_"W=5_Z!UG^;
M?XUQ_A_2X-8UB&QN+P6JRG:&V%F8GHJCU^M9KC:[+Z$BN;VU2U[GNK+,"Y.'
ML]5Z]?F>IZ#\2=3UG7+73VLK2)9WVEQN)''IFO1=E[_SW@_[]'_XJO!_ W_(
MZ:9_UU_H:^@:ZL/.4HMR/G<ZPU+#UHQI1LFOU96V7O\ SW@_[]'_ .*J2)9P
M3YTD;#MM0C^IJ6BN@\8**** "BBB@#G/'-S<VOA:>6UM'O6\R,/:K;>?Y\98
M;TV\]5SSVK%\&WGAZWU/[)H_@[5M(EN%)>>XTXQ+@#."Y)_ >M:WQ O[W3?!
MUU<V,TENP>-9;B-=S01%P'<#U"DGVZURWA:\M;?QO96/AWQ-?ZY87%M+)?K=
M7!G6 C&QPV!M))(Q6B7NF<G[QZA11169H%%%% !39/\ 5M]#3J;)_JV^AH ^
M26^^?K6IX?MK.\U$6US9W5Y++M2""WD$>YB>2S8. %R>GUP*RV^^?K6AI.MW
MNBO.UGY&;B/RI/.A63*=QSV/?UKSEOJ?<5%)P:CN0ZK!:VNKWEO8SF>TBF9(
M93_&H/!KJ_A1_P C[:_]<I?_ $ UQL\S7%P\S)&C.<E8D"*/HHX KLOA1_R/
MMK_URE_] -5#XT8XI-8::?9_D?0=%%%=Y\:%%%% !7AWQH_Y&JR_Z\E_]#>O
M<:\.^-'_ "-5E_UY+_Z&]95_@/2RG_>5Z,\ZA\GSX_M#.L&X>8R %@N>< \9
MQ6UXBT_3[*'3IK.&XM9+F-I'M;B7S'1-V(W)P,;ASC_&L:WG>UN8KB,(7B<.
MH=0RY'(R#P1[5=U?6KS7+C[1>K;&8DLTD4"QLY/=B!ST[UQJUCZ649.::V,X
M=17U/X=_Y%G2?^O.'_T 5\L#J*^I_#O_ "+.D_\ 7G#_ .@"M\/NSR<Z^"'J
MS2HHHKJ/G@HHHH XGXK_ /(A77_76/\ ]"%?/E?0?Q7_ .1"NO\ KK'_ .A"
MOGRN.O\ $?3Y/_N[]7^AT&E:?I-YH5]--'=I/;0/(]V9 L229Q%$%Q\Q;GN#
M^5<_6K'XAOHM&720EF]FI9E62U1F#-U;<1G=[]16563L>A34DVY'K_P1_P!5
MK?UA_P#9Z]:KR7X(_P"JUOZP_P#L]>M5VT?@1\OF?^]3^7Y(****T. ****
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MYKY0KZ5\ ?\ (B:1_P!<3_Z$:TI5'-V9Q9A@*6&IJ4&]7U.DHHHK<\@****
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MD(I*@ GDDD=V]JGH7K<W**;(F]"H=ESW7J*K_8V_Y^[G_OH?X4AEJO-/B_\
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M;+_GDW_?9H_LFR_YY-_WV:\W^U*-K6?X?YGNJO24G*SN_P"NYL_"?_D:Y_\
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M]\.02#^E.,[R1%?#N-"5GLG^1]$456^P0?\ 37_O\_\ C1]@@_Z:_P#?Y_\
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M_P"?A?\ ODT?V&W_ #\+_P!\FN5X_#NWO?G_ )'JTYTX.33W=]OZ['>_!_\
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M_P C)#_NM_Z":ZL%_O-/U7YF&*_@3]&>HT445]X?(!1110 5YU\0/^0S;_\
M7N/_ $)J]%KSKX@?\AFW_P"O<?\ H35Y.=?[H_5'HY7_ +PO1G(T445\>?2B
MK]X?6O9]*_Y ]C_U[Q_^@BO&%^\/K7L^E?\ ('L?^O>/_P!!%>_D'\2?HCQ\
MX^"'JRW1117TYX(4444 <_XT_P"1:G_WE_G7EE>I^-/^1:G_ -Y?YUY97R.>
M?[TO1?FSZ/*?X#]7^@45O6,*3Z%+&L)CE5))6GDM@R.HQP'/*GZ=S6#7EU*3
M@D^YZ$)\S:['>?#O_5ZA]8__ &:NWKB/AW_J]0^L?_LU=O7V.4_[G#Y_FSYG
M,?\ >9?+\D%%%%>B<04444 >,:K_ ,A>\_Z[O_Z$:?I,MI!=F:[9E**3$1'O
M ?L2,C('7ZTS5?\ D+WG_7=__0C5.OSYSY*KEV9]DH\U-+R-+7Y(I=;N989_
M.1R#OQU.!FI?"_\ R,=E_P!=!616OX7_ .1CLO\ KH*TI3Y\3&7>2_,BI'EH
M./9/\CURBBBOO3Y **** "N$^(G^MT__ '9/_9:[NN$^(G^MT_\ W9/_ &6O
M-S?_ '.?R_-'=EO^\Q^?Y,XE AD42$A,C<0,D#OBMW6[JQN-*M$L[@E(I76.
M$Q[2B87KSZ\Y[DGTK HKY"%5PA*%MSZ25-2DI7V"O7O#7_(NV7^X?YFO(:]>
M\-?\B[9?[A_F:];(?X\O3]4>=F_\&/K^C-6BBBOJSYX**** "BBB@ HHHH *
M*** "JFIF]&F7)TZ."2\\L^2EP2(V;L&QSBK=5M16]?3KA=.DBCO"A$+S*2B
MMV) [4(&>66TOC'2M:;0K/PSX1MKB_MWN)!"KHLB*0IW$'G[W3ZUZ-X9MKVS
M\/6EM?VEE:7$2E#!9$F)%!.T+GGIC\:XV3PS\09->AUEM9T+[7#;O;+_ */)
MMV,P8\>N5%=SHT>J1:7$FLSV\U^,^9);(50\G& >>F*N3T,X+4M7-O%>6LMM
M.@>&5"CJ>ZD8(JM8:7#822S"6::>4*K2S-N8JN=J]N!D_F:O45!H%%%% !7%
M?$/_ (]K'_>?_P!EKM:XKXA_\>UC_O/_ .RUYV:_[G/Y?FCMR[_>8_/\F<#1
M117Q1]2%>H^"?^1<3_KHW]*\NKU'P3_R+B?]=&_I7KY'_O7R?Z'FYK_N_P T
M=%1117UY\V%%%% %;4?^09=_]<7_ /037BS_ 'V^M>TZC_R#+O\ ZXO_ .@F
MO%G^^WUKYG/_ (X>C_0][)_AG\BY8ZDUDC1F"*>,NL@27.%=>C#!'K56:9[B
M>2:4[I)&+L?4DY-,HKP74DXJ+>B/644FY+<ZKP#_ ,AZ7_KW;_T):])KS;P#
M_P AZ3_KW;_T):])KZW)?]U^;/G,T_WCY(****]<\X**** /,?'/_(PM_P!<
MU_E7-5TOCG_D86_ZYK_*N:KX/'?[S4]6?783^!#T04HZBDI1U%<IT'M\7^I3
M_=%/ID/^IC_W1_*GU^BK8^*>X4444Q!7*^/O^0%#_P!? _\ 06KJJY7Q]_R
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M'C"Y\SP[,ODSK\R\LF!UKS.O4_&G_(M3_P"\O\Z\LKY'//\ >EZ+\V?1Y3_
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MG^3.'HHHKXL^H"O5O#MWL\/V:^1.V$/*ID=37E->O>&O^1=LO]P_S->YD/\
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M]1\$_P#(N)_UT;^E>OD?^]?)_H>=FO\ N_S1L?;1_P ^US_W[H^VC_GVN?\
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M"BX4VVGKJ8U,9/%OGFDK::%7[:/^?:Y_[]U+#/YQ(\J5,?WUQ4M%;F84444
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M]_3_ /$T;[[_ )XP?]_3_P#$U]V?(EFBJV^^_P">,'_?T_\ Q-&^^_YXP?\
M?T__ !- %FO.OB!_R&;?_KW'_H35WF^^_P">,'_?T_\ Q->?^.S*=7@\Y44^
M0/N,3_$WL*\G.O\ ='ZH]'*_]X7HSE:***^//I15^\/K7L^E?\@>Q_Z]X_\
MT$5XP/O#ZUZ]IC7G]DV>V* KY"8S(?[H_P!FO?R#^)/T1X^<?!#U9J456WWW
M_/&#_OZ?_B:-]]_SQ@_[^G_XFOISP2S15;???\\8/^_I_P#B:-]]_P \8/\
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M_D:Y2NJ^&Q8?$70]@!;[2."<#H:);,<?B1]<T56WWW_/&#_OZ?\ XFC???\
M/&#_ +^G_P")KA/0+-%5M]]_SQ@_[^G_ .)HWWW_ #Q@_P"_I_\ B: +->$_
MM$?\?/A[_<N/YQU[;OOO^>,'_?T__$UX=^T$9C<>'_.2-?DGQL8GO'["M*7Q
MHRK? SQ:BBBNLX@KZV^&/_)-M#_ZX'_T(U\DU]7_  T:['PXT/9%"5\@\M(0
M?O'VK&M\)OA_B9VE%5M]]_SQ@_[^G_XFC?>_\\8/^_I_^)KF.LLT4#ISUHH
M**** "BBB@ HHHH *;(S)$[*A=@"0HQECZ<TZB@#RNU\0W$WC#5-0N_ &H37
MEL4BMY8K>/S8D,8R&;=@YR<$9X.*[;P7%>0>$K&.^TZ'3IU#?Z+"NU8UWG:,
M9/.W&??->?>)-0TR3QUK%OXCUS7;:W@$(LH].,JQJ"@+9V*<MGG/H1^'H?A!
MM/;PQ:G2[J\NK,E]DMX6,K?,<YW 'KG'M6DMC*&YN4T(JLS*H!8Y8@=?K3J9
M%-%.F^&1)%SC*,",_A69J/HHHH *XKXA_P#'M8_[S_\ LM=K7%?$/_CVL?\
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M4^VRD/%]WEB<=!TZ?A6)16]M;F%]+'5_#,,?B/H81@K?:."1G^$U]7^7>_\
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M"*]#TK2[/1=-AT^PB\JVA!VJ6+'DDDDGDDDDY-:2>EC."UN6I)$AB>61U2-
M69F.  .I)JO9:C::BKFUFW[,;@5*D9&0<$ X(Z'O4ETS+:3,EN;A@A(A! \P
MX^[SQSTYK'\-6UXHN[W4X)(]1NV5I@=NQ  0L:8)X49Y/4DGO@1T+OJ;U%-D
M5F0A7*'^\ #C\Z@^SW'_ #^R?]\)_A2&6:XKXA_\>UC_ +S_ /LM=9]GN/\
MG]D_[X3_  KCO'T4D=O9;YVD^9_O*!C[OH*\[-?]SG\OS1VY=_O,?G^3.&HH
MHKXH^I"O4?!/_(N)_P!=&_I7EU>E>#897\/H4N70>8W 53Z>HKV,C_WKY/\
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M\04445J8GN'[/L<CP^(/+G:/#6^<*#G_ %GK7M7V>Y_Y_7_[]K_A7C7[._\
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M6_\ SPC_ .^:QKUXU4E:QU8/!/#-OFO<FHJ'[);_ //&/_OFC[);_P#/&/\
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MU[HFHJ'[);_\\8_^^:/LMN/^6*?]\US>Z>AJ344=**D84444 %%%% !1110
M4R:&*XA>&:-)(G!5T=058'L0>HI]% '!WOPC\+W5\UW%;O:.US'.5MCY84*N
M"B[<;0>IQSGH178Z9IZ:7I\=G'/<3)'G:]S*9'P3G!8\G&<#VJW13<F]Q**6
MQ6U"^BTW3KB]GW>5!&9&"C).!T'O5>PU.2YO)[*ZMOLUU%&DI02;P4;."#@<
MY5@1CMWJQJ-C%J>G7%C/N$<\9C8KU&1U'O5>PTR6VO)[VZN1<74L:1;ECV (
MF2 !D\DL2>>_M1I8-;F@2%&20!ZFF^=%_P ]$_[Z%.(### $>AIGD0_\\D_[
MY%"MU#47SHO^>B?]]"N.\>J;BWLA"#(07R$&['W?2NP\B'_GDG_?(I1#$.D:
M?]\BL,50CB*+I-VN;8>LZ-15+7L>*_8[K_GVF_[]FC['=?\ /M-_W[->U>5'
M_P \U_*CRH_^>:_E7C?V!3_G?W?\$]3^V)?R?C_P#Q7['=?\^TW_ '[->E>#
M2(?#Z)*?+?S&^5^#VKH/*C_YYK^5'DQ'_EDG_?(KKP650PM7VBDWI;8YL5F$
ML13Y'&WS#SHO^>B?]]"CSHO^>B?]]"D\B'_GDG_?(H\B'_GDG_?(KUO=/.U%
M\Z+_ )Z)_P!]"CSHO^>B?]]"D\B'_GDG_?(H\B'_ )Y)_P!\BCW0U(+Z6,V%
MR!(I)B; !]C7E[6UQO;]Q+U_N&O5_(B_YY)_WR*7RH_^>:_E6]&NJ2:M<XL7
M@OK+3<K6/*X#?VK%K<7,188)0,,U&;>Y9BS0S$DY)*'DUZQY4?\ SS7\J/*C
M_P">:_E6WUU?RG)_9&EN?\/^"<-X/C>'6':5&C7R6&7! ZKZUW/G1?\ /1/^
M^A088CUC3_OD4GD0_P#/)/\ OD5S5:BJ2YCT,-A_84^1.XOG1?\ /1/^^A1Y
MT7_/1/\ OH4GD0_\\D_[Y%'D0_\ /)/^^16?NG1J+YT7_/1/^^A1YT7_ #T3
M_OH4GD0_\\D_[Y%'D0_\\D_[Y%'NAJ<)XLC>;66:)&D7:.44D=/:L-(;J-U=
M(9E93D$(00:]8\F(=(T_[Y%'E1_\\U_*NN&+48J-CRJN5^TFY\UK^1Y5/]ON
MG#W N96 P"X8D"HQ;7&1^XE_[X->L^5'_P \U_*CRH_^>:_E5+&I;1(>47U<
M_P /^",CFB\I/WB?='\0I_G1?\]$_P"^A2>1#_SR3_OD4>1#_P \D_[Y%<7N
MGL:B^=%_ST3_ +Z%'G1?\]$_[Z%)Y$/_ #R3_OD4>1#_ ,\D_P"^11[H:B^=
M%_ST3_OH5SWC ^=I$2Q?O&\X'"<G[K>E=!Y$/_/)/^^12B&(=(D_[Y%5":A)
M2,JU-U:;A>USR;[-<?\ /"7_ +X-3!M1%N;<?:A >L>&V_E7J?E1_P#/-?RH
M\J/_ )YK^5=;QJ?V3S%E%MI_A_P3R;[-<?\ /"7_ +X-=KX-_<Z=.LO[LF3(
M#\'I[UTGE1_\\U_*@PQ'K&G_ 'R*BKBE4CRV-L-EWL*BFI7^0>=%_P ]$_[Z
M%'G1?\]$_P"^A2>1#_SR3_OD4>1#_P \D_[Y%<ONGI:B^=%_ST3_ +Z%'G1?
M\]$_[Z%)Y$/_ #R3_OD4>1#_ ,\D_P"^11[H:B^=%_ST3_OH5Y1);SF1B()2
M">H0UZMY$/\ SR3_ +Y%+Y4?_/-?RK:C75*^E[G'B\']9M=VL>50B^MI/,@6
MYB?&-R*P.*;)%=RR-))%.[L<EF0DDUZOY4?_ #S7\J/*C_YYK^5;_75ORG'_
M &1I;G_#_@GG/A^&6/7+9Y(G10W+,I %>C>=%_ST3_OH4>5&?^6:?]\BD\B'
M_GDG_?(KGK555=['=A,+]7BXIWN+YT7_ #T3_OH4JNC_ '64_0TWR(?^>2?]
M\BG+&B?=15^@Q6.AU:CJ***0PHHHH **** "BBB@ HHHH *P_$E]=67]F):O
M*IN+P12>2BLY7RW; #<=5%;E5;[3K;45A%PKDPR>;&R2,C(V",@J0>A(_&FA
M/8YZS\4RP:?;/?JDCM<M;N=ZI(I\W8H,?=@"I;''7&:D3QG;R6BRBW(FDN/L
MZP%SO1MI8^8,90@*>,'\:T?^$9TC(/V3G@M^\;YR'W@MS\QW$G)SR:D_L'3B
MK9B<NSK)YIF?S R@@$/G<, D=>A/K3NA6D<V/&,R+<WLT=P(([APEOY:JVU;
M=9"K9_VLX/T[5IS^*UM96MIK)DO!/Y(BWY7_ %8DW;@#Q@XZ=?;FKTGAS29H
MW22TWB1BS[I&)8E-A).<_=&*FGT:QGF>9H669Y!*94D9&#!=F00<CY>..HHN
M@M(L6=R+RRAN5CDC$J!]DB[67(Z$=C4]-C18HUC7.U0 ,DD_F:=4E!1110 5
MS4UYJ4NI:\(;\0IIZQM#&T:E#F/<=YQG&?0BNEK-GT'3KFYGGEB<M<;1.HE<
M)+@8&Y0<'CVIH31E)XO!2#-B6EGLS<QQ1S*SG"!RI7J."0,]2.U:=CJXU>"[
METY$=(P%AF=ODD8H&[<@#(!]\^E/BT/3X+W[9%!MG#.ZMO8A6888A<X&0!^5
M.TK2;?2-(BTVWR(D4@L/E)+$EFXZ$DD\4:"5^IS;^);ZU\*0F>YMCJ]Q)<1)
M.Z;(4\MW!<C/0 # SDD@=R:Z;1[LW^BV-VTBR-- CLZXP25&>GOFBSTJTL+.
M2T@23R)"Q97E9^6)+<L21DDG\:LP0QVUO'!"NV*-0B+Z # %#:!)]22BBBD4
M%%%% &/XAN[FUBL%M9C"UQ>Q0.X4,0K9SC((SQ5&77[G2KC4K:Y,=T+18Y5E
M>1825<,=I[%OD.,#G(Z=:W+[3[;4HDCN49A'()4*NR%6'0@@@U5?P[I<B@/;
ML6W,QD\U][$KM.YLY.5XY/2J31+3Z%6#Q1!<WD5K%;R^=,\1C5B 6B=-_F?0
M88'W&.XJ/4=2O++7;>!+N.3S6:1K;8-L-NJ'=([=0=V .QSC'!-:$&B6EOJL
M5_&H#0V@M(5Q_JTSD\]3G"_E[TJZ%8)J%Q?+'*)[D@S'SGVR8& "N<$ =L8H
MT"S,GPQK%]J%SY5XS?/9QW"B6,(2S$AB@'6/IC///-=/5&QT>QTV0R6L)5]@
MB!9V;:@Z*N2<*,]!Q5ZDQJ]M0HHHI#"BBB@#D+/5]231K'5IKOSQ/>?9Y+=H
MU VM,8QL( .1P>2<X-7(_%UOYLB3P!%BGCBFD2972,2 [6+#_:&TCMD5?A\.
MZ7 %5;=F1&9DCDE=T0MG)522 >3^=03^%=,ETJZT^.-HX;J-(IB6+EHU/"_,
M3@8)'MFJNB+2'F\NM2T>WO+5I+3S,R[ BO*\>"0%!X!/RGG.,UD6^MZBUA8:
MG>2NNGF%1/+;*G$ID*G>K#( X!V]"3Z5TMWIUK>QQ+-&?W+;XFC8HR'&,J5(
M(X)'T-0#0M."PH+<B*$*$B$C>7\IR,KG!(/.2.M%T-IFC1114E!1110 5B7L
M]Y-XG@TZ&\>VA-E).=B(Q+!U4?>!XP36W5&[TFTO+I+J595G2,Q!XIGC.PD$
M@[2,C(%-"9C6GBIUBM$O(HF>2Z:T:1)0NYQ*8PRH>2"0"?3/?%7=-\1PZC(R
MK \?DPL]SN(_<,&*[#CO\K'Z#W%3#P[I0EBD6T5#'Y>U49E7Y#N0D X)!)//
MK4VG:7#ITU]-'S+>W!GE;:!DX"@<>@4"F["5SG-+\17>LWNI"._M+: P13VP
M8 O#%N8.S\_>(4'!X7(SWK;\.7UQJ.EFYF)>)I7^S2LNUI8<_*Y';/;@9&#C
MFIM0T33]5CN([RW\Q;A$CEP[+O56+*#@CC)/USS5JVMDM8O*C:1ESG]Y(SG\
MR2:&T"3)J***DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KBK
MC4]2BUB]F\^X2UM]4A@,A9#"D3+'E2GWB27Z]BP/05VM4#HNFM>M>-9Q&=W#
MLQ&<L!@,1TS@#GVIIV$TV84_C&2$W"_9(Y!"49YX7>2*.-@_S,0F< IC(!'S
M YQFJ^N>++H6&J?V?:RA;<&,72*6"OY8??G;MV\@=<\YQ70CP]I*Q^6MA$%P
M!@ ]!G ^@W$8Z<U)/HFF7,CO-90N9$V/E>&&,<CH>./I3NB;2,!_$]S:W.IQ
M1VWGBT\^=S-/CY(RH*J OOQG\ZT++Q#+?:O):Q6$IMDF> S[6^5E7.X\;<$\
M=<YQQS6BVD:>S3LUG"6G5DE.W[X;&X'ZX%.33+*.]-XELBW!'+@8SQC/UQQG
MTHNAV9;HHHJ2@HHHH S]=GEM?#VI7$#E)HK65T<?PL$)!_.L5[^YT>YTU3>&
MXCO+>1Y%NY  C*JD-N R!DX(P>2,5TT\,5S!)!,BR12*4=&&0RD8(-4DT'2T
MADA%E$4D4*V[)) .0,GD $ _6FFB6F8H\:!+9)9+/_6--!'M<XDN$;"QC(!^
M?J,^AXJ[KT^I02:3)!<I!$UY%'<1JFXR;F V[CT7KVR>.E76T.P8VH6$)';7
M!N5C4##2X(W'U/)/UJ:^TNRU(1B\@641-O3)(VMZ\=Z=T%F<Z-?N;CQK:VHE
MD@LMTT @:$AIG4 ^821PH.0,=>3Z5UM1M;PO-%*T:F2+/EL1RN1@XJ2DQI!1
M112&%%%% '*W,UY)?^(I1J4UN+!4: ?+Y:_N@QW CD9Z_P!*$\6W#&&-;**6
M>:T:=(8Y3N#JBL4;Y< \D8R2,#/6MN;1--N+M[J6SC>:0@NQZ/@8&1T./>G)
MI-A%=M=QVL:7)+-Y@'(+##$>A/&?6JNB;,I66K_VYIUY<6,R6]L/E@O#AL_*
M"S8/'RDD=>JFL!-5U&X2WCM)[R:UNKJ3[)@HD\\*QY+AF  7?R">2I':NHAT
M/3XM#&C- LMEY?EO'(,AP>3N]<G)/UH.@Z6;<0-:*T8;<H))VG&.#G(XXXHN
M@LV&@WDFH:!87<LJRRRPJSNB[06QSQ]:T:9##';PI##&L<2 *J(,!0.@ I]2
M4@HHHH *Q-=DG.H:-:Q7,T$=S<NDIB(#,!$[ 9P>X%;=5;W3K345C%W LOE-
MOC))!5L$9!'3@D?C30F<W-XEGT=-4CF>*[2PE(5Y'VR2((U<J JG+#=C/ Z9
MK2M_$)N-;;21;8N8Y&,@W_=AV@K)T_B+!<>H;TJW)H.E2PI$]A 8T5E"[>S?
M>!]<X&<]:FATZ"'4KB_4$SS1I$2<?*B9(4>V6)_&G="LS#N;B^M]=MEM[]IH
M[QIT7?M,0=48K& .005)+'T(ZX M^'KB</<V%ZTS7ULL9F+RB16W X*D 8R0
MW&.*O#1M.%S+<"RA\V4,';;UW##?B1U/>IK.PM;"-H[6%8E8Y;'4GIR>II70
M).Y8HHHI%!1110 R4E8G8=0I(KC['4;VRT?P_J,M]+<-?A%N([AE"G,3.7!P
M-N"N3VQGVKLR 001D&LV#P_I-M&8XK"$(8S%M(W (1@J >@/H*::$TS('C*.
M&-Y;N!%@AN#;S31N2JDQB1",J"0<[?KCKFF^)==O[30(A$CV5]<V[2O+Y9D6
MU"KD\XP6R0 #[GH*V)= TZ6U-L( D+31S2*O_+5D(*[B<Y^ZOY"M"6))X7BE
M4/&ZE64]"#P13NA69R[ZA=2W^DBTOI9[BZ$4IMU0!([<#]X[\9YY /'. !P:
MZNL\:'IBWQO5M$6Y;9ND4D%MHPH.#S@5H4F-(****0PHHHH **** "BBB@ H
MHHH **** "BL[7'NTTJ1K(.9\C&P9/6L)KC6QX.U*1_M*WBGY3L(<)\NXJ.N
M<;L>]:*G>'-<P==*K[.SVO?H==17%ZM)IEM:V<FAM')+]L@9HX)2Q<#=@'GJ
M3QSR>],@\37[Z6)KB[MXY)@AC,01V#E69D(W *!@8W'/4=<5/*:\QV]%<UX7
MU34]:DGO+F6!+54C5+=(B&W-%&Y8L3TRQ &/QKHY,^6VWK@XQ2:L-.XZBN$\
M(7/B2762NK+>"V\IB/.C*KNXQU%942ZRW@E],1[O[)+;27AO]QW1QC<6AW==
MQ; '^R3Z53A9VN2IW5['J%%<.-6U"+[3':20P;/MT['RB^\Q&/;G)[[CG],5
M$NOZBEM<36GD0';>73 QEMQC6)@#D]]Q!Q^&*7*/F1WM%<+J'BF_L(;Z-KE&
MN;8>=&! /WJ^6C[3E@  6QQEB.W!K>\..SRZUN9CC4G W'.!L3@>U*P*5W8W
M**P?&DFI1>#M3DT?S_[16+,'D+N?=D=!WXS7GGA"Z\777@OQ9_PE)U)'%N!;
MFYC,3 %7W;3@'T_2FHW5Q.=G8]AHK@KH:P\VFVMXUQ'!IEY$IGS@7Q8X0Y'4
M!#EA_>/M4&DZK=1W\*+<):175M:;Y6&4B_<LVU0QP"QXY]/6CE'S'HE%8WA-
MVD\):4[N79K9"6;.3QUYJ+Q5)J<5A"=+$QE\S#>4I8XP?2L*]7V,'-J]NQK1
MA[62C>US>HKB[]-1O?!MG#=3W-M>2WT*>;RKI^]&#_+ZU1OM1UL7]MJ]S;2V
M\MI#/!':'.R1U3+RD#[RY'R^P)[U=&7M::GM<FJO9S<-['H5%<?_ &]>_;%L
MQ?P&U-QY?]I[%V,/*W[!SMSGC/IQUK*T[Q!JMMI-I%"8<0V$,J_:' -QN4EB
M,G<<8X [CGK6G*R.9'HM%<4WB'4;.VTPW%[%/=S^1)+%';!$V2N%QDMG@$],
MGC)XJNFMZO:O);)?12N;B\)EN61 C)+A(SD\ J=WK@<<4<K#F1WM%-C+-$C.
M &*@D*<@'VKA?'USXE@OK0:$+TQ&,^9]GC+#.>^!6<Y<JN=6%P[Q%14TTK]7
ML=Y17"ZV]['IVD7LTMM<30V0:XTV\<QO,V%):,CI*"" "#][M4Z:]KMRUZT$
M=LCPF4BTD8>8!&WRC:#G+*.2>/F!'O:5U<YI/EDX]CLZ*XF3Q/JEQ';7%KY$
M5K>+-/:R3XC!12HC5BQ_BRSGOC&.AIDOB#75N69IK5+:2[FMU.P*(?+&1EV.
M"6/L.%XY-/E8N9'<T5!922S6-O+.(Q,\:LXB;<FXCG![BN3^(\_B"WTJT;P\
M+LSF;$GV:,N=NT]< \9J)/E5S:C3]K-0O:_<[.BN"L)]7M_!.EZYJQNEOM.F
M>:Z652': LROE>^$(8?[HI4U+5K*&"5?+BEU-9KYI+F0*JG*B.++'@!",@<\
M''>JBN97(J+V<W!ZV.\HKB9/$.MV8N-3G,,UBEY)9"UBA.]6SMC;?GG+X4\=
M&![5=\2Q7ATK3O,OM/%U&VZ6&\)C@NCL(9<CE<$Y'7IT-/E(YCJ:*XFPU[6+
M^98+:&#3QY:+%;W+@N T08-@G<Q#'''!"G//1!XJU2[M8;F*)+>WFN!;,\@"
M^4Z(QDY;C_6#8,_W3ZBCE8<R.WHKA9?$&OK))*9+,01O;P2+$N0ID0,TGF$X
MP#P,C'S<UUFD3W%SI<,UTT+2MG+0L&5@"0#D<=,9QWS2:L-2N7J***0PHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@>VC@$VX"/<H4;2"P![9/&?3%4+2>\@L(XX'F8I;K\C1?=EW *G3H1D'T'-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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4H **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>img254193463_25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_25.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (Y G,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***;)
M(D4;22,%1 69F.  .I- #J*J:=J=CJ]FMWIUW#=6S$@2PN&4D=1D5;H ***0
M,"Q4$9'49Z4 +1110 4444 %%%)N&X+D;B,XSS0 M%4I-7TZ+5HM*>]A6_EC
M,B6Y<;V4=P/P/Y&KM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWQ;4;IO)PR%7@4CYFP>_8$=SGM7$?"3X<CQ5?-K6KHS:5;2?*C?\O$@YP?\
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MPJZQ7,2S('&&VL,C(^AJU0 4444 %%%% !1110 4444 %%%% !1110 4444
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MUN%%%% @I"0.I ^M+7#_ !*2WDM] 2ZL)-0MVU11):1(':4>7)P 2 ?7KVH
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MI&RLK;3K*&SLX$@MH4"1QH,!0.U2HB1C"*JC). ,<GDTZ@ HHHH :[K&A=R
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MY[>]<DU]6I^PI_'+?_(A^XN5;LNZ%I+ZO>C>"+:,Y=O7VKT1$6*-8T4*BC
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M<[RJ,P&7>1L':BG(SR21CO5CP]K=UJ<NH66HV<=KJ&GRK',L,OF1L&4,K*V
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M,\T?+UROK0 '\?>CD^N?ZT84?Q# HPOJ/2@ Y[9I/SQ_2E^4]QSQ1Q_>'/-
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MT@!RH^;J5]/\_2FDJ5/W.4#<'_/Y4,5PQ^0\!NO% #AN./OY*D?E1\S9QO\
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M2@E2I/RG*[^OZ4 +SU&X9^8<TO(S][CYNO:FL5&3E#C#=?6@E4).4.T^OK0
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M SC/7-*<#=DKQ@<']: +]C<X(C;.#T)K1K !VMG<N0V.O^>*V+64RP@GJ.*
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M<LD1/G+&YM/NA04W$9.#]%.?;% &TWC#5XXW+21[TF#@JG5"<$8S[_F#2_\
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MP."/QKNX(5@A6-1T'/N:Y_P[^\MU,A\PE50%3VZM^'0_D*Z2@ HHHH ****
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M:?E.<[OS_G7HFF6=K=:3:3R0(7DA5F/J2.:M?V79$8^SK^M8G(U9V/,(?"<
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MF+A58;G&%Z')X_4UZ<VG6;=;=.N>!BD.G69(/V=.#F@#S'_A%H! H6Y4%(N
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MLW]:ZV*RMH'WQP(K>H7FN=UKZLN.-M'5:D6DV\EII%G;R_ZR.%5;Z@5<HHK
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M'Z5YQ\$3GP)-_P!?\W_LM>CM]T_2O./@E_R)-U_V$IOY+0!Z11110!PNM?\
M(1G_ -ZL64UM:U_R$9_]ZL62O%ZGJ+9&MJ/^O/T'\JRI36KJ7_'PWT'\JRI.
MM+J/H>D:6,:9;_[@JW5;3AC3;?\ ZYBK->S#X4>9+XF%%%%42%%%% !1110
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MNG/Y"NGT;X>>%-""FRT6V,H'^MF7S7_-LX_"NGHH 1$6-0J*%4= !@"EHHH
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MI&6W?[CIK9'7:4:;]Y;G"M=RFUBMCCRXG9UXYR<9_D*GN-7GG:=_+ACDN/\
M6R1J0S#TR2<#Z5=E\,78/[N6)Q[G!IL?AB[8_O)84'^]FO0_MC+VN;VB_KR/
M._LG')\O(RI_;5X9=\8B25I%D=T3F1ATW?F?SKTGP?93VND![B&. R'<D4:X
M"@\YY).3_("L#1M*T_2KA9KA!=..A/13]/\ &N\AFCN(A)$P937F5\UP^*O3
MH=-SU<+EE?#OVE8DHIJR(Y8*ZL5.& .<'WIU<IWA1110 4C-M4M@G S@=32T
MC;MIVXW8XSTS0"/,O$7Q$6XT@)82W&EZG%=HLUO.H5PG.>O!'2NLT;QC8Z_J
M\]EIT-Q-!"F6O-F(BV?N@UYYXWT#69;"+6/$=Y"T[W*016ULH"QH2<_-U)X]
MZ[GPMHVO>'[IM.GN[>ZT5(\P.4VRJ<\*0/;//-<-.=5U;/;3^O(^HQN'P$<$
MI4[<WO6UTZ7L[>];HG;=[G645D:AXETW3F*/-YDHZQQ?,1]>PK&?QL[M_H]B
M,>KR?T K:>*I0=F]3PJ6!Q%17C'3[OS$^)^N:AX<\$7&J:9,(;J&:+:2H8$%
MP""#V(-<I\%$O-0.K^(-2TR;[9?RE_[2E( E7^XB]0 >_3H.U;>JZJVO61L=
M3T^TN+-G5VB8L Q4AAGGD9 K4M_%IMT6-].5(D 51"^ !Z 8J5C*3Z_@:/+<
M0NGXHZVN<U?PK'>.T]HRQ2GDH?ND_P!*OV'B#3M08)'-LE/_ "SD^4__ %ZU
M*N=.EB(6>J.2<)TI6DK,\YD\,:I&^/LS-[JP(_G5VQ\'W4K@W1$*=QD%OTKN
M:*Y(Y503N[LGF9!:6D-C;K! FU%_,^YJ>BBO12459$A1113 **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KS/X0\2>+E[C6I>*],KS/X2_+J'C-
M!T&LR']30!Z91110 53U?_D"W_\ U[R?^@FKE<SX^T&X\1>#[VRLII8KU5\V
MW:-RI+C^$X[$9'XT 8WP7_Y)=IG_ %TF_P#1K5W]>3_ OP]=Z?X;EU:\DG'V
MMBEO [';'&IY(7L2V?R]Z]8H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ JAJNIQZ;;@*8GO)@RVEL\HC-Q(%)" GN<5?K
MQGXWWVJ6UWI,^EV>HI+9"1C?1QDQ)O7:0#V; Z\8SQ[ ':V&A^(==TR]7Q;?
MK#'>JFRRT\F,VP!SCS!RQ/0]JTM)\-:/X0TZ[.D6AA,@W2LTC.SD9P26)]:C
M\!ZZ/$?@G2]1+;I7A"3<_P#+1?E;]1G\:Z"6-98GC;[K @TI)M-(<;)JYP\S
M2O)?+;^0LRZ@($,N,!?FX&3R3@4R/4(#->SA#);6:Y8 $"1P -HSS@N<5GZO
M%>6UU=6]RD8\V[^TEE!]\;?SJM=:A=72LF5A5W625X697D(&!DYXYY..]?.S
M=.,K-6L^WF_^ >W&,VKKJOT7_!-B3Y)K]#L^6V::(R': #@J23TQG'X5 WF2
MZE]AA0(D(/FSN,;SC);V0#IZ]:S)+ZX-L8!L<&W>W+R%F8JS \G/..<?6HY;
MR:2&*'.W8"OFJQ5]O9<CM64O8M:+^NQHE53_ *^\W%N(9;RS-O&R021\%N&?
MYRNX^F1SBI5>9HG-I:I++]N>##L<!%SZ'VK&L6OKJZMQ&LLR6L?"[V8G#;B3
MG\JCDNYV"#RQ&ZWSW@8-DH3G ''/7K5?NDW)K3T\O\R;3:2OKZ^9NIJ-D9+R
MX=B]C:G!9#]\Y  4]^3^E,VR[M0A">9/ !Y8W8!RZ@'Z8.:Q[G4)I5,%M$MG
M"TOFR&-@2YQP ,<#.3^--NK^6XMI86B$C2VRP/*[\MAPP8C'7 Q0_8O1^;_X
M'Y E56W]>?YFF)?/U!K.W "096:X<D L/O'V5?7O6SH6JP_VO%:VQ8VT]NLB
M%SRQRWS8[9V_K7)7.HW$J@(S1R,GERS(_,B]@01S]>];WA6"[U'6(;R8N8+.
M 1J21\[<\]/?]*VPJA[5<F]U]W_#7N9XCF]F^?;]?^'V-2Z^'^@7.NC6DBN;
M:_\ .$SRV]RZ>8P.?F&<$'H:@%QXHT'799-2N+*^\.RM)*UTY$$EBO) ;LR]
M@>M=?7C/QN\47]K=:=X?TEY#-/&\ES'&NXNC H%*]\_-^E?0'BGL<4L<\22Q
M.KQNH964Y# \@BGUSO@5W;P3I,<EE>6;P6Z0F*\7$@V@#/T/45T5 !1110 R
M6&*90LL:2*#D!E!&:Y?Q3JTRR/I]M-]G2.+S;F?J57. H]S_ %KJZ\_\9P-9
M:E/<S)(;&_@6)Y(QDQNI!!Q^ X[\URXMR5-\IWY<HRKI2Z;>O_#?B<[!'!/<
MP16\S2O*VW#IM(.?J:T#:(FJ&R$X*>495F5<AD"EL@?A6'87EIITKSP22W-R
M(F6(&':@9N,]<\#/XXK1L=1^6TEDMVAGMHYH5$:_+L93MZD\AB?P->/!02M(
M^EJSJ-MPNU;\?ZT)HX!<"&6.Z86\L,LH8Q_,/+ZC&?US50&2>W6>TN/,C\Q8
MG$@\LHS=">2,'!YS5F&5I98;FZWI/]DDMI0BY7E2%90,8SGD#OSWK+EB:TTN
M2QB$DOVB1&FF,> JKG "YR>N30U$<9SOK^7F[_@6[NW>'4X[1;N%]\:R>>6V
MH 1G.3V'ZUVGAO79%U6;0KR?SY(CB*8C!; SC\J\WU:XM;FZMO+N) J01PN7
M@(*E5QG&><UTWAN :QXX;4K1Y&M4/F.S)M*\8 _.M\/>-3W._P"!R8VU2A^]
MZ)].O]=#U"BL[7GU&+0;Z72?+^WQPL\ D7<K,.=I'OC'XUYUX ^+UYXNUN/1
M[G0UCN&4LTT,V%51U)5N?3H3UKVSY4]6HHHH **** "BBB@ HHHH **** "B
MBLF_\2Z7I[%);D/(/X(QN/\ A4RE&*O)V)E.,%>3L:U%<F_CJW.?)LI6]-S
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M!V>:Y^&FG2SRR2R&2;+R,6)_>-W-=W7 ?!?_ ))=IO\ UTF_]&M7?T %%%%
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MG5)L-(HV6\1_Y:2'[J_U/L#0!4NO&D:>/K3PI9V;7<S1-+=RH^!;+C*Y]?\
MZX]:Z#4X9+G2KN"$XEDA95/N17(?#3PO<:/I4^L:OE]<U=OM%T[_ 'D!Y5/;
M&<D>IQVKN:35U835U8\5TVZATV#49[IF%SM^S1Q*0)!N^\W/H!C\:T!JEE/:
MM=K<".5].EM9(Y7&]G4 *>/[P_E79^(O!=GK;M<1,+>[/5P/E?ZC^M>?ZAX)
MUNQ8XM#.@Z/#\WZ=?TKS949T]$KH\J5"I2T2NBQ=:C TVHW!NHWL)K01V]N'
MR0V!M&S^$J03G_&EU.^CNOML=A>Q1SM=1R>9YH0.@C X;V;/%8,6BZE-=Q6P
MM)4DE<(OF(5&3ZYZ"K">&M0-_<6<D91X0WS!&97(Z!2!W[5'OOH96F^AMG5+
M"YN;V-GC2Q>8N+B*?RI5<1@%MG\:D@X'OVK%\+K<W/B2Q2WSN$JL2!T .3^E
M:&F^ -9OF!FA%K%W:4X/Y=:](\/>&++P]"?)'F7###S,.3[#T%:PHSG)-JQO
M3H3J23DK6-NBBBO1/4"O,O!_R_&CQNO3*0''_ 1_C7IM>9^%QM^./C-?6W@/
M_CB4 >F4444 %4M7_P"0+?\ _7O)_P"@FKM9NOW=M::%>M<W$4*M"Z*97"@L
M5/ SWH Y+X+_ /)+M-_ZZ3?^C6KOZ\Z^"MW;/\.-/M5N(FN$:9GB#@NH\UN2
M.HKT6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*KU:$W."<MSVL/.4Z:E+<****U-@KR[P1\GQB\<Q^OE-_G\Z]1KR_P "_/\
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M!BT/Q';7K!M6="\LS#B>+/R,@[*.FWL<^N:=<W4EG:Z\MY)G57M7>.X'RB2
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M9!ZBN'U[X>6]Y(]QIDBV\AY,3?<)]CVKN*YKQGXZT;P-86]UJSR'SY1''%$
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M/()X]J]2\+)JR^&[(Z[.)M2>/S)R$"A2>=N!Z#C\*=V.[-CH,"BBBD(****
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M37B>NV46G:]?V4&[R8)F1-QR<#U-9]-48EK TVKW9[Y_PGWAC_H*I_WZD_\
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M;INYSC]:I_\ "*3--J"QW2-':VR7$4FPCSPR[@JC/!P&]>E":%!TTK]7_P
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MV:24J&NYKA$U4T.NUWQ%I'AFR2\UF^CL[=Y!$LD@."Q!..!Z _E7/?\ "VO
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M)X46)<?>(<$_I7V2A"=&+AMI]VA\O*+567/OJ;UZKK+<P)<J\]O#Y[IL(!7
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MX5'1/_KUT\4,4*;8HT1?11@4^N#%9I5KKDCHCIH8&%-\SU84445YAW!1110
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M-'&Y(4L?E!(Y)QQ3X/M^M:#XPU]W\OQ']BDT][&%2IM @8A1SEBV=P;H>,4
M=;_PG5G.\ATS2M6U2VB8H]U96P:+(ZA26!?'^R#5N;Q?I*>%+CQ'%*]Q80(6
MD$2_."#@J5.,,#U!Q3_!YM#X,T4V&W[-]BBV;?\ =&?QSG/O7G&NE6T[XIM:
MX^PYA V_=\_8/-Q[YQGWH ]?AE6>".9<[74,,]<$9KF&\?:8/"UMX@2UOI;>
MYN?LL4*1KYK2;R@&"V.2/6NAT_\ Y!=K_P!<4_\ 017C49E'P<\/& (TW]NI
MY8D)"EOM+XR1SC/I0!Z?8^)IKRX,<WAW6;*,(SF:YCB"# SCY9"<GZ5G:?X^
M_M6RAO;'POX@GM9ANCE6&'##UYDK1M7\1M;WG]M0:5'#Y#;#932.Q;'?<H&,
M5R_PSM_$A\&Z#(NH:8-,\H'R3:/YNS<<C?YF,^^V@#HM2\916&NMH\.CZK?W
MB6ZW+K:1QD*C$@9+..<BM'0]?LO$%K+-:>:CP2&&>">,I)"XZJRGH?TKB-5N
M-<M?BKJDVA6=G=SIHL3/#<2LA8"1^$P#EB?7 ]ZGT'5+71_ NL^,GNA=7E\6
MNKA1'Y828 (L 7)((("\\GK0!TVF^+]+U7Q+J.@VS2_;+ 9D+* C] VTYYVD
M@'CK5;Q#XS3PV+F6[T/5Y;.W4,]W!'&8L''JX/?'2O/(+_\ X1VP\-:DVEZW
M#>6$[-JES<Z>\<;I<']\68\<,5(_W:[KXHD-\,=<(((-N""._P RT 6'\:QV
M^CWVJ7VAZQ96MG$)6:XBC!D!.,+ASSSWQ6AJOB73M'M+6:Y,K27>!;6T,9DF
MF.,X51UP.O8>M8OQ"_Y)1JW_ %Y#_P!EJE8\?%:Q-W]UM 46.[INWCS,?[6-
MN?:@#=L_&-I/J$%A?6&HZ5<7)*VZW\(59C_=5E9EW>Q(-64\4::WBR7PTTC)
MJ*0+.JN %D4_W3GDCN/_ *]8?Q5*?\(+.H_X_&N(!98^]Y_F+MV^_7\,UBZG
MX</B'Q]X@6.;[-JEK964]E=KUAE'F?\ CIZ$=Q0!WMQK5M;:_9:,ZRFYO(I)
MHV &T!-N<G/7YAVK2KS#2?$1U_XA^'UNH?LVJV5I>07]J>L4@\OD>JMU!]*[
MSQ#K,/A[P_?:O/&TD=I$9"B]6/8?B<4 94/CS2Y[R.-;;4!92W'V:/43!_HS
MRYV[0V<]01G&,]ZZBO,]+U2_^'VE+%XAAB;1IP]Q;SVX++9R,2_D/GDKDX5_
M7CTKOM'NKF^T6RN[VW%O<SPI))"#G8Q&<?A0!>HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ***QO$6OQ:%9!\![B3B*/^I]JNG3E4DH05VR)SC3BY2V1J3W$-K&9)Y4B
M0?Q.P K)D\5Z2C%5E>4C_GG&3_.N"\Z\UBY-Q>2-(2> 3P/8"M*,+;J/E6O5
M670AI-W?D>7+,92?N*R\SJD\6:<WWEN(Q_M1_P"&:T;34[*]XM[E';^[G!_(
M\UPK:M"G#*/RJI/?6TGS(=CCD,IP10\OC+9-?B*.8R6]F>H45QOASQ899UL;
MZ0,QXCE/\C795YM>A.A+EF>E0KPK1YHA1116)L%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5FZ-H=IH4-U%9F0K<W4EU)YC9^=SEL>U:5% &;=
M:':7FO:?K$ID^U6"2I#AL+B0 -D=^E,7P_91^)'UV(RQ7DL(@F"-A)E'W2Z]
MR.QK5HH Y=_ FG+-*UC?:IIL,K%Y+:QNVCB8GJ=O.W/^SBKLOA/2'\+S>'8K
M<V^G3(4=8FPQR<D[CDDD]SFMNLSQ#K=OX=T.YU2Y1Y$A  C3[SLQ"JHSZD@4
M 4=,\*?V9=PSKK^N7*1# @N;H/&1C&"-HS3(_ ^D1>'[+15-S]DL[L7<69/F
MWAR_)QR,D\5-I>H>(Y;](=5T.VM[>1"PGM[WS?+(Z*X*KR?5<CBG>%?$#>(]
M,GO'MQ 8KN:WVA]V=C%<]!UQ0!LRQK+$\;9VNI4X]#7)6/P]M]-M(K2R\1>(
M8+:$8CB2\ 51Z ;:9>>.I+73O%ET+!6.@RB-5\W'G94')X^7K[TI\6ZSI<FG
M2Z_HUK#8W\T=NEQ9W9E\MW^[O5D7@GC(SB@#?BT*TA\0RZVIE-Y+;+:MEOEV
M*Q8<>N367<>!-'N+^>Y+721W%W%>S6R2XA>9.C%<=^,^N!5KP]XA;6+K5K*X
MMEMKS3;LP21A]VY",I(.!PP/Z&J5WXPDBU+Q%!;62S6^B6/GRS&3&Z8J7$8&
M/[HY/;/2@#H-1T^WU73;G3[M-]O<Q-%(OJI&#5"\\-65_P"%#X<N9+A[,P+
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M3])MK4XW1H V/7J:\W.^10BNMSLRR+4Y/I8NT445\Z>R%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !65XDMM'OM#GLM=DA2PN-L3
M&60(-Q(VX/8YQCWK5J"\LK74+5[6\MXKBWD&'BE0,K?4&@#A+"/5?"?C/2-$
MBUV?5],U".7]Q=X>:U5%R'WCDKG"\U;^'$L=K8:SIDSJEY9ZI<M-$QPRJS[E
M;']T@Y!KH=+\.Z'X=$LFFZ=:V6\?O)$4 D>Y]*35?"V@Z[,D^IZ5:74JC"R2
M1@MCTSW'M0!YI?LMWX*^).IP'?9W5VP@E'W9 BHI*GN,Y&?:M+[+>VGB7P]#
MXKU234-(FV/I[B)(8TNP,JLH4<\?=.>HZ5Z)-I.GW&E-I<EG ;!D\LVX0!-O
MI@=J+[2K#4]/-A>VD4]H=O[IUR..GY8H XSQ7?1^"_&-MXHE!&GWUJ]G>X'2
M1 7B;ZG#+^(J/3],GL/A)K-U?+C4=3M+F_NSWWR(2!^"[1^%=OJ.E6&K67V/
M4+2*YMLAO+E7<,@Y!J>XMH;NUEM;B)9()4,<D;#AE(P0?;% 'GFHV,\OPH\/
MZM9)NO\ 1K:VOX .K!$&]?H4W#\JN^$KF/Q9XLU/Q7&=]C#$MAIQ/<8#RM^+
M$#/^S7:P6EO;64=G!"B6T<8C2(#Y0H& ,>F*AL-+L-*T];"PM8K:T7.V*-<*
M,G)_4F@#SBVFU7Q!KOB'5[;P_'JNFW:MI=O(]\L(\E,A]H*G(9R3GV'I5*]O
M[F;X&ZUI>H KJ6D;;&X4MN/RR)L.>^5*\]^:]7L-/M-+L8K*QMX[>VB&(XHQ
MA5&<\?B:JW/A[2+O[?\ :-/@D_M (+O<O^NV?=W>N* +]O\ \>T7^X/Y5)6#
MIO@OPWH]\E[I^CVUO<H"%D0'(R,&MZ@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ J&YM8;RW>"= \;C!!J:BFFT[H32:LSSO6/ UQ"[26/[Z+J%_B'^-
M<K/IMS;OMDB=6]&&#7MU-:-'&'16'N,UZM'-ZL%::N<%3+J<G>+L>&&TF_N'
M\JT;#PUJ%^X$5NY4_P 1& /QKUY;6W0Y6WB4^H0"IL8Z5M/.YM6C&Q$<MBG[
MTCF_#WA.WT<B>8B6YQP>R?2NDHHKQZM:=67/-W9Z%.G&G'EB@HHHK,L****
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M_+FK$/B_2[C5M+L8VD8:I;&YLY]O[N4#DKGKN YQBCE8<R-^BLHZ]:_\).-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP/3.: +'VV W<=LK%I'C,HVC("^I/OVJQGC-8%G9/9:;J!^R23.961$9CDQ
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M,4SV^P2>:B@KMQG/6KR-O16 (R,X(P:Q_LMU/%IEE/&%CC19;DJ,(2N,(/\
M@7/T%;- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (RAE*
ML 5(P01P:7&!@444 %%%% !1110 4444 %%%% $<D$,Q4RQ(Y7H64'%2444
M%%%% !28 )( R>M+10 4444 %(  , 8'M2T4 %%%% !1110 4444 %%%% !1
MTHHH .M(54L&*@L.AQR*6B@!-J[]^T;L8SCG%+110 4444 %%%% !1110 44
944 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>img254193463_26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_26.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $F QD# 2(  A$! Q$!_\0
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MBU^%7;H9HI(E_%G4 ?B:[%65U#*P96&00<@BAIK<$T]A:***0PHHHH ****
M"BLNV\0Z5=Z]=Z)!=;]1M$$D\/EL-BG&#N(P>HZ&M2@+A1110 4444 %%%%
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M@3#A6^OI_*NU!#*&4@@\@CO7%.$H.TCMA4C-7B+1114%A1110 4444 %%%%
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M@*B1<U910*^<KYC6KZ7LO(Q56;?NZ%F74]4NB?-OKA@>H\PX_*H%^T*VY9I
MWJ&-2K@4\,*Y;7W97+?5LF@UK6;4YCOYS[.VX?D<UMV/CNYB(6_MUD7N\?RM
M^70_I7/Y%1NJFKC4G#X9&D:E2'PR/4].U:RU6+?:3!R.J'AE^HJ[7C44TUE.
MLUO(T<BG(*G%>@^&_%$>K 6USA+L#CL'^GO[5VT,4IOEEHSOP^,51\D]&=)1
M1176=P4444 %%%% !1110 4444 %%%% "$A5+$@ <DFO%?%VNMK>LR.C$VT1
MV0CV]?QZUZ-XYU3^S?#LB(V);D^4N/3^+]./QKQG.3FN_!T]YLX,94^PA0*F
M1:C4582NULX42(M3JM=78^']+TO2(M2\0/(3,,QVR'!(_#G/XC%07S>%+K3Y
M9+$7-G<QC*1N"WF?J1^H_&N;VJ;T1T>R:5VSGA0:ZRWLM(M?!T&JW6G?:IF<
MJW[]TS\Q';Z>E03Z7IFJ>')]6TR&2TDMCB2!GWJ?7!//0_\ UJ7M%?\  ?LW
M;?I<Y<FF%L5U]O9:/:>"[?5[K3?M4S.58>>Z9^8CMQV]*A73-(USP[>ZAI]K
M)87%H"60RF16 &>IYZ4U47;R$Z3[^9R1>F&2NVT[PC;:SX*BNK9-FI'>P?><
M/AB-I!.!P.M<OX?LH[KQ/:V%]"Q1I"DL;$J> >#CD<BKC4B[^1+I25O,H&2D
M\WWJSXCMX;#Q#?6MLFR&*4JBY)P/J>:RM]:*S5S-IIV+GF^]'F^]4]_O2[_>
MG81:+^]5;B\CA(7EY&^ZBC)-5YKB5YEM;4;KA_R4>IK6L-/BLEW ^9.WWY3U
M/T]!7!C,?##*V\NQ,YJ"U*\%I?3$-*XMD[*OS/\ GT%=5;Z[J\-C%9QWTWE1
M+M4D_-CZ]:SHT%64 %?/5<96KOWI?<9J<WL[>@LD][<<S74TG^^Y/\Z=%->P
M<PW4T?\ N.1_*G @4_<*QMYC4>MR[;>)];M"/]),RC^&4;OUZ_K71Z;XXM9V
M$=]$;=SQO7E?\1^M<<2IJ"1%-:QK5(;.YM&O5I[2OZGL,4L<T:R1.KHPR&4Y
M!I]>4:/KUWHL_P"[8O 3\\3'@_X&O3-.U&WU2S6YMFRIX(/53Z&NZCB(U=.I
MZ6'Q,:VFS+=%%%=!TA1110 4444 %%%% !6/J^I&+-O"?F/WF';VJ_?W8L[5
MI/XCPH]ZY(LTCEV.23DFO(S3&.G'V4'J_P CNP=#G?/+9#AR<FI *:HIXKP(
MH]%L4"G 4@IX%:)$-B@4\"D IQ.!6B1#9'*P5361<R98U=NI< \UCSR=:RJ.
M[L=="%E=FOH&J&VO1"[?NI#CZ'L:[2O*A(5<$=J])TJZ^VZ;!-G+%<,?<<&O
M=RNJW%TWTV/-S&DE)5%U+E%%%>L>:%%%% !1110 4444 %%%% !1110 4444
M %%%% '/>-KW[%X6NB#AIL1#GUZ_IFO%"V6)KT_XHS[--L8<\O*SX^@Q_6O+
M-U>GA%:G?N>9BW>I;L2@U*K56W4\/BNAG-8]'\)@W?@K6;2V^:Z)8[!U(*C'
MYX-</YA!((P1V-/T?7;S0[S[39N Q&&1AE7'H173O\0;5I/M/_".6?VT<B=F
M!.[U^[G]:Y[2C)M*]SHO"<4F[-$OP]+#Q'<(X*LMNP((P0=RUJ:-!I/FZAJ6
MC1W-UJ5J7Q!<N%P3GE=HYSR!_2N2TOQC/8^(+G6+FW6YEN(RC*K>6!R/8_W<
M5GZ9X@N-)US^TH%ZN2\1/#*3RI/^>E3*G*3;*C4C%)>9U?@.\EOO%][<SG,L
ML#NWU+K1I6NZ''XF6*/0C;W$DQB6Y%R9"K$XR%88')K'L_&5O8>);G6+?2MH
MN(RKP?:. Q()8';[=,=Z(O%>C6MV;VU\,1I=@EDDDO'D"MZ[2,4G3;;=MUW_
M .".,TDE?9]O^ =/H%E/8?$?4H;BX-P[6QD\UA@L"RGD?I6;H6HV_BO2Y/#>
MJ.!=1@FSN&Y/';ZC]1]*PM+\9W-CXBN=9NX!=S3Q&,H'V!1D8QP>!C&*YM+B
M2.X6>)VCD5MZLIP5.<@BJ5)N]]]!.JDE;;7[CO\ QO:3:?X1T&TG $L.4?!R
M,@5Y]NKHO$?C";Q'IME;3VHCFMSEY0^1(<8SMQQ^=<UFM**E&-I;F59QE*\=
MA^:,TS-07DWE6CL.I&!^-:-V,TB;3X!J5^T\@S;6YPH/1FKHURQJCIMN+33H
M(?XMNYOJ>:OQD5\;C<0Z]9OHMCDJ2YY^2-+2M-EU.\2UA9%=P2"Y(' SV%7[
M#0[F_OY[.)XA)#G<7) .#CCBI/![ ^([<>S_ /H)K4T"<Q^(=9=<;D25A^#4
MZ5.+2;[G71I0:BWU9R\Z/!,\4@VNC%6![$5=&CWC:(^K9C6W4]"3N/.,@8]?
M>M;6--_MN\T_4+ ?NK_"R8Y\M@.<_@#^57-7OH9O"VKV]J +>R:.W3'?!7)_
M/^54J2]Z^W3\RE12YK[+;STN<Q=:7=V=C:7DIC\JZ^YAN1Z9K0G\,7%M((Y]
M3TN*0C(22X*D_@1575X(X?#N@3H9-\N=VZ1F'4= 3@?A2_$!]OB)!G_EW3^;
M5+C&*;:[?B1*,8Q<FMK?BBEJFFW>E3"*[CV[N4<'*L/8UGQ3O!,LL;%74Y!!
MP172*YO/AH\DYW-:W 6%CU R./\ QXUQQ<UC5CRM-==3"M'E:<>JN>R^'-97
M6=-61B!/'A90/7U_'_&M>O)_!FK&QUR*-F_=3GRV&?7I^N*]8KU<-5=2%WN>
MUA*SJT[O=!11170=(4444 %%%% !1110 4444 >5?$N^\[6HK4'Y8(AGGNW)
M_3%<0#6SXPN!/XJU!LY E*_EQ_2L/=7L45RTTCQZSYJC9*K5.C\BJ@:GAZMF
M9Z/\0%::UTN]@&ZT,9 9>@)P1^8_E7#J[,&*J2%&3@=!6QHGC:ZTJS^PW-O'
M?66,"*4X('H#@\>Q!J74/&XFT^:RTW2;33HIQME,8!+#\% _2N:"G!<MCHFX
M3?-?Y'0P/8?\*VM&U(W(M_-.3;[=V=[8Z\8JOXD8:+X6M[728]VFWGS/=%]S
M,>#@\#&0/T(P*YB7Q/YGA*+0OLN/+??Y_F=?F)QMQ[^M+IOBO[)H5SH][9_;
M+27[@\W88CUX.#WY^M2J<D[^>Q;J1:MY;G5075I;?#&TEO;+[9#YI'E>:8^=
M[<Y%,L)K7Q!X3U.TTB!M*, \R2-7\P2C!."Q&?X?_P!=<_9^+[.+PY#HM[HW
MVR&-BV?M1CR=Q(Z+GOZU%/XPCATN;3]%TJ+38YP1,XE,KL/3<0,?K[8H]G+7
M3K\@]I'372UO,W?[2N-*^&VCWMJ^V6.\)'H>9,@^QK6LK.T\1ZIIGBC3 L<B
MR;;R'/(.",_7I]00:\_N?$?G^$K70OLNWR)3+Y_F9W<MQMQQ][U[5'X;\27/
MAO4#<0KYL3C;+"6P'';GG!'K3=*5FUOK]P*K&Z3VT^\E\7G_ (JW4_\ KL:P
M]U6]8U'^UM7N;_RO*\]R^S=NV^V<"J.:Z(744F<\M9-H?FHKFX%O TAZ] /4
MT[-01QB\UFWMSS''^\?\.?\ /UJ*U54X.;Z$Z+5FMI%D;2V\V7FXF^9R>H'8
M5JQKFH@<MD]35B-@*^*J5)59N<MV<5W.7,S5ATB9](DU(/'Y*/L*DG=GCVQW
M]:L/HEU'HR:GF-H&/0$[EYQD\>M7[9P/ %V?^G@?S6MC2[RW3P_I=I= >1>B
M2$D]CDX_PKKA2B]/(]"%&#T\K_.YP\2//,D,0W.[!5'J36C<Z!?6VK6^FL\+
M3SKN4JQV@<]<CV-7].L#H-QJ.I7JY6QRD.?^6CGH1^!'Y^U6-;Q<^,]%24MB
M2%"2K%3U;H1R/PJ52]V\M[HE44H7EO=?G8QK70KVZU6YTY9($FMP2Y=CMQQT
M('O4P\-W4RM]DO=/NW49,=O<;FQ],5H: BP^,M;B3=M2.0#<Q8_>'4GDUQ-C
M>2VVH030L1(D@*D?6IDHQ2NMVR)*$$KK=O\  FF#1R,DBE74X96&"#6GX<UQ
M]'U!6R3 _P LB>H_QJ?Q[''!XBW1@ RPJ[CWY']!7+"0@UE)2I5-'L8RYJ-7
M1ZH]ZCD26-9(V#(P#*1W!IU<KX$U0WND-;.V7MS@9_NGI^N?TKJJ]JG/GBI(
M]^E-5(*2ZA1115F@4444 %%%07D_V:SEE[JO'U[4I244V^@TFW9'/:U>?:+P
MQJ?DCX_'O4%M:23P2RJ5"Q#)R>35$/O<DGK6WIA']G7W^Y_0U\I3_P!JQ#E/
MK?\ +0]R<?8TDH^1%;V+SP&821(@."7;%$]G+;QK(2CQGHZ'(JU:*)M$E7S$
M0>9]YS@=N]-O'33]/%F[;I7.XX' 'U_"NGZM!4N9KI>]^O8P]I)SY?/;R(+6
MUDNW98]HP,DMTJ,@I(8V^\#@U;CG^P:0LXXDF<$?0?Y_6HM7(2YAN$^Y.H8'
M_/X5,Z$8TE)?%HWZ/;^O,<92E.W3I\@N(6M91&Y4L1GY:;>1/:QH9&4%QD*#
MR/K6I-;K)J?G,RN8XMPA!^8GUQZ5S;2W&K:EY>")';&/[@_^M5XBBJ5TEJW9
M!0;J:MZ)78J65Q?0S31%1'$"26)&>,X%8,KY-=C%>1&6[L+7_CWM[9\D?Q-W
M-<.S9-<]:C""BXN[UOZG71J2E=-66E@)YKL_!MUOMI[<DY0AA^/']!^=<3FM
M_P )W'DZPJ$\2*5_K_2NC!2Y*T3+%QYJ3.^HHHKZ(\(**** "BBB@ HHHH *
M*** "BBB@ HHHH **** /-_BL<#3/^VG_LM>:9KU+XK0[M+L)L?<E9<_49_I
M7FFFVXO-5M+5NDTR1G\6 KTL._W:/,Q"_>LO?\(_J!N;&UCC1[F]B\V*(. V
MWG&<X X&:T?^$"\3_P#0,_\ (\?_ ,56E8W1NOBZ&/"I</$H[!50J/Y5EZKX
M,\0P/>7LFGXMT9Y6?SHSA<DYQNSTI^T=TFTM/ZZB]FK-I-_UZ&;I^B:GJEW)
M;65J\TL7$@! "\XY)./UIFJ:3J&C3K#J-L\#L,KD@AOH1P:?::I=3:;'H,<M
MO:V\TX>29R4W$\?.V?NCZ5N>)X)=,\*Z5IK2?;(Q(TJWL9#1<C&Q#GZGG%4Y
M24DF2H1<6T<K!')<W$<$2[I)&"(N<9). .:?>6T]A>2VERGESQ-M=<@X/U'%
M2:&?^*@T[_KZC_\ 0A5SQ@?^*OU3_KN:OF]ZQ/*N6Y3;3+U=*75#;L+)I/*$
MN1@MZ8SG\:I;JW9++;X#AOOM5R=U\8_(,G[H?+G<%_O>]:L?A[PU9WUGI>JW
MFI-J-P$+&V5!$A?H.02>HY'Z5/M$MRO9M['&9I,UT=YIOART\1W=I+?7T5E:
M@JP*!Y99 <%5(&!]3Z4^\\/Z;=6-CJ&B7-S]FN+L6;I>!=T;GH<KQC%'M$+V
M;.9S1FNGUO2_#6FM=V,5WJ8U&V&-TL2^5(P[ #D?4\?6K.G^$K5-)MKW4[?6
M;E[I?,CBTRWW[$[%F(QSZ#FCVJM<?LI7L<WI^FW&IM<);;"\,+3%6."RKC(7
MU/.<>U8U_P#.UO%V>09KN5TYO"WC?2FC>5K>9XY(S+&4?8YVE64]".17(^*K
M==/\130J,)!=NJCV#<?I43G>+MV'R6]3=9_G./6E$F*KE_F/UI8UDFE6.)&>
M1SA549)/H!7QECS4CH?"^IVVGZ]!<W<OEP*&W-M)QE2!P.:NZ1K=C;:QK$\\
M^V*XCE6)MC'<2V1T''XUSSZ+K"(7?2[Y5 R2;=P!^E5(H+BX$AAAED$:[GV*
M3M'J<=!6L9SA96-XU)PLK;:G0:/XMNM'TZZM(XPXE!,;EL&)B,$CCFBPU:SA
M\&ZI8RS8NIY5:--I.X KGG&.QKF=U)NI*I):?+[R55FE;R:^\ZC5=7LKGP]H
M=K#/NGML^<NUAMZ=R,'\*T_$,WAS7M26\/B#R (U0H+.1LX)[\>M<1;V]Q>3
M>5:P2SR8SLB0L<?05$25)!!!'!!JO:NVJWM^!?MFT[I-.W?I\SI];UZS;2X-
M%TA)!8PMN>63AIF]2/3_ .MP,5SN^H-U(7J)2<G=F<I.;NRW;S-'<(RMA@<@
M^E>^6\HGMHIATD0,/Q&:^>HF)D4>]>_:9&8M)LXVZI BG\%%=V"ZGHY?]HMT
M445WGI!1110 4444 %%%% !1110!\_\ B)L^(]1_Z^9/_0C5?3=/GU74(K*V
M ,LAX+'  '))/H!5_P 91>1XMU)<8S,6_/G^M3>'&^S:)X@U!?\ 61VRP*?3
MS&P?T%>JI6@FCR7&\VF5]-\,:QK$<LNG6HN(XW,;.)449_$BG:EX6UO1[0W=
M]9>3 &"[O-1N3TX!)K9T+2[W6/A[?6MA#YTYOU;;N"\!1GDD"N=U30M3\/R0
M-J5H(O,)**SJP;&,@[2?44*;<FKK^OF-P2BG9_U\BW:>$]?OK(7EMITCP,-R
ML652P]0"<G\*QI \4C1R*R.I*LK#!!'4$5U&E->^+?$2W\^IVMG+"Z>7")-K
M8'18E)]O7O6/XIN7NO$VH3/;/;,TO,3C## QS[G&?QHC)N5F*48J-T5[;3[N
M\M;JY@BWPVJAIFW ;0>G!//X56C5Y94CC4L[D*JCN3TKI?#!_P"*7\4?]>\?
M_H1KF+<;[F)<E<N!D'!'-4I7;78EQ22?<L:C87>E7KVE["8ITP60D'J,CD<5
M5+5UM]X=2Z\=7>G2W]PT$$?G37$[>9+L" GGN>PJ6#2/!UYI&H7UO<:R!9 %
ME?RP3N.%(P.F?>I]JK*Y7LG=V.,R:3-;VG6_A;[+!_:=]J+W,I^9;6-0L/./
MF+?>]>*OQ>$;6VU;6(M2NIS9Z8BR,;= 9) WW< \#CK3=1+<2IM[')9HS6X=
M)T[5=9LK+0+BZ<7)PRW: -%CJ25X/&3QZ5OGP3I]P[V-K%KR7@!"75S9[;9V
M ^FY0?4]/>AU8K<:I2>QR$^FW%OIMIJ#;&M[DLJ%3DJ5."&]#W^E4=%.[5;V
M0]57:/S'^%=+I@,_@O7;20'-K+%<(#_"2=C?I7*:.^W4KU#U(S^O_P!>N+'M
MO#S1%2/N.W8Z,/BG";%5=]6+6ROKX,;2TN+@)][RHF?'UP*^647T.%1>R.D@
MUBS3P3<Z>TV+MYPZQ[3R,KSG&.Q[U%J.KVLWA;2K2&<FZ@=S(H4C;DG'.,?E
M6!=6%]9*&N[.Y@#=#+$R9_,5%)!/%#'-)#(D4N?+=E(#XZX/>M7.5K6Z6-W4
MG:S72QOZYXKN=;L;6VDC$8BYD8-GS6QC=C''?\ZT[_7]-F\5Z/>QW.;:WB19
M7V,-I!.>,9/4=*X?=2;J/;3O=Z[?@+V\[W>NWX'<Z1K^EV_B[5KR>ZV6MPKB
M.3RV.<D=@,U3LX?"^F7*WDNL2Z@8CO2WCM&CW,.F2W&*Y@VUS]E^U?9Y?LY;
M;YVP[,^F>F:@W57M7U2*]J]+Q7?KU-76=8EUG5)KV4;=YPJ9R%4=!6>7J$M3
M2U9.[=V9.\G=G9^ ]5M[#666ZN8X(ID\L&1PH+$@@9/?C'XUZS7R_P")F/\
MPC=S@$Y9 >.G-8_A_P")'BKPVJQ66J226R\"WN?WJ >@!Y4?0BO9P5-RI7\S
MU,+5Y(69]<45X7I?[0CA575M!5F_BDM)L#\$8'_T*MY/C]X6,>7T_5U;^Z(H
MS^1WUT.G+L=BJP?4]6HKQ'5OVA(0&31M#=C_  RWDH7'U1<Y_P"^J\U\1?$?
MQ1XF#QWNI/';-UMK;]W'CT('+#ZDU2HR>Y,JT5L?0WB7XH>%_#.^.>^%W=K_
M ,NUIB1@?0G.%_$Y]JX/3?BUJ'C'Q#_9L=C!9Z=Y;2$$EY&QTRW '.#@#\:\
MJ\/>"/$7BB0#2]-EDA)P;AQLB'_ CP?H,FO7- ^$,GA*WDUB\U,3WR)M$,"8
MC4,0#\QY;\A66+A%8>:6]F:86<Y5X/I=&W]IQ6GIVJV\.G7\<TFV21,1C!.3
M@USI>I(+:ZNMWV>WFFV]?+0MC\J^0HN4)7BM3ZBJHRC:1NQZK;CPY-;&7_2&
ME!5-IY''?I4BZI:7^D);WEQY-Q"V$<J6W+^ _P X%<[/:W5L ;BVFB!Z&1"N
M?SICQS1QI(\;JC_<8J0&^A[UK[6HM&M+6MY&?LX/5/K<ZC4O$SI.D6F3XMT0
M+G8.3^(S3)=;AO\ 1MMW./MD<@9/D^\/P&/_ -5<MNHW4WBJLF[O1].GR$L/
M325EJNO4Z75];0ZQ%=V$VX(@&<$<\Y!S2:AK%NL\>HZ9<>5=2+B:(IG!]>1B
MN>,,_D>?Y4GDYV^9M.W/IFH2:)5ZC;;ZZ^C[H:HPLDNFG_ 9U.G>*KC=<?;K
MSCRCY7[H??[=!_.N<GN)+F=YI6W2.<L<8R:K$TJFB5:=2*C-WL$:4(-RBK7)
M@:O:3*8=4MG':1<_3/-4!4UL2+A,=<\4X.TDQR5XM'K-% Z45]0?.!1110 4
M444 %%%% !1110 4444 %%%% !1110!S?CJQ-]X2NPJY>'$R\>AY_3->*Z?<
M_8M3M;DC/DS))^1!KZ,DC66)XW&4=2K#U!KY[U[2Y-(UFYLI 1Y;G:3W7L?R
MQ79AI:.)Q8J.JD=1$D.E?%99YYXX[625KA)I'"J4="0<GC'.*H77A)9[N:5?
M$GAX*\C,,WW."<^E<[=W]S>16T=Q)O6VC\J+(&0N2<9[]>]5:W46M;G.YK:Q
MTMAI6D:II)MAJ%I8ZM;RMNDN92(KA.Q#=!CV'/\ *76I;+3/"]OH-O?1W]Q]
MI-S-+ <Q1_+C:I[^M<K15<NNK%S::(NZ-(D6N:?)(ZHBW,;,S'  ##))KJM?
M\.Q:IKU[?0>(] 6*>0NH>^ 8#WP#7#T4.+;NF$9)*S1U5S) O@"+3UN8);I-
M38^7&X8D;2-P'7!]:ZV75--TY;.TN=4LK34;6WCC+76G-<3PMC_GHK;>_3M7
ME )!R,@]B*Z<>.KYU1[C3M)NKE  +J>U#2\=#G/]*SG3;V-(5$MS9L+&'1]9
MUB"[U#33K#!);2\O?]40W+-SP&Y'7\,BC7M634?#"66H:];7=RFHH))((P%C
MCVG)4#!=1GKCVKAKV]N=1O);N[E,L\IR[GO5>G[/6[>HO::62T.]E2"TT:^7
M5O$.GZO!Y!6RC1_-F60_=.3\R =QG%+%J$FMZ'IRZ?XF32+NSA%O-!<7;0(X
M'W74CJ?\_7@:*?L_,/:>1UUK;27WC?3;5M<?5EA99)+AV9E0*=S %B<C Z].
M:Y/Q5<C4]0O[Q.5DN'E7Z$G^E36>H7-@+@6TGE_:(C#(< DH>HSVZ=JJLH92
MI&01@TU$7,7K*X^TV,,N>2NUOJ.*VO#G_(RZ;_U\I_.N.TJX^Q7CV<QQ'(?E
M)['M^==EX<7'B;3?^OE/YU\SB*#I5[=+G.Z=JB.TN_\ A)?^$^/V4WXL/.3)
M;=Y&S W=?E]?QID4YF\1>)I-'NH(H?L^YSY6\.P7DK@C!SGGD58U/3O%;>*Y
M+FTN)XM.$JL&:Z C50!G*;NG7M3HKBQN=?\ $LEAL,?V##M&!M9\')&.OUK6
MVO7?_/8[.5\VM]WOZ/8Y*Q\+V]QH$.L7>KQV=NTC(X>(L1C.-N#\QXZ<=Z;?
M^$;B"\T^*QN$O8=0&8)@NP'N<CG&!S5VZ_Y)99?]?Q_]GK>LKZ#3[+P?/<.$
MB(D0L>BY7 S[9(K%4X/1KHC"-*F[)JVB=R+PKH5CI7B@I%K4-S>0QLLUN(BN
MTXYPV<-@US$'AZ.XMIM4U+48]/LFG:.-S&9&D;)Z*.W7\JZO0?#U[IGC>>\N
M6A6WF,IA8R@M+NR>!UX'6FZ=J.I7OA=;3P_<QQ:E:3N)86V9="Q.1N&.X_(U
MI[.+235M]/N-/91<4I*UKZ?=YG+-X2<:UIUFEZDEIJ W07:)D$8SRI/!]L]Z
M;K_A:+0;/?+JUO-=^;L-JF-P4Y(8\Y' ';OUK?ADUW_A,M#BUR]@GE#,RQ1E
M-T65Y#;0.>!ZUR7B,%O$^IYR?]*D_P#0C64HP46TNIE.$(Q;2Z_H1:'8-J6L
M6MH 3YD@!QV'<_ES7OP   '05Y]\.=!:)7U>=""P*0 C\V_I^=>@UUX6'+"[
MZG=A*?+"[ZA11172=04444 %%%% !1110 4444 >1_%&Q,.NP7@7Y;B(9./X
MEX/Z8K(\,#[9I>NZ6O\ K9[42QC/+-&V[ _#->D^/](.J>&I'C7=-:GS5QUQ
M_%^G/X5XU97EQIM]%=VLACGB;<C8S@UWT9<U.W8\^LN2I?HSJ-#AM]0\#7FF
MG4]/L[A[U9%%W.(P5"C\?TK+O?#\>E1)=RZMI%]$LBAX+2[W.PSSQ@?G6&[,
M[LS8RQR<#%-K91:>YBY)K8[&7PYHEQ?+?6/B*PMM,8^88I92)XAU*A3R2.W/
MY]\;Q3JD.L^([N^MU80N0$+<$A0!G\<9K'I*(QL[MW"4KJR5CKO"!MYM(UZQ
MFO[2TDN88TC:ZF$:DY-4KCPZ-,$=TVMZ-<A94S';76]^O7&!Q7/44<KNVF',
MK)-;'HJW$$_Q1N]2AN ]E;Q>;)<0N&15$8&20>1GC Y-/OVMM?TF[LM'UG30
M40W$MM;::]MYP7G)9B<FN&TC6;S1+PW-FR[F4HZ2+N5U/4$>E:-YXOO+FSEM
M;:RT[3XYAME-E;^6TB^A.3Q63INZMT-545G?J=-;:A%8Z+93:)K6E:; L"_:
M@T8>Z:3^+Y2"6]N@_"JFJO#JOC2_N[#Q';V$WEQ&"9I2B2?(-P+J<#&.E<'S
M15JE9WN2ZMU:QWESJ^GZ-KNAW;7%K?7T&\WUQ9* KAN!R  S $\]Z==1W"RR
MW2?$%5T\Y>,+>2//@] 8P<Y[5P-)1[/S#VGD=1I[&T\#ZS>2N2U]/';1Y/+%
M3O8^]<9'+]DUN.1N$E&TGZ\?X5J3ZA<W-E;6DLF8+4-Y2!0-NXY/3J:R[^ S
M094?,G(J:E/GA*+ZDW3T-\\'%=MX*^T?\([X@^R^;]H\I?+\K._=AL8QSFO/
M=+O!>V@W'][&,./7T->C>!HKF70M>CLBPNFC41%6VG=AL8/:OFH4W"MRO?7\
MC*A!QJV]?R)M-EU*+PKK/_"2-<>0\>V!;S.\R8/W=W/7;_G-9VJQ7MUX:\-P
M3W<9@G;8BK#ADZ $G=\V ?05L:=%JFE:5J9\5W!:UDA(CAN9Q*SO_L\FJ-__
M ,@#P?\ ]=1_Z$*T<?=L^WSW-Y1]RS[==]RL_@>SCU4Z8_B"$7K<Q1"!B6&,
M_,<X4^W/%9NG^%9KAK][^Y2QM;%BDTS*6^8=@!U_^N*W=0_Y*W#_ -=(_P#T
M 5>N8CK-AXCT:U=?MXOC,L3,%WKD=,_0_I4^R@V[+9OYD^Q@V[+9OYE&_L8H
MOAY#;6%VM\DE\/*D12I8G/!!Z'-9G_"&VPNAILFNVZZNR\6ODL5W8SM,G3/X
M5MQHWAWP?8F\,;/;:DCS)&X?9W(..,@5>U*7Q9=:@;C1=3MCI$H#I,WE;8QC
MG=D$]?K5N$79M=M/Z9;IP=G):V6G],X_1_!L^K6EY*]W':R6D_E2I*O  ^\2
MV>W/^-8VL6,&G:G):VU['>Q(!B>/&ULC/&">G3K75VDLTO@;Q-+/*LDSW2EY
M$(PQ++DC'&#7&VEK+=W"0PH7D=@JJ!R36$XQ222.><(I145JSO?AEIHDDO;R
M5 T>SR0&&0V>2/T'YUI:[\)/"&N,\AT[[#.W_+6R;R__ !WE?TKI= TE-%T>
M"S7!=1ND8=V/7_#\*TZ].C%TX)'J4J2C346>%:C^SU*"6TS7T8=DN8",?\"4
MG^58S? 'Q4)=JWVD%.S&:0?F/+KZ.HK?VLANC \$TW]GN_=@=4UVVB4=5M8F
MD)_%MN/R->@Z!\(_"6@E)#8F_N%Y\V]._GV7[OZ9KNJ*3J2?4:I170155$"(
MH55&  , "HKR 75G- ?^6B%?I4U%9M)JS-4[.Z/))4*2,C#!!P0>U=%X:\W^
MR-7\C?YVP;/+SNS@],=ZJ^*++[)K$C*,)+^\'X]?US5SPND\FEZJEL6$S( F
MUMIS@XY[5\_0IN&(Y.U_R9[=::G0YN]OS)+*2]CT+4?[9,OE,F(A<YW%\'IG
MGTJI?I<SZ+HT4DZ&*0[5 CP5[<G//7VK0LX[ZQL;TZ]+F!H\)'-*)&9O;DU6
MNO\ D$^'O^N@_F*WE'W+.^W7?XEO^AA%^_=6WZ;;$#>&+=+XV3:O&+EO]7'Y
M1.>,\G.!5.TT&29KIKJ=;6"U)625ANY] .]:EW_R/\?^^G_H(JU-&=1M=8TZ
M!A]J%R9%0MC<,C_"I]A3;=H[-JVNME_6Q7MJB2N]TGZ%6[M43PA'#:W"W2O<
MC8ZJ5SGL0>AJC_PC<(G%F^JQ+J!'$'EDKG&<;NE:B(=(\.VWV@HS0WBM(J,&
MV]\''>K5Z^OSW9FTR]A_L^0!ED.S:@QSG(S_ #K1TH2LY1ULM%T_%$*I-747
MI=Z_TF<WIWAJ6_@N7:X2![>7RW5QP!W.<]JSM0M8K*^>""Z2Y1<8E3&#QGL3
M6] \C^%];>617D:<%G4C#'(R1BN5'6N.K&$8Q45J];_-G52<Y2DV]%_P"935
M[2HC/JEM&.<R+GZ9YJ@IKI?!]IY^JF<C(A4G\3P/Z_E1AX<]2,2JTN6FV=[1
M117TA\^%%%% !1110 4444 %%%% !1110 4444 %%%% !7 _$GP\;RS35K=,
MRVXVS =2G8_A_(^U=]3719$9'4,K#!!Z$54).+NB9P4XV9\UD4E=5XR\+OH&
MHEX@6LIB3$W]W_9/TKERM>E&2DKH\N47%V8S%)BG$4E5<FPE)3L4F!3 2BEH
MH 2DI:* $HQ1FBD 4A-)10,K7EK]HCR.)%Z>_M5G2]5WXM;L[95X5F_B]C[T
M8J&XLDN!D_*_9A7-B,/&M&S*T:LS<(Q3#6997L]H1#?*SP=!*HR5_P 1_GVK
MHCI-V]DM]!$UQ9O]V>$%E]\^GXXKP:V$G3>JT,W1>Z,\FDS3RM-Q7/RLSY&)
M24_;6AI^B:AJCA;.TEES_$%^4?4]!0H-[#5.3V,X+DUUGA+PC+K,ZW%PK1V*
M'YFZ%SZ#_&NCT+X=Q0,L^K2"5AR((S\OXGO]!7=1QI%&L<:*B*,*JC  KKI8
M;K,[:.$ZS$BBC@A2*) D: *JCH *?117<=X4444 %%%% !1110 4444 %%%%
M "$!E*D @C!!KPOQAX??0=;DC5?]&E)> _[/I^'2O=:QO$V@1>(=)>V;"S+\
MT,G]UO\  UK2J<DO(QK4^>/F>!$4W%7+RSFL;N6UN$,<T;%64]C58BO03/.:
ML1XHQ3B*2F*PVBG8I,"F E%+10 E)2T4 )1BBD-( S29HHH&4)%EL+D7=MT_
MB';Z?2MZSO8;Z'?$<,/O(>JU0QGCM55K*2"43V;[''.VN'%X.-976XVE+1F^
M:::9IMTNH2+;2XM[QCM57X60]@#V/L>/>KU[IMYI\GEW=M+"W^VI&?IZUX=3
M#SINTD9NBUJ4LT4XK28K+E9GR,2C%/5"Q  ))Z5T6D^"]7U1E;[.;>$_\M)A
MM'X#J:<:<I;(N-*4MD<]%"\KA$4LS'  &2:]7\&^$1I*+?7J#[8P^1#_ ,LP
M?ZUI:!X2L-"42*//NL<S..G^Z.W\ZWZ[J.'Y?>EN>A0PRA[TMPHHHKJ.L***
M* "BBB@ HHHH P/%EC]ITP3HN7@.?^ GK_2N (KUR1%EC:-QE6!!![@UYEJV
MGOIVH20-G:#E3ZCL:\;,J-I*HNIZN JWBZ;,\TE.(IM>6>B%)2T4@$I#2TE
M#33.]2&F$4T(>E>C>%+'[+I E88><[OP[?X_C7$:+ISZEJ,4 !VYRY'9>YKU
M)$6-%10 JC  ["O7RZEJZC/-Q]7100ZBBBO6/,"BBB@ HHHH **** "BBB@
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M:+2[16'1O*!/YFM$*% "@ #H!2T4)6!)(****8PHHHH **** "BBB@ HHHH
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MB@ KEM>\":7K&Z6)1:71YWQCY6/NM=3133:U0G%25F>'ZQX)UG2-SM;_ &B
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MMM1@\JXCW#^%AU7Z&@#G?^$V_P"H?_Y&_P#L:/\ A-O^H?\ ^1O_ +&LC5]
MN=+8O_K;?M(!T^H[5DT =;_PFW_4/_\ (W_V-'_";?\ 4/\ _(W_ -C7)44
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M^@QT]ZTZ.E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI*ZJ/HZ@#ZBKY=#/GU/8YYX;:"2>XE2*&-2SR2,%50.I)/ %5_[6TWR+6?\
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MJ'4JP!E)Y!Y!]C6+XIU]V\9WFCZUK^KZ)8JD?]GQZ7;MYEX6'S$2*K'(/&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV,)TUHQ']G5=JA1TQCICL1TK!TSX=:=IU];7,NK:YJ"VK![:WO;XO%"PZ%5
M'3WS784478W%,\8U;1;$^(]5F\6^!M:UB[GN6:VN]+C9HFAX" ^6ZX('7=D^
M]=%X:\#/=>#KS2=66]L;&YOA<VEF;@226L2E2B%B"!RN2.<9]<UZ+15.;)5-
M)W,CQ%X;L?$^FK97QF39(LT,UO)LDAD'1E/8UF6'@'3+'4=.U%KS4KN_L7=E
MNKRY\V23<I7:Q(^Z > N.:ZJBIN]BN57N<?)\-]';6+B^BO-5MH;J0RW-A;W
MC1VT['J74<G/<9Q4C?#O1#X9&@JUTEO'<M=02QR!)8)"Q(*$# QD@<&NLHHY
MF+ECV.5L/ .F6.HZ=J+7FI7=_8N[+=7ESYLDFY2NUB1]T \!<<T__A!=.3Q5
M)K\-[J=O+-(LLUK!=%+>5U& S*!D_GCVZUT]%',PY48FE>%=.TK3]2L4\RXM
M]1N);B=+@A@3)]Y1@#Y?\YK C^%.AHR12:AK4^F1ON32IKYFM5P<@;,9P#ZF
MNZHHYF'*F95SX?M+K7]-UEGE6XT^.2.%$("$. #D8SVXP12S:#:S^);;7FDF
M%U;V[VZ("-A5B"21C.>/6M2BB['9!1112&%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
61110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>img254193463_27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_27.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $G Q$# 2(  A$! Q$!_\0
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MHH **** "BBB@ HHHH **** "BF22QPH7E=40=68X HBECF0/%(DB'^)3D4
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MGR9HY,==C X_*I*LD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/S,!@5CBU4K8:=.,N73_ (-OF:890I5XU'&^O]/Y'&:5JUCH4K1G7QHLL^"
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MZ111161N%%%%  <X..M9L/VC^V?](\K/V<X\O/\ >'K6E5,_\AH?]>Y_]"%
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M1(VID'V)P#@9QVJ[':PVVM1"%-NZ!\\D_P 2^M)[E+8TZ***0PHHHH ****
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M7WGK%% ((R#D&BN4Z@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[O\ ^A+5ZLQ+:&WUN+R8PFZ!\X[_ #+0!IT444 %%%% !1110 4444 %%%%
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MJ39O+0?NI#_RVB[,/<?Y[U;]]<W5;_YDKW'R]'M_D='11161J%%%% !1110
M4444 <O\0Q:_\(-J1O+:ZG@549A:8\Q,."'7/'RD9_"LZY\(6NKZ_:ZO!K\B
MV<LD%U/:)M9;F6(#8^[/' &<=<58O)QXB\3:[X5U*%)-+BLH)MJ%D=BQ)(+
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MK<1UDC5T.58 @^HI.,H[H<91ELQU%%%24%%%% !1110 4444 %%%% !1110
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MV35-1\4K?:OHE]"L)>.R4M&8H%(P9&(?)=AQTX!QW)JDB6V=E1114E!1110
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MAU675+J\M?L8?REA$46<_*!QG.#FDL? MX+_ $R36-?EU*UTH[K.W,"QX8#
M9R/O$"BBIYY%>SB9[?#"X_LQ]'3Q',FD+<_:8+;[,I*-NW89LY(Z^G/-;T7@
M](I_$TOVUC_;@PP\L?N?D*\<\]?:BBASDP5.*,V+X>SV$FEW.DZ[+97MI9"Q
MEF%NKB:('(^4G .>_/:L;Q#X:D\/^"FT"T>XU&:^U$70E?8NW$B,=Q)&>!U
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' **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>img254193463_28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_28.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %2 W<# 2(  A$! Q$!_\0
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MQ3?&> PZBK] !12 AAD$$>HI: "BBB@ HHHH **** "BBB@ HHHH **0$$D
MC(ZCTK.TWQ!I.L75W;:=?PW,UH^R=(VR4/(Y_(_E0%S2HHK-NM?TFRU>VTFY
MOX8K^Z&88&/S./\ (- 7-*BDR-VW(SUQ2T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN?I6-XW!_P"%T>"SC^%OYFJ&E:K;_#KXD^)_^$B$L%GJT@N+6\\MG1AN9L9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML"J$QC;CC%-B@A@!$,21@\D(H&?RKGE^(/A-_/VZ[:'R%#O\QY!Z;>/F_P"
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%Q@HOH%%%%2:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/_0:M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ,"'_P :/^$6TO\ YYS_ /@0_P#C6S167U2A_(ON1?UBM_,_O,;_ (1;2_\
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M_P#@0_\ C1_PBVE_\\Y__ A_\:V:*7U2A_(ON0_K%;^9_>8W_"+:7_SSG_\
M A_\:/\ A%M+_P"><_\ X$/_ (ULT4?5*'\B^Y!]8K?S/[S&_P"$6TO_ )YS
M_P#@0_\ C1_PBVE_\\Y__ A_\:V:*/JE#^1?<@^L5OYG]YC?\(MI?_/.?_P(
M?_&C_A%M+_YYS_\ @0_^-;-%'U2A_(ON0?6*W\S^\QO^$6TO_GG/_P"!#_XT
M?\(MI?\ SSG_ / A_P#&MFBCZI0_D7W(/K%;^9_>8W_"+:7_ ,\Y_P#P(?\
MQH_X1;2_^><__@0_^-'BKQ!'X8\/SZH\#3E"J1Q!MN]V8*H)[#)ZUG:/XAU?
M_A)#H&OV5G#=R6INX)+*9G1D#!65MP!!!(]C3^IT+7Y%]R%]:JWMS/[S1_X1
M;2_^><__ ($/_C1_PBVE_P#/.?\ \"'_ ,:V:*7U2A_(ON0_K%;^9_>8W_"+
M:7_SSG_\"'_QH_X1;2_^><__ ($/_C6S11]4H?R+[D'UBM_,_O,;_A%M+_YY
MS_\ @0_^-'_"+:7_ ,\Y_P#P(?\ QK9HH^J4/Y%]R#ZQ6_F?WF-_PBVE_P#/
M.?\ \"'_ ,:/^$6TO_GG/_X$/_C6S7->(O$5]9:OI^AZ-:07.J7J/*#<R%(H
MHTQEF(!)Y(  IK"4']A?<A/$U5]I_>7/^$6TO_GG/_X$/_C1_P (MI?_ #SG
M_P# A_\ &HO"WB*37K:\CNK46NH6%RUK=PJ^]0XP<J>ZD$$5O4/"4%]A?<@6
M)JO[3^\QO^$6TO\ YYS_ /@0_P#C1_PBVE_\\Y__  (?_&MFBE]4H?R+[D/Z
MQ6_F?WF-_P (MI?_ #SG_P# A_\ &C_A%M+_ .><_P#X$/\ XULUS/B#Q%?V
MNMV6@Z):6]QJ=U$]P6NI"D4,2D#<VT$G). !36$H/["^Y">)JK[3^\N_\(MI
M?_/.?_P(?_&C_A%M+_YYS_\ @0_^-1^%?$+>(+&Y,]M]EOK*Y>UNX ^X)(OH
M>X(((K=H>$H+["^Y L35?VG]YC?\(MI?_/.?_P "'_QH_P"$6TO_ )YS_P#@
M0_\ C6S12^J4/Y%]R']8K?S/[S&_X1;2_P#GG/\ ^!#_ .-'_"+:7_SSG_\
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M7EK%<VTJ302J'CD0Y5@>A!J6LF;(**** "BBB@ HHHH **** "BBB@ HHHH
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M')/)/O53ES$PCRW)J***@T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** *5YJ]AI]Y96EU<K%/?.8[9""3(P&2!@>GK5#4?&&@Z5=W%K=Z@
M%GMD5YT2)Y/+#'"[MH.,^E<Q\1X[R;Q-X,CT^YCMKMKV81321>8J'R^I7(S^
M=2_#&2&UM]3T:\A,/B*VN6?4FD;<]R6.5F![J1T].E7RJUR.9WL;&F_$'POJ
M]_%96&J">XE;8J""0?-Z$E<#\:Z:N#^&S,(_%14;F&NW) )QD\5+KFK^-'\.
M7(M?#1MKZ2188S;WB3LD9SND (49 Z GJ1Z4..MD"EI=G3V.MZ;J5_?6-G>1
MS7-BP2Y1,_NV/0$].W:DTW7]*UB:\BTZ^BN6LI/+N/+.0C>F>A_"O.O ]M O
MB3Q!HAT#4;*QELX$F^T.@9?E?)=E<G<^2<CWZ5=\$0Z3I6M>.+2%(8=.AFB
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MM89A*4(15?+#U8$@'D UVM*6Y4-@HHHJ2@HHHH JV_\ Q_7GU3_T&K55;?\
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M^R;;^]/_ -_F_P :/[)MO[T__?YO\: +U%4?[)MO[T__ '^;_&C^R;;^]/\
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M=$M6MM+L8+.!G+F.! JECU.!WX%7:H_V3;?WI_\ O\W^-']DVW]Z?_O\W^-
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MZCJNGQQV=[;O/:B&0M("%W*CY&,LO<=#Q[U?O=$U.]\4B^=[$Z>;1[-XCO\
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MQ0N^0Y9L#&2>YK2I-2M8BG!QO<DHHHK(U"BBB@ HHHH **** "BBB@ HHHH
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MU<ZM#:Z&VK20W#0K")O+CB+R$$9P%')//2N8T/Q^;WPWKNM:KIS:>FE3R1O
M6W/A5! /HW.,5U$+W.GZ%$]V);NZ@MU\T0KEY7"\[1QDDYKS+3=,U+7="\9Z
M++HVIV$FK7$UW;2W<(1,';M5CDX;(Z>E))=1R;6QU&F>,-5_M;2[37M'AL8M
M71FLI(KCS"K!=VR0;1AMOID=JV]1\5Z!I%T;74=7M+6<!28Y9 K88X!QZ<5R
M4$6L>*-=\,FZT.[TR'16::[DN=H#R[-H6/!.X9R<^E2:MHEY<^,/$]U_9SRP
MSZ$(()"@(>3YLJI]>E%E<5W8ZRR\2Z)J6HSZ?9:I:SW< S)#'("RCUJI#XY\
M+W&IIIL.NV4EX\GE+$DF2S=,#'6N/TO0KJRF\$S7.GO!!9:-<17SLH01$QKP
MY[<AOUK#\"3VUK>^'9M7&K(B++#I"M9H+<;P3@2J=TF5'!(%/E0<[/1=5\0W
MD.N7ME8I"8M/TU[NZ=P20Y!\I!@\?=8GVQ4F@>*;:]T30Y-2NK:'4=2M!<"!
M3C=\N6(')"CU-9^CZ;>OX2UR_N[:1-3U@3SM P^= 5*Q1X]0H7CU)KD?#^@7
MOA>T\[5[2XN;+4="\FXGN2 ^GLB',+-_!$0>/0CFBRL%W>YZ#9^./"^H:DFG
M6>N6<]W(Q5(HY,EB/3UZ5T%>/?#Z6&#5]!;6AJR7SV)MM,6XLDB@";0S!70D
MN< 89@./K7L-3)694)75PHHHJ2@HHHH *HZI=R6EO&( IGFE6*/=T!)ZG\,U
M>K*UO]V+*Y/^K@N59SZ Y7/ZU<%>2,JS:@VB.?6;@27;6]JDD%F<3,TFUB0,
MG:,=O>I=1UE+.P2:&,S2RIOBBZ9&,DGT %4M4TA;[4UBB@DC27#7,X8A6 _A
MQT+'UIU_HMQ_IEQ;7;9DA\M8?*#?*!P@)Z"M4J>ESE<JZYK:_P!=-O+OJ78]
M0E.HVL3JHAN;?>F.H<<D?D?TK2K!ACE&H:1;R.7E@A>60[<8!&T @?YXK>K.
MHDK6.BA)R3OW_1?J%%%%9FX4444 %<QXQ\3S^'4TV.U2R:YOK@Q*;VX\F) %
M+%BV#Z#\ZZ>N<\53P1?9/M?A:;7+?+$F&".8PG''R,<\^HZ8IK<4MC2T.YU"
M\TQ)]22R69R2OV*8RQE>Q#$#/Y5HUR7P]T>]T?0KE;RV^QK<WLMQ;V6X'[+$
MQ^5../? Z9KK:'N"V"BBBD,*PM>U75[2ZM+'1=)%Y<W 9FFG<QP0JO\ >8 G
M)[ "MVN,\?ZQK]G;V^G:#IE_*]UQ/?6L(D-M'G!V@D9<]L\#K3BKL4M$:WA+
MQ$?$ND274EM]FN+>XDM;B(/O42(<':W<>E;M<]X+AM+7PY%:66EZAIT,#%=E
M_&%ED;J7."<Y)/-=#0]P6P4444AA7*:OXGU0>(I=#\/Z9!>W=M;K<W37$YB1
M%8G:@P#EC@^U=77"7R:EX9\=:EK4&CWFJ6>J6L28LPK/%-'D ,"1A2#U[542
M9,Z7PUKT'B70;;5;>-XEE!#Q/]Z-U)#*?H0:UJYGP%H=UH'A."UOPJWDDDEQ
M.BG(1G8MMSWQD"NFI.U]!J]M0HHHI#"N)U+QIJ@U#5TT71HKVST;'VV22X\M
MG;;N9(AM.2!ZD5VU>;3P:UX<OO%-G:Z'=ZBFMRM/93V^W8CNFUEE)(V@$9SS
MD54;$R;1WVE:E;ZQI-IJ5HQ:WNHEEC)ZX(SS[U;K(\*Z.^@>%=+TJ1P\EK;I
M&[#H6QSCVSFM>D]QK8****0PKR7Q9K2CQG?V>K>)+S3H;98FM(;&S$_#+RS'
M:Q#9'0XXQ7K5>2^)]6DT+QEJLECXCDTUK@1-/$-%:X&53 ;?TZ5<-S.IL>B>
M&9H[CPY9317UQ?(R$BYN4V22<GEA@8].G:N77X66T.L76JVWB+6[>\N6+/(D
MJ;L$YP"4) KJ/#%X^H>&K"[DO/MC31[OM'D>3YG)P=G:M:E=INQ7*FE<RM"T
M:71;:6&75K_4B[[Q)>N&9>,8& .*U:**DI*P4444 %%%% %6W_X_KSZI_P"@
MU:JK;_\ ']>?5/\ T&K5 !1110 4444 %%%% !1110 4444 %%%% !1110 4
M45F:WK^F>'K,7.I7*Q*QVQH!N>5O[J*.6/THW"]C1E3S(G3<R[E(W(<$>X]Z
M^5[SQYKG_"13P6FKZLMEYK11)+>,7'. Q('XXQ[5[F]EXC\:1O\ ;GGT#1G4
MA;:)A]KG'8R-_ /]D<^IKG;?X)16NK1:G!KBI<Q$,@_L]"@(Z':6QGO]:V@X
MQW,:BE*W*=IX>\(PZ3,-1U"ZEU76G0))?7'51_=1>B+].3WKI:9$KI"BR2>8
MX4!GQC<>YQVI]9-W-4DM@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :ZK
M(C(ZAE88*D9!'I6)IO@WPYI&H&^T_1[6WNN<2(O*Y].P_"MVBG<5D%,FBBN(
M7AFC22)U*NCC(8'J".]/HI#,32?"'A[0[QKO3-)MK:X88,B+R!Z#/3\*VZ**
M&[B22V"BBB@84444 %-=$D0HZJRGJ&&0:=10 4444 -V()#(%7>1@MCDCTS3
MJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH H:WJ)TC0K_45B$IM8'F$9.-VT9QGM7!W7BB^U)H[O
M3_'/A[3K:>&-Q:SJDCQ,5&X$[AGG/:N\US3FU?0;_3EE$374#PAR,[=PQG%9
M%CX!\,VVGVT$VA:9-+%$J/*;1,NP !/3OUJHM):D24F]"YX2L;;3?"NGV=I?
MK?P1QD+=*01)DDDC'&,DUM5#:6EM86L=K:01P6\8PD4:A54>P%34GN4E9!11
M12&%%%8=IXKTZ\AN+CR[N&S@1I&NYX&2)E4X)5CU_"BPKI&Y16''XMTE[6YG
MD>>#[.$9XIX&23#G"$*1D[CP,=^*O:9J]KJT<K6_F*\+[)89HRDD;8SAE/(R
M"#3LPNB2W_X_KSZI_P"@U:JK;_\ ']>?5/\ T&K5(84444 %%%% !1110 44
M44 %%%% !1110 5!]MM?M#6_VF'SU&YH_,&X#U(ZUD:_XLT[0V6T+27.IS#]
MQ8VJ>9,Y[':.@]S@5\[6'@+QC?>-8X;_ $N\$DDX>YGE!V%"?F)<<'(SP#[5
MI&%]6[&<YVT2N>[W7BZZU>ZETWPA;)>S(=DVH2Y%K;G_ 'A_K&]E_$U=T3PA
M;:=>'5-0N)-4UEQAKVY'*#^[&O1%]A^=;MK:6]C:QVMI!'!!&-J1QJ%51[ 5
M-4WZ(I1ZL****DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK
M.DU;RIEB-E<[G)VX4?-C\:O1.9(U<HR$_P +=16-.O3J-QB]4-IH?1116P@H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444C,J*68@*!DD]J
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MUW*R(I895%"@DG')/09%5?[,UW^U$UJZ-E-?1JMM!;P[O+BB9U,C%CR6( [
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MCMF(N+>W./[]I*GZY-5W^(][ VV:QL2>VVX93^16NY!U(R,I%L% &&PW/ZU
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MM6NM&<MK?B"WGAEPL1FB2 A_0$'!'MU]ZH7%_KEEXBL(9+JVF%[.Z_8(XO\
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MPO!&2">><DFNG\':9=Z5IMU'<P?9HY;N2:"W:7S7B1L<._\ $2=QZG&0,G%
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MRIE$\LTK_/+*&#;V([Y _*G>*%:3T9AW?C6YCL+*[AL[9(KXRO;O/,0#&@!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>img254193463_29.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_29.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $G HD# 2(  A$! Q$!_\0
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MQ<'4+2TDVZ?>-&$:[!48&!@'YSM##K55_$&MZ?X'\0Q7UW&VO:2A8SH@VLK
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXG_OMO\ &C^R[/\ YXG_ +[;_&@"Y15/^R[/_GB?^^V_QH_LNS_YXG_OMO\
M&@"Y15/^R[/_ )XG_OMO\:/[+L_^>)_[[;_&@"Y15/\ LNS_ .>)_P"^V_QH
M_LNS_P">)_[[;_&@"Y15/^R[/_GB?^^V_P :/[+L_P#GB?\ OMO\: +E%4_[
M+L_^>)_[[;_&C^R[/_GB?^^V_P : +E%4_[+L_\ GB?^^V_QH_LNS_YXG_OM
MO\: +E%4_P"R[/\ YXG_ +[;_&C^R[/_ )XG_OMO\: +E%4_[+L_^>)_[[;_
M !H_LNS_ .>)_P"^V_QH N453_LNS_YXG_OMO\:@L+*WWS/L)9)V"DN> ,>]
M %?Q+XFM/#-DL]Q%/.[GY(H4R2 1EB>@ R,DU=U?58-&T]KN=7?YECCCC&7D
M=CA54>I)K'\>)=7/A2ZL;.PN;N>Z 15@4';@@Y;)&!Q4.O?;]:L[5K72KI)+
M.:WU!$FVIYI5SNBZ\-C)].1S5)+0AMZFMI&MC4KBYLY[26ROK8*TEO*58[6S
MM8$'!!P1]0:UJYO1K>ZO?$U_KL]G-90R6T5K#%/@2,%9F9B 3CEL#GMFNDI,
MI;!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9<@
M(UJW.V?&6Y9OD^[V%:E9LIC_ +8M@MP7?<^8MP.WY?3K0!I445!?*[V%PL=R
M;9S&VV<*&\LX^]@\'% $]>(?$KX??\)-\18(=&G1+^ZM3<78ER$C5<*K9&3E
MNF/:N/O_ (M^*(=4EBLM>GFL4?:DLEM$KNH[X"X&:]'^#NOP^(;W6[V\O9+C
M6I&0'S5 (MUX7&..I.<#TK91E#WC!SC4]TL^&_AQKW@C3O-T'6X);V3YKJUN
M8?\ 1YL= "/F4CU]^E=!9>/+>&Z33_$EE+H5^QVK]H(,$I_V)1\I^AP:Z^J]
M[8VFI6KVM[;17%NXPT<J!E/X&LW*^YHHV^$G5E=0RD%2,@@\$4M>,_$O3[WP
M!X<\_P ,ZIJ%I8W<OD2VGF;XX<@G*$_,G3'![UYY\./%_B+3?%MK#9M=:BMR
MQ22R,O\ K>#R"W (ZY]JM4[JZ9+JV=FCZIHKC_\ A*/%1Z>!;C\=0B%'_"2>
M+S]WP*_XZI$/Z5'*R^9'845QW_"0^-3]WP,@_P![5HO\*Y7XB>)?&T'@R[9_
M#XTN)BJ2W4-^LKHI." % (STS[T*#;L)S25SUA)8Y"PCD5BIPVTYP?>GU\@^
M!O$5YH/B_3[N.\:*%IU6YWL=AC) ;=[ 9/X5]<VUS!>6Z7%M-'-"XRDD;!E8
M>Q%.<.45.ISDM%%%0:!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW-Z_*:K:5XELM6NOLT<=U!,8O.C2YA,9ECSC>N>HY'OR.*NW/_'_ &7^\_\
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M0W[P,,#IVSFO7/.-&BN5U&%M:\:-I-Q<W,5G;Z>MPL=O,T1>1W9=Q*D$[0O
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MDC.1]/8^U6Z\.^%%MXS\.>';BZM]!6\L;J4.L$MQY,HP,%E##&#Q]<5Z9?\
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M+V.&6Y>T4VOGA@0A8'@YKT[Q3X9N=;FL;_3-3;3=4L2_D7'EB1=K@!E*GKG
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M+LD_&-^I^AJS8_$/P[=3BVN;I],N^GV?48S W_CW!_.MBXUZP@D\I)#<3?\
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MZ,S]+UW2=:A\W3-1MKM/^F,@8CZCJ*T*YS5/ GAO5I3/-IL<-UVN;4F&0?\
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MP&:-H/-O XN1Y8!,@QS@\#..@JYXVUJYTG4/#D:WPL+&XOMMW<D# 4*2$)/
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M110 4444 %5+#_EY_P"N[_TJW52P_P"7G_KX?^E &;JFBWLNKIJVDWL5K>&
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MK G<****0PHHHH **** "BBO._B-K*R6]]H[R7-K;16;3RRI$_[]\'9&K 8
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M5\:?V]JEUI=S!:QWD$2SAK.[6YB="<?> &&!ZBO/]2N;F3PS-X@4RO=W_BA
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MCG8N2)VVCV4^GZ7!:W-PEQ,@^>6.%8E8YSPJ\"KU%%26%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>img254193463_30.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_30.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %U!7,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%[1)M,Z_7?'&B>'-9L=+U"=TN;S&S:A(7)P"3VYI=0\::9IOBNQ\.SB8WMX
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M$1E+FLS7\2>+M(\)QV[ZM.\2W#%(]J%LD?2MN*19HDD0Y5U##Z&O&_C_ /\
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M_P"$_@76M%UNYU'7H&C-O!]FM S \$Y)&.W^->OT52DTK$N*;3/$6^&NKO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGTI-6U!2N[&O1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%9VL:A=:;:K+::9/J#
MEL&*%E! ]>:\/O?BSXOC\?&U6R,42W/DC3"@+D9Q@G^\?7I5Q@Y;$2J*.Y]
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MX4#@#@46"YTM%%%(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "FM(B,JLZ@MPH)Z_2G5PGCC3;2XL]1U&%%
MN;RW51-(UP5:RC W;D7^]WQWII78F[([DN@<(74,W12>309$$@C+KO(R%SR1
M]*\T\FTU#1-?UJXFD?4K6?%O,SE7A"A?* ';=D'WW4@03Z!J.O7&?[=AU+9&
MY8AD*R*JQ@>A7MWS5<I/.>F>8GF>7O7?C.W/./I3J\RN8DC\/#Q A8:[_:JI
MY@<[BQF"&+'ILR,>V:] N9[N!MX6$P[E').[GCZ5+5AIW+M%%%(H**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *JMIE@]\M\]G UTHP)C&
M-X_'K4ES-)#&&C@:8Y^ZI K%?Q#(NI+!]D<#&TID9W?6N3$8ZCAVE4=KZ;,:
MBV=!3)8HYX7BE0/&ZE64]"#U%0VUS+.Q$EK)" ."Q!S7/>/&8:58HJSNLE_"
MCQ0.4:123E01ZUTTYJHKQ_R_,4M#:DT+3);""Q:SC^S6^!%&N5V?3'(IZZ/I
MZQRH+2/;*JK(,?>"_=!^E<5IEU<"RLGA:0>9>SK:17$S%K8+$WRR8Z_,I.#T
MR*OZ)XAU1=*M!?FWGF?2WO?,7(SMVX!S]3FM+,A21OOX=TB0(&L(OD=G4C((
M+'+<CU/.*?/H.EW*(DMG&0C,ZXR"">O(]:P+;QA<S:E9:?)! DMU%%<B3<=B
M1F/<P)_O9!P/3GM5%_&^I)<"!(;*=IWA^SRKO5"LD@3G/)Z@Y'6BT@YHG>(B
MQHJ(,*HP!Z"G5C>']5N=06^@O4A6ZLKEK=S"3M?"JP(SST:N7UB]U/2-=\13
MP7DUQ(FE">&-ONQG>1\JCTI*/0;E97/0:*X[3%&CZNL-K<33P3Z:;J42R%\R
M CY^>F<]N*H+XTUQ[,3_ &33QFP.HXW/Q&&VE/\ >/8]*?*',NIZ!17&6?BS
M4K[5E6.UMTL0Q,P8.7BC"!MY8?+SG&*RO[8OM/UZ&_F\QIM1MF:.*1SY46Z0
M"/=Z #O[T<K#G1Z117)P>(-7G\1?8$M[9H8YC%/\K[D4#)DW?=P3T'6G^)KF
M:+6])6*9T5[>\)"M@$B+(/X4N4.8ZFBO// ]O?,-(O+=;V*VDM2UZ]U,66=S
M]TJ"3SU.>.*SKF2[CU/5]15+R/[/JNPZ@+D[(8]R@KY?<<XQ[T^76PN?2YZI
M17F9U:;1KR?Q!<74SV5OJEY:SQ%R05/,>!Z@K@?[U%G=ZM)+;^&+ZZF%]=W4
M=\T@.&%N?G90?0,-GTHY0YSTRBBBI+"BBB@ HHHH **** "@@$8/0T4'I0!F
M0^'=%MKI;F#2[..=#E9%A4,#ZYK0,,;3+*44R*"H;'(!ZBN8&L:Y:ZM81WT-
MH$OIGC6TC),L:J"0Y;H>@SZ;JCE\0:QI=Y"=5BM?*GAFF,$.=\ 1<C)Z$'@9
M]3569-T=';:9864LLMK9P0R3',C1Q@%OK2VFF6-@TC6=G! TIRYBC"[C[XKD
M[KQ9J>AP6EWJL-O+#?P/)"D.5,<@3>$)/4$<9]:TK#5-7M]6L;/5TMF%]"SQ
MM "/*=0"4.>HQW]J+,$T;%_]^U_Z[K5RJ%[-$TUK&LB%Q.N5##/Y5==BL;,%
M+$ D*._M4E"2Q1SQ/%*BO&XPRL,@BECC2*-8XU"(HPJJ, "N2U_Q)JEG;0M%
M82VK,V"TFUL\=*=H/B/4[RT=Y;"6Z8/C?'M4#CIBN#^T:'MO9:W]'_P_X'9]
M2K>RY]+>O](ZQ@&4J1D$8(K*E\,Z-,L2O81E8D$:#) V@YV]>1GM6A<,?L4K
M\JWED^XXK@O#$UQKZV=GK$MQ;+%:[[>$3<W><@R%AUQTV]NM>@MKG"WK8[67
M1]/FM9[:2UC:&X;?(N/O-Z_7@577PUHZQ"-;&, 3"?.3GS ,;LYSG'%<]X>T
MVUTR]U:]7^T+AK2Z:&.,3-*=N!P%)YJEXF\2RRZE;1JUY96]K=0;@8F4SLQY
M' ^Z!^9^E59WT%=6NSLX]"TN$.([*)0\;Q-@=58DL/Q)-1MX:T=HA']AC"A@
MPVD@@A=H((]ABL<M=6_Q#8RZA*UM)ISRK&W$<0#@9QZ^YJ'2(WT_Q;%"+BX:
MWN+9I%N)9_-6\;()8#HFW/XYI6?<+KL=)9:/9:?/YMK$(OW2PA%/RA02>GKD
MGFJC^$]$D^U;[(,+H8G!=B)![\^U9/C6!_LMQ?07%PT]K&IV13[!:CDF8K_%
MTZ=\5+K7B2^T^Y,5G%;RI%IKZ@[RD@NJ'E1CH2*+/H#:ZFK;^&=(M0!%:8 .
MX R,<'!'<^A-6+#2+#3!)]DMQ&9,;VR22!T&3VKEI_&&IV\\=I+!:++,T928
M;V1$=&8 J/F)^7''KFHM7U34]4T I+&UE<1:=->W*QL08SM(C3UR3D_\!HLP
MNNAUR:-IR1)$MI&$2$P*N.!&>J_2N<?P(LVI2O+>EK*6;SFC52KL,8\LL#RO
M&.F<<55L?%UXVA6LT4<*1M)':*\^YG5@F2SJ.>2, #USTKI-.O;V]\.&ZOH!
M;7+QNQC7(VCG!YYYQG\:-4'NLNW&F65TP:>VCD(B:$;ER-C8ROTX'Y5S'_""
M_P#$SEE%^RVLDWG%53$AX V%L\K@#MG'%8VCZU<:!H]AJE[=2S6VH:4K 2-N
M(N47@#W<'IZK7320W6F^ ;A)IY&O$LY)))"V6#D%CS[$X'TIZH+IFQ#I=I M
MF%B!:SC\N!F.648QU^E,U'1M/U8)]MMEE:/.QLE67/7!'-<C9V0T*'P[>6=Y
M=F:_>&.>"6<R+*K+EFP>A7KD5K:$EU;^*]?AN;V:Y4+!(IDX5-P?A1T X%*W
M4+]+&K#H5A;3V<EO"(5LPXB2/A1NZD^OXU4U3PAHNK&9Y[0++-RTD;%3N[-@
M<$_45G^+[0SNHM[N[;4Y4V6-O#(5"/GF0@=AW)XQQWKI)(;B33C"MULN3'M,
MZJ#AL<D"C7<>FUC.E\*Z3=RB>]MEN;DHJR2L2/,P, L <&M*2QM96@+P(?LY
MS$,<)QC@?2N)M;'5M5\!:?;6\SW$@N6,[37#1O*BR-QO'/.!72>%;J"Z\/P&
M"*2$(7C:.27S"K*Q!^;^(9[T- FB6Z\-Z1>6=O:3V2-!;-OA3) 0^HP:;-X8
MTBXL(K&:TWVT3%T1I&.#Z]:YZ+4+O0M1\5SSW,U\;>."6-9#@!G!PH'9<XK0
M\)7=ZCW6F:M&ZZI'BXF?S?,5P_3;C[H&,8]J+,5UV.EBB2"%(HQA$& "<\4^
MBBI+"BBB@ HHHH **** "BBHKF 7-N\)DDC##&Z-MK#Z&@"6BL/PW:&.V>X>
M\O)W,DB8GF+@!7(&!] *W*&)!1110,**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@"EJMM+=Z?)#%>-9[L;IDQE5!^;![9&1GM7)6>M/HEEJ-TL\U
MSITMPD&F"X<DN^,,=Q_Y9YYR>P-=7K.DPZYI<NGW$L\4,N Y@DV,1Z9]*KZ5
MX?@TN*2(W=Y>QL% 2\D\Q4Q_=&..M4FK$M.^APVF:Q?7CP:-)K+3O=:S+%/<
MQ-@^6L6_:I_A!(('MFM$3W9\0CPR;VY^Q_:R?-W_ #[/*W>7NZ]>?I71/X2T
MIK>XB2-XFFNOM8EB;:\4N -R$=.GZFD_X1.P^P"W$MT)A-]H^V>:?/\ ,QC=
MN^G'TI\R)Y60^&KVX7^V+*9YKI=/O3#$Y^9RA56 )[D;B*V+%_,>Y?8Z9EZ.
M,'[HI-+TNVTBS^SVV\AG,DDDC;GD<]68]S4EK_KKK_KK_P"RBI>Y:V+-(0#U
M /UJ.XE>&W>2.)I649"+U:N.U_Q1JMG-"L-H]KN4DB0!BU<F)Q=/#1YIW^[^
MD=%##3KRY8';45S>BZ[J%Y90M-ITTI8X:92H7KZ5T,Q(@D(.#M/\JTH5X5H\
MT":M*5*7+(ACT^SBN[B[2VC6XN %FD"\N!P :I1^&M'B4JEB@4NK[220"#D8
M&>,'TKB?!MW<ZW:Z=8ZO=7$,2PN\"^9S>_.P+EA_=_N]>]:'AO3;?3]8UVZ#
M7]Q_9]QY<,7G-(=I0$@*3R>:Z6K=3G33Z'4W/A[2KLNTUFA=Y/-9P2&W$8)R
M.>G%#^'M*DD,CV4;,T(@;.2&0= ?7%<GXJ\1S/+%&CWEA;V[1329A8/,Q;[F
M1T ')]>E:\XN8_'%C.U_.UM/:RD0GB.,  YQW//4TK,+HT?^$8T;[(;;["AC
M+B3))W;AP#NSGIQUI[>'=)>+RS9IM#*PP2#E1@'.<].*Y_38VT_QE!"MS</;
MW5L\@GDF\Q;MA@DX_@VY_'-2>-;=I+6ZO+>YN)+BT@W""&X\O[/U)G(ZL1CI
MWQBC6^X75KV-U/#ND1Q/&MA"$<*",?W3E<>F#S2)X>T]=+33WC>2!7,@W.<[
MB2<YSGN:R=0\0WMK#;"R^SW"_P!G&]>68%3(% . !T)_2JTGBO48(S'-%:+.
MY@*.H8HB2@GD=21MQQZT687B=!-X>TJ>TAM9+)/)@SY:@D;<]>1SSWJRVG6;
M/;.;=-UJ"(>/]6",''X5RE]J=_J>DQ0W*?9;D6\]W,D19<(JL(\YY&3S_P !
MJ"R\87;:!!/#"BJ)HK/?<;BZL5RTC*.<<< <G.>E%F',C<U7PG97NGPV]HD5
MJ]NH2%MFY0@.=A'ID"GZ!X;31A-++.UQ=3$[F.=J _PH"3@59T:]O;_15N;Z
M!;>X8,?+4$?+D@'!Y&<9KCM+UJ70=.T_4KNXEEAO]..!(^<W"9( ]V'_ *#1
MJ] T6ITNJ>$[&\L(X+2..UEB4+&X3(VAMVTCN,C\.U.T/PVNE,)YKEY[C<YR
M"0B;MN0HR>/E'ZTVTMKK3O!<JW-S)+>_9I)I9&;)$C L<>@!.!]*YBR@?1-%
M\-ZK9W=V]Y?26\<UO+.SK.) -YVGH0"6R.F*>NUP=D[V/0+2RM[&W^SVL2Q1
M;F;8O3+$D_F2:HV_AK1[6]%Y!81),&+*1G"D]PO0'Z"L_1TN[?Q=K$=S?37*
MF&&10_"QY+\*.PP!]:A\7VHF"LMS>/>/&8[*TMY"G[W_ )Z$CL.,D\ ?6EU'
M?2]C;31;$:4=-DA$UJ2Q*2?-DEBQ_4_A6='X-TJ"XG:)&%M=1>5<VS$LLP'W
M22>01ST/>M9(KEM+6!KD+=>4$:95!P^.3BN*T^RU74_!GV6*>6ZECU*99&FN
M#&\B)(PQN'/84+U!V['7Z=H.F:5*TMG:K'*PVER2S8],DGBGQ:-IT,L4L=K&
MLD3O(CCJ&;[QS[U5\,7$5QH$'DQ20["\9CDD\PJRL0?F_B&1UK#6_O- NO$U
MS<7,U^T,<,D:R?*H9MP"@=%&<468721O1>&M(@U W\5ILN6D,I<.W+'N1G!J
M6TT+3K*_DOK>WV7,HP\F\DM^9K'\)7UZL]WI.KPLFJQ@7,S"7S$</G[I_A Q
MC'M74TG= K,****104444 %%%% !1110 4444 %%%13W"6Z;Y-VWN0,XH EH
MID4JRIN4,![C%/H **** "BBB@ HHHH **** "BBB@ HHHH **** "LR]\/:
M3J%V+JZLHY9N 2<_-CIN'0_C6G10%KF;<>']*NKY;V:QB>=2#N/0D=,CH<=L
MTLF@Z7+J0U"2SC:Y!#;SGJ.A(Z$CUK1HIW8K(SO[!TO^T_[1^QQ_:MV[?S][
MINQTS[U-J/\ QZ?\#3_T(5;JIJ/_ !Z?\#3_ -"%(9;HHHH **** "BBB@ H
MHHH **** "BBB@ HHJM>K>-;XL9(4FW#F52RX[]* +-%8'AF_P!5U2S2]O7M
M/)?<H2)&!!#$=2?:M^FU82=U<****0PHHHH *@-E:ERY@CW$YSMYS3+ZYFM8
M0\-I)<L3C8A (]^:\_F\6ZRM^Z LJB0CR]HR.>E>?C<;0H-*JK_+_,Z\-@ZE
M=-P:/2J@N;2WNQ$+B)9/*D$B9_A8=#5>POKF[=EGT^:V &0SL#G\JR/&UW>6
M5AI\MC&\L_V^$"%9-GF\GY2?0UW4YJHKQ_R.6I%PT9L_V38"Y-S]EC\TR>:6
MQ_'MVY^N.*J'PMHI@C@^P)Y<9;8NX\ ]1UZ>W2N5O;==6\"ZIJ]S>71U&..6
M5UCD:+[-*JG]W@'HOZ]>]:NFW4'AS0?W5IJ-PQMEN6=MT@=RHX#$]<]JTLS.
MZ[&ZNAZ8L806<6T.KCCH5&U?R'%0P^&=&M]GE6$0V%2G4[=IW+C)Z @8%<UH
M%W=ZF-=MCJUR+MPDID6(J(<KRL8(X X'ZU)9P2:GX'TKS)KBYN5MVD6U6X\M
M[DCCENO'6BS[A=/H=.NBV4>JC48XMD_S$E20&9@ 21W. !35T#3%U234A:K]
MKD4J\A8G<#V(SC'M5'P_=&X\%VTTNH-N\A@]R_!0@D$G/IC&>^,UE:()-)\3
M7MIYUP8?L/G1":;S1=$$9FS_  ]<8[YS19CNM#I;+1--TY95M+5(Q*-K\DY'
MIST'M2#0M+$0C%E%L%N;;;C_ )9$Y*_3-<POBO6F@6;[/8A39?;L9;A VTI]
M>^>E6X?%%]<:T8DMX19)(5F)#;HD"!MY;[O.<8HLQ71&/ JMJ.][TBR\[S?*
MC4H[<8V,P/*_ADUTLVDV%QGSK6-\P^1R/^6?]WZ5PTNNW&F:E9:@_FROJ$4C
MQQLQ$:[G 0L?X5 YS[UM1^(M5F\0FPCM8&CBN!#,-K%E7;DR;ON@=L'FFTP3
MB-7P45U9I_MQ%J9&D\M5(<Y7;L+9Y7'MFN@&D67E6R- '^S1F*(MR54C:1^(
MK'\1I+=:QI%DEQ)$ERERK&-L<[!M/X'FLS2=4N?$%]I5D9V1M.#/J05L$RJ=
MBHWU.6_*EJU<-$['4_V19K'911Q^7%9,&A1#@# P!].:@;PUH[WSWC62&9Y/
M-8DG#/\ WB,X)K NM+BUOQUJ<%W<WB16]I"T?DW#1A"2V3QWXJE<W.I7O@JW
MO?[2N ;:\$>^/@W*B8(K,?0CTZT6\PNNQVCZ-ITEO+;O9Q-#--Y\B$9#29SN
M/OD9J9K&U:_2^:!#=1H8UEQ\P4\D9]*S/$T5K)91R7MU<);1O\T%N2&N&(^5
M..3SV%8.HC4[;P=I=E<23R:A-<(AMUFVR3+R?+,G;Y1R?]G'>A*XV['<T5Q_
MAII+GPUJ-G=7TUK)!<RQONDR]JF<A-_?"G[WO5>RM(3I>H337MY;: 9D>!6D
M;?(H7!P3\VUFZ#J?QHL',=Q17-:7:7(\(RP7UW/9JYD='=_WL,&[*J6/<+Q[
M?A6;96!N-,ND26\2PFGWV-K).4DN%5.5W'D*S<_2BP7.WHKD/#^H.FBPI<7L
ML<J-(C1R#>T>'8;2W?&,9[XHI6&I'7T444AA2'.#CKVS2T4 <EI>B^)+;7)M
M0OKG2KEI209!'('2/LB\X Z9]:BT[PWKOVN\?5[C3+E+U&CN)8TD$H0@[53)
MP /2NDBUK3)[]K&*^@>Z7(,2OSD=1]11;ZQIUW=26UO>0R31YW(K<C'7ZXJK
MLFR.;?P??:HEO;ZW>P26UE"\5K]G0AB2NT.^>,@=AQFK^FZ+JIU2UO-9O+:8
MV41BMUMT*[B1@N^>^!T'')K5M=9TV^EEBMKV&5X@2X5N@'?Z>]+8ZOIVI.Z6
M5Y#.R<L$;) ]?I[T78)(;?11K-:N(U#F=<L!S5^J=_\ ?M?^NZU:=BD;,%+$
M D*.I]JDH;-;PW"A9HDD Y 89HB@B@4K#&L:GG"C%>>>)?%_BW^QIGTCPQJ-
ME<Q'?YTRQR)L'7(SZ5#X5\9>,'T5+C5_#.H7\TQWQR0)'&NSMQG/YUG>/->V
MIT^PJ<E[KTN>F,H=2K#*D8(JD-'T\1V:"U0"S;=;XZQGVJ;S7DT_S6C:)VBW
M%&ZH<=#[BN TS5]5MK:*\BD2<0Z,+B5;AS\V)&SCW('6M4KG+)V>IZ#!:06S
MS/#&$:9_,D(_B;UI+JT@O(T2XC$BHZR*#V8'(-<LWBS4"DEVEI;BS6[CM@&8
M[V+E>?08S5>^\1ZI<^)+:QLS#!'#JIM9-V3YJB+?S^?Z"GRL7,CI'\/:7)JX
MU5[8->@8\PL>GIC.,56/A#1A#+'%:"$2E<E&.0 P;"^@R.U<WI_B>]AM9H;"
MUC/E0W-VQN9F<G9(P*@]><<>E1P:S<ZEKEM-IX:)Y;Q<I-,S(0UL&Z=@,]!]
M:=F3>)V=]H&EZE<)/=VB2R( N22-P'(!]1]:FN-*L;N1Y)[9'=X&MF)[QGJO
MTK"'BFZD\'W.JQZ>\EU"TT3QPD%0\98%N2/ERN:J:_K%[<_#:YU$07%E=;(B
M 2%8DLO(()P#FE9E71H:]X2@U3[/);&*&6$CB1-R. I50>0> 3C![U9TCPS:
M:9I$UC*SW7VA2MP\ISO!S\OLH!P!6-IL1\2PZA+JL]S#=1ML-C'*8_LP&2.1
M]XMUW=_PI/!SIIOA;3KYH]1O)[]%\U@QEVGGDY/ ^E/6PE:][&AK7A"UU%(F
MM!#!+&5)#)N20*"JA@"#P#P>M6="\-0Z-;LK3RW,KH4=I&XP6+8 [ ;L#VK
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M2-.%"YW=/7/>M&BB["R,B+PQI$-U<W*V:F6Y4I,68G>#V()JSIND6.DHZ64
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MBXWD>N.M $]5-1_X]/\ @:?^A"I?MEJ;K[+]IA^T8SY.\;\>N.M1:C_QZ?\
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M8O)+CJ4ZX-.L[.WT^SBM+6)8H(EVHB] *GHH A>T@DN8[EXP9HU94?N >O\
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M3Y/E)Y7]S:,?E7G5IKNIW-Y'HT=Y=0I=:CY*O<KBYAB$1=@?<D$ \\&KPO\
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MCC9TNEW\$ D#^]_6M([&4]SUNBBBLS4**** "JFH_P#'I_P-/_0A5NJFH_\
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M:_\ OVO_ %W6KE9U['*+BV9IBR&=<)M''XUHU!84444 %%%% !1110 4444
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M(#>^(M0TB2W\M[6**9'#9#JX_3!%;=<)\.K9;=M0>32];@NY=AEN]6QOFQD
M#'8>GO7=TI*S"+NKB8&<X&:7 KD[/4=5A\=WEIJ5W#]B%@UQ'%&N%C D R6/
M).,Y[5GGQ9>2:I+?1W$0TUK*:2UMQC=)LQB1CUYSP/3ZT^5AS([S %&,5Y[J
MNMZMX:L]-O7OVO#J$#AXY4&V.7R]ZLN /E!XP>U;5I)J6EZYI=K=:C)>QW\+
M^8)%4;)%4-E< 84\C'-'*',;E_\ ?M?^NZU<K/O9E:XMHP'W"=>2A _/I6A4
ME!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!DZA>ZE;7L,-O;VKQS-M5I)64@XSR #5+Q+XDDTF.WL+* 76N7
MGRV]LIR!ZNQ[(/6N.^(/Q2MO#'B.WTZ+3VNI[8>9(S2;%!93@=#GWKK?"&A_
M9H&UN^G^V:MJ*+)-<$<*I&1&@[**OELKLCFNVD6?#/AM=#@EGN9S>:K='?=W
M;CEV]!Z*.PK2U#2[35(Q'=H[H.RR,H/UP1FKE%3=WN596L06EI%90"&$,$'3
M<Y8_F>:GHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAQ<3+W_V%/\ .FE<F4K&19I>:OK=U!)=M)IZ'YB!C> >!FNN1%C1410JJ,
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M:%.4KBA&VX4445)84444 %%%% !12,VU2Q!.!G@9JC'JUO+.85CN XQG="P
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M=:N5G7L"+<6THW;C.O\ $<?E6C4%A1110 4444 %%%% !1110 4444 %%%%
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M&-2W-J>YT445D;!1110 54U'_CT_X&G_ *$*MU4U'_CT_P"!I_Z$* +=%%%
M!1110 4444 (2%!)Z#FL&?QIX?MEE,VH*GE*7<,C# '?I6\3@$^E?.%YXXU'
MQ1\1DL+R#=ILMTMH]I#UDC63(!/?D9-7"/,9U)\NQZ]X/L[C5;^Y\7:DA6:\
M'EV4+?\ +"W!X^A;J:[*D151%1%"JHP !P!2U+=V7%604444AA1110 4444
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M9V).,GN0,#\*ZSRH]JKY:848 QT%."A1A0 /04W.ZLA*%I<S%HHHJ"PHHHH
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M?NZDDD$#J:LTZ49>S47HP>Y3TZ0&TCCVNK*O(9<5<HHJZ<'""BW>PF%%%%6
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MM9H6N+B.(8_B:N8LM?UJ]U&2"WMX94C/+$%1CL<T1@VKBE4C%I,ZYF"J68@
M=2:S)M:C\SR;*)[R;IB/[J_5NE,_LB6\PVJ7+3#KY,?RQC_&M2*&.",1Q(J(
M.@48%'NKS'[TO(R_[/OKX[M0NO+C_P">%N<#\6ZFI#8K;2P"TL(]D3;LA@#T
MQ6G11S,.1" DJ"1@^E+114EA1110 4444 %%%% !1110 45"MW;,^Q;B(MTV
MAQFI20H))  [FDFGL-IK<6BL^?6]-MVVO>1%NRH=Q/Y5 =;:4?Z'IUW/[E=@
M_,UD\123MS:^6OY&BH5'K;]"]/>Q6\@1UD)8X&U"<GTJK>:N(W6VLXC<7;CB
M,=$]V/:N+\10ZY=:L)3:RQ!@H58V+#./;O7;:)91V6EP 1;)70-*6^\6QSFN
M*EBJN(JRIQ7*EU:_(ZJF'IT:<9MW;Z#++22D_P!LOI/M%X>A/W8_91V^M7KF
MV%U'Y;22(IX.QL9J:BN^-*$8\J1QRJ2E+F9'#%Y,>SS'?W<Y-2445:5E9$-W
M"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 </K]E)>:M-'8:!=1:
MG)+$R:HK!8P%(RQ(/901C'-0RZ9J<=A?^&ET^>07EZTZ7RX\I8VD#DL<Y##D
M8QS7?457,3RGG\^F:G-I?_"*C3YP/MJRF^./*\D2B3.<YW<8QCK78:C;0^5Y
MVP>9O3YL^XK0JIJ/_'I_P-/_ $(4F[C2L6Z***0PIDLT<$3RS2+'&@RSL< #
MW-/KSCXDW$GB>PF\(:$&N=3=E>?RVQ'"@.<.WOZ4XJ[)E+E5S1USQ*VN2Q:!
MX6NDFNKI29[V([DM(NA;(_B/0"NFT71K30-*AT^R0K%&.6/+.W=F/<FO/OA!
MX&UGPDNHSZMLB-SM5(5;=TS\Q_.O2[F5X8BZ1!P.6RVW HJ24%Y(4$W[SW)J
M*S(]9MVC#3%(]PRH5]Q/X"LH:H)-5\BW-U(I&%5I-OS?C7G5<SP\.6SO?[_N
MW-E!LZ=B0I(&3Z55BNYI)S$;5E*XW'>.,U QU5U+,;>W4<]V.*Q+(7D^J.)K
MQE60@,8W SZ5CB,?*,X1C&6K[)?GK^0*)NZD)(T$J7+QY95P,8Y-68V2"/;)
M<!B.[L,U@ZQI+[8S'<,5R ?,DY))K2M=(M1!&9X4DE Y8G=S2I5<1+$SBJ=M
M%O)V_(&E;<;?ZI91O;YG0XE!.TYP,4LVN01QLZ132*!G<$P/SK*UK^Q8KV..
M>X$+@@,BCH*C\0ZY:)H2Q6-]NFRN"G)Q[UA/%8B,JKE.*MM;5_BS>GAIS<4D
M]?N+ND:K/-:^7#9LY0G)W =369XJU>YCM$B,<4<F[[HDRV/H*S/"C7^IW,MN
M=0DAC"98*!N(SV/:NMFT;3;6S,>TIN.2_5G/N:QPZQ&(PGQM+:[LEI\K_>T=
M#IPPM9>TU:Z(YGP?%<WTL\WG!'C555F7<0/;TK872KO^VU:>1;@ ;OWAZKG%
M:.AVUM;VX$#N6*C<K#I^E3;Y?[1\[[-+L\O9VZYK6G@*3HTW-MN]]&[?=JC#
M$U_:57*.Q? "K@  #L*JPNIO[CYEY"]ZM$!E((X/45 MC:HX=8$# Y! KV:D
M9MQY;:'*AMY;37(V),$3@D;,\@YJ>)9%3$KAV]0,4^BJ5.*FY]7YA<B>V@D;
M<\2,WJ14BHJ*%4 *.@%+15*,4[I""BBBJ **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1@"I!.!CK7G+0:?+=W$_AY
M8HQI\%PIN%D!>ZE93E1SE@N<Y/?I7HQ 92",@\$5G6OA_2+*=9[73K:&5<[7
M2, C--.Q,E<\[UM;>RTW1)/#Q5;J6RE^U&W/S-%Y669\=]W<\YKH;&'2[7Q-
MH0T/R@LMH_G^2>&BVC:S8[[L<GFNJMM,L;.666WM(8GE^^R( 6^M+::98V#R
M-:6D,#2'+F- ,U3D)1(;UIC<6P9%$?GK@@\UH5XG\5?'_B/P]XMM[#3<16R*
MDJEHPWFMS_G%;*^*?B3>V$$MMX<@A$D:L)3\Y;(ZXR,5G?2[-8Q<GRQW^[\7
MH>IU@^*O%^E>#].2\U21@)&V1QQC+.?85Y=J/_"T]1.)EU-%[K:B.$8_ YK!
MUGP-JESHTUUJ-GJ43VP\QY[F3?D=\<FI=6$=97MZ'0L%4DK*4;^O^6GXGK]M
M\3?"EUIT-XFIC]Z.(?+9I ?0J <&N?\ %WQ)OD\,W=QX?T;4T=0!]LN;;RXX
MQGD@-R?;BN>\/Z%>^'](BM?L^N!7'F[[.!65MW/J#4VH6B7=E+&R:^SXW$WE
MLZJH'4_>(K&>+4%S*#:_KIN;4\OC*T9U4GY*_P".P>!/&'C/Q!H5QYVJ:7:Q
MQ2;1?7P_>'C. N0#CU-;C0V,['^VO&NI:DQZV]D#$GX;!_6L#PK/I.EV9EG9
M66;E)FT]YE/T(&!761^,-&B&!X@M;<>^GLG\Q4QQLJBYHP:7R_5HJ6 HTI<K
M;E;U7Z,BL[3P[;YETOP==7<X!Q+<P\D^[.>E<SX!2>R\5:E-IV@6QN9 =R[O
M+\GGH">U=;/XNTJ[M)XH_&=@[-&R[-BKNR.G/2N4\':]I]SX@9;;5K:W=%8M
M)*0%].^ :YJ^+K1JPBHMI^G_  ?Q.JA1H*C4]Q7Z7O\ \#\#TH7OB9O^819+
M];K/]*//\5'I9::OUE8TB7E[*1]GUO2YOP!S^1JP9->5<I'8S>^]EKJ]J^JE
M^'Z'#>/2,?Q_5E;=XN8_<TA!_P!M#7'Z[8^-)?%U@Z2@L?\ 4O#D1)_>W _U
MZUW O-<0?O-,@;_KG/\ XURFJ^*];M]4FA51 %( B*JVW@=\5RXK&4J4$Y\V
M_9_K8[,&ZOM'R1AL_P"NIT!TWQ6[<Z]:H/1;,'^9I?[$U]_]9XDD'_7.W459
MCN=>F1"MG:QJ0#N>4D_D!4HM];<?/?V\?_7.'./S-=*J)_#&3_#\VCD=6<=W
M!?*+_),XGQGX6U"XM(%?Q UU*KY$-R508/<8]*WM+\,7 TNV4>)+Z150+F)Q
MMX]..E<]X_=-(>REU35>) RJ\JD#(QP-HKHO#6GSS^'K.XM]5G2.5"Z #*X)
M." 1^-<M.I5>(E%TG;U_X-OQ.RI7E]5A[ZW?3_@?H7!X8D_BUS4S_P!M<?TI
M?^$60_>U;5#_ -O)%6A8ZLGW=6##_;@7^E(8==4_+>6;CT:$C^1KKY^]-_A_
MF<7MJG2HOZ^1FZAX)M[VPFMQJ>I;I%P#)<EES[CO69X9^'<.G6<@U65IY)&_
MU<<C*@ ^G4UIZY<>(+?2Y7 @&,?/"S!ASV%9?AK4?$$T\X*M<X0<7$A '/:N
M6>+I1KQIN#N_+]#KA/%?5Y<M16O_ %KT.C3PGH*8_P")9 V.[KN_G5Z+2["
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MC@U:K:AAJ=&*C!;=>IE6K5*DFYOY!2,JNI5E#*>H(S2U6U"^ATS3Y[VXW>3
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MGZTAOM5N$/D:6(ACK<28_05KJJH,*H ]A2UT>RJR^*?W*WYW,/:4U\,?O?\
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MJNK.)U;P?JM_?&X:ZBF) RS?+^E=+I^B6L&DPVEQ;0L0!O\ EX9O6M6BMZ.
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M/^>*?]\BC[-!_P \8_\ OD5*A;J5/$.;NXHX[[1X[;K=^&D^GF'^M&?'+?\
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M%0"#3('?:K?_ )[Q?]]BC[5;_P#/>+_OL4?9H/\ GC'_ -\BC[-!_P \8_\
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MEG#=1^']0:&50RNC(P(_[ZS4I\9QQ_ZW1]43_MAG^1KH([*UB0)';QHHZ!5
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MXF\Z7>57'!&?RQ5O4O#FKW^EOI[:_:/;LH 1K<#&.F"#Q77_ &.V_P">$?\
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MBN^TRQ73=-M[169Q$@!9CDL>Y/XTEQ81/%B*-$?<I#8QT(-7*:@D[@%%%%4
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M(ORL%/+LH(QN'&.N*[:]L;74K1[6\@2>!_O1N,@_6J,/AC1+>WF@BTVW2*<
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M@0H,*N"1\OMQD>QJ6?P]I%S;P6\VGP-#!D1(5X7/7%:$<:11K'&H1%&%51@
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MJ#3O#-AIMVES&;B66)#'"9YFD\E#U5,]!P/RJ^9$*+-BBBBH+"BBB@ HHHH
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M')Y61:N59O13C!_"MS1-<M-?LVNK-9UC5RA$\+1G/T-<;\5_^/?PW_V&(/\
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..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>img254193463_31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_31.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $] J # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V_7=8@T#0
M[S5KE)'@M(C*ZQ@%B!Z9(KS?_A?_ (9_Z!VK?]^X_P#XNNN^)7_)-O$'_7F]
M?(U;4H*2U,*M1Q:L?1?_  O_ ,,_] [5O^_<?_Q='_"__#/_ $#M6_[]Q_\
MQ=?.E%:>QB9>VF?1?_"__#/_ $#M6_[]Q_\ Q='_  O_ ,,_] [5O^_<?_Q=
M?.E%'L8A[:9]%_\ "_\ PS_T#M6_[]Q__%T?\+_\,_\ 0.U;_OW'_P#%U\Z4
M4>QB'MIGT7_PO_PS_P! [5O^_<?_ ,71_P +_P##/_0.U;_OW'_\77SI11[&
M(>VF?1?_  O_ ,,_] [5O^_<?_Q='_"__#/_ $#M6_[]Q_\ Q=?.E%'L8A[:
M9]%_\+_\,_\ 0.U;_OW'_P#%T?\ "_\ PS_T#M6_[]Q__%U\Z44>QB'MIGT7
M_P +_P##/_0.U;_OW'_\71_PO_PS_P! [5O^_<?_ ,77SI11[&(>VF?1?_"_
M_#/_ $#M6_[]Q_\ Q='_  O_ ,,_] [5O^_<?_Q=?.E%'L8A[:9]%_\ "_\
MPS_T#M6_[]Q__%T?\+_\,_\ 0.U;_OW'_P#%U\Z44>QB'MIGT7_PO_PS_P!
M[5O^_<?_ ,71_P +_P##/_0.U;_OW'_\77SI11[&(>VF?1?_  O_ ,,_] [5
MO^_<?_Q='_"__#/_ $#M6_[]Q_\ Q=?.E%'L8A[:9]%_\+_\,_\ 0.U;_OW'
M_P#%T?\ "_\ PS_T#M6_[]Q__%UY-X<\)Z9JFA6=_?7&I++>:I_9T26<"R!#
ML5@[ G./F[>E7-?^&UQI^E6MQI\T=U,D5T]XOGH"PAE*%HDX8K@9/6IY(7L7
MSU+7/3?^%_\ AG_H':M_W[C_ /BZ/^%_^&?^@=JW_?N/_P"+KQ:+P/KMPMFU
MM#;W/VN584$%U')L<KO"O@_(=H)Y[ TMKX&UN]GGBMELY5A=(S,MY'Y;NXRJ
M*^<,Q]!S3]G GVE0]H_X7_X9_P"@=JW_ '[C_P#BZ/\ A?\ X9_Z!VK?]^X_
M_BZ\4\*^'(-=\41:/J-^--S)Y3;T+2,^[;L4?WL^O P:+?PAJ&HZC?VNFFWE
M-K<20(DMPD<LQ7)PB$Y8X7/%'LX![2H>U_\ "_\ PS_T#M6_[]Q__%T?\+_\
M,_\ 0.U;_OW'_P#%UXIH>@1ZGH>IWS[S,DMO9V:*P4-/*_&XG^$*K?F*BUSP
MGJ_AV!9]0BA$9F>W+0SI+LE499&VD[6P<X-'LX7L'M*EKGN'_"__  S_ - [
M5O\ OW'_ /%T?\+_ /#/_0.U;_OW'_\ %UXI_P (7KGVB:#[/%YD(MBX\Y>/
MM! B_,D9].]0ZUX4U;P_ L]_%#Y33-;EH9TE"2KR4;:3M;'.#1[. >UJ'N/_
M  O_ ,,_] [5O^_<?_Q='_"__#/_ $#M6_[]Q_\ Q=>1WWP^U"%]-2RNK.Z:
MZL!>RD7*!8%Y+,QS@(!CYCP2<5AWOA_5+#6(M*EM2]Y,$,"0L)!,'^Z4(X8'
ML10J<&#J5$>\?\+_ /#/_0.U;_OW'_\ %T?\+_\ #/\ T#M6_P"_<?\ \77F
M<GP\LH'M&DUGS+>.RN;O498$#",PL%9(_P"\=QVY/&>:K7O@[3XM"O-0L[JX
ME4Z?#J=FTJA3Y7F>5+&ZC(W*Q4@@XQ2Y(%<]0]5_X7_X9_Z!VK?]^X__ (NC
M_A?_ (9_Z!VK?]^X_P#XNOG2BJ]C$CVTSZ+_ .%_^&?^@=JW_?N/_P"+H_X7
M_P"&?^@=JW_?N/\ ^+KYTHH]C$/;3/HO_A?_ (9_Z!VK?]^X_P#XNC_A?_AG
M_H':M_W[C_\ BZ^=**/8Q#VTSZ+_ .%_^&?^@=JW_?N/_P"+H_X7_P"&?^@=
MJW_?N/\ ^+KYTHH]C$/;3/HO_A?_ (9_Z!VK?]^X_P#XNC_A?_AG_H':M_W[
MC_\ BZ^=**/8Q#VTSZ+_ .%_^&?^@=JW_?N/_P"+H_X7_P"&?^@=JW_?N/\
M^+KYTHH]C$/;3/HO_A?_ (9_Z!VK?]^X_P#XNC_A?_AG_H':M_W[C_\ BZ^=
M**/8Q#VTSZ+_ .%_^&?^@=JW_?N/_P"+H_X7_P"&?^@=JW_?N/\ ^+KYTHH]
MC$/;3/HO_A?_ (9_Z!VK?]^X_P#XNC_A?_AG_H':M_W[C_\ BZ^=**/8Q#VT
MSZ+_ .%_^&?^@=JW_?N/_P"+H_X7_P"&?^@=JW_?N/\ ^+KYTHH]C$/;3/HO
M_A?_ (9_Z!VK?]^X_P#XNC_A?_AG_H':M_W[C_\ BZ^=**/8Q#VTSZ+_ .%_
M^&?^@=JW_?N/_P"+KH-+^*.CZKI\=Y#:7RQN2 '1<\''9J^5*]2\&?\ (K6O
M^])_Z$:\K.*TL+AU4I;WM^#/2RJ"Q-9PJ;6O^1[+_P + TS_ )]KO_OE?\:/
M^%@:9_S[7?\ WRO^-><45\S_ &UBNZ^X^@_LO#]G]YZ/_P + TS_ )]KO_OE
M?\:/^%@:9_S[7?\ WRO^-><44?VUBNZ^X/[+P_9_>>C_ /"P-,_Y]KO_ +Y7
M_&C_ (6!IG_/M=_]\K_C7G%=$_AZV\LJD]QYZVBW;%T'EX.,KGJ#SQ6U+,\;
M5ORM:&<\!A86YKG2_P#"P-,_Y]KO_OE?\:/^%@:9_P ^UW_WRO\ C7):IX>G
ML[^1(-C6_G>2CM*N5.,@/_=X]:KC0;_>XVPA%19#*9E$95CA2&S@Y.:J689A
M&3BUMY$K!8-I._XG:_\ "P-,_P"?:[_[Y7_&C_A8&F?\^UW_ -\K_C7#G1KY
M;+[68E\O9YF-XW;,XW;>N,]ZDLM,@NM,O;IKL":WC+K JY) (&2>PYJ5F>.;
MMHM+ZJVA3P&$2O\ +<[3_A8&F?\ /M=_]\K_ (T?\+ TS_GVN_\ OE?\:Y"]
MT*2*RM[JVPZ&T2>53(-RYZD+UV]*9:Z0UWIUNT(W7=Q,XC4L%4(BY8G/?G]*
MIYCCU+ETOZ$_4L);F_4[+_A8&F?\^UW_ -\K_C1_PL#3/^?:[_[Y7_&N'?1K
MU)EBVQ,602*RS)M92<9!)P:LZ7H+WEZ8KJ46\2L(RX(;<Y&0JXX)[^PI1S''
MRDHV_ <L#@U'FO\ B=?_ ,+ TS_GVN_^^5_QH_X6!IG_ #[7?_?*_P"-<G::
M'#<0VL;7+K>7D;R0($!0!<X#'KS@]*HZG:1VLL#0EO*G@290QR1D8(/X@T2S
M+'1ASMJW]?\  ^\(X'"2ERJ]SNO^%@:9_P ^UW_WRO\ C1_PL#3/^?:[_P"^
M5_QKSBBL/[:Q7=?<:_V7A^S^\]'_ .%@:9_S[7?_ 'RO^-'_  L#3/\ GVN_
M^^5_QKSBBC^VL5W7W!_9>'[/[ST;_A8.E_\ /M=_]\K_ (UU%M.MU:PW" A9
M4#@'J 1FO$3TKV?2?^0-8_\ 7O'_ .@BO6RK'5L3*2J=#SLPPE*A&+AU,'XE
M?\DV\0?]>;U\C5]KZM86NIZ3<V-[")K:>,I)&20&'IQS7$?\*P\%?] "#_OY
M)_\ %5]%2E9'@UU=H^7Z*^H/^%8>"O\ H 0?]_)/_BJ/^%8>"O\ H 0?]_)/
M_BJUYT8\I\OT5]0?\*P\%?\ 0 @_[^2?_%4?\*P\%?\ 0 @_[^2?_%4<Z#E/
ME^BOJ#_A6'@K_H 0?]_)/_BJ/^%8>"O^@!!_W\D_^*HYT'*?+]%?4'_"L/!7
M_0 @_P"_DG_Q5'_"L/!7_0 @_P"_DG_Q5'.@Y3Y?HKZ@_P"%8>"O^@!!_P!_
M)/\ XJC_ (5AX*_Z $'_ '\D_P#BJ.=!RGR_17U!_P *P\%?] "#_OY)_P#%
M4?\ "L/!7_0 @_[^2?\ Q5'.@Y3Y?HKZ@_X5AX*_Z $'_?R3_P"*H_X5AX*_
MZ $'_?R3_P"*HYT'*?+]%?4'_"L/!7_0 @_[^2?_ !5'_"L/!7_0 @_[^2?_
M !5'.@Y3Y?HKZ@_X5AX*_P"@!!_W\D_^*H_X5AX*_P"@!!_W\D_^*HYT'*?+
M]%?4'_"L/!7_ $ (/^_DG_Q5'_"L/!7_ $ (/^_DG_Q5'.@Y3Y?HKZ@_X5AX
M*_Z $'_?R3_XJC_A6'@K_H 0?]_)/_BJ.=!RGS_9^+]2TWPJ-#T^:>SS>-<O
M<6\[(SAD"["!VXSUJ]9>.YK.VTV$6".;'3KJQ#&4Y<3$DL>.",].]>Y?\*P\
M%?\ 0 @_[^2?_%4?\*P\%?\ 0 @_[^2?_%5/-'L4N9=3QN[^)"W-E9V<>A16
MEM;W,5R$M;EHL,B,F$*@%0=V>YSW.:D_X6G<M-=A].=+:=HI MM?/!+O1=I9
MY$ +[A][(&<#I7K-Y\// >GV4UY=:)!';P(7D??*=JCO@-FH8/ WP]N([EUT
M6%?LHS<+*9D:(8W996((&.:5X]AWD>#:'KT>E>*(]<N+)KR2*;[1'&;@I^\W
M;@2V"6_'KZUT>D?$BWT2]N[JR\.0+)<7;7)=[@L_S##(6VY*Y)( Q@GO7J$?
MA#X;R70MUTB(.9%A!83A?,90P3<3C<00<9[TZ\\'?#G3[F6"ZT>*-X8UEE.)
MRL2,2%9F!PH)4]3VIN47N)*2V/%/#GB"VTK2+^TN4=G-S;7UJ%'#2PO]UCV!
M5FY[$"EUSQ?)K>EW=BUDD(N=6EU,NLA)4NN-F,=!ZU[W_P *O\%D\>'X#_VT
MD_\ BJ9/\-? ]M;RW$V@P)%$A=V,DG"@9)^]1S1O<-;6/(K3XAP37%NMUI<<
M$DSV*7EZLS-\ELZD$1XXX7D"LWQEXKM-7>\T_2;);?3Y-3FOGE\QG:YD;(#\
M@;1M_A]Z]D/@CX=KI]U?G2;86MH"T\F^7" *&.><_=(-)<>"OAS:V\=Q-I=H
M(9(&N$<22L&C&,L"&Z?,OYT7BG<;YFK'C\'CM8X+6&71XY572_[*N_\ 2&7[
M1!U7''R,#SD9^E9VH^+;ZYURRU/3Q_9K6%NEM9K$^XPQJ"!\Q^\3DY/O7N=[
MX&^'FG,5N](MHB(C,07E/R!@I/!]64?C5T_##P6#C^P(/^_LG_Q5'-'L)\W<
M\5C^)FJ/;6=K?0QWMO'!/;W4;D)]I24\_=4;2.,$>F:9<>,K:YT74K=+0VI:
MQATRPMD)=8H!)YDC,YY+$@=N_M7MO_"L/!7_ $ (/^_DG_Q5'_"L/!7_ $ (
M/^_DG_Q5%X]@O+N?+]%?4'_"L/!7_0 @_P"_DG_Q5'_"L/!7_0 @_P"_DG_Q
M55SHGE/E^BOJ#_A6'@K_ * $'_?R3_XJC_A6'@K_ * $'_?R3_XJCG0<I\OT
M5]0?\*P\%?\ 0 @_[^2?_%4?\*P\%?\ 0 @_[^2?_%4<Z#E/E^BOJ#_A6'@K
M_H 0?]_)/_BJ/^%8>"O^@!!_W\D_^*HYT'*?+]%?4'_"L/!7_0 @_P"_DG_Q
M5'_"L/!7_0 @_P"_DG_Q5'.@Y3Y?HKZ@_P"%8>"O^@!!_P!_)/\ XJC_ (5A
MX*_Z $'_ '\D_P#BJ.=!RGR_17U!_P *P\%?] "#_OY)_P#%4?\ "L/!7_0
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MRX_[B_E1Y<?]Q?RH YO(]:,CUKI/+C_N+^5'EQ_W%_*@#F\CUHR/6ND\N/\
MN+^5'EQ_W%_*@#F\CUHR/6ND\N/^XOY4>7'_ '%_*@#F\CUHR/6ND\N/^XOY
M4>7'_<7\J .:R,=:Z.W_ ./>+_<'\J=Y<?\ <7\J=T&!0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXC;M/?.<CVHN-%FMVNTWV\LEIGSTC8ED ."<$#('J*7LEW#VTNQ[;_:VF_\
M00M/^_R_XT?VMIO_ $$+3_O\O^->)OH-VK%%6)Y5>-'B1LLC2?<![<_6I8/#
MLT\NP2VY4^:HD4Y7S$'*'I@\CGIS1[*/</;2['L_]K:;_P!!"T_[_+_C1_:V
MF_\ 00M/^_R_XUXP-!$<=JUS+Y3W$,DPC$6XH$&<-R,$CG\:R2J;CM&5SP2,
M&FJ*?4'6:Z'OO]K:;_T$+3_O\O\ C3H]2L)9%CCO;9W8X"K*I)_#-> ;5_NC
M\JV/":J/%NE\#_7>GL:3HI*]P59MVL>XT445@= 4444 %%%% !1110 4444
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M86.EV<-I:I:_+%$N!G<W/N?<U-+XBJWP'+4445U'(;,LVF:E;6CW=W-:SV\
M@=$@WB15SM*G(P>><U,=6M/)9A))AK%;46NT[5<$?-GICC=ZY-8%%+E*YCJ1
MXAM/[0O)Y'FD22^$T.5)*)L9=P!Z$9!Q[5!#K45GI_D174SW*6DL2W*J02SN
MI"@GD  'GU-<[12Y4',S1U*\CO;/3\3.TL$'E2(P/7<QW9Z'.14HN;8:+96X
MO&2>*[:9BL;94$*,@]R,$UDU?NM'O+/=YRQ?)((GVRJ=C$9 ;GC(%.R%=C[.
M^6TU&]N/M$KL\,RQSD'<SM]UCZ$GFKTVOP7-K>0B#[,LUNV43D23LREF]AA>
M/2LB.WBCD_TR81QA"W[IED+$=!P2!GU-:%SH]O90O<W$TP@"PD1A1YH:12V#
MV& ,_B*3L--V&7&JB;2-)M#(Y:VD9I05[!ALY[X7('I5BXU&RCU35=0AF,SW
M0E2&/RRN!)P2Q/H">!GFLK4+,Z?J$UJ7#^61AP,;@0"#^1%5J+(+LZB77-/>
M1FD:6>U,L#Q6@0KY(3J"?XN,@=<Y[53U#6#+:A4O'N;@R2YE,>P+&^/EQZY&
M<]O6L.BCE0.3+;ZI>2N'DF+N/,^9QDG>,-DU4HHJB0K8\)_\C;I?_7;^AK'K
M8\)_\C;I?_7;^AI2V8X[H]PHHHKA.\**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ">]M;9@L]S#$Q
M&0)) I(_&H_[5T[_ )_[7_O\O^-.S%=%NBJG]JZ=_P _]K_W^7_&C^U=._Y_
M[7_O\O\ C19A=%NBJG]JZ=_S_P!K_P!_E_QI\-_9W$GEPW<$CXSM20$_D*+,
M+HL4444AA7.>+_$-QX=L;:>VABE:6781)G &">WTKHZX7XG_ /((L?\ KY/_
M *":N"O))D5&U%M&1_PL[5/^?"S_ #;_ !H_X6=JG_/A9_FW^-<1173[./8Y
M?:3[G;_\+.U3_GPL_P V_P :/^%G:I_SX6?YM_C7$44>SCV#VD^YZ%I7Q#U&
M_P!7L[.2RM52>98V92V0">W->C5X5X<_Y&?2_P#KZC_G7NM858I/0WHR<D[A
M11161L%%17%S!:0//<S1PPH,M)(P55^I/ K._P"$H\/_ /0=TS_P+C_QH UJ
M*R?^$H\/_P#0=TS_ ,"X_P#&C_A*/#__ $'=,_\  N/_ !H @\9?\B?J?_7+
M^HKQ2O4O$GBS0-3T76-+LM7M)[V*$$Q1R@D@X.5_O?AG%>6UTT?A.6O\1:;3
M[E=+34B@^RO*8@X/1@,\^E6H] O'-H)'MH#=H'@$\NPN"<#MU-6++6+6VTNV
ML[B)KB O+]I@^[N4[2A!]05_GZTMQK,=Y=:1<SN?,@E9YP%.$'F;@!Z@+6EV
M9VB5)-$GC:Y!N;-A;*#,R3;@F6VX.!USVJO+IUQ%/;Q;5<W&/):-MRR9..#]
M>/:KT=Y:O_;B--Y8O&!A9E)!Q)NYP"1Q4BZC:6UO;1PR&1K&&5HG*$;YI#V'
M8*.>>XHNPLBJFB7,KHD4MNQEF>&$>9@RLF,[>/<8SC--31KN2*%U,.^:-I8X
MB^'95)!P,=?E/&>U7M+U>VL[.QMY"1M><22+'EX0X4*Z'U&#P*BGU?R+*PBL
MF0S06\D+S&,[AN=OND],@]>O-%V.R*ATFY$1<&%BH1G19,L@<@*2/J1],BEN
M-'N;=KI=\$CVI(G2)\L@!P3@@9 /<5>\W3K32XH;/4%+,\<ERIMW#2$,#M!Z
M!1U]S^%.GU"SAU75M1AN/.:Z$J0QB-A@2<$L2!T'89YHNQ61@5ZS\-O^16;_
M *^7_I7DU>E^ =9TNP\.&&\U*SMI?/=MDTZHV#CG!-16^$NC\1LZ)_R.?BG_
M '[7_P!%5R'Q-_Y#]I_UZC_T)JZGPU=VU]XM\43VEQ#<0E[8"2)PZD^5ZBMR
M]T;3=2E66]L8+B15VAI$!('I6$)<KN=$X\RL>"T5[C_PBN@_] BS_P"_0H_X
M170?^@19_P#?H5M[==C'V#[GAU%>X_\ "*Z#_P! BS_[]"C_ (170?\ H$6?
M_?H4>W78/8/N>'45[C_PBN@_] BS_P"_0H_X170?^@19_P#?H4>W78/8/N>'
M#@@UJ76M27!OF6(1M=7*7&X-G85!&/?K7KO_  BN@_\ 0(L_^_0H_P"$5T'_
M *!%G_WZ%+VT>P>QEW/'K+4Q#?1W-]";T1 E$=]H#=CT.<>E2RZK;S"YB>TE
M>WN'65Q)<;G\P9^;?M[@D$8KUS_A%=!_Z!%G_P!^A1_PBN@_] BS_P"_0H]K
M'L/V,NYXM?7;W][+=2*JM(<[5Z* , #Z  57KW'_ (170?\ H$6?_?H4?\(K
MH/\ T"+/_OT*?MEV%["7<\.HKW'_ (170?\ H$6?_?H4?\(KH/\ T"+/_OT*
M/;KL'L'W/#J*]Q_X170?^@19_P#?H4?\(KH/_0(L_P#OT*/;KL'L'W/#JV/"
M?_(VZ7_UV_H:]9_X170?^@19_P#?H5)!X=T:UN$G@TRVCEC.4=8P"I]J3K)J
MP*BT[FG1117.=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 445P7B#Q[>Z/KES8165O(D)4!G9@3E0?ZU48N3LB9245=G>T5YA_PL_4?^
M@=:_]]M1_P +/U'_ *!UK_WVU5[*1'MH'I]%>8?\+/U'_H'6O_?;4?\ "S]1
M_P"@=:_]]M1[*0>V@>GT5RW@_P 47/B1KP7%M%#Y&S'EDG.<^OTKJ:AIIV9I
M%J2N@HHHI#/+?B> =<LL@'_1C_Z$:XC:O]T?E7<?$[_D.67_ %['_P!"-<02
M!U.*[*?PHXJGQL3:O]T?E1M7^Z/RI:0$'H15D!M7^Z/RKJOAVH'BZ/  _<2?
MTKE00>AS75_#S_D;8_\ KA)_2IG\+*A\2/7JAN+NVLT#W-Q% I. 97"@G\:F
MKE_$MG:WWB;PQ!=VT-Q"9K@F.9 ZDB%NQKB.XV?[<TG_ *"EE_X$)_C7!^.=
M>TK7M"M)M*U"WNT2Z*OY3@E2%88(ZBNV_P"$7\/_ /0"TS_P$C_PKA?&GAK1
MO#>A6L>D:=!:"6Z+2,B_,YVL>3U/TZ"KI_$B*GP,Y+2K#^U-2BL_-$6\,2Y7
M=@!2>GX5-+ID#Z?->:??"Z2W ::-H3&Z*3@-@DY&??BC0+R"PUJ&XN69(55U
M9E7<1E"!Q^-2B;3],TR]AM+I[RZNXO(W>28TC3()Z\DG KJ=[G(K6(;G3$L]
M;_LZXNU1 RAI]APNX Y(STYIUWHL^GVUQ+>L(62;R8DQDS$<DK_L@8.?<5=U
M-M&U+5C>MJ;K%(4WQ"V;> % .#TSQ4>J:Q;ZS9,)X_(GM6"V849!AZ>6Q]1@
M'/?FB[T&TM2IH$B0^(M-EE=4C2Y1F=C@*,]2:]G_ +>T?_H+6'_@2G^->+Z#
M%'/XATZ*:-9(GN$5T<9# GH0>M>R_P#"-Z%_T!=._P# 5/\ "L*^Z-J&S'_V
M]H__ $%K#_P)3_&C^WM'_P"@M8?^!*?XTS_A&]"_Z NG?^ J?X4?\(WH7_0%
MT[_P%3_"L3<PO&>JZ5>>&GMX[^RG:2ZM1Y0F1BW[^/C&>:Z'^Q-)_P"@79?^
M Z?X4V/P_HL4BR1Z18(ZG*LML@(/J#BM&@"A_8FD_P#0+LO_  '3_"C^Q-)_
MZ!=E_P" Z?X5?HH X[Q/X:T2PT36-3M=+M8;V:$!YTC ; P !Z#'I7E%>U^,
MO^1/U/\ ZY?U%>*5TT?A.6O\1?TW3UODO'<RXMH?-"1+N9_F Q^M)'I5S=$M
M:02&/?Y9\P@,AV[CN_NC )R?2DT^_6RCO(WC=EN8?*)1]K+\P;(X/I5FRU>*
MQBGACM6DBN?EN/-DRSQX^Z"!QR<Y^E:.YFK%9M)O$M_.,:%?*6; D4MY;<!L
M9SCFE71[QG546)]P<AEE4J-@RP)S@$"KTVKVL(C-O!YTCV,5M*SO\N!C<N,=
M>,9S1/XA61-D=IL3$X WC"B10N  H&%Q^-%Y!:)1.D7BJS,L2QA5;S6E4(0V
M=N&S@YP?RJ23296\MH(V2,PQ.SSR*HW.. #GOV'7UJQ9^(&L_)Q"Y$<"P-'Y
M@\N4 L?G4@Y'S?7CWICZU'/:I:W%J6A58<!)-IW1@C.<'@@].U'O![I771;]
MA_J0K%W0(SJ&9D^\ "<DBDN[6SAT^SGM[P333 F6+'^KJV_B&2:_M[R6W4R1
M332D!L!O, &/;&*Q0, #TIJ_43MT%KTGP'H6D:CX=,]]I5C=3>>Z^9/;H[8&
M,#)'2O-J]9^&W_(K-_U\O_2LZWPFE'XB7PW96FG^+?$MO96L-M"/LI$<,81<
MF,Y.!Q61\1]0O;*[T];2\G@#1N6$4A7/*]<5NZ0P7QGXG9B  +7)/_7,US/Q
M1_X_=,_ZYR?S6L:7Q&]7X#D?[>UC_H+7W_?]O\:/[>UC_H+7W_?]O\:SZ*ZK
M(Y+LU[;4/$=Z6%I>:I.5&6\J1VQ]<5"VN:TC%6U2_5@<$&=@0?SJ];I+?>'K
M6VL+F**6"=WN(FG$1<G&U\DC( &/:IK:&T(MOM#VL\1,W]H3LX9MPSM*D\],
M8(ZFINNQ5GW,Z;5]=MV59M2OT9D#@&=N5(R#U[BH_P"WM8_Z"U[_ -_V_P :
MV9);"Z/E7A@\F*PM3YB@;PV4##=U)VD\5)!%IZWBF\AL<BZD\E%*['A$;$;L
M'D9VX)YSFBZ[!9]S#_MO6@@?^U+_ &$D!O/;!/IUJ4:GXA:W-PM]J1A'602O
MM_.I+N[-YX:MRJ6R,MS*94B14VY";<#KCKT]*GLH+F#1)+[S8YI7MW@AC-P@
M\B(_>)4G.3SA0/?THT#7N4(M9UR:58HM2U"21SA469B2?0#-+'K&NS2&.+4=
M0=P"2JS.2 .IZ]JGL6,'BRS>7[+#LD0DP,/+7Y>#G./K[YK3T[5-/^U&YB*I
M>7\4@N@PVK%A#D*3_?;!_2A^@+U,?^U/$'G"'[=J7FLNX)YKY*XSG'ICFGO?
M^)(X?->[U18]H;<9'QM/0_3WJ2/42/";-E/MJM]C23=\X@(W$8^O&?0D5?R(
MO$EGJ+2QK916L/G/Y@PRB(!DQG))Z8H^0?,RO[4\0?9OM'V[4O(_YZ>:^WTZ
MU(EYXE=HE%YJ0\W_ %9:9E#<9X)/I5\2VYTT;6B6'^RS$;DOEU;=GRMF?7CI
MG'.:DU.^6);VXB: ?Z5;RPRK(&:ZVC&2,_+QR< =<4K^0[>9FB[\1[%=M2O(
MT:)9@[W14;&. <Y[FHKK5=<M+AX)=6N_,0X8)=%L'TR#27^MO?6TD'D+&K7'
MFK@_=0#Y8Q[#K5&\N/M=]/<[=GFR%]N<XR>E4EW1+?9EG^WM8_Z"U]_W_;_&
MC^WM8_Z"U]_W_;_&L^BG9"NSW7P[+)-X<TZ65VDD>W0L['))QU)K3K*\,?\
M(KZ7_P!>R?RK5KBENSNCL@HHHI#"BBB@ HHHH **** "BBB@!-P]1^=&Y?4?
MG7@%\S?VC=_,?]?)W_VC4&YO[S?G6_L/,Y_;^1]#;E]1^=&Y?4?G7SSN;^\W
MYT;F_O-^=/V'F'M_(^AMR^H_.E!!Z5\\;F_O-^=>L_#<D^%CDD_Z0_7\*B=+
ME5[EPJ\SM8ZZBBBLC4*\7\;?\CCJ'U3_ - 6O8;N]M;"(2W=Q%!&6"!Y7"C<
M3@#)]37COC;GQAJ!]T_] 6MJ/Q&-?X3 HK4L]'2XM8)[F_BM!<R&.W#HS;R.
M"3C[JY(&:AM=*FN-6;3I#Y,B%Q(=I;9L!)X'7I71='-9E&BM!-,CN-12UM;Q
M&4KN>6>,PB,=\@\^GUS5>^M38ZA<6C.',$C1E@, X.,T7"QW7PM^_JGTB_\
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M7_29?_BJXGN=RV)_!G_(D:'_ ->,/_H K<J&TM(+&SAM+6,16\*".-%Z*H&
M*FI#/GZ^_P"0C=_]=Y/_ $(U:&N7XLOLHDCV^481+Y8\T1_W-_7%5;[_ )"-
MW_UWD_\ 0C4%=UKG!>QHQ:W>0F3"VS1R*BO$\"F-MOW3MQC/O3T\07ZM=,XM
MYC=$&;SH%;<!T'L!CITK+HHL@NR2>8W$S2E(T+?PQ(%4?0#I7JOPW_Y%8_\
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MTY+[2;R.Y@;J4/*GT8=0?8US2@XG3&:D:5%%%26%%%% !1110 4444 %%%%
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M[_SZR_\ ?]_\:/\ A7_AW_GUE_[_ +_XUT]%'/+N')'L<Q_PK_P[_P ^LO\
MW_?_ !K:TK2;/1;/[+91LD.XO@L6Y/7DU=HI.3>[!12V04444B@KS[XL^,=5
M\&Z+87.D^0);BX,3F:/?@;2>.1SQ7H->:?&?PSK'B;0=.AT>R:ZE@NC)(BNJ
MD+L(SR1W-5"W,KDSORNQX]=?%WQQ= @ZUY0_Z8P1K_2L6Z\:^*+T$7'B'4W!
M[?:6 _(&I+KP)XLL\F?PYJ0 ZE8"P_,9K%GL;RU.+FTN(3Z21,O\Q76E'H<3
M<^HV:ZN+DYGN)I3ZR2%OYU" !T HW#.,BEJB0HHHH$*IPP/H<UV=QXX:;QR-
M41IDTD:C'>&!(T1VV8QNQ]YASC)-<76OH_AR^UN&6>VV)#%(D)D?<1O?.T84
M$]B2>@'4TFEU*BWLC4TSQ4L&E16TUS<V]U!?O>I=1P).[EE ZN?E8%1AO<U)
M-XFTV>UFF;[6MW+I,6G>2$7RU9'0EMV>A"9QCJ34]CX*LV.C6NH7AAO;Z\G@
MG4$_NA$<,JX4@L3GG..G6L^;PZMWI]I=V,<4%L8KB>6ZEN6=?+20("1L!')"
M@ $L3T%3[MR_>L6O$WB+2O$GVC<U[;;;VZN8 (U82"4*0&^8;6!7!//!J2;Q
M5IL\NI[?.B&IV]JKLUJDGDR0JJXVL<.K8)SP1Q6##H$MU'<M:WUE</;I)*8X
MW;<Z(NYF&5QTR0"03@\5HV'A9X]=AT^^-M/<&-FELEN&CD3]RT@W-M(&  2!
MGGCC/!9"O(T[/QAIYU#3KV_GU&6:PN;F7<(DS<B4 !FPP"L,8.,\8KG])U*S
MBT/4M(O6GB2[DAE$\"!R#&6^4J2,@AB>O! J1?".HLNT26QN%2&66WWGS(DE
M*A&88QCYER 21N&14MMX)U>[FFBA\AFAO);-\.2=\:%W( &2, XP,GTH]T/>
M-6T\8:;:Z5;6?E7;&&VB@W%5^8I>>?GK_<X^OMS26GC*PA>^,D5T?M%]?7*D
M $A9X&C7//7)&?;UKFK71;B]UDZ9:R0R2 ,S2Y*QJJKN9B2 0  <Y&>*UKSP
MM&-,L+NUNK?R/L)N;R[9V\H$SO&H V[LG &,=0:+1!.0^;6-!OM:BU6^6^<M
M!'%):!!L1DAV [@P+)D*=O'!(SZZ]KXXTFUO('$%R8HCIW"1*@Q;LY?"[CC.
MX8&?K7.7/@_4[*TNKNZ,$4%O((_,RS"0E Z[2JG@J5P6P#D"K/\ P@.N?:(K
M<1Q>>\R0/&2P,;LI8 DC!X4_=+<C'6BT1WEV+=_KT3> XH@%_M"YFEM1('!<
M62OYH5AV_>-@>H6N=T37M4\.:BM_I-Y);3CJ5/RN/1AT8>QJM>VAL;M[<RI(
MRXR4##!]"& ((]"*+"PO-4O8[.PMI;FYD.$BB7<Q_P ^M-)6);=SZ&\$?&G3
M-<,5CKPCTW4#A1+G]Q*?J?NGV/'O7J@(90RD$$9!'>O&/!'P.M[<1W_BLK/-
M]Y;!&_=K_OG^(^PX^M>S111PQ)%$BI&BA511@*!T %<L^6_NG93YK>\.HHHJ
M"PHHHH **** "BBB@ HHHH **** .5G\'RW&K2ZA+J*LYGCEC0VP"J$D+A3@
MC/!(SU[T:EX%LM3O[Z]FN)!-<L3A1A<>4J*''\85E#CI@UU5%/F9/*CF;OPD
M;B6YECOMDDSV;KNBR%-NV1GD9W?ABM;2=,.FI<M)-YT]U.UQ,X7:-Q & .<
M!5'4]*T**+L=D%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %(RJZE64,#U!&:6B@#,N?#>AWH(NM&T^;/7S+9#_ $K#
MN?A=X)NLE_#UJI/>+='_ .@D5U]%.[0N5/H>;77P-\&SY\J.^M_3RKDG_P!"
M!K$N?V>]*?/V77;V+T\R)'_EBO9**I5)=R73B^AX#<_L]:FN?LFOVDGH)8&3
M^1-00?"7QGI5C<6'V32]3LYI4F,8NWB(=<@$' /()!'>OH6BG[61/LH]#YI/
MA3Q_I,FE.OA;>NERS2PK#() WF')!PQ.!V[UB >*-(TN'3;SPS=_8X[>:VD6
M6VE'FI(XDY8="&4$$>G>OK&BG[7R#V79GR&GBZXL-/;3XM*AM8O+GB5=\BX6
M5=K%@3\[ '@MG%1KXPD_M=-7_LZU;4=I66?>_P"]S$8R2N< D')QW%?74]G:
MW2E;BVAE!ZB1 W\ZQ[OP1X6OABX\/Z:_N+95/Y@52JKL2Z,NY\MMXOO-DKQV
M\$=[-##!/=C<6D2(J5^4G )V)DCKM]S4UQXR>X##^S((@]Z]^[0SRHQF9=I8
M,&RN.H _6OH.[^#_ ('N@?\ B3>23WAGD7^N*Q+OX">%I@?L]WJ5NWM*KC]5
M_K352!/LIGAS>*[U_%$VO210R33HT4L39*R(T?EE2<Y)*_Q9SGFGMXK9K)=/
M.F6PT[[*+5K<._S 2&16W9SN#,>>F#TKU2Z_9XA(S9^(Y ?2:V!_4,*Y[5O@
M3KNFV-Q>1ZII\\4$;2,"'1BJC)[$9XJE.#(Y*B.17QO?K/?7"PHD]W";<E)7
M"+%Y?EJFS.U@J]"<G/-5;SQ(+^^2_NM.A:[,BR32K-(AD8#&1AOD)."2.X[5
M2T;1=2\0Z@ECI5G)=7#_ ,*#A1ZL>@'N:]]\#_!73M%,=_X@,>H7XPRP8S#$
M?H?OGZ\>U.4HQ%",Y' Z+X&\2?$[4HM6OU-AIPB2(74H+/*BC V[N7;U8\?R
MKW;PMX-T7P?9?9]*M0KL,2W#_-++_O-_0<5O*H50J@  8 ':EKGE-RT.J,%'
M7J%%%%06%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1D>TMF1A@JTQ((_[YI0]\J@"UM@!P )CQ_X[5RBER/N_P_R'S+M^94\S4/\
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MR^60'W*!E<$C.?6CV<N[_#_(7/'LBYYFH?\ /M;_ /?X_P#Q-'F:A_S[6_\
MW^/_ ,35>/Q#I<T\445T'\TJ$=5)0EAN5=V,9(Y S267B'3K]K<0RR 7()@:
M6%T$HQGY2P /'./2CV<N[_#_ "#GCV19\S4/^?:W_P"_Q_\ B:/,U#_GVM_^
M_P ?_B:F2=))I8E#[HB V4('(SP2,'\*AO\ 4K;3(XGN6<>;((HU2-G9G()
M  )[&CD?\S_#_(.9=D'F:A_S[6__ '^/_P 31YFH?\^UO_W^/_Q-/LKZWU&V
M%Q:R;X]Q4\$%6!P00>0001@TV#4+6Y=%@D,H<.5=%)3Y6VL-V, YXQGL?2CD
M?=_A_D'.NR$\S4/^?:W_ ._Q_P#B:/,U#_GVM_\ O\?_ (FK=117,,[S)%*K
MM"_ER!3]UL X/O@C\Z.1_P S_#_(.9=B'S-0_P"?:W_[_'_XFCS-0_Y]K?\
M[_'_ .)JW5:ZOK>RYN',:;'D+E3L55&26;&!^/6CD?\ ,_P_R#F78;YFH?\
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M^>T?_?0H^TP?\]H_^^A0!+147VF#_GM'_P!]"C[3!_SVC_[Z% $M%1?:8/\
MGM'_ -]"C[3!_P ]H_\ OH4 2U4OK%KUK<K=30>3*)"(FQOQV/M4WVF#_GM'
M_P!]"C[3!_SVC_[Z%3**DK,<9.+NBKK5I'?Z/<VDMG]LCE7:T'F;-XSV;L1U
M'N.U<==^'_$!T>2RA1[G_6FSFO)Q)<6W"[%+Y'<,=WS$<#GK7=_:8/\ GM'_
M -]"C[3!_P ]H_\ OH5:=B'&YQ4OA6]6>65+=1"^I3SRPP^7F9&7",=_RG!S
MP?7(YJ*Z\/W.FQ:I?QVK&YCBMI[.X9@\CRQ*!Y;[>26(P2!@@UW7VF#_ )[1
M_P#?0H^TP?\ /:/_ +Z%/F8<B,+2=(NH+NS%UEEM86E>0G/F7,I)<CV49 _W
M_:JLNB:@;._01JRRZN+LPAP//@^7*YZ#..AX.,'@UT_VF#_GM'_WT*/M,'_/
M:/\ [Z%*X<J.'E\,ZPZR-&GE1L25@6125B\]7\GG(Y4'_9YQTJ1?"]TEY+>B
MQ-P8;)EM(;N=0%E:1R1A,*HVL,8Z XS7:?:8/^>T?_?0H^TP?\]H_P#OH4^9
MAR(X)/#>IBZ$ESI4=S;JUUY5N)$01B1(0N%W$ ;E?H3C.:6;PMKIM;F-F$\Y
M@=%F,V"S&UBCSSR,NC?S[UWGVF#_ )[1_P#?0H^TP?\ /:/_ +Z%',Q<B.'O
MM%OM-6_O-/M8XM1.I^;:2H 5E64!"K <@#+,<C&0#6MK.BW*Z#9Z7I]I%=1Q
MQM&SS'+*=A ;!(!)/4YXSD UT7VF#_GM'_WT*/M,'_/:/_OH4<P^5'#P^&-:
M^Q-+D1:JUPC"Z\W+*GV81L<^F_/'?K6MX9TBXT_4;JXDT];**2SMH=HD5RTB
M>9N)Q_O#D\GO71?:8/\ GM'_ -]"C[3!_P ]H_\ OH4.38**1P3^!KY_#[VI
M>,1O9L[V.>&O=A17W=-O()']X UT3Z5=MK<UR$7RGTH6H.X?ZS<QQ].1S6W]
MI@_Y[1_]]"C[3!_SVC_[Z%',P44CF;#2]1GM_#=M<VAM$TI4>5VD5B[K$8]J
M[2>/F))..G3FL_Q!H>N:E?W;VMI#"KI/%YB2!6F5HL+N;.?O8XP , @UVWVF
M#_GM'_WT*/M,'_/:/_OH4<P<JM8Y&?P[=Q:INBLDFTL3*YLQ( K'R=N[!..&
M['KG/)%2+X>U!O"_AO3\F">REB:=HI!F,*C E200<$CM75?:8/\ GM'_ -]"
MC[3!_P ]H_\ OH4<S#E1Q^G^&=2^TP)<R/;1I:7%O<3P.I:X9Y5;?\P)!<98
M^AX]*G_LF_FU80R6#PZ7I\9BTV..1"I;RROFR?-G@$JHP<9)/7CJ?M,'_/:/
M_OH4?:8/^>T?_?0HYF'*CF+#2]1GM?#EK<V9M$TH))+(\BL7=8BFU=I/!+$D
MG' Z<UUE1?:8/^>T?_?0H^TP?\]H_P#OH4F[C2L2T5%]I@_Y[1_]]"C[3!_S
MVC_[Z%(9+147VF#_ )[1_P#?0H^TP?\ /:/_ +Z% $M%1?:8/^>T?_?0H^TP
M?\]H_P#OH4 2T5%]I@_Y[1_]]"C[3!_SVC_[Z% $M4[:Q:WO;NX-U-*)R"(W
M;*QX'\-3_:8/^>T?_?0H^TP?\]H_^^A4N*;3?0:DTFEU.=\4Z+<:G<0SV,-S
M#J$,3"WO[:Y$?EL2/E=3]]. 2,'ITK&U;PYK.IR:@#86R+/;3Q$*P F<R(8V
M)))/"L>0-N<"N[^TP?\ /:/_ +Z%'VF#_GM'_P!]"M%)HAQ3.3/AJY.KWAD1
MVADD8P,AC$:Q&+8(F&-^T'/RCCH>M4K+0;NWNM&T];?[+;R6D9U*%<8+6Y&P
M@KQ\['![D"NY^TP?\]H_^^A1]I@_Y[1_]]"CF8<J.=NM(OKSP=JD)B']I:B)
M)&C9APS<*N>G"A1^%1ZYHNHWFI74L$8D,T<*VEQY@7[&RL2S8Z\Y!XSG&#Q7
M3?:8/^>T?_?0H^TP?\]H_P#OH4N8.5'%Q^&=2%\'G$[0EF,0@DC!@;[0[ELL
M.-RLIRO/&*KR>%=1M_#2V=KIT#7TZ3O/.\FYDF/^K()88X/WADK@8%=Y]I@_
MY[1_]]"C[3!_SVC_ .^A3YF'(C@W\,:L\=XL=FL5S)-=RM="9?WRR1,JIP<\
ML5// VYZTZ_\*:I=V]_$8(F6:WN557D!!=A;[,_C&_/;\:[K[3!_SVC_ .^A
M1]I@_P">T?\ WT*.9BY$<K:Z7.?%JQI"UOI:(E^\'0)<8,:H,?+C W$#N >]
M1ZOH>J:GK4KK96\=NPFC:7<,S1M RKN.<_?*_+C P#DUUWVF#_GM'_WT*/M,
M'_/:/_OH4<P^5'-3:'=3^%M&L(;?[)+;3V[2K&Z@QA&&Y@1D$\9JK8>&]4CO
M;-99G@\@7:37D3*7N#(T963!!VL0ISZ%>.,5U_VF#_GM'_WT*/M,'_/:/_OH
M4<S#E1S TF[&L65G_9[QZ'I@3[((Y$/FR!<!Y,MG"=A@DGD]!4>GZ/J<NE>'
M].N;,VPTV2.::9I%;<4! 5 I/4GJ<<9KJ_M,'_/:/_OH4?:8/^>T?_?0HY@Y
M4<O<^'KJ\\6FZN($ETXW D*N^05%N4Y7O\Q''XT]]%U.7P_X?M-Y2ZL[B)YI
M-X8HJJP)!.0QY%=+]I@_Y[1_]]"C[3!_SVC_ .^A2YF'*CD;SP[?0ZC:K86R
M/&EU#<27CN#*Y,VZ;)R-N5SPH((..,5GKX3U:.Q6UM8$M/+2Y5VBD51-ON(Y
M% QZHK+DCCITKOOM,'_/:/\ [Z%'VF#_ )[1_P#?0I\S#D1Q;^%;F9I3]FD,
M1LKE(HYY$'ES.4V;0GRJ/E)&.A^M,G\,WY@U )98NI;M;J.9/*993Y(4K(K$
M;EW!B?<@CFNW^TP?\]H_^^A1]I@_Y[1_]]"CF8<B.;U[0M0U./3EA*1F2(V>
MH>5(5"PN 7*=\@H ._S&L>7PKK=Y82B\2*2YN+:\AD!DRN3&D</YA-Q]"QKO
M/M,'_/:/_OH4?:8/^>T?_?0H4F@<4SD+?PW=+J$E]'8);.U[:R1@.H9(DC59
M!\IP/XN!UK4DAU&S\1:G>6^GFYCN;:%(F\U%7<F_(;)R!\PZ UM_:8/^>T?_
M 'T*/M,'_/:/_OH4N8.4Y/1-$U#0S<6AMFN(Y+&WMUGC= H9%<-D$@@988X/
M%9T'A35'L;2-8'@EMK&&.075P)5EECDC=57!;8GR,#TZKQQ7>_:8/^>T?_?0
MH^TP?\]H_P#OH4^9ARHP-475-0;3I5TF1!:7L<[(9HRS+L<-CG'!8=3S70PN
MTD2N\31,1RC$$K]<$C]:;]I@_P">T?\ WT*/M,'_ #VC_P"^A2N-(EHJ+[3!
M_P ]H_\ OH4?:8/^>T?_ 'T*0R6BC.1D44 %)M7^Z/RI:Q]>\01:$+.,V\MS
M<WLWDV\,;*F]@I8Y9R%' /4\]*+7!NQK[5_NC\J-J_W1^54(M:L6GMK2>XBM
MK^XC$BV4TJB8#'3:">G/3TJ(^)M!%M-<G6=/\B&3RY9/M*;4?^Z3G@T[,5T:
MFU?[H_*C:O\ ='Y5GMKVCK=P6IU2R%Q.%,,7GKNDW#*[1GG/;'6J#^,]%37'
MTS[; 3%!)//.)D\N#8RJ5<YX.6'Y46871O[5_NC\J-J_W1^59<OB;0H(8II=
M9L$CF3S(V:X4!UYY'/(X//M5^*[MYIY((IXWEB"M(BL"5#<J2.V<<4K!=$NU
M?[H_*C:O]T?E2T4#$VK_ '1^5&U?[H_*EHH 3:O]T?E1M7^Z/RI:* $VK_='
MY4;5_NC\J6JE];7-PUN;>\:W$<H>0!0?,7^[4R;2NE<<4F[-V);F>VLK66YN
M7CB@B4N\C\!0.I-5H-7TRY*+#=0LSR>4%SAM^TMMP><X!/T%5_%5K/>^%=4M
M;6,R3RV[K&@ZEB.*Q-8\+7EW?03K>S_:;FXQ-<VRB/R$6&55(!)[OR<D\]JT
M21#;Z'2-JFFI937K74'V6%BDDN?E5@<$9^O'UJ2SO+/4(VDM98Y55MK;>JGT
M([&N<O+._N? ,NG1Z:MM>0[(5AB \L[77YTY^Z0,\\]CS577M)U2U2\ELH[B
M[U"]5I?M$+M$L<B(%C4(K=>^6)'!SU HL@NSMMJ_W1^5&U?[H_*N(.GZI'#?
M3S6^H7,]U?.H!NY D40!*$(K#C/ICD\\"H+'2]?G^RR:A]O\UKBV2<?:"!Y7
MV<"3@-C&\<XYS1RAS>1WVU?[H_*FQM%*@>,HZ'HRD$&N%TVQ\0M<V?\ :,UZ
M@"0JA52^T*QWASO !(QDD'(/'(JK8Z-K%II]E:HE[:P112HRQ NRW&_AQ\XR
M-O0G*]<CFCE\Q<WD>C;5_NC\J-J_W1^5<%/I&LQ6#W22:A-?O>S,;>65VBE0
M,_EK\KCRQ@@@CH<9! K8\00:C+<1,D5V]O\ 9)%2.TE*LER2NQB01D8S@G@=
M^M%A\QO)=6LEW+:I(C3Q &1!U3/3/I59]9TI(H)3=PE+A"\.WYMZCJ0!U'(Y
M]ZS/#.EW5E<:K->QL+BXEC9GWDK(?)C#,!G &\-V'Y50\(Z3?Z(]G]JMI)1=
M6B1M(Y!>T9!_JS_TS/48_BSG.1@L@NSIM/U/3]5C:2QGCG1>K(./S_ U)]ML
MA>O9^?#]ICB$SQ;AN5"2 Q'89!Y]JR?#MEJ%IX;LK=BMM.CR&1)8]Y(+L0.&
M&.".>:RK#P_?6>N7,VIQ07T%Q9O]JF2(EIV+@A=I)X   7I@8HL@N]#HFUO2
M%L8+W[=;&VGSY4JL"),9SMQUZ'IZ5?C:*:))8RCQN RLN""#T(-<=I,=S:^$
M[.TDTN_AD431&2!%$UOEB5* ]B#C(Z<?ATF@VTUGX?T^VN8HXIHK=$>./[JD
M # I-6!.Y?VK_='Y4;5_NC\J6BD4)M7^Z/RHVK_='Y4M% ";5_NC\J-J_P!T
M?E2T4 )M7^Z/RHVK_='Y4M% ";5_NC\J-J_W1^5+10 FU?[H_*C:O]T?E2T4
M )M7^Z/RHVK_ '1^5+10 FU?[H_*C:O]T?E2T4 )M7^Z/RHVK_='Y4M5+:VN
M8;V[EFO&FBE8&*(J (@!R,]ZEMII)#233U([W5M,TV5(KRZAA=U+@/\ W00"
MQ] ,CFKJ['4,NTJ1D$="*YW5M*OK_P 2HT$GD6SZ;+!+.8P_+.GR@$C!P"<D
M$<5B_P!@:I9PW!MY+_RDOUB$9F9Q]C6, !$##^+!.,$@'Z5I9$79VCWUE'<B
MV>>(3%E79GG+ E1^(5ORJP0B@D@ #D\5P9TS7(I \'VURQAS*Q".RB.XX8;C
MT+1CDGMWI]KI>MP-%(/MQDC&GL-]PS#<3BYR"W/R]<_A1RH7,^QVT$L%U;QS
MP,DD4BAD=>A![U)M7^Z/RK@M-T[7TMDN+D7[7<1L=BM<'D!5$PQG!S\V<U'%
MI^N7]TD<D.HV=C+<V[R(ETX91ME\P%RV[KY8., \$>M'*'-Y'H.U?[H_*J+Z
MMID=Y]D>[@$X.TIGH<9P?0X[5B:!!??V_>V\MQ+)8:8[16[&4L93)A\/GJ8P
M0HSGK3]+2ZTRQN=+FT^XDF>XG<7$8!219'9@Y8G@@$ @\\<9HL.YO6MY9WRL
MUK+'*%VDE.?O*&'Y@@_C3XYK>6>:%&1I(2!(HZKD9&?PKB-,T?6&N;&VO$O4
ML455=%G** +2-<?*>GF!OQ&:+:UU[? VI1ZA-:?N/M$<<IWL?LX!(PP.!)G(
M'?!YHY4+F?8[>XFM[2!Y[ATBB099VX %,O+NST^%9KR:&"-G6,/(0H+,<*/J
M20*XC5K36KZYN4M].NX[=X9HW228OYF-GEGEMHZ'ITYR>:U_%&CWOB&_@L5C
MC6PBADD=Y@2K2L"BX .<J"S9]2M%D/F9U&U0,D#\J@CN;66;R8Y8WD,8E 4Y
MRAR WT.#7*:?!JMU*1K=I>O*]ND41CD(C1PK+(6VL/O,-V3G@CTJA8Z=K=CI
M=JUG:7J-8:=;,MJTVT2SQNWFQ\DCYEX!Z?=]*.4.8[HW5H+AX#+$)4V[E) (
MW$A?S(.*GVK_ '1^5<!=Z)JTBQ_;8[N[6.2QN9 )2?G\R5IM@SV#*,>@'I6M
MH,5^WB"^@FGE>PTUV2!C(29&EP^&]3&#M&<]:&@4F;4FKZ9$K-)=1*%E,/N7
M'50.Y'?%-FUS2+>*"62]MQ'.K/&P.0RKC<>.PR,GM7-:-!<V5_!?/:S7"0+=
M6DRQKEXI#/OW@=PPQR/:H'T+77O7N;+-E)<?;IHPP5A'YAAVHW7!;8S$C."3
M19"YF=8VMZ0ETMLU[;B5@A W#'S_ '>>G/;UJS>7=II\'GW<L<,6X(&;NQ.
M/J37"#0]1/F/#87$6F!+%9-/8KYDD<8P5#9^\A"GK\P!'>NAUF635-&L;NUM
M+EA'?PRM'LPX5)?F.,^Q/TH:0^9FU:7EG?QL]K+'*JG:VWJI]".H/UJ&\U?3
M-/G6"[NH89&7>%<XPN<;CZ#/<US5]9ZC=ZU+JL5I=0V$GD0W$*'9-.B>82V
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M<P3VLC6R7'DLNXLKMM&S'WOFP/Q'K72US:>$8(I]$43-);:4SM&)/OG( 1>
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M<MQ%;H'FD5%+!06Z9)P!5C8OI4-U8P7D0BF7*!@V,]<4 5WU.S1S&TXW!BA
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MY4^F%//L..3R..M*FI6<CA%N%)/3J!TSUZ9QSBFIHEK%'((S(DCC;YH(WJ,
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-;O>I-B^E&Q?2@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>img254193463_32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_32.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '< J # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBHY[B&
MVC,EQ-'%&.-TC!1^9H DHI%974,K!E(R"#D$4M !16+XHU&[TS28Y;)XTGDN
MH( \B;PH>15)QD9.#ZUFZ3XBO[CQ$=(N#;R>1+-%)/$I EVK&P(&3@C>01SR
M*=M+B<DG8ZRBL70]1U"[U'6+;4$MU-I<*D0@R?D9%89)ZGGT%;5)@G<****!
MA1110 445S(UR^CLH9W:%S/$[JH0CRRIQSSR#_.L:M>-+XOZV_S-:=*53X3I
MJ*S;N[NHM2MH(6B82$9BVDMM_B8GL!QCU-:57&:DVET(E%Q2?<****LD****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%% !17G][\5;:VUG4-,M_#>NW\EA,89I+2W$BAA]#Q^-1_\ "UF_Z$GQ5_X
M_P#UZKD9//$]$HKSO_A:S?\ 0D^*O_ '_P"O1_PM9O\ H2?%7_@#_P#7HY&'
M/$]$HKSO_A:S?]"3XJ_\ ?\ Z]'_  M9O^A)\5?^ /\ ]>CD8<\3T2BO._\
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MO6KZ .CVT<<3Q%1UW#).>]:M8.DVB:?J%S(9K987ABC0++G&T8/6MG[5;_\
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MNG&G3ORO?7<B<ISM?IY$M%1?:K?_ )[Q?]]BC[5;_P#/>+_OL5IS1[D<K['
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M_#;ID)_WT=S?\"%='4=O!%:VT5O"@2*) B*.@ & *DH;NP2L@HHHI#"BBB@
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M#I][.*L27$,5NUQ)-&D"KN,C, H7USTQ7A_BN.&RD^(-AI"HFD"QMY9HH?\
M5QW)D7( ' )7D@5ZIJ]EI%[X1C77F5=-ACCFFWR%%(4 X;'49[=ZIQL2I7-:
MPU.PU6W^T:=>V]W#G'F6\JNN?3(-6JX;P+ISRZOK'B6*R&G:?J8B6TM FPM&
M@.)64="V>!Z5W-2U9E)W04444AA1110 4444 ,EEC@B:6:18XT&6=S@ >I-4
MTUO2Y+)[U-1M6M4.UYA*"JGT)[54OI;+4--N&UNPEM+&V99G:[= C;#N!^5C
MP" <&LSPIY^I:KJGB9X6M;*_6*.TB<;6>.,'$KCL6W<#KM IVT)OJ;4'B+1;
MEG6'5K*1D0R.%G4E4'5CST'K5A=3L'L1?+>VYM#_ ,MQ(-G7'7IUXKC;'3'\
M8IK&N&4(MVRV^FLRY"P1.&W8]'=23ZC%9<%S*-4>>6W%_;)/<:@L<#;(Y9$V
MAY%W=53@*/XF+'C JN5"YF>HT5%:W$=Y:0W,))BFC61"1C@C(J6H+"BBB@#S
MOX=?\CAX_P#^PJ/_ $$UZ)7G?PZ_Y'#Q_P#]A4?^@FO1*J>Y,=@J"[OK2PB6
M6\N8;>-G"*TKA06/  )[GTJAK6I:II[6XTW0I=4$A(D*7,<7E#CD[R,]^GI7
MD/COQ%:ZUJ-U)J'VVW32KV".PM3:R[783)YLS,%VGY<JHS^IHC&X2E8]GO-9
MTO3[B&WO=1M+:>;B*.:949_H">:>^IV$6H1Z?)>VR7LB[DMVE42,/4+G)%>6
MB+2M9N/B+>ZK%#*ZPH8&N%PT<'D;D*AN5YY^M9HTB_AT[P[K?VF*?4K];26&
MUE@W7#SQ)A<29^6+;AGXZ ^M5R(GG9[0EW;2W4MK'<1/<0@&2)7!9 >F1VS4
MU>?_  YUBVD,E@;.Y6\NT:_:_F*DW_S;&DP#E0#@!3T&*] J&K.Q<7=7/._B
M5_R,?@/_ +#:?RKT2O._B5_R,?@/_L-I_*O1*;V0ENPHHHJ2@HHHH **** "
MBBB@ HHHH **** "BBB@# \:JK^$;]&@\Y650RY;@;A\WR_,<=<#DXK+^'DZ
MW%A=/$DY@_=8FE>1M[[/G WG. ?3CGVI?'&@ZCK5Q9&VT^WU"VBCE#0SW)A"
MR-MVR# .2,'\ZV/#']MII4=OKEK!#/ B1J\5QYOFX7!8\#!S]:O[!GJYG#:[
MJ&E:SXH>X4Z/>PQP(ACO;\VK(P=L@C'SCC[K9Q^->HQG,2'"C*CA3D?A5*30
M])EN9+F73+-YI,;Y'@4EL>I(J^    , = *4FGL.,6FVSF=7N=06^L9!N1PY
M LHW8^;\P 8L!C ')!H\/3WLLLP::>4?9T,QN%("7&3O5<@<8QP.!Q734AZ&
MB^EA\NMR*U_X](L_W14U16O_ !ZQ?[HJ6I*"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** (+FSMKQ56Y@CE"G(#KG%3*JH@10 JC  ["EHI
M**3NEJ.[M8*CBMX823%$B$]=J@9J2BBR;N%V%-:.-R"Z*Q'3(S3J*;5Q!111
M0 4444 %%%% !1110 5A:WX-T#Q%>17>JZ>+BXB3RTD$KH0N<X^5AWK=HH3M
ML)J^YBIX1T"/0)M#33(4TV?_ %L"Y'F'(.20<D\#G.:SE^&WA);2:U_LG,$Q
M4R(UQ*0VTY7JW;-=713NPY5V,71/"6B>')I9M*LS;O*H5SYTCY YZ,QQ6U11
M2;N-*VP4444 %%%% !1110!1U?1K#7; V.I6_GVQ97,9=ER0<CH0>M,AT.QA
M@G@47+13QF.19+N5\J1C W,<?ABM&BG=BLBLFGVL>FKIT<(CM%B\E8T)7"8Q
M@$<CBJMSX>TF[M+>UELU\BV3RXD1F3:I&"ORD?*0!D=#WK3HI7"R$551%1%"
MJHP !@ 4M%% PHHHH \[^'7_ ".'C_\ ["H_]!->B5YW\.O^1P\?_P#85'_H
M)KT2JGN3'8*JZCIMIJMH;2^A$T!=)-A)'S(P93QZ$ _A5JBI*,/5O!_A_7;Z
M.]U/2X;BYC 4.V1D Y 8 X8>QS5\:38#5$U+[,OVQ(?(20D_)'G.U1T'X"KM
M%.[%9&3I7AG1=$N[FZTW3X;:>Y.973//.<#)X&><# K6HHI#M8\[^)7_ ",?
M@/\ [#:?RKT2O._B5_R,?@/_ +#:?RKT2J>R)6["BBBI*"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHJ">ZC@.S(:<J62$,-[X] : )Z0]#7.?\)9B
MSANC8LL8MUN+G,@S"A8KQQ\QX)[<"KNG:W]N=DFMC!NA6XBPV_=&Q(!.!P>.
MG/7K3Y62I)FE:_\ 'K%_NBI:JV]Q&EO&K;@0H!&P_P"%/%W"20&;(Z_(?\*1
M1/14/VJ+U;_O@_X4ANX1C+,,G'W#_A0!/14/VJ+U;_O@_P"%'VJ+U;_O@_X4
M 345 +N$]&8]ON'_  I?M47JW_?!_P * )J*@-W"" 6;)Z?(?\*7[5%ZM_WP
M?\* )J*A^U1>K?\ ?!_PI!=PL 0S$'N$/^% $]%0_:HO5O\ O@_X4GVN'.-S
M9ZXV'_"@">BH?M47JW_?!_PH-W" 268 ?[!_PH FHJ'[5$>[?]\'_"C[5%ZM
M_P!\'_"@":BH/M<.2-S9';8?\*7[5%ZM_P!\'_"@":BH#=PJ,EF ]2A_PI?M
M47JW_?!_PH FHJ'[5%ZM_P!\'_"D%W"20&;C@_(?\* )Z*A^U1>K?]\'_"D-
MW",99ADX'R'_  H GHJ$7,1.,M_WP?\ "IJ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SOX=?\CAX__P"P
MJ/\ T$UZ)7G?PZ_Y'#Q__P!A4?\ H)KT2JGN3'8****DH**** "BBB@#SOXE
M?\C'X#_[#:?RKT2O._B5_P C'X#_ .PVG\J]$JGLB5NPHHHJ2@HHHH ****
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MX_\ ^PJ/_037HE>=_#K_ )'#Q_\ ]A4?^@FO1*J>Y,=@HHHJ2@HHHH ****
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M;."#@X.* %HHHH **** "BBB@ HHHH **** "BBB@ I" 1@@$>]+10 4444
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M)<Q>6Q?,;$@ \?>X^G-/E9*DF:=I_P >L?TJ:JMO,$MT5HY00.?W9IXNXR2
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M2W*3V'V:5PK3[952/<"I4\L>P!Q6/!+JZ/:)<37(=[D\JFY/+& 2_'&[G [
M]>*W/[$TO_H'6O\ WZ6C^Q-+_P"@=:_]^EH30VFR_P!:Q-3EO%U%XX;B9(FL
MWP5@WK')N&#D<DXSQ[5H7JO;Z1<K9)MDC@?R51>C!3@ ?6N4"2K+\FDB\6:1
M=LUW; -R!O+'C@$YR1Z^E$4$F=5I4DTNF0-<(Z2E?F#G+?C_ #JY7/Z'>3O+
M"BZ9':6D\1E41I@J<X^8].<<8S704GN-.Z"BBBD,**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \[^'7_(X>/\ _L*C
M_P!!->B5YW\.O^1P\?\ _85'_H)KT2JGN3'8****DH**** "BBB@#SOXE?\
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M6)K'4'DE']CSV"I&RC.WRI>K8&#U.:]/J6K%1=PHHHI#"BBB@ HHHH ****
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MB5_R,?@/_L-I_*O1*\[^)7_(Q^ _^PVG\J]$KI>R,%NPHHHJ2@HHHH ****
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M ($Y_*MR[N8[.SGNI3B.&-I&/L!D_P JR?!]M);>%[)IAB>Y4W4O^_(2Y_\
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M_ <__%5IT4>QCW?WL/:OLON1F>1K/_/]:?\ @.?_ (JCR-9_Y_K3_P !S_\
M%4:MK*:9):6ZP27-Y>.4@MXR 6VC+$D\  =3]*I#Q5&]H3'IUV]\+K[&UFH&
MY9=N[EL[0NWG=G&*?L%W?WO_ #%[9]E]R+OD:S_S_6G_ (#G_P"*H\C6?^?Z
MT_\  <__ !59Z^+8V1H187']I+=?9#9%EW>9L\S[V=NW8,YS5BV\36MZVFQV
MT,TDU\K/Y> #"B\,S\\ -\ON>E'U==W][_S#VWDON18\C6?^?ZT_\!S_ /%4
M>1K/_/\ 6G_@.?\ XJM.BE[&/=_>Q^U?9?<C,\C6?^?ZT_\  <__ !5'D:S_
M ,_UI_X#G_XJM.BCV,>[^]A[5]E]R/+_  !%J+>+/'0AN8$<:H/,+1$ACM/3
MGBN]\C6?^?ZT_P# <_\ Q5<=\.O^1P\?_P#85'_H)KT2KG23EN_O9,*C2V7W
M(S/(UG_G^M/_  '/_P 51Y&L_P#/]:?^ Y_^*K3KCM1^(EAI]]>1_P!G:A<6
M-A*(;W4(8U,-NYQD'G)QD9(!Q4J@GLW][*=9K=+[D;WD:S_S_6G_ (#G_P"*
MH\C6?^?ZT_\  <__ !59E_XYTFR\4V'AY?-N+Z[<(?*&5ARI8;SV) X'6B?Q
MM90>)AHQL[MD$Z6KWBJ/)2=UW+&><Y([XQS1]77=_>Q>W]/N1I^1K/\ S_6G
M_@.?_BJ/(UG_ )_K3_P'/_Q5-T;78-<DO39Q2&UMIC"MR<;)F'WMG<@'C/0G
M.*U:/8+N_O8U6;Z+[D>8^/X[U/$O@7[7/#*/[:3:(XRN#CZFO3J\[^)7_(Q^
M _\ L-I_*O1*U4>6*1DW>384444#"BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HI-R_WA^=&]?[P_.@!:\Y\1ZK;:%\6M.U&_%PEI_9$D7FQV\DH#&0$#Y
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M1V$]C)=M%<:=J4EG>:E:V'GDJ(]T1\H9QN)"GCCVI\C%SH]0_L^T_P"?>/\
M[YH_L^T_Y]X_^^:X_P .^)=4\1:CI\32Q64=K /[0&%W7%SM&Z% ?X4SEB.^
M!ZUW-2U8I.YYO\1;>&#Q'X$\J-4SK:9VC':O2*\[^)7_ ",?@/\ [#:?RKT2
MF]D);L****DH**** "BBB@ HHHH **** "BBB@ HHHH Y?QX\L.@1S(SJD=S
M&9FB=$<)SG:S\*>G/6K'A91-H,L,@O@#(Z,M[.DL@X&1E. /;K5;QY%;3:);
MQ75PUJKW:(MUA2D!(8;G#<%>2.>Y%.\#>1_9=Z(;IKPB]=9+OY=L[ *-RA>
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MK=A1114E 2 ,G@5A7UDOB1-A8QV<9.R0=9&Z9'^R/UJT['5I#$A(L4.'<?\
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MG;0X9+N]\9_$?P]>HEDUDVE)J,%O="0^3\ZAB-I ,F>AZ8[5N>(_^2J6'/\
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M5H3J[02+&J,Y4@!_NGZ^U8]CI^I:>KB"*R^; )>:1C@# '(Z 4D-WN:WV?\
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M]EK>I6=G_9NHV7V^ SV<MU&JK.J@%MN"3QGOC-8GBK5KE?B''I4OBM]!T_\
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I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>img254193463_33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_33.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %M ;P# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O.-"N_$FJ>
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M$ W0E@D22$'INC*AQGMQS1:^*]%O;^&R@NV,LX)@9H)%CGQR?+D*A'_X"37
M^)8M)N/"OBO4['Q#=:S<MIR02S,(C$%#DJ T4:HS ENY(!^E='XD11'X)(4
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MS='C"36<#1Q/\[@;<LV_'(W X/MBDHZ7&Y:V.G\$^)V\4>'K2\GADBNWB#S
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MDM%%%06%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M66.\2R?3[N*2Y@W*L;-MVAB.#G^Z>#CI7=6MK!96L5K:PI#!$H2..-<*H'0
M5+2YK/0KENM3S#6+O4[GPSINCWFG2Q:[::G###]G7R_.\L%O.MF(V?ZL'(;Y
M5R0>V=[PY/:VGB6XM;RUUB/6KV 3&?4S QEBC.,*8"44 OTP.O>NDU/2+'6(
M$AOH/,5'$D;!V1D8?Q*RD%3R>0:BT[0-.TNXDN;:*1KF1=C3W$\D\I7^[OD9
MFQ[9Q3YE87*[W-*BBBH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK
M \5>*%\-VUL([*6_O[R7R;6TB.#(V,GGL!W-8MM\0G'AK3=8O]):!;G4#8SJ
MDH86YW,NXG'/(JE%M7(<XIV9W-%%%260W=W!8VDUW=2K%;PH7DD8X"J.IKC]
M,\:7;1>([_5+06]II\,=S;P@8E,;(S /_M':..V<5M>)=!GU^WM88[_[,D$X
MF=&A$J3%?NAAD9 /..G KE9?"VNZE>^+;2ZOUD2]LXHDD-IY:S/L;;@[CC:<
M9QGKVJXJ-M3.;E?0T3K/B32(=-U76)+&2QO9HXI[:&%D>T\PX4ARQWX) / Z
M\5V$ES!"VV2>-&ZX9P#7"7UW?>*=-TS0O['U"UN!<0/J#SP%(H5C8,VUSPY)
M4 ;<]<\5WK11N<LBL?4C-$AP96THYTR CIM_K5RJ>E?\@R#Z?UJY4%A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <9X
M^T^YGDT6_P!,O+:#6;.Y8V<=R<).64[H_J0/_P!76N'MM"\4/IMO9>*?[.T7
MP];WQO;F5IU+2LSE@@.XC&3@=/QKH_BO%933>&UUII(]#^V/]LEC!RIV?)R!
MD G->>S:SH\MO8Z ;RXET)->6: W*OM-H!AN2.5#%OUKH@GRHY*C7,[GT+:W
M5O>VT=S:SQSP2#<DD;!E8>Q%2UP7PP:W,/B!--.='35)!9;<[ N 2%_V<]*[
MVL)*SL=,9<RN%%%%(H**** *>E_\@R#Z'^9JY5/2_P#D&0?0_P S5R@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M* &+#$DC2)$BN_WF"@%OJ:?110!3TO\ Y!D'T/\ ,U<JGI?_ "#(/H?YFKE
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MY?\ T&OIVN2O\1V4/A"BBBL3<YWQ[_R3_7_^O";_ -!-?(%?7_CW_DG^O_\
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M79_\\C_WVW^-7**DHI_V79_\\C_WVW^-']EV?_/(_P#?;?XU<HH I_V79_\
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MW,,\4TEG)(6NO,4JIDC("@KP<Y))':BR"\C6O/%EA8Q>9+#<D?V7+JGRJO\
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8H **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>img254193463_34.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_34.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (O @<# 2(  A$! Q$!_\0
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M-$O;D:]J&GK'<^6T5LV%?Y0<GGKSBO7O#_@31_!>C7ZZ>LDEQ/"WG7,[ N^
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MNCRZ7J2.UK*5+!&VGY2".?J*Y^U^(]B=1M[+5]*U717N6V02:A!LCD;TW D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "LW5?\ CYTO_K['_H#5I5FZK_Q\Z7_U]C_T
M!J -*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S=5_
MX^=+_P"OL?\ H#5I5FZK_P ?.E_]?8_] :@#2HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "LW5?^/G2_P#K['_H#5I5FZK_ ,?.E_\
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MEV[<<G''TJW533!<C38!>9^T;?WF<9S^%6ZF'PHNK;GE;OTV"BBBJ("BBB@
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MM(QA6'6F^%/#47A?2I+87+W5S<3/<7-S( #+*W4X'3Z5;U7_ (^=+_Z^Q_Z
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MHJ2@K-U7_CYTO_K['_H#5I5FZK_Q\Z7_ -?8_P#0&H TJ*** "BBB@ HHHH
M**** "BBB@ HHHH **** "H+QTCL;AY$WHL;%E_O#'(J>J]_*T&G7,RH':.)
MF"$9#$ G%*6S*@KR2'6C(]E T:;$,:E5_NC' J:HX&W6\;;0N5!VCMQ4E"V"
M7Q,****9(4444 %4M-2W070MY&<&YD+[AT<GD#VJ[5+3VMR;L6Z,NVY82;CU
M? )(]N:E_$C2/P2^1=HHHJC,**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N<\<ZY<>&_
M!U_J=FJ?:(PJQEQ\JL[!=Q]AG-='6+XMO-*L?"]]-K<+S:;L"3QHFXL&(7I]
M2/I36XI;,X.WN->TG2_&UO=>*)KFYL;.WN(+UP J,R,Y"#D '  _"O0O#>H2
MZMX:TS4IXPD]U:QRR #'S%037@<+?#&&],LU]XDGM"RG[)*O[LX^Z"1R0.U?
M0VF7$%WI=I<6L;16\L*/%&Z;"JD# *]N.U:5%8SINY:HHHK(U"LW5?\ CYTO
M_K['_H#5I5FZK_Q\Z7_U]C_T!J -*BBB@ HHHH **** "BBB@ HHHH ****
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M_K['_H#5I5FZK_Q\Z7_U]C_T!J -*BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ JGJ<Z06J&2)95::--K=,EP ?PZ_A5RJ>HS2PI;^5&'+W$:-E<X4GDU
M,_A9I25YHN44451F%%%% !1110!#<3-&$6, R2':H/3ZFLXG[+JLTK2^;+Y"
M>:NS ";FP1[YS5N_\PF$6^W[1N)0M]T<<Y_"LN62;^U&AFC4,T"&:3OY>\@
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MMS)YAA0OUSBIJHS"BBB@ HHHH *I:E LPM6:98O*N4<%OXCTQ]3G%7:I:K'
M]D#<RF*..6.3>!G!#@C]<"IG\+-*+]]%VBBBJ,PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *Y/XEVMY>?#_ %2&RB>60JA>.,99HPX+@>^T&NLK \:>('\,>$K[5HHA
M+-$H6)&Z%V8*,^V3FG'=$RV=SQ._O=.6TUB/P?H^K+I%_81VC*(793=;P1G)
M.#L!'N?K7<?#V;3KSQO>3Z!"8]-BTB""YVPF,&Y#=P0/F"Y!J.\TOXEZ+IDW
MB"3Q3:W,EO$;B:P, $94#+*#CTSZ?6O1= OH-4T*RU."!85O84N"@ &"P!.?
M4^]:REH90CJ:5%%%8FX5FZK_ ,?.E_\ 7V/_ $!JTJS=5_X^=+_Z^Q_Z U &
ME1110 4444 %%%% !1110 4444 %%%% !1110 52LI_/NK_]RJ>7,(]X'+X1
M3D_GC\*NU4T^2XE@D>Y4JWG2!05P=@8A?T J7ND:1^&3_K^M!]T[@1QHVUI'
MV[O08R?Y5%-;_9H6GAD<.@W'<Y(8>AS5F:%9X]C$@YR&'4'UJ$VTTN%GGWQ@
MY*JFW=]:HS+*G<H/J,TM%% !5&XU!U(2VMVF8MM!R N1U^N*N.RHC,QVJ!DG
MTKGYK^6""W1(6BEC)VL_\2XY('?(H TTN9DC$S.LD6<.-FUD-/U9;=])NOM2
MNT"QEW"?>PO/'OQ68GVIX7G.\6TKJSB4@DIP,C'0FMN=%DMY(W0.C*593_$"
M.E*2NFBX/EDF.1Q)&KKT8 BG55TVX2[TRUN(T\M)(E8)G.WCI^%/DN&$IBAB
M,KCEN<!?J:(NZN*<>633Z$]%0PW'F.T;H8Y5&2IYX]0>XJ:F2%%%% !1110
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MT7&?H<T <['=!8O+,2ES@><W4#TQ7H?AZ\CMOAQKDRCH77:3GEE"C^=>8AW
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MU2$W%G.2Z_.;=?,5#Z''/Z5>HJ.6WPNQI[2_QJ_YE9M1LTN5MGN8DG8 B-V
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MSK8.M1YG-?#H]4]>V@*29N4445RE!1110 4444 %%%% !1110 4444 %%%%
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MD[H[ZBBBOFS8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&94&68*/4G%+7F;:
M;:^-_B;KUCK2/<:?I$$,=O;&1E0/(,E\ CGMG_"FE<F3L>F5FZK_ ,?.E_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%<7JOAO7;+Q7<>(?#$UAYU[ L-W;7VX(2OW7!7G(';_&NTHIIV$U<Y[P=X:/
MAC1GMYK@7-[<SO<W4X7 >5SS@>G05<U.*-;S3'6-0QN^6 Y/R-6K6;JO_'SI
M?_7V/_0&H;OJ"5E9&E1112&%%%% !1110 4444 %%%% !1110 4444 %%%%
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M6I10!E_9];_Z"%I_X#'_ .+H^SZW_P!!"T_\!C_\76I10!E_9];_ .@A:?\
M@,?_ (NC[/K?_00M/_ 8_P#Q=:E% &7]GUO_ *"%I_X#'_XNC[/K?_00M/\
MP&/_ ,76I10!E_9];_Z"%I_X#'_XNC[/K?\ T$+3_P !C_\ %UJ44 85@^M7
MUE'<_;+1-^?E-L3C!(_O>U6?L^M_]!"T_P# 8_\ Q=:G2B@#+^SZW_T$+3_P
M&/\ \71]GUO_ *"%I_X#'_XNM2B@#+^SZW_T$+3_ ,!C_P#%T?9];_Z"%I_X
M#'_XNM2B@#+^SZW_ -!"T_\  8__ !='V?6_^@A:?^ Q_P#BZU** ,O[/K?_
M $$+3_P&/_Q='V?6_P#G_M/_  &/_P 76I10 @SM&3D]Z6BB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@"BVM:4C%6U.R# X(,ZY!_.L+7=)US6-7W)KSZ5H45OO#V;@322=
MRS$8" 5;D\"^%)I7ED\/::SNQ9F-NN23U/2N4^( \2W]Y!H>G>'[N?P^BJ;H
MVLR1-<C'$8)/RIV/&35QM?0B3=M3<^&NL:CK?A,7.HRFX=+B2&*Y*[3<1J<!
M\?F/PKDM;\1K<>/M9L+SQI=:#:VAABMXXD!5V*9<DD$#G'6NLTW6M9M](T^.
M+P9-9C[4MJ;9;A,00X'[SCL.F/:J7BB_UV_M=7T*+P9+.UTK007?G1F%E(P)
M')P5(ZX]J:^(E_"O^"=K8Q^586\?VEKG;$H\]R"9>/O$CCGKQ5BLOPWI<FB>
M&M-TN642R6MND3..A('./:M2LV:+8****!A1110 4444 ><A]:\:>*-?@M-=
MNM)L](D6VMUM0N9)<9+/D<C/;TK<\">)+C7_  ='J&HA1=P-)#<E!PS(<$@>
MXP:Q#!KW@[Q/KUSI^AS:O9ZNXN(3 ZJ8IL8*OD_=).<BK/A72]6\*Z/I.B3Z
M8UX;]YI=1NHI0$MF;G&._IQZ5H[6,HWN<Y#J'B?5O!=]X\AU^XMY(GDGMM/5
M5^S^1&V-K+C)) /.:]1T;45U?1+'4D7:MU DP7TW '%>81:3XITKP=?>!+?0
MY+@2O)#;ZD)5$ @=LEF[A@">,?\ U_4-'TY-(T6RTV-MR6L"0AO7: ,T3L.%
MR[11169H%%%% !1110!F>($U>71+B/0I((]1<!8I)_NID\GH>0,X]ZXNQDU?
MP_\ $?2]"&O7FLPWEK)->)=;28-H^5UP/E!/&/\ ZU=AXFOM4T[0IY]&TYK_
M %#A8H0P R?XCDC@5P_@0:_INHL=3\)WIOK]BU]JT]S&23@D *.B#@ "KCLS
M.7Q(VOB=K<VB^';3[/J#V#W5_# US&,F)"26;\A4W@66VNH+NYM?%MSK\9*J
M1,%'DD9_AP""??TI[^(=>.B6E_)X/N'F:9A/:+<(9(E'W7 /#9].*I^$-)U&
M3Q9K7B>]TXZ7'?QQQ16;,"Y"]7?;P"?\:/LV#[5SN****@T"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHKS[XBZWJ>E>(?"$%A>26\5Y?>7<*F,2+N3@_F?SII7=A2
M=E<]!HI'=8T9W8*BC+,3@ >M<C%\3_"$VH+9IJZ[F?RUE:-Q$S>@<C;^M"3>
MP-I;G7T5@^(/&6A>&7ACU2]\N:89CACC:1V'KM4$X]ZI?\)I9Z[HU\?"%Q#J
M6J10;XX#E<$G +;L=.N/:CE8N9;'5T5X[XA;QCX'T73_ !'>>*)KR\DN$2YT
MZ1%\EMP)*)CTQC(^M='>7=UKGQ:T[38Y9H;/2;,WLZ*VW?(_"JWJ "./K5<@
MN?I8[^BO,=1TWQI?0ZQK.I>(WT".V+FRM8"A38HR&D;/.?\ /I5*;Q]K]U\/
M_#?V=4AU[7+@VJ3E!A0&VF0+TYROMR:.3L+VB6Z/6Z*\OFN?$'@'Q3H<-_KT
MVL:5JTWV:7[2@#PRG !4CMST]C3+*X\1?$+7-;EL/$$^CZ9IMP;6V2W0$RN.
MK.>XZ''O1R=;Z#Y^EM3U.BO._"/Q"4>&;V7Q5<I#=:7>FQN9U0X=LX5L <="
M/3C-;MA\0?#&IZTNDVFJ))=.2(_D8)*1V5B,-^!I.+0U.+.GHKQS6O'6L>'_
M (O7<<]Q+)X>@,,=S%@;81(BX?UX8Y_2N\\=>)QX9\+2W=MB2^N"(+)%Y+RM
M]W [XZ_A[T.#T\Q*:=_(Z>BN"^$>KZKK/A&XGUBZEN+N.]DB+28RH 7CCW)J
M'Q5KNHV'Q3\+:=#?/#872.;B+("OC=U_*CEUL'.N5,]#HKS9->U;QSXT^QZ!
M>RV?AW3'Q=WD6,W4G]Q#Z>X]SZ5B?$.V\6^$=)?6(/&EY*DMV(UM_)50@;<1
MSD],8IJ&MKB=32]M#V2BN6\*Z!K>ESO<ZIXHN=6BEA 6&6$($8D'=D$_3\:V
M==FU*#0[R31[=+C41&?(C=@%+>^?3K^%3;6Q:>EV:%%>.Z\WB_P5IVF:W=>*
M9;[49[B..?2W13&^[JJ >G3(KK_$=CXLUOQ#!96%\^CZ&D/F37D)4RR2?W .
MJ@>OU]JKE\R>?R.SHKS;P7KFO_;O%.BR7(UQM)Q]CNGPIE8@D1LW3J!SVYK&
MUY/&OASPL?%.H^*WBU175CIA5# 06QY8 ZG!S_G-')K:XO::7L>Q45FG5TMO
M#0UB_3R%2T%S,A_@^7<1_2O--3U;Q#IOP9N?$,NHW$>J7]PERAW9\B-Y %10
M>@VXX]Z2C<J4DCUVBO+[?PWX]&BV^JZ=XVDN;EX%G6UN;9=CY7.W.3],X_*J
M]_\ $&]UCX/:CK5H[6&KVDJ03B/^!]Z@XSV(/\Z?)V)]I;='K%%<3\,_%-UX
M@T%[752RZSI["*Z5QAF!&5?'N/U%<EJGCS5=0^+&F:?I=S)'H<5ZME*R8VSR
M Y<$]\9Q^&>]"@[M#=1))]SV.BO)]4UC5O$GQ(U'PY'XF/AZUL$7REC $ERQ
M ).21GKTSTK9U77-7^'G@.:YUK4$UC4?.\JT?R]F[=]T-CKC!)_+WHY YUKV
M._HKS2V\(^/-0L%U"[\;3VFHRJ)!:Q0#R8R>0I'?\OSJ'3-:U/QMX0\2>'-4
M8VOB'308W>W8H'89*L,>I7!QQ@^^*.7S#G\CU&BN<\!ZZ_B/P5IFI3-NG>+9
M,?5U)5C^)&?QKHZEJSL4G=7"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "O*OB]<PV?B#P5<W$BQPQ7
MY>1VZ*H:,DFO5:J7VEZ?J807]C;703)03Q*^W/7&1Q51=G<F:YE8XOQ5XGTG
MQ1X-UO3/#NJ0WFH-9LXA@)+,@(W8_#(_&N2U37?#5Q\";?3(+BV>]:WABCM%
M(,HG#+N^7KG.3GOGWKUVST/2=.G\ZRTRSMI<;=\,"HV/3(%,C\/:+%J)U"/2
M;%+S.?/6!0^?7.,YJE)(EQDSR#6+VY\)^*?#5Y)>V]GJKZ&D%S)J43O!QC@%
M,MOSG/;\ZZGP/?\ AWPWX5U?5W\06E\7N6N[Z6W7:J._1%3J,]!ZFM'7/!^L
MR>*Y/$.AZE9I/- L$D&H0&5 !W4CD=.E2>&_ <>GSZG?:V]KJ-[J90SHMN$@
M4+]T*G]33<DT2HR4CAM.\4Z'XO\ $D?B#Q3K%I:6-E(?[-TIGR00?]9)CC/'
M3^G7J='F2+XU:X"P;[;ID$\!!^^JX!Q76?\ "*^'O^@%IO\ X"I_A5;4O"L-
M[XET?7(+AK6?3@T96-1B6)AC8?0#^II.28U"2.)U[Q'X(\;:)>0^(WETV[TY
MY5%M/*4F5L=0H.'Z#CGFN:DN=7_X0SP/XJU:*62/2[\^:^WYOLY8;6(';"XS
M]/6O:;OP]HNH7:W=YI-E<7"])98%9OS(J^\,4D)A>)&B*[2C*"I'ICTH4TM@
M=-O<\I\8ZQIWC3Q5X2TC0KN.^:*]%Y<20'<L4:X/)['&?T]:;X%UO3?!6I^*
M-$U^\CL)5OWNHFG.T2QL."OKP <>]>FZ?HNEZ3O_ +.TZUM#(<N8(53=]<"D
MU#1-*U5XWU#3;2[>/[C3PJY7Z9%',K6Z#Y'?FZG@.H033_##Q-KTD31P:MK2
MS6X<8+(&;G]2/PKN?B)''#=_#\Q(D>W48E7: ,#Y.![5Z7<:?97=H+6XM()K
M=<8BDC#(,=.#QQ2SV%G=&$W%I!*8&#1&2,-Y9]5ST/TH]IJ+V>AYC%I-KKWQ
M9\;:5>#,%SIT,;>H^5,$>X.#^%0>#/#7B+4/$MD/%$+BS\,H8+,L#BXDR=L@
MSUPH7GV7WKU9+&TCO)+Q+:%;F4!9)E0!V Z GJ:GI<_0?LU>[/.?@P<^$]1Y
M_P"8I/\ R6LCXC:99ZU\5O"6G7\1EM9XG61 Q7(Y/4<]J]6M+*TL(FBL[:&W
MC9BY6) H+'J<#O22V%G/=Q7<UK!)<P_ZN5XP73Z'J*.?WKAR>ZHGENA3S?"W
MQ=_PCE^[-X;U.0OI]RYXAD/5&/Y _@>YJ_\ ',C_ (0&+G_E_B_]!>O0KW3[
M+4H1#?6D%S&#N"31AP#ZX-%UI]E?6ZV]W:07$*D$1RQAE!'0X-'/JF')[KB5
MKRRFU'0#:6]]-8RR1*%N8<;TZ'C/TQ^-8 COO GA[4M3O=2U/Q"$"OY;A=T:
M@X)'MSD_2NP    & .@%*0""",@]0:E,MKJ>'>.=6\,:@MAXH\,7[/XJFFB\
MB*)R[],%6C.0N!QVR?6NZUSQ9HG]I2^%/%$3V45S:*YN99/+AESC*JP.00<^
MG3Z9Z6U\.Z+8WAO+32;&"Y/66.!5;\P*FU#2=.U:$1:C8VUW&IR%GB#@?3-4
MY(A0>IY7X"U)-&U+Q;'H"7.H^&+!!-;(GS%I<9948_>[_D/QH^-M=\&^)?#D
M7B>SOGA\21K&+2%)294D#?=,?(XR><?C7L]I96MA;K;V=M%;PKTCB0*H_ 53
M3P[HD>H?;TTBQ6[SGSQ;J'SZYQUI\ZO<7([6.)\5W-_K6A^&/"UR"FHZUY37
MZKP4B10\OTYX_.I_C)&D/PNO(HU"HDD"JHZ !UP*[0Z/8'6AK!MP;\0^0LQ8
MDJF<X S@<U8N[.VO[=K>[MXKB%B"8Y4#*<=.#24K-%.%T_,X.V^)_A/2?"EF
M3JD=Q<PVD:?9H06=G"@;>G'/<UPS:)?:9\#_ !#J&I0M;W&JW:70A88**9%Q
MD=L\GZ8KVFW\.Z):S+-;Z1812KRKI;("/H<5<NK2VOK=K>[@BGA;&Z.5 RGO
MR#34TMB7!O<\H\3:/KVE?V7XE\)V\DUW?:<EC>11@D\H DOU''/L/>H=2\.1
M>%;_ .'&E(0TB7[//)_STE;86/Y\#V KV)$6-%1%"JHP% P /2H9[*UNIH9K
MBVAED@;=$[H&,9]5)Z&A3&Z9YOXJN?AIXCU>]LM>F2UU*R/EM<-NA<X_NMT;
M'OGVKBK?2-;\0?">[>V>YOH-,U0SZ<9@2\L"@@X'<<YQ[$"O=+_0=(U619-0
MTRSNI%^ZTT*N1^)%78HHX(EBBC6.-!A408 'H!0IV6@G3N]3C+#XK>$KK14O
MKC58K:4)F6VD!$B-W4+C)Y]*P/AU'/<W_BKQQ=P/:V6H,S6ZR#!,2Y)8^V,?
MD:] F\,Z#<7GVN;1K"2XSGS7MT+$^N<4GB317U[PW>:1#=M9?:8_+\U$#;5R
M,C'H1D?C2NMD/EEN^AS7P?ADC^'-E(ZE?.EFE4'^Z7./Y5W=5=-T^WTK3+;3
M[5-L%M$L48]@,5:J9.[N7%6204444AA1110 4444 %%%% !1110 4444 %%%
$% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>img254193463_35.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_35.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'M X0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y_7_ !!J.D7445GX;O\
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M8'F23:&<8]!E1^=;%2U8:=PHHHH&%%%% !1110 4444 %%%% !1110 4444
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MZ**V225D9-W/-M/\*:E8F_U^PMC#K<.I7,B12-A;RW9\[#V&0,JW8@9XK?\
M$$-WJ\7AJYM[*=3'J<-Q-&Z@-"@5L[A[9KJJ*OF)4$E8Q;C3;RRDO]2T^ZN[
MN[>-C%9W-QB#=P0 ,?+TQGWKF[>#4;GQ0=9T?0KG3YC:2_;5OF"+<RX'EH,$
M]&R=PXP>]=]10I XW.#MH;^^\56^KZ?H=UIEUY$@U%[L@),=F$C&"=V& .X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M% !1110 4444 %%%% $5RDTD#+!*(I3]URN['X5SVL6.KC2;CS-169,#,:P
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MNN>*?*Q<R.KATZTATZ/3UMXS:1H(UB905VCH,'K1'IEA%')''8VR)(,.JQ*
MP]QCFF:MJEMHVF37UT3Y<8X51EG8\*JCN22 ![UQJ^)M>B\)>(;R\,,>HVMW
MY,*Q1[U@#"/ ('WBN\Y/?%"38VTCNX+>&UA6&WACAB7HD:A0/P%(+: *JB&,
M*C;U&T?*WJ/?DUA>%+UKV*Z8^(AJY1PI!M5@:$^A4 'GW]*B'CW124(6]*22
M-#%(+5]LLJD@QJ<<MP<#]:5F',K%[5?#T>H75O>6UU+8WD&_;+$B,&#@!MRL
M"#]T<]>*=HGARQT+[1) #)=W3F2YNI -\K>^  ![  54'C32VM(Y8TO))Y)W
MMA9K;DSB1!EE*=L#!)Z8(]:BNO%D5WX9EOM'$AN)9A9VPFA*'SRVWHPYVG)/
M^Z:=I;"O'<Z(VUNT;1F",H[;V78,%LYR??/>N;M_!,$+6T,FHW4^GVLPG@M)
M%3"N&W#+A=S $Y )^N:CT/Q,RI=0ZI<-/<G5IK&U6.(;W5".<+V R2>@JTOC
M72GO8K=([UDFG-O#<+:N8I9 2"%;'.,'GIP?2BS07B]S>GMH+J(Q7$,<T9ZI
M(H8'\#5&TT&QT_59M0LE:W:= DL,1VQ.1T8ITW <9':LF^O]6U?Q+<Z)I%XF
MGQ6,*275V81*Y=\E416X' R2<]16-J_B+Q#H":E837$-W=V5LFI0W(A"^?;K
M(%E5U' 8#N/7I0DP<EN=^D,<:%$C15))*JH )/6ECC2*-8XT5$48"J, #Z5Q
MNM^,+BS\3:1#9K&^E%8WU"4CE%F.R$@]OFY/M6KI.JW>I>*-;A#+_9U@8[9
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MNW-M;D$8XI\I/.COJ*X9-1UGQ##K&J:=J;64%BQCM(!$K+*RQJ[&3(R02VW
M(P!FNDTO6X;_ $#3]4D!B%W DNT*6VD@$C@4FK#4KFK145O<PW2%X7W ':>"
M,'\:EI%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 45#:W=O>P>=;2K+'N9-R],J2"/P
M((J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJFIV<M_IE
MQ:0W<MH\R;!/#C>F>I&>^.] %NBO++^Z/AC4-=&DQ7>G"WTF0I'=2,XNI P
MG3)(.W/)R"<C([UH:I:)X,71M2TV2=YIF:&[$DS/]JS"[;F!/W@R@Y'J1TJ^
M4CG/0Z*\T%I_97A70/%$5S</JL\UH]U*TS'[0L[*'1ESC W\ #C:,5%) [^
MKCQC]IG&MJ[W23^:V%"RD"+;G&S:-N,>_6CE#G/4**JM<S>7&\=J\F]0QPP&
M,]N:DM;@74 D"%.2I4]B#@_RJ"R:BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HIK.%95/\1P*=0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (PRI )&1U':N0;P
M_P"(=1DTZUU>]L)K2QNEN/M4:,+B;;G:",;4)_B(//XUV%%-.PFKG$+X1U;^
MS(_#CW5G_8$<X<. WGF$/O$6/N]<#=GH.F:?<^%M9%KJ>C65W:)H^HS22/(X
M;SX%D.9$4#Y3G)P21C/?%=I13YF+D1Q\WAO6+%M3M=$N;*.PU([F\\-OMF*!
M&* <-D*" <8-=-IMA#I>EVNGV^?)MHEB3/4A1CGWJU12;;&DD4[+_7WO_7?_
M -E6KE4['_7WO_7?_P!E6KE(84444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445P7Q?U;5M&\"2
MSZ2\D4CS)'--'PT<9SD@]LG S[TTKNPI.RN;W@T8\/#/_/U<_P#HYZWZ^>?@
M;KNMR>*Y=,,\\^G/"\LRR,66-NH89Z$DX]\U]#54X\LB:<N:-PHHHJ"PHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *IZKIL6KZ9/8S231)*,>9"Y1T(.
M00>Q! JY10!S<7A)9YY9]:U";59'M7M%$L:QJD3XW\*!RV!D^W:BQ\)>3=VD
MM_JESJ,5BC):0SJH$>5VDL0/G;:<9/J>YS7244^9D\J.6M/!<=M)90R:I=SZ
M982B:TL7"[48?=RV-S!<\ ]..N!2/X)A?S+3^T;D:-)<?:7TW:NPL6WE=V-P
M0MR5_I7544<S#E052TO_ (]&_P"NTG_H9J[5+2_^/1O^NTG_ *&:11=HHHH
M**** "BBB@ HHHH **** "JU]J-EID GOKJ&VB+;0\KA1GTR:LTUT208=58>
MA&: ,NW\4:#=W"6]OK%C+-(VU$2=26/H!GK6M7.^%88@NK$1ID:I<8.T<?-7
M14V);!1112&%%%% !1110 4444 %%%% !1110!%)_K8?]X_R-2U%)_K8?]X_
MR-2U*W93V044451(4444 %%%% !1110 4444 %%%% !1110 44URPC8H 7 .
MT$X!->5C6=9UFZC2\\?:5I)EF,26FFQ"8ALXP9&_#GH3TJE&Y,I6/5J*X;^Q
M_'NCL);+Q%:ZS&",VVH6XB)'?#IW^M=PN[:-P ;'('3-)JPT[]!:***0PHHH
MH **** "BBB@"G8_Z^]_Z[_^RK5RJ=C_ *^]_P"N_P#[*M7* "BBB@ HHHH
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M$);>92CH3C(_I5BB@#S[Q)K,>G>)=.TS3?#]]K>HV$'VD(D^U(P1L#N3G<^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M***!A1110 52TO\ X]&_Z[2?^AFKM4M+_P"/1O\ KM)_Z&: +M%%% !1110
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MWU(=-D65[QUW8,_\2D'[J]C5^J=E_K[W_KO_ .RK5RI+"BBB@ HHHH ****
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M&WES,'4,-D9;K]*BTEMUB6 (!ED/(P?OFKH 4  8 X JGI?_ !Z-_P!=I/\
MT,UF:EVBBB@ HHHH **** "BBB@ K '_ "4%O^P4/_1IK?K '_)06_[!0_\
M1IIH3-^N \9N_BCQ)I_@JV8_9SB\U5E/W85/RQY]6./TKK]<U>VT#1+O5+QL
M06T9=O5CV ]R<#\:Y[X>Z/<V^F7&NZHO_$WUJ3[5/GK&A^Y&/8+_ #]J<=/>
M)EK[IH^$T6.#5D1555U.X 51@  BN@K \+?ZO5_^PK<?^A5OTGN4M@HHHI#"
MBBB@ HHHH **** "HKC_ (]Y/]TU+45Q_P >\G^Z:F7PL<=T2CI10.E-D<1H
M6/:FW978MS"N"WVAP"?O'O[ULVN?LR9Z\U$D>&B9AEG8D\>QJW7-0I<LG(WJ
MU.9*)2U'[UG_ -?*_P C5VJ6H_>L_P#KY7^1J[6L/CE\OR,Y?"@HHHK4@***
M* "BBB@ HHHH **** "BBB@ KA?B;)I+:=865[8ZA>7UQ,?L*:<VV=7 ^9E;
ML,'GK7=5Y]\3#-]K\-K;WT&ER-=N%U64_P#'L=AX R =PR.>.!50W(G\)E_#
MG3$TS7 K>&=?AF,!C6_U24.(D'.Q0   :[#Q_K,^@>"=1U&VCCDGC50@D7<H
M+,%R1WQG-8_A2'4TUU#=?$*UUN+8V;...)23ZY4D\5VUY9V^H6<UG=PI-;S*
M4DC<9# ]J<G[UV**]VR/.M?U/4K[7]'\+>'KC38;^:U^TWM\MNLBHH'92#U/
M\Q6]X UB\U+3]1M-12W^W:9>O:32VR!4F*X^8 =.M6O#G@[PWX5NYUTBV2&Z
MF3+[I2\FS/;)R%S5WP[HVE:'I\EMI)#0O.\DC^9YA:0GYLMZ]OPH;5K((Q=[
MLUZ***@T"BBB@ HHHH IV/\ K[W_ *[_ /LJU<JG8_Z^]_Z[_P#LJU<H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *PO%'BFS\+V"RS*\]W.WEVMG%S)._8 >GJ:9XJ\5VOAFTC!C:ZU&Y;R[.RB
MYDF?^@]36?X7\*745^WB/Q)(EUKTZX ',=FG_/.,?S/_ -<FDNK);Z(9X9\+
M7DFI?\)-XH9)];D7$,(YCL4/\"?[7J?_ -9U=#)_MWQ'_P!?D?\ Z(CK>K!T
M+_D.^(_^OR/_ -$1T7O<+6L;U%%%24%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!Y7\3(](U;78-+&BZOJ&KI;;W?3'",D);A7)!!!(Z8_G6M\-
MK5;$7T(\-ZIILC[9)+O49?,DN#R,$X'3^M9OBZ._F^),<=AKEMX=D&FY-[)A
MC<KO/R;6('RGGUYKH?!EOJD-Q=G4/&-OKZE%V)%&B^4<G).TGK_2M7\-C%+W
M[CO'^N7FB:;IHLFACDO-1AMFFG0,D2L3DD'Z8K!UG4]<\0^.9O#OA;4+73X=
M/MQ-=W7D++ND/1.1[C]?2N]U?1[#7M-ET_4[9+BUE^\C>HZ$$<@^XK+T'PEX
M?\.V-YIVDP"$3#%P1*3(000,MG(X)Q4II(J46WY$7@'7;CQ!X6BN[R.)+J.6
M2"8PC".R-@L/8]:Z>LSP]I.G:'H=OI^DX^QQ [&#;MV2223W.<UIU+M?0N-[
M:A1112&%%%% !5+2_P#CT;_KM)_Z&:NU2TO_ (]&_P"NTG_H9H NT444 %%%
M% !1110 4444 %8 _P"2@M_V"A_Z--;]<3XGUZ+PSKM]JTPW>3I"B-.\DAE(
M51]3515]"9.VI4\0_P#%8^.K/PRAW:7I96]U,CH[_P#+.(_S(]/I7H/2N6\!
MZ!/HF@>=?DOJVH2&[OI#U,C<[?P''YUU-$GT0175F!X6_P!7J_\ V%;C_P!"
MK?K \+?ZO5_^PK<?^A5OTGN-;!1112&%%%% !1110 445#.9$0NK@ 8X*YI2
M=E<:5W8FJ*X_X]Y/]TT] P'S-N_#%,N/^/>3_=-*7PL<?B1*.E5W_?3B,?=7
MEJED?RXBW?'%-@C*1Y/WFY-3+WGRC6BN$G^MA_WC_(U+44G^MA_WC_(U+5+=
MB>R*6H_>L_\ KY7^1J[5+4?O6?\ U\K_ "-7:B'QR^7Y#E\*"BBBM2 HHHH
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M_HQ:WZ?074*YWQ9XM@\-6T44<+7FJW9V65C%R\K>I]%'<TWQ9XMB\/10VMK
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MWO\ UW_]E6KE4['_ %][_P!=_P#V5:N4 %%%% !1110 4444 %%%% !1110
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M1W8WLBEJ/WK/_KY7^1J[5+4?O6?_ %\K_(U=J(?'+Y?D.7PH****U("BBB@
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M?&W_ "*5[_O1?^C%K?I-MK4:23T"BBBI*"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@"!GG615_=_-G'6IEW;1NQGOBHY/^/B'_@7\JEJ([LI[(****LD
M**** "JNHW;6&FW-VEO)<-#$T@AB&6D(&=H]S5JB@#S<+\1O%H_>&V\,:<_5
M0/-N&7^0_2N@\(^!-*\'"XDLWGGNKG'GW$[Y+X)/0<#DUEZ]X\B\+^/HK#5[
M^WBTF>RWH%C+21R[NK8YVD X^E=!H/C#0O$\LT>CWZW+P*&D 1EV@].H'I5O
MFMY&<>6^^IN5Y7<6V@RZM>^%M+URXBU674FU&V=(-\=G<*I9EST/1LCWQ7J9
M('4XKR2YT/QAX?\ $,+:1H]KJEG#J%S?03?:%C.9D*E9 3_"6Z]\40"IT.R^
M'MO:P^$XY+74SJ7VF>6>6Y,?E[Y6<[_E_AYSQ755SO@G0[K0?#:6U]+')>RS
M27-P8ON*[L6(7V&<5N74SV]I--' \\B(66)" SD#H,\<U,MRHZ11-17%Z=XL
MU&#0_$FH:W;P+-I<S 6]N<@ 1JP3<>IRV,TK:WK>@S:=<Z[/:SV=^&618(2A
MM9!&7 !R=Z_*1S@YP:?*PYT=G17#0>(=>M].TKQ!?O:G3M1FA1[-(B&MTE($
M;!\_,<LN00.IQTIC^)==_L.;Q6CVO]E13-BP\H[VMU?87\S/#\%@,8QQ1RL.
M='>52TO_ (]&_P"NTG_H9J62^M80AEGC3>-R[FQD5#I+![$LI!4RR$$=QO-2
M47J*** "BBB@ HJJ=3T]6*M?6P*G!!E7C]:GBFBGC$D,B2(>C(P(/XB@!Q(
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MGBK*L&4,#D&L.6WF,QRARQ/0&MBW4K;H",$"L*%24I--&U6$8Q33):***Z3
M**** "BBB@#S[Q1)K&N>,?\ A']#;3[.2WLUN;B\NK99G(9B%500>./UJSX*
MN=2L]=U3P]K*V$MY:Q1SK>6<(B\V-L\,H P01^M8GQ(.GW?B6TM;.QUR;7X;
M;>9]';:\<);@,>XSG_)K2^&=H+-M05]"UFSN9-KS7NJMNDN#R ,X[>GO6K^$
MQ7QF_P",_"</C'0_[.ENYK5ED$L<L79@".1W'->0R>$=-\'ND/C32KJ6R9]B
M:O8WCE"3TWQYR#]*]>\::GKVE:%YOAW3/M]^\@0)C(C!!^8CC/0?G7E^G6VM
M27J:IXG\&:WKVI#E?M$B""(Y_@CQC\Z(-V%42OMJ>M^&=)TS1M"M[;2"[6+C
MSHF=RY8-SG)Y[UJ2LZ0NT:>8X4E4SC<>PSVK/T#4+G4]*CN;O2IM,EW%?LTQ
M!90. >/6M.LWN;+;0X*ST/6-2MO$VGZEI9L8=8=Y8YQ<I)Y9**H! [Y7-6)-
M(UOQ')IMKK5C#9VECN>:2.<2?:)/+9!L &57YBW//0>]=K13YA<B.$AT/7[K
M2M)\.7UI!'9:?-"9;Y9P?/CA(*!4QD$[5SG@8/6F/X?U_P#X1^;PBEM#_9\D
MK*NI></EMV<N5\OKO )7T[YKOJ*.9BY$-6-$14"C:HP/I532_P#CS;_KK)_Z
M&:NU2TO_ (]&_P"NTG_H9J2R[1110 4444 <GKFB:3_;N@G^R[+,MY)YG^CI
M\_[F0\\<\\UORR:=H.ERS.(+*QMU+N54(B#J3@5B>)M5TZRU_P /)=W]M ZW
M3N5EE52%\F09Y[9(%<\BR?%#61*X=/"%A+E%/']HRJ>I_P"F8/Y_RNUUKL1>
MSTW)=%L;CQ_K,/B?6(6CT6V;=I-A(/\ 6'_GNX]?0?Y/36?_ ".^K?\ 7E;?
M^A2UNJJH@1%"JHP !@ 5A67_ "/&K?\ 7E;?^A2TF[@E8VYD:2%T21HV92 Z
MXRI]1GBN=_X16[^WF^_X234OM)B\G?LA^YG.,;/6NEHI)V*:N-C5DB1&<NRJ
M 7;&6/J<4ZBBD,*1FVKG!/L!2T4 1+.&8@))P<'Y>E2U%#]^;_?_ *"I:F-[
M:E2M?01ONGZ4RW_X]X_]T4]ONGZ4RW_X]X_]T4?:#[))59)/+M$P,L> *9J$
MS0HI1L&JVGR-)< ,<A5X]JPJ5?WG(MS6-/W.9FC#'Y:\G+'DFDN?]0WX?SJ6
MJ5Y>11AH6$F_CI&Q'YXQ6DW&$+/0SBG*1=J*Y_X]I/\ =-);W,=R&,>_CKO0
MK_,4VZEC2"168 [3UJI2BX-IZ!&+4DBP.@HID<B2#Y6!Q3ZI.ZT):L12_P"N
MA_WC_(U+6?=QJM[9 # >1@PSU^0FKZJ$7:HP*B$FY27];(J222*>H_>L_P#K
MY7^1J[5+4?O6?_7RO\C5VE#XY?+\@E\*"BBBM2 HHHH **** "BBB@ HHHH
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MK06%II^H:2+5;:V2/SA<K('90!T'(Z9K?I/<:V"BBBD,**** "BBB@ HHHH
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M8_&M(22V1G4BY;NQ-X<\ V'E6NL>(!/JNM21+)(]^V\0L0"55/NC!]NU=N
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M+Z1X?U#48XUD>UMWF5&. Q52<'\JT*R?$]G/J'A75;.U3S+B>TDCC3(&YBI
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M'W_7V%35E6Z:29\+]C+[_P!U@KG\/QS6K54I.2Z?(5168C?</TJ.V_X]HO\
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M^02^%!1116I 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB86\2A&)90@^;@C!_G2PDJSB_;;E8R-",E['8O[U_O#\Z-Z_WA^=5?[*L/\
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MM2TR4QB)S*5$84[R_3'?/M0!A6'C+2=1O8+:$W*K=%A:W$L#)%<D<D1N1@\
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M)&&68#.WV)I#)!%&KNZQJ&?&\@<MVY]:CMK*TLE9;6UA@#G<PBC"[CZG%4=
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M1'*SHJ***S- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKC_B;HNH>(/ ]UI^F6_GW3R1,L>X+D!P3R2!TKL**:=G<35U8\TU-/''BK1?
M^$?.@0Z-:S(L5S>37:RG9W"JO<XJ#6?#.O0ZI;Z7:V=[>^'X;%+>SBMK\6R1
MR 8+38(9O7O]*]2HJN>Q/(GNSQ+5= U#PU\*]!DE(M/$6FWQ6S52&+M(Y&P8
MZY!!_"NFU+P@FG^"M&T7_A&VUI;?+3/#="&:*4\ET)QG+$]_2O0+BRM;N2%[
MFVBF>!]\1D0,4;U&>A]ZGHYV)4T<=X2T36H? USIFN32-<3B98DEE\UX8F&%
M1G_B(KA4TB]\6> ?"VFPV7GR:1J8MM2@9@/+6,D-G)'\)'YU[73(X8H2YBC1
M-[%WVJ!N8]SZFA3ZC<$]#F;WP'HP\-ZII>D6%KI\E] T1ECCYSVR>N,XXKD9
M=&\6:_HFB^%K[0TL+>PFA:YU#[2KHZ1\#RU'.2/6O5Z*2FT#@F>4_P#"-ZT_
MC6WOM*T&?09/MOFWUU'?*]O<0YR?W8ZLWT%:NA:-JEAXK\26-_HGVG1]8N6G
M-WYR[ A4_*4ZDGI7H-%/G8*"//?&/@.W7PA-I_A?2(8IIKJ&62.,A=P1NI)/
M8$U<\?6?B&[GTL:9%=W&F!W^W6]E<BWFDX&W#DCY<YS@UVU%+F8<B/%3X#\1
M+HFJVZ:88WN-9M[N*(W8E(B .<N3DD9P<UT_C'PEJFO^+9I;>(+:3:'-9^>S
MC"RLQ(!'7'2O0Z*?.]Q>S5K'D4FG>+=5TWPGI\WAIK5=%OK9IYFN$.\1\;E4
M'ICD_IFK<>E>*O#4'B#1-.T--2MM4N)9K:\%PB"+S1@B13SQ[=:]2HHY_(/9
M^9YMX;\%ZGH'B_0I&02V5EHIM9;@,,>:7+$ =<<^E9<W@S7W^%&K:*+'.H3Z
MF9XXO-7YD\Q6SG..@->NT4<[#V:V/.9=*\3:5XE\6ZSI>G+/-=VMM%8[I% 9
MU4*Q.3_#R>>N*IZ)8>++#PAJ6F6.@S6&L31-.VI3W<4C7%P2-W3H2,XSP,"O
M4J*.<?)YGDWA[PMKB^-M"UFXTJ^MX((I4N9+[41<2LY0C=C.%!/ Q^0HTSP]
MXEM_ 'B#PI-HI#L)GM[H7"%)V9P0H&<CC)R:]9HHYV+V:/,K?1?$7A;7+/7+
M'2/[36?28+.[M4G5)(9$51D$\$<5FCP/XB:WL+V:TC^VW/B1-4NH(Y5Q;Q\\
M9)^8C/:O7Z*.=A[-' :I!=:%XYUSQ9<Q!-+CT8(LVX?-(#G;CK6K\-],FTGP
M!I5O<*5F>,S.IZ@NQ?'ZUT\L,4\3131I)&PPR.H((]P:>!@8'2DY75BE&SN%
M%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 5=3_P"05>?]<'_]!->>?";6=,TSX7VCWVH6
MMN(WF9_,E (&]NW6O2Y$66-HW4,C JP/<&N9C^'/@Z.177P]9;E.1E,C\C5)
MJUF0T[W1YAHTU@/#.I3W]A>3V>O:X6TRRAE,!GZ_>;( 0YP<^GM3++0[C4KG
MQAH%E;#3VM88;VTLX;OSU@N%&?E;L6&01[^U>T:IX?TG6=/2PU'3X+BU0@I$
MRX"$<#&.GX53&A:5X<L+R[T;3[:SN%M2@=(^H4$C([\_C5^T(]F>>:/?7/Q'
MOI=7^TM8Q:5I)MTF?Y5CO9$.]_HH_I4WP_M;;P_XJM=(U#1D@U>6S9TU"UO6
MFBNU')9ESP3C@D5V?@[PU::9X,CT^?;>"[#37321@"9I.3E?I@?A5_1O">@^
M'YY)]*TNWM99!AG0?,1Z9/0>U)R6J!0>C.8M/E^*GBT2??;2X#%G^Y@@X_&N
M*\!:)XL\0_#5=+LM0TVTT6Y>6.1FB9I]I;YAZ<\UZGJ'AQ+CQEI^NQ7!BD2W
MDM;B+9D7$1Y"DYXP>>]:NE:18:)8K9:;:I;6RDL(TS@$]:.>RT'R7>OF>5Z?
MX>TF^\>ZAX<UYFDT_2+""/3K>:8HK)M&Z3@C+9[^_M6-I^G:KXC\.0V\$\6H
MV&FZM<1VUE>71C%] H&W#9^;;S[<U[%K7A70O$3QOJVEV]V\0PCNOS >F1SC
MVJ.]\'>'=1T^VL+K1[62UM01!&$VB,'KC&,9I\XG3/(-;BT'5_!GAV>UTN6Q
M2+75LI8);AG$8))=0V>5Z8/:O39=.\1:<UI:>%&T:+1(D "7/F._WB6PP/3F
MM>7PMH4^B+HLFEVQTU""MOLPH/J,=_>KVGZ?::5816-C D%M$,1QIT49S4N=
MRHPLSR_1/#ECXA^(GBV35)+F2&POHI88%F98P^"=Q ZGY<?B:Y7Q'=V$NGGQ
M1H.E3V['4@8=7N-1S-(V_E5BR3M]CVKW>TTFPL;R[O+6UCBN+Q@UQ(HYD(Z$
M_F:QSX \)F6XD.@61>X.9"8^ISGCTY],52FKDNF[:'!P^'M.\1>./'L>J1RS
MQVWEO"GG,JHQC/S8!QG@8-8V@2OXG/@?1-=NYGTR2SGE9#*4%Q(DCJJL0<G
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MQX$\+W=O;6\^BVLD5JA2%2#A%))('/J2:1_ GA>338].?1+4VD<AE2/!^5B
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BA5"J % P .U3*2:*A%IBT445!H%%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>img254193463_36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_36.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $' T,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKD[1M
M4\6"2]CU*;3='+LEJMJ%$UPJDCS&=@=JD@X &<8)/.*L?\(@?^AD\0?^!@_^
M)IV)OV.DHKF_^$0/_0R>(/\ P,'_ ,31_P (@?\ H9/$'_@8/_B:+(=WV.DH
MKF_^$0/_ $,GB#_P,'_Q-'_"('_H9/$'_@8/_B:+(+OL=)17-_\ "('_ *&3
MQ!_X&#_XFC_A$#_T,GB#_P #!_\ $T607?8Z2BN;_P"$0/\ T,GB#_P,'_Q-
M'_"('_H9/$'_ (&#_P")HL@N^QTE%<W_ ,(@?^AD\0?^!@_^)H_X1 _]#)X@
M_P# P?\ Q-%D%WV.DHKF_P#A$#_T,GB#_P #!_\ $T?\(@?^AD\0?^!@_P#B
M:+(+OL=)17-_\(@?^AD\0?\ @8/_ (FC_A$#_P!#)X@_\#!_\319!=]CI**Y
MO_A$#_T,GB#_ ,#!_P#$T?\ "('_ *&3Q!_X&#_XFBR"[['245S?_"('_H9/
M$'_@8/\ XFC_ (1 _P#0R>(/_ P?_$T607?8Z2BN;_X1 _\ 0R>(/_ P?_$T
M?\(@?^AD\0?^!@_^)HL@N^QTE%<W_P (@?\ H9/$'_@8/_B:/^$0/_0R>(/_
M  ,'_P 319!=]CI**YO_ (1 _P#0R>(/_ P?_$T?\(@?^AD\0?\ @8/_ (FB
MR"[['245S?\ PB!_Z&3Q!_X&#_XFC_A$#_T,GB#_ ,#!_P#$T607?8Z2BN;_
M .$0/_0R>(/_  ,'_P 31_PB!_Z&3Q!_X&#_ .)HL@N^QTE%<W_PB!_Z&3Q!
M_P"!@_\ B:/^$0/_ $,GB#_P,'_Q-%D%WV.DHKF_^$0/_0R>(/\ P,'_ ,31
M_P (@?\ H9/$'_@8/_B:+(+OL=)17-_\(@?^AD\0?^!@_P#B:C%QJ?AO4K."
M^O7U'2KR46Z7$RJ)K>4_<#%0 RL>,X!!(ZYX+=A7[G44444B@HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&[.+.<C_GFW\JF
MJ&[_ ./*?_KFW\J ,KP:,>"-!Q_T#X#_ .0Q6W6)X-_Y$C0?^P?!_P"BUK9D
M)6)V'4*2*;W$MAU%>1V_C;59].\(27^OKIJ:E;7,EU=+;QG+(P"  J0/P%:U
M]XRU#0?$E@LEP=3T'^SH[B\NA&JN@>1E6;"@94?*" .G-5R,GVB/1J*Y70_$
M\3C6IM6U*TBMH-4>VMI)72-2@1&4 \ GDFI+[QOI^G-JJ7-M=K-IZQOY>Q2;
MA)&"HT7.&!8X[<U/*Q\R.FHK#U_Q+%X>@%Q<Z?>RVZQF2::%4*PJ.N26&3[+
MD\50O?'VFV-Y>0M9WTD%DT(N;J.-3%$LH!1CELD?,,X!(HY6QN21U=%<+XA\
M;RI<0VVD07.V/5H+&XO3$IAR7 >,9.<X.,XQGO4OCG7KK2-9\/VJ:P-*L[UY
MQ<W/E(Y&Q 5QN! YX_&GRL3FCM:*Y&3QE8Z#;6T6H75W?&>V,]K>"% +P[L"
M- N!OY7 P,@Y]:6Z\?V-E<WL=QIVHK'82Q1WLXC0QVYD"E22&R1\P!P#CZ4<
MK#F1UM%8$OBRVM]<CTNYL;V!IC(L$TB+LF9%+$+AMW0'!( ..M4+#XB:5>0Q
M7$UK?65M/:27D,]S&H62., OC:Q.1GN!GMFERL.9'745P ^(!BU^:XOH+O3]
M&BT?[9Y=S$HD=C*%5AM)/((&TD<]0*O6_P 2-'N8&\J"YDO//2W2SB,<DDCN
M"5VLKE,85B3NXP<XI\K#G1V-%<9HOB+4=0\,^)M0FW13V5U=QVZ21J&B5%!5
M6 X)!^N:K6'Q#BMM$TYM1M;VZNSI,&I7DUO$FQ(WX9SR.A!. .G2CE8<Z.\H
MKD7^(6G113F;3]1CEBD@40M$N^19B1&ZC=C!(/&<CN*=:^/K&XO(;:33M1MR
M]Y]@DDEC79#<8R(V(8\D8.1D<CFERL.9'645R\7CK39K'3+M8+H)J,5Q+$"J
MY40@EMW/?'']*AMOB)I,MNUQ=6][8P?8?[0BDN8UQ+", E=K$YRP&#@G(Q1R
ML.9'745S_ASQ?IWB:6XAM \<]NJN\;NC?*V<'*,P['C.1W%8=GK.J:]876MG
MQ#;:'IRW4EO:I)#&RL$8KND9^Y(/RJ1QW-/E8<R.\HKD=1^(>B:3J?\ 9US,
M99(A$+B>-D"1E\;3@MN;.0?E#8!YJ2U\>:?<W\=O]BOHH9+V2P6[D11$9TW?
M+D-GG:<'&*7*PYD=517*:)\0=$U[5H]/LVDW3!S;R,R$3!/O8 8LOJ-P&1TK
M)USQ5=V/C=],OM5?1++$7V*5K,2Q79/WPSG[N#\H (QU)I\KO8.=6N>@T5QM
MOXO:UO-2@N/M&H3G57LK.UMX%1_EC$A7)8 @#)W$BFV_Q(L[N"W>WT;59))[
M>6Y2%4CW>7&^QB?GP.??FCE8<Z.THKF+KQQI]K9V>H&TO7TVZCBD^VJBB-!(
M0%R"P8G)&0 <=ZH?\)[):WOB9K_2;E+'1W51*FPDY53@_-U.[(XQCK@\4<K#
MF1VU%<QJWCG3=&FOXKB"[<V7V;S/*C#;O/)"[1G)Z<_IFJE]\2M(TQHX[VVN
M[>?R1//#+Y:/;H2<;E+@D\$[4W'':ERL.9([*N>\:?\ (!A_["%E_P"E,=;\
M;K+&LB,&1@&4CN#6!XT_Y ,/_81LO_2F.A;CELSH:***0PHHHH **** &R-L
MC9\9V@G%>?M\3POP['BP:2QS<_9_LWG_ .UC.[;_ $KOI_\ CWE_W#_*OGZ3
M)_9V7!P?[3Z_]M#5PBGN9U)-;'K>C>(/$]]J44&I>$'TZT8$O<F_CDVX!(^4
M#)R>/QIG@CQ[8>-8+D0Q&VO+5RLMLS[CMSPP/&1_(_A4^@:/XDT^ZDFUCQ.N
MJ6[0E5A%BL.ULC#;@3GC(Q[UYCX8\.WO_"#V'BSPZ@&N:=<7&^,=+R'S#NC;
MU.,X_P <8=DQ-R5CU3P[XG77[S68/LWV?^S;UK3<9-WF$=^@Q]*WRP&,D#/
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MF<U>U3PB;O79-6L=1-G/<1I%<!K:.8.$SM*[Q\K $C/(]N*Z:BCF8<J$4;5
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MHSD%3T88/Y?3-<K2)YDWJC=U/P?X=UF^%[J.C6=S<C \R2,$G'3/K^-9.K>
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ML>1ZM:>5HGPO:&VV.ES:[BD>"N47=G'3)ZUW/CW0)O$_@G5-)MF N)H@8LG
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M*6S.AHHHI#"BBD)"]2!]: %HIJNC_=96^AS3J "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***,CUH **,CUHR/6@ HHR/
M6C(]: "BC(]:,CUH **,CUHR/6@ HHS10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4-W_P >4_\
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MJ451@:D,GFQA\8SVJ2H+3_CW'U-3T >/:A\./%UY?ZEK\>JV\>IMJ\=];6>
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M'L!0!H_V=:?\\1^9H_LZT_YXC\S5JB@"K_9UI_SQ'YFJE[I\HV?8;6T?KO\
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M]*O56F_X_P"V^C_R%6:0PHHHH **** "H;O_ (\I_P#KFW\JFJ&[_P"/*?\
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M@*D(2"#BNDTGG1['_KWC_P#010!<KGO&G_(!A_["-E_Z4QUT-<]XT_Y ,/\
MV$;+_P!*8Z<=Q2V9T-%%%(845ROBBXULZG96&BW<$37,,BR[G4/"-\>9@"/F
MVJ6  [L.U6=&%YJOA6T,VH;[@.P-RC E@KD#.W +8 SCC.:=M+D\VMC8N_\
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MZ=-)/-+++$8G:./*G_@7X_G6A5:+_D(W/^Y'_P"S59I#"BBB@ HHHH ****
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MD F9F)"( IWJ?O #&,9- 'L'A0?$2_TE9O$%YI^G7?G,H@^R"1F0=R0^!W_
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MF5KJ SI_#%G&YNH&>W(KD+.30IY7DO=,>-)K:(&$,6"2?-O ^;W SWQ0%ST
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M-!_[!\'_ *+6M2Z=HX@5.#FF]Q1V)ZAO/^/*?_KFW\JI?:9O^>AJ.XN)3:S
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M,@4 +X%^'6I>'-1F\0Z'?V*6NIP*Z6,T,NR)6PP_BSD=.?4UWNSQ=_SWT/\
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M_P _,/\ WV* )Z*@^VVO_/S#_P!]BC[;:_\ /S#_ -_!0!/14'VVU_Y^8?\
MOX*/MMK_ ,_,/_?8H ;?_P#'L/\ KI'_ .ABK-4;RZMY(%5)XV8R)@*X)/S"
MK4_F_9Y/(V^;M.S=TSCB@"*+_D(W/^Y'_P"S59K+L[AX9I/M\D4<[1ID;@,_
M>_SQ5W[=:?\ /S#_ -]B@# \4:==WMQ;-;V[2JJ,"5(X.1ZFN:LM-GOS*(;;
MSEBE:"5<H=K X92,UW-[%H^H[/MAMIMF=NYQQGKWK-@\-^$;:_-];V5A'<D
M&1&QG!SD\XSGOUH%8Z&**.")(H8UCC0!51!@*!T %/J#[=:?\_,/_?8H^W6G
M_/S#_P!]B@9/4#V-I(Y=[6!G/5FC!)H^W6G_ #\P_P#?8I/MUH/^7J'_ +^"
M@!+;3[*R+&UL[> L26\J,+DDY).!W-6:@^W6G_/S#_WV*/MUI_S\P_\ ?8H
M;=?ZRU_Z[#_T%JLU1FN8)IK58YHW;S<X5@3]TU8NYI(+226*(RNHR$'>@!MO
M_K[K_KJ/_05JQ6=9WL>9FN2EO(S*QC=P"/D6K7VZT_Y^8?\ OL4 1W>FV][(
MKS-< J,#R[AXQ^2D9JCI?AC3M'BBCM6O-L;LZB2\E89)).06P1DFM+[=:?\
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M/PHNN_WLO5_F,ALM+MX1#'9D1B19-NXGY@NT'KZ"FV&G:5I<RRV=HT16,1*
MY*JN . 3@'"KD]3@5+M;^Z?RHVM_=/Y51E<N_;D_N-63?72MXDT=MIX6X_\
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M@F&YU"262UNXH)(T51%(WE2?-C&<C&!S^%1QR+8_#F.#5$U2ZE25\Q*9/-F
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ME,==#7/>-/\ D P_]A&R_P#2F.G'<4MF=#1112&%%%% !1110 4444 %%%%
M!17GOA]?#MS"E_KEU%_PD2W++.9[@I-%+YA 15R"%Z  #!'KDU:M/"VA1>/K
MH1:7;*8;."XC 'W9#))\P]^!S[57*3S'<45R.O3VLNDQ2>++>&W G*PV,=[N
M2Z8K\H;(3/4G!X&,D\5A7;S0Z-I&@+K.GP6LD4MQ+=74QDAD57XMU?<"P&X
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M6>X5+7P3?ZQJ31:AYD.^&:X"* 8GW.5R,D\ DYQVQS1RBYCT>BN>\7-HJZ=
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %0W?_'E/_US;^534C*&4JPR",$4 8O@W_D2-!_[!\'_ *+6MNN.TO5H
M_"%JNBZYYD%O;92SOBA,,T.?D!8#Y7 PI!QG&1G-7O\ A/O"O_0<M?S/^%4T
M[DII+4Z.BN<_X3[PK_T'+7\S_A1_PGWA7_H.6OYG_"ERL?,NYT=%<Y_PGWA7
M_H.6OYG_  H_X3[PK_T'+7\S_A1RL.9=SHZ*YS_A/O"O_0<M?S/^%'_"?>%?
M^@Y:_F?\*.5AS+N='17.?\)]X5_Z#EK^9_PH_P"$^\*_]!RU_,_X4<K#F7<Z
M.BN<_P"$^\*_]!RU_,_X4?\ "?>%?^@Y:_F?\*.5AS+N='17.?\ "?>%?^@Y
M:_F?\*/^$^\*_P#0<M?S/^%'*PYEW.CHKG/^$^\*_P#0<M?S/^%'_"?>%?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
4 !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>img254193463_37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_37.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $# JD# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSG75$/C]7F5
M0LOE>66C1\X/.-Q!7\!7HQ( )/05YOJ<D;^+GU..1'LCY8,T;QD J>=P8;AC
MVJH$3/2**R]3UVVTQ+=G5Y!/]S8.,8ZU0_X2Z#S GV63<6*?>&,KU_#T]:5F
M5=&U#_Q^W/\ P&K-4[5_,N[A@I .W&>_%7*0PHHJI<W:F&Y2WE0W$2Y(/8T
M&I3W$%H7MD5Y=P !]S5I-Q12PPV.15%#,\-DEP09C\SX]A5^@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%JFL3_$$1/H$)?R0YMHYQA2<8,C@]NP^M6K?7-6TF>UT^#2TNFGA\J>>-L)
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MQD^M/HH I-H^G.T[-90EI_\ 6DK]_P"M6HHDAB6.)%1%&%51@ 4^B@ HHHH
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MPI\C,L3LB[G"DJOJ?2L/2[O6IKR,7EMY<9!W?*,?7/KT&*+ ;U%%% !1110
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M(&>*-Q-I*[)J*KV-Y%J%E#=P$F*5=RDC!Q5BAJV@)IJZ"BBB@84444 %%%%
M!1110 45GZMJ?]EP1RF(R*S[6P>@^G>LG_A+EW%?LASNVYW\9QG.?3'&?7BG
M9BN=-15>VNQ<;?D9"45QN]#5BD,**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#FO&5CY^EM/$D/G\1F6:0JL:9R3U%'@5I&\
M,1>8J@B1AE3D'GKU--\>Q/+X:)4#]W/&[9*\ 'MN."?8U<\*;AH48=65@[9#
M*@(_!.*K[)'VB?6-&75UB#7,L7EG<-G0_6DCT\6-G;1>8S%90<]!R?2M-Y8X
MR [JN>F3C-5[IE>*%D8,ID7!!R#4E%JBBB@84444 %%%% !1110 5G7_ /R$
M]._WG_E6C6=??\A/3O\ >?\ E0!HT444 %%%% ')?#K_ )%J7_K]G_\ 0S76
MUR7PZ_Y%J7_K]G_]#-=;3EN*.P4444AA1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5YWK4L@\>K&\Q2)?*\M&D=!UYVA1@_C7HE>
M=ZTTC>.@TC-Y \HQE_,*]>=I4A1^-5#<B>QZ$T:.0656(Z9%-\B'_GDG_?(J
M*ZU"ULEC-Q,J"0X3/>JO_"0Z9D#[2,DXQ@YSW'X=ZDLLP_\ '[<?\!JU52V=
M7O+DJ01\O3Z5;H *J:F0--G! (9=N#[\?UJW5+4_F@BC_P">DJC]<_TIQW)G
M\++-O$L%M%$JA510  .!4E%97VG43XE-NJ1_V>L.YF_B#=J$K@Y*-C5HHHI%
M%+5K[^SM+N+L(SM&A*HHY9NP'XUR5CK^MVML+&XB9[Z,O([W*D%D"AN,>Y*_
MA797UY!864MU<G$,0W,0,UG+XETQC%N9T>1S&%=,,&'8U2]"7ON8UAKFHW%Z
MAF7S2UPVR",E2B^4& ;/!YZ55N[G7)+S6)X)+B*.VSDM("BKLSM5?[V>];,O
MB"X2\N;5=.5;@7"06^]^),@G<?08!K5TJ_&IZ>MP8O+8DK(G7# X//>G>W05
MKZ7.1@OYQ8W0L=7G>V&GB62YD.\PS>@)[GT[5UVBW)N]$LK@R>8TD"%G]3CG
M]:N".,(5"+M/;'%*JA1A0 !V%2W<:5A&17QN4''(R.E-\B'&/*CQT^Z*9=WM
MM8QB2YE6-&8*"W<FJ7_"0Z9R/M'/3&TYSZ?7'-(HMIQJ,G_7-?YFK-4X)8YK
M]VC8,#$IR/>KE !1110 449S10 4444 4M7FN8-(NI;--]RD9,:XSDUS":S'
M8644EAJ3W3SD>?+=N62$[2>0/NDD8Q7775S%9VLMS,VV*-2S'':LA?$ND&$,
MVZ,/)L*/'@[N#R/Q!JD2S'/BO6'Q(EC#'&0QV.&W?*NX_GVJM:^(]0*&*0F;
M,S-\A(>(;N WL:W+GQ#-#?W=H+ ;T:)+<L_$I<XR?0"M+2+W^T+1Y'@6*:.5
MH95'(W*<'![BG\A;]3F9?%^H6]J6GMX1*R)-& K88'.4^O%,'B/4HVDFD E9
M9GV1)D>4NP$;QW SG\*[<HIQE0<>U+M7).T9/7BE==A\K[G&KXJU-BQ2WMY8
MH,%Y4W8F!?;\E=G2!% P%  [ 4M)L:304444AA1110 4444 %%%% '$?$/5K
M2"UCTVYB<JZ_:&E254:,*< J#]YL]JUO!4:IX<C9>?,<ON,HD9O=B.,XQP.E
M0^++ZPL3#)?Z9;7BE&\MI%#,C=N",[?<5=\*RO/H,,KV,%EN)*QP !"/4#M5
MOX2%\1/K&DG5EBC,WEQH26 7)/ISVIL>GK8VEO%YC.4E!ST&2?2M0D*"20 .
MI-5KEUDBA9&#*9%P0<@U!5BU1110,**** "BBB@ HHHH *JWEA#?!/-+@H25
M*-M(JU10!F?V';_\][K_ +_&C2$\IKN'>[+',0N]LG%:=9VF_P#'S?\ _7<_
MRH T:*** //?!/A^UO\ 0YYY)[Q&-[/D1SE1]_TKI/\ A$K+_G[U#_P*:J/P
M[_Y%N7_K]G_]#-=96CG)/<Q5&F]6C!_X1*R_Y^]0_P# IJ/^$2LO^?O4/_ I
MJWJ*7M)=Q^PI]C!_X1*R_P"?O4/_  *:J]G8+I?BN*W@N+EXI+9F99I2_((]
M:Z:LS4=#M-3N8[B9IDEC4JK12%.#]*:F]I,B=%*S@M33HK#_ .$5LO\ GYOO
M_ EO\:/^$5LO^?F^_P# EO\ &E:/<OFJ?R_C_P  W**P_P#A%;+_ )^;[_P)
M;_&C_A%;+_GYOO\ P);_ !HM'N'-4_E_'_@&Y15'3M*ATW?Y,D[[^OFR%_RS
M5ZI=NAI%MK4****0PHHHH **** "BBB@ HHHH ****  C(P>E>?ZG)X?L/$#
MZ9+:W6&"N8UNF5'9F P$SD]<\5Z!7G>MSL_Q!C628#R?*\H&98B,GG /+542
M)[';W>DV-ZD2SP*XB&(^2-M5O^$;TS<&\EMP.<[SG)ZG\>]:I95QD@9]32>8
MG]]?SI795D5[<!;RX &  H'Y5:JM#_Q^W'_ :LTAA5*\^>^LH_\ :9_R'_UZ
MNU2/SZRO_3.'/YG_ .M31,MB[5*R^>ZO)O638/\ @(Q4'B'61H6DO?&$R[6"
M[0<=34NG.L.D1SS'9N7S7SV)YIV?+<ER3GR]M2_16)9W%_#/?W^HRHFFX#0*
M1\RKW)K6MKF&\MH[B!P\4@W*P[BAQ:'&:D-O+2&_M)+:X4M$XPP!Q44.E64+
MR.L",SR&0EQN(8]QGI5RBI+L8\OAJQFN+F=WN#).RN3YGW&7H5]*T;.SAL+6
M.VMUVQH, 9R?J:GHIW%9!1112&5;[3K348UCNX5E53N /8U3_P"$;TW.?*?=
MG.[><YZ9^N./I6J2JXR0,^II/,3'WU]>M.[$5H8UBO3&@VHD2JH'8"K=5E_Y
M",G_ %S'\S5FD,*"<#)HJKJ,_P!FT^:7&2%P!ZD\"IE)13;Z#BKM)%3184@M
MII1<&42R,YW-G;[5H6]S#=PB6"19(R<;EK,LM.BTC1Y@ 2TBEW!/<CH*M:3I
M\>F:?';QYQ]XY]3UKFP_/%1A:RMK^GZF];DDY2O=WT+U%%%=9SD-U;17EK);
MS#,<B[6&>U00Z38PM(PMT8R,'.\;N0 .,^P%7:* L9$_ANQN;RXNI6G,DZJ&
M_>8"[3E2OH15ZQL8-.M5M[<$("22QR6)ZDGUJS13N*R"BBBD,**** "BBB@
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MRQR[O+D5]IVMM.<'T- #Z*9)-%#M\V1$W'"[F R?:ECD26-9(W5T;D,IR#0
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M(07*C=@8YQS4E%%0:!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5YSKC_9/'PD=F"S&$#9)L&<_Q?(<_F*]%)P":\Z@O&\17
M4%S>Z5K3#S]A\A@+9MCD!L=<<#-5$B9VNK:D^FK"RP^:)&*D9Y'!(K('BJXW
MA?L/5BN[)QQWZ=#VKIRH.,@''3-&Q?[H_*EH45+5F>[N&9-N0N!GVJGX@M6U
M.T33(YWADG8$NAP54<G_  JZCK'=73NP5%"DL3@ 8KD_$NI2OILTUG.4EF*A
M)5; CB!ZD_[1JZ<6Y*QCB)QC!W)('$GC0-:VDDK0VWDQS[L1C'!SQUK,F#:E
MXAUNRO[V1[6-5,@Y$<?'+?AV%7)9H;2\@D.J?8P;<*MLC8&.[M[]\=:Q].U'
M1K?5]<>9G-DRJ?+R6,_U_&NF*>Z[?J<$Y+2+?5_E_6YU^E2V&DZ"+\RXM%C"
MPLQR=@Z#ZDUIZ-"\=@)9?]=.3-)]3SBN-U.[M]3T"*1K.[@T>/;Y4$*?,YSU
M)Z "NSL]2L)3%:0SKYOEAA$3\P'N*PJ1:5SKHS3DET25OG_6A?HI&944LQ"J
M!DD]JJ7NJ66GVGVJYN$2'C#9SG-9)-['4Y)*[+A( R>!7/?:QXBN[W3&A=+*
M+"R2?\]@>P/I5_$FHKYD@:.SQD(/O2CW]O:J=AXCM[C2;Z\-G+:QV<C1F.0
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M9&6.S^\0.@]ZL7^N6&G002RRE_M'^I2)2[2<9X [8KE[;2=:M+2TE33D>?\
ML\V$D+2K\ASD/GH5YZ=:NMHNH:5)HUY9Q+>O8VIM982X4D$#YE)XZC\JJR%=
ME^;Q=I5NL)D><>9&9<>2V40'!+#' %;,<\4RJT<BL'4,N#U![UQVK^']8UR[
M%X2;)S9-&T2395SO!\M_52 0<5:TG2+VU\2_:UM!!;218E61PVP@8 C(/ ]B
M*5E8$W<Z+4/^0;=?]<7_ )&N+^#W_)/X/^OB7_T*NRU618=(O)'SM6!R<#)Z
M&N)^#4\<W@&,(22EQ*#E2.IS37PL'\:/0:***@L**** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
2HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>img254193463_38.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_38.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %" K8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^N2^(/C4
M^!M$M]16P%[YMP(/+,OEXRK'.<'^[^M=;7D_Q_\ ^1)L/^P@O_HMZJ"O))D3
M;46T8?\ PT1)_P!"RO\ X&__ &%'_#1$G_0LK_X&_P#V%>(45T^RAV.7VT^Y
M[?\ \-$2?]"RO_@;_P#84?\ #1$G_0LK_P"!O_V%>(44>RAV#VT^Y[?_ ,-$
M2?\ 0LK_ .!O_P!A1_PT1)_T+*_^!O\ ]A7B%%'LH=@]M/N>W_\ #1$G_0LK
M_P"!O_V%'_#1$G_0LK_X&_\ V%>(44>RAV#VT^Y[?_PT1)_T+*_^!O\ ]A1_
MPT1)_P!"RO\ X&__ &%>(44>RAV#VT^Y[?\ \-$2?]"RO_@;_P#84?\ #1$G
M_0LK_P"!O_V%>(44>RAV#VT^Y[?_ ,-$2?\ 0LK_ .!O_P!A1_PT1)_T+*_^
M!O\ ]A7B%%'LH=@]M/N>W_\ #1$G_0LK_P"!O_V%'_#1$G_0LK_X&_\ V%>(
M44>RAV#VT^Y[?_PT1)_T+*_^!O\ ]A1_PT1)_P!"RO\ X&__ &%>(44>RAV#
MVT^Y[?\ \-$2?]"RO_@;_P#84?\ #1$G_0LK_P"!O_V%>(44>RAV#VT^Y[?_
M ,-$2?\ 0LK_ .!O_P!A1_PT1)_T+*_^!O\ ]A7B%%'LH=@]M/N>W_\ #1$G
M_0LK_P"!O_V%'_#1$G_0LK_X&_\ V%>(5N>#=)MM=\8Z7I5YO^S74WER>6VU
ML8)X/X4.G!*]@56;=KGJ?_#1$G_0LK_X&_\ V%'_  T1)_T+*_\ @;_]A61I
MO@/1;N.&XN]-O-)DF@O1]BOYV)'E("DX.U6"Y.""*Y(>!+D:K;V,FKZ8@NK>
M*XM9RTA2X60X7: F[KUR!CO4J-/L6Y5.YZ)_PT1)_P!"RO\ X&__ &%'_#1$
MG_0LK_X&_P#V%><S^ M5M=+:\N)K:-_M4EI';Y9GEE1]A4$*5!W= Q!-)XE\
M!:OX6L4N[UHI(O.^SR&-7'ER8SM^90&& ?F7(XZT^2F3SU#T?_AHB3_H65_\
M#?\ ["C_ (:(D_Z%E?\ P-_^PKSZY\/Z(OPUBURSNKF;4?MR6UP7&R*/<A8J
M!U.,#YJSM;\+SZ-I5MJ8OK.]LYY6A$MJ7(610&*_,HSP>HR*.2'8?/4[GJ7_
M  T1)_T+*_\ @;_]A1_PT1)_T+*_^!O_ -A7&ZEX&BDEDBM;JSL(M*L;1M0N
M;IWQ)+.-VX!0>A8+@#M6&O@[4O\ A*;[P](\$=Y9QRR2,S'81&F\X(&>1TX[
MT*%,'.IW/3O^&B)/^A97_P #?_L*/^&B)/\ H65_\#?_ +"O.K7P)>W%@M]+
MJ-A:VO\ 9\>H/+,SX2)W9!G"DYRO0>HHL?![+\0;+PSJMU%&DTT8,\3%ED1P
M&4H<?Q C&1U/.*.2F'/4/1?^&B)/^A97_P #?_L*/^&B)/\ H65_\#?_ +"N
M!C\ 3W=PWV75]-$$UXUG8O*TB_:I1R47Y.",@$M@9Z&LS0/#4VJ:E=)=B2WL
MM.!DU"54W-$JG!4#NY/R@>OL*.2F'/4/4?\ AHB3_H65_P# W_["C_AHB3_H
M65_\#?\ ["N8U3PAX>T"XU*[OX-0FL%U.+3[2!)@C@-&)&D9BIS@'@=S69XQ
M\*VF@:5B')N;'5)]/GDS_KUVK)&Y'8[200/2DHP?0;E474[K_AHB3_H65_\
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M*DH[^;_S.X_X6*W_ $#!_P!__P#[&C_A8K?] P?]_P#_ .QKAZ*G^UL9_/\
M@O\ (K^SL-_+^+_S.X_X6*W_ $#!_P!__P#[&C_A8K?] P?]_P#_ .QKAZ.U
M']K8S^?\%_D']G8;^7\7_F>V65Q]KL;>YV[?-C5]N<XR,XHJ'1_^0)8?]>\?
M_H(HK[*FVX)OL?,324FD7:\G^/\ _P B38?]A!?_ $6]>L5E:_I&FZS91V^I
MV,%Y"L@=4F3< V",_7DUK!VDC*I\+/C&BOJW_A!/"7_0MZ9_WX%'_"">$O\
MH6],_P"_ KI]H<?*?*5%?5O_  @GA+_H6],_[\"C_A!/"7_0MZ9_WX%'M Y3
MY2HKZM_X03PE_P!"WIG_ 'X%'_"">$O^A;TS_OP*/:!RGRE17U;_ ,()X2_Z
M%O3/^_ H_P"$$\)?]"WIG_?@4>T#E/E*BOJW_A!/"7_0MZ9_WX%'_"">$O\
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MFR0S+#)N.\,WF@(ZC<&) /SYX]*](\F+_GDG_?(H\F+_ )Y)_P!\BES,.5'
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M_?(H\F+_ )Y)_P!\BB['RH\Q7P<YA=)=29B\3*[!2"9/NH_7M'\N._6IU\+
M7$,QDBPOWX@\FT'>&W+\V<\=^*]'\F+_ )Y)_P!\BCR8O^>2?]\BGS,7*CS:
MU\)K;6:VTTZW$.2T@*_.Y,3(5!)X'(*CMS6KH=G/9:7&MX_F7LG[VY?^\Y_P
M  _"NT\F+_GDG_?(H\F+_GDG_?(I-MC44CG**Z/R8O\ GDG_ 'R*/)B_YY)_
MWR*0SG**Z/R8O^>2?]\BCR8O^>2?]\B@#G**Z/R8O^>2?]\BCR8O^>2?]\B@
M#G**Z/R8O^>2?]\BCR8O^>2?]\B@#G**Z/R8O^>2?]\BCR8O^>2?]\B@#G**
MZ/R8O^>2?]\BCR8O^>2?]\B@#G**Z/R8O^>2?]\BCR8O^>2?]\B@#G**Z/R8
MO^>2?]\BCR8O^>2?]\B@#G**Z/R8O^>2?]\BCR8O^>2?]\B@#G**Z/R8O^>2
M?]\BCR8O^>2?]\B@#G*MZ9_Q^C_=-;'DQ?\ /)/^^12K%&IRJ*#Z@4 <IXKT
MZSU;Q'X;L[^VBN+>1[G='*@8?ZDX.#W'K7+>,_#>D>&-)TJRT>QBM8=\A;8/
MF<X7EF/+'W-=GK?_ ".'A?\ ZZ7/_HDU@?%+_4Z7_OR?R6M*7QHSJ_ SSFBB
MBNLXPHHHH **** "I(();F=(((VDE<[41>K'T%1U>T:[BT_6K.\FW>5#*';:
M,G'M0P6X3:-J=O)%'+87"R39\M=F2V.H '<>E.CTFXCNH8]1233X9"<S7$3*
M, 9.!W/M[U-'JR0Z4D*J)+A+U[C$J;D*E,<\]<TT:A!J%W NII'!:H27-G
MY]NO_P"JIU*T+*:#;7(M;BUO9!92K*\DD\05XQ'@L< D'J,<]>*IW]A;PV5O
M?65Q)-:S.T9\U CHZX)! )'(((K2;5K"/41()YIK.2![5X$@\H0Q,.-GS')!
MYYZ]^M9]_=V:Z9;Z;8O-+$DK3R32H$+N0  %R<  >O>DKC=C,HHHJR HHHH
M**** "M_P3_R..G_ .\__H#5@5O^"?\ D<=/_P!Y_P#T!JF7PLJ'Q(]IHHHK
MB.X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]H?^07_PK:U#_D&W7_7%_P"1KY^3[B_2M:<%+<RJU'&UCV?_ (3OPY_T$/\
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M=P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6M?Q#_R/7@__ *ZW?_H@UD_%%6:'2]JLWSR=!GLM<U+XT=57X&><44[RY/\
MGG)_WR:/+D_YYR?]\FNLXQM%.\N3_GG)_P!\FCRY/^><G_?)H ;13O+D_P">
M<G_?)H\N3_GG)_WR: &U=T>SCU#6;.SF+".:4(Q7J![54\N3_GG)_P!\FI;=
M[JUN([B 2QS1G<CA#D'\J3V&MS8.F:7<6]M<V[7,,+7+VT@FE3)PNX,&( 'T
M--G@M](O+2?3BMW.6(6.22.8;L<':AZY/&:R3)=-;?9CYIA\PR[-AQO(P3T]
M*=9SWFGW2W-IYL4R9VN$R1GCN*5F.Z.HAN3-=117,B7NKV-I<3%R V), JA/
M\17D_7CM63J,\M_X;LKZ\;S+K[3)"LS#YI(PH/)[X)(_&JLNK:M--#,\THDA
M;=&Z1!"I]?E J&]O+_49%>[>:5D&U<I@*/8 8%)1&Y%2BG>7)_SSD_[Y-'ER
M?\\Y/^^35D#:*=Y<G_/.3_ODT>7)_P \Y/\ ODT -HIWER?\\Y/^^31Y<G_/
M.3_ODT -K?\ !/\ R..G_P"\_P#Z U87ER?\\Y/^^36_X*1QXPT\E' W/R5/
M]QJF7PLJ'Q(]GHHHKB.X**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I"0H)8@ =2:6LOQ+_ ,BQJG_7K)_Z"::5V)NR+_VJW_Y[Q?\ ?8H^TV__
M #WB_P"^Q7SWM7T'Y4;5_NC\JW]AYF'M_(^A/M-O_P ]XO\ OL4?:;?_ )[Q
M?]]BOGO:O]T?E1M7^Z/RH]AYA[?R/H3[3;_\]XO^^Q4BNKKN1@R^H.:^=]J_
MW1^5>Q^ !CP=:8_O2?\ H9J)T^57N7"KS.UCIJKW_P#R#KK_ *Y/_(U0UKQ#
M#HL]G UE>WD]V7\J*TB#M\H!8G)&!R*YJ\\?ROK8T0^%]:1;BT:3SGA \OJ,
ML 2 OOG\*R1JSS%/N+]*=2*/D4#K@"NIFTW3CJ%[HD=IMFM;=G6[\QBSR(NX
MY'3:>1C''%=S=C@2N<O16KH=A!<SI<WP/V)94C*@X,SL>$'\R>PJY<6UAI4%
MS=RV*W6Z_EMXHG=E5$3J>#DGD 4<VM@Y=+G/5ZO\-?\ D6)/^OI_Y+7F^M64
M6GZM+! 6,)"R1[CR%90P!]QG%=EX(UX:9H3P'2]4NLSLWF6MJ9$Y XSZ\5G5
M=X&M)6F=+XF_Y"GAC_L*?^T):WVAB:9)FB0RH"%<J-R@]0#VZ"N/O=3FUS6=
M!2#1M7A6WO\ SI9+FU,:*GE2+DDGU85V=<IU'SU+_KY?]]OYUJ+JUE)8V5O>
M:6;AK1&1&^TE P+%N0![^M9<O^OE_P!]OYTRNZUS@O8V5U_S9=0:^M!/'>)&
MACCD,0C5#E0O!X' J(ZP+>U,&F6[60:997D\TN[;?NC.!P#DX]:RZ*.5!S,M
M:C=I?WTETMNL!EPSHARN[N1Z9/.*]!^%W_(/U'_KNO\ Z#7FE>E_"[_D'ZC_
M -=U_P#0:BK\!I2^,[VBBBN0ZPHHHH **** .9_X0R%)IWM];UNV2:9YVBAN
M@$#.Q9L#;QR32_\ "(-_T,OB'_P,'_Q-=+10!S7_  B#?]#+XA_\#!_\31_P
MB#?]#+XA_P# P?\ Q-=+10!S7_"(-_T,OB'_ ,#!_P#$T?\ "(-_T,OB'_P,
M'_Q-=+10!P-[\/G36O[;_P"$FUIA;VC1^2T^3)U.&..5YZ8_&O-%^XOTKZ U
M#_D&W7_7%_Y&OGY/N+]*Z*&S.:ONBS96<NH7L5K %\V0D+N.!TSU_"F2PB/!
M66.48R3'DA?KD"KN@W4-EKEK<W#[(HV)9L9Q\I'058T^\@L;UKBXEMYHO)9&
MMX(RJSY_@;Y0 .^?:MFW<Q21D"&0@XB<C&3\AI/+8)O"-L)QNV\9^M=?]NB5
M(+W^U7%N-4>8DHP:10B';@#&0/EQTJB=0TX:;<I'/)F: A87+'8YD#;0N-H
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MFN;F*"/&^5U1<G R3@?SI>QCW#VTNQ[7_P );X?_ .@M:_\ ?='_  EOA_\
MZ"UK_P!]UXG*AAFDB;&Z-BK8Z9!P:;FG[%=Q>WEV/;O^$M\/_P#06M?^^Z/^
M$M\/_P#06M?^^Z\66WE:T>Z"_N4<1LV?XB"0/R!JQ9:9-?1RS"6"""(A7FN)
M-B!CT&?6E[&/<?MI=CV'_A+?#_\ T%K7_ONC_A+?#_\ T%K7_ONO%[RTFL;R
M6UN%"S1-M8 Y'YTZ2SECL(+UMODSNZ)@\Y7&<C\13]C'N'MI=CV;_A+?#_\
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MZ*2N5&LV['M-%%%<YT!1110 4444 %%%% !1110 5%<7$-I \]Q*D42<L[G
M'U-2US_C?_D3M1_W%_\ 0UII7=A2=E<N?\))HG_06LO^_P O^-'_  DFB?\
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M* "BBB@ HHHH **** "BBB@ HHHH YS6_P#D</"__72Y_P#1)K ^*7^ITO\
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M (FL+XR^+];\)V>D'1;I;=KJ2596,2N2%"D8R..IKQ6Y^)/C.ZSYGB.]7/\
MSR81_P#H(%:14Y*]S*;IQ=K'T/\ \*TT7_GXOO\ OXO_ ,36]I\&F^&],CL1
M>(D,9)!N)5!Y)/MZU\A7/B#6KPDW.L:A-GKON7/]:SV)<Y<EC_M'-4Z<GNR5
M5BMD?8EUXW\+66?M'B'34(["Y4G\@:QKGXN^![8?\AM)3Z0PN_\ ):^4P .@
MHH]B@>(?8^E+GX\>$8<^3'J,Y[;8 H/_ 'T16/<_M#:<N?LOA^[D]/-G5/Y
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M^'V@CN%%[!)>6T7G3VJJVY%XS\W0D9&14S>&E6_GM/[3@:2W0O-LB=BO3
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MOH6W_P"/:+_<'\J^>F^Z:^A;?_CVB_W!_*L:_0WH=22JU_8V^IV4MG=(7@E
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M\,=M-"EPMU&EQ%O$<JC 9?PZCH<#CBCWK!>-S;O/!RS:VUM!=16\][/=&PM
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M9-IXC0^TUKC]0U>ZT4_:2[DNE#L?-6K? WQ'I=A<7HO].GBMXFE?#.IVJ,G
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M1UZ5;JO8V4.GVHMX PC!+#<<GDY/\ZL5T4^;D7/OU,)\O,^78****LD****
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MY, 'N<>XXJ^2NZ=I/6ZVTT(YJ*GHM+>NIF:?K,Z7,L5U'))"]^]O'/N&%/\
M"N.N/>NBK,CT*SCO/M(,S$3-.(VD)02'^+'K6G6F&A5C%JH[D5Y4Y.\$%%%%
M=!B%%%% !1110 4444 %%%% !1110 4444 %%%% #)8DFC,<@RK=0"1_*JW]
ME6?_ #S;_OXW^-7*P]>\0RZ/>Z=96VF2W]U?M((XXY4CQL7<22Q Z5+IQD]5
M<:FXK1FA_95G_P \V_[^-_C1_95G_P \V_[^-_C6$GC[1I=!&HQ2J9S$T@L9
M)4CF.TD$8)P,%6YSCBM&;Q7X?MGFCN-9L(9(/]<CW"@QG."",\<\4O80_E7W
M#]M+^8N?V59_\\V_[^-_C1_95G_SS;_OXW^-1-X@T=;MK0ZI9_:%B\XQ><N[
MR\9W8STQS].:CA\3:'<17$L.KV4D=LGF3.LZD(OJ3GIQUH]C#^5?<'M9?S?B
M6?[*L_\ GFW_ '\;_&C^RK/_ )YM_P!_&_QJV"" 1T-+2]E3_E7W#]I/NRG_
M &59_P#/-O\ OXW^-']E6?\ SS;_ +^-_C5RBCV5/^5?<'M)]V4_[*L_^>;?
M]_&_QH_LJS_YYM_W\;_&KE%'LJ?\J^X/:3[LI_V59_\ /-O^_C?XT?V59_\
M/-O^_C?XU<HH]E3_ )5]P>TGW93_ +*L_P#GFW_?QO\ &C^RK/\ YYM_W\;_
M !JY11[*G_*ON#VD^[*?]E6?_/-O^_C?XT?V59_\\V_[^-_C5MF"J68@ #))
M[4*RNH96#*1D$'(-'LJ?\J^X/:3[LJ?V59_\\V_[^-_C1_95G_SS;_OXW^-4
M++Q'!?2W;HB+96LDD4MPTRC8Z'!#+U7D'&?3W%$_BC3X[W3K6"5)VOF<(RN
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MM@EU]ICG\P(T4<<@)D5F"@CVR?TIVJ:V^GWR6D-DUPYMI+ICYJH%1"H/7O\
M,/\ &CV,/Y5]P>UEW+G]E6?_ #S;_OXW^-']E6?_ #S;_OXW^-8@\9P,)+A+
M*4V$0MVDN"P!43*I4[.O&X9_K3[WQ:-/CG:YTVXC*V\MQ"C,H:58V56R/X?O
M*1GL?PH]A#^5"]M+^9FQ_95G_P \V_[^-_C1_95G_P \V_[^-_C5>VU=VU--
M.O;1K6YDC:6'YPZ2*I ;!'<9'!'>M2E[&G_*ON*]I/NRG_95G_SS;_OXW^-'
M]E6?_/-O^_C?XU<HH]E3_E7W![2?=E/^RK/_ )YM_P!_&_QH_LJS_P">;?\
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MEA&8$9=LDBW"N#DD[B4#?,V.I' H]C2[(7M:G=G90V=A,90L,J^6^PERZ@G
M.02>1SU%2-IMBH)9" !DYE;I^=<E<>&M1FOIIV@D^Q/<2L+2)XL@-%$JMA\K
MP4=?49R*FM_"UU&2[P*TQU'>999 SM;F (0Q[Y/4=^N*/84NR^X?MJG=G1VU
MKIEY;17%N?,AF4/&ZRMA@>01S4W]EV?_ #S;_OXW^-<CIOAW4;-M!>*Q6"2T
MAB@N$?RGA*J3N=<'<KGJ".O ;I5C7?#VJW&MW%S8;?("I?1@R[=UY&-J*1_=
M9<9/M1["G?9?<'MJEMV;4RZ3;3&*</%\T:!G9PK,Y(50V<$Y'0=.*?9PZ7?Q
M/);!G5)'B;YW'S(Q5NI]0:Y5_"5^(T,EI'=;#8S.CNI\QTDD>;&[C^/OUK1T
MGP[<V.HVEW]FCB?[;>23LKC)CD9B@..O\/';%'L:79?<)5:G=G1?V59_\\V_
M[^-_C1_95G_SS;_OXW^-7**GV5/^5?<7[2?=E/\ LJS_ .>;?]_&_P :/[*L
M_P#GFW_?QO\ &KE%'LJ?\J^X/:3[LI_V59_\\V_[^-_C1_95G_SS;_OXW^-7
M**/94_Y5]P>TGW93_LJS_P">;?\ ?QO\:MHH1%11A5&!2T5481C\*L)RD]V%
M%%%42%<[XC\*P^)-4T>>[*M:633-+"2RF3>FT8*D8P>:Z%F5%+,0 .I)J/[3
M!_SVC_[Z%-.PFKG)7_@99HM:AL7MK6&^L8+.W18N(1&6/;L=W2HG\"2OJ0NV
MN;<C[9>W)!B))$\>Q1]1WKLOM,'_ #VC_P"^A1]I@_Y[1_\ ?0I\S%R(\[C^
M'&K>;;?:-:BEAM8##"FQ@%!MC"1MSC@G.<9(XS6A?^#'GO/"UNB'R+* 0W\L
M>%26*,*RQD=3F15(]@WK7:?:8/\ GM'_ -]"C[3!_P ]H_\ OH4<[#D1+147
MVF#_ )[1_P#?0H^TP?\ /:/_ +Z%242T5%]I@_Y[1_\ ?0H^TP?\]H_^^A0!
M+147VF#_ )[1_P#?0H^TP?\ /:/_ +Z% $M%1?:8/^>T?_?0H^TP?\]H_P#O
MH4 2T5%]I@_Y[1_]]"C[3!_SVC_[Z% "W$$=U;R03+NCD4JP]0:;:VL-E:QV
MUNFR*-=JKG.!2_:8/^>T?_?0H^TP?\]H_P#OH4N57YK:CYG:W0Y>Z\*WDVKR
M:M;R6-EJ 1T%Q;Q$-.&(P)0>#@#@\\\^U,M_!DX=C<7P99&O#)MR6Q.JKPQ[
MC:>:ZO[3!_SVC_[Z%'VF#_GM'_WT*OF9'*CE8O"=U#;6VQ[5;FVEMV5]TC"5
M8MP ;<3M'S$@#I[TD7AF[-YKDD;F&.Y?R;4.?]5'(5:=EQ_>;<1GN!75_:8/
M^>T?_?0H^TP?\]H_^^A1S,.5%&]TGS[O2)(62**PF+[,=5\MD 'I]X?E6-<>
M$KF:)K7[5"+9)KFXA;8?,+S+(,,?0>8WN<"NG^TP?\]H_P#OH4?:8/\ GM'_
M -]"E=CY4<C)X)D:&^@$L+I<B5TDD:0M%(\13(7.WN>>N#CWJY?^'-0NI;.*
M.^BCL;9K9UA5"N#$X8C Z@X&,],=*Z+[3!_SVC_[Z%'VF#_GM'_WT*.9BY4<
M?%X,OCI]G:SW=L#90+!$T<;?./.CD8MD^D0 'J2:DD\&W924QWD/F&- F4.-
MRW1G&?;D+^M=9]I@_P">T?\ WT*/M,'_ #VC_P"^A3YF'*C TS0I8?%E_J4R
M[8-JF"/C;YSJ/.=>_.U!SW#>M4M8\):GK%U</-J41C:.XBA4H<*LJ@ ;1QQC
MD\Y]JZS[3!_SVC_[Z%'VF#_GM'_WT*7,PY4<_/X<NAXA_MBVG@\Q7!6.13MQ
MY6P]._0@^F1WJ2#PW)'H&B:9)/&YT]XC(Q3Y90JD$ =LYK<^TP?\]H_^^A1]
MI@_Y[1_]]"B['RHY[3_!\6E:A83VUR[K;R3.YF^9V#($10?1%  ]AZT2>'+M
M=,MX(;B S0:H]^"X(5@9'?;QR#A\9]JZ'[3!_P ]H_\ OH4?:8/^>T?_ 'T*
M.9ARHS;/2KI+Z^U*YGC^W7,20H(U)2%$W%1SRQR[$GCTK&M/">HC5[?4;[4(
MII4E@D<;2<^6DRG'89,N< 8&*ZO[3!_SVC_[Z%'VF#_GM'_WT*+L.5''MX,O
M4M;JVAO+;9=B,2LZ-E-DS2#;ST(;'L>>]:FO>%HM?OTEN)-L2VDL"[1\R.S(
MP<=N-G0]<^E;GVF#_GM'_P!]"C[3!_SVC_[Z%',Q<J,'3_# &H7%]JIAN9Y?
M(8+&&6-7C0+G9G'49&1Q5"7PMJM[;ZP;ZXLY;V_C:)+@;\0Q@Y2-5[*.IYR2
M<^F.M^TP?\]H_P#OH4?:8/\ GM'_ -]"CF8<J,R'3+NXUF#4]1D@#6T3QP0P
M9(!?&YB3U.%  QQSUK8J+[3!_P ]H_\ OH4?:8/^>T?_ 'T*15B6BHOM,'_/
M:/\ [Z%'VF#_ )[1_P#?0H EHJ+[3!_SVC_[Z%'VF#_GM'_WT* ):*B^TP?\
M]H_^^A1]I@_Y[1_]]"@"6BHOM,'_ #VC_P"^A1]I@_Y[1_\ ?0H EHJ+[3!_
MSVC_ .^A1]I@_P">T?\ WT* *&N:A/IT=BT 3,]]# ^X9^5FP<>]-NO$-K:7
MLUG)%-]HC:%40*,R^:2%*\\@$-GIC::DU.TLM5@BBENC&8IDG1XI%#*ZG(/.
M15-M(M9-=L-2GO$F>RADCC9RN]F<CDD8&  0..YIJQ+OT*T?CBQ>%9C97J1-
M"MR794XA9MN\_-V/;KCG%5]6\:K!HUQ<VEK/'+LF^S/,@*R-$^UQ@-GU(SC-
M7!X8T06GV;SG\O[&++_7C/EAMP_'/>JMOX2TYK!K?4-0>Y),^T"4*L8ED+G:
M.QQ@9.>^,9JO=%[QH_\ "2Q&Y-D+*Z-^)3']E^3=@('W9W;=NUAWZG%5D\;6
M$Q7[/:W<R%H8]X50 \OW%.6SG/!]#5JXT?39[Z2^6[>&[:3S!-%* RG8$(&<
MC! &1ZC-0P>&]#ME"PR%%$L$H F_BA^Y_P#7]:7NC]XD_P"$IM1:V]TUM<);
MRRB%W;8/*D\SR]I&[).[@[<\<U7OM>NX]15;<1?9?[1AL2S DL2"9".>V5'U
M!IK>$]#>;S#<2?ZP2E3,I&X2F48R,CYB>F,CKFK<NC:=+IUM9F]=3;W N5F2
M10YER6+'(P<ECVHT#WA;SQ3IUEJQTZ1F,J&-9""OR&0X7@G)]\ X!YK.U#QK
M;1V%C<P9A6X6"X9[A0%2!IDC;//! ;/I6G'IEG'>?:UU*<3,%$S"5!YVTG;N
M ';..,9'!JE'X5T2-H<W,KI J)%&\X*HBR"15 ]-RCKDXXH7*#YATOC7383%
MYD<R;XA/A]JL(F8JK[2<G."0!DXZ@4C^,[5%9_L%Z8PL[A@$^986VRD?-V[9
MZYXJ:#0M,M'1K2^F@*+Y?R3CF/<6"<Y^523CN <9Q0?#^C-#Y1F;;Y=S%_KA
M]V=MTGZ]/2CW0]XB'BJ*WL[V\E2:>VM[AT>1(U01H I[MEN&SQR>>.*TM7UF
M+1[3[7-!+);JI>21-N$4=2<D9^@R>#61<>$-!N8Y(WN)-D@<.!,#D.%!ZC@_
M(.1@]>>:MZQH6DZYM%W<-@0M 0DHP4;&>N<'@<C!HT#WB-_&5A"9GFM[J*WB
MDGB\]E!5GBR6  .>@...:DTO6;V^U'6()+,P_9!$887(#DLF[!()'7\J27P]
MHL]NUO+)OB:6:8J9NK2A@W_H1QZ<58L=-L;%[R5;Z66:["B662<;CM7:,8Q@
MX]*- ]XQ=$\8BYB*7;2MJ;.D3:8;4PS12,&)'S'#)A3\W3"GGM4LOBLR:@BQ
M$PV_[I)%>+<Z2&X\IE/S  >_..O-73H.F/()Y;Z:6[39Y=T\RF2,+G !QC'S
M-G(.<G.::/#FB@H?.8LK*Y8S EV67SMS>I+]?;BB\16D)IWB.35-?MX(+=X[
M">RDN8Y)% ,N'50PP<@$$G! /(J&34[^QU?51=7PDLM/M$O&1+<!W#>9E<Y[
M",8^M7-.T73-+NX[B"ZD8PPM;PI),"L<98-M ]B!C.3BK$VGZ9<7%]-+(KF]
MMUMIE,G!0;N!Z??:BZ'9E:;Q3;1WZ64=I=37$AC"(@49+H[CDL,<1MG\*@@\
M:6%PL6RVNA)<)&]K&RJ&G#D@8YXP5.<XP!FI+7P_I5M?17AO)IKB)D97EG!^
MZCQJ, #C;(WX\U&OAC146V"3NKVL*0P2"8;D",64CWY/U!Q1[H>\(_C2S2<0
M+8W\DBQRR3B.-3Y B;:^[YNQQC&<YXK7TG4XM8T^.]@7$4GW3YB."/7*DBJ-
MIHNEV4[7$-RXG:*2)I3,-S;VWLQ_VL]ZLZ79:?I,,T=O.I,TIFE=F7+N0 3Q
M@= .@I.W0%?J:=%1?:8/^>T?_?0H^TP?\]H_^^A2*):*B^TP?\]H_P#OH4?:
M8/\ GM'_ -]"@"6BHOM,'_/:/_OH4?:8/^>T?_?0H EHJ+[3!_SVC_[Z%'VF
M#_GM'_WT* ):*B^TP?\ /:/_ +[%2 @@$$$'H10 M%%%  0",&F[%_NC\J=6
M7K&OV&B&!;LS/+.6\J&WA:61PHRQ"J"< =30&QI;%_NC\J-B_P!T?E389DGB
MCEC)VR*'7((.#['D4_<N"<C Z\T )L7^Z/RHV+_='Y4N1G&1FJ<NJVD.K6^E
MO(1=W$;RQJ%)!5-N[)Z#[PH M[%_NC\J-B_W1^5+N4#.X8]<TN1G&: &[%_N
MC\J-B_W1^5.HH ;L7^Z/RHV+_='Y4ZB@!NQ?[H_*C8O]T?E3J* &[%_NC\J-
MB_W1^5.HH ;L7^Z/RHV+_='Y4RY$YM91;%%G*'RR_0-CC--LQ<K9PB\9&N0H
M\PQCY2?:IYO>M8=M+W$6YLVF>%9X#*F2R!QN7ZCM3P\!* -&3(,H,CYAZCUZ
MUPL.BW5XNI3&&*&*VU.[N%<*?.EX8!1Q]T[NN3D"K/@^WEL;BT34XGDN9]/A
M^QW)C(5(E1=T./X&!Y/][/\ LX&G*0I,ZY+BTDG:".:!ID^]&K L/J*FV+_=
M'Y5PEKIMR?MFH21""&PU2[NP\,9:YE^^-J@C&#G/4YP*98W^MZEJ]O9)>WUO
M9?:F)F"([O'Y*N%+E-N-^1D#U&:.47,=]L7^Z/RHV+_='Y5Y^-;U>[U 16DN
MH):3RVQ+RQJ73=,5=>%PORXR.2.O%)+J?B2WLXGAFN9I)A<)*98O]4D=PJ!Q
MA>OEECT.>N.*.4.='H.Q?[H_*C8O]T?E7G]Q+JAO=-O%O);AT6\6V\O=L=]J
M&-')4;B2&&<#(%.AN]>O8[&!-6F1;BYB2>2&+=)%F.0N"7C 7)"\8.T_6CE'
MS'?;%_NC\J1A&BEF"JH&23P *YKP_?:E)J6IVUR[W1BRT<ZMB(_,P"%2H*.
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M\DX'KFIO#5]<^7?:MJ4,JRMIUK+-^Z(+,$<L ,=?;WHY1\QUJF%V95*,R'#
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MWTUU_:?EQSQ3;3RT1?>N ,8*\CI@^U:<I',=3FZ_N0_]]G_"C-U_<A_[[/\
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M]G_"IJ* (<W7]R'_ +[/^%&;K^Y#_P!]G_"IJ* (<W7]R'_OL_X49NO[D/\
MWV?\*FHH AS=?W(?^^S_ (49NO[D/_?9_P *FHH AS=?W(?^^S_A1FZ_N0_]
M]G_"IJ* (<W7]R'_ +[/^%&;K^Y#_P!]G_"IJ* (<W7]R'_OL_X49NO[D/\
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M))SC/6@#=S1FN?BN]<DA600+\PR R!3GC@C/"]>>OM3VFUU4PL<;OMZ[ !G
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>img254193463_39.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_39.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $1 J # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1FX!\F2&0LI(&2IR 0<5FL33<N6_X>;7YHOV$[7M_5K_ ),U:***Z#$****
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M;$.27+9?\#_/[R?9T$G[UW_7]>1-JFLW>GZA9VL>G"<7<ABB?SPOS!&<Y!'
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MZ]#I-O(D\SQRNS1N"(]A4$'WRWZ&LA/"]TVHRW5RD$JW/V=ID%W*HC:( #
M ?[H(SC!SUI^B^'+_3KW2S-):FWTZVFMU:,MOEWLI#$8P#\O(R>319#NS0L/
M$UG>ZAJ]DX:WDTQ\2-+@*Z;0=ZGT'(/IBLW3_',&JV]DUE8R&XO!.\,$TBQ,
MR1/L)Y[G(('H><4ZX\&I?7$TMS<LGF7KS,(?^6L#!-T+Y[$H"<>GN:JWO@V6
M]TF;3KFUTVZ22>XFBED+*]LTCEE9"!U (X&.1UI^Z*\CLU)*@E2I(Y![4M16
ML+6]I# TK2M'&J&1^KD#&3[FI:@L**** "BBB@ HHHH **** "BBB@ HHHH
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M?2L1?#>[0BA:3[>UIY*M+*6$9(Y [ =N*@ETFYO6DEETPPQK:K!Y$<R!I&#
MY!Z8&.,UPQJXF"]Y7_X;R7]7MN=CIT)/1V_KS9L2Z_IL4UK']KA87!(5U<%1
M@=S]>/K6A--%;Q-+-(L<:C+,YP!^-<W%8ZHDFG74]MY[P32[ERBOL884MC@G
MUQ5K5-(F:WC:W::Z*7*3-#-+D,JDY49X'7]*N%>LXRDX^FENB^_6Y$J5+FBE
M+^K_ .19M-<M;G[:[211V]M($$QD&U\J#G/XXJT^I6,=ND[WD"POPCF0;6^A
MKG1I5_\ :WO38C"WPN!;;U^9?+VY],@\\TR31K]86GBM'2Z>>66%8Y$Q"& &
MU@W!!QDXK-8FNHZQO\GW_K3<MT*+>DK?-=OZU.G:^M$N$@:ZA$SC*(7&YOH*
M6*]M9YW@BN(I)8_OHK@E?J*YK^P[L:A*US;2W"S2QR[X;@1HI '53SP1QBKN
MC6-Y9ZE+B%X;$JQ"2LCD.6S\A'.WOS6L,16<TI0LK^?_  Q$J--1NI:V\O\
MARU_;0.O)IBVTF&5B9F&U<@ X'KU'--?4&N=4DM%TX3Q6\BI)(6&5+#.0I'0
M>N:CO5O'\165Q'82O!;JZ,X=!G>%Y )SQ@UCW&CZR);F2WCD%Y(SB2X$X"S1
M'HN.H8# 'IZUE4K5E=6;U[=++3;O^6^Q=.G2=G=+3OUOZ]O^&-S4M8GL&G?[
M [VMN%,LS/MSG^X,?-COR*O7%XL MPJ%VGD"(!QUY)_  FL/4(M0OKR"*739
MVTV$*YC65-TKCINRW0?J:T[_ '+=Z;<E6V)*5<==N]2 ?SP/QK6-6I>3UMIN
MO/6VFUOR,Y4X6BNNNS\M!EOKUO/)$/L]S''+(8HYG0;&8$C&03Z'K6B)X3OQ
M*AV?>^8?+]?2N=LM'N[0VEPZ/,4ED+6[RY6/+':ZCID \CW/>H'T>]DCG*V2
M1-+9O&Z($12Y8$ 8/(Z\FHCB*\8WE&[_ .!_F7*C1<O=E9?\$ZD3PLC.)8RJ
M<,0PP/K31=6YC,@N(B@X+;Q@?C7,ZQ8I8I</';QQ02+;JH&T*7#DG(/'3^]P
M?6H+6R2ZMHY+6U>=(;AS<1CRUWLP&&7&4('3&>]$L744^3EU_P"#Z?,2PT''
MFYM/^!_2.J6\4W_V4K]Z+S4?.0PS@_EQ^=6:P["V,=]90K T*VT#LZLV[;O8
M87/3L>!TK<KJHSE--R_K_AMCGJQ479!1116QF%%%% %+5])LM<TR73M0B,MK
M+C>@8KG!!'(((Y KF'^'W@W2'349+:2 QR1D2O>2_>W *#EN?F(&#ZUN^*;"
MQU+PSJ%KJ5RUK:-$6DN%?:8L<AL^Q&:\VTC3O NJ?V?I\+W5OJA:)X;V6&>.
M.Y=&#'8';:=V#Q[\5I"]MS*=K[(]@HJAJVLV&AV@NM0G\J-F"+A2S.QZ*J@$
MD^PK&_X3S3(\/=6.L6D'_/>XTZ58Q[DXX'UJ%%O8MR2W9U%9^H7\\,.;""&Y
M<,1(9)Q&D0 ))8X)'3'3O5V*6.>%)8G#QNH964\$'D&LG5O#\>HVWD6TPL5>
M42SB&%")SZ.".1GKZT+?4;O;0ST\8-+"MVFG,+*-8#=.\F'C,H! 5<?, &4D
MY'!XK=F>&:]@B.URI;*D9QQ69)X8$\Q:;4)FCF\IKN,(H%PT>-I/'R] "!U
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M2-)"@PNY0<'@5HY)W,U%JQ@Z/:7.G_%K5!<ZC<WS3:4L_P _"QCSB B*.
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M2JG^5;510ESKF[_Y(JK'E?+_ %N%%%%;F04444 %%%% !1110 4444 %%%%
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MML#,,EB96)[G=Y@Z_2O-]7BU:R\7:WJ-O<:HOB.6ZBBTVWCM]]O-:C;PS;2
MO+EN1@C-$8W'*5CNV\::*FL'3CY_%R+-KH0'R%G/2(OTW<C\>*MZUXAL-#DM
MX9XKBXNKG<8K:UA,LC*HRS8'89'/O7%:CK=IXA\:V^EW2S66D:;>+(1]DDS?
M78.%P0N!&K<DGJ?;FKU]JT-OXXL/$TD%Z=+^Q7&GO(+60M%,L@/*@9PVT@'&
M#@4^47,=0WB/21X<77DF\VP=%:-HT)9RQVA0O7<6(&/6H8/%6E7,>GF(3&:^
MG>WCM_)(E1T)$F]?X0F#N)Z<>HK!\/Z-'#\+V@UZ&XMXG:6\:) 1+ #*94V@
M<AQ\IQZUS-BFN>&-2M;V'3Y7N=17S(X[F%YY"KS F$NN!'(0QE=CP3QT6CE0
MG)JQZQ8WMKJ-N9[9@R!WC;*X*LK%6!!Z$$&K.U?[H_*L#PR5>ZU^6+_4/J;[
M,="1&BN1_P ##?CFN@J66G=";5_NC\J4 #H***0RGJNEVFLZ=+87T1D@DQD!
MBI!!R"".000""*XO3/"WA*PO&MH=?O7N;.X4R1G5' 61W)564'&2>,=^]>@5
MXG_HZWNHA-2WZ9%=*KVR6+?:Y]MTS*L;9VOF0XW@],9P:TA=Z7,JEDT['J_B
M#6DT+3!<FVDNI9)4@AMXR TLCG"KD\#ZFN9LO%D*:E$TGA.6Q@:Z6QGNSY8,
M5PW\.!RRY(&\<<U-XRUO3;GP/;:A)"+G3;NY@60,K!T0N 2H7Y@Z]L<@BH/^
M$H\(Z]JND0LVH2SVTX-LCVTRIYAX#-E<$CL3TZT):;!*6NYWE%%96LZ]::/8
M-<.Z2.9!#'&' W2'HI/;N2>P!-9I7-&[;FK5>;_C[M_^!?RK$N/%!BFEDAMH
MY["V,*W-PDW0R8P4&/F #*2<CKQ6P\L;W\"*P++NR/3BG9H$TRW1112&59O^
M0G:_]<Y/_9:M52FEC&IVV9$&$DS\P_V:NUG!ZR]?T1<EHOZZE6[TZSO@/M-N
MCL.CXPP^A'(JI]@U"SYLK[S4'_+&[^;\G'(_'-:M%*5&$GS;/NM!QJR2MNC*
M_MDVYVZE:2VG_33&^/\ [Z'3\0*T89XKB,20RI(AZ,C BI",C!K.FT2T>0S0
M![2<_P#+2W;83]1T/XBIM5AL^9?<_P#+\$.].6^GXK_/\S1HK*SK%EU$6H1#
MT_=2_P#Q)_2I(-:LY9!#*SVTY_Y97"["?IG@_@::KQO:6C\_\]ON8.E+>.J\
MOZN:-%%4QJ,1F\GR;C?UQY1Z9QGZ5I*48[LS46]BY152]U&VL HE8F1^$B0;
MG<^PJG]EOM4YOF-K:GI;1-\S#_;8?R'YU$JJ3Y8J[_K?L7&G=<TM%_6Q)/JQ
MDF:VTV+[5.IPS9Q''_O-_0<T6^D@S+=:A+]KN1RNX8CC_P!U>WU/-7X8(K:%
M8H(UCC48"J, 5)4JDY/FJ._ET7]=W^ W4LK0T_,****W,@HHHH **** *&JV
M<D\27%M@7EL=\)/?U4^Q''Y54T?6++4;NY\F9?-?:_E$_,/E /Y'BM>6,2Q/
M&20'4J2/>N+T;P;)::M-(U^ZB [4:'Y6.1WS[&N#$>UA6@Z4;I[_ ->GY([*
M/LYTI*I*S6W]>IV]%9?V'4XO]3JQ<>D\"M^HQ1OUR+K%8W _V7:,_J#73[9K
MXHM?C^39A[-/:2_+\S4HK+_M.\C_ ./C2+D>\++(/Y@T#7[%>)_/MSZ30.OZ
MXQ1]8I=7;UT_,/8SZ*_IK^1J454AU2PN,>3>V[D]A(,_E5L$$9!S6D9QEK%W
M,W%QW0444V1G6-C&F]AT7.,_C5,0ZBJ=K=S7$CAK;RU1BI;S >1[5<J8R4E=
M#E%Q=F%%%%4(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:C_S[3_]\C_&C[4?^?:?_OD?XUS^B>)[ZZUJ/2=8TV*QNKBT^VVWE3^:K1Y
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M !JIJFOZ9HUS9P7]W% ]W(4B\QU4<*22<GIQCZD#O5I=0LFOFL5O+<W:C<T
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M 0,C)Z"H)O\ C[M_^!?RH L4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% ","5(#;21P?2JD%E+#.TINY'WD%U** <#'I5RBI
M<4VF^A2DTK(****HD**** "BBB@ HHHH **** "BBB@ HHHH **** /+=/\
M#_BK_A!)/![Z/':BX:9)=0DND9$CDD9B51<L6VG !QSWK6TK3=:\.>+=9DMM
M$>\TZ]^RQPS)=1J46.((2RL0?_U5WE%5S$<B.+CM=;/Q+GU1]%D73I+(6/G_
M &J/( D9O,V@YP01QUJY?Z3?Z3IZPZ3;OK%M+*1>VFHW;2/)&5QA&D) YQP>
M",UU%%',/E.;\$:+=Z'H4EM=HD'F74LT-I&^];6-CE8@>^/;CGBNDHHI-W&E
M96"BBBD,**** "BBB@#,N-)0ZB^IQRW<ER(BJV[7;K QP0 4SM_'%<->>"M0
M\237LDND6GA]'TN2R\N*17\Z1F5E8[ !L4KQGGGH*],HIJ31+BF<'!9>)IM:
MB\07>C0K<Z?I_P!D@LQ>+_I$CNID??C"J O /)]JI7?A/7'M=4\-Q6T)TK4M
M4^W-?&8 Q1,ZR/&4ZEMRD CC![5Z313Y@Y$<[XNT>?6[.ULK>TMW9Y@&O)55
MFLTQ\SQ@\[R.!CH3GM63X9\/ZYHWB22,M)'HT2RI&IN=\3H2ODA(_P" J VX
M_P 1.>:[BBES:6#E5[G)V.D+=RZWI=U)>V^W43=));3O 72101AE(R =P(_V
M15+6_!VLSW+7%AK]Q^]O8)6C>")O+1&&,,PR0H!(!ZDGU-=S13YF'*K&&^G7
M=[XG@N;L#[#I\6;;)&99V&&D('3:O ]V;VJIJVB:IK<T=[%J%QI<MNDL4=OY
M<4RMDD;^0<$K^(!(]:Z>BE<=C!\/Z7=:=X,L].U+_3IXK54DB94 .%_U?'RD
M#ID]>IKG)?">LQS07EK(]O=R1\K9SB..W?>"JL/XXPN[(YW,2<<C'H-%/F8G
M%'->*M*N+R^T6^MM,AU V=RS2PR,BDHR,N06&."0<>U8-IX6U2*_L[5M*ME:
MVU1KY]:$J[Y4+LVW&-^XA@ASQ@?05Z'10I- XINY0O-(AOKZVNWN+V-[<Y5(
M;IXT;G/S*I ;\:Y$Z+JM_P")M,U$^'K32O[-EFF>:"=&:[W*5"# !P2026QR
M.]=[123L-JYYYX?M/$R^(+S7-<\/O)J<T;QV["\B,-K$!E8D&2<L0-S8ZGT%
M4_$/@_4]6U#4K^3P_:WEUJMC#%$\ET =+E52#@]2 Q#97DD=.:]/HI\VMR>1
M6L<[K6E7DWA"+34M;;5+T)%$)+Q5:-7  ,S!NN.6P.3TKG;#PYK/AK7HWMY[
MC^Q;;]])+]HRLD?E'S%:$<M*TGS[_3CVKT2BA2:&XIZF+X2MIK3PO8QW$9CF
M96E>,]4+L7V_ANQ^%;5%%2QI604444#*FIW5Q9:?+<6MF]Y+'@^1&P5G&>=N
M>"<9('?I7(77CZ635;6+2K9+BW<QJR/'()G=FVN@ &$9!R0^.OXUTWB+3KK5
M=#N+.SN!!-)MPQ9E# ,"5)7Y@& ()'/-8.D>"[G3XHKM;_[+JJREG:!FDC>+
M=D0OOY< 9 8_,,\<<5<>6VIG+FOH=E1114&@5R7B<7DGV,7<5LMN+ISYA1YX
M@OEL%\U,#))/'. 176T4T[":NCS2""X-K&L]K=#5V2S&G-(C,R(NW?\ -C"\
M[RP..",UZ ZR"_@+2 J=V%VXQQZU;JO-_P ?=O\ \"_E3<KBC'E+%%%%24%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%0&&8DD73@>FU?\ "@">BJ_D
M3_\ /V__ 'PO^%'D3_\ /V__ 'PO^% %BBJ_D3_\_;_]\+_A1Y$__/V__?"_
MX4 6**K^1/\ \_;_ /?"_P"%'D3_ //V_P#WPO\ A0!8HJOY$_\ S]O_ -\+
M_A1Y$_\ S]O_ -\+_A0!8HJOY$__ #]O_P!\+_A1Y$__ #]O_P!\+_A0!8HJ
MOY$__/V__?"_X4>1/_S]O_WPO^% %BBJ_D3_ //V_P#WPO\ A1Y$_P#S]O\
M]\+_ (4 6**K^1/_ ,_;_P#?"_X4>1/_ ,_;_P#?"_X4 6**K^1/_P _;_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;6RY>0DXP/S_ "KS?0KB>;Q;%K^I:+K-A>2GR_LMAIKQP_-QF=S_ *PC.<X
M%:PV9C4^)(]8HHHK(V(I9TA5CRSJI81KRS8]!WK!A\33W=G9&WTTB^NY9HUM
MYI@H01,0Q9@#Z#@ \G\:W)+2!Y_M/DQ"Z"%$G* NH/8'KCVK$A\+RP00[-5E
M%U!/+-%<>2GR^8274KT().?; ]*I6ZDOFZ$$7C,7$/VN&P8V4)B2[D:0!HG<
MXP%Q\VW(R<CKQFMR>Z@6\A#2J"I;/MQ6/'X-MH56"&[G2S?RS<P$ ^>R'(8M
MC()(&<=<=JW)KBTCO((IKF)+AL^5&T@#/ZX'4T.W04;]1WVVV_Y[+1]MMO\
MGLM3T5)97^W6N<>>GYTOVVV_Y[+38+BTO7,MM<Q3&$E&\J0,%/<''?BIXY(Y
MHUDB=7C895E.01[&@"+[;;?\]EI/MUKG'GIGZU8JM-<V<)>XFN8HQ#\CLT@
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M6O\ SW3\ZE:6-)$C:15=\[%)P6QUP.]5X[NQ,UULNX&>+F<"4'R\#^+TZ=Z
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MMS%;Q%U0/*P4;F. ,GN2:L4.5T)02=SF]7ME'BW1;U+&>62,R+).D98(C(P
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MUS5)OM36UO;212S8DN MOB0!5XVO@?-@9XSZU$LP<4KQW5]_/T*6#3>DNO\
M74]!HK@FM]Z0 7<XLA:J+:9+=Y"7R=Y !^5L^M=U$"(4#,68*,DC!-=&'Q#K
M-Z6MYW_KR[F-:@J5M;_+^O\ @#Z***ZCG"BBB@ HHHH **** "BBB@ HHHH
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M&&55;:0HY5>%Z$<=<9/)-6T0GJ;E%%%(H**** "BBB@ HHHH **** "BBB@
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M-YYD^<L&9B<_[6]@>Q'':CW0]XVZ***DH**** "BBB@ HHHH **** "BBB@
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M-7J**0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>img254193463_40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_40.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $+ 1X# 2(  A$! Q$!_\0
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M)$W*5.",C(/2O*;G4I_$?@OPSX:F.;Z[OA97RYY"VQS*3]0JG\:]: "J%4
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M&/\ T +O\A791DE!79Y]>$G4;2.5HKJ1\./%Y8J-!NMP&2,#_&E_X5MXQ_Z
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MN6LY@.G*&OSU8/$?\^Y?<SZOZQ1_G7WHH5M^$_\ D8;;_@7_ *":J?V'J?\
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M(SA"^.X&<_A6/%H,VGW#6P:;5-+U*0&\<R8F27^^6&-T;8P5_A[<<!I$MF)
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M*P\'27%A8_VO=2?:;:+R5$:QY5,;2H<+DJ1R#P1Z]:ZZ.-(8DBC4*B*%51T
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44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>img254193463_41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_41.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %- O8# 2(  A$! Q$!_\0
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M"^M]3TZVO[5]UO<1++&Q&,JPR*Y&?XJ^'(;5[I?MLMNEX++S8X,JTG).TYY
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% &-XNN_L'@[6;K.#'92D?78<?K7D>GZ
M]JWA#X8>#4T8!KK4;YBT)4'SE+GY.1QG*C(YKU3QQI-]KO@W4M+T[R_M5R@1
M?,;:N-P)Y^@-<N_@353/X#B'D?9=#0-=_/SYF%/RC'/(K2+5M3*:=]!FGZWX
MMTOXFZ=H>MZC:WD.I6K3M!! $6W(#<*>I *XR>M=OXFTL:UX7U/32,FXMG1?
M]['RG\\5@/X8U&?XMQ^)9?)_LZ"P^SQ?/\^\YSQCI\S5VE*3V:*BG9IGB>G>
M,)[+X&6EM;;CJTTK:5;HOWMQ;M]%(_'%:MY%=>!K?P-X6TN2)7N[L&\+1*_F
M'*ER-P./O'!'(&*D\-_#&[TWXA76K7LL;:1!<2W-A KYQ(Y')'; 'Y@5T&O^
M%]0U;XB^'-83RO[.TU)#)N?YMYSC _!:MM7,U&5M?0R]+\;7NFZSXUM=?N1+
M%HY%Q;?NU4^4V2J\ 9/*#ZFLR+QAXM31]"T]IH7\1>(96EA,L("6=OV. !DX
MYYSWJ_XM^'5[XA\>07\<T::/<QQ)J2%L-((VW!0,<@X4?A6CXQ\*ZM<^(M&\
M2^'C:M?::K1&VN"522,Y& 1TZG\_:E[H[2*OAW6_$.F?$*7PEKVHQ:JLEG]J
MAND@$3+SRI XQU_2J/QONI1H>CZ:)6BM;Z^5+A@<94= ?Q.?PK=\*^%=3B\1
M7OBGQ)+ ^KW48AC@M\F.VB'\()ZDX'^36KXR\)VGC+P_)I=TYB;<)(9E&3&X
MZ''<<D$>]*Z4DQ\K<&C2M='TZSTI-,ALH%LDC\L0[ 5*^X[UYK\4HHX/%/@*
M*&-8XTOMJH@P% :+  [58MK+XM65FNE1W.C31H/+2_D),@7H"1W./4'\:M^)
M/!>OZO<^#I6O(+R;29O,O;A_W9D^9#D*/]TT1T=VPE[T;)%3XN:BEY+HGA$7
M,< U*Y62ZD=PH2%3W)]\G_@-5O"%Y8>&_BOJF@V%S;R:7JT0NK402*RI(!RO
M!X/#?D*U5^'[ZY\0-6USQ1;6MS8F-8+"W+%L*#]XCL>#_P!]&H?%'PSAC?2]
M2\&V-G8ZG8W2RD;BBR+W!//<#\"::<;<HFI7YCOM7_Y M]_U[R?^@FO!/ ,D
MG@NWT#Q.&?\ LK5G>QU$=HW#G8_^?0^M>^WL,EUI=Q"H EEA9 "> 2N.M<;X
M;\!LGPO'A37@F]_,WM"V[82Y964D=1P:46DM2IQ;DFC@OB#,WCBX\07\<A.B
M^'(/)A9&^6:Y9@&/N ,_D/6NFN?$VK6>C>"_#.@-##J6J641-S,N\0QA!DA>
MYX/7TK:O? 26/PNO/"NB8:62/B28[?,<L"2Q'T_053U;P-JTFG>%]0TJ>WBU
M[0[=(]DV3%*-H#*2.?7GW-5S1>A'+).XRRUSQ)X7\=:;X=\0ZE#JUIJD;&WN
MEMQ"\;CL0.".GYCZ50TO6/&'CF76-4TK6+;3-*LYG@M[9[42^?M&3O/49!'(
M]>.G.KI_A?Q%K?C6R\2>*?L5LNG1LMI9VCE_F/5F8_7]!^-#2?"/C/PQ=:KI
M>B3:8VCW\[31W%SN,EONX/R#J<8]N*6GS'[WR.;\*^+I/!WP2AO+9(VNY[^2
M"#S?N*QY+-[  UI:=X_O=-\0Z1!)XNLO$5OJ$ZP7$,5J(FMV;@,A Y7/K_7C
M0L/A?>O\,1X<O+F*#4(+QKJVGC.Y0V?ES[$9^E;>D1^/Y-0LTU.UT&VM82#<
MS1;G><?[(_A)_P ^E-N.HDI*QC^ _P#DK/CK_KI'_,U=^*"_;+WPCI;G]Q=Z
MO'YH_O!>Q_.KWA?PMJ.D>//$^L77D_9-2=#!L?+<9SD8XZU6^+%K.F@V&N6R
M,\NC7T=VRKU* X;^A_"IO[Z*LU!G._$?41I'Q:\*WYM;BZ$,#GR;9-TC\N/E
M'?K2:'<GXB?%"T\1V%B;"RT9#%.TQ432N0P"E0<CKW]#]*Z35/#][X@\?^%_
M%5@T+:9;V^YV9\,0P8C QSPPIFH>$-6TKXA1^*/#0@,5TNS4K2238)/]H<$9
M[_4>YIW5K=;"Y7>_2YC>,+VQ\1_%72M OKFWCTO2HS=78FD"J\A'"\GG@K^9
MJS\(]02RGUOPB;F.<:;<M):R(X8/"Q[$>^#_ ,"J?PQ\,X99M5U/QC96=]J5
M]=-*!DNL:=@#QZG\ *DE\ MH/CS2M?\ #-M:VE@D;0ZA!O*@H>K <Y.#G_@(
MH;C;E!*5^87P4OV'XE^-M.B 6W:6&Y"@=&=26_,FO1*\[^&0;5M2\2^+"A6+
M4[SR[8G^**/(!_7\P:]$J)[EPV"BBBI+"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ ILD:2QM'(BO&X*LK#((/8BG44 (JJBA54*H&
M, "EHHH **** &10Q6\0BAC2.->B(H 'X"GT44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRT>&);.W/(&!FA)7$VVCT^BBBLS4**** "BBB@ HHHH **** "BBB@ HHHH
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M6NX6DF\L1D$ A^#@#G.,G/&*2.[L[;XAS7&H620:A#H0GN;I+EF14$GS(%(
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MKM.<#/4CVKU"RNXK^QM[R DQ3QK*A/7:PR/YT2C8(RN3T445)04444 %%%%
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M'P0_Y*!_VYR_S6O-Z](^"'_)0/\ MSE_FM=M3X&>=2^-'TC1117GGJ!1110
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M8\#(QP/>NZTRS_L[2K.R\QI/L\*1;VZMM4#)_*KE:VA$;WNRU5:__P"/1O\
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MZJZ,C %6&"#W%+10!Y%?:&-#US48-$?Q-=0VT,372VFH)$+:,*=J+N&7(7)
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MM+TUXS#J%]DZBULD4BAOW<7 W*@' !(R?H*U:'Y#5[:A1112&%%%% !1110
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M1DR YV@-P3QG:3AAGWJAH_AVZU*^&H:O81V1 9)K< $SDDEB2&(*,2&P>05
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M> .36G7$+JFH-XINX+O0VN)Q:+&8!-'M9=S9>/>1N5@5#>A&#VH6HWHK%SQ
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MW#Q+'NPN2VXCU^@_"MV?1]-N<F:PMG)[F(9_.E^QRYSYZ>O^I6G^3=?\_?\
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(4 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>img254193463_42.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_42.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %. OX# 2(  A$! Q$!_\0
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M;=VQE.<XR.V1^-%USWZ#Y7R6ZG*:4H\9_%6]UE_GTKP\#:VA_A><_?;\.?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;K=2B*;SDDA.<,IP#G*D8(ZU'9>,KQKK3_[3TB.SL]1D6*WD2\65T=@2HD0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'AUE+#<S#D;<@>E7D\):E-#H2ZCK$,\FDW:SHT=KY8=%C*!<;CSSG/Z4^_\
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M4C&+[%Y31.$8[9(RQ^7CH0">:KVNLZY<7'A?2-+FL;)+[1OM,C?9LK$0$Y1
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN(O][GC\:3^V=,VVY_M&UQ<_Z@^<O[WG'R\\\^E%A71=HHHH&%%%% !1110
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MF:S/)UO_ )^[+_OPW_Q51.;CLFRXQ3ZV-2BLOR=;_P"?RR_[\-_\51Y.M_\
M/Y9?]^&_^*J/:O\ D?X?YE>S7\R_'_(U**R_)UO_ )_++_OPW_Q5'DZW_P _
MEE_WX;_XJCVK_D?X?YA[-?S+\?\ (U**R_)UO_G\LO\ OPW_ ,51Y.M_\_EE
M_P!^&_\ BJ/:O^1_A_F'LU_,OQ_R-2BLOR=;_P"?RR_[\-_\51Y.M_\ /Y9?
M]^&_^*H]J_Y'^'^8>S7\R_'_ "-2BLOR=;_Y_++_ +\-_P#%4>3K?_/Y9?\
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M'M7_ "/\/\P]FOYE^/\ D7I;6&>>"=TS)"24;.,9&#4NU=NW QZ8K,\G6_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBN+:WNXQ'<P1S(#G;(@89]<&I:*    8' HHHH **** "BBB@ HHHH ****
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M7*-<J2"@SU !(!Z$@$9&<BIK2]MKZ)I;6598U=HRR]-RG!&>^#Q2'<GHHHH
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MEB!U )5C]*Z>BFG835T<3IFL:;>>,-3UVSNXO[(6R@MI;L'$<L_F-C#=&(#
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M5S:ZM':-IK/%,66%EE7?(53>2$[+_#DGJ1Q@YK9K(;00VKW&I+J-ZDL\?EE
MR%47& %RN1S\W7KUI(;OT'Z/JLNHO=Q7%H+>:UD$;A9/,7)4-@-@<C.".QK4
M)P"<9K.T;2$T6R^RQ75Q/&#D&<J2/7D 9)/))R2:T3R",X]Z&"O;4YT>*'A^
MV)>Z>T,\"1M'#'*)&D9]VV/CH_RYQR #G.*V=/N_M^FVMYY?E^?"DNS.=NX
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M/2PM;FE1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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+ **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>img254193463_43.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_43.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *Y QL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"-R/S'/XUUMA\+O!NFW*W$&B0M*C;E,K,X4_0G%=:T:/$8F13&1M*D<$>F*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:\5-JSW-S#!J<D<,!G8)'D E@ >M9$.N:I'\/(=,AOYT>77&TH7;-F1(-_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&SQ[_P ]O#W_ '[F_P : .JHKE=GCW_GMX>_[]S?XT;/'O\ SV\/?]^YO\:
M.JHKE=GCW_GMX>_[]S?XT;/'O_/;P]_W[F_QH ZJBN5V>/?^>WA[_OW-_C1L
M\>_\]O#W_?N;_&@#JJ*Y79X]_P">WA[_ +]S?XT;/'O_ #V\/?\ ?N;_ !H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2PGM,.]D[KT?^5C2<N:S%HHHKUC,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH 0@,"",@\$4R&)8(EC7[J\#V%24T.A<H&
M7>!DKGFERJ_-U =136=4&78*.F2<4"1&<H'4LO4 \BF ZBFLZIC<P7)P,G&:
M=0 4=*** "BBB@ HHHH **** "BBB@ HHI"P'4@4 +1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44C,%4LQ
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M&F^/M'O[^.QFCO=.NICB&/4+<P^:?]DG@USWQ'_Y'+P3_P!A#_"K?QA2#_A
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MGP0M-82::0;.>U;:T/&.,\$>QI-%\'VVE:O-K%Q>W6HZG*GE&YNB,JG]U0
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M*JK?ZQ3TH U**:DB2+N1@R^H-.H **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2X^9O>J)T9));XRON6YQQC[I'>KMG#+;VJ12R>8R#&['4=J )Z*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *I:F(OLI\U%;GC<.E7:
MS-=C+:>7&24.>/RKEQW-]6GR[V8GL<F='AF\376IW8MY[:>U2#R)(]V"K9R<
M\5J&6WC@$$<,:P@;1&% 7'ICI65]H/K33,?6OBY2G))-[&8R2SM+21GM+6"
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M_P!D8J6NC"9="@^=N[!1L%%%%>B4%%%% !1110 4444 %%%% !1110 4444
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M($\3>$-/U-2/,>,)* ?NNO#"NAH **** "BBB@ HHHH **** "BBB@ HHHH
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M%% !65J4-S>W$5N@VVQ^9G!ZTNJW<RLEG;*WFR_Q>@JW8VOV.T2$L6(Y)]Z
M)HHUAB6-!A5& *?110 4444 %%%% !1110 4444 %%%% !7E7QT_Y .C?]A%
M?Y&O5:\J^.G_ " =&_["*_R- 'J-O_Q[1?[@_E4E1V__ ![1?[@_E4E !6)X
MCMO,M%G4<H<'Z&MNF2Q)-$\3C*L,$5CB*7M:;AW&G9W.;TJ4262KGE#M-6+E
M=\17&01@CU%90#Z-JK0S$^4_ ;L1V-;?!'L:^+J0E3FU+<[8NZ.%\0:#;>'K
M>+5-(0Q!\QSHS97)Y!Y_&L32H[.[A2[D9WE+$,"W&17IE]90:A8R6EPFZ&0<
M@''XBLSP[X5T_0+B:6,S7"R#Y8Y<':>]?18/-:<H*-9V:_$YYTFGH4+W7]7N
MK06MG'%:0A0H*2$MCZU2;69=*M'&KW,=Z[(?+BF0/@]CSS7:310$'R;"%">^
M!7%Z[X01R^HRW$LIR-Z$YX^OI79#,,/.HJ:>YRXGVE.DYQ6QR-G:'4[_ .V2
MC]VK;B3_ !-Z5T#L%4DT(B11A$4*BC  JLZS7]U'8VBEYI3M ':O5V1\A*4J
M\SH/ =BUYK4^HLI\J!=BGU8__6_G7I%9VB:5'HVE0V<>"5&7;^\QZFM&N>3N
MSZO"T?8TE#J%4=7U6WT73)K^ZW&.,?=099R> H'<D\5>KE?$L@N/%/AG2V ,
M<D\ETX/?RER/U8'\*1T'302--;QR-&T3.H8H_5<CH?>JFKZS8:'9_:M0G$49
M8(HP2SL>BJ!R3["N(@N/$&NIXEF_MB73M/LKN86TT04NQ11P<CA 0<]SGMBM
MG3;VRO/".C>)?$(B$]M;B?S7X"NRXR!ZGM]: -?1/$>F^(%G^PR2>9;L%FBF
MC:.2,GD95@",T6_B72;OQ!/H=O=K+?P1^9+&@)"#..3TSSTK*\-:=<W>H:OK
M][ UK_:@2.& G#I"H(!;'1CDGVXK-\+:396/Q$UT6,"Q06=G!;C'.68ER2>I
M)QR: .]K'UWQ/IOAUK5+YIS)=,5AC@A:5G(&3@*":V*\^\5W=Q#\2O#[6VG7
M&H/:VL\Q@@*AANPH/S$"@#I])\5:3K27)M9V5[49GBGC:-XQUR58 @5J6MU!
M>VL5U;2"2"50Z.O1@>AKS+Q#8ZJVE^)_$]ZC:5-<V26EO;HZM($!YWGD9).,
M#MWJ]>1:OX3\-^'].TN^N+J\N+N")1<LN%7;\R< ?*,?6@#T6BO.KO4-7\.:
M[J%M/K,M_&VCRWC"15'D2J<#;@<*<\ YZ4C-XFA^'[:_=:M+]N^SPSBW10$1
M002/4DC.3^E 'HCMLC9MI; )VKU/TJEHNK0:YI,.H6ZND<N?D<892"00??(K
M#AU.]UOQA!#93F/2[&W6:Z*_\M9)!E$^@')IW@$AM N&7'EM?7!3'IO/_P!>
M@#J:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH X#QQ\-(/$%PNL:-.=-UZ([DN(SM$A']['?W_G
M63X9^)]SINH+X=\=6[6&HH=BWC#$<OH2>@SZCCZ5ZK6-XD\+:1XJTYK/5;59
M5Q\D@X>,^JGM0!H_;K3S8(OM,7F3J6B7>,N!U(]>M6*^4KO1_%FA>)HY=+M=
M8FM].G;["\L;'Y0?3H :^EO#6M'7]!MM0>VFMIG7$L,R%61QU&#VSTH UZ**
MCDF2+[QY]!43J1IQYINR DJO/=+$=J\M_*HY+X*A8(>G4FLH7"EBS'FO$Q^;
M145##O5]>PF[;E_[1*W5\?2GK=2(>6W#WK+>[4=#4)O37BK&UHNZD[^HN<Z6
M*9)ERI^H]*DKG++4?+NE!/#'!KHZ^HR[&/%4KR^);C3N%%%%>@,**** "BBB
M@ HHHH **** ,[7M4_L30+[4_*\W[+"TNS.-V!TS6)#J7C6>".9-%TC;(H89
MOGZ$9_YYU:\>?\B%KG_7G)_*MC3?^07:?]<$_P#015="7N8/VWQO_P! 71__
M  /?_P"-T?;?&_\ T!='_P# ]_\ XW7444K^0[/N<J+OQL#G^Q='..F;]^/_
M "'3OMOC?_H"Z/\ ^![_ /QNNF:6-#AG4'T)I0RE=P(QZYHOY!;S.8^V^-_^
M@+H__@>__P ;H^V^-_\ H"Z/_P"![_\ QNNG5E<95@P]0<TC2(APSJI]SBB_
MD%GW.9^V^-_^@+H__@>__P ;H^V^-_\ H"Z/_P"![_\ QNNE$L;' D0GT!I]
M%_(+/N<O]M\;_P#0%T?_ ,#W_P#C='VWQO\ ] 71_P#P/?\ ^-UU%%%_(+/N
M<O\ ;?&__0%T?_P/?_XW1]M\;_\ 0%T?_P #W_\ C==111?R"S[G+_;?&_\
MT!='_P# ]_\ XW1]M\;_ /0%T?\ \#W_ /C==111?R"S[G+_ &WQM_T!='_\
M#W_^-UH>&=9EUW1([Z>W6";S)(GC1]P#(Q4X.!D<5L5R_P /_P#D6#_U^7/_
M *.>GNA;,ZBO*OCI_P @'1O^PBO\C7JM>5?'3_D Z-_V$5_D:DH]1M_^/:+_
M '!_*I*CM_\ CVB_W!_*I* "BBB@"GJ.G0ZE;&*48(^ZPZ@USJR76C.+>^4M
M!G"3 9&/>NNIKHLBE74,IZ@C(KAQ> IXG5Z/N7";B8:7$;@$,"#4@8'H:F?0
MK,L6AWPYZJA^7\O\*B?191_J[G_OH5XE3*,1%^[J="K1>X9]Z@N7A:!XY&&U
ME(-..BWK=;F,#\:?'X=C)!N+AY/9>!4T\KQ+E>U@E4@U9GG'D7E[J#6%C"TD
MH;;D#@#U)["O0O#/AB'0H3)(1+>N/GE]/85M6]I;VB[8(4C!Z[1R?J>]35]9
MS2<4I;GC8; 4Z$G):L****1W!7/Z[IMS-KNA:G:Q>8UI,ZRC(&(W0@G\P*Z"
MB@#S30O!.I:GI#K?ZOJ-E8WEU--=:;Y:J7RYP-Q&Y01C([UM>(?!5[K%]8RV
M.NMIUM8H!!:K:K*BL/XL,<$XP!D<5V-% &)IVE:S:Z3<VUYX@>\NY,^5=FU1
M#%QQ\HX/XUD:!X/UC1M<N=2N?%$MZ+HAKB(V<:>80N%.1TQ[5V5% &/X9M-1
MLM),>IW,MQ.9I&5I2"P0L=H...!2KH:CQ8VO&=BQM/LJP[>%&[<3FM>B@#*\
M2:''XCT&YTN2=X!,!B5!DH0<@X[\BN5UOP_K-U?>&K ZI>S36\DT\FJ+"HV.
M$PN5QMQST/6N_HH XY/ 8;2-6AN]6N+K5-4B$4^H2( 0HZ*J#A5]JZ5].BDT
M8Z8_,1@\@Y';;MJY10!R=IX?N_"_@R?3](9[W49 1]HDPI+-QO/LHQQ[5N:%
MI,>AZ)::;$Q801A6<]7;JS?B<FM"B@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M (;F;R(2_?H*RO,+DLQR:DUZ5HH8B/NDG/\ G\ZP/MI X-?*9S5G+$\CVB1*
M3V-2\FS;.H/.*P_M)]:>]UG.3^M8^KZA'I=A->NI=8QG8IY8]@*\V$'4ER]2
M6^YIF<^M,\UF.%!)]A5#0YM0U.\5;K1KBTM0"6E>5",^F <U;'C.VM(YKJ'1
MKQM)@D,<E^@7:"#@G;G<0#WK18:;ERQ5WZK^K^0U;=DL8G-S&I1URP R*]!4
M84#VK'2>*6-)$;*L RGU!JQ!>['"N<J>_I7I99BZ>'DX5.O4M)+J:-%'6BOI
MQA1110 4444 5-4U.ST;39]0U"=8+6!=TDC=%%<I_P +=\"?]##;_DW^%.^+
M7_)+=?\ ^O<?^A"OD?0- U#Q-J\6EZ7$);N0$JK,%!QUY- 'UM_PMWP)_P!#
M#;_DW^%<IX9^/&D7NMW6FZT4MHQ.RVMZF?+D3/&[^Z??I7D__"C?'G_0+B_\
M"$_QKG-&\"^(->U^;1K"Q:2Y@D,<[9_=Q$'!W-TH ^M_'$L<_P /=:EB=7C>
MR<JRG((QU!K;TW_D%VG_ %P3_P!!%>:6?@BX\#_"/7+*YU6:^E>T=BA/[J+C
MH@/05Z7IO_(+M/\ K@G_ *"*?074R_&7B,^%/"]WK(MA<FWV_NB^W=E@.N#Z
MU@I\0KRVU72X]8T!['3M58):77GJ[;B 0'4#Y<_4T[XQ''PPU;Z)_P"ABL>3
M2-?\8MX7@N-+&G:;IK1W,L[S*YF(48" <_G2&8WBO0HKSQCKFK>)= UNXTZ/
M8MO/9.H1(U7YF(SD^O KMQX?TWQ+X+TBST;5;BWT1=KD1$[IXA_ 6R"/>C6=
M0\77-MJ6EQ>&HF\\/#;W0NU\L(PQN<'D'!Z#-0VV@^(O"7A'1+'07@O)+%LW
MD#X7[0IY(5C]W!/% &%X+;35^)5W!X2F=="CL_\ 2X&D;;Y^[@HK<].IKH_'
M?@?1O$5K/J=^MP;FUM7\HQRE1P"1D=^:JZ7HVL:K\1$\47^F+I,%O:&V6$RJ
M\DY)SE]O&!VKLM7@DNM&O;>%=TLL#H@SC)*D"@#RKX2>"M(E\.Z;XH=;I]21
MI&&)CM.&('R_2NHD\=:G8:C8_P!L>&Y=/TR^N!;0W#W"M(KG[N]!]T'ZFE\#
MZ)K>A_#%-,>-+;5TCF\L,P8*Y+%22..XKC)O!WBG4X-)EO-.O7U&VOHI;NXN
M=1#HX#<E(P< ?@#0!U5W\1-2_P"$KU+P_IGAJ6_N+*2,%TFVKL(!+-QQC/ Y
MS574_B?J<=AJ.JZ5X<6[TG3YC;RSRW8C8N" <)@G&2*U/#NA:CIWQ$\4:M=6
M^RQO!'Y$FX'?M'/'45YO:".3^W/$4VFV&H:>M_)/Y<FHM;_=/>#&">.,]: /
M1;CQ[?K-9:7;:(DVO3VPNIK5KM4BMTSQND(Y)XXQ7/>-_'>H7OP_N)],MGM+
MJ*[6TOL7.U[9\C&TK]X-ZCM1J7AIO$.NZ?XS7PZFJV-]8*LVG3.$DB;J&7)
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M]!.S_P"_R_XT?V[I/_03L_\ O\O^-0?\(IX=_P"@#IG_ (")_A1_PBGAW_H
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MQU ^O%;$WCO0H=5ETX37$LL,@BF>&W=XXW/\+,!@&@#I:*** "BBB@ HHHH
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MR0^(8Y!O5=I!,9ZCVK9E%I);RI(&A=N$"G*GVJ.2#R=,M_+!0"1@D@^\/QH
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M.HDI/8****@S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZT =517,W?CW0+#Q+)H-W<M!=QQ&9FD7$87&?O?2D\+^/M#\7W5W!I,DS&U
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M;M?CCJ.NS6+KILIEV3DC!R!BO7* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KF/'/@Z+QMHD>FS7;VRI,)=Z*&)P",<_6NGHH S]"TI=#T*RTM)3*MK$(P
M[#!;'>KEQ"+BVEA)P)$*9],C%244 <=X#\ 0>!H[Y(;Z2Z^U.&.] NW'T^M=
MC110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
7 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>img254193463_44.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_44.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &F ?T# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M478605'/#'<V\D$J[HY%*.N<9!&#4E%(9Q/_  J/P-_T E_\")?_ (JM30_
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MT47=K!RJ]S(T7PQH_AZ6[ETJS%N]V^^<AV;>>>>2<=3TK7HHI7N-*VP4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%%):#:N9&@6.J:?:+;:A<6DR11I'$;>(H< 8RV2<]JUZ**&"5@HHHH ****
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MNS$DD_4T+_R&W_Z]U_\ 0C4EAJ-GJEJ+FQN8KB$DC?&V1D=1[&HU_P"0V_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ;AG:XP1]171"K"?PNYC*G*'Q*P^BBBM" HHHH **** "BBB@ HHHH ****
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M_N8HGD?3Y J L?WB]!^-*M[=.BLNG2889'[Q?\: +U%4OM=W_P! Z3_OXO\
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MZ[1C-3U2^UW?_0.D_P"_B_XT?:[O_H'2?]_%_P :%%15D#;;NR[15+[7=_\
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MLEXXRMNTJB0_1<YJY7G;6FBV-]JVC^*K>&-;ZZ>ZM=1F 42AN0HD_@=.@Y'
M&*:5R9.P26>B6VHZOI'BJ"&(WMR]U:ZC+\OF*<$!9?X'3H!D< $5J:'9#Q5X
M1@M]9E>\MHKE@LA&%O8XW(1G&.0< GU(]*?X9ANM9T:REO[LW5K"TT0$T*E;
MV,-B.5LC(.!GWSFNL50JA5   P .U4V*,;Z@JA5"J % P !P!2T45!84444
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:444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>72
<FILENAME>img254193463_45.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_45.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &' @D# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML0W[V*564.&3JH3:Q)(QQ5\J,^9]SJ+KQ9>->W\6CZ'+J=OIS^7=3+.L?[P
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M11TH!!&0<B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGG33J+5ZWZOR\S:$VH/1?<C1HHHKH,3F/'(NCHJ^1N\H29EV^F.,^W_UJP_
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M=UYK_P"1.JHE"DJOLU9^3_S*GVSQ+_T#+;_OZ/\ XJC[9XE_Z!EM_P!_1_\
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M)(56?/4E+NPHHHK4S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#"BBB@ JA>_\A+3?^NC_ /HMJOU0O?\ D):;_P!='_\ 1;4 7Z*** "BBB@
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M6T=O"NV.-0JCVJ6JP])TJ:B]^OJ]7^(JU3VDW);=/3H%%%%;&04444 %%%%
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MLI[DZ9?PF+.(94422<9^4!B#^8H X_0)O&VD>&['1HO"EN);:!81<SZDGEY
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M+W_P':K5M$8+6&$G)C0*3ZX&*EH H?VJG_/I>_\ @.U']JI_SZ7O_@.U7Z*
M*']JI_SZ7O\ X#M1_:J?\^E[_P" [5?HH H?VJG_ #Z7O_@.U']JI_SZ7O\
MX#M5^B@#.36(9%W);7C#)&1;L>1P:=_:J?\ /I>_^ [5/96QM8#&6#$R.^0/
M[S$_UJQ0!0_M5/\ GTO?_ =J/[53_GTO?_ =JOT4 4/[53_GTO?_  ':C^U4
M_P"?2]_\!VJ_10!0_M5/^?2]_P# =J/[53_GTO?_  ':K]% &<NLPL[HMM>%
MDQN MVX^M._M5/\ GTO?_ =JG@MC%=W4Q8$3%2!CIA0*L4 4/[53_GTO?_ =
MJ/[53_GTO?\ P':K]% %#^U4_P"?2]_\!VH_M5/^?2]_\!VJ_10!0_M5/^?2
M]_\  =J/[53_ )]+W_P':K]% &=_;$/F"/[->;R-P7[.V<>M._M5/^?2]_\
M =JG-L3J*76X86(Q[<>I!S^E6* *']JI_P ^E[_X#M1_:J?\^E[_ . [5?HH
M H?VJG_/I>_^ [4?VJG_ #Z7O_@.U7Z* *']JI_SZ7O_ (#M1_:J?\^E[_X#
MM5^B@"E'JD3S1Q-#<QF0[5,D)4$X)QD_0U=JO<VQGEMG# >3+YA&.ORD8_6K
M% !1110 4444 %%%% !1110 4444 %%%% !116=KFL0Z#I$VH3QR2A"JI%&,
MM([,%51[EB!0#T%US6;;P_HUSJEX)&@MP"PB7<QR0  /J14VFZE9ZOIT%_83
MI/:SKNCD0\$?T/MVKC]3UJ>:.+3O&6B-IMA=S1>7=V]V)8ED5PZI(VT%.5'.
M,'UINLQ3^#==AO\ 08UN%U:<I/HN_;YTI&?.B."$(ZOGY2.3S5<I'-K?H=Y1
M5>Q^U_88/M_D_:]@\X09V!N^W/./K5BI+"BBB@ HHJ*ZN8K.TFNKAPD,*-)(
MQ_A4#)/Y"@!TTJ00232'"1J68^P&365X;\3:9XJTI=0TR4M'G:\;C#QMZ,.W
MK[BN<NO%VHR:,VH:EX:GB\.W<)W7$%P'GBA<<2/$!P,')P25[U'K.G6?A_1[
M/Q1X;NXHI+6UBA"EBT>HP@!4C;')<\!6 SDXZ=+Y>Y'-U1W]%9VB7&IW>GBX
MU6TBM)I6+);HQ9HT_A#GH6]<<=NV:T:@M!1110 4444 %8NC>*M*UW4=1T^T
MF87=A,T4T4@VL=IVEE]5R",^WTK)?Q=J]PUS=Z1X;?4-*MIGA:9;I4FE*$JY
MCC(^8 @CD@G'%5%TC1-8\,QZUH6H&RN+:6>[AOY#\T#LQ>5)0?X,DAE/:JY>
MY#EV.[HKG?".L:SKNG+J&I:?!96\D:^2JLQ>4\[I.0-J'C:#SCD]1714FK%)
MW5PHHHI#"BBB@ K'7Q1I1\4/X<:XV:DL0E$;C <'G"GN0.2/0_7%"_\ $NJ-
MJUY8:#HBZB;#:+J26Z$"AV7<(TRIW-M()S@#(YK,M-,T#QM#JMSMN[74Y)HO
MM$<C;)[">-=J%?0XY!Y#<^XJDNY#ET1W5%<=X2US7M3NI+*[AM9[?3W>"?5(
MV(2[88V^6O8CG?V!&![=C2:L4G=7"BBBD,**** "L;5?%&E:)JVG:;J$_DS:
M@6$#,/DRN.&/;)8 >]%YXM\/:?JBZ9>:Q9P7K8_=22@$9Z ]@3[T[4_#>F:S
M>?:;^'[0#:/:&)SE"CLK$X]<HN"#Q32[DMWV->BN$T:]UW2]??PI;F/5;:U,
M<GV^:0[K: Y_=RX'S28'R^H()QBN[H:L-.X4444AA1110 5D^(/$>G>&+".]
MU21H[=YEAWJN[:6SR?8 $GZ5K50U/1[75VLC=!R+2X%S&H/#,%9<,.XPQXIJ
MW43O;0N12QSQ)+$ZR1NH9'0Y# ]"#W%/KSZ0ZCX+UN/1M BCU"UU%7>UT^23
M:;%N[YYQ!D\CJ#P.N*[^/?Y:^9MWX&[;TSWQ0U82=QU%%%(H**** "J&L:Q:
M:'I[7MX7*;EC2.)"SRNQPJ*HZL3T%6;NY2SLI[J0$I#&TC8] ,G^5<.VJI\0
M_#$<^D@VFMZ=/#>QV=UP4D7YE#=,HZDX;IS[8II7)D[>IN:9XQL[[4UTN[L[
M[2M0D4M#;W\80S =2C E6QW&<^U=%7FGB7Q1HOB+PQ/93)/:>)82&M+!HR+F
M*['W-G'(W?Q#C:3G%>C6WG?98OM 43;!YFWINQSC\:<E8(NY+1114E!1110
M4444 %%%% !1110 444UVV1L^TMM!.!U- %/6=4BT31+W5)T9X[2%IF5>K;1
MG ^M<+XD?Q1<^&IGURSL9-*G19)3IA?[38X(99!DXEV$ G&WH>U/M(O$_BGP
MLFMP:O:W$=_"S-HTMNOV=HSD&+S!\X;&06SU[8J/PEKFOVNB+;0:/<:S91%H
M(3YT<=Q;,IP8)PY )7IO'48..:T2L9-W)G\276I^%YM*U?0+S4+B[MBD,]A
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M0 R**.&)8HD6.-1A408 'H!3Z** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
7!1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>73
<FILENAME>img254193463_46.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_46.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &2 8H# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSVM[9\+(!U##L>#Z=*XSP5_Q[_%3Z2_^UZZCP5>>"M2\3K_PC?A:>$PQ,_\
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M8B^:VMHTM%<="PP#_P"@&O4:B>YI3V"BBBH+"BBB@ HHHH *0J&&" ?K2T4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%E(RVT,V.!GM]:@T+-( !T %>'_%G6?%DOA.%=3T*/2X?M2D3PWXD);:WRX
M'O\ E7GOP\U368_'6FM8I)?W(9]EM+<F-7^1LY8\# R?PK54KJ]S%U;2M8^L
MZ8(8@7(C0&3[YVCYNW/K61H%_KUZ)_[;T6+32I'E>7=B;?Z] ,5S5MHUOKOB
MKQ8U]>7\36MQ"D$L-Y)%Y \A&)4 [>I)Y%9-6-D[G=K;PIY>R&-?*&(\*!L'
MH/2H[FPL[W;]JM()]O3S8PV/SKRM+K4[[1=/\3ZVMY>Z7'9#S'LKLP26[)(P
M-QL! <.H5O89P#FNZN[F#7K22R9M0L8O-0"0_N/M8Z[$?.<,!SC!Q0!L#3+
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M R._-7[?_CWB_P!P?RJ+4 !IER ,#RF_E4MO_P >T7^X/Y5!H24444 %%%%
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M_D-;%]K$[2^X GTS7N.E:-I^B:;%IVG6L<%K$/E11W]3ZGW-9W@Q5'AFW(4
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M8Y\T[=P]AQBB&QEBBE1K^YD+C =]N4^F!0!<HJE;6,MN[,]_<S@KC$FW ]^
M*2VL)H)A(^HW4P'\$FW!_(4 7J*:BE$"EBQ'<]:=0 4444 >=&\L]+^-5Y)J
M\J0&YTV--/EF.%P#\Z@G@'-8NNZ+X>TO5M$LM$>*ZUZYUM;LRQE6E6,N6?<5
M_A [&O1M9T70O%,;Z?J=O;WAMR"4)^>(D<'(Y7(_.N;T"/X?>%O$+:5I36T.
MJLWDDL69MW79O/ /MFM$S)Q.]HHHK,U"FE$+ARJEQP&QR*=10!6U#_D&W/\
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M?0T5[:A1112&%%%% !1110!YMXWO=,L]?:[T^6_M==LXE>XO+2V:6%(CT6X
MX*X!/J!S67H-BNI:TFEZIJ4NG!KL:F-*\M6CN9-V_P R&?JR%N=O4=*[;6O
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MJ5DZMX@MM)GBMVM[N[NI5,@@M(3(X0=6([#M[GI3NV2TD:A"N&0@,.A!IP
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M;2V\DFIW$JK*N"RDC!^AI/EMH-<W,KG94445F:A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !4#P0O>PS/$C2QHVQRH++G&<'MFBBF
MA,PI88O^%C6TWEIYO]FNN_:-V-XXS72444WT%'J%%%%24%%%% !1110 4444
3 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>74
<FILENAME>img254193463_47.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_47.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ".!"(# 2(  A$! Q$!_\0
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MGV"YO(_LDJ3PPLJ%)9A&RLI8D,.2#GGTJ35O&6L6NL7]A:)9YBU>SL(6E1B
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M.,CUSD_,<5Z?4R5F5%W04444B@HHHH **** "C(SC/2HYU9K>54D\MRA"O\
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M.A'0U?\ ^$AUC_H(S_\ ?5'_  D.L?\ 01G_ .^J$J2U4G]R_P Q7J/HOO\
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MT&!3+'P?X=T[S_LVEP 3Q&%PY+CRSU0!B<+_ +(P*M?\(]I'_0/@_P"^:/\
MA'M(_P"@?!_WS1SU^R^]_P"0<E'N_N7^96M?"'AZRM+JUATR#R;I!',LA,F]
M1T7+$G [#H.U6=(T#2M"64:=:K"TQ!D<LSN^.!EF)) [#/%'_"/:1_T#X/\
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M1;B_\IYQ']IE+?+%C/(V*_'JRUZ15&UT>RM)[R>.$-+>3>=,\AW%FVA1UZ
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MX^?\:/[,M/\ GE_X^?\ &K=% %3^S+3_ )Y?^/G_ !H_LRT_YY?^/G_&K=%
M%3^S+3_GE_X^?\:/[,M/^>7_ (^?\:MT4 5/[,M/^>7_ (^?\:/[,M/^>7_C
MY_QJW10!4_LRT_YY?^/G_&C^S+3_ )Y?^/G_ !JW10!4_LRT_P">7_CY_P :
M/[,M/^>7_CY_QJW10!AZ[96]OH=W+%'M=4R#N)[BO,?M]S_ST_\ '1_A7JWB
M3_D7KW_KG_45Y!7S&=U:D*T5&36G?S9[V54X2I-R2>I9^WW/_/3_ ,='^%'V
M^Y_YZ?\ CH_PJM17C?6*W\[^]GJ>QI?RK[BS]ON?^>G_ (Z/\*/M]S_ST_\
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M[3'+N3M&-RKMW;M_J*YSQEH>E&\\1W^FW,XGL-1$=Q T"I$!(S >7@YX*XY
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MW>E:.H>);BX\/63"%8FU/2+BZ9D<YB98E8!3_P "Z^U/E8N9'3_V9:?\\O\
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MM]+NKZ3R/+G8R.@BDQYBX P<;L G'%=+_P (S8+JYU&)[N%F<2R00W+I#(X
M 9D!P3P/K@9S4-IX.TJRO8;J'[5FWF:>WB:X=HX68,&V(3@ [CQ1>(6D;]%%
M%06%%%% !1110 4444 %%%% 'F_B1K:7QCJL-Q'K4\Z6$!LETUI_W<A,G/R'
M:I)"\OQQ3H=8\1:/-JMU/##=/965G+?K+.5P1&?,$8 (W$Y/8<5W<6FV\.J7
M.HH&^T7$:1R$MP53=MP.WWC5:YT"PN_[3\U)#_:42Q7&'(RJ@@8].":OF1'*
M]RCXLN)$T_3)(9'CWZG: E6*DJ9!D''8^E7/$5U+!I9@MF*W=XZVL!'56?JW
M_ 5W-_P&K-]I=MJ$%O#<*Q2":.=-K$?,A!7]13YK"*?4;:]D+E[97$:Y^4%L
M M]< C\34W'9F+XHW66D:5%;RRH%U&SBR'.2OF*"">^1U]:D\)2R2VVJF61W
M*ZK=*N]B<*)#@#/8>E:NH:;;ZG%#'<ABL4\<Z[6Q\Z,&7]118:=;Z:DZ6P8"
M>>2X?<V?G<Y;\,]J+Z6"VMRW1112*"BBB@ HHHH *K2V$$VHVU\X;S[='2,A
MN 'V[N._W15FB@"@^BV#-9;;=8ULY&DA2(;5#,K*>!P<AF_.LNV\$Z/:C:GV
MME$4L$:R7+N(HI  R("?E& ,>E5(/$6K/INH:_)'9_V1;"Y*VRJWGD1%ADMG
M:"2IXV\ ]:J7GBC7]&M9&U!--GEETV6^M_LP=0C1[<HV2=P^<888Z'BKLR&X
MFU/X.TJX,P;[2J36:V4L:7#*LD:@A2PS@L 2 :JR>"[:]UO4;R^EE>VN7A(M
MHYW5'$: 8D4'#<C/\ZS;_P 3>)-._M-I4TIUTQ(KB7:D@,L<A/R+S\K#:WS'
M(/' YJ)=3U;1[C7;^#[')I\6LA)XI WFN'6%3L;.%QN! (.?:BS[BO'L=+=>
M%--NO-8_:(9GN3=">"=HY(Y"H0[6'(!50".E:,%A#;Z<+%6E>+84)DD9W8'J
M2Q.2>:Y8>)]7WIJ;1V/]D/J7]GB !OM _>^4'W9QG<,[<=.]5_B+J%C*=/\
M#][>O:6]X7FN)8PQ94C'RCY03S(4_!32LWH.Z2N==#I5K!HB:0BM]D2W^S %
MB3LV[>OKCO3+?1K.VN+.>-7$EG;&UBRY.(SMX/J?D'-<+/?W7BSP]X4N;2Z\
MK4A=/\X) ^T1129##^ZS+R/1J2_UF;Q1J.B7L(FM["QU&V26(Y!>Z9L.C?\
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MEOCPC_A(EY_Y=T_F:Y?(]:[WQEXCU6RUQ8K>X14\A6P84;G)]5KGO^$NUO\
MY^X__ :+_P")K] RW_=*=MK(^)Q]OK4[]S#R/6IK6[GL;N*ZM9FAN(7#QR(<
M,K#H16M_PEVM_P#/W'_X#1?_ !-'_"7:W_S]Q_\ @-%_\37=J<?NBMXSUYM0
M6^^WJLRQM%A8(UC9&.6!0+M8$\G(.35:\\1:KJ!O/M=ZTHO!&LP*J 5C.44
M#"@=@,"K'_"7:W_S]Q_^ T7_ ,31_P )=K?_ #]Q_P#@-%_\32MY#OYD)\3:
MN;BYN#?-YMS+%-,VU?F>(Y0].U27GB[7;][9Y]2??;3?:(FC58R)?[YV@9;W
M.33O^$NUO_G[C_\  :+_ .)H_P"$OUO_ )^X_P#P'B_^)HMY!==ROJ_B+5-=
M$2ZC="5(BQ2-(TC0%OO-M4 9/<]:BGUF_N=8CU:6Z8W\31M',  4* !, <#
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M\S_WVW^- %NBJG]FVG_/,_\ ?;?XT?V;:?\ /,_]]M_C0!;HJI_9MI_SS/\
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MG_A$M/;4%NY9[Z8+()OL\MTS0F4='*=,YY],\XJ_)H]C)J-K?&!!/;!Q&5
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M8[9ZXJ_4=O;PVEM%;6\:QPQ($C11@*H& !4E06@HHHH **** "BBB@ HHHH
M**** "N+OM/DA\4V?V34KZXU:6[$\P\]A%#9Y.4:/.T+C@<;BW.>#7:5SL'@
M^UMM6EU&'4]666:?SY4^UG9(WH1CE<#&/2FG8F2N<9::I?6][!JX%^R2W-S_
M *?+<DV]ZH60QQI#GY,X7!VK]T\G-:VF1S::WA74X]0O+B?5RJ7JS3LZ3;X6
MDW!2<+M(XV@<<5OVO@W2;2_CN4^TM'#(TL%J\[-!"[9RR)T!^9OIDXQ3]-\(
MZ7I=^EW!]I8PAEMHI9V>.V#?>$:DX7/3Z<#BJ<D2HLW:***@T"BBB@ HHHH
M**** *AT^ G[TW_?YO\ &C^SH/[TW_?YO\:MUQ-IX@N=-\6:Q_:EW_Q)Y;@P
MP._2VD2%7*Y]&4L1[J?6FE<3=CJ_[.@_O3?]_F_QH_LZ#^]-_P!_F_QKSDZQ
MK=]:ZS-<7MS:BYN]/:VCB;8]M!+(!M![,5Y/N:V[[[=X7U"TMX=5O+RTOXKA
M"MY('DBD2)I%=&P#CY2"#D<@T^4GG.K_ +.@_O3?]_F_QH_LZ#^]-_W^;_&N
M*TKQ3J,/A6/3[B03^(F6&*U9A_KQ,NZ.4CT4;MW_ %S;U%-MOMUUX(T[4M1\
M1WMO%#:MN:VP)IY]Q"DD@[N@ 0#DGG-'*'.=O_9T']Z;_O\ -_C1_9T']Z;_
M +_-_C6=I.MJL>FZ7JUS&NNRVJ22P!<$MMRW3CL:XE_&[CX:/_I&I_VL(2!=
M?8Y=N[?C/F;=G3OG%"BV-R2/1_[.@_O3?]_F_P :/[.@_O3?]_F_QKC/$NKS
M0VWB)8;S4(6MY[%&:-P=BN4W>4 N02"<]23TJE'K;6UIKB0:IK$UA;QVSQ_:
MCY5VCM)AMOF)N\LC;R1UW 4<HN='H']G0?WIO^_S?XT?V=!_>F_[_-_C7):K
MH\S>--/M$UW6HH+V*YFDCCO" I4IM"\<#YCQ]*["XW0:=+L=BT<)PQ.3D#K]
M:3128S^SH/[TW_?YO\:/[.@_O3?]_F_QK@X!J6D>!++Q3%KFHW%RMM#<7%O=
MS"2*96V[U (^4\G!'0XZUJV%O?>*9;^_EUJ_L8X;R6VM8+-U0((VV[GR#N8D
M$X/&,#%/E%S'3_V=!_>F_P"_S?XT?V=!_>F_[_-_C4J31*?(:X1YD4%P6 ;Z
MD=JR_$M[)#X;GELI@LLYC@BE0YVF1U3<#[;L_A2L-LO_ -G0?WIO^_S?XT?V
M=!_>F_[_ #?XUSL_BV:PNKF!=(FDT_3[F*TN+PW"Y!8)A@IY;&\9Z?C5.P\2
MSZ7X@UG^V+HG2WN9EMI'Z0-$BLT?XKEA_NM3Y6+F1UW]G0?WIO\ O\W^-']G
M0?WIO^_S?XUP-CJ^MNFI:E?W$L;P:A:3I:YP(H)0J^41W.U\G_:%==K,\K:Q
MHFGQRO&L\[RRE#@LL:[MOT+%<^P-#C8%*YH?V=!_>F_[_-_C1_9T']Z;_O\
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M_D']KTOY6>/U:L[YK/S5\J.:*5=LD4@.UAG(Z8((/<5ZM_PCVD?\^$/Y4?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
..*** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>75
<FILENAME>img254193463_48.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_48.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $3! ,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HKF/'OBF;P?X8?5H+:.Y=94C\MV*CYCUXKF3XY\=VUBFI77@=)
M+ H)6:VNPS[",YP,GI[52BVKDN:3L>FT5C>%_$^G>+=%CU/378QDE'C<8:-Q
MU5A_GK6S4M6&G?5!103CK10,***,\T %%%<=X=\6WNK^._$6A3PP);:85\IT
M!WMG^]DXII7$W8[&BBBD,***\^U[XCW2>(9?#WA717UG4H/^/AMVV*+U!/\
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MBBB@ HHHH **** "BBB@ HHHH **** /.?C=_P DXF_Z^8OYUVNA$#PWIA)
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MVOKJ\CM8YU9H;>8QB4DMC<1R<<X'O5[P3=O9VOC;PYJ&MW,&FZ5,4AOVEQ)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!"H888 CWI:** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV0@YD25@RM[ =JUJTIRE)>]&Q$XQ3]UW"BBBM" HHHH **** "BBB@ HHHH
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M,\8Y4>O/%=A0U8$TPHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFV\O=GG=D'I5TZ99&\^V&W3[1G/F=\XQ6-_PDNK_ /0FZO\ ]_K;_P".T?\
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MF[# $CWZ57O/&OAVPNY+6XU2,2Q';+L5G6(^CLH(7\2*33;&FDC>HID,T5S
MDT$B2Q2*&1T8%6!Z$$=13Z10445!>7MKI]J]U>7$5O;H,M)*X51]2: )Z*SX
M==TFXTR34X=2M9+&,$O<)*I10.N3T%7T97171@RL,@CH10 M%%% !1110 44
M5!>7MKIUI)=WMQ%;V\8R\LK!54=.2: )Z*KM?6BW4-JUS$+B=&>*,L-SJ,9(
M'<#(_.K% !1110 4444 %%9UQK^CVFHIIUQJEG%>OC; \RASGIP3GFK[NL:,
M[L%11EF8X 'J: N.HJDNL::]I:W2WUN;>[=8[>42#;*S= I[DX-7: "BBB@
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MK[PQ_P! Y_\ P*F_^+H_X5]X8_Z!S_\ @5-_\77344<S[ARQ[',_\*^\,?\
M0.?_ ,"IO_BZ/^%?>&/^@<__ (%3?_%UTU%',^X<L>QS/_"OO#'_ $#G_P#
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M# 'I6K4MEI6"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD\4'1+VTN3#9V/E1XEC &)#O&9-Q)X4C J>7PM=:=8^&H(E:\N8]86]U&Y4
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MP_X5Y!-\4="124:>0^BQ$?SJHWQ6TO\ AMKH_P# 1_C0![5_PG5Q_P! ^/\
M[^'_  H_X3NX_P"@?'_W\/\ A7A\OQ8LEV>593OEOGW$# ]O6KZ_%'0RH),Z
MGT,1H ]B7QU.QQ]@C'_;0_X5Q.HW>GZ[\2;J?5M%M;U$TJ()%,<A3YC?-TZ\
MXKG]+^(&D:KJ$5G TOFRG"AD(S4FIWW]F^)-7O@F_P C1TDV^N'-5'J3+H;[
MKX21B#X)TSCV/^% 'A _\R5IOY'_  KR.+XHZHK$RV=LX/3&14P^*=WWTR'_
M +^'_"ES/N/E78]7V^#_ /H2],_(_P"%&/!__0EZ9^1_PKRG_A:ES_T"X?\
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M3_A.I_\ H'Q_]_#_ (4?\)W/_P! ^/\ [^'_  KPG_A;<./^0;+_ -_!2_\
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M=Q"9MZ$XW/D=,>GO6O33L)JYS-MX,M+;QA+KRSN8V+2QV>/W<<[@*\H_VF4
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MX1#5_P#GG#_W]_\ K4 >/'X9G'_(;O?SIR?#1 1OUB^8>F[%>O\ _"'ZN?\
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MA7L(\':S_P \8/\ O[_]:FGP=KF\8AM]O?\ >_\ UJ /(A\,M,[R7)_X&/\
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MC8@$*\R@D'IU-%@N6Z*0$,H92"#R".]+0 4444 %%%% !1110 4444 %%%%
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MR^&_$-K*5;3KU6'=4)_45')INOLNV2UOR/1E:OKXP1-U13^%,-G;GK"A_P"
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M&V@<C!:*)5)'U JU0W<(QL%%%%24%%%% !1110 4444 %%%% !1110 4444
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MZ/[*M_63\ZO44 4?[*M_63\Z/[*M_63\ZO44 4?[)M_63\Z/[*M_63\ZO44
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MZCX \+:M?S7U_H\,]S,<R2,S98XQV/H!6EHN@:7X=M'M=)LTM8'?S&1"2"V
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>76
<FILENAME>img254193463_49.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_49.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (@!94# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ7E'P;'G:GXKNWYE>^*DGKC)-*.S94MTB;P]XNUJ^^,FKZ#<76[3K?S?+BV
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M12@KET5B <XR*D,D:MM9U!]":\NNM+M/A;X%U'7-+N;Z>[N((XT%U,'5'8@
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M$QNZGM3OC/HNIZO_ &!_9UC/=>5<,9/)0MM'R\G'3I7JM%"F[I]AN"::[D<
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MW*I[-YF,\=<=*]FHI<^M[![/2USD?AIH%]X;\$6=AJ3'[3N:1H\Y\L,<A?\
M/K6-\9] U'7?"=L=,MGN9K6Z$K11C+%=I!('?DBO1Z*2D^;F*<%R\IYG;_VG
M\1O!&HZ+JFA7.CLL,8MY9LX>1><X(! R!^!K$T'Q/XT\(^'T\/7'@^\N[FV!
MCMKB($HPR2,D ],U[/13YNEA<G6^IYW\*?!VH>'K._U361MU/4I/,>/CY%R3
MS[DD_I73^-+:>\\%ZQ;6T3RSR6KJD:#)8XZ"MVBDY-NXU%)6//O@[I=_I'@C
M[-J-I-:S_:7;RY5VG!QSBM_QU9:IJ'@O4[71W9;V2+";#AF'=0>Q(R*Z*BAR
MN[@HVCRG@&BZ?>'P5+H%I\/IO[9DC=)]0NH@J]_F#,,YQT KI_"$GB+PE\++
M80^')[R\%R_FVC_(PC)ZXZFO6**;G?H2J=NIX/J.C7/C3Q;I%UHW@^[T+R)0
M]W=31B('!!Z#@]^>M;WQ<T;67UW0-?TO3Y+Y+!L21Q LV=P8<#G!QUKUJBCG
MU0>S5FC"\*:Y?Z_I;7>H:-<:5*)"JPS'EE['H/Y5Y]\2-"U74?B1X=O+/3[B
M>VA*>9+&A*I\^>3VXKUZBDI6=T4XW5F>5^+M&U.Z^,?AK4+>QN);.#9YLZ(2
MB88]3VIWQJT;4M8T[14TVQGNVBNF9Q"A;:,#DUZE134W=/L)P337<\D\<^%]
M=M-?T7QCH-H;NYM(D2>U ^8X'IWX)%;6C>-O%.NZU9V\7@^XL;+/^ESWC%=H
M_P!G@9KT&BCFTLT')9W3/*_AUHVI:?\ $7Q7=W=C<06\['R99$(5_G)X/?BK
M/Q0\)ZM?ZAI?B708O/U#3C\T''SJ#D8]>XQ[UZ711SN]PY%R\IY9%XZ\5:C)
M!:V/@":*Y+ 3270*QJ.^#@?Y]:Q_&VEZE%\3[;5]3\/W>MZ*(5$=O ID5&QR
M,=.#Z]:]KHH4[/1"<+K5GARZ+K5_\3O#VMIX4.DZ8KA5CCC **,_-(%&%)S7
M1>)/$5U<7E]IFN?#N[U&W#,MI+"@D#CL2W\.?8UZ?11SWZ H6V9Y!X)^'6H/
M\.M<TO54:S;5'WP0,<F'&"I/X@?@*J^'=>\5^"])70-1\%W6H/;$I;SP+E6&
M<@$@'CWKVFBCGON'L[6LS \(WFLW^C?:-<TN+3;EY"5@C.?D[$^AK?HHJ66M
M HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@"GJFJ6>C:;/J%_,L-
MM"NYW/;_ .O7F3?'*V+//#X<U*73E8C[2 .??T_6NE^*>AWWB#P+=6FG(TEP
MCK*(EZN%/('O7#^#?BUI&F:+:^'_ !!ILMD;=/(9O+W(PZ?,O4>]:1BFKVN9
M3DU*U['K>AZU9^(='M]4L&<V\XRN]2I]^#6C7!^.?$W]@?#I-7\,RVJQ;XU@
M:) 8]A/8#BM"+7KYOA>-=+I]N^P>?NV\;\9Z5/+U+YNAUE%>2Z;\3-3MOA++
MXEOTCN;\W1MX@%VKGL2!V'-6_#]_\3;H:?J4IT>\L+HJTD2MM,:'OD=P/K3Y
M&)5$]CO-7\0:9H36BZC<B$W<HAA!!.YO3BM.O OBU/XF/C/2K>8V8M_M._30
MF<]0 7]\UZ+!=^/]/\*WLU[965_K'F@6\4#;5V$<D^N#VH<-$Q*=VU8[BN*\
M>>/_ /A"IM.C&ES7OVMCDH<;0,<#U;GI7'ZOXI^)/@V*UUC7X]/GT^24)+#$
M.4SVR.A_.M;XC^,[[2HO#,^EF#R=0E#-YL0?CY<8ST/S'FFH:KJ)ST?0]-B?
MS8DD (W*&P>HS3J\U^(_C?6?"FKZ#'IL<<Z79(D@9>9#D  'MUK$U[QC\1/"
M$EIJVMVVGG3)Y@CV\(R8P>=N?7&>?:DH-E.HD>RT5P7C?X@MH5IIMKH\"76K
M:J%-K&_W55L88_B?YU@7WBWQSX+>TU#Q*--O-+GE$<PMN'A)_P#K TE!L'-(
M]<KCOB!XX?P39V,Z60NOM,QB(+[=O&<]*RO'GC^^TN^TW0O#=O'<:MJ*JZ-)
MRJ*>G'J?TQ7G?Q-_X32+3M+A\4_8I8C<;HIK;@AL<J150A=JY,YV3L?0L4WF
M6B3[?O1A]H^F:\KG^-JVR.\WA75$C3[SL  /QQ7J-C_R#[;_ *Y+_(5S'Q2_
MY)KK?_7$?^A"IC:]FBIWM=,Y2#XX)<Q"6#PMJ<L9Z,F"#^(%>IV=Q]KLH+GR
MVC\V-7V-U7(S@UPWP7_Y)I8_]=9?_0S5?7_&&KZ?\6M(\/P2QC3[E5,BE,L<
MY[_A522;LB8R:2<GN>D45YU\5/%VK>%5T<Z7)&GVJ<I+O3=D<?XU2\:^.?$.
MA^--'TK2(8+D7L _<2#&YR2!\W:I4&RG-(]2HKQC4/'_ (W\%:LMKXEM+.\-
M["QM%MN ),X SZ9(S3K_ ,:^//!NKZ;)XGBL)=/O9-K) ,%/49]1FG[-B]HC
MV6BN#\?^/IO#C6.EZ/;"[UG4,"!&^Z@)P"1WY[5S>H^*OB'X(%OJ7B2"PO-,
MD<)*MOPT9/N*%!L;FDSV"BO-?B)X_N]!T70=7T:2-[:]E#.&3=OCVYQ[&KGA
M'5/&^L:_]OU2RAL] GB+P1''F ?PY[Y(YI<CM<.=7L=%XM\21>$_#L^KS6[S
MI$R@QH0"<G'>N"7XX0FV6Z;POJGV5N?.7!7'UZ5M_&7_ ))IJ'_72+_T,5SW
M@CX@^%M#^&UC::C?QM/%$ZR6H4LQR3QCWS5QBN6]KDRD^:U['H7A;Q;I/B_3
M3>Z7,6"G;)$XP\9]"*W:\:^#&GW%BFO>(KB![33+@EH$<8^4$L2!Z <59L?&
M'C?QM/=W?AA=.L=+@<QQM=\O*12<-78<9Z*^YZY17G7ASXDR3:)K9UZV6'5-
M$4FYCB^[(.@*^F3Q7/VWB7XDZMX>E\5V;Z9#IZAI$M63+%%Z\_AZTN1C]HCV
M6BO)M,\<^*KWX9ZQXGNOL$1C3_0_)0Y#!L-N!)J#P]XO^(/BZ/3+O3+"WBT^
M-T2[GD 'G'/SE03T'M1R,7M$>P45Y9>^./$?B;Q1>:-X-6SBM['Y;B]NN06S
MCY1]<U>\*>-M8'B>Z\+>*8;?^T(83/%<6Q^610,]/I2Y'8?.KGHM%>.:5XQ\
M=^-K[4)_#CZ9:V=I)L2&X&7?TS72>)_&FL^$_A]#J>IV-NNLRL(?*1BT:L<_
M,?P&<4W!WL"J*USOZXF_^('V'XC6OA3^RYG695S<@\ D9X'<#N:S/#]U\2Y)
M]/O+LZ1>:?=%6E6-MK1(><@CT_&C5/%.I6_QGT[08_(^Q2P@L3$"_*DG#=1T
MH4=1.6G8])HKS3Q7X[UF7Q8OA+PC;0RZD%W3W$WW8^,D8]ACFJ,/CCQ7X1\2
M66F>-8;66TOCMBNK;C8<XY]>U'(Q^T5SUFBO+O&GCKQ!H7Q"T_1M(MHKR.ZM
MP5MV&"SG< =W8< UFWWC3QWX-UW3CXGBL)M/OI-A6W'W.1G!]1G\:%!L'42/
M8Z*16#*&'0C(I:@L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH RO$FL_\ "/>';[5OL[W'V:/?Y2=6Y _K5+P5XH/B
M_P .1:J;-[1F=D,;'(R#U![BI_&&H3Z3X/U6_M2HG@MV=-Z[AGW'>N&T_P :
M:N?@I-XB#0+?Q%E0K$ @ ? ^7ITJU&Z(<K2/5**\<MO$_P 3=>\,QZWIUKI]
MO:QPESOY>?:/F8#L..E=M\._&#>,_#*WT\*Q744AAG5?NEAW'U!I.#2N"FF[
M'6T5P_Q2\3:CX4\+QZAICHLYN%0[UW J<Y_E7,:IXD^)C:)_PDMM9V-KIJ1"
M;[,WSR%,<L?YX]*%!M7!S2=CUYF"J6/0#)KR3_A>MK([_9_#NH3QJQ4.A!!Q
M73V'BJ7Q7\,+O5]/M7-Z]M+']GC&XB4 C ]>QKSGP;XPUWP+X42VN/!E^]C%
M(\DUV0R\D^A7'3 ZU48[W1,I[69ZYX5\3?\ "2:"=5EL)]/C#L-EQP=H'WOI
M_A7'7WQHLA>W$6CZ)?:I;6YQ)<PKA?<CCI]:Z_1]9TKQ]X6DFMGD^RW*M#,F
M=KH>A4^]8>H:GX<^$?A^"RBM+EH9F=D5%W%VXSN;\J22OL-MVO?0W?"7C#3/
M&6EF]TYG5D.V:&08>-O0_P"-=!7E7P6TMEM-6UWSH-FHS[D@A<-Y0R3AL=#S
MTKU6E-).R*@VXW845P/Q4\6:GX1TG3[O3#&'EN=D@=-VY<9Q7.ZYXE^)EEIA
M\2BRL+72T"R&S/SR*A[L?\XIJ#:N)S2=CU;4M1M-)T^>_OIEAMH5W.[= *\R
M?XWVV7N8?#FI2:6C[3=X 'U]/UKJ;;^S/B?X$MY+N.1+:Z :2.-\%74\C/UJ
M'QG=:/X/^'%S9E42W^S&VMH.[L1@#'?U-$4MFM12;W3T.CT/6[#Q#I,&IZ=-
MYMM,,@XP0>X([$5R'BWXL:/X:U2+3(8S?W9<+*L3@+%]3Z^U5OA3X>O+?X9-
M:W<DUJ]\7DC9#M>-6& 1Z'O7 ?$3P+IO@S2]#%L\EQ>3WI,]W+]Z3OT["JC&
M/-8F4I<MT?0T3^9$CXQN4'%.J*V_X](?]Q?Y5+61L%%<UXQOO$UG8P)X8TV*
M[NIGV-)*V%A'J1WKACXQ\;>#O$6FV_BU;.XL-0?RQ);C!C.0.OMD<52BV0YI
M/4]>HKR[QEXZ\0:'\1+'1=)MH;R.Y@&RW<8+.<X.[L!BLZ[\:>.?!_B'3%\4
MQV,NGW\FS%N/N<@'!]LBFH,3J)'L5<;X]\</X+&F%+%;K[;,8CE]NW&.>GO6
M7X]\>ZCIFM6/AKPU!'<:S=X;=(,K&#TX]<<^PKSOXD?\)C'_ &'!XI%E(HN=
MT,UMP<\94BG"%VKBG4LG8^B(VWQJ^,;@#7$^-_B3;^"M3L["73;B\DNH]Z>4
MP'?&,>M=I!_Q[Q?[@_E7B7QBE2'XC^%I975(T569F.  )>2:4$G*S*J2:C=&
M_'\;+""[CBU?0M3TZ)SCS9$R!]1U_*NJ\4>-K'PYX5B\0)&;ZUE=%3R6 W!L
MX.3]*Y+XJ^,/"U[X)N["+4+2]O)=OD1PN'*MG[W'3C-<OKMG=67[.VFQ7BLL
MAN4=588(4EB/TJE%.SL0YM75[GMNA:JFN:%8ZI'&T27<*S!&.2H(SBN=UOX@
MVVB>-;#PU)8RR2WFS;,K *NXXY'X5>^'_P#R3[0/^O&+_P!!%>9^/?\ DNWA
MSZP?^A&IC%.314I-13.W\9_$NQ\%:U9Z?>64TPN(Q(948 (-Q7H?IFNU@FCN
M8(YX7#Q2*'1AT((R#7B/Q=TM=;^)OA[3&;:+JV\O=Z$NV/UKH?A#K\R6U[X0
MU5RFHZ2[*BN>3$#CCZ']"*;BN5-"4WSM,ZSQKXTLO!.D)?7<;S/+((XX4(#,
M>YY[ 5<\*>(8_%7ANUUF&!X$N-^(W()&UBO;Z5X=XSN9OB!KFO:C&['1M MF
M6$J?E=SQG/N>?H!7J/P@('PNT@GI^^_]&O1**4;]0C-N=NA)X[^(]AX&DM(9
M[:2ZGN0S>7&P!51W.?4_R-=-HFK0:[HMGJEMGR;F,2*#U&>H_ \5XWIMC#\3
M?BEKUY./-TNSMWM8F[<@JI'_ (\U;/P5U2>VCU;PG>N?/TV=FC4]E)PP'MGG
M_@5#@E'S",VY>1ZU7#>&_'-SX@\1^(H8K5#I.F#;'.#\SN,Y'IS@UT7BJ_?2
M_">K7T9Q)!:R.OUVG%<7\*;!+/X3M.!^\NQ-,[=SU _04DE:Y3;YDD;W@;QU
M;^.+>\FM[*6V%M($(D8'=D>U5O$_Q(L= UZVT*ULI]2U.<@&&W(^3/0$GO7C
M/@3X@P>"_#FMQ)#)+J%Q(#;_ "_(IP1EC[5Z3\(_"L9M&\7ZC<I?:KJ!9A)N
MW>4#U_X$>_ITJI046V]C.,W))+<]0B9WA1I$V.5!9<YVGTS3ZX#QUXYU#2M:
ML?#7AZWBGUF] 8-,?DB4G@G\C62/&'B[PCK>GP>+3876FW\GE+<VHP8G/KZU
M"@V:.:3L>JT5YG9>--8TWXL3^&-;EB-E<C-D^S:>>5&>^>1]:L>+O%VKQ>/M
M&\+:%)&DD^)+MV3<53/Z< T<CN'.K7/1*R?$NOVWAG0+K5KL%HX%SL!P7)X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >;?$WQ1KND:SH&E:
M!<1PW%^[*QD0,#DJ%^G>LV7Q=XT\&>(-*M/%(LKVPU"3REEMUVLIR!G\,CBJ
M'Q&?4KOXP:!;Z3%#->VT'F11S-A"<L>3^%'AAKSXA^/GD\4S1PW&@OF+3(TP
MI;/WB>^"!^0K9)<NI@V^9V/99KF"W ,TT<0/3>P7/YT\.K)O# KC.X'C%>(^
M,3%8_$:]O/&FC7=_H+HL=G)&6,< P,G [YS5CQCXDL-&T#2?"N@7%U#IE[$)
M9=1 >4I;L3PO<D\_2IY-B_:;W+6J_$W4=1^(&EZ1H!"Z8UV+:6X*;A.V1NVG
MT KUW<H8*2-QZ#/->!1^(?"L7CWPC#I9G72M+A=3FV8,TK @$C&3DXR:]6U'
MP?\ VCXTT_Q'_:=U%]D3;]F4_(_7_'FB:2MT%"3=^I3\<^/HO"ZBPLK9[W69
M8S)%;HI(1?[['TX/Y4GPMU[5?$GA#^T]7E62>2X=4*H%&T8_KFKGQ"DALO ^
MMWQC07 LGA27:-PW#&,_4U!\+;3['\-M%C(PSQ&0_P# F)_D12TY!Z\YSOQ%
M^*4FB"[TS0(6FOK?'VFY*9CM\]O=N:[SPO=75]X7TR[OG#W4UNDDC 8R2,]*
MX7XVB&W\%B..)$EO;R-795 +XR>3WZ5Z+I5O]ETBRM\8\J!$Q]% H=N56"-^
M=W*OB5=4;P]>'1I1'J"QEH25!!(YQSZ]*XO0/B? WPXFUO5W47]FQ@FA P7E
M_A ';/\ 0UZ!J%_;:7I\]]>2K%;P(7D=NP%?,4\9GUL>,IM,9/#5QJP)@9L!
M^<DD?G^)(IPBI+4523B]#VCPCKNMP^$[OQ/XON4BMW4S0P+&%,<?;W)/85AV
MGB+XA^-@^H>'H+33-)W$0M<C+R8[U:^-ETY^',)M#FUGGBW,G39C*_ATKJ;2
M6ZT_X>V#^'[.*\G2SB\B$MM5\J,\_F:.E[!K?EOL0>"[OQA(UY:>*[*!# 1Y
M5U"1B7/M_6NHCN[:60QQW$3N.JJX)'X5Y;9^,/$GC;P9XGAM=/2UU&SQ BV\
MA+$_Q 'UP#5+X:Q^$KG5;*V?2[O3/$UDA9Q-(X-P<?,Q]?7%#CNV"GLD>RT4
M45F:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSY;#[K?GS71T4N9ARK4X[2/!UQ)X _X1?Q)/%=J%,2RPYR$'*GGN/Z"N=L/
MWCW0K8Z7I'BJU&FKD0F>(EXU].E>IT4^=BY$>>:=X UCPWX9DMM UU4U::Y%
MS<7$T64E..5QV%6_#W@W5$\4'Q/XEO[>ZU-8?(ACM8]D<:]R<\DUW%%',Q\B
M"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKYW^)O
MC_7&\67FF65[-:6EF_EA(FVEB.I)JX0<W9&=2HJ:NSZ(HKR3X->--4UUKW2M
M4G:Y:!!)%,_+8S@@GO7K=*47%V8X34X\R"BN.\;2SZ-?Z/XCA>3R+6?R+Q Q
MVF&3C)'3AL'--\2W,NK^+-#\/VLCB$'^T+QXV(_=I]Q<CU8_I1RC<K'9T9'K
M7%R>/P()M1ATJ671893&]X)E!(#;2PCZE0:S;#6=0M?%WBI]/TR;4D#PR\3!
M%5?+!P,]SZ"CE8<Z/1J*XB'Q%HNJZWH.K>7<H\]C/-'(TI5(D7[X=>A(]?:K
M^F^)M0UB..XBT&=-,N ?*NFF7=MP<,4Z@&CE8*2.H!!&0<T5YMX2\3'2_!VC
M6<<$E]J5[)<>3"9 ORK(V69FZ <5U^@^(%UE[RVEMS:WUFX2XMRX?;D94AAP
M010XM I)FU1114E!1110 4444 %%%% !1WHH[T %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%59]2LK6[AM;BZABGGR8HW< OCKBH+37M(O[R2TM-2M9[B/[T<<H9A18
M5T:-%>;?$?5]=7Q'H&@Z!J/V&XOB[/)Q@*.Y_6M+PGH'C"PU7[5KOB9-0M-A
M @1.K'H<^U5RZ7N+FUM8[>BO+[Y_'?B[Q/J-KI=XV@Z58MLCE>++3MZ^XJY\
M-O$NM7^I:SX?UZ5+F[TN0*+E!C>,XY]Z.72XE/6QZ)1114EA1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115:[U&S
ML#"+NZB@,S^7'YC!=[>@]Z +-%9R:_I$FHG3TU.T:\'6$2@M^7K7+>.-3\42
MZMI_A_PS$UNUT"\^HM'E85'8'UII78G))7.ZHKR2TUCQ9X*\=:1HNO:LFKV6
MJG8DFS:R-G&?P)%7_B-X\U72Y+C1O#UE,U]'!Y]Q=LGR01]<C/!-5R.]B?:*
MUV>F45R?PVU2]UGP+I]]J$[3W,@;?(W4X8UUE2U9V*3NKA1112&%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445PWQ8UK4
M= \$R7NF7+6]R)XU#KUP3S32N[";LKG<T5XX;7XCV7A>/Q)!XIBNT^SBY:VD
MA_AQDCWJ'Q+\1]5O?A[H&MZ=,UC<W%]Y%P(^02%.0,]NAJN1]"/:);H]IHJ&
M%V:RC<G+&,$GWQ7F_P ,O$FKZW%XF;4;UYS:3E8=P'R#YNGY"I2NKE.5FD>G
M45XE\+_B-JM]XGETG7KMYH[LL+220 8=3]T'W%>H>,/$4/A;PQ>:I*PWHNV%
M3_'(>%%-P:=A1FFKF[17E_P<\2:UXBMM7;6KN2>2&5 @<8V9!)%0_%#Q5KEO
MK=GH/ABX=+Q(7NKDQXRJ 9&?P!-/D?-RA[1<O,>K45SO@?Q$OBCPC8ZGD&9D
MV3@=I%X;_'\:Z*I:L[%)W5PHHHI#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS3QM\(K;Q1JSZI9WOV.YE
MQYRLFY6/K[&O2Z:74'!8#\:<9N+NB904U9G)>!/ -GX)M)A',UQ=SX\V8C'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[+\3SWX52QVVI^-)I"$BBOBS'LJC=_2N0\+^,K9?&.O>)-0TO4;T7I,-NUO
M758\X(S] *]%@^'$MKI7B2S@U9D;6IM[2>7S&N3D=><YQ73^%_#UOX7\.VND
M6[%U@!W2$8+L3DFAR6K!0EHCRSX/:['9>)M7\.F.>"WN'-U9I<(48#N"#[8_
M*O:ZX_7? RZKXRTOQ+:WQM;JSP'4)D2KZ'\"1785,VF[HN":5F%%%%06%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6%>$BZD^M;M5)+"*60N2<DYKGQ%.52*43:C-0=V5M+.9&^E:E5X+1+
M=B5).?6K%50@X0Y635DI2NC@OB9.ULWANX2VDN7CU1&6&(#>YP>!GO2^$DB\
M5W]WXAU4*]W$[VT5A(/^/%>A5@?XV[FM[Q)H$NN7&D2Q3I$+"\6Y8,I.\ '@
M>AIEYX<F3Q-#KNE7*6T[@1WT3*2ES'VSCHP[&NFZM8YVGS7.?U'0M(7XGZ+
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MPO)-/FM[)$)N;4M\S-S@\X! '/X5S?BO0Y=.M;E9[G;::EJZW<LX@,B0(JC
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MFB3&^1%STRP%.5E==RL&![@YJ2A:S9]>TRWF>&6Z59$.&&T\'\JTJ\L\0?\
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ME]JVC?V?X@O;U+I?-U%)+8!(AMSA21\O/&!7I=2U8<7<****104444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%'2N<C\;Z+)=I$))Q%))Y,=TT+"%
MWSC:'Z=::38FTCHZ*P]4\6:9I5X]I+]HFFC4/,MO"9/)4]"V.E27?B?2K33[
M6]\\SQW?_'LL"EVFXS\H%%F%T;%%9VD:Y8ZW%*]F[[X6V2Q2(4>-O1E/2M&D
M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M Q ]Z?-_J)/]T_RJ#3/^07:_]<E_E69H6J*** "BBB@ HHHH **** "BBB@
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M7:I:9_QZM_UT;^= %VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTOY_-SC[):M-C'KM'%8T'Q%TJY9UAT_6I"CF-]NG2':PZ@\<&@#KZ*16W*&
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M 5@>-_\ D2=7_P"O9JWZP/&__(DZO_U[-0!M6W_'K#_N+_*J/B+_ )%K5/\
MKTE_]!-7K;_CUA_W%_E5'Q%_R+6J?]>DO_H)IK<3V/BZBBBNX\\]$^"7_)2K
M3_KA-_Z#7U!7R_\ !+_DI5I_UPF_]!KZ@KEK?$==#X0HHHK(V"BBB@ HHHH
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MI?BS6=519H/"TP@,IC9VNX_E*MAN/8@UUU<UX&_Y%Y_^ORX_]&-72T %%%%
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M'=6&EVEM.8PIDBB"M@]1FM>@ KF_"/W]>_["T_\ ,5TE<WX1^_KW_86G_F*
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M8FMNBBI9:5@HHHI#"BBB@ HHHH ***KSQ':[B60$ G /%*3LKC2NRQ67JO\
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MB,E%WU9;HHHK,U"BBB@ HHHH I7G_'_8?]=&_P#035VJ5Y_Q_P!A_P!=&_\
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M3/\ D&6O_7)?Y5F:%JBBB@ HHHH **** "OD'XA?\E!US_KZ:OKZOD'XA?\
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MT%%%%62%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5XG\3FL]-\2ZS<:S9--'?:4(=,G,>](I1G</8G/6O;*X3Q=I?B_P#M
M234-'ET^_P!.,:A]*OD&TD=2I/0_C5P=F145T<UX<U>W\6^./#D^C03&'2=/
M,=Y=,A522H 3WYKV"O._!?Q"T_4-6_X1R713I.H@$F*(*8B0.<%:]$HGN%.U
M@HHHJ"PHHHH *I:G_JH/^NZ?SJ[5+4_]5!_UW3^= %VBBB@ HHHH *P/&_\
MR).K_P#7LU<U\5_&^J^"[+39M+6W9KF1U?ST+< #&,$>M>1ZG\:/%&K:9<6%
MQ'IXAG0HY2$@X/I\U:1IRDKHSE5C%V9]-VW_ !ZP_P"XO\JH^(O^1:U3_KTE
M_P#037SVGQU\6HBH(M-PH '[AO\ XJO5?#'B6_\ %GPLU'5-1$(N#'<(?)4J
MN O'!)H=-QU8*I&6B/EVBBBNLXCT3X)?\E*M/^N$W_H-?4%?+_P2_P"2E6G_
M %PF_P#0:^H*Y:WQ'70^$****R-@HHHH **** "BBB@ HHHH **** "BBB@#
MP3XDMI]OXD\3?VY$YO)K2'^R)'4E  1N"]@>M=-X=U:R\2?%"ROM##26]II1
MAO;D(55VXVK[D5?\86GBI-4FN5T;3O$.B'#+9RJ/.AXYVGO^M6O OC/P]J=R
M^B6&F-I&H1J7DLVA"].IR.#U[ULW[I@E[QWE%%%8FX4444 %%%% %*\_X_[#
M_KHW_H)J[5*\_P"/^P_ZZ-_Z":NT %%%% !1110 4444 <Q\0[JXLO &LW%K
M-)#/' 2DD;%64Y'0CI7R]_PF?B?_ *&'5/\ P*?_ !KZ<^)O_).-<_Z]S_,5
M\CUTT5H<M=M2->#Q7XAM8_+M];U&)-Q;:ERX&2<D]:]:^!FNZOJWB#5(]1U.
M[NT2U#*L\S. =XY&37AU>P_L^?\ (R:O_P!>:_\ H8JJB7*R:;?.CZ#HHHKD
M.P**** "BBB@ HHHH **** "BBB@ HHHH \^^*D:K:Z+>WMM)=:+:7HDOX4&
M[*XPI([@'^=>=3>(-'U?PG<^&-$MWFO[O5VELXHH2!$F_(;VXKV+QAIOB&_L
M[=O#M_!;7$+DR17";HYU(^ZW%</8^/(O"6JI9>)O"MOI=U(=OVJP561O?CG'
MXUK%Z:&$U[VIZQ;H\=M$DARZH Q]3BI*:CB1%=3E6&1]*=61N0/96LKEY+:%
MV/5FC!)IWV:#R3#Y,?E'JFT;?RJ6B@!J1I&@1$54 P%48 IL4$,&[RHHX]QR
MVQ0,GWJ2B@!DW^HD_P!T_P J@TS_ )!=K_UR7^53S?ZB3_=/\J@TS_D%VO\
MUR7^5 %JBBB@ HHHH **** "OD'XA?\ )0=<_P"OIJ^OJ^0?B%_R4'7/^OIJ
MVH;LPK[(YFKNC?\ (<T__KYC_P#0A5*KNC?\AS3_ /KYC_\ 0A72<RW/:/VA
M/^/70_\ >D_D*\*KW7]H3_CUT/\ WI/Y"O"JSI?"BZOQL*^H?@G_ ,DUM/\
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M^$-$\5IXIL)M:CM8K32K)[..6&0,UR"1@D9]JUNFC&S4CTZJ6L:B-)TBZO\
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M$D:6K7L@D?RPPLI-N[.""<<8- '5U\@_$+_DH.N?]?35]?5\@_$+_DH.N?\
M7TU;4-V85]D<S5W1O^0YI_\ U\Q_^A"J57=&_P"0YI__ %\Q_P#H0KI.9;GM
M'[0G_'KH?^])_(5X57NO[0G_ !ZZ'_O2?R%>%5G2^%%U?C85]!^"?^3?[_\
MZY7/\S7SY7T'X)_Y-_O_ /KE<_S-%39#I;OT/GSO11WHK0R/4?@-_P CY-_U
MY/\ ^A+7TG7S9\!O^1\F_P"O)_\ T):^DZY:WQ'91^$****R-0HHHH ****
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MM#E;O?7\$1C:ZK5+I6MH%%%%>B<@4444 %%%% !1110 4444 %%%% !1110
M4444 8WB;PQI_BS2QIVI&80!Q)^Y?:<CWQ7D'B_PE\/O"$RVTT.M7EV8_-:&
MWG!*)_>8XP!7O%>3?$/3M<T_5M8U#3]*?4;/6-.6SE,7+V[+G!QZ<UI3;O:Y
ME4BK7L3^&?#/@_P_XSTM;$:DFH7-D;JW,\FZ,J1RO3DXKU*O*?"T.O>)?$VB
M:E?Z1)I>G:-:F*+S^'F<J%SCTXKU:E/<JGMH%%%%06%%%% !5+4_]5!_UW3^
M=7:I:G_JH/\ KNG\Z +M%%% !1110!XO^T+_ ,@O1/\ KM)_(5X'7OG[0O\
MR"]$_P"NTG\A7@===+X$<=;XV%?17PQ_Y(I?_2Y_]!KYUKZ*^&/_ "12_P#I
M<_\ H-%78*/Q'SK1116AD>B?!+_DI5I_UPF_]!KZ@KY?^"7_ "4JT_ZX3?\
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M5O\ KHW\Z +M%%% !1110 4444 %%%% !1110 4444 %</X_UV[ MO"^B/\
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M9==M].:YL;U;.Q@:$L8^996:0*5]EP<^]3:]<W6J>*].\,PW<UI;R6KWEU+
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M^ KB](TKQ_XBTJVUA?&\%N+M!*L2("$![=*])\,66IZ?HD=OJ^I#4;P,Q:X
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M2?$#_D?M;_Z^GKFZJ.R(ENR]HG_(>T[_ *^HO_0A7VM7Q3HG_(>T[_KZB_\
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MOV@_^1@TG_KV;_T*O':[*?PHXJOQL*^@%_Y-M_[=O_9Z^?Z^@%_Y-M_[=O\
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M_P"P>?\ T,U\Z5G3Z^IK5Z>@5[#^SY_R,FK_ /7FO_H8KQZO8?V?/^1DU?\
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M )&#5O\ KV7_ -"K@_B%_P E!US_ *^FK-?Q&:O^&CF:NZ-_R'-/_P"OF/\
M]"%4JNZ-_P AS3_^OF/_ -"%:&:W/:/VA/\ CUT/_>D_D*\*KW7]H3_CUT/_
M 'I/Y"O"JSI?"BZOQL*^@_!/_)O]_P#]<KG^9KY\KZ#\$_\ )O\ ?_\ 7*Y_
MF:*FR'2W?H?/G>BCO16AD>H_ ;_D?)O^O)__ $):^DZ^;/@-_P CY-_UY/\
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M:'T9@*<)$)P'4GV-4[Z?389%^VM KD?+Y@&<5G4GRQNFEZ[%PC=VLRP+NV)
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M3.S%W=>F"Q)./:I3X7T<^'XM"-DATV+:$@R<#:<C]: -6,EHU8]2 :=2 !0
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MT)_QZZ'_ +TG\A7A5>Z_M"?\>NA_[TG\A7A59TOA1=7XV%?0?@G_ )-_O_\
MKE<_S-?/E?0?@G_DW^__ .N5S_,T5-D.EN_0^?.]%'>BM#(]1^ W_(^3?]>3
M_P#H2U])U\V? ;_D?)O^O)__ $):^DZY:WQ'91^$****R-0HHHH **** "BB
MB@ KGK?PR8/'=WXE^TY^T6:VOD;>F"#G/X5T-%-.PFKA1112&%%%% !1110
M4444 %%%% !1110 52TS_CU;_KHW\ZNU2TS_ (]6_P"NC?SH NT444 %%%%
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MY?\ T,UFUI>(?^1DU3_K[E_]#-9M=ZV//>YT?@'_ )'_ $+_ *_8_P"==_\
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M!+_DFEK_ -?$W_H5>B5YW\$O^2:6O_7Q-_Z%7HE<4_B9WP^%!1114E!1110
M4V2188GD<X1%+,?0"G4A ((.,=\T 5M/U&SU6S2[L+F.XMW^[)&<BN0D^*FA
MQZFUN8+\VBR^2VH" F /G'WO3/>N4NM0TG0_$\LG@76K8WDLF+C1G8B"X;OL
M/17^E,\.Z1-XHL9]!M?$1M-*6;?=://; 74/S;BF[NN>]:*"W9DYMZ(]F5@R
MAE.01D$4M-BC6*)(T^ZBA1]!3JS-0HHHH **;)(D4;22.J(@+,S'  '4FL[2
M_$6CZU))'INH07+QC+*C<@>N.X]Z+!<T)O\ 42?[I_E4&F?\@NU_ZY+_ "J>
M;_42?[I_E4&F?\@NU_ZY+_*@#P?]H/\ Y&#2?^O9O_0J\=KV+]H/_D8-)_Z]
MF_\ 0J\=KLI_"CBJ_&PKZ 7_ )-M_P"W;_V>OG^OH!?^3;?^W;_V>E4Z>HZ?
M7T/G^BBBM#(]B_9\_P"1@U;_ *]E_P#0JX/XA?\ )0=<_P"OIJ[S]GS_ )&#
M5O\ KV7_ -"K@_B%_P E!US_ *^FK-?Q&:O^&CF:NZ-_R'-/_P"OF/\ ]"%4
MJNZ-_P AS3_^OF/_ -"%:&:W/:/VA/\ CUT/_>D_D*\*KW7]H3_CUT/_ 'I/
MY"O"JSI?"BZOQL*^@_!/_)O]_P#]<KG^9KY\KZ#\$_\ )O\ ?_\ 7*Y_F:*F
MR'2W?H?/G>BCO16AD>H_ ;_D?)O^O)__ $):^DZ^;/@-_P CY-_UY/\ ^A+7
MTG7+6^([*/PA11161J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !5+3/^/5O^NC?SJ[6?I\T<5NRNX4^8W!^M)M+<:3>QH45&D\4
MAPC@GVKQ+XP>/;^WU5-#TB],,*1AYY('^9V/\.1T ]*NG'VCLC.I/V:NSW&B
MOF[P!X^\60ZD-(LV&I/=?+%'=R'$;=<Y[#&:]0;PIXRUY0=>\3_8X2.;73$V
MCZ%CUJY4^5ZLB%;G5XHY'XE?%35M.\03:/HDBVZ6IVRS;06=^X&>@%5? NJ7
M7Q+\11VGBB],\%A%YT5JJ!4F;.,OCKC(J[XJ^!\TLJ7'AZ\\QB,2QWDARQ_O
M!L?I74?#/X</X-$][?S1S:A.H3$?*QKU(![D\?E6CE!0TW,5&HZGO;'H:JJ(
M$10JJ,  8 %+117,=@4444 %%%% !1110 45"]W#&Q5FY'M4,EQ]I(AA)Y^\
MWH*SE5BMGJ6H29!<0M>73&/[J@#)I;?3Y(IE<E< YZU?CC6) BC@4^LUAXM\
MTMRW6DERK8****Z#$**** "BBB@ HHHH 3('4BC(]16=J+:5'*#?-$LC+QO)
M&16387NAPV$<LTL1G7)/)+=3BN.IBU"IR-Q^_P!/+S.B%!RCS)/[CII)$BC:
M21@J*,DDX KSC7S)JFI2W=M!,T &-^PX.!UKJ([:Z\02+->!H+!3E(.A?W-:
MU[&D6DW"1J%586  & .*X\72ECZ?\L%JN[_R7XLZ*%186?>3T\E_P3B?"EE<
MQ:U%))!*J%3\Q0@=*[BXT^VNG#S1[F QG<13[3_CS@_ZYK_*IJZ,#@88>C[-
M^\GKJ8XG$RJU.?;H44T>PB8,D 4@Y&&/6KU%%=L*<(?"K'/*4I?$[A1115DA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <W
MXY\/W'B7PQ+86DD:SB1)D63[DA4YVM[&N>\/>&M;N/%]OK6K:5IFDPVML]N(
M+-MWG[O[W; KT6BJ4FE8EQ3=SD['P5'HGB@:IHMRUI9S[OM=@/\ 5.W9E'\)
MS76444F[[C22V"BBBD,*X_5HTO\ XE:197<:RVL-E+<QQN,J9=P7..Y _G78
M5CZWH(U:6TNH;N6SO[-BT%Q& 2 1@J0>"I]#33L*2NC(T:&.P^(6N6=FBQVT
MEK#<-$@PHE)()QV) %;EU'J-P$'E6X"2!Q\QYQ46AZ FD27=S+=2WE_>.'GN
M90 6P,!0!P% Z 5L4-Z@EH4M^I?\\;?_ +[->3>(O@I=>(/$-]JSZJD+74ID
M,83(7/;->S44XR<=A2BI;G@1^ 4XN5@_MI=S*6SY?I5FV^ 5S;74,XUE6,;A
M\;.N#FO<#"IN%F.=ZJ5'TJ2J]I+N3[*'8X#Q]X$OO'5I8P27,-H+5V8%<MNR
M /Z5P-Q\ I[>WDF;6@509.(Z]]J.>%;B!X7SM<8.*2G)*R&Z<6[M'A0_9]N"
M ?[:7G_IG7H/AKP=?>'/!L_AU9H9UE$@\XY!&\8Z>U=N!@ #M2T.<GN"A%;'
M@W_#/EQ_T&E_[]U%#\ YIVE"ZT/W;[#^[[_Y->_5%# D!D*9_>/O;/K_ )%/
MVLNXO90['E?@SX27?@_Q'%K$>HQW+1HZ>6R[0=PQUIGB_P"$%WXM\1SZN^HQ
MVS2A1Y:KD# QUKURBESRO<?)&UK'@,GP#FCN(H3K0W29Q^[]!FIA^SY< _\
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M/_H.2?\ ?L5VP\#78\ _\(C]JB^S>7Y?VC!WXW9SCI7=44G.3W8*$5LCP_\
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M8W$O%V4FES;/;<[_ *I25#6-W8U_%6IPZE<P/;B0(J8W,N,\]JSM$ ?6;16
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MM(OM3+RS++Y!NSL8F0%B<]^I_"I[K1-3T7Q&FJV]D^NVYLDM?+FF'FQ,I)W
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M(QLK>F#2<6MQJ2>B-FBBBD4%%%% !1110 4444 %%%% !1110 4444 %%%%
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MI)CA%H****@L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(X8H
MP5MK$<'&<4M% '@OQ2^'":;I%WXFN-:O+Z]:501,%Q@GH,= /2O%J^H?C5_R
M3>Z_Z[1_SKY>KKI-N.IQ5DE+0]@^%GPYBUS28O$,6L7EA>PW#*A@"X&/K7T!
M$KK$BR/O< !FQC)]<5YK\"_^2?G_ *^I/Z5Z;7/4;<CII)**L%8_BK2I];\+
M:EIELR+-<PF-"YP 3ZUL45"T-&KGEFD>'OB7H^@P:+9WNAP6\*;$F"NTBCUY
M&,_A5ZU^&3V/@O6-.BU)I=8U0;KB]?C<V<X]<=?SKT6BKYV1[-'CTWPX\2W^
MBZ78RP:%9#3YHW_T96WSXZEFQU]JL?&/3(=3G\.6-N[+J\]P88BG7RR,,3[#
M_&O6:@>SMI;F.YDMXFGC&$E9 67Z'M0IN]Q.FK6,6\TG4M+\+VNF^&!9I);*
MB!+M24= .0<>OK6!X3\&:G9>,;OQ+JD6GV<DL'DK::>#L[98Y[\5Z!12YG8K
ME5[GG_Q3MI+:UT;Q+ C.^C7JRR*HY,38#?R%3S>&+O4OB9I?BV"6 Z<EEY94
MD[SD-@@8_P!H5V[HDB%'564]0PR#3@   !@#M1S:6$X7=R.:&.XMY()%S'(I
M1AZ@C!KS&R\'^-_#6FWF@Z!>Z;)I<[N89[G<)H W7 '!->I44E*PW%,X.T\)
MZUX8\)Z?I'AXZ==>6S->)?(=MP6ZXQT_^L*K^&O %[9VOB234'M+6?6HS&+>
MR!\F ;2.,]3S7HE%/F8N1'$?#[1/$WAS3TTC5O[.;3[="('@+&1B6SEL\8K?
M\4:5-K/A?4M-MBBS7,#1H7X )]:V**3=W<:BDK'$GP=J$GPI3PM]K2&]6V\H
MRH3M)!SCUP>E<I/\./$FH:3I5G+!H=DNG31O_HRMNGQU9FQZ=J]AHJE-H3II
MG'Z7X6OK+XEZOXBDDA-G>6JPQJI.\,"O48_V36$GPTNKJ#Q?;7T\*Q:Q,LML
MR$DH5)(+#ZD5Z;12YF'(CR;4/!GCS7/"4.@7][I,<%J8_+:,,6G"GC<>V!Z"
MMC6/!NMVWB2S\3>'+BT&H);+;7-O=9\N4 8SD<C_ .M7H-%/G8>S1Y[H_@K6
M9=5U?Q!K]S:R:K>VK6T,5OGRX%(QC)Y_R:JP_#[58_A')X5,UM]N9RP?<=GW
ML]<9_2O3**7.PY$>>^)? VIZQH7ABRMY;=9-+EC>8NQP0H .WCVJ5/"FN67B
MWQ/K=C-:J^HVJQVA9CE'&.6&/:N]HHYF'(MSR_PIX:\=>%T,,<>@RB>?S;JY
MD:1II<GDD],XSBJT'P\\16EWKD$0T>>#4Y7<7]TK//&ISP!7K-%/G8>S1YC/
M\.=4F^$]OX9%S;K?P3"57R=C$,3C./>K&O\ A;Q3XH\%6^G:B=-BOX;J.0>2
MS;/+4>I!YKT:BESL/9H\^U;PAKUEXJB\3>&KBS^UO;K!=6UWD1R  #((^@IF
MD>!=6,^OZUK=U;2:SJEJ]O&D (BA4J0!D\GM7HE%'.PY%<X"+P5J2?"*3PJ9
M+?[>T)3=N.S._=UQG]*QM5T^XFU+P/X+8;Y+%4N[QT^Z!& !S]0?SKUBF^6G
MF>9L7S ,;L<X],TU-@X(=1114%A1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
$% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>77
<FILENAME>img254193463_50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_50.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &[ I4# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%% !1110 4444 %%%% !1110 4444 %%%% !4=Q.MM;2SNKLL:%RJ*68X&<
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MT+*4+$E1AE8_*3C)"[<XS@FM.QLH-.LHK.V5E@B&U%9RY ],DDUC_P#%8?\
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M 4444 <_XJ_Y@G_85@_]FKH*SM6TQM3^P[91']FO([DY&=P7/'ZUHT %%%%
M!1110 4444 %%%% !1110!S_ (&_Y$;1?^O1/Y5T%<_X&_Y$;1?^O1/Y5T%
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M\8QR!P !6Y=6<1M&YE 2(JH65E& /0'!INW04;]2Q;?\>L/^XO\ *I:BMO\
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M_P #?\B-HO\ UZ)_*N@KG_ W_(C:+_UZ)_*N@H **** "BBB@ HHHH ****
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M#3[O4+B1UO-,^R*!E6\]9-Q]..E7Z0T[A1110 4444 %%%% !1110!B>'/\
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MW21$V\"Q[E7& =H&<9/7UKHJNHTY72(I1<8V;N%%%%0:!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 >=_&72]5U7P9''I<,T_EW*R3PP@EF3!'0
M<G!(./Q[5'\%])U;2O"-PNIP36ZRW)D@AF4JP7: 3@\@$@\?CWKN]8)&B7Y'
M!^S2?^@FC1R3H=@2<DVT?_H(K3G?)RF7(O:<Q=HHHK,U"BBB@ HHHH ****
M"N*U'7;?PKXQU"[UE;M;.^MH%M;B.%Y44IOW1D*#M;+9''.?:NUK'OM1GM-6
M21KBQBTF"%C>2S3!3$Y*[<YZ<9QGW]LM$R*?@D7#:)/<S6\UM'=7L]Q;P3C#
MQQ.Y*Y';.2V.VZNAFFCMX))I6"QQJ7=CV &2:2WN(;N!)[::.:%QE)(V#*P]
M01P:<Y8(Q0!GP=H8X!/N><4/<:5D8[^)[%;*"[\NY:.5'E($7S1QH<.[ \@
MD<=>>G6M6Y.;28CIY9_E7,C0-6-BJ!K.*=X;BVDQ(SJ$E8,'!VC++R-N,'/4
M5O75HGV1@'E4)$5 60@8 ]*;MT%%OJ6+;_CUA_W%_E4M16W_ !Z0_P"XO\JE
MJ2@KS'XZ_P#(AV__ &$(_P#T"2O3J\Q^.O\ R(=O_P!A"/\ ] DJZ?QHSK?
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M;?\ 'K#_ +B_RJ6@ KS'XZ_\B';_ /80C_\ 0)*].KS'XZ_\B';_ /80C_\
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M ,D^'_7W+_[+7H]<-3XV>E2^!!1114&@4444 %%%% !7#WEQK^E>-=6N=/\
M#/\ :J7,-N$E6^AA9%4-QACG&XM^1KN*XS4;R\\,^++[4CH>HZG::A!"B2:?
M$)9(GCW#8RDC"G<"#TSG--$R+W@B*Z31[J2[LELGGO[B86Z3)*(PSG(W(2,[
MMV??-=+7/>#K.\MM'GFO[46DUY=S7?V7()A5VR%)'&>Y]R:Z&A[CCL%17/\
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M 07O_'C<?]<F_E7Q;7VE>_\ 'C<?]<F_E7Q;75A^IQXOH%>N? +_ )&/5?\
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M'_7W+_[+7H]><?!'_DGP_P"ON7_V6O1Z\^I\;/4I? @HHHJ#0**** "BBB@
MKSCQ>KZGXM32K."&WO)H?*,S2NKW$95FPR*N&B!&-^X,C'(]&]'HIIV%)7,3
MPK!]GT?8]K>6]R96-PMW*97:3H3O_C7 &".V.G2MNBBDP2L%17/_ !ZS?[C?
MRJ6HKG_CUF_W&_E0,+;_ (]8?]Q?Y5+45M_QZP_[B_RJ6@ KS'XZ_P#(AV__
M &$(_P#T"2O3J\Q^.O\ R(=O_P!A"/\ ] DJZ?QHSK? SYTHHHKT#RPHHHH
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M]L?_ )\[G\E_QKT3B+517-S#9VLMS<2+'#"ADD=C@*H&2347VQ_^?.Y_)?\
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MA_3+/3M/#6#7'V>Y"S[)FR=S#);GD,W4]LY..3G6J64@HHHH&%%%% !1110
M4444 %%%% !1110 4451UC4AH^E3Z@\3210 /*%."L>1O;_@*Y;\* (]3UVQ
MTB:.*\:16EC=XL1DB0J,E%/=R.B]3@XZ5Q\5U=7&I6D.E;K9+6<I ES"S-;2
M;#O@G&XG:X^=9 >OJ, RZ]?'5-;O=,O)UBLK1D?R@BB1LHIBDA;.XRF4[5QP
M-ASR176:;ISP!+J^$$VJ>4()KJ)-GFJI)7(_'..Q)QQ5;(CXF2:;9RVT/F7<
MD<U\^?-F5-N1N9@@[[5W$ $_S-7:**DL**** "BBB@ HHHH ***HZMJ)TVR,
ML=O)=7#G9!;Q_>E<]!GH!ZL> .: #6+JYL]+EFLXA+<95(U*E@"S!=Q Y(&<
MD#L*YP:=#J-U=OKT:7]WIK^2%A4(EZI19$5HV.UF#,P4$XSSQGB]HNHZAJ_A
MJ&6"YB.H^;Y=WY\>TVK[LNFP=U'RC)YX))[V(O#D0\37&LSSM,6*M! 1\D+!
M A?W8@8![ G'4U6Q+U%\-Z3_ &=I4"SVT<5PIDV+PS01-(S)$&'95(7CCCCB
MMJBBI&E8****!A1110 4444 %%%% !1110 4444 %%%% !115>^OK;3+&:]O
M)A#;0KODD8'"CUXH +R^M=/A6:[F6&-I%C#MTW,<*">V20.:R/$_AXZS:B:S
MF-MJ<"LL,RL5WJ?O1.1SL;OCD'!'(K#UN[35M7L[G2+R'4[*XM)H)[%90\5S
M@AO+QG"R%3(03CE,'@G&KX=TW45,$UQJ<TVFPQYL8G5DE96''GYY9E!V@?B<
MG&*M;4B]]"3POHWV**>[ETRWTYKF19$L80I6WVIL!R!C>1G)'8@<XR8[MY_$
M]II^J^&M81(X6>1>NR9L8"2+UQ]X'H1D$<BGR:QJ^H3WIT*WLI(;&5H'%T[*
M\\JXW*N/N#G 9LY/.,8)I:58,TFE:AX;7[#I]W GVR)U#*JH%"@*3D2X&PGD
M8!SRJY/,/)&CIEU'XBFM=16"YM)["22*59%&"Q!62,-_$ P4[AP2H]\;]-CB
MCAC$<2*B+T51@#\*=4LI!1110,**** "J,4^GZ[87$:[+FV+/;SQNO<':RLI
MY'T/8US_ (FU_2;_ $S6-$@U9;?58HV5(S(T#F4 .H5CC.?E^[G@U3L+#5-0
MG^T6E\]I-/#']HO4ARE];L/DE7LDZC@]N<X(V@58ERULB6Q\)W=MJT=O(L<M
MA;W*7<6H2N7N2%&$@YY 7^]GE>,9+&MO5+VVG:Y\-VMXMIJD]BSV_!&T$,H8
M8]""<#G SVHU347TO^S]+L0IO+LF&W>Y+-&H1<DL<Y8X'"YRWJ "1D2VMSJ%
MQJ&G:K!"VKQ0)<6=]9 Q&0*7V%0Q;8RLS @D@A^X) -]6+;1"0BUT37;SP]I
M7G6S7BQ30QVJJ?(SN$DN'RH7Y5SQR6[DUT^G6":;:"!)))6+-))+)C=(['+,
M< #DGL !T%1:58SV\"3Z@\,^J21A;BXBB"!L$D*.^U=Q SS^=:%)L:04444B
M@HHHH *S=6OY-/6*9")%3<\EJB!IIE Y\L;AR.I&#D# YJQ?ZC9Z9;^?>W,4
M$9.T-(V 3UQ^0)^@-<-:VLWB34I;F[432NP@E5-BSZ4REGADB?\ C0@@[N<\
M'D94-(F3Z&SX;U.>8B-+6>X-S<23O?$DPO"=QC9&Z=-B[.".?3)TK[4$TJ2V
MTO2[&*:^G#/%;*PBC5 ?FD<@':N2!P"26''7%B*WCT;29C;P*[(KS.L:A/-D
M.68X' +')_&N?:S6]\+V.K3ZNQU)VCN+6_V[ECEEVJ$55',;%@I7N#R<\T]Q
M:I$,DB7B7\-[I&HKJD5W'<3VVGW9^8M$8XY$DRA\LA,=B&4Y&,UU&BVL]EHE
MC;710W,<""8Q@ -)CYCQZG)_&JNB65\)KC4]56&/4+I$C:&%MR11INVJ&(&X
MY=V)Q_%CM6Q2;&EU"BBBD4%%%% !1THK@M5U74KN[U31+VV@EB%]&ML,[4N4
M 20V[D\!F4D GY6(93TY:5Q-V)]:U'4M5N-2L[5 +>S,?F6RQYNF7AUN83N*
ML 0,+CYMC#(.!6W86KZ2M[JVL7ULTTD2>?-'"88U2,-@D%F.?F8DD^@[54\-
M:'%;RS7SZ:UB!.[6-N[+OMXG5-Z80E0I=68+D@9'0\"Q([ZQXAO=,FD4:?:P
M)YUL45OM/FAA\V0<( .@P2<Y.!@M]B5W93FUAKG4-*FU'2+NSLC<AK2Y:1?]
M8R,B"5.J!@Y ]RH.#Q5;1-"AO#<6UU#J$VD1"+R(]1RC&7Y_,.T8RA!3@C:3
MNP*+'3M1N&311*ESH5K=+(EX[YEQ%)D6Y!ZE70?/W48Z\UV=#=@2ON%%%%26
M%%%% !1110 4444 %%%% !1110 4444 %8.J:1JC37$^G:@LL<Z[9M/OAN@<
M8P0K#YH\C_>'^S6]10)JYA>&]-GCT+3!K-G#_:5DAB5V*R,H!*J0^.I4 G&.
MM;M%%#!*P4444#"BBB@ HHHH **** "N'N?$,\?C6UCGTB^:ZM;>ZCDBM4\P
M&)Y(3'*"< J=A![@@C'<]Q5*]TJVO[JSNI Z7%I)OAEC;:PSPRD]U8<$=^.X
M!IIB:;V*6G6=O=:F=>@BO+*6>,PSP2IY?G;3A6=3W&" >X/<8K:HHI D%%%%
M PHHHH **** "BBB@ HHHH **** "BBB@ HHHH *X_Q%KNJ:3KKPF*RN=.EM
M \=I(K+).V_8Z(PR"WSQX4KSNZC!)["J%_I<=]>:==%]DUC.948+G(*,C+]"
M&_04T)IVT,/PQH]NMPUV^EB(6YVV;W< 6ZMP00T1;G<@'W6#$8./X<F]XFG9
M!IEJUQ);6MY>""XFB<HRKL<JH8<KN957(YYP""0:W:@O+.VU"TEM+R".>WE7
M:\<BY5A[BB^HK:6.<U'3IAX@']@7BV>HM;*+OS$,D;PY*HS#/^L7!*D]0I!X
MZ=%864.FZ?;V5ON\J",1J6.20!U)[D]S4.F:/I^C0-#I]LL".=S8))8XQDDY
M)XXYJ]0V-(****0PHHHH *R/%%S?6?AZZN]/F6&:#;*SF+S,1JP,GRY&3L#<
M5KTC*KHR.H96&"",@BA SA8#=Z[J<<TFF0.V[[/+=QKYEEJ$*_># _,I&3M)
M##((#$$UV\4,=M D,$21Q1J$CC0!550,  #H*KZ58+I6E6NGQR/)';1+$C/U
MV@8'Z8%7*;8DK'#V::;>^ _MNIRSS75T4:Y99#YT=YNP$C!/R,C_ "J!C&!U
M[]!HNE7EI))>:K>)>:A(BQ>:D>Q5C7. %[$Y+-[G'0"IAX?T@:L=5&FVOV\G
M)N/+&[.,9SZXXSUQ6E0V)(****104444 %4M6N+BUTR::T-L+A<>6+EMJ,Q(
M 4GL3T!]2.#TJ[7%WFN3:VS+:Z7)?:44\NXM7\O_ $F-\[7C.[AP%W;&QE6!
MX.*:0F[%"ZU0>*I]D/VJ"ZMKWRHX)[.81LAB02PR2*I"G<7!.>@_NG-=C:0K
MI6GR75_)$9DC9IYTCP%0%F"COM4$@#T]S5;PWH[Z=9B>Z+-?31JLKN<N57.Q
M7()#.JG:7ZG%5]9US?<#3M+87=U'*/MEO;R)YJQ[2>-Y  W; 3U ;UP0WKHB
M5IJQM[XOMK.\+".:XT]8#*;BVMWF#89@QW+\H"!"3DY.1@>MJU\*:59WRW4,
M<X5)#+%;FX<P1.<Y98R=JGD]!QDXQFLKPWI!N=/7+!-$+N8]+<;_ "G5RI42
M X:+*DJN.C>@ KL*'IL-:ZL****DH**** "HYYX;6!Y[B5(H4&7=V"JH]R:<
M[I'&SNP5%!+,QP !W-<KXEOKBZ@TFZT6[MKNUEN&AFAW*\-TK1MA&;D#) 4'
ML6&<BFE<3=C1\3>'HO$.GI'N\NZMW\ZVER1M?&,':0=I!(.#GG(P0#53P[H<
M'V>>[O(KYI;KRTFM=1D\X1-"S8VL1EADY#$G("GBJOAZ/59!;P65WMT*)]Z/
M+S<QA3@VK @XVL""V<X&WK\U=A3>F@DD]0K)U3P_;:G=1W@N+NSNT0Q?:+27
M8[(3G:W!!&>1D<'IC-:U%24U<KV-E;Z=916EJA2&,84%BQ/<DD\DDDDD\DG-
M6*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ>HV
M U&&*,W$\'ES)+F%L%MIS@^U %RBN8T/7KK5-1FM6N+27$4K'R$.ZW992BA_
MF.2PR>WW369=^,K^'2)[PBWAF@#(87BR))8DS, Q=<#>0@ZGY3@'L^5D\R.Z
MHKB[7Q#)933V;30AWO0($D/SR;[^:.0+D\[4"].GTJ72/$.MZGISW"VMO)+F
M,^5;^6[Q;@VY74S+@@@#)(/7Y1BBP<R.OHKBH]1\K7S)>7C0WJ79\Z"2<JL=
MJ+?<6*;BH0-SNY&[C=5>?4+6&\N9+S5)XMK7G]I!;E@8H%D_=?*#\A*[ I !
M(8XR3FGRAS'>T5P<=Y;V]MX=N&UKRXI=1DV0?;E=-C!R$9LDN5RHQD@$XYPI
MK<T6Z@;Q'KEJFH_:9%D1S&TP8Q\8*A1]T#@=/KDDDJP*1T%%%%(H**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH Y_5KF[T'4#JQDEN-(=0MY#RQML=)D']W
M^\O_  (=#F+P[HEJA744M[JUB:62:VLYI,K%O)R^W&59@3P2=H8CCD5TM%.X
MK:G!ZQXD-]L<LMGIZW,L4-VC.US!-$K$R-$%/[O(*E3SA@3@&I-/T>?6M3M;
MRXM(+>"T<LX1WYE8NTAC.-KQ2^8C$YZ+M(STU-5\+O<:N^I:7<QV-Q=Q_9[Y
M_*#&2+^\O]V08 !Y&.H.T8Z"W@BM;:*W@0)%$@1%'\*@8 _*G?30E1;>H]$6
M-%1%"JHP% P /2EHHJ2PHHHH **** .?\0ZU?Z3?V$=O96]S;7"2^9YLWE,6
M4!@JD_+G:'/S8'RGD5SGAC2=#U'43/9Z2R6:LEU&)8FMI[20,'6-L8\R,_>7
ME@,$=,8Z_7]&CUO3DMV$>^.>.=#(NY<HP)!'<$94^S&M2JOH3RW>H4445)04
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!%;V\5K"(8$"1@DA1ZDDG]2:EHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKGK/Q#J-SXVOM"D\.WD%A
M;P"6/57/[J9CM^4<8[GH2?E.0*Z&@ HK+\2VMO>^&=3@NK>*>%K9R8Y4#*2
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M]KIMO!XPUSPQ964,FC'38+T:>6,=O'.7D!CP 0J.%4LH!!P3M.2#C7&EVO\
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M @DMY(XKY7MKF2[B/]IW)VRO]]O]9R6R<YZ[F_O'.7?^"GM&L8M#M!):6Z3
M)+KMY:RHTC(S8E3>S*=@.TX (SSGBE/+JNCZWXLOM/FMVN(([&>[,T,DJM&$
M?S?+3S 5( +!02.,8R<UV>DW5U>F\GEEMWM#<,EH8HRIV+\I+$L0QW!L$ <
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M)QGGID9R.<U3Q%XLM6LM/T^SM+_5;FUDO2(;<"-$!0+'^\N$SRW,@/8?N^>
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MR"_\. 1ORD!\;>)KVQL;;2=,@N=7=+QYMD2F(^1.8!A7GC*AB,D[F*\##9R
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M([E+*RB$,-O'>S)&8P -KJK@2#  P^[C/J:UFBC<(&C1@A#+D9VD=QZ4^B@
MK#'A#0Q<7,ILV9;GS#+;O/(T!+@AV$);RPS G)"@G<WJ<[E% '.CP/H7D0PF
M.^98)4EC+ZE<LRLGW/F,F<+SA<X!)(')IW_"%Z($G54OD,\YN'=-2N5?S",$
MAA)D9'! (!%=!10!F:AX?TS4]$&C7%NPT\*J"&"9X0%7HN4(.!@<9Q6;-X"T
M"<W!DBOV:XN([F5O[4N@6EC&$?/F<$8&,?W5_NC'2T4 %%%% !1110 4444
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MPP8>3\_[D9 X3:. .@J.'X?>';>?SXHM064"8!O[5NCCS?\ 6'_6=6."3U)
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E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>78
<FILENAME>img254193463_51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_51.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #B FD# 2(  A$! Q$!_\0
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M[OP__9>LZA?:A=6\QUZ">=W$?[HDEU;B,A^ !CTIRA9NW];_ .01GM?^MO\
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M@-^+'^/[9Y6WR\?W-WSX_O5T_A;2=5M]$T S:A-;16]A#'/IS0(07"8.6(W
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M-SY.<''&,=<BNEAE6>".90P5U# ,,$ C/([4FFAIICZ***0PHHHH *3:-V[
MW8QG'-+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBN=L/$FJZBGGV^C6TT 8*ZPWX,J9]5*!?_'J:38FTCIZR?$:L^E%4LI;MV<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@="2/J#0*Y:^TC_GC-_WQ1]I'_/&;_O@U/10,@-PI&##*1[QT?:1_P \9O\
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MKW 3']:EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,T +129HS0 M%&:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!AI#110 E%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4M%% "TX444 +1110 4444
M%%%% !1110 4444 %%%% !1110 E%%% !1110 4444 %%%% !1110 4444 %
F%%% !1110 4444 %%%% !1110 4444 %%%% "T444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>79
<FILENAME>img254193463_52.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_52.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '2 _<# 2(  A$! Q$!_\0
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M9HD>GEL3O!(Q<+CMEC4[Q12TFSDM-\9:_+\+_%FK/J!-]97QCMY1$@V+N3C
M&#U/4'K3-7UOQUHWA'3?&DWB"VFBE$+/IJ6JJA1QQENI/KTZ\=*O6'@#7K?X
M<>)]$DC@^VZC>&: "4;2NY#R>WW36KXF\'ZMJGPEL/#MLD)U""*W5U:3"Y0
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M^D1N_P \;NC_ "X[_?%4[(F-W^!9U*P\66/AW3[>?QG863(7^W:E/"H9LME
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MX.!R#C]>V.8O .I>._&4$-[)KD$&GV5Z4F)A4R70!#,IP, !2 /K[5UVA?\
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ME^S)I4;FR&Q?W) DQCCGH.N>E7-6\.>*-)^(=SXG\-P65['?VZP3P7,FSRR
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M8****DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \
MBTO5++P9\6O$[>(IA:)J2I+:7,JG8R \J#^('_ ?I6/ W]L2_$OQ)8*PT>XL
M)(8I"I43.%Y(S]"?^!5[==6-I?($O+6"X0<A9HPX'YTX6MN+;[,((A 1M\K8
M-N/3'3%:<YE[-[7/(Y,?\,SCI_QZC_T?7H?@@Y\"Z"<Y_P! AY_X *U_L5K]
MD^R?9H?LV,>3Y8V8Z_=Z5+'&D4:QQHJ(HPJJ, #T J7*Z*C&SN>4Z%IUMJ_Q
M2\?Z=>)OM[F".-Q[%1T]ZK^"O!'B'_A*;5/$BE],\.!X]-9NDS%B58<]ACZ8
M4=J];2UMXIY)XX(DFD^_(J ,WU/4U+3YWT$J:ZGD?@@_Z#\2>?\ E\N?Y/5#
MX7_$'PQX;\"166J:F(;I)I',0A=C@GCHI'ZU[+'9VL0E$=M"@F),FU -Y/7/
MK^-5AH>D*01I=B".A%NG^%/G3O<7(U:S/,_"D=SXW^*,OC06DUOH]G!Y%FTR
M[3,<$9 ]/F8_B!ZU2\&^'8/%6A>.])GP#-JLAB<C[D@)*M^?Z9KV< *H50 !
MP .U1P6MO;%S!!%%YC;G\M NX^IQU-+G[#]GW/+O 7AG7WU&[\0^+8V6^M+4
M6%DCXR$5<,_7OZ]\M47PS\0V'ACX0/JNH2%8(KJ7 499V)&%'N:];(!&#R*J
M_P!F6'V7[+]AMOL^[=Y7E+LSZXQC-#G?<%"VQXCHGC3PYK7B0>*/&&K(L\#$
M:=IJ12.EJN?O,0N"W_Z_0#W2WGBNK:*X@</#*@=&'\2D9!_*J?\ 86C_ /0*
ML?\ P'3_  J^JJB*B*%51@ #  I2:>PX1:W%HHHJ2PHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *X[XH>(?^$=\"WTL;[;JZ'V6WQUW/P2/HNX_A
M78U#/:6UUL^T6\4VP[D\Q VT^HST--.SU%)75D>2Z7\._&<7@E=!76M,AL+B
M$F2W>TRP+\D%L9R">OL*Y:6XU#6?@S=:(R.]]X<U!5N81RWDC< <>@)(^BU]
M$U#':6T4TDT=O$DLO^L=4 9_J>]6JG<S=)=#E]'^(OA;4VTRSL;]7N;L!8[=
M(V+1D#.&X^7&,<US?P51!9^)) J[VU1P6QR0 ,#]3^=>D6VF6%G,\UK8VT$K
M_>>*)5+?4@<U)!:V]J&%O;Q0AVW,(T"[CZG'>INK-(KE=TV>2>"]<TWP1XF\
M6:=XDN!8W4]Z;F.653B:,EB""!SUS^)]ZS?#]IH^H^&_&>JZZ\MCX<U;4%-M
M($(8$.Q#@ 'NR]L<'TKVJZT^ROMOVNSM[C;]WSHE?'TR*E,$30>08D,6-OEE
M1MQZ8]*KG)]GT/'_  MK=U8^*QX<C\1IXD\-M8R23S%,FUC"G@L,YZ 8SWZ"
MLBVU1/"=WI:^!O%9U:RO+M8_[%F3<ZJQR3TROY#KGGFO<K/3K+3U9;*SM[96
M.6$,2H#]<"FPZ5IUM=-=06%K%<-]Z5(55S]2!FCG78/9ON5?$NDG7?#.I:6'
M"-=6[QJQZ!B.#^>*\Q\ ?$'3_">BCPOXK\W3+W3W9%,D3,'0L2/N@]R?8C&*
M]CJI>:7I^H%3>V-M<[?N^="KX^F14J2M9E2B[W1YIXN\00_$7X?:_!X=M[R1
M;-HW\QH2JW"JP9@G<D8)QUX'K7-))X1UKPS8VNI>.]<D241(=-X8HXP-NT)T
M!Z&O>(H8H(EBAC2.-1A410 /H!5=-*TZ*Z^U1V%JES_SV6%0_P">,U2FEH2X
M-N[/+X5"?&;Q8@8G;H0&2>3\D5;/P5_Y)K:?]=YO_0S7>?9+;[0\_P!GB\Z1
M=CR;!N9?0GJ12V]M!:1"*WACAC'(2-0H'X"DY75AJ%G<\D^(NI6>D?%[PG?W
M\PAM8(2TDA4G:,L.@R:Z'6_''ASQ+X/\1V>CZFEU<)I=Q*R"-UPH0@GYE'<B
MNVN=.L;UU>ZL[>=E& 98E8@?B*9%I.FP;_)T^UC\Q2C[(5&Y3U!P.1[4<RLO
M(.5W?F>%:U_R2#P'_P!A ?S>NQ^*1QXP\!GH?[1_]FCKT=M.LF@C@:SMS#$<
MQQF)=J'U QQ3YK6WN'C>:WBD>([HV= 2A]1GI3Y]?O%[/2WI^!XA/!%HGQ1\
M1IK?B+4=!6^87%K<VS!4F3)."2IZ9P/H?:N[^&UKH21ZQ>:)J]]JGVFY'VBX
MNEQN< \J=HSG=UKLKNQL[] EY:P7"#HLT8<#\ZEAABMXEB@B2*-1A410H'T
MI.=T.,+.YXYXZTF#7?C?H.FW,L\44UB=SP2;'&/-/![=*[KP_P##SP_X7O9-
M2LX)[B_*D">YE\QP/0=AGIGK73-:6SW*7+V\37"#"RE 64>@/4=:FH<VU8:@
MDVV>!ZKXVU#Q3X7UJ6[\1V^F%A+!%H<%H'FD '1F/S#/.2!Q@GBE!_T;X1Y/
M_+<_^C4KW!=+T]+J2Z2QMEN) 0\HA4.P/7)QDT[^S[+$ ^QV^(#F']TO[O\
MW>./PI\ZZ(GV;ZL\W\6G'QQ\'$<'R)!^CUR.BQ6^@^)/$6FZ]XJU3P_=&[:=
M# P6.X1B2&R5.3_C]:]Y>UMY+A+B2WB::/A)&0%E^AZBF7>FV-_M^V65O<;?
MN^=$KX_,4*>E@=.[N>$>)K/1;/X8Z>VA7]W>VEQKXE,UTNUB^Q@<# XX!KZ
MJ"6RM)H4AEM89(D(*(\8*J1TP.U3U,I7*C&P4445)84444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?5-"T_7$T6+3(XB MNDLMRSKN+?/P$' XH2N#=CO**RK.:YTC0?.\1:C:/)
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M2W:XR/)612Q([@<$^P-4K35]+;QGJ>JV][;?V:EC!!<W:N/*:8R-L7<."P#
M?\" JDM"7+6QU4]]:VUQ;6\TZ)-<L5AC)^:0@9.![ 9JQ7E]]J=Y:^)=3U@Z
MG;?VG!=+8VNCR1!I)(-R_<YW OG=N QP,\#CTXL1(%QP1G-)JP*5QU%%%(H*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;O@OR0.QQ32N)M([*BN,OO%&K:'<RZ;?16=U?RQQ-8O"&CCD9Y!&5<$DC:S
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% ' 76C+X@\77VEZCXNU-I(4%PNGV/^CI%$QPH=AG<?Q!Y
MKF-)E\-ZAJ\-CX9\5^(].U&4NL)N&:2"1E!)!5^&Z'O6S-K-MX$^).M7>N++
M%IVMI ]O?",LB-&NTHV,D>OY54M[[1O$OB3PYI'@^W9M-T>Z:]N+E8V6./()
MV MR2Q8_YSC97,':_F>H0)=1:?&DTL<]VL0#2;=BN^.N!G )KD8O"NL7%AJU
MM>RV$+W5Z-0MY8&=S%,I0J"& RN4'YUVU%9)V-G%,XZ\\*ZGK4\VH:C<VD&H
M1QQ)9"W#/'$R2"3<V[!;<P (XP!Z\UIZ7I.H?VY/K6K/;?:6MUM8H;4L41 Q
M8DE@"23CL, #K6]11S,7*BF?^0RO_7N?_0A3K^Q%_$L9N;B#!SN@DV$_6FG_
M )#*_P#7N?\ T(5<J)14ERRV+C)Q=T<#XC\(WK3I/9R3WBE=K>=)N=?Q/:M#
M0O"<UO8?Z5>WEO*[;O+MYMH'U]ZT]3\8>'=%O#9ZEK%I:W 4,8Y7P<'H:M:1
MKVE:]%)+I5_!>)$P5VB;(4GL:X(Y50C5=:SUZ=#L>8U94U2NOU$U*V=?#=[;
M1F69_LDB+N.YW.T@?4UR'@K3+_PU+8+>6]Q=1ZG8P+]JD3,UG(D8_<28'$?4
MJ<##;@>2#7?R2)%&TDCJB("S,QP !U)JAI_B#1M6E:+3M6L;N11N*07"NP'K
M@'I7H)65D<;=W<P=&T_5@/$"VT_]GRRZU)*DD]MY@DC\N,9 R."1USVJE=Z@
M-4\6P:=<6&HV^G6%VL@9-/EVWER#PY<+M6-3SDGYB,]!SU]MK&F7E]-96VHV
MLUW#GS8(YE9TQP<@'(I;O5]-T^>&"\O[:WFF.(TEE56?MP">>>*8CBM-CFM-
M65-"M-9ETY8+E[ZRU!76-G/S(D?F<;F8M]T[<$Y[5=T RWOC6XU.*VU 6CV(
MC8W]N8C:OO!\F+(&5QDMU&57YJZAM6TY=2&G-?VPOF&1;F5?,(QG[N<].:(M
M7TV;4)-/BO[9[R,9>!95+KZY7.?_ -= %RBJ=CJVG:FTJV%_;731'$@AE5RA
M]\'CH?RJY0 4444 %%%% !115%=3C:[^S?9[D29ZF(XQG&<^E3*<8VNRE%RV
M+U%%%42%%9L]S=)JD=JMQ:J)%9PK*=P QQ][OG]*TJB$U)M+H5*#BD^X445S
M^L:O'8ZI;P-J9@$A^=1&K!!@X.2/7%36K1HQYI;?+]2J5*567+$Z"BF"6,
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M)2V=OWL';CH>N>*[ _ZY?H?Z4W?J*-N@^OEO4/\ C_N/^NK_ /H1KZDKY;U
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M,9R1D8^M=%Z%&<4URRELK+IYJ_YG/^^JQDT^:,=W=_D[?D>AT445UF 4444
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MDULSG/\ A ?"?_0 L?\ OU1_P@'A/_H 6/\ WZKHZ*5D5[2?<YP> ?"88,-
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M,-K45^[/'S&$8X:32Z1_,DDN;H.0+R[ _P"OF3_&IO/N,_\ 'W=_>_Y^9/\
M&JLO^L-3=_\ @5>A1C%U)W77_,\#&-K#4&NL7_[:/,]P' ^UW>/^OF3_ !IQ
MGN I_P!+N^G_ #\R?XU$W^L'TIS?=/TKLC3A:6B/'G4G>GJ]E^;'&>XP/]+N
M^H_Y>9/\://N,#_2[OK_ ,_,G^-,/1?J*3LO^]2<(\VW0J,Y>SWZ_HR03W&W
M_C[N^_\ R\R?XT>?<; ?M=WGC_EYD_QIB_=_.D_Y9C\*'"'+MT!3E[1J_P!I
M?FQXGN-W_'W=]?\ GYD_QIS3W 4G[7=]/^?F3_&H5^]^-/?[C?2G0IP<=D+&
MU)J:LWL>]Z;X<TF72[21[3<[PHS$R-DDJ/>M2QTNRTXN;2 1E\;OF)SCZFC2
M?^0-8_\ 7O'_ .@BKE>#+=GNQ^%!1112*"BBB@ HHHH **** "BBB@ HHHH
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M*M*,JSK.-6#M;1MJZ?R)JQI>S3IR5^J2=FOF;-%%%=AS!1110 4444 %%%%
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MH7Q+_%^IYTOX;_Z]O_TD7NWU/\JDAZG\*C[M]3_*I(>I_"NW#?Q5ZL\7,O\
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M@_W1W--CL;K6G%QJ@,5J#NBLP>OH7]_:MU$6- B*%4#  & *I.I7V]V/XO\
MR7X^@GR4M_>E^"_S_+U."N-#UI?%$4AWW<8=2)I!E<=\]AWXKOL8&!111AL)
M##N3BV^9WU%7Q,JRCS+9!117#>+-3N;'7(@D3B+ )_>.HD_(\?AZ56+Q,<-3
M]I)"P]!UY\B.YHID+K)"CH05*@@@Y_6GUT)W5S!JQCZSK_\ 8TT"-I=]<K,Z
MQI);B,KO8X"_,X.?PQ5V74(+72VU"])M((XO-E\X@&,8R<X)&?H36+XJEMTD
ML!<7_D;;B.54$8;!4GYC[5YI\0O%MSX@UU/"^FE)K*S43WMQ+\L+D8.Z0_\
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M072X,#F-OO'<-^1_#QZYXKU&N+\<W=CH$=A?SZ;9M9W%^BZC<R68E*Q[&P2
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M &-'GZC_ ,^,/_@3_P#8TAEZBJ/GZC_SXP_^!/\ ]C1Y^I?\^,/_ ($__8T
M7J*H^?J/_/C#_P"!/_V-'GZC_P ^,/\ X$__ &- %ZBJ/GZE_P ^,/\ X$__
M &-'GZE_SXP_^!/_ -C0!>HJCY^I?\^,/_@3_P#8T>?J7_/C#_X$_P#V- %Z
MBJ/GZE_SXP_^!/\ ]C1Y^I?\^,/_ ($__8T 7J*H^?J7_/C#_P"!/_V-'GZE
M_P ^,/\ X$__ &/TH O451\_4O\ GQA_\"?_ +'Z4>?J7_/C#_X$_P#V/TH
MO451\_4?^?&'_P "?_L?I1Y^H_\ /C#_ .!/_P!C]* +U%4?/U'_ )\8?_ G
M_P"Q^E'GZC_SXP_^!/\ ]C]* +U%4?/U'_GQA_\  G_['Z4&?4>UC#_X$_\
MV/TH O451,^H]K&'_P "?_L?I09]1[6,/_@3]?\ 9^E %ZBJ/GZCS_H,/_@3
M]?\ 9^E!GU'M8P_^!/U_V?I0!)>:98:@,7EE;W'!'[V,,0#]:Y:[^%WABY9F
MCMYK8G_GC*0!] <BNE,^H]K&'_P)^O\ L_3\Z#/J7.+&'_P)^O\ L_3\Z5DS
M6%>I!6C)H\\U#X.0-N?3=5D0X^5+A PZ>HP?TKG+KX5>);6.1HA:W0' $4N&
M(]<,!_.O9C/J/:QA_P# GZ_[/T_.@SZESBQA_P# GZ_[/T_.LW1A>YWPSC%1
MCRMW6FZ[:GS5>6EQ87LEM>0203J,&.1<&HA_KEKZ1O+:6_C9+O1K*=64J1)-
MGCGC[GTKSCQ3\-+O>+W0;") N?,M?M);/NF1Q]/>E[-J2:[W_$[*6:4YP<9J
MSY&OG:WXGFW=OJ?Y5)#U/X5%*EU!-)%+;>7*C$,CL00<=QBEB:;)Q$G;_EI_
M]:NG#?Q5ZLPS%WPLO2/YDDO^L-3=_P#@5596F\P_ND_[^?\ UJFW3Y_U2?>_
MYZ?_ %J]&@_WM3U_S/G<;_NU#_"__;21O]8/I3F^Z?I4):?S!^Z3I_ST^OM2
MLT^T_NDZ?\]/_K5VQ>DO7]#QIKWJ?HOS9(>B_44G9?\ >J,M/M'[I.H_Y:?_
M %J-T^!^Z3[W_/3Z^U2W[WR_4N*_=_-_DR5?N_G2?\LQ^%,#3[?]4G?_ ):?
M_6I-T_EC]TG0?\M/_K4[^[\A)?O'_B7YL>OWOQI[_<;Z5 &FW?ZI.I_Y:?7V
MISM/L;]TG0_\M/\ ZU%!^Z+&K]XO0^E-)_Y UC_U[Q_^@BKE8VESZB-'LL6,
M)_T=,?Z3_L_[OT_.M*WDN79A/;I$!]TK+NSR?88[?G7@2W9[\?A1/1112*"B
MBB@ HHHH **** "BBB@ HHHH **** .-UZ3Q1;KJQ-YH<5G/)##IXNT8@[CM
M99 !R23@5BZ%HWB#PUKMD]W'X/L(+N;RG^QVS1RS<$[5..O&<=.*J_$$^']<
MN;_S]=U>PGTB2W6Y6 .8OF;<"$'5NN&[''6LWPU)X-NO%.F8\1^)-4NDF#6L
M-_O,8DP<,<J.E;)>Z8-^]_P3VBL3Q?%?3^%;^+3O.\]T"GR/]9L+#?L_VMF[
M'O6W16*T-FKJQY@^GW+1NFA0:G<:)8&TN%MKI7#-)%*"R1"3#?<'3ID #G-=
M+II;6/&5QJ\,%Q%8QZ<+0231-$97+ECM# '"C'/J3CI75453D2HV,Z&W2WU<
M!6D;,!^_(6_B'K6C5,_\AE?^O<_^A"KE26%%%% !1110 4444 %5[Z\CT^RE
MNI3\L8SCU/858K#N/^)OKJ6HYM;$B27T:3^$?A_C6%>HX1M'XGHO7_@;FM&"
ME*\MEJ_Z\]@L;=[/2KO4+R3R[NY0R2R8YC&/E ^GI6!X1TK44NY=1#QJ#E")
M023G!['TQ6_J/_$VU6/2UYMX<2W1'?\ NI^/7_\ 55W3?]9?_P#7R?\ T%:X
M%AX5*T+;0NEYO=O[_P ;G8ZTH4Y=Y?@NG]=K%^LK5M0EB=+"R :^G'R^D:]V
M-6]1OHM.LI+F7D+PJCJS=@*JZ-82PI)>7AW7MS\TA/\  .RCZ5VUI2E+V,'J
M]WV7^;Z?-]#EI145[26W3S?^2ZG->%-3NX]7?37MQL)8R2;3OW#/+']/QKN:
MX[Q)KATS68X8S<*" 9?+8+D>W%:U[XGTZPAX=[APHRL8SCZGH*X<'7I8>,Z4
MZE^5]=/DCJQ-&I6E&I"'Q(T=0OX=-M6GF)]%0=7/8"N,=+'1=2CU3587%W.Y
ME2WBQMC!/4Y[YK1CT_6-9O8]3EF2SCV_N8RN]D![X/&??K5V3PE87)#WLUS=
M2_WY).?I]*FO&OBGS0AHOAOMZVW]%;\=JI.EAURSEOO;\NWJ67\3:0D:/]L5
MMX!"H"QY[8'0U'_PD)E.+72[^;_:\O:OYFM&*ULK"+,4,,"(.6"A<#W-9KZW
M->.8M'M3<$'!GD^6)?Q[_A754G5A95)I-]$KO]?R.>$:<O@BVN[>GZ?F<IK7
MB;48]0,4 N+256^>-I X[8P,<5L)KNJ_9(I;F[TNUW+DH^XR?4J.E37'A*34
MKI;O4;X/-D96.+:,>F<@_C6W;:1I]F!Y%G$I'\17+?F>:XJ.%QKJ2E*32>UW
M^B_S1UU:^%4(QC&[79?J_P#)G,MK.JS ?9;N:;/>"PR/S;%9^HZ1K^KL#(ES
M)SG]Z4C _#->AUFWGB'1=/N3;7NJV5O. "8Y9U5N?8FNF66.JN6I4;^;_5LP
MCC_9N\()?UY6.6L]"\4VMLL$%VL,8).WS>GY"K0T/Q0X^?6%7/7$K?X5V"LK
MJ&4@J1D$=Q6'XN\5V'@_0I=2OF!;[L,(/S3/V4?U/84X952245*7WLF683UD
MU'[CROQO>:AX?\0PVVHW,%U&]IYNY[C:^=S *-QZ<5=\*Z,WC&"\EAB\O3\)
M&9YE!6=AR5 _B53GGIGI7D_C.34M5UH7^HS/<:C<('GB1#MMB?N1#W"X)'8G
M'7-?3W@B(0^!="C";,6,65VXP=HSQ]:TED^'B^=[^K_.^IG'-*\O=6WHO\CF
M->TVZ\,Z#<:G=Z],(+=/EC0MEVZ*BC/4G KE;QIH+N.VEP=0GACFU*/?S!GF
M-&/\;<9QVQ6EXN\1C5?$)GBB^UV.CW M[&U'(OM2/0>ZQ@Y/O]:ZW0O EI::
M((M4)NM3N)3<WMUGYGE;J ?[HZ >U9XC*J2HOV2][I=O_,TH9C4=5>T?N];)
M?Y&1H7A2^NX/MB7K6HE4!70YW#)X.#V-; \&WA'S:W,3W^4__%5U5O;Q6END
M$*!(T&%%2U-+*</&"4U=^K*J9C6E-N+LO1'#:CX9FL;-YI=6N7C );:F<#WR
MU2>!K">VDGFD:14D3"H48!AD?-G&/_UFM#QO LNA-(TYB6$F4_*2I !SDCI]
M3Q6/\/O%ECJ3-H<&YKBWC:9G\U'4C<!QM)XY%84\%&..7)&RBKWO?]36IBY2
MPOO.[;ML=[1117MGEA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP\J>HR.HXHL*Z%/_ "&5_P"O<_\ H0JY5,_\AE?^O<_^A"KE PHHHH ****
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M$\EWS,****@L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC<ZC<N9[ZZ;K-*>I^@Z#_P"O2^!>8_C?D;-K:P6-I#:VL2Q00H(XXU& J@8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI(B3M.\H".&&U@,<BNVI2?1%175A1114%A1110 4444 %%%% !1110 4444
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M** "BBB@ HHHH **** "BBB@ HHHH **** ,_7-)@UO2+BPG52)%.PG/RO\
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M_P"/OQ_J#9ZBWM(HOY9KMZ*SYF:<B/'?$7P@LKW7=.>]U_5KN:]E,,DL[*[
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M_D#6/_7O'_Z"*N53TG_D#6/_ %[Q_P#H(JY6<MV:1^%!1112*"BBB@ HHHH
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M* "BBB@ HHHH **** "BBB@ KSOQYK?A2\N1HEQ8C6-;3F*&VD$<EN?[QF)
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M;'5;4 RJS8CF4G EC)ZJ3QCJ#P>V>AK$328-:ETC6=3MC]JMX!)';2 %897
M+'IG<.G7CZ\UMTG8I7"BBBD,*CFGAMXS)/*D48ZL[!1^9J'4M1MM*T^:^NW*
MP0KEMJDD\X  '4DD #U-<%KGB"PNO$6F2:SI-TEI!'+YUG?6X.T-MQ<*H+*X
M7!5L9*A\XQFJ4;DRE8V[_7=8TC7+R\NK;S?#<8C0R1IEX<KDRC'WD!.&[C&1
MQFNEMKVUO0QM;F&<+C<8G#8R,CIZ@@_C7(^'#:Q:U?Z1H=^MQHLEH)XC"XD6
MRD8D;%/(P1\P4],'L:Z;1M&L= TR+3].@$4$?/NS'JS'N30["C<OT445)844
M5SVL>)X;.:ZLH;74+AX(P;B:S@\P6VX9!(SDG'.%!.*:5Q-V+.O7EW_8]ZFB
M2QOJ:;515PYC)8#++[ D_A4&E>)8Y3-9:QY5AJMKM$T3OA) 3A9(R?O(QX'<
M'@\UP5C<Z!_PB4=S;7%MI?B73H/,CN$.&NV'\0/69)#U')RV.&%>B?V/;:K?
M:;K.H6Y^UVT.8H9 "L#L 6/3.[M[8]:II+<A-O5&Q1114&@445!>7UII\!GO
M;J&VA!QYDT@1<^F30 ^:>&VC\R>6.),XW.P49^IKEKW7M7T?7+Z[O[;?X;1X
MXQ,B?/!\@)E./O1[B0>ZXSTS47B@6?\ :FEZSJ%O'J.@K%)%+\HE2!G*[9BO
M(*X!4GL&STS3?#HMUU/5-&T?4!<:*;9987A<2BS=RP,:L<@C #!3G'/8BK2T
MN0WK8ZZWN[:[#&VN(I@A 8QN&P2 1G'L0?QJ:J.D:18Z%ID.GZ= L-O$,!1U
M)[DGN3ZU>J"T%%%% !65XCDU./0YCHV/M[-&D3%-X7+J"Q'< $D_2JOB_4;C
M3-&CF@G-M&]S%%<704$V\3-AG&>..!D\#.>U58;C4_#^KVEG=WCZGIE^3';7
M$H430S!2P1BH 96"G#8R",'J*I+J2WT+6D>)8KGS;/51'I^JVS*D]N[X5MQP
MKQD_>1CT[YX/-;]8L6D0ZG?V&N:G9&*_MX2L5O(RN+=F^\00.6Z#.>W&.:VJ
M3L-7ZA1112&%%%% '(W6OZOHVN7UUJEL/^$<$RQ),J?/;_(I,C?WHRQ()_AQ
MZ=.I@NK>Z#FWGCE"':QC<-@X!P<>Q!_&DN[?[79S6_F-%YJ%-Z $KD8R,@C\
MQ4&DZ39:)ID.GZ=;K!;0KA47^9]2?6F[6)2:9=HHHI%!1110!S_BK4KBSMM/
MCMKL6<=Y>+;2WH4/Y"D-@@'C)8*H)X!:HK"]U32==AT;5[@7L-VK-97VP(Y9
M1EHY .,XY#  $ \9%8%QI+>"M($=V3JVA79\J_LV&YUE=OOPJ3DAB>4'.>1W
MKHM"\.06IM+^:347EBB(@M[ZX$OV4,.0,=3CC))..,U>B1FKMG14445!H%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!AWVCO96M_=>&[+3X-8NA
MS-,I568GEF*@DXR3CUJGHFGZ[I>E3P"STU+IG63SFNY)3<.2/,>0^6ISCICC
MH. *ZBBG<5CD;G3O$D_BC^T)K73+FSMWQ8QO=R)Y(/#2%?+(:0@GG/ X'4D]
M40//4]]I_I4E,/\ KD^A_I0W<$K#Z***0PHHHH **** "BBB@ HHHH *IZJ)
MSIEP+;=YNWC;][&><>^,XJY10!S\]U'"S)I<<*LT:#SD3)7+JN&&/0D\G/!I
MM]JEU:-)'%.\C1QN'9XU #!,AL#GK^'I714R2))HVCD4.C##*>A% &&99[K4
M8$2X9HTG81SJHY'E$D=,<'O2W&HWATZR9)/*EFB8LP3HP P2"#@9ZUO5#/:P
M7.TS1JY7H3VH Q7U&^'VDI-%^[1B@."741Y#@ <Y/OCM3I;Z^A9HS)N7?'NF
M90NQ64D\X(Z@#)'>MT *H50 !P .U+0!A)>7H::2>Y"Q11QC$40(9F_BR>W3
MVJNM]>F4SAY&D%O,(XB!B1E?CH.3C!XKI:* , WURR*KW2"!]W[Y,,<A1A3\
MH&22>W;'6E^T7MOIFFQVWWI[=8E+)D))@$,?; :MZB@#FY;NZO(&F"M&7AN/
M+PGSIM51P?=L_I3HI9XYY;B&=W7%L#E01("<'G'OVKHJ* ,*^N)7OUC>5E$=
MU%LB"?>7@EL]>N1Z<57:_N+F1,7$RP+-"WF;5'#;@0<=!P.#R,\UTM% &387
M\MQJ<D09WA\LL"Z@;6#8QQR/QYK/NKVZGL&5Y"69-TRA,>0PD7 ]?7KZ9KIJ
M* ,'[5,]Y;.UU(;=+IT615 $B^7D9XY^;(X]/6HDU&>>X3&9(U971WC&1E),
M].G0>XS@UT=% '/F_P!0B@0E]Y>*"1G90OE[B0W;V'4'&:BO;JYEM)(IKA1^
M[5H_+7/G9<@\X[ #ICKGI72T4 86HF>'4+RXA<^8EM$(]R!@I+L#CC/ZU(;J
M\ANO(:<R2))&BQF,#S4.-S\>F3TX&VMFB@#G4U#41"DK2ECY,<I7R@,EGVD=
M.F/QJ:;[&-6U#[6%),,6S(^8_>^[WS]*W** .<AOM3CCV3NB2Q1C*.?F<>7D
MMC')S[XXJ.:6;4K:.(W#2(S6["9%P4D))(&/3 /XUTSJKHR. 588(/<4*JHB
MHH 51@ =A0!SQ>[-_#?7J20F**6,(HW 8 R^.^2./8#UIHU:Y,C1O=&) )"C
MLBDOA4*].#RQZ=:Z2FF-#*LA4%U! ;N <9_D* ,F;4)2MN'E^S$Q$S,%SMDV
MJ0G/U/UQ5<WVH^7-<2/Y04Q)Y C&06"EL$]^3C]:Z"F30QSQ[)4#+G.#ZT 5
MM,DDEL5:6<32;FW, !CD\' '(Z4_4?\ D%W>?^>+_P#H)J:**.&,)&H51V%.
M95=2K %2,$'N*:=F)JZL4]'_ .0)8?\ 7M'_ .@BKM-1%C1410J* %4#  ]*
M=0W=W!*RL%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %8?B/4[N
MR?3;.R>&&;4+G[.+F="R1?(S=,C+';@#(Y-:.H">?3;V&QF5+PPNL3Y^Y(5.
MTG\<5Y?>:;H<_@R6_LR]IJ=BJ_VC933L'FE7&Y7!.?,)Y20<YP02#BJBKD2=
MC82?Q%HWC)_,M[>[N;N %TB;RDODCXWIN)V2H& 9"<,I!!&*Z#PYH[PM?7=[
MI\5M]IO#=06K%9#;DJH)R. S$%CCCGZU)IGAZ>&^M[[4-6NM0>V1EM5GC1#$
M& !+%0-S8 &3[\<UOT-A&/<****DL***XR"^\2:H^I7VFWUKOLKN2W_LF6$
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M'_=_4U)10!'Y$?\ =_4T>1'_ '?U-244 1^1'_=_4T>1'_=_4U)10!'Y$?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$\$#MCMBO2J*.?H')9W1XE:^%+S3+:]\/ZCH/B'4EDN7:-K._*6D\;-D%QN
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M4GN . [I]YO=FS^=>B445+=RU%+8****0PHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVD:(TVD+#=3D'_5%.DN!@[L#G/6O4'C$UJT8!0.FW&,8R/2IDK,N,KHQ=/\
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MU"^OKP02NNQG!4!"&/;K@_6LO2[.6)(+B.+5;R\TVPF5-.ETM+:/F/'DM($
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M?'>= 6$WW]A2X\S[VWSESL[;_3=QZTDKL<G97.U?7=)BF>&34;99(YTMF4R
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MG _4_G5;4M6T[1X!/J-[!:QL<*TKA=Q]!ZGZ5<KD+!$N/BCK+7H#3VUE;_8
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MM<XUB*]ECU*547F&'DMC&!Y@:+''\9QTH<04^YWM,DECA4-)(J L%!8XR2<
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M%O+$+[+J5!*@Z*X5AN')ZYZU)?>&]*U"&UCEMC']C7;;/;R-"\*XP0K(00,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
L0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>80
<FILENAME>img254193463_53.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_53.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )/ NL# 2(  A$! Q$!_\0
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M.* %HHI <T +103@$T Y&: "BLR]U<V>NZ5IOD[OMPF/F;L;/+4'IWSFM.@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YI?^2F2
M_P#8'7_T<U=+7-+_ ,E,E_[ Z_\ HYJZ6@ HHHH YKQ_+=P^"[][0RJ?D$K0
MYWK%O'F$8Y^[NZ5S6HP^#K>QU8>'Y(ENGT.X9ELFS$T6WAGQQN]">>M=#<>-
M[:*>9H]+U"YTZ";R)[^*,-$CYP<#.Y@#P2 :=%JNC6UGXD:'2DBBTS>+M$A0
M"?$>\\#KD''-!T1YHJUOZT.'\-V#6GB+PY]IL-.TK=I[303V0.;_ #&,HYX^
M8 [B"#GL:Q="ABM])\+W_P#Q)05U"+=]C)74),N1ACGYASR.X%>L:7K.FZU?
MQV26 #VUI!>1&2-2(UD!VA?0@#'%5M1OO#?AS7=+M%TNV&HW\PCB-O;H&C!X
MWL<# SQ[\^AI&GM9-VMK_P /_F>?7K'1O#VNS%F-CK%S>0R>D=RDS;3[;U!'
MU45[1%_JD_W17-7&OZ+_ ,),OA:6P#^80[.8E,(E(+A3G^,@%NE=13,:LG)*
MZ$9B.BD_2F[S_P \V_2GT4&)Y[J6_6M<U".[EF\JUD$<<".5 '][CUK9\(7E
MRWV^QE>2>*UD BE8Y."#\N?;%9/B>?2+S4Y%@M+RXO(\+-)9OL'T)P<FN@\*
MW>E2V#6^G1- T3?O89/OAO4^M2G[SU-)-<B5OF;F\_\ /-OTIP.1TQ2T51F%
M%%% &7J]W-!"JQJRA\Y;TJ/1[R>5620,X49#5IW"120L)@NW'?C%-M8X(X1]
MG"[".JG.?QJ+/FW-_:1]ERVU,/5KR<W+1C<BH1BM'2;J6>W82*QVG ;UJ:^M
M+:=0\P ((&[..]68HDA0)&H5:2B^:]RIU8.DHI:F'=ZG=1ZAM1655.-F/O5L
M&9Q;&7RF#;=VW\*25;8W$9D$?F_PYQFK%.*U>I%2<6E:-K'.6^IW9OL'<P8@
M%/2KFLW,L<:1JK*&SDU=BBM1=2,BQ^:,9P>14EQ;1W,6R0<=CZ4DGRM7-'5A
M[12Y;)',Z?<2PW"; QRV"!WK8U>\FMXU6)67<#EJ?8Z=;0MYB-YA!.#GI5RY
M2)H&\X+L _B.*44U'<=6M"512M<H:1>37$)656;8!AO6L_5+VX-TR NBJ> #
MBMZV6)8%$.W9C^'I45Y:6TVUI@ <C!SC--I\NY,*L%5<FM"/3+J2>US(C$@X
MSZUG7&JW2Z@ J$*I(V8ZUO1QI&@1% 4= *8T$33+(8U+C.#BFXNR5R8U(*;;
MCHQLL[I;/((F+!<@5B6>IW37^&W.'8 KZ5T55H8+=;F1D1 _&<=J))MK45.I
M",6I*]R;>?[C?I2!SC[C4\D $DX [TR*1)4S&ZL/4'-5=;&)2U6\FMK<&*,@
MMD%L=*DTZZEN+4/+&P8<9QUJU(BO&590P]"*<BA4 4 #T%*SO<TYX\G+;7N1
M2/DIE&'S4_>?^>;?I39F4&/+ ?..IJ6J,S#DU2Z74B@B;:.-F/UK5N)WBMW=
M8F) R!Q2DP&Y S'YH'MFICR,'I4KKJ:SG%VM&QSVGZE=27NQ]SJ[<CTK4U"Z
MEM[8O'&Q.<9XXJ2WCM5FD,(CWY^;:>15AE5E*L 5/4&E%/EW*J5(.::CH9.D
M7T\X9959P!G=Q^5+K%[/;HJQ*5##EJT+=(4B_<J@4_W:6X2)X6\X*5']ZBSY
M;7#VD/:<W+IV*VG7<MS:[Y(VW9QD=ZR]1U"X%YM4L@1N!ZUT"*JH @ 7MBJ]
MS;VTDD;2HA;<,9.*))\NXZ=2$9N36@MG<//:I(\;!B.:Q_[5N_[0QM;;G'EX
MKH%4*H50 !T J'RH/M6_:GFXZ]Z&GIJ3"I!-MQO<BOKF2"T=TC;</TK&T^^N
M1> $NX=L$$YKI&4,I5AD'M56VM+6*1VA5=V[GG./\*))MK4JG4A&#BUJ)?W4
MEO:L\<3%NGTJ#2;R:X@(EC)V@88#&:TF 92" 0>QID"JD*A5"C'0"JL[W,U.
M/)RVU[F?JU]/;(HB0KN_B(!JU9W+SVRR/&P8U+.(C'^]"%<C[W2I      /:
ME;WMP<HN"C;7N8U_J5S#>K''&0H/<?>K621FC5C&P) )%#Q([JS(I(Z$BI*$
MG<)SBXI)6L0ASYK'8V<#BH[VXD@M'DCC;<*F'^O;_=']:>0&!! (/4&J9$6D
MTV86EZA<R79C<,ZL23QTJ]J=Y+;6P:)&!)QGTJQ;V\4+2&.,*2QY%2RB,QGS
M=NSONZ5"34;-FTJD'44E'0S](O9KF)O-4G;T;'6H=7O[B!U2(,@X.[BM.V$(
M@7R-NSMMZ4L\,<R@2(K8/<46;C9,%4@JG,XZ=B&RN9)[59'C8,?IS6)=ZC=?
M;L@LNPD!:Z4*% "@ #H!56:VM7NHVD1/,.<9/6B2;6XZ52$9-M:"BYD-AY_E
M-OV;L>]8<&I77VW<2[;C@I738&,8XJK':VJW3,B)YF!G!Z?A1)-VU"G4A%2O
M'<@U6ZE@M1Y:,"QP3Z5EZ7>3K=*GSLK'D5T4L:2QE) "IZYJK96MI%N>#:QR
M><YQ2DGS+4=.K"--Q:U++N=I&QNG6A7.T?(WZ4LC*D3,Q  '4TL;*T:LI!!'
M!%:7Z',<WK7_ "//A?\ W;O_ -%K735S.M?\CUX7_P!V[_\ 1:UTU !1110
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M=6_JQ8F\&>)Y[*ZU(7MO'J,FH_VDEF8E;#H<(OFYZ; !TQR:],C9FC5F7:Q
M)7.<'TKB-7\1:]%:^&+FV%FEK?3VJ7<\;;]YD/*1@C[O^UUYXKN:9C5<FES"
M$$]&Q^%)M;'W_P!*4D#J0*9)-'%$\C,-J*6/T'-!B>:V,BZ=]HL;Z58;I)F9
M_,P-^3]X&M;PLCWGB:[O[=B;18!$TF.'?(/'KQ6/?QOXM_TV_D\N G]Q%'C(
M7/4GO6]X8U">QU!=$N'62!HR]O(%"D8Z@X_G7%35+ZQ)Q>IHZC<5$[#:W]_]
M*4 @<G)]:-R_WA^=+UKM,PHHIKMLC9O0$T/0#+UQ7^Q_Z\  \J<#=4>@*WV9
MCYPP3PHQQ6+=7+W,SO(^3SCGI4'VN2SB\Z)]K@#'/?WKQ98J*K>UMH:<[Y.0
MZ#7+::7RRLP*CC82!SZUHV44L=I&LDV]@.HYKCS<O=1":1]S-R>>]68=5ET_
MYE;<K';M)XJZ>+@JCJ-;@Y-Q42]?:=>R:EN4LP8Y5P/NUNB.00[#*=VW&[ Z
MXZUR<E]</.',[9YZ'I5E]=G>'[/N D R7'4CI^=.CB*5-R=GJ$YN22?0FM--
MO%U,L6*A3DOZULWJ2-:2A9]A(X)P*Y))Y$F+K(0W'.:5M4FU'/FOPAV@=C[_
M %J*>)ITX."3U'*;DTV:^@QR+)*?.4#D;00<G/6I]=CD-HK"; 4\J<#-<Z)C
M;HTJ,59<D8.*1;V6^C\V=]TG(-0L3%4O8VU!U'S\YTFA1R"S)\[ACD*,'%5]
M>B=I(R)E(.!L+ 8.>M8;7LMC$)('VOT%#2^>BRLV2V"230\3%TO8VV#VCY^<
M[*S1Q:1AI]YQRPP:IW%O.VKQ2+>!8Q_"2,CVQWKG/[4FL=J128$APWL/;WH9
MR90Q;G!YS6LL;&45&VWF2I-.YVK(Y4@2$$C@XZ5AZ?87<6J2.TF #\S @[JS
M?[9N-OV/S>,;MV>?I4,<SQS%T<JW'(-.KBZ=2496>@XR<4TNIU6HV\\]FZ12
MD-Z8Z^U4-$L[F%I))"40\;3W/K69+K,]ZFPL%5#M8#^(^M16MY+:L'1\8SD$
M]:4L33E551)Z IM1<3I]0MY[BT9(9MK?3&?;-2VL,L5M&DDQ9@,$XKEKG59K
M]-Y<HC#A :DMM7EL5R6WQ]-I/0UJL;2]ISV=N_\ P";NUC2U>PNY[F-XWW+D
M #IM/K6K;Q21V\:/(2RJ 3@5R-Q>37$@>24DYZ9X%6(];N((O(W[F?[K,>5J
M*>*I1J2G9ZE2DW%1[$\FFWK:I]XG)R)>.!6]-'(ULZK+AMN <"N/,SF<2&0E
MNN<U,^LW%R#;-)@1XRP."WUK.EB*=-2T>HY3<K7Z%O2K6X742?,V[3\Q!!W5
MMWT$T]H\<4NUC^&:Y&-RDC,K;6SU!J=]8GOD\MG 6,[>#][W-%+$4X4W3:W"
M51RDI&WHMG<6\3F5MH;HG!Q3M8M+FX@7RG+!>J],U@6M[+9GS$?@9)4G@TZZ
MU*:_7S&?"$95 >!5+$4_8^RLPYWS\YTNGV\\%HJ32DMZ8SCVK)UF.0WT9%RI
M!( !8#8:S_[8N;5%B64E9#MY/*^XJ!VW,"6R<\G-35Q,)TU3BMA1FU+F.T@1
MQ;Q@R[B% +#!S6-_9UX-8\SS>.OF<=/2LA=5GLBL4<F%EX/M[BF^<_G;_,.[
M'WLTZF*IU$DT]/,(S<;VZG9RQR/"ZI(58C ..E8^E6%W!>.\C[5!(/.=_O6<
M^M7$T9MB^"@&YAU:J\-Q)#*7CDVL&]:JIBJ<YQFD]!1DTFNYU]S%++;.D<I1
MR.&Q4&FV\\%DB2R[CV&,X]JP)]9GO4PK[%'RD*<9([TEAJ,MHR?O,IT*DUI]
M<I.HI6?]>0KNUC7UFRNKE$,3EU'!2KME!-!:)'+*68#GCI63J.MR!REL5"C^
M(\YJYINJBY219B Z#<2.A%:0J4?;MIN[^X;FW'E-'!R,MG\*7:W]_P#2N;GU
MVX:X!B*K&"< C.1[U>?6A_9PF4*)B=N">,UHL92=_(@TP&\UOF/0<XI7RJDF
M7:/4@5R:ZE=B<R"X;) [\4V?59-1R6;:JG;M!X^M8O,(6VU'8W=+1XVGW7BR
M[G. "#^-/U>UN+BUQ$Y.#DKCK7,1N48LK;3G@@U,VL7%_&RO)A4.,#O[USK%
M0]E[*2+YGS<QNZ+:W$%NQE9E#'Y4('%3:G:7%S JPS[2&!(Z9K!L-2DLF4[]
MT?\ $I/:GWFL7%PQ,4AC3/RA3S6D<125'V;N#FW+F.FCCD6-5:4L0,$X'-8U
M]IUY+J:R+(65CPW]RH[?7GCA=9<.X'R'U/O6?)?W$DRR-.V<GH>E%?$4IP2U
M"$W%W1UHCD$87SB3C&<"L*SL[E=5+&X& 02P8'</2J<FM7$T9M6?E0"7'5AZ
M545R)2P;!P.<U%;%4ZCBTM@C-Q32ZG6Z@DC6,@68(<=3@5D: C^>["8*O(V\
M9-9(U.:^W+-)D1G"C/:B*0QG<K;6!X(-1/%1J5(U4M@4VHN)TVL6L]Q:8B<G
M;RR_WJ72+6XM[7$KD;N57'W:H/K[?90B &8 AR>@JYI6JFZ_=3;1(!D$=ZZX
M5*,JZFF[L.=\O*9VM?\ (\^%_P#=N_\ T6M=-7,ZU_R//A?_ ';O_P!%K735
MWF84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <TO_
M "4R7_L#K_Z.:NEKFE_Y*9+_ -@=?_1S5TM !1110 A&01ZUQUEX(T_2Q86E
MSK-[<6=O-YEK97$B",R EAP%!;!YQFNRKD/B,;9O#B0;'?5)9T&EB(@2"YS\
MK*>P'4GTS0:4V[\J>Y"W@W2Y)[RWEUZ[:RNKQI;C3_.C6-Y'.[:<#=SZ9YJ>
MZ\)6\^LZBUMXAOK*74 KW%K;R1C*A0F0"I8# QFN0LC;IH.@02AEU:'Q)#_:
MOG$%S<'>68GN".0>F*K#69!KW_"9_P!GW_E?VEY?VLQCR/L&/*ZY_O?-TH.C
MDG??^O\ @GH-QI6@/9Z7HBWT4"Z;<0RP0K.N_=']U2#R<]^]=+7DG_"-W?B7
M4O%EK:VNE!)-4VM?7"EIX/D0YCP/Q'(Y->LQH8XD0L6*J!N/4^]!A5C:VMQ2
MH/4 _6HY8(YH9(F4;74J>.Q&*D)(/W2:3<?[IH,CSB2WNO#R&SN[*:2%&Q#/
M!'N#*3P#Z'FMGP[I=W<ZL-5N[8VT,2%((G'SG/5C6%JTDFKZW?K=M-LMY?+C
MA#X"@'[WXUO>"KZZD:_LI7DFAMF7RI'.2,Y^7/MBN>-*FJKDEJ9QJQE-TUNC
MK=B_W1^5.  Z"F[C_=-*#D=,5T&@M-D7?&R^H(IU%#U XJYMV@F='3!!/:H&
MMFNH?*B3<[ ;0!UK1\52F2:*W:/,87=GU-0^%I#!>>3'&=CKSWQBO'E@KSY+
MZ'+];2J^RL5?LS6T2Q.A5UZ@BK$.ER:A\L: !3NW8XX[4GB2XDFOVB="$CQC
MW]ZVO#US+-IY5T.(SA3ZBJA@HN?*WH5#%1E5=-(PY+66.<1M"0_IMJTVB3I!
M]I*#<1@QXY ZYK/N]2NY;[S2\B,I.T!L 5TK:A<#P]]K,9$VS^N,U4,'3=[L
MFGC(S<M-CG%3=*5"9/& !3O[,EL 1-'C>=P./TJI!=30WOVA-YER"3GEJZ;Q
M!<RC2H@(B/-QO_V>.E0L%%Q;OJA4\9&<92ML8'D>=&T07+-D# YI$M'LXC'.
MFR3DD'M4F@2M;ZE&(XR0[;6[U/XGE-Q?>1)%F.-?ESWR.M3]2TY[ZA]=C[/G
MMY%-[1[V)8X$WR=0!WIWD^5&L97!7 .15SPO*T%YY$<9$;KEL=B!UJOK\S3Z
ME(KQE1&V%QQGWH^I67/?4/KL52]HUY#3IDUZ5:*,D1G+8':@J X!4#KQBN@T
M.ZD;1G8Q',60O'WL"N4GFDEO?M#@^;DG/<4Y8)12:>K"IC(PC&5MS1&DSG-Y
MY)V;<8QS]:A1-\I15#-D **W;G4;G_A'5N C"5_E)[@<\UR]M/);70FB#"0$
M'CJ?:G+!QBURL57&QIM*V^IIR:3-9(9)(_ED.XG^Z?2H[:U>Z81QQ[B<Y..E
M:WB"]G2Q@1%91,,N1].E97A^ZF@OXXHU8QR'#+V^M4\'!3Y4]"IXN,:BIV'7
M.FR:>HB=<J!A7 ZT^VTJ34%VA=J=W([U/XFO)Q(MNN](RNXX.,U8\-7L\J20
M2!V1 "K'M[4U@J?M.6^A2Q475]E8RKBUE@D"21%3NQTZU8CT6>XC%P(\%,[5
M(Y:K>O:M=6MY%#"FQ1AMQ .[VYK;M)WGM8I7C*,RY*^E5' P<FFS2%>,YN"W
M1QYB82[/+.['3%2/I,]KNN7B^63MZ5;FUJ\77?+6'Y5;9Y>T9(SUS6UJUS);
M:;+)&A+8Q],]ZA8&+3;>Q,<3"2DUT.41-SD!<DG@ 9J5M*FL4+R1860Y'?'M
M5;3+J6VU%98T+,SX8'OFN@\27<\,$<4894DSN8?RJ8X).+E)ZHSCC(RIN=MC
M'MK-[P^5''G/!..E.N=.DL%\ITX485P.M2>&[N>.]6!0S1/G</3WJ7Q->W'V
MC[, Z1!0>.-U4L''DYKZA]<C[+VEO(J?V5/=QI,D7R1G)XZ_2HV4;A\H'S<\
M5N>&[R>>"2.7>PCQM9N?PKG]7D:XU.1I(BA5\  X_E4RP245*+W"6,C&FIVW
M)1ILMZRR0Q;EB.6XZTFS,NT)SCIBNCTVZE_L'SO*.]$;: .N*Y87]T+[[3N?
MS>O7]*'@HQ2:>K"IC(P47;<OOH\\"&Z:/AP,C^[CUJ&&!II2D:;F)X&*Z+4K
MV>+1?/1&$CJ,D?PY'6N;TB]G@U%=F]Q(^'7/6JG@HQDE%CJ8N,)J+6Y9GTB:
MQ3E-RMEL@9P3VI+'3Y+QE"QD)W<C@5O:W?365@9(4.XMMW?W:J>'-0N+J*2.
M8%P@&'/\JOZE34[)Z&CKQ53V?4BU'1)/,9[5 RL?N]Q5[3-)^S1R&8+OD7:0
M.PJ#7]3NK&.,0*5W=7(!_"KVF7<MU81RS1E7/7W]ZWAAZ2JMK<%6BZCIK=&+
M/H=PEP%B170DX;I@>]77T,#3A&NTS!M_M]*SM6UF^AU,QQ;HTC. N/O>]="+
MJ0Z;]H,3+)Y>_:?7%3#"TKRM<4,1&<G%=#EEL9VN#&+=MP'3;1-I<FG?+(@(
M<[MV./I4$6K7PO?.\V1F.,J3Q^5=-K<[II#,(LEL Y&=N>]<_P!3@XMIZHBG
MBXSC*5MCFD3+$!,DG &*>=*GL8BTD7RN=P..GL?>DT"5HM40+&6#M@YYQ[UK
M^);V>)(X8PZHX)9@<9]JF."3BY2>J%'&1=-U+;%"QT][UU4+A/XGQTI]YI,U
MLY5(B\>?E91GBIO#-[.\C6S[WC";@3SBI/$&J7=M,D4.Z-<!MWKS6JPE/V=V
M]2EBH^R]JT);Z%)+ [R@(V/D7'.?>LZ6UEBG6-H2'],=:Z73;V:YTQ9Y(COP
M?^!8[UQ]S?7,UZ)W>02 G'/W?I2J82"BN5BJXN-.,96O<T)-&N($^U-']X %
M1U7WJJJ@R$!<DXP *Z:SO9Y-#^TO&6E",>?XL5R]I?SQZD)PI=F(RN!S4SP<
M4URO<)XN$.5M;BKILMEN:6(@2'*DCM2QJ'X50Q)P .:VO$\[K:Q0B,[)"=Q^
MG:N?T9OLFHQ-#%RS[2!W!J'@E"7+%Z"J8Q0J<EC;?0)!:B1-OFD993^E7M)T
MHVI\Z8+O(P .U:C,=I^4]*%8[1\IZ5W0PE.$E)=#KN8&L1@^,?#4F>5-TH'U
MC'^%=%6!J_\ R-GAS_?N/_15;]=0@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH YI?^2F2_\ 8'7_ -'-72US2_\ )3)?^P.O_HYJ
MZ6@#-TO6H-5NM2MX8W5K"Y^SR%NC-M#9'M@BLQ_&MBMO<.+:Z>:/4'TZ*WC4
M-)/*HR=HSTQSDXP!6=I\7B#0M;UUX= -[;W]]]HCE6\C3"[%7D'G/!JG'X7U
MJUG?58((7O+;6[F]AMWE $T$JA2-W16QTSZ4&ZA"^K.GTKQ)%J+WL5S976G7
M%DH>>.Z0 !2"0P8$J1P>AJAI?C31]8T6]UN2"6"+3<NXGC'F*FW<'4#/#*>/
M6N?D\/>*[JTUI8TFM(]32.VCM[C4#<&!2Q\V7DX'RG 45;M_"OB'2M4N9+>X
ML;^&\TTVK"6W$42/&/W6] 26!!93CIQ0/DIZZFG:^*;6Y,LMUH%[9DVQO(I)
MX4(G1%S]Y20& /0XZU/H>O/K45L@\-W=MIUQ")$FE\KR]A&5^4,3SQVKF-,\
M*ZU!-<BSTUM'LY+*:*>S-_Y\4\C(0GEK_P LP"<Y].,5=\%Z!/HLM@LOA0VE
MQ' (IKW^T%D!.WD[-QZD?AF@<HP2=G_7W_YG0:OXGTGP_J-CI\@)O-0G2-8H
M4Y&X[0[>@SQ[]JWZYWQ9I%UJD6E_8XD>2#4[:XE)8+^[1LGGOCTKHJ#%VY5;
M<*K7][#IUC-=SG$<2[C[^U6&#'HV/PKG?&EO/-X8N/+8ML978 =5!YH(.)U:
MSO/$UR=0>8Z:6 "BW'SLO8L>];GA;47T*>'2+M(S#.W[NY08+/Z-[U CK/;I
M+&^8V ((%5[^-[BXL;2)B;B2X4H .0 >36CBK7/)H8NK.MRO9GIE%,VO_P ]
M/TIPR!R<UF>L+1110!CZY)8^4([E2\F"5V'!'XU'H+V"KL@5EF*\[SDD?6L_
M78)DOFD9B4<?*<>U1:)!-)?Q,C':G+''&*KDC:_4\>5>?UJUNMCH-4MM/E5&
MO H.0 V<'K5RWBAA@5(% C[8K!UZPNYIUFC#2)@ !1]VM/2K:XM[%4F?#9SC
M'0>E+E2U.VG-NO*+A;S(;JUTIM00SA!,>V3S]:TRL8AVD*(PO3MBN2OM-O?[
M1*X:0N3M8#K6_<6MPVC-;B3=+L Z4<B6QG1JR;G[EK?B9]K%HHU%MA)?(VAO
MNY]JV;T6_P!E876/*[YKC8+6XDNQ$BL),C^'I6_K=I<264)1BWE_? ')]Z?)
M%:(QH5Y.E-\BT\@T9=+61OLH82Y/W^N,]JS]?NH+N3RXU&Y!CS/Z57TJTN)K
MQ#$64*V6;'055GCECE=)"0P)R,4U3CL<]2O.5%1M9-FGX?NH+63RI%&^08$O
M]*T]672C(IO /,R/N]?QKF;>*266-(R2S$8 &:NZQ:7*7KN^YE=AM8#]*'3C
ML.G7FJ#7+=)G56WD+;+]G*^2!QCIBN>N?[%.HABCGKNV_=)^E7=.LKI-(FC9
MV5WSM4CI7-O!*DP1@X<9&-M+V<7HS;$UY*$/=6OD=M(;9[)MY7[.5P?3%<]9
M1:-_:+8,IY&SS,;<U9:QNO\ A'ECW$N&W;<=O2L*&WFEG\M V\D#[O2CV<7N
M+$UY*4+Q6W]([6\AMYK9EN0OE]<GM5'2+738PSV;>8^3\S=12:M9W,NFQI&Y
M9DQN 'WN*SM LKD70F.Y(UR#D=:7(GJ=%2HUB(QY/G_78V]3ALI;?_3<;!R#
MGFI+&*UBMQ]D"^6>ZUD^(;.YFV2Q[GC5<%5'3WJ;0;2YM[>1I25#X*J1S1RJ
MU^I:J/ZSR\GS+]V;;,/G^5G>-N_%6AC''2N;UK3KRXOEDC#2(V  !]VMNRAF
MALXXY9-S@<DBAI)7-*=64JLHN-DNHI^R_;!GRO/V\=-V*EF,8A<S8\O'S9Z8
MKEY=)OSJI(+'<V1-V K8UBVGGTTI&Q9E() '4"GRHSA7FXS;A:WXE73SHXO6
M,";9=WRE^GX5>U66S2VVW:[@3PHZUREK:W$USLB#;PW)V]*U?$-O/YT<NXLF
MW;D#H:.2-[')#$R]A)\J^[0LZ'+IRY2W1HY6_P">AR3^-6=8&G&(?;0"<<8^
M]BN>TBWFFOH3&2 K9+8Z"K7B"UG6[:<Y:)@,$#I1R1V"&(E]6;Y5OVT-NTFL
M8+ R6Q585&3CK^-<UJ-Y%>7:S"W0<]\Y/UJ:WL;LZ7<R D*P4@8Y;'6LP@Y7
MYN_I34([&.(Q$Y0C&UE8Z_2M1ANH3&$6)D'*CICVJIC1/[3!P/-SG/\ #G/\
MZS=*MIYWG\IR#Y3#..Y%4C:7'VGR=C^9Z;:/9Q>Y;Q53V<6XI_([*^N+>WM2
M;@!D88V_WJP],O--BO&*VIB9FP'+;O\ ]5/UFTN$L;4ERPC7:WR]_6L.*.22
M39&26+8  H4(O5E8G$U(U5IMY';W<]M#;DW)7RSV(SFH-+GLI+=4M-J@#E0,
M&LK6;.Z^SVS;F=8T"L ,X/K47A^UN#=+."5B4')(Z\4N56N=#Q,_K"AR_P"9
MT%X]LL/^E>7LR/OC/>IT9&0%""O;'2L#7[&[FD66/=(F,;5'0U?T>UN+:QV3
M-@DY"D?=%*RM<VC6FZS@XZ=R>Y2R-Q$;@0^;GY-^,U:. #G&*YG5-,OI=2#J
M3(KGY6 ^[6S+;7!THP"7,HCQD#J:.5(*=6;E.\+6_$H1-HW]J,R@"7U/W<UI
M:A<V]O;'[0 ZMP$_O5QZ6EP]R80C^9T(VUK:Y:W"16SM(65$"-QT/K3Y(K1'
M'3Q,_93:BE\A=)O=.BN7VVWDL[8#%L_A[5MWL%K/;D72J8QSD]JXJ&*264)&
M26+8&!72:O974UC"L;%S&/F4#EN.M#A%:#PU><J4KQO;R+NFP6<-L/L878W)
M(.<U+=Q6TL8%RL;*",;ZR] LKFWB=Y28U8#"$?K1KFGW=WY;0MO4<%>G?K2Y
M5>QTJI+ZOS<GR-M0JJ @ 4= .E<Y>KHQU%2X;<"=VS[I/O6O;6UQ%IH@>;,N
MTC..E<A-;3Q7'EN'WY(^[UIJ$9;F.,K2C"/N[]SMO-@AM X*B$+QCIBL.WOM
M)74#(ML48XPYZ?EVI9+&['AY8RS;E;>5QR%]*P5CD:4JNXMQP!34(LRQ&*G%
MQ]VVE]CL=3-FUD?M9S&?NXZY]JR=$&F)<GRQ)YN3L,I'Z8I-5L[I;"U)9F$:
MX;Y>AK+L+>:>ZC6(G.[J!TI>SB]6%:O-5U[O8[AON-]*%^Z/I3'5MI._C'3%
M"J^T?/V]*D]<P=;D$?BSPSD$[I;A1_WZ/^%=%7,Z_P#\C9X5_P"OB?\ ]$M7
M34 1F>$"0F5 (_OG</E^OI2K+&SE%=2P )4'D ]#7CLTIN?ACK,J?Z[Q+K[P
M1GNRO.(__0$-)_;.M:+XG\4>(M.AL)-*AU*UTR2.4-YL@0+&5C(X&"^><YH
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M;\TN?;H9=OKT$MZT1CVJ3A7SUK3N+F*V@:61AM45E6_AZ&.],C/OC4Y5-O\
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MH,SA_%&IWK:[_9ZWS:?;QQ"02*P!D;/KZ?X5M>$]2N]3T-9KL;Y%D:,2=/,
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M.W&:N'POW;DN$I.ZZ%J61TC=EC+$#(&>M5--NYKJ%FE@*$,1GUJY+*D*;Y&
M%0VMY!<@^6V2#T/%2E[KT^8^63][H-O[F6VM&DCAW$>_3WI]K-)-;1R/$58C
MD4ZXN(K>(M*X44Z&:.>,-&P84?9V^8<K^+H4M1O)K>2%8X-P+CG^E7E9B 2A
M&1Z]*KW5Y!!)&COAMPX':K*.LBAE((/>B7PK0.62U90:]N!JJVXMSY>/O9_6
MK^YO[A_.H3>6XN!$95WXJ<D 9)P!WHETTL'*UN-!;+?+W]:@OKB6"U:2.,EA
M2PWMO-*R)("P-23S10QEI2 I['O22:DKH;C+8S]'O;BZC83(2%Z/Z\TNLW<]
MM;@0J1NSENN*LV-U;31[8 %QGY<8IUY/;Q0D7&T@_P )&<_A6E_WM^7Y$>SG
M;DZC=/N9;FU5Y8RK=/K[U#J%[/;SP+';EPS=?7VJ[!+%+$&B(*^W:HKBZAA>
M-7D );I4KX_A^0^25N7J3AF(!V'\Z;D^9G:<X]:>""H(((/>JPO;8W7E^8-^
M/3C\ZA)O8I)O8EFD=(7=8\LH) S63I>HW5Q=O'(A922>PVUM$A5))  [FJ]M
M/;/(ZPLF[=R ,5<&E%JUR'"3=UL3DM_</YTV,L(U^7/'K2RRI#&6D8**BM+F
M*>%3&^[ Y[5%G:Y=G:Y#J5W+:VX>.'<2<'/059AD>2%7:,JQ&2I-.E=43+,%
M&1R3BG@Y&1TIMKEM8FSO<86;(^4_G2[F_N'\Z1G164,P!/0$]:?4C,V*]G;5
M7A-N0F.OY\U<GE>*!W6,LRC(&:B6]MS=M&)!NP!TXJR[*BEF("CJ35RW6E@Y
M)+1F/I-_=7%Q(DJ$KDG/ Q[5I74TL-L\B1%F X&:9:7%M(TBPLN=QX Q5B66
M.%"TC!5]353=Y_#;R$H22Y7N5["XEN+19)(MK']?>H]2O)K6%&CAW$MSGM5F
MVGBGB#1.&&*=-)'&@,CJHSW-3>T[M?('%VMU".1WB5S&5)'W2>E!)WJ=O(SQ
MFI 01D'(JK+>V\=RD;2@-R,5-FWHBDF]BQN;^X?SJA!?7$FI20-;%47OGI6A
MN 7=D;<9S52/4+:2X:,2<\=>AJHK1Z7%RR>Q+=320VSR)$68#@9K.TB_N;EW
M25"0,D-TQ[5K.ZHA9R HZDU7LY[64,("H.>0%QFG%KD:M\Q.$F^9;$Y)*G*D
M#'K0I.!\I_.G/]QOI0OW1]*S&<UK_P#R-OA7_KXG_P#1+5TU<SX@_P"1M\*_
M]?$__HEJZ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
MRKQ?I7BC_A(_$3:5H!O[75]/CM/.^T*GED*03@]>OM3M LO%5YXH\+R:IX=_
ML^TT>VD@,WVE9-^8PH.!TY4>O6JWB[Q3-I/BSQ#<7.J2V\FG6"+I=D'PL[RJ
M09,?Q%2?T]J@\-6DWA[Q=X7MXM6N[G4]1MWDUBUEF,@0%-ZL1_"03CGTH [Y
M?^2F2_\ 8'7_ -'-72US2_\ )3)?^P.O_HYJZ6@#BK"U\1Z)K6N26^CP7EO?
MWOVA)#>B,A=JK@C:?[M5(_">LVLTFIVRV_VZWUJXOH(9)/DFAE4*5+ ?*V.A
MP<8KT"N"\;:W=Z?XDTVU74[^QL7M)IIFL;99GRI7!(*M@ $Y-!T0E*;LBD_A
M3Q)<6FM"-5L4U18[=;<W[W'DH7)EDRW&2I("CVJ]!X2U[2]6GGM-1M[R.ZTX
MVCFXMU1(V3'E91?O#!93[&LD>(_%3Z#HUS;3F:6>\G>$R1*&O;6-"Z[@.%9@
M"./:I]<\7WSZ7K5]IE_(EN&T\VK1QJS(DN-^ 0<DYZ'O2-+5'II_5D.T_P (
M:O%=3R6VFVVBP/9S0SVUO>M+%=2,N%(0C$8!YSU[5=\'^'KG1);!9?"EC:S1
M0"*:_BNPS,=N"=NWN1Z]Z5;W6XO"VIWFEZA?7=P@)#ZQ:B#R%5"Q95"*7/3@
M\9J+7=>\0V_PRL=8L)H%G:SBFNKJ0 L"0OW%QC)+'D\"F)N<M--=.H[QQX'U
M+7FO;W3M6D6>6W2W6T>--FT,&(#$97)&3CK@5W%K%)#9PQ33&:5(U5Y2 "Y
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M_P Z*=623L@I.HTVD2:K;320(5=F"=1@?G5'2;:=KA74LBJ>3BN@>5$0LSJ
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MV^%?^OB?_P!$M734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPM)(JH;A8U\T 8QAB,CIBMJ&&.W@CAA14BC4(B*,!0!@ "GT4 Y-JS8A /4
MT;5_NC\J6B@1S6M^&);W4#J&GW@M;AE"2;DW*P'2M/1='BT;3A:HQE8L7>1A
MRS'J:TJ*!W=K";5_NC\J7&.E%% @HHHH H:CIZWD8*X61>AQUINFZ:+,;W*M
M(1CCH*T:*KF=K&GMI\G)?0SM1TQ+LB0-L?@'CK5JVM8[:$1J 0.^.M3T4N9V
ML)U).*BWH9EQH\,UV)=VT$DLN.M7W@C> PE1L(QC%2447;!U)2M=[&-#H:K=
M%G<-&",#'-:%Y9I=P>6< CD''2K-%-R;=RI5IR:DWJC(T_2/L\OFRLK,I.T
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MQ22N.I44$FS5I V68>E)EL_=_6LRRNKZ34IXYH-L8[^GX]Z$KA.HHM)]35I
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MNQ,FTM$;=,'^M;Z#^M 1\?ZP_D*B6.47#L9\J5&%VCBH*+%,CZ'_ 'C1M?\
MYZ?I345B#A\<GM0!(_W&^E"_='TIC*VTY<]/2A5;:/G[>E &-KG_ "&_#O\
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MSOO'[M $M-3J_P!:-I_O4U0<M\QZT 2'I38O]4OTH*G'WC34!,:X..* '/\
M=_$4ZF.#M^\:7:?[QH 4]12U"\3-)&PE90IR0.AJ3:?[U #1_KV_W1_6GLP5
M2S' '>HP#YS#/85%?6\EQ:/&CD,>?K32N[,<4FTF+;74$[.(Y Q#'BK/:L#3
M-/N4N_,?<BJ3GWK<9"5(WD9'4=JJI%1=DS2M",)6B[A%_JE^E*_W?QID*,L*
M#S&; ZGO231L\>!*R'(Y7K4&9-3&_P!:GXTNT_WJ:0=ZC)YSS0(DI@_UK?04
MNT_WC5""QECU*28SDJ><>M-)/<J*33NS1J.%E96VL&^8YP:;/"TL#QK(5+#
M(JCI=A-;>89)3SD8!S^--)6;N-1BXMMZD5_J[(SQP < C<:6QU=G=8YP.> U
M8]Q"\,CHY.1GK2V\3RRHJ%LG'2NOV<.4]#V%/DM^)9\4_P#(8\+?]A/_ -HR
M5TU<QXH&-7\+#_J)_P#M&2NGKB/,"BBB@ HHHH **** "BBB@ HHHH ****
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M ?34ZO\ 6G4U.K_[W]* ''I38_\ 5K]*<>E-B_U2_2@ ?[OXBG4U_N_B*=0
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M?NTM'2@!&^Z?I0/NCZ4M% $<O6/_ 'A4E! /6B@!/X_PI:** &K]YOK3J**
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MJEQJ,,$"RCY]_P!T"J,&N9E82Q *6ZCM0YQ01H5)*Z1M4BD,H(Z&J-WJD-N
M%_>,1G /:H[#5DGV1R+L<CCT-',KV!49N/-;0TB<#FEK.O=5BMF*!3(PZX/2
MK%I?17BG9PPZJ:?,KV$Z4U'F:T+.:*JS7UM#,L;R ,3C [58,B"/S"PVXSFB
MZ)<6MT+N&XKW'-+68NKVQNF7Y@, ;NU6;N^CM(@Y^8M]T#O1S(KV4[I6W+(8
M-G'8XI:Q[76E:0K+'M!;@BK5YJ<5K\H&]R,X!I<ZM<;H5%+EL75(901T-!.!
MS5"PU..Y"QE=CXX&<TR]U>.!BB+YA!&>>*.96N'L:G-RVU-.D) ('<U6M;^&
MYC9@=I498'M5&76XUN%"1%E&?FS1S+<%1J-M);&Q2;AN*]Q5<7T!M?M&[Y!^
M>?2J,>MQ&X8-&57@;LT.20E1F[V6QKTBL&''KBJ-YJ<=LJ[ '9AD>F*I6FM,
M7VS(NTL>5[4.:3L5'#U)1YDC<)P"?2@'(S32P:(L#D$9!I5^Z/I5&)6O;^"P
M^S^=N_?S+ FT9^9NF?:K587B?IH__84@_F:W: "BBB@ HHHH **** "BBB@
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MRQ,)$5N.XH]GI8/K:Y[VT.<L[6XF64QLP 3TZU396! ).<XZ5V:(J+M10H]
M*JW%A;2R*[Q#<6[&DZ6@XXQ<SNM#GX;6XE@ED0ML YXZU6VG?C)SCTKLTC2-
M J* H["H/LEO]IW^4N[;Z4>R!8Q7=T<Y-:3PP1/(QVL.!CI5=58L0"<Y]*[)
MXTD0JZ@J>U5H+"VAD9TC^;/<YH=+70(XQ6]Y:G-SVT\!42ELL,C/I26D4DLT
M:QL0<CMTKK)H8YD*R(&%1VMM#!$OEQA3BCV6H?7/=U6IS%Y%)%/(LA).[J1U
MJ_HL,ANC(&.P#GCK6U/!%*O[R-6Y'45(B+&NU% 'H*:IV=R)XKFI\MM3E[NT
MN%O-K!F+$X..M:K6EP-&,)<^8.?UZ5J$?,*6J4$KD2Q,I):;'&"*0RE!NW<<
M8J_J5O-&L!=FP$ Z=^:WEC07+ML7=M'..:D>-)5*NH8>AJ53T-'B[R3L<;&C
M.VU2<DXZ5/>6TUO+B5B20.<>U=';6=O"[LD8#;CR3FII88YEVR(&'O25+0IX
MQ<RLM#EK&"6:XC6-B#G.0.E1W$4D,C+(3N!YR*ZNV@BAA41H%X[4EQ;PS &2
M-6.11[+07UQ<U[:'/V5M/+',R,P&S&<=:I,K!P"3GZ5V2(J+M10!Z"H)+2W>
MX1VB4MSS0Z6@1QBNVT8"VEP=.,@9MF[.W'ZU2"L7(!.?I7:!0%V@#'3%5TM+
M=;AG$2AL"ATNP1QEKW1S,UM/ 5\TD;AD9]/2HD5FX!.2<=*[":WBN$VRJ&%5
MK73K: [T3+9/+=J'2UT*CC%RZK4DMHV2RC5F)(3FIE4X'S'ITIS_ '&^E"_=
M'TK8X&[NYS?C,E;32,$@_P!KVG/_ &T%=+7,^-?^/32/^PO:?^C!734""BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /+?$5[X2N/B-=VWB
MVWT]$LK>%[6:4,&D+9)5L'# =@16[HVI^!-1\7O?Z7>VMQK=U&(P5+$[57HH
M/ X'./2H9K;P_#XY\1:EJ<T$Y@L87G@FM=X@10?F#'.<CL!6M!>>&;/5]'@M
M+&VCN=3B>6TEAM57*!0Q); (X-  O_)3)?\ L#K_ .CFJUJ6J7%J=0",BB!(
MRA*YQN/.?6JJ_P#)3)?^P.O_ *.:M2ZTE+I[EC*R^>$!P.FTYKFQ,:DH6I;Z
M_D_UL;47!2]_;_@K]"MINJ23WLL1N$N8$BWM.L90(V?NG\.:--U2YN)95N55
M!)%YUN!_<R1SZGH?QJQ=:0MQ+.\<SP_:(_+E"#[WO]<9'XTU-!LH)X9K5/(>
M/(X).Y2,8Y-8*&)BUV7GO?[]EW>YHY46GW?]?U8IZ7KDFJRP01.BL$\R9ROW
MN<;5'\SVJPFKO/KD5M"JFU97'F=W9<9Q[#./K4RZ/$EM9QI(RO:ME) .?<$>
MAID?A_3X=0AO(81&\6<!<X)/>E"&*48IO6ZOKTTTZ^=^_P" Y2H-MI=[?C_P
M#5HHHKT3D"BBB@ HI"H/49I-B_W10!R^L>+)+:_ELK"S6Y:$@2N[[5!]![UJ
M:#KB:U;2,86@GA;9+$3G!_PKF]9\/:E;:I<W6GVJW<-T_F,F\*R-WZ]JV/"^
MAS:9%<W%Z$%S<L"R+R$ Z#/K4KFOKL91=3G::]WH=%13?+3^Z*<  ,"J-0HH
MHH RM7UA=. C5 \K#.#P *9H^MC4&\F5 DNW(V]#4&O:-)=R+<6Z!G"[67O4
M6A:)+!.+FYCV%1A5/4Y%97GSVZ'"YU_;VM[OX6-B_P!0MK%%,[X+$8 &3UJS
M%*DT:R1L&1N0169JVBQ:CY;A_+=>,XSD9J]:V<5I;)!&ORKW/>K7-?R.F+J>
MT::]WH)->6\5W%#),JR-G"FK-9=WHEI=:A%<OD,.JCHV.E:6Q?[HIJ]]2H.=
MWS+3H11SPO=21+*ID4#*@\BIZH0:5:0ZA+=(A\Q^HSP,^E7?+3^Z*%?J./-;
MW@C^Z?J?YU1U358M.C 9=\C E5!Q5Q%4C)4=361K>BF_VS0[1*JXVGC-*=[:
M$5W-0;I[EO2]4BU&'Y1LD4?,A.:NR8VC)QR*R-#T8V*M+-@RNH&T=A6E<6T$
MR*)(PP5@P^M$;VU%1=1TTY[EBJTE[;1WD=NTRB9APAZU/Y:?W16;/HMK-J<=
MVVX,.2HZ$CI3=^A<W-+W$:E58+RWFNIHHYE:1<9458\M/[HK,L]%M;6_EN(P
M<G@+V7/6AWOH$G.ZY5IU-1F5%+,0%'))J&TNX+N(O!('4$@XITUM%/"\3J"C
MC!%5--TFWTZ)E3+ECDLW?THUOY W/G22T+-W=0V=NTL[[4Z4ZWGCN(5DB<,A
M'!%5=3TN'4+7RV^1EY5AV-26-A#8VJPH,CJ2>Y]:6M_(5Y\]K>Z+=W=O;&(3
M2JA9Q@'O5H$$9!R*S-2TBVOI(7D!!5L''<>E:"0QHBHJC"C IJ]QQ<^9W6G0
M=_'^%+T&33-B[ONCI08D92"HP1@TRRO;:A:W4\L4,H9T."*LNZQH7=@JJ,DG
MM658:%;V5Y).K%CR%4C[H-:-Q:PW,#PR+\CC!Q4KFMKN94W4</?6HEI=0W</
MF02!USC(J27_ %;9.!CK5/3=+@T^!DCRQ8Y+-WJQ<6\,MN\<B HPP1ZTU>VI
M4'/EO):D]9E_K%K97$<4A8MNYVCI]:T!$@4 *, 8K$U3P^MW>K/'(J!R X(_
M44I\UO=(KNHH_NUJ;B.LD:NA!5AD$5%Y\/VSR?-7S=F=F><9HM[2*VMXX47Y
M4&!FJ_\ 9=I_:GVS:?-V],\?6GJ6W.RM\R\2 "2< 55M-0M;N21()0[*>14[
MP1R1LC*-K @UFZ;H5O87$DJN7)X (QM%)WNK"FY\RY5IU-&XGCMH6EE;:@ZF
MHK"]@O;</ ^X#@Y&"*2_L(KZT:!_ESR& Z&J^D:3%IUN0&WN^"S8Q1[W-Y";
MJ>T22]TN7=S#:P^9/($7(Y-3(ZN@92"I&015#4]+@U&!4D)0H<JRU:M[6&VM
MXX8U^1!@9IZW\BDY\[36A(Q 902.:=4$EM#)-%(R M&25/IFI?+3^Z*96I"M
MQ";UX1*IE"@E,\]ZEEE2")I9&"HHR2:I1Z9:IJDEV$/FE?7BK%W9Q7=K) XP
M'&,CM2UL2G/E=UKT*VG:O:WTLD<18."3AAC(]JT>U86DZ ME=-/(ZN5)" #I
M6WL3^Z*4.:WO$474<?WBLPCXC7Z5'<3101AY75%R!DTZ-%**=HY%5M0TVVOX
M5CF4X!R"IP:;O;0TGS6]W<N@@C(.0:H7&IVEO>QP22@.<CZ?6K:01QHJ*H"J
M, >U8][X>ANM16?S"H8Y=<9S2ES6T(JNHHKD6IN9&,YXK.@UBSGOWMTD._@
MD<$^U7?(CV;=HQC%8MKX<BM]2\[S<HA#(N.0:)<UU851U$X\B]3=9E1"S'"@
M9)JK8WUM>*_V>4/M8YJ6:VBGA>)U^5Q@U1TK1H-/,CJQD9B1DC&!Z4.]]-BI
M.?.DEIU--ON-]*%^Z/I3610I(4=*%12 =HJC0YSQK_QZ:1_V%[3_ -&"NFKF
M?&O_ !YZ1_V%[3_T8*Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#ROQ?I'BD^(_$3Z3H(OK35]/CM/.-RD?ED*03@G)ZT[0=/\67?B
MCPO+JOAY;"TT>VD@,RW22;\QA02 <CD#\ZU(O/U?XK:M%/?2QKI5D@L[0/M2
M3S4.YR.^"<?E7.>'/#UUX)\6>%+=KQY-0U"*XCU&W$YD4JHW*XST' _$?6@#
MO%_Y*9+_ -@=?_1S5TM<TO\ R4R7_L#K_P"CFJUJ5L&U:Q FF59F;>%D(!PO
M%95JCIQNE?;\="Z<%)V;-NBN7UK41#J BCNC%]CC$FS<?WC$_=/K\H/YT[4+
MOS-2\U8[F>V^QB79 ^TC)/.,\\5S2QT4Y)+5/^ON-HX:32?<Z:BN=MI+B>+3
M+6>Y8I-&\C/&_,F.B[OH>?I4-S<2+IE[##)=!XIHP$E;#*&(X#9[T/'+EYN7
MI^E[?<"PSO:_]7L=116-!9,UK.)H;B#C(S=%R<9].E3Z'%LTR&0R2.\B@L7<
MMDUM"M*4U%QM=7_K1&<J:46T_P"OO-*BL>W-RGB66.:XWH;;>D:C"K\^/Q/O
M6Q6E.ISINUK.Q,X<M@HI&8+U-9>OZD=.T&\NXB?,1/E..A)P#^M:$#M0UW2]
M/;RKJ^ACDX^4G)'U JY:7MK?Q>;:3QS)TRC9Q7 VEE!! &D42W$F&DE<;BS'
MKU[4Z%TT?7+*[M!Y:7$P@GC4$*P;H<5T2P\HPYC*-5.5CT.BF&5 <9/Y4X$$
M9%<YJ+1110 C?=/TH7[HK U?47$[01N551S@=:9I&HR+.D+N65\#GG!KH^KR
MY.<R]JN;E.A?[H^HIU<SJ6J2O.T<<C(J-@;<C-:6DZBURCI*<L@SG'6IE0E&
M',QJJG*QHM_K$_&GUDW>LI;7PAV95?OM_A6DTZ+$9,\ 9_3-1*$HI-]2E).]
MA5_UK_04^L*WUTO>E60>6Q &!R*T-0OA9VV]>6)P*IT9J2B^HE4BU=%N/[I^
MI_G2M]T_2L+2]7DEG$,QSO)P<5%JVHR-.\*.51>"!WJEAY<_*R757+='1+]Q
M?I39/NCZBN?TC49%GC@=BR-P,]JL:GK#P3F&(#*D9)'6AX>7/RH:JQY>8VZ:
M?]8OT-5[*]6[MA+C!Z'CO61+KT@NQL5?+!(QBIC1G)N*Z#=2*5SH:8O^M?\
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M["]I_P"C!735S/C3_CSTC_L+VG_HP5TU !1110 4444 %%%% !1110 4444
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MZD.H:1&+;4+&XD\O"I/ F]7';Z&K^DZ7>ZKJEO>W=L]M96S>9'')P\C]B1V
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M[H^E9E'->-?^/32/^PO:?^C!735S/C7_ (]-(_["]I_Z,%=-0 4444 %%%%
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MNOSU-*?+?WO,9>:O#93V\4J-NEY.,?NQD#)_$@4MQJ317WV2&TDGD\OS#M8
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M!^]+H^?]<[_=((YSQS75.EAI?@:"VUZ<I;"U2&X9V.6)&",CG.<UR6GKI/\
M;T,/A^;Q(DS["Y&?*\H' +;^=HY_6@#T*6TM)=(%E>0Q1V\D8B>$-M4 C[H(
MQ^E<GJWA31=.^PI%)J8CNKN.%;>*[+1L<[LD-G(&VM;QAJ6CV=E;VNL64MXE
MU)MBAC7.YQ[Y&.OK7.^%]+MKOQ#YUMH-U80:?*0WG7I<++MZ"/GLW7/% &UX
MK\0IHFK:9YMT88/*GED7M*0F$4\=R?TJ#PYK)U;5].(DL[B;^R_-O)X44L'+
M !,C[N.>*["2*.5=LB*Z^C#(JO:Z7864\DUK96\$L@ =HHPI8#UQ0!;HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)M?#'^SR(49UA>%_M,7;(=D4D<]R>M 'IU%%% !1110 4444 %%%% !1110
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MP#(XYW C[PYX-=-10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%(S;49L$X&<#J:R-.UN.[M7NY+FV$2)F
M2-00\+?W6S^70<T ;%%4AJEKT9G1O,6/8Z$,"WW>/?UIL^L65L',DC#9+Y)
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MYX3:2V\D?G00>0P<':PXYXZ<K5&/2[RUNO*MF0H;0QM+(#C<78G 'UZ5T%%
M&3#HQ@@NX4E&R:V2!"1R-JE<G\ZC_L/;<>9MMY0Z(K^<A."H R/4$#H:VJ*
M,DZ=>)]I6"X14EN/.[@D$#*DCITZBC3M(DLKL3-,KC;(,8.?G<-U)[8Q6M10
M!DZ5IYMKR]G8,J-(5@1OX$SDX]BQ)_*I+*SO+-I4#0-%),\F[D, QS]*TJ*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>81
<FILENAME>img254193463_54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_54.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +[!A\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<>E1^&_B?#XA\97'AY=,DA:'S/WQE!!VG'3%<#\!_P#D;-<_ZX_^SU6^&?\
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M7M$M-4MT=(;F/>BOU ]Z?J^IP:+I%WJ5UN\BVB,C[1DD#TK#^''_ "3O0_\
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M)JDFI.3V);3@HK<D^/4GG7N@28(WV[-@^Y%.^-NHSC3?#>F*S>0]N)F4=&;
M J;X]VLTNIZ*(89'586'R*3CFNG^(_@>Z\5^#M-N-.CWZE91*5CS@R*5&0,]
M^])-)1N$DVY6,K2_%6KZ?H$.E0_"^_:T$00C:<2<<D_)SFLSX=VWB'PU;^+;
MN?1[W3[0V<EQ;QSQLH#KD@#(Y./Y5+H_QBU;1=*BTS5_#=U->VZ")7&5W8X^
M8$=?I7<^"]9U_P 8:5J)U_2%L+.<%+<\AF4@@C!Y_&D[I/0J-I-69P/P*T>S
MU.YU;6;^)+FZ1U5&E ;:3DEN>YKVD:+I@U%-0%A;B\12JS",!@#UYKP32KC7
M_@YXGO89M+FO=+N>C)G#J#\K C.#Z@UW7AGXB^(O%GB>WBL?#CP:, ?M$TY(
M*^X/3\.:)IMW6P4Y)+E>YQ7A[_DXNX_Z^9__ $ UW/QS_P"2??\ ;U'_ %KA
M_&-EJ_@7XK?\)1;V#W5I-*9E*J=IR,,I(Z&CQOXM\0^/_"TOV+PY-:Z5:NLD
MTSDLS'. !P/7MFJM=J1-[1E%[G5Z9_R;K)_UXR?^A&N<^&NH2Z7\(?%5[ 2)
M8F8J1U!V 5TVFPRC]GJ2(Q/YGV&0;-IS]X]JS_@QI U#P'KFG7L3I'<SE"&7
M!P4'/-3T?J.WO+T./^%^L7^BPWM]9>#KO6YY9-INX@3Y?&2OW3R<YK0U]/$O
MB'QGI.MV7@C4M+G@D42N(F/F?,.2=HQQFFZ)J'B3X/:Q>V-WI$MYID[[E9,X
M;'1E8 C..H-=?HWQ/\2>*/$5I;:1X8>.PWC[1),3D+Z[L #]:IWO=(F-K<K9
MZNI)0$C!QS7C/[0?_(*T;_KN_P#Z#7L]>.?'^":?2]'$43R$3OG8I./EK*G\
M2-JOP,[KX<?\D[T/_KV'\S6AXN_Y$_6/^O.7_P!!->(^'_BYK>@:!9:5'X>\
MU+6/RP[;P6_2NRT?QSJ/C7PIXECN]*^QF"S?9MW'?E3ZBJ<&G<4:D6K&/^SZ
M";/6@#@[TY_ UC>&M4MOAM\1]8'BBVD5IRS17*IOP"Q(88[$>E;OP!AEM[36
M3-$\8WH<NI'8^M<I<3Z[+\1M<O\ 0[./Q(@<JS&'SD52> /ITXJ]Y21DM(Q9
MJ.\/Q$^+VGZAH5@_]GV[1O<7$D6U6"G))!_+!KUGQB?"5MI\%QXH6T$$#;H1
M*N3GT51R?I7F$7Q9\1>%YXH=;\(PV5LYY6.%H"?4C/!-0_%Z&[U#5M#\1PVD
MU[HSPHP0 D#G)4XZ9%)Q;:3V*4DHMK5AX_\ '_A7Q!X5N-,TS1[K<"K07(ME
M2-,'USD#'M6CX7F>7]GC6%=B0D,ZKGL*K:[XNN_&?A.[T?PQX1N+> 0[KB61
M JHB\X7'4\5:\*V\R_L_ZU$T,@D,<^$*G)_"C:/S$G>5_(E^ ^D:?-H%]?RV
M<,EU]H\L2N@8A< X&>E<YXZMX=)^-^G/8QK 7D@D(08&XG!/%=G\!X98?"5Z
MLL;H3==&4C^$5RWQ)MIY/C/IDB02,@^SY95)'WO6FG[[!K]V@^.%W+?>--(T
M9G86RQJVWL6=L9^N!7KLWA_2K7P?+IZ6%O\ 9TM2-OECG"]?K7G_ ,;/".H7
MYLO$.EPO-):#9,D8RP7.0V.^#52Q^*'B7Q'I:Z'IGAEVU*2$Q/<.Q$:\8+$$
M<?G4VO%6*NHS=RA\  %U_70!@"!,?]]FO>Z\+^!%E=V7B+7H[N"2-UB56W*0
M,ASFO=*FK\15'X#Y4T/0YO$7Q.O-.@U"6P=[B<B>+.X88^A%=KXD^#.KPZ9-
M?1^(Y=1>V4RB"Z#'<!R>2QKBM.U>^\*?$2\UB/3);GR[B8!"K '+'OBNPU3X
MM>*?$&GS:;IGAN2&2X4QEU5W8 \<<"M9<UU8QCR6=]SJ/A3X\.MZ%>6$ME#;
MW&FP[T$"[4=<'MV.17&_"*R@\3>/=5U7546YFC!E43#=\S-UP?2NW^$7@*\\
M+Z==WFKH$O+T!?(R"40>ON:XRXT[7?A)XWN=5L]/DO\ 1[DD KW4G.TD?=(-
M3I=J)>MHN1UGQOT*PD\'#4EMXH[JWF55=5 )!X(-<QJ.I7&I_LYV\ER[/)%<
MK"&;J0K$#]*@\4>+=>^*8M]!T70IX(#('D:0]2/4XP *[_6/A^Z?"-O#%BWF
MW4,8D4G_ ):2 [CCZ\XH7NI)]P?O-N/8?\%_^2;6?_7:7_T*N"M_^3D&_P"O
MAO\ T"JW@CXBZIX,T=O#\_ARZN9XY6\I1E2"3R",'O1X=MM>?XWVE]K>GM:W
M-RYF9%7Y5!0X&:?*TY,7,FHI#_C-$D_Q,TF&5=T<D<2L/4%\&O5O%WA[2$^'
M^J6D>GV\<,5HS1A8P-I49!!]>*\Q^+MO/+\3]&>.&1T"PY95)'WZ]B\6JS>#
MM8502QLY  !R?E-3)Z1+BM9'EOP5OYK7P)XCE#$BU9I$'H1&3_2L_P"!VEVV
ML:YJ^L7\:7%S'C89!NVLQ)+<]ZU_@58N_AG7;:YB=%FF"$,I&04Q7)Z/?:Y\
M(?%NH03Z5+=V=Q\HVY =0?E96 (S[53U<DB%HHM[&Q^T!96L$^CSPV\<<L@D
M5W10"P&,9KV7PU_R+&E_]>L?_H(KY]^)&I>)O&%A8:U<Z')9:8KM%;IRSDD
MECQT/;CM7T'X<!7PUI@8$$6L>0?]T5$](I%P=YMFG11161L%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !65K8_=Q-[D5JUGZPN;+
M/HPH FTYM]A%GJ!C\C5JL_1VW69'HQK0H **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *" 1@C(HHH :D<<0(C14![*,4I 88(!![&EHH
M155!A5"CV&*3RTW;MB[O7'-.HH :R*XPRAOJ,TH  P ,>E+10 Q(HXL^7&J9
MY.T8S3@J@D@#)Z\=:6B@!JQHARJ*"?04"-%;<$4'U IU% !361'QN56QZC-.
MR,XSS10 4444 (R*XPRAOJ,TH  P!@"BB@!DD4<J[9(U<>C#-. "@!0 !T I
M:* &LB/]Y%;'J,TZBB@!C11NP9XT9AT)7)%/HHH 1D5U*NH93U!&10JJBA54
M*!T &*6B@!&574JRAE/4$9%($54V!0%] .*=10 FU=NW:-OICBA45!A5"CV&
M*"0HR2!]:4$$9!R* $95=2K*&4]01D4B(L:A44*H[ 8%.HH *:R*_P!Y0WU&
M:=10 SR8O^>2?]\BE$:*"%10#UP*=10!#-;1S6TL&T*LJ%#M&.",5XGIGAKX
M@_#:\O(M L[?5-/G;<"0"3CID9!!Q^%>Y9&<9YHJHRL3**>IXI>^&/'WQ'NK
M2+Q+!;:7ID#[RJXW'UP,DYQZU[':64%E80V4* 00QB-5// &*L44.381BD-1
M$C7:B*JCLHP*78NTKM&#U&*6BI*$5%0850H]ABD,:,VXHI/J13J* "FK&B9V
M(JYY.!C-.HH 0*H)(4 GJ0.M+110 PPQ$Y,:?]\BG*BH,*H4>PQ2T4 %(0&!
M# $'J#2T4 ,CBCB&(XU0>BC%/HR,XSS10 TQ1F3S"B[Q_%CG\Z4JI8,5&1T.
M*6B@!K1HQRR*3ZD4X@$8(R*** &JBH,*H7Z#%#QI(,.BL!SAAFG44 (55AAE
M!'H12@8&!110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !5;4%WV,H]LU9J.==\$B^JD4 9FB-Q,F>X-:]86BMBZ=?5:W:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .?\;>('\+^$
MK[5HE1IH4'E*_P!TL3@9IG@37;OQ+X0LM5O5B6XF!W")2%X.. 2:\Z^.6CZF
M+ ZL-7E_LXM'$;#G;N_O55^&?@G6[O2](UJ+Q'+%8K)YALANQ@'D=<<UKRKD
MN9<[Y[6/<J,CUKQKXC>--<OO%L'@SPS,8)G8)+*IPQ8\X![ #K6=KG@3QMX3
MT>37;3Q3/=36P\V>-6;IW(R?F^AI*'=C=3>RV/=J*XOX:>,W\9^&_/N55;ZW
M;R[C:, GLP^M=FV=IVD XXS4-6=F6FFKH4D 9)Q17CMYX!^('B?5+J76/$2V
M5L'(A2!B05[$*N,?B<UE>#]>\0>#OB4/".KW[WUK,_E@NQ.TD95E)Y'TJ^2Z
MT9'M+/5'N]>0>+/!/C_4_$][>:3K/DV,KYBC^TLNT8]*]?HJ8RY2I14MSY5O
M)?&EEXM7PW+KMS]M:58@1<-LRW3FO0M#\!_$6SUVQN;[6_,M(IE:5/M3'<H/
M(QWKF/$?_)P$7_7]#_2OH^M9RLD8TX)MWZ'D3>%?'!^+AU47;_V49]X?SOD\
MK^YL]:]=KP4:KJ'_  T"UI]MG^S?:R/*\P[<;>F*T?BSXLU<>*[+POI]^=.@
MD5#-<9VY+'N?05+BY-(J,U%-^9[2"#T-%>3:5\.O%>D:A97FF>,S<0;PUPLF
M2K+WP,D']*S?BKXJU=O&%EX5L-1_LVW=4,MQG;N+=R?05*A=V3*<[*[1[6"#
MT-&1ZUY1I'P[\5Z-JEC>:=XR:YM=X:X60$AE[X&2#G\*P?B=JE_:_%K1K>"\
MGBA;[/NC20A3F3GBA0N[)@YM*[1[K1D'I7/>.II(/ VLRPR-'(EJY5E."#[5
MP_P0U2XN/"^J7.H7<LHBFR7E<MM4+D]:2C>-RG*TN4]9Z4=:\%AU/Q%\6O$U
MY#9ZLVDZ):$XV$@D9P,@$98]>O%+?W?B/X2^(=/:76WU?1KIMKI(>< \\$G!
M .1S5>SZ7U(]KUMH>\T5C:EXKT+1S -1U*"V,Z"2,2-C<OK2Z5XJT+7+EK;3
M-3M[J95WLD;9(7IG]1469I=;&QTHZU\_ZSK>M^./B7<>'EUTZ/8PNZ(-Q4';
M],98_6N\\(^"_%/AKQ KS>)S?Z,4.Z*0$LQ[8!SCUR#5.%EJR%.[T1Z)0"#T
M->(>*/%6O>-?';>$?#U]]@LX6(FG!VEMOWB3UP.@ ZU5\0Z)XH^&=M!KNG>*
M)-0MDD59X9<XY_V23D=O6G[/N]0=3LM#IOCO<36_@ZR:":2)C>J"48J<;&]*
MZOX<R/+\/M%>1V=S;@EF.2>?6O/OB]J\>O?"W1-4B&U;FY23;Z$HV1^=;5CX
MJ7PA\$],U(*'G^SK' AZ%R3C/M3M[B7F2FN=OR/3\@=317A/A_PAXI\<:=_P
MD.I^+);)KDE[>)"3QZX! 45K_#GQ7K5CXPO?!?B&Z^UR09\B<G)X&<9[@@YJ
M7#LRE4VNMSU^@$'H:\&U_P 4>(_B%XYE\->'+PV=A [*9%)7=MX9V(YQGH!6
M_I?P\\:^'M7LI[#Q5]IMO,'VB.?=C;W^4DY_2CDMNP52[T1T7Q.\:7?@O1+:
MXL(X7N;B;RU$P)7&,G@$5U^GSO=:9:W$F \L*.V.F2H-?/'QGT74]-UB&XO-
M8EO+>[E=X(7R! /0=J]'\!>"-<T>\L]4O/$DMY:M;#%JV[ W*,=3VJG%<J9*
MFW-JQG>&/"WC:R^*%WJ6HW;-IC22,S&;<LB'.T!>V./IBO6L@]#7A/@C5+^?
MXW:G:RWD[VZRW $32$J,$XXHN]4U#P-\:DBN;VX;2;V7.R20E0DG^#42BV_D
M$9J*^9[M1D'H:X;XL>)9/#G@BX:VE,=W=D00LIP5S]XCZ#-<YX=UBY\#?")]
M?U.66ZOKL[X4F<MRW"#GH.YJ%!M7+<TG8]<) ZFBO!_#WA;Q3X_L6\0:IXKE
ML1,2;>./)Z>P("BMGX?>)];TGQM<^"O$%Y]M*@FWN"<G(&<9ZD$?K3<.S$JF
MUUN>OU\__&'6]9L_'\5EI^IW-M');Q@)'(57))&>*^@*^;_C9*(/B5;RD$A+
M>)L#O@FJI?$*M\)NI\-_B1)&KCQ2F& (_P!)D_PKNO NB:]X3TS5)?$NJ"]R
M1(C"1GV*JG/45RL7QZL(X43^P+\[5 SN7TKU/2;^+7=#M;[R"D5W$'\J3D@'
ML:)N5M4*"A>\6>'PZMXV^*NO7B:-?G3=+MS@'>450>F2!EF.*C_MOQG\+_%E
MG9:UJ!U"PN<<%RZNF<$J3R"*]DUBZL?!7AVZU"RTH,B$,T%J@4N3QFO#[C6Q
M\5/B!I\>J2P:1:6V%CBD8[WYR1G^\<547?IH3)<O74^CHW62-9%^ZP!'T-<;
M\5;VYL/A_?W%I/)!,I3#QM@CGUKLD18XU11A5  ^E<-\8?\ DFVH?[R?^A5E
M#XD;3^%F?\$]2OM4\)74U_=37,@NBH:5BQ P.*]+/3CK7E/P$_Y$R[_Z^S_(
M5ZM3G\3%3^!'D?@SPMXWT[XBW>H:M=NVGL7+L9MRR@_=PO;^E>N5X-\-M5U"
MY^+FI6\][/+"K3XC>0E1AN.*O^-=<UWQ-\2HO!NEZBVG6J8$DB'!8XR2>Y]A
M52BW(B,THW1[2"#T(-+7SKXYT3Q)\-HK6>R\5WEQ!=,4.24(8<],FO2;+2_&
M-K\.&&GZT+[6KD+-'+<#&U& RH)[^YJ7#2]RE-MVL>@9&<9&:6O#;OX8>-O[
M+FU:Z\52'48XS+Y*R.>@R1NSC/X8KH/A-XWO];\,ZA'JCM<76FJ6$A^\Z8)
M/OQBAPTNF"GK9JQZD2!U.**^=?#[:]\4]>OWNO%+::L1S';H3G!Z!5!'3UKU
M3P9H7B'PK#J']O:Z-0L47=!D$LH')))Y_"B4+=0C/FZ:';=*.M>"6^H>)/BU
MXEO([75VTK1;0X&PD$@GC@$;F.,]<"GWEWXC^%'B73A-K;ZMHUXVUED.3@$
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M'B%1C(],DG%'.GUL+V;6EKE7XNZ58Z)\+M&T_3G9[2*[41,S[B058YSWK/\
M%MA<7?P$\/30JS):E)),?W2&&?S->D>+_A];>)O#%CH5O<FQM[.16C(3?P%(
MQR?>M?1_#=MIWA*W\/W)%Y;QP^2Y=<"0?2DII)%.#;?H>5^ _A_X4\4>%;2]
M_M34UN@NVXBCNPH1QUXV\#O75>'OAYX0T;Q,;G3M2N;C5($),<MTKD C&2
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MLXNTKFLE>+1Y_P# N^M+;P==+/=0Q,;HG#N >@]:]4AU"RN)/+ANX)'/\*2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  :*#THH P=5&S4
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M@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  ]
M*;WIQZ4PT /KGX/W.L8_Z:$?G705@7G[K5RW^TK?RH WZ*** "BBB@ HHHH
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MBM^BJYF3RH*PM=\(:/XCO;.[U*W:6:T.82'(QR#_ # K=HJ4[#:ON(RJR%&
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M"98&C/YCBOH"F211S+MEC1U]&4$57M$]T8>S:V9Y%IOQ_P!*E94U/2KFV/\
M$\3!P/PX-=AIOQ2\':H%$6LQ0NW1+@&,_K5_4? WAC5<_:]%M&8]65-I_,5R
M6I? SPM>!C:O=V;GNC[@/P-'N/R#]XO,]%MM0LKQ=UM=P3#UCD#?RJS7A-W\
M"]9L&:31/$*G'*J^Z-C^(XJHNG_%_P .2(L<ES<Q9 .R19E _'FCD3V8>TDM
MT?0-9^JZS9Z-'')=LX61MJ[5SS5NV$HM81.0TP1?,([MCG]:Y+XA?\>-E_UV
M_I4([\%1C6KQIRV9V((901T/-+38_P#5)_NBN5N_$.IWNJSV.AP0D6YQ)-,>
M,^@I$4</.LVH[+=O9'645S>E>(KNZ@OK>XL\ZE9CF*,\2?2LZZ\0>)-*2._U
M&Q@6R=P&C4_,F?6BQM' 592<-+^JU].YVM9^H:S9Z7/;PW+.'N&VQ[5SS_DU
MF:]XDDL8[.#3X1->7@!B5N@!Z']:YK6Y=9;5-(35[>%&$P*21'AN1Q3L:X7
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M[,75H6,1)7++@Y%7*Y?P#_R+*?\ 71OYUU%(QQ5*-*O*G'9,****#G"BBB@
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MTBPU/XP:R]];)<"&RA*)(,J">^.F:W8OA[X:BA6(V+2(C*T8DE9O+VG(VY/
MK:ATBQ@U>XU6.$+>7"+'))G[RCH*IR70A0=]3@]?EBT/XC6LUO9VU[OTXQBT
MED6(0J&ZH6^7GIBL?6M)NM*^&^NWT'V2*?4;Q9;A+1@RP0E@&4L.HQUKH_$6
MB:@?%,VI3:%#K]E)"L<,32A'MB.N,\$&K/A#PM+9SZK=7NGP6-KJ 55TQ'\Q
M$4#DMVR?:G=)7%RMMHR9_"^IW]AI)6Z\.V4%O-%-;W%K$ZO@?PJ2>=PXJU86
M%@_Q@UQ9;6W*C3X7 9!][<>?K[UN6?@#PY8W<=S#8G,3;HD>5F2,^JJ3@5:U
M3PCHNKZI%J-W:DW4:A?,1RNY0<@-@\BIYD5RLW!TXHI  H '0<"EJ#0****
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M^,$@# JY45M;I:VT<$8PD:A14M5%-))GSDK-NP44450@HHHH **** "BBB@
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MFL!/$/C.XT,^)8;73AI^PS+8MN\UHAWW= V.<5TL&CO=>!X]'N08I)+$0/\
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M"@"2BH_/A_YZQ_\ ?0H\^'_GK'_WT* )**C\^'_GK'_WT*//A_YZQ_\ ?0H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&,UG7/S@FL*::>IM.UK(B63CK2CDYJF7,;9;H*1KZ(+G+_3I76HG.V:(R*D
M)%9L%[(PW @J>@/.*2ZO)V0KNP#V7BIY+LKGLBKK;O=6TMK;N 6!!/K7#_V-
M<1OL=,,/6NP0-YF3UJ^UJMU;[2/G'W3772KRH:1V,M9:G,6>E1H@:1R&]JO)
MLB'R+QZUVVE>!KZ[M5F%O\C<C<<9%1:QX&U&QMS-Y ,8Z[#G%=52O7G':R)=
M9/W>8YR!O,P37KGP\LE@T)Y_XI9#GZ"O+K/3IRRQK&S,3@ "O9_"VFR:7H4,
M$PQ(278>F>U9X)7JW[&&+=J=NYLT445ZQY@4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:*
M/C;_ (5U\0_^@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^
M@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->C
M_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->C_A77Q#_Z NI_
M]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:*
M/C;_ (5U\0_^@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^
M@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->C
M_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->C_A77Q#_Z NI_
M]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:*
M/C;_ (5U\0_^@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^
M@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->C
M_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->C_A77Q#_Z NI_
M]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:*
M/C;_ (5U\0_^@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^
M@+J?_??_ ->C_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->C
M_A77Q#_Z NI_]]__ %Z^R:* /C;_ (5U\0_^@+J?_??_ ->NC\!>!O&^G^/-
M$N]0TG4(K2*Z5I7=OE5?4\U]344 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P!JG_GPO/\ OW_]>KDOWH_]ZI* ,_\ M4_\^%Y_W[_^O1_:I_Y\+S_OW_\
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M:DH **** (Y/]9']:DJ.3_61_6I* "BBB@".7[T?^]4E1R_>C_WJDH ****
M(Y?O1_[U25'+]Z/_ 'JDH .U4-'_ ./#_MH__H1J_P!JH:/_ ,>'_;1__0C0
M!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)5\1VICSC)W?3!K?#5Y0J**V9C7HQG!M[H]7HHHKW#QPHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "L_6_^07)_O+_,5H5GZW_R"Y/]
MY?YB@#0'2B@=** (X_OR?[U25'']^3_>J2@ HHHH CC^_)]:DJ./[\GUJ2@
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MZ-D,*\XKBK7YAL*3S[BSDCO;20QW5JPFA<=F'/Y'I2U'</Y=O(V,G:0 .Y/
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M?W3^W3\JPKK2KNT)+Q[E_O+R* -7_A)5_P"?;_R)_P#6H_X25?\ GV_\B?\
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M\C6G2'N%%%% !32BE@Q4%AWQS3J* #'-(0#U I:* $"JIR% ^@I<#.<<T44
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MV=I$L5O"@1$7H *@T?\ X\/^VC_^A&K_ &JAH_\ QX?]M'_]"->H<!?HHHH
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M **** (Y?O1_[U25'+]Z/_>J2@ HHHH CE^]'_O5)4<OWH_]ZI* #M5#1_\
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M6I,N^%U]5(K&T9L73KZK0!N4444 %%%% !1110 4444 %%%% !1110 4444
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M-/FTLGU#EUNUT.(;Q%J6F?"/PUIVG7+P7.J7#0M<*?F1 ><'L>16AXJ\!R>
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MDH **** (W_UT?XU)4;_ .NC_&I* "BBB@".3_61_6I*CD_UD?UJ2@ HHHH
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M$I)NQ?HHHI%!1110 4444 %%%%  >E,;I3STIC=* ()*C'W1]*DDJ,?='TH
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M#-IUS;L) J@20JP^]@'M5+QMM?X_6"WN##YEO@'ICM^M>Q^./^1&UK_KT?\
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M]:A=0%104"F15Z9/8FJVC>*O$FM?".XUZWDA_M:)G9<1?*RJ>1CUQFM7XO\
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M -='^-24 %%%% $<G^LC^M25')_K(_K4E !1110!'+]Z/_>J2HY?O1_[U24
M%%%% $<OWH_]ZI*CE^]'_O5)0 =JH:/_ ,>'_;1__0C5_M5#1_\ CP_[:/\
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MQQQR:]*TVT-AIEK9E]Y@B6/=C&<#&:F3NK7+A&SO:Q:HHHK,T"BBB@ HHHH
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M#WP7XJ\#^);J B&?0[ACN(EY&/NMM]<<&O6:**4I<SNPC%15D%%%%(H****
M"BBB@##UGP?H'B&Y2XU738KF5%VJSDY _ UF_P#"L/!G_0"M_P V_P :ZZBG
MS/N+E3Z&?H^AZ;H%F;32[5+: L6V)G&:T***0]@HHHH **** "BBB@ HHHH
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MZ"I*C7_7O]!4E !1110!&/\ 7M]!4E1C_7M]!4E !1110!&/^/@_[M25&/\
MCX/^[4E !1110!'_ ,O(_P!S^M25'_R\C_<_K4E !1110!&?^/A?]TU)49_X
M^%_W34E !1110!&W^O3Z&I*C;_7I]#4E !1110!&W^O3Z&I*C;_7I]#4E !1
M110!&_\ KH_QJ2HW_P!='^-24 %%%% $<G^LC^M25')_K(_K4E !1110!'+]
MZ/\ WJDJ.7[T?^]4E !1110!'+]Z/_>J2HY?O1_[U24 ':J&C_\ 'A_VT?\
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M%-Q:5R8S3;1HT445)84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5S_C75[K0O"=YJ-F5$\6S;N&1RX!_0UT%<G\2HI)O .I)%&\CX0A47
M).'7M3CNB9?"S>NYY%T.6X6=()/LY<2LN50[<Y([@5E1^*=-TS1M/DU75899
MKB(,)(T/[T=V"CD"L_\ X2K3=;T2[TVQ%VUR;)\*]LZ X7IDC&:Y='N]/O\
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MZ;X5\%:/X0@F338W,LYS+/,VYW^IJI22^XB,6_O. ^"%I9RVVN/+;P/+'?\
M[MF0%EX[>E5?#O\ R-_Q*_ZY3_\ LU=I9_"W0M/\1'6+2:^A;S?.^SI/B+=]
M*OV7@33+'4M<OHYKDRZPKK<!F&%W9SMXXZTG)7;&H.R78\W\%Z+IMS\#-3N9
M;*![ADG)E9 6RO3GMBHM+TG3W_9XO;UK.%KID=S,R ON$F <]>E>HZ3X*T[1
M_",_ANWEN&LY@X9W8;_GZX.*9;^!M-MO!$GA1);@V,BLI<L-_+;NN,=?:CG7
MX@J;_ \@UQVD^%W@(NQ8BYP"?0$8KT+XA:O#;+;:+I.GVMWXCU(".(O$K&)<
M<NQ(].E:-U\--'N] TC1WGNQ;Z7)YD+!QN8YS\W%5=:^%.D:WKTVL3:CJ<-U
M+@$PS!=H Q@<9 XHYHL.626A!)I/ACX=_#F2VUB);JWEP+D!-S7,IY  ^HX]
M,5Y_\19;N;0-+NE\'Q:):)<I]FN?.02D8X!1>1TSD^E>F0_"W15T2[TJZNM0
MO8+AUDW7$^YHV'0J<<4R[^%>DZCIZ6FH:EJMWY; Q237&3&!V QC]*%))W"4
M9-6.3^+$,+:QX+E>*,O+<+YC%1EQE.I[UH_&NWMK;P38I:PQ11_VC&=L2A1G
M:WI79>)_!.E>+-.MK2_\Y3:D&&:)MKIVZ_A6?=?#/2+OPQ!H,MU?M;PW'V@2
M--N<M@CDD=.:2DM/(;@]?,X?48H+[XR^'K7651K!;!#;I+]QFV9_G4WQ*M;+
M3?'OA*;1H8H=2>?#I H7*Y7&0/JU>A>(/ VB^);*VM[^)_,M5"PW$;;9$Q[U
M2\/?#30O#^I#4E-S>WR\)/>2;V3Z4U-;B<'L<?'I]GJ/[0]]'>VT=PB68D59
M%W ,%7G'XT^RM8-/_:(FALXD@BDL=S)&-JDE?0?2N]A\'Z?!XTF\4K+.;V:'
MR60L-F, =,9[4#P?IX\:GQ5YL_VXP^3LW#9C&.F*7,OP'R/\3H:***S-0/2F
M-TIYZ4QNE $$E1C[H^E225&/NCZ4 +5F$83\:KCD@59B_P!4OTH R-:;,T:^
M@S6I:ILM(E]$%8VIGS-1V^@ K> VJ .@XH 6BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** /!OC38OHGC'1_$ENI7>5W,./G0@_RK7^,>MG4
M_#^A:18L&DU:1)<#NO&W]3^E=/\ %[0_[:\ 7;(FZ>S(N$P,G ^\/R)_*O+?
MAE]I\8^.-(>[!,&B6@QW''"_J?TK>.L5+L<\M)./<ZCX+W<NBWFO^&;YMLEF
M_G 'CIPV/T-9WPSMF\4?%76?$DPW16S.8R1_$QPN/H ?SJI\3Y+GP9\1I-7L
MUPFIV;HWON&UOZ&N\^"^B_V7X%CN77$U](9F)_N]%_2B6SEW".LE'L<#_P W
M)K_U^'_T6:M?'CP_IMA]AU6VMPEY>SN)Y 3\^%&.*J_\W)K_ -?A_P#19KH_
MV@;:63P]I-PJDQQ7+!R.V5X_E3^U$5O<EZF_X"\!^';32M'UR&QVZAY"R>;O
M/WB.3BO)WT.'Q'\<;[2[F62.":\EWF,X) !.,^^*]7^'WCWP]?Z3H^B0WO\
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M+O\ [ %J!IIN GDACTVYQGZUU?P+T*\>]U+Q)=Q%(YP8XB1C>2<L1[5F2_\
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M (Q_Q\'_ ':DJ,?\?!_W:DH **** (_^7D?[G]:DJ/\ Y>1_N?UJ2@ HHHH
MC/\ Q\+_ +IJ2HS_ ,?"_P"Z:DH **** (V_UZ?0U)4;?Z]/H:DH **** (V
M_P!>GT-25&W^O3Z&I* "BBB@"-_]='^-25&_^NC_ !J2@ HHHH CD_UD?UJ2
MHY/]9']:DH **** (Y?O1_[U25'+]Z/_ 'JDH **** (Y?O1_P"]4E1R_>C_
M -ZI* #M5#1_^/#_ +:/_P"A&K_:J&C_ /'A_P!M'_\ 0C0!?HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ /2F-TIY
MZ4QNE $$E1C[H^E225&/NCZ4 .'6K8& !55!E@*MDX!- & ?WNM>H\P?I_\
MJK?K T[][J>_MDM_G\ZWZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/N,PY7Z&I='\/Z3H$#0Z78PVJ-][RUY;ZFM*BB[V"RO<****0PHHHH ****
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MU25'+]Z/_>J2@ [50T?_ (\/^VC_ /H1J_VJAH__ !X?]M'_ /0C0!?HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ /
M2F-TIYZ4QNE $$E1C[H^E225&/NCZ4 2Q#+CZU)</Y=M*_HI-,@'S_A3-3;;
MI\ON,4 9^BKFXD;T6MNLK1%_=ROZD"M6@ HHHH **** "BBB@ HHHH ****
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MCC^_)_O5)0 4444 1Q_?D^M25'']^3ZU)0 4444 1I_K)/J*DJ-/]9)]14E
M!1110!$G^OD_"I:B3_7R?A4M !1110!&O^O?Z"I*C7_7O]!4E !1110!&/\
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MJ,8K>T[4(-3M%N(&RIX(]#6]#%TZSM'<QJX>I35Y+0MT445TF 4444 %%%%
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M:-^J?\\K;_OHT 6V_P!>GT-25E23ZFMW#'Y-OE@QSN..*FWZI_SRMO\ OHT
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M&Z4 025&O05))3$[4 6HO]6*QM8;==HHZJM;:C" >U8-Y^^U8I_M!?\ /YT
M;D*[(8T]% I]%% !1110 4444 %%%% !1110 5A>*+Y;33PF?F<_I6[7(>-H
MI&^RL/N,=OXURXUR5"7*=.$2=97,J.4W.5)PH%5KJUA=6!(XJM>S'3\)GDJ,
MUE2ZD7R U?-<CO='O<R2(+JS(ERIZ&NJ?Q DMO%+(/G"A6'H0,5S$5P6;FDN
M)E*E?6M+RMRLS:C?F-B>5]7)$1Y':MSPO<RZ09(Y4+1R<G'4&N4T;SXKO=$I
M?CD8KIR\R1AMBY[TU.5*2E!V8I1C4CRR1T-[X@0#;;DCU8BLB3Q5-93*6D\U
M#U!KF;G5MMYY<R[!5P0V%_&"9!D=P<&KGBL1*7.W]Q$<-1C&UKGI%C>Q:A:1
MW,+91Q^1]*F>1(E+.P51W-</I,CZ2,VLS-&>J-R#2:QK\[-EEP/X5[5Z2S./
ML]O>.!X"7/9/0ZF?6K>,?)ES^0JI_P )+%$X$Z!5/=3G%><WNNS!<.^![54C
MU%[ML;R?QKD>.Q$GS)G3'!T5HSVJ"XBN8A)#(KH>X-25YKI,]YID@D1VV=<'
MH:[73M?L[["%Q'-W1CU^E>CAL?"J^66DCCQ&"G3]Z.J-6BBBN\X@HHHH ***
M* "BBB@ HHHH ***;)+'"A>5U1!U9C@4 .HJ&"[MKH$V]Q%+CKY;AL?E4U !
M1110 4444 %%%<IK7Q#T#1+EK9YVN+A>&C@7=M^IZ4TF]@.KHKD=&^)'A[6;
MI;59WMKAN%2X7;N/H#TKKJ&FMP"O-OC/*J^&+5"^"UP/E_O8%>DUX;\3]7_M
M;Q;_ &<I#6]@N"/5R,G^@IP6H'#_ -GI?1*ZDK@=Z?;VZ:=EG8$^],N+FXAB
M;8NU!6'<7DL_#L:W$;C:E!;,9[2>6"X'.^)RI_2O5?A=\1;G7;@Z-JTGF7(4
MF&<\%P.Q]Z\#+XXKMOA/:7%SX^L&A!VQ$R.0. H!J96L!]-T445@,**** "B
MBB@ HHHH **** "BBB@!LG^K?Z&J6B?\@>V_W3_,U=D_U;_0U2T3_D#VW^Z?
MYF@#A9O#5^VJZG)'IUP+N74_M-M=&?\ <JF5Y*9P> >U7_\ A%YWU-;B6PB;
M.M27#LV"6A*\9]1GM7=457,R>5'F5YX>UUM#FTN+3HMC+<>2X569"6)49/W1
MCTK370M2'B2SU1K0-;0^7'+ 7YD<(!Y^.F5Z5W5%',PY3G=,\*KIVKF_%RCD
M[OE%N%//OFHM$6^C\1ZS//ILT,%R5:)V((.U<8Q[UT]%*X[' /I6JZA%J1_L
MZ2"5=1CO[<2,,2[3]WCH<9J^VC2ZM+J^HZCITBB>.-8+42 29CR0VX=#D\5V
M%%/F#E.3T_PW<6'A#4;=F>;4KZ-WE+R;B7*X"Y]A@5E77A>_5"EI9QHCZ7##
M(J8 :59,G/J<=Z]!HHYF'*CA+WP7="&\\N436\<9_L^UZ>4[D%R3WZ8'H,UV
M\"E+>-6X(4 _E4E(3@$GM2;N"5C$T3]]JNKW&/\ EN(P?4 ?_7K4OHO/L)XL
M9W1D?I6;X9!;3IIB,&6XD;]<?TK:KDPL>:@K];O[]3IKNU9VZ6_ S/#TQGT*
MU).65=C'W!Q_2M.L/PV?*6_M,8$%TP ]CS_C6Y5865Z,;]K?=H3B%:K*W]7"
MBBBN@Q"BBB@ HHHH **** *NI?\ (+N_^N+_ /H)KQB()/\ "NPB;PT8E"(6
MU7RU_<@/DR\?-Q7MES#]HM98<X\Q"F?3(Q7$6O@?6H_#\?AZ;Q"G]E"/R76.
MV D:,]5W9XSG%7%I&<TV22Z]!IOB*\G:*":&UT077VI4_>R '^]Z'K3&\1^(
MM,L=/UO4TLGTV\DB62"($/ LA 4Y_BZC-;#>#[-M0GE9B;673AIQ@QT0=\_2
MJ$?@W49DL;#4M8%SI-E(DD< AVO)L^X';N!Q^5%XA:1CV6MR:$OB>:WA66ZN
M-;%O;HQP"[*H&?8=:U_[?US1-:@TW64MKO[9;RRVTEJI4[XQN*$'U'0U--X(
MBN+35H7O'62]OA?0RJO,$@QC'KT_6H9O#>K&:36=0O%U+4+2UEBLH84\I5+#
M!/\ O'I3NF%I(R]+\7ZY>WVCI'=:7=#4G/F6T2G?:* 2=V/3&.<<U)9^)KBT
MT=TL+&T2^O-9ELH%5=B9[NV.IP#65X=&I6$^GVVCM>O<;U6\BNM.6-43^+=)
MC)QVZYKJG\#I_93V\-\\=TFH-J%O<;?]5(3TQW':F[(2YF7#)XBL=(NWOKO2
MS,N#%<,"D:CN6'MVKDI_%-QJFD>)]'N;JTOC;6 G2ZM5*JP;(*D'N,?K71:A
MX7U?6-)>WU+6(I9Q-'-%MMP(EV'."O\ $#WS4(\#W$TVJ7-WJ*//J%BMFPCA
M")& 21M'XU*MU&U+H='H/_(O:;_U[1_^@BM"J]A:_8M/MK7=N\F)8]WK@8S5
MBH9:V"J]]?6NFV4MY>3I!;Q+N>1S@ 58JGJ.EV6J1QI?6R7"1.)45^0&'0X[
M_C0-D6AZW9>(=+CU+3V9K:0D*67:3@XZ5HUR/PV&/""\8_TNX_\ 1C5UU-JS
M%%W2850UC6;+0M/>^OY?+A4A1@99F)P%4=R?2K]4M3&GI:_:]2$(AM3YPDEZ
M1D?Q?6D@91T;Q19:Q>2V2PW-K>1H)&M[J(HY0]&'J*VZY'0(+C6_$4GBB>%[
M>V\C[/91.,.R9R78=L]AZ5UU-[A%W056O[^VTNPFO;R58K>%=SNW859JEJK:
M<++;JIA%LSJN)L;2Q/RCGWI(;,O2O&.GZIJ26'DW=I<RQF6!;J$Q^<@ZE?6N
MAK@]0-W;?$K17U?RI+67SHM-$'!C?;DEQW^7CTKO*J2)BV]PHHI&4,I4]",&
MI*,:V\4Z1>>(I=#MKD2WL,9DD"#*K@XP3Z^U;5<);:99Z3\4K&TL+9((%TB1
MMJ#N9<DD]S]:[NFTNA,6WN%%%(0&!!&0>#2*.6;Q_HRW)4+=-:";R#?+"3 )
M,XQN^O&:ZH$$9'2N&UJ.'63_ ,(=HD"1VL;J;^:-?W<"YW;!_MGT[5VZ((XU
M1?NJ !5-(F+8ZBBBI*.8O_'6DZ?=W$31W<T5JVVZN882\4!]&8>G?TKI(I8Y
MX4EB</&ZAE8'@@]#7&>*8Y9O"6H-X;DL5LV$K7VWJX_Y: 'H&QD<UT7AR:UN
M/#6F2V2-':O;1F)'ZA=HP#5-*UR4W>QJ444$9&#4E&-%XHTFX\2MH$%R);](
MC*ZH,A0"!@GUY'%;-<*FF6>E_%338+&V2"-M+N'8(.K&1<DGN:[JFTNA,6WN
M%%%'44BCEYO'FD0W4B;+I[6*3R9;U(28$?.,%OK73JP=0RD%2,@CO7$Z\8M3
M\SP;H5NBJ_-_*BXCMD)R03_?;T_&NS@A6WMXH$SMC0(,^@&*II$Q;N24445)
M1S6H^.-*T^^N+;R[JX%H0+J:WA+I![,1TKH8)XKFWCGA</%(H='7HP/(-<EX
MBBDF\,:F?#$E@J.TQOB.K''[P9'1\>M;7A:6UF\*:5)91M':FUC\I'.2J[1@
M&J:5KDIN]C7HHHJ2C'U'Q/I.EZO9:7<7(^W7CA(H5&3]3Z"MBN(\5Z796NMZ
M)>P6R+<W6JQ&:4#+/A2!SZ>U=O3:5B4W=W"BBBD4<]JGC'3],OY+,07=W-"H
M><6L)D\E3W;TK8L+^VU.PAO;.42V\RAT<=Q6%KVHQ:6\ECI%FDVMZEG;&@Z<
M8\R0]E%:7AW1QH.@VFFB3S&A3YWQC<QY)_,U32L2F[FI1114E&%K'BJQTB]2
MQ,5S=WK)YIM[6(R.J=-Q]!6AI.K6FMZ='?6,A>"3(&1@@C@@CL15*]"RR:A_
M8CV2ZVJ(LC2C)4=5W8YQUQ6;\/'0^')(]I%S%=RQW1SD-+GYB/;FJLK$W=['
M64445)1C:IXHTG2-3LM-NKD"\O'"Q0J,M]3Z"MFN&\8Z38VE_IE];VJ+=76J
M0>?-C+/C@#/8>PKN:;2L2F[NX4444BCGM6\8:?I5^]EY-W=W$2"2=;6$R>2G
MJWI6OIVH6NK:?!?V4PEMIUWQN.XK$U[4(M*DDM-*M$FUS4A\B*.N!CS'/915
M_P ,Z(/#WAZTTP2^:T*G?)C&YB<D_F35-*Q*;N:U%%%248FL>*++2+N.S,-S
M=WCKY@M[6+S'"?WB.PJ[I&KV>N:<E]8R%XF)!###*PX(([$54O0LDU[_ &,]
MDNMK&JNTHR0O;=CG%97P]=?[%NX74_;8;R5;QLY5Y<\E?;I565B;N]CKJ***
MDH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH #TIC=*>>E,;I0!!)34&<?2G24D0R5_"@"W6!!^]UG/_30G\LUNNVU&
M;T&:P])&^^+'J 30!O4444 %%%% !1110 4444 %-9U3[S!?J:AO;G[- 6_B
M/ KF;VZ9BSR$MBN'%8U4'RI79TT,.ZOH;UWJ]O;\*PD?T!K"U+5&N8U\Y5"*
M<@ 9KF)=55;DX/&:;=ZV%C(10<CO7D5<;5K74M%V1ZE+!TZ>N[,7Q+?JTY(/
M7H*Q;></@YI^HA[AVD8Y)JC;_NG.::C:-QN7O6.D@ *YID\88C!JE'>9  Z5
MJ6$0N'"GO6336IHFGH:VD7HC1;>08QT([UL@Y.=^5/:N?N].DM\,.GK6A83/
M)& YY%9-N.QJE<6]T2VU%E9F:,J<Y7N/2J\F@PP+FWFD!']XY%:WGHAPW6DE
M'G1%HCS4-RMH*WO7966]CM+=5FX8#  K&O\ 5([ER21@=*V(;6V9"UX0YSPI
M[50U:STN2,B.,(V.&3C%4I7W!IWT.3U$F7.UN*CTE_+N!O/ [UMP>&Y;BV\T
M7,>*;_PC-RJDI)&?QKH=2"C:YBHRO>QIG7A';^7P?<UCS:L1.)$<JP/4&J]_
MIL]M:L[ C'!-85HKWU]#9QL-\KA02>!FJI45/452JXZ,]\\'ZI)JOA^*:4[G
M5BA;UQ6]6;H.D1:'H\%C$<[!EF_O,>IK2KZ*G%Q@DSPYM.3:"BBF22QPKND=
M5'N:IM)79"5]A](2%!)( '4FF13Q3C,4BN/8UX5\0O'<E_J]S81W$D=E;N8Q
M'&V/,8<$G%5"TM@::W/<C>VH4L;F':O4^8,"N)UWXH:?IUR;;3;=M0E7AG5L
M(#]>]>%S7MLMD9(F923RN>#6=)J\[;51]JKZ5HH(#W73?C+ICSF#5K.6S;^\
MOSBI-8^+^F10E-&A>\G/1G&U%^M>%0W45V?*N^<]''45)%B"[%L)-P]C5<D1
M'H5Q\6/$T3%Q-9<_\L_)SM_6N;U+Q)J_B*;SM4O6FC'2)3M0?\!%0QHB2F-8
M1@CJW>L34X'M+D[>%?L*I)= +*>(+C1M2CNM(G>WFC.<H>#[$=Q7TIX+\1KX
MI\,VVI;0LK#9*HZ!AUKY+.2Y!ZU]$_!';_PA<H!RWVEMWMP*SJ; CTNBN=\1
M^-='\,E8[R8O<L,K!$,O^/I61I?Q5T&_O4M+@364DAPC3@;2?J.E9\KW&=S1
M2 @C(((Z\56OM1LM,@\^^NHK>+^](P I <K\3?$;^'O"S>1+Y=S=-Y2,.H'\
M1_+^=?/KZND&/)7+]68\DFNU^-/B&PUV?3XM+NTN4@C9F:,Y&6/3_P =KRF-
MGX#"MX*R$:EW?R7,@?HPY!':O2?"WQ*\1V-BD,_E7\2#"^=PX'U'6O/],LE=
M?-N!B/L:UUNXK4E/+81]FQQ5-7T [O5OBWKDMN8K#2XK>4C'F%MY'T%>8227
M\MU))(7:>5BSL>I)ZFM,7REBR,,5EW6LR!F6( $]Z(Z;("Q<B^2RR[H5_NUS
M@8N[9&"*G>ZE<$-(QS4^FV4NI7D-I FZ:9PB@=R3BFW9 ;/A/P/JWBNXQ:0[
M8%.'G?A%_'N:^@_!G@>P\'V;+"?-NY1^]G(Z^P]!6KX=T6#P]H-IIL &(4 =
MA_$W<_G6I7.Y-C"BBBI **** "BBFR;_ "G\O&_:=N>F>U #J*\\F;XH1[W,
MFA+&">6R,#WJ?1+WQQ)K%LFI7FA/9EOWJV[Y<CVJN7S(Y_([RBBBI+"BBB@!
MLG^K?Z&J6B?\@>V_W3_,U=D_U;_0U2T3_D#VW^Z?YF@"_1110 4444 %%%%
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M]W*^M37%O&&^T%VG#<,K#.",9^F*7*/G\CM8O%-Q=V6IRV>EO<365[]D\H2
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M"JM&N=H89Q3-2U6]E8W-R^?[J#H*]:691Y?<6IYL<!+F]YZ':S>);*)&8AR
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M:I:)_P @>V_W3_,T 7Z*** "BBB@ HHHH **** "BBB@ KB_&NNS6I_LV%0
MZ R,1USV%=I7-^+M-MKNSBFD3]\)%C5AZ$]*X<RC4EAI>S=G^AUX%P5>/.KD
M_A35WU;2\R(%>$B,D=",<5NU3TW3K;2[1;>V3:G4D]2?4U<K?#1J0I1C4=Y)
M:F->4)5&X*R,36-L6LZ1.>OF-'GZC_ZU;=8OB3"6UI.?^65RA_,XK:'(J:6E
M6HO1_A;]"JFM.#]5^/\ P0HHHKI, HHHH **** "BBB@"#[%;"^-[Y"?:BGE
M^;CYMO7&:B.DZ>9;J0V<):[7;<$K_K1_M>M7** L8(\(Z1:65Y%IMC!:S7,#
M0^:H)(!'3GM[5'H'@W2-#AM)$LK<WT$0C-PJ\YQR0.V:Z*BG=BY443HVFM#/
M";*$Q3R^=*I7AWX.X^_ J#4O#>C:Q<)/J&GPSRHNT.PYQZ''4>QK5HHNPLC(
MN/"VA75TMS-I=N\JH$!VX!4= 1T./>GW7AS1[ZSM[2YT^&2"V.84(P(_IBM2
MBB["R,G4/#.BZJ\;WVG03/&NQ6(P0OID=1[4V[\*Z#?&$W.EVS^0@CC^7&%'
M1>.WM6Q11=A9#418XU1%"HHPJ@8 %.HHI#"BBB@#A?'TBZ=K?AC6+K(T^TO"
M)WQD1[AA6/L#WKKIM7TZW@2>6^MDB<@*YD&&)Z8]:GN;6"]MI+:YA2:&0;7C
M<9##W%8%EX"\,V%VES!I<0DC.8PQ+*A]@3@55TUJ39IZ'&Q:5<>)/$GB4WL%
MA<RV]SY,:WDCAH(]O!0#IZYJY!:7-CXJ\#VMW>)>31072F=&R'&WCGOQQ78:
MIX3T76;L75[9AI\;3(C%"P]#@\BK":#ID5Q8S1VB(]BK);;>!&&Z@4^8GD.?
M^'O^HUS_ +"DW]*\V\564DVJ^([EO#EH&+162R?:LE9)&X8#N3^E>X6&F6FF
M+,+2$1B:4RR8[L>IJ&30M,E+F2SC;?<+<MD=9%Z-]10IV=P<+JQ6\.Z7'IV@
M6MM+IT%FT6"85?>JL.X/K61\.F!TG41D$_VE/W_VJZ;4=.M=5LGM+R,O"^"5
M#%>GN*S])\):+H=T;G3K/R92""0[$'/7@G%*^C*L[JQMT445)04444 8WBRT
MGO\ PEJMK:Y\^6V=4 [G%4/ ^LZ=>^#M.,$\2>1 L4L18*8G48(8=N1745SM
M]X%\-ZC>O=W&F1^=(<R,A*;_ /> /-4FK69+3O='-^,KP:WK7AVSM9[6XTNY
M>7<))"(9I%'"DKU^E9^N:#<Z+X0\6DRV45I+9J5L;5V*Q.#RV#TS7H5SX<TB
M[TI-,EL(?L<>/+B5=H0CN,=#5>#PAH=OIMU81V*^1=KMGW,6:0>A).::DD2X
M-LY^/_D?/#7_ &"&_D*J?$JREU'5=$LTT6WOO-G!#R3["=N25QV'3FNY&D6(
MOK>\$ ^T6T7DQ/G[J>E2SZ?:W-W#=30J\T(81N>JAN#BCFUN/ET://?A=8QK
M!J.LOH]M90W,\K1SK-NP@;&W'91CK5][F/QYJL.R5$\.V-P'#E@#>2H>,?[
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M8P?X2>"*]@KSKX.Z!_97A3[=(/WUZV[/HHX']:]%K"6XPHHHJ0"BB@D $DX
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#"/[C.GY,16Q6'X9.V&_@_YXW;KC]:YIZ8B#[IK\G^AO#6C)>:_4W****Z3
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M[0W82&WMY"-ZQIW;'0DGI5]".IU5%%%06%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%%  >E,;I3STIC=* (L9<#WJQT%0*,RBGSML@D;T4F@#$L?WN
MJ[O]IF_S^=;]86BKFY9O1:W: "BBB@ HHHH **** "N.\:VX+02K]X@@^_\
MG-=C7)^)LRZA&C?<1,BN',6E0=SLP*;K*QPK12%L%3306CZ9K><1 X"BLN]
M1\!:^=C*^A[CC;48NHM&H!:K=IJQ;";^#UK N%<G(!I;9'C!9N#52IKEN0IN
M]CJY-0^7:#Q2Q7VQ,@\FN8-X>A-+'?G.TFHY':Y7,MK&_-J!.<M6=->D\9JF
M\Q;H:HSW:QD L,GM5QI=Q2J6V'W=RQX&22>!69)HY1RQ')Y-:]G+;(WF2JSR
M=O04M_> K\JA16\?=32W,9>\[L33;MM-01(HP_5O2KLFHDK]ZN3FNY ^<\4]
M+XL,$U/L=;L:JZ61K2WX5\]:>FIR-U&!6.02P;-6(VR0,52II;BYV=%978=P
MS#=CM6RD\9!<@ G@"LC3; R*K+WZUMRZ;E45#C'6N1OFE9'0M%J1Q6$+2B0G
M)/.*M7 CCVJ  *K6Z/'*5)R!5BXAW0F0GI2;NK#V91O3'*NT8K">Q=Y0%Z5H
M;'DD*J3FKD4/D1EY.H]:TI)WL@Y>9C[*UBM(P6.9,=/2IVNMAW56M(;B])D!
MV19QO/?Z5H1Z;;J/WK-(Q_O&N^&"OK-ER]G3=I/4P]4U+?\ 2O-_$EVPOE*O
MM#+DBO5=2T&*>-FMODD'09X->4>*].GAE>5HV#QC!4CMZUT4L(HSO<QQ$8U*
M;=+H8\5Z96V9.3[UZ#I-Q]HTNW.061 C8]17E%K(R7 9CWKT?PN^^REY_B'\
MJ]>C'EC8XE[]#7HSH 1CH:9))A>*7=\N*B89&*UN<K1'NR:?FFA<,*AU:;['
MI<\P.&V[4^IXH6KL9J+;Y3+U#Q/8Z?,8L/.ZGYA'C"_C3!XVLRH*6LA_WG K
M@=1WQH3S@UD_:7VCDUT6IIV9O-T*;Y;7/3+KQON0I:VX1S_$[9Q7+2W#3SF2
M1BQ8Y8GO6!!)*7W+SCJ*T0VX9H<DM(G//$*UH*Q?GDMV087#>M7['4/+@V%P
M4'0'K6$7]:4,,5!R%J\N?,D.*IO( ,DTDC;4+>E4,R7&3V[4-@(;A_-80C)-
M1237 /S,15BWC\N0ANM6I8E=.E2Y:@9T-VT9YY%7TN4=02<$U2%F6EP#@5=2
MW0+C'.*;: E$BR?=SM'% ZTRW0[ @'-3R0/$ 64C-3U 5D&5)]*M6END[[?,
M1!URYP*JF3"\\@"KMEJ*6\6UH@Y[&G8#UKX=> =/NYX]1N]0M+L1$,+>!]W/
M;=_A7M%?)&C^)+W1==AU&R<Q,C#<H/##N"*^L+*Y6]L+>Z486:-9 /3(S6<U
M89/1114 %%%% ''>.=7U*TFTK2=+NXK&;4I71KR5<B-57=@#^\:QM,\4:JD?
M@L2WR7#ZA++;W49 W/C.)/;&/UK6^(RPR:5;Q7F@7.JV1D)E:T;$MN0.'6L?
MX?V'@."_6?1[F:34@I18[]R)8@>H56Z?A6BMRF3OS6N>F55OM1M-,M_/O9TA
MCS@%NY] .]6JY?Q&\=OXET&ZO,"Q1I59F'RI(5^4GT[U"5S1G0VM[;7MHMU;
M3I+ PR'4\53T[Q%I.K7#P6%ZD\B DA0>GUQ7.^')[5(]=\R<06-_>S&T[;E"
M@.RCTSDT>'9/L.N6VEZ=J/\ :.G?92SL4&8"#\OS =_0T["N=G)_JW^AJEHG
M_('MO]T_S-.NH+QV=HKL1IC[OE@TS0\_V-;9.3M//XFI*-"BBB@ HHHH ***
M* "BBB@ HHHH *PL>9XUW?\ /.SQ^;5NUA69W^+]2/\ <@C4?C7-B=7!?WOT
M;-Z&TWY?Y(W:***Z3 *P]'(CUS6(/^FBR?\ ?0K;9@B,S'"J,DUP47BZWA\2
M7%R(#Y$P5&)/(QQFN#&5Z=&=.4W;7]&O\CKPM&=6,U!7T_5'?44BL'4,IR",
MBEKO.0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ K!\,^)!XB;4P+8P?8;MK;EL[\=_:MZN"^&?^L\3
M?]A:2J2T9+>J.]HZUP7BB2XUKQ[I7A9KF:VT][5[NX\EBC3;3@+N'0552&X\
M)^/;;1M+NIY+'4[*618)Y"_DRIT92>0#WHY0YCT;<N[;D9],TM>&1QVVI>&U
M6&35I/%\D^V21&?[V_YOF^[LQ7M6GVHLM.M[8,[>5&%R[%B?J3UHE&P1E<LU
M#=W<%C:2W5S(L4$*EW=CPH%35Q'Q9\W_ (5[>[-VS?'YVW_GGN&[]*25W8<G
M97(8?'6N:O&;O0/"=Q=:=D[+B>98C,/55/\ 6NJT'5GUK3%NY=/N;"7<4>"X
M&&4CK]1[U9TSR#I5I]FV^1Y*>7MZ;<#&*Y;Q]>WF_1=%M+E[4:K>"":>,X94
M R0I[$]*K1NR1.J5VSL\YZ4=*\XU735\#ZYH-UI-U=>1>70M+JWFF:19%8<,
M,]"#4>DZ,OB7Q;XJAU*^OFM;>\"Q6\<Y1%)7KQ1R]0YNAZ717C46NZM%X-71
MXM0F6637#I:7C',B0[O7UQQFNV_X1NR\(6%YK%A-?/+;6<C&.6X9UE(4D%@>
M_%#C8%*YU^1G&>:*\6T^SOM5\,1ZO':>(9=?N(_M$5ZDF(PYY  W8V=NE;E[
M%?ZUX_T73=0N[JS6?1FEO(+>79N<,,J2.@R>U')YAS^1Z82 ,]JH:-K%OKEA
M]LM0XB\QHQO&"2IP:X;2=/%GXL\2>%DNKMM+-E'<(K3$O$QSG:W4#BJ_PYT.
MVM?!<^K1377VDQW"8:=B@&3R%Z9XZT<JL',[GJ-&><5YI\//#QU'0]*\1ZIJ
MM]<7B*3&OGE8T09 !7H?J:Q/$MQHMII][J.E:IK-YJT$OF+>JSM$K!ONG^';
MCBCDUL'/I<]5OM9M=/U/3M/F#F?4'=(=HR/E&3FH;O4M2@\265A#I3S6$T;-
M->AP!$PZ#'^>M>?^*-(M]6\<^#9;F6Z#7\4K2^7.R@$1J1MQ]WWQUK=O0^G_
M !)\,Z?#/-]F6QG!1I"=V!P3ZFCE0<S.ZS17F?AG1E\=6E_KFL7M[YLEU+%;
MQ0SM&MNB' P!W[Y-8TVMZK?>!K:WEU&=;JTUT:>;R,X=T#<'ZX./PHY Y^I[
M+17F^IZ6OA'Q;X;ETV[O#]ON6M[I)IRXE!4G)SWR*](J6K%)W"BBBD,;\V3@
MBF32K;PO--*D<:#+.YP /<U(._UKE9;<>)_$]S;W66TO2RJ^1_#-.1G+>H48
MX]30!8;QMH88A;QW4=7C@=E_,#%;%CJ%MJ5N)[*ZBGB/&Y#G'U]*L)%''&(T
MC14 P%48'Y5ROB&U7PY.GB73D$:1NJZA"@PLT)."V/[RYW9]B* .KPW<C'TI
MU)D%<CH12T %%8WB75[S2=.W:?I\E[>2Y6)!PBD#.YSV44GA/4[G6?"]CJ%X
M$%Q-'F01C"YR1Q3MI<5];&U1112&%%%% !1110 4444 %%%% !1110 4444
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M:1F03VR8E1XV7:221U%=<0&&" ?K0%5>@ ^@IWTL*VMQ:***0PHHHH ****
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M>O+N>B+W)K/M;6.=#^\PX[5ZU\)_%VE:7(-$O+6.VNYFPMV#_K3V#>E0[I:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH I:O_ ,@6_P#^O>3_ -!->7_#GQ'8V?@K3;271+VX=2RF
M6.U#*<L>]>IZE$\^EW<,8R\D+JH]25(%>=>$+GQ9X8\,VFD/X3EG:WW#S!<J
M <DGI^-:1^$SE\29M^*_$MYI6JZ5H^GR66GB\1F^UWB_NX\?P@=,FL;XA2^(
MO^%77WVN;39-Q"S2P;L21[A@KSP?6M_6KB^O=.M!?>$5U"">/,]N75FA?TP>
MOUKG!X+UA_AGK6E)"(9;N<S6=BTN\0)D$1[OPHC96%*[N:>O:IK6B?#^2]U*
M'3+J96A6.,1DQ[20.0>]6=4\0ZX/%EIH&DQ68-Q9&?S9P<18(R<#KUZ54\16
MNM^)_A_-9#1I+6[#PA(9) 2P4C)]NE:7]C7W_"Q[+5/)_P!#CTUH&DST<D<4
M:6U'K?0R;#7O&6K7>HZ3 -,@O=+;;/<NK,DQ(RH5>W'6M;2/$>L>(/!D6H:=
M9VHU,R&&1)7(C0@X9O4CVI?#VCWUEXJ\47EQ#L@O9D:!L_> 3!KEO^$8\0P>
M!K6Q6WE(34WFO+2&78\\!8G:&_I1HQ:HW=+\1ZY%XH?P[J4VG75Q/:/<6UQ;
M A593@JXS[UE_#V;Q!]HU>XN9=/^Q)J$QNMJMOR!SMYQCIUJ70_#5Q!X]L-7
MM?#T>DZ<EG+"RA@7+$C!8"K?AJQUC2=3U72;G26>SO;N6;[:L@VA&'IUSVIN
MUM 5[JYEIX]U;4K6XU>QU+0[6TB9O)L;A_WLRKZG/RD]J[S2M6CUWPS!JD2E
M4N;?S I[9'2N)TC3M6\+V3Z,WA2#5%B=OLMVFP!D)R-^1D$5WT E71P)H(X)
M?).Z*+[J''05,K="HWZG&>']2FT?X2S:C;A&FMHYI$#]"0YZU#=>*/%MCH-I
MXEN8M-&GOY9ELT#&0(V!NW=,\]*31+=]5^$-YIUD4ENY(ID6,.,Y+'&?2M'7
MM"U&\^&,.DP0;KU8H5,>>ZD9Y_"JTOKW)UMIV.;\<Z7/K?Q L)K!V2^MM)-W
M:$'&75R0#]1D?C6[J/C<W_@:TN-,'_$UU-OLD4/\4<W1\_[O)_*KZZ-?#X@Z
M;J?D_P"B0Z5]G=\]'W9Q3M/\ Z=IWC.Z\0QR.?-R\=L?N12, '<>YQ2NK*X6
M=W8POA;I,>AZKXHTV-F<07,2EV.2S;.3^)S6K\-O^03J_P#V&+K_ -#JQX:T
MR[TOQ'XIOKU%BMKNZ22&1F&&4+@GVJM\-&5M'U9E8,IU>Z((.0?FHD[W?H.*
MM9>IVM%%%9F@@[_6N>N]?O+N^ET_0+6.YFA;;/<S,1#"W]WCEF]A4WBN_N+#
M0I!9,%O;F1+6W8_PNY"AOPSG\*OZ3I=MHNEP6%JI$4*XW'EG/=F/<D\DT 8X
MTCQ2ZEW\4I'(?X([",H/SR?UIC:SK&@8.OPPW%CG!O[12/+]W3G ]Q744UT6
M1&1U#(PPRD9!%  DB2Q+)&P='7<K*<@@]Q3JYGPP#IUYJ>@Y)ALW$EMG^&)\
MD+] <BNFH **P]=O=:CNK.RT6SC>2X+&2ZGSY4"@=P.23V%0^&-;OM1NM4TW
M4XH%O-.E5'D@SLD##((ST/J*=M+BOK8Z*BBBD,**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ****  ]*8W2GGI3#0 \=!6!J'[W5=GNJ_Y_.M^L!/WVLY_
MZ:']/_U4 ;]%%% !1110 4444 %%%% !1110 C*KJ5900>Q%9E]X?TZ^B97M
MU1C_ !H,&M2BIE",E:2N5&<HN\6>4:KIDND:BT#\IU1O452EFPN,\UZEK&CP
M:O;A)/ED7[KCM7(2>!;TR$"6,KZYKP\1@)QJ>XKH]>CC(2A[[LSA9BSR>U0R
M)A2>]=G?>"M0MEWHHE'?95*W\*:E>2A!;,@)Y9A@"L?85(OEY6:^U@U>Y4\(
M>&GUZ\9I24MHB-[#J?85Z9'X4T>*#R5M!CU+'/YU/H6C0Z)IRVL6"Q.YV]36
MG7LT,-&$%S*[/*K8B4I>Z]#Q_P 0:1_9>LRPQ@F/.5^E4&X7!KT_Q+H7]I0_
M:(<>?&O0_P 0_P :\RNRL+%6C;([9KR\5AW"IILSTL/64X>9C7A^; J)(^.M
M72R2MS$M.\A>-HK%+D-'[Q28E130V?:M)K9/+)/6LUTPQ]*I.+)::+FGW@MI
MSO;Y'&"?2M.=V=,J=RGN*P5"XYJ:T!9\*Q ],U$H*]RXR=K#+V=H 2!EJZ7P
M>S+IC7,S%GD<GGL!Q7/7D6X<BM+P_= 6C6F</&Q8#U!J:L;T_="#]_4ZFYN
MX)KF=0DPY(Z5<DG;&*S[D&0&L*<6G=F\VK61G22@\4B!3WQ^-5[A3&XYXH:X
MQ'CRU ]J]&E5G'X3)5I0-2VGN;8[K>8X[C.0?PHO]4O'A(FGV)W"C;65 ^Y=
MRDCUQ52^C>0'YV)]S71]9F]RGB5\3BKF;?ZQ=,YC@NIHUS_"QJ*QU_4].G!F
ME:ZMSU60Y/X'M5:6UD5SE32$A%^89 [&NNGC'%6:.>5?G?OH[&/QE8O 0EC*
MTF.C$8_.N+NM8EUB\S<RE82QV1KPJBO5O"G@"UU#0$U>6[BBMY$+Y(SM ZY]
M,5XM-$D5Q*(G#HKL%8=",\&O0P]76]CEJ5Z<%^[6I>U*VM!:9MY#O^O6N:5C
M'+]#6JS$KBLUXC]HR> :WYK[GFRDY.[-BUMGNXLQ8-/NK![6U,DA'TJ32XX(
M!O:5QD= :NW*PZA;F*&4[@. 3UK.VHCA[B0.^ .*@9<58N;=XI65E((.*B\F
M1NQQ[TW!] );1MR,I[5K6R.MNK$$ ]/>L^WA9> .O4UNSW,<D%O$@&]%PQ'2
MJ<7% 5MQS5ZTL8;[='(2O&0P[&JGED 8!J5+Z33]R!/F<=3VJ5=@4+[3G$QB
M3#%>-R]ZJI8SV\JL1R#FM^TT^[NR)0=@/<]Z9>03VTNV1@WO6B44(E_M>Y*#
M?"AXQG;5-;B82F1&*,?3BIC=9BV%1]:KEE4 MW.*6BZ 69KZXN81'*V[;WJN
M"1TIDLGE1%A38G+KN(ZTF,MP0S2MF(X:ENA?6TR,482 Y5A3(96B8,IQBK4N
MK2D?-@XI7 ](TSXM^+/L4*R6=D_E( 6=3N?'<\UZ!X*^)=EXJN#87$0L]1 R
M(]V5?_=/]*^<_P"TIY.=Y ]*GT6\GL]=L[JW=EF2965AUSFI<$T!]@44V-BT
M:L1@D D>E.KG&%! (((R#110!Q/C*X&F2:=IVC:5IS:EJ,C)')<0KLC"KN+'
MCD^U9FE:]-"GA">>PTXMJDDD$[Q0!'609PRXZ#CFI/&&N>"]?O4\/7^KM;:A
M#+F&X@)!ADZ<-T[XQ67H6C>&O"OC'3K&76+S6M8R8[:)CN2U4\EB!P*U2TU,
M6_>T/6:***R-@HHHH ;)_JW^AJEHG_('MO\ =/\ ,U=D_P!6_P!#5+1/^0/;
M?[I_F: +]%%% !1110 4444 %%%% !1110!4U23RM*NI,XVQ,?TJ/1$\O1;1
M1_SS%1>(G"Z#=9Z,NW\SBKUFGEV4"?W8U'Z5S;XCTC^;_P" ;[4/5_DO^"34
M445TF 56U"+SM.N8^[1L!^56:",C!Z4I1YDTQQ=FF9OA^7SM!LR3DK&$)]QQ
M_2M*L+PL?+L;FU[V]S(GZY_K6[6&%ES4(-]C7$*U627<****Z#$**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI*;+$?[3$T 7J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ3+'I95U RTCJ>?;!K1TWQII\]FKWLGDSCAE"DCZ\"ICF6&E4=/FVZ]/O'+
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH #1110!@7'[W62.V\#^5;]<_9_O=6W=?G9JZ"@ HHHH
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MT15C\&:6E^+G+E0VX1$\5NS6EM<0/!)$AC<8(QVJK%I5LT*$B3)49^<^E/\
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MU-6$[G:4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 50U=MMB1ZL!5^LO6V_<Q(.[9H
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M6ZMUE=4Z D=JU*YWP%_R(.A?]>4?\JZ*LWN:QV"BBBD,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "HIK:*XQYJ!L=*EHH :B+&BHHPJC %.HHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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KV\EO<1++#(I5T89##T-2T4AD5O;PVEO';V\:Q0QJ%1%& H'85+110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>82
<FILENAME>img254193463_55.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_55.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %M 7H# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **@O?M?V"X^P>3]L\IO(\_/E^9@[=V.=N<9QSBN-_XNK_U)O_DU32N)
MNQW-%<-_Q=7_ *DW_P FJ/\ BZO_ %)O_DU3Y?,7-Y'<T5PW_%U?^I-_\FJ/
M^+J_]2;_ .35'+YAS>1W-%<-_P 75_ZDW_R:H_XNK_U)O_DU1R^8<WD=S17#
M?\75_P"I-_\ )JC_ (NK_P!2;_Y-4<OF'-Y'<T5PW_%U?^I-_P#)JMGP]_PF
M'GS?\)+_ &'Y.T>5_9OG;MV>=V_C&/2DT"EY'04444B@HHHH **** "BBB@
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M1?""^'KUK]O$OB*_58V!AU"^\Z/'KMVCD8K#^,W_ "*%E_V$X/ZUWUX";*X
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M@*!DD]!1<5NIQ</PNT*WO9I(;K5(["9S)+I:7A6T<GKE!R1[$X[=.*MM\/\
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MSGWS6K4/<T6P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)QSD#UI-:,I/5'>4445F:!1110!@^-=!D\3>#]2TB"0)-/&/+9NFY6# 'V)
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MD^[9GCKD5C5?TW_EK^']: +]%%% !1110 4444 %%%% !1110 4444 %%%%
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M 4444 5-1_X]U_W_ .AK,K3U'_CW7_?_ *&LLD <T +14+742GEJ;]N@_OT
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M3S:G&"QY:OIKPG*TNA0,QZBODS08VEUFW11DEJ^MO"T)AT"W4C! H V:***
M"BBB@ HHHH **** "BBB@ HHHH *OZ;_ ,M?P_K5"K^F_P#+7\/ZT 7Z***
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)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>83
<FILENAME>img254193463_56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_56.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )  CT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH Y/Q[)>-ID%I!9K/:W#,MRQLC=E %RO[L$
M'D\;L\5D^&?#EYI.I:=J-YI44YN(07FD?-Q8OLY#$G]XN/EW?>'0Y'-;OBV#
MPRZVLFOWR6$REA;7 NC!(IXW;6!'MD=*P+'3_!>K7T5I)XLN=;=C^[M+C53(
MK$<_<4C=T[YK1/W3)KWCT2BJNH78T[3Y;D6\T_E+Q% NYF] /\3P*Q9/%H^R
MV\UMIL\Y>Q6_G174&&(_7[S<' ']T\U"39HVD=)4!_X_D_ZY-_,5B0^+8)[J
M,Q6LC:?)<+:+>;A@RD9 V]=N2!GU_.MLD&^7G_EFW\Q0U8$TR>BBBD,****
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M2FM?O_5_F<=>493;CM_7H%%%%=!B%%%% !1110 4444 %%%% !1110 4444
M%%%% %35$EDTF\2&X%M*T#A)R<"-MIPV?;K7F7A'3M3@U;2K=].33+5+IKM9
MVOUE%T#;A&6, Y?<<N2>@KTK6HX9="U".X65H'MI%D6$9<J5.0H]<=*XSPUI
M5]J+:#=WOB&SN].L8Q+8PP6XCE?,95?,^8X(4G('>KB]&9R5VCT&BBBH- J
M_P#'\G_7)OYBIZ@/_'\G_7)OYB@">BBB@ HHHH **** "BBB@ HHHH ****
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MG-SDY/=D]%0;+K_GO'_W[_\ KT;+K_GO'_W[_P#KU9)/14&RZ_Y[Q_\ ?O\
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M ]@EF+66.-+HW:-'<2*ZRD8+!P=W/?FIKGPAHEW!<Q2VA_TBX%T[K*RN)@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO$?B#Q#XLOO#_A:2VLX=. %YJ%Q'YA#GHB+T/X^A_&3X._\ ),M-!ZAY@?\
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MH#@CH:T:LC).\CIZ***S-0J.&0R*Q('#LO'L<5)4%K_JW_ZZ/_Z$: )Z***
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MTL#3QRQACZ))G;] 0/:K>A:*D-X;^7Q#>ZO<*I3,DZ^4@/7$: +GCJ<FN?\
M'>BZ-'=V3)H^C#4-5NC$U]J$6Z./"%LMR,L=N ,]:N?#U(;3^U]-CMM+62TG
M19+G3$V13[D##(R<,,X(S6GV;F:^*QTM]K=GI^HV5A-YIGO'V1A(R0."<L>@
M'!J@WC'3(VD:83Q6R^8$NGC_ '<ICSO"GJ2,'MS@XS4VO6&HW\^FM9?9=EK<
MK</Y[,"< C P#_>/Y5B7/@N\O;)-+FO($L+5Y9;:1%)E+ONV[@>,+N/3K@=*
ME)=1MRZ'2:9K$.IR3P^1<6US!M,D%PH5PK9VMP2,'![]015JU_U;_P#71_\
MT(UF:9I=X-0O-1U1X#<7$<<(CMBVQ40L0<GG)+'Z<5I6:A864=!(^/\ OHTF
M4BQ1112&%%%% !1110 4444 %%%95_H,&HW7GR7>HQ-M"[;>\DC7CV4XS0!J
MU!>6J7MG-;29V2J5)'49K'_X1*T_Z".L?^#*7_XJC_A$K3_H(ZQ_X,I?_BJ4
MDI*SV&FT[HS--\#?9-32XGN5DBC8,JJ""2.1GTKLJP/^$2M/^@CK'_@RE_\
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M8_\ !E+_ /%4 6AX<TH7_P!L%HOFYW=3MSZXZ5JU@?\ ")6G_01UC_P92_\
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M\)%M=0S$=1&X;'Y4O:QORW5P]D[<UM#A](\+ZE'=ZQ>1Z5;:);7=@UNNFP7
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M,S);V>EE6=SY;9*!N%(7.3Z9%:/@.S6"'4;A[778KFXE4S2ZR4,LN%P,;>,
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MW!FDN0T8*.S$#'R\;>@Q5_9L9_:N==1114&@5!:_ZM_^NC_^A&IZ@M?]6_\
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M%W(RL.F0<U%:_P"K?_KH_P#Z$: )Z*** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 51UG2+/7M(N-,OT9[6X
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MGVM+.-9LYW<X!]0.E:%%%1"G"'P)+T*E.4OB=PHHHJR0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!"P49) 'O5#3]
M3-[?7]N8@@M9 @;=G=G/Y=*Q]2CBU'Q=#8W['[(MOYB1EBH=L_Y_*L9W:RL-
M<73Y&\O[3''O#Y(3D?>_(5Y=;'2A.]O=3?J[)O:VGWG?2PD91M?5I>BN['H
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MM_Q_X8]3-*5*FX^S21RO_"P=(_Y\];_\%%S_ /$4?\+!TC_GSUO_ ,%%S_\
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MUO<12V\;V!FD$XZ8P<L2<\8Z&JAN1/8/AO<0W1U"2&30CMV*R:;8/:R*>?\
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M^F7&N62^ S)('T1[J1V!QPO%J<_]M,_\ KV0  8 P!5:+3[."^N+V*VB2ZN
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M#N=E4 L?4^M+-#%<0M%-&DL3C#(ZA@1[@T^B@".&W@MH!!!#'%$HP(T4*H_
M5';V%G9JZVUI! ).7$487=]<#FK%% $*V=L@A"VT*B'_ %0" >7V^7T_"IJ*
M* "BBB@ HHHH *Y5[H:WXPU;PWJ,-M+ID-C#(+>5,M,SLV6^@V@?6NJK@O&E
MUX$N-3CM]?U,6>IVR_)+#(\4J*PSC<HY!]*J.Y,MBYX62STGQ7KGA[3;*S@L
MK>."X3[,F&5G# K(<G)^7(]C78UR7@:7PBMK<VOA:Y2XVL)+F3<S.S'."S-R
M>AKK:);A#8****DHA@^_/_UT_H*FJ&#[\_\ UT_H*FH **** "BBB@ HHHH
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M0R>BH/+N?^>Z?]^__KT>7<_\]T_[]_\ UZ )Z*@\NY_Y[I_W[_\ KT>7<_\
M/=/^_?\ ]>@">BH/+N?^>Z?]^_\ Z]'EW/\ SW3_ +]__7H GHJI_I?GF/S4
MP%!SY?O]:D\NY_Y[I_W[_P#KT 3T5!Y=S_SW3_OW_P#7H\NY_P">Z?\ ?O\
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M[,1,!N;<<+CG')XZ_6F7&K317]A MG-BX,FX$+N&T?7_ "* -:BBB@ HHHH
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>84
<FILENAME>img254193463_57.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_57.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '" _<# 2(  A$! Q$!_\0
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M ,/QK*O6C1INI+H:4J;JS4%U,F,'Q=XF:1LG3+/@#LY_^OU^@%6M> 'CCPV
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M$8&.M3Y&.:K9$>%P0!WJCJ-Y+;P&0#([8H*M=FJV[^$C\:FLM2O;&0217+*
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MX+D+_4_H*G$U?8T9U.R;//2N[%3PK SQW.H2<R3R$9]AU_4_I6AKJJ^DR@L
MX(:,G^\#D?RJ31X!;:/:Q]_+!/U/)_G5;5<7%Q%:[L;V"GGIGD_I7+0I>QP4
M8/=K\7N-N\CGM1U)]2E@-Q;/;Q@']]$Q)SC@ ]N:MP:C//Y4:2W%Q$J 2&/
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M:;/Y/]XC!^N.M7K1)HX/-D0@'@9JE<3+T95&.>E7(+Q5%9DDBLG!YIEMO>0
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M6OFRZ3">C70/Y8_QK562NCSZBE.HHU'O_2+.L:+/J.L:3>1R1K':2,TBMG+
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M1B%;'!S7,VJ"9&N91G ^08QCZ"NC1 /#-HX."[$MS]3_ $K*A4G.4IOM_P
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MX:C'I(X/YUYL]<;#_"_S1Z4/]UEZK\F=%7)Z_P#\CSX;^LO_ *#765R>O_\
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M'7O6KI>8[9$/0J,&@B;N2,=[D$=N#63>Z$/,::TF\EG^^A&Y'^H[?A6ZV%?
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MIBZ;;$F\OOW:JO4)T/Y]/QJ(J[L7)\JN4/"8.N>*]3UYP3$A\N#/Y#_QT?\
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M_81@_P#0JVK?PV8T?C0S0/\ CUU?_L(7'\ZE\)_\BKIO_7$?SJ+0/^/75_\
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MXK.U8,XA>*:2)HFW';_&.ZFI;.99(^*6Y0R+BD):,YM&CNHS,TFY]SJ<MC#
M\C\JC>]@TRV:>??-(I)5=QVD8X(J@!_9FK7-I<!_L\[^9QV/9A_*G32?:]1@
M\E"T4>4V,/E8'N!VIF]ON)]$:6^G>YG.,X54!X %6]?U:+2K,Q0D&\E&$4'[
M@_O'^E9TNIV^C1N(?FER0D1['W]JY6>>6ZG>>9R\CG+,:=BX4^9W>Q[C\/\
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MAL[JX>GR1@O76[?=ENFF>E?V[I?_ #_0_P#?5%UKFF644,MS>PQ),"8V9N&
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M (2#2?\ G_@_[ZK@[;_DG>G_ /7R_P#-JS*UI86,XW;.'%9C4HU.5);'I_\
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M)/4TVOL#[-!_SQC_ .^11]F@_P">,?\ WR*.8/KZ_E_$^/Z*^P/LT'_/&/\
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MY5\K_J^_^?GX?\$^K_MA?R?C_P  \0P:,&O;_*C_ .>:_E1Y4?\ SS7\J/\
M5]_\_/P_X(?VPOY/Q_X!Y#H^MWNBSF2V;*-]^)ONM_\ 7]ZWF\1ZYXCM+K3[
M;3;-O-C9#B?:P!'4 GFO0/*C_P">:_E6!JOA&UO9?M-FYL[H'(:/@$_0=/J*
MZ(8#%8:'+3GS1[;?=>YD\9AZT[SA9]]_OV,:T_X2ZSOIKM-#MV:6&.(J;@8
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MT4>TD'LXF/8>%M%TXJT%A&77H\GSG]>E;%%%2VWN4DEL%%%%(84444 %%%%
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M\@BJ9UC3!?\ V$ZC:"\Z>1YR^9_WSG- %VBBB@ HHHH **** "BBB@ HHHH
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M63;G.,C.*^?IK71=2^%>LZ_JLR2>)Y+EU=Y9R)%;S !&%STV\XQ_+CWO1_\
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M%4I-8TR&^6REU&T2[;I TRAS_P !SFKM(84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%5[N_L[!4:\NH+=7;8AFD"!F]!GJ: +%%(S*BEF(50,DDX
M%5++5M-U%G6QU"UN6C^^(9E<K]<'B@"Y14%I>VE_#YUG<PW$62N^&0.,CJ,C
MO1+?6EO<PVTUU#'/-GRHGD 9\==HZG\* )Z*I7.L:99W26UUJ-I!</\ =BEF
M56;Z G-7: "BBB@ HHHH **** "BBB@ HHHH *\X\?+_ ,(YXN\/^,HQMA23
M[!J!'_/)^C'Z'/Z5Z/65XET.'Q)X<OM(G(5;F(J&(SL;JK?@0#^%5%V9,E=:
M'&A?^$L^,98C?I_AJ# [J;F3_ ?JM8FC^,[K1O#&DMHNA:>CZAK$UH;6'<BL
M>@.23@YQD],#I7=> _"3>$-!>TGN1=7L\S37%P ?G8\#KSP /UK LOAK>6MC
MHENVH0,=.U=M0<A#\ZDYVCWJ[QV,^66YC>(+KQO_ ,)IX/M;N31H[]VN9(A%
MYIBW!,'?W/R],=R:Z_1/%.HWWB/Q-I=U%; :1'"4:(,-[,A9LY/3(XJ3Q;X4
MU#6=8T;6=(OX+34-,:39Y\1=&5P > >H_K5&X\%:W%XDO]4TK6[:U7588X[\
M/:[R&5=NZ,9P,C/!SC/>E=-#M),9IGBW7]8^'^F:W;+H]M<7+N)YKV5HX(5#
M,H('4GCIFN3\4^*[CQ-\*O$45Z+-KO3[V&!YK)RT,P\Q2'0GL>:W?^%8ZA#H
M/ANS@U"QGFT9YF,5W;F2WF\QB02F?O*#Q2S_  OO9?#OB'3?[4MC+JUS#<"0
M6_EK&5(+#:#P,],4TXIB:FU8]$C5GT]5C;8YB 5O0XZUXGH]KI7A7R-,\=^$
MV6?[66770OF)*Y;<I9QR/IGZCK7MS0N;(P)*8W,>P2*!E3C&1FN N? GB;68
MH=+U_P 417FC1S+(ZI:A)YPIR%9NW;FI@TMRIINUBW+XF\2ZUXDU73?#%MIJ
MV^DLL<\U^7_?2$9VJ%Z#CJ:KZCXK\6/XOE\-:1I^FM=K8Q7+2SR-Y<1)^?)'
M+#) ' ]:MW7A#7+#Q%J.J>&=8MK--3VM=0W-OYH5P,;TP1S['BKVG^%KNU\<
MR^(;B^2<2:<EFP\O:S.I!+\<#..@]:=XBM(Y'4_BG>)J.J)8W.AP0Z9(T1AO
M9'$UXZ#YQ'CA1G(&<Y/Z7=:^)Q6;2+73I-/L)+^Q6^DN-49O+A1N F%Y9L@_
ME5Z3P7KFF:QJ5SX;U>RMK34IC<30W=IYIBE/WF0Y[^AXJSK/@[4I]4T_7-*U
M6"+6;:U^R327-L&BN4Z\J#\OS<\4_=%:9@R?$_4&\(IJ5M:64]]%JRZ=*$=O
M(F!!(>-NH!XQG.*V]%\2^((_&[>&_$-OI^^:S-Y;RV)?  ;!1MW4]>>/UINK
M>#=:UOP]9V6H:O;2WD.HQWC2);>6@1<_(H')^IYK5F\-S2_$*V\2BX00PV#6
MAAVG<26+9STQS2;B-*5SHZ***S-0HHHH **** "BBB@ HHHH *\\^-7_ "3>
MY_Z^(?\ T*O0ZYGQYX8F\7>%I=)M[F.WD>1'$DBD@;3GM51=I)DS5XM(YKQI
MX)T"T\$W.L:;80Z9J5A +F"YM%\I@RC...N>GXURVMZF-7\2>!=2U/1I-7-S
MI3236<4*N96*GD*>.OS5V-QX'\4:_;II_B/Q1%)I0*F6VLK41&8 @A2W4#BK
M/B7P3JEYXBT?5O#^H6FGMIENT$22PEU .1P.F,'%6I);LS<6]4CG_&5OIR?!
M_6KBQ\-MH1EDB$D$ENL3MME7!(7J.3C\:],T7_D!:?\ ]>T?_H(KD=3\)^*/
M$'A#5=&UK6[&>:Z,1@EBMB@C"N&;('7.!5[P[I'C'3KRV35-<L+K3H8]AABM
M=CG"X7YOKBD[-;E*Z>QUU%%%9F@4444 %%%% !1110 4444 4Y])L+G4[;4I
MK2)[VV!6&9A\R ]<4NI:78ZQ9M9ZC:QW-NQ#&.09!(.1^M6Z*+A8S=6\/:1K
MT,46JZ=;W:1'=&)4SM/M6-X@\$6FH:)-8Z0MOICR313.$A'E3>7T21!C*\#C
MVKJZ*:;0G%,X+1_A_(OB!=7UA=(1DMWMUMM+M##'(KC#&3)RW!/'O75?\(]I
M!M["W_L^#RM/</:)MXA8="M:=<!XO\3:I%XPT_PSINHV>D&XMVN&OKN,.&.2
M B D#/'?_P#6[N3):C%'9Q:380ZC=:A':1+=W2JL\H7YI !@ _A5&Q\(>'=-
MU$ZA9:+9079)(E2( J3Z>GX5#9:A>:#X=DN_%^IV&87.;J%2B,G\.0?XCZ"H
MK?Q_X7NM,N=1BU6/[-:LBSLT;J8]YPN5(S@GOBBSZ#O'J:2>'M(CT^[L$T^!
M;2[=I+B(+\LC-U)^N*;?^&=$U2RMK.^TNVN+:U $$<B9$8 Q@>V *I+X[\,O
M8WE\-7@^RV<P@EEP=N\]%7CYC_NYJWI/BC1=;LI[RPOXWAM_]>7S&8N,_,&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDU[111SA[,SM ##PYI8<$.+2+<&ZYV#K6C114&@4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN?E!(.SB),=":]*L+K[=IUK=[=GGQ)+MSG&X X_6DXV&I)Z%BBBBI*"BBB@
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M0/#YJ[0P8QO\RGGH:ZNI:L[%)W5PHHHI#"BBB@ HHHH **** "BBB@ HHHH
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MK,;2YD$OE-<.1$X)(,?/R')/2I+?P-HEO%;(J7+M;WB7RR2W+N[2J"%+$DY
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M#5/5-?TG1#$-3U"WM3+]P2O@MZG'I[]*;=^(M'L9(H[G4K:-Y462-2X)=6.
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M7<@.GP3^?/;%<^>0I"@G/ !.?? JI;>#-.TS7K74M(BBL56.2&ZA2/(N$;!
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MI%$@2-%"JH'  X I]%)L:5M3D;SP==S+J=C;:L(-(U25I;J V^Z4%\>8(WW
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M* "JNF_\@^+\?YFK55=-_P"0?%^/\S0!1L_#=C8Z_=ZS$9?M-TNUPS94<@G
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M(&+Q,R@E&(()'H<$C\:EJN8CD/,K;3O$NHZIIEWJ%I>(UNMTDT1CAC@B9X6
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M.D9B@;.",DAF(4G&<#C)%<QJWA*33Y=,L)8KJYL[&U=()HM,6[5W>0LP:/\
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MDT_5IH[IIXGBF>*/RE96!! &3C@^M84GA35KGPW=Z'=ZZDUJ]H;6%A:!7 X
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M@RY ()Y%.F^(SV*ZDFI>'[RQN+6R-]##+*A,\(8*3E<A6!(XYK,\3>!-7N-
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M60D8V+QY661A@,QST S@8ZFG&U]12O;0Q-!\57&F^&=?35+C^TK[P^SF216
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MG/S;?O8]L\T_4XYKCQ/JO]H:U9Z=J"7@%B9X96G6+Y=A@VR!2IYR IYW9HY
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M2+_KB_\ -: +5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBBB@ HHHH **** "BBB@ HHHH JV7W9_^N[_ ,ZL.Z1KN=E5?5CBJ]E]V?\
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M+.5.05PJB/DL#Q^E>MTI)K<<6GL%%%%26%%%% !1110 4444 %5;;_C\O/\
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M>J6NH7,,?]G:B+*='W9>$2HXQ]UER#CZ$&L&3P6]S9W/VO41+?7=];WEQ.(
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M>7?S*-11XH"@VFSC8LQ5#_ONS?EZ5K'Q'HRZN-*.HVXOB=OD[N=W7;Z9]NM
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M_P#-: +5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+4(YI$O$4$.I$LFP,#TXZ>U=S@>G2C%)RNAJ%F%%%%26%%%% !1110 4444
M%5=-_P"0?%^/\S5JJNF_\@^+\?YF@"U1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!5LONS_\ 7=_YU$;.Y.L+=BZ;R N##VZ?Y-2V
M7W9_^N[_ ,ZM5G4I1J6YNCO]P7.3\?3Q6NG:1<3R+'#%K%H\DC'"HH?DD]A5
M/Q#JMAJ4NBZUI]S'J5AI5_YEX+0^:8U:-E#X7).TL#QSC)[5VY (P1F@*%Z
M#Z5LF2XW,'_A--!DM[B:UOX[I;>!IY# "RJJ]BPX#'H 3DU@ZOI\EMX&LUO8
MP]U=ZE:SW:D9!>2="RD>@!V_05W311NA1T5D/52,@T_&:5[; U?<\^_L#55+
MZ+=QAO#VE^9<VTA;)G&"88F'7$9S]=J>]4H6TB#0?#ES-K\VA:O'I$0CN0N4
MEC(!V,&!5\$9VCYN?>O3J3 ( P.*?,+D.8CN-4U?X:S37D'E:E<:?+E%0J2Q
M5@IVGD9&#CMG%<[<S:/<:AHYU]PN@/H\367F.RPF;/S9QQO"[< ^^*]*JM8Z
M?:Z;9I:6D(BMT+%8P20N22<9[9)X[4*0W&YY[J3:"^MW_P#PD4TR62V4!T?S
M'D7Y-AW&/N9=V/\ :^[4#W&OZ+8Z?-*LQU'Q!IT5D^X$F.] PKMZ'8S$^\=>
MI$ ]113YA<AY%XR:TL8[G3+&WCCOM(LHEM[BXN91.V%W!H$4$''\3=SD'@5/
MKANFFUDK,L-D^M0?;I)(W>,1?94QO",IV;]N>1[\9KU7 STI<#TZT<X<AY1'
M86\\6C6B:G#?:=/K>W98K)%#&OV=]T:DNQ*DC)P<9)%0:QIEC%8ZO9S09TS3
M=?M"B2%BEO"PB,F/1>6SV&37KN ,<#BEP.>.O6CG%R'(V8LCXUTM-*V"TAT:
M0CR_N^6TB>7CV^5\5UU5H;"V@O;B\CB N+D*)7R26"C"CV R>GJ:LU+=RTK!
M1112&%5;;_C\O/\ ?7_T$5:JK;?\?EY_OK_Z"* +5%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% %9/^0G-_P!<D_FU6:K)_P A.;_K
MDG\VJS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 55?_
M )"D7_7%_P":U:JJ_P#R%(O^N+_S6@"U1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !573?^0?%^/\ ,U:JKIO_ "#XOQ_F: +5%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %6R^[/\ ]=W_
M )U:JK8_=G_Z[O\ SJU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 55MO^/R\_WU_P#015JJMM_Q^7G^^O\ Z"* +5%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% %9/^0G-_UR3^;59JLG_(3F
M_P"N2?S:K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M55_^0I%_UQ?^:U:JJ_\ R%8O^N+_ ,UH M4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4U%5$"J  .P%%% #J*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** &JJKG: ,DDX'>G444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %-55#,0 "3R<=:** '4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -"CS"V!N
M( SWIU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !32
MJ^8&P-P!&<<XHHH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
..%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>85
<FILENAME>img254193463_58.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_58.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'Q!&8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0D $D@
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MO_6VG_7;_P!E:K55;O\ UMI_UV_]E:K5 !1110 4444 %%%% !1110 4444
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MG^=>=ZO*D\[,A^7M]*\S$5E-Z;'D8NNJDDEL8<C$Y&:CBED=O+')I93AJO\
MAW1KC7]9CL;4 ,_+N>B*.I-9*',TD8JFYM)&YX1\'W7B&265)8XX8B \C GD
M]@.YKV31-$M-"L1;6H))Y>1OO.?>G:-H]KH>F16-HN$3EF/5V[D^]:%>G1HQ
MIKS/7H8>-)>84445L= 4444 %%%% !1110 4444 %%%% #9/]6_T-0V'_(/M
MO^N2_P JFD_U;_0U#8?\@^V_ZY+_ "H L5Y/XQNEU3XKZ?I4@S;V]GY;'^X\
MQ.6'H=JCGWKUBO$/$.I0)XR\8PR[OM,S00Q$+T B!Z]NM95W:E*W]:FM"/-5
MBE_5CH;J!/"3+!II,R3C>YE^;!'':NG+F"PBND&9&520>G(KC_AY<I:V-\MS
MERTJD<;NU;+^*],M)F:7SMJDC CS7DQ<:,FY2LGLNQZDXS<K-7?YE75-#M-:
MGDO[J61)BFW:C #@<=:Q_!T0TN^N9(,LSQ!2&YXS61XGNUUSQ#]JL&<0NJ(
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MZ***X" HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0;?P[I*6-N=QSNDD(P78]36J %    '0"EI2DV<N)QLZ^CT04445)QA1110
M4444 %%%% !1110 5R'COPP=:L1=VRYNX%/RCJZ^GU%=?14S@IQY614@IQ<6
M?-4D11B&&"."*A?FO3/''@N874FIZ=$7BD.Z6-1RA[G'I7GCV[J<%2/K7DSI
MRA*S/#J4I4Y69G.AHBD:)@P[5::/MBDALI;JXC@AC9Y)&"JH'))J42FSWOP3
M,\_@_3GD.3L*@^P8@?H*WZHZ-8#2]&L['()@B5"1W..3^>:O5[$5:*3/?@FH
MI,****HH**** "BBB@ HHHH **** &R?ZM_H:AL/^0?;?]<E_E4TG^K?Z&H;
M#_D'VW_7)?Y4 6**** "N/\ $O@6/4[I]5T6[.E:RPP\T8S'<#L)5[_7J*["
MB@#Y[U>WU32K]6\5V$L+;@OVQ1OMW /9EZ?0X-='K&F:??V$$OAV..[)?+&U
M?S/EQ[&O7W19$*.H96&"K#((KE[[X<>%+Z8S_P!DI:SDY,MF[6[?^.$5RO!T
MF[_\$ZZ>.JPM?6WR.;L%LH= CL;\I'<!"LD,APP.>A%:G@RVLK;7;D62J%-J
M-VTYYW5%+\)-'DE,BZOKJL>_VW=_Z$I-2P?"?P_&Q,]WK%T",%9K]P"/0[<4
M4L/*G4YKKE"MBW4@XVW\S3\4>,M'T*T9'U6W2]) C@C/F2L<] @R:P[2?QKX
MMM_*59- TQ_O7<RC[7(OHB=(_J>:ZO1_"N@Z!SI6DVEJ_>1(QO/U8\G\ZV*[
M>9)62/.]E>?.V_3H9FA>']-\-Z>++3+<11D[G<G<\K=V=CRQ/K6G114&P444
M4 %%%% !7,:_X/34+]=9TB[?2M<C&!=Q+E9A_=E3HZ_J*Z>BFG835SSR\\7:
MKI@AMO%5I-I#1N,ZE:(9K28>Y'S1Y]&%7Y-%TSQ/?#4M-UBWG@?!?R7#_P C
MQ79LH92K %2,$$<&N7O_ (<^%-0G-PVDQV]P3DS6;- WYH15QG;;0YZN%A5T
MFKG3QH(XU1>B@ 4VXA2YMY(7SM=2IQ7(#X=PQ#;;>)_$]NO94U(D#\P:#\--
M+G/^GZKK]^O]VYU*0C\EQ4Z=S;5JUB3^V?"_@:V>WN=7C\UVR(5;S)6/H$7)
M_2J;7?BOQE^[L;>;PWH[?>N[@#[9,O\ L)_RSSZGGTKH]'\*:!H'.EZ1:6K]
MY$C!<_5CS^M;%#EK<4*:A%1CHD9>A>']-\-Z>++3+<11D[G<G<\K=V=CRQ/K
M6I114F@4444 %%%% !7(>*? =KKEQ_:>GSG3=948^TQKE9A_=E7^(>_45U]%
M-2<7= >':A+J7A]C%XCTV2T'07L ,ML_ON'*_1JYV22.YE:2WD65"<AHSN!_
M*OI)E5U*LH92,$$9!%<KJ7PV\):G(99-'AAF)R9+5C Q_P"^"*[*>,:^)%2J
M3DK/4\<LU87294CGN*Z$ GI76O\ "+12?W6JZY$.P%YD#\U-/B^$?AQ3_I-Q
MJUX/[L]\V/\ QW%5/%1EK8\C'9?+%34KVL</<:OI^GX6XND$C<+$GSNWT4<U
MJZ9X8\1>)R"T4NA:6WWII@/M4H_V4_@^IY]J](T?PKH.@<Z5I-I:MT\Q(QO/
MU8\G\ZV*REBI-6CH>EAU.E1C1OHC,T+P_IGAO3EL=+MEAB!RQZM(W=F;J3[U
MIT45RE[!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !7)?$"2Y71$CA5C&[XD*^W3^OY5UM,EBCFC,<J*Z-U5AD&LZL
M'.#BGN:4IJ$U)G@<5M*\N1&Q_"O6_!%FUKX?#/%Y;2N6&1R1P!_6ME-+L(UV
MI9P 9S]P=:M@ # X%<V'PKI2YI,WKXE5(\J05Y'\9O"DMS#!K]A;L\T?R7.T
M9^7^%L>W3/TKUR@@$8(R#7<G9W.0^-)$FF<-,6&.[4R2V=U,; %2,=>#7JOQ
MJO=*76+2QLX(DNX$)GDC0#&[D*?PY_&O*'968_*"/>M4[ZB(+>S6SG+JK9(P
M5/0BKW^BJP+"3Z<5J^'-$U+Q!>QV6F6_F2-U9NB#N2>PKT>U^!-U)<1-?ZM
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MT7>,"1A@+]!_6NGHK*-"$7=(RAAJ<'S)!1116QN%%%% !1110 4444 %%%%
M!1110 V3_5O]#4-A_P @^V_ZY+_*II/]6_T-0V'_ "#[;_KDO\J +%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
MX?\ $[X<:UJ'B6;5]*MVNX;H*71#\R, !T].*KZ+\#]1O+1)=4O([)VY\I5\
MQ@/?G ->\457,P,/PQX5TSPIIHM-/C^8_P"LF;[\A]_;VK<HHJ0"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** *]RC/);%5)"RY..PVFK%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)&"75<]. QP/:ERZ:%<VNIZ;17A7_"2:]IWPVUCQD+F<7NNZ@([3>Q86T&2
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M;\@W$JDY<_TYY..IK5HI78[(\\/AZ[\">&?%U_8O-J=WJ,LEQ####AD9^ ,
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M'-O/XCN]8LM;U336O@HO8;20*)\#'7&5_#U/2JTGPHTAO"<_AR*\O([.6_\
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ME3UVCUY//O6CX=\(VOAS4=:O;>XFE?5KC[1*LF,(>>%QV^;O70T4G)L:BD<
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MNU90D36:><T:]$:0G!&.,A0?>NI9@JECT S6?H.LV_B'0[35K5)$@N4WHL@
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M?ZY>O<7D"SM:(5%LJ,XP@3'&!CYLYR*].O=!MK[7].U>623S;&.:-(QC8XD
M!W<>U<_+\-;"72KC2#JVJKI,F?*LA,OEP$G=\ORY(!Y 8D4U)"<7J=C;_P#'
MM%_N#^5>3ZUJ^B:[XP\01:N]R;2VLVTNU,-I+,HD;F5\HI 8$*/PKUD1[8?+
M5BI"[0W<<=:SO#VA6WAS1XM.M7DD569WEE(+R.S%F9B.Y)J8M(N2;T/-M5UU
MM>^!3S3L3>6\D-K<A@0?,29 20>02,'GUKUF6,RV[QB1XRZE0Z8W+D=1GO7,
MZEX#T_4DUJ,W5U#%J\D,L\<97"R1D'<N1P6P,UU7042:Z"BFMSRCPQ/<>'OA
M]KGB%+Z\N9;>:\V6\S@Q%Q(<.0!G.>3SW-:.IKK/A71;#Q$WB"^OYC- M[;S
M[3#*LC!2(U &PC=D8/;G-=#I_@NST]]0A^V7<^FWIE+Z=,5,*F0Y?'&[GGOQ
MDU!;> [:*2S2ZU;4KZQL762ULKF13'&R_=SA0S;>VXFJYE<E1=K&QXDU1]$\
M-:GJD48DDM+9Y50]"0I(S[5P^F3^)%.DW\'_  D%W<SR1&^6Z$0M7B?[Y10?
MDVYRN/3G.:](N((KJWEMYXUDAE0HZ,,AE(P0:YS3?!ITR6V2'7]8:PM6!ALF
MF78H'12P7>RCT)J4TD5)-LYY_$^IZ-H'B#2)KA[C7+2[%K8/)@O,)S^X;W(R
M<_[E7-95('M=,N/%6M&\@M$!M]-BWS._0RR%5)P2.AP*WK[PCINH>*[#Q%-Y
MGVNS0HJ C8_7:6&.2NYL?6F7?A19M>N-5M=5O[&2[1([N.W*8F"9"\E25(!(
MRI%.Z%RLXW2]6NM<O/AOJ%ZP>YE-Z)&VXW%8RN<=B<9K6TG5]1G^'GB2^DNY
M6NK>6_6&4GYD"%MN/I@5KV'@G3]._L(03W.W1FG:W#,#N\W.0QQSC/%5Y_ %
MI,^HQ1ZKJ=OI^H.\MQ8PRJL9=Q\Q!QN /4C./Y4VTQ*,D9=Q?QWNE:$EYXDU
M:"ZFTV*8VFF1[IY6*C,C%58@9^@S7/7=Y?\ B+PAX1NKS4;Q+@ZZEH[QA8R^
MV1U$A&.' 4>V<\5W8\%1075M<6&K7]E)'9Q64QA*'SXX_NYW*=K=>5QUIC^
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M_9[VB6<<G*1&1%!./3+9/TJUJ<6J^#7TC4/[?O\ 41<WL-I>0795DD$AQNC
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MRZL+^SW"&ZM6 8*WWE(8$$''0BJEMX$TJ*+6(KF2ZO4U=(UN_M,FYF* @,"
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M@]\\C'6HKKP>+^[S>ZSJ5SI_V@7/V"5D,>\-N W;=Q4$ A<XX%3S(?*S:U2
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MZWM<P5\86'_";OX5D1X[O[.)XY&(VR9Y*CWQD_@:M>)_$=GX4T&?5K[<T<6
ML:_>D8\!1[__ %ZXG5]$EUOQOXG%FXCU*TMK&ZL9O[DR^80/HWW3[&J=]?2>
M/=+U36)[62#3]'TR=4@E4C-\8CYA]Q&/E'N2:KE1/,]3U'3KQ=1TRTOD0HMS
M"DP5NH# '!_.K-9/A?\ Y%+1O^O&#_T6M<.VF#7-?\<B\O;_ &63QM:QQ73Q
MK$_D [@%(YR!UX]N:E*[+<K)'IU%>2P)/;Z#X/\ %0O[U]6U"^MH[N1YV*2Q
MRY#(4SM  QC &,5L:5I47C+4O$5UJ]W>B2SU*6RM8H+IXA;(@&&4*1\QSG)S
M3Y1*=ST*L:+7UE\87'A_[.0T-DEWYV[@[F*[<8]NM>?V6KZCXETKP;I-_?3"
M#4;B[2[N(7,;7*09V#<.1OP,XZXIFHK_ ,(?XH\4RZ.9=UMX>26$2RM+Y1\Q
MNFXDX'7!]Z.3H)SZGKE8_A[75U^VO9EMS#]FO9K3!;=N\ML;OQ]*XW2-$UN*
MXT>_T^SGBD,D;WMW/JQG6[A8?/N3IGG(QC&*JZ?I^JZEX1U>'22SLOB2YDN+
M=9S"UQ")#NC$@^Z3QS[4<J#F9ZI17*^"+G3GMKZSL[74+&>UF"W-E>S-(T#%
M01M)9OE(Y&#755+5BT[H****0PHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KF_"_C2P\576HP6D4L9LY,*9.DT>2!
M(O\ LDJ:A^(>LSZ1X1N5LE=]0OB+.T2,99I)../<#)_"N.BU"/P_KWAB[M]#
MUC3K*WA&DW<U[;JB-&Q'EL2&/(?G_@1JXQNB)2LSKKWQG=Q^([_1=-\.WFI2
MV*1O,\4T: !UROWB/?\ *KVA>*[76KV?3I+6ZT_5(%#R65V@5]AX#J02&7/<
M&LCP_P#\E7\8_P#7"Q_] :H]>87/Q9\+161#7-K!<RWA7^"%E 4-]6Z466PK
MO<V/#'C&P\43ZG;VR/#<:?<-!+%(1D@$@.,=B0?RH\1>,+#PYJ.DZ?.CS76I
MW"PQQQD94$@%SGMDBN!TB*31],/B^T0EK#5+R'4$09,MHTQW'W*'YA^-.U""
M;4X+'Q;>H5FU/6[)+.-QS#:+)\@]BW+GZBGRJXN=V\SM-4\87-IXEET/3] N
MM2N(K=;AVBFC0!6) ^\1W%;&C:A?:C;/)?:3/IDBOM6*:5'+#'7*DBN*N[?6
M+CXNZD-'U"VLY!I4)=I[8S!AO;@ ,N*ZJ^U*[\.>$;B_U2>*\O+>)CNAB\M9
M7)PBA<G&25'6DTM+%)O5LJWWC."QL/$%_P#8Y);31G$3.K#]])@%E7TV[@"?
M7/I5>'QR\,UHNLZ!J&E07<BQ0W,C1R1;V^Z&*,2N?<5E>)=)?1/@IJ-G,V^Z
M^S&6YD_OS.X9S_WT34SZ)XF\4V6G6>L+IECI,3PSR"UE>66;9@JN2H"C(&3R
M:=E83<KG3:=XA@U#7]9TE87C?2C$))&(VOYB;ACZ>]-T'Q'%XBDO)+*VE.GP
M2>5%>,0$N&'WB@ZE0>-W0]J\VU?2]<U3Q9X[CTBX!B5K,W5B!M>\3RLE%DZI
MD CISGM7I?A?4M,U3P]:3Z0BQ6BIY8@"[3 5X,9'8CIBDTD@C)MV-BBN*\7Q
M27GC/PIIPN[JWM[G[8)Q;RF,NHC!P2/Y]?3%8SHWA_5O%VB:?<7)TY-#-ZB2
M3M(;>4AQA68DC( /6DHW&Y69Z=17E<T$^@_#2#7H-1O&U74;:TBFO9IF81+(
M4!95)VK@' .,]ZTM3TN/P;K?AR?2+J]S?7ZV=U#/=/,)T96)<AB?F4@'(Q3Y
M0YSI$\2/<^)[C1['39KA+/:+R[WJJ0LR[E4 G+'&.G3-5?\ A+IH[;1)+O1K
MFSFU2]-IY$[ /%PQ#''7.W]:P_!NA64?C;Q5,OVG?:WR>5FYD(^:($Y&<-U/
M7.*P])GFN?#7@"6>6260ZY)EY&+$\S#J:?*B>9GL%%>4P0ZIXHU'7[F6QNKF
M:WOY;2U>+5#;BT"<+M0?Q?Q$G.<^E>CZ&NHIH=DFKE&U%85%PR'(+@<G\:EJ
MQ:E<OT445)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !116;XA@U*Y\/7\&D3+#J,D#+;R,<;6QQSV^O:@&6=0N9+/3KFY
MBMI+J2*-G6"+[TA SM'N:QCXHD&JZ9IQTN=;B\L)+UXF8!X=H7Y".A)+8Z]J
MX6]NK>Q\#>)HK.TU+2M:ACAM[FWGO'E >1@%D1MQ!W9/S#!XJYXBN6L_$WB&
MZ1VW:5X6\I'SR)'9B#GU^45HHF;F>AZ3>S:CI5O>7%E-8RRKN:VF^_&<]#5V
MO-[:"?6M4T7PI=W=U'8VFBQ7EV(YF1[J0D(%9@=VT8).#R3S5S4[';K6B>#;
M:\O8M,FCGNKEOM#&5T0@"(2$[@N6YYS@8J>74?-H=Y17%^#5:R\3>)M(M9II
M=)LI(/LXEE:3RI&0F1 S$G ^4XSQFG>*AI6H:Q#IUQ#J^HW20>9]@L)FC1%)
MP)'(90#D$#+=N!1;6P^;2YV5%>/V%WJ.J:%X2M;C4-0A9M9N+2219\3&-1(
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M)%M&XW'8IX#!5QNZDDFCE$INQZK17!Z=81^'OB/:Z5I5Q=-:3Z=)/>0S7#S
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MEO$,;,"49B0<@$':M'+KH/GTU/5J***@L**** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>W]X_G1O;^\?SH ]1^V6O_/S#_WV*/MEK_S\P_\ ?8KR[>W]X_G1O;^\?SH
M]1^V6O\ S\P_]]BC[9:_\_,/_?8KR[>W]X_G1O;^\?SH ]1^V6O_ #\P_P#?
M8H^V6O\ S\P_]]BO+M[?WC^=&]O[Q_.@#U'[9:_\_,/_ 'V*/MEK_P _,/\
MWV*\NWM_>/YT;V_O'\Z /4?MEK_S\P_]]BC[9:_\_,/_ 'V*\NWM_>/YT;V_
MO'\Z /4?MEK_ ,_,/_?8H^V6O_/S#_WV*\NWM_>/YT;V_O'\Z /4?MEK_P _
M,/\ WV*/MEK_ ,_,/_?8KR[>W]X_G1O;^\?SH ]1^V6O_/S#_P!]BC[9:_\
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M/_CG_P 31]AF_P"@A<_^.?\ Q-7SR_E_+_,CEC_-^9=HJE]AF_Z"%S_XY_\
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M#R3<DC;MW;1NQZ;NM=7_ ,(I8_WY?S'^%'_"*6/]^7\Q_A1SR_E_+_,.6/\
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M3:8!(<]7--2;>JL)Q2V9SWA[P\;HK=W:X@'*(?X__K5V@      Z 4
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M>7\Q_A5*3M8EQ3=S-\+Z'_PCV@P6+S>?<9:6XGQCS97)9V_,G\,5L5#Y#?\
M/>7\Q_A1Y#?\]Y?S'^%2]2DK$U%0^0W_ #WE_,?X4>0W_/>7\Q_A0!-14/D-
M_P ]Y?S'^%'D-_SWE_,?X4 345#Y#?\ />7\Q_A1Y#?\]Y?S'^% $U%0^0W_
M #WE_,?X4>0W_/>7\Q_A0!-14/D-_P ]Y?S'^%'D-_SWE_,?X4 345#Y#?\
M/>7\Q_A1Y#?\]Y?S'^% $U%0^0W_ #WE_,?X4>0W_/>7\Q_A0!-14/D-_P ]
MY?S'^%'D-_SWE_,?X4 345#Y#?\ />7\Q_A1Y#?\]Y?S'^% $U%0^0W_ #WE
M_,?X4>0W_/>7\Q_A0!-5/5-*L=:T^6PU*UCN;67&Z-QQQR#Z@CU%3>0W_/>7
M\Q_A1Y#?\]Y?S'^% &5HWA+1= N)+FPLRMS(NQIY97EDV_W0SDD#V%5;[P%X
M=U+4&OKJTN'N69G\P7LZ[2W7: X"Y]L5O^0W_/>7\Q_A1Y#?\]Y?S'^%.[%R
MHJW&B:==G3_M%OYO]GN)+;>['8X&T-U^8@=SGUK0J'R&_P">\OYC_"CR&_Y[
MR_F/\*0RN=)MCK@U=M[72V_V9,M\J(6W' ]20,GV%7JA\AO^>\OYC_"CR&_Y
M[R_F/\* ,;6/!FA:]>?:M2M9II?E(Q=2HH*]"%5@ 1ZXS5N3P[IDV@'0Y89'
MTYEV-&T\A++G)!?=N(_'VZ5>\AO^>\OYC_"CR&_Y[R_F/\*=V*R'10106Z6\
M4:)#&@18U&%"@8  ],5SMO\ #[PO:WR7<.EJ&CD\V.(RN8HWSG<L9.T'Z"N@
M\AO^>\OYC_"CR&_Y[R_F/\*+L+)DU%0^0W_/>7\Q_A1Y#?\ />7\Q_A2&345
M#Y#?\]Y?S'^%'D-_SWE_,?X4 345#Y#?\]Y?S'^%'D-_SWE_,?X4 345#Y#?
M\]Y?S'^%'D-_SWE_,?X4 345#Y#?\]Y?S'^%'D-_SWE_,?X4 35232;%-9DU
M<0#[?)"(&F+$GRP<A0,X SSQUJ?R&_Y[R_F/\*/(;_GO+^8_PH FJI;:99V=
M]>7L$(2XO65KA]Q.\JNU>.@P!CBI?(;_ )[R_F/\*/(;_GO+^8_PH KWFDVU
M]J-A>S[V>Q=Y(4W?+O9=NXCN0"<>F35ZH?(;_GO+^8_PH\AO^>\OYC_"@#"U
M7P'X<UO5)-2O[!Y;R10C2K<RH2HZ#"L!BFGP#X;;19-':P=K"283O$UU*<N!
M@');/X9Q6_Y#?\]Y?S'^%'D-_P ]Y?S'^%/F8N5=C!T[P%X<TG48K^RLIH[F
M(DHYNYF R,=&<@]>XKI*A\AO^>\OYC_"CR&_Y[R_F/\ "AMO<$DMB:BH?(;_
M )[R_F/\*/(;_GO+^8_PI#)J*A\AO^>\OYC_  H\AO\ GO+^8_PH FHJ'R&_
MY[R_F/\ "CR&_P">\OYC_"@":BH?(;_GO+^8_P */(;_ )[R_F/\* )J*A\A
MO^>\OYC_  H\AO\ GO+^8_PH FK&USPKH_B3:-5MY)U52FP7$D:D$YP55@#^
M-:?D-_SWE_,?X4>0W_/>7\Q_A1>P-7,2;P1H%QH9T:>TEEL#,)O*DNI6^<=/
MF+9Q[9Q3--\!>'-)U&*_LK*6.YB)*.;N9P,C'1G(/7N*WO(;_GO+^8_PH\AO
M^>\OYC_"GS,7*NQ7U72;;6((8+O>88YXYRBM@.4.Y0WJ,@''M5ZH?(;_ )[R
M_F/\*/(;_GO+^8_PI#)J1E#HRMT88.#BHO(;_GO+^8_PH\AO^>\OYC_"@#G[
M;X?^&[/4$OH+2X6Z0J1*;Z=B=IR <OR!Z'BFWOP[\+ZAJ-SJ%SI\C75RV^:1
M;N92Y_!P*Z+R&_Y[R_F/\*/(;_GO+^8_PI\S[BY5V*^DZ19:'IZV.GQ-%;J2
MP5I&<@DY/+$FKU0^0W_/>7\Q_A1Y#?\ />7\Q_A2&345#Y#?\]Y?S'^%'D-_
MSWE_,?X4 345#Y#?\]Y?S'^%'D-_SWE_,?X4 345#Y#?\]Y?S'^%'D-_SWE_
M,?X4 345#Y#?\]Y?S'^%'D-_SWE_,?X4 35G:QH=AKMNEOJ$<KQHVX".=XN<
M8Y*$9&#T-6_(;_GO+^8_PH\AO^>\OYC_  H Q+;P/X?L])NM+@LY5L;J,1RP
MFZE92HZ 9;Y1],54M_AKX4M9H98-.E1X65H\7D^%(Z<;\=NE=-Y#?\]Y?S'^
M%'D-_P ]Y?S'^%/F?<7*NQ%JFG1:MI=SI\[R)#<QF.0Q-M;:>H![9''XU8BB
MC@A2&) D:*%51T ' %,\AO\ GO+^8_PH\AO^>\OYC_"D,FHJ'R&_Y[R_F/\
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MC+<3RS/"9+R=H7W-P^,]^< !<5<8W(E*QZOJ-_;Z5IMSJ%VQ6WMHVED(&3M
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MV6G7,EUM_@5RJH#]2#@4[*PKNYVU%%%06%%%% !1110 4444 %%%% !1110
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M=0OM_KG((_\ '=M%M6+F=DSU#>N6&X97J,]*S-?UA=%\.7VKK&+A;6!I@@;
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M4E8****!!7/:A_Q_S?[W]*Z&N>U#_C_F_P![^E:T=SFQ7PHK4445T'"%%%%
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M;E)7>8(68#)"#'./>C2@?^$GU_\ WK?_ -%FLJVLKC6&UFY@U&334:=XG@B
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M2&1:=I=EI%J;:PMU@A+M(47.-S')//J:6?3;.YO[:]F@62YM=WD.V3Y>X8)
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MPGY4>9_L)^5%WV%9=RM=VD%]:2VMU$)8)5VR(20&'H<5(B+'&L:*%10%50,
M =!4OF?["?E1YG^PGY47?8++N4[NQ@OC;_: S"WF6=%!P"Z]"?7&<_6K-/\
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MCJ,CD=Z.56#F=SUZ.6.9 \3JZ'HRG(KGM0\230:GJ]M:V\<D6EZ<;J>1F/\
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M>LO_ 'W1]G'_ #UE_P"^Z+L:26A-2,H92K $$8(/>HOLX_YZR_\ ?='V<?\
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MK+_WW1]G'_/67_ON@":BH?LX_P">LO\ WW1]G'_/67_ON@":BH?LX_YZR_\
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MA%W8!=?NDCO@\X]<5:INS_:;\Z-G^TWYT!9%+5-%TS6X8X=3LX[J.-BRJY.
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M_%VI6LMK+<Q16UC:S##06ZRIG([%FR3[ 5KRJYDY2LSUR6>*"+S9I4B3NSL
M!^)I3+&(A*9$$9QAMPQSTYKAK^TM-8^**:?K<4<]G%I8ELK:<9C>0N0[;3PS
M 8'? -<MJZQVWA7Q_IVGL?['M;JW%JJ-E(G8H940]@&QP.A-2HW*<['L*7$$
MDKQ)-&TD?WT5@2OU':L7POK[ZWHL]_=I%!Y5U/"=IPH6-RH))^E<WJFB:;X?
M\7^$)])LX[26>YE@G>,8:9#$Q(<]6Y .3GFN7T-I)!96VNA5\+RZM=@&,G;)
M<^<=BW&>B9S@#@G&:%%6$YM,]EENK>"-9)IXHT; 5G< '/H33O-C\P1[UWE=
MP7/./7'I7F=[8WFL?$O6K22VT>Z%M;0"SM]45F58F4[FC4<?>R">HP!39]*N
MO#&@Z/K_ -K@NWT6[D68VK%U%E(^'C!/)\O((STVT<H^=]CT_P Q/-\O>OF8
MW;<\X]<5B^)?$D7AZ"V5+66]O[R3R;2SB(#2OC/4\!0.I[5F>"4.J7&J>*Y0
M2=4FV6F1]VUCRL?TW'<WXBJ?B^9-'\>>&-=OL+IB">TDG;[L$DBC:Q] <$9I
M):V!R]VYIZ?JOBX7]O'JOAZT6UG;:TMG>;V@]W5@,CZ&K?A779M?L;V>>*.)
MK>_GM5"9P5C;:"<]S6A+K&F0/;I+?VRM<N(X%,HS(QZ!?6N:^&__ "!]6_[#
M-Y_Z,-'2]@V=KFI)K5Q+XVBT6U2,V\%H;F^D8<KN.V-0>Q.&)]A6RMS \BQK
M-&7==ZJ'&2OJ!Z>]<EIQ"^./&:/Q(]O:NF>Z>4P_F&KA(-"TZ/X5>&-2BM_+
MOYKJWB>Z1B)2DCE&7=UVE21CI3Y4Q<S1[,+N&2"66"6.41@YV,",CMQ69X1U
MU_$WA:PUB2!8&ND+&)6W!<,1U_"N9@TVRT/XF366EVT=G:W&@M++!"NU&=90
MH; XS@D9JS\+;NV3X:Z(CW$2N(F&TN ?OM0UH-2=[&_XCUB71[& VL237MW<
MQVMM$Y(5G8\DX[!0S'Z5IO<P1 ^9/$F&"G<X&">@^M<U'_Q._B#))]ZTT*'R
MU]#<RC+?]\QX'_;0U@1:#I>M>,/')U*RBNO+%N(Q*,A,P<D#H#P.>O%*R"[/
M1?M$/VCR/.C\[&[R]PW8]<=:SK&_OI-0U.._@MH+2WD5;:5)PQD4CDN/X3G'
M7U_/S"WTZUA\!>$?$*1?\3F74+5I;XDF:3>^U@S=2"O&#Q@4_P 0<:5\4,?\
M_%O_ .@)5<@N?J>NI<023/"DT;2I]] P++]1VK+UW6)=-FTRTM(DEO+^Z6%$
M<G"H 6D<X_NJ#^)%<GJNAZ;H'B+P?=:59QVL\UZT$TL?WID:)B0YZMR <G/-
M;>F?\3GQOJ6J'FVTM/[.MO0R'#3,/_'%_P" FILMQ\S>A;T#7I=6O==AFBCC
M33KYK9&4GYE"*V3GO\U;#WEK' L\ES"L+8VR,X"G/H>E>/W$ERNK>(4O24\+
MOKQ74Y(&(E ,:8#>D1.T,1SU[5M^+&TVQ\9Z2L]E8:A9G3'2"QN)8X8HL./G
M0O\ (200N!R ,U3CJ)3T.L\3:W<:%%IU_&L;Z>;M(;TGJD;_ "JX/LQ7/L:W
MZ\KO-#@T+X+ZO$%M/.NMTA^RMO0,\H\M W\6W*J#[5ZE&&$2!SE@HS]:EI6*
MBVV9.JZQ+::SI&EVL22W%[(S2;B<1P(,N_'?)51[M4?BO7I?#6C#5%M1<6\4
MT8N1N(,<3-AG'')&1Q5+P[_Q-_$>L>(&YB5_[.LC_P!,XS^\8?[TF1]$%=!J
M%C!J>G7-C<IO@N(FBD7U5A@T:)AJUH5M;UJVT3P_>:Q,0T%O"91@_?XX /N<
M#\:73M1DET2SO=42*RGGB5Y(FDX1F&=N3CFO+]-N+K7SHG@&\R\NE7;G5"1P
M\%N1Y6?4/E/RKI)[2QUKXIWUIKD4-Q#::=%)8V]Q@I\S-YCA3P3D 9["GRV)
M4F]3?\.Z_)JZZR]RD,*6&HS6BLK<%$QAB3WYK:6X@>#STFC:'&?,# KCUS7D
MND:"FL>'-6L](GLEAM_$TLL%O<,6M[I5 Q$V.2O?O]T5?&GIXBT*\TJSTVPT
M;4+#5(VN;)FW6EW(%W;"5QE6&"1C(QR*'% I.QZ9%-%/&)(9$DC/1D8$'\14
M=[>0Z?87%[<OL@MXVED;T51D_P JYKP3=VS_ -JV*:);Z3>V=R$NX;5@T+.4
M!#*0 .1CC ([T_Q?_P 3.XTOPTG(U&;S+H#M;189\_[QV)_P(TK:V*YM+FQH
M-Y>:CH5G>WUNEO<7$8E:%23L#<@'/?!&??-<VGB?Q)J.O:Q8:1H^G2PZ;.L+
M27-XT;,2H;. A]:[4# P.E>8Z+I.IZCXS\8O8>(+G3%2^0,D,$<@<^6.3O!I
MQMJ*5U9'2SZ[KL4NG:6-.L!K-VDTSJ;EC!''&0,[MN23N48QW/I3!XT%QH.F
M7-E9&35-3<Q6]DS]'5BLA9@/N)@DMCT]:F\0:=IL&@0WVNWUT9--C)^WPN89
MB2 & V8Y?@;1U./:N4TFSU6QUJWBMHK+3=0GTYYT2Y0R)9VR, ENH!'S$MND
M;/7\*$DT)MIGJ SM&[&<<XI:S/#NJMKGAS3]4:'R6NH%E:/.0I(YQ[>E:=0:
M+4**** "BBB@ HHHH **** "BBB@ HHHH *Y*U\<VTGCZ_\ "UU#Y$D.P6TY
M;*S,4#E/9L'@=P#76UYM'H%OXD\4>.K&=FBD6YLY;>=/OP2K -KJ?4'],BJB
MEK<F3>ECKYM=>+QG::"(%*3V4ET9MW(*LJXQ^-<[I7BOQ;KMG-?:;H&F26T<
M\D*B2_9';8Q4\;"!T]:R?#VKWVH_%&RM-7@,.K:?I<\%U@?)(?,0K(A]&'/M
MS6O\,KFWM_"5P9IXHP-0NB2[@8_>'UJFK(A2;9T'AOQ)#XA@N5-M+9W]G)Y-
MW9S$%X7QGJ."I[$=:VZX3PC*FL>//$VOV)#Z9(L%I%.OW9WC!W,OJ!G&:[NH
MDK,N+N@HHHI%!1110 4444 -D_U;?0UFO_K&^IK2D_U;?0UFO_K&^IK2!A6Z
M#:***LR*6K:M::)ITE]>LXB0A0L:%G=CPJJ!U)/ K-\)>(9_$FGW=S<V'V"2
MWO)+8PLVYEVX^][\\XK?& 03C@]ZY'P"08?$ !&?[<NN_N*?01!<>,=:CTRX
MUZ+P_&="@+%C+<%+IXE.#((R, =2 3DBM/4/$=T^J6^E:#90WEY+:B\=[F4Q
M10Q$X4D@$DD] *SM6OH_&5W/H=M=1QZ-"X74KPR >>0<^1%SST^9NW05/XIL
M;;2\^*(-6DTF6UMOL[M'"LRSQYRD>QNK9^[CUH T_#^MRZL+VVO+/['J-A,(
M;F /O7)&Y65NZD'/K6G=W4-C9SW=P^R""-I9&]%49-<]X(T:]T[3+B_U:1WU
M;5)?M-SOQE!C"(<<9"]<=Z?XJ_XF,VF^'4/_ "$)O,N<=K:+#/\ ]]':OXFC
MJ!JZ+=W5_HMI>7L"V]Q<1B5H5).P-RH.>^,9]ZP==\;IIFMVFEV=E)=NUY%;
M7<YRL5N9#PN?XGQS@=!UKK?H,>PKD?'Q M=!&0/^)Y:D\^YH6X'47EW;Z?9S
MW=W,L-M A>21NBJ.IJAX?U*\UC2Q?W=A]B29BUO$S$R&+^%G'8D<X[5@^.[=
M=5U3P[HUU=/;:7>74C7$B,%\QXUW1QY/ R<_E3](:?3/'L^B6VIW5_I[6'VF
M1+F;SFM9-^ -YYPPSP?2BV@'8#DUE:!JLFM6,U\8D2V:XD2U()S)$IVAS]2"
M1[8JOXMO)K?0FM;-MM]J,BV5L1U#/P6_X"NYOPK6LK.#3K&WLK9=L%O&L48]
M%48% '.>,?&D?A>UD6VLI+^_2+SVA7(2*+.-\C=AG@#J3741/YD,;D8W*&Q]
M17,_$<@?#O7.0";<?C\RUT=L0;6'!!_=KT/L*.@$M%%%(8#K6 _^L;_>-;XZ
MU@/_ *QO]XUK3.;$;(;1116IS%74KY-,TVXO9(Y)5A3=Y<2[F<]@!ZDUC1:[
MJUMJ&GPZQI4%M!J$GE0O!<&1HY,$A7! Z@'D=ZV=1U*VTBPDOKMV2WBQO=5+
M;03C)QVYY-<UK*BU\4Z)J"7_ -N%U="&*RD8,L2LIS+%CI@#DG/!ZT%11>N=
M:UF:[O4TC2(IX+)BDDES,8C*X&2(Q@YQTR>,UJZ3J4.L:1:ZC K+%<1APK=5
M]0?H:R]2FM?$6FWMO;:W/IYM)'BN&4A"I Y#AN=O?(QGUJ;PC=&]\):9.;:.
MW!AP(XAA  2 5'H0,_C2!K0LZUJ+Z;8H\$:RW4\R06\;' 9V..?8#)/TK1/
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MW^]_2NAKGM0_X_YO][^E:T=SFQ7PHK4445T'"%%%% &3<ZG>/J4MAIEI%-)
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M]DSG]4\/:-K;QOJFF6]XT:E4,RYVCKBI].TJPT>V-MIMI%:P%BYCB&!N/?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
@0 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>86
<FILENAME>img254193463_59.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_59.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %M!#<# 2(  A$! Q$!_\0
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MJUZUOIMU<L]D"OESE8P=S<9S]/05Z[HFE0Z'HEEI=NS/%:PK$K-U; ZFN?\
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M/^)AK(FOYR>HW@[!] N/SJE)X(\2/X-L_"=SJ4%Y9?:T$USRCK:*=VS'.3D
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M'JJMXRU.XB:U+*940R(Z_,2'/8@8Q[]:AN?AL]QX*T725U+R-4T=O,M;V-.
M^<_=/;I^7X5K:3H?B9Y+L^(]>ANX)K<VZVUK;B-!GJY)YW?I0VN@TGU.!^'U
MIK>G_"B;6M(U"\N;D03K;Z<55HD?S/O*,9+8!..Y-:?PXUF/4M2@$GC+4[C4
M?*)O-*OX@N7QSLR. #SP>GI6GX8\%>*?#>C76D6_B6V6T".+-ELPSQNS;MQR
M>>XQSU]JL:;X*U>X\7V?B/Q'J5E<7-C&R0)9V_E[B01N<DY/!Z4-IW%&+5C$
M^.9<:'H9C4,XU-=JDX!.UL5/XGU7Q[+X5U=+SPUIT-JUG*)9%OMQ1-AR0.Y
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MZ5J5P,37-K'))C^\1R?SJ&E:Z+4G>S-..V@A9FBAC1FZE5 )J6BBI+"BBB@
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M!<CT4>M=6T$+SQSM%&TT8(20J"R@]0#VS@?E21VT$,LLL4$:23$-*ZH 7(&
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M;I3YE87*[G5T445F:!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YW_PB5[<?&6[UN\T
MV*;2'L1&DDNQ@7 7^$G/8\XKT2BFG83C<B\E(K=HH8T1=I 5  *\X\!^ YT^
M'>H>'O$]CY7VFZ>0)O5BH*KM<$$@$$?I7IE%"DTA.*;N>8:-_P )CX/\(ZQI
M%WI\M\;-"FD7<!#F7<=JJ5!W#&0>1P 1V%=EX-T$>&_">GZ8>9HX]T[==TK?
M,YS]2:W:*;E<%&QYUX'\'W6G^)?%5[K.EP>7>7QFLY) DA*[G.1U*]5]*Z;Q
MGIMSJG@K5M.L(1)<36S1Q1@A<GL.>!6_10Y-NX**2L>4:#<?$C1?#5GHEKX1
MM5>WB\I;J:^0J.OS%0??UKIO /@R7PM:WMWJ-RMWK&I2^==S+TSR0H]LDG/O
M78T4.5Q*%@HHHJ2PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^% %BBJ_D3_\_;?]\+_A1Y$__/VW_?"_X4 6**K^1/\ \_;?]\+_ (4>1/\
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M2Z5X5N=->PB*0XBN$EFFCD)W".-E!*G&&8MSC/3DGBBR'=]CL:***DH****
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M 57O/^/?_@:?^A"K%5[S_CW_ .!I_P"A"@"Q1110 4444 >=_&S_ ))M<_\
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M!N4D[O4[%&<#  Z]:+(5V=2LT3N421&<#)4,"0*?7/Z/X?GTS6;J[>6"2.5
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M15;3[U-0LH[A 1N'S*>JMW!_&K-:QDI14H[,SE%Q;3W"BBBJ$%%%% !1110
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M/^>FI_\ @0/_ (FD_P"%(^%?^>FI?^! _P#B:T]K$S]A(^>:*^AO^%(^%?\
MGIJ7_@0/_B:/^%(^%?\ GIJ7_@0/_B:/:Q#V$CYYHKZ&_P"%(^%?^>FI?^!
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M[[_A"],_O7/_ '\'^%)_PAFF?WKC_OL?X5\]_8F*\OO/:_M7#^?W'!45WO\
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MR:&*Y!66(L <@]"I]0>QJN6NK5,,KW,'KC]XOX?Q?S^M3=Q^(=E+8N%4R.E
M5-[=.U-BN8KA!)$V]?4=OKZ5 =00R,MO&]P_3$?0?5N@JG.*5[B46W:Q8*IL
M/2F3S6UO@S2(GL3R?H*@:*ZG4F>4Q)_SS@_JQY_+%30VT%N<Q0;6/5L98_B>
M:5Y/9?>.T5NR'[2TKG[/:.PQ]^7]VOZ\_I4RA@(-^S?O.[9G'1O6I=WSGY6Z
M#M36.7BX(^<]?]TTTFM6Q-KHAB!29,_\]?\ "LR;3;&#Q(NJ3(0[QA%DS\JM
MR.?J",'VK40X,G!/[W_"I'VR J\996&"I&014U*:FE?H[KU'";@W;KH 5,MT
MZTA5-HZ=JIJ9=/SA9);0'IU>+_XI?U'O5M95DB1T^93@AAR#51E?1[B<;:]!
MVU-PZ4!4W-TZTN[D?*WY4@;YF^5NOI5$B%4V=J4JF1TH+?)]UNW:E+<CY6_*
M@! J;FZ=J1E3RSTI0WS-\K?E0S?(1M;\J  JF1TJ-0,1YZ>:W_LU NX7N/)1
MBTB\L%&=OU/04*>(SC_EJW_LU)-/8&FMQX5,-TZFH)K8;_-@8)*3R#]U_J/Z
M]:L!OE;Y6ZGM0S?=^5NOI2E%26H$,,T<CF-T\N4#E"?U![BI55/FZ=:;-&DX
M =&R.58<%3Z@U"MP]ME;D$H3Q,!@?\"]/KT^E1S.&D]N_P#G_5O098*IM'3J
M*7:F[MTH+?*/E;J*I2:JD>L1:>;>4M(F[>!P/\XJIU(T[.3W=OFQ6+JJF6Z=
M:0JFP=.U*K<M\K=?2D>0+%ELJHQDG@58"E4W#I0%3<W2H#>>81]GA>7_ &ON
MK^9Z_AFFB*:5CY\K ?W(AM'XGK_*L_:7^%7_ "^\=B8@":''^U_*DC"E1G_G
MH_\ ,T !7@55( R!GZ41'"C@G]X_3ZFM!%1]+ACU%]0MP/M+##*S?*P_H>.M
M6H)8ID? VNI(9&X*GWJ;=\Q^5ORJ"6$2_.N])5SMD4<CV/J/:L53]G=TUOJU
M^OJ.Y*RI\O3K2[4W=NE0)<MO6&=-DN>,?=?W'^'6K&[YONMT]*TC)25T(:%3
M#=.M!5,+TZBE#<-\K=?2@MPORMU':J -J;NW2A53+=.M+N^;[K=/2D5N6^5N
MOI0 A5-@Z=JI37-S'K%O;Q6>^V=<O-G[I_SC\ZL2W<:8C 9Y./D09/X^GXTZ
M)YV?,L81<<*.3^)Z5C-\]HQE;7I^3_JXQ]M_QZP_[@_E4M16W_'K%_N#^52U
ML(YZY_X^)/\ >-7=+EPS1GOT^O\ G^54KG_CXD_WC202&*96'4&@#HJ*16#*
M&'0C(I:  G R>E>?3)%JGB^>XCTV[U"PD>WD$MC>HL#G:I#31F0;BO!! Y '
M!Q7H->>36/AVU\7S6]GX4LWN(YXFEN'N(XMKL 041CDX&.@&3FJB1/H>AT44
MA8*,L0!G')[U)8M5XO\ C_N/]Q/_ &:I4ECE+B.1'*-M;:P.T^A]#447_'_<
M?[B?^S4 6**** "BBB@ HHHH *S/$&BP>(="NM,N"569/ED7K&XY5Q[@@'\*
MTZ*%H&YP_P /=;N+I;[2=1 34K.4K<)_MCAB/9N&'^]7<5Y[XMA/ACQEIGBV
M$;;2Y9;+40.@SQ'(?U7\J]!!! (.0>AK*E'D;ATW7H_\G=>EC2<N:TNO7U7^
M?YW%HHHK4S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO>?\>__  -/
M_0A5BJ]Y_P >_P#P-/\ T(4 6**** "BBB@ KDM=\3:EI6JSQ06*W%LB1(NU
M&+F67>(^G&W<H!]-V:ZVB@#F=<\07NEC3#;QP78F9DG6'YG9Q@;47/3=D$\E
M?0\X+7Q#-+X9NK[[1:7%]';M.L$2,-A"Y*$$Y."0#T_"NE5%0850HSG &*-B
M[]^T;@,;L<XH XD^*->MG6.\LH(YP(VB@,;;[P.Y7"X8A&50"1EL9&<"FZ#_
M ,E?\8?]>=A_Z"]=S7#:#_R5_P 8?]>=A_Z"] &WJ7A+2[ZVE6&WBMKEWDE6
MX2,%E>3'F'WW8 ([BKVB:6NBZ/;Z>LOF^4#E]@7<2Q8G X')/%:%% !1110
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M HHHH **** ,W4/^/A?]VI;+_4CZFHM0_P"/A?\ =J6R_P!2/J: +@I:04M
M!145T[1VDTB'#+&Q!]P*\R\)VWCOQ/X5T_6SXY6V-Y%YGDC2HFV<D8SD9Z4
M>I45PW_",>._^B@C_P $\/\ C1_PC'CO_HH(_P#!/#_C0!W->7?'#P5)XH\)
MI?V,#2ZEIS;D5%RTD;8#*/7L?P/K6Q_PC'CO_HH(_P#!/#_C1_PC'CO_ **"
M/_!/#_C0!I?#_P *Q^#O!MCI( \\+YERP_BE;EORZ#V KIZX;_A&/'?_ $4$
M?^">'_&C_A&/'?\ T4$?^">'_&@#N:*X;_A&/'?_ $4$?^">'_&C_A&/'?\
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M\=AVIC??BX_C/_H)H :F,R9/_+7U^E2_)NZCIZU%'UDX_P"6O^%3<;NG;TH
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MC"EE;;E0QXR,=\'\J5;^T>*:5=0#) <2$;3M_2H[[0K?4;B:2X>0I+&D9C&
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M>15>\\/VU_<S33RS?O"C!4;9L*YP01UZGKFE&@6L>F7EA#)-'%=,68E]Y4D
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M&.^,GH/UIZ"U)KB[@@F\F34%C=%\QU?;PHZGI4T\L=M$)9[SRT)50S[1DDX
MZ=235/4_#UEJLYFG#>9L" C&.#G)!&#TQSVSZU8N-+2?2X[ 32JB; ),AF^4
M@C)(/I1H&HBW4 D:-M13>9O)"@KG?C=MZ?>QS3)[ZVB<QMJ4:O'(J.&*_*2,
MX/'!QS4$?AC3XKM;E#<"19O/7]\Q ;C/!/0XYJ2YT&UO+F6:X9Y%DDCDV8
M*C&,XS@]_7I1H&I)_:%G]E:Z_M$>0C;&?Y< ^G2D^WVJ3F)]3CWF0(%!7.2
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MTU[3XBZ"#-;ZEI_B2W7EK>X@%K.1Z(ZG;GZBNM36M.>$2-=PI\JLRNXRNX9
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M)V<<B26VIB6.*2,LD0!5G12,L,D;B#R1BI/B)#?3^"KV.P2>1MT9GCM\^8\
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MD=*D&KW&H6EI'J*VDMO+?6\4K-;,A^9 61<'@QMQN_#KFO0@;@YYBX]C03<
M#F+GV-5S$\GF+:VT%E:QVUM$L4$2A411@*!VJ6H?](SUB_(T W!SS%Q[&H+)
MJ*A)N ,YB_(T?Z1GK%^1H FHID3F2%'(P64'%/H K6L87S)/[S&K-   P**
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MK=+MJO1_Y/\ !HUJ>\E4[Z/U_P""OQN=E1116YD%%%% !1110 4444 %%%%
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M8J7BQ_?/_H)IX/[P\'H*:Y^>+C^,_P C0!C:SXDTSPZ(FU&1U%Q<F./8A;G
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M";DW=NE(I3YNG6GY^;H>E(I^]P>M!(TE-HZ=12[DW=NE*3\J\'J*7/S#@]*
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MMKA \;CN#_7VJW7G+SR?#GQ3Y)5CX:U>4M$!TM;@]4'H&ZC\14R:A&_;^O\
M@C2<I6/1J*9#-'<0K+"X>-QE6!X-/IIIJZ$U;1A1113 **** "BBB@ HHHH
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MN[=_H./K5/PSX=;PY;-;MJ%Q>>;<M(#,,;!M(P!GVHLK;ZA=WVT-I N9,_\
M/7_"JVFJJS7\1Q\ERQ'/9@K?U-6D.#)P?];_ (55MV\O7+U=I_>112#_ ,>4
M_P A26S&]T755/FZ=:"J;1T[=Z56Y;Y6Z^E!;Y1\K=NU(8;4W#I^= 5-S=.M
M+N^8?*WY4@;YF^5NOI0 A";.W:E*IN'3\Z"WR?=;MVI2W(^5ORH 0*FYNG:D
M8)Y9Z4H;YV^5ORID]Q';VSRS,(XU&6=N * %=X$DC1G16<X4%L%C[>M-7&(\
M]/-;_P!FKGKS0H?$FN:=J]U%/!'8-NMQG#2G((+#^$9'U/?%="IXC./^6K?^
MS54DE8E-LH:X NC33* 6MW6<<_W&#'] :TF"?+C')]:;(B3V\L,L9:.0,K+Z
M@\$5F ZAI2J"LNH62XP0/W\8^G20?3#?6I-%JK&MM3=VZ>M(JI\W3K4=K>V]
M[$)[602QGC*]CZ$=0?8U*K?>^5NOI02(53:.G44NU-PZ=/6@M\H^5NH[4N[Y
MA\K=/2@!%5,MTZ^M(539V[4JMRWRMU]*"V4 VMV[4 !5-PZ?G4%S<VEC"\]S
M*D40(&6/4^@]3["JDFK274I@TF$7#J2KSOQ#&?J/O'V7\2*9_9#>7/,UP\NI
MM&RQ7<J B%B."B=% /IR>Y-!7+;<OQNLAMY%5E# G:ZE6''<'H:=&%*C/_/1
M_P"9K$\*:=K.EZ1;VNO:D-1O1([&<9^Z>@R>36Y$<*."?WC]/J:!223:10LC
M'%K>I6K%1YFRY1<\D%=K$?BGZUHA4VGIU-84^K:!K&O3:";C=JMJGF[4!5XN
MG*OZ\C(![\U8%]=Z6I7409[3D"]C3!7_ *Z*.G^\./4"F4XLU65/EZ=:7:F[
MMT]::)DECC>,[T;!5E(((]C3]WS?=;IZ4B!H5,-TZT%4PO3J*4-PWRMU]*"W
MRK\K=1VH -J;NW3UH54RW3KZTN[YONMT]*K76H6U@F^X<J7;"(!EG/HJCDGZ
M4 E<G*IL'3M4275I)>O:QRHT\8W.BG.WTSZ'VZUGE-1U,#S_ #+"S/\ RRC8
M><X_VF'"?1>?<5I6MM!90K!;0"*(?PJ,#/J?4^]!320^V_X]8?\ <'\JEJ*V
M_P"/6+_<'\JEH)"BBB@ HHHH *\ZS9ZWX^NKFUTVPU?[-)$/.BOA&T&,!M\?
M23#+D$^F.PKT6N,TWP/?:7?6MQ!XEN-EM'Y"Q_9(N8MP8H3C/4=>M5%I$23=
MCLZS-2UVTTN[M[><2%Y^A100!N5<]>>6' R>^,5IUCZMX=MM7O(;F:65&C7;
MA<<C<&X)&5.0.5P<4E;J4[]"QI>KV^KK.]LK^7%(8]S%?F()!P 21T[XI9+N
M&UU%DE8[YMB1HH)9C\W0#L.Y[4VQTA+2ZNKF2>2>:Y"HS,JKA%S@84#^\>3S
M5"Z\/VMYK(N54++#&J$-DJ\9))4\\'C(/\Z-+AK8Z"BLW_A']+_Y]1_WVW^-
M'_"/Z7_SZC_OMO\ &C0-32HK-_X1_2_^?4?]]M_C1_PC^E_\^H_[[;_&C0-3
M2HK-_P"$?TO_ )]1_P!]M_C1_P (_I?_ #ZC_OMO\:- U-*BLW_A']+_ .?4
M?]]M_C1_PC^E_P#/J/\ OMO\:- U-*BLW_A']+_Y]1_WVW^-'_"/Z7_SZC_O
MMO\ &C0-32HK-_X1_2_^?4?]]M_C1_PC^E_\^H_[[;_&C0-32HK-_P"$?TO_
M )]1_P!]M_C1_P (_I?_ #ZC_OMO\:- U-*J&M:/9Z]I-QIM]'O@G7!QP5/4
M,#V(."#[4S_A']+_ .?4?]]M_C1_PC^E_P#/J/\ OMO\: ./\.WVJ:-J,NA7
MI$FH0#>$/RK?P]IH_1QT9?7FNYLK^WU"(R0/G!PR'AD/H1VKG?$W@K2M4TB4
MQJ]G>6ZM+;7D+'S(6 Z@YZ'H1WK-\.ZI_;,D=AJ0;2O%$$*L61LK=1XXD7/#
MJ>XZ@USNE*G[U'5=8_Y=O3;T-54C/W:N_1_Y_P">_J=[16/_ &K<Z>=FK6Y5
M.UU""T9^HZK6I#/%<1"2&1)$/1D.154ZT)NRW[=0G2E#5[=^A)1116IF%%%%
M !1110 57O/^/?\ X&G_ *$*L57O/^/?_@:?^A"@"Q1110 4444 %%%% !11
M10 5PV@_\E?\8?\ 7G8?^@R5T^OZ?<:KH%[8VEY+9W,L1$-Q"Y5HWZJ<CWQG
MVKY6\*2>-M8^)']C_P!M:G;ZA/*(=0F69@ZQQ$YR?89Q[F@#Z[HIL:".-4!8
MA0!ECDGZFG4 %%%% !1110 4444 %%%% !1110!FZA_Q\+_NU+9?ZD?4U%J'
M_'PO^[4ME_J1]30!<%+2"N5UCQ=+97MY:V=GYLEO'@;SS)*60*J@=1\QYXZ4
M =715/2KM[_2K6[D55>:)7*H<@9%6)YX;:(RSRI%&" 6=L $G Y^I H DHHH
MH *\^^+_ ((D\:>$=ME$'U2S<2VPZ%@>&7/N.?J!7H-1P3PW,0E@E26,D@,C
M9&0<'GV((H R/"'ARW\)^%K#1K?!%O&!(X'WW/+-^)S6W15&34#_ &Q'I\2J
M6$1GF=CPB9POXDY_!30!>HID4T4\*S0RI)$PRKHP*D>QK+\2:U_8FA2W\2I)
M)E%B5C\K%B!U^F3^% &O16):^)]-=!%<WL"W:1[YHUW87 R>HI\_B.R6W,EJ
M6O)?+6401 [W1L8*@CD\\"@#8HKG8?$Z/J3PS&&"%2D>T[WE9W"E2 !C9SC)
M]#5^SU>-[.[EOFCMFLI&BN2S81<8(;)[%2#SZT :=%0VUU;WL"SVL\<T+='C
M8,#^(J:@ HHHH **** "BBB@ HHK'US3;O47MQ:R)%L#YE\QE=21Q@#@CU[X
MX[T(&:<PQ&H']]/_ $(4Y<Y;IUK.LK*>ST](I) ")MP1"655+\*"><"M!0<M
M\W?TH 4YV#IVJG=:<DT_VB%S;76,>='_ !>S#HP^OX8JV0=@^8]NU+AMP^8_
ME33L)JYG)J,EK)Y6IQK"S$!9U/[IS]?X3['\":T&SY?04AC$@D1\,K<%64$$
M8K.-E<V";M/??!WM)6X'^XW\/T.1]*>C%JC4.=PX%(,[VZ=JP+GQAI%E?VUC
M>7$UO=3Y B>$[E/;.!W[8SFK@BN]5),YDM;,_P#+('$LH_VB/NCV'/J1THY&
MM7H',GL.FU"2=GMM.1)74D23M_JHO;_:;_9'XD5/::>EK(9F9I[E^'GD^\?8
M=E'L*F2%(+811!8XU&%15  %2$-D?,?RI-]$.W5@,^8>G04Q\[XL_P!\_P C
M3P&WGYCT':F,"'BR<_.?_032&-CSF3_KK_A7/WEGXEE\:Q7%K/;0Z2+;8S%0
MS$]<$=3SCH1QFN@C!S)SC][_ (5+AMWWCT]*J,N4F4;F<-1GM,C4+4JN>9X,
MO'^(^\OY$>]78YH[B!)(9(Y(SC#(V0:>H;+?,>OI5*;2H&?SX6>VN&(S)!A=
MW^\.C?B*-&/5%_G<.!2+G<W ZUG&?4;/_CYA%U&/^6ML,/\ BAZ_\!)^E6;2
M[@O [6]PKX.&'1E^H/(_&DTP3)VSY?;M3CG<.!5>ZN8;2 27%PL:D@#/<^@'
M4GV%5?,U"_($*FR@/_+25096'LO1?JW/M0D#9EV_BN=_$FHZ5+H]S&8,?9W'
M)N/IQ@#OG. .M:D=A+,ZW>H,DDJG,<*G]W#]/[S?[1_#%6+2PBM&?RRQD;&^
M60[G?ZD_RZ588'RS\WZ54I+[*L2HO[3''.1P*B7_ )9_]=6_]FJ0ALCYC^51
M+TCY_P"6K?\ LU06.DF2""26:2..),EG=L!1ZDFE259HHY(G1XVP5=&R&'J#
M5#6=%M?$&BW6EWQ<VUP-K[#M;@Y!!^H%/TK2;;0](M-,LMXMK90D8<[CCW-!
M6EO,2ZTI)K@W5M(;2\Q_KHOX_9UZ,/KSZ$5%'JLEH_DZM$ENS-A;A"3"Y^O\
M!]F_ FM3#;OO'IZ4QHA+'(DF&1LAE9001[B@+]QYSM7IU%+SN' Z5D'3[O30
M'TN0/!WLIF^4?]<VZK]#D?2LF?Q[8P>([?038ZD=0FB+K&( ,'GY<Y]C\P^7
MWHL-0<OAU.GGNH;.&6XN)$CB3EF8]*X_Q;!XMUK1D;0EBM1YR_Z/<85IH^Y?
M/09Q\G4C.?2NBMM.FN+A;W4V5[A#F*!>8X/I_>;_ &C^&*TF!V#YCV[4PC+D
M=UJ,MHVAMH(V2)&5 "L8PH..<#TJ09W-TH(;</F/Y4 -N;YOTI$#&SYL/X_R
MI(L[1_UT?^9H(/G0Y.>O\J(@=HP<?O'_ )F@"O'I&GPZO-JD=C;K?RH$DN O
MSLOH3^ _*K@SM;IU-&&W'YCT]*0 [6^8]3VH&VWN9DFF363F?262(LV7M7SY
M,A]1_</N./4&K%EJD5W,T#HUO=H,O;R\,/<=F7W'%6V!^7YN_I5>]TZ"_55N
M 2R?-'(IVO&?56'(- [WW+*YPW3K0V=J].HKG=5U75/#FE7=S+9RZK'"A:-[
M=0)&([2*/_0E';H*9I.I:GXITBTN3:SZ1;S(&EWG]ZWLG]U?]H\\\ =:=A^S
M=N;H:ESJ4LERUEIB)-=+Q)(V?*@_WCW;_9'/K@<UC^$]:T76-1U..QEFNM1L
MI/*N;BXCPS<D?+Z+D'@8Z?C726UI#9PI;VR+%$HX51_G)]Z2"S@MY)W@ABB>
M5]TC)&%+MZG'4T@YHV:)CG8.G:N>O]'UVX\9Z=J=MK7D:3!&5GL<']X>>?0]
M1R>F.*Z @[!\WIVIV#N'S?I0*,G'89;?\>L7^X/Y5+45M_QZQ?[@_E4M!(44
M44 %%%% !1110 4444 %5XO^/^X_W$_]FJQ5>+_C_N/]Q/\ V:@"Q1110 44
M44 %%%% !117(:_=6\?BD0ZAJ5U9VO\ 9Y>/R9WCS)OQD!?O-CM@_2FE<3=C
MKZ*X33;Z2>[C'B6_O+.^$=O]F@5VA5\JI)VKPS%]P8'..F *H6>H7MQ'J"3Z
MN]L'CW/++,^(F\_I)T\IBGR@*<8R>PI\I/.>E45S=I?ZG)X9L[C3;+S)F9E*
MRR%\J"0'#.RD@X!&><$56\6W;0Z5$SW<]K?^0SQ11R-&KR<9 *@[G'\*$X.>
M<]0K:V'S:7.MHKF=0UO4K74'6*.+[-"+7>)8V#OYK,I^8'"[< ]#WK)L_$VH
M:S8&-GA65RLNV %)$C5-[[AN) +80'C().*?*PYD=Y17 W'B/7GTNX,BP+O@
M*@P0NKJSVS2AE))^Z1M]\]C77Z-J-MJ6F0RV]REQM15D9&SAL#(/OS2:L"DF
M3:A_R#;K_KB_\C6)=^&[+Q%X=TY)R\-U!#&]M=PG;+ ^T?,I_F.AK;U#_D&W
M7_7%_P"1INE?\@>Q_P"O>/\ ]!%"=AM7.6M/%%[X?N(]*\9*D>\[+?5XUQ;W
M'H'_ .>;^QX/:N@ET2TD?[1:.]I*W/F6S8#?4="*OW5K;WMM);74$<\$@VO'
M(H96'H0:Y ^%M8\-L9/"-^IM,Y.DW[%X?I&_WH_IR*BI2IU5[R_K]!PJ3I_"
M_P"OU-W_ (GEGVM]0C'_ &RD_P */[?AAXO;6ZM#W,D1*_\ ?0S6/!\0+*VF
M6U\1V=SH-V>!]K&8'/\ LS#Y2/KBNK@GANH5FMY8YHF&5>-@RGZ$5DZ%2'P3
M?SU7^?XFJK0E\4?NT_X'X$$&JZ?=?ZF\@<^@<9_*K?7I52?2["Z.9K.!SZE!
MG\ZJ?\(WIZ_Z@3V__7&=E_K2O771/YM?H_S':B^K7RO^J_(UJ*R/[&N(_P#4
MZQ?+_P!=&5\?F*/L&LIC9K*M_P!=+5?Z$4>UJ+>F_O7^:#V<.DU^/^1KU7O/
M^/?_ (&G_H0J@8=?7[MW8/\ [\3#^1IK_P!L@(+H6)A\Q-QBW[OO#IFFJ[;L
MXM?UZB=)6NI(V:***W,@HHHH **** "BL+5_%=GI&K0:8UIJ%U>30F=8[.W,
MI"!@I8XZ<D5'IOC#3M1#R-FT@0R*TMS(B ,DAC(QNSR1P<8_'B@#H:P-/\(:
M7IOB[4_$L$>+[4(TCDX&%V]2/=L+G_=JW-K^GK&&MKF"[;?$K)#/&2HD("L<
ML..<^_;-2+KVCM!-.NJV)A@($L@N$VQYZ;CGC/O0!H45AW?BS2+:[ELH[N&>
M]CBCG^SI*@9D=MH(+$ ^O7ICU%7VUC2U:X5M2LPUL0)P9US%DX&[GY?QH NT
M5%;75O>VZ7%K/%/ _*R1.&5OH1P:EH **** "BBB@ HHHH **** ,W4/^/A?
M]VI;+_4CZFHM0_X^%_W:ELO]3^)H N"N:U>[L[+4&2XUW4H796E:.$*RQ(JD
MDGY"0...I-=**S[G0M,N[F6XGM$>:5-CMDC<,8['TH K7.FW%_I%O'::M<(<
MB3SY-P=U(Z'84]:@U#1-3N/#2:;!J*_:1(K-<RJ6X#;APQ;/( Y/3-= JA5"
MCH!@4M '*+J^I:8WV+^SEV0^3%'N=V,SM]_82/F"]<^@-:FG7NJ7-[<VU]9+
M;QJO[N:,DAN2.X_$>U:]% %"TT^6S=W_ +1N[HE<!+AE*@^ORJ#7,06GB#P[
MIWV>)5O+JYF ^U(C.L2<$Y3IP6;![XR>>*[:B@#D&\6:HEQ;6TND""XNKMHH
M8I&)8Q @%C@<'DGTP*TD0Q^,;\.JM]IL(C&&Z-L9PP_\?7\ZW<<YJ.2WBEEB
MD>-6>(DHW=21@XH Q-+T:\A\)1Z5/*+2=%90]H^0!DD8++TY]*6'3WT?PFD%
MSJ=X/LD >2:,IN 1>57*XQQQD9]ZWJ@O+."_LY;2ZC$D$J[70DC(_"@#B(;3
M2-6*.]SK&V9?,EDE\H+$IW8+MC W<XQGKVXJ[+IVC>'8TN/[=N[997CM@RRQ
M\DD;5^[T&<^PK7NO"FD75H]N;<QAHA#O1SN"YSWR"?<Y-2V?A[3[/S]J-+YT
MRSD2G=AEY!'T//.30!DQV]KJ%ZL#ZOJS"*;,,LK1*DDBDY"';EB.<_C44^G7
M.L+XBBM&58[J]BA9RVWY$5!*5.#SPP'&,BMT>'].2_2\CAV2K(TO!R"S @G!
MZ=3TQR:OP016T*Q0HJ1KT5: *&@Z;)I>F""=EDN&D>2:4'_6LS$[C[D8R.@[
M5IT44 %%%% !1110 4444 %%%% $<P)CX!)#*<#V(-1K,"S@12\'!X]OK5BL
MK2I-2>ZNQ?*PC!^3*@ '<W"XZKMV<GN30!<>8*@S%+U Z>_UIWF<_P"IE_+_
M .O69KLNMQR0C2X \6UC(P*EL[3C@]@<'BKFEM>/I$)O/ENRIW%E[Y."1],4
M["OK8E68%W BER",\>WUH>8+&28I0![?_7K%TR?Q +^WCOH0UNP<LX ![X).
M..G3K\_?::EU:;6TNKJ/38VD!ME,6Y%"J^XYP3U;&.#Q18+FA-;6EQ=07,U@
M))X,^5(\8+)GT/:I1,#(X$4N1C/'_P!>LZ&767BU4W,7D,%S:>7MDQ\IZ>IR
M,\^M9\T_B$*9!YP1TB"!(5+*Y W;ACH,$GUR ,4[7%<Z%Y@L;$Q2@ 9/'_UZ
M=YG(_<R_E_\ 7K(U2?6!?S1Z<DK 6Q*[T41ESTP?[PY.#P>!ZTVQN-9\F\>]
MCG4K#N"HB%@^3@1]F^7'7C-*P[FP)AYK+Y4N0 >GU]Z4$O)'B-P Q)+?0_XU
MR<EUXJ\M_+24_NUVDQ+D'CVY/4'Z9P!781%S"AD&'*C</0]Z&K G<@+>4S!H
MW.Z3(*C.:?YG.?)E_+_Z]4=:DU)!!_9X<Y)W;%!^;C:#GHO7)'-:4S2+!(T*
M*\H4E%8X!/8$]J07(5F!+XBE.&P>/_KTK3!5&8I>H'3W^M8FCS>(&U.--2B8
M0^6V\X7&[)P<C^7_ .NK.LOK4=U$^FA'B$3ET8<;@./<]1@ CH:=@OI<T_,Y
MSY,OY?\ UZS]0T^UU2*>.2"9)BIC$\?RR)D=F!SWZ=*62;43X9>4+)'J @.
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MIU% &+X;T(Z!;W\ >,QW%_-=1I&NU8U<Y"X]O:MJBB@ HHHH **** "BBB@
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M23;$KA@%+EEP1[''X5L5+&B+[+;_ //"+_O@4?9;?_GA%_WP*EHH&1?9;?\
MYX1?]\"D^RV__/"+_O@5-5'6;.74-%O;.!PDLT+(K$X&2.^.U "I!8RD7<?V
M=HMA&Y0I7KR<_A4XM;8C(@BQ_N"N7DT:[GT76K5])A1+Y2\5JLR[(VV*@!P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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3I5NH+04444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>87
<FILENAME>img254193463_60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img254193463_60.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 13![,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHK&O/$=M9^(K31WBD9IU^><8V0LV?+5O=]CX]UQW% &S1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% ',^/O"DGC3PC<Z''?"S,SHWFF/>/E8-@C(]*
MT/#&B#PWX8TW1EF\_P"QP+$9=NW>1U.,G&3[UK44 %%%% !1110 4444 %%%
M% !1110 4444 >?_ !M_Y)#KO_;O_P"E$=<_^SC_ ,D\U#_L*R?^BHJZ#XV_
M\DAUW_MW_P#2B.N?_9Q_Y)YJ'_85D_\ 145 'L%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%5=2U"VTG3+K4
M+R01VUM$TLKGLJC)KQ?X8?&+4?$OCFZTK6WC2VO]SZ<H15\DC)$>0/FRN>3D
MY'O0![E1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** //_C;_ ,DAUW_MW_\ 2B.N?_9Q_P"2>:A_V%9/_145=!\;
M?^20Z[_V[_\ I1'7/_LX_P#)/-0_["LG_HJ*@#V"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***JZEJ%MI.F76H7D@
MCMK:)I97/95&30!Y'\<]>NKYM+\!:0=]_JLJ-.JGHF["*?0%AD^@3WJC\4/A
MXOASP1H6K^'P4O?#80/*@PSINW&0^XD.[_@3>E<_X3UF6?6=:^)^J0"2ZGF:
MUTJ"0\!B,$_[J)A??<>]=1I7Q0O+NZ>R\1Q6]SI5V##.%CVE$88/3J,'D=:P
MJ8FG3ER2>IZV$R7%XN@\12CHOO?H>G^#O$L'B[PI8:U!@?:(_P!Z@/\ JY!P
MZ_@0?PP:W:\'^%M[)X#^(^J^ [V;?8WC>?ITI/#G&5(/3YDQGW3%>\5N>2%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M12$A5+,0 !DD]JYW4_'?AO20PGU2&20?\LX#YC9]/EX'XXJ93C%7D[&U'#U:
M\N6E%R?DKG1T5Y3J?QFC&5TK2V;TDNGQ_P".K_C7&ZG\1/$VJ95M1:WC/\%J
M/+ _$?-^M<L\=2CMJ>[AN%\?6UFE!>;_ $5_QL>]W^KZ=I2;[^^M[88R/-D"
MD_0=37'ZG\6O#]GN6S6XOG'0HFQ/S;G]#7ALDDDTC22NSNQR68Y)_&K5AI6H
M:I)LL+*XN6S@^5&6Q]<=*Y98^I+2"M^)[U#A3"45SXF;E_Y*O\_Q.UU3XNZ[
M=AEL8+>Q0]& \QQ^)X_2N+U77]2U%7FU/4;BX506(DD)4?0=!^%=?IGPF\0W
MNUKLV]BAZB1][_DN1^9%;-O\*])_X2*TTR>YGOE@3[5??\LTVY(C3 Y!9@QZ
M](R.XJ51Q%9^_>QM/,,FRZ+6'2<NEE?\?^">26<,FS<RDS3-N91R03T'X# J
MY<V=U9.J75M- [*'594*DJ>XSVKZ;T[0M*TA0-/T^VMSC&Y(QN/U;J:Q_&_A
M*+Q5I!1 J7\ +6\A]>ZGV/Z=:N> ERN5]3EP_%='VL:3A:'5MZ^K7YZGF'@C
MQ'$]I-X6U:=H[&[XMKC/-K-G*L#V^8!@>S 'UKV30-1EU+2E>Y54O86:"[C7
MHLR<-CV/WAZJP/>OF6XMY;6XDMYXVCFC8HZ,,%2.H->E_#SQF?[=AL[Z3Y[U
M%MW=C]^11^[<_P"T5RA/?$?O58+$?\NI?+_(QXFR=6>.H+3[7_R7^?W]SV*B
MBBO3/B HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQG_GL^YL?1<_J17/[?$UOA_ ]595DV7ZUVF_[SO^'_ .7U+7M6U<DZAJ-S<
M\[7D.T?1>@K/ )( &2>@%>UZ7\']&ML-J-U<7KCJJ_ND/X#)_6NSTWP]H^C@
M#3].MH"/XU0;_P 6/)_.JC@:LW>;M^)E6XIP.'CR8:#EZ+E7^?X'@.F>!_$>
MK;3;Z7,D9_Y:3CRUQZ_-C/X9KL],^#,S;6U75$0=X[9-Q_[Z;&/R->NT5U0P
M-*.^IX.)XJQU72G:"\E=_>_\CE=,^'/AC2\,-/%S(/X[H^9G\/N_I73Q11P1
MK'%&D<:\!47 'X4^BNN,(P^%6/!KXJOB'>M-R]7<*Y#3$\4:<][(^B6%Q<7=
MR\TDW]I%<C[J*!Y1P%0*/P)[UU]%48'/_P!H^*?^A=L?_!H?_C5']H^*?^A=
ML?\ P:'_ .-5T%% 'COQ"\,:_JROK<6@6L,\*9N!#?>895'?'ECD#]/I7DQE
MOQ@QP+'(I#)(D^&1@<AA\O4'!KZ[KQ#XE^"_[&O#J^GQ8T^X;]XBCB%S_P"R
MGMZ'CTKSL71Y?WL%Z_YGV?#V9^U7U'$3=GI';_P'5/Y?=V/2/ WBI/%.@133
M%$U&%52[B4\!\?>'^R>2/R[5T]?,GAS7[OPWK$6H6ISM^62,GB1#U4_YX.*^
MC=(U:TUO2X-0LI-\,JY'JI[@^XK;"XCVL;/='EY]DSP%7GI_PY;>3[?Y%ZBB
MBNL\ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*(K;=<R-M Y=L$\@#CZL*Z#]G7PW)I_AB^UV<%6U*4)"#_SSCR-WXL6'_ :
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MPKIH5E5AS=3PLVRV>7XATW\+U3[K_-=0HHHK<\P**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBH[BXA
MM+:6YN)%CAA0R2.QP%4#))_"@#R?XZ^)Y[71+3PGIFY]3UJ0(43[WE;@,?\
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M*,9/OW->!?L]>$)I-8O?$]_;R*MLI@M3(I&Z1A\[#/HO'_ SZ5]$T >,:_\
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MIW!K;KV8R4E='YM6HSHU'3J*S6X4444S,**** "BBB@ HHHH **** "BBB@
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M8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^*OT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#S_ .-O_)(==_[=_P#THCKG_P!G'_DGFH?]A63_ -%15T'QM_Y)#KO_ &[_
M /I1'7/_ +./_)/-0_["LG_HJ*@#V"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@^-O_)(==_[=_P#THCKG_P!G'_DGFH?]A63_ -%14 >P4444 %%%% !1110
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M20Z[_P!N_P#Z41US_P"SC_R3S4/^PK)_Z*BKH/C;_P DAUW_ +=__2B.N?\
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M2/M%J@_M*U4F+'61>Z?U'O\ 4UQXS#^TCS1W1])P[F_U.M[&J_W<OP??_/\
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M3=%4M)U6TUO3(-0LI-\,RY'JI[@^XJ[7LIIJZ/S:<)0DXR5F@HHHIDA1110
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M]%14 >P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>$_%#Q+_;&O
M?V?;OFSL24X/#R?Q'\.GX'UKT[QYXD'AOPW++$^+RXS%;CN&/5OP'/UQ7SN
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M/A_]!% 'G_\ PS=X;_Z#.J_G'_\ $T?\,W>&_P#H,ZK^<?\ \37M%% 'B_\
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MZ??7=J]K<W%O'++ XP8V*@E2#SP:OT44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1156?4K*VSYUU$A'8
ML,_EUII-[ W8M45A3^+-.BR(_-F/^RN!^N*S)_&4[9%O:QI[NQ;^6*UC0J/H
M9NK%=3L*:\B1+ND=44=V.!7GT_B'5+C(-TR#TC 7]1S6=)+),VZ61G;U8Y-;
M1P;ZLAUUT1+\;=4L9OA;JMO%<QR2L\&%0YZ2H>HXJ;P/XKAL_A]H%O';/))'
M8Q*2S!1G:/K7"?$O_D0[_P#WHO\ T8M;W@?2K^[\&Z.8+65E-I'AL8!X]3Q3
M5"G&=I;6$ZDG&Z.NG\6ZA)D1+%"/4+D_K_A5#^W=4\S?]MES]>/RZ5H0>$;^
M3F5XH1Z$[C^G'ZU>_P"$,C\K'VUO,]?+X_+-:<]".FA/+491M_%U_%@3)%,/
M7&T_IQ^E<Q\7O$EOJ7PMU6V\F2.5FAQR"O$J'K_]:NEN/"6H19,1BF'^RV#^
MM>>_%.PN[3P'J'VBWDC&Z+EEX_UB]ZF<*,HMQW'&51-)GI7PUU"S?X>>'H1<
MQ>:MA$I0L <[1VKL:\.\(?\ (G:1_P!>L?\ *NDM]2O;3'D74J ?PAN/RZ5'
MU2Z33*]M9V:/3:*X>W\77\6!,D4P]2-I_3C]*UK?QA9R8$\,L)]1\P_Q_2LI
M8>HNA:JQ9T5%4[?5K"ZQY-W$Q/12<'\CS5RL6FMRTT]@HHHI#"BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX^(/B#2YIM6^R:9:0LLD:J6=F+9RHZ#(XR?0<&@#=M_B=X)NKD6\7B73_,)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *IZMJ=OH^E7.H738A@0N??T ]R<#\:N5X[\6_$O
MVF\CT"V?]U 1)<D'J^.%_ '/U/M6->JJ4'(]+*L!+'8J-%;;OT_K0\\U;4[C
M6-5N=0NFS-.Y<^P[ >P&!^%>L?"3PU]EL)->N4_?7(*6X(^[&#RWXD?D/>O-
M?"N@2^)/$%MIZ9$9.^9Q_!&.I_H/<BOI.""*VMXX(4"11*$1!T50, 5P8&DY
MR=67],^MXHQ\</0C@J.EUKY16R^?Y+S)****]4^ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .2\?>$E\3Z,7@4#4
M;8%H&_OCNA^O;W_&OGUE>&4JP9)$."#P5(KZOKR'XJ>#_*D;Q#81_(Y NT4=
M&[/^/0^^#W->=C</=>TC\S[+AC-_9R^IUGH_A\GV^?3S]3JOAWXO'B/2?LMU
M(/[2M5 DSUE7H'_H??ZUVE?+NBZO=:%JT&HV;8EB;.#T8=U/L17TCH>LVNOZ
M1!J-FV8Y1RIZHW=3[BM<'B/:1Y9;HX>(LH^IUO;4E^[E^#[?Y&C11178?-A1
M110 4444 %%(S!5+,0% R23P!7GWB?XJ:=I>^VT@+?W0X\S/[E#]?XOPX]ZS
MJ584U>3.O"8&OC)\E"-W^"]6=S?ZA9Z9:/=7US';P)U>1L#Z>Y]J\I\3_%N6
M7?:^'XS$G0W<J_,?]U>WU/Y"O/M9U[4M?N_M.I73S/\ PJ>%0>BCH*ET+PWJ
MOB.Y\G3K5I #AY6XC3ZM_3K7F5<9.H^6FK?F?;X'AO"X.'M\;)2:[_"O\_G]
MQG7%Q/=W#SW,SS3.<M)(Q9F/N374>&/A]K'B,I.4^QV)Y^T3+]X?[*]6_E[U
MZ3X8^&&E:+LN=0VZA>CD;U_=H?9>_P!3^0KN\8&!5T<"W[U7[CGS+BJ,5[+
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M/Y!>J6_^$SN/^?2+_OHT?\)G<?\ /I%_WT:J?\(IJG]R+_ONC_A%-4_N1?\
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MBBB@ HHHH **** "BBB@#Q_XG_!4>+=2DUS1+J*VU*11Y\,V1',0,!@0,JV
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M\4_&EEX>\-PO<VEO(T=OM_Y;R'[TA]% '!/8$]Z^@_!/A6W\&>%+/18&$C1
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MKZ^%K:WYO]2C3U5<#]3_ (4.6'I:NQ/[R6YS3NTC%G8LQ[DY-(J,[!44L3V
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M8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M70?&W_DD.N_]N_\ Z41US_[./_)/-0_["LG_ **BH ]@HHHH **** "BBB@
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M#0J1C<1_"2/E [+]<#=\(?!SPMX1N$O%ADU"_3!6XO,-Y9]44# ^O)'K7H-
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M_,?X5SU,+*.L=36%9/<ZJBF131SQB2)U=&Z,IR#3ZY38**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** //_ (V_\DAUW_MW_P#2B.N?_9Q_
MY)YJ'_85D_\ 145=!\;?^20Z[_V[_P#I1'7/_LX_\D\U#_L*R?\ HJ*@#V"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBH[BXBM+:6XG<1PQ(7=ST50,DT#2;=D<1\4/$O\
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MX174/[T'_?9_PH^L9DNK#V<^Q@>6/4T>6/6M_P#X174/[T'_ 'V?\*8?"^I
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M&BBEL@HHHK0H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[:<'Z,:ZVX\,:A#DQA)A_L-@_D:\A^+MU.L5AX:CB<7UY,LAB(P=N2%_-O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >?\ QM_Y)#KO_;O_ .E$=<_^SC_R3S4/^PK)_P"BHJZ#
MXV_\DAUW_MW_ /2B.N?_ &<?^2>:A_V%9/\ T5%0![!1110 4444 %%%% !1
M6;J7B'1-%D2/5=8T^Q>0;D6ZN4B+#U 8C-4?^$[\'_\ 0UZ'_P"#&'_XJ@#H
M**Y__A._!_\ T->A_P#@QA_^*H_X3OP?_P!#7H?_ (,8?_BJ .@HKG_^$[\'
M_P#0UZ'_ .#&'_XJK5AXI\/:K=+:Z=KVEWERP)$-O>1R.0.IPI)H UJ*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BFRRQPQ/+*ZI&BEF=C@*!U)/I7A>
ML^/O%7Q*UZ;P]\/0]IIL7RW&IM\FX?WMV,HI[ ?,?;D  ]GU#6])TG']I:I9
M6>1D?:;A(^/^!$5%8>)-"U201Z?K6G7;GHMO=)(3^ )KR_2_V>-#5?.U[5M0
MU&\?F1D<1H3WZ@L?KFI]1_9X\*7$1_L^\U&QG'W7\P2*#[@C/Y$4 >NUYA\6
M_$OV:SCT"V?][.!)<D'HF>%_$C/T'O7'+KGCKX,7T-OK[OKOAF1MD<X8DIZ
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!DLT<$32S2)'&HRSNP
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M?@K19O#/QZL-(N)O,2PN9%60GCRS&[*WL"&!^II707/J^BJIU*Q7.;VW&/\
MIJO^-1G6-.49-Y#^#9J75@MY(7,NY>HK..NZ8#@W:?@"?Z4P^(]* _X^<^PC
M;_"H>(I+[2^]"YX]S4HK';Q-I@Z2.?HAIA\5:<,X$Q^B#_&I>*H+[2%[2'<V
MZ*P#XML<?+#<$^X4?UIA\76V?EMI2/<@5+QM!?:%[6'<Z*BN9/C!.<63'ZR?
M_6IC>,&_AL@/K+G^E2\?AU]K\&+VT.YU-%<D?%\^>+6,#W8TP^+;S'$$ /N#
M_C4O,</W_ /;P.PHKBSXKU GA+<?13_C3#XGU(YP\8^B=*EYG0\Q>W@<!\=O
M&6LQZE#X'TN%/+U&WC:1U!\V0M(RB->< $J,^N<=.M+PH_Q:\&Z''I.D^!M,
M6%26>209DE8]68B89/0=.@%9WC&]GN_C?X;N[AAYB11%'VCJKR%>.G7%>K'7
M]4)R;MOP51_2JJ9A3@DVGKJ$JT58Y7_A+OC=_P!"5I7_ 'R?_C]!\7_&T#)\
M%:2!]#_\?KICK.I$8-Y+^!Q5:2YN)E"RW$T@'_/20M_.L)9K#I%DO$+HCS;Q
M7KGQ.\869T74_#MA# KAI%A^56..,L92#C/;O[BN4\':-=P^+I?#>I2+#Y0\
MUT'S%N <*<X&0<Y]J]OKS'5F6'XXZ6Z'!: ;_J4<?RQ64,3/$\T.7I^/0Z</
MF6(I24J,N5Q3M^O],]F_X2*[CMX[>TCBMH8U"(J+G:H& .:SY[Z[NO\ 7W$C
MCT+<?E50R#MS2&0]JJ.7X^O\2:7F[?A_P#SY3G)WDR2D) ZFHBQ/4U9M=.O+
MP_Z/;2./[P&!^?2NRGP_;6M/[O\ -_Y$J-R(R#ZTTR'L*Z&U\'W,F#<SI$/[
MJ_,?\*V[7PSIMM@M$9F'>4Y'Y=*ZX8# 4>G,_/\ JQK&C)G#0PW%T^R&*21O
M1%)K7M?"FH3X,NR!?]HY/Y"NXCC2) D:*BCHJC IU=*KJ"M2BHHU5!+<P+7P
ME8PX,[R3MZ$[5_(<_K6S;VEO:KMMX(XQ_LJ!FIJ*RE4E+XF:J*6R"BBBH*"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\)Z6^9)(S_K>2 ^#U9L';G[HR>N0=KQY+=:)X.U2=XI(I/)\M2RD8+D+D?\
M?597PRTY-/\ !5I*HQ+=%IW8=3DX'Z 5TT\=4C2<ZBOK;L6JLE&\CVO0/#FD
M>&--2PT>QBM8% SL'S.1W9NK'W-:E>?6^M:C;8"73E1_"_S#]:U;?Q=*O%Q;
M(WO&<?H<UM3S*C+XM"U7B]R]XI\':)XQTUK/6+-)>"(YU $L1]5;M].A[@UY
M+X*U75?A9X^'@37K@SZ->OG3KESPA8G:1Z!C\I7LW/0DGUZ'Q1ITOWS)$?\
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MEK5Y!##<S-(LB0YV95RN0"21T]3755YO\"O^24:;_P!=9_\ T8U>D4 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;\021\.?$F#_ ,PRX_\ 1;5Y/\*_A7X2\4> ++5M6L99;R6257=;AT!"N0.
M<=!7IWCS4;*;X=^(UBO('8Z;< *)!D_(>U<=\*_$VD^%O@E9ZEJUVD$$<LXQ
MG+.WF-A57J2?3^E2TUN5<UO^%%> ?^@7/_X%R?\ Q5'_  HKP#_T"Y__  +D
M_P#BJX]?'?Q*^)%PZ^"]-72=)!*_;)PI)['+L",^R D>M61\+OBB_P"^D^(T
MRSC^!+J?9G]!^E(#I_\ A17@'_H%S_\ @7)_\56+XO\ @UX)TCP;K6HV>G3)
M<VME--$QNI" RH2#@GGD5DW&M?%SX;@7.LQQ>(='C_UDJ?,57U+@!U^K BNO
MO?'.C^.?A'XDO=,E(E33)Q<6LF/,A8QMU'<'G!'!_,  7X%?\DHTW_KK/_Z,
M:O2*\W^!7_)*--_ZZS_^C&KTB@ HHIKND:[G=57U8X% #J*SI]=TV#.ZZ1CZ
M)\W\JSI_%UNN1!;2.?5R%']:YYXJC#>2(=2*W9T5%<7/XJOY,B-8HAZA<G]:
MSI]3OKC/FW4K ]MV!^0KEGFE)?"FS-XB/0[Z>]M;;_77$49]&8 _E6;/XFTZ
M+.QY)3_L+_CBN(I\4,LS;8HGD/HBDURRS.K+2$;?B9O$2>R.CG\7N<B"U4>\
MC9_05FS^(M2GR//\L>D:@?KUH@\/:E-@_9_+'K(P'Z=:T8/"$AP9[I5]HUS^
MIQ4?[;6[_E_D+][(YZ6>:<YFE>0^KL34==O!X8TZ+!=9)3_MM_ABM&"QM;;'
MDV\2'U51G\ZN.659:S=OQ&J$GNS@(M/O)E+1VTI4#.[:0/SKPZQ\16F@^.[G
M5].<S:'J4K1M*R-&BN<,>HS\I8'IT:OK2?\ X]Y?]P_RKP'X+^%M+\8?#'6]
M)U6$O"^H;D=>'B<1KAE/8C_ZQXKMHX"%---WN:QHJ)TMSH?Q NX5ETJT\/I%
M(H9)9+UY0P/0C" ?SK''@SXR)*9(]7T5/]G9&P'_ 'U$:JV\'Q*^#[FWM+4^
M(O#88E%168QC.>@RT9]>J_C6K#^TCH7E8N]"U.&<##1H4< ^F25/Z5O#"T8;
M11:IQ6R'#1?CNH 'B720!T BA_\ C-<+X[U_XG:7(/#&M>([2]FU*/RWL[*&
M,N5;@ D1J1N] <FNLN?C#XN\8[K'P)X7N$+G;]ME'F;/?IL0^[$BNC\ _"G_
M (1R:?Q%XBNO[2\1S*[&0L76$D<X)Y9CW;\!ZGH+*G[.U_+=> ;JUD"!+2]=
M(RJX)#*K'/KR3^'TKUZO%_V;O^1-U;_L(?\ M-*]HH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH X+XM>$[CQ1X*NK?2M)MKS5R\?DNXC
M61%#@MM=L8X!'4<$UH?#SPI#X8\(:9;S:;:VVJ+;J+MXT3>7/)#.OWO3J>E=
M;10 V2..:)XI45XW4JR,,A@>H([BL'_A!/!__0J:'_X+H?\ XFN@HH Q+?P;
MX6L[F*YMO#6CP3Q,'CEBL8E9&'0@A<@^]:UQ;07=O);W,,<T$B[7CD4,K#T(
M/!%2T4 <O!\-_!=O=BYB\,Z8)0<C, (!]E/ _*NG "@   #@ 4M% &5K7AK1
M/$4:)K&E6EZ$^X9H@S)]#U'X5'HOA/P_X=9FTC1[.SD88:2*(!R/0MUQ[9K9
MHH **** "BBB@#S_ .-O_)(==_[=_P#THCKG_P!G'_DGFH?]A63_ -%15T'Q
MM_Y)#KO_ &[_ /I1'7/_ +./_)/-0_["LG_HJ*@#V"BBB@ HHHH **** /F;
MX\WBV/Q1MIW@28'1_+V.,C+^<@/X%L_A6%X*\6:A\*Y[>_232]3T_5HD>YM;
M>[1YHL9P&QED< G@C'..O3WSQW\*M#\?7MM>WTUU:W<$?E>;;L/G3.0"&!'!
M)QCU/MCD?^&;O#?_ $&=5_./_P")H ZS1?C)X'UFW$G]LQV,N,M#>CRF7\?N
MG\":LZG\5_ ^E0-)+XBLYR,@):MYS,?;9G\SQ7%?\,W>&_\ H,ZK^<?_ ,31
M_P ,W>&_^@SJOYQ__$T <CXH^)-Y\4]1'AW3KRS\/Z"QS<7&H7*1&10>K9(]
ML(N<GJ<=,'P)IMMH7QWTVPM]1MKZUANW6&Z@E5TE4QMM.5)&>0".QR*],_X9
MN\-_]!G5?SC_ /B:NZ1^S_X?T?6;+4XM6U1Y+2=)T4L@!96! .%SC(H ];HH
MHH **** "BBB@ HHHH *KR6-I+_K+6!^_P T8-6**+#4FMF9DGAW0Y?]9HVG
M/W^:U0_TJI)X*\,R?>T2R'.?EB"_RK>HJ'3@]T;QQ=>/PS:^;.6D^'/A.7[V
MCH.<_++(O\FJI)\+/"K_ ';2>/G^&X;^I-=I14NA2?V5]QO'-,=':M+_ ,"?
M^9\X>(_!.E6WQWT'0(7N5L[JU#N=X+@_O>A(Q_".U9VK>#+/Q'\6XO!NBW5Q
M)8V?S7UQ)AMA'+XP!TRJ?[Q-=+\:(]>\->/]+\=:?;0O:VMJMNLLK J)29!M
M*Y#'A\C'I[&N<^'L'Q-\.P7&LZ)X5M[\ZN%F-W>\NZ\D$?O%P"3GISQ[4_90
MNG;8AYAB7"4'-VD[OS?G]QW-U^SSH]P<IJ9C.>UMV^@<5<\._ 3P[I.HB[U)
MAJ2IRD#H53/8L-QW?3I]:H?\)=\;O^A*TK_OD_\ Q^C_ (2[XW?]"5I7_?)_
M^/T*E%;7^]A4QU6HFI*.O]V*?WI7(?C/X9;P\=&\;^'+:*UETF1(Y8X(PJ!-
MV4.T8&,DJ?4.*SKC7+7Q)\??!&LV9S!=Z:D@&<E3B?*GW!R#]*N:IKGQDUG2
MKK3;WP-I4EM=1-%(N#]TC''[_K[UP'PPT35=.^-&D:9J<+6UU8F0O#,X!1?+
M9L+SSG=GCU)]:T.,^LJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *Q_$OAC2?%ND2:9K%JL\#<JW1XV[,I['_)R*V*
M* /"O^%:_$7P'/(W@;7Q>:>6W"RN&53_ -\O\F?]H%2:G/B'XZN/)'AC3U?)
M'F83^9EVU[=10!X9!\)_&GC6^AO/B%XA86R'<+*V<%A[8 ")]1N->RZ/HVG:
M!I<.FZ7:QVUI",)&@_4GJ2>Y/)J]10 4444 %(0",$9'H:6B@"G-I-A<9\RT
MB)/<+M/YBL^;PK82<QM+$?0-D?K6Y16,\/2G\442X1>Z/)?$]ZWA75%MKRVE
M>WE7=#<1X(<=P0>A'IGT]:HV_B?2;C ^U>6Q[2*5_7I^M>G^*/#MMXFT26PG
MPK_>AEQS&XZ'Z=C[&OG#4+"YTO4)[&\C,=Q"Q5U/^>G>O&Q>#5*5X[,^IRC)
M<MS.BXN\*D=[/?SL[_,];>&6, O&Z@C(+*1FF4GPM\8"Z@7P[J$F98U_T1V_
MB4?P?4=O;Z5Z+-I-A<9\RTB)/<+M/YBG#+_:0YJ<OO/F\QRFK@:\J,WMMYKN
M<##>7-O_ *FXEC]E<BM"'Q)J46,RK(!V=1_3FMZ;PK82<QM+$?0-D?K6?-X1
MF'^HNHW]G4K_ "S2^JXNE\/X,X/9U([#H?%[CB>T4^Z-C]#6A#XHTZ7[YDB/
M^VF?Y9KG9O#VIPY/V?>/5&!_3K6?+;S0'$T,D9_VU(H^N8NE\:^]![6I'<Z#
MQS?VEW\._$:P7$<CMIMP H;YC^[/;K7SOX5N=>\<Z/H_PZTAVM;&(R7&H3 ]
M5,A.6]5 *X7NQ&>@(]9U2[_L_2+V]P#]G@>7!_V5)_I7%_!R*:TT2]U9)G6Y
MO+@JSJ<$JOK^):NREF#=-SG':QI&M[K;1[=X3\%:'X,TY;32+-$?;B6Y< RS
M'U9OZ=!V%=#7"P^)-2BQF59 .SJ/Z<U!<^)_$S29M;C2(D]);&20_F)E_E6D
M<RH2WNOZ\BE7@SK]<\/Z5XDTY[#5[&&[MV_AD7E3ZJ>JGW%?.?BBRUCX/3ZM
MH<4LMYX8UZSFB@\P_<<H1GT#J2,XX93ZCCU;_A)?&'_/]H?_ (+)O_DBN/\
MB;+KOB#P3=QZG<:3)':D7*>1821N"O7#&9@."1T-:+'8>3LI?@RE5@^IU_P+
M4-\)].! (\V?K_UT:O0GLK23[]K"WUC!KR+X/^(3IOPUTZW2 28>8DEL8)D;
MBNZ_X2^3_GS7_OY_]:G+'T82<7+5>HG5@G9FX^C::_6Q@'T0#^50/X;TE_\
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M0IVN]RX5&I(7X:RZMI'@73[8SM"K;I557!&UV+ \>H.:ZX:SJ?>^E_.N,^&
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M\V'\AVJE5?%FI@\F$_5*=_PEVI?W8/\ O@_XU.?!MSCBZB)]P:;_ ,(;>?\
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M;4\;_9N_Y$W5O^PA_P"TTKVBO%_V;O\ D3=6_P"PA_[32O:*D84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 >?_&W_DD.N_\ ;O\ ^E$=<_\ LX_\D\U#_L*R?^BHJZ#X
MV_\ )(==_P"W?_THCKG_ -G'_DGFH?\ 85D_]%14 >P4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <!\4/AS<
M_$.VTV"'5_L*6CN[(T1=9"P !X(Y&#_WT:Y2/X/^.(8DBB^)^II&@"JBR3@*
M!T 'F<"O:J* /%_^%1^//^BI:K_W]G_^.T?\*C\>?]%2U7_O[/\ _':]HHH
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M5/\ 9E'S%[")Q'_",:E_<C_[[I5\+:B>ODCZO_\ 6KMJ*?\ 9E#S'["!Q?\
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M70?&W_DD.N_]N_\ Z41US_[./_)/-0_["LG_ **BH ]@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_BV/:O5H((K:"."")(H8U"I'&H55 Z  =!4E% !1110 4444 %%%% !1110
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M,E3@]\YJ3XD_!V?QYXEBU>+6DLPMLL!B> O]UF.0=P_O=* /3_M]G_S]P?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#S+XI>#OMENVOV$?^D0K_I2*/OH/X_J._M]
M*\CL;VXTV^AO+20QSPL'1QV-?5! 8$$ @\$&O!/B)X//AS5?M=I&?[-NF)CQ
MTB?J4_J/;Z5Y>-H<K]K#Y_YGW?#.;*K#ZC7U_EOU7;_+RT/8?"OB2W\4:)'?
M0X24?)/%G_5OW'T[CVK;KYO\&^*)O"VMI<C<UK+A+F(?Q+ZCW'4?EWKZ+MKF
M&\M8KFWD62&50Z.O1@>AKKPM?VL==T>!GN4O 5[Q^"6W^7R_(EHHHKI/#"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^?/C?K^H^(_$L'@
M[01+,=/B:\NUA/)=4+X_X"HS]6QUQ7M/BWQ';^$_"U_K5S@K;1DHA/\ K'/"
MK^)(%><? KPY<-9:AXUU;,FHZS(WENXY\O=EF_X$WZ*/6@#J_A5XP'C+P/:W
M4TFZ_MO]&N\GDNHX;_@0P?J3Z5VU>":;_P 6G^.$NG-^Z\/^(,&+LL98G;_W
MRY*^RMFO>Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH S]<T>U\0:'>Z1>!OL]W$T3E3R,]Q[@\_A7S+?> /B)\,-4EU'0
MGN)K=<_Z78#>&0?\](N3[X((]Z^AO'?BEO!GA*YUQ;/[9Y#Q@Q;]F0SA3S@X
MZ^E<5;_M#>#9;3S9H=3AF YA\A6.?8AL?GB@#,^&/QOF\0ZO!H/B."&.[G.R
MWNX1M5V_NNO8GL1QGC KVROE#P=93^/OC6NLZ98-;6$>H#4)<<+$BMN )'&Y
MB.@[D]A7TGXQ\1P^$_">HZU-@FWB)C0_QR'A%_%B/PS0!\__ !T\13^)O'=I
MX8T[=*EBPA")SYES)C(_#Y5]CNKZ#\)^'X?"WA73M%@P1:PA78?QN>7;\6)/
MXU\\_ KP]-XE\?77B/4,S)8$SL[_ ,=Q(3@_A\S?4"OI^@#YSU#X9_$BR\?Z
M[KWAT16WVJZN)(9UN8PS1R2%L8/0X(].E4X/BQ\0? GB9=-\8+]JB4J98)8H
MP_ED_>C=, ]\9)'&.*]$TW]H#P7>6V^\>]L)<\QR0%_R*9_I7COQ'\2CXJ>/
M[&'P]9S.HC6TMPZ@/*=Q)8CLO/?H!DXH ^L;:XBO+2&YA;=%,BR(WJI&0?RJ
M6J6CV/\ 9>B6&G[MWV6VC@SZ[5"_TJ[0 4444 >?_&W_ ))#KO\ V[_^E$=<
M_P#LX_\ )/-0_P"PK)_Z*BKH/C;_ ,DAUW_MW_\ 2B.N?_9Q_P"2>:A_V%9/
M_145 'L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI2J8B<Z,;1;T7D>]T4459S!1110 4444 %%%% !1110 4444 %%%% !1110
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M]%14 >P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(==_[=__ $HCKG_V<?\ DGFH?]A63_T5%70?&W_DD.N_]N__ *41US_[./\
MR3S4/^PK)_Z*BH ]@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** ,KQ'H-KXDT:;3KH8W#,<F
M,F-QT8?YZ9KYOU33+K1]3GL+R/9/"VUAV/H1[$<U]2UPWQ(\'?\ "0:9]OLH
M\ZE:KP!UE3J5^HZC\1WKBQF']I'FCNCZ?AS-_JE7V%5^Y+\'W]'U^\P?A7XQ
MR%\.W\O(R;-V/YQ_U'XCTH^)'QB_X0GQ38:1:6D%T %EU N3N1&/"I@C#8YY
MR.1ZUY%+>?V=&UWO:-H/G#*<$$=,>^:Z+X<>$8?B78>+=8URY275KY3' 6',
M+$[A(!Z;E51CLK#O2P-5RARRZ%<48"G1Q*JTOM*[7;6U_1O\3Z,M;J"^LX;N
MVD66">-9(W7HRD9!'X&IJ\@^!/B6>32[[P=JF8]2T:1E1'/S>5NP5_X"V1]&
M6O7Z[CY8***"0 23@"@ HK/N-=TBSS]IU2RAQVDN%7^9K)N/B#X5M<[]8A8_
M],E9_P#T$&H=2$=VCHIX/$5?X=-OT39TU%<)<?%OPU#GRQ>W'_7.$#_T(BLB
MX^-%JN?LVC32>AEG"?R!K)XJBOM'=3R+,:FU)_.R_.QZE17C%Q\9=6?/V;3+
M*/\ ZZ%G_D163<?%/Q5/G9=PP?\ 7*!?_9LUF\=26VIW4^%<PG\5EZO_ "N>
M^T5\UW'C3Q+=9\S6[T9_YYRF/_T'%95Q?7EW_P ?-U/-_P!=)"W\ZR>8QZ1.
MZGP=6?\ $JI>B;_R/INXUO2;3/VG4[*''_/2=5_F:R;CQ_X5MO\ 6:S W_7,
M-)_Z"#7SE163S&?1'=3X.PZ_B5&_2R_S/=[CXM>&8?\ 5_;)_P#KG#C_ -"(
MK)N/C19K_P >VC3R?]=)@G\@:\JM])U*\Q]FT^[GST\J%F_D*UK?P'XINL>7
MHMRN?^>N(_\ T(BI^M8B7PK\#?\ L')Z'\67WRM^5CJ;CXS:JW_'MI=G'_UT
M9G_D163<?%3Q5-_J[J"#_KG I_\ 0LT^W^$_B>?'F1VEO_UUGSC_ +Y!K ^(
MOA.?P/X;2XO-2MWN[M_)@@A#$GC+-DXX ]NI%-+%S?5?@3.?#^&BVE%M=/BO
M^9R.HZ]JOC3Q7'=ZA?2W$5@,1,3@#![8X&2,_05O7&H7MW_Q\WEQ-_UUD+?S
M-=_X)^"-M!X<LYM6O;F*\N$$T\,2JOED\[<D'D#@^^:[*V^%'A>#'F0W5QC_
M )ZSD9_[YQ6E;#5JDK+9>9P9;G678.DY35YR;;M';R6VB1\V>([(W%D+F//G
M6YW CKM[_P"-:WA^*]\06,<ME9W%S)]V00Q%\,.O0?C^-?35KX0\.V2%8-%L
MN1@EX@YQ]6R:\?\ !CO\+_C'?^$;ABNCZP0]DS'@$Y\O_P!FC/J0*T6";IJ$
MWL<U3B6-/%RQ&'AI)6:?5K9Z>6A4LOAMXIO<'^S3 A_BGD5,?AG/Z5T5E\&=
M0?!OM5MH?40QM)_/;7L=%5' TEOJ<];BK'U/@M'T7^=SSZR^$&@08-U/>73=
MP7"+^0&?UKH[+P3X:L,>1HUJ2.AE3S3^;9K>HKHC0IQVBCR:V:8VM_$JR?SL
MON0V.*.% D2*B#HJC %.HHK4X&[A1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% 'G_QM_P"20Z[_ -N__I1'7/\
M[./_ "3S4/\ L*R?^BHJZ#XV_P#)(==_[=__ $HCKG_V<?\ DGFH?]A63_T5
M%0![!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ+<+_P!="L?_ *$17T=16BRZ'61PU.,<0_X=-+U;?^1X/;_";Q/-CS%LX/\
MKI-G_P!!!K6M_@O?-C[3K%O'Z^5$S_S(KV*BM5@:*WU.&IQ3F,]FEZ+_ #N>
M9V_P9TQ<?:=5NY/7RD5/YYK6M_A3X6AQYEO<W'_72<C_ -!Q7;45JL-16T3A
MJ9WF%3>L_EI^5CG[?P/X8M<>7HEHV/\ GJGF?^A9K6M]-L+3'V:RMH<=/*B5
M?Y"K5%:J$8[(XJF)K5?XDV_5MA1115& 5\Z76NZ1X^^.*W.K:K8VOA[0\B#[
M5<)&D[(>VXC.Y^?]U0*^B^HP:\Y;X%^ 6<M_94PR<X%W)@?^/4 =-_PG?@__
M *&O0_\ P8P__%4?\)WX/_Z&O0__  8P_P#Q5<O_ ,**\ _] N?_ ,"Y/_BJ
M/^%%> ?^@7/_ .!<G_Q5 '4?\)WX/_Z&O0__  8P_P#Q5>8?&NX\,^(_#<&J
MZ3XDTB36-*D$D*P7\1DD0D;E4!LD@@,/H<=:Z?\ X45X!_Z!<_\ X%R?_%4?
M\**\ _\ 0+G_ / N3_XJ@#H/AYXLC\9^#+'5<K]IV^5=*/X9EX;Z9X8>S"NH
MK$\+^$M&\':=)8Z);-!!+*97#2,Y9B ,Y8GL!6W0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7+_$+Q8_@KP?=:U%;)<RQO&B1.Q4$LP'
M)'MDU<\8Z_\ \(MX0U/6A&)'M(2R(QX9R0J@^V2*^<O"GA;Q-\:+C4+[5/$S
MQPV\BAO-!D&XY("1@A5  ]OYT ?2'A+6IO$7A/3-8GMUMY;R 2F)6W!<^A_6
MMFO(OA[\./%O@7Q9&)-<2]\/O"ZO$LC* V/E_=G('/<'UKG_ -IF618O#,0=
MA&QNF90>"1Y6"1[9/YT >^T5\U6O[.6KW5I#<+K]BHE17 ,3\9&:]L\ >&)O
M!7@RVT>\O4N7MVD=I1D* 6+8&>@&?YT =0S*BEF8*H&22< 4D<L<J;XW5U]5
M.17RU>76N?&_XD3Z7;:B8-)B,CPJ<^7# I #E,_,S97\6[ 53\3>'_$'P2\3
MZ?<Z;K+3QW"^9'*J&-9=I&Z-TW$$<COW[&@#ZSHJEH^IPZUHMCJEL?W-W DZ
M<] P!Q^&:NT %%%% 'G_ ,;?^20Z[_V[_P#I1'7/_LX_\D\U#_L*R?\ HJ*N
M@^-O_)(==_[=_P#THCKG_P!G'_DGFH?]A63_ -%14 >P4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \_^
M-O\ R2'7?^W?_P!*(ZY_]G'_ ))YJ'_85D_]%15T'QM_Y)#KO_;O_P"E$=<_
M^SC_ ,D\U#_L*R?^BHJ /8**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH \_^-O_ "2'7?\ MW_]*(ZY_P#9Q_Y)YJ'_ &%9/_14
M5=!\;?\ DD.N_P#;O_Z41US_ .SC_P D\U#_ +"LG_HJ*@#V"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]G'_ ))YJ'_85D_]%15T'QM_Y)#KO_;O_P"E$=<_^SC_ ,D\U#_L*R?^BHJ
M/8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH R/%&A1>)O#&HZ+,YC2[A,8<#.QNJG'L0#7
MR_#'\0/@QJUQ+';O%;2$+)(8S+:W !X.>QY]0PS7TWXN\46G@[P[-K5[#--;
MPNBLD(&[YF"Y&2!QG-<]%\8?A_>Z>TLFN0K&5^>&>!]W/8KMY_#- &3\.?C3
M8>,[U-)U&U&GZJX_=A7W13D#)"D\J?8Y^M>IU\C^%[6#Q%\<[6;PQ:R0:<FI
M"[157:(X$8,QQT4'& /]H"O7?C3\3)O"5FFA:22FK7L.]IQ_R[Q$E<C_ &C@
MX],9]* .*^/WC&#6]4LO"NF'[0;.4O<&/YLS$;5C&.I )S[MCJ#7K7PJ\(R^
M#/ MM870 O9W-U<J#G:[ #;^"JH/N#7C'PE;P'H$J>(?$NOV[ZN26@MVCD86
M_P#M,=N"Y_3Z]/H'P]XPT#Q7]H_L/4H[S[-M\T(K+MW9Q]X#K@_E0!\_3Z'\
M0_#OQ/\ $6O^'_#]S(TMY<F.5X-Z-&\A8%>><C%:^C_'OQ#I&NKIWC/1HHHP
MP28I"\,T.?XBI)##OC ^M>GZ;\7? VIVWG)K]O;D [H[H&)A^!Z_AFO!/C#X
MBT[QSX]M!X<5KP) EHLD<9!GD+L<*#R1\P /?GMB@#ZPBD2:))8V#QNH96'0
M@]#3JH:'9R:=X?TVQF;=+;6L4+DG.2J '^57Z "BBB@#S_XV_P#)(==_[=__
M $HCKG_V<?\ DGFH?]A63_T5%70?&W_DD.N_]N__ *41US_[./\ R3S4/^PK
M)_Z*BH ]@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@"IJ6F6.L:?-8:C:Q75I,,212KE6[
MC]><U\\:Y\+],'QKTS0K#1[N+09HUDN"ID*='9L.<X' '6OI*B@#%\.^$=!\
M)VS0:'ID-HK_ 'V7+._U9B6/XFL?Q9\,/#7C35(M1U>&X:YCA$(:*8H"H)(R
M/JQKLJ* /+_^% ^!O^>%]_X%'_"NH\'_  _T'P.;PZ+%.AN]@E,LI?[N<8]/
MO&NHHH \NU+X ^";^X::)+^QW-N*6MP-OY.K8%;_ (5^%OA3PA<B[T[3S)>#
M[MS<OYCI_N]E^H /-=E10 4444 %%%% 'G_QM_Y)#KO_ &[_ /I1'7/_ +./
M_)/-0_["LG_HJ*N@^-O_ "2'7?\ MW_]*(ZY_P#9Q_Y)YJ'_ &%9/_145 'L
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >?\
MQM_Y)#KO_;O_ .E$=<_^SC_R3S4/^PK)_P"BHJZ#XV_\DAUW_MW_ /2B.N?_
M &<?^2>:A_V%9/\ T5%0![!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'G_P ;?^20Z[_V[_\ I1'7/_LX_P#)/-0_["LG_HJ*
MN@^-O_)(==_[=_\ THCKG_V<?^2>:A_V%9/_ $5%0![!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 445Y)\:/B9J'@R.TTG1=D>H7<9E>X=0WE1YP-H/&XD'D],>
M_ !U&I?$6RT[XC6'@TV-Q+<W:*WGHR[4R&/(Z]%_6NSKYG@^%WQ1U2>W\7'5
M(!JS()(C)=$7"@KP/N[1P<8SWKV_X>S>)I?"4(\6QE-6CD>-RP4%E!^4G;P?
MJ.M '4T5\SZSXQ\8_%+Q[/H/A349+/3XV<1>3,8E,:'!ED=?F()Q@=L@8SS5
M2\UKQ]\'/%EM%JFJRZG:S+YGER7#RPSIG! W<JPQUQQQU'4 ^HZ*KV-Y#J.G
MVU];/O@N(EEC;U5@"#^1JQ0 4444 >?_ !M_Y)#KO_;O_P"E$=<_^SC_ ,D\
MU#_L*R?^BHJZ#XV_\DAUW_MW_P#2B.N?_9Q_Y)YJ'_85D_\ 145 'L%%%% !
M1110 4444 %%%% !1574M0@TG2KS4KHL+>T@>>4J,D(BEC@=^!6#X/\ '^A>
M.?MO]BR3O]CV>;YL13&_=C'K]TT =11110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !15;4+Z'3--NK^Y+""UA>:0J,G:H).!]!7/^#_B#H/C
MA[Q=%DG<V@0R^;$4QNSC'K]TT =31110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !117&^%OB?X;\8:S+I6DRW+74<32L)(2@V@@'GZL* .RH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKC?"WQ/\-^,
M-9ETK29;EKJ.)I6$D)0;00#S]6% '94444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 445QMG\3_#=]XR;PK#+<G5%GD@*F$A-Z!BWS?\!- '
M94444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445QMG\3_#=
M]XR;PK#+<G5%GD@*F$A-Z!BWS?\  30!V5%%% !1110 4444 %%%% !1110
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MX>?]"]_Y.W'_ ,<H_P"%)?#S_H7O_)VX_P#CE '/_P##1W@__H&ZY_WXA_\
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M1W@__H&ZY_WXA_\ CM'_  T=X/\ ^@;KG_?B'_X[70?\*2^'G_0O?^3MQ_\
M'*/^%)?#S_H7O_)VX_\ CE '/_\ #1W@_P#Z!NN?]^(?_CM'_#1W@_\ Z!NN
M?]^(?_CM=!_PI+X>?]"]_P"3MQ_\<H_X4E\//^A>_P#)VX_^.4 <_P#\-'>#
M_P#H&ZY_WXA_^.T?\-'>#_\ H&ZY_P!^(?\ X[70?\*2^'G_ $+W_D[<?_'*
M/^%)?#S_ *%[_P G;C_XY0!S_P#PT=X/_P"@;KG_ 'XA_P#CM'_#1W@__H&Z
MY_WXA_\ CM=!_P *2^'G_0O?^3MQ_P#'*/\ A27P\_Z%[_R=N/\ XY0!S_\
MPT=X/_Z!NN?]^(?_ ([1_P -'>#_ /H&ZY_WXA_^.UT'_"DOAY_T+W_D[<?_
M !RC_A27P\_Z%[_R=N/_ (Y0!S__  T=X/\ ^@;KG_?B'_X[1_PT=X/_ .@;
MKG_?B'_X[70?\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE ''>(/C_X
M5U;PWJFG0:?K*S7=G+!&TD,04,Z%03B0G&3Z5Y]\(/B+I'P_EU=]5MKZ87JP
MB/[*B-C9OSG<R_WAZU[E_P *2^'G_0O?^3MQ_P#'*/\ A27P\_Z%[_R=N/\
MXY0!S_\ PT=X/_Z!NN?]^(?_ ([1_P -'>#_ /H&ZY_WXA_^.UT'_"DOAY_T
M+W_D[<?_ !RC_A27P\_Z%[_R=N/_ (Y0!S__  T=X/\ ^@;KG_?B'_X[1_PT
M=X/_ .@;KG_?B'_X[70?\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE
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M0!S_ /PT=X/_ .@;KG_?B'_X[1_PT=X/_P"@;KG_ 'XA_P#CM=!_PI+X>?\
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MMQ_\<H_X4E\//^A>_P#)VX_^.4 <_P#\-'>#_P#H&ZY_WXA_^.T?\-'>#_\
MH&ZY_P!^(?\ X[70?\*2^'G_ $+W_D[<?_'*/^%)?#S_ *%[_P G;C_XY0!S
M_P#PT=X/_P"@;KG_ 'XA_P#CM'_#1W@__H&ZY_WXA_\ CM=!_P *2^'G_0O?
M^3MQ_P#'*/\ A27P\_Z%[_R=N/\ XY0!S_\ PT=X/_Z!NN?]^(?_ ([1_P -
M'>#_ /H&ZY_WXA_^.UT'_"DOAY_T+W_D[<?_ !RC_A27P\_Z%[_R=N/_ (Y0
M!S__  T=X/\ ^@;KG_?B'_X[1_PT=X/_ .@;KG_?B'_X[70?\*2^'G_0O?\
MD[<?_'*/^%)?#S_H7O\ R=N/_CE '/\ _#1W@_\ Z!NN?]^(?_CM'_#1W@__
M *!NN?\ ?B'_ ..UT'_"DOAY_P!"]_Y.W'_QRC_A27P\_P"A>_\ )VX_^.4
M<_\ \-'>#_\ H&ZY_P!^(?\ X[1_PT=X/_Z!NN?]^(?_ ([70?\ "DOAY_T+
MW_D[<?\ QRC_ (4E\//^A>_\G;C_ ..4 <__ ,-'>#_^@;KG_?B'_P".T?\
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MQ_\ '*/^%)?#S_H7O_)VX_\ CE '/_\ #1W@_P#Z!NN?]^(?_CM'_#1W@_\
MZ!NN?]^(?_CM=!_PI+X>?]"]_P"3MQ_\<H_X4E\//^A>_P#)VX_^.4 <_P#\
M-'>#_P#H&ZY_WXA_^.T?\-'>#_\ H&ZY_P!^(?\ X[70?\*2^'G_ $+W_D[<
M?_'*/^%)?#S_ *%[_P G;C_XY0!S_P#PT=X/_P"@;KG_ 'XA_P#CM'_#1W@_
M_H&ZY_WXA_\ CM=!_P *2^'G_0O?^3MQ_P#'*/\ A27P\_Z%[_R=N/\ XY0!
MS_\ PT=X/_Z!NN?]^(?_ ([1_P -'>#_ /H&ZY_WXA_^.UT'_"DOAY_T+W_D
M[<?_ !RC_A27P\_Z%[_R=N/_ (Y0!S__  T=X/\ ^@;KG_?B'_X[1_PT=X/_
M .@;KG_?B'_X[70?\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE '/\
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MB'_X[70?\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE '/\ _#1W@_\
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M1W@__H&ZY_WXA_\ CM'_  T=X/\ ^@;KG_?B'_X[70?\*2^'G_0O?^3MQ_\
M'*/^%)?#S_H7O_)VX_\ CE '/_\ #1W@_P#Z!NN?]^(?_CM'_#1W@_\ Z!NN
M?]^(?_CM=!_PI+X>?]"]_P"3MQ_\<H_X4E\//^A>_P#)VX_^.4 <_P#\-'>#
M_P#H&ZY_WXA_^.UXYI'C73=/^,LGC"6"[;3VO;BX$:(IEVR!P!C=C/S#/-?0
M?_"DOAY_T+W_ ).W'_QRC_A27P\_Z%[_ ,G;C_XY0!S_ /PT=X/_ .@;KG_?
MB'_X[1_PT=X/_P"@;KG_ 'XA_P#CM=!_PI+X>?\ 0O?^3MQ_\<H_X4E\//\
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M *%[_P G;C_XY0!S_P#PT=X/_P"@;KG_ 'XA_P#CM'_#1W@__H&ZY_WXA_\
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MT+W_ ).W'_QR@#G_ /AH[P?_ - W7/\ OQ#_ /':/^&CO!__ $#=<_[\0_\
MQVN@_P"%)?#S_H7O_)VX_P#CE'_"DOAY_P!"]_Y.W'_QR@#G_P#AH[P?_P!
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M_P#QVC_AH[P?_P! W7/^_$/_ ,=KH/\ A27P\_Z%[_R=N/\ XY1_PI+X>?\
M0O?^3MQ_\<H Y_\ X:.\'_\ 0-US_OQ#_P#':/\ AH[P?_T#=<_[\0__ !VN
M@_X4E\//^A>_\G;C_P".4?\ "DOAY_T+W_D[<?\ QR@#G_\ AH[P?_T#=<_[
M\0__ !VC_AH[P?\ ] W7/^_$/_QVN@_X4E\//^A>_P#)VX_^.4?\*2^'G_0O
M?^3MQ_\ '* .?_X:.\'_ /0-US_OQ#_\=H_X:.\'_P#0-US_ +\0_P#QVN@_
MX4E\//\ H7O_ "=N/_CE'_"DOAY_T+W_ ).W'_QR@#G_ /AH[P?_ - W7/\
MOQ#_ /':/^&CO!__ $#=<_[\0_\ QVN@_P"%)?#S_H7O_)VX_P#CE'_"DOAY
M_P!"]_Y.W'_QR@#G_P#AH[P?_P! W7/^_$/_ ,=H_P"&CO!__0-US_OQ#_\
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M/^A>_P#)VX_^.4 <_P#\-'>#_P#H&ZY_WXA_^.T?\-'>#_\ H&ZY_P!^(?\
MX[70?\*2^'G_ $+W_D[<?_'*/^%)?#S_ *%[_P G;C_XY0!S_P#PT=X/_P"@
M;KG_ 'XA_P#CM'_#1W@__H&ZY_WXA_\ CM=!_P *2^'G_0O?^3MQ_P#'*/\
MA27P\_Z%[_R=N/\ XY0!S_\ PT=X/_Z!NN?]^(?_ ([1_P -'>#_ /H&ZY_W
MXA_^.UT'_"DOAY_T+W_D[<?_ !RC_A27P\_Z%[_R=N/_ (Y0!S__  T=X/\
M^@;KG_?B'_X[1_PT=X/_ .@;KG_?B'_X[70?\*2^'G_0O?\ D[<?_'*/^%)?
M#S_H7O\ R=N/_CE '/\ _#1W@_\ Z!NN?]^(?_CM'_#1W@__ *!NN?\ ?B'_
M ..UT'_"DOAY_P!"]_Y.W'_QRC_A27P\_P"A>_\ )VX_^.4 <_\ \-'>#_\
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M0!S_ /PT=X/_ .@;KG_?B'_X[1_PT=X/_P"@;KG_ 'XA_P#CM=!_PI+X>?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBJ.I:UI6C(CZIJ=E8HYPC74ZQ!C[;B,T 7J*KV5_9ZE:K<V%W!=6[?=E
M@D#H?H1Q5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ>H
MZMINCP"?4]0M+*)C@27,RQJ3Z98B@"Y156PU.PU6W^T:=?6UY!G'FV\JR+GZ
MJ2*M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4454U'5-/TB
MU-UJ5];6=N#CS;B58USZ9)% %NBJ.F:SI>M0&;2]1M+Z)3AGMIED"GT.#P:O
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 444$@#).!0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 444$@ DG '4F@ HJG9ZOINH2/'9:A:7+I]Y8
M9E<K]0#Q5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHJE;:QIE[</;VNHVD\Z9W1Q3JS+]0#D5=H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **I0ZOIEQ>-9PZC:272'#0I.I<'W4'-7: "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJ1UC3!??83J-I
M]LSC[/YZ^9_WSG-7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBL;7_%F@^%H$EUO5+>S5\E%<Y=\==JC)/X"@";Q'K,?A[PWJ
M.L2IO6SMWFV XW$#@?B<"OFWPIX(UCXTWNJ^(=7US[-LD\I6\KS/FQG8J[AM
M101^?U->^M?Z#\1O"6IV6E:I#=6]U ]N[QD[HBRD E3@CUY'.*^>_ 'BZ_\
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M&(-:@M)K4.S(\4O.UEZ[6P-P]Q^A!%=%0 4444 %%%% !1110 4444 %%%%
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MY(6/YD+G_9+ !OPS5*+X=VL?Q3N/&K732M-;>5]F=,[)-JIN!]-@(QCN>>U
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MRX()^N#P#GT\?$_P2=5&FCQ)8FY+;1ACY>?3S,;/UJ*U^'.E6OQ(E\:PRO\
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M%WB"-U#!;4RC/8H0P/Z5YS\!]<T_P_\ #C7M0U.Z6WM+>^WNS>\:@ #N3C
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M 6C"WMP)K^8 W5V5PTC>@]%'8?UKKZ** "BBB@ HHHH **** "BBB@ HHHH
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M$:W_ ,(KXE\V/33*8L3Y#64F??\ @)ZCMU'?/=?"?XPV_B"VBT3Q%<QP:O&
MD5Q(=JW0[9/0/[=^WI6%^TAHVEQ1Z3K,?EQZI-(8)%'#31A<AB.^TX&?]H#L
M* +O[2EE-+HFA7R1,T,$\L<C@<*7"XS]=IK#^%OPNO/%MU!XI\7>;+8*J"UM
MYNMPJ@!21VC  P._TZ^R>!HVU7X9Z$FKP)<>=81"2.= P==HV[@>N1@\UU*J
MJ*%4 *!@ #@"@ 5510JJ%4#  & !2T44 %%%% !1110 4444 %%%% !1110
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MSQ5X1\1?!OQ3;ZOI-U*]D7_T:\"\'UBE'3..W0CD=,!WA7Q3KOP9\976CZM
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MD">$'"7,63MD0]CUQZ<@]Z^E=/U7P]X]\,R/;2PW^FW492:)NJY'*N.JL/\
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M)ZXKU_X2:B=>^%.D&\Q.5B>UE$@W!E1B@!SU^4+53XZ1"3X3:HQ'^KD@8?\
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M1:=&4LKJ7[7&J\ YXFC_ !R?H'%?2MC=VFJ65KJ5JR2PSQ"2&4#JC 'CZ\4
M>$_%;X.:%H?@U]:\.P2V\MCM-Q&TK2"9"0I;YB<,"0>,#&>*Z/\ 9WU26]\
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MJ ,+PCX3TWP9H$.D:8A\M27DE?[\KGJS>_ ^@ %;M%% !1110 4444 %%%%
M!1110 4444 %%%% ''>+?B5H7@[6=,TK4'=KF]==P3&((R=OF.3VSGISP:YG
M]H&_U.T\ )!8QR_9KJY6.\E3^% ,A3Z!FQS[8[UG_M">$1J7AVW\26T6;G3C
MY<^T<M QZG_=8_DQKI?A#XJ3QCX @CO&6:]L?]$NE?G< /D8@]<KCGN0: .9
MT7]G_07\&1PZH;@:[/"':Z60@0.1G:$Z$#@'/)P<$=N$^"%Q=^'OBY-H5PQ1
MIDGM)XP>-\>6_38WYFOJ.OF*UO;30?VF[N]O9DM[6&[NI)9)#@*&@<D_K^-
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M",@CO2T (JJBA54*H&  , "EHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M< 6[*H4E^^, '(SW'IGO?@SXN'BGP);QSR[[_3<6MQD\L /D;\5XSZJ:]#H
MYGP/X'TOP+H:Z?IZ[YGPUS=,,/._J?0#L.WUR3TU%% !1110 4444 %%%% !
M1110 4444 %%%% !7+S?$?P9;ZB;"7Q)IRW ;:091M!]"WW1^=<)^T#XNO\
M0M L='T^5H6U0R>?*APPC3;E0?\ :+<^P([US5O^SN+WP?:WMOK1&L30+-Y;
MH# 2PSLR.1UQNY^E 'T,CQS1*\;+)&ZY5E.0P/<>HKY=OTD^#OQN6YC4C2IG
M\P*O0VLAPRX_V2#@?[ ]:C\#_$#7?A7X@D\.^(8)CIJ2[9[9^6MR?XXSW'?
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MR::*WA>::1(XHU+.[G"J!R22>@JEI^N:9JNC#5["\CN; JS":/D$*2&_+!H
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MX3S:I-!XK\6H\J85K.TGR3(  %=P?X0 -J]\#M@'Z#H **** "BBB@ HHHH
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y?Q_XSMO
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&OA[H*"ZF@M88(]MM90X\QP.BHG]>@[FO$?@[X>N_%OQ(O/&MQ:B#3X;F:X
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.O3B@#V2BJ&AWLNI>']-OI@HEN;6*9PHP S("<>W-7Z "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>\2+\7O[%;QIJ&HWME:9#_9[>Z,1A1B I\I3P.0.<MZT?M! #XGV/'73X?\
MT9)7N'Q4_P"27>(?^O0_S% &7\&_&M[XS\'O)J;"2_LIO(EE"@>:, JQ [\D
M'Z5PGBKQ[XJ\:_$1O!O@R]^PV\4K1-<H2C.4'SLSC)"@@@8Z\=<@5?\ V:_^
M1>US_K[3_P! KRGP9HVJ:O\ $BXTJVU^?0]2D>=?M,3,K,X)+)\K \X)Z]J
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M/=(30]#OKA4M2S76I/.4=BQ)4&7J,#@!>>_3IZ9X[_Y-R;_L&67_ *%%6?\
MLW_\B+J?_83;_P!%1T <7X%\<>,/"7Q*M_"WB6]NKJ*:Y2SFANIC*8V? 1D8
MDD#+*>N"#],>G?&'XC3^!M&MK?3/+_M:^+>6SKN$2#[SXZ$Y( !XZ^F*\I\>
M_P#)RMM_V$-/_E%5O]I*&5?%NCSG/E/8E%_WA(Q/_H2T 2:7X7^,NL:-!XCM
M_$ETIF03PVLFH.KR*>0=F/+Y'."17O'A.?5KGPIIDVNQF/5'@4W*E0I#^X'
M-2>';ZTO?"VF7MK(AM9+2-U8'@#:/RQT]L59&K:<VE'5!?VQT\(9#="5?*VC
MJV[.,>] %RBLW1_$&D>(;=Y]'U*VO8XVVNT$@;:?0^E:5 'R[\5W_M[X\VVE
M2?-&DMG9 'D8?:Q_60U]'>)?^15U?_KRF_\ 0#7S=XV'V']I6*:3(0:I8RY/
MIB(_XC\*^D?$O_(JZO\ ]>4W_H!H ^2/A[XU/@8ZW?PINOI['[/: KE1(74[
MC[  G'? %>F? ?P/'J,LOCC5I5NIS,ZVRLV\B3/SR/\ [7/&?4GT-<9\&O#-
MEXNO?$.C7PQ'/IOR28R8G$B%7'N#^8R.]7?AIXGO?A?X_NO#FO'R;&>;R+D,
M?EBD_@E'^R01D]U(/84 ?1'C'PU!XN\*7^BSX'VB/]TY'^KD'*-^! _#(KY<
M\,^-M1\":'XL\-S))%<W*&*-?^>,X;8_T^0MSZH*^P.HR*^3_CK8V]O\59?)
MC"?:8(9)=O\ $QR"?R H ]&_9[\'_P!G:%<>)[J/%SJ'[JVR.5A4\G_@3#\E
M'K7+?M)_\C5HW_7DW_H9KZ,LK.#3[&WLK6,16]O&L42+T55& /R%?.?[2?\
MR-6C?]>3?^AF@#+\7I)\//BUHWB*W0K;W,<%Z0O\0*[9E^I^8_\  Q7LOQ?\
M51Z'\,[N>UF!FU)1:VS*>HD'S,/^ ;N?7%<Q\;O#W]I_"_2M7B3,VEB,L?\
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M_"O-OAQ973_ 'QM+&6 E\[:,=0D2EB/J#C\* *T'BKXB?%SQ+=6WAR_?2;"
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MBBB@"AKNGMJWA_4M-201O=VLL"NPR%+H5R?SKQS0/!_QB\+Z-#I&E:KHD=G
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MNV1C_?\ TKL?B#X5F\9^#KO1(+E+:69XV6212RC:X;D#Z5U%% '%?"_P/<>
M?#-QI5S>17<DUXUSOB4J "B+CG_<_6NUHHH \A_:(UA;+P);:8&_>ZA=+\O^
MQ'\Q/_?6S\ZWO@MH;Z'\,M.$JE9KTM>."/[_ -W_ ,<"T_QS\+;'QYK=A?ZA
MJ5U%#:1B/[-&%VL-V6.3R">!^ KNT1(HUCC4(B@*JJ,  = * '4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV@#W"F/-%&ZH\B*SG"AF )^E/KQ#]H7P:U_I5MXJM$+362B"Z '6$GY6_P"
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MKZE"9PQ<MN>&1_+VCMN&1_P*N3TRS^"R7T<UUJ?B%X=V[R+B(!0/1S&NX_\
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M $,5]0(H1%5>BC H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR!D'(.1R*Y?_ (4_X!_Z%R#_ +^R?_%5W%% &/HGA30/#:D:/I%I9EAAGBC
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
LB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>88
<FILENAME>kymr-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-22T14:29:11.4905+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.kymeratx.com/20221231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:kymr="http://www.kymeratx.com/20221231" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2022" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kymr-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kymr-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kymr-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kymr-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails2" id="DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails2">
        <link:definition>100020 - Disclosure - Leases - Summary of Undiscounted Future Lease Payments for Operating and Finance Leases (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100030 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss2" id="StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss2">
        <link:definition>100040 - Statement - Consolidated Statements of Operations and Comprehensive Loss 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails3" id="DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails3">
        <link:definition>100050 - Disclosure - Leases - Summary of Undiscounted Future Lease Payments for Operating and Finance Leases (Details) 3</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100060 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails4" id="DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails4">
        <link:definition>100070 - Disclosure - Leases - Summary of Undiscounted Future Lease Payments for Operating and Finance Leases (Details) 4</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity" id="Role_StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>100080 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" id="Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
        <link:definition>100090 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100100 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies" id="Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies">
        <link:definition>100110 - Disclosure - Description of Business and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100120 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100130 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecurities" id="Role_DisclosureMarketableSecurities">
        <link:definition>100140 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations" id="Role_DisclosureCollaborations">
        <link:definition>100150 - Disclosure - Collaborations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment" id="Role_DisclosurePropertyAndEquipment">
        <link:definition>100160 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeases" id="Role_DisclosureLeases">
        <link:definition>100170 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses" id="Role_DisclosureAccruedExpenses">
        <link:definition>100180 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingencies" id="Role_DisclosureOtherCommitmentsAndContingencies">
        <link:definition>100190 - Disclosure - Other Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStock" id="Role_DisclosureConvertiblePreferredStock">
        <link:definition>100200 - Disclosure - Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensation" id="Role_DisclosureEquityBasedCompensation">
        <link:definition>100210 - Disclosure - Equity-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" id="Role_DisclosureRelatedPartyTransactions">
        <link:definition>100220 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100230 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>100240 - Disclosure - Net Loss per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100250 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100260 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100270 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesTables" id="Role_DisclosureMarketableSecuritiesTables">
        <link:definition>100280 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsTables" id="Role_DisclosureCollaborationsTables">
        <link:definition>100290 - Disclosure - Collaborations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables" id="Role_DisclosurePropertyAndEquipmentTables">
        <link:definition>100300 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables" id="Role_DisclosureLeasesTables">
        <link:definition>100310 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables" id="Role_DisclosureAccruedExpensesTables">
        <link:definition>100320 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables" id="Role_DisclosureEquityBasedCompensationTables">
        <link:definition>100330 - Disclosure - Equity-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100340 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>100350 - Disclosure - Net Loss per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100360 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100370 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails">
        <link:definition>100380 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Life of Related Asset (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" id="Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails">
        <link:definition>100390 - Disclosure - Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" id="Role_DisclosureFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>100400 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails" id="Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails">
        <link:definition>100410 - Disclosure - Marketable Securities - Summary of Available-for-Sale Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" id="Role_DisclosureMarketableSecuritiesAdditionalInformationDetails">
        <link:definition>100420 - Disclosure - Marketable Securities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails" id="Role_DisclosureCollaborationsAdditionalInformationDetails">
        <link:definition>100430 - Disclosure - Collaborations - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails" id="Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails">
        <link:definition>100440 - Disclosure - Collaborations - Change in Accounts Receivable, Contract Asset and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" id="Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails">
        <link:definition>100450 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" id="Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails">
        <link:definition>100460 - Disclosure - Property and Equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" id="Role_DisclosureLeasesAdditionalInformationDetails">
        <link:definition>100470 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails" id="Role_DisclosureLeasesComponentsOfLeaseCostsDetails">
        <link:definition>100480 - Disclosure - Leases - Components of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSupplementalCashFlowInformationRelatingToLeasesDetails" id="Role_DisclosureLeasesSupplementalCashFlowInformationRelatingToLeasesDetails">
        <link:definition>100490 - Disclosure - Leases - Supplemental Cash Flow Information Relating to Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesDetails" id="Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesDetails">
        <link:definition>100500 - Disclosure - Leases - Summary of Weighted Average Remaining Lease Terms and Discount Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails" id="Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails">
        <link:definition>100510 - Disclosure - Leases - Summary of Undiscounted Future Lease Payments for Operating and Finance Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" id="Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails">
        <link:definition>100520 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>100530 - Disclosure - Other Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" id="Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails">
        <link:definition>100540 - Disclosure - Convertible Preferred Stock - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" id="Role_DisclosureEquityBasedCompensationAdditionalInformationDetails">
        <link:definition>100550 - Disclosure - Equity-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails" id="Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails">
        <link:definition>100560 - Disclosure - Equity-Based Compensation - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" id="Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails">
        <link:definition>100570 - Disclosure - Equity-Based Compensation - Summary of Equity-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsDetails" id="Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsDetails">
        <link:definition>100580 - Disclosure - Equity-Based Compensation - Summary of Weighted-Average Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails" id="Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails">
        <link:definition>100590 - Disclosure - Equity-Based Compensation - Summary of Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" id="Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>100600 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" id="Role_DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100610 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails" id="Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails">
        <link:definition>100620 - Disclosure - Income Taxes - Rate Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails" id="Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails">
        <link:definition>100630 - Disclosure - Income Taxes - Schedule of Significant Components of Net Deferred Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail" id="Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail">
        <link:definition>100640 - Disclosure - Net Loss per Share - Summary of Basic and Diluted Loss Per Share (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail" id="Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail">
        <link:definition>100650 - Disclosure - Net Loss per Share - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders Anti-Diluted Effect (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract" name="DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" name="SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_ScenarioPotentialOutcomeAxis" name="ScenarioPotentialOutcomeAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_AccruedResearchAndDevelopmentExpensesCurrent" name="AccruedResearchAndDevelopmentExpensesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_AccumulatedAmortization" name="AccumulatedAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend" name="AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_BaseRentAnnualIncreaseOverTheLeaseTerm" name="BaseRentAnnualIncreaseOverTheLeaseTerm" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_CollaborationAgreementTransactionPrice" name="CollaborationAgreementTransactionPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_CollaborationTerminationDate" name="CollaborationTerminationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_CommercialMilestonePayments" name="CommercialMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_ContractWithCustomerAssetNetAdditions" name="ContractWithCustomerAssetNetAdditions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_ContractWithCustomerAssetNetDeductions" name="ContractWithCustomerAssetNetDeductions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_ContractWithCustomerLiabilityAdditions" name="ContractWithCustomerLiabilityAdditions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_ContractWithCustomerLiabilityDeductions" name="ContractWithCustomerLiabilityDeductions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_CostReimbursementPaymentReceived" name="CostReimbursementPaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_CostReimbursementReceivable" name="CostReimbursementReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions" name="DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities" name="DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities" name="DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities" name="DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_DeferredTaxAssetsLeaseLiabilities" name="DeferredTaxAssetsLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_DeferredTaxLiabilitiesRightOfUseAssets" name="DeferredTaxLiabilitiesRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_DevelopmentMilestonePayments" name="DevelopmentMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences" name="EffectiveIncomeTaxRateReconciliationPermanentDifferences" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity" name="ExchangeOfConvertiblePreferredStockImpactOnEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_ExtendedResearchTermOfCollaboration" name="ExtendedResearchTermOfCollaboration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_FairValueAssetsLevel1ToLevel2TransfersAmounts" name="FairValueAssetsLevel1ToLevel2TransfersAmounts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_FairValueAssetsLevel1ToLevel3TransfersAmount" name="FairValueAssetsLevel1ToLevel3TransfersAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_FairValueAssetsLevel2ToLevel1TransfersAmounts" name="FairValueAssetsLevel2ToLevel1TransfersAmounts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_FairValueAssetsLevel2ToLevel3TransfersAmount" name="FairValueAssetsLevel2ToLevel3TransfersAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_FairValueAssetsLevel3ToLevel1TransfersAmount" name="FairValueAssetsLevel3ToLevel1TransfersAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_FairValueAssetsLevel3ToLevel2TransfersAmount" name="FairValueAssetsLevel3ToLevel2TransfersAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths" name="FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration" name="FederalNetOperatingLossCarryoversNotSubjectToExpiration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties" name="IncreaseDecreaseInContractWithCustomerAssetRelatedParties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_IncreaseDecreaseInOperatingLeaseLiabilities" name="IncreaseDecreaseInOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend" name="IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_IncreaseOrDecreasePreFundedWarrants" name="IncreaseOrDecreasePreFundedWarrants" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_InitialResearchTermOfCollaboration" name="InitialResearchTermOfCollaboration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" name="IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost" name="IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares" name="IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_IssuanceOfVestedRestrictedStockToConsultants" name="IssuanceOfVestedRestrictedStockToConsultants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_LeaseAdditionalTerm" name="LeaseAdditionalTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_LeaseCommencementDate" name="LeaseCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_LeaseTerm" name="LeaseTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_LeaseTerminationDate" name="LeaseTerminationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_MarketableSecuritiesRemainingMaturityPeriod" name="MarketableSecuritiesRemainingMaturityPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent" name="MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_MilestoneReceivable" name="MilestoneReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_MinimumPreFundedWarrantsExercise" name="MinimumPreFundedWarrantsExercise" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_NetOperatingLossBeginToExpireYear" name="NetOperatingLossBeginToExpireYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_NonCashResearchAndDevelopmentExpense" name="NonCashResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_NonRefundableUpfrontPaymentReceived" name="NonRefundableUpfrontPaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_NumberOfMarketableSecuritiesSold" name="NumberOfMarketableSecuritiesSold" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_OfferingCostsIncludedInAccountsPayable" name="OfferingCostsIncludedInAccountsPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_OperatingLeasePaymentsProceeds" name="OperatingLeasePaymentsProceeds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_PotentialReceivableMilestonePayments" name="PotentialReceivableMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_PreferredStockIssuancePremium" name="PreferredStockIssuancePremium" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" name="PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_PriorNoticePeriod" name="PriorNoticePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_ProceedsFromConcurrentPrivatePlacement" name="ProceedsFromConcurrentPrivatePlacement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" name="ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_ProceedsFromIssuanceInitialPublicOfferingGross" name="ProceedsFromIssuanceInitialPublicOfferingGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses" name="PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities" name="PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification" name="ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_RemainingResearchTermOfCollaboration" name="RemainingResearchTermOfCollaboration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_RentalAndLeaseExpenses" name="RentalAndLeaseExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_ResearchAndDevelopmentCreditCarryforwards" name="ResearchAndDevelopmentCreditCarryforwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_RestrictedCashFairValue" name="RestrictedCashFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_RoyaltyReceivable" name="RoyaltyReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_StockIssuedDuringPeriodSharesRestrictedStockVested" name="StockIssuedDuringPeriodSharesRestrictedStockVested" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_StockIssuedDuringPeriodValueRestrictedStockVested" name="StockIssuedDuringPeriodValueRestrictedStockVested" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares" name="TemporaryEquityExchangeOfConvertiblePreferredStockShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue" name="TemporaryEquityExchangeOfConvertiblePreferredStockValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" name="TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" name="TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="kymr_TenantImprovementReceivableIncludedInOtherAssets" name="TenantImprovementReceivableIncludedInOtherAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_TenantIncentiveAllowanceReceivable" name="TenantIncentiveAllowanceReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_UpfrontPayment" name="UpfrontPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="kymr_WrittenNoticePeriodToTerminateCollaborationAgreement" name="WrittenNoticePeriodToTerminateCollaborationAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_ScenarioPotentialOutcomeDomain" name="ScenarioPotentialOutcomeDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" name="DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_IncomeTaxDisclosureLineItems" name="IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_AssetsNotYetInServiceMember" name="AssetsNotYetInServiceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_BilledReceivablesSanofiMember" name="BilledReceivablesSanofiMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_CambridgeMassachusettsMember" name="CambridgeMassachusettsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_CollaborationRevenuesFromRelatedPartyMember" name="CollaborationRevenuesFromRelatedPartyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_CollaborationTargetOneMember" name="CollaborationTargetOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_CollaborationTargetTwoMember" name="CollaborationTargetTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_CompoundCollaborationAgreementMember" name="CompoundCollaborationAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_DeferredRevenueSanofiMember" name="DeferredRevenueSanofiMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_DeferredRevenueVertexMember" name="DeferredRevenueVertexMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_FacilitySubleaseAgreementMember" name="FacilitySubleaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_FederalAndStateMember" name="FederalAndStateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_FollowOnOfferingMember" name="FollowOnOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_IRAK4Member" name="IRAK4Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_LabAndOfficeEquipmentMember" name="LabAndOfficeEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_LabEquipmentMember" name="LabEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_LesserOfPotentialOutcomeOneMember" name="LesserOfPotentialOutcomeOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_LesserOfPotentialOutcomeTwoMember" name="LesserOfPotentialOutcomeTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_NoncancelableFacilityLeaseAgreementMember" name="NoncancelableFacilityLeaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_PrivateInvestmentInPublicEquityPipeMember" name="PrivateInvestmentInPublicEquityPipeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_RestrictedCashMember" name="RestrictedCashMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SanofiCollaborationArrangementMember" name="SanofiCollaborationArrangementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SeriesAConvertiblePreferredStockMember" name="SeriesAConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SeriesAPreferredUnitsMember" name="SeriesAPreferredUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SeriesB1ConvertiblePreferredStockMember" name="SeriesB1ConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SeriesB1PreferredStockMember" name="SeriesB1PreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SeriesBConvertiblePreferredStockMember" name="SeriesBConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SeriesBConvertiblePreferredStocksMember" name="SeriesBConvertiblePreferredStocksMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SeriesCConvertiblePreferredStockMember" name="SeriesCConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SeriesCPreferredStockPurchaseAgreementMember" name="SeriesCPreferredStockPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SeriesSeedConvertiblePreferredStockMember" name="SeriesSeedConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember" name="TwoThousandAndTwentyStockOptionAndGrantPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember" name="TwoThousandEighteenStockOptionAndGrantPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember" name="TwoThousandTwentyEmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember" name="TwoThousandTwentyStockOptionAndIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_UnbilledReceivablesSanofiMember" name="UnbilledReceivablesSanofiMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_VertexAgreementMember" name="VertexAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_VertexPharmaceuticalsIncorporatedMember" name="VertexPharmaceuticalsIncorporatedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_WatertownMassachusettsMember" name="WatertownMassachusettsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_CommonAndPreferredStockValuationPolicyTextBlock" name="CommonAndPreferredStockValuationPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_ConvertiblePreferredStockPolicyTextBlock" name="ConvertiblePreferredStockPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock" name="CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_EmergingGrowthCompanyStatusPolicyTextBlock" name="EmergingGrowthCompanyStatusPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_FinancingCostsPolicyTextBlock" name="FinancingCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock" name="OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_PatentCostsPolicyTextBlock" name="PatentCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_RestrictedCashPolicyPolicyTextBlock" name="RestrictedCashPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_SegmentAndGeographicInformationPolicyTextBlock" name="SegmentAndGeographicInformationPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" name="DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_IncomeTaxDisclosureTable" name="IncomeTaxDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock" name="LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock" name="SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" name="SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock" name="SupplementalCashFlowInformationRelatingToLeasesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="kymr_LesseeOperatingAndFinanceLeasesTextBlock" name="LesseeOperatingAndFinanceLeasesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>89
<FILENAME>kymr-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-22T14:29:11.1634+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails2" xlink:href="kymr-20221231.xsd#DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss2" xlink:href="kymr-20221231.xsd#StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss2" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails3" xlink:href="kymr-20221231.xsd#DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails3" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails4" xlink:href="kymr-20221231.xsd#DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails4" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" xlink:href="kymr-20221231.xsd#Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureLeasesComponentsOfLeaseCostsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail" xlink:href="kymr-20221231.xsd#Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ContractWithCustomerAssetNetCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashNoncurrent" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="0" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails3">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncome" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingExpense" order="1" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails4">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiability" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_RestrictedCash" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockPlans" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" order="4" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="4" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="5" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="kymr_NonCashResearchAndDevelopmentExpense" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" order="6" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="6" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="7" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="kymr_ProceedsFromConcurrentPrivatePlacement" order="8" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties" order="8" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties" order="9" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="11" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="12" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" order="13" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="kymr_IncreaseDecreaseInOperatingLeaseLiabilities" order="14" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" order="15" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="16" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" xlink:label="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" xlink:label="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NonCashResearchAndDevelopmentExpense" xlink:label="kymr_NonCashResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" xlink:label="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ProceedsFromConcurrentPrivatePlacement" xlink:label="kymr_ProceedsFromConcurrentPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties" xlink:label="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_FinanceLeaseInterestExpense" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_VariableLeaseCost" order="3" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="kymr_AccruedResearchAndDevelopmentExpensesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="kymr_AccruedResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:label="kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="kymr_DeferredTaxLiabilitiesRightOfUseAssets" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="kymr_DeferredTaxAssetsLeaseLiabilities" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredTaxLiabilitiesRightOfUseAssets" xlink:label="kymr_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredTaxAssetsLeaseLiabilities" xlink:label="kymr_DeferredTaxAssetsLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment" order="1" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>90
<FILENAME>kymr-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-22T14:29:10.9463+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations" xlink:href="kymr-20221231.xsd#Role_DisclosureCollaborations" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureCollaborationsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" xlink:href="kymr-20221231.xsd#Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail" xlink:href="kymr-20221231.xsd#Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesSeedConvertiblePreferredStockMember" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAConvertiblePreferredStockMember" xlink:label="kymr_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesSeedConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerAssetNetCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesSeedConvertiblePreferredStockMember" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAConvertiblePreferredStockMember" xlink:label="kymr_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesSeedConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationRevenuesFromRelatedPartyMember" xlink:label="kymr_CollaborationRevenuesFromRelatedPartyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncome" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="kymr_CollaborationRevenuesFromRelatedPartyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesSeedConvertiblePreferredStockMember" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAConvertiblePreferredStockMember" xlink:label="kymr_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCConvertiblePreferredStockMember" xlink:label="kymr_SeriesCConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" xlink:label="kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" xlink:label="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity" xlink:label="kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_StockIssuedDuringPeriodValueRestrictedStockVested" xlink:label="kymr_StockIssuedDuringPeriodValueRestrictedStockVested"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_StockIssuedDuringPeriodSharesRestrictedStockVested" xlink:label="kymr_StockIssuedDuringPeriodSharesRestrictedStockVested"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost" xlink:label="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares" xlink:label="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfVestedRestrictedStockToConsultants" xlink:label="kymr_IssuanceOfVestedRestrictedStockToConsultants"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesSeedConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesCConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_StockIssuedDuringPeriodValueRestrictedStockVested" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_StockIssuedDuringPeriodSharesRestrictedStockVested" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_IssuanceOfVestedRestrictedStockToConsultants" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStocksMember" xlink:label="kymr_SeriesBConvertiblePreferredStocksMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1PreferredStockMember" xlink:label="kymr_SeriesB1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCConvertiblePreferredStockMember" xlink:label="kymr_SeriesCConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStocksMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1PreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesCConvertiblePreferredStockMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" xlink:label="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" xlink:label="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities" xlink:label="kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TenantImprovementReceivableIncludedInOtherAssets" xlink:label="kymr_TenantImprovementReceivableIncludedInOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses" xlink:label="kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCConvertiblePreferredStockMember" xlink:label="kymr_SeriesCConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification" xlink:label="kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" xlink:label="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties" xlink:label="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_OfferingCostsIncludedInAccountsPayable" xlink:label="kymr_OfferingCostsIncludedInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NonCashResearchAndDevelopmentExpense" xlink:label="kymr_NonCashResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" xlink:label="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ProceedsFromConcurrentPrivatePlacement" xlink:label="kymr_ProceedsFromConcurrentPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" xlink:to="kymr_TenantImprovementReceivableIncludedInOtherAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesCConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" xlink:to="kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="kymr_OfferingCostsIncludedInAccountsPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="kymr_NonCashResearchAndDevelopmentExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfFinancingCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="kymr_IncreaseDecreaseInOperatingLeaseLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="kymr_ProceedsFromConcurrentPrivatePlacement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCash" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201409Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FollowOnOfferingMember" xlink:label="kymr_FollowOnOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_VertexPharmaceuticalsIncorporatedMember" xlink:label="kymr_VertexPharmaceuticalsIncorporatedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAndCash" xlink:label="us-gaap_InvestmentsAndCash"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PrivateInvestmentInPublicEquityPipeMember" xlink:label="kymr_PrivateInvestmentInPublicEquityPipeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ProceedsFromIssuanceInitialPublicOfferingGross" xlink:label="kymr_ProceedsFromIssuanceInitialPublicOfferingGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:label="us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralPartnersOfferingCosts" xlink:label="us-gaap_GeneralPartnersOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MinimumPreFundedWarrantsExercise" xlink:label="kymr_MinimumPreFundedWarrantsExercise"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseOrDecreasePreFundedWarrants" xlink:label="kymr_IncreaseOrDecreasePreFundedWarrants"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PriorNoticePeriod" xlink:label="kymr_PriorNoticePeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfWarrants" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="kymr_FollowOnOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="kymr_VertexPharmaceuticalsIncorporatedMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InvestmentsAndCash" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="kymr_PrivateInvestmentInPublicEquityPipeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_ProceedsFromIssuanceInitialPublicOfferingGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_GeneralPartnersOfferingCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_MinimumPreFundedWarrantsExercise" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_IncreaseOrDecreasePreFundedWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_PriorNoticePeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PaymentsForRepurchaseOfWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SummaryOfSignificantAccountingPoliciesTable" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MarketableSecuritiesRemainingMaturityPeriod" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201613Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_MarketableSecuritiesRemainingMaturityPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201912Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_DeferredOfferingCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LabEquipmentMember" xlink:label="kymr_LabEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kymr_LabEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="us-gaap_CorporateBondSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RestrictedCashFairValue" xlink:label="kymr_RestrictedCashFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateBondSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_MarketableSecuritiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="kymr_RestrictedCashFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_UpfrontPayment" xlink:label="kymr_UpfrontPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationTargetOneMember" xlink:label="kymr_CollaborationTargetOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_VertexPharmaceuticalsIncorporatedMember" xlink:label="kymr_VertexPharmaceuticalsIncorporatedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProjectMember" xlink:label="us-gaap_ProjectMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IRAK4Member" xlink:label="kymr_IRAK4Member"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SanofiCollaborationArrangementMember" xlink:label="kymr_SanofiCollaborationArrangementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:label="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProjectMember" xlink:label="us-gaap_ProjectMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAPreferredUnitsMember" xlink:label="kymr_SeriesAPreferredUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DevelopmentMilestonePayments" xlink:label="kymr_DevelopmentMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationTargetTwoMember" xlink:label="kymr_CollaborationTargetTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_VertexAgreementMember" xlink:label="kymr_VertexAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CommercialMilestonePayments" xlink:label="kymr_CommercialMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CompoundCollaborationAgreementMember" xlink:label="kymr_CompoundCollaborationAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationAgreementTransactionPrice" xlink:label="kymr_CollaborationAgreementTransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CostReimbursementPaymentReceived" xlink:label="kymr_CostReimbursementPaymentReceived"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CostReimbursementReceivable" xlink:label="kymr_CostReimbursementReceivable"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MilestoneReceivable" xlink:label="kymr_MilestoneReceivable"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RoyaltyReceivable" xlink:label="kymr_RoyaltyReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="us-gaap_UnbilledContractsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BilledContractReceivables" xlink:label="us-gaap_BilledContractReceivables"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RemainingResearchTermOfCollaboration" xlink:label="kymr_RemainingResearchTermOfCollaboration"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_InitialResearchTermOfCollaboration" xlink:label="kymr_InitialResearchTermOfCollaboration"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ExtendedResearchTermOfCollaboration" xlink:label="kymr_ExtendedResearchTermOfCollaboration"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NonRefundableUpfrontPaymentReceived" xlink:label="kymr_NonRefundableUpfrontPaymentReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PreferredStockIssuancePremium" xlink:label="kymr_PreferredStockIssuancePremium"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PotentialReceivableMilestonePayments" xlink:label="kymr_PotentialReceivableMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" xlink:label="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_WrittenNoticePeriodToTerminateCollaborationAgreement" xlink:label="kymr_WrittenNoticePeriodToTerminateCollaborationAgreement"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationTerminationDate" xlink:label="kymr_CollaborationTerminationDate"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_UpfrontPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="kymr_CollaborationTargetOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="kymr_VertexPharmaceuticalsIncorporatedMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProjectMember" xlink:to="kymr_IRAK4Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_SanofiCollaborationArrangementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="us-gaap_ProjectMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="us-gaap_ProjectMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesAPreferredUnitsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_DevelopmentMilestonePayments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="kymr_CollaborationTargetTwoMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_VertexAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_CommercialMilestonePayments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_CompoundCollaborationAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_CollaborationAgreementTransactionPrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_CostReimbursementPaymentReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_CostReimbursementReceivable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_MilestoneReceivable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_RoyaltyReceivable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_UnbilledContractsReceivable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_BilledContractReceivables" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_RemainingResearchTermOfCollaboration" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_InitialResearchTermOfCollaboration" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_ExtendedResearchTermOfCollaboration" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_NonRefundableUpfrontPaymentReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_PreferredStockIssuancePremium" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_PotentialReceivableMilestonePayments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_WrittenNoticePeriodToTerminateCollaborationAgreement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_CollaborationTerminationDate" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" xlink:label="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_BilledReceivablesSanofiMember" xlink:label="kymr_BilledReceivablesSanofiMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerAssetNetAdditions" xlink:label="kymr_ContractWithCustomerAssetNetAdditions"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_UnbilledReceivablesSanofiMember" xlink:label="kymr_UnbilledReceivablesSanofiMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerAssetNetDeductions" xlink:label="kymr_ContractWithCustomerAssetNetDeductions"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredRevenueVertexMember" xlink:label="kymr_DeferredRevenueVertexMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredRevenueSanofiMember" xlink:label="kymr_DeferredRevenueSanofiMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerLiabilityAdditions" xlink:label="kymr_ContractWithCustomerLiabilityAdditions"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerLiabilityDeductions" xlink:label="kymr_ContractWithCustomerLiabilityDeductions"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="kymr_BilledReceivablesSanofiMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_ContractWithCustomerAssetNetAdditions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="kymr_UnbilledReceivablesSanofiMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_ContractWithCustomerAssetNetDeductions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="kymr_DeferredRevenueVertexMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="kymr_DeferredRevenueSanofiMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_ContractWithCustomerLiabilityAdditions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_ContractWithCustomerLiabilityDeductions" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LabAndOfficeEquipmentMember" xlink:label="kymr_LabAndOfficeEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LabEquipmentMember" xlink:label="kymr_LabEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AssetsNotYetInServiceMember" xlink:label="kymr_AssetsNotYetInServiceMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kymr_LabAndOfficeEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kymr_LabEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kymr_AssetsNotYetInServiceMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LabAndOfficeEquipmentMember" xlink:label="kymr_LabAndOfficeEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AccumulatedAmortization" xlink:label="kymr_AccumulatedAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kymr_LabAndOfficeEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="kymr_AccumulatedAmortization" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CambridgeMassachusettsMember" xlink:label="kymr_CambridgeMassachusettsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NoncancelableFacilityLeaseAgreementMember" xlink:label="kymr_NoncancelableFacilityLeaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_WatertownMassachusettsMember" xlink:label="kymr_WatertownMassachusettsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLeasehold" xlink:label="us-gaap_ImpairmentOfLeasehold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="us-gaap_OtherCurrentAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FacilitySubleaseAgreementMember" xlink:label="kymr_FacilitySubleaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseTerminationDate" xlink:label="kymr_LeaseTerminationDate"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RestrictedCashMember" xlink:label="kymr_RestrictedCashMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseCommencementDate" xlink:label="kymr_LeaseCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseTerm" xlink:label="kymr_LeaseTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseAdditionalTerm" xlink:label="kymr_LeaseAdditionalTerm"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TenantIncentiveAllowanceReceivable" xlink:label="kymr_TenantIncentiveAllowanceReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RentalAndLeaseExpenses" xlink:label="kymr_RentalAndLeaseExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_BaseRentAnnualIncreaseOverTheLeaseTerm" xlink:label="kymr_BaseRentAnnualIncreaseOverTheLeaseTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="kymr_CambridgeMassachusettsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_LetterOfCreditMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_NoncancelableFacilityLeaseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="kymr_WatertownMassachusettsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_ImpairmentOfLeasehold" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherCurrentAssetsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_FacilitySubleaseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_LeaseTerminationDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="kymr_RestrictedCashMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_SecurityDeposit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_LeaseCommencementDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_LeaseTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseExpirationDate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_LeaseAdditionalTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_TenantIncentiveAllowanceReceivable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_RentalAndLeaseExpenses" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PaymentsForRent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_BaseRentAnnualIncreaseOverTheLeaseTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember" xlink:label="us-gaap_IndemnificationGuaranteeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_IndemnificationGuaranteeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCPreferredStockPurchaseAgreementMember" xlink:label="kymr_SeriesCPreferredStockPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesSeedConvertiblePreferredStockMember" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAConvertiblePreferredStockMember" xlink:label="kymr_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCConvertiblePreferredStockMember" xlink:label="kymr_SeriesCConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend" xlink:label="kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend" xlink:label="kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_SeriesCPreferredStockPurchaseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesSeedConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesCConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember" xlink:label="kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ScenarioPotentialOutcomeDomain" xlink:label="kymr_ScenarioPotentialOutcomeDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LesserOfPotentialOutcomeOneMember" xlink:label="kymr_LesserOfPotentialOutcomeOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ScenarioPotentialOutcomeAxis" xlink:label="kymr_ScenarioPotentialOutcomeAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ScenarioPotentialOutcomeDomain" xlink:label="kymr_ScenarioPotentialOutcomeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:label="kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LesserOfPotentialOutcomeTwoMember" xlink:label="kymr_LesserOfPotentialOutcomeTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandEighteenStockOptionAndGrantPlanMember" xlink:label="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_ScenarioPotentialOutcomeDomain" xlink:to="kymr_LesserOfPotentialOutcomeOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="kymr_ScenarioPotentialOutcomeAxis" xlink:to="kymr_ScenarioPotentialOutcomeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="kymr_ScenarioPotentialOutcomeAxis" xlink:to="kymr_ScenarioPotentialOutcomeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_ScenarioPotentialOutcomeDomain" xlink:to="kymr_LesserOfPotentialOutcomeTwoMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="kymr_ScenarioPotentialOutcomeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_GranteeStatusAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember" xlink:label="kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandEighteenStockOptionAndGrantPlanMember" xlink:label="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_InvestorMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncomeTaxDisclosureLineItems" xlink:label="kymr_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncomeTaxDisclosureTable" xlink:label="kymr_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FederalAndStateMember" xlink:label="kymr_FederalAndStateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration" xlink:label="kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NetOperatingLossBeginToExpireYear" xlink:label="kymr_NetOperatingLossBeginToExpireYear"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ResearchAndDevelopmentCreditCarryforwards" xlink:label="kymr_ResearchAndDevelopmentCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="kymr_IncomeTaxDisclosureTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_EarliestTaxYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kymr_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_LatestTaxYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kymr_IncomeTaxDisclosureTable" xlink:to="us-gaap_TaxPeriodAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="kymr_FederalAndStateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="kymr_NetOperatingLossBeginToExpireYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="kymr_ResearchAndDevelopmentCreditCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OpenTaxYear" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationRevenuesFromRelatedPartyMember" xlink:label="kymr_CollaborationRevenuesFromRelatedPartyMember"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="kymr_CollaborationRevenuesFromRelatedPartyMember" priority="2" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>91
<FILENAME>kymr-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-22T14:29:10.9944+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="kymr-20221231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="kymr-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies" xlink:href="kymr-20221231.xsd#Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="kymr-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:href="kymr-20221231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecurities" xlink:href="kymr-20221231.xsd#Role_DisclosureMarketableSecurities" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations" xlink:href="kymr-20221231.xsd#Role_DisclosureCollaborations" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment" xlink:href="kymr-20221231.xsd#Role_DisclosurePropertyAndEquipment" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeases" xlink:href="kymr-20221231.xsd#Role_DisclosureLeases" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses" xlink:href="kymr-20221231.xsd#Role_DisclosureAccruedExpenses" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingencies" xlink:href="kymr-20221231.xsd#Role_DisclosureOtherCommitmentsAndContingencies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStock" xlink:href="kymr-20221231.xsd#Role_DisclosureConvertiblePreferredStock" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensation" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensation" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" xlink:href="kymr-20221231.xsd#Role_DisclosureRelatedPartyTransactions" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:href="kymr-20221231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:href="kymr-20221231.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="kymr-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="kymr-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:href="kymr-20221231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesTables" xlink:href="kymr-20221231.xsd#Role_DisclosureMarketableSecuritiesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsTables" xlink:href="kymr-20221231.xsd#Role_DisclosureCollaborationsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables" xlink:href="kymr-20221231.xsd#Role_DisclosurePropertyAndEquipmentTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables" xlink:href="kymr-20221231.xsd#Role_DisclosureLeasesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables" xlink:href="kymr-20221231.xsd#Role_DisclosureAccruedExpensesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:href="kymr-20221231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:href="kymr-20221231.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureCollaborationsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" xlink:href="kymr-20221231.xsd#Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureLeasesComponentsOfLeaseCostsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSupplementalCashFlowInformationRelatingToLeasesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureLeasesSupplementalCashFlowInformationRelatingToLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails" xlink:href="kymr-20221231.xsd#Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail" xlink:href="kymr-20221231.xsd#Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail" xlink:href="kymr-20221231.xsd#Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingParValuePerShare" xlink:label="dei_EntityListingParValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="79.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="80.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="81.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="82.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="83.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="84.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityListingParValuePerShare" order="85.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="86.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="87.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="88.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesSeedConvertiblePreferredStockMember" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAConvertiblePreferredStockMember" xlink:label="kymr_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesSeedConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesAConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerAssetNetCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesSeedConvertiblePreferredStockMember" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAConvertiblePreferredStockMember" xlink:label="kymr_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesSeedConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesAConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationRevenuesFromRelatedPartyMember" xlink:label="kymr_CollaborationRevenuesFromRelatedPartyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_5"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncome" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="kymr_CollaborationRevenuesFromRelatedPartyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesSeedConvertiblePreferredStockMember" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAConvertiblePreferredStockMember" xlink:label="kymr_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCConvertiblePreferredStockMember" xlink:label="kymr_SeriesCConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" xlink:label="kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" xlink:label="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity" xlink:label="kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_StockIssuedDuringPeriodValueRestrictedStockVested" xlink:label="kymr_StockIssuedDuringPeriodValueRestrictedStockVested"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_StockIssuedDuringPeriodSharesRestrictedStockVested" xlink:label="kymr_StockIssuedDuringPeriodSharesRestrictedStockVested"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost" xlink:label="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares" xlink:label="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfVestedRestrictedStockToConsultants" xlink:label="kymr_IssuanceOfVestedRestrictedStockToConsultants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_27"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_28"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_29"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_30"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesSeedConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesAConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesCConvertiblePreferredStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_StockIssuedDuringPeriodValueRestrictedStockVested" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_StockIssuedDuringPeriodSharesRestrictedStockVested" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kymr_IssuanceOfVestedRestrictedStockToConsultants" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_27" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_28" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_29" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_30" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStocksMember" xlink:label="kymr_SeriesBConvertiblePreferredStocksMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1PreferredStockMember" xlink:label="kymr_SeriesB1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCConvertiblePreferredStockMember" xlink:label="kymr_SeriesCConvertiblePreferredStockMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStocksMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1PreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesCConvertiblePreferredStockMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" xlink:label="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" xlink:label="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities" xlink:label="kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TenantImprovementReceivableIncludedInOtherAssets" xlink:label="kymr_TenantImprovementReceivableIncludedInOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses" xlink:label="kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCConvertiblePreferredStockMember" xlink:label="kymr_SeriesCConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification" xlink:label="kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" xlink:label="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties" xlink:label="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_OfferingCostsIncludedInAccountsPayable" xlink:label="kymr_OfferingCostsIncludedInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NonCashResearchAndDevelopmentExpense" xlink:label="kymr_NonCashResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" xlink:label="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ProceedsFromConcurrentPrivatePlacement" xlink:label="kymr_ProceedsFromConcurrentPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_9"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" xlink:to="kymr_TenantImprovementReceivableIncludedInOtherAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesCConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" xlink:to="kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="kymr_OfferingCostsIncludedInAccountsPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="kymr_NonCashResearchAndDevelopmentExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="kymr_IncreaseDecreaseInOperatingLeaseLiabilities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="kymr_ProceedsFromConcurrentPrivatePlacement" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCash" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_9" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecurities" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201409Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeases" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LesseeOperatingAndFinanceLeasesTextBlock" xlink:label="kymr_LesseeOperatingAndFinanceLeasesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="kymr_LesseeOperatingAndFinanceLeasesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStock" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_PreferredStockTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SegmentAndGeographicInformationPolicyTextBlock" xlink:label="kymr_SegmentAndGeographicInformationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RestrictedCashPolicyPolicyTextBlock" xlink:label="kymr_RestrictedCashPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ConvertiblePreferredStockPolicyTextBlock" xlink:label="kymr_ConvertiblePreferredStockPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PatentCostsPolicyTextBlock" xlink:label="kymr_PatentCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FinancingCostsPolicyTextBlock" xlink:label="kymr_FinancingCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock" xlink:label="kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CommonAndPreferredStockValuationPolicyTextBlock" xlink:label="kymr_CommonAndPreferredStockValuationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock" xlink:label="kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:label="kymr_EmergingGrowthCompanyStatusPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kymr_SegmentAndGeographicInformationPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kymr_RestrictedCashPolicyPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kymr_ConvertiblePreferredStockPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kymr_PatentCostsPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kymr_FinancingCostsPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kymr_CommonAndPreferredStockValuationPolicyTextBlock" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kymr_EmergingGrowthCompanyStatusPolicyTextBlock" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock" xlink:label="kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock" xlink:label="kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" xlink:label="kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock" xlink:label="kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FollowOnOfferingMember" xlink:label="kymr_FollowOnOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_VertexPharmaceuticalsIncorporatedMember" xlink:label="kymr_VertexPharmaceuticalsIncorporatedMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAndCash" xlink:label="us-gaap_InvestmentsAndCash"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PrivateInvestmentInPublicEquityPipeMember" xlink:label="kymr_PrivateInvestmentInPublicEquityPipeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ProceedsFromIssuanceInitialPublicOfferingGross" xlink:label="kymr_ProceedsFromIssuanceInitialPublicOfferingGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:label="us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralPartnersOfferingCosts" xlink:label="us-gaap_GeneralPartnersOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MinimumPreFundedWarrantsExercise" xlink:label="kymr_MinimumPreFundedWarrantsExercise"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseOrDecreasePreFundedWarrants" xlink:label="kymr_IncreaseOrDecreasePreFundedWarrants"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PriorNoticePeriod" xlink:label="kymr_PriorNoticePeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfWarrants" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="kymr_FollowOnOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="kymr_VertexPharmaceuticalsIncorporatedMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract" xlink:to="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InvestmentsAndCash" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="kymr_PrivateInvestmentInPublicEquityPipeMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_ProceedsFromIssuanceInitialPublicOfferingGross" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_GeneralPartnersOfferingCosts" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_MinimumPreFundedWarrantsExercise" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_IncreaseOrDecreasePreFundedWarrants" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_PriorNoticePeriod" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PaymentsForRepurchaseOfWarrants" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SummaryOfSignificantAccountingPoliciesTable" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MarketableSecuritiesRemainingMaturityPeriod" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201613Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kymr_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_MarketableSecuritiesRemainingMaturityPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201912Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="kymr_SummaryOfSignificantAccountingPoliciesLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LabEquipmentMember" xlink:label="kymr_LabEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kymr_LabEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="us-gaap_CorporateBondSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RestrictedCashFairValue" xlink:label="kymr_RestrictedCashFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateBondSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_InvestmentTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="kymr_RestrictedCashFairValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel1ToLevel2TransfersAmounts" xlink:label="kymr_FairValueAssetsLevel1ToLevel2TransfersAmounts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel2ToLevel1TransfersAmounts" xlink:label="kymr_FairValueAssetsLevel2ToLevel1TransfersAmounts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel1ToLevel3TransfersAmount" xlink:label="kymr_FairValueAssetsLevel1ToLevel3TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel3ToLevel1TransfersAmount" xlink:label="kymr_FairValueAssetsLevel3ToLevel1TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel3ToLevel2TransfersAmount" xlink:label="kymr_FairValueAssetsLevel3ToLevel2TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel2ToLevel3TransfersAmount" xlink:label="kymr_FairValueAssetsLevel2ToLevel3TransfersAmount"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="kymr_FairValueAssetsLevel1ToLevel2TransfersAmounts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="kymr_FairValueAssetsLevel2ToLevel1TransfersAmounts" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="kymr_FairValueAssetsLevel1ToLevel3TransfersAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="kymr_FairValueAssetsLevel3ToLevel1TransfersAmount" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="kymr_FairValueAssetsLevel3ToLevel2TransfersAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="kymr_FairValueAssetsLevel2ToLevel3TransfersAmount" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_MarketableSecuritiesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions" xlink:label="kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months" xlink:label="kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities" xlink:label="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths" xlink:label="kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities" xlink:label="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NumberOfMarketableSecuritiesSold" xlink:label="kymr_NumberOfMarketableSecuritiesSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesSoldAtPar" xlink:label="us-gaap_AvailableforsaleSecuritiesSoldAtPar"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities" xlink:label="kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="kymr_NumberOfMarketableSecuritiesSold" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_AvailableforsaleSecuritiesSoldAtPar" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_UpfrontPayment" xlink:label="kymr_UpfrontPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationTargetOneMember" xlink:label="kymr_CollaborationTargetOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_VertexPharmaceuticalsIncorporatedMember" xlink:label="kymr_VertexPharmaceuticalsIncorporatedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProjectMember" xlink:label="us-gaap_ProjectMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IRAK4Member" xlink:label="kymr_IRAK4Member"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SanofiCollaborationArrangementMember" xlink:label="kymr_SanofiCollaborationArrangementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:label="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAPreferredUnitsMember" xlink:label="kymr_SeriesAPreferredUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DevelopmentMilestonePayments" xlink:label="kymr_DevelopmentMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationTargetTwoMember" xlink:label="kymr_CollaborationTargetTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_VertexAgreementMember" xlink:label="kymr_VertexAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CommercialMilestonePayments" xlink:label="kymr_CommercialMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CompoundCollaborationAgreementMember" xlink:label="kymr_CompoundCollaborationAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationAgreementTransactionPrice" xlink:label="kymr_CollaborationAgreementTransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CostReimbursementPaymentReceived" xlink:label="kymr_CostReimbursementPaymentReceived"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CostReimbursementReceivable" xlink:label="kymr_CostReimbursementReceivable"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MilestoneReceivable" xlink:label="kymr_MilestoneReceivable"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RoyaltyReceivable" xlink:label="kymr_RoyaltyReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="us-gaap_UnbilledContractsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BilledContractReceivables" xlink:label="us-gaap_BilledContractReceivables"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RemainingResearchTermOfCollaboration" xlink:label="kymr_RemainingResearchTermOfCollaboration"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_InitialResearchTermOfCollaboration" xlink:label="kymr_InitialResearchTermOfCollaboration"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ExtendedResearchTermOfCollaboration" xlink:label="kymr_ExtendedResearchTermOfCollaboration"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NonRefundableUpfrontPaymentReceived" xlink:label="kymr_NonRefundableUpfrontPaymentReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PreferredStockIssuancePremium" xlink:label="kymr_PreferredStockIssuancePremium"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PotentialReceivableMilestonePayments" xlink:label="kymr_PotentialReceivableMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" xlink:label="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_WrittenNoticePeriodToTerminateCollaborationAgreement" xlink:label="kymr_WrittenNoticePeriodToTerminateCollaborationAgreement"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationTerminationDate" xlink:label="kymr_CollaborationTerminationDate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_UpfrontPayment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="kymr_CollaborationTargetOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="kymr_VertexPharmaceuticalsIncorporatedMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProjectMember" xlink:to="kymr_IRAK4Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_SanofiCollaborationArrangementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="us-gaap_ProjectMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesAPreferredUnitsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_DevelopmentMilestonePayments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="kymr_CollaborationTargetTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_VertexAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_CommercialMilestonePayments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_CompoundCollaborationAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_CollaborationAgreementTransactionPrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_CostReimbursementPaymentReceived" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_CostReimbursementReceivable" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_MilestoneReceivable" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_RoyaltyReceivable" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_UnbilledContractsReceivable" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_BilledContractReceivables" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_RemainingResearchTermOfCollaboration" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_InitialResearchTermOfCollaboration" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_ExtendedResearchTermOfCollaboration" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_NonRefundableUpfrontPaymentReceived" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_PreferredStockIssuancePremium" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_PotentialReceivableMilestonePayments" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_WrittenNoticePeriodToTerminateCollaborationAgreement" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_CollaborationTerminationDate" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" xlink:label="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_BilledReceivablesSanofiMember" xlink:label="kymr_BilledReceivablesSanofiMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerAssetNetAdditions" xlink:label="kymr_ContractWithCustomerAssetNetAdditions"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_UnbilledReceivablesSanofiMember" xlink:label="kymr_UnbilledReceivablesSanofiMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerAssetNetDeductions" xlink:label="kymr_ContractWithCustomerAssetNetDeductions"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredRevenueVertexMember" xlink:label="kymr_DeferredRevenueVertexMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" xlink:label="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_3"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredRevenueSanofiMember" xlink:label="kymr_DeferredRevenueSanofiMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerLiabilityAdditions" xlink:label="kymr_ContractWithCustomerLiabilityAdditions"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerLiabilityDeductions" xlink:label="kymr_ContractWithCustomerLiabilityDeductions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability_7"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="kymr_BilledReceivablesSanofiMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_ContractWithCustomerAssetNetAdditions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="kymr_UnbilledReceivablesSanofiMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_ContractWithCustomerAssetNetDeductions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="kymr_DeferredRevenueVertexMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="kymr_DeferredRevenueSanofiMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_ContractWithCustomerLiabilityAdditions" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="kymr_ContractWithCustomerLiabilityDeductions" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability_7" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LabAndOfficeEquipmentMember" xlink:label="kymr_LabAndOfficeEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LabEquipmentMember" xlink:label="kymr_LabEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AssetsNotYetInServiceMember" xlink:label="kymr_AssetsNotYetInServiceMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kymr_LabAndOfficeEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kymr_LabEquipmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kymr_AssetsNotYetInServiceMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LabAndOfficeEquipmentMember" xlink:label="kymr_LabAndOfficeEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AccumulatedAmortization" xlink:label="kymr_AccumulatedAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="kymr_LabAndOfficeEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="kymr_AccumulatedAmortization" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CambridgeMassachusettsMember" xlink:label="kymr_CambridgeMassachusettsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NoncancelableFacilityLeaseAgreementMember" xlink:label="kymr_NoncancelableFacilityLeaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_WatertownMassachusettsMember" xlink:label="kymr_WatertownMassachusettsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLeasehold" xlink:label="us-gaap_ImpairmentOfLeasehold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="us-gaap_OtherCurrentAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FacilitySubleaseAgreementMember" xlink:label="kymr_FacilitySubleaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseTerminationDate" xlink:label="kymr_LeaseTerminationDate"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RestrictedCashMember" xlink:label="kymr_RestrictedCashMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseCommencementDate" xlink:label="kymr_LeaseCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseTerm" xlink:label="kymr_LeaseTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseAdditionalTerm" xlink:label="kymr_LeaseAdditionalTerm"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TenantIncentiveAllowanceReceivable" xlink:label="kymr_TenantIncentiveAllowanceReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RentalAndLeaseExpenses" xlink:label="kymr_RentalAndLeaseExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_BaseRentAnnualIncreaseOverTheLeaseTerm" xlink:label="kymr_BaseRentAnnualIncreaseOverTheLeaseTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="kymr_CambridgeMassachusettsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_LetterOfCreditMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_NoncancelableFacilityLeaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="kymr_WatertownMassachusettsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_ImpairmentOfLeasehold" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherCurrentAssetsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_FacilitySubleaseAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_LeaseTerminationDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="kymr_RestrictedCashMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_SecurityDeposit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_CreditFacilityAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_LeaseCommencementDate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_LeaseTerm" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_LeaseAdditionalTerm" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_TenantIncentiveAllowanceReceivable" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_RentalAndLeaseExpenses" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PaymentsForRent" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="kymr_BaseRentAnnualIncreaseOverTheLeaseTerm" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeaseInterestExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_VariableLeaseCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCost" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSupplementalCashFlowInformationRelatingToLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_OperatingLeasePaymentsProceeds" xlink:label="kymr_OperatingLeasePaymentsProceeds"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="kymr_OperatingLeasePaymentsProceeds" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeaseInterestPaymentOnLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeasePrincipalPayments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="kymr_AccruedResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="kymr_AccruedResearchAndDevelopmentExpensesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedSalariesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember" xlink:label="us-gaap_IndemnificationGuaranteeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_IndemnificationGuaranteeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingenciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCPreferredStockPurchaseAgreementMember" xlink:label="kymr_SeriesCPreferredStockPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesSeedConvertiblePreferredStockMember" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAConvertiblePreferredStockMember" xlink:label="kymr_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCConvertiblePreferredStockMember" xlink:label="kymr_SeriesCConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend" xlink:label="kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend" xlink:label="kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="kymr_SeriesCPreferredStockPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesSeedConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesAConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesBConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="kymr_SeriesCConvertiblePreferredStockMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember" xlink:label="kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ScenarioPotentialOutcomeDomain" xlink:label="kymr_ScenarioPotentialOutcomeDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LesserOfPotentialOutcomeOneMember" xlink:label="kymr_LesserOfPotentialOutcomeOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ScenarioPotentialOutcomeAxis" xlink:label="kymr_ScenarioPotentialOutcomeAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:label="kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LesserOfPotentialOutcomeTwoMember" xlink:label="kymr_LesserOfPotentialOutcomeTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandEighteenStockOptionAndGrantPlanMember" xlink:label="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_ScenarioPotentialOutcomeDomain" xlink:to="kymr_LesserOfPotentialOutcomeOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_ScenarioPotentialOutcomeAxis" xlink:to="kymr_ScenarioPotentialOutcomeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_ScenarioPotentialOutcomeDomain" xlink:to="kymr_LesserOfPotentialOutcomeTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="kymr_ScenarioPotentialOutcomeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_GranteeStatusAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember" xlink:label="kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandEighteenStockOptionAndGrantPlanMember" xlink:label="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_InvestorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncomeTaxDisclosureLineItems" xlink:label="kymr_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncomeTaxDisclosureTable" xlink:label="kymr_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FederalAndStateMember" xlink:label="kymr_FederalAndStateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration" xlink:label="kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NetOperatingLossBeginToExpireYear" xlink:label="kymr_NetOperatingLossBeginToExpireYear"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ResearchAndDevelopmentCreditCarryforwards" xlink:label="kymr_ResearchAndDevelopmentCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="kymr_IncomeTaxDisclosureTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_EarliestTaxYearMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_LatestTaxYearMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureTable" xlink:to="us-gaap_TaxPeriodAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="kymr_FederalAndStateMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureTable" xlink:to="kymr_IncomeTaxDisclosureLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="kymr_NetOperatingLossBeginToExpireYear" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="kymr_ResearchAndDevelopmentCreditCarryforwards" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OpenTaxYear" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:label="kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredTaxLiabilitiesRightOfUseAssets" xlink:label="kymr_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredTaxAssetsLeaseLiabilities" xlink:label="kymr_DeferredTaxAssetsLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="kymr_DeferredTaxLiabilitiesRightOfUseAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="kymr_DeferredTaxAssetsLeaseLiabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>92
<FILENAME>kymr-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-02-22T14:29:13.6120+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RentalAndLeaseExpenses" xlink:label="kymr_RentalAndLeaseExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="us-gaap_UnbilledContractsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RestrictedCashPolicyPolicyTextBlock" xlink:label="kymr_RestrictedCashPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel1ToLevel3TransfersAmount" xlink:label="kymr_FairValueAssetsLevel1ToLevel3TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ResearchAndDevelopmentCreditCarryforwards" xlink:label="kymr_ResearchAndDevelopmentCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PatentCostsPolicyTextBlock" xlink:label="kymr_PatentCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_UpfrontPayment" xlink:label="kymr_UpfrontPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NonRefundableUpfrontPaymentReceived" xlink:label="kymr_NonRefundableUpfrontPaymentReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PrivateInvestmentInPublicEquityPipeMember" xlink:label="kymr_PrivateInvestmentInPublicEquityPipeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ScenarioPotentialOutcomeDomain" xlink:label="kymr_ScenarioPotentialOutcomeDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseOrDecreasePreFundedWarrants" xlink:label="kymr_IncreaseOrDecreasePreFundedWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DevelopmentMilestonePayments" xlink:label="kymr_DevelopmentMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_StockIssuedDuringPeriodValueRestrictedStockVested" xlink:label="kymr_StockIssuedDuringPeriodValueRestrictedStockVested"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities" xlink:label="kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationTargetTwoMember" xlink:label="kymr_CollaborationTargetTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel3ToLevel1TransfersAmount" xlink:label="kymr_FairValueAssetsLevel3ToLevel1TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" xlink:label="kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel1ToLevel2TransfersAmounts" xlink:label="kymr_FairValueAssetsLevel1ToLevel2TransfersAmounts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredRevenueVertexMember" xlink:label="kymr_DeferredRevenueVertexMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCPreferredStockPurchaseAgreementMember" xlink:label="kymr_SeriesCPreferredStockPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AccumulatedAmortization" xlink:label="kymr_AccumulatedAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CostReimbursementPaymentReceived" xlink:label="kymr_CostReimbursementPaymentReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration" xlink:label="kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncomeTaxDisclosureLineItems" xlink:label="kymr_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LabAndOfficeEquipmentMember" xlink:label="kymr_LabAndOfficeEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LesserOfPotentialOutcomeOneMember" xlink:label="kymr_LesserOfPotentialOutcomeOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FederalAndStateMember" xlink:label="kymr_FederalAndStateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RemainingResearchTermOfCollaboration" xlink:label="kymr_RemainingResearchTermOfCollaboration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PriorNoticePeriod" xlink:label="kymr_PriorNoticePeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SummaryOfSignificantAccountingPoliciesTable" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_OfferingCostsIncludedInAccountsPayable" xlink:label="kymr_OfferingCostsIncludedInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusAxis" xlink:label="us-gaap_GranteeStatusAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MilestoneReceivable" xlink:label="kymr_MilestoneReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_WatertownMassachusettsMember" xlink:label="kymr_WatertownMassachusettsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseTerminationDate" xlink:label="kymr_LeaseTerminationDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ProceedsFromConcurrentPrivatePlacement" xlink:label="kymr_ProceedsFromConcurrentPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_OperatingLeasePaymentsProceeds" xlink:label="kymr_OperatingLeasePaymentsProceeds"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationAgreementTransactionPrice" xlink:label="kymr_CollaborationAgreementTransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LabEquipmentMember" xlink:label="kymr_LabEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1PreferredStockMember" xlink:label="kymr_SeriesB1PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:label="us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandEighteenStockOptionAndGrantPlanMember" xlink:label="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TenantIncentiveAllowanceReceivable" xlink:label="kymr_TenantIncentiveAllowanceReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities" xlink:label="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend" xlink:label="kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLeasehold" xlink:label="us-gaap_ImpairmentOfLeasehold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:label="kymr_EmergingGrowthCompanyStatusPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_StockIssuedDuringPeriodSharesRestrictedStockVested" xlink:label="kymr_StockIssuedDuringPeriodSharesRestrictedStockVested"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LesseeOperatingAndFinanceLeasesTextBlock" xlink:label="kymr_LesseeOperatingAndFinanceLeasesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NetOperatingLossBeginToExpireYear" xlink:label="kymr_NetOperatingLossBeginToExpireYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesSoldAtPar" xlink:label="us-gaap_AvailableforsaleSecuritiesSoldAtPar"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember" xlink:label="kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ConvertiblePreferredStockPolicyTextBlock" xlink:label="kymr_ConvertiblePreferredStockPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses" xlink:label="kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PreferredStockIssuancePremium" xlink:label="kymr_PreferredStockIssuancePremium"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths" xlink:label="kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CommercialMilestonePayments" xlink:label="kymr_CommercialMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerAssetNetDeductions" xlink:label="kymr_ContractWithCustomerAssetNetDeductions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProjectMember" xlink:label="us-gaap_ProjectMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CommonAndPreferredStockValuationPolicyTextBlock" xlink:label="kymr_CommonAndPreferredStockValuationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CostReimbursementReceivable" xlink:label="kymr_CostReimbursementReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" xlink:label="kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RestrictedCashFairValue" xlink:label="kymr_RestrictedCashFairValue"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesCConvertiblePreferredStockMember" xlink:label="kymr_SeriesCConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAConvertiblePreferredStockMember" xlink:label="kymr_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_InitialResearchTermOfCollaboration" xlink:label="kymr_InitialResearchTermOfCollaboration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerLiabilityDeductions" xlink:label="kymr_ContractWithCustomerLiabilityDeductions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" xlink:label="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MinimumPreFundedWarrantsExercise" xlink:label="kymr_MinimumPreFundedWarrantsExercise"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NonCashResearchAndDevelopmentExpense" xlink:label="kymr_NonCashResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_VertexAgreementMember" xlink:label="kymr_VertexAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SanofiCollaborationArrangementMember" xlink:label="kymr_SanofiCollaborationArrangementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_BilledReceivablesSanofiMember" xlink:label="kymr_BilledReceivablesSanofiMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStocksMember" xlink:label="kymr_SeriesBConvertiblePreferredStocksMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="us-gaap_CorporateBondSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_VertexPharmaceuticalsIncorporatedMember" xlink:label="kymr_VertexPharmaceuticalsIncorporatedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties" xlink:label="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IRAK4Member" xlink:label="kymr_IRAK4Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationRevenuesFromRelatedPartyMember" xlink:label="kymr_CollaborationRevenuesFromRelatedPartyMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel3ToLevel2TransfersAmount" xlink:label="kymr_FairValueAssetsLevel3ToLevel2TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities" xlink:label="kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ExtendedResearchTermOfCollaboration" xlink:label="kymr_ExtendedResearchTermOfCollaboration"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" xlink:label="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GranteeStatusDomain" xlink:label="us-gaap_GranteeStatusDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseAdditionalTerm" xlink:label="kymr_LeaseAdditionalTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend" xlink:label="kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity" xlink:label="kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember" xlink:label="kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_PotentialReceivableMilestonePayments" xlink:label="kymr_PotentialReceivableMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" xlink:label="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerAssetNetAdditions" xlink:label="kymr_ContractWithCustomerAssetNetAdditions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months" xlink:label="kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RoyaltyReceivable" xlink:label="kymr_RoyaltyReceivable"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LesserOfPotentialOutcomeTwoMember" xlink:label="kymr_LesserOfPotentialOutcomeTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IncomeTaxDisclosureTable" xlink:label="kymr_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseTerm" xlink:label="kymr_LeaseTerm"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock" xlink:label="kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TenantImprovementReceivableIncludedInOtherAssets" xlink:label="kymr_TenantImprovementReceivableIncludedInOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ProceedsFromIssuanceInitialPublicOfferingGross" xlink:label="kymr_ProceedsFromIssuanceInitialPublicOfferingGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesBConvertiblePreferredStockMember" xlink:label="kymr_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_UnbilledReceivablesSanofiMember" xlink:label="kymr_UnbilledReceivablesSanofiMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="us-gaap_FinanceLeasePrincipalPayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NoncancelableFacilityLeaseAgreementMember" xlink:label="kymr_NoncancelableFacilityLeaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FinancingCostsPolicyTextBlock" xlink:label="kymr_FinancingCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BilledContractReceivables" xlink:label="us-gaap_BilledContractReceivables"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" xlink:label="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel2ToLevel1TransfersAmounts" xlink:label="kymr_FairValueAssetsLevel2ToLevel1TransfersAmounts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesSeedConvertiblePreferredStockMember" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfWarrants" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ContractWithCustomerLiabilityAdditions" xlink:label="kymr_ContractWithCustomerLiabilityAdditions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AssetsNotYetInServiceMember" xlink:label="kymr_AssetsNotYetInServiceMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares" xlink:label="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:label="kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification" xlink:label="kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CambridgeMassachusettsMember" xlink:label="kymr_CambridgeMassachusettsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="us-gaap_OtherCurrentAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ScenarioPotentialOutcomeAxis" xlink:label="kymr_ScenarioPotentialOutcomeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndemnificationGuaranteeMember" xlink:label="us-gaap_IndemnificationGuaranteeMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_LeaseCommencementDate" xlink:label="kymr_LeaseCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredTaxAssetsLeaseLiabilities" xlink:label="kymr_DeferredTaxAssetsLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FacilitySubleaseAgreementMember" xlink:label="kymr_FacilitySubleaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesB1ConvertiblePreferredStockMember" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SeriesAPreferredUnitsMember" xlink:label="kymr_SeriesAPreferredUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationTargetOneMember" xlink:label="kymr_CollaborationTargetOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredTaxLiabilitiesRightOfUseAssets" xlink:label="kymr_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralPartnersOfferingCosts" xlink:label="us-gaap_GeneralPartnersOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FollowOnOfferingMember" xlink:label="kymr_FollowOnOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" xlink:label="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities" xlink:label="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_RestrictedCashMember" xlink:label="kymr_RestrictedCashMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAndCash" xlink:label="us-gaap_InvestmentsAndCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfVestedRestrictedStockToConsultants" xlink:label="kymr_IssuanceOfVestedRestrictedStockToConsultants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:label="kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DeferredRevenueSanofiMember" xlink:label="kymr_DeferredRevenueSanofiMember"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" xlink:label="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SegmentAndGeographicInformationPolicyTextBlock" xlink:label="kymr_SegmentAndGeographicInformationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="kymr_AccruedResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock" xlink:label="kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingParValuePerShare" xlink:label="dei_EntityListingParValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CollaborationTerminationDate" xlink:label="kymr_CollaborationTerminationDate"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_WrittenNoticePeriodToTerminateCollaborationAgreement" xlink:label="kymr_WrittenNoticePeriodToTerminateCollaborationAgreement"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost" xlink:label="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_CompoundCollaborationAgreementMember" xlink:label="kymr_CompoundCollaborationAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_NumberOfMarketableSecuritiesSold" xlink:label="kymr_NumberOfMarketableSecuritiesSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock" xlink:label="kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock" xlink:label="kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_MarketableSecuritiesRemainingMaturityPeriod" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriod"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_FairValueAssetsLevel2ToLevel3TransfersAmount" xlink:label="kymr_FairValueAssetsLevel2ToLevel3TransfersAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock" xlink:label="kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:label="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions" xlink:label="kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:href="kymr-20221231.xsd#kymr_BaseRentAnnualIncreaseOverTheLeaseTerm" xlink:label="kymr_BaseRentAnnualIncreaseOverTheLeaseTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rate Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Tax Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss attributable to common stockholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Due from Related Parties, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Due from Related Parties, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable-due from related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Authority [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RentalAndLeaseExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Rental And Lease Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RentalAndLeaseExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Rental And Lease Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RentalAndLeaseExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Base Rent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnbilledContractsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unbilled Contracts Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnbilledContractsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unbilled accounts receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of restricted stock vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Rent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rent paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RestrictedCashPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RestrictedCashPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash Policy Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RestrictedCashPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of stock options vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares authorized for issuance under plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets, operating leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Employee [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Modification of Employee's Awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Securities [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less amounts representing interest or imputed interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel1ToLevel3TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value assets level 1 to level 3 transfers amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel1ToLevel3TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Level1 To Level3 Transfers Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel1ToLevel3TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value assets, level 1 to level 3 transfers, amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ResearchAndDevelopmentCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development credit carryforwards.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ResearchAndDevelopmentCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Credit Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ResearchAndDevelopmentCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense for financing lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Patent costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Patent Costs Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_UpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront payment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_UpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_UpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, immaterial effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of shares under employee stock purchase plan, Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Segments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NonRefundableUpfrontPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non refundable upfront payment received.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NonRefundableUpfrontPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Refundable Upfront Payment Received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NonRefundableUpfrontPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non refundable upfront payment received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unvested at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unvested at beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred stock, par or stated value per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PrivateInvestmentInPublicEquityPipeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Investment in Public Equity "PIPE"</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PrivateInvestmentInPublicEquityPipeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Investment in Public Equity "PIPE" [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PrivateInvestmentInPublicEquityPipeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Private Investment in Public Equity "PIPE" [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201912Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2019-12 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201912Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2019-12</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options to Purchase Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, remaining lease term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders' equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxPeriodAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Period [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxPeriodAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue from Contract with Customer, Product and Service [Extensible List]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ScenarioPotentialOutcomeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Scenario potential outcome.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ScenarioPotentialOutcomeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario Potential Outcome [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ScenarioPotentialOutcomeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario Potential Outcome</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseOrDecreasePreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase or decrease pre-funded warrants, maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseOrDecreasePreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase or decrease pre-funded warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseOrDecreasePreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase or decrease pre-funded warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adopted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DevelopmentMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Development milestone payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DevelopmentMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Development Milestone Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DevelopmentMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Reverse Stock Split</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reverse stock split, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from employee stock purchase plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing lease, remaining lease term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_StockIssuedDuringPeriodValueRestrictedStockVested_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period value restricted stock vested.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_StockIssuedDuringPeriodValueRestrictedStockVested_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Restricted Stock Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_StockIssuedDuringPeriodValueRestrictedStockVested_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting Restricted Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchases of property and equipment through finance and lease liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchases Of Property And Equipment Through Finance And Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of property and equipment through finance and lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Contract with Customer, Asset, after Allowance for Credit Loss, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract assets-due from related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of shares under employee stock purchase plan, Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Loss Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NOL carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Nature [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingency Nature</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationTargetTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration target two.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationTargetTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration Target Two [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationTargetTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration Target 2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel3ToLevel1TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value assets level 3 to level 1 transfers amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel3ToLevel1TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Level3 To Level1 Transfers Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel3ToLevel1TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value assets, level 3 to level 1 transfers, amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Recurring</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, discount rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Repurchase of Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments of offering costs in connection with initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payments of offering costs in connection with initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock value vesting of series A preferred stock in connection with collaboration arrangement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Value Vesting Of Series A Preferred Stock In Connection With Collaboration Arrangement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting of Series A Preferred Stock in connection with collaboration arrangement (Note 5)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel1ToLevel2TransfersAmounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Level 1 To Level 2 Transfers Amounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel1ToLevel2TransfersAmounts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair Value Assets Level 1 To Level 2 Transfers Amounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredRevenueVertexMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred revenue - Vertex.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredRevenueVertexMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue Vertex [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredRevenueVertexMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Revenue - Vertex</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesCPreferredStockPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C preferred stock purchase agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesCPreferredStockPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Preferred Stock Purchase Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesCPreferredStockPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C SPA</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in Accounts Receivable, Contract Asset and Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accumulated amortization.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average common shares outstanding, basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Finance Lease, Liability, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Present value of lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding at beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LatestTaxYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Latest Tax Year [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LatestTaxYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Latest Tax Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in operating lease liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CostReimbursementPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost reimbursement payment received.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CostReimbursementPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost Reimbursement Payment Received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CostReimbursementPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost reimbursement payment received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Stock Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting discounts, offering costs and issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unvested Restricted Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum number of shares to be issued, percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Marketable securities, remaining maturity period classified as non-current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities Remaining Maturity Period Classified As Non Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities, remaining maturity period classified as non-current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Liabilities, Goodwill and Intangible Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Fixed and intangible assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average fair value of options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Federal net operating loss carryovers, not subject to expiration.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Federal Net Operating Loss Carryovers Not Subject To Expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carryovers, not subject to expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate fair value of available-for-sale debt securities, continuous unrealized loss position for less than 12 months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Interest Payment on Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash flows used in finance leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options granted in period intrinsic value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock into common, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accounts Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of net loss to net loss attributable to common stockholders:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncomeTaxDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncomeTaxDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncomeTaxDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders Anti-Diluted Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Restricted Cash, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Office Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Valuation Allowance, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Shares Converted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of preferred Stock converted to common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of December 31, 2021 and 2020; 0 shares issued and outstanding as of December 31, 2021 and 2020</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LabAndOfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lab and office equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LabAndOfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lab And Office Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LabAndOfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lab and Office Equipment Under and Financing Right of Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest Income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Interest and other income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Lease, Liability, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Present value of lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesserOfPotentialOutcomeOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lesser of potential outcome one.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesserOfPotentialOutcomeOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lesser Of Potential Outcome One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesserOfPotentialOutcomeOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lesser of Potential Outcome 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant Date Fair Value per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment losses on long-lived assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock, issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total minimum lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FederalAndStateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Federal and state.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FederalAndStateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Federal And State [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FederalAndStateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal and State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RemainingResearchTermOfCollaboration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Remaining research term of collaboration.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RemainingResearchTermOfCollaboration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Remaining Research Term Of Collaboration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RemainingResearchTermOfCollaboration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining research term of collaboration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PriorNoticePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prior notice period, minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PriorNoticePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prior notice period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PriorNoticePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prior notice period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of stock, shares issued and outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Loss Contingency Accrual, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Loss Contingency Accrual, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Accrual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities accrued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase of valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in operating lease right-of-use assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Lease Right Of Use Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Operating lease right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Lease Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_OfferingCostsIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Offering costs included in accounts payable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_OfferingCostsIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Offering Costs Included In Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_OfferingCostsIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering costs included in accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive loss:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201409Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201409Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Topic 606</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable at December 31, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from stock option exercises</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from sale of common stock in public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Preferred Stock, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GranteeStatusAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grantee Status [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GranteeStatusAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grantee Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MilestoneReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone receivable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MilestoneReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MilestoneReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Property and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_WatertownMassachusettsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Watertown, Massachusetts.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_WatertownMassachusettsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Watertown Massachusetts [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_WatertownMassachusettsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Watertown, Massachusetts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rent expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyNatureDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency, Nature [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyNatureDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingency, Nature</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseTerminationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease termination date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseTerminationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Termination Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseTerminationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease termination date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ProceedsFromConcurrentPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from concurrent private placement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ProceedsFromConcurrentPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Concurrent Private Placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ProceedsFromConcurrentPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from concurrent private placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_OperatingLeasePaymentsProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash flows used in operating leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_OperatingLeasePaymentsProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease payments (proceeds).</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_OperatingLeasePaymentsProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Payments Proceeds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average common shares outstanding, diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued upon exchange of Series A convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity, exchange of convertible preferred stock, shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Exchange Of Convertible Preferred Stock Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity, Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other non-current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Tax Expense (Benefit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationAgreementTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration agreement transaction price.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationAgreementTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration Agreement Transaction Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationAgreementTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration agreement transaction price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LabEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lab equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LabEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lab Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LabEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lab Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Tax Assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Tax Deferred Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accruals and reserves, stock and other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OpenTaxYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Open Tax Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OpenTaxYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Open tax year subject to examination</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Shares Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesB1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B1 preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesB1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B1 Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesB1PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B-1 Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unsatisfied performance obligation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-funded warrants per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accelerated Share Repurchases, Initial Price Paid Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2018 stock option and grant plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Eighteen Stock Option And Grant Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adoption Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting standards update, adoption date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of shares, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarliestTaxYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earliest Tax Year [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarliestTaxYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earliest Tax Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TenantIncentiveAllowanceReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tenant incentive allowance receivable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TenantIncentiveAllowanceReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tenant Incentive Allowance Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TenantIncentiveAllowanceReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tenant incentive allowance receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized recorded in deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt securities, available-for-sale, contractual maturity of 12 months or longer, number of securities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of available-for-sale debt securities, contractual maturity of greater than 12 months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other non-current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital related to temporary equity deemed dividend.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Related To Temporary Equity Deemed Dividend</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Reduction of additional paid-in-capital related to temporary equity deemed dividend</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Common Stock, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Common Stock, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Temporary Equity, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Temporary Equity, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLeasehold_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment of Leasehold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLeasehold_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reduction of right-of-use asset and liability due to lease modification</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Professional fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Restricted Stock Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Marketable Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Noncurrent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale and Maturity of Marketable Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturities of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_EmergingGrowthCompanyStatusPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Emerging growth company status.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_EmergingGrowthCompanyStatusPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Emerging Growth Company Status Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_EmergingGrowthCompanyStatusPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Emerging Growth Company Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_StockIssuedDuringPeriodSharesRestrictedStockVested_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period shares restricted stock vested.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_StockIssuedDuringPeriodSharesRestrictedStockVested_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Restricted Stock Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_StockIssuedDuringPeriodSharesRestrictedStockVested_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting Restricted Stock, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesseeOperatingAndFinanceLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating and finance leases.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesseeOperatingAndFinanceLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating And Finance Leases [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesseeOperatingAndFinanceLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NetOperatingLossBeginToExpireYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">NOLs begin to expire year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NetOperatingLossBeginToExpireYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Begin To Expire Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NetOperatingLossBeginToExpireYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NOLs begin to expire year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable at December 31, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableforsaleSecuritiesSoldAtPar_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Sold at Par Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableforsaleSecuritiesSoldAtPar_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities (Note 4)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investor [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investor</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock, authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value; 150,000,000 shares authorized at December 31, 2022 and 2021, 55,039,380 and 51,573,924 shares issued at December 31, 2022 and 2021, respectively; 55,039,380 and 51,536,181 shares outstanding at December 31, 2022 and 2021, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2020 stock option and incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Stock Option And Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized (loss) gain on marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ConvertiblePreferredStockPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ConvertiblePreferredStockPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ConvertiblePreferredStockPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Tax Examination, Penalties and Interest Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated interest or penalties recognized on uncertain tax positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201613Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201613Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2016-13</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Contract with Customer, Liability, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Contract Liabilities, Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Contract Liabilities, Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Property and equipment purchases included in accounts payable and accrued expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment purchases included in accounts payable and accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock issued during period shares new issues.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Shares New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Series B-1 Preferred Stock, net of issuance costs of $49, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense):</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PreferredStockIssuancePremium_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock issuance premium.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PreferredStockIssuancePremium_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Issuance Premium</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PreferredStockIssuancePremium_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock premium</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value of available-for-sale debt securities contractual maturity of less than twelve months.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of available-for-sale debt securities, contractual maturity of less than 12 months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LetterOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Letter of Credit [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LetterOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Letter of Credit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Area of Real Estate Property</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Area of office space</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Leases, Rent Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Rent Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Base rent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CommercialMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commercial milestone payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CommercialMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Milestone Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CommercialMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Units Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxPeriodDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Period [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxPeriodDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerAssetNetDeductions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable and contract assets, Deductions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerAssetNetDeductions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer asset net deductions.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerAssetNetDeductions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Asset Net Deductions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerAssetNetDeductions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable and contract assets, Deductions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProjectMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Project [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProjectMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Project</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CommonAndPreferredStockValuationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common and preferred stock valuation.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CommonAndPreferredStockValuationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common And Preferred Stock Valuation Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CommonAndPreferredStockValuationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common and Preferred Stock Valuation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CostReimbursementReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost reimbursement receivable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CostReimbursementReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost Reimbursement Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CostReimbursementReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost reimbursement receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of weighted average remaining lease terms and discount rates.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Weighted Average Remaining Lease Terms And Discount Rates Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Weighted Average Remaining Lease Terms and Discount Rates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid In Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Dividends, Adjustment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deemed dividend from exchange of convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deemed dividend from exchange of convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RestrictedCashFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash fair value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RestrictedCashFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RestrictedCashFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesCConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesCConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesCConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesCConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series C Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Weighted-Average Assumptions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net (Note 6)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization expense related to right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award aggregate intrinsic value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Aggregate Intrinsic Value [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_InitialResearchTermOfCollaboration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Initial research term of collaboration.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_InitialResearchTermOfCollaboration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial Research Term Of Collaboration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_InitialResearchTermOfCollaboration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial research term of collaboration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity By Class Of Stock [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerLiabilityDeductions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability deductions.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerLiabilityDeductions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Deductions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerLiabilityDeductions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract Liabilities, Deductions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Premiums and discounts on available for sale marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Premiums and discounts on available for sale marketable securities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Premiums And Discounts On Available For Sale Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MinimumPreFundedWarrantsExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum pre-funded warrants, exercise</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MinimumPreFundedWarrantsExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum pre-funded warrants, exercise</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MinimumPreFundedWarrantsExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum pre-funded warrants, exercise</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Revenue from Contract with Customer, Excluding Assessed Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration Revenue&#8212;from related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenue recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less amounts representing interest or imputed interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NonCashResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non cash research and development expense.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NonCashResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Cash Research And Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NonCashResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash research and development expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_VertexAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Vertex Agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_VertexAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vertex Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_VertexAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vertex Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">US government agencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">US government agency securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-funded warrants outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SanofiCollaborationArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sanofi collaboration arrangement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SanofiCollaborationArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sanofi Collaboration Arrangement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SanofiCollaborationArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sanofi Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total equity-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments of Financing Costs, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Financing Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payments on financing leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_BilledReceivablesSanofiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Billed receivables - Sanofi.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_BilledReceivablesSanofiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Billed Receivables Sanofi [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_BilledReceivablesSanofiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Billed Receivables - Sanofi</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesBConvertiblePreferredStocksMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesBConvertiblePreferredStocksMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Convertible Preferred Stocks [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesBConvertiblePreferredStocksMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateBondSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Bond Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateBondSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Bonds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_VertexPharmaceuticalsIncorporatedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Vertex Pharmaceuticals Incorporated.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_VertexPharmaceuticalsIncorporatedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vertex Pharmaceuticals Incorporated [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_VertexPharmaceuticalsIncorporatedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vertex Pharmaceuticals Incorporated</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance lease liabilities, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Securities [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation cost, recognition period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value By Balance Sheet Grouping [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of business and summary of significant accounting policies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description Of Business And Summary Of Significant Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Contract asset-due from related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in contract with customer asset related parties.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Contract With Customer Asset Related Parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock, outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Over-Allotment Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriters</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal research and development credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IRAK4Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">IRAK4.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IRAK4Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">I R A K4 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IRAK4Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IRAK4 Program</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 9)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">US Treasuries</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">U.S. Treasury Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationRevenuesFromRelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration Revenues From Related Party [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationRevenuesFromRelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration revenue from related party.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of business and summary of significant accounting policies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description Of Business And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description Of Business And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel3ToLevel2TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value assets level 3 to level 2 transfers amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel3ToLevel2TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Level3 To Level2 Transfers Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel3ToLevel2TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value assets, level 3 to level 2 transfers, amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt securities available for sale decline in market value for unrealized loss position number of securities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of securities decline in market value for in an unrealized loss position</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ExtendedResearchTermOfCollaboration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Extended research term of collaboration.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ExtendedResearchTermOfCollaboration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Extended Research Term Of Collaboration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ExtendedResearchTermOfCollaboration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Extended research term of collaboration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Supplemental disclosure of noncash operating activities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Disclosure Of Noncash Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of noncash operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GranteeStatusDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grantee Status [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GranteeStatusDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grantee Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable at December 31, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses (Note 8)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseAdditionalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease additional term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseAdditionalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Additional Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseAdditionalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease additional term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase in accumulated deficit related to temporary equity deemed dividend.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase In Accumulated Deficit Related To Temporary Equity Deemed Dividend</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in accumulated deficit related to temporary equity deemed dividend</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exchange of convertible preferred stock impact on equity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exchange Of Convertible Preferred Stock Impact On Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty stock option and grant plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Stock Option And Grant Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PotentialReceivableMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Potential receivable milestone payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PotentialReceivableMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Potential Receivable Milestone Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_PotentialReceivableMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Eligible to receive payments including development, regulatory and commercial milestones</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Contract with Customer, Receivable, after Allowance for Credit Loss, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Receivable, after Allowance for Credit Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accounts receivable and contract assets, Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accounts receivable and contract assets, Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Intrinsic value of stock options exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerAssetNetAdditions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer asset net additions.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerAssetNetAdditions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Asset Net Additions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerAssetNetAdditions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable and contract assets, Additions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Private Placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate proceeds from issuance of private placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate fair value of available-for-sale debt securities, continuous unrealized loss position for greater than 12 months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than 12 Months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than 12 Months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total minimum lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases original term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RoyaltyReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty receivable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RoyaltyReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RoyaltyReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesserOfPotentialOutcomeTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lesser of potential outcome two.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesserOfPotentialOutcomeTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lesser Of Potential Outcome Two [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesserOfPotentialOutcomeTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lesser of Potential Outcome 2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Marketable Securities, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities, non-current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Description and Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Business and Summary of Significant Accounting Policies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Disclosure [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating and financing lease liability maturity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating And Financing Lease Liability Maturity Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Undiscounted Future Lease Payments for Operating and Finance Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TenantImprovementReceivableIncludedInOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tenant improvement receivable included in other assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TenantImprovementReceivableIncludedInOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tenant Improvement Receivable Included In Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TenantImprovementReceivableIncludedInOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tenant improvement receivable included in other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ProceedsFromIssuanceInitialPublicOfferingGross_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance initial public offering gross.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ProceedsFromIssuanceInitialPublicOfferingGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Initial Public Offering Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ProceedsFromIssuanceInitialPublicOfferingGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross proceeds from issuance initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less accumulated depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing lease, discount rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of business and summary of significant accounting policies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description Of Business And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description Of Business And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares remaining available for future grants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series B Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding at beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_UnbilledReceivablesSanofiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unbilled receivables - Sanofi.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_UnbilledReceivablesSanofiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unbilled Receivables Sanofi [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_UnbilledReceivablesSanofiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unbilled Receivables - Sanofi</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Principal Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing cash flows used in finance leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NoncancelableFacilityLeaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncancelable facility lease agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NoncancelableFacilityLeaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncancelable Facility Lease Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NoncancelableFacilityLeaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncancelable Facility Lease Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Deposit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security deposit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FinancingCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Financing costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FinancingCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Costs Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FinancingCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BilledContractReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Billed Contracts Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BilledContractReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Billed accounts receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock and accompanying pre-funded warrants from private placement, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Fund</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gain (Loss) on Disposition of Property Plant Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on disposal of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on disposal of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Property and equipment right of use assets under financing leases with cost basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel2ToLevel1TransfersAmounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Level 2 To Level 1Transfers Amounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel2ToLevel1TransfersAmounts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair Value Assets Level 2 To Level 1Transfers Amounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series seed convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series Seed Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesSeedConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series Seed Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable due from related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Due from Related Parties, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Due from Related Parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-funded warrants, exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Repurchase of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerLiabilityAdditions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability additions.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerLiabilityAdditions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Additions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ContractWithCustomerLiabilityAdditions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract Liabilities, Additions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AssetsNotYetInServiceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Assets not yet in service.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AssetsNotYetInServiceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Not Yet In Service [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AssetsNotYetInServiceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets Not Yet in Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock at Private Placement, net of issuance cost, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of Common Stock at Private Placement, net of issuance cost, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock, outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Temporary Equity, Beginning Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Temporary Equity, Ending Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Available-for-sale Securities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available-for-Sale Securities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from initial public offering, net of underwriting discounts and offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax effect at statutory rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective income tax rate reconciliation permanent differences.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Permanent Differences</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Permanent differences</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unrecognized Tax Benefits, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unrecognized Tax Benefits, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reserves for uncertain tax positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of available-for-sale debt securities, continuous unrealized loss position for less than 12 months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Basic and Diluted Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reduction of right of use asset and liability due to lease modification.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reduction Of Right Of Use Asset And Liability Due To Lease Modification</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reduction of right-of-use asset and liability due to lease modification</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation vesting period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable at December 31, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Liquidation Preference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock, liquidation preference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IPO [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IPO</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the issuance of Convertible Preferred Stock, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from issuance of convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Available-for-sale Securities, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available-for-Sale Securities, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Liabilities, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other non-current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reverse stock split</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CambridgeMassachusettsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cambridge, Massachusetts.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CambridgeMassachusettsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cambridge Massachusetts [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CambridgeMassachusettsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cambridge, Massachusetts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCurrentAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Current Assets [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCurrentAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unvested at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unvested at beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Prepaid Expense and Other Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding at beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Marketable Securities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options forfeited in period intrinsic value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ScenarioPotentialOutcomeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Scenario potential outcome.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ScenarioPotentialOutcomeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario Potential Outcome [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ScenarioPotentialOutcomeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario Potential Outcome</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Strike Price Per Option</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndemnificationGuaranteeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Indemnification Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndemnificationGuaranteeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Indemnified Parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease commencement date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Commencement Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_LeaseCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease commencement date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accrued Liabilities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets lease liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FacilitySubleaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Facility sublease agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FacilitySubleaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Facility Sublease Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FacilitySubleaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Facility Sublease Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Deferred Income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B-1 convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B1 Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesB1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B-1 Convertible Preferred</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesAPreferredUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A Preferred Units.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesAPreferredUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Preferred Units [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SeriesAPreferredUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Preferred Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationTargetOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration target one.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationTargetOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration Target One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationTargetOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration Target 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-funded warrant purchase price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities right-of-use assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Right Of Use Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralPartnersOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralPartnersOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General Partners' Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities, non-current (Note 4)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fair value of available-for-sale debt securities, contractual maturity of greater than 12 months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Follow-on offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Follow On Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Follow-on Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Significant Components of Net Deferred Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from follow-on public offering, net of underwriting discounts and offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from follow on offering, net of underwriting discounts and offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from follow on offering, net of underwriting discounts and offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt securities, available-for-sale, contractual maturity of less than 12 months, number of securities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of available-for-sale debt securities, contractual maturity of less than 12 months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RestrictedCashMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RestrictedCashMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_RestrictedCashMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsAndCash_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Investments and Cash, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsAndCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments and Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsAndCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, cash equivalents and marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease term remaining</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Salaries, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payroll and payroll-related</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IssuanceOfVestedRestrictedStockToConsultants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of vested restricted stock to consultants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IssuanceOfVestedRestrictedStockToConsultants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Vested Restricted Stock to Consultants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IssuanceOfVestedRestrictedStockToConsultants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of vested restricted stock to consultants, Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2020 Employee stock purchase plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Employee Stock Purchase Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 ESPP</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest and other expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredRevenueSanofiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred revenue - Sanofi.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredRevenueSanofiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue Sanofi [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DeferredRevenueSanofiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Revenue - Sanofi</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock shares vesting of series A preferred stock in connection with collaboration arrangement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Shares Vesting Of Series A Preferred Stock In Connection With Collaboration Arrangement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting of Series A Preferred Stock in connection with collaboration arrangement (Note 5), Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SegmentAndGeographicInformationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Segment and geographic information.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SegmentAndGeographicInformationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment And Geographic Information Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SegmentAndGeographicInformationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment and Geographic Information</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gain on marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AccruedResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development expenses current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AccruedResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Expenses Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_AccruedResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Costs associated with license and collaborative arrangements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Costs Associated With License And Collaborative Arrangements Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Costs Associated with License and Collaborative Arrangements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Equity-Based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by (used in) investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furnitures and Fixtures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Furniture &amp; Fixtures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of Stock Options, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityListingParValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Listing, Par Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityListingParValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Listing, Par Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Inputs, Level 3</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationTerminationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration termination date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationTerminationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration Termination Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CollaborationTerminationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration termination date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_WrittenNoticePeriodToTerminateCollaborationAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Written notice period to terminate collaboration agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_WrittenNoticePeriodToTerminateCollaborationAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Notice Period To Terminate Collaboration Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_WrittenNoticePeriodToTerminateCollaborationAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written notice period to terminate collaboration agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock at Private Placement, net of issuance cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of Common Stock at Private Placement, net of issuance cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CompoundCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Compound Collaboration Agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CompoundCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Compound Collaboration Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_CompoundCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Compound Collaboration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated useful life of related asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NumberOfMarketableSecuritiesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of marketable securities sold.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NumberOfMarketableSecuritiesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Marketable Securities Sold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_NumberOfMarketableSecuritiesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of marketable securities sold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity, exchange of convertible preferred stock, value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Exchange Of Convertible Preferred Stock Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity, Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of estimated useful life of related asset.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Estimated Useful Life Of Related Asset Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Estimated Useful Life of Related Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Available-for-Sale Debt Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Off balance sheet risk and concentration of credit risk.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Off Balance Sheet Risk And Concentration Of Credit Risk Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Off Balance Sheet Risk and Concentration of Credit Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Marketable securities, remaining maturity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities Remaining Maturity Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_MarketableSecuritiesRemainingMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities, remaining maturity period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel2ToLevel3TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value assets level 2 to Level 3 transfers amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel2ToLevel3TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Level2 To Level3 Transfers Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_FairValueAssetsLevel2ToLevel3TransfersAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value assets, level 2 to level 3 transfers, amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Supplemental cash flow information relating to leases.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information Relating To Leases Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental Cash Flow Information Relating to Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Project [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Project</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of available-for-sale debt securities, continuous unrealized loss position for greater than 12 months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">DebtSecuritiesAvailableForSale Continuous Unrealized Loss Position Greater Than 12 Months Number Of Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">DebtSecuritiesAvailableForSale Continuous Unrealized Loss Position Greater Than 12 Months Number Of Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_BaseRentAnnualIncreaseOverTheLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Base rent annual increase over the lease term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_BaseRentAnnualIncreaseOverTheLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Base Rent Annual Increase Over The Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="kymr_BaseRentAnnualIncreaseOverTheLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual increase percentage of rent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable lease costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock into common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue remaining research term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Estimated Useful Lives</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated useful life of related asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of additional shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anti-dilutive stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other non-current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of noncash investing and financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedPartiesCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_RentalAndLeaseExpenses" xlink:to="kymr_RentalAndLeaseExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnbilledContractsReceivable" xlink:to="us-gaap_UnbilledContractsReceivable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_RestrictedCashPolicyPolicyTextBlock" xlink:to="kymr_RestrictedCashPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FairValueAssetsLevel1ToLevel3TransfersAmount" xlink:to="kymr_FairValueAssetsLevel1ToLevel3TransfersAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ResearchAndDevelopmentCreditCarryforwards" xlink:to="kymr_ResearchAndDevelopmentCreditCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_PatentCostsPolicyTextBlock" xlink:to="kymr_PatentCostsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_UpfrontPayment" xlink:to="kymr_UpfrontPayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_NonRefundableUpfrontPaymentReceived" xlink:to="kymr_NonRefundableUpfrontPaymentReceived_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_PrivateInvestmentInPublicEquityPipeMember" xlink:to="kymr_PrivateInvestmentInPublicEquityPipeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201912Member" xlink:to="us-gaap_AccountingStandardsUpdate201912Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ScenarioPotentialOutcomeDomain" xlink:to="kymr_ScenarioPotentialOutcomeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IncreaseOrDecreasePreFundedWarrants" xlink:to="kymr_IncreaseOrDecreasePreFundedWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DevelopmentMilestonePayments" xlink:to="kymr_DevelopmentMilestonePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="us-gaap_ProceedsFromStockPlans_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_StockIssuedDuringPeriodValueRestrictedStockVested" xlink:to="kymr_StockIssuedDuringPeriodValueRestrictedStockVested_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities" xlink:to="kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="us-gaap_ContractWithCustomerAssetNetCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CollaborationTargetTwoMember" xlink:to="kymr_CollaborationTargetTwoMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FairValueAssetsLevel3ToLevel1TransfersAmount" xlink:to="kymr_FairValueAssetsLevel3ToLevel1TransfersAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:to="us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" xlink:to="kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FairValueAssetsLevel1ToLevel2TransfersAmounts" xlink:to="kymr_FairValueAssetsLevel1ToLevel2TransfersAmounts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DeferredRevenueVertexMember" xlink:to="kymr_DeferredRevenueVertexMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SeriesCPreferredStockPurchaseAgreementMember" xlink:to="kymr_SeriesCPreferredStockPurchaseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_AccumulatedAmortization" xlink:to="kymr_AccumulatedAmortization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_MarketableSecuritiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LatestTaxYearMember" xlink:to="us-gaap_LatestTaxYearMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="kymr_IncreaseDecreaseInOperatingLeaseLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CostReimbursementPaymentReceived" xlink:to="kymr_CostReimbursementPaymentReceived_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent" xlink:to="kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration" xlink:to="kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="us-gaap_FinanceLeaseInterestPaymentOnLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:to="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IncomeTaxDisclosureLineItems" xlink:to="kymr_IncomeTaxDisclosureLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_LabAndOfficeEquipmentMember" xlink:to="kymr_LabAndOfficeEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_OtherNonoperatingIncome_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_LesserOfPotentialOutcomeOneMember" xlink:to="kymr_LesserOfPotentialOutcomeOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FederalAndStateMember" xlink:to="kymr_FederalAndStateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_RemainingResearchTermOfCollaboration" xlink:to="kymr_RemainingResearchTermOfCollaboration_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_PriorNoticePeriod" xlink:to="kymr_PriorNoticePeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:to="kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesTable" xlink:to="kymr_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_OfferingCostsIncludedInAccountsPayable" xlink:to="kymr_OfferingCostsIncludedInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201409Member" xlink:to="us-gaap_AccountingStandardsUpdate201409Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GranteeStatusAxis" xlink:to="us-gaap_GranteeStatusAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_MilestoneReceivable" xlink:to="kymr_MilestoneReceivable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_WatertownMassachusettsMember" xlink:to="kymr_WatertownMassachusettsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_LossContingencyNatureDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_LeaseTerminationDate" xlink:to="kymr_LeaseTerminationDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ProceedsFromConcurrentPrivatePlacement" xlink:to="kymr_ProceedsFromConcurrentPrivatePlacement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_OperatingLeasePaymentsProceeds" xlink:to="kymr_OperatingLeasePaymentsProceeds_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares" xlink:to="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CollaborationAgreementTransactionPrice" xlink:to="kymr_CollaborationAgreementTransactionPrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_LabEquipmentMember" xlink:to="kymr_LabEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OpenTaxYear" xlink:to="us-gaap_OpenTaxYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SeriesB1PreferredStockMember" xlink:to="kymr_SeriesB1PreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:to="us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember" xlink:to="kymr_TwoThousandEighteenStockOptionAndGrantPlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarliestTaxYearMember" xlink:to="us-gaap_EarliestTaxYearMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_TenantIncentiveAllowanceReceivable" xlink:to="kymr_TenantIncentiveAllowanceReceivable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities" xlink:to="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend" xlink:to="kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLeasehold" xlink:to="us-gaap_ImpairmentOfLeasehold_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:to="kymr_EmergingGrowthCompanyStatusPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_StockIssuedDuringPeriodSharesRestrictedStockVested" xlink:to="kymr_StockIssuedDuringPeriodSharesRestrictedStockVested_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_LesseeOperatingAndFinanceLeasesTextBlock" xlink:to="kymr_LesseeOperatingAndFinanceLeasesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_NetOperatingLossBeginToExpireYear" xlink:to="kymr_NetOperatingLossBeginToExpireYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableforsaleSecuritiesSoldAtPar" xlink:to="us-gaap_AvailableforsaleSecuritiesSoldAtPar_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember" xlink:to="kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ConvertiblePreferredStockPolicyTextBlock" xlink:to="kymr_ConvertiblePreferredStockPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201613Member" xlink:to="us-gaap_AccountingStandardsUpdate201613Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses" xlink:to="kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_PreferredStockIssuancePremium" xlink:to="kymr_PreferredStockIssuancePremium_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths" xlink:to="kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LetterOfCreditMember" xlink:to="us-gaap_LetterOfCreditMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CommercialMilestonePayments" xlink:to="kymr_CommercialMilestonePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_TaxPeriodDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ContractWithCustomerAssetNetDeductions" xlink:to="kymr_ContractWithCustomerAssetNetDeductions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProjectMember" xlink:to="us-gaap_ProjectMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CommonAndPreferredStockValuationPolicyTextBlock" xlink:to="kymr_CommonAndPreferredStockValuationPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CostReimbursementReceivable" xlink:to="kymr_CostReimbursementReceivable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock" xlink:to="kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDividendsAdjustment" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_RestrictedCashFairValue" xlink:to="kymr_RestrictedCashFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SeriesCConvertiblePreferredStockMember" xlink:to="kymr_SeriesCConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SeriesAConvertiblePreferredStockMember" xlink:to="kymr_SeriesAConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract" xlink:to="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_InitialResearchTermOfCollaboration" xlink:to="kymr_InitialResearchTermOfCollaboration_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ContractWithCustomerLiabilityDeductions" xlink:to="kymr_ContractWithCustomerLiabilityDeductions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities" xlink:to="kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_MinimumPreFundedWarrantsExercise" xlink:to="kymr_MinimumPreFundedWarrantsExercise_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_NonCashResearchAndDevelopmentExpense" xlink:to="kymr_NonCashResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_VertexAgreementMember" xlink:to="kymr_VertexAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SanofiCollaborationArrangementMember" xlink:to="kymr_SanofiCollaborationArrangementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_BilledReceivablesSanofiMember" xlink:to="kymr_BilledReceivablesSanofiMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SeriesBConvertiblePreferredStocksMember" xlink:to="kymr_SeriesBConvertiblePreferredStocksMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateBondSecuritiesMember" xlink:to="us-gaap_CorporateBondSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_VertexPharmaceuticalsIncorporatedMember" xlink:to="kymr_VertexPharmaceuticalsIncorporatedMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract" xlink:to="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties" xlink:to="kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IRAK4Member" xlink:to="kymr_IRAK4Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CollaborationRevenuesFromRelatedPartyMember" xlink:to="kymr_CollaborationRevenuesFromRelatedPartyMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FairValueAssetsLevel3ToLevel2TransfersAmount" xlink:to="kymr_FairValueAssetsLevel3ToLevel2TransfersAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities" xlink:to="kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ExtendedResearchTermOfCollaboration" xlink:to="kymr_ExtendedResearchTermOfCollaboration_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract" xlink:to="kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GranteeStatusDomain" xlink:to="us-gaap_GranteeStatusDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_LeaseAdditionalTerm" xlink:to="kymr_LeaseAdditionalTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend" xlink:to="kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity" xlink:to="kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember" xlink:to="kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_PotentialReceivableMilestonePayments" xlink:to="kymr_PotentialReceivableMilestonePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" xlink:to="us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ContractWithCustomerAssetNetAdditions" xlink:to="kymr_ContractWithCustomerAssetNetAdditions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months" xlink:to="kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_RoyaltyReceivable" xlink:to="kymr_RoyaltyReceivable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_LesserOfPotentialOutcomeTwoMember" xlink:to="kymr_LesserOfPotentialOutcomeTwoMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IncomeTaxDisclosureTable" xlink:to="kymr_IncomeTaxDisclosureTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_LeaseTerm" xlink:to="kymr_LeaseTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock" xlink:to="kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_TenantImprovementReceivableIncludedInOtherAssets" xlink:to="kymr_TenantImprovementReceivableIncludedInOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ProceedsFromIssuanceInitialPublicOfferingGross" xlink:to="kymr_ProceedsFromIssuanceInitialPublicOfferingGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SeriesBConvertiblePreferredStockMember" xlink:to="kymr_SeriesBConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_UnbilledReceivablesSanofiMember" xlink:to="kymr_UnbilledReceivablesSanofiMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeasePrincipalPayments" xlink:to="us-gaap_FinanceLeasePrincipalPayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_NoncancelableFacilityLeaseAgreementMember" xlink:to="kymr_NoncancelableFacilityLeaseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FinancingCostsPolicyTextBlock" xlink:to="kymr_FinancingCostsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BilledContractReceivables" xlink:to="us-gaap_BilledContractReceivables_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts" xlink:to="kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FairValueAssetsLevel2ToLevel1TransfersAmounts" xlink:to="kymr_FairValueAssetsLevel2ToLevel1TransfersAmounts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SeriesSeedConvertiblePreferredStockMember" xlink:to="kymr_SeriesSeedConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfWarrants" xlink:to="us-gaap_PaymentsForRepurchaseOfWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ContractWithCustomerLiabilityAdditions" xlink:to="kymr_ContractWithCustomerLiabilityAdditions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_AssetsNotYetInServiceMember" xlink:to="kymr_AssetsNotYetInServiceMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares" xlink:to="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:to="kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification" xlink:to="kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesNoncurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CambridgeMassachusettsMember" xlink:to="kymr_CambridgeMassachusettsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsMember" xlink:to="us-gaap_OtherCurrentAssetsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue" xlink:to="kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ScenarioPotentialOutcomeAxis" xlink:to="kymr_ScenarioPotentialOutcomeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndemnificationGuaranteeMember" xlink:to="us-gaap_IndemnificationGuaranteeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_LeaseCommencementDate" xlink:to="kymr_LeaseCommencementDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DeferredTaxAssetsLeaseLiabilities" xlink:to="kymr_DeferredTaxAssetsLeaseLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FacilitySubleaseAgreementMember" xlink:to="kymr_FacilitySubleaseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SeriesB1ConvertiblePreferredStockMember" xlink:to="kymr_SeriesB1ConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SeriesAPreferredUnitsMember" xlink:to="kymr_SeriesAPreferredUnitsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CollaborationTargetOneMember" xlink:to="kymr_CollaborationTargetOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="kymr_DeferredTaxLiabilitiesRightOfUseAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralPartnersOfferingCosts" xlink:to="us-gaap_GeneralPartnersOfferingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FollowOnOfferingMember" xlink:to="kymr_FollowOnOfferingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts" xlink:to="kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities" xlink:to="kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_RestrictedCashMember" xlink:to="kymr_RestrictedCashMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAndCash" xlink:to="us-gaap_InvestmentsAndCash_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IssuanceOfVestedRestrictedStockToConsultants" xlink:to="kymr_IssuanceOfVestedRestrictedStockToConsultants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:to="kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DeferredRevenueSanofiMember" xlink:to="kymr_DeferredRevenueSanofiMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement" xlink:to="kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SegmentAndGeographicInformationPolicyTextBlock" xlink:to="kymr_SegmentAndGeographicInformationPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_AccruedResearchAndDevelopmentExpensesCurrent" xlink:to="kymr_AccruedResearchAndDevelopmentExpensesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock" xlink:to="kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingParValuePerShare" xlink:to="dei_EntityListingParValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CollaborationTerminationDate" xlink:to="kymr_CollaborationTerminationDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_WrittenNoticePeriodToTerminateCollaborationAgreement" xlink:to="kymr_WrittenNoticePeriodToTerminateCollaborationAgreement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost" xlink:to="kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_CompoundCollaborationAgreementMember" xlink:to="kymr_CompoundCollaborationAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_NumberOfMarketableSecuritiesSold" xlink:to="kymr_NumberOfMarketableSecuritiesSold_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue" xlink:to="kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock" xlink:to="kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock" xlink:to="kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_MarketableSecuritiesRemainingMaturityPeriod" xlink:to="kymr_MarketableSecuritiesRemainingMaturityPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_FairValueAssetsLevel2ToLevel3TransfersAmount" xlink:to="kymr_FairValueAssetsLevel2ToLevel3TransfersAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock" xlink:to="kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions" xlink:to="kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kymr_BaseRentAnnualIncreaseOverTheLeaseTerm" xlink:to="kymr_BaseRentAnnualIncreaseOverTheLeaseTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822139442144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 17, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KYMR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">KYMERA THERAPEUTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001815442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,183,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 792,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-2992166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 Arsenal Yards Blvd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Watertown<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">285-5300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portions of the registrant&#8217;s Proxy Statement for its 2023 Annual Meeting of Stockholders, which the registrant intends to file with the Securities and Exchange Commission not later</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">than 120 days after the registrant&#8217;s fiscal year ended December 31, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingParValuePerShare', window );">Entity Listing, Par Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822140141440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 68,395<span></span>
</td>
<td class="nump">$ 47,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities (Note 4)</a></td>
<td class="nump">338,771<span></span>
</td>
<td class="nump">394,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets-due from related party</a></td>
<td class="nump">2,537<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">9,713<span></span>
</td>
<td class="nump">8,720<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">419,416<span></span>
</td>
<td class="nump">451,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Marketable securities, non-current (Note 4)</a></td>
<td class="nump">152,328<span></span>
</td>
<td class="nump">125,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net (Note 6)</a></td>
<td class="nump">13,334<span></span>
</td>
<td class="nump">11,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, operating leases</a></td>
<td class="nump">8,909<span></span>
</td>
<td class="nump">9,426<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">3,017<span></span>
</td>
<td class="nump">2,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">6,130<span></span>
</td>
<td class="nump">6,116<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">603,134<span></span>
</td>
<td class="nump">605,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">4,335<span></span>
</td>
<td class="nump">4,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses (Note 8)</a></td>
<td class="nump">27,502<span></span>
</td>
<td class="nump">22,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">35,260<span></span>
</td>
<td class="nump">61,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">2,535<span></span>
</td>
<td class="nump">2,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities</a></td>
<td class="nump">1,408<span></span>
</td>
<td class="nump">1,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">71,343<span></span>
</td>
<td class="nump">92,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">28,000<span></span>
</td>
<td class="nump">39,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">12,146<span></span>
</td>
<td class="nump">13,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">112,983<span></span>
</td>
<td class="nump">146,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 150,000,000 shares authorized at December 31, 2022 and 2021, 55,039,380 and 51,573,924 shares issued at December 31, 2022 and 2021, respectively; 55,039,380 and 51,536,181 shares outstanding at December 31, 2022 and 2021, respectively</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">878,884<span></span>
</td>
<td class="nump">689,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(383,790)<span></span>
</td>
<td class="num">(228,982)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(4,949)<span></span>
</td>
<td class="num">(660)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">490,151<span></span>
</td>
<td class="nump">459,638<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 603,134<span></span>
</td>
<td class="nump">$ 605,905<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822146127152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="nump">55,039,380<span></span>
</td>
<td class="nump">51,573,924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, outstanding</a></td>
<td class="nump">55,039,380<span></span>
</td>
<td class="nump">51,536,181<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822139458336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration Revenue&#8212;from related party</a></td>
<td class="nump">$ 46,826<span></span>
</td>
<td class="nump">$ 72,832<span></span>
</td>
<td class="nump">$ 34,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue from Contract with Customer, Product and Service [Extensible List]</a></td>
<td class="text">Collaboration Revenues From Related Party [Member]<span></span>
</td>
<td class="text">Collaboration Revenues From Related Party [Member]<span></span>
</td>
<td class="text">Collaboration Revenues From Related Party [Member]<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 164,248<span></span>
</td>
<td class="nump">$ 137,017<span></span>
</td>
<td class="nump">$ 62,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">43,834<span></span>
</td>
<td class="nump">36,345<span></span>
</td>
<td class="nump">18,233<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">208,082<span></span>
</td>
<td class="nump">173,362<span></span>
</td>
<td class="nump">80,338<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(161,256)<span></span>
</td>
<td class="num">(100,530)<span></span>
</td>
<td class="num">(46,304)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Interest and other income</a></td>
<td class="nump">6,624<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="nump">826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Interest and other expense</a></td>
<td class="num">(176)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="nump">6,448<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="nump">711<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(154,808)<span></span>
</td>
<td class="num">(100,217)<span></span>
</td>
<td class="num">(45,593)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized (loss) gain on marketable securities</a></td>
<td class="num">(4,289)<span></span>
</td>
<td class="num">(532)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">(159,097)<span></span>
</td>
<td class="num">(100,749)<span></span>
</td>
<td class="num">(45,727)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Reconciliation of net loss to net loss attributable to common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(154,808)<span></span>
</td>
<td class="num">(100,217)<span></span>
</td>
<td class="num">(45,593)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDividendsAdjustment', window );">Deemed dividend from exchange of convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,050)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (154,808)<span></span>
</td>
<td class="num">$ (100,217)<span></span>
</td>
<td class="num">$ (54,643)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (2.87)<span></span>
</td>
<td class="num">$ (2.09)<span></span>
</td>
<td class="num">$ (3.15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (2.87)<span></span>
</td>
<td class="num">$ (2.09)<span></span>
</td>
<td class="num">$ (3.15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted</a></td>
<td class="nump">53,933,229<span></span>
</td>
<td class="nump">47,989,023<span></span>
</td>
<td class="nump">17,349,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic</a></td>
<td class="nump">53,933,229<span></span>
</td>
<td class="nump">47,989,023<span></span>
</td>
<td class="nump">17,349,582<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDividendsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDividendsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822134996736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Private Placement</div></th>
<th class="th">
<div>Private Placement </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Private Placement </div>
<div>Additional Paid In Capital</div>
</th>
<th class="th"><div>IPO</div></th>
<th class="th">
<div>IPO </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>IPO </div>
<div>Additional Paid In Capital</div>
</th>
<th class="th"><div>Series Seed Convertible Preferred Stock</div></th>
<th class="th"><div>Series A Convertible Preferred Stock</div></th>
<th class="th"><div>Series B Convertible Preferred Stock</div></th>
<th class="th"><div>Series B-1 Convertible Preferred</div></th>
<th class="th"><div>Series C Convertible Preferred Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Temporary Equity, Beginning Balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="nump">$ 29,237<span></span>
</td>
<td class="nump">$ 59,918<span></span>
</td>
<td class="nump">$ 14,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Beginning Balance, Shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">14,720,126<span></span>
</td>
<td class="nump">14,827,580<span></span>
</td>
<td class="nump">3,059,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="num">$ (74,406)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="num">$ (76,456)<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,929,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement', window );">Vesting of Series A Preferred Stock in connection with collaboration arrangement (Note 5)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement', window );">Vesting of Series A Preferred Stock in connection with collaboration arrangement (Note 5), Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Preferred Stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series B-1 Preferred Stock, net of issuance costs of $49, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,182,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,539,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue', window );">Temporary Equity, Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,950)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares', window );">Temporary Equity, Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,988,802)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,988,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity', window );">Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock</a></td>
<td class="num">(9,050)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,334)<span></span>
</td>
<td class="num">(6,716)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of Stock Options</a></td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of Stock Options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_StockIssuedDuringPeriodValueRestrictedStockVested', window );">Vesting Restricted Stock</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_StockIssuedDuringPeriodSharesRestrictedStockVested', window );">Vesting Restricted Stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">5,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on marketable securities</a></td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,527<span></span>
</td>
<td class="nump">$ 182,748<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 182,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">676,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,987,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock into common stock</a></td>
<td class="nump">211,332<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">211,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,900)<span></span>
</td>
<td class="num">$ (25,509)<span></span>
</td>
<td class="num">$ (64,718)<span></span>
</td>
<td class="num">$ (14,025)<span></span>
</td>
<td class="num">$ (101,180)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock into common, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,625,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(12,842,112)<span></span>
</td>
<td class="num">(16,009,845)<span></span>
</td>
<td class="num">(3,059,695)<span></span>
</td>
<td class="num">(15,527,943)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(45,593)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,593)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">283,888<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">412,777<span></span>
</td>
<td class="num">(128,765)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,482,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of Stock Options</a></td>
<td class="nump">7,633<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">7,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of Stock Options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,431,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_StockIssuedDuringPeriodSharesRestrictedStockVested', window );">Vesting Restricted Stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">24,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on marketable securities</a></td>
<td class="num">(532)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(532)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,346<span></span>
</td>
<td class="nump">$ 240,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,468,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(100,217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee stock purchase plan, Value</a></td>
<td class="nump">788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee stock purchase plan, Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IssuanceOfVestedRestrictedStockToConsultants', window );">Issuance of vested restricted stock to consultants, Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="nump">459,638<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">689,275<span></span>
</td>
<td class="num">(228,982)<span></span>
</td>
<td class="num">(660)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,536,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of Stock Options</a></td>
<td class="nump">3,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of Stock Options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">601,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_StockIssuedDuringPeriodSharesRestrictedStockVested', window );">Vesting Restricted Stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">35,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on marketable securities</a></td>
<td class="num">(4,289)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,289)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(154,808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(154,808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee stock purchase plan, Value</a></td>
<td class="nump">1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee stock purchase plan, Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost', window );">Issuance of Common Stock at Private Placement, net of issuance cost</a></td>
<td class="nump">149,826<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">149,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares', window );">Issuance of Common Stock at Private Placement, net of issuance cost, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,769,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 490,151<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 878,884<span></span>
</td>
<td class="num">$ (383,790)<span></span>
</td>
<td class="num">$ (4,949)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,039,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exchange of convertible preferred stock impact on equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Common Stock at Private Placement, net of issuance cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Common Stock at Private Placement, net of issuance cost, shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_IssuanceOfVestedRestrictedStockToConsultants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of vested restricted stock to consultants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_IssuanceOfVestedRestrictedStockToConsultants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_StockIssuedDuringPeriodSharesRestrictedStockVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares restricted stock vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_StockIssuedDuringPeriodSharesRestrictedStockVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_StockIssuedDuringPeriodValueRestrictedStockVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value restricted stock vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_StockIssuedDuringPeriodValueRestrictedStockVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, exchange of convertible preferred stock, shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, exchange of convertible preferred stock, value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period shares new issues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock shares vesting of series A preferred stock in connection with collaboration arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock value vesting of series A preferred stock in connection with collaboration arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822146128880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Underwriting discounts, offering costs and issuance costs</a></td>
<td class="nump">$ 17,003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesBConvertiblePreferredStocksMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Underwriting discounts, offering costs and issuance costs</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Underwriting discounts, offering costs and issuance costs</a></td>
<td class="nump">$ 320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesBConvertiblePreferredStocksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=kymr_SeriesBConvertiblePreferredStocksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822141349520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (154,808)<span></span>
</td>
<td class="num">$ (100,217)<span></span>
</td>
<td class="num">$ (45,593)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">35,480<span></span>
</td>
<td class="nump">24,972<span></span>
</td>
<td class="nump">5,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,977<span></span>
</td>
<td class="nump">2,397<span></span>
</td>
<td class="nump">1,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities', window );">Premiums and discounts on available for sale marketable securities</a></td>
<td class="nump">889<span></span>
</td>
<td class="nump">5,807<span></span>
</td>
<td class="nump">1,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_NonCashResearchAndDevelopmentExpense', window );">Non-cash research and development expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(992)<span></span>
</td>
<td class="num">(4,016)<span></span>
</td>
<td class="num">(3,816)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties', window );">Accounts receivable due from related party</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="num">(577)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties', window );">Contract asset-due from related party</a></td>
<td class="num">(2,401)<span></span>
</td>
<td class="nump">721<span></span>
</td>
<td class="num">(856)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">4,519<span></span>
</td>
<td class="nump">12,599<span></span>
</td>
<td class="nump">5,754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(37,774)<span></span>
</td>
<td class="num">(69,356)<span></span>
</td>
<td class="nump">117,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">517<span></span>
</td>
<td class="nump">419<span></span>
</td>
<td class="nump">8,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(1,004)<span></span>
</td>
<td class="num">(1,015)<span></span>
</td>
<td class="num">(2,647)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="num">(998)<span></span>
</td>
<td class="num">(1,992)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(153,085)<span></span>
</td>
<td class="num">(128,946)<span></span>
</td>
<td class="nump">88,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment, net</a></td>
<td class="num">(2,836)<span></span>
</td>
<td class="num">(1,597)<span></span>
</td>
<td class="num">(9,096)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(445,972)<span></span>
</td>
<td class="num">(456,404)<span></span>
</td>
<td class="num">(529,382)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Maturities of marketable securities</a></td>
<td class="nump">469,327<span></span>
</td>
<td class="nump">358,166<span></span>
</td>
<td class="nump">115,890<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">20,519<span></span>
</td>
<td class="num">(99,835)<span></span>
</td>
<td class="num">(422,588)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts', window );">Proceeds from issuance of common stock and accompanying pre-funded warrants from private placement, net of issuance costs</a></td>
<td class="nump">149,825<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock option exercises</a></td>
<td class="nump">3,154<span></span>
</td>
<td class="nump">7,632<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from employee stock purchase plan</a></td>
<td class="nump">1,150<span></span>
</td>
<td class="nump">788<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering', window );">Payments of offering costs in connection with initial public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(397)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments on financing leases</a></td>
<td class="num">(1,130)<span></span>
</td>
<td class="num">(849)<span></span>
</td>
<td class="num">(554)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts', window );">Proceeds from follow-on public offering, net of underwriting discounts and offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">240,760<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from initial public offering, net of underwriting discounts and offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">183,146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ProceedsFromConcurrentPrivatePlacement', window );">Proceeds from concurrent private placement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,346<span></span>
</td>
<td class="nump">13,527<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">152,999<span></span>
</td>
<td class="nump">250,280<span></span>
</td>
<td class="nump">289,262<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">20,433<span></span>
</td>
<td class="nump">21,499<span></span>
</td>
<td class="num">(45,196)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">54,092<span></span>
</td>
<td class="nump">32,593<span></span>
</td>
<td class="nump">77,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">74,525<span></span>
</td>
<td class="nump">54,092<span></span>
</td>
<td class="nump">32,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities', window );">Purchases of property and equipment through finance and lease liabilities</a></td>
<td class="nump">1,506<span></span>
</td>
<td class="nump">1,918<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses', window );">Property and equipment purchases included in accounts payable and accrued expenses</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_OfferingCostsIncludedInAccountsPayable', window );">Offering costs included in accounts payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract', window );"><strong>Supplemental disclosure of noncash operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification', window );">Reduction of right-of-use asset and liability due to lease modification</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">68,395<span></span>
</td>
<td class="nump">47,976<span></span>
</td>
<td class="nump">31,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">6,130<span></span>
</td>
<td class="nump">6,116<span></span>
</td>
<td class="nump">1,589<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</a></td>
<td class="nump">74,525<span></span>
</td>
<td class="nump">54,092<span></span>
</td>
<td class="nump">32,593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesB1ConvertiblePreferredStockMember', window );">Series B-1 Convertible Preferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from the issuance of Convertible Preferred Stock, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesCConvertiblePreferredStockMember', window );">Series C Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from the issuance of Convertible Preferred Stock, net of issuance costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 88,181<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in contract with customer asset related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_NonCashResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_NonCashResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_OfferingCostsIncludedInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering costs included in accounts payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_OfferingCostsIncludedInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Premiums and discounts on available for sale marketable securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ProceedsFromConcurrentPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from concurrent private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ProceedsFromConcurrentPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from follow on offering, net of underwriting discounts and offering costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property and equipment purchases included in accounts payable and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases of property and equipment through finance and lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction of right of use asset and liability due to lease modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental disclosure of noncash operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesB1ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=kymr_SeriesB1ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesCConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=kymr_SeriesCConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822134876880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract', window );"><strong>Description Of Business And Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">Description of Business and Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 1. Description of Business and Summary of Significant Accounting Policies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kymera Therapeutics, Inc., together with its subsidiary Kymera Securities Corporation, is referred to on a consolidated basis as the &#8220;Company&#8221;. The Company is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body&#8217;s own natural cellular process, a method known as targeted protein degradation. The Company has devoted its efforts principally to research and development since formation. The Company has not yet completed product development, filed for or obtained regulatory approvals for any products, nor verified the market acceptance and demand for such products. As a result, the Company is subject to a number of risks common to emerging companies in the biotech industry. Principal among these risks are the uncertainties of the product discovery and development process, dependence on key individuals, development of the same or similar technological innovations by the Company&#8217;s competitors, protection of proprietary technology, compliance with government regulations and approval requirements, the Company&#8217;s ability to access capital and uncertainty of market acceptance of products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has hi</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">storical net losses and anticipates that it will continue to incur losses for the foreseeable future and had an accumulated deficit of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">383.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as o</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">f December 31, 2022. The Company has funded these losses principally through issuance of preferred stock, convertible notes, common stock, including its initial public offering and concurrent private placement completed in August 2020 (&#8220;IPO&#8221;), follow-on offering and concurrent private placement completed in July 2021 ("Follow-on Offering"), August 2022 Private Investment in Public Equity ("PIPE") offering, and from cash proceeds received in connection with the Company&#8217;s collaboration agreements with Vertex Pharmaceuticals Incorporated (&#8220;Vertex&#8221;) and Genzyme Corporation (&#8220;Sanofi&#8221;) (see Note 5). The Company expects to continue to incur operating losses and negative cash flows until such time as it generates a level of revenue that is sufficient to support its cost structure.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company had cash, cash equivalents and marketable securit</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ies of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">559.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million. The Company believes these cash, cash equivalents and marketable securities will be sufficient to fund its operations and capital expenditure requirements through at least twelve months from the issuance of these consolidated financial statements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company expects to finance the future research and development costs of its product portfolio with its existing cash, cash equivalents and marketable securities, or through strategic financing opportunities that could include, but are not limited to future offerings of its equity, collaboration agreements, or the incurrence of debt. However, there is no guarantee that any of these strategic or financing opportunities will be executed or realized on favorable terms, if at all, and some could be dilutive to existing stockholders. If the Company fails to obtain additional future capital, it may be unable to complete its planned preclinical studies and clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reverse Stock Split</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On August 20, 2020, the Board approved a 1-for-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.5949</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reverse stock split of the Company&#8217;s issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each of the Company&#8217;s outstanding series of preferred stock.  All share and per share amounts in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to this reverse stock split, including reclassifying an amount equal to the reduction in par value of common stock to additional paid-in capital.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Initial Public Offering</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On August 20, 2020, the Company&#8217;s registration statement on Form S-1 relating to its initial public offering of its common stock was declared effective by the Securities and Exchange Commission (&#8220;SEC&#8221;). In the IPO, which closed on August 25, 2020, the Company issued and sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,987,520</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, including full exercise of the underwriters&#8217; over-allotment option to purchase an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,302,720</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares, at a public offering price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share and the aggregate gross proceeds before deducting before deducting underwriting discounts and commissions, and other estimated offering expenses payable by the Company, were approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">199.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. Concurrent with the IPO, the Company issued and sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">676,354</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock at $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share in a private placement to Vertex and the aggregate proceeds were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Follow-on Public Offering</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 6, 2021, the Company completed a follow-on offering of its common stock and issued and sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,468,250</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, including full exercise of the underwriters&#8217; over-allotment option to purchase an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">713,250</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares, at a public offering price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. The aggregate gross proceeds before deducting underwriting discounts and commissions, and other estimated offering expenses payable by the Company were approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">257.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. Concurrent with the follow-on offering, the Company issued and sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,928</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock at $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share in a private placement to Vertex and the aggregate proceeds were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Private Investment in Public Equity "PIPE" offering</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On August 18, 2022, the Company and certain accredited investors entered into a securities purchase agreement pursuant to which the Company agreed to sell and issue to such investors in a private placement (i) an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,769,228</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#8217;s common stock at a purchase price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, and (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Pre-Funded Warrants to purchase common stock, at a purchase price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.9999</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per pre-funded warrant, (the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8220;Pre-Funded Warrants&#8221;)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Pre-Funded Warrants will have an exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share of common stock. The offering closed on August 22, 2022, resulting in net proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">149.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million after offering expenses.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As the Pre-Funded Warrants are indexed to the Company&#8217;s common stock (and otherwise meet the requirements to be classified in equity), the Company recorded the consideration received from the issuance of the Pre-Funded Warrants as additional paid-in capital on the Company&#8217;s consolidated balance sheets. The Pre-Funded Warrants are exercisable at any time. The holders of Pre-Funded Warrants may not exercise the warrant if the holder, together with its affiliates, would beneficially own more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the number of shares of the Common Stock outstanding immediately after giving effect to such exercise. The holders of Pre-Funded Warrants may increase or decrease such percentages not in excess of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% by providing at least </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> days&#8217; prior notice to the Company.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the twelve months ended December 31, 2022, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Pre-Funded Warrants were exercised. As of December 31, 2022, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> pre-funded warrants outstanding.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of business and summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144592352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 2. Summary of Significant Accounting Policies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note, and elsewhere in the accompanying consolidated financial statements and notes.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary Kymera Securities Corporation. All intercompany transactions and balances have been eliminated in consolidation.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amounts of expenses during the reporting period. Management&#8217;s estimates and judgments are derived and continually evaluated based on available information, historical experience and various other assumptions that are believed to be reasonable under the circumstances. Because the use of estimates is inherent in the financial reporting process, actual results could differ from those estimates. In recording transactions and balances resulting from business operations, management makes estimates based on the best information available at the time the estimate is made. Significant estimates relied upon in preparing these financial statements include revenue recognized under our collaboration agreement with Sanofi and Vertex, accrual for research and development expenses, equity-based compensation expense, and the valuation of equity prior to the Company's initial public offering. As better information becomes available or actual amounts are determinable, the recorded estimates are revised. Consequently, operating results can be affected by revisions to prior estimates.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Segment and Geographic Information</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company&#8217;s chief operating decision maker is the Chief Executive Officer. The Company views its operations and manages its business in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> operating segment.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents are highly liquid investments that are readily convertible into cash with original maturities of three months or less when purchased. These assets include investments in money market funds that invest in U.S. Treasury obligations and corporate bonds. The Company maintains its bank accounts at major financial institutions.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash represents the cash held to secure letters of credit associated with the Company&#8217;s facility leases.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company classifies marketable securities with a remaining maturity of greater than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three months</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> when purchased as available-for-sale. The Company classifies investments available to fund current operations as current assets on its balance sheets. Marketable securities with a remaining maturity date greater than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are classified as non-current. Available-for-sale securities are maintained by investment managers and consist of U.S. Treasury securities and corporate bonds. Available-for-sale securities are carried at fair value with the unrealized gains and losses included in other comprehensive income (loss) as a component of stockholders&#8217; equity until realized. Any premium or discount arising at purchase is amortized and/or accreted to interest income and/or expense over the life of the instrument. Realized gains and losses are determined using the specific identification method and are included in other (expense) income, net.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company&#8217;s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer&#8217;s industry, and any significant deterioration in economic conditions.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 1&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted prices in active markets for identical assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 2&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar asset, or other inputs that are observable or can be corroborated by observable market data.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 3&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets, including pricing models, discounted cash flow methodologies and similar techniques.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The carrying values of the Company&#8217;s cash equivalents, prepaid expenses, accounts payable, and certain accruals approximate their fair value due to their short-term nature.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Leases that are economically similar to the purchase of assets are generally classified as finance leases; otherwise the leases are classified as operating leases. The Company has elected not to recognize leases with an original term of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or less on the balance sheet. Options to renew a lease are not included in the Company&#8217;s assessment unless there is reasonable certainty that the Company will renew. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets, lease liabilities and, if applicable, long-term lease liabilities. Lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. However, certain adjustments to the right-of-use asset may be required for items such as incentives received. The Company has elected as an accounting policy to combine lease and non- lease components, such as common area maintenance, for all classes of underlying assets. The interest rate implicit in lease contracts has not historically been readily determinable. As a result, the Company utilizes its incremental borrowing rates, which are the rates incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. To estimate its incremental borrowing rate, a credit rating applicable to the Company is estimated using synthetic credit rating analysis since the Company does not currently have a rating agency-based credit rating.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment are recorded at cost, net of accumulated depreciation. Major additions and betterments are capitalized; maintenance and repairs, which do not improve or extend the life of the respective assets, are charged to operations as incurred. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset as follows:</span></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:62.619%;"/>
          <td style="width:0.208%;"/>
          <td style="width:37.173%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated Useful Life</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in years)</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Office equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shorter of life of lease or remaining lease term</span></span></p></td>
         </tr>
        </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon retirement or sale, the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction-in-progress is stated at cost, which includes direct costs attributable to the setup or construction of the related asset. Depreciation expense is not recorded on construction-in-progress until the relevant assets are completed and put into use.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Long-lived assets (including right-of-use assets) to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value, determined based on discounted cash flows. The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t record any impairment losses on long-lived assets during the years ended December 31, 2022, 2021 and 2020.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company classified convertible preferred stock as temporary equity in the accompanying consolidated statement of Convertible Preferred Stock and Stockholders&#8217; Equity due to terms that allow for redemption of the shares in cash upon certain change in control events that are outside of the Company&#8217;s control, including the sale or transfer of the Company as holders of the convertible preferred stock which could trigger redemption of the shares. The Company did not accrete the value of the convertible preferred stock to the redemption values since a liquidation event was not considered probable prior to the conversion date. In connection with the Company&#8217;s initial public offering on August 25, 2020, all outstanding shares of convertible preferred stock converted to common stock.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Warrants</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determines the accounting classification of warrants that are issued, as either liability or equity, by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and then in accordance with ASC 815-40, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#8217;s Own Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Under ASC 480-10, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate the issuer to settle the warrants or the underlying shares by paying cash or other assets, or must or may require settlement by issuing variable number of shares.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If warrants do not meet liability classification under ASC 480-10, the Company assesses the requirements under ASC 815-40, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature. If the warrants do not require liability classification under ASC 815-40, in order to conclude equity classification, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable U.S. GAAP. After all relevant assessments are made, the Company concludes whether the warrants are classified as liability or equity. Liability classified warrants are required to be accounted for at fair value both on the date of issuance and on subsequent accounting period ending dates, with all changes in fair value after the issuance date recorded in the statements of operations as a gain or loss. Equity classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Costs</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development costs consist primarily of costs incurred in connection with the discovery and development of targeted protein degradation therapeutics, including those in the Company&#8217;s most advanced development programs, IRAK4, IRAKIMiD, STAT3 and MDM2. These research efforts and costs, which also support the development of, and enhancements to, the Company&#8217;s Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> targeted protein degradation platform, include external research costs, personnel costs, supplies, license fees and facility related expenses. The Company expenses research and development costs as incurred.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent Costs</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recoverability of the expenditure. Amounts incurred are classified as general and administrative expenses.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Costs</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Costs incurred in connection with the issuance of equity units and shares are recorded as a reduction of proceeds to the equity carrying value. The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process financings as deferred offering costs until such financings are consummated. After consummation of the financing, these costs are recorded as a reduction of the proceeds received from the financing. If a planned financing is abandoned, the deferred offering costs are expensed immediately as a charge to operating expenses in the consolidated statement of operations and comprehensive loss. There was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> deferred offering costs on the Company&#8217;s consolidated balance sheet at December 31, 2022 and December 31, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under ASC 606, Topic 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers (&#8220;ASC 606&#8221;)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,  the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the contract(s) with the customer; (ii) identification of the promised goods or services in the contract and determination of whether the promised goods or services are performance obligations; (iii) measurement of the transaction price; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As part of the accounting for these arrangements, the Company must use significant judgment to determine: a) the number of performance obligations based on the determination under step (ii) above and whether those performance obligations are distinct from other performance obligations in the contract; b) the transaction price under step (iii) above; and c) the standalone selling price for each performance obligation identified in the contract for the allocation of transaction price in step (iv) above. The Company uses judgment to determine whether milestones or other variable consideration, except for royalties, should be included in the transaction price as described further below. The transaction price is allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. In determining the stand-alone selling price of a license to the Company&#8217;s proprietary technology or a material right provided by a customer option, the Company considers market conditions as well as entity-specific factors, including those factors contemplated in negotiating the agreements as well as internally developed estimates that include assumptions related to the market opportunity, estimated development costs, probability of success and the time needed to commercialize a product candidate pursuant to the license. In validating its estimated stand-alone selling prices, the Company evaluates whether changes in the key assumptions used to determine its estimated stand-alone selling prices will have a significant effect on the allocation of arrangement consideration between performance obligations.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the transaction price based on the amount of consideration the Company expects to be received for transferring the promised goods or services in the contract. The consideration may include both fixed consideration and variable consideration. At the inception of each arrangement that includes variable consideration, the Company evaluates the amount of the potential payments and the likelihood that the payments will be received. The Company utilizes either the most likely amount method or expected value method to estimate the transaction price based on which method better predicts the amount of consideration expected to be received. If it is probable that a significant revenue reversal would not occur, the variable consideration is included in the transaction price.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer. Promised goods or services are considered distinct when: (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on their own and whether the required expertise is readily available.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation in order to determine whether the combined performance obligation is satisfied over time or at a point in time. The Company receives payments from customers based on billing schedules established in each contract. Up-front payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#8217;s right to consideration is unconditional. Amounts recognized as revenue, but not yet received or invoiced are generally recognized as contract assets.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Exclusive Licenses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;If the license granted in the arrangement is determined to be distinct from the other promises or performance obligations identified in the arrangement, which generally include research and development services, the Company recognizes revenue from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. In assessing whether a license is distinct from the other promises, the Company considers relevant facts and circumstances of each arrangement, including the research and development capabilities of the collaboration partner and the availability of the associated expertise in the general marketplace. In addition, the Company considers whether the collaboration partner can benefit from the license for its intended purpose without the receipt of the remaining promise, whether the value of the license is dependent on the unsatisfied promise, whether there are other vendors that could provide the remaining promise, and whether it is separately identifiable from the remaining promise. For licenses that are combined with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition based on estimated remaining research and development costs. The calculation of the total remaining estimated research and development costs includes forecasted costs associated with internal employee efforts, materials costs, and third-party contract costs, as well as the assumed timing and duration of these activities. The recognition of revenue pursuant to collaboration arrangements is subject to these judgments made and estimates developed by management and is sensitive to changes in these assumptions. Therefore, the measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the arrangement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Services</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;The promises under the Company&#8217;s collaboration and license agreements generally include research and development services to be performed by the Company on behalf of the collaboration partner. For performance obligations that include research and development services, the Company generally recognizes revenue allocated to such performance obligations based on an appropriate measure of progress. The Company utilizes judgment to determine the appropriate method of measuring progress for purposes of recognizing revenue, which is generally an input measure, such as costs incurred. The Company evaluates the measure of progress each reporting period as described under Exclusive Licenses above. Reimbursements from the partner that are the result of a collaborative relationship with the partner, instead of a customer relationship, such as co-development activities, are generally recorded as a reduction to research and development expense.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Customer Options</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;The Company&#8217;s arrangements may provide a collaborator with the right to certain optional purchases, such as the right to license a target either at the inception of the arrangement or within a pre-defined option period. Under these agreements, fees may be due to the Company at the inception of the arrangement as an upfront fee or payment or upon the exercise of an option to acquire a license. If an arrangement is determined to contain customer options that allow the customer to acquire additional goods or services, the goods and services underlying the customer options are not considered to be performance obligations at the outset of the arrangement, as they are contingent upon option exercise. The Company evaluates the customer options for material rights, or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the inception of the arrangement. The Company allocates the transaction price to material rights based on the relative stand-alone selling price, which is determined based on the identified discount, and the probability that the customer will exercise the option. Amounts allocated to a material right are not recognized as revenue until, at the earliest, the option is exercised or expires.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Milestone Payments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;At the inception of each arrangement that includes milestone payments based on certain events, the Company evaluates whether the milestones are considered probable of being achieved and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The Company evaluates factors such as the scientific, clinical, regulatory, commercial, and other risks that must be overcome to achieve the particular milestone in making this assessment. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. At the end of each subsequent reporting period, the Company reevaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. If a milestone or other variable consideration relates specifically to the Company&#8217;s efforts to satisfy a single performance obligation or to a specific outcome from satisfying the performance obligation, the Company generally allocates the milestone amount entirely to that performance obligation once it is probable that a significant revenue reversal would not occur.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Royalties</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;For arrangements that include sales-based royalties, including milestone payments based on a level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue resulting from any of its licensing arrangements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Collaboration revenue&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company analyzes its collaboration arrangements to assess whether they are within the scope of ASC 808,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Collaborative Arrangements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (&#8220;ASC 808&#8221;) to determine whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and those that are more reflective of a vendor-customer relationship and therefore within the scope of Topic 606. For elements of collaboration arrangements that are accounted for pursuant to ASC 808, an appropriate recognition method is determined and applied consistently, generally by analogy to Topic 606. For those elements of the arrangement that are accounted for pursuant to Topic 606, the Company applies the five-step model described above.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Costs associated with License and Collaborative Arrangements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Costs associated with licenses of technology acquired as part of collaborative arrangements are expensed as incurred and are generally included in research and development expense in the consolidated statements of operations.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounts Receivable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company extends credit to customers based on its evaluation of the customer&#8217;s financial condition. The Company records receivables for all billings when amounts are due under standard terms. Accounts receivable are stated at amounts due net of applicable prompt pay discounts and other contractual adjustments as well as an allowance for doubtful accounts. The Company assesses the need for an allowance for doubtful accounts by considering a number of factors, including the length of time trade accounts receivable are past due, the customer&#8217;s ability to pay its obligation and the condition of the general economy and the industry as a whole. The Company will write off accounts receivable when the Company determines that they are uncollectible. In general, the Company has experienced no significant collection issues with its customers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for all stock-based awards granted to employees, directors, and nonemployees based on their fair value on the date of the grant and recognize compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. Stock-based payments include stock options and grants of common stock, including common stock subject to vesting. The measurement date for stock awards is the date of grant, and stock-based compensation costs are recognized as expense over the requisite service period, which is the vesting period, on a straight-line basis. The Company has issued stock options and restricted stock with performance-based vesting conditions and records the expense for these awards if the Company concludes that it is probable that the performance condition will be achieved. Stock-based compensation is classified in the accompanying consolidated statements of operations and comprehensive loss based on the function to which the related services are provided. The Company recognizes stock-based compensation expense for the portion of awards that have vested. Forfeitures are accounted for as they occur.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes options-pricing model, which requires inputs based on certain subjective assumptions, including the expected stock price volatility, the expected term of the option, the risk-free interest rate for a period that approximates the expected term of the option, and the Company&#8217;s expected dividend yield. Prior to the IPO, as there was no active market for the Company&#8217;s common stock, the Company estimated the fair value of common stock on the date of grant based on the then current facts and circumstances. Upon becoming a public company, the fair value of the underlying common shares equals the closing price of the Company&#8217;s stock on the date of grant. As the Company&#8217;s IPO was in 2020, the Company  lacks a sufficient period of company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of guideline companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#8217;s stock options has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain-vanilla&#8221; options. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#8217;s common stock on that same date.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compensation expense for discounted purchases under the employee stock purchase plan is measured using the Black-Scholes model to compute the fair value of the lookback provision plus the purchase discount and is recognized as compensation expense over the offering period.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company records income taxes in accordance with FASB Accounting Standards Codification Topic 740, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (&#8220;ASC 740&#8221;), which provides for deferred taxes using an asset and liability approach. Under this method, deferred income tax assets and liabilities are recognized based on future income tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities, and their respective income tax basis. Deferred income tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of changes in income tax rates on deferred income tax assets and liabilities is recognized as income or expense in the period that a valuation allowance for any income tax benefits of which future realization is not more likely than not.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company provides reserves for potential payments of tax to various tax authorities related to uncertain tax positions. The tax benefits recorded are based on a determination of whether and how much of a tax benefit taken by the Company in its tax filings or positions is &#8220;more likely than not&#8221; to be realized following resolution of any uncertainty related to the tax benefit, assuming that the matter in question will be raised by the tax authorities.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Off Balance Sheet Risk and Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has no significant off-balance sheet risk such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and restricted cash. The Company&#8217;s cash, cash equivalents, and restricted cash are deposited in accounts at large financial institutions. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash, cash equivalents and restricted cash are held. The Company maintains its cash equivalents in money market funds that invest in U.S. Treasury securities and U.S. Treasury obligations and corporate bonds. The Company&#8217;s marketable securities primarily consist of corporate bonds and U.S. Treasury securities paper, and potentially subject the Company to concentrations of credit risk. The Company has adopted an investment policy that limits the amounts the Company may invest in any one type of investment. The Company has not experienced any credit losses and does not believe it is exposed to any significant credit risk on these funds.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss includes net loss as well as unrealized gains and losses on marketable securities and other changes in stockholders&#8217; equity (deficit) that result from transactions and economic events other than those with stockholders.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net Loss Per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company applies the two-class method to compute basic and diluted net income (loss) per share attributable to common stockholders when it has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income (loss) available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to share in the earnings as if all income (loss) for the period had been distributed. The Company&#8217;s convertible preferred stock participates in any dividends declared by the Company and are therefore considered to be participating securities. The participating securities are not required to participate in the losses of the Company, and therefore during periods of loss there is no allocation required under the two-class method.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including the pre-funded warrants given their nominal exercise price. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) per share attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including potential dilutive common shares. For purpose of this calculation, outstanding options to purchase common stock, unvested restricted stock awards, and shares of convertible preferred stock are considered potential dilutive common shares. The Company has generated a net loss in all periods presented, and therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Standards</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The Company adopted ASU 2020-06 effective as of January 1, 2022. The adoption of ASU 2020-06 did not have an impact on the Company&#8217;s financial statements.</span></p></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144362080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 3. Fair Value Measurements</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents information about the Company&#8217;s financial assets measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values as of December 31, 2022 and December 31, 2021 (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.798%;"/>
        <td style="width:1.049%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.212000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.049%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.212000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.06%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.223%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.06%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.335%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements at<br/>December 31, 2022:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50,551</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50,551</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74,045</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74,045</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120,467</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120,467</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">144,259</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">144,259</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, non-current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,804</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,804</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,653</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,653</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73,871</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73,871</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,130</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,130</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">150,530</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">397,250</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">547,780</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.735%;"/>
        <td style="width:1.058%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.07%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.07%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.07%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.341%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements at<br/>December 31, 2021:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43,182</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43,182</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">169,481</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">169,481</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32,170</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32,170</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">192,791</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">192,791</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, non-current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,172</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,172</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47,363</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47,363</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,652</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,652</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,116</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,116</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">315,484</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">253,443</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">568,927</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the years ended December 31, 2022 and 2021, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_d6816af5-4bc5-4791-ba3d-860c44e2a341;"><span style="-sec-ix-hidden:F_edecdabf-262b-4f31-ac10-5d70725bc297;"><span style="-sec-ix-hidden:F_47aa0c7e-13cd-4b61-a6e4-d8d951681874;"><span style="-sec-ix-hidden:F_17c26d05-9f3b-4274-bf66-5ed27d17bc5c;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> tr</span></span></span></span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ansfers in or out of Level 3.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144389264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Marketable Securities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 4. Marketable Securities</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the available-for-sale debt securities held at December 31, 2022 and 2021 and (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.234%;"/>
        <td style="width:1.208%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.502%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.195%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.49%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.195%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.49%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.195%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.49%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94,958</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,111</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93,850</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agency securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">180,967</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,873</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">179,119</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">220,119</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,014</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">218,130</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">496,044</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,998</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">491,099</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.135%;"/>
        <td style="width:1.208%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.494%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.195%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.468%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.283%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.468%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.283%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.468%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">186,700</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">186,655</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agency securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79,657</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79,532</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">253,929</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">488</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">253,442</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">520,286</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">658</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">519,629</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company held </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">149</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities that had been in an unrealized loss position for less than 12 months with an aggregate fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">330.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. As of December 31, 2021, the Company held </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">113</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities that had been in an unrealized loss position for less than 12 months with an aggregate fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">515.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. As of December 31, 2022, the Company held </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities that had been in an unrealized loss position for greater than 12 months with an aggregate fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. As of December 31, 2021, the Company did not hold any securities that had been in an unrealized loss position for greater than 12 months.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of  December 31, 2022 the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">118</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities with a fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">338.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million with a contractual maturity of less than 12 months and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities with a fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">152.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million with a contractual maturity of greater than 12 months. As of December 31, 2021, the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities with a fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">394.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million with a contractual maturity of less than 12 months and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities with a fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million with a contractual maturity of greater than 12 months.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company evaluates securities for other-than-temporary impairments based on quantitative and qualitative factors, and considered the decline in market value for the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">185</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> securities in an unrealized loss position as of  December 31, 2022, to be primarily attributable to the then current economic and market conditions. The Company neither intends to sell these investments nor concludes that it is more-likely-than-not that the Company will have to sell them before recovery of their carrying values. The Company also believe that it will be able to collect both principal and interest amounts due at maturity.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822223656128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member', window );">Topic 606</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaborations</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 5. Collaborations</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sanofi Collaboration Arrangement</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Agreement Terms</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 7, 2020, the Company entered into a collaboration agreement, or the Sanofi Agreement, with Sanofi, to co-develop drug candidates directed to two biological targets. Under the Sanofi Agreement, the Company granted to Sanofi a worldwide exclusive license to develop, manufacture and commercialize certain lead compounds generated during the collaboration directed against IRAK4, or Collaboration Target 1, and one additional undisclosed target in an undisclosed field of use, or Collaboration Target 2. Such license is exercisable on a collaboration target-by-collaboration target basis only after specified milestones. For compounds directed against IRAK4, the field of use includes diagnosis, treatment, cure, mitigation or prevention of any diseases, disorders or conditions, excluding oncology and immuno-oncology.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the Sanofi Agreement, the Company is responsible for discovery and preclinical research and conducting a Phase 1 clinical trial for at least one degrader directed against IRAK4 plus up to three backup degraders. With respect to both targets, Sanofi is responsible for development, manufacturing, and commercialization of product candidates after a specified development milestone occurs with respect to each collaboration candidate.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, pursuant to the Sanofi Agreement, Sanofi will grant to the Company an exclusive option, or Opt-In Right, exercisable on a collaboration target-by-collaboration target basis that will include the right to (i) fund 50% of the United States development costs for collaboration products directed against such target in the applicable field of use and (ii) share equally in the net profits and net losses of commercializing collaboration products directed against such target in the applicable field of use in the United States. In addition, if the Company exercises the Opt-In Right, Sanofi will grant to the Company an exclusive option, applicable to each collaboration target, which upon exercise will allow the Company to conduct certain co-promotion activities in the field in the United States.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Sanofi Agreement, unless earlier terminated, will expire on a product-by-product basis on the date of expiration of all payment obligations under the Sanofi Agreement with respect to such product. The Company or Sanofi may terminate the agreement upon the other party&#8217;s material breach or insolvency or for certain patent challenges. In addition, Sanofi may terminate the Sanofi Agreement for convenience or for a material safety event upon advance prior written notice, and the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company may terminate the Sanofi Agreement with respect to any collaboration candidate if, following Sanofi&#8217;s assumption of responsibility for the development, commercialization or manufacturing of collaboration candidates with respect to a particular target, Sanofi ceases to exploit any collaboration candidates directed to such target for a specified period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In consideration for the exclusive licenses granted to Sanofi under the Sanofi Agreement, Sanofi paid to the Company an upfront payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">150.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. The Company will also be reimbursed for certain research activities for a certain backup degrader under the IRAK4 program as well as contract manufacturing costs for the lead 474 program, unless certain criteria are not met for an initial IRAK4 degrader. In addition to the upfront payment and the reimbursements, the Company is eligible to receive certain development milestone payments of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.48</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> billion in the aggregate, of which more than $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> billion relates to the IRAK4 program, upon the achievement of certain developmental or regulatory events. The Company will be eligible to receive certain commercial milestone payments up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">700.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in the aggregate, of which $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">400</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million relates to the IRAK4 program, which are payable upon the achievement of certain net sales thresholds. The Company will be eligible to receive tiered royalties for each program on net sales ranging from the high single digits to high teens, subject to low-single digits upward adjustments in certain circumstances.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On November 15, 2022, we entered into an Amended and Restated Collaboration and License Agreement with Sanofi, or the Amended Sanofi Agreement, which amended the Original Sanofi Agreement to revise certain research terms and responsibilities set forth under the Original Sanofi Agreement. The Amended Sanofi Agreement also specifies details around the timing and number of Phase 2 trials required under the terms of the collaboration. The Amended Sanofi Agreement became effective on December 5, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally with respect to Sanofi, on December 2, 2022, Sanofi provided the Company with written notice of its intention to advance the collaboration target 1 candidate, KT-474, into Phase 2 clinical trials. The Company is entitled to receive milestone payments upon the dosing of the first Phase 2 patient(s) per indication up to a specified number of indications as further set forth in the Amended Sanofi Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting Treatment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company analyzed the discovery and pre-clinical research activities as well as the exclusive license grants under the Sanofi Agreement and concluded that the arrangement was indicative of a vendor-customer relationship and would be accounted for under ASC 606.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company identified the following material promises under the arrangement: (1) research services for Collaboration Target 1, (2) research license for Collaboration Target 1, (3) exclusive license for Collaboration Target 1, (4) research services for Collaboration Target 2, (5) research license for Collaboration Target 2, (6) exclusive license for Collaboration Target 2, (7) option to extend the research term, and (8) optional research services during the development period.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determined that Collaboration Targets 1 and 2 are distinct from each other. The research associated with degraders directed to each target is at different stages and the licensed field, should development activities be successful, are different from each other. As such, all promises associated with each target are considered distinct from promises associated with the other target.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The research and development services for each collaboration target were determined not to be distinct from the research license and the exclusive license and have been combined into a single performance obligation for each collaboration target. That is, two performance obligations were identified, the combined research services, research license and exclusive license for Collaboration Target 1 and the combined research services, research license and exclusive license for Collaboration Target 2. The exclusive license for each target is not distinct from the pre-clinical and clinical research and development services under the Sanofi Agreement, primarily due to the highly specialized nature of the research and novel technology involved with developing protein degraders &#8211; the pre-clinical activities and studies and first phase 1 clinical trial could not be conducted by another party in the manner required.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The option to extend the research term and optional research services during the development period were evaluated as material rights. The fees associated with each option are at or above the standalone selling price. As such, the underlying options are not performance obligations and fees associated with each option are excluded from the transaction price until the underlying option is exercised.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determined the total transaction price to be $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">150.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which consists solely of the upfront payment. All milestone payments and option payments are constrained as the achievement of such milestones are contingent upon the success of the underlying research and development activities and are generally outside the control of the Company. The reimbursement of costs for the IRAK4 backup degrader is also treated as constrained variable consideration as the criteria for reimbursement may not always be met, under which circumstances the Company would be responsible for the costs related to the backup degrader. Upon becoming unconstrained, the reimbursement consideration will be added to the transaction price and allocated to Collaboration Target 1.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company allocated the upfront payment to each performance obligation based on the relative standalone selling price, as follows:</span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 1: $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span></div></div><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration Target 2: $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span></div></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determined the allocation of the $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">150.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million transaction price between Collaboration Target 1 and Collaboration Target 2 based on the value of the research and development for the programs from projected research and development costs for each collaboration target plus a developer&#8217;s profit and the total potential milestones for each collaboration target.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes revenue associated with each performance obligation as the research and development services are provided using an input method, according to costs incurred as related to the research and development activities for each individual program and the costs expected to be incurred in the future to satisfy that individual performance obligation. The transfer of control occurs over this time period and, in management&#8217;s judgment, is the best measure of progress towards satisfying each performance obligation. The amounts received that have not yet been recognized as revenue are deferred as a contract liability on the Company&#8217;s consolidated balance sheet and will be recognized over the remaining research and development period until the performance obligation is satisfied. Reimbursement consideration added to the transaction price will be recognized as revenue on the same pattern as Collaboration Target 1, with a cumulative catch-up upon becoming unconstrained. Pursuant to the November 15, 2022 amendment to the Sanofi Agreement, the Company reevaluated its rights and obligations under the Agreement as amended. As part of this reevaluation, the Company reassessed its accounting pursuant to the arrangement concluding that the amendment had no impact on the performance obligations nor revenue recognized in the periods presented</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The performance obligations have not been fully satisfied as of December 31, 2022. During the year ended December 31, 2022, the Company recognized $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in revenue under the Sanofi Agreement, of which $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 1 and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 2. Of the $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of revenue recognized in the year ended December 31, 2022, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was recognized from amounts that were recorded in deferred revenue as of December 31, 2021. The aggregate amount of the transaction price allocated to the Company&#8217;s unsatisfied performance obligations and recorded in deferred revenue at December 31, 2022 is $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. During the year ended December 31, 2021, the Company recognized $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in revenue under the Sanofi Agreement, of which $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 1 and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 2. The aggregate amount of the transaction price allocated to the Company&#8217;s unsatisfied performance obligations and recorded in deferred revenue at December 31, 2021 is $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. During the year ended December 31, 2020, the Company recognized $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in revenue under the Sanofi Agreement, of which $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 1 and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was associated with Collaboration Target 2. During the years ended December 31, 2022 and 2021, the Company received $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, in in cost reimbursement payments under the Sanofi Agreement. The Company recorded $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of unbilled accounts receivable related to reimbursable research and development costs under the Sanofi Agreement as of December 31, 2022 and December 31, 2021, respectively. The Company will recognize the deferred revenue related to the performance obligations based on a cost input method, as described, over the remaining research term, which as a result of the amended agreement, is a maximum of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.0</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years as of December 31, 2022.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any consideration related to performance-based milestones will be recognized when the risk of probable reversal is resolved, at which point the Company shall adjust the transaction price determined for the agreement accordingly and recognize revenue on a cumulative-catch up basis, reallocating the revised arrangement consideration to the performance obligations. Any consideration related to sales milestone payments and royalties will be recognized when the related milestone events or sales occur and therefore are recognized at the later of when the related sales occur or the relevant performance obligation is satisfied. As part of its evaluation of constraining the milestones, the Company considered numerous factors, including the fact that the achievement of the research and development milestones are contingent upon the results of the underlying research and development activities and are thus outside of the control of the Company.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sanofi participated in the Company&#8217;s Series B Convertible Preferred Stock offering and as a result of this, was considered a related party during the year ended December 31, 2020 but no longer are considered a related party in any other periods presented.</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Vertex Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On May 9, 2019 (the &#8220;Effective Date&#8221;), the Company entered into a collaboration agreement (the &#8220;Vertex Agreement&#8221;) with Vertex to advance small molecule protein degraders against up to six targets. Under the Vertex Agreement, Vertex has the exclusive option to license the rights to the product candidates developed for the designated targets at which point Vertex will control development and commercialization. Pursuant to the Vertex Agreement, the Company is only responsible for discovery and preclinical research on the targets, and Vertex is responsible for development, manufacturing, and commercialization of the product candidates after it exercises its option to license. The initial research term of the collaboration is four (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) years, extendable for an additional one (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) year period upon mutual agreement by the parties and payment by Vertex of certain per-target fees.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vertex provided the Company with a non-refundable upfront payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and purchased </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,059,695</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#8217;s Series B-1 Convertible Preferred Stock (&#8220;Series B-1&#8221;) at $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.54</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> a share, pursuant to a separate, but simultaneously executed Share Purchase Agreement. The shares were purchased at a premium of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which was included in the transaction price and will be recognized as revenue over the period of performance. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vertex additionally purchased shares of the Company&#8217;s common stock in a private placement concurrent with the Company&#8217;s follow-on offering in which the Company received proceeds from Vertex</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. As a result of this purchase, Vertex is considered a related party.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is eligible to receive up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">170.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in payments per target, including development, regulatory and commercial milestones as well as option exercise payments. In addition, Vertex is obligated to pay the Company tiered royalties on future net sales on any products that may result from the Vertex Agreement. None of the payments under the Vertex Agreement are refundable. The Company may also perform follow-on research for an optioned target upon Vertex&#8217;s request and at Vertex&#8217;s expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The term of the Vertex Agreement began on the Effective Date and expires upon the expiration of all payment obligations from Vertex to Company under the Vertex Agreement or, if Vertex does not exercise any of its options, the lapse of all Vertex&#8217;s option rights under the Vertex Agreement. Vertex also has the ability to terminate for convenience with prior written notice to the Company, and either party may terminate for an uncured material breach.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting Treatment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company analyzed the joint research activities required under the Vertex Agreement and concluded that the arrangement was indicative of a vendor-customer relationship and would be accounted for under ASC 606.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company identified the following material promises under the arrangement: (1) the non-exclusive, royalty-free research license; (2) the research and development services to be performed on up to six targets; and (3) the option to license each of the targets for development, manufacturing, and commercialization efforts. The research and development services were determined not to be distinct from the research and development license and have been combined into a single performance obligation. The Company determined that the option to license the targets in the future was not priced at a discount, and that the option exercise fee for each target is at or above the standalone selling price for research at this stage of development; as such, the options and the underlying licenses are excluded from the performance obligation and the option exercise fees are excluded from the transaction price until the underlying option is exercised.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As part of its evaluation of constraining the research and development milestones, the Company considered numerous factors, including the fact that the achievement of the research and development milestones are contingent upon the results of the underlying research and development activities and are thus outside of the control of the Company.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the commencement of the arrangement, two units of accounting were identified, the issuance of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,059,695</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#8217;s Series B-1 and the research activities the Company will perform over the Research Term. The Company determined the total transaction price to be $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which consists of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million attributed to the premium from the Series B-1 shares sold to Vertex and the $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million upfront payment. To determine the fair value of the Series B-1 issued to Vertex, the Company performed a valuation of the shares of the Company&#8217;s common and preferred stock, which took into consideration recent financings, and the Company&#8217;s recent development and future exit strategies, as well as a discount for lack of marketability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company recognizes revenue associated with the performance obligation as the research and development services are provided using an input method, according to the costs incurred as related to the research and development activities on each program and the costs expected to be incurred in the future to satisfy the performance obligation. The transfer of control</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">occurs </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">over this time period and, in management&#8217;s judgment, is the best measure of progress towards satisfying the performance obligation. The amounts received that have not yet been recognized as revenue are deferred as a contract liability on the Company&#8217;s consolidated balance sheet and will be recognized over the remaining research and development period until the performance obligation is satisfied. The performance obligation has not been fully satisfied as of December 31, 2022. During the years ended December 31, 2022, 2021 and 2020, the Company recognized $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, in revenue under the Vertex Agreement. All $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million revenue recognized during the year ended December 31, 2022 was recognized from amounts that were recorded in deferred revenue as of December 31, 2021. The aggregate amount of the transaction price allocated to the Company&#8217;s unsatisfied performance obligation and recorded in deferred revenue at December 31, 2022 and 2021 is $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. The Company will recognize the deferred revenue related to the research and development services based on a cost input method, over the remaining research term, which is a maximum of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> year as of December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any consideration related to sales milestone payments (including royalties) will be recognized when the related milestone events or sales occur and therefore are recognized at the later of when the related sales occur or the relevant performance obligation is satisfied.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Compound Collaboration</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2017, the Company entered into a collaboration agreement (the &#8220;Collaboration&#8221;) with a pharmaceutical company to jointly identify, research and conduct preclinical development of collaboration compounds against specified collaboration targets to identify drug candidates. Under the terms of the Collaboration, both parties provided one another with a non-exclusive, royalty-free, sub-licensable research and development license to each party&#8217;s intellectual property to develop five agreed-upon collaboration targets, as well as an exclusive, royalty-bearing development and commercialization license to sell any licensed products that stem from such research. The parties also have the ability to nominate additional collaboration targets if agreed-upon, as long as there are no more than five targets at any given time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In exchange for the non-exclusive license rights, the Company provided the pharmaceutical company with an equity grant and is required to make tiered royalty payments based on net sales of all products licensed under the agreement in the low single-digit percentages. In conjunction with the Collaboration, the Company initially issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">886,305</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Series A Preferred Units (&#8220;Series A Preferred Units&#8221;) to the pharmaceutical company. On November 1, 2018, these Series A Preferred Units were exchanged on a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_cb8b44a8-0a30-4420-9476-09eaa4fdd848;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one-for-one</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> basis for shares of Series A Convertible Preferred Stock (the &#8220;Series A Preferred Stock&#8221;). These shares vested in equal installments over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company recorded expense over the vesting period based on the fair value of the shares under the Collaboration. The Company recorded $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million to research and development expense related to the vesting of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">166,183</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series A Preferred Stock during the year ended December 31, 2020. As of December 31, 2020, all shares under the Collaboration were fully vested and all expense had been recognized.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The royalty payments are contingent and as such are not being recorded until incurred. The Company determined that the license is representative of an in-process research and development asset, with no future alternative use. As such, the Company records the expense related to the vesting of shares as research and development expense in the Company&#8217;s consolidated statements of operations and comprehensive loss.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Collaboration was terminated by the parties effective </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">April 27, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents the changes in accounts receivable, contract assets and liabilities for the year ended December 31, 2022 (in thousands)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.959%;"/>
        <td style="width:1.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.102%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.117999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.117999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.102%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at<br/>December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deductions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at<br/>December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable and contract assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Billed receivables &#8211; Sanofi</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,650</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,650</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unbilled receivables &#8211; Sanofi</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,052</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,650</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,537</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accounts receivable and contract assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,702</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,300</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,537</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contract Liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred Revenue &#8211; Vertex</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,212</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,813</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,399</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred Revenue &#8211; Sanofi</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81,822</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,052</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,013</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54,861</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total contract liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101,034</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,052</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46,826</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63,260</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI https://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144708624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 6. Property and equipment</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment consists of the following as of December 31, 2022 and 2021 (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.73%;"/>
        <td style="width:1.696%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.439%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.696%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.439%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lab and office equipment under and financing<br/>&#160;&#160;&#160;right-of-use asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,475</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,969</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lab equipment</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,383</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,805</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">357</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">273</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture &amp; fixtures</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,064</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">943</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,802</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,741</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets not yet in service</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,146</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,227</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,797</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less accumulated depreciation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,893</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,916</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,334</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,881</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation expense for the years ended December 31, 2022, 2021 and 2020 was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in property and equipment is lab and office equipment right-of-use assets under financing leases with a cost basis of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and accumulated amortization expense of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as of December 31, 2022 and 2021, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization expense related to right-of-use assets was</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million the years ended December 31, 2022, 2021 and 2020 and is included in depreciation expense.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144468320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_LesseeOperatingAndFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 7. Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2018, the Company entered into a noncancelable facility lease agreement (the &#8220;Lease&#8221;) for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,836</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> square feet of research and development and office space in Cambridge, Massachusetts. In March 2020, the Company signed a termination agreement for this lease which was determined to be a lease modification that resulted in a reduction of the right-of-use asset and liability of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. The lease termination was effective </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 31, 2020</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the Company no longer has any obligations under the Lease.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2019, the Company entered into a facility sublease agreement (the &#8220;Sublease&#8221;) for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,471</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> square feet of office space in Cambridge, Massachusetts. The term of the lease began on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 24, 2019</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and terminated on June 30, 2020, and following termination, the Company had no further obligations under the Sublease. The Sublease required the Company to share in prorated operating expenses and property taxes based upon actual amounts incurred; those amounts were considered variable lease costs and, therefore, are not included in the measurement of the lease and are instead recognized to expense as incurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2019, the Company entered into a noncancelable facility lease agreement (the &#8220;the 2019 Lease&#8221;) for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,522</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> square feet of research and development and office space in Watertown, Massachusetts. The term of the 2019 Lease is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months and expires on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2030</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The 2019 Lease has an option to be extended for an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">s. The lease is not reasonably certain to be extended and as such the additional term is not included in the measurement of the lease. The 2019 Lease includes a rent escalation clause, and rent expense is being recorded on a straight-line basis. The Company received a tenant incentive allowance of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in 2020 as the tenant improvements were completed all of which has been collected from its landlord as of December 31, 2022. In accordance with the lease agreement, the Company is required to maintain a security deposit and provided a letter of credit to the landlord for $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which is recorded in restricted cash as of December 31, 2022 and 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2021, the Company entered into a noncancelable lease (the "2021 Lease") for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100,624</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> square feet of office and laboratory space in Watertown, Massachusetts, which the Company expects to begin occupying in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_6df59bfa-c32d-4351-8e0b-684185a0ee07;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 2023</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The  2021 Lease is subject to base rent of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million per month beginning two months after the commencement date, plus the Company&#8217;s ratable share of taxes, maintenance and other operating expenses. Base rent is subject to a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% annual increase over the lease term of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">following the commencement date. The Company also has two consecutive options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">extend the term of the lease for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> each at then-market rates. The 2021 Lease also includes a tenant improvement allowance of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. In connection with the signing of the 2021 Lease, the Company issued a letter of credit for $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million which is classified as restricted cash as of December 31, 2022. The Company also paid first month&#8217;s rent of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million upon execution of the 2021 Lease in December 2021 which is classified as other non-current assets as of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. As of December 31, 2022, the Company has not taken control of the space associated with the 2021 Lease and therefore, the Company has not recorded a right of use asset or lease liability related to the space as of December 31, 2022.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s financing lease obligations consist of certain property and equipment financed through capital leases.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of the lease costs for the years ended December 31, 2022 and 2021 (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.685%;"/>
        <td style="width:1.613%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.902000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.613%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.188%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,095</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,095</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing lease costs:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of right-to-use assets, financing<br/>&#160;&#160;&#160;leases</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,184</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">906</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense for financing lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">179</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">158</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,192</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,015</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,650</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,174</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental cash flow information relating to the Company&#8217;s leases for the years ended December 31, 2022 and 2021 were as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.02%;"/>
        <td style="width:1.578%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.364%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.592%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.448%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash paid for amounts included in the measurement<br/>&#160;&#160;&#160;of lease liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating cash flows used in operating leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,581</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,691</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating cash flows used in finance leases</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,130</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">933</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing cash flows used in finance leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">179</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">158</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average remaining lease terms and discount rates as of December 31, 2022 and 2021 were as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.844%;"/>
        <td style="width:1.139%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.696%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.139%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.183%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining lease term:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.3 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing lease</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Discount Rate:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing lease</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.5</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.8</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The undiscounted future lease payments for operating and finance leases as of December 31, 2022, were as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.274%;"/>
        <td style="width:1.572%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.79%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.572%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.79%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal Year</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating<br/>Leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing<br/>Leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,659</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,463</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,732</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">839</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,814</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">402</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,898</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,041</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,129</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,936</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less amounts representing interest or imputed interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,448</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">282</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Present value of lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,681</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,654</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excluded from the table above are all future payments related to the 2021 Lease.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_LesseeOperatingAndFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating and finance leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_LesseeOperatingAndFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144468320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 8. Accrued Expenses</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consist of the following as of December 31, 2022 and 2021 (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.015%;"/>
        <td style="width:1.592%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.359%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.592%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.441999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,975</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,169</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payroll and payroll-related</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,149</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,033</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Professional fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,971</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,417</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">407</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">352</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,502</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,971</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144548528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Other Commitments and Contingencies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 9. Other Commitments and Contingencies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Legal Proceedings</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the ordinary course of business, the Company may be subject to legal proceedings, claims and litigation as the Company operates in an industry susceptible to patent legal claims. The Company accounts for estimated losses with respect to legal proceedings and claims when such losses are probable and estimable. Legal costs associated with these matters are expensed when incurred. The Company is not currently a party to any legal proceedings.</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Indemnification Arrangements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As permitted under Delaware law, the Company has agreements whereby it indemnifies its investors, employees, officers, and directors (collectively, the &#8220;Indemnified Parties&#8221;) for certain events or occurrences while the Indemnified Parties are, or were serving, at its request in such capacity. The term of the indemnification period is for the Indemnified Parties&#8217; lifetime. The Company believes the estimated fair value of these indemnification agreements is minimal. The Company enters into standard indemnification agreements in the ordinary course of business. Pursuant to these agreements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally the Company&#8217;s business partners or customers, in connection with any U.S. patent or any copyright or other intellectual property infringement claim by any third party with respect to the Company&#8217;s products. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. The Company is not aware of any claims under indemnification arrangements, and it has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t accrued any liabilities related to such obligations as of December 31, 2022, 2021 or 2020.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144551008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Convertible Preferred Stock</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 10. Convertible Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Immediately prior to the IPO, the Company&#8217;s Certificate of Incorporation authorized a total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52,483,788</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of convertible preferred stock with a par value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, of which </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares were designated as Series Seed Preferred Stock, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,886,305</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares were designated as Series A Preferred Stock, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,009,845</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares were designated as Series B Preferred Stock, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,059,695</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares were designated as Series B-1 Preferred Stock and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,527,943</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares were designated as Series C Preferred Stock. The Series A, Series B, Series B-1 and Series C convertible preferred stocks will be collectively referred to as the Convertible Preferred Stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2020, the Company issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,182,265</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series B Preferred Stock at $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.06</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share to complete the second closing of the Series B Preferred Stock issuance for total proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. The issuance costs related to the second tranche were insignificant.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2020, the Company executed a Series C Preferred Stock Purchase Agreement (the &#8220;Series C SPA&#8221;) to issue </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,539,141</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C Preferred Stock at a purchase price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.5366</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share for a total consideration of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, net of issuance costs of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. In conjunction with the Series C SPA, the Company exchanged </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,988,802</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series A Preferred Stock for an equal number of shares of Series C Preferred Stock related to a transaction amongst investors. This resulted in a total issuance of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,527,943</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C Preferred Stock. The fair value of the shares of Series C Preferred Stock issued exceeded the carrying value of the shares of Series A Preferred Stock exchanged by $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">which was</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">recognized </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">as a deemed dividend through a reduction of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million to additional paid-in capital and an increase of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million to the accumulated deficit. The $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million deemed dividend increased the net loss for the year ending December 31, 2020 to arrive at net loss attributable to common stockholders in the calculation of earnings per share.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Company&#8217;s August 25, 2020 IPO all issued and outstanding Convertible Preferred Stock of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50,439,595</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> were converted to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31,625,534</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#8217;s common stock and were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> longer issued or outstanding as of December 31, 2020.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144543744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity-Based Compensation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 11. Equity-Based Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2018 Stock Option and Grant Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In November 2018, the Company adopted, and its stockholders approved, the 2018 Stock Option and Grant Plan (the &#8220;2018 Plan&#8221;), which provides for the granting of stock options and other equity-based awards at the discretion of the Board of Directors or any subcommittee of the Board of Directors to the Company's employees, officers, directors, and independent contractors. No further grants will be made under the 2018 Plan. However, the 2018 Plan will continue to govern outstanding equity awards granted thereunder. To the extent outstanding options granted under the 2018 Plan are cancelled, forfeited or otherwise terminated without being exercised and would otherwise have been returned to the share reserve under the 2018 Plan, the number of shares underlying such awards will be available for future grant under the 2020 Stock Option and Incentive Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2020 Stock Option and Incentive Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the Company and its stockholders approved the 2020 Stock Option and Incentive Plan (the &#8220;2020 Plan&#8221;), which became effective on August 20, 2020. The 2020 Plan replaced the 2018 Plan as the Company&#8217;s Board of Directors has determined not to make additional awards under the 2018 Plan following the closing of the Company&#8217;s IPO. The 2020 Plan allows the Company to make equity-based and cash-based incentive awards to its officers, employees, directors and consultants. The Company has initially reserved </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,457,370</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock for the issuance of awards under the 2020 Plan, which includes the shares of common stock remaining available for issuance under its 2018 Plan as of the business day immediately prior to the effective date of the registration statement. The 2020 Plan provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2021 and each January 1 thereafter, by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Company&#8217;s outstanding number of shares of common stock on the immediately preceding December 31, or such lesser number of shares as determined by the Company&#8217;s compensation committee. These limits are subject to adjustment in the event of a stock split, stock dividend or other change in the Company&#8217;s capitalization. As of December 31, 2022, there were an aggrega</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">te of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,744,415</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> remaining available for future grants.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2020 Employee Stock Purchase Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the Company and its stockholders approved the 2020 Employee Stock Purchase Plan (the &#8220;2020 ESPP&#8221;), which became effective August 20, 2020. The 2020 ESPP initially reserves and authorizes the issuance of up to a total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">445,653</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock to participating employees. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2020 ESPP provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2021 and each January 1 thereafter through January 1, 2030, by the lessor of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">438,898</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Company&#8217;s outstanding number of shares of common stock on the immediately preceding December 31 or (iii) such lesser number of shares of common stock as determined by the administrator of the 2020 ESPP.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The number of shares reserved under the 2020 ESPP is subject to adjustment in the event of a stock split, stock dividend or other change in the Company&#8217;s capitalization. As of December 31, 2022, there were an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,208,252</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares remaining available for future grants.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock Options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of stock option activity under the 2020 Plan during the year ended December 31, 2022 is as follows (in thousands except share and per share data):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.337%;"/>
        <td style="width:0.856%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.870000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.008%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.295%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.856%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.144%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.091%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.543%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br/>Options<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br/>Average<br/>Strike<br/>Price per<br/>Option</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,239,182</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.91</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.56</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">246,933</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,761,441</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35.33</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">601,594</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.24</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">641,740</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33.89</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,757,289</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27.60</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.01</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55,934</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercisable at December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,505,520</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.27</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.61</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38,500</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The intrinsic value of stock options exercised during the years ended December 31, 2022, 2021 and 2020 wa</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">s $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average fair value of options granted during the years ended December 31, 2022, 2021 and 2020 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.18</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29.95</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.35</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the total unrecognized stock-based compensation expense for unvested stock options was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which is expected to be recognized over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table outlines equity-based compensation expense for stock options for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.541%;"/>
        <td style="width:1.374%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.654%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.374%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.654%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.374%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.654%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.374%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,388</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,161</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,084</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,941</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,628</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,864</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,329</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,789</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,948</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average assumptions that the Company used in the Black-Scholes option pricing model to determine the grant date fair value of stock options granted to employees and non-employees for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.193%;"/>
        <td style="width:1.052%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.535%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.052%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.657%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.052%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.457%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.86</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.87</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.09</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Common Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has granted shares of restricted common stock with service-based and performance-based vesting conditions. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of restricted stock activity under the 2018 Plan during the year ended December 31, 2022 is as follows: </span></span><span style=""/></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.152%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.443%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.607%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.676%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br/>Units<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grant Date<br/>Fair Value<br/>per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,745</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.60</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">295,892</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24.01</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,866</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.60</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,928</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29.93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">281,843</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.64</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company granted </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">295,892</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,500</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of restricted stock during the years ended December 31, 2022 and December 31, 2021, respectively. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> grants of restricted stock for the year ended December 31, 2020. The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t grant any restricted stock to consultants for the year ended December 31, 2022 and granted </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,500</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of restricted common stock to consultants which were fully vested at the time of grant during the year ended December 31, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the total unrecognized stock-based compensation expense for unvested restricted stock was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  million, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">which is expected to be recognized ov</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">er </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the years ended December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company recorded stock-based compensation expense for restricted stock of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. During the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company recorded stock-based compensation expense of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, within research and development.  During the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company recorded stock-based compensation expense of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, and an immaterial amount, respectively, within general and administrative.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">      </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equity-Based Compensation Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation expense recorded as research and development and general and administrative expenses for employees, directors, and non-employees during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020 is as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.442%;"/>
        <td style="width:1.473%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.621%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.473%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.621%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.374%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.621%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.374%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Years ending December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,008</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,731</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,305</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,472</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,241</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,885</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35,480</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,972</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,190</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144484256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 12. Related-Party Transactions</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to the collaboration discussed in Note 5, the Company had the following related party transactions for the periods presented in the accompanying consolidated financial statements, which has not otherwise been discussed in these notes to the consolidated financial statement. The Company made payments of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million to an investor for rent expenses for the year ended December 31, 2020. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> payments were made to related parties during the years ended December 31, 2022 and 2021.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144484256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 13. Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company records income tax expense related to profits realized by its U.S. operating subsidiaries. For the years ended December 31, 2022, 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">021 and 2020, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> income tax expense was recorded due the group&#8217;s net operating loss (&#8220;NOL&#8221;) and full valuation allowance.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The rate reconciliation of the U.S. statutory income tax rate to the Company&#8217;s effective tax rate for the years ended December 31, 2022, 2021 and 2020 are as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.06%;"/>
        <td style="width:1.327%;"/>
        <td style="width:12.443%;"/>
        <td style="width:1.996%;"/>
        <td style="width:1.327%;"/>
        <td style="width:12.443%;"/>
        <td style="width:2.008%;"/>
        <td style="width:10.399%;"/>
        <td style="width:1.996%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax effect at statutory rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State taxes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.4</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.8</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.6</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permanent differences</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal research and development credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.6</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of the Company&#8217;s net deferred income taxes are as follows (in thousands):</span></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.612%;"/>
        <td style="width:1.565%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.36%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.551%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.36%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.551%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="8" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Deferred Tax Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32,320</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,957</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,835</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,651</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development credit carryforwards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,581</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,611</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,011</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,285</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,315</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,130</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accruals and reserves, stock and other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,350</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,156</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized Research and Development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,435</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125,847</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83,790</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120,096</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77,990</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,751</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,800</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fixed and intangible assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,187</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,941</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,564</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,859</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred tax asset</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As required by ASC 740, management of the Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets, which are composed principally of NOL carryforwards and research and development credit carryforwards. Management has determined that it is more likely than not that the Company will not recognize the benefits of its federal and state deferred tax assets, and, as a result, a valuation allowance of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million has been established at December 31, 2022 and 2021, respectively. During 2022, the valuation allowance increased by $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million primarily due to the increase in the Company&#8217;s NOL during the period.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beginning in 2022, Tax Cuts and Jobs Act (TCJA) amended Section 174 and now requires U.S.-based and non-U.S-based research and experimental (R&amp;E) expenditures to be capitalized and amortized over a period of five or 15 years, respectively, for amounts paid in tax years starting after December 31, 2021. Prior to the TCJA amendment, Section 174 allowed taxpayers to immediately deduct R&amp;E expenditures in the year paid or incurred.   The Company has applied this required change in accounting method beginning in 2022 and the computation may be adjusted pending future IRS guidance.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has incurred NOLs from inception. At December 31, 2022 and 2021, the Company has federal NOL carryforwards of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">153.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">123.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, and state NOL carryforwards of approximately</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">139.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">105.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. Of the federal net operating loss carryovers, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">144.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million is not subject to expiration and the remaining federal and state NOLs begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2036</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. These loss carryforwards are subject to review and possible adjustment by the appropriate taxing authorities.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Utilization of net operating loss and research and development credit carryforwards may generally be subject to limitation under Sections 382 and 383 of the Internal Revenue Code due to ownership changes that have occurred previously, or that could occur in the future. These ownership changes may limit the amount of net operating loss and research and development credit carryforwards that can be utilized annually to offset any post-ownership change taxable income and tax, respectively. The latest Section 382 study was performed through December 31, 2022, noting that historic ownership changes have likely occurred. Nonetheless, the Company has determined that as of December 31, 2022 the prospective utilization of all net operating loss and tax credit carryforwards generated from inception through December 31, 2022, and therefore the corresponding Federal and Massachusetts deferred tax assets, should not be restricted by Sections 382 and 383, although ownership changes after December 31, 2022 could impact the Company&#8217;s ability to utilize these tax attributes in the future.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At December 31, 2022 and 2021 the Company had federal research and development credit carryforwards of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, and state research and development credit carryforwards of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. These carryforwards begin to expire in 2031.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company follows the provisions of ASC 740-10, &#8220;Accounting for Uncertainty in Income Taxes,&#8221; which specifies how tax benefits for uncertain tax positions are to be recognized, measured, and recorded in financial statements; requires certain disclosures of uncertain tax matters; specifies how reserves for uncertain tax positions should be classified on the balance sheet; and provides transition and interim period guidance, among other provisions. As of December 31, 2022, and 2020, the Company has not recorded any amounts for uncertain tax positions. The Company&#8217;s policy is to recognize interest and penalties accrued on any uncertain tax positions as a component of income tax expense, if any, in its statements of income. As of December 31, 2022 and 2021, the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reserves for uncertain tax positions. For the years ended December 31, 2022 and 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> estimated interest or penalties were recognized on uncertain tax positions.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has not conducted a study of its research and development credit carryforwards. This study may result in an adjustment to research and development credit carryforwards; however, until a study is completed, and any adjustment is known, no amounts are being presented as an uncertain tax position. A full valuation allowance has been provided against the Company&#8217;s research and development credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the balance sheets or statements of operations if an adjustment were required.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company's tax returns for the years ended</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> December 31, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2019</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to December 31, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> remain open and subject to examination by the Internal Revenue Service and state taxing authorities.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144708624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 14. Net Loss per Share</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net Loss per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic and diluted loss per share is computed by dividing net loss by the weighted-average common shares outstanding for the period, including the pre-funded warrants given their nominal exercise price (in thousands, except for share and per share data):</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;">&#160;</p>
      <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:56.524%;"/>
        <td style="width:1.385%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.375%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.652000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.375%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.652000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.375%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">154,808</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100,217</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,593</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deemed dividend from exchange of convertible<br/>&#160;&#160;&#160;preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,050</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss attributable to common stockholders</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">154,808</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100,217</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54,643</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Denominator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average common shares outstanding, basic<br/>&#160;&#160;&#160;and diluted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53,933,229</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47,989,023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,349,582</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.87</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.09</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s potentially dilutive securities, which include convertible preferred stock, restricted stock, and stock options, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders at December 31, 2022, 2021 and 2020 because including them would have had an anti-dilutive effect:</span></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:57.826%;"/>
        <td style="width:1.014%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.541%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.024%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.541%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.024%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.622%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.409%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested Restricted Stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">281,843</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,745</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110,104</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options to purchase Common Stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,757,289</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,239,182</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,580,924</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,039,132</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,276,927</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,691,028</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822140499088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary Kymera Securities Corporation. All intercompany transactions and balances have been eliminated in consolidation.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amounts of expenses during the reporting period. Management&#8217;s estimates and judgments are derived and continually evaluated based on available information, historical experience and various other assumptions that are believed to be reasonable under the circumstances. Because the use of estimates is inherent in the financial reporting process, actual results could differ from those estimates. In recording transactions and balances resulting from business operations, management makes estimates based on the best information available at the time the estimate is made. Significant estimates relied upon in preparing these financial statements include revenue recognized under our collaboration agreement with Sanofi and Vertex, accrual for research and development expenses, equity-based compensation expense, and the valuation of equity prior to the Company's initial public offering. As better information becomes available or actual amounts are determinable, the recorded estimates are revised. Consequently, operating results can be affected by revisions to prior estimates.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_SegmentAndGeographicInformationPolicyTextBlock', window );">Segment and Geographic Information</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Segment and Geographic Information</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company&#8217;s chief operating decision maker is the Chief Executive Officer. The Company views its operations and manages its business in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> operating segment.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents are highly liquid investments that are readily convertible into cash with original maturities of three months or less when purchased. These assets include investments in money market funds that invest in U.S. Treasury obligations and corporate bonds. The Company maintains its bank accounts at major financial institutions.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_RestrictedCashPolicyPolicyTextBlock', window );">Restricted Cash</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash represents the cash held to secure letters of credit associated with the Company&#8217;s facility leases.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company classifies marketable securities with a remaining maturity of greater than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three months</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> when purchased as available-for-sale. The Company classifies investments available to fund current operations as current assets on its balance sheets. Marketable securities with a remaining maturity date greater than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are classified as non-current. Available-for-sale securities are maintained by investment managers and consist of U.S. Treasury securities and corporate bonds. Available-for-sale securities are carried at fair value with the unrealized gains and losses included in other comprehensive income (loss) as a component of stockholders&#8217; equity until realized. Any premium or discount arising at purchase is amortized and/or accreted to interest income and/or expense over the life of the instrument. Realized gains and losses are determined using the specific identification method and are included in other (expense) income, net.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company&#8217;s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer&#8217;s industry, and any significant deterioration in economic conditions.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 1&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted prices in active markets for identical assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 2&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar asset, or other inputs that are observable or can be corroborated by observable market data.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 3&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets, including pricing models, discounted cash flow methodologies and similar techniques.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The carrying values of the Company&#8217;s cash equivalents, prepaid expenses, accounts payable, and certain accruals approximate their fair value due to their short-term nature.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Leases that are economically similar to the purchase of assets are generally classified as finance leases; otherwise the leases are classified as operating leases. The Company has elected not to recognize leases with an original term of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or less on the balance sheet. Options to renew a lease are not included in the Company&#8217;s assessment unless there is reasonable certainty that the Company will renew. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets, lease liabilities and, if applicable, long-term lease liabilities. Lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. However, certain adjustments to the right-of-use asset may be required for items such as incentives received. The Company has elected as an accounting policy to combine lease and non- lease components, such as common area maintenance, for all classes of underlying assets. The interest rate implicit in lease contracts has not historically been readily determinable. As a result, the Company utilizes its incremental borrowing rates, which are the rates incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. To estimate its incremental borrowing rate, a credit rating applicable to the Company is estimated using synthetic credit rating analysis since the Company does not currently have a rating agency-based credit rating.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment are recorded at cost, net of accumulated depreciation. Major additions and betterments are capitalized; maintenance and repairs, which do not improve or extend the life of the respective assets, are charged to operations as incurred. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset as follows:</span></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:62.619%;"/>
          <td style="width:0.208%;"/>
          <td style="width:37.173%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated Useful Life</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in years)</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Office equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shorter of life of lease or remaining lease term</span></span></p></td>
         </tr>
        </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon retirement or sale, the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction-in-progress is stated at cost, which includes direct costs attributable to the setup or construction of the related asset. Depreciation expense is not recorded on construction-in-progress until the relevant assets are completed and put into use.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Long-lived assets (including right-of-use assets) to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value, determined based on discounted cash flows. The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t record any impairment losses on long-lived assets during the years ended December 31, 2022, 2021 and 2020.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ConvertiblePreferredStockPolicyTextBlock', window );">Convertible Preferred Stock</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company classified convertible preferred stock as temporary equity in the accompanying consolidated statement of Convertible Preferred Stock and Stockholders&#8217; Equity due to terms that allow for redemption of the shares in cash upon certain change in control events that are outside of the Company&#8217;s control, including the sale or transfer of the Company as holders of the convertible preferred stock which could trigger redemption of the shares. The Company did not accrete the value of the convertible preferred stock to the redemption values since a liquidation event was not considered probable prior to the conversion date. In connection with the Company&#8217;s initial public offering on August 25, 2020, all outstanding shares of convertible preferred stock converted to common stock.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Warrants</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determines the accounting classification of warrants that are issued, as either liability or equity, by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and then in accordance with ASC 815-40, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#8217;s Own Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Under ASC 480-10, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate the issuer to settle the warrants or the underlying shares by paying cash or other assets, or must or may require settlement by issuing variable number of shares.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If warrants do not meet liability classification under ASC 480-10, the Company assesses the requirements under ASC 815-40, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature. If the warrants do not require liability classification under ASC 815-40, in order to conclude equity classification, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable U.S. GAAP. After all relevant assessments are made, the Company concludes whether the warrants are classified as liability or equity. Liability classified warrants are required to be accounted for at fair value both on the date of issuance and on subsequent accounting period ending dates, with all changes in fair value after the issuance date recorded in the statements of operations as a gain or loss. Equity classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Costs</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development costs consist primarily of costs incurred in connection with the discovery and development of targeted protein degradation therapeutics, including those in the Company&#8217;s most advanced development programs, IRAK4, IRAKIMiD, STAT3 and MDM2. These research efforts and costs, which also support the development of, and enhancements to, the Company&#8217;s Pegasus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> targeted protein degradation platform, include external research costs, personnel costs, supplies, license fees and facility related expenses. The Company expenses research and development costs as incurred.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_PatentCostsPolicyTextBlock', window );">Patent Costs</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent Costs</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recoverability of the expenditure. Amounts incurred are classified as general and administrative expenses.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_FinancingCostsPolicyTextBlock', window );">Financing Costs</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Costs</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Costs incurred in connection with the issuance of equity units and shares are recorded as a reduction of proceeds to the equity carrying value. The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process financings as deferred offering costs until such financings are consummated. After consummation of the financing, these costs are recorded as a reduction of the proceeds received from the financing. If a planned financing is abandoned, the deferred offering costs are expensed immediately as a charge to operating expenses in the consolidated statement of operations and comprehensive loss. There was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> deferred offering costs on the Company&#8217;s consolidated balance sheet at December 31, 2022 and December 31, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under ASC 606, Topic 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers (&#8220;ASC 606&#8221;)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,  the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the contract(s) with the customer; (ii) identification of the promised goods or services in the contract and determination of whether the promised goods or services are performance obligations; (iii) measurement of the transaction price; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As part of the accounting for these arrangements, the Company must use significant judgment to determine: a) the number of performance obligations based on the determination under step (ii) above and whether those performance obligations are distinct from other performance obligations in the contract; b) the transaction price under step (iii) above; and c) the standalone selling price for each performance obligation identified in the contract for the allocation of transaction price in step (iv) above. The Company uses judgment to determine whether milestones or other variable consideration, except for royalties, should be included in the transaction price as described further below. The transaction price is allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. In determining the stand-alone selling price of a license to the Company&#8217;s proprietary technology or a material right provided by a customer option, the Company considers market conditions as well as entity-specific factors, including those factors contemplated in negotiating the agreements as well as internally developed estimates that include assumptions related to the market opportunity, estimated development costs, probability of success and the time needed to commercialize a product candidate pursuant to the license. In validating its estimated stand-alone selling prices, the Company evaluates whether changes in the key assumptions used to determine its estimated stand-alone selling prices will have a significant effect on the allocation of arrangement consideration between performance obligations.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the transaction price based on the amount of consideration the Company expects to be received for transferring the promised goods or services in the contract. The consideration may include both fixed consideration and variable consideration. At the inception of each arrangement that includes variable consideration, the Company evaluates the amount of the potential payments and the likelihood that the payments will be received. The Company utilizes either the most likely amount method or expected value method to estimate the transaction price based on which method better predicts the amount of consideration expected to be received. If it is probable that a significant revenue reversal would not occur, the variable consideration is included in the transaction price.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer. Promised goods or services are considered distinct when: (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on their own and whether the required expertise is readily available.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation in order to determine whether the combined performance obligation is satisfied over time or at a point in time. The Company receives payments from customers based on billing schedules established in each contract. Up-front payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#8217;s right to consideration is unconditional. Amounts recognized as revenue, but not yet received or invoiced are generally recognized as contract assets.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Exclusive Licenses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;If the license granted in the arrangement is determined to be distinct from the other promises or performance obligations identified in the arrangement, which generally include research and development services, the Company recognizes revenue from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. In assessing whether a license is distinct from the other promises, the Company considers relevant facts and circumstances of each arrangement, including the research and development capabilities of the collaboration partner and the availability of the associated expertise in the general marketplace. In addition, the Company considers whether the collaboration partner can benefit from the license for its intended purpose without the receipt of the remaining promise, whether the value of the license is dependent on the unsatisfied promise, whether there are other vendors that could provide the remaining promise, and whether it is separately identifiable from the remaining promise. For licenses that are combined with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition based on estimated remaining research and development costs. The calculation of the total remaining estimated research and development costs includes forecasted costs associated with internal employee efforts, materials costs, and third-party contract costs, as well as the assumed timing and duration of these activities. The recognition of revenue pursuant to collaboration arrangements is subject to these judgments made and estimates developed by management and is sensitive to changes in these assumptions. Therefore, the measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the arrangement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Services</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;The promises under the Company&#8217;s collaboration and license agreements generally include research and development services to be performed by the Company on behalf of the collaboration partner. For performance obligations that include research and development services, the Company generally recognizes revenue allocated to such performance obligations based on an appropriate measure of progress. The Company utilizes judgment to determine the appropriate method of measuring progress for purposes of recognizing revenue, which is generally an input measure, such as costs incurred. The Company evaluates the measure of progress each reporting period as described under Exclusive Licenses above. Reimbursements from the partner that are the result of a collaborative relationship with the partner, instead of a customer relationship, such as co-development activities, are generally recorded as a reduction to research and development expense.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Customer Options</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;The Company&#8217;s arrangements may provide a collaborator with the right to certain optional purchases, such as the right to license a target either at the inception of the arrangement or within a pre-defined option period. Under these agreements, fees may be due to the Company at the inception of the arrangement as an upfront fee or payment or upon the exercise of an option to acquire a license. If an arrangement is determined to contain customer options that allow the customer to acquire additional goods or services, the goods and services underlying the customer options are not considered to be performance obligations at the outset of the arrangement, as they are contingent upon option exercise. The Company evaluates the customer options for material rights, or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the inception of the arrangement. The Company allocates the transaction price to material rights based on the relative stand-alone selling price, which is determined based on the identified discount, and the probability that the customer will exercise the option. Amounts allocated to a material right are not recognized as revenue until, at the earliest, the option is exercised or expires.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Milestone Payments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;At the inception of each arrangement that includes milestone payments based on certain events, the Company evaluates whether the milestones are considered probable of being achieved and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The Company evaluates factors such as the scientific, clinical, regulatory, commercial, and other risks that must be overcome to achieve the particular milestone in making this assessment. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. At the end of each subsequent reporting period, the Company reevaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. If a milestone or other variable consideration relates specifically to the Company&#8217;s efforts to satisfy a single performance obligation or to a specific outcome from satisfying the performance obligation, the Company generally allocates the milestone amount entirely to that performance obligation once it is probable that a significant revenue reversal would not occur.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Royalties</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;For arrangements that include sales-based royalties, including milestone payments based on a level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue resulting from any of its licensing arrangements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Collaboration revenue&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company analyzes its collaboration arrangements to assess whether they are within the scope of ASC 808,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Collaborative Arrangements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (&#8220;ASC 808&#8221;) to determine whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and those that are more reflective of a vendor-customer relationship and therefore within the scope of Topic 606. For elements of collaboration arrangements that are accounted for pursuant to ASC 808, an appropriate recognition method is determined and applied consistently, generally by analogy to Topic 606. For those elements of the arrangement that are accounted for pursuant to Topic 606, the Company applies the five-step model described above.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock', window );">Costs Associated with License and Collaborative Arrangements</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Costs associated with License and Collaborative Arrangements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Costs associated with licenses of technology acquired as part of collaborative arrangements are expensed as incurred and are generally included in research and development expense in the consolidated statements of operations.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounts Receivable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company extends credit to customers based on its evaluation of the customer&#8217;s financial condition. The Company records receivables for all billings when amounts are due under standard terms. Accounts receivable are stated at amounts due net of applicable prompt pay discounts and other contractual adjustments as well as an allowance for doubtful accounts. The Company assesses the need for an allowance for doubtful accounts by considering a number of factors, including the length of time trade accounts receivable are past due, the customer&#8217;s ability to pay its obligation and the condition of the general economy and the industry as a whole. The Company will write off accounts receivable when the Company determines that they are uncollectible. In general, the Company has experienced no significant collection issues with its customers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for all stock-based awards granted to employees, directors, and nonemployees based on their fair value on the date of the grant and recognize compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. Stock-based payments include stock options and grants of common stock, including common stock subject to vesting. The measurement date for stock awards is the date of grant, and stock-based compensation costs are recognized as expense over the requisite service period, which is the vesting period, on a straight-line basis. The Company has issued stock options and restricted stock with performance-based vesting conditions and records the expense for these awards if the Company concludes that it is probable that the performance condition will be achieved. Stock-based compensation is classified in the accompanying consolidated statements of operations and comprehensive loss based on the function to which the related services are provided. The Company recognizes stock-based compensation expense for the portion of awards that have vested. Forfeitures are accounted for as they occur.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes options-pricing model, which requires inputs based on certain subjective assumptions, including the expected stock price volatility, the expected term of the option, the risk-free interest rate for a period that approximates the expected term of the option, and the Company&#8217;s expected dividend yield. Prior to the IPO, as there was no active market for the Company&#8217;s common stock, the Company estimated the fair value of common stock on the date of grant based on the then current facts and circumstances. Upon becoming a public company, the fair value of the underlying common shares equals the closing price of the Company&#8217;s stock on the date of grant. As the Company&#8217;s IPO was in 2020, the Company  lacks a sufficient period of company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of guideline companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#8217;s stock options has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain-vanilla&#8221; options. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#8217;s common stock on that same date.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compensation expense for discounted purchases under the employee stock purchase plan is measured using the Black-Scholes model to compute the fair value of the lookback provision plus the purchase discount and is recognized as compensation expense over the offering period.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company records income taxes in accordance with FASB Accounting Standards Codification Topic 740, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (&#8220;ASC 740&#8221;), which provides for deferred taxes using an asset and liability approach. Under this method, deferred income tax assets and liabilities are recognized based on future income tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities, and their respective income tax basis. Deferred income tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of changes in income tax rates on deferred income tax assets and liabilities is recognized as income or expense in the period that a valuation allowance for any income tax benefits of which future realization is not more likely than not.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company provides reserves for potential payments of tax to various tax authorities related to uncertain tax positions. The tax benefits recorded are based on a determination of whether and how much of a tax benefit taken by the Company in its tax filings or positions is &#8220;more likely than not&#8221; to be realized following resolution of any uncertainty related to the tax benefit, assuming that the matter in question will be raised by the tax authorities.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock', window );">Off Balance Sheet Risk and Concentration of Credit Risk</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Off Balance Sheet Risk and Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has no significant off-balance sheet risk such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and restricted cash. The Company&#8217;s cash, cash equivalents, and restricted cash are deposited in accounts at large financial institutions. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash, cash equivalents and restricted cash are held. The Company maintains its cash equivalents in money market funds that invest in U.S. Treasury securities and U.S. Treasury obligations and corporate bonds. The Company&#8217;s marketable securities primarily consist of corporate bonds and U.S. Treasury securities paper, and potentially subject the Company to concentrations of credit risk. The Company has adopted an investment policy that limits the amounts the Company may invest in any one type of investment. The Company has not experienced any credit losses and does not believe it is exposed to any significant credit risk on these funds.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss includes net loss as well as unrealized gains and losses on marketable securities and other changes in stockholders&#8217; equity (deficit) that result from transactions and economic events other than those with stockholders.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net Loss Per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company applies the two-class method to compute basic and diluted net income (loss) per share attributable to common stockholders when it has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income (loss) available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to share in the earnings as if all income (loss) for the period had been distributed. The Company&#8217;s convertible preferred stock participates in any dividends declared by the Company and are therefore considered to be participating securities. The participating securities are not required to participate in the losses of the Company, and therefore during periods of loss there is no allocation required under the two-class method.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including the pre-funded warrants given their nominal exercise price. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) per share attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including potential dilutive common shares. For purpose of this calculation, outstanding options to purchase common stock, unvested restricted stock awards, and shares of convertible preferred stock are considered potential dilutive common shares. The Company has generated a net loss in all periods presented, and therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Standards</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The Company adopted ASU 2020-06 effective as of January 1, 2022. The adoption of ASU 2020-06 did not have an impact on the Company&#8217;s financial statements.</span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Standards</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The Company adopted ASU 2020-06 effective as of January 1, 2022. The adoption of ASU 2020-06 did not have an impact on the Company&#8217;s financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ConvertiblePreferredStockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ConvertiblePreferredStockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs associated with license and collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_FinancingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_FinancingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Off balance sheet risk and concentration of credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_PatentCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Patent costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_PatentCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_RestrictedCashPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted cash policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_RestrictedCashPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_SegmentAndGeographicInformationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Segment and geographic information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_SegmentAndGeographicInformationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144652496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock', window );">Summary of Estimated Useful Life of Related Asset</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset as follows:</span><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:62.619%;"/>
          <td style="width:0.208%;"/>
          <td style="width:37.173%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated Useful Life</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in years)</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Office equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shorter of life of lease or remaining lease term</span></span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of estimated useful life of related asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144434160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents information about the Company&#8217;s financial assets measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values as of December 31, 2022 and December 31, 2021 (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.798%;"/>
        <td style="width:1.049%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.212000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.049%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.212000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.06%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.223%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.06%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.335%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements at<br/>December 31, 2022:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50,551</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50,551</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74,045</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74,045</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120,467</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120,467</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">144,259</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">144,259</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, non-current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,804</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,804</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,653</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,653</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73,871</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73,871</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,130</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,130</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">150,530</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">397,250</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">547,780</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.735%;"/>
        <td style="width:1.058%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.07%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.07%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.07%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.341%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements at<br/>December 31, 2021:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43,182</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43,182</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">169,481</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">169,481</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32,170</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32,170</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">192,791</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">192,791</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities, non-current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,172</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,172</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47,363</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47,363</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,652</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,652</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,116</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,116</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">315,484</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">253,443</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">568,927</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144438752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Available-for-Sale Debt Securities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the available-for-sale debt securities held at December 31, 2022 and 2021 and (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.234%;"/>
        <td style="width:1.208%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.502%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.195%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.49%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.195%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.49%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.195%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.49%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94,958</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,111</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93,850</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agency securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">180,967</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,873</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">179,119</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">220,119</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,014</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">218,130</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">496,044</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,998</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">491,099</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.135%;"/>
        <td style="width:1.208%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.494%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.195%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.468%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.283%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.468%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.283%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.468%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">186,700</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">186,655</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US government agency securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79,657</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79,532</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">253,929</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">488</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">253,442</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">520,286</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">658</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">519,629</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822141334832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Change in Accounts Receivable, Contract Asset and Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents the changes in accounts receivable, contract assets and liabilities for the year ended December 31, 2022 (in thousands)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.959%;"/>
        <td style="width:1.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.102%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.117999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.117999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.102%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at<br/>December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deductions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at<br/>December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable and contract assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Billed receivables &#8211; Sanofi</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,650</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,650</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unbilled receivables &#8211; Sanofi</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,052</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,650</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,537</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accounts receivable and contract assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,702</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,300</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,537</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contract Liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred Revenue &#8211; Vertex</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,212</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,813</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,399</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred Revenue &#8211; Sanofi</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81,822</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,052</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,013</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54,861</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total contract liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101,034</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,052</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46,826</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63,260</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144551008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property and Equipment</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment consists of the following as of December 31, 2022 and 2021 (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.73%;"/>
        <td style="width:1.696%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.439%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.696%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.439%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lab and office equipment under and financing<br/>&#160;&#160;&#160;right-of-use asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,475</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,969</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lab equipment</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,383</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,805</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">357</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">273</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture &amp; fixtures</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,064</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">943</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,802</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,741</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets not yet in service</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,146</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,227</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,797</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less accumulated depreciation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,893</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,916</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,334</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,881</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822139294208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Costs</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of the lease costs for the years ended December 31, 2022 and 2021 (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.685%;"/>
        <td style="width:1.613%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.902000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.613%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.188%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,095</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,095</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing lease costs:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of right-to-use assets, financing<br/>&#160;&#160;&#160;leases</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,184</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">906</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense for financing lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">179</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">158</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,192</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,015</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,650</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,174</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock', window );">Supplemental Cash Flow Information Relating to Leases</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental cash flow information relating to the Company&#8217;s leases for the years ended December 31, 2022 and 2021 were as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.02%;"/>
        <td style="width:1.578%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.364%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.592%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.448%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash paid for amounts included in the measurement<br/>&#160;&#160;&#160;of lease liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating cash flows used in operating leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,581</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,691</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating cash flows used in finance leases</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,130</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">933</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing cash flows used in finance leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">179</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">158</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock', window );">Summary of Weighted Average Remaining Lease Terms and Discount Rates</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average remaining lease terms and discount rates as of December 31, 2022 and 2021 were as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.844%;"/>
        <td style="width:1.139%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.696%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.139%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.183%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining lease term:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.3 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing lease</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Discount Rate:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing lease</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.5</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.8</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Undiscounted Future Lease Payments for Operating and Finance Leases</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The undiscounted future lease payments for operating and finance leases as of December 31, 2022, were as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.274%;"/>
        <td style="width:1.572%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.79%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.572%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.79%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal Year</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating<br/>Leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing<br/>Leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,659</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,463</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,732</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">839</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,814</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">402</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,898</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,041</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,129</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,936</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less amounts representing interest or imputed interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,448</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">282</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Present value of lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,681</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,654</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excluded from the table above are all future payments related to the 2021 Lease.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating and financing lease liability maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of weighted average remaining lease terms and discount rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental cash flow information relating to leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144397936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consist of the following as of December 31, 2022 and 2021 (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.015%;"/>
        <td style="width:1.592%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.359%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.592%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.441999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,975</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,169</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payroll and payroll-related</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,149</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,033</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Professional fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,971</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,417</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">407</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">352</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,502</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,971</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822140660224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of stock option activity under the 2020 Plan during the year ended December 31, 2022 is as follows (in thousands except share and per share data):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.337%;"/>
        <td style="width:0.856%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.870000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.008%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.295%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.856%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.144%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.091%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.543%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br/>Options<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br/>Average<br/>Strike<br/>Price per<br/>Option</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,239,182</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.91</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.56</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">246,933</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,761,441</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35.33</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">601,594</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.24</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">641,740</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33.89</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,757,289</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27.60</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.01</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55,934</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercisable at December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,505,520</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.27</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.61</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38,500</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Equity-Based Compensation Expense</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table outlines equity-based compensation expense for stock options for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.541%;"/>
        <td style="width:1.374%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.654%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.374%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.654%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.374%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.654%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.374%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,388</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,161</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,084</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,941</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,628</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,864</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,329</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,789</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,948</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted-Average Assumptions</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average assumptions that the Company used in the Black-Scholes option pricing model to determine the grant date fair value of stock options granted to employees and non-employees for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.193%;"/>
        <td style="width:1.052%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.535%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.052%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.657%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.052%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.457%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.86</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.87</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.09</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock', window );">Summary of Restricted Stock Activity</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of restricted stock activity under the 2018 Plan during the year ended December 31, 2022 is as follows: </span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.152%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.443%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.607%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.676%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br/>Units<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grant Date<br/>Fair Value<br/>per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,745</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.60</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">295,892</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24.01</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,866</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.60</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,928</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29.93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">281,843</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.64</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Equity-Based Compensation Expense</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation expense recorded as research and development and general and administrative expenses for employees, directors, and non-employees during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020 is as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.442%;"/>
        <td style="width:1.473%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.621%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.473%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.621%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.374%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.621%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.374%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Years ending December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,008</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,731</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,305</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,472</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,241</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,885</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35,480</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,972</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,190</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in restricted stock units (RSUs).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822134985632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Rate Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Tax Rate</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The rate reconciliation of the U.S. statutory income tax rate to the Company&#8217;s effective tax rate for the years ended December 31, 2022, 2021 and 2020 are as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.06%;"/>
        <td style="width:1.327%;"/>
        <td style="width:12.443%;"/>
        <td style="width:1.996%;"/>
        <td style="width:1.327%;"/>
        <td style="width:12.443%;"/>
        <td style="width:2.008%;"/>
        <td style="width:10.399%;"/>
        <td style="width:1.996%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax effect at statutory rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State taxes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.4</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.8</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.6</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permanent differences</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal research and development credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.6</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Significant Components of Net Deferred Income Taxes</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of the Company&#8217;s net deferred income taxes are as follows (in thousands):</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.612%;"/>
        <td style="width:1.565%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.36%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.551%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.36%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.551%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="8" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Deferred Tax Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32,320</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,957</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,835</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,651</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development credit carryforwards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,581</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,611</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,011</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,285</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,315</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,130</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accruals and reserves, stock and other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,350</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,156</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized Research and Development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,435</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125,847</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83,790</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120,096</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77,990</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,751</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,800</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fixed and intangible assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,187</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,941</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,564</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,859</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred tax asset</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822144595920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Summary of Basic and Diluted Loss Per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;">&#160;</p>
      <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:56.524%;"/>
        <td style="width:1.385%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.375%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.652000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.375%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.652000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.375%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">154,808</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100,217</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,593</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deemed dividend from exchange of convertible<br/>&#160;&#160;&#160;preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,050</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss attributable to common stockholders</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">154,808</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100,217</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54,643</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Denominator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average common shares outstanding, basic<br/>&#160;&#160;&#160;and diluted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53,933,229</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47,989,023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,349,582</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.87</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.09</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders Anti-Diluted Effect</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders at December 31, 2022, 2021 and 2020 because including them would have had an anti-dilutive effect:</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:57.826%;"/>
        <td style="width:1.014%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.541%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.024%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.541%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.024%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.622%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.409%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested Restricted Stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">281,843</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,745</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110,104</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options to purchase Common Stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,757,289</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,239,182</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,580,924</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,039,132</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,276,927</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,691,028</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822134455728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Summary of Significant Accounting Policies - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 18, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 06, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 25, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Aug. 20, 2020</div></th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Description Of Business And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Aggregate proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,790<span></span>
</td>
<td class="nump">$ 228,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Cash, cash equivalents and marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On August 20, 2020, the Board approved a 1-for-1.5949 reverse stock split of the Company&#8217;s issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each of the Company&#8217;s outstanding series of preferred stock.  All share and per share amounts in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to this reverse stock split, including reclassifying an amount equal to the reduction in par value of common stock to additional paid-in capital.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=kymr_FollowOnOfferingMember', window );">Follow-on Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Description Of Business And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from sale of common stock in public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 257,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,468,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Description Of Business And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,987,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ProceedsFromIssuanceInitialPublicOfferingGross', window );">Gross proceeds from issuance initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Description Of Business And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">713,250<span></span>
</td>
<td class="nump">1,302,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Vertex Pharmaceuticals Incorporated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Description Of Business And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Aggregate proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,928<span></span>
</td>
<td class="nump">676,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=kymr_PrivateInvestmentInPublicEquityPipeMember', window );">Private Investment in Public Equity "PIPE"</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Description Of Business And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues | shares</a></td>
<td class="nump">2,769,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock per share | $ / shares</a></td>
<td class="nump">$ 26.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Pre-funded warrant purchase price | $ / shares</a></td>
<td class="nump">25.9999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare', window );">Pre-funded warrants per share | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralPartnersOfferingCosts', window );">Offering expenses</a></td>
<td class="nump">$ 149,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_MinimumPreFundedWarrantsExercise', window );">Minimum pre-funded warrants, exercise</a></td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IncreaseOrDecreasePreFundedWarrants', window );">Increase or decrease pre-funded warrants, maximum</a></td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_PriorNoticePeriod', window );">Prior notice period, minimum</a></td>
<td class="text">61 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfWarrants', window );">Pre-funded warrants, exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Pre-funded warrants outstanding | shares</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of business and summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_IncreaseOrDecreasePreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase or decrease pre-funded warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_IncreaseOrDecreasePreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_MinimumPreFundedWarrantsExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum pre-funded warrants, exercise</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_MinimumPreFundedWarrantsExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_PriorNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prior notice period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_PriorNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ProceedsFromIssuanceInitialPublicOfferingGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance initial public offering gross.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ProceedsFromIssuanceInitialPublicOfferingGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralPartnersOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of offering costs allocated to the general partner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB TOPIC 4.F)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187171-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralPartnersOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of investments and unrestricted cash as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=kymr_FollowOnOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=kymr_FollowOnOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=kymr_VertexPharmaceuticalsIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=kymr_VertexPharmaceuticalsIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=kymr_PrivateInvestmentInPublicEquityPipeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=kymr_PrivateInvestmentInPublicEquityPipeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822139677680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segment | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Leases original term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment losses on long-lived assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">ASU 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in accounting principle, accounting standards update, adopted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in accounting principle, accounting standards update, immaterial effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member', window );">ASU 2019-12</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in accounting principle, accounting standards update, adopted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in accounting principle, accounting standards update, immaterial effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_MarketableSecuritiesRemainingMaturityPeriod', window );">Marketable securities, remaining maturity period</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent', window );">Marketable securities, remaining maturity period classified as non-current</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_MarketableSecuritiesRemainingMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable securities, remaining maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_MarketableSecuritiesRemainingMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable securities, remaining maturity period classified as non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL120154346-209984<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31010-122693<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822141212544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Estimated Useful Life of Related Asset (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabEquipmentMember', window );">Lab Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of related asset</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furnitures and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of related asset</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of related asset</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of related asset</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful life of related asset</a></td>
<td class="text">Shorter of life of lease or remaining lease term<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905813&amp;loc=d3e1205-110223<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822140041760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 491,099<span></span>
</td>
<td class="nump">$ 519,629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_RestrictedCashFairValue', window );">Restricted cash</a></td>
<td class="nump">6,130<span></span>
</td>
<td class="nump">6,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">547,780<span></span>
</td>
<td class="nump">568,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Money Market Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">50,551<span></span>
</td>
<td class="nump">43,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">144,259<span></span>
</td>
<td class="nump">192,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">73,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | US Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">19,804<span></span>
</td>
<td class="nump">17,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">74,045<span></span>
</td>
<td class="nump">169,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | US government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">120,467<span></span>
</td>
<td class="nump">32,170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">58,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_RestrictedCashFairValue', window );">Restricted cash</a></td>
<td class="nump">6,130<span></span>
</td>
<td class="nump">6,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">150,530<span></span>
</td>
<td class="nump">315,484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Money Market Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">50,551<span></span>
</td>
<td class="nump">43,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | US Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">19,804<span></span>
</td>
<td class="nump">17,172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">74,045<span></span>
</td>
<td class="nump">169,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | US government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">397,250<span></span>
</td>
<td class="nump">253,443<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">144,259<span></span>
</td>
<td class="nump">$ 192,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">73,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | US government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, current</a></td>
<td class="nump">120,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">$ 58,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_RestrictedCashFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted cash fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_RestrictedCashFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822145696656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_FairValueAssetsLevel1ToLevel3TransfersAmount', window );">Fair value assets, level 1 to level 3 transfers, amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_FairValueAssetsLevel3ToLevel1TransfersAmount', window );">Fair value assets, level 3 to level 1 transfers, amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_FairValueAssetsLevel3ToLevel2TransfersAmount', window );">Fair value assets, level 3 to level 2 transfers, amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_FairValueAssetsLevel2ToLevel3TransfersAmount', window );">Fair value assets, level 2 to level 3 transfers, amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_FairValueAssetsLevel1ToLevel3TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value assets level 1 to level 3 transfers amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_FairValueAssetsLevel1ToLevel3TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_FairValueAssetsLevel2ToLevel3TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value assets level 2 to Level 3 transfers amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_FairValueAssetsLevel2ToLevel3TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_FairValueAssetsLevel3ToLevel1TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value assets level 3 to level 1 transfers amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_FairValueAssetsLevel3ToLevel1TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_FairValueAssetsLevel3ToLevel2TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value assets level 3 to level 2 transfers amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_FairValueAssetsLevel3ToLevel2TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822141508896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Summary of Available-for-Sale Debt Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 496,044<span></span>
</td>
<td class="nump">$ 520,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(4,998)<span></span>
</td>
<td class="num">(658)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">491,099<span></span>
</td>
<td class="nump">519,629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">94,958<span></span>
</td>
<td class="nump">186,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(1,111)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">93,850<span></span>
</td>
<td class="nump">186,655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">US government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">180,967<span></span>
</td>
<td class="nump">79,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(1,873)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">179,119<span></span>
</td>
<td class="nump">79,532<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">220,119<span></span>
</td>
<td class="nump">253,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(2,014)<span></span>
</td>
<td class="num">(488)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 218,130<span></span>
</td>
<td class="nump">$ 253,442<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822139411072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Security</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Security</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of available-for-sale debt securities, continuous unrealized loss position for less than 12 months</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Aggregate fair value of available-for-sale debt securities, continuous unrealized loss position for less than 12 months | $</a></td>
<td class="nump">$ 330,900<span></span>
</td>
<td class="nump">$ 515,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions', window );">Number of available-for-sale debt securities, continuous unrealized loss position for greater than 12 months</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months', window );">Aggregate fair value of available-for-sale debt securities, continuous unrealized loss position for greater than 12 months | $</a></td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities', window );">Number of available-for-sale debt securities, contractual maturity of less than 12 months</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths', window );">Fair value of available-for-sale debt securities, contractual maturity of less than 12 months | $</a></td>
<td class="nump">$ 338,800<span></span>
</td>
<td class="nump">$ 394,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities', window );">Number of available-for-sale debt securities, contractual maturity of greater than 12 months</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Fair value of available-for-sale debt securities, contractual maturity of greater than 12 months | $</a></td>
<td class="nump">$ 152,328<span></span>
</td>
<td class="nump">$ 125,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities', window );">Number of securities decline in market value for in an unrealized loss position</a></td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than 12 Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt securities, available-for-sale, contractual maturity of 12 months or longer, number of securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt securities, available-for-sale, contractual maturity of less than 12 months, number of securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt securities available for sale decline in market value for unrealized loss position number of securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DebtSecuritiesAvailableForSale Continuous Unrealized Loss Position Greater Than 12 Months Number Of Positions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of available-for-sale debt securities contractual maturity of less than twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822136178640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborations - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 06, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 25, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Aug. 20, 2020</div></th>
<th class="th">
<div>Jul. 07, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 09, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Nov. 01, 2018</div></th>
<th class="th">
<div>Oct. 31, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_CostReimbursementPaymentReceived', window );">Cost reimbursement payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_RemainingResearchTermOfCollaboration', window );">Remaining research term of collaboration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Aggregate proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,826<span></span>
</td>
<td class="nump">72,832<span></span>
</td>
<td class="nump">$ 34,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164,248<span></span>
</td>
<td class="nump">137,017<span></span>
</td>
<td class="nump">62,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_CollaborationTerminationDate', window );">Collaboration termination date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 27,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Vertex Pharmaceuticals Incorporated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, Shares | shares</a></td>
<td class="nump">49,928<span></span>
</td>
<td class="nump">676,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock per share | $ / shares</a></td>
<td class="nump">$ 47.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Aggregate proceeds from issuance of private placement</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=kymr_SanofiCollaborationArrangementMember', window );">Sanofi Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_UpfrontPayment', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_CollaborationAgreementTransactionPrice', window );">Collaboration agreement transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized recorded in deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="nump">30,500<span></span>
</td>
<td class="nump">18,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Unsatisfied performance obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,900<span></span>
</td>
<td class="nump">81,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="nump">54,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=kymr_SanofiCollaborationArrangementMember', window );">Sanofi Agreement | Collaboration Target 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_CollaborationAgreementTransactionPrice', window );">Collaboration agreement transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized recorded in deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=kymr_SanofiCollaborationArrangementMember', window );">Sanofi Agreement | Collaboration Target 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_CollaborationAgreementTransactionPrice', window );">Collaboration agreement transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized recorded in deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=kymr_SanofiCollaborationArrangementMember', window );">Sanofi Agreement | Minimum | IRAK4 Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DevelopmentMilestonePayments', window );">Development milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_CommercialMilestonePayments', window );">Commercial milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=kymr_SanofiCollaborationArrangementMember', window );">Sanofi Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DevelopmentMilestonePayments', window );">Development milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_CommercialMilestonePayments', window );">Commercial milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=kymr_VertexAgreementMember', window );">Vertex Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized recorded in deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Unsatisfied performance obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,400<span></span>
</td>
<td class="nump">19,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_InitialResearchTermOfCollaboration', window );">Initial research term of collaboration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ExtendedResearchTermOfCollaboration', window );">Extended research term of collaboration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,800<span></span>
</td>
<td class="nump">$ 18,500<span></span>
</td>
<td class="nump">15,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=kymr_VertexAgreementMember', window );">Vertex Agreement | Series B-1 Convertible Preferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_CollaborationAgreementTransactionPrice', window );">Collaboration agreement transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_NonRefundableUpfrontPaymentReceived', window );">Non refundable upfront payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, Shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,059,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_PreferredStockIssuancePremium', window );">Preferred stock premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=kymr_VertexAgreementMember', window );">Vertex Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_PotentialReceivableMilestonePayments', window );">Eligible to receive payments including development, regulatory and commercial milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue remaining research term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=kymr_CompoundCollaborationAgreementMember', window );">Compound Collaboration | Series A Preferred Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares, Shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">886,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement', window );">Vesting of Series A Preferred Stock in connection with collaboration arrangement (Note 5), Shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,183<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_CollaborationAgreementTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration agreement transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_CollaborationAgreementTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_CollaborationTerminationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration termination date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_CollaborationTerminationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_CommercialMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_CommercialMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_CostReimbursementPaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost reimbursement payment received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_CostReimbursementPaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_DevelopmentMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Development milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_DevelopmentMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ExtendedResearchTermOfCollaboration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extended research term of collaboration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ExtendedResearchTermOfCollaboration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_InitialResearchTermOfCollaboration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial research term of collaboration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_InitialResearchTermOfCollaboration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_NonRefundableUpfrontPaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non refundable upfront payment received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_NonRefundableUpfrontPaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_PotentialReceivableMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential receivable milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_PotentialReceivableMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_PreferredStockIssuancePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferred stock issuance premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_PreferredStockIssuancePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_RemainingResearchTermOfCollaboration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining research term of collaboration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_RemainingResearchTermOfCollaboration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock shares vesting of series A preferred stock in connection with collaboration arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_UpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_UpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55302-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=kymr_VertexPharmaceuticalsIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=kymr_VertexPharmaceuticalsIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=kymr_SanofiCollaborationArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=kymr_SanofiCollaborationArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=kymr_CollaborationTargetOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=kymr_CollaborationTargetOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=kymr_CollaborationTargetTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=kymr_CollaborationTargetTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=kymr_IRAK4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=kymr_IRAK4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=kymr_VertexAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=kymr_VertexAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesB1ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=kymr_SeriesB1ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=kymr_CompoundCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=kymr_CompoundCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesAPreferredUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=kymr_SeriesAPreferredUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822139689744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborations - Change in Accounts Receivable, Contract Asset and Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss', window );">Accounts receivable and contract assets, Beginning balance</a></td>
<td class="nump">$ 135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerAssetNetAdditions', window );">Accounts receivable and contract assets, Additions</a></td>
<td class="nump">15,702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerAssetNetDeductions', window );">Accounts receivable and contract assets, Deductions</a></td>
<td class="num">(13,300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss', window );">Accounts receivable and contract assets, Ending balance</a></td>
<td class="nump">2,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract Liabilities, Beginning balance</a></td>
<td class="nump">101,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerLiabilityAdditions', window );">Contract Liabilities, Additions</a></td>
<td class="nump">9,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerLiabilityDeductions', window );">Contract Liabilities, Deductions</a></td>
<td class="num">(46,826)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract Liabilities, Ending balance</a></td>
<td class="nump">63,260<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=kymr_BilledReceivablesSanofiMember', window );">Billed Receivables - Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss', window );">Accounts receivable and contract assets, Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerAssetNetAdditions', window );">Accounts receivable and contract assets, Additions</a></td>
<td class="nump">6,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerAssetNetDeductions', window );">Accounts receivable and contract assets, Deductions</a></td>
<td class="num">(6,650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss', window );">Accounts receivable and contract assets, Ending balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=kymr_UnbilledReceivablesSanofiMember', window );">Unbilled Receivables - Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss', window );">Accounts receivable and contract assets, Beginning balance</a></td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerAssetNetAdditions', window );">Accounts receivable and contract assets, Additions</a></td>
<td class="nump">9,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerAssetNetDeductions', window );">Accounts receivable and contract assets, Deductions</a></td>
<td class="num">(6,650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss', window );">Accounts receivable and contract assets, Ending balance</a></td>
<td class="nump">2,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=kymr_DeferredRevenueVertexMember', window );">Deferred Revenue - Vertex</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract Liabilities, Beginning balance</a></td>
<td class="nump">19,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerLiabilityAdditions', window );">Contract Liabilities, Additions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerLiabilityDeductions', window );">Contract Liabilities, Deductions</a></td>
<td class="num">(10,813)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract Liabilities, Ending balance</a></td>
<td class="nump">8,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=kymr_DeferredRevenueSanofiMember', window );">Deferred Revenue - Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract Liabilities, Beginning balance</a></td>
<td class="nump">81,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerLiabilityAdditions', window );">Contract Liabilities, Additions</a></td>
<td class="nump">9,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ContractWithCustomerLiabilityDeductions', window );">Contract Liabilities, Deductions</a></td>
<td class="num">(36,013)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract Liabilities, Ending balance</a></td>
<td class="nump">$ 54,861<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ContractWithCustomerAssetNetAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with customer asset net additions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ContractWithCustomerAssetNetAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ContractWithCustomerAssetNetDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with customer asset net deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ContractWithCustomerAssetNetDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ContractWithCustomerLiabilityAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability additions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ContractWithCustomerLiabilityAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ContractWithCustomerLiabilityDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ContractWithCustomerLiabilityDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right to consideration is unconditional.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130534-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126942793&amp;loc=d3e3073-115593<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=kymr_BilledReceivablesSanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=kymr_BilledReceivablesSanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=kymr_UnbilledReceivablesSanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=kymr_UnbilledReceivablesSanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=kymr_DeferredRevenueVertexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=kymr_DeferredRevenueVertexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=kymr_DeferredRevenueSanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=kymr_DeferredRevenueSanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822141466000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Summary of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross, Total</a></td>
<td class="nump">$ 20,227<span></span>
</td>
<td class="nump">$ 15,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(6,893)<span></span>
</td>
<td class="num">(3,916)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">13,334<span></span>
</td>
<td class="nump">11,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabAndOfficeEquipmentMember', window );">Lab and Office Equipment Under and Financing Right of Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross, Total</a></td>
<td class="nump">5,475<span></span>
</td>
<td class="nump">3,969<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabEquipmentMember', window );">Lab Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross, Total</a></td>
<td class="nump">4,383<span></span>
</td>
<td class="nump">2,805<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross, Total</a></td>
<td class="nump">357<span></span>
</td>
<td class="nump">273<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture &amp; Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross, Total</a></td>
<td class="nump">1,064<span></span>
</td>
<td class="nump">943<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross, Total</a></td>
<td class="nump">7,802<span></span>
</td>
<td class="nump">7,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_AssetsNotYetInServiceMember', window );">Assets Not Yet in Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross, Total</a></td>
<td class="nump">$ 1,146<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_AssetsNotYetInServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_AssetsNotYetInServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822136162384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment right of use assets under financing leases with cost basis</a></td>
<td class="nump">20,227<span></span>
</td>
<td class="nump">15,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization expense related to right-of-use assets</a></td>
<td class="nump">1,184<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabAndOfficeEquipmentMember', window );">Lab and Office Equipment Under and Financing Right of Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment right of use assets under financing leases with cost basis</a></td>
<td class="nump">5,475<span></span>
</td>
<td class="nump">3,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_AccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_AccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_AccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=kymr_LabAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822136148752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 20, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 30, 2019 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2018 </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=kymr_CambridgeMassachusettsMember', window );">Cambridge, Massachusetts | Noncancelable Facility Lease Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLeasehold', window );">Reduction of right-of-use asset and liability due to lease modification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_LeaseTerminationDate', window );">Lease termination date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=kymr_CambridgeMassachusettsMember', window );">Cambridge, Massachusetts | Facility Sublease Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_LeaseCommencementDate', window );">Lease commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 24,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=kymr_WatertownMassachusettsMember', window );">Watertown, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_LeaseTerm', window );">Lease term</a></td>
<td class="text">134 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=kymr_WatertownMassachusettsMember', window );">Watertown, Massachusetts | Noncancelable Facility Lease Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space | ft&#178;</a></td>
<td class="nump">100,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_LeaseTerm', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">120 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_LeaseAdditionalTerm', window );">Lease additional term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_TenantIncentiveAllowanceReceivable', window );">Tenant incentive allowance receivable</a></td>
<td class="nump">$ 20.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_RentalAndLeaseExpenses', window );">Base Rent</a></td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Rent paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_BaseRentAnnualIncreaseOverTheLeaseTerm', window );">Annual increase percentage of rent</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=kymr_WatertownMassachusettsMember', window );">Watertown, Massachusetts | Noncancelable Facility Lease Agreement | Restricted Cash | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=kymr_WatertownMassachusettsMember', window );">Watertown, Massachusetts | Facility Sublease Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_LeaseCommencementDate', window );">Lease commencement date</a></td>
<td class="text">Nov. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_BaseRentAnnualIncreaseOverTheLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Base rent annual increase over the lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_BaseRentAnnualIncreaseOverTheLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_LeaseAdditionalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease additional term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_LeaseAdditionalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_LeaseCommencementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease commencement date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_LeaseCommencementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_LeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_LeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_LeaseTerminationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease termination date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_LeaseTerminationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_RentalAndLeaseExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rental And Lease Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_RentalAndLeaseExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_TenantIncentiveAllowanceReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tenant incentive allowance receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_TenantIncentiveAllowanceReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLeasehold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLeasehold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=kymr_CambridgeMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=kymr_CambridgeMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=kymr_NoncancelableFacilityLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=kymr_NoncancelableFacilityLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=kymr_FacilitySubleaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=kymr_FacilitySubleaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=kymr_WatertownMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=kymr_WatertownMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=kymr_RestrictedCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=kymr_RestrictedCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822141030432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 2,095<span></span>
</td>
<td class="nump">$ 2,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization expense related to right-of-use assets</a></td>
<td class="nump">1,184<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest expense for financing lease liabilities</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">1,192<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">$ 4,650<span></span>
</td>
<td class="nump">$ 4,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822139566576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information Relating to Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_OperatingLeasePaymentsProceeds', window );">Operating cash flows used in operating leases</a></td>
<td class="nump">$ 2,581<span></span>
</td>
<td class="nump">$ 2,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows used in finance leases</a></td>
<td class="nump">1,130<span></span>
</td>
<td class="nump">933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows used in finance leases</a></td>
<td class="nump">$ 179<span></span>
</td>
<td class="nump">$ 158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_OperatingLeasePaymentsProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease payments (proceeds).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_OperatingLeasePaymentsProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822134586528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Weighted Average Remaining Lease Terms and Discount Rates (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, remaining lease term</a></td>
<td class="text">7 years 3 months 18 days<span></span>
</td>
<td class="text">8 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Financing lease, remaining lease term</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease, discount rate</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="nump">10.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Financing lease, discount rate</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">8.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822141172816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Undiscounted Future Lease Payments for Operating and Finance Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 2,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">2,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">2,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">2,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">7,041<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">21,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less amounts representing interest or imputed interest</a></td>
<td class="num">(6,448)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">14,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">1,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">2,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less amounts representing interest or imputed interest</a></td>
<td class="num">(282)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 2,654<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822145750928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_AccruedResearchAndDevelopmentExpensesCurrent', window );">Research and development expenses</a></td>
<td class="nump">$ 16,975<span></span>
</td>
<td class="nump">$ 15,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Payroll and payroll-related</a></td>
<td class="nump">8,149<span></span>
</td>
<td class="nump">6,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">1,971<span></span>
</td>
<td class="nump">1,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 27,502<span></span>
</td>
<td class="nump">$ 22,971<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_AccruedResearchAndDevelopmentExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expenses current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_AccruedResearchAndDevelopmentExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822134308288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Commitments and Contingencies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember', window );">Indemnified Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Liabilities accrued</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822133789136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 25, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 24, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,207<span></span>
</td>
<td class="nump">$ 17,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDividendsAdjustment', window );">Deemed dividend from exchange of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 9,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued and outstanding</a></td>
<td class="nump">50,439,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible Preferred Stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,483,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible Preferred Stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of preferred Stock converted to common stock</a></td>
<td class="nump">31,625,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesSeedConvertiblePreferredStockMember', window );">Series Seed Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible Preferred Stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible Preferred Stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,886,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,720,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible Preferred Stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,009,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible Preferred Stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,182,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,827,580<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesB1ConvertiblePreferredStockMember', window );">Series B-1 Convertible Preferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible Preferred Stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,059,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,059,695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesCConvertiblePreferredStockMember', window );">Series C Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible Preferred Stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,527,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible Preferred Stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,527,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 88,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Shares issued upon exchange of Series A convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,988,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDividendsAdjustment', window );">Deemed dividend from exchange of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend', window );">Reduction of additional paid-in-capital related to temporary equity deemed dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend', window );">Increase in accumulated deficit related to temporary equity deemed dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesCConvertiblePreferredStockMember', window );">Series C Convertible Preferred Stock | Series C SPA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.5366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible Preferred Stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,539,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital related to temporary equity deemed dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in accumulated deficit related to temporary equity deemed dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDividendsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDividendsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesSeedConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=kymr_SeriesSeedConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=kymr_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=kymr_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesB1ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=kymr_SeriesB1ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=kymr_SeriesCConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=kymr_SeriesCConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=kymr_SeriesCPreferredStockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=kymr_SeriesCPreferredStockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822134534000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 20, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation expense</a></td>
<td class="nump">$ 35,480<span></span>
</td>
<td class="nump">$ 24,972<span></span>
</td>
<td class="nump">$ 5,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation expense</a></td>
<td class="nump">18,008<span></span>
</td>
<td class="nump">11,731<span></span>
</td>
<td class="nump">2,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation expense</a></td>
<td class="nump">17,472<span></span>
</td>
<td class="nump">13,241<span></span>
</td>
<td class="nump">2,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of stock options exercised</a></td>
<td class="nump">$ 15,800<span></span>
</td>
<td class="nump">$ 67,600<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value of options granted</a></td>
<td class="nump">$ 20.18<span></span>
</td>
<td class="nump">$ 29.95<span></span>
</td>
<td class="nump">$ 8.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 57,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation expense</a></td>
<td class="nump">$ 33,329<span></span>
</td>
<td class="nump">$ 23,789<span></span>
</td>
<td class="nump">$ 4,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation expense</a></td>
<td class="nump">16,388<span></span>
</td>
<td class="nump">11,161<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation expense</a></td>
<td class="nump">$ 16,941<span></span>
</td>
<td class="nump">$ 12,628<span></span>
</td>
<td class="nump">$ 2,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">295,892<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation expense</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation expense</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity-based compensation expense</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember', window );">2020 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance under plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,457,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Maximum number of shares to be issued, percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares remaining available for future grants</a></td>
<td class="nump">3,744,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember', window );">2020 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance under plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">445,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares remaining available for future grants</a></td>
<td class="nump">1,208,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Share-based compensation, description</a></td>
<td class="text">The 2020 ESPP provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2021 and each January 1 thereafter through January 1, 2030, by the lessor of (i) 438,898 shares of common stock, (ii) 1% of the Company&#8217;s outstanding number of shares of common stock on the immediately preceding December 31 or (iii) such lesser number of shares of common stock as determined by the administrator of the 2020 ESPP.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember', window );">2020 ESPP | Lesser of Potential Outcome 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized</a></td>
<td class="nump">438,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember', window );">2020 ESPP | Lesser of Potential Outcome 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Maximum number of shares to be issued, percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kymr_TwoThousandEighteenStockOptionAndGrantPlanMember', window );">2018 Plan | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">295,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ScenarioPotentialOutcomeAxis=kymr_LesserOfPotentialOutcomeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ScenarioPotentialOutcomeAxis=kymr_LesserOfPotentialOutcomeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ScenarioPotentialOutcomeAxis=kymr_LesserOfPotentialOutcomeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ScenarioPotentialOutcomeAxis=kymr_LesserOfPotentialOutcomeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kymr_TwoThousandEighteenStockOptionAndGrantPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kymr_TwoThousandEighteenStockOptionAndGrantPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822136156800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Stock Option Activity (Details) - 2020 Plan - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period</a></td>
<td class="nump">6,239,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">1,761,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(601,594)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="num">(641,740)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period</a></td>
<td class="nump">6,757,289<span></span>
</td>
<td class="nump">6,239,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at December 31, 2022</a></td>
<td class="nump">3,505,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Strike Price Per Option</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period</a></td>
<td class="nump">$ 23.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">35.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">5.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">33.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period</a></td>
<td class="nump">27.60<span></span>
</td>
<td class="nump">$ 23.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at December 31, 2022</a></td>
<td class="nump">$ 23.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">8 years 3 days<span></span>
</td>
<td class="text">8 years 6 months 21 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at December 31, 2022</a></td>
<td class="text">7 years 7 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at beginning of period</a></td>
<td class="nump">$ 246,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at end of period</a></td>
<td class="nump">55,934<span></span>
</td>
<td class="nump">$ 246,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at December 31, 2022</a></td>
<td class="nump">$ 38,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award aggregate intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822140146544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Equity-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation</a></td>
<td class="nump">$ 35,480<span></span>
</td>
<td class="nump">$ 24,972<span></span>
</td>
<td class="nump">$ 5,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation</a></td>
<td class="nump">18,008<span></span>
</td>
<td class="nump">11,731<span></span>
</td>
<td class="nump">2,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation</a></td>
<td class="nump">17,472<span></span>
</td>
<td class="nump">13,241<span></span>
</td>
<td class="nump">2,885<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation</a></td>
<td class="nump">33,329<span></span>
</td>
<td class="nump">23,789<span></span>
</td>
<td class="nump">4,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation</a></td>
<td class="nump">16,388<span></span>
</td>
<td class="nump">11,161<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation</a></td>
<td class="nump">$ 16,941<span></span>
</td>
<td class="nump">$ 12,628<span></span>
</td>
<td class="nump">$ 2,864<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822146221440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Weighted-Average Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 10 months 9 days<span></span>
</td>
<td class="text">5 years 10 months 13 days<span></span>
</td>
<td class="text">6 years 1 month 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">62.00%<span></span>
</td>
<td class="nump">66.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822140155360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Restricted Stock Activity (Details) - Restricted Stock - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">295,892<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">2018 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of period</a></td>
<td class="nump">37,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">295,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
<td class="num">(36,866)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="num">(14,928)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of period</a></td>
<td class="nump">281,843<span></span>
</td>
<td class="nump">37,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of period</a></td>
<td class="nump">$ 1.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted</a></td>
<td class="nump">24.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested</a></td>
<td class="nump">1.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited</a></td>
<td class="nump">29.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of period</a></td>
<td class="nump">$ 23.64<span></span>
</td>
<td class="nump">$ 1.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kymr_TwoThousandEighteenStockOptionAndGrantPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kymr_TwoThousandEighteenStockOptionAndGrantPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822141017888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember', window );">Investor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Rent expenses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822134996320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Valuation allowance</a></td>
<td class="nump">120,100,000<span></span>
</td>
<td class="nump">78,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Increase of valuation allowance</a></td>
<td class="nump">42,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration', window );">Federal net operating loss carryovers, not subject to expiration</a></td>
<td class="nump">144,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Reserves for uncertain tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Estimated interest or penalties recognized on uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember', window );">Earliest Tax Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open tax year subject to examination</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember', window );">Latest Tax Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open tax year subject to examination</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">NOL carryforwards</a></td>
<td class="nump">$ 153,900,000<span></span>
</td>
<td class="nump">123,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ResearchAndDevelopmentCreditCarryforwards', window );">Research and development credit carryforwards</a></td>
<td class="nump">12,700,000<span></span>
</td>
<td class="nump">10,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">NOL carryforwards</a></td>
<td class="nump">139,800,000<span></span>
</td>
<td class="nump">105,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_ResearchAndDevelopmentCreditCarryforwards', window );">Research and development credit carryforwards</a></td>
<td class="nump">$ 6,100,000<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=kymr_FederalAndStateMember', window );">Federal and State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_NetOperatingLossBeginToExpireYear', window );">NOLs begin to expire year</a></td>
<td class="text">2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Federal net operating loss carryovers, not subject to expiration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_NetOperatingLossBeginToExpireYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>NOLs begin to expire year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_NetOperatingLossBeginToExpireYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_ResearchAndDevelopmentCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_ResearchAndDevelopmentCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=kymr_FederalAndStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=kymr_FederalAndStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822141171136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Rate Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax effect at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes</a></td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">10.60%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">9.60%<span></span>
</td>
<td class="num">(0.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences', window );">Permanent differences</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Federal research and development credits</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(1.80%)<span></span>
</td>
<td class="num">(5.10%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(27.20%)<span></span>
</td>
<td class="num">(43.80%)<span></span>
</td>
<td class="num">(28.80%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation permanent differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822139687360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Significant Components of Net Deferred Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred Tax Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal net operating loss carryforwards</a></td>
<td class="nump">$ 32,320<span></span>
</td>
<td class="nump">$ 25,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State net operating loss carryforwards</a></td>
<td class="nump">8,835<span></span>
</td>
<td class="nump">6,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development credit carryforwards</a></td>
<td class="nump">17,581<span></span>
</td>
<td class="nump">14,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DeferredTaxAssetsLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">4,011<span></span>
</td>
<td class="nump">4,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">16,315<span></span>
</td>
<td class="nump">27,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense', window );">Accruals and reserves, stock and other</a></td>
<td class="nump">10,350<span></span>
</td>
<td class="nump">5,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts', window );">Capitalized Research and Development</a></td>
<td class="nump">36,435<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">125,847<span></span>
</td>
<td class="nump">83,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(120,096)<span></span>
</td>
<td class="num">(77,990)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">5,751<span></span>
</td>
<td class="nump">5,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Fixed and intangible assets</a></td>
<td class="num">(2,187)<span></span>
</td>
<td class="num">(1,941)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kymr_DeferredTaxLiabilitiesRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="num">(3,564)<span></span>
</td>
<td class="num">(3,859)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_DeferredTaxAssetsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_DeferredTaxAssetsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kymr_DeferredTaxLiabilitiesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kymr_DeferredTaxLiabilitiesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kymr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822134746352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share - Summary of Basic and Diluted Loss Per Share (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (154,808)<span></span>
</td>
<td class="num">$ (100,217)<span></span>
</td>
<td class="num">$ (45,593)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDividendsAdjustment', window );">Deemed dividend from exchange of convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,050)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (154,808)<span></span>
</td>
<td class="num">$ (100,217)<span></span>
</td>
<td class="num">$ (54,643)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic</a></td>
<td class="nump">53,933,229<span></span>
</td>
<td class="nump">47,989,023<span></span>
</td>
<td class="nump">17,349,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted</a></td>
<td class="nump">53,933,229<span></span>
</td>
<td class="nump">47,989,023<span></span>
</td>
<td class="nump">17,349,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (2.87)<span></span>
</td>
<td class="num">$ (2.09)<span></span>
</td>
<td class="num">$ (3.15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (2.87)<span></span>
</td>
<td class="num">$ (2.09)<span></span>
</td>
<td class="num">$ (3.15)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDividendsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDividendsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822134924336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders Anti-Diluted Effect (Detail) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive stock</a></td>
<td class="nump">7,039,132<span></span>
</td>
<td class="nump">6,276,927<span></span>
</td>
<td class="nump">1,691,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Unvested Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive stock</a></td>
<td class="nump">281,843<span></span>
</td>
<td class="nump">37,745<span></span>
</td>
<td class="nump">110,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive stock</a></td>
<td class="nump">6,757,289<span></span>
</td>
<td class="nump">6,239,182<span></span>
</td>
<td class="nump">1,580,924<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>kymr-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:kymr="http://www.kymeratx.com/20221231"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="kymr-20221231.xsd" xlink:type="simple"/>
    <context id="C_09c6030c-9215-434e-be32-4ed40bf22526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d08b0ba5-abc0-4746-8241-00292ef51a98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_7df38be4-2853-4015-a6b5-9f73bad5256f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_5e70b6ab-252f-4914-b65d-a19b70d29f38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_588fd5b5-72cb-4b8f-8a09-d3c8c62edc57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_15ff43a4-1a79-4140-833c-62eca307fcca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_22763f63-4293-43da-81e5-a51fcca60bff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_760ee65f-8938-4d70-852d-717a500268f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_97589b7d-a19b-4817-9cb4-54e5513837fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAPreferredUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:CompoundCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-31</startDate>
            <endDate>2017-10-31</endDate>
        </period>
    </context>
    <context id="C_efe35265-ca7f-48b1-ba12-d45e10f0072e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b43e2e96-8c18-4279-8325-186feb642b24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_79fff542-33ec-47e5-9833-9eb8b9292809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-24</instant>
        </period>
    </context>
    <context id="C_0847ba81-8f44-4437-b8eb-633b0c7d610a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_5e41c878-2f37-448f-8041-6169a741fafd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_6ad1ca74-8cd0-428a-8420-0ed4140b55c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-25</startDate>
            <endDate>2020-08-25</endDate>
        </period>
    </context>
    <context id="C_b732179f-e38b-4ac0-966a-36f9156f251e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_fab1d0dc-259c-4d99-aeaa-b68f059f306d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:UnbilledReceivablesSanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_f388feec-ab4d-435a-a116-98c364680e81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="C_1fa761db-d666-44a0-af4c-79d0be38cd5f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_dfba4027-fdf3-4f74-b209-0790ae57b570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-25</instant>
        </period>
    </context>
    <context id="C_80f9fc1a-bada-456b-a7de-e066beca9a76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_a4ff2b85-04a0-48ba-94cb-7f1135555ba1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_540998ce-bee4-4ad6-941f-3538588a5c1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_9a28714d-4117-4d6f-a425-e5fffabba86e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
        </entity>
        <period>
            <instant>2023-02-17</instant>
        </period>
    </context>
    <context id="C_21c4c029-6c05-4698-8da3-0afb2df18536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_7739607f-6dbd-41a0-9e92-62301ab965ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_7bfbb36d-82da-4ad3-994d-90f943b534e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_74aee4f0-c621-4b65-8a33-0e483df74a09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_ffa8f705-3f5f-4262-91ee-9dc0b63d32dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_13c32f2e-7c2d-451d-bddf-0c2c9dd15260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_34088ddb-035f-4002-9357-123ac90f1d11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201912Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_59441261-9496-4c98-982f-a7f3cbd75e89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_1f5790c2-3ca6-4592-b151-991462b1693b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_6d1928e4-c54d-45cb-bd65-a8ca6a70568a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0a508e8a-8ed4-432c-b50f-3e6ba3cf849e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="kymr:ScenarioPotentialOutcomeAxis">kymr:LesserOfPotentialOutcomeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d12a3336-c1b4-42ef-b4e8-d151bc4f6073">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_5bcbd011-9c2a-4bed-8e4b-8ad966e7a3df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_fee29a3a-aedd-47a5-a81d-24177eb305f7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_706ff543-02d9-48e2-ab79-2493d3f2d922">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2e7ba5c8-f99e-4875-a133-bee00f42bf56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAPreferredUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:CompoundCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0a44a408-71c2-4d39-8813-0b78ecef7724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:BilledReceivablesSanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_4ab02c5d-c1ed-4254-9c17-05221638469e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_ec425b46-47ad-47dc-8171-83d01e53a978">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2349e822-42db-4347-927f-0f4069526a6f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-07</startDate>
            <endDate>2020-07-07</endDate>
        </period>
    </context>
    <context id="C_5848cdd9-12d7-4f30-a785-9342a4c7a6f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:LabEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_136d87f1-3086-4833-98e0-254742d30599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_d7917064-c478-4770-ad01-038576ee96ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_cd15099d-d559-460e-9cc6-741a7742e2e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_609eabef-de99-4804-9f3b-bfe0014a08e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_6313fdc6-f629-4f9c-b2ab-a0f4799044f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:UnbilledReceivablesSanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_07b901be-39ca-4958-8fa3-0fb35bd13fe8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:PrivateInvestmentInPublicEquityPipeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-09</startDate>
            <endDate>2019-05-09</endDate>
        </period>
    </context>
    <context id="C_1af1f196-8f7a-453c-8f26-b468bf9f47e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f8adf4fe-2bfc-43b4-9f31-817a19df61dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-06</instant>
        </period>
    </context>
    <context id="C_e2615d23-21e3-4021-a013-590aec8dff1e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_1067d521-9ab9-4291-b211-b3b28cc5875e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_14b69a89-5ece-4633-95eb-269916567868">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e797a856-6bbd-4491-93c3-86302e550709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandEighteenStockOptionAndGrantPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_364f0411-8f1d-481d-848d-0b732287ee1b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_842a256c-4f35-4914-9766-3edf46028402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_449c3352-cd32-4f01-af2a-4da22097c606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_4dc0482d-1972-405a-aca2-c6d2771a5668">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-25</startDate>
            <endDate>2020-08-25</endDate>
        </period>
    </context>
    <context id="C_61237bf4-e312-4023-95fa-e105e4b526af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_dc36945d-778f-40c8-b34a-d7b7257091e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-20</startDate>
            <endDate>2021-12-20</endDate>
        </period>
    </context>
    <context id="C_bc832249-6262-4522-b906-00d2da961c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_e29716e7-cfe9-40b9-a9c6-244c78e60765">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_e838c8dc-9e7e-4afc-9c1b-ef93b8e4bf4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_233f48ad-667b-4b14-9534-dd4453d81c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a018222a-a47a-445b-bb16-6f9dfa165490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_da066593-343f-4eae-86aa-8434db5d2bc4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-25</startDate>
            <endDate>2020-08-25</endDate>
        </period>
    </context>
    <context id="C_e29dbbc6-2913-48f5-ae93-32213dc0a589">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_1e66e0ff-3fd7-47c3-9d78-6a55c4496d6b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0e8deb54-698e-4ab2-af83-21ba04dff085">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-24</instant>
        </period>
    </context>
    <context id="C_2d89a721-4703-49d1-bd93-8012ab6048ee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_5f869677-7ee2-4413-aebc-fa0d38400637">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_a19a1934-1bfb-4c71-8877-7d13aaae909d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SeriesCPreferredStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_b259fb45-0841-4caa-af6a-3436ea59b8c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-09</instant>
        </period>
    </context>
    <context id="C_7a1721f2-1cc5-4103-bee4-aae009ac5e28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a2e3e97a-6104-4a6a-845d-96d26416a456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e4780686-685f-4d62-af29-362e17c976f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_baa1be4a-3f8a-4703-8ce3-1a52e5380d29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5c3de9fd-e34c-40a7-886f-e337a1c4bbf8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_00ea0bf2-b4b5-4c08-b022-561003946977">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:AssetsNotYetInServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_5ecfa09f-e84b-4a4a-8989-6581bbb4d5de">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_3363a5aa-7bac-47fb-9504-1359994babd8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b6180323-5b57-488b-848b-ccefa15e0d49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_7ed674cd-4eeb-4640-9889-2c6678deaa43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_a3474749-9778-48ea-8068-ff4b03644db1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_27b0ac27-e9ee-48a9-8244-480576173f08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_062f8b1d-9242-4851-af55-d6d0942205c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
        </entity>
        <period>
            <startDate>2020-08-20</startDate>
            <endDate>2020-08-20</endDate>
        </period>
    </context>
    <context id="C_64fc7649-e229-4be0-9da4-464cbc4ec931">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="C_393387d1-e62c-4d39-9c26-01748ebd1fc5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b43f0ac9-9dd1-43f0-9c2f-f1e6e998903c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_cbe473e2-0c3e-400a-b19a-6ab0d1df53c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_e3f5946c-97c3-41b3-9ef5-e15537183ae3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_e6afb047-c3cb-439e-93ba-6a0d534e4847">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="C_2975af70-dd29-413c-b9dd-b4bce328cf7f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="C_5b5104c9-4084-4a40-bdc7-f2c83bef3744">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0e2b9cb4-93a4-4a46-8ff4-8c907b9948cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:PrivateInvestmentInPublicEquityPipeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-18</instant>
        </period>
    </context>
    <context id="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_8be60b28-58be-4691-8add-44fa167e85d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_5bd98592-a6f8-48cb-b2d8-69e2fb37cced">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_f905c3a9-aa7b-42be-b38e-38c2c85fc17e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:UnbilledReceivablesSanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_24dbfe2c-9946-41c1-a96a-9697c75159ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_71ee1d85-28a5-45c6-8c2c-1fe698d0852e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d71a034f-8114-4bbc-b37a-9706f02f0795">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_905b1e51-7f5b-485c-9c36-6955cd326bbc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-20</instant>
        </period>
    </context>
    <context id="C_e026c58e-80f9-43a7-892c-915846f96c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_ffaeb917-acaf-403e-b35f-ee9c0815e0fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandEighteenStockOptionAndGrantPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandAndTwentyStockOptionAndGrantPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_9b3d185f-ca4e-4abd-8e59-83567a508d6b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_d4188fce-d0eb-4f3f-bcf3-22439576a842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_3c25311b-f928-4131-a217-3def376fa07e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-24</instant>
        </period>
    </context>
    <context id="C_234197a7-41c0-49b0-b46a-6e4f533c6f82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a33af802-fd5f-453f-8566-ed374579cd72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:CambridgeMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:FacilitySubleaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-30</instant>
        </period>
    </context>
    <context id="C_477496b5-689e-4d9f-889f-43f954b285a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_f8675fbd-b497-45a1-8f98-17bb97d337a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandAndTwentyStockOptionAndGrantPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_bfc05416-87db-404e-9f86-a8b01e216a23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_b71771ba-3d9c-4451-8eb3-75b4fdf5da6f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0562b153-f7d2-4919-a735-90f6be837fe7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_c311266f-1fb4-45be-8f19-a199951e6b7a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_f35c6b15-85ad-422b-890a-5ff664200b70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kymr:VertexPharmaceuticalsIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="C_31efc25b-97c7-4143-86af-cc79d0a18d8d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_c641fd16-c54e-4ea4-bc93-31046365f9ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueSanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_fbbcb1bf-5bb2-467d-99d4-b373ccaddd38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_92cf5785-cf06-4620-8a2b-76822df706a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_040be217-5d7c-4430-aeb6-a639e3672c4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_c965787c-a43a-4142-aa2d-b72d421bb8bb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_40496514-8b4d-4ab1-ab44-cabf51a7a931">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_68b2899b-3bcc-43f6-ac60-1964d739bcc2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:BilledReceivablesSanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2b3d220a-8dfb-48f9-8630-e9c3cb556015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_9f2c591c-cdd0-4e59-b139-60ee5abb1b89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="kymr:ScenarioPotentialOutcomeAxis">kymr:LesserOfPotentialOutcomeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_322d6f2f-d9c6-4dde-bd2a-00b4fe2d9953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1d3282a7-0917-49af-8ec3-cef4fee801f9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_8d546ca3-b4f9-459e-94ab-382557abce03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:LabAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_476fbf89-ead5-43aa-a71f-121b8c5b80cd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_22bb0630-1f56-4e08-be75-2de87dfa8f47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_dda1079b-6eca-441a-a05b-3722b9bc66cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_cfa523b6-c249-44ac-b04c-c2b414d9ace4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandTwentyStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="C_081b7ddc-7d3d-4ad4-aee3-4d90b3c47ad6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c4d086ec-121e-41c0-8f9f-29a659fc29f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:AssetsNotYetInServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_1df7a9a0-1093-45f8-b738-6e2b781d6256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:PrivateInvestmentInPublicEquityPipeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-18</startDate>
            <endDate>2022-08-18</endDate>
        </period>
    </context>
    <context id="C_4b0a689e-0b9b-43f2-8a8d-71565e0e91d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_e8aab3b3-a22a-4ff3-bc89-71d92652daea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-24</instant>
        </period>
    </context>
    <context id="C_1c2cea65-c96f-40f3-85ee-3f904357fc50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_6a76246b-2b22-46e7-b98f-f3af778c41fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_c448089e-36a2-4d25-8667-2eff989ca829">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:PrivateInvestmentInPublicEquityPipeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_2c4981f1-d2d1-42ff-abb5-fb290d5cfac2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:FacilitySubleaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-20</startDate>
            <endDate>2021-12-20</endDate>
        </period>
    </context>
    <context id="C_28099439-7f67-4ba5-b139-b21c74762ca3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f04f21d2-40bf-4a93-8a51-d233d78fb6da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueVertexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_6fc3eaa2-537c-4116-875f-333d3da37c5c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d26a9a00-5e7d-4d4c-80e3-ac47ef881e7b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueVertexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_835ed024-44c8-4f1f-8d6e-765f4caca866">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a127836f-8972-4634-a63e-075a16b278cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_945eb7b7-5b44-4a38-ac68-221560bd90c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_2a30fc5f-816c-4384-aaa2-91ea6a589f09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_36be0cca-7b17-4bd5-9ff6-6f599abd4d25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:CambridgeMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:FacilitySubleaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="C_da71e1e6-ad8b-46b6-a6cc-c239a69a2d15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_3d5e6adf-2cb4-4ff6-abed-16ed9bba1142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kymr:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-06</startDate>
            <endDate>2021-07-06</endDate>
        </period>
    </context>
    <context id="C_71808508-9486-45a9-a60f-55c647268f87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_08714960-9258-4fdb-9361-563b0b151dda">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_06738e58-f7fd-48f8-91f1-9bb2c730b938">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e4243250-6638-48e7-889c-97b8a1f4c6c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_e603dc4a-23d5-4e8a-ba86-53a78b470fd8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_b416434c-2e1c-4143-971b-fbbf1771eff0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_f2fba413-6548-46dc-aa3b-627f610a3ec7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_d991933b-0bbc-4e49-adf6-0e1709f50056">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_b6fa59dc-4675-40d7-8994-3d7f6fdb43e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-20</startDate>
            <endDate>2021-12-20</endDate>
        </period>
    </context>
    <context id="C_8de70d1d-2b5f-493b-8b0b-26530520a358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_ce764760-07d6-464c-9e95-7ae23ffd34e2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_c24a6bd6-ab8b-4a23-9222-6e239419ecc3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_611d8018-b7e1-4bc6-a151-16f06fc1c9e5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_7b553fef-df42-4c26-baa6-85e17e44d192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_bc744543-b39d-4939-9a52-727450458e7f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueVertexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_bef4bf34-693c-41b8-a9a0-8e9c28f7789b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-07</startDate>
            <endDate>2020-07-07</endDate>
        </period>
    </context>
    <context id="C_f90b9a09-ed20-4574-8cf0-a5475c3bafe7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="C_f9e0671b-5bcf-43c6-8613-91b1eee2aa9d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_565059dc-67cf-4057-8152-e525a8f12af2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kymr:IRAK4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-07</startDate>
            <endDate>2020-07-07</endDate>
        </period>
    </context>
    <context id="C_2c23163c-4ca5-41b2-89bd-6f956a18aef8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="C_fd5b0988-24e0-4f79-92bb-866fe46cad5f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5c9218ac-b38f-4b4a-b639-9ec2b585df0c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kymr:VertexPharmaceuticalsIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="C_b519ea9f-6482-4c50-93f0-fae0c804af59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_7358d6d6-fbab-43d0-9f78-318ce8621d10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0d3c3a6e-4f6e-4e86-a583-6b94738c1223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-09</startDate>
            <endDate>2019-05-09</endDate>
        </period>
    </context>
    <context id="C_b7c4a6f5-3116-4dfc-94b7-2777489e2b5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAPreferredUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:CompoundCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-01</endDate>
        </period>
    </context>
    <context id="C_a28bf33d-a98c-4e5d-bf76-7f54880914c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:CambridgeMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_d51bc1c7-aa3c-43cd-8c22-e7fed24f7dec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandAndTwentyStockOptionAndGrantPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_46a95b63-fac0-4c7e-886b-297fe0b6508c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">kymr:FederalAndStateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_612b21a6-29b0-4a04-b6c6-2d057f6f698c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2022fb22-d24d-4bbe-bb9f-9dab9e88b500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_a36aa140-8b72-464d-955e-145c92e86542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_ce893baa-f44c-4ebb-a74e-bff63f53114a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:CambridgeMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-28</instant>
        </period>
    </context>
    <context id="C_f5b3b459-dd6e-414f-b28b-4d450e611a1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueSanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_d8fb09f6-e120-4543-92a1-1556cdd15765">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-09</instant>
        </period>
    </context>
    <context id="C_c9486884-24fb-4c2c-83c0-60db6edb5eec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:BilledReceivablesSanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_edc39a4d-75a6-4b3f-af07-3ff0619b84c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">kymr:WatertownMassachusettsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:NoncancelableFacilityLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_68eb4b8c-30b8-4277-ae3e-2cf3c48588f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f5672204-3c86-40cf-a340-5ea7293720f7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_92f87a14-6091-4b98-ab40-77d4b06dc412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-25</startDate>
            <endDate>2020-08-25</endDate>
        </period>
    </context>
    <context id="C_76c8ae03-3308-43f1-b225-daad19fb4a85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SeriesCPreferredStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="C_3d0188f0-21c7-4f50-b44d-994dd494ed83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c6c8d2a8-fc5a-4ae7-a353-aba76870f2db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-24</instant>
        </period>
    </context>
    <context id="C_74fc36db-9df8-4a3a-b61d-d3906dde152b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_eefb7cbc-9caa-4ace-97f5-4dd5fa0c3875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_eec48a46-4598-43e9-a039-7466eaea4546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_c2702504-9407-4568-90ec-019c2a2d2ec4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_ec1630b7-f419-4a11-a92d-8d8f0402646a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:LabEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c78e13b1-5a22-4766-9c4e-481992abdd5d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0cf55378-3493-4d42-bbac-071bc03a0b45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_ceafc2b0-0999-4cab-befa-221a85b5170a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_68a7c495-1305-45e9-99c0-9a0f59885e6b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-07</startDate>
            <endDate>2020-07-07</endDate>
        </period>
    </context>
    <context id="C_bc0e09ba-86f9-40ac-bd79-7819763b03d9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_9611dcfe-598d-44f0-becc-70cdcf69b398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-07</startDate>
            <endDate>2020-07-07</endDate>
        </period>
    </context>
    <context id="C_da156e8f-4b74-46f4-b36a-d8334d9e178c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_9c751372-08cb-457c-aad4-5cedac83bf5f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_84f17940-92a7-4e17-be51-01d2d2326192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_fad25e8f-82cd-4241-b5a5-deda1a16ec70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_5736292d-6714-4a50-bbea-d38622c2466f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_e385f6e7-a66f-4abf-a4e6-7cc879be5486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_84cd998d-445c-4b16-bb46-4ea2853490a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_1e352199-2021-4cbf-89a6-6b3fb1a9cb86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b9849062-15a8-4157-94eb-425887d7c4d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">kymr:CollaborationTargetTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_568f226b-696c-4f67-8494-4fae12a09dcd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_167de5a4-50cc-4901-9c67-4c426f16265e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandAndTwentyStockOptionAndGrantPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_997b8ca2-0e08-4b7f-bb20-e67b92117eb3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_5e341025-329c-4ac7-81f0-c034f045d05a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kymr:VertexPharmaceuticalsIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-06</instant>
        </period>
    </context>
    <context id="C_87c3d75e-6f9f-4fee-bf73-1e3449016f7a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_353d5cf1-900b-4407-901f-6e88343b6e28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_76aa8dac-964b-4401-9f4a-e42aa52a6fa3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_5570ee25-70f9-4703-b517-2f4ecb794156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:VertexAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_5441244c-f6a1-4c98-ab13-fd0944167cea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_b1c3605d-deb5-4fa5-a122-f271881338b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_502b15a6-ea47-400c-869d-e335729cdbc1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">kymr:DeferredRevenueSanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_cb4393fc-15bf-486a-9195-7df9d32c0b65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9d10799d-d7e1-4d27-8675-c80ab8ac70f7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-24</instant>
        </period>
    </context>
    <context id="C_8ff041e4-b315-4e52-b81f-f83d9f3192a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_2b8cccc4-67af-4d70-a28f-55b723676bd5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">kymr:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_61d31205-c2b5-4c89-bdaa-f543c2398e40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:LabEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_7ce88c48-9db3-4967-b6cf-209b8a85b29a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0ab6f045-1ad1-4153-a9b6-962038299ee7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">kymr:SanofiCollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_e683523c-eff3-4658-979d-24ea59364214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kymr:VertexPharmaceuticalsIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-25</instant>
        </period>
    </context>
    <context id="C_be95bba8-f456-4a90-a5f1-287d343806dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_bb8b7969-bb82-4041-994e-9433633910b6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_fdb41358-831d-4444-b8f4-0d53bd52e986">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_443e4a77-30f5-47ad-b864-37c3741dcda6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_bdb2440e-1e74-443b-8199-85bc8484ff9e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_ff725650-2c6a-4920-8877-da2405efe942">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_9637e2ee-ccfa-4f69-ae4f-52730c923c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f62f379d-f310-481c-a34d-1f3d65032cd1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_19cbc32f-ec79-4363-8ead-cd45c0522894">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_02126e7a-b6e0-43d2-9ccf-f5a5b79c8acd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kymr:LabAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_a0c7a845-3be7-4f46-849f-63f833e1d24d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_b7ba11fe-25ad-4dba-9808-5ea7f213c68e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kymr:TwoThousandEighteenStockOptionAndGrantPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_44015c49-ba45-4506-b30f-8927b0882496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kymr:VertexPharmaceuticalsIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-25</startDate>
            <endDate>2020-08-25</endDate>
        </period>
    </context>
    <context id="C_2838053c-edc6-48eb-99f6-f1c1c948532c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0269e2a0-73d4-4767-b9f5-307b464b1430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_efce9fe0-465e-459e-b1a9-4b6162542b7f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_e35141e7-840c-4c80-868b-75ce55213382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001815442</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Segment">
        <measure>kymr:Segment</measure>
    </unit>
    <unit id="U_Security">
        <measure>kymr:Security</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      id="F_59dd5951-129a-4921-a76f-3a77497db12e">http://www.kymeratx.com/20221231#CollaborationRevenuesFromRelatedPartyMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <kymr:FairValueAssetsLevel3ToLevel2TransfersAmount
      contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056"
      decimals="INF"
      id="F_15177ffa-26f9-45d3-97f9-2f3f4476600f"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel3ToLevel2TransfersAmount>
    <kymr:FairValueAssetsLevel3ToLevel1TransfersAmount
      contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056"
      decimals="INF"
      id="F_b87cb352-a683-4457-b6a3-b1e5cbdd4e65"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel3ToLevel1TransfersAmount>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_68eb4b8c-30b8-4277-ae3e-2cf3c48588f6"
      id="F_b05166cd-b41a-4edb-ba37-ddead2c7ce38">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <kymr:FairValueAssetsLevel2ToLevel3TransfersAmount
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_17c26d05-9f3b-4274-bf66-5ed27d17bc5c"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel2ToLevel3TransfersAmount>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      id="F_f278db45-7d50-4cc7-9df3-e40961d927bc"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_6930f9de-9815-46fa-9020-cd8359eb249c">0001815442</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_00a38e07-86ee-4f89-b2df-9c54865fd329">FY</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_744a2776-a92f-4e1a-a3f0-f007a657a324">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_33d39829-bb58-4fa6-afba-41c3a06619f4">false</dei:AmendmentFlag>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_34088ddb-035f-4002-9357-123ac90f1d11"
      id="F_49320e69-2deb-4571-b75c-f5ce13224fba">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_59253975-6be0-4361-b050-c3fcd7cb5491">--12-31</dei:CurrentFiscalYearEndDate>
    <kymr:FairValueAssetsLevel2ToLevel3TransfersAmount
      contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056"
      decimals="INF"
      id="F_36542e98-256e-4b6c-9827-dbf2e0c02061"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel2ToLevel3TransfersAmount>
    <kymr:FairValueAssetsLevel3ToLevel1TransfersAmount
      contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49"
      decimals="INF"
      id="F_da9b41d8-1030-4c51-9b6e-8526848e4757"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel3ToLevel1TransfersAmount>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_dc247878-85ea-4ea3-88c3-f656dec50fb8">http://www.kymeratx.com/20221231#CollaborationRevenuesFromRelatedPartyMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <kymr:FairValueAssetsLevel1ToLevel3TransfersAmount
      contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49"
      decimals="INF"
      id="F_b12380f5-0b0a-4217-9861-2223af5ef47a"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel1ToLevel3TransfersAmount>
    <kymr:FairValueAssetsLevel3ToLevel2TransfersAmount
      contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49"
      decimals="INF"
      id="F_23a625d3-cd72-4352-a158-20585e71389c"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel3ToLevel2TransfersAmount>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      id="F_fbb4303c-a232-44f8-b305-22f13b9fd4e0"
      unitRef="U_USD"
      xsi:nil="true"/>
    <kymr:FairValueAssetsLevel2ToLevel3TransfersAmount
      contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49"
      decimals="INF"
      id="F_04c71c59-946d-49a4-904b-666ce72c2fa6"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel2ToLevel3TransfersAmount>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_ae10bbc7-71bf-42d0-a616-ec6d368d4c60"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_34088ddb-035f-4002-9357-123ac90f1d11"
      id="F_832519d8-6bb8-4432-a341-503227a48b41">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <kymr:FairValueAssetsLevel1ToLevel3TransfersAmount
      contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056"
      decimals="INF"
      id="F_cd7e99d8-1ab4-4cf7-b3ce-eb07021b9806"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel1ToLevel3TransfersAmount>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      id="F_0a629c5c-447e-4e13-9f0f-f5c8e97606a2">http://www.kymeratx.com/20221231#CollaborationRevenuesFromRelatedPartyMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_68eb4b8c-30b8-4277-ae3e-2cf3c48588f6"
      id="F_85f778a6-0d2e-4bfd-85a2-b83f14d4f0bc">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <kymr:FairValueAssetsLevel1ToLevel3TransfersAmount
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_d6816af5-4bc5-4791-ba3d-860c44e2a341"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel1ToLevel3TransfersAmount>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_b7c4a6f5-3116-4dfc-94b7-2777489e2b5a"
      decimals="0"
      id="F_cb8b44a8-0a30-4420-9476-09eaa4fdd848"
      unitRef="U_pure">100</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <kymr:LeaseCommencementDate
      contextRef="C_2c4981f1-d2d1-42ff-abb5-fb290d5cfac2"
      id="F_6df59bfa-c32d-4351-8e0b-684185a0ee07">2023-11-30</kymr:LeaseCommencementDate>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      id="F_a9f2aefd-6d15-4f49-976d-74b2deaa9149"
      unitRef="U_USD"
      xsi:nil="true"/>
    <kymr:FairValueAssetsLevel3ToLevel1TransfersAmount
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_edecdabf-262b-4f31-ac10-5d70725bc297"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel3ToLevel1TransfersAmount>
    <kymr:FairValueAssetsLevel3ToLevel2TransfersAmount
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_47aa0c7e-13cd-4b61-a6e4-d8d951681874"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel3ToLevel2TransfersAmount>
    <dei:DocumentType
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_9c0f3c0f-72d8-4dde-b1d2-6ec1afdb44c1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_74a9eb48-4366-4736-abda-2dc46fe33931">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_67fe0723-8ad2-4370-9069-b48264f2e406">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_38e16004-3236-456d-ba04-dbe3780da955">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_c340ebe3-b095-4053-b752-c07b90de7de6">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_1904cdd3-1128-4e37-ad37-fbd23727737f">001-39460</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_e7d9db36-af14-4699-b7bf-e5902e24d690">KYMERA THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_0ac3e054-db74-4e0e-881d-c49964424b9f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_4d6e17ab-fcaf-4770-bd9a-baaba55cebc6">81-2992166</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_14c5a786-db9c-4071-95a2-6318611b85c1">200 Arsenal Yards Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_3c3693df-1412-4aab-a408-c1c4d0bd9009">Suite 230</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_ba5221cc-b4ff-4c0e-8206-0d259ed6dbb7">Watertown</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_957c9e73-8ede-41b1-b60c-5f3dd6d1c122">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_35b99a28-1f46-47d9-bfdb-6f60ac88c4f9">02472</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_83a88446-b331-4aee-bca7-ee6886b947ee">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_d63c8542-7822-4115-8e40-e5f057e483f9">285-5300</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_f2efdaf6-22df-434d-b61f-45df836db86d">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_634d82ae-89bf-40b6-99af-28772ee781d3">KYMR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_dd19c61d-cb8b-4bde-bc43-2e7a2163a70a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_f977b396-7852-440d-9c8c-7662083aaa43">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_7cdcab3c-d847-4744-b6a6-7f16d279a427">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_99dc148c-798b-40ea-b16e-a2cb9e17ae95">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_81c36dd8-87d1-40fc-8076-40fd36f216e4">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_3ce6b900-b5bb-480b-a4a5-241e18c43c77">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_80077e83-3b22-4a72-bad7-670b6a6c7ab9">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_75a628f5-745b-40e1-b7e2-ecf326df8d0f">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_15bc09da-ed97-44ad-9d97-e81ecd2982f5">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_18dd2615-40e6-48ed-bffd-0cc8e5785f3f">false</dei:EntityShellCompany>
    <dei:EntityListingParValuePerShare
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="4"
      id="F_133ad779-2f43-45ce-bedb-6b024972af9f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</dei:EntityListingParValuePerShare>
    <dei:EntityPublicFloat
      contextRef="C_443e4a77-30f5-47ad-b864-37c3741dcda6"
      decimals="INF"
      id="F_4dcc504b-b6f8-4f8e-a5eb-c66aefedaf5e"
      unitRef="U_USD">792000000.0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_9a28714d-4117-4d6f-a425-e5fffabba86e"
      decimals="INF"
      id="F_e803d908-eb09-40d1-aa16-ac7bdca43fc4"
      unitRef="U_shares">55183644</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_1db838d2-d134-4d56-aff7-c1e342774842">&lt;p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Portions of the registrant&#x2019;s Proxy Statement for its 2023 Annual Meeting of Stockholders, which the registrant intends to file with the Securities and Exchange Commission not later&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;than 120 days after the registrant&#x2019;s fiscal year ended December 31, 2022, are incorporated by reference into Part III of this Annual Report on Form 10-K&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_972257f9-441a-448a-bea8-6f5daf3c9803">42</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_fc49d4bf-9d2a-4199-a8da-56ddfdf2b0e9">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_969277fd-1cdc-44f5-afa0-44c80c912cd3">Boston, Massachusetts</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_835360e6-cfa6-465c-a0e2-fd3bce327ac1"
      unitRef="U_USD">68395000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_053c4942-9549-4fe6-89d3-52f6413738b7"
      unitRef="U_USD">47976000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_9c65ad31-d5e2-4364-aaa3-01245dc22be7"
      unitRef="U_USD">338771000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_335e4e97-fc8f-455a-b743-f48f8a6816d8"
      unitRef="U_USD">394442000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_5f53df31-0f3f-49b8-a06e-ef596a9482ee"
      unitRef="U_USD">2537000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_e67fefb8-5c50-4f43-a4e8-3727ed2cea03"
      unitRef="U_USD">135000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_ef169ebc-1f79-44a0-a64e-5c499604a546"
      unitRef="U_USD">9713000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_c8ee96f0-4959-49f9-b533-53986de4813e"
      unitRef="U_USD">8720000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_429a31fd-9a57-44a7-b3a5-207f744cc40a"
      unitRef="U_USD">419416000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_1d9cfc54-082e-4232-a373-b3e0a3030c55"
      unitRef="U_USD">451273000</us-gaap:AssetsCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_da1fec79-40c9-42c3-a90a-5e78379623e5"
      unitRef="U_USD">152328000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_e7944113-354e-4f56-8cd6-56ca3ca54137"
      unitRef="U_USD">125187000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_39be2817-9e10-48ee-8712-078dff5dac49"
      unitRef="U_USD">13334000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_e114d67e-a7d8-46b5-a87e-3f6a00a3e0e4"
      unitRef="U_USD">11881000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_24602630-7fd0-4dfb-9e2c-d98d33871e81"
      unitRef="U_USD">8909000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_1e341f52-c81e-4a5a-9eb0-9281f2381d5e"
      unitRef="U_USD">9426000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_eecc86be-ef1b-45ee-96d7-1a25500b336f"
      unitRef="U_USD">3017000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_3a2c2159-db07-4859-98c6-721681bc4706"
      unitRef="U_USD">2022000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_fb0f4632-1949-4db1-8a34-c58007ce07c0"
      unitRef="U_USD">6130000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_25c87401-446b-40e5-b318-28a1db3472b4"
      unitRef="U_USD">6116000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:Assets
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_596016a7-d4d5-4657-b1e5-cba6162c7594"
      unitRef="U_USD">603134000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_414d1ac1-f4c2-41fe-ae60-a9a3ff21f1ed"
      unitRef="U_USD">605905000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_36c5e100-d30d-4cc5-be6b-6f5c29f4c6e9"
      unitRef="U_USD">4335000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_e57b3999-5c14-4208-8e5d-9d5e897054af"
      unitRef="U_USD">4005000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_035b58f1-e482-47c3-8845-24f5cb9bfc27"
      unitRef="U_USD">27502000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_674167db-e9e7-47f3-b432-3b3e76dedb29"
      unitRef="U_USD">22971000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_4ddaf04c-9c02-4e35-90b5-a0ae6d1e8180"
      unitRef="U_USD">35260000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_8b7ecfa6-b1ec-4e3a-9b25-0f975fb7df82"
      unitRef="U_USD">61739000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_4cc67d80-e6dd-4e6d-be97-749572ea77e3"
      unitRef="U_USD">2535000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_ecfb414b-6cea-478e-81b3-5ce7f97cc0ea"
      unitRef="U_USD">2461000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_3b6b4cd7-434c-41e2-b58c-c106c61640b9"
      unitRef="U_USD">1408000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_30e1827a-5873-440e-a6d1-2a9e8d2ea780"
      unitRef="U_USD">1138000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_810e7d9e-e79f-460b-a5f8-c63866bdbfe4"
      unitRef="U_USD">303000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_d8a07115-f1e2-4f71-ab20-ec3f55fd5b49"
      unitRef="U_USD">228000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_8f6323d9-6e73-407f-b6ca-ca09e305549b"
      unitRef="U_USD">71343000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_0b60a2b3-1b97-4d8c-8db3-ef0e0ab7e2e0"
      unitRef="U_USD">92542000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_f8f13765-4852-4490-b8a4-0d66e5dc5ebe"
      unitRef="U_USD">28000000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_21ca6add-3cef-4546-9d58-350a44e1dfc2"
      unitRef="U_USD">39295000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_e9f79d15-191c-4d13-9daf-bce9cf6b06d2"
      unitRef="U_USD">12146000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_dabadda0-a9e9-4d9f-b3a8-d35dabd57006"
      unitRef="U_USD">13224000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_d7f8aaea-e161-4509-a81c-a4178f196f43"
      unitRef="U_USD">1246000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_5a9db3ff-97f5-4816-8eb2-0b01f28285f8"
      unitRef="U_USD">1140000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_eb624179-3277-4237-9a62-91033cd64366"
      unitRef="U_USD">248000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_f6eda52b-de2e-42c7-83c0-2a2c2fa4c621"
      unitRef="U_USD">66000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_208c28d8-ea84-47b8-b7f9-95c6bfb13a36"
      unitRef="U_USD">112983000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_b1309252-e11c-45c8-9fc1-6845e32cbd3b"
      unitRef="U_USD">146267000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="INF"
      id="F_09a742b8-dc4c-4b0d-aa3d-68990a3962d8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="INF"
      id="F_3fd411cf-257a-462c-8f14-aa406fbd18f4"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="INF"
      id="F_189e4a16-c949-46af-a759-9a656ef96030"
      unitRef="U_shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="INF"
      id="F_1783c4cd-f597-4f8a-b574-f8a061a2bf4b"
      unitRef="U_shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="INF"
      id="F_a7e84c30-5a66-4dfc-a93b-f3486dfeb048"
      unitRef="U_shares">55039380</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="INF"
      id="F_0aef9346-3827-4b0c-985b-61db0d567845"
      unitRef="U_shares">51573924</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="INF"
      id="F_43173008-a82e-435e-9364-56b49570690b"
      unitRef="U_shares">55039380</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="INF"
      id="F_73fe7456-ca81-475d-b6cb-6ecacf266dc7"
      unitRef="U_shares">51536181</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_21a33c41-fd8b-47b2-91ff-fa603ac16585"
      unitRef="U_USD">6000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_95237b43-26c8-49e0-827e-e844aadfb902"
      unitRef="U_USD">5000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_9a03e194-f0b9-474a-8983-63cea930583c"
      unitRef="U_USD">878884000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_84515f0d-5b31-410a-91bb-c9dddbca8f81"
      unitRef="U_USD">689275000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_b0a95125-f7e1-48ac-b147-cc46eee1966e"
      unitRef="U_USD">-383790000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_db941c40-bbc8-4706-8ab3-61904c0353b0"
      unitRef="U_USD">-228982000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_756c1d81-28e7-4b27-9915-b456261ed5ed"
      unitRef="U_USD">-4949000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_e6e17b04-abcf-4871-aa3b-9c643b62bff0"
      unitRef="U_USD">-660000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_266e0737-ee21-403d-a023-51069475831f"
      unitRef="U_USD">490151000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_16a3ebbc-552b-4501-82da-552c8f5198af"
      unitRef="U_USD">459638000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_294ff13e-9428-4ded-8a2b-4d7460e3a1cd"
      unitRef="U_USD">603134000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_401d7b85-fd32-4c71-b29f-e5b2cca12871"
      unitRef="U_USD">605905000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_2f960aa8-0158-43f4-b0bf-76c9a35309bb"
      unitRef="U_USD">46826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_af528321-129f-4726-a0ea-209d02e0a2dc"
      unitRef="U_USD">72832000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_ea131961-fac9-4cdd-b159-a5310380e842"
      unitRef="U_USD">34034000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_e0691037-6cfb-4bf4-b3d5-54f6f53f7bb3"
      unitRef="U_USD">164248000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_826edae5-6585-40e2-be15-9c0603e75d59"
      unitRef="U_USD">137017000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_51b3854f-63e6-471f-975d-f7b51f8a1bcf"
      unitRef="U_USD">62105000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_e4b0bde4-0e84-4904-ba8d-385538993b28"
      unitRef="U_USD">43834000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_670ebc72-92bd-4470-b0cf-8752a6c56e06"
      unitRef="U_USD">36345000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_27caed2e-5f62-4dc1-aad6-a3bbddbafcb3"
      unitRef="U_USD">18233000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_778714b9-bbb0-4123-8baa-07b6c7b3cf5b"
      unitRef="U_USD">208082000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_c60b7640-1e41-4831-9edc-f973db95d779"
      unitRef="U_USD">173362000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_cc397617-73c1-4a21-bf9f-cfe4e2f2cc79"
      unitRef="U_USD">80338000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_93d3ea10-c591-47a9-ad7b-0257c7b1c964"
      unitRef="U_USD">-161256000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_20dc8f94-0b70-46c6-8cf7-195d92f30a98"
      unitRef="U_USD">-100530000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_62a2c52a-62cb-46c1-a114-c397e7ca5d11"
      unitRef="U_USD">-46304000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncome
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_856c600d-6d0a-4786-9769-1e4431811811"
      unitRef="U_USD">6624000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_90044248-5ee7-4273-b262-3e75d77a1dd1"
      unitRef="U_USD">488000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_668eec40-67d7-457a-848d-3e073450b2fc"
      unitRef="U_USD">826000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingExpense
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_b9bb0776-9048-450b-8403-079404bbbb09"
      unitRef="U_USD">176000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_2d65e1ba-537c-4a72-bc2c-fc73e67cd26f"
      unitRef="U_USD">175000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_62555f12-85b0-4dd2-86bd-1cc718f8be5a"
      unitRef="U_USD">115000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_ee1e8e70-4ec9-4e58-98ad-146d9a97f659"
      unitRef="U_USD">6448000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_389f2071-3a1a-4501-9fda-f6d9ea2bff11"
      unitRef="U_USD">313000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_9ec6ff3c-c03b-43dd-9a57-2193267e0a43"
      unitRef="U_USD">711000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_cca690e4-9326-4cfc-9d33-45e6186eda91"
      unitRef="U_USD">-154808000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_2c953ad5-1aaa-4030-a2e8-7a5ee1ee2472"
      unitRef="U_USD">-100217000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_d056b228-4f47-4882-94ee-0b1df49cb84e"
      unitRef="U_USD">-45593000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_25a38056-50f8-4913-aac5-878e9a6d7904"
      unitRef="U_USD">-4289000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_05cc9588-5749-43a4-95de-3a2b38d7bc1c"
      unitRef="U_USD">-532000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_9b6e5a96-76b3-485c-aa5c-88daf1596a03"
      unitRef="U_USD">-134000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_088a0c37-135d-4aa7-89b9-e43cac1b5a8e"
      unitRef="U_USD">-159097000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_191a1ea4-c387-4285-bd4e-2751749d28a2"
      unitRef="U_USD">-100749000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_07ea3046-de16-44eb-9825-bb1729957521"
      unitRef="U_USD">-45727000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_e7340d10-5346-42a0-9b36-18751ce5bbd9"
      unitRef="U_USD">-154808000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_b5dab053-992f-40b0-b1d7-8604794d02db"
      unitRef="U_USD">-100217000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_9e5185f1-9a6d-4474-9d3f-f6fa65a2880c"
      unitRef="U_USD">-45593000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_b33b8a2f-f4df-4e9e-bcb3-a3b51cc11647"
      unitRef="U_USD">0</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_34b76745-8a6b-4f18-aa8f-9aca81f3890e"
      unitRef="U_USD">0</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_72f68393-0e12-4d8b-8cbb-8af9e4b9f2b1"
      unitRef="U_USD">9050000</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_80c21a62-a4ff-4ff1-9e93-639b17d3fb0b"
      unitRef="U_USD">-154808000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_d42b094a-9d14-407b-b148-bb49534848dd"
      unitRef="U_USD">-100217000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_dbb5b03f-a771-48c0-b2a7-37ecf929552c"
      unitRef="U_USD">-54643000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="2"
      id="F_db160915-dba5-43bd-938c-cd35d19ed175"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.87</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="2"
      id="F_8b70b499-83a6-49dc-ad08-bc489e1d87e1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.87</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="2"
      id="F_dec51d82-a455-46b5-9144-daa946847807"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="2"
      id="F_adc3ef73-36a8-4646-9731-05970ef4d016"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="2"
      id="F_12de0623-d3e9-498a-92d6-4a9a51279674"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="2"
      id="F_dc46e217-b280-42bb-9d9b-0499cc92aa04"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="INF"
      id="F_a613bc6b-892a-43bf-a678-bfcfacc6ebb4"
      unitRef="U_shares">53933229</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="INF"
      id="F_aa7db214-a26d-4d0d-a95e-477a854180ca"
      unitRef="U_shares">53933229</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="INF"
      id="F_fd0cb5bc-e3e6-44ec-a715-7ed78c72960e"
      unitRef="U_shares">47989023</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="INF"
      id="F_853630fd-2a3a-40fb-bb92-f65520321374"
      unitRef="U_shares">47989023</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="INF"
      id="F_31372fb9-c071-4253-a2e7-eff8a1f6a7b3"
      unitRef="U_shares">17349582</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="INF"
      id="F_abfac52e-e155-440a-ac4d-d080197b32e1"
      unitRef="U_shares">17349582</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_588fd5b5-72cb-4b8f-8a09-d3c8c62edc57"
      decimals="0"
      id="F_f5e6d807-e609-4c74-90ff-24a17b75346e"
      unitRef="U_shares">3000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_588fd5b5-72cb-4b8f-8a09-d3c8c62edc57"
      decimals="-3"
      id="F_18b25778-f886-4d9c-97a4-0c5ced41b23a"
      unitRef="U_USD">5900000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_74aee4f0-c621-4b65-8a33-0e483df74a09"
      decimals="0"
      id="F_215a7826-4d59-4e16-b6e3-16a4cfdcda8c"
      unitRef="U_shares">14720126</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_74aee4f0-c621-4b65-8a33-0e483df74a09"
      decimals="-3"
      id="F_cfa57289-1eee-4305-9d8e-db6ec48203f7"
      unitRef="U_USD">29237000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_b732179f-e38b-4ac0-966a-36f9156f251e"
      decimals="0"
      id="F_24568c58-2f4e-42cc-9896-188b2d28b7c7"
      unitRef="U_shares">14827580</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_b732179f-e38b-4ac0-966a-36f9156f251e"
      decimals="-3"
      id="F_c515f105-a84f-4ca7-baf7-d5c0a1b8c49a"
      unitRef="U_USD">59918000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_2b8cccc4-67af-4d70-a28f-55b723676bd5"
      decimals="0"
      id="F_677a0a63-794e-484e-838c-d0682ce0a3bd"
      unitRef="U_shares">3059695</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_2b8cccc4-67af-4d70-a28f-55b723676bd5"
      decimals="-3"
      id="F_b1aff938-a11b-4cec-8fd8-eb31b438ef55"
      unitRef="U_USD">14025000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="C_4ab02c5d-c1ed-4254-9c17-05221638469e"
      decimals="0"
      id="F_745bd010-346d-4e47-a578-35065d43d6a5"
      unitRef="U_shares">1929516</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_e4243250-6638-48e7-889c-97b8a1f4c6c0"
      decimals="-3"
      id="F_ff56b46e-d86f-4bc8-bc50-30bde868fb17"
      unitRef="U_USD">2044000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c78e13b1-5a22-4766-9c4e-481992abdd5d"
      decimals="-3"
      id="F_edf36df7-ab13-406e-8266-0aaeb6ae7735"
      unitRef="U_USD">-76456000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_ceafc2b0-0999-4cab-befa-221a85b5170a"
      decimals="-3"
      id="F_e878d985-6b63-4653-b72e-16f4d0253f8e"
      unitRef="U_USD">6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056"
      decimals="-3"
      id="F_e6f17d8f-d318-4ab5-a787-222d291e04dd"
      unitRef="U_USD">-74406000</us-gaap:StockholdersEquity>
    <kymr:TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement
      contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0"
      decimals="0"
      id="F_450beeba-b74d-4818-9298-0574074ff16c"
      unitRef="U_shares">110788</kymr:TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement>
    <kymr:TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement
      contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0"
      decimals="-3"
      id="F_89958644-3b7c-40e1-b2a8-1224508b0ac2"
      unitRef="U_USD">222000</kymr:TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_364f0411-8f1d-481d-848d-0b732287ee1b"
      decimals="-3"
      id="F_d01442d8-3f31-404c-a64b-839dbe6b8914"
      unitRef="U_USD">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <kymr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_5bd98592-a6f8-48cb-b2d8-69e2fb37cced"
      decimals="0"
      id="F_cf7b72cc-c8d1-4974-9bd3-efe19b0a2a70"
      unitRef="U_shares">1182265</kymr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_5bd98592-a6f8-48cb-b2d8-69e2fb37cced"
      decimals="-3"
      id="F_6c08fb58-62ca-40af-af97-14e5573577d2"
      unitRef="U_USD">4800000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_dda1079b-6eca-441a-a05b-3722b9bc66cf"
      decimals="-3"
      id="F_91fbd8f3-7fa8-45ba-a7b9-d09f77a1df30"
      unitRef="U_USD">320000</us-gaap:PaymentsOfStockIssuanceCosts>
    <kymr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46"
      decimals="0"
      id="F_b38de459-c152-4bb3-9940-a85290e61411"
      unitRef="U_shares">13539141</kymr:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46"
      decimals="-3"
      id="F_1a1755f5-6e89-495a-923b-663fa0441cb5"
      unitRef="U_USD">88180000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <kymr:TemporaryEquityExchangeOfConvertiblePreferredStockShares
      contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0"
      decimals="0"
      id="F_e5c59759-2e2d-4fdb-93fc-3a71ce10251d"
      unitRef="U_shares">-1988802</kymr:TemporaryEquityExchangeOfConvertiblePreferredStockShares>
    <kymr:TemporaryEquityExchangeOfConvertiblePreferredStockValue
      contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0"
      decimals="-3"
      id="F_0f190249-5c4e-451d-8080-6e327fb4e5e1"
      unitRef="U_USD">-3950000</kymr:TemporaryEquityExchangeOfConvertiblePreferredStockValue>
    <kymr:TemporaryEquityExchangeOfConvertiblePreferredStockShares
      contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46"
      decimals="0"
      id="F_89433764-0bcd-40cc-9d6e-2e59dd95da13"
      unitRef="U_shares">1988802</kymr:TemporaryEquityExchangeOfConvertiblePreferredStockShares>
    <kymr:TemporaryEquityExchangeOfConvertiblePreferredStockValue
      contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46"
      decimals="-3"
      id="F_4d2f3ac7-4fa5-4ced-8015-ef678f96a404"
      unitRef="U_USD">13000000</kymr:TemporaryEquityExchangeOfConvertiblePreferredStockValue>
    <kymr:ExchangeOfConvertiblePreferredStockImpactOnEquity
      contextRef="C_477496b5-689e-4d9f-889f-43f954b285a8"
      decimals="-3"
      id="F_3ab0a57e-4e42-4d8b-b76b-617f37d64e3d"
      unitRef="U_USD">-2334000</kymr:ExchangeOfConvertiblePreferredStockImpactOnEquity>
    <kymr:ExchangeOfConvertiblePreferredStockImpactOnEquity
      contextRef="C_449c3352-cd32-4f01-af2a-4da22097c606"
      decimals="-3"
      id="F_cdc35004-9de4-4b0b-b3ed-7da01d4bb7f2"
      unitRef="U_USD">-6716000</kymr:ExchangeOfConvertiblePreferredStockImpactOnEquity>
    <kymr:ExchangeOfConvertiblePreferredStockImpactOnEquity
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_c1ad69d9-ca94-4377-aa98-f228c94d54d8"
      unitRef="U_USD">-9050000</kymr:ExchangeOfConvertiblePreferredStockImpactOnEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_a36aa140-8b72-464d-955e-145c92e86542"
      decimals="0"
      id="F_05cc5c3e-7924-4fd2-b394-5c09e1854250"
      unitRef="U_shares">78852</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_477496b5-689e-4d9f-889f-43f954b285a8"
      decimals="-3"
      id="F_beae3b34-6807-414a-8cfb-5ed92fcfb946"
      unitRef="U_USD">162000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_90dad999-a743-4de2-ac58-aa0a1dec696c"
      unitRef="U_USD">162000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <kymr:StockIssuedDuringPeriodSharesRestrictedStockVested
      contextRef="C_a36aa140-8b72-464d-955e-145c92e86542"
      decimals="0"
      id="F_5b50d48e-c680-41ae-9648-c2becf12c79a"
      unitRef="U_shares">184410</kymr:StockIssuedDuringPeriodSharesRestrictedStockVested>
    <kymr:StockIssuedDuringPeriodValueRestrictedStockVested
      contextRef="C_477496b5-689e-4d9f-889f-43f954b285a8"
      decimals="-3"
      id="F_f11f87a6-6492-4188-8380-ac6e09ecd63c"
      unitRef="U_USD">112000</kymr:StockIssuedDuringPeriodValueRestrictedStockVested>
    <kymr:StockIssuedDuringPeriodValueRestrictedStockVested
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_7bef61be-abb5-4d87-8c49-585c328a2383"
      unitRef="U_USD">112000</kymr:StockIssuedDuringPeriodValueRestrictedStockVested>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_477496b5-689e-4d9f-889f-43f954b285a8"
      decimals="-3"
      id="F_523e4af8-deb7-4b19-a48d-f310aba7f9fa"
      unitRef="U_USD">5190000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_55ad978a-c6d6-47af-87c0-890aae23fde7"
      unitRef="U_USD">5190000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_c24a6bd6-ab8b-4a23-9222-6e239419ecc3"
      decimals="-3"
      id="F_29855007-e3b4-4c48-a39e-cb8490bdaa55"
      unitRef="U_USD">-134000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_48e8e356-6245-47d6-a6a6-9334ca2bffdc"
      unitRef="U_USD">-134000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_272fbd1f-68b0-4a00-8e3e-7d5108887605"
      unitRef="U_USD">17003000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_be95bba8-f456-4a90-a5f1-287d343806dd"
      decimals="0"
      id="F_11b2cd20-8bec-4233-b6f7-fe20a8d10529"
      unitRef="U_shares">9987520</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_be95bba8-f456-4a90-a5f1-287d343806dd"
      decimals="-3"
      id="F_3f8b6b40-5c6b-4cf9-bd15-344d01993649"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_ff725650-2c6a-4920-8877-da2405efe942"
      decimals="-3"
      id="F_9a46ab95-6f37-4402-9341-dad1c1c00f59"
      unitRef="U_USD">182747000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_21c4c029-6c05-4698-8da3-0afb2df18536"
      decimals="-3"
      id="F_6ad210b2-60a9-479c-81bf-37afb3d5500b"
      unitRef="U_USD">182748000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_b416434c-2e1c-4143-971b-fbbf1771eff0"
      decimals="0"
      id="F_db686747-1bd1-4efb-bf96-1bc745a9d9cd"
      unitRef="U_shares">-3000000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_b416434c-2e1c-4143-971b-fbbf1771eff0"
      decimals="-3"
      id="F_e9f82769-6e45-4603-aeba-4811659ffe8b"
      unitRef="U_USD">-5900000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0"
      decimals="0"
      id="F_65363f92-772e-4281-bf89-4e59020813a4"
      unitRef="U_shares">-12842112</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_84cd998d-445c-4b16-bb46-4ea2853490a0"
      decimals="-3"
      id="F_78c210ee-7a63-4d12-9e68-2b0cab8435c9"
      unitRef="U_USD">-25509000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_5bd98592-a6f8-48cb-b2d8-69e2fb37cced"
      decimals="0"
      id="F_906bb213-a9dc-4878-84ab-3b939d982890"
      unitRef="U_shares">-16009845</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_5bd98592-a6f8-48cb-b2d8-69e2fb37cced"
      decimals="-3"
      id="F_de43a1da-2f21-49ad-acfd-cf56dfb5fa20"
      unitRef="U_USD">-64718000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_d4188fce-d0eb-4f3f-bcf3-22439576a842"
      decimals="0"
      id="F_380e99ac-d9bb-485d-9132-75010b8fb535"
      unitRef="U_shares">-3059695</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_d4188fce-d0eb-4f3f-bcf3-22439576a842"
      decimals="-3"
      id="F_e314324b-cb39-4d7b-b5d3-2580d6e7eb71"
      unitRef="U_USD">-14025000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46"
      decimals="0"
      id="F_ad8dc84d-e1eb-435c-ba62-a4c4a730100c"
      unitRef="U_shares">-15527943</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46"
      decimals="-3"
      id="F_b03aa15d-fc0c-4780-8741-afefee09f50f"
      unitRef="U_USD">-101180000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_a36aa140-8b72-464d-955e-145c92e86542"
      decimals="0"
      id="F_425368ad-b3f0-4074-86b8-82f005672737"
      unitRef="U_shares">31625534</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_a36aa140-8b72-464d-955e-145c92e86542"
      decimals="-3"
      id="F_ad0c51a9-178b-4b42-aea6-503540748a33"
      unitRef="U_USD">3000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_477496b5-689e-4d9f-889f-43f954b285a8"
      decimals="-3"
      id="F_4e3e7c28-3eed-4368-9e4f-b2dc5ff7d907"
      unitRef="U_USD">211329000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_6dabae08-a4b3-4817-8929-3aac5b8efe55"
      unitRef="U_USD">211332000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_7358d6d6-fbab-43d0-9f78-318ce8621d10"
      decimals="0"
      id="F_9ffe31de-7438-47d5-ba45-a6660c1617b4"
      unitRef="U_shares">676354</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_84f17940-92a7-4e17-be51-01d2d2326192"
      decimals="-3"
      id="F_9bbe60af-95a7-417a-8a42-2eadf00c0c54"
      unitRef="U_USD">13527000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_f62f379d-f310-481c-a34d-1f3d65032cd1"
      decimals="-3"
      id="F_96cb27df-ca0e-46a7-90b8-57822827eec8"
      unitRef="U_USD">13527000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="C_449c3352-cd32-4f01-af2a-4da22097c606"
      decimals="-3"
      id="F_789ec107-379f-40f5-bfd2-d75e882c2d8a"
      unitRef="U_USD">-45593000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_c70387f5-2077-45ec-8867-0cd8c36893fa"
      unitRef="U_USD">-45593000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_0562b153-f7d2-4919-a735-90f6be837fe7"
      decimals="0"
      id="F_bb9359bf-fe2e-4424-8a04-4cf20299b66e"
      unitRef="U_shares">44482186</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0562b153-f7d2-4919-a735-90f6be837fe7"
      decimals="-3"
      id="F_723bae4a-832e-4da5-bd56-fbcce78041f6"
      unitRef="U_USD">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_5441244c-f6a1-4c98-ab13-fd0944167cea"
      decimals="-3"
      id="F_108871af-46fe-486f-880e-9345e7f73f2e"
      unitRef="U_USD">412777000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_997b8ca2-0e08-4b7f-bb20-e67b92117eb3"
      decimals="-3"
      id="F_bdc3a149-c290-4442-a304-736cd2d16e79"
      unitRef="U_USD">-128765000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c311266f-1fb4-45be-8f19-a199951e6b7a"
      decimals="-3"
      id="F_8c2604f4-0fbc-44ff-b654-710f8fea50ad"
      unitRef="U_USD">-128000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49"
      decimals="-3"
      id="F_270b12a0-635f-407c-85b7-835c2abc7b69"
      unitRef="U_USD">283888000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_0562b153-f7d2-4919-a735-90f6be837fe7"
      decimals="0"
      id="F_713a16ec-84aa-4645-9d5b-3be81fa2e3b9"
      unitRef="U_shares">44482186</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0562b153-f7d2-4919-a735-90f6be837fe7"
      decimals="-3"
      id="F_883f27fe-cf9c-427e-bedd-344026371cea"
      unitRef="U_USD">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_5441244c-f6a1-4c98-ab13-fd0944167cea"
      decimals="-3"
      id="F_88c50c8b-ab8b-44d5-b5ba-6698a300fc42"
      unitRef="U_USD">412777000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_997b8ca2-0e08-4b7f-bb20-e67b92117eb3"
      decimals="-3"
      id="F_719fc714-fb3e-4e4f-ac1d-33c22e0c11a2"
      unitRef="U_USD">-128765000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c311266f-1fb4-45be-8f19-a199951e6b7a"
      decimals="-3"
      id="F_90745e04-e242-4e7f-b607-32bcda2f172d"
      unitRef="U_USD">-128000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49"
      decimals="-3"
      id="F_29494918-ae34-4f4d-ac05-36883528a24a"
      unitRef="U_USD">283888000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0269e2a0-73d4-4767-b9f5-307b464b1430"
      decimals="0"
      id="F_6241033e-4b10-46c4-93e3-790bedee101e"
      unitRef="U_shares">1431271</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_0269e2a0-73d4-4767-b9f5-307b464b1430"
      decimals="-3"
      id="F_45629e0a-1234-48da-ba29-549cddb10f7d"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_a0c7a845-3be7-4f46-849f-63f833e1d24d"
      decimals="-3"
      id="F_5cf1b9d4-9838-43b1-a8c7-f006056c19b0"
      unitRef="U_USD">7632000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_bd00fd25-223a-4202-8cfe-7ad7f42fc824"
      unitRef="U_USD">7633000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <kymr:StockIssuedDuringPeriodSharesRestrictedStockVested
      contextRef="C_0269e2a0-73d4-4767-b9f5-307b464b1430"
      decimals="0"
      id="F_c5ed8181-3411-4207-9a4d-428aebe2c9e8"
      unitRef="U_shares">72359</kymr:StockIssuedDuringPeriodSharesRestrictedStockVested>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0269e2a0-73d4-4767-b9f5-307b464b1430"
      decimals="0"
      id="F_6b75d7c4-d531-49e3-9163-3cdcd5de7828"
      unitRef="U_shares">19687</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_a0c7a845-3be7-4f46-849f-63f833e1d24d"
      decimals="-3"
      id="F_0b406984-c2ed-4c02-82e5-c28c66ee38d6"
      unitRef="U_USD">788000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_2c421039-7b31-4ad5-8246-222960e53720"
      unitRef="U_USD">788000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <kymr:IssuanceOfVestedRestrictedStockToConsultants
      contextRef="C_0269e2a0-73d4-4767-b9f5-307b464b1430"
      decimals="0"
      id="F_84fa9065-dea7-41a4-a1d7-5456abe5c7b8"
      unitRef="U_shares">12500</kymr:IssuanceOfVestedRestrictedStockToConsultants>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_a0c7a845-3be7-4f46-849f-63f833e1d24d"
      decimals="-3"
      id="F_aec7271f-b52b-4e09-8353-1b0093d62a3f"
      unitRef="U_USD">24972000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_6d5fa9a4-5ae7-4ee2-a49b-717aad24122a"
      unitRef="U_USD">24972000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_f9e0671b-5bcf-43c6-8613-91b1eee2aa9d"
      decimals="-3"
      id="F_5f79b46d-5b42-4040-ae62-c3e714e93b0b"
      unitRef="U_USD">-532000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_0907c118-b834-4bc0-9dc9-fafad156c7dc"
      unitRef="U_USD">-532000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_8b79b2f2-a980-476a-95c3-1f70c5efce7b"
      unitRef="U_USD">16207000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_e3f5946c-97c3-41b3-9ef5-e15537183ae3"
      decimals="0"
      id="F_2d63be7a-0a25-4f60-a0b5-4a4b4e3e6fe4"
      unitRef="U_shares">5468250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_b43f0ac9-9dd1-43f0-9c2f-f1e6e998903c"
      decimals="-3"
      id="F_800ab9d3-3dca-4e02-990f-30dbb5ed6b44"
      unitRef="U_USD">240760000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_1d3282a7-0917-49af-8ec3-cef4fee801f9"
      decimals="-3"
      id="F_8c578900-cd0f-4f60-9a17-93bea0998cef"
      unitRef="U_USD">240760000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_9b3d185f-ca4e-4abd-8e59-83567a508d6b"
      decimals="0"
      id="F_08658a02-65b0-4f5e-9cd0-9ec2ebb1995a"
      unitRef="U_shares">49928</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_476fbf89-ead5-43aa-a71f-121b8c5b80cd"
      decimals="-3"
      id="F_500847f6-4f9e-4379-bd1d-7489dab126ab"
      unitRef="U_USD">2346000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_a3474749-9778-48ea-8068-ff4b03644db1"
      decimals="-3"
      id="F_bbfbfb4a-abbf-4532-ba77-ca1ef97bea00"
      unitRef="U_USD">2346000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="C_d7917064-c478-4770-ad01-038576ee96ad"
      decimals="-3"
      id="F_d08debb1-7948-46a5-bab5-80d156d65653"
      unitRef="U_USD">-100217000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_ba97e0fb-073c-4622-a58b-804208dc202c"
      unitRef="U_USD">-100217000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_06738e58-f7fd-48f8-91f1-9bb2c730b938"
      decimals="0"
      id="F_89b66aaa-d55e-4dc6-b683-bd268473674a"
      unitRef="U_shares">51536181</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_06738e58-f7fd-48f8-91f1-9bb2c730b938"
      decimals="-3"
      id="F_d3adf2d4-9b57-4865-8bed-b4c731aa201a"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_fad25e8f-82cd-4241-b5a5-deda1a16ec70"
      decimals="-3"
      id="F_ca3e8d26-f96b-45d6-ad69-f3024900a044"
      unitRef="U_USD">689275000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1af1f196-8f7a-453c-8f26-b468bf9f47e8"
      decimals="-3"
      id="F_d140092a-6789-439f-9aef-b9e95dc40943"
      unitRef="U_USD">-228982000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b519ea9f-6482-4c50-93f0-fae0c804af59"
      decimals="-3"
      id="F_38d0b899-ddd5-489e-8ebe-d0eddd2916ee"
      unitRef="U_USD">-660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_b44c9753-6329-474b-9b9a-9c4cd32751b1"
      unitRef="U_USD">459638000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_06738e58-f7fd-48f8-91f1-9bb2c730b938"
      decimals="0"
      id="F_d72ea4f4-bdad-46b3-9ddc-61b4765a36f5"
      unitRef="U_shares">51536181</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_06738e58-f7fd-48f8-91f1-9bb2c730b938"
      decimals="-3"
      id="F_e35eb16b-60a7-42d5-961c-dad5298d442b"
      unitRef="U_USD">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_fad25e8f-82cd-4241-b5a5-deda1a16ec70"
      decimals="-3"
      id="F_0758fef9-0aa9-4f8a-91e4-834a5055e7e9"
      unitRef="U_USD">689275000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1af1f196-8f7a-453c-8f26-b468bf9f47e8"
      decimals="-3"
      id="F_6b166f82-fe02-41bd-b6a1-34b55929868f"
      unitRef="U_USD">-228982000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b519ea9f-6482-4c50-93f0-fae0c804af59"
      decimals="-3"
      id="F_0103a076-7416-4b10-ac5f-cdbfa61614fe"
      unitRef="U_USD">-660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_c8720668-7a58-49ce-a997-bb7e8456e578"
      unitRef="U_USD">459638000</us-gaap:StockholdersEquity>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_a1dd06bd-628b-4a21-a020-4c297199d4b8"
      unitRef="U_USD">174000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares
      contextRef="C_08714960-9258-4fdb-9361-563b0b151dda"
      decimals="0"
      id="F_2ce2e539-40e7-4ce9-82a0-89e609748a2f"
      unitRef="U_shares">2769228</kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares>
    <kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
      contextRef="C_08714960-9258-4fdb-9361-563b0b151dda"
      decimals="-3"
      id="F_12efa25b-d07e-411c-a117-fe5633a9c8d5"
      unitRef="U_USD">1000</kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost>
    <kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
      contextRef="C_76aa8dac-964b-4401-9f4a-e42aa52a6fa3"
      decimals="-3"
      id="F_8381726e-1d59-4cbd-ba54-f7504b2757d2"
      unitRef="U_USD">149825000</kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost>
    <kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_9d8b5b95-b9d4-4b53-98e1-a2489277516a"
      unitRef="U_USD">149826000</kymr:IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_08714960-9258-4fdb-9361-563b0b151dda"
      decimals="0"
      id="F_3b907cbd-ca56-42e8-8317-671b5bc8f9da"
      unitRef="U_shares">601594</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_76aa8dac-964b-4401-9f4a-e42aa52a6fa3"
      decimals="-3"
      id="F_5d3bf8e9-f7a1-4da4-8d04-6d76eff6863f"
      unitRef="U_USD">3154000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_3424af99-57aa-430b-ad4e-773cb3e59298"
      unitRef="U_USD">3154000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <kymr:StockIssuedDuringPeriodSharesRestrictedStockVested
      contextRef="C_08714960-9258-4fdb-9361-563b0b151dda"
      decimals="0"
      id="F_87de8cf5-008e-4f0b-bd68-880d61a1bf44"
      unitRef="U_shares">36866</kymr:StockIssuedDuringPeriodSharesRestrictedStockVested>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_08714960-9258-4fdb-9361-563b0b151dda"
      decimals="0"
      id="F_ec43a0f9-d6dc-469a-9a32-4edab0059358"
      unitRef="U_shares">95511</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_76aa8dac-964b-4401-9f4a-e42aa52a6fa3"
      decimals="-3"
      id="F_f77a3455-2928-4962-9a38-32f0a22a476b"
      unitRef="U_USD">1150000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_f93d5f92-93bc-4871-b5d7-4440f75b9db3"
      unitRef="U_USD">1150000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_76aa8dac-964b-4401-9f4a-e42aa52a6fa3"
      decimals="-3"
      id="F_e27d764d-00b3-49cb-b6b6-6201224e5cc7"
      unitRef="U_USD">35480000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_4fbf7b61-4d74-4c70-a7b7-3ee0d35fa4f5"
      unitRef="U_USD">35480000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_24dbfe2c-9946-41c1-a96a-9697c75159ef"
      decimals="-3"
      id="F_aa81b784-cd95-4c03-9ecb-cc6db07e17ae"
      unitRef="U_USD">-4289000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_30cd2373-a236-4e69-bd31-9637fcb37d61"
      unitRef="U_USD">-4289000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_0cf55378-3493-4d42-bbac-071bc03a0b45"
      decimals="-3"
      id="F_f0ec5c57-0e95-4844-8aef-39fe7868c00b"
      unitRef="U_USD">-154808000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_01c9498a-a2e5-4784-9930-3feb92c3be66"
      unitRef="U_USD">-154808000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_611d8018-b7e1-4bc6-a151-16f06fc1c9e5"
      decimals="0"
      id="F_3a68621b-7173-45eb-b351-a00cfbc08f38"
      unitRef="U_shares">55039380</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_611d8018-b7e1-4bc6-a151-16f06fc1c9e5"
      decimals="-3"
      id="F_06e4d779-112a-4072-afa2-88be22b48c87"
      unitRef="U_USD">6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_2022fb22-d24d-4bbe-bb9f-9dab9e88b500"
      decimals="-3"
      id="F_c468b551-d90f-42f9-9cd4-ca617a8a4b23"
      unitRef="U_USD">878884000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_ec425b46-47ad-47dc-8171-83d01e53a978"
      decimals="-3"
      id="F_8400f894-7a13-4b76-8a6b-7e39dadb78f3"
      unitRef="U_USD">-383790000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_71ee1d85-28a5-45c6-8c2c-1fe698d0852e"
      decimals="-3"
      id="F_b6e3ad64-f501-4cb3-a997-844687a3e39e"
      unitRef="U_USD">-4949000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_e94b38be-066c-4417-af2b-32362105bac9"
      unitRef="U_USD">490151000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_f0787a8d-9ce9-4700-a7ec-e9b0e00a83a8"
      unitRef="U_USD">-154808000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_cd62e68f-54a6-441c-a596-5ac6adaeea63"
      unitRef="U_USD">-100217000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_2cdc89f7-28d2-46c3-8207-364972057474"
      unitRef="U_USD">-45593000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_63a71a96-d7b8-444e-86aa-8bded771e32c"
      unitRef="U_USD">35480000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_c1b61339-232d-4874-9109-59dc44683189"
      unitRef="U_USD">24972000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_dc85d13d-2efa-4815-aeac-03e7ec09ed93"
      unitRef="U_USD">5190000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_560319a8-b280-49c8-8724-a0c1457c681b"
      unitRef="U_USD">2977000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_3cda8756-6c81-4698-8469-0ffa71417c2b"
      unitRef="U_USD">2397000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_41905981-8aa8-4efb-8d92-326a94dc749e"
      unitRef="U_USD">1763000</us-gaap:DepreciationDepletionAndAmortization>
    <kymr:PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_72d4cf00-ecf6-41d7-b130-4585cfdb8945"
      unitRef="U_USD">889000</kymr:PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities>
    <kymr:PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_124d2b36-93c1-4eb2-9cff-8a122a4e59e4"
      unitRef="U_USD">5807000</kymr:PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities>
    <kymr:PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_df1f5e37-9b31-4c9a-9834-c66048fede70"
      unitRef="U_USD">1571000</kymr:PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_b708601e-2f8d-491c-91cc-1e96cb1690b9"
      unitRef="U_USD">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_5c03560c-c0fd-4dad-835c-efbd0fb05fdd"
      unitRef="U_USD">-18000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_d09617ac-9a45-4330-b0dc-37b78a260462"
      unitRef="U_USD">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <kymr:NonCashResearchAndDevelopmentExpense
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_b182d274-89dd-4deb-a2c4-0ceebd94d41b"
      unitRef="U_USD">0</kymr:NonCashResearchAndDevelopmentExpense>
    <kymr:NonCashResearchAndDevelopmentExpense
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_ffa3648f-fcb9-4b49-81d8-d4eee2d956fe"
      unitRef="U_USD">0</kymr:NonCashResearchAndDevelopmentExpense>
    <kymr:NonCashResearchAndDevelopmentExpense
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_58d09b00-85e0-4174-8183-0d84522c1d8b"
      unitRef="U_USD">332000</kymr:NonCashResearchAndDevelopmentExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_ae3e35fb-995e-4aa2-a7db-6dde22280f73"
      unitRef="U_USD">992000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_d93733bf-eb44-46c2-a4c8-f6b8cfd52156"
      unitRef="U_USD">4016000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_a013ed40-460c-412a-9b93-0aed26652543"
      unitRef="U_USD">3816000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_8f7b3a3b-fcf5-4aec-98f2-42fad0b36b46"
      unitRef="U_USD">0</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_065b9f0b-729a-4139-beaf-84a96d1a0edb"
      unitRef="U_USD">-577000</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_be8f945f-6abd-44cb-82f6-14ede3f9cfd1"
      unitRef="U_USD">577000</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <kymr:IncreaseDecreaseInContractWithCustomerAssetRelatedParties
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_24a16876-c65a-48e9-a67f-6e5978e2ebc3"
      unitRef="U_USD">2401000</kymr:IncreaseDecreaseInContractWithCustomerAssetRelatedParties>
    <kymr:IncreaseDecreaseInContractWithCustomerAssetRelatedParties
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_ab4fc6a2-94d2-45b2-93e5-6cde131c63aa"
      unitRef="U_USD">-721000</kymr:IncreaseDecreaseInContractWithCustomerAssetRelatedParties>
    <kymr:IncreaseDecreaseInContractWithCustomerAssetRelatedParties
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_4e921b6b-f156-43de-bee7-d30021c0586c"
      unitRef="U_USD">856000</kymr:IncreaseDecreaseInContractWithCustomerAssetRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_bbfc2ec4-45f5-4acd-aacc-45baa964a863"
      unitRef="U_USD">253000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_04ddb500-c36d-4459-a326-83493fe10a8d"
      unitRef="U_USD">54000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_2d2817ef-ccc8-45eb-a315-b99a8b67cdaf"
      unitRef="U_USD">990000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_7f95d109-cb75-4544-ae35-3c064ab93962"
      unitRef="U_USD">4519000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_6783b8bb-e12b-4f6f-9d5c-6d08a0ac2d88"
      unitRef="U_USD">12599000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_5b18b577-5d39-44d3-9bb5-4dc4d0fac268"
      unitRef="U_USD">5754000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_d295edc9-1279-4799-b321-b6a975c2eb91"
      unitRef="U_USD">-37774000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_bffbd4c4-2541-442c-b4b2-4047fba11730"
      unitRef="U_USD">-69356000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_478613c5-6160-475f-8fff-0bacb7ecc8ec"
      unitRef="U_USD">117400000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <kymr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_6fda8602-329c-4a65-b9f9-762d1884186c"
      unitRef="U_USD">-517000</kymr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <kymr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_8562c00a-c46a-47e6-8781-a71cc785fd3b"
      unitRef="U_USD">-419000</kymr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <kymr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_059dc094-44b2-4198-809b-24500c30ee72"
      unitRef="U_USD">-8444000</kymr:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <kymr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_ad7960b9-cdf2-430e-bfd8-b9edd6460d47"
      unitRef="U_USD">-1004000</kymr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <kymr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_3e77ba10-c3f6-454e-a58a-dbcdbb173bbc"
      unitRef="U_USD">-1015000</kymr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <kymr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_73600f29-d694-4a42-8e5c-a067e0e1f0c0"
      unitRef="U_USD">-2647000</kymr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_229462e1-afbe-4779-9b80-65243bafdc2a"
      unitRef="U_USD">998000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_939c4ef7-63a2-4daf-baac-e492ef34c380"
      unitRef="U_USD">1992000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_b6a41340-713c-4e77-b809-c71511353e99"
      unitRef="U_USD">30000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_1e81cb9e-69e9-4445-8242-08623e3f2fcb"
      unitRef="U_USD">257000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_55ccca88-b801-4d2c-a093-aa0cccb21ba2"
      unitRef="U_USD">86000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_38a06638-5d4f-4387-a9fe-91cfa67e5ff7"
      unitRef="U_USD">205000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_f2abc022-755b-4767-8b82-5eaccb1c8f3e"
      unitRef="U_USD">-153085000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_9771d5ab-0c4f-4dfc-810c-2fb7a61b625f"
      unitRef="U_USD">-128946000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_8d352143-23aa-4dfc-9835-cd1be3ee0c42"
      unitRef="U_USD">88130000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_52293e25-0dad-412d-87ad-d36a5efe569c"
      unitRef="U_USD">2836000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_a8318ad8-4d9d-4943-a1b0-b52f589d2e5e"
      unitRef="U_USD">1597000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_46253423-df6d-4389-999a-ebe6bed01e34"
      unitRef="U_USD">9096000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_8782dd9f-f05a-4969-887c-9ec0d2211e85"
      unitRef="U_USD">445972000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_e46bb837-e381-4243-aa33-07567a43b327"
      unitRef="U_USD">456404000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_8975738f-fe1a-4c98-859d-c92f7619a85c"
      unitRef="U_USD">529382000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_a53af20f-941b-4dac-9a39-2663704270f3"
      unitRef="U_USD">469327000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_da4997e7-14c8-4ed5-a3d9-49726dde5f27"
      unitRef="U_USD">358166000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_3a04eb27-fa93-4ea9-938c-fc5a5c2b23a1"
      unitRef="U_USD">115890000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_180f4b80-d80b-4da5-8efc-91c8aca4c962"
      unitRef="U_USD">20519000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_f7439f45-fb47-42dc-8954-14db0a97c0ad"
      unitRef="U_USD">-99835000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_85840b20-4dd5-4b75-a333-60f02e824a37"
      unitRef="U_USD">-422588000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <kymr:IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_7fd19ac6-10b3-447f-a520-4d2b0da28858"
      unitRef="U_USD">149825000</kymr:IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts>
    <kymr:IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_2f3a7d47-236f-49cc-8d56-7d7f7dea9f47"
      unitRef="U_USD">0</kymr:IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts>
    <kymr:IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_67ad4c45-2a22-47bb-ba58-c5169f42110c"
      unitRef="U_USD">0</kymr:IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_842a256c-4f35-4914-9766-3edf46028402"
      decimals="-3"
      id="F_57cb3838-25e8-4b48-bba0-755ae717340b"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_8ff041e4-b315-4e52-b81f-f83d9f3192a0"
      decimals="-3"
      id="F_1a3d6d9f-ddfe-4b77-ba10-a07ee267d2e2"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_d4188fce-d0eb-4f3f-bcf3-22439576a842"
      decimals="-3"
      id="F_6f54714d-7fb9-4fca-be78-d560cc7e0520"
      unitRef="U_USD">4800000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_cd15099d-d559-460e-9cc6-741a7742e2e1"
      decimals="-3"
      id="F_83234beb-de59-436e-a58d-a9282947052e"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_1c2cea65-c96f-40f3-85ee-3f904357fc50"
      decimals="-3"
      id="F_475ab3ff-ce7f-4ab4-8f2c-22a30efd96ed"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_a7390bb2-e4b5-4521-99ff-a62dbe405f46"
      decimals="-3"
      id="F_f9a394fc-6969-439a-9fa8-cb32eb797441"
      unitRef="U_USD">88181000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_8d9eff06-f573-490c-b31b-a4e664e6d9d2"
      unitRef="U_USD">3154000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_1bb7b655-b669-4e02-a535-7e3c9702c57e"
      unitRef="U_USD">7632000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_2d532037-2fb4-4452-acd6-6e5f02de6de2"
      unitRef="U_USD">162000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_fbccc1a5-5d11-4d02-9127-487cc1a1d8e3"
      unitRef="U_USD">1150000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_0a397653-a3eb-4e1f-a488-bf8dc6a0d4b5"
      unitRef="U_USD">788000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_e818f6d8-dab6-4266-9983-858cfcaf7956"
      unitRef="U_USD">0</us-gaap:ProceedsFromStockPlans>
    <us-gaap:PaymentsForRepurchaseOfInitialPublicOffering
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_087a8caf-302b-47af-bef5-aeeefc020ce4"
      unitRef="U_USD">397000</us-gaap:PaymentsForRepurchaseOfInitialPublicOffering>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_cccddf49-49d5-48ec-9e06-410caa6a8d1f"
      unitRef="U_USD">1130000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_bfd86429-d1a2-49a7-92c1-1d036805bb33"
      unitRef="U_USD">849000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_36941ce6-d132-49c8-bf17-7f9f4c62599f"
      unitRef="U_USD">554000</us-gaap:PaymentsOfFinancingCosts>
    <kymr:ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_1c6010d8-5b06-4ec6-97d2-ef89d0d9747d"
      unitRef="U_USD">0</kymr:ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts>
    <kymr:ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_f58e4a97-1da2-4038-a757-25aa2de8cc53"
      unitRef="U_USD">240760000</kymr:ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts>
    <kymr:ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_6bfd09fa-5807-4c0e-9386-40e255ab41a1"
      unitRef="U_USD">0</kymr:ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_19c02132-69c1-4cd2-8a5b-61655a12ec87"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_7db4ee79-e2f8-4a4d-a59b-d166f517c655"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_84b1d69a-3862-4ab2-9fe0-104f80dda151"
      unitRef="U_USD">183146000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <kymr:ProceedsFromConcurrentPrivatePlacement
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_369c0779-1400-41e9-84fd-c5ea44cb79a4"
      unitRef="U_USD">0</kymr:ProceedsFromConcurrentPrivatePlacement>
    <kymr:ProceedsFromConcurrentPrivatePlacement
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_30af8697-e6c8-4878-8e48-b4fa62dddc32"
      unitRef="U_USD">2346000</kymr:ProceedsFromConcurrentPrivatePlacement>
    <kymr:ProceedsFromConcurrentPrivatePlacement
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_ac5c43e4-0632-45ac-9f38-a8dcbb8565cf"
      unitRef="U_USD">13527000</kymr:ProceedsFromConcurrentPrivatePlacement>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_0d8f7533-fa7c-47b9-ba5b-d5a95a1859b1"
      unitRef="U_USD">152999000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_e284464d-c6e5-41f4-833c-3ab12f29e3fd"
      unitRef="U_USD">250280000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_cc91d3c6-b883-4a8a-b66f-ec8353039b84"
      unitRef="U_USD">289262000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_10eb537a-2a53-47c5-a4b5-1ec470e83bc4"
      unitRef="U_USD">20433000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_3fed6930-dd90-44c3-825b-60b58a3e280d"
      unitRef="U_USD">21499000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_adeb8231-80b3-442d-ada8-f77f989260ee"
      unitRef="U_USD">-45196000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_926a730d-552a-4f07-b6c3-d6ad8078c639"
      unitRef="U_USD">54092000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49"
      decimals="-3"
      id="F_d7703966-05a7-4260-b411-0690fc9af333"
      unitRef="U_USD">32593000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_d991933b-0bbc-4e49-adf6-0e1709f50056"
      decimals="-3"
      id="F_5adce1b3-11de-4876-b734-e37e7ac2861b"
      unitRef="U_USD">77789000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_0062067f-b483-4c09-acb1-466a6f5d6640"
      unitRef="U_USD">74525000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_dc705fb0-ca14-4dae-b11e-dafbc53dd750"
      unitRef="U_USD">54092000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49"
      decimals="-3"
      id="F_b296904e-46a3-4001-813e-a2f3456f5dad"
      unitRef="U_USD">32593000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_8ae99998-f59f-4d23-b743-097f4db541b5"
      unitRef="U_USD">179000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_6f959998-2555-4848-a4fb-b404bb05832d"
      unitRef="U_USD">158000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_acbd6fa7-b154-44b2-a465-20707d965300"
      unitRef="U_USD">115000</us-gaap:InterestPaidNet>
    <kymr:PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_a4ee04b4-4365-4a1d-9be8-a1ced803addb"
      unitRef="U_USD">1506000</kymr:PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities>
    <kymr:PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_1873985d-8e10-4e56-9f80-7b5d1b072ef7"
      unitRef="U_USD">1918000</kymr:PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities>
    <kymr:PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_e555732b-92f8-4c9e-bce2-bcee11f2522a"
      unitRef="U_USD">0</kymr:PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities>
    <kymr:PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_49f6808b-934d-4dc3-b1a2-5e70c94ba148"
      unitRef="U_USD">87000</kymr:PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses>
    <kymr:PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_b92b5f18-1792-42b9-9995-d99cf6ddd5ff"
      unitRef="U_USD">42000</kymr:PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses>
    <kymr:PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_55505d5b-7124-449c-8f05-3024fbd8d662"
      unitRef="U_USD">27000</kymr:PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses>
    <kymr:OfferingCostsIncludedInAccountsPayable
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_773c8dd4-8185-4b24-b1e8-e84bb6bc1f93"
      unitRef="U_USD">0</kymr:OfferingCostsIncludedInAccountsPayable>
    <kymr:OfferingCostsIncludedInAccountsPayable
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_9b5bf58c-8e58-42f7-abe5-03b1239ced7c"
      unitRef="U_USD">0</kymr:OfferingCostsIncludedInAccountsPayable>
    <kymr:OfferingCostsIncludedInAccountsPayable
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_53d1825f-bfd0-418b-b082-e8f859bcda04"
      unitRef="U_USD">397000</kymr:OfferingCostsIncludedInAccountsPayable>
    <kymr:ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_b609a507-8c20-4bc3-a531-9baae9e46b4d"
      unitRef="U_USD">0</kymr:ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification>
    <kymr:ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_cf96bd1b-449e-40ba-bb7d-9f91b883cbe1"
      unitRef="U_USD">0</kymr:ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification>
    <kymr:ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_62b207c3-4c86-41b1-96b2-9d950cb39a54"
      unitRef="U_USD">2161000</kymr:ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_a41ea73f-e9ec-4ec2-bcf1-47030704673c"
      unitRef="U_USD">68395000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_c7276c28-0801-4afe-bdbb-a6eef56b1eb2"
      unitRef="U_USD">47976000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49"
      decimals="-3"
      id="F_f40fa797-17ea-4d8f-828e-b393a640f874"
      unitRef="U_USD">31004000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_5f876f2d-a33e-4083-b2cc-070a7a1cc0ed"
      unitRef="U_USD">6130000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_95a2bf4f-a5c4-4b1c-a5ff-4e264975f84e"
      unitRef="U_USD">6116000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49"
      decimals="-3"
      id="F_d7d9a90b-80e3-4241-a5fc-1a2eec16bf13"
      unitRef="U_USD">1589000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_bdcfb40f-cb09-455f-951e-2f5b9a808d66"
      unitRef="U_USD">74525000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_4525c74a-0914-4fbc-838d-fc977586520a"
      unitRef="U_USD">54092000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_b6180323-5b57-488b-848b-ccefa15e0d49"
      decimals="-3"
      id="F_aa0ff114-6248-46b7-b819-892b3f33b8d4"
      unitRef="U_USD">32593000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_1fdb58f2-0e8e-4843-9165-18c9403019f3">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 1. Description of Business and Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Kymera Therapeutics, Inc., together with its subsidiary Kymera Securities Corporation, is referred to on a consolidated basis as the &#x201c;Company&#x201d;. The Company is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body&#x2019;s own natural cellular process, a method known as targeted protein degradation. The Company has devoted its efforts principally to research and development since formation. The Company has not yet completed product development, filed for or obtained regulatory approvals for any products, nor verified the market acceptance and demand for such products. As a result, the Company is subject to a number of risks common to emerging companies in the biotech industry. Principal among these risks are the uncertainties of the product discovery and development process, dependence on key individuals, development of the same or similar technological innovations by the Company&#x2019;s competitors, protection of proprietary technology, compliance with government regulations and approval requirements, the Company&#x2019;s ability to access capital and uncertainty of market acceptance of products.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has hi&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;storical net losses and anticipates that it will continue to incur losses for the foreseeable future and had an accumulated deficit of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;383.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million as o&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;f December 31, 2022. The Company has funded these losses principally through issuance of preferred stock, convertible notes, common stock, including its initial public offering and concurrent private placement completed in August 2020 (&#x201c;IPO&#x201d;), follow-on offering and concurrent private placement completed in July 2021 ("Follow-on Offering"), August 2022 Private Investment in Public Equity ("PIPE") offering, and from cash proceeds received in connection with the Company&#x2019;s collaboration agreements with Vertex Pharmaceuticals Incorporated (&#x201c;Vertex&#x201d;) and Genzyme Corporation (&#x201c;Sanofi&#x201d;) (see Note 5). The Company expects to continue to incur operating losses and negative cash flows until such time as it generates a level of revenue that is sufficient to support its cost structure.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the Company had cash, cash equivalents and marketable securit&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ies of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;559.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;million. The Company believes these cash, cash equivalents and marketable securities will be sufficient to fund its operations and capital expenditure requirements through at least twelve months from the issuance of these consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company expects to finance the future research and development costs of its product portfolio with its existing cash, cash equivalents and marketable securities, or through strategic financing opportunities that could include, but are not limited to future offerings of its equity, collaboration agreements, or the incurrence of debt. However, there is no guarantee that any of these strategic or financing opportunities will be executed or realized on favorable terms, if at all, and some could be dilutive to existing stockholders. If the Company fails to obtain additional future capital, it may be unable to complete its planned preclinical studies and clinical trials.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Reverse Stock Split&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On August 20, 2020, the Board approved a 1-for-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.5949&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; reverse stock split of the Company&#x2019;s issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each of the Company&#x2019;s outstanding series of preferred stock.  All share and per share amounts in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to this reverse stock split, including reclassifying an amount equal to the reduction in par value of common stock to additional paid-in capital.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Initial Public Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On August 20, 2020, the Company&#x2019;s registration statement on Form S-1 relating to its initial public offering of its common stock was declared effective by the Securities and Exchange Commission (&#x201c;SEC&#x201d;). In the IPO, which closed on August 25, 2020, the Company issued and sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,987,520&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock, including full exercise of the underwriters&#x2019; over-allotment option to purchase an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,302,720&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares, at a public offering price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share and the aggregate gross proceeds before deducting before deducting underwriting discounts and commissions, and other estimated offering expenses payable by the Company, were approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;199.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. Concurrent with the IPO, the Company issued and sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;676,354&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock at $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share in a private placement to Vertex and the aggregate proceeds were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Follow-on Public Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On July 6, 2021, the Company completed a follow-on offering of its common stock and issued and sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,468,250&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock, including full exercise of the underwriters&#x2019; over-allotment option to purchase an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;713,250&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares, at a public offering price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;47.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share. The aggregate gross proceeds before deducting underwriting discounts and commissions, and other estimated offering expenses payable by the Company were approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;257.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. Concurrent with the follow-on offering, the Company issued and sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;49,928&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock at $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;47.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share in a private placement to Vertex and the aggregate proceeds were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Private Investment in Public Equity "PIPE" offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On August 18, 2022, the Company and certain accredited investors entered into a securities purchase agreement pursuant to which the Company agreed to sell and issue to such investors in a private placement (i) an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,769,228&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock at a purchase price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share, and (ii) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; Pre-Funded Warrants to purchase common stock, at a purchase price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.9999&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per pre-funded warrant, (the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x201c;Pre-Funded Warrants&#x201d;)&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The Pre-Funded Warrants will have an exercise price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share of common stock. The offering closed on August 22, 2022, resulting in net proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;149.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million after offering expenses.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As the Pre-Funded Warrants are indexed to the Company&#x2019;s common stock (and otherwise meet the requirements to be classified in equity), the Company recorded the consideration received from the issuance of the Pre-Funded Warrants as additional paid-in capital on the Company&#x2019;s consolidated balance sheets. The Pre-Funded Warrants are exercisable at any time. The holders of Pre-Funded Warrants may not exercise the warrant if the holder, together with its affiliates, would beneficially own more than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.99&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the number of shares of the Common Stock outstanding immediately after giving effect to such exercise. The holders of Pre-Funded Warrants may increase or decrease such percentages not in excess of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19.99&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% by providing at least &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; days&#x2019; prior notice to the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;During the twelve months ended December 31, 2022, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; Pre-Funded Warrants were exercised. As of December 31, 2022, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; pre-funded warrants outstanding.&lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-5"
      id="F_2a47f0e6-89d1-4aa8-99c4-752bd8bf2bc7"
      unitRef="U_USD">-383800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:InvestmentsAndCash
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-5"
      id="F_e0ba7c9d-61b0-4809-8ea9-083aa0f8f5f7"
      unitRef="U_USD">559500000</us-gaap:InvestmentsAndCash>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      id="F_4f6f802e-f915-4a3c-982d-2712f95cdab7">On August 20, 2020, the Board approved a 1-for-1.5949 reverse stock split of the Company&#x2019;s issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each of the Company&#x2019;s outstanding series of preferred stock.  All share and per share amounts in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to this reverse stock split, including reclassifying an amount equal to the reduction in par value of common stock to additional paid-in capital.</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_062f8b1d-9242-4851-af55-d6d0942205c2"
      decimals="4"
      id="F_04931b77-5108-435c-bdc7-0bbdcbacdc18"
      unitRef="U_pure">1.5949</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_6ad1ca74-8cd0-428a-8420-0ed4140b55c2"
      decimals="INF"
      id="F_54db873c-c191-4735-b58e-9a5f0b595ecb"
      unitRef="U_shares">9987520</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_4dc0482d-1972-405a-aca2-c6d2771a5668"
      decimals="INF"
      id="F_6b1eaf5b-ba19-4652-82c7-fd1b84017e85"
      unitRef="U_shares">1302720</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_dfba4027-fdf3-4f74-b209-0790ae57b570"
      decimals="INF"
      id="F_8e309425-9da7-4ac6-ba9c-c21c5b93de74"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">20.00</us-gaap:SaleOfStockPricePerShare>
    <kymr:ProceedsFromIssuanceInitialPublicOfferingGross
      contextRef="C_6ad1ca74-8cd0-428a-8420-0ed4140b55c2"
      decimals="-5"
      id="F_6fdd3417-98f5-40dc-8508-723d0b13e410"
      unitRef="U_USD">199800000</kymr:ProceedsFromIssuanceInitialPublicOfferingGross>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_44015c49-ba45-4506-b30f-8927b0882496"
      decimals="INF"
      id="F_6a07e227-9e44-472f-a3e1-20a5d9af0551"
      unitRef="U_shares">676354</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_e683523c-eff3-4658-979d-24ea59364214"
      decimals="INF"
      id="F_0e269459-0b21-4914-83e6-3730a5a0f5e0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">20.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_44015c49-ba45-4506-b30f-8927b0882496"
      decimals="-5"
      id="F_bac12e17-b309-46ee-a441-b1d67c654eca"
      unitRef="U_USD">13500000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_3d5e6adf-2cb4-4ff6-abed-16ed9bba1142"
      decimals="0"
      id="F_4cde095e-28c6-46dd-b2d6-8e9c59618043"
      unitRef="U_shares">5468250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_e6afb047-c3cb-439e-93ba-6a0d534e4847"
      decimals="0"
      id="F_11266c42-27a9-4630-a0fd-2ded12b07d17"
      unitRef="U_shares">713250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_f8adf4fe-2bfc-43b4-9f31-817a19df61dc"
      decimals="INF"
      id="F_2fe9fff1-7894-4d4b-aa13-377b4792f8a1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">47.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_3d5e6adf-2cb4-4ff6-abed-16ed9bba1142"
      decimals="-5"
      id="F_e82998e3-dda4-48f6-bcbe-c30c625a9df3"
      unitRef="U_USD">257000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_f35c6b15-85ad-422b-890a-5ff664200b70"
      decimals="0"
      id="F_ba13c6cd-4fac-4e7c-bc7a-7a93fdf40c61"
      unitRef="U_shares">49928</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_5e341025-329c-4ac7-81f0-c034f045d05a"
      decimals="INF"
      id="F_fa261d1d-d832-446d-ba5b-0f8d10355769"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">47.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_f35c6b15-85ad-422b-890a-5ff664200b70"
      decimals="-5"
      id="F_6a5ac945-0d9f-4ed9-943e-da15ac8e9e3e"
      unitRef="U_USD">2300000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_1df7a9a0-1093-45f8-b738-6e2b781d6256"
      decimals="INF"
      id="F_a4a829b1-8ab3-4022-a9bd-26796137d10c"
      unitRef="U_shares">2769228</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_0e2b9cb4-93a4-4a46-8ff4-8c907b9948cb"
      decimals="INF"
      id="F_83ab486b-6837-4291-8a1b-70c85f3ee247"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">26.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_0e2b9cb4-93a4-4a46-8ff4-8c907b9948cb"
      decimals="INF"
      id="F_e0260c5e-0d59-4de1-b718-20548d671729"
      unitRef="U_shares">3000000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0e2b9cb4-93a4-4a46-8ff4-8c907b9948cb"
      decimals="4"
      id="F_6c6a8ad5-5b79-464c-8a00-24fedd574c1f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">25.9999</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare
      contextRef="C_1df7a9a0-1093-45f8-b738-6e2b781d6256"
      decimals="INF"
      id="F_8e4613a4-ed8e-43db-a2f4-b4013b92042d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare>
    <us-gaap:GeneralPartnersOfferingCosts
      contextRef="C_0e2b9cb4-93a4-4a46-8ff4-8c907b9948cb"
      decimals="-5"
      id="F_222763ac-5fa2-4a3e-9c68-bd8d470be123"
      unitRef="U_USD">149800000</us-gaap:GeneralPartnersOfferingCosts>
    <kymr:MinimumPreFundedWarrantsExercise
      contextRef="C_1df7a9a0-1093-45f8-b738-6e2b781d6256"
      decimals="4"
      id="F_64040601-ad05-4fff-b96f-dd18a57dcff2"
      unitRef="U_pure">0.0499</kymr:MinimumPreFundedWarrantsExercise>
    <kymr:IncreaseOrDecreasePreFundedWarrants
      contextRef="C_1df7a9a0-1093-45f8-b738-6e2b781d6256"
      decimals="4"
      id="F_b30ad824-758e-4a38-a7d1-2bff15ba54d2"
      unitRef="U_pure">0.1999</kymr:IncreaseOrDecreasePreFundedWarrants>
    <kymr:PriorNoticePeriod
      contextRef="C_1df7a9a0-1093-45f8-b738-6e2b781d6256"
      id="F_c995c9c9-e340-4cec-84d8-dfbd5b831e07">P61D</kymr:PriorNoticePeriod>
    <us-gaap:PaymentsForRepurchaseOfWarrants
      contextRef="C_c448089e-36a2-4d25-8667-2eff989ca829"
      decimals="-3"
      id="F_0fed3bff-f6b3-4625-afa6-f46bdfbcf96c"
      unitRef="U_USD">0</us-gaap:PaymentsForRepurchaseOfWarrants>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_07b901be-39ca-4958-8fa3-0fb35bd13fe8"
      decimals="INF"
      id="F_65c9099f-e547-45ad-8607-aeb6e508e6a2"
      unitRef="U_shares">3000000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_0d021c53-d9d4-4c12-9559-f7c39059c0ba">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note, and elsewhere in the accompanying consolidated financial statements and notes.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary Kymera Securities Corporation. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Update (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amounts of expenses during the reporting period. Management&#x2019;s estimates and judgments are derived and continually evaluated based on available information, historical experience and various other assumptions that are believed to be reasonable under the circumstances. Because the use of estimates is inherent in the financial reporting process, actual results could differ from those estimates. In recording transactions and balances resulting from business operations, management makes estimates based on the best information available at the time the estimate is made. Significant estimates relied upon in preparing these financial statements include revenue recognized under our collaboration agreement with Sanofi and Vertex, accrual for research and development expenses, equity-based compensation expense, and the valuation of equity prior to the Company's initial public offering. As better information becomes available or actual amounts are determinable, the recorded estimates are revised. Consequently, operating results can be affected by revisions to prior estimates.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Segment and Geographic Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company&#x2019;s chief operating decision maker is the Chief Executive Officer. The Company views its operations and manages its business in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; operating segment.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents are highly liquid investments that are readily convertible into cash with original maturities of three months or less when purchased. These assets include investments in money market funds that invest in U.S. Treasury obligations and corporate bonds. The Company maintains its bank accounts at major financial institutions.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash represents the cash held to secure letters of credit associated with the Company&#x2019;s facility leases.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company classifies marketable securities with a remaining maturity of greater than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three months&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; when purchased as available-for-sale. The Company classifies investments available to fund current operations as current assets on its balance sheets. Marketable securities with a remaining maturity date greater than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; are classified as non-current. Available-for-sale securities are maintained by investment managers and consist of U.S. Treasury securities and corporate bonds. Available-for-sale securities are carried at fair value with the unrealized gains and losses included in other comprehensive income (loss) as a component of stockholders&#x2019; equity until realized. Any premium or discount arising at purchase is amortized and/or accreted to interest income and/or expense over the life of the instrument. Realized gains and losses are determined using the specific identification method and are included in other (expense) income, net.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company&#x2019;s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer&#x2019;s industry, and any significant deterioration in economic conditions.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 1&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted prices in active markets for identical assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 2&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar asset, or other inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 3&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets, including pricing models, discounted cash flow methodologies and similar techniques.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The carrying values of the Company&#x2019;s cash equivalents, prepaid expenses, accounts payable, and certain accruals approximate their fair value due to their short-term nature.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Leases that are economically similar to the purchase of assets are generally classified as finance leases; otherwise the leases are classified as operating leases. The Company has elected not to recognize leases with an original term of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; or less on the balance sheet. Options to renew a lease are not included in the Company&#x2019;s assessment unless there is reasonable certainty that the Company will renew. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets, lease liabilities and, if applicable, long-term lease liabilities. Lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. However, certain adjustments to the right-of-use asset may be required for items such as incentives received. The Company has elected as an accounting policy to combine lease and non- lease components, such as common area maintenance, for all classes of underlying assets. The interest rate implicit in lease contracts has not historically been readily determinable. As a result, the Company utilizes its incremental borrowing rates, which are the rates incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. To estimate its incremental borrowing rate, a credit rating applicable to the Company is estimated using synthetic credit rating analysis since the Company does not currently have a rating agency-based credit rating.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment are recorded at cost, net of accumulated depreciation. Major additions and betterments are capitalized; maintenance and repairs, which do not improve or extend the life of the respective assets, are charged to operations as incurred. &lt;/span&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:62.619%;"/&gt;
          &lt;td style="width:0.208%;"/&gt;
          &lt;td style="width:37.173%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated Useful Life&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shorter of life of lease or remaining lease term&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Upon retirement or sale, the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Construction-in-progress is stated at cost, which includes direct costs attributable to the setup or construction of the related asset. Depreciation expense is not recorded on construction-in-progress until the relevant assets are completed and put into use.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Long-lived assets (including right-of-use assets) to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value, determined based on discounted cash flows. The Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t record any impairment losses on long-lived assets during the years ended December 31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company classified convertible preferred stock as temporary equity in the accompanying consolidated statement of Convertible Preferred Stock and Stockholders&#x2019; Equity due to terms that allow for redemption of the shares in cash upon certain change in control events that are outside of the Company&#x2019;s control, including the sale or transfer of the Company as holders of the convertible preferred stock which could trigger redemption of the shares. The Company did not accrete the value of the convertible preferred stock to the redemption values since a liquidation event was not considered probable prior to the conversion date. In connection with the Company&#x2019;s initial public offering on August 25, 2020, all outstanding shares of convertible preferred stock converted to common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Warrants&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company determines the accounting classification of warrants that are issued, as either liability or equity, by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, and then in accordance with ASC 815-40, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#x2019;s Own Stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Under ASC 480-10, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate the issuer to settle the warrants or the underlying shares by paying cash or other assets, or must or may require settlement by issuing variable number of shares.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;If warrants do not meet liability classification under ASC 480-10, the Company assesses the requirements under ASC 815-40, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature. If the warrants do not require liability classification under ASC 815-40, in order to conclude equity classification, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable U.S. GAAP. After all relevant assessments are made, the Company concludes whether the warrants are classified as liability or equity. Liability classified warrants are required to be accounted for at fair value both on the date of issuance and on subsequent accounting period ending dates, with all changes in fair value after the issuance date recorded in the statements of operations as a gain or loss. Equity classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development costs consist primarily of costs incurred in connection with the discovery and development of targeted protein degradation therapeutics, including those in the Company&#x2019;s most advanced development programs, IRAK4, IRAKIMiD, STAT3 and MDM2. These research efforts and costs, which also support the development of, and enhancements to, the Company&#x2019;s Pegasus&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;TM&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; targeted protein degradation platform, include external research costs, personnel costs, supplies, license fees and facility related expenses. The Company expenses research and development costs as incurred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Patent Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recoverability of the expenditure. Amounts incurred are classified as general and administrative expenses.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financing Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Costs incurred in connection with the issuance of equity units and shares are recorded as a reduction of proceeds to the equity carrying value. The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process financings as deferred offering costs until such financings are consummated. After consummation of the financing, these costs are recorded as a reduction of the proceeds received from the financing. If a planned financing is abandoned, the deferred offering costs are expensed immediately as a charge to operating expenses in the consolidated statement of operations and comprehensive loss. There was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; deferred offering costs on the Company&#x2019;s consolidated balance sheet at December 31, 2022 and December 31, 2021.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under ASC 606, Topic 606, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;)&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;,  the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the contract(s) with the customer; (ii) identification of the promised goods or services in the contract and determination of whether the promised goods or services are performance obligations; (iii) measurement of the transaction price; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As part of the accounting for these arrangements, the Company must use significant judgment to determine: a) the number of performance obligations based on the determination under step (ii) above and whether those performance obligations are distinct from other performance obligations in the contract; b) the transaction price under step (iii) above; and c) the standalone selling price for each performance obligation identified in the contract for the allocation of transaction price in step (iv) above. The Company uses judgment to determine whether milestones or other variable consideration, except for royalties, should be included in the transaction price as described further below. The transaction price is allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. In determining the stand-alone selling price of a license to the Company&#x2019;s proprietary technology or a material right provided by a customer option, the Company considers market conditions as well as entity-specific factors, including those factors contemplated in negotiating the agreements as well as internally developed estimates that include assumptions related to the market opportunity, estimated development costs, probability of success and the time needed to commercialize a product candidate pursuant to the license. In validating its estimated stand-alone selling prices, the Company evaluates whether changes in the key assumptions used to determine its estimated stand-alone selling prices will have a significant effect on the allocation of arrangement consideration between performance obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company estimates the transaction price based on the amount of consideration the Company expects to be received for transferring the promised goods or services in the contract. The consideration may include both fixed consideration and variable consideration. At the inception of each arrangement that includes variable consideration, the Company evaluates the amount of the potential payments and the likelihood that the payments will be received. The Company utilizes either the most likely amount method or expected value method to estimate the transaction price based on which method better predicts the amount of consideration expected to be received. If it is probable that a significant revenue reversal would not occur, the variable consideration is included in the transaction price.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer. Promised goods or services are considered distinct when: (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on their own and whether the required expertise is readily available.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation in order to determine whether the combined performance obligation is satisfied over time or at a point in time. The Company receives payments from customers based on billing schedules established in each contract. Up-front payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional. Amounts recognized as revenue, but not yet received or invoiced are generally recognized as contract assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Exclusive Licenses&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;If the license granted in the arrangement is determined to be distinct from the other promises or performance obligations identified in the arrangement, which generally include research and development services, the Company recognizes revenue from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. In assessing whether a license is distinct from the other promises, the Company considers relevant facts and circumstances of each arrangement, including the research and development capabilities of the collaboration partner and the availability of the associated expertise in the general marketplace. In addition, the Company considers whether the collaboration partner can benefit from the license for its intended purpose without the receipt of the remaining promise, whether the value of the license is dependent on the unsatisfied promise, whether there are other vendors that could provide the remaining promise, and whether it is separately identifiable from the remaining promise. For licenses that are combined with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition based on estimated remaining research and development costs. The calculation of the total remaining estimated research and development costs includes forecasted costs associated with internal employee efforts, materials costs, and third-party contract costs, as well as the assumed timing and duration of these activities. The recognition of revenue pursuant to collaboration arrangements is subject to these judgments made and estimates developed by management and is sensitive to changes in these assumptions. Therefore, the measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the arrangement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development Services&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;The promises under the Company&#x2019;s collaboration and license agreements generally include research and development services to be performed by the Company on behalf of the collaboration partner. For performance obligations that include research and development services, the Company generally recognizes revenue allocated to such performance obligations based on an appropriate measure of progress. The Company utilizes judgment to determine the appropriate method of measuring progress for purposes of recognizing revenue, which is generally an input measure, such as costs incurred. The Company evaluates the measure of progress each reporting period as described under Exclusive Licenses above. Reimbursements from the partner that are the result of a collaborative relationship with the partner, instead of a customer relationship, such as co-development activities, are generally recorded as a reduction to research and development expense.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Customer Options&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;The Company&#x2019;s arrangements may provide a collaborator with the right to certain optional purchases, such as the right to license a target either at the inception of the arrangement or within a pre-defined option period. Under these agreements, fees may be due to the Company at the inception of the arrangement as an upfront fee or payment or upon the exercise of an option to acquire a license. If an arrangement is determined to contain customer options that allow the customer to acquire additional goods or services, the goods and services underlying the customer options are not considered to be performance obligations at the outset of the arrangement, as they are contingent upon option exercise. The Company evaluates the customer options for material rights, or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the inception of the arrangement. The Company allocates the transaction price to material rights based on the relative stand-alone selling price, which is determined based on the identified discount, and the probability that the customer will exercise the option. Amounts allocated to a material right are not recognized as revenue until, at the earliest, the option is exercised or expires.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Milestone Payments&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;At the inception of each arrangement that includes milestone payments based on certain events, the Company evaluates whether the milestones are considered probable of being achieved and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The Company evaluates factors such as the scientific, clinical, regulatory, commercial, and other risks that must be overcome to achieve the particular milestone in making this assessment. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. At the end of each subsequent reporting period, the Company reevaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. If a milestone or other variable consideration relates specifically to the Company&#x2019;s efforts to satisfy a single performance obligation or to a specific outcome from satisfying the performance obligation, the Company generally allocates the milestone amount entirely to that performance obligation once it is probable that a significant revenue reversal would not occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Royalties&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;For arrangements that include sales-based royalties, including milestone payments based on a level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue resulting from any of its licensing arrangements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Collaboration revenue&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company analyzes its collaboration arrangements to assess whether they are within the scope of ASC 808,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Collaborative Arrangements&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; (&#x201c;ASC 808&#x201d;) to determine whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and those that are more reflective of a vendor-customer relationship and therefore within the scope of Topic 606. For elements of collaboration arrangements that are accounted for pursuant to ASC 808, an appropriate recognition method is determined and applied consistently, generally by analogy to Topic 606. For those elements of the arrangement that are accounted for pursuant to Topic 606, the Company applies the five-step model described above.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Costs associated with License and Collaborative Arrangements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Costs associated with licenses of technology acquired as part of collaborative arrangements are expensed as incurred and are generally included in research and development expense in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounts Receivable&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company extends credit to customers based on its evaluation of the customer&#x2019;s financial condition. The Company records receivables for all billings when amounts are due under standard terms. Accounts receivable are stated at amounts due net of applicable prompt pay discounts and other contractual adjustments as well as an allowance for doubtful accounts. The Company assesses the need for an allowance for doubtful accounts by considering a number of factors, including the length of time trade accounts receivable are past due, the customer&#x2019;s ability to pay its obligation and the condition of the general economy and the industry as a whole. The Company will write off accounts receivable when the Company determines that they are uncollectible. In general, the Company has experienced no significant collection issues with its customers&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company accounts for all stock-based awards granted to employees, directors, and nonemployees based on their fair value on the date of the grant and recognize compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. Stock-based payments include stock options and grants of common stock, including common stock subject to vesting. The measurement date for stock awards is the date of grant, and stock-based compensation costs are recognized as expense over the requisite service period, which is the vesting period, on a straight-line basis. The Company has issued stock options and restricted stock with performance-based vesting conditions and records the expense for these awards if the Company concludes that it is probable that the performance condition will be achieved. Stock-based compensation is classified in the accompanying consolidated statements of operations and comprehensive loss based on the function to which the related services are provided. The Company recognizes stock-based compensation expense for the portion of awards that have vested. Forfeitures are accounted for as they occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes options-pricing model, which requires inputs based on certain subjective assumptions, including the expected stock price volatility, the expected term of the option, the risk-free interest rate for a period that approximates the expected term of the option, and the Company&#x2019;s expected dividend yield. Prior to the IPO, as there was no active market for the Company&#x2019;s common stock, the Company estimated the fair value of common stock on the date of grant based on the then current facts and circumstances. Upon becoming a public company, the fair value of the underlying common shares equals the closing price of the Company&#x2019;s stock on the date of grant. As the Company&#x2019;s IPO was in 2020, the Company  lacks a sufficient period of company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of guideline companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#x2019;s stock options has been determined utilizing the &#x201c;simplified&#x201d; method for awards that qualify as &#x201c;plain-vanilla&#x201d; options. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#x2019;s common stock on that same date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Compensation expense for discounted purchases under the employee stock purchase plan is measured using the Black-Scholes model to compute the fair value of the lookback provision plus the purchase discount and is recognized as compensation expense over the offering period.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company records income taxes in accordance with FASB Accounting Standards Codification Topic 740, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; (&#x201c;ASC 740&#x201d;), which provides for deferred taxes using an asset and liability approach. Under this method, deferred income tax assets and liabilities are recognized based on future income tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities, and their respective income tax basis. Deferred income tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of changes in income tax rates on deferred income tax assets and liabilities is recognized as income or expense in the period that a valuation allowance for any income tax benefits of which future realization is not more likely than not.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company provides reserves for potential payments of tax to various tax authorities related to uncertain tax positions. The tax benefits recorded are based on a determination of whether and how much of a tax benefit taken by the Company in its tax filings or positions is &#x201c;more likely than not&#x201d; to be realized following resolution of any uncertainty related to the tax benefit, assuming that the matter in question will be raised by the tax authorities.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Off Balance Sheet Risk and Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has no significant off-balance sheet risk such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and restricted cash. The Company&#x2019;s cash, cash equivalents, and restricted cash are deposited in accounts at large financial institutions. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash, cash equivalents and restricted cash are held. The Company maintains its cash equivalents in money market funds that invest in U.S. Treasury securities and U.S. Treasury obligations and corporate bonds. The Company&#x2019;s marketable securities primarily consist of corporate bonds and U.S. Treasury securities paper, and potentially subject the Company to concentrations of credit risk. The Company has adopted an investment policy that limits the amounts the Company may invest in any one type of investment. The Company has not experienced any credit losses and does not believe it is exposed to any significant credit risk on these funds.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Comprehensive loss includes net loss as well as unrealized gains and losses on marketable securities and other changes in stockholders&#x2019; equity (deficit) that result from transactions and economic events other than those with stockholders.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Net Loss Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company applies the two-class method to compute basic and diluted net income (loss) per share attributable to common stockholders when it has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income (loss) available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to share in the earnings as if all income (loss) for the period had been distributed. The Company&#x2019;s convertible preferred stock participates in any dividends declared by the Company and are therefore considered to be participating securities. The participating securities are not required to participate in the losses of the Company, and therefore during periods of loss there is no allocation required under the two-class method.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including the pre-funded warrants given their nominal exercise price. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) per share attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including potential dilutive common shares. For purpose of this calculation, outstanding options to purchase common stock, unvested restricted stock awards, and shares of convertible preferred stock are considered potential dilutive common shares. The Company has generated a net loss in all periods presented, and therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In August 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The Company adopted ASU 2020-06 effective as of January 1, 2022. The adoption of ASU 2020-06 did not have an impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_d5ec9a6f-547d-433e-b700-73553821dd3c">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary Kymera Securities Corporation. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_d5999ae1-8ed2-456c-8cad-134ce4850acc">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Update (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_384a006d-f81a-4fe4-8e4b-e1c3404d384c">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amounts of expenses during the reporting period. Management&#x2019;s estimates and judgments are derived and continually evaluated based on available information, historical experience and various other assumptions that are believed to be reasonable under the circumstances. Because the use of estimates is inherent in the financial reporting process, actual results could differ from those estimates. In recording transactions and balances resulting from business operations, management makes estimates based on the best information available at the time the estimate is made. Significant estimates relied upon in preparing these financial statements include revenue recognized under our collaboration agreement with Sanofi and Vertex, accrual for research and development expenses, equity-based compensation expense, and the valuation of equity prior to the Company's initial public offering. As better information becomes available or actual amounts are determinable, the recorded estimates are revised. Consequently, operating results can be affected by revisions to prior estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <kymr:SegmentAndGeographicInformationPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_3f4f4815-2d0a-4703-85fc-2c2d8ad05c9a">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Segment and Geographic Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company&#x2019;s chief operating decision maker is the Chief Executive Officer. The Company views its operations and manages its business in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; operating segment.&lt;/span&gt;&lt;/p&gt;</kymr:SegmentAndGeographicInformationPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="INF"
      id="F_852db266-1a87-4a12-853e-d6be88244715"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_fb22c044-6983-4180-8690-53a574837677">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents are highly liquid investments that are readily convertible into cash with original maturities of three months or less when purchased. These assets include investments in money market funds that invest in U.S. Treasury obligations and corporate bonds. The Company maintains its bank accounts at major financial institutions.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy>
    <kymr:RestrictedCashPolicyPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_88f9c374-07ed-4f67-9d1b-b5d18d2dff9b">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash represents the cash held to secure letters of credit associated with the Company&#x2019;s facility leases.&lt;/span&gt;&lt;/p&gt;</kymr:RestrictedCashPolicyPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_1282176f-0225-4863-926e-093f5aaf8a28">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company classifies marketable securities with a remaining maturity of greater than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three months&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; when purchased as available-for-sale. The Company classifies investments available to fund current operations as current assets on its balance sheets. Marketable securities with a remaining maturity date greater than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; are classified as non-current. Available-for-sale securities are maintained by investment managers and consist of U.S. Treasury securities and corporate bonds. Available-for-sale securities are carried at fair value with the unrealized gains and losses included in other comprehensive income (loss) as a component of stockholders&#x2019; equity until realized. Any premium or discount arising at purchase is amortized and/or accreted to interest income and/or expense over the life of the instrument. Realized gains and losses are determined using the specific identification method and are included in other (expense) income, net.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company&#x2019;s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer&#x2019;s industry, and any significant deterioration in economic conditions.&lt;/span&gt;&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <kymr:MarketableSecuritiesRemainingMaturityPeriod
      contextRef="C_1e66e0ff-3fd7-47c3-9d78-6a55c4496d6b"
      id="F_2eda4071-56fa-4387-9b72-827104aa6977">P3M</kymr:MarketableSecuritiesRemainingMaturityPeriod>
    <kymr:MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent
      contextRef="C_1e66e0ff-3fd7-47c3-9d78-6a55c4496d6b"
      id="F_04f271e2-0f41-4af1-babf-f47aac5a0931">P1Y</kymr:MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_d6f1014c-dbed-4f2d-939e-8d17f00944d8">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 1&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted prices in active markets for identical assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 2&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar asset, or other inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 3&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets, including pricing models, discounted cash flow methodologies and similar techniques.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The carrying values of the Company&#x2019;s cash equivalents, prepaid expenses, accounts payable, and certain accruals approximate their fair value due to their short-term nature.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_09068e9e-4471-4f78-8d63-4cf4d1d6bf41">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Leases that are economically similar to the purchase of assets are generally classified as finance leases; otherwise the leases are classified as operating leases. The Company has elected not to recognize leases with an original term of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; or less on the balance sheet. Options to renew a lease are not included in the Company&#x2019;s assessment unless there is reasonable certainty that the Company will renew. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets, lease liabilities and, if applicable, long-term lease liabilities. Lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. However, certain adjustments to the right-of-use asset may be required for items such as incentives received. The Company has elected as an accounting policy to combine lease and non- lease components, such as common area maintenance, for all classes of underlying assets. The interest rate implicit in lease contracts has not historically been readily determinable. As a result, the Company utilizes its incremental borrowing rates, which are the rates incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. To estimate its incremental borrowing rate, a credit rating applicable to the Company is estimated using synthetic credit rating analysis since the Company does not currently have a rating agency-based credit rating.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      id="F_817b1cf3-b36c-4b93-a4c0-68592fbc4ff0">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_80cc2636-2a21-4f3d-87e6-8f048203edc7">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment are recorded at cost, net of accumulated depreciation. Major additions and betterments are capitalized; maintenance and repairs, which do not improve or extend the life of the respective assets, are charged to operations as incurred. &lt;/span&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:62.619%;"/&gt;
          &lt;td style="width:0.208%;"/&gt;
          &lt;td style="width:37.173%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated Useful Life&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shorter of life of lease or remaining lease term&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Upon retirement or sale, the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Construction-in-progress is stated at cost, which includes direct costs attributable to the setup or construction of the related asset. Depreciation expense is not recorded on construction-in-progress until the relevant assets are completed and put into use.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <kymr:SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_3b3bb647-359d-4e00-8726-3dc30a85251b">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset as follows:&lt;/span&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:62.619%;"/&gt;
          &lt;td style="width:0.208%;"/&gt;
          &lt;td style="width:37.173%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated Useful Life&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shorter of life of lease or remaining lease term&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</kymr:SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_ec1630b7-f419-4a11-a92d-8d8f0402646a"
      id="F_1a16c0dd-4345-4635-b95e-493f2dfd1e3d">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_d08b0ba5-abc0-4746-8241-00292ef51a98"
      id="F_603b2c22-cd7a-4f61-ace0-7df0b0196bb7">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_5bcbd011-9c2a-4bed-8e4b-8ad966e7a3df"
      id="F_69b28a9d-4ca4-484b-aa8f-8e6ef3f7e6ca">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_e4780686-685f-4d62-af29-362e17c976f3"
      id="F_08adf91b-bf68-431e-94bb-7b708fb41fab">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="C_6fc3eaa2-537c-4116-875f-333d3da37c5c"
      id="F_21f20880-8b56-4194-9437-b4961cf211e5">Shorter of life of lease or remaining lease term</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_794d381d-bcfd-4c01-98bd-08b153e186bd">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Long-lived assets (including right-of-use assets) to be held and used are tested for recoverability whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value, determined based on discounted cash flows. The Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t record any impairment losses on long-lived assets during the years ended December 31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="INF"
      id="F_a06f0aef-5341-4320-ba92-838f9206418f"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="INF"
      id="F_96586e3b-de96-4eb3-85f5-90d83f81d9d2"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="INF"
      id="F_a36b2bce-9c49-43f2-8bee-95f0e4408a5a"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <kymr:ConvertiblePreferredStockPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_9664691c-1517-4589-a192-caed682f492e">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company classified convertible preferred stock as temporary equity in the accompanying consolidated statement of Convertible Preferred Stock and Stockholders&#x2019; Equity due to terms that allow for redemption of the shares in cash upon certain change in control events that are outside of the Company&#x2019;s control, including the sale or transfer of the Company as holders of the convertible preferred stock which could trigger redemption of the shares. The Company did not accrete the value of the convertible preferred stock to the redemption values since a liquidation event was not considered probable prior to the conversion date. In connection with the Company&#x2019;s initial public offering on August 25, 2020, all outstanding shares of convertible preferred stock converted to common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Warrants&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company determines the accounting classification of warrants that are issued, as either liability or equity, by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, and then in accordance with ASC 815-40, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company&#x2019;s Own Stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Under ASC 480-10, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate the issuer to settle the warrants or the underlying shares by paying cash or other assets, or must or may require settlement by issuing variable number of shares.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;If warrants do not meet liability classification under ASC 480-10, the Company assesses the requirements under ASC 815-40, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature. If the warrants do not require liability classification under ASC 815-40, in order to conclude equity classification, the Company assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable U.S. GAAP. After all relevant assessments are made, the Company concludes whether the warrants are classified as liability or equity. Liability classified warrants are required to be accounted for at fair value both on the date of issuance and on subsequent accounting period ending dates, with all changes in fair value after the issuance date recorded in the statements of operations as a gain or loss. Equity classified warrants are accounted for at fair value on the issuance date with no changes in fair value recognized after the issuance date.&lt;/span&gt;&lt;/p&gt;</kymr:ConvertiblePreferredStockPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_d19e7589-84e1-4e8a-bca9-0d3dad5451f0">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development costs consist primarily of costs incurred in connection with the discovery and development of targeted protein degradation therapeutics, including those in the Company&#x2019;s most advanced development programs, IRAK4, IRAKIMiD, STAT3 and MDM2. These research efforts and costs, which also support the development of, and enhancements to, the Company&#x2019;s Pegasus&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;TM&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; targeted protein degradation platform, include external research costs, personnel costs, supplies, license fees and facility related expenses. The Company expenses research and development costs as incurred.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <kymr:PatentCostsPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_8732c8a3-c37a-4869-a235-df3c7e41f12a">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Patent Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recoverability of the expenditure. Amounts incurred are classified as general and administrative expenses.&lt;/span&gt;&lt;/p&gt;</kymr:PatentCostsPolicyTextBlock>
    <kymr:FinancingCostsPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_1581888a-8ca9-427a-8826-6849ebf175f8">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financing Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Costs incurred in connection with the issuance of equity units and shares are recorded as a reduction of proceeds to the equity carrying value. The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process financings as deferred offering costs until such financings are consummated. After consummation of the financing, these costs are recorded as a reduction of the proceeds received from the financing. If a planned financing is abandoned, the deferred offering costs are expensed immediately as a charge to operating expenses in the consolidated statement of operations and comprehensive loss. There was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; deferred offering costs on the Company&#x2019;s consolidated balance sheet at December 31, 2022 and December 31, 2021.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</kymr:FinancingCostsPolicyTextBlock>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="INF"
      id="F_204fc2e3-edd8-4fd2-b2c7-5c3b60033c13"
      unitRef="U_USD">0</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="INF"
      id="F_9d156514-a9af-4f8f-ba27-feed255e2f25"
      unitRef="U_USD">0</us-gaap:DeferredOfferingCosts>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_0a4f5a5d-ef1a-43db-9b4b-8fa379ca93fd">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under ASC 606, Topic 606, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;)&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;,  the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of ASC 606, the Company performs the following five steps: (i) identification of the contract(s) with the customer; (ii) identification of the promised goods or services in the contract and determination of whether the promised goods or services are performance obligations; (iii) measurement of the transaction price; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As part of the accounting for these arrangements, the Company must use significant judgment to determine: a) the number of performance obligations based on the determination under step (ii) above and whether those performance obligations are distinct from other performance obligations in the contract; b) the transaction price under step (iii) above; and c) the standalone selling price for each performance obligation identified in the contract for the allocation of transaction price in step (iv) above. The Company uses judgment to determine whether milestones or other variable consideration, except for royalties, should be included in the transaction price as described further below. The transaction price is allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. In determining the stand-alone selling price of a license to the Company&#x2019;s proprietary technology or a material right provided by a customer option, the Company considers market conditions as well as entity-specific factors, including those factors contemplated in negotiating the agreements as well as internally developed estimates that include assumptions related to the market opportunity, estimated development costs, probability of success and the time needed to commercialize a product candidate pursuant to the license. In validating its estimated stand-alone selling prices, the Company evaluates whether changes in the key assumptions used to determine its estimated stand-alone selling prices will have a significant effect on the allocation of arrangement consideration between performance obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company estimates the transaction price based on the amount of consideration the Company expects to be received for transferring the promised goods or services in the contract. The consideration may include both fixed consideration and variable consideration. At the inception of each arrangement that includes variable consideration, the Company evaluates the amount of the potential payments and the likelihood that the payments will be received. The Company utilizes either the most likely amount method or expected value method to estimate the transaction price based on which method better predicts the amount of consideration expected to be received. If it is probable that a significant revenue reversal would not occur, the variable consideration is included in the transaction price.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer. Promised goods or services are considered distinct when: (i) the customer can benefit from the good or service on its own or together with other readily available resources and (ii) the promised good or service is separately identifiable from other promises in the contract. In assessing whether promised goods or services are distinct, the Company considers factors such as the stage of development of the underlying intellectual property, the capabilities of the customer to develop the intellectual property on their own and whether the required expertise is readily available.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For performance obligations which consist of licenses and other promises, the Company utilizes judgment to assess the nature of the combined performance obligation in order to determine whether the combined performance obligation is satisfied over time or at a point in time. The Company receives payments from customers based on billing schedules established in each contract. Up-front payments and fees are recorded as deferred revenue upon receipt or when due until the Company performs its obligations under these arrangements. Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional. Amounts recognized as revenue, but not yet received or invoiced are generally recognized as contract assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Exclusive Licenses&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;If the license granted in the arrangement is determined to be distinct from the other promises or performance obligations identified in the arrangement, which generally include research and development services, the Company recognizes revenue from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. In assessing whether a license is distinct from the other promises, the Company considers relevant facts and circumstances of each arrangement, including the research and development capabilities of the collaboration partner and the availability of the associated expertise in the general marketplace. In addition, the Company considers whether the collaboration partner can benefit from the license for its intended purpose without the receipt of the remaining promise, whether the value of the license is dependent on the unsatisfied promise, whether there are other vendors that could provide the remaining promise, and whether it is separately identifiable from the remaining promise. For licenses that are combined with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition based on estimated remaining research and development costs. The calculation of the total remaining estimated research and development costs includes forecasted costs associated with internal employee efforts, materials costs, and third-party contract costs, as well as the assumed timing and duration of these activities. The recognition of revenue pursuant to collaboration arrangements is subject to these judgments made and estimates developed by management and is sensitive to changes in these assumptions. Therefore, the measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the arrangement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development Services&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;The promises under the Company&#x2019;s collaboration and license agreements generally include research and development services to be performed by the Company on behalf of the collaboration partner. For performance obligations that include research and development services, the Company generally recognizes revenue allocated to such performance obligations based on an appropriate measure of progress. The Company utilizes judgment to determine the appropriate method of measuring progress for purposes of recognizing revenue, which is generally an input measure, such as costs incurred. The Company evaluates the measure of progress each reporting period as described under Exclusive Licenses above. Reimbursements from the partner that are the result of a collaborative relationship with the partner, instead of a customer relationship, such as co-development activities, are generally recorded as a reduction to research and development expense.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Customer Options&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;The Company&#x2019;s arrangements may provide a collaborator with the right to certain optional purchases, such as the right to license a target either at the inception of the arrangement or within a pre-defined option period. Under these agreements, fees may be due to the Company at the inception of the arrangement as an upfront fee or payment or upon the exercise of an option to acquire a license. If an arrangement is determined to contain customer options that allow the customer to acquire additional goods or services, the goods and services underlying the customer options are not considered to be performance obligations at the outset of the arrangement, as they are contingent upon option exercise. The Company evaluates the customer options for material rights, or options to acquire additional goods or services for free or at a discount. If the customer options are determined to represent a material right, the material right is recognized as a separate performance obligation at the inception of the arrangement. The Company allocates the transaction price to material rights based on the relative stand-alone selling price, which is determined based on the identified discount, and the probability that the customer will exercise the option. Amounts allocated to a material right are not recognized as revenue until, at the earliest, the option is exercised or expires.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Milestone Payments&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;At the inception of each arrangement that includes milestone payments based on certain events, the Company evaluates whether the milestones are considered probable of being achieved and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The Company evaluates factors such as the scientific, clinical, regulatory, commercial, and other risks that must be overcome to achieve the particular milestone in making this assessment. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. At the end of each subsequent reporting period, the Company reevaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. If a milestone or other variable consideration relates specifically to the Company&#x2019;s efforts to satisfy a single performance obligation or to a specific outcome from satisfying the performance obligation, the Company generally allocates the milestone amount entirely to that performance obligation once it is probable that a significant revenue reversal would not occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Royalties&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;For arrangements that include sales-based royalties, including milestone payments based on a level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue resulting from any of its licensing arrangements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Collaboration revenue&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company analyzes its collaboration arrangements to assess whether they are within the scope of ASC 808,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Collaborative Arrangements&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; (&#x201c;ASC 808&#x201d;) to determine whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and those that are more reflective of a vendor-customer relationship and therefore within the scope of Topic 606. For elements of collaboration arrangements that are accounted for pursuant to ASC 808, an appropriate recognition method is determined and applied consistently, generally by analogy to Topic 606. For those elements of the arrangement that are accounted for pursuant to Topic 606, the Company applies the five-step model described above.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <kymr:CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_9602139d-a917-4d66-a4f9-03508962a04d">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Costs associated with License and Collaborative Arrangements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Costs associated with licenses of technology acquired as part of collaborative arrangements are expensed as incurred and are generally included in research and development expense in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;</kymr:CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_2febf10e-32db-4ef6-b827-a055eca92b5f">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounts Receivable&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company extends credit to customers based on its evaluation of the customer&#x2019;s financial condition. The Company records receivables for all billings when amounts are due under standard terms. Accounts receivable are stated at amounts due net of applicable prompt pay discounts and other contractual adjustments as well as an allowance for doubtful accounts. The Company assesses the need for an allowance for doubtful accounts by considering a number of factors, including the length of time trade accounts receivable are past due, the customer&#x2019;s ability to pay its obligation and the condition of the general economy and the industry as a whole. The Company will write off accounts receivable when the Company determines that they are uncollectible. In general, the Company has experienced no significant collection issues with its customers&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_8f7f2a70-c62d-42db-84bd-8fde7c37f2cd">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company accounts for all stock-based awards granted to employees, directors, and nonemployees based on their fair value on the date of the grant and recognize compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. Stock-based payments include stock options and grants of common stock, including common stock subject to vesting. The measurement date for stock awards is the date of grant, and stock-based compensation costs are recognized as expense over the requisite service period, which is the vesting period, on a straight-line basis. The Company has issued stock options and restricted stock with performance-based vesting conditions and records the expense for these awards if the Company concludes that it is probable that the performance condition will be achieved. Stock-based compensation is classified in the accompanying consolidated statements of operations and comprehensive loss based on the function to which the related services are provided. The Company recognizes stock-based compensation expense for the portion of awards that have vested. Forfeitures are accounted for as they occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes options-pricing model, which requires inputs based on certain subjective assumptions, including the expected stock price volatility, the expected term of the option, the risk-free interest rate for a period that approximates the expected term of the option, and the Company&#x2019;s expected dividend yield. Prior to the IPO, as there was no active market for the Company&#x2019;s common stock, the Company estimated the fair value of common stock on the date of grant based on the then current facts and circumstances. Upon becoming a public company, the fair value of the underlying common shares equals the closing price of the Company&#x2019;s stock on the date of grant. As the Company&#x2019;s IPO was in 2020, the Company  lacks a sufficient period of company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of guideline companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#x2019;s stock options has been determined utilizing the &#x201c;simplified&#x201d; method for awards that qualify as &#x201c;plain-vanilla&#x201d; options. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#x2019;s common stock on that same date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Compensation expense for discounted purchases under the employee stock purchase plan is measured using the Black-Scholes model to compute the fair value of the lookback provision plus the purchase discount and is recognized as compensation expense over the offering period.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_c84a7fd7-5ceb-4118-a35f-d32f6f177727">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company records income taxes in accordance with FASB Accounting Standards Codification Topic 740, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; (&#x201c;ASC 740&#x201d;), which provides for deferred taxes using an asset and liability approach. Under this method, deferred income tax assets and liabilities are recognized based on future income tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities, and their respective income tax basis. Deferred income tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of changes in income tax rates on deferred income tax assets and liabilities is recognized as income or expense in the period that a valuation allowance for any income tax benefits of which future realization is not more likely than not.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company provides reserves for potential payments of tax to various tax authorities related to uncertain tax positions. The tax benefits recorded are based on a determination of whether and how much of a tax benefit taken by the Company in its tax filings or positions is &#x201c;more likely than not&#x201d; to be realized following resolution of any uncertainty related to the tax benefit, assuming that the matter in question will be raised by the tax authorities.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <kymr:OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_20d86663-48f2-4f36-aad7-caf83f610850">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Off Balance Sheet Risk and Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has no significant off-balance sheet risk such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and restricted cash. The Company&#x2019;s cash, cash equivalents, and restricted cash are deposited in accounts at large financial institutions. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash, cash equivalents and restricted cash are held. The Company maintains its cash equivalents in money market funds that invest in U.S. Treasury securities and U.S. Treasury obligations and corporate bonds. The Company&#x2019;s marketable securities primarily consist of corporate bonds and U.S. Treasury securities paper, and potentially subject the Company to concentrations of credit risk. The Company has adopted an investment policy that limits the amounts the Company may invest in any one type of investment. The Company has not experienced any credit losses and does not believe it is exposed to any significant credit risk on these funds.&lt;/span&gt;&lt;/p&gt;</kymr:OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_4bf50c60-90f7-476a-a838-c7ca44f9b564">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Comprehensive loss includes net loss as well as unrealized gains and losses on marketable securities and other changes in stockholders&#x2019; equity (deficit) that result from transactions and economic events other than those with stockholders.&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_69b937ab-2553-46f4-89ad-8acccadb7d28">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Net Loss Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company applies the two-class method to compute basic and diluted net income (loss) per share attributable to common stockholders when it has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income (loss) available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to share in the earnings as if all income (loss) for the period had been distributed. The Company&#x2019;s convertible preferred stock participates in any dividends declared by the Company and are therefore considered to be participating securities. The participating securities are not required to participate in the losses of the Company, and therefore during periods of loss there is no allocation required under the two-class method.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including the pre-funded warrants given their nominal exercise price. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) per share attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period, including potential dilutive common shares. For purpose of this calculation, outstanding options to purchase common stock, unvested restricted stock awards, and shares of convertible preferred stock are considered potential dilutive common shares. The Company has generated a net loss in all periods presented, and therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In August 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The Company adopted ASU 2020-06 effective as of January 1, 2022. The adoption of ASU 2020-06 did not have an impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_9c342bfe-6dff-4559-89c9-fa51c4b07e85">&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In August 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The Company adopted ASU 2020-06 effective as of January 1, 2022. The adoption of ASU 2020-06 did not have an impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_1cd41eda-05a0-4ae4-ae5c-9f6a14efe449">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 3. Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents information about the Company&#x2019;s financial assets measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values as of December 31, 2022 and December 31, 2021 (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.798%;"/&gt;
        &lt;td style="width:1.049%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.212000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.049%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.212000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.06%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.223%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.06%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.335%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value Measurements at&lt;br/&gt;December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market fund&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;74,045&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;74,045&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;144,259&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;144,259&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;73,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;73,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;150,530&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;397,250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;547,780&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.735%;"/&gt;
        &lt;td style="width:1.058%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.07%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.07%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.07%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.341%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value Measurements at&lt;br/&gt;December 31, 2021:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market fund&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;43,182&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;43,182&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;169,481&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;169,481&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;192,791&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;192,791&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,172&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,172&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;47,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;47,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;315,484&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;253,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;568,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;During the years ended December 31, 2022 and 2021, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_d6816af5-4bc5-4791-ba3d-860c44e2a341;"&gt;&lt;span style="-sec-ix-hidden:F_edecdabf-262b-4f31-ac10-5d70725bc297;"&gt;&lt;span style="-sec-ix-hidden:F_47aa0c7e-13cd-4b61-a6e4-d8d951681874;"&gt;&lt;span style="-sec-ix-hidden:F_17c26d05-9f3b-4274-bf66-5ed27d17bc5c;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; tr&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ansfers in or out of Level 3.&lt;/span&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_b9d7a26e-9bc0-4a97-8210-254489c0d160">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents information about the Company&#x2019;s financial assets measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values as of December 31, 2022 and December 31, 2021 (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.798%;"/&gt;
        &lt;td style="width:1.049%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.212000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.049%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.212000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.06%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.223%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.06%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.335%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value Measurements at&lt;br/&gt;December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market fund&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;74,045&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;74,045&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;144,259&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;144,259&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;73,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;73,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;150,530&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;397,250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;547,780&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.735%;"/&gt;
        &lt;td style="width:1.058%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.07%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.07%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.07%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.341%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value Measurements at&lt;br/&gt;December 31, 2021:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market fund&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;43,182&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;43,182&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;169,481&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;169,481&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;192,791&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;192,791&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,172&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,172&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;47,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;47,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;315,484&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;253,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;568,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_92cf5785-cf06-4620-8a2b-76822df706a4"
      decimals="-3"
      id="F_015901c7-d106-496a-a1dd-f37220105617"
      unitRef="U_USD">50551000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_a4ff2b85-04a0-48ba-94cb-7f1135555ba1"
      decimals="-3"
      id="F_31e465c3-ddcb-452c-a05a-e555c65abd42"
      unitRef="U_USD">50551000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_cbe473e2-0c3e-400a-b19a-6ab0d1df53c3"
      decimals="-3"
      id="F_e4a61929-e08c-40c8-a322-dde6f772b870"
      unitRef="U_USD">74045000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_bdb2440e-1e74-443b-8199-85bc8484ff9e"
      decimals="-3"
      id="F_9ff8b754-c57b-44ad-ab4a-07f82c42cfa2"
      unitRef="U_USD">74045000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_fdb41358-831d-4444-b8f4-0d53bd52e986"
      decimals="-3"
      id="F_6009f366-82d1-4e09-a4b5-0be8134d2b68"
      unitRef="U_USD">120467000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_353d5cf1-900b-4407-901f-6e88343b6e28"
      decimals="-3"
      id="F_590fdb52-4c53-4811-b8c0-c3d5326fda38"
      unitRef="U_USD">120467000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_f5672204-3c86-40cf-a340-5ea7293720f7"
      decimals="-3"
      id="F_4aa22648-d36e-4237-b14d-0d5ab9d57c22"
      unitRef="U_USD">144259000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_1e352199-2021-4cbf-89a6-6b3fb1a9cb86"
      decimals="-3"
      id="F_e42b00b2-d2f7-41c1-ba30-bb48232d80d7"
      unitRef="U_USD">144259000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_cbe473e2-0c3e-400a-b19a-6ab0d1df53c3"
      decimals="-3"
      id="F_b5cd3cf9-d340-4f02-93cd-d9131093bdb3"
      unitRef="U_USD">19804000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_bdb2440e-1e74-443b-8199-85bc8484ff9e"
      decimals="-3"
      id="F_c0dd1629-dfea-48eb-93de-1517f2d22fd4"
      unitRef="U_USD">19804000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_fdb41358-831d-4444-b8f4-0d53bd52e986"
      decimals="-3"
      id="F_f86f57da-cb00-4664-8066-27f8ed14a1b3"
      unitRef="U_USD">58653000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_353d5cf1-900b-4407-901f-6e88343b6e28"
      decimals="-3"
      id="F_b87adaec-fa72-45eb-9de7-f54a44b2407c"
      unitRef="U_USD">58653000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_f5672204-3c86-40cf-a340-5ea7293720f7"
      decimals="-3"
      id="F_82a7443a-45ec-43e8-9eeb-e1d9b8e0fb89"
      unitRef="U_USD">73871000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_1e352199-2021-4cbf-89a6-6b3fb1a9cb86"
      decimals="-3"
      id="F_5d9d4541-e04b-4f47-8319-b144bf82ab74"
      unitRef="U_USD">73871000</us-gaap:MarketableSecuritiesNoncurrent>
    <kymr:RestrictedCashFairValue
      contextRef="C_7ed674cd-4eeb-4640-9889-2c6678deaa43"
      decimals="-3"
      id="F_64c0b1a3-d934-4732-8194-43715b892dfd"
      unitRef="U_USD">6130000</kymr:RestrictedCashFairValue>
    <kymr:RestrictedCashFairValue
      contextRef="C_b1c3605d-deb5-4fa5-a122-f271881338b2"
      decimals="-3"
      id="F_21a65e7d-bdb9-4ea2-93b0-ee58537291d7"
      unitRef="U_USD">6130000</kymr:RestrictedCashFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_7ed674cd-4eeb-4640-9889-2c6678deaa43"
      decimals="-3"
      id="F_0f146951-67ab-4798-9db8-b62e4ed1f3ef"
      unitRef="U_USD">150530000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_760ee65f-8938-4d70-852d-717a500268f2"
      decimals="-3"
      id="F_582993b7-0c5b-4928-aae6-04229588b7b9"
      unitRef="U_USD">397250000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_b1c3605d-deb5-4fa5-a122-f271881338b2"
      decimals="-3"
      id="F_9a9ad4ef-f0f0-49d6-bb6c-2a207a3beb55"
      unitRef="U_USD">547780000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_5e41c878-2f37-448f-8041-6169a741fafd"
      decimals="-3"
      id="F_769fd769-d67c-433e-a834-0beb1b812cb0"
      unitRef="U_USD">43182000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_22763f63-4293-43da-81e5-a51fcca60bff"
      decimals="-3"
      id="F_ae2ad5ca-4bb6-4d6f-978b-17f1728971aa"
      unitRef="U_USD">43182000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_6d1928e4-c54d-45cb-bd65-a8ca6a70568a"
      decimals="-3"
      id="F_ad818ff4-3d88-4bd9-b5a9-a6a9d98ad087"
      unitRef="U_USD">169481000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_eefb7cbc-9caa-4ace-97f5-4dd5fa0c3875"
      decimals="-3"
      id="F_8be088f7-7778-4f4f-95f9-94f3b78fa58e"
      unitRef="U_USD">169481000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_f2fba413-6548-46dc-aa3b-627f610a3ec7"
      decimals="-3"
      id="F_c41df630-10b3-401f-a1a3-8ee880aa9b00"
      unitRef="U_USD">32170000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_2a30fc5f-816c-4384-aaa2-91ea6a589f09"
      decimals="-3"
      id="F_a62e689e-656d-42e5-b9ed-0e497ebe1b95"
      unitRef="U_USD">32170000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_568f226b-696c-4f67-8494-4fae12a09dcd"
      decimals="-3"
      id="F_82528739-4ec9-4819-9334-a484af3c90f0"
      unitRef="U_USD">192791000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_9637e2ee-ccfa-4f69-ae4f-52730c923c29"
      decimals="-3"
      id="F_6f107061-ee6f-4a9e-997a-4a9443fb2515"
      unitRef="U_USD">192791000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_6d1928e4-c54d-45cb-bd65-a8ca6a70568a"
      decimals="-3"
      id="F_be252ef4-4a10-4181-8bf2-4b3ea5f11a3e"
      unitRef="U_USD">17172000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_eefb7cbc-9caa-4ace-97f5-4dd5fa0c3875"
      decimals="-3"
      id="F_5b81dc23-fc48-436b-90bb-d11a32c98392"
      unitRef="U_USD">17172000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_f2fba413-6548-46dc-aa3b-627f610a3ec7"
      decimals="-3"
      id="F_d402c4a3-b3f8-4697-8219-7bdb67f44d9f"
      unitRef="U_USD">47363000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_f2fba413-6548-46dc-aa3b-627f610a3ec7"
      decimals="-3"
      id="F_6340e663-8979-44d1-8c47-906ecc75d66a"
      unitRef="U_USD">47363000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_568f226b-696c-4f67-8494-4fae12a09dcd"
      decimals="-3"
      id="F_e25096c6-3870-4f24-87a9-ec2adbd4b607"
      unitRef="U_USD">60652000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_9637e2ee-ccfa-4f69-ae4f-52730c923c29"
      decimals="-3"
      id="F_f7c65528-bfbe-4f95-940e-c2de4e11a95a"
      unitRef="U_USD">60652000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <kymr:RestrictedCashFairValue
      contextRef="C_a018222a-a47a-445b-bb16-6f9dfa165490"
      decimals="-3"
      id="F_7273c13a-a81a-4ef6-93da-639ec8d24b5c"
      unitRef="U_USD">6116000</kymr:RestrictedCashFairValue>
    <kymr:RestrictedCashFairValue
      contextRef="C_e026c58e-80f9-43a7-892c-915846f96c73"
      decimals="-3"
      id="F_55756549-5476-4af1-afca-8f8582d6cc1e"
      unitRef="U_USD">6116000</kymr:RestrictedCashFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_a018222a-a47a-445b-bb16-6f9dfa165490"
      decimals="-3"
      id="F_f2e7dab8-cdb3-4300-b616-a21b9e0c4a9f"
      unitRef="U_USD">315484000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_bb8b7969-bb82-4041-994e-9433633910b6"
      decimals="-3"
      id="F_e092b0bf-c77a-4e88-87d0-b26096d813e7"
      unitRef="U_USD">253443000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e026c58e-80f9-43a7-892c-915846f96c73"
      decimals="-3"
      id="F_1cbdee96-dee3-46c4-8e86-c08e9dc99625"
      unitRef="U_USD">568927000</us-gaap:AssetsFairValueDisclosure>
    <kymr:FairValueAssetsLevel1ToLevel3TransfersAmount
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_5fb562a6-5a25-4b2f-8f9c-893ea418964d"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel1ToLevel3TransfersAmount>
    <kymr:FairValueAssetsLevel3ToLevel1TransfersAmount
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_81a9c3df-a0d1-47bc-b67b-a727b54e19eb"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel3ToLevel1TransfersAmount>
    <kymr:FairValueAssetsLevel3ToLevel2TransfersAmount
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_26f35c82-b63d-448a-9fec-5bd2ffcec78a"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel3ToLevel2TransfersAmount>
    <kymr:FairValueAssetsLevel2ToLevel3TransfersAmount
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_3c3942f3-80a1-4c09-b3c3-067c0ce4b839"
      unitRef="U_USD">0</kymr:FairValueAssetsLevel2ToLevel3TransfersAmount>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_311264bf-96b5-4130-87d1-91d2b5008d19">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 4. Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the available-for-sale debt securities held at December 31, 2022 and 2021 and (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.234%;"/&gt;
        &lt;td style="width:1.208%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.502%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.195%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.49%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.195%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.49%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.195%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.49%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Description&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;94,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,111&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93,850&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;180,967&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;179,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;220,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;218,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;496,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;491,099&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.135%;"/&gt;
        &lt;td style="width:1.208%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.494%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.195%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.468%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.283%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.468%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.283%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.468%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Description&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;186,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;186,655&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;79,657&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;125&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;79,532&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;253,929&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;488&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;253,442&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;520,286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;519,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the Company held &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;149&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; securities that had been in an unrealized loss position for less than 12 months with an aggregate fair value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;330.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. As of December 31, 2021, the Company held &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;113&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; securities that had been in an unrealized loss position for less than 12 months with an aggregate fair value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;515.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. As of December 31, 2022, the Company held &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; securities that had been in an unrealized loss position for greater than 12 months with an aggregate fair value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;115.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. As of December 31, 2021, the Company did not hold any securities that had been in an unrealized loss position for greater than 12 months.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of  December 31, 2022 the Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;118&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; securities with a fair value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;338.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million with a contractual maturity of less than 12 months and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; securities with a fair value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;152.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million with a contractual maturity of greater than 12 months. As of December 31, 2021, the Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;79&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; securities with a fair value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;394.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million with a contractual maturity of less than 12 months and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; securities with a fair value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;125.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million with a contractual maturity of greater than 12 months.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company evaluates securities for other-than-temporary impairments based on quantitative and qualitative factors, and considered the decline in market value for the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;185&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; securities in an unrealized loss position as of  December 31, 2022, to be primarily attributable to the then current economic and market conditions. The Company neither intends to sell these investments nor concludes that it is more-likely-than-not that the Company will have to sell them before recovery of their carrying values. The Company also believe that it will be able to collect both principal and interest amounts due at maturity.&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_a4ff26bf-f392-4864-b27d-747fe3ae2ac1">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the available-for-sale debt securities held at December 31, 2022 and 2021 and (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.234%;"/&gt;
        &lt;td style="width:1.208%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.502%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.195%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.49%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.195%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.49%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.195%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.49%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Description&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;94,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,111&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93,850&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;180,967&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;179,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;220,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;218,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;496,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;491,099&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.135%;"/&gt;
        &lt;td style="width:1.208%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.494%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.195%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.468%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.283%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.468%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.283%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.468%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Description&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;186,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;186,655&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;US government agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;79,657&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;125&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;79,532&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;253,929&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;488&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;253,442&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;520,286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;519,629&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_e2615d23-21e3-4021-a013-590aec8dff1e"
      decimals="-3"
      id="F_5c1d50c5-2c23-4571-97d7-199c2a95f23a"
      unitRef="U_USD">94958000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_e2615d23-21e3-4021-a013-590aec8dff1e"
      decimals="-3"
      id="F_f4800ba9-47fe-463e-988c-87d502649b9e"
      unitRef="U_USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_e2615d23-21e3-4021-a013-590aec8dff1e"
      decimals="-3"
      id="F_09e65be0-ea88-42a2-bea2-0ad37e1d425e"
      unitRef="U_USD">1111000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_e2615d23-21e3-4021-a013-590aec8dff1e"
      decimals="-3"
      id="F_694b365f-69f0-4bad-8914-7169851c8fde"
      unitRef="U_USD">93850000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_5b5104c9-4084-4a40-bdc7-f2c83bef3744"
      decimals="-3"
      id="F_1648eb6d-271c-4920-b30f-78ab0b63941a"
      unitRef="U_USD">180967000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_5b5104c9-4084-4a40-bdc7-f2c83bef3744"
      decimals="-3"
      id="F_705f966d-5ff5-4f22-9481-9272bb762322"
      unitRef="U_USD">25000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_5b5104c9-4084-4a40-bdc7-f2c83bef3744"
      decimals="-3"
      id="F_8546a093-35a1-42ff-99d6-c4b02a429f24"
      unitRef="U_USD">1873000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_5b5104c9-4084-4a40-bdc7-f2c83bef3744"
      decimals="-3"
      id="F_638b25b8-e2a6-4e1e-9612-6181bd7c4bfb"
      unitRef="U_USD">179119000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_ce764760-07d6-464c-9e95-7ae23ffd34e2"
      decimals="-3"
      id="F_de83686b-8d0a-4f68-946a-7aa72936dad9"
      unitRef="U_USD">220119000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_ce764760-07d6-464c-9e95-7ae23ffd34e2"
      decimals="-3"
      id="F_8b73fb4a-a567-46e9-a4bd-69a5223736d8"
      unitRef="U_USD">25000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_ce764760-07d6-464c-9e95-7ae23ffd34e2"
      decimals="-3"
      id="F_9afa4c6f-4b97-4584-b39a-a4d8d4e2e8e1"
      unitRef="U_USD">2014000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_ce764760-07d6-464c-9e95-7ae23ffd34e2"
      decimals="-3"
      id="F_a014cac7-3b88-468d-aa04-799c8158093f"
      unitRef="U_USD">218130000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_4eb991d8-0b4e-4d87-99cd-18b69fdae0b7"
      unitRef="U_USD">496044000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_ce6bbed7-c4cc-4fa2-8ffa-a621ebd19145"
      unitRef="U_USD">53000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_11e6ce24-7a2c-441e-b9e4-4a0091be17cc"
      unitRef="U_USD">4998000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_f0e3caa4-2d99-43ac-98e6-4ed188b8b8ca"
      unitRef="U_USD">491099000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_efe35265-ca7f-48b1-ba12-d45e10f0072e"
      decimals="-3"
      id="F_f2fc57c8-2aa2-4a2d-beaf-c5e37e36a839"
      unitRef="U_USD">186700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_efe35265-ca7f-48b1-ba12-d45e10f0072e"
      decimals="-3"
      id="F_386dcbc8-abf5-4d63-b0fd-01f8358f041c"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_efe35265-ca7f-48b1-ba12-d45e10f0072e"
      decimals="-3"
      id="F_3a905583-fed4-4f05-a54b-f21f5593e5c1"
      unitRef="U_USD">45000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_efe35265-ca7f-48b1-ba12-d45e10f0072e"
      decimals="-3"
      id="F_ab2ca967-1ac3-4212-8207-5647e3cb16e0"
      unitRef="U_USD">186655000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_28099439-7f67-4ba5-b139-b21c74762ca3"
      decimals="-3"
      id="F_97a36501-a21d-4e98-92d8-486e6d2feb5f"
      unitRef="U_USD">79657000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_28099439-7f67-4ba5-b139-b21c74762ca3"
      decimals="-3"
      id="F_fb17698b-66c1-4d78-8225-4921d92b067e"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_28099439-7f67-4ba5-b139-b21c74762ca3"
      decimals="-3"
      id="F_0561c1f2-80e0-410e-b115-494bd4ebb749"
      unitRef="U_USD">125000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_28099439-7f67-4ba5-b139-b21c74762ca3"
      decimals="-3"
      id="F_18349183-1de8-4696-ad54-61cdde769386"
      unitRef="U_USD">79532000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_393387d1-e62c-4d39-9c26-01748ebd1fc5"
      decimals="-3"
      id="F_6e8867e1-915c-44af-b92c-812fa38d9cc5"
      unitRef="U_USD">253929000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_393387d1-e62c-4d39-9c26-01748ebd1fc5"
      decimals="-3"
      id="F_c316295f-d5ab-4aca-8cf2-8badeed8ccb2"
      unitRef="U_USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_393387d1-e62c-4d39-9c26-01748ebd1fc5"
      decimals="-3"
      id="F_7cef362d-c872-4913-bba9-aad1ecfbe21e"
      unitRef="U_USD">488000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_393387d1-e62c-4d39-9c26-01748ebd1fc5"
      decimals="-3"
      id="F_e4ee229f-d316-4773-87ac-7279f955b039"
      unitRef="U_USD">253442000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_66dcc2c5-239a-4a6e-9219-a7df8751e610"
      unitRef="U_USD">520286000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_b06839f7-f899-42de-bc18-efb902bc108a"
      unitRef="U_USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_65240b2f-3fc6-40ef-8246-ffa8634489d0"
      unitRef="U_USD">658000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_add1ddd4-b6ef-4ba2-bdf7-9f0464ba136d"
      unitRef="U_USD">519629000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="0"
      id="F_7b98637b-473d-4bb8-86a8-575714ac6320"
      unitRef="U_Security">149</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-5"
      id="F_f2b60ce3-4fb2-4e42-8bc6-ab059c40a45e"
      unitRef="U_USD">330900000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="0"
      id="F_c11fdf9b-de5a-4f92-ac37-ea0648e2b4cb"
      unitRef="U_Security">113</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-5"
      id="F_b40c617f-b2b9-46a4-8680-1604a73fda2b"
      unitRef="U_USD">515400000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <kymr:DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="0"
      id="F_fbc1bae1-ba58-457d-8a4b-9311c1d47a2d"
      unitRef="U_Security">36</kymr:DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions>
    <kymr:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-5"
      id="F_b4875846-6a82-4c8c-8306-8e73fd446f0d"
      unitRef="U_USD">115000000.0</kymr:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months>
    <kymr:DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="0"
      id="F_e0359f81-244a-4387-911e-2a4438dfd197"
      unitRef="U_Security">118</kymr:DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities>
    <kymr:FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-5"
      id="F_414c2f9d-bc2e-4afc-8a3d-302072e7a1cb"
      unitRef="U_USD">338800000</kymr:FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths>
    <kymr:DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="0"
      id="F_14eb44e6-866f-4029-b870-e180da8ed574"
      unitRef="U_Security">81</kymr:DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-5"
      id="F_99123f4e-6b68-4a8b-ade7-4dfeb2e150f1"
      unitRef="U_USD">152300000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <kymr:DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="0"
      id="F_17c4ef78-42f3-478c-92f9-0755d61c319c"
      unitRef="U_Security">79</kymr:DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities>
    <kymr:FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-5"
      id="F_cb880007-d3f4-4612-84d3-13d613babe05"
      unitRef="U_USD">394400000</kymr:FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths>
    <kymr:DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="0"
      id="F_5e7e2e64-5382-42f2-bc3f-0ddc2e279b77"
      unitRef="U_Security">37</kymr:DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-5"
      id="F_0e23e11a-2eed-43e8-a894-1eef4933d09d"
      unitRef="U_USD">125200000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <kymr:DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="0"
      id="F_a5248b11-e610-4341-8c41-e638f8bebac7"
      unitRef="U_Security">185</kymr:DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="C_4b0a689e-0b9b-43f2-8a8d-71565e0e91d0"
      id="F_128886fa-6582-49fe-8de9-466df0b7f2f3">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 5. Collaborations&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Sanofi Collaboration Arrangement&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Agreement Terms&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On July 7, 2020, the Company entered into a collaboration agreement, or the Sanofi Agreement, with Sanofi, to co-develop drug candidates directed to two biological targets. Under the Sanofi Agreement, the Company granted to Sanofi a worldwide exclusive license to develop, manufacture and commercialize certain lead compounds generated during the collaboration directed against IRAK4, or Collaboration Target 1, and one additional undisclosed target in an undisclosed field of use, or Collaboration Target 2. Such license is exercisable on a collaboration target-by-collaboration target basis only after specified milestones. For compounds directed against IRAK4, the field of use includes diagnosis, treatment, cure, mitigation or prevention of any diseases, disorders or conditions, excluding oncology and immuno-oncology.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Pursuant to the Sanofi Agreement, the Company is responsible for discovery and preclinical research and conducting a Phase 1 clinical trial for at least one degrader directed against IRAK4 plus up to three backup degraders. With respect to both targets, Sanofi is responsible for development, manufacturing, and commercialization of product candidates after a specified development milestone occurs with respect to each collaboration candidate.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In addition, pursuant to the Sanofi Agreement, Sanofi will grant to the Company an exclusive option, or Opt-In Right, exercisable on a collaboration target-by-collaboration target basis that will include the right to (i) fund 50% of the United States development costs for collaboration products directed against such target in the applicable field of use and (ii) share equally in the net profits and net losses of commercializing collaboration products directed against such target in the applicable field of use in the United States. In addition, if the Company exercises the Opt-In Right, Sanofi will grant to the Company an exclusive option, applicable to each collaboration target, which upon exercise will allow the Company to conduct certain co-promotion activities in the field in the United States.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Sanofi Agreement, unless earlier terminated, will expire on a product-by-product basis on the date of expiration of all payment obligations under the Sanofi Agreement with respect to such product. The Company or Sanofi may terminate the agreement upon the other party&#x2019;s material breach or insolvency or for certain patent challenges. In addition, Sanofi may terminate the Sanofi Agreement for convenience or for a material safety event upon advance prior written notice, and the&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Company may terminate the Sanofi Agreement with respect to any collaboration candidate if, following Sanofi&#x2019;s assumption of responsibility for the development, commercialization or manufacturing of collaboration candidates with respect to a particular target, Sanofi ceases to exploit any collaboration candidates directed to such target for a specified period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In consideration for the exclusive licenses granted to Sanofi under the Sanofi Agreement, Sanofi paid to the Company an upfront payment of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;150.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. The Company will also be reimbursed for certain research activities for a certain backup degrader under the IRAK4 program as well as contract manufacturing costs for the lead 474 program, unless certain criteria are not met for an initial IRAK4 degrader. In addition to the upfront payment and the reimbursements, the Company is eligible to receive certain development milestone payments of up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.48&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; billion in the aggregate, of which more than $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; billion relates to the IRAK4 program, upon the achievement of certain developmental or regulatory events. The Company will be eligible to receive certain commercial milestone payments up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;700.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in the aggregate, of which $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;400&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million relates to the IRAK4 program, which are payable upon the achievement of certain net sales thresholds. The Company will be eligible to receive tiered royalties for each program on net sales ranging from the high single digits to high teens, subject to low-single digits upward adjustments in certain circumstances.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On November 15, 2022, we entered into an Amended and Restated Collaboration and License Agreement with Sanofi, or the Amended Sanofi Agreement, which amended the Original Sanofi Agreement to revise certain research terms and responsibilities set forth under the Original Sanofi Agreement. The Amended Sanofi Agreement also specifies details around the timing and number of Phase 2 trials required under the terms of the collaboration. The Amended Sanofi Agreement became effective on December 5, 2022.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Additionally with respect to Sanofi, on December 2, 2022, Sanofi provided the Company with written notice of its intention to advance the collaboration target 1 candidate, KT-474, into Phase 2 clinical trials. The Company is entitled to receive milestone payments upon the dosing of the first Phase 2 patient(s) per indication up to a specified number of indications as further set forth in the Amended Sanofi Agreement.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounting Treatment&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company analyzed the discovery and pre-clinical research activities as well as the exclusive license grants under the Sanofi Agreement and concluded that the arrangement was indicative of a vendor-customer relationship and would be accounted for under ASC 606.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company identified the following material promises under the arrangement: (1) research services for Collaboration Target 1, (2) research license for Collaboration Target 1, (3) exclusive license for Collaboration Target 1, (4) research services for Collaboration Target 2, (5) research license for Collaboration Target 2, (6) exclusive license for Collaboration Target 2, (7) option to extend the research term, and (8) optional research services during the development period.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company determined that Collaboration Targets 1 and 2 are distinct from each other. The research associated with degraders directed to each target is at different stages and the licensed field, should development activities be successful, are different from each other. As such, all promises associated with each target are considered distinct from promises associated with the other target.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The research and development services for each collaboration target were determined not to be distinct from the research license and the exclusive license and have been combined into a single performance obligation for each collaboration target. That is, two performance obligations were identified, the combined research services, research license and exclusive license for Collaboration Target 1 and the combined research services, research license and exclusive license for Collaboration Target 2. The exclusive license for each target is not distinct from the pre-clinical and clinical research and development services under the Sanofi Agreement, primarily due to the highly specialized nature of the research and novel technology involved with developing protein degraders &#x2013; the pre-clinical activities and studies and first phase 1 clinical trial could not be conducted by another party in the manner required.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The option to extend the research term and optional research services during the development period were evaluated as material rights. The fees associated with each option are at or above the standalone selling price. As such, the underlying options are not performance obligations and fees associated with each option are excluded from the transaction price until the underlying option is exercised.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company determined the total transaction price to be $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;150.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, which consists solely of the upfront payment. All milestone payments and option payments are constrained as the achievement of such milestones are contingent upon the success of the underlying research and development activities and are generally outside the control of the Company. The reimbursement of costs for the IRAK4 backup degrader is also treated as constrained variable consideration as the criteria for reimbursement may not always be met, under which circumstances the Company would be responsible for the costs related to the backup degrader. Upon becoming unconstrained, the reimbursement consideration will be added to the transaction price and allocated to Collaboration Target 1.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company allocated the upfront payment to each performance obligation based on the relative standalone selling price, as follows:&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Collaboration Target 1: $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Collaboration Target 2: $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company determined the allocation of the $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;150.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million transaction price between Collaboration Target 1 and Collaboration Target 2 based on the value of the research and development for the programs from projected research and development costs for each collaboration target plus a developer&#x2019;s profit and the total potential milestones for each collaboration target.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recognizes revenue associated with each performance obligation as the research and development services are provided using an input method, according to costs incurred as related to the research and development activities for each individual program and the costs expected to be incurred in the future to satisfy that individual performance obligation. The transfer of control occurs over this time period and, in management&#x2019;s judgment, is the best measure of progress towards satisfying each performance obligation. The amounts received that have not yet been recognized as revenue are deferred as a contract liability on the Company&#x2019;s consolidated balance sheet and will be recognized over the remaining research and development period until the performance obligation is satisfied. Reimbursement consideration added to the transaction price will be recognized as revenue on the same pattern as Collaboration Target 1, with a cumulative catch-up upon becoming unconstrained. Pursuant to the November 15, 2022 amendment to the Sanofi Agreement, the Company reevaluated its rights and obligations under the Agreement as amended. As part of this reevaluation, the Company reassessed its accounting pursuant to the arrangement concluding that the amendment had no impact on the performance obligations nor revenue recognized in the periods presented&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The performance obligations have not been fully satisfied as of December 31, 2022. During the year ended December 31, 2022, the Company recognized $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in revenue under the Sanofi Agreement, of which $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million was associated with Collaboration Target 1 and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million was associated with Collaboration Target 2. Of the $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of revenue recognized in the year ended December 31, 2022, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million was recognized from amounts that were recorded in deferred revenue as of December 31, 2021. The aggregate amount of the transaction price allocated to the Company&#x2019;s unsatisfied performance obligations and recorded in deferred revenue at December 31, 2022 is $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;54.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. During the year ended December 31, 2021, the Company recognized $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;54.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in revenue under the Sanofi Agreement, of which $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million was associated with Collaboration Target 1 and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million was associated with Collaboration Target 2. The aggregate amount of the transaction price allocated to the Company&#x2019;s unsatisfied performance obligations and recorded in deferred revenue at December 31, 2021 is $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;81.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. During the year ended December 31, 2020, the Company recognized $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in revenue under the Sanofi Agreement, of which $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million was associated with Collaboration Target 1 and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million was associated with Collaboration Target 2. During the years ended December 31, 2022 and 2021, the Company received $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively, in in cost reimbursement payments under the Sanofi Agreement. The Company recorded $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of unbilled accounts receivable related to reimbursable research and development costs under the Sanofi Agreement as of December 31, 2022 and December 31, 2021, respectively. The Company will recognize the deferred revenue related to the performance obligations based on a cost input method, as described, over the remaining research term, which as a result of the amended agreement, is a maximum of approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years as of December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Any consideration related to performance-based milestones will be recognized when the risk of probable reversal is resolved, at which point the Company shall adjust the transaction price determined for the agreement accordingly and recognize revenue on a cumulative-catch up basis, reallocating the revised arrangement consideration to the performance obligations. Any consideration related to sales milestone payments and royalties will be recognized when the related milestone events or sales occur and therefore are recognized at the later of when the related sales occur or the relevant performance obligation is satisfied. As part of its evaluation of constraining the milestones, the Company considered numerous factors, including the fact that the achievement of the research and development milestones are contingent upon the results of the underlying research and development activities and are thus outside of the control of the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Sanofi participated in the Company&#x2019;s Series B Convertible Preferred Stock offering and as a result of this, was considered a related party during the year ended December 31, 2020 but no longer are considered a related party in any other periods presented.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Vertex Agreement&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On May 9, 2019 (the &#x201c;Effective Date&#x201d;), the Company entered into a collaboration agreement (the &#x201c;Vertex Agreement&#x201d;) with Vertex to advance small molecule protein degraders against up to six targets. Under the Vertex Agreement, Vertex has the exclusive option to license the rights to the product candidates developed for the designated targets at which point Vertex will control development and commercialization. Pursuant to the Vertex Agreement, the Company is only responsible for discovery and preclinical research on the targets, and Vertex is responsible for development, manufacturing, and commercialization of the product candidates after it exercises its option to license. The initial research term of the collaboration is four (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;) years, extendable for an additional one (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;) year period upon mutual agreement by the parties and payment by Vertex of certain per-target fees.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Vertex provided the Company with a non-refundable upfront payment of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and purchased &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,059,695&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of the Company&#x2019;s Series B-1 Convertible Preferred Stock (&#x201c;Series B-1&#x201d;) at $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.54&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; a share, pursuant to a separate, but simultaneously executed Share Purchase Agreement. The shares were purchased at a premium of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, which was included in the transaction price and will be recognized as revenue over the period of performance. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Vertex additionally purchased shares of the Company&#x2019;s common stock in a private placement concurrent with the Company&#x2019;s follow-on offering in which the Company received proceeds from Vertex&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. As a result of this purchase, Vertex is considered a related party.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is eligible to receive up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;170.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in payments per target, including development, regulatory and commercial milestones as well as option exercise payments. In addition, Vertex is obligated to pay the Company tiered royalties on future net sales on any products that may result from the Vertex Agreement. None of the payments under the Vertex Agreement are refundable. The Company may also perform follow-on research for an optioned target upon Vertex&#x2019;s request and at Vertex&#x2019;s expense.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The term of the Vertex Agreement began on the Effective Date and expires upon the expiration of all payment obligations from Vertex to Company under the Vertex Agreement or, if Vertex does not exercise any of its options, the lapse of all Vertex&#x2019;s option rights under the Vertex Agreement. Vertex also has the ability to terminate for convenience with prior written notice to the Company, and either party may terminate for an uncured material breach.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounting Treatment&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company analyzed the joint research activities required under the Vertex Agreement and concluded that the arrangement was indicative of a vendor-customer relationship and would be accounted for under ASC 606.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company identified the following material promises under the arrangement: (1) the non-exclusive, royalty-free research license; (2) the research and development services to be performed on up to six targets; and (3) the option to license each of the targets for development, manufacturing, and commercialization efforts. The research and development services were determined not to be distinct from the research and development license and have been combined into a single performance obligation. The Company determined that the option to license the targets in the future was not priced at a discount, and that the option exercise fee for each target is at or above the standalone selling price for research at this stage of development; as such, the options and the underlying licenses are excluded from the performance obligation and the option exercise fees are excluded from the transaction price until the underlying option is exercised.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As part of its evaluation of constraining the research and development milestones, the Company considered numerous factors, including the fact that the achievement of the research and development milestones are contingent upon the results of the underlying research and development activities and are thus outside of the control of the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;At the commencement of the arrangement, two units of accounting were identified, the issuance of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,059,695&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of the Company&#x2019;s Series B-1 and the research activities the Company will perform over the Research Term. The Company determined the total transaction price to be $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;55.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, which consists of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million attributed to the premium from the Series B-1 shares sold to Vertex and the $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million upfront payment. To determine the fair value of the Series B-1 issued to Vertex, the Company performed a valuation of the shares of the Company&#x2019;s common and preferred stock, which took into consideration recent financings, and the Company&#x2019;s recent development and future exit strategies, as well as a discount for lack of marketability.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Company recognizes revenue associated with the performance obligation as the research and development services are provided using an input method, according to the costs incurred as related to the research and development activities on each program and the costs expected to be incurred in the future to satisfy the performance obligation. The transfer of control&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;occurs &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;over this time period and, in management&#x2019;s judgment, is the best measure of progress towards satisfying the performance obligation. The amounts received that have not yet been recognized as revenue are deferred as a contract liability on the Company&#x2019;s consolidated balance sheet and will be recognized over the remaining research and development period until the performance obligation is satisfied. The performance obligation has not been fully satisfied as of December 31, 2022. During the years ended December 31, 2022, 2021 and 2020, the Company recognized $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively, in revenue under the Vertex Agreement. All $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million revenue recognized during the year ended December 31, 2022 was recognized from amounts that were recorded in deferred revenue as of December 31, 2021. The aggregate amount of the transaction price allocated to the Company&#x2019;s unsatisfied performance obligation and recorded in deferred revenue at December 31, 2022 and 2021 is $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively. The Company will recognize the deferred revenue related to the research and development services based on a cost input method, over the remaining research term, which is a maximum of approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; year as of December 31, 2022.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Any consideration related to sales milestone payments (including royalties) will be recognized when the related milestone events or sales occur and therefore are recognized at the later of when the related sales occur or the relevant performance obligation is satisfied.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Compound Collaboration&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In October 2017, the Company entered into a collaboration agreement (the &#x201c;Collaboration&#x201d;) with a pharmaceutical company to jointly identify, research and conduct preclinical development of collaboration compounds against specified collaboration targets to identify drug candidates. Under the terms of the Collaboration, both parties provided one another with a non-exclusive, royalty-free, sub-licensable research and development license to each party&#x2019;s intellectual property to develop five agreed-upon collaboration targets, as well as an exclusive, royalty-bearing development and commercialization license to sell any licensed products that stem from such research. The parties also have the ability to nominate additional collaboration targets if agreed-upon, as long as there are no more than five targets at any given time.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In exchange for the non-exclusive license rights, the Company provided the pharmaceutical company with an equity grant and is required to make tiered royalty payments based on net sales of all products licensed under the agreement in the low single-digit percentages. In conjunction with the Collaboration, the Company initially issued &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;886,305&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; Series A Preferred Units (&#x201c;Series A Preferred Units&#x201d;) to the pharmaceutical company. On November 1, 2018, these Series A Preferred Units were exchanged on a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_cb8b44a8-0a30-4420-9476-09eaa4fdd848;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one-for-one&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; basis for shares of Series A Convertible Preferred Stock (the &#x201c;Series A Preferred Stock&#x201d;). These shares vested in equal installments over &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The Company recorded expense over the vesting period based on the fair value of the shares under the Collaboration. The Company recorded $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million to research and development expense related to the vesting of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;166,183&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of Series A Preferred Stock during the year ended December 31, 2020. As of December 31, 2020, all shares under the Collaboration were fully vested and all expense had been recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The royalty payments are contingent and as such are not being recorded until incurred. The Company determined that the license is representative of an in-process research and development asset, with no future alternative use. As such, the Company records the expense related to the vesting of shares as research and development expense in the Company&#x2019;s consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Collaboration was terminated by the parties effective &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;April 27, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents the changes in accounts receivable, contract assets and liabilities for the year ended December 31, 2022 (in thousands)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:46.959%;"/&gt;
        &lt;td style="width:1.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.102%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.117999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.117999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.102%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Additions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deductions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accounts receivable and contract assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Billed receivables &#x2013; Sanofi&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unbilled receivables &#x2013; Sanofi&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;135&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total accounts receivable and contract assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;135&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,702&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Contract Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred Revenue &#x2013; Vertex&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,212&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred Revenue &#x2013; Sanofi&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;81,822&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;54,861&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total contract liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;101,034&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;46,826&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;63,260&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <kymr:UpfrontPayment
      contextRef="C_bef4bf34-693c-41b8-a9a0-8e9c28f7789b"
      decimals="-5"
      id="F_db77341e-6a29-4ce3-ad75-d16b02d35d02"
      unitRef="U_USD">150000000.0</kymr:UpfrontPayment>
    <kymr:DevelopmentMilestonePayments
      contextRef="C_68a7c495-1305-45e9-99c0-9a0f59885e6b"
      decimals="-7"
      id="F_f9aaba43-0db0-4a34-824f-33871772319b"
      unitRef="U_USD">1480000000</kymr:DevelopmentMilestonePayments>
    <kymr:DevelopmentMilestonePayments
      contextRef="C_565059dc-67cf-4057-8152-e525a8f12af2"
      decimals="-8"
      id="F_b64508b6-e70b-4baf-9539-07611fbca6d4"
      unitRef="U_USD">1000000000.0</kymr:DevelopmentMilestonePayments>
    <kymr:CommercialMilestonePayments
      contextRef="C_68a7c495-1305-45e9-99c0-9a0f59885e6b"
      decimals="-5"
      id="F_09aa89b3-f08c-47b9-bb5e-cf03526aec1f"
      unitRef="U_USD">700000000.0</kymr:CommercialMilestonePayments>
    <kymr:CommercialMilestonePayments
      contextRef="C_565059dc-67cf-4057-8152-e525a8f12af2"
      decimals="-6"
      id="F_adafa589-3960-46b0-a936-20acdd3acdfd"
      unitRef="U_USD">400000000</kymr:CommercialMilestonePayments>
    <kymr:CollaborationAgreementTransactionPrice
      contextRef="C_bef4bf34-693c-41b8-a9a0-8e9c28f7789b"
      decimals="-5"
      id="F_3bb071a9-84c0-4fd6-beaf-f9f2fd9d2c36"
      unitRef="U_USD">150000000.0</kymr:CollaborationAgreementTransactionPrice>
    <kymr:CollaborationAgreementTransactionPrice
      contextRef="C_9611dcfe-598d-44f0-becc-70cdcf69b398"
      decimals="-5"
      id="F_ce07cbec-ed54-4042-8379-5fc91064d32d"
      unitRef="U_USD">120000000.0</kymr:CollaborationAgreementTransactionPrice>
    <kymr:CollaborationAgreementTransactionPrice
      contextRef="C_2349e822-42db-4347-927f-0f4069526a6f"
      decimals="-5"
      id="F_9c73223b-d8f9-4bda-8e46-9a66e4f68cd2"
      unitRef="U_USD">30000000.0</kymr:CollaborationAgreementTransactionPrice>
    <kymr:CollaborationAgreementTransactionPrice
      contextRef="C_bef4bf34-693c-41b8-a9a0-8e9c28f7789b"
      decimals="-5"
      id="F_6894c0d4-0870-40ae-a932-f2d8087f635c"
      unitRef="U_USD">150000000.0</kymr:CollaborationAgreementTransactionPrice>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_081b7ddc-7d3d-4ad4-aee3-4d90b3c47ad6"
      decimals="-5"
      id="F_1f9a1ac7-41b7-4e6a-be25-aff69bb965a5"
      unitRef="U_USD">36000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_bfc05416-87db-404e-9f86-a8b01e216a23"
      decimals="-5"
      id="F_6d975936-af1d-406b-bf68-d11c4c1c607a"
      unitRef="U_USD">19400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_b9849062-15a8-4157-94eb-425887d7c4d5"
      decimals="-5"
      id="F_77945896-117f-466c-b24c-5206303e8bc6"
      unitRef="U_USD">16600000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_081b7ddc-7d3d-4ad4-aee3-4d90b3c47ad6"
      decimals="-5"
      id="F_9073b50f-e5ae-435c-8918-dd29b6bcdc4d"
      unitRef="U_USD">36000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0ab6f045-1ad1-4153-a9b6-962038299ee7"
      decimals="-5"
      id="F_b1fe2a3b-e2bd-4d5d-9634-d6d230bf40ca"
      unitRef="U_USD">30500000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_612b21a6-29b0-4a04-b6c6-2d057f6f698c"
      decimals="-5"
      id="F_dc9447ab-8257-47e5-908b-414d09e3525c"
      unitRef="U_USD">54900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0ab6f045-1ad1-4153-a9b6-962038299ee7"
      decimals="-5"
      id="F_562d0209-ea7b-457f-82b5-512ee7c7c42b"
      unitRef="U_USD">54300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_d12a3336-c1b4-42ef-b4e8-d151bc4f6073"
      decimals="-5"
      id="F_0adcd55c-0836-4bef-b25b-d99e86d8ef6c"
      unitRef="U_USD">45500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_e603dc4a-23d5-4e8a-ba86-53a78b470fd8"
      decimals="-5"
      id="F_cde49a3b-1497-460e-ba18-76a9f34fc3d5"
      unitRef="U_USD">8800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_14b69a89-5ece-4633-95eb-269916567868"
      decimals="-5"
      id="F_cd87510c-8d5f-4dae-b54e-1f722c48c5e5"
      unitRef="U_USD">81800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_8be60b28-58be-4691-8add-44fa167e85d8"
      decimals="-5"
      id="F_5dc337d0-477d-4bf2-941f-e4d1143da482"
      unitRef="U_USD">18800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_eec48a46-4598-43e9-a039-7466eaea4546"
      decimals="-5"
      id="F_f24df0ac-7c4f-400f-8c47-ee5c679b8ec4"
      unitRef="U_USD">16700000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_59441261-9496-4c98-982f-a7f3cbd75e89"
      decimals="-5"
      id="F_d0cd681e-6b11-484f-b184-888b4ae377fb"
      unitRef="U_USD">2100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <kymr:CostReimbursementPaymentReceived
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-5"
      id="F_6fdf3672-7d69-46d8-aa4f-c61bca08a82e"
      unitRef="U_USD">6700000</kymr:CostReimbursementPaymentReceived>
    <kymr:CostReimbursementPaymentReceived
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-5"
      id="F_ec7a9492-44f9-4832-a660-9c016f8f8289"
      unitRef="U_USD">4800000</kymr:CostReimbursementPaymentReceived>
    <us-gaap:UnbilledContractsReceivable
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-5"
      id="F_1d972867-75c3-480f-b902-e5974c13e97e"
      unitRef="U_USD">2500000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-5"
      id="F_7cdbbecb-ceba-4387-b161-c90ba1ce75ed"
      unitRef="U_USD">100000</us-gaap:UnbilledContractsReceivable>
    <kymr:RemainingResearchTermOfCollaboration
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_66a8d438-228c-4ad0-96aa-849997cec134">P3Y</kymr:RemainingResearchTermOfCollaboration>
    <kymr:InitialResearchTermOfCollaboration
      contextRef="C_0d3c3a6e-4f6e-4e86-a583-6b94738c1223"
      id="F_68ef6269-362d-4567-a64c-779ac696559a">P4Y</kymr:InitialResearchTermOfCollaboration>
    <kymr:ExtendedResearchTermOfCollaboration
      contextRef="C_0d3c3a6e-4f6e-4e86-a583-6b94738c1223"
      id="F_ba9d1493-668e-4535-94dc-2c2a0bf9b93e">P1Y</kymr:ExtendedResearchTermOfCollaboration>
    <kymr:NonRefundableUpfrontPaymentReceived
      contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac"
      decimals="-5"
      id="F_be898d62-52d7-4285-9d1b-48ec0c3f8664"
      unitRef="U_USD">50000000.0</kymr:NonRefundableUpfrontPaymentReceived>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac"
      decimals="INF"
      id="F_d419e17e-c6f1-4bba-882f-fb1dfc36f110"
      unitRef="U_shares">3059695</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_b259fb45-0841-4caa-af6a-3436ea59b8c5"
      decimals="2"
      id="F_4a3e101a-f15f-4d53-b843-c690459b8776"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.54</us-gaap:SaleOfStockPricePerShare>
    <kymr:PreferredStockIssuancePremium
      contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac"
      decimals="-5"
      id="F_667259d6-a221-42db-9a5a-56cb2e65dfa3"
      unitRef="U_USD">5900000</kymr:PreferredStockIssuancePremium>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_5c9218ac-b38f-4b4a-b639-9ec2b585df0c"
      decimals="-5"
      id="F_77a8b8f2-e159-4505-94eb-338add0e3445"
      unitRef="U_USD">2300000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <kymr:PotentialReceivableMilestonePayments
      contextRef="C_d8fb09f6-e120-4543-92a1-1556cdd15765"
      decimals="-5"
      id="F_424ac5dc-54d9-4ce5-ba86-708c8a29a833"
      unitRef="U_USD">170000000.0</kymr:PotentialReceivableMilestonePayments>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac"
      decimals="INF"
      id="F_faad8266-5ee9-45c9-83cb-043eb03adacf"
      unitRef="U_shares">3059695</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <kymr:CollaborationAgreementTransactionPrice
      contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac"
      decimals="-5"
      id="F_f465294f-5404-46e1-b292-25836d05a883"
      unitRef="U_USD">55900000</kymr:CollaborationAgreementTransactionPrice>
    <kymr:PreferredStockIssuancePremium
      contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac"
      decimals="-5"
      id="F_d5645e48-0e99-4498-95c4-8f96e68ddfc2"
      unitRef="U_USD">5900000</kymr:PreferredStockIssuancePremium>
    <kymr:NonRefundableUpfrontPaymentReceived
      contextRef="C_d7398eae-c0e2-4cf5-aefa-11e68b54ecac"
      decimals="-5"
      id="F_36d89d65-603b-428c-93a0-9982392382d9"
      unitRef="U_USD">50000000.0</kymr:NonRefundableUpfrontPaymentReceived>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_5570ee25-70f9-4703-b517-2f4ecb794156"
      decimals="-5"
      id="F_1df43815-9f14-4d06-8fdd-554706f38e15"
      unitRef="U_USD">10800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_22bb0630-1f56-4e08-be75-2de87dfa8f47"
      decimals="-5"
      id="F_c3cf7777-fe11-4d88-9255-fb701fe97dc4"
      unitRef="U_USD">18500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_e385f6e7-a66f-4abf-a4e6-7cc879be5486"
      decimals="-5"
      id="F_8e388fc0-e0d9-47d6-828e-6a8b9c5e6b27"
      unitRef="U_USD">15200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_5570ee25-70f9-4703-b517-2f4ecb794156"
      decimals="-5"
      id="F_f11046bc-74ca-40d1-a1c1-49987edfdb29"
      unitRef="U_USD">10800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_40496514-8b4d-4ab1-ab44-cabf51a7a931"
      decimals="-5"
      id="F_ba8e9458-7337-4e09-aeae-d657925b63e8"
      unitRef="U_USD">8400000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_1067d521-9ab9-4291-b211-b3b28cc5875e"
      decimals="-5"
      id="F_b4e55ad1-fc3a-4256-a2f8-e2b49fc105bf"
      unitRef="U_USD">19200000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="C_baa1be4a-3f8a-4703-8ce3-1a52e5380d29"
      id="F_c354de59-efd3-4800-a2f2-5b363ef6befd">P0Y6M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_97589b7d-a19b-4817-9cb4-54e5513837fe"
      decimals="INF"
      id="F_37325020-5bf8-409d-899a-d7d87d2fd7f7"
      unitRef="U_shares">886305</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_b7c4a6f5-3116-4dfc-94b7-2777489e2b5a"
      id="F_e550f697-70fe-4de0-917a-2cbb2cd51f40">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_2e7ba5c8-f99e-4875-a133-bee00f42bf56"
      decimals="-5"
      id="F_c114254d-ef1b-4f71-b6ef-fb64abbf550f"
      unitRef="U_USD">300000</us-gaap:ResearchAndDevelopmentExpense>
    <kymr:TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement
      contextRef="C_2e7ba5c8-f99e-4875-a133-bee00f42bf56"
      decimals="INF"
      id="F_51a65bbc-cde6-4b26-844d-443e5c1c8cac"
      unitRef="U_shares">166183</kymr:TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement>
    <kymr:CollaborationTerminationDate
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_90f7cf53-030c-4200-9388-007e37a990db">2022-04-27</kymr:CollaborationTerminationDate>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_9cdb71a0-363d-4171-9973-196cab6fa41e">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents the changes in accounts receivable, contract assets and liabilities for the year ended December 31, 2022 (in thousands)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:46.959%;"/&gt;
        &lt;td style="width:1.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.102%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.117999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.117999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.102%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Additions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deductions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accounts receivable and contract assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Billed receivables &#x2013; Sanofi&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unbilled receivables &#x2013; Sanofi&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;135&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total accounts receivable and contract assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;135&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,702&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Contract Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred Revenue &#x2013; Vertex&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,212&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred Revenue &#x2013; Sanofi&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;81,822&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;54,861&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total contract liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;101,034&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;46,826&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;63,260&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss
      contextRef="C_0a44a408-71c2-4d39-8813-0b78ecef7724"
      decimals="-3"
      id="F_12187f06-ebd3-4d7b-9263-88231e1b39a3"
      unitRef="U_USD">0</us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss>
    <kymr:ContractWithCustomerAssetNetAdditions
      contextRef="C_c9486884-24fb-4c2c-83c0-60db6edb5eec"
      decimals="-3"
      id="F_1287db8b-4fab-4bd0-aad9-c1911eec7e7f"
      unitRef="U_USD">6650000</kymr:ContractWithCustomerAssetNetAdditions>
    <kymr:ContractWithCustomerAssetNetDeductions
      contextRef="C_c9486884-24fb-4c2c-83c0-60db6edb5eec"
      decimals="-3"
      id="F_6facf4b4-cb4b-4278-b9fa-e17e0445f91b"
      unitRef="U_USD">-6650000</kymr:ContractWithCustomerAssetNetDeductions>
    <us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss
      contextRef="C_68b2899b-3bcc-43f6-ac60-1964d739bcc2"
      decimals="-3"
      id="F_d07b07cc-69dc-48ed-92fb-1bf045dba7dd"
      unitRef="U_USD">0</us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss>
    <us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss
      contextRef="C_f905c3a9-aa7b-42be-b38e-38c2c85fc17e"
      decimals="-3"
      id="F_0e62c1f3-b7ae-4b95-8654-655639afbce1"
      unitRef="U_USD">135000</us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss>
    <kymr:ContractWithCustomerAssetNetAdditions
      contextRef="C_6313fdc6-f629-4f9c-b2ab-a0f4799044f4"
      decimals="-3"
      id="F_efcbd2b0-e89c-4971-988f-0621b00179ec"
      unitRef="U_USD">9052000</kymr:ContractWithCustomerAssetNetAdditions>
    <kymr:ContractWithCustomerAssetNetDeductions
      contextRef="C_6313fdc6-f629-4f9c-b2ab-a0f4799044f4"
      decimals="-3"
      id="F_be121822-bf5f-4271-9393-a011bedece77"
      unitRef="U_USD">-6650000</kymr:ContractWithCustomerAssetNetDeductions>
    <us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss
      contextRef="C_fab1d0dc-259c-4d99-aeaa-b68f059f306d"
      decimals="-3"
      id="F_e862a115-6e4b-4a5e-9347-6fe29b2d95f8"
      unitRef="U_USD">2537000</us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss>
    <us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_35c30d9d-0c82-458a-ac52-9f259de91af3"
      unitRef="U_USD">135000</us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss>
    <kymr:ContractWithCustomerAssetNetAdditions
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_98d36b7b-7ba3-48d7-ada2-0ff12a560aeb"
      unitRef="U_USD">15702000</kymr:ContractWithCustomerAssetNetAdditions>
    <kymr:ContractWithCustomerAssetNetDeductions
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_f160b201-3f61-45d1-8b31-e804cc0f4f6b"
      unitRef="U_USD">-13300000</kymr:ContractWithCustomerAssetNetDeductions>
    <us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_b4447c1c-94d1-4499-ad2c-3f2203664846"
      unitRef="U_USD">2537000</us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_d26a9a00-5e7d-4d4c-80e3-ac47ef881e7b"
      decimals="-3"
      id="F_94a2aac7-f5f3-4f56-abaf-21d42371b230"
      unitRef="U_USD">19212000</us-gaap:ContractWithCustomerLiability>
    <kymr:ContractWithCustomerLiabilityAdditions
      contextRef="C_f04f21d2-40bf-4a93-8a51-d233d78fb6da"
      decimals="-3"
      id="F_5fb20c08-4d30-4dba-ac8c-a9ea91140f03"
      unitRef="U_USD">0</kymr:ContractWithCustomerLiabilityAdditions>
    <kymr:ContractWithCustomerLiabilityDeductions
      contextRef="C_f04f21d2-40bf-4a93-8a51-d233d78fb6da"
      decimals="-3"
      id="F_39af6a98-91a5-4989-9138-6fd3052cd14d"
      unitRef="U_USD">-10813000</kymr:ContractWithCustomerLiabilityDeductions>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_bc744543-b39d-4939-9a52-727450458e7f"
      decimals="-3"
      id="F_c08430a7-5d06-476a-b6f0-2f7c922c5ea3"
      unitRef="U_USD">8399000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_f5b3b459-dd6e-414f-b28b-4d450e611a1a"
      decimals="-3"
      id="F_e8934131-3f43-4432-b169-0390e60d89b9"
      unitRef="U_USD">81822000</us-gaap:ContractWithCustomerLiability>
    <kymr:ContractWithCustomerLiabilityAdditions
      contextRef="C_c641fd16-c54e-4ea4-bc93-31046365f9ac"
      decimals="-3"
      id="F_9a84d6e2-3dc1-49f5-b274-c170172620e4"
      unitRef="U_USD">9052000</kymr:ContractWithCustomerLiabilityAdditions>
    <kymr:ContractWithCustomerLiabilityDeductions
      contextRef="C_c641fd16-c54e-4ea4-bc93-31046365f9ac"
      decimals="-3"
      id="F_567abf42-5bfb-44c9-bd0f-546336c554b9"
      unitRef="U_USD">-36013000</kymr:ContractWithCustomerLiabilityDeductions>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_502b15a6-ea47-400c-869d-e335729cdbc1"
      decimals="-3"
      id="F_f476e999-6a25-444d-b810-1719e8648905"
      unitRef="U_USD">54861000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_f33c2664-d975-4e7d-a866-90791b81ac46"
      unitRef="U_USD">101034000</us-gaap:ContractWithCustomerLiability>
    <kymr:ContractWithCustomerLiabilityAdditions
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_b51c7b71-e941-4d28-a585-31e64e1b28a8"
      unitRef="U_USD">9052000</kymr:ContractWithCustomerLiabilityAdditions>
    <kymr:ContractWithCustomerLiabilityDeductions
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_c6d3ca84-4470-4520-915d-ca437a7c1fb9"
      unitRef="U_USD">-46826000</kymr:ContractWithCustomerLiabilityDeductions>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_6a88e530-c5fd-4d08-8921-12e3340ba196"
      unitRef="U_USD">63260000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_888d7bc9-bd8d-422d-9cde-d925e840d11f">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 6. Property and equipment&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment consists of the following as of December 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:69.73%;"/&gt;
        &lt;td style="width:1.696%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.439%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.696%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.439%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lab and office equipment under and financing&lt;br/&gt;&#160;&#160;&#160;right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,969&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,383&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,805&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;273&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture &amp;amp; fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,064&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;943&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,802&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets not yet in service&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,146&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20,227&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,797&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,893&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,881&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Depreciation expense for the years ended December 31, 2022, 2021 and 2020 was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in property and equipment is lab and office equipment right-of-use assets under financing leases with a cost basis of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and accumulated amortization expense of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million as of December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortization expense related to right-of-use assets was&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million the years ended December 31, 2022, 2021 and 2020 and is included in depreciation expense.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_82ee2c70-871b-402a-8371-ec14030fb8ba">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment consists of the following as of December 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:69.73%;"/&gt;
        &lt;td style="width:1.696%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.439%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.696%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.439%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lab and office equipment under and financing&lt;br/&gt;&#160;&#160;&#160;right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,969&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,383&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,805&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;273&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture &amp;amp; fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,064&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;943&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,802&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets not yet in service&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,146&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20,227&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,797&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,893&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,881&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_8d546ca3-b4f9-459e-94ab-382557abce03"
      decimals="-3"
      id="F_4f4bce94-e45d-40b1-9184-9fcb06d82b7f"
      unitRef="U_USD">5475000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_02126e7a-b6e0-43d2-9ccf-f5a5b79c8acd"
      decimals="-3"
      id="F_b7b0f7af-25ff-419d-b9bf-471c20fb2bde"
      unitRef="U_USD">3969000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_61d31205-c2b5-4c89-bdaa-f543c2398e40"
      decimals="-3"
      id="F_9f1530ce-2695-42c5-8da6-b0a53eab075f"
      unitRef="U_USD">4383000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_5848cdd9-12d7-4f30-a785-9342a4c7a6f5"
      decimals="-3"
      id="F_f98e56ca-d0db-40a2-a87f-8eb26ef31c44"
      unitRef="U_USD">2805000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_fbbcb1bf-5bb2-467d-99d4-b373ccaddd38"
      decimals="-3"
      id="F_e95f48bb-1dfa-4e01-9864-c26c6b1f4287"
      unitRef="U_USD">357000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_c965787c-a43a-4142-aa2d-b72d421bb8bb"
      decimals="-3"
      id="F_d864d122-0619-4065-a62b-bdcbe93875c3"
      unitRef="U_USD">273000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_31efc25b-97c7-4143-86af-cc79d0a18d8d"
      decimals="-3"
      id="F_7011fad6-b13b-4918-b4b5-1d792e74e169"
      unitRef="U_USD">1064000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_2d89a721-4703-49d1-bd93-8012ab6048ee"
      decimals="-3"
      id="F_7ba0e2a5-a9dd-4b3e-bc76-9d7b8281a9e1"
      unitRef="U_USD">943000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_87c3d75e-6f9f-4fee-bf73-1e3449016f7a"
      decimals="-3"
      id="F_ae5d43c1-99ab-4da9-af00-050c6ce30af0"
      unitRef="U_USD">7802000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_7739607f-6dbd-41a0-9e92-62301ab965ac"
      decimals="-3"
      id="F_3f7dd602-febf-4d25-a92a-bce2643bc413"
      unitRef="U_USD">7741000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_c4d086ec-121e-41c0-8f9f-29a659fc29f6"
      decimals="-3"
      id="F_3365580d-6932-42ff-9c74-40044cc3e7ee"
      unitRef="U_USD">1146000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_00ea0bf2-b4b5-4c08-b022-561003946977"
      decimals="-3"
      id="F_462362a5-aa92-4eca-84af-710f7caa1aa6"
      unitRef="U_USD">66000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_21ec3d0b-ab04-46e4-b1d8-bf4b1624fd22"
      unitRef="U_USD">20227000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_c1e1e7a7-f89a-432e-89c3-a25aaff78e57"
      unitRef="U_USD">15797000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_5c631c4a-bc55-49fe-96ca-6e5664ba3625"
      unitRef="U_USD">6893000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_4146edee-5944-44cd-917e-829d5a0e8499"
      unitRef="U_USD">3916000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_6659efb1-ec32-4342-aff9-d6102e955533"
      unitRef="U_USD">13334000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_8aa254a3-f89f-4d6a-b846-daea861c2129"
      unitRef="U_USD">11881000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-5"
      id="F_bc4e1e2c-1373-4bd5-981e-2ff3f312e87e"
      unitRef="U_USD">3000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-5"
      id="F_3aee5568-002a-4f1e-8bd8-2db204b09b0e"
      unitRef="U_USD">2400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-5"
      id="F_683943ba-8d17-400f-af9f-55dc1d6863ca"
      unitRef="U_USD">1800000</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_8d546ca3-b4f9-459e-94ab-382557abce03"
      decimals="-5"
      id="F_f85dc815-c0da-4daf-8211-fbfc918f5063"
      unitRef="U_USD">5500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_02126e7a-b6e0-43d2-9ccf-f5a5b79c8acd"
      decimals="-5"
      id="F_94debb26-c5af-4a0a-a3df-a1f2910ea033"
      unitRef="U_USD">4000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <kymr:AccumulatedAmortization
      contextRef="C_8d546ca3-b4f9-459e-94ab-382557abce03"
      decimals="-5"
      id="F_995b3da2-6fc5-498f-9858-8a496ff18679"
      unitRef="U_USD">2700000</kymr:AccumulatedAmortization>
    <kymr:AccumulatedAmortization
      contextRef="C_02126e7a-b6e0-43d2-9ccf-f5a5b79c8acd"
      decimals="-5"
      id="F_07b69d3e-dd1e-4a86-9422-449744ba03f0"
      unitRef="U_USD">1500000</kymr:AccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-5"
      id="F_c17b10e9-d80e-4abd-8ce3-3886c77e56d2"
      unitRef="U_USD">1200000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-5"
      id="F_a47b51bd-6a3b-4f2e-ada6-04ef34942639"
      unitRef="U_USD">900000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-5"
      id="F_16e44404-fb6f-46c1-92a3-861593467a2c"
      unitRef="U_USD">700000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <kymr:LesseeOperatingAndFinanceLeasesTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_fbae3e92-95d1-4640-8f13-d6c540ba26aa">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 7. Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In February 2018, the Company entered into a noncancelable facility lease agreement (the &#x201c;Lease&#x201d;) for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,836&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; square feet of research and development and office space in Cambridge, Massachusetts. In March 2020, the Company signed a termination agreement for this lease which was determined to be a lease modification that resulted in a reduction of the right-of-use asset and liability of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. The lease termination was effective &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;July 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and the Company no longer has any obligations under the Lease.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In April 2019, the Company entered into a facility sublease agreement (the &#x201c;Sublease&#x201d;) for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,471&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; square feet of office space in Cambridge, Massachusetts. The term of the lease began on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;June 24, 2019&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and terminated on June 30, 2020, and following termination, the Company had no further obligations under the Sublease. The Sublease required the Company to share in prorated operating expenses and property taxes based upon actual amounts incurred; those amounts were considered variable lease costs and, therefore, are not included in the measurement of the lease and are instead recognized to expense as incurred.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In October 2019, the Company entered into a noncancelable facility lease agreement (the &#x201c;the 2019 Lease&#x201d;) for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,522&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; square feet of research and development and office space in Watertown, Massachusetts. The term of the 2019 Lease is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; months and expires on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, 2030&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The 2019 Lease has an option to be extended for an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;five year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;s. The lease is not reasonably certain to be extended and as such the additional term is not included in the measurement of the lease. The 2019 Lease includes a rent escalation clause, and rent expense is being recorded on a straight-line basis. The Company received a tenant incentive allowance of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in 2020 as the tenant improvements were completed all of which has been collected from its landlord as of December 31, 2022. In accordance with the lease agreement, the Company is required to maintain a security deposit and provided a letter of credit to the landlord for $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, which is recorded in restricted cash as of December 31, 2022 and 2021.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In December 2021, the Company entered into a noncancelable lease (the "2021 Lease") for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100,624&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; square feet of office and laboratory space in Watertown, Massachusetts, which the Company expects to begin occupying in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_6df59bfa-c32d-4351-8e0b-684185a0ee07;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;November 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The  2021 Lease is subject to base rent of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million per month beginning two months after the commencement date, plus the Company&#x2019;s ratable share of taxes, maintenance and other operating expenses. Base rent is subject to a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% annual increase over the lease term of approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;134&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; months &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;following the commencement date. The Company also has two consecutive options&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;to &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;extend the term of the lease for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; each at then-market rates. The 2021 Lease also includes a tenant improvement allowance of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. In connection with the signing of the 2021 Lease, the Company issued a letter of credit for $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million which is classified as restricted cash as of December 31, 2022. The Company also paid first month&#x2019;s rent of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million upon execution of the 2021 Lease in December 2021 which is classified as other non-current assets as of December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. As of December 31, 2022, the Company has not taken control of the space associated with the 2021 Lease and therefore, the Company has not recorded a right of use asset or lease liability related to the space as of December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s financing lease obligations consist of certain property and equipment financed through capital leases.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The components of the lease costs for the years ended December 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.685%;"/&gt;
        &lt;td style="width:1.613%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.902000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.613%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.188%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,095&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,095&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing lease costs:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortization of right-to-use assets, financing&lt;br/&gt;&#160;&#160;&#160;leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;906&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest expense for financing lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,192&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,015&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,174&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Supplemental cash flow information relating to the Company&#x2019;s leases for the years ended December 31, 2022 and 2021 were as follows (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.02%;"/&gt;
        &lt;td style="width:1.578%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.364%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.592%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.448%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash paid for amounts included in the measurement&lt;br/&gt;&#160;&#160;&#160;of lease liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating cash flows used in operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating cash flows used in finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;933&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing cash flows used in finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted average remaining lease terms and discount rates as of December 31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.844%;"/&gt;
        &lt;td style="width:1.139%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.696%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.139%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.183%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Remaining lease term:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.3&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.3 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing lease&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.4 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Discount Rate:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing lease&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The undiscounted future lease payments for operating and finance leases as of December 31, 2022, were as follows (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.274%;"/&gt;
        &lt;td style="width:1.572%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.79%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.572%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.79%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing&lt;br/&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,659&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,463&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,732&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,814&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;402&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,041&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less amounts representing interest or imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,448&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;282&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,654&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Excluded from the table above are all future payments related to the 2021 Lease.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</kymr:LesseeOperatingAndFinanceLeasesTextBlock>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_ce893baa-f44c-4ebb-a74e-bff63f53114a"
      decimals="INF"
      id="F_cc5985d8-6470-4d6b-92a4-e36256a39069"
      unitRef="U_sqft">9836</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:ImpairmentOfLeasehold
      contextRef="C_a28bf33d-a98c-4e5d-bf76-7f54880914c1"
      decimals="-5"
      id="F_fcc87e29-1eb9-4d5c-96e1-899d83f59401"
      unitRef="U_USD">2200000</us-gaap:ImpairmentOfLeasehold>
    <kymr:LeaseTerminationDate
      contextRef="C_a28bf33d-a98c-4e5d-bf76-7f54880914c1"
      id="F_73133e46-97e5-4f9f-b0b1-4a78a743db13">2020-07-31</kymr:LeaseTerminationDate>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_a33af802-fd5f-453f-8566-ed374579cd72"
      decimals="INF"
      id="F_8016c0c4-bef3-405a-ae1d-0e166f3648b9"
      unitRef="U_sqft">1471</us-gaap:AreaOfRealEstateProperty>
    <kymr:LeaseCommencementDate
      contextRef="C_36be0cca-7b17-4bd5-9ff6-6f599abd4d25"
      id="F_5ff67c10-1160-4563-a603-5895d4fa1dd1">2019-06-24</kymr:LeaseCommencementDate>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_64fc7649-e229-4be0-9da4-464cbc4ec931"
      decimals="INF"
      id="F_6bb96fa3-9004-43bc-90f6-8c58d341faac"
      unitRef="U_sqft">34522</us-gaap:AreaOfRealEstateProperty>
    <kymr:LeaseTerm
      contextRef="C_2c23163c-4ca5-41b2-89bd-6f956a18aef8"
      id="F_3616caf3-8268-47ec-bffd-ac63de6b06b2">P120M</kymr:LeaseTerm>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_2c23163c-4ca5-41b2-89bd-6f956a18aef8"
      id="F_1e664fab-37aa-4374-82ff-f39ec83c0f35">2030-03-31</us-gaap:LeaseExpirationDate1>
    <kymr:LeaseAdditionalTerm
      contextRef="C_2c23163c-4ca5-41b2-89bd-6f956a18aef8"
      id="F_e1487928-fe71-4734-99fb-45196d35730e">P5Y</kymr:LeaseAdditionalTerm>
    <kymr:TenantIncentiveAllowanceReceivable
      contextRef="C_27b0ac27-e9ee-48a9-8244-480576173f08"
      decimals="-5"
      id="F_cb56c9c1-1c41-4602-9884-f67e7160d49f"
      unitRef="U_USD">5500000</kymr:TenantIncentiveAllowanceReceivable>
    <us-gaap:SecurityDeposit
      contextRef="C_7b553fef-df42-4c26-baa6-85e17e44d192"
      decimals="-5"
      id="F_9607e4e7-dfc1-44ba-805f-7e7115683897"
      unitRef="U_USD">1600000</us-gaap:SecurityDeposit>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_905b1e51-7f5b-485c-9c36-6955cd326bbc"
      decimals="0"
      id="F_72571eb5-4d3a-42be-aacc-1118234d5294"
      unitRef="U_sqft">100624</us-gaap:AreaOfRealEstateProperty>
    <kymr:RentalAndLeaseExpenses
      contextRef="C_b6fa59dc-4675-40d7-8994-3d7f6fdb43e3"
      decimals="-5"
      id="F_3286953b-cf39-4909-ae3d-7c9017eb40d1"
      unitRef="U_USD">800000</kymr:RentalAndLeaseExpenses>
    <kymr:BaseRentAnnualIncreaseOverTheLeaseTerm
      contextRef="C_b6fa59dc-4675-40d7-8994-3d7f6fdb43e3"
      decimals="2"
      id="F_a9219a03-ff32-455c-aa89-69516acd5f21"
      unitRef="U_pure">0.03</kymr:BaseRentAnnualIncreaseOverTheLeaseTerm>
    <kymr:LeaseTerm
      contextRef="C_dc36945d-778f-40c8-b34a-d7b7257091e7"
      id="F_c8927dc8-16ec-4582-a643-746558da2b74">P134M</kymr:LeaseTerm>
    <kymr:LeaseAdditionalTerm
      contextRef="C_b6fa59dc-4675-40d7-8994-3d7f6fdb43e3"
      id="F_8a7a679e-8f4a-4ba3-91be-b5c89e0b7945">P5Y</kymr:LeaseAdditionalTerm>
    <kymr:TenantIncentiveAllowanceReceivable
      contextRef="C_905b1e51-7f5b-485c-9c36-6955cd326bbc"
      decimals="-5"
      id="F_43090138-1834-446a-be23-684356236cf3"
      unitRef="U_USD">20100000</kymr:TenantIncentiveAllowanceReceivable>
    <us-gaap:SecurityDeposit
      contextRef="C_3363a5aa-7bac-47fb-9504-1359994babd8"
      decimals="-5"
      id="F_8f78c535-798f-49a2-ae95-e7e9baf472d9"
      unitRef="U_USD">4500000</us-gaap:SecurityDeposit>
    <us-gaap:PaymentsForRent
      contextRef="C_edc39a4d-75a6-4b3f-af07-3ff0619b84c6"
      decimals="-5"
      id="F_f21f5f41-b007-46a0-a575-2089bf359f34"
      unitRef="U_USD">800000</us-gaap:PaymentsForRent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_59bb90b7-e53c-48b1-bb0d-eb2305e93287">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The components of the lease costs for the years ended December 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.685%;"/&gt;
        &lt;td style="width:1.613%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.902000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.613%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.188%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,095&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,095&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing lease costs:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortization of right-to-use assets, financing&lt;br/&gt;&#160;&#160;&#160;leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;906&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest expense for financing lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,192&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,015&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,174&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_34e6b9ae-7c58-441d-9993-1be2ea9e61f8"
      unitRef="U_USD">2095000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_fb3749b0-1b3e-48ce-b7cd-c273649781ff"
      unitRef="U_USD">2095000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_37f42830-2488-4da7-8ccf-d3b5080f00a3"
      unitRef="U_USD">1184000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_b9c836e3-f585-450d-999d-e93e10b6619a"
      unitRef="U_USD">906000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_884aebd3-d3a9-436c-b3f5-582f098bc0ca"
      unitRef="U_USD">179000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_0b370a7a-5b93-473e-b69f-51c4e0e2d93e"
      unitRef="U_USD">158000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:VariableLeaseCost
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_dbb7a537-ab89-4776-8fb9-35ebeb185a9b"
      unitRef="U_USD">1192000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_3aed6c8b-4a9d-44a8-aa0e-95aea18daf35"
      unitRef="U_USD">1015000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_2c3fa6ca-8b1b-4956-9f85-96e8d725f1b8"
      unitRef="U_USD">4650000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_aaaba36b-0b9c-479e-ad4c-201bae3f31cd"
      unitRef="U_USD">4174000</us-gaap:LeaseCost>
    <kymr:SupplementalCashFlowInformationRelatingToLeasesTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_8ace5db2-03a2-4872-ad5b-9a8728929622">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Supplemental cash flow information relating to the Company&#x2019;s leases for the years ended December 31, 2022 and 2021 were as follows (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.02%;"/&gt;
        &lt;td style="width:1.578%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.364%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.592%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.448%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash paid for amounts included in the measurement&lt;br/&gt;&#160;&#160;&#160;of lease liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating cash flows used in operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating cash flows used in finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;933&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing cash flows used in finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</kymr:SupplementalCashFlowInformationRelatingToLeasesTableTextBlock>
    <kymr:OperatingLeasePaymentsProceeds
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_c496e6eb-6e09-4f6a-846d-7c8e8bd7d5a6"
      unitRef="U_USD">2581000</kymr:OperatingLeasePaymentsProceeds>
    <kymr:OperatingLeasePaymentsProceeds
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_0484180e-8da5-43f6-9b62-fc86b3281cfc"
      unitRef="U_USD">2691000</kymr:OperatingLeasePaymentsProceeds>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_2dd7d7b8-02d2-495f-aeee-d4e4cb3e4f67"
      unitRef="U_USD">1130000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_9ec52508-c161-4855-b477-4f22051254ae"
      unitRef="U_USD">933000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_44d0c0c4-68ed-460e-b898-896537748935"
      unitRef="U_USD">179000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_f132a7e6-95c0-40e8-a705-8f8d5e9f2c2b"
      unitRef="U_USD">158000</us-gaap:FinanceLeasePrincipalPayments>
    <kymr:SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_b153a933-2bc4-495e-a525-8a3df1992718">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted average remaining lease terms and discount rates as of December 31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.844%;"/&gt;
        &lt;td style="width:1.139%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.696%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.139%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.183%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Remaining lease term:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.3&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.3 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing lease&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.4 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Discount Rate:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing lease&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</kymr:SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      id="F_8e07e18e-a6a3-4ef8-a665-9058f5de3f40">P7Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      id="F_8efed8e1-b350-49b9-bcbe-b931718d760e">P8Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      id="F_611e1205-8ff6-4aea-8fef-94f3cea9b2f9">P2Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      id="F_2d7856a6-e2ee-4400-91c4-902f03e698bf">P2Y4M24D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="3"
      id="F_c2575c1a-fe95-4e24-8f59-231965327edf"
      unitRef="U_pure">0.105</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="3"
      id="F_a7313397-724e-48ae-9204-7133c220bcbb"
      unitRef="U_pure">0.105</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="3"
      id="F_2462fe41-fd66-4e6d-b9ac-192dca9a3c27"
      unitRef="U_pure">0.085</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="3"
      id="F_0f3c8267-e62d-42e7-a68f-31c13dde0bdb"
      unitRef="U_pure">0.088</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <kymr:LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_d53fd60a-c095-4191-8902-27e7aa50edd5">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The undiscounted future lease payments for operating and finance leases as of December 31, 2022, were as follows (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.274%;"/&gt;
        &lt;td style="width:1.572%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.79%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.572%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.79%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal Year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing&lt;br/&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,659&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,463&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,732&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,814&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;402&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,041&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less amounts representing interest or imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,448&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;282&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,654&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Excluded from the table above are all future payments related to the 2021 Lease.&lt;/span&gt;&lt;/p&gt;</kymr:LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_16786e11-cc96-423f-8324-18ea2114a74c"
      unitRef="U_USD">2659000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_63b547d1-444d-4c1a-bc0f-8963677ed23e"
      unitRef="U_USD">1463000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_e0a63a4b-4596-40a1-9c3e-2524ef887c0a"
      unitRef="U_USD">2732000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_eb487bf1-55e6-4cce-8300-d8d333785749"
      unitRef="U_USD">839000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_b133da59-b8b0-43fb-9398-9f3b08ab7ab9"
      unitRef="U_USD">2814000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_1eb8dc9b-eaeb-49dc-bc46-0f6e5238f729"
      unitRef="U_USD">402000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_7c7f7b46-80b3-4b02-85cd-296b523f0ba9"
      unitRef="U_USD">2898000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_264053e0-ebf6-42cf-b0af-cbb3ea6b1118"
      unitRef="U_USD">133000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_1763db65-2e1f-4447-bafa-3da9888317e6"
      unitRef="U_USD">2985000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_e90a5c97-3475-4838-b25d-9ae4922dcb84"
      unitRef="U_USD">99000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_cbf785ff-a771-47bc-8778-bcf30d27277c"
      unitRef="U_USD">7041000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_d5f40c78-7ada-4ac8-9c68-38481fa2dbbd"
      unitRef="U_USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_6be3edd4-428f-42dd-b3cc-5a77d0fe0c6d"
      unitRef="U_USD">21129000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_e9e32516-14b0-47c4-b6ae-81f251c54d21"
      unitRef="U_USD">2936000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_457f7908-663e-4ad5-ada3-dfb3aaf270ae"
      unitRef="U_USD">6448000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_16f7f007-58ab-4224-b3c3-a2e800661846"
      unitRef="U_USD">282000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_f7155e11-f59f-4171-b5d9-28b7c5144678"
      unitRef="U_USD">14681000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_ce910980-b5c7-4776-8df9-3b3aa6fc0a70"
      unitRef="U_USD">2654000</us-gaap:FinanceLeaseLiability>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_daad84ce-4d48-478d-89ff-36dfeb6a526d">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 8. Accrued Expenses&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses consist of the following as of December 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.015%;"/&gt;
        &lt;td style="width:1.592%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.359%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.592%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.441999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,975&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,169&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Payroll and payroll-related&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,149&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,971&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,417&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22,971&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_fa885460-4a40-4ecc-96e4-444741c25466">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses consist of the following as of December 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.015%;"/&gt;
        &lt;td style="width:1.592%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.359%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.592%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.441999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,975&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,169&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Payroll and payroll-related&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,149&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,971&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,417&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22,971&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <kymr:AccruedResearchAndDevelopmentExpensesCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_08396ef1-5745-4653-acb1-776e3fa71f11"
      unitRef="U_USD">16975000</kymr:AccruedResearchAndDevelopmentExpensesCurrent>
    <kymr:AccruedResearchAndDevelopmentExpensesCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_d238f93f-e958-4471-87d8-6245a52d9fcf"
      unitRef="U_USD">15169000</kymr:AccruedResearchAndDevelopmentExpensesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_62a5f5ab-b563-4f68-a84a-ba350d76ac76"
      unitRef="U_USD">8149000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_96e09e22-ab2e-43ca-a22d-56f08279b366"
      unitRef="U_USD">6033000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_64e34b30-91df-4d30-93d9-3ba9807df253"
      unitRef="U_USD">1971000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_bed8b37a-1695-4c6c-a586-fd5db53a8950"
      unitRef="U_USD">1417000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_4dae4093-eb90-454a-a995-d8cbf2b05248"
      unitRef="U_USD">407000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_982dc80d-25b2-42a0-bee6-26c3740c5994"
      unitRef="U_USD">352000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_263a404e-32e1-4ecc-b5ac-507a65c97f81"
      unitRef="U_USD">27502000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_d75b8ba4-1cb9-428b-a413-e0bde1eadfe1"
      unitRef="U_USD">22971000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_7df802b7-e348-441d-9337-86267b0f2781">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 9. Other Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Legal Proceedings&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In the ordinary course of business, the Company may be subject to legal proceedings, claims and litigation as the Company operates in an industry susceptible to patent legal claims. The Company accounts for estimated losses with respect to legal proceedings and claims when such losses are probable and estimable. Legal costs associated with these matters are expensed when incurred. The Company is not currently a party to any legal proceedings.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Indemnification Arrangements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As permitted under Delaware law, the Company has agreements whereby it indemnifies its investors, employees, officers, and directors (collectively, the &#x201c;Indemnified Parties&#x201d;) for certain events or occurrences while the Indemnified Parties are, or were serving, at its request in such capacity. The term of the indemnification period is for the Indemnified Parties&#x2019; lifetime. The Company believes the estimated fair value of these indemnification agreements is minimal. The Company enters into standard indemnification agreements in the ordinary course of business. Pursuant to these agreements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally the Company&#x2019;s business partners or customers, in connection with any U.S. patent or any copyright or other intellectual property infringement claim by any third party with respect to the Company&#x2019;s products. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. The Company is not aware of any claims under indemnification arrangements, and it has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t accrued any liabilities related to such obligations as of December 31, 2022, 2021 or 2020.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="C_e35141e7-840c-4c80-868b-75ce55213382"
      decimals="INF"
      id="F_ca79d3d1-7175-4cd5-9ae2-85c3383fdd2b"
      unitRef="U_USD">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="C_a2e3e97a-6104-4a6a-845d-96d26416a456"
      decimals="INF"
      id="F_4f8a1a70-a946-4767-a3b3-38f099d5b10d"
      unitRef="U_USD">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="C_80f9fc1a-bada-456b-a7de-e066beca9a76"
      decimals="INF"
      id="F_109a1f30-7d69-4ce6-8450-ade3093c15dc"
      unitRef="U_USD">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:PreferredStockTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_5d64159f-64f7-456a-8978-a9fe5f9a24e8">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 10. Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Immediately prior to the IPO, the Company&#x2019;s Certificate of Incorporation authorized a total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;52,483,788&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of convertible preferred stock with a par value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share, of which &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares were designated as Series Seed Preferred Stock, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,886,305&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares were designated as Series A Preferred Stock, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,009,845&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares were designated as Series B Preferred Stock, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,059,695&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares were designated as Series B-1 Preferred Stock and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,527,943&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares were designated as Series C Preferred Stock. The Series A, Series B, Series B-1 and Series C convertible preferred stocks will be collectively referred to as the Convertible Preferred Stock.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In January 2020, the Company issued &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,182,265&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of Series B Preferred Stock at $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.06&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share to complete the second closing of the Series B Preferred Stock issuance for total proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. The issuance costs related to the second tranche were insignificant.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In March 2020, the Company executed a Series C Preferred Stock Purchase Agreement (the &#x201c;Series C SPA&#x201d;) to issue &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,539,141&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of Series C Preferred Stock at a purchase price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.5366&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share for a total consideration of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;88.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, net of issuance costs of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. In conjunction with the Series C SPA, the Company exchanged &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,988,802&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of Series A Preferred Stock for an equal number of shares of Series C Preferred Stock related to a transaction amongst investors. This resulted in a total issuance of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,527,943&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of Series C Preferred Stock. The fair value of the shares of Series C Preferred Stock issued exceeded the carrying value of the shares of Series A Preferred Stock exchanged by $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;which was&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;recognized &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;as a deemed dividend through a reduction of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million to additional paid-in capital and an increase of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million to the accumulated deficit. The $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million deemed dividend increased the net loss for the year ending December 31, 2020 to arrive at net loss attributable to common stockholders in the calculation of earnings per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In connection with the Company&#x2019;s August 25, 2020 IPO all issued and outstanding Convertible Preferred Stock of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50,439,595&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; were converted to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;31,625,534&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock and were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; longer issued or outstanding as of December 31, 2020.&lt;/span&gt;&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_c6c8d2a8-fc5a-4ae7-a353-aba76870f2db"
      decimals="INF"
      id="F_4c2d91d8-b582-4a2a-875f-401545ed282b"
      unitRef="U_shares">52483788</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_c6c8d2a8-fc5a-4ae7-a353-aba76870f2db"
      decimals="INF"
      id="F_19b713b1-db3c-4061-95d8-8a6146cfc121"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_0e8deb54-698e-4ab2-af83-21ba04dff085"
      decimals="INF"
      id="F_c5130fe3-fb75-4967-9f99-6bea878bde02"
      unitRef="U_shares">3000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_9d10799d-d7e1-4d27-8675-c80ab8ac70f7"
      decimals="INF"
      id="F_921ee0b3-7fab-45fb-8423-d916e25a0a06"
      unitRef="U_shares">14886305</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_e8aab3b3-a22a-4ff3-bc89-71d92652daea"
      decimals="INF"
      id="F_3354daab-e335-4bdf-9538-9735dce44074"
      unitRef="U_shares">16009845</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_3c25311b-f928-4131-a217-3def376fa07e"
      decimals="INF"
      id="F_1997928f-75d2-466c-9129-fc77b60ff8d2"
      unitRef="U_shares">3059695</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_79fff542-33ec-47e5-9833-9eb8b9292809"
      decimals="INF"
      id="F_170890d4-79c5-40ae-a50f-79a8ac52971b"
      unitRef="U_shares">15527943</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_609eabef-de99-4804-9f3b-bfe0014a08e4"
      decimals="INF"
      id="F_ddf22eb2-dd6a-448b-9d15-ee9e6d13f76b"
      unitRef="U_shares">1182265</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_609eabef-de99-4804-9f3b-bfe0014a08e4"
      decimals="INF"
      id="F_5ec441e8-93ad-400b-82cd-b4c9fe0044bc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.06</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_f90b9a09-ed20-4574-8cf0-a5475c3bafe7"
      decimals="-5"
      id="F_41837cd5-15f3-4a32-9e9f-e27fe31bf37d"
      unitRef="U_USD">4800000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_a19a1934-1bfb-4c71-8877-7d13aaae909d"
      decimals="INF"
      id="F_9b2ad80f-178f-4b57-ae42-e5d14ec8740c"
      unitRef="U_shares">13539141</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_a19a1934-1bfb-4c71-8877-7d13aaae909d"
      decimals="INF"
      id="F_ffd2422a-64e0-413f-97a1-fa7818c5085b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.5366</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="C_76c8ae03-3308-43f1-b225-daad19fb4a85"
      decimals="-5"
      id="F_9ebc2bae-d82e-463b-bc5e-69d0e3850268"
      unitRef="U_USD">88200000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_76c8ae03-3308-43f1-b225-daad19fb4a85"
      decimals="-5"
      id="F_b5400ebf-f257-4ba1-abbd-b3826f0f29d8"
      unitRef="U_USD">300000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_2975af70-dd29-413c-b9dd-b4bce328cf7f"
      decimals="INF"
      id="F_d2b3dfd1-3748-40d1-a71e-3d9d1f9b2362"
      unitRef="U_shares">1988802</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_2975af70-dd29-413c-b9dd-b4bce328cf7f"
      decimals="INF"
      id="F_595b4aa3-1c7d-4d63-bf83-b0365025af6e"
      unitRef="U_shares">15527943</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="C_cd15099d-d559-460e-9cc6-741a7742e2e1"
      decimals="-5"
      id="F_7a085488-1e1e-409e-b869-cf2e50c7c5c1"
      unitRef="U_USD">9100000</us-gaap:TemporaryEquityDividendsAdjustment>
    <kymr:AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend
      contextRef="C_cd15099d-d559-460e-9cc6-741a7742e2e1"
      decimals="-5"
      id="F_94844da5-3c52-4ca3-b48e-dea50b1f349e"
      unitRef="U_USD">2300000</kymr:AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend>
    <kymr:IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend
      contextRef="C_cd15099d-d559-460e-9cc6-741a7742e2e1"
      decimals="-5"
      id="F_33cc8238-4a4e-41f5-8ec5-22ddf057dd8f"
      unitRef="U_USD">6700000</kymr:IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="C_cd15099d-d559-460e-9cc6-741a7742e2e1"
      decimals="-5"
      id="F_d9ec379c-c81c-45e7-9fb8-d2747d379f95"
      unitRef="U_USD">9100000</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_da066593-343f-4eae-86aa-8434db5d2bc4"
      decimals="INF"
      id="F_63e6c213-e4a0-4645-87db-4e4bf1083daf"
      unitRef="U_shares">50439595</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_92f87a14-6091-4b98-ab40-77d4b06dc412"
      decimals="INF"
      id="F_18aa396a-e5e0-4ecf-baa3-2788e546f49e"
      unitRef="U_shares">31625534</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_6a76246b-2b22-46e7-b98f-f3af778c41fa"
      decimals="INF"
      id="F_67470dfb-c976-4208-8c16-4ea04c5a6946"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_6a76246b-2b22-46e7-b98f-f3af778c41fa"
      decimals="INF"
      id="F_2d1ead5e-6b14-4225-a118-2f9387ecbce2"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_4e71da36-154c-4162-b4f2-6022486c5fc0">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 11. Equity-Based Compensation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2018 Stock Option and Grant Plan&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In November 2018, the Company adopted, and its stockholders approved, the 2018 Stock Option and Grant Plan (the &#x201c;2018 Plan&#x201d;), which provides for the granting of stock options and other equity-based awards at the discretion of the Board of Directors or any subcommittee of the Board of Directors to the Company's employees, officers, directors, and independent contractors. No further grants will be made under the 2018 Plan. However, the 2018 Plan will continue to govern outstanding equity awards granted thereunder. To the extent outstanding options granted under the 2018 Plan are cancelled, forfeited or otherwise terminated without being exercised and would otherwise have been returned to the share reserve under the 2018 Plan, the number of shares underlying such awards will be available for future grant under the 2020 Stock Option and Incentive Plan.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2020 Stock Option and Incentive Plan&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In August 2020, the Company and its stockholders approved the 2020 Stock Option and Incentive Plan (the &#x201c;2020 Plan&#x201d;), which became effective on August 20, 2020. The 2020 Plan replaced the 2018 Plan as the Company&#x2019;s Board of Directors has determined not to make additional awards under the 2018 Plan following the closing of the Company&#x2019;s IPO. The 2020 Plan allows the Company to make equity-based and cash-based incentive awards to its officers, employees, directors and consultants. The Company has initially reserved &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,457,370&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock for the issuance of awards under the 2020 Plan, which includes the shares of common stock remaining available for issuance under its 2018 Plan as of the business day immediately prior to the effective date of the registration statement. The 2020 Plan provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2021 and each January 1 thereafter, by &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the Company&#x2019;s outstanding number of shares of common stock on the immediately preceding December 31, or such lesser number of shares as determined by the Company&#x2019;s compensation committee. These limits are subject to adjustment in the event of a stock split, stock dividend or other change in the Company&#x2019;s capitalization. As of December 31, 2022, there were an aggrega&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;te of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,744,415&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; remaining available for future grants.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2020 Employee Stock Purchase Plan&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In August 2020, the Company and its stockholders approved the 2020 Employee Stock Purchase Plan (the &#x201c;2020 ESPP&#x201d;), which became effective August 20, 2020. The 2020 ESPP initially reserves and authorizes the issuance of up to a total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;445,653&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock to participating employees. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The 2020 ESPP provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2021 and each January 1 thereafter through January 1, 2030, by the lessor of (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;438,898&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock, (ii) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the Company&#x2019;s outstanding number of shares of common stock on the immediately preceding December 31 or (iii) such lesser number of shares of common stock as determined by the administrator of the 2020 ESPP.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; The number of shares reserved under the 2020 ESPP is subject to adjustment in the event of a stock split, stock dividend or other change in the Company&#x2019;s capitalization. As of December 31, 2022, there were an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,208,252&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares remaining available for future grants.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A summary of stock option activity under the 2020 Plan during the year ended December 31, 2022 is as follows (in thousands except share and per share data):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.337%;"/&gt;
        &lt;td style="width:0.856%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.870000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.008%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.295%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.856%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.144%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.091%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.543%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Strike&lt;br/&gt;Price per&lt;br/&gt;Option&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,239,182&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23.91&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.56&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;246,933&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,761,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35.33&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;601,594&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;641,740&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33.89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,757,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.01&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;55,934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,505,520&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.61&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The intrinsic value of stock options exercised during the years ended December 31, 2022, 2021 and 2020 wa&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;s $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;million, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;67.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The weighted-average fair value of options granted during the years ended December 31, 2022, 2021 and 2020 was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.18&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29.95&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.35&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the total unrecognized stock-based compensation expense for unvested stock options was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;57.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, which is expected to be recognized over &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table outlines equity-based compensation expense for stock options for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.541%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.654%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.654%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.654%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,941&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total equity-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,329&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,948&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The weighted-average assumptions that the Company used in the Black-Scholes option pricing model to determine the grant date fair value of stock options granted to employees and non-employees for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.193%;"/&gt;
        &lt;td style="width:1.052%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.535%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.052%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.657%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.052%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.457%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.86&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.87&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.09&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Restricted Common Stock&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has granted shares of restricted common stock with service-based and performance-based vesting conditions. &lt;/span&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A summary of restricted stock activity under the 2018 Plan during the year ended December 31, 2022 is as follows: &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.152%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.443%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.607%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.676%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;br/&gt;Units&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Grant Date&lt;br/&gt;Fair Value&lt;br/&gt;per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unvested at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37,745&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;295,892&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24.01&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unvested at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;281,843&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23.64&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company granted &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;295,892&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,500&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of restricted stock during the years ended December 31, 2022 and December 31, 2021, respectively. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; grants of restricted stock for the year ended December 31, 2020. The Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t grant any restricted stock to consultants for the year ended December 31, 2022 and granted &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,500&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of restricted common stock to consultants which were fully vested at the time of grant during the year ended December 31, 2021.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the total unrecognized stock-based compensation expense for unvested restricted stock was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  million, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;which is expected to be recognized ov&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;er &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;During the years ended December 31, 2022, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the Company recorded stock-based compensation expense for restricted stock of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively. During the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the Company recorded stock-based compensation expense of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively, within research and development.  During the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the Company recorded stock-based compensation expense of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, and an immaterial amount, respectively, within general and administrative.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;      &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Equity-Based Compensation Expense&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total equity-based compensation expense recorded as research and development and general and administrative expenses for employees, directors, and non-employees during the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, 2021 and 2020 is as follows (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.442%;"/&gt;
        &lt;td style="width:1.473%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.621%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.473%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.621%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.621%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Years ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,008&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,731&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,472&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,885&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total equity-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35,480&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_cfa523b6-c249-44ac-b04c-c2b414d9ace4"
      decimals="INF"
      id="F_80f83e9a-ba4e-4d8f-bdbf-285b9f343681"
      unitRef="U_shares">4457370</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_09c6030c-9215-434e-be32-4ed40bf22526"
      decimals="INF"
      id="F_0f7fa5b9-8646-4a59-8b57-924acc6b4713"
      unitRef="U_pure">0.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_5c3de9fd-e34c-40a7-886f-e337a1c4bbf8"
      decimals="0"
      id="F_6bac0e5f-3a30-4420-ba8a-d4ba22e472cd"
      unitRef="U_shares">3744415</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_f388feec-ab4d-435a-a116-98c364680e81"
      decimals="INF"
      id="F_b2a74cf5-b05f-4bc1-9223-2c33a1c6276f"
      unitRef="U_shares">445653</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
      contextRef="C_5e70b6ab-252f-4914-b65d-a19b70d29f38"
      id="F_da7ed364-633a-42c3-81ef-3efdb01ac995">The 2020 ESPP provides that the number of shares reserved and available for issuance will automatically increase on January 1, 2021 and each January 1 thereafter through January 1, 2030, by the lessor of (i) 438,898 shares of common stock, (ii) 1% of the Company&#x2019;s outstanding number of shares of common stock on the immediately preceding December 31 or (iii) such lesser number of shares of common stock as determined by the administrator of the 2020 ESPP.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0a508e8a-8ed4-432c-b50f-3e6ba3cf849e"
      decimals="INF"
      id="F_a063ed09-8bf5-4448-8917-465923cf83ea"
      unitRef="U_shares">438898</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_9f2c591c-cdd0-4e59-b139-60ee5abb1b89"
      decimals="INF"
      id="F_c5db524d-ba30-4bbb-825b-dc405756d1a4"
      unitRef="U_pure">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_2b3d220a-8dfb-48f9-8630-e9c3cb556015"
      decimals="0"
      id="F_5d8449f1-9e8d-4bf2-84f4-a1660a254bf3"
      unitRef="U_shares">1208252</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_547463f6-cd33-470c-9c18-0bfa6ecf2dbb">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A summary of stock option activity under the 2020 Plan during the year ended December 31, 2022 is as follows (in thousands except share and per share data):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.337%;"/&gt;
        &lt;td style="width:0.856%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.870000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.008%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.295%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.856%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.144%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.091%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.543%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Strike&lt;br/&gt;Price per&lt;br/&gt;Option&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,239,182&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23.91&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.56&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;246,933&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,761,441&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35.33&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;601,594&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;641,740&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33.89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,757,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.01&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;55,934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,505,520&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.61&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_d51bc1c7-aa3c-43cd-8c22-e7fed24f7dec"
      decimals="INF"
      id="F_80f9bf21-e5b0-4290-b1c3-b53b09274ac7"
      unitRef="U_shares">6239182</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_d51bc1c7-aa3c-43cd-8c22-e7fed24f7dec"
      decimals="2"
      id="F_418edc58-074f-433d-88e8-828441272dbe"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">23.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_f8675fbd-b497-45a1-8f98-17bb97d337a6"
      id="F_a165097e-058e-4448-b025-c24462a1a066">P8Y6M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_d51bc1c7-aa3c-43cd-8c22-e7fed24f7dec"
      decimals="-3"
      id="F_b31ab616-5c90-41be-953d-b032b57ae1ef"
      unitRef="U_USD">246933000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e"
      decimals="0"
      id="F_2182f700-a895-4c5e-8152-0cafcab4d0eb"
      unitRef="U_shares">1761441</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e"
      decimals="2"
      id="F_154a154a-79f9-4478-9fbd-c0e6b489452d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">35.33</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e"
      decimals="0"
      id="F_1abf4073-ee48-412f-b27a-b817d0970b6d"
      unitRef="U_shares">601594</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e"
      decimals="2"
      id="F_7f7ecd2c-37b6-4aa4-aed8-740046355973"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.24</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e"
      decimals="0"
      id="F_738ba2a7-d4d1-46ad-973f-512bcfd9d214"
      unitRef="U_shares">641740</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e"
      decimals="2"
      id="F_fdc6a054-91d2-48fa-aa1c-de2299d4545c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">33.89</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25"
      decimals="INF"
      id="F_95cb2ca9-00b5-40e4-b073-b09dcb7a7047"
      unitRef="U_shares">6757289</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25"
      decimals="2"
      id="F_f076cf74-2ce8-48a9-8586-c67f23157513"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">27.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e"
      id="F_929c170f-4699-4a2d-bbb6-0bc4c39d1e29">P8Y3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25"
      decimals="-3"
      id="F_872dc47c-805e-43cb-bf47-b7105db5abe3"
      unitRef="U_USD">55934000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25"
      decimals="INF"
      id="F_6bf0c47e-5522-45c5-bb8f-72856898d3f3"
      unitRef="U_shares">3505520</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25"
      decimals="2"
      id="F_958a315c-2cfa-4672-b17a-b9aec1702b5a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">23.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_167de5a4-50cc-4901-9c67-4c426f16265e"
      id="F_fa0d96bf-a73b-4d12-b8ab-c5c578f87981">P7Y7M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_cdf618e7-06ca-4e21-bd39-cad11f69fa25"
      decimals="-3"
      id="F_06de5af0-b693-4f13-97e4-9f7eea2e22c7"
      unitRef="U_USD">38500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af"
      decimals="-5"
      id="F_203ce7bd-408c-46a0-a119-ba52670b0873"
      unitRef="U_USD">15800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_2838053c-edc6-48eb-99f6-f1c1c948532c"
      decimals="-5"
      id="F_319a5e9e-777a-473f-9d0a-53a2e71ff650"
      unitRef="U_USD">67600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_540998ce-bee4-4ad6-941f-3538588a5c1a"
      decimals="-5"
      id="F_527a1980-68a3-4a63-86f7-caf9c41689fe"
      unitRef="U_USD">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af"
      decimals="2"
      id="F_c873cafc-25ee-462c-8e30-c89031528678"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">20.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_2838053c-edc6-48eb-99f6-f1c1c948532c"
      decimals="2"
      id="F_b018f610-445f-4664-b2a3-91db3fd6b4e5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">29.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_540998ce-bee4-4ad6-941f-3538588a5c1a"
      decimals="2"
      id="F_3a5451bc-002a-4a36-b2e0-2e45a60d450e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_a127836f-8972-4634-a63e-075a16b278cb"
      decimals="-5"
      id="F_986b420c-7d73-4b9c-9913-b840ddb35950"
      unitRef="U_USD">57800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af"
      id="F_6b04b6e8-2fea-4aea-afa2-fb27b3e3c371">P2Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_c146e781-d80b-4d8b-975d-e1321fc0c26f">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table outlines equity-based compensation expense for stock options for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.541%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.654%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.654%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.654%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,941&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total equity-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,329&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,948&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_74fc36db-9df8-4a3a-b61d-d3906dde152b"
      decimals="-3"
      id="F_0adae75b-cc63-49bd-a4d5-84a7bcd3cd63"
      unitRef="U_USD">16388000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_5736292d-6714-4a50-bbea-d38622c2466f"
      decimals="-3"
      id="F_6c4cf721-2723-4694-bb17-7542993fc21e"
      unitRef="U_USD">11161000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_fee29a3a-aedd-47a5-a81d-24177eb305f7"
      decimals="-3"
      id="F_eb275342-c0f0-4fc0-b139-ba8b62196dc1"
      unitRef="U_USD">2084000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_bc832249-6262-4522-b906-00d2da961c93"
      decimals="-3"
      id="F_8f226f95-2125-41c5-8b8c-e9001fe2ec29"
      unitRef="U_USD">16941000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_71808508-9486-45a9-a60f-55c647268f87"
      decimals="-3"
      id="F_ba4c427e-15cb-453d-9f29-0f48a46befa4"
      unitRef="U_USD">12628000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_efce9fe0-465e-459e-b1a9-4b6162542b7f"
      decimals="-3"
      id="F_fb42f8f7-941c-4901-945f-325521ef95ee"
      unitRef="U_USD">2864000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af"
      decimals="-3"
      id="F_c2c271dc-94f3-4bfb-b9f5-66fea33bc4d1"
      unitRef="U_USD">33329000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_2838053c-edc6-48eb-99f6-f1c1c948532c"
      decimals="-3"
      id="F_70ae4294-a344-49c7-967d-a573809c3d6f"
      unitRef="U_USD">23789000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_540998ce-bee4-4ad6-941f-3538588a5c1a"
      decimals="-3"
      id="F_f5e35aec-70eb-43df-b64d-cbe3a7f0b77e"
      unitRef="U_USD">4948000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_56e24e63-ffaf-46bb-b23e-df4d761ac047">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The weighted-average assumptions that the Company used in the Black-Scholes option pricing model to determine the grant date fair value of stock options granted to employees and non-employees for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.193%;"/&gt;
        &lt;td style="width:1.052%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.535%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.052%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.657%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.052%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.457%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.86&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.87&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.09&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_822a7ffa-0f26-42e8-bbbb-3f13062fb64c">P5Y10M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      id="F_2dcbf6e8-92f1-4ec8-9c9b-e23eb8072ca6">P5Y10M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      id="F_5a40c7be-5425-4e94-9619-5ea5bd64efc4">P6Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="2"
      id="F_4a57eb23-c3fa-4306-a5f2-aa80ca4d448f"
      unitRef="U_pure">0.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="2"
      id="F_4851a4d0-8f1d-48da-bd04-f23a42d64201"
      unitRef="U_pure">0.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="2"
      id="F_d322dd41-1ad7-43f6-ada3-7cbe3a7e06f6"
      unitRef="U_pure">0.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="3"
      id="F_f05b0629-974c-4630-b38f-aa314a40405e"
      unitRef="U_pure">0.021</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="3"
      id="F_d63cf188-f3d4-46dc-976a-a85d5facdbe3"
      unitRef="U_pure">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="3"
      id="F_cdbd9836-0eb0-476c-bd49-3a4647d80fb8"
      unitRef="U_pure">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="3"
      id="F_1d5886f5-05df-4bca-b028-bbd61a2cbccd"
      unitRef="U_pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="INF"
      id="F_c1f70585-5804-4450-8da4-2786b20c1dd6"
      unitRef="U_pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="INF"
      id="F_e6459ae7-decc-4a93-9a34-13f52e6a3a50"
      unitRef="U_pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_f5d281ac-916b-4c27-867b-168e45887a7a">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A summary of restricted stock activity under the 2018 Plan during the year ended December 31, 2022 is as follows: &lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.152%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.443%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.607%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.676%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;br/&gt;Units&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Grant Date&lt;br/&gt;Fair Value&lt;br/&gt;per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unvested at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37,745&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;295,892&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24.01&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unvested at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;281,843&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23.64&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_b7ba11fe-25ad-4dba-9808-5ea7f213c68e"
      decimals="INF"
      id="F_74ec480c-5e90-47d7-a257-cd2185b2d554"
      unitRef="U_shares">37745</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_b7ba11fe-25ad-4dba-9808-5ea7f213c68e"
      decimals="2"
      id="F_eaf9c9ca-89fa-4be0-bd4b-e9f1dcca64d8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8"
      decimals="0"
      id="F_ea2d3a90-809f-4373-b743-e1fd9e46e561"
      unitRef="U_shares">295892</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8"
      decimals="2"
      id="F_b29ed6c9-0927-4497-9b09-da5658dda8c5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">24.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8"
      decimals="0"
      id="F_fae34e71-d1bb-4f59-9881-cac8bba2f236"
      unitRef="U_shares">36866</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8"
      decimals="2"
      id="F_1e6a6a05-6935-410c-9f26-6853ca86ef33"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8"
      decimals="0"
      id="F_423ef196-df01-40e1-85df-569cbb9bd4cb"
      unitRef="U_shares">14928</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8"
      decimals="2"
      id="F_60a0ae4b-8191-4e56-8bbd-af1326418d25"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">29.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_ffaeb917-acaf-403e-b35f-ee9c0815e0fd"
      decimals="INF"
      id="F_bea3f12b-5ebc-41d3-a71c-664eadd1118e"
      unitRef="U_shares">281843</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_ffaeb917-acaf-403e-b35f-ee9c0815e0fd"
      decimals="2"
      id="F_1c326fc4-883b-4b1d-ab4c-42bd69392abf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">23.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_7df38be4-2853-4015-a6b5-9f73bad5256f"
      decimals="INF"
      id="F_e670228a-7b4a-43cd-ae9d-a6deded1a9b8"
      unitRef="U_shares">295892</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_13c32f2e-7c2d-451d-bddf-0c2c9dd15260"
      decimals="INF"
      id="F_9dcf1827-5e0c-443b-84db-4eb56a360518"
      unitRef="U_shares">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0847ba81-8f44-4437-b8eb-633b0c7d610a"
      decimals="0"
      id="F_e6a48db5-043a-4ab3-bd96-04291bbc8920"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af"
      decimals="0"
      id="F_746c743e-b51a-437f-82b1-681c04832290"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_2838053c-edc6-48eb-99f6-f1c1c948532c"
      decimals="INF"
      id="F_1387361b-725f-45f7-9d15-66f679aec95e"
      unitRef="U_shares">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_fd5b0988-24e0-4f79-92bb-866fe46cad5f"
      decimals="-5"
      id="F_ef11f991-ad22-462e-a604-d51e148b4b4e"
      unitRef="U_USD">5300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_7df38be4-2853-4015-a6b5-9f73bad5256f"
      id="F_0c88729e-cd3c-4a80-bf4f-f7257ce03b41">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_7df38be4-2853-4015-a6b5-9f73bad5256f"
      decimals="-5"
      id="F_0b235c2d-a378-4e16-987b-d9711a3dfe1e"
      unitRef="U_USD">1400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_13c32f2e-7c2d-451d-bddf-0c2c9dd15260"
      decimals="-5"
      id="F_1309da40-b70d-432c-8fb8-3bd662fbd6de"
      unitRef="U_USD">900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0847ba81-8f44-4437-b8eb-633b0c7d610a"
      decimals="-5"
      id="F_e5e5ecea-3361-4fc3-955b-b061b876c01f"
      unitRef="U_USD">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_234197a7-41c0-49b0-b46a-6e4f533c6f82"
      decimals="-5"
      id="F_aa5c54f3-a72e-40ed-a6da-e71cd1efe107"
      unitRef="U_USD">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e838c8dc-9e7e-4afc-9c1b-ef93b8e4bf4d"
      decimals="-5"
      id="F_761c0304-5626-4640-a68b-b3f87aeb491a"
      unitRef="U_USD">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_7bfbb36d-82da-4ad3-994d-90f943b534e8"
      decimals="-5"
      id="F_a521b227-5123-481e-81eb-5cf463407869"
      unitRef="U_USD">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_ffa8f705-3f5f-4262-91ee-9dc0b63d32dc"
      decimals="-5"
      id="F_bfef20f6-bcce-4d38-9bb2-0b5bd9f8ebce"
      unitRef="U_USD">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_9c751372-08cb-457c-aad4-5cedac83bf5f"
      decimals="-5"
      id="F_e4fccfa4-02f4-4ff0-91cd-ee2166cd4dcd"
      unitRef="U_USD">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_61237bf4-e312-4023-95fa-e105e4b526af"
      id="F_585a5c9a-34ad-4f58-9f1e-76cc9c8d44c8">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total equity-based compensation expense recorded as research and development and general and administrative expenses for employees, directors, and non-employees during the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, 2021 and 2020 is as follows (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.442%;"/&gt;
        &lt;td style="width:1.473%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.621%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.473%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.621%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.621%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.374%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Years ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,008&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,731&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,472&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,885&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total equity-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35,480&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_233f48ad-667b-4b14-9534-dd4453d81c14"
      decimals="-3"
      id="F_c849d81b-d913-476f-a153-34140322772b"
      unitRef="U_USD">18008000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_19cbc32f-ec79-4363-8ead-cd45c0522894"
      decimals="-3"
      id="F_9a408c82-1472-417d-8c70-1921a64b0972"
      unitRef="U_USD">11731000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_1fa761db-d666-44a0-af4c-79d0be38cd5f"
      decimals="-3"
      id="F_bdd940d9-b6bc-4850-b24f-b59cf5f1e15b"
      unitRef="U_USD">2305000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_8de70d1d-2b5f-493b-8b0b-26530520a358"
      decimals="-3"
      id="F_5641dbfe-73a7-4c33-b7c6-2a714278ff80"
      unitRef="U_USD">17472000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e29716e7-cfe9-40b9-a9c6-244c78e60765"
      decimals="-3"
      id="F_2c23d4ea-895f-4bb6-aeae-1f2de325f58e"
      unitRef="U_USD">13241000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_136d87f1-3086-4833-98e0-254742d30599"
      decimals="-3"
      id="F_49063940-a94d-4e43-a35d-a97888e89cf8"
      unitRef="U_USD">2885000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_7011d727-275e-4194-9c61-a50ff03dac0c"
      unitRef="U_USD">35480000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_e586fc8d-455d-4ebb-9a9d-a9a2c369a1c2"
      unitRef="U_USD">24972000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_def59aa5-1052-411d-a085-bf55b6e2dbb1"
      unitRef="U_USD">5190000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_856a7ae9-8dc3-45fc-a849-89c93ec7dfc8">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 12. Related-Party Transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In addition to the collaboration discussed in Note 5, the Company had the following related party transactions for the periods presented in the accompanying consolidated financial statements, which has not otherwise been discussed in these notes to the consolidated financial statement. The Company made payments of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million to an investor for rent expenses for the year ended December 31, 2020. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; payments were made to related parties during the years ended December 31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="C_5f869677-7ee2-4413-aebc-fa0d38400637"
      decimals="-5"
      id="F_a5703c8e-f525-4afa-ac1b-07008ab50d40"
      unitRef="U_USD">800000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="C_da71e1e6-ad8b-46b6-a6cc-c239a69a2d15"
      decimals="INF"
      id="F_cd6d4e17-7a25-4b19-8311-42f7decce3ba"
      unitRef="U_USD">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="C_b43e2e96-8c18-4279-8325-186feb642b24"
      decimals="INF"
      id="F_78915df7-19b1-4f01-ba4c-560b23cee7a6"
      unitRef="U_USD">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_1bd7efef-3580-45be-be25-95b08954cc7d">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 13. Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company records income tax expense related to profits realized by its U.S. operating subsidiaries. For the years ended December 31, 2022, 2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;021 and 2020, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; income tax expense was recorded due the group&#x2019;s net operating loss (&#x201c;NOL&#x201d;) and full valuation allowance.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The rate reconciliation of the U.S. statutory income tax rate to the Company&#x2019;s effective tax rate for the years ended December 31, 2022, 2021 and 2020 are as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.06%;"/&gt;
        &lt;td style="width:1.327%;"/&gt;
        &lt;td style="width:12.443%;"/&gt;
        &lt;td style="width:1.996%;"/&gt;
        &lt;td style="width:1.327%;"/&gt;
        &lt;td style="width:12.443%;"/&gt;
        &lt;td style="width:2.008%;"/&gt;
        &lt;td style="width:10.399%;"/&gt;
        &lt;td style="width:1.996%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Tax effect at statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Permanent differences&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal research and development credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;43.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. &lt;/span&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s net deferred income taxes are as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.612%;"/&gt;
        &lt;td style="width:1.565%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.36%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.551%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.36%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.551%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="8" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Deferred Tax Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32,320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,835&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,651&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development credit carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accruals and reserves, stock and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,350&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Capitalized Research and Development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,435&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;125,847&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;83,790&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;77,990&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fixed and intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,941&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net deferred tax asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As required by ASC 740, management of the Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets, which are composed principally of NOL carryforwards and research and development credit carryforwards. Management has determined that it is more likely than not that the Company will not recognize the benefits of its federal and state deferred tax assets, and, as a result, a valuation allowance of&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;78.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million has been established at December 31, 2022 and 2021, respectively. During 2022, the valuation allowance increased by $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million primarily due to the increase in the Company&#x2019;s NOL during the period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Beginning in 2022, Tax Cuts and Jobs Act (TCJA) amended Section 174 and now requires U.S.-based and non-U.S-based research and experimental (R&amp;amp;E) expenditures to be capitalized and amortized over a period of five or 15 years, respectively, for amounts paid in tax years starting after December 31, 2021. Prior to the TCJA amendment, Section 174 allowed taxpayers to immediately deduct R&amp;amp;E expenditures in the year paid or incurred.   The Company has applied this required change in accounting method beginning in 2022 and the computation may be adjusted pending future IRS guidance.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has incurred NOLs from inception. At December 31, 2022 and 2021, the Company has federal NOL carryforwards of approximately &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;153.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;123.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively, and state NOL carryforwards of approximately&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;139.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;105.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively. Of the federal net operating loss carryovers, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;144.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million is not subject to expiration and the remaining federal and state NOLs begin to expire in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2036&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. These loss carryforwards are subject to review and possible adjustment by the appropriate taxing authorities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Utilization of net operating loss and research and development credit carryforwards may generally be subject to limitation under Sections 382 and 383 of the Internal Revenue Code due to ownership changes that have occurred previously, or that could occur in the future. These ownership changes may limit the amount of net operating loss and research and development credit carryforwards that can be utilized annually to offset any post-ownership change taxable income and tax, respectively. The latest Section 382 study was performed through December 31, 2022, noting that historic ownership changes have likely occurred. Nonetheless, the Company has determined that as of December 31, 2022 the prospective utilization of all net operating loss and tax credit carryforwards generated from inception through December 31, 2022, and therefore the corresponding Federal and Massachusetts deferred tax assets, should not be restricted by Sections 382 and 383, although ownership changes after December 31, 2022 could impact the Company&#x2019;s ability to utilize these tax attributes in the future.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;At December 31, 2022 and 2021 the Company had federal research and development credit carryforwards of&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively, and state research and development credit carryforwards of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively. These carryforwards begin to expire in 2031.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company follows the provisions of ASC 740-10, &#x201c;Accounting for Uncertainty in Income Taxes,&#x201d; which specifies how tax benefits for uncertain tax positions are to be recognized, measured, and recorded in financial statements; requires certain disclosures of uncertain tax matters; specifies how reserves for uncertain tax positions should be classified on the balance sheet; and provides transition and interim period guidance, among other provisions. As of December 31, 2022, and 2020, the Company has not recorded any amounts for uncertain tax positions. The Company&#x2019;s policy is to recognize interest and penalties accrued on any uncertain tax positions as a component of income tax expense, if any, in its statements of income. As of December 31, 2022 and 2021, the Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; reserves for uncertain tax positions. For the years ended December 31, 2022 and 2021, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; estimated interest or penalties were recognized on uncertain tax positions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has not conducted a study of its research and development credit carryforwards. This study may result in an adjustment to research and development credit carryforwards; however, until a study is completed, and any adjustment is known, no amounts are being presented as an uncertain tax position. A full valuation allowance has been provided against the Company&#x2019;s research and development credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the balance sheets or statements of operations if an adjustment were required.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company's tax returns for the years ended&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; December 31, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2019&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;to December 31, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; remain open and subject to examination by the Internal Revenue Service and state taxing authorities.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="INF"
      id="F_f3d6b906-5a7c-43ed-83ef-9a6bd5702dd2"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="INF"
      id="F_48401829-1817-4f42-9a21-ccdb61fb65fa"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="INF"
      id="F_f4d4ecda-67dc-42a6-a6d4-648038a4a2c7"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_019a4ee2-65b0-4f17-a57f-53333e77dab6">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The rate reconciliation of the U.S. statutory income tax rate to the Company&#x2019;s effective tax rate for the years ended December 31, 2022, 2021 and 2020 are as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.06%;"/&gt;
        &lt;td style="width:1.327%;"/&gt;
        &lt;td style="width:12.443%;"/&gt;
        &lt;td style="width:1.996%;"/&gt;
        &lt;td style="width:1.327%;"/&gt;
        &lt;td style="width:12.443%;"/&gt;
        &lt;td style="width:2.008%;"/&gt;
        &lt;td style="width:10.399%;"/&gt;
        &lt;td style="width:1.996%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Tax effect at statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Permanent differences&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal research and development credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;43.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="3"
      id="F_2625f12c-903c-4cda-9259-b0e1f5433465"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="3"
      id="F_52270832-6c1e-4387-902e-56752143d583"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="3"
      id="F_fafa4090-5a8b-4a5b-a763-d0b063707729"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="3"
      id="F_9c612822-3b15-4954-99fe-6a8bf230fa2d"
      unitRef="U_pure">0.064</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="3"
      id="F_040d0ba8-cc03-479a-bf47-d23196b2f982"
      unitRef="U_pure">0.106</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="3"
      id="F_2d383e25-1c85-439b-8449-b4d6b87bb6e5"
      unitRef="U_pure">0.058</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="3"
      id="F_68ab4b7f-f76e-430b-8b52-37745c039998"
      unitRef="U_pure">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="3"
      id="F_c35fd6a3-47b0-4bda-ae4e-70e1229eaaba"
      unitRef="U_pure">0.096</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="3"
      id="F_4ba02abb-8a0d-4f7c-9fe5-bbd15d37e084"
      unitRef="U_pure">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <kymr:EffectiveIncomeTaxRateReconciliationPermanentDifferences
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="3"
      id="F_7f9636c2-42bb-4f00-949c-bbb60397fe6d"
      unitRef="U_pure">0.000</kymr:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
    <kymr:EffectiveIncomeTaxRateReconciliationPermanentDifferences
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="3"
      id="F_ae447f21-b680-4230-95d4-f2656065347e"
      unitRef="U_pure">0.000</kymr:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
    <kymr:EffectiveIncomeTaxRateReconciliationPermanentDifferences
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="3"
      id="F_cc292aa4-4198-4ba3-8c9e-69de7e396145"
      unitRef="U_pure">0.000</kymr:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="3"
      id="F_799b91ac-bc3f-4f2e-a590-8887d1959087"
      unitRef="U_pure">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="3"
      id="F_a29157cb-2cfa-4cd8-a40a-823cf75671e5"
      unitRef="U_pure">0.077</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="3"
      id="F_0f7fbedf-0aeb-44d4-acdf-75e5f2fa2859"
      unitRef="U_pure">0.036</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="3"
      id="F_87e60cf1-b4f5-465e-9381-eb7ca9b92e59"
      unitRef="U_pure">-0.018</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="3"
      id="F_34c15cc0-0da2-45b1-b426-fcfa4918171f"
      unitRef="U_pure">-0.051</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="3"
      id="F_147a53c3-211f-4124-b1b8-e3dd14522cc8"
      unitRef="U_pure">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="3"
      id="F_6ebcbbc2-d98b-49ba-9dd8-4ee2f7dbdfec"
      unitRef="U_pure">-0.272</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="3"
      id="F_8cec631e-88eb-4199-93fa-2c093f263b4e"
      unitRef="U_pure">-0.438</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="3"
      id="F_65e17f8e-46a7-47c2-bfe9-1e2534b5842a"
      unitRef="U_pure">-0.288</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="3"
      id="F_af35ac95-efa2-49b2-913f-266781eadbc8"
      unitRef="U_pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="3"
      id="F_57e8ccd5-d9bb-4e5a-9111-5478857b7540"
      unitRef="U_pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="3"
      id="F_f56de057-33d7-41ba-974e-f8ece66c2d8f"
      unitRef="U_pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_07bf1015-9676-4e0e-b42e-3262c93eb226">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s net deferred income taxes are as follows (in thousands):&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.612%;"/&gt;
        &lt;td style="width:1.565%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.36%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.551%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.36%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.551%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="8" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Deferred Tax Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32,320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,835&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,651&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development credit carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accruals and reserves, stock and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,350&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Capitalized Research and Development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,435&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;125,847&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;83,790&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120,096&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;77,990&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fixed and intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,941&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net deferred tax asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_dee2c3ac-8a90-48ea-b8ad-406ead9c10c8"
      unitRef="U_USD">32320000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_6097d72f-27b3-464b-b7d3-412780759a22"
      unitRef="U_USD">25957000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_bda5bd98-d9da-42f5-8178-1db0d8ec703d"
      unitRef="U_USD">8835000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_3f87eb2a-343c-4a92-9c8c-7afeb719c2fc"
      unitRef="U_USD">6651000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_f91d3838-0e29-406d-9008-fcccd10f3913"
      unitRef="U_USD">17581000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_588cd87e-13fa-45e3-bcc1-7415fb48c6de"
      unitRef="U_USD">14611000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <kymr:DeferredTaxAssetsLeaseLiabilities
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_bba678c0-45f6-40b7-b89b-cff8bd2030d4"
      unitRef="U_USD">4011000</kymr:DeferredTaxAssetsLeaseLiabilities>
    <kymr:DeferredTaxAssetsLeaseLiabilities
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_f586b735-4d0c-47d1-b2bb-c02ec3b87968"
      unitRef="U_USD">4285000</kymr:DeferredTaxAssetsLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_90d4324b-4279-4e38-b57d-8050e688d3a0"
      unitRef="U_USD">16315000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_4d39d083-4ffa-4d56-a134-6ce79055065f"
      unitRef="U_USD">27130000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_1148f447-c36f-472d-aec7-c2fcfea0240b"
      unitRef="U_USD">10350000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_b170a74a-2fb6-40f8-ba5c-91ef55dee394"
      unitRef="U_USD">5156000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_74666ebf-0574-47a3-a70c-efeb1854b283"
      unitRef="U_USD">36435000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_6de0204f-0726-499c-be54-32c16cbc8021"
      unitRef="U_USD">0</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_9a9cc296-b879-4de7-84a6-528efa445a19"
      unitRef="U_USD">125847000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_8b8bc63d-5fd4-4fd5-b319-94a9f0e81da8"
      unitRef="U_USD">83790000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_d5f7a5c3-c802-482b-85c5-1a98b7404294"
      unitRef="U_USD">120096000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_4d01d015-3d28-4bfe-a169-13eae040689e"
      unitRef="U_USD">77990000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_250fae1f-8a56-4dde-86f0-51e742b8713e"
      unitRef="U_USD">5751000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_9f4b232f-d2b0-437f-b139-80022d95a0fa"
      unitRef="U_USD">5800000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_cbfdf665-b8fa-48c7-806c-5224409997b8"
      unitRef="U_USD">2187000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_6308a0d3-abe5-4f8d-97f9-86ea3497c2d7"
      unitRef="U_USD">1941000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <kymr:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_a784a8d3-e05f-4a6f-a5ed-76f2a442b618"
      unitRef="U_USD">3564000</kymr:DeferredTaxLiabilitiesRightOfUseAssets>
    <kymr:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_bdead8dd-a8f1-4577-bd7e-2c2fd54512b6"
      unitRef="U_USD">3859000</kymr:DeferredTaxLiabilitiesRightOfUseAssets>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-3"
      id="F_4330ca86-81dc-4c14-a08f-69c7234c5140"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-3"
      id="F_7aeadab3-b283-479b-ab2c-2773af94eeb6"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="-5"
      id="F_755b92fc-1c39-446d-b863-647be95a6485"
      unitRef="U_USD">120100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="-5"
      id="F_8848236d-f437-4788-80fd-31e606b8e3b2"
      unitRef="U_USD">78000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-5"
      id="F_f156f24b-e19d-4f6c-bc76-b18ce9e7f380"
      unitRef="U_USD">42100000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_706ff543-02d9-48e2-ab79-2493d3f2d922"
      decimals="-5"
      id="F_d7abf093-7371-46b5-8d61-1af7d2c76d7c"
      unitRef="U_USD">153900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_da156e8f-4b74-46f4-b36a-d8334d9e178c"
      decimals="-5"
      id="F_6ab4c74a-d022-411b-9ec7-a63039f999e5"
      unitRef="U_USD">123600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_15ff43a4-1a79-4140-833c-62eca307fcca"
      decimals="-5"
      id="F_cb75f35c-7788-445e-a443-0081e7be4745"
      unitRef="U_USD">139800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_e29dbbc6-2913-48f5-ae93-32213dc0a589"
      decimals="-5"
      id="F_50825821-22cf-43fb-a961-67c900047c1a"
      unitRef="U_USD">105200000</us-gaap:OperatingLossCarryforwards>
    <kymr:FederalNetOperatingLossCarryoversNotSubjectToExpiration
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-5"
      id="F_6d175ec7-299b-4a8a-826b-00f54e9125db"
      unitRef="U_USD">144100000</kymr:FederalNetOperatingLossCarryoversNotSubjectToExpiration>
    <kymr:NetOperatingLossBeginToExpireYear
      contextRef="C_46a95b63-fac0-4c7e-886b-297fe0b6508c"
      id="F_9844ba1b-964a-4f65-aa1e-48d52dffc029">2036</kymr:NetOperatingLossBeginToExpireYear>
    <kymr:ResearchAndDevelopmentCreditCarryforwards
      contextRef="C_5ecfa09f-e84b-4a4a-8989-6581bbb4d5de"
      decimals="-5"
      id="F_1755e9d8-0dc2-49c7-907c-0c97d1b0c4b3"
      unitRef="U_USD">12700000</kymr:ResearchAndDevelopmentCreditCarryforwards>
    <kymr:ResearchAndDevelopmentCreditCarryforwards
      contextRef="C_c2702504-9407-4568-90ec-019c2a2d2ec4"
      decimals="-5"
      id="F_edd56dc7-f997-41d3-9b6d-07b1465273eb"
      unitRef="U_USD">10400000</kymr:ResearchAndDevelopmentCreditCarryforwards>
    <kymr:ResearchAndDevelopmentCreditCarryforwards
      contextRef="C_1f5790c2-3ca6-4592-b151-991462b1693b"
      decimals="-5"
      id="F_c34b0cf6-d978-4cd0-82d8-dcc42389d9bc"
      unitRef="U_USD">6100000</kymr:ResearchAndDevelopmentCreditCarryforwards>
    <kymr:ResearchAndDevelopmentCreditCarryforwards
      contextRef="C_d71a034f-8114-4bbc-b37a-9706f02f0795"
      decimals="-5"
      id="F_d480e11e-4704-4f9c-8519-b322be788727"
      unitRef="U_USD">5200000</kymr:ResearchAndDevelopmentCreditCarryforwards>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_040be217-5d7c-4430-aeb6-a639e3672c4d"
      decimals="INF"
      id="F_19569389-f934-4671-9307-2583716224ea"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_cb4393fc-15bf-486a-9195-7df9d32c0b65"
      decimals="INF"
      id="F_707f1476-b8f6-431f-80d4-0431b8a9519d"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="INF"
      id="F_420e5f67-76cb-4a99-b2d6-2b618a5e8b69"
      unitRef="U_USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="INF"
      id="F_b4769a13-5efa-482a-8890-48ee5177a9db"
      unitRef="U_USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:OpenTaxYear
      contextRef="C_3d0188f0-21c7-4f50-b44d-994dd494ed83"
      id="F_2dca4dfe-4b7a-456c-bb1e-85444d57220b">2019</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="C_7a1721f2-1cc5-4103-bee4-aae009ac5e28"
      id="F_bdad85f0-7bbc-4132-8203-4d060855b091">2022</us-gaap:OpenTaxYear>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_0049115f-e844-4bd9-b0f1-ab0c16e5d212">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Note 14. Net Loss per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Net Loss per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Basic and diluted loss per share is computed by dividing net loss by the weighted-average common shares outstanding for the period, including the pre-funded warrants given their nominal exercise price (in thousands, except for share and per share data):&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&#160;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.524%;"/&gt;
        &lt;td style="width:1.385%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.375%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.652000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.375%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.652000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.375%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;154,808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100,217&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,593&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deemed dividend from exchange of convertible&lt;br/&gt;&#160;&#160;&#160;preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,050&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;154,808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100,217&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;54,643&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted average common shares outstanding, basic&lt;br/&gt;&#160;&#160;&#160;and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;53,933,229&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;47,989,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,349,582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.09&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s potentially dilutive securities, which include convertible preferred stock, restricted stock, and stock options, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders at December 31, 2022, 2021 and 2020 because including them would have had an anti-dilutive effect:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.826%;"/&gt;
        &lt;td style="width:1.014%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.541%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.024%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.541%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.024%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.622%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.409%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unvested Restricted Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;281,843&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37,745&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;110,104&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options to purchase Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,757,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,239,182&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,580,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,039,132&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,276,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,691,028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_24c6ab7f-6faa-4f1a-9c90-dac4d0f357e7">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&#160;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.524%;"/&gt;
        &lt;td style="width:1.385%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.375%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.652000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.375%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.652000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.375%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;154,808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100,217&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,593&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deemed dividend from exchange of convertible&lt;br/&gt;&#160;&#160;&#160;preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,050&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;154,808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100,217&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;54,643&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted average common shares outstanding, basic&lt;br/&gt;&#160;&#160;&#160;and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;53,933,229&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;47,989,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,349,582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.09&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_9e5efd74-f7d7-45b0-8b95-859e94af3f95"
      unitRef="U_USD">-154808000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_2ca4154b-8e4c-44cd-90c4-2e8a1d9b1409"
      unitRef="U_USD">-100217000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_cc7a3bca-e96f-469b-90a1-3dccbfea109b"
      unitRef="U_USD">-45593000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_f1966a96-ccc3-4951-9d5e-bc962831a1e3"
      unitRef="U_USD">0</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_7116b64b-5b67-49f1-843c-142c80e17359"
      unitRef="U_USD">0</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_46b078b3-6127-4d7b-b6a8-3d3bd8152ac5"
      unitRef="U_USD">9050000</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="-3"
      id="F_fad8a508-eb33-4574-9922-4a71a4602aca"
      unitRef="U_USD">-154808000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="-3"
      id="F_d9340975-23a2-4b65-9e85-b124ddf74827"
      unitRef="U_USD">-100217000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="-3"
      id="F_708b74c3-e4ff-4a67-9d56-3e64807fe3c4"
      unitRef="U_USD">-54643000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="INF"
      id="F_bede1706-e543-4c8b-8d8c-6bf57763a136"
      unitRef="U_shares">53933229</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="INF"
      id="F_68d17092-676f-478c-9091-bb42e8016b58"
      unitRef="U_shares">53933229</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="INF"
      id="F_e71aaece-cc06-464d-ba93-e8854d6f602b"
      unitRef="U_shares">47989023</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="INF"
      id="F_c2746def-758a-43aa-b07d-46e1c40f5703"
      unitRef="U_shares">47989023</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="INF"
      id="F_31c4a46c-788a-4c92-852e-1acca1170820"
      unitRef="U_shares">17349582</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="INF"
      id="F_cd18809c-9a04-4bca-8b85-675c4270cf84"
      unitRef="U_shares">17349582</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="2"
      id="F_e7db484b-39d4-4566-8d37-2b65eeae02e7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.87</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="2"
      id="F_57726b23-af45-4480-a93d-f13040936b84"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.87</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="2"
      id="F_5873a8c4-97b1-4c6a-a1f0-4ca0f481089c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="2"
      id="F_a4e71e49-daab-43ae-9874-476b776fdfc9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="2"
      id="F_c5ad7141-643a-4b24-b72f-10cf690dc119"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="2"
      id="F_653c87e8-8f38-4718-9160-8580c310cd2e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      id="F_03e8b339-e2fe-47c3-a35d-e4a64a18cd36">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders at December 31, 2022, 2021 and 2020 because including them would have had an anti-dilutive effect:&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.826%;"/&gt;
        &lt;td style="width:1.014%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.541%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.024%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.541%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.024%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.622%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.409%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="12" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unvested Restricted Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;281,843&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37,745&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;110,104&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options to purchase Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,757,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,239,182&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,580,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,039,132&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,276,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,691,028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_945eb7b7-5b44-4a38-ac68-221560bd90c3"
      decimals="0"
      id="F_795d10f1-39cb-482e-a2ed-148c088ced2f"
      unitRef="U_shares">281843</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_322d6f2f-d9c6-4dde-bd2a-00b4fe2d9953"
      decimals="0"
      id="F_3c2b876d-ccda-4f30-8342-fdce9540b739"
      unitRef="U_shares">37745</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_bc0e09ba-86f9-40ac-bd79-7819763b03d9"
      decimals="0"
      id="F_8cd54650-801f-4394-8211-dea25a7d6df4"
      unitRef="U_shares">110104</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_835ed024-44c8-4f1f-8d6e-765f4caca866"
      decimals="0"
      id="F_feeed76c-3995-4a2e-97b1-8772bdf471bf"
      unitRef="U_shares">6757289</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_7ce88c48-9db3-4967-b6cf-209b8a85b29a"
      decimals="0"
      id="F_ea5866c1-5930-4b44-815a-57f921f44b0c"
      unitRef="U_shares">6239182</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b71771ba-3d9c-4451-8eb3-75b4fdf5da6f"
      decimals="0"
      id="F_5a5b7ec0-c27f-465d-91fe-45e390a1c4a0"
      unitRef="U_shares">1580924</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_e797a856-6bbd-4491-93c3-86302e550709"
      decimals="0"
      id="F_3ad2b9d1-2ba7-4bd4-a6ba-219f61fedbb8"
      unitRef="U_shares">7039132</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_59d6e9e0-0e19-4721-b6a7-86fd777bb736"
      decimals="0"
      id="F_8f77ff08-166c-478e-8231-ca727a3b12e4"
      unitRef="U_shares">6276927</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_32f933dd-dcf9-429f-8e2b-d1d801973ad5"
      decimals="0"
      id="F_b52c0307-69ea-4b79-a660-e10a84782abe"
      unitRef="U_shares">1691028</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>156
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M['P"749":-ED\>(9#IRW-E<?TUAT)&,'S@L:YP4/9+UD5,2IR>@$ I;SC>[
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MWE!@6_E%QN570Q4.&$BF5+#7^KUL%EMY5;;"_560D[#;[^PPI]OM;##W9$B
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MH()J[EFOAX?6]%$M0+40U2)4BU$M0;44U3)4RU&MH+1V^#5=+>KY;2V[TZ?
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MT,?:4#)1%(4N/)#\@9-OY10QX:@DZWB(6.W$>UXUV7_:&Q AWWS4T-<&_08
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M*"-)L22H1TP$2F*?D_*!2SB-7>AF1&3O5V(ZO1I.FV3M>VFF"@V]7<S(WW4
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M:P\P0NL-QZRS-^A$%FU7TA8L*D8>$>^A83:#!TOI@19 (2(<O-RP)O*EW:A
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M'5=_"]QAS1VQ7UY6< _H_UL0RXI5/)"PP %)<D'![X"1:YALKSXCV3&0[^S
MT1GL3HU3![\9- I0?)\34W\DE2*&4Y6(G0BL%89P)QB\^^SZ; OJ1*;'M^$=
M9-H_HH$8,*X 0=T9&A;BOX*R;.'AE/((*F!0("3.F\_1<\Y1]_X*4X\J#V[L
MJWZ@P=?9!W@_6#>4-J*O^3>1!S0G^[3,"G1M[VJR:!X=; =4015"! .Q**L>
MB='"NW 0(F\_PWK;O$#O K8.UHRR_(ZH0^)C/'>[T**&@4'9D]L3;O;Q9O:.
M8<Y($N0JV4X*U$!7YSW9W+Q)=S;=450)09(O07XN/?#;>FDF=J>C @#JX#9G
M,#4RUE8F?+@J3(/:@W:.C&M&,$5*D'NMD;RO9)4H8B>P.20&8<ZTP@9TC$P#
M[,!DN?:-^+#R&"OEN&:1[D[9M(% J$=JI_QL1YMCYZ]/H,B[CJ8.\I-7'9D_
M%[EK:.!5-1GK'8D">; M:D*52=*-[*NAQN_<'D&S6Y15M'?9 [S](>U^- FX
M%/#_BL\0:H(/X(5]U>!B)(#N%;^:0R<8^5 -!]+F8"A0#F$%%2EDF+WR&1F,
M SIL_V#_]!%963(L)%T4HK)VH/G)+>((9.VM^(]UM0U.-\IV-[ B_;!($&N\
MT;OQZF[[(^A_T.U95<(0,9HZ./ 3V8G."3,8$_2!S.JA3':5-0[Y"GR;O-@;
MSQ1Y=)4$\V*C/!G>Q*FIX(:JT] F3#BKT$B?[):;=;$;@NZ$T4?\.SBW<42D
M/ME)YBDF7EG=5B6Z.<)\J)S 35MG/X/[TW:>&1SX@->N4\*%@0[A,(!>)E/
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M#N\HN2!46%X\.%/CW&Y'&%*>@ MK5>U+M#BW>%EW.A=: CC'\RLPH<;"8JA
M,59-OS95TZ\(H?BP5%3- (96I(&W<LA);9._X'N#UU;SO@IY_E1&,QX:E0-B
M<IR+!=M$$?2NR\5Y0F;,CVY (YJZDEALOY"9B04+A4M?1V!(?H"AWGRX_LNW
M_']OWE6O5]G-Q^N/W]#\WKU^=Z6UJ*'0W&UAFS3+AHL.R'7M6TV_\F*3Y<DA
ML6:/D]$TQ&IVVN\A6O<#^%#OSM,$HO(>(^I50 \0!>T:/IW TY4I H-ZW(]:
M+^!$:TJ @^X@"&GKQ!4)5:0*/&DF-76<P]F2Q1I\P;LLJOH^[R.?X:&Q(UVX
MU%=]G8VV,#>"PXDFGNJG4=AY8'.TCZ5+9EG::9AD+JC5F)CCPO0^5GL%W;8-
M*2<L_R$+="U5^V'0J7*45"FCCR6FTQ$I)NL822K>&BR!B?+J7H(4!#H>5!B:
M2MA2G)\4J^<$31FA13K0XLJ0#5.;-X(UDL@W0/0^Q(=4BX59]W:+;G>+W&>4
M,&EHL2155UYBF<^)>2UX^ R/UJ=)C3.CE@1$;)5,<@Y3 I(0W3#C,+1)&3/[
M@'BF>,"TIY)24HSADHD0PU,DF=XI#Y\G)2<NA9RQ_DJ!FC HPV,!30O7J7)R
M Z1J&XQT6'G,KS#AZ>IP<"72BVB'>2?*:YBT!CP7Y+32@L EO&%TR""MZ&5;
M]I$RVQS#+LZQG=?&R8M'B>I^BL^(<4JO/D'CQ6>)/K"AHSV(8<GWC[]?91_;
M(T2^]*?>39OQ*GC&')O1(7?T-\W11GPL'%5,O:-@6GTXT$1H'GEW,A:$+5RG
MH6@)2]H!#^MD.W"#*5K!\AVL-UI)?9R T.*OTTEE'S8+ RIFTEC6A:%;?Q)X
M4&H7B.VH6E'+ [DN#PWDY,V4T8SUOQ278_T+&'5"90,JKBO5TW;!NR!O)=:I
M> OU\<U(9/67"F N.B:K>V0)&^J5^Z3D;8OK\;T[^J?9@^KAN((ZXC.TJ0_\
MPZ@?=3N>P8.+3R[OBY$5CH78M$G&.V 5QD<^,Q:*;(+BQX,H-#V8GRUTG F3
MJ#@-[[U]J&>4S#(F=X8*GJ67XFH>P%B=$2&SU<34#W![,4-C]@G/S7DZH4$E
MZ//CIR:C;5 WL:\ARO#67>*F<J&8A%TJEBQ.E"U04"QD683GJ5H&"P XI6;E
M@Y^D^VH)O";2,",+^)S"D,$<*@=1Q7W@@U#8M8*5%:. N?I79"")^:=3#/PE
M ](&S+(G#=%Z%^WK A^P7S(.8WEG+3>;>= 2$<EJBC[=9X*LC(+,HXXDW9)D
MV68XEDYN^7 "KXS0:D 4YI<QY=:%^S!-*_Q;4L$*NB(A?96B:6S[K79+-XM
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MHEB:*Y["ZAPVFN$RI.'(*H"E?@Q/*7G"MNL%;/.D[G&\/9@/=1+#!<H \8$
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MLM:$9A<N5.=-Y+BP2;DQBG8Y^9G%!\85?&%UBW")3+<*Z<:-G@6&P*U)4.R
MSCJ@>  HBN%2"E-I>"]6N'H*$!"KGEK\0.TL?A7Q HLC2"(?XC".7\%+^E 3
MAY?\.-0+KHM:VF@U_'VZU$91=?SS4M =9/HRI.V88[UA!<X]:@F-Z@Z]Q;LW
MT3@\>85PVA-.7T/_F=R\#O2G- C)$0P PJ<*H90U-2@7:S!L62.X>.PF%UWK
MNQY:4E^#(?-SV6R8N'_W9A)'^8F&D@LF"LYJ8%HCN37= 2M@!DI[[IT[UX)0
M,Q>M4O8L:BBN@8D5';/B!3.4$ M?XQW6($LG[+E7'!53174/K>$U_Y?PC:0N
M-*BH.9!F2U'MV1.TMBA42M@L4?7EY(X\U$;P"Q=THFPU;>M?CT=#%\;,Z*-C
M&$'WC7??!#Y)P^K1J;N$X]$YTQ7@UY83'>LYHA[!>VI@=4L#MVR)Q5O(0C_+
M(EJXVXQ/GJRZS=&E\W"9T?;VN.&H?;#W2+BCSS=@E&-(:LA3/TRS'N3AVZFM
M[5K>H1(V%J#)2WDCIP>K* []=)P?RJ-SJ392489@*>EV'O?3U(^SZ:$\Q%A(
M\=O+K*.I/PG39ZP[]8]89Q-_G"4'XB#G//$G>70@CJZ1!@$O#!558?,V]J,D
M['Y'+JV4CLCF@[1O(9GF%&?X-%EI[N>3\'^JFS3QHTD\4#?=YL_5332>^NDD
M>IZ"3C^4@R3VHSSLK3MQN%ZFL9]/HT/Y/]1+3N?$S\DZ]1!72E R?JR33ASD
M.@ZIC.(#\:4ZB<;/>#AM7S=)E-$5IK2*L\1/T^1IW8PG_C3.X:)U4]$.O7MD
M2@/:_]*!\64GEF]M%<+6_@A)UT-;ND1EYS9(!79>TP#<5=G12_]*P=[KH4&U
M=F\D#85LA>D>$KVV?X:==J^/1_/N#4<Y7'.A:7R7Y!H>Y9D'JGL7=8*1&_<6
M64I#+QNWK.@IB<H:T'XIZ:]J)]@#^L?IXCM02P,$%     @ "#I75@MLSL0C
M!0  7 X  !D   !X;"]W;W)K<VAE971S+W-H965T,3$N>&ULQ5?;;ALW$'WW
M5Q!*$23 6EKN1=IU; &VTZ!]2!'$=OM0](':'4F$N:1"<J6H7]\9KB0KCGQK
M4!3PA4MRSIPY')+#TY6QMVX.X-G71FEWUIM[OS@9#%PUAT:XOEF QI&IL8WP
M^&EG [>P(.I@U*A!$L?#02.D[HU/0]\G.SXUK5=2PR?+7-LTPJXO0)G568_W
MMAV?Y6SNJ6,P/EV(&5R!OUE\LO@UV*'4L@'MI-',PO2L=\Y/+C*:'R;\+F'E
M]MJ,(ID8<TL?O]9GO9@(@8+*$X+ ?TNX!*4("&E\V6#V=B[)<+^]1?\08L=8
M)L+!I5%_R-K/SWI%C]4P%:WRG\WJ%]C$DQ->990+?]FJFYNF/5:USIMF8XP,
M&JF[_^+K1H<]@R)^P"#9&"2!=^<HL'POO!B?6K-BEF8C&C5"J,$:R4E-BW+E
M+8Y*M//CC\+>@A<3!>P*JM9*+\&=#CQ"TX1!M8&YZ&"2!V!XPCX:[>>._:QK
MJ+\%&""G';%D2^PB>13Q/51]EO*()7&2/(*7[@)- U[ZDD#9G^<3YRVFQE^'
M8NX0L\.(M%U.W$)4<-;#_># +J$W?OV*#^-WC_#-=GRSQ]"?OS"/P_QF/+"L
MSPZ'?ST'-C4*=Z;4,]8-=]M3_HW#'H?%4DA% \=X AP[@3-JF'CF[E#FH&HF
M/,,E@V8"=K=L3.B:&CPTWDB-B*9U^.'>GAR]!U=9N0B;\[PQUJ//FMUH/%O4
M_>8'(>W1=_A'-_VK/O,XR[5VO4_I)U9F49D7V$CQ]PWC$>><O:6!-"KR^.CF
MBLW,$JS&$\8S/']T]0T"+^*H'(Y8D@?K8I2B-1^5B%,>71J[,%:@M'L621+3
M8&>11#'/T"+A1<33^.C:>*'0>U8.HSC+L)5WQ)!F601B6<FCN"Q_7!?^F"Z\
M&$:C.,;6ZU=%PI-W'8L\4*#!89X_*0[*,,Q'.P04*.D <"!/DP?TR=.H3$K&
MR5]!,5-/EB4[<7)4,"F&1"2P&N:=,CE'?VAY[IB9?I]F44C42],LA%YWV<BS
M<M^UGV-ZSD7-)@":81X*S=H[%95QCBV,DT%SS'.FP 4KC9&QICO95M+/R5#,
M9A9F%-P4U6=+H5H@7IAJ:=PO\916"G'Z#]#EA^CR]'^@F_.\GSU%]Y"ZZ?"'
MV"(?I&-?3I@CX?B%^M:R9MH@04.'E%[_!\P?E.Y;Y02M<['OOXOX0!H5_6(;
MYG92A:[HHFIQIV Q0A!KFGYHZ>FT+?@S//$\Z:?/]?2RX.^G.48_*I\3?)G=
M)>6_#3X=/2?X).\G/QK\]5Z,0. XR^T[I[0QJ(0])M-C#PV=C'@J2S22E@Y8
M%^K*FB&++ZW07GI!I6J(!#O4]GN*O(QU41A HD[68-&.=*ZAHJN?DK@)5_TF
M4G)/X[S(]UD]D>OBP:/ X%YA"RNI1%!KO/6]E9.VJQQPD%SAK\;2U5JZ.P!Y
MFD96@?.&&7;5P<\]_31($@K)>< 2@?"P?%<$Z"BR)3C?Z:4Q*D2I5%MOM['$
M'X?+8N%8R5M0ZTYOVOIA?#\95[CFF)%+V'?18&2H%N!3HZ*[+RP[]F/25,+:
M-55(0=-[K(5R)(J20'@;*L$#*K75!<MT>H>P":8"R:<KN< ,(U$H6BP?\9IM
M3$O!U;ALB++-OOZA8G*P5_$W8&?A7>/0#2)TQ?^N=_=T.N]>#'?3NW<75H8S
MJ1WNI2F:QOU1WF.V>\MT']XLPOL!N>-K)#3G^/P#2Q-P?&JPQMQ\D(/=@W+\
M#U!+ P04    "  (.E=6J>?/J[ 9   (80  &0   'AL+W=O<FMS:&5E=',O
M<VAE970Q,BYX;6SM/=ERV\BU[_Z*+F5N2JXB99(2)7FMDL=)W;G)C%U>DN<F
MT!1A@P &#4AFOCYGZT9CE2S/5.5.Y64L8ND^^]Z8%[=Y^<7NC*G4UWV:V9='
MNZHJGCUY8J.=V6M[DA<F@SO;O-SK"GZ6UT]L41H=TTO[],EJL3A_LM=)=O3J
M!5U[5[YZD==5FF3F7:ELO=_K\O#:I/GMRZ/ED;OP/KG>57CAR:L7A;XV'TSU
MJ7A7PJ\G?I4XV9O,)GFF2K-]>72U?/;Z#)^G!_Z1F%L;_*T0DTV>?\$?/\4O
MCQ8(D$E-5.$*&OZY,3^:-,6% (Q?9<TCOR6^&/[M5O\KX0ZX;+0U/^;I/Y.X
MVKT\NCQ2L=GJ.JW>Y[?_:P2?-:X7Y:FE_ZI;?A8NJZBV5;Z7EP&"?9+QO_JK
MT"%XX7(Q\L)*7E@1W+P10?E&5_K5BS*_524^#:OA'X0JO0W )1DRY4-5PMT$
MWJM> 3:IWN2E1AK9%T\J6!/O/(GD_=?\_FKD_>5*_9QGU<ZJOV2QB=L+/ %@
M/$0K!]'KU>2*;TQTHDZ7,[5:K%83ZYUZ#$]IO;.1]3[F11*I\\7Y$'*3KZ)"
M/+.%CLS+(Y!X:\H;<_3JSW]:GB^>3P!VY@$[FP3L;M)/OC\,W2]Y9=3Z1+47
M5Q]TEF^3]E5U598ZNS:@8I6ZNBX-__71E'NKWF;J_^KTH"Z(#XN9JG8&7M\7
M.CLH>,R4)E9)5N5*JZBUJG8KS51>TFNR^55SXS:I=G(95LYAA7EL;L!"%"HN
MZVL5Z2Q.8ET9J^*D! 6&S>"QZC97FR1/\^LDTJFJ='EMP"2I3R!Z8UN%<%\#
MOK*4/*C1:*0QZ)Q1YFN4UA9LA$J3",R.P><$K!GH7%9OP8;4I5$ '8"\WYLR
M2G2:_,NHR)056$"5@EW$6T5>9[%5UR8S0!;8,J[+)+LF:-KD\OCI:UC 5NJG
M]U=_.R/:M;GUD;!5H!BX?9X!&'&<X"T@!>R6V"C-+6+'#P(T.FO=V"8FA3>W
MJK9F?(/5B?I01SM/A,0"91!3JS>I4<CA#@J\X7QSF ]=1Z,):^092)/>@N H
M6Y@H 6!B,&BI 1.7&6 B&-F <F-D00*&> ":P+68!$5?9SEL!0^!>ZJ8_1'P
M"Y@'=+IFH& 7T)8;N$F_M@H% VADP+3#J_!77H(T647@9$QAN$'2$2,/\RQ"
M$3P0'Y+]OL[RN;MVHM[5I:U!S$A>[Y1(( RH;@$[)$A<<+((093?F)+7!U@C
M4'R2=U1R70)K6/ZRN :7!@!I]6X'T*NE\H]6)0@F+:<K%$H@($I,;$ %4%>&
MR:L*4 !5%PP[  R\B[[ ;_<>L.F?J+H(,[R/SVUR^"V:.'/8#J'%BL0D:)0)
MX)_U]$D[WA1ECDB&]H!%2 ="%*S<")3*(V"]94L3@&LTT*\MIG[Q$_53YI5J
MIHH[.2E7;I,T9=OB'G7L!05LK$I>\+I C+=%-8>]* 2:_2;J5>V T02(* 3!
M4>(&"-1Q\EAM0;'4>O$_2%B\^2E+4 (^5&QG RI&N:TL<:V]H[!C0#LM6HS&
M\.#RNBC A!!2+85%9A\G (_=:;"EYM=:IV :Y*T,%H!MM@GL@D_B;[!>H)OX
M?B@D*/F_ WARNT6<CF DV[8W9/892U?;K'V8A 2P#8LLHP)^=)? O1H4S4/!
M>P%)(1@)-R(OF[$VB;,"KPLDV^=-> P( AI" B;+,#T^#NI#G8'V@;O099J@
M0X9((LG0_<T8*O.U ,ZPC NS4*R=ECM'01NB0B)/Z!UO$  O5>@#26F^2<6H
M6W1S(Q% SP*0+,B6C(@C$<B[O+W7AP9Z%A>_'E$;+X'A@ST+75:'/__I<K6\
M>&[A17@-3>^F)+;!DB" >0K^)J(-2*F$_@4\C-JV ZP,!&)=.1L%IH<CJVH&
MNR2PD7$;Z08>J[>F EF]\2CH^$;CLT69P*.W95(!-"H#:8@,F^10?.X!1)?0
M^-J(I045F@&$**2HQKR4)Z*VD"(6CN7>D21I AAL):AL^9,!YU&VG0Q;CT%@
M^DY"$U>3J$YUZ75-\(TH4""]_%JD>5)-X=D.7T,KQ.QIG%@!;,IC$H (L8V-
MK.7P[46G=B"<'5<##W^ADWC "-7%MH0\KE&NK?I!+=>+DP7ZU!0@:>N*6!D+
M 0"X&9/L-^ M,<8,Y+N)5QK;PGB[)SKA10"_Q"-E#G?V(!'JUN"&%JE3E;!@
MA[V-R\*W*0P_N_ +>-/D31^(.RJ&0A<$,J_VCB<9*"R "BK#(#C86KKI"-BE
MFM,:3Q"\:GLAGP'#E8AU!_$PR%4'V7 T(QN0$^3X#+AS<G8)Z1 QQWNU:V X
M&$6,[[?B'O9YB1H+F.$["_]*:5(24<&E1?%98^; C"4 DY.* 3B!5D YV!?T
MI<I+L3)V0&! 5J9P;]1X"'6']\4BD,HIQ']09XOFP6ET^0V4!MB//.]=!,#(
MQ.J4W#Y(^BY/XV] &90!,^@R/^C4*P:Y#"?S>;@%)NHHYB!N>P)J!_&%LG )
MEHUA^8H0HZN5,9BPV'KS6>P9F-EY^]FZN-4EQ$?QY]I63%ZDO^-#4D;UWE;H
M'P"GMYGZ!3*2_09T<[GFP@Q0S'3J )FZ@I5B#+M #=X#^RCS;2>9>.OODEEV
M7(>K!X@.N\4&J@?,*[E/01<$N@GFP3VG1"2_P;BH9Y4J*G0@0"T7@\RP; T
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M2U-#1WQZ:\\,/"7$#B;:95SN3[(;+.1X(T @H7$"':D,I43.+E I8_E\ ,7
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MR:S]'H52UM'O+916.P#?U4C]C,APF=1/!N+,8U)PWC.<OWZ 5 !V>0TW,M#
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M'#X ][=Y7KD?N('_GQ^\^C=02P,$%     @ "#I75J4VFD#& P  $@D  !D
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M5'$S"PUA6XLPW^%<=SC)&9PX@2]2F(V&]Z+ XB% 2$'UD27[R*Z39Q'?81Y
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MK#+_R6S_H6I_)J0O-9GCOV(;UL98G%;.F[P6A@6Y+L*OO*WCT!&810\()+5
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MDI.*@O+@##Z5:.<6=UIMP3BY*H$M41 P!G+VX+3X>#5RZ("VC40+=AO TF?
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M=M\P-V%T/VX/'T#8OS?8U5D):S2-AQ?3 3/AHR+<.%W[07ZE'7X6^,L"O\/
MT 9\OM8XVK4WY*#[LEO\!U!+ P04    "  (.E=6\MC&89$*  #N(0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6S56EN3V[85?M]?@5&:U)ZAM;Q*
ME"\[L[8WB3N39,?.93J=/D D)"$F"04@5][\^GX'("GJZK7;I.V+1(+ N9_O
MG$/I^4;I]V8E1,T^E$5E7HQ6=;U^>GEILI4HN1FKM:CP9*%TR6O<ZN6E66O!
M<WNH+"Y#WY]<EEQ6HZOG=NU67SU735W(2MQJ9IJRY/K^I2C4YL4H&'4+;^5R
M5=/"Y=7S-5^*=Z+^:7VK<7?94\EE*2HC5<6T6+P870=/7\:TWV[X68J-&5PS
MTF2NU'NZ>9._&/DDD"A$5A,%CJ\[\4H4!1&"&+^U-$<]2SHXO.ZH?VUUARYS
M;L0K5?PB\WKU8I2.6"X6O"GJMVKSK6CU28A>I@IC/]G&[8VC$<L:4ZNR/0P)
M2EFY;_ZAM</@0.J?.!"V!T(KMV-DI7S-:W[U7*L-T[0;U.C"JFI/0SA9D5/>
MU1I/)<[55S>_-;*^?_(2BN7LE2KA;,/)7L\O:Y"G39=92^JE(Q6>(!6$[#M5
MU2O#;JI<Y+L$+B%7+US8"?<R/$OQM<C&+ H\%OIA>(9>U"L;67K1"7KO5ER+
M5M=;?H_8JMFUUKQ:"GO]C^NYJ34"Y9_'M'>TX^.T*7F>FC7/Q(L1LL,(?2=&
M5U]]$4S\9V<DCWO)XW/4/\U-9TD=%_1[50L6!&-VDA%\$*3L7:VR]^R'M<NH
M*F??P'HUNRUXQ=Y4['MU)\JYT':SQ^J5L#1X=<]XKM:UR#U[2M:&&2*U4D4N
MM&%\O=8XF[LS'V7UB'9]]44:AOXSNYE6[7WP[+''-BN9K1A1E+DP#-!ER2Z)
M@*R63"T<=Z8L=6/)*VS13#C]YU9_ON$ZQ]/:'L^ER;2PXH  K;Q4>$XWKZ4&
MRB@H E:DK6GFF2I+6=="G-E=JZ&-_FJ8*->%NA?">-BXD!ELXX%QN[\U'K(+
M;LDI8C,D' 4L'HYA?;9HM%7#JFJ )47!Y@* D0O6X(C>VI=,-F;?JHVX$]K;
M77<'B;BL&D%B+N$=#<6;VM00@JSH3-49R7*$S8B]L*S&[$>GGOA0DZS#LYWA
MNU-'9&/(59;Q*@-B4V# BPLA:3-L;)VUD0:R"0U8Y+2^D?4*3*"P%>^#T)FT
M;H31-JHI\L&Q%;\3V"BHLM2-KDAR)ZTAD&!M9AP3S-FJ:FR@4RC1 >-V%O?$
MVC0(O]8NG0OX'9<%GQ?"AN.B =,V(G=XA/YAX+^!#2HJ7JW/'K*+LO&Z6:*
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MTN=K7[(PP?\N?+LIZ[9O:#TP-=P(8%/Z.X](6RG;-KDF'&?NT^XS6$XM#%:
M"(,MCL\11\*IJ8OS[&U8+V[SQ0_/VMGUPA$&>Z,!WB_H+SSEGIC>W>1E3[(
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MGLVR3/P"4=?IRS-[-"EE."5)3QR;AT90T@F<?3$-:X2TKG3FAIDC)AC*=\!
MWB*(D5,XP'C#'%W0DU>XH:VOKOT])S<ABL^#;$N.?C)( ,79(Q6-H%D.29!]
MC=)2S&2M_D&^#1 :TK1?2]9_ I!300\:I)KEA3@;14,0XH[.E0WI;SM9=/A&
MP<GFPO)BP9FJCGH[P-KR!(0Y5]$^1XNEQ<NZT[G0$L!<GUZ!<7YF%K-H>\>R
MM8OEJK/WMM;DE:DU>8EHT*3Y_4<&S-[/U;8P^J1IGF!"'7+2)63$M)U!_OVT
M 44.$N6F#8=&B86 *J<4@,(DH&'7Y&+1X0G)CZY'S9[:MUCS-!/CBWDW&Y=^
MCI"L_ !#O7Y_]1_?\O^\?NM?K;+K#U<?OJ'YO7WU]E+SW4.]C]L"[VB\%A<=
M8B!E6VL6 2\V61Z; J[:XV0TH+6:G/8[M\O;'@R[M\LT.99YA\##*H L"&$W
M%1>)\71EBG!J6MR/4G_ B9:4QP$"C?"_K1/[**2)*VJH"0&I-1]*_&9+H02L
M-)#XTG&(13X7RQ4Y[_)NF?GO_SK54A_IAS-=[=V<O 7R4&R'MJ6EFA44@CRP
MZ B148U30A66$B8M M1-C#)S,5 7LSB#S-^&^"FF]9%FOI+ZK3#H6&E(W)_1
MZP(34S#20%9#V-6E38D%,1?+92QB"0,9YO=E<83IG@&#8>7_WR5F@@R.U71]
MY>70BKV:AJ$X$%I$U)RJ+ET1HLYJI@RPL02L"-&G-KCTE/Z)J37U%CVE&L^F
MT9ND5$7Y^Z8XPUR^$Y_$X)0Q\E^>1B4>#,@3FK55,M%Q*]2'# XI\S2C]A29
MMB^(,X&],#K*8B==%GXR3GUXB^16Z_2$+Y.2$P2$G#')4M&^,"ACK &2#;]3
MLO8:2%57Z)RR:)U>87+<_.'@"J07T0[CNQ2R,Q$[>"](,:\YR',0T:#F+"TB
M8//C V60,.PP.\=Z6E<E'QXDA'1CD$]4=_KKQ7FV=)ACA=/%715*7#7[G@V<
MN<+)+Q_%.+7?/_E^E7VHCW[#_]2GB2]>!K^*/7MJ!8/>BFE'@*^%]@*I;1T,
MLS84 !,Z3;Z!C 5.+Z=F*=;&A_Z Q:W9#IPH\G51#&%^XTKR<26H(M[>%A-&
MVL WZ([S>8EII.CX=R>!NR5=B4X Y6IK.C+G :,E,_HR)3'$Z@="=3#?#JPO
MBC*$*(^N5*O3@VU*MFY,36LM=,T/(Y'5VMX GU-K"]TC2]A0K=$E*;9;7$_;
MN6/[8_;0/QK6CT1TCS;U8?LHBFK=CF?PXNR;\_MBCBU[TFR#2))+0+J,A[4P
M%DJ/)"H5JQ)I>C _FU@]X613,BP^>_-(JV?-,D9/AJ2]N8_B:A["6(TY0F:K
MB:D?XO9BQ-'L$]:9MU2?1@4XT^.GVJNN4$RR42AR^<:=X:9R8JHX[7HL^3A1
M]$LAU1 U%)ZG!#G,^>' M3T?_"8]5XK;/CH-$V<!WU,0.VAFY2"J-PI\$'(Y
M5["RS0!N\7_D#"2(T7B*@;]D0-J 2?:D(>K6154_PP=LO0U!$-Y9R\UF'K1$
MQ$&K39?N,P&>1D#F44:2;$FBQA,<2V6\;:@-+R(P'_"HZ66,N77F.4R&$/XM
M*$<-K:(0CDVQ6#9#K'1+-XL@1XPGVOBO=A5)ZLI^S'*>580<Y[8CB2>FPH:A
M(SHU),_ GK]Q P@*MWQVI\G@XWV3_!%Z:^[Y@?A[EJT?S6Q<.C.=&HN8S2-%
M6JHB+S%9M75EJ;GITFM@7I $J1U!FP39I'U+I>%H>K[2N=W(U%*V[9'U)S<N
M4/;@2P>BH'*FQBX R8G\65$4^"@!^?J4EUS2T.XU9#S,'AY/F.SL=M/X-<6W
M&_K<&AO]\<0GEC@X-4L4I7Q)3H&XD8TYF]H9J9;#=42;8\$,RHDVG+@QKWAL
M0YL@N1"LC\?R=36J=9B?)0;S \Z0)E,&^Y=-&M=A")=*&K#6@;!.3)S%J ["
M&IAJ@X_>^((K-7)CT!W'T'%,7)$JCE@5A[2XA6D2\$L:ZRP4P$IIYAAHVL9*
M4(PXE]I0K7*[NO-YJ.8+S622SU F;T5Q(,%)G&VO(BT2&,JQ+8@4FA#2R5)J
M@IK0L3VM3.+%"(%9B8H.0 )X@.0U:OD2E6Q6X)[%,*-K,*J%^?HYOHW>'!;?
M%.2?8)$!.MA=2,SEK26N ,>8HK#HMW4V47:6/08B6Q-HHJ8;).=\<J>$.EK%
M9DJ$[_EA-E$DZ]9J",>-M43$I[++5GFD5HT6YLV<J@%\9K9]2EHD2B9JY?2+
M"=VBBS$L9E2;*>2/W-^@EIJBY*L8VU(VI9C!UG]VQ> A;:HUEK[GD_4V) TM
M;>UI:&<%^33GC"V9H\9@8_YXJ-Z+<;-@PH:'B$,,/0=:2?/D)5Q.IQ-!9QKS
MI'/0?-XFICU)E27_H3-IZG=P TMY>4_Z/1TQ-UP=T3E6L0E7R7I>;R<-^?1
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MN_,(S4X&)$?^AO7%]88P[?QJPS.,9G+Z-&I9%L1;'\MA0W(9^1^1 <0$'*[
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MYJ:\E,&&03.LHD1MZLQ=/SO@9^7PBK*O37F5(/&O9N7A5Y"*\WYP2G]T#ZC
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M 5%^LO&"D2LW3<RDP=G$+6L<!D%9 ]Q?2&FV@CV@'R^G_P!02P,$%     @
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M=*7$U@WMHI/*8,Z://2X<]I_FA^Y4*-_\8\>QLLQ,1BE=]BY(TF_D#(-RZQ
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M36-4-H#V<RG-;F$/Z.9[\@=02P,$%     @ "#I75ID[9^]F!0  &0\  !D
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M]O/F5M-NU%DI1(72""5!X_)\<,%.+E,G[P6^"-R:WAI<) NEOKK-A^)\$#E
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M93(<TP&+AA-ZI</,'ZO\*U"\U#1-DY1HR.AXYH6.:#>#8Q*\16HI$J6%0A
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M" 7K55G%53=;[@]<X^XY$KD,;D-I#I3F0FD>E.:C:&V9-?:!I;</[I. ,Y6
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M/TEV[ P2!=+Y)='M?/K.T2<?G?&:BR>9 2CTFE,F)UZF5''N^S+.(,?RA!?
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M3%=B(,P"/9]RKC8=LT%3VTW_ E!+ P04    "  (.E=6D04HLG@&  "],
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M<Y87 NK[!\[ESX?B!OO^?RR,_P=02P,$%     @ "#I75A"5OQ:J @  \0D
M !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&ULK59=3]LP%/TK5C9-(#'R
MU6:#M9& %(T') 2"/4Q[<)/;UL*),]MIX=_OV@E9*X4F8[PD=GS.N;[GVK$G
M&R$?U0I DZ><%VKJK+0N3UU7I2O(J3H6)10XLA RIQJ[<NFJ4@+-+"GG;N!Y
MD9M35CCQQ'Z[D?%$5)JS FXD456>4_E\#EQLIH[OO'RX9<N5-A_<>%+2)=R!
MOB]O)/;<5B5C.12*B8)(6$R=,_]T%AF\!3PPV*BM-C&9S(5X-)VK;.IX9D+
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M+VB?K"\8=4>+TIZ@<Z'Q/+;-%=[)0!H CB^$T"\=<RBWM[SX#U!+ P04
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MMO"8M<.@["1.3K&U[#,0DY5,M :^+(\=#[>.-X)N\_.A.16")OGEAN E85F
M?+^B5#S=9$=.Y1'C^']02P,$%     @ "#I75@]\]P*J P  2PX  !D   !X
M;"]W;W)K<VAE971S+W-H965T,SDN>&ULQ5??;]LV$/Y7""T86J")?EFVG-D"
MG&3%^M A:-;M8=@#+9TM(A+ID93=#OOC=Z1D1;9ESPF*],46J;OC?=\=3W>3
MC9"/*@?0Y$M9<#5U<JU7UZZKTAQ*JJ[$"CB^60A94HU+N7352@+-K%)9N('G
M#=V2,NXD$[MW+Y.)J'3!.-Q+HJJRI/+K#11B,W5\9[OQB2US;3;<9+*B2W@
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MV@-I!/#]0@B]79@#VODQ^0]02P,$%     @ "#I75H$.<;[[$   8_(  !D
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M\C:N%_%&^7+X61\/'^\8C"9:/T(U"]5L5'.,@<NE38R%N3!.PXDVBU#-1[4
MU4)4BRA-#&?7+#+DS:*FDE]O/LLJ7WYK.@O'0-;!_$4YEX43;1.AFH5J-JHY
MK39_%$[SK:&?)A-M":&:CVH!JH6H%E&:F,RN3&3(RT0/0\+WX2R2;3K\=7.Y
M-#J-:(,(U6Q4<UI-V(L=.,9$FT&HYJ-:@&HAJD64)J:Q*QH9\E[+P$<YDO,_
MR+'1@43+1:AFHYJ#:BZJ>:CFHUJ :B&J190F!K<K'!FS5_*)#5I/0C4+U6Q4
M<U#-134/U7Q4"U M1+6(TL3,=YTE0]Y9LC?I^E"KJ/+[T=^'KYDK:;;<[%=I
MME96W6DBWM33K?>;N,J+GTI<OR\L![ZJ/GPDC#:?4,U"-1O5'&.@FC,;&D)&
M.TVHYJ-:@&HAJD64)@:Z*U(9\B)55T+<QFG69%>H#P_F$BU-H9J%:C:J.:CF
MHIJ':CZJ!<^\@DUEFV?5[= F)$17)*(T(:IFUY RY>=>NLJWNWQ?;T'%VL1#
M\_&RZSHJ7[-T^+PO\F6,#2^J6:AFHYJ#:BZJ>:CFHUJ :B&J190FYKEK/YGJ
MZSA^-M&F%*I9J&:CFH-J+JIYJ.:C6H!J(:I%E"9FOBM4F?)"U3_9V)"KHQ.,
MEJE0S48U!]5<5//,_B7<YG-S.CDID_CH4@-4"U$MHC0QFUV;RGS^XG=%F;0?
M"I>[33IXPC:Y,CJ+:'L*U6Q4<U#--?M=+/5TA,M#%^FC6H!J(:I%E"8&L6M.
MF?+FU&&#^-MU7":'T>)=<CCY2WVH>Y>453-$M:L/>//!UK%<'AU.M#V%:C:J
M.:CF/O/\3I\\DX6'KH>/:@&JA:@649J8V*Y19<H;59_OQXR;#W@>??@S&%&T
M4H5J%JK9J.:@FHMJ'JKYJ!:@6HAJD=FOR4V?^G*\V36JS.<:5<?-9'V,.3 T
M_.6P>YMF]:8URY+CE^R^I]6M>)H8)7XTVO3K'WF5*,;?7G:LBC:T4,U"-1O5
M'%1S4<U#-1_5 E0+42TR!ZYV:)KJ?'H2\?/R-DDJ*Z[BB_?;I%@G5\EF4]:)
MW&?UC,WHTL.]S??QZK< ]=VE=G;>NS]0WT5J<_]YQUR\W\7KY/>X6*=9J6R2
MFYJ<O)W5*U6DZ]N'7ZI\]^%,/5.N\ZK*MX>;MTF\2HIF@OK_;_+Z3:#]I5G
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MS$'"7"3, \$:,IML93;YV:G%=C)QOYY'Q^<36C_GRA )LY P&PESD# 7"?-
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M0F@LI+:9XU,'T@3@?":$WG3, MWC&?\%4$L#!!0    (  @Z5U9M*HD"F0(
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M7+)U8>9R^PD;/P/+E\I"NS=LF]C @W2MC2P;,"DHN:B_[+[)PQX@&CP!B!I
M="H@;@"Q,UHK<[9FS+!DK.06E(TF-MMPN7%H<L.%K>*-433+"6>2+T@YT/ >
M;NHR@ES"K?..&5QL4%$I88YV/7"Q A<.WU&5&IC(8,9U*M?"P)P9HGDS0\-X
MH=^.?4/B["_\M!%R60N)GA RP[0'<?@.HB"*.N#3T^'A(=RGE+1YB=J\1(XO
M/IZ77Q<+;12MM=]=CFJ*?C>%W7_GNF(I3CS:8!K5!KWD]:MP&'SL\O>?R [<
MQJW;^!A[\JVB0AM;X,+Z?D?[<U=Q-P"&*MZ5@>.T9_" 3&F(H93"Y!K"$63L
M07?9/\XT.HGIP'N_]=X_2GW%!1/I/W@_3ALUBH>-XB[/IS'T=YZC_G.>!ZWG
MP<OJG>WV,0UCE]F:+PP<H;T:-DG0"X/!V-_L.WHV[$#NL)4[?%F)GI4[[-(1
MC ;!_A,^$O\$Z.S#P?/(BK]W]MI[[RM3*RXT*5T22] [HY2H^BZI.T96[CA>
M2$.'NVOF=/VBL@$TOY32[#KVA&\O].0O4$L#!!0    (  @Z5U9T8\4!= ,
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M1%LRD]8<2YQ,.-LBKJ.5FVZ8VABURH94^B\N)5>C1.ED<I.FO($,?7A4ZT*
M0.=HJ59*UE! +$<'PZ=SD)A0\4X%WB_GZ/3D'3I!I$+?"]8(7&5B8DO%I=WM
MM&.X;1F\%QCFD%X@WSU#GN-Y(_+9Z^7N<[FMJM&7Q.M+XAD__Q\E^4+PBE B
M"8@S-&LXATJB7S<K(;E:?+_'\FR-@W%CO2&O18U3F%IJQPG@&["2MV_<R'D_
MEO5_,GM6 [^O@7_,/;E3CIBG!5)_5.V*C=KM=:GSAVXAC&7?6D;&4I\>F\2-
MKN)P8F^&:8U$A2JNCWK&&_2\P5'>!7[BC%*#6[?M<PX42\C&2%NS<,!PZ097
M>Z"'09'C^^.<8<\9'N?D+ >ACT!,40[C=0P/)G:O8G>/;B0H<.-QNJBGBX[2
M?9,%\#&BZ&"RP(GW@ YC_- ;YXE[GO@HSVXG'EMT\<%R\N+0\?;@1J*\84U;
M/'MPCNH[["OF:U()1"%7.N<B5MGQ]EYH.Y+5YFA=,:D.:M,LU%4*7 >H\9PQ
MN>OHT[J_G)._4$L#!!0    (  @Z5U:8'PF/7@(  "\'   9    >&PO=V]R
M:W-H965T<R]S:&5E=#4P+GAM;*U576_:,!3]*Y8W3:VT-2&AW<0@4DLT#8EI
MJ%6WAVD/)KD0J_[(; /MO]^U$R*8H..!%^)KGW.X]]B^'FZT>;(5@"//4B@[
MHI5S]2"*;%&!9/9*UZ!P9:&-9 Y#LXQL;8"5@21%E,3Q32095S0;AKF9R89Z
MY017,#/$KJ1DYN4.A-Z,:(]N)^[YLG)^(LJ&-5O" [C'>F8PBCJ5DDM0EFM%
M#"Q&]+8WR/L>'P _.&SLSICX2N9:/_E@4HYH[!," 87S"@P_:QB#$%X(T_C3
M:M+N+SUQ=[Q5_Q)JQUKFS,)8BY^\=-6(?J*DA 5;"7>O-U^AK>?:ZQ5:V/!+
M-BTVIJ186:=E2\8,)%?-ESVW/NP0>OTCA*0E)*<2TI:0GDKHMX1@==24$GS(
MF6/9T.@-,1Z-:GX0S QL+)\KO^T/SN J1Y[+OKL*#!EK*;G#W726,%5BK!Q7
M2U %!TL^D-NRY'Z;F" 3U9PUOVD7.3C&A;U$R.-#3B[>7@XCAUEY[:AH,[AK
M,DB.9)!#<472WGN2Q$ER@#X^G=X[0,]/I\?[] BM[/Q,.C^3H-<_HC=1)4C%
M%QQ*,F/&H7^'+'E5Q%_U@:U9 2.*=]F"60/-WKWIW<2?#QET3K'\3&)[YJ6=
M>6E03X^8-]76_G/V?DT10R8.I/U]R,CTG$:>4RP_D]B>D?W.R/ZKIW#*V9P+
M[D\?=M;"K* \9%XC<A-$_/NPSO *K'<=^2\B?PW1Y![M="?_E'QC9LF5)0(6
MR(FO/EY38IKVW 1.UZ%AS;7#]A>&%;YH8#P UQ=:NVW@>V#W1F9_ 5!+ P04
M    "  (.E=6#-8Y/>X*  #3B@  &0   'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6R]W>UOXL@!!O!_Q:*GZD[:#7['I E2@N>MZE;1YK;]4/6#%R;!6K Y
MVR1[I_[QM<'!##83O'ER]^$V$,]O'/($G'EB<_6<9M_RA92%\7VU3/+KP:(H
MUI?#83Y;R%647Z1KF92?>4BS5524-[/'8;[.9#3?#EHMA[9I^L-5%">#R=7V
MOKML<I5NBF6<R+O,R#>K593]?BN7Z?/UP!J\W/$Y?EP4U1W#R=4Z>I3WLOBR
MOLO*6\.],H]7,LGC-#$R^7 ]N+$NA6=6 [9;_"N6S_G!QT;UI7Q-TV_5#3&_
M'IC5'LFEG!45$97_/,FI7"XKJ=R/WVITL)^S&GCX\8M.MU]\^<5\C7(Y39?_
MCN?%XGH0#(RY?(@VR^)S^LQE_05YE3=+E_GV_\9SO:TY,&:;O$A7]>!R#U9Q
MLOLW^EX_$ <#+/?$ +L>8!\/\$X,<.H!SKDSN/4 ]WB ?V* 5P_PSIW!KP?X
MYPX8U0-&YPX(Z@'!N0/&]8#Q-@Z[[]_VFQ]&132YRM)G(ZNV+K7J@VV"MJ/+
M[WF<5&&_+[+RLW$YKIA,T^1)9D7\=2F-NS)G,LODW+@OTMDWXZ-Q,Y_'52:C
MI2&2W4]6E="?0UE$\3+_I=SDRWUH_/S3+\9/QM#(%U$F<R-.C"])7.0?RCO+
MCW]=I)L\2N;YU; H][B:=SBK]VZZVSO[Q-Y9QJ<T*1:Y09*YG'>,)Z^,MS7
ML'RH]H^7_?)XW=I:\6;S>&'8W@?#-FVSZPO2#_\491>&8YT<'NJ'_SU*M,.)
M?G@H9_OA=L=P>OYPJV,X.W]XU\[S<QYY]^1P<?;LUE@3!&?_@^-L/>>$]ZM<
MK=.L?'TPR&^;N/C=^,\_RBT,4<A5_M^.W;O=<6XW5[VF7>;K:":O!^6+5BZS
M)SF8_/4OEF_^K2ME2"Q$8@2)423&D!A'8@*$*3EV]SEV=?ID]U0?Y_DF2F;2
MF*5YT?5$?:M5^L87B85(C" QNL/\+58==3Y-+-\V1U?#I\-<=FPU,DU'W8HC
M=TR ,"5PWCYPGC9PH92K\A!C'C_%<YG,C8<L71GR^VP1)8_22!_*"#:').O]
M(4E>Y;0KF-K9^@83B85(C'BME)AJ0NAN"^_T%JQMC$WO:"..W&L!PI2@^?N@
M^=J@3=/5JCQ8O3\5'.WHOL%!8B$2(TB,(C&&Q#@2$R!,B>UH']L1]L!RA,PQ
M$@N1&$%B%(DQ),:1F !A2HZ#?8Z#5YY^JY?Q[:)8^:*^??G^L%\A* \WR]?T
MJ'SY3S=%7I0?Q,EC5[B#UHN:9[K.V!M[ZLO65+LS?8.+Q @2HTB,(3&.Q 0(
M4X([W@=W?$9P.Y?$NA*JQ?H^_2*Q$(D1)$:1&$-B'(D)$*:DV#*;E5T3>R!1
M>Z H0[40JA&H1J$:@VH<J@F4IB;ZH*NP?O29^8,1;8I%FL5_=/8$MWJY=[:1
M6@C5"%2C4(U!-5YKRL&A[0;.* C4@T.!FE?-K=WDUCX[MT<K6A^,=909:5;>
MBHKRSJ=HN2DWDMGN4+DSRMK)>D<9J850C4 U"M485..U-CI<O+LP3=,Z#C)H
M5C7(3>=E::L(_1/P[I>ZSL1"NR^H%D(U M4H5&.UIED@YM )!4I3P]H46Y:^
MV?KG9O6U?!Y-'PZ><W=M5]TPE+>+M+RQ728^V2_4LQP^;([EVY[GN$=+$/K]
MZ1U,:*\%U2A48U"-0S6!TM0,-UV9I2_+M$^XKRR=Z>G>S[K0:@RJ$:A&H1JS
M7JWE.'1"@=+4Q#:EFZ5OW>YE%LO<N)=E3GNNI.GEWH&%5G)0C4 U"M485.-0
M3: T-=M-,V>!JSD+VLU!M1"J$:A&H1J#:ARJ"92F)KKIZ*QS2KH?6U%#%CY3
MJ!9"-0+5*%1C4(U;[;K5,;?_':]#O$=!9S4-G?7#%=WKA\70P@ZJA5"-0#4*
MU1A4XU!-U)KNIT ]=Z"IY&QM0?)R<'S3]\A8S_;-+%0+H1J!:A2J,:C&H9I
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M3_<-+50+H1J!:A2J,:C&H9JHM:/E97OD!2<Z9Z>IYAS]27,OZVH?K>Z5M<[
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M+W=O<FMS:&5E=',O<VAE970U,BYX;6S%7%UOXS86_2N$VRTZ0":6*,F6ITF
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M*@AW@ZUSZ@YGCR:SQ>DB&#IM;!:>>J/0_1;RU57ZU;4+V"]%Q>)R6:3_$Y%
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M ]3[!6/R_48[J,YZ)_\#4$L#!!0    (  @Z5U:L? Z\500  %D9   9
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MF33_9&=CAQ@<;Z3B>07&#')6V"=]K7PX @3]"X"@ @3G@,$%0+<"=,\!W0N
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M<,,(6^!M1_'2E+PE5UA 33/%.Q$('8#O5YRK0T=/4-^RPC]02P,$%     @
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M,$1$>W&5P$KAL!"J^KF?N>-A.)8+9W^*HCL,ND/':8Z*NJ..(QJ!#^O A]K
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MK<[?EHK$%] N!:@K0EVB^:[0ZH22BE!B?2 _P[+,%MX+/(SU:DZA#=A;S@_
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MPV_0"IH9OIQ3:7_1H;4-/93OI.)5"]8>5(0U__BE#<01($K. .(6$/<!TS.
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MV./9QPK[=I &@.^70NB7@?E _Y_ [#]02P,$%     @ "#I75LJ$"."  P
M.@X  !D   !X;"]W;W)K<VAE971S+W-H965T-C(N>&ULS5==;Z,X%/TK%BN-
M=J5M^0R0;A*I+1W-2/,1->K,PVH?'+@$JX!9VR2=?S^V(30D).I(/,Q+L)U[
M#O>>ZXM]9SO*GGD&(-!+D9=\;F1"5#>FR>,,"LRO:06E_">EK,!"3MG&Y!4#
MG&A0D9N.9?EF@4EI+&9Z;<D6,UJ+G)2P9(C718'9CSO(Z6YNV,9^X9%L,J$6
MS,6LPAM8@7BJEDS.S(XE(064G- 2,4CGQJU]$]F6 FB+;P1V_&",5"AK2I_5
MY&,R-RSE$>00"T6!Y6,+]Y#GBDGZ\7]+:G3O5,##\9[]O0Y>!K/&'.YI_ITD
M(IL;H8$22'&=BT>Z^P!M0!/%%].<ZU^T:VTM \4U%[1HP=*#@I3-$[^T0AP
M;/\,P&D!SC' .P-P6X#[5H#7 CRM3!.*UB'" B]FC.X04]:230VTF!HMPR>E
MROM*,/DOD3BQ^"*WUB?*.:J H56&&: KM)*[*ZES0#1%$<EK 0GJ#)>=X:T0
MC*QK@=?25%!T3XM"IG(E:/R<T3P!QM%M*<C5GN,A366ZT9\1"$SRO^2;N"+B
M,U/(4)1#9MRZ?=>X[9QQVW;09UJ*C*.',H&D3V!*#3HAG+T0=\Y%Q@CB:^3:
M?R/'<IP!A^[?#K<'X-';X=:%:-PNK:[F<\_P*=D3I;HL*K2"N&9$$)!JO<1Y
M+05#[QDM5,(JF3Y=@%]3](!92<K-88K__22)T4<!!?]O*$N-%]ZP%^J;=<,K
M',/<D!\E#FP+QN+='[9O_3.D\)ADT4AD/?6]3GWO$KM6_ZJ3GZMZ&!*O(9EH
M$O5]WBX"RYW:KMQ^VT-=3NU\)_"G3M"WBT[M;']J6T[8V?6BF7313"Y&\U1N
M@:OR?90/1F(U7)V+Z2+5KVZ(,<FBD<AZ$OJ=A/YO48[^F.J/21:-1-93/^C4
M#\8HQ^"D?)S0#CWWJ!I/S=P@\"9'M7AJ9=N6;7G#I1AVD807(_E:J<W!U6&[
MK%F<R0M/[]0="NLBXZ_NB3')HI'(>DI..R6GOT5%3L=4?TRR:"2RGOJV]7KM
MM,:HR9:E=_8%D\ )IT=5.63HR,,T/#I,HP%#>Q):4^>X-,V#2W4!;*.;$XYB
M6I>BN59VJUT#=*NO_4?K=ZHQTI?U5YJFJ_J,V8;(<LXAE936=2"]8DVCTDP$
MK?35?4V%; 3T,)/-'3!E(/]/*17[B7I!URXN?@)02P,$%     @ "#I75JP6
M;%5# P  TA0   T   !X;"]S='EL97,N>&ULW5AM3]LP$/XKD1D32!-I&TB;
MT5;:*B%-VB8D^+!OR&V<UI+C9([+6GX]/CM-7_!5'1\&72J(?8_ON>?.E\;0
MK_12L+L98SI8Y$)6 S+3NOP<AM5DQG):710EDP;)"I53;:9J&E:E8C2MP"D7
M8:?5BL.<<DF&?3G/;W)=!9-B+O6 =!M3X&[?T@%IQY<D<'2C(F4#\G#V\?>\
MT-<? G<_^71RTGHXO]ZUGUG@G(1>TJL#2"]:YD*9+8K1QX?1[R/'J+O;U%M*
M#U#6\[N?;GJ?8L[)06GMR0HA[K8\JM:2G)ZP;I=A/RODNFLBX@R&E^8L>*1B
M0$94\+'BX)71G(NE,W? ,"E$H0)MVM4$:H.E>G)PV\V@DVN>G,M"V=@N@OL]
MKI?O *L9".1"- ([Q!F&_9)JS92\,1.[V!I?0$$]OE^61N%4T66[<T76#O9F
M@HP+E3+5A&F3E6G8%RP#.8I/9W#711D"J'61FT'*Z;20U&I8>=0#0SMA0MS!
M8_XKV^)>9!L[9O=+-D,CJ!XZ&C<!_DTVQ[U)>_DJWJ#DCX7^.C?I2#N'%F.W
MBF5\8>>+K!& L;=Q=EJ68OE%\*G,F4O^X(##/EWY!;-"\2<3#5IE8@Q,D>"1
M*<TGFY8_BI;W;*%7[;3(<,V=(]3\;^L\99(I*C9%F]Y_SU5^M>*H^U:2[;?*
MKF"OQOK=_=Y%7AV#R/@81!Y%3_:.061R!"*[;_:M>;C(Z'T6,JQ/0AO'K:W#
M5F,-X% [(#_A<"S608/QG O-93V;\31E\L69R]!K.C9_L&WQF_4IR^A<Z/L&
M')#U^ =+^3Q/FE6W4(AZU7K\'=)KQ\V)VL3B,F4+EH[JJ9J.[3 P Q.UOL!A
M%[FQEQ_!?!SF1P##XF *,!_GA<7YG_+IH?DX#-/6\R(]U*>'^C@O'S*R'RR.
MWR<QES_3)(FB.,8J.AIY%8RPNL4Q_/C9,&W@@<6!2']7:WRW\0[9WP?8GN[K
M$"Q3O!.Q3/%: ^*O&W@DB7^WL3C@@>T"UCL0WQ\'>LKO$T6PJY@V[ G&D23!
M$.A%?X_&,5*=&#[^_<&>DBA*$C\"F%]!%&$(/(TX@BD #1@21?8]N/,^"E?O
MJ7#]7\SA,U!+ P04    "  (.E=6EXJ[',     3 @  "P   %]R96QS+RYR
M96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY
M/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL
M/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%
MY4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.
MW&,EC'%BM/XU@LD/['X 4$L#!!0    (  @Z5U;R[^IO]@0  $,I   /
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M7!OO%/[ZO.SN.@ N:D-WJ.&$.R];<#[($SBVE2[AWTMQ+"MI"B7:QO4(,"$
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M#7\RFKT!4$L! A0#%     @ "#I75@=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  (.E=6@^Z@E.X
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ "#I75B,\S!%" @
M$P8  !@              ("!NA<  'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;%!+ 0(4 Q0    (  @Z5U9MP7"J,P8  -$:   8              " @3(:
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    "  (.E=6KG -
M26D1  !4_0  &               @(&;(   >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&UL4$L! A0#%     @ "#I75J%F(-6. @  W 8  !@
M ("!.C(  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (  @Z
M5U9"BSBY$0L  (T[   8              " @?XT  !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6Q02P$"% ,4    "  (.E=6JG+-1RT,  "D(0  &
M        @(%%0   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%
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M+GAM;%!+ 0(4 Q0    (  @Z5U:E-II Q@,  !()   9              "
M@4N8  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ "#I7
M5O0*4XQ>"0  'QD  !D              ("!2)P  'AL+W=O<FMS:&5E=',O
M<VAE970Q-"YX;6Q02P$"% ,4    "  (.E=6NZ^7V:\"  #L!0  &0
M        @('=I0  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0
M   (  @Z5U:K*O9$ P4  /T+   9              " @<.H  !X;"]W;W)K
M<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ "#I75LQ<2+>"!0  Y0T
M !D              ("!_:T  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"% ,4    "  (.E=6\MC&89$*  #N(0  &0              @(&VLP
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (  @Z5U;ZN3?E
MWP(  +@&   9              " @7Z^  !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&UL4$L! A0#%     @ "#I75E?::;1W"P  +1\  !D
M ("!E,$  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  (
M.E=63C $N9X$  "Q"@  &0              @(%"S0  >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (  @Z5U8T%NFQ1#$  *BT   9
M          " @1?2  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#
M%     @ "#I75E1X[NK' @  (@8  !D              ("!D@,! 'AL+W=O
M<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  (.E=6,OIO;04$  !J
M"@  &0              @(&0!@$ >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM
M;%!+ 0(4 Q0    (  @Z5U:=>ED810,  'X'   9              " @<P*
M 0!X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ "#I75NMP
M1=1> P  J@<  !D              ("!2 X! 'AL+W=O<FMS:&5E=',O<VAE
M970R-BYX;6Q02P$"% ,4    "  (.E=6)H45!18#  "X!@  &0
M    @('=$0$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (
M  @Z5U:M\.R=WP0  !\-   9              " @2H5 0!X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L! A0#%     @ "#I75A][^>.X @  ZP4  !D
M             ("!0!H! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"
M% ,4    "  (.E=6F3MG[V8%   9#P  &0              @($O'0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (  @Z5U;Z\F1AJ00
M +<*   9              " @<PB 0!X;"]W;W)K<VAE971S+W-H965T,S$N
M>&UL4$L! A0#%     @ "#I75E8^2O;K P  V0@  !D              ("!
MK"<! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  (.E=6
M1.1LWI4*  "M80  &0              @('.*P$ >&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+ 0(4 Q0    (  @Z5U:[Z'Y\A 0  !X:   9
M      " @9HV 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%
M  @ "#I75IS"8T@X P  YPT  !D              ("!53L! 'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    "  (.E=6D04HLG@&  "],
M&0              @('$/@$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+
M 0(4 Q0    (  @Z5U80E;\6J@(  /$)   9              " @7-% 0!X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ "#I75OHWNT-$
M!   ;A0  !D              ("!5$@! 'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6Q02P$"% ,4    "  (.E=6#WSW JH#  !+#@  &0
M@('/3 $ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (  @Z
M5U:!#G&^^Q   &/R   9              " @;!0 0!X;"]W;W)K<VAE971S
M+W-H965T-# N>&UL4$L! A0#%     @ "#I75HO<VC&8!   $1D  !D
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M=#0U+GAM;%!+ 0(4 Q0    (  @Z5U8E-+,]K (  $@'   9
M  " @2!Z 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @
M"#I75FTJB0*9 @  W <  !D              ("! WT! 'AL+W=O<FMS:&5E
M=',O<VAE970T-RYX;6Q02P$"% ,4    "  (.E=6=&/% 70#   )#0  &0
M            @('3?P$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4
M Q0    (  @Z5U:6@90\O0(  *@'   9              " @7Z# 0!X;"]W
M;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ "#I75I@?"8]> @
M+P<  !D              ("!<H8! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX
M;6Q02P$"% ,4    "  (.E=6#-8Y/>X*  #3B@  &0              @($'
MB0$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    (  @Z5U;9
MCR=$-0H  .97   9              " @2R4 0!X;"]W;W)K<VAE971S+W-H
M965T-3(N>&UL4$L! A0#%     @ "#I75M3$#?&J!   ]Q4  !D
M     ("!F)X! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4
M"  (.E=6K'P.O%4$  !9&0  &0              @(%YHP$ >&PO=V]R:W-H
M965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (  @Z5U:5\;TG#0,  '$)   9
M              " @06H 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L!
M A0#%     @ "#I75O93/;$*!    14  !D              ("!2:L! 'AL
M+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    "  (.E=6-:6"A8,"
M  #&!P  &0              @(&*KP$ >&PO=V]R:W-H965T<R]S:&5E=#4W
M+GAM;%!+ 0(4 Q0    (  @Z5U:-D,5>- 4  '8@   9              "
M@42R 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ "#I7
M5EL0U0.: P  R P  !D              ("!K[<! 'AL+W=O<FMS:&5E=',O
M<VAE970U.2YX;6Q02P$"% ,4    "  (.E=6.RS3SO$#  !%#0  &0
M        @(& NP$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0
M   (  @Z5U;D4T&PH ,  !4,   9              " @:B_ 0!X;"]W;W)K
M<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ "#I75LJ$"."  P  .@X
M !D              ("!?\,! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q0
M2P$"% ,4    "  (.E=6K!9L54,#  #2%   #0              @ $VQP$
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (  @Z5U:7BKL<P    !,"   +
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4!08     1@!& "$3   "U0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>261</ContextCount>
  <ElementCount>409</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>77</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100080 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100090 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100100 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Description of Business and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Description of Business and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Collaborations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations</Role>
      <ShortName>Collaborations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Other Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingencies</Role>
      <ShortName>Other Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStock</Role>
      <ShortName>Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Equity-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensation</Role>
      <ShortName>Equity-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Net Loss per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecurities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Collaborations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsTables</Role>
      <ShortName>Collaborations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeases</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Equity-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables</Role>
      <ShortName>Equity-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensation</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Net Loss per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Description of Business and Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Life of Related Asset (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Estimated Useful Life of Related Asset (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Marketable Securities - Summary of Available-for-Sale Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails</Role>
      <ShortName>Marketable Securities - Summary of Available-for-Sale Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Marketable Securities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails</Role>
      <ShortName>Marketable Securities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Collaborations - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails</Role>
      <ShortName>Collaborations - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Collaborations - Change in Accounts Receivable, Contract Asset and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails</Role>
      <ShortName>Collaborations - Change in Accounts Receivable, Contract Asset and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment - Summary of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Property and Equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Leases - Components of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails</Role>
      <ShortName>Leases - Components of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Leases - Supplemental Cash Flow Information Relating to Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSupplementalCashFlowInformationRelatingToLeasesDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information Relating to Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Leases - Summary of Weighted Average Remaining Lease Terms and Discount Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesDetails</Role>
      <ShortName>Leases - Summary of Weighted Average Remaining Lease Terms and Discount Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Leases - Summary of Undiscounted Future Lease Payments for Operating and Finance Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails</Role>
      <ShortName>Leases - Summary of Undiscounted Future Lease Payments for Operating and Finance Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Other Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Other Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Convertible Preferred Stock - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails</Role>
      <ShortName>Convertible Preferred Stock - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Equity-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Equity-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Equity-Based Compensation - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Equity-Based Compensation - Summary of Equity-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Equity-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Equity-Based Compensation - Summary of Weighted-Average Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Weighted-Average Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Equity-Based Compensation - Summary of Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Income Taxes - Rate Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails</Role>
      <ShortName>Income Taxes - Rate Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Income Taxes - Schedule of Significant Components of Net Deferred Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Significant Components of Net Deferred Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100640 - Disclosure - Net Loss per Share - Summary of Basic and Diluted Loss Per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail</Role>
      <ShortName>Net Loss per Share - Summary of Basic and Diluted Loss Per Share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="kymr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100650 - Disclosure - Net Loss per Share - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders Anti-Diluted Effect (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail</Role>
      <ShortName>Net Loss per Share - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders Anti-Diluted Effect (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 20 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, kymr:FairValueAssetsLevel1ToLevel3TransfersAmount, kymr:FairValueAssetsLevel2ToLevel3TransfersAmount, kymr:FairValueAssetsLevel3ToLevel1TransfersAmount, kymr:FairValueAssetsLevel3ToLevel2TransfersAmount, kymr:LeaseCommencementDate, us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted, us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect, us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 -  kymr-20221231.htm 8</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="kymr-20221231.htm">kymr-20221231.htm</File>
    <File>kymr-20221231.xsd</File>
    <File>kymr-20221231_cal.xml</File>
    <File>kymr-20221231_def.xml</File>
    <File>kymr-20221231_lab.xml</File>
    <File>kymr-20221231_pre.xml</File>
    <File>kymr-ex10_10.htm</File>
    <File>kymr-ex10_12.htm</File>
    <File>kymr-ex10_13.htm</File>
    <File>kymr-ex10_3.htm</File>
    <File>kymr-ex21_1.htm</File>
    <File>kymr-ex23_1.htm</File>
    <File>kymr-ex31_1.htm</File>
    <File>kymr-ex31_2.htm</File>
    <File>kymr-ex32_1.htm</File>
    <File>kymr-ex32_2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img254193463_0.jpg</File>
    <File>img254193463_1.jpg</File>
    <File>img254193463_10.jpg</File>
    <File>img254193463_11.jpg</File>
    <File>img254193463_12.jpg</File>
    <File>img254193463_13.jpg</File>
    <File>img254193463_14.jpg</File>
    <File>img254193463_15.jpg</File>
    <File>img254193463_16.jpg</File>
    <File>img254193463_17.jpg</File>
    <File>img254193463_18.jpg</File>
    <File>img254193463_19.jpg</File>
    <File>img254193463_2.jpg</File>
    <File>img254193463_20.jpg</File>
    <File>img254193463_21.jpg</File>
    <File>img254193463_22.jpg</File>
    <File>img254193463_23.jpg</File>
    <File>img254193463_24.jpg</File>
    <File>img254193463_25.jpg</File>
    <File>img254193463_26.jpg</File>
    <File>img254193463_27.jpg</File>
    <File>img254193463_28.jpg</File>
    <File>img254193463_29.jpg</File>
    <File>img254193463_3.jpg</File>
    <File>img254193463_30.jpg</File>
    <File>img254193463_31.jpg</File>
    <File>img254193463_32.jpg</File>
    <File>img254193463_33.jpg</File>
    <File>img254193463_34.jpg</File>
    <File>img254193463_35.jpg</File>
    <File>img254193463_36.jpg</File>
    <File>img254193463_37.jpg</File>
    <File>img254193463_38.jpg</File>
    <File>img254193463_39.jpg</File>
    <File>img254193463_4.jpg</File>
    <File>img254193463_40.jpg</File>
    <File>img254193463_41.jpg</File>
    <File>img254193463_42.jpg</File>
    <File>img254193463_43.jpg</File>
    <File>img254193463_44.jpg</File>
    <File>img254193463_45.jpg</File>
    <File>img254193463_46.jpg</File>
    <File>img254193463_47.jpg</File>
    <File>img254193463_48.jpg</File>
    <File>img254193463_49.jpg</File>
    <File>img254193463_5.jpg</File>
    <File>img254193463_50.jpg</File>
    <File>img254193463_51.jpg</File>
    <File>img254193463_52.jpg</File>
    <File>img254193463_53.jpg</File>
    <File>img254193463_54.jpg</File>
    <File>img254193463_55.jpg</File>
    <File>img254193463_56.jpg</File>
    <File>img254193463_57.jpg</File>
    <File>img254193463_58.jpg</File>
    <File>img254193463_59.jpg</File>
    <File>img254193463_6.jpg</File>
    <File>img254193463_60.jpg</File>
    <File>img254193463_7.jpg</File>
    <File>img254193463_8.jpg</File>
    <File>img254193463_9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="818">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>162
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "kymr-20221231.htm": {
   "axisCustom": 1,
   "axisStandard": 25,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 818,
    "http://xbrl.sec.gov/dei/2022": 40
   },
   "contextCount": 261,
   "dts": {
    "calculationLink": {
     "local": [
      "kymr-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "kymr-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "kymr-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "kymr-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "kymr-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "kymr-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 652,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 12,
    "http://www.kymeratx.com/20221231": 13,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 30
   },
   "keyCustom": 86,
   "keyStandard": 323,
   "memberCustom": 36,
   "memberStandard": 37,
   "nsprefix": "kymr",
   "nsuri": "http://www.kymeratx.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Marketable Securities",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_4b0a689e-0b9b-43f2-8a8d-71565e0e91d0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Collaborations",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations",
     "shortName": "Collaborations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_4b0a689e-0b9b-43f2-8a8d-71565e0e91d0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Property and Equipment",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Accrued Expenses",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Other Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingencies",
     "shortName": "Other Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Convertible Preferred Stock",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStock",
     "shortName": "Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Equity-Based Compensation",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensation",
     "shortName": "Equity-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Related Party Transactions",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Net Loss per Share",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare",
     "shortName": "Net Loss per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "22",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kymr:SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kymr:SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Marketable Securities (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesTables",
     "shortName": "Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Collaborations (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsTables",
     "shortName": "Collaborations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Property and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Accrued Expenses (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Equity-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables",
     "shortName": "Equity-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Net Loss per Share (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables",
     "shortName": "Net Loss per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Description of Business and Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:InvestmentsAndCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "kymr:SegmentAndGeographicInformationPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "kymr:SegmentAndGeographicInformationPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Segment",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_ec1630b7-f419-4a11-a92d-8d8f0402646a",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Life of Related Asset (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails",
     "shortName": "Summary of Significant Accounting Policies - Summary of Estimated Useful Life of Related Asset (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_ec1630b7-f419-4a11-a92d-8d8f0402646a",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_b1c3605d-deb5-4fa5-a122-f271881338b2",
      "decimals": "-3",
      "lang": null,
      "name": "kymr:RestrictedCashFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "kymr:FairValueAssetsLevel1ToLevel3TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "kymr:FairValueAssetsLevel1ToLevel3TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Marketable Securities - Summary of Available-for-Sale Debt Securities (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails",
     "shortName": "Marketable Securities - Summary of Available-for-Sale Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Marketable Securities - Additional Information (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails",
     "shortName": "Marketable Securities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Security",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "kymr:CostReimbursementPaymentReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Collaborations - Additional Information (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
     "shortName": "Collaborations - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "kymr:CostReimbursementPaymentReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_cb4393fc-15bf-486a-9195-7df9d32c0b65",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Collaborations - Change in Accounts Receivable, Contract Asset and Liabilities (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails",
     "shortName": "Collaborations - Change in Accounts Receivable, Contract Asset and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_cb4393fc-15bf-486a-9195-7df9d32c0b65",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
     "shortName": "Property and Equipment - Summary of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Property and Equipment - Additional Information (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails",
     "shortName": "Property and Equipment - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_ce893baa-f44c-4ebb-a74e-bff63f53114a",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AreaOfRealEstateProperty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_sqft",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Leases - Additional Information (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails",
     "shortName": "Leases - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_ce893baa-f44c-4ebb-a74e-bff63f53114a",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AreaOfRealEstateProperty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_sqft",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Leases - Components of Lease Costs (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails",
     "shortName": "Leases - Components of Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "kymr:SupplementalCashFlowInformationRelatingToLeasesTableTextBlock",
       "div",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "kymr:OperatingLeasePaymentsProceeds",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - Leases - Supplemental Cash Flow Information Relating to Leases (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSupplementalCashFlowInformationRelatingToLeasesDetails",
     "shortName": "Leases - Supplemental Cash Flow Information Relating to Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "kymr:SupplementalCashFlowInformationRelatingToLeasesTableTextBlock",
       "div",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "kymr:OperatingLeasePaymentsProceeds",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "kymr:SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock",
       "div",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - Leases - Summary of Weighted Average Remaining Lease Terms and Discount Rates (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesDetails",
     "shortName": "Leases - Summary of Weighted Average Remaining Lease Terms and Discount Rates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "kymr:SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock",
       "div",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "kymr:LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Leases - Summary of Undiscounted Future Lease Payments for Operating and Finance Leases (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails",
     "shortName": "Leases - Summary of Undiscounted Future Lease Payments for Operating and Finance Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "kymr:LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "kymr:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "kymr:AccruedResearchAndDevelopmentExpensesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails",
     "shortName": "Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "kymr:AccruedResearchAndDevelopmentExpensesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_588fd5b5-72cb-4b8f-8a09-d3c8c62edc57",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100080 - Statement - Consolidated Statements of Stockholders' Equity",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_588fd5b5-72cb-4b8f-8a09-d3c8c62edc57",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e35141e7-840c-4c80-868b-75ce55213382",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - Other Commitments and Contingencies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails",
     "shortName": "Other Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e35141e7-840c-4c80-868b-75ce55213382",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_59d6e9e0-0e19-4721-b6a7-86fd777bb736",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - Convertible Preferred Stock - Additional Information (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
     "shortName": "Convertible Preferred Stock - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_59d6e9e0-0e19-4721-b6a7-86fd777bb736",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - Equity-Based Compensation - Additional Information (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
     "shortName": "Equity-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_61237bf4-e312-4023-95fa-e105e4b526af",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_d51bc1c7-aa3c-43cd-8c22-e7fed24f7dec",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - Equity-Based Compensation - Summary of Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails",
     "shortName": "Equity-Based Compensation - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_167de5a4-50cc-4901-9c67-4c426f16265e",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - Equity-Based Compensation - Summary of Equity-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails",
     "shortName": "Equity-Based Compensation - Summary of Equity-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - Equity-Based Compensation - Summary of Weighted-Average Assumptions (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsDetails",
     "shortName": "Equity-Based Compensation - Summary of Weighted-Average Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_7df38be4-2853-4015-a6b5-9f73bad5256f",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - Equity-Based Compensation - Summary of Restricted Stock Activity (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails",
     "shortName": "Equity-Based Compensation - Summary of Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_30b72286-d718-4d2a-a3d6-551f5e4bb3c8",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_da71e1e6-ad8b-46b6-a6cc-c239a69a2d15",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_da71e1e6-ad8b-46b6-a6cc-c239a69a2d15",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - Income Taxes - Additional Information (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - Income Taxes - Rate Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Tax Rate (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails",
     "shortName": "Income Taxes - Rate Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_32f933dd-dcf9-429f-8e2b-d1d801973ad5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100090 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical",
     "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_364f0411-8f1d-481d-848d-0b732287ee1b",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - Income Taxes - Schedule of Significant Components of Net Deferred Income Taxes (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails",
     "shortName": "Income Taxes - Schedule of Significant Components of Net Deferred Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_040be217-5d7c-4430-aeb6-a639e3672c4d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - Net Loss per Share - Summary of Basic and Diluted Loss Per Share (Detail)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail",
     "shortName": "Net Loss per Share - Summary of Basic and Diluted Loss Per Share (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100650 - Disclosure - Net Loss per Share - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders Anti-Diluted Effect (Detail)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail",
     "shortName": "Net Loss per Share - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders Anti-Diluted Effect (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100100 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Description of Business and Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies",
     "shortName": "Description of Business and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "kymr-20221231.htm",
      "contextRef": "C_e797a856-6bbd-4491-93c3-86302e550709",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 77,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r626",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r626",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r626",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r626",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "verboseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "verboseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.",
        "label": "Entity Listing, Par Value Per Share",
        "terseLabel": "Entity Listing, Par Value Per Share"
       }
      }
     },
     "localname": "EntityListingParValuePerShare",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r626",
      "r627",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "kymr_AccruedResearchAndDevelopmentExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expenses current.",
        "label": "Accrued Research And Development Expenses Current",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpensesCurrent",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_AccumulatedAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amortization.",
        "label": "Accumulated Amortization",
        "terseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "AccumulatedAmortization",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid in capital related to temporary equity deemed dividend.",
        "label": "Adjustments To Additional Paid In Capital Related To Temporary Equity Deemed Dividend",
        "negatedLabel": "Reduction of additional paid-in-capital related to temporary equity deemed dividend"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalRelatedToTemporaryEquityDeemedDividend",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_AssetsNotYetInServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets not yet in service.",
        "label": "Assets Not Yet In Service [Member]",
        "terseLabel": "Assets Not Yet in Service"
       }
      }
     },
     "localname": "AssetsNotYetInServiceMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_BaseRentAnnualIncreaseOverTheLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Base rent annual increase over the lease term.",
        "label": "Base Rent Annual Increase Over The Lease Term",
        "terseLabel": "Annual increase percentage of rent"
       }
      }
     },
     "localname": "BaseRentAnnualIncreaseOverTheLeaseTerm",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "kymr_BilledReceivablesSanofiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Billed receivables - Sanofi.",
        "label": "Billed Receivables Sanofi [Member]",
        "terseLabel": "Billed Receivables - Sanofi"
       }
      }
     },
     "localname": "BilledReceivablesSanofiMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_CambridgeMassachusettsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cambridge, Massachusetts.",
        "label": "Cambridge Massachusetts [Member]",
        "terseLabel": "Cambridge, Massachusetts"
       }
      }
     },
     "localname": "CambridgeMassachusettsMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_CollaborationAgreementTransactionPrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration agreement transaction price.",
        "label": "Collaboration Agreement Transaction Price",
        "terseLabel": "Collaboration agreement transaction price"
       }
      }
     },
     "localname": "CollaborationAgreementTransactionPrice",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_CollaborationRevenuesFromRelatedPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration revenue from related party.",
        "label": "Collaboration Revenues From Related Party [Member]"
       }
      }
     },
     "localname": "CollaborationRevenuesFromRelatedPartyMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_CollaborationTargetOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration target one.",
        "label": "Collaboration Target One [Member]",
        "terseLabel": "Collaboration Target 1"
       }
      }
     },
     "localname": "CollaborationTargetOneMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_CollaborationTargetTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration target two.",
        "label": "Collaboration Target Two [Member]",
        "terseLabel": "Collaboration Target 2"
       }
      }
     },
     "localname": "CollaborationTargetTwoMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_CollaborationTerminationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration termination date.",
        "label": "Collaboration Termination Date",
        "terseLabel": "Collaboration termination date"
       }
      }
     },
     "localname": "CollaborationTerminationDate",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "kymr_CommercialMilestonePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial milestone payments.",
        "label": "Commercial Milestone Payments",
        "terseLabel": "Commercial milestone payments"
       }
      }
     },
     "localname": "CommercialMilestonePayments",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_CommonAndPreferredStockValuationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common and preferred stock valuation.",
        "label": "Common And Preferred Stock Valuation Policy [Text Block]",
        "terseLabel": "Common and Preferred Stock Valuation"
       }
      }
     },
     "localname": "CommonAndPreferredStockValuationPolicyTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_CompoundCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compound Collaboration Agreement.",
        "label": "Compound Collaboration Agreement [Member]",
        "terseLabel": "Compound Collaboration"
       }
      }
     },
     "localname": "CompoundCollaborationAgreementMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_ContractWithCustomerAssetNetAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer asset net additions.",
        "label": "Contract With Customer Asset Net Additions",
        "terseLabel": "Accounts receivable and contract assets, Additions"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetAdditions",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_ContractWithCustomerAssetNetDeductions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer asset net deductions.",
        "label": "Contract With Customer Asset Net Deductions",
        "negatedLabel": "Accounts receivable and contract assets, Deductions",
        "terseLabel": "Accounts receivable and contract assets, Deductions"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetDeductions",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_ContractWithCustomerLiabilityAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability additions.",
        "label": "Contract With Customer Liability Additions",
        "terseLabel": "Contract Liabilities, Additions"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAdditions",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_ContractWithCustomerLiabilityDeductions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability deductions.",
        "label": "Contract With Customer Liability Deductions",
        "terseLabel": "Contract Liabilities, Deductions"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityDeductions",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_ConvertiblePreferredStockPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible preferred stock.",
        "label": "Convertible Preferred Stock Policy [Text Block]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockPolicyTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_CostReimbursementPaymentReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost reimbursement payment received.",
        "label": "Cost Reimbursement Payment Received",
        "terseLabel": "Cost reimbursement payment received"
       }
      }
     },
     "localname": "CostReimbursementPaymentReceived",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_CostReimbursementReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost reimbursement receivable.",
        "label": "Cost Reimbursement Receivable",
        "terseLabel": "Cost reimbursement receivable"
       }
      }
     },
     "localname": "CostReimbursementReceivable",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs associated with license and collaborative arrangements.",
        "label": "Costs Associated With License And Collaborative Arrangements Policy [Text Block]",
        "terseLabel": "Costs Associated with License and Collaborative Arrangements"
       }
      }
     },
     "localname": "CostsAssociatedWithLicenseAndCollaborativeArrangementsPolicyTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than 12 Months",
        "label": "Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than 12 Months",
        "terseLabel": "Aggregate fair value of available-for-sale debt securities, continuous unrealized loss position for greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities, available-for-sale, contractual maturity of 12 months or longer, number of securities.",
        "label": "Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities",
        "terseLabel": "Number of available-for-sale debt securities, contractual maturity of greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "kymr_DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities, available-for-sale, contractual maturity of less than 12 months, number of securities.",
        "label": "Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities",
        "terseLabel": "Number of available-for-sale debt securities, contractual maturity of less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "kymr_DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities available for sale decline in market value for unrealized loss position number of securities.",
        "label": "Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities",
        "terseLabel": "Number of securities decline in market value for in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "kymr_DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DebtSecuritiesAvailableForSale Continuous Unrealized Loss Position Greater Than 12 Months Number Of Positions",
        "label": "DebtSecuritiesAvailableForSale Continuous Unrealized Loss Position Greater Than 12 Months Number Of Positions",
        "terseLabel": "Number of available-for-sale debt securities, continuous unrealized loss position for greater than 12 months"
       }
      }
     },
     "localname": "DebtsecuritiesavailableforsaleContinuousUnrealizedLossPositionGreaterThan12MonthsNumberOfPositions",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "kymr_DeferredRevenueSanofiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred revenue - Sanofi.",
        "label": "Deferred Revenue Sanofi [Member]",
        "terseLabel": "Deferred Revenue - Sanofi"
       }
      }
     },
     "localname": "DeferredRevenueSanofiMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_DeferredRevenueVertexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred revenue - Vertex.",
        "label": "Deferred Revenue Vertex [Member]",
        "terseLabel": "Deferred Revenue - Vertex"
       }
      }
     },
     "localname": "DeferredRevenueVertexMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_DeferredTaxAssetsLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets lease liabilities.",
        "label": "Deferred Tax Assets Lease Liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiabilities",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_DeferredTaxLiabilitiesRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities right-of-use assets.",
        "label": "Deferred Tax Liabilities Right Of Use Assets",
        "negatedLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRightOfUseAssets",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of business and summary of significant accounting policies.",
        "label": "Description Of Business And Summary Of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAbstract",
     "nsuri": "http://www.kymeratx.com/20221231",
     "xbrltype": "stringItemType"
    },
    "kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of business and summary of significant accounting policies.",
        "label": "Description Of Business And Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Description Of Business And Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kymr_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of business and summary of significant accounting policies.",
        "label": "Description Of Business And Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Description Of Business And Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kymr_DevelopmentMilestonePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development milestone payments.",
        "label": "Development Milestone Payments",
        "terseLabel": "Development milestone payments"
       }
      }
     },
     "localname": "DevelopmentMilestonePayments",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_EffectiveIncomeTaxRateReconciliationPermanentDifferences": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation permanent differences.",
        "label": "Effective Income Tax Rate Reconciliation Permanent Differences",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferences",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "kymr_EmergingGrowthCompanyStatusPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging growth company status.",
        "label": "Emerging Growth Company Status Policy [Text Block]",
        "terseLabel": "Emerging Growth Company Status"
       }
      }
     },
     "localname": "EmergingGrowthCompanyStatusPolicyTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_ExchangeOfConvertiblePreferredStockImpactOnEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange of convertible preferred stock impact on equity.",
        "label": "Exchange Of Convertible Preferred Stock Impact On Equity",
        "terseLabel": "Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock"
       }
      }
     },
     "localname": "ExchangeOfConvertiblePreferredStockImpactOnEquity",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_ExtendedResearchTermOfCollaboration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended research term of collaboration.",
        "label": "Extended Research Term Of Collaboration",
        "terseLabel": "Extended research term of collaboration"
       }
      }
     },
     "localname": "ExtendedResearchTermOfCollaboration",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kymr_FacilitySubleaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility sublease agreement.",
        "label": "Facility Sublease Agreement [Member]",
        "terseLabel": "Facility Sublease Agreement"
       }
      }
     },
     "localname": "FacilitySubleaseAgreementMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_FairValueAssetsLevel1ToLevel2TransfersAmounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Assets Level 1 To Level 2 Transfers Amounts",
        "label": "Fair Value Assets Level 1 To Level 2 Transfers Amounts"
       }
      }
     },
     "localname": "FairValueAssetsLevel1ToLevel2TransfersAmounts",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_FairValueAssetsLevel1ToLevel3TransfersAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value assets level 1 to level 3 transfers amount.",
        "label": "Fair Value Assets Level1 To Level3 Transfers Amount",
        "terseLabel": "Fair value assets, level 1 to level 3 transfers, amount"
       }
      }
     },
     "localname": "FairValueAssetsLevel1ToLevel3TransfersAmount",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_FairValueAssetsLevel2ToLevel1TransfersAmounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Assets Level 2 To Level 1Transfers Amounts",
        "label": "Fair Value Assets Level 2 To Level 1Transfers Amounts"
       }
      }
     },
     "localname": "FairValueAssetsLevel2ToLevel1TransfersAmounts",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_FairValueAssetsLevel2ToLevel3TransfersAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value assets level 2 to Level 3 transfers amount.",
        "label": "Fair Value Assets Level2 To Level3 Transfers Amount",
        "terseLabel": "Fair value assets, level 2 to level 3 transfers, amount"
       }
      }
     },
     "localname": "FairValueAssetsLevel2ToLevel3TransfersAmount",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_FairValueAssetsLevel3ToLevel1TransfersAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value assets level 3 to level 1 transfers amount.",
        "label": "Fair Value Assets Level3 To Level1 Transfers Amount",
        "terseLabel": "Fair value assets, level 3 to level 1 transfers, amount"
       }
      }
     },
     "localname": "FairValueAssetsLevel3ToLevel1TransfersAmount",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_FairValueAssetsLevel3ToLevel2TransfersAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value assets level 3 to level 2 transfers amount.",
        "label": "Fair Value Assets Level3 To Level2 Transfers Amount",
        "terseLabel": "Fair value assets, level 3 to level 2 transfers, amount"
       }
      }
     },
     "localname": "FairValueAssetsLevel3ToLevel2TransfersAmount",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of available-for-sale debt securities contractual maturity of less than twelve months.",
        "label": "Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months",
        "terseLabel": "Fair value of available-for-sale debt securities, contractual maturity of less than 12 months"
       }
      }
     },
     "localname": "FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_FederalAndStateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal and state.",
        "label": "Federal And State [Member]",
        "terseLabel": "Federal and State"
       }
      }
     },
     "localname": "FederalAndStateMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_FederalNetOperatingLossCarryoversNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal net operating loss carryovers, not subject to expiration.",
        "label": "Federal Net Operating Loss Carryovers Not Subject To Expiration",
        "terseLabel": "Federal net operating loss carryovers, not subject to expiration"
       }
      }
     },
     "localname": "FederalNetOperatingLossCarryoversNotSubjectToExpiration",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_FinancingCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing costs.",
        "label": "Financing Costs Policy [Text Block]",
        "terseLabel": "Financing Costs"
       }
      }
     },
     "localname": "FinancingCostsPolicyTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_FollowOnOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow-on offering.",
        "label": "Follow On Offering [Member]",
        "terseLabel": "Follow-on Offering"
       }
      }
     },
     "localname": "FollowOnOfferingMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_IRAK4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IRAK4.",
        "label": "I R A K4 [Member]",
        "terseLabel": "IRAK4 Program"
       }
      }
     },
     "localname": "IRAK4Member",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_IncomeTaxDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax disclosure.",
        "label": "Income Tax Disclosure [Line Items]",
        "terseLabel": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureLineItems",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kymr_IncomeTaxDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax disclosure.",
        "label": "Income Tax Disclosure [Table]",
        "terseLabel": "Income Tax Disclosure [Table]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTable",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kymr_IncreaseDecreaseInContractWithCustomerAssetRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in contract with customer asset related parties.",
        "label": "Increase Decrease In Contract With Customer Asset Related Parties",
        "negatedLabel": "Contract asset-due from related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerAssetRelatedParties",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in operating lease liabilities.",
        "label": "Increase Decrease In Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_IncreaseDecreaseInOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in operating lease right-of-use assets.",
        "label": "Increase Decrease In Operating Lease Right Of Use Assets",
        "negatedLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in accumulated deficit related to temporary equity deemed dividend.",
        "label": "Increase In Accumulated Deficit Related To Temporary Equity Deemed Dividend",
        "terseLabel": "Increase in accumulated deficit related to temporary equity deemed dividend"
       }
      }
     },
     "localname": "IncreaseInAccumulatedDeficitRelatedToTemporaryEquityDeemedDividend",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_IncreaseOrDecreasePreFundedWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase or decrease pre-funded warrants",
        "label": "Increase or decrease pre-funded warrants",
        "terseLabel": "Increase or decrease pre-funded warrants, maximum"
       }
      }
     },
     "localname": "IncreaseOrDecreasePreFundedWarrants",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "kymr_InitialResearchTermOfCollaboration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial research term of collaboration.",
        "label": "Initial Research Term Of Collaboration",
        "terseLabel": "Initial research term of collaboration"
       }
      }
     },
     "localname": "InitialResearchTermOfCollaboration",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kymr_IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance costs",
        "label": "Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance costs",
        "terseLabel": "Proceeds from issuance of common stock and accompanying pre-funded warrants from private placement, net of issuance costs"
       }
      }
     },
     "localname": "IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of Common Stock at Private Placement, net of issuance cost",
        "label": "Issuance of Common Stock at Private Placement, net of issuance cost"
       }
      }
     },
     "localname": "IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of Common Stock at Private Placement, net of issuance cost, shares",
        "label": "Issuance of Common Stock at Private Placement, net of issuance cost, shares"
       }
      }
     },
     "localname": "IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCostShares",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "kymr_IssuanceOfVestedRestrictedStockToConsultants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of vested restricted stock to consultants",
        "label": "Issuance of Vested Restricted Stock to Consultants",
        "terseLabel": "Issuance of vested restricted stock to consultants, Share"
       }
      }
     },
     "localname": "IssuanceOfVestedRestrictedStockToConsultants",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "kymr_LabAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lab and office equipment.",
        "label": "Lab And Office Equipment [Member]",
        "terseLabel": "Lab and Office Equipment Under and Financing Right of Use Asset"
       }
      }
     },
     "localname": "LabAndOfficeEquipmentMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_LabEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lab equipment.",
        "label": "Lab Equipment [Member]",
        "terseLabel": "Lab Equipment"
       }
      }
     },
     "localname": "LabEquipmentMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_LeaseAdditionalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease additional term.",
        "label": "Lease Additional Term",
        "terseLabel": "Lease additional term"
       }
      }
     },
     "localname": "LeaseAdditionalTerm",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kymr_LeaseCommencementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease commencement date.",
        "label": "Lease Commencement Date",
        "terseLabel": "Lease commencement date"
       }
      }
     },
     "localname": "LeaseCommencementDate",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "kymr_LeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease term.",
        "label": "Lease Term",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LeaseTerm",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kymr_LeaseTerminationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease termination date.",
        "label": "Lease Termination Date",
        "terseLabel": "Lease termination date"
       }
      }
     },
     "localname": "LeaseTerminationDate",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "kymr_LesseeOperatingAndFinanceLeasesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating and finance leases.",
        "label": "Lessee Operating And Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasesTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating and financing lease liability maturity.",
        "label": "Lessee Operating And Financing Lease Liability Maturity Table [Text Block]",
        "terseLabel": "Summary of Undiscounted Future Lease Payments for Operating and Finance Leases"
       }
      }
     },
     "localname": "LesseeOperatingAndFinancingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_LesserOfPotentialOutcomeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lesser of potential outcome one.",
        "label": "Lesser Of Potential Outcome One [Member]",
        "terseLabel": "Lesser of Potential Outcome 1"
       }
      }
     },
     "localname": "LesserOfPotentialOutcomeOneMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_LesserOfPotentialOutcomeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lesser of potential outcome two.",
        "label": "Lesser Of Potential Outcome Two [Member]",
        "terseLabel": "Lesser of Potential Outcome 2"
       }
      }
     },
     "localname": "LesserOfPotentialOutcomeTwoMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_MarketableSecuritiesRemainingMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable securities, remaining maturity.",
        "label": "Marketable Securities Remaining Maturity Period",
        "terseLabel": "Marketable securities, remaining maturity period"
       }
      }
     },
     "localname": "MarketableSecuritiesRemainingMaturityPeriod",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kymr_MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable securities, remaining maturity period classified as non-current.",
        "label": "Marketable Securities Remaining Maturity Period Classified As Non Current",
        "terseLabel": "Marketable securities, remaining maturity period classified as non-current"
       }
      }
     },
     "localname": "MarketableSecuritiesRemainingMaturityPeriodClassifiedAsNonCurrent",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kymr_MilestoneReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone receivable.",
        "label": "Milestone Receivable",
        "terseLabel": "Milestone receivable"
       }
      }
     },
     "localname": "MilestoneReceivable",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_MinimumPreFundedWarrantsExercise": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum pre-funded warrants, exercise",
        "label": "Minimum pre-funded warrants, exercise",
        "terseLabel": "Minimum pre-funded warrants, exercise"
       }
      }
     },
     "localname": "MinimumPreFundedWarrantsExercise",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "kymr_NetOperatingLossBeginToExpireYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NOLs begin to expire year.",
        "label": "Net Operating Loss Begin To Expire Year",
        "terseLabel": "NOLs begin to expire year"
       }
      }
     },
     "localname": "NetOperatingLossBeginToExpireYear",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "kymr_NonCashResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non cash research and development expense.",
        "label": "Non Cash Research And Development Expense",
        "terseLabel": "Non-cash research and development expense"
       }
      }
     },
     "localname": "NonCashResearchAndDevelopmentExpense",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_NonRefundableUpfrontPaymentReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non refundable upfront payment received.",
        "label": "Non Refundable Upfront Payment Received",
        "terseLabel": "Non refundable upfront payment received"
       }
      }
     },
     "localname": "NonRefundableUpfrontPaymentReceived",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_NoncancelableFacilityLeaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncancelable facility lease agreement.",
        "label": "Noncancelable Facility Lease Agreement [Member]",
        "terseLabel": "Noncancelable Facility Lease Agreement"
       }
      }
     },
     "localname": "NoncancelableFacilityLeaseAgreementMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_NumberOfMarketableSecuritiesSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of marketable securities sold.",
        "label": "Number Of Marketable Securities Sold",
        "terseLabel": "Number of marketable securities sold"
       }
      }
     },
     "localname": "NumberOfMarketableSecuritiesSold",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "kymr_OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Off balance sheet risk and concentration of credit risk.",
        "label": "Off Balance Sheet Risk And Concentration Of Credit Risk Policy [Text Block]",
        "terseLabel": "Off Balance Sheet Risk and Concentration of Credit Risk"
       }
      }
     },
     "localname": "OffBalanceSheetRiskAndConcentrationOfCreditRiskPolicyTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_OfferingCostsIncludedInAccountsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering costs included in accounts payable.",
        "label": "Offering Costs Included In Accounts Payable",
        "terseLabel": "Offering costs included in accounts payable"
       }
      }
     },
     "localname": "OfferingCostsIncludedInAccountsPayable",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_OperatingLeasePaymentsProceeds": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease payments (proceeds).",
        "label": "Operating Lease Payments Proceeds",
        "terseLabel": "Operating cash flows used in operating leases"
       }
      }
     },
     "localname": "OperatingLeasePaymentsProceeds",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSupplementalCashFlowInformationRelatingToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_PatentCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent costs.",
        "label": "Patent Costs Policy [Text Block]",
        "terseLabel": "Patent Costs"
       }
      }
     },
     "localname": "PatentCostsPolicyTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_PotentialReceivableMilestonePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential receivable milestone payments.",
        "label": "Potential Receivable Milestone Payments",
        "terseLabel": "Eligible to receive payments including development, regulatory and commercial milestones"
       }
      }
     },
     "localname": "PotentialReceivableMilestonePayments",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_PreferredStockIssuancePremium": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock issuance premium.",
        "label": "Preferred Stock Issuance Premium",
        "terseLabel": "Preferred stock premium"
       }
      }
     },
     "localname": "PreferredStockIssuancePremium",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums and discounts on available for sale marketable securities.",
        "label": "Premiums And Discounts On Available For Sale Marketable Securities",
        "terseLabel": "Premiums and discounts on available for sale marketable securities"
       }
      }
     },
     "localname": "PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_PriorNoticePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prior notice period",
        "label": "Prior notice period",
        "terseLabel": "Prior notice period, minimum"
       }
      }
     },
     "localname": "PriorNoticePeriod",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kymr_PrivateInvestmentInPublicEquityPipeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Investment in Public Equity \"PIPE\" [Member]",
        "label": "Private Investment in Public Equity \"PIPE\" [Member]",
        "terseLabel": "Private Investment in Public Equity \"PIPE\""
       }
      }
     },
     "localname": "PrivateInvestmentInPublicEquityPipeMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_ProceedsFromConcurrentPrivatePlacement": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from concurrent private placement.",
        "label": "Proceeds From Concurrent Private Placement",
        "terseLabel": "Proceeds from concurrent private placement"
       }
      }
     },
     "localname": "ProceedsFromConcurrentPrivatePlacement",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from follow on offering, net of underwriting discounts and offering costs",
        "label": "Proceeds from follow on offering, net of underwriting discounts and offering costs",
        "terseLabel": "Proceeds from follow-on public offering, net of underwriting discounts and offering costs"
       }
      }
     },
     "localname": "ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_ProceedsFromIssuanceInitialPublicOfferingGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance initial public offering gross.",
        "label": "Proceeds From Issuance Initial Public Offering Gross",
        "terseLabel": "Gross proceeds from issuance initial public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOfferingGross",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property and equipment purchases included in accounts payable and accrued expenses.",
        "label": "Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses",
        "terseLabel": "Property and equipment purchases included in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of property and equipment through finance and lease liabilities.",
        "label": "Purchases Of Property And Equipment Through Finance And Lease Liabilities",
        "terseLabel": "Purchases of property and equipment through finance and lease liabilities"
       }
      }
     },
     "localname": "PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction of right of use asset and liability due to lease modification.",
        "label": "Reduction Of Right Of Use Asset And Liability Due To Lease Modification",
        "terseLabel": "Reduction of right-of-use asset and liability due to lease modification"
       }
      }
     },
     "localname": "ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_RemainingResearchTermOfCollaboration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining research term of collaboration.",
        "label": "Remaining Research Term Of Collaboration",
        "terseLabel": "Remaining research term of collaboration"
       }
      }
     },
     "localname": "RemainingResearchTermOfCollaboration",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kymr_RentalAndLeaseExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental And Lease Expenses",
        "label": "Rental And Lease Expenses",
        "verboseLabel": "Base Rent"
       }
      }
     },
     "localname": "RentalAndLeaseExpenses",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_ResearchAndDevelopmentCreditCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development credit carryforwards.",
        "label": "Research And Development Credit Carryforwards",
        "terseLabel": "Research and development credit carryforwards"
       }
      }
     },
     "localname": "ResearchAndDevelopmentCreditCarryforwards",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_RestrictedCashFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash fair value.",
        "label": "Restricted Cash Fair Value",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashFairValue",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_RestrictedCashMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash.",
        "label": "Restricted Cash [Member]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCashMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_RestrictedCashPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash policy.",
        "label": "Restricted Cash Policy Policy [Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCashPolicyPolicyTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_RoyaltyReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty receivable.",
        "label": "Royalty Receivable",
        "terseLabel": "Royalty receivable"
       }
      }
     },
     "localname": "RoyaltyReceivable",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_SanofiCollaborationArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi collaboration arrangement.",
        "label": "Sanofi Collaboration Arrangement [Member]",
        "terseLabel": "Sanofi Agreement"
       }
      }
     },
     "localname": "SanofiCollaborationArrangementMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_ScenarioPotentialOutcomeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario potential outcome.",
        "label": "Scenario Potential Outcome [Axis]",
        "terseLabel": "Scenario Potential Outcome"
       }
      }
     },
     "localname": "ScenarioPotentialOutcomeAxis",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kymr_ScenarioPotentialOutcomeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario potential outcome.",
        "label": "Scenario Potential Outcome [Domain]",
        "terseLabel": "Scenario Potential Outcome"
       }
      }
     },
     "localname": "ScenarioPotentialOutcomeDomain",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_SegmentAndGeographicInformationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment and geographic information.",
        "label": "Segment And Geographic Information Policy [Text Block]",
        "terseLabel": "Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentAndGeographicInformationPolicyTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_SeriesAConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A convertible preferred stock.",
        "label": "Series A Convertible Preferred Stock [Member]",
        "terseLabel": "Series A Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesAConvertiblePreferredStockMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_SeriesAPreferredUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A Preferred Units.",
        "label": "Series A Preferred Units [Member]",
        "terseLabel": "Series A Preferred Units"
       }
      }
     },
     "localname": "SeriesAPreferredUnitsMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_SeriesB1ConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B-1 convertible preferred stock.",
        "label": "Series B1 Convertible Preferred Stock [Member]",
        "terseLabel": "Series B-1 Convertible Preferred"
       }
      }
     },
     "localname": "SeriesB1ConvertiblePreferredStockMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_SeriesB1PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B1 preferred stock.",
        "label": "Series B1 Preferred Stock [Member]",
        "terseLabel": "Series B-1 Preferred Stock"
       }
      }
     },
     "localname": "SeriesB1PreferredStockMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_SeriesBConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B convertible preferred stock.",
        "label": "Series B Convertible Preferred Stock [Member]",
        "terseLabel": "Series B Convertible Preferred Stock",
        "verboseLabel": "Series B Preferred Stock"
       }
      }
     },
     "localname": "SeriesBConvertiblePreferredStockMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_SeriesBConvertiblePreferredStocksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B convertible preferred stock.",
        "label": "Series B Convertible Preferred Stocks [Member]",
        "terseLabel": "Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesBConvertiblePreferredStocksMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_SeriesCConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C convertible preferred stock.",
        "label": "Series C Convertible Preferred Stock [Member]",
        "terseLabel": "Series C Convertible Preferred Stock",
        "verboseLabel": "Series C Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesCConvertiblePreferredStockMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_SeriesCPreferredStockPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C preferred stock purchase agreement.",
        "label": "Series C Preferred Stock Purchase Agreement [Member]",
        "terseLabel": "Series C SPA"
       }
      }
     },
     "localname": "SeriesCPreferredStockPurchaseAgreementMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_SeriesSeedConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series seed convertible preferred stock.",
        "label": "Series Seed Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesSeedConvertiblePreferredStockMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award aggregate intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options forfeited in period intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Intrinsic Value",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodIntrinsicValue",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options granted in period intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_StockIssuedDuringPeriodSharesRestrictedStockVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares restricted stock vested.",
        "label": "Stock Issued During Period Shares Restricted Stock Vested",
        "terseLabel": "Vesting Restricted Stock, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockVested",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "kymr_StockIssuedDuringPeriodValueRestrictedStockVested": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value restricted stock vested.",
        "label": "Stock Issued During Period Value Restricted Stock Vested",
        "terseLabel": "Vesting Restricted Stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockVested",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of estimated useful life of related asset.",
        "label": "Summary Of Estimated Useful Life Of Related Asset Table [Text Block]",
        "terseLabel": "Summary of Estimated Useful Life of Related Asset"
       }
      }
     },
     "localname": "SummaryOfEstimatedUsefulLifeOfRelatedAssetTableTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kymr_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kymr_SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of weighted average remaining lease terms and discount rates.",
        "label": "Summary Of Weighted Average Remaining Lease Terms And Discount Rates Table [Text Block]",
        "terseLabel": "Summary of Weighted Average Remaining Lease Terms and Discount Rates"
       }
      }
     },
     "localname": "SummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesTableTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_SupplementalCashFlowInformationRelatingToLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental cash flow information relating to leases.",
        "label": "Supplemental Cash Flow Information Relating To Leases Table [Text Block]",
        "terseLabel": "Supplemental Cash Flow Information Relating to Leases"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationRelatingToLeasesTableTextBlock",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kymr_SupplementalDisclosureOfNoncashOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental disclosure of noncash operating activities.",
        "label": "Supplemental Disclosure Of Noncash Operating Activities [Abstract]",
        "terseLabel": "Supplemental disclosure of noncash operating activities"
       }
      }
     },
     "localname": "SupplementalDisclosureOfNoncashOperatingActivitiesAbstract",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "kymr_TemporaryEquityExchangeOfConvertiblePreferredStockShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, exchange of convertible preferred stock, shares.",
        "label": "Temporary Equity Exchange Of Convertible Preferred Stock Shares",
        "terseLabel": "Temporary Equity, Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock, Shares"
       }
      }
     },
     "localname": "TemporaryEquityExchangeOfConvertiblePreferredStockShares",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "kymr_TemporaryEquityExchangeOfConvertiblePreferredStockValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, exchange of convertible preferred stock, value.",
        "label": "Temporary Equity Exchange Of Convertible Preferred Stock Value",
        "terseLabel": "Temporary Equity, Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityExchangeOfConvertiblePreferredStockValue",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock issued during period shares new issues.",
        "label": "Temporary Equity Stock Issued During Period Shares New Issues",
        "terseLabel": "Issuance of Series B-1 Preferred Stock, net of issuance costs of $49, Shares"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "kymr_TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock shares vesting of series A preferred stock in connection with collaboration arrangement.",
        "label": "Temporary Equity Stock Shares Vesting Of Series A Preferred Stock In Connection With Collaboration Arrangement",
        "terseLabel": "Vesting of Series A Preferred Stock in connection with collaboration arrangement (Note 5), Shares",
        "verboseLabel": "Number of shares vested"
       }
      }
     },
     "localname": "TemporaryEquityStockSharesVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "kymr_TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock value vesting of series A preferred stock in connection with collaboration arrangement.",
        "label": "Temporary Equity Stock Value Vesting Of Series A Preferred Stock In Connection With Collaboration Arrangement",
        "terseLabel": "Vesting of Series A Preferred Stock in connection with collaboration arrangement (Note 5)"
       }
      }
     },
     "localname": "TemporaryEquityStockValueVestingOfSeriesAPreferredStockInConnectionWithCollaborationArrangement",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_TenantImprovementReceivableIncludedInOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tenant improvement receivable included in other assets.",
        "label": "Tenant Improvement Receivable Included In Other Assets",
        "terseLabel": "Tenant improvement receivable included in other assets"
       }
      }
     },
     "localname": "TenantImprovementReceivableIncludedInOtherAssets",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_TenantIncentiveAllowanceReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tenant incentive allowance receivable.",
        "label": "Tenant Incentive Allowance Receivable",
        "terseLabel": "Tenant incentive allowance receivable"
       }
      }
     },
     "localname": "TenantIncentiveAllowanceReceivable",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_TwoThousandAndTwentyStockOptionAndGrantPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and twenty stock option and grant plan.",
        "label": "Two Thousand And Twenty Stock Option And Grant Plan [Member]",
        "terseLabel": "2020 Plan"
       }
      }
     },
     "localname": "TwoThousandAndTwentyStockOptionAndGrantPlanMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_TwoThousandEighteenStockOptionAndGrantPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 stock option and grant plan.",
        "label": "Two Thousand Eighteen Stock Option And Grant Plan [Member]",
        "terseLabel": "2018 Plan"
       }
      }
     },
     "localname": "TwoThousandEighteenStockOptionAndGrantPlanMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_TwoThousandTwentyEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Employee stock purchase plan.",
        "label": "Two Thousand Twenty Employee Stock Purchase Plan [Member]",
        "terseLabel": "2020 ESPP"
       }
      }
     },
     "localname": "TwoThousandTwentyEmployeeStockPurchasePlanMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_TwoThousandTwentyStockOptionAndIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 stock option and incentive plan.",
        "label": "Two Thousand Twenty Stock Option And Incentive Plan [Member]",
        "terseLabel": "2020 Plan"
       }
      }
     },
     "localname": "TwoThousandTwentyStockOptionAndIncentivePlanMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_UnbilledReceivablesSanofiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled receivables - Sanofi.",
        "label": "Unbilled Receivables Sanofi [Member]",
        "terseLabel": "Unbilled Receivables - Sanofi"
       }
      }
     },
     "localname": "UnbilledReceivablesSanofiMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_UpfrontPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payment.",
        "label": "Upfront Payment",
        "terseLabel": "Upfront payment"
       }
      }
     },
     "localname": "UpfrontPayment",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kymr_VertexAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vertex Agreement.",
        "label": "Vertex Agreement [Member]",
        "terseLabel": "Vertex Agreement"
       }
      }
     },
     "localname": "VertexAgreementMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_VertexPharmaceuticalsIncorporatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vertex Pharmaceuticals Incorporated.",
        "label": "Vertex Pharmaceuticals Incorporated [Member]",
        "terseLabel": "Vertex Pharmaceuticals Incorporated"
       }
      }
     },
     "localname": "VertexPharmaceuticalsIncorporatedMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_WatertownMassachusettsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Watertown, Massachusetts.",
        "label": "Watertown Massachusetts [Member]",
        "terseLabel": "Watertown, Massachusetts"
       }
      }
     },
     "localname": "WatertownMassachusettsMember",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kymr_WrittenNoticePeriodToTerminateCollaborationAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written notice period to terminate collaboration agreement.",
        "label": "Written Notice Period To Terminate Collaboration Agreement",
        "terseLabel": "Written notice period to terminate collaboration agreement"
       }
      }
     },
     "localname": "WrittenNoticePeriodToTerminateCollaborationAgreement",
     "nsuri": "http://www.kymeratx.com/20221231",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r184",
      "r408",
      "r409",
      "r412",
      "r413",
      "r485",
      "r588",
      "r668",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r184",
      "r408",
      "r409",
      "r412",
      "r413",
      "r485",
      "r588",
      "r668",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r329",
      "r516",
      "r544",
      "r589",
      "r590",
      "r606",
      "r612",
      "r621",
      "r673",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r329",
      "r516",
      "r544",
      "r589",
      "r590",
      "r606",
      "r612",
      "r621",
      "r673",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r241",
      "r519",
      "r607",
      "r619",
      "r665",
      "r666",
      "r676",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r241",
      "r519",
      "r607",
      "r619",
      "r665",
      "r666",
      "r676",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r321",
      "r329",
      "r359",
      "r360",
      "r361",
      "r492",
      "r516",
      "r544",
      "r589",
      "r590",
      "r606",
      "r612",
      "r621",
      "r662",
      "r673",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r321",
      "r329",
      "r359",
      "r360",
      "r361",
      "r492",
      "r516",
      "r544",
      "r589",
      "r590",
      "r606",
      "r612",
      "r621",
      "r662",
      "r673",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r242",
      "r243",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r608",
      "r620",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r242",
      "r243",
      "r572",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r608",
      "r620",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Initial Price Paid Per Share",
        "terseLabel": "Pre-funded warrants per share"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Topic 606"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "ASU 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201912Member": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.",
        "label": "Accounting Standards Update 2019-12 [Member]",
        "terseLabel": "ASU 2019-12"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201912Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r10",
      "r618"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses (Note 8)",
        "totalLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r12",
      "r595"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Payroll and payroll-related"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r63",
      "r153"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation",
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r160",
      "r540",
      "r552",
      "r556"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r18",
      "r21",
      "r107",
      "r478",
      "r547",
      "r548",
      "r640",
      "r641",
      "r642",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r648",
      "r649",
      "r650",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r192",
      "r193",
      "r194",
      "r195",
      "r205",
      "r248",
      "r249",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r368",
      "r369",
      "r370",
      "r388",
      "r389",
      "r390",
      "r391",
      "r401",
      "r402",
      "r403",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r450",
      "r451",
      "r453",
      "r454",
      "r455",
      "r456",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r520",
      "r521",
      "r522",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r93",
      "r94",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense",
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r363"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Equity-based compensation expense",
        "verboseLabel": "Total equity-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive stock"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of a real estate property.",
        "label": "Area of Real Estate Property",
        "terseLabel": "Area of office space"
       }
      }
     },
     "localname": "AreaOfRealEstateProperty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r124",
      "r130",
      "r155",
      "r181",
      "r232",
      "r235",
      "r239",
      "r256",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r408",
      "r412",
      "r434",
      "r618",
      "r669",
      "r670",
      "r720"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r148",
      "r161",
      "r181",
      "r256",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r408",
      "r412",
      "r434",
      "r618",
      "r669",
      "r670",
      "r720"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r252",
      "r273"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer.",
        "label": "Available-for-Sale Securities, Current",
        "terseLabel": "Short-term investments",
        "totalLabel": "Available-for-sale Securities, Current, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r53",
      "r251",
      "r273",
      "r535"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Debt Securities, Available-for-sale, Total",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r52",
      "r273"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Marketable securities (Note 4)",
        "totalLabel": "Debt Securities, Available-for-sale, Current, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r52",
      "r151",
      "r273"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "terseLabel": "Marketable securities, non-current (Note 4)",
        "verboseLabel": "Fair value of available-for-sale debt securities, contractual maturity of greater than 12 months"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt and equity securities which are categorized neither as held-to-maturity nor trading and which are intended to be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Such securities are reported at fair value; unrealized gains (losses) related to Available-for-sale Securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income), unless the Available-for-sale security is designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis. All or a portion of the unrealized holding gain (loss) of an Available-for-sale security that is designated as being hedged in a fair value hedge is recognized in earnings during the period of the hedge, as are other than temporary declines in fair value below the cost basis for investments in equity securities and debt securities that an entity intends to sell or it is more likely than not that it will be required to sell before the recovery of its amortized cost basis. Other than temporary declines in fair value below the cost basis for debt securities categorized as Available-for-sale that an entity does not intend to sell and for which it is not more likely than not that the entity will be required to sell before the recovery of its amortized cost basis are bifurcated into credit losses and losses related to all other factors. Other than temporary declines in fair value below cost basis related to credit losses are recognized in earnings, and losses related to all other factors are recognized in other comprehensive income.",
        "label": "Available-for-Sale Securities, Noncurrent",
        "terseLabel": "Long-term investments",
        "totalLabel": "Available-for-sale Securities, Noncurrent, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableforsaleSecuritiesSoldAtPar": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with interest rate reset through auction process, sold at par value.",
        "label": "Debt Securities, Available-for-Sale, Sold at Par Value",
        "terseLabel": "Sales of marketable securities"
       }
      }
     },
     "localname": "AvailableforsaleSecuritiesSoldAtPar",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r108",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BilledContractReceivables": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.",
        "label": "Billed Contracts Receivable",
        "terseLabel": "Billed accounts receivable"
       }
      }
     },
     "localname": "BilledContractReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r43",
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Description of Business and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis": {
     "auth_ref": [
      "r119",
      "r120",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by project.",
        "label": "Project [Axis]",
        "terseLabel": "Project"
       }
      }
     },
     "localname": "CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r37",
      "r150",
      "r593"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.",
        "label": "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r31",
      "r37",
      "r42"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r31",
      "r115"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "terseLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "auth_ref": [
      "r142",
      "r143",
      "r191",
      "r248",
      "r249",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r388",
      "r401",
      "r402",
      "r414",
      "r416",
      "r417",
      "r427",
      "r435",
      "r437",
      "r438",
      "r439",
      "r442",
      "r443",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r473",
      "r474",
      "r520",
      "r521",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether accounting standards update was adopted.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, adopted"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "auth_ref": [
      "r142",
      "r143",
      "r248",
      "r249",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r388",
      "r401",
      "r402",
      "r403",
      "r414",
      "r416",
      "r417",
      "r418",
      "r421",
      "r427",
      "r435",
      "r437",
      "r438",
      "r439",
      "r442",
      "r443",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r473",
      "r474",
      "r520",
      "r521",
      "r545",
      "r546",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date",
        "terseLabel": "Accounting standards update, adoption date"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": {
     "auth_ref": [
      "r192",
      "r204",
      "r250",
      "r265",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, immaterial effect"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r181",
      "r209",
      "r210",
      "r213",
      "r215",
      "r222",
      "r223",
      "r256",
      "r287",
      "r290",
      "r291",
      "r292",
      "r296",
      "r297",
      "r301",
      "r302",
      "r303",
      "r304",
      "r307",
      "r434",
      "r591",
      "r633",
      "r645",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Pre-funded warrant purchase price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Pre-funded warrants outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r404",
      "r405",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaborations"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r15",
      "r126",
      "r134"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 9)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r67",
      "r280",
      "r281",
      "r575",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Other Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r648",
      "r649",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued",
        "totalLabel": "Common Stock, Shares, Issued, Total"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r4",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "terseLabel": "Common Stock, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r4",
      "r618"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Common stock, $0.0001 par value; 150,000,000 shares authorized at December 31, 2022 and 2021, 55,039,380 and 51,573,924 shares issued at December 31, 2022 and 2021, respectively; 55,039,380 and 51,536,181 shares outstanding at December 31, 2022 and 2021, respectively",
        "totalLabel": "Common Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Deferred Tax Assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r22",
      "r165",
      "r167",
      "r172",
      "r536",
      "r541"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss2": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer Equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r105",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Change in Accounts Receivable, Contract Asset and Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r310",
      "r312",
      "r318"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Contract assets-due from related party",
        "totalLabel": "Contract with Customer, Asset, after Allowance for Credit Loss, Current, Total"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r310",
      "r311",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Contract Liabilities, Ending balance",
        "periodStartLabel": "Contract Liabilities, Beginning balance",
        "totalLabel": "Contract with Customer, Liability, Total"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r310",
      "r311",
      "r318"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r310",
      "r311",
      "r318"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized recorded in deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r310",
      "r313",
      "r318",
      "r574"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right to consideration is unconditional.",
        "label": "Contract with Customer, Receivable, after Allowance for Credit Loss",
        "periodEndLabel": "Accounts receivable and contract assets, Ending balance",
        "periodStartLabel": "Accounts receivable and contract assets, Beginning balance",
        "totalLabel": "Contract with Customer, Receivable, after Allowance for Credit Loss, Total"
       }
      }
     },
     "localname": "ContractWithCustomerReceivableAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r39",
      "r40",
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Number of preferred Stock converted to common stock"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r39",
      "r40",
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Conversion of stock, shares issued and outstanding"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r301",
      "r302",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r2",
      "r3",
      "r74",
      "r75",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Shares issued upon exchange of Series A convertible preferred stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate Bonds"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r609",
      "r611",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r255",
      "r275",
      "r603"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Aggregate fair value of available-for-sale debt securities, continuous unrealized loss position for less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of available-for-sale debt securities, continuous unrealized loss position for less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Summary of Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r661"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r102",
      "r709"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r383"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r708"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r708"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r102",
      "r709"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Federal net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r102",
      "r709"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "State net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r101",
      "r102",
      "r709"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpense": {
     "auth_ref": [
      "r102",
      "r709"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.",
        "label": "Deferred Tax Assets, Tax Deferred Expense",
        "terseLabel": "Accruals and reserves, stock and other",
        "totalLabel": "Deferred Tax Assets, Tax Deferred Expense, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "totalLabel": "Deferred Tax Assets, Valuation Allowance, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts": {
     "auth_ref": [
      "r102",
      "r709"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from research and development costs.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs",
        "terseLabel": "Capitalized Research and Development"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r102",
      "r709"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Fixed and intangible assets",
        "totalLabel": "Deferred Tax Liabilities, Goodwill and Intangible Assets, Total"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfSignificantComponentsOfNetDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r35",
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense",
        "totalLabel": "Depreciation, Total"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r35",
      "r230"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation, Depletion and Amortization, Total"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r333",
      "r364",
      "r365",
      "r367",
      "r372",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Equity-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r159",
      "r289",
      "r290",
      "r291",
      "r295",
      "r296",
      "r297",
      "r482",
      "r594",
      "r647"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Accounts receivable-due from related party",
        "totalLabel": "Due from Related Parties, Current, Total"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarliestTaxYearMember": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earliest identified tax year.",
        "label": "Earliest Tax Year [Member]",
        "terseLabel": "Earliest Tax Year"
       }
      }
     },
     "localname": "EarliestTaxYearMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r173",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r206",
      "r209",
      "r213",
      "r214",
      "r215",
      "r219",
      "r425",
      "r426",
      "r537",
      "r542",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic",
        "totalLabel": "Earnings Per Share, Basic, Total"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r173",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r209",
      "r213",
      "r214",
      "r215",
      "r219",
      "r425",
      "r426",
      "r537",
      "r542",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted",
        "totalLabel": "Earnings Per Share, Diluted, Total"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r44",
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r182",
      "r377",
      "r395"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Tax effect at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r705",
      "r710"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r705",
      "r710"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r705",
      "r710"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r705",
      "r710"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r705",
      "r710"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "terseLabel": "Federal research and development credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesRateReconciliationOfUSStatutoryIncomeTaxRateToCompanySEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation cost, recognition period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options",
        "verboseLabel": "Options to Purchase Common Stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r73",
      "r144",
      "r169",
      "r170",
      "r171",
      "r188",
      "r189",
      "r190",
      "r193",
      "r201",
      "r203",
      "r221",
      "r264",
      "r309",
      "r368",
      "r369",
      "r370",
      "r390",
      "r391",
      "r424",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r478",
      "r547",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Assets Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r111",
      "r113",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value By Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r298",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r429",
      "r489",
      "r490",
      "r491",
      "r604",
      "r605",
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r428",
      "r429",
      "r430",
      "r431",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r298",
      "r322",
      "r327",
      "r429",
      "r489",
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r298",
      "r322",
      "r327",
      "r429",
      "r490",
      "r604",
      "r605",
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r298",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r429",
      "r491",
      "r604",
      "r605",
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r298",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r489",
      "r490",
      "r491",
      "r604",
      "r605",
      "r609",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r432",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r459",
      "r464",
      "r617"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest expense for financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r461",
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows used in finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSupplementalCashFlowInformationRelatingToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Financing Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r458",
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails4": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "totalLabel": "Finance Lease, Liability, Total",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r458"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r458"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liabilities, net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails3": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails4": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails3": {
       "order": 0.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails3": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails3": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails4": {
       "order": 0.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less amounts representing interest or imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r460",
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows used in finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSupplementalCashFlowInformationRelatingToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r459",
      "r464",
      "r617"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization expense related to right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r470",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Financing lease, discount rate"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r469",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Financing lease, remaining lease term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r253",
      "r254",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r276",
      "r277",
      "r300",
      "r306",
      "r415",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r603",
      "r656",
      "r657",
      "r658",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furnitures and Fixtures",
        "verboseLabel": "Furniture &amp; Fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property and equipment",
        "terseLabel": "Loss on disposal of property and equipment",
        "totalLabel": "Gain (Loss) on Disposition of Property Plant Equipment, Total"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative",
        "verboseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralPartnersOfferingCosts": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of offering costs allocated to the general partner.",
        "label": "General Partners' Offering Costs",
        "terseLabel": "Offering expenses"
       }
      }
     },
     "localname": "GeneralPartnersOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r330",
      "r332",
      "r334",
      "r335",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [
      "r330",
      "r332",
      "r334",
      "r335",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO",
        "verboseLabel": "Initial Public Offering"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfLeasehold": {
     "auth_ref": [
      "r35",
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced.",
        "label": "Impairment of Leasehold",
        "terseLabel": "Reduction of right-of-use asset and liability due to lease modification"
       }
      }
     },
     "localname": "ImpairmentOfLeasehold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r35",
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment losses on long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r57",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r182",
      "r378",
      "r381",
      "r386",
      "r393",
      "r396",
      "r398",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r706"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "terseLabel": "Estimated interest or penalties recognized on uncertain tax positions",
        "totalLabel": "Income Tax Examination, Penalties and Interest Expense, Total"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r183",
      "r202",
      "r203",
      "r231",
      "r376",
      "r394",
      "r397",
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "totalLabel": "Income Tax Expense (Benefit), Total"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r168",
      "r374",
      "r375",
      "r381",
      "r382",
      "r385",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Increase (Decrease) in Accrued Liabilities, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r517",
      "r643"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueFromRelatedParties": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.",
        "label": "Increase (Decrease) in Due from Related Parties",
        "negatedLabel": "Accounts receivable due from related party",
        "totalLabel": "Increase (Decrease) in Due from Related Parties, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r643"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets",
        "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndemnificationGuaranteeMember": {
     "auth_ref": [
      "r68",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.",
        "label": "Indemnification Agreement [Member]",
        "terseLabel": "Indemnified Parties"
       }
      }
     },
     "localname": "IndemnificationGuaranteeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r175",
      "r178",
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAndCash": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of investments and unrestricted cash as of the balance sheet date.",
        "label": "Investments and Cash",
        "terseLabel": "Cash, cash equivalents and marketable securities",
        "totalLabel": "Investments and Cash, Total"
       }
      }
     },
     "localname": "InvestmentsAndCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r56",
      "r123",
      "r129",
      "r137",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestorMember": {
     "auth_ref": [
      "r717",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.",
        "label": "Investor [Member]",
        "terseLabel": "Investor"
       }
      }
     },
     "localname": "InvestorMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LatestTaxYearMember": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latest identified tax year.",
        "label": "Latest Tax Year [Member]",
        "terseLabel": "Latest Tax Year"
       }
      }
     },
     "localname": "LatestTaxYearMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Lease Base rent",
        "totalLabel": "Operating Leases, Rent Expense, Total"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r471",
      "r617"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease Expiration Date",
        "terseLabel": "Lease expiration date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee Lease Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee Lease Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails2": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less amounts representing interest or imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Lease term remaining"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Leases original term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r11",
      "r181",
      "r256",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r409",
      "r412",
      "r413",
      "r434",
      "r601",
      "r669",
      "r720",
      "r721"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r9",
      "r125",
      "r132",
      "r618",
      "r646",
      "r659",
      "r713"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r149",
      "r181",
      "r256",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r409",
      "r412",
      "r413",
      "r434",
      "r618",
      "r669",
      "r720",
      "r721"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r69",
      "r70",
      "r282",
      "r283",
      "r284",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r69",
      "r70",
      "r282",
      "r283",
      "r284",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r282",
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "periodEndLabel": "Loss Contingency Accrual, Ending Balance",
        "periodStartLabel": "Loss Contingency Accrual, Beginning Balance",
        "terseLabel": "Liabilities accrued"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r69",
      "r70",
      "r282",
      "r283",
      "r284",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureOtherCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities [Abstract]"
       }
      }
     },
     "localname": "MarketableSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities, current",
        "totalLabel": "Marketable Securities, Current, Total"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]",
        "terseLabel": "Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Marketable securities, non-current",
        "totalLabel": "Marketable Securities, Noncurrent, Total"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]",
        "terseLabel": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Fund"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r177"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r177"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r31",
      "r33",
      "r36"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash (used in) provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r23",
      "r36",
      "r127",
      "r136",
      "r147",
      "r164",
      "r166",
      "r171",
      "r181",
      "r192",
      "r196",
      "r197",
      "r198",
      "r199",
      "r202",
      "r203",
      "r211",
      "r232",
      "r234",
      "r238",
      "r240",
      "r256",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r426",
      "r434",
      "r602",
      "r669"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      },
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.kymeratx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r206",
      "r207",
      "r212",
      "r215",
      "r232",
      "r234",
      "r238",
      "r240",
      "r602"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Reconciliation of net loss to net loss attributable to common stockholders:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of noncash investing and financing activities"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segment"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office Equipment"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OpenTaxYear": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax year that remains open to examination under enacted tax laws, in YYYY format.",
        "label": "Open Tax Year",
        "terseLabel": "Open tax year subject to examination"
       }
      }
     },
     "localname": "OpenTaxYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r232",
      "r234",
      "r238",
      "r240",
      "r602"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r465",
      "r617"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r458"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Operating Lease, Liability, Total",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfUndiscountedFutureLeasePaymentsForOperatingAndFinanceLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r458"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r458"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r457"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets, operating leases"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r470",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating lease, discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r469",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating lease, remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermsAndDiscountRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "NOL carryforwards",
        "totalLabel": "Operating Loss Carryforwards, Total"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r108",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets",
        "totalLabel": "Other Assets, Noncurrent, Total"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r103",
      "r104",
      "r106"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss2": {
       "order": 0.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized (loss) gain on marketable securities",
        "totalLabel": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r162",
      "r163"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized gain on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r108",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r618"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Other Liabilities, Current, Total"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities",
        "totalLabel": "Other Liabilities, Noncurrent, Total"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense",
        "negatedLabel": "Interest and other expense",
        "totalLabel": "Other Nonoperating Expense, Total"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncome": {
     "auth_ref": [
      "r174"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income",
        "terseLabel": "Interest Income",
        "verboseLabel": "Interest and other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "totalLabel": "Total other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Underwriters"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRent": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to lessor's for use of assets under operating leases.",
        "label": "Payments for Rent",
        "terseLabel": "Rent paid"
       }
      }
     },
     "localname": "PaymentsForRent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfInitialPublicOffering": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public.",
        "label": "Payments for Repurchase of Initial Public Offering",
        "negatedLabel": "Payments of offering costs in connection with initial public offering",
        "terseLabel": "Payments of offering costs in connection with initial public offering"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfWarrants": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt.",
        "label": "Payments for Repurchase of Warrants",
        "terseLabel": "Pre-funded warrants, exercised"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Payments on financing leases",
        "totalLabel": "Payments of Financing Costs, Total"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Underwriting discounts, offering costs and issuance costs",
        "verboseLabel": "Stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable securities",
        "totalLabel": "Payments to Acquire Marketable Securities, Total"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment, net",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r3",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r3",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "totalLabel": "Preferred Stock, Shares Issued, Total"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "Preferred Stock [Text Block]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r3",
      "r618"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of December 31, 2021 and 2020; 0 shares issued and outstanding as of December 31, 2021 and 2020",
        "totalLabel": "Preferred Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r639"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from initial public offering, net of underwriting discounts and offering costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net proceeds from sale of common stock in public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "terseLabel": "Proceeds from the issuance of Convertible Preferred Stock, net of issuance costs",
        "verboseLabel": "Proceeds from issuance of convertible preferred stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Aggregate proceeds from issuance of private placement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Proceeds from issuance of warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Maturities of marketable securities",
        "totalLabel": "Proceeds from Sale and Maturity of Marketable Securities, Total"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r28",
      "r91"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from stock option exercises"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r147",
      "r164",
      "r166",
      "r176",
      "r181",
      "r192",
      "r202",
      "r203",
      "r232",
      "r234",
      "r238",
      "r240",
      "r256",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r407",
      "r410",
      "r411",
      "r426",
      "r434",
      "r538",
      "r602",
      "r615",
      "r616",
      "r642",
      "r669"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProjectMember": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Planned program of work.",
        "label": "Project [Domain]",
        "terseLabel": "Project"
       }
      }
     },
     "localname": "ProjectMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r66",
      "r576",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property, Plant and Equipment, Estimated Useful Lives",
        "terseLabel": "Estimated useful life of related asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r62",
      "r152"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "terseLabel": "Total property and equipment",
        "totalLabel": "Property, Plant and Equipment, Gross, Total",
        "verboseLabel": "Property and equipment right of use assets under financing leases with cost basis"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r64",
      "r133",
      "r539",
      "r618"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "terseLabel": "Property and equipment, net (Note 6)",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r64",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life of related asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r328",
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Rent expenses"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r328",
      "r481",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r479",
      "r480",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r96",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r96",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r95",
      "r138",
      "r728"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development",
        "verboseLabel": "Research and Development Expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r635",
      "r644",
      "r729",
      "r731"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash",
        "totalLabel": "Restricted Cash, Total"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r573",
      "r636",
      "r644"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock",
        "verboseLabel": "Unvested Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r6",
      "r76",
      "r131",
      "r551",
      "r556",
      "r618"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Accumulated deficit",
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r144",
      "r188",
      "r189",
      "r190",
      "r193",
      "r201",
      "r203",
      "r264",
      "r368",
      "r369",
      "r370",
      "r390",
      "r391",
      "r424",
      "r547",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r228",
      "r229",
      "r233",
      "r236",
      "r237",
      "r241",
      "r242",
      "r244",
      "r316",
      "r317",
      "r519"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Collaboration Revenue\u2014from related party",
        "totalLabel": "Revenue from Contract with Customer, Excluding Assessed Tax, Total",
        "verboseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "terseLabel": "Revenue from Contract with Customer, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r597",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Unsatisfied performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue remaining research term"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r468",
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Common stock per share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders Anti-Diluted Effect"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsChangeInAccountsReceivableContractAssetAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Significant Components of Net Deferred Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Summary of Basic and Diluted Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Rate Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r89",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Equity-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfEstimatedUsefulLifeOfRelatedAssetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r117",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r330",
      "r332",
      "r334",
      "r335",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r84",
      "r85",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Weighted-Average Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in restricted stock units (RSUs).",
        "label": "Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r636"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit",
        "terseLabel": "Security deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [
      "r637",
      "r638",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B preferred stock.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Preferred Stock"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [
      "r637",
      "r638",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C preferred stock.",
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C Preferred Stock"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense",
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based compensation vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": {
     "auth_ref": [
      "r82",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Description",
        "terseLabel": "Share-based compensation, description"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested at end of period",
        "periodStartLabel": "Unvested at beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Units Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested at end of period",
        "periodStartLabel": "Unvested at beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of restricted stock vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized for issuance under plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares remaining available for future grants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at December 31, 2022"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at December 31, 2022"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Exercised",
        "verboseLabel": "Intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Outstanding at end of period",
        "periodStartLabel": "Outstanding at beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of period",
        "periodStartLabel": "Outstanding at beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period",
        "periodStartLabel": "Outstanding at beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Strike Price Per Option"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum",
        "terseLabel": "Maximum number of shares to be issued, percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfRestrictedStockActivityDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r337",
      "r356",
      "r357",
      "r358",
      "r359",
      "r362",
      "r371",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r332",
      "r334",
      "r335",
      "r336",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-Based Payment Arrangement, Employee [Member]",
        "terseLabel": "Modification of Employee's Awards"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable at December 31, 2022"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at December 31, 2022"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r353"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of stock options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r43",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r181",
      "r209",
      "r210",
      "r213",
      "r215",
      "r222",
      "r223",
      "r256",
      "r287",
      "r290",
      "r291",
      "r292",
      "r296",
      "r297",
      "r301",
      "r302",
      "r303",
      "r304",
      "r307",
      "r434",
      "r591",
      "r633",
      "r645",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfDilutedNetLossPerShareAttributableToCommonStockholdersAntiDilutedEffectDetail",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r17",
      "r73",
      "r144",
      "r169",
      "r170",
      "r171",
      "r188",
      "r189",
      "r190",
      "r193",
      "r201",
      "r203",
      "r221",
      "r264",
      "r309",
      "r368",
      "r369",
      "r370",
      "r390",
      "r391",
      "r424",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r478",
      "r547",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r188",
      "r189",
      "r190",
      "r221",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationTables",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r16",
      "r73",
      "r74",
      "r76",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible preferred stock into common, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r3",
      "r4",
      "r73",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of shares under employee stock purchase plan, Share"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r3",
      "r4",
      "r73",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of shares, Shares",
        "verboseLabel": "Common stock shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r3",
      "r4",
      "r73",
      "r76",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised",
        "terseLabel": "Exercise of Stock Options, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r17",
      "r73",
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible preferred stock into common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r3",
      "r4",
      "r73",
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of shares under employee stock purchase plan, Value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r3",
      "r4",
      "r73",
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r73",
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of Stock Options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r4",
      "r7",
      "r8",
      "r50",
      "r618",
      "r646",
      "r659",
      "r713"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Reverse stock split"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "terseLabel": "Reverse stock split, description"
       }
      }
     },
     "localname": "StockholdersEquityReverseStockSplit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow activities"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r0",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity By Class Of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r287",
      "r290",
      "r291",
      "r292",
      "r296",
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Temporary Equity, Ending Balance",
        "periodStartLabel": "Temporary Equity, Beginning Balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityDividendsAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).",
        "label": "Temporary Equity, Dividends, Adjustment",
        "negatedLabel": "Deemed dividend from exchange of convertible preferred stock",
        "terseLabel": "Deemed dividend from exchange of convertible preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityDividendsAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Liquidation Preference",
        "terseLabel": "Convertible Preferred Stock, liquidation preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r0",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Convertible Preferred Stock, par value",
        "verboseLabel": "Convertible preferred stock, par or stated value per share"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Convertible Preferred Stock, authorized"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Convertible Preferred Stock, issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Temporary Equity, Ending Balance, Shares",
        "periodStartLabel": "Temporary Equity, Beginning Balance, Shares",
        "terseLabel": "Convertible Preferred Stock, outstanding"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Preferred Stock, net of issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r245",
      "r246",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "verboseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r253",
      "r254",
      "r300",
      "r306",
      "r415",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r656",
      "r657",
      "r658",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r192",
      "r193",
      "r194",
      "r195",
      "r205",
      "r248",
      "r249",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r368",
      "r369",
      "r370",
      "r388",
      "r389",
      "r390",
      "r391",
      "r401",
      "r402",
      "r403",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r450",
      "r451",
      "r453",
      "r454",
      "r455",
      "r456",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r520",
      "r521",
      "r522",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborations",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "US government agencies",
        "verboseLabel": "US government agency securities"
       }
      }
     },
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r599",
      "r609",
      "r611",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US Treasuries",
        "verboseLabel": "U.S. Treasury Securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureMarketableSecuritiesSummaryOfAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled accounts receivable"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureCollaborationsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r373",
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance",
        "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance",
        "terseLabel": "Reserves for uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r46",
      "r47",
      "r48",
      "r224",
      "r225",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r185",
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount, Ending Balance",
        "periodStartLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount, Beginning Balance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Increase of valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r466",
      "r617"
     ],
     "calculation": {
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r208",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average common shares outstanding, diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r206",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding, basic",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfBasicAndDilutedLossPerShareDetail",
      "http://www.kymeratx.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(a)(32))",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6806780-109447",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1,2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31010-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130534-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org/topic&trid=5833765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL120154346-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55302-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r622": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r623": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r624": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r625": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r626": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r627": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r628": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r629": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r631": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r632": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907419&loc=d3e10037-110241",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e13051-110250",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>163
<FILENAME>0000950170-23-003935-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-003935-xbrl.zip
M4$L#!!0    (  @Z5U:AK)R0+>(& .9-"  2    :6UG,C4T,3DS-#8S7S N
M:G!G[+T'7%/;MN@=NH*(($VJ2@<1*0&EJDCO 0*$MNF0"-(%I%D0";U#0'H/
M(5)"!Y6.])(@70B$)M($Z7ZXSRWGWGN^[]UWWCYOWWL_UB]_R"]KK9DUYIS,
M.<:88PY^?O[Y!7!%75E-&4!$1$323-(, /R<!"@"2(B)?[W.#M*S%]D%,C)2
M4C)*"@KR"Y<H+UVBHJ2BHKY,=X7Z,NUE*JHKC%=HK](S,#!<HF%B9J1GIJ-G
MH/]5"!')V3VD9!?)R"[24U-1T_]O'S\_ &@OD%<Q)9(0W000TQ*1T!+]; -P
M @!$9$2_'X!_.HB(SYZ1G.+"14JJLPLP5P#$1"0DQ*0DOY[Z[&S V7D *2T9
MW0W1!^17]:PH;KK1BSV/S;[ ];#\(P-H:)-;W-K]Q45*1B;F:RP\O'S\ H(2
M0$FIN_>D%1\I*:NHJJGK&QB"C8Q-(#:V=O8.CDY0#T\O[Z<^OGXO7X6\#GT3
M!H^+3TA,2DY)1>3DYN47%!85EU145F&J:VKKZEM:V]H[.KNZ/PV/C&)Q8Y_'
M)^;F\0N+A*7EE=6M[9WONWL_]@\.?\E%!" A^N?C;\I%>R87,2DI"2G%+[F(
MB)_^NH"6E.R&*#G= ST**[>K-\6>7Z!_&)M=_O$BESAHD\':?8B2D5MBCF?K
MEVB_2_:?$^S%WR79OPCVKW)- "Z1$)TU'@DM0 %PHI\#YP><<\XYYYSS+Q 5
MH@3A_%ED.3FP-_$;=QFNC3HGEWY28 %4ZNH\HWX_^]A0:/8*!-*A@\@[@?7Z
M.^'S0\QR3S'J4@P#ZFGMD("ZUAYXH52T9]''DTV%2/_8^8&P,;VN(VZ%MZY&
MG PB$V8767=0AN)2NH=''18RF.80+)L-FX>EZ+$V1KJBYYT#T$AURXM0&-S;
M"9Q>/F4)<#;R6P(ZN<<'VBR$HU__D&+)F&.UD4_\'OHADWR@L.?R A>I-]IX
M./!BI^LG@LAP$U>K O6(BMW-.Z+KVH:W2_E'*NLF]UW$&9-9,M6Q1;?FCF1O
MR GZ+4H3I^KD?<@BA7CQ"C@!])3HSSGGG'/.^6\'G[860)BA'S;#K25G2N@0
MZ@?.AJ\4)IT01#<,<L:E5*IPVIA2)3L2?[P"Y. 0O_?"T-Y29K=43@-/._K1
M,/G>CY(%VQVN05GS+>[/R9-\:Q;Z*'_WC)F'I(4[I5J05;Q9MUGZF$# YK?3
MDW!2FTSHA*BYJO-WZ>K]:0\?[X.\4PD:.C/8E N?EP>+4<NSW82KK%[?T>!-
MRU;?N;-R%1*E[-XE]JN<,JQW5.X\/KL?(1*\TZ7H*WQ@-')*OVEVIR-MT%5.
MJ#)<K2K,]8;^+D-RE=TVI_#^TR^]21%U;Z);FD); BE,V=-R5]8M8JKOB*@F
M!#+<[ @;NE_D_AC#2CLQT0EC*2DB+\R!OWAQ-G43_Y^05O]6*XN,/ E1M0K@
MSX'_CJ):?6)Q%>"0/V_Z/I42KY/CGZVCG'/..>?\#T/@UWSV04!<0ZU*EWA(
M3:_//0E_R^T^W9#Q#P[^BNJC;Q1X YZMTS3.XRK+_K<I47$FI/S&W\N"0%N>
MTH'N1G""UT88&'7UPJ+EA[%(GY%..DW.GIA3+[>PVV"YN!T\63[RBGF0>ONH
MO.2D:C[8D%/1DFL_O WQ*EZRPQ_,4XTJT;I#^AZ"U5?V7QK.X-E_X\43$.<@
MO[N0P5O;."KU^)8'N%&@8'J5C/1Y%.RSK-3FD!>9^=:2?$Y&+&.%O&F\(I8G
M[;J"I=]*H]2<Z0&O^2IV%Y/Y4>9A5I6Z/*;281/1/_3\0J/!T8,2AS@?O@_.
M=W3$%(:;PI7W/>S?(3583@W?%^Q;LRNP&BH+N1D(!DN#;QL!]>XM'U,7J S?
M.#"<#+H\/GG2=B($ABO1ME.VU.K!X_Y29;\#LG^]HI5%89^4JFV1 *C24P+0
M_U%\"N !W!PIR@FFY#_GG'/..>?O)T\"4*7_% 0'0/[Z8P'!@NPB)0<J1M?+
M<H[$K3IL0;X?BM) U1:5_,>P[F/S+9*O,GO=T1V-H1;[6&!E];C.$H1?TJ$_
M=M?_<#&=4BU5!V_&&>[_A%ZON9MBR5)<;:N?\'22D-D?LH7IQWRT]@ 7?S9;
M>H!7"+O:L5&A>#"6O*I CSYN(8T\&'/X";C@?[@D8_RMF&N?26ZL;_'J/AC>
MU3>=;I^*?[:N%FQOD^FW[AG $0!S^:(->_9@GU.X%*ZILHV&;!:VEMM4>OIT
M8OAX!J$BQ00<)UE4#@ES929TNNHD$R=&$W]H-,ABD<R0+O3JVB$XQ*:_ST!O
M09JFQ7/$.U.$>0_]:,A38F34/_>YJ8%!]3CXK#+RK)3H=8G^'<1ZU4EP@%85
M:.@^&;W>_P8):45$HW\UG?'P[NZ6/$U^<=VWE!7UK,>F3X8(^\02 ED4]IKC
MHD'4?-T@_70OYX-Y3EQ2S/_>-YUSSCGGG/,?2:@"Z*DI.Q(YT:A#^(D2YH:3
MX.3T('%GD)8UU((W7(?"C83^PE1.XY+N/@9FV\8$:6_<GX.]"XE5&48FQO=&
MJ^$P"2-XA3O,:,FQ9L';&:9T>([==I_P^1>KE)/<_0%KW?Y:1=-0F3W&>RBN
MRPOJ*J4S_D%7NE0R#W%R/P$=^")BTO&!)O_=@.Q5CUY5&AS&4X%R54RU 8NT
M,'#H'7B$Q73O?O NET'&-6_*?<M3N] )7+6@V)2M. BT#DQ<GV'??^J\*! '
MY SAXZ$MFMJ?&9@3_@E(ITF83?23>M5\S4SQYI,WIX:[LH$4(S8D/VP4U.MH
M7C_..BI2$ S5Q9 \WPQZP?5:8I9SQ2+<.6?"M(/^8>$F\LY$I\N=EPS"MN,Y
MX!NFK%XK=-$M><9Z?M<Y0^3AL2%_3,7;!S/^[MP4$#_3. 0E4X0%NUA2: JJ
M 84&1C05XJKD<A^T=R%:JB)^GT8QM!R^9=X;D,E,1$E+W5CUNY+ W5M^+>5'
M6$)RQLWMS\=8LO?P(-\?)74/ETK+\DKE=Q_(ES#H])F99[PG%!V4.*$CPC\6
M?A)*]I(S]7:%Q8T"R6_Y(I^ZBSL@6NOO\9:T3378%5?4$AKDF,!=NEJ^F0@;
MZ/20%PF!OT^11<ZE']^OUV=:2DT>) JN61-K.7OF<X?K'XPS0!H.'2GZ+_ D
MYYQSSC^2/)>$JLCA8%9MBX0)]^]99 48Z;A@5IV\#_E9I.VL2L!\U=,=(MWJ
MW,=O[?7V!\G@C^-*-9+NEL3!P&X1J6,[93IMIQ(UKWDO7O_B-Z(^7S<\M1\U
M/"8S1=-1F;>UE\;A<?/4:^=]9/--#5:%Y!O':UW )W"F'B&RV)\ ::R^N$?Y
MGC=J2[#W8<L]^D#@PHS8UER*0C+? FQIC9-S=J:[JB%]S"%G<@K&/%U+J%I8
MY,M8 LZCKUKV<'VU+U/RB@292+^''')J[2M[*9'E] <@LS$GF6-$C;$'>KVQ
MLJB,JW//8).$^T>1SSA#3CF#' 5]8Y?DL=/+F13Z.G;RNK^;EK)B"!_+>.8B
MCZ]F-E-S$C\!+_8JKMN'J8R"L>@65B'W"THG0D/W*0%LE)">5(1[;MJ(/_N3
M0CRTJ-WS2MN-^SEY.;$/E.A!?U\+Q'L)_TV'JA2]<R%(%\"?DU.7HOPZF Z6
M']UD/P6CK#M <AEC&QMWS$).&R>C^\ Q9=Z5L/"&#?VLL>2G,VCQ>#-KG3Y=
MA3>]"IV&5AR=' T<LXV"&=EEO*T[1G%!+4Y5^-X3I_C]AE[+]X>#61JQHS#(
MEZE9H'LR8D;M 'E5=^Q2WC$V7.Y(TA>YR"2:7PQ3X2.43@98-0XTF3S5W@:-
M3Y9;08H^AW(-5FGII5V#K@EOD%SO1LL-&^82U[#JBO)!W,LO5@9N[Q)GP"X_
M:[>7Q3%FEUU1G3:X@;T4C:M8E&R*@JL1;4"D93,;(4OX9'<"YKN]//3$<9$N
M<7PMD/5QSIB^67+(Y )D#?86D2U0=:A5]5HRO8E_4@D@_*>KJ/_-N2%1A<LB
M\9).T\XB3JM^JP2X3E^5FNMU7K'GG/,_&.II=6I>:L%!XF'0T'WJ20V-LTG&
MD%U'5X-?3?BEA=<\39A0(6-;2F>31)G0Y]U;HU)&L:;*)NDDN^BW0)'HA]BN
MG?>0UL;]KT^(]*36C+JZEE3*?2H[NJW1F$.CB/UX/%MUV9SM"2P#*VLC6<M,
MP>?E#@D-$0':<PNQX<KAJQK)-O9+>$R/JE&?PEM@(-?4&ML3/F /7POL@)MZ
M46'1'!URRFC^<*5>\KCD9%2Y-,13)C*H_%YQ[CZ/W-;T8GPF](<(V3[U;P:_
M;&-TX;)D=3GZ6T*Z'QB4::-$LK#.]T6S>H?86B'1+S0D\%K:7Z* IFXY=ZH:
M;1>6TJ(?Z>T;W*L&DMHZ0MC =R*RNE!E;_E7E&'B#QSS\O_/8H'.('^NG0._
M?S9IW_F+H[YD9^I")P20_HY=2ZK7\JS>L&U![29]\U<*-_3?1=7>E5MY2@-9
M&&D3.MG I<]PW7\?M)O3*JWFPBB**]8H%OQ19KW6!GL96FJ*I@W"@+.ZW,MG
M"XK>SY3X)95FF+1ZHZ73V@,M H-P168^[WOQ06LZ"?21D4_T9CK)ZYZ%78K$
MI4H6[[WNA]*Z4M]A%8O)PY&C7(>6$+,(JW=CXJ6BC['*M[15EVYCU!@5^ZZL
M5DAM&9HBO7UI&.P[M;S7(5_MZOP$,J -U$BUB5)C)Q62FS7.WS>SW)0&#S2!
MPSW>2/!AX/!=5#O&<%TE@1[GGJH71M9HRE]/886DS$EU^X0(X>U95,7O:DU&
MBFMUQ]BCH7K$'3DC^,GKJ*'(76E6XY\ ;R$;-1"/)4JWTKQ+Z)D:9OHZD,XN
MSX_I-7,(Y*O1-_ABHPPY%K*:G%5F#PW)@0M<^N<8JU^XK.HZ"8#_R5UQSM_=
M9S$\\O]:J>><<\[_-!"]#&IR_$2C8&=<@S/L[?HASG9&=B3[K@/G6QG*)0T3
MOZ0Z]F#NV':/Y-FKM[@B7[G?#L00 D7V7U0*';@[;)7H/3:2HP+MYSM;J][&
MA+AM=0P9/!=\:2GNT]K.%"]^\!B[% ]CR8M+9VI_7)S+IWO8:;Y?Q[Y=D5<W
MT.1K&8:9C-0)2NKU,&,*-=)M3%3\AK;=S'QAJ6NP<_5>2<6;L@4?>W0NU A$
ME]V5J[:9D3=,_6EWCS=^TWUF_HZ%Z %X_?W'-697;V$1QY?CF3+[?!^EZ"0"
MK3G;C!KVC>86A%F>O DT''.:(:E^UX&U$,K%5)D:ML"[^PDEDJ(W-F^GL01;
M@P(373@I/[?^L"'91,&%9"K@N$-_R9\ -S>P8TY,R]DH2"HQ$4 /"!].^B-\
M*7%I]VER8AVA (A UD@1\;U,:_NZ)AO0=HV'*2(APXRW<;)M(C8R#5$;?[.Y
M&,66B7AGCV,]LZW#^TP]TA&]F7IL.Y#/:FD[/C$M-'V'.,\9"4'5V<.Q&\C5
M?(,O8S?<2F54[P.A_%$V.(6Y6^)NS4E:5GD6U+ZX:/>=.TO 26.(;"P<AQ.S
MT]+0]^JGMK[][M2>BF792Y@G58>A7RN_0D']=>A5ET[0K5S>LDC%F7<HY^EG
MAEUS4'IU A"\UFN! :]R2LT48(+3P1'>SQK ""XI;X^P_(/(X6K/$QXC-G >
MBR,>/EQ3/CE1'NLVB'Y26%(TGQ]W):<L<0*C/&]F7RFIY,1*GFV?[S#E)%L!
MA3!/8R]MSSF-!'XKWZ6:8\F J3Y*544%W)GR+?IJ>_*E-+Q)T3.ESWS8=O;Z
M(:[SWL3*5%$94JVE8DPT']TEE%T9WV-ETLW2GA&69W;+\1[J-5;OV=A%6%'*
MV+5"G1(I61Q;0:%+?0OC&CB[T:2>98<<AY!<1.IK;5V_1 0UR_887('QZ>!L
MWM[OAVG? VN_SLK^_D<&O/W_$9"A+SHWM#A+*[_.'IY5W\B-=T6*3JOP*=,3
MQSV[JJ>&@)#_Z<]XSCGG_/& 7#BJNGE5$RKOD*S=O^Q@>-3)0&4YV?DC7\\L
M%-YHPHYH'EO9L!":1X>#3"K78[8VP+GN9J4!_!/MB$NI8SNE[,\Z&-\]_,C-
M^=8_,FAK>,[LN5"@%T0!7B-=R&'#=H2#IW&]Y2C'/WE#PQQT6Z=K+ PV>_5)
MDOWDV57OV9A8?A1/ZZML>@=H$+:[!S 0=9G4AJ9HN=#YV[ENU\E5[I55*M75
MXR1?3WF8RT5_N)<;:]P6)/C]"=4Q/XPN+;=S3B?5DRY\U<W/LE42.\H8?6^O
M+&G@"Z7:ZSN!B>L9K)NCWOP-,6[KY@^+](+O"#%)0G-\7.(WU67X*+I7UBU"
MLO:!$EB]2N:R#GB4O:6@XLV(1\_O?R@<!KD4\WO1OTCZQP0!VLFG50?3I5>E
M.3D2.0E A<)DJWB#Q3 ],3$U0/SI[5%YAX]E/P'M+$E=4_:-ENW2L;YL]O7%
M/*.?E!D(6?ZM+PT6ZNT'@)9N23H=:"5K<S]PG'G$R!V@V+9 *4^E0QIBO>Q[
M94V^W4^ PX&[9R&MV$_ Z^];VPM&^2O>T)ML1A1Y7=<G)^I[M)RLHU%,#)&F
M:\9[&4)I=94/OY]HM*D3'2 OP5ZH^2TA;I,O-J>7WF5PELB$AJLUT#TW9V^$
M]J@ GPNENJX<B;9;OIYR:S=U;!DQ#+Y9GI FI5?.+?GE<J*C,C'6*X%(U244
M1<NKZM4AB6AMY./%V"9[Z2+8QW.+AA[2)B%[F"?[5-ADG(:[RZ'S$0N]?7HO
M!-K=6-KG+KG"2K"\M_(H\1A^B+(L.*J;+N))%5,:RO.0YC:FYR2]%#/BR =#
M.;A/R#&I64[#/T=ZXR1C9AL8JM*'^*P>E=,71D'[IS]!X_P+4+<^&N",),6\
ME$6)8428CIKD#>OJW="90H:65;WW*:H%%#G+\K=X$IC0JH.8_%K#'OMF]Q&7
MC(M$W6L6T7.1_F4?(-EM-# UDJ+K(T@*Y=&0-EB?2U1BJO60$GWPGV\'_!<B
MK^]OKW;]1]3NTWNQ?GQRE6TLU2>WHZ4[;:D3;QX=7J;)./!RHMEL/WM>37@A
MGL94/UI</DBB79IV\#O1EMJC_9UGAV,FV<</-2+?-Y[ YH6BV;38";*M8[@&
M-.7^P:EF5Y#TJJ=.9':&3D9?IO.*!8]&EOP37+W,L^=B41Z64OM"'?8>S&(.
M6VC7S?Z<V[F*#1CW?K;"J2]NR"M1&7#^4AW;/[T2_^\TDMI]JK\187O..?^]
M^)N187'_/&670%[G)0FJ21!YP^<P.F_V#@/=U]H]*OU=JL+>B*&,A!B&5FN,
MJ)Y0W;M;1M46*&LNY<W=(;<6AFL65_2)0-XY7NLYUILOQFB=FL8CAN_<Z-K8
MC8YZV/>&[A0S,.4?* 4H2MM%4X])3#_<32GR, '+TX].6"4&8FINBKH[5$$M
M:;EQ#XBZ!YK<(4GA3U&B@LP$M(_"QZ?NTKYO9A.?#;P\Y>R\J4)0.8"_'GU@
M89IYNWLSXW"QQO=Q$.6*K-1FQC<!)D_GL>'FSLI-CK>7?I-0UQDN4YF3D^=L
MN,(9(N+H6)PA\N5]:,>L_?Y/@/J>%FLK&/>NV/'CW>\H?HF&9_Z/-0W?249<
M3@Q/[ .57RBO8;]A^2FC>DODUW))@D'$_6R_2Z"AOPS(-_(FG$9UB2DA?X^[
M69V?R/%O#C1_O?8B4/K1;Y"D^-J+W9)XRU(30OD&$ L*A'J39-,5;QA@9(++
MV3BP ^@W3$=8BR,(G;+R*I)R261^;033 >ORZF910S1QM>G[3C:,D03 FA5-
ME:Y56X^W:;Z$KY0ZM_+/%XVO_ 3<F:\17C_.1PV]M'L6SF.W8EP#OBZEOES&
M2WFAM"Y%1L^]]W5$V]T2*41NRP7R&ON:J48CF1*GKVU?0._*;*97MS4_=Q=_
MWXM3(RJ<6!;ASO2N#Y!J)0!)44(7*S4>3)6(FX>4-A@823G3C)^4;,\ZDR"T
M2$WJN%L9+/L(%:SZ/PI;_:[5XX19"SU,^R3ZVD9=I5+!22Q#%]_4242"7#%7
M_;&,E0+&=N#:B%@CL+BB,B665S/'0RHIO[+=QMSI@ +^E8"AGB@R,U[T S==
MDDZG[LC$U#($J07GO81/U YO3PLX>_X$"(<RI#Y+JS=U?F JVF/"Z):H9S1V
M-P<2)<TD^X5,^4> ;TG%O9)A59CX0UCH#HQWM;5W@"' %&AEJ$HHP-]S*M6\
M=]VZU.EI).DG\2@8^)"!'T86FB@)4UT5CK;9#,PF"!+#AG*=AXHY$K_,,(\I
M5?(+PW?-F=H$9*%2#O!/&J!X::@@O_W5VTH:)@G_>0OCUW3#\Y]5#OX;$CF<
M! ?824?FG(T\ H4HP4'B(54_?8_[-/\Z%OW:X",>A2&MB6U/1Y :YU1.&H=[
MBPD:[Y+&9Q?<MCU,6BY DE^C7U7Z?5477->HRL6-B-9M-'4< "YE\&_Y32 C
M]X^=\CWBFF]*&'Z>95OKWO,E7SW0F?=:FN".)V]B[9"_2X<\LQEPC0KMTEV-
ML:>/Q^SN;F>^M4]9A*QP.!0]FH5R^^'V0ETW$Q>P3MDFW'PS:),6QH;1V"V=
MZ:<JI3Y<EHZVT<(K,\WP3<L(T-UXCU/,-D=\T!Z8E,VZ04ZALZ/CCFROS4S=
MJDK*X2WT'4^.PO%W^_.3/=?L^-:,G/V-GKBZ7@N2WJ\]MO3\378#5S]+>6P
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M5TWS;=XF":/: I0T))X;$6?7U]&*,-PWOY9V+6>^G'VAD+<8F00=@2G>7&(
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MMTEIU2\ZRCSTLPM*#'K8Q1XK7>\J\5#6ANFVZ@&;Y TT['62//25*;'5KPQ
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M?M8:]G[/_VQ?[S\ 8BE%8Y;UE9JP-W=1>T<%=9R,#E\WOI>9/4K_;4+:=8N
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MLYFI71N8(+%AV'D/V8Z^PMJGEE* 1^!=9(6*^R1=]P>:7+(BS%*_&64R9X)
MI'E+,W5O0:MX\_YA;5C*YNR+C0FE*=2!4?4^WX?'1[)=/P'J[#'8F26XF3^P
M:93Y76140$E'VJ;W@0-IVVQB0&+VL4)E%(,3E^6G&J86::CGJT!#CL%F1<(
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M.0-79-BH'O(G3$G88=CF86EM#ZP3*HOHBK)P0//T2[ROO6+NW>'W*#^WI/@
M&8'S^-585R#$<O1\_QE&_U+Q=L!J:\MQ6Q:B6F%6 7;7KS 4M"'ZX*!T7!5
MY-1_W81JLRU.V72WE$X@D##/M^D8Z*G?D8"K6G+77=;,#G$%TD*."HA-2U8"
MUS3#U3;JR7#F$UX=T!QN?U9#555!68LU)Z.]N89%6N,O(;,:*K?A;\S2A<YT
MRF\#6S:'E9W*S"_RK_<#2X>=-!HBKHADSL0&+'[JK@A1>^A$MO)(^_#&+0WC
M4N&L.'W_M;CIVD(#ZTRQY:T)I,3LXSN7,)+)IY.RI<*=&9"*.1PE\WC;I'4E
M?AWUZK1L6I$[NRHU^<;X(#'=Y95\#**UI^'34 <&-;),*M&(;RU?.T#PBE\)
M*'Q)?HB,GEZ-[@U&8+V9/6^!GIS)LRW*21#,ZM.Z99KODWL-^#?%5=_%\@J2
ME^*'BY.-R_CZ&Z&#897R&T76JV)QU];&E4@5G=XR5DAU4]IHI&\%\,+5L@"3
M%;P8J O!V];9_F+X5.$(2 0UA[NP_QU>_B(((?>NW&YV]8QJQK! EV?^ZOE>
M+/ZSC]>BN0MH#F;2&/YZ>J8)VII6L_L(P3VL5FA0)V!**A^XU?%JPI*^W 4J
MWGM+U@%>VA=U:':^>?3<:M?"MD3\XQM#(>WV:OQDXRBP6'449%IYT;AM>^2C
M>T-BJ;PK\$R 6FHLY[)+X3G_I[YRMX\GO.MJ5-?UU9(Q\AP^IE G]\]$59.G
MG4GL& =VI7/Y,QQ"H@T]U^[>B4HCW/.5,OD\$F5A]_$S6V+,(OHQ&E:"/]MG
MD8O4.I4F-!H):#)+R[3^D7AZM!W1A,Q*@$HT(46W+>Q^3.MK5%H,CE0DILR-
M GT>#EW:U107F#]&?AIVJGFM#WN3D8=827K.)&RR(RNI%X6[B37W()OA_;;0
M?Q7_%#12]H]<Z(+UQJ^Y?Z]PPX1\V'38G%(-J5J4(RDK@L[<_UY^TW/\,6L*
M3BJZ_H,[++*0EEK.87@)*B,3GO>HW,0)]>Q[O=^B)_?#Z[A_DLLO9#KH*EQQ
MW#M6Z$@?^5.J^I70[I\<@N88!I$L+HX.3:R2-  @^QZ;)_T-V^WZC1M/#N%A
M/(L\"$*%-(MW*>_#A8=*Q;8"BY]6!5Y5Z'M$3)8.8*5<O<J]O7[K1G3G?/;3
M7-'3GA:_X*3D9^S0,_3_B\M-SVA//DE;P.I4!$2(JE1::A"=WN-C4;HC GR^
MVFK1<J^L$8KJU:Y9*M3,/<@MWSH:LA6K0WF39?^W"ZY^(#)0N#[&X:[=!EP%
MT2S:$+_RQHYL^?C-0;/L-<.1136Z0821;% Y)%.&)BDNS27PG!&>GC YE!H(
M7:BL*-5*,ZM92)O6$/!O?S212<\O;]K*3@=UKUZ-EF4WWY.7$HR*J))/X_3E
M_/I5R7=]W>V4@7B_1/Y6HK%EP&A)218P?52(?Z0[4VXA1O=W9F?)^B34)00'
M2A5.#(Y9%+"VK5.IA"6)+UE_$3K(:K"\YF>7LGB:PPFVDO.1_^EBY9,U8[.O
M)1'2TIPFJ4LZC1_D=#&ZA-L1HLU\86<^;]<._I2SGVJ]Y%/6G7,*XV1A<^:K
M<\J%X<K1?WI[WM04J:!&7ZT<XOP5^G0R*V."2[VFD%:X:V.$RM^=IE#]PK9Z
M+<ZSI**)9U_6KHGS.F'\7GKEE.G5RU=6)%9&!1#O\>4TU)0YG[))(]K4W6C
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MS M"5A&S@&W8@$^-51\PZWZJ;[=Z[;. 611(*&Z1?ZTOH$:%=;<$JM7QK!(
M+;5#O4._-."/<K/([,L)CN7<X8JDR=^8\8+&^+SMZ?8BM(AW/9OF 13-N05.
MW%R,7%,L-:DI6 P!WIG?ZXOU^TWCLY8158_:ME+C/M+9RFIR\%=T9U\!<R4Y
M7BYH8F^E<\6+LP-G&EV8J5)VP>8]:RN6,]GS(F^2%[KFX9_FOH;$IV[Z]([+
M$PSFIA4GVT.O 8M&07\ASPD3([S2K:6(*Q$+6,^2@/CI33<XDDZ^M]09A,4K
MHL,$I%M_Y/PIG/5T*A.GM*G6OA4)75FB=EGJ+4V^V.'T<252BWA?Y0"; L?
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M0=_8R8>'_N<C,!_ [:J[WN 7"=_OB*FP+CZI4)7?](0=ANQ_.UMDD'P(/4V
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M<U5'U143=;$,NEZJNT;><Q3;C*/NR5#+MN 1V:MV-.0"_!J_)037W$ MIA?
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MFRD6XIVD<L[-W\F9'-FM#/3=;@&;!SXYSKI!^WLOQ9.2"F<T"?(M#NT8SB9
M,AV#6ELR@GID#PQ/F,[3@]9YU;)NJA5P= F()CTJ<^@N4OM.JK&F!D%HVY!$
MA*G/>2?BOOU620B 3:Q$\.DF!2:;&:J/K.&VP#O-NS#KR(5_W%BQA(2B_O[=
MTR![ $7[&'SKN=1J<PQ<<>5Y4**C)+3D-E[MT%'T-?DMBF?AO0A$=T_JTC>8
M)M8Z-6\Y',E]X-;A*/'/"KSXV:9;6P<@E7C[5;O.E*<OOCUH]P[T,SZ#ILF
M05\)RNSW%\^"HF*3L.X,Y+T2@!QP;G;$?Z*2Z6#AP[0Y?F<$38NOW"1P\"W]
MRHNT:\7QRVXSS3%4LYR\9A,3K$S;U?2*Y)C=G8'6HR I:^)0$S;DK:>Q?7B6
M"2)=>^^:@M;;F=&_U#.>MGQ1/_Z9!-@5WRG$_V9[;Z0CM&6FJS^SP&)_90<6
M^MBV%O-*D5"!8PV7QC;:,^T5%XU<'W\RG!&O*D2H*8/V,1WB^Y3W/@U9*:B1
MI^DW'UGF+^&:?7"LA\\/\834-:A$[W&"<%ZN#F^#?LN$J3?:=%,F%-4MI(+L
M5Q4Z&Z]!: ZE!N57C/5+;$7=*14>J[*XGW\F;A5\=G/'[5YP,L:+[,#H1M\O
MZZWGAFOFG$<" AD.PXPN\FOH/,IUB@O(@JSCO,IS.SQ//?<WP0A=_*GAH7M>
MMX];\Y'T\J:,@,_3N^Y5.PR5M2R(- -$0<=F%(??W;_1A3BP)VA\B=#Q0?>Z
M_Y8H]!4.3(@C6.J)#EPWT[5B+?<7:]/7[A)&[7,2'[:L9$?[>;]YL;40RTDQ
M<YP"6ASQ=YY_8O %RUI\KOP)^T1#Y \3I-</M PU"(6JYEFSRABVF]Q$3WWQ
M5,OG=*<\M(78FXUM!0F,E72)<6ZCHX18A/!# A!4E]A0LQLE[G@A<=-WP<BY
M:VJA?%S QI>QUH!HOZ VQ?9DM@!DSP:$2*2@'U.MQ^HBR7#VY!,F;.[OVR=,
MZ[\/-[YYW8X\;:T"-97ZY<'9ZW->?\)'8'04OV'ZI"G*H*U2ZLB,K3N,*#:!
MA1*R<KZ*GT&.8<15&[T.H6]01G537]VMK-R,D]YI[VR5H$83[/NR[C3;-P3Z
MXP(CC[K/(. <TN3"PQ%EI:TQ7IJF?L-:U5Z$@V:$]N[ :77>!O8UJZ-YOI3G
MT4J<V_+ORB,ML83&/MFNUNF[V\K^^&G;NI\>5QRI93WGC!I_'5J"BA+O3D&4
MX6MA+U8U4+06=L@*FFRD1;GUYX3[YGS[)XW9TEM^F;%&E(Q?>HX+;$/-EM0$
M7M]X)[0Z+E"0)4Q[&P+;DN%"WJ-D+(&VS'#R68+@E5TE\*4" 2O*$J78?+:S
M*6A^>BE1&(6/"^=:X]E'W]^T7([1/D!_Z,GO-EG"$8D#NEWXF;]&5'L\>"JR
MK;*=$@"(;4BH<L@RD=0X>UF_T< E/W RN+POI)[:+Y$L+=HU .< A40O\)5^
MWY6Z.V4A_\@7;4*M4KK2W><3FMF\'+641HM5+)OV9M]%%40\80=)_D:M)$?L
M,9YYZ4#HYSY:97,Z)>T!H6E[?CU-:*L?6'6SM7C$R%[4*=RU@. O]MY#L?SW
M:$1,XF!Y&7(041 F/UZ"BP[LT&2+NJ)-BZA>%*\9YZF]3P,EEKYTLWPP9H'K
M8,X"ZMR[8_*R7];-6VN@A4U5^DO9>RG4*!$(K^HESC0/4I.M+V)#KY4NR(29
M'#GG'>(741HA3R9?'D-"*R]]ABKV<>Y9G-JP6MS<?W*KV@8TGV:]EA* '%'E
M\USL 8"VE2RU'KT\?-B?5GPFP&WN6&^@YA%B/QR,-#F$\FW2-ZMO1^U5=,$.
MRB97X%6/B]=N[4, Y0;C!-8LL. %'1&?$&R@/?H5->K6%C0$V4+F(\.3[$Z8
M^""/?@;^\\RTJWDM$+/!0."=Q%3"CQTTRY!U'^$8N;SQ?M#I9<OYQ6[Q8BA4
MV;TD1LXR-@<%R=-P>A'Z<L'D6S@4H\X@^5T?X;H8>)UQ1)21%F%4>%%T7.L)
M1L<QGWL-?H<&JS;MK1/ [- _3SHN'D+[ %Q\WNE4?.\2Q>K;H62,O@G8<82*
M=2FW&)[;-GUJ:4Z'L.)JY+CWE?'$)\0^P]R]<[HCPVJ ;\JWXE]N879.F-YX
MI,QC3( 36+[YXZ*+ ,X=^V"PN:W Z&'G?<W;.F.T6M5R<16+:=-1O_/=>,DD
M;?.8T2JSPZK A6/@[U7AN8$/!1/QX"!J>&&9]?V(@Y8.\E<[AH/=;X^MET*U
M$2&[##;8M;V<+V:S6Q;QR! JJZK ,'N]771^(%?M(;JU&;$Y0 N0P34G4:T@
MHX&< Q].F-BN*6ULCN\$QKA;)_ZDTLG=M0E9HZ/+---\UVQVX4D7,;727:Q%
MO2L><K.U*_URW+9,NY3%P5;4/EI^NWGP1I\''5+7-Y*Q7W&OX^LHU?E.;J97
MZI')I;1@#L]F/@Q<3><:>1D0NL8!MG*#JSEPO9W^2&IB5:>$54W^N<_2&X@^
M?T4_2]3VGF=BW*Y&4OD%K]4[RD].F"8-%7@ F:@CUG;L=0$7LA&ZO3)[MZ4\
M8**_V-R=(&!@<B0P7@Y7ETK? BZYA$?R1XO>AN%GK[QKA_8.$*W<";$<+&L'
MCOC0-#N.2H[?L?:2/:N/,\=)?HDMAV:'>+UY\UC!!Z3Z'G*^0WAI@]JR#E<:
M;2_C(V(:$&0D[5$VD$\[57:M,GIT7?D"W>/Z$;07SHJ1ZN/N"[@Q+X[J\3R$
MDNNEG'WR @TS#!<2['4T.*"X;(E__V5"_W:Y?O[FYY1_O<4C(B5ZDRD_[[]Q
M]]Y!36YMWVC4K6XK*@)2LQ40(2(J!)06%>E-6@*A9$N'" A(#[ 5Z24" @("
MTFN(E-"+=) F)0F]A1Y*0@TAP ?[><[[/G/.G&_>]_OFS//-^6/-K'7/FN1>
M[2KK=_^NZR27:X1-+$LGQ\\JJCPFR^T[8_&,9>07H2A/&+]$L[<D:X,+@\P)
MI>5:S16WW4&G9EN"TK/Q-5JL22>1_*2T:0T.YDJ/[[75>J##:CSM_?:<K!:1
MS35:A8B>WJ)$"B;]TIKEK#?$F3HS_"GG"U-KQ1'@&DK/6%Z?+[ZW%O4C#IX1
M11()(UI,8V3I&R^OWL+OBP7-6TX&K=OCH*;^$=Z@C_64NDR7NR]JO9FG@8%'
M 'O=3=X>[_R!K<F/K':W1&Z@<]+C7Z)JVEI'F#ZX,-]94V#D#Z.8IY0-HKO"
M#O7678]%3X%PSPN1.4-7V>ME1:UXQ,\TO0?:[[MI#M,'W_W5(K%SQFH^UP?2
M7TE'[D%K'A8(XCQU8\*'4Y-8_:R8QL,N5K+4O#UH:5&5O_U_#S3[WRQ*IT,$
M!?^RC$TL^_R?87ZTM0<,,0!A8;#G0,Y_*8IS1H:M"L ;7#60BR'\=6O<YB2E
MI\V@UC.FC,PL'$#X9JC&MW-:&F(COSVU_G81?DZGZNO+K$J,)O12A67I=D>7
M[1@Q>3FNR_QU0JFR*PDJU0LV,7Z;=[#<&NL$>UI@]X+1R@3.&U1+01 Z00S\
MW,0?^&%S>V3&(#8L9(QX9D:<7Y_0!WTZ^WBRV40WQ;/*6*(EW?HD(!X5H_K*
MRX-)9IG3EZ54X 3'(!#O+%09NW]1JO?=+O35)CX_/X^5TKSEX7?2_0.I^9S]
M&:T_A=T#=1^S-A2H2]J83+F0H21_;"(1W&]=Q\[_?I2N,R?P95GZ3B].U"3<
M*NE#I3"S)FNJ>XO+PRZ69[DBSG(]%VL&KO1CM!*<8"'=R7.?MS,ZBR65UA7-
MH.F58Y)$CJK8UEE">%9A-CLX6I W&RH,?9D(PY@;+O_>22BH_37:4+ +%MUN
MF@==W#R :6Z:2\,<<L;.=3L3']]=0[J_7$A\:O%KUSG$0$Q/[RE\,5;I1UX<
M\1[O$W ZOV@P7HPV\/1TY=)K?WT**)W()US-TF[LD?R:_$HO'&GHGO(]9UM&
MYC+?3'QF05ACF7U!@JISFZT\#W@FE.4R \9V\-D\\;U)^HS=HYK6F<H#B+K6
MPS&I 9:?=+9 HRG_PD;N!X;N@;]!B8$KK_6,WAN?;?FLS@;0\OI]1IC1\ODJ
MLJ3/#J[?BI24 <-)V9ZKI3+2]^5"Y$6%O! B.?D<)JS/X9*80OP4U"5,K1AO
MU,U;UV>ECT?FE0Y& RQK#GL4(AY!S^50DW%)W4\UGR4L\9O@PCUNN3XI0!I;
MEY_-5[B4(L6%3W^T4W8$D'$8;L/):Y=\E !C'5C/6HC;W=3 A$"C/K^T=O\9
MTC[X06%/W7Q2=@Q/SJWYCKRZ07:4QO/)F?V6[6)MJ+X1@;RFOJG7;O]LW5#>
MZ*="1ARG%\%XK: HESUKPO@U$[@5F1 J^(9C@O!P/,Y%_;5Y+[AC<L*>ST^W
M$'S>YO>[WVPNA82.$6-;77/?KF158. 2KN"Q,;D:'M"-?<W?>.[-W65D7S9U
M\:Q%#EH6CAOD/9K)^W9QB$7X9LJC^NQ5$J$:?54M_PXL92B S[3:^+0$5$>)
M0R;T>15"&.F$G+M J B_8QD.+2T4X72 ]] 3^%.S[^9=K\+GR]@X$RJJ0V,M
MIP9N5T5J.-G^M96)CTPG&\01R;W@SJR<Y9J$?.=\YF2;BZV#]$_L\\5K.+DA
MPOV1+"^\9?5CGE)AE:'^J+VOV_E0)U9><+Q]LB7(LF>,VH),$[6<3PEH1=I*
MZ44BS^$-?L=4&X9_,R?8RVGQ5O3+"<X4V:^@OA*UB<'E4: ST*H7V>=**EV?
M[N>>GH6Z[XV&Q"YU13CJ+.TH*'!!:T8N?8Z=$#<O&$>H14UKG'6M\OEDH-@)
M]Z6@[X?^')BOE"Z3M@5>EE*/JB5G#:!DYG+VD!7>YYY4CFHEO@O(N]==$I?0
MMD).CD&[%'A_GOH*T\&H1#;B9V6%\#65AN?RE!PCAPQI02JT<6/9Z'>6#=WN
M68%YI42 5:WGKO]D5[BHT49P'ZN;N..:5D+4S""+M$Z!SV+^XPV0<.C3_,Y'
MO2Q:=B'E*A,5@:ZVV,BRO!E1OB"JH0\W>I>\74 .$\RGWY^^B\!H#W6O>07Z
M#7H@C;T]%OQ=Y"/ '86M,J:/T_DL*^<JB\5R\GY-\M5>T3\/YOW_ TOK[Y*S
M3$18E0N,8*$B(7R7S"=5K'NR&WOO41?"9+NX[+$I*..9N4J/4V^(#E3#5X]*
M*\";$L&H9QU2C'%R\74HY%$7E>7IF/H5TX.[KD\+G68H#]XB;RPT&P;OY:4.
M,M:VBZW^BG;042!#A;(3?M3AV3>[544]XN>+L7=DD.I7*UJNJ;M4)-N67!O.
M>7!!1P^^B%&+Q-]:2K54:GD^%S;@\PN>Q+EF^U%&RWY"]BOT,[226R@3:TO\
M&)[V(5(!:9>>J?5IS\Z034T\H:5REJH4?*<;TW,+.H?Y\=HHXXU>/O3G8L#-
M+O.(<$QSOO[NB)4)R*2'Y!F"XZ^(]]2[8Z;5DNSE8:J'9M$3_ID<,X*P,2QI
ML12/U:O2D3S ]2EJA@6P$&R:\T(Z2P=^?I\IMUO=453G0<VYROF*7R,*>HO/
M@_ML,3AUQ]TH'PHAT(+%<>^*-NB4+D'%]PM2D%.%38PWH50X8SRD(4(N8: D
M.M/*.<JQZ%A_I7I<F"]]O?=9NQM9Z:FC_5"C:[;PM52X.*>3/G2%[B&0^5A*
M!M,?+3X/Y<6A.[5@\JT-A%2+(:'J2H&;*U;V9BJ<I&H,<F2<5:O;&;JL>L80
M6G_O9H]M\!U&CPI>=#</^F;PR5Y>C]-<H=O%]1J>@@'^M['(S8M;(N>OE/#;
MECWU<!#SODZ9'TIY4!=.R9!ZC8[ ;TXV57\,4XQ&/*,YZ :]2'FX9,2B.>!D
MK]_"'2XL=V70^8'<Q82*WE*-_1,;HO'?O6O_-\IO#E7(SU08PZO6Q>X_HP2J
M:5*&!P)I?9NPYOI:8?>[.;[]:$+MYLRK3E63\WE8NM8_0@-J#F_X3O/F43S7
MWM&)OR9.EUXMHB)DW*4.3&%]1P"F]E%N+W8.]?2?/:/*R?5I2YUS6.Y\Q+Z,
MS-GG:9&SZ$P;(EDLE4?7!Z;M$/_Y"% RL)_V/OO;BM <"U9(=-Y2[S Y@'5/
MWD,SXKZ>%@UK474$>(6?/91\/5?KOO>9K<0*&Z>\_Q)%(MW[H,SOX;+[CV"
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MW7XH!LC?%>G')O -?W4+7'W@$E[=Q$5,70)>\"W%J\I_W8<Y3B/\CP##HZ)
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M1K3#1\@W-XZ*_83R.@( -;>QV/_K0<T_'W15),Y8+8Y)4-(O-=53*?7P703
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MU*-H(65 N96KT3T#XV\HZ>OJ0 LR)V5[L=G\#]';[3 %5WPLT"".U]NY<R5
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M&>-F)/@*ERMPREM=D#4;^&+[1O8=]PN5]W>!$31!8JB]1D_GCZXEV6SZ#*+
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M'8D'IK"9$49M"A5<H2?@Q>HG:O)*-:B$S/?T(4G0WO%;=?;%DS+]T.]P^5-
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M)A,3L+0O6JLXBIL+GK+M.3<%#'-LJI?,'$ZXQI(&;9Z?>J\]/ &F&M$))N9
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M'B,=_?D1/Y44"[NWL+V^I#H$HPMWST*]?O.X4IQVIH3OH?07!7K:B/52B(7
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M@<N<A@F_ZJJU<-[*H^*CT<K:>)'CE:V"X B\C'E8&Y5 Z?'X/3FQ>8BNW-A
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M0KYHI7;OSG(BB%PUSX_%>B@H0!!X>1WNM;$P?'X2BPF.Q]@41ZXH/RC-WAP
M=)E_^_6]JMR:.6,!;R$.'2W07]K9_=6M48R+8<0$#;SQ!42D\&)M^STR6-8E
M+>W6&W4]K=[YQOB$?)L\KFH_Y8T0)@@):I(Z\61O++!?RDK:^<7-/U0HM9*
M-=5XHAZ^KDS9<%6QYM.%E8#F!T^2W7:O+%N:1!%- <+U+[VMF=3F^<>7MQ#]
M34ZMBB)0WN7?D,S6MC27P#&$B1G.@RVXKBPH/=IMSH0U(C _8,*M>&:#9*%:
M/U\[_3-EORR"CZNBV8FI6QE-[L+<&-2(I-^-2G"_F*PH6(Z7MR!0MS:'L>SF
M^&U/5LK@?%7EB_ML/4/'LAWZH?/[)2=M&#!1HB[;6.8IB(>KWX0G5AOC,@[[
MB70VW:3'V(WG9Z9(:#X^!3D2829W-T<,NE- I6Q]*U@9I.1=/EP"9.5,I?"_
M'#R_ORL"C_^""IIY4S'-S+7,-J(IWYT?WB'K2Y]8C>5$7YM[8BX/=+LX;1L.
MW[8^1[KB^A)^$,) ZH<%HA4+A$)1;SJ"3;EL_N:;IW^S_L_$]9*Q=(8E'\\G
M93GCA('8E-YX^$7]$<Q3<$%:9^!,+-8^-J%Q+8P5TN( V_Z)SCYQF_=+<&+]
M0P5:+;YEM^1](ZQ2A\N\B^5#4,KCJ6Q"VEHNLU:1XP0\\?3N?<F?3ELD<ZF@
M#L.2;Y<;Z>4XKX.^((\REX,([SK /S5W86%:O^2DZ;?&1Y(T[MK1+RB*Q'A1
M2IV7#2UI!)I93?'>T"X,1IW,%0(1],"927R1NTH'3V*4]"E4+:D;NY<8FTPG
MN7(*KO?PJ&\P?OXUO?I#1RQDY.1^&2H[)B5V%Z=(<+Y<*[SD+!9N^6)DT2-U
M\AC=JBB5P"GD<;[Y]79B?%X.U^_9$](L#4U \MG.N\2% !V@+Y\\<WX>7/#;
MN5Q#,OBGT+=A%XF-7G83N4+.1^7[N\N1H3Q< N&B)*N4@@"B7(0U8A\M]<+Y
M5[:B8HY*N5R#H,B F=9K11N06 \W&TM_=S$S/SAJ4(4N[K\NJK6@YW]80/&_
M4+1_G!_4@/_;E''_G13@F/^]OKXEKKZTTN$=&H4)I@Q:_)Z)L:L]O6]Z:*44
MRW:Z'>K;*V3\T+T_8ZY,S]ZO[ZNJ1BN2M %Z?.ZHO!_#&3-(]>1#J&\/>.:.
MR1-//I*5F^M0/$/\7LFB;]&^6JEU0/W]OU242\L=W%%*V-^0+HP'![/TWZR:
M&X9=XE+K,B>D)3+SLFC;0%[[0O;,'86=76)R\0GF-^3\+^)GU[/]$8T0Q1K*
M.2TKY=CAB-=^(C(( Z-$ZD;>D$M"D?#1_!G19M[ S(X6U$OK@/V"@2TE$'E@
M(S.+ N,?*7 O(&3)$PMUQE:5^8MO17V:#OBZ\+=%.Y;,]N7O';TY(7Y;&LL,
M)(N[7;HANCUS]V\F??)%:D\QX>W'W^$0&<.G^QRF%3*:!FM^JF*)STJQV0BL
M,Z-A$*(?%?@@\:$)],NF2\"!X.\B:T.U<>Y]@%TO7;-IL=.D3+IM"X*OM'"W
M8!^@E*;P<*>[D TI$BV_O%^X:SU=M-/)>DE.S/+V$7I+#7ZZ+_55]:M*AN5M
MR2$:D)ZB'BCGO?[G('U'17OEY6]K+KE0#*27+M>TT&D2J.+I*5I:A!F9+D(%
MVB;E6VN:A'3W-=*S;'ILL4#]4]XJVAD>W3LHOFH"-[!4PW%TX(\_]"9FX MK
M&@5H=UEZ=EJ+JMP 2+"F@C:/KOB*GTGNPR2Q7?P4 L8A[W@&"'H''/(W^IMN
M^BFS/_:5X7O[[IB#X$"^V)TX'8IIL2,K]79OG6E^PB\#XU,N3<"W= K,?[A?
MH+VT4SXW^YC3R/0$:*44?(S?1W0LIG,V_88LL(;1ZA9OL<P,0\W$:=.5<H*J
M ]X6X7*-7=_FKG):FU)6>;O/YF/%%:J>8K=,OQ.:.N^D4Q^&;Q3F(S*FUXJ'
M8O8"7#>TB$[]1'$@9P2GSH05]_=';4A"Y&K875J_)6M\0SEGC)A&XC1-?W-"
MFH,JQ'NY;!%3VI2HGE?/:LVBHJCX"@(>,$V89[*QW$9?6^^_II\MK5I(-_JR
M-TD7U?>_+U/@_XGRCR)7_]@F\A_\!RD.55^6::Q:;%81H_=^C+T4T[Z5$+NC
M8#C/+27T](/GEL7&3'?/+6 _9PY0D%%<(<4"GU\)^SS_YF^=JUBEL5]D$;$M
M"]U*LBE8\ROW-\7]9<4'#0VCAZY"WB!5]KY%D6ZW$B@TP/)UQJEOHFC7JN@W
M:\GL7X24*8JH?L/[]XG :J4H>%1N8U+#L0FV4A68-#D%22'E7)-!0EJB:H,J
MA6@3((,GC+/,0*>,J!VTQ_; &S<\O;BJ;)"1C+E-E_ F% ;9-B%G</*W"&R=
M\&VG!0.?#7)^;RY,;)>B+3E_.XRZDB/1A7,JFCK1&1=XZTJ;U74M8YU!PB?S
MU6WSC\:P,(&TQW>4&NI*!7DW02;,B\6'C#O%;A<^GD_[?Y-!;L-U1@ \5'*^
MPN*(?U4Z4?6S^2KZ1Q3^"\M)X6J>#&+RSJJ;G9"N8)]\\#QEW>85=_>\#F^G
MUQ^J&&PP1T[CX4>[:2S!B#+,=H=V.;$?JTP$=OKM\EP_T[S7D"?:N2X3=SB:
M,0UOLI(.RDY\]20XPDB6'''D-+DT_66:_A9Y1N*E;^\YQ5ID25@YLH"SI;1F
MF"STG3>B8)J3W ><"PN@F;=L*ARW5&4VO6M]-8"1.(V/EYQ!A=#.ML0,3JDQ
MB8=3\+I2@/B*X!#ZQ$)(Y4S9^]:E&D'QMO\6ER*9Y3+R3UZ!!6,'N["[V\*\
M/- %L/?JL,+?LBYAC9&9;N@"$1T7RCJ^R]Z,V56*$<85MGLF0#:M8\<%M-@*
M:$"4+:)4KO F=^N6Y7N9HNAFCK4BN0[61L+$S"7?UX-MUX. R]T16Z>]4.P\
M_'AY=B#V7:BZZ.ITD?,+I\D:PVNH'^&Y D$+V/L5PE-PZ!BQH5/N->![_P=A
M>OJ.-KIOR,R3IVS";UL-F&M5[,PI;V42I*F'(E<=V%BHOI)]8["U+R\'H#\H
MB@68A%2)EVY9.^'.][^CM7(B7_^:M,8P!'V]$&229%^U*VC%&*3[L7N)"A"D
MUM828V!JH8KF9U+$#)V *(X_ODD46#65+Y,02NV'W641@/R1B$_'$K.(&(U@
MVUB';]THQY-G! 9B_S-6>98CB;D_5)W2F)W!0BXR6G,$&M20&L/AZ*7@TB;[
MKO#3XA\J6HR?>>FC*=*5-MDD./F<PIH',Y>U=I\,SGC;"DZ"9OM7-+L;>9E)
MA4"V$_HLHA,DK'569,'M$.9N\-&9-9L3LT/L01>NS]-.="F41^8WRMW/XV6[
M83"H8NO,8P])/YMDW6 3)*I&'-)_XHT,R9U^VH@QTG"*.'E)/G='\T(0(=KE
M^%/=2*0YI1Q%*4<R%Z4C0#O7%<S7#[]633?:Y<E,(W]QSLFVD9AM!5=@_+;F
M1COD83C%OQ5Q)UT7=@YJ-]T4ID*99P/G]W?/6WP!9:DIK]1OS-?'%T0SZZ$"
M#^-/V<?7KBYR75$<32P^ 4<N/OF[SC;0B2C,#<<GWEOZCI8#68KW3NX+#'U1
M.:(F*]BUU8+8^KZ:O8)LP33E%,Q8-[,)293#N3WII!Z[)V'4>"&$\K('->5T
M7BW3.">2YFP!;_\BSEL&JCL,S%M=(M)$'C+4"O6\\_YI4OMVK[%)<?'<S:]%
M0W?J#T[#T2*ED%ZG5Q7*Q"OA?Z@PJ$6!S!Z WEQ3'XP-W$% 7W]<7$M-RH[M
MM1WH3XS]0W5K4V@I$R_%=@SLAY^D!QDABU^=;]$_Y8?*1AY/FYA^[=E#1X>*
M0D6#77@<XO;*XL,_G&EF+XV8&R.DP([TZP-!X: A^Z&E5T^9D%GL6F[$^,.*
M=WN/((:KZ'"_9T1G+XD>=&TS!P4L(V3+(P?L^$-U;MF,-RJ7V/+DE+D+7=RY
MA^1UHP5PTG2S_/Z^N.\&X((U@_;=0#WBR9=>'2_E0FM:2Y\,T)%ECU0^"PYL
M+CBF-9EWLBA72?=:!8845HO;QZXE=-UYSB#5I>U8,S?L+ZI97E1B<KYA2NJ'
M]N5+^E*/FR!J'4)^!V@F\@<W#ZY9V^:"T6HE\:EFJ]'9/U2W3V2_%MQWKD,&
M6J5PZ?B<VT?;;B<D5*F^BR>DF(YGR7U-2H#\A#*7YG6]AHMP!1L-)LL91FQ8
M&1)UE-R^MFY9S;PR69M)"$#+D452?K7]_.BD-&?^B-LB=J^.5\O<L_\Q6O9+
MG:5"_>-.EMKXY_JW.?=+^=G=\XD.$=$TQL@3G>6>RVL[P0-WFD:Z;YI/LR9K
M+#SSUO=*=!]TO]1Z<==\&.LYD;)AD1ZURZ8%;T&".2P;O<=+;@&[6&;?6%SN
M#$#$ /RQJ:_!)*AGF03C5[2X2U\ZV_$H<Q-.AT8-4CJ2E O!GR@5=SNY7V,B
MUBG=PK$)%) M =W1#$RO6/*Z8J+B,#YO&:@(<21XE9X$53#!ABC\%!U'Y6V1
M>,"=\JV17I.[Q@O^SNUAOZ#B% X;CO$'PL^I)YC4_3;HFZ@G9K]AWWH+F&,;
MA(WN$5[[7L1&/M*%$-$T,X"FH=TSTW8KXI2/]N@I8A\)HT_\M"6OQ+[Q2<Z[
M,\"_(_'JD>VS4JO?<SB0($F%]0VQ$NLT5STB//GZELO-?**PYK2EXO8L;;@E
MX0U4A5O[-<:=TMNJ725CM+5J,9W^L=?NT9'ZUS+N0[<K0$9]7EU(06(O_YEE
MR'FS;[OL+:0LQ+2;$71;PFI'O7[5PBEZ207V&7Q3JZ/97!IW]E'>",5Z<[0P
M_BA!JXLE/;UE"<T_ZFL[E 1?D]<O"\D/O1FXW^K">P(V,T]'959PTQ-6&K@L
M[!9Q-A1_/7'U>OIU#OK!D0?V1ILB1?)6C(*WY2"*)"TI9  :E-PF&57HV;"1
MM^E*77WGD4]]G^ME"+JRX2;3Y?JK-OP\D*?>BP^7JL7K@\V,DB6L(!43)^M/
M*L9W_E %)<$7 18:*695ZME?EJ3*\8?]36N8M@UPQ9?9'Q)!<C5)D3J^TXQ+
M1FBEVKJC"'\K^@Q&79?S"KUMJ.BA1F?-5&:TXO;"+QO#W-$?-9_O=^,,G'UV
MA$*MP?-8C= T<O,M ;,3]6:SH_(!K"7:W:3=.,^L/P!A*M[3"K!=.5@BSMXE
MF;&D%=AG+QRB$FEFA%P+X#_"Q[$T15UE6:_1ZI#'EVK=4^=/V<GBYF4G/RNJ
M3N]R.U<V5SGDRW7)NKJBWUCQ$;6\(8*T)*LJ%.4-G\E1E94+D=>\R/5%=%+;
M),3 ?.&\BG&4:=J:MCV\,21/ON^50 AGN^BRB$FDI.6P3[WHDQY>S!^J.5H/
M43G!VFU$I&K'=X*?O"!S^.;!WJ=[BD&-0RP$)1%!CC7'>&(3HI.#F3:RC9!"
M&O>,5"5F\FJ++CW"^< !)=-U]'V@MU^\+7.C$M/><#7]L*/MPI26JC<_9=XP
ME?)_RW0\PA+YF3JI(;-P3\:#[F;?SXI;.U*3D"J\R+N.7?@R: :7PE3D:"/<
M6+EJ /VQ7U$SH+Q[5\[;[!B?[#:2;22AQ38Y_F85CBD6JWM_"S,P4YE@(/AI
M.^]H6!3_OD;A;KOLM8:QG:4FO?;FRR(]VF&%AA3_?&2;/"KX#U7DB1Q+5Y3S
MJK(#3Y]C@&$;OP=+<NKP=(&?U/+K1X)^K(\W;!ZW$NN5Z+2UW>GP<E7F9AP>
M\SKVT.]%6,0+M>:,0US0E6A7A[K4.MZJO99;59K7A3WLD^+<,F0YWX'\+Q9!
M6H9.!&K6Q!&%/M/LV\>JY:GTHV&V%?V7],0T^22*5O2;SX&R#+:SW:[)*6FN
M"?G,W3WO<EQ-;G<?XRI\6JS\%6J9%Z= 84)+IAA!Y+#NW8"U%EK?Z%'[K_2[
MTQ@438T43="*GG(F2@]*"2,:#-T3M3KZM/8,XK L#^SFH,)_[T=(!QT#OQZW
M9+J'^X/;5,D_-S=90YY4)KM4]G'K&]X_*I=C +UE^3RX =)RO(R0N%FM<-DP
MVQWGW="AQ%\1J]P(2"E3R\ ][M'ABDRC7?:I2&\GP3!QGC1;Y1]_##.A>"KA
MDVM<?ZA,!##=AH:;$^R&:3HX,].1E_(C9?R57>88D*GNN+:*C#G]"]W>>TO5
MO.]F1^]>V[U"U];M-"<S5J!YP,ZT- ),#- 5Y]:5(WQ>:2&O"<K0.>NKT-_[
MSP>T *1><_X;!NIYL;84J[!YV(OQ-LKCBF./?4=L(M$BPFWQZX;E3_52(^#C
M2B_/HO4 ?Q@6O*T]JRBS7\%+Z!X"=!_WGV*RR-1SG>V[%I<*)X3&>%O4/T6%
M%U<>H8*&C:45D[8/89FC7G\KP%L'E&B<ZR6\73F>BU##Q0[7D?5IY\-(%LE?
M*R ??9<?CR\#*R#7!:5Q\ 7W"@95>3P/(?H&,A1<T?#&W=OJ';]7/HPWMPC6
M5C$$R1S=/^?.>KEB!AQL)T^X0A0VRIDD/+?%"7LI:'5<\60MO^/VLO[7:'@(
M%*2,,Y!6PS>81#S,>;9FWCB,_T,U71^]F8@")<S.>NLD?EC-'ZF<+CK]P<=&
M + MY&+RP3=2,RV*DIH\0/"9%P+M<&1-?._01_B5Z*74[N\)R\\(\O6,2VCC
M[9;8OF#%,'RSSY=F9WLV8B/Z%NEFZE$YRX</^"*=Q^LAR@44'#9I][2ZH3B>
M_?T9O@3MA' "/82@HY\\RSRL0%AT63?\@!,OP -)VP^[HR4$VT7T?UX:@>L6
M56UY,'HN52V-& .W@%"7+D%E1GXMKQ#-/U0+[F?X4/TT='._J0QL_N5<A2WY
MA!B,SZZ1*J[OL%[]52!OZ.;69P]4]G1JE#<VKOZZ:JZJ6L65\*P<7SZIMP;>
M2Z. .D?$,\N\'CPRX(FU:42Y_OQL*_@^P7O)MR)=S;;C18'%ZAC[9CA?FA$!
M%:!D_DN.#W=FN3Z0P.CXCENVM]=B[ SD5^:MUBM"5.9HF"X9_3UOW;?D[(P1
M$!TX)O3(TD1S1WQP!ZR&LI,-<\(#3TB+GAFWW/3W3"V^#@TBM,?6>A5E<&"U
M>^\]K0SG0ER*QW8=F_BTT_OB@=\(^>MC!TP6!A6P,^.P;D#]/Q-0YR#CW"E,
M17]I)-3>L;A@]@?7]Q/?HC,S,_8HBLB0:[S0LPE9#V,R0Z9MG0'Q8"(,WKV4
M'410D3&EN))N]F7N)GS.DV$%# SXE$Q!]#H)MM<0E^M88:;5[]PKFB$(JI*=
MJH+@K:"^YH:I7(B,J)9_R::(-/_2QY5X:F"*NYWQ7%B&OJ(I7-V(#&3P4U,V
MP&N;O+5B:OV*C)YPTUIR:G(O,PUQ=\DQ(U!*3D=<+DN89?D;O6\+*/EP%+^F
M,][5&;?UGHV0'V#W N)KP;(+DQ4O +KEU4B-% 3BJC<3E=V\5*-8&X$RI98:
M@APZ9K7MHKQ%OQY\@Z_"DN1WTI9%97N.2$9\P].ZZA6+/K[N(U^<RZO)AL)/
M=J^C)"N\!!\0^Q;(5NFESK]#04MHR2_( "12LE]7T# WM13",3UJ@^P(<6;2
M++R@TRM60V>8?F-4;Z [R+C^J&%X02)5(DP7!NT$K%@Q9]HZ+&$;^BF"MR#E
M@_NOD3+EBP+9,I8#!5#:,IO\I:9?;?Y6/BXX:,ILB$]@S"YP*/<"GD$][Z@\
MMO)P3,%G7'M? )3 G&9TD249N[OY+%9 QM%4U?2'N*8@QWS'H[8.!GJV4+XW
M ]-TZWU-!:*0K%0$4FK"*Z3$$CR5+E?.:4&P??3YAJRA.CSU0=Z^?!S1>$)
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M"UW3\NG>1UZ<K008)%=V1'X8,X-&N;'X2W@K]HZ&BH D72M[\E<@O5C+^?D
M].*W[&.6HZ7N3CALY#6#M^5RY+J[K^VGKS+[90N+?)E5.621TA"?S1>U@)[
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M/H?C3XGO-T-?GCAN>QQ8$"[RBN6.[KH. RI*PUMO6ON?_I!E^7:07$ZRI@E
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M+O-3\\FH*->HE! G&WQ3[8[T^<'\& W\L='AB:;_%A"F(5B]@7XR+*Q9PE0
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M" ^*$U%64KWH;+NYKD%^)Q'1F]C??'[PE*^I_.&N9V+0GO#U>;XT1HE0#$[
M2=L^I,4#:=Y_I?]<.4328_#K"61A0W0>=-+2\AM2/1CZB'L]OY\SQV%]K%A<
M\35.S?-1I+B.IRP-+*_Y!;0UC&5X%+-R^EV7/(S/3\VK"%SN1(5]K\JXO Z9
M"XN!8]/A[V*9<B&K _$<7#=OM"JAH%FHI5]&[G^H #Y/F7L07YL9TDTR _@
MJ[!M/_.XE]/6'IK3%.&YB!RB4.:)X!I.M'4;\-;Q?L]>(;\IU]TY=N79ZK+N
M0[6="FM3"E"X3&QG8-'ZD__,K9<I2@V<J9Y6 A0@JWG][=-4MJXTI<?0IW-F
MKEH.8K&+J/E@R*>)R\TUE/3MF?5I&UJ[;72VO$9>UO7B(\]P4&>&)E_P]G#G
MY:Z 9J@/NB;T%F5F(!(@FJL V0U6'H7CR52NWM; DYMDP<S[EP:6GZ=%J*I-
M!.6%05R*V18ABS0)'-1):4[72=8F 5(V)2ZDW%#0HB)_@(IH]5B6HRX->!DD
M83G0YP;J=^,S<EVP*9]LIJ;4M7N?KSID)Z51ZN<8*IM34\7>!@/99T/<=?@,
MGI@S@2>\Y<80)8KGR-26JV38&+$Q]>7WJ^@T11K*BLX-3?L-DK6VL__;'9PI
M&]GTF^D@"V @H$HG-IB1)QBH;#$0!WC^%O?5??2"HAAE/Z\K;[;LF-#6+!<_
ML4:3H C^53M?A&;+F[W,3IK[0\6N?)!U,"Y'>*X?+JG(W+-CJ:K0&3*XK:<A
MH7:.:ZA9C**5)Y^>!&WJ#(TXN?'#SWQB,=@P+4*%@SP7(F\^P<=$;-!$.U!%
MTE/9(H%R_Q=U[QG55-NNB^++:P5$P="+TB& M-"+C2[2"80F'1**2(< -EJD
M2(> (+TF$2'THO06D)*$(KWW! 0" N_1M;Y]SC[[K#/6^;/6'N?'/<;\\<PY
M,IXY\]SENN_KDF'X'531OCD)@-0?8:Y0BHIJJG0>'&+"$@/N =;"E$?4NRJC
MO*#UN[JJUR@1U!8SO5I[5GM1<%>9Z<[+56]MLLBY#UUM[)E_G[@$3\$OK?)\
MSXGV>(YAC= !TMIBBA@'=$A-\0C'W26+S(8EE8!.ZN;_H>+0=ZB6NDTAUE$T
M%T_J3.CDMLS[!?HU)^783'/RN-45*CD?+^!0\_(/8/T_U>(,)0R<N3\&G-[O
M>@^+^]1?0J[,ALBL:@A@26; 5UT.W*E!1RTD_O0_:-"IK2;9+^U319HQ<E;6
M7_&-KS%2O*L?[O?I3""MFZR?%DP<M:6KN3*V$ U8!Y;;7IL*>OT& UFO.1=G
ME^_&LQ9.C(K P&*7,WN*X%MD8-?8A'*A) LN%%AA@<)5TX*'U0#*3,>ZPJ:"
MJ-M7 O$)764+;1U_@+]-1?W.Y=:JCK[Q8"*N5834-93JNPN(I+/K6M+]R.\O
MG0B!+'.5D6%&44:1]M<4 .3CV!JLQ\-HSBT\%L.E<N9>>3+<$M2*>5$'9MU*
MAG2Q]F7ETG@,RB6&JH?ND9S74<W4*A%P.=+1W3K#[ !,S<4MO5KYJZ/Y6O6;
MH9H%VJN6"46N9FI1MG[UIV8=H6-6V^,KS0]#5SQ9T=1&X\J3U]#573ISJL!A
M].VSI4,4CZZHJ/TS;[/;C\B&TR7]TL:75\L7JVA'=LN9#>**:UGE*[=6YO$:
M3_I<7]CPCW7V_@!'!2[IR?[J9<'D'[)[25HB]C'<KL5:A>UKB.F,]IY!Y% !
MGX_46@N;,EVIEC3.FJP1P1?PS#\'J_9NYRPF_<6>^JZL?RLW*?H#KP=Z3Y]$
MP<9RUN0P)W&+75'W&^39#^S1@><W]-L\K>W7U%E25J\HK["K".DZ?C-I>Q6P
M%':7?"G)[,%XIF7B)G*LIA,8@**G/TE_*1Y4J2?^[5#X=3=L#"ZW,.)>WN5M
M,9.2[]MX,Z."(8VSG(#A,R/EI-).90>'MDK'WCB88PH<,9&@/\47/TU%A/'A
M;SNZLZT6-#(S/&=; WG=9B][Q@X*:-\^!FLI+N-]&"N4].YW[,&W(G#!X1%A
M'+I"1@Z_ WRX&,EU7#F_+WL)&_IPP2M*H@/&*IG0W^ DYY,O8:8:ZA7E1==V
MVCJ;NGH!(L&K@ OT*[9^,X%,3.]>O=W'J)$UVU.:YZ+;=  :@G^'>056=/@4
MM/6&BRQXRFQX_%B^;1L8.#:?T[ML1[]A*T?YA^KK_<+FC-C8$#/$DY<Y0)[/
M*C!=K>80MSN[Y8VQ8E[2?TF^->RY9XA\7J,2T,$E!3-]8-.BU#&KS"@E''SR
MAE-]H9O.5Y$^9CG2Z>37Z??(R:.UB,/Z/5Z;A^@O3C$[?4M%</R\+<>VR9]H
M5P4>Q Y9&N14<752S^2^S9,P\.'&27(WX1^J5CBXGM+1V>?+X84+)$:3?;<U
M99+N%+YH#&V0 VQ<,(X^'<P&"Q9N.*$U.;>FE:D_[4FNP![QX.*8.U K9=/6
MH)QXAQ[ E&L.JVUUV?04:F9]P[,$(<.>N*;8TI9\?;&YH*NNU= ;>;C'K/.Y
M<[&9OANL7@1G<]7D+;5AY5/&B_WV0)K2:1]&I3WN](EK@D3CZLV\IFX<ERUF
MA0.8:6[CDMRJIM-1U[;/AO >[O[W=6[-1DI;A)@5)SVY*:+T>@5/7WLB1LAB
M4+E)-)F^1H6GV<!U@)7LREFOL:+3^NEKA%3</@&GI]*VC/6A5*@KT99HF/C^
M.9@79,\39R:+@NEVQ043@=ZE"PDR'Z!.\9>*O#E[CM(67D%YH9Y9Q3 Y;7"]
MG?5N5'ZF[(IK?:731@ZG\[=I2[V\C*4-:W1ZGI#A/B$[AWNV+>!GF3M!B!QJ
MU+4T=-E'KJJW ?,"K\QG&]!W"F:MH*BG_[XPK,^)2L'Q(7J0OM(*RLAUO_OT
MRD^?_3#[FP2J?BD\\>:G;OU+J+Z8NKUJY;UY9$3S [46W8>36?L>AB;+WZ"]
M%S_HNS>K/0(%5%SKXRHX=@$3KD?V2U2(Y9K#'U^)(0O8*1-D11RO,[%#I/_F
M5-7Y![$);VNN;)/N*\)$LX6&O[XXEW;&R:(E3?Q @QX_47UB1P358E6S,J$#
M6X9/[!5120?;!QQLNW##8YOF86.'50[3XB?Q YKDQYJOV!IUK5]:5M)U-[=I
MQFOSL6!T2$-I^U(,PA_\3@72CBL+8XF%KJK<$N55@*P%:Y!]G#9@W0P:PR0L
M-6**5NWADD:L^F$8@BQ.*HP[DUE&HC&\9*XBP8ROC-J74.%+SE:O#M_Z+ IC
MV*F2D9VU6.2IY[MEHLLGBLJJ$S\THT[ZY_D5#]-NDVQB8:#F0I.GAO I6/>W
ML[E:&"(GN&%35;#A3TB,?05DYC7O7)AK+W-PZE]"D-5BF(1:G2^' A<'>NWJ
MGA?Z8C);^:!"HSJ72NBZI/MX8S5#>U A]SM:(9)[-GR>U2$]?V0A0Q)R%&>V
M[3B'BY7%KLEN_$3]BB:;<S&F^S6& O.S([M>UI6-)AKT))J@\T#E"#I9RQ<#
M#P:UEI3*B+?/4H.UGOAIK#ZX(@V^\Z3( 8G/W[*Z&/U"-"P5@A-H/R^<FG7K
M&W\B[71/,B,/_Z&B?<9G@F$<#1"M0!PF7.WO+(9=9^L\!%J:)DEX/TO6IVT1
M\9!8_6':W[Y:3..ZD*"3,Z=K/JQ#*,I?O!=_F^UGR=A&DQNM3?XKR0=%_S[7
MVUM4;)Q>1"7V?W9 ?101%D]2+<Y@! /(-[:V:]$/>P#X<->>+1L7LJZ9L9L
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MC9R6X@!K%JY[^'?0(*LSY_*R7#R'.A#K/W^QJEI16YN]GU<0F()7GX!#"LY
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MR;.&/@"A1E-E=UB3HC#_9>S1K*WW5.L>Q3COO9+YR_K%YC^%O]>/>FC<MY7
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M3SP:'J+]0_44RA,;.9^6C'H40GG&RB1U_ZT^2%L$L:ZQ_W]18_BO-A%A- .
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MJJ&Y8.,5NC#I8;ZBA1E1XX#S6C1WWUHC87+A'J2BG?>I_P86#!FJVOX23E
ML%O&$D,P%-D0"_;;B10POW?A,'MV'HK6'VCY*0'9*, ?C)>M2U+]-(I>V7KV
MU0H,?(O<.)-#92FD[':]U.D@%"*V^I;9'%3+*3YD]FW4+2F'7,BIUS=NAH*&
M> FGJZ]GVV1]O0 J*8B Q&%4\-K;,&!+Q5VI"^R[3S!6[D*D2S0*DW\U$.?&
M/VX42KC2^H 4U?U@Y)-T&';+AIV2"ABQZE=3[$DAK!53OOV-M#R>)[:WU5Q.
MV!._J0+;UH-U$0XV*N7B<[#[@CVZZVCX>2$7]@6/9E?P:(:?\<5AB-RWZ;=K
M[2I;/6=/V\@R]FHM-E4DE]7&Z!#$>@BKV'!;V*TJF*O^9XQ/W3]49L"NL)O3
M_U#EM8=&A+C#L _0VIS72LHMQ/ UKV+)MD)G+TDNV=4?<EHJMEJ;P9EP+5+]
M^-V4[2'-(J'/+JO%=?G:15#UVM1O&"V*]U)R40W4L5MERVNQYPUD5-M*0.T&
M2:GEF377>ES7"UB!CUA"#7CQ#:[$ 3?,A9VW98*;WQ]\I68;O% )#Q></,JD
M7[.:Q5;JEC]]P+=:+LG?NQ9>/6<P_N7*2]AZ[EO5&T$"[S)^Q>._GBF1K)"I
MR^X&V;DZOQXO"'8LP#A$'7J>C1?=1:CH+N1&FA&&I(RY[Q<%6TE$@ZE,Q6YV
M6D#*7\<#=1HLY1[^#VG@E!K#![=^6(JUSR.^CL/OT>V^?+7:"!%^/3]W2Y6U
M_7/OXN\CIV^. 2Z5)JWSEWW;0_C+\BE+1Q\$I6YQ7.38:#X 5./X)#\A8Z^&
M$!1-W<+?%K%:O_Z.&.KTZ;S\@&7/IN!W.K!(!A\'G0'S='K4A ^F V\$,?/(
MGE5(;7VMN[V\[=7?NE!-D>5[QRU85^0 "[]R=*53K8BC8]FE<S0P+,0&IV<A
M4+VK =Q0NPT7"CRVOS_:/&U%\5)VJF(]*[.^G+E&LQB#:HLE[X%1JKPXJ.:>
M_IH>OIG&CYV#-\RT;Y.+L3DZ-[%-Y/'X(:?<$M_GI=^?U_?I,WM8Q WGX25;
M)>V"V4<S+"8?0LOGRJ#O>9)57XTKVW$571]P)&8%OM%:S>7EA"$3;-, 4^;X
M\!W-IGIJA=74]RW#8(J'O4!S G4]IC[LEFN6QX)2R W*K_E6))'9($D)\>L?
MJ@75A)7)=ITC@)3=G6#/N*O)5%SX(L,.[K3Z,B#C@]+E:!5M];O"VB45_I4[
MFKHTK/*H34S(6VKGCUT. WZ]\#3H2F$]\!Y@BI*IL8IF6E$+A)EH.RMEXZ>#
M7G79[TWK6\Y_W'R'J_B]B1^", KDJ'<.K7%#@Q< 8MS3X'$PL[;B!V@23:XP
M96EA4N-#97A1X"QV01OEZ/4!\:L"0OH!><.=PK:?P Q728!]UA^-SP_.%<#9
M\2G?@M8-W\98DJ^^/<MDOWX*Y@Y9(+"W0L;RXGL$3@L3Q:41W>,@8<%>G"\Q
MARLY6[BR>J$,HM\(DQI3D"[I"Y"8SX&-7'!3A'?1O/V,PT6VI+G7LXLF_2XD
M3"@E:%Z]5JA;;?0]4^8X7)H2RB'Y!,>]88-W*NDJ_DI%9?8L@C;8K_%W@JB/
M!WV^\\K-G%UP'*,Q>@FM<:HIZHULO*_7F3$$_:%H4;_&6L[K<W/([>^/>GZ*
M'EL:!0*?+CKV&[K,&E,@99Q"/V05WX?Z.-!B?<W8VO58_D:0LQ)N73,_PZLD
MQ(TR4;5MZ?4\+.,J0J^3H!]D33B($8&_%F(#N!Q$+;:F6M2>DCN-1=XL':#D
M0D(ME#@(ZKETE.J%V,^]O^QY21C%\68:9?Z8V O3TZNHP"NS!X+/SRH&X7:D
MU=E9UFOJ&QLF&>:4<).1'*)2.@!G+< -V/F'BD%&:QNI5\"" 30;'WU1V=A]
M_#U+OUI*2P)(5.5:+]8NZ-VSLHWP3?;MZX:M<T>I,HN0/^86T<*,"<V7%P[C
MK\78X*<VZVYO$%P^?2WU5;+]/"G,RP+HA&N0Y28]EB]5&5GT4 ZZ[>]+/LDX
M@WUM-EQ<0X([+K!>W3E"L/<Q5&$7V+5CR]WL[-6R6Y/^*A#=&-5##_.T#[2$
M*UG/ _Y2]VL,K5=G!;BQ?A%\1XC,95F22<I_K1=IQVE\=Z31U#S.^[1CQP$Q
MU]C:?]NJN[!;0[YR&UIH5I5QTMXBW=ZF.DC,W"#ERH-+*7K^[V2V@1^79<N_
MOU0R8ZK*K_SU&?M=4W8B0G465 ^_C<SS#!*H6$A+$&5HV%B /7[;%4I=2O$6
MJ!/T@NZ'L[AZN ]'E#9X<%A:7;]YO2A^>M#.8A_8I7!5!9;__=/!LH&Z:9]&
M6E0AL]\);/Q,,H^4*^8<Z/*8]LX.1I]TD5#M-:!]QW4=:=-EF]:D)Z?/X6CJ
M(:=_HP QE7 +4:R-+6ZOLJ^SRQ8A6\4J1LX>5KC!N3D(4C)&<LJX[FQO!(HV
M/PU69$@H_%Y6*7$+&ZC9^;J%?[&EPK3)+"(2U@OW\CB*2(XE)&H8J1J26QH.
MYA 'UH\X)#'NY.X/\!YYS#T"BDW6#C&2R,@PQ;EOWY1PP^V*VQC-;(,'3]=*
M/37GUG0K)\6WC\\1Y6*/#D[H4*-)VX_1'VU]3YJ+ H@1@=.C]0E1IR*6/:S
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MQAP%-TRBE0^^M7(X2#FIZ9RR?VOD3K[!B8U:"+]R0EOBLF%35KBQ!;O&TN7
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MGG5YA,5A]SV\;JI)P D@P]C?U1P'$6A;JA6?\$(^0ZU><6F$SB_^\ZZZ+K5
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ME<_.;576CO!=MW,^$J3M.T7KY>6N;_MV'HX_\"D-4, 6AW/L[TP/7)4.":R
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M.)17#GKH=$=\TNT FQK K]$D]<4?-OJM&0E=N<\UP=,;2">C1WB<&Q@(WG6
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MT<5 D2"SF[L+;5=/VY-Z_3>FWW+3@7,O37Q)7.Z<ROP[_Q+]_4O%K:_'7'A
M#)S<>:T&OP:#?I(?F2KQ*&91QZI498Y&_I'$3G!1^X^X=C&_05)YT$\/.V91
M:ZM//X>>__DG64KI<?<#?DC/=[UXDR0$<-Z&A6V\ '<WNX02!]"WJ+DQ#\1R
M*-&QJIR,I5!FB<+O\RZ^"0 N,O>UA,4IMGQ%NRNF]]CHM/?'P97,1</YEC);
M7EO*^YR,=0YZ[[WBAO>-HB>\ST;"=@+!0S^8?K[:].-@:YN#_T'"8$J=E/ ^
MXOBF.N7C:< 1&3/TBK30U?VS;S3&DGWXQ%? _['VOAX(22RUWL;R#,*U]A^=
MCKAIC7%TR /!69K5BH4?9:P%FN'D%>;VECZN<9^O:+<,,=)E!'8?A/ .:HD[
M+I7(J/1[1EU9N^5ESG"M[WP-'764+U-$\U'\(U-7N[X>Z.>)TIX 4NZ/;#]%
MOZCV5A\1%][3]<K,^_DWE)"!TKL_@#SK9BB5$HD_8!I>))6R+O>($GP2_/96
M"L&'%L'R\\5XAIN.2H QI:02\[@7XIJU;"?DE/=Q93J:/.OMN;,)E6K]F[$I
M;209(X,K[-(GG%F9/;;R<(#+-XK,MKG-X(>TZFP=<1/P9S5[.X\>'^4=WCWR
M:I*2,&X]P'KB?E/I?%4];IZ_C6-NOL8O#1I@MB&:3&)H)3$JZ<*"8RP+ I>A
M=[YVIXW9:)L8A_=_ (B^F@^,8K\@?-QSK]$.YC4(U'P##$"<_KV;7%>='-Q'
MC8._(K$TN1K.*,]?^X[Y6'&=<USN&F5HDT@OM#;3^'4WL;%ZMWW?#GB,GF/S
M/T"UZ(Q_QY;_ND/I,%6ZD=2WH/LDZ;X_BY8I&#UL8ZAMYRPH,/"]5T'3D)G=
M8J&/JKW(N./EI=@U<YY3#8J!A8^IU1E@!_7Q/O%1J:B9PT+,1:4BX]J[*W(C
M>386HON:>H-V XZI5!@:TT&X$S"1OI;Q".M.R=[%98N*M)Z "!E/^FT'5P*N
M48V]K'@ZPG:[=B'7Y<*?0HL5=S_LUDWRBA2P:5UB,'3"<,QN=V9D&VO)DP&M
MN^GI;[QK]_S>M50'?[=Y-C'P9'N;)/8:A3/7DE'%;.2@+1/Z\/W59R#^J$'!
M 06&E!=_;I'4H1[<HL]I"@<=_B!KWKS^2T4%0?^#^]84S;S)Y]<JU]_\>\US
MKP83X][1>4C'._Q+9;SM.LA,![G@H:ZYS D<AJFJ(N<\'CL]'8VEXYU57PXR
M(6]RA1.KQ>-'LVJ"K8 E(G&U79U6G8_U1$2,7;W1;#IK @/1S['B),T(@V'Q
M<RP/JXWNV9XGT6N)2]P8KB+I\7 \Q:8 -3\2Z,/N>9$+QD\U7)N/OJ)?A9?'
MDL$4!"\UC=I949P[<'\YB43?&=EY,F:>3QFPF4PZL]=Z(+QQMSK]]6@[!-AG
MW_@(\=8FQ..I6:L+QV7M+XX^.Y'93MR:^? A$JV&B$P* ]DK CV2[;9E+@E_
M'J6_2("QB#+9PX_\\LYS;,:ST>VPG!W WDA$LH%:[ON9NIU;:_4I<B;]Q+LV
M%CF,\QU@SZ1;L=,7^L 'P'[XI$O(EOZ6C*#!*EOZ&>^C'^/>@B/+(1<8!C;,
M6.C <2"<VMQ/>ES4I5L@_>)NVA_*C&M&LSIQ<C"25XB!^*<M+.^HF!5K\!5L
MKHQU4=L;4-QZ(N1Q(6+@7M_3>+4 9]ZR<;S#8 .S['T)#L^LVOX!O4^5U+P$
M2&1_^5BV=Z#>."K>1.]PPW$F03:C5*!70O\1>UCN.O.GN(NB9A#BZ_T\Z)B#
MLW+R-+*[SJFR;.?5R]J6&<A69ZL;,J1>"4F^[M[?X8TQ!P_ZSNF)@>VH)JOU
M$*4NX'*(4L^:@<7@&0H@4ANE>;G#HN[5$/+$^/O)7'2KHA^HUY>MJ#I%4Y4L
M0&NX)S#LN&7\6-#*F"AP-)$=X&;&X ]++???&(8K%-\L&K>M8:GW'XQ[4B;Q
M%TZKY$E-S5W>Y0)CNTV^Z&R+9P^;D-=%M_%*A[K-EBALBU+UG$I,6^T6M&E1
MU+FI5BT"$-4>6IK2'[NF3N(S8J1]^LMCC*+4KOZXLTZ#/.<RT<-J!QRT']NQ
M[O*R_-17%\#A/2BN?"2_83:=34&P?!Q;9C@^FA?Z*&3;\:<&:NJ4@:348WW5
M?/2=7'6H38TV(MVA=XJ(/VJ2$T'L2>[_)76$5:QL1'B[7@/>RA72.M8;HT,K
MRT$W<<5RNHC],_#+'@7)]X1UFM$R,\OR7\"O+K=/1VD6KS"F@5Z*^*9."#0E
MFHSYY9L\*@(N5DD44+..Z1=NV-FS%%EO>IZ$YN2(!DW4F+KN]/!<Q7;"A[#@
M+CP.(N*B\M=R;9\/8<4#@WJ1FD!PVS-,@!,KW8_QH0PO9?F:YN%E!%/C3X3O
M&.D^O>/G!)B1F4^D5&D^W>O>F!XN-T/?D0%E8^1X\'9T&7!5[?5X<72("KO4
M@H-*LQR-SZ+OYTSHQDP#72L2IMS7ZMRN(MR7YH4>$BZ;]9;7^8M;W7<Y#,57
MLC@68E_.HF\&0^%(=T.4""KK!NW5W&7L QU%DR;A@0A\Q"^Z1ZBH\X2GG]3V
MQGCG%R[SH4E[^6\J1TYGYE2N\11OX)*T4SB['8=X(/.V&*S9&16O^5DJ(DGK
M <&&0)VH@DG(83>#98PLW[7%"&6GQNC*[D35.T/)T8U=WQPQX/6-GO@@]5#+
M/-;AS@=T0PX>3E)*0%<I+]:QZP7KU'_9UDV+6_W%MD&G6SBXS->,W*ED^? -
ME#[^@1'D-C_HRF?8NTR7W"J76_V;2@_'9:VEK2#RCD/95\<V\1V+!AMOY=+:
M?\R93GU2(^?=G1O@)UFWG.X%MI>=1W!YAN@E9.-GTK,K%?*JQ[E$O]!]'ZR3
M("7FV0,NQDQ.^&N< '\:*'H6G)!&FFG8:'\:!@&TD8M>OO'&#N[N56I^*MY1
M[BN/R(?Z6%B5;AA,-&$[!3G1.VZ\CT*&X&TE)?=^%-O&NX>63C3C]9EN.CE;
MH#:*[]40]!*'AZRJH7&=RPUR...?SU$>^1F/4$8/=!B@OG>+OSJ5L,M!1ZL;
M12X0G$>/E)R7Z]@$+5OTRDL][F9_TJ]QZ!IR']YG<#-VF8C*17Q?Y;Q'1K0I
MX5Q.JI:M3+?.4OB\,59:0^$\B)H*]5X=H VT8CD!7"L0/3.B.*]J\#/N!? [
MN:3197HTT1;(O&>_Q)1OYZHHA8[PZTT;O5*7 ="9$6VEN5<M/E\S;1 ;86#-
MIP"9X.4'<-O;&WVO#7&_7V5E3RR"[!Z@QYU+ !G/]9"R$7J1;[? ;HK6Q(**
MH9Y(R6+C*UV)GF^5B74L;+)I%Q#U5KF)[0S#JR=,MN:)%9\'AXDE.V41=O.C
MJ1R",,_)[UL5S^15#VAI*:">R<^8[:'O5IV]7?OK5O1B4KSSZWIV?=)AH6 N
M>9XUPWMKBE+"58T?2=3!X@ +>=4Y(3C_C-?UF:I<A.X+@^#B51>D&6+LUM6)
M _.;%+8"&SFSP!L#NU^#U913- <;JIODZ)1'7!.:(]OY8*_JKP1Y6*>*X#GG
ML!4E;)GYOIBD_-([[T XH[+!A>JH '!#I#OV8XLEFYW;P2UQ-NVH&%%*T TN
M?)HG-NX7YYRFH"QL(_-C;&*HZC$G48_+-FG#7.VSZ(J;?8802@6'K&D +URI
MQ528.)2.-*^GV (/C3-YZ6ZO.Q"TE(Y*U#[VKD<#E[-SB^DDIDOKVS; FD<P
MP=5[ZM8#^!N*K^H*HRJT^1_CP C6&SV3EC=CZF#WUU2XJS$/EDJ+<Z9&"#H\
M_M<-N^\B$Y^YK8&L<*B;3HB5)6DN(P;.( 8H<%*3[WY*73& =3 ^%J"B71F:
M"^$3$DEO$MLV^;@/OH]+<N*"3%:KK@;5]NF(BV\6\B)6W7\NM .[7DX#S)I>
MQ9I>'Y^/JYV8F+JO33#=KRD%2.WF(JL<4=X5"&V!^D1'7'Y!2T]3V=;B3%,=
M^OY?DS!PYO5$MAH]=5KD^+%'^T90MRU6$1]E<,G,B>CSL@+48;F9%ZCLG."C
M<5TT+6X!QNP.R@1:J[OL9]@CYK8QUWK.5-V&-S:%E"V"S%+F&IR_/V(;7\9[
M::;&FH9&%;'X%P)UCSX5-.2]]?>:<V*]Z3TD$H!;KY*_FWLW9N87CB2>M&!0
MJ;V_0$*O!CP1@U*GGHPE24O8M1/WDH<3-OT_?;UK]9LJXRO:!$=:=+U[CMX;
M@6'$^/A?U63TM"C1I>-L9\/(WV1O*6XM1ZX=1[+6L5KA2#>1>QS! 0_PV.O-
M)"GS17:?C$; ]1G_. :,:@3)_%C<;_QX(JY)W_*U35X:;L83_C6&C$W.IQ1)
M!*+/H'Z!B"".C4!PP/>P0YFMLH.0'<2CJ.NSYP3%>ZA->]/E*QDK,2SW)#3R
M#]"?;667AT51XLDE(=1NUZQ'6,FO,^_(O(D72WX[%N0=KT6G.@XL(\K?E6V6
M()AP+0T@7Q%\*Q>Z8@;V-FE'YA"8UD5@<2&8R:75;K+%[(5I=)!%/1-#_TQ8
M Z]KVV9BN\(^/1R74\=H/H^):VO5$6Y]8,R)X1W>#/!)<Z%_JM&9MG,(;>WE
M97=QK$$E):D%(99Q@-X:8%!JG+QPCV231];"?= HD&9=$888#O1Y""SSD8J-
MLE5G>HML:U^J*=4KTW6-37[@(&5\M3".U0Z!Z:Z*;:<'1_OGHD4@U?KFH@Y*
MCX<')C4>J70SN_M#Z;B>Q#/<LRVO=;^KW;&!*!EC]2@R\Y_>X'*3_#X5IW)%
MN\9A1+A;]\V5DNBB5:LI16-@NMAKD!I7AI^^5*EH!A_3M$:)DHR*KD[;,E;M
M;T7OHM&>$SV6VH+'_-"NVM:[DYFJL19 ;IIL_6@H&<5<5 QR:.,;Z!.+*!EN
MM!'VU7% $WWV^)O. &9]R([W4@QHR-Y(6KR$ "<U0X,5K)X5)&_WU 1DG/,E
MW@'&F.8Z/CUH(7P'5C6P\]J;"0.^PW"A.*MQ;Y$1B(YF4BGP]<#M=3+2=R[0
M,:^(H;:ZI- =CF&7D316<@Y,7AH#KP<C$>3?5!>\_:WL>P'=[@TZDGDFL6;Y
M<[^I[KT,N3IOI-<0D]U=/*BKGC%=L+:>F.4'XEA0Y^E5^K9ERAZ.47*Y]ZX)
MO2X.\.=XLXS?LNQK++XVFM]-MQP%:^8?JNZ<'413 IN4O+L"$C:J9^[<4];H
MJL^CZ+V*23I GV'">MIYSY8VG>/L'TT,GZ:CND\=96+_:O470-ES;O9</,0R
MD-I#'G_J#!%3!%FU6]AHW$?(_4U27(G="*K[&":%=28)!2U&I7T^ W23"8\G
MZEU,O0SD'J&96F>4N->TQ5Z/%#<:M*H[.2WKY1<'VZ 1-Z&$"<S$&O;A3]R0
M_0S'3]T+50W4BA1?6RU/D&KYU+:>'3![67SBDLABX9KVC'VC3GQ50\G"=\O>
M>ZJ'&)863[6+7XKB-2U4TXI/E9)-7BR5,>8%%:'J(@,;@-JZ#F[ XIXE_YO]
M7R8UW&GT7D]""?C)9(.!_E&:=AW[M]75JB.X ;#ET\HM\8><-PX";ZP"O#N$
MD=6/$I0,3 K,0^& QW$\G2>@>F_J)BR+HFI @M_W@ M&XFP)F[_8=GW!):?)
M&.D$VK)O2_!.C=;?5-<A!3/T"PR30M,,JFVM#OVW]->)CBN3 X6;N5WG3$FE
MYC]W,JOXKZ8H^G[U[V]9]W-OBJR3+:AY&*)<B$\6K/;'@$0LW4V%0"0^WI@2
M^3 V+.5D-#;(+@S18Z$PL5+;1RP:"?A-M6'2BUOX'&Y\+P!'C(>KSA0>9:+=
MI/NBD7^/^ZZ&L*^\_]@[&%/7IT#B:6&;_!9/Q@J2J"/!#K/R&R89Q405;MMC
MU$7BV9)5O"DB/>9CJZU;Z9&8ASIDV6K?@'Z,YJ',<%JGNKW?R%OOTUZ-S7 5
M@D;253GRI0Y.!GV,W-L;$5-^;&P%><T-:A[>.TS?2XVO\C=5)<["/>PG1.R$
MBY5_AI?.XD16N.M,7S9C&=Z[6'JQWOC!%@N:0@$';(!]T. OCT$:=3!Y*-8O
M.U''18>@G],GUCA;,W(Q:LT4??A!/Z;;2 >B\,Q 2:>HU*V>.2]:A !&%R[@
M5-@29X932FT5[-BG;'&<-==P;]K+4>J\#!'<&DN3J+D7RV7;UOO7\^,4K;32
MSJ#,@D]*!VR1 \328?67X?U8RUIBD@= 0,*)==#"Y=MP<>NK_J%J^(C]O65!
M)0+XHQ6#ZE44:>2&'D&-J8I8+T\+S7B-<#.A%ZAFP-IX6K4#E>?2WO;EG#(M
M8,O>'I,H8U7>,.)'/M3R>=H1"*U_S/]T9,;;J=6-/V(?&:ZK\^SI<?"J?4R]
MS+,%!;S-V7(@\X&Z.,DQ]S([;%'H J6L6BD)FX7G)-K$B;%L(/4V_7M-D_E*
M!NWR!B\@T##OZAM/W0Q0R2=Z.R7G#/W]?\R4Y[/U'S]K;OL+]O^=C<,_K:[F
M7;Z#4<GRBZJO,?;NY&%8^<5/@AJ_G)/C6XG JU:1Y%A807T9TJ1L3V<.,C:%
M(,K8'Z&2J9)HLX=]//$7J3T2:?>)^@S601;0W\Z7%X><5'TYTI$ ?OXJZF8>
MMR#LVJ*^'H -;FJGO6EH9E0.U6?5V:+'K12E$T(XHN@C/3'08("+?EYL]=\Z
MQR&I#,7YJSO^CTYK\^*+-C_H:(&LI<U2N1;?.1!\,X-.;XS="F[/;,)X [XY
M<'+2GP%FS@';056TB$YC'Z!S6C%?#&X+22V!M/%W[\9\N#^M]0])]S-1]>A!
MX;W(X<,JX8FL"SXH_1-'ENNW9-[&'E=Q,LB\QC0AGF#V_R&\QGN-P)2?=968
M)%;Y+RHJ_]_#2FOM?X]A?*:JU+'6Z?]O3[C_LTX-_[\&V_H[ CK+(HS6(PA>
MH(>MV.9VC 1),VAPC37X#- B8S-'QY'\.C#?WP98]R;O*>99RPQ#]+I$DR<V
MM4>DPR "PJ'TCL#S4D4<+H6Q=S7JF!44-F1)8;G:&$UJ?Q>S<TV5Y.#5C+7B
MA-=@NTCC3/.+!_+:WQ:R/R*&6R.7? KUO:RN?R?F1:N/+!;VDQV&4\4D5!T8
M7B?DO\K@(T3M3W3<=B%P7RCB-G$O&A5<13\N[0/MFD<R,W'^.0([H?MN)F0T
M<"%PM%%@R(,:]XGU" O:58IB?O#<K+&=E\#VY^*-"[D$S3/)B2G;=#)8?_J"
M8()]NFN.2%P7Z[8C856J:NBR_EK^JM<\%N7-'=/M0L^EZ&D]K*W@D?;!,8MU
M4 ?]/W":^I\=*?]/(Z1_.I3$<AB[Z1!4<8@%CSYF[C26E3; AQ$Y"07;19\&
MV?5:8X8^!]L;(AI77&<>D\0\^<8#$A:\,CDXD_BXSV IHW*/Q4OS.%> .4%<
MG6QAX;_X4^_#U2+]QC+-X/!8MJ1>I]Y:&L_1'8,I71>"JPA<?MB1JT-Q UR4
M2\W3?Y 2\)10G)YC('544J[B@G7OG#9D9Z? X!6\UHZX;79J2L! :8!E@&7H
MX#ATQZUCB:+O4;R_%)\)S=2DL+F77[243_#WSZ;(C5[3SWCJC<;U;R;E 8S\
M%"&; _M.P;_HU6Q7S80&&[!-,W31A >NMV51Z!B-ZICMEBL:927^ X@P[JXE
M%C:\<Y&^PJ4US0E9ZB4UA1>6.@/J4EE7II]+%0RBJ:1+UNE\Q#='H!6XA2BY
M5\_9C18TF0/M=EA(,;XD[%VXWL^-\S :2#S,V:VL-QYM-"8)?5PV3F+I V\&
M:_BHMOL38UC.ZKWZ,MOP&UJ-^WD\:"O!HB/U#S]0W7<]+H^I]G]?-_E2-]%4
MQRCX70/7L;VG#@[3:;L*F>IL&1W&-.HB5@09.]HJ4Z*^%?UJKHY_H?8RH2$F
MY8,"V$%8WU>_P[-]--7'.YQI^1/K3/:-%N52(\S%(Q3S85$)@>"2-+%J( ^T
MG0 J3]0,!P>VZD5_N?YSI&.6$H1A+O]--?_7<=VHAF*)A"R;T^7T-:-J$%OA
MQO>R?= K.SAW.U#U-=!R4A%24@_MFD\2ZWS E!5G[".L2W"IDL-E+K\M$L0T
MFE4./4$5F5O$ !6?Q7-ZE(S%)5H1!#[R3PU/Y8+O!PB#JT14KVUHKQTVVDIB
MXC4'JZT0E;;M:UN<5E+H&H?(Y(["'VO95,3*P8>,#-GI70(%-+6M=J:O%EFC
M =!ULI49K@=:5[)/X+'((4?7');?$F88'J<,*O<'[/[R6-R#!@5>+7U5(O%F
M>)K>-VHG*M^#LT<^W2UIYDG<F]/%7\!NX+[DAOYB>JJ8B2(>V8+E?L6\BI<G
MJ@A8ZYC$M-7H)R$##\/#&,6V[Y>1G9IG/RJ*1[WYBO;GG<MDB2A:^.,U<+JQ
M&Q.>IQ9\H7YLF./&J0+_C#(_+,-%^B'GIK\(Q:1("BU*< FX72?Z,O@$!#'I
MF5*O7'^2=\ES\/W_6P>S8#N_H/_B=C[]A&O_Q8%_!5/7?)F7R01G0Q1\O-7=
MZ8AES>P%": #L\__CHK.JT"2"EM>W'%9#L#-LPN2FDU%B6]^ 5,6=NA5N3\Y
MRL)Z,,"PFJ1XTS*$%(_KK[(2-5?#;6!\P8P:6S]7#+B<484#F +LFNRAL>\Q
M6!G,O.ZQPYLS]9L*[?\JFY(A_R5K1MIW[)O9+5)66:P<'(2S_TI/5:V][$G&
MV+&DQR:&#4Q41W%6ZYX3S1H!&#'../&<8)JI8.&*(IR6FJ/XU%8YV?B51YJC
M(6\T[ ;[3\U J>Q>&V;OYS59!;,Z)%;DR,=DBX5.Y 'M4S(9F]M(2TG9GF&M
M\M7Y?(_5QFW302ZPTCATPP#&V;1W/ %E77D/ @+R<=7\&H#4XB_5X&#/==>1
M<!>B?6X\2_N*"74DWCM1[N]]8<2>K!KQFW'0SW/*7/)>IGWX)*">X?NE )B-
MH<@B*^+8N/GK?;VNK.Z3,:RW$Y'5RZ5P1QZ<HO@MS]>&(=8.H^2<M4TP-5YT
M)%])+!955[FO$9JI?)D@\&_Y[T_Z^T?%:%PD@HJ&>\($(?J<)B<)DM=*18\:
MC?OLD47]3\+IA5343(2],0\KZ"-<@22IO'AA8P#O4^*?>%VJG6$OJ67VP1;D
MZLEJ(4LR(4TB&OY\G\#-(3.6:F*B*1;&)#,:M8T^RW9NENK$Q#<',/P:M#EV
M0VZI*[!&2;'2*;D:2T+CN&HO.X]L)WZ]\68@:.E7@A1%M3M^*>"SWVM!19^K
M2,<+;+"ONRWQ3F_BC1UVM[8"ES+7=+[GL<F6@QA1D;&?<_J>[TZ%=;]!KFZG
M@*?V)_!-'/=H9'TD6U_XDW@Y=0I4UY8-GBYY/6@;" 5]QS*-\H-54EG'3-$4
MXK,V3D\8'R%>*]EO3&PQND@A;1C,&C.@#L+W+T6IC,,F\/+S8GC]\_6N.LHQ
M7I_OT!S\LB*^**<^\A Y*\_+T*?IQU<EA2V J^]&'9;=S>S"MQM2K,0$9^OE
M$P3=09PR7<_&9*%37ESUH^?,)7BILJ]#419U@SB]U0= 2'VJ50OX6TS4 #3Q
M0Q-H^2Q]O-#YG@?_2,-\PZM-W8>]3V$<]A9(IS0+*?I@?_G=V?:FX3:9G@#@
MP<[[4W^V'I<@'B?PZ=+N4?CCBM@ 2\"D# U)"@W_8GT&DU)<'H@]H2Y8+S-3
M?+H@#Q[ )LL(D3[(%MWZBO:UC2?I\"YH+\?TUJ:]=7"K)<G%L^=;?L-H )9H
M(S,NW8B7;M^8:,RH()F /WL+WH:%4!(*F@.M>!EEM-D8C^1E@# ?,7_M+S?F
M49-RM[Q[FEUN5":OL,&B*(7S PX^@)(C8 =%PM0!H*5=SP@<J'OZ(S-_YB:)
MS\Q(46*16/]QTO?#L[%NCFMXA\//X3=_>F +*HVS/2PC;WMC( !1C[* E,=J
M(@PNGR!DC2,M-?W'L3JB?8T/O>5FUB=TO[C+HHA]D1FT:D;<?.\\MLPAWMVM
M_6@\PM =^UD. (U=OZ?\(&VYCG>JUYB#$XIDC8+K"?D>"@7]NAN[_9#KV8D>
M<V!P='[ [9[%$]!YZ&AD^VAP7_C$$_6Y-'(NYF^*2O99X@P_1A)KHXU[?HBQ
M:T)*#A&U(T':)NBIM7/0_^F_Z[E&*D@CJ.SIU_]KVBIOG;V<[=$UB2[.3XM'
M[#"]\BC=F+S[EXQ^:WB&A=?UD!B&D!+H(\9>#4 -Z7Z&A8$DEIE4D/=VI,W%
M.-^-]QGK;*2,WA?4_#FZVW5B]"XN\+IP_G."5/TQ)>_352SO,"9C79?@F!#M
M\^PSD.:E4=YCX;R*NA1:75TE6_,X7C/:)^X%JK:XZ%JN1I&VNIL<K,!:IG.6
M*HFO%RYNM3"%Z2A.T2D0: O$.,+?,[D);9CESP=^5'&F9W*CC#6+RSU!2G (
M8Q5V,V,>AR0)&<FJ-L1@R7UW6EULVYW7S*5.54<?],"!)JE$H13;%_'5:!]0
M)/ZE4]Y;<8C A74E*W=!P9,5)#GPVB2*#Q1J[V6W]3Q^IB&I"5Q>4@ALV(ZL
MLBN',/NJ,T?J3T9Q/W,V=K"F>!E&EGP8P:+68\]2ODRC1*T>+;2$%[ ZMO&E
M94@;AP"6SU&J)*F@<J#C)[BF0T;E46<WLTEN[;KTKR_5-]H]87U  06K3W%0
M /8.$Z<4=,&CP:*\7>SMX^@J&E_@V_O%RR.YB7(T/IRPWG(/M+^\">0SS<CU
MSV]AR'<FQ%HF7)*1I.Q&5DTUK'4!V5ZWNQF<. '%R!GG&+-99#)!U\1^9G-?
M![:=A6SY/,*YUS>57M&Q%0F?O'HK(:;8^+IH*W1MW9&3;>UHU$\7:)T&@RP$
MN&C\9-0>Q)H^C2*I!Q^74N5G=;D4A[^_B&TNPL,B1W[ZLQ5J/4<!YI.<YO/N
M/RUHC'.4'IP$BVU+8A)GFT2$?R946\SKLEPT2-ZT70U@D/#N&C/\>JMQ@/;D
MZV =!PVDV+&[!E2P)CQY_/<=/B48!] [;)Y7WVHI(&&%N:\Y_JWA\3E5*4-#
M1H<4O1F6 OCZ_VZ>5U#[.!P3!Q2B2360YY:_L;)=.B/XH6&A)8/CY<Y[$_65
MD-,V>0%;>Y_6AI;1K=A8TYA0. B8%I'$22HT]=;+B:^JG9P$E5D^;P5<Z<N'
M4Y.>-PT U$[&!LQN48*3!K)$[,YS:7<N!6'\+.3XXW>L+\5I824JEX9G0P%C
MVH=;;%3K<&4!=J]_"GJX8](>>FI;?1^5M&4L5)+_??X]^EY9^O;+PS,8CU;Y
M=-J-61V.?'&8%K$T**BFVGYV$ .I[WX/]HWZV*=Z#HPG_UIH$)&0=N#^UH.*
M!>_9YW;W/ND_+$$[J3_R :;:QH9_AX*]8V0,;F76!P!*QQZ;(VMOAO6$%M_K
MKJI@E\+$J&7&FJ#K+:O=?S1:O&)^%L'RKNLJ5&W#14RQXF"E%Z #^=#D"I52
M6Y:9;9F 1JTP+)]\5F,-JP:NS0@T:&$1>VB=N4[AD]%PQNJBCN7)_B'D?-DH
MBMM%B^!2J5VFIKUO)N=2ESC5*1JM">XSPG=28>J;?>TFF%QY37)!S8?W[NL&
MF:5F-0T4=90T<NQ2[A9/FKZ1]@[QU5WF[E%+C1%DGL>_*(*W7#)U+$Z(1.R?
M.1BE#<!N+X--'\15,D1/=%4'AXN"285=?&99$1-N'$]!@=ES)<OX7]U++J:)
M,7!.;<(KH)*';:XS9K*YIFL,:;0>!"!X2M_&T&.!\0H9F0].<*UR7] >^7OM
M0%M9(T-RZ:9VL?JC[-!5E9G"O(L.A><46<+A2?Y_M!"Y@ZZX9(PY6$O1$.<J
MO1*9@Z-)ND1"6VCH>KY6A3Y+=T=^UB8#.0[Q<CEX*SU* KVC4K*\-,$\?.#/
MI0#VI203SH\UKJ65/9NXY2 3=J$>1."X![3Q3%K&%+9DWHFS-SY*;X UX1V(
MV<X[86>PV>[=:%K=;VU$GRI)<X:IZRD_QQ(V#%H7'X,<4% YM_^+M_<.:JI[
MVT;Q\;$BHD) N@(B$ $IH1<5 >E2 R& =$CHO:,B+33I&IKTDD8+'51Z"SVA
M@X3>A-";>/3WSCGS?G.^;\[WQSGGCS5[]LPN:^]UM[7N=5VW!*A_NH.;I[D#
MN:026>C^8KIC(M?O)O9/H#[-NV;D$UH,*//PH \<R*H6.P3$E242"V"WX%H_
MAK#>"=H(,5AOXBI&FD:1AE1(KA2:G@S7>V?$6._73:[GQ?X;K95(M"'0I#!:
MQ8?WH>* (>HU#^+X!X=W9X"&G9I3<?Q^B"2Q??QD;CT+^%9N&3FF0X[_5W[1
M WUUO<MJ<#?.?31\2U;<%[/JWOMZNC6#Y##>#&<U):6/(;Z-/E%;06S_%.B@
M!40'6;+(&E(2?.I6TL275(L-O,<TBQVL[1"=B83D?6QZI "8VW FPPK17?.A
M!&.BJX\(UQ4CA_H\AZ2*1[B65DLZ@I_;W;^/]5/[-N'=/P>+X]]M<Q#H N0X
MORLWJK;C$2&U=;4BUJM,_^U2Z37P;+"9!@[*RMQT_F,'U[O;[3U*,_K;)A4^
M0)Y]?>1]RO'>Q/WB9_6YD-VM=$G .C-[+!W_O%)@_V,67OL 7T=NV+I',,=.
M=DH-GRD!^QYU_0K<=DSM5?*;FX-&[[' %7YR@7@0@)6>;U]VSW1G,$6+H;:[
MD;'>\8]U"@AJ3R1,EK#14-O98TJL;*Y89=]-*XU;8P_Y<JSQ0G\3]V+8D^*<
M%Z._L]9[^RD_&4ML=S?$\>/T<+1AL?32"+X;[>Y94>V^/Z?Z:H)EP-U?Z07$
M524 !S5Q@@E.TW;XP'0*A$*M&6IND%R3L_<Y0T^%</'(*5'R""MOL2R,36^G
M^_F9 FUS2@,="8\?=]OW5$XX;^E/CEEY8B-Z;^&5UQ\2@$@N!H,.V(?!GZ B
MUT8D;FE4U*B!/G&.?OEU+KIBJ]2'QDC4?EV_+K$XD5KOY_WE+WH$CZXM1(6@
M\A<=KBL YNZPTB,Z0T<U00U5F^7<:0^=G].P5Z0<F.=4RLT9_JO7O$PF5!>)
M1L7=#ZM/ $7.!VJ2U<1/_</ W.N+Z!%Q)ZU-0T+B/C:X7TO)9;SK*5#OPW2-
M50W@C4TI!G4;J R@,7FY\ED :X J&79N\UVN*V"!$1O[FF@<#,WFLVXC2XQY
M/$]3B_]]C-Q3H(.Q3-1A(U[7>L?L0>4KZSY7F@,02<L*!9(^M,SZ2<HRFG6Q
MVC=.2DL[?#S #Z%@>NTZ8J5M>SEB,GRCUPP?"OON!KXU#=96K)!A^.E5&)UG
M<(W"A0I:T,>)3* G'CZ*M=6(0W#0JS9L(R<K*-;1\1ECU#1U*(JR896AC3)?
M5@1M;('VB7V(=$*CE]#YOD*FZ\U.4OY- @+[$KYI,;X5'[NDL#MXX<7INV[P
MFRHU8@_+^FRTTU -6AS<P19W<.[$'?K+XGQ#<*_-1=Y] JNR=25@Z#!.>LA:
MN_P]J2-VAI(F2W(]62S\+*%_F/#33<-M%^39("0< 9A:/20#_D5T#Z(5KY#K
ME:.[H^/5.O+1:-^)#I'[_C33#3Q?RCIC#M%LB@;3OB 5W69K;MMRZT;!:>0/
M=;T3%?G. 8!Q<:4RO.5DN0)WOQEFM#BCSAV06E5.&5PVOQO%'3AZZQ/&X<N&
M<0T_&,0@39^0_925R%1NZ,R1I&\-,Y0H?,[E83"S;BSZ.J78SMJH93164&;X
M:3LX!25:R#__J/UN=UUIGC@$/5G"D\TWTH5V,.EL #A9T/<:Q0,\7\"8)0LW
M>YRN%V?=1=1QO[1%J7D/68E-9,H"UPP"R^LQ4%52J;,4VGB"85.M'&'^."MY
M%3;JMAQ]EV")_$[09C6!34X-6DT9)F3D*S/DOUJ%ZI<O((:XXG1YPF4-:OLG
M<6S&L3X&GQ1\:USXIH%E@SQGC6,/G6Y, ]%#5D#$Y)/%DIRQ],RR%3F4%)ZM
MXJ!(O:'[')C=]#G/'>Z;T2/;&9*__N/2GN'<86=O*SAI8L-,IV-]JF;LY5L:
MHB&GCJM, DY$@<;4/#S0@-O]\<#I6(JB[R,NY)J8,:*K<;3;7E-Z+Z9*OG!'
M",'L\H01YSAHR^@FZ(=+.J<NO?]9"I=SSH(32GU;LV%F8Y2=;R.)]4S^O$IC
M0^<%<9_L:+HBSM*U_%I1?_[=J@<T8MS8\T%ME7%R#)B+3$N=O]KY!C1E %]M
M^YC%GXRVTTV& 467MUE]#243%2MK"@(G%@ABSY]\NH^K. ^RJF>2W#('GK\<
M&<A\S+:!37<\_TTEF<?L,,%.ZW5CKZO3?W3$:2^.OVW2&![:Z3\[O/_8YC[D
MIUKGMQ&7C)F=#[R/-!!'M+317M70+1S+\'ZWTWU6L";#UT<9;^[!I;"=I#<;
MQ2JS*N9D5/$]QBG$SF\J /0&&\64O8Y<F&GDC*73;3A39(=9,8[^Z"!;/,[I
MFU6J?P'+2-B"C&<]G2B-=[;N^J=Z2;8G>._ILB5&=Z++Y^:P$V!QA7YNL_KM
MKK#NOK3-SSP]]=K)#>2A4,01!1V5"&RU^-A&;E"XM4& <YZ/%\,5D2E*S!F=
M4UF7FM[EQ2>8U11VLW2(DYOE=H3B;\D;B03C?UXP4B;52M)^P</=[-8F;"UN
M*"EEU2A9C!\G,@VY?R.A)1(&CC3?!&G8,3EVK^8BE/[W\B5_FYX)AHI&5:W)
MP?Z2?2ZRG['DRS6P EE]@)-Q&2^(E\0L<-> EF=%*?J6$I?6<[%NEBCE3 EO
MO[0VESMBP6]HS65\L]N&3P8B0&O!\J2P5M5P'("TL)=OM6V6(CE^'@IJZ_$(
M1+]J5 &&,)6$X+.T,$;EDULEWEM8%->*W\JCDMPQE@$((!R&Z-[6VBN?36*.
M)4B.ZVH^H#;NV';Q1ZCW':%M/)0TG$:G,PQ\=P<T$X[PZK<92GF;]<RU6]X@
MI\(I &'DDN9JI%<QB_&D/RF*S;6HH+]TW=,+%"_*L][G]*9LP\!FM&DM>635
M4WR+ V^48F6-U0'I-JU;H%F]T./H(;O7^-A*Q+?Z2I9X0-&CH\]S(&I:D0+.
M+WWBY4QKK[OA-7AGU=LR!C)A_R3')6^^,56IP=OT-9*6)E= *6*!)-L>,)_(
MJ"#>(0WP;S38*O=)\<']DAF8K'X5O%_"V>'FR)$>$^J!&85%WZ^HTC;)!52
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M!+;I2TX[5 5ESBM$&TW5NY#J8_7(^N#4 HTOE WS>T;'\YN4LQ8%YG'MJ I
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M_6SNN8>J$M *;Q3^$_#OA'/R!/3G-XPIAWK !+W3@%ANIDK/>]W7T#Y36M6
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M="WGH2:G)HV.HF88;*!(@&EG3^<\U. H8K8]<@KQ+T%.2'>7Z(=%S.G24=W
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M1:\VTT:C@;4CWZ2E6K(I94@OZ^!G>;+ ?IEWE>BU*O$V0A.HR GQPCRB.JD
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M@L^-.F-7OF%2,EO]%%QOK@F7M(7_K?FJD(:Y,1F+1LP()*I2S[X4,8L(<-X
M]#7&%3+^)*V8?*0BETC]PG?,2XYR& &/N(T$2'Q5Q2/X"Q7:W_75;SUU8W^Q
M)\.BB+;OP<[D_;_%..Z("=&>G!V3DX[AOVL@"GY:*-ALRP9_1+[0Z7"VMM+(
M)"Y5MEA_+ 4M>>Q&+7XQ_1SELVX+0OXBBBFET/VFP_KFJM!>LB:KG>(7%+M+
MO 3<LRE+S8..:XTL0Z/O4(U?BT7X9:FT:D$%F7!-2(S0$":WG=?R?MU&O>[#
M:9%Z8V9T_CFN*^$EA[7&THOV.2[V%.8S\3NZEO?YTE):[[I-P&=Z[DE#6^=4
MS]<GL8L<@</"47R>W)?U3@&[YB_;^-)I^5^3.MJ'A#]-:XOT\G)F+>M@?.(D
M#C0[>CVNW,@!MD1-/WW"8B(F!IZY1U<).,JY(EG(DGSH!QO!"GXQ-AZ%M!CX
M/!-Q>WU$!Z3OXOT7RV.J2N)Z&*GR!,@Q>TZVD%:X/!O[Y=_(';?"7"7(!$YJ
MP%&O"GY%\>)Q!-NZ[2N'WW0S261OU<W2D?=7PQ9F%/?Z5/<>M27-DXZ#B;LX
MZ[K?=*; W;:Z ZWC!:E3H*!72VC:PF^Z&^W?\Q*"SX6,[N)X#])^.A[#=@SG
MI)[-+A2N2%R3.+([HIAOG82%\9*;O?[MTFIK+VR$_XBR=.#U,W6W3>TWG8M*
MPM:7K_:E$\U)7&O=XU;9YD;YM-*DXL#2KE\O:GM?VN;;KRDBX85SWC5FDK(N
M;#X++QD_<OXZ&B]#/:7H/C\\AI/VX(<J7SXPDUN2+I'$QM!7X7/E#FL&I7PJ
MU.H+V2([=37OVS%. L[-<5CC8#<I;<#J1%@4(['F3K#Y'>H/ABS39VPW<6K7
M-7!""L1HK/;0J^*W!^/YF6JJZ]#1N?< ^H\WI_.ZV_5:FE(^[= M8/:9(ELZ
M>P4>U&Y8.@5&C#OIU^D-G;FHF\-K NE=?H0U)AND!JET1.2.Z>/4F8R!>P!C
MI?*&4.?5OLRB!!B0Z?1&C+*Z DJ77O8,2S LI//+4"T>:D4S.='#?]L_>F'-
M@ TD$7DQ,R8;U@HOC3M;N9M8%F(2AM*5'C>W>V']PY@\QHOTCBC<5 .)R76;
MC$XRG]8I_M" ==9R[$3M^NGW$/ZY2?E^5ZT-F^BO"Z=SU6H?W_&*J:1]I:PW
MF1)25(6)<AN6L=7?:#96J?4N@#G;&VTJR7<CQ$)N!_<+F,<?ZS0P,F0'49*S
MAN/+Y1S&/L%U ,;-.^*C\+(YGQUS DIR[ J)1Q^96'Y)7^LW'0%:N;7I$<L+
MVE*P)N3>+OR!$*YXS:R<"AYO@+@H5_:#A@"<@9PKU7F05E6']8DVW6Z.. '<
M0 B/4]QK?E_4ODU$_)*S%Q0YG_7\SRXT2>HRGI9CT ^<)HQEF(1G+U**#@P[
MWT%%4XHH_<-=9EV?>HXXO@19N$YCCCS&^DT7*;:E,[U<@8(Y)0=Z!1*]1V99
M&S(3'4@28'?7=:R4QQDUK3.VIM/S@78Q9N*\JMRZQ9$0F@=._&,]9+8$\0E9
M.\S'+?P"Z @QTQ;TIE=T34X98Z'5<A6LTK"E/-S<\$\VS49OZO'*1%->E$=+
M5UBK#99TE*DZ#3H"LUJ/,:O*$S73ZS1CCC7(F!'M>SY0M]*#VIE=QI,3>,D!
MP=LA!1J,H4WSK68]X?J)&]CA,LV/7=([89+HZ+;P= [1G<LQ'>*X 6]K&HN0
M_16[ 7TX!RRHT1R"K2D]Q![*>NSXXVHZ[ -=$=*+-/E0V''9)UI&POF:I[Q[
MN%OC;4]_FMPS'UJP/%6B<:48K'$2GAYXDO5UYA&IJ;9L":1!@J=6W7=OY*4G
MQ4/\)74MN?Y#H&:O<EU8LP!Z]C.* W+>/H<@3+L8A2%/QUC[V$AVDDNO(E*0
M:).\V^$2"9C9%W^60[ODH'_*X,+I*7Z%1U!J\E-G+OYB%*Y(#IXZTX;#F9J9
MLJ^':&27[Q2%6,T1'DR)WH#CWX^#!R=]W'V@MEO[/TZX+RM7&G8?S3?6HF3E
M<9_+[$-R.7/RSE@Q;4ARQ:RTN2T4Q^;\<;E+BAEH@;:TAEI0)'7HFC8BZ-/-
MO4H5MI&B,4?CAPJ@K3?Q?GIFYI?R$-$?33I&3)++2P=\^,\-^*8?C:4;;7?Y
M6!T9_GE=[ZN#,VFIU(3S&W8>A5SFL'QP@@HBG%(,045=Q2YT&V:$K8-1$M2&
MMA;;/*4C2NI!3DECTU/M=:NPJYN9N&O,?TS 8BVE2[@A&'1/9B'ZF29EYFK;
MK&>5(6R,#!JOBSQU][$F13AO[^ZIC/>A'M&8(=USLL#=9GM"(KO6\;*\K4>,
MCT987)N[G&+T"7S0$U_NY73?(A>.(2L]O#,^ROAUN:%-&KY?SM((VC+S226:
M+>G]^F-M=F[3!1^E*S:7J]V"CM.?/>_78/1]]ZUWWWH![ZUR2\V%_WJWR%C\
M%CFM(WL^YN?=8*\(E&.5D>XI?@WC6=;H\^(J$I>H=)_:V-BB/MT-_Z9Z]B!U
M [R>/@38/31PV@CI'L(,2,VZ_"@*F.@N:_"N'93'\=(R$B."Q[2/*+H+!/=.
MYT4YV&$>$7HKG4H;DURW=&%/+=SL:BN5,,N327QI3#/-2,FI,E2I7V>O%KC=
M7&5+O_H,=D.$7P&T'J3Z\OWPQZ^#RL#EFMTU:I["+A+]NJ;R]<+RF$!CS*9@
M$Q,+G =Q33^(A&Y3)&\UL+:I=NV_4WOV807KLZPR@EYR@4)7QU$]DUO:-VQO
M_\1A0SFJQ1R.S'M.Z:B;?Y:($L;XF^XO7R?X6(XPQ!2S"[X_(5SP7EM5\=]E
MZ!)='P^G\145/)>W94':B1<B&E4C47\>'+KX!O.(>1>'%1<C([]<)[<M=$,!
M5F6+':%I.X'IMAR?/?A7G_5WF#JGNA Q#>G[.W)]Z*'I1O0^$R?R\:3TJ[SB
M0(UBF,<B/_?Z]EUG#HO ^B'RO:8WU%L8/O"TP>23+F0YT;O$7_)2669@.20E
M:XR9&^[K\>4Z-&XNCT7&1$,N%+\L?0ZBR'W8D&G@,^ [7WNCT$@&8>^J@9=#
M_(G19PY>Z;,$>I$)XC-S>F]?8@YU/ZC<VX[_5U=Y^@[,M[98%7?*=P6H(NAM
M(6+[[N@Y4>EGM5^-M*X^D,'O1@_^I_>LD,:$L-#]FZR+T9#4ARQ,\XE:-WB?
M?<K48>:YHH[&TPKMN2L[D[BX=-G#\Z,[5?JZ"W?JA].TV;9 UE6YCOY'L^C"
MT9>H Q(A\+26A@%>X!\X@0\=FRTLH'!+[8@?4! 5WK=.LH],@-\,D$:H/&\]
M.&'O80[%#ZZ%L:KB62)3%7[B<E3K_+0=!WFQ_J',6QN[(X)[L';3F&7G_6;0
M8&VK\P*&^D/I?!E4RX*?!_[-]A*2:>.,4M?0/+2R&"7Q;CNM*$%S7E-1;6E9
M16;XE'VVJ@(BN[X*)<[E1;\CU?7'GYKMLM@R^7ZI>0P_!.?@HC;$?/ZJI\@9
M+Y59+!^#YBJ1!28"#DFPM<+/WPMO7L,MF3LDV%L+4_,LK4>(9J,>J44ZHKZQ
M_+\JSJN@U?YE?#H0^).SB\:C(KMT)FYC3\Z!<_X#97K=)_5L1J\TD+A;!VES
MKUOJTQI<7DX0JFM1^B78Y=P%[O(2P5 WE/V6:R/&GID[V'R@A9QHW^332 @-
M1[ENQ2 4OJY/M*O2,J)/!Q!"?8GP$L4W6MN<"??YBQUFOA'K(JNWK227'0"B
MW];Y=DL6O(V5BE8E.%W<L#;W?>4!$S;($.]02+\'2Z$W7L2B=4HW0+R@2D8
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MW3(:E9_MF__\8G</T"^,M(A6!CJ+%_(39"Y^FF6Y*\[M-,$4=.C0/1&R/7C
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MK?#<QIJ3;]16_0NSSA/&ES;]9<MC-$?J\/)](E@KKSV'52.;AVT\P'-%<WY
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M0TKNVD2-W@X8)8;TDKB.R'6[>C_/_%B:!NH:U9!+'6DG'M@%"VP1FU)M^5"
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MW>N2<VX6]?13<YA.:Q266<,Y"&6Z)X"!-_Y77')A<3C5X%\L#[W_;YUP_MO
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M[; 3]$L6K_5)$CV-=-BDJF_TH^?9NC(I\*H=8Q"I3[E=S1\##Q7Y.QMZAK-
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M/L!J<SPR@YX^O$V'F$"O];.4,E["^$A11X3'8KT-'OF@50Q@;G:<&231/6G
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M#"@3:TCA3#OHZ+UAD6[56_^&?N94N?>D!<.SWN;9M:6X5;Q?)]1@$ *+<1!
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M^#KT[AO+5H*VCZP]O]=!6;TN4/POA8%]_S6,NP0&H'FH%<B88^A*DWFLLG8
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MF$V9H#YMQKC!WY>J7%O+B51_?0W5QG"IMH@9 S@\886G&6K\](8KQ+F$,!K
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MJG(6RA:-G:VI#EN!"6!)/6$"W59=?G<7RS*4GWT)VZJ)2]4*;[53A?MZX2*
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MU8M5.VS8Q%^DOO*G46YJE_230F#&NUSX==8BHFLE]D80HD>8<+YZ@6!D*-R
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M0OWRIP,#3ZC,APJSI:I:O"7)7)HE5J([R!<?TQBZ[7TR<^?J!?9=@7<%0 ^
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M0GI>1\L&<=E;,G,_8<7J\'OB:9H\%;AXFM@&&+4/' <NM.Y^::,Y-Q%(^2D
ME]\;*LC4C&E'!N>]A=^K(Y48'Y8:!7$'NED(NP?R^(?L-6C#]%-GQUKJN_-H
M=1YUJ9Y!9E]_$\V02F7'(3W:'NU9>@,9V"Y0:1(39X_ YJQT#'O*[UON'@>W
MZ=C--&BCP/4IL?Z8*GC(DD?,'89?J0=3T2T*^!KEOO@0(!(&%^:/*3R2S9%M
MN@)Q^V@'RN*H%5;72B*LK6Q:\ VT3B<&M8M5Z');-H0,&:3,8>VE"V@%M5\T
MN=,[KSHGQ^*Y<QH#J0#K/-1C.LG\X/+F.^/P_>I-7MH+D37)9Z7K-D;D!YW
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ML0UNM]!8%OI0L&Y1^@C#4N*LE]+X<N1%KH51<6"2XC#1*/K^>4=953W/A1N
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M==ZY<0;1X8?7V:=7E-?";Q"X&2H=W-,!.!L=NQ? =9OWN=><%I[R_<E)#)@
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M&+U=T[6F'G!OZ0?:@!W3N6NK;3H:J_&]W.0?0^,X:6!,KZ"AL$3K6-K24F%
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M-1O>Z9JP9J-_S(':_P[MFF'",5NJB,\TXJC"MY?>G CR6NKO1;0F33IE:6R
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MH?WLP3,?&V$JA-C21>N1LEM:=T3,A<.\A&5V2PZT)>1#6>')/9QO4P.A/:'
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M=SA,@ZC-'5\? ? T! N1L<K()9GR+X0/TZ[A>#U^UF:L/=6>^$_Y5K.;'N_
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MQ*MW7F*(VJ72#&D3=1ZY),5T"T7Y>8^$VNSN0^AP(]=PFY17NAW.<[XJ:N'
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MW5U?W28'PP?P9B8C.R^E]^2X]\D=0$,0<.,<\HITOV O46W]W^,3K/<O7?U
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MKX&&)4J,%Y!C\BRNLJGWRFC-R+!K2POWCR#E!X7IXS*R*,87\-VYJU8.X+%
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M#.D_%2#":YU;R[/N*"*/J8KM299/OJ$E%P+!9+_8TF#KWR#5<I/=]$A4?]Y
ML=H=R<W3JR1,M+7>6(M/RC>QR6E1XZY5?!ZQ,<'=3NS\E95::;'OQZ;*HXT3
MS*GCO<*]R0MP9G,KK;')"EO9_HBEQ[4CP4H;.OKX*"":<SK_J["@*G=MO/F8
M\O:HV'ZQ9D+1P*,.;M0&3?@W(ZWV&N4U_>\U1D"GV(+(:]F)PV&C#+_8>8OJ
M^\>B,U.>X/5-B@Q<,E\A<-R3QN.Y"GSOH#KQ13H\T"JW[\ DMXE^ \UIA+?>
M7>;6IJ0$R2H.QM*3WML<Z?S=-1WKS!\XV1PFM8N2'O$T,(^G]AC_&%=(KA</
ME/2Z=X!B6.S3[7><;F$%11 /#L>>:WEB9J[>]#!1EY(."[NN/E+4[@%!6%DC
MMH5S;N37A"N/N,L;*D5SO6KWZ7%/'JFJ%P )HM2KU*M<\MQ-[5^95]<J6D*7
M<>'/RN:3I^MCG6RKS0,WKBD[O%-?)_;,^(^57&%^ F(8"ZL(E)S^*75_3 TH
M3</,K) 2!GE9T-&5(VFIB3&<:G?I=#H?1AVBQ\HR[V@8G[*4'/X.F"*AC,2^
M'5-P'#5_U(JZV6=4^F&E[+JMO0]M6Q!50+;,%4U";Z L,07:?W]BMNFQ_..L
MO*7KNZL(HO!GRQNGPRO 4'"P?9(@.Y.$\KC3+5,IZ-MP%7Q=T"VX3#Q3XN?(
M9;,T0L@*KNN[DKUMAUK1MIF19WO'.K+4QJ(CXT;RKI<$G5W'<@9P: VJ;V&]
MW*^63[90R[.,(I22A;^AN%NL?_.]ES^J9P&I1,7U.@N9"SU7Y;S<F%).]BHW
M#6N?PE?_ =R!*X@H+Y^Y&'>_GHPK#;E13J%XI8&MUZ)R["5-E!IP;Z"NP-S!
M _/\VP4CN/@B7ZF=8737:H.:ET()E AU=*_@6)5<4;Q/MI%WZBN$$>19%EG\
M?T:;CZ[.UK&4P%@V7KL5<.3ZLW.HY<_8AZEUM1M7D:;'2[[64#;PIUP_O[;?
M13$CCJ:,(PP;^6LV#&VU1A0X"&8!5F[B==P-"?--'_NGHT4U5^J]YRT_V8X*
M63^XR@0\;&J9NW@DTM(!QD? J/C&R-+-&JRU-G(09\:0>$EVX3736J'$^,H?
MUCB'.Q \)JX,^J6K,H3JL6JMT.S8N&2U0E&3+5M<3>*1MI\"EY]^BLH9/@GJ
M/A_)Q2SS(6ZI3$)WS03_LW%LNMN)!6<(N^G1KA=5HZW(RKAR@JLK<#BU>(@R
MQ.A.EG:ZW'R351YUXOD].\\V_TWNS([)-:_UIV>HN41#%8L%3/Y/\I5NCL[T
M@-^C8:.3O  @!TY%V?Z\LJ.A8R@W4@N@VJ\IV"\H]I;1DZ6(-_/2C-(9 +="
MV#JTYOW+P.=K,:(</Q#-!'DYUK&*M,Q3X-"H]YU=2T6D>VSHD)8YNP3\"?']
MO:B/Z#2*21Z-2488Y'O&S7DCA+8<I*?IEE2G!/)PPAG"%:L(8=6>3-?R#;;B
MCTML5SS]Z=N9?J!G^N[KGJ51I:)'D?9QD #SLJ?&=OUX?I%O\TH-ZY,?73J2
M];IJ]*ZN8IW)@V(NCC'&;,JYIE(6V17^:</##(*0/%/76L=2<%T1FR9B)"O\
M]T+<7"#VS9H48B#.IMC?5[YVT4^\EC*,J7 7^0X3S3TJJC"G%"07VO5ZHJPE
M/$ZX#X2/F@3UTPI-I/6Y]!Q3:D3#$W_:3,*T9U_,;%S_8E0T7SNE5VSZ--_
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MK'/V6X9_UOCU/YIR_LI;=J5_F26D.@K ZHMK9U[ZC\"@^)?C-=M20]/5*98
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MC72<J*@T=A,U[%/AG6*]SB B=;A?BK[IHRQ7_=WI[@D$PMK2@;M;I<8#?-!
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ME[1;7%(=F^K]#5JK*^&*5N.HG^MDP"BY\JC/2M*F=_QXR5O#SN%3H:S!'90
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M %XZ3Q5^$51;ZIQW9<6I)S14%'%SW7!-8LE#S*5WFRN@[NZK6!EO3FL?Z)]
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MB"MJ+Q=H17K[?;SB[W8JIVZ%8#IR-U[8=E5R45T7WPH;AKE29(6=?W'>-4I
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M<Y4['DESH.4SHKI_//9VP8:%A'RG<*J@'J-X4'2KAKO2&=Y>5VU#FV]7:CE
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M S7_$HL__NV"J?Z:).[3R?^_[8O$_U&Z8G'"<CNE2H:'ST!&]HI4X3(T<Q:
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ME3EKLU9)) QW4R9/I4WY+GPI*QJO""]([NZU]%Q,/G[?C"A)4I)(T%01BYI
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MKX*I2_MGK],F2+*!D#(\PJE#-[XR6?4S)NB:7/]2> FYTIFW_\OD!X[Z(//
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M)P3C]6XZH%]"S^V?[-?F/5*WF]#FQE-1YKG/4XL2OYS!&#RB^42IP80TG9?
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M1L:VS(<]8:^Y$)R+W[KXQ]TLR.;DV?T'4>;_L-K8KBSV<6<YMK+I5P*D>@2
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MV9&Z$H-+%GJY=T!*F?K.O2G)IQ.JA27@=5.UVO7O0G3H?Y@N((1@OL\_QS/
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MW@<2OQM'\&E[0.H<;/$A5#IX /70TFF;7P,.P(#>(=.$DVO+_S A/\\>!H1
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M469RY@6&@/A-YLA<=I?V$8(9H^V3;18=\TPO+@'A4:J[5; 3!_G]C'BC9P*
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MC4P^+$4\NU_(\U/QW3G@#]Y1C$!\IPY/@Q]NWKO^E''F5,G_Q5F_M)84ZM*
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M;9]^.4#W!DSDZ8CJ54%<(7EGE$ZSG)4*8WUF;@ZR3/O11]>Z(/=@SCI[WN<
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MDM2ZP9IE#,AZI[G-M3:A60\ZDLUI%>OY9Y)Q:P:4;V%;RKN(R=AI /1$(WL
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M1>VZ:!0511&1HC2CTH0(2 F=H"*]2@N&$A%I"46J@ %4I#?IO?<2(B7THD!
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M/;U+4!R@NEMG,=^10*H4Y5;%[?Q]7T>@=+L]A^U/-,C]QFN+AH?'L_5]EK3
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M6V?IOSJ[WUWH3<#7VEYY4YVI^MS>V>,L#BWM0!._6S2]%=M!X;ES.'S'VCU
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M9TS<$G(N:=4E"BH!)Z"7Z]B95KIE?61OS#74!T3W0F(.@!_/F*^S7%4.9_6
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M.YN'![]6ZH'5>CHRF89$\C;Y[!G,#MV216OW6;&D;F[USAI$:6J;K2\;P.]
M& ^?2- 2*?H;=F9%"ZRYXI@X/:!BI"I];!C>B&'9P EB!F4P([)Q*WG>T?U)
MO-*@,HS3ELM;F_+P&$Y;80Z:0(31'0^55);+E#R5 2'OHF\(W($K%RA-"TH4
M:]*XZ1NNSA$EP$7N+(_)IE-U:?ZQI1WNC(H>=:/T,:/+LC?/[M17\K9)DY9-
M'(Z?N?%5C#,%J+V&CGI3.X]XET6O UWK0?N%%6$RD$4J2:BT^2:SBFC@UON6
MXT!;:=W@ZO#4)LVSBUUV];( L[1H;]Z3IJT>:-OU3^< /M!NU(Q=WCZ0NKD]
MA'L7#;(Q4RHE%<DKLT=48V*QOJ)T2E!\ X;XOG5D?4HI^!@:M"R,";)X73\W
M^$P*8<U5X@X/Q2[OE\T-/YA=?VX-OLR1BEV?DB2;<8_"C%/*390M,RM3"FQ!
M(<Q+^I5^ZB*]J"V&0;\^H<FB3#P''U/'NE'3)\?*HEWTJ7%O+)*[QOBFN<-^
MZ1[&A:QX5@O,QUR"RB+^P%KO+X]12UZ9T96L[R%-6^TGGP>60"9ETH+G@/L5
M1U3#)5RNEQ\PY61^O5;Y;XG."U>[6:S_HY?MGXB?7-YM2[^:GQEG"^"D?_D4
MD#.N5+$6!+#]EQRU8N I_YAH?Q /(,TU(BG((3<F_8I.;&B%<^%K\1L#!5EY
M#8_R!Z]!<]Y-T_*IX1U?NY;,>RT5TS# 3C.'_(1Q1B]0%*0Z.==(IRI\HP:)
M*Q5_H!D1AMQE(5+ZHN93/GL,XYINBXAB4[7I\+6T4=+?-.>K8.7[OZ%H,_CC
M(L&[,@B9;=XY'Q4"MAM;K2^#F!/F=%1']>V!.3S:IG:-'KNJ,?CJ5%=1&_Q>
M34^VP/+9^[;QEOA:6$[^@?/Y[*6\DZ"L8_$(IY=)6KD1F1':DU1\\L[MB;^W
MOQ<.M-2)W)KLTM>&%7_'LANNBP2Y#ES\_IJQ?#/[4%VC?POAVV+7_;3'ZTRH
M"Y$LFO>>:$B'2_35Y6%@?)R(OPU @]S&L7J?VAGZK/:]$:\!A1R?)]D<8+';
M#&WJSOIG#*[^[V#-^.+L@9UM(H-5$B.AEO7&4/R!ZD BT7:/:Z=Y.-=-0-GV
MY5<SB<+J8J<##U17MB_X.377;&Y;"[XQIA]"6YEAEZV8'*XR4$5F7'T"T?16
M237=3GVYM=E<UNW$))B:A?4LV+)O_LSPL<PKIL.-;O9:1:30FU/0'XARR4W7
MFJ2X3;Q8%AVJ+7-=KES5D(.J6AS-&S0J7:UGO>8)>NB;/TT?HF$MD7XIITTB
MP]KJ@MC+D'Y;D9IT0(BV-I83\"![7&/,VO4W@#&THD*+0@E'CU:@!K!8\PR.
M_<MN*<Z%BYI%_<F-@=BDBH%H[8NPS\=)K@4K++WD P2 ! Q\>;8!;VM4)OL[
MS!DI]WH<;1*LQV\TR<'OH* U@IT\#*-7'+M9<\(#&%G2Q<P2]VDNDU.Y="_C
M4&F>)1WVKN\T82LH*6*'K>M)6W)V^]6LC=X;JXP#ESKY/.S\99*#:D#P:^3W
MA)WQ]:[X$V2_,S#LF>@"'%_ZWF*,??WTR2LAFCJ8NAE2B(@@-&K_;I1DM[UB
MCV^@D"?C&-HF?LE*]G05I>85N,'&B.+RLKZ.8W$M/RU[V($Q1OWUGI>GA._+
MAKJX2G9C\9#7"!>*#OM&>D5^AZLG18F#7C>*$TY[E^'*F+C[OWQ-E?"EL@:#
M9_38ZT"N213-C=%M697,/X-PTHA*ZV^LLQ4=K6WCK1BCK@AZ]Y'9NC3M[BJ0
MRJN7Y0VPOSZJ;>I")#U*,;RYZ1FX]PI.J/*6E]Z\B1#Y3=4MI1>O3D!N7=VM
M)STD?[_YJH2SY[)4LQ>[D<X2[(G'=PAQ+0J5U@'!NY@DE/QL546M+)=$T41W
M$9MFBS=]I^EC=\<GGLBUM"_>M]T^P> :>UM<::"1ZG63CJWA-B%#HQ?74['J
M5E2**Y1?4"\2HWEV+!_6UAY&S7*'O>A[P:R);_3K=S&O#U6R6:AYBQ736$#3
M_]/C[A][);GK>2^?7A7/^3]DA7+=7&,N#](O3:KPB";^T]#SHAG8!*D7):V7
MR)/W6N+X](&Q9J=1;&GZUCOLLNU=.VR*>U[Q1Y+QK>*^+P6Y;B:83,DHWQ+8
MIF8LEPQRRD6 YIKP]C!;$=G2CEA91]13=0K2G7"5_L42R!>N#;)7)TD]53#<
MRW<)Y<R8]"W17S;W#8=QJBNI. :N)L)#:R^> ] N8_9!>"/S/Y3P<&Q8*Y9K
M-6BIXAQ )W*W$\J1G^)06)NF.(*D_479#2L04NXK^B$RS>;N=OEO-6A%$UMQ
M/,MJJI;5I+K2G@HH?@"E5&5P6)059![Y9+0XF*-$!^?%$:[N>X9ZK1^+17-&
M"^R876Q\1\:2KG?<+NPXZJNF;WSHMKJN\.*5\#C:W3PU3K34Z^[%4<0"$"=0
MA.!47>3&-VS.ROJ9#4KGF283*D=ON\I2H3ALQQXN'T&;#)LKMPH??;]8BI*=
M7:I8TOHT5K7*U6:!9'X!^\+]Z-H1-.!$GFPAP/ZU&)[C2:&W46Q:'U(<0$TA
M*R/]:FO*4W)V1$&!)L=B2;+UZ/(O/T[7Q&,@@?N3;7:0@BX;:.X<$) */.M.
MU?:YBW[8(2/7? Y@K*]['2IF#UML9$>],.R4$.1WE$$N=M3K\2<\,)XSF_HF
M_8PX7.T;W9$J@ZAYX>1-NX>I-.[<L4S<L99U4T>NQK5MZTMTO]D Z5LZV%;)
M/7GM8!(\2\/8D5N+^O/M^AG!29CK17UV*Y'+HW_PKY^7D*HU5;AX>%L%.#PT
MLOOZ!<'E5;BD00Z^+W0H.]%S_GL;<\9(7>*9"#G0I4"8H"!Q@.&O1S:HF*6T
M@Y?U(1=J!UDMA)!-6TT_F.R,KWTYTS6R]%^"7*ZN3S!HTYPU^3$+O-Z9LV;&
M='<?@]I*^Y[&#^8"]M<NG]V,-SU\TWXO>C#0BHBB)$ 'U! :@G!Y-^[VZT+I
MEJ?([_;U=)"X!P^N7BRV]F*/DW>H"<#=AMZNV9>OK+L1.UMUT6'52#94&A:[
M=&Q2_WF ,!)&[0?'U]C3H9Y*?GS-T>.Y0J^R(,EFB5M8<:183(/U;:V3(N7?
M3*ZVH_?$$CU;#TJ&Y?&^M3=2$6/74X^SR9]L9IAL'%XE'H1_>?37+2'6R.UG
ML1NU464I08*_W$\D6M&I$@]Y4"Y,([Q7(J=-0L4Q'?8N&H6V#JB=JM.._R3W
M(%4YE#.<"E4A7F9Z+-U1-46N^QQA\E9R>:3^;(N[53$-UH1^E67M[QZZG[][
MO'08F3]K%V@0&)D_*,DVP.2P&Y30T)<P2MASZ>X5,1XX?G_6@4XH5LRQG'@5
MPTI5%( ?D-;C+,^?0O:="!.SHJ]HXNN?J[[7_TG +!]%C7Y;I'\EY *I^(V"
M1=WO/,-B70B/(F^_W\?$5X3?8S&Z2#Y!FA )6I&/W5,:D! YU92#$&D$._3B
MG[/ 6[T>?:BY2\F=B"EQB]@L]^M!)M/6][\=&FL-B>NJB9( >W5J6K3)&Y:6
M+BFA.PV?".( 07A7*0<<H@4A3LCU&\]C\+JN04D?Q*MHOZY3?&\HBRT.J[PO
MBW@N' M$P/DQX,:I(0K%(/F'C6-(/I5.Y<I/,=DJ11R>R&?#8X4_&]S2?:[K
M^#@ZEV@C':,LV5:KZL/?@7OAAKX=A13(9N8,;,*5-6@36<"$[B'UT#:V)-VV
M!$#).ER&DL"'1"J(:7^X:-FW7^;^U4='WRN8.^%MWE@%Z&+K^-.[.9D?;_7;
MY2#4<S^RR7/R_>>MJ,F_F3/ (Y&*8-6G]ZX?*Z>18SK/-G<QW33,8B>ZFF?G
M@#U,?].8:4#__#G@_1%T03$TVYZL-!U.+!F38HUY#\D^33)<\-G"-$CS>A.,
M@?V-ETX3C39\($,'P[[><RS _M*B&K1,R#2S[!%KF@HYF#@'>9\,P>ZWAP8>
M/VY2(6.([ISS)]8Z$[Q <3?[EG. ]7#<?&_O*7(=Z-=XC3H]8_0OD5K\E$5=
MDJM(@D[)WK#5(GN*GU&-98<49,TUA:<RB&XK^^+<%YN/H96#T"KP+G"=R2YH
M^S74SXU^?="/TJ.?GT0?FX<AQ^E^\*3^-MT"YW3;:1THR3\'2*RNPC7=JNN6
MB@%GS(>@MC'4 ")\.Q7[3BG!:%GZ 4'B%?2Q)M&XN+:SPO@#E&8&3M/)U56
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M2B@\W?)K<6KJ0'P;?*F8%%'Z97AB%UE_SE?7>%(E)VEDW2S.R\._F+XE &4
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MP]@H3XK!-SY*RRF]0//XC&X#L'#)M%=U]:!8>;6_:$_7&I1_6'%=]TMY[1\
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M?'?NL-ZNQG?,F!:P\.*[62+8NQ_<AQ0_*4V&*]Q-?CR2P^/S[8H74JLHK+%
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MI[)V6QSLD5G'GW/T$$T:+=5(0X1D<_XNA*]O&9V[:M[;?&8*U8$_ )2KPQ\
M,]U/QOQ]=*PWO][QG$*_=R4^1+"M(;1M/*@@\UBB^-3BM<,SQ_!3*/5MO^8A
M@_#:-0\9V(*,."%BJ?Y28M2B.55[]]&DVTC^U^(4>Y0?86YDH>059@).@N,9
M)FOBL0+%1/;JL66-">8JOXP9%REDT:WIG%VER%P.!8_K,NO3LO=)[R%?;L_'
M!\.6_?9GDU:\?66IB;KQ!.'V5C.L_%7K/?&%E9BVX?O6/G[H5S7)@PU4E@]/
M68@W&G>43O?0R">,TH,R5&ZJQFM*J;2Z>D+_6;K]_]X4GMW42!/F^'$!)6N
MKO;AN]YR_.X!*V_'4Z.U1UIE*^=,JM;\4)Q<L4NT0SE!\@MZV1_R$6Y,]>\>
M:H1 CM.-MON^EBVAGQ+E(O3HK&M;7ADOY7)^%.";DEZN6XX^GK G  VP/BS
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MYKDW_;>Q4W\ ,+ZR*V,>'>G!=28@3YL9;<8Q3'U<0K\!:F\BL::^-7+]TQ^
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MULBG+?S^-# ?L@+CF+(WJK0+TFGKS;@,&C[0  ^=]JX*&B^%;:#DR/+YV_<
M[<I.7VC\)\5-V 6 -N;QI<?-E0X!6H:;"O2X=&';HG<<JEBVBDF2<W&+QX:&
M*N(KPQ@0USX&UZ71RZK&JI<YYI1>--6DQSMD%J]AY7CT'%FRJ=\@HH'85PH\
MW@;:5@][9)X 4#:/SY>!T*95,8X\S$]'1SC!.6YYP9UM:DZNS\2+I"$_BA&V
M8RD'AA_WY#54& A24+">?OZ]ZSH]OBYQ W%2H8XX [LL+Q5\O*SR3>;4D:YO
M(VMKVO1T^$_<UP?+/*Y'"HC$5+?9?=S_[@C"UZRDJD+9(-R[<G5(:!='P='+
M0B]A1ZPU)K#:HT!?0R@OOH6WCS81\GS5OTCYP:1VL82\V3.#W$K+P=3?E];T
M33[.9_@\X?W I*70;U>R>S6==9$[*8M^3@^@.^$WQ+SAY"MN\#5"]]IW]Q9$
MA.K4:.&@NE&#L>8M;*?(R!!7:CA.4@N?'1G,,CQMDZ>X142V7]!W@+<GA"1T
M1RFC+#<K"^,'4$!2)=_O&?C24W3+M0^UU45R*8N?#S1<S)A"Z:EVQ"*_/KAW
M1@7>NHAGMH?A(+RYYOCZ3G-BA,I(0O\*\(R*[EZ;$Z*>!.H9O&/DIF3H XSQ
M_!2C?FMN9"M'JW/9W,</(GX'Z CCT[536![7&G]5/KZ>?]JV!B(]"#>,N&6W
MS:0L?%-5\F9<JIL]2!*D]ZB:US AOL&[8,(NI:>H8IC-<PA?(6 ^CFBKL4!J
M#Y0-UR?4^>&#D/-$\1*S7HDB.8V4W_KRJ7$9MRTJ9JM,>2]KU/YDP6>:76*%
ME-APVBL4%AF"LX_<X&9K[ E(JV4Q4VN?O&H%T=N#&_LM:;N3B\+!>BCACVIE
M-D#"HN^W-S<("P?SFN0O6^D^T?-1S4:).Z_OYV='*8SUE _K#;OI__%C) GS
MP.>0"C;,HB;QFHY1E/&/E]#TX76A>XC^AMI>GV)>#+^:?[QR=*V#>-;O\C#2
MF'Q^.;!L4+\A6/=:K\&I/8YB9(O"VV)&,7'L<828(FEKP]I:GE1HRC#P8;$/
M4K53*+>&U>)5S7R)MF4>P-6M"#;M6XPI<&3WK=ZKLPI !PPN5HH7#T?D 2RS
MCLS[P*67IJ6@EZSWB^@F+"H:>I5_+GT?AN\C[YF\*Y&&_.:HEN*9$&83+U*:
MM]VYQZK1^Q/KCH!\863>]N=:+!( 3BT26FSGTUJ567L3'H_^%$<>^;_-I8(0
M+8??:WW21VZ\"?]5!$X9_+)TR-78??^@"'?\F,@W3KU\L*&:^ND\[\#QX_P7
MM6ZF ;RT3 H+"LSU!5B.):F[FMM9IM#,L'4M4Z]9WO*'7&J^-'6.8:!FXH-.
M7O9,<QX_)>,_ *E$I_HO(R+W4N1?B:.G>>H8Y]^BU8F;]R5Q?MTS<)\2)VV\
MZ *"3&9L8Z7#J7]**O(HOMB'-5Q#O0_8=3F,J/:9+^4B*#DUF"H23/KTGTO1
MJD6V7C]9?DP^OR8CMF)J=$9UE<Z,F)]+%N38T!]HEZ!=1J1&E!+/!;> Z JA
M1B/'N"1_9-*Y^9KN-:4_+I$_.#J_]U!WF.Z[7[YC'S!^/VTW03K#,!)X;2(^
M/XPFJ5) :@GE[((OOZVSHD/-I\@=)9BXOF)4R]<),H7^-^[>,ZS)K\L7QH85
ML( @58H(A"(E]"9*!^D$ L)?Z8F B/2F*,7005KH)4 ((5)"+]*E]X2.A-XD
MH8;JP6=FGIGWO#/G/>>]GKGFG/-A?=C7O:_[OO=>>^]5]EJ_E68$S,\O40%[
M"VAXYXS)"OC*OX .ER=7M@-:3H0]GPD!U]-9JOC#+&9NY%7(,MO(0-P,]?\X
M)W<?A__M1C,X 4:AZ/ O&59SOH[YIWD/)'L]C!(+Q\)")R-'V\+R-QVJTDP@
MZ7W9,=LTK4(T\0[4$T0=6E,OP7FZ?9U6#,W9+Z7[#<:DI83!*35ARP0"L9]&
MKVS77)!S\BEG^QZ/AZCQE7;XD(3&KX4AN/JUMI?EQ!2=05&R\5>4_?N1+TN#
M*^C3B?(:4Z,%4 '-935Z^9?Z-<3<F(PJAZY:<++*]73_&BFK ^B+CN92+95[
MP/%5?SHO&PJ$-^:S/W,*.CE*(8AV7;J&8RD>Z.XE_NFG*5Q9WO0$-5YW[V<U
MAWUGU"[&D+C5;#21VW8$REEII#8>$?I%(H/<9"L0JCU>;F4,RB;]1&Z8(TX6
M[<,:F_ZRBG4T*'>%8YA"$("HC.K6 DW\]>17^)O^Z'9CH[1!(*V>1=/2?S4^
MRO\*75-1 ?3[<YI28N,B1U?<NCP)LWU8)QD0JZ#LKG5D#U<U),_7BG3Q!WHD
MU:.8FJ%+&&-/#LJ)DPVA6Z1W;] *B=PCN[]ZVEQFMYETH^N]_L/LG.E>-4#_
M-&LTWGPXQUD0%FD[@56@SIE]5D+,0RY./9R>:8"3[0H.N]GDX[<I/[VWJK'P
MP0]EW-C3\C*5C]^7HN8\^"(Z7S8EMUH1E6/E.(C<SS<2$%_0<0J1*]STKZ9W
M>^^O\ZAKXWQYZK'_;Y L\ ^G<S,P0I&J5SY9)_-B3 HD3M-T(OYGY9=('\,N
M#;Z-@H[DL9V +]*5X_-QE W.I,?AZ4QY+>D-V/5&6JRS\",*?(\\=_)"C9,/
M?N%P7T2OX-#T*%WY4UC@DJJC%>GZ?,<6S?++^RDDH_E7Q\.'^-!F3"3V-2>?
MA(&E@(XPFC5_9*1[I3MKMR&*9%]"T7V$]\HYT8W4KLT]A2XPL2BIN>PPKO#[
MFCZJI4D]<]MZM9/<0; +"NU<[;?V2\LG$VYB+WDJ1%BD;!QE[UX%;B\'G[Q=
M_.I\"AT_82)8N90)P(_?4+]!F;+11W351XSC)#[.)1]<ZU@T8[0,,6YA,#=.
M3WG[^ /KWKN&"I&EB/ZXKUXO@_,96$?*7R<4/!-]P<(K/C3PW^=R7@@C1,@<
MJS3%/2 TJ),[B%G%X4/\IFO>H/&^0.6F8ITV5KHHPZ#VG@5OHW;SHF1 QM?T
M)\3>K>!?N?:#B0Z;)O<5[F$=N;4_+E#XX&?EY<D7@<'115+]6$\<XOBQYJ.F
M5Q=.4#5 #EP^<^96UDXD@J1C/)(S9O$LP[OQIX_,M(_N,XZ2SBV+WQ30X\<:
MQ:+GO8?KKAY+_::PUF828VC:1<:K[?(^W1/Q9SN1=!!;L(VJ1!B1\!]F)L0G
MV58M#<C0)N%5'"1%^&-DO&H;ZR5M99/+IX",# ,G;9K/H!:)FUX'-.#]_F!O
ML8%#GZ_XW(#F5,IYC_C9H9K?%#2^<HR>;-S"ADL:8=6+ORGNEB=S#UI3L-5:
M4I,Q397O/+]^BRAI'&K4/7GZ,Z; M-S'-<;B*=+WDEG:L]YMGV6$Y,@B;?9X
MMW_O$3_.VY=])!)00)Y#J+OE51D]ANW17#B19[S%5RL<!1DDA02VESCIYD$E
MA+P7"XXK%&3?^ +>U8S+,&V!2DS(KQW*OR%TIC&O0W["T7-QG5OI\6,F)T 3
MQ^:-S57C)8TO1(76@!"0 &=->P#?=O# UBXRDBZ8RC^1'/9S#7)CMJ9_SL*F
MR+_/PO=SJ((&#GA'\!9Y7J=A1-*@IF@://M2:!IRU(#?A_)R^T8-5;PZ37,O
MZ&%#"-D'_>B/]Z6?FZRH4]*K.0(UKGK?FAWWG/#?]+8-(3XT54,OS+..SIKY
MBMV9W-@^]C9^5Q 6_H!$$R$+<!',B@[!(+P3FR(N0MVTNY1]7J")#DYYTXMV
MQ.*PY@ J>O6.<S&@N_P>R*)SBSR=U>N6JT:G?N@'F*^7: )!"9DS9E8!^?7^
MF>3&N9^CFQIO^EGC%]U_4Y0==2"OUT4>KH)N?&'72'FSWFCK)[=1/O8LW+=Q
MJ.%C,>?<05!'R.;@Q<WO;>Y[O8\]7.U1#S'P1@=M$<UNAWU>6<8CXRHV-D]%
M**F*MU8L>Z-98^6DIY+H-T"ZOR5PSLT&.-$Y9)&1$?GL %JG\Q%2.>,<-RL'
M&-AU#LGNZU$M8_8&/<]W96CO: I@EF?3*=!F-^D\ ?PX$2+&+CI_?))1OVJ)
M2.<AR\-S[K[NGS,!.W_WW%R<7KC0C]!'66OFN_NV9)XHP''C >ZJK/'>\RVB
M;=^?'8)P R>/U.8IE(^,-#&? >Q_BEX;'FM&C6>(D%U;#'K??\A:MUB>^TU!
M\:"<5",_$X]?.==R<#@;9Z%&A+=3S%PNMN)Z)?9Y_EC5=W+<O- 'ZXI(8[4C
MNTQ,HC,&*W!5US$%3V6)3)<C.\$7!"][]6-]-PE1XU]GS&N+6$X!]H;&(UUO
M_6ABK<DA*&WGQ:VX'>0)+S2@>$W-^M;W2N\C:85Q6\79-9K%E\N! 78*&]4Q
M$[?^.C*2ZL@2#EL#D4'$S=SA>;OSK<=V]^3BP&2)R;$W:"C]#M':6[N0N^<O
M0W]^(A@2<Z=,:K_8W^]%Y$N:_K$3H"MUIN*S<'RQIU!SZ;1*5O29T7JL[P.#
M]Y9=6ZLO$X//6(HS*H7/%YA^TE>=VZ3'+?HXK1F0L\:A%2$CZ%=Y-4(XYQ9K
M<^.+/9IK'2X0 SMG#9)0*-M%/-A!F-IUT^A&@G<<C[L"<&,OXD7?EOW,$^B0
MKR@&0O_HDC,FTTG!QA@:V$Q]%C^XHE &!4O[+S/LHQ?U^9=UXWMF/QN+6FC>
M<9,E-(36$*-K!G_P]LUJ('\J!.4H"\>Q"F]:5+(F9/=W R:J$ (OJCJ>[53.
M=[146U6E#7$>@OJ-*^&)(4Z1O>N?+ LR;OO?SZLK]5_G.@9]('_:MY80E>%G
MT4$X,\)PM@8A5@O0_B^,=5V<L]S2;IAG9+T""&-PUCWUN@78'OLQ7Y?MU1^G
M@&'92\<*:?=-QEK"?8RDVEM5[C;D._Y$TVV)Y=ZJEH'V-0B=R#MPQ./D.[!^
MHG,!MZCD1W6+)0MD37^.C&:ZC:?"EO7+I,V=HKII&.SQ-7+S7XT9Y K9:#QS
M#"JCN9?;_-#S0N.[D'=2M^T>#U6M6X['S*?(JZZ^E!\2ESIDZ8?+&OD5K"5H
M4<_'F"M\\N7T40C-<8]H^$V!\!O_37&+8!WB\$DAR)SXFV*#4$$?]C@FG'DW
MRTC-HC>Q@6JE%$QVN\1[U<;3<E-J+B5L]='89_SD&3U1<6CCLIEP.R",'$0,
M\E7L\46/[Q<9XH&]J>]+B,[?V:Y.@]<'RU2^.^UB!@ TMYAF;WZVZ1P_!<02
M=;ZW#3HG/*6>8M[%^ V5&U5^NT.W"3-(FQZ88^+<Z9B/:LX_MA[*E>M<M;@)
M1/^F"!D/! @"]M@Z FY9X4;[OU+[H9I]M8_%3TNFBEC\4&HCPP:\3V>?S>V2
MG)"/!K0:1"UFB0EKV[\( G,UL%VU !N06=J9:H#&GM#%DZO28J%:)AU8PT*5
MYG"6_F=D*]OV"8Z6;QBKDJCN<!K(DJS0W&">4E@E0W$)Y>C%JH5??>7J6KV"
M:QHQ_R[XGZ#VH[]+V6L\B D'WEOGUI'UWT+(4^)>Y$XJ7E<:\,SR'KA4\,?S
M,IXWJ-@Q9/#6/M.#<5K[D7I%G.,ESDF5B6@T._AYQ%6QUXF4B8["X9RT\=P3
M3K,0"D?:S8:16K^"VUTVFJ5QCF(BTN]V\QVSC.._:_ N.B1E\K,?Z3TUT-3B
M_^.)_W.O<+'I7#V2N4*KOYFII/<G[X#BJT'%H.+ !.](RO\3G__.<$*B,Y;)
M_H)Q>OEWWG7%NP8.(S.[%"A--4E$)O7C#CAQZ%5TPN1'2SY?+?)"C59L5/E?
M4=[["A/W6B^VX_S0X9<L$RU9Z@+>.B\;1N_)K1?'RUO!<P]U\F45CI^E]#XU
MV.3:.5T[PO^<C6RLF ]-EK";:6229R$G;/OI,=3ZK9TRG<)/# ?;WK#4\ZT9
M+#X?3AL_4),)5J9+S(8X^$'"J3U1H$3HQ85TP.=U 7V\] QW,.\3<__WDQGW
MS8J>A["ER5P82([Q_H8PI:MAQB=!_.5@O&IW_;&NST@CHM\HGQX.?XM2+G*^
MO1:6_]TT4A*%@W^5<+D*HEM4>'#R0NSX :SB2;GRRT]CP;\I"-;B!X]D!Z3V
MT-/T'7<L"R:Y QC)-]L5'K .F[CME.QXXY$G[&3$*7+QDV  XXSAKK#!R%&9
M!3[9<3R^%A3FV=)>>7](G"7(8W!6,.<U]<8"*)5<V?*;PMX6>(<YV;*Y0;JZ
MJLY(<-H/NFIY849N$5[&3+(4)FNVO&9:.,(/^U-&"+S1O1?)DQ&MM&RF5_ZC
MWN1&-PZXPF^E((F1&VUXR/7N-N8(YV".6T8)M#H.MLG716F1MCL?=I]A9U;.
M.((WK_90,6>Y9F8G,P<J_Q"+,U=U"DK[0,?)W$>/;!/3>7#&;@X*K;.A0MTN
M!J16D$.8M"[$-:*-@EQQ35?SQ; ]*_Z\@23%&6J_]6SU6.4I)IBBNK*=!21F
M,MV,SN#L+M2-N2I7U#%)R #FG)HQ0]>^-B,:^$@R&B3SF^+FQ4>)YW,]^@ZV
MC+I(\\(!&C%XXN#L]G&)IJ\&93;VZRN=6!$]O[[HE347[5C#"$U1"D BZ2KL
M9[D^70?K[B.7-.'JT  &A&E,S1/@O$?&[=9W,8V-:(A]@ZQFL*YUX2)=OP&B
MJ)[3*');.'@!EPZA% #F&JVY& &I- !B,DFV51'0#MW)L@L/3U;'0"4K;/;A
MORENYW]*CU^HL+Q]5_W#SM7EE_M!A&M"67IUMBE*^M6UR@__FOH$!\<&_D]C
ME/+&:I6$E[112/V9 8Q+P3.G:MLB1ZA%Y/0+)H17_A??]Z^FL>MJ'4F) ):E
M:D)55L2W^1T,"ZFR]=4;S!<7,AY H&&KO<JTWB[K1NBT!;4PKD;(,)<BWRU'
M-G "Y]6R]0,8M\T05;AB:I%QX-W3',.Z#JY[%IW$R;G:-:I[8N>2WJ#TKG8J
M6\@9H[97X."]#,C:([(2@?]0=GZH(8>(:<X-IN46&JI9E6=Z_KHC0?I<B8,#
MPX'R5T=]K\BGMX;^Z,""B;-I^5,\;\(9C^;;+*_K*[_C. 6TGV@35W?;;4U(
M49 @455:#\M;)ZJ,7D_';!LBB'V-CF+7+E''$]LB,?(A3QYP4M8_:PJ@9;%6
M=E  )P,B[/V\8_E349=T,$ B)B*GX7E/FM_Z %HP=NE)UWA1D5'WGR,IB%;_
MGN*#H[;0NL^!HFV>RY&RC-P@=@6- X4Z )OQX!")P4IL^!M<_A$IX#-7T.SU
M(Q#<TM-?C_>*SQ%HLH&;[%YI%AJ%P7JIAC8P'MY:4#T":5G;$OI34EHXE&7B
M=HO-6M/IU>;?\&#>X<5$\W\Q"5M "3K)+UV4BZ^/':ZW2MO%</[E40Q6TX@%
MC-9IYOV:<;%P0TX>"MIS'XA:Z:-QV#=;<-:]Z%+?45G(-BMOH#3;9K!-^QI\
MUMA^C!GG%QS'/_83CF=E2NG^86#@LITR 0J'X]GD%1@WQ2R_7#%533G"1\RL
M@L0/?X[R%/\2,(M5%JF0;R8VMHHE_B5RAEV79R6)@30:)8%$E9!Y+_XE77/8
M_A;%B=K,X*?'Z_IB_9BB/-/O'%C.$(17?^");F))?C]\=U,.YW;955_$DZ/-
M3.^C!N=$>4K![=.QPAWUC\_480A7";#[ XLUISJ<]= 2HCH%K>?1B>1AV-%7
MD2RHY_7]#K/GZL,YR29-PK=G[T&OF :O;<EJ>U\6ZO6<#2W6BA.G\1[BT1_H
MKTJ:4O/JU81"=VP+39&V2Y4"63^-\VS"WD_"ZAE'[J@.E:-?32E;]][Q>%$I
MV +;%$MA^WH70*-6=I@(VR@R5&8X,HY1T6?CO.FY#A_%WOKU *UM0>2+IG(!
M!XW;<HKE=M#:K1DX6YDDWO)",R5,P[NJY*"B!O([O^!+0@HXD/I[?_"R8+L-
MZLNM55_.LVK E*S$&0+0)LO)MA5;W]$2<S8'L3;4KM/U-DAZG5Q3RJ_!DYUT
M+G*5+J!UU2 @N;7KC,D2 "W/HO6$GZ/CDQA@H@>WJ-8M.5MS]N)G?=-N4=ZK
M0&2 ._1K9;<%#1I,&_62[&&SK,[V )-3!\@+S7H&.U=W@L1])OAA1ZKJ%;<G
M\EE0O$^^> ,G,@T*LDOY_ZM1*OY_@;PQI015AI=(YDU-"]3$:K^U$"0%@I5^
M4RBL@X?SUF0XS$IZ3S3Q,59?G?8PL?X<D&ZQH9/1<R/DKJ\OUXYB'+[>=Y&
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MY07T1F_5V!*L_)?/N;R;0/9ZOPS_F,V,AY&=38S&=T!Y*S69R:I2F"_M^HG
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M7G,R*#GV#.@M0<BAOCMG<EDE,;'CT_YN:/\LKJ&0[#.?56C"E6[KN8?IA I
MMK1)'%FV# 'KEEZ^E"3:1$8QLY2T\L*G7"^ES/=_4X2RW:.,<)JMGR3C R&-
MC/*S[SN7#_8*_.4@H.M0=B5O4$>BA435MU$FGV]->XAK+R_G#LM7U)!BXCT.
M&]'JV2?/[05IO1K1OOTT;0_WY[12YW'8$U%"R B&'FK'7?Z67O@@X\/9P\-N
M5NO^>8N8WQ378?PR8?CN66JMF>>.<4.U.G?(,;N3E(]('6A7R34((JN:1$.
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M<M.+C"\\D1AI%6V+FP(E0<315$U<'FC,S74VZQJ=%.8A*]5I2^J]5V+"'_P
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M1*,V/^QS>O!&80R\M[9Z>B;6M# U7)N[X[44$S>J4Q^K_$BM:S-.3W.HR+%
MD/H^\I+(EC=C<XR'-AE7OY$&^2S\ZZMQ@JB=Y<\Q!<]4$-8>6C$-[3SA=,;&
MP?;J'X<:E\:X")B[%>Z]GD<K8BD#T0(\M/D([DL0[OR2 FN(O1;,N-!  EPB
M:@0(_CEZ#?'^A'$1B_R65XGA7C=O*)JQ=<CEMAU?@GZ06\?[7LH^['TP:6&5
M.9;LE @[XIQKB#FN^@)&VG^)S,\FVVD<RZJW2]+A"YH_&KUQ?/X$PU(X[2H.
M^6<$J__Z>)S_!1+%0J.X.?Q0WQL T%)^D0_3J!FW'^'1M^4 3?Z/[-^9%R69
MXU&!BTN@)R@?-MH3W1$[.,%"!TSJ<)CXN2P'755@(7.;VD8?VF$07KDSEV*L
M%6H5XOW#0M!7+D=1(L3'FU677. 3PU:VK^ K3$VE^2=E"O'R+-<W=?A4YUZR
MCFI:2="_PNVW=!<LO42#-+TT/QGFO>U];KID&,:8SU&*5=.T@XT'RXV4C1V&
M@1\C>]X:F%8F#Z'-FLJ-3]L3:)?I--0NNU4"V]XQM//IEC<=%-KC)9'WV&-9
M1E]  R#C=ZR-O++6VW2$$9+3R:P60Y!6L?VH)61F,*)L]/.;$%56AS,UU/7[
M5T2,;^JY/@V[AKJC I#7_)Z/YH \],CN$73B*T0;UT13>!6J&C!YX_R6$'BX
MAL W%J\GG4M(KPR@ ?PWA2LK!%ASB')C8F=4>5I1:/[DS4B _4%!NG9[VH<7
M>Y 9@;%"DN 2'<;.>2AEP'I__[APHOE^&F/HB.&]Z:#>5RZQ95=RIQC+)G9<
MW?(%.F@W.*9BKQ0:F%-[%3@)[F/ /;%;KFXHO3NO"?,S98+<!TBN:*Q>!A#S
M-"M"JA\<*R5AQ'W<GO\)&#_=%QP?ME8;!"00<L-)^F[H&N:$D>Q!1N7P(Z-Y
M!LB[9SI)*#K.RL?8E\&SCB;!4RYM)B:!(U+WNK@L!;1*#5_R&I?5]][_/#ZM
M)^;5*^FB!D[Z(9L*KX92,QBR5Z.>J(GP6#/=7]V&F0J,1UT,N[]SC6[4_NBF
MA4A$=:^KAGE-:6QU_]AJJ<PM 7=&^0@A-M[B@Q8%JHEUA^W?%!J[]6QSFM>:
MMALU?B+#/[\,A^I^30B)>I;[HT D#VDY)OUI&]\P=2+U)/^H<:C:T>I[476S
M?_S->]??>#K32-;K7![A?UG6]FK*P:D#X6.S',A<<CJ[:A@P=\G=>2\ P3KT
MB$<]77"".2+C*\YQ_Q,?4D9GT?*YF:^D _VIY:K>&MLMLVZ%FE, [VO.DCK[
M3HAOF5NN!CJB'+SRJW>HOL68_)94?8I?-;W4Y'PS '4*L,<*A"\^9NF7KQP<
M-W3127S!5P\8T EA!![':ZP_<\Q?1#-?-]*1JL+R>1M=MVJ'EHWLQK&^ \2-
MT'=R&0L]LU^S[OGD]AP5G-_Y9%J+9L<0GL!A/D+ ^WL6H"=CP/LNP7^@BKR6
M8<6X)=&A6IIOP1;Q2CO:'9!(LQC7B[(+1C]6P3VH]UE6 .-L#B/:M><&!AW7
M)0F%S0PHG3M&!9NGA7I.?CS,%;S\_J/N0_+*4H[J'719#K8>[U%JS0N#9DX:
M@82>G38G\(2P7INF8*JI#NV@; ?;_KL(L+C4+;[%=GA3%"UX_(E+F^ECL[F=
M+GSF:L[!ZRH6ZOOF+B_W$V,SC=J8L50^NC-_8=2)KQ62XEM6W;7YP]J\*S^]
MSR[ZC'9]O9!SNT6YRP[CJ22ZF <=%*@*!;',A5D*BA%JU53&VOP#OB2*10T^
MT5O\,*\T8 \FR+$[T#S35//^ _^M4R&.X2&)9P4[08?K].(C4&VR("E3)OAA
M75-MQM./*E<VEY:<H"+JE) '2X]ZE1N!A'8)U1*!3JZOQC:+'5U>*'VL[335
M.%I?U%9[H:W,5$38%ECB0NUJNOVTHO)Y=*L\9!B[:=JRR%'4(CYE8"5M=ET8
M-AP;,+U7[-XUCX!XI<163[G1]4RK*/5 OCY)B#8Z_CHU,NE);,:.,^P!WU=5
M$&JF%<)!PM9-+B]?Q,HV V(UEE;'UL54'->@P[(*PA/5Q?1/OTU7PG996'O:
M<V"[3]ZFFBX3$ \X\S]6\B#7;KI-9.=C4$&;R)VA*9YLV$#TOQ/4>D&$)[<)
M ?ZG"%"G"3=:B@^O_ZU#*E>L//C#/>ZO^HYB_^?X(:\YY>RP<]3UMQ\QP*6H
M)_;N];Z&'KVMJO07;7M+*"C\9K_9C'N?ETSJB!+#E/WX32$(Z!94-PT]P&3+
M\]@?,RK=K[MDB!6>9I7!$ZK1]!HH!=NN=;ZOT3',:/F<J$4]?=NZ3[C7E=,%
M%PE:(X>$)&5NL??I3*/RW7PG8QA_L@]!^TS_URET<<PI7"2<<2\J1'K0-.<*
M:F4[U2Q?[_GA!OY:H<$[^9:!7\IM!5+]= ASCT W=F!AQ#3JV[IEF6Y&>5XR
M>=->TM >S),+K/Y0;N!A4/!?'OS\CZ*\A6%DE=B?3-WR<@ICI^JW#TM>:UO
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MZ!V%  3?0F5D3E6:L:I\.I3"QTR%[[<D-@K:3R-,OT-_]1EX#^RDLQU[U8T
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M@2\^71RI*2OR9X@5(P)/.M.;\.,JC<WIYZX,)N@.U:,6B,?>,M=];6-7H U
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MC5F2U"':?@BQ'[G%V=GK-<M!?CBGAFE/"P!AR<O-LMM7Q4_1Z[,7J5XE+P3
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M&NL#%+4C]UC5RY;*(ODJ@QV/&'3KS)-&@E.J+9C?>A*]V6R]?(IW>%XC]KB
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MN4\6"/]B_JPHO2; L72F'D%*YT'HBOP*]O8[;%QP7J+<Z\<B74E+,\CC?=S
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MOS(H.Z3EWBN(EHDU$B*!=6'+P\YK?6%!N("Y8M3ZH9Q\[KHH%MP=B?ON[-5
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MJH1Y735)W\4TO^DQA'*=QU<)?G_H5\RL!'Z9924P _\;T/386BBRH'G\=?B
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M:PWAV16^P)\-=#(F1N\4N%I$BYQ1;"\HR=R @M2@/,_SQ>.:]M_ -/AW_/?
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MD.3+;^QRX>"L3R"B(@P%_531;'A?;7P8P49XIB@?X)37VJ((/L30J?Y ]>*
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MG =7V]BW%DQ?W7XCZ*_WYBXOK[OTC"RAPZQQ_ @*\4=/RO\7(L)>C T8BF2
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MF3:N.5E8YVFE:?E6DV=NH$(H_<7H+=3;IKKKW C5P&+5,78<U)!)I.O+X-?
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M/T#(+"J[2G%S9GO DO[._:@1KB"JGUQW]:FOU<%M?1\"1E(6XG;S;7MW>?:
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M,M? PGD=G7[8P@SDY6]('W?VO#1]6,[;\GAN5C'-\J&WJAJL@XL0KM0,"1O
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ME]45 =<V[B9HB_8H:-Y_'U&)3N4>5=X#$JJQ!J645Z4ZBV#$YL;N2:_J"F0
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MG*$\1TEYCHF.EH[I?_DZ?@M@/,N(9DVF(+L*(&<DHV D.^X \   9)1DOUV
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M\N4,)W*MD%;A8/7#$6^@67US-KCZ4C_&3S!O+F+=LDY!-=I+,[T'./E#R91
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MO0XS*T[42(S,X+A?^2MTCV.<]'-;.Q:'7L-]=<=5(WW]E>@;A@\<B@;6SWL
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M?'OKU9BC$?H-WTJI0@7]/<_6)7T\L'"2_[)AFY@GEPWUH#9'2HGZ[ZUA_@-
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MF5\^[XX!KWJ"+@L/.SV9;LW<V*[D+H:78Q(C9Y/\]#\;I TIH)BVOQE3.KB
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M/M]<.MW3@;IU4O/9;;QGX$NP14F%^6,QM<NC:$Q0JH],E)+EYKR77$?*&X5
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M?HWH5U;'0N)!Y!=/!LWA^^\]@?]+.'UD(\05E4N.G(+AAX0!)UN8,]/*;X7
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MQ;I<LT\LM0'.RG@#GV)O5QSK<=I3G_YV[!5\I=EQ(4EBB']9[XY2K+A^R>?
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M6<M=K!E%#_&\+C1]ERYJ$$&0USF^M#JV9LE>=V5?&5R]G:F72H8R(*B)3>Z
MB67H<R_-U36F?-=T8"^&G6/GI6OV*>O\^/,?'R_]Q[@13>7<*%XG"ND*)-4Q
M'^#:O;Z-Y%3$1^/9%%U_:$5"?L969(AN0(6\XBV2UU$+LO 5^4@?]7(-9Z@@
M)473:SUUKL&\WRHJ,@S$'%^0#UG"/9;4R\^7Z?:4M5-_\M,E;@235[+ &.&T
MS38Q[&5I".]UVW= )4<#\X=W_$9G/TO(6,)KACV$K JX)?7 -PR\(2$.LMQK
MIN5F=TJ G/O3-V>3+[,F77F/ZX=I2K>],BOSZ:BOLKF04W>S;[&W_;.C59^;
MD6&=JW'5)P7[T:O2\7!]"QN2WX\69%_<'.;.Y<7:W\7?<T3&=83:HN0FN42#
MQ2+V9:A^F(7O8&E)A1F=)?=4<3=*0<31J4OZ5X?H;-5FK-4R)69<^_3C#:Z*
M(@MX"#^W5;)\(_H:5A_.:;=[YSOR@&*=1;L*+XLK8:LX*Y86QN%TTNH@.TC\
M$QXV\A:.:F /+,=+PEFL6]#HV( '2>WYG;N@'U.B"^6\Z1F](<M%#Y\M%&N)
MP.)3D2_I@*Y&MV0%/\*1@[@@LD:._6B!#>/0Z%@<+B)W[+#'/ 3E=%#6=GY7
MW#&;'Q?H>;NKI%PW]!(\KE&O>LCJ)5-<,#*91\$4^42"NZ;#9Q!7)^-J=NCH
M:1A5QRF=<2V=1)EVA2163>[V*-TV,SCP#>R0&%3YZ> H];MH)3.QIHXZL /4
MX"0WGY%9Q93YD:!$0*62S:D?<&,,$AX7WIU?* .2LIZ2X(YDA0ME-A^ [CE
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M&BDC:V2M->?\YOSF-]=R\X0*F/\]&+V]#%4 U^FYZU.44'NX%MV@=Y2+0EP
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ME4&RK18NA?Z6G<-:RSO(GT87#[Z_-V@CVXLL5ZFBXPD_U#BV+D#6#JL,%K(
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MIG@(B$U!WT@[YU:0T/*#3W.UXE+=/LX(E3?Y[Q-^9)Y'.17#2F5]P-6$9XI
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M"E6>W%MG FZ;JJ ,U(E_5Y,)7<$*Y0E_'$) \L__LTCT_>],)_#/C U;D0*
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M:ASJ\/+],T4PS6L4Q4;"#\2UBVY/A%GLOQ"Y\OCJ/3KU)BU9<P]+:EB[[;6
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M]\#>&&T_+VN+Z\SU(99E&2?,Y;[J1ZS_4 LH5\;2(<M]Q:>6U0AM+9<F,6)
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M&^Z55(-5ZNIG\4H%%B7KN7='Q\%0H7\=,'R&29TH% 3B.E,P@GH4#Z;W^#7
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M]701]8IXWY$VT[2B1BY%N,GALVM4&">/0[2-57)_O>.&M4T(;%6Q L0REX6
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MUI_6[D+MVS%TI@,76NG5=FB_WURI=MPV>,WGN%*<,_SPJ5W<?L]T.7 ./ED
M2Q))W\9W6E!:!B%<%J#GBAP/#_B2ES'.:(0>1?%7S'TC:M'S=&;HDLB_:/%/
M[1/_B\HYH;)"O2(:TRF2Y*NR"ANM,1;3#K03OI<O;"U;9\6J^2?29QO^.5B[
MDNKMJ6B0RB_P)]/EU63P$?>B2]<>7'IS>;$:\1NZ0_,B>Y)ROFFA7>7HUY=K
M?(&7:PZ5</49[^5K**O+;U[B892U7HGG$/>\Y6JCH_POQZ+WG!0D^JNE?\DU
MW.<%?L5R>9D,P]3DQ[W[F]'\)/!2O>29:EKF$]H?,*MPQ265))CLPZ)>GM',
MWZ)! '5]$<.2R-N"\ )+'%.>Z_EKK)C=W^LPV*6:*]FZRZ@L),V+T+I_>P.(
M'RP=Q+J6+-[>75LGKGOJ ^21&L58 -$46D -N",78@K+]@>(^)51MM#_KBO<
M3)P)MRU60-"U=ECJ4H_LH-2V7''+#;?DD4W8^KPYZTI[]I'<%ZHP;_K@X*6
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MJ*MXPQ9_4 :ELZ7R76S.@#X*40/TGM_H4=W9+'+,^OZ.(!((3"D4 GJRPJE
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M:O1N:0O3V+&EW5U9:-?>::Z=?3-9)7CP9/4NA=5BB7(W=-RH@0R%-LMS[<L
MH640L@2T"M;5%@?,NZV^.2] <K?\6.> K$.OB4JP6$_YEAQIK,SL&ON$5;X<
MA*V)\BO#)N.Z1&__'MC/%WGK.1,1^-/<SN$+]]P9.8)7KN-S]WHQ\_;(;HPW
MJB!^N264M/_]9>MMT06O;%+0Z@MB#<>0A)JSSI[40)4TW@4YU/AZVA#X59;M
MB=S":Q(]0],"4>GB-^\TJTW^G)I)S)*MI:+9Y<3>S+<:!D*UH@:M8XYZR$<N
M.B@+(U1^\4H^&W6/#F\:FWO*([/,)[0PM]<(!RF^I-(9V!7&]6H^*_AUX[,C
M.GG $*\,J$V7K^H[OI0Q6>:R>A@F5IY&GF5WHMR-6<+H =!&C3GWSH=MDC#)
M>*]'_W)+(G5V^BO(H'$761=Y]_Q6&3%C$A&%7HE*]YHSU90RXU6<.+H9!77B
MTV'RK\'TY-Y,.M!DP3GHV]32D9,$RH_$SJUHV?[^<D#W$KEM2/L.F-:VT?%&
M'J,N@=]7LE/+223-KGVSU/"6IZ[AT0]DEOAF;#1<@#^X9_IT)5][0D#\;ZW+
MBO_MNDC]UY&T2&:DD]P_^GB!/>3S5)^5.IB8LD  TT(!H_6Y:KA-+/ Y1/KH
MJ/)\$J:XHX*7UOC=?O6=G=5.W:=?EVY?]5$2F9$RMIXA##FQ.*,<P4*%KPJ!
M[;0154*TU8ACPS[NBZMU:7IJ6LJ9OX +$7$IZ\CC%QR_S*-.U(YN< SR7+TR
MT"(T-(_5.REJW\Z8%)M)27@*A:3F!72P5!/;;Y]<>VHJ]D[BR/S]J?"1FZ^;
MR +OL7FH8Y+4T.D':B5/*K.\/P!ZZQFY ?$^DNFORRF_O[AY7(!92@I]K!SH
M5"9^)]XC.+^MT=!8K6:1_BYN NP;U=NC9N\C*%#WF8P_C9&#Q=,M5J"+4'=O
M,B.=OX>8(4)+FV[OE^2NV*>_9_*)Z8,X)\LA9/+#7%45I(,CV5X,H0\P]"M^
M!+G,9]V)/CACTCL' QLQJUAV".H#Y835WV_CQ8=3X##_)5;Z1S^" ,X-^]R
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MV1:ZS""3KRD4.6TSGF%TKAFEK^(!RD)=G0Y!Z1,WB>+,J<V4+?2&Z>-G8UA
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MQF"%X&*E!EM!L559[RNPHLE5T*B^VZ99>T]3LPG?T+.A&@YH@HS%)BQ+WLM
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MPX0)R:#2_8%J7@Q]_.'&>ANQ/*7+\<.Q6H5SIYDQP=NC4RHMOT4VX*V\-R(
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M8,'KH]!;76M_;BV7A#.XIR)9(66C+;F0KM^5TE'BM]F9KGOSH'\)O#L5Y"1
M4\GSENRRPD+''VL(5P\M6UY/+-Q'&/$?T5IS/X3Q!RJ^@[3Y#J8>$8G!<A'\
M*=G[0);K;B[(4-[9*542%]WFJ7BC6M75C^_>)4HOVY JUB&=VV@#T)0NJ+#'
MV%M;71STXL\\UCLCB91!FGCJ,<E1+CQ'.@([]B,_0N][I._BM"?R"8Q$A%X#
M?Z2%06;!O?WF]T?* K_$.D,LO_Z(+;A<T-<V1PV1>L,T<P.X:'MG/TC(G%]E
MB*"W.VMCL1]I/FC+X?%FM\IO;K*K.^Y0LXOO(H3=Z\_EW7N_&5A;\8D[\UL5
MC5/ZQ:E=#TN!&.>+ ([1/EE)\W7QGL+U6!CP&EMO-G^ZL=P&I097=5] )M&B
M%G92><_8Y@E#8&7\1/32F1JA9OOI2F(N5;YNC6Y1_X982S(,+ND'0BSI6BD-
M#>+YL%P];UW!3!O$"_%N22"4^WGEZ 1BH%[F14HW(KD/4Y:#="E_79GZTVST
MYG<T,H3< ,[NG;4IKA17Q>I;/D"..34X3I('OVV[\;];ZUHS?_3DX1Q"XK:E
MTPU3'DHK\NL[6J-,RVCA'RJT8F%/XA<5OVBQA1'3:X<<GGT/:W;$Y2C>KKCX
M(!!7U'*B_(S60?FS1,OKF^CY'@A^[TV)=4Q4X#JD/1CE$+ SF>SV0/W,VP;B
M&<>RXK274<7I_%G__/Z\_XG_+J[D&B#'A1EL,_!&JN<U!O_*,3"*_U_C3'CC
MP?_'_A]F--W8C8U4G'Y-7%ST!PIYLV48@D(#[A<E,BMGO,S,R@#["^MX#<;=
M@S_=4,7_H8^2%DZ*/B5L\S]@UU&NQDU-E\H?5/%U-@U%/8'4*VH&N,V'P8E'
M-G/LB6_=<>9G'^7E"\FW"T(>)%]?N2#52PI9G%=KTI:TQ<R!G$JGI1$[[9=$
M<O+;?I[7'"OY"C?]GC9"O[# ;V(6B%W7Z6?5%Y/$'KMGKI5P[ZQI.TIJ ,9<
M(!%@6WA*??U?+SKT7LV[HJYO?<9M2^AE_Z@!;\A5K<^M\(+!"2;"@ 0GX_->
MRS?7.C%T=LSWNL5MPW4SV&!U*B!*PO&!!C$^5*8>UM $M267H@\\(BAU81^K
M<DXV+AIW2\>G]LE?,_U>F??(]%(DR6><6)0D>\,\.Z!XO7#JBYB6LJ.R:7Y1
M>4!I[^VE7W"!XZO1B6V_&5:MA>JK ,X'F/Q0^^PM,I7+*#@/3ZY3&M;>?[72
M\:, &W0Q)NRFM-1?GTM&):%.DP_H%W0VUM)&.:BOBOV*%7<7?FY7>72K-+%E
MH#&<TOI(:]M8YLD;7,+1[?DS";?[;3-+]_>[+_VBJ7 =W+$]L_DX5/8BUQSA
MV8!\=WQ)DM!!MP%DQ^Y:B.IEC\X"K"?7CT[CP7?T<,B.!]O^6-6%XYVLJW>I
MIAZONY=+%'B#YQ3>N/XY! #E 8?FCC\[#J@G0G$R0WSYM4)MT(O3N"K4JU?@
M[CXP4=_ >]!^N[.YG1)&&'9INY\ZII:^A[N2-%M+J?<)5>U:I9OU7[S@ZEFQ
M=[=Q%YC5XE["Z4$IAT5^.4WE*(1;GVAJOA 8U<>Z]V'MX'J,OYR,[SW(E73G
MYHL7IF1<2X"9P->*<WB95SM/^2#C*-2I;K<N=$Q#@,9^32EP>=RU.<7;5G*6
M&]O\  <96)KBHMN=2BJ%2N]6HG$RQL\TVOVBBE6:=9/@Q.H]EG@2SW"FBQA)
MC/%CI#I *Y>%))\:=8LEP?=!D GTWU=782RG Q$^*3V4#KS)8R([<'*("W(.
M>2)AL*8$'L%G$H<5PK*%:J&5P9\FH%RUT82K/O9@@1;+)I[AL^PZ(Q4BRC^
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ME/"BT-S&CR(K<:.-4LT?%967'>_JCU[[:1Y_I$7A(@M^( 9K%*H,6BW;*8=
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MO>;A0$\J-5R25C;XKBE;-K"R?)3+A_I "89,NVJJU<N%J0T>SJL0*GQT;22
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M1G9  XKTF, _\F)%N#C[X__7U9@NDZBMRHI>XAFN:%UHLWZZ6^C23P%>]KC
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M])-'>7<O=#J,=]+H1]\N&*DTZT4MCN.\!U:O7T4PK'.$C!))YNXU;/V_F"[
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M+X3;U1\3>.JTL1+&W6H1_5"HG[A<V'_@G&5B\%<0/E;5\!QW"S@%9%LA946
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MUOF&B5=2^%BBXV0R^\/_$ZDF4'#](2G9V6L="$/]_'4W.>G-KD;COJ/J0G&
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M^QN#H'[_RJ@/)/6"^]](*,+][M'Q[)8:_ZL9$3W^M JIHG-E15"3/3V-![^
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M0' 7-YJ(DALC3_"%V%X17P:N!<" <^(VQH_YP0]@7CF U_=Q7XT9$%4IID!
M];VH0.2V-O5QP1,T.RQ/@SO&*%V5'R[2.8[NYI0HD6.#2/VN[G2PMHS ^T("
MS4#X%6D5'[P>?N3![OG;)$7?;.2/YH8KW<B!I-#> <V54B#;2F1I@@38'C<(
MK^/,*RNK0B49\2J89.K9L+2.@NIPMV0GQ#/UY%C-Z[2'+/6F*M9;<[Z17[FK
M(%PM@HTG+9);@-[3_:(R*.6QV8QBU]P(?L\1BP?NJ1\GQ'/3?F@51*X;YO!Z
MP-._?NO!155"F_; :%!E!A(EOYZOV5_NN6LJC=?Q$@/]XT:#/$ZZ*BV)V?Z!
M 89X_R"7FY>0@<4CZP'V,>G]?&@UCV?Z,J@JB[IB-ZC+SY>=SAHEB=I>:7&Z
MK&X3P[@UMXD$X2.H^:#VV$C-JXY0G+ZZ<0-C3G7:;7!+6M;F;3 E<W;[:SAT
MR?5(HN9UW0[6PE1S$*R:/_&I#*.S](<N ,J"-$AN$6945ZQ0\Y2+_@:_/^_.
M]U!3S]7YL.>4H<>7B_7#L\5K](B-0:;$DA@6 M?@[+KG0RM<</C+"EYAF@UH
MZ7#V988(+'[V#QW ;8)V@INU?U 'Y<J]Q5HN+[&4(TIETP#575F96NW>>0XX
MBSIM0%J>YKEN3ZE\AXI(=IJ<];FD+R4?-G>SJ0ZLB"W@XT2HR[X.P$*NFA#B
MU41BV0K>HX6^4#Y\+!WQ'VDR?"AMR"B5!G^B&#Q2CB+FF)[YMW)'+I)T*T)G
MBC]<#>F$/'>LL\\ET#(Z;#@XI-YY=,_!]N:6Z<=Z$K7W/\\!=LKYZOEK8N27
MU"1NF.^_[U+G\EBU6EB,GUY5;A:@5HH00+*MPS,/5[408;S,R0AWDXE2/<[U
M+NS>[8T*8UW\]"<,5LL(F:R#=D)>;36--?"J:S&NK]^KR+@U%51Q'>9>\!5O
MUY$2.@4_R0M:^$CY&+J.)V(L>U5NQF5C@TD1(-HY 3RLT&GN LL7C_55&R7G
M##5S'^N-O,#U:VSY*<]<]OLZF+SCI"&Q"#S?L+0)+*?B,8D^A"02D'\0%U@F
MW,-E'00_HEI(7Y-90XQL',EG'^'B_68W/HN8O:"5VS[7?O:@=F5]?FOS-\BL
M1C%^#XZ6%V]-O#S9#+%TSC<%Z^7DI20 5;#_( SLDC_^[GF%\=D;=N='3\,V
M!D&GSVW9C=%\OI!X4R3[D%\GQ __3Z:WA@[[.LI8S2@H4/(+DF4"8I]<KB[<
M+XN_*Z$.$('6^L\G=1I5)?H#PP?NU)>8ZOR2F@*6#LW1KUJM25RB0L?=MJY?
MA<<HBND\O<NMW4N5@O*7^X9\'WJ)M+93EKOQR(J:>*W\NJ+/=6F\]6*T+ZTA
M 1C9]*;[;I% V3OL2@.]F67P9T9-EO618KAE]W#U*>'#P%N$(RTCA>N31@TQ
M4"/=LZ #E(W!76L$;Z'9JJR2E^: 1EA^3B>"H" 0\0PT'\Z=DE:I/00Z<[8<
M[]C=YQO2';%I!+B &+HO=OT)*XA6FT*NNGPN7)E]LX:;[7Z6^A\Z8GYA5\>(
MHO-IIR9"VX=WT^J-:.!)@Q8?XR .!C6EE)MO>$;*A9Q9(9QSJ/E(0E<P_<J&
MX[4N+9G*N_MIZ*C9#,JZ'H<)-$\IU(!@5I3JU!+H7GP'Z7A(\J%RF(M;:4L'
M5$I:YHF?ME!]"[V2/"%0S O]#7[UX:G0M"8(K=\@<6<\3SM!QZ2V]F10YY?>
M5'F-4\/@O2S4,XA*?L^]YKZ>5>/BJ!T4^%<3ZVVPO\0IO9%N_WR-E?U^W>HI
M.Y'NZ.$39"!UL5\M<9V'><&Z?WYF _Q@.,&)W#83Y(:,SZ!['\"77$G(0$C'
M<_B3@VK82R<OR@?0:X6*U ,+]^R:<6D3V:\??<R*7UHJF$66K$\Z\Q7_NKD:
M@[ORL$V6SK0_'X)<Q.%=[A?:-[%^0%5#5\&O"/KF8*<COE\GCM*) \T>73;,
MG9F>]TX[GN_,K=I)^X'-5=,D KVH!@E\V'&#J578 B1S+8QJ(^&B?.NERN\9
M(AH6^M2P=&\&<QM=B:J>Q.'!8_D>[WTK+^XG@IIC12]MFK.7=EWK/4UA23G[
M*>0[K5<4^A>G,4]62K4*(ZA%@B-:,;2L;X^KL(-0@MK$PP%$:NM!-:0W^&-\
MG"R'.[PFV;T<.T $J111RB837,V\^DRK08\P>!X=YK("=0:]ZVX L$O#!_M<
MN*^/MW#Z=E=)K&2G#_1RQ:0/V-0"Y75#15K2/AFK0@/[\M1@.GGB.?Q0*$ZS
MVG7H-5H,';P#OEZB2@_O[C2@MROC\7"Q<(1NUC#8K>&^NBC(5.IM57CXDO,S
MC):"W[YVU1R#3<R6T:NG492NX,Z;Q.P>7^>LPCCP+E9='YTPBB@U-C(,*ACZ
M;Y!"_F?!V*VXZ-N'?Y8?2?H5,SQB^#^,8[E<I$;*_JW2Y3LD]+'$HTOL.5JU
M_Y<I,'.%U*8!/!J9 E'QO)!S]WA,LG,^QG?R\8SV5P'OL;;]QLV^^(-U&^7
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MOOPPGIC6)Y=7M[EI:,"_@%X-NMRIQ_<#*AL=(+%)PCR=%.M'V/V:JP3%2VS
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MT@TQ:_34J@P5/>L@-48RI_ QX?2W431IUR7J9J'"^KAB<+J+<>VD=<D1QM[
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M"[/DQ0O^1-B&(!$NUG!&ZWX%0B'[$9+<.$7IU_[;GR]RW.(H1GYD $%MH \
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MO?+E]K'PH5A_IM.#_2JE]*.?O^FD9F+0T #T.V*G<Q/(RF^HH)OY0F7%%WA
M'+373 AXV]((3A;RV5?@$)?4?^:J3-+@4J[\Q:P<"6:LJ?*5@AO,$D%LK?E
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M2'EP[5L)4O 9^G+<464UA663D"1<3BV2S0=CF!_3[U!4 L!!J%@E6E/L)O(
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MN=(\)/VQ;ZLG9:/7I>L)H25ZU:&/=-ZSH@Z;U#E:FY1SBF#KKM])M$6M%-E
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MBL>/!Y?,A&;#>T\T 7*28?G1\]"S-B07P:+@?Z;]:Z96_=*[$,<05V^L.O]
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M\6F^]#(L]'  <I>/-5?CMI2/< ^Z2BY=CB: "WL1_S$"@/I'I+$S)G'_^**
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M6.T6T4I?*L"<34=F?!#>Q>%*VZMGX.TFHWO8;0I<@*IL>>"&\!=]]RHF)?!
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M.6ZK ^Q64Y\7L/2I,1K>NR4G ]H^1%^/J?BN_%P"<%W7](YH#N\/4YA1V)6
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M5GID6LM!MDI?L=[4Z:AS8JHP[C\6CC(J/CTUPV5A3X4LTNP+:FLD;W7 1[8
M_S"E\?*-)1YBNZ*YNU</WF=[6!Y-!0/''?A9-^.C:O]-@7$K3*B_^>_&-O##
M-854P8)X*;\W+W_\1LS:L%[)^#.<FK);$#NOG>MCMX?_3/^E#%US4OK> =P.
M7OI[SL;N+#_32\[?B"\U67V_A+__;$F'-.1,AJ(?;4^>;S/LOAXQ]-JAH'9^
ML4!X9W^O1F9+$5\G'T'[_L33()>ZO6.04MT^FDH5OBZ+=[*D/'JY93?&$W44
M^Y>-4?2 :T(3NCVCKQ,2)7ROG(Q/&B?I7]W'%WOG(@1^K0@/2J1/JB[!A.KF
MF0/@4:!NQ/5C2Y8\GB^YEF+W0*-<4XS%VF$GA/(%1C409_-#C>Y&VE$,J^Z/
M+UFSTU'DO%4WT=3^Z"\"*/:"D%<_DG 6<6TN@295,9N/.2=;QQ1]AG :JI]5
M*4L2/8^;F!()_%T+WB[XHDU]D?T?>Q(BMXBOET&#CJ?U<3GE._*6I4T[=SQI
M^GR[7\8K,SG4L6&[E&D,M@*P80I!RYY$8=&H#LC79L)$.U#4315USBX[0EH?
M9^C9-@#V+M7.MM:"LC&1A9R(LE[^*A8EM9]6(%@N%OT&,VB!N5 3@66B1I=-
M_)89LHDO#'>M5U02\2C!TKVZAU7.1I_/HH6@5)1_FXPN&-1J-N?5)%-P#^$6
M!*4G'@\K9L(\Y6 @5M.+O^C6^8LXUU5(;%]8-0^?#EREP&;'9L?IQQ!(\]?/
MU+#J<1G9 K@MI=C[=_U,^@RJ'5%X[-$N[.1'+\5;&&^:,5\!I6B49:K1$/'%
MTZNOE:':9';#@&F.3=LT62_JG*'9?B0M+V,PVQ90XL+J$&-OZ>1!4K?V?NQC
M7TWF\N@)?Y_EN)>.0YK)XMB>6_CY*%E6M6(Y>!/#Z7DWV.X(9V2^><(,?2Q<
MFOJ4$^?N,!W$>%4Y-<*3.9I ZX_4"E;&:^,3?Q">?_Y6SP:[F:&82*$O! .-
M[^<@;A@>;3F &K@AV&QNSN$E$T#_*D>%WWSK6OR#SW72#<-=6\:,MW.N!%\#
MUZ=U'PS6%D<^;9@V)G*^P]VX(5_-CF5>D?2): NPQ;I -\Q?]E/R!T0P-%OX
MI!Z#.'T%?+F?'!8A1T2O**AVVW*BS5$CR.$#=8%#!2UTEEGSD3\P8]@W#A6&
MB^_MU[7O4W0'"8T7BE8_2=L$=^3.[T>_G/TU=JVJKZ\'D,._4YW_C#Z(S E<
M)>K]DO_\1TY.[E_KUV=*;_8V&R0BQFM23FY5ZKD:([Z;G)J1EPP#[>0D<LA:
MZ^)>D?HL-%Y3?JA](<&MI=Y-<40CRN*V"3]'DX#W'Q9I>";!E<SES7D&U@2)
M+^%W8=^&;U'-?4J"F-BG1C&RR/.G\XU.YS^(^I]PNKPX40S/QLEF1KVMZGH1
M7&)5)K7$>,7BER32%$@*X^P">BXF&I\+U\%52=YM(CO>7\#Y<=O[O%LI.3^^
MTY2TN[1S^Z;UV]"H(5=43_C!?6XGR2&1T,VW5%FHW>VAHN(6<,65.Q/=V=7R
MAA&3]C3!AB=[51#^ZZGN:28$A-R?[SMDY8HIB>AA&;"K^]1C6R+U'(M5B8]M
M5>B&29G[>:?QI#*;IOK;B4!S5?Z>,M@$K(#:XY*1G]-CT$;O\49,KGQU3#^J
M_NB8H9-7(1CI%0GD000T;SF4+67[T#)$"S-7]-(*$ZF+?M9%]<HKD.25/[1P
MWE,]["]Q%>-YB<#RVEA/@#G]JQA\-#K*0EMH5*;?UGKXQQ"@A!%3ZODF73:O
M?R)Y6ESM]8H#R]?7$TGK6P7I-KJJ^P'F.LQTZL1SVHIMT]7T#<LS16D, *%B
M*(9O3%5 "YQ1.JGWKF2X 4&N4L;U$DXM04&=*R'99]!CJ=^/(F%7/=;&3G5:
M P+'D^G[M?[&87@?6R794MF?,@- \XM_S&PSEQF )I?66KU3WH_SJ[I4[B0G
M($>BILZ1(4CMN&A90-'/";G?$S61<QG,3PD4R*S8:5QOG>=0>'%UF$99R1'W
M$>+T7$2C4#NP2_&E^+T:1=IS?9ZRY#Y2E:(/K(HJRTB.*SE"V6J3P#$X&0//
M2QQ&!#5_=\P!]JKK?$-S2C ? 0%;C?ADNU^[#"! KPQ(^'@F:?Z,;$XN1] D
M ZG']^[52/_,^WR]I4:?0 <\.:,0Y^[>ZLD9#(RC.J\Y^#152>8PFH_7/HXS
M,A):;(=F*^W'E"OO0Z:I%1=  S,=^F50[0 5:"KL*D4OK/+ ]"S95/U^\"IJ
M(GO$\:'I!L85'ANDC812-S 1@Q(=J[XY$*&K1[DW:>(2G1JK-6+*I>=@O-R5
M/ :I7E1>?867X;4@-0/(VYMB?&!4>PV!2650GN3S%2]KN>$=#BZ]ML'>KXW[
M(.4VJ]6J!B[_(8'KYE6XO/1#ZCGT[U>-NU(@=N>1O!'J3>#;6CBO*59?(KK(
M)T;6M%=QG6;C*@_R(--Q7\9%W[E.ZVG;\Z#O9Q8N#O<W)E?K\TW"*?;/Z+X&
M5LE(:$N5M/BC7*RZB&CU[?1+=62=9=RMU!(/LE$LA[22U8;&=<HI));Y!VZ#
M9RRPGW2NOO%GXAN?4I,LT.;,N9\RV<*B]RG-@C&_#'IOVT)^E7R$W$9<]O L
M#PM:M<GM=+QD8R;/=8)MK1TVG];M QKWC=Q*>&+5U_=XJ\*L48N5V-7&C$9*
M7'X$NL&<YLWK>3LF/:C,K<RJ]"[[MSN3&]IW^0W_NR4'_P7>4'R*,'=.[>;"
M/-^=G=0_@%'I[YA *CF&Q)>LU.)< _'OI^?1X'QB8G$R*WLOG@.D-NJ>Y18
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M.CLE"VNTI!-6([:%;UH"OJ3-'-:;<_QL NT,=5VY<0YV?K6Y(%. )\\ZGL"
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MN-Z!??3\^7KIDFDT1;CERY3M2?>[8_%=/&K]0"!#\&LDUM%9^+JJ14%&^,3
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MV!YU5Z<#)6[> J)URC5$H.?GLA\FPMW'WFCQ8KD=ZN /;;[+0'7)SK-VJ J
M6=L#OM^KH1V<9_ (O:GM)1.+,V9QK_G MZ.,]B:,H,O[E9R=QY.JB.>!J%N/
M292YE*]!^$YCRCC5U9((CA)V3G&(3"Q(>3=?F__(<@Z*3M/]_'MBB#AJ@)EO
MQ;ZUX >*;I]U Z$K-5\Q?F6T2B.8W;R[V\]8C'8NGVZ91-U9_ ;>2G7SYR-T
M><"J@=^'0)/V,-P0(/9%6=-]*5$\)$N\IS?9$X6"V<-\JD,KK4V"?-+IT15^
MSMB?N(?\+8[%U3W;M*D*EPWB 0ZA >11KK5^UTPR&Q(NCGF"-<]]U81SZ0G8
MWBM3LMDT3'\T\3K&PIYT, .J5>_>LLVZ]D.T*/]JBJ;2!"U87)YDZ=F(3KT1
M SA34$YHT_ !/C.B'-R=K]\-;?M\#[^L7\_E*-%2[7\/53\:0>"S/&!9PB'"
MX/&V38<2<%]_KP!(QHC#U)CLLTJY6@91W>#Z.!YJ6N]5 +0J\@.^@"N&4[=6
MSQOOH>G>S5O@#:_)1'&Y7=%<>2F76<@>/L/;>%#;K*/IR 20JQA'FM8BH#QZ
M23ZKU^90+O9/C9R%B6@@09Y>0!U6Q@>UU-].Q&M-5(F9@5U N %;/Q/V_X>[
M]XQJLHW:!5%?&X@- DI5FM*4%CHH(KV7)!#:2R<)A%Y%K""$WB$T:8&0@A%"
M!Q4(/920(EU @H T*6)]C^^<.66M.3-SUII9ZSLS/ZX?SX]GW3^>Y][[VO>]
M]W4-VH7+^6 ^H"JUKH8:@$0T684&=IFG+,PSJ[P]DJ4QW^(8L+S"1K!0C6G=
M_4Q&2^52 4K&^P.8E)3"?I]*L<]L8Q0Z$>Q"T84-IL9Z5&?R%3&<85&JGU/_
M8VD]S@9@@-=T177I5W@I/", ![KEH\T8?+]HP_;<NITT!K39XO)%8R5>Z,#:
M4TT+:5@_U[3 (@("UNSM'.J@^)%9_52XN\ER57LIQNK%]B@_^C-A.^$=-7HT
MT32>6"&;Q4^ &@E5A+D%_G6 BV"9OF>W3-U&-4.;/>MBW_HTF^F7;,6<++V2
M M'S:+]+-#+JN.R)WL#/!@#&E%(O70F2'O0J:D E^<R8'7ZH(9BV#ENO-:K;
M2D$/'IV=DWN@47^1Q.A68+>GGS]*-!S>@Q2F5*WP^ N'F\)7:5# ]T8$-8PT
M<M4@:ON%MCD>MP=Y6+.1^$D7?A1K<-:@K&I1,1,+P$X,S-2IVH'<WYAH,>B9
M#L&NSA43&_=,]4'!MO5PTV/5O$ZB!M>J"4G_GJE>^9_M'GM1;4BU!2J@.,1U
M$"6[T#SRH^JP1$5'S94W)5SG?%&<::M#"Y<)SAUO4J.06,%^95]F5^WN/QPO
M?DY<GW&[$U5IH# R&XE+VEP</6_>!$^EG\QACN11O+3M^14V+7-IF>LS^BB&
M_-LQP,""?@)\\R"/JZV%JO?$T]K*]KDGMQ,?KAA\_Y$RRZ!ZIE"1<C(_P/V0
M\,#A%"S@L[%U,.3OQ[BPJK\F>N)KD:_K$% N_WI37*U3@#[%6HCPDQ() =:Z
MAK/;N!U-MXCZUJ/+Q@:RR154)B[YV89%$?#,!YI$PZJ OF*ML@&'!9MG/M.9
M7<F[<BJ#SS,4[)G! .(N'O#VNC4/*Q#F5)44'2,4MBAAJM:;UL&6*Y4/+!ZV
M$'(+(U#LO _W.H.MAPG^.G[2)7(CJ=;R%1K$X/!Q2S5P*N:5X%7@_2(N']*7
MDXJS&#_4-Z\3:)-7W4\S2V(I.2SI6J?\C%V7 %K"J09T_P@RYX4GC]5DLH(Z
M\:GP'7@8+D+3SSP8&G#&?NUN6LB2,+E$PA<X[M)W%E@DH7+,4C07A^S;0&K@
M"446%L@9!VN3&1@MR=Z'. =#!%]=:OTE]1%[E=C6YYU[5X4W^K!S<:$SGLAO
M.S'-=T?^P>86.I\SBJCELO-INE?^KU+-G8(9-&C#:;HOSSUB&?!B)3?6EO37
MQ%/X9T> <*-@O*M9G#1??(*YP'M22Y_L=7>--8C\:\R3DK[LB%,:!,'AB95P
MHN'H3M]I()")B6V@:CV!@-L%9]"C":OR]N&"W2.6\"JU^VK0<F38[HA D<P6
MH"@PLO0@3N.$C0<>DK6@40OEI,VTPF^8WO4>%)%I+ 9798*X$JG7KW[Y6F=[
M&]JU1KVW\\.FI=#,6ZR?ZJ XN?Q"7D],'V ^&(^M3.9=XT$97/T2;+Y@.Y*
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ML :M[U0LFD+(K(CYMM''1+!U3SXH2S[P?K\<'A68C'Q._,G,U)F59JN!%[V
MV=C83/1"UX^^UD[W+D/ >+IG^3O$5U%ER/7@ZYFIX5"ZP7LF;\3)A9H8BZL.
M]9[^7AG!+GWQ-1]O&=A.[+N,*,FVT<)( FG28AD9:V_:A>SR>B[0FBN;CQF(
M^@HVH%YZJP<TU9B.,JS/4)&#STU7#V )-.6[N:/BCD+HY?KQ+> T'-&:&AJ9
M-^5)$4-K%-HS? FX9&=?U%C>[)[QR$LJ"I!JSF1G!E"O\83K.%6+&S5E1+SD
M.@-GO)D'V&JV!GZM/5%!6QX C-]O%\?KW" C?;\^BN?F1?&S3NH=?T4D%ND@
M(-;;#OE<6;!4$FE6-8:92U@#"S&-YFKD9F 9:5UC]C,IZ$D78Z4#XN5_+P0_
M:F8>O)P0?C']UPN"4S-HJ=7,Q4R=W40(/]:OTKUZKQT$ETV.Y]ASW'STY:".
M'_K"%7:F5?M= \CE&=@+G=YIV/88J6S,]5G9*BD.7BT\[LFLGWGE(9T#?[^+
M6@M;&UI&K^+[3:?)PM*):]?;SK4 W:R;'2NU[57K$!ZR;D"9^]%NB8U9D1?)
M/;.PD:Q2+5;GNJO('OUG*]'T1[>HHI9TXEX1(L*5$7<E$F(0O+A\*@Y:P?3A
M^VA[U5$N,J*&7),/^7"\1"G%QKW02!JT)2$!^B8^"'0UBZ5=>A)V 6B6"Y]I
M:]Z@> ]?D*KU:MJ[B( RD;G)G!D(TP45XJG7@U]H@8- 1X?QU[%]!7P_.[MQ
MSDX'2X3N;S7&[?'7%"2?<5LW G':V@QP.EI?^6<Z'*VN4S>6;SA'OD<2S4>E
M&6"'[03950G6:%VR??\FE'!^_?',#[OKN9X)]0;G3\H%;6*Y3O)R<W4SHF_,
M6*"7Y[$FBCIK/,%[SB!I"7G3$0LUY/J]2Q I@KZPD5 X$DBQ5;F/+  8>A.D
M==?PWQ),RK.&U@MQE_I-!.@]J"P#$$4V#-.PA(86],K?A0=<5TD2HIK+FZ!O
M"E-4CD:G+<EBU:H25'G= +SL:]KMTT*LT\=D&.V8.8 W^^5D*.U?6OLW8Z3M
MB^QI_;:%9O1:=T):9G&%YC XZT\0<&$E_+1<'\[_A1C9.L]<:MQW^E=\);MP
M4C=_IS[)S'\80HB*M%>6V7-3/M+]-GP#N/7[0F&A[<L/!"YQ1H!3R D[AHY&
MPQE<CHC9K/D$VK#<[^+Z?^AT?M7 RY,56?]%.Z#JOW_XS^ )5^R4,37GY/!9
MR*N;<SZ33W".XV4IUKN= ;6^K,6UGV0WBM]@U]W9R;BUW?F=Q46(>C8<(8@K
M+J(8G/VVCH\)^S0G,BB:R/.#WJPK9I!8LM1A:B44_>C+Y$&=VL+%1Q%&A=\G
M5U2B0EMV(U/YYD0O?&>AHK*7]!RO1)<1W(\F^[EE!I/N0'=%+T55&!5VA8(\
M*E_H%.J*DP(/R@@!L$>7AU[]VMYP4S):TKC3@;@WUDM+^-%7-;.^RFH2Y;T3
MFJ[63/ Z2EXZUI+T./M.:NRWFJ,*C\I5(+ZM-U]VF =<(6DX\F;)PGM; AGJ
MG)-1>"4;VB"=G6V_)>QI!W78>.ZO-"L'K P(:G]+]%FU.6/)+9F'+7RALU9B
MYLGZ>?M*WOWZZ!WA]%GU^M*?%V(%C+\@UMQ>?)%(%@7FI"M?(GW6%4T?CH_:
M=,HMJ7S)]R'== )O59:WQ(=AEUG(ZIV(M*,H7U%9>>E9^Q^N*_Q_#FEIF,!C
M031RW1.H%G[2(3NR\VKM'E5>?E "&KR,]@\S#ZJB(7M\(K!133O-P*4W%SL\
MY)CF_ZK>B_*O^\S/6P938FMV WM'NX(NI/=U=IP2G5'NIX _*FI;[-J4M_PM
M^0O!N;!4.;"P8;7J*KPT=FD Z;:ZO>'8YMKVN4?>+=KHV$EAFSU@L)+_=Y.N
M:R;!5T7<?V[DLCI,Y/OB/)U]LNL*CZ_@W"M_W(_&.43I?4KQ!)L/M#"K]RZ,
MP)XY9"9P"83_2G1&]V7I"7H"9Z[T]N%"5*2*J<5,[U[)!CNCD"[R->^82<_2
M2[!">1^3-9M?J3G[A/TGT&HG221#NU_?!UEV%GR5B&8J##^S%R=/I<D<=$&F
M*Z!)QF'34%--D.$$*$8^X-Z4$+U:G[/?HY48FEH3L&D#3-MBO%'QJ' P1!B(
M.2F<SVXGFXADZ<B6?P%!JL&%>9I$'R];%WD=&:W4<\8UQPG]$6H>37(@G^/9
MV?JFJZ7K4"ZC++Y7\XQR_TNH0ZY?DA(I/\D4^+1#:MI)9QGG+KO+PRD^37_W
MG?02G2TSS=/:;&$3<#F%G5=<&@<KP8"\MOQ.K1_Z.NO1#AJ7YJ=POJB>MLE(
MD=QQX$#< 9=,)[C'?*7,3&/-7%-OGXAWPF*7&_2G\X&IO&E:/Z[5JV,77RGN
MH3:@%-7]NFQHO+!,#E'*NT=D*!.=YY9#%WP-*U3<&(885!"9@/A $39@8DW1
M$Z 4PYO618F\!H" 2?//EXBP-^'P@X_7*X!]<X7E*P*4\M1T0/HYWQ'BC.OK
M82'.5=M)_Q+9UTKCE"W7R9PZU/NT90^FEWHJ3*)M6I,9"(9Y_&2]WP8Y6=_H
M]!D.;>\T6!5BW$S.F51S:J<KF;3A*GELG\N;O[B,B%;H;M.1\6PYQU([9R36
MK/(F-]X\B30]W<\VE,%4^WX1D>DK"3K. 3>; M!9\M.>I!XWQY_]*&]"DIPZ
M88KP/)6&GUKK5"=$-][$!OJ28T"($2,7B;P'XFO.\_AJ$RRTX:IEGZ=9"QW5
M7M>(R"=<\?R&L!-!I-JO6=IC(Y:*<>"T:&-_A"U "VZ\C.,Z4_?I;\_9F>Q2
MF?PIRZU<&KD6'H\WJK:@BGWVQ'O#.[:;FFXTSY3*7CXP9:/I"P7/-J]L&],"
MZY"]0(=G[/)>YR65AQ;67=:\S,;D>*H'7"D<7UCE'9K/\)SM(\6-FD'TP[I\
MX"^;!-O VLU:GM;UB,!-"/,BSNR<U@.[CUK@$CQHRRZOTB%2("R=JJF&+R!_
MTO'DE.F<Y&A<(ZH2O%U<P]D-V<;3O,6)R$0I+.^L7]YJJ*V1U++S:UC)[C.4
MW,S,EKM3A&KT"52YSPD%(JI/\0F(-Y2>_1XM>#TM%ZZEV _0C@*]G)5A?EK*
MU.9;#(8L<I(S#U=<]Q>QQ^:?\?.%*9J>D@7W>7W@<8:N/V,2G#:T'&(9]T.$
M)^]E2WJZ^?TH3.2%Q307/;8(R^C+O\00"Q@*;CJ4_ZM$MGY\*C] *4"._P.X
M--^=] ( D;+2C[@,5;2O%YM#,Q/.&<H()L>NHJI&P:.&WWFR'2)MU+0AON&^
M+:6RJLOF<Z6RX>*JHWSKJH/X;[S/7$KFTRSCH/TM-,YFT]H&OTY.58U961R-
M]<0!?.BC2FC7^,L!YS]JY(BI^^C3SBW)@]H;UKDK+<2RJ8+WB*.[31I.3#:^
M9_E1G%J?*PF\FPB_MM[!_(<#+2S[%#;+U-0J/C@H==@%N9-EYF3AGXXS>*T3
M"-?+$V0B4Y]9V1)E:=HWI,&FBY\WX]PID2)"*7W#KCZJ%>24+T=O8*%3VEJZ
M-M'$ME.S%2UWSE/)$/2FO.1L19?@)=P=UW=FLP9]Y1;B(3==&;WI)MGRFI70
M+'S&?T?]3^3NIF"TC,1I7=I'5*()<O(QX] JF?!S0ZV_.C9\%Z<7+1#".ZF)
M1<9BZX_0ANWN+0<'^$+@J197"^?=6PD[\XKO-AR#9PJ.@'Z':W[@4OHP.D%'
MC;WF%.R4@ MZGSHGDSE=6.A9]447NKX_I^-I;8R5"]OA#89,WY&,JCOOX5PE
M3?%Q<>8;X+72$I%17U(2\?/F]6Y2!DDW?CF[U%9 .*4!$*:@O]ORJ*].#NI(
M3ZS5T-I4R=8Q-BL5X[)7'DW]@%2#T*R ,!ZE#TSO"5>_5U>E=#"Y<3LU ]V5
MW'?Q?M!75+>]7# I[UXC(2P8S"_9U?;A U.R)Y_JV%(4;NL#$),U$8$W9J+;
MMF3XWF%.\NNCQ;]9.(0#7!+F<R%RG=S,^0,_ERUAQ(4165NCH(?PJU+X- 'L
M2 _Z"3%-DP$CFD6^E-,$"S$\IE12;\'XV2IOR1S#G)_"1F[)'I^S I!@JK.V
M?/V0P"2^RHY)\V?JM2K#+T=.(6J:[Z,5[97CB\QN]J,Z,>]+>E"?;LO99U,T
M^T9.K1E'")Y'.QH!>*>=8B!.OC[XTP /"WDGLF*QV%I5!,'BCE5 #VH^0.($
MK=YAK0ZOCCE9<L$*J5ZO-_'YL'8 KR/%@ C]>2]>#W773Z:N%ONY4'OQ -^.
M>XJ"EQ"QK^.L8C@." ! )>!T$G] NR>MH4,-=SK5$.$&3M\$UPCMZLE]^X>C
M7RU0\ UP^7L39A[VU]?ZD-W#%"I;"/(\ZFEOC]8ON/EG,.K#X'R18MVKIM']
M-0Q6/"?!MRX+J N3Z?I,UA*\GQD-]%$$+0.\I=&JTI@\+">/Q9>SFWH%<PPY
M7_4JOLTUNQXDO2]I\2KAC+@0Z,$#\#)J(N%R9RWI?D:W^E(C@1=W#A3EN08%
M!ZW$'V^E?=+PL7%]AGF?5"D$N53N]'.8$N/Z[#S(0"FS[,'BK^$2<I)4\HK:
M7#W(1<<K)=@A!I.'RSHIRQ>T._W7WXHNED\KI*"#I1=N6>8BAY:'Q=')/+(.
MA^FGUX^IGF.]CHH[,A'8<P,>N8%[$Y5=%S_\^(=#D0=-+>63.5UC.),C(/"R
M,6#\F9U]Z5V[M9R5E_]Z'%],F4&,Q5V?3]RL6B5'3JHR/%U-=I6VO3LZ#NL,
M]Y<C8MMWS6SG5"IUJ%$/=_8P@8082"]57TUI;[ZC?E.O6OLKX=*V^[+'"-]0
M!Z,&-(6J:SZ1!I-H ?KBFY3#;_9QAZ"?/U*DA/._1E)#6</%DQIP\5.6W'?'
MP$3^;/N2A^MG])EVX.LM=;Q8*>E\SXBK#:@WYW*?! +]>H#'U38_"MGW&?@S
MQ>8#MBV=?G[%@*B&[N8P1?LX1NG^ME;X]4Z3D><,W,UA8YF<.XJ$.1E66#(H
MA+\MPI6O06Z0\L#W.4&U+MC5?5'K3F%4O??.R'4;&5=,&B9/1[R'ZU5U#.;9
MC2'R2MO9'OD8UZ>6?*_]=G=E5A'(A6O8]>I:+0/HIG54^EWJ5=YNF!K(H2C+
M%GA-Q3Y%FMZW>8_,86+PWYTS_'\4TQSAO(P:Z^/V_C)0B\9)'EFER7O%C 13
MBYPJ%8.F@B%XWS0,:C,N4NTL3#_Z?6#R.MY<8+2"+01Z,5!4X>[JN'M!GS]H
M\,MA/?BW %O;Q/TPT2V%>:2A:6?.[NTIY=,5/,K_L/-Z:$;G 21^?5JCJ3!!
MT<WOI\G.UDK.9GUAK'=5HE2<%FOM2,BH$674O20=8KR7N#A3S. V#4 %0_,?
MM<O)EM Q\J6(:<-+J2/)P]U7]D"5] L$H^AA@>KV4T1VUYA^'/?=7:K#O]Z?
MG]@S\U4_K#J5+M/7Q.F*:?!9Z.,#HDG@F6VP>-=7+,FY!A$8(2C$.*KB=@X@
MEJ>$.O%]3UQ&O[AL&:\((4P9RA99&(TS!L+/%]._% ZLEQ?>K2%W/X HA8OA
MF.4/';[30W@0)>=8G%IT43_PMO./=>_V"<"NSX:1M(G#FG9U)N*V]63N$W6<
M:N3)G% [9P5OH  &V:113TJ<W06#]2[3\\UYT?WM'3.E"&^L7-97Z[YH_(/D
MI=X]ZSD7OAMHS(@#<]<0>>L^-<CAH-Q-O5:C1M:3=RA%#O$^Y16QP<2EA:AO
ME<T&L-8"OZ#8M6%2X7EJKM9"S)6N*M5PHH&$.C9OM]*53!WR5@MU<^ARJ4%_
M()MMSXL@[&SI7-)7B>!=M!%PXJ2G^MM"9+,]R=@,51UX2:IQ<S,=VH1 ",98
M].>CUL3H3370C]<]S\N Z1%I9*IDA+>T( M:OHH>T\SFVW!4<D-NWU=*<*>"
M^XOL["K)';[;D-9,A%AOFFS(PDD#FX0^;T9AM@8@-[CZ*R4\ZYI8 _+I8W@V
MC^\=851E&&ZG#R4CF/1T#P3](;S>_)=;&5+V5OAL7]+MR,C:GU2Z ^/>QS@+
M)>,=<H A['7]L&-+7K[TV/P)JD^\KC?2I:>8<:'A)UT\:N!-M2(80-<+_M%%
M'H;^WB)O(M5/J#PUP%5 ZTYZ$\[L2LG8^ B2X86#XK>I[A#Y*@\#JU_HAS)1
M_IS+J$)EK<M&UT%US9'Q]GO@C^G#KKE)6+-F;:9WE<\Z^LD[=@L!NM,439@S
M17:PY&M_3N&KPB?'!]$>(["Z*<S0&Z F<,YYL[18Y$D3)D'<3A_N1'9%S=Z&
M!D.$JO3/W3A.P$?QKE@W5L<CAKQ#<J=W$,=_: #?A,TA+N\BT.4S^J'2#51)
MTS6;3:)43&V,0 /@;A*XW#*WZE8HG9RT#,VY!]OI!_-I?D9I%P[;7ME<[PW:
MQ(+N8@:EIF.N_A@A<9W$R:IJ,=6F(TH;EQ\^869G,%2I)K>,"'>1H :JIU7M
M \:CS1.EY'P-AI!63!'U9JV NZ,;4K>QKT.W\5?Y(P@0^C&B*NW3EA#3N%5^
M'J\O%7S?-\37<&!M_\=2"[M-UL):)@WQXNG#DO5'FV(E&P^*+]>$3A#"#4(T
M"'Y>COQ MF;<J\@+Z'9Y4>L]0'1=$E43K/91T-  \GM<H1E*_OU:FZE:@5&5
M:K\6:GK#I ;AIB"((TX"CXFEH+]H:75GG4>\H@&5R=%UQ<B_]W5$-"9R0JU=
MC-LMW)W6O6K9F*R=@1IT3QZE;P3U97OXS[9 X^1*8/EW!RSLS7QNTYI08 6<
M-^F]W_?A!#=TIVA/S!YQ =U19-;L[;W43N!7W"3")Y*-=-1-+3]]%3T?]9AD
MA>ZTZOF>7XRCQGY=_/&:6,RJ/S+=?UT#W'V_+AOV,,W)U@:F&D/!%RWC9*<;
M5 :;#65-$,OKL4;S=K$3K4HTFKR\[7L,KXV!XO^%WQ+TL; !$ ;]=QS/WT*>
MXY:TH@7L^'D+FS9&%D!#K 1E0OK*.@[09IU=L@@R%&5C._26:I?!W_I77:V6
MTOEE^7I^-SILQ OF:MO5\R_L00H0D 0?;<:<FRN/<NP"(;29_Y[Y'KA1!Z7R
MS7R8<D.J=<XF1*!-<##7G@7$SA$%T0SC_5LA,;DM<J'VU^-!%#\XORS5P^0!
MJ8T1ZIS]BE:J0@EC?DVLTZA7:&*>\R4@9A#]@?/8$^/+76[04-=S/BW##WW5
MO]7U;(C>GJ]8:FV.KN6H0;/)@IM3;-P\//[/CS7KDK]]U_D69K:O 6,--Y&0
M.*C[HG%0I35;$WQ1HXY''[("QXF#KCM4C=O%HDK016U53ZM>,<#II\C"^J!H
ML9?>4>LKS3:@Y['[N#S2S^['FMS*X@!R^PH^%1AG ^4Q(4O/OD[=2T.(++X
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M<D,\0K I'MK8])$&;*TSY$Y-1^48\U7(@'$FTLZ37&A9A9H$;D>NH%!FO=.
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M K+Q@AM$VL%B<#JZ@;0\5&1D'D-[8CTS).%,WT_1,)C1JZZ"WT_5'C\IKQ7
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M@*S7W"U83V[;8X8^-L[M1ATZ;VPZ# N/*_>?6BFG/8HQ=;#PC#V/S"_Y./X
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M)?Y\9QR?DRHR= &[&$O0YSXNDGP-68>O+R!;],<4R>F*@M7LB;99."TE*^"
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M?V6+=.[/SL:ERQ@:JD*MW\;[3AM,*3',,+]Y#"4R:ZG4@@4TX4'L6[KB]H9
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MO4:N70"'[7Q6'GG\-R;M6@OXEI+M]\+78(?URGB/_I_C+_X,7GWU]XC1SN\
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MA[*.*<('KN7[()[*&*=IAY\-Q&B$ZX%TZ/LF12N@(#-=#EE;A]$,=HD[.U_
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MU)FC"ZYVG8M;>2R0N2;9XR<KR+8$CB0(!NCU_+ 6]V&W_ +!.YI\K/8(OI^
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M4UHA5AIUY"6!2<K5 ;[&E1C(1LM!069^_&&P^G!EE?*IR2WA!H<3":'M^AZ
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M>IW;ZPS[[%B:Y5'PO@^=H&LXH91P$T6L^D6&*0G8IBB@I%XLJ;V+K?5[LDW
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M%L#[H"MM*)Y9K6\FYXK+5G4SK#U?(+DKRN"Q9,:T>F2(MEQ"-/%6U1K0JRL
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MZ4)/59N&83;W7DDW0GDKO3=$,E!K*_X<_0[Z8MI.TOAY.?N&26O@B082\ZI
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M' 7WK[3H6VS961EXI2+7[RM@X6G6FA76FIZ. 8N(#J&^I\MKP2V>./:CFRM
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M$A-GVR:K9!EU%H23B,2SZCJPS@N=-K#X06%?P:SZ@:N>R5F&8MUKMQ3S:[N
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MSQP:0\**^46S3SE1)?P&H\MDBI0))IKE-C'A:\'=-N\&@/-@27[*HS$@6#L
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ML/9L<?IWA[.N6H5@I^E/DB[U"Y9WC,=6C:6ZN$EER*>%B43YVN]*UY$X9&N
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MEP(UN$H9'QIQ#)_37V!FY/CJB,Y$3IXY;SFYKZ!>']:/XK_.8I[,/ZGEF\*
M$6Q>< K0SSV@GDW=T3S7TA(AAFZ,HN7 "O\9DQ?$Q2/VFW"JR65@RKL EN2$
MHY+Z]ZI-]!=H>58.Q>])F R)=QIJX,^#-3'F?G59IH@. ^-IH[%LQ=SR4UB%
MY'9VU4<P;R2A._BRX&*Y9@GB^7/3/GR")UEAU[9'W/=<SB[8]A5^O"FAKOSY
M\)!YZ:;-%LG;@NZ8)_B2&TE2#2.YK.6/6*MA=F\ARG?<*W*K\C.[C&M#8.YY
M =85E)S2^>;&H)!1_.C3@ D:<O9^#FPQ+[9>.;L.KC@>PE."'QX=E$J3HZ W
M$0E^F#&F1 OE)^XP13D-TE-!Z"IQ,"'IU-:?ZFD?BD/.%,SQ<6IEXNC@^B+(
M<?,5K]89"<1B&.G<4L.[0--N=@DXXTY);W\1Q&"$-F- KTI.:7BNY)3>=<#T
M^]#SG@(-Q)$J/K\N*;NR55<U>L??G3'#T]_:TQV]'*H=/#'?)O(N^O&7B_/E
M7;UPH[HCA=%'D;6@=:N3$U6([F[D8<;<6R=8*F0O^WE8)4=0)%Y?Q]]>1/>4
M/3#9'F<X^TON!#<-Q%VIXR-NXW>&J?5JU_ANB&5I^M^7,>:I"/ECOJ6OZ%S@
M_P:_/2Q8FBVCMXL]2&C#3Z<,(+V&%]3.9#\LS^5& 9=AV%OSE$/(ROA!)<1^
M2NN^9IQ?+'.?=J?5Y ]07EF_>U"H_EOKY*?A\<-G])N:M$=3+EBK>6I,3&>&
MZ-"= %AF-?&X@>YJQ 7$2;43C'P%W_]W7GB9,6&DOWJ&YXI4HU]2'\:SWHQ[
MU-HZ_LV4#>^<2?%^4"8S7Q-F=='(O6+YA/A^9V32?.AEY +KQ':UT'9%ES';
MI.$QIXU'P]%>$PFSF?C&%S,?"G-Z$\VMN]X?:[?-@*2,#_Y"_:$5X5AWOW.;
M.;_#%O2D#LIT1M1E=7Z.MQF!G.KZLQ1Z)KY=P!1=XBZO3575'(P^C&!FO_%O
M"A^((D&L+O?%=BM9QJWS^"4OR[7]T @S<3RK%]";)('@#7.#I67"1EYZJ9O>
MF:Q(0P+?DODNV-EU38^%D=*K5 1SP]7G<?AB6$4@K1U5=@SQ*HQ 1"3QXK2A
ME9%NT#(R?R&.<AZ1)PS;A$5<LG=##L='N+?)^T>&14A.(AU>;<.R/DH1L;.T
MS[+H@ 6JDQRP@ZQ_GHO\,(4"#'J(U@:?7T<^P4\UH]6NK3K3TKLQ*[@W8<ZC
M6(+<@&JGEJ^W!V8^"'S/$C5"[W*I@"PS6B[<X-2S7/H7*VK1T"PK/"7J64"@
M-PV6I47KPS1+ AP9HXB"B\(D?$8?$8'S<UB)X0=NDN9U1L-'QZG2699=.$H.
M,]!A.J ;,C"%'Z=[,,WC8PH"L,7_$4;![T_'()U3QC Z-1"S@%_.#+RB-=,G
MJZ5MW4UTG_JXM]18W_R<0L]@R'71\BIV-&B-%C4=6&!YJK?8'6;HZW^D;9QK
ML\H!9_#3BF'Q58:&:!=-EW> @CB/)1^,=/,[5N_#1OZ")9J?3=I?5,WZ=">B
M0]WH48,H7)_^;%+3-U1+/R 9VO?AIB$RI=##!B8;L.Y<$.BS<8A%62?7"5<'
M(2-XIO'CZ%4;BI1JAM/N"L0\K*WA"M%^3/*<T _H4JOQ.-5];3*]MA )F%(?
MED[</A$ =@;O)?9#/J!&H^)?HU(8J2'"7YX.I9_YC:3SV#_LAKNE$I$GTX@.
M#JO2B+PGMGK6!F0. 6VO;S_4@\GR'![SX[U)C;Z<2'\ZGNT7(>( CRA9$T&S
M0NR3?-^VB&WX\J"M>X(8Q37M O)"U'41MY!DGMVU6]XT?DLK_<(,*_"1VDKH
MTWX]Q-;FD;JW=?AO7 5J3N[](>@]";L8KGO&[9I2H@3Q(*C?;><1;L:WD%_H
M?GKCWN-SFU.9M&63(<X-/<0N<(FO\-LE4$N+H5[2'#W>J,\EH+!0RH;IW%CK
MP$;;;3 C<2C-(K?$=UT8*8=O;+*)+1%-'>!T8.(D5Z%N?!6C"FPNCF B42=Y
M)*#<A#=KWN8]S:YS4M3V[N=*6H?)2?>FP:LHOZ"3N4A& $DFN8JIT5*D=V0Z
M/!?O^0G>)W[K0Y!,SO?J4CU@)/U6](G?])W45,A;M&(.\F<KGZ;I39\N=Z(X
M2GH0$G-D/OV=4A:5P2&O99\JUQD#Y*6Y$HCO-T(,BU2:AYRF [_ <=_!#R8M
M1NAN&2 7:Z1QAPW:@W91N$P&0C@:<]3FA Q5]F0*"R-IDX5& $="I:UAMO_K
M6MM<5?NCWG1U.3+^T_ #OB[BO<IQNJD$P-O?I=A>0%UA4_:.M/"]E^WYM=!P
M)( D1?%[)^LWV8!VX&PB&G"M-DD0P4" Z# F-B!>E&W7AR$[/-.:Y\^ \D:2
M,XR%2\XQZM#'I.<IG6SVW^SM#@-GZ,M@N=3",2!141G_6IK*^UT*6J$6YJX1
M5]4QF3&9\>I7;NZB<!UOY"9<KRM.(;:@?LM(GGV(],H B%C7GU8(UD3NMTY0
MWK/'<FI!]Y(7+Y6/;+6'5=\9DIUI:&VQ<)>Y3XV^E2BRB.BEO>@"V;VA-^_,
M 5*I:_<5A$I1@TKB;>0T#N2N8P(J7;E%'<GD,]T-K<!GFS .F0^<I[<"Z3X6
MS5-_+;4(#"UGIMJ-!)XS;!VEFYQ-YN@E1N%L\).YL2OK>(ZWA?-"-2"YJSZT
MJ<<-5CYJIH>&A_Z4 "<"@J.%#3XXK*I=3>US?5D:VX)*'%XXU] 2!V; GR5/
MM.K$_2SHRE:?_N])F=!JK9KLP#\T$]CLBEI W0S9>IT^L?$E>_,B_Z;KM6W0
M.[DUS?/3OP&;6?YRR2<<7:6&1G8N[2PU,8H\XO$O#[>W+[W](EI;4$2,3*@K
MH[>R=KY7OVG_*U;[RCE)_N6OU?DZ?E\7Y]+>)[TAHN(NE!%=K^LO9QFF)MNI
MC,VLB5](USPS\1A(EGCN&?3I%S#P0SU1;$![::_BP;CG[XLXPW")WKK O9N-
M@WV8X:L*9?F/B3*^#GO4TS7:-1@ZBEAWXQ!U+R7=P,DIW!^-2/O0,(NK*5_Q
MGSA$E==]K3,N^_Q+/ESV@^@YI]I"7$7%5(L'9FO^JV@&_XO!1:<?5N_\+&^%
M/@:R7B\;G3Y?./ FO.J^GU7]$7T+]IC/Z\-O\AZAY<!+^OJ/LD/;)4F.T4"W
M15C&%F<KHZ)1 AR=__'<XL<_WY!_/'X799\Z4]1;I)Q'2]5SNNEP@.AC*WJ]
M$N>+27Y\WLOK7R[X#[M_N>;@)G_]RP7]81NL$C:\>[F"T*L2CE\.+(TT^33.
MQH]W5!CW[#PVW2D"1/*8V2[W=<_9]-L#=\5-EM4M=!WP+22_ )3D2?<ZZ+<&
MA5TQ42:1-+]NH[_K3I4),\'%7*$L3G8P M31S."'BX@&Q4">UU0ETPSM&5U<
M)JQT*@'0N]IXT T90;ARG\#SF;U&Q+LATEZG@&YNFI+Q"0'6YX\5>WX?Y69Y
MR[@12FB\,ZM#1Y2SY:?-2BI3N1MIY>)WA#:=X\L)KY^P'/(<SQ.X"3W- P<U
M^G7PO+6+!9NN:55%=.]F%$NF11SH,*!T3W,5*M>[Q%@>^O FH=+5UU_PJ#XA
MN-UM!H% 74;?FS0#A9)AZMXJ&J6=9;3AFGKX[2O*XZKE/8N;M'3.@]Y3UNI>
M2.5+^*Z?FGY:<&C4F>@2L4)/43LEK>31^E\3\XW%HP_;@''7K3ZA77B%_1YH
M$)#SE) B#]!D2;JZW3^T$5T^PF_A[-_\5[(EKJW:A13:U@RL+'9B0!.QIUM[
MQ%&Y(SJ7KN6\N;;J6OWI(T];BYS='BE8 SE6JQORUCBV:=?E)UKH!UQVCBP=
M)(R>9*!(K2WANMN.SE^KS/!&24?.&=]MY]N5#EXL;]K&H3:*7JZ-=H-CLQ<V
M96?G]1O;_"Z-O5V)4EIH8F-N0GOV."^Q!OJ+.+(NJ>\N=Q(F/AL%;=0 V'J7
M)[L#>QJ*EG^.7<X.,/J6&NW/IBOF58&;*Q%!T9?=;*4ZNF%N+G2+0*XOEC^1
MU=%<8[M<B('V=][D'M(%!%EV:VOO##GDC,RVXXX39BC=8LSE:XAE9V8R1##M
M(7+A.MVP5Y/ [3P,59"F.F95]K:SAWICD XM-HV3A4DCN<:-@KA 32U8;!39
M)IPDB\^J_>^1G5.- 32Y<>WXL$G>M^I#5[2^)1_>B@\1IBUZN"A&\&Q[Z)*E
M;1MW5=#VMMYZ!0^'^T&C1T)4$][AHQEF%*LMU_$TX$.DMYQC5C%4=V7B1]W<
MFQ<S69)-O\/V)!(A%^BW<S7GVZ$'P8ZQ;SK:7WU]GO*9J*\73@=I%\1MX;--
M@U6=]\?C/7RN>86]$NAC&0^3PP!7-#UL.A<58V^**NHA/C;4.MAS*<,Z[T3;
M;A:_-'F/3*'+JA09/Z'>GB^P0'*YL.W\]HX)(:"(,/#QB[RVPP8G>.1+__[_
M?<2/0R!R"L>@9=_*O!R!"NH_K?_^&ZR+M&AG!W0C']S$V^ 1-HY-?Q]S*)1Y
M;4)U6* 'CHD]"*Q#<HH8PP4&K,NQ;[95S:"[#T'+J?R.F[E-7^[;Q9K2IV7G
MVP.WG?6<!^^7>(V)/-4#7;%0*$0]/G]U#)"\14WZ@K^K /8W[T2[_LNEGBA<
M8WO&S)[JM[-'2Q@W4&R>LF*,] ,C*8=I FE=,__P6X1$YU4M,:BH[\"QY1^L
M):$$5*GB(*R_X*X;R\W%^#S2::JT/XK2(\?RLC4BWCT9;,(R%"]+V_&K'%MN
M1L8H8^/I2/H)=Y*T?9\<R/A]!QKB7C1;. [(:A3?V\\9-T>*6N*2_*?J+)RC
M[8'[P+: R[G)I3TU3 A)IQ=EXN3BT(=K@.0)#JKD2K-EU[/LM"4-UVV["[X8
M>W^OZM\;V2^BUP2=3SGCLTSU=W#>T:1Y:Z),NX)R8*^I_<$#*=BEKKA_0N!)
MVPX_+)UYIAW.3ZX9G:P'J9M!I^0CTI@RX2UY1/_5;Y'2F*SWS8$#_:=. W1V
MSH7J5@5T7/T%.N'(OOOT& 4Z=2E"JGWLAA7$4-=N>=WA"@.[K,/F=RV801'O
M">A>LF#?],#/6-3]5:T]\N7K._Q&_=3F&C>JD* 8Q/]]TC?V%3 YVHHUPG!@
MFYZZM5$<3LDL9+IV*8;KN6J4OV\!!5!W1\C.C@(7!)T)6\GP5Z-E?1!'=:,(
MTY'1O?!7J5F4I4S<>\5B12/ T,3DLB@T#WPJX?SD;,WPQ(, 6I0)CUVM_+L
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M8&A"VI-PGF>.E$?(Z?;$9XX7SL[8N>F>[FAFNCP51XHX,&!MU'8T\_CE,S>
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M12NH>/#WE-SB7JUL-)E=:_$ZMHL![][(^8T&+ZH!ZYT\,UOS"%Y(22,C6)O
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MQ)D1V?R]A7K'VJE&HI\"=3?:H<WJDHU7ZC0PSRH":]7DZ$E\X5"YX!GSH25
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MCA!)64$!/*.8>NUT8G0M)O$6,!=Z_7'P_?H<#IYF'62H!*RE0K<^7XD_53"
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MJ#D\<J20X8E>B2ZS/=Q5)Z?/WI)JY+V[#E)-Q? Q^46!2S,M1Y)\%6AI@KO
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MH4P<OT6O^=[Z@%_Y,/Q,>3UZDZ/".QX5]X+K,>$_8DBV==ORWHY,#O:.'"T
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M($@X>7:J\ANRK^NWM IK$*6^X5*VYSB^WQE&/LLU61QCAL9!>3.E?EY*&9!
MR^^= P5_<Q&XP_G6+__L]!O*DW!#A3F&0,61W[Y6TC1MGQ_B:C\-I044G"$^
M_C1K_K GV1GQE20[Z68;X=A<+W_(DXFZ=B(-0'.%VGG?!HCHY?QE>9V/$#7
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M]D%/CU<[QJ70)B!1V'P7EG<P2'$<_ ^RT)]QQIJMQZCH;2X,[SRW!X'#:"#
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MA60HOLFTN;C[Y'[(W:W!GNWZJ97,%0>1)(VDK12J*/;ZJI6@1J/KQF?!U+$
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M-B+YN\VT9DB],Q8 )<9Y'HYWF+^1Y&YHBGM<B< Q5NU,1OF63V[QE8<26C!
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M> *'^Y(3U772D)$/^KRR;26<HE3 -LP.)@=8M('.+]^_X?2.B+--MC';P_%
M*,(71Q*-1$KM[%A:X-79<#H/]M4KZNED1SL/5<;#>)O*CGZ;2BG)\H?.JD,P
MY?<WWA) =P#<RG& 9WV'<.$89JGQ&W%:.J %P34&5#$A37QJ-'QB7XWJ=Q7E
MLXO^2H8G6+(/DHGCC[^;Z9NHR& 'L\6?:.(3#>\++EJ3>\B@^T[VD@$V%A]3
M8&2)'H UWNL$Y%SP>URVQQ:C=F^U(MW(4KPZ+!1L"NJ'*\0@F23\-W_T B$#
M"=(2TP]^"C?TN8^]!$^-,ZL0H\F8K.O2PQP0U4.[1N7,YJ)//SK;T4L[U/N;
MU'-/<H?@NKS<Q<A(ZI^9WCSEC$KMY,Y$X1ZO6E $46D^44;ORPM.JI2:,PH:
M::A75/$YD2H^ ]]ZN>>&U$?;5/,DB+LO*2U(4-92(BW.:L+#RZGB:C&:C(R
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MRG0MZ1#[7^PJ:.;.)/*.^3:D;2_U24"RA7^C=TNS"+,6Q&[N9$FU:F6\ VF
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MJHL@3T6WJAP#D@(LRQEU M]9[9+??97\'D.\+J:K$B .+A!VF4K_8F,UY>F
MB=%32]E#6DWEUKE5)*F;BWE$WHY&KL**ZH@Z%_&7(_V,/L9]T:!P9(1NV_@]
MX,DPA/0\T]*C+RYQTXH]=FV4.%W<T2.8.PT<EEY,"4T*1C/@\SN>19S0$)X6
M9J%JFSW4 UET<3Q[WW6"M0[ <+C'<MS0=$;>?(GW!=*FTDD9A_+4<+032T.Z
M!]'*Z>8IDZ'.AB=&\7OTCJWWG<S7)%WZ[9]\^Y>A9ULD)8]P\"_#TP-V#MFU
M")AW/A29(7/TY$,=D<=-=>OFM\-VI%P)N,37YVTE@V5+E7HVY&,Q1IW] /$V
M8TA0R\*G1(&;&83!![C5RPC5N&%(Q-LJ$,.>#5E-*=?DBR77]N"!X[%E-H\N
M&&!S^DIT4XYRWF])M3FJA<-'EM@[^=\U_-T\/C>-\)^_R56KNEL1?75'@G5X
M=\,D:Z/"QLYDY G[D3?.Y4D:U_<:C64C?Z?.NJ.X;Y0?>C 9<KNVU5'(HS1%
M8<UT->&Y,C.%,)J^R;9=^!'KZI,A^6-SPT\#--LWFNG>ERHQ!GHT-^5J<U)C
M*\1$.R)R#97=1G!UDC5N%&)2>^XT=W,_!.QA[8X>C3W7EF*C^'J;&*FH4>H:
M(4"XA6E,@.K8ZQ]M68_G%5J<+H+61&I&>I%2_1Q3.4+U4\Y;>FZXELOFKDM*
MBZ7P\_61F_D2'GYU[=;E66"Q\\!2\\ JRKZ5?)%Q3Y,W<F+"A]N%"YQQW0_O
MK2&8!9.?\;'M+S_2M RE:F(Z5CYTWE SY:S-;;C.#J@U^K93O[I]7/WM*-/
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MVKV6Q;G-DRYT:<:/87M"/W510 5OY7-9!G&5'3SA(U;9'N29$_3 3ULG'2:
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M>EO>()KL@])8_HF.8K+):LJ]9GF.GU(1Q!U).?\<"V?>R=XD>Q:'VCP"*(X
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MGLUW"'\OB^O_M8QMS;@?MV5=?83\ ?T2&C()>\Z#5Q#"'W<7.[?B>=*=G[O
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MC:G'N>,]LK^,IX]>2+W&K?!V@( U01!.0&^)#\.6P-!18T4E;_<?^"%N)6?
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MEKYAA*D:)?DDFT;R &56;V9B."Y/5;ZZB2UZZVE2;(<.T>YAU?5LK'?^4%%
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MOHV#&K!8Z#(^J)0+W7%/$5T/$Z!BQ<9)U JM9]:M,B!12J7'0'R XZX(-'K
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MG-,QB5&#YME4AKI^2:+RBH%+]O=TDQF8SY\!6X3>V "3+5^+=#;<EW7)2N9
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M#S">@M=/, "1,\?-20DUXQ<%(FX,+IHB2JCE286.HU3<%%]&[K5IE8:1+F*
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M<CMCRIRT9VA.3"!$D<)VV9[@/'/XG4G;@"#I5:S1H.%>F<_!(9.."IC?3-$
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M$,G07DF:_E:NV O_9.Y/L]R$>=1JL?T__YTGTUQS,GK!7E\@'['J(?J6<D/
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MW!OMB/+*'76!3EB@M_Q[IU"[M$WL@WD'4B2KF0&'GA^VT7(&DU,"&$&O^^
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M6P[_'<[Q'Z\S?K1?U02O>@(2HG=,U'^,CRV+RPS,1OS1\@SFZ*_O8/&TSMD
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M(%2O&Y/:@L$<GV)$+NT5-OKY4#0G4_;P$)15IX_6R5XW6)Y='K]U]0:8C%8
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MHB:MEMNJHFT'UDOGO]O.#NA"\@MZYE[,(1ELN$ US.AJ5]P&HKO[:I<MR;O
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MDN+17/'W]/-?M*^/R7-/8&K)$^PC7]G,DE:)K89,?=C /!4P%I),F 2I-96
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M@3.08 WN@;0.LOL0"Z5H/D58F%EDEEQ!&;V6%F]RQ\(E.6TXM?3A&'FW\\I
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M&AOA>#A/P,TZ%JL/DJ(?&.H??B'Y?KV"TSE\Z7@>>SB^J2]H!RW5>E#<:3<
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MX8I?*K55?3+L+"'TB0BN??<:GFH!D(?C/+BCCI8!]GS!'E>#5&5*C$^B*1>
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M=*.FB6E8K%5]_;4N=,[>'KD2?52^KBUE6KJDVRGT?L*<DMIKY/ML%F(3\[P
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M[R=\1D@2NOG'T/MC:>7O_MMLT^+\\UFM\L5.1*T^5X?WQO=B$6A_/XD.(4J
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MN?D-XP!C@;_ L+%FJ:KB[]<DF]):KK@@EQC>6VH#;T/?>NXO&^3$EQA-/L6
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M:TFB"6C&Z/OVLK>[%-<.'+@U.64DICQIY>Z*X+]Z]@@F9NPO7-!E7E&*?:K
MQQ[,EI-7XG/<'@V=%74*5_?Z4B6D^'ERK/'2]4/1@;@^P[%6A>?99D.WG%E;
ML6%$;Z_O 1WL$DUO[V(3NF?XDBYD79RIONUW %F$Y)G'YH?*H;4*N7_F->-U
M&1+2?N#;X0[O9  FLX8\WM;6FZ(PW<P)VY@D->B&'^@24[N$K%Z531=B0ZY9
MTXS'Q)]UP&KZ(04:0N"81\.R!./0ML%GI*F\.)B5630\9Q@\%#45[V*=&0CT
MJ;&.BL 'FK?)2-,:U]^^[4?;[JQWN%HWD)F\\Y"--E96'MV>J"TLMQNM$7YT
M4;H?IQ5[5J:/Q&6^;G[FQ+_2XL\+)<A#K59X?<J"TV1,ZB9<@.;HOF=9/]$V
M%ES90PY4@*[$B3J("L*C@0)6GAN6:>E9?;3ZVY_DQ?1VK@-['SRVPKM-N"V/
M55KV8!"?\?5V>ITFCE/]R-F/L=D0"0R,@6Z*&EC1?>TJ8G>+3?ILE=7<?/&0
MTEC56__*:^_BR"7%4[5)4L!^7B+0'WHF# L?1;,5BE]I7&D"\.93]9DGM8J0
MM&_^C"_JC0-OX3(Q?L.>\J[C->09Q7-$V]0OO^FNU+IGANPVAVH,WL6B-2!1
M5,[R,JA1" >IZ$*>01"D>W*4'O8M'&!Z]=81>EF=<4:G61'XE8^S*>!BLEV^
MD_^2$#9,RTGO3@A?'$_6FKUI)4<UHC4>\/7&9MBG%#0E*36$>N^UL2;[#3:P
MF_FK?SJ#_S_9OGED7/</\CVX=E-Q,8P.)8$85#Q5C5.18N_QR:=\7WL*8_@S
M@H9T'WK5+"IJ@AC9S[$BML0PB$ )TR25+--M#?%L[6,(,S9(P?.KMMT#:\O*
MS_-50"F6XKX(NS%TQM?HFT6+&X&=&]P*_=9.OQ#&PP-VAH?IG?3U<^IZ>S96
M'1LT'M%5D&SUW:S<!WP(R[8-KY69:VZ.=DG-69<8:G34#,>:9UF"A$X5EZU"
M?*9]$[=_TSUO(5CW'D.@[9=2NG[AON%T1T]DWE6<Y)7X 8K*TN/P/+VWJ\X1
MCP\B-=!/U/^&LF98[W@=J>O]T+;87NN+V_V5NO#K[G;$TKM7/\6Q_B8XWX5P
M+]U=FS;HLE#]1"_B^S!'D.9"XG;.3\ 03D5MI_$()%L_X2N8MHL*J_B4K.>D
M*J[^=5<9+*G$-E>_2O!K8D_(%(@U4[8!9KYFGS[4ON<F8IA6C#*K5E8_O7)[
M]^9%.^V@Z[JN@K&)UI"N6<:P<CU(DVO(K;JH"&AT4! RNX?\8N,58_;/-7=X
ME;=!N4HBJ39&__\<-)=_%H:-PAQ01SZ]FQL;N/R?"1.OI/UG5QQ$HJM-.8V\
MI$<'(J68>*+NW2P%$V52"DU$;5,[3[1KKIO[,+D@-MG;H#W4VM]T=9U=G'T8
MMQ\8&<=:UY/CP^FY:#?1Q[FMZ$7UZZLRT"G=W07D3[5#]/;>AK'>P^ OWW&(
M-O$PE5#+4@')7ZG[A[<U\ E72N1SAC-/O4]GP-XZ@C^ C!;7-'BE\U"L/,&(
M@_3V"AGP2O^MNZ5_3(T,O*2633\CP@R*2_^&$G3>TD_K\/G8V_3Z]43>!=3W
M:':=W%"./8*IDRT\($C6<OS^AL60J*D04O8I3(=2?&<^%<*.T(I+TC9_PG[F
M2649>[5T(DR!H%A\4#'C?%:ZM,*]*R6QN+_$N"F?F0A]B=0WMQKEFH!\[&SZ
MH9]?%0]/J%66ANJ'5WDCM\I<BP916S*;&.]&D,]X_6 P^@"2ZQQ<V<\M86RB
M]6W.40<S5FQ>T8%:([,F%KUU5+U[IV*-+%"O]UG'NGA-\U&<V7.4<1/DH9 O
M*3[JTR(!&O\E?O\^5_'L<YL**)^9#C+&+QP6M"AA@9*>AE(4W<&*/);>IONH
MN0!HTMT(*%QR(MKM/%*^7M.;Z&YEQ^./]10AN%HU5AZ!G."\0I#B@V+DE]S]
MO-.YXKTSY7>61!!S7?[8V8Z#H1I1U?7743*:_K\X;:I%*:4A18R)<-/P^]N3
MIC>TTW %*LKEZ'N9P-VRYUXG[[*I^!4UH=UY0V0;X$Z7KW(1]<,"NX(;7T\U
M 'N_+!C1"GJ:EBO&U# -!LT_1A^T0X\,[>6^AL-Z3+Q;AZA#AELF;]D.<'>3
M>V!Q<;_I,)8U.SZ#?]-I-OQF.5C'JF]9^*'];!.Q2F55&^=>(I2R^Y8.:WF?
ML!;86>Q<*R&E]Q=*2^=]8;(_W<BIT7\OQ@YR+MW*OW"K-+K(GTX)80\#?<.>
M24GY\+E$YNSB2,X'ZUCCAA R($?C[OV!)U5>*B"F&R=?(H#626G=>\*-XRH5
M%;K CB!J]P4GIE?R=U1AI24+Y47F?(]/UGLCA()6':.-J@-4U\<ZYX05 =GL
M.XSB?;23X)V'$[HWKBSLX*23Y[_%2?\\6+<-W[G8;6)MK8OO7Z:TT)17)TP"
M^? '?G?NQ )5O.!BLFOAY^;',U,XFX^I=8?\\^(SP8_[\WK:&,?V=0L2#19L
M:[[D\:AFO\V\M&R=4<DD5*LT9X89'IEE7I>VU6B_LVKU(YT$&5 [=UB.YCHM
MM6Z;EG=5T)5^+S2$VDOY,"0SRI>JM%-75A@48X*8(';89T,^SG( %[WN,NQC
M:WIFV5GMGXILK-O)'OZFZQ4T2KHG-!2^3AG8]HEMS(P*06$N*>[8YCLW1812
MY3E:K=HRIA\9^!+5N%40/UPGQ'L3)"R9;IN2DZ4OZE (O@1()H)L[7VCJ<D^
MFRM?,F]P?2:-IJ%;\7$6"&>K=!+9#+#EI=A^)FT10B$O5,(HORQD''9PV1N>
MC [L8Z['71\&HH&]MHCRN +!3:GS81I7Q?_VI[D@*%?YE76#>EP8Y]PS;M5F
M$4?UG-!+T1&BP;#&]'W<.X)3?:#.OAA%WW=]P,/@NO$>8VU]HH(6^UY<'N&5
M&7_K3[C!^'RU[*79"/R\/KV)U /4$X%P.BQFY*4!3GRT34#;]SGMY2'5JV2]
MWZ^(1O0=>C776 OKT=IGYQKD<'XI[-,H7%!-2D*\'BS>$TO]:*CYL-IDLU17
MF&V$M/:OE'!64R2OIJP_?3G]-W"@\=^&B%O)W\9I</T_X&B3_\Y"SSG]?T'?
M^0<$'%M6U-^K:PI&I\N+S\G]UY OI7,C^34?T,:.4N@EV#Z0OOZ9\;I_"6PR
MBZ?OL12^X_JG6#X<#%)!@&KIN27D^& F[7$*3G2JT!QC#SG?>U>HJO.A0@U1
M;;;>5C_BP"WU>ZG/\]T^YP%.3+9GEC)>_00L&?*XXIC&PAIH[?=; N>\O9E>
M>P;ATMJ$@F3A?0$AWS&%PUX7S=S#6K\'Q(,3H?(509@-!XT?<L3=^6H*;P*B
MADJC?6IW;3%/T2YQL3HIQ-Y.H7<'JH+]S72;S"8#IMR> _'8/Q:W9<%J0;$M
M@(%4\1Y;IMELZD2+3*Y6??9!"0;0)H2SSITW$] [&N\(J0"( C=_L5.N#A@B
MJQ(7YJ4$QZYOQII0PMORDV[1L$(5/YF=@X8D6"9<.TJ(G/GO"F-'_X(]>ZX9
M_:5B3O[+6/3BOY*'_O^4TLW\<\:@::TU.O]_%RCT_Q8IQ2N]0] YJZ[.9QE
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M;OU$.A\YIT<'9P)P1M-R,:8"G;&DC_@S+H@<0[9!Q_XB=ID=,W*%QS1 IT;
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M_ZGTEF75B<[;6:\,=:6C^A[UJ]_[?CC]A,=6'18(VCS#;*W;Z3/5(!54^I\
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M__'%W/<?] *)RJPF5D.FB/2K^KR#7-%+ZX9)#T2"L1$]BW6*F$F[//;8U#<
MD+MM>;^S>9,@QZ29YTV.XN*/5=&7B\S6];LN\(R+O.:LP*6NFNW0?W)K&IX^
M0]6'/Y5D\T7N*2N_J%3$UFN3U%9$WJ-8"((%#557).]59M;N%N_8L&</R#U)
MF_]LJ7NJD82\JBA?#] 1Q.B7:^"-DI> U8[NPEJ[1L-&.M_ZV/. W))KSE])
M_89/*G5A3![(]1/U2B!:;#H6(I3J? $I^PXFS.?D#%@+/_OE-QUO!N>YS&-J
M<Y#"/&-?U4O1=;LKJTI='[IH?RR"V7@^4MF6]"$U!M'14ZA48-S]HUEKQQ0L
M<#+?=-[?=7&ELTUW>ZM[ON!^^C[NT?9!]]D&<:;,$_@2P&E3<CE<1=MW:NR+
M[EC>JC7V+59X3(J(7'O\=(TY&%PZU[BB%=8=8P(.&$?+WOO/;IQTV;BEZZD;
MLT"]WW1^)%@[4&_6[^>MTT,JOFCNN[/9D.CU7*4@3YW964HK?-XG3_(19#!"
M9/9[SW(K74A[5)CCP95\J6-J8Y#2X?29?F(8ZHO'K[ PZG@["^EK@AS]"O,!
M*"B0D,<JGU9M7X4XN/:CM,WY\*#9_=-!_B4@_C!5$*8<UG70"B?Y/;O62GCC
M\7F^#5+CIHX_SFNUW9DS<QZGYI+HO;HCQ(,6U176S?PN<<A:2]JU8WQ_2<:E
MOL6:])K(UUS*XAF17?=B.$P5,AV(P*_6';^2U:KD@/3Q<>U4U7_^,4QIU=8\
MC%7!,]A1GO-]K0;X*99[->"35ZVU8A9</?42[O#W-)';]='@E]D(NMU+/+/Z
M3,.UR"4_#VA $UTRI?42X5C/6ID'(E6R(IY^8^%/SZ]'NP0+6E/A;CE%P,%#
M'Z)]'+P@][NRQ=$-H[-UB1 40<OKIBT6$+US+K80/R1T>@<KLC=_#W(WO1U#
M%QK4^NHW'4=99=\T!]>V180(O0A3.\;_%_].IVWUW]\2J:K\=+_HZ7YEE@W(
M\8T\+&[VC6#4>PNC<[H-(6-452=L21<=5UU!^J#UR)G/?]_W8WVI'IR,Z/M-
M]RI)79:[=_D>-Q+M4?4N0>_HH'>B>'OJK@E\2IAT;6TT4K$/)[X3'9T.EA:(
M5.0_OT:]8LW<O0!<T\=P6ZG4." 6PQ3F2,\["+H+^L-??USOZ#E+IP ^C*S;
M8Z5%X OR#W<D'?E;AA?L;A]V]5[R"NH:[%7#PSMF+W.66@_,4B+5EL?P*YL2
M'=,3[U4LR_DEZI![ZN</%XAQ],GJ<?[U7"_66'<_$^F>3L2C[C;<%<7XJ7&2
MG)QMNL=%1DS<%)[@:W,D)#)=3X^IJ'NWL29;*:<$8A\8DI*&I/>>9(;/]Q6
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M(ON%!YM@L65ZYC;RF?)K-@J*S/';P)8NJ[%-MY UL&T'X=6ADA"$/:3 G_K
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MUR\?Q@<D2P!68"=_J$B+W?C6Z'_J%F8[ESGEIO/P;H<J(J&&Q0,NOMT><I5
M!V[ @4NO6(SS2)"%!FQ7Q+MS>G@HWOQ[-N2<(-2?)KMA&NV^<.AW9<G2;"O
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M90T;H+U-TJKC*T<AQSZ(BCIK\_%S0 -#9YX_YL)QR-UAOP.Q:+DHY8Q=R^(
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M'A2^*Z&C"1->H8\.[IQG 1Z*O?5[YLHD8DL'-PY03A,I3_F>@%/O*DZDL&H
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M4T8BGS&.4^WT<WW]MQI6K5?7NA7BK-.8Z+O:Z*&LD&>.6Z]V!UH ;N9^KN#
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M8E6^$ZJV'0_4+PAS(L%P*G"\]#2N_LASXL+5/-V&O/L7Z\U&-4__SW>4_L>
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MK50+VEA\0".@Y;*NJ*P7G)B]6#HN]0PX3[RP','+S22Z;IB\;TG]BMSRNI0
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MQD?(X/Y3C(R_/];_I:1<AR[V<(=E$GPK&:FEHDOKOY6W&'_W@CS:.]*U&KJ
M6!Y\*=0@B< 9_Q]I<+Z77'GBR6EW_SFVW(5YW-\&*[O67[E[^?;TVZ+?-.(7
MQ3GF2S%,/OQ_07HS"V\$;9R/Q0J3#X.Q&!BA8>""EQPNGSA,)?^3ZS]1B%?P
M)*L,Z+_WD#="?HQ$29;8&5Y6,%_E',UITQ>&>=5>2B$@Y"=MXTE/ 3\<+C<*
M8F:]2^-VB/DC#SCXYNOU<RE>R#\LLH%$DW]71%2!YN:Z3$IKW+LF)_1]T?8+
MF,!&3,&OY!\$X%I<-)S'M )@,MAX;S,Y86-2D[LA+":%\3.>MG]LI0GQ_AGN
MB@/+G<*;;\W&D1]./EY!C94Q5\!>2CXV%0;W<)P",9E2I'XMC*RE_;>R<;YD
M?6492"R7Q6#!DSN(K=>P\9YZN[*2GW#4_>4&<PT4[\.U-Q'NS,S<A,S< HG*
M'4"P^4"D@FU>EN%[^CEFP71J-SH-F.?:U9J<H8W$'9.3+HTB^[+(R,NEAI..
M]EJP7.JVQ9HX%3IN"#&&95R*>/L6Y*)6\ YC]X[L^_6S'R!-+5Q7M;"HH,$M
MUK]3U%MJ10&";# 12))AI::Z[.'*# ?+<A,G"2UB+ETU32['D4NDH).E!*E>
MN+8O+)31KUKB''TCV#^Q^(RE#\P'=7V8']>+WQ6W6H9HD<>.Z%V+RSY*!'^S
M[V';JH2AYL/AA.YMQ_I@00?F$;TA?[E=21CD9)ZEZ(;25ZG+L@HT:7OLS_G7
M3PMN_##]$ WJ'J:,LD?V:(<%[X3R4WX;1'<>#G=-EZKW/5@L_?;N:JBJ$/:<
M;,"%W@CZ=>%6X!>M*80TXG?5;C&W,#= _]?>,ESWIUO:TB^$]5XHJO796'.K
MG'!,X/?H1K%SM_<3=PG"K<)<;_I+KX21I\,4-VDI1OL??_LM/;X]$3K[1!W<
M9UF_W]7]3#?].Z-J1SAJTD7AUK*# 'P_TD?U#A6!T+R-_A;=H3L#WRG_9NL4
M:S7RTYB\*>]"\IS\N4MDV8^:\:]&R/U]%.\KQW>#KH\QK^P/<Q.6XX(I3"KJ
MW5<I3R=)*V_)I='6JLM5/6"7KZ$B1OQ>RU:8C\GBN8C*X?+<2M6)/IV-OJC\
M,N=_\7W+/[0BJ?]$\[Z '5SR8XNI!@VXPL631U+F1:J]>/1HMOSWW84#_[ T
M]]KBU'F?!P_''VMOBGP/RE)ZP;?5H$P9/'/W]F^R@^7F]7KV6^CMA1])DO9\
M!B$=\[M?Q--B?!)'O0/Q8Q].O_G,Q':\JH#W^*H:05[GH>0F<,9ZKVG\K\DH
MGX=/*U,O( N],#-D7[.I8AW2Y5L&(=2KSZ 0L3N0YSI=$\":QL&O?8"WFND1
MBS =9YY-+ [(BRM;_$WW %Y $AS]%/)>9M+E2#*CY+RRQ38;6SDI6]X^\@>-
M8O$RS:3!7Y^"S?GE)HI5(WPX7:%D'<;\8&W*4, M@QP_I[GYR.JN:=?Y$7FH
MM(6T9,5#JV)&!N\X4-]-OXS#.K;(P< )7S3SJV_*6JU\!A0=(',UC.'#B*B^
MX5>R1?$S:@!ZF+^KXZ)J1R:DMF=T.N7]H"\X R-[(0?%/>#!Q$M$C@FI66_(
M0^]+T.L)Y:[Y5&UD?%!Q:>-=G-FV39*C%:SLLH6C';UZ!JL@R&>Y1*(!U&2<
M6^&#,V/7B"8;,?,C(^=15+<P"("QR!TA<!&%SF5">'=,WM:;RM#9CL- RYI\
MFXY4DN<OU"Q*ZS*HQ@'=(/I52-8%+0=O? $(-X>J25IZ/64<VO?7F/J@!Y\0
MSGT-IHQ>-R('H*[Y 3:ML$>J0K\D?:ZG+1O@#>A"7C;M4#4;T!WWAWASH)4-
M;_F]P>2/YO0S_S%:F*()_;OGJOLYQ:1VL]G_>QKU4SH"H6QZTGS03/_E8/"
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M_DK)LANJEF03 9<L#@VI%:6#55/48X9TY[6V8,]P3_L;<>@?TJO_?/2"I_W
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MW&0]DAEB><Z@O!%'\%QV/45?%>.\V-EF^//]'Y9&8 PCY'ZM?8[8YBMXR'=
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MW6N*K^@%Y5RORE%,R=QE'ZT**#J;G-<),GF@:+U=3C8/6#8'2$F1:#&B-:=
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MJ(+\>5%22B)X75DI&YUP<-N]&Q-!13"X%%="0<N-!!A>](JQ"U6^#'P&R2R
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M$![@;U]AF<98H.;O<Y+P*R-?Z=L%W3DU7TO8_H:PX6\,Q$\ATNCB1E/D&UC
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M+97?D,&6>P2^FMTR3YO'&BI#JA=4=B<08@L[CUOET-5(LZ//4V":P%/25C.
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M'? (N>"0[Q_W\,V@N&MMDEF?0DV7SWF.O!(VV\/0P=\1P_M.,19B<!,$/R;
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M54I"*L%7_V!.G+Y%AY6;7%!5JG)J4K08JFO&ZPW>8A27<)KS51T>%NM6_*W
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M',\<RW)03M314E<?@ 6T$I]5OSLH-AJ+)8E\^,<VL]?3J.OZ'MI^OE):4(<
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M",+*PA2U*VM[T]T'H;^Z4@<MS@:0!Z__9+]&:('DXC+B9^ GA3:="DCE$@7
M9OL](_N?&17:!/-QT^YC2KT]3)J?QYB!):@!JE&M<H(R?#:#X0C]S%<[O Z
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M@XL+&I 3^KW2'LG$CDX4'US:H9;)I'12B^9R+SMI'AA \@,=#?M[K15K;&Q
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MDG=-$MIKP$+3_X'(BY;G+NOF!F%:Z-Q8,XVP3_+%6\:<S/;A,&1A<-A*EME
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M ,L/#E)"@3G>*(".-7@:#A8-!4HK:N3U8?N;8BAS.),<FA]AIG\CNU8/0Q[
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M^E![(?B%3G'Z4<CZ5(?'CLZ[23??!.CGSWR:BB+\K^T1C!V]KLCS12UOHGN
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M?0@&\E6+ / 3;M"1?$\DX-G%45$;"N*KB++6M(DLR?L6W('TD(__*:[RP3D
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M@04*"->2Z4/KH4#&X:S7EK<C-*G6FC"WQ15XY^<+(SPUM-8L0Q\D['W?KM5
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M'4C_:!X+,/P^XL&#,Z>72F:V+7X;\>%]OAN?*6^2'%Q_!36BFG.7;QQI"7^
MIV9A\V?<_9CMR0H"F&N>8A2?5+$'4'T=O'_HXA)R3239Z\(7597S0,KD]+M'
M=@7NWM5$HT!&>$+<_C4.\F,C3,D=S=QB'_F]%3[_2NTM4OU>Q3]Z;[PO@>C'
M4I@(&] @M7_VHD*R3K6_8=P'6B X.70=D7MHK5"(R+=X00)LW2/;AZ:_8IXN
M*?(]BX-\4>/L3$MT<?ZO(<(E>O0\$]IWCMM5/.-);F96:;7/9!B4<NL =$#%
M9?.QHZ>XK6TS-2MY@UC3^^9,K@I%6-8:;9)5XY UU^[GU:(VL6X^)U'Y!AK;
MK3*RO-SF89C9IYQV(1Z"^LA=* >S*.D.(&>_2;&,SGY>WA]=OHS3)\2K,NU'
M>?42;GUHB35+&"U.!@LAOT:+POY3[G=A;)N7E&09]5<R$CK1,[XQ&=R+"8R?
M+AR.W12O3_\R9?_1UIZA#*WF&+JU')=44:[W@B>Y3,)%+7/)DU.;PIG'L%*[
M_(42RW,CHQL'KZBN/3MD,XHQ=\4+CF<#=.',>'0+ZEGP>YK)3C]O X8'#L"F
ME23'18;,_WRSLVOSJH2600T(C59,QWZ3SRHOJ_1@O_NATF"EP?@2^ISMLS/X
MRH+HX5U^G6M8KE&7?H,DB(0$^J5X\<?_:QOO4QY(QZD@L[N0+NYD+G=\P;G3
MTIYZ>K@G&KX*6 FV%F<1KB:N6-.7$.NZ2W4=L<8<TQN&Z !T+"[Z91%.@7ZF
MU-NL\=U%LY76T=6D*R9:7._^QT?H_W4@P;>)0VK_+'EY[[&0XH^+>9!#TD)S
MD>W'R^00PN+^'[8'Z2NVG,?6LP+KD3/#I^/#F@W;N@L$/RN/3X5>VXK-;C:P
M!>Y5OE'G/4S^J6%L4"^#6?MV]M@H3DT9+(>*1[+M_6$[?+0^_T5X;,OB ?I9
M(V!YW)9+>$/\>%7%]JW)C.[9S/&YEVIPI92+%^)<.&LXO)4=&Z51IQ3\R_9#
M_)$%MZKO\WG@I^>>O8/*^0MVSX?:V_8UBAW& \H;Y>('*W6VT:?B?SD??SVA
M^OPSB-T:/&OB77=0&=DNK>P2F%VH+C-+6A,2.(9C=WI'',Z^F6M7/XSML![+
MKJ2EY5^J_6S[]E:6:92^4)OM"W\%3;%(=B'(H>)GV_!;KW_?%@_$_ASOE,GP
M,8?^,#[3]6O*#AK[W5#K_M7A,<;&X_PSE4@S?2VV1^_&7L2:@W#N?7 >3A[
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M.R]G2?:K#OXW^7> 4%^]3UYXI9MPGF1<B/@_A*V0L21+:;T5X\.I5=T-JXI
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M_<CZV@/EFXE.,?>8]17Z;OBPD[7K%.PB=B7R::\M,KKZ'+:BSU-*/I\Q,KQ
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M:A'WL9!<3%!WHT8D#.>+,U4">HV#ZVRO,%JO2M3==,3EG_A[]/5\Q)3N?1\
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M^9OH@1=4G7H/I26X:#(*T'0W3?9S"RS:..8R'(:^EG+@V@NG4LI6_:UETA<
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M)JV3$QGM;XZ5?@;G$SA M9K7.9T_B(!U+9^?);/'8N=QKR22"!<MRWLD46]
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MOBX&QUQ#SU9S;W &C[U=# Z@74J_6=7DAINU\D?R;:Y7%#VODQGRL<;JSM(
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MF_%AZ(J_!>0V\I\L;)(^_:YHFGEX<M05* QBV.E;A,SN-:8:7KP %R5M8:D
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MQH_4XR^ZNL#K*5'V2@%YX4H;?F1HI]US_&.>OYW2W5DAN+R[0$IR)GDRB1H
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M]HQ!JKE\V"Q4+<TZ+L= ?-G"/V',T]G!UB&-^0Q@IWV]Z0@1]3*_$$7%\LH
M/Q;L,RO\9!)=<OR$'@5H%%.\6"2!O*,@6._(V8<F5^:FK1-3;(&E%Y?2,ZKR
MF%E3+5?VW'=LK%V.DKS<4$?E\"-HKBWB:[('6)5C5@"1<(AOJ/@SIF0&JBI'
M'6I>:,X)/HG$3XXN*IJ!/HLJ*O;A8,%FE3SM6=26R^LEIS[0HK!>;EK<6$U<
MWT]'<.Z 7\N2:/#K"^)LLQ!BL&V'NS:Z-E!Z@9QNO7$F\.!G4BQNO;WOKKAE
M<DI -<J:^@1$6T(PG_0MD$1VKA1>ZW"=+KZ4WP=($[_J4G"5UKF0G$?6!QNA
MMD,$48$_KZ('(R:UA!Y]<W\T,]776'K.1"8@I6>@?U=0\EN8<L@--=3,=AZI
M6I><.?9MNM.=8&C[NMCE5@B0WP9!$/A91W=):X(#T](M+'->;-<J[>'^YI/<
M7&1T6+>*;IU^>C;[H0?AV!)AX]*E!--44$\1Q%V_:O(7G1:?TG-22ULH=+J]
MU*YAOIETSBCS,</L9.@!F '4K0P4 <_.0=*\1XXP4!_;/ZN#4B=#$<0[(J&N
MFP/SK,?MWZN;BX7H<U[@X<Q^25:D[Y:ZPWY\]JN/.?6(I%5HT4E$4\!]],%-
MK]38,NN>0D_G: T'Z\CL9?M@CKF2\9"U!?^9KC*G&ZL.?2%;I^0O*;24S3>R
MX7XA+6: H0#U51\RV])N4)$!2.Y#9O,0L-UKJN"V$!3I$:;U]6'WPW#Y&J2U
M/Q_(I.0$!QBU8"2(=%. Z92^,'EV_16&;2+0#CM<Y=75ZF;$*;?O]7\M\A+V
ML_4$9GKH&\_ML9%$[,;F'QPQX$M3<-2EP>+\-4+N,*]1Y@$--5"1KDJ(%.X\
MGPFX=+FLG9$J'T89U4X=%G)1RXP@VKU.4[QK<<LJW F.>))F"S*SF=UY1ML<
M 2W&S;W[U$)*0\(XA>@7K<T:ZHN::[8*+V5\RD":H?>I>I-K"_D?<70+X3H'
M'SZ83Z\N"9@Z!GTW]S'LA$,3Z$"5=Z5S*T-$O$,Q]?T8N2T46C8W*E^3\8M%
M]#D-KA+P *%<9*<<6K0U2=P#)A:O'4^JL,KS,,9*%\=R/F*>N.XLY+ EMP^H
MISH&G:&IV8X@HG-QKXY-J(.K#PLP62B^%D%_EPSGT!9BAL5U,36+5!BNYF>H
MTYE!M/'QT^?7H,--EJW[*2!.@-#1&^Y^A/YH4MRIE,OCBLG!;KT&#:Z=Q8^1
M&)X*H4>VY>Z-IKI7I^*AS9>=?)LE@JV'/I&_.S;YPG3(%Q"/B2 +I;F%2^KE
MO<T@7Z=$)/CU%N-^BQ<S@D0T8N&"+H$_-;CC;J +9%-D/PEWW'OW_:>Q !O+
M0U.3XN22_7R\SZ<$0SC;L4D]Z.E6M+[Z.UJH^]GG_57X;8X1.P*)R5( TSBR
MXH"+Y%G3^M,4;LM=(V;-(\RW"'FMZK$P@T&68)Z^6K4.R1PY.5&:%$6PH>;.
M64Q%@EI'J^3_ND!0_O]!S?>_  <=_G6'&;Q[];XXA<*JL.-7$"YDN<?>NHX?
M=FA\]!4ZII+4T2;.;9?CPI_]>2_^Z&Z<6>K.3 CJ;SXMG=JL1.68UPU@_C_4
M-9_QD  @Y0Z\Z.;PG\LQ_5-T^<^%Z#XJL#M47?<;[)=)#8CV_A=G65)C(=RC
MY$-Y%4U2,Q?UF6JA,6-M=FF0*MC3@4XL]TTLE@UWW1F+%IUL#?I4\RQI $0Y
M-*@?6P4]?+';L8Z\ABL5E5(2+@E .RA?693F8WW]):WY2/_T/(1^<<UY&+A&
MX&"^7EEO;US.? R+F(A-?ZA0I1!H:0)H!L)(W_*D\4DD6X(>,*R<>%,C;NQK
MIRY12#6'FH?>Q'S$VF:WS 5F:@2O\OMABG>#TERRU%!#S;?+R4K&M,U1O.&.
MO>\^T?1#;$[YML2'\<#-."BSX2T/(=R8<.+U^F$(S6O^@T!R$S_5])]MM3UJ
MDJK68/VE9%I2^)X&LT!%WNW*.L-HKB3<IBJE35>-7#D&_RNWE7F@9=E2VK>4
M9">,1%%%JNU9E7390^0IJ//5<)@+X18DW-'I&-(&];O=<3QH"SZ;$B3X)/-8
M%[>V6QX\XC>A2'F9%#\6K*WT%;%WN!=MM+0<'=<7=/W'J!'3VS# 5/@@[RX=
M=MF-92S,00CO!,*4^R0/FX0_+R>9]9]__Z2>>D$"B]H? :4#A5AME3?'ZN:>
M+9!S,LW^-=I(\ZP"V"C41RF;R8%;SN/PN8>@S<M:SY0;O*&Z2[UKB@IJ_C<U
MILY:"YBX^%<5^=$AWL_79-/*6$E-NU7"I_(=FE=\K(-=J/;9PZT:Z-;B[/XX
M:!6@CD[MG&9=RC8)LD4W4?T&3DW$/\LAEP)DE\+Z5FTWFZMO;9UIV+#7$,V=
MK73V]S&SK^XE&;/L(HEG1?.$WV]L$\_V-;/\74!5?I)<^>!>GSQ+5VXC*>BZ
M.TXP7_H@Y7D08'C^3N8EH22:&Z53;5 -K49_!%.:U;!JKIE8N^66'KR'K-%W
MO:4QW=FS%Z)O'2)Y]W!"^'JMI6_SX]F.NP7K8T-](9<DDA*"T8-Q>^&CTAX<
M#.Z(/+3K-$&1W?=)LOI?7;C5_YAWCRG/^M7144L'R$4&4F(!TN1H:6D?I?Y2
MBQA6)CK;;C)S;"T#^Q;=""]_?S$'">C0PRIU13 SMOR>)8K5/-BXQ'.WKTY0
M"S'(N' /_!/\-U\W+^(4!#3B&G-*0<S(Z1=QLA1[QRS=Y5#92,XO_?6>FF<Y
M;3_@M7OH&:Z9J.\U1L>I]^]")U__VVTKH3 <.-=/.K'[=%>ZL(=OS=6T7Q!'
M&=U /-]SU_FA'+%\T9VY6LIH_YLO1#;N;'>OK$GC\[HHTL75'B3!FJ:R-##0
M0%8SOS!?&JUI[XQ7/IA/F;BC*8CE6+;FF5PU^VC-L7EUX[^)*-(0_P/;$ 4F
M7YJ%;<E]$1,C#!\8\7]^EES;LE>'$)&@*OE_EVSS.8;?(X*NF&G_:( H)S?I
M*D>O46-W:W)]:V^P6T6_1-JVLS;W:%5K,VY8Q*:!;UW%79(+F[-\9,F(.AMI
MV/85?A7B.F\M.PH>GW1/TL#&OU")'PN<\Z6L/7E78UD5"VHY+NBE8:^E>"3_
M@PP]1$@F>;"D>N !OK$/0U0CJ9A@UEC\5,N_0,?+<P4\%_(>X7.4Q="W^.U$
MJ0!CJA[D]0 3'V4-"E@"BOA#4\P06E2P)NFDMQ'NT7.G#T_N*)H>/>_2:Z.X
MY+(&>%$N+*\HQ*I 'I>!E%(.M\(:B_RV3@$S'5IJD%Z[12BG4\!7E-=*1\]S
MY&PY6"!Y-*+@;2A$--C*H6K0!\'SPP+C;4<QLY@Q*N-ZWWO$<][,=6Y'G$[X
M4)4KINOS;7$8\UH4T>S4.YAP1VO$OOTBV+6'XN"@C?BJ(6$BQ?CP'YU"_A/_
M:\&/R,PW#3A&X[NB-LIKKCQHV+E-M*0P'H#EB4)!W);?<3?%53%?-3;'A%M.
MYYT;JTO<U,CN&_Z;[SSU.. *WP]V?]$9E6G+IU?CV>-%YRF-_O,Z.[7/$R\[
MY:S)_!/W=F&L]--"(VH!QY]O04.NOH<C+DV+)B]<RN[,W^(.!R]).3'5)C-9
M)%"=+\]2D"Q&" CWSI)^V!>&5?1AB-[L&AO.\UOXMZCJGCZGS5 =*.JJP[F[
M#>[ZG2[;<P\HNWAS'UX6$_)6P[I!_0]NJ5-PSWXW[3&MJ*NCK?O:<8>+S)RZ
M/?@CS)!CA)F)GM7&O1._E+>T@E.V:ZU&$\]-[B,C+/?AY68S;7<E#7#\DJPL
M8DPKV_)0L#UFW2>UROYGA4MYIHYR^(Q/F=9* I7'<Y>8'1%X5_YMXI571Q/M
MTGE2^TN[Y7WVR+6S!J$2LQ;4-XB=U\$UA16'5M(5V'Y.OG^)]FKK?K,:4Z7W
MK-SX!O6\0ESRHNB^'_A7&PSU@M!<3?;]O>ILN%7:TZ#2B ZTGBV.:+XBJQUT
MF9L5>3GP@V%*2!4WLRK<P91YH$J\0/%W3;.GT\=^U-15;D.FR%@ F_\.@#'!
M-0%T\[Y?4EMH$U0)&@1FHFC"P3._/W&;TQ(/1GMU'/'9DB;'0T83IC9,=)U3
M-P7!G)X4S,CF(/Y;9-"%  .X<JROEQQF6QI8C%CP/Y)U%*3"*<\*<OJH)' #
M0$1KJ=-]3$2(=;^(#EVF3&W)'9]@PV5!7R!$^5W-OKDIT36><;?B*,GW[JL?
MC/V^,:P#%M/U$WT*74SM//7*M]DR_F%9.&(W[H%KN!/XKX@F^Z?"KVN+)S,5
M?\&[3);MW+@F5=C[PU&QF(5JBRBT\1(SGUN_ICRXT(KT,@4-K^WP#^0SK6K*
M\2T@ZOUP"\BMR>K3*N4I\U4B?B$ L19$KLM\99D5XV2JRT,QDEM3V_>:7H=R
M?#VN](5*1.C4$0F4V-,C#+266.DH2*DA&&)W09$N1[?RP.?**4.,<<6%\[&E
MRXX<-;27>4RU]EDDZ+KC;T7_)=EE!Y/\T8,[K9M 5%\R(#UD@JKL(@!4$)0(
MSALD!5A((FO2KC0#&F/3U\D*AM8"P)YW('M$[1(_R7>KM1';I21'ATDUJ<1!
MG73COE+R/+3%'2W&'XZE>44KT.)44U:[5NFW>1,Q:3=H$5I"3YS@Y^>'3B.+
MFQ^#WLRX>\RZ2 WN 7C7 D\+:TRT>)QQ?H8+!LKD+OR3P7=K*][DQ]3D1NQN
MUSJR#*YERP6%?X_3<6>]=]#VM<_H'^?]S:?33ZZUK;M>*E7U^X4Q1S&2>0B8
M^O%BP=F,L"46 'UD$[!0XX8^4*_AS'"/I4R 6K+NGIKBULF&D=R4&;&Y-?KO
M(5GV@]:#ZYS5;["7CI.? 3C%%]695MT=-KT9:<.YD6X<'O=G=-R\ ^]EAS-V
M:_JEVN\\O4L4OPZ3*WT=WJ1O':H3#=-%Z@8D8;\B4)&&<(5F6[666)W%0^!K
MS:\?F)W.54ALL;2-ESFL1BG"1,(9J\>1+K0*#"U@U57\*H/*EY* CI,8UID(
MX2Q/$]>?=A++@"N*E$\J_=\<<Y4E9"[<C$9\JFL3#W<]#Y]W(:&=EW+Z0"5J
M_MN6+H3)L6?$>>BRZPO1X8_?JYH0O?/70):R/:V]A&8U>IBVE>]S5MYR]V4#
MEDY>>+CSEA,UPI\7M1=*B]8#_RII_FWXD-M*U_JBHEN;05=+%\*;_TAH$UG!
MMS G>HX!(CT!N>@H+2R*.\V/16_^@I]FA05);[=+AM@,:+DZT9R3C5#Y&D=(
M\NH>(,S@T@>72R:V:A6&N5%C1KG$;I2R7UF7$8JT4'G6G'Y10*!ZF"["U=#Y
MB)V?;)M/E40+;SEPG@OZ?$;1GBXT6'_*:&4O.\/ I7[(K7RV'J35JNG.G_"Q
MA0?(A:MLW9,^R6CJ>FNR#STQ-Z6K6NT:D,8M<-8@8$?>-PT#7VP<ZM4*9GT5
MO/A3=<8]=%:@KYU1)5=_M?04,KNY4RP=!%]]%(UXQZ1*"Z1J3%?VU00'4WCA
M'I!61RAVB3$G'N[2^)(/B?^R$BDPB^<T,F.6W>JS4Z3+(GF50=\@Y$JS#;@\
MZ%0^\UF<;5Q?_E.('F7LV!]%1OT&OVGW EDD.)WDE,QK>%<-\Y.913)7#*Y[
MOU5VV0T_F>J'WRS0VL>E@#[Q]%[;M8"$4I!Y+@6_TUI317G;[;+JKA+)]20L
MFL@(>9P76ZO2[@%A=!>L%80V 3X@W"(66@2- A^X1'T7"Z4GS,=\*H*DY(XA
M.'Z .K3*"OR27V3_0JNA4<(L?M,W/2Z5'!1%%NO-EET0T1D!3 +GT4!(_07%
MMYC^;:F5D1<&D3-^F1;';-U9<Z(C2033D.=_H+OE+5]H[9Q-OW7R2?C>;1G.
MSUI&]6*I34<Z]EN[H>+<B]_ 7":%G:(+V,&^6>\;2$O'_8"GQK"[WGBI;B+7
MB88(J&ZZ4.L1K07BTSMH2T339KE4?>AP0$%R4DVN-)Z=(D!-0B5ZNIRQV,04
MG_4PV\3/@VZ] XVY-0VB\<R740''%LJO((KX';-N;D%(7W0!E^E>4^IKQ-W=
MO#J:L)9/'2T"I@?1,D*4O,!D1Q&<0MU,LRNDGKD)#ALAOD9T'/ZN^AY&N+UH
MTF'$*3 #D%O1];\GQC_\TOG6-/\;2&E8?V2 G/L-M/'4E1XD:[Y\QZTC4[('
MN!WDK7<KQ._7P NU"6J#BW._%8/-KAI\M_TH,B<.?Q43TBVH\CF[UO_/!=_G
M"46$N+['!C*GA@ARTKIT&>17HZ-7@X;N$:+C[G5_G$_M^P&/?A7C)@T=3,1-
M(+YN]%T40Q>\A]"J7" T\J]3KWOO1?^ %^PUF A7_\VG N05A-&$9;MV:P7W
MDH(!WF^K3;=14_MO:+9S#:=PBPC<S^#;@G&7TJ1ES6JUV^O]?+DUNY<U"MN;
M RYN06?=>FLY 6ME^= ;)TUCSXMM"1>G'BZWJE:4;1XW5"QC3V_W!V*_B8^!
MV!"X7RMGNJ'\+C-U$")I#<U8&IK"5RAK:JJ7E7GD5I47G5F@?#AYQXSN83)I
MYU(+\,2R:L8?% 'X#=7G=,N]J9=/!2AJ*.P0?#3I+PY(64"(&U#X(X<^//+6
M9-4@)8-L_4_T,A8"@<( FOVSQ#M]C(*'/1^*26(Q(P#!=A AY (8:?Z&T/>3
M5GO]HUHE\-DH=^(M&^H9.O]J(=?JTYN<8_3P>G.9Y\P);/%F!I[F\FXALDS&
MK;U)4(3;;'L&,9.'6;O2?D2:'J8W>ERDZABW\/.B072%<BTUX'>^!O1)S?>H
M5TI^-U&F.B1+EZAMXEBK+U>'%']7CI]@7_+AF663?@K@:^&%.F6I4->QO HO
M$VX'L$LO(. <AIZA7<QS/SF*97([PLU&+4W;H\B0=WI&\^GSM1X?(T+G:R6J
MQ0SPU$"_<9ZW&K>5<Y7]WIYF)*$I%PC=\SRF*&;0,I)3$'-^OOR1#<),9^G_
MNK7N?U> $=9,/@<&/Q[!9UI3$!8B*VS$(CDERO[-EP[9KI$3&SB^$A/20XHM
MP=BWC75:[&4003T,0<XR[S0F+!^LX0'<8ST;^IL/\?NH8OD+B %JD[D%Y-+O
MV'88?4ZJ<#/Y.>IP*Q_.VM:YN#H%U<\F#N5#]9]\O94+%QQKF,_"?VQ-)R&'
ML-YOR4]PGLO'<YO)*;?65YILU,K^ .22$J[)%E\5+%OH?+87O4[A*/F4_ 8^
M._<D#5!5XQF>M%[1':N"\55E=+A8[>DAILZ=#@'OCAS]I609F:Z>B%O22CR6
M#+QC4#?*Z+QY%H_V'L[YZ-?3*;\'&_NH=?DWL/?7S2_[RKZ>#9>2$M-BB&_5
M78W'TYL("3]GWR3'BQI+_08V'<W9"J8I*NUMSIKY;V4XTG/=6<N=LNO/)O33
M<GX!'W:.6BEU [8IRPJD4Q:F?0;$>EP%$":;'F27&XKGH*YGNDG&UOQ\]I"E
M](H5]9CJGY'5(A!HR;Y)P.(R0GRC3_W#7E-\%?U>LX:36==OF(PF(3 B421X
M:QXI;-)A\()#&"H7%=E3!+K1VG3=O-ZK HNH<B (>*_* <"^1 %43?EC*>$R
M"7_487]ER[.8UU2H*,%9T=1FE7;FUXB=AF/VW+?S*]+!PV?>AL+F4A59\5IB
M)D[-6?/DZ!93MVXD"!=Z>0KU>U(<_SZW!51C:M;\@YFA#?*0S4_#-$K#.*VP
MU*L'G)[34Z&$YN\U-1J)T[>M$5D"N$<AD<GB8ZG1-UZ2?&3T7T0>VW):/<YA
MM"J\L'0L9(MSR:K7-3)/H^YET%PV&YE7$TJJ5[PEG1 9Y@BBTB2JS1W9X?;8
M?T#-?>=XLR0U[\I"//,>:J%(05O+X3K+2XWD%#J-['!-WG-L3AT[FPZV+JGN
MBSD=E^O+@7@]O:,@8V].LL[@'3#EF0KZ6+6/$=[OU.3BJ4\/H=J9U>V.\I]!
M3MB:["?>V&IS:N4 #8+7.V$B&J>M>142SQ)V;TI$A]%:X?K!-FA?V@]8V"WW
M/HC_WWSRQ+9Z:@9:;A"(8'_/ ?2S'G/ZA8]FWGC@EI+4;GB%.;"YB,_J_B..
M_I0U3X]OZOZ;+Z5M0NL?5C;PI,<TW^1B(_US4N=9_PDIA\ZR]>"B72<[I#A<
M^DO145)-:$%.'S4NN0BES!3PZCPI\60WK7!-,@_#;(V#".?W9J"[E^+XOY9@
MZOZ'-#ZF$PCY UK,0$4PTNXRQ=[23-[5CK*N;B41-[H4"*65$4HJC>VL!:VK
MD&>K**N4H.++J8@["#O*"I)J+ZW%@/ H;\%AC .V4.[SXR8J$VX4OJ"R"DC4
MAX.D_\:J_%!ID/)YOKP __\G3(ADV2"L*:^\_N^+]HXT(6[83)I.\/T7EW2
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M##[[/,@G*'RB(IFYQKLNY-+W7-$9J8^B=[P!&#Q/Z%"T4)N0QL=UP\M2CN3
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MU?Y&[<D;\'Y?K[L$6D1F7]VCU BTCG<SWK/Z ]B2Z[%-)FEF!J5OU[Y^OS'
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M]U=VDA[W&V5]!74'%6"W>;^R3>(_J%3Z0%@1_=1!ZG-._WV4J"+BHRM10+F
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M]FC56$9"E&_]M0J7D1><C78*='DWB&3G-<X,^;2!)':?PCW'%9,M!9UW[9T
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MA:!/SJB7PN\(=3B5YKZN32#T&>>.IG#[%=_N?7R<^5O_#/\N5SY3,P;TX'#
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M84(+TYA#6T5]A)"4D[<L62BI9+T+TABBYN#^UHQ5AX9X>^"N$*\)39;U1W*
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MU,.NV_@UI'=EZ7K$8@RYWSN0W3S%^7"ZE2(P>LM)=9"X].N#4CBUX4JJ$00
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M$;OHL&YSG)''W>X&M)=>K5-B@*>E)6]'O%1F_;5=R;IB=YK7NKL44?;'R#K
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M&)C6_%FZZ5F^19G\:S/>_U;P@@0:<N>,S-#?;0E+Z&O2W-9#@.1*8Y[2TBN
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MQ)P"J*MP%9A<"U9DLCS$K%@,L=Z&/Q+[CE*)>=4.DQGY.^"W F21HE:][LN
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M(7/?O$IK JBF"TT%!+!OV]B^A[M30:(L6>]K>:I!'\]6(5<1?7 / SQ"VW\
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M'(T6/Y5]TEBG_G_("F"1<+$C28OPOUS6_^9O_D/\67=Z5$13V8,/I6;\DGP
M-=:]QP8)'NZI]%FQNQ[BL3KSYFQO>"]\;WUN!,+#39)?:WLV"(TP3%0/#]ZY
M-=:ATX@-2MC57!/Y6![5;M!$&SSFE=WN.8('[!U;8YWXE*G+?6>)42?=_/BT
M4[FK\'EUEI\76&.C<Y-[SQ1?[ST6VT5"5G)R'ZUE-VR$6E9W.<'X!SR..0(6
M\7C),P]2(Y\;M:/,PU:4W>QO]Z&W\U].#\.IMR5>[&A 6&X72]SI-MZ(^$91
M>>!2^.F=&ISBY6T6?H?W6XM%[,BWDP!%D%8W=K@-Y*GG<R6HQ84QIP(KAL;4
M#9R__I%VO6*N>JEPF^*WE\B>7ZTWP@4B"[XHPV""^TT?WWI-EG4<R*A"6[0B
M6E5I1RYB-'7YZVA>I[%FE_JRN\6<NNU>!1RQ5%A&(?NSNYV%(X,X>Z411$ T
MH! ;2<7)8&'P9,=1G7<9]."QD;?&PF@[9_F=E9>J0'L/K5M04!6\6R?%)'8D
M@&#4>&1!:S3_3=>P1L YG&>G@-4A=:@>Q5S2@0XOZ>1W*9\1&ZIJD#LJ9YG8
M:)T(M7(QH#SZM(L\/,\3,[M"@#^6/:+G(R@!D5(?YR JODM8L&4IW7")0^^E
M3X9A1,[QF_?8'GD95#I(^\7$/GU$F)3<Y41U#>5>?)05.>A<*$@OZJXHE[?;
M FX23W, 5LM3BG^(O&NXGX,%'$$JFH[D6)9C#! ?3"I,1L@*J9W0?HA>V05>
M A7;(DRE0H4;^_%)%.L6"S].@AXCX]MELK'F#2%-1=&4)UQH+>Q?6Y'PUW)Y
MX3:K?I[\[Z#ONT&^# .1(WLWY\V)*D,!Q"01.TT)8/=^6>W2XFVK,BAL%< 7
M"6;_6JNS:S?EF4FX4F?^?.G<RSDOXJ.XYFZ;*Z^M%8-7B7"?*]W=R#A<GBK;
M3OH<@2#59RJR3RN'4(+I>>;7?+57A(NMLF2KWU>$C**L]&I&FC"YU;&Q?)!.
M7<E(BLV[^Y\D1M XI+NU_M5RQB@03*7-^$!/T2ANEJTW<UM+!N3)M;XM 0T"
M=I(#U0*J=Q-LM-*]1=KD8Y5:Y\L"S8W/KLS52^L-]CD>\PO9SU]J,%!#?O50
ML3:)V6(7# 6KM-4W$?,<,96"V:\?@J8JU&Y<U^ZU44N?>K+3.>"OLFO/4)5T
M83<L@;796,ILP%8H>Y].RL=:WFFNUZ&UQ-^8>D8[*ZD4;.*6K?$U?^;S/^+:
M!FSV<:0]#OFRLMNH%4PFM\AOF&8^&V$U"XK7P9IDX--K89X0V6I/[S#YSV%?
M6"=<&NQVTB9.7T%87%NP0]I8$COB-8-^Q-2)L VLGW^.>Y3*C\JGWB08ZQ^,
MKVF'7RE/6,>:GPYU,WX)VG)M,61O0:['9YOWW/I9U/9@XLS6'A?7>W),KZ#W
MK.M%7W<+WJZ4KKF:H!P!"8+5B17;.)F,V%#WGF_)+LJAE'P/K6 37H$\G%E[
M /!G!]Y'0:+K2]$%<9>B>R,.I0GU*' //9W?]%9H5MJEJ9IZ=0C?$>'RI&+5
M+CJ948>.M4A&.:P+B?$V5:6S&ZBM?K*\C7RMAF0?CK&LA/K<CI173BFT@6>!
MAV-5T):2&I*&,MHB5ZY"[G575'Z_7J4"D^RNAH&*;9IOC1DD5][W13=61G\#
MO"\@@=.88PK-9XO>="A@RD@49/CF-*+8L5J2VQRMR)O=:>Z)'8&8 6V.1I7R
M/C=@@:@Z$LXUF6:@@^/;SDT1F\Y-Y4>,%P"<[5MOXA,OQ8((8DG=M4B=WIN%
MXASK=P"LOW]0?V5DF 3CRSS%M=M^I#FBZ]L"'+8=1O=7-JHOZO()+WQP-/?+
M&C5Q62, W,<B_I%9R@$.M&+<WR2L,0ZFT>Z!\$K/#U7%,]:&FCN^N%>>(I^Z
M0^-6*YL6M@-CQ^CKD4T (;>H1>"*=/A$:(J4LOFGN42$8#+WR";*"E!YFXG
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M/XUKV/&5@=YS72=EU[%/F-6@5=JR&NNEU%^L&3*I&7J!5XM<6-X6^YGDSX0
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M2-\+Z-7 YK?G3.>ICEF% !\GSI4/ ]ZAQL38X*6/VS]X.HB.-B&*E?&)L\2
M(%Q)' I4+C=K$Z<4-YG$]YX>UT%>.108UJ:;FCOKZ0V;?N-/6'ZP-/'(^1"
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M+7!OD%-4Y5@$+IO(I"CZ%DOUP)EEN\/]1,41I\1R$_UN<*'!\/^EADN\6#P
M&KK(Y,((_JPI\5D66'@PI$,2VWDUN:9:5^ 92+(N>=S"ZU95EAA+]_9WJH_K
M]8IB7/PRFQ3>$K(;J*_H]&CPBQ"_O&2##ZN=<""ZZV/(00 II[&G+1TNFI_H
MD\R_3?S4,UMB HXO 1:4>WPPI]G/=L4)&]-28[(Q69 ZF1&2ZJ+XR0[D6UE
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MY6P"$YVF4>B HN<BZ$5"L:9S_HQ0VCWT1E/!!<V@58[FVH.4#!*_K1W;HY^
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M1$H4ABV_Y=+)"< &45C0$0AN_"$58*U_V?G 3=GTM64.2F>XG+%(EO,2PS3
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M_!1TIF+[!@RZ<VIL,#BG995KN:&1^R= -XP!N[VKK#Z[_%UJ8@6$_S(VB18
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M@'QB?Z+PED2_-M08;/\)-VCK-10GH4!J"W0VXS64[#G1+MGS9W4@8-RV^P!
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MUE2'?BT]NCJ[>'*(-_]",EX$3CQ7DD*L6O7^PTD9!(&6GF-8B,%7G*,@1XG
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M2=IN;JYFA>/QD-S"TO,7P<F2DO?)"LS]*3B'9P1%;D(IV19]W$4;?H]FI$@
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M63)*$[S^;G@:%H_P7KR7 \2G%R92+(@=+G&C1'.3 _+>L5P!*!\=Q+T<74:
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M0NBG,OC)1)5C-<<MY8P "%QC,&Y_I&Q![]RSVR2W1Q ':!DU0:X^LTVIU^6
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MSO39AO2$WYJJ&_=*%X/[#:/>UL0@AN7E+34AJ\<9I'.6\RJ+3E?3J)R5RX>
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MOBORB>[&Y_=ZJRIWOG:O/70%!Y]\9V(%VXJPJ\O\OGGE4=#O&&,121^!OBO
M!<,R])KY.^Q]!S6T4V#'W7BM7#]-%%/1BRYVYV"RC@TU#.VC$K<*@0WB;J7U
MNRGM:!+]4^R7* :UPB,JT2&,BVI:X<.S%61_+DWE816QW\C'6H!A?C$[8<S%
MEKV),=^@8]Y#!5;Y31U,/(-XSY=U7-M(,%TN*/+*]57]@KB>[9$K13OV0J_6
MHF%;%WZ<Q)^X&[A%>\N>\U[F#8TI)_EMS"6>K.$&X_EI>OK:%U8Y_ 2B(GX
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ML4:J<39J(T!U6)$X>K$)T41\NL5;<]$5:370BRAUE4SG_SZ_1A@>3R?8.E*
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M;A3#%==E<BJIG'I8$$$_UN1=@=*VH8XN)0;.LZ+UM$0!PG$TX@_A3Q%JS!>
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M4I2.+3=OWE5^(:/%OZG%&_)(7N&%+-/&=58V6MY K33S S%P?C_F5J.=8?Y
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MU$W2P.^1_C,Q':E&XU\Z/"G/ JE%?8 45TH=3PN'S/BG2!$AJX1O1)\>X7B
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M2C"T17U%VZ*(TG]XN'ZUI$@>9E1EILS(,V[3^E;&+[3J\CE6Z[-SR?W3>G7
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MQ(1=^4GW=6@SA2Q@8M0Y=^0!<?2LG,[_53"(;#LR:=%/O0SI!I.^#%LNGTE
M+2\+O$$N?$_:I%A:) HRY!/MJW+MW664E9'4.O=>0'9=VAI/ UJ\%P#PSL7[
MR^H7N8,QP.+&QC%RIE+1-A>R"\*>\K!. %ZF_M&_U$.V2I5^INFPD;XU.;_7
M7#YB40=6H%\EG2$^&N&L:3""61;"L]WO2T^KT0-)9]09S_9M=KVB^\#DV,'
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MU=(!<SZ!0H9QT]1S5?-CTY&G/]Z0>?H(U-.,^)3!RMP4"UIQJ?DV%F0_EC%
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M(<^*7=>0\?P]KSOJG2T)<E,R'K2KWKH8=+3Z\>T/24%.8L]F[,N@/^<0BR[
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M4>,@^^%WE(:-]F)UH';+LK!2>(E]MYUW-'XZ6;#&:R@GZ*'3:GYRR&'/]KT
MV#0.G\;(;+1Z7D,WE&86R=UN;HB"5;X@T(?+VY%)B8Y/F9@CCY=G(M+_A!JD
M-=#-;F><S'US_VB$5U)MV%95Q?WSW[R706= V$W_^-WH9I30GW:U"$UZ:^&Q
MZ0<,#.M.<0J3BF&C7&2W?PIZ/!HUB(0];()I"V]<_6:OJ->!NZY9YS[SC1>P
M]_;["#+MNB[Q(6D\5$?_U_U,9Q9']057=C7C+M4QH)/*I^^3,V>+U_2WE;#-
M+=]8UU=:6-Z79)3!@*<B#L8_A,B#$0BE(Y!A.XKF\W?_:D6Z?P^X200K@^^9
M10GAY?YT%5HW7[3 L__9LXG_&_]OX._"AX@@2A\ 2$?EEMDGDFX 9@$P=Y@3
M&W$$7I\JD<$VN4V1$R1U9KHIER23:2'WH:3 =<?;[_0=SC^VY3'@?R\J_)Z;
MO-TJF%BB)#1!"7DX!5RL' "BVIJGPW"2YAL6&&AZM[5/5VD$&+^#T>U?,=,P
MVX[+GV._Y;^:?L.>4)LG6/%=ET4^6IY*Y#-QKB>+&9?XD$X#/A.C&OU?K)C]
MD4M1TV:5ZB(HHGS*(==#+K^P&#4_&JL08""7R"Z3*U24673>=HT6\SR8]22C
MB41JT8%G=G1;^!P "]-US*WBT27C%@(KM/W"<HLT] Y!($X':<LK*L-;&7LB
M%ME\?G*+B%)3A39.99O#P#9%Y#YK5+HSUO&)[>F.WQ/(>7J0T9!<#?LU<J@.
M3O 71=S*7G&J\?94_U MS%JD=7((%2=I M;Z!_ZN'*'<.*HO8'7@\W^&.:K^
MO55-$&CR8?")^/S3@DP2^321U4N;;&7)"()H(28+*(.;#.MZ'D593O+D.DAX
M48S^.D0<WHN[BEQ\ID$X5U@?1ZV\M.1\8L"KW!1=P"9Y:QD<S!K5D1,<'JLU
MKZ)?'@T8JX-(9G3OB=.53"V1HZH_@LO'/HZ1LQ-NMZ%<D5#J#B6F9IZN@XXF
M-22'G;L"7S?+$GVY[BA_> P?( :<D92[W9&F:W[EWB:L5\,OTTW$Q1 P0"CJ
MDGWF?<0"%-CWD6!'IR\XAH;^5*\ FG'R%'I@][8HX^J-4"U[3("CX*NM*J62
M%+_$*TX/%;$UZJ7M+7+M]1Z8@(&_DZ?_2V0=_E>"F37VWVQ6]UV3'3?5YY/Y
MNU;C?UP=$#&AY2)N,/CD!2#"?'!S6B[1AV_<0)8I4LZGTHX,4@,(O3PX:8HS
M+\T3?'#">OX*JHLAE7;0K "4LJZ6D&Z9E/S#U@0I;:!@T9G.F/H3RYG\=4>]
M*KOU<OB7JSA!2Y?MZG41[AUHYNW7E*BVF2HA\%9*?/^,BPSHS* X\<NJ71^K
M!%MP>?UQO]:/GS]16:X [4#OF"6G*0)1)4UQ$O>FF95C"?]R,2]GET:T;GO7
M06Q;WS?-%U%("2X0^Y:W)''_ZW95O@R[1+X-UAI/-.7)3:!*SP;HWJ?)<<6!
MNB-?JAB'/^2\V*ZLG>%:YOBG*-=1HHJF)_WL\:[9(_IJV'S)N;_XX$2N<T5
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M6M0!6>A*,[[<8\O#56I[H[TGB&3K@1"12YM]BV-#GCW'YG?RV72"W F06I&
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MNHRYG-#+JRI\M%USVI.!_72##@H(+.*S3S#/U:<TG08+V7EYR89YP&1NX2I
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M>40Y.NN$[F!-LNTU<HU-#PWX=(%/6"AI](BL72F,YQ%BK](G29D4Y0P!R7H
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MR>P@>Y%T"*OFO]_0[_\36 ?O"29*$$0O'Z\J:7O %5D!EK"6XYSVU53EWI/
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M!-V[N>@X"%QMBA);&MK)3FFK]YC;98$^G$UI^R-88;?]R!>7/_2)AM5+K*2
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M-NX-@"Q4%9;-\_O:PD0#>^^@6B-G4!D9H"HUF&5\_F%@*N$(R!SWH5S/$$!
M<^'1:E&(V/DP$%".6\!IEYC"\H0IL\Q!*[/>O&_FLZU,X[6J].9[!N#DN/!2
MGJ#SV DP%/D07M]F*.!FD#7;>$A-4ZKST]/VDZ(A^(C>PT__%IGXUN[Z:3DA
MGHUZ)89KJZ^='+9>VC;*UQQ[(U]@/"O:4K-6),4.Z.U7KP5:X#U:6HZAC.-?
M-B,JE5)R#1U6-"(]7<C,CI=;A):6619:8C9JU0V0?J3G/2;_O*_A3U1-GUOQ
M;<K(,:C=9-40[:WFM1OBRV<!'GCZJ:5>+_P< M/C^M"UGFG\F[^'IC-8ZS;>
M5%W4NR:YC1O"4RI#'017&?I;KD5:G*K'!TSSE)QYQ4I3J@X%:G/5[X&9*NK'
M,Q6NPPE( PI:GV7<_X;@N]LC;<?5X+[C'&,<GLE9HUY@P4VD(_74:5<+BJG'
M2EV['$!&AI0 W/,(XVK3P_(%!NRK@>*OS("50CP2?\]%^2D\;O+'BDJ;2A8T
MP /Q^K.]O><#8YYE48QJ,2*R- R!&YJ-%M2:WSZ\ZG[T'%7O<]E+_*2.T6UW
M:T;1J7NM%#[T>Q6I-0_HL64,'].IE4&"G?&D61NA-+4]!NE7#E7V<%AYGB<;
M0TEWU&0X#1^!GXTX#RC0[I-FZA9S8#YM%%5EF^MY'DU\ !>YD^ :Y<5N$WI*
MM!X!XER,5#J.,8OBF^RX]HI'[A,-!<]F8^L=$IRZ"5>;OME[QJ=B4CD AR4%
MR$*]A4M\?,W<4PSOT1-ISO2LGF335+OK:J I<&4%.'O;>\NHD0@\CIW6O/%P
MD1U$_V.+ZFR+6W_5M>0:.C3J\9R)F M3OZ1#[5]XZ/U"*R5WG!1S"=&'6_C*
MZZ,)/5QV:N.ORU_WT/Y;)%BEG(8@UR&:18.BBO4FC+K;")YW48627V&$#%B7
MJK]/9)ZY$P-<K8"M73&D8HXX@S3 ZEU R_U:[Z[Y0[!R37D*3T=<-<&A_<??
M5/03=9F>_;KMC<[ G'Z-7)ZA/]BD !ZVA0L"6[[Q?\*+5P)?U$)=TN!O!(G7
MPI[D.>G%P00IQ=MWT->B6IKT)G4\"2$34VMLUZ;F72IJX'=MM][8(:*M:!W3
M,^MMJ(TDX#Q IR ;?L%<XA3\X_Q1^Q33KEJ:*J ;*'=$:=A/D@W,D$XO>-;7
MU!"ENZ@Z26&6W/U=9)34,>6^TUS2R D OA>MJ2),=^"J.-=&PVJDA%Z)8R9?
M\]KE$=6!^!E+H-3LW!$,E):D'I"%CTC;)R![:0N8TK(\)*WO>$&'4A#\^*3D
M16O4BZ?V: ZQ?A!P>%0JP<WN^J#$K8)>="'9I-,(1F@$<5TRW F*UJ]:RS>X
M,,PU2N0MI(+RJ6'II@SU!TW:+K2"JD/OW0,Y;CD7'83 */@):&=O9#?423*0
M+/9$(T:]VUK2A7_%]?H3?DIUUZB+[D, P@/84MRJ5D2OC=VA&]2UK'J]''#=
MHFI?/XMX:?V>]+@IU5)K)XZD,465E^KSP[&.!K8&G1[.]/:#2JDOJ(++1+V3
MV^"J!)LB ,K0[2';3(]CNU!$KR:/3];GZ AA3WV;%NHU)ZDVI"=&\#3YT&L!
MC&]HL\_"V;I9SP:X\FL[CB?)KYL>>5X_@??>20=;5?B!9$#-T?N3$RI5?A>T
M8F1M 78+-<7/0*@M(Z69R]W0X 4%DB?1>TO\%K=+'L0IF#*M4?4-9AYPZ:%^
M6DD-1[#]U9$P[+#<OC)B:,_=EAA*9N14&T_YR>C#(ZT78<Y%8LNIF%;1=_.X
M-V^Q.6':SI(K7JCQ]V*;7X>5=_KX]1:SQMR+-WP<P6\/O5<OX*6?&2L>! ]X
M7X\15,0GE0K=X]P\TP3,^K]\0;6/&J\G\*-'ETQ&_4NP9*7\#XD_( /S.+NA
M3*<P$L@I2CWYBS]UR,9#F^69@J ?_PH3;0FB1DPG\#6B$G@U II_SH=1"BJ>
M2]5T=@/KX):&5J A0YDK"Y:--U%#R>3K<OD3D?I3\',5 EE^@@TV.6S[C2'-
M']."Z6@P=?ESK$3%(>$?M^^8BT^[DD +=P_-!OK7D>Y(6'M4?0>].*'I6#1G
MA'6=V"IZ%&;WA&1*;4G_X5Z[[\]3><?N0C;5NA3WLL9#[AS%-AL_YTR/%I ?
M)7*W$,.EBO?PI%%$CB]T+ID0EB\RZ24-B1%1&;44-<**!(A__1_3:GH"$FJ&
M%;GRWQ[3LT>Z!,+-/Z16A=W[IX6XD\0_*>SSKVI5]Y,5H<.7CU556&.<]B&E
M"[%^4C9MI:\,\5/6U])V4)W/+H;P?#"N^B\VUKBB\LH;$M,-UFA!N,RY+*LZ
M<N>YT%,]-[2^7_81V&!Y\DUR\K:4&<"3;,R@;1GWHT]VZ1TF1 Q9_D%/=SXO
MQE$Z#Z;)\<JD7L[3NAS+S]!)X)^K"+4776==F.:UA-!]O;=4ZG:_\2E>E:@#
MQ5E_BV#P*?.A&D,Y.-H?=)&%4,\5"VT.<FK5WT]0>X4(<LCZAER]ZB^4?WB@
MX]47*F3L=0;-#"-\'&-FQ'O$:]HA]D^V?FASS,#IG>WX@6X=_I[4_,\+00M8
M^$N)CC5LN(!.X*I>&P5_';/<^!+ZXM=[->E=Z;HWPW^@%WZ<80^VWKG+;Y\Y
MRSZA\A:79^F0:_K0A9<\9")H#;5\.R@*T]@ROR K8/ MH@4/*N5=DOF,T#^S
M)H4S"993[8MUP3R 'NZOK;[H)\R#X>"<A2($$FX"KTO9W/X&V9AM#ARYEOG'
MNF>YS-#=.R_.8XY#<DW#W]VIN'\&L.F0&J;8Y&WL]B319.0[(1N[S3+]+79E
M?X#*;?"$L1,B'XOT5C]^BD17UE)C[]N_ZH _ZO#GL]^J,J35]L#+[!$Q_PY*
M4__!_Q.4Q1G_M=YI1QH)%?_/'GC_-"C_,VF!AKK4_/%L/]%E66]HKZ91GN2_
MCZ.L?_M73X'\+Y\ZR78D,D6N84;S-_$!@@(+G2N<:SR0B]Z(YBFA(^(Z WHT
M^1Q>I:0M[1SPV!.N3-9*6<I*1K>SN%UJ%\^(=YO+78GE3^/9CRK4:-_*;$*_
MEKJV)7]^):4T]O3VJZ[#@76I;#\HY-#FIW%#WP#_K-EP2?,]O[><S=2[)//'
MDOS-NL+OSAO6?X+VG%]UQ]QE=R/K!3^9B[82K;0DU]NQ)%5P-N-CHCF@Z\(?
MO$6N(J@4NUO]\F^1T[_U_F,CW9K:_=[OG_#761:C=)O7@'M20,/P!LC2+Z>W
MZR2^$"A=H8L+T>2ZSM]5"]]V?%SU-MTXW?7@-G[/WR*(7E9 ;X('W,. :U_]
MRDSU!LA1Y01FHZ]OL%1XO2)KRR_BXE]+.&%3?Z[T+JH!FO/-6TRK3"EUEVBY
MZA;*W7!&3!::@J RH52OM>Y*>[TWLB>9L+09Q.D:1-4K@>X9I_()*D1BV:/I
MNR]MMR2!#]4CU5<OA:X[-U4N[M!V6KHQ)' WZU2ZK""'9$;SS. 'L/\H(=-V
MUR)F*3_:#])CKLC+*T L2AX#\L>,*9?/@!G_'$3[AHL_)AK[>O?KD.6>77]Z
MILDF[84&HZ"9."5O0,;I5)5Q/IJ$L<.G)M+.$/R7MQ<CV-&%MYU Z24%Y1W(
M&7'!,&QLC1_0]6!?TN1J05$HO'@?G$(?0+[;,J2&:EB^RG S)[UZ?B331Z8-
MMAHSY<4+B!I].1RA=<X8.95\;20441F1L+B$>[?8;AI(RSRL"EN'$3J.SM8'
M\DZ8<!4^]<PVN?;GVHWB/C&#INT0F=_:N*>CZ>(AZ#Y_EY8P>^@37D\[SQ!4
MI2IZ51MJJ2[&_3*%&UIT=+D*H))?8BOW83LR],9,LJ&9-+$>!DQ*"UO.# R+
M\F@$<EP5U.FY2<^_CORHP9&>CS[@=]3,VQ=V"%<=/#+AXJV_U%GQ'>-,ILYL
M+"<P_ ^\\'EPO5<7V4<50S;QDR(JL_5L&M0.\+#Z1_9?JTC8(&O)@&75;>'I
M?LG?+9,IFW2U,0*4X:V^_9'J]1E33E<.3E<!F;UKXQ7[4UST/@R+ Y1<BEO!
M7KSB,^!]6J"D;"V\Y7&FCJOK)B7AE%C,LKD\L*1&$YKY]13KFH7=./&CH&P@
M'M6ED4"!76<L(.0?S-$L%#]2<NT=BRGY'(3[$EDAH&6'>LJ^?.N)/]M&CC_*
MKP#V4CU6PKO^X+(L CQG-@5UW7KO/!@870'^?F'5(JIGEW(&X29;!?;OQF"F
M$WB!NU'.NP5PG:4(+3#[VBCO[D7=TCR;:QP.*ZUCU.HIDBI5F>Q4RQ9U=.&X
M#8(U A_D:1 0]R+5:8&T:[P2*R^I.K3*D'K\V<BYQG>Y=59"^/FHX:Q?NX7K
MS[M8@)IH2<7V%\<R@XO[H'HW6<"&4I?Y!9< +^PQ0KU]FI^#^XY+QPL<[6IU
M!O^Q8$7C)+^L\\)^US<P?-:20'9H& 4'?R_K<ZW]"SC)U!6(U9#K:#N6U@"]
M^M 9V0!NEPZJ[I<2WB:C>CEL'[LC@751N?;54.-!3+/<.BN*K TPNN['DJV4
MYAN=:$[@AMY=]SB+,F/P*\ FQ)_CTP^$4<?1OB/7QVNA U?=W6S]RJK:/JVZ
MU&8Z^-F78-.R5D+H394>9J@MPS:YL*0#TU;\AC#%5<1GO7>N*@ Q-X,54/&J
MO*AG<GS-BOL4H$B+9 )+'WJ.J!B07/7X&0:D1V1MQ=5/2*<I+.0=J16>0)"4
M>6X)E/3II0*HT,LU<&FV$=^Z4X-8G<T96)7.C%AW+FZ<;;S#*]_<J@!;>O,7
MMU#%QC"U!6J]_'[;-(;RK1A*G=R-WUTUF$!IB#YP-[I*^KGK$;O[UT\9[FI=
M]L%_1OF^Q/D#AN4.15CG*D^YO0MMH0T: TST9;<(P/')TGS[1[E$RV77CU.W
MJ#?O@0JAIH=81[<_'%#_^D:/?V:RHW.S8M)@W2NR!H7/J==]58YZM.,^"(;8
MF\=A".#AL*V!%<! ^IDS\:JX_G+?K@+\C/.'&0]#+T%I*W8PSUY ET1V>JM9
M70(>(4"HMHPC3B]K3FD@1TCN*[]AGM=!NC:>;Z5'D NY^JB0T!&:1@DJGA;=
M!:1;<[!?7:'N6D:N'R.P%BVBGEU!FA#M$ [N]?$'-?;H9F:TA3DOGJX?2[^C
MB',-B1*['#]'[D$YHI:5&Y8(%MNGIMVN^=YRO<^1@;+(G1Z(]\1Z^0)+M(ZQ
M2_"K_#XILGILDT+R(^[>]'.3P9\YWEE3,78::7+JH\<M TJQR<0I1)Z'_&U:
M>TFLUP;DPP"2?9(YQKHVNE83D)F*\ET"TP(J%P<<%KXUNKPJY=V>UT3 "_'S
MV%Z[]]5G5!!-&1L(_J=R Z+'1+D!/3W!N]1--[OJU7"(_X4*R/,:"X1M8BPI
M'M8_&*A+TY-GDL(E#3A.F1'8]F/MJ'D00*WAZU0=P<J44F "U1R2>Y] GUFU
MN'C&02#WXZGA7(.,_;$9$+[EW$I=H3Z\M%OCT_<NF>6[Y_?6>'DT!&%7^2>W
M]O/+I6S8P<4]&L#N4/5XZDD_L.GWO2K@*RJ3/#N!LU-@/R@';D+;I'U+N,_V
MSKJ5P->4^X1[/M:\78.08X82 -X>%HYJB[Z-6I/9,1JYQU&T/-\\-\-IFH,P
M@D]E\@\+J/81ZZ[XT@4AXN6Q1?*-?![ZPWE$=4S-/,LYUZ^IL1;O=WTX*S7M
M<9=[8\3=EG)4R738NFM9B>X!L!<I8R/,[CD'E]P^W,XOND5^7MKZ>'F*;/#L
MV)!?J(T8I%&V &'@07GIJ4\X&*J'P$)81X, 9;(6&-XJ9JELT#>-<)+C#J-\
MDFYK84>VES,D'E;OVGMEML52J@%J3_83R#S1@SW*L$6\) &IPXMR;!82;]#=
M-#F*QM8?OQ\D]8!?)\;5U7:*O3__..LMY)-C,DZ,HWM),XGTJ?T5659;CI6,
MD<3$!KW>.'ZN9GQS_="R0-)%4=;-RX""26J;NFH< <<%>!-9+>^SWZBJ KVN
M=PS#M,!J\^NNGE[9ES!/\SV8N$.< '.:Y=\BK]4_N*6K8GPC@I\? $K?^VN'
ML (4TRO2S7?QKXR#/K0G(,SE+/1-I"$B2>+]HZD0/PFL)?[ D^/_6U$:*F*$
MM?CO3UP/,)4-R?I.Y]0(')W[654E>8X($0BPZ]\JK&'V:L_V5V'-+Q^UL=>T
M:;LGSY,B"7!6F-^..K!U,J==)(F7R]"*"+[8(?>P;G'.#2>)]_'L>+?T[]<7
M09E_B]!UHUV("_WACQ%?&ZSWN7'*=3N%^#MHUD9<6F9/1#MXX>NT(%YR"5RY
MYDSR2^?ZO3T'=C['#N&$>+2YWO7?)N8LLX.AF;&XBOY)AJ 9! M4CH+;2D5$
MK=NE+ E67=<DUTB>QYX3%9\QGCP'Q/7-N(:XW4?D#"EDLFL3X(G\%CE0Y:TC
MO*,%DKI[!KQ>PVOTW,#,Z.I?8<B,D0;:9;O1?T5UIFRZ4T,ISE>+/KQ%;=JQ
MNB6HGW>!5[[QL3X^9=%A7(3;##\Q<[8(]SE4WDYGK.K]:;]PW;2@FN7F=M<H
MQ-\B4WL-?FY%P)LM_%;M.GA23D)KRS7RG,B>76KN"_ZCC#NHU[R8E"6<((Q9
M)?F=*UW=V=AA(^D_AGS7HR@&G.NP=1S;;MFEM@PEVC0C9ZQ?!G\->HE@P%=*
M[WL7D+[DJF2(ONR$C9KX^NP[\74,1ORR=5^DYRN7$<]3$YZU[J8IE4G3K2*5
MWJ/9FXY2A['_&*^N,\HB O<):NK91L=5;W9@;R&JPQ-IU;B6Q@.R\B@'/=HE
M<<8,5_HW(VPP"B&"4,.C1!# 5EW&?RZ4_P?_P7_P?P\;W*^MH_^_.^7?VE[S
MG-0S$6GI>]K6W*?'PAA4:\P(??]Q10*8W$U0=OXMU+EPCN!C-ZGFKZ,2AM27
MKN@[BX@K9.HK ]@&1RI\>9YIN;)"QV+%T&'UN9+H.8,TRJF5M'89,MAX\YO,
MR1DR! _5<4[D&V1+WW[J<>UO$3V0X,5C;Q.-$;6\K;HK7QKK)"6\P(DY\^&G
M38J@HMWTV^X=EH56'V0O/GQ$!RJ<%[N=:TLN.8[YRH>ET-5[RKI:>V(4=4MQ
MC?N'8'6%!3917C]*5AAEQDJ8\N3YPYJQWQ?\9MN/WGV<O7A?<(?YUZ5)NLPM
MU$QGL^I.9MS(:XCJ?4\@23]!?C%B?BSGQ/HEQ%RBS9Q5&WRW\<L84+[F\_E9
ML-QKSN^&NBN^LCFND>,N<=9+S"YTVF&:+M.82FA+C8'J_2%?\ >)O-J5"WD-
M?_Z1[1FB/@J+Y48Q04T<PWAGZ J"\$) )O50OL73^=VZ4ZUA$LN.N1!:0RBQ
MYQ++@GG6](F]/LL)-U<8WR;T*-*7' 2/2I8GH?ARIMTLI]R[&"RZ#E,S)K_5
MD#8_P)J(^VC%?X:[H4/9;27[[#X-;$;(BE5HHP;&^GW8,=)AY1<,:&5ZVCG7
MO4O/8 74BW4G'*$<%G%VG&J;3[W0)4W42TB%" .T A.>D/R=A6](&B44&XW'
M'^W<(5ND!&EU-__A&G+<(T3JG4EJ1 PCAK A5__@@8;7]?WK[D5%'H.Z?=1U
M3&_Y:L0JPK(X&96F ,]OC*&>;&;Y@X>\-]/)^]>ORY)^BSBB\;[P2A93?(1_
M#?,D?(Y<N-2_[MP;_</')MC,1IV1Z:+/<;(VH"M$.ES3X%*5+9?$V;FT10%W
M),6[X Y0!R0M900;#YAKS _#B*/.+!A2<L^#54OLIB6Y].-I-CIGM?+ZJ.BS
MXD3UQ->? 7K.S9,TW=LU)=CS$09/&KCVT$97.U2_Y*(?I!M\HAAK#OXM2LEP
M5/>+KZ!22'FMLQ>Y8N?E>?YENX6-TE. ;(BV<_]WN*GCU>W'/4J#F/LE8-F\
MFURS.!8JIP^8R[S*_315,X&K/FSF>QSY#N6HE2<N-?G*DV#)<40]@."!UC=T
M2NFP/MG1 O+XX-,6NKDL+UQ?;CEQ'9.[RU!L07 JL"]T[V$'6L*8# >C#+(B
M+[!E<@8I- UR5 53TM[QR;T<3_2 %;@Y*%HRIE93ZP@3B4 91W" 5W#O-M*,
M+S*S+K^B@_[B[^\DC^)8<I_N;/7/#:^].B6E$.]&A_NXQ-]/OAB&>O*V PPG
M91FASH-18'S?(^>S1=@L"VK[_BM*=WA '&2_;")WRV049V2!&%IJPF\P[>A.
MR@Y5E66G--C*2$2?QU'XN[S0(*78EW!=8D13@Y9D&%5L.H+?2,S3=#Y)5>H[
MR?3XO'.$L"_*;3Z\D-:#>JR4&NJ&3&Q[<=[<X\RC6M1<I.M0=%%9HWU*TB"_
M0>5I"FEJQH=J*TLADN+PT_N[[*//%09O>-_UJPGM!@\O?WWV^U[4\1K(/-/>
MP"#DR$*,IDFEB=NS^/1;G<R2).+AR,ND>CQY1CY<22-SI&K:C1YCE)+7J H8
MF+WLIT*6CY[OO:9"HC$KE-CV1L;83I<<GI&<R7]B[[VBFMK>OU^W;AL*;H6
M5!40A%"DA(X-Z;TE)!2E0P(H)6 "B V00$"J$)JT0"HUA*I;(2!"0" )&)J
M!"$4$1 !=1_W_]R\%V><\1OGYKQCO+^+[QICCCG'NEASS;F>[YK/_,PU;\_H
MDM)V0/=29-R;=F,=[P7,2H6D#/Y,53\$^)4M-8OU:LF6K=&%+=<OOX7*SS6N
M*>R0A.L/<$Q927B[WHNPO(M:D4[F:N'0=]VXSCOB(6"EYL@>.].T;(=^W"M
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MW^8TJ5F&'6,Z%40'8H8M32B0EN2[5*KOHW#>^("*) 9Q3:)4)4 '=+SEA.M
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M=<*%5V"&(C\D%'?"CR.%.E@/H^<6IVNLPW$$T%HL.[I-ILGCQ)V+SBV%!T9
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MOB+G^JKTMF'Z)5)]V2 \KW3S$B5H%..C/OZCA7*/]X:C?8H.0.LWVJ0(,S4
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MH=CMWYR97)@6RYYYRAUUK\R'[S[NE5')#<@60C"ZYXP+]HY8Y_X,&#-O_.?
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M0$2XQ\(.)LOH7[30[>^D[G.!D-UZ+T?*/<:3M$._FE:BG:LCQQ-F5<!W7L'
M5RZ<RL"]3*C?,.D_O\M$MGEU3+BL_0S^6EP*:3,>''4#.VZ"GZ ?O4)_E;QZ
M)K<'UKP2YT#N4M\;7="O3@[:JLH'6?Q?[+UW4%/I&\>+!0N*!0G2+2!"(BB0
MT,$%I!-:"A"*TDDBH2--7-<%UM"D0^@E0"H""1U<A8"44),@U35 %!"4+M:[
M._>_^_^=._?>WQ^?F3-SSIDY\Y;SGN<YS_O]ZCE#:M9L;EV"!)N&R$5#M'3\
MY)TP*F]CGTTH6H?M5/ZORN1__/^%ZG+ARJ+V[,@CE\RT(Z]@CAH]FWPPL<$6
MDB%Q!MW'CM35X&H8.2?R\+]#V=:T]I(_%NNJV6"FT(SIA[KOH['VM_Q33EII
MH("7-!?RA_F9/@,[Q&/E:!6D70[]Z Y,.VZ\8Z' Y2&D :J*#WP&NW )L5&]
M]0[B3<+<ESCVGGF'X2S^P"(WWI0'[72Z-S7XXIP!_&?\DT=K=TV^PUMG95N-
MF%O',^ANZT[A"]T^<HBJ/2/)GC[D?58[E_!NQ UB;M5]GQ>O*=</7J%K30U8
MM37M64["%RO*LT6:I$1=3L4D_??_YM0"(_4^W#?0_3<IJ+<G*I>-.;5\+Z9.
M3=*22>^[D'WKC ^F#?N0D8X!O6[/= T;]L$QJR-O(53;9EU6?_<A3'A8^7HR
M!9NK?4:[55B:O!&F&XG/M61$H!C>@>P87E>M'/NQ1^/J8;^7D+*'_FJ:+ _=
MK2[["P!KA);!@KZ$JYZS:<UL+@NME0IH:B:F3PVLNPU6!O:<32R6FS9LG6&"
M;I'9U_. )V\:KF7.EYG961.:5*W^ "9.I*/?8D9C\58/$&9@A'5FEJ::,RW
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M94=:/X&4B3.C="UHZGGCH4XX/H6:(X4^\6Q@&\;#4 1.X-9J\-!0:$N7C9Q
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M9DD%G_<'- 6<&0.64!'$2X.,Q0N5.2==_Z YMK;WH?<UO;#R?!\"#@FL/K"
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M;6C!@X(L].IZ"^%@P/N:4L(+^YNUUL#7$QQFDJ\N9A$29)EGP,NK4)^)H5O
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M2Q4PPZ28S:NSQ6Q_GR9G7;N?H44<'"02:LX5PYL_;V#&W1R<B8&A8<U>[%R
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M.ZJIYO_S/'91]*$$I?I(4Q)06D"J!>DUA 0(35H@"44(O5D!"4TZA"8MD(2
ME-!!!0)20@E)Z*B4(%U$0$0?U]_NGCW[Y^Y?NW]\_WC=<^:>>V;NS)WYS/M]
MSIU/:K?-YH*HM:C\]>9SEEM^'OQZ+E94IP6F^-,TD4_C8)2'W4GIB-P!H,'M
M$+1^:%7N)P]Z,/1>-34;ZWXAM#I&\FFYIFC],0I<?I)38U:1UG<L54XH H+%
MTY58I1>4[07K2A;Q-&LO&D_@*J/XJ,\=%+ 5M'^@F+P7+<MWUT%*X]E6+R;"
MM!TI*5-<#27<>C[\A'*_ !@SGQ^VT*2RP[E.1S37PW5IGD,^]*'D8YS97@N
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ML+OJ8JD5 [9'MHE!I%VTSEZ*?Q032?Y55KN.T+]V+S-)R.^<)][0]X4O]6X
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MT/JS:,[E)U/?=X?%KB/V0W+[5&[E06GDR?D;B,=Y,3:Q9JR'4=,KZ=JA5(A
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MTIQ"]0=Z7C<?QOA4O>VSA\RNI8^^8R[.X-]E612V\K@T@P?-KN[R1&3,QR7
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ML.A/1YUMHD!(RKZCNW:7A(2J<5XA<!]Z8004V*<>V(.L1V+M#[(\3^-ZFYM
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M'\4[:?S=)Q%7DQY]-92^@G>X_0AQ^-,C.FXU[((5A[D4%YK>T_7#\[#>X5M
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MWQD$Y^0%-22CW1TNL*4O7B9=RFJ16BAP"14R /OJ\<F[,-D&BF'B;S%YS&O
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M60NI[5)U6XO:ZW>;:8;2IHQ([O[Q%".W2QUGQ8142\@!JR>.#\7P>H)DP8K
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M F&$XF>#5DS,82QS=:O1^[^MD+,H LF1 (.NHM$T=[^1OG18\[K0AON20HE
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M(SV3(3X-JZ*H28$?E014B#PBS?IF6]5!1[IL-%'9]H+'I:QPCZO(T(-U%[(
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M5]AB$D<:PO045-L,YQJ =3"MY.IB!?KU!*>(8K3^#UC1/$L7, 3LIRG<$"?
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M.9%!H.Z%QK V"Y6:=\GUD%*NB+K%J"S,0FF(UFNU[;Z,,!O%G<+X9K3521@
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M]>(.S!7UJCRXA2*DCT)3&.=\V V^@ K9AV'@@A9$[(0P1ZU^L1N]1R6MN9H
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M8@;\2W$.7.X".<*23S7N?!YT2)KO#%=!/(TW(/DV[I!\/'D)DOJU6M0,$D<
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MT,U<FF87RJ_1D/JKO7P>5[$3:V4N,=>X42"I"W"14N@&D(."6;A",:6X:X^
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MLLFVGK%ZE_57'-YF&Z;JP9A9MM*20#8J@RDK[$M_ZD#G DT/R#E.X& QQJ:
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MKEJ5&O#@I/UHB3-*%8V%4?JT"B-\#KZ;/%B%*U0VXV4EL \6:4-3-]2ZV(%
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M1S)=*5GA*E5C :4X1;C/U'1Q)!/*53)<S#74!V.XUP9FW'&.Z %'I"*[44>
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MLGRSW#'E$\3(C%\C[B72C7*V]@Y5-DL(]%CU_P?NPOW_#1CGO=4D/&OIOQR
MJD)CD;LW(-K_]:Z?%4EX3^[/AKC[OX^T/[NEML[W_WL/JRICY>:R@R,V!B[#
M_X.A_P^AX.+\O_]^^H_ORO7_ OXM*K;FSGNEB'I&D,6T;51%4.W0-]PUW=.
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MK9#$LGU3]O]F[_<H,"O8 +<+.QGY7P2E/;(HW;'J_W:4(VFE;+\X*YOU[Y:
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MX&V?<_%Z3#<,O7Q!YO6/++"PS1<&1&U8[U,C2#S]*B(>"X"S%[S7H/0E9'F
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M1^ A^2%XD:K2IOAA*L3!L=%D J-+MR9?A05Y\5867FULG)JLKNFK'XZO\EA
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M=>3O-[X,L*,'-;9?#YNR1)#.]YAE1MK4?VM?4QO<NJE),5K@I8#.^40FDT+
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M7*%'[_W+P>4B6,?^0R55'CDFL?_3O#I7R6(/IR4U8C^%FOZ&%#U.D5?O/DM
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M!4FOBHAE%TAK]>S 4RLU)2KL.I!CH^MA/#0CH9_R;P?:;$.P/0U*CAM9R,N
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M=75H)#\ES#O\!/^:T[!B_+?%VL'+58^TNA-/%K^7Y6 GG]F[<O*@J>J-GU\
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MC5JY<FK&_"0F3RK KO3"'[Y7:>K??_^T+4,*<7[]X7XLA?,Z;/!"SZQ\5+C
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M<Q@I;YI@JF\N?]8<_VP CS<'MG2C'&<R>D^%PKT:]\BY[!M]4-3+7F!":OE
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MJP/"9SW8<$)57PX;X;5 3*5BO<D,?% #^, =Y#7:/5/XZA\_Q#/+QS?-:H\
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M.5\XP;H;H/%($BFX>10JZ*\PQ(O5)02-7[CR8\+IBD4[)'6F2+2M[6U[.,5
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M9?-4G@"H1;Q#89HWNBL:/LS6JLD!<2CM&!8Y@+YWR*KV3-5?5&/)GEIF3U$
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M3((/; DDID%7%Z&;7P"SH$SF]VNJ%!5,*C3K!(?Q2K2B]I!M2%!Y0GS\0^Q
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MHX?X]I_MWO3\7,>TU7J0.6YWXUMPXDP': ^+<SU^\?:MV0;?<A&E;J\:TP9
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MTRS$&F :5U'CBTBM6%Q<Y7BB2U-:+3H !RJ$8DZL87VI3!N 4R<3G?AF&L#
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MK9#:+/;&QI^8<*X<43W^DX08*\XV?@@(2N58<PNUL)5.?*4)1AB7Y3O7PLK
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MN6*(RO1]HO]-9U(V.0O+JE(]5MK?;C18>4P=)./;NOS!8:,L4D3,Z^8LP0E
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M]5Z-4MGF<O[4-+I+0D\Z T5MVJ8X3 ;0152J,14;/<*E>+#?"E($$:]/G<*
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M;1)V'\5H[]U=:3\31W_C6I- 67O,C.E) '6&7<!_KN)M_0W849R#F]'4\R_
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M/9G3H2'_,!2Z2Y29*^RN"UZ*B[@!L:):[XBL^C:C/1*L7]<B(L*\R[5A]1A
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M2Y:W8D96YD,\,@P?9I DPAZZH9@ZCZ'9Y5^9CH/_]NIFVBSR*KZ2U@2MV@N
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MYB6)JSSR.^AVHG_S&]ZV4X;SKNU\1DHRO'@QSI=J9#<3,/YZU[=U VNAUN#
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M>=5]S>"-G^5?P*O-X<6;D&%OZ:BZL<T0/GH<C4T#"J_QH1\HS+:L>*FNR:@
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MC04G,518WH%^0,W.56IE[E:P'=UD2P6RV^.CRTO3V$'^=-I;H)FQR%5GU_4
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M20TK"6): ?/G8\V38<7>2,;=8%1EAWG3,'0Q%=P%C.0]-9FL'G'Q)#2"<-;
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M67PM:V)TW]BE7_OY#:!%(6[EAA1H4@^NM;5G&)R-3'M!)%84P&";M&I:=+A
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M9&JDI!M7-0T*Q2"?J0_WOR9+,5 #R'W+P_*'2R[TXOR; =4_];GQ]@Z7%B3
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M4D#VZKQID&$G=='?Q-BZ,]Y1GN!<YDEXX]*[AX,^WB#<UCWOWU-@&9L8H_"
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M\\6MF=/M(C.?H-K[P95TL_.N$-I*J [57\.\E,"?D02IOE&,,2U2%\>=9C)
MC2/KY(, Y;/6KQS1^$Z"/JK=' F[[E1?-!.7&==RQ/S"P?0([3LDF&37[:,X
M3O>,B2+*0[,0^-<[M,AOL<@.\DB*9M*._W,3F3]#&.W=O+],T?8XN$*998Y
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M?E$61YJ-K(O_V!>T276->4@J?8@VG@%..^@2Q+-46A'LNLB24Z'!()FTH5T
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MO]9G@B&0V:P/0;DZWUZ#AL5-XG,L)G Z@$38(FDNYB;"6C#F]M0,OUXI2*D
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MR^C(W?N95_3FFS&TD4CI8N.,O$!;^G6% U2RFX%%,I"*KQ@=J:.\=85I^/D
MA2-3N_"D9*Q:FJS@O5X=]DEBE[8UN(LH9E=6@=E^@^BO%R=UC'JS?0/8S!#>
MM 9C'Y)F)8*%U<(1E2_B[AOTIBH&$+T$MOE49^A^:DI7F4^AJA+;,!'6.?F
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M!E*'3B.@I8$T^WI>&X%.% PD#G*+#VQ;)QPMCR *XV"O%<#%F>GZL)I*^H7
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M7 LJ;K]/%_$S<O3L#ZX$YV+!0Z10L#A5U=>R0^>^F'O)*.Z]RU!/XEC^Q*R
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MX6+!6ASQ*-5.3\SJ11P :EQ86=7ZGNIJ]AFL&!Z&*:A\XNBS;76Y *X8Z$R
M4K\MXAFJ:X.YF;K&_P#G<_;HH"2<8H8Z%U'O)APL2;W7!W#^H&HCDK;TOMP.
M"+M1?8,BDIEFI;-)NBP1K,_X1>,]5H(C+D7B!Z9I!-^[^,J/"!Y5 ?C3VY@'
MB9XXRT,:5C_=/N,\"I:2S^E# +:[EZYX77]6&(:O;P3.9!DYD4>A<!'W$L2+
M;^4]EL]%L%@M^JE#'*S.L*)$71G@9%"E(  +YWMAA#B7=\<+2QQ[F.;*)-<-
M#^-P9X&+[" U^@]XI@>FUR!86J\'>%!1FC;ZBL @3=>@2K%M/ET5#9Z3>1D7
MK6MXI!VP=[CK?'UNF]Y:]X!&50=EL.+ ?1VP] TLZ68O.BA5/ACBD:^Y7I",
M#=1:-VW#I]C(.(MNPDL1KOX'!/\^7:6G!CJ&X#H7?TH".!.'J?L+B%8*[M.M
MJ^O\%(B0#F^)F)!VD5RD1'77UWE$@76W*BZ90N42JF5DSON0C^V:K)HL@WG!
MM12=QNY0(]H#7A1;,\I$L_#C543\YMVZ0\*+E"RD,YO=;&50+T8^?1CY 7C
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M \2\_%R(%PUQ[7+9J1T3Y@US<VWRXZ1$$7:-%X[-QM*$:U'+)-T\SVAQ\_S
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M"7"&6ZZ_3<GXH++1S/@!<0FC&FXBJE??F5\EI%*3SA@"I@ C-35$8C&MHJS
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M<D-Y A$_HM_R,+%I$ZP)QL'7T]!7/0.^E@BT99>FZ<%7S-_I_0T6>W$)VKN
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ME-PZ-?*W,D<UXEVG)=6A_;5 $L.ZX2@S?@ ZG8!ZT,!R0,!+VF+^=G- G'2
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M$PQ/DZ= 6DO@53 Y19E=XV;K2%,5ZQ+V64CKB[%-*="]T[3/%K]90LH\]A+
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MG0,59/4\_WO7@H0;-EK=N@[0*V5%$PIY BH'1G0;:Z0>G['QN BK;'ZS83M
M21ZWU&NI91%$:Z'?0)C5LXY_=%#CLB(*D.!Q!M';X."SK=./'<0$S*Y_D2Z
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MLF?YMIDWC V9J-3\6C+7W[06-F>-@')PYUS.20&54QP6ZZ47INA-#UI$JME
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M<UT+,(K<@2]K17UMOZ-;%K:K#-/XBHA2J>"I#>"BF4<HTN!/,6]8];W&%>Z
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M^B\VU<2Q>C;$6L7G'_Y,=\A(_N:TO!!W>,GZW(U9OT :)M(\257).CJUDV+
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M8!Y@G":/5CFTV#YR'+?HI3GG17.@_<&8^2#W*S"O4J&"'GPL%E\^8,O*%CD
M$+#2D)I :<A88P*A?JS\D/&! \'PZIJ#7LM#L^^<"!V"N.B.HO$2UP&I\RR;
M;KGLFXRH,J%W(8L,%(0%9?\^&V] $)X*:69>>%?V"UV*"4^=R&M$TP3>+9"
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MV)_-41A'MVS%/V&Z9LS=DU*L'GBUYJ9?:/A\"[-;_%3NB8@[J*S0RHY)?9(
M,I?&1CK,EU'/<^\A]V:/1_Y2!AS+^S[^Z=J3GU[J(9<&L3._)6.OA_F^R=BM
M@26'A2RJ64D^>I0IL%^42I9CR2XSE1C>.<^?7[\$6#(XLOV\!:?RZEIR-+'X
MCK+L,>WYMJ>]9C]#1!.*>,OUL#VNAYU?+YH6OVTU=?EFX^K=Z4:X6WR7T!-<
M*0L>F(DT$773/;;D!'^8MN9UL(LT6!]*H__A>7S%6[IE<^5O0XH?_W:=ZOKN
MT.04J7KD5OCIOI88Z=.&AU(S$:'S9=%:5=]IQIY#U[9F[R_03_Z7MERRTF*)
MZ#.P19IC)6+_,?O#HPSY;-KKT&5?M>N)HY3?5PA/-;2AXB.?#P_"PT$W:._M
MH8<>O29KBD&4# RI4@KA8YS"+E!B9GQZ%H* \3^\!(@D]$1;H5FX<VOF1?1*
M]>[*TL/9%:Y99VD0>N+_,>GN7_5\-,OF$&SD?ZP.Q051XMCGDJ-2"LW+6>3+
M%S-(U49=^,BF^&_5K:%5A3"!B_YX[^&LO)W9SFO\&^A3$UO29WU_6R9WW8U?
M6%>Q#)9P8+IJU3DNQ8%NQMA[1DDT1(9TV>.5E1HW9'C7'2=2A,$^E9*6>12
M+=Z/&]N=+]'!>71CB)=ALNIG/VJQPW%9;,,\]51#!4>1XGOT,55U8G\[1 9"
MMR8ZJW**D2;1@QM^I.K^_%VEW24 [PK1;K2AM):KTN7OZ/NC-LWJC4<&E#]U
MBY.<^B0IR0#Y96$DYS!N=.PK 2%A]^*+Y^>94UR5O[Q]"AW'+T#2O0<9'_ZR
M &WE72UU3#=0N>[XNF%DE&TJ0MT:>+X-FS'315S9D>PYFIO7^*LB<8;"I"D=
M9][N5_O.B:TWB&;EE;NOV9P]S+SE9O!EK'4A!5/(FA(SV5;=J)CH+DW9O[UF
M,VN=Q+',B7&F'7WBC*4 >IC.+0%U?1W+-7H-;=IKSBUW/[PK&406O2KYEK8P
MR74H]?U]%2BL_'W\$;JQJJDZO1^1KA>,=IS/TBTV^=Q^E<_$;;?Z#X_I]ED(
ME3O>+V;]3$I>&ASQ_5@29+W_-^/4)?7/J.]6XS;F]K'LJ(M\6N!%'>4DH_7_
M*L W0FE! 8*Q[+QE5ME\*,U2$OU\0,X6)F#8A55918N2U;J4D4=E&+IAXKZ"
M/*L*"K[_$"@GGW8^-02H",:C2]I20)U2$LY=@3FTJ&K&UOCZ694=;C%FG]-H
MN@J4'[L51S5F+L#+E^NWBB_]<EAQ"/W[$<ZAS@FON-VXY^G\AR>8X*+S[^>'
M:0$O]3JN;_&%QX=(7>/]RJ]LC)M0V<&QA#ZW"0NV*13LD.6!W=1A]YS#HQGR
M&4$EB2D3^@HTWFMPP9<4!>*$SJB8PO3*5?,"4M7X\#J[G@Y/7'>Y=4P1U4!>
M.#XW-/1]V%]$(_2(HO^U%M YY+9<&_W*X5-9;[%%UWC%S\8QEHODM[EU#1=_
M849U%HP+K9/TT$*?_NGYY.H5-?]NQH/KP#_O)F(NVSCT?5Q8\UD%5ZV)\W2#
M< H1PTA].A\X#Z"TL%255$&O_7[:K_UE^C2JFXB4ZA\>FF^JK>)I6Y;2PIT[
MV#R6,N)J#WBH=_[UVG\5K-VL6*-ET&W2H<%:ZH/G_$$M"541$F!3TJJ)B=[X
MM; [COCKF!ZJ9,<RS4(?*]V%<BLP)+NW>FU:GC9.=3Z(VX7^:FB;:/T%EG?]
MNL<6YSQP7 \ PY^'5>67R3-ORQ.G/-F3,:]_?18%=*5\V78:<ZS[A%N1F92S
M^%54=RHS5P)_?95-\SBA11,:O:[=9<[?A*LXF1T^F8G 3ZXC*P-5>Q#X[?!=
MRC^C*L95B6ME:DSGII8CUN#4"/DO8X>5=CYRF3[@-],<VK12B-.F-%A6T2@T
M D&C]<Z_F+?K\G5NF+BA69I_'DY:K*)&8;["X/^42R147>PF_2?PXM-V2+EB
M,8(<Q]YTFO'B5[01LXC:A"7.1G>@F\O7'3=A?>\GL)O1-7+[;9YMLVV(]"_?
M64F<#)M]2OKLN9EZZ!MU3C#K=1$V_<,RA=[#27M&DMR&&3_[.9'F19$*@_+E
M)ZN5"2GWJ+RK3C5*PQMWA7"V<F1QZZV*Q+R+5@JGRA'ZUJ]QRV9KGU\=H1X?
M R_\_F?8>F-P=K3M4T?TO8RS0;@\:3 NC=/UFQ:72;MY+Q36B'FW8S)&UL C
M_T\MU/Y__+\$R_^TD65AHS9'=)]I/$*Y/=NUEM'X!!C#C,L(>KA:+"0'V4H$
MU%R2=/[0V1<\O!R6"J!'\&GN[U)G)+>=TJ^?'$_'3LRL)1R\9/V6&&^P? 6.
M]=E[!#^MS4(7V_I.O,:##^I=_HV^?Y+3BNUHEY-"+E$)@8+ GOVUSZ2%C)2J
M+_$W1SZ#*(=>!U#W]F6N:]< &[>OIU_7=/ J77UXIW7<7\+>>U\C:4SW2"4\
M)DI3&5G4]O1EN:%O!7&9=&S$3 <V_(_9]&5]A20TCR=L3*%_-)'O+OCE6 Y!
ML-.4J9/CKW-?C/\"YJY*/(^4E]+J;9$*,HM7K/#5!."!:/4EQ!9E2D57S?7I
MR 9ETUN<X759(<!#!Q-39//[N&7Q].\L9."_-3^YOT#C5OA*A@H]2Y]:Y.AH
M43JP5:OG;GUD_=KJ'Q[(\)B>\F+3P3W(KOSPR*N$^)$L70>)NF^-,6)O<<_2
MRM'N %=01<+Y$ON@R2A7]NT8AS Q7KQ.+ZR"E,/0>7G3 #_MBPP[?SYK+XGC
M,D-Z\4F^&J.\U F-RDG4N^ZO&?N^&F4<Z%WMI1U<3LWO'*G9_LTX^ZWPQ(__
MA'J]2Q?*,@3:TR>[$RS_6[V)9:#Z9VH':X4,[C=N'S*+V\5,NIVX_Z;FS$BL
MY9CJ3_:*V!&N)27$M?VTX"K>I%%E@AJ %"MC7.P&8O;%6G0R!#!PHJ)9FX+<
M+2$\:Q4+/PY1<*#I/.>K4&2"(HAV_TR2^]C2T<'#_V9VRZH+S><RF3S_XN"D
M.G0?)N#?A/1,,3'289PNSGLU.-A7E']GX_YX?"PL=3_X-W@SXF2+$&#AVKDK
MEK7]#]906J292T) O6&#F]O.@)9[-(^):<"FBW5R:'?*O%'*;M<9#W?0W+;@
MNBSW"RPH0],_3!XA#0[3L:*OI>:.'_&>S'4PK]Q.P6;D]7CP@B6'#.G;1B;'
M!N[IK(9>$Q+V^B\6[]QE=H/*MZ:"Z?WCM(C;5(O<W97Y2S'2QM_L'#3%XS!?
ML>C&&P99BP;'X]\2L1SU70.;&GJYQ@)YM\FB5WXPI&OP#X]/!H!KW1EH8'[Q
M,'@W@$'\1102&0(L2BENF4X4I@R,RU_0EC8VP5SJ=<#K[6N:+EW"K_S4_4CV
MGK#T_ U8:_C#P]>(\NG_.T:.GZMYHB!6[?$+U!OI&E$[M2U!VE$4?IVN-/NW
MD\U\CA.(Q/TL)D2S4Q\L))N^ [F>/EGA>(!M2>&732'*U>.W9E)NG\RJ_MXM
M(.&!HP42GP8]<"@_B*P)+I03O--G=;.*91>"A].2GFA."W(P=K8-OM%G&;+/
M ZI^T%0"U-*0$B..$* W66*JZ!S.I-?PP'[OMS!.^B-@&.?"[OWB(?PB[T'0
MW%>O'PRS2*3^A_?7@&L&N^*ZG)GNL\Z\W8K$Q\\7E@ TOD,"K\GU*:QX2NGQ
M-Y\O?!QE154>=KDA_3^[;G;@3-8LT>QHO-1]"Z>6K.%&/G.JJIL)S@K[9/O>
M4R&167Y4%M5$H(UY&]K[/IPP[_G@Z11(YS2@(O7^KU_8=ZWF"T>=<H]MVH<&
M"NIEG,YOBXU'Q7RJ71]Y\Z/1(&V4<>'.4?[ L@W4>-8W4^=3PHJN.1[1=6];
MQT<_8A4Z=[;M#YS\/?CA&S0C94@=S:BP [ * 9I*6,FZC%E27O-R"YW?>L_;
M[<1EK>\+N0>P;T"/B#Z;1&5=)OL&<THH&Y'+^1]MEP_]?3MM(S]ETDA]?QE,
M;NC-I[\F1A*FC"=J4X3TDU;F/*Q+!_OGFGZ^:D8U,.; ^7=.?'<@J2:X9L&@
M^MX!QF$QQRM"?X#E/%YO_I8^]KPQYSO,^9N[OGYP+VX_IN9TM\<E7V94:HK'
M[R&<)9^#WN<*A/!A4;9IYK?1U9,Q48(>A-CQA7Q".OHJ=BQ.)C+!.,HA+!+1
M1@9W)F>X&OM^*!Z.U8W?LQ\9G+GL#<X*BF=BS";KG2*FO)M$]]ATM0UYBK_*
M+J$I#HJ8OF$:#T-F4,]9T$=OOJ2,=J4ATE1>7GZGP];6Y50-2V$>CRR 455]
M9;6&%)TB8U*?@[W )[-GS23\6;:_[#2NF;_H2Y!+6O* ?GY:FF2>/H45;L!N
ME"K2!YK43TX\$9<4Z,BL\F](ZPK50#.,;1N?\(\V^"^(8TJE/-BEIVQ%MZU2
M;A<Q)'OZ3H'T*X'L7E<A78DOH>$[">0/1HJW/DQ+I&"]3SQ21FXOG8OLSR6'
M8,=Q0]F2C$8-?IM"$Y#Z%\USO&OGQ;I:GU=CRUH2P[&\WZ>X7:%OBDPNZ(K4
M6X98-3[/%JR;+&0KTLC,P#"/GJ6,--JM:1#FJ+BQQT1/0W54EW%(O]T8(9)F
ML:,Z3[9N*(VI7[/1^T&^3/=70(6(P9_#33+4J7)H#SE%BWRN"?#R)/@V!NI!
MFJ9W(].>DBH"Z/W975$\%+M]JFHOA]+/]::;%MM.#31O.HV&T9PS![$Z9@=4
MTT0GW;1NS!=%.!S8Z4Y>-=8M^^H/$Z)0INSV68Y?/?1/1(P>%,#OLI:6'U[<
MT,\)4S>RZ\ZG]'78!2]8+5TX014P&J5% 2X&N:=XE*E_T9F9C,"TM$1YK5CX
MELLT^OMW7*XBR!)5M,E?=]HHY<@L?1"]V/I(-,)XNNAM9$5E<%M>5J"4"K*!
M#!?2I^%&&E"\%YDR5<[)D97:KTD#;XXA:>"/;Y9K&<SF=$GU2:S2S@)-L8L3
MPPGKC*?Z=GXB@S(W*JY@1+@MA'35[C39KL#:#I_@1?ELW]C7&*UVN[]7M)G&
MF,J5#DVA.[DXVMZ-0NJ+&&.O09#&\H#2'9!7[3)$)^^,*1W':G3-XFF<1*R/
M PKR9I\\BQ;Y1FXMV"-V((819WW:CA-QKWRZE*89_N.XRFO]D"MR4K9U$$'$
M?W,^&/-%/4[H%RNL_1U$?NV_&9+LBZH%;+3"%GYX9^'2 *;CDB1Z!QI/J;TF
M^*&"X/&JZ)W?N-1NL3IK)7>9--!-EAV@PC-.&& :L=RK5>^>*2(YER,K%0\E
M->>1L=(05H+.WTT?R$0EOCI\J+1<\I],=RHS!8,6HUBR%<3L93( _SF8WT32
M306?E) ;6+RO[><-K\\/)]LP( - >KJ=!.VV"*Y&UO9BUF%]I-82Z#07:(PA
MMQ34V=6FDYRG%)(B2;$3MG+09.UAFBU#'U].O'TI2(,U0@.?"T,E2/GZ-1DV
M7 E:M+<S;=1#X(P9&,;H1WO4:N;99\F7EPL#FF7RPCIL_6:OTG2DKN2T^R-[
M\ TC/QF U//P7N&E^3K]"95]OORT)/8)@UVT"WFYOM *,]+K$!P#7VZ@.>"Z
M&?.,]44>>[.9Y#1TB[TE:_DY/"*:*5O;RX>'E*M/8YQF']E7Z'%&M"CFJ4ZJ
MTYA%B?GZA34'VB3!5GV&P/S+]F3![M=>6GO.U_FM+ZDYG4(#@A 5*27WLHN6
M51'"=VSAQ.=V\L4 *XND3WA201B04"I[M?+*0Q*=-4O_P<DOF/D@:V8&A/MQ
MD%/PIY]68",56-0PGT('GEAOOVW>0NQ!>598+'YB7&C<HZHHK;YXL0CS^VQ_
MD#1T_KM=]NP$/6YH'?)B@:'[I [4=8SAY+@%-$XIB"3Y?4XZ>],9W9=7DH9/
M5P4:FMK^JTN.8ZXCSN R0+  <IF670#P2W 0KJI*X4?\S2=]S^MO4\ICB00\
M"JX@_XFF52[_Q3D%)39:?ZL3(1@< *:Z6PL2SD8QHV3%045LZ7[YQB)+TV\.
M:E7F',JE*XO>C#E^3GDV%\0A]5^8BB+A[5PD*J]0,BSNF*_9_BIAA_NQ8B@I
MYM"IX92%F2I3C1@.RA\AF^%_] 7)?[+) ]GP3:LZ>.938/1X?:M$B).Y%(WW
M&7XRDN)@P:%5O,FF3E_5KD)\*I7'#W>V2&(UK!BT._GU3CLWL,0KVUCCNKQ*
M@G:I029POFHA">F5B_EZEY+D<Y1F\@LD']%Q>T?)D!)<&=W$M,F:OB&!\P+J
M,T+Z*W9")N@FL00H/1[3?\/WS+#G2E96$"Q@ HAX,E&2!QF)P4V1<.9 :@-Z
M%'S=&4^5BET*5U)#T.:F4X BXT$  E88XJ!!L,ZM]_?3!_X,6B>^;K7OY/@7
MT15(#\-H)Q$]T8-V3.1#2_>Z-+:P![S=L^KER]BBK+AC4PI<$U&,;,E45))Z
M(A;Q^+P_A7N?UF7^;U;MHWU("_XGL5EWZ6#M1?M!YKANF']S*B!(KZ^W-^^D
M-,,QR0-P"YDVD;^41?4!$H>7 C!3JJ$4"#"R951GI;<<<6P0=&/V$B /6P1R
MG8Y&J.I'6RW1YS#:%=UH"W\ +.KNVN7R.I@Y7U0JS=K_PD6XY"2^&KE'$WWL
M\H'T*KS$ZX "OZ9H,HU58WS!H"FJ(&I=FJUQ4':$E!.@YE1I#]+%]%P9_J-J
M$?;4@04>KUNC)C%68;,[=LC*>T>_N0K4T0CFK)Z))3:[6*FJN5SFKNG*'EK%
M#&9;89C;Y_%]V:Z^M5P&$3)J[VT=_8! #&3"GO6LG[10='KH:NQ#M ).70Y6
M<+:#!$=H?O%<<<X>U, M?]EA,/PO':HCW947BQ9;?4LT 1AZSQ.<J,]WR]5=
M9U2@:NZ4 ]:LFCIJLOB&>?5IF@T>^H'*/XBI[W$(P44_K[D"G&Z->4I9$6#Z
M?G@;?%F^(*!_+_Q#E]_$Y"DM2D/0_2-HV:BP,OVG=G57JH \I #9 RN@1OM)
M*)81MTNW@5AX '\L,6_-&*BY2'X\50D8G+T1C)FRUJ"_%$TW9UZQMC4[+E]X
M:'%<CZXE:\L5%POMUCP&_NP*V#Z,["O6  U^6: Q#8PD$IDW,5KU,^4 A$;:
M[J>W?WA$A'P?W..T$[<"ZI04QY:' %N7.N[>ZKCBIJ$-V&WL*#X3B%-YR;A[
M2JA1]9K\?!(#>[E\.O9U?Y=:[S33=DRI]1MKF7'_ ,N>^AF3\Z&OT[:G@<AM
M8'F.B> +DPNJH7L/H?+K[#,2K#Z&61H<'3[VFC )@\E43,-465?XD3>;3R,J
M:\"''MG)R5=!GJ\34WZ.O2;BC5&HT0#BB'EI@&Z8G)Q@ I"5.%I>:2?R72%S
MJ>1(V?\=V_?_%U 1D$FW^=?3.[V(E7D\8HL37O(>01/K9PL>>#]<:%Z*T\N,
M@CDPI73\1_7OBB\0 I4@!SW=M2II7&1%C/IIE=8?3-1R5>=A%^.O,8[CBE5W
M.51]DE_POMUZB*UIV*8-AI_!M'5*P:2?$(<&M9"G&E;]E%RK[N;V3CPI/7HS
MZ^0N+4I][RNESBEMHB*=#N(B.,527^ B_BD;68S*UT:G@,]'&BLG'J6 2NCQ
M'K9.V0H,8S?TGJ+JAQ+)2*K&#D]D=<SZDS#GQM:AZ!.F/I4S_CW@9OX%K364
M:W'8&/[SEX"<%%^%<GNJ.9S0N(GP:+G>AF$PYV]Q#?.L''L@9+FF2HO8ERUC
M!AS:#+&C%K*JC\,>LVG:X3)#-=,/)30Q@^^^))_T4/W.#=+C^*4'@!'SFZ%/
M\+&P@!(J'J'M#>!\WE.4/07*&RV?/E]CM=7VL'T =Z(Y CHRZ:M%RQQU<B"$
MMKAF%SG.T_.AU]L4LD0*M.,_&F0%#]G'A$MPB*7NE-. H:F_HT=SO%9YP_!/
MR]55S7%JI$-G_M[2VB=G\7+!1_C-5LV:J"NOP-XC'0B\S]AWI0KYY*CJ!(T9
MQL)OX6W5NI)IUZR*U7[5%,R5R#"R.C,!&?"QK#Q[!8X5^LM S4*8LBD#$]C[
MNF/EF2IKJ)LSP.O?9A%5K5")) ,,[Y*/MP)68\C>/#,$>?)\0.8)8GPI&5WE
M>R:@/)+HG7Y?;MIDU5^P4P$3X*O.*0F7$P%+)#<4))2V^C^%GC>.H<X=UP8S
M5V?DS&Q^[EITMHQ_R&KNBOS#@VOU])@YS*X(LZL,(6QKIOQ[N_;2FJO#_&DI
M7;5YHX-QT+RTL-Y Q[TU%'2O>DSE@'HS%9$E6\EJO7WQPW]EH4MAT*BE06=P
MGMS,%ZZ]4L64#MMQ,UE6$]&NU(/_Y-VBV\(I*I]Y47D-+ 3ZL)-M_..\Q%C"
MB[6?\-PA6S4[!;6@L/%/R^J;Z]X9Y*HC8!EF8YNP*%F1L[$+,YV&(S_-Y.VE
M1 \+7Y(I5VS(& 2XHDF'O M\:-*^^U5[^?C PDW(?#-1J7D-L;[9L%\EK4-,
M63A&$Q9]_Q[SES>4U;<@;)E1S+855(BS1DLS7&+L<$.ZYZ03=XK'BM_]#X^?
MD"OCG)NH[JA [=Y0_B/K'[;Z:_*BC6(-=7PP47>+1RD,&+K>=@IU1!*KX_PJ
MGZ9^Y%DN^'HO/G']^G[EQ9)]8K=E[7R%A!V /%_ZM)XOESK"=#)L8/6"D8?=
MM5<'0A!Z=O FKPI9&W,S)IP#"5_UN%%O?X6M:"H#<_>KWK'G.R![0A+[M2L.
M58)OV^'\@E@_XI!'@NG4-Y1SAYF^ \:PG&/J?(3!U9':IR]/ :N"EJ@1D(;^
M4Y=/8<5:_%/66QT(WY2MCOI^VT2EY/O?;W4H^68A,%",S/;1]HW9O!_*V%G0
MJG&N90AT_E>>KSA1Y:OF2O6XF@ZN^L#]ECC5H%7^C=0E/Y%Q/TQP2BSL,.]E
M(H-'!^=E\#]^FO'_RPCX3__^OB!LE%?MND1J8H7*VT6'(5>]UCS\=34WLV\X
M%LKD;6M,EQ1 ^-0?'L5(IWAA6]\0>P-_-A]3[5P1'>_/RMXY9 4:W2T^\O21
M).,M!N_S?NJC>_O1!B&;K ]+\#$[TJB>V<AE<:I7J\W J[C6[IFYK&W\%(,K
M=YBFU1=>I\UV&-X,I04MYL:RUZ0$6(D4S_&GG[.# ^T>N=;,P2/WO-M0@ABR
M2U&*E/]&C%1Q4(L*$P,*0BTG7P R1DS[<#_PJN&LW>S7R/3"A@S_\//N9*U*
M.V.MT-*G8OBH2K!&^C_AH^N$LMP3_YGO_5>* 7//QO% Z?EWR2R;0_[E@O3_
M38=93,=0TMR8Q[11,*_R!3&TY%@-4A.FL)ROY@]#/RBD082FV[,^2I\%RTKG
M/7+MG;][W?APTEY-0;OLJH&'.3-2.W'?"CA:I_?J;\!:-UVF?C>HV/$_H*:R
M/!5#XQC#WR*6)]V*^I%/GBFL1C?&$[T]+X[7?W-=@0O+MSIT#%R :U?/6F_+
M3'P,J*E^8Y]\F1@^DI4:Q&@U20I!<&RF00.AQ8!G+S3C&!]66E*+CH&_JF_;
M%CW=4^@U%W];C,>=:PZ!K=?<4%1WI+OCD#R6_ZTBRRMHC)%*CN]Q(>5XA/HP
MBV>'(:ZL#X2RW.^?!ZV;0M+:,!JD?R)@&\R;4!YVR/F+DU:NQXD@N\Q1X],9
MF> WD?T6/^P#N[%MET!.T5G/BS3>,7T0>N\&;9>34]-C[\T%B]TX][4&P%%O
M;,QJZ@'O.22W:M3U7.IW,X@<ZG 7#A9JMQ:&3!1?2'F[JU?'A#2"AQU[N?_@
M^YL:-78$-AW4L]#RA]JC;2,, M2GO#SJ1]6YH?W=V+%8T)S+P!/_$"F^,>2-
MQ[28ROA0AKUU=MN4D'0>\:[):3X"%1RK67:WT&&I>IXSZYX")!8'R-IV86JF
M 7N"*R2JM+45D/==BMF_N&"0#-?(.:F0T5Y6^,!^I:M0;V"I=.LMZ/"+.#C#
M@TAH^L$H-880!"4&KI>$$\IP',[Y&PKQ& CP_BUD^ 12@6>:'H_^:O.OJXO\
M+"8[WQQT:AYH8S=1U*: 004(BU!Q?T\"IK](@/E7^I?[RS_GT[-I0SOY'GI\
MN,Z7WQQRQ$9@2H,MWUSH[/A#(ZHK-*+'[PJVO]7KWB*5BQ*AI @,3V1&52C^
MX4FZ&9/PG3LD%%D_F/SZ'J<Y\&QD7FE:]_>/#.6SC Z!EG:U<TG9/:-S+WI7
M4>P:_&JPX1"XO(0*>H1B5G7[]"ZWM(D\P&U=@NTTK_;II>E?ZL GWK##[P:>
M6DU6)<FW^AC#!IIJ[+<JKASR;B^_4K61QM4BA$<;UVS*,BW[<;C7[@((J?8Y
MW?+N51.>RB!S8\A4A,!38I#1F ,-8R1-#[*04K,P>Q6=U>=\MG=??,45NBTS
MRTQ G6*O[@0GM$[V8',]+XW6%_7$'75K-^V>/?MUIZ[O[MI;1J9*'_OKO:XC
M_Q!J"EK-?G@'TF(W9! ^7TUN_N$)K_;X],BIL9]3;2H?8C/5T][:*/NYEO>'
MQ/1H83<EF-_/Q;D@ S>8+J$)::K_1#$DFOM% <B''H* TMDU'1HSNR,\Q-&I
MVHM&@)PP$5':":6C,XR<B#O:RRWI-VB7WU?*[!*?UD-5ERB=6K>17;(#([6W
M&Q<1656R?XFF!W5O+0GQ>94@Z)ARX0$4KX(X)XX13_@X(A\M098YOD5SF"\X
M4H6NUI"BOR'Y;]Z4\\B?N)PO?/;HT;KE)?*13WDS!95WO1QF0,6YZ9/G<1\:
M,Q\X<;:XHW0/2\4HN$)] ZY6E@FOR%!?$:*:0>\PR/0*#<.6^@U:!/LM:\EF
M%VN$LUWV%D=/YA.L3Q4W,@),?<49%GLV;:0PWA11D?E)7Y(\"M$Z$E_5'T]-
M>AC*LBWX."9.L)"[T=V@Y7EUE!<)\=8W7XBU?PLAUEAQ]5<<V69UHR&VYO(A
MMIO$#:;0,1EM_IO&3I,M^)$?=LV)R7WG3.TKGN#9Z3K5PV-:%%BS\6WRZ!3[
MZ<=>ZM[>RUIK?*?)LTS_B=Q;@9 5.^B4CEU*QKK=ND#E"Q^U18;9<_Q4!G1R
M@MI6/<,ZJ+9'@YN1<E3;,8 *[')%F(G&3:H%SG'5*Q7,]^%FV$M_S,R+_ >.
M:5VX$89_!2+8>S@Y;[A:$J1F\Z@&$#YQRP$?._PLNPZI5OI^J;5,JOK2.T8P
M5K)UOGYCLA\&@@XZ_2#HK@TIZW%N-B[ETY1*+WB#\90!-MT]*IT,RGG<]8/U
M4)7-=P;_2B*.;0H'#S! 45*L*'!0)F]\K1G9^(S_)*PCJ*XTC=*:+F#9%R-N
M.W,4Y9U5*^?>HWV4[N\]C5.*&D6F8N]A;KEDE9%$,86CZP#=?+N<R[4#1UP2
M;CLJ!C$HS+;Q-LNR:/H:+?GMCVS*X$O20__WRT2@B+WBJ1DO=4_H:5>0063?
M<F/E4P24=1?K6P H+<VXA)355^ J\1N]!) 7+*:]"!DS6?EA\%,8XVB3[>Q'
MGI#*B_"H?-R#;G2NE<)SP]-,Y^PS7ZO>.^ _U+TF9X [WJ#8C:F\P+ZOE*T7
M\U5_P]R7[SHQ9Z"C9','[Q^,&]Z49UDNQ]\'V6AWZ5=0=JX!RK3D.]%!IA.G
M:0[>RWA,5; VW4E3(HQ4Y,?25L\K>QLF?G$0G<S!*3R?[H9Y%["Z2[I*IB%5
M:/J28(*>Q!@;C0,.H/'>+Y)[S^/HMY^D9!UI#2L7"[*5C\XL,>FG(\+&H]E9
MD563%6MV9ZKH*DK"&=!&<4?XL_DU&\HZN':^3R/M?R+O/8.:;*-V4=37!J*B
M!*4K("V"M(!(4Y%.*"$)$)ITDM![M0L2FG0(O062$!!(**%8(/100A*:H( $
M 0%I*HJ^^WWWF7-FSYQO9N]S_GS?[/WCFGG^WO>SYEG76L]:UT5QEU9&Z-[W
MK(L6;&;1.A8;&SY/U&8TH!;NU*Y6 *[G/MB'K?#"TXM,TT5(S=6IZP'1I3M0
MW0?G$)H6>G[>9=06AP8ZT 3;'[]4#8K6U'##]<%N%7:_]P8Y&Z_-S\O+">1W
M5 0WII#@9?[9]M2)\6WSYYM-<,V;>"'75$I>BW ,@S+:"4Y-\TGWLH]F:58M
MYDUX$0=[6%+!3'P<YON%8E3=(MA,(@,YKD^M=Q_*"/8T4;6Z=(5=F],!DU,8
M+,Z:,%2MEK@YM0UW=Z?IBWC \I;HQVV2I-) T1^TH4KO4%^4V'[%)-G&C4ZG
MM,L$:UZ*7GYS@W?5);=PFD8@@6%I16'+V@KCW;[GG8SVR.0N]2?(*<:M??%:
M%YCY:%-!7:5[DIE)RN6]NN]G+X6FQ&S9 ^50F=>93'!<DU>AK4,!R=$DF)+N
MGQ!(,H9NU'Y*K_2:7U*\S!(80(UEZ$R7:RGT57&;7/)WT[II%DY:OQE>4Z/@
M]U<<87-!B W)G@JVYZ6^E,<N4Y"-?=A)IF(K:&CMDG B:3&5>Z0W-F57R/.J
M+S;\)LF")YVB(<),_J?D5%5_)L9LQTPT,U2P[J^>?*R/[O2.#-:L92>SDB)'
M#(  "XCY*JENIP*;8=("#VN^B\F?:6BNIIQN1^G%X_+TH6+A$VQ<_/W>O,W\
M,SD_-F >:7XHDR>4NTN=6OD6/&7V#B>J4WY"CZBPO&17\PT_E8XWE[3PE\D)
M5RK;%!^WLS.0(.E%6ALS!O@Z)"IVWN"E\J"\2H1[@STIEVD0:O(9YI^'G7?4
M"G*>IE:,];7V@V!V.8>HC<%-:6+?Z3G$GK97B3**%8*9HJ1569&3+I-B0C_"
MS;\%;DN[Y#QA2<_+X6X]'7_%TF:.-\MAR&VTXQ6&,Z9-4A\4/+ME0,@"H/W4
MN*\-]6$>X^X^8"@$_+C+%[:G*;VOT,]#LHG1Z:M"O3V?49MT==4(E/@-6;AK
M?S^4$.+@M^%T[UM[#!S&ZE*E@20\P9<?6(+4E+"OQA8(D:Z$-C[<K1D=2H7P
M<<)@NX&Z23/;TJ:YP-H@'T=0H6^99\0R[>?@Z5DKX6!A#W9*_4V"^K88$#ZO
M4PIM0MA>KY[##5@L&,!S3(M&JB5@F6A8C??WVD]^O55P>92=G&II4\%-#L7-
M;\AQ+JLOL"[7PD458.T[[I2]I3"$7VQ+@0POM-8;H+D&&*\H?FK'_8%U9U9(
MO.>D60J83%I("]\KU)Z.K<6G;<<Y=OZN&+"\;YB-F]5,B:],546,5F]L6)/J
MV*NV[H\A$1(M+2,W2;(*T4$F 2<IR.YSQS"]1D3#U*>N3_V<$L,7TR7QV;=L
MU?*_0!)D]T'R6%2?Y>R&71'BL8X<#,\]1D"!+WH,ME4?J*7++9(('V%"AMH]
MIWUO$MFOW 'G;X*B1WD=:,(3)L;M_NWPI,1FDBD!@+[UT_&8!4*L$&LE.^<"
MD,$^T3'>[$5E+PE($PW:PRQ!:45XB..,J)KJ 9%^)\I7, 16^TG^.+)<;:@/
M5.LYC-XVLLEI;YGIK7ATW!4[QU0;4+*869&QC;<PN&!T N-]Q_LIAM7R8O-$
MVYRTV_"1ND::!A<:8S3A*AGY.;R+CZJ^TS<"7+6,[[IR;%#X-W 9J/6Z\95F
MO?77<YCD"+Z4W[_1X]W09>_1E<A+\ +ON6)^9DZD3>&V4^K'\6UGP:\K/8:+
ME_\$L#LSWJV,)*)75\WRQ4<%BR]-,3V7G7I+/G%R /A'EXG>:1?$Y2NAU1O\
M9/XK"#F?2N4J9(JHF8$6ID?B5C1)%Z,HP'V73,Z*EYX!=S$WF.0>U0"*XDP8
M?[R&G^(,0O;(?PF#LO\7LLA97._'"ZVZ15$4UF!/92:&J]$3)H(=9=Z0V.GO
MK_-VW#:U)\;^.$0_8G5)2?EV#_]&96A4GYBN7O+"&'_XRW943#TQMH\6H7ME
M>\<1^&!WOUYZV^B%P$)>/!V5AL#X+()\@: @;/=3*E44\4-5 S2 NACUC%5<
MZ*!9="="N?;#]4T2,>^[5VGJ9$AH:74-\FN&$8 Q;1=OG6[_#3X;Y)"S<QTE
M*\='KY9USLX-NJ\1"$2A:7T(8IL'ZDA^X-3A'-!YL"<YR-;W"ZN?E.<+LU5[
MB>$S6J[!#7]00%![PC)!;_8)LN@2+.Z)$\5@\T3TN A+J@A ^9";BKZK@QX2
MCVX+(&\X4PQW(1XGL:XA[7]S/:L($%ZKG9>:.X2M0%"CQ>1EIF@#_:KCYM]<
MS4D/ 99G2:W[=?+SJP6=R-GAR.H0?6+&WURAWMA/E-7O_IPZT#@4])3@**AJ
M3"_<[^D;UD-0T!J=$*P*':*?70J_11=RY2A$ESS?NKM1?VG"OUFI[F^N;BJ.
M[>QSQWU.C7X[RKV853[9'8!8(#OI#]^A^Y-7AM:AM)ASS!O'O+$K]=(G06X[
M'SF-_M?6;5QWE5_[3,VA-E(;75_&LAX'*0,,Z@5=2 (7F=\^G/GQJK=?XP]E
MO4MP.]#3\?6ZB\SJK:;>=7JT7ORA\?;& 3ZX<!>'U<TJZ!ET'?FYH U>_)L+
M&#'Z<U)^7E[Z3,!O=,*VQ@LA\ >0HLTHU%9YW"GR<V+:EA[B-2[RZZ9XQ]:Z
MLW $42_O@?_>NLMY;7_= #;)0.Q9X';#_NOX#@_I&8V5[7HS1IA!J\$*:/N?
M>]5&#$EX_LV%^/[A^(]\KWO'_WE,[.TK>5&>TU?G#31'D:KG%7K<BRFAI/N1
M&_;I$T\F@NC:T$>M_+UXN=KC5KS\9,A&Z6TB#&0XZP]VJIT+OIV34F+*D[J2
M\N,71(FXBSG8HF&[U5(U;!L.S3MF.?<GZ7]D7NN&[,XW&]4;2EN413(T.8V<
METLD?=#6*#M_Y22B8K+Z@IS,E7V<&BTGN^(]4DR'X',KP%W<RI\WY#O$-25@
M37(9-.+L+?WTM.ER>$Z%"M07V88SN8JM0#^U;A=ZG$B_(OWKCL[JD$8G#)$>
M#3N=^;MTKZ8RKWBOFUV0BC*4!&G$ ;D34XZ*<V(FV*:D=FPT12*I81#UWO:O
MB%I:+)2HH=;C9Q#H(,)J=:ER>ZMA.A[OGS4(<B_PN^#B)XI6,2LB0A4#3HVJ
M\:/ -?Y;4*F.%9)GYX+.FIYV)ON)(EIA4@?%ZAPQYKS*T<>^1E]]+Y>B6AH/
MGB+J==M_(TU@NT@[C,O)R$%F;Z4C)^^2JSO-,24-4'(.U<X+/-,F#!W</VK3
MXE9C4(6"WT?5%/AIC8B1$U\U*H#<*X:KX/S\ID3PRX^0J+P:SYS'=O'>A.KK
MJ)!=6$',[0UC;O:W+\,WZ]+,GM7=K+9??9H*=)L?-DJ5$VSVF3XD &O'%)\%
MR]&#E6-;20["]7():A?V=7Z]I2[VO?*O=QD']62 #HC+"N=Z7+P]#QJ<T\LB
MIR1J/OQDD@.A52&?\^J7/$68);YI[([XR3Z35_]\6HCB7POK#_=^HW5M1K)%
M+6TO61?O;:L4[R]_ZU*S==W]0QE;G9<P2XYEV@U"L;=VKVR Z384JGTNR<DY
M6UI=A+SF4T4_>AZK@@R?\#D"+P([D]?^TQ?G_T^%?&=/%P+;8/\S]1[81L9#
M.F2&_>H5T6/R2&UD!B\]!Z"76C\_YW(2\%%,=MNW>5=OQ"!R*MDT=06 M-L#
M!S@\\9G]RS8G,F-5*KV9??%'KTDCSQ^*4SUBNQ/]:1N659R0 J]6?TH*GD@C
M112+3G2-MV"60SMUL 8WZV%?_0MVI>%M@>/!+VMH T5B3Q>*!JL#5IV^I9?F
MA1]2 KIO(:+0M/#PG\'RJ< -I;T*][DJHVQ'/&XFCQGD$/2UO,(LL$C>H!ZN
MW# ]]L! '0,L.^4H9&V@P"4)\5-;D[<ZSF\-/?(_V,/]1SBJ89J"I\_GWSZ+
MP.PW]Z \:@)R0PT?%WLO.;QK&'"Y^6/S!SG#8W*\6)WBE?BC'AL;YS\@56@[
MXG6!JEUHX[.KU?[(_QR[A0Q<$)M'O^QR:RHAV9,[E>H1/_!&\VT?=U'1OW-?
M_!5T!J3](SVY$!3U#+'$=6)M8H)R GN'#C;7?]*HD6(8X_)\OR_CW@%Q1OM&
MI$>*9GVQ]I65:-OVR+OZ%.#D$-HTV*@E(2>A>EIT'$.!DMG#;G63G\__L/Y\
MI1PCW_M_DPAE?*O:M\K2XZ)(YF <E_+CFBDHR;HE&B[(AYN8*6AN1&:ZOBLF
MLZH5' V-Y>H*LACUII<7P Y3WGR+0V$[Q5VQVWLHGFT7P\AR@0R--_3(@.10
M.47!KY63"9CJX<@?K;OB>A]F!16-CW6&/@!\77<T3_ +5?HA;:(8;+6_5V_^
MU?M)1_-=]]] 6BK?H%&:Y8EE8$ZLZ(*^B$_X@^RUGXJYGPC)T!FQ)R_OOKZ!
M^A#/-.H%?OXZ%?97G*B0_"EC]UFX;=45QR +P&I1XEE>,VJ^::?/Y=_,C@GD
MWJD[_T_+V0,R\:^Y**O:ZNB_[UCVR'&%_\'^SP[B5F+,K#T69,&OH& E^+.C
MRZD]#MBC>Q7E(&"!GCHTD1Z*^&D[\N'"#0SY*6C1O:I"ZU5#1YK8-KR<8?%#
M9SUCMZAR@.2$6AIN]8]A!UH73J[8X6.&?YEK^Z;XZ<81@%4,"I=(B*-CL-\J
MXJ=V,H,4V+OC"8\6&U\PZ:FE?.FZE.R+V!;_JW<8TCGY;ML-5-\X=&7":' Q
M=8;II@QYA7/XFXL(D RM;TM[ER:8SK!94R]_)_1^C&AF2N[1\[OB@BTFMY;Q
MJ]S9$:^*:DD3/C^P5V^:^]LA#CB@*^7\PC6S$ K^'*T9&V OKG@(R>3DEB .
M6GH8#PZZ*)L?+E)N,P8U;$=_?BGVI6,.8N$K>XJF;<@*]1/O49.YK3"TIR9Q
M51RP(C5:L\Q1K5-HFFGT]_M6G,V@7Z9YSMTI9E7:M*TLRMD[OO$ER13"ZP90
M=GLU'DU^G4"J4KAN>.6!/01=D4HI"@IVZ+3O2.[E]3#O"].QT92Q;G31XI!X
M["/NP\7^H(TL@X>!Y6=7U*Z%A^8,4>O[Q.3KBMNSX*GO;0,4$]I,;W&_#B>^
M#R6:4GC?!:*NB9[M+9%['$T+L??3Y$5\;U@!Y5YKDZERR]1&M;1=H[R5(?DB
MU+_ =3K;3E V;/V!T#HGX7UUA:_R4UENC6P_HFG+7\64Y\9$,;*\W;C7G!4Y
MJEQ@#IZC]*ZCS8;YV7D[5\K#^J(?ZC6H*P9F](SD>LU=SG F]^I+[NQ"/OMB
MI*DNRRXXBV#7I $JT;:GFT]>;9_@.4&2++N0D9ZO!K(O S5NQ]<@)F>:S3]E
MG:F7_0F]<)32<*V% FEMULTV*=QY:HC,Y'_BC_1Z@2=4:Y+X!N34$*HQ8XV[
MDR#;H#*[B5=R0NE*J"S<6M5?Q?MEIWFM1O+:LV>$TOI'40P^_PU3A=\U;0]&
MED]M;-NZ6K7BM8LH/)ZH@*"=':S5+5;**H9F_P+_8&R>4B*[Z=CJ"2I0Y]6L
M4K#JBB)B&A3X-JKE8YE9/Z;@3^ RJ;?(Z:S(3P!7#T!6:LU4%I>J:>,&Z'1F
M/8C'!))-D_%+L;O17$QI\@Z4<FZKT_2Z2@PQ*]RFRUS4:D)M& Y/RA!,XD$3
MCB942<?FRJH\%DV0_KXWW3S% C-9G.UV,XJ(/ ]@EH?(KMT!O*: E]UJY1^;
M2,M[7JQ3-\;?&)1/9L"&XM?MFT!WLGK5LB\63MBWE=<N9U%Y5VU]/W5SXU .
MX3/OLI,+_4.;1]N.WXEM0Z0R K*@3:)#8$G!F&J=0-,&G$$@=)]X*3&9_5"+
M@-7,]J:[1X^L5Z&ZE5P=-W"1)&,/B;89G4,=(S^S)G6TXFHTZX-JX#H,YS2-
M(VN4=+B_OP$"$RT6=2D&DR>K?-(D:L.N(,(/;9HQ3RSV1ARF8LQ,VD&.%!T'
M;).BVWMI,NG3K'V04(OP4J=7N'5V/N4,*UCS9JTQCN8<[\OVEZ%8E*&\%YOJ
MA$C]TXBR0!]CF(=ME+R +X/"W48Z*Z Z7V"3MZ9NZ@5)!%PS(8\WJ0GNI(]#
M#J"^M$N7@)*SX%F(M>'BLN2LX4S&(_+3++M)Z;INT3O<>\2QFK*FND(SI3Y,
M<Z'"'5%32J:.4/C=@7Y"B%$[*)#I2W[)J?.@!T K$T2)X<81,'N_3N*]4=TJ
M8-[P/Z7N5<18SH<9_!"O_5M9TVM(&9#XC)S7757H)S\*ZQ0NBH);1*#3<LJ0
MA"9C)&$:%(R+FI^U,3P=!2#Z'G+W-J\ Z@.^&P3U?_O:Z#MF\P9G0I??*Z-"
MQ2;OUA9"8PCV\D(56/^W'"%P+Y8)4>+X.F(AE1/I(3:UH7)V,\IMQC2;[LMX
M<S5"X=C^<4N(I932*@Q'^4;<5M!<ZJ]I-ZS+\.E&QY'@5Q*P#5)Z(+X42H3*
M-Z1*I*L(K'4! ->\BVD2?5/C#8VRULNU-MF92'FS7^.1)<)0X]R[J,PAM&,;
M9$ \TC&PBN)[9SAY'B!5(_.=WX34B&!="[DU7*4QV#[^0SK-3 39;,3O5=\=
M0"WA?4WQF7UK+6>W^5Q+XK)?^#=BDMA,MI7\A.";6LTZY[?+*2RW:SRPG#N6
MN_*(MDF>2T+WG^#?._UBJO2C"I-12Q?DS>YJ#21YO?+?S72X&#=AKZ'/J7M1
MK.!EO069,$*DPVLYF-8"GUG+65.B.>N>06K1)V8_1?JM34B =YG-$ ?W^ 1R
MF/S#%NN>#%)\UV&M<;3R>2!%]&WMSZ)1X_R=+J&<>7=J66L MH GQ';LX\KW
ME"!I.'%H2$CR84[NEM#3IE"5FVM,)#A%/@SA;GT^-8O0P=BH5@!B:4<<N>OE
M0)X%&)+"T7S[J5VK_MZJS,Z[B_F#_1W=Q@P1*WBFG_TH,%W%'W^U&7_A5LL9
MMZ1,[HCHI#-:0;9N3JTUDUR01&6K:#ZRV=UTPKE;>1._&.HK!D^OT.[MP+Q;
MO]<D3Y?W!M>D"$<,D #+:"&V!1JB&3]/40%5*W"WF T0MM79 *_EQX1KS12(
M<LYW#5^<2(A#>*D)YI/")O<K#E5!>AT'OI=.4H6@18<*X0)EZ"9M6V@CT<@.
M6RH.DL4.B'2\ !",D8HWW<$I!R2Q7GD:SB4'/U*-[10?EFO2IS9.9RV%2.'I
M8&ZO(BD'ARH3_UOPSE/6S/8 44<;"@H8MECY4@1^?3/9-QZL?H3@)^=NIBJ&
MDF5F0LDJV;.*#H<L=Z^UU'E5VZ6$,&\YT="EH.M,HJU#18OIRL<$)-UWRF1Y
M\443E7^$JM)EMV5'[9TCV2AP)-?MJ)1-6%L=U7>(#VS'";O;GA(R:=X&*L._
MSP"'?%<5[:5JIN43**+2[)J.EW1K8@8K^/@<ILL=JP1.XGT-BM:*MG,7@4TM
MK=(\I:-#\>E& ? +\[5&EXD\X@"Z@B6\2"(O@;_8R=&3=OL]7 %K*B"QLPOI
M\T=4ID0(C;4\U<'3'"4MEHTW@C A?62AB9W;SMD6RT%8-EM]>5E6U95XE]8
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M;HFNZ%*CH^=N=T751N'>@^\H<&)87JW?"8:K=J\,U["7^P 0S29XQ<N@VY<
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M3H9R,DAI$W>08H4N)[%Q5-\&@F\[$9SZHT^_<BPL_HG!OX4B[^)B\J/.V/V
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M5?5)"*!(CZ)*_(21Z6X@1+[#T4?DUDK(F(V,*$I/;8S%$W2[0'Q%'.$.MM9
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M)_ ^1T]2;'%QSXU0% ,CB:/'TX96+><L<7O$(YJ5-!T#7N,(2=\)33ROAI_
MM61.(8D1CU!GEM[-M-[4K-Y08[02%;C;\+<)&TIII/_&WGM&-;5&[:)80#>*
MBA*DJR M$9 2$*2(&$H@E(0D$(K2(:'W:@<D0I .07I-0D DH:-NJI10DX!4
M:4&J" )BV\=]SJ_OG#O.&/>.[]YS[SCWQS-6^;?&FNMYGSG?9ZZI+U-*FDWS
M.DZ$-)6>+.6\VA,/\ G*[%+X3=:N>^*(7O0[#VYNXK.O(Q<[:?7);?AJ>XG4
M_CMM9"5D2/!:BKI$JP'\RZZ1OU'.=^;Y\+FA^*Q?N/>=+H"J<%;M<Q>+;D<9
MZ8*5&L6V<0FO9S-H\*;'IMD$MKVN#D?ZATOD$%H=(EVTBP1"2Y.H8,<=R&?'
MOS\J\"4^@X[+?OQ\BD85!CD>?ISC>X8\,[GO?R,L^,/Z_/4M\XW-G](N2^TO
M0ZMK?+D]5D,79L%"5)$?O '+2<FDIQ'(.#CY!Z*2:GI!8.8-\[L\%TN 1H,?
MD:<MPHH71&:\4)F$]NQVO!SI7!*L8M2'+,<-3L;$R$PS=Q*=F>F/(+I)3[O'
MLLK47[;)3W,7X^6?_8]!EE)YQ+/<ZA;_#-](BKU[0_$OBIXBCNZ7BW]4U9D'
M,<5G+IKW9&@\1ID$NE!GI/X>>=?_H_4^8*KZY<.OI,4&FQ\HB?:+:ONI0*_O
MV,G"=UV>H67%#8G6H:H^M6V5F!# [?_Z$TV7L(HQS$.ILJ)*@>IC6<N56[\]
M;:PS3L=K(R]$2=@M,H1F.F0N@G<J.N>.F-PTON.Q4].T)Z[@._Q8U3%JX4%\
M[2RE0$DO-LBZ@E&T%^'HM!<AM6O4>?\(47@Z>^@NE+.R7?6L\</=P&\]\\#,
M0,E?H &_WX &XJWG;\LBTOZ>0^R)" _(6J"BYXN_Z=I67SSPH$9E/8SFVJCE
MZ(VV/#C]4T87FW9QU7'NXS]<\:;>I']Y<Y[TQ*/'O8GHLU/'H,UQO>ZNZ*^Y
MO?W@J9F*4F]R>QMP[N_*VN2TK]0DU8[B#X^F\/AP<8M'U&<9YD4EGSBB 8\F
M&X<2U ,52K._UB -33VWPVMTOL7&',.\_TL<-%41MVQD?M2>?D'W]+<>G%*>
M!L^;R,;8S.T5]AOJMR8!1*_Z==R*.*87OOI,?,T-.O"K0*%R^3BJ[NY,(NO3
M(A_2R:$1$"F!%=X3* DTGI?(\))<+%,!4T[$%DFD.Z?*VW,=J3J\>@KUN722
M[]Z,?098)2]9E1\D<LJ_N,+N(6LPAK9"M6EHE6V["-=>MIJ>=A;)6>*4U*>%
M@F[?^!MP1NZK_(\NR)/)@F5D^:UBBHD<IM^E+@/R%TU!VTR0U!NL@ZW*<MP;
M.TZ 9EB'@B7^Y&H1LCRO75NEVNXT/#T@I_1O;GF:?:@Z#(29O_:KN!9%22TU
M\<NF"'B$X&Q)0I4+#P-0)>WC4L^-('*VT^,-3H_015TN'>J3#>)# +'W>\4,
M]6Y@[,1"WGX5$Z[[G5)NIZ+XJ&I5@%/O'A^&K63WR+Q*-]<<\RY.82XH(TXJ
M3Z8;Q@"%X^ODALX"<K1/!"PTZ]5M 4X3[V^QM-F:%9 ZGI/F:Z-Q2IE5"H19
MEK;_0O["4TTH[,C70@,"*[JCZ\Y'!2D< *.-4&=^OEQI&RMCW@FO7JNXJKF)
M5FW.6]H2&$E+5G[Y:J'<)M9\^ >BY-F8MU4%Z42:.4$"^S%^\N4KZUW1P+.O
MS:Y3&WNVUA5G0NEWS\\#%8.LX^)TJ[78YX]P@NR:TWAXFCZ43G:.W[&0J')@
M4% 0*W@O<!&_TEV(:#,FQBVR:1C>L^EM ;M(#8996OPZ+"6S62#I5Q$/[*;O
MFHI\$$)>!#*-[58!AB\"SA<0J[KL7WO<L?R'2VFYLO0]18<L?XMD2)"6%V*Z
M)<&NAER0 0ZX5O&RW+7*4NG7 A=2Y(N_TS&QZZJ;0J2/C;WK\)%6+(@X%X'3
MW1%_QWKO.BWO^CS$G>:!2-;2I#QW;$4*G^MF,?O=7H174?IUFA;JX4T<5#&[
M//BBH8HF-4K'H%#F%2>Y'WLEFQ)"#;Y1!+<,U7I+]W6D0SFWL"\U[N!MK\[8
MVNSIU*B9."]3H+.ZW.Y3O^8QKZZ_(Z6T2?HI9F\_0?@*@-U#;6V*]TM&,V_&
MM)%GIT=CR1S5)8@[C()<TF8UK6L9JBF8>12I6*\5D^_ [*!.1Z&JL!FK+9)&
MH-C2/1;H3R9L(FV5#V6)T:6+H//-+)D@%$>T#BD>@ IG*?FC2(@T9)=M'/%.
M!\HF28?L1GCFPK"UP=K."67T#9.#4-II%L::I=C"]XN)Q)2BPTCDL_D*$PEN
M"",F/TYGP(;A;M;(\'%0<@1)+B:R1[2KS* JO,D^NEA7K U[)6Z1Y'SR !7;
M5KT18/FA8PQ<YW>VW]8DOUHBV;^A_A0!N- IWS@I?YQ%6&D0JBSB\%L0^(F0
MS)>OF?5>1>YR:_;.A02G=;@:/9]#*@7'807-Z8H;1!Q=Q>ZROP!2LVP*,:T+
M4HS08J<8J2T[#>G<'A-Y6JNVX4[7%,N],""3)RJ&%Q1C?IDJ@'(+U1L3;E7Z
MRMR@2)AS6S<G[EIJ91D/$3^N4 WV2\R)YS'%.WS8JHCS@4W7&W5IQ4%FYUXB
MH"G&%U*5IOJ)+'J'\ZM[SB+U579E9LG0ITTT=9]Y/LSU*3S%O:46\ZHLD#'Q
MG==J&#N5&%QZ_0>2GEPF3WC%N=F6UZ?K*,>+'3/8A/'O(@<\Y'92GJV&8Z)>
M_)$E-<<C.$2T9IG5K3&[6,>O'.;1L&IG&$*80X91)"*H,3F]VA@C2 0ENH)3
M'67)U%@A,AJ9_1[$$ND1[UU,MZ!V<V.UT\'Y+9FBNY&)]8OF",S$ H<CLR'_
MI5XDQQSJUA,$G75NY%27K0!2J?B 7!\/EY%8<VOO4X51S.<W=-9/;8;K8&T^
MZWQ:5D"C-4:>P&E1=;;L [M:AF?/92?;MC/O>TT$JJ]4]6;Q-/@* *HHV=]9
MD&QD DHK&L_+C.'3HWI'I,7VJ1CM(BE&('// WB/!)^I$_3,M0_TW,O(&5:&
M;Q=VK7>'?7I_M5\_RYX-8<;@, 8M8.B"-NO.(+E9><D> 7@&QGJNO9DCUFLG
M0*8;O+MI\PSW*4407,RZKCRC5[!@><FRD70"FC::" V2=I_V -.!3ZQEXT/^
M>KE7$I/XDDCD45M58%P+6""OG'_^7.WR"D"JAFYT9)+;''MF8@U?11=.GJ3Z
M,"0<;B9TEBW_0)B%!)249Y-3M,OTE"9+"7K8]!Z&B=A]9K9<J@' IIM5FN2U
M03^]:CE,O9J+!3>"KZ4P'6%JSF.-7_QCL#-M(T(<TK,8LK4#3=6F/!BE44'
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M2@;G*,PYX@RFRJM,@O^NLPVZCH S@J_C1"W?3)Y5$ZW?4-C<1FJ/@Q^0N2S
M=M8LXR%P_QPV/M^S:?! XQ\NNL&%/QS:'<1N?$\_/^H"'@^/CBG* AL^8S:,
MB?BRU/(OW8S K'VEZD2_"D!M^2Q"U$[NDFAWK_V:--[ [U>G6;JB=$!* S!F
MU8W73^M+20M-#/?.36VT/[F*GDNR21#X GE4]YX.@E>'5\U+B+2TV1E)$[B#
M1E?-J =>*MX>=CT8?J-8DM-87WZ&6^$$[8BA.3<RC((&%( L)4-27[H?:X/O
M F6SA[GW&]>1KKDZ:Z59)]A%7@F%H;*A,V931.=ZK*MPH3J_,VF!D"%899C>
MT^0\$XDLOT>QA+PK-ES(;Y]XO&!.-S=DF*A*8-N,XR3HUS072J9VK4<4N.QC
MDP&Z:U5)>"M9M2.@L#+(S4JX2$62H>=15C[.Q&:ATJYZLJG1AR+_EY2(^QAT
M0-4BT1<L=7*8^-;GB+L8PF?S $6EOP$^S.]CTUT:1"'Z?K%=#DD-".F,\@:)
M#%OJX:J=Y$3O9$J5\:9)@G'W#PVZ9O"<JA@JZ\-]WPQ2^<0A007(=T@#?<J_
MB$NXN%3CN.W7T2%_V_F7?/Y?PW#;"T#0IYICWQR51<0?%]7U=EHO7]?6VYY'
MJ0W<+0N&;7_7R=Z)7W8L\"CI.8Z]SFV+$] A*X8/TI(%L^9W_/[A0GY'MESB
MDGSU:WS5\=4D1O 3T/CK5[, Z-(/6['[61^S2WJV>I8=CNL*/;ZN:V5G(J3?
MI?4\=<TD9^33"UFG0^LOJU]ZAI%D>?Z YR(UT!@!RRORM#_DF/[]/XZL___Q
M?P/2!&B6QXQ+*R2\U(>/_MLJV<>%N3\K_Q Q]53-U"DG,NE=+"SB'ZZ$Z%L*
MK-_856VK2*>DIII37^I;YTN/4%:46=.2&_)G63]=4;>/_:;#>[K<;4\,?1_/
M7A,IZ;UR2/91LG0+8-R/>-8%16@VT74.(.,-/OWH!R5K[9!+X.C#XK6!LOO8
MKP_XU@:[(FKN*G7?H.54N4=)4[OWQ%C4#X#!3P>&=^S'#2X-T ^^1?PPGAX.
M'&.G^0DL;SH^'C[AG/F?.8E*5L"W5%:-R[<D1%IQDLMW3>.^FD\)GLO1L_2:
MCI=&,H;G2JFXISM/+I'7.$:X!Z/=984L;[OSV7+91:/(SW\362USLISR#Y>7
MT:]YV^^9E<^%#\D.$&=[&A [^;X!L8L6K0SO<HGV^X6[V2UQF1\TO]ZE;;(H
MB$?]NV.Q@UN(L%UV5M:N:.A=/)ZIHOWWX3CQVZ[-!8B,J%Y2Q-)]W9B)73U,
M!3D\>\[0<&,\RPX0GH\T<TZM[5T?'XTI>R9+138P9::8[/1,GN]FB^#:BF^0
M9:L=].,UK=3:I3?8&H/<1VZ-+XZE.3[Z^ _7&7IG0@;#=C3ZS&_G-/'(GB?1
MTDNOW?2@^]<;'3U"0X;;6]9\PE7;%\")Z;] ;)J#MEUQ$MW@UBA*:'RYNOAD
MNT(,6 M(U&TX"X.<+XX]6I!F8EK?8C4A5U8J(%)T"J(1HO60U\ 4YG+K) -6
M_!"D6':F&*^*43#AQ?BNP9@;QPZLB+Y>/V*/"F$>,8[CN2U[3EO"--1RR9
MYO(JK )>>\M+U4 $@G6^]-_O IJ80K@T?*1U<^L?BN+#RT?Q7"$"!4D*_]%
MR:Y 8!Z*,)]##3V/ :1X?M =AL W16)C,5<*4>*K:;=228MJ+@!)EHWDM#G"
M=GLZ[-[/)SO5<+_X6A.9Z)K1MGO=5";B_I!$)"]*!QC>VX59R??*Y\;/G>C_
M!:JH&SW//)L%&+DF/\&+7T5*R=2FVKVD8_LH($.7I(@NZU:VPJ9UWCNTSH(%
M_Y_L,OI;3UOX@Z3?"@KYVS(]BU:"A%9=GI!Z(U)XR<)Q0<]O+\YVMU[J>0L
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MEQK8'U< 2=K7_GI'?;;%_7</YG6S9T80W@0@.['$24H/KH+I?PAR8.WGU%H
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M8[^H_]^ V,84I17[W'+<?P)^@GC5DF SW^@7 []S8NMO*/E1,WVN"Z>0P3#
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M%O3:7X(:-)9N [6CTN_+DV>JYF:OW;?L"T0\<.FT3%)LK)&>6X:)%N2/2QM
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MM_%-#Z%1OO0ZPHT< F[T=VLG.9G)1=K>]M[I3)P9)'N90NM(<E]M_[ TWMR
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M 1.?V]2R)I?QI_<T7L47>15?=B;MD[N=YDSMZXJT1<*#GXMIH%8_'EMEGLU
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M93T'(T^+ 9S!!*M*8Q^^0#4TO2*W&9A.="(E!K$>XYF'I1-E\E60[97V\?V
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MDB'@J:M#4RF<!]'.?>+;EN-?9,Q9*JZH#GO*G;1L3#3?+'ISX&Z9PQ;MJ3.
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MCG?4CX]\)P%@J[\3.%"08@VV 7<8BKFPAE0N)I44L?.#/IND(5'@2PW&.>-
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MNF5!7)S[H-&1JA+">/ZHKOXY,P=!.2=G(Q T"KE'ANQ9R3/X[U=IGP/=1OX
M^GF/01E*4AK3MGOIWOP^O;PUMG'" R]2NH%K$SF7$[_?M.]2KD@;EYZMENCI
M##@0>I"SS<[,MJ-N'[V.:#;1]2LE"Y18C$^$6]T[4EX;61E+5!E'%S]:?48E
MHD"X)14F7W74!N$,RDA:&I(95<]*DNA8X(T*;\#.J]*R-_SS:S 82%S]<FZ3
MK!-:Y(!0(.HA\NWWMVR>P&W:8:XTG/6+>%S!C:AJ<FU0IE!M_B ]_1K#U%05
M"%AQ+^WZA_(Q*(]!RUU1D:DW)H;'*5J)22T#.[_NZAL(K7]L2V]#XE#ZTYJ=
MU_3TRPS=C%1>%YE,&6T7/BA.>1L8>WFT-#_]ZK2PG-48A@ 4S0?<AYH43FUI
M7;EJQHVTI] 'V], 7FU(',7J]+DRJ;@FTNJO2B]K66-N7)>^/OIZM'8\AKF(
ML?XPO_#JE'2ZC, L5';TDABF/'LLRW4*^I#1KK"PJ)CBWY CR=>94I'_BK[Y
M'\7(:.3A]1*Q?W=F;R))GUI<W*-BO)]'YVPQ,:%[N<8>V &U8<K#.!G?Y8ZU
M13B2:%T3^B.[*-#Q2I8DGJ59!5'4!"%,I=\S9CCWV$U508W<>Z$'J05[Z!CI
MW)NSLX G\JABW-C3@/YAZHGW"+?P%UPOSC:+\2J"3TK_N1QV+D.4GKD]YKZR
MG'U]PGTN-YJ9:2\O49WC2)KBJ#BW7&SA-;M,<8'21#29LONM+\?SWL3@S>_[
M35\#KC[W><@<Q8@Q9M-M<:'83V'7431 -X;Q74K--+^[\A&VEE:6=VUMRH!_
MW^/%#;U*%@<#RD 3X^E*7K[1*G:[)"O]=TH/1>U"LUCRZ)#Z#$]C8Y!-SF7\
M$T]L'D!M&#I $8B9<^P,G+Y+&]%[.G N3?&+,3+_];Q3K#E7?J&'"P#LJSZX
M' =E&N/5*PX3,S1-/)%;@SX_;32@K%%WC<U\N\J0HPNPR"_CU&0N*SPG1(T9
M7-G0>JTXEO:Q+'[@01ZE[SVH*.<X3RP&L"'<//&6'AQ^"A%=Y D3'S&U'^,-
MB2RQH-R7!IP(W9#(=08#$I'E)V^\LF\]:TS6G0D3PWL4%[[62Q[-!"2F%IB5
M>#!>=,)ZSTP%RWSXQCEF^$JC\(,5"P4VGP=@@"_0&ET *8[ O?U&D4?+F%4&
M#*<3BB6$<3=^,"C/-+ZMAZ$0 UJ@%R#%*>+V(9%AHL;^1J]9O'0<.P&*OO?4
M'K-G^FT 4I&.*F'_H3;;_\>%/<YU[%^3;*Y."V%.M !"+/XE%U_R_QUXFD+B
MF=F'9V. \=-QSAW9G?T2]$R^[S0KXZ5A(OHM <7G_1S4=RY3XYNC$W=P.!2#
M4:U]^@=P#X[.PMV&*Z<4W5$.,BT._!Y0L!)KZ[=-U4"[_%,W4!6)B:SS/PZ:
MR)GM,HTU'8)(-4KPQ5^'JC:9\>V8%MXV97K0\DAN4+LQMBE6(KDP)DG'7+_(
MY7>N=' NXTWG8T%\0KY,WH@Q&YLCXZ4$_17414NK<R&OPF-HS0IFJ?:P? OJ
M@\]D->05J"QD+5O R/@I@OUI,V8=#XLLN;.*W/ASL>"X=N4R#_;TX>^GIIB:
M0Y1I]=1DH:4-5)173/35EAFS'C76M1NV99;Z3P4^)3+&;%2C")2DSY4RW ,
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M)?F(/H;V[']Z:3WP;O#YC)7<X$QMLS)L5:=DIOD/0#MCI7XU!T9H9G=P>/D
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M['#>18LU$CM&!D*>'(,RA#VH-UC 1/3E;1_"(;DBR$_,QOW>L\ RH-Z&9,K
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MAT_7AWQ*E[-#3,H%OQ4]].4L=M%VN2=:FUIK:Z\%B'@S:WY_9C9K@=6J:EI
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M#,9PX7,K8IRYA&AN3K<;$']E+S%M@2]JBSWC'#0M0U*0YA5Q"XDE#P;>_3Z
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MQ6,ZM,-.-3ILST'+EP,(PGZ;+_!C=&N+AI__O%=CJ.*?<>KG %*>MK]![6E
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MB(T<H0"(*I/^+7[+JO1?BO@J7052WC]"CAU_&($J$L)_Y3[_E+H20,()];?
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M5VC5G*4^1NA<TQ  !L!B8XRI%=G;,SQN8$"$\TSBSR6L3V/PD9TQY1*EO)3
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M[#'NO1SNR49X5R:S!/S.5.IQ6:M0MIS4.'>"<!K:"'O/Q&X\G]CP=8?JNV)
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M[_PW)SWY\>&6-^:%],^MP+\RV>OWN"&GYB2#IXU420)CK2W\Q4$C+SV8BE6
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MW&R\Y(>*%<Q]V;8S4YY\+]Y,_1$GCD2$,R41^9X!ODNV?;WPS20ZB6D>;K6
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M1QD?&=J_\%YQ GIW/:#7_RO1B$?MV)!F>*G.I1&QQOZ;ZGP.[5(%%$(V9NV
MOC:]YR9F]S4 >"EV, ^PG7E1N1(X5!--GV+#)>*WGT4W>437#,U+^CHCXV#
MKF9]=BO"("&\ P7[D5(&9#O/K&?P3ST>Q!\22?^@?]?-+!I5"'3^307>Y&4%
M]!WF$OJHB7?M5E4T<3F[2EUIA3.WL!?&Z_"N,W[$X=]4E_=L?6(6FDWU1T_2
M0CYN6UR+^&ZRBPSZYC%Q4.6*4)6Y^]I__ <2\AK5PIE\$'RD@A1VUNEE-OP<
MSUDM=O,Y\6&N0[PV_]*HZ:&L1LKED,;?5(R'O(]C-<#K49R0RL^;UHB\2K)Q
MDGD0J:6M4W*36^L82O_U-Q7#T1DQW(:L0DP(:*&U4[ACIZR:T/E(TT-_>AF6
MAS'WO5\YY#!"[?04F1I6^[(@D+GFW:K.25$*LJB;9D*5G6*VGQ4EI?'F3T#Y
M]$2Y$;D40VKN!GT/^7HRL[$D6I\*L?TTCN'_U-NPSBD\<_'V;RK8<@'%S:3U
M-]6&V<W6NR+7I2:TT-42J3/P.]U@K>/!!MG2S>]M#(=CEQKB][$/<)2.GUD_
M;5U@1QY@(J>8HL/: D6S7"F 6*E\?2%:'\/LYQ,A[\QVHRL+@Z2-:-8:ZS_T
MJU[0998K8Q@G^146VZ16^1.%15A(Y3[/[J\OF%O(CW+JPE8#A#75&_8K8%RS
MEQ%8<KG:)QC9"B^0.:Z^\_B[RYG/%^6K4=]=&$U\W40 BW^&\>N1%=Z_]AWC
MY(TU"T1RUY&\N;:V70CA;#J!48"M-7N'YGWQ9P>8*HPJU$EXKB=_6G4J[<SU
M*>U$R7[S&AZ>QR4ZAMWJUY.=GO38Q.5/V4NBJ4*9EV$OIF!4#VK(_/!_6H5Y
M[?XQ^/NO3N6<<LHII_Q'(<@K/U:M7;[L%E$DQ%SVI$)2P5X7KYT_8RJD(3 +
M>V<0 14I10;:#@V@-V\2KJIRR1M!\EB_V0KI"C>2':K_!#S0O2QZ3!-3_%X%
M>;(L,^%P\Y%WN55PA/G@.,A#;$Z3$RYJL"TO&2\JIP1>&S][D/-J+[>00WU&
MY6:$(B"2_<_6R>I1HYO/$.8&?I#V;FUY>?O$_K#YZ $S"%Y(LNG::,?[=?<Q
M.[RPWF2LO7V9;MGE&4)#X<@#NIX2<Q52"< =W0]D55V4_@E]:!HY)XRX<"C$
M$Y#P$SC*1C53DCL.38=>(I?F$7RD)<A:CY0:CHT"5]X\N1;VYXJ_SR2DQE+\
MO-I$SHB)FK.S4;YQKL-20'%ES5PRON"(Y<C-7.3 \C>5=V;2,UFZT4S @T>?
ML4FYF#J'=U G=>!(D",P"IZP7(B103S[W[B]JF;3U/G9V/^TEQP[0_<-]KK<
M,,K-B'EL5S/APFV<\0]#%'_^F?^1P:7*C=DK)+VB<Y)%45DS'PLZ2H <V-^=
MLRPW$F[P6%+ME5@6-OZB[WVK>2+ITG*ER55D";45\F3C-<46I5TF/1?=TWSP
MDI-+.EI\'XONMO+EB-* ZBF&X2AWU.>01OB*XBI&AH#MO,.^?.NC/U?WO9=,
M&X76%FF@3"[63WAN<_6]PY4YU/MF5.>8\R64#*;^!W0,DBRA?:V^7$!0RR;%
M#V(W+ YF2\%K,SP:CNMF[I(I AEWYZ)EQXK_23^SY<05%B\!KDW2_:;JU@_^
M(O#ZA4,L0M:*&^&*?U -F2K<UC7"F%V..-H;?XHL#\>?Y_G%MO:Y5/+)3%FF
M)_<M&99F^>+V+<R6XN##*%%H0(X.W8T";4'!2_>T9/7'H#C9IG_;5577M/_*
M4[%'[)?/P(8UKBS4K--O[]M4%;>,3%)T;ZX6#]R>ME \K-.Y/'@(V*>-R!%B
MIU@H(3L&4[.X6P*\)1,_+UHN^'9CJOONLVS#0^=?,J6]*DAZOQ=^3HJ:N\6O
M+O09:O8R$BN<Q"'#Z<12-H/VXPM:N.USZZ2L9BP >'7Q C 31^2N>TI-M^DI
M]$Q8,H+4^B:1_S,G7C#&CQUM$_6>OX.H[,*5E(<SJG[&\W1\')O3^4&%$ZVG
M^7!=#,'>=?];G;.<$2'0(;.2<\-[$>?9YWFW*8^$?7==:8,1^ &$W?,/Z0X4
MI[!U50UT!\PL;!A%V4IO6["GC#8I.C1^'U3:>B2-U[Z>S>1'$N$3%25E_QH%
MSK;:B.K9?EZVN#@SO?Y:=Q8#&O\0O0U-[2Z3_(8K<RJ[;N9<D3\$J_*1!&&4
M7>6)MR6Z"TX0^NM62GY%G)FCZHQR$_KAMLYL9DUHM$)E>G$/@A# -4^,>RR'
M0)-M0V?MGP"P>?+GOY(-+^J.-I$GG;U=PKKN7O-H/Q8W+?<U@V+M[:L @/C\
M52""[:2^XLV% W[  8L#Y^ 1V[A,*@A40H 6NX>U\/]U(6&V3/H7ZXNS*/N-
M1\/_N)Z V?YL4RGX\TH@X5@[]]7Y@OR"__*;J*><<LHI_U'0;!6RQ38:.#WH
M*A*23+2WHRYILB= KK#"[25W]1<B<8_>H\Z+,'OF?\R?8E-F.2@DI/N-:5C
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M(&!\MVEB+$]W,+>Z B*=(/\XZ?. Y?L52A?XKP-N)P3 XB41X>QSU4SP>_D
MWN3939S[5>24%)R'*\,#30P/F>C\A5LD#B881<Q Y!I.#&+37?)#NP5N4P<B
MC0H6:4V8AH[']K)8Q#_2_-I?^$WE"#.JEW4\YB0:7+.BJ5D(7&ANZO3;SJH3
M@K\K_.(;)H-]>3'RH$?GNL2X/:%D- 2;&T44I?/;+UY7*<*[ DIJC@5>Z:F(
M);8',H<KZ[E>*0G)4-$DT$!"_$='P.V"HZ-"LB54_0)[:2I/NF!>S$]NY<8V
M0NS._,]*AO^&=M&?T_[?#_U/6R,?,.2B9^R-"FYQ@.<\1PD0\!6FT;1)1K5N
MJ.J%+#29BQ.Q#'O8V!+:"WME_)S4:DTY*$E]OM(2T*I8I!QZ>4^& 6&P6^"8
MN9_J\+6?P>;+[(V472-'#1L 91\P,Y11UC"]NGM^&N_'^+8TS'L7;F(E&@VH
M=JD(S.*2!)XW^9#!8KK+>92'C!&,1C<)276=-0L8W_5.71B\_]<+=D_W$J)G
M/IF$?7D^PD=Q-E+)?:5YK2[3]>9$_\\1,]N0;Y?"THGV3,>5%FZ/BN1U8*A!
MA%<!GD&[(H\'+*L_QCRV]F]["026A)X3'#[G+BF.UV]HOKR"QI8XW)FYR ?H
M0,P*&_O\-:1Q)5:4H#O2XF4#E;O>N:37 M.;*!W *ZW-TV:46*?)EQ/U_MO,
MX-&;,EAZ0 I_KZH_,SG@X_<?%FP\$32_J28:S:7,;K <E9$"N;KT:P:20!N<
M5\9AYG\&IL/*7&,2/0E7\9ATRM^E MDZ T548_K8)GH+ C$*EJF+&B9O]HL@
M1AFPN'^NWW\F[RQ;Y+%!Y&C*#/_9^X(JA6Y@MHSN?B-"WN[M9W I"O4#1$'\
M\A9\^LZV&50&8U?BQFZ-"+VBF\IJ6#!T;9&)^=!P,?73['XOWM)IYP*V,,!C
M?G+1A'&*;,'\H';G/B>.DH*^67XX:,.>^.5#;8SJ^,B:;._GSZ[C/1)=HA_*
M)(D,31C?\!G;1+:HS-[JU=9[_#=6?B(JJBBAU"O8"^_;/'M!PR;K<6Z[T#S=
MJPL8C]&"B-@]QK<++V55V)N(.;"9G[E?/#*!*UFTL^J[?'P8?VS(9)]SPQXV
MKWW<0S&-U@3OX)XI'QPAC"!E<0#O1:./B3V2M[?,%G$!;13!036>%(#TL=E'
M9+ER0<F\7TUJ"FJ,_.6.!G3#^+CG!:%SMD[^_O1SLS]? B??B[R?VE+3L)5)
M/S+JI87:-Y?Z$(MGRT@DO:!N,Q1]@UCENCAPD]([5A!(0X=.C':0>5-"Z*XC
M"Q9> *]YOKP4[FV1U"3GSS)UWU70J]IX^K6%]B4Q%<TK@V%[/P#!M  WXBBZ
MR):YJ0YJ9IGK7C<HA78?/B_C;Y0,"-4?4?F7Y83JFJ8*E5C&GP=0\9_#Z[_!
M&?&44TXYY3\.B"E&]D^<\"K!)@WMQ2OJ;L]HKUCC#!!XQRLBD8?A2VFM8;TQ
M4;IZ?D;+N68B?C0^4%?LS-X3C#((])0'$(D=M RNA/6/QU=TV 2W)B9:!-F&
M'P[ X[ZTLA 3U^%B:!GV%:4,/VRD!%]ZZ_7FE^;D\OY!;_1AN:>#A7)IYF(.
MI2OU0\POSQ_1 -;AOTZ(KHW!$1..?JA/OT:1T^>(_02/=9]N;FSS^*4(G?4T
M, '5+[-M%C>WS>&PG$C\)(/E+3A"V7-N??UI17H :\GJG'J5!/IKD%F1.W#G
M*;$1*7F4;]"'+>\7E,O_)!A:-EV[Q+PFR "J>R0XAGF1J#U+RUQW!P].P-?L
MYSBK'_/GXJ@*(6N2H^\9<I.=V.W>7]3)<Q*Z?H:_6XBY'0SCSSZ;B@X4*RBD
M#@6SQ7N=(P6=U5.Y,U;/.*-*T=.^%>DK71[>8F+)1RKQT/NB/?D9$0S?UW'2
ML%I'G'UYF9<);]:#6T@,NJFT80:JU'LCYG7/)Q*KBHDD'.Y_G#XLZ\3*^U3I
M[F=A-*T6<S<57TXTMVW=]6<-M.1KY"V.\P39R+WZN=%?TP9X5[G[ O=Y#?8^
MA=$#CKFI7QR9IZ>^]MTF'G13[.(-C(9Y7QJ-O;L]?^GEY8)"C.RKJVGH0"DG
MJC\Q):. '56^ PRA?R8D>$/;2L>HTP#3'E>UKZ'E5C>*HS]#6*CT&BB>N,[>
MI%^\==6Z<DGILLBD&A]HUR)2^%*\DL+&*E.8%'B ER%@?\%E5FN?7'\\D+*S
M(:"^,''=_B4;L3+:1ESS?'&?Q,:[<]1OX?(V^>YCG> \"<5A;C@NS;\X\1.#
M7OR3>Y/X1_U$FLH,8)9&\$!#(,G1[CB\3YH5ZW3X@A/"@5P)D8 FS>LPP8[Y
MYB?>?*Q<@N8$97_SUQ9TJ]S(O!%4KF'>K+3>_=3.6]$ V.NP:F5>9N$;'!ZA
MRUG61%/(B;LK#EAE>:<+)Z39?_B;(HDMH4J+I); $_9!#V1+9[^$6?&@JW1H
M$+$4H[(#I 5-0=.=>4Y;JR1*W;OKG[F8X/0++]FNI[;'MV&< QY3@*(Q-%CZ
M"1!?TGS#M@4 #76;/%@=629L]M02GY\0T@)Z\.XP\S7:>-/*=6IJ]-%%HT1S
M)K](C%7A: )/.-ZO[JWSV012L^H0Y,Y#O)_N6Z]'SW40A/8*C5PWT6;=O!.E
M^W;)Z#F^Y0KNCKJT!1U_J&5T@\J+R-#B@G,!UM;V5TL*A+1H0M;,^;N\U_4)
M'S31K6]H'  E"64F<T]X^%#V>%Z[,I8I0>V:-)4[W\Z663#-2 %<F/OR9O/U
M[GHJVX:?/-:_$]=J2:F.E?N)V- -8W-)O93NC4V6?UE0I<T'V$7VV^(7<X=D
M3,2^3 27"8#>>37.##DXM>8;Z>!V]@5J]Q05W<&P# SZ;014N6CZVS,SY\3
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M\T(3O5<'<:V>!7<N\)SW79>U)SCP.+T7]I$UHS)$2)E#JV;Q?:B>"N I,T3
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MYTVG_$-MR^F=%XE3]HULJGG+/X%TTIH**LHT>24#=K_8KT^_T((^>V:[7+R
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MP2]>C!>X+>Z'_^U1;^ZT2A:*QG:.'<0J(+9BZY3!566>H&682]3UA0?R@[]
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M(\M)XM117_71:XQ_GX]]LLG1&#%FAZ=B7BX<*Z::46>+;1H5>G)5WSD7[?#
MM2 ?!OO_2% +,#!?ZZ;R:#SA59]J5NN%R0VTT<-_4P4RH0OK6_P[%S9\!N Z
M0,9U%H+9QR.F+D[6V$*7F/WR#9%+ZICOP#4.S79+6[Z!GX+I2DS>6?M_+NF;
M.Q-#P@;_3WOW'=1TFR< /(#B:T%?%90B(%(T1!2$T)MB**$G0" TJ9*$@)0
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M!)E\#:Y@[M1INVOK:Z[]W??+.3@X.'X/C[8[N6!E^G$"RESEJ*#V-A/>&=*
ML1'QD@A$Q&O06)=OP+@D!6^R8T"_'WE*EW\[ -,S-NP$I.4-&D'D#^-4PN7T
MNY*H/#6P6;*<3AP\]M$>/@T<&(5JB&SO!,'.M7/%617&/0SF3\*C,!<NQ+69
M:'8F17OFMO+?$K[B)/N %T$T98(;UA["%EU\KB%,PP8L>HAK_4M-T>O4?>[?
M'SO>NPJM7_(]$O+HK>1F5W/O&CTM4N7K"C6X;H-I-\Y5WB-)8C?WZ'V><\Y
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M[P_&>X>0!*K$MW4:+_72>'% 3E)OYZ9MDV+8UA1&SW>T.Y&P4LU&G)4\Q&=
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MU#D.L'+-9\*6M96(\;$4^=102<)?Y8C)/?]'KS3HS3KC/1MFU''? U$K[B(
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M%-'"1.QSR.]A=>"BAJ:+"!S2T-$4B.BHOK:5B^</C@=60VXB-#4P7QL[/@+
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MU9;P\R7=Z7S=7P;"'QQ'\%\2<._28W&0^T+:/%?IVN'C$XZ%:#@CVT4SC4^
M@!-&E.@@ -;^(OQ;IE=YXO=]7>+CU"$^.O?3CI1T1&L5J<8E:\'.(04.EO2@
M?;^K2^)NXA\VCG6V1.:L E@$WW\5DQQWFKB+*KI7KTFQ;265)OQX:9'T=48<
ME0ZMRER''^TP4+ U+'=EJ3SOX&DFOZ"M;"A(7FJ0-;QXGYGU-92M:WJG85_T
M[K%/_PEO<?R]C53*JVN.^YEMW*C'&;6:D4G$@5KE$P;)=:O524&:'LN SV^X
M%R#5%<(]'8V90"+;5'=U$94!K.2$P\\^7UY^#YNV'*)[C#-TW+>S5)16\P<9
MBR7-%:GY712NVB2PS92?6'MB*) M#5+6=@T7+PM[E*8FI>2V)ET+$(&"Y.CP
M4.LO9E+0I!)&NN@RHTYTVS'.V%9@:5V5\EEV>&G%A9VJK"BQR@"L$A*Q>=%]
M$;Y-T0^:9V]*YUQ?7([7]+E9X].HQ7$YDT;S)&&0)_3;BUFR^&0$=A<P\E7D
M+9P$$-;=/PH3'S^(;^RT^NF6L\NU1M+_(,[::ESZ[8CA:8$4F2E#,3/(QEM<
M=5)A5I]AV:I)C&6>;![R/GA7G.GV/07U[.]6KDU1I6L]ZD7VY]$5Y,NV=BIO
MI:3I;&E<Y0D# Q1UIJ2KRD?*Y1X[O!RN'*3MO<VC23"8V;G2^W5@<!AZ4:F$
M6H;L*A]#S?%11Y%TA2/4S6J135A13)&(Q6=VZH78'W/O+=7MKR"DF%5((_VL
M9678QG7=JPA#:7T_ X>@<X420L]H_K[7-)!($PTBW\+:LOG1SR#/60%^XBJ'
MXA7FX&^:RU1\G[^VL%PWN\UFY'F'NCU_"#GV2&.JA 0M'B\2<C"9M/S #'DM
MM_T%F5J>/:.2PUH-PZ#B\@ !&%Z\G+UB,[+U);ST(BOHRX!@QKYRU\SP7\;.
M<_] VKDG?Z9BI\4_9:>'?1DK?A68&3V1NS1\?ALB6:GQEADPM)L.B6;Q4XN_
M>T>*DX:B;IB.HIMEAY5N 4G'::1T,8A*_L&G(X(N"OMSMGP =/ 3S+?ISG$3
M2,HO/A2&4]HD)L5,,UV,OI6";=??EWF"YXYE]+V\GG'K#8.$&LDEPM\*CE,T
MQR1#X\++BKR=%*>J&)KKB.UYB]Q#%1;R<5PB?UO3I .XI>TQ=6?K<='&,5>-
MY4KT#?3'.A7(Z.BK!UH!JN\7WYN.R4)2$ZOX,FA%B>ZNU01L UP(VT:;0@CI
MN$^Q+-\[DGR](!J\+/I35;ITRJ!2G-W$D-^ZUG8.VG&?TEE2 #Z'#J1%N+O_
MN*9.-';<B Y[IUU5(* "+H<IJ#OX/1LE6N\4T#2="!)"\0TO*;6?M/4-28Q9
M8#]V="*2#F&;4?)T&&3XA70=QAB-*\HCO=;OJ?T&E4A['P6$:6/M/4WOA@\:
M<4H36NE_3R=ZD)Y7RQG"//JV'VX<O?;N8<#0^X-2_"O:D/S$3)H3+Q?ZWMZ:
MO)IGV]]1.)3"(F?]VW&35F<]P+G5T;KFJ8RO+,IR4O08A-0XJT-58R6WL/"T
M=L\*6J7Y(^2FCQT*FOGCEGOC#GT^$-(X.L\/TM&;AS=MBNI!E$*'%WM?MW<T
MZ=OHO9<?B%400JXDP(_>)623.'"7UBEN[&M;TU[RNR.9A>-UA(XH!O]I0  ^
M6+.W-&9\6NI5K"= T=P/Z7?F)*:Y\ABVQ[=;)0%'5][5-8?4814>H&]$N9$*
MON$.?T$GU+62KOZ97'.6K\)7_&BD1>?PN)=3!DN%$'E$:]?=(E/N1-*.?0@C
MGU%/;$I-2WO.Z."18X;2@;#' -H<Z>FU9IM%O/C\0=H-=SA919!2FQ$E+R':
M>9C+<-3 (M]-,X?95F .COR0:BI%H$D2XK(J+LR>580 .-C%&HZRM;6>=OXF
M?=9P,_@Z/&#B?3]DJH5L] SK?,G;22,3TZ(I]9V<(8W'<LW+(@P99U^SU&6U
M^?-1'">4#*>/#J@#&HW3%DTQKJV@US0&K\84_,N1!BBA-6>.M?:%-WF2P>KW
M6'H&U<LB%ZL?R]$U#8O+ _>%QMNY##*3J[R#QGL7I2JNP[%[!9SLSO1D3"G,
M;"PEY=0C0Z1)Q%83#YI#L\Q+]'V$0]*)58);1C(Y(73MN+Y--C">T)+Y\Q4T
MC9G M6QH;5]AE+A>APU;W67UQZ07<(<:-&3&XR"W^?LS:.+HDCT93K:(@'=2
MBOT$1-'J&_*+\R&GZT!-NO!]9HMC#<*D'<J=K)+1S31L:3HK-K:\>-K*T1W.
MV$((F.(S!*JZL'<7##T]\(V8+VD(E373_VABL:H1?[L?E8<Y3I\^)R'%DF@6
M=:GZ@RV=-HRG4I_BDL_W?]E)G2)1E2( _ =#4M9L)2+3')WSAC  5_?$#;2\
M0GFW(GIB6<_*4A  _ZXY(<8BX\^:0.)W!@S1B:2WQ[M(U8^3", <#9QP,I?5
MI92FNQB *V$@Y_=)(VV1>4V@[('50]PUR-#BY%R/HQ]2_35Z9BCFIN!!*J:E
MT!BT09 U 50N\$A4T 2;S;CO.S! G(=!U_K5%5R\!8(E'S:CRQ[:J'I5BG.7
MK4_;J&\?(NJS<&IM79YO3=9^KF-E8&WLHK0+"_5X:Q6JR'\= >6I_@IG. Q
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M8 -V_:<A90/Y?,O+HSZO4V**CQZ5(=)TUXDY"O!5(%L']:![P+!;R;FQ* *
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MH)N#B<A" .85]0BL,NCNB)75NCGA21M50_=8J+NU8J@R&!X>EHV%$F- 3@=
M,IVL58T0G+0.*?AG=]%!^:HAWXYSF2>QJ6T[['J]=O;F+*!^;W/QP8?[#NT0
MF PUE++TCE&"@R>M0Z0M)79DH(W &+JS(ANRF*O"J.==0K'8\<!687@ D&PS
M[[[TO&#*Z/P12!EHK:F\JA:E5"9S!TP>!)=7X:T!K?<$U)'#+,_!!\M & *
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MU-E5TF?/?Y(EAWFPL*3TOE2VIW?]I(Q7HH892&E7T/2R+657C/C,<GFQ/Z,
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MXZN/.. NX50C6VK+\QFJ.0S/2Q-7-QC44-0-3C!A_+$F=DRB\5?0AI+DUXG
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MYGE\X'I-AJ2^-:GI#3]/87;S"YBYB4R1;,S7J+PQ_J;\D#!\'/HCA4N&]/L
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M]5W:V:]A!S?.((8C2A'$<-=1 ">;V?OH-/M##_=Y,*__GP1EF+X4=W;G5)4
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MFY0E'O6P6B30LT\&D?:?%VMJV*XJ_GG&]E_UPO[7XP$'=J+O[Q^-_3_^D+5
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M>QQ] ,[D==A)WM/P?R9FPA6%::4C/,EW8<L3;MINSSWIM-_T8B2-/FF[=>P
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M'\*E*8P[YSYG!4H[$C7!ILV<4VST^NP1KA3>I0NJKGEUD-'+[RG]747D.L%
MR6?9K\..^&^7B/8@IT7LMEC"0TW^$24F.BL[%;M[[%Y#/EU<7#1+EK_S)62/
MHDI(^S5?X7_["=-*T(HT'#XN9/JKU1E6[-?K3_> [Y!;ZQ6% !VI6$8VP1\
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MT[E,O^ULMYQ+>$]:N/=4$?FC<91=);X"QB\\-CX^)\4V<9:GA/ZU[$ S&F>
M*7G0:4E]X/*S4FID9FMH5"LI$W^DHPX^LD/3.\\ "V24&K.HS\KA;GQ#2[K)
M3XV60$AIJJ!]P(AMCY@+\$F!JGV#:0$7"Q9QT0<1D:T_;?6ILQHO^#[WU.U)
MVQ#,(<AH]A\&3/RDX\^3/QA@R@04$;&3Q=6U?.SBY+\.;7Q^\5C1K,?'X^Y2
M9DWK\=E)'M!N_RZ6[O'\QF?BZI:6*U5]7=-/MQ'6?S:"8O^<X!#@I\_,-I;
M48)Y%T^P(1^=[CSXT>I$"<%N!ZIX>:[8^[-XCY.X26=]<'Y]QB;V>KA@S>7
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M#Y!VTD.(^8#@_^_?Y/?3_P=02P,$%     @ "#I75L59%10-@   )ZH  !,
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M %DE>-:AUD0T1*8;*41?DFIXB^;]"7GGQZ;]+).E.^CT7%>3-FOFNB'!;M?
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MX4?S;ZU1[<KYVQ04_5U1@4#^=#L!@"D1 $]>N7,&EPKXAE2^U'G5;U_(TQ"
MC V#!2]\^Y3&VW=)X03@F<AG!-X[%H_6"^=PI/!,N[/=1 :-E)?A>9WT"FPV
M\#^9VP[%_8<V;8\X62GR:-*6,A>YFR78XLJI.S3C\_$,'3 =9#^*[.V/PSYZ
MYN8)8<ZZO?M^M/[\T)GI.G[(HE86E.8"_+AHE>(X#AF7T./$QVHH1PX5:^=?
M?[MZU!OKF#U*OBX9[GG3>I(2UF";*Q0U<S4L7(2;0=1$SF [)Y]Z2<RV#D6+
MMJTY./7Y<NC1K=5F]C/'@'VWABME4*W<&ZD+U5#T6+(.VH:\6/=2"K[#G\;9
MKY:N:=F>%F^$S+9'QEY5$"G78RLQ,*[7?VEE&Q#SHJQ01&&&FE9X)$_'^O'N
MIT^XZ_T61O!)'%QNXW1MJV&W6FEA8<C<LO8IWI(WGWPS>$K8STP[Q.^\=I'M
M1NM&V"9YWM,W?XV.OD/.-=&I&]"S_XASM.KTC9<:OK>0+_5* Z?4-"4]"T[P
ML,3[DA5?UXZ76T^ONRI;D%['JZDJI7DWWX<"5Y1_L\-Q*9C])O)]>744WE4C
M^VO+7HHH)R?'P52^I;WYFPOQJ+?),K0:3(?^QIRSXJ$O>&T3,(:?3]M6O7G?
M[/".C\[J^YQ3#TFX(U>+1>MN=NCV25)L[5Z<Y%Z^@FJB+$>/\8HV=*%9TW\"
M4XURZ<ZU[)1B6)N8CV]K'EYQ.:,GN7.OEJ_MB6M*Y?N0^AU>X[:XP5S$59N:
M(*Z%>6_COF)+_Q(P:Z24PU>9$8 .)< UKB14*':-:O@&_3/)MFGE\+B[%*(4
MOIL>?:'82WPGX8\I%?'4&>*?H-$S<$O/-SN8.*OH]3WL2[U'. _.S=R+0&FU
M0+^V8LQ'\Z,?=&_YW\RB_+CQ<5_,3HNY\0!C/ 3Z^QI1JB6-@4Q<YF;I)T;;
MB'RAZ#OAQEQD'^3:]TX+DJ147^N/&CV@GIAOJO1:5LXDRN'SFF:NYZ,\.6=6
MQR,M>LTID!5QF[,G/<<X88[>#S.],N#M5>VX Z$3 I'Q"S%#TQ2OJ#%YPU+X
MUR35XF[Y+_*GP?+>^9RM1G;HBC+[TIZWBGMPI76^4&1<YCKVOK6Q>\ENPE?L
M'.6F8TX^$K*_5T8 4+)I%&=8J!%Z0!_TI+B4T/67!  M.S$F[JT;BE&?4?7A
MEU2NU%2?XG5<.)Y& .[Q17UPB[?=31A52?^ZT*J1Y".6?\*UBP#HHP/,K#,L
MSGV>0[Y.C_2833OIPBP'$\EUL9HHU58L+<"8]0VFTKP]'MPL>XW%<;(R^1,!
MV-1TA!UL5> 5C6:D&(.39?O[M(TM$,+/J=5=(*"\O"T%.\[=YILDZDENV8O[
MKZ<1T5NY[EQD'/-7J=/AJ0;PA"G;+S"W)LQH%7?MK2"5#,7=V*#11%EF_U.P
MD5P%+C+&RNNG=/3TO/*F>8O\I3#^LW/7Q!UG,Y:8+.5R4N=CU/J/-=U%1#Y)
M>*"M\B/UFFX4SKCN8AS#XB(ZE73+L=-T-S8X<6\_UG\MO2O'ZRFL*'RO-<(^
MK?7MO@JJ+[?32#V3L__ ;*"5Z9))@X=*47NQ-I7QDZ\2 4@%QQX1K8C]KME!
M9[]VRIWL(M45SJ^7'L$?-+P?31_B/#<_\\)&_1T6%<?=E6SV@<US;![E@D!U
MKWEK>A$#1N<*Y]C!P"4U)LNCJS-;J:U=*_?C3RVHLC()%Y848^Y@[ME/%+9X
M0"V[DD(M)"=,T@=.863UQX0-NR[4O-V74Y9#T1EC:/B6O]%?\8W^5(L.L8XL
M>2?\*YWH6UVO6JE2YUJKKW0^W_,,B/C,5MGKMSZMF&ZHZ_5A/K?NF33&?^83
M"Q6HSH*P_<.0O>']ODAW-&S/U?W<^;(W0Y>L7>[;[;[=>OB4SN4)FJ'%H_OT
MC1>F/:=6M#E7TB\I0B+"O8W;D!EY88R\"76="PN[V6&[[)%G ]J;8"(S*H;T
M0A6H4LR=_4KIH(K2.T%F7DO*@4"]+=6M(:=<Q/#EXN'F!Y!2F\<1GZ;2A;X<
MEQ&KQXV]P<18G'KH;53EC9P7^KF4>[*X=^UJ:SJSVVO4!U,,Q:!DI_ (IF1N
M-A-?A[()6?H287_A(SA89=C%5CK4Q6MQ\I*I)*D)R)BQ]EB:4OO!:8]CKP;.
MQ@RI"-\9SNL0J/6R'*&U3\3(NW %BU(,1;=%XS@CVD<.U(IC@EFSW$!53W[G
MBZAJ<\M&U*/5.IM]AQ3+[NIPE9;%MD8(Y'6537A',G8E"]OINVU9![?XMW,.
M]!YPS=Q8.?\U=U<(XV&X'V[S8+ 0QK67E9LJRYN;4[E?_-GQK2>V5MQ.S^FG
M##HC33&3H\@K)&&!.DZ+\N;*J55_V"6YBAF;(\2A<EI?5KSO8K%;$5["?_3X
M*G/TNW&[[L#!I,JI$?ZV%XP(E>@5$<8/4H$B)R1A54I,)Z0L80N@[QP<V8*,
M;'JOI>OU)?GP,TN]&'__$G2=NL(S9_V-7WG;-J<8,@E55Y6#(U,A'11;J@PT
M8S;T'.\>9G>UH>]:6?8>="IFO),D->5P*A["*IH-'Y3'O3^(1@COAK9L;FU2
MO9OJ#^Q(\KE*X9_(=-T"95T^T.46?_\^*F'JVD*]GMBM1QHE*,PM3$)H"_7J
MOOXS?KE\H609P)0O($F?I\48^36R/,+-NI:[[<FU!356*H'+",XA&X$'3S5L
M&"+21W<6](K87I.\L$ZH.U,-LP2=EXJ!R!>82__J@5,FM'9#HNH7F%49:>L>
MSV%&[QNU=BMZ6F,;*U ,DIBF'+:<[\S%S8P-<?(ZL=7$5FN,G\A'T>E6"AVW
MN#L :OPEM;?D3_TGE5U!!U$\GT4:L*L&?UP,&DAEX\R^[KYDZ4Z6U42&]FVO
MZRO1^FPJ E\NB82\<URHM^Z48FR4"UIT+ADS1SA5>NLHC?$\D55!"9&ZNG,4
M5A7_%.2H>$P"@68QVH=*HOA>._RS1 T;:.7"7I6[&N6Q*T,OO;*F<-=.CEW!
MC1E7+/0A,Q).N*QC5:Q,*896I8J\%C_Y&[^;*,V,E@MV8FYI+U+6FX5=2EN+
M="5C'POL D7.7'NW.((>L=N24-#\@.8P\XLYWT9ERSDB&P3 PFW+=A.+XH%Q
M]B_=_>H:H(PL#3_*$?$E:.)90R/%.AT4>Y[)&+L=C<>6H+4"@^5V=7WK.I7;
MK-:8JIG\'-\Z$H!B0^MPU;.OWG\5L^M.IS,K<AU6+:H"AS(W>;/&ACB47OL9
ML DNT#SF4E![,ZB:4+2"(&I_@0^W;[N>OFP)YSG=EP$7P]2K0.JBHOO 5+SL
MW,I>(3VCLH/?9.SE%PRE79 A&U@'7G._&D^QX;Z-LX#_W%Q2=-V0J>)1&D4_
M$Y55_0[,W8P>O!:W2<:P?'[E!T&NNIB7.%!^H@KOO_ZJ$&FP@$F/ZSQPY->G
MYIA>WQ,HT5H[>0)P5#:: $@07Q7@Q=/":U13"4"[/'RM!>['UI"^68"S#-C*
MKWPOZ-J0ZN2Q^V+/0&[F]<AF/O# 8T-3'Q1P&%L<*. 79R.^G! YU<XJYJ!,
MG$]7) #Q8.8Z%D5<N_Z##$S5]W6\OK6)Q+U&#+.K;<V.LF]B*[$( _=>H?4>
MGE2E^[LM21^:.?CIF9\R$&W8Y>>AR*W<&-%O%)>[VE3Q>HJ1CC^=:^F\Z6VM
M=-4AFCM)0X+6&;JC7DE>?07[]T4\\S\Q2F)[Y"?0X4,'$.37,%?,X,L3Z:(U
M&WK;&DR,G-+/B]]Y$]4.,'[CO46T)@7!:W7E00C+4@*@K)8C AF9@_V65*U,
MS,<T_YI45:\/@XHWOG$G5OFVN!SE>HR6E?^0J>EFWLGMW/+_I(@6EI$-CI)*
M/7+6UY&]VJ*795W.P?823=[\C'2(0 ^UKQ2+:L\V"N(ZI]!9%,MZ8:A;U=_B
M\@4_.@9:1C*>I_L]?0=^!>@2H=?"]/HS78=JC<_A=S8NC*3,'7(]6)?@B>J1
MI#&WFO)B8C:D5T\6%V!N."5*\G&?W^6!PX+^D)S?\"UT[*D!'7GZX,,!N^8I
M;3.0.7J><(=X^5PH=_AL=57;SIN+428 &4=\[S3;&;15,KJ:IU6]1F]@S$6L
MLD/N"=-(K,N7.JH;BW9+1M7-C KO#]W^1%'U9"B]QI;*: 0Y\[2B<_7-].=T
MI9EG\)%I2"UMPDI/9L.2*11/6PG?%EZ"[ZUK/YHHZ1:L,/<4L<U)W9EY)_-.
M/#&-IR*;9*=QQJ $>U$+<=1K"DIM\&F4W<%'KMK!4#M G#$!K2;,I/1,CB=(
M?-6EB0!HB4\-V"DK+VEQ-;3+F+H3IZ*.Q:2E6B4O:.M%+L<;(G.4+N4&34A]
M;LS,4^MN9 HT6 C-13MMCUS7##,I*L4H-#4M\[^\" C3KSQ[XBKD,2D<ZY3M
M*=ZWG)/,;R!1\"#8O4R-V7SO6KT#V_D-^L@I2N;:<J, -\K>E=E$*Y&P4V8K
M4\&^36UB:1U7VT0G?:Z/.!@4KN/?]/>G23]]QF%WUNV\\X0JK9.)*VDF&E9G
M/9D/N9#1I_*@5;" @76/G]:^$F%TL8?M;*=-S@54J!I2.&I+D+]M\]"M,.5C
MX:X4'-Y.S=@+/8]M/'EYBTX7;[:5]-L+RE\L/"10S>#CX!O67@4X,_TTQY:3
MJS#RRVX7+LV$\@N\@L.:!2>@IP_9&_*!R@C<QV-4WQ, KPR2G9OZ!.#5X60"
M8/2! ,Q?R'L,&[-,S>5FHD]R0:!W0!=P0Y!D:RT -:W7#5L:A$5::-D&O !-
MV>K._C!>(F)?*TH?LP(JL1FJNH<(@"I6#5X)BV2T74.2G47,V21O$"OJ%KA7
M!A& I*"2O2$B^/"YPO *Q.EI(Q?X9ZNOV;6>9R,VU&_M@ZW?)&:Z8[]2N*TN
M#%U#,O]*N0A(N1J11,#K^XJ1/GA/2[(X1<5LZU3+'R<8'-6L"8!Y9PDNV4C4
MI%,>/,J.[0:3'L:D+R@JW=^,5[H\YB!5GQ1ABY$-KI[UH7_:%V%;EL '<^TF
MT[\)RN4>2 $JSD++R#]EX>46M)H M!4Y@]1XZ!"S.W91&\G A[6XW620 NW;
M 9UW!N#5/;]2]_.>FF'BUU0)N+2]6=C&KYMLU-L;UZ!O>6EC5?:"F4%P9#G7
M*5]$ %P[B7\Z2+#&?KPB%"ZC$MS.B#4F0(];&#P(?SO]L>O&$9>.:4A^XMUM
MM@5%'X3N=^M'\(8L!MJ %*6 E/3.0J5^I2^52!>PR!T+"C$X !RNHT)UPHM,
M%O1"G$!!_0U<IBD!@#T!W;))QM)G3/9='<18".JF[JC> :1)^^WS!@T_[2.I
M#]04&@C ;FHH%E<+BB40AKP$GUN%8I:U***J?3=IW:SF86=UO;Q+S- $X WQ
M59H?S?IFZ4SA)2<(0+7?O6]X<M\>^1W9/MF&4J'^GI3-1!-TE([S>Q_'YI*#
M/9'CCMNT:[Q>%-,734-RPCN]8;,L&6/XG@("@"B%KQ7(_4#_N-G?X2T=^@VW
M&J7_ 0O_(OHS'=*I_JNCTV$G/I]E=7[7+S*3GX#UT^_L9GH]SN(][WC0V]70
M&WF[05[7-[  ]<-(LGO/>-&.@&*3_UTAG7]7R&N#!&":-P/,KN'SW/Q>YG$J
MN\7)6] =L&A6LX:-"BTX;QN'C>]XYV^=YNP+0NC=@?XVB@8(/=.(:DGX<U!?
MG;MQ4ZJEUZ?V0T=AS;]<4(Q8DE7)O0#>E 5!JO[S3C)G7X0%?B,9A 12:<^2
M.;3*9EZL-*B?=-$X.[V9KU!>O.G>MWOJ.#_3+<0.CTX_6O*1,@0]QM?+I/'=
M@$K;-?[ R<[/\[Q5X'V-O$^G#[SE8;^^L]3QYQ6I/)=Z;Z;R#7*M+IVEZ'+-
MF6SZ0$7G?0;$6OX&I+&O_")W^GTA+XC(9C6O!0$H5PRF4+_Q,4KF@>D.&>DK
MM,>D;+5X[J,Z+7?-Y"<;"V$1[!"EQK#]/D2@-^=\]>E>^(?1T<V#?0WQ,#U9
MYA:*L/#;<PRPX!L38X'.DNS]O-L9CH9:H_)[)KJ3=U_Z<89#D,955@/M(U5Y
MSN[6X0OEULCP5L$E<I.K'&ME U3+'C&M&RXO[J\C BX[N25:8'.SPK@_N9CZ
M" R5\+Q!^Z:,6L4?K^HNPEQ;S4L;G$D)?WSL)EDI2XBLP%VD>S1/:N+G4 :L
MRBN*T(_O?[D?">$[XS$3L)DOW6&#9!ZAZIO2*M2_OJ?V\*FR-$N\0,0PW9R=
MD>>#$(Z;J0M4FE*7V\IL';9V\F]U&&M&W$1ZV7 E]00B),Z*WK5WM_<PK=(H
MGK_#YYT63*MZUYS.B)GYNMM,_'&=<S'&.^$<]W7Q*?:6];0DACF71D=6AKK(
MCA<\"FH0+N 494\432GNSGD\$M_7-DIQ_UGGK:S;V^.:,?]PU3&+:0SK(P0]
M^.;(A;PSK.";0 ]\J<\81]Y!T1[/1@#"K.Z $>,!7C-5M_H/E[\F)M!Z3DSM
MOJK<ACQ^':_Q?67"XX]S$D;,XP1@_V(Y%.<V0@#.Y]O_DTLV8$]'QAQQW!;,
MJXA47C+B9N!?5V8^]OZT'!.;2 ":KL"KQ]J*LH=  BIJ.ZEY:P*Y\L+^V2W(
M1XG^E7/#F[;H&T<_S_3^M$SSS9_.!G+E7SGXW03(.(T(@#:HW8:-FT)Q>F)[
M!Q4J!ZNPL)S%]0WCQNB634%]L'T#XA[I*\S0 ^2!>B;HI[*-4\72KI_UHU6]
M<T.K"+Y_M)T &$3O]^HAP;C;I P_F$:U%25CS=WQ06P-*[2JQE(/?U^*L7,
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MSZFD)@#2#;$$P%OFJC>3*T=A*%I6<!2"W6![33)CY C;&N+#+*O.@18KD40
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MN%BOYOAP*.45R=)3>5SA(P*@1 #660E 31&89Q& E5C8@2U89:WA:>&/!PE
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MRX/33P^SL\.VYM=@>@P0+?0/JX^6JCEOGT'#,Q+9 'B:/ \U^U\ +!*00=(
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M>;HQ>W2@4I+L(>6TKA^AC:Y -W_<&5F%ZQ2&#-]P7#5G9_H?=&;W@]4^ P
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M:>X5]J[:+S^/XIIR&LCVP\+DR)@;G@KB&^#N^?SL&?5)0O_A>3197DZ)Z1W
M'JP$YH0NR(]B1,,DCQF<^NO.=%0S=X$\L&T*\>16W7E68VGEEAAX\RC]QXDP
M>D9N/=8WL0-ONHG@,U]A:CA>F6KH]<:&ROIP.96=B.&*U7-BZ3O _5)?>362
M]D46QR>&%_IP]H=ETR:W6WLTN/<?62%SRP5%GPS;61>.273$8K;F;B)#!\;B
MHK9?N<318M/D^D\'AP1A23) 64QF.I JZ\6H:8YNM+6U583OEE2G7S.0)M93
MYALLE_J)+(LQ(R?;ZUWFFJ-04ZD@A@*A% H_YM:K4IC#Q? H$+%P&V1&R,%Q
MZ_$7@LF."?9JSBYYNOXO.0SDO@+52"$M+*M8S9'3!C&'+G 3'W*9$1;_U",1
MZ[N31T)T]&%&8J?2,C;Q]\E+NGG$S<?GXXY)0YOJ7<J?4;\1R1/M4V%D< UX
M"+,G4H9=<X'SD+*6!!Y+.MI!%F;</N?F"1>3*#F!;5H246%URY2/YE5<3'NK
MT#W1$EX]%J0#>NA_O1H8.\%+1) V!X,#A XQ$>M-GF#//$/IG#ETMY%2:GK?
MX>Y^+$G2&K]:-)B'AT_B\D6]$FG\O,P:Q,2P:Q$%G0F=VO=F5?2<OO%8[\"J
MAO?RM*J9)%QGC \].:G/V!>F!0HG19/@WNF^YS-IGR_-V\Q7#5&(:;<E46QU
MECA??U]X?=;=</N J4%/H2'=_9>=0/];*QOX)D>WDVHQ%@WISV4%'\9J:;<L
MT0T'?J=!V]!71 B**"I(:,F/%-)Y=;;$%<M8!K8I_9PA#\EB?XN]4' SO7S4
M^F/D<H!RP]2'\G/Q==F>%=P[-@+G#K"$?1%I5EXYY[W+*4.:DB2_PNR\D$5Y
M0+(7^ >Z3C+P +G%$5#CT;:[_+3JT\>*^_)HWQ6N-TMT\,\FY]\>G)I.![J*
M5LI!D"K@MI$+!Q67.X!&L+9AYYAYXF+UVU):9@O \QW^&Z8:+ Y$$_UEGV3U
M*'O.X7WB%4BO*8**^^D ZQ0ZHGYWU45HVZ3IU[[[#B!))"$L\:<(I[T2_<TG
M<N/,=P"6JUC>D25$^46P_4F3T#ZL=HP^:6G?K1KJBRMYLSR+$Z9\@E9>8HKY
M/5AD5T1M;&"W)8)J[.W1AZK7(Y6/'\\[N/;;88MWPWPYKFGK.6X>F%U_OP.\
M39:Y WR*IDRG-,JYWMZ7OH29KOU4*4>QJI:0@IC-GG-FN7A2*/JZR-/L9-%W
M7(\7W2N '+GEO&G(IW,(<*QB?:!,N$OKWO5BY@+X^0[PS]0/_U3@6_,)I<XO
MU(LZ:@Y+3IQ>L3GNQH$$4J.4P+PD7'6I\CVH_&%F 2J?S,G,\;>$&;DO%DP2
M]>JE'6WM]@(A+\@'EU'*-@P"#^*_MYS@A!P7G:5VA[.^;$/NS4L(ZZ8J/SL6
M<3=76/Z.."QKNM\VKK84Z"I@4U+VIP1_QVMFR?"M^WGV3>@O6O+]BXO$*^5^
M3,Z'3.G< L]Y="&]?\_2'S+D;/,&IOM_%_LW@.)TM%^]0"D%E+3\+S;Z7P$B
MUADK9K04DR2&_:_R\9\"TD@T) T2%"(FWP2SW.(:$]X&<P:X_5T2^-7DG\[P
M Q-O^L>S*_[,'7)_AL%OV0'[%?"'Z>R  <M_ D6EN"5@N('HFU GVU\EI.'3
MU%^B@J*M[*BE+K5*%_B7(:G_2TA*[OP:^BE_G=G^AX"BL]X7 [0/),EM_PN<
MYBGAN78<*D;1.L#TB2PXQ23).ZW^.A7\?1.<DOA5.*T/%/"X"K2A?$^*T%X
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MO[(G.*&XWBP.)+2==)H<JNQ'O)KSO:FS7AI@)G5W3[(9 ::Z/#[ZZA#DMI*
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MZ&!50*!&E<9W?Q>OLX3X*JX[)$@XPP4,[GI3@BA#WT[3:[7T&_JF;?U:.4V
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MX]7WL%FKCS5CUEG!"=)&I21,FA@OCBE43QU9;E]J4,92HYS2]R\J!,= XYU
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M59G>&&/"E[$<(ZX.^&*)!,BDH>;NW2(!1XCE[BU2Y;Q$A^,[I0J.2M7M<21
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MXR)X,AE;36?O\8?%14C-,[+:G52&,AMQW):7[M][J*%N;N[A11IAZG,G*".
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MF^0W7W]@Q,A@A$J=*[9O+M:!^VXL7)'XOFV8ZB4&<\:[N$7* 2.6ZUJRQ_N
M>C5>F*/3;K<IU]%B>4%@AXIUOM"W8F-X54M4G^G"W$'HPD58P],XY*7 J+)/
M<T:PG)O8/2!2D 5%:DI]M Y'7)7(GD=L-%DRU,6)/*P[5I(,JV7]@I2TG.D:
M@WIU39\[NKOCJ]IZO#4:3'5>U(+WF8N>Y@_LZ?$USHP9"V47^\E:>7E;YVV=
M3R>M1QJ9O!X1V&GYH9[HA@.8D5V!!(!(H0Z#^J'\U/,%AGSNE4$,H;[+P4H]
M \MYJ965_V3(.+_$X9R:/)4GNW@^O[;4S'OI%.#!]DM/,M]/Z6@#7MQ9F#<C
M-#$?6$3AN4^4>CL.%83#T4Z=723;XPYT5OF?[@%VL42=5@W;"*LT/2:4/FL)
M7=3*G. 31PJ]?BZ&@%/>,B]%=8M[P,QI2:3Z2^:U6DGJ2/:BO]WP[$8!(T_C
M\+ES'29J.#R>)=)@<6%<],H8T7_$P*$_940L(>M2G4O-T.JJ35@_/(J^9N+@
M$#3TP4%AAK4#LR9H,]U =,I6S%HUZ!("O*G^[&OU+PC&&9K<[:/PJ32G:>J
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M'MW$  FTQ,2[HL?2LO\D/#\MR",$96]>V2V@>KOPTVR5PVTG$DLSPUK9Q_U
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M\]W8P- D45BHXJ?>P3>FQW$%#N8/B@  ' #AY/Q90Z(DE^OT$JD$V-T*PN=
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M9JHP-PQKF$'$1=<QJ?3RY1:F/ADKL1Z&R]%3FA+LDDPTB%$F+,1,_-?MP"2
M5?8B/Q714)VXY>>E:U##_:@E+C(6VO3F\"LT7Z3$4#/C'H@:^!%T5]FM<E\6
MHCJ9M@70 +86E^/#Y3NFRMD.BT*U<;Q,[P060E.HOYR%L!  T5^GDNTO=]JA
M*""'V>KLN\2\C#[.E*I[#^$8A)$&$OH=)-. E>A5^)+1BTYW?Q!0914?4$TW
MQ=W]LNVQ]"A9A848FF6$Q2 I3"198>0-]/(ALYV1U54!:+6V&'@L-!B6F+6N
M!#T3U8?Z5!PY_T5%!IPP!@-6*-/$!1K^RD(4H1)-YG",4',4TS?=K!C,-P^$
M/*_1B\FSKF.V$?!&L"N0;A#>&/;"FXIQ,0(J?P\5>"OK&3'/"T%?HO>A.D$@
MLT+36C5"Z)D0,0ML8JDGT^P:!L+TB?_19+U"TJK$*D<!>@0E!]>].[)[0 /Y
M8)MM0W._,*G:]^#V%?KJUF8!0\[E-E-2M^>>R;Y-O=B^T',OU^V-^&D6XL"&
MH\K:2)TBEQ/],2!VKY2M> @BUOFDC]X5<;D[BA[K#!U3WQ55XXZY;*H+'&9S
M'O9.TM;+_6V7]C\+'5-\_,E_=/O!?A^QYZI9SXHJ\O,OQ8Q-K3$WZ=GZX&AZ
M\]-F(QV+2.4MK99WTK'.2@I$U;9N7>[J?6%7-BH/&2^'-\Z<YD6>CH9.=G@=
MS!)1/NOL(ZI[L23R)-\+P<.2ZA(9MCJ5#1&S-$>J*0>;X1M1\/NU[$+,M;<E
MP07$D^>O71#L_J)IB?Q@NH7D?G-N+!E#7R/ANB@:I15E]0.;<K]1JY-9+IA]
MAXG]&YS&_D2BQ10QL+E]<'$YTVL[S.K _I#6=[U@S0!Y6X76PSOPGA"2%GS"
M DLG"L!WI*KW@TP9 M12B\]G&+CY<WN!_2%M,PU_QO(7B7UM9X,8K%F,.;7(
MY(6/*J&9OM5@]*$14!ASF#%)%T1^_JOM).T?>'KETJ_P-+WE'&_^" NQ>7'Q
MA8K;E#]OC@<+L1_;TUV^ER L7P6MA:STN?2+<#.84>N" 0QM<WXR?92IY[-S
MT^O 6S33G.O;,=1CW]O,8N?PF>TBC8 +T8IL5#&)"0:V^!#"'V00#];.CWZG
MUL?<=7DLA$J-J^\B\#NE6JV!)\G@19G_E\PLJ%9H&2X' VK1\__B +S2(0*E
M#G4?^XRRKS&]KV;K/A"K7XAH&X72%GNJ*K9'=O&Y\DY=B%$P6D[I &-/2IE,
M^A<L?3 7G+]HO;']2F[*=8=(65'%;9G]-5SSN7FGO+@/Z9,V]'<.#A94,PA3
M%I];4Q/&9+"3FA0*4ZIW.RU>+8(-$BS$,85)P@;<B"&*LJ0(WW%N$+MPYV\5
M[A/0^UT0<<:5R8-?;<O8/7766TD82Z4C9WC'G)K #MZAP1X3<V].*]+I6V/D
M.R<G:#(!TEEX!<U$+:B S5S&:(JI\.C"C=AUH8B+Z'&TAD\8D6[:%-^*G'O@
MC*0LR\R_4!7+HX*EV=YG 5?$ FS/+9EG.R)+3)4L*J_ E4Y',U>7$-^K?*ZX
M4]: 8H2K >]2S\_@(C-JP#*3-Q?^'KCW3F4]:O\,.7[G5#4;.AS]%ZMV_SNK
MEF@Q=G]_JXTA+[:L=0[,ZP +<0BK*,P ]G+Z\XSW+[@THW_3VV]M Q<6BU#$
ME\#M3'W"]9EFJ328DN!A+'8EJ8:!B:]9)K$0$P58GWD!_ )V%:D2.9?DC)RM
M82%2N^(F?ZL GKE'D7F]$+Y3,"F N\H^9+H/KNH]:E#Z3V+U:SND ;,0"UA%
MV'X3[??Z<^@?U>:BMV+(N[#7YWL"(I#.(DED@XI -RTP(^S?X%1KR)F7>MH"
M+AN&[?/\?]-BB'=[+S^$)G86'415QJ9,2#>;E(']#E&WPE[&\'# >K,RL:_?
M*\M1KRON9$G G!3FIK%A7!C8?'+8MZ#S.1P(4"FOP"MOM@$QIG0=#)P%4.^4
M_<Y> S!+8+.LTY+R\.^%Y=!UN3(YIY]>7EF_F(*,MYG-.]S<KF!3W&=:M:1(
MSXZ];\EM=L(IJF'U24'E#LPQE)C>VG@)=%M,@U7"1&"3P_+AARJ"<H6N>!6C
M]*[\B?TC!0]&32Z]G;7*X"Y]?OJ G.7DW&WRT]>;<PIN7Y&K><6U.X%#>Z7M
M=H]D\P<B$N9D+TF'.WWQ\)HA1_^OTSL._?;Q""7#3BHOI;CS\N7Q2.&P8.U=
MB!?;%R0XDVXE'<F*;IZ*O\BL+B@/Y]YR+&A?0]O&=VDKO/>K7;C9WE6R[M0E
MR=30X^M(?@D12E+E5I?+%+(M/_?+?UI"7CE[]-YV69J3CS$!WU6N]:&D_9+2
MOMC7Y@F9]<_.O!-VH8D$O6AVT?.YD^&]NT/Q?A]5Y[!T?M9-CY=K9N,L5<I/
MV06,2M6MS@^2>]%LAQ$U'T <.+!**3[XE)/1S(#MY-G]!;P*^Z]X9H4=\9*\
MT2 CJ6;M]VK;3;-X(7G\<LBDI:?23('[U?A3AMW"L44/%"K(F)C:4.X+'G5U
M/7A^;#JQM<_1K9QQWZ)//H);_.MJK\/*'K#/\\[;B8V5/^(S_FW(&;4Y[&;J
M(RV&Q$.V(V67M@_(8VA;\S%TAC[1NA?J$B*M!S[S9'XD-/I[+5NL0>4/IC[X
M,U/;I0CKJS;/YUBMOU$>&P5G0TIT,XA[Y'H^%!H9]"- 3T@3F8-HM>LO,%0]
MKWYH= YL(VY+AURY'R'ZH\IAL(&[95!D=H-];=U8F64]-:NEZ*O]/S#:Y(2=
MCVWR?'Q7RSGNA$BM/OX%"NI.LP OXUP"93X70)'8Z6\IZ\)>NAC J.NF3=TD
MY-PCHC\+4<_X!M=9_P+7KC= 3G^[20T:;7(=BYZ2BUIT+(:W,+(^@NA5AKU/
M>/?I^-.</DY8U1YLD S:NO<KSWM8Q'-+%B3L@G+@H(J8PG?-$MR,$XZ]4$T^
M;@8YBI93AU] 903Z)FSZN->AM@%,$13MW\PA>F:<?9?HF,)'WXPTQ@[@R7)!
MTF\Y"!=,E. 80<@I5*)/\WMQ9'<\7HQIB>HJWV)Z@7F?$9E&ZVRGMD:[#M:W
M5/Y52'Y72P&1_-&Y"C#Z<YWM%@.'#^"J]_\:I2>MU#LF"RTQE-^;+VE]'ARG
M:K@GI4P@>: N9_2L!B/BVE(R:08W"Y)VY&"4,"4)"I49<2X$_H/83,+.8\5@
M6_Q+YMH<D!WS+_^],AQ76V,^Z1ECD%[Y0&V6HK!@#&]I!IBW"2# 1FCD:!<+
M0?R"2[]NY9?\8;71P'K7E5!-'J0S5X8Q'U$5:ZO8!M5FR3 #&QG5GH4X7V0F
M;-SH?U@,WF0&Z#;V"^YQ[H.%B);Y7A CR&Z$66(G_,P&"H+1<=;_*/9&WL=(
MT[XZO[J)_TIB5+$1 1:S<S]?L6>;Z8](39D-VY=1V3J H3+ +KD_XI#C(7IS
M\O<RPZD0N!2D16GK74%>EA,V :6?]U<1@S=^!F.)F8<FJBR6;ON\]O@,Z)OL
ME@PR>D6:G(KI'+)^7JIN:?TUQR6!24N+J%?S5@^4OJ(?>_+/#AW2$N?V\8_D
M^B5J!^X_H+;M5262]*UYTZAV\USRJ&6-S]<* ;"/=;7 F,]F*:)(BU OLBGK
M^GD,]41^(#3:N;>Z#ND, !Z!E=K'0OA!<MM<YX)OP6H#X+IG,8BYN<=6J'5R
MH<BM4*)7*7[Y?7FOYD35JCRI<]#W,FT$BGD61^ED(1+YFZ[%3*2&(C2%'V5.
M:$K=0*T;6,TK]:'DJ[:KF*ZKT.F4"_9-UR+*O%")OJM\<!@7"WAS@K!V!GYW
M_B',COQ6C[&07H1WS=QP9+E3FM_$B6GGO%=SA)#4N:Z$W4],O14UM?N]XT=O
M*<O9'MGN9Y)]OWJ/T:Y+HZ?/OKEU:_J<Z+J-&%[,3E4;^7F+T<[*^67?AV2Z
MJ8;VC.'GL<&Y9T%3E)F"L(07,MX^<W5\Q[>'K^+A.\#=$U_\;$),K\0O$YLK
MXR*T^Z;=8\D]0D^".8Z*Z!O5Y81*EG+O8"OZ<CG9:QX/,6]O 1F^[^RO]2KK
M"0Q?77C:;VX:GL!R_"!0&1F#',;I IP*@&C'8/O"!225'/M[1LWQ4PLA>2ZV
M%MAG]8% 2; QPKP H['5(M77TT'2K<]6#-"$%G&A*/+./@A_#K=PT'J/.]O_
M_$71TS]3])3>SVW$$ EXMSXQLP[3+=X$4GX9U*P,^84_\.\[#P&0M<8R7E[A
MA*VA?O3H&>HX?.** \A,::;I%L/VCUT'98B9 YF_DI#L_@56?T?H^EFXPA6
MS=,<:6X8)0Y,S);6Y0Q,,X$)G+J4[C&P:'4XXF/8BYT47,.D,J)&P(OKM+S
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MW>(7175+AQ? V_%4P 7P KH6[\K6F!%A.EC<(;6MP!2Z</UA-*'I6=1P'T1
MCUMK,6JPQO0M%E39!:EKN;':G,O["9A!^'EQ;F?;)(K,#2*,-SV>OA?XCG'
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M.GN!<T*)/LAYT7+3"3W7@?J6G.X2*PE8'83]&1;"R!+O-.F93%L%?&TI4R^
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MIQH/7]KK*FU&WL:IA'1&8C.2B!RWU8N'L_3PQ><.Y/)"?K_DV1#?%>#/'H_
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MO:JFFA$KW)TQ$2K<$M5 HA(:B.Q(Y>:FM](=]K/*<W<BP^&E6"VWT1C4 &V
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M1_R@K3<-0UN+<G>*7H2$0@L$+S<6&1]1DU38/[V5X8'4P?QHT7PJU#A4:80
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M?Y]TGSE:VKHC!6S<RGL;*2WYZMUBWLU&^-RNP5BDJP$!9E5%3/;:+MP<9O^
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M>[MD-IF;&1S=+]&NQV6-OJKV5N-V<ZL9_A<:W8:3[@K;9Z'.?4"W^':6^2L
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M8/+(]9^_1%8;VJ;Q3-IFYNQ>5'DB07DBUY8_*>-<L@/IB%.O(8AL)!R3=VL
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M$^__)<':?UI[U)\Q6UU-_V-<P9^YXO>77/EWA/)/2'3_"@4M1\;?%S+U#Q8
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M<,EID:F4%<@(C,[PM:#TRV^V AN:WXI#P%J;A*'HX)7T)E%$*,4"0PA CV&
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M7%SD=/S"?!Q"+)Q<''\Q@4)"0D)%025 0R/@>$_RGN/_<7OK!F A0I5"[<-
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M':#@9!F$[L/Y6=D,[^&Z%VO%D(ZTC>A?T6;8S%99@$@#J?1UYO _5O,J8OV
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M@KJ&KX^JQ-)T7_Q(T^V%_-.,YKP2^ 0(D]'T>T-CY:9[%Z0@0<+-;W?BVAM
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M6_TS*!N@TT!1D-[OD;.=%O%'^LJR%L<PK7<VJS S6\UJ=:/1SA3"XO'?M]X
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M&'U=86$N'+Q?R^T9?A'[XQU"S90=$KEG@<QIDIZ1A.M_KA%?VV/*!&(RS.$
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MEO<; $;O?4'CG./RX@3E:,WQ8@O:%W'"?5&B!IY"M$X8ZA:LATK<P+GBTI=
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MF#D\%J:Z:MQ"9%0PH'YA'$-]=/ :RK0T3[-P17USGK<Z-%QL+1QH$UJZUOV
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M+O\O[XOY=32-^'9*EW$!9E[N;JR2#OLWCU<10%(_;/G 5!N90.$Y7FW1PD/
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M&?P:[R:RR8O99KLO?2.K^SH@L%>7<7SY#ZBS_A6X(<L&_XPYPIQ(HDA<'H8
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M4KWH"</I._%8=:U;SN8W5-*(&9A*^=:9UFS\XJ=B+G[(ALCO#Q]XIK!J3/#
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M#V\)76F'K2OY>#'%QL85NK<. A:CI(6D/[\5]%,/U>,ORDN74BA??QEB_\S
MA?^MHON>=T"_QIBO9MY691=;?/,P%]N(858B@Z0D6X<G8*'^G%3VS4^]$5/W
M?\JPL>/[6AM[<T4V+C34%94)K![1X:TUDV*SQ>.U/Q*0V#I+>VL:ON\YZ(R?
MIV]OI9RT.\U[]&G'_*5>K/E#AQF5_73K:IP<GL_M3QHKXA?$!'JL:5T8EZDK
MZ8Z)UIR&K]RW#'^3XM8/*79=Z)@$B0=CQ)VE<W4Y6C%^35U[X> F(ERYL;_D
M@Q)>9UZV-1-<,]KN1B9O/**\2Y2EP^*,+Q7K=2 MF>$\^&/@5S^84.4_Q9 '
M@5W3+BMRVC^)Z^0PXY;G#F<D-XM<NP75E,UYUM-L8I@X7TVOW7F@TN)7B&NZ
M>\UY>?*#99E#65I.@V,KZA& I(*$^R*C>MG9:O;UV 3%:XJW&CTHCO-/#AOK
MVW0U V_"_%]KAS'H/_-<%#$B%F2DHG62)+M"_Y3NMKPG[/GB#KV/!7-5=C*J
M=>LSX901^. /#J8$NCZ3^!R!0VG/W<G**@]M\M1]85-?.[P5KU!,=(/U'R;P
MCY$KP#*0)$G<'4D#=T'!^MFO*$+C,A]K:U,3RP+Y?S%,M!M<LE)%HS*6CCC]
MO&IR!'A?OV8"8K;]1"A]TCX?#7=B\_+>S-"-Y\Z?Y5I8+A0&!>_4H)&+H3!,
M-$K\X7WQU@:^C6/>33),L^8Q??HDNJB.1O:8:!97.E'\C-*_!^Z?@I.RS-WW
M,[D3PBK)+@6J+Z*(FY_+XI#U=)EI-7/7:MK<6!"3V-VS8C!4(&HRCDO.:!84
MO>URH ON2\4QIG\^-NF7EFH6Y[X_WQ*($E.,S7O!VT\_(,].PYP5UO.VIBG4
M?*R)0$6U(7_(6,GT7U%=1PO.-KP'5MV]="!3B+;X/O6%TL:OZ:C.?4B%9TBS
M1%0SSY:'5^UK;P^:2\]Z61M9K"4J8>LSH0X2,U>;/QG&LXM2=O9F"='X+8AU
MZ.T1MA=QB=HBU4C%-XTVT'D4NUQ$*-<:*W_,>#KJ=!;83M;KB )J=K_2,O@B
MS%^=*SD3QVXKV1CF.Q$5IEY_)Q"+H8Q9J9[BMHR]DR/1YV'-KY+7)ESDSCR!
M(A0)?Z!6;4:1S;FP=NE\RPBEC;IH;=SEV@V4GH'=.VWKI7Y%BR[E&22;G1N4
MG5K>&8K2A'\+\(;$&@FRW]J8"UJ3NXP_U?0+J-6-N\[Z7.NPHVU28Y$)BH7N
M^JAAD#1XY>C97;$1&H9Q6KPKL:$98M!%]Z@7JVX]O]+]0YG$>.L)^=N$TGSS
M:=Q]J,5=#'1S>2JR^"9@YW>W_Q03[1_RUU27O_EGX,X# ( ,-9.HYL^=P+\M
M6O7CO->J GL"9Q67AKZ#W);&J9_VG3T';=G=E,6O':<.2LL$;O1]4RR/O85%
M)A9#A.(0GL]?^G'6(+7P%$>OM)V(N[FWB(SJ3KQ3VEGQ;56\L0=\S95]A)'%
MG6V);RJ)4.ZYB+,?UGRZ=RT8O6L8FO6!)Y')Z67]P>BW-NJVLI1PFRF*AF\4
MR0%NH6#6!_25U<UA'VWR KD8ZAY91+X&TK*C4JM0>AC-,6H'@\''_E>)NV<"
M=:;V@6X/0Q[1RS+T4H:A/*J^LSWW ;R@KOH^H3=&)&BYI+;?EKZA&ONC!+<4
M"H%<E?M;LE")!T_;#,7>+"M9'FY_']6HJ!>H=;[77/'DZU "_:7E0/> IR:$
M::'E5KC0.^><T(9#WDE2CQ4Y9%#<AG'BQDL^6<,BCGPRW?:$ [CRUO&Z<"KP
MRQZ[GV.==-9_-TP'ESN$&_J>*O%+4.22>3[?YHGZU_9$&N4R7Y$Q^U+[Y5'[
MS*;7H5\J.K.(JJ2^I07*+8KI.3\TD#@L/RA=&IOAK!:MZQXN'VC]4B5,BIG&
MG8GI2+[D6BZ?'>U.52#)!9SD_=O_M\-2NI]O]C%;#'8*+FKX_/Z;%JX?AC)@
MD%V=?X019<<<OJI;$?XH*[#'.?RE-Q7A2)FTFZ,S(Y<JT2=#>[]H2CMO*E=>
M%';BM"MX%&TB1*?"5/"YV.1-@<C5:*^U9S52W=U;DF0T#P[7/C $CA U\6>3
MQKT?LZP8%O;]M.H/PE[FRP!LMZAHK:JK&PGD.PWM+.](9LJ&DN).&\\Z#P@1
M[VAI/^!5"K="]5HVO6TT9[)HI)0_]\0WQX;(+*%';TWNS@,F@#J?B9R).H2%
M=3!D1)6M'*\C#62=M-1@Y_LN2>%UP&K;B@RJ@]W09L[[-RRBWQW?Z,9X;;#O
MI86/8F&E$ S>)KUO]BWM4(^ZQ*]HOWPI-4KV6-\RY4M'X6OQ%T,D*6SHE*A6
M^]0-70UE,[^I=C#_PLMS)I+3T<\&+TVWWX-*"8."K9?6-F[HZ9V @ &ODE+#
MY7'8AV1[FK38@3:Z:+?@&TD6W EW<26?^;8VIT6W%(\7Y*0C1S*RV"H<G"N@
M&R=MS6%5;1$]I;A8[_%:UAPOC1O7*BYCPR3,TOY,!,=';;;Y79+80CU@=5*X
MF3MKKD"7'?X ]^^.TOY6"M;K0Z:U\U,$$]_1)S_-K%Q"^; Q\JZNMOS%.:L+
MCF1J72^5O=%+9V_<I^NOF+*SP,VUG^H,(Y1"R^XZ-C&J4*NNL-@"+)3=>.-O
MSY9KWYM;S$>_)RLLR,07:KCP\"!)IY=R<G3>P6+&];D7KUI]*8+[?D5BI:N<
M: <?:V<PQW"&>'0WR["VOJ$NB7OQA2BQ#3\_)H.(%-V2'^LP<]&&Q7>&UZ ;
MRMX)I5^'.GL3VG%V%_1$=[@KSY8*398^>'U$ )];,KC[SV;5&2/O<46XK&$0
MLJ7R;\!,^P+%5.Q:LJ.?4X6NFA]J'6Y=:2FX6#'6\@QR])362:[H,$+?+Y5Y
M;DQ.9(G?^'#/"MQ2&^U!&$8U&\A(8(3U<E$2>Z-@0,:#Z(=?4:'1WLJM :,9
M2XM],9$*2Q'+O\,;J<6OH#;;>M;EW3/RB=IT;JJS,1B<5Q-'G6?1AS766:"$
MYH"]AR(O&NB,83=NG9,>$4=.@9$NGH&W58]=[N+%V$9<#?;4WIBT#;J8:"'2
M2DK\3_Z]%2[D]I9JJ0V>)54Q(?FS!!]<6 _Q(#S(!%3D*S;._D)O1E2 &S,*
M,X$,GQZ+_&M5R O1M#VHPEFY5G9*PB.G)\?UHI1EQ@;Z[6ZP5'M+]"!#Z6>I
M4[,BLMII_"\'![A=D/R^7PB*[N$NFT6_M>,-5VH!?Q&W>%R"<5^G:V%M'W-,
M-PL9\2(2:>S=#GOW]B+5M_E'X3L]".#)Z_JV.KVZ50E?XNX3C-HR*(,+1Y:-
M"]6$<^C):963"Y8+#<]U=[2_CM#&)FOY#Z44'"N5APC8?^2+2M^+Y.I#>]@+
M>;Z]=4>:[N29BN?:U7")KUB+L?B^CT"(S[3!TJ?QF>]8N)YH"<?V4RI8;>5*
MOP6J8S'25H%*HZVKQ"\DA\UH/ ;)3UMS(Y?'"ENMYH\YY&E6P_=\'^:KYGDZ
M#XSL6-=K6[V]VZWSG$WR#+WR0J>%*"V5(EQ*ADB#[.]^??A_F'O/J*B6;5&X
M"8H@@B!(!@44)8KDV**21+($B9)SSK$!!10D"TALD)QS1AHD2\Z2<\ZY@:;[
M+3Q[;W'?<]X]YWYOC/O]6&-4=7=5K:Z9:\Z:4UY4<8CK 6>"L/IXZ-*#W9HW
M[0O>Y\98R;8!6>FFC]:JW57*9YL4EHUMWC;0G2I58UC_$1B,T2ZHG6I*4L<P
M+-QC1(==8 ]E5:YX++X7-2&QTF#7EE,-]2USW)6)N?>QJ#G+Y-2\1,3.RFIA
MO)TM%NRXA@UZ''ZMVVTDJ3S/N)C_:F0 N_+H]4),!S+TD$TIR-8$9(83.JO4
M+?MPH5HTKZLTUK"@8(7G?@])X\:F^4"@0'1\H>-'W% 5KWH(_X$L1H<=CV^2
M6]YC*K[.< N?:[@/*UP:,07S9[OQ\\Q0(%- ,W:<1X'04E&@.6/D8 5RLQ6)
M 9B43;V+UO)%M@$9YUE6Y^,AB*L1*-"'E#.%Z;,*&O@-!A3HEH+\_^W;)R0/
MLB%C42C0)* WU9N X;'@,A9 @[)!@;SZ(;N<:/_=8/%7Y53*,Y#Q6BB@\>:9
MK8*1&#"XW)4UQI"CL@+@;>%X*-"L^*7V$Y+,;/#8<!TPVXP "N1+<ZD-TOJ2
MB0*9J9W* LMO X: V:A/<JP2IN^59.O',ECT<I=N2/SQ[$,(GQWADYOR1Z6E
M<1WPD+N*IG<?63@0X5VW$A-MI_B )71J^)4VJSU;K96C24W,N9M"_V4]I1$9
MQE2LXRT5P?0]9P<3>Q:PQLY$U&W'HSZ-Z7OEGS?H0R$Y%0I$H8&-/,)OAW/5
MX)"F9XK#TY*2;\J&RQ[F;:O)AC;<O).[^W;P$W.M$Z.;2OH%B*"S%WOH OX6
M?7F3E+I9%;_%/:\N*ZHHY>:1:[%_O:EW(ZVLS_#L>9QB1EO3FZWC+C<_;\I"
MN-W+ #<[B\=J3078'DN/B=#3:N:'TR[#NN\R)-(>:A"9:WS)^K\AQ^"G_^8'
MO5>^,T*/TF#'EN =<EGD_5^8BY &_7\;^S= _M5$<PU(^0M1Y']#F;=FW,9I
M">E*5*^3K+%655;^GA .X]/N8>F(FO+G0A'ZSNJRN$)1YJ<?1.CG"P_S[QG$
MROJ[MOHK2@V2HT";=IVOQB2(Q"R=K+!(W1].5H"YV;5*[-RNQ'Q\V4G^]&EV
MLJ[-B!?CW>QQZD!KR.:4[$ZV0O&]EHU%)*7ZA(A1+F>1A&Z<G(ENE9N=U9&7
MO(@.P9D708B[88W:OR8&R9JB--U%8MG+GXE?VI[0CD]*X$M;1/,;U8&J1!7_
M):B3KO\^E.&O:7>2KI<JT6R::0-C=J@ \1IRJ>W%)O\*4I;G ;Q)O=-%_I=+
M;=!747GD<-D!%(#L-.+!I2;Z(;'XF=I(/P2!!=E)^:N5='WP%?>(W&3STM/F
M3^R*D7=\^'UN2/\>;&9-0\!ZWU^Y__;#U(]<4:D2XG3TZ@OV!_G('(VR4(<S
M^0H\M/&EL'AJ/(YU:0%V+GN7H2G8;'L=A?&>*7^CQK4W%2IE9;4XQQRD.W2V
M>.*"\6$##&FVKJWCR16EB@[WL^Y5^",:G<P\SRQ4NQN[K\@8[#4T;#T=*0ZT
MPO=EO#N 'A'.W?IQL(\[#&?S0ZX>Q0L='/QHOM:!L2Q)6A=9UEUA6*94SOC$
M:OCT=./LN+%1N!O7)'%37EGJ_C4AP=Q$1)GK4-H@3[GUY'AE.':8?E"KF,+C
M&RH!FHS7QGCU2X*YUS)?88PG9='5%@9P!0L$ZHN2*JG(@8Z(XJHD5<M$5<X\
MH(CS!A0(@@7O.SH#GYR]12+Q=[/(= ,*?G53-H\@^\=8YPB:^2>W'V2C0%8E
M@&U6"=Z>N?"43!NA0&!KR'0#DA/MGP\CNOPYSJ\!?YOL/_T]L'C\(P/<U)LN
MF$Y)5RY37;Y;*\T>PS2D'GS E>]7M4T):8-ZH$"@BZC);##A?<AUJAGH"1&S
M< @*E%QF-8SE UF0*SP%(_V&8,_K[M^$RZGP%3BW]#0>VZEK-&VLFAQ]:C@#
M#-#)K[S"2]7\:4ZIJMJ"/7;FX9R]YXE/)4]2NAW/'YLP.5# GC')[GHD#&@&
MUI=?Q4:$1K2??7-I8/J8;Q,V2#"54;1[K7*02T J1[R4&Z>8@\-O(JCFAO>
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M"(K0 UX^FLPD/!-W)S/NS*C0L2+O_*"BFK C\=!,U[#C8"31/"]O3K0G<VG
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MWK%S?6B?&<!XNSFV$Q1(%H$5<F'=(&]!"0#&!9D1A""DE8$%9)NT#S#K "5
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MKVI)7U&@D.LAIPO3;<.EZS(X?89V:=@"I2[@Q@Y-0K;;+4?D95V=R.>?@Z7
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M5KP()-5)?)&C'\P??&WYJU+L_=6XI>\3T]<'"./":#[1"SU=IL>7@81F[Z)
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M= 5+ZRF#.: M96MB?S>%B%44&*LU1^VG?$B8JUK$!EK<E+(SL@&ZHSX#E *
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MO>!D;TQK7MK"?$&JM-'7]98. N\M6/IT+#8""L@<+-[->VE@M/#/V#0#;YJ
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MB4P.Y8,N->,J$L*::4PY%3L%/<QVQ0QTFU4Q.G&O'\CP<_N#LF)?!J,F]A(
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M?*\LNJ6PN8VUV9++4]@VWMET%)@_5ZL$'F. H9A1H7_\K&+^EV"9_C,8OOG
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M ^"Z-53_:&URVYBB[D@H<.'D9"QCX0$HOGO*='*&X)W!0@B_BKQF8^L628%
M"_[8>%@9!V,U_417#ZE=86I=;L6:@Q"#X_+M%_%2II^EXFWQ+O(]6#5Q#3]J
MQD^_ >K_\(1EY9HI7XK%<UU/ZB%2$C \?4:#N:7"D)23.;U%_&Z,0"0(!T#Z
MI)GR(3@#8,0:9)?#93=,^;3/:JA,+5A$WC,]82V,)R16R&DQ?Y.<JG@X;KKW
MR%#:_^5S50(7:FS C'@.M5?$3G-NN!.'5/A>__6AF(7/M$;:':(P), 2J?O@
MMY"++656-_8L[>M$A_HZMBX:-@T(J0T;I7<3QF>OKN:S=F7OD:C%18+Q;5VU
M- ZJ+G6V5AMO%!I[O/2NT+-(C4T.M7&VYS4G05MH;XW5$"1P+70!WY/*LQ38
M_P$ <;BN.9*[6E9<_XSL#%=!G'"S3)3\]W_*I7H2_1,U__RO< # ^/=6?XDI
M57+N)%F!YLO@V7AG'JS43Q!<0P]=QM1\3!*UF4URC!%S\T>FA32B]XE/+&.(
M:\#$C39T^[7D3_X-H!0;%U />*[O6#0^@G'._PJ0DT;[E7-RRSW!5A@.*Q9<
MBVLO'>KL?S[O:7.Z 835=RXW+OQ)T* TSU%W0KWI?H;4<"L!CM:YCDQ5T@N:
M(8TT@:1\B2WUT8B%0.<"0=9,C0&B$).=02W,U\\VU$>7Y18=A'BA/WSG ?^6
M/3?D6'[.DW%.1V."1L[J"E]- 8^W7RT$ -V,;/0[GBX0>6>^XLQRWTI)G\YB
MC$%2R'>%6GA4."]]&H0_.#WK/4C3S3W'UDY"26'!^!B(9&K=]Z[5.6!.C3:$
MB1Y0RTY-:?'@B"*:EY=H0U8UVG7=3'/+ 3^NH"&>,\.B$%G>(9RO_ZD+VG?8
MFW8(15L0UFC U((G'^7>GI+!?E+<5$'BL=X"=]4DJ=.#9AK]H!#5-43CH..<
MA;**R@/!DA>6N#:RYC7*+P'5\R.0D6\[W\RNI8_4U&>$+PI2(,7! X1T%,$<
M5QSP)6(RR0]^'>7LU&VF@,;).##T?/HWEAU@*1PN%P<5-X!&:1B>60!+2U?>
M=6S6#6 @N/+Z4F<_[;_?_C#9[[)][GW!E,:&]]2]],JYGE.3:>:JH,/R3G"+
M<2&\Z_9&V!TX)MO&]0_$7X[:"[GT:Z#SKZYR54SU85L =@55X!"Y]P-9OY4I
M<K%S3RY5*1\0+@(*E'<W+G",@]<6YV\ @,7;8K0W@ \#6O![# 1#$>#FE7\V
M> '[@.+WND@PK!]X^U$O:6RDKA%!8.3H\9];%.XM^-9FFUU&I9!M%_-WHC[=
M]L))2-[UBCO:.W]Y*_5^%#@"U9^KI6[&:6=EUU_[M)<(TN-^C4&S<5%6&@4:
M[>BKL[AMG@D]#Z O8CK^0=E\^9<&GUC*#8!RNN@2?N==@_#%#.65Y>5R8]=K
MI(#_:8X'&_6/P>H]BM5?9(4E,P).!=YT/&]8;[W>-D>A(WQ<,Y7#$JT'C%U3
M:Z:+612?\=S5Y?9V?\6;7C!B<8UF3MT. F<R13QK.8]6A*/L86%C4ULVZFSU
MY7'6A@<5: !3&NSZ[F  U_?)SLZB,SG=T@HU$8V!W6+Y3MD6HP"UH3D(3;GM
MX=N7=UZY'.R)E@<7)AJ>N@HX??<1>42ME<8I@)S&:9N(WW74>\_Y$K7V3=GO
MZ75X,"6'L '6\PZ)]^+-U&?A=L(M=7ET5YU'178'>Q^*W)3( B8'$,5F$RH3
MDVQ09##-X&]QX?46^.@&H'?1>*Z2\;'@%>?0N^]%4C;QIN3@B.NEB\';W?AG
M<$O*V U@#=9Z!-Y/@^%A5-X @*<4\? EB/E)@%9O??"KSN1E^(H%9F=PN[=?
MI]C/MF^\N %\@<Y#Z>&GO2B X_;ZX^IM$LG8$T=,?<7BM0O@'#"1Z';G@@)E
M(+.$@;>!/#\X?O^X)WEX]ZT3(]O.,+FST#6QVYVV%_R<CQIP_%UA]MT 6JI7
M]U<"!*B=LB30TG,HZK^'GJ,K%-Q_U[8A:Q&$EKQ'T1]TNZL$+Y!_@9OZ>7 X
M=C5"92GV0U7!WT;A0[ZL WN<+ A.EZ-F*P'7@?FW&HBPW>Q-P\&CTO/7<?UP
ML+NTPGP+*&YN"8@/N(:=$,3+2@]\R@9!4_;3?LMW"7EV^;33&%#P$M6*C*[1
MG[0?I4UDIP8<8LHP_&1XY8V*7<& =GN7V_.7"+\6X.:;QW+Z;$(@C:/>S0;B
MVQ4)5O-CWVFB1/!TM-]1*FLD<L]<76'=D<T.QI9($W4VL+-<NJ.")+F+28;!
MF![7/[5PUH=HPQ,U:/@)I[BXVN,C O54:NE0V;6PFF%IB?=]VH[3X+M1G3+#
M0RUCJX;1?K15!WAC\<QE(.QG%H\@I*7\OE,BA%M)K;Q+0F;]'^VB4R\7.2/Q
M"E_AF_2^8PL<E:,J%,F<F)J3<T1*9]>4@U6\>48$RTP=O@'\,\G:1#?P'WP"
MI*%M Q=8EN!Y^*KJ!=["C\%UO0&$%NC7[;O//)UM-O$)B\WJ'[WXJ'D7U/FG
M(7'AE:1%=TW@C:GD>'"+VK3;7<'\N7@^<-UL\ 9PR/JC(AOU&,4Q%UQJ71#<
MBIY"N :46%TVSG=CA\]HXF%8C22\2^)MQIAS,(@L^8-Y2L#A@S*,95EDA^28
M2T]05A%583E%SJ;B^4.XJ1S[2[#N?YF;K6SLQZ68LJZB'A;8=XA+%MMATP16
M'\XN9%ZH]?I<Y4_KWW#(VR5T^1J%%J[:>QIR*340\.+FW"-WC3%J7XU0XDU'
MOM5<XD4ALS'KSUER)2$)%KX'29*N]0FN6S%Q*V/"K>Q%=J8$\!]M:%BFF8;/
M,2]'X??9%*W>E]']\NY.PN4^\)%RIC>)CU(<31@CRAU?*Y$NX&NS0A\C(SEG
MTB3:LC*L7G).2""GS$-O%+&.^Z=X16]8&I?9LZYI8<^+1H+^*KPBI1#<A:
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M0>/*/*SYDD\AU)S:RO/QJTM ]>WF[L>#/0'!0\9DHA9K+=IQ:[#G:<+8Q^/
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M4&S&XGCM(&_\RZPL0$,ZHR+"P;%,VY@\IJO09)T 2P>DDF/T8BYK\K5&+U8
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M$J<*C/LH9<,_)J\)OXH(L!,@G5HTI2IL<S)[-]X^FJ>@^4U;NWU\\^1J[I,
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M7G)?UQ/E\[F5T&P)M*M8S!9_ G 7-#&;9[D.Z10:FH!?KK^F9#*P+FKUHI8
MUG#6\R;=!)>U<*6UFZ8%16Q"(,8X$QI;R-6!%?0/0Q7=+)'TE)+Q9M^H=V 3
MENRE>\B[#*&/D(RXDBGZ5F5_C7!%XZT%ZDGRZ5J .#[*^8BV4#GL)Z!+'HR;
M6LUO%F#X5C/;L6C1]PTJD,1X7D5U"6\=Z^2\^-QO23)/$M*M4S]]2+HW:LW!
M\27W%3"%6:7S"(.Q&*H0)015-HA%L;<7 > 59'QM$61N.J$9-T,TS6IJ72TN
M]F"&6_WE!A;IDW?M!T(#9T?SB2/[]:6>N8A9$.-/%.BJ-K&Z2HQJ'7_])NDD
MC"U.7)A;#PIQ*C51#+ 3TW9A'5)[R]9=3&+3E/.63-WO^_8L<E2.JW+=_P-?
M,N^ *KVG9#_(,/A9\57#Z /XY-'-DMF':LKHB"3<Q%&T9XN28Y/OY4;V/S^S
M -H<]R YXRII4[Q*S7I#N<93#U9YEZ?B X-?,DQLSVQ.@J8KS71B""_695M
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M@<O5)'Z$_;]>U.W]OT)0?R[\!U!+ P04    "  (.E=6@]!E;\LL  "/.
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MBV,285FBG<<+VAXO-6H6E]CO*?D.JR^1=1=[G.#?F1*/\WHNF6YI$P>)$-:
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M_XVU_[<^:/E7A0PR]W\ 4$L#!!0    (  @Z5U8"A7%K!H@  !67   3
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M__1N&]^=1Y5%D7J^B8&27X(2^C>H,B/V&JK*=@$VQXL,&QTY9[Q[Y>J8 ?+
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M4S-Z;NWK)>V:8"<M,FY51R\^D!?=R<3Z!(3S5?[8:\=QI*GQ@CJ F>[<.M%
MZ%(!7KY_]DTZY2A6#\:VJ0G?<HR$,68>T]5#'C) Y5-1\=#A/%MZ791LT=F
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MQ\\AYYDI-P1DTJ3\[^4H"SH 3PVP![+]_G)^O\C7M-9@2?ZUE$HLF7>Y^@?
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MA8-C2PC#85(I&(Z(A&VOODK8'L')#Y;S$_2ULA<*5*GP" WF//J-^FVJB77
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MTW/9@T:3<4-2"F>\-)H)!G]#4.2(-/8]ZRKOGI[8%M.[&;P',_-V^>76$QB
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M'+T[DCQX<<(9V?.GJ@?J'[NI(@Z@SZ1R1&8H/@!\G^ OJ*(\_K1^84P<*[%
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M-@V&4W./E&YYN=Y897%O%C0XFFS:"2C4PSY%\Z:<:!'SIK=#[ EQ:-@726&
M!),)%,;)2QXB1&!SE\4UL1!Z5S;K=9+&HN>-CQ4R;<^,E+KODLS$?J)F?:H
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ML7!P\O#P4#$(B@IPB;!Q\W#]8P0!#0T-$P.3^,T;8BYJ<FJN_]?R\@> BXK
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M@B\ HMN>BRZBOKB>L5_?@&_Y7L6EM\TTR#F>O/\IPY+_ZXXN[FXG&^PR64U
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MC*XNY43HO4COG4<\8FS.V=9''BB#G0OV W1;>K(L55>X<%H:LUA1Z+ $*#O
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MYE=REG(482P9%)@ %*MMYIA7]JCY;CGJRYU*=4//B@]T4XO82&VT>Y."H9\
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MDSCEI4<]!E^D/[G@"T"[BA9'?'GS;A8$]^F>:2M?MH7%&/J&LWD_Y%7%&G,
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MHQH/XBAMY!ZI_YJ\!1)ASH/]'D*KGY4<L#R;?LNBLZ:U*I,W:JG3X]"QRK)
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M_[<MJO]HYG^K],\P_RFZ][M2#_@[WC;_<KS_:M+OSVI>_+=.# B!A/BB^ _
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M<#0B9.29W-EYEFH65'O4G"$K6M,0_B3OOR3V,8)G%\RSJ)H>^'G<S@5;J$%
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M)$0'.'/E;%QKCY1+*A'M<DKUU[X4S ^[ )N'(HU/\(5]*RR?-M&B$,+K+P1
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M59$>@FL?^YD2=3C\H:XTF]36#Z]))WJ6=WL@UB.MVN^_XM47GCLWZ=L*3/I
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M?@\2 %?-*SL9K):Q&3WD'8AQ^T: MN,ZVNI9RV,\5W-4<=^P)\&DVL\Q_@/
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M-OL+!<"580+*8-9.K4^55[ZS+XS.O1%@1JL1<6\,+3K/P55Z*Q$S;)X9NL9
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M_95U%K!EM3K<S>FKH30K1'>CI>Y%RA-++WR3C[D]$H$_V5<>$G;5?N C!:,
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MMVAXBWZQ_5C'VL2R6R<V?7-&C,R72HV_[$X=PS'A<'-V5>22O'^P\K><" [
M_\7_V2CB/7;\</.NL;4Q9/[AS<0PHX)EL93>>2]XWIFY1X8\6<Q_20JD4[5;
M''"*3O5(8700QU;\#::T7*]01<]2_,QO.W*3I.\-WYOKFSZF8UO%222>8Y+A
M4<\DN?M>B%QGI->'9US 1\J9;O5H(TYY+ V;JC7I]^*[V9(\';(5JMRDEO<O
M FN2MCW1=/R/A9O7U9EF7R*LVSJM0QRIF!IJ4@&#30*G61>-F+/"9GFG&>>D
M/]^>6L6HYX.*'.A_D_YV8@SZ]'2\3_/YP2,[7-:<M)@$Q@\V-M(XZ8$:WQ[\
M97?P?W%4U3(0[7J;C]4V-L0M.ISB/9-C&2F^W=+3T?<;P;";I5NM7-E??M;\
M]4XFILQ*?(])>=)V;: @[NN.AP$H>3XXW=#3O5^ZI;21);JJ3*:6/KO8!&BP
M+WVPK.>P@.[(,X+=#[BFWI)"NRENT;9E0'HO[+MC*=DLEOS*G1,D04RA (]E
M-] Q;_WX[@*F1Z-*N4AM="1S'9Z2F<0'-:6TK_&/0;91 !2 <0 %Z)ENE;6<
M%#8-"1C<'HXW]++D28GZE/G\G&Q]>AHI>Y_&GJ$ YWLKU\2SP4$CW#/EU&ZJ
MPU<H0.H^5&!>KUC5U6E_$AFKG!/!O4N(QY$3 ?BO#NZ,V1KNA0QGM5FA1L8;
MQX !JI"-I)CWBW@!'<1YC['$9%^8DY%.?D]K[!<-XO4H?V'0#D<WS;4$KFNH
M^2C9&N4L&B4<E!C7T]Z.1X$*S!#.EM-G]N;HA@W?)1P<*1L;@Q>'/,/D<+2*
ML#-RV=U!T&95SE-^MWO&Y5+E_@TI<K[>9[\+F7Y3^J?O_WB?_7\U;%=(B8,>
MU7J5O&_Z[*FSPA59M%5WFNNI_7'UD4YYC& "P2.%#T*Z&EUV6^\"LQ<0D%<W
MM(0L91-2D^ILHL/<Z=7I(/9K?3Y*8+UW13PIN=95U=.UP2/<OAFJC5AM<PRR
M:&_56E$-4T%583K.XO[LC>TNB=5X:Q%9P0<=7L5CUK*]1UPA^=9030(A0_($
MX>!5R5SKVO7/!$5S/QGOK ,MVE" $Z+0NT85Y$3D/HV?XOAA12XAS<418=&9
M\.;3--*LFFRVO+K6\BOZR%^;VF[Z$9L^\Y?($?8N!M(/MYX;0),::[693_-6
M\>T@SG-%F;90V#!H>FU9$@9X^+1Q 07@O;1KE?WM#$.6RG9;DOC*K4:&?6@G
M[>:Y2 -';-"-E(@-UL-CTNF5ZE7/7+XD6< 2-HOJ+4M.Q/A)S7%5)#L/4 "E
M+3]T!=N=^>6O4'P)R5O>(\FOH)V?7IAC,=]NJ,<J$AG_LQW&WZ.2I:D-$;[.
M8ZG7 *O+M2T$FO@MS+]D[0!F2&1J-V69$?C7[K_\B,T"D$@TTXA>\[-_#F_=
M7 I&\JV5*QKS%M2\/NT7)"CME_<CU.#OL\LY=&/[^B-K+3;,,-','.S>2[ZN
M :=K<="*>V"V2HQS,>HO)MV*$1LX/Y-?">8\%E8;X*V0^<WDE4#O^;&!H;@<
M0@-F&^HSL<O]43?E>.>CUG,S+FJQ9"C=3C2LC3!>*U?KRB1)5)^V?MEP8Y9
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MVH?;.Y*G.N\MB5H$*W_RK+:3SZ9VUK18LFGY/0.S[ZA[?!#E^;).>?SX/H/
M_8NY]\"=4HKL_>FSU"8+(Y8J!GN%1GI(@[*RG-"&R'X"5MUGZG:R);%+=]Z9
M[XB(^E.G/.<_^.'C7(UAN:;>0'E)ZZ\_^N_*6@K&Q K^."*7]#?L^.?*_]K%
MKC^!\L6=4C4*8+5R6VQ:&R2[X2-[@8\"S"<UF\TYU]^Q.5L>_(4&\SK^/("<
MA"_4[BD/T .#("/J+)50@+'Y>F[">]8YX?KMQ_!'BQ<K'!AN6F5AE3]72)#
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M**(^O2AV# (EW=U9#T;H6GMY-K%T(S+$27CO;UJ/BQWU8AAQ@(=/IK =63C
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MK+!/BNLKPA'+[ZIJ1^3O-*..'A-^DUWV2T+!?A2F5H1RU)DW62K0 DM5G>T
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M,>.[VIL),06O !2,VBKVN^QISVL;BD04!J=**LQ0^:VTZ@5"?$:6N]"-_46
MEW-LATNLT&E"3)K!]%R;@^TJ-[LR/6B%NW??6P#-IJ-9UC@BR)CS"Y+ZA/>=
MTT;X(<.Q 4$;@Z3_O>H 8)F>Q4;T0*0T39\)<\\JXGN4 <_=:"];ZPGKO==]
M;RN%1+^N-60 OO+-*904@:2B7N4+#J+A2A."M".S2L$+JI;>56H91W1^UV5O
M\U$W!?J-52C,597D9EOK:I6LXQ6>LTNCEMA0F7*IS:!]<L:JL&3,76M=S8&C
MZ=EMYT\+CUQFNT3+0TY4/G&'HB1#BY:1\* ]LW)1[[)W%H65(IX3IM%K%&Q+
ME'ZPGW=E)/\[+V&-_/K+;<YO/>LM3(D*!RK3XJ6<#Y,?W./K=KCJGFGZEL,3
MWG<E#9W2D3Q^D4^MV^&G1T/?$BO=W7*YAR@8_O\U/Z<ZIV#\>8U<GE,U.3*T
MY$+CNYJ'A6#-5_>#_+DMU"QB[D';QRH*>0$ENE<UYVY,T4GV2L5NCC)UY5&C
MZQI',#WG8+[EB1J$W*;4D+[6%?70B<O WM,#1@\[ER@$?0)):"6#&E"X_9!?
M\1Z1\ >1KL/\.*'*6 _O":<[C$=5 ]^>V$_17XR?M'G*X  _[*XJ\*>56TP)
ME+N<]!/>9S?P8%-Z1_#<=,\#!XC_O'J^7(^"?]WG-9-?#E I=S,-\N.Q8N[A
M 0+NA$8;ID,\+-WJ=JM4ALH8ZW,)3,3Y(S)=DQUA5*CK65]/FRJ _.>S+\X5
M2)_7B?2P5/PR/@H9_Y43I53E,-*^%AL@P AA+W#WHNZ%MC:/-FTLG&'11EBN
M"+0V QASN8 #+!+C !U@^%7Z5ZRCVZ):.Y1-M);[.P[P]7,F=*CAX K9A-%D
M118+P,_/&G" 1EH<(#C]$DB,V93(#,3*.CF".7$ 8@(%'"#%8_%R&8K.DUPV
MMC0Z.L"_F.=3'( :>!I.>S[LI4B."=W>+%+'TMR(P0$DSIK.\'P.I?'7A]IC
M>GKT\R*6[9Q^8H)3T(M/R/77.(1Z/,;,<OPN\#V_MN1?GZ.(0+5:L4%Y?_U9
MRZ/X7RKSK]@C$U8[/QQOR8CRRFVUF97E+%8H/XK[LN$_NT)=T7^8H;7:MG<K
M9IHK2&)\H(HC;'J#V7[ O514D:&'D3L=T-O[Z:;X3<'EB=U:#HR/X\'%20@.
M($5E)KP%-NS)_Y2)E?KQCDWF\LU!_XQ[\&.XZ=%?I$2Q)VA,#@<H#C6:K,HG
M:K\2B+B\V7%EG4B+H3W$#" 7.XRFI!;POW4D9=OBZ9U*'&!$42\F8*GIG%Q,
M' <P[K.[HJJH,0 YP/[6?6@>Z=JV H-;K_1%$&_&3M*,M;<PG&(_YD9=ZR8"
M.!VD9+ZS7K@YD37N*62_,D0N4>3$J_#2Q9?F ?OK6R_)" Y5#1O@Z)=MV$>A
M87IO?=UN-O\@*7TZTDGBUIB.=- <-:^J0\(:'LW*=_33@+L>EQ*T$-K#0)H8
M:XM><8%G2693ZF/'3TDVL?3EU@8LK=S:T[Z7GW2Z-W7"Y3%*5E,<2UY&'0Q?
MP)58KE&USOV);^R1$5'&#MV__$*=Q2_!.CHO%]4M$ BFN+!Z18E0A&U*EJ5U
M[H[+8=7TDB=$*7T],L+XVNE!=\<G->OH'1B@$?6B;KGP$0Z@-0)G#^B==GZ0
M_N203T^X1WA0>,"Q\>6(8 U< $[N"GD0ISD:ZJ.G\+&L<^F&83I,'&B4Z;80
MG85Y/>&8#&Q33"V*-\LU[!.?7^N4DOE$S/7K:(R)(,6V(D.MY'MB0\2GLMKP
MB\Z%?9YS]<[2+"\Z4Z@H[&=I>7AKZ\(@S[G*FY)'[LNO",XU3B*+_V<5I+\H
M$2:DC!-!BY@UN_*SWC9?+@5.@80RPKT\L=-3/'5H28B8+:#/+';P5Q]CG;?;
MM"X?=;(V>-^OKR=4EGK9[46B%_MX/2@MAGK5WE^+GA!\*W>+MI&J 3L^JI,P
M)ED?>E3N+I1W>0KG4H']H>QXDG5F4#\5N9D+I*DQS[B0P(+Z#W(*!FCU*R;W
M/*>59\!7IF\.LR\BW,?@RLERX\%)S&/"'+=>*_-I61S"_S&K%>,ZA95MD,1V
M0O#']U54@U99&Y08NQ"'_=X'QX"^0X]_FW]M3>T7[J.-ED'D!V[':Q4U=N>N
MY5>SYN.?#U/:&8[J(KY*\"._'+@MS3NMO_W5RMKK?)';*[D:D>E12&WUZ8VH
MO3N,]1TJW1!Y-3KM.O0J1M\I5KA?C7RGHE$+<Y-ZRYL%=>;O":IPW%-C^[AX
M>,!YN#:4-3:%'( L;E6*%N;K6=%\,W@U;Y+P;/50<!UV'TW]T^IZUDC1H]$-
ML2_KVF7''&Q(R:\O6_4VE;*9*\2U@I%&3U>:VIJJ];3'V';Y/_[T$HX$;AFP
M!F!?6L1U&$_Q?ACC&"0.[:/Q0@J1=5]9BMHYY4QHE@V?N'-E)>=I6YVF;2@W
M^.X38#YV,WF1BK):5:E8_%>K_G&1HA8MC>W4D[R"U24L-_XYO0,R54#_S:#U
MOS)=N=FU&P5_W'RP(S>6<#@+]M?& =PGMT>^]\:VV&RL2<1L/YE53;Q>S/]Y
M?"K&$#W)2HTFUJJ=\&1S'T88 NG*C^@$ ESO^57="U]EC1#\J+O0KK1EVL>*
M;,#<QP'$3B0O?T=[.XS0E" 9N:O!">^K.K<X!Z_D^3]H ESZFE?#@<OZ'!A>
M;BD<0 !A=WDJB9YW!_EYRBUP#@]<6D9;UIE9?*& ?01L_%Q-&4U*-_M-R%8Q
ME@4(-+15US_7!4+=^\HG@\]'<^X;%=-EI*;G0[L;9<OB_&KCY4H2"_O;U[B[
MF&Z#B?8CN^CUF9P'.9O(C[DCR-%DZF.[XPTCFK'LK.W=+957<H1>2I]@-]$5
MR[^0\UDI1?K)+U5*@R"_Y!^\9S6>K;Y+*OJ)5&2 '<Y\8\W2RM*U3[L*&1?H
M"$"P)"#$=[.(@^J_+H3+M3 97YMJ_.C^OH&T7JAC@;T*G;I22-8&8]8Q+Z^J
MH:45,KOM<^/:/?)O@"$.>G8R>(WJ0].BNRZVL]<_; ?HRM_S>BAPKD*Y(>-\
M0&_[ ['-R'R1B^%6"/:3CHQH.;2R*S*P/GP]Q5!17/Y<CT+MI@;3]??7/O3P
M1A'9<C&FD.Q<-(99_[0ZHR%2"DNG%7I6%V\[<O.^ O4U_G+3?5L,V%(&S,\1
M\[NBK6KX)[KTI_O_.;G_YY?9CNX)+.C&UJQC@82<!F8 2["0EBFG'I(T'\5U
M]_M:'[6S85U=54F5=4B\UN.X_.=PH:D3Q12J^;3IZ7ZDGKEM.T^7\*_5;(4Z
MR+L\=.^F@=%+*>/LQX#5S?2F<1S@)+^ZI+ARK%!K8?(^D_6T$\<X;+T^-Z\F
MN/3,$OL4>VVS8ZSE99,[U!<'\'4=Z*?4F9.V<Z)L$>C/I?J4JQ49 7@L%O7Q
MXW7G!>(1R=7+2]!;' #F;82 X  +@T)DV5O:*>3X4.V%C+CZLHL#')M,Y6FY
M\N0EB\)&S\JL%C]K%W0Z!)15%$4_Q@'>6QH=WRG% 9J=<(#;DB4"\(L;.M E
M43SI,4QKB# !G8/GW!HGO6: EY1X8O/3+ Y+ $>K7@5E0H?Y^G" :U,8KA,J
M#P9H;^/2:=E^K^1T OB*@*<)R0QMC=A5XL9^CC5"DS8M@W/2I\>PFF=$%2G.
MJMCVT:9->C,<P&<'2P7]RQ,TR+!TIAS"J\4++DLC3A_A^=&KOJ<8(B,DG']"
MP$#Z4O>L>^Q)?8HXING)C=DJ^\YGST/!A6HL_M6H>">QMVIHR RSL(W-YHNS
M)H?V=[[6B9$00A!O2\@@^8-8$Q;G_>8-6]>AMR@#LZPRN*L5'05V8JV,JXX0
MKQ2(KM61;UH+M30=JNU!=W7MKGBL3H3>1-Z6R^MNNZYMRK#<NJ9,M:H5(YLQ
MZJV+-==B>[:>E#ON:_DB=("[7=>Y". +*7/Q5V;$ >!HK<)/"?#/>T_D$Y6A
MI4KC3S4XSB/:#@NZ*^8]VC[Q,%34Z>MMW-[]!"4Z.!:[XBXTX1H>HV:6C+=J
M] J5*%2NK':SGL&C*R$>N>:?&HZ=..( ,DEN/WJ"T/9H%_S!:KBI$29W)#7/
MI/[EY[EI06OPXWSV6P#3I&NJ'?9WD+=6$D0>B#QX8PP.KY^4R!9(2-XX%<^/
M>45@J-#4'("^=B+96VJBB@/<A,5_X"O1-SHG)3H3FV+WCND0,^)!!-?*7VUE
MVG6IY]%Y=+PX@7@A=M#,^K2553)?&_KYJ2];10A,=H*[_R-[Z%S!H#N_1:OR
M.%RF3DY"Y8;JX4VLQB+E\:CD+AOM2:8A9"S)K+9J4U1%P3YJ9L[E[_*'[]!/
ML6] 9-!IOEG\._+:@CWF5L-;9*C4Z+[\6Z-HYE#[P77$G-AO:[ [$_/G)//M
MGWZZ$L^#UI&&%50NY+-U,PII.JSOBS1.;-L6ZIO:E)!!&,%LQE]CH\A7:4OZ
M^T=BS1(V6)'33JY5JHD9BFCE[A,EX@Z&IT%1+B/PT3WC>W*:VA .X6VBU-R*
M'8_+PC^P)$_LKV.^\<WV*O_1*"S2<J##<@<'^"+96X__"]SU-ER[!,Z4A1Y5
MB6"L<W+=Q6]4Z*:\Z"MTW9";E$U>2:'<=L?SMQ,7,K)D2H\U$,@^Q1/L9KY,
MQK!-D^MDCGHVI]?-%]5!L_9N5QH,6DVA1H-DQS)+4;?\=[MK:*X11DFFSF(D
MVE>GIPB0&VTL#T!48=9O*VJ&Q5[LU4_/*YOR<S)_#[U@@B4'%=HY>86Z0;AM
M/01#^?6V3H?GWIK#A&/8OX?:&0-XT3 K]\<%RCY_*M/\\>=>),U%[.MG., 4
MIV2"YO][LPLGO>9X/D C]"Z04&WD%1-+Q<]Y"]H4Q 7G.XJD>I-DOR;FJ7.P
MXD]7WT7]BMZ5E]]9ZP-AL-5QK1IZ.L&U1OZQO?*]CP\+O'45[W[/V;S%0RI.
M1+WZGJKT=$<-S8(ZVJ]CR:0IR9_10,<.83K_GG+5\S6P+>, &!]S_-'*P@&&
MM=)Y^Z_*KR)X&SD\SB"G1RQ"UW;3]]S@I;.E50[Y:<'<<V+_860L<FEGN8Y<
M#)H(S\YL/6(]=PVUB<->,*5T/:CEXLR:;+44'R(?][YMS?!PI EIV\3SZ2DW
M5='[:);$*?^+N]?!?BL!X6+THKKH-FGKP,^(1]QK)1>B:XR8(\,]U0%"H6?U
M_.U1[:MWHAZ;O=LGTVVRA ;I#\W,+CL+XP!DGAK([,!*(,U/GGT]K+:A]^[&
M,&LME"!A[QKA'Z12<!$468L=L;5>9EG0<;[?X([1B>EEZNIAAWU *Y2RD349
M07)IY>[N\*O=)10Z]>@7M)D?R&/8+Y+-&L1R)..Z$(1:H$K<]7X\^JBT6KUB
M[;/\;2A"]CSN2' ;O[4%[,BE-BP98AH0GZ/8H/'>>6ZL@;D?K3^M"O>9J 4_
MSOV/CH:_TK(V3X6=9;)+>AL<X-1]WPK6'8-ZEI:SC>A,3K4\@.89=%G;)-&S
MBU_BS^4N5UP QN G.O,AA%8U?+,CXOGK4KZ-5$0SD\=*3'+1R_SIV;32=-23
M"*% HU?!%R*"<JM\]3=O(=*+M.\0=*^*G!;J:C&W!O=)L(T&!/K[/*FR@ADE
M&,O-5V;G/V,$H]AR3JAS7^G_C_JR6#L8G'/S+-3U+!!QIT[G9A;[S[\]D[IW
M2=[E/ET HMERSRI9KLMG9E2#B%XH-1JTEN@;^\J"(R,[902K85TIANBN+NP-
MI85'I:-.BGAR]_3N7,$3;Y]5R5<Q"VC)CE@8_[!_KCDA4I;=(OY1IS3@5N>M
M[E_@,)GE&4]RD094]I<X_=>+AW<55Y]BI>T:T)\-^Y:N7&11I#YQ"502,E$U
M$;V';SSHC"/+[><<"Q_%%(7^G-^=:=(_A2\9$>]4R>ZHC4 ^5-LU/+Y.WY@I
MQX'*EWC4-"'00*HW_Z#9:/YU;^>L,-\C;V-Q5)3H%9E"M]_*C<1<M)#ZE,!/
MLYJ22C>STNBU* Y-#NOPGZ9.3!^M*#S292?[YT<PDAFNWG,M&5N3IX&+'KUO
M:2Y@V:A"+E0,BC6X/$Q( 24^%&(C*&R7^44^$WB;H (5\UIDKN9*9,!#D$+)
MECS*X_J?\JC7_K<\[-KUM;7&%(LSL)K;QRRA%[<ZE8D(8%EYEA?8^+PY 1JP
MA$UP7>^Y3;WIG4.BG$*VX4E6/SQN:.(YPF>\,(/H'R7+&#Y3TLDZG9*MQUPR
MRCX[558^4WK:B#647?OMR__O;6]\ENE57]?C)X6'S>+# =1MV][LC5-%X8FI
M;(&S_M_OT+#48*FOK.,H0_R9/1!5I7IE[G1ND^X6L0=I O52*^@"[9FM)7U#
MUN^1O:G8;#QN36@<&]U2<I(\#:\?X"ERN:G]*^6LJ0W_?]U&5F1%96B:I?.0
MJWLW\-9NTZK!=0?U5@WX0S#U883,SGPR9?OK4"\8Z_I%DW*WC$H>]:O;-P#,
MUWFIP%D?6< H5BQP\29>CRH/X0"RXNZ9KJ!V.\9--?2&3!1B9T]UJZKR2%^,
MX)-/>(<O[,NA*!CNZM#!(!F\2[(>Z5J6EB3W!>(ZE,[YRP6/_Z+/OIL\,9N(
M4;/_'I/RQN8?S(&__5MP+P_K;!TE-P][YH9RQ5IY4TA>^MPP4;SK7RU=1I)H
MAY6G <>+3+/;0GR#E4$9C#3?7BNS"]UXNUHTGSV&A+N6-%:,%Z35EU:'KR#,
MYIE**C4#)LO:6E52E>1U#N'=>66A^4H=B^#S6,ZH#B:4P*?.4MFV.P5\9,N@
MM'*K"SYG$1+UYF&Y]56%'XA^TM<4SAO3)ZR%JG[M"5,!ZWH0JYGUD)_?KE:/
M;<,P.PTY&[Z,/W0Y5^39;/-6[TTEBS7(ZJ/=/BDBO7/V_)]7].@X/.TZX-Q*
MF/ O9-F1GTBD?PZC]TXKYPX?QY#"S!&.;H@%,Q'R,B;SF=K@?,A*LMZ;)-V=
M6/B#8PH3D@@5=Z'S]4R3/%7/ZIS9RSY-' "0_>6KYD! # :& R"56R'<RM4Q
MF0FMD_*,!R];,U+:@WO]VJQ9_'F)HDFFXP9T5HQ62'7XAY,((JS&QBJLF;6>
M\@TNFW9I;O:=,%OM.7DP4'L=1]=ZN"5A1PLEG>:AS7RZG:<7IZ-Z1[:1NE4_
M2EK[9Q?I"'_=,8&)7$Q _YU7%6[_9_TV5$;P-E_E_F*JQH<U-0DP\]^ET;2]
M_S[1AC@3,?E;T=9M!XWMTV'A&7MR3)Q=-?H>*L*:V>HKI6^RQI'#],O!$,_'
M;YG[-&TF#AA)CVAEQ$D+W;C $EU#-FD,5[R$R)>#2!M#<U!!FDUKN?>+H:10
MT9V*'>O+^3^P4V^K::9&FWL(.X*_?!(6 42B;X_DZ7;FW@A*-[2*XV:3LJ94
MV*&['D@@9OHYI3/:Q47FH=D'U]@X9$!7[8L,1!@,GNI5$NZY]3G^\\GU96&)
MU80M:+$W/W1X-AVZF(D#K%+/2J_LB7H!WY2&<9A/\B9LSS2KY06GAJ_"2,EL
M)J_4$[<#-59'8G8IML5%9YZ:ZMA./J2L=31OG@,2^#I,:_ZV6;P.YN8B,9>9
M[+_P"B\S=W@>5I69.2H6V.18217U3&YC//B/7Y'6%P)GZZW,AJV*PW(OMC[Y
MOPUO>BR2:W<"$5+0@ !5RLO PNKV?)UT%R3M'ZI!=-JZ6PPTT3]UM^!F61U.
MMK(%+0IZU!\=#J,N9QE=[A(-]!1*DCRP\GZ!,K@:Y8F:'6+^<K_3LSKVF1S+
MYQ *+ZMSS2(@?T-XKPB%]J3<O '=;\,9R\^Q_##D_4O>LZ!R5_R+CW:IVY7E
M;#%TI_:2&<NO5EJ7.-_\&LA.]DH>\U51RXS#\=6?K7&"\1_&WR/8Z8*P&)N&
ML7'-7NE_;I<I*#0XT8I"S+XE9DWH&J@QII,E*ME6DI$_!"9,'7.1;\3 3;2"
MUX]W!M0,I%5'LAN ,+HVH',)*7]X_IA8<&Y>94.VO"6A^T&*@\.C]HC=2#CS
M-,R5NH_'2F7C%\3F=&1A<O&P9KBXL"\ZWFBC N[5Q ]/B[Y/R3/W>"TQHGV*
MUQ*^8,7RN"J<K>SM=[D2WW2^/2)>6/7086'>RGWY#D6WEU!#68W-WC2(HVC>
M$320]9#%#]L Q@%>6QT'<XO9TNYH-"3O6GYM][B==%JS'#.%?MGN7&L*>N?R
M8U1>J&#^\[T[K%)=NH,H.";,'7H5BC#"?G[H3EKV<\9:9:]:J33G_*%1?=.*
M>'YWZUJ,!18;>L".*-.;J5@LC)!ME$@&[UIU*>+I)GC7,I\[Q^Q>+CTAR\U,
MN+C_ 1AIT.V[1=()VUB[A\+K8?&(WT7U*;ML*^>$PF+8J,H.1CI5?1-H=5(\
MW3WI&:5?II=]9>4V@1S-J(FN-U*;QP-6P+._!\CH0K3Y&Q23A!8\2V_^CC%_
M$;-WJ CK9_BSR4;"#/ZKJM;:]DGP;1=V]9)FR=WNIF>8, ]>:@6(S=M4>EO7
M9ZB ]B$ ,^S^6*):L;+8UHWE"$OU; SQHSH[,L\/R**J4N[<1<4:<;6#+T-E
MX<]/.MS)KWTF_(.,D.6DPS5@&?@%(]T(+*8!\^( O+LE]$.U5V/GY@OY"4\=
M@3RKR+(R?XNB^SKO(MG#.C5'/A-ZD(/@M^*64\(QU/SZ:&D]ZYQK<\9:A]-7
M)N]5F\0N-9.%5FUST^>)R>@V*3JXD*.M_D(7/V;]3@A5=P^0=0'E5>T%'A#J
M(32T$\N$$H6?&N;>B4HY-]XP3<?^\1$T;@J64AG32W@$Z_I+L3=KJB)EEU?,
M  ?X8"4:;GKKUQ;2;=0!YOS+OLO(7G_HKPU.B3,45>:"IP8O.Q/,_+.]TA;?
MG$8+G)XF^-+IR]4 2DU]R6S6JW$ X@'['$_MB?4IQW,! UTO'AF2)%LFL9?^
MID<:A\TY3-<NP&8K0[?@05&]%DZWCO=D6]5Y"^?8[%_+WN1R-?:2;%^'!WC2
MOH@K&H);,XPC.N'LDN8Z"]1?32)$$#DU!"E'/5D)Q0DN0.XTM ,(V=29KT@B
M8CJ-H%1DCVH\BY7F-YL^XR X+#KJ9$ CN[Z<,)L;1Q:F]W)N&@1J#E6N4_=6
MM1U0-@6-M9.L%BSBOQJ,[0D)=*&9"9O>!@D/V,ZA12HX3S9/E-[O'RE-F&@H
M/EJ&V,^3NF\0_=P:M*Q,5"H.MA2(W$B@G@IJ9,FL+(-;7G@-5-8XI]C4RM/-
MITMRUTD^ 0Q2W?$(/JU=XFUD,NQSR"ZJ6TEL "N-9>A ;!+FWS/&[<<9?T*?
M%6&_(TQ\+1[_'N92;<>,]NO0O8Z-N0IC"3UU_]JOQ7W:\;V[K,:&LOQS&< ]
M:2-XW]H?'7U6?Q\',.%-P0YI,O? NL#I.( 5#F F?55U^G2/-7'PDN: XX"Y
MSL7AS#[I;,#PO^@?_*=72;UZEI5[IQ]O>&1N9:(+VY,G<2(RA#2=(H,2,67:
M"URH.Q+4R+7)$@'>9SZ/M;\O=?>WO"+:MBP\IJRH$-Y[N53Y)3JDT/D"!]"K
M&]0I>LB5C21R6>^LNQ)2*!XIF!Q2*O,?G5=^\_&G:HJA:(K[:OT[%(T1J16#
M;<R[M(%<J[.2\ZP15A*&HR[ +^1BI. (6J_=&<LU_&Y\;R7JC_Z1/L(4=TZJ
MY>\3BO'YI2:]R9%/ T]V0'<VA70K-IW] 1)OZ,W?O[HMWO.@/D!+**$IR 8N
MN<Q2BPRO\WSK7%7X.(JQLM,S=_QQB_'S;HYQ)OL=V*-A7D_0\F7A(]2"<!8@
MZ.YRNMF]?++4/^I3G<0IE5""20N\Z(BK8H$:Q5F]M@\=;_Q\!D?\"2.*O+::
M$Q)W2AQ:7L#(_=I[S K0'Y@9.[Y5K@%=GO5[B-TK,?K)^EF\P;\Z_DD].4IT
M'K+<X+OO2A9/^<@$]H!L0:7YA3 ]'GG5$FM4M'2O4X&?KS18;7-",))IQ=C9
M<:EI='?%%R:Q@>--<=!H)O?W^7!?Q,4H:D-1+X?#@OWYVP??GH=U:=HX2G3^
M_"=C>PPHH*VL2T.!=[?@CZUU)H77.)[6I ;2<DSQZ$E4#*/'Y"I&).@.BK67
M$V7EBG@?O>(K"JW?N"J2.AD <W'$3Q_D9$ES)!)^@G W2!N?=F?$.@;Z]-T?
M.F/[@'W]L_3ETQ,2',# ]/>8AP)-:QH2&VWS&SID;$0'559E_W+1X=JF];]-
MB( V_ZU]N.T?Q,DH#N 6@#8[;U^0;([+PV38XKGVZ#^=AT,MK3FQ)^"A+C[^
M [M"5K\Q?+L?112\5_[5XMZL^(92_++D @YPNVNTGM^MT( $9.""F"O@\'\W
M*SG/,K$QU2DD:1*@/X:AA9\SEQ?W !&3SA$K5[>7G:",!OLBE6.J34ML.$"P
MW=J>05%\IJXE31JQW&EX05>LP[:2;O#CI:#W0=1L4E\UZ0#JV\AI0?E+^4;+
MAMFKEP^X5PQD>J@MBOYF+'1.2M6'MR?NA+U<7JAPL%A[=-?F#NG-.RWR1%.$
M$R &C-*(&"/CJX/3 1"]GIQ>)/82>O/**W^ 5X"5 6-4%XX#Z"27[]UD'GDR
M>C?BXD-*.Q1AAZVPI#OQH!^$FMFZKCFQ$*#( CW%B^H7F,JL=W+?/SY-H_TN
M>M*C<0\5WE!3B /0>_)BFU'B_HG9VRPV#&'M*J]M;S#PLU$S!M+=@XCY2/RV
MEWLSZ*!91)Z8INRY)_65K,]^E<%NDS:I+U)G5WY)V\OU317N,R#EP-* .XPN
M**"',7AVVZ&*#_K<*_"K6Y+G"K4XP$K^G$7!^92)MSST^?(BLK21"[];HG&
M[_GPWS8!'2-JZ*8\#M"K.84#4!NNRC#M%']2/(\@Q0&^QJ# V"\IF$P#Z.]"
M?B\Z'\],0%BUHB9TWAG#XPT#ORBC?E<7# \\N.F8'0=8X]KY;1[XZ]. JT>
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MHXMZQ>1X(C@[/K#S/C>?^T?C8V11S,H5^]9%P=L1_T6FR&0XHSM>H9P$KPK
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M*XGO<T\+I#0JHX9/MCF_#5"W<PKPL4<*SQ6%TFN[^XJ.[?"_^FV5@G.AHW$
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M"XTVG78.-?ZP1P6#K7PIVI3/)KM^OO:Q3_T6U;U[\;]?=O_]:AYN7+68N '
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M2<M0V@LP-1)E'>Q+C3DJ8?.X#[YNK*Z!;&M&^K)*]3O[<(DBF6 FGB_"-N3
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M,&*6<CF\J]+859N)PB6=H8ZE[08U%K$!:1-5=.WX6@V]\<QZ/MEA<Z@@(9?
M\VZ9^]2I25+.E!V]4!ZD,CC-U4>6Q[Y2/>K[-+T9YN%Y5, 0[EN\WFYNZ+E
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M)EHS(%#903W>QYO3WCJKO %\J*ZH@5 (O"EQ,]^3 WC?2\2.U,_3E$3)M-P
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MZ+O8X8M2E2-/:P%'2RP/(I!?"[U3EJ' 'OBG4=6!9ZKLG)L5VX^6=!NJ@*-
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M)IBTQ/ZIN0Y?GIU50E1&"#Y-*Y2=U-=C5J@)EV94'%) 9N??=CYZ3\*MRMO
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MV>.9L$APLM$P[XX#ICL[>ARH<MLH]N ^2)V3IW590I,V)_"L#CC0V+^?2EQ
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MQZZ\Y>5E_15YD[D2*AP)(0\D8:P1CO0HA"S+6!5(N1+LE]+L+J2WLLVJ6()
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M(7=>QR.#92WLV/HT<U631]*9CYZ<<5=55%)Z**MS1KO4DN0T$F=_?LIBU2N
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M7%M,3-SQ0[/D>=N5G%6:7(^G2D X/.UMTD/3]T<$+R5N/F.W4PRHN<L,=$,
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MRF!'VSSB BYVT%LL,&J-HNNG(4\\B*V@-#YAEM$V)KH&D:MX%,$)%=OJ?-@
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M;_CAPT*!PF:<Q:Y?3)7R-;^"!QZ-W]<Y*$'[Z@/?A7/8[<-0Y .NY5QH"&3
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M=#1 XW_RP+S_AX?\G^E_ U!+ P04    "  (.E=66TF?\\0K  !]-@  $P
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M:]Q[\S;/<%?6(]9(VD#]?<]R$NT$;=$O<R &.0<T%,82FRDE^?F=LT+:QG=
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M7K/N/!Q3*-\]86,MK+"Z(CV-N4+] 9UJ@5YCER2J(M=3+$?(K7<O O@0WFA
M4?8+-S5# @W*/Q3=YM:W7]&>&J8OL9&*(3E8K1QID97XET!A=U[?L9I]\\@E
MVI3V038:>>9O"_DL"B7Y'VPA.Q\00$4H CA]H 4#(P#ZB:R1ME,&W;\-1#D0
MXL\F'\63ATX%6#[$8BI\(8F!A-+;I"XJ!Y_A!;03^G8A,>@:5YNM(ZNK%]<Y
MJR,J.C'.:04;O6=6->SP0 [CP4T)_.24A.Q<_"#_Q([,,Q*))OF58-!(C,XM
M^-G"#)Z\#I5'/,M43LZ2CGN)IJ.K'\2M?Q,JI:3Y%GX"@RPA (,4T+3N==9
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M5V3%-V!E^8"1$Q\._$L-Q/3_ E!+ P04    "  (.E=6XHN3<O+)  "@V@
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M[M&) LM[Y2\;Z.2!9!Q!U>GS!(A!NN$P>;MX6T,]K=UYZ09M8ZJ$VV7BU$'
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MZ+&DCEN3^+C$= 4?NS%(";M%**[LE&7F8U'C(ML@^GR!ZI'R,U]F+69IJQM
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MA)[J<V %7\KGK<[NLUNM/%Z9:ZXU(0-\<70OY*OK0K5MF=(AGD!"#%O$/M4
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MR84Q].>PVB";-ON!J.MTZ)S0@A_PX66QJX!X86$NO2PHH:KI"J[ACB])Y>5
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M;1[&^IME)3;&R40TW;DNH9#I<,)_CP>M2M@N0M"5Q2 ?'OPT7H: (8NA<<<
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MK>52GX*<B_DGGWR#?"(""%W4S].-\:8 Q".4YJ*,;*L9Z.7Y6HGC8F0:U9
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MP1VI<8DBD#:Y=:T?)*AM:&INU+#D2QF.(/F.>'/^.T" Q!S//MAB6 FX[;&
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M>(D/=)(T_< J8;LF]\5;<*K"1=V,0]U%(@\C5@$1\1%*_#KV@HL!0RTA9,K
M*LTXN&B0]DR(&"UO6^\Z=H2=@U<Q_G1[4GP$1OJ;.'>+Z:FC 81B^^?()A(Q
M@^W^? K@]G"WM<5&%+J%H"X.GK=CX6$Y/1:GWS;F3X;8=!O771A[2 .DOI\5
MORBH"ZH-6W1P#/<^*E;]RZTXTZ3?-XI73=RKP\:ND+T;S&^->0+3%((5.[5:
M<0O%&5'@+PK03F]#E'+*2(%TN?;&M_!H6,AGG"%$K_NS"B\(2G7$2:<\9SU
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M)R5P$U%-E3%(8K59V:D8I/9\[B%+W1UL,CQ6[E+S0"7X2.>5)1B.I:?CM^*
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MY$YB+J.JBM:$/>W0-%Z*K1/M[U7ODG)3![?W+TYQ"WPS"%)XOON)/C7B*^<
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M)D^[+'2X<(2>!O]**YYT$%5H;JH*3QGSZ2F _S?K%_^O6DH<]*%5 (YP>0^
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M"@ZSU+I:T7S_!P9F_G\3 %!+ P04    "  (.E=6(N4'$48W  #]/@  $P
M &EM9S(U-#$Y,S0V,U\R,RYJ<&?-NP50G$'6-OHB 8(& @2'X,$]^"#!G>#N
M"1#<(3!(L,$]N+L37 +!'8('=W>"P\PE^^_NW=KOJWMW_V_O7[>GGJJI?M\^
MTZ>Z^SGG]#D#FX.M B]D)64D 3AX (![^@"P!4 <0$%"0D9ZAH*,C/S\.0HJ
M.BX&.AH:.B'.2RQ<4B)R,E(B$A(*:A8Z"DHF*A(2^K=OF-C8N;BXR.GXA'@Y
M!%DXN3C^"(%[_OPY.AHZ 08& <=KDM<<_W:#=0#8*'#/X(T1X"@!>&PX!&PX
M6#= _C3/9W!_:<!?&QP\ N(S)&24YZAH3R_4O0#@X1 0X!$1GCU#1'QZZOWT
M'$#$?H;SFET4Z:6*,3*E RZ'7TPV"I58]0\\U9^GU)PFCO[/4?%?$1 2T=#2
MT;]AX.+F><O+QR_^3D)22EI&]KV:NH:FEK:.J9FYQ8>/EE9.SBZN;NX>G@%?
M H."0T(AL7'Q"8E)7Y-3<G+S\@L*BXI+:K[5UM4W-#8U=W9U]_3V]0\,3DQ.
M3<_,SOV:7UO?V-S:WMG=VS\[O_A]>75]<WOW1R\X  'N;^V_U0O[22]X1$0$
M1.0_>L'!N_UY 1OQV6MV)!Q1%61CAY>4''XHN&(QV=4_GE-QJI[BF3C^1,6G
MYEJC.?NCVE\T^]<4\__?TNSOBOW?>LT#Z AP3XN'@ V @.L[^AQ?U/\_@Y&Q
MVZV!WS58:"D[:B2DU/B7IN.F&?RB6?@&=\SJB)+&E,*"E5MB UP"C;I?].VS
M, NFXAV E>Z[Y8(<Y&[N@#X'(H[:/<O-F"HS0^R!PZ2K8*\_^QH"%_C@%'?(
M:)O=6-?0K*X;HBI22,$VBL%%ZP2EF*UDXD(C/K /9=IZR\@B,A@'R5X[(:+I
MZ8X^>%M??WC_#JY?82?M'(RZ7UF[H""+%W2,3?UQ(4&)0(@19^<'$69N05UK
MO2QB0-SL[6RZ:B3= 4,9S3&8^2%R5RW[4"@MJ6VY3[:L(CLFX,WF"T<,9@]=
M=Q88T'EL*#_#S8AF[TC3(/R9ZO%&-PL&.,^TU;=M* @_2]R0KS[#2'IXV'.\
M==R8ZEU2JJH8=#%6.2\G_Y +;<.4Z536M%8\4'.KU:0Q/B/O2G(*TRU-=FX9
M7EW89_]*+)PL2-XQJTD2RH <,3W^VYP/J<ZRO%]!*%A% C<(5T4"P)V-H=*?
MX"^Z-(6X.'WG\W_S\-J3)D*/I9-S[@1WIDSA%^D+/D)2^CQUU&PU(SA?9"L=
M\7]I\<I2 M.2)K1IAA5<"(8ZB;=5CAE&C"S[ WI3-K[HKWRHNZT>>Z@M^#+R
MM NC.R'T6?#_ 6#:]3:W129EQ[<V5H=6D*JR>[U*)N0C'-PT0QT\?:D]4+0?
MJVM@F82I2@$#?KDNJZ%%S.W0,<\*SY4N\T6NDQ*M/]JQX!/DJO.<B<5^7IB]
M]F7C,^+LH?/_X&_>^L+ZFK^(6.;EKULR#:?)3;V=LSW-*WGHSQD5"3RD+ZK#
ME/0MVLD#:('4'Q;]^J9F.<G:2H2J9'Q&\ ;K)@4 61-\"OJQ2D+AY(JR<W8U
MI+!")DG6FFRQ;7EVNFTA);IVL(Y5IV6<]I)WH5)#LQF#>81>$6&OI!7:3+JS
M3,J"6WK5T3S?@]"99L?3,@! !T(=Q\JCV)2BX$_K)I7/Y1Q!D1."FD!ME"T-
M)7Z2 &35\R)\.[MI7&QTUE.O=W#W?$'2-.YQ:T^72\.@DP658V9E)CU"J#8^
M+3=_U&)_>_!(,G,]G06N94N;1N2T_6?4$DAGU"X8WS5BY\9:8XI+2O!+?>IG
M9.BO>DGAKQ6C'TT:0W-2N&-Y"!BZ*&88+=\VRQ%R639T3?U2_&5X@^:B(ZM>
M='(B=08# F[O(GH3#(_;NZ!P85=CY+O@LTMCXW4T8QC S$Q^> $#5C#.,SNF
M4T&A_(C?PO1E*KBLVV\WBL6,'[X^M)?;S%DGSL8^IJA[Z?ZX+M]>:\=2^5V:
ME(B?$HZ$MJ!E:R*D:H8)HM+M+&-@['M/.)E&FDS-V>. ,X183/V)@Y#@!1A;
M5?/5VRY]CF6-3)'O[>.%=*#=]^1,F>X+#%8@SG6D0&@-*:A;8VB9\\HZW!M3
M+7.P8N!PH$4WM[&,G C<GPO^K?2(8<VRL*X!H=.UL6 <P=P]V]I_$:_JG7D<
M<Y)B%_$@45 8]$&I3O>K+94&Q($C_A/_)J:'X Y$:<EJXR:N>EX=[<AB2+&U
MIK8I.O3$['Q-)&_S_@ZK7+>A,>AXB86Y(/*C&7&L]!Q'U26B2YF">%>-=+U,
MH1Z:^]&)\,RZS422G8C6*1\7*YO;KF[MK,T)MZ7SCV=3FMA]V]A,NJ+Z"XY8
M37C%VO.N"5>,"_>_S"\J6&G0M<(_B; 5"06#0KESQ9_Y9$O@JA(\'7;@"7 !
M90/.@A+9XL\VJ[JX8D-S1=C6E*M&O7OL-# K80"55##XH P&W+TI]4S=I6E!
M_>>C655[<DM2-W9W70<#YNM:M'3<'B)U=AZ]YF' D8YU4::X*X0^CRT'0@_\
M!X#PLB=."CF8Q4"]T7RP8L$KZO4 $P!WSCYBX<ZI./7IF'6KN;Z]KB%:DA)R
M=W_$VOC! 9F:?M.G3G<=[S!6EQ927DBMR28CV'OG&JK_HK(_7UH@%!3$*/>C
M:K>T\#%7NME#_JSWO/>ZW-Z$=]6QCQ3:6#I/;4>5GQ,=S1Z+Y*DZA2_!=8#J
MUR38.Y88_D,NS1EO- IGF6MR0<K:COKTQ,(E^M:,TG\0D\](FBQA0@Y'@5"*
MY(6DZ _"WU0QVC$WUK*0048NOVYL>.S/.X/^;)).:60;;=RV.6Z[AG7-<J7T
MML']L3F-Z)YF%IEVT&S+ 2(IHEX(/#V<&B: NP"^1),VB__#SD]0:Y]DYJ9O
M;2D2WSAND'R_CV4U! -"ZT,?CV2[P2N[?="1AP,?2*\S%=T(*<V23QO4HJID
MO<F@M.&R6K7K?>W4^@6S!594:V'0^UTI%8T##A@@7M^:=,3..;^,U>* A7%S
M%U6N1E1^%?O.<UA@;9?52*_RX3DX^%;-R_+]1,UD\\+.POD%XR])STDP2_N3
MO<J,J7:RMO- $'=!?-^]R"'K%P]%:A5?;^_24EEM.]V*Q]^-^;;84::N-)S%
M$1EP8HJ =\PVAM<MQ\3!%%/5_V2!FL#$X'[A'6@;%C0BLEDH-R+-X(B WTI3
M]7#4KC,#_6PV2%# QM*\<F]?4KN<Q68XIE=F%,$?PP9L?0/M@@H_O"VTPJ[4
MK&F=ZX/";]S-VDCH)ES3B"UPAL* P/#Z-"LHX6SMQ>)CTJ@*#( 7L[I,ZK9#
M6>FGBM*KBS0X&Y67%VZIUI=0:?M9VR:#:F@YD\3@I8#:<(&K_RQ_L=K&P]H]
M]<C6.!W4]C*(/%]!+W"LB_RY(M1,Q_A;O+,77P:)-WR:3P+6 T5S>N:#OZ!E
MN:[?3Y9D6S4?=/J:XU=)IG4YC9G?/DM6P0!-<(Y53.2DV*GT"B2]%MRIO=Y"
MQ@U"U.L'M17J4W>=\W(Y7F':[MA(.%B>B8M$U%NQ6_&;PH!7"TSIN.".*@D;
M2RC+Z7%)UMR!Z\L/6=JSH)C\P?&I.*II&+#Y\?3DT243!DAP&TRS4M>%^!+Q
MSK]E=74];.BX'WZ^ P/*]<9"6C6SM&ZZ1/QW-.HBI3?C&UG3_7(9FH1JW"NF
M EU^P,5'%5$&C\L5;W7U\G_1<6:U+J8Y*DO"XM"38;)F[/0#N;*Q;POPB&T(
M>!\4MLU>K.L#HJ6BI.EK,6131^B'N!O4::>2; *STL9UH?:F@8# ]UV2NRDE
MAX)2I%AKD:%^IJ$8Q8.JLEG5+3S1RQ$:86BQ6;ON%_*94KGU=BQQZ#>]R>#'
MUL*;B6\,NW,Y34W"%.Z2Y.WKS+S@!6/UU'4W?[4-*(X CC=>*%0L4G..+\FI
M/*=Q^R9_#>Z:6YSNT<E?$II >%.\5KD*G8B#-NU=O(4.*25<O1+T2B\WMEPY
MY[/.O#RQA@%UUGC?Z2UI>=@L/0_+X"@P>)2QMAE'!%G/(%!P" 9+_K,\?**P
M/!P7)#S]!<QU\#S?V)Z"F.+FH(,"6=\ZJ7%9.4MP)FU:E8U%:^R+_@X8@/[Y
M?"<++\!\_4CA\A%9H6WAI2R/_CH2I381K?E<!UY'QRB6JA?JD;G_I$J]"I/]
M8L><^2)"\6^J.F&!CY32L;RF:F&/.B6^+_UY?Z]FCL9:]7"=-#'CJJ@J_Y6C
M_R> "UL7$&*08ZW?]^2WDK/K-Z20W<\+C\;:Z<M7/RV[P_O1$M=UI[,P3YI[
MI+(0DMLH^+@<Z'NY-R*^H4\V>J#$_R4QRL'EA=8ZV>>8G&,CCA^8TH0#)]H@
MC%R>!OZVN'E=71G;W<C$$TZ&:"VCVW![]S'2D-)[:L-ES@=UX_RY@[ /6Y88
M#ERT6\=U"WNBGZJ)WY.R1]GFM%1B_,I/#/P4,TJKJ7^?Z)J,Y$7U5L";,?EL
M*^%Q>IWK94@,Q7L<*1)FII/V'=%M>)GG_0CAEQ65(B^QL"QAP$?];][I;R/Y
M5ST=;I6AN-@&%RQ#'-U-O$RB\\E ]6_"$RWQ[LTA[L8:9A?,"THF7]^2[-1,
M Y&^RL].NG$+??:!9LKN%&]=^GM%#ZW?M')_.CYOZ^G2:Z2_."9.1CV:=^]E
MO]E)2;#-%_C-S7QLVE0'V<*D2D"H\$89X7]RL7[B8G<AVE/"D5CA:8YCQNO"
M@"(=<>I_-%5Y%&P4OJ+[&,;[DPK-B$Y,+SFC@^B8(!S"%JM.1R>2F5>-W(Q!
MC;&286Y)[4P_%M/\D83UT+%DM]T#QP9,P4:W'A7\-L^/"JS3B< ULAX?I8=5
MO34;IC2QRFX@URH>Y2SK_NP!"%\O.I;S,I1*(">_90BSFZ02M65'YSQ$$2.G
M1VX".G/D<IHE6A4\&+B:&M,3X#!;3XFK!4W;[$WHU=-,F1BW6J8-Q2LB=!SB
M<T/TYC^/=L[<S9]SN[-0)E'=$!!5:W/<.,DUP2V/4'[U2PR$1/ODXF%=T5PV
M/+A;OT5%?M>HPA!UH/]PF7LF"8WZ[?HPJBBK>F-NIP[5?(@89'QY9$!1"P/T
M36W< V[*-^=6XL"R*NM>TG/,AZ\T%&" 0@[O0Z\$J/R](7G+?OG-(6OIR /_
MW=.Y1)S/*=6UPG<+:Y[?)Y2ZQ\30+M^@H7$^-IM4''Z*W$R(SO+"ZM]I&$H2
MXH46N7-VZ>3:MHT?TH!/OJJQ/4AQMTB\JDJ1OSWI 2%OIO:>+7R<_&%G[$$[
MK:T=&O)E<;F) !EOS^'SF]/]+A*GH>)1=1&:NN>28&!1(_#D(;)9\_&S' S(
MVVY.H5)5C:QLWZ939% <:MAT"#NM[&2<Z72# 3[G%E";]ZQ=K,BL^IC(,, [
MN3VYHAY28>F&*7W%%WCCLCJUMU;.!0/: -!HN=1J)5H7M++KSNJ1.>Z!T16B
M:;HE^<F'[.>3IZN9-U<YL03N+*M(-\ET'5SRB:&')EA --$H:>K]? [9HW(@
MT0 2@+ G)X& >G&"=:/4=7X3I>7A[/7V0X-O_8T?H1,M%*L"R2=A5Z@TZ73E
M(?C2\.ZJ#NHXI5]<*76;79OF8WUNX76#?R\>4R%(7#I0&+ZY=ZV=./WH*UBX
M)H<<M2*7;"-HG#^4*Z^(O^MS/B-^1''?+OEPT%"TXT_\58=P7<;$(4A*N2/*
MWMK ^EB*N1[-*\1V5?MH^ZD_P7V.C6J?07:=19@\G<.U]32HD"6,C\_ZDT=B
M#;G[V-)=Q9OBC0AQ49> 7AWQ7RSVW,3R0U;+.^0</ER.*T;;]3M.$IHU[;53
MY:K[O=N,7TG,S4*[WCQ(:!73/RTR0)_CS\'V$<AI6D'1$;4T_1S]^MVK20 -
MOP/#EX^VF>&3S-(S7!5I8PE<9;A_ \A\&S:2:.18 \3[;+]&^)Z3)X/BS7>8
MLMN_Q,1D_"KYCOQMAN(;AU4T=\TM=A>)DB.MQ4(+!SZ)(VIDX?%VYGHEEM5\
MW67;:))3X3O595T/_*O%013'0D9_-A^=AC4;D,$DT_>ALA5M?2D<:E<88!&8
MRP#\6(IUFB]55.7>YLW$M<;G;X?@*]">IHLK"LN?R17(@9+\%RM^]KJ17/'B
M[::@8R]\Q'\A-L'ET $II\0U 8X+"R?K/$Y"*TY<HK!-H=B/NDJ1@_*TA1^L
MOV\;8;TS$E$7OKW3+)A7NDKE_7"^%>6)](OCR.7*>&XRL5]E*<ZYC/O,()-!
M=KS/@36)J@"'_0)1>7B#+J$+T^NJ7*Z%T6LW7!-E^,L+$5<]?S:G@#VME=-0
M7;$+H83N^I'7QGUC7^B+U,Q@0 VFE7ISXLGX<I!9HS]?CLW/_NSXNP"9/]YI
ME:Z4G25>#<)6;_:K#/MGS.UW7_(X=/XYY,^! >>DP="V/!@P'ENI\3DRP-!/
M#NC]=<HYMBP[6C$T[6,1?^T3/IX#811GRS-'S]>"QU*V_)B%/I2)9:FIT':X
MH2T@"*;"ZE:W.V1LL?W$'?:U8X_D)@%L -99S*E*)(ISJ\M,S(RIJ51A-#@8
M,QSNNG@0MX363\Q<(KL;#IG>D+V1"BW/$; KMSV,*JO&:?\Z8C,N0H5H1F30
MF^?S_/$.!L0]2!U10.D?Y\$I#ZCUS0D)NR-UBQSWC/Y@ACKM!AVD!%<W.7/\
MDQ.*>3"[]FPS[E7]*PS3$H.<D*^WBLM&ME@(@E&=<<4&J.<0GZC?X&U4W+S#
M_"<J--P4]7J*GRH28( A#@S8XZLH:0V6O =?72:.=&X,WPH>;O#RC:T9!$?A
MW.VMW%PZKIY!YS'.A8@O+OC9>4'F D[EX+6(9L:79#27D^UG^^SKAOH",("L
MHKT,[&CH,'((;OU^80OI[@OU=CYY\ QW3YI5A %]17=]US37R-70\_N1_SHX
M]X!\,6F1K.]^Z(1GMTS^;V/^*B/JCV1[+_(3UM8%(<9_I)5I5EP,KWOR1XJ%
MPPM-J%"#W1@HW^P&I*K J=P<>RI/]3%!^RKV90::)V9=CV"/%$[Q(#.C[6]H
M/7^NOV/6=KZ;=]+EMJ<^'LFK%XO=-3\89(B=S?CP:#Q#"RJBA$H_=J;LQN92
M0RK"V0:[*" NN!T;K#YD\UW.=\%!=A;C=G/'=M^<$(,?&Z.03WM$! TK;CZ%
M/!CF)M:3@*WV2LS"R"HR/4 J^M.(\&R2HB7;QTJL)AG)I99W(SE+>PW12R)+
M9'3HPL'C]T1->I&%I_<*&4=UI&0>OX7D+Z["7M;IP8#Z3)?@-;7V-:HSJ4"H
M$LZ>X;P&(PQ@9V9^3N'9JB\U9:9B?4@R8NOFK&$;4;GW9-SN%1.\,::\K]XR
M'DJIW,PDR.A^S2"  5&Z)T_[Z<D%%RMO[C[M>_!< <\^/,7.>&;N?:IGZ#IF
MI[\L&U1HMV& 7*U+3"=]_ZT,L8R@6\>(>L5 6\PO%0.GW(-FB'NGZW>OZ5IA
MDZ]Y&@+"JPJ#2+@XBBAT?-MUK<2E^RF1V445N80T(?$O2-!\9$.DC2,Z !E2
M)_$PD;SD.14)/)HG>A3Y ]RZT)VZGY4LS,GX'[,_B&U047R(49S(6-=GF-$M
MQI%9IG$ST\^*Y>PHJENY?75)?G<5!P-$N5F28 !%*NO=:N8=2N&XOIRSBL3K
MP+]*_.] ,AMAIRH$OS_#V+_>8H:UE9J-P.7E:Y?V..YI\>T!CB8\T^X>KR$N
M(K5]W?IJ^++/J>$.BM=>.61J7C#DY69,N@!0:0V^8='V14M<A7>8A12N1<@I
M?4>O]S1SY:AK?=]?70+&-H)C7,3C-C2+JC7>7Z8^8PVNLZ3Z;H-UJ.I@S3R]
M$ZUW+%3E ?AZ.9SHM\5_4S!%;$ C&MPE[%9J$J6J/A8Z0.@F(Y^RJ^.>XAHX
MQ-=HN&<J]K8UUT^F>V)O#^$^R,)$F:;\A V3JCCE0G=U,!5Q%7L*:1FW5^+7
M0-5A>V" ]AMFFT5]]2)O,HZR-H*DXR"2G.E]EE-*FR"\$:86QPZ" ZHB* 2A
M_XI[+ I]-';( ;%*E!IR=DM?./C.'(@6<H2[WCN1T;)]Q(SEP]>:>6?4W\$1
MLTADTWX76*"K4UX7SE,RK$&MALQ+AX![ +Y\+FU6^]<H_^_HPK6AB.[-[X,+
MV?3ANJ.W6OW'IQP?/JY_T)H7XV>XY ZZ2U],*:NVM=;Z@O5M.,I74M@1S+^2
MQT!@Y.OEI#5=^&9^HCJ?KU>@]&M84=DR.<34O7=5LNQS;$MZ%.!,%:<S$\KE
M&D/3G6'V0_*Z8_-Z3Q7EIR=E5%:ABF):S@F=-]/+%*L!%W9P39E=W8!MA<V,
MS)&^/(O,L^<&#I#Y$HW,<^QV&. !^DW4HBZW=ML^ BF  6Z;3Y/\*/(G'%%[
M^TIY/I!3>'P)<P*<))L2F8L4UU9+5'?)=SF[G3&S[>6>Y0)10[A.[OZ$3$=Z
MNZ=1IZ_J15QD&OFB_^8'1?JA(D^X,^].2A-+Z@<.Z2AXFY@ 7A(S/[^)C'J-
MW<$A@L%JX[@T'/;,<L<2E\/)I+$=J.3#[TH?5:>))CLL74.6.K!@O2R3+44H
M5>H(LH/"[> EN=?OBL(ZU0GP)B'6. S@U&U?9Y6Z(_0.WF]7C8>21?+I;,BE
M'[)@44L-VUT:Q/?,'-=N8Q]H%'#OLF0]RP49'.C6?D%"9$,DRYJQPQH\D3EO
M[SJ& 8Q$#+,3.>T[US#@:S\=9)LF\3F.]$+NF_YB1GPP5IYC76^"P)RBQVN^
M"&CIY'D!2X-+(5N43BT[JZ@+I@[5Y7%M6TM00D+K';CC]G'M4*T]Z&1K%HK5
MOY23&^1>8:)M%&,6T<R1%J"J*699FHM4GOMD:+^2U'];9:92:^8/K$S-WP](
M:*NR8QYX"I0PB<_*=$]>W%1VU*LN6L]46Z>H44%!Y>RX W,>(>X'D5*5LK_Y
ML\L7YO1W9S7FTWS,XXM4S7^ WMR!^3_O,0Z9>+ \+HVQW7B=6<NV-[553^,(
ML0TP+DHPQ3Y$-.Y8TF7C[56Y!T@T]\64:LEE#-@'W\V^7 4%?R>:7&MODB.O
M$UB404VMHEX@R@ 0C;RN*R+!P5#L1NKV8.=5)0UI>/)ADQ*]\EUYCXFIW9@)
MB<7P,BP7OD+-)RI%?:#5_<SCAC_VN,M*H^=#7/T4-P0ZD8#.MM:C<'3N& R/
M#?LA&OJ#K2VDY7@]X$ZJ]1#0QEA?4A;F+(^#PEV:RF/J&?[*HV)[SA)X=B2.
M%GP2()%DO^T=.0-9CSCIMK9KS]O5;(0!&6]9\<$G61]AP)?"GIF5L]M5R]39
MPZ2? P]G4O1.5']N;FZT5+M&KK]\EK 2B+.B)K\Y(')\>'\ZXR!@A5_8/L]$
M(^\C\''+>#@B"G? @2R.'J*F%D,MI9I,_<GTQQ@I2&=\,MWTIPUIHWJ#F/L8
ML83'2H0P_8VV,\4G%Y23'1;-?M^U7I4D.B&@OR*JPX=KXD%][<:L'DS[$0B2
MIC$B84.(V<<J?V=,,[P"'B_D;:&9\QZ#T!+UA 1QI*@/!LHE&QE11R?"<=B_
M/[[&3?1AS$!3L-77H0^P#)31M5\17NN :[[HL UJH/OIO% NREI8&RD73Z!I
MG.9R--GTL%_K@S>^'IJKP$,:$2V*N(D=[K1 *B2@OO32$FUM1/\R@EY!T(*Q
M<;'/ 4ZL@([D:&<<>\QSMJ2>R*4@^1/S89:6R8!-Z6)&7L9VN:JIKA7N7TR%
MAM[=XQ>B%LL(EH/XAK<X#-&R%'LQ4W&C &D16DJ"E*K'^CU3U:@IO+.F0E:P
MAE'CU8%Z>:M,H9Z[_4'9T3-(K@#74&V1JFC_T416DF: 2GWM>6Z\1Y0=&XUC
MMG8O1U?XZ4<;*7N=<HS]?W S^6  T6/6C>JI;@Z?P#M_:<&M7XVV-,ATX;^W
MFU@1#88LRQ?V9CRUJFH3.7?$K]Y&>: JI9$V];H6J8(A+5@$80%KUBO?^*0
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M88#?!99)?OE;,$O[J8_DT?MI\":V!PS0,[PE^H;^\Q\DE\Q7/OBS@@["GL(
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M/CBYE<XZM![;8,BZ!KFU:WBI'4;R2@O$_%"NWY/TUJ#N?)L\E1[ZUEC.TM2
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M+E2IBHF4XLEK\5]9N'WR0OCU912H*#/AF,S83NC1*E%D@F'9RUCU-XW8L!^
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M2-  AT[%1\(@^<+J3"7TX)?&NHRV%T',+&?GGN0&"SJ%4GD3*IS?.F!Y39_
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M&]9W7>N$$='*XS"N13ITI@2VN (U7=<1D1J&VF[:BK+BMQ\4KL1O$'A$>4+
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M<JR?UUA9FR[^-DR#M*N=[/#1]V-Z1V1A\"FV,?F.79;9HG\YW'T;&*Q4:C^
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M#-'9COY/3[PA2@+54\IC6;955]LG+P!@6,J%7'74W#7SJ=S7%9P7O6PCKMG
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MLK"7Q1"&A6XUV:?,<7N("W9J"%$_.+*"G(%906M$8&L[(K@93.^F6-37P)=
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M!!;J';:E."A00!ATMHP=12\C9ILO-1JZ4H-B\QB+ONF1HA;H%N4/<^" PPD
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M83F?4',J.)?MMC<)MV-++'S;^7A2U )(,++L=JT# -]9Y$AL:[K@J0#3Q!\
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MRM/*I) Q#1&,0B1XLO0LER9?:4>IL$(@AU!M+D!FQ"QH%+9A%&#'PL<=NB2
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MQ]L#"(I+.:'!8NEPW2]7L]4;*C"[4WR]BX2PKY;+W1AHK.\;*3-MB#HQ.BI
MF5#SOU@A/ NZP1Q^-#=X<KV:A_9.78_#N5 Z@R0#FZ)8]]-[\6^%U1/T"=%N
M2Y#"3!S9YXF*%'+S<_5;I*%TF/:X4\I6S+)EK<O]"(@U_1$,*H1Y+9RX?RU]
MT%_]J:^#R=(PS_/I"2B.\=V$Y_P-7RHG^:DST4;P(-\6)1<"[YQ:Y\/!9/#6
M_0B9)?>'QN/( E?6S&4_?0E_Y>LL=Y95ZG574SN&SG71T>U83P'XRA+_+2,P
MT,70/BX]-@L@W5H0[*+9"ZALIM)#KY0 C*V77HZ]G?_M^6LW9D$/&?<K<8Q;
MH#0YE;-FR<5/#+2/=76_\$/Q_2OV3#X>&F;V/^QM2146\>GT)&8QGR.NWVC&
MRTNT?DF3?F>@T ,ZT0S-N^?W)?T34HWWDJESLQXW^F.<XT3*4@G'C:PMG\E@
M$F6SU,W4H*WUP(9_58C);$.Q2WX3B121I,* 9"2^:W:U(&(X8R9BHY4PAO'G
MFD%O6W'5:EN^X9?R]N"O7#2#B+(Q4.8]RTST%+-O5M-,GV?J-4-D1%TG0F,V
MKJD1[C1$RU=N+B.-*>0O2PWFM+"-HN9<U"(2YZ11<)1GTB__C N56&K_98[*
M34] ^.XC5-!R5Q,O.5%65)BD/. 40< +@.R8IY,_-1DDVQO'CPJ*!1#*S#O'
M")JN6""%_^+X4K.36O[C\*BX1ZM^ZJ#LR\N1O.B3=)P-&RG);$U'\ZB$\6:)
M/28$3#"V!)NY.;ZRO(4:B3&0"5)6+NUFG?\0+G.8$A=0,[TJ@:]$G4N/G8M3
MRN;P!+R*6Y+S16 OH9]DFU=3?ITK39%'J9<*2(-FRJV!PS?A+#\]:1+%>Y@3
M7$5(I'\3?,OW8.GR>KNFOWLG4</W@C,.D%',EX&MZFG$EDFM'N*H3+NTBDJ[
M#,[WE;HL"GP3"%=.C$W&<U1X-X"9D90Y;*WCL:V1TK/JRT6F$G?$HBM#B5::
MF=!'O/$5GQ.=H#IB.\)U!:FAI;INDHV^MJ4^:FWI7>U:HC@+CH,-G\))>D">
MN+"&CGR)C$/>:S(^>]4'^M33P_&*VG;\?3_*RLJZUKKJ>/66Q&F^NG K(ZVI
M=ZS*[WS.4$$S;[':(USG;W@:V&H&/<K+V1GJS9MEC**OK5JDBSI$QX5P4T_3
M+Q#&YCP@7=.\SG.Z5KQ_?@MH)+Y_?,PEZ-_WEQ0K%=(ELZ$3J LQYAXP3[(_
M;>S5NC]A&:W5AW8G3=?QGK*%E.78E+U.'!VF"9><HT!?":H(!..\+7!<,\1M
MME:QNM+Y7'?'C^:YU;<W,4"'O<8^ % CS@X#;I.:# 4>\6K3#V*V%_O>'R;H
M N>V9 K8ML"R>75%47R.DZ>7957^Z)OV/FHF4\(_U#RY>&?Z-ENMIV;"J8-4
M=5WU_[#8QCX^%G/W>"DA6T_G,/X]?W]_87UVZA&FDMI6SF9\R95:UCI3^5<<
MK/<^KM<I HPEVG",88/(1^C,=[1\],J+],"F&.VK5KC/HE<2VCE+" T0^*)/
MQ,JR+'LT^8'NI&B_NXUC\ON),.G;R(U8.>J5 ?4O?S,FK\IS/Y>4UNPS?CY8
MD6;+$HOM#4(0.U3)IC=Y491#OX+IY,FS]^]*:]/4&[+@GVD:KY=S4]\_];[J
MJ-ZD'G"^S#L5K<$EG7NSXKLF=*^NB&:9OV5_:%-[BP]?U6V$7WI,<1%P$8>@
M8P^(0,M"7\4GE.+5DT?\T7L<#;<]/'[(Y.O$GG;</]3MVV>UH>4T-8J1<C1(
M))<0'"X4^CL-5OGKBJ^LF_ O\6S5R5U%SV&HQ)?/U@0KYLMF[!LD&EBMFI_#
M>6]&#/Z\0Q:'WQJ>9.+(_2-WRD5N8D\Z1WLU2KU-Z>JF<PSC](PLD&X,[RB7
M92^8&1'+DJT_UQ0+O0<XQ6)7H%694-G:__[+# 24J3D=V/?-:(D2EC2-M8^K
M==$2O]Z:FS5_6N2GK<AK5?:(*6 +'/+ETD_XU4,_^K-W;6^D.#\MSHUU<8\;
M1A)B[G1X/7*4WEDE<R0O,.\<KW67GLT6]2<.Y@_2F3$U3[QX*]QS68 4]:X,
M*A=WKCQI4H=-8R6ZZM;',%Z7(C0HQ;DP+UN&#7Z9"'G/J/)N<,,UG6**_KNJ
M!=-BR #>0W%NF467H-J?CS/U0+ZF-=/^95E*P[[N3_&EW[^*F#X^Q[)O[]\W
M4)L^RGYKRM:1(4CTV%M-16LMRKCRJE +)0G7E7%75T&'7X(I/TSCG!0LD<,9
MR_4NY%OYNKGGP"4;_<3K]&<H;HZR\=U5O?.QH>_*N4HC&;HK=IOD-[BEA?^&
M[BAEM*9S0DA7>XPF]/[HI-;N.-L0_'+O3F<5]!FV,"7(5SYOW&"ZN)M!<X>Z
M^]+$[:W):#T!G@U4(> U<?JAC8WX.$5G94T>XYS*&84$J^(/3M*GJ;T'!5,*
M+$TGT5_SFA*L9D:;WD-<:?8<_\Z -'AN=;!41CXP.(W\@$U_92E]7_I6!8M[
M=B<[?$-8K.113CI(+4,QQ2)6IW=#K_>E/P:*V>_U?.+I$'R$D<4;;OGFADGZ
M<SLCW>TH=VD]QB@7"&N?8Z(?JJ)XE 3=S7N62'8YH45=M>:$@7B8*^L ?>B'
M^U+**?2&.^?EMW_^B)%OM+T,]V8T^:DY17F%%C&VAVIVGF/<+$W%OICKH&F'
MDV\=E;?*,GMT01^F/JEM:Y8N4Y[B>C[9XH%LYK8N;#L?X5;6&PYL&?[F99#0
M%^'@R/FA_VW"AQ[5+0/B$\>I^-F$>!U_<!E)QT!1*%)5K3[JD( C*]1,O;GS
M</"A$3D@4*W,YE>V/_=G'CEY/N7FEKJ%_"U^8Z[32D+.]R'$ZT$Z:LIBY)KA
M+M#J ?M/AHL"MQT'5G""J6DS7\J+4,P7T>ZGV/OZ+B<P1XPNYB,I8MJ6"9T)
M\W%7G)@8I>.OL%T#]C<_.Z?55UIG&D??]K.;5;(7%\AD[YE3*\;!7#@.=R\)
M9G=("R<_=PKYP;E"KREK,Y K;IJ[-LF+EB1F'I,N[TBW2MB/>$JEME#,OM8U
MI5]^2YIB+IJ\#&XO[]#<2 +/IB=+B-LX4RQ6*>(.-(R.YY?[@55D2J,2CI[G
M/"=Z_\Q;B8HZYH+K$OZKXIEZ*[//XXT[_)3Y+7MW:]LZD]-+F"U5=:!,JE4#
M Y-PQ\<>R%<X!APM4GM^43=ZO&;71Z(HYKYMD&21Y>[>5][%@'[Z52?*!&M%
M%4&7[1/PW697=?1U>7#-ZU!6GN'.J*/'_C+>\;EMC4E>1 .KG^S;]:U.\KXZ
M&14%IX/0,YK[;XEV@TV$<7>M.TLOZB(VYV?F6G%QC2--)-##.8$#YK8,$^PT
M\^\G4?A.T!9?ZRFO'\+,79V+!ELUJP.!X8QEU6+_$A//"7#N]_KF;OV^GDOJ
MUIYJO)6]968U^5Q8=WVVO;4(X9;H"2 %+HHV:]L)Y7(7]Y7RLJ5Y#ED-?[%+
MGLE%%D2!!F>6FE)6A-7SK(ETHL,IEP:L--;%M&@8&U_)-"DF>*5+;8N1CNTM
M,08I-$ZZL@G)1$VS2#485B_V'4GK=[PT0:(L>$O0'F74>O)ZYHMM::6S#=7Q
MP:9M*7X0B2JL[1V,.DCLI$;'/L25QGPN849UMTIB8]23=9E+O+.X$MB.8D'J
M\2.< H6I*O^A-F]MJ B?4*Z"\;T $/R?@/0O4*Y8,0K%;SXJ<+()V_SZ*KYZ
MU<9YN]*@2K66R"< 00DJZ]>ZQE12$\E[+!.*T?B6[,>GH)&8;&,Q:6,Q!G(O
MC;='\6L4NKWQACHRMF:V!7/?I$FO_N1K1_CS1&0*KC@4I]^\C:4,*&X/Y3G&
M6M;5Z^-9M&/L&6ZP[)IWZOSPR2E+W'9EPZ04<!6$AG,0VJH,:DT(%Q^*TJ?%
M_1[N'(J.:>;':F:6?$'9RKP=4CL?_=)JAHA/ V*<0M9H.X=$[=2,+4 7\<A"
MU?5=U4-A6Z<ZI?-H%VRWVBYA9=8476,'BZ=U06J M2J?')5[FV3O;UBFY!(I
M>HH,5RW,);PB,<2-+I/N.^ 6(YNAI)ND8'\"JB[*ZP27,(2<6XJX$9(\R4#6
M3'VC]+%1ER9=<XO3!>Q99H6S,)M"J[,29U;P;6R%&69)J;_#NQTQVD)K[B4/
M2"=O79-YFFOA$D"+2OS17V!STT&@5X9_3P;6*K\R@?.7G8"UEM^.5)%WRU=R
MOM\[F=CIYF(%$QL E$!RS^(0X7\:+)&.FOM3>@)PQXSKB@OG\!*=(N1NN!CA
M$L-35OI9V-[BM9Y'9?TE!LF5?_>?6[YEE*)V.#[*5PW0%L>(;7P$$0+0W%H_
MB;#C>( [+L3C$B8+F&U&N,<>^K75!A3N.&AI#0KBM=,QE&_92"E/$L./Z$*.
M?&U0C^!KQ/220W5'#4R+BH5E10XI,@LGIUJID-JXS1F;VV3786L'P;W*OG=,
M@=R[^J2I3X#LYPKZ+NRLL%;[URZ.O1I6/Z8%=/?=54-E$%!;!??U)W*2C+J'
M"C UB4%[7C,O4GRK* ;)+.H,J=5CLB11+ [B%W:CF)5LNW[MN+G'&'1MB:V4
MOQ<*K]2S#V7@VL,SC25*.O=UXGJT*29RV/ZU'Y4XJ")<5242\593(R6>(3N3
M*";V.GI3K#FX4*CI?#QS(3W<?^D]D5#TQXL\/H>@R,73<?\W):7N'^%_JF\A
M,U(#]_?J3T!M5PS?L]^DYE9'EP_3$Y5^!B?$*L=_:Q*>^I,= Z--_.3P+K=L
M677BX"UY-1[YCY$32)K33-.':;%&4X^ 7K5GS)>[QEFJ\LF[JN5H=PDV*3-?
MY>9-]E8TY?1&OP:\TN7+#:S+Z/Q<+Y&_+Y]G;:GIF1V)P$9G2[!%6F]D8]B9
M8K.73AT0F%$]5_%=\C!V3+5$F-O9D_:K[F!$NJ+.!<6;Z2[I&ET;HX#).L$,
M5>T1*Q:ZN#9:KF_*"U/9F?>FP@^+J%[*5WV>M]&44R.>IA=JB&=X#U)E@BK/
MOFU<@#(#E1*:]Y^%G!LN1F5)SPB.%%?%"!F+MJY>.L;/4##>?Q9 8LBP_M\J
M"=S#\I_[^OM/7Y,(QN%E'$8"&R>.XS&&[R6=_'YD8KS]66IE5:0-_N19/,#7
MGJ=][R+D'#_!WX-Z]Y([_E9-K8 TUN'[D/R;DM&WE:T977<-J4QSV/TYEQ3[
M>:?L:127V3:\_- $$JX'N?U+JNT\[AX='SY@20R\_I6(PG<O.O@RRT1@@GWT
M3KC@VO0,_\X7RR,FK#J^<WKVX EXXYQGT4\+Q;2A,DO5'5ANC,^"=-HTE M,
MUUQ.E'^;WSX8)R^X9QAOLL?9MW*TVM#C>M7-#UDB*$.L*1Q>+7IH+^\K<G+T
MB=AA(@ED,N<'3%/*KW;^15<A+%4:'#S?*<UP3'K!I9485C!RO;MG)7!6G"Q*
M/QTYU,L_VL>O)#3=%I OD;D;9ZUYHQNF/Z2H9C!X61*-M;LK,G.5N/.&1^#K
MBWO8S XSY-4^="X)8A$0/4LCG'%<?Z,9*W7-Z9'2-* +38[PG1JYYK[$N+U,
M^S#2D0;[K!S55>MN0/4G2;9F89T/C-EX<54"P=@]?2_Q."8TBLLNZ#VC??47
MC+J^.][,26P!M5=UKW3)NDHV#B^_^LL="3O+.:PP?8"=E2O]?0XA487S.=5
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M4Q1FLA/9H3:QI*.V??!MW:'1BB'Q[(S>#P>PQ6#";T23X0F<0C^<IS3+=Y^
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M1L0@*MR7V5H;D@V6^<@EOX)= 5N5'.#.-*KU=R;6[[5#9;J C[')A.)DKUK
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M0IHR"I'L% OOQE 31#FFNI5EQ\M^8Y__@!MK<3W<D$,CZ3S:M<(7%_/$B@'
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MS5R3RN*C"3["YN@JBZ=M9\WN$T!Y[UC_%]./'W22UWB25M//9#46%^Y87RX
M6Y&$"EXB%6A7_*Y7'$C8O0HK;7(=E07.R:+1.X[IVWS,@N@>EPK<#OR0,X;&
M^8(/IXVH&R*3S57 K1["<"#6(-5E'^QD.R$P;&%=5W=";\ZO1*G@J$[<*$3'
M?)DC^?,76VQ'>7#IM/1?O3<^O?H]GK_UF]M?@C8_^.'[2T>PX\JQ^J>UE"E
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M.4F<BA>FOFZ,V#=%<X-W&BN.40YUO3DO^]R=@_WF"P,)X"5 _(>%JP#PJZN
M2YG&[$0DBT,%\MSR[[1&B;<(_7");Y"N\,'\KXGX?09!>@H6N I%XD2,IA8
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MDM1T^UTXX.KOX<UC<\!T):S]1NWRRZ/&ALA6S^JCO.4,A.MRU(N8-X)PZ;N
M=R$V\YF(D@X\!519M"EU?L-^:WJ!_NQP[HF*:^+2,5(KBV< +BGH2=C([M[
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MK&E(9OVH5A,)_#J+^R;JDM@BA#/TOOB$26[)RHO9928WG/"$8NK8=>GE)M7
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M"\&;SHEJ&I>LW6A45U0%E0U?$S<+2%.-WZ78SVO+.-DO&48:0_XH3,E=PS-
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M/@<2<^R33V@S<4CCG0T'/!CE1!4K90)OI/2U<XWL/DI3&<W/[%O?:\X*?L]
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M8E\7>Z^!95M".?U-]]X5M?^AHR!WEP;N"DD2;=U,!/YV1,#V^YG0YS-!'SK
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M>)A##W(=B>,]1+ZJY+^U,G2 D=BHG#T7OZ=*SNLNE/RSN(?@^J3F\!]13M3
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M:@=)AD5C**E>#4EY AGIO"=U<SBO%FE/RLNQEC]S ']_6?ANJ'[>?U[F\0)
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M] 1L(E2G %U6H>!\U:HS>[U!*^+Z;Q0W04.F,K-J87II\>@\7[LCS@)ZQ9_
MTE2S8<N>=9-/S1]MI_?,2_A,\SA97:AL$X*(@OUYT<Q&%[M92((.H[LJ@50Y
ML,,>G-H\GV*?HF=PI Z?U'WR??2!?I3R\PU9UB;/L5R1)=0Y'DNNV&!1JV_'
M$MQ3BF^TB\+I5_8H>=H7GS?NF=H:N1>.?'@]IUP7'8<\Q#[&GM4%OFK'W".E
M]*?A], _AH5"<AJ%:?O8.RN VK<2ZWJ?I3-GN^4A58WQ<$QJ[/AW"#'<#GU2
M&P;&YH[Z)&?>@;!2.Z;X(@EV(T84?F/%DDR??+>;WB<5R6F&.K ]A?3CMH$&
ME=_]F^DYHW7F8"'24U<M!JLOD&S#BAW^/*&&P]P]W>@^$D)5P<Q*PO>DXQ0J
MPC_\97<.XN^ WEHT_5CI4=^UK>.KN\P/KI<E9WL)E(\_:@:\BT$C-JV++/LV
MQ)\6?H8Z[/(Q!P[%)\4NSFW-LWNVZA(MY+!%JD!/5Z;FM75NG!0EOQH+U>Q1
M82ACW0&12)M>W[(*S.(7#9J; C:2!N66==Z[,0F/F4(F&Y?[I0M#_$65\NV8
M6><;54N\G#>U*VF?-&$7*+;-M=-V894YYK4'][E0J"Z"'Z]'"M"R2(!)TCV^
M \=T1]6_6ZRIIGI:Y5AC!GV8LK=A\%TT4=2IK4/G2:H><H_S[.1>/<0YA^9#
M\X/X5%Z^2[NI":I#G2U@(U5_MB0 Y'/P2_;MMDSZ74P0I0LYK'5XW;GZ4^%Z
M 20%(IA[B)#IG"EU58G\,W=)>N*#.(-LL=4\F?[5T1]ZP-'XO85;<&E(;7DX
M8=Q)G_TN7G<A+Z$(U%CQCE/U<\6<IT2>J^D@,V?:[N'1BBC6(#D/@RC/FCO\
M'5#P#SH"=?A<LD%]5IE? #VSXV$"U'FN_5^B%6>SW<IS$[Z4Q+&1=+S%%+TT
MTDU^I,D"O !^LVV\ %YMO@ ([[JG:6XO8#X_*A_1RK3WO"D"*_,A]*]Z6S4A
M))@\I>WP3-9,SP0Z<@X"M=+6IHA;]OTG[JF]9RZ=S&A:MW*J#1,<X8V</&N?
M%K#<B)./ L<Y?S_B3H(QB-9'6S,+300SAI9D^VA_EP)T @)$B*^;BSBOVYT$
M@LFEU:5RHA!U:IJ635SX6%XMX,P;56@R7Y5X4T]N38&'$\A_N# %5ZL.E"2I
MYFEKE*-'AU('XG[L7_G0*9SO%?>#6I*)R.+&W+,E9T;+X:2XU;VB9JDCF>YB
ML7NGZ3LY3@<ULJ (9VQ17U)$*.,!@3YV D5O_T@C/._-92DTJ-3*\SZP$HI#
MD40SPHWZ<Y@./?<MFUKZU:Y(V9.9\L.76"HLRBY&0\FG^8&OON_BV&<+?E [
MIC[7G5_];HHM+#68?38>-@1]S!\Y!=%_@$1[%$.<3GS97 <Y)<>NY>0&*BCL
M232))Y?&L;4%6Q-K@RS>9-EW^.!)*'9X%Y3HB'[L[;&31&-G :#N_6 F<&@5
M.((L16SA. U%.]4TX#DKZ;ZY,_=K9U5E*RW6@$N(>"LIBJ.C4,_E;@5N/""V
M+#R(LISQ%#\:N7,6RN3> BX!.CIRPNAD42M=GHN\?/(U2VY\]H/G[M74;@EL
M;V,EPV@JX,MHRJ*Q]UT(N8-LKM!$"1H"X2)D\RKDX 80S,K-%O?OVY(K10L.
M+BPN)!RL&'M<N";JA(#)_ITS*0V=8X<S-/45U%09D09O+6S*7=T?OD2IAQY_
M8PW%-V9NQ!XFH9 3]%&>3C4V;@YZG?CJO(!%E.IAN]9&P"6G]Y<E86+&[P80
MQV!(+T6<XO):A7/\HV9_J]@*W]24:KT%-4K!Z+>+8) ;0I!$#-.K#3M\ZENO
MO7QZS;2^&ZXI.<H>O*:(J&B,T3SG;:S&A_S!\6^8A]]J6YC7Q4];QXJO/9+B
M)O?%0:YI5!UAK+6"'>.D_F!&<"O;&4S.8V"3;=&K@JVQ6R+=&KG0H"_%!H9!
MMS_9MX\VOX)VM&IJBTD%1;%>^@J?OI'/[&'X4)"($X@<T2)LA]%3;2FKLD0;
M\W/9MFSQ,WH4D JCFW(%+']5LT]?F"(%A5*R1+SR%K%K%N1+5ZDEF?@61I/'
M-OH77BO6>KH @FJ".^QG;OW#:,HCNOY/S/;^[#J\>'B#?@%6U9A$Z\PF8(>+
M\!V^B#1[CO,I^ \;_LUT\_S(?0N<Y- 8JI6=Y?\5:1<662]D_=P]\P+8Q?MC
MQ;V)'NE%K<"!OXGD]"AN37=UW7*HR;HAUJRW<[\Y5*]7/KMNWX2N$[);0N4C
M9RJO/^6M.)3Y:Z+'-)"_\Q<9U'>WNRH^/N;$$'52;SY=/BB_'+;U^UR92%&Q
MXFWPT\-.?UU"$3Q[37U@>;/UJ(B:I*<O#U1J>^YJ)?M>Q[4H4'_'5M)<"\EJ
MGEK)(CEN)BF(?;7KXC:UN72R"3F9-J;+Y.FJ?=/7&JXR>[E,H2-]A5;G=_+Q
M[6+0^ GQ)3R9LC;V4V6,EY4/+4QI=7_/HT3A'BFGU!UHMC#<<UIR6D3,Y+P!
MB.)3+R4:U0*W*@+3Y!I"!%.+(*X9CX-J-%^,G="YC>\)K_EH/10I]&E]:"\\
MS)NZJ\VF;+1^;H7Z-5*?YOW]-.T1TK4V'X*N;AX+1U?GW=N?7IWXG'3[!'H
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MVAEFC2<JH-.51!)NXA6LG?3EPY!2A,PX+F8('7$O+O5,2+>52&(HM9S.)+X
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MF:\[3D0(I33J:8FDMF7UY(XB4;YFK\7Q?SV[RO?2'OP(CAY#O]$\][^(\7A
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MVG^^G.=_(Z^'"&2K$*4[$6PM[/S\_A,C0QSSF56507K+'5?)3N7?'  _ 7&
MP0.Y?[WR!; @(8,9_Q,C-1E& SB05O\WM*5- \=5\?0@>6C$L_,_K?E$]K+P
MOP!02P,$%     @ "#I75A__D=9)9P  +F\  !,   !I;6<R-30Q.3,T-C-?
M,C8N:G!GK'L%4!Q1N^7@)$ (%AP2-#"X.P&"!W=/<)@,[AI(</?@[JZ#$W20
MH#.XN[O[\K_=??OV[:O_[6Z]VW5JJKIO]?3Y^M[S?:?[]O/,\PK@K9R4K!0
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MY"P6J_%_[?F?0:N]#0+[SL)JLW%V>+AN1>N==ZC,H8A&?Y*%@:])^$"GB_9
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MUJK\9DPT!I#%>FJQE][LR\(D:%BOFJ G?3XJE];GCZZ]<XD-P\2^=/-"$I2
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M?*#A7]"/?O.&;RWOQ!-I3=#^X!EP]ZI< =&1,M@Y2=_F<T+0"GQ7+4RV?=N
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MVY,L=;=Q5C;0U?-BKTN\&CJ,OLUS-[2*2C\<D>3H AF]=5-2JYMX#_[X1VB
M6NL<.1=YI9KXB?(98.!XY<-:&]8=O0-IYIW_$!%F<2@EE-X3&9;Q5(__Q!9)
MS@(6E9S(@9FDX7"&?*GHAMDC458V?+QRF%;L>'\5 S-@MN5TO9=;E[L!YR[-
MM<^:M-)X4)CVB_35EY4="DF76&5\A"%"J08:SLC.WJ"/3A?"WX)&C[RDMV_D
MIL7O69:IU%@SMRQ<F?L6[*_;/-5]2$]I1P,OD>Q?WU;SS3/15I&Y;*?A["M,
M)*3J[5\CEI+F7<&.:4_=GP&A$+5G0$5?U;5&FXG*T]3DD>U#)7#4X9[79OXP
M[75NRDX 7-5"J#[.TL<:F.IGBR3C<8$$A]4J2Q.U3H$/1]FA]] '_F> J&[H
MI 8??_NOG7KSAAA3,'/KK'MCZI:#A]^,9ADH)9BL04E-D_HK<*U$/4&G:<C%
MWF!$_^]DD$SR10CW^]/;C_>O8UTMHKZ[7I9BYQA(Y](5_IY#%4803$HS/=W7
M.DS#!AADWKE1#H-,Y%LA2MB[+DF?W ES9&2%(Q5%NYI7Y5B5J,<"B(2%*L^;
MNGNBA 8P)1Q;4%3V%"P7=@BGYNK;4T8QE 2.5,M<_$;UHTRT+O:1LA:L!1+V
M-K\[1&\_Z?+O2*](;Q]J<K?JWXQ*RLH;RRC'EJE?VOQR$'V=(+_8"FFF59$C
M3+PV2@\'&;R^VM=H@B7*X(+LY)-,(&1.[SWAW=VN:D#OV&NE%F=B]OD%F^_>
M[+HDB$PB'%-K"O.J_("%WJ@E<MF-:3P3=^:&;.2Q:ER:'\64NLD?>X'E\U1R
M;^7V79X!B%8_I:EI0C7@JPF!Z-R%J\/V%]YB>C1_G@%,(7NB?86G!_:=:\SC
M/S"K2ANO-WS%]*NB?^K(RB4H4/1Q;.5J29<([_'C:D_)S'"P8>:YHJ;K5_IQ
M2WCF<=<V&"ZL6-P7%NYG3C277!6/9C#*7.\JJ/O'[KU(@4[6?\_[8NZBLV6;
M2<V5E(;P?%K\^1VN5!=IX7)#[YR3OL*-J"AHFQC8BN9$GC$!X^W P,;DV_N%
M6(^II=_25\[7]YECTX,OX\BZAU^I_!G C.U@?\45&Q5#T!8VBO!;%O<]'^T\
MOI(%<ROHP\?3C,@@JG+=CZF?$[QZQ+:\M_G(6V"VY%R/0CHM-@DCZWY_*(VZ
MFGW*4>23*Y+:[J[8KF(=-\_G^_VGIN0A9E&6?P:8)W+?YP7RW/]9F6S<OD>-
MKHVD2>ZD%'ORU0W3^L#RK5&I22 0[>&)@#.;:$+5Z%W$G7!')7N?:OPAK+"?
MY0-(Y[.->C7QK14D1KC,TM0,I4_\9__=5-[4/EWA-B?P]]K"![0M^FF*A.$Z
M"$E#_N9*"'EUU!'V4[TA56B^4V+Y+ KJGO52B$%HHA;AV#"7Y&=[1%EC*;<1
ME*^#M]PSO>XXB4==TT_"AX>9-+YXKMS=M:;3PM9L_F%A+5-/A08DL0DP35WM
M5ULMHJB+M@T9"W'Q'X+6H1>4Z?;\+Y%[M> NT)4M))/O6WE1$8[?!/P\1$AA
M_>6X*"?TCKKK_UQ4][\@M+Q6_0<F>ECX-&1HE7+)&CIV-'% !UU(2!)5R=PU
MM"J8#QO6G)AL5N"0\GV'V,8D^#@G]%?\<9_5MTNTB#255'M=NJDM;#CT_0K/
MDGW:RAM4D/336U:\9\ 8YTO!"GT&]&HF1(PWWS03G13;G7X\(% N>M)(*KGA
M[&$3WCQ(\6$>S]#T%> ,&.#O.[@H/"2? #.+5N1<60_G+5_NF._>T166& R
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MF[C;.3L ,BN\&!&5/OE^5Y^_4>E*7I88=ZN:5_H'Z1AW]G#T9HJGV@0UO7@
M!/8D/Y!!I8\BU:,6^IJ1+C"M9<4T<4/:,S'*.,"YR.#^-IR=J8F:[.LTJ16(
M>;%+XC5AS QC$5F<MB*[+$VD>Q>#I*3UR/5J8@I-[-69.A;%* TJ,5:&S"/:
MMJ[N<9<2.BC\C%SP@!/R4%]CR_H,(-_TE=MUPJ+E,J# X.YT)LW[MAAE=/(
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MS'4ANHB.R((P(;_I-C1/3\?0MHM4<V $F_:I>+:J)XD/9!-YGF1=?<6&;LM
M(HGXC/8K\XQRX\!O=(+Q!=KJQ5*W\5O5*56$2_(!#U.;RMYXV =(O2<L],C?
M3BL6EPJHJ-PYXI'+XDW$Q@=K!M7]NGXF5PG6,78O,HT)()Z3ELDW%7:H;U&R
MFFC-T=IP>L6M?3<8L(4O0,GQ5I4E+X8G[C\:V%WWMUHAA%]Y>#A3 0G[AY;N
MA5T57](=M< <P?8^7-#\%%*D\A.6V8F9L8NT+B\+UN#O=T@P"4D?)"_%2RJW
M#=8G]CQF\D?+%K%Y/ 4&/^$K-XHOFT0LNEYF(UB/JT^ R3%[NEK6T;W%=LH>
MJEJL&4HO8KH=\BG_D5Z>YYJ]G-Q-1FIJ7CQN2GWBE"V.G7I=NDU&;ZGXW6C>
M MBS0BNW+\'(0O?4L\_2=8WR^=>8-ONN]OMAR@O>?G5^Z#*1E(3MG8!=GAD=
M8+'JZ)8N%A2*[-73F\Z[O_:;^+7<S%5VT+KY0E\2C_$C8RWM;M9O2FYJFII[
MAW&4^HDIXA'UJH//' W29=1Z*&]3*"[4Y143"SL#<[(WG-['Q.O/^9?7&LR^
MKJG# 1),^7S(*MSPY0I-\F*L_\V3TQ&DI\^I$[@@/%UV%0=0W#?Q?//S4::9
M;:U.<MA&_&8J>KM1[/F3S>@O9Q*_;GAS]2S@_"*:X1Q0&\5K_F=\SUQ)MI,I
M_$,_X0"0A--JSB)COJN$0QFICZ&-[0GB*(<%\UT?V<[,BN]D[T 7;^Q_-+15
M,008U'P,<.D;9@0ANC#)8&]F;(0"#B 'NKW  7:G9G\TY!^:25X*RE4*[5W>
M=)!?[C-M$M3/Q&K(8LYL8PCGYRX?'C[%9L$>#?^I"VKM#'IJ<G968\(YP*HR
MVSXQNVNJ.VRWW+X75V;]*ZVI2GO\Q.$D5J-5]'"XYO8EW"&O+4KA):_(W/$F
ME_BH0%<,=QG[OR)8X4N=;7U0N$M?&*U4.+'I;[UN?0"?GM 0@[]TTS6PC]QE
M>H#TA/[\B_@.P4'#1H%6%_%YB*XF]D=AEJI(B_R5439]@GTO\A;F53RG0.L,
M%'!9+\L(,O[G(D:C?68W+9O($Z$JUNA-O3E1LWH=9-(+6]&XW!R<KEP>EWJ&
M T#?E_<,CB=NP@)*%LSSKY\=W<U.J9CS4P.=Y ;2^@1GF8R"6HMQ@.CB_?Q%
MBS[S>"%7.+?)R9- JO<D86+YSEFY^K!K/KNQ%1<8-<G2>L]FDQG+;5%R]:,R
M"NE</2Z 7;,,_0^IOFHX<GD@^"]:&[?K)%A-SU9NH^DG3G)D!ZTH:F[%Z&&_
M@>7&:BU;3@Q2IID_0WY!GRL1\94T-S/\22*EO"*=F=)1>K?@^SU72<GX+T%1
ML?HO:.[NB1NDGB/W\:=Y1#5F&&P,[U3Y/U.E+9K8(-22?56<\*.CKXTZIF2P
M_YTMX;#'9INZTK1H^FMO9-(K/Q%FGDNFE.R82S65_/2':C%;ON7$868'N;\T
M\+3?C=JO2=YRT]MO3S9  S>E:V[25YH*%O8M\KVQ18^3[4N;KS2>R)7TVHYA
MOQMJG8JG)@6H"YT \RH?B[\$X3>BH/!Y'*#K^Q%IT/K8+0[ C"VUNK"LDKS9
M0[HE6(HDG/S/;#,(P24$?)4:NZ*]R>IWHFB:8EBU=IQ\^U?ZPAWTBXRKO@:-
M@3JO(WC-?;[4'-M_-C4>\W[6ZTJ<-.#+R\/9 GV\4KD_: P1IYZ ',^FR8T;
M%IL8F1CUL=4WQ% RO!.]6V&@6X'NF\BE0BBJ3U2(.@5Q]BU9,_<L&;<7MUGF
MQ?2=BZO]^+^G??QW#<]&D,V:KER"@4_LSO4')UCSD=F9QU<7T09HO[6X9?'P
MJ.>, 0Z@V3#]]KB*;5$N/%+_D@ZP&;0BA@.4!-TJXP![#CC IX7;7!S@#ST.
M4%L!M91'3,YU7"X$3MZ9VGEAH & =&!A0=-R. !;T)EH4!<8!]#& :ZA.,#<
M+(?2?_C4-$,N8G-:;%36JF$WTW_L! >@ Z!JCX _\R5B%M3Y_;)?A#,5[%=%
MV3LL F0Z)4O 8):Z8$77)Z\8(X,\=O7&_[M)P1=0/MCYR2R&'M[GE<4:"W=C
M?XR^_6??C(U\^R-^38MKW'^*^.M;]>D_?!O[IU3DWSYVO8S$ =9<;_L0L'+5
MO6+A166=?NOE1=]IRCM_,>5__> $#O"@\481!S@6QP&LS5+^LQ<JM >ERRE5
M?NY]H%)6K>H'8>N]KNP[B-C;7IGK![9W# 6+UE>J[>I: O>DHPA74&:IE\2>
MYY524O\O%&;_OA$.T:K5X*O\N >I,C3"EH"GMKL)2B-K<0#O:[[RO&#IW(E\
M]_A"8TU"MGMZN1&FT0;<.EG*$@_SDRW"R[:\FLO6^],D&-3RL_N1A5.>,'-!
M@1I.LX0,Y:O1VP!N/*Z_01LLV+<3\2^]"O@;=/%)5=)_2RK[SQ2O\BP;7-+Y
M#A$GO.=7>GJ_*>#O@IYZ,H!(7:@/]KR\-,S5)7]"+L^"53B49](RH;-(@)2I
M1Z4YRU]/-BK<<C8C_+FL.+8R752:Z_G&LZWG_()X%V*X5Z#6T52/E.^6=%+>
MT7H]*>#9U-"%^/R/4/JO">"6_[*\\K]O(=5@ZC_.)CN/O+9LC(C#1FP9J(EF
MF4Y2S\^\D\88X8N/!UUNS88I0^+ -TB\W#-@'QH'& 1/_MW@)$*W<57J:DUI
MW;) Y+6FC7615J5Z\7M>K6&*SQ&2 34C"K)0@WQWACT_29:[JIV,.Z&[&>J.
MRRB^,F-ZQK\P(/AX^*<;=+[/H]<CB!S(%\V_+_V\<$3OS=^R!++P_PIZ-G@A
MQ)S R!<SV5%W,A:JV9SZ%:@N >1*&/@8IY2072^V3OOD9\"E=C[D@\?WVEW?
MB.^%VT3T[TU2OB4-J"AZ2/71,[HUQ4T;,#V= *K&2076%J/5[JN9+A;$$53=
M ?9?'/Q$GO>B">'-#1%^]LU?19_EV%BMQQ-*TTTC;QDOO+6G;-0%>*<TV^0M
MT#M#'*$J!<R>Z_*':D.H\*6E^.;<YI:&V@8_6$M4Y2^%M%1[PC*9P5^&DMA#
ML^8CLE!G(5=$J_GXR%S?AC)?\L&'!^><->UL!<(78=V7$8VVP,T(<%S1-L5S
M5A /,]M L'M^MNO8/1UDM_NY2_Q!]YNI4Z/7*,A-Y9K:!PNT;:+"R5"RP6XB
M]M+G^7#+$4%X[M1(Z+)SQSM9(]2S3E'K<&D(7T9'D0_L"M0YB+&L^^A72;>Y
M=VOG5O^XT4NF&9,L7[@XU]0&K_?1W=AX8N+]J(?],T_BF)+9J6Q7<;7(D5UK
MXZ56\.DL/,4@0(T^X7L/<=5S>L;R8'&F)7RP\<7&I=PC$T<I'""B2A32\:[!
MD,0]F3].$K7@H\S&8'-Z[7C<0O3-;)^[BG.S7ZJ@N?>T*GI%O5)W2@LVT-QL
M^B66%,#.*BZH' #:X>/J]]UHI(F6%F!,B[1ITJJ_R;O#@7HUI;HN+/+9HSZX
M)\EG-8;22+(@X75>$U2Q/^WR-4KIVWG$!EU1(64EXQ=Q/C;^J$Y>%SP7PA>Q
M-OB TW)O)LXC2CI(ZO)]<_5RLT,!1\9%.VY]3=F/1_44A"S6LY/Q!K(VD"^&
MI-+@$DL?;V.'5AE17^17+W/'0\^PM[;L$LGYQ![]7 Q>%8< GP2=&BRP O4S
M]HR1;EB3@C/_K"?Y)]Z3FSGZ+XF[)X<@OAK$S)AJ7I/"ZK[)O)[VC#2CGW6N
MI.7))@): #7Z)?HY(1TD?>QV: A,H'TO[!,*IE? KJ%&>^M5!::(OH2PDGW+
MH;[J"<D,.MU:M]X$62KI3[FL=4SE-*=.^JFRF]4_#F9ZOO5!I5R?X]_"3'*.
MTX+&I/E^"-[2R]S"<!O\<:;PM!("=-+/RS&=X%%;;_P1A9BT4/G=)@@M8Z];
M!M=U"@Y %32;4GT,'+P&(M*Z'\^K2\=Y5I./B?I]O:XQ+Z@JDXW/(2LI7Q\?
MR]:;V\RB=V#/PKR)>3+]?9 -7Q^OE!V+;WB+G/*/-<8!Z@6DRQN(7+DR6^RX
M<A2SOV:_7Y'E-!^K?':AJ)6>;]_HMZ_\"@=(]=IZ0'1J!P@ZA>K6P5Y'_F F
MNY]?*' U[';/8&^*\I@A5!$KZVQ]D$7R4,K,Q7?N1$;1<J(^W4! W:"F+G'6
MO7!T2-G(-[C'37/JM(W+0%!T27?HI!A]!>Q2;=RMSS2DJG)$2A7W:0@N:]<U
MMH1=L2H?5[$:T[!JDA*R <7CKA\7FCK02+6'V9*FE&]/ $=;ST2B5'F?Z8?&
M";,\"N6N&Y?,*@[0KX;3,PHN[].%[[<52/:GN_'V(4X&6?2U2-Y75OG8OYYA
M?"DS4Z>VTX;W:(!I?O1#H!!87.L">K\0LTN#&)?M8H6GJKQ&8E^;;J!SF%3Z
M'C /?TI9BN0Q-CN!O=C54)YW<:[*082T[]6H,&J-Q_/ZKEHAL/T1K0+E%VG=
MU T>\GH_4_C7%^CKXN_??\G )(^W:)"%P+CNN>*K8X3J/J+-'HC/7X\BEN+%
MWUY>ZC:^W3AP5O5SHEH42S+K2GM^WR'7$>"-5ZJ_X[9,)?-Q+ ;.^?TB=H6O
MYWO6CG)]\_'^+_.1O:$FVBV"4@F A\DE#52PVE_>D]%; :8T;<(F33A+)/4Z
MK(I1GI8I:_J/>17#T)G4)5]$W=%!>9D9#/JBBZ;1A.5;+LV@QQ.O;C!_+0/%
M\V5@(D; HT?;7Z\F?KC[_E'EWN:55$"[Q/7)NW3_[);0G+?'#CKO/ P0.Y2&
MCX)6AZ\TP*+<TD @LIKCB[<ZF'$HF.AQF_$ *M?MO,Y=!5.Y\W?/4G7,OZW%
MVLZL[W9^-\MMB>>VXKJX5R&\1[AV9\MAW7H#9*ST,2VFU=:C_%IP^I!?U+$Q
M4>#;M?M("=)9UH#KZL;/]\;)4O/();?HPOSP6FEEVW-K124?'D]?@$C:AP67
ME<=1N/TX/<M/F3/;V00KN:4&BL[D30L\/2(+%Q2--1U\17UNZ10/^4U_4!Z^
M_GP<LH:!>:Q"=37>74Z]PA8BRQV+1]>6S 6&E"(!%(_HT]AD\T\IW6M_Y\.+
MAOD_]!P/[3(X%*;/_>)F5)4)%WM / [B@:X*YC9(= N"% _-A'I'WYDR$^
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M]4#.(ZY(T3;U-U?$J(9D3,!HW1.!M=[=D'!7H?OB)#>K$?UN!JW6):-%Q:'
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MY6W#$.?[#LZ=M^>E\,^_$_K/UU(L)H$8Y5.MKDXT'-OB&6_[C1W^(;X"T?>
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M'=K@,PCC.78CT $JWREO9SDX?OBQ.&+Q0Z[KT'E6/6^[<HI$0Y8 \'_#>P5
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M)S_*R9'JHN(>&0_>LP6B/VE@Y.D_DALFJ@330 NADA92 D54%BQ@ ]_[<G'
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MI@&0EV]NT.M1I*1WAG&"'I1-3N="8G/X?VF\J6UXP5\O"OB&)_&)PH8P7[&
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MGE/A9;JH_>67D[1_]L&O9F\)Y^A,WE>\W?? YM+$^MI"JU]_-<YI@RI,#3+
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MC0&'A:QH#3EVNXMS,Q1?5B5)^J-*WH3X>KO?>0NX_J& ]P3YA:(S^$8G@P^
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MK4H7VDF9V8R=T3DQE@HITM'&J&2!HB?J-^&3K&ZNOP<%=N40["&L]AOO#!\
M6;T.FXWAQ7NB3SJT\B=Z=:;SY1(,'F>3JO;_AG'\4SH8ZTK+B^$55BG9"59N
MR_&2JI5]G&(J^;C6+27HK@3NN/7\R^S)!$E[9!OH:Z"7:/!&C$YE5"+\8B__
M218:UV>_ )1K&$J()ZU3]A8OK]/\G-&<D9$X3X$'H?2:=-9-)A>]->"<YOZG
MBA910Q;_> 0S]U=R@YUXZ,67;C<GI^5E3,RF-4>:W,\G/A1'JU--:N.>(HEP
M<%;[]7<M_&&>(MJ[IHG/V>Q,> 'H3I%@ZHS,$-N9!AP\<-?&?+<OZ+61;.JP
M(0+WHD26NS%J-MO(TID?';"ST#B.TQKO&D^@E;A1>^V_.R-C;D\)U88] U'6
MC+C9665FI21Z\,51'0E(4/B/[P]XESE!+[QW*]*=ALF$=Q,1I=_I*LOJ$L>V
MU^)5IRCK:9@*_ )(S4Y"& I#YWM3^(XKW44#=]T<\^?!@1KQZO6-U3>$WHS&
M6!+)M^F.R4L;T=VM4-\'@'R,]M3Z!,0YJWYHKK5\^5NK)?4A)D-F7JJ$!U_"
M_M'OU1N.4V<$:6\VZS#\4\T-9W18@PM19;3 HZEC+[%T&N*-(W<.$YWU0Q,J
MOTF++"4]F8*',#C%/%-D&/RQO'>.;>TJH-C &KN?$UD>9VQ70A=$&O$S&3GU
M]KS8'O/21@GCDK$*5:IVPJ)Y0F(D]IQM3CK4%5L23/9^=UL"3R7)7M5<D='*
M!8Y7 \$[J*;+ -' QN9C+*)M!QQ]AA5GMC#X2,]*18X6OU63 =M8C=T@<[IZ
MPA/17F'&8;[UO9&N(.K056&KS.@8F6E2'&O1=RW0HPX.<+SFY'K2D(+L A\-
MU.SJ0WZWX54A03-@G.*W>'N]$PF)L<!P+<;;N-<-R:GN)B&,3IQ7U-.[5IDA
MT?\:S?7_6]!1I(^>5V=TV!8+&="X2)HRZR7AOJEP(Z(7&M=;+EXT\<(6Q51,
M)7%K'/_TQF#);KY,9LK.*S^S-%7R:Y\@:6[5E+O]CS._31M\@>QCINU1719.
M"2JF9Z$Q;_H\PCE2SZ8NZU_K*CVS*O7"'LZ?7= ==BF+!<3R?S;SD<"SO:53
M,<(2O%0]7E6OG>)Z_<6+^D:3"UBK^S2>!IWHBP,D D)@^+PE_/YX5Q*!"Z.
M8Q4N/H?J>,*0GTML5P<-*VZ$,/'/E-+HF,H=D:6&%5E=N+BRE5O7V'\NY_0U
M8Y%A42J1$68JN'0E.LKI\K_+OK%HN;%/64?SJ^69LYR%X*IN1MXE>Q#6+)#
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MGPSK(V*SW_YK@N?#S/\!4$L#!!0    (  @Z5U9/X%0J77\  !>2   3
M:6UG,C4T,3DS-#8S7S(X+FIP9]2[95A<798P6D@"08.[$S2X>PC!G6!!$QPJ
MN!0: @0K' ($)[@3 H6[.\'="B_<'2[IGN[.]T[>[IZ9>Y]O[JEG_=E[G[U\
M[;7.VG4_=;\$>"HG)2L%@(,' . >?H#[68 $ /GQ8Z3'CY"1D)">/$%&0<-%
M1T-%12/"QL'$)2.F("<C)B6EI&6EIZ1^3D-*RL#'^)R=@YN;FX)>0(2?4YB5
MBYOSYR9P3YX\04-%(T1')^2D(J7B_"\_]\T +&0X-000 APU !X+#@$+[KX=
M0/% YR.XOSR _WC@X!$0'SU&0GZ"@OJP /(4  ^'@ "/B/#H$2+BPZS7PSP
M$>L1-A6'^&,<U7=(U/:XG#Y17Y%I7I:UX*D-']!R&3GX/D'!)R D(GY&1\_
MR,3-P\O'+R H\4I22EI&5NZUNH:FEO8;'6,34S-S"TLK1R=G%Y"KF[O?)_^
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M\]2[?PHF>9ZJ!VN4BQ7P]K3O>JVGU;J/89E*=_$:+Z#8QJR*8$0&5\#PBY,
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MG4" ]NFY&Z7)1K++@'LQ[F5'MRLON$ONQQWIME8PK;O7YRI91_;0*"P7*GD
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MQ$]T4&U_>M)*))%\[B+N^4$P.-<L56-@3'P^ZHU]0X@QS4*)>ARNJB3@_RO
MB\^#[9MZV3ZD8O%<2D6]6.-V!*4Z8R4@[6IY,9RM>*XGB(QH7Q.,S5KXNUX
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M?@DWZ&E'GK:B^0;OU*J+EMK"I_RE6Z!!39C:EO.%]0[WQ;J#F72T9G"4L88
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M2N.I#S79CS?3K'PQY>.#VB?=I9H'\TW3PB*F@-''"64<9QR4,;VKA]7.IS?
MSY +-S=\B$4YK*PO?=J@X;8A+298>(+VX\ <O"SN:+G19UVYCM* GO6MJ]2<
MF7;!K*K)#R;?)>$"C1$UF+K=D'ST(6\O'%]6C]B<%M;59$1;2YV6 /QEU%]\
M57=<1(C9UAW'!IEVO'F$U]_%FTO1SE8^9[!?'M<J2UWYJC5G^BF\LMI<FM6&
MZ3C$%O/-XIR58AY=P=FHO$WYW/.X@4 *9ZVO*KUV'F:)82V]75FJ!MZ%"[!&
MBC&CD7?C-JQB%=1!J"%A13\$$FC,##A\*3ZZ(G[ J\M2=C8M@26^BN<C^-:"
MQO>T/HL[I,F.03?TJ(;H-#->WC>NDO?7F,JK1L2Z3Y1I,;AVJ4MTW3CN_JL'
M_&O(HF6*=H=+U&% B/ .OL.1]<QIK,%V_'2-=LD/>S'=74B\#^[GK72I)37:
MUQK[P9/\//LE%6D?I7 !Y@=9:/U&!P5>Q2QF4+Y(2E&\V/39\?2>&4H8,^?Q
MW2:S+W#4DR6=C)?1F7G;OV&"K=FCL&R4+$KDJ0M%F 4THZ3_<W)*%%] O1!!
MX$X6.K.^X5Q5DIL;_6*JLN%;0;@IS>#1]T]HIW6QO;>B[P'^.AD9.\.T%5@:
MJB\S_!\J&T+XN%__MOF?H$#V-G.=+_Y,/^$29#,HL@D_CR=]1Y<:EW9Q2G'(
M?5)Q#^C*@S_]]\804FP?+4Q9\56)DATBUJKSC1"5L(1]'Z+XXO[=).S3.8Q)
M_A[P2*2]UOFVI ID6SS5_H[8C[K;7&+<5 '0)GS68>O=/CHR>@\@S_R/G47-
ME)F8-J\43Y,=4W2U8C3BS) V?&C"A='>/74:\HS17GA^H+$?[,R,&@3IJ(!\
MIUKY[L&32!=ICM'\;9"_681#G^)&481%[! F!K7<LKP'1*B"/,)["DDKFY92
M@.WNBBEAYV!Q;5/.P<>I7UF5Q%6VZO8BE (;WE0?.-]]S='MR ,NF'TUM:O"
M)X@[L\2<[B:<+:?E3'7@A]9B7B2ZZWBOC/V-XMS^CM[0?4Q7B\U)K1G_M6L8
M<?:E885>O1$'1 I/0WI>=<AQH@H6\0=RU&Q6Y#H>4J@_#A,]Y-KW !QE>>4;
M]XC_P 3W/QFS<H[=7=6FQ9+K?2FC9?=Z:B7TEIFF390TI"W1,XHDL+Z^.G(
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M.S"0UI$30DXC')T>3M^(+)+BDKT$:+"JR>@=*YA&H%'+.L&Y0S]H8ZT/B _
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MVL;*AIS>C^!3%2I2,O"2M^:QR\K;T&EX3[RNCHUW:"8ZNI;%@XE%?',*/[T
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MN3R&W=#UOV>5(\7"_[JQ;Q.LK=WR:^A58F SO?>*$8KYD/Z\E?ZY#\9E<N\
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MX\-,A#P=Y!8#GP&L5;L72T]L"JX4MNW0!D;'O#^V9>XA20"*@,*K9F8]V6?
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M774QLS#WZ7-I]+( G ,/L79)@B?:V8=[!E;>VQLE&]+J<56&30\;5'\.,4H
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M:G!G[+ME6%S/MR[8. D6".X$"Q!<@A.2X,&=1D(:;QIKW$."NP=W=VD:=R=
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M%SR^4[S%'+5>MAG;+<X\7KY2VPSSZQPWK7=;M0B*^> KS3L9GAO#(PS5VQ,
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MX)7U$^"OM\Q\W>/^(>!@Q&,]/:G$404CX0E@?O_LW?WLN_LT_,=[\8J&V69
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MVO-86"0Q$;Q]C-FZ*[2=YZ%T\N:<9A/)A?*J0JCN%"_B7IUBSYNB=KS,,?R
M_7%!9\ A<]V%"JDC#RMK4BY-QO^R14&39+JQ-_F=[4&N1I1TSWH43P!V^'+D
M8,XI9YCQR=3D*[E<JYE>#0[RP>7?FMNDS*+D/C\]Y9B#:N\B87->D6K5:645
M[.=1,;@KUZC4;&F(2+'9YMK:<7[(-[%O%CI '4O$/-WH<E1&8TZ^A<)2#?HA
M1;:.*#1O_S8^+7[TYV79*$_09N-$;W^**#?#Z8^EIKUS3DQ+O8C2SQ.(FFZ5
MI=G?11[&#MJ;]C\B4HL.9%0-4^2U].@ZZLH[FT>[(:56XB*M$X?\\RT"MTL#
M3&.'*OX!AY4*B?U=7WW_^27Q2SFSX6G[^+U.\CMOTK9)6RT:X1=T^/>#,L.5
M51@1@80R7ACL,!['$H]E7-?ESQ.!09PPBGD$0ZQF;7W*L,Y) \';1Z2V38 3
M>@M/\QDGR=Y[:NXQ]ODN$KT/K=%KZ1[]Z^P\I=:#67&Q'5LMN,&HGI&\I]1%
MZ$4ELP]PM=:3A"RS<0:'49O26/3V&].[W*_FJ#/ U31.U4JYO)93AKG?ZFC<
MO+TAK\D&T-RWZ<]*,RCV]>+3LPIVY[S2PO>44<_UYY=?%9YF&OZ\WC@-V;B7
M*,F+# G(R9J3!&>.3-?5S+TK54X2/L8M2<LL:A<\3"YY_UHDCQY^"@^]\,'6
ME<*ML87RM]PVZP2(M8<!)(5(^VVW#2WS@3II:D2_7'OWO[C1L8 Y,GX:T^ '
MVE_'^^2Y]X5<^N#M"HMDX(NB3^L7!F@LF8J'M,B5\W9HS<61GS14QE]D8 O>
M\,WO1[^+C+)3=>_FC>!%J$=$OR@9["M4E2**KOSW\N\QZ<:RW!"E*_/1$=F[
MUO@L#>8 ALE#!IU)$=Y-WXW[?%_.,2FS_=O*/Q<*:9\[3<\^W"#URM$ZW5N^
M-W76H&,9^"C2@B<R[4110H._?W4B^+D^'F7%0;JCUX=\Z82ZQ)Y-KD#N_'.0
M :[X,3W]93G9O4IR0HZ/DT!H\U(CQ"GN<<=_?H;R=B8/(2Y"X27.E?^7DY',
M2:ZK!FEB=S]B:D7=7\Z,<L_=.ZULSXM:G'H(9TAPWW3>,:&-/2*YZC+Z2B04
MHBO9C3&40K5N>R(ZW2,CRF*/&M7?%"/%VC5)?K6O?A5E:3LQDW4^63# L+2<
M97@&GM(9#L/_0E'D)K ^090!*K:::3"MA&/&D"[<+&**7A75LJ0"!XQYS3S>
MGXUX5)QD#-VHKCX!$)>-3X"*!I\TAR+YW)7)9*5;R[RR_-ZK,'J&M;2R\A9O
M,QBAJL$VK29X6'Q(14IA7L0C3CU>-QL7Z9*,R*S$<(]XSM/JFD-39\58[E&3
M)]EO*[::/#2V6ILU$F?G@Q^?@2#^GX=XP0?6^ZN3A?8390(%K/ RBD)3XQW)
MTIY3@;A#__IOT,A+R,Q9F?LO+7]E/[E;G@)Y%41\A+K:&&R8Y?#H&;E-W?0I
MYDBDL+__)(%#F)#T=JN4Y1PB4;%^*D,F9I5V"B1E#HN*4OH@02>(B^X>,EMZ
M")0<O^SY:26@JF1LSZ#4A1V&ZT#JP 9>AK(!0=(AYYQ48&J.D_BRGN.K. =+
M3O&-^I!%[*N;$7K6/C"'_;E3Q?LQ<0[7_"> 3EWM)/^8I2WO3]Z\. ="9E_Y
MTQY^K))\A<+8&IGQ6G6ZT5CJ[:5Y:2/2Q3Y]YX))\G\O]/SIRR,+<.%/$6\!
M40:\U3UZ'BG=>;_Y$10RDJ>CKIU295? LDL$54IAB.[VWW#Z_$_:NC3M=O%Z
M(8(",_)4XICAOO&EHSM:B6#,Y7\$N4T/"R16^[8NG@ _$.0>;_O6$Q<K[O&Z
M:8S@+MRS7?P'/R(7*@;_274'P4J6S)+9,$=/I,[;'BY<:?S!;Q@L\(DT93[D
M -0+KW@S3AG/]#C/[S_-]4J@>C_XK'BCF[;^ &&G@WMG7ON,RLV[/8"_ - !
M[=DA<X19BGHO>Z&I^<?,=MDA?F<8#;4QI$<,<!=2@K[PH8MA71:#OW$26]9/
M +C$0^HTS+YM-G'Y),HKY9$ ZPG >S!_?\!T8-.[]*O/?>]@Q0,LNQJSIA"H
M^N/=KX5E?6T!JC8/I=*][DYN52OM,9<GP!OW9VM/Z</_/0\3 &P"VR>5OPES
M;_I^OT.NN!-<6&IYKYL)W/X]5:8D?.#U!+C%M8+?,R6#G@!]I>^OW78W]$3P
M-M5'J;?V7QB4%$K4[Q26NSP2L,O;(BY/IN[<^7Y'1TYN1<(0=9XW[H9IX!VS
M!DN)BU<LT*P'+?":I<_\T/V1H\9/$_S]7?WC65%M<=%%J\%9EU=ZQP\ZXQDX
M2_TO&D^)"SB+/VO1^M ]6&QY_9A5!TX:L;5-7(J&]@@?ANR[.RK@%CR&%J9M
M7A)_:T<6-Q17/S:L6@$6<EZ\;X(#<[5_%0%#8[E)4;+$A&>"P.F4IUA6"<</
MH<(EBQF<OQN"DVY77C=5-%2 $):VA;JN-@H&'SL.&>4&D')E%C IPW.G[<*.
M*FZI$X1=7>0-AYOJRDZMRLIO;9R=TLS!%,/V+#PV)#CC'S%L_O983/W';T,-
M:Z3"P0WCHH9S;;,<%>PV[[1F'Q+$CBE#-GWI_P3L[PF5[HN1:*5TTG=U_:YJ
ML+/A8'2][M:2(TL&M/](I200^3\Z^\JP.)=EW<DBP8*%X&X),H$$MP&"6X#@
M#@D2W-T)! VNP8,SP."#2W"W8;#!(;@[#'999S]GK[7W<\]Y]KT_ZE]+=755
M5]77;_5'=E!4O,&8L-[,6+@S)1 %O?M96X(RSQA'$Q0K\X)NW;%W'6!,]7-:
M59(@K1Y6V74KEJ6<>&9#KJ2+*I#1V4W3YB]/1>B&%=U1'\:-2V*!0"U;-<3]
MCHV_]_YB?,8__ZMJ@]0[_D]^F&=9A+.6\;49;GD62)>%A;S2G6F8 'I5_<#^
MX7FY4..Q=*C+]_YF(=R0&FP]/6$[HN[?[."^#5E45/?S4<(\'H[,S<J8JE_J
M][MLY%N2'EE!S68Y[E8*(5(<EKP"UB^;W^T$#T$:P4Y0^<L>AZ;L<OE8M;FJ
M_@X"VLH9X]2C_&E:@?='.5>CXG\":NAH>6?S;S3CFP0=ZFR]OB00GK'8#G-.
MW?*O;(S;<GN!RUHGA//=I]^L\ 3I 8K1*BBMHJ^B5X'1N%<!4^[G015:>T/C
M8G18MADFI)$C'$_TUI:XM^V+&=CS_!S4GB&-&LH)S9.1$6/S<^ZQ7*'&"F54
M4_PH%.?SF]'Y3"VVO:\.9E^XO^W"706V.&XP/^M)3Y:K=1-C38/_?.7I!*WB
MU+=QI'IV/Q/FHBMD<*([86=/M/B[H[+[C:DCILWNX:&^#[,MWWZ1)LJJ';'%
ME"\[%+9QU'V?"];!K=&1QWSKTDG $&"/@^TVF5CN[MG9I4&'N";AX+DR"ZL=
M1+DP^=S'%:\)=U2 X*AV9K*G=9,=!UQV:%9 ,W['=CH?!]3.*$8YG;1BH%'E
MM/S1@!NB(38GV?K#,AI,#A&S(%M9/9FIH$6GGV:&:^K-8KKZZU*@["IJM 8$
M[8/;;R6"H/(+])(AXA5PVT(.>8KD@WZ*SX"^9QX,@1.(E!7#IR0NJD6[ CB1
MID)-8:QMU0SQ%KZ.(WG+L3VXUJG9J[P^1EKTQYJ!+K5QXVG]R3(_!DE''6K
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MX,/A&J)J4896 \Q*$WM[1V$C=*31SPFN!2^)L0= ]5Y<_T88:(4KRG604\9
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MTVD;*]>Y'F.R/,V<ZRZUJF DF2GQ B&#DLC/.O_$(%J;3/,V"!J-W,M" LI
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MIH.4[E(N!K/>[F7Z[K$Y-9$@-0NT$*Q!02TY[";!["2L<']VK:73CVT'Y \
M*# ;7(C><R$ULZ=N.8"95Y[C]YBU %5'_Z.7._\5%9 QSS[J\)P?GSSX%\*G
M"$4N?),;N*]RVN4W@]"':_@J_&Q,<@L98J@F5 /$?CV)4YH@V.?5@$/;T'L]
MC"EK/.,W7N/C&TMK,FW"OP:\/_Q5^-F)$IMPU-WU_MY&7F/BD"VW19XQ4F.?
M[L7!%[TJ/+Z!XXGI3*OL[)(_W!Z9B>GI6^7+%$]G8EA#-*>I3M[*0JYX#/%V
M7EB\O+*T9XC_\.H;!.<X>A'E\@J-JEFS1&]>T@8CSH(^TA.%_MG3S$#&J6;[
M*U6->QAOUE&Y6GG:QEW:C;D'^6GZM8_ :53FI'UEAOR94-Q\=FUH#[I8H+G0
M^U["5Y^NK#0FS]]"I4NW79'.1XES!)I6[#2!_7.7?F2+8,ON?U36!7FX=8'9
M[.S($*,=J<W(R!RTRJDW]@6\]'RC*ISMA#M<JHHCJW&-E>M+N&S4\O6!BE08
MDWN;C4\7+>O<C>F7X_0;ES,#%UNDPIEL#U8(33_EA#-C_5F1]=\$Y%&CUZRU
MH^-^EG7I?SM\<KF&G$K\F$G7F)^7:?*-4V1 :4!8%>;_%N[444=T(K:>:**2
METM(0RTFH):HJAQPLCH]6-E,%&^+-L2.P7?6GG?!0HT_M6B6LB-,5?6]Z\1(
M/L>H#?I]B#-NA1+GP'.3KUQA8H]NPH8(09PR+LN?)+8_VE#VLDL'%5SX"QF1
M.I.XT5CW]CZ"> .+4,E@MEPL3-](,O:R_B-I963O-&4)F7)-9@CXAX8+LZJE
M]Z!M4UY3GG X$V24(=RJQ,O:X[27R-/N$^?U%$^@WY<*/7K]]Z1E>2Q8@8R,
MX3.9,,2N'8)U-=E.B1W%^+0H66YB,I ULN*3(WJ8^QTP-8^E,=P!FKQCAS'Q
MT<&MB75<DA#VB5#GW$Z'^X8@)G=S@P-,3QVDG5.@O*%!H9\Q1*X@J%,=YRJ?
MQKDY8.J=ZT*#(\*RF!,>KF8LJ\-Z.^O"TABU]RA@^!#$R^85G):^,6D^,&-\
MC7$N=3BZ\Z3[3=7K<O=R9JS-]>MH);FYG$IP2*&*'DP'6:VED4Z8>TU+8/,1
M@^%K1.99C;(NZ3]\K\:KR_ WK&8\M?>FYX>W-XC(WSY*HE<P&]9A9EB&M#DP
MS249?!6B /LA[2"\&WQ3>XQ]PCLNS9UQ(8*W"UK2*TLT]UL/*K%-B+[(V[_2
M*$C)WD:(957.L<@L^6I<9]R7>G#SQL_,S<(*;V7U+PQ+'@! 9(JO62BT0DPB
M52C-C^"GK"#NI>_./7_IM3"I^38%AY:>@99AQ]"VV],?-KU@%BF84*4^A !N
M?2!QC)_@8=2@:8IL65ITG-9L?7UTE_&#A_HHA@[X'+P,Q)H=?6:\Y;X;.%53
M>BM?H$\NDY>NH[\@N=%KX1*ZT>-PJ50/\1R:\A;*NPI8ZINTIFE4OI0O'VH[
MJ%.^TDA6<DH=MK: $R=M',!DGL)^Z1D/A=56W6$[U2'?AEH+CRR2369KL:YH
M!04AB:5[_=YY+]\[URURU8Z5?:Z;WK>U#I2(F Z@NYCK6W>+DL(M(FBPJX!?
MZU]0/@#0+7U*]@WG=.JRJ@=/0?>NFWS;$]QM9K8VK/3^HV_644']NDZ\\.ED
MOXZ;QW/K8G36M]/M@O7&=SKV >!CO1L]C6C1(#6N#^;/L3_NRXX-$<.E@5UX
M9V";A6>86@C.^! HB_[X?WB J>SPCF7AKV+?]Z2-!=^]V,I2:^.]""$K_G-R
MKT/[HE+F<9Z0?)+MG2HN#.&6Q\94 ,I.X2^ _&.'+F[RM)\3Q8DY<NB"<'H:
M/9D7OB>2^)+!WM;HTILY":7'O ;EUW[-I7ETFT;:=?@>HQ!;9<G7!QA:CWJ+
MJ@:O&:0TZI%GE9H"IED(GSFRB9Z)&'JNMZUHFV^?Z.X(+#13GQ[BY-)$4_T8
M=DU058!\6\W<4 Q9@=!WQC1[ZJ=VF+0GB<F#0NX*^%]#BW(2#[@@%?_KFC&6
M)2997Y'750L[=D4W;</*)S&FE(MU..6P3+,L;=JIF0]3 6U_@DQ$UDP75G23
M[M>Z'@ )X58^BNO8.YQ:F>P*]WB3:'G/VMBL H^IN["M9*<VJFK,0:$PCK3<
M_G6"<V1JCPO!*[=U9&8F.9HJL=R[PD9'SP? 7&&ILAYQ@+<]HL;-;TZSUEZ
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M)5K4Y3,>E7,+\G[NLQ*I?*BQ\SQ@G.2"HHQ#=,1A7R\^GU]MVGB[XCJ8'#<
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MT"Q;?"AK(6:K"T8;'D0'W=$S^8OJD%@C3;'<6ED&Y"9J24*FT_A6,<*[:K0
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M>).4&:^_G;)KY=YM"M1MB&1S8Y+N7$ "T(. T.Z,P3AID.%<5['@F/!OB%]
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MO^_XM'BO':^=T*_CJG^X8]8##F&&\_2TI!KV2.1&U,3_XL\2ES8(Q#]RGWN
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M]Z4GF$&P,U [9G3 E[_/F2WM&_$J9B24 89K1L2VR8;AY,U1^Q"US"P^A*Z
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M;:/))XK!E.,[)>S8([GN),/8V#@-EYHS&6/73WQC["][])RC/[\6A'/NAJ"
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MI!D]<H=8>WZYCQX1V47%=E6[7A$XW+TV#U48_31JXS%C:*1B9V%EO N+J\N
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MI'=DK@0R&SYA "2$^7.?G\7;W#//Z&HFB[XI?9[$3FJ;K>DE&1CZ.4;Z!-*
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MN="/1CF@.6)1>M3EUU?3D,6'&$"G+KNLK\A9#.?%-#)3LQT#8!*'_<U]#0R
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M-[]NSDXOB3:-O@X8\55?K!\;#T4)T^N%'[^&3S9Y@&WW"3,IZYVZOZJ2'!V
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M1MG_*@?VU@L("FEJ*!\Y$W^6U;)UP?C'0L,B[[QBLVP]);^"N6X',&6_PB9
MNP^Q.$/?K=EXE/@IR:F?M5H$N^SE74?^XW@IP13 ;5T%'RXY5%\ [>IWHS$
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M O,'#PH0[_T3P4G[-^*M3=^R) A<;P5#+<+[)]:3%LA-C12 ;YH"?(>5"E
MJ<FZ+UOF^*MG.V&EL3+4)-4E'SC$1PM_]4,KO'2F]7!7C"S]'U.TO7!%KN0=
M!6&G,+LD"_^FV0]OW,%=$"7%?K"DL5Q9=U. _\CT@?VQ! 9,& 7HP(NL*QB0
M3QPJ0F#2.J^VQ<@F!Z[UPAL/THJ1RK@O&T-5%Z3YUH;B0&#A<<*NI+@/\V?F
M5];=N1CVOH+F\8IE([=W%SXK)X@G@4#*324P'"4BPRG Y7W[H/\P#Q N31Z]
M-2LL']V_3H<&"?CYD>-5=:#R4M;M7++6:T.OX;^DQW^8/UNT[2T;144![FJ
M]L%,*U3!/[L)6CI"._CVO?*NRC8WZRZ,E7R/5&B^6W>0K)(#;Z1BP=2A+B6A
MG&>C0!SN_51_'(URQJ"JH*I@V(*G>UL319",CN/[,WBLD)(U:\3(17E29-:R
MT&T,N()2# I1I-:7#QMT^W=+J .7X('&O.KTF&D'\YRUK9]K.&9-<)2W]/"+
M!A%+ =37N_#FT//C5001Q4Y/:]!&B\BM)-LZ;$VU2@3\P8)AZYA_@B88R8K2
M(<->YK-$\]V0[1;X')%UESL/]!B:NVW;O=;GP36 @"0I,3R=>J6J6<3^_)'U
M5\ZHMC7/@LN@/7#3)O,$ 440D*!\>4;RYQ3$3'QH"CUMW(>7;;P<WC J<M'[
M?[."P3\W(<*;Y^,RT0V)?=(400$<VB*HD;QN"C!$C;<Y401Q:AXV8L3MHAG0
MQ:<W1#;:O_T3W?RF;5LS" QI1>W=OQSW/WCHO9\>RD-2Q0SA";KP1FH&$FTJ
M!B1NE0!DV\1?'90/=- U4+YGZK_#Q7\23P'>]X.IUX_0??DZ^R"#;;*#P:N0
M:P]$Q'H!WHS,"WY&/PA--OT_% _"Z1X(I]36PQ1 5\Z=#.VOPSY13(0[7'"A
MVXL&0QUTZX<YMH:H%@%_:&/8 ,&M\074K??50+"U\C?!@/30YNX7&'@1#'9&
M'O_.@V!3!T).DU$(-CX046#(@X A[^JY7Y#F!B'-4&=VYR_&/KEO[%]T\)==
MO]8U,KL?\U[![TW!8W'P.0B*F0*\PYK/^F02SVA;PE#.,P>+9J/ N$<"X]Y)
M:PA*+3%H']-7"3_UKU;[Z8D-)J GAL3 !G5_P_IOP/L7B&6!'_N%J!D.4'R2
MV,XB_#<B,.7K*F;E!)+]5SA(!PA']$K24;;?8-*KF_+#O_-86ZEAD"O[#0F;
M?[<!,/S5]Z@J@N-^IOF3$S;!F/S\@! *7JH'II*\[LN(NL'JS'\'6# 2[^*$
M,>@1'V[7*IAU;,$M"I"[_!\6L<]JHK]9X4\;Q8$VBE(%;03[-VB5^^VW##)"
MR*+V?JP62'W_PJ%:Y!,719&8<MP3U]DH,/?\QP9$@]ISP:.J<T#E7X@B]NU#
M#;&.?0\F4:_@?[(J[SZK@OS\K^20]4<X&?.JEUE74>S#$\ \J)&:WIE4_+8=
M\D> R=GW]+\(7Z0 0G+[\)UIKNC:U@]*C*4 W.N>R_N7>T@A062M%@KP!O[(
M@.S4 (]>VJ<#"G#M(P'^[20Z$[>S;WQ:R-YQ%339,&H<CBCQ-B"*P$_!NP6N
M@X 67O?X4SZZ&;EYI!L,V]^JD_; GYJ;_^J<!<0S('EUVX'9:[/G(M%_<3_\
MGB:/@FCX118&^_%E!\='.E LC%Y?XW-$KO>5&);BMW)SX.DV/K>R.F^HX[ ^
M6U9_WU8* .YK!CB4ZJ<QOH#&T-LW#\C_]#_#EZ9?=#<(Y@%%T.'8B"+YG:^'
ML/ 'XS(<?D3Q&U%O8JEIX,5T@S5GKE&9G8O(HO'OB0"++<5V;+A7@ BQ@^?M
M]/GBGW,P_,G/9RS;N;2N[8 K.!#X$\]"('UR,NXL5ZZ?Z_1+Z[S6V=/O)HZT
M#F1;MVP],F.SX'TND\!#]Y,.KM05.\/VG44:_AO[1T'?D'_Z2YSC&N@]D2/K
M*IIO"5OCNZ+[>=+9HF)W3NH_ZJP9#K"P6PZ#?;X,_^5[G%H; 4>)41 P?)<Y
MD$? HNT/H+ST^A5@464>?A]^1:=5XL]:'(2A#9@D&CF-O$>5M8-E?/FHK'M;
M+V(E$;(.KKF)H,+XB['B/V,UHVF>C)F4?*-%??JDDUQ>/P^+=/M4DE1\E/,X
MC3/_+/\)@&:+N&1^00A570Q&O-]R]VORR%]B*Q>F/G:;5X6I2!AM\1,=?_A?
MMXE,#)^[L!+4.I7X[#"S]:]2MEYF3):;*GOTN:A_E/+)C)75SI[$&"H)RQ6L
M0ULL]V5:R:C EP*N9_WP10@)L1C1<G<N&\(-Z:XD[LOTGO0A8+'^E]H?8AVR
M;WJ@M:?;C?@1^%OM7ZP(ENNI?Y3KYSCW2V!DI=P6<8$@#]MHA:(;Y7X-H0#)
MA3ODL_MU_,\V0!F.G@23_6OIWS,+BI('1?&4:7U]PO"WTA])[SR7X4(WP:4%
MSO*KW0!Z%KH 5)-^7TV&<2Z5OPR:?[P@2[[MC;/FM@.]Z_&2SY'?#8/(U _[
M,RG][ HDI7Y<L*&"]M#N-PQ8P)3[L89<9[CTAI[,T<BFK-DC3K^:(<] PW.K
M9GK_Q7NN'B?<XO#T[@&YN]QM,<$SB053>]_:XV\=FS]<Z^_E_>^!8!HE%Z+Y
M=D^O>J',88-1YG=KX&??0*'*8\9F<0CRNS4@!\ZYB,P#I#"7][>V=6459/-%
M;0U!*S+JU*6&Q]X+SKV9!'$V<&-%?[4-;C,JL=66-MM=,4F6371_?Q3R'\J*
M8O_D8Y;M"#9J#I5K7YB\_U%'=-.:9:;:[)6C70IWW]!UJ!P9EJ?W)5A5+/H=
MM#+?D2UMB+F\P(8;^L#%+\+BIXTM"WIH?^7@UM*3/">[[.N6[ZT61!?;N>/F
M=I 0"967[X2H;P6Y:%X8/SM?<*; ;*M+3_"#Z88F.PD=G2MVY)6!H/5><O0_
MYQ[_DIT8Q,'_A<\@^_D#!;B:=[2.6-6.+B 6K]W]S97FO\D^YY]%_TMF,O #
M_J>@,E 0*I-8C%'99V=+R(@1"UB&^_X2_B\1,/M_P92@\'^7T?PCNO" T>7#
M?PHC8-*D]#-IH@53_4U(0.SOH/@,I+5K#;" ?R2!##)T8*S^N  ?W(\BJ#_R
M'N:VD;0%;Q[2PW^)@CE_4O!9,$7.? DE\8$IC\/X/^)Y0'71'\)K&&2.[T?J
MQV"1XD04<3J)0>V70!S.V[8@*_V[Z&W\3Q1:,YAGY,6C%G[*!%W2&#3^I($I
MZNVJ,WXHF@$!Y9U@6S0ZO5OF3/.VZV>J86RDU58N%;J%H+]QEL<VIB?X^GQ&
M*R<%0%]/=#$1-QV M=1UO)@;2$]%3OH^3).4%#WJ>R>8]WB9W0GH(\\MZ:R
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M#"1(KR#%?7! ?,'O3A9>&=6%HQKH%0A1I2E2H8LI'T[CC"!PYRVV:!TUQ'=
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MUV'DB*Z::?)3)6_1D!DHDAU=,A?WD2K8'OC(L?@R?$]!)&HKR6ZHM98J!&/
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M K85_6J\H'$_;GU?[6P3;./=2U"OO:$B)[2X%['W "-^^-'JMT_A[PSG31Y
MJLY]HHLJ[YHW2\+1#Y['O49,C<MVW?Q4TI^7]QS!\I;VAS=GE@5*D7Z,EDN@
M/2</)Q+U8*A:+WWYTW!>;J6?=HIR[^[3B$>&IQ[+SF<N:^0Y7BR.O54(:Z(
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M;A5%,:.)KA0@>O0;N2$:OJ!E4A!!O&D[W?' [M,BCU9%-%!Q%+H9UX9[6NP
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M-Q5>9;]=''C53;2^Y_2M[-Q<VNEZ1$7$QF"V?*%OK+"M@.&<6\&NC(,KN=J
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M) 687LZ_@N#OGTX\_WU3VDZ@@@($*<QT[5'!9\<@1%,(-K/:FP)<%2&^"Z0
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M+;W(F]HUVP0JH%0]8*;D8/9:,)*5\\*NF+% B 7SCL' 9=W/FP54&G)$?WR
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M"R"JHUG[S:4T:K-G0-=D?^1:[[=P4K?P()>^&3Q( WR<<:C%@YCK-3E0%:?
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M;Z0\]SJ/1?X0U!G"@U#Q4)@[4 8\5H58P$G.@7G1KEWZZAA506;$M@#4RVT
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MC)6O=RB'\2 /G_"9L+(9\8-O#M0K_,5?_:0TAUG8*IXQLBRKP;B&>J=^.<O
M'F OJ-VL=BY4KA)73$\+J=FGCR <"RS)T%I9@KXST2Q7^J'#.6@^70ZJLSAB
MQ?0&^).^ _:&+P<>E&:A!Y@ "0P3?Q2O3KO<7:SG+9>:<3GU?=U]&1SO+#8G
MH"6>PH$2"L/@00LX" 8P.M?"LEA37E.6I?84U#M,+NY=D@4>! *HS*PE'O26
MM]EDEVL-@CG#BP=1FF@0%))J01 :'D0!" </.@O83A2@/6(F:$+C2".L_<@5
M!Y[%+N]_76=ID>J*A<V0HG5.2,6[<" 5/*BI!P^Z:!*$6-8;A*'.FN!NUV<
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MI9'JS*TAK*<*;@;WI B&K#79I%AXNND[,*^2PF[1 7#F.73'E9.2]>+U;<A
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M=^9O(N).50!L5A@-Y#M@:EHUHF]-B((3RU]U_6:Q[X"<)#-@X, ZK[-_'+<
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M__</?^RWN.:-9YG9K@(=WH%-# =\I R+"#OP4?IHDIC$+]WV;SE2=K=2S=G
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M'!0]AO&7Z4[7^08!VT-*_5&8\-P##L(%I$FY.?8*S'JB;.UPF>"4[KLF@C,
M#H?LJDVX&3]%B> G-_1CDL0C(]<?*Y44:<<]L';!/OBY]G7XZWZN N>$A,:
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MY7DO^/C_P<6.___\QP_IR<A_ 5!+ P04    "  (.E=6M G$X.3P  #[ @$
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MP+GUWOP+QHI-B(ZS"8Q6SV_Y- '3]+W$C?D !Q\\3\PZRY:!H^VQ0+3@(::
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M)]ZH[?AQ-JN?D)\M",FNG4'/5NU8BF*LM,QDR!!5'R(JH?/)R1:7]61BW\A
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M4'O80G+Q1ZF>#,5OYL[TVE-8<[P3>.]UG7KPS;\V-!P,D_,+]27\^9PJRE-
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MZ@TKY).70#XP*QBO;+T_D3BFN'&OLTR H06-&G7S)['PPNA,BT*P4,\R]==
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M6&9/<&S-%K8Q_1D9BNY6Y9W_T6B9Z&L!W+@Q' /*7JKZ 6W# ZU\(0[AKV=
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MCD9C?VRN8PO)[6GW$O>=<*AK ^(.'*.?MM,#M@_)!5UCVP?05X_BX9R%EH)
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MCN;N!]V9QU.J#H@1\5R/_4/KS4!ZO\FZ]H-8C/XS +SG:1 3U:Y399-PN6S
MXM'A9])0.9WT570]S9A$T.]U[VP>HUBF!8E&M8*G)*,MGXU*J/;4[DS^9'9S
M^/&7,%D:.4<5IPB(@/OT(?3)^IU 2A UMES.#>[%X&]@>,"!4LU-H@->V =>
M:Z3(;7^_VAVQ>7K"P8/DH2GL.STG"Y"#!UV!%RFLN)OY([.M^MH1=80]$CU5
M!D-3Q-E4#U3R,"+:P$<#O2E:#E%\)BZ* ZFP8&^%<HI;)XPGD21W88>IFN-8
MZ9A5;. :K_, A3[8QCF%A0KJX%  ';S*LPSQ@+0L;IOZQBA]N2R[)_G-/?[V
M]]G>U3F-*\\96H*[+COY-D!R@'2W\B*K]U6L@/4SH.-%#&;+-5T.'4-#S4&A
M[]+L4Z0IPBVG\?_5V;#_,2-V\QE S%I')J/[^XYT2H$9+K_-;RFU^ 2WBF*H
MI0+'/<1+]H6CJ^M<+M8]3I)K(KP8&+AYM\*LDT-R\I.R?6#2L06YV?+4XVTN
MC6F&G3BT7.2@"><Z/AJSFPS__L.)0EE[ 6JO%W5K-4:I&VEX?U.O*]?\,V"F
MXI=:L5Y+DZR.]C]G,TO;G)2GG1<_9BA.IJA^?@:T!=,B=WEK"2O5 2Z$=A4#
M>^BU3Y&N$/WSEJ 0D'S3)7Y/RS,@M&'Y8MSJH@W7L#S:EIO$R\NKLJ,U9'Z'
M6V1F"_J=''/:!9@RO(KA7F9W9,I&8XV;P^S]WB'D@NUUV]!>A^E33^,4UPTN
M2P.T8!48<1]HUS,;.S]$DH9[VEHIY##TJP4=!?>5^MW:J?ZA"$:$,#^,=OIH
M^QD@>Z_/L8Z7E>A@W V?&OMK2_,1MJ6)[[BLT#$<[OB!T5RD$T.V])&S!Q\:
M$$Q7PFP'0E>@C+;H9*R,<KI5!R8+NC!F("W*5(]R;X\TAXXEOKJ(QXC(0:N%
MJT7'9@\C388\4$4APQ$DOGK0]RZ =; ^ SA)/$ULV?O80YQNTKDF#\O#4U=<
M'MHU\NJE;E$&$:Y4?&3'Y2*?L.N8*/%Q(""2R)K'6/LQ6$M-2_YRZTY&JU(S
M:$_@DX!D22].:[4\M0+7)$6RM+#VD\1941EDS@ R9_08ITXL549>AC!2U<JI
M-_0EG>" )(S4ZT1\O$W)^JGYX*GY&7"8'<OH@6_Y_XQ_I:->^M4G3_&TL M_
MY:^%Q1QG[+^+!6.EUJN"BV\JY"=<%,2A&_Q'"5P1@C+Z7-4RLC]]#QZ*E=!_
M$\A[T >YP"K*],M?P<?51M:"'I4\SRD0'[CG<F[^0*S[NF>':W=5K^D]^:7&
M7^3AW/!4"\CR-I6-15M%$@_1W[KCLK[C\L4?,[,J*%:B.<M/M)%)^)*D#QGF
M.KY)KJBP5ME+Q!\X&1AM\8PG)4?NW[$ZBC4_^3!'@.0RT[4*]/1DN,(#Z3AQ
MTMVFA-PFLJQ%0!'\:!>)T>%4C!KU^ G0Y1D!3+&:ED7M#5SU"1_M9:I[4 ,(
M-Z,D925Q_S)5]ME]7NHK3FFPK2Y4M+K=7"6F52O%4K/J^Y32 Y,/YM$S8'(D
M-'KJ.C7L?LYAD^+M7H+]TF]HC]ML0H,][KVC7F*0[3X'YQ^7>-U=D,R][ 7P
M-RKKZVRJ=H-<9/U&,@(2".HL;U48S G*Y+_2D#=OT&_M!D'@' RO:O%1=,=C
M3?&$!J2]6=0=MS(S6/ET$&A4"--W"V6[X*^PK85W,K-V\2RT*[=P,6(5%4\O
M%>N$+] =!=9('9:[Q![HFI6=:8][([@IA5=Q^GCLW4X.ENY560$+V@Z!KO.O
MJ%9YE,0ORU%UG._!%#U0[RXE&-%19%3X\!BR$6UL"P"P-X7X@XSJY*@@7[\:
M8C=8="2S^&A2%2W'1^8*.YY'+5?U&!<C'DMV83M<]T9:Y(RDAXRF6E#HNQ;L
M_T?F3RM=?Q#G!N2<R^3R#("Y?,%Z!NB2?B)L%X MQ*;_*+]7"5$"0M(7>0N.
M3MBGOW$E5ZFX<?U'%N^_"8:7P2GM;,BA8J30+V>=!'5 6NX%/756\2I&&90-
M$;HDTYAPN0([WS]4.NO]_/!Y%L;\((J1SI8=\.01:X4S\,%^Q!L14_?8N=&X
M?A),Z1N?'8&K;L:/ .#'LY-)*K/X_4(>F-[\EYN6K!KV%N@,NH@<L["GY="7
M,_6:N4>\%0T\^M4H7L-/_6NGNH+Q0UP>V:1Y7':>*GO":-R#8/G":FO]K]MT
M\^O8'7UT_/'+\H#&9P#B;]6%C(9!AN$B"?(5]=W9%M3=X6U-=9SBTF> A(TI
MJ*]&??G7BP9 '?]D67@5_PGX?PY/BB3ZEC%;&A$?\P2\,"J\^Y,N!/UEZ7?T
M:6#HT05*S)SBE"1L/&I.S2[6N!<["N6:GSKDH&1,A$XZ;\5@08>[O8JG])0_
M\I[AU09K>(L0>(PIN_R2#IR7-0MJI^1MIYKF"F9Y:*@+88SN-A5H?'PO"9Y#
M.=E? "\J>W"UV:(UN1+97MK8I1 !T%W)TR^7)V-JD%M*@GU3U\P37S4)"DMK
M!/:[)23'+XD:X[]Q(%4IQW]/ T\;2;/)#]/9[4V,L8I9E7; FM(= K& ^WAE
M:PBC(PV=.B_^-H<EXAR@$J:5OM^\4K9>(LQS>0P]V<?B<]\6K^?_VK8_[".B
M[-X%T].,L=(U;,J#+EMQ&/9#T&[])%6J)947].'\A<*<I!F<2!+_/?E1>K\0
M7\Z2 W>-,A?S'7,\S_)?G]W^IYCN$S3'UQV^7UR$MCKQS(!HS2@WA7S>J)ZR
M!=-,OM"@:A\#Z\0,EK;J5-_]0R_*RW+!#<Q>H!VZ>\2J8JB2=1$L,(F:*P47
M7\WWU^Y*\RJR)<3<MZYE[VFAQ(JA6L%>&C775.J/ZI!V/6 U?SE4,@/]!NS,
M1YN^X^11O$QV[6;+[WI!'B*(.CG-U:*@RDX&%<P\K.;XX[*+J"1.?7EE6T>W
M!S\A6D?LW??WXE-.":)).P7_@OWG:Q2R]O#8Z#A<!+-_ZS1/7V UU.>*Z6GZ
MC/0EG5/OB616.H@+S>#3AR^<\,U"NR $/\X;K7AWOT6EZ:\JWB+A%AM-"+S8
MM,,@'^1//<8*+YJ91=4F__-7E]UZ"2'XXO:02N:JK*ZS)_CINL.SB28ZE<1F
MJBE^O3Y&>\UC60N(C85&(1[SVO[MGD![UGI**+ ,W_*G%1T,EI?$[H(CHY_)
MU&-!>.!K&/PIQ')7X52FFE5F*#4L(CM/$']F7#2T^R[5+=K:-5E/C[9N/IF,
M,5^U]Y--A+2@1L2A;ZK#L69 8DEYH9"B\QROJ"7+%1S3;;I*I(4^;#G=(=5K
MSM0.K$ED;OWCHW(,C>,FLK2RDA5HVL8_<E%AZ=442>LSX+U-?[FGVH[I60YU
M-]1@Q&%?R^V4D&[:-FP'\-"3]:&0QNWGUN9L';.)=OHV 1_V-4U&L[#5B)JT
MD#PS!W-TXU SJ9]PN,3?0;,;(_#_#9L98Z4F?P[$<-E(P9=SB KL4L[$2D_:
M7AJ8J+GZ$9$+"12.80  Z G"[ K X!9BZ%B-6>9>S.JJ;#4-*8!C;#E>VM$;
MF/;KPGK96E4)^R:$(P8NY8UPDY[&T[GG@+>7FC.8[KK',]>0YA2=CC8H-G]O
MQ)%2[1G 0NKF=*<%4@*_;B_MJ9\NS3W%&Z*=9AXE9H#KIT\'VB93A9%^5_9V
M4,SM\\MJ;@X96]Y-J\^.\'XLFAHE:V7C*L?F(C(7+F&:)>*VCF]OEI)WYF_P
M?>&#]=USD\D&VGE RP8@"3\WL$7^_I(I7V5K,6-='R?VR!Z873P'.0!##AJ>
MAF;,@P5#WM;]68SXOX96BHI6=$%0LU'8Z:M9Y)$8;,[.JW)1Q=.QV"NB.J1?
M!94RQU1UX D&AQV Q@ 9$O5Y>49/U+R^NYURH'KL4)4[X:?;OIE^W5,6UFNE
MEAG-E6= 3^(UU.;:?G@[/WE@JOJ+R=*R3^?>;&V8FI13[*<[Q,R8H4D+-I9:
MUOZ;Y/<*2I+FEE+@=0Z: ,+AS)]5*O%WQ.A82=_[:#A\?>ZEUD3J:''A**(Q
MTW8]9'<V2:["Y^^FB2,?/"&=4\^ #WBVQ?]WR4Q^2ZE#31-J,0K-%2[<NA'N
M5UJVH"=Z'>B\ 5N&TRN4UD[73HX/%Y?]<E?>F)^(6?W-\H,_=9C[FZQ 0N'+
M/'9"7>CR(*)! 6E>G ;[<GM4'[31++LTNHYC1SU=6E<M&V0_.DHW6MB$U@5.
M:\;:#A*IR1T9#/Z/,;= $@,3H7I=QV? <$_F"[I]\>!V/%"^9PX)!W,&?"X>
M0D01;IX%YX@4E2XOY?_^-N:'P Q'N<ORA#<8E!QS)>\*.UM^0E(@Y.NPO#*:
M?% @ SX)YST#RL\@OZ4J-(! 1C :O/,D-2>[:J:CHA7,3I8;(;DJ7"HU15P2
M5_,['!\1M[Z1'B<8A]%.KDI]$_Y>\QO27=U37;R.'"N3L/:O^V? S6GBWJ/5
MP)[&WP$IVDW%Q+>L7R_//_V7PYX,+4Y1(<#>.SZ!0UT S^3&,X#(=>O;8=BF
MW3>OD(NAK=8O.0<"::,UH/ LA(_OG@&U90]]8Y# B-?J;G16ORO69+]7KVSV
M66\PO[[]4'CF>=YU_ BL*T?KC#%<M(;VQ1=!3-%2G(/[K\"-X3IZ0K&/;]QJ
MY>T#^D6^OA_=T)K-T&AV/"4D7HCA) KE7[AV"KO?25_!FL#(PMN8U^N;Z#FU
MB:!5EC!)1])-G^M)-CMJ<,I='#-MJ@\=C?._!8PA+T]1IL>_K@CE6BR)"\7I
MB0'6<LJ_U=Y&1C$NF']E.2T\B2Q$9$F(MMA2<F/LG]D0XMCH2_C9UP>%;Y.>
M'L]$_F02-%?DPI/EYDW#?LOS#+ $WL==$,+3%]#3I=AMP#C,'_>2%XCITAE9
MJ1FJ^W)HXZXW,_(4\F\BQE6;Y4TC-E!,(\>^*[U5XA9M;3J85BED57UQOU;J
M7A;V0(LI[3\__NMGY_6<T@>MG3PF4["4VY63#-?6A#V<BV9>D!?4"?9\HZH_
M@84,4]7.J?$F6EL3#H_3F\'?IL](='\C:XJ 7<(\)KUMUQU\1.358<00M94B
MUM*$.^I42&!"<D2>2=%-/KM7B<%X\^>(CPZ%1@GOD92%O>9RLYD=BJG\)0D!
MSJ]J[)SY*LIGUX^.J4WY)2,,B@L(UXQKHUVIRF4[^V2W?BW_9*_<__?\RS\I
M\+V&O]F"ZBY%!/[H-C4:$.DG1"=Y;(V=ON[WO#1ZT_X,P(3R7A7..&:<W@'(
M[83=R]ET3G:#MZ<KRL$I/PWE98X)FVI&?L#:JN:FY]360C<+;T05F[\ +")W
ML*3>PB'X <A*9*W"LG)XV#(#=H:T;4E+61L=20LH5"8;P73[.^-=B?C0UTWI
MXA A2KUX$P1SJ5L?&@OX/+<S2=*)6L?L5IL_QW)$.BCK[EUI"K8/@EZ_/%+;
MMA2!J+XZO3&T1:A ECUW]BIV8:DK3[JB RHR$X;__L'W5K0/CG^31K.ZK."!
MUJHQ\![M7K*2[ZSUF/ZL#X(^EU675]/+K&2'(\VX3!6'P'])W<:U=V4^=1@P
MB5D#&:=@MGEHUG#"&7!J?[O4L>@WJCX?+MX^Q/F];V:Y8='5TVOV,=KQ6N2S
M\HK=.T7I93QC!A,_VA#"2;[I+RJ(@#O4@+E'EY?K&; @*>_& J0:Q?V?%9;_
MQP W>8T9FPL#'KW[V^^:I^@QGK'S<$L9<H#QTX0:5M]U%FG5!O;0(&.ZM^_6
M.L2$Q^L\1'\&<QL16$_);[P37BX+,/>1:S'1F3^3Z:>_U7(S^>*T05)[RAL<
MM:BMEW9%[)Q&3987Y^8T[UK6@6ZD,_ZZY[U,WL,M:2'A6OH;RPPFR\%R$)W=
MA"1>4I&<:)UW570Y;K:/P_:F:)E>S,<0'@]")H9!FA,F0!>;N3DE@YBL< F7
M[5S!X-!>= -9V!;DL$ZS*<5UPI99I;W)O@$'R/+=@ET*LEWT='IU458>Y_,:
M  "0 AA!O(XY))YQQ^;A='7H^\B)-#A/@R6? P!_1'E-XDKQ,^7>A]@3$N*^
M8?GP]['-?[2%D?I^<JZ%6XS66_]X&KH-UGO=>/EH'?ZKX-1M_F+B&8!B$9B^
M:@II0>:-V]P>+^<K?P88-L0<B+?Y ?F.R65"0CTHK 8/E:Q.%[CX+P1#@6T2
MZU>Q(+CFX#>=;>9G@U_^\/&VE@&;,/X^\DK#U1 LT_TY=#8[N;'/=V2;8OH6
MYYR_S_WE33F&#+6<XB>9%;T1T4F!?62<CZXQ$>;T[150PMISL!+][)5)OX+U
M4&#5]#NO^94WXT+([ZGBY/\$7+TG;#*V>_E#"BLC44C\+]CJX_(RKY=&FO23
ML.@:Z!F0A2K19/N/B@::(!1&@^#UANIZ8S9N1OPQ@,#V&,H#HH+S]C0I/N ^
M>=-48^Z)3HH7J>[7VHK# .?@U"G:PWY.VT#Z[)$+L6$&1GS>BV[MXP/=$[CA
MYS6:_P&I&9ZST-.3*2==-TG2SL@'0=]4-4SF6%"T_4C*%8&-G_4Z&/(DK-?5
M^YI&]5<I=BIR7I3/B;%"WR1%54&8+=QTSWX;X]G8;-KY?RO(T@TM\ ^K."56
M5Y'T#$S'H\C =]BA@ZP4,<5V85[%09H534RNI0M+]X=4Y.,L6S2HGP%1+V[I
MY2BD3*\X^ADPH FYV^F8S2\_N7PDI!(VWA<T$!Y.U_:'GRV7H!I%E0EDZL2R
MQM$,YD;+(1J,6."X$>WQ1%VH;XB8?8LK]IT,CK]<%\]JNE=A;R!&OFWF&:!7
M$065I=)ER&Y[]>$OJC(0!T:J!*F./Z.@I9K>:<6YQY#I]:A*.I1]%3X7\M$@
MW1\F!#RR&U;+P-/G>53TP.</5X!P;GQMZ4_&XRE-[)IRSL]XCA?&V#/ZRDFB
MU4SDUU?2'M/P-@K\<R9RO'-E&HS71CR.A$7+W/!V(6]FIZV@4[_9E_K7:[8?
M?R@2LJ6,/?HV+4ZV8<==(W^E)R+M8POFD$LV.(,^?E^\';;\R4EWTI]J4N Y
M3L!K2#?-JGH@-\.\.)A @I P&L-7G4O@)F36C"EN&"A)VKTMM*HQ=<F&J[.7
M\!XTIQD#JA1-G4.ITGEH\\7-:$4YXNL%+\B[E%G?&?1?F2W':6)UI-I2+R2:
M+59!6I'T(X!EV1&?MSDKOBPZ@.E3WHT<G,5VEA$70*YAD(/FF:%_&"7YQ\*(
M8>\P5P=@,74/[.%I)YOJ[=F?'*7V<+V:.*<Y\F2*/ _I:3^-O)*<V3<T@'X"
MAS#I+?J9I<V34H5=CBJLKV*N*!5"?LINT&K.Y.J+VV*H#G$^ )_FBHKKZDS/
MC3X*=K>3-_..;E!@O4_43G(@%=MFWA3M3'\J:'-15Y%M"0>^_E>-L8[GXU5!
MP=X!3VP>!*1/].K'UW5R@M1ZI?7;V3P.69,@>)H0G]17_40B<906H5:ZN(G)
M8==NSP ,]:6E 5/ON\GR'?IT3L.J]0'=U>XK^_H?S5]DKAZC]?E"%ZG+/#3S
MT_$4( ;/@.\K*W<*"N6I"]6EN82BVQGQ#6&/+^CO3F87VY5LO$^EXDBUI7#]
M<W=[^3A,\\]@<XH6V+$^AN2C=&/_T:S4S]VE.?[<96MH@?\J>+ERVG\I2K@K
M<DM#!S5!X\B>#[$9-*OE.TN$X!A]UL*ZACG5YL2X;B EC'C^2<&^_RHIV4B
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MHS)Z&KOGY(V!7>.W>-R=70SS,H?J]HQG #G6,Z!%%LADA3PBIH*#K60KB8_
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M4B50C)V&L(:\U6=T;5?5Z&XB U51V&PR.DK"$E7<1.1VJR+P=I8')Y*CDO=
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M<JX&'B&AS^,!Y/'V&#8L3"%.-LW"Y0W;?)X9C!%O8W$KIEGJ8O)?]3-5;FA
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M@(LY^VG-=H\7 &,I?,[GTRDO]$[(T]S'4U*WH]INYG\:OV27F!IXPBNF3Z+
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M"7X+A1W)./8@M(086EAY[557(B%TUA%_>)>_S*2D3O?6S4PP5-Y7>4@/_[Y
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M;4!/_M5:^BEC^(5;H,)%)<GQ<A_4:TNS,2:0EJW>Q1(-Z;<F,@E3)@MSDX,
M X;1U2#;$"C <0W+!]+3/"]7K_F+I'7VOH;ES$Y<;(KL04"[5>LP^;T9\6V,
M;:*1]\NI*)CPU<E8V-H)TJ]EK5#G'W"U8V2(M_>[R<H QQ6H:)QK.=R)JIOL
M)OS4:#:*LVN^\EJ1<%<[T_9^F2O[.P:1T!9HP;K-?DBIHUH-Y"'&")!H#+8-
M:#8T;;GO*0 YWTB<BCX">AX!9,[LHLI 6)P9?95Q2^OU=Y,GS^!!^6FBI7=*
MU+GT;:5=P0[<2(/CS>*P5=R3([)RX;FH /?H$*48'#>W3,8=FO4G[Y"8I7L)
M5@P*MBJSXZZNSKQ6@V"KJMQ0V!O;&\I!.D[)[:9;W%26O3?55%^"&T9:#$X\
M]R."SOGE8=L0W)'WURTK8R&I7<"6NP >GA.O>!*CVT^-F6P%@?@]^.*6TWU+
MNVC].Q%=LP%BI6\VGF.YD='?^,?@M"M;B1K95=BQ& Z0LO.6^E?;(YQO[T?S
MN@EO^2-7AI3$A'KXXRJ'-JLPE_+O4L<=354T/_ECR^5]NB_[_NL\6AK$P3W#
M_^Y&U(@%9Z9NG$]/X<DL\V?%WEH_ E99Z2)#<O/70 $=@QNM?/+M)K8[6X\
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MF""J.X@7E2CJFI?197Z/ /G=[?(XPB::(6,#:3%"[IX@^@G^I,#7#Y?5KH\
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MP^>YVU<M&&!G3P>/S.Z5L!P^RSH0\.E=\++]4Q2<>0)9-H_]9^=_$>U_$08
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MMC'F'1>7<V:L#1V_>6_![<A&NHX^"RXWZ>$H/0*UYT>@$WU(0BFM?MNSO,Q
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MGWL /?O=83XS<=G(S;K+;"1,XFQ82U5_Z)>-=_BWA%%#SRVPBR<^>)ZZ44>
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M9%0\S4>7^4%N*.$!OF5Y( CU(TR-_%EN%7 =7*/I>\M \8LK/J66Q*_C:>3
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MXE0K*\&F5OPL2<D8X[Y[H?OJM_?;(]^_BO*>Q^.TI_&\4;=;RUH)-B(US;?
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M.$IM$^C\5$XF0$;>793MM]E-S9(77H<V2.O*K53%6?.LB:5D9=* \)V]$YK
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M4_W4>*B_JMQ<,+=H)%L".N]&!M,C4I&61&5V647D\W,*,--#C2E6RJYF,1\
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M0YH^I7+B@NSPE@_L; TF4'CI:9BGQ;Z/%V-SR!"3'*<LZ+)=<RN1O9^:<+<
MATL^:%(A28Y# 27D?#IZO7-L%@7@0.=9^,G"*4MF!,ANA=R)BYM8@&F*!"QI
MSV@?]/8O-"-OA!QX[0A#U9^&UJ*>M(5\N4UFJ$Y\DI$3:\E1U)X Q'60.S34
M_@5* FJ]N_=D4ZV3B 9]E^/Y^=T?NTX$$QNL$O3]AC!0>G2^48LP^QVD7=>:
M8B7B8"<5]KR:-(-(,>L/LFSWGUOY*Q1U],B+>.SY_F?98-PV'8"\ZE2<LJH]
MV2H?3H$I,0+C^LY82%S#"J;A*LA5P'0'06=#"^F_$U*^.9H%_R?2HD[V:Q&1
M_HD=\9\9446N589WEQ_;'3V<F@COH^-[7>9!TZGQ-R!?-A1,^J#F38!<!58(
M/]>39W1QS74Z8V=CO6 [/JR0\M7'%]76N)KTE^O8G:BJM<>V%4Q/]><E[JM9
M4,%[T(Z1WA?""XQ3>= ;R[N#V-SVIZLT?RC;N'P.I88 UUII?.DR&1Z<#&B&
M]"A*IHJT#CW9S'?,^0SRHW@H#$HTUS>-PR[J;]A:$J$9"D0]F/K0RL"6-P<.
MWK$LC7^PXX_5IX0R"RR4TWT[[X#G/7ETEU\4#K2>#\5:9-XI?$#H2T3=F+/'
MEYHP52D#Y))] #?P#/#M&>BJ,?L@@!:U0RJLK?3W,"HF"ZAU]ZYER!FCI2N/
M)9KA!LIU!+2.'>FS\B^6%;*,DI:<>6BKU9],S,-WQWB^[ J-"O4WQIG=EP7J
MF 5=A2BLFFA[_D)U^$YZRDZ76=ULB8;B#0=FGUO<G?43,!>B"5=IC"+9>4U^
MN&4J,5Q8Z3()3[3U3M#T1$"9TS\8W: X7SBMV/_#E.R?G(!8LDLYU349['27
MDC^?^:9'9]Q"A6A@TE/T[&P#R1&I >VC;.EGKX+"<H5]"WNJ9HQ<D#O6,(7X
M0#/$^6K@MJ&]78!G]J>:XZQA[:[Q55^F,F3E(&Y!Q6ZBS.Y]#U[(-K(Y08]-
M>6C(A=SQZQG=3!Q:P[Q9*&=2 R>WA7D'FBUNH6BPQP;1[$]THC.!LGW"KJ?*
MPNHN\_2SEXE*-?JFY'8?"<+FH!7&G$F<IPB*;.'G;^E-VJ%?]M.X7G//TZ>"
M4J7!W0@(JDPB\GN./;:E?X?_!U:#BU^]]LZ["_;6D9.4^1"?5URC2#<J:[<-
MR=)$BWPQ5#;&^>H[Z:E8*A26">(+82PIPT#>?+:IK?@3Y'\C$\4H]HID$;P\
MN%H8Y/JP*PFR.K YW/0Z/;K1X.1](#9_M]6'MQ?6!UHS,\BPLXDMPQSH2Z76
M=0%"+*^<ZDV(H$O%S<^ RN+"EG*T7]-/2=6X!&')#&S103QQ/9T%E-*>ORD1
M59<1I"GG],-:2>8!).HT)1[:Y:8(%^BJQ!&61739&7:$7]%";.M_1GXZ@8_>
MSZ=X^+]LO<VSE(O.S-Z2>\G*CN"4<?8 ('3;4[5U4E'O:<K8(I?7V%#7$B)N
M/K#9 ^V\?KOH@TE^_+>]#Z.Z]8\4Q?1[N,2>_?B+&\;K0V];H(E@B%P<CR[:
M@(-89,!,+3!4K>:4N-#3OC M^0B<+9<V+&W8W_:HV@EM2!!)W^_O6Z'&H'>;
M7Y0(5,>&N[/K;,,VJ^KK=3=<'I 1=9KCHY.90G"(,M"">62K8-$F'H_KJD($
M4*;;$RP2!>A=-3O X6<<(H(?*+6]?YI1S!P\TM,\J)/YAD^DB).J1OHLHVK8
M>Q]"'#M,I\X-L=@GI"I.N5_(,G;AMQG@B^G9_U1,6:+I])B?_DRQ)!_G1&V:
MJXFC//E'LTY;&J-39#W<FJB%06=G;[YX>ZS7Q1\#$P6L'LD"+H2_Y,RB'M@>
M_M8R,_JW3F>:Z+6EQ)GP">^P\@]']/AL[R:*DK%<X!B[HRH*85_3)(@G#3*L
M5,X>Q0\FJL *IOR.XC,?"CTS)$_[LW^G9B;\$E+OH)>AWF>@3-A)DMF<M\C9
M+.,Y^MJU!&=#A(BG=U)T >&9!/!\Y(D*^\.H$LT1#P'3:S5+$IG[/QN@6@RN
M@Q^@OTHUM.R@3Q'NFZ\@1#/RI#SC%[[1_%IQN)TI1Y?)ETA;3L>"^)*/6>XP
MW5&APT7QSW:ABM)(!']IV9H8 5#ZLY&;'B/"7[J9VN1?U YWZJ=Y]]3C#5"+
M$](\\VO6>#+1I$VI;C<\E[CM;<NB:V=GQ/\^7+$EIEU5,%[S_?27P;C(AU.L
MHPSO2/C!-XK@CAU^Y#L4[5/-LJM6HFDVL!FG"EMSF;5@(GU$UXPPFZ>[#_*^
MMQC<SNX9SW!UV.U;'0M-6GSO-@;@.1PFC[OPV26Z!%1LP;-O*'&IHY,7M[.E
MA89LM=\[DU?34C-%#V*S@&AJP1>\BK_05U4XG8W<[[1S[H[OEH(]L?NT2/W/
M1F:-,P1N\K#.1\V&-6=A&>K33Q]70]:/53]J)1WB-DM5]841\Z"7S[;J0#M&
M51FK,6OJ_FP444&[^RW/846%IS7;663ZO CU2!PJA<#XG 6;:Q>B(OP@L%=Q
M=N>&-35TX7:FH4Z^%XY.K3W?'N\_UW,Z(C!,F3V\Z;[PFYV"GG&%@ W&SUZ<
ML1(5)$I5IY@&\]\!UL->_D#FX)>M8V7NH4+M/V[F8IUP*"-*S7)MB5-]$DH>
M'Y;A23-S=F%6+]JO]8YP\GYA8)FE3Q5XTSV\Z<7[)Q\<-';)A[1P7.)L"(P_
M'@R!MQ+@3*I<U[9G#6<]Z+204#+D!W.GR.11]7B<TFZ7WP'F4'4A>85J@[AF
MTE@9&:Y #ZIOXZ;G%/VNMH\7ZXKIN$\!YA+37).B";H7&4QT@1KN&(IOGV*O
MI'E!\A"FG 2NRD:Q=MVUM,G+9JLJ&QH2>:V6%?K>)'=RD+53=+K1)*B>0.+]
M<D2RX.5Y[PSU@&#Z6*/Q6+]2L2]#%Z3WK#L"I*R!![NP.Q65:3,0JQ7$Q:@L
M*&;TA(=AX77P_OSUR5T!_]M1XK5&U3@DO#ES:I]2ALXZO>#"D(/RN7+8YS,R
M?)VK.,PJI!#258AG62D.SHKN?A*7C:.$#TIWVEV)>5AB1F0@"8C!'X#@9?(J
MDK9Y['.:_@1Q#^9*O3X%Z'Q+H0P]GFQDT?6SEY?F5SA3CKP9XVD#5ED#;=!8
MD(%;/-7PA[<'A\")XS6HU#@9K32!_E:XNO\E[09](4VH_/L%):NU.U'X-N-Z
M*HN++$2L*0_ P<1CHKQU]Y<48B)\\B<X;(2 OPC 2Y@J(O@/15$?%\?X:UX"
M_N_F:;*55YA^;$ZT[4EETB'-80:$(?2->B7"04#N>!5UH27]%Y,6<A_8LX.7
M%/V_ Y:0$7O'L" V>P>N6,T*T%C9YRP9T[#2_>\ _%P)!NCK;Z\K%06BQ%AW
MSWYL#=L9@'C=K[X#3&P2'18I/)_>YK7IO+6T=+SDB0+@(>&L=_!WT-+D@\RE
MY^$B%^_<Z>9WPE[H:EMZ#B*^]'VD?U:*3!<H!\!6(>K(X#*($#_QJ1TD=6;!
MA0S0-ZR%;(S!S.*\W0OANUZ+#PF##GOD>C([?3HY%I79G3"=SRY&UV292;@.
MW,844:9;G-O[@>J,YJZ?)8[5_Q&(!C8^Y=F)>79VZ1O#KM=N+ ;4XIH$6%9H
M8KS.:MV%^TE7\I2Q>[QNG(L++6%)RF0R\V_:#>J.6G7XVX7Q]F49G3VI@_X1
MPIQO=2E4._/41PC\0@I6V3T./MA"6D\"4*XN[PY;ZO'[30N$I.UZU'LTGM#@
M9!9P/(_:*1=35"SG[-E13%-IB+-JR.CN,B&$FKN9;(6O^HO3GO>2Y70V?K3U
MM'I3-E/=RVB8]V[GF-'T.A!G0P7RXZ>IA.:@1[1RN26;YE8G%?0OQB]"&JOJ
M6A2GJJ0U770'&!$G>'H'O#P#VO!2V<I=#T]X\ZFS>0J/1,<IG3(.?$<0Z+&P
MD5/ZJ$X\<Q,P4RZ%O,/+#VD]CZCHPE%U%_Q1.,^.1E6"+5M22>FM=#K[G@<.
M.>3NR2,V1.M-ZK4V-BKZ"!X)N8=8+P&3VU*B,W6WZB"AA<I.GN5^A-97K8_:
M KO-HE_3A<A3;2.7*K3GK"*E%['.7[!(QUZG3(%5.<5O2]"/P!9I_1"=94G2
M=R@" Y3^*Y)!!@59J*6N3.1+^?L#E[N$,@+HT90LK,%UE3=#?.8[@2+,P9",
M\KE=MW(KD%>T::$^)QRV(%73<[C=VT^_;82P>^7#N(5MUL2G%;BVRMGU6*GY
M72SZHISQ4%!$UC^K9KOAYU18),V"67.SSF958RR&_/5MOQXX2"2(L?<]=4+Y
M^V[?9=K60-"6]T.>>5JS1T]DDG!"+IX%P:Q$K*T)4VJ??"B0*ILPE,JVX+A)
MHGJ)O>G>S0MVEJN/P##_6(\W4G9:*8!5&MT+Z:1GJ'76XR;AU3XQ%BF;Q4!<
MTGM156'$A'5S%;#(T4L/?^^#:>@]VU@]_"Z)QBZ5HT-'=IO4+=>U QS5%;4:
M+QW;F#+#6Y_W>&*!Y[ A(1"7#^O-=X![9OKE12E?DEOJ&VJ?Q:I.XM6 M&8"
M?]&\671N$:GKF(?!77HFBD3Q*J]:S:$]'"]Y?<]P"S\,(5#M9\]8Q+\<+[,[
M!+/KR/IAE5,/\;],VN8?K1)3()?<MIS.W\JX?7U9W<M<_,_Z5R2F%W*N/<E]
M/8/97&0*3?+0YO^T0Q'S?M398/HB,]>]7+&D^\<.^&VF%!]N]CSWYTQ3-G\G
M 'L0E1S:@L 5.4,8N]00L0EYCTY+HZZB(D9&V-O&D=EGE'8'*MQ.V<Y<'QL;
M:JMA<7O;<NOUT>XMT>UJ^R\A'W/#$E7J)$/B!Y"^UF^X+7UT#LC*M]R[N8A!
ML7%+]<GXI%!%2A^BB5 -V!VE/SVPP6S#,7[HUO--J- [W"YRT4 6/SB<& -/
M7%W%K<=3>"QNCW=%TM75YUE!")XS21HO[R-2!A'1E(Y]#:,57=!X7I)3GB)]
MV*3#S7"@ YJSOQ_S=L67FQM[@E[O@D'?N.:N^API2; S>137M]* ]AY.\56(
MS5$Y=_T,'#O7'N1RFK]N($\:<Q46PH2J<*>#TQ.),E]X5U[@$WF891MT<%-G
MORAZ=>7;NF1#<HH=2=XSZF>7W<G1?U"(G"6.@\8S^AU@N1*#_QWP2?*2J;7_
M,OTN/H:+6B5I!SS"9Q7ENG#<3;X%*2\S[G<N[!"IYDUC?6RIB?JZKS&F]=,
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MU%-SVX(2>6>)M[(1K_-ZQI]E<(!OP/-M_!NDHSQV]PM=<5\S#46G>8(GM9C
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M>:7[4O*^2=-7V@^(JHY+^&AE!A)-+@8#*@MAP*BB-YW74E?%#:DP" :8JL*
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M$F+M[PA%WFKMZ<_-2_/UQF=1!3A^\B&WAJJ9D=[ZK1D2*-J]L<C8)(#03<.
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M/57?317/_-D:UF/:Q.S,8PG&=-"7S<5*AV*9-Y\S_V(A#9"UT4,/0KX%A<K
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MG#GEJ_76KUFSVXH?  $W),[8"IJ8V HJSHPB:/2RC6V-UA7S/4:&9WL"H]*
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M/OS33#UI;"/L4GH?I?0NV:GYRZ&X4!-HD^RRPV*;CJC$J;DZ9>XCJJ/X>(5
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M=_W PQ]Y,&W/NOTX%[8HAC&$,V4A<[T#F0> SS!%DYBB] !@QZOZMUSWOW
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M8[7&&4I>6R_&5HK!^>/V\\(\9[T5*5M]K6/QR7S7T]Y@Z[43J,XZ^'OBIW8
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MJ*?T?G2G)IL]G:43'V"K'T@JT=<_YRF7+[+H%EOXH_/[_T5CK;56W!@X&(!
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MX[\0W--=GCP0S_QO!85+?$9_AJJ5TU[2VKK@+;B_I_^K]WYZ'U+X&2TW6%/
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M:K(ZM$GYU-!61M&V?9"/\Z<C$KX-6NLN#P>FAQE :;V\+CH1R41U5A^MAIH
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ME'UT&?1S LQ(K1/+D)VK/D,1U.X;F75>/$-*?$RO:ZYY7M/TP6,?W#PGCT*
M5E/)TM=I:$<).#LO6PWE^<J=.Z)_Y5EL;@G::7*^R\N@\-]875TY>/D9*_G^
MYK@/'AZQQHJ?OLQ\CC2OPH)S$&QQ:>(Y6(.*BV,%OXYJE*#08S_*,?>+Y?=1
MW(U7)L>[%X[F8&.2ST*FKZ14(H9(E7!?<6[#AFZ[;C)JM\X4I.HN"4.U2%W_
MXU[?_^R"TQ\_$24+SC5*@"@X!'&H?_87@:.6K@3XPXUX"U@L?SY(T:%SR\]X
M0PAQ^?(5W/4ZUZ+NB;_XV^E!+\F6)L^"R46;N2'-Y] @(GA>[>&&V\AVDER
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M%?)4]>29EF=MZ[=OWGH*NG%#_,/!]\DY$457J+ I.;N"?1XJ[B)Y=?JTNP?
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MZ'ST1$OO?:D;U[68_?MUE*I!G)5NV-0DCG5]BV28?FLU,66/YB=?J$'3I,]
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MY)]Y%WG1!AV\LWBY^^W6N>9063I[J9=/[:C-C*8RN!Q>/ 6>:R>%][!5%%E
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M*VYD/"DU%!,G?!J> %0":7!F92<:+:_Z&:&I\P0Z$1W?.OWY'ZS]A;-_C['
M_R7._L;8W_E:!& B(CPI#Q$7( FXO6/*^HS^_S5=1J"?]B3E?\8)Z0_E0#HH
M[0E$LUN[%[[8<D-_'2[TG'K7S5O<*^%SBY!;^;=XL.$A:71%$C HIH\63VYX
M=P#]!&WGP^WO^[0E37E3>I_Y ULQRWRE3&O!.=OSI0.!81&]3HSQ5P-D%2$8
MA,^O>W4:S[]].^:[!]U'*#,=VU-D1VIA10RA68CYYMB)D3MSSS:*OQT3Q]E
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MW'>5A*8LRR"^HZVAS[8UV[I\S4)\&9"20KI]W0J4F[.O297I1F8XYTM0C?E
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M2FF(W^RA%&V>B%@>(;5/M":(S2TYQACFRXE#^A4,8$E#(&$(<G0716<=<7@
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M96+NH\*UKN#<_PD-<"9R;O@U@4L:8I[&9]]@"9A#\_/PVT@5?/>KO?(:0S_
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M>I9#6,.30#/FTK0S'T!/&HQS@P,,7L$!OT#CK$U4Z&)WZ?A/W4L^_S4WFY!
M\Q]4J'_2@=>33=ZYMYE"Z9_FH5F%M6[_,6I_<:O\G.*'Q(NL,%9\E]3STX?8
M1W]8"\-3FY)O@+$Q]!:F"&N' XSP_?<8VEZ7%9'QQN(V/2U1+]SUUWC35@"5
MA /HNA6?)-I^QW^X[7V7O?84(F*Q&&&+<,#>7 GH@0'J'W)BE16V)?JL!65S
M)FYF/,RUK[XN29-(AT%H&.!1G^MS3:B:P-J(_XVG\ES[1OG)P;R^+[^_6%V7
M__.#L<TTKZ$^))HQC2ETCZ)K][*TK7++[-J?=Q/G*!4("[@UOMUN[TIRA5R#
MS02T7\WC%9G:1HNLF:VTC<*F*N" =(C#_5W[IL%.88$N%96G5]!RHV9MZR >
M)LZUQ)6?V8!$^8YO^6-LH?\OB4/80SU4[4_WV@O^B^Y4E_=V<("_]H/U^:J>
M$G4D:P'%N*PN D-4B1?*S,-XN'^5&^<=RK+_:CP<@'[PB6R__M?#FPFZ^*%U
M7'OACZ&?R2FAY<5,.8?+>MTZ/J)+3%EA'7O_D'=%KH?IOSV<407_UO@Q&#L:
MJ' 9,:0MD4B L+N($W:BOT[KF0=;P6@>B)>S0*W\UA/T>LVI5V5C]<6R-8S@
MEYNAA)#=3EM3G2Y"A#$:33RU^:?:P?D'KIDR/F;7>RHJNB1UWGXV;F9N9A0V
M5)R <;W"/*C9O?O=.% E5-6&V9)%D2)1BW9KOX:HLV/\W9P\FX-/2LM4;>EO
MRGU90L+1$2WWJJ4QR*M0C.8/*0B#0N1SPM- .3FG-%D7[33^*;E(^ZM!I*V+
MT1N0U=N:3^8]YC@_,0'8BGO(('#8QF&W^XIPXTLXP&8Z9@QMT7>7I\8A)KLJ
M4 [E Y+>%W.14,HL"MVP8*1OJC@TJ49NQ7M$E(03?*66[[X/3=N=V,6#/BO?
MYX)GZ/"H-L8VO/;D"5=&^<[;:&IYRB3.'"53&4HK-EGW!OZ^;_)S77([P5_J
M\S>U6=[^YWNH]$'_+#V$WX%J:7E_D?]ZIEGF!5XW!D_,RS191SC@[#.T&1;4
M^@3&$)(?6.NPG+,#G7S'95*RFB2AKWT-GT#12CX<\'D41N#?A;AQ>D=T+?F
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MH3I;R&*/*/P+H";^]A ^4 3'_I8"(SI)-C57-_(F]2T!QW?[-AH[6[%T:X'
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M-L.J_?[28E%*[,MXG@JAP9YW6?I3%J!GLZ#BG.2LHT(X4DX:G>]<557L2M]
MFQ(I2XH25.;Z?RW6[53ZCJZ0=O_J2@FFI4LK75H:;U9]/^]EPGIVX]I5KP,S
MBVX[Z.;EZ[TKKS2[=M![0P"W6>14!TF9259="PL?<V>4'+FB=+G4>G:A]$EC
M9Z[_#(M;DM;O+^:?Z;5!:Z>-G):]\(_$TEYG_RMAA_WV3[J8TG'KE?;OE8+?
MYCS/SDT(27AK(Z2M'?2A;W-ERC0!:6YKMLT5ODM[CVS;Z*AM/.EA<N"S)LFB
M-2$IPGT>"U5X3[Q0_6@BG_=;=VKONP6!RI,R=0.YCJP_-7EGHTI?P8(Y96OF
M&A^]Y%Y<*;:4]?&A75NF>58H.XI$UFY<^,3P2>,.34EEM64;+GQ=*_8MTN0_
MPYN?B_=T,18^/_$J:9+%D=0IK-8'0V6$]O3MN9S^8>^;76*+DS;=_KG=:M=]
M19W;+DD/50\^?I\;9&O<5WUQ0?6Q;RM7VLV52;.U^O;+DY/)VB7(C<U3=69(
MG?J\FVOF__#5>?9;ZD;FK]X_T\OF9_?J/G9P27CP[MXI1O:>])>S9A^9E;9V
MQ=D4'3VF6POKMQS^ME.W9^:Q2RH]8C\+[FL<*[Z2M.)']J'MLU2OS?GLS]*9
MO6SO;-$TU1FG9.3<??B>6WY][1EUX/;.K.?'P@I>%KR:<..5>1A_CMZ3'6V"
MFR1V3[MS>&*3U[H(QDL+NH\\NW]D5NO6RYZJBV-O1T<;*;WM."GV(.)#073/
MY].,$<8_I(\89RB[9__@W7CYUAVM.%^NHYKZT[2Z;"XX:QP68+.2F7/_6HER
M\H(?BUY]J[AFN?;A-/9NG9,JABN"FZS>![A97=[B6BFV=;^$;VXYBU3:[/+R
M[<'>FG=M%JPIR]?8?2?E$UL%0_-YG_O3CV[;&.LI'7%?0F&JPLY='&T:*CF)
M$>].'GMZ,L#AO-KFX^VFHA_.]4WX.W.K=?;1*WHLYTY,.G5[EN,.-N7I%@^^
M,"V(9]L3=?;LQ8M[;*OTUK5>CKE[?%<&)W/5^A/E/4TATV+2^DML'V]?U*7%
M2^PL+34Q__^; %!+ P04    "  (.E=6[05M<Y55  "]9   $P   &EM9S(U
M-#$Y,S0V,U\S-"YJ<&?$O&587-O6)EIX\*#!W=U= @0/[A3N3G"70"!H80$2
MW-VIPB6XNP9W#>Y^V:?[]-WGZ_Z^VW?O\W3/>MX_:ZUGU1ISC/F.=\RQJE[F
M7]8 ;^6D9*4 4-   -3K!_"R")  O(&'1X"'>X. @("(^ 8)!1L5!1D9!1\3
M"QV;F("4A)B B(B,BH66C(*)DHB(CI>>B8V=BXN+E)9?F(]#B(63B^./FT A
M(B*B(*/@H:+B<9 3D7/\_QXO/P$8;Z!9H1%@H"@ T!A0,!A0+]T TM?GA(/Z
MQP#\]P$%#0,+!X_P!A$)^?4"R%L -!0,##0L#!P<+.SK6;_7\P!8##A,<G8Q
M>"P58P0*)VR.SW'9;RC%JSMP5"=.J3A-G(,0D7#?X>$34-/0TM$S<''S\/+Q
M"TA\D)22EI&54U/7T-32UM$U-3.WL+2RMG%Q=7/W\/3R#OX2$OHU+#PB/N%;
M8E+R]Q\I.;EY^06%1<4E-;5@2%U]0V-39U=W3V]?_\#@Y-3TS.S<_*^%]8W-
MK>V=W;W]@[/SB\NKZYO;N_L_[(("P$#]<_PO[<)XM0L:%A8&%N$/NZ"@/?ZX
M  ,6CIP='E-,!<'8"8N"X_,;;/&X[.H.1$I.U5,<$^<))%PJKG7JLS],^X=E
M_WN&!?TER_Z'8?^O70L %!BH5^?!8 !$ 3?W=#F!2/\9Z/$3WS97::C$R_Z$
MKIKKS<"S;:^I#..:$G&J/6*<NR@TYHEKEK2P)2&?=$6VJN &[I4;_ZB3.DEC
M[_7L@U@SPBL/.K_IY_KJ9)43 :#[,\H.HWWD(#-KDY;3S)O3+/![Y;].CX6_
MK@4P3&1!1] 3SW)9NB.5<,CNP0&8<0+;^$]+V9 WF-D2IIZH WKKRBO*3\AT
MCBPC/(%Y<7SFHF&%%E]2S, JDN0AV"KOX?X 3CIN:[Y2V4AN3Q&P+1?I)'Y>
M=#07M!KV>"CU:EK)W'U(1K+5C<<-.Q"8#96?&%0T\'/K81PNA8$0V.QSJ'U<
M;B&;E>A!%5>G\;6(FQN K2+YWZ#!K*55-<%$\J#:)&^K3L85DP:MB""7,7N
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M68=,0C[(:9^ZC E=Y665%RLZW!.7W_2D"W093H,E\@^P5A?X0'3E4\.\J*L
MUSX#FQ? %Q&*^=M2U:;)C-Y#A>FCWAU((YY)BR7))F60X!SUVKCHNM]MV5I
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MYE?5APF,6-AM.%(=4VTEQ*.Y)!SJOP"ZTJ''NMK>/5"'5J3DUXZ>,YU]!I-
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M+Q =OC$/2CI1.2T!V'A+8@EC=+%D@Q55A)JU(Y2P]@S1KHCESH\J'%GB%RQ
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MD,5MK>GPIQDL@I'[&ZV,?PMJW0QO[R9? (>_ _90=3522UX ?:/)+P!#TQ?
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M!VN6M'Y-?$JWW8+7]OUVWN6&_#GJ8:-,-:8SHOBL73DG@B'L'R85%HA1M_X
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M1'=TEK":<HBDBY+_SE^_A#/"(6'M2'RHTY^Z6L88_#PE"U>03K0C<U1+LN1
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MGFW6XNBI5H=]Y=Y7284E.AWV ;;KFN&P-K$4JY(UZK[5=U\!@0BDY5X>'2\
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M*7"/;V _HJOOPHW;#N-]$+8Y#4U@)!V,LD.14^YX']>9^@5XZ/EL.%)9\B/
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M]@\.CXXOKZYO;N_N'_X^_@<7'  ![O^T_X^X</[A@D=$1$!$_@\N.'B/_W3
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MN+=G)]O\69#%J,'.2IKD GOK\O[*\*!NBFCQ'R9]P^ZGAVKZYP^M%WZXGE#
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ML$)<^N;GH;!= DY9%HWAJSUBXXAP"X\:+I)43S?*LM+%FPPF*M":E[)V$>T
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M3.?TE?@[JQ<'KY6-A\_4P\]C#G5\ DJ,P1,F4IZ23FO&?77O/P_##9[%73X
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MJH!"I"^ =O/D1^\:3P-UJ4"'EPE)" [JGLL^!;KY(9]S>;@$*GJ@;E.588%
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MT=YY!Z(*+F+>L2K^3@,%^''\%JZ">Y,B?:H>WED9!!_U%^BB3&$D[<;I3(3
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M!^O!$>OA J%=5Z"4K*![P)USAC(;/H H3[0JY W::6 #9AD8ZO+E$W&"J;Y
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M3')SM0>IAF;\DGVL.;Q*F]TO0H,L0P"(Y,L8/30WT5NI9.%[ +%Q2TB,7?'
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MRU_=GL16)LI<(Y5M("ORWR-V]X M]6Q/7>S>#/^XC0<5HWOA1Z/9CL&WJ?<
M/#^XUR$/1Q[ !^>)A^9@MJCP'OV0QHF8\^K4=#/%F,6Q".Z9\H?)J*HJZZ2F
MWT#Z5M$U[^MH>,-1C*$Q@YJ5MUB5IVC4>Y?@4+(ZZ7 !_TV2*X\JPSJVX26:
MS5B'Z(F&":\;$^](<3NV=OS;_A/!''JNGLFRM6TC?^>+D_&6WX//PDS3;Z6!
M2<V74:5SG><)F+5M>7EK8;BG@]&_T/ $Z_*T$[S>J#G1,>?3Y_,DH]NCCMHX
MUDGC%4/KCS63IH+9DRT^"EMUT__%2[46_-GS&F&XB\55E!+;W/ZN _B6BYV
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MF )-W(!(6^3D[_9ZF<FJP3B>Y<"A 5$YQ8]A-VE^&?C5L<2//DA![JE6NT(
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M!)W'8<.3WG39YAJL#@7[W/4UO)UQG/=5>^B&1XRF86Z&QJ^I(&4@CK(H[#]
MW T"D*E"@#GN%S6N?SKY#)7XKV^4#[$[VR]HS$5NT ,@@$2YS917F, K!FE#
M"1PEJ/]=T+W]YQ=!>U:9YT5/OH80X%=D\DM"GX) F Y'3F[8.Q3ZW##@W^'"
MJQU#\\YH4[+*I_@YAWE[*C>4B)?H4\.@PT7 GJ4[5?OY;M3ZW#'3B35G&_NH
MIHU9LSCQ&$<I2N!AK>VH3]O=-1'#?<C6I3!HDJD</OC+67U=R>%L0ZC#Y;Z]
MQ<&"PUOQO.\#I&ANWQ(+-K165OO(&*H;K!JM6=>"!.X-IWXOQM>@^N=[F%GL
M.8TJ%GBY.+IE0E4W3E>RVKCH&2CPE/\^8&0L#V4T(J0(\/>19$B8N::<LC!W
MQ/ME#JZ,:D5SWL)O_JBM6PH]1";5CQ2Y0.Z.>3\MS#K'RN)B@&DN0^)IKV/'
ML()06]^8I@R++DG"$ 7G]0WWH%D]T237PO7!-@LA:!9VD0@ZW>UP*3X^M4EU
MK%@WE8S6A/6&=L[7941[Q74R9S*R*>;#I <VAKVLKW0_Q3>R&1SPMYP-4KH-
M]GU7#:4!%P<;0:4!Q,CM"),HG,O^75(%G\.EGT7'L$=/8S1G+1;:8Z%7[[!U
M9D]9.:]\8F2*RF2LD;[D1V!\<3WP\IQM_X,JC.#-R#6D3:4G=/68;WZV90:=
MV<8X09^_[?(U@>G$/I,O,O\<Y,\6F& PT )-@1I0;FR1A7ZM \+O,;0?7,&<
MJDA3KHZVYTNLJF?G7T?;A "'E2JY<6FR'6MI+8*TG$.'68 <IVN\KIC91G!S
M2_UGVH+O9/9M#Q @74,&][@][(5VW[/>STYDWIK)5&ZHL,$\L>$=,ODPG+3@
MYA/C],_"'5J%/O\T/(.%>B;M6*>;C">IR]UC&+,YWLU]O4^WO]PU-O1SR@[/
M%&^('Q%41H^_6*@A^1*))& A"D* A\-I\[QTH8QHQ):).MP[B4K=<,2-AJ:9
MET4K2R/*3=_FRX9?-U<[S5Z'CZR8WA_/6/),B$>,!SR"XN!T,3*D#?NH _2S
M)$C6C\;PIIU]Q%72-GR"4E#\+8SKXG@G'':,F#H\XZ >7KCL_AP7'))1GKUP
ME3L>7"JH&-7'*VK&S6UU2GT)@(8F5;2\/J#?13<KWGJ!%\OW%IB[UG0V;FF7
M:TG"K-6R$.WHW*0Q$O2Q(I>?9JFK)'9G@0#'7_>I/53$; JY:KD#7ZN\SR3/
MFYT/1BMM?\*\'W_=>#%FPA=9\1L+(YSKA\PZC94<$ 4.NY[WF8_M5%&P$*!X
M%V6V?N-JW_!"E>O\37)6&4:E_+8H7X<V<<D8 I1)R><H5LR*E'L*^ZT?LJ*"
MEQ;G:PM86/2WGV:7W.HYHN!)E,O=/<<,XCI6.7L%& .;I!-_11W>NJ$XPA>0
M'&S<V*Z8L$*;LZZO(BZ %>,]*'CPK3UKQX;,]J?.*I"[SP97Z.Z^?[05-W<(
MI%2D,]_7[Y203<P8M&^NVO*L*TK,]68UMZGGUP6?O"-#VL9W=9BB*W<3%AI_
M>R[B[R+_=L&W,97BZT '2SX;>2C!DU5>;C!S4)Y5IE'>DVK-K_'CVF=5Z9F-
M.>9<3?T>IN54*>7HA*O./L^:<Y^"MCM5!ZK%3W'2XWR!R2PI7^Q%QZC:\,+X
M$D]B'%NT:L@>9>,USX[4E0]X4KW8);T?>1:H-N&!S7;9[2>YRH&SQ3]5.E).
MH#)+#92-%9UJ8^I"K7YR%T?> ZMQ^OPL>ZNJ+3*BIJDZ5C3W@$\3)Y6V3\H_
M%X:X>HY[6B1VA=EP91ZS;3O([BM\K*^LVJ#%)[WY<O5UW'\CKE\6/'+TGO&_
M"MZ") +W</6B$I1;F1YMBKLKC!DE<=>T:6;\)8+YIHJ$/+G.DPL7$;P3J9<W
MD*P:W44F=)Y.%%FW\ZQ%Y86)VC*PNXY Z1K5Q+L[/LL=;WZ\/A:D+&_;9YO'
M<N4^1LYW@.J5B*N[Y27",<ATI'0WM&'$E0V>=?C^5AC-T-KOFG?$:']BI,A"
M!-WE^<.LQU4:@IF<;Q4^&P<6[J!?NO-NO7#B\97R*-GPN;PHJ4FKQP8J^Z3[
M57@&\Y<HR>]]-RFBA"8J4+Q;9J2'=FH35PB_\>\\[%)]F*AT/B6K)Q4,J\*,
MW@/P$?'IMUP'.'^AV7@A.0#7EQ<=H!?S+XOCC@[9B.H0H(*-3A-YGR# GQ99
M^F+;H]JRLO\2S/Z?"6KBSK(+HV*=F%4P/@R609<O@D40H,+FJ42_IVM#2B#O
MSDRV:8*)Y6V06Y*.^_+\LMP0+DQ6FP9H'6NB?7?%[@DI&0*$E>J30X!8)SD(
M4"G=?@6E)FA 4^5N:^:W)0,S#DS$H:'THRM:SSH4H:GES!G@AZ@9)ZR<EN*_
M8#(3O_CL0(".8M!=B<B_8*QD;8G7G6KE, '9VJI+^3]X)+(8)U90@TL;@QXC
M6AH WGOW2K$LI7,4[OH/!,RJ8[',>2N?(A8Z+Q4_H>:\Z"LXC&C4!!N;70]+
M/3TEKPQ!@+-0\]7+4YX7V->;[%$3*]"V$*:;?.FN[GTKT^T[>D(,Y="%K<=E
M9$E^P;'7?J(+VF-4I9=@+%B\Y,H++>?C';4IE7.% (EIG,H2EO9_>PRX0WKN
MI_*UY\]%W\G>R2]W"YNEO]_.P^BFO*64J2C\UWVB#'4G.59%O=%N;*'&-F'2
M@NEX?5OY+[@I1INHZ$I6+O['?DTQ$N@9,+$>49]_(3=)?E-[Z\M#_Y/IE/GT
M.&EG5HR&21H%7A<+_0!5AJ88*^X('F:SJ4\7[0IX8. MC#*?_6A=2N^0B8:N
M@"ZKRF0H3H@/@X7FZ2>*GIL7Y%Y!(9,32Q,F@1)51.FW)U8$K\Z+@MAKCVX)
MN/Q#@YQ6."% #(K(#68U!)C\<9A3X?7/"VZ\)^^L1X/"Z//9<L,^?+BF\#&'
M,B\LS7N>57\@F?H)Y(;1_P^ 7<@<R(V(UOZ__Y[XKVK^WX7_KCG4%25T$7SA
M&&6D^Q>KL-"' ,7DIZJOMH'YW @!QM[?3VOP%)33$<._;P 9*4W108!HB_;#
M-!"U3"+I>"KNO@&Z1<"7C=G7:'2$U'ZS =K^\71(_/%5H'!I$$"_"K1'51F5
MQ_7^3KD M#$T\_(:6< R.PCG9)?I;\_C#_W4=KWD]H]9:")IO"Q08MB'.FP*
M9#8K420<\+5-<QR$%EFR>!O=+.)4?&T($V+*GS<3"'#+\_:_*92QPH;6AP_]
MZ$:"I2_K+\E'"[:TI5Y-S:,N>W2  )E&EV6EA[DKU!.+7]9M!2! =9UEC9W(
MED@^J.5U.)OYT\UC.X>W2.\S+03(KW$[[GOQB!Z-;B"_WQ'A+Y90]BM&R;0V
M/(^X*69 5KR[)5=5'8>/MB1'$]3S !5;G1_4GQ_8E/;YV)CY&KTC'R+;?]](
M&A@$CWOHAL]H84([O.[?';A$P>1.2 $U6_B3%6M#Y]UF78IAH_F\%"/+6F04
M(NGYOBBA60\>8][0SP'<Z:_O ELZSK\J4U+ +AZXL7H[:?/;YMF56HP;@#DX
ML2NVF!I%0BJL7C"+B\YR+2X,-%NM*!KC5+$YW5#*"%(<^^RM29<>G'L9$*^:
M.&G.TNT/\&$*]AI<PC[$]$=4<W.;$1  G@ ]=/W?U1 :NQNL-EIN88-;/S(Q
M:FRS"TVF4WEIJ'FZUD0[Y>S%W=QH5_-T,43;)7W63P4N)Q1BN^-:F! EH9^X
MUF/\PR9T?#3B@8#TI18"J--X(+"P\9#1"&+[S=7);["B6O*DS@3V9A'Q^L,&
MCV9:!P+IVPX9\WN#3IEH$JX)2O#Q+.$N'N5#>3XI^L=4#@[.6IWTZA0_%=XW
M^$/![)*XE3X$^]>93F\^TM;]K(W:DD'4>G/O<-^3PB9&S>".[#=--K/_60D^
M76I=R,&Y9XJZML$?G0GKT,DW7Z=61Q2ZQ7OA2K@NK]!=X5+Q/*1- G.^5[-7
M>1J=J?<G52\/!@)=?-2S57V97#2!.5Z-',I#N@S-)[7IH'OI0[ O]UX%S\>[
M@G5F3\2"NNDP!..+>7GL=\+?'<;G5 U_:ENZYAX,FJ3BT<#K;E)7:@,U_Y.*
MAJ%M.]VMBLD1ZTUS8P>IV)AGE03PM2+<ZNMXV3<C1%JH@(8OQ).EEN#,R#S+
MI"2W6(1)][<9)Z0W^>_(EI)H;EE@;?1>TX*ZU\C4!0'$++O.T0/*GR1\;M+"
MFZC)3?%6M+.I[3)((N?FAI"O.*$RO#99D<!+FE(X50K)DBI33-]IWN$_]!H=
M26\T"RCG&\CP:]>J<J)@Z44IS#(0H$" YHX7JBK*,ROP(7Y#L7V-E""^KP1%
MKW%CK.8N^9\W# ^S6=^=<<]6@YB<IX(R>1.69%K<4EC@=L:^N9-U*,%%W[@4
M/9V3I^0]\D^]N$</SY30OZG\>U])<K-WGMF\C0UY!000UM#U- )FRW&@!K4+
MJ]R<D-]F%##G#M%HP"Q)Z]K8-!DDD\1XSHD_9UA  $&I'4M4XA<A6Y'#$] S
MP4R>*$[!U#$,RT=J2D6G?67YKW,WKEGM]+B.\Z,ZC%'9T=KM/ ^A(LLB@[D-
M<;Q'Y;?-%48$2PY@7XXODR\C@FQC3K2#3:8"HW#V FC763\/B7R20\NOZ*\N
MA89CPD,1,XP6,+^V^'Y%CO67UO?U\M,YV:>]KI)4AW:G(;G!C2V]^WRHO9UX
M/?-(;,6G[FXS"X,2Q^*!M6D/'Q%U=Y6-E/2-X2QP)\/*N^%7#^I2),X;%;7T
MH,6.JP&2JRW/&8M6O?7S_(H<$S,7+VP#G^\>RNGPEV]L:<[P:9Q6N4C;NZ(9
MCY >EKMZ;'!;6?QAR!S%WB=""8D.=!F=?B%[G8WMR,E(^I;989)1[K0>SLKD
MZUW\L)JM%X_JBB^_W=&AXOV&"(?4W^5=^ED)UN#O?9J> 4-F):W"ZK&D.:':
MW$VMYENF \L7:^=36>7.,VLBI&6SFSV>7L1#T@A5T-A\*M_<]GTM\\C,OIJQ
MJ#E[*B17@ ^((@O2I KRDS%37&DW.6Q0&Z*38:L]39O;_T["@-D=6E[SA6+/
M$0)8: [4[XNXQE7197;9:3_\3M\<[$%T8DR92^*>T!JBDJB;D8'![BPG*@>]
MAB1L"-!HQ;)Q:8#5SWQD9(S6R7,FO4MXWY+^#29SOOA="Q&[&,Y#.**1QAO*
MR"[>K5F<U)&60WP\=2+DE4XSAAXOYR N:4U?::@0EL\8"OQF31OUG+?-<8YS
ML65.!$%JH!6[R]GJY#^W2:EUSRO)%6-F=C[O&I,6C_8I+L-@F0B;@'49LKR?
M(Y31=ACN,C:S3CY%/S)B<9/AG7B7LHU^\]V06@F+X%K$R1MB[=7P+-816G]U
MB< ATV%/-MWC^!7#/^4, 8)#\\;,WB:7+HG=:!7$PL32!%OG"$[$+Z?PV!XW
M1B5^18<=L'3F#%!W@$MVH!U+&F<DS'=\#.7;#"5 ><T?G-LQ]E,+J^O?%1"L
M99AR)W_"*.^+6Z?I(/&+[_6,LLI_A"UZ>I2  -Y(G>."I&C!WUB$E[F&[6FJ
MM#X>9.OT49\ZQ YAB1(*!<\V6P*5-\B*]S?A+W>X*I.#X@[NK$Q'29CT>(64
M2>8W409"MV9%UNH9.% &1WA9E\?XSV?T_XG]U0\IM=0VA.&ZKT5J2O]@:!1Q
M5_=.M6WMN3GXB<CT^:B7W7US,:O"IU0; KP(!3\[1T, <5S3C.Z9X5(=;H\,
M5IVQ6&JQ]$SAV]WK,H=RL-S/92FK/$7N#!-&<;>?'B55W0?L=RJ+/U@_B!Y.
M\7)-OA*E),ZZI88 "Z59T7\TZMV(?*=:Q1RL3#R8:IY_B!'_V(X_Q?W*$1'7
MX2J\I$(H8*6/IT@# <RUR?F54;R,F=OZ4?VB6MEWIZBY LDCG4/IZB(L5+^J
M1\AZS\"]9RK'^?B.SSN!YI@$J:G 6T0>:6/@*D/=R[T<3U.%.]3@%HLWIE#1
MI^-IV=YAGJBNZ(ZH=_!0(M-">.HYUFIK$3Y4;'5%95FFUYX?)7[6EP<"U)2+
M[(8\C9 OS&9==G\S+5<6Q07]O>_SKU^QDZ &L$[O'S>,$&-35+QO*DX3(0>,
MZF% Z3]<F/G+Z&N0S*2^Y+(, W)HR_ N%P5EZB(::;"G+$I[_"/B@&LN_<-G
MD\IG5_('Y,_:2<EHA56(^8G>]4S<W!S7UQ#@>ARH_Z6KNU1;W!H,8"G*E^IF
MS$4\"5GEMVWJ9 E5&#<TU%Z*>-BKV-%77W8P+\WI%74D_7$W&IVVAU-07-+>
MHKBSP$%%JJAQV3+%:XP>4ES]L6L1I%/B/^H(KX\*6.@>OA '#:DVUAMZ/SC&
M"^*EQ(E-VW,<((R)!<1WENNQ"PC)R=:TZZAB-/F]11B)RTD@(2%KG>.S.[L"
M[^/7*UMQ>,0O1/*_ \,,<W=4S0/K/T[XC,9D#YT7)7]-,=N0&7!EAQI=<L,N
M^T6L.6=#_SU 3/R'AY_!@=+X>^<L\X/^ C3%E#49-4-O2G,,>8J__S=%SWW&
M77F#3?)0I@JS29.@/WL+*S&V-)&)^9@#L3%H\*(,>?C,H0G3;D+MLM6_8RM
M=;6/]&\&/Y*;9JPZNC+'L%G)_1W]'-19^\;;@LWP<DG&1QU-V!+J=[YLHQN>
M6UFR5ZGRG$=]A.\8<Z,7<AO:&R[B;=?N.P6O2F>T[>X@0/V#R 6N:<R?__&.
M'Z:P310HLNO(?RU"M6;@-'V%]MMZ2(.>,UGO=^I0ES"1^?HEQI)6!PLO-UZU
M)?Q^FL=)TGH7:DY8Q^VFV L?/127$X%*F'0*46)L@0H"C,/*_5S2V3^C"5HH
M]*#1S MCXQ$@"XB#+]Z=S!M_&^'N] EV3L0XO/WQ34:QV$V7Y=ER'T[2):+D
MU4KY12)%1-2P1P%Z(+[!7?6U"=0&,EYZ)VG$*4.+%%6@\J\*.>/X*#CT)P3/
MJ8*Y,B/N@WH>M%N\?4%9#-3%$"A'!8Y1Q2^PGPU0[R55T4IX/KV]U)8.P)HL
M"3+L[QP,N-K(SQ+S^NXW6H2E*X[TH2SF*1M8BREH7K_;]<_]V;]8:V6UR,N2
M&XTY'$X51,!++3CK\O0^&FNO@Z)3)_H9UDIE]>BF?D*GCV(!"T8WL^.+NFD.
MDUDW^#T:&]YF^R.CJM!OJTN>+F^[28,'.:Z7,?RG2VWAOQT%[]IW<U^</<Y!
M8Q)/!Q'P)24L.( 0+#-5=>-@C-3/@FP84R3V;J@#R\+26@O\M'+C%@/:2SO"
M+KG.>ZFF?=W5;G/UW0\-?KMAE+3]P"A!3XL59KL==6R,O:3HB+GYH(TW02&S
M AS5.U+;>6P<#R90R*[E%:$0GB^?1>WBP!.:C4WMXI!ITK5M!;-1+1(6VV$3
M=40Z#XGOMQN"S70U/[@\JR)WAI4-, &5W#;:=]Q8A0%7[SP&87WI,7@_C9QS
MVN7@@*)IEK=>Q62F48,6E$BCP8$>N/#(Z9D!VWU.:H6SR:K59X)QTI-+RTL]
M M*_?DD*RYWL$I!DP@)N"7_?\/$/P$5I<!UGTZJ@B@SI1ULCGRVL4)?'EIT5
M-"G.D%.H:WT/7OS.T4UN_O;3IA ]=,[+1!4$R!H"/3ZT;TJ#$T/4WUXL^2+R
MQI Q<KQ@5"*_:EI; 0188P %&M\EKV<%UYVB+^_7-_MD9@AV6#?[+XA+BL'7
M\V["9UY!I9TU=/\FG+[*4*L-^5HE,4UKIB$1[FY*B_Y\Z7<<=BI2:PW:O5A]
M>:F\FTNY<YWKG/W&8!!\O-Y_4NG\2.LV35?[Z9,H3'ROQ_+<6<7FOQ$'+$'F
M\Z^5Z';[\[/!>2G%EK$&^88B_)TE.O+!9$_V?C&5UO#@D+5O,8(TQ4:S/%T&
M6=]+V^8K @E ]U\K^?^R=::(M.<?6V<T&#?"(ZT/7-6)F)<PN8;9F5HRQ/_P
M]*7X4N^ "WRA6]!FS"3Q4RL#;5# 08^^1ZB#;+3^3= "]LA?4#8C=C)JFP3!
M\_.O[D#+"@+H!;_XSYA6,=<NE-%^'_*B[=T/@C:##KJFVQ,*]ES,5_GGQ1&.
M6KN[Z]="N[() EP9J4=^W4_&[N-?+$^/$V?NF1+J^()'1<,+X\(WL+^O\QD8
M:)^6>=E_4?L@STTJ^6?"S PIC "6.CZZR+;NF]TU%J@9E*@NU\C,9#-\ 8-*
MT.NU[@@2-8=3JYT\KFTI=3_N,FS(^K'[J]QR3&?(JV71":;DT2T@.KL<">H_
MU@^\SQ]%0?W+A1!@+N35CT4;B,_%/:G=.56X#QG4M$V._ PB5L;VF,05:'A_
M)1126CB95.BBZE MZ+8^"0%Z>L>)T\-KR<M]/ R$[\C7I4*.!&7RK53J8NO\
M71+_#,O9P$^1S5SAJJFGC:>^M[!4GQ;9(A=Y#"J;>97:/?S8RWK985J&@UY/
M7;X"=*/>TAN.BZRVU:(=GU(.]1'*U^0!_[4&8GP:T2Q;%CK)3Z_;LHSW$*=\
MS?<J+\L9Q/_]_\F,!J"^7Z\38B' WM?J_-DZ3HLW^UC2.#$%;J@=9/Q1KRKR
M$#;3_NK"7VLVO=>D9+Q'J_"MV?Z4C.#D$),DG?GF8-8=_N;];*!Z^,L''I$3
MJ=>40"WUO]+1 _UG<5:C5M$^^YHNS;WBS*[CW[E8&5&K>*O915K:TM1K3P_%
M_#JT#)I3?ATMURRI=Z2I=*"Q)B02%8.O[*^S_$^\]]#=<1;B/42_O.3^0 #K
M- >=1"!C-WO!P&"N5Y\. L16:KXJS4+[%8>.\G+Z77"ND-,:\4+=2\.-IEG$
MO;+MI0EZIDXASM>VWE;\&W<8 RN_*,5$?)%PC;;/G^\BWWDCE/,\@19]R.^1
M:M1>'W;THUW>JWS5+5'_QWM;M37:#^ ?9]+^;7DI9(1 R6'4XC7210P:0X#S
M8YYG)[LMR]MYG1=/],'<IFJ3VO13$LGEMLBWG]TD]4,A  4JSTO;U[\,5Z9X
MJ2TIV<D)*R@1^]:P&8\.^2%694]=HE6H,&,S3;,%](MAN3<%=1A+S-[(/=UP
M(ACF<]^Z9"($"&?5N$^O?0@JPJMX^.1F+\- @#%J2+A,2?'4U#>(FW:NS5*G
MI\#,3_Q#P[-N./8^%\4?Q@\#,ROA_=C(L1[4V4KF($8G8N<2+]^H4_JND)2V
M\3?RR37ZB7SD[6&];U\_]/N$]CJ!?_9G^**([J&:ZH/Z0=(0P/75V8AJ+SUB
MTD2S&;ML5)^6R]Y%2^EM)C8>OPQ.C]FUO(:MI[^%+69E]9<_JY?CWS[[!+;O
M9C^51""6BVPN^<@K*G>1)Q)\< J+\^5K)_AC:V/-[%W8I%7A7Y<Z/$'L5Q?%
M4RGZOB63-Z]KF/9,$&0!KVS (F$NS2*-TC4H<*8982W0'#LBM?F#I8(S!&NT
MURK%^[PNVU2+RB:?$4X%*2(V?C\U6;PN502&N6QK/ZI*-LB8F!!.$]&^>SWD
M?E1FZU(49<J.>6-B)TWQ[#31">;8>M;>PPA->OD2NL&.(O[X@"%C)P>NU'"=
M<4CS$YM,<>%\"+0M=8)1U/L^&(>PK_/[%W<H/>AARIR)JLTWF$05XUT4L7V\
M%+<"T9YZZH-3PV>!8!G<Z:I5&@<]JI*@B![*^P]/V<[[HJ0%.-A^J9NUJQAW
MI>I3V>VU9R\9-QYSWM],<SOK=R.B60-$B;3[0IT?;;31T?I*Q2PJ]'OU%VA"
M^GE/1#MVX8'8= WBC4.#4#P>5\_>Q U4?B\!8V&3IN_=<348V9CQC211CN_#
MJBK=C33.46]O(N<":[NG9\%RYI74,[J"LAT1?MMKL?'^GJ:MI4H0X'NX])U/
MR9W(Y]"K12'N$W:N=X4QB"D_8D+>9!Q\.X,FZ)4'O. #X;OEGFE-SV%WLHKT
M[H=ST:L1"6/<:(3A01W0>CWEVW5'DCHZ/VRI43ZW*A 8NQ"2'OZ9DCC?#7O2
MR3>0LT&<=':GYJZAW4=T+Y 2_@(3M_RB'"7A*HQZ-MNV9L/B(R([;KWRKI!#
M0+&DAB0&#OZD&8 %/.5Q1\!6VA=6>.J>%;%F=K@++EI?6MEC!@N:8.%)R*XG
ME:!T\YMW$O/NAE2)$I_P"N5T'/TU%ANAWSKHZ1EJ4[5'N-@,%CWC+?Z\3?(E
MA@"([4$B>P)&$  D =_[@@_$5\RO.;W4JN_&OR93BH];JL:A,-;J.*:=?V+@
M% L 1WZ>[E78PP]>I7KJ")D\%S]&?^NPO98(:N6*=_)/[U]]WB+YXP,C]/IW
M[:(;VT*N:*3Y/04[PKPH,$6NDF<<NU-4RIY5R\6K76>^IOW>8<"6H-0F*^K8
MNH\V?5WIV]BC'35E^@%:A#?--G21_Q&Z5<X_*D<C6M%(ICRB0( _(HV6)_&O
M'L**_.'VM085PX%R;#HE O7#D3\B+(#V/[F,SPEM*MX#KR[8D)CU^5U4NAM.
MO9FX!(X*X4X6IO65YO4SOU>+/!IC^ ^398\2_'G7(RC7'$+!,T51A%.]K,!6
MO_5P*.M99H1H)&N<,ACCYPX9WI>F,CO2_IB"].H,&R-B/Q]N=R,E!3:2?BGA
M'[?ET4A2/OB!1]@JE\*S&,F7N@)K58R-41P19B1J[8&$!:<U'T[_4=>II9:[
MO53/O;2@/\.6C(AE*TO@ '^!1J@WJ+6Y-DWL46AX_$3K<KM)]R(S\;AN(XN<
MB>6T</SW$+1<E>ER;12?HG8S"(NC]$R 3";;,M7O'"TUZ&&K5*\O=J<>3=>L
MS2?2@&Q/&Z^8/.1J@6Q4J=0)4[ "6.$[-#!4FUW&%!,0B$A[_IAUDK6MMED?
MMC,X+]OBGTT=Q^:ZV5#%]?7O68-RO%*PXM2Q_I=MO3>1V2Z+6?N::6%)KK,:
MKOLV2!^+/"@E!9#&R]*$5%8_-_O+V:]KN-_/D09:*2'0ERU[ZI@[IV@?0/.#
M4+1Z=P[@O!P98VKB/V1JQ-U^<I^T,O?[_OY+G/=BQWU;QYBW$KX0@-&!(0:?
M@U,G+O'X9N^FRL)/?92^VR&;;Q[HG3H1.G@&<"4A@)R\Z';%Z9=[60B0-SKQ
M(NA6.JT$!Q>_3HQ*I+E=US2-G&]!R+[<<OIY=+PCG:SHLOR!/AL)'/P4L L!
M[&=2RW^"^H5!MZBFNF,;L*G_J[RWC(IKZ=I%%ZX!@KN[!:=Q2- 0-$B@<8?&
MW36X0X#@[A82W"'!$]R"N[L$AT/VWN_>R3O>[YSOG''&N'?<^V/UZ*ZU5LVJ
M6;.JGCFKZFDQ*P@*N3,R&(9I<''E&KU (:N ]IO8KX!B7ZABP=[FZ:,G;?3L
MYILF5] _N%J'YEC@RP)-[3%M=M[VL<P/GD!L&9+/DI_ID:A0V>R]&/(60I3C
MPIJ$:L..GP63\AVC?5H-<8R40(RD,$GB%'AZ@EF82+X6]F.&\(.D3&E.S<6M
M!_KU-ME]$&-9RGTJ%BAN*?OY"VM)_!Z=^8\B[&J5;:O3/E./T\H9^RM"M0QX
MX1YXH6'2JRR2ZR>?,@12&]9#ZQC$]_V%+V"=2R?D9[B"3EQ7)<3?K$*IZ*&W
MJ/^S?8:1P5K/3U:.RZZ(W'@:*KY]5WFJ7Q?K\" Z^KS)T([BK18T1@8\0%GR
M=,.9TD%1W71"?R(*QT^X.UU7\!9UW*;BUL$YB5=9EFQ:*]!P^/#E-6&H5,*T
M;5Q<XV]P!US*!)Y0;?"C0;1O"F;T$MN7<?K'UF4DP*!1NOHH;N1P<@!MD7*B
MI-+FOG7WOO'1W;/H @QV7^^PS\V$DRB\JI9;&DP*T0ASZ%\.YNO1]8;P]RA.
MU,!^2'9J810:@Q&$1D\>H\91UEK*X.M2.[:C4M7"%+%/%R[7T 2S3["(44?S
M"S\ ^V%(K85YCV@>&V>3<"K $XMK]"47@U&31[YYLEX]'[Q8\[7C_-A1I51.
MBI4E;?S<2BN9>0K-._>(%).,Q$]W.=)&[)^Y]&.U]LB:=^S&H\YG1B28YLS!
M!M6+QP^ U9G/&N,WM=1[D?W6Z-M C?^#,T#_QMM1PYJ>&X(#XBNXP':F*[(1
M^8ONH]BKP.9JRT(@/%2NK+VA)W&Q=[PE//I+:+/( T"YD?0 Z,3Z;$$WR+GW
M*&<JMF3V)9=3O[\-A3+IS*%=$NLC$SB.ZJZM%@B5"CX;)E[=^V/]C7N\)#]%
MB]%?1LCW7ZZ_3W*\26-9*TW3N-I0?Y"TN&UUPP:7?O<"3]7 T_,*R WACYT9
MGFBY6$JC)[:TM0+)O9\_Z C;;=0BW:\[]G0I,5)'XYR('PFUQV9!>=9T@RL]
M(]S77N<>BRO+?]AO5AZ5PFP2._G$?Z#C'4S'+2F>@>=_S10I#]E5\ZN@EE%W
ML.YE\CLCAX/U4"U_<2_IA7<W\-,B;*J_/0!"C[!JB.(8+48V+?#1+1I6*_#P
M6DQN);@Y_ F@^"V8./<Y?89>2,V8/$XH047M8SG9M<ZN,.Q]?<5%,#!=25.)
MA)Z8,T,LS29ZGX:PH=4BV=QFY@Q!L)F:&72-29UE]^ =7A;K6</&2'W..A!J
M?6= ^[6:;A2U/L12(D#;#3-4W/Y+G!@=*O('$QW1 0\]PJ9EQ-I+_MX73$^.
M/^5R5& Y8 )0(3.<OARNT+YL22\G=3_;!8_B+Y:?[&!]IA[QXRPMGF[R5D0D
M8_6IY^S[QB''JSAFU4SVY/-G3-K\9"LE7BMGC3? U5;6:B%7ST0-XCTQF,")
MES\B2>?U7&\GI:+6.^8OZ/,5H#D$ NSI<X&F%I$.)">2KR<RGH2RG7@#_7FY
ML)MT0F(]5!F<HJ1!BXYW3)E'SVY#KJ7N/*(W(%DVC=X)&XUD837:=,OG33.7
M"J^;>28#<QW-?LA$+$7P['D3_,A"EZT4/IZ/:JBXC)89%OG(4BG([AKYXXJZ
M^W+:=.-U6K&2/R)Q?,";#YYZDS';;59'K 7A=A":+]_(0"CQ";".G:=-"!FW
MIKPWUN@$NQFDQPUC3JD*'\I26=X>O7U/01.6Z$2-MH8FVF,!G/E 7W(LMK>2
M\<O5K%V8F9C+?NM&Z@'0 J*'N,?4@\P> (*:IDQ\7'[QJ6NT?(I@^:AYQ9<1
M]8/R;H(G2"1BQ&KOR)[>>I0_ "9:VSI(]6'3.M7J.?*R63W(8")YSCA)#@0N
MJ*V9NMN(GQLP*L9\MA++&U>C*MV*+@N?1ZT^;_V@&F= 76_67W62ZE<3.G2I
M;B@*YX 7O^.N&UK)6GXF4/X<)=5550?)0#M?=@UC#_T8>7LK"\WF'E/(\/[M
MW>O[!P#\Z+CT0RZ#U1T?79BW4JI$?@18L_XB)S2.XU,2L03XQF\PO-]!K3T
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M1G6\,;TCH#H';_288)^#Q<SDJU<BH!X=/N?LY2',YFV<4OE. H*R"IKFN0^
M;I*R_=J!%C&Q82T?L/  O,63?P"R@NH>@ "9!^ G&0;<6-L61?DCUAGUN6<L
M=7TM.6E5B;NIFG(D&<O1!5L'[JRRMH?BV^Z@7N6>5D1@?P 06=,? +$G-@\
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M-V?\C"@,.?4?@]X8RQ@:X3OJ]7N_53FG^;]"2/3_+M))O[)RTGWKF4G<!J7
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MZITOHH%J4MR=%BF(Q#%#OZ\( M^C,^7^K\(26ERJ;XM-UT!?=82-1,R;^01
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M;LLY>E96BMP8__6<F)*)0XK_LRD94^Z]=7*8OB%'1I927X1)6AZ"Q7=I YX
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M\NYS+B,RA[+_\U_B551/@.R6T;M[>[T(L5+9&ZD# N$DMC+<WL!^JP2O^XN
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M/,_1!3A?1?P=^(QJI+)\&%ME^&LW9075KA]8\Y\ P0J#CX&76/?H=GDGQX_
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M<4?A&\/,Q.06M7ZLD4[R(Y_INPB.G&=D%9T>ZQ4D@>.1 Y084[-7C4>2YD%
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MK:VST7-)7KWSO=Q>FFU%?C]_==:*T,1Z:]:*1S(U N",C$!+L!,7"X$JHJ'
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M 8FQE"D.MKGZEQHM4J&:$\$!TXJ#L]C!?><CB\-C9L+W_57<;L_(?;M54U)
M#R[ .J6C!6G!\KMTQWCT:&;\M/'OSHNRQ!91#X)M$ JOQ20F;4E3'7@[2UGN
M7\C:_W2]I"6P2U8N/M:-6%*8I7U57:=8VFUCP5KJLM/K$_IN.7[%L6!6;,FR
M*'.Z$8LW2J^J[,L@N:_:-!Z]/%-#?-2*/3^Y>I4$0C+MF5FMUL5=[FX0=; J
M[T6S!79[$183^$+"G;8?^CK6! WMG-;_I;('AG9WSO'%A6=V^]WLBC-'QW/2
M;T4LYQS[L\?R$(!H.E0&V8#:*5?TT>&+.1JR0NYK?D:7%\.*Z!'VA3+HS1P8
M0HOB)$5IOI[N-*[.=@K")C=RF\K:%T*-4:%^1@=[L7@)RH[37AK??5YQC-/Y
M"X1O$%DI)(EJ.=<5N#^MP3>=<GO&J%4DT./3T]U@RV>QV<818A[1*BHX\E/+
MA")CM^ZGLJSU. 8-FW6K8R@?1],5TB<A]?JW%PJ-FD&ILUK.;HJF&@E29.ZV
M^:HUUSEYR WU>"+" IEV_5=ALMQ./T#E_4BCPI;GC@\:47_@ZTU.27T\.GH1
MM;YJV+@AKKWB.FI\6)$\QU5U*%!9SL>'%/46H_+;1F=Q=*&U;)T'DAG"B'IT
M!5:+NSR?7PMCQ[F[;U@WSV4A7):XZ2$:#&^6'2WE2);;3O8':.:0F?TK45#F
MEO46J6+FV+#^C]*2(*I.(WF%Q;[=YGU*NZGJ3JAZ]HQS#3M^20/[HR@!FJ#7
M>,DO4,7%:@#D H^',,P#=]MFDH->;Y+ON=_*9Y"0&6VHG+(^0M]X-R3B4>,M
M]C[UWKR7(L_V:>\J$=GB\,[68&.([#"&M.-XA>DV+:;\]_<QHA_B0W'(:'GZ
MI[=="S):6ULSLUPL>)J)8Q9BTMCD&1G-2%:2^NH3*5$/_$@HR8<Z3H^D7_\\
M:/?Z8!Q,(LQCPC)$*U<L8;+&VR#.ZCF!C[8LRZESI_=46%+OZU7&[.[,55!"
M5 IVRZ V)BAYEYQ3YFE^$J]L51^.JRJV5<MNOJFUIAP=J)H]"U(?<X 27D\H
MZ3F 2E7@@<?HY4Y%P,Y\8?<"XZNAU0R6#[) JP1H40Q55WRX=;$6Z3Y&XTKY
MQ$/.+R@FV8U4(00(>[KUYQRM$I[T3%%Y/AJD'1-;)"D/;Y-S/Z13T_)O#]Q[
M/V*C7N!.MHB9C=*]"'KLN5&J^=FJ4.3)]3.E1T>MA*<F4.KZ^Q3N HA*8C[L
M-B[A]8DMD@]S!2YW4B""0H=[EK3'6W?,1;S "SN%=<_K,(7_AR+/_Q8QV/XC
M&AP(BQ6[6F4\*DJ%_!V $/3RP.0+JQ5*Q=7=)((XN9G03S;:%U77Y@\R:S*#
M#DK>Y#59I<G&*^LBJ//>7A""0[OUKL^8:75$'QX<-8S7O#%\^98]$K#\W@<6
MO)0.57-]PMYRY12OHEE5VIM=V S#!Z."!Q#6.2 !(Q)$>2@A B$:D28;P0'2
MHE,G/&CW(>.UI:^QS2E("1+],F'-YTVIS"!T<N%IF_.^#A^4#H:!R'@0:[O
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M<73H<J 24?@O/AQ+W1I3>3NI-6=FO%B %T:V2X]\I[4:<+L:TX9LKR*6%Y+
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M_*T:45H4G%-#((5[;/IU59%^58KK7>I3V6(U-GVRPO[:4Q/F@MIKVQ-09#A
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MY[1R [DBIM5IT=W5E41#^ 6'E_<0ZR'LA.V*R!3WR?P%O?RI"$]7(2(%*J1
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M^>!889 9NF3Z?'80 P>Z<B5N/JWT:6&E9-CY%I6O@[W:KM]H9K D F S C9
MMDKLNNT=4^Z?:&LY'F)>F88,8"C0'^(@D_DSR;\3S1ESF#D?[*!/M E/::G+
M#O;?E25/TXP@X^OK/:'3W[-(/61(U'U! IJ>YXPTV9B(@EWF=%,AC$@.-ZPK
M+Z[-4RH@44<;E^L*H^#\2H][O\11F#'-TL',98M4_1S]RS%8VJM12,Y!I$#]
M H#X1>  8BB$D7R.O-61JE\'W5H2&3*/9'."Z>.\X'/!<'%-M3[=#D>A$(Q@
M9D[D?F:8:"SLZ@-^\&O*.</+HT]?%^15>K^,Q+HLC'R8UPR2QX5E(]/@Z!J
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MJA7#NYH'6+/(2?O>(6@W.Q'Q)L,%FMG6B_G"S\OU'X'LSOC;D (O+2^T8O
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M?0_[?BS@O7-QUM$=4JO_]EZ8$%ILX22N7O3M7>$\XZZ.\^NFZBG=.JZ@&*K
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ML=^9$^]/V#W>ZX&EOM>JU+4^N-V3&K6 *3 =,>&5Z+]NGKX"W ^/U2JYY4/
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M]EW9 2\*T+RPI9Y2>UN50EWR73UER'V-<Y0@R48<&Z(.S5+9L&1;7*QXB)8
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MFB(;,Q8"*=PC:QH8!WNT,+PPQ$H%_U)G9>BH"=[EOEIMTR(%C^SCL41,L:\
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M3VQM20 S>-$/8R2.FF2Z-I:LP#TW-65)L2Q-F@U'3[KYGB6-(3O6M/L@,H^
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MUS3*_T2:@\J6#P:(B2%%DPS4EBS?/Z^KD07&>1Q87S(M(S"!D_N?Y*I:O3W
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MW!SET'"J?YP9<.7-0!T+MQ3'Q69//.9.'0D+NDWDZ/XY5K0;%G7:[H6[KR3
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MAC_!G?]7.]\9U=2ZK1V*(-)[D !*0@V]=T2I(KT30)%> H0@U0B(H$#HAFY
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M'UB%CH7S'HD3;CZ\KL;/#@0VR9,+!2*D_"C)9$/_J8?W?XO]6OA_4$L#!!0
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MK^/PTXT@(R6^U.7W*M]R(BKIGO-TSA?:>D!N7-S];\6YF:^IO# C)%G5I#X
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M%UXBONDZ7E6 -3D+J@O##%-JXJ,,="(\K)6U-Y?CW1.TI3LBS^ T2YY9Y[%
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M;*CT+SDB=)R4?V0/KMF#;X), O90>U=IY@MF*X\KKB-=[+^?+T 7@9LV!M9
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MU$)ZJ4'>31L7>9;6Q)B-Y)Q&[''K*][&DW6/*R#-MII9._;MI"Y@'&VBJ1V
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M?YSGR%^\BU2#,8165EP-#T@U0/' O8$&W0[ZW,%?Q*R(3\$'1\KG9R'712^
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M+2I SYT 1/;.B^1QI/4H[UD%#IP5V_IH3'=CVB"-((74.?YV7!DDN\$&LT1
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MJOD/E@S_"(*C?,^<7JP7P%)PI.1-W876T"G6GN]*GL<3LSCN76F/]B784/]
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MXX)\A20BQ'/<<-)ZOLA85(@<NWK#'J?GO11[>4&W!ZV\%HGBCL1)9U%HD(\
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M6^S,3:GKZZ@7@)@UQN,;Q;,LM+=,H@_>4B^ K/J?S_"%MQ-/;;DO@'&=KA<
MK.JC!:PHMN%8_JVY:D?#XN[BHE#U,2&Q/[6IZJ.H-T_^^@C'_:9]NJ,U;HTM
M 7&R&!]YA+''D,YDP:E!/8E7>ER+]B">ABMU>F'6B,RZO+U,V.][9B>K1&FH
M";*9]0]XTL# $8 KK@;P[P3E_IV8<<0@O,Q_)NAY9>(%L,=B] +XSO#,!9,M
M8?X"L+=X 5SB5[UBUO@7 )'HWQ@!L%!6[A+2Q"RKDHWM7G6="(2[I/QGGB)_
M &X.VM^@*2H9O #ZXE>/B3+^J0L.'ZGLHIB(4"NDGD5GN(<VP^6N+$\U0Y<Z
M[K+L2?0WM'AOIN$>&,)222[98CZU$XO!1FTC.BW[YBY8 ,L@74*3DRJ&Q/G6
M1#?IL[>,79U,7J+M>1?M+Z'@+U]9X<PI+EK*E5X 0>Z>ENM/V%.*TR9R1XQ'
M%9NQ6G*?Y<P9W_&_Y>SCWL-5'N[KC[27.9WN"2ZO-!QQ)ZDL*=-C-G/#_91W
M)2PS8JSC(](Q>3D"4W>D07"E3TH=(D^-D)/"2YU@-BIET%3Q#.+_Y405 6EE
MJC!4S#Z0*]<%6EN6L^X;S-[8U0"0WQ*'P_1Q:[>^*=(^ -=:\M[[N(&GGG+4
MFZMPA!0<6XSHLOO$)UN:Z5]52222RBEZ(=?")9%;/5I%>CGL#99PPXWVVR-!
M!4F83=%\.RL_HMA7*:AX.-JI4UMS-UR MDP!G%%_FAE?'Q^,%)>9:#4I7.RS
MI6TI&(+GV:&/U\9['[#^1K"I#_Y^FD6PD]/#;T?P 4TB+T/7$D<-FX'V:I&9
MQ/F\RMCQJ,<]7GFX*X9,?>T$T5K@9[ //WZMQ_NI,IIWG[H7<5.'-6C4YS*2
M=PL4K(NJ3S\[[OE13-K;^>RY>A<7TKRS#!=A$\G%FYD03S56DM[DLG\+;;;Z
MM37-55.MR\4F@Y^2/5\=Y,Z_2]H)5:\;@ST@\FFN/W3W,GT''L^C9/)FUO4I
MI,G@6*IU$6;7W\9U9C^G&C6Y-6.;M"M_7K2&G]7Y\:Z<M Z!(D3JD3YY4WA$
M'^*#54)<;L85\8U)7E3'^"9&SKYMXI?1L#E5T=6^_@BN<[73YZW+,82"N TX
M7UL'A))]]OWJ/YH[Q KN."MU0N^S.H)]V"WS9!QJZQ N*"O&W?GM,B/LE&4&
MJHORJY0E<$'_:>^FKC-4AZ9Z3U9;$X\ACCX73I(T]YO+\D'K'&FV@S)AY!$S
MG<RZP-!\AG,9Z6V%?"\6GR%C%BK0!"VF#;RY(\&]<8&MP@&#G<UVJ^T^(WR,
MB9+"UI(4'QQ4__UG_L'B_M_]4&GCB-IF;GZ*--".ED[844??V-C4,>]]-_G<
M<]WY<X4C+Z^3H<Y3@8UGI7%J%7N:'LP34]ZT>9/N(HJUYS"EF\,P+LZ?W39+
M3^5-,IW+/L7>-'49>'_I/<?)-+8:D'MBQ6K@[ GN&5:<1N3L([!_:W.FGKI&
M+I!R<$JG+MNG"MZ4C9  VBLO8CW RBM^G=\:(!CFI@V!&;#3C.1[KA_O<[2Z
M/G(D-&1DZZPR^ 5]+)'^S/$Q KLR<<[LS]E5V0R1D\9UTM3EU4GEEFXE7B5-
M1Z7XKR@=2$B&(@<58]F/16P4J<A?RF.D%S/E!<5;J;P">>Z80BW?HH-@_/3\
MI6_*>RV,8^1L-../R,H<T_SB3QB%4X7J%M,V+7JM-H.+.K:WGU\ %] 7 .J7
MTM]/84"#G^1/Q2[:E9N4,D&Y@$4/N)%>QT,FH$1SQ@[_X_Y&.IZ_E!2J8Z38
M8H]!\EI]L,S6VQ"0'(\ >D$F9M20*@$,<G]G9Z$4!J.S_.BS85')3/AFGHVC
MTLH06>37R&U:C8#-X4 +$25 M.(F%*J9I-0>(D.I!X.+O=C]?HY-O,0\HPU:
MB"7)&0(Q_7H&4>$#\<TO4681_XKI(X7RK>WBG1U!%V?;V\(2&3F &%= Q9@!
MF2(]>4]+AV_:%2:Q3BRP_B;OB0$WQ<;3KF]8:L#5G(+='#RUDMI58G#@ZEW0
M@;J)C71)H?LP 7K[)7(N8;<5AY/'"53^ZP&+;^[L;(W^"Z#"_XQM,>Z^[0&H
M_T6M+8/4E86F#9OA3AV3@6Y[8$4@JF@CPEFIN;XE@"!?UR.#QX03#U"UUV0G
M#+4WME^M=S<AKA[A#N>0V6KH=>"U$3J#ZC3C;#GN+N\_ZR8S5N^H;,\#O^S.
MJK4\CP<@-2K2&C(/,;)^MA$3A'D!6$<56.4'Y[*TM84\?)+"J87#-7*/-:4Z
MSI"^U_QR@U_JTA"N.1IM/_=.-/1R?R6=<U'WSI9"8NB'.+CILJR]DJG)6[X#
MK6[UOJFR(:)\H..1G.J#&$O[DVD+1S\8X]<BH8&'2.L,=W"NL[T1JAO8FN&\
MP/P'Q3 ?=> + %K1O*#%2GFQQCCX NA&Y(QDE(C C2W*BHE$$"T95(YBOFYO
MOK*\.:>#OI'5FUA9\/*)E%.#;+4V-&G9PP3S9;E9G'JRPCGKZS<AKG#07GQ7
M?A@5L??CR\?LQ2V* %#!VY(R=/Z5VB< HZN<2R\SJ-+V ABYNTN>+B64D&2<
M>0'XLTB)/GH//*\_J]/\8S?Y%?\%<';T[B'P3BV!M./16^)Y[?5]P+]4I_QM
MX>VL()P6?"_9FP7K!$>8.3NX"E:9IN!]HY"=VYK-T>M,TJA9[->B+E(&-2##
MFP3.S=*<0G_/DF%,GGQM:?$.W6UVA^_7@A]8_+VGJ'KL6P0G_HSYX0UPO*D
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M?T2-<)L=;9GZQC;&[/C%YS?^QD=&!P?ALQ%5<.2C%=LV:\]XDXE0N&*LT2[
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M<-.,8VOE_1#5%Y9\(Q%J&]JD(FGHATVA&9(KR??7Q1^H,HA99+<SUK]9I\?
M'L(Q,'7N^GMN*:WPU;JV/)#F]PSIKO9]S98M2I3:4XN+:-H4@3RLXNJ*FQ31
M%N>/X5XW]&Z74\\]VWS=I!=C].R\IE;U0#(W+^^0\\NJ!D$_Q?J6Z)K.W<AC
M?]G8X$;?X?Q>A\HC36Y0GVUD3BVPQ*E' PF_'H0O(T#KXE_B^+A):M%R)A*5
M<ZM!^HU@H#;^0QPN,AR_7:=7I,SE[^+C5CG2]),DFJ#5>7R+->^V+,K^VP4
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M1]3L^EUIFP0E2EU2B=Z&!NT=DS@)G@:"BXKCY8X%!LL'*2 F:HW:$'%.6CD
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M!O&DZ_H=XH*U"?7;E2^'VE.1/S(4(9-672HMU?G_YAN(_2-E+^#F6:C@!>
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ME]M-*U9]H:N0(A)9)*=87PHGSXV)"<%8O$1TK%_HV14SJ]A&#RJ0FNQ5D53
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MUB,-UI=>-0$)HDKXK'K.JRB+]RQQ1UR8KYRU8]MXPU>HIG"'<@Y>(2U>,7_
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M!Q.ZF5F(=TSV/KXKRZ 1NAUS=_9DO;MX%>EQ_*.TA3AD<=8-J+,*@V$9WO*
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M_R\5>)=?#*>YVZ7KABH&RU@L>]2U(.B+G^&#L0L(3.QF+?=G ,:!SWEN,\+
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M!7])!J&,![@[)^_$=NXZ@W?HH?ZF2&O+($TO'+^4PSK[;V'E^T/-,$F$ICF
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M[0)["JDR,*X'S3#V95YO*KZ$"$3=Q<2_U.["5+9@0[D91ABFY@5>Y!7 !_(
M> ?1]D4NBSVNM9X!'=J-LO4Q? G<^R6YW^TJ!+XK[",Y4U(,,>L))R]X<S]F
M-*G%'3]F;]W[:'U')P%LQ*2L/WIC_9G/K4U(93NY]J8@_<J#&WL-8 8(.@^W
M%=EG[TNXS8<@FAZ\IDJ'(/KU7TLL/F)N.*V,4M2X[@JR@RVS)FLBB#9T0D4S
M649]<S&Y!P[(.WIXOZE[1".=7):VOP&E5_X<-<)N*?[RFV^A9H;/^]CM8.O7
MMR-:]<94>O*^U0#5E^+?5['%BW_;1<MKP#^:Z,9OY2?^&<ZFC.=,2.T\-&XS
M(W-%$PF-_4_W#OZ3!9]W_?NAF'6QGL-;U;JS=L@I3<=P0#N"K$ BL-0]/AF4
M@P'V5Y_R7>\Y%XKN11P?HJ?=C-@7NQ.TRB2/^SJ&Y1LM&BO<J D4NX!M,M@^
M9)WS&-H!L'=2TF[GE5L,Y;ZI5*1X05+6.-X0GT=0(!D=]Z)NQJ2%6_+S_7KU
M/H).-Y0C43WEFC%A42%P>"TF&BXGNODN_9';PWH<DCV9&7G<OD4?.PP45.0B
M>8_,W48L+'%7=*-P$]R]D2X E@9/4?9[SR^+1NQ]BX'V+"U\IE= #2=0J3NK
MT?7QJ]TT4+E[6U)H3?+RW59HK+.@[T^ JR%R0F<'9]ZRX%S947=4,ET8@7YA
MO.=F_ 7OC31=).\"W]5I<J#,6,E1^9!GBBI6R]AW+D9[31)H'Q6<]W;L.&J9
M]XJ32(WN7K$ZX%@X40ND/$C&F*00DL0!15"Z5V%S W6[#OP*[<=Z$J=G:-;7
M7Y5X]'@JQ#C-#ZE]-"O4"H3;26!E<!MCZ3XQ*/LZY=0+K!:W)EAB5(LQ&7F.
MMJA8KA& "^8=>$UK;ER65-Q%[Z0_E--],@&,#KQ!BFQANI$](7G"/^.?FD[/
M5RNBGZN?.J;30]Q],D #.C)I1=<;^2YNUUB=_4 ^<CRZ?&A*36R$3PMMS J*
M21$)LP&(Q=5RY>"XL0L?QMG9KB@Y3I1B<H+7UA9+Z[FHXVC#N4]4)WRI'-U%
M#??<W\+U(!"(*3?:\@03JK,7RAL)C3+P-_D-8HZL6D-VD?/M:W]!@;!*$T[V
MNE_G>DR=+C/P*50X_2]_?).]UKD;K@79?/KV)&]8ELU2/UI##W<XA?21,D[@
M,1N#<HN@-NXR6R)J<[23O&+.Q>OXOH=\8N%BS5O7O2N/5F,%&QBUO5LI@.$C
MI),9%;P5*8=%L0OK5C8E*MJ;#G&R+W"(8_^JZXD=]JY*KI.JH@\M\M5\PYZF
MV@9(A\.QYF%P=Z,Z\F[S,Y4&1H#T71(T2,R]8./4;SB<FR.Y.-461%Q2IE_:
M>1=&3&TL)S<-R- X K+[4CM9(5P6%D4Z!5(ITD)UZ0E1/L\=JSX#QJ/<Q->5
M6XED[-C+L"(F["?NY(^RS:2WS3C1$!0*(^@D^5Z:]_OW"UJ@0@.Y,*V&H%<H
M6[*N;SXA5]K<>N]D==V'BCDD[)?35WC3G@>$TQ*<%\[% D894_9JP'3V>"94
M28/7J?UE5;JDOCU+B-.KG",P$M142RF4J9#MW^:LQR'_[@/TLT@]%EZJHU!K
M5LCEF 4!HOYI:?Z;;-B]9\(=(%R[X*=Z]K@ 5K++1'X!KOS<)*?CLGBUG37V
MZ%QY"Y4'#=^DQ$]E-D2C1W)&"PCB=\N+ \C2=!5S=K.5C#^^&LJ -,?N;KE4
M>Z$X_>*>KL@ZI:ZIF_C5[X<S7\JNDBT^_#.>7F7AVX!".VH:+NQ"]SAY_D,"
MG$?P%\WY6FU,36!>+^PZ(QH-R)X@[+B!$8Z4%JC0BL?7"6;O7!@I8#<YQJ40
ML,\V(NBH9'&6[K0HDPQ:NOK0^.":E%-)).B<!,#_R>9:3VN[+!ZA&=7.RQ$%
MS>TO: /GU I4-NH5*2&UH<U2)GT6M>2#99Z\50M=2GEI.>:T?.[N;5D[Y/"D
MM'$3KFPNW0<@2+LNV3XSFA$Y3F5(!7MZ@J'FHJD?7I?0*>*I'G6AT6Z3^]Q/
MCV1G&JD5&#H8N-_6M 2C0(9.[PKIK (#&L@">+#]0"*<Z(MZBM8"R<7$9>RK
M*0RQ,!?&E/%Z3U<>+E>1UV^95KA5;WI$C\KYV;G+-NTNOS4JR_]=H4P[@6['
M-5J:I >=;#KCVU6RQ]S>S*#/S/A<[88B=&NSP$PR\,N@L[C(E-<C!JI W$(O
MC(%APJ0[.1I??[%)P:_?LMNX^71K<$5O>=:!9GI]>7*NSP2)*I9'^Y2'JZU,
M>F?7SC?+:.''QMFD(/>':1^5/X/B22TLJ2_Z;GC28MMLM\0\BV-NJTC[LZ(^
M5C2U8J'JXM=(:W^(Q<SSY.JG3<,\4[=[PE:A B#*.?C6S!/"D:5LP']\'I?$
M"Q,D\)O',1F5IU%):@/F=X;J\+WAFD>Z)G+3O>2]:DKB8P_=I!EOEILE& C:
M/6V=\H<JN]U?=PTUR_=@D,7JP>6X_$# D^[K::BQ?Z;QH+4U5>CQ%?*="W>/
MU\CZ"SD%=$*LDZ_T32*+RH6H-5/Z5G:/X36N@$#JZKX.M]Y/-2:W[PT36NO"
MM.W<6N1,1?9GWV/@N]33[FQA?8'C^&H<ARU3NFP(L1]#?NPA2D&V;G6(MTH$
M%KS@]I[#F(OP51<@AZ_BM9\.W]WE0[&+J!CPAK/:,;+(\#-Q!3$Z:CB9-O16
M@V'B"B3MINWP-LP]/6/_K'KK8/2^=;J0\<OH]9#/5\0>K:PG_0 W@@+D!#2.
MH!9FR:P'8 =$N7TZ*UUC;0K[R\?V!#TUDR$,=?(QHT Z5Y!-@9V/V9B;*#N7
MDC5118F)N1&D[2"T5?.&V?$O^J=.LPT1DRVP^\51,=M>\Z/&OCQ[GJ=PF\7[
M\]6=,K)?M;+WNO)<LV?>K+Y"<:X\:[LG ]*%]7ER1^#N3V2_61_@54\(X4@S
M/[.1B%_(X?P+HV"@65?<K27%E2K.RUE]AABL2+.ZB=Q8#9*[\-2Q'ULAHV>V
M$E.>'_A9PZO/@FJ7NO,<(6M5+3\Z[6%4IARV)&UMHL'.S@HDW59VR_Q$3Q3C
M02?)L$(C&;ICE%Z2V3)=%S9M&$!8J)24\Z6RX[U?<V.J2NY>M?=TPK("$!/I
M-<G%!=JB2]M1VGIQ]ZI:E:&>7^P]9:U!V_01_7#60*S<B.EQ+)>T&*[=WX+T
M=NW,O>4RNBS>W+. 59J\*P)7%H_VS^*Q><+J*>]X;F(W,$9O<8F8@=GI$QLQ
M@,>H,4]>G*?CIRG6BL$*:8LHT- 33KS>B.504J;U>1<)"?L5>:^J4-&-"58]
M')8T >3>NUBAOPL\7*V(YJDDO;A1-/UX,9W8*.FEPFG2&J78D'QX7,L,?-KG
MWGIC_#V6"Y! Y0; WBZ9O^U9T&BMJ9DXA!RK#-?HFE@$Z40RL@ER,Q:P>)%(
MQ .=4*N3ZE9Z^A!O"?ATB=851E,>JA%4$)//:9%JA-#.Y3<JR.O,^$=Y>+.R
M5BA4)"]'%AIO5B;F4[?0AMRT-62E__'6HPK:C1LHA?)T*R#G_4<!H_8XVSJO
MJVK%N!-,2IZ9Z_PSHZ=D1GP=AF6H;NA5L_W] _!#TA90NMX,5]\PL@%@-?'>
MAT:_6075(+,25S0&BE4?S=7.0^V\(H5F_&XY85SMW;Y [M$S8+H@WC5M ^ZU
M$[KEZ$M?:/@G7.'WT[ZR@$49]/M/IBZ7?:^\]M6'@S!E<H%K5CMP"9@!<;'N
M6SMR-8_-)? ,\-K,2,(IU8D1C)EK^9-CHW[#51@4;X76VV=(*GW)2$MI,#PM
MIFB?X^#S*>WAW?Y5Y)2]#G+!?E=&.<"]!(/RE4/ ,T"MJ24!>4(H0^>UX@J=
M59+'61])^S/ 35>ZT%[+Q"OP8[,Q7+99]Q4U8UJ].I?H)5])F6A="+_XIT'5
M<:M6?+HU,]#WC8@>:]D>I?M(>8DKB?3"O&SZ<SK'#*L&@:.XF^\ZCE$/!Y=E
M+&JO#N+V@-,X6%D8XAPP5!=N"9# <&FX;_8K8]7TG$5IBEJR$8(CA!H=Y!N]
M3K;LZ S5[_&*.'!DPQE#.BZE;7WH7O<D<)R.!]G2]F_R,R5S\;SBU(C"Q*^Z
M6T)LW;53UGC>-WS<)'.G_.;36S?&;WIH+/HQ86"$LD(%]+"[-9I2*<3F@@C_
MDD8P^<1/^.WKB5FJ[QZD37]92GCDG?Y@.215C4\?;6[L&0 VE.<_;? Z6JTY
M[X<K)H(@).3GDA0M16I'I9SN5<\ N_GCAFVD[?(3R:6=E$WV9L9B S_XCG7-
M^ )_ZO=W[U'SF# =>2-?,E(]>!36+A%TB;3CY7C431_'X,<HM+*RI7ZWT&+C
M#K<D%O[G:G9*KSZBJ:*^.8[H=&&8376\ N#MJ%T'P^95BS(8WZJ#;XO+3?W\
M?)0@S1(OLZOJ5>8$'#\NE:#T"I[[K<C7LZ^M<+X0V,035?:RP.9TNQ#FPV\)
M J'&\%<J4W, S8DN+@0642[.VGO&;HFD/=S>4C"/E>9-C)7_-/\T5"'2]SH-
MVWMT[8K?#B1B#OOZ+JCL &)+X?!T@A@>)1R663L"DM[R4Z.U)MU_1? 8LM7C
MT7;1KE7V$R]ZD3!4]7ZI1<HVLA^"6\4L**,2]'LI25RC/ITXD: PTET<J/9Q
MTI8VG]F$V%HA(@H6FE^L@<-Z::++>LDN%@JO"VG/"#\'>Y?M!(P3[W#EQ(XD
MQ7V6)A9S]J$ O=4Z77I,B3C:R@$>8M;QRN+Y-0VQ=7_9B'P)F(*5XQQT&9<B
MYL9%!QNVXT!E5[H1A,Y#^9&D5)APIBJ,OGW'*X43?M8'OO=8F5&<T3(GQIV$
M+N8AUMY ?GPAI#1L/>QDR9 R_XY&^N5PQK=RO+^6I[DTJH=<4)TF=>4U'T,-
M'?XY]?]GI-__&&0GH>Y8<M-@B@F5AM!YY8-1ZJU83EZ'.\=%S*CCT !VUX</
MTY+5S3)0$!N/H2(4ZU CZ3/>AD_CYB4JKGR+T1E#C%^A8N[BWO@"?7?0S#SR
MXHO99P MAX2)?YADD.VBE]*)L2#4*^"<* 4DS+86.?8R$LT7XI2TE;3J@XFI
M4VRH27Z2Z>75JXP[3#?H"1GKJ2J!&E8U%PP1*G%J)5!9EBF,L#"<U<63:?*=
MF72<+=)7=UT/-RL-Z.NB%-).3.I*%GK9W(]V(@K_I.?=C=.IWS6Z5R<CGVB.
MXZHZ<Z<7CV86NOG1/&B>_^@D UZG_!#,.OJ9(-!(K<?%2LT><Q[1M5&Q)YO%
M.FB9G=@MX'&^D-M=^HC!'?&QRI!+(?E6QV,76X&BZT*_L36<$ (&7W:G5Q?*
MVK.W?TY2-<3.O+=R&RV5+;U5UIKF)PVAN"="V*^EH- J)KTGI$=&0<3F'(M=
MO+]5UHXPKU!>4#L<!"L?G=D(7'SG(7E-D.:L=[$2^8-#'2)7\XEC?"O5XD_V
M@"5-M[,Y#7,R$AM>4QJKG[-+2@ GJ7TBT?6%--ICUN[Z%' .8835%$8E+D6N
M8F/_ZX4?7ZK5-R60F_X'014,OY\0S!>J+C%-I$V1'67&MR;KIJ_W?*0B.]8.
MU_2&$I$FBUG0<$B9!S(NNHF^G] 6!$OS,3,!U?>)T35S;"<I@C-TW!;L'6L&
M#?6/3;;U++2]5TJ^8A))&M2J_]=V?NY2DP-\K[)>A0FGS&I%,'V]9^S*,%TQ
M$TI![W(9O&')4F$J]XP07IFK;$6!8<\^+_KS5C1956[EQKZT/Z$;ID8PF&_D
M(.+__1UGS1R;)MOT6!T'_GL=KK3HA2]&4%V<,+>KK]NLE>X[+R5ZS"1<7)L^
M+^S5$*1M(%>5/1)(Y-O#7 J6I05*H70\Z'B4U*CRS,2:KKH)(ZJJ^\/3;J2#
M[!*_,5A%WSM]&!_.6U!:Y]<V$P33R,2ZQ/>(;A>-62TK[,I'7.:%SF5'WLLW
MV.,3 Z?"(\>BR2QG,_)?E.'@SV'I.-)'[K_PL(JT_\G\)OQG@H[EY"K!+1F0
M,[BF>"YWPFFG+G2$%0^*Z5("";9RS5&L#;&F"Z;C'OUT17#+J=X\9=XPR9F5
M3-.0HB8(3:80E%>O9W0 8XM@N\AFB?:EW8ZSID,5#4U%V'G<ZF/U=SYG*7U/
M#:2E6'J*]VX&Y\B"^(?;&A&A0K)MO(95R31]I).>).8G?>M5NNT^Z9OO_."%
M?G;3'@+5^ID! C@T8C 4LC1D !DVB^2M=-GF6-DA!?N[5Q1H01S@5;.C8$UE
MJ].7)H%B-UECA)M.G&%L<#US917IO)B/</5:<#_%4>:L^VLUU:>I%J/1D$=1
M]]+%MNN>\5>T /J=$00NV>8/%F<Y40J)V@FDSR^@)YI'OVL_9<J^T23^CR-
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MVT/1W&ER-V#=Y3SH\6D+-C"]F:FJCD-J5\-0Z^ RFY9F<GSY$-VLBW W:^R
M3=S)%E)CAFJF)SX%?#.JTNV_1=\5IL]5[J":?W5*FOHJE^<2EA/:)NE\HS,L
MSVXC5^/&<QNL_V;M(?%KLDQ*2.)*]82'JZC,"?YS2<A,@Y(,%'A8K\<27B1,
M][>;AGO=4\L?8G<JBR3CN1U#?9KV_9M<&+;_$/]!&PIT(]_(<NWQZ8+?6^]M
M^=\):"JZPCMR9>F^+7S] LXQ"RSH:B;IY>_X"WY?&9^^#I8+SJZ;UM5;9J+-
M_30B,_)9EK**Z(<GIJI,% S3XC2M)QQ2ST(]'^/@UBA>%W.>&1R6J807I"<C
MBM1+<L4ZJ/7+EW@5)BOB6YTJHR^V3\:_?.'2P] E G" ,HBJW-2EM?ZC1^X1
M#41=\0T?H<:M(F#\WHFK8C_[SS?E0OHP)0E-/R5^]\^W?NCQ?P;:]UR2U;YV
MF>HM%=4P2A^!E$.<Q&<OK!<Q97;"]Y."Y#XTRQ>:CT *A(U;5YS8OL8:T;Q"
M _R$C\BBX'5M(@L.@G-AR[5!8/I@FKLK]3@VCS]6G(R89MQ.56DV^]'SC"$!
MOCTZQR[X5U.''[/PPD'Y:?JT^"BA*?W8J4$+<IGG%>_T'(@G0NJ3'Z1^2U/-
MM/)_IHC]0C#OCHILNJL)0M]!4;G,TJ3OW3R-_T(L]MC,^TOQ1(6]OF>>5[RV
M[E389U?>IE"DZ(V>^"87[?_O&AD-AZ(!%N>3F\ O$R5HX/PWM/R82K]9LHWA
M1 8&Q230^]T9E_A^OXAO<WSOP5B@0B 8( $+<\Y:Y*MXW.HM_L] =\5L9P^U
MFRJ?[VA59J ,<R<L ^94R?-@1J1%PRKKO+%(XKW,O):AS$BG]73K< 7*NC>A
ML7I1F)Y8F9T-!9P^JR=Y R=RZ>_J+GL,+FCFWV9./[QYY954X4/CJO8@4N#U
MDQ?&W++#5'W9G: +^LU[B#>%,2I4LX(2FU\6X\U5XK>ADJC];+G]F!G(]:]K
MK,EJ(52B?6]JX$3^6?+$M[MX$A 9LBUW+26_1RO_J!'&D8AR$<KJH&?CU$.%
MB.#:1=/G!RSU[Y?TI /BAR7U.8.OA(JW:";O[W3>,-8:LDV=U48]FYZ)B"C4
M]CV:G>R+D!9Q758;HK)*L66MK??A3)IW%M#3#B8NW%:2 ^_KM<87*_FF3#:X
MC&Z0F<XGLTG0KKD.&=L]&2I8@Q3DP'B("?Y%TX0;^4]S8@YJ2WJ!LPD]F;18
MK5G2FU-95$D-NV&['04UCV3CSMG0 /LY%#F;.> PNC,LBX<&!F193LXX#XV/
M?8^VW[TYX4(#Q+2?T,#!Z:T6-GG@QFUH(+KN\M9;Z#ETE1RTZ4P5[K/F6S1S
M<QO\(@@<CI1=ON:1*C\_3OTS.HI;%>0VWGX#W/9'&S^UV1<:M"!;V3V+GHQ+
M;#VX'#-8+_I]!]Z&CP;ZNQS1 "8:^*%NJ;\0C 967]:B@0#HYOW&"HM?PFB@
MNTV(2&/_]28:8!N[;;371!>WNN4"_@*(M(?:S=0.[M8XMY=(E2,]-F!+F:0I
M"*EG_ES&UNG;\_.&LP;V=H1"6*!'Y32@CNS1(Q\8GE83Q_L7<NW(//LHMC%G
MTQF&K H)T972>IW#&QDY^B,H?EC- S([R>#(I1#;W4XE[/S52&G[.R$,^!TV
M6!&Q::^JH[X/_U' ,%XV0T39;MG/-\+G2PY-G6OF;I[WL@8X&>/[6:)K7MG.
M??P;>Z4.9H;V&8QJ!;?;F_?<,WO"79>G%?U,@L2VA.<NXI]NKNK.-7GC9F?[
M[!PYNKO#5A@^!V3PIK<<M 3KEYW:(BDB',-'DDBEKZ;$EZM%PB=W5!H#*9/S
MX@2_M.JX07F.,L]53IPO]C-OSH7;YZ%A=46:Q#BBLS-@DX/#WYF?\DV^'ARI
MN1>_+<BOQF(<_"3[$K=ND-* "T52E*]H]$R,D33FT&YA/WI[X6A)[GK?ML+T
M.%W*HF+B]4-4_\\E+\9L1OU\%W.RRJ9Q$3J.YIH48=O!H+7X825/J'/0F,7O
MPX4EU==Q_Z3!3;D(2='"Y;?\/#+,G<M;67'*,7S6CE@"DM?$/F)7O,ZTMZQC
M_CJDFE8&RYME^'F#$8YLB3F-L?LK/6NP2)P=%SHVT)4==,G$N^_&GP8: _=9
MF?TV/5*YR_*W,8,&.IMX1TB]I7Y*PO-.D7)V7E.C\8<Q#[TO#1Q/SV4XT$ ;
M_PU5EXZ1T&@>'"LY_3]:V<?:HS*Z48X.N:.AMLZLJ879^)OKNG.#2.VTV;EX
M&6,(#(9X>MO:8MVVZ?052%T9H"'BO-;OXJ +MQ(EB+:1_=YF1[+Q)-/U?2(3
M\LI7_7\3S0O%T\3[5'AUZ+Q?8&K>?3KVI;0G&0\TZ*R1[WMX;K1>'G88^KMO
M!VS,G[UM$_Z;<@Y:;P?/V>9J<)#PWQJDOSIY<<!RM&<!D2W?H82F^VUFF[RG
M0 .QH3,WV&@@*Z7X^D,Q&AA)6#CK@&N0VB&3)+_3T%!7L:NEU25Y7ZB[+^[7
MK(05S#*5-<JNB\..T[DY.*JVHQ5ROERWDH*AO[Y!0V1YBPK\8.PC%BFB+-\-
MYC(?:ORC0R=V5-RDAXE>B91F_<2JFY-Y-/P^L>N<3;TQ\K@I\5-G',H'Y( R
M2FA\6164MC_?%NGE6W5A+'*<^>JW_HP/0S\:R/BKC@[+L>8VAY:)1?A*A;EK
M<.MC5">IU^CQFOT[&M->ABMFM(68>KYR.X_]*9+YQ8[,/D,QN;"NOLYR5 ,$
M;,4&2F"]B-8R_F,M*N5[,<YW]VN-=D5GDRY%_ EG@XS]T)]K8F*Y_6[>5%(H
M3<:>9B=>(J3%?^!R$=,5L1@P!,Q]-*#QY'V+77KV$/Z-Z>#)&#"$S/HU#T=F
MVGG2I)Q6>?A1EV-5!MSY;?KP77FBG/"+S#@].ATD'2ZPWH*3JG]?8$F)4IN+
MJV@CV7%W-3EQVDJ[^UZ2)3 "N&G4N*%:<T0(Q_B<5FK?\EI4)Z\GE+KQDA,(
MDI0<QIA\2;/*X,YW%;/*J6ZJ;$[QJFZ V=T)_O0M1G1,R-]UO,6DS*!3DFD^
M$PLR(I5#V5YGC:GQF/V%JF/62]> H#1KI)[B+$4CXM9Z*1(4%F][7JH7H@3$
MTH?9HL21D/X-_R]2\6I%]J(HFXJ,M<_<+V!%(=-3QP2Y<0XPA//>7FD-[TZ8
M9=MH'L_FD)OE]90X/GGTYV<,$IRXK!@_QQH$/:5250(6>YK#-H.+44NU&8LK
M+1J&*0*APD,*EUML=76A+N%4+8V[FB5I0KX-([+M'O!&VEM_3!E*E?KVRU3/
MNY1W>UX)1ZM.'\E!75+,_K$!.R,M!DB1*3YRM2>-JLYYT6=.!U4J%&)XUFPA
MV/4;5,,]1$@#E$=!2=[,D->I'?W,KI?LFX!/=$+^HHGLJU:LS&D3[&J?K)JP
M! /Q6 _Q?JD97=Y/<8^D1W7DD=/J!K:_< .W,R6\!GPQC*DX_MF^,8Y\/"$\
MAU8)MPBNO=D3D8K';[(A7LTI?L7*3.@:D&G<-\[_0)I[>4@6L9VK4SW1W#^7
M'RJ2(D'E%=0 S.9A/O0UT"GSAJ@>L),IEDS#$:ZRYQVOS II1P:5-,>N0$N1
M#%H?-<>/\T*W^7[&#WGRQ@9-A&WII]2$N7HUC&DI46&'4+J7673[#GT7(S<R
MD:Y=EW+UV%!B^?R]R7^VY.II6V^+ZDN8G:GZ5%N1@Z@Z3J&MTZNZAMH(IVDZ
M06"6-^OF;GQ U K5L,K2M?%NI919WQ<3R5G^@]1K^EU$8$-T>G!$($![(L(<
M_[+(0;)PYK2+\&-B>GFNFREQ+C>#U9N8>A#C/CZ6$UWYXR_GGAP"CH.32=23
M]ZT<"7HV^FUB#<0%?-/<Z7Y%M=S6BBXU%?$$@EI_Q!7"TT-@!:ELIQ._J1%Y
MZ9 D63,VG+1KYV4EK<S]YK5V<" >AS5=A\0>Z9(Z_N?+FW*(0-Z^79U! 1X"
MONJB#'+4OTBAN3GGQ&)IQB#L+S$6"V$]BEP[#]RG/KI[GQ5$$<C!H]*_ZK<H
MS@[RMY.66(+73B)1>13R16OFRRSBPFY/,WD&VUT,_4D+GKNF['#7.9)Q6^C?
M>E;PRV<^.>&Y1NQ/[!CL<5X0,KX&(1;I;8;F6E)X9[_'LDGVEFX E>*@ Y%^
M%6>_+]7O.:OJR;<UI6/S@TNELVDMX;0K:Y ZJ<M3:1U5]:D/W:BTK>(%U&SV
M0U28\XM8@2>".3&:%Z9,N^FSS+)OO*A^;#9B&3N6UA[R011/:QOJR(F'F/?<
MP#?\/5%^VP[$ NTHDV>3M#&/TOR*<)/$G)Z#ATG\2.T1!0OR'/"I6^8YL)^,
MY87:6B9+'YL_9DT845!ZY8!"^)HE+$M8_C;.J8_\;,TFKG"^AP,YUY<V)D+Y
M=9G@I.J.G7!C-$/NWP=#6PVMW!TCJ&Z89UWHG]1:/B;]B/70O'?4=,%(6F#4
M]/KB[HI0-^X@*$Z9M/*X7*&FQC#PV[TG3B@1\"N]CG>DYO7#=J-&QAW2\5V.
M1!"U:,$GC^D.QCE;-!2]\'H[_NQ:_\4N.CR!!JI[&FM3B>&]^$?P#<M6^Y6<
MBB4-!-GQCJES2+,$6TO37<1Q@W!J+R%V.U%<KXI\G&NB%%@G4)?1('M47>J>
MJ=.>(*UE79@2$9C2893L,:A-7B,'IO2WRKS+ZL'JE<^.$>>"[8I*_F""@!=4
M($('L&)0<T^\^&CPTXJ9Z,S<",ZF'@T3"Y?=_VG8>B"0[%HTNV5P\-A]E,YH
M/46IUR7/!MJHZ#(W IHL^/&.H]".UB-T<BG7;;).5O-(@:S]]8W0P$5C;,0$
M+RDNV/6EU76Y!R?*,>=05[ER38?AZ0?"N#PW4BS?D[)&\3':."X$S[T0/2:
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M[\S<.[.N_+BGU_.K:G75L\\^>S_[[*IZGG]>!>!^D ?* Q!> 0 (+S_ \R)
M%H"&@H**@HR&BHJ*CHZ&@4F A?GZ-28I_AL< DHR:BI*,@H*&GI.)IJW['04
M%,R"+.Q<W'Q\?-1,PN)"/&*<O'P\__@3!'1T=,S7F"186"0\M!2T//^7QW,[
M  \-0?G5-2+"6\ K/ 1$/(3G;@#URWTB(_QS /[30'B%B(2,@HJ&CO'ZY008
M+N 5 B+B*R1$9&0DI)>C 2_' 4AXR/BTW-(H;]1-4=^Z$/!\3<A!HY.I["#4
MF#BEYS5S#4;'("(F(25C8&1B9F'EXQ<0%!(6D7TO)Z^@"/R@^4E+6T=73]_<
MPM+*VL;6SLW=P]/+V\<WY%MH6'A$9%1BTH_DE-2?:>FY>?D%A47%):55U36P
MVKKZAL;.KNZ>WK[^@<')J>F9V;GY!?C:^L;FUO;.[M[^V?G%Y=7US>W=_3]X
M(0 0$?[S^)>\\%YXO4)"0D1"_0<OA%=>_S@!#PF9EAL%7UH=U=3ES5N>KV@$
M,@DYE1WH=+P:IX1FKA,81/1\:PQG_Z#V3V;_YX@%_R\Q^R_$_BLO.  3$>%E
M\A#Q )* FWOFW"",_QVP)/;_[CQOZ'R;8G[(QM9ES/#[S#CIL:#PKLV:A\]D
M, -(!Z7*G'#,;9,UBV+C[28[*@J[M(497/U<E-$)_)'QT^)K9H R>6P3F;N6
M_>N# %65VC98P.P-'GME)<G@[_X*^<"H5HJPF>/4HZK%@M6J"_,0UDE7E2FP
M%*)D1&&2'_H Q^A*%',^5VY4U/[^:S8]3L="19-();%$ 4*%$CX$#L(=Z%E>
MYVMG\S?&8JR+6(.+;T@DC=L*G/:IA";X=B9"QN@'RB6&@#3*@TO% ^+APZP-
MEO-@[]8B!3G-&9B2$3&P81IJ6 "KL0*BD0I1A30<?6KF70_@[6E4GW9OH/R%
M3S*OV*2GZTEW1E!^Y+)LW#M"2-D]  *QGUM;*!K]YG%&43:[->@E4XAQ*&R<
MM/34M3C?!+ZQ9^E5H J?FY^PKC<R[KTBC%UW(K#]@C_9FU,Z./!:D4Y+;FFX
M[S>UE+*-[<WO?7T/V%7K">,V0XIX%ZH]9DQ\;[2H(2?4;(1 T_*[W)M^:=I/
ME7TPVKC<WP],Z]&JQ+OVI0NR?&HUL21Z05C)]V\,?O";,@6HJ>N2*40[7&7C
M[=_3XXZFDAFP#AZCS(Y^.<;V\RJ38#Q#AH8^2'J4+0=/M#?+8V/&J+R*+^$[
M/#%IA(W8L<7/MM+M/E$]C<5_"KYFRUCTR**)HSS\]0Q []AG'0L7"UP[(3!J
M 6=['GB'N-2!><DW6A$.;M4'CUS<Y*\;IB9TGQC.)#+6Q-G^*GQ*F$6DB4&;
M<^.E:O^"]$1HKS0#\<@B^_/IMU7*RKHDCP27:EWED5Q6A6C9?(N<J;=2#]$*
MQT3L VY+4SX4<UQ1VB9+53;>@;JWSI;?1.7^5VX4,XFZ' '@_T4@Q*X?M/WV
M%M5K',7TU$BXFG>YGTO8N[^&K.&$46$IDZ T3CO]K&&0OOC1<"=,8<W*(PS]
M=-:;%%!Q*Z@Q>7GR[DB'&<^_%UZ_A+ZSB^5ZLJK\:6Q5*#SAV@@+T>CAX>ZG
MYGF,6S_D[0R,)]UKW"H;<ENG=)M19..[DF?O@UU@-U6#*X4'ZL?J!.>_JA\X
M,&J+K*F$>'_6G%(<J*]U_WQ3>9X]1ACT1#)M?5M''6EY'EC]Z_=?L<^28\T[
M8N9%PS-PC:2%W-RL=.O(O14N\-"J90&L=J-,F<U6>[?-S\7QCQS=68_=BIS'
MJGT@HK>!4B*#7]-OI]?OH=L4):Z"B/'-S@HT9OFG?[K(6P37"6<A?NR@?&D7
MCI%O&'?=<0KTGNW4/PG'[9^(I_F=(EHI9M\,/HU.:<@R[MS596X@GNK7S@Q/
M6X(",%O>]<XU.E9O&!A]V50BBI/KJ3N>4?VQP-J,D#2(4U+>WVRZ/CUQR2%>
M&/H@MTZJK_OQ=U"*YV,<@%1H)_.F[(GCUL-OG9I*.I!BHC#>C0)80NO %RRP
M1(#IBDWPA3!O@QIC?T[B[42STMJ&W1S<KD8>OIH,I!,F07+?#Y2T,]X]>@L-
M]VC#W<O&+3A-:2GN*2U/";0+VZ/!X[D8_"[4]WFR^,&I\8>-KT0Z@PW$"9K,
M24)AJ2 5^":[L\Z?;<U(Y1V>\6U1=V+[?<NT&<EJW4 <G/:!!IR_&IBDW\IS
MFE44TRS)F.J^S;A$'V9)REV_Z[+D*DUU6?$CB9K-V682-G%Y(,["U^_PRX ^
M?@CW$/G#W[BK[3:"W#@<@EL,9G/=#:6CT@@N I1H /:,&7QH?28Y?4]]:7=*
M/F1(Z0Z=!WD7G7)47/K![D^D&#%T_T8".QE*TYP!S!ANJ0]<3I.P$,:07.93
M4/#L-+YT2-!<W\Y-3=P%XQ%SM_.S)2?N*SCGT&HN9?MGWV)IGX9NA8<]L>VG
M8X6.-*<;0W ;8;B*Y24T%%#4D*XO,C"=M;\'V;C\(+<>HMDZ 4;^X,ZE2@=F
M2>^XOI!G0 !9> \UYEKL98M21ZV ITA6[.2@_'KTVQNDBR6<]G3;WJ5<.YUM
MT://3U)U?ZY.F)Z"[3O$$.G!K^O&Q51(GP%5,&L_RO>>L5U9\4\!.!"_HT,>
M(ULOW.)7>J86 # "6QRL]]:IW2'[=5\H_VK&G^&5\=JC;PV6EO0>%&3JMAP?
M,@T2;59;:897A.K/D!]<W^3>NN(P$LG?6358(<37(TI^OZI(W^F&P\"QJVV8
MNUB8(BDEEGB"O)QGF*8HBL8[(7.3M5!_I!3)UU QMES3@D0)^I]'%Q2_Z2NI
M5<>UQ W:X37I7J%76*Q^WK C[&6Z!8&/&K&_>!*%KW:69MSD=A78D^J'.-RZ
MP<1GLQEK?W#WU?9GT_,=0,<I2S)G]8=2JW'9/^^UL-[IGH7'6<[R*[/IUD[Q
ME0F#7_M9P_#O_LJK7$Q;X/5?;12)- :^N#GD=G:H&\SRE[!J;Z(*K@<7#OQY
M965^]8BZ(0L\C8]YX/8HW?.EAYO;W%S43"P9'O,8'*\^A)3TBM<7% U_N>G?
M?F!;WQ.C//U /F016['3EH@F]J>^W(=]I1U17]\K_L3]#^X>+G#]X!V>P?Z;
M<F+<'KNW]IZ.B+2(R6/0JPV9KK6 @P=N*HKFAB@LF=>]C;5@W@99ZZVQ2M)[
M[94$ZOC-:?8I3=@X"&)*LS1"M./3]Y?N%O@,D/BQ&)?[X4.O9- S8+/\]N"I
M4>%AQ.CV5YM#RVE<RLX-L6_S%YNG4^.^B[(5XM/:O'SOB^[[GKFD:V7@>$?E
M^9*U,,D&1/NVTE[$1H!LJXIW*.^S@N=@RP?$L*?PTY*VUJAJ-6O1,VIU,H4>
M*,:?#(/H'$QL_PR+9;KSC2W*^TD;+Z9UII[7JGCSNAFO.4@Q-6MZWD\V8+Y*
M1J6#!LI>5B1].GT\B7C)6(&$NGP<A0:+QY[67;@=$>U]8ER%=E2X,S70"/7;
MO"X91,+)PVD(?9))TF-.!^G)%=5VU@QDMG/+JTWIYPI72^49=8\1FU1K0UV\
MTF2>H(Z9[:NR?H77 SO!;6EEDFA72%79!J>1#7$NA4LU*55T83BOJ;K]5I\!
M[:6!F/Z\87HP(]5> 6TO>/+5U <4I7+;><2^D@= "</I:QL)L4G8,P!S41^N
M2P_"SD$Y_Y6SW^Z6%))]BY93O_@#/_DN]%3C,7S]<VS-;I"!9PKY]U_NUAH&
M%XPM^,TG:]]!!AIG[Z(Q"*,UF\^/(I^8\_I1KQXZH.^+P5M=)KE1K$K_6XKO
M_VDX).17UKB^;7;$J/K=3W/]-DL.\+8T-U0+XY<)@ M0D!L%8'Z!A5J/$VX4
MR:307.[;(-15EDMU*62"_Q__#4QONPR=L&Z5U&?RI,X[B(]_7'(J:HW5*D(&
MA\ZHHHDCFL4#\C]NX>^__=H^VC5-W1YD6_997711]M70VE.V5Y&<1)WXUA/D
M+6K*Z;)BS(LZ]R0(^D45A-'D ZD-YP=_+=(WMA<I6G@8B><)PPN)/5=<P@2C
M4J07F4.]DY0KHU6G_=_Y^01BH/7T9";\9&QO-QMN+_0+%BIFJ)OC:WO3L^[#
MY]GT5QM<6Y>2HE$V@%A&A.P%PA;NV-.":O 9$#0;K$N7>Z,:1/>#NS0JT]&.
M(5EAMY$):+0_5DLHT0[TOZN<^6O.1%X8T4WDN)!9;-[%C_O.8D/6'IVT)QXT
M2ULSZ 5]J_498&%;/.SJ0EO]0DNN*KSMA'6!1?:1&Y1>ZI.KKX!\%F&3MMR_
MATE'_TQ[K(-3ZJ[&]5>> 7,:R]#HXT!8N<.5T:N3C]%J9BE)2JP2.XB><UK"
M,E(2+:P%<]W$P;,;GZ*EFK-EZY)S_*93N'J2:_$K$]&-EJSI]@RO*J++5PXD
M**>MJN:&X$9E*\"2Y3QF"8-7&@RB4@-_VW$*K.$R8TZ!4.6UO[%*<H)NQF72
M)1$@,+^9[&-6!'G8TL5TS$W18.@(W;A3LY8+Y:6O8T;NTA\[8YDE5=3TA&AW
M1Y0;^M@^5(!U3FGJ9UP.2,TB><'4._KT]8>]27UF*@=>@,HD;\BX5R\:?TB9
MC38\KK65)4FJ:=9]66,0GZ[N>Y\8)BI2Q142(9W8J9S*$T4RR%_(?0Q[J+"/
MJC'5"Y?T6TPQ7NJP6]*8"H_+APG*3?=TA2BFIMFMB2LC1B/..Y._'^TNZ$O8
M]>"*EKO2='0K$._@_4&GU_N;HY/=*8DUP;,F52"X6]AA );5BJT.[\/'ZC9[
MC7O?/9[% =H.HY&W6?E^078!2EUDH/@PV$]W9:I)^/;^J.XUO+TR#7NJQB7F
MW,Z]07\A3;N5W8BUJ\M7*RPY((#C*9.Q5CM-*;:T67$',<]U99GU$1I[E*HZ
MRS1SN#WER.=/WN1E^3VHBUDK-6QY<:7JLH58(]SXU.)\H;]2S^8$>8CBR[Y,
M\2NP[ZE=8=.:LHYNVUF-<\=6]&YY^B@0#9WM/8_.8D)\;^D$X_E3"Z+^'+^1
M@N9IT2*?: LGBX?WBJ#/Q$U%WYTARR!8NN-2(GG6]@M#O&;5+*?VS 89:/IZ
MN.#K!6: XN6(6^,/^$[$R8,@TP.=5XJZGIWZB.L<OD)R)Y>H3.7@Q4W]48_
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MG_#X)R_\D_.^S7#)4-4BNW-OU;6;B,L2^G<>OZH7#5+V#VB&4<]64-<4:-S
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M?1?GD>.76'>>D@UIG-DX0PT!N;]6%F$C=>3GG](F]T'LJ6+42=@P05%C%MN
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MS/+%&JTL7!@V;6BK#5-KBA+[)<"=N9XG HZ;\]Q<T<N(_$Z"?;6T[PN2> 9
M-+Z\K[_+S.I-ABAX%1EW8 8KA-DZ#;]'E_2A=S"74<4D,/%C041%R3^-*^#?
M;G-E:FWX4?7!/#;#E0M_PX>4%EL@J)["JI'PC#)M>K/:>:+<GHYTZ2OU\2#*
MCD0%ZC09#.17J.0G1E1'!'''ME1<\#KK5:3XJ]D:E-@:L]5,G?=YC\.!_[5V
M]A@,K4J(M 8.Y,85@ON&421U'.F386>7Z=ZJ*@<C8,&ZN;A22,T'K'9L^L7<
MKDJ.FK6(<C"5BW27E@=/T>%\K*WZ2:&80 #W#J(X K^3U*Q*4Q'':25XEA3
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MA,"7\EV5Z"/*5X^1D/HTI/_^FI-=U:Z3H%@@T.P3\^)EF*__\>%(R)4BE4)
MU661,#N@[-9NK =_9>B7'?[^^)?#Y:X")5HZDK7@U;/> +; KOBBUKC80CU5
M:P>C_BAO,J8EW10& S"0B=]IC3>^QR]]1O\9\"1F>:\%\K2NFR+3:B-B+L=,
M\C%==+I1HQ)\$R0D^0'B))#_1/X5AB;=Z'W!C<2YXMU_U<N#ZC\]WW1@[O@_
MZZ 75SB:5=<FKGNR$9BSRZ2TWV/;Z3,CLJF<4?T?M7QU4%SOTN80(! LP9T0
M-&AP=X(,! WN#L/@;L$M:!C<@[LSN =W"S)(<(*'P7WYW?KNW;UWO_NMU.X?
M776J9LX[]9[3_;S/T]W3B:7+1,R54;486YZ*[#'?(8 )*&]O([M4SO(2;\J,
M ;6N.!G]5<QA/J!3L?D0@5M>MJ-QIIR[K+6$1Y(@CY^^9)\-< Q<P]KZF4G7
MO['S^T GPYMU2[5:3-%W!/OQ[=4$<NRD"[X&<#FRH=RA\[4(WLJUKL&7SVHM
MT(QR\W<QE+I(FSLT 8'LL':-B/<)&9D+Z\C(_^M,XG\82II'U"\=CQGE-&+7
M UF+0#)@_D)YKBJBI:>1)S' %.I%_M5BYB@U3<,4!S+#.D^/F(28<X&_8R 8
M#VQI)JPJ!#5BKPYL+5FK'KP$C'+PJ3S,K+;3 P/E]4GZ5RV!M!&K7.ZQQS5H
M"-2P2EUJOOM/HZ>V_7D$D"G0G^5L;CUY1_OH/\6J3M_CSG"[A%MF&^#+RQYN
M/1;([C^POREDWMQ\N9W[)YKQ^0MZ0R/SU/]KF3[/Y%WI$3.OW3 S(S.3L>)9
M2,@[*J+6?1.6W$T9DUI9D*EL'HZXVGRD$'3=*9ZH:!HC6'$HP*K.'@]KVZ5I
MM"RS&#MP2ZW8! =_3"E>+5Y*H%@CPXCMR2_,#W\". 9]P10(GEG0^"MXNO['
M_#>3J"Y8?:HR^B@AN6&)G;;>X::"<D(L\T B G 6R;GVLZ,1[H/BC;1J<N/$
M$UUG/(&9X1BK<^YUVOI -ZV$I^!(_E!^-6G-W]24!0SLKQ*X\=@$<ZSUJSEP
M<(YYT^J-KL^.G%*<Y>B5NT\MM-JJ.-*$O+C_(<JV969FN=KDR>V9-BS-.Z]1
MA9PCX%0QPM>:(;<O2Y\JW@-X;7$/GEY4GRTK-A=Z(RV>SYZSE& 8?WPZLP<4
MQ-MTRB\T=;72HU180>!',2Z#&FP^BK#X'>0\ 285M$K^5B.!O_X7E#&X.+U[
M%/,2?? 1?0QDZ@8WQ';%"F+?2WM;'C[,&]P^,_&Z^8;YK[X3*ZXG^6_OA+UM
MG>>N%^?#'DF>@;66Y]^5OOF> *1[. >- KZ9%+FV]X.5<L^RP0+XXD4L_ +-
M*^AAOV[M?7[0#PL&GA+YDH2/]* H+2<>SD::&#^YP=/\JY@I?3]+@\4Q2X=3
M74/Q8MT>;6)-^JLP9-W"F7%-[L8UUZ\^W*0R>.$3S+%,\B[)KZF3AMQ<!($B
M*P+JG<%C/A8_+S/-2[HH.Z 1.Y3=/7(!_L:39ZNY:7/HPN\JCG)E<Z(=PH,0
MI+W1VO^>M!?/L?@OZ[F,I"7Y@8O;$:OR809QTF(6MV8!MY-(/R5UV],5)JM.
M*M;/"AL;/54Y?$_5:="J\@YBR]I2IH^/\J*S.&GZA>PU8)IHO1<3-H[J=*)_
MXG]QU\8_1(/IZ(VGC\5\URZD1+UG3R=)\J&S2<?U0K_6-=I+KJMZW>7+I'9U
ME^I6<]262!1[,>*6-_DF%!6\U67PWG012>)($VT=*G/XH7D+Y!Z; "ZX%(&M
MAXP.CAIV&U/J)JT<K:7]BJ_)D>5WY)\ 0GX\^ G6TG*_?W97$+/@*Y(696E(
MP02CSC[?2'7<1WT)>Y%@S<#4:T=6.?J9RSA5WE^S4H'"0=11OR/HWAK=VY&\
M-YC',:93KO$C63YTDB8W*X3O> NR_HT2L9JNZ.$)D&]ZRE7RV*&4^P30@81+
M+6G@6-]2048<[+0=  ,Y?5J]3X#56+CHIL0SXQQY K2(II: )%AAU0EM$1*Z
ML=#$KGYAU+<Z-2W&<URBSVARH"RZ^?L)T/3\-:M@G8X<!M8^]1:ZK8\C]:;S
M0C]+PZP?BGWRCBV+VA74L6SM^IA ?\U!&/J'^X&_NYC91;&!9I51D"W_[(.M
M6%7U505SDW! MPY)L[8-T>- H]>C*R\]UKSG+0L763,+8%IE=17U#*@6^TMJ
M&-G#%2H*0^U#*O(F67DEDH4#I'+QLM,\LS&H43$#2!D(AZ\*A9<)81_=W:9?
M4:90]_]H@:!ROPYG<95?0K O5$"26L+E*DA(N0MAFLQ*/;HH ',%R38"*0-H
M0DS%:BRMC0)")OCROE\TE_SU]QS-5Z>1C\#*YQ#5IWH"3$7JKSAD$W5NI>V_
MO9C^\$ $=7FDD3(,R&:;S_=Y\PRI 4\ .Z<G '<5[S_I+GVHR$O/V0ZN+YC%
MST^X:E-K401:]]=ER>T<B\_.A^NPJ?4.1'FYNXGS9X4Q4][.="(Z<\^D$#Y
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M9.&$@$?)M+UCUG?UC9"-#:D(HMFZU@QDBL+\2OD^K^BC@LML7"W/!GM74II
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MOEEV'I^)^8D\5U8LM4F4DP[TS)?W_,@83PE4JUV?\20V:@W"RA/NKCC"_:3
ML=)+9664\A5G;)#)1FE5?4 \RQ&"PK<1'=(1+$"0SLSS1]\PY\XI/R[4A-?3
MYL[_2QM!EU[<+VZ1YLK%WP2BH%:_U)C!/"2[N/:77J]5/1#C=5Q[64N*>2/L
MUEHG81N.5C4I2%-'YLN+'E=QS5KXF+^E7UL3Y'DQ$0J))?/",O.3F+P[IHCM
M0@KQAV41$,@[5"6IXF,<P+H?9\R@T,"-B\]W4A73#(M\G^LA?&26._R4:BTB
M:2WJR8NY$-.71U-23"_A>$^ $3;OXEWB<0$7_!Q@AW^R<FX$ ]Z_)MC?4;X
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MTM\BHSEU;'Q'S;N@C/B2%"O0]Z,/I[)!-K>&8;]&6%@U!E/AQ\:@K7S=3*?
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MV"C\1S4/3<XDNAZZYBNV3:)NR2PTPPF1/4W#L7:0Q%AX!OY463MG0T\/ L\
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MKZ>W^60/A.IHX<4MY<LR;ZG2_'S=<%GJ0#'@CEJ0JYRWM,*>7\*IY*6DE39
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M;*J*\AF LI$+*V21;-0?+;H4#NWVI?F:+<&^GZBRK"^7B"A)B;.L?G,F39K
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M IDZH;I*?P@.%Q0P]N.)VRHG0**/9[#5FUPT7QZH%A&E^D%A5>'W;L(P^,_
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MPJ8";U&=M*;ZUOH+[TGZDR(P]32LGV!F^,5XV O?+.?[Z5;^7"F,.G=\[Z'
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M#@,2//'R0@')52E QM[WJ09A77<),C&?9YD9?Y2Q)-VA =\2DMB[E[B@#K*
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MEIEX%'UL.!Q;3$7K">O1[ZR, 7/=#:AH4Y)VI9*,[:JF0\5;Z6\ R3TWT-N
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M644D43']'@>;DG7D1*>&$'WTK^XL=*3//"5)1!$K:DZ8?TY^^#J(?.*A>)Q
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M*D83< =E G3?W,J_&$5?4@QAR#I"2VW_YTE#&2H.B?!C9G$<C+EA:RS=U;-
MG(MU;F*"4W#0DEQ"&2/$/MPXBZV(-[?URT=SD0HB>S[08U4-UD!E9 'DO*WM
M9AC3G%#A_^V>Q3NZ'^TVK2) 9(V %EA:J%;>S>3LQ<NQS;'U%=A&]'X<]\UK
M:2 _=+4(*PH^]KGWAO) Z>$FZ"O<NL@H%+"=115F9J)8ME'HD<Z:+[J;B?YC
MH:+$>2&GF6.*OQ$E!6<Y5&<^Y4(@9C0Z&^DM'G;"A"FX\0KX2YKR%_MFX]*K
M16!5O$7^1G]I\5._>G/S?[==QJA+I$B*Z<73$]A1[HW?GD>95J#B;2N<YV3!
M=+/W4T+SDA@OO(Q!=0&IV"."AD/%)T+]34=SNY-D[7#,=Y4I;F_GWL_<<N<U
MM;:G=_[Q_WH952BB/7<PL!KLR3]O\/!!U!8#M/.):4]KO]X7/Z'VRE]9"O?<
MB+M/53I=9ZYT@DW[+;WM6,KDP;,XWC<HA0>CGNB, _<M@6%=>V.PY3""73B&
M>44[\;Q[)L]-2T+4;!RN5T]] 4]AK$B@7AQ2T6VE";9N2N[[%).QK:.G#ZQ)
MWR9OS@F'49%OD:&]KT!&* ^Y'NBDO$*_U<>X(<8HHAE+5U:8.J4I]_C;@9./
MCTF=W=/OZ\<HUS]FHM4[&]<\?46J3CKCRCFYOLYGWZ4VK2\;5\KX0F.K!0/X
MCGRCHTLT@P%;J?Q*KH=B)SL[A\WUMSTVM!"BOK7A$$-N<%AXT>/9,SU<BY_&
MU%D%6EM[O@G[=IG-6%G/!1*'8Q-!.\&#^/H)&#&^:MC\Z)#=<NA$XCZ9I-YM
MKZJ./(1ML/+(U3/5+G>QKR ]\C$^'[3Y5 *((_U, <[.;D=9!U0@TY\LI_B6
M1YXSJ-"-!K1MY*=NTX6T?*5NEO,:(QE =#_@]0>41EUD,ZC"^CPY+] K<8R9
M.3[!#:2=ZG<!]R3J8A=^+V*GZB_=#>1CWGPMI<-:!*W++<G@[1=H!::G<9C,
ML<Q#ZS)?T2?J,:X>"IL_H5<M:+P89%"E^<"6YJUA"4;<NCB6JRO7:M*G>4VA
MP)]0RD+SI<H ^P/]#E-6BH]KW\#[,"(;F>; \4&EH! 6[8R]U]OZJ+>LYKPC
M740,K%\_=!Q+#? [%O^$*FWIO5L[LMI<UN%A?T+U^UGIJN?04[G6O]XL,&8*
M5QX&FBZ8,YZB;A:?H0R7H@%(2C*""CX\NPC/QGU]*-SR /VQKF_F5QZJOOX]
M '=9"')7;M$[65Y>A&@R615(+HW-V<YS;H[A-'!;>2+2P\V:_A.;C2'N:UP7
M#6N1Z8YR66$C/Y$'#LSV*X#QW@OAX150OY";SJR57S>M-MZFKA#"@I8N,(X(
M,IMRH5J8;#TS[L[8!Z$OD+ORWS]Z45DT7'0$,[4J;"[+@18B:NG&.E9L[I,N
MV&&J_R-XJ[F4GM90(URD/BP^''X->MN%4\T-&,T)1K4?G>W=U@;RJ1^^ D=]
MP$\?G]!_#W5'YF^93]+)W**]7"**7RX/00[[F>^LAMKJLH0^%,>TMWTP/JD
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MN1>BR=.ZL'00'W+$<P]B[&;@WH:AKRM&/L#6 ^I;:\H5<W/+6S&+;7P%OO'
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MO]XKBEM?BZ.<:*@S8BS=&E];5A P[!I^\PF--\NAT@![W46]I8<KP,>,%4Y
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MO"_%FU$HVA98PTQ#QV&[0_H?QI&?*H:7V9]5E[]<"LQDH+?/ZL^<674U3OV
M&.+T9O[JP>KLE[?3G14#.+APE#<0.W^308[^N=M>=*Y^FQ51&RL[JRZ! >W0
M)/E+"Z;FYV:J15T:I?#,+XS9,R?8RM5N3AL9JFT8YM?#I:4M*+13><' #ODO
MNZI'OP6BX_QA[JM!LDCRQ=D@FL0!D5+GH[7^M141_%0[3C9,'H9,4.Z/S5'Q
M/>)4OW?=T^$^E%T[^X7F"AB@OZI:]K[^E&E%[BJ .-YMOV,.4F>%(__) %+=
ML#(%C6B]8ELQG$I/TRFN3#[9^&-:^0LAT(=VU?]#+$,DPS+-*X!Y8($J%_>"
MA8$O\[8SS"75S/!  ;&%^*D8PL?':*$JVOFM9:[X8:J;X2-UQY7[X#:EM5 P
MD;2\G-W/,UH>N7R!?#=21<IX3%L,BE#0-;$"]MH@YK3J&D5:D(#PS7B^0[-E
M*1V4NF9E3;HKE\;J2"'?Y,,[Z3WL[B&6O0XM_+I570%R>9?(M^6]9D=>W8U,
M?.(SS"=GMPV14GL)U411K= KSP0^J??5;+*7[#%?N=C>.9-E1CCQRJVH\[+C
M8_;L2M0&#_QT+'7*@:PL%@:&[LZVO0*_]XTN1OON V]:'!?AJV)H,DQ4]VE4
MO3"==37*T/K"?<&9+&J=G;=D=6UW=9?H<5Y61*WO/AD>C[GZ:<^V-TX\>#WQ
M2ECQN7Q1^/$*W,Z(I\8_%R[I%16+YR;QK@JT_AK27-8Q5V;G7-&Q5N3Z8J<;
MZ,Y!LX93-[7;C#=/$>0DBZG79J>6F$1$,Z%]^F?Y76&VGO1\>\LKX!^D51NZ
MN&BH4TBQ47RTOJDU=+;23&.E- 2V;:$M?T9/9*+BOM%@/V>I[_41C42A<,A!
MHP&9BLHUQ$<4J4CVI.WS<.CU-OLW>Z85(#$P<L&[OO%3;6^NO>C]=(WE1%7T
MJ94D0\Y.G-718[$'626)4<'1S,R13K::I06%AJ:VBE3.)3-TG_6855MX3RC9
MB&'C<Z7HDWMB!N'3CYF%Z"]:+B0W&_-8)C\<MIA8KZ2H5BF>MT=Z8MWHR[/2
M=QE(<>):C^1NJQ(YG<@7)X^KI6,E([GH=[:?2T[/\E^6+WI/?[;DQ5+!1IVC
MSPX\4'T-4VV:-B'.24=^L\J]_\>X&<QZY,QQ:/\*Q(!54;ZJ]B,+;4KG@-?K
MLS6EAHY/CJ](-XDMACW0<EJ]._?$/Y3/(V9F'S@1619Z.+''5#6^P?EDRW(,
MPELJ;UM=N:L.NJ94'(WQ\=-LYJRUL;D;:#6ZRC&$^$0^])F<#THE"YG1<M7/
M?^9H62SCX%M4Q&+,UAC<)MSF&%_HOEXH0R-\-_Y97H+[MES+F=G]VU9(ZQ5H
M[GW_92<RAO39LGBMQ8(EM*;F2XL*0R>TU$4U_&?*@<-0*\.BE(75@^%(72IJ
M)IH%Y^B][ZGIS@":G\[J-#G.@QLXOI@D+V+S[U<<V9]W*1@E6&D<8KFIB6+5
MC$+7P+%7OQ186J@S^#90$AE<WN 7HX0_;N(A6]R@GE!X3CUM ,F4O!A:_I)A
M]#N93V"<YIL]*@E-0ZUHO=F+(H$MICW.\:@K$^O0G-2V"Y&*]NEQ',CKI[=L
M%22TIN8,68&[;&5W:%HK63KO#Y'%EEL< '0"&.8@^C+Y?YO6YA_*_^M>JK(?
M3*XRQX[&P5Y*:+D7>"$Y2# (,&1AB/\W_E5)J4#F+B$YB^2C, 0\]3<B7=Y'
M?G1W<Z%M:YU84Z"XMJ]Y&Y(&<^_F(5$.>/")&3P8*LW>RI'Q15A(O8PV"QA<
MP^VX/OVUO!21<,MR*ZIYW*&]N(*SX\<VOR^$59X'10P/!"RFSC\RG2NB3)_=
M?+>6V-9F#JX$9T%B^0A4YZW58K^E;T^X*2*^S^>(.&VY$/G@.-PY:I,B/8@1
M;!AMI;HDPI*1NU3_ R]6:R@6,6#9_XUMX5)N+ :=;,-5ES#-]UB,5J&_/ 3O
M$?GC;O0JP@\ACQ9FN\B]UE= Z9+D?OZ:[_<I^6JPB3>2N^M<8B7-W"-[N(;E
M#SC;#'2+B/#]XE%[11G;K2CY"^,B*\K$-4V"9D!58]_G4(?O@F5&_9?S)SNR
M-EB?Z,[B1X,V5M'(]!)&1DGEE?.?-*P+PCL[\81" 1HES:;]OWX*'2:_J)K7
MT#"F7/J/\^/QTK"Q*YLGP>(;<>MC$J=%R2,*$1U:Q%_")D-M-BV2N,,<>@67
M%V'('U&RT"T%'._%'R(\J%LPT+]>F)6EAFC0,"98Z:?!>AP7<IV^ JAOCK@:
M&<S,\LLB\ZN\:S.37U!5[>60S4%.(>6W,NH:MXQ_&J._QR^5E E]#-V#M,'U
M.J4HA#,Q;ULU$-M7UR=$PA^$6HO<PYNL3"#)F5RB]Y\KU0= 5J51B9OX2W6^
MF#KVL-W!-2(AP4>:[XY'0)XX9M\Y%VB5HJ@QUW['3ZOZPXG^U)%O5RZP'YHS
MR5YDKW6,*H-"E?&HE5P/?Q6$57@?0EVT#5NRIF'NQ/O<$46ND/1YI0QKP<4E
M[J2)<0_K&9K>,Z&(I%_F7(-&"=YX0IM=*^;W-#B\*R%3Y(M;@#DRGP^\?7"7
MR2W(16B].QK[;9"FGQ"_$376A,&E.L5OLF7V3;RYI66&.NQ)<%.=!5Z5HI3K
MPMMEP+5IDW&QE2_7V>1K:U4C%_[6-YJA1HWUC_O6_-<IP,1#E->G] WP%]/W
MIK3?8\J"EZ7/OK.BV>'-59FUTTQ,]WB^;YLI3+1F+M]I??KB0O G^15P0LJW
M<I>6>C_Q<U.++ZP(](*73A$V(@BJU]H]GZK9\&6RZ@.)S?EM_KDI^KFX=G2F
MI5=KI9R'W/T*X"D(+F2AI3MM(23&"(RH+7G<%?SLMR(;^ZR\X@7I]<G45U_O
M6W(G"FBKFWLR:JKEBI'[!,OJDZAW[\W3YW)26HX!Z#D[+G]MD;EK]&J0OW2O
M08SC$85^#?< RJUP#XB"0A>6EI<AG$LX(J>+TR^"%;#/DR_]B!C%[#"KIBE%
M<S=%=0AU*6L,-8::@81)_)Q\)N6F\QR&6W%,:R$_/B4XP!UQCK[?4RQ%I=A%
M/DXY-/VG0CC+(IQ$Y4 KR<M#37!OMAMO."K%V)><1,/3=";W$EGELLV5F58[
M4GP<X^,>;";\#O^N7CW^4EU_-A4]UO,$$DR4_@WNU)&K"E$:K1&QMKW-BZO:
MCX"V-1_B7J;6)X.^P:ASN)6G^6\EA?C@L?M@58K3O P__J\%.M\4PJH=MB]+
M/3\03N3!5>QV02TX[QZ7SO7^F@#/2]"17D."VYLBJ%SY\MKA% ADZ<+%@!8.
MYS<5W+=&)D(PG))2WPM*_&6Y)*MN':#E@\E*?]!#/M8D)WAG'["9L)B-]I1O
M^>NF4FP*,A?;C5'_'O_[\^*9QS%JWR,B&5^J(G5P9AI,IQ7(NBB^2;H0],&]
M\IOQT!@W/U5H,&X&YGGD3OA,!B[X\0WE"Y*]4+IZU1SX#-+S@Q)+ONH4N""&
MJWZ)S\",]HB]8K5^9^L%BV#">-5RSY*25)O$>=^$'@P:[^.:BYA261/,>@5\
MRK2&N3_Q:]]=E!(4Q,,"V]9/ZW.05A&6FDNT\M-B-8, /0N3H@&%H3I[)D']
ML.7>WCS/4ZT2OYE,.Y7\89=[\9A,VB,GO1 OY6G*F9^M?E>XKX!:I\?T"V[O
M896.LQ7(I<+@&N8WA2OY%NY! L)L'E<,P9YP3_698$+X!]N#.QXSM=U[W>*T
MC XGO&(/?7AT4IH/W/?\?QE-W9;VBIZF1H'KCL]Y'Z/SCY-;;@=B]>OPKYF4
MD7 V\\<:CVF/_DLGL:AF.;8^7T[IR$6UN@9^:1Y$-ML&\;OHA@BU.H5^,I[E
M8)2#[4D.(3,C!4@[QO,=7<'^( =_M6J? )+,;RMSS($0I!K'CE:"YNCO=/=(
M'6WV=1&:S(%\)+/[I)1(.=!Q@5G[N2EW^8;J=_A>*=[V@CF0<F:#ILNO7)C/
MBXC( BHQ4\UR,O)!RG6?A[M(<B-++$*3Q&;LTY4^1<-B^I*\+1XHMT I?I]Q
M5]WV(28-E'A776DT#"X_BHWSK5\<KWK?=*Q1P5SF7=<$*V&])7CB1A13)X68
M[4([ O/U;A0+>1%^K[X5-Z>N+D=/&V.MYC2<?!/4_@.YX<!LK'@Z/N.1N)DS
M.44M(_HM(<8H-?HI"$=)&UQ_-LZI;.NDKXT1]5.-,9B9FH!U1ZB)]+B]0J^_
MBCA5QK0+#ETC[J8T[Y0=')3$]-4 M/(*_-0U^SQ\;R \Y>I>1SD[![9?KSD/
MT"NP"2!E9%88A>#G$]_G"#%@9/''@5YP+EZ!I<Z69MIR"12L@_V9>2UI+/ C
MF7^\6=?@(_-,C0.3A6Z+2$&0[ZP6$[.84,BQ3JPOEBA)/0][<!@1O-B;7&^@
M$^=H.SYNDGJDF(.1IBQ:20P74?_?NTY2 =]X\$XK-G;XCN&T-O$D6G?P74;6
MN88"Q47FF(<3(;2#'ZU+>%/R,J@@+))CA#J(7TSXVN,M'NWGJ[]>H(T2\N@I
M6D0VQ2(;7Q4D?RP=JBR^&07 >LZ)=OH\5_-[H@G:NQ+S';C!I6BK.>&((3-8
MWY:HURF>>-G]TUML)I[F'IU5#7QI E5U2J\9" GOLC#89NP7C&:SZB,62AI_
MD]5-#IM9?OW\1UI9,&3!;5H\G33@N;?"?=F/$HCI?O[0Z[*;6GPL3+(?"9YY
M,/N%B<$T3T"*X.+JC40>X48>##;IF-R'^(BXX,1E=-KI?J5\XUA%6SMJK^2*
MCYUWP=&17I%[MD7S2:+2ZE@W@>+3LLH[C0V8E7GFC0@J"QDI9A/%"-[3")O?
M>J!S""JU0Y'+B) #$L^M0"EO36M(W,PQ1=100Z3061$N+8Z:P1O?O:&EBVY+
M2LVWK"B&'P6/T?U5;ON@LC%>FV2UD%@O*KZV+\A&<2-7%P$UZYSBW(C>?-*,
M(]^)Q".V+6@O^E9BEP? [$OQ-MKLD_"H5^^D*#@M"C+[I9#\;I[=%YJ>++J+
MK5J-" E@QNOMA$G%</N.! 4Y&YI'RS.B!+8/X8F3-&'IY;)#!L_'%<P3IP<L
M7+SR75RUCPO,(W:7=5M\FNX2^\<:-ZY/A4D]U)S+R14C);!2(:*U='MO7*.%
MRNV(.B)39NLP3LK?ZTB3LF.[<,=+D!B]38!_WH,KPL7+=::]5/"[E=PV7;JE
M#9FX79@\ YZ1<6"6)O\UQ1 *I,&BKX6%H5&%I2RH2'L?MN _Z,B2[Y"WJ/O.
MV$>&?(N$?"IV7J*JEB^[7GA]C3]SKE))X=?2/&.&6EUW3(*.=$W@MQFR&X@R
M36_SQ6C:"8C58'!7@BI,[ZWF\KZ-T[@B@;=G78.8'B2]W$[/2GFN"<0D.(:(
MA@N1[LE>'M7,"4T\;TH%_XMC'^5_#?*@!'R1?PL4FV:]O9MDOQ/B:,YP^CY[
MJUB"*PQ8 _DY?\6YWM__W57*F*I,,O)12M[B.\4DOA].<:9K&Z?-5DGTH)37
M[5FJNZ^ ^&_:VADGW(4^(M%W T0!8@2 (\[CAWQEY9H?,Z6\(0P"OJ'T16S_
M*WZ9#$?E5&9.3'A._MQ]+O*E^C8<\[^($B.\#UR)[M[!P&-%6_! ^/#B7$1]
M;;_Q*R*J^WZL8+KQXMS!G"*/)VLD/2[,4U51+ $4/P.G,L(D\BUOS2JDJ:GW
M%,\$T'[$,W%3G"U/9.!Z^C65SM?;=E5HE\;*L%AK/?@4_>+9V5[R?D>[G)E<
MBQTK9S*\.?I!9KU>RK3=;,?;4TTP3RVY&^/(?+8@T\&S9RC<_YS:&NEAND4+
M1HW>J#&!PL=VM!.P1G"<PY/2-XVFX]Z-*BZZ>68E%62KW8MIO\XHJ)CZSTD4
MOO4]?EV:*]Y<MOMQEXI\_G9>RYN^!-.GD:SI?7,S/1S1*R#J*X1NSDDDEM]6
M%K?\.YA:V+M:&=%&FWZZ5:;T\ 6G.NYK;/> ?*N_#DTL(Y\_N9M?]TOK?/&D
M,)D]N\?W!XE^GND=_,>(E7Z"&B[)M ]I^U-UG^RUJDN<OZPQ&G.ZVK+)4/1C
M^6NI"_VJZ \%KK0B&/LR+P*.,H@:)I<XKU<S+B3S=*@',Z-->"@VXJ9Q9\1@
MCP2YIK-#?/Q$(%3*O"X5+5^>O^S,_U :@%>$1.!(1E!;VN821Q7?9J'\L[N
M@="7P9A;D54A*[_@=]A',/';4M@\-R)@;[Q7"+D45Y"B!IX$JSWJ02,#\Q7(
M]AUX>:J0Z7T%4%K)]3='E5_0!%4;0U=WQ*]7-KW'9><)+[PZ/<DO+4.*M(_Q
MHMBK5N"_U-1L@,<-A<EN"\SGB$:36Z8M<YL::(IBV6)B9E2'MLYN,5"A[R?
M&RPK(C_81Z@UNJ+/^A6^Z; =S17G<%;TO0Q1/(GPN2PV."EH*R(<,:9<W$?:
M6V&;WC<7I$VG6K!^;3=R4T!MW##)8,1M9W7FL(_QNEN4U\[R&WH^I&Y?5W"?
M0/(2L]G>\@I0" QL=4"KSQ_1?_-RTW'O>#M^*'_1T9N)[MQ\6G9S_ OOX-,F
MSF%ULM- .> PHR81[*Z0YZS;JW-T'P)OM(E?RG,#V%JD3 E^=A;2:)?A/C=J
MB%DV)TZ^8R2O%'F80'+YRW-3^XBL_&_R9^HXH[4@OI\-Y ;H"LD##%;<52X@
M1.61*0VV<C8NNR=7ABLX[9R! E%4?P%Z=!8JDF?*4I92D6ME6G[O/M\E)#(S
M%W.HQ_7@N"YWN=_'I.+<?NDC;F-E>?7SK6H5)KG^<AO@-A:U%8&A]Y&]7'GI
M,*FD_Q7@VG$I=[U^YMO$#X)$X2P>IQ@E<6ZM)#YQQ]FRG-BZ#-2!Q[?+\=;[
ML1YTQ3.?I&7!L$)Q,1E--UGHB:%=E^IA-Y5(&CTNI>S=#'E7TT-R XXH+PED
MM=M@<I&+TXPFUVE4QJI JIC==H<55L%XF$DE[??EEV[=1%^K!FA/XB#59<D-
M49X3/=2"0:2EA5.MH@46KO2SD..$C&DS@^%9FQFLA2=%Q'S<'KJ^<63.B$\%
M5GF2VTE#5RE":VP.FVY1KAV;>L$99)?^4UJ'29\^*5I^'DDEB%(Z%B95Q1U9
M?;@7KKK\F(*V.BSB1")N;(:/%=#O>3\5U_TB. '5<W!"C*,9 0N;F%$O(8^Q
MTL,5YC3*&6[=^]N#Q4Y^M"1N:8S16)C>EV3*WD,9"R?<Q?*=D^3P'U67%!"M
M%S:R;_07)OZ.K,O<BZ"5//^(55-@Y;K5Q**M56Q2P=.KNUE& ?? :8T<[(@F
MCEV01;M'!\,R@S5#;@XLED58]?'2!1&M.H#%B=4:P=5!_)F>O!BN.YL/\QM-
ME0A-+8T1,N#K#%CLZ^-'-:L^"R\$W=&<5>? K5N0;#!-#8Q_2+2DX,HMR012
M"2-C3O/G'_K1$E\8S/V34CPC<IEZKP<L#.%%,1B_?_#ILY&ZK.T".^UXU.R*
MV^PEHX]?/M/#3=*7_;EM0;;GX4AHU"PS#![YX1^$(%' .T_'W(^!))HG6I1Z
MB)P06@;+/SR@K%Z5A7X5NM_*O*V#T8\I]3[.7F?K%=#$":N;7R=+F)CX7_$,
M@L?G=+PWA[]DW,X6$%,6)*]BBJX0C #%*R(0V(<1:'SV9B%=3FD%X(#O_X?2
M?.H_C+]\;3-Y::-Y!28LQCI,.O[@W5H]/NH]([8Q]^'5KCMKJ=35B])<:_%2
MH>]$(MB0(T"Y2IVMOLQ\GSU9FY.RA,NI1J*VY%-$5#A%?06HSF)> 3VY5R!K
MWL;N%: IT7N")W_&57EA<!;<[B?#X;S3\ERVHDC!-?1>^5ZYQ1@V'=6']JVG
MI^>=V6>-SOH]I+;,8EE#P*281!&>'-%K)\6Y\/F/T(UD[L:GB()ULY2ZV=5P
M[+':C_J[P@LZ39VC8'>6BX*Z;&?B7E[/7*,+[17^#.EW@NX#/E']95#\B[G*
MS7)JY2#U6C<SVG1-W& >8ILE;^XH!%,B"ZC]+&2^3J*FUBTH$(E0E=*;Q U.
M#:II894#=9]8EP]@@NX%I!L2B] D\&,HZ2 %\#.4+[B;S=VVI.)'R:>-[\I+
M]EA^%Z,+;V4H/]+#A^@83/7M5GGW[,DB=V^&L,/X5/3SJS]]T3H$91A5U5$J
M(QU\&>@@#[/3T>LG1SU$VT!-/2C[[KLU&),32_/&6H-!E\_N\4W8%K[W;0B_
MG,4V^9M3WCP$V:HXWP<">)/(-"P-UQFA=^U46GTYN@>39IR"W\UVZ6"JCP?I
MYF&]V=REBK6/,FOG8@26(;'Y4WUMS54ZG9[)%=>;A3Y0 0Q_]G1I.4[4L#]*
MEFB]I4T]#@1T!=Q]*I?G/A7JFPY10>RH)LUNFM';%'B=?,G/4A7S78Y<O"9^
M[*F,C>'JF,LEDD$/DJ?"Q'5[GJP/'/D/24I)*M7-'KR/WYKE2I-7VVP6GAFG
M\MY.<HLO[6"6AV\\SH>R0K4O$K/M2.">+.<T47,;QG@$?"@JI_,!HP/7RM!V
M(JAP]<5>J?M\(KYE*$ZUP\* Z8]Q"K_EI<JCCBO;.[V[\5= +*5M\QS!N;)W
MC;O^4CU<E4EMI%34DB5695<<21B#0Z@W"O'!A]]$?YO\;<]=:K+CGVB;:/7L
M 6L)1&_\.[]7($9!]A6H7'^.*8GJ(__S_TQIGO1_AJ+K0&-#]<5?R@O^J5ZP
M9/LM%[&-T5Y2UAKGWZLD'\SS=]#V?W1UR[9Z]B_2D1>67/@[SU+D/P,WQP;W
M9QK,RSZXMY1PUDG?<%>;GO.?(7LKO_$NIC,>3YY\CE$_V)FR;?K175'6IEL*
MC?6J4O)B_H6:35Q;X[/M0VS?S&4O"F(<33>(7=\X9ZJ3Q8ES1MIK?]0_L*R1
M?*CK%?V=?^6](V?-+D]HT#ST?.?KR0XRZ0?F\OM<2;NFGY^S:,<\\9#>I;$'
M&4]:L.]5[])Y\.']\;E2OGJJ#3$F/A^/&!@=65WX3IO_8=W21V^U=,.>'YZ5
M(C5%+FG-!\O#S.<X7L:N;[61?.0O\.-%Q>&C%]8N;&AF75_3O_MX@GT4PW.;
MS"71K_?+ZVXYO>C0O<>G(IGF".WV5/YXM$J_=XW)?P;6&MMK>B6\5M*:2UJ<
M4K8[K&&T.&G?N<8V^- L8/]85F?KC3>R6VZ<RINOS,SEN-[OVI?9M>6N>RZ]
M:_R4M\APFU7/]S\:S ?_R=S/FA7?9ISZP'DU=Z?$WH=:Y=]NGU^:4\%_^)]*
M]U$YQ7.==KW+LLHVK7([^\GE2<V./V?-73?_F/CA;OJE+7_5=.-]C<1;&Q^D
M[P]PW['N]J'+-8X[MUYY;WIB36*EDGWB%F56^6V/C(\_=Y +!#:=/C\LV;ZK
MO--&_=L,U>EJST^S/%[.X\A2ON[SD3(Q.^L?/B<?S%CL<>10_J9%'2<3YYYP
M_[[S_-Z@?=?MU.Z^++?2_=[\=MW2F5+*18:;V7L>6ZR^Q=]J$_X@O[W.K5UV
MS:\KEW]^YU1.#2WL73V/\X (XZF*\N-50*??JB@^)B<87=K!<2MMN\SC'S,]
M3GY76ONG=-*]E ]'IJWIS;O=DVKW,GZZQ!_-?\K-Q^\+ZKS=DGV>Z^!RK5/K
M51]O]RD\;FOY0NOYD?V,KZY'Q;>9O!4ZY[WCRXL_RQ,<#DA76OZ28ECY\="W
M2H4/]_ID)]VJL9GQXOA39GN_>JLOWO=9*VI^Z.4:9$X[+71KPAIEZ6;6WS=?
MS_D<>5]P#[M^SQ[SC&F3=*+F3N#E+&ZXP[/2=E?I.K?8Z$=[K_64,#]\XBEG
MK[B^B/%V3[KE<;\OC%,_W/KWR+]-SN#RDK**W,5IW;;B17,:?Z9MJV-Y(>5[
MORW?E'LVA_HN<S5[HQ >IU89GB^OHV^)'[[YQ_##Z;!+%[KG!OT2SRPKT7-C
MZOE5=>4^NXW]JHKB0]/%9FU='.UWW>=5C^.IM\PVM1K,W1]2##/CMXBM3TYI
MDDY2B]>M8"BHGUM]M%*N\Z%OWO7'?8O7G4UZO>Q4ZDU+97:%I+U$'+DTT/B9
M3?&#%WMR%[DO.UOV[=1DSO)%;>H,/<5?U\WK8CA_8<O2"U^T=755C=:N<3)X
M8Q M^^KI$:5'MR(\#TSD2K^L+*HJPGB\@O^ 0(64]9.V7][KMUHD[V5Z>_SR
MZ]A>>JY/'OZ8_?]- %!+ P04    "  (.E=6[!N3]W]3  "07   $P   &EM
M9S(U-#$Y,S0V,U\T-"YJ<&?LNV54'5&[)GAPAT!P#^X$@KL$#A+</;@>W-W=
M"9"0X"X'@AQ<@KO[P8+GX.[2^6Y/WWN[Y\Z=KV>FUYJU9G:MYT>M755K/[OJ
ME6>_NUZ77G\#WBC(RLL"X. ! +B_!^!U!2 -0$5&1D%&0D5!04%#0T7'Q,?"
MQ,# ),%[BX-/04I%24%*3DY-Q\%(3<-&2T[.Q,_,]IZ+AX>'BE%05(!;A.,#
M#_<_'@*'AH:&B8%)C(5%S/V._!WW_W1[_07 184K@7M&@*,!P./"(>#"O?8!
MJ/Z.$PGN7QK@?VMP\ B(2,@HJ&CH&'\O@+P!P,,A(, C(B A(2+^[0WXVP]
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M#5P0$)Q4@;#8:LWVX7TG< /SD^:Y8<+9?:YB7>JARMQOPXU"0 JS:3>%*Y#
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MJLH^@MV,.;D*L=T$7;;"6R-H!NJR0.E=L##PIYO"RK40\"ZJ;.7.L^<B".T
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MXD:=.6X0QGUJS-5T\KNF%OFK"$4I%@_T/E/6S95C')9V^^+]6^S(8Y!X@&N
M^?*=:UUUL.5LNR3XSU3[+-2 [L-*41TAURE6"S^_P,B.=8F]&53>8H&.NW>7
M?WD ^??R?5(QJ6P,<C('!7W6UMYN[Z2;,+(/*C')+P!  (#-HO7?N;D.186A
M-AE\=6(U&7S /P=O0O#YI,DLY/LAP6S#K8%]S#M,Z0N"Z$D3N[+N43-+7HK)
M@(*6O](@VIARACJ"TX-XM]-='03&']F-GH"O=KE;L#G7B?>8X*%")Q/0]6_2
M;^\TV=Y-M-DUG4AX!>#']Q:?Y]YE&7B^ APA)T[L;(4;'FZ8:,\P0^IG^SW.
MF-2[G-G^"^GR R?17XF,XWDV6QJ)\/'7E!!8$'8[TN:S4X]08'W5TG! T'LW
M6J-/1P*>"+M_4W;MWU\T'"9XR=+D*2).^Y)0E@CU((>RID]<7,FO@.V6*@J5
MK;5VFSJ;+.SBB@$X6W*)<Q:X#7IEH/YQE;]XH6T%X:!"71-":3I\S07!;A?E
M3EN<TO3"^+X,)\<Y&C5NQ&&LJIIC[_?4A(G(R<%UILX0R[C-YY=%U>G:%BUU
M'/]DEL&;VS[6I&LQ[-I@SP\'[[HD6+_>(=\ZE=B] NQL5_" ]>-TYPU7XWY8
M> U&50+&:AV3PG,@,>K#1F[=#9@Q$5_=MK^&_ >$L)19F'X@]IEH3GAY@$<Q
MS-ENV_6^$5XB!,?IZW7U0&R.M3W!4(US02R+PC^[Q8%UW<?58-CQ4:\DX8NL
M@6V@('S[H(03I0TI?6,F3E2#GED3DEK.M1?!A*RSC]CS8?O\DWC1AAU?UOR3
MH_6LNO3;*&J6G_=U*,:L ^ K%9R#]W'@#YN=+5Z6#)\TGEL6QT@.XQ>2(?$E
M:Z^ F@O1%16_;^XKMIPTB60E,9]J!U;2R<B#_>+G3F"D1)Y:JMQZB8 *(7Q%
M[)#2OHQ4O0J#@0*H[.HTH'"7L87B@U:[HFW19&G1PVQNK?X0@\WP/1WU9V23
M[9VSC@D6H2QWWO8_[;G"XRJL)!O-H,%JF[<?32_#H\T&O"*)!ZOMQT%7&8F'
M<O6=C8\<Z15V:48</Y[8[&C&7'["AI%&KB8IRM-6#$KC37K_Q+:^/7!N2$:(
M[HM$#N*DX,O0 G5\T!I1$81-#Z7F>:\9D26/N&)IFMQC=3W[U;R$V^=.F1G@
M$-S%*<^FT-8G?/YF2@[$KP8W X0LD.AP3'Q7&A^!-WVY-KB.CP*#&<I<S0]S
M$+.TEN)_SNRTYYSR9ZY6OC\FK"LU*+$>DPA+#/_*P^!9IDLDALH;J?.26)D'
MH[34\(J3NOO=T]9-.7!Z8"E[7OP.F?MKWDLY2,9QW4(U,70&-61VLMZ7+3R5
M?,R.N:>4U7;W[.<V0-$7"OF:0%I)#_<;2H+9_<4:G4CO0 /OR4=U2G&6+7 G
MDJ%=_>J!T$WU3Z,UA5D>OI03339Y6L9#XU%+<]M2_6)P>H/V&77/(!Z2VAUZ
MK51VYQOGO;MX(X0>7\[(8W4*?I501BVX$K3+%H1R\W&0FHRTUVH1N';RKH+.
MIJ&1JYQ1HQ$Q?9+L,$!+3:HB N$G<54 L*=5K-+=T0FTDZHN;3V9(D&;#^"#
M V.0803PS8/ Z1GT=,$3$SZW=%F^N@0G>E5!;W0/LA(*]6&WA,F#;$[D)5LT
M^YA<Z=W$IP;XZOI8E=](D1++2Z'LC?DNMMPRI$#<INC\7\2C%C]N_LK=_%#M
M_]D]01]XV<V5&EJBE%K;(UG;^H)HF 4W0B8ITW=('8L]BG2!YI;G0-E$*%OT
M]B.'%+Q;2$Y/1^K+S*^4LC6]?IZ%Z&/R!&)KR43/G&6";2JH_OR6P9J>MV*/
MRXJQOJ(?B/PGLANY]Q!COJ-;[ (R+[]HKFSZ_C2;I=_0*<5O67ZN>+:^D$NX
M)4H(87V>;2=U)#%$V(U;FO$[,1XWR'%PES;+!,>0?2/R:N7+!=\HB"SI'1]P
M)*E5&,>NBZVV]^TH:X5L<+TP.1)".4/]<M9)O/M93GR6>P:5I6>3#V*SS]HW
M0W=+LV6-*YHB2N+IR"\/3DM?5D1R["V_MJ15/]^OM6T(5G+;ZUOHJQ_4!#@V
M8N9'=+O\#)O:*XCK$Q)Y<,B*UT^OU_OHV;XE"5$I"?#!M^-T__YIQJ'!SS-R
MA(K=**Z-D&UBL(V++NV:A_,I<N.E8_$5(,5+'UEH7:$?]YWL:_4[NH3S1EF@
MVI$=[[\/4VE4^9[_N_U"_R-\!@? LK>?SCZY+:V-VW.UR6Q@1A#'\Y,0[+T"
M,#V"R ZSBJ]SLJOPQ@&7')Q%MOX1D^LRC!E@ N'!KQ-:[!P&E+ M3D);,>(F
MG:ZO#1<N6%6LG;8J!67[YS##B)>4;2I*V"+-@],=\&J9UA0KEGR<^7B?W_):
MS8@QJAVGQ(8?*XA6L<SNPHTCW]-K2*4Q\,\-P:QZJP'VA$$.[29GZ,-BU)-.
MR<$B:4)XBOX8G;O48_2@0^S- 5,QLZ"C0#?PXU^-+R_Y?YH)_N= =!LFY[L8
MY7QHD)H<\$;(.M=;><'CQ%E>@07A0!AF:+Q21[QKPE4@PVN)S=I7,.-9=UW]
M3UJX2[)+.@+J+E./.I%WKG(&4DU6=]^>D_MJA?QEI RR!W<,?_SV!%-;:K@G
M64_E&P0@J$0X)$0KNJO9&;A$H8M]NAW\-&/O22@4^?7L@*G&L=1'!U0A!VN;
M\Z-D4:*E6EK0[>#O'5*Y*DS:<!8+%/6=N]7V7%PX=O)RPC]KTMV5& E"4)N;
MS>_^DY'1VM3+B;TR7-%KH=I/([C4G2W_SGF5RM!/2ZU<T2NHI*28MV,@N_30
M"L$[)3S1ZD(^(9J*B67?5I0;R<L^SV;4ZB:N6#?.&G2,VF04T>$2;[U>%62M
MAX'S\SEQX\C/\YY2]^(<UD1<L4>;_F,O6MN)Q/O;$9VD0\^:T92E_UFI5ZVP
MIU4C.-7F.@9Q%LU@B/@=WV]'7L>9"6C/&NCH>*LIPA?X+VXN(FB'[Q5P?=+U
M@%ONN%ML8500RXSY'ZK<:B^]\\7(*SSU6ZVHR3_4X?>I;V$05_LA,1I_E7-2
M.T^G(H;B0KUVNHI5V8K9I\%]J"2U9V4\>72ZS-OUDU/V*O:<O9,M)FK)C%0=
M],)SWK[)[<<.1YV&,^V,A[0P2,T^LK#N9+4*^Q7!F#_?-,WY3;+'*X# R,CN
M;Y;<H-8MDMLBD4=^1(QX:=R%B6L@E=R-)X.'R4(3H449C/V%I^ (K87U*)&[
M=_.LK5U)I7_Q%+Q1/O)Q&]2 \AS]^*RR:Q1.J-U8I;\.)8XA9A#HV0DD$"5@
M;U2/E?R?2QC_4\ 1S,40%,THM!7*+7]S^1$L2+!-JMX=1/ \MTYT-J;:F?B0
M'6\V11',I4KGN ^XJE$ZUXES?P6@ZTO=IJBXL(_>.QL8E-Q^V?Z!?J'XW23*
M:AYBV;I0R"TL_1R<2N!ZOVJ^/,>A[+N=VP,)G1HHG+LQP5R7*?,V46@/70,5
MY"SPZZJ:FB,!1T0C#+NZ&F;9BML[LJF;HBUWW(+%)XME"H7E"W3;])ZC&U #
M1U\!(H%J%X$4XNA630S9R%F7!U9PB$!OVV"6FJ7+C:S)\AHIA*T )AO/UN9O
MT(53FR8,,J(O33*: _)B7[JWQFD?N4[C9UB*>M;R;;Y^HA>EO3AO<[D:['"&
M$CS7>7MU^Z;)T=7/ZFUUL* ]"HM8L H<P0E,@N;99HLZ69SP"]IL7 YP63^]
M27>0&+*Z51TC\KJJW/WH5C_% S:;U(W5@5CC8-R[R;#@IS(<1FH,;6>YO@*&
M0*^ P[6@*UK#E]#12N^T/M+L+XELC(FH-,V2(:P%C7OJOB'-F(_:)3GUDI7R
M%+-M\CO!%"OOSGQK[C1YS69;!7'B6E]R\V 92CY%<3".C[5]+[;2:%!!XL.Y
M0,U<5,BSN/%L#>FD/"&W 6IA^M/,GGG8I*A0(,1KRR2*)Q<7NM1?86348\K-
MP^J$,-P138Z7MYUW:+@7\KN\@8DN2>)<MK 4K1'2D\ _/@HWR"8PH*0(1GU,
MG9W,8]%PRA*Z]Q -C+T\=,+RCKW^!NQC__23Y#//=5*20ZQ5Z::1_:?:U!L5
MTL-,LO?HS G(."1_;!6<5=WVM&5D/[BI[GI9%Z@9*Q8LK]W%'CZ*W1HOW'!?
M3!E6>0.L&7<GQ>:GDB*$W@8-]M] W'(Z'?/VQ3-8V1AHB+,"9S@?GK"X>*RE
M_!,H/(Z/VPEGB5IB^5"=]26X^OW!)7>G?85&#8\JT=<X]1A?+OE7&]>^1[I-
M?M*9XO)G/G-P(+G*%8SR.:%+NX?8Z=_1]BQ\) M 4)82OD=7.31*^6*^YSJ!
MEYF2Z7*NT_.F5@["V.;RQ/=3Y-N3Q."AUF2?XN%L EEWUNYO4;HL+GBJ_GJC
M*D+/QD+"FZD^<5@6THL6K\SV4IMBRT5-O+_)UI"(4=D@[_7+-^IDPOJ_4V0V
M$A8L.=A%"3D4(SF3F8P1X2Q>/WQA6G!ZU]PH+U.GLINW^B&2-N,A"^;!&9F#
M-W]-<HUQS*3D(>R4*OTA8?#,[D_#L=B*PFS>S_JDT<80>-GO,=#"O.&]:BV"
M]/AMI;5+$BAGV)/XYIEX/<]W&ZKV-B^YP"K7(/U<C;.].+!"ZH&O4?%.2O6<
M[1:FIL>O<3LUO;43>\M:%:69AF?*I17;1F>HA&Y+(CYZB^B96+KK_Y'/_+^!
M31&G4N^()\6\0R'L[TB72W2;,[92 $,FE)J%%C\EX4'M3M:N<]PSQW3VXRF)
MXA.X"\]XO%)1%1*Q^57OMCYH1GI "8R4,I=@K[+,R:9OLI'G(Z"6\9P@_16
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M@LI_.O[S,'/U?\EIAUQ\_@]02P,$%     @ "#I75ENQ&5O<3@  KU@  !,
M  !I;6<R-30Q.3,T-C-?-#4N:G!GS+IU5%Q-NB_<N+N[NVMP @0/[I[@$B"X
MTTAPAR#!W1T:E^ 0W$/C[N[^\<[Y1N^<N3/GKKO6K5Y/_[-K5SVV?_5(O?Y^
M70.@RTG)2@$@( $ B+<?X'41( & AX6%@X6!AX.#0T" 1T3&1D%&0D(FP,1"
MPR8A)",E(20F)J=FI2.G9*8B)J9_Q\#,SL'-S4U&QR_,QRG$RL7-^<<B$ @(
M",A(R/@H*/B<%,04G/_Q>/T)P("'"(%$@(*@!$!B0$!A0+SV LC>^(2!^-,
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MN[6U%:Y3P'>"/FR0N1!@/[(9:V-9+_:6Q6WV\2BU45DNK/-"=EP\<*)+*F-
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M2VW5KC.K5I'$1O[#,1C_KL3VK/SWU32 T3^6-2N!O?=)!HPS+O''VL]P<*\
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MQMW74SWP.==PZ8@\Z/ KJ%#X?WPO.G7,F_3F.KM@$NRJ=(]?.Q1X?!H56AI
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M[5G+C<0*.0\#7EX/,.HL;15,Y\TX^P:8@U/NP\E-J9)8F'Z](ID,+4).EBM
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M:1T+1N4<3<-RK35GE45W?EXK_%G&1%@8Q7K='XY'ZWIC\$"&"\/9$F-ZW7G
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M2$/AO1R1.M*_T2Q9/).YRAY1;,X:TW@ E9PS NTX"-PKG[:QWS+H:2<JZ^0
M<^_ I[R-F23?88%8?F28T)66(](D?;0H\!?I)OIX/P!QG".(5MT'0-KFW.!D
M)(:@*0NO1F\LXQX"ULA>L6GT)^0M.^(=K96->6+=VSK[X@$817,VQ14S+ 57
MXKT_!X5%5<PD/D]*]S.B;H',6$4\ $07&47T]X2T_H>!)OS+,81R1[NZQT^B
M*O66L#8:3VF?RA@-3N+Z2J.26QMS)=081\/:%WFGSF$QSU^NR8"2#NKFZ'N
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MF7'2+@XD?P8K01Y($\>53,N_'"@1;(N1#9.*%"&\@[IOC_GU$92V-J7ZD2@
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MF2BOLH.P,5>Q;RGN%QJ/]7VE"W9:9!41CXF\$_5@J/NQV+QRFJ4HY1A$!NR
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MC?B6&%OW;"["9U_Y),7IZ&AEICS5#S!"!@N)#P%>OL2;R4X"WXNV"7_OS,S
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MTVWM(-/:R/L'@".?.NOS78*ZQU78JOS8\F/0A3F=RGSK4PJ&I3B_P+C-:WT
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MA1IRI^P?Y5:K+?R3B*#?OZ/ZR/0>9SK[ZO)J)L7&_\D=MH_R1F6#"UIYELM
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M>Q46<&:0[]F8*9U,Y34D/.J A^SF)\F6@\8XS,ZV[8)\.H]_S<2&I'"3/_Q
M5/_BY< 3P.F,P2F:S>!09N)5Q=YR?4W4>/_8?GU[6 *%4E9>3H5PO [/NMW\
M6&YX7HG)_*P\A:%US1+))YZ.O@+YDGFYCS:&UKF*.HR))/(;ZC]0[]'0K9(L
M@@NDV7!+2<CH?^OBKXI3J+5.6E17?^FO7%0F.EGDM;?%G(SD<EA9?EHJ$J_V
M9MIBOSE_D?18M=JY[+[:P5\PT5'M\+WY.SIM<:F>10SCQ7,E!F&],^-_45FV
M7*+8G&#X))73GHJR1;N6%D^S_^J%F&\"!8@7-IY?(Q->\!CU2-ZX/F;-Q0]
M6/:]B/_:)))[^$C8N3Z*O;)6)S'90A_5]@-PS/L %*G=>05PCFFUKEH^;IWL
MJW.YK1U3VUL)#D%/[]-3UV%F%*7_=KZX<X6+%0Y3%S2AA=YF202C_]GCI#'J
M:'#6Y+LW#\#VQ"/'A7TW&4XUV3^?YF2OYN"<Z?CPV+R5ILPQ '9(\=,CP_W_
M\6 .3JWVJZO4!V"B""'^)EI%&RZE.250-ZIZF.(5#HSFEOAWC2 R)8]W)/_.
M*6"<6T/NJV!<T,+!TV<J*?@!X[RD]9]N_F.$>55I3V"004,?J?'"B,%_-U<)
MS3X7U@/P^E',4E%/"%LZ>%/#BGB2"\.#""E/3O,?DO]][*-KM,S;J6 (UYR2
MB46A^FTO^O8!^%?+!Q_P,S2$('-@Q7)C;*[1(!J!B?]&FLT$[? 7.TD_"6(2
M/<Q/U?Y9V?^-#:HL1(UF>WD#R&IBFX6$ROYS@R30;;GJB<F2LK=30=<EK\0U
MPWQ;C5<&.53R*Y]WIJ(;6>V5R;Y2'!V5TOVXO(S\!T_B$GT1:"A';>HJU-8;
M!BO1ZJ.M_=*W@J%#_V/_P.LMS+PVKEBFWIR6ZX]T$0  N$A&N!I*$S;4/*/\
M2,[C?7C=&9$:U QR;RG0;^-9<*6%=C]WNZ61_$R[2(,>P>>E4;]>FEH9E^\&
MGIK]V#WOL;)I*W!1"F?.5]>0XU\PB\IWQP['^L@$("T&$,7F,02(JU \][O/
M<^?.< E?=?-U>7.LDWX?T7+0(RX79W=026L>O2&++"-8!CAE/,L(SYK0F103
M+>U<V?U=-'F'^,1IUNY"2LN5/EHLZ9^'[U6IZ1GWF/T2O_Q;(9@./OOV<^^+
M&GX[]SD%\ NPO;V]Y;P9%!+Q*R[1[Y$[,LIL#:.?<RJE.\];.(XV"QKW4$-G
MU5)&2_&SR+3N>_K[/CD=X/&%.5<OLO[5[@?>(<&3?HJ)5S&%UCX ==V6+@Y8
M;6^%4#P1'/5B > 163ADF_]]D6-N.#.IN@(*P_*3LV>!">/US69=:2:P B-K
MZ8,*VDE9@_9B%10<3[WC8'\_*2:R?16V,!A54C<GC=4\.E*O4)$N&<EWSQ6<
M/WR*:_63^YS.C;8]LF_J=RE3Q8HIOYXM7U0.AY1CS3/GALMB,Q<S-4/JDH2*
M&D)87@I%,<2RN.SA&P#IM!GFEN/!?Y6T6*,!E +GQM:0<Z:9S>,GR<68AWE!
M0LN!IQL*I7J-BGNSI/2)]/QY*R-/8PCT(;_<!4GZOKZW=@IQBFU7D.1"-?.0
MA6?6UE=5I$+^_A7J7R*E0_03C["H\ NTI_:6-,:J/IG%OKY\*B;=-[PP /(W
MV/C0"#OBFX9K13B5;$-I8#\P/48H A'%ZR>9G?[XLCUX?)6,>^Z3FLA*0: G
MPM3?:O_F#(@I$SIQ7O2S6PT[!J8@]\Y-E^P:3,5\/=N<Y"=[HS,P4+ZB_*ZZ
M;5F7OK0[3S"<J?Z8B,MHVZ"@2=G,EXE;1DI89:G-, 2OQQ=,--[ J2,Z]2A^
M*;'\.Q;;M".[7S\-EF9]JZOV/U6^$8 60,G,X)AHK:$E+Y4]>J<;#<A_3#1B
M,__]X 4;O<ZQ0$+N+[H6V,D&2U-P5/:'+8IT*U%=\6%F2#O,GOKE5,%8K8L+
M,FA";*PMBN4%'V>[K(3D%TO&!@Y5-4(K!,O$(5/T^(XG045>/.T'Y0))[N!
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M;C<MTV5<YJRFJM8ZBB[Q9)A$L#+6N8IN>P+83^6)=UM@!6U&7_CT.!,V8__
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ME$#?+R)5P#(V* #?^KS_-P%02P,$%     @ "#I75@[ D.LC4@  X&D  !,
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M#KT7.;U;A3*]AX4Q;];#+!=[FR[NQ2QU%^>A -SH[W ''D*3IR042'U'?C%
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MO+>::!;A@P(Z ' GK-BANLP@N;%\I%=A-SG)^OUA?6XAM-:1E+5N2Z-%,]]
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MR>(V=VM[SM(V>]RH5_9/J7P5;L(F_+@_T*3/TB;8O-YN3^PI(?QJ$EU]Z-B
MU<AO/Y,Y<AI<+["I91SXM"I 0PWT-A[234SMTLDWY& ^[/'UO*XS S'Z7.U(
M9V&'*'04L[)?\:D&A/X4T:?L%+91>;RJ45O1"^-ZA QU5KV!8[J#TKB&-:+8
MYRA"?#DS#(,AK^)PE7OF0ZT[X21#K4V1BOT:H3H&9F[/&R$.96TWC];1==3/
ML?+LA,]BV%=#QTB:=\9&DX=K-7MTK1PN/W40T4R"759>AFWL[F+]T)4\K&<5
M[@8([H^$8]+P,QQ-#A?.7\4D+/?+6Y%DKMY&<5I.[XL"]WC#LNF:_%J?#23?
M=W'HB):%YE)3?J#&J%UHOWN(+Y@OR?VU7R:HQ1C[CUK8^PY>,4(!W?8$9M_^
ME0:3?(ELG6GS\X1V%_1,S;L&9)M7WA;. D:?5V];?!PD1NN0JL3RW" O:JN2
M!Y(78CBWT\(F^UZ)466+/CLKDN41@U2<Y-2JU#;5?I_BJ-OPI(?_05['N[5O
MZ7=)+HL]0U,UF69V+D;?.@FA0<D,(8P3F>\F("T##6M&69Q(+_!/+EGHM,?&
M9BF4S63&LXON)6'VIAT]EO5:9B)_R:.LK3DO(7A2B4.PH,_(3(7&!^SW=&+
MR_#X%675:V=-<+F9'1L%2%$VT)L@)V?=R?>[7Q21JK\JG[1>#MLSQH2U#7#+
M?,XH&V*C1N(7/M3(4! VV(E0]#X%N1I2.9917Y]PK79L5!-EY?^1?BT<9I&4
MEW#UO!#=2J]YG(EL-VL!3#EJPH3,0D9J8Z3[#2LG<C@" ]UY[\>=T![^L]IQ
M,N<O S*=]8[\W-RKPFY74@0DV#-@D8^5LU_AE*O&FS<'WNI)32=')O'1A%/O
M*PXMR7+*A 3=<]?55HR^S:K2S(RVY/X&0OM I&!,3BL%FY*4I(;F$3Q_Z;&B
MUQ"[=$#;[#LCP[OA!HI]IGI<<T^95';_8#-7O-EM?NNF/%RVN0 &M*,YVLFN
MP=!:;[2@#,\E+_;K8\\\'!5//^RO$I2JD>EVW>W>;E@(7KR9":4SKKP% ^++
M#(UBF2EKRV&Z&E\G75[GO_H(2,QW\5)ENQ4%A^-MQT;,W07+0A+&7I?[KB]E
MUQE245'2J*_Q&> >RW-5\7QT*@A(JAN(#VUY)^F]5N?_Y126+(;!S4K.G&6)
M@;EOQ[@Z\>)3-(B>;=.N*\'UQ5KDASRW(87P=M3LK?,91W#E2R!H>2G6%0.6
M$ ]/OAMF)Z6SNH%U@,@R%A0L8>9-;6^\@?2B&\$+$GGZJ+2X 2^W;UG*-JTV
M@#K*?%6[9B/^62@NW?%MZ;OJ)?O877=$O/'-:\,QIFQ-&IPA>WN:]F($&%,A
MX!06\*)SJ?93;\H.Q554T/B7'Z'YO<'$_?6;4COWU% @TN/BOA8**.J)Z3.
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M+:I3>+S:ACYK-&D[!8+LRIR[O%(]AESH8KK&U?S%Y4A2'MK]5/"-XLG#0Y3
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MX@Q%)[C/WP"9L+"O\P52,]6^>Z=-7/^J9W+P%C9X"8OJ?7TB'U^XX.HZT]M
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M,,T212UU89(DM#CZ@_^I87)Y&Z'DC9;'" 7,N>-0!1RJR<>E\*F1./6]5-C
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M"_A5]]_M)LGGF0J'9NMN1QO!/%3]*#^X\#&J<]CZ=$;&ZEOW.O?FV)_-+RS
MGTZNU94G#4-J['\D:@1^;+[^#%7#/N]?OAQV/TA-;4DW)<XI?L[&8) ?/*J0
MH^WU2,4#L\*23+5H>*L*[/V:Y>"VI;&^4).Y;9-[/^N7%..,WHR2;<W5Y9-^
M!ZKH)I]U^9? (37*38EPT,%NXPRH'T)\VQ;JA"UH-Z P5#C31ZN/7:&Y,*C<
M+D>D2:8A1P3X3P!:+UQT2W;"9QUBN0C9'M?WSL&1[43PCV?*B;UQW_@A1W8;
MI+?*__V<,G#9L;]TBO9>IX4UR;CAU,'W--/49?\58A=1YG)G:ZJTGK+!%4EF
MN$0#E88$B0J#RK?D3:Y26N8P)>8 IE-+M0^I0]=@;9&SPET0=PSB?JV+6*,R
M]WG]'.L=P>F+;"1@G!DG;T%G*FM4@B4^C?R$QB=/C=M[L'AS=IURVM'R">Y:
M'9/#19FR)=BE4:7F"Z-MD 8SV[/"M.\TWZFP>R%8NI+-YPR6?<,;6W,@Q3RV
M'1[ 0&0('B:F8+UOQ%;>">\W.E^M,2=)_H="W6.;]97UE?8G/XG>+A/4*[['
MP[6!L4 '\#',L3[FOXT:>_8><^GC*]UT3271@O,RW#ESEQ]&DI,;%^>1WT*'
MUWWFY?&<<0" $0D\CTG&Y6 VZ(N*"2<#L3%MKLLX%W&&_KW/,NSIEXH9U>5C
MEIKIG<L,1H^A8"2@3VQ.)TE<6FJ7A^A'V2U]L(Z)EN""\(C"^$IY>:TN=P:9
MXG0M+-U!>Q?<R,$QT*Z7U)*8NT@)'E:GT4[;7/'L[;)H5YQO.[;%8I04FTIU
M0' >#\(R?SZ2+5 UQ[#'8@IEU-'[UH[6B?>&8#SCZ/D\32]!?L:$!.]:.J$,
M.GBG(31!Y0UGU4]&39PNYX44O'6 Y??*":=A1MWCB^J[@^K)W,)0TFCJEI'*
M']U-Q)^B.K_@06XF<WC]CLJJ5!64)RZN#Y>;/G< 1S-#NO#MJG 00LY[G<<+
MB]OQW!)!4!4!>0!9-%_,UK'H:D'5\V!AMLS,^@0P:%#\W@LS?9^)Y8^55LS.
M%K$+D=S$P22-#A+L7""Y<?E=<EV"/DE<X*WA&>)S+21IZA&Q:E'1W0@\-(TF
M\^"J[$QHKQ=NMVK%:E0S_;9A@B%H22U(MX1KB?Z01[H](L1K<CNKOO^\3 DQ
MW80$?.=>VJQ6T(ORLI%K&F<9*\L,VF4)3.-OC"$("9E4(%62:G5  AB8_?.G
MXFZGKU,.+L;W:'B/8Z#4<(!*WD+A A'_??1!G.?K']:-TSBSC].*()Y.EKC*
MBGGUX[RX%75ADE^TH,7%.JR8N+YA(H5C[4P-F\E%U *O"&=DF AR7UMBSD5Y
M]4"=$Z)V=!I2)T &MRU9=I>!Z+$=U$%U9 >GXZX-VGM(P.?64\+.-VHW7GOP
MGX5!?7]+7M7O-/>-WLUDC"=*D#(QT/#^QY,W48VM\ZBX&7VW*TG<<H'X.$E,
M11AXL)9P#R.(#'V.48C9D=7)\>UDE0@MB3G4*BW8;658;,+ DN(\;#?,I>XC
M4/!G[V&ALU0;=G 7")'D)"+!6;!K;F-LB2V5Q=559&!WVM722YER\]9%* OS
M2S6GJO:M9LV)ZIB!H;!)Y %]9$W8MT?L'6%M=@:.BCO6D?WTD1V?QQZC&8>I
M8=ZK:I#W++FFD;6$$%]UMF+*Y>J#FR=;*JW(<;!TEWBDWTIE^1A,!>?OEKO6
M7$E/\C*TS)G%1\PST6B@)<9D "+<R#$7T]+P:E3Q7XPAIOE4.0[%\Y?0^8FX
MI*66GEF,JA(RG;QL.$I!?(JS-'O?!@78SUZ," HGL%59:,@1/PB@Q8?'49;=
MHO4B 5E)B?F%<W#=48I?]^-V.S9LGB,!1)95/4.2"1'X]262ZAVO+,2V+KO<
M<W.,7:VZ*X6R\S,B^-X^-)$<UAN3$#?)&I8<D.P>WE_FJG71=(MJ" M.^XPO
M#2AJ8!@Z,\*T(( QOBB?XE'!)=7RE[675X]U]+NLO:O2FD.<AH/&CB]3G6B[
M'N$JO,9)2BO)G9^?YX%,LKM^M0M7+?*Y&'8!N014'8@_KQW]RK#Z$ST&'$&;
M.N<C84QWGC=O%A</&@)EYQI)<9IS2^/ZL:T_.4J/<4BR5E3&ZUO=_S"%H-6;
M-6^(+<G-6CFO4Z1O_GR01'WTE9]^I>6]J!%H_/A],8+AQ&JA[V=F0^3GN-O^
M>YG7TN[L&.GNS3;+R62F-0)&NRYQ4S^PK YX2E]&R@]>J;^L$;=F);9\?=R<
MEN'M]-#:1O#V4H9R?E:E(EOCUU.Z(N,:>04+U>\:9GVQVG.K&_F5:* ]Y<BR
M6/>G.AJ4SUI4 %Z</XI+:#NG0)PC@BSFAX>* @OS?1_B]!WOA[^;P4'; 55S
MQ\7^^_]K^Q] J6SW-"@ SD1#,;9?S1G\L&PSU33J_O-U+@__9P7HD3L&7G:(
MI_X7$G(KJ9IS:@TM_CWF4,=J+5.T+*@(DXM4M<9\XB?APSWMX["<W.K%(I:"
M["7]DNQT\U 2,R9(77L$&X<Z!D&/@I"Z[(EVIH1'D;E[\M%X;I.'EY0^VL;
MM^)1*KS=67+$3I%.I(4AWX1@W_J8M>,"Q\ .+XO'<*9>JNB+-YJV OU,EZL9
MX1W38J%E@<NIH#&W:IL:\RLF](I)QEFZR_EL6HU(K3Q-IQ9?(50<[@*/4\W%
M#!-9AJ4H^Y8GF-K$UR/UXN@C9W7L>J_\Y).&%RM6K<!JT=V8+YJKZI_.SEQK
MK.JVD44<D4?;L?HQWLN+[Y@&.87[?P\$G6Y*OK-QHHP%V#@K+-%?]@,\WF>=
MZ#^CH:]L&2OU).6ZRI9PUO'+-(L6?<2:&-$?5M?CX9 D^*0^+W]7+"UGU>EX
M,=&5J[NY<'[)\)NOR+SB&VE[-!&F*+S["LR+!2M6EBI?KC2C7X]=L",&F.I0
M)F.AB]T X)1\$?M@IR$<60AS =5,E=!Y:1EV<'(_9WK+_#'\<"#Y&X[;6QG&
M_&XI,R%>DCW0RTKS> KKV-QYK^*[XOPXMYC'GSFBJ^65F-)<5^-\IS>=!5$-
MYG>:V#9+4BG67U6.TT=.[RZG&L+XLGLI!''*Z#0H:A8V+E,.1UZY=KL,S6DD
MWR\7\)F83H8N[;H@&! STTU\)16U]H)[(AFA6;74$CW,/3OXI4^S\DK>*"9F
M>QKPI*X!"?0,F"_624;G)$@NXWJT0Y4)]VW%3*G5QQH.I!#36N,'1_LYA'/Z
M=%'/J-N+N1DZ3O$I7=,NP2XJEME5CQ7M C@I'_3^2G+Y_(GG? 1]Q]GEEP0I
M'R-FZ$FL^,SEI:"X+J-'*C/1FR>&4'!+_^&[P(K4,KK7X3W9/]PY\BYSTY$
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M5\=(@)\YK+]F6_0\%E+BUF A'$V(D:]K*RW)AHY*^%]7U:]/PQ$(VN,LQ)-
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M2??\2PQ7SU82KGC36!/QC1:O+AQ\&U!+*Y$C__=HL719@N_X[XVHU7IIWX9
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MU=->C=#.!PV%;)MX6A/+AW "!]/EY%#AJ94+;K750ZRMAI2OYLZ* 2GI*R\
M.)=7.2<&M=^$O"S$%7YE-QV?DSD'4=9%+/2WHUT]=D:'2_9M!1UN9R4&,'"8
M1\_KZRHP3_KJJO0)'S"T_!*A*F#, 6<&_1^_?\?!)\/91O4ON45WEEU"M("=
M^/BQA:)Y&:X\WO6^-T_V#,]6*;$NJ 7Z:K _G!&7]Z+?JV=<H=8_V^C\1RBL
MV\.%?2HV=J>W(7NY%K0P[40D(&'A:LNP'14RWJ@>2@*5#%M;?T?FX]\=20KP
MZ@H54-(T$M[D*9 ^ZZNS/-;.%Q@V4[P)[M;=[D@ ZB"I1P+B?O<#2XAJVN.
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M23*(Y%!,L\=S);)W4\H/'>+/ .]P /3O5D467QBL<$:UIO9T:MX2[1,<?9+
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M\["F0PM%?G;'KK@M^!%?V0CCEAQ44+QX.Z:YBYR?_XP"'C?/;A_6<Y8\T/5
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M;].^3% RB1W+Y"\*W8.LOMFE2FA]()2YRG\&F#PHB?9X/@-\$6_G)A=Q7'!
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MV<^+W3!$,;Y;M>,!@YN4NIZ./:(JXVJ[*QOEY&,C>]XI\5&YEK9A=-WI)^0
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M(J:"2_1K:7Z<NL:+3 _\&T 0_7J$LN^; 5MV;"SL3@D8%-9WG'[V\QM%[Y5
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M+/$MQ<RVR,!M ]+'DE4]\9VZ(=6A>I2.89.J> U3C&"W:51JG=2VK_F!R*?
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M!;@ !Q)%'97"_77+PU[.?,8$QUE7QBP6**^$ RG>/\3@EU7_\OA[#>X;^%S
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M1J_ C>#TZ%X0G ?Y>DBO>JP,VM='% UXSFF:^^##Y>'G&!'<5#+$&I==1$)
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M>)!&,1+=MG DMV!A/5.M298]&9FVDS<U=3:\BJ(\D_W')/%^TV#.D=MKNU@
M@[SR+4\J(:2+7F';/]'\BW NA5H[+7@ORJ%E+_XGX%40^OOE71N_^1;%^9:*
M;X>81)V]B)3,#W<*9-=RBN<Z(Q7L6^H.=>[ZAW,"X/5=^N6>[+])=EC.TLKD
MCOA06(HJF2Z?*T )D&&SE(2E.X$EKZ3C$G6 7A5A!GO;J?Y#;Q8C^-\\'HW.
M[C7N?UJ*$Z0>>6AS3-5@+E)_7QADXT!Z3'I=6C8' <>E3E)I+2$@4:T&4M)C
M0D+41=?!&)Z,YMN),%=I"L*1&,9TL"U>M[^59/[,J)$G:3";=D.HW> K\KO
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M!?I2FJ+D^U8=6]G2]/N& ZW#R*_M)^W_X57:_^_M\L_I?P%02P,$%     @
M"#I75L:H3K\$( $ %T8! !,   !I;6<R-30Q.3,T-C-?-#DN:G!G[+=W--S1
M^RXZ@B!:]%ZBER!Z)PBBCA)$3R*B$[V;('J+"((8T0EC"*.7:$,B>AF=F='K
MC#I1C^_OGGOO6F>=L]8]]X_[UWWW>O_:>WW6Y]GONY_W>6YG;U<!#W6U=+0
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M5=RNN]25:F?>H*R0F$OQJ[D94>WKW"-0/'-UUT/_(1 !+BAXO%_@\\56>-^
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MP-#%I)'-S)LO*R+CAX69G=M$6VY#8:"[IZF)O8DN>VG[SSQ;,VQMEF*O4Z'
M=3],!*DG1O)RV,71-UA!C_^KU<[3/0IQ. #5WH6"7F4"2:]-;P%:#XSTOOY(
M.0(OM 1Z+,JRS_U'8"UH5+Z>9<9Z)8C;V5[98*XS\Z]F3&R>U06/L[^@YT1C
MJD?9<*\C6.R=<^%)/US)E9I8^(XWEMJ3J4,H.F-C2!=L^W:L+MQ#L9QD&9$&
MEE2_YW=F3^2A[-@#2"4N>X!9-;KZ\&T=K#F%MR4HE:F)[":ZJ</O0JQG6+5W
M?JFFM&SGHB3"^/H$*.!8<'U */HBJ[J4;SG^H+VO6Q%!B@!_*<S,?O]*NT+Z
M>#GA^XZ="/8P4>KM=%G]I$&OGA^WO%/OP^]FMP".9=6/D 8Q_+F=0*/9S&/1
M@T\TPH\<X$2-(:9G(?-KEP9B#DOTSWQC_'E"F,W_2Z^6((;GRXJ1AY2PK-)5
M"-!2%O.GTT^6A&\NNT4> +K8G5)R1.Y24H5'&\^T&WB7N;Q[:#>FRVW.XR2O
M:K<ZAGS]([MEZ\$.6J [KD*^,)_F4.).OK?3] 8VJC#@ZNXLOI-UN(;F'6\]
MRO[[H(\=G1R%-]IACB5<2AGM%S%9&0BTRNP$IYH/JC]_VO(/B%\F/W@XD^94
MT5$3-_8K2H)"4VHP<4&O0N4CXEO2$ =^V),I?Q%*\SSS./G&SR[MOV+BC8AJ
M1[SM'$J&D 9 ;;<5JMT0]&[] 4B&YU,U?^,3^4)UM+](X0F,;K. "+:O887Y
M4K<#?)QA.?+:TI'(MPR/:11!M^5/;CG;W%850VO\_+4FK1'>_Y@VY\EK6%8K
M_*X8=*S>Z7O=WU/E8?C=TF/C!HHD5<7]A^W>Z'U[G0(M=I)<Q1:TN'*W^;QD
MMQPW!\0V^Q?B@J%;<8GM46B^H0_O9SDM='/M/RV%U0>GK4(MEUS*!0%!!W7?
M=R:N""9/FD]VL[J 8O[-R=F,;X!TLVKE2] >S5J9"=*NO4F.C*:-I:8R9;>?
M11GY\$*'GOW/MX!>T#W1ZD-F6XD;%!*=*F\4E^'-(< 6S/0CY)D*#R8KG[[H
MSJB=_(L8?1C0PBWQBK(]6$YEU:(VJ+='QDYB_*8[F.?33]4<LO'KK17$<@L^
M9J&?X7UXU"U@P,)DN\0]:.*Q)+10_A; /&Z@_'>1.81)1>9.H7.'/:[KFI!:
MR.%UJ^6)DEXVJN \V5'>64F^8JJVVV9G0?@%6<)LA8BG]_.B_@#DN@\H@LZA
MNN-2UAR4VT]<<OWL;!NX'Y#\YF_A;Y$N-![U2#H+7#RJN I$M1V30])Z_Q6W
M/288]7G0U]DLQ[$YTV&H#)<2+;3&YV3]X#+UHA$\6)*[!&9#7ROVT:_0[\.N
M)=5;I[@:4_G8K=BJG\HSW6OP4O+&<IA%5I\<WM=SD"IVSC]G Z,Y\>RZ-2U4
M_8#UTW/@< P:N7+%->\Q=9&7 -,[Y5J-_I0(^LB^"3;PR>51X<=9_-@Q3P^*
M0%M,>)8</\I"?.[,^:7<BF@TUE:<09^Y_EFBY,$4Q,$.J:XT,N"Y-^!Y=V/1
M!3<G517OR()7DO\FVW6@RZ[JMP!]A KKTE*GI0A?HC@G=]U*,A1ZO^-=HOQI
M1W2&GLT1!WF8W-0ZSJ#".23^4GIIK2R(RZ% (-F#:%)N<]?L1(P&!^V9E[*B
M.X\\@'IZ6 S%!F4+K/K]!MSX[TT9CX;W[^W7BX<)^U<M.WN/0K;'ML^3^[YR
MN7_H2#A1F>X)VNVU6LY!)XFQ!(6,[A\RQ[3 B#8XR;Q/B9KT+7Z,Z^B.K,LM
MO<2*4:LF=@KJO2Z!QA[XY:L(?JP?]4\?U4B.'*.QMF>X4@P-7(5P&(SO.;5=
MBOP1'?Q41USW,PJD>ZH@>+P#&2MP\CN<*B^!8YW/Q =+;470YJ93#XNY6J")
M,@PA!;W[6A/P9;VDN*.S >;U5%::_@"I%^5./O.M=7U!#$^/51CFMN:G,P2"
M\OFB'+L!=5<I/BI4$U>:F$UX$_/3VK9.S/[".G\"*?'Q>%KA'DCAS$KP^' #
MR#4YN-[);6FSPXXW#7%?_1R:P(7'G>SX=<V/#H@T+ @NQ=T;F;F9MW:+"2;5
M%MI_G85.W'<NSM.CS%[>>%BA_%1Z)&C%?/K$BT)'-*9<)S1BCSO%07U!\NH9
MI>ZV0$D3BX7V2 1=7O\R\Y0GS#*,+KABI^FQGNVBL*/:#JU#XFD*0U^$T$R8
M2,62#A+I4*6NN[ PTF]NIW DW%#TP[1+G9O"KCR=(]Y.^9)E5F?5+;HB4X#?
MJ$?I9"G9X10" N!HC,?:N2O[@WT\8!ZFOFU]P1]7T05VOG8IFA0AEH\JW (.
M@AK345[Q[&11MAPFF/6#1N/1] "V!>ZE6A]5JUF<(S+<51EDCK6/%^F'+'\W
M'%2LX.=)7ZB%&A?%J3X2L-P9$4-]:2W$& R#TYV\??V#GO$\C4DLO!Q(!1>D
M..!,D1RQ:,QPVME,:KVK"/OVW/I[#7;O#[^\[7(T>?DRTPU)VNK[KKQ6&3"=
M+45NG63C&UPDOE+TE]_66#<_ [FYJG<OM..59-&S[5Z%VR8K"W;/R(=_1&\\
MXO0D\#_9I-OS,SU+JU09]I.SQ>^/X,72_]@6BRF;;"@D]<S=CO_4*?=K0#H-
M8Z\UU1!JX.+/PK2OWZ3V23\FD,R?"6I2E"V3]3RLM6QNG9UA7%K/*[F3>\JI
MMCEUQ#_C3_ZGCV'IR<QI2(M8Z"H,:P"&OO9V(]^+(?J:%RA(1L)T@8",&PQ'
ME64H:3_UH@D3SSK6+N@UW65VTW_;U-QH.P!6IK23@ZIC[*#0W7L'Z)=C-#K1
MW'L[P$/&P$7AZJ(XX1/BGB4@'G8T\NJIDC?(H\CR[[QGXWC#!!=U?.#; ^5:
M'Q#S:8IO#_U%P0='S%\>K:@EAYBNUJ&H\F,.B-^4T<92I)KP/[ (\O A#MI]
MH>#,'!=5 UUO_&,]^F#=QNG#<Z*TD+W[7:@A$&&*EOT#K8L,@]BZ1/V(W<N^
MD+/^0"FCM8*G1FZ5JZWP-%\TB-I%8NN&O&UL+?;5>:"OYCI^%*4G">OQ3,?6
M>X&B+Z7><*5"3=H77VB--0'_8]*EH9KY6C'@*@*JA@P=]YWX8MX$-D)W8_7[
M[SD>^+GEJ<8)E^W,F#P]TGL2],Z&NCJ<LJ(BC 93ANA1X6J;MMJRR<B$F7P]
M^@+V/9SOH$\LEX7F/" %<@_QC\,DL0=L1B]'W EK3;UK]T;^.DA'_Z^)N .>
MZ!KPQF_27"GB&'X+H#H-8AXRQ+@WTNC*)"S6S8%7/P%J\I!-'T!(\EHPZDRS
MP+Q-L3S=4#VU3>UPU-1VFE;>Y:TTN>?2Z&.<0]%.B%=RNYEWJ(-RNRSU!G\Z
M,85L'1H!L>K :3L$8TG"M#QIK9@(CBSW+B=2_YWPYY[D"O@&-@L(6X*ML:&:
M4S!K* 6; CPT,VK7#VQ"/RO17J!;AP6:8_7-J9QO6"<.UB_U[;O:(DD$%#P8
MMX"0$#-:08\U"H;.-C )4MFI/X)RHK.__$JEV<FAU66-LM/\E-\+Z'H&N7^S
M:SJV+R96#?ZS\^)OUN&,Y+:5E,D7Z!@WNUUY/.X6 ,020OOSE$'Z8P<P8HA#
M2EQ6G-M#"JVGYU4(L"PNK>K7C!4HVK$VR[AI]-/=G?P?<THE8LLFMTTR&N>+
MP05IZ[6$JZ&;IPZ[T"C--:%;@!\- JH"@V_-='+CK'_LR.@AYT[SF5% ":97
MMG\[\]/<[RE7+504Y^]Z'XF(C"'#5%$>GD<++Z;\(13*1 :QU&-#@M>KW&UD
M?H=VQLA\Q;Y F:.=WAYZ%4[+ W:SCA8BOSBY08)4N1-HX:F(PHKYI*??98.8
MES=3ZE,*"O+@X:9>,:IMJO D32QLNO$;R1R-.LG34/P"S(_DK!)=,;568+(3
MMN!CNW9Q/N/L3H#Y,!,LZ9,/,8#LO8]XX@Q.K<S>184@%6$$RYKQ]N8.]JF9
MZ893"-OWL)/686*J422.+>TM'N>RIARY6C=1K58Y.NY)R78I!T%*5A&%Q6$:
M,U[^MP#BY=V;T PGKOZ-[TQHZ%#RJU#S@JAV:8@VEM^B?5H*N+=KO2O;TX>7
M@/^*D,#[&T7F7H/I6=2+Z5%23 O6J5=$PV1\LM?""E9R=-"4Q;J:_DL>D*IU
M5SD[DO$P/8Y^#VOS&2EX@UM5 $@<SSDSCQ&O+3UMHB,QD?5PC$[1VC;MWMAC
M?W*BOMRVH.ANV=:#4J6^A<6&B#<._&V.3Y5\YULY8EKOPTJ#$'T,"F6?W4W\
MR"*)#B)%\G^$L%K4&&M4OG^Q-_H LWG%<X.'S8(18_J7B^E._NF\)O*<Z-N4
MXRZ$# VSO,A&#V=5M_J/SA*0M(;'O<F/BPIQRCW-%90_)03>20<VD#KBB@U+
M;T^_9>6>6YJ_RK6QK-I9<@J7WT\W$]MKU\%J]S-;+SL',FLEO;EQ8$EE^D>
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MT#%Q<$/>TS6!*T(1.EX.E:!E$".NN.^'9YAXQ7"QE6Y8E;2660;1H3C^MUN
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M71;;<!X8P6BK,* 7^=<;MB(F2/M-.H#5J:ASL\;8SA\YFB!A4.3F9-?XTM^
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MK,#/6MC$V./8OU='0NQ[H!'!"ID:?JG\-/,I&(L!/Q!\<^$8.T^W>+ $@$J
M4L[F0K^&R5?JE!;ORP8!PL-5K78\NNI5^''4RWK-:WINWYF?H\/H_)62KUTY
MF):<;RAQWK[OS*A7]N#S\Q0'?:_( D^E-$5RITR\_$X4E"FM:[$4&??+RPTV
M%O0E*)ZH'1#O:?JPB^#JBG%N+Y+T8R5! 3:/JV@^U(4#H3!SG"ER=P@4:^ 6
MR#,##;-[/D>!2'GYBFHK%(&'I?G5ZA4MU4%FK93-D+&<H;S8%6)XK?B@ JXT
MPV>2+3)^(@7<>):6[&GD;5@!Z4)/<)PS_'L!2Z\UMD$D>[4;.#G<"W(P2#S8
M<9J=T)U]J5W)MANK(HYMBF[7+%O P=P/'DL3'?5EH>]+?E*X?.O]HFB.PD49
M:%?4W@:W4\#>C\-2#VA.>!2VIV[@_5R"D\J/4!S\>E-?<^6"+B"Z\_+VM ,.
MH@4@OK_6:2V#1$0+7+G1-'<ZPPR..Q^@7*TKHZVSAC;^?2,?WN:=&A(Z8Y\6
M%EJQG3N=%MLN31#(/+S,XA<MS*@L=SJ@TM-^B-*^XA._!;SN1J4[<B7ECPU[
M=(\RF0CV,+BB\O7X';;B%\)<<?!5<F\565R&URK$<*3'5@9UI%=Q7O[E5R!<
M?->VA -[R' 9_<\B(>Q-YB-<&M+%T?_YN%G.UU4 [UJND<Z?OS\^N\IJ78%8
M'G.VI8K8JT^=;'U##Z=+$$WY7U7]P&JG5(?)(U^V/TW/V[6TI5/*PG_OOKIV
M+?P95X6F)+7#\1WTB*A/G!W9=CY[W^P#*>@8,)2TZ6QS\G>\5'2ILQ-^'+O.
M9A9+;/(R;:)24U'QX<;T]$&H9\R/LI;"ESOI\''>1>$G6O)"Q"/"^3,WG O.
M8.E:S%26Q&^1C>%Z84!5,SH=9W88=PLX C907F"3;@%J=!L1RG>3=A\Y6LUQ
M0569;)JAJ6N@*=F$+>AKXR!T,P\)7_\R21K?%_OBU3WR_A".,C=8E//!J]0@
M&R43 ;_78U$2Y$%I_4LB_ET)G>R33(U)55YB@86BL]=NA3@-Z-\L1.?#:9NR
MXI(V(6&P_E-T6N$U<1FJQ53=-&Q?LAH+37G<3E/">[KH)3G$F2IG].%O*#@4
MST))$,5X989LLWW'R$[0O!*_&*4U([RP;<>&5LSIY'3+/2MFJ1MO('WW4K<@
M<Q'[[1(<\<&BXHJ3,TQT@F3[\O":^4174.M:7=(S8$L'W15_QG[_\P33?DDK
M>$TRV+N6\$6@_*GJ(,*@R'7,K54$7.E1P+<ASA4]Y51Q14F'#O%(5J6)$'1#
M9*3)ZM4WA;[,:^+\D7X+2)-VOZ*;YF],,\?D[Q:H&N3G2BM_^?:$?6[SAE C
MROB8>+@EF!UF(QM[Y>N+HJ3")3)"[CS;JP76U:L1M#S[M]4[PU9U/G%U9QVU
MO'GH?RI<!WRS8,"4=3^^H6E8C3C:,Y!L\IVB'#/1L5J7^?=9ZSRRW=\+G13Z
M&[)7VD@_0<"E112@#3/'JO8EL>';-8Y!W,NG8/*#]UE\5/1/","G:!4"7#11
MU)4\I._3;]%";TZ96X#88#F!8QHL!-BC^@#NP=)_D?+'WK4U\AVUY](Z/N*&
M(/3"[\<76FLO![GAWSQ-RNI\@3',SV;7U1Q' @KT)W<_8!&I_N3"5G481!P$
M56#9@1>M'_'\"YCD*N5M&F-06X_"<@%1DD',3!Z(_TN33/%]?I5.V /R7/F2
MO1 (W4: G=2,U$H2#<[!.HO;T4?R[:4,.-@8_&\MW'4@J=VVJA^]S](S3YM>
MDH'2:WJ[:"9Y\9Z<-14Y O$=%^;O:[UNBO4CA5CMT:<2COQZ;P,&L&_ J@9N
MQ.ST(+AH=8Q'U6<$S>/Z'^"^52?,[R*A@]YOU34!$838_>Q4#\^2QJ90%X]O
MPOW<]YXK$P^X[KKU$WB'J>#FO%A?:93NC%6_\C-Z3[3U*\)_^DZ%1U0B20V$
MT/JS^@A%7BV#A2FR53.YI>VIKR/C84N4:D7MH?98V;YAH=X;:IW'>R(G,"'X
MZ&'KHQOLZ85?3941+MW!$7-$2?N/-Z4GDJXS9#"D4B6:*!>LI>(7<&*1QA:(
M^C[>A>1YXK+R9F[S.L-K=/WTX@0R!(WW<;5_X'D%+!5H:H_W<%[TI&KFI#J0
M+Q_LG><>=X9RP+!B?5U4.%=R>YV&G["F5+:_$ZL=0Q2E%K4GD *RH 4;;%JD
M9XW?((0+ 6'5YOI+^25TD^VGHM'JF%!"?DTVU*7U[_FG69L$\(B]T'L\%NO)
MY8:JS8*88;3+^M3ZV%K=D15&^G!>(4LYX(:I9J4O0@GAU6X3QK^*X_Q\1C<\
M_'?Q!]44WG[Z*$26W#TA1:^J?G)7TAQ[/Z?PMPM[H<^CT):P"CR"0R]#%=AF
M%KL\5C6VW=*I,&B&Q2(1%TFXU 6@?B^Y(SD \^6@>X=5PW:F$0R_X[XTW)=\
MI;H,8#@?$3":^>M3Z>@7,IJJ]"*,#0F?ULQ8:LJMBY]:)=O\'$HAK/=T.K;M
M^YQK%%'TOCB)4OE.R[X="&7K!;=CQ?D&AT-DP/-Q\\;<1V@*L.4I4:<;T!@7
M^1^!UFL@:]N6X-39%D/@+?:G>LT)<R];-)=(I37_FF[=7+:+OCQJY87,O,VG
M(=A-7X36;/AQ=W](+KUXY7NZ098/\MV5KOU:%DJMH!0J44AP^4*0KU'KYQDM
M[2>?EB@D(RVN5+$@[1GI^).J!>$.T0,3>G&?8C>:,:<FE/"($AMJ2;+'GBI,
MQ[<RI[VE))WA3W++: YXVM=N:J]3\$I]O&@\<;[TO['W5D%Q1=^;:$<("1[<
M2?"@P1U""-*XNP2G@8;@#@D$=PBN">X!NG%WU\8:=Y=&.]# Y?]PJ^9A:N[]
MS4S=^S(/W^.I<VK7WM_ZOK767B?WE4%D()T'Q8]_DEOQ,>BM]FO-I*4)*X\
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M6[N7[19G1&!]D8%C'[XQ-5HZ$9,1P<*78 '>51!.[RANBF/L79.OAOI*6@>
M*2<56'XOY<9A9(="I=<7[\9_9@LF=M^65\*)#AT"W>_*$KOOO 5VC8?S/0.
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MNKW%:Q$D?=[CX?9\5M-1/. 0<$88^G?THB$)_=M7.W"*83UP)1X0JU1MXA&
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M@%YR]&'EA2/D0!_:]_<UXF.*)<QQBKG]N_0C0!&QVE@EFZ2_2\/3&C[>\PC
M*1]^0_X]Z0=+R)!2C_>/B /70Z2;PFM'<$_@!YEM_/<R*,DM':Z2@$&=B4?
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M)*5OOO.'BW?;5N(9(<B4RG_T]L3:&^H2NT6C47?'O> EO\J9/RX>K?I:Z@6
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MB?4G Q82I_O+*HFC[M%+%!34QK94^\);&0-M7,*(A"P/+7FN!5&SZ%%3EV!
MOFYC#X$D)"<_S0$Q?PL>"G_7>3@^EH7))3W;3>I_S_4G6Y8.>+:\PI;NF?2H
MY;L9LC7:8"/^Q6FJUT&KI>7(_@S;;"F^BX?B;0Z679A^HX;KL*2&CKD+-KSZ
MU'@JV]N$5+P?9-;P (GKY(A_/L !J/PI#P.B)P@&>PZ!QW(W;.FHF:_LZ"T@
MX?L%<Y4-0<*<:R4+5=+>UM6E7[DB'_$8FMB!F#08 \E O@D&24]F-LM'>O">
M[DOE#SWNDI25A) ,M*5"Z0U0;Y;Z=E;];O'>+NI,<(\X+(#*H;H6%4)Y!!JJ
M([MWR E?13Y@?K3EC<\7OVBII$R'5HUMC8G9ETTW/_8;?ZAO8_S&_D)Y4SEB
MRT%9V*E$S""(+9OWM\7]T #:<?&W':^NX&*X*XX_'C/B9O<AF9;9O[60LPL^
M6IH_^KSTA!:?Z7L''Z>L+4%E><QM&V;)CQ<R;'B^* 5[:Y"?56I120RQ.&V7
MYNRJ9Q_[.G.2$L2PW8##FJ E:U8L2ME4K+O%ENV=Z]U#P1]8P'@A:"\\> =#
M&]]P'95(#:O].J?@'BW9=?_Q@(5UB(>1-9)N$J7;<E/9SKA2CK7R+7M1[LE:
MV6IMX6";TF#QS+'OJXV"+/:6N\.C-M(KTVUW[(LNKV^PRW=._#9@;^<1S%B
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M3U<2/8D=H-=K#3,,-IP8:(EYP;#H^LE[,3P-SCF,"1;PFI00P[H"_[0A:8K
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M.4Q&T<71G73[% M@>E"(!1C@"'9*4&Z@7;%Y17]X\D9JT']EL?_B(!5'Y=#
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MK0V\G]\75\2-(NY.4C@]6?7*ZIF*PYMQ<?*MQ2]U=MV780A]X241:E7:\I"
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M%K^9,G\GV0S<YY(XC.26PCW^,RK@&YS^PP/Z#O57;,=1$UI_Y VGX_5!*)P
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MIZK./Q:4LU 8'&J&+^9*C]DM0\VO0CS,+M$4&$X)+:UZ=>%EP,R-,Z&T[=V
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MTUL*Q.K5E<YVVG<SPB ]#Z,HGO^:GY:OO<F7/:X$"9M"ZWXS?@<\.IK(4VK
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M7VME3P/)(T-&JB'Q/ >15YNC$>^B&K%]-;:JUX$;1/LVK_Y%MX#?T<YV_6]
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M'<$7/S?*NZ%%]ZG,^@"+RT0/:J*+MMTNS4-XQ?%UK%P3WK3]T&DO)VB_6X>
M69TPJ\J*8F),_7QB8@/"F"'('-.\*<C8S:CF( >&K#[3P/)+DO^JH\RM&&5%
M"&O45]2%K6%LTK\EI?F>\QM&OO??YVK_#HC_?\O5_IF#S/\3C3DJ3B:^DF=T
M"ZBC00:PB%]X'*&@7"+HA7\>E=0SIBT62;I=!4+D2W*W&\_.G\"X19U'Z0)@
M.8_8?HP,8 :?A?/@<._NVD& >AXC%#DQ!](^0/_T@(G)[(H2$9U,*S=+H$FQ
M[HSB!0NE72S0S/]/*T?"R</&C([_!>Q1?(>%045=M 1BJ: $1&2IJUB1J:\'
ME%+M ;F;FD^NX@_Y[TCQ,%:XJ8Z6G$2* ;<OAA]:2*_'U&-U'^Q'GH@3SLC;
M%0S0UD:ZD>:'=/UHF0,@B%?KT\&"@Z9#>X@_( KXSR+!+H7!?\#["YB@6((L
MT[S3[GI2X[Q4KN,=GK-K24\E;(=T<02\*S&[M*&+P^#.9T7)*7:2S?_5U;UP
M*[D_)?M;U996^507S"J)@B(ZDVK+2WC:YA5<N%AP.?T!ANJ;">Z,KO![W7;_
MU7EU<U.][/>CES0D?P:$\,00T,J',?'M/:,;;+B-&SA:=,_9%PT5=J)L^RV@
M;.(6D.;V'][O;R2C/J8?: 4TV+)]*KYN< O8Q41!-0S4NPW[4%!-TVY9.OS<
M^G#J)XDD%FYTP;=X"WAWC#J3?#'<_)?CJH+Q47B9TLN_$(Z&HG\MQ4Q3"@K[
M?ZE;JO(=;'%Z?=ESP]+E_!LU.=EB8527[?,!&4]P/I3K^X#Z\2]G/$ISMV4E
M61=UO8[Y2V+/9Q[SK1P7# DMB,.?[CY47^T\:1XOZ*<L]%>C*[4/,<:A*TX?
MI5AA@U@N3P !N%SS/&AZ2J/6"#V>AO*ZJ*59Y$Y,:M@*_7E1%JP(4A=P/<7:
M+&]UY\X[O%2?_;=GI:K;RL/.XH2]C/XNQ28>K'_4#J6%!"PV[(@2([\,X&X2
MNF=W^6",=TB/R.E 9RV.I]%<\/IJ\_>VTQ'9 ;-)@M!LT21M[D]JGZ4EB*HG
M<K2SWXSL90?12"B6]/VM^YQU++U*=:Q0-BWK#Q@ ;32Y?_A:*F=;598ZI5#"
M\3"B,L<1LU0XVI/U,<__)1C_=Q&,_]/X;0\XN&\&CX->94.0F(F];W6*O$/N
M7%<0,;D24?#]A0RK0XX(:M$6Z)B:Y##'6\Y<X_58S(NTZ(,59_3ATE2?G,H7
M1>)FI0,.V<VV!YC1C3JXN3SA?.1QL]X5,FY/.FS&!7>XDA$8!P41D%5,PT/Q
MB46Z% ,NON@L$WBI^H5A28CFNE:8($VH$3&OC7 'H<4E?;AM0H%UE<V]M"O_
M=#\-HSM;B48$UU)4!6$<;P^TI=:EK J)&:R7.:)JNXN;F<]I>"KS8,%E(EUT
M!#"/)[TT^QBP30.9=O%@O(4AT=WKH;Y"Q2PN&A9R!"WURN&%9I2R\H@3,7E4
M05/%AM77$'PBYL)O@'=H\E+$/US_Y,N)'\ZV4Q";K7BI<^O[Y(88,V8TS@54
MQ6N#T_,*93_KOQI/?&MR]170DP<=60DS==0"K(.-HGA#[S MJ&WS!H=[#\]
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MNJ&B0-W&@/WY'NV*<;1NDQ3Q-)9]<%N)TW?5Q(X](A4IG2?_[J+\J9CF7\[
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M9/NT^+A>A&%Z@8B?\X&6WI<[;UHC7 5*6U"WB[U^P'8S-IMW:<#;\>II%3N
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M?A&"!N=S<T%-HES:&0=?MA^:DQ36-]H5-AWX5XNS.3[VG:V]NO);=Y,;KCZ
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MF1%$JA_I[EE\S%\M?BY?P%I9E=BEZ*D&WI%JS&I?#^ *@TK)Y=QC!UII0=+
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MHI,;S-FU@W_"HF,Z67)D$8&7_8#D.OS >J?H'G_,?1H2AC82>.]6J"K;Y3S
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M2Z_MBQ"A>&LCY#MR^)_@]^NO*G/#''"E<_\JO16[/^0V5+1RTG#^'##PS.&
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M6D\F79U_.U?_/P3%^<Q_ %!+ P04    "  (.E=6:P&;*E_@  "Y[P  $@
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M1!/^(2B>85*>?W)B^_*L[ 61FKJJFA01X-]A<9"V'1JW'=5$^3?Q1(:"U&U
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M68Y$%3B)[PBP@\GZ,?;PZLP6K&TM89ER;/1O3C;FAT_R=E]?#JP;*;KI5'V
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M!%C7\7C[&')H,MK17\-#[0Q&I#Z^^EE>(2).=<L6_6M&Y-XG&%EYU69+1*%
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M0V1:0';&+-$P3$AG\M4L*.H0I+7,,QCT4(C<Z&O0[T[(S91ULKE'=@G6]HX
M&[9.<5>=#/!6%RP=%P5ZC\Y?HL&54RKBZOJR*E30PWGVYYF;H@D?(<\Z,QN;
M*A:O3J<ZHF%F/W.IG%Q2_:7HRX+*=[ G0"0'3\D4,(Q+_WT7>NE=Y,5@@5RN
MGNGGP9[7L1O5OZF4*6:HWX)[]G(C@_#_0ZK670V>DEZ :%&!78X<9U[1[VW!
M<!V('CP'III9;S@WC&O$*N"8C[<,]/E<X;9+9@Z988>)$K3Z:H9A/1GN6G/W
MG%@@;>Y%DP_(W(,AGWJH!![K(!-(:B/87-7DIC'#OW-<T=&A^94\B#*&PH:U
M@-AA2NTNJ.S@H@1-"&](S-^"W=J&%$57C]E8<8H4,KJ&:!E4N5>XD9%$?A]:
M=[IEQ&O1P"&+GZ=RZ)P<;W1R5'PM;=8Y.+(CXJ02)/(?70"'40:@'V+3J%PA
M^SNOO_FY*FA/'//^K/C2C-IESS5&#[#]VN%"^]GS'CCJQ[W@$;@IGX:PL;;/
M@=XH4>&;R8F$! B/7\M\T['=8,=2A=.&LO,<LFO57B2.\'/1)YR2H&VA$D3?
M3J#+,#H:2JM_DE.]U$;Z7JAD#G(B4K'%SO%08_Q2=3'J:1QD:YOC8T'Q-M0\
M_8Z7YPP:C2;ML9DHSK(K8'/9# A<F9N;>5<?2"9YMZ+_XAZN(%I7!RUN#&1)
M<D(-)\,;:W673OBXKA*Q-;A5L=T_W7C?\=9>_H(V+.X)0+(KZ4F5=<'\;.Z6
M1P$N[_0-]$_N1%O?G1QN9QL^:L;KZ_=P#Q&WOA]>]8P'F%[R&GNOUBT8@N/=
MK=D/^GVRS;!SJOJ/G*,AJ?=B5;,NJU%^K^OF>/D[VOCP1]A^AV /"*C-XP8&
MB/(-R-=.5YZ>JET;K@S2:'_E I!ABH98!;X<?!UG<ZX2OD()BXW)/EAA:)L6
M65S@TK@>$QG*"EFCU<CJ;L8+A:(^U_-EF3N-V>F)[#=4">LU,63) P[_=[:2
MLI 'EIA.8$]-FQE-<MT&,G](/CIR;DC%X2F(N,63S]TE9NK?RS?_,C''5^2U
MRD:PZPPW3JC6END;'59W2ME>*,2R#_"[?GNK[:^?8MJI-N%XH\GF@(.NKRU'
M,,*L?"EUNHF.2-_7K#-8!6Y350F@S%5C&HZ<<W>L=Y8X5>5&U8>IO-B0=:@(
MO>#U-'QWJ+JG3Z7?'WOVX6^JP_EA\P^HS3OJ!"@W?VEF+0O[]P]VK$KV\\D_
M:R/+9GYC7C1*ZIKBS#"CGX$U)"8R"A3*\J&DR1\/C5R===+L!B]A1.;*'"K%
M:E+$WU?^E>F.W^!C4!!XO 3-XGQ%<2R4SW9"6]=7L]942E-W2_MVOCG$DT1#
M%B3E/5#^K^3XWFX"U#R-ZR/+.!$4]# MBR<[7:G]V T,>:0;O.#M\QC1!D75
MF%-^9?:[PM,NA8I';DZQVQU;KAVS8SP!0%--NXV@8-REFH3>N[2S#!JYANF<
M$$RJ&J>[\(BAW$B6C.]21.I(+P?[O&@#ZDB:IK9KXZOG1@?N"ENOFL?#A--5
M9V3OOA/1@FU8?=Z*L;R5RPR3(M)YO_7?999D(B[1IT7X_=W)%^D_?:"5%L';
ME6L!)K]L&I)R%?0G])'D<W>ROOV0]S?L6V(#:]$$[N7?RDC7<_[?T-J<CI;O
M#6?]P,3 ;=.ET83>K<25=-Y-P1L/,+]:FYVO$AN.$"A99F=<^]G@Q45#6,S+
MPF=_'RN$D*$^ 6J%=43AATK!'M+]!V0)W#@K<E(HPM_!A,>XCN<TP$9XQ@BH
M T6I-\RE_B0]KKE>/ 5HPTM5:YGZZW.>%.N/A<S$=>$N_W5J^D/!<W8&QMN,
M;-H9[3Y'$PRPU'B/$NWOGY-YXD$4QR#G0<PU/P:KM)3*,@]Y([')W=AQ]7,P
MN>P#U+1DU'U6^UR]:GHK4'BD\;-WV-FZ'A5+?!MZ23:>P,Q7"(]*U&UHA_WZ
MR+%\O_?+;)UZ,]IWA]?AX!(>(X9^$MB!_G7(%+!VN-Q]L((>X"M)WZ"C7NTK
M=;'=$KR2BT$!V/0JV9,]C*R3H'&&:XN:J,(.]RADPBHY?28I(]:9&90JKI5E
M!3O+*';:-KK6>'RQ>O@CRN7NOF/_3<\!F/Y=6[O3,2HY;%:.VGX"6!]HU_M]
MZ?8\"UZ^&-4#'4I5WX$,N]G=3L^C8M)]G:>)D'9I<=9;)MC;>SA#>*TJ.=R5
M/$N,>"Q'4\FW0M]2A[B)$<!15]Y,A.:)1ND)ILFVYJZW'YJ^CLV>'14VF.+M
M_6$-C2DXJ,2E2Q(3:RS[(TE<BX%*D*_VNCL7&R : O!T2UZOL,##]9%H2%6)
MMYBQ*_268K0P!P;(B(]5(C@UY[Y=X##T-,<%U<G."9! 06%6?S^;HF:E"U1*
MYP:\=UG%L?*CNI,:B\LS,%#</X_RZ*[]N86YYB+8*M%!7$?MYO_RP$'/A@1N
M@.86=RWE5?.E6:=<38**--*%6J9/3&22W;+.<?U!^('+6H[2XJ?OS$"#_@J<
M-/SMQ*F+!_UTVH'P765-2UG U\%!@=/5LXK;2 4KIDR6_! :72=3-\.D<72:
M)"3V_S2S^A^!-/8L<MU+0>WBTZXQ0IU=Z_U"T954[!'M1GGNH^-%!5Y,CBML
M3X#XD:Z.RTOQQZAL#/.YRV/V"V%;;79!<.4I!892_4/D3T;B)>>L"CM0P]F^
M%\[#/6L<>RL>/7#7^K69)759.GQVN2VV8AV4WK09B#J#X<GTN33ORX&*?$WE
M(52L8EW4CEU8LZ8E_EN^A8'G[""EB@!: #>A%B+LX4=S3AULZX<GO?,KGN%M
MQ]_(RDA]=E*;1L0BO$6':2%+;GS75679OYJ&C@?TUWE-T(Q[ULI$I1?U(9RV
MF]^96J;SVVP3I0+T-'%_4I?)Z/NB'4!ZFC/C*O6MIF3LNOO ]#A(T=^3OL%>
MWCYKQ) B&VW]NB3W--^_[GQ3O@L,@F@5.M2P:PU?&>49E$5=NM#CQ&,^C'K*
MO "%RC/>^0DD*2)5-(N<0JP?#D*W5!0#)CC)['1DG8PU5&E[X,I7"YY=]HH;
MI1_+%\>9&Q*O[3:Q$G^ 7%G.;FC,]M=%ZRM7!)K$;FYG;*^5E%Q"@4VFHA\)
MU"!Z6T=C'S6U*7Y_NECNTY/4=[]"7@M%V=&(U]LAS[.MH$2Y*"\B=2Z,GE+B
M<\T$L%-?]OK^<C:JZYL-YCK.U-5Z((N&I.V3\KLA2T<HVM,?XWI]/V"%MF;3
MKO"+)"X]V!AQ6+J!%,A*/B:PWF;&4PXP?LDS-Q/%S&29[;&"YM?K#,;V]C!\
M";L$[S0=2';-7\ 0(?K\DE)$FM3_D$62!$0_BW%FE!#(17UU,Y>TN,M]G,T
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M/7X$^"NN*E5(^9CVB8V:E).7?2R[:QR%6(@IUA"JVSC0Z,>'&N +UO:\3"6
M:Y(.*7^$B)+[!KN.\J1+AIB5R[4L5"$JY4/?#WX)O HKA'LO/S3T^4D]N/72
M.^ KK28@2M]TL0M169>@IO[OPS(SQ&^4=2--@O@K/?$+0OW9^(U"X#J[7IB:
M]=O'0"N4?X[SKMX0UXG?WM+>XG@]>*(?_7.8L?[9F)M\? )(5IK\KR^V-RE\
M6_11:=-S$H,4Y7U2\8T)I2T&@XM7K;6OK]W<E8TXV+;.Z1.X@P:[- [R':0
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M!@JX*^B.HQ8MK/<Y>IH74+3^Q-BZ&&71*@JT;:4E=9+T"3]Y*5AQN8LOZT^
M&WX)_V;!-[*BRM4CBZ,V[]-C(2+C(QPAC'\:;,J#1 -L9V#Q[)_K\ 2>7-X7
MM0$L'W^17'+W.84)_L7FAPB4?7D".<T&/3&U 3T!4_>F_"^-+<"/R7CH,7PI
MULVVP]VM, HZ=QQU@5#*M [J\=PL0#S#86M\4DOAC>IPO\[7#ZCTOD HN1IP
MW76 01*(&X5&-Z<$&#X[DWK#CB4]5.82+[,QU5L#?4*RLDOGYMX.6NSGQU^4
M1@[00'PO\^,?5=L\S:&Z@E1.&QU^(''#44$3K8:\1S*% JN1Z\AO!C[]+8\,
M35F,Y#_]AWURBR:+BJ&@S;^"B1QL+M48RQH'^N%X2Q^I4*(!6)"97<=+A>M
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MS$WJ-\:AZ2@Q79T-C"GO!_IW8D1=_"CO)GUMZB"K_\6=_QU,LA7CQ+[IXAE
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M99@(XQF6>^+P^7X#*WPAYV= BN<;8NY^W7%@0K]1'>FP3/!'UK8H;G(AJ8=
M>LWO/W=8@KD_1!'X^0H$>UZJG=P7OWZ$_$04'CB 7- $;RGBOU@?WM8_7IS!
MJ!ZQ73DP83L 8[L9N[L-L2>%.U0B0R;0*(;XA38#=_Z)8+9?O3MDV43QQ!+8
M(R./3:"HBD!LA$WZ\I<=BE$H?B26-T7KYH=(/02AR)&6Z5!953^.K6#<[5)%
M;PF438WZ,="I&)&]BEIFD5[ *$>[1P8CD'@G(  #MLY%,6+I*PBJ1V4T;+D1
MFUHPZ3>(Z^PHC!5%;9$N*N+^\RX#*"GQZ4_WQK,MM3(XW5G5;O;!X3GUZ<S*
MXPF5&+;F4B3?&]-VQ$Z9=<T&3>BWC,5V-*M%>,,$$^Z,'8@>Z:9)K8UU*#*5
MYYZ:F<\KQ2KYIOI<O)2> 7(HGI\<-[@D:I(><"Y?JFD:D_R/=I&M/8BTN%BV
MC9BISX7.V1;V3W^K.EC)@W+?D;4)& ;I8O1X)_;&-AC<;;3P=,RD;5:8,$ I
M77OEU'(<],^XT HW_"T9?*?W'E 7?\C0WW7ZI%3*5C*=\)GT"GEV=;6)-Y4^
M2"1'/#$/O%0UO/7?.IT'_7]V/*)L3ZMSJBR/_C8.XHP=/ 2,*.@[G)89$$GX
M%=1(]-P%>- C[-JIO_#-I!MA&YI0?H<*]W:8U&VJ,4VUTR.N<5M78V4@+\(X
M/Y)A'/5B>.Q5* +)PY+?K7&+]DOGTHZJ^T:W4)3B%(R$7DDJ2GU F$[+=\G\
M(K>5?F_'=M]N6$ESRAQ>R2_L0_7^C%_;V290C7OUR*>KZAQ9%,._RJ5N_!)F
M)M=W29IELH=GYH)13J@@@B5<4(D[WJHG&.":_LGR\_R&I.:6R;0GT96.3DJE
MC7&37W<O?9 ZZ6\H!0=E--Y/"&G9?BH'KI*ZX__N!NC_;5%OCQBT6',Y4+<H
MS,P<*$%1QL(N&90B7'(O=>,<X__&09)VL%45)+ZD@1IR:!39@#)846E'3 :\
M$M-9V._'\RA4,(T]5O'/WE+CSY(^O'ST^3INLV'S[8@ 1P/-[ZZ:INKBNBR\
M\.\7C&HZ8(SP@90Q7AT?35++?;1HPK@SS):#=H?^JP-ISYR=7!1[J&M?CL;X
M*Q<CY1]'N]YD_GE8BKEA])A=_[9T;<W+O&)&KB++]07K5]&N$,Z$8G@QMI3&
M>5&HB6T<W8,%PL6+,9A:>TI.&V$%7)=R7U>(R-$?<=$;?0^[L/HBP%":1*\Z
MQ[2W5Q22@-? OR- =N3VBL*N!%IP(A>O]8[*<.ER^9&AO/,B-RRE9,P&R"\+
M62#3\UE?+#85U)4=V@-^+,;$>:B?L&'R6:Y4F+T$LPE/92G.F$LRQOHG&RUE
M(*C;4->VUD?M3VPD$>([2A$B?[GB2"NUJH8R1CEUZ1.#/]=M#_0<M8@\ YPU
M-,3PXFU::N+RE[:'_SG-4^@?DJ;.'-HJ9K<^\F7I#]>?W>\LYL=<-^HS'L!>
MA@:[M\((HP,YR%A_J7/SFTR<*I&$-<IS&",6.]Y:W=5&,LYLE49.<B]:^=TH
M64-78(=$<XJIA%[X5.2=<_QSHRH6&Z6UY?)2'/VC8T6:%HM)?_I;W"5Z8V_\
M48-L2L!O;J>='1[7]3A^/*YC"A^VJAA]K";.1UM9.S40FE.C.Y=0V74B8;=0
MNW8UTD??(,3N,8AT;1;!N;--630@1=/7?:)!.JG4/)T+V3QI^&E71VWX"?T7
M'JB7TA[4?U)!O&87M%T_:=LJXXG>-*T9$GI01::PX72K7@3Q7"A6>Y4-0 60
MEEB\S.?>T^]CP$ ..LK[+AQN:"G4QR+Y#MR;G^5J2NM#)*>'+RW-)G>8>A[A
MQOB&0IZ>A\82FQIJM:#6%UL\8NX8:!I9?4D:4DJED7%4*[C"_TMWJ+CE8-&;
M2$^@_V>L <V?V$2IBP-]&EQF_C)<::WY-0!OVAVP2YO/PINDOB;&^+M=C"<+
M7&=]:J=IVQPG+#?W^OM2;AA#^6WV_VV:Z/\L=SKJ)G+-O=5Z_<J/DSH'57]!
M_?())AC4&!UD\&9[BN8E( #UFD$KX.E_&M)L>7V0R+>L%Q@";P).9KO[DMI_
MZ-BX6 0?50#6._[:*1TO^/)E.[+R*NF_7E\-T7X&=(\(N?OTN4X-6;2*.<S$
M@H6?/CV*>>G'0F'-EV$KELD.NIW=QY3F9#VN[ C>8?2$1WD-Y"RW+;0'0N]4
M<59$L=4'+_"2'7P^_P7 #835T*E]V:EFJ&BV%//..=2."N/Y,CMX@\( #JXT
M/+L+\4[D&Z#,3[B ENB2/"\W8^_:!$7D,@=ZDF#*/:L>SX3!ZZKNE1(E(6+%
M_;>2@G8Q3XG?WW1_\!<H2RO):4I"O26(MIU&&%>S$56JG2PW:VMOE&3,U1NC
MS  PI)R2]T2^[KHJJ$-OT-O<K@_97GP $9WEUY^Z]67*RMGKR)]<V)U%D*9<
M/=U[7> "K-P6*ONR"/J+YC_'N'N/G(V* _0/?18$@JVNV[CDZR>=%\&"HRRD
M;<UH$Q*&]$7!K7R%-R92T?)3']Z*!.S8;3CM]S=!M?_]1JCA)WH+Q^'ZNUI:
MK;<_FJH$]PZMI^CB>DE.V95S6VV__.G^$);:GZJYBJDW7EI*N2/0F-_KN5-]
M\FMVQS59KOF>VR2+KD\5C*E8<R/#G(:YD^W/?_91-_YVCCB/[Q#\V8F?+9HM
M=O1!<,)L^D$.>1$[]ON/06(2AW%OEZ,Z":F)PUJ93W75(1($6Y!#L%2Y ?G-
M+Q#P1GU7\4]Z(9G>+_*-F(L'H/9^$9:8R>[I?&7YS(X.8S333;P75U0[E67[
MF^J8NKI67[F&V-:SGL?W;7U]HZ2\7:\9G-$QWH:\Z "5X<\3^HVZY&=;?K42
MQ.L%/T$5D&+JH%T9^;9^DS:)D9BPDX?-M_0CVX^!8%-#-C6HRPC]Y97._OLS
M3H=:[L$"9^6?:<W:1"].F%46[-7-ZQ9B]-KC/972F70&ZQP^3==7MF\""M<^
M<(FQ\TK9W%S5349MWN)-A@G=JJ1@EO5G )*E)W*N"Z:#(Z_4A_L.83T!7#7:
M_/((*[5,+2>YY4!<)=GA?^7=&<-S_*""FZC?Y74ZW$<4 EQ8JG<!TT2GCRKK
M$J'\E.X+E7Z7/!G,U//U<Y13$^U!;:,US)5-9^NV?%79V)DNE>$01MZ@C :6
M<+XV3G$V\>S*# 4"LSOS\TK]D[&P[P\Z^=0YWY\!/!L6*0\3'?;6D/8;I>Q]
MS\R^'+ #F'VJR6W8%\O+08>,_$0]?-UCQ8:)9],#W_HX->7M!3O"A%):E)0:
MJE3Y$%2;NR:HQ%'&2=O97&F!=H8)J**4_I.\AR&A:6Y4$K5F:W:+YIBH=^-C
MM#Q$25WZ\ ASR>0F$/$,=/QJC5@]X1GP-I^HMNF^+^^ =N^I.[-! $TWYXE"
M&1WW@F,7!I4&A<S,<^P@F\Y\_JH5*9M6KAYLA<9>%V -I4I!*=-F2$BP]YR=
M2$OJ3]7 5(Z_COW]('UZY^X]4POE5%S(&#K_E77YRNO1.G2BU6 3["-5/UXK
MF0K!.]MJ,6B+5C>9NIW+7?WQ^:2]P(EQ>$+/XZS:W,'^+W6ENT'GG=O/"MM/
M4Q6V8:,Y^G2:>)LY=S,I)&/!@F]U=$:96\4<75[_<F/W^,1VI,"H7U.T#,VW
MM'VKCD*LIFA(>X4G'P: J25.L\8([XDQ&FGKU;6<QP470VM=8I%*!M@!^_]!
M?/PV54F&!4%HD*:J,NNR+-6;Z4$A0+K6_*EG:CXXQID>>W@U6EC/K@]$U)Y<
M1!-TT<!8:D6@@3[+/4:>[@Q]!@3IHT?_;B?ZFBH\;>L;M_V(;4K6?;OCR_?:
MRQW*F-O@AVS?X_<6* 3HQ$O<B 3S\^5)N:KR%VV%8KMRU.F;G-I:XM]S?@"Y
MNC5L]HI).?;6NA@6E\YLHG]WN,9O\(0.Z5N]8__%,C;L3M;I6KRP@;()>#L>
M-9-@NVH[OJ3*2$%#W=@47:;:_#U:]80K(C_NE#W\-B+L09B!3/@)Q@'C.!?(
M[.[V0B[)'%@/$JR[R,<R:X@2^:*%]/82;TK$5GKXA$V7W5).6D#JQ>R7SD3^
M\TXS^9\(?=OV0,//M8==/R&\NM<CV=V$NS?1%^6ERC(X4H/YV8C9C1E??\:K
ML'16V.FTL90H6M$PJ3D5O1:>+<X-:X94"=,7-OVU+<@\897:0V&_3=8@QH^3
M^Z[]&Z\* =6@!5)8A!Y0%AEO+5E15)3V;5XV*BVRJ50@>?^>>;@ *]:!":.<
M$MB@HOUFC_,9T*/W#"!1&_#CL)2?F&T;,$NQDEEO.1=\]Z[GMH)N=<&1:6+J
M=/6402)GP>11Y(E_.EBXUN@I!X1%K^)2TR;N@L,WNZH:,"$,'CA_!M2RN+5
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M[S^;GAV-7]$ 3Z'[.PEP0S!/122Q(X-GQ#A2\;]P_!E\;X*+, VT3QZ#[*?
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M*1+.!+"A].X>ZH7K>*73U3]\F(ZQOH)@5]B/&&HRL$NUFTC7!67MUL*N+\\
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M5PFCSQ=UO4W5*ZK2T&F;[]OVC)7C;M26=!WMH O?C;H+]]KM?$%_>31QO)W
M"KE*!,/D,1]\O8D*I?6&?/41-MY^(?]7_O [2IF(1GY-C60A]*_'?;?WXW9X
M_>7L':0==34\V5%;<;0. Q;" GBN@9:!I>L1L-=]'8HIPD\V)YK\*)?I2=B(
M);HYGTI6P]:TGEYI:)Z_C;T#MH8[Z<LO6#6=ZZ8M-VW:8@'FMQC Q+6U"=O<
M,"J 2KBTH1T]HW.49"$8S->[Y>["G]"*(8VLC^'-7P<H#L?[H.#+K53\#PD'
MD6UC]UF@?5!+_E,Q4$;]MK]*W/HVZXYV((BW3G>5&+]YQKIVS/)+6,#).O@@
MY@GJU6+P:_U5]("5H(S]69&KEZXO,S91[P-XHT#W,K@W$CC0$O:0-W ]=C7B
MTF^^Z[_3('Y9V5C@$=G>QEY%CG5%KB &G4O2I7#X 6#P8-B]PO"[/''C9YV*
MI_Z!?@K!<^KZ/U4^KW%ZM:;#&ARW9)WL,SOVZ2ETB"#=HXMU/!HIGR,!+=O?
M*]3-YM[0%ZH-ZKEG98-DGP?IQQ1[5C^\O63X4.^<WW[,$-LK:O[3&K_1.)/X
MC:A^>WYPKOA,3O0A2RYX^$@16'8AT+7T%\3/H\==#]&,MG.8M67>:LY5GYI+
MNP()S2+M&MOU=C?ZP#R&8C02H@RQWBP.Q*NM"=Y1YF/N'156(SJM:.+[52L/
ME>[Z<V@.PF6CM:9$^&G;DB]1 [,#M7W=-A7S2:V#W2]E)57SM+>4]RMCE<?M
M""\T0RL0QMU9O<[$!:?4=55QI1CE15'>'EOGQ+(KSI/=N6.:WC4?OS-E(-]6
M%KIX>>_NB/ :R2[:-E%NU8LT6J1-?4DY9)@W0P"07RQL*T[2J+587B8FKQ35
MR(NS672601TIMC8Q<:%84R6\Z&+; W^_BK17SQ#:@A)CW&AF0TX(*QWX,FZX
M_$(;M]6W,E%&"W*CP19XN +5RE[J!D/&<!P/UP:O1F^R%A*.1XT-\Y;W(-Y4
M7)UTGP<DK^#[4LLPIB$&I>[L/0<W1\(/'H.I1_#R<RCY,O,_D\G>H#MW=+)C
M\Z6P6)45EL6HYCR^OU%IZ:XH%+T@*42GS;]19&IX4M;"\N<43]J^]J!DOP-8
MM%&R_-IXC.#&N;EP?# Z.6Y 86$%4A^-](&,_2H/A>\ AJ&@CSP6*A\_M"E
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M2Q5>3HMM%\G:>D+MU#BC\V2SK(2)6!WR-=D#1SB/VX1_JWT]BN-QTO>OOL.
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MM8ZO5\:-P>J?EZJ3$[10DPDE3VDF;&YEQ-[.U4&_J$$G=TZA;TJQZ1Z7 AJ
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M=848--S?L/@H($O2[LQ70GK&NQB-S?;AUCN1\J&#&A56D=&,]?MP(X%'YA=
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MH75:]11RQE.2SNS\EA7 'CT7?;9L%]N@&V,\3@S2V;3KMR#7^D:Y[\8,C^,
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MX1&2^O?T-2GFW778<W/LCG;LFE$YGNJ;;;%#C:=IE?]VT\O"_P%02P,$%
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M/"@,0 2XNJ7+\$&D*R9:1[N/;K)ZG 'M7.]FNQE)S^H>F9?0?%6I/DX(L;W
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M52'!3*9_S^OU9HZ)K09/^C,VQU?=G]JKR_9/K)05G(06U-\,B7"UJNINE+;
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M'?%\Q%'=V2Z<0OBTSO;H\W-!!H/E==[8O:G,-J9P'B%(=?!,NDX).YHE$CA
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M<JQI8B]$T*6>3T0_KOHJJ\1D*,2'Z> :<;,#,.@8[D(N8XXZ7FF.*F$SY+5
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MDJ,$$I697RN>NDW! 7LY?2B?M0RTHV\O0+]"!B7*0>;.W SA]([$,K$/NJY
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MH#V&P*3CBR!EM<'.O)$\!]U+_&^>^DJL 6E[=>-G=RHVQO<33S0,O@-<VQF
M,7/O!E *:*J/SZ-O4P:_=%\8HW'?ZIJQHZ"MTY1PW%K@UDG@Y>8-)K'L]7C/
MD]T>3M+,(LY"Z7SQO)AL]<D[Q#I7=5?BP:M]PY_.E\YX[<9O)H,Q@:"0Y7V*
M@OZIV)[(G<)%OVJ_<1_OSYO%J]=YB6Z5-&6MZWHE._E 1&="9\P7$W^9):K)
M=!Y!Z YR.1<I[:Q'D:<OZ7$5<D7<B1J/\C*67Q5V%<:W.6=$[95R>[M)T^;D
M,!EI#%&)]V\W%N)U(\H$M1N5C2BB[6:Q54^3G:!?TK;;9\0AK?2)IIQX+>DH
MV$G\/PO32+2#$JNP%:3_O3[=_UL<_G#([,90%ZE/-(QYN<BU)U;?,@J-#_!Z
M^&O"J#3X%A?G$?8?/4A:.YHCBA,=',!%$\-=63WKUOI!8L2>H8RQ\NY-FFW5
MY?W?:$&OUZ@;5H^_(3C5-PI%C?H%E(;&YIY)=HZQ:UV'HFV]2%*;.UQJ%C6<
MC%+DVFIRFR'ZFJ[7J6@IC+Q4/F!\GA/5%'VS^,6/^^Y%YXF!\93G:W+7QYR?
MO_-&%'N[>C?BS0 ^%"?X<['!FYC53@6M0:CRQ&CR= -Y9@03V3>?D\DV"^?(
M!+3DL2MX27 !XFQV!45U_SJ'X1*_.:#HZXJ"B[4+P@F>^#/'<5.33)V"/>GJ
MT YQ;>97FF!T&"J03:"Q^.;VG3)31H,QA"FBNK0IGM<CICZ._]5=:@H0S7U$
MY#$ $F>XD+CQP7<W!_QYK#.5M2]> 0[1>N"K5JH\4N/:S/^;%'SZ3UO1_PWD
M75Q(JQ@H"$%FB23O$J&/T'*[_\8HD/\?X,AIO,0O1.PZG&&KX6]*F[L 4L2U
M9\]++%OWJ2W;CZ _5:5J0O\NXQEJ:;GKH5S<ZFB-]#98'8_5PBT*5-RZ[ <\
MROO\ 01QN1LKJ9#AF4):ZA?=UX3WY\] K5*4F+C.1".R]2YI0<'1/I0_PS$J
M-$P<?+;B</X !ISP/B"9/L5#"XRZJF^U8#2_5\+2X]OYS3/1$+.DB^OC^=XA
M$!\/#MC^PMGL+%FQ):?T&A!ME!WUT7LK^F8/%^ NH(OS.O2'Z;U,4R68ZY3G
M::A$W_U,^TTE^^%>=!L(78Y)EG"7GAJ.)[WC:PANPJ,S;9PK<-#KF>2+YXO=
M&5D7X25DYBVEYGWF5DCW&@!XAT<2FS_WZ1"7%ZXHF79L5#HXZ7TF@+-FU_H3
M?G)W67)GZXB3#ICD ^6Z0050EC1,O*QWOI)N&B/E/MO5/39J=2TP2C$E3?+^
M+)WB2EX'A,>D485CN#D/M%R/&E29T,S7()T8U5).. JYOISPM<+RG2J):].*
M*"4L^$=1% =? &[L.3"@&0_J_N!F)NV.X#EG;B(&OHI)>GI 4?TS*3C$-W+?
MPU_)GV.G>;@Z!.2%K,FUIO8BCP"U?$[@_+D.Q"NJB"_##D6<JP#>R9/VG4BP
M+UM<OCUJ61:1T^1:)/3/<+#U.6>PPF,:,E/BC?3"-=LU9^K4]9=Z1GKXGG;N
MII?TZ%=);:VA/'?Y[5J9RE3(*[WP8FOYB([A.L"@,YBI(VO)4G"F\N)NT(1U
MT7VQHU.N.>7\8D+G '-)GFF+HH^;W_"9F_#/-@#PRU$M]R5/F,"'Y=\*)9.E
M!H=#&6[CSIL&Y:^5=EY=FVV=IY#-B)RSB"W-?F!<:+X7X'ISW)(P6P(;H"<C
M_0-02,N.C5386+$TCU/(P]^)O':):+WK2 W[K5&\VD2T!D/:97SW<045#Y)B
M:H=^1B7V0L?+;@."3DSO:W5"#S5ZFB.GFZI?J4<.[&S,Q0P5=W7/<X0BV_AK
M",O'WGKA#0)HJDD/7XQ&>0@N_/CF6\DE!.5*R#TE7YH?>2/AV;>^SV)<*/HI
M*%5=)F&Z,I?L/ACOW1-SZ\)SM<8E)X&SPBD?:^B0GM,JBM+/_ XA1&M,9QJP
MNZ!-F8[4P2 L.DDYUI^-P; R_-S1+\RWTKM0&$KYH0U5[5.P)O!=7&:UE_N_
M<V7V'P'QQ'.)GK\]S4W5_7KP[MUZ@VJ] %DI;J3T9!8JG.\XUH<A4 2;C20Q
M+UXKX?,/DB: AHE"]7#)\1/XDGC=[K-LL<FP"VUQ>7&5RUYA*">%!\H*ZKS9
M1W8LFF7+45KBBW5) @^L,_?*YS0E66\G"0LY.1+7"H6WZAU39M1,C0+?,9'.
MPI:0S$%E:H7'GN1DD,O?.RT=?E&.,77<LA4^]O"0\F_G]BF9>?VV.URJ 015
M.NI4DHT38^VQRMU#8=:S4R<$4Z,I7X.AFH'X'9$[[BK$F-4>_MC?9.?EURW
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M;CKD<** F@3[5$%X#]A94"_&6&9O4!MZ5OM#T]&997WP=$[ ]=,XMI2-A32
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M'])HECC\=W-T9Q*)%S'-( S@$R(:M(M&B$4WD)'QK7$2^UEKHMVJ\X)Q5\Q
M!0/J[19)0I\4EJUH'=9-3:E27:9:L%7&<<T+Z*:Z7CLFQ46A;WW?KUUPGT:@
MV/=^9$YU"2S#,PF(1,OALE"WAC);95 -H' ;D6L>N.%3G,V<>Z_-^2GO$!"M
M'7\OC>%F(U>K[^I6#M][/,YRMHX.?5S!K@Z6W<OZ1U%4=@)0I*MF7-P?4ALZ
MO @0+@?06^7?N$YM$7KH8Q0;R]2$?1;-(T%.?K>M[[([F:;LTYLCGVR;WY9R
MA#]I.5(3*@'C"<R-OI1&^>F^7UY>>D_W"B;-_;$1+5KB/JTB8-)MWIE]U3@B
M6&K\Y)TIKOV5@XA5TJ1XU[R"Z, (!5-@N1$J+?B]]UK/0A8J6%SQV=HTP\#3
M[<C5R:IU6UU"48N;VOGJIW+A(V^6VN4R$EB'?&A\*X>Y8QU.95A'&IND6.U=
M9JZ1+G#'6%;CXBY&3+X*5K"1\E6FI:.-' )]C9;BVB"(BVJ%W]['**I7SRBK
MO%#EI[GS];E$MRW>7H<3TF"U']ZYA&0DEKC1O-,?9X'O;2'Z\O >'?I_T86S
M^#1S0$&)BA*S+V,/]/Q6KK-KB$(OL$#.,UB[)+T7X7:R;Y5OZH@F<G3/=Y+G
MR?AP(09,+RE*T.>U$II=8PJIBR2(+A9S)()7;]:XE$CG][F8UJ'PJ6\BM5-3
M6#8FFBP@2[0?%>]LBI D.2\O'DMO,X]NEW<VYW>6-AT*[7)DQ!)0(Z=XIYL1
M=UZVDMRLP+KV"Z$@+YHIQ-J&B!$JM7\/'#5E71O^!\"0 HAO0PO*VM)DOB +
M K?QR[^?=G6EF:I^+'?'4:88D/";P>P;D>SHW: X$'"@RD9LJX6^F)\?N,51
M9LUPDM1NAJ<R:4!0Q/!?.UG4%,6[?HXY_JV <+$N"K"Z=WCK0/F!F1%C54.L
MY4WX0%>%5E#09Y38)A3\Y.UJG07#ZX-888L'K58\\9YFSTGF0QO)HVBQXHW.
MA/;Z1(B:(%)+*&D<X4 ]CYQV8(Q.8V8U%H^ 6/^.J!%1(W50/VI]8N:#71U=
M*B#V#2HZUCE&'IXCSMEE29T&[4_']NO<4-;F3%P"7&N_2A>WAKO?-B7B><Z>
MSGRT(*ZD]8(D3?#COZL_P03,&]I[Y= T+#/7Q^00U:K:9NC9=!#11Q@>8"H'
M*N*TH>/$>\8+ VXR.%(O(96<M(#<MY%?51>]#$?.$Q.7KC@L0;@T@QCTU+:Q
M#NR'PSWT(2:]$=4W0PNG/S)51.VN:?7?NI)1>4J][;%SCLDZVW4^ 'RW^R]6
M]4-_ !_4H \VQ1XMUS.+A7S&SP,D:-3,7F^[CCV3Z@/AHMIC_B;(D]]NW-YK
M[3!F;?G>&/40]\8)KQ=N>HMH%=L5G/*N>;K3[VRURT!;</]*M&*0=K6C^TF%
MR!8D--\KC(*=D]F*"JCF<"%S>*YB61;.N3_O@?.SZF6+O'5;1/Q8Q=E+B^JD
MY]:>-1N#*4@WE!4%&+4.ATTU7X3EU:# S+PEQ?[XNMJ#_JS?DDK<!X%L,$C9
MLNRC-Y)3HM3M >C!UB%;WXLTHGNWOW-I4^B/%VF"A#6^$105=G8ZY[(.==!\
MN4[PZ>?/H#Y='7;/%+3'.8F8G>^$&_9+6&6&L(0UXY/4#J]DIX-7Y8%*_7?U
M@#^ BK68KL?3Z#, C8PW0BU.);$?[T2!,0*4['+XO!/7S>;K 2V NE4*0Y7]
M+#37H<2 J[K(E^&M80KGU-!>XRMB_8A_KK6RDHQ</HAI5WN'Z2L>M,T;+!KX
M+.O<?@9G3%BLR1%+IDF9SXI"/%M1F\6T=W#.L ^FANA#)Z0V/;Y,=S7(5;=K
M:^>\>LB_)EOO*U\+U@7GX2G' -4ZEIV:RW6VOAHR*N!PK5=$5M^%I5"9SZ"[
M@9&O/EN(*P\:V%27#0=XID(.6&DW:#G&"[#C[D*)^@YC77.3?7Y"P# Q#5]S
MVP">I,)CJV^UMN*GD0:8ZA#,%--TG$;SYV!U')Y27H/[RA%R1DB837AMV:KQ
M1F8(;J>6W!BYH^^3M35<>I.?3LQI,-#)^!Y'.4PIA88=BVQ;X*ZNU3#S(35<
MIN_I-.809P:E?ZT?<(9:?'$;Y 7S=';9M?-$D,@:=/0^JX/LV !=<"& 0[ X
M.O^IGVS9-W(R74(DK*5QX][) ],Y0RA#<6."3(:_EX4Q^DI*S)(T;%MX0:;Y
M(J50*+=D6JC2_#:S<FS;.JW!D!+HQ"G]*11^M4<^@WD#N(FQE:M?/I5/*4@2
M0Y5/==0EEO%BF\@J!/;W?_N;9F$?>K@\*W+-G^-J_=[CN[J3J=O9\KC+&=CE
M]M*2DADR41&XUBYF%O_-A.&O,00\6)S?#2ZUM,(-IUTX*^G)GBS]QOX A)A%
M]662^<Z=>?DY:$='-IF_@.I:FD.48DKBU*^Y;4.M1:M+M##&0/Q[O#_UKW"H
M=VTH@&5S-QS?H)RE;5T): S&M[V.;>UT0KQBXQ0N0+3])+ 8*1#]J35?[]NM
MQ>:EE:YL#U4XB&\:N$NUZ[&O)ADGFS ,KSOY-1H!ZO*-:K-8X.[B<GGOQ*"@
M"TFW'B/&PGB95 ,VPL4E=C[.Z&DN/3:P+G);":]Q-_1<>(WLI),D*N2,!@&B
M.VA1L_B>ML?0X\)^OW0M@2T;J.:#.X*A:+U(N(D:WOY@P(*-9EL\@"ID*Q#]
M"Y!TSO!82*C#$C8G_11YTO\EK3[)TXO,0OD5=:)>(A3,7'Z?^[9G3HRNPCZE
M?FW6Q]H6M&V]GE OSZF*KBK,0GE8 G$#3VL.F7 V.W!)JC4V]7YQ=K+J9J""
M,\H]0QU]F/PPRS45>$O7>1B(G[(V^(*K\)CGV0<[I)P*7I2SA3E$O4KD.AZ#
MA;GYVY2??/F)R&5#>F'PTJ3:)7JV"U.]URN?)\<W0PTM X7>ZL6JKKWP+9V8
MVFA!CU3EU[D6WD6+/W"H:IDWOJ095@T;OWJ)5$L:$VWL#.:3HCDC'9C<<2%&
M>GMRF>@)?$M>3%F$72 +72*AF52F?D'6*/J*9G/G]-'<TD2S.[7/CY=TW!Q>
M^/=DMN_IU["TVGZ(.:E/X1VG#WD9,4EFE/\LE?XSAO]_,NP,C3PEWA2I[.#V
M<3O9LR.47?%7--&]#O_]:\5@7]]*]W;#25T?LPS#M0A)[\FFIO0D?CCJ[Z'?
M>;A!;^Z#B*<O#H?*]OM>6 _ZQ6KM6UJ T5P3QHX@TF,@'2KO2L-Y2H&UL:9C
M[AJ+I@>2! RB@07HOE,J5RK29VRUEV+ -A #1HN97=7;Z.%KB9[C]'Z64VB3
MOKM-/Q7@N+*-YC!Z<?OS'3%^UR;*Q8]1I-B*R]<S7@47(0_EVDT%NG6,N^SV
MPUJNQ]TLPUS2^YRO6B'R9+_>I.8B@T<,!T"*Z;0;)0IZ#8KT;&,\OX717":D
M_)QV'-:HJ)Q8W@0?ZKIW^;3(E3#NJ9I1Z.;PYX>/BZ;5 O&R O&+[D4A#I63
MB:T'#BO/N@<#8$:_+Z.W JIV*849$]J[536?"+LQ<=1;EG%N[>0[/G5G*P_A
MR[D1_@%T:R1]]!]$B_VP:,*Z+.A$-W!AKZ-#-G)YV!RI[%L>KO=[50-S/7 O
M^'Y6]?<N;#AL6((A3MVN9B091(:<>F=T1L+/H7+ P&O];$REQ^('5V=N>ZR4
MH+,$C;?-46^F@V_S4(6EL>J^.F<I/T-9_#,=<2T /@:UUA_ 1<@14XU^?I=G
M>R@K$T_9.A\;$1[M*Q;<(BO>053H[!1B\N1)?,E]LEJ'PVON^]0+_Q_KRK@(
M=JFETU[&R<2&EJ5)AH_L?:A2+ROUFP-(8[P@\U,9['\ =@:S[@N/.3I7+10]
M4IDCYZ"1LT'PS)>U4,"""P$>MW+4-/&*BK]G.>[W,OM7#3_M,?%"-RGBWN#N
M[8?Z+"\XTL_?3!I+K,KT.Q$/4P!PGU'0<"2$#8ML+*R:RK0 WRS6EBR<[?*)
MJCB?6&DGKWGCX\A!I4@"^YR%04NMERG-!\>5[K^\'^2S)];9#20LN\+;B,KY
MKTHG4J-M[Q02VLR %5&#(F_>GC3XI^\_?0%W0P\3M5)C>EU7RG["NU#Z@'FD
MND^$V6BK7)72[B>)H(2QN^NF.7Y4<JOBNSQ W4 ='=\/P79[;K)Y(L]+\3'I
M@R9%#1S+Q+Q$J5D+%64IZIU[@D%7I*P#6<[G49+$"=S7_(6-2M))OASH\!5
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MF9DQ9F:Z_G9W9K[9N[,S=^Y_SJ\^3Y]^NW0DE:1Z5"7I?5MXVP!\E!25$ 6
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M.#K]MYIO ',+G+JEL"+CJE">%3DK;'ETE@??U.?598"?3"[9XJ1$V<&<8B<
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M-N%A/DL1B66&0(RDT4ZE1#4LWO6R.<708CI_*O<A^MH'>>TP;K'4D6VDP<W
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MYT]!_>*Y?*V!!TW8N!*8Z%+$(XYU/6H],1'7UO.7JB9LP""Q3-_G6Y72I.
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MCE$L%2P=?JAO2RK$%5);G>9\K[,<_0A.N,.!&N9 M03^@<H0$Q%S);GX &G
M7(W8]]/\<YA;GE620\>?#8V-,2XP&>X#/7[S,5'YU"#^3W,5#'DS>[-EB8K
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M^/W&88OWU%1-[0E?%H4OR G*'<MZOC,[*V /&6%6N@"9O[I5X\XO'AB)SS$
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M4U'US055%9X._0X8^V+2P5S<E4;W8Y2_T2^J"Q,\DV5_UK^$"+H8Z4?Y1T[
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M/EZK"XQ_"LH9UG?'$+.B\E5ACG3#*<?C(JIUBSPX.:!0VK98IN<349\_#<S
M-]#RI0,?XA.L6*?J7!CW76FV!=G,O(M*L; PS7G&AT+I01?BC0H=:VLCY?Z
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MIONT-G!^88 _MOVLJKA252BW9'E1MD21$FC.V2?AQ*?$L+Q4H^\"P-H$>%V
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M/>OA:QVT>T^!PWOH\#_4Q>KXK\I?X_I&BGJ+4X+_<C21I0\AFR[F)87&AD2
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M9E*/&EG8$QW^WNAUF-TX:Y=)(7VO W;?DTEQ$WATZ]K]+7;' 4[NZW(E1^,
MCZ!,Z/-P'$"&TK'!%URV$-[R1T9+M7_)>_M?!0^)44-XI1!T!MJY.!.T\9R-
M=_:._'2HOCO_@D7RBCOA8">97/K1+RH8F4N2]$JG9&WNSH\'+%M*MMSYJ. <
M8TC#O7BH1""OG J%T]Q+@<&7_?A5YP!L18<> [?\H?'G9,I#E?E\MMT.N(?U
M.<Q*)P#"+A=>(X./6:L(;S$#?COMYD@K%2'F9O &98G /7(OPGAL,I[1=C.4
M_I* N<UA[6+,<C?CX<H3-A7ZZPB](MZBG\3#X-F.DI9*UTKQ>_8>A#G,2=^+
M @?^L3V^J@D\HC5!GP/1]_)C_EO>2\IFE5R]!?<?!>O?@X%B"8Z6YR&R(4P?
M"IWCV]L0@AT9!L_T+6GC9:Y%L;SGFYWI./W5WX8]KW+<ZN6^H,)/4:*\W&-&
M'&"^F%H@7VQ::&S8&FN'N, !6I.S;B6:N8E:C"#@*1>P5@:*(.%ZN1V''#KS
M=#SV^9MAXAQG3.L5=A\I7ZC]<37L,[*?5[I?PDKA_BW!V>25L:"3#0U[50U4
M,@ZP4@?'D'\ME'_2PQ"WL+[5._.J.%H]&6+ZR2S!UK5;R>AG6(*"M8J<3N7(
M67I<E-ME!%)4PI?2  ?0_+'76%8^R+@3TO7X\E>XYOZNYN;T&W'?S=N"AHT"
MH"<\'6@RZ_;7*C7.)OD^DG W%'_3$)*3<^R";0(#7T?%8 <*K&'"O3C U-EZ
MAEIBIV*M*X:KKSC@I$=AOC*?]4=7E$EB]'8?9)RW(Z@\WZO:QMA2H"/"-4M&
MVF\^<*1UJ'Q;HN'H2IP_0L$E;UXH+@E^>A&_,]1\W]+\U>C[Z*8;)0G:M:.3
M[>GMWYI;C;J?^ET-S8Z8E=2,)QI:?VRWOKM1T+R]8;(PC5"G$B(*HGS1!# E
MSMC2G9D+OT8I7;[2G[UC$.>9*/YC3+TJ\;+<.+S]_BNW.23#JWB9V [O,P94
MT24-#86Z OUM4HGH8+L?"^JZ;=VEX0)3!!2Z=Y;Z5-<Z#+^QJC(W/3D/2P-U
M'J(\M=\=/FO5/(N2;1UT6>\,6PMZSU<J&_:%DHOHT?II]H2LF^Y3:Z1T63$.
M8*9R0P3NXU@FCHP"?^O>-_O8*.B7TDKI:B1+8L1;03)L\RB,7\3D^4<SFJ[^
MV[1H<KT&KK@YUE_4U%B%F6^K6O>_-FOXFNT:0PY)VA'2CR8T6] 0I8*"49"7
M W\/2:1?C=PU>H;G8@]_N^9FZE!RB2N[-"RLB4?$/N<*MRQAK%VFKAV%MXFJ
MW68+)(T727IVP9N^>59]=7O9^G0S#%DRTCQ1$YI[2!@L>;%70;5 !.?:\JLU
M772*]-\A<&FX<:"QK4M29 WAB;>/4+9%X)/Y/+I>7H[N]ERU;1!N:RY;E/A0
M%6;I;^RRPN_)'LUFJ%\D&Y3@W?Z]_-RZP)!+*Y/+V;R'[RJP]?6]G#QM7:/:
M^/D'PX\0;XNLJRH&G8GB>47$P%PTF.%>'U4E]9-3RNQ,/4/4I69P&]TH/U4
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MTOJN6J ,ZSIAR4F[W1;P4&3,;'@BP=V!=X@!!ZA)"3?! ;2-1F#CUY\373C
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MY\%O(O>!7B^'/O:$_$UT'8@]Q8VR!>G:T-J=G,Z2LQ1,O*&) SR.Q0&*G7"
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MHXD4]_#%T*1>04.K]I_5S<RW[.:J!W)78;&>=R@SQ<NR]JDL-6*XO%]=5.(
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M13$:.Y*R:'+M#&P%>@T/#DOON#R3?FH-%V$D>R6TW64Z6F2K_OC5P\#W3&V
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M4-E9";#[,MZ12?!G@!U"^HDPT A3K'WQ.?VF\=D#P]$];ZQIH>XJUG((_<\
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M=WI+C4?"!YZDQCD9,\**3!-"Q.?[SREUVV'+L:.<U6PV;:RN%G@('!@K%A_
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M^7O5SRJBZ93,.=3C+2:7]\L;RU\ -1ADD5TQ/6,?=]0&MYCI8^39[A0:DQ>
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MY.5M37;&UD:+IH"9(N25E)B&$:1RS+N7L-TJ1NOE/,TF0WGR>5O6Z/BW)P8
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MV[/F;!QC([#7@RD&<(86N-V<ON(_#%"R)R8@%'PH_#R\6H3%2>&86RJSD-^
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MN. PN6%VBCVMS?BX6%AYNQP"64Q2C[_JW)VL^607X+C!]!P4D#[W+AW74\8
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MZEH\)A$8_HZ2C>D]K&GZ UA:2A"4 H[7T;LI12V^]$!\^UM*@^18%^:8224
M7R,IW[=^F9BSQ1AW:.*8PS0M1[:+8P"$'%,Y@&W0M65P90S-.O,\#D=]&Q%(
M-<RZ3XI2]H?P.&K8^G_4>5MPK[4H"7CQ61=7LM]OZB_:5]00K\9<:UT;HJ4^
M6=)\<,+$T%=^YBM*#;)<[4^_26ZBX),,.',.YX[US _5\$!P)0Z4 ]1>EJV)
M,Z%E.H^;@&+Q]J$FVBZTP&?C$(J":+K,>B$86>9YL(*<JR.M(.4@9(/?"F+
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M?V3X<\$\<.%G_8U@XD^O\?]0&;WH!KNF_R-;V^A?%"#_[I&]<-%XR8S/00>
MB2;4XC;([$HL+!+!U^^3,OZUOK@F><REP529K2(-=F-,P^!KH/*1'?<:\_W[
MSF9:93?J>G<!FS#CM!TO,"/'4I119L+SW96$N5ZA)8%<NOWTKQ+)Z+0:(K2M
M%559H5XUF/2,3Q]V*>Q4Y_)GG)V/ 75-M6WU"[N@)<@211!/1RES2,BO:^QH
MI66>N]AN$D>#N2ITM:H32/),81REZK=7EW0"?HP*;#"?"HWGSY9*VLCDVK,I
M1LM! ; ^WRP\ -/+9.83ZHX.!BW@OMDR.;<H,7=+=#2F&^LSM7?81EN9?K.?
M2W/V4<-*[%N$'\-?Z9VK30 9_=:G@]&O1L$ZNOI1OP7?3%W9_C!6J-GY,#ET
M,@[XZL%WI"&QX8#[22AO<<%!7&=>A1_!;0Y"CJDE99\RMGYFD#%H(S_IM?GP
M'&OO\]OSMOK)C,B/B&1@I4W\"@=S$M^(EB3U%9PWFF/H!$3#$0XU&MP!9?4X
M00JAIYULZ2W*5)8VEL9W,DK5R(;TE9ENDP&;1B+9J.H$7!;R&OR7_4&]VDQA
M5R4>R_+:&E;\'O<&CC:7=%N>@)#,K6LY1Y,(@:Z!W/S]$&"=OQOO8#N8@STU
MD\IJG@:P9D?Q^7_U./K?,G"NE2C>M@Y156],D-QN_MI7Q>$5'.#VMOJL,K&X
MM5;5^52T^I[P\NU%/).';L^QA67$S](#@V:5#+<2\\'MQ8[0Y9K$V-<XNG[H
M1OV]&Y(G6'V1I9U0BJ;FF(4)PL0>7,+WA"HJ*GIQOO10O2H(GE?; E3KK#VQ
M<!D^TTI:OQ?*ZKN;8$T**\N8/Z8G3BU)Z4216A#D?G2O"\BUO,P>-(9F;? =
M$<&@,:TS&E4,^R]-S%84.5KJZALC?(N#E+@N<?%#8" <+QE";V:]X4TZR4H!
MRVFXP%4W4;DY=K-^3US5BF4][)\!:Q>2^2O//>:FZX<US0<K3JTNF>U4>9%5
M/)TI\2=8RAR1EOS+QU.=:54?0.!%W_M-NFKI\]N,^$/CZKNN7\[2T4D[R=D?
M_4M6SO7P6%\3D"!B<#%)BW%0Y<L^E4=W_N^FF7\AN#Z5JR ;P;,OZ:U#HI^L
M*^EPT,YA7'4$>4\KI!-%E);P@O=@9WXKH;&]MVS4T1'Q33Y["P4NN'M%?5VC
M$'-))YKHQB21?-664[0AA<YQ-LDR2G.!C$=.C4>M)+^'PB-0/B)V2)"GK!3L
M3N=0/"(=YXM!(>,S-M+IP']T*B!8^3$!L^:-#D]KX"&&,XN>(/TN?92=J']7
M*S#_S"N<8F@L.?8'DDHH%Z9$K^N\W$3F-0/8RB2&&LBOTTX&UL:DW5C?*+G=
M)#*EKA[*CHM(C7W^BR:YKR?+4&;F4'.HNTP3GE2F0>[V-D=4C>)EIA]I@-]U
M97(BA @PD4$96MP-URSO)2O<ZL!3'UJG#ZHG34-I88M$;40;*DQ=IP2#D 67
M.>-)HL*MNLQRKVV8US;C,PV2R,UB!GJ19T6Q;D05@78); YADC;!OJSQ[RX,
M_:JMGN>*<3ZQ2:OIYLVA+2!B9/O^HNGVL_L]W!Z>FDSK>%$J<U]E\&91U'^W
M7+;Z%9#9CXQ-I.[SNRI+,:>:%%1>0R($;P;R(@)77B[59.:LG0?[&_22FX7&
MJP0P=NWJ/'K<' +^HMGYZQHE$+Y5L.7]M16D!_G$DF]<\)V<+'6%#7M0H-!3
M;5S_-6C['RSW03_^:51Q3LH%/XB\O8D?W!D- DR]O1A8LT.K2W 5=I6&ZIKN
MW5#Y(9)+Y9#^P\R'F$WRS&YAF[EKWN7_&:OB6112.!_]6L&.MC*?5].C>(>T
MCI ^9#YF67J&2Y8A;[%3%N\?2?P2JP'^T_L?203WV_<7\?K]%\KCK1.BC[^%
M^:5W5@/J09]JD&%15<L\'5LD!\1@U,=$<($2P"O/8D7\UO>CKUF,4,((<(_G
MFMR4+ZI45JIPV+IT0:Y&_"$SFAUUZK(B@H8WYBZ)4<1#]Q<-SQZ5U*WMYO2X
M3"GUJ6E%2)@XDED7(V95W-'Y/[7#R+.;-&B@G=_L-F>]M@!EF$H4Y@ +KBZ&
MP&M)*7J]]*)(NPK<]IG=L&\)L5C=/=UR*N]"0O9-R/][7=$_%!/%B+I&RC"L
M.MWD40AOUSGW 08+#@Y]U.5[D[O MW7-B*;@I8J&ZM87-?$9#C+8']Q]!]&V
M+DT\_AM.#R.=V H?(M%^<5F8_7(92.<<MWUO@(-YLV\ OR(2F-U9\?=_$WU\
MK)FI ,2O(<4S]3C :0/K*,\;4R=_)IVHP,II;(CCS^QS] 1O69)1\(9B9A(5
M1'F4Q^VA MKKH.6]3N6!GK2]H@M2MN8A#/*_E2:K)OX;7+JNR<BO=%RS.!2[
M<__'Q%2-]5(DZX\1I*5NE<);;[+B.H/-+H D@7]HT_&'K:V4 6'!"P4&A?+Z
M_VRF6 VY DV&.?HVXGXE'(2RBM;$1+(0$L1HKXR_![U4H*@GZ<1TI-<I>?.&
M&C__"]I5*5?>$5]4R9-407_.J] ;,8A8-^_K(R.&$:,++;\$*$Q&KVZO04+'
M2-6-;HB/'0@?'NA-FGZ!)S5,3S8GEOL?0U",_0SV\/K9TJX42-2[>)_8*OWU
M_%2NEJ)?JQOAH?<NX_6D?VKC'XI)3^XWC4)+E!<]@K4'>J0Y>Y448>N#AS $
M^VW8%5R1SFB[0>AWM->B7&LT01>R$W]  0.-T&,#4?+/OHATYS2[ F/^PB@"
M0N;D#D!"SU8-9P+P0%LLVWN=@?3A1J/TF$"T$I NEC3+G6J-M8GCR(CSSL]@
M^;]0TYU[6U_7UMH:S%^W4MMZC,SJU>/:;$0CYFFOR9EWS%L\+A4_!,O.F].L
M<*ATTA!^9?P:,947&1J?5'0'?3NYF["!RW!B8Q8KUS,N&AK8TC0H>;/_SMA'
M_LW422YL9:8S*%*!;IRM'X\Y*D^$XOW@GLSL]G]:&7I;)0PN0$MO$KIY?O@L
MV1IK8Y+\RRSM0NNC.?:=(9 M$5;J#7"Q[Z<"^:Z,090D/:$'/)W[7[2HR;+G
M@1QX_2E@"Z1*HFYIIKWTX5*>45EE2[#7)^!&<^)?IR[L3;#1[VD]B6_JI'M%
MHBQA+[UJUCP9RKTBO"V'HNA6<<$2#ZWI%7D7,@ML)*+5YL,D\]*"0QWHJXR(
M M%ABZ.B*795V$R^D/0XFYJ9]KN1GL2YIO+_F5H(&8DF^,>46R?EXV8?MYOB
M%X><;"5$2'$PJ/=1E6 3BK"8C_YJ6Y<?.Q+ 1;XVKM+/QH =@QWC?I-YD=7_
M5^/!II9Q@MZ2NQE/QT-'F0SVJ?:1&FUJ+U+?C$8T%:$8D=EF=>YB2S%HRCEC
M:.F!1(.%=0+'E/7W_.3!2IL&LY[HJM0^$!I)8]"H[ME<R&F]QF]&XZ)&GR,G
M9TBVI5,=\*4G&UL1CI34.-RK7F?DV-*]?&D=_HFS IRPZ$#IOC 8X.+KSQQF
M:$E?O01LP?K";F2IK2@=,6/&IM]TSA%;88Y(1\ 1(^\!A#T?511;W*4ZS(']
MD_],NGRYK8H5N&8@/9OO29R8YR!D,;I[.HV!$Q3QI1M=ZWJ3V=8O/=ST3*6N
M'!A H.UT)OKMQOE6-Z=1>?$Q%S\ZN^NS-:R-]]=>?EID//WG_/51<\=Q,O::
M6O'TF89?%S(X$0K/D[&?Q2DPT^_.A6BXY#JFB]VW3$9_W3D8PQ6P;HK_!8CG
M?G>@KZ7RG,?M%]0LX+\KD_+%NW9U$]^W-;8$D[C@*V]K,J[O2.F:?KC!H>Z4
M"U"VL[BS=S#G__.K)68%(G756)M 1?.1G]DYM>_E\T]SJLJ\,<MCPHM=#R,N
MN=U07Z(>6KG'0<*QXQV@LY7GNZ6 <R3A;IS(;%JICP4HX=&PJ:;Y.^G- QZ*
M1*;K8R@+[D1=";MP!WW4%J%W)2KBTXAIR>5B(,;!K%O?S;A5;5%M>D+?Q= !
MN4)UT<XP&6SW\-C N96M_(#4[."6S+BW0FX&WO,B]V,0Y3/U?'%TF49Q+<F!
MS8@3^_RT<%9)_U,\1]KEL5)HB;:M(_LRO/EU-66<,D XC<J-V9F&;6J*X4!3
MM3M]YR=[[UB!$_]VK%9377W$BJJGH/ 7L_D29M>7:'+W8B@=51%B/;<;&-/L
M58!RI<=N]0\SH\5%T\@PMVU9=3WIM4\=8?+<BU-PX[->6&DN"&Q"/J' CV@+
MNJQDX^_)K48;Z,2T>3@WDR-OJL07%T%85Y0$7876Q)4S2?,6V:X@-QVY9+0"
M%"KU6]G@JG:>8O4WU<L6#L].3B97[((YHU3KADFYEIZC1Z))T,?PMN1]/9*@
MRR3.6@M0' (97/+K6\W^K#>F!#*1W&/+Y68 ,A]@L"S>CZ?JLTZM0,]R^U6K
M-)><&-YOSLN)UJHMCJ7OW%_V4&SF[#2;<%\*<16X1Q?XA&C-7!,I:4"D[:;S
MOXTU$IY_^_AFH<V5SCT^]L?:^5QZN-*9TP/#DXK,U^05?@8G"7&E^G9K&7&A
M+\2G)D?VA2/=2?1FL5\1=*#GN!W._+.:M%*4=KI:&HH#^%O08(5=>GU^P2[I
MF2)XD</<)6@0:E7[O4@"^G:./9^'SI&04_)>S^,4U8;]S_=2)-I V,4N$)']
MKA'DW\1JD P ?+62PI"=$UJ',_5(JX2[Y*P8[]<:<R5(";"U!FS3I":\Z(]Z
M6D$L3*AOUG3>^7>,YYLN*'/$Y\IZ?2)24 K(>XV.O^BU;E&DM;D: ^:7Y:Q2
MLLS=%P86!X2KM<=XIIF-)/85UB0MADJZO$_<-SLFOT]M(NFV;R?\^<MY2K<V
M8<;%MC5SI4AK.,,[*<W=K><;;F=_R1[TW\R,\_CJJ:]9)=P;<E.4Y2* X7M0
M>'O,0T78#<!>DB;F_<7U/P@L.HO)00%FS3U_IC^<WL2QQ\C^E 7&9/MC[,.N
MFN>^NES3Q9( "1O6'%1ZNIMBA[<:0-X,C];RH5X_=/Y]5L9 ^)T$:%90\.WM
MR[>Q'HFH4?;I_*%H8]#0Q>N%)\X=J3&_CRU$PCL/VZ?M"R[T0(HI5><![5,V
M-,MO;"&9L5J2<'QN"5>=.BF)*;'?\KW-#>7%(/#M2XO^9Q#8_H:-4!A.@1.Q
M]^<D)=.);/WSOEB:5\;)<R,SN6_K7>BUJFA/F.UNO\;JBOPK(^]#?FQ5/0GY
M>_QYR<V'\?AQAJ5QF"DIF4.I)09;VVG&S+_[%HSWDY].&;S^6"ZA#ZB3X8G3
MLXZ_8)IL\>/:L1R*(5.:N,[2'>X6<6 =HN,77^;XJG@RJ<D2;G6"2?0%6XI&
M2LQJJLOPS,>B"V6MX6PWZ;P.\R+TJLWYX'4^>!]N:FBG3#\BI=,5V,56\1?M
M0RR![ZS%?+O7*<+917[P4G9<\*/XR1^&Q69HU/0<(\DTQR]$)$7ZDH9_1>3=
MH'404P;=VOEM=?A5Y6R$5*H[6^S,DT2%J4/ZS$V&/T/+"@C52T(J+'&R'%GZ
M0;@EJ9K:)B*E"T;3/"$&T7IPPP3[TS,K,?0DDMNL9K9F9K?*O8*UF9%#98RD
M]$_(_V]W<OX_"[;A=P^]<ZIP%X_BQ.%'Q0]29IU&+_3BEVR(>6%3K6(E^Z6>
M<C&1Z\OR[UY2?X MM7SJB:H9BA*06AQ3HY^#*(NB#,@BG'=3?$*ZYLRISPR:
M["P%LXNTR75#$SGTFRY?R'P@UO]"Z+L6$O.<KCD\5$R0S-1TL+*ML#8@&,3K
M4?<Q,0T_.3X2_7=OUV_?RLE_409[XRJ^@B&RL+RPO$_+$)X%9J]IJ2:TY>NF
M^\+S+&;+YK>C@\SS%P>T8CMIY0SB@.31XZ^S(T=C1RW>:U_(/>]]'^: _YSA
MP$U/-!?BR: XIXK\63,I4"4Z;S*-&CKY-4I"<.F\F.1J*.\112IWT&-.,>UQ
M7]^FH5$WR5]Y3+C/_N/M/D9!B^_S^JQ-J\M&F)\AY#_?DH2N1[,^JL>^ARAJ
M^'*T_O2OZ,S*$2[I?Y6AZ3RAK.%-:_"/^(-"_]\:Q?[_\O^),/U=^#\ 4$L#
M!!0    (  @Z5U:H2[133.L  #SW   3    :6UG,C4T,3DS-#8S7S4S+FIP
M9\Q[95"<SY?N$%P#! T:-&B"NP</[DYP& 9W"00"@<&=X#;XX,.@"1+<!W=W
M]P !;GY;>^_6;FUM_>_]=/NM\^&M[K>[GS[G/?V<EN>YYS4 OI*<HAP Z04
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M]C=HE"J8;=^$6#<<V[,Y(0%?@KS/@2$3J*%5AM%3QK:4Z?NT^3GYRZCXIM8
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MTUD@AY)EBZ@T6NS!5K",9F'W)68OX"&_]#HZ;85(J\B-9"H54<DR4N$\TMT
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MF$N?LRMR)S*/,J)5<(SKCVF]T?+7DAF'2//*+8E8W?07 U](.3"H_+ GMY:
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M,X\]T&Z[$2>&9<X.88W^U%X/AX'FAU3XANU"3T&,;".A&;V=<VNNPWP[R3/
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M_7521S@:EZO6U+"$9UF 0%>^T?Y09]R!100L0,99(INR-8IIN1DYOS!1H'8
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M8/XY51,4O(%'6MS_CDF0E CR\FM$TH[LKN96[OX,CI?ST0^)MNER7G;;6"1
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M=CK-_;F7/Q6G%Y!\.K&]#Q4D)0QGV_\95,@7(?M3GM*ZX9W#BN=&B&Y')K!
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M/_J@ST"#Z TWH.4"[";=>S@4U5[7]*=2-@9%;M(7^36$N'G_S%?(K0_"!H4
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M0YCB@F6Q6/S2>]J^ 3O?MB5O?_3E!ED\E:9XZ_YH&*U/43AD-:XH2\XL#H3
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MT9X*:!;)S5"MJ4)A\XZ"MQA>WP,*S+5YKWINK$[QF!W$6S*]>@5M[@'CRK!
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M][W)BEW%*)EN'FEQM)&D&1:A31&7L24''*>CDWO KF9'Q'*J(>XXK8?:V]C
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MAM=YQ_ET#;@)%KO*?XU8@-F?D 7CI&/*H/DV^3] I(*\_J <J==1@7=<5P]
M-,-:=Y-7!&%@#3J*_D/S'MB6"@KE*W,Q2EZ(("M"K"FSG:P#[+A XJ3%<QEE
M7?V.<YE-^9N 4 16O!CVS>,_+1@.0*CD]8.Q&DA44/\;(8FS.UEQO[_5X+D5
MXH%1_R$'^%-+T?F[?M!YF[6<:0;H=N>?LL%CD:TQ86LYBYN&>T @ D7^ELL^
M,OTI\\ZK: I4=AM0 "!V0"@MC?@]R6]<"NC+?P ,B:C:$#$<_0;$_9*W/WI
MQ8CID!E"E#RT(.<-U@5$6(R:!*7C<"K]G;=_2%5^-N9$P^A1=*O//U-$&]"/
MP*<S1'%]5RBJ292E\;R7ZK>9I'\S4">0DNZV;K;SZT^7+=)=U/YZ@_]JO3#8
MM_LH8MFCA#'DUL4/XS0;[8\ZX*\P &[".W)_(CH"^??,-GAM*T141-YY;LOG
M 1E:L//6:#:(SR M9;+V)M0:8TA=Y);0NK!I4??6V$%A&S:949?:W6=G^DGP
MKL/*&Z]MRC-"A DP&=QL_?\'0RC?^+.V*1;:0Q,;PFK2>7(MS>AKP1X>7OZD
M,8,NS1>2?8M#6D$36=T.;R^BRZWO&*#S5I1GK*,C,QOL-@R>JBC&Y@DW'YZW
M!DUQP^=O!'Z/5G[JJ%^I=G+;))X1Y8\ ,NZL".T].0#[=02Z/E*4WKC"? 6T
M *J_GB/+?V=QU4V"]X%U(4B, I3GN:D#JTNAGMS+M5I_ODN(KJ=CSON$JUR-
MO7;?#-]WU !VT=+C75%-FZHN8-:>8N:&5M"C-::FL^ZFZ28]AE]L!.AB$8=X
MM9->6+M524-3U,90&S3D/ZJR6#J746%L H['(=KQG9F4R3UYAG&3J<<C.O4I
MI$/'ZG;/O;SF6W$XP8#CQGVHL')OLGPQT,;/(F!%JCH,(_R01(_1>?C8),*?
M-7[4\ON-(GR]@5XVVXJKT8$-ZO?)4W8QCF$JDW@ XU45]W=M3[RW4VX)TZQQ
M:TKQHX[@\\>3>4-OUACYB#>/RT@"0NH4N6R02=]T:\?FMSUG=^"J=^;?XA?R
MF<#@758FLFD^J^:N*+$C#MI[OL.?4Y?T# \OY!F'WPU*3'<E]Q;WQY\'6%8B
M1,=CZ?')7YA:X\>.ZJ>O2Q_AA9*'VO]?MR1TB6T77,+VRC:A$"/6>I<6QYAZ
M_R_<E?^7V,SO(IN(O?PIKNZ_>WW_+0(.0>Z^/1S&P4VX5%#^LIPW'+@%^(#>
M?UQK>2C\^Y;9Z/U_0]@>SJ3D .0(OO@/Q@2T,MXR8F)  *Q<]X!RPYPBU2@7
M,;0_CC'E_$[4S(W %['^>ZSD?SM$V8]&<%TDLC8$X?!43W@0".F!SB#HG?5#
MV%@Q@IMFN<<]1!04K>(_Q>S*1DYYI8ZP<+/$ :?D#(#"@.& "]S3HLF@]/-L
MY-0,PUVE/*)LP$EA[X/UL@, &+EFHR-XAY1 ,">"\^X\D%V:OSD.K>7><*:[
M2 $X1%<1?4]=JSR, OVOU3-U6(04%"1.O(N0O&.F:/5AT-G(7T2_\4X$Z/H1
M$8][ QAC3T0/2/P 2+# 9_]V+--FN2U&-AX9L#HEB]C]VXKN(@BF-%^'<PUG
MJ/U0EC?*[RK66Q#9Z!^(3KIQTE/_'V?]>]H4N$AJR"WT._-]M,=H ]^8,*?:
MO_)=B%ZDNI0+[3,]14&)G(*CSDOQ[5-1N7!X!,&:NO':KTAL9IY-34^ZT!=#
M5J@]F+-/.9S2G3V+WNU,SG(WCT0WOVO<-%JEO38%CZXPTL[[X)<HS@V[2(#'
M.^"9?;+]W^D238W  S(LWMAV,Y S;LU4F%&.I&PWD4*ZV[Y?*+\Q8]^YCT,>
MFIS2S(Z5JBR.&$T;J^V_9_5Y^5):D=4EM>@S55VSC[P>\, \(IIS:"O]9!QB
MN4VR6%'[J)44)COVG3KF?<SU!(+5P1"+\>F?B/^@5*2!4=,?UDOR=2J!LLO5
MA=J[]-+JZ0SCASC\)9M:U0W3.\['VK.O4%)U!UMGU.B_/W?H(J8]G"F?MU99
M>#OB+Q'"\H1LYPPO3U4F)?>G$2;Y**OQ8 4NO[MD(O&.%[>GM>;&U/ABOV+;
M\;9$ZGLF AJ;W%DC[:B5I&J0/H6/_4=LIP&AZ6&($@.UIF%&NIE87B:-*Q-]
MXN?L,&+\HJ#4_KJ9Q#3; ?SG7I2Z>HNFTB,Q#+9N)K!D(3NGVW=%O*R1CLZ<
MLMH,@Z>]9MK6=RZT( 9-(71R)IM1M:7%FQKBV6<9;27'9?K)$KG)K)'8"D<8
M$+'DF+:F=-X!@8U:2OW;J[T/^)LE&Q]I@[DL7IE&-HMU5I/W@NR4D&PV0])_
M$[9;1WAO'LS[BC'V*^5^Y,OI"P7:1C8CC8*:X#D-X?KDZV$28(A%.>VOY^I'
M@T)/G1DVM*H2B1N/Z7)*E= M=W6^S97J)KTUV!<X#F0\TTWP"*#G$1$PCS+S
M>30[GIPZ1RB/UN>3KC:C,5.-[UQ*?=#M[*)EU!;F^;AT]A&< NY"CY, :Y&*
M. 8ST^[&/HK,Y0!1^G!['1C)O^</B#DYSP&^223N^Z87'Q(G4\!J)@YY>\S1
M:H;NB..B67&*"<&WV##F .2EZ"YOC8KH6>MBT'"Q8^=G!M?:NIDVOB<M['L5
MY5GR&LI@5TN,-D\6),,![9I,36:%OH:]0"'>=]* N&':FYAC6*G&X5J/-\YT
M)KYU6I=T$]YREG7*4U/,CRQ5['9?NAA5;X"_3UW,-ZFJ7$(ON0?82YUEG2K6
M4OH(W:F[]!"01-8E]?5246W.KI3J6[_I0AX2\4-L_MAYZ$TIVO)/L?6*]R33
M5:1#@<SY=G^3>!<O[L3,!Q*>1T@[XEI'=6L"SV2H?SGSG7"Y,,\B#(UC/4G9
M=!PK&X%S#?!W,!K'F]T06+FNH91GD<5C@9*BD<KW B#5#1N),<O26D,]28Z^
M(T#/*@I4FX,J>H2%9Y4_=ROY18/$_I_$X#/&.V=]V\D;* #[/4W[@[RZ3_R7
MG_TF!"='P&>@9LV%&B(>IUG$4MUS*[#"'J:8T MFFMXH(J@<0C^GX4-/%H#V
M;:FKK5>[R9JANG+A!8VJ5,%7FQX1&T1'H;LHM$VO!H&I+S\\R_1$S,'/7]8N
MSO,@I9@8Q".B">T(V^ Q<D\D-O+1('9KG/DI\59'VM]V<J0!33K/CJZZ&MAH
MS[R@X>2'!+V6/HCQ]SHI9=]U(@U[0JRQ;#^* \1236M+ZFNCKGK?7\$4N5%$
M7E/12?[%U-NX1-=&P=!VH$6>0@N*8R5(0"8,E$FA<4Q']F- 3#^L*Y<%1YP8
M/1%A[VD0)58Z+%==BV:TG!^S8-59;-BGG)5IA*[XIXK>AE+=F3=8_L]2G;?V
M]_BSP;D.\#S#7(I9VS+#C<,><6!<J<,JAWHR95&CF+(^LOF*YUU\_+IR#S!L
M@M-^R_%B^U5$=4E)?VI&^570G=P2!?J?3D,U(D%*C4VM5B]@_/[Z4AQR)I[C
M'<6EN_^2EXP);J(I5'/7?K0-=_20MDWR8.&:V*?S)..J4.(\6N76/0"VM+<U
M)U:\(%IZ^=C$R%FK1&1A9I$@O:INK?S@_%*[0%=>X];&A:Y\?V/JY*( VRS,
MU K3?C@S()&D#;*^PUTCCM=SP<AHRZ6 N]0?8*L)Q5\B86/C]9[_C:93F%%/
M$EC*5&M/!5"&"("9LP<>'"426%M.P+J'3:XX&Y>[/I&KR?Y79?Y3?99?:X/]
M7["60Y:@K4P0KQ72^6MWAQK,#W1GR[*78S(36B"?HN]+V=<:Y9Q[-!3&Z+W:
M8(;E2!,P=R1A8.D;C)]JN?%-Y67\XN(GA%9WEP7$*/&INDP1P2$P, -*3%/D
M:F.L092XL-3;6" #%C'=%R, <UE+3? V,-;?B._]3)I549<UDIB\R0&O;O]W
MP<S@/BD9.R5=V:67U8./6Y]**:.5'Y='DO+@NQSL&="-YN,%FD:P#VP>EN2%
M4QL4Y\A L9-R/<<]I$KZ8B0!P''ATH":!;^TL<O6UBM_Z.3@>]OCO#I)#^%#
M3=^ZHS,[4O8($S !51*[E:E3('F//?^5^M'<.*9T3/J;H6OL+=C7:0N+9T\6
M/,J>=Y,-UKQ]++QUIOMDE6 ZZ2/9IU\\);1QCH#L;EKF]0%9,R(J\ ZD'+(\
M+$.!H_QJ5][-#&V 7NHR<(?1AUZTHN^L_N-K!_RXH4\1'L_9^^7TRKS>IR1)
M !>_D=L4UM6$?4>*]#=&!^ZJC9((1&Y!!G8XE;];RO>QV;WX*(I6T#6UX3B"
M']LG,..%X7C90C$]!P!THE D:IQ<:V;H]_"Z+*45S:KTYO_@X*^UXPM4D/<R
M7?:S?HIEC,1_I65N(I&&'=G&KD$]M9?7&)OT,E/P$ C[I>[TN91_&U(43N/U
MR,YL8+5 !E5-;B<VOC&3KZ)K%:AE4TRSE-L #4;ZDH=M>:8;;B*\J%GTV@NU
M2I%ZH)__E0B4)PNU5A^)]%F@LY,!>6\K*.=YMKW@5$X8GPJ+-3[HS'LA^7,K
MJYV2A+JK7X4VS_Y*I>[<.%UDEZ8MF9$)Q'Y!KYM&^AVW2:.SE%+I0_)F06P"
MP3>9;#N#9.\UGYN\XCLI.YK39TLC3;)K">\30 $O\21MV-W)V??KJ_<@OQ&C
M@84JT'UN*X_BX/+P*P72+CMIO=[;",_CX#0Q(NZ'NK+K29)%##X/&U=ATHJD
M,ZC(^=A&,2[>:MB:JDN6F*XFS\%BNBD<"BSN9M'BN(Q0 E*M0EV3SB8Z.YHC
M6%E[5(?QL)[I1:U$6Q2$[-IDGDULLNS9T^LHV':BGNRJ?]=^BL4_)J!E_JFX
M154B6HP)TAM:5\/<*NEDWQ=?D+T:H3^V*YD5-K.B31?[R!8E4V#:KLB?PR5:
M[A>,*Q(Y-S"OJEADT.$LXTYM?WY;I@8M0LM#AI\[_W<7WD"_#0ZZ@(:;)HO8
M*_Z3BL%5X-.R8B8?#4L6UIS8#)K+VH6-C_(&R'R]#E[6+B[SRDBJC+95 ^,%
M=/EJ\EPVI$^=!5TK:BQ-4K '@D)E;.P>/WN=3 0""R?EG(Y[:)2,O).B!0W4
M/%?:SW<KNV+A(,VC,JG"\=S5 W7AEUT/3#>12\E^JJZ JV!D%Y9\7PA?:2HY
MF@<EM]0UZHV6$W_&"XF"ELXDHTB_218QVCS=UOW@^S6I1)PYED4A/RF-S @L
MR2C>XD%F7+FC>2Q=16C>*2;@L=&0Q$7(-D_H/CG&7T+!E2C7'$815@":F%PY
MH/WE5)TG:*?FK"2@?IXTI3<<KATGMDDQ/3FO,_]U?Y#H2>.1DK75^RBS>6IT
MBI-$5FS/WI'R.GX;(KK4%>[(3_QC8MNJ"U*T'!P#2LM> Q45<Y@YH6\M":/@
MR2]^CR#%<9O$RM1,&.KK?ZO_*&IF)U0],C""/F)!;AW/C &(__\H>ZNXN)ME
MWWL(!(('@CO!W=U#T D.@TOP 09W0B 02'!W=_?!-;C+,-@@P5V"AF Y>9ZU
MUSYK[?<]Y[/.1=_U1<]T_;NZZO>MZIPB3\7PB$8"I'U6= Z.M0W*?,V52]FB
M7 62ZF7Y9P@C2N%ATB;'R96/C8ILQ#2O_DS_)&V<B^4^H L$>K38X#$[8%!R
M?J.PJG%WXS-40S+ECVNQM)F%Y<M9K[^*=X&UHU=MMJC4E[[7J7(_LL6Y>M>D
MQH'XLW,8T3RNAXWT35'QHP+6])]WBW6$J7D.8)F_ 2Y=B5RKU,J+ZXZG>T);
MO*!9Q6\TOP'V"+?? ,AS]\;QVX4G"?Z8>TQ$P/XW8X%G_XE8(=[<K]N%WW(;
MY0797/:7P!]=(VY,5_]6R!&O4^O<XXD".HTJNWVE<>[W_<"KJ9EL%6[.K5TG
MIN/++(Z#)GQ5:MWTXT%2Y)RHJ&P"91>3Q,2;L7&-1@YM%\LM,[H'!"7.)FV8
MN_+F8(<4M,(W?2 ,H7.ZS 0\#+4OUJ<!_Y8'-4@N<['S $2&TRB.XK<.;DWZ
MVY7_*SS4R E-;/-+YJW_M8'4<P#=;:WC*6,V2+Y[4KNN:R1^SA7@=,MVQ09N
M*TQ8&\-K :;B<YR(#JK3V9SF]*7SKVKN;NJ#=G10XGSFUP/<Z-T.?:D'*XW!
MF"[L9Q13N BZBYT7DC^[%TBIHP3XR9F90NVU+ZC$H]'%$B,M$O28S<T7K/8Z
MGQY3O%H+DHARO!X#0"P'OMOIE;4RK_)KU7AMV'ZV#LY1C]]4H%=TW&V#ILLS
M0+I4-EY6@R['?#%5[]K$E2 V9(JC-U6)L3C^WZA"TZB_7-UZO'"B_2Q_;H/D
M%J3FJQ[*(L_2Z5A3H\)_M/?Q-R!PAQ6[*<7OH]0/; /F_,Y7L7\K%X6LN!KI
M*A&/,](4776;(QPU._6U#8;)GS^QM9^H^Z-UVMF*;MJ#8#PAN=E$2^QO]] >
MV#+F/TB4&=JE"!GXEZ_VN3]9,/ZHC/I>8[?XH^N+8!KAQ,"^C)MK3ST7+6"?
M[TBSM:9Z4,-#!&&_NN^NK?4!^K1?\L>)E O\92F\C?[OW=?IM''9L-9_ (IM
M[Q;AY"-)SX#-=$ZRZO8(_A17CH$V5.=V?3^X 5$8^ZN(C-0;0A(="54Y*Y_+
MY;S>/=-EQ-K9AH7Y;X!Z4YT<7Q<F7B"JFD$#01F_/;T#*7FLG+4=@MT@)GGC
MH=F$+W+;NL9@:0#L$"O?S?I3XG!!X"$ZM2U[IKAS+4C%QXEP17V$MS(JDZ5"
M(,4KW\#8#L^H2Q:G7%10%)0\\+1?7..O')SUG7<VC\"M]Z?FV_JR..G1X.&R
MP\]D.H6BGYL5OXQ_+!#'NM/YSB'5QJQ[*'QIN/;B;\Q'VT,%Q"'*3>HUW).D
M[J*+IQV91*EB:>_+TKW,+_:VO 7A/<&RAL SGI#Y8XU7G9H<\M2)#G$*XY]W
MJT>B"I@HPH>GKRS,J]@7>=L^03T)BUP@*,/YBGW/S?J.WCI!Y.3@[K/9.^%5
M#"=0K[AEZ"CC^UZJ1JGDG%7"#,D(>\$2RF5'+!%647Q1+:]]HQ783[PR';..
MYO1#VS]W;;E!;9V8/^MEXYV2:VSL3M[D=O7&7'*;_^*WC^_6MF/@(4":1-#P
MDL!5J13"N=[^M0,?35U1N$0%0O"C0S6W(!)/AW^5\;MJ6!+O3C10*$!9H#M6
M2-(]?KK!RP,[JQTH=J*:>.2SU1)B&=9'2X&GXR'!2?EF8<PI+B7I_2(\6?#E
M(J*2F5<TWB_'P.#[L&Z.1-5IA)>7DX/Y*^52_4&D,] G%$N*\'$X-,+^@-8'
MZ;DA&N50D2T]3SXK:R1S3W&-R\!4VBIXVNO\B: 3587/_/2^H B5WHJF]!L)
M_QC;LAU1L]88 6^HN_#KRO9*6^-%UM(1ID8K/5O0C6Z\:J7>!:'B?>Y\U$"E
M$+<X+]?P%AHA6SKBU$H%[OQS_H\!R'KAIJ%\6A >+OMSIH"6A$F.M*]6.;$E
M414O!O[\6M\Z%R>LIC.*KQC<WZB@<R=EZFX['<F%UVD!E09+1@H$(1&.>[8'
MUU5(^,\!S#TDE2I:?4=>O@U#KW-=D8.D-)0_S/]4K#YD?CJQ<Z2KC*O(>ZYG
MB:?A\^.Q8>12=V(I*VV/-'\-QF;OO2'W2]W,NN(WP H18.?? +[TO)JB-O!-
M7CFNNN3"!]!G(NE !# -6^D5&7!&?0C%OE'\W?'CA4!&\3[HAAA?N=HH&T!'
M+L?D5X'A^&$L"0R?:<D6LS70-[3#*<ZO[0RZ61'';<'!D7]1V%T;?C>3&Y B
M'HJ<5WXGGT"4Y2@-.;UE7QR@^BD4FU%V@@]<Y31>Z;/'31/_1$R7H$57D6M%
M4T:*HH.M!@S6^*3Y1CUOM'ZNPD\/4K45*O#KI9EU=O,%B\@E=/YSI+052C1X
M#B5Y>H1?D_?93+SVG771Q>Q]?II!;%4_X_4&?EDB,P/?E&^RON:+='T25N81
MQC*%8H/B,H9%V=VDZ\U*XZ4!+WMZ'&X*"[I&#@=EMQTO@S_',Z*SZJI> <]L
M/2&49/BFBFHNI' ?T\I]=OAP1^D%X,#0[]5]?J)(U1F>'-SE<;/AQ6W4QR3*
M_AD9$A]C#5=4%5%^S7#/:#D0G'_9_A8DDKA.$52"FM$)Y<\1Z%P=RPWBQ9$I
M)R;+*NH\=E9BQG&5S#%HBE4@8V7]*^1HM%B[]26ODK.YQ @5\1AT4S::GPZO
MS@_?-LA((YGTKMP7B! Y6UNE%[L%Q'V3G/,:CK%>+2 9,$?<NK+Y R<O7;_*
MOMZ*M4T1F O1@*N*1\!7K;7?C#OG6J976/A#O&MN?&1/+-*3[6U+0C8]?AF9
MS5&RR0>K\8K6Q:7&Q?-\.I#MO%HL$[DL3,Y2$?RG-JE/P$*KH$Q($.@97B";
M>5[SX O^GREXW_].P?]'[(%XS<"=0KC:UX>W=ZI!7%4"_I)B:L(KA1_U,62$
MF9BJQ&1F'_2]-F,PQ\IO?1PX_NX%R@%3ZN8)00ET%4&^K%+L>#3=;*HB^ D;
M;-.)QQ23OM=4$\#9H^M"']HQVOLB+N&QGD/DK;E:0Z4BJQZ^*2&_HFJI62[$
M%GE%@=OO;XO<\7_A?ZOL0-\:[5\RIH&L(1N6-!1<A$EVT9F.23</[IR9!%D9
M@OO5I@;PMZ*!X6(%Q(M;^ XK =[]C[-'%\&_9ALQN_DT+T%B:2==@PQ+R"=T
M])>1EP-N0$J"[?@YJ:-3P6@R%::5@])J3P0P;'.6PZ;5/$'^@F_P820ZHGW?
MYTY;2 B?,\T/B]<8+=RV1\D0*^_KNJ#?]/E82D9*R8&??T_MY$WWM1^E'&'4
M\P2!RDU;1YHM.B&YD4%_4>T["D/^84M>Q;/700,K32H0#%@BW CB$7#TUH85
M+/=GMVHZ8/EU)Q.CWLEZNRUKH<N^\@48W9)2K\X,"8M$,P_:#2;[)RF:,%A(
M@ZX%4FH.%52GG3@WF<;?_E(5Q7?&/3)X*::^X-XIT5%1L6^1$).8&7?]K-K
M!/%]8!>A1C$RR[PTX"R8K"X# !, 71C)E(P<V8=J3.#[QOS^KJ.GTSY@%^X@
M;_C+2O*\ 7<@+G-?ZJB 5E*,;'ZJE;1+PB^M/\>RKDCI7PPMG?_L7W97B6VJ
MX2(F0YZD0['N40PFBXP0?7.J;XJ<[6Q?<'BQO<=[4Y&1N/\WZ:7+5V87WW%"
MX<K+*HBZ$CF?G%#:."JJ[#K,E^E1EH0N3S%N5^Y:E_\WUS"OLE:?O-!+F:9S
M?_)$6#B;WV\Y!;"YFGB;QUSX73,QH3/$]+KFBN"NMWD!N)9D267X$A7M-50
M<\,&TNEC[LR:15K&W)6O\WINQE&J[6/)+]A?%>2]L&L?ADQ9GLD+9Q<-.T1D
ME%AOM YQ$)IOT9<4*3:&.:-FA;?=_V#$[L+WKJ+DY;*%*2/HG/D0E7:^?=]$
M0FEX"RWCYK_\F<U*5D%E8N&8'C#/-3WGQS;7WH2_A9:WU6D)K%'D'!PP9<?G
M"4^=R<P(WQ?29#':!_\#IRCR*:TT\)U,6UF';!7;XV"#-L42:).^TEM2Q.E@
MX*=#,'2TC:/KXSZ>@+*O:1ON95""D)"/=* 36B=%<7"VR&Q1"X'T$B9BSJ_5
M5GYD*C_58)]^RNET=0*!UK%!JX'7_/>&PZ<0F,XP6AU!JRF7D,PEVV+\?Q$:
M8_!&;6BZ<*^C"-;'I(]L7W>B*)7ZL**9G>.5U:P9Z%?#_E([*H?FME3>&A[3
M^\/6K@4+_&Z FD<_PWHV<QJ28$T;DY7?S1%_B2$5R4WS3-&N,,7)P@MLAT.#
MF"7:-\%[']-.=%E?12;ZQ9</%-\3)YS"@$]E74DQA8<UXMGO]MPH8A?+&HW5
M$>;"/9SRKG),\LH?LA1.Z,;&[6;I#W/.=-@HWQHA.B*Y9ZZ'8+6.'BPEJ5*I
M/:CK.'/J>2Q*U?VCY4J2>\;_30?K(QP+]@P4K<32>;*SY&P"'*=N.I>H3%5:
M"DM5FE)DVNK^S :JJ-8\76MW=!/=O/$@94>5(ANNG[>^5UTR]6VP(#E0)K!B
M;J5)4BRQ=O]2)"AU#;RJ?-32$'0IC3GK<G:!Y<($%%HDWZW$MF*'*R=FBMSA
M(C@=M8S_@D_FLLKL(FS(0E2.5_EZ*@2;P1Z.]=72$N5&] 43TQ]&;Y@DY#BL
M3.S1(=ZUOWP #T,/;&_?A7+_$J:38$YD(,@XQ%!JI_FG^-,788S]028&KPD@
M<:1\<P[A2#>RC ;\+$]BD2N<W]2*T'U[_H^J($0M],1JI_6B&!EG" 4GR4L3
M'I()K+5:+E8@6"4M<[U^KLGA1OSG/JS=K:Q[WQUE _;-0<PD2R,S'SY7"BB3
MLR'#+XJ@0E-.454V2H9_.%P9N+,(J%(;S* XH ?23)+8Q!D]#C;SM&&3(Y%E
MIQZI9K&H0$-82D_=H?] EN?0&[G;]%I-2%LHO"H5KX&?6WG3]*Z&10:,N"_2
M+4?+P^;_AF4$4@+*28XWO"?G$VV$#_3O/"O8M4+BY=VM]T3X%7!9%%(I]4HL
MB@/^^;1=H68A\J0$,SXSP";3%X1:(K9E>GL%DSKF O\YY)^[SXW?SCZ)7_UW
M%/J?M?ERZO?[CM/5$KNB=\15IM_#D'VO^,MD'C\@K#VZA'I+(:CPQPH5QTOO
MCQ*RAFWQ?#>==H>RKWO;75_R4"KU]#PE"87QYQ .;&;Y[BG,Y'4VSCG@PX=_
MLI&^8T$)5).PF_KTJO^.0M3QB]]&!3GFBRTVAG$O.^,53B\(&GW"PI$T^=B_
M9&'W+9O#]2V2IOGZE=X$?)&PS_X7CP9:021E=71I+_ ,_@:L6H2'C:+[G1B.
MEY8)G<8707G2E.61DIJE[A5(GG0HB(B:QJNP9/2UQM"80B9=?LTB#E%X4-,(
MQOI]I/P.5%JZH8W."2L*Y'&QE3ZOB^X9*IJ"C<[D7 5AQ^F+AAD>%\%$.B._
MU$HENC%D"O4X*I8QK?!$5OIR4N\2YDOLQ]R;B;'%S?%YJ9V_%3^V+1Q_M[U_
M^U'QB'$C/(6,4G-YS.F"+;W&JWOKR0)R=61H_*1MZ41NR#E$=RX@SCV$PD*@
M3,1/HD,9 GJ:J[U8>IHCFJ-YU5X<\*CSYQ[5N<BX9IG(I?E%N 1-CC_/*2F$
M0<O'R&MIDYAQR^PRW&'U:=(M/#X7.&;38N^>+9CFF_L^3FL^SB4 '>?Q3?DA
MB.?0P/W&-9.]K%GR2]W#X1SA&_%#V5(P7@3DS>"F&A=&0D_&W)!37L6=:HI?
M^6'RSV;/*8B5PYJERTC?\&,896#5A-8 &2B%ISE[([*//)Z>7?<HO+/$+MFW
MDLHC\8@5.3CZA>16HSWK;**/(:U6N)?<*'-^/?M?\?&?V*.[\16[ _)6WCZX
MS3$>DF:5],E9&+G([B\4CO@T?&%9+27Y#N]XZZ,%DSH,Y=0RJC>9CB9:=&Z9
MG* ^LE0L]5K@_=,?1^+!!'(4K]K'P%/= 5?1).^*4'&;9MN- "*I$O]LO%Y.
ME&1>TV@]\T#QLH+GY7.QEO4K0NO--;'42%>LF!W5?[@Y1U?'DR^L!J0W9):"
ME998QO7.:G81FK"H,?XZ;AP%FFPVU;^]W/0Q(6EJ(.#0+DF_S,U4TXC.GC3=
M.A$2/L;V['8=)ZBD:]:LG78ER2$RZ0RT:>4-KWC& R?[J\:$V<-R9\)?Y@V+
M'FT(S5<%DM[P(L8$" -LU MY!"%*-OTWH"/ ZJIZD+B9'1GM9[O7S%W;>S-D
M-QHLB^DZL#WZ3)C2WC&U^\CT1WF4_H ^C[!<>ZUMW.;%DLP["T+"HD+!TK=L
MD7=SX7('&N,G[Y=,MJRC&,+BX+QQP_REY5\)I0$X0?]D>31;1A= M9,S_'6A
MM*'8^@!F !;2M!;#$?7]9F&)YUR(I30D3^BU!<DEX!Y^%.'>^GGP$?= ,X!Z
M ZC U]D[/-0T#1,9&V&\1@MY!G6LHFN/&(OU?W&B^7=I2K6.#9-G?QY!9;CH
MQRS"6':2]FPAO/#XNU'RECH:FNA(T;G/_T06.7W<W$S5=T"UPQSYS5]&HSZ:
M_#K3)S:@(TW*CX58[Z]6>/X# ,BT&^4\".OET(]=6BHJ1.6YM#E[M58>8+[\
M6#.^LNR2U?6KZG^30LJ%LQ")H1%R@S[KYFAO+%5)4\>Y-[,*X>@(>==;IT0\
M6"-+V=P3E#4^O-YL,Z.=MKTA^H*CWEGAC9BVJ,=G4!RJIO[P3I2)!,L?IUYN
M^F>-KA??I7=T6PGGH$)X(4G( 'E6;;FH9W\]?LK\-RO)UJ[G:9BTVQ#D$Z]$
M]WPAKX+@2VE17M-/S-?QX)LQ7]CG7[4X8CIEYDH%/"VCV=!_]I=1&>DT?$X0
M><\AB*EO(K<RT?*IO5&_K3'\E",^,KK?@_"_Z*.\295+H=)6G4J=^H90V,O7
M(U,@"16@N,;X)TOI/KI@U7]@EZ=/_)D97A9*#.^E 68X$FR<_F3HG$E]A&CT
MI805[YRNRVYG(W<HS?LWBUHIDNN4(#>NW*E;A E4G^5&5IF7/LU6.<X"'H^H
MW^N0-42'A?7RKM1XO*<<QZ1>7>0N@97I[?>2HL2W..!+$]:]BSG-*<O328]A
M]<7NY5AQ^Z_*&>9_NAMKC0GO?\MJNDD*_ ;$J- ]]=[DW''_A^UGJ&RVN@F/
M$-;=C]E,HH+A,T$>[RT72"W@+KU;:V4/?+/0$[5^@Z8:P1K).C\K5W-H6[JK
M4F3NV/.I#W&&!C']Y)2X0V3%"36K ZC9R3,"+=P-1-9HGLZXC;K3-5WDA]G<
MC:W3XRR5&S?^V4Q?A1%>EF8L6_Q(T__R))."1J1@53&/2H_8]E;)F/[8O\E^
MHM#'0LAN-YIK'J=N@%;:W.NV[JY6P9LHIJ4"O-Z-WI,$VK!O1],XS)[MW?"!
MB837(K58*'';1"L?3>W^1#RZ01V9F=GM3Z%'>)9)32)^'N$(;$$;!<$9MB]K
M:1=%$L.4#7$#LOPQG$D?-O L^.1!MKE6N%-,X*/PH](!8,]]1\>JF(]A]_5*
M@/[\S5.-&R/,MIKCE,"X:N:%VEUL*LF=F];^,-W,B?QJ2Z1+I,X=6W$6E3Z+
M4+W]7;LU;YD[3$$ XF;O54UOF__B9-N"!*^6MY4BWJ7GR0,V(T? W*:TNG;6
M&%0(1]2_3,A^+NM^H6 C-M@:9V%>\)U"^PJT:Y.V/RK50.3?7IR:G#0RPI&]
M"W5W^+8E#$*"JB&GS:FA4:(3%@6L_W!DR%'I]N,2"!;W0RYV@^/,E138$MV)
MQ&O037EPW8UL'RKD7A&.J.$RSWN03V,;Y2BCN@P/<!#.(RDJ33U+#@<,+]BT
MA"^]E0XQE^46,.R[7.'C=\!\2V"6 &NVE(O_NY?6&Q::4&$+3'Q67&FV=&WZ
M(]:4::PLQ].+[V-XV*4^*Q)N,.@)?3I0;\VV=UA><4*)9C0Z2\&T2A(:)5B\
MO1:32[+P,^7<CGL(2XKVX+M7#:SQ8O&^8VL^5-B#JK5$ZS.%(63MSYE",D^<
M<G&H65AGS@-W7SZ8\IWN2K:MW/'6XD0CY);J>']5 HL2S-W<">#FAHJUMVZ[
MI[@-\EWR[/NS2KU4$8ZC^X9'.(565K6?I*.H@YPPK<4)R6_]6CA,8M%M-["Q
MO7\O"9'>NT(O(3;10QG4W=TK*3*8K^%Z'T?$P)Q)V9>9HSS7V!@T3T,;R2D]
M<FJG]'%_G4K!@/9+?,'QK\H>J_;QFWW8(-$;2:LI63VAYH6#"@>5/C2,X *,
M Y;(<FMY5G3 ^E:<@4X1RX"<\CP2Z?9+(O3[B=;E[-L#O3;CG0=$9!@O_I<S
MY!D)'D-X_V^ (=.&CJBC9H1F8V#HC?XF-&XCQCW0F4__CG)N97_3BCU8V&U!
MY,"0'P[@ B"=O"UKUE"]XPS4AI>TA<(;H8;?+WONO"I>BM<XD2M1#=$E32G'
M=1WDNA,J<V6D_P;0\#621PP7!1I^ZP1&9G=_:9Z'(CFXMD@9.'1J/6YH:I!
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M^KR^GPZ,CN8TEBT&DH^QV'QD4J@/FC=^?8@2(ATM9[OD?9 T+&4 6X!6?'W
M=U^5,)$/9=YB(47 Y L=-4ZU\6[G:>#OYQHI,9;?-,"K+.M3?;Z>\VL,H$IZ
M./Q0 V  ]L5UL71-J.SM(X8YZ..V%F&/@\[?@N+@0?(\1A/%@0NB'>J-D_^K
MMZ^*B@-HUAR")E@@N =/D.#N/L$AZ  )SN"NP8/# $-P=P@,$F9P".X3",X
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M%E(I8@FXQEZMA9&;AA$0UOLJIA,GQ[>0N]!!E[R6J-))4! C[V92^/4TU1]
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MP?&2^]:ON0\U'ER9VF5P@N\.Q*0#2-PMJ&X V;I-$-2(180X'=8+UV*KR&[
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MA,14H<Q5O<B:D#YX23Q;21X[E77^6^=UAP:MT)G7;04O8,50L5$37B!)]1^
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MSH.N7$V5Y3F(CLZOCA:4.U!M*9/K5?V=%+^,+QI,(/!KQ?TOE[BJJQR@:%Y
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ML4Z49;S3YI7NO;RJ[Q(& @U/>VGL6AKG7T]+VP0RM"<MWBYP><AV" RX>CX
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MO>/P@.KR\)3_;_YF5>;%J."YK@L,<2+TH8"F2RB\:&]EA.[FR&-1;MW+((S
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M]$!1"?.[!:Y2_P? 8+MOAHNM-%'@_2L-IC_/)["%9AI1BC 0^:$E1LQ[:;D
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MU?@8==$LQKY2!$VTCGXN<.@A'XG-Z4A>K8YW7^VY90%CC>CH.D92T5225.>
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M24:2FD>R0DR4WDR.S"#+_*N-*A8Q+IX@<9$"&"(=K_5UZG<M'@@P/3O1M+3
MQM4!E9<NW3RD3Z+#L4N948S/H][8/:!'(#]X;2)CNK[N0PW/:E"?C+AH#'B8
MN#=;D$C'UUHMB-&?X+*H^(RZVI%UC^%YZ28+?X8M-P:F)8EP<3.,.18O\6*
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MK--@9*!A+Y>EY1#B'K!*Q'C==],!8#S+OP>DH@]=_P:0[+L)L5]+[O> C_>
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MY/QI:SC4U=B) 2DB+Y/B39*>EZN5K/I1\>S)3&<=1T%B9+YIULRW;^=YQ<O
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M\_P6O"-4SYPS\("0H4V5'P_TK4PX->\"FD@S*Z7H^,RJPGT)^DQR-*Q\SJ6
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M,7V7>Y [%'8:V!8[5%,1(X%0O.NJ5<06T/V6 2.?S2-OCX$T1(0G9P$D8EN
MR68E*1^E@,MVH?1ZHY)@*#[B]D[=@LH'I-N2:IG81>$0=R&J*\@A8QJM/:0.
M7M;C69#* CX!%CO&%4,/B *$GW8ZAFL]?[#BT*K%\)%S?/)-=$5**+Y0#"G"
M;:5S#!W4[L-0P1>00@(SY, (:U1B[R0E+F]#C49L!2/8VZG),SGJOIO_?&^#
M^' 180*/^[8V_H[S._L? ?S24G=^>=(YW_[XL6.16-F,>:$!N&SJB5PF,OFU
M&S^/2^[YW>%L49O28FU.8*LZM[^Y_G*E%D,I1>H-H*Q?]"9P!]V#%7*2&W8*
MYN5&-<: LXTW*_ /-^AIS(UXQH^T#.^ X]P;9,5#PQ]6V1D-S\2O-J3J*;.A
M*DG(]" M+OJ&O3R[RT#GD//2J%>>(Z\$B7P+-SW>/ZV,-2CZ1++T?/7;IB'N
M:_'HSO;I(]\@#=U?GEAOTF*> LP24=-\+"BV3%Z8^X'<8)\I_JI), -VU)Z(
M.G32O"I2)YGXJ3.7^Q%-*<-H] [/S]%UR%<]KPB</.^0F?:I2.G2[&6"N <!
M+^A%\N,D#)K<:>Z3;EAW!_+I2Z-X8)7/2U+SRB/2,11?:>]F5KD/:&>TS<&
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M;S\K2['@>Q2_L=M=RX4O.*NG319CVWGVWT+JO\TY__%%N/?(83Y+7O<<\ 5
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M1<(K<#*?]''(,:65$+U511YT87#&;>T:F%V/P[18_O@<T>E-P$2R-"!B:^'
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M@ &F;N?=9X.I*\H2[2"FQY<9D"8G<=L'?R#!O+YT/R\$P!?<J>'B@0GV\Y"
M87/:Q3<7/;ZY*]H^U+H_EA>"SYK#;+^^%][U*CJ<G^4%A8+57O?&.FZ\B+62
MSY]VNP(L<[M)\[ROY] ZT:^5ADGPNN%$.241K)5<**$TVN%@A'A)JH50Z%).
MB*9MA#?2[1(:AVK0'O-R>M+N6%5-].@A?I9!@5<F'N4&=1,1.B1/5]G":7E;
M^Z,YQ_:Q0P\X@$KQ?D/6]*R;?H=+$S?RLJK8:K\HD_C3?J1X?G'B"H8!#=IN
MU<.9<9Y8-DC@O=NKID#X&5?L3-M8]\7D\(Q(56[BA>,5(,;E"G!T!#P0$FE5
M/66GNMZ9-UI_]1]_T?/MJ^ []=P7]Z5"YPRUB=^M2U[DJUZ-9)7LZ4ZC7$OT
M#<%PN<4,;XNKI)I3^I,-=VP)W&=*$ -G\^W@K?N:6Z*'8M=!OO/=E-#V.KRH
M74F1G(%<MRJXA$B5# &AO0LO'J/$^PQ.CED61%QDT-)Z!Q7*&J*S1=4VIEVQ
M;!DDU]IZWZ5UQX"HNLOH7DYZP6:SJ1)B3$#&)/JYXQT3,>Q2RDDW@25X^=(5
M@'H.>A9?3#3^E;3FBSRM>K\G)J[CXF&@&(@;2KQ1-!+22P;:/'ARW=*MY+78
MUC,L(-GH;UW'\[@HJOQ2!"&T7N%DYO3SSE I8Z>QI1&9E_MR,8?>1N)S <.N
M[J$&\PYKB;ODX9-97HK7S\FIY HP6:@-1!)B9.FO &?G5X!I659;;6ZBW/Y,
MQ])/&#;TQX4NQ:54ZIENAM&:"+/G,Z^'7AY\)"EVG@>CM.J7CBJKA]\KVNW:
M_B"\_ZPW:-AOOJ%]F9,;5:_"[-^T$'U4JH :ZLB3Y/3$C;-X>W)6M$@9H')K
M/<=[*%N$44/AA9[@?#=IOMODLNNG&$8E2%D5E):%H/>>P\YG'Z.N^CF++E7V
MME,OM:Q[,30XP8Q.E>LXI*>3R5[/&M%^WHN%"4([XEU]+_GE="DK[DL$CDS"
M2Z;(?-]N)Z5<=VS/&$4H1GU,U*U@/S6JT.4KP'M66L<>Q G'$2J/]78MEQX!
MAF@8;QNA1*(D[99$#[D1&XOW(&U$'<JX!#5@_J/%%=PJ#'8[F1N9E980F:+;
MTA2Q/I9#ZF =,,20GHD-"5G]SF;[ALD+KVEU!QT^:LNE538:&R1T)+(,YS$?
MIM8A!O6_.3BQJ!(P]$:.=?D\1.74YQL8_*&A4-TCJX!4(M\/OQ0K%:I"'49[
ML:2VLR)VK@"6]^0D3MEC3YG =,?7EI:)@8D6^3HNDX.:K#15K)L5D>2#?2LV
MBLN5P6QM(J+1XV+3X_8E>AN'Y/Z97Z<;>VLR&9 4W7:N-?Y%!9XY>$OZ\^B3
M+9^X/=##,AN-]L2(4._3G3GJ+7G*)2 .K.<]F')^D_K7 \_RU72G<(4LI*_>
M Z3$;=5($5!HGC&LJLK*\,[#D&R;??[[ZNOC*_GYA1(:-8J5Q2^XK3(]@]/L
M7^N0%5>N,,/,WKG[5*.4(!->:KS^B]_NE*0\?)WK4",L'MT#\$PL9._PI4,+
MJ%6'=8D;J.OVV[-^>G.^Z/]1/EOM,O6B= =BT8\X3N5YDE+S8^#]%8!),A7]
M[,V!\&FSM1&?E(=3Z/P/I?ANJ9\K0TZFRR3AO.]]L3I+-C2>=UE$]45_M>>:
MZ)I&KR^#0P452@X9F2@C*3HF;\OO)3E/X1?-60Q> 0*=1B]VFSS>70%<'3H]
MJ%N'3MGJ7,]'?3?DXKZ8>CHSSF9##T7GP']Z0Z%B\07%T</L;QTEOTKWEX74
M+G2&CK*JT G7/Q*B<Q9>HB*20,\[S#-?$7QTJ+EG__2PZ-KYY#4CJX1B*\VU
MWGEZ';%W8X1V*"*;9)RN +<**MUKWZD*UKJ7N("I)&T*T,\F7Z0JNCG8[S3W
M*T\#;H&33557P,'S#\L@2NV)#Q&;6W[5O5CN"EN:Y*-Y%ZY7@,\D@5> 1:,S
M@LE"-S#F^0 0?+ .Q'SD$E13Z=SFA#E%HTU1;';4B@[96^4LXMEU>Z>X.*'$
M)(S!)71]&!7EYNU=U4LJJU02']_(1'\]RGU7 _+(;TX8T=QIWQ\_JB^]?UP!
M,@8@,;9SP6LVW"<2S<% ,G,D)IO8/WTF;."MUQLF+<E#FEUEIY,F;G3RDL3[
M":$YT."*RJSD1#A1#TF-I#9SOG3^K)=+;>#HT:/2E,U/ CWU<3Z&HJ")#;JO
M?IC[6V?OX=3SCV#Q,^8SF\?V_& NK?!W$KW*4W 4>P@L; ]+'YW:QM_UU$A8
MQRS*G7O66SJS%4Q6++2'9[#E\26ZW3DW7\2ZX:[+&RF2@V(C'#=K53PW22O7
M$S65<L'(05P*3C'FU*XFJ\D)-CBL+XI$7GRCS2C5UB6 I\N[8O2+2?9[L1=J
M%5+-2^MA#6HK-B[[Q])$3?[8<;*D7OV>O'NY;(URM:I!U.*R0W[OQS(YE-Y'
M0;LOE-A1MB=#0A-PQUDXO2V%FJSB/_IOMY5?;,%'V[0;4NX8<VE6[E**,1)#
MA[PD<MS@?4KW-LY* D!)-'_<VHTVQ5FW!,79=<3/O"U%D8WV06*8<Q&ZM#'X
M63,1#]Z9G2UJBM-O^-"C_9RMLN=G6G,@NB&)K$GNT/OO'(9P0D>XF=EV!\>>
M*9L_4IAD@<5L.[16X? N=,&XZ#T+/6LN^JQ6$@0B1LJ,4]MRBJ8SKGN]?O^2
M#/OGQ!*5W&#]ZT9DD+K'=T"!]>><8YNR@-^:=N9- N)&K.@^^7DV'O?G,/;B
MWR4WFG;>3?[A1AZY23CDW2C<-T?=)!PR;Q3NOW([-TI-',W-B.F;BJ88$,DY
MC%4.O+)X!:C_7?@/>$[^"L#'?#GT#ZG( @.BOAQ3U_R]_8_"S$VZ(?-&XKXY
M\^]TPV^-^T;F84C=9O[SSO[:_"ZZ$;5_9Q_^G7Z#]_<TPP3F7Y3N-,+#?Z-?
MNAN%WD?R=(?M1NQ$8.J+^&][2LBZ-Z3AI=WG/!YXXR65D(F<C*S<@"]S2[BM
M/6ZU?XPRU_\H =3;B6W1B_^V;*/T>OAHQ((IZWSW8<RL@O2@REB*^%@E.,@F
MHW-9]+J7Q[1R;DPKTY/*3X5#YNTN5,H/*S'MW?-DX/-KP$^# @EYG96V980V
M0QUC*I*Z*QEL&+G)O*%J0!S!>LJ::-/:)JB%UV&X(S4H:;+"S;1U;VD/1W%I
MK8%<(*MP':>%_@"!$ J#(@NFO,!VA N&"<%_##'VLHU&($*]MLY.J"M<QLI_
M7+Q D@0U2"#W)>;$AWKK(Y;E_A!C>WDT-S59@G;%R!8+8/[DOH9EW8\6VB :
MFL,JR07H[UN_.BOU E_*,TG).78S.$)'*Q$RQCEZTU_GWX28SH5;8-/FQ];!
M^CZ]VX-2Y66$]@__IX4X_AS:&\?RUSC?IX2J47M1Q?Q9G[R6/[!'5\GU>]Z"
MDLM#)L.[OZ= M2ZK=/I]ISM?C5 GZ&]P8!O^/2?7H+',UQY%OHT1]3954/ J
M9_!DS":0X8-Y0BC58L/JV-34M2P"?-L$4&&8C]>>V(\00SDOLWB^<.]"7)F\
M4X-ZG%AG\(Y)1.H7?\@ Q2R"+"=Z69B)%)V]I*"2G+%%=4)%'_6UMKM'ZJEM
MZHMM2=;%!=)6W'SV4*%IWH57P5W#W%3/>[8DL ]+GV4$";=J*"#G"%NN *0-
MY)[.-FF*QCS9[4Z/BIYTR_CWB!:J7_"A)-SZ%";WA&B.\#L*65?(J_M:-S)K
M;C5FA/J,A$WS1 FADY$SOE1]=@56 O+$N8 9F>2,IV(,QP_+C9&J'6 R':F@
M$%CY[="NIZ$BMW/>@" =+H,"AC]D687C C=S=MU+VX&X4!_*82&H!#R4\%M@
M/QFS'8'+(G#P^_(8B&_S]J^=TJ+2)1,'!X%;[6 #TK/)4C5YB<;VZ4)=)F\D
M8NERZ-/\B?H$K[JW^LGEV\'7N([NNTZ&_K*4/%6[O>&:KZ-7K@#W?.BW3S!\
M81U-]/'@2J^BUTG<S*7/!%I+VML2M4/,A_=L)"T<[%QL%;'N8</NM.)A4TZI
M*0_ 3#3)7"45?1C=5EH]XOJ;B,<?Q@\ZI;+) <[-F/BEK.=#D/6&\ 9%IN85
MSY^)"E/\B/2YI/=X94QMC:%_/9OG3P$ K _B! ?-H3Y8#:A/5-H>!N79EPGW
M'P5AC1],EN-H9XRH?U/9J)55U$V12Z%#QRTK/][4V\VT,C9>_>7+CJMH+XH3
M.<>U]T&2L,C-K@UT?W0O'@A"?>OA.+TK;$-[N-8("BUQA9+E%\X>D'SRN0/W
M8CK+G\@, 8VMGOH8^%5$3&-,TM#9BU)VG88/QO@$>Y8M;580#]QO?79]VZ@7
M*K8@\MA3J*^7GY(3Q]*CX(,OUWYJB.%M%#"B0=6L"O/20[DNX(!.Q5&UW\&P
M0I;C1^<<\773-*/2LM\\%CYVV2"C8=89D7^#>_L-^J =B(Q'O]A^&9XQRZ"(
M#7ZZDN.K!N&AB*VHF5'6.0#BN-%K!K72105<J-Y]"]=BHXI\VNDTZW'O.B)I
M;VDFO: 6A,_3-U?7E,?M8Y<!/..D2$8;VT)+7.0K]!A4_23%EB%L^GU[9%!5
M=P?GJ$-[1 S881.M35)\(8QR^;J2?W0%(% EV9M+HK+/%O%>E-[B1N2E*^<Z
MU%D5,GD6HNTZQ;O;"ANIU6NJZ^$Y'#*<,UGXE&6JPW2C:*NE[2O 73=Q1A%U
M3?V N*E/-NTX/YT@ 12UR45"MSU3]%&F2_/IRWW?B.3E=##3]YZ\H#TV]_!/
M-;T.OJ."FJCM\-U>+*C^P3?S1P(O0=+']86I-]JO98F5"V]]5%\3)0E>(!KK
M>D:XS0F??%U%HWAGJ?L5/D,X4V"M<8:7<<RL57&^?C> WF=LK6095#.T:3@B
M*R0<]^GZM3!Q4Y5O'/:2LC/.LU;?HN:,&5-P=-^)_8$]7[61D5[_):Y2="@$
MPS NJ;&$.U;9(5<CD+F$L&S9'E!$CK5/8FB0[\1ML_*JN;EK[R "\5<2MS<*
MUES*:K5%G@0M#]W515=+?U.JEY#Q&NG!??E.G-10WWB))!1$'E*Y0_ZJJJ9L
MUJMQ\/&'$ZPZ;[%2VXP MDJ*M&^U;6CR=A#[J$5],XJMYB1V-MP[Z8F9S/8O
MGX]E/DQNA ;(]4B8E/:K4%98C>XSBL]/)%*9H[(].BF<&KW:HZU^&KL-*=7"
M&Q@+K*JLBQT<L!3:&6[YP(:\.) Y^4M\)'.Z6_ET2JS=?Z0#[;L )6>A8LE%
MH-<#_>[ <!_@=MU01[V4XR"'7B];<(7@!^"7@TXE%/726G4!.F6RHXDQGJ_J
M&?63'H2"N>0]5<JM0PT-#_PQE?4H:Y^[Z( 5*3I++YE\/7TNM@V;^]AD"N)V
MS#!K/3=NG:#%60R=VS)FQ'[JU8H=3PILLU)ML'TZ,Q2MOU0LW]9$9B.A\5S)
MWW'?F-Z^%9L!0SDC+)P\U24VP*,YP</:-+IK\R )\4/0'"?-K,1SO-K515U+
M2WX0 T3.105C!.:ZWP14UD/CD_=%6Z3 5*59+2TMFP9!?I)8%HMAGNF4[7,&
MLV7\+[>P6C;P#DJ:"ASK'R:Y:Z4;:J\L^ ^C T^/;,C,*L89=J/I/T4WNFU
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M#E/7.5C^%52.+YH:(IZ7AJXUY5T/MZ6_V&5_ )34)CYN[DLG\\(@![[T#N'
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ME@? _A,+A"2KIZZO(F4@75[@R5N4D3+22T48]8(H90K^&I6A*RV3.-A$^@%
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MG>^4Q]3]RMOTB]ET1#WP< IE3]+2RD!#/Q%9(HP=GS2K@;LC'<4Q%7=S630
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MTIZ?<3:^T.$;&EWH*B7-Y71E1G%0$'7X_O\^:X:J6C"XWQMM)V97#<XFS*.
MKY+4SX<3"9E= FXI%D/L74]9\GD9GH7;X/ <)^-/16YAZ@86%0PWVZG$+)=Y
MM1%.[/B^+6"H]OW)G!H3OKMI)D@P&6<X9Z<D%:[#S3GX[.IPGU9U0<BE]^>W
M2WA5L,GK_[V?2\HPM2U4YZ@'ZA3;K.)0$+[?%@"H4IRO54$*DP>E90Z0@Y+-
M$'ICQ>0-Q9:GKUTRX=XD:*;-MT!+/L+7/!TUIL1_L>'E3U,XJV=Q[526]ZY0
MM]L5-R_,IAS^=0^>$P(Z8P1OX<&ML-?<"T+!@WWTS^55[,%9K0Y=>/!ISP7&
MJX[0=<4+YA8MW/P6/0/?D!3E:+%%^0T.,_N&@) F)NHFF2UG5Z-F>$B>QLB,
M]%CB3D0$R)UR.KT5J%YQX)3[\.@1"];<Y/],BHX@O92=/D<"HV-HS;\O(^GK
M!1)G?EG2UM9'2^>F/2DN<[;/702ZCAV9W$^*QL]TDJ[6=H>'/WJK((OFL(R0
MW4VC<@AN];2>4?0>H,##=[R47=1**-N8J$YP ;D'R<8(4,JW5;J?3!D\"K*Z
M)>&L2KA06NBF_B*?R!PSP,:WS>@[A.8VU92;MWSEQPBLE_\\;3Z@5)_M>(@]
M_?XZ((GJXZ5\4?]]22("&71/EEMUG3>-#=Q&]MUF*5U3;1=WQXZ4.6Q>W0SF
M&:\56E":X>QBP/*>GA^R%S(S>00Z=- ZN5!JCL^5YX"/-\A_)KX^52W:P=2I
MJMZ/UNK+F9#K$MVO%GW[EEJYPK+TA&5DP91R+C2LK:*1S45.QD^+68QD:DEZ
MH97L2-\&$9]2X'I2GL7REAXWP=[8&\A4O4'=F:)?:6<3/@U_+JRYY-_%YW"M
MLY2!ZQBR9$W.2$,H1@7 =H^1\M PQZDZL+<6P'O=$T6D2L;_YJY%T%Y.MVUD
M=-0@B02KCS$XFB :!YW002DBSJO28=&$^3U_^*A@5?5@M4ON2F:7N-#WO%U=
M\A_C#LF-'_HJ.RV>Q'W2[[ _."^LK!V48L13@HFEYNZP ;'X!1LZX=\A:/0[
M +S3XGZ$D> $B1'D?EKHFA8>*V/B&+TTCAF(]:X ]UGHOHJ1A.$L7S@ B5V1
M***^=3AW6^P:/  D8''MCC><%?EW9_;* DJK\Y*?DI7D^QE64UC%2!Z=8QA;
M[)[REZ(Q)PL]/]7Q;?O)=MD4:D)'W' OYN7;"'^I)L+X9-09G32#DZ:@1NVB
M"[9VG"](3P."R><0\Q@ZW;$A$+PW]>5;$S7\F[_.'53\L[LKIA^B$8R,("D8
M8*SEDOZ^H5;+W5.W3^/["L5 3A(3'F=!T=K]R'+R$UN">N73%_Q-^I N6ZCJ
MXZN84=-87>\:O>00E>'-(I_/3S1R,W'VN+RJ539736 NC:WQ3G&S0<(KP4'R
MGCM/.[&5G?$PYK1Z;6TINK$-[>N)GY%6/:'^>\"H3)1"!DN:""&\Q?C3B/_(
MI*?8[.%^&G[/"PE*01Z.)V8.6056D\+;<35W9V;+1=[#C-8W.R//:G^?=XB#
MOT[NY<&8#R^+4#_ME&E6?@"DJ2Y?CF:@G*F@7N??GE0_ )K"B<[E?FY:/@ \
M"0$U?VRPJLIO+*R9^EY5$VDA,EE8_NU"@%Y6@?6_*JOZ37D;%_?B.GF8+]BR
M]?V3?C*I9*_"!X  J/DH^]$@+/J[#N[=]-.^^?MKCB?FOP,R,=C7R3I#?D0>
M>0NIW<0AZ?_U/LL_MO&XV)A=DQ/UVV2/(O_4;ARN.Z5[5RWOY5_;GO+?KOU;
M;9_._-[O516'"Y.[(WMK>M[:UZ[E_;T1UPR!?WU"^-\;K/6;1HZ13J;PKCS[
MQ/($@\N9V)'SORE;_HNEH"'DE7^QBA=CG<[J]'A?X>7?VN 5DOFWT<C^>XMQ
M_V+5E^0E*^%])8NQCOZR;=MM\=_[TO)W="EVW,+@A.>Q3^)H^2,8_NO(5?\.
M0*DJQ^P"G5]XR32ILPVM_XG[:GY;+JK*E19 ^Z?XEB<;/B*D/(-_9H+]9A0V
MEA'*BWF;1V0/"<8W_.^#M_#;ZNE+LY2A^H)O.;3=TD[XW_O$ZK>19*PM5]@U
M H<*6217\',IK/G;___,3OS7UDW4.3;$5_OQ2B4LJ!] >P<!FG\B9O5/Y9]X
M21N?25*S\<L_*VB>#.F:(G*<H]LMUK)X[>.NBKI]!#9(/WCV !!.!5B]KW\5
M+HB-[/GOHL^Z=$U:,@(T7J;"N5;3K];-<JPK?MR$.=US]H?;*5/W.:QB.<8-
M%&QR\RK:9*@ B]5UU+%XBJ8K2821TJ3"II3KHCQ\)D^U(R[%&P>BR>LJ*;0+
M=X!%WAA4U3!I\I]M 9]VWG;:8VKC6IFST"CF>@*E^Q9*!@N6O\^DJ4WV8I**
M6RP<-P[4O8OFE:^RL[.=(-SDL!9B;!RE]^+%+TUIZ,6W#$T[F]B4DI)W,H@U
M5!2H$!=Q7X.'LX103@:7?!50X8SMTY3C1)<')D(FJY=<[5E:U>"Y\&!^1@0D
MK:W%:8R8]/8UEYC$G/A=4Q H+G>Y!6[40MNL.%G466':AZ_2_,\4%J;1<WJN
M)09+!D;3"A;\)4N IY7&"7!7:F WZ3>1E?-+/*1/M2_D1 K3-6O"/!+M?R(_
M3@TD)@6>EQDJ@A/;.-O<=?NM-D>^!RJ4$[H'Y0WI71!2?DS:@<1Q8A*<;,$B
ME.!2 RP1BCK2E8FXK;J/ETE&?A^<9J<1,TNG9:?WCWX$=-@[BPEZQ>VLEA\7
M_33.B1 00W:XV]D-UZ3+JA\B_]<Y\#FZ&QDO;A+#T80'&[#+@,]R4.K+=8DI
M'=&D%=B]J?2/E*1]0#V,,U2L35":4VVM+B$/GM-R(52&Y@*N. M"0K0F'@1.
MS@5K+,VMUBK7ZM1'9@@REF;FU0#*N*Z&&<H"F>6;4+31$VYF<*"<J\TOS[T/
MK'$? *;TJ-;ZM923/;WW?BFX&38/@%FH)U9=="T)].("FF^<ZBMTUA^:'&Q@
M&0I^]FE!5UH8K:L&LW8N%G? M"I-G061?\TN_ZQ,Y4H'AKNM4\O'!:)-M,/^
M;BJ !U=^60;'&L%8?25G;FN_OH?PA:3\)>4W'N0GA7$EB../)K3^OQBFOT*Z
M%=[%WIE%FK2WO@?-B\(#D[/"D\TCD\PO[]]>+!^F;YG!!22WJQT4[=J)YVNC
M0!R%J^9U"!X =H5Q&WDV+HA@O0? %UWGB:DUK>?)?!,):(-^FE@-IA.F8&=E
M%7MV5X4MM332:2V19.E0V5!#YN[H595$) -EH[O12*EQ'11%4JK*2<(1SBHA
M;;L6O41B<E(O/F,W-4=1X@%>6>>/QT70.4@S'MW&X4_16J7A)@MF3.ML&&FE
MP/7GD58[E2PG<G^P;9C[M)PH8T0WX%JUN$"TD&P?2A[GB']TT!'&QC)^Z;)C
MF]0TQU%75=>470 =HTOCF4)1(,<R$?@V'R02T^F$K;2%IA0S?LMM^VD556PQ
M<6NB+-LYMB'YJUTM2OHG7PTU7;QF97IS4T)*J$T[11[ 7/5CRG6*<]F[K @3
MXH)55@\\AU<-)YLOM;H)[H?!T$W^;]HQRWF(&8-.Q_32+I.UK]X*QTE*R#ZA
M!=,<(JEWC I[%NU>/KJQ\6NO/=^2W;E--(4._TAC,G4P\HI+7OVF)9MD\-JX
M-JI9VUMJKO0CDVL!XWG]S3D?L%[5"6K=,G!\UN6)/!$3KS+3O4#L+35>(HR:
M3F]]P.;[;!P@&"F\KA6GKJ$;9CVW[/1E#:>H;WFR+82NU!_C'P;\:6GN X"\
MOOEZ[0%PC52&'TSU $#>I[!&Q8^EP)WT -_UH,>PDG'C'"2\OLN:4K>/9$,V
M':?$Z="\(M.,;(==N5ECY%_(1_8Z1LP@$;Z9=#8-V\:Q-2<8Y))D:41(7F/L
MG:.C"9S^@*=GH7RW[T-VY$9:U04C"Z[J)Q'6FACK/9OOI= @#\8X9OKRC/>>
M)9OSQQ)ZI>5[5XVOX 190EM_$@SGX;$"\95%,:/R'Q-@7_N<68EH<4 0L+?R
M$-%JQ?:G@DM CN$LT,Y,>LT5M*IA5<I9;FT59H-244!P00+4N_'6'N4LX%@T
M9BZ]G[5FJA[3+%1J8JO-1)QPX.18>AZR-JX:<$1BU-B$-])7/(#UPI"T45@S
MT!IUM\N<,_4]S)'Y_=B4>DEF@$"N8CO\ Z#!3:GNDSDEJS3,"^+NF9WCK*DS
M,I'R,WZ4?MDL \O9<!Q_FW@BWHNFMFITD8G)$NOZ5".^[YG*3.+A040^8$HM
M2"SWDU"Z939X;\%:I2%D3U9]\N55C618BM->TFYZ"_0N]N)X6<!9LH KT]JV
MYD[YRUFW[5QR!=:6<3MM<(E#:$U3_=A OS].^].H@D-U=Z=2*6_L!8LD\:]G
M[LG%TNN6^K32Q2H,)43DA8BUW7LZN)FKGGKJ8[K+BE,4\;8<]J+5"\\3/@TA
M/P P!$_E(^$69+@*[9T+LH<+U$')SU>?1_E($HFO*X(F+*4S1W>$3UC-F\\/
MR.[]&-\7SVC>A<I5@Q?K>[\:+N[YADV&!&K.,#2>GY<F&S-O;D"?-4A#-NQ]
MGJD7N44D&!>)$^II4;=]6%-6VT @0>._YT"-,G-;3 AVJ#UG%DP$Y5#1&\_)
MHO&IAML)HP8*D#<8WK&L/P#$.!TGYBJQ=<8^*7.&F_2_'U^ZOM=CP7DEAJ#Q
M/>5Q=TF7:E8&L^7GELV=OWH>./&S3=)-3!SF:4YN3$+4B:O9N5$MC3H(VC"C
M KH7A/"*C 85@.HV')ZS<#9C2JY]775WMZ;<OU#@::\PI9YQ&OX$U7'DKA5=
M?*;:W%P]MD_3V!!G4!/@S%_S2=4BOFC.IF*^Z+MH)5\I3==8QVUVNIO$Y_ZQ
M!L/\W:1H=5=NIP3V+F-?JTRVGSU\<>>E@;6";Q?G/:1&]=1.<L )0Z$R&#:&
MGA#J;N^$2*DCAIROH=8V62%B\GW*9Y0(.=F$\YU\HMO!N2,'I1]J?G09?2/O
M*T5[+5<&ME1#LLS3@ ICEU@R,4<_QY.(JLXX-.ZENA36/(16U;W$75H5Q?Z"
M (_YS84CA-<$=A]60_U^D3,CN8>['^DUTILPJVM8TJXOO)%#*9%F!(G1 Z"-
M).MMU%S7KO56N+?STVVGUOO9LP.=.O((3M&;(@".#(7!S"Y=5D[V]V;85$S^
MXL*'T<5!G&++.D@@%NRM)T%0OK<4E"*>=U72P 96%ZB*Z(<NHFT:8AAOC62!
MN@IA4AW\ O*L*8[\:?9DAXB >%ITM1=D)<"9)VT43E(\+V8@OHMGUL(IPZ@=
MN[AOH2 *;Z0_$6LHNA9.L]X!RGAG1]TL$59:P([]% 'I?,-6B[,M+]$T]U9Y
M7+^\6H+2DF5UAGRW2[27%E*ZFRR=R69YB*T@KB"1G9#<G?2!6Y&F/Q\<(D>C
M-?'E.^9I&.[UM&P)B0C],XD>RD9;/EBHTJD 4:965O&I-P,+9?5[NW?"R]9R
M7?4\K[3<73(^'H0_?7'])"0OBLUJ(U9!5%*<L^!J76K\J)2YH;[8U^QM7=(2
M%A2Q$G.L#I\V9&OI=Y!U=#H;KH>SUR6$GN:X*\^#C=HONZKK*J+$]J8U:A2V
MIZ6+&S]EC6RNJ"$V.I>L?IMC'UU<I4^8%U<J977!N9,5$AWF*=YQ+9M0/&ON
MC$=Y,!V!1?>X^<EE@$+6!-1R9S7WW*CW<7MJN#5+Q,S?]@MA^P[G@YW.YE2I
MN9T?IP\]MOU<?IC#'?N]--NSQ861 M?.$AHY:CFG,U HRHVE;!O1/.^'ZE,Z
M!]L%5=S&@L[<AG@^T209T*[&/"%:BN' MPL%35V2T2[_C#GS+#FV3+E46/B
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M<%JK%B0IQ_S%,YE8A=,3<'AN'>JV4;W%B,K"Z"K1_5W+E>R=[B>JA)-%2:J
M.5?URO)=R5W@1SUZ@YYVG 3'DAZ">/(G@CL1R>1,VJ$;%?UU./<']KZA]4;Z
M(:F'N38B$MV<0LG&++FNJ#E(=>8I%+X+,2&6LT\J5X7A=I<8:SMS^/65@E*O
M1&_=DZ[16],0?QQ[)C/1#M;'>EW8\=V@O]-L(AG5/[[P-\]K07CUEB0(QFW_
M<RK7'L+UZ'DRO/W]33F9Y@% ?]M@/>>TG><N#U=0)I#81"?>.)"$U86T6?%:
M<-<3Z[(;"XC;6ZAK)F>B=5EL]=-.L CBT;-]PM_W:+?\^#-.Z].[?_<A2,3I
M7B=E>"?,6RJI *CHJLF\?OW!@D$Z'O5"=%PMZ8,0D6+=LT+*9].VMS(6DX+T
M HTTDYX4>IMJ#&;B\;%JT22F;M%>G]M_()!A[]IN;\911HFO#EJI4K6(KMTX
M#U_OF7QT^V:OY9A&)$IW$7/K>"==5AQ6GWME?OVH7(?F'^-&B&^*KK).QCLH
MQ<;/@IIJ,5SW/_3YL-@NE;EX=V "1[0-EK2 R1H?N7%/[G:62P6O2J6U_-72
MU[3711M"Y@X<2B*Y!%?OK1!K!/=(@;/,]\3+VG/#3)HEE[#N$LE7[1V=?DVV
MH[8^Z)D@7B4QC\$W4Y.3O@PMOA/^TK56\U%IM8.N#7S,77$7>Z'FGRTMM61B
M)2TM[4X(T(0T$.3@W2(U![FJW;R#!)B+S2_MFL"<G0V?FD9T\E';&5^LA)E"
M0[2S'X="O4')UMFXL-\TM[%C2JW9Z.2+#QX!P>?T,J@.S3&.]"?)?3EOJ1.9
M=WTNTIW&VH6$)W;YB'=&CA!KX_R]>Y;I<=VXQ)(P<TNX 4/U;,;4E:=\:6<\
MF?1O1@@F;2$^O2V]>\JE8"UW&:F^MO=+CJNV^'"1L49;M>A8#P 3"SS"6"XG
M&5>69+.BRS?+^.M!#%*QVUN?[9,RJG'=IK)7M$#R#=':LY+;$B;&B^ G).AZ
MV^^#>2\$+5/5B+Z_2'F15O6FZ G$;V/%:*VAR)T>/(SGXK>TH=E_(<S"KWYH
MI2M,0Y&(YD-JYQTZES?I )RH_M$T8<7,6;"_SS4,O*@D$TGG?"Z0\L+H6J%_
M2\B;<H*NB(]Y "^).GRPHJZ5ZOEH21 3 L^@;@$30UYN?EZ^R=28C !#!\FQ
M9'DS7XTHX-.5=ULU*1%:]4N=[\NT_4D&NTB\5.B*0+OR6\DU?FM4\ZQ=EXTD
M#6+19PTBK!Q!62'=0=JP$,D7-6EXH?MCKU_\T$&(?^T>-;+>J)(\D9R;.:,J
M'NS!^VG-4_"SXTLV'Q[/<@DE*H=AD'FOP.N*DHJN@%KY 02ON,B"O6'#-1"E
M. 8C]77?X"N!O-8DJ3N$@PFKJ%5I0<+3 WF=7:SJL7I3B*FV)ZJU*FW@^?2T
M8;-I@,$-\_Q\&/$ARE+FI( ":6I)*$8Y7VY*C1+OMZ?);BR"DGGCGR5S(@*+
M+#0M\\KR!PT]D0>MZ=KI[PU'IB1@EKG-7T".\[!-I%&I=K*A@8-+!=N)).\O
M'J*T7ZN"&N-[2Q9I7<)8[/JK+B]S3< H^1F+C*W7)G$%U->-DY,39H8ATH5A
M@=2"[[=S'; 51)P))3__RK^4TGK,DN08,"FSE&,U32X\%XDLZ_0 J$^;'!^G
MB>=YY9JK'Y45;R((()&Q=5IBAJ'5$RVY>+?#^O/\/B@M#F\FM@@JN[DG@33X
M/AQ 2^O7C:C"6\+\_1CB$[P%E^)(%N^2S4^^>?08ZSMA'HWC:'6XK8PVL'J7
MS!=I>R914A18$<&P0: @3Q9#K5O.44NX4"!(%>/0Z!/).NJ 6\PNL$ST>8A/
M-+8AU:DZRAHO40>?;N*%X[R[B97T=APEL4H9%O!KAMG)DJ4D]3-5GL2+(Q/]
M#*^JQ:4U[6)#W5_<*1\5=8",%*Q1>125 I8-$'J(#]QXKL&C;V==,C<_:U$7
M_Z5Z3G"AD+ F.3$+S:9D[Z>14W9<$#LGJ\"SK"7M!8EEBPBBA&5;2^Q-BKCZ
M>(6]Y:DZB:R(YXIT48H<\D5%KP$DSX1!V,F?S:E__&+&L7]Y1223KGX_Z=XH
MH1,6X%A':1$3G3U/F>NPHO_D'?E3R1:<SK)0<*K%[HJ+J5C$;M_B@*6S/7=\
M-,\NAC/IV;D1]&55SB>(1"\!_EJE@];-WJ) ?R%T,'^!$L=EMIV^&_:47WDZ
MZ8N-N1KW#_:/K\)3+#_[O1UBI_MQ:!]URSV:X9J$ E(DXQ-A2M-99]D2E"S]
M7\2]95A<X=8E6 0+! D$]P0"!'<"P=TM:&'!*0IW=PD$U^#N%!8*AP1WAP(*
M=W<-VLGM[IF^,W=ZOOMUSS,_]K]S?ISG>=^]]SI[K;7KB;K9"N2T@U5R:@8^
M7G$/B:[_-C-\E6 5=&_)\PQ(?S0@%/"$'4/+>O)V;[3.D[IQ?H0P1W5C)2[=
MA3M"OEUJ\17>YEB1#&D3K:OB1[IQ-/=CS3KZ*KBMFM=LG8U6U',<.-QZ_*S.
M<\088YE/1>BPSTITK-Z6@ISX7X(7AE+'X+FZ14M.2&\2HTWV!P6][F8ED7!T
M=?N0<"H<I')Q\+[0DP'H TT; _GR^63Q.+*-.=74;*)HZO]N81KUTCEUS:Y<
M>;^T-'+7:LH%QN_0D"+_=0BVA2W9,!LW:,7!N-%)I!;[]KVF9X:MEGEKIZZD
M)X^83EP4Q=A(M)GREDU0[_MRA*:O/-_D3>_M5O@@=FO>/7PF@E1"B@+J%9&'
M)8FQSX5#P#^0I$S&,2:MNI1V6+U6R6GOM9IF*#94(_8W7DB%[B50.9.Y7D..
M>)5CY&NB)S^8Q[W)5WSK*JP&QA(FW3O7 6F)$5];:?TT_OK%S)#&]-Y!GZF6
M254@IC,O65A4_>0';OVN"WY8L7O1T.>FFD"D=)>CEL5>N5,<)0X?#F6\$USW
M?,53:*0;?W"DP#R2@U00TZ$/:L-GN=%K\IE*Z7)W><49*(+OF!/8[<>0!\2<
M_4=QO@D$!/+4R(HJ[C,Q(4QY88'(1Y-5D+4Y4[(HBRO#SX;DR[7/<OV*N3."
MOH S"]9*7GPP^\W)P\F7&+V61@L97]N9RA.V!&F& WMLJZ@KP'5<44TQTS>E
MY8DSWOJ.W -<BH@*_%FYZ*&-M*)D*HCCG)[9<IYM:*[ 3'W\L%RKYI[#J04P
M":.V_&N,][(2<3+87WS 9N^CQ3IH-!D[ #MXW$;%3FGMIP0)?A6+5E4.)=)N
M']%/,*?H$'.(=@7+G>2G\B8K<">)+9+>? 1MLJR$<P\VQ-#H8YVHWJ-O8WX^
M).6](@T\?@1#S36(C0'D T4GTZI;N\SX Z!E'D6I#:5PF\#'YG7W*0XL7.JH
M9T XGI40+>SG&E7SY*4B >-)[3NN25G'=X &*HQHT-^C& U94Q36;-?=]DK7
MK<[228-])N6_(W,IARO%F>6!]LR,"%/0XSWXF)35E!VMP,0LA36A\G,$KY+U
M!G#;5XO'*:Z,O[6%QO^GN)C_X^YRM5\<0Y<%\9FVG^Y5$+SOF8KLKC$M++^E
M)+4!\)TT;>HQA%M%2IPU>EJC]J<1BO]Y.A:\^F9/A*R^H8)!G\LGP9\QK14F
M&EERHL%]4.0CY8H:V-M4GEZ\Z63(K#I8*,US(Q288:*$1B/KXHQ4,5^6;</!
M@_S9<;*=X:@PJ&DP<KTN\G5&.E[[62 4*?EH7M$9[IL17SF9GMYFR9--TD[R
M-@8H6* 9=&VS;^]0$$[+YJ!/D<!149;Z.PK8]J-A="[_=YAGH87I0(G$R7E>
M1K9GZH"VPS>%@ZVO8^!J1Q^KPK:*V':G$05XG4,D0R1ZWMTO4/MNCZ/7\#RH
MJ00P-IQ:8+<H,9Q_RJWH@F>.A*%Q(6";^W544DW-J]J<I. B7LISRGSJ&-T"
MQ =!],*OL0<,<-.0M"+AO$5\$8S15TT8[G#M;L+:<H+E[P6+;/:YQ/G!]-4)
MGL%M.9&:!WBSG.\C):M%O#J]?!>2[?,'RI9BC%BX$^,J)_YID7'TBN<LIKB%
ME.38S(P6/6<+"$6R6S4<=KNXQ9X!A[QHV1_$ R(C]G*_;KK6) $%X(M7F3P.
M3D7 82*>V\1C\MM26Q9C:,QP:F?5117?A("D6Q%H (Q>+M4$)[+ &Y'7:$N*
M&AG:N2_A1[\J3)5.601F6=OC;M]DA8%YPZWSI(S)_#DSC!M;QO!)4X%BV#2K
MGN@;W#%O%O5D8)KG[SAB,A=J+BM!=E $QW'HM;13+[+R3(UV"1U//"O<Z/3<
MZD.])\EMN_RGRRQ>.%Y4U[2G5L;M-Z6(&[V?C;6Q1*9-K@I9W5.R#9GI(VV.
MRSFKZFHZG6]M4L(0Z\'C'6L4Y%Q;30/AW0PC7)'74S<C6]2HVJ':T:EEF#94
MQJYDKNL--G;,5%!38]X86"E/"<:\*:G39(N24?(=^&7K[X4AT7&*HOQZ*BL4
M,?N@-DMRL5=-(@LMEIT0E;900[;V10P5_]DG6(1\)&+ @5+:>:\F(_O*GE[[
M>G%$/-O(&+"@JD8U*+EWV)5M=%O>33QFS6KV]!JZCHTELZ/0:/G.%>.L@5YY
M?):=M)6I]D,'/E=SU'")ED?/YR"N9 H'+<M)6'%;UIVBW/&JH@"D+9T[QL7M
M_6#42,)<1"BHP*6+CQN/">>\BW%/?KJG*&I!^/5^_1%>[#ZOJB(%P(C1CV'F
MY^PQM)B0/_.L*5/J-=^:=/6>WCF3%@8!=4V,"5 59/N=J>490)(<BX9+.@_7
M_&J#6/V+^[LUK8=^*H\_V';[MTVG1+[1)7Z*AQ./HU.0#(JN%:,U,>EVGV1!
MME::NQP9@G9"X \S90/0'LOQIZDYM.[*XE N"_L="#^>E@N&/8-N8SR;0"VF
MX*\*]NG+RO)?A-4Z[BLR\5_*7V>\T*T10+R;I5_\2!'$=>MHID?AI-,F<O,3
MW_MS\HI*VI#DN80]NRQ+P>\ HVGZRS)?DMLV3C .Z&XB5,;\2]XV]T)=5BI%
MTN:/O0N][*5JF3"%+*B!EU1M&NT%_IAAXF517@7JG(]EQ1BV85?IK6?G,1IB
M02PK]30&SF]8YO\QQ$0,OOU6.%:^Y.X[J=Z<()-\8;:O&X^&[*LV]T0VB[:V
M1"H__N!5I*T+<A/7JO^99+Y<87+/AVKM?[D1<:E,804<J4L3RLQ?DC:&APQ$
MR \0VG][%2M4E#/1*KR>KF^^O'W?<[8L4GP3^Q6/&+7($U8*I^70BEN<D,2/
M^]LR ?XOB-/J,'M_9=<J.?P90.5E=Z-\\?^@X6G\27+P YA].*<.V,6(E-:[
MQH=K\:X?\<"/1S\4**^@$7 ;[2K+K0WGJVF#O'@M[LC="9$-!/8WG_!F5C0G
M+]XAN\M$QHU'.NA"E16G('4MD@WUBJ73"=/9G[48O;FLQ!)-5)=EK4P,5)*D
M5BLB%4VL@:-Q? ?;7!YW,4]0&QAK.%LR+"'[MYECV,5'2&Y_:6$A\-O$$\$C
M>BGDH[#&[3.@XT\):%;XIYWA0CW6K%$GL=E6'[9^-_ZNO^JUHB[8V]8MQ<QX
M7SEKT\'X5.<'/="BSV'Z$O-RCR!9*PY4SP8<<4(4WRZA\9=6\O)2]T0-<H["
M(I7%'5Q<$7T=N<APD>$H<I2V6U+LRJ*NRL^3-CZ&5AO<(]#N7*85YHNU<?*K
MA)L5<Q?>TZE< CH=8V 9/^3KR^U3/01K1K!T]O<WGM:'N#@W<()<3QAR1%Q7
M\<D1R+$$]VX,R"9.*HZ.6)QO30/GMO&H7P@7,:K]?6-@6H S;[^*= 4TKG!6
MV6/,)G9GZD(QO? 3?9>W]XU3X8)P;.#')STC:<F-!JCU7]$#IH3VAKHD>@1;
M&0H ;Y^^X.^Q0PPYN_Q6#/8E@K'4<MW+=])YFTHW&FG?(RXW[T%]^)>1LG0/
M3,/[T;=%0^F*!*V\TK59;0KJFT)H0T6A&PZQ78N:R"G^K9Q&KBEL( <T:KY(
M=J82GX"/^%J*5HIIGF360(V^< '9]<]>R"'#]3=""F /ZM! P58\Q.)*JTV"
M%!XAAE-!R-*Z@2(>H9R%5+]#0[3768\K27'PI;[YH;[!?&@VJ<+7GE?8XD']
MY6@Y>W%ZVB/D>=1SY>_KEY&,F@.4OV>)9]]Z/>7K/0.J"U8F6Q=Z--44RVZC
MMUKY+(GJ-.7IX+6:LJ2AB$W"A5XAH:F@(J;.21RBM,],WX_[2DM,Q^L&Y%.9
M-FQN7CG.DYL:1%WA?9A?)&.IT#P]3J'(S $NR!>+FD]\^:YQ4U9]C TQ]>;_
MXIPI8?KFL5#8[[J\:-KY0%]SX(B5FO75:A*&5G%CQ2-=)Y ES-G6^4"85NTE
MS:?73K.!#G)W'!7'%39__=;^_K0A6F:JR_H#?( 02*7W;YM,%:P=?/%?=Z.9
M7JM''SL$9#=%:N1QOA31J082N6YJJ>H=W01X\Y8LMRWUIE)FOAV.#"YZ!MSX
M"\S00LSEE6ZD>3<8.R '!N0_H%FP#?DF#S<TFG?$!:J=\6V^2=F5EKS\K,$"
M0(5Z5:"\>:&UC7Y$]^KYG""G08C3VLB[$SE%#MV7OGT4 HU)KL'4C7WB&JNG
MH6%V14O:TL;MDO"C;"<"$&HNS79:O$0CSZBO\&]* >YGP)?0)[$R;[G:%-49
M9WFN"9N3UOD.;)I[M(5X+?(P)7 3B>37]H;6U]AUNI*;W;_O2_?4QHKABTM=
M+EP,%V)$4CMEH:OKT3:V0OHD C=K+I%@E/R*]A@;,\SA\SJGBH7J@)H&\D03
MB*'7]P>/LJY:=66LN454+&U$#P8*]J=?@O>SNH]1Q5%D>^_F-;MSQ=%/>;+R
M:DQN7=8LZW][&I<8-B-% AXMMQ47]2 TT441D@CJ]+LHR,RB.7\I[<B'RMPA
MW:H9G[H'BQ<C-IZ(K0C :R^YMN,_5C'IK#6%?$?1PG"4N;FJ7*YV449Q]]-N
MY75+<[:Q=P>]3C2_BX.5<H,Y@&[-?"N4^X9V]9/,UBRK7HQ1$KI+/]/$3%^(
M<;***(H3AMG6>;CH;/@(38XJ\DC&=T[,A?I.?KG<>-?R=FV$W-FIH#(;4"UH
M]*K7Q[?]"B5[C9E00;8'\AW%?=CQ$Y\YO5\8S67Q,,183]?M8[KPE1^F;[S?
M;@W0$)\J[42V%AHC'W@QUJB=5)!N)$5CC^KM[YL$*PHHDN):K1]$R<RNO7BJ
MHD:E# $V5T/;W"FV\6,7^M]_<SNM)AH[D.9IH*2-HC [?08H:'./@+52NJYA
ML9*<$O$]0A>$R;DZZFY(.VE39TD]]2VKSX"C-F$=U>+N+!-@!E)CQWW,(L5<
MY?YH[X*R?Q<8O8?8U;%\Z?MF]FB-<D KCPNBIW-CZ^23D5YF2)OK#O$#_;96
M8Q-Y1504AU_=GFO";P/E5'3>E,?A@!Y@#@8&5J(ZR=_+\-(I*!K:Y<UV/II2
MSO7]:9P_XQD 'EM>:HF\-RETTQC:]WWYHVV&9OKPQ(YK:$#DC2R(=H+UOBM7
MZ$JV7#LY\_CK@U^%(0C(7>=IN]74WAHQSF_BB"(0E\6YES8Z?G2U(&BC+EH:
MQ2)#0XBJDFG*L&HFMS&;"_GZ@%WD9Z*W-ZNFK_]8&#0@<)Z<X+[[ZYH:7CSY
MP'7G,Y#E8ZC2]HZ3I.+<3)W2:/I^JAD:8KXTQ@=]!L1Y=5!>L_UI5,?TL[M;
M)LS62$-'<RI_!8/9'[1_87E]& '&=)!XNP(52])\TFQ.%HSYMK)I5N^=@'>C
M<7:5H&> <3/+6PZ:R-<;KC ,A.O^W &#=557R_,89/$7[BU4[L&O2#^NJ[Y[
MG1/0E-1&2/7%K>QNY>NABR"O]@RW3-5GU3B!;Q\I1JX7)!O=>GEYG6ZUJN=
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MJ&B[@RTVVVK@8['#FDBWD^+&ZX!Q/4:OY&CH:"XBH/;4,5;^@#+8[MF@>D:
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M<O&<N&@Y7V^L-AG%9%F!G^ADL[GNI/8F(L8!EXALP+*6\6F5-"W9==\2]^]
M;0.VXY\:P:6?#/DF!6ZXTCS3]SX'T8:M#_Q631\.VKO=Q@X_T:N*8:"EOEW;
MJ),=N-X4.*[#'9YMQF+NY!GGU#@:X&[9?WBG\YAH.*Y22YWJ-$I2J$BD%PE2
ML\>->^?G-M*X?/I561:K=L]D?>31YP$+Z N&]^9$L4T+LLB^0#XEQM<'5%)K
MR\"Z-JARU>%JNO+M55$8:$_=$:2E5OMV>FK/)7@C*='I%WSP: U5)<WTUO+S
M+2C7H43DQ61=B5=.2>VRS$2=XZOC;[\XNMH[?+I6&9>?VM)V3=R_;L;L*J$)
M/: \S+-KN@;-MF__NFEK[^CQDG)5OQVOF^6ZJ::M%1XD/'DG_7YL.F7[LL[P
ME_JX4\-@1'O=-A[EIH2\3)!6$!>V[5K+L5+"9J3VB71%B:G6?2LW]O5';_TK
MQ=/B>H?!/;[W4]B6XIBQWJ\:W3Z=KCJ+XSV?V%TPZ\54H>$7'62P<IUJ?@A2
M1IT](_E!%LB_R%/2[)8B[F)%C?&SPQY34X/X>\\M?]O)@XB&<7?^!(3(T6.,
MTPBZS%%5$K*5S0OQMCO D[U3'ZT>,\:P6W;I66Z^A7EN /S(@?C!NJL95!R4
MH'4'8 [^? <X/[>_ Q1,E\_N407>'$SF5*'=%HR?&WW3':*75U5V"1P1ZF14
ML3]1-<<WDR,V2H0__#1RQ)?Z^,'.*".B\ZG/F(^ '/GSOA1S]?E7T=_#%U+B
M7;!<Y]Z_?Q_=[OU-C<0Q0PVKO;&.$$^U B][$B?<\(3M_?DHT0_(9-7Z1Y39
MQ!(YQ<WF\I)*@KO^$((-:O#VO.;AKMN>-!6J@6.<& SW3)L4OZ=DAZ[V_F1^
MRK!M?KY!?UH-J?>']O]QL)K@?]M?Z)\!3HZJPN9^:&CM1$EA"%54;6%A+&<L
MAN8_^"I624J<!TFDT^.1BL+48/]7"H^5*&06M#F-_T>[/9A8OTA7WUO;C%7B
M\S&GX*Y#FX)7%ZEU#=.OU1N:B0"U/Y/"$83=B&V8%Q=3XHG-.[;)JK/E_>@J
MQRRMQ'8O5&_KDB9?)-!P*IC0^9 9?>0)KI+&'QYF12B?_<#KI9#Y(K<1YZ=(
M@H8:/ ESVJ2/1("13#TGML9IZR)K+$1%W!+8GYYC4(J5\[1SY!N9WE3,*]5#
M M:5:P%R51 .T_@!)#I JFCWM+@U,LO1G3%P*OUWTFH]?K875;4&'<*)GPWO
M+L%F8BJ@2_/ZP]^^0G#^:=#EVM13;T9?9^'ES(RQ/-4M2=V5F$!GV?>JJ-Z.
M6%N_#,W[O@:?F6,)MX2FQE\X8JILV]BV$J852PR^ALV#51A^+K%WIY>M'X^\
MYRVX^"D(?]DV$H!ZO)AG/%D8\[&.W4Z<-0/^,WB.C.Q2&CCD6T;M/)%Y!\"]
M3;BPCWE=.H_+2R$Y'M4WS53 B"@KW.>&U-LV@HC!*D*5FA>PYP*\ZC8PNC2#
M8,*W32)(?^D,6Q94K&#58VXE37L=" B?*>F$/OQ0R /%O?_LU4<4]V:\KD/C
M=1.)0PCA2RP'6RA69Q;<SB\Y<9K\%-N-A%T?$^!_XS_50')X0:COGU;X$1%Y
M83]P4*26&4*L2K[I(FZ%SB ;6YP?='8E'B: Z(]'RC^2UQE7MC*X.)X#_U[N
MJ7H)[$B)7MX+G=%# &7I[V;_!5!+ P04    "  (.E=6J/TOSDXF  #J+0
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MK'A(21/;3($WX7DEMC[P[/QTF0#GU9N*)?N<BT>PGPON7CB@EYVF!4_SP.Q
M'CCL:)^ X/$!MVD?#!93F'2H-JZ9X"0B3CR&)D!ATG8[HSVZ=["[>FQ?P43V
MXDIY7XN/F!CWVK83(->4^X_!^Z#+./LPI'M][^AV 7MOCC<QXTK7--H,Z>RZ
MY+MCS[T@6SNV'EV8X:/MW+@G=+A'ZC?GO+=CD/W((Z"-!)0.Z[ORHX:Y=:FY
M[NF(*[ZGX F'1$A2$S,Z/IGTEO2X]FL0;TD7Z89!*,H\Y/GFXI%9U%>.A-=2
M(2_-)X:WX9PB;&Q>."(2@TWND@R($!N#,E'!E$+UTIUG+]X^J%2L_*J0X>#I
M0&X%7N:)+9K'07JXASQN%NW_XBJTP,0%\_ >F'7?@-=8MD /NSOW9 ]>I7+9
M"QA2AI;/KCZQ[6E7J#V4\);,&M/WO"%J(4'VVJN\2GP!=[,YL3<V/T[ 8WFE
MI7\<K"6WN%*+ C# *2:B8PY0SCYU J2YO_V3@J>SL_Y?N%9>X>AH3<TJ^.F^
MZ2JT6LZ.$B78],3SQ$YT%$])T=VE$CA^:%NTU"JRBW>PZ0QJW_-4/NS*+-FD
MVKNIR2R96OAM\*Q.ET="?\U2RXF::71T2[G/%^?9](9.'G)4;;R:<T[-,OG'
MUAK\<G[5;&]*7E$RGY8D $+Q<SM+!"[0@F,+TT0*7DJ0+?>^B47.,OB1TXN$
M']AOB& B!@5B!*#=D=7J$9<#B31%W1I'R4-?5_;H%"^FY/E<H]TVBDTRB29B
MK@7\#YNM[04HB3JF#5MI$P2WQJ_S!#]W&<8966"(=$IJUQ.D-DV-(@ENE6Z#
M4( ):< F8SW'AA\6"F!& =(H (+;<D)J3&'%U6]1=7<:/K:!V7/0_P/ GYAV
MC_UB?V8O.S"_C_[<6X_T253\T&(P1PPLU$_LC1/L03UV"F9/;P]%AFW[IG2_
M'9PGHE&OP,L$-UNKEO%5["37LM;1KWEP?N*8K\OCTMT/>PW\^V7V/'[9T.E6
MJ43Z9![!IS,T;F\&927D6/9"L_(=[ _*Z>L#C\RSGFX'8'2Z:/BIC31/$%)E
M)558]XE] /NK=7125VYBH <8[%G;Y*A*@&M$[6-3',_\)7NG1V@V^F"1%D:7
MBP 'U_/G(^YOY<>J&SA',A[7P90$;X0PP/5[58)^5M9L%!V@B%KD&Q2 EW*F
MA["_8IN6VH*DG)_=2K K-7V8-LRLUE3 5"'7+'/.:<LCQ*(+U&%WHZ6;7_:-
MX$^G+,Z@2'L!D[-!VZ8,2B!I,GU9]]PG>F2$/79^GEK%:V\O-Y;20N,+C2V%
M-G$@V@\*%G(--+G_($R<E]A'7R$+E^<,$"\2MPYHDW*<$_'-8!0G Z)7V08G
M/L?]ADH3XEPKAMGDUH)L+[^-:>II?5,@8']#HYBZ[3PS>[FJ[9/',IP5_+/B
MZ3:E)0UIE@)CXT&G"6^#XT.IL.H]W]^&R.:QTG8TFR?[Z^JT8VA"V2C9).+>
MN?J+.Y9M5R1?\H0(?-YXTK VGOO@6]Y&8D;"K >&0,JR/V#3+)C2D4+W4/W>
M%JRFCZ*#=(;YN)7#B9:T^9 )6+GF6RX[)<^$A[80>'U=]G<X;H=-[V=#GE8+
MZ5[&?)2IM;)C!G_X^NTG$VUIC..%H"8*,":Y3:(Z$.<ZHVY(+\V4^F$E\T%:
MQ\&!BQ&6)L_V:3+?0VQ#6*"']J$."@CSIK(Z>W-P%OY9?<HO[#A@914VV^7C
M.EJH!;VU3O'U2QWU:C<9ST%@Q^787)971-*NDG!NZ_$^2>4,9)*>-)X]/P7%
MJ2Y=&;L,C"BZ]RLO:,:;GNOQRJQ^+Y**D?DA,J@VGK1<_G)7"0MZ_L%1H)];
MO]75'MTHZ2,=6F2#1>:XRE)SMK_-@W)7EM"NE$)CH_#1DYE@SQ^!9I$OSX7H
M/,Z^7+'P1.Q;YX%#I/^25/X#R&FZ,IWDEFQ=O?G>Z\@T.)BR_GIO+M9CXU&W
M<(70+3?D1JGE0D"5,[*!MI^B/:!S' 5\$4(!K"4H(*H4!6@YWJJ^7#M^*!0_
M.VPD=&UL>ID8<&0;AZQO.65% :OC-,UF_:N>_'I$*."AWFW!PG5:_M]T*O!\
M=O7^ITHU^]9IYA5<Y9P6$.X!VZHHH.?KU.'Y-2N=W\)A @HPNQ!32+I)WW"8
MR_)T7*$\*1AZ[$V+1:ZIF/.?6IC\0N_84KOE6C^O=ZP(R7R[(MLGANII\W 1
M,J'5SZ9,]('"$C\N5UXCQ3HFI1"FME)(O(=('9>*55?);IU"VQK1^4S:VTSA
M++AL*S.^O).B^#T2#=LUYP6")_OO)&FW:B8^JF)NCCK$6K*W\]4]PLG*F+!0
M*A6C>.CNE =^3-@&%[=:ZD<_$I-XJ5=34^MG+OCN&T[N.__A?6?#!^=/30P5
M7.W%7648]Y4L7O>VCY&V0D0/)\[>A,?YJ13N?.QR]Y='%$%](ZJXN<!K.I2Q
M'H$RH"4#H33[P2"VQ)=#Y5GV^+(&5RI1B3AEWXCG-X4EFLH[W\DFSFZ?Q)AT
M&X\RCKE-75\IJ6 F6G![)!2' :?8$#W2P^B0P]'?.%P(!D-VKC8JYHN4!SKE
MYECO> 5#*+FF--9_ A0#R$TCH>!37AM/=QO7M1!R>.XO\$P8[_?U5G$:#];*
M)^_9IY4L"(R1 1U/C2CH+"W4/=$:%L\IE+E*\XP2/*Q\Y31'!!2AF7R<2+/:
M,!'7B'USWI]/%=?4U9)\"GY_--#*(GZ5_2S\M*9$2P(5K5N@)0@[-"GBXMXO
MY_;[9IXV)A)OZ-0EZ#?)%A+; 6>)ZZ16>F)F=\<GP@B"\W]%V^PO"OG1+7^1
M@[JI)*C]VMLKM]_-N6?02DZ*KJ] AJ6AU"-,5Y"('!M74!QGA+O]A"R%+5.N
M#3#51733MS(E28CJ;"=\U)0C!_X,M%T[-V;Z2%*9WYM3+#QJYY;G(['0TI2F
M$UE! 43SR)>RL.9*1!QX-5GEYR*C_V])TU,]B\1>%0=RA\%(GU/(3$<S8XM.
M3%"X1O-Q?G?%7'X\N!W9CP(80U-N/BS>0A=,T-]5 (\D#0,XAF&]T6-ZS^A'
MW'UI757"M4:+CW?7,;M9NXP6/WJ])M'PU<%$O ]E"P^ P5& J D*X!D\RO";
M.;-PF%OPC4V*/,P<O:7P2/#DIF A=!TE$W0UPFV]22LZN9)! 2-I1E_/CG&$
M["[H2NU6X@CG=Q(VX9>=C2D(ASG*GR#V/K.(:<5'/S%7<$92"Y#G;=/K7Z??
MII?)2"P.,.&WOQ<14P*$@"R\"M/EHO0W#T.J]1FA8.&\,7JP0(S'!WFL5_*B
MZ,*,Q<AX0MWZN."B8&:P_FD)@X(<4&;U-<XBJ!/_<<BG^ F[9M;AQF>V,*J!
M7(H"!Z>@JE?-8#2V0_)^C$X?$)@AP?BA)GA7WFD;3=?TMU) >F> ,Z4J5JPE
MYO)+BXZ-O=O/F. 6,8WLS)2A?>'!)JH1.1M$>KN6_E>6\;GR-I-02IY[1E\<
M33^__^12'O[K7! BR8!\J:[E (U885S;\[A0,_SU/(Q:=@.('^ ],!9>?=MX
MO!2:637O57,BFVWK[[+,F@+BE0E^*)G*/)$[DJ T1<P%];@[7DKR4F#HZN%@
M&,]I>-RO*WYO[=MC,@J%468]CGJ]CJ(JJI1K%EW&34CZ3>I-1K,Z)&7=_]IC
MT-1GUWV/:J)#E'8]T3N;<5TB6N]K5FYX+3VHK3;Y.S*$"'8F@^ )QZJ"))VM
MQW0.&5F(2:X?'*?5[KZ N)8?)C<WLQTVQ58P'J4MD:2"SHV5=#%FZ)=K2CG;
M#22R@I9FN+C;9%B:ZNW)+&GW,K[3>#(G(N'E*M"3QR;3=^% \>W_AS:;_4D2
MA<T3V?CLS7*3("?UE@,36&3$Z?5K:I<-C(]>ZS4E!6_Q"S\'YE@F#FDZ&W[I
M;#]LD(4UI2DZ0!5W65V9ZPU,**I=?-9PF'WOQ\X)E]H?H@!%1RRE)1F!:9L#
MAD27^LB'?(X_Q)RC$:.%=H9>*3)-#0^2Z^?3)7J$[W5Z4HM([8>DC7UU2=%D
M[\Z-608132&3V^8'CEZMQ!)$[).W_2#K&:()Z>1N6FJ0NM=3)#'[/7<40G;$
M\SAP=F=(4.;GI<6.(44\2>2)]ZX YR9$R- F08EBYD)-O$8FF;)+#:?(AO62
MJ' ,LLR#L]7,G$R0NEI?W0S#?.[[AA=LW;J-0;R@J8GT;/5Q#.<N;HJUF]F3
M=\=CV;N^=>M4D)L+"AK-V97 <M"?G]D6?' .3_!.GB MJY3$G2WC(R9A"IDO
MSMN'$^OXIHH^#"\7%Q= LV$^.-OIX6$YUJ<16V%PPJ'Q'(1#2_*25Y1;[Y89
MYQF"<)M@D?;U5NR6!_V%LB!\)KX!9\+![O.H'^UAQ<9O-5G"U1</%)-"5/QF
M!A00?M<@S>D&"*G@IRQ04Z)A[&.WR95C-B4]EX^-)_LNV!(($R.RX?* ZI3%
M;5HF.JO,=;F-BX#Y(^>,E0PK1#E3Y:<]U[$33EI.U>'%ZF%=EM%1ST^,B3Y'
M'1DT&4?J/L-E$"+)>)[P=T5#>6 N0?WKGUH"T^3W$W@G-T3.^VW')/H?W!FM
M]>C7]7/18"2.OJA%O7&$I%8,M&;5H?5T)FV=?P''C[-NE*LXEDM2+H'E]<B"
MX''\M:D4SIA'Q4Z':B%;^($E? 5L+"A\W3.B,UO (R&6$13GIY>"66UGNL>"
M% U7[$[=\([WOC4];\RP$MYX=&VGN/M&S.A4 K];>=3-BXM?)]+M9&X-MV"^
ML9(-ATT\<;[:CK-=O4!E:>9Q-7M>E&JR%!]YC$<HYFJTA\B _[$!E,15[MM=
MK@G[LW\H4*S?,BD@4CJLKYG$CXJB+*QY>/(B>ZG#F;'DF3(;0^(@?J1;%.M9
M+)G7% A6T .CYTR;*6=Y V?60["I65+H)+'B(LE@,UJ)PXLS497!\/?WFJH$
MRY>N<%.BE1QQP7),N<2UCO#,9=#]UB6W;Z/V3QS<N=0V*7=W<]]]#Z7YWN"F
MV:6_<;'$?<N E!_HK!B,>,*J44=J.%"E.!](+S*X9&0:N\>U@8"$0V?V5'1&
M^--+G[USM+=\*M'X(5EC-:3ZJ;#(R5E1HN,\>9K*G.C-_<[S%(,VZ\NS$,'(
M$E5JE7<Q3HG=HI!Y_)VNI8R5D3HBIML7/)%29Z1C4B=H>FZJH+:8Y3T^E0":
M[?KU?,=U%4?,:?!<WG4!KY@>0>OIH^4O-J C!C\E%/ M-A<%Y."7<G^8:^KO
MDR*'A-V"D&K"[UC'! AV%!FJJR.#4ZG[,!.Z0S'JSB\G9);V''7'5K.(+-I3
MJ,010+O;EK@:23[DO0CE"G@MR4^ )U"< 2=" *-8&>X$39K^969=0$H8SR8G
M+-79>E[ZGAB!-;X1)2!!1?O:KEZGO-%%H<1>=;A.^"@JAX"-9I7$0-6Z5UW;
M\Y.FW%OKWW?Q-7)")K%CGF2L.H(9CQ\1QY5>M/;Z!\A<&A3C:K?2Y/P$*^B0
MM>&FXG[?-*-IU4'7LPTKZ@!\^SX[23$$=W'QJYV'5&HAA<I<:PD]P8.N@FBO
M04C9#=#0F?U$H( _]OC!];/E?EN52;2/AK9ZZ%Y6W8?Q0<$^5A?NY13)T3TU
M<\,C2)!,>KL)T6AU:0J1,]DS%5B.AWD'R6M#4*B;0/R2O8<4&?)MNWX,9H!-
ME&N.R.3B4OBB3+E/N.^V#;6A].]\N151$<(6V0CZ8G-/D<QFA<Y02+6W-5"R
M(U"*:GVBVV=9GP!C4=7SRH@MI?I%RYN%:*N! <%;\IEDN)_GLK&ZVG<X-W\F
MCO(GPSZ61*RL]7?H/Z0.0P>D<G=G((#M)5'I M*J,VTLY1L&?<U8!>;A8-P2
M$P;FR>#1C@$GUZ-$^X;\PD/)$*&P1NIB&SUNJF7FMRF.TKN=$70_:J3P-^V8
MVJ9WW[,<]H=54N'>CC[8D':M;&TG^1%B<$I\/C8B6!-T%RXH_RPKU.(+URI#
MTWHJ0T-EP([!/=KN0Q&Z,+U[8BPZOY&]\-PVXOKT(K#?VLBPU1.CU97057:%
MB ;\2-\W!%Z0%Q4*-G@?4[B%OU.T5>,A<^%LC][=L%--.)JH/)H/JX.I$.B$
M;:7N,^EK/_DUR^L<S2MQ#"\?EFOK5')K$O67<+LHX[*LTL&O&<3__(,6T.(-
M4JL<+7-K"/B^=:9[]M$2EN)(UE5W^@/026,G^!NUIWN59^<#"77G(9WI6:)U
M.>6&1N[GI4TOL/_L0 M^GUH>@B#1H(]#RHC?E7J![==V#7FEJ9(?V*'?14C"
M'@CY>+;OB<(OX8:&GVRBY#B2WOPJDY<Y8ZR_9"^8F^M5[OTCXJZEL<*^(O6T
M$+2-6:03/%H[^EG;C\O+CZ*CI2G9MM(FI>Z=HN.B@ _W.Q:0A%)=#?4<=8F;
MLE&&SSXBS2P\B_TD1\L=R]] Z^0_5VM]T37J[; $F7-"\L"J<[,%967_3IU#
MVL\G&Y0MS$:#'[YW& "]>"F@@.>0>D /RBW;!L:N_$![[[7]FTG.6CCZ\@(%
M)!=PKDR30(XA-Y#>JLT<(G58Z^W$FL+,(@JP.RJK9\=X^8<2S3.DU/1U*3?X
M?T^#5KM3XOY4ENBJKH#I:, :9.G&&OWF3Z[%(SI&HC-VP;.,@$TN'7.1Z+?5
MIR](W@6>.04\?Y530HD=2/MW9D5!\[V XU4$90X>>]DC<?6W,$:0@*<59;^]
M#%\_I;L(=B#SWPOUZ""E6I\A].&_G0Q%?>*BKT;;]V88K)QXMZW1U_YJK]W'
MJ$Y!U]D+WMZR^:[Z?I:.2"9BY&TU6N&?I7Q2D8ZZ[0J^R9LQV4,3H7'1I!75
M9B)'SRW<?4$=E+^RR.IT=K)O/DUTPO!UUZ7E<2VN-S%VYNYW"HHVU?>0_W0]
M,%1QI78S,Z79HF,8XW_;7[9;>C,[86B'L-*#:3S"6!D;PAG-<@GPTO+NV>;<
MT&]^9OK:$0;*U$<!H3V\-)UQ78$21[Z;2[*=H=ZF<>\9%(K;#J4O/AT" NVV
M 0]XN',>D[W.>I9VO#,S=;!OX#W[_?Y\(/_+CK2H[3ZW"9*$E;5!BI.[$R!P
MWSGW^9/PA'P12)*;W7/?KZVX1FNA_ISXS?%+O-_,DJ6VI&D%NB/*[&?>)>9E
MN_YF>M_F8&19ZFJ[61=^+5<R;^OZ76T;XR,@(".0*2.Y-Q:"R"&YR[[OG+,E
MI$2_N"[O"6*Q5#!1H@#;YI=W/Q>BW24YQ;:ALS[.XX#-4NL!,@ N'QH@(453
MZ$R)WBC *BV[S42,CJ&NP[O3;PQ##.!3@K@C%9;.H2%[?!@I&VG F=.B/"7\
MP9?E=%K^;%$=(Y^TX3'*3LM5=_3FU\B@4A/U"E4,Q3;>&7ZT?54$FR+.K>3+
MXQ(69&8AO=06_ONP9O-9?_4->?4O.20Y J!H43?Z#]S=TXT['=ED4"+M:H]?
M%A'GFW8AQ9WW^SFZ I,M@J1I44"[MP#!G/NK-<_?CI0@7TY8'CO\.&U# 0:(
M@-#F1U=$5?V,9C-I9WOL]J]P1B^'L$-=15% +/\>AF:<ZA5K_A=;'E#ZF:KH
M;#]CD7-M="#.BK& =VR"NU(S/?)6E?Y5III49;>#H^>%C,<1\;QST$PS1U[B
M;*I@C9@Z$;)8#:%:,*I_,=SCR !>GEZ6XM8'754TM6A.#,''O0^"V&X'X>)R
MV$V?K^5W89Z%3N8)]+CR41ABTHLA SYP>"3B85L6X]BHV@C4M-JX]DGE39;V
M3PRV9 U1WZ&5BN#HZK%M]@J0_N@MO?K9SH[ZO4F;+3R/FLJP7\HL,KT7"5(<
MW<W86%K9W9<Q&R'B8JX%,S(WL(J?])$L.+V182]BG0>&XR::V==V)=]OY(V+
M^6OU[F@VCBYF2(QG#58K5,>D=^EEO%[UT<6.+T .=)W0*G2<I2651;1)3_NT
M'=9(:H6J45H]FINNC</;HGM<BU@ /Y!ZZ*TU,_N#>_6V/Z9Y3#"#\/[1:T)G
M6?"$IH@$OP23&ASBZ*?TU2;1&B984V-&*#0"2MAPZIGI$CYC6Z" &KV-JMC6
M>R^)>)LJ,7 EAKMH9WW&?M3'P/7SD8ADP83(4E1<A G/81E5M23S]]%#6G--
M\P1HCRY]*AZEFCSV\&B:7^XO'RA%/Y*DXZ57<=L#G\)?MBE<]2+!A-RGY@5Q
M%M&W B/:4"OSQ/K:?\:1+9&Q:*X%XB\L>;LW[58@U#9D-B:,M;+I%F][TZZD
MM-#*/X$. IZ;**T,8LA5,"G>W]B5 _P&Y=S2NH-/C;E=\N96?SO4UN7<FHB_
MN?+&&=/ ,N P_7Z7"<73C_)W1P,&6:]+T#DT\(0QF,<CJJ_JTDEG&D!F)I&+
MD/"'0C#269,N'=>/!1I8V6%T]Y+M"INRGD6ON7#.N!M2V+/D=E,[Z_+;4]'R
M35G$ #_V]"I6CNG-8L?0C@*B3AX_@;XR869Y%%GA9/#+1]YN,\:WW<Y3[#Z=
M]TF9US5E*@K0DN( [FK3*C6IM72M\HQ=)Z9W$_79V IQITQ'!5&MO152+G<C
MCK/QO)3M^B974XF'?,R;XP[WTVH$%8.D?Y39X[3WO=/>Q3BL&& FS;E+B2;R
MS+ W3% _%("XW[9NUY5%WOZV.=PLB;'.V%'.L(BYPAICK3W79(-.L^"VO6GP
M,M]4-J"-]<X2;2D.=>0+C>Q3BZ,<$HSP=L^J;]2XUYR-AW%!"*>$WE1'9Y,4
MQR7V=L+N2SV5HLW*&;2C(.G[UO4^4]-?0[NPW.H=KZ'74N567T,I*7*+4$"?
M:?OE$-;ED;&8<>W0>U;DO-NP *T:=L*8TDU6L!*3Y*N9(TLR$O'8S^<0@S+_
M9^T>/KI-I3OW5,2,;,.>B3:@1WV[)QB(1NO=(Z!I8[+:(V1',_%AUUW5HLLG
M/-I=0M"8[S&7;F\O_#T+;TA=:K=%5@@*@/MV#8S"J"N[_&VL"^:ZDN)(H4/K
M\+6LODZ3!PCB4DAU54#!H%CGZQ V&P5=@)UR\?$9[=?3N##HC"F 5-"L'LT\
MM<=?5[*L_/0N07%J4C3ZA/EUG(/"NRLL"J/=4%6:BJCEO>?&8V;!//BV9X)(
MUO45+1D@+A:=A_6W+#&+<M=IO\OBL/=,7A^4EO:TSHC,EW%@==41_,HY9E&5
M]-S/%D81$)6\%*%X(TA=ZZ:H_ZX4F9^-.U=AFZ&1PCN&U'P&%D8^XM%H&E\=
M2"A<SR>@O5P4?@:WL_OPS %LW2NZKL=$?SP48IQ$+F*,'I,YP+0D$+J>OBC,
M=5#.!LTP^NVWEUV:@=Q.3MX5\^#'0I[.A6]>_\[=V?/ P'_'EQ(4T%V/ EIN
MB-[P<48_[;?=ED+LMQR@@.>O/J%EN^9/&VWX*;_/JRHZ?)O*RU*^(A7J5JV!
M0^^'5I"87=5]H8D"<+$348!DY:W.Q+ T32<LN+K/@[!F.*X-ME>6"]6HS ')
MZ++GH ?S\<J1HQFH4!:(<#PN+6Z3^J!3SXX.F\R]W<QY)4OL ?XN!P@P:8/8
MR;?O1J<-E[K?">A2C%+[8/%/H#8.97:T7'*//SHA6RU'$X>W4-F_"M5H[__L
M>]*TN&M?R!4*&(*_<;Q'HIFF6GHS?*&!3<& 4]GI:&^Z']<;\Y=OL*FOQM*5
M;CDV!2'G"FORX[>;UR48F(1:\/T_Q.F6.5 28*9IV*!WE7^4;XL"W-YKHX7*
M.>S]7SHH*!J@ ?52''^HD*;4UOWWY^H$W,6JY);PT]*9WR?E *( .YKU/]C7
M_PGO$IA5ZB;9!T1*;B=PKD\I'N2C +J=6Q1P(I J30VR"[GU 4O^T1,G![SS
MKR"YV&:_,@(=C^E*D*-5GM5*;93D[SD%#&KJGVA@=T_?<=ZLO#AH*PJ0D+,8
M_M]24-S-[[)A@=UMI,OR;S-E"@$0\MST' 7DEO6.C@6LS 4LW(9]_]??7)5>
M_B72:?Q- $SSP,<QR@>=!MT=3<]E1OQ4;A)M[-[0_@"]!OLE!BKTARS T_3N
M>TC0@=?Y5:D[J=PO:N'B)NYVFH] ;ZDLG3+G8M>8$8-TIZ%O_?R7:YG'RZ%>
MUR+OC.'P-F-Q)::O"6B?6CC4Q(@_7?AU]J_ZL-RE4NH./4F6P\WZYC!A2$Z6
MBEU2E)AXAS"+ZR1"^Y9YQR<V:"D"PM\7Q^C1&,9X1=&L*\Q$B%O8>_!Z7;=N
M4E/.M5XU-ZKS<JX5P6F*]\(4P<E-,EF[$]--77\"BC/ GAK6U":N*R!2N>+?
M3F9$ <)7/-/W^P>O4@>W]%C3.*U-;-84\V22/5]_S1]+'/FX+PDN++:C>EL1
M>_DVW\:G,D.D)M,2W_\L$6PY?19G_[[F_C:<UX07S7Y^Z8&L^F^/1?+:ZOG9
M2RJX7W^'^4:EY@?C=FTDZ.%_E5 2QP]7'W?;,V!-46V!-L:H/=HK>@5(?OC"
M3PC[![4"EJK"K<3$#0K8M..K/OW[GE9)T]P5+!K0,65O6\>9G-L;0#\OY\H2
M-)]CW!8 #F3+*X6N<O 95$%I?3B]!N#D:'5U 8V/[0;S$-9V:UA=SW:,QS-_
MU$.5%'R K'\63/Y!+&K,.U>#NX-BJ#I\N!MNXOBVOGWO.WM1.U\'XJ9<=!VP
M&]^)&+\F+9OU:M[H$.4!!U05U0;1N]T.*AV5[O?'YH]\Y>Y0->F:#S$KVWHP
MP07QBG'7<.IA>M7]CD&#V+5Z\4;]-VTZQJIQ/X7\%_-4" Z;'<;DX^7(MZ_&
M8I]>7 3,F]A*/)1!"&0>2T*7ATNGJM^%C6W%R^))G#\>A-"=QCULW[-34:BZ
M8QHQ//QS+)^KIIKRU(;17605.RCHLC*]BPL/G.#P2M>EI%57+Q-#4@NBC$O[
MV1I//(+O3+W%3Q9A;"*#S&F%B/#;%[52NPR.=PNM]W*IA5@?::J@*MC]RY+0
M,N&5H6OO1BGOOJHV A(ZTSF-.ZIUM:O&II3LR/:K]65V0_SU9OUZ+?_%$S>=
M#4F0$@LR=V5R.;$O/K=&.V _\5%K.:7XLY6(C9@U9.AZ5QE!]TT4^OZC52MQ
M*W@9"FB3<,VSO65'T"9&[93+SA$*RDODB%M+&T]ML$UJE$%*Q!JLO1VR[2S\
M%[WY%?VPO$OL7"Z^54 HJAK)^FKC^(VRG+/\A3M]L/,+O53:WQ,/5[>0&K;U
MW,]5T2>=V1-"\V84N+I@/J5<?=MXI9S25F-@J:NZ0D*YE9:%Y\\ZU$\9^[+G
M19S9OF^-NJMQ9TJH  JXA[1HOPS+_SIKD\4R^BN&:/1'U5-Y9G/%GE;S=-?+
MC;0Z[]3NGYW#!VX'2$,?3NMFFC%^R@I[*_"R6!2I;0K O<:1'Q(L(J6<Y"?Q
M9LG7_N4MV0)>=^FK/F?F(SNG#UFJ%5-]7SHB@\8J%(XKJD9;A1Y#;$3G\R&S
MVP_/.#E^'KTH2< Q DH*GGCM#"7.GG2*H0!@QR=8M;A_Q5_F1.3S14V"8?YO
M/]64[^H_7]IZM^44OGU)/?M8W^YG1K;- H?KF1;YK V%A9%-8=U[=IBN=$&1
M#I3LK<!EM@\LS\;@VD1D5(#:$4-FJ>%IPG,_>TB.6RIN[]I]FC",CR0&.^X+
MV :V-=.>D_MO1GFJ*Z.H&_P>?+"PT2(A+$#[&-"5GN?E:O1]+.'< &$__W7X
MB_Z2BEM-5/QXDB3B9%#9J+=]S5/4ASWON\!_OQ_(OEW!5$WL@WT;UCACBH@6
M5.NE(?2=L%]1"8,>'O]L\@RZI+K@[/09[[C\%+\OW _XV'=W",-HE*5$RR09
MY-4O6R\FP _-7?1OW=+C[HI1][CNP^P+6RE17S_IH("UDNN=-HQOF]W'.0UT
M90&BP-E,=H3S)S%+4*:+3TOL:I*B/-NFW: GZ*52&K!]TD*J+EA,^<3;]M*N
MS:6ZGIRPNP22R$\Y;?QVCMPR&5+>R(47+@W3>BJ=0Y3VSZX[MOR5!X__7;IC
MQ/^O.Y+_#7SB2M8\;N&!T6LMN9#/U_:+AK6.!5GLGS>FFTO^DKU /^%8Z^GV
M/@4JE.;6&"N1;E&3D208A#H>-:F21Z2F.B9>9%TNZI^@H>Z'(_T]'4K2(,$D
MII("2*[ATIMT]U#;ZA;\LF[%A$!QXF+PB'<$::[ 7OM2:!Y-M8KNTJ%Q3"RU
M.:$&#MOA2NM(?XF"L_,C-$-Q\"7C/ 4LU-PDN!8%D"C9V-#'X,?ZVU7K$J+A
M, 8^^!-Q\T]R.-SU4"MI2 9&%@?)+M+?]+C430/K6=$/WY8-55'5RGT4<#YN
M<O<<$;%.DJQ<;Q7+01V*U*^VJZUS"%,.]Q)/^6Z)M!W$20MG@VGW%:ZJ+"[U
ME.0 EWO7PL.O/RLFS._CB/??E1$5P;2L\[@?;"WI?6I43?,".0*LVK=10"9H
MZO"R94-W,P<_^P])X<Q/$G(Q?L=HB_^0AF^R24IOW1WN"/8?DMM?YQG^ZRK&
MAF8*J&NLUG<2M8;_948#0DW]%U!+ P04    "  (.E=6:@>(4C>?  "]JP
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M.#.T&(VZV) S?7X&T(PP&Q+!]Z-BRHB+]#C TJA)TFB;L(K:/!6VX]GSOYD
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MX'8]Z,H1LWF0EJ07A+INA*HVNF6Y;T&4J[T5T*,.>:.K<=J;['R<\;DD&15
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MG*^ESV^*%>^'>B&B$&DF- <-%%!7/YO)9M\?X;3)[AL*BV3:!1K1#3(?\J.
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MLY-TTY]J".^ZS?!U6W9F].H["X(<H3X: 1G:M,_NY4:+9;=80&22L!+XP6&
M(W/T5UZ6DNRAE)%O;@!\FDRWG^YKW+.\1LR>93 C"L^.Z&6O$<6&)I_T&C0
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M!TU5O?1<0*'@6^M4N04N@3?50CBV^Z;O,>B706,08<>&BY;*+Q8L3=5Y2<\
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M^V\4I[<1R)!%77K]JCV.GW,/K1.H]045M)_=E$7=;QL7R&AGWI!;%O[RE =
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M+F;.GO=@]_*TEV1_IK8O]XWK;4"8*<7:L -UH@1JIB\++\L8DF_G>+M#FK)
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M2[WA^=/5]J&CF-76C0!:53%MP&?GZ=0AU>"G$>'0)#%5[G(G=W,KU-+P'8Q
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M0M=4//O":1')M,OGMOD^O4Z=:$Q84!KU+?E-E>C\1Y?]#&6WT$"$CL4[)<$
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M&VY""%[U1W52&3[DRG*8H@D2(_9AR/Z/_7L$($@E6G8*FOC.VKGF8X8&/@*
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M!4'\+I$R565?"C-]9\C_I4[!"5#\I*CM"E!NF-JL3>@T<:83T6_/+-,.4,_
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M.G\AG_L@61R(@[HH\RQT0N !-O4:V%D)6[BQ"EZY_<&169;968VI1S?Q\@B
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M\!;RH5X&0^806U=3;E^Q!TJ\JB:.R(Y6"=3 V*\S3OTV9Q<7#YRUFFZ0KPA
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M6ENGOQ^_6U?ND"#H.[&$!MPRORY4Q<2M7N2.+/*M-OTEX'%)FOHM+(>UX5F
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M2Y@^N5Y*-#)B ;M#(TC *24*AZS78NWEWA'&$-,5'MES_PBT'O:[*3_3V";
M0<L?28^"_M=OJH)((@RC$@"=0BUYZMA>;ZSN+KLVN#4/+S*FJ3YG6E">*>JG
M,]X,K&A=_.+G6U-VS!5'-CN/S+FK\@HK*A4KR5\J<I)<*APE(9H(XZ0]_-Q+
M,.+ E/F3$E=[N.9M/E$AR)=PQJ#Q5PZWCP#</-"R]S'7[W/89&DT)K*0L$W&
M8S1<R$:_NN2\3?4;3XW17AM5;?8."\?))P>-#]07W$%K7SOO?/Z0-)^ 8^"0
MRM* !=H[4OFFYR*@JX*]<5XO[,V-PMG5_W;=TP5CNY3*P[G5\JKH3\=W\D(
M8-$BQ ^#",#O62W=C+9__H@0#*]Z_B9W*_V:?LFEI(=]Y .H_Y^##SUT_O\X
MZICR<'XR?[8B1HS@N/'_QT3U?TW,,HO0'K)-[6=V/E$_$$-"-PRN!>R??A@^
M.YT2NTHA.7C!LU/^$T'^@&^C<_=M)+KGYQ7YW=4,Z!"^>3^U\N[9Z*A^00#*
MD;/'0)N3S\*DXC%Z5^5.$2XASPNOQQA(/+\"IW"5U+1H;@VG,&0W1IE@@;8\
M4N$=_0A #I:=QG^>G12Y7IM#W?5_,F2'3?4-G>,9&V"O/KN;#&8P*SA/_<PG
M6!%S(7ZN_MG91^K/OM1#@V5D6H"?4&?< WIAJA_)-<&[NF\1 +_H.X.=J+_P
M/02@NXW.Y5F"N*<9Z0N?T[[XU9V.<7<6+T8-4AH"W1CI=^F;G&?_C0K//QB/
MSAC9M1(9XH1-^;EL-HP'@YOE6H.4VF.C:B(<NF9*=!H'K>,8^V+%48X\"\MI
M&9IYK%*_EI0<#%J1?3B- L8_NNX4N=*9LW>\63I!4Q .*?LZ$PJY[+\NOHFE
MT:9=M%VZY.AQ[%>>]3]<21XGR VA'2[YA)H8*U-ORI7);N=)N(E^E=\:;^2,
MRTXMUGVB@D/P0%83LQBC=/*:PG;;?V352='D6 \KZI<+191DN-UD/5M=0;G@
M&-;<SI&+E?R@!./+-Q?+/V\>9CJ"%Y8!ML4>'0X*OB(9P158(B<K^SN=S;3(
M2:,LO> O,[Y7M@QO.UBO@;>O3:A;<2IF)_R=G=FC49TK>4;&99&&OLV3^&47
MSQ^^TUZZ=PK\[C#@%:CTEZO>+7;LX[V_DEA!/;D"%*U034^*(^*5&B\*8:\8
M"%.5D37B"OA*PU*<C<2B3%O0H.A! ]N?;8$EF_^@?J/N;RLV$C>]$"3IQ5;A
M;[;35\)6JAC8+_@ BB0/CV,R*)%)QFH1:T0:GV.P]DK1J:GY\N(H*?C)V?)>
M$Z($6!+LC3'J,J#L:^F30'4R(S0*,YU&T)S0[1,0 $W\TN@FP'E&QC1YIP=V
MWD8D6,\(@BI*>$,/ZM>\+!BS6GCK9Y!\Z*(L(=KN.=I]EPA<1GOJ,8ERBA*6
M5$, *&S&U=65U3]AH %(V77!W<-"*W<B6FH^-U7,.?NWBO"@S,XZ'U[P4]%Z
MB\@EOQ6%WNHI4N!#H):4;*2[,!$<CI'P:][6K]"\:/U07@:VGL0J)6-RF G6
MWCVAFBJK*-547:7AF437BG5'(T, (&Y7ZO7Y3I/=LDRC:HY>QU?.'K^DZFO-
M8JDPA[S99DI6]S[\"G4M'3@Q8^#ID5I1GMJL@[JCO4P.Y)+^ZD(K*2$C%_>8
M(H6W%A>P"#MQ<#X(43D[CDHE?(+%E;)<D>)<P$JD_N:]'U2<P THG6#*-"4!
M9^99DF/I2/FQ'M/8N"\W62H-9BKAR(:==CD9'+#K+>LGLI>/5SHB  =%VVY<
MZE;.^>EQ3?=I",#/<@/=Z:MEH&* 5)U_<P^E!]_^%8D?='GQ?M5"L<;VTO'2
M=C_%+ _2DJ"OUVPDY;STI.A5J4DPOYQV;5WT5PSX&;_=1_S,:&I#8"0I:8J2
M,/8#7(<! 9@/.=1[PI-EDAU2 X[\F%KSK @0<C*=T)^Y)Y-A:<=MJWBDJS$_
M)[U>^B%%G] 2X/@PRUNLJX, 6*]PYS)B*G+RO#&A;X!9-VL&<Z;-D!P#=6_,
M@@L8!6(C*\8.C:=<7R;A.NW.I<V<I)??E_]9_A[EH4F*,]-\9_W->[IFRN<O
M(,,ZX<A(%2,7*E4XKN7UXKQM8GQN>^S(Y#!LJBR^86N E</1(OVN[DEP0S.$
M.41$@Y8:_B)S"[('V=4&P11:6:PUEPAJ[H:D?=L788.SV3,NT*9+P7/X1IY<
MC>;*-<8N3(_0EI4?_4SN"<L%/[U<YZE LN&+:= *^_'H52DGAEW^^]P/YI[G
M;A:@[1J-]POAHT#9)#J"46*9PWO-S^'X^2F774@JFD,+6_%-I)=?!91;,C_'
M&@>9K0C%/'YGC'[F;9N"CPA UCW-"27/[M3&GP[OJZG-:;9F)Z&9FPTX?#_.
MBJ3/$\1(X=P#*.C-X2Z22YTSO^AEH"'0L&N/+G-/49:(7&_'CI FO8G/W$VI
MV&#829Q!(HHG2"#\R'E5;F5V&#N=4-X[/+:])9;HC;["1WC+_?NK)VYW 4/@
MR0T] 5S=0JKJ4>)!=N^+<OF9]%I\^\-MOK5;J(73/D$GR4>RC-61GQ,)1J.3
MA@V2!&:-K=)YZ=U?ERG$(UAT6R=S)TS?:@U<]'P:LG-2\,42?=&<]W=, U?P
MQ2WU[+[FZ>#+XZ@UGJX,7TFKSM>QM= 3-/F>+,X>JC!^*?ZY+@"Y=K\T;4,J
M%O7;7HPWU]QVCOPJEP%X",#F[IBW1G!DKNX@N]'CGQS,+2?._=.P[:UTJ\*#
M@;G]FJ3C8Y<YZDAE-)XXT,\HSNMBWESNHPA^0CB$8]%3SM4X=YV=BU]H[?I)
M%'8HLN$2ANYF^)%]M,P+2FMMS:*]FO4R;,<BNNN\!SD(,OA&DS;8.?;P:Z+3
M9VHLBGA+/I&OHSN"@?O:O+;.CEC%PLW(?!]03(/2(IS3U$U,*?R=F3!)>]'1
M6_&BEORX=]5W$B9U:%1(OPU-<CE6U>O^Y.#Y3ERTFX7RG7%FG[8NF6[&&Q)3
MC!WA>_ZEME;+S--L#DFE/<=,]$$]W-LMTF?':98-5^7O91U*V^S#Q ^=:GA;
M>;OTT,S-8P%E.4T_4PC *PY<)NH-\*A904Y-7 ?L<7X'DTSK!#(?4?NA8$TX
MCPBB7)?IN/)FT-2$\,M9=O3FHX$S@$RG"^+S" "GC,]*V_>9E'0/ H+L,.#^
M4)1SKQ(AC-XUJC(!#// .=278 ['C9(PUOK%DJE]*Z\Q>?P@OUS@:6Q&KON\
M2B,6OK)L%RVI24>HVI 0K6145@;)TSK&'-B%WJ9&I4TO>N];&!*<&#BJ(P"5
MN>C$T@_3/ZH3Y_U1PEIDQBIID.:J,"V@XM7VRA(SI;5O@B'.U+[=Z*CC5N56
M[NN)6N]7S YH#)$>5,>TTZXO!F85Q,XU2I7'TCOKAJ%Y Z]8TFE&'>:'100)
M<G[VLVJ2+5M]=0=J5?=2Q+M-*R;%SV$,AW%[YOH<:SAUB?R8:=F2O>GAB^H;
M7>G?;BG!S8GAGY\(?EGI22UA"X\,K"[WE5>JJX5L7=(8C_321JMJ')DFKJPG
M2O^([>\J.@'Z8?&AM/,=I[ XM(1IQ/QIW\4?LSJ#&$Z)6D3X0+-(C#X U'/%
M+8 ;<XZ>M@+(-(LQ795HC:LOK7CJ&,D:J&+=YE%QFC)^P+F';0YIKX?8%XM^
MF1S9YM#:C+NP@!XYI0+F(C@BZJ9FU/5BR[B=)<,8RIV=H^YB^11QQ'$\[?!,
MYI#!O\OS.\FKK6;&P*-\$!#%"\=65M""'\NXRW>GXI5O@7.99ZKWLZZ:+%2Q
M::[Q1FJN24.-W!M(\=OO[IV?F*ZYQV2(J5T,18O"J[\4]::P"H]X=QW4^9'X
M$YCF<)"W3\CAQ&UQO-L3+11B88?&/2K^ C7^$A9P X7@-[C:T8KAZ/=.U)6<
M3%G0$:]F?9@&^BX0#FPHX0%+?YOPKQ=SQZX? @,4*:[H]^5=/<PHFHI(7UX]
M3$Y/F.GV/ZXZ3JD18<=D:7@8.)Q@;*+]W+9/Y"?E\=HDN!W^'-<7]).!L^?E
M*-[NISF(&QD_X9;2!]S)00"#).J9&AQ*STMHP P\7BLJS/GU4GU=[\<U?1[-
M'X@SQ!A'P1*  *@<7GRTWU?PD8X8#]'W5!UY\<7V$KF:'1.]PIJB4W(+:^E[
M+Y<NLX0=F>2<UCQ[8--OLJE6R7ZQ)I^&(MN8?K=QWQ4L$0\,O>[<73>&^N,L
M_*X*K)KSOU_.OMA^2;YW0\.WOID=^5$JFU5G,9&W2M1-!0(-X 7M0N4'MV=5
M6B(;^XU?[S)+CUA.KL<MF[VU0W$G;DO_TI03JJQN+#KV+EZL<\2Y)@X<B@!T
M0GH2NXU,= J2>3D_=O2*:JU0I<>+UZ/Z-UF_(-FEJYU9 A._.^+#'_6 UK%$
M9;Y'D6=U0"] N>;.P_?ZV?7^WE(& =#>^V;I>*]-F[))&,&[.WI=AO'-\6>V
M].Q)=A"YJ$)I[LFB &-O(H;PS_+LRV.Z\,?S*K@)_K 'MNV"T%D&$?\HN1+.
MW:RZ+C@$YP8<=JW'E0;,9$<?.W_X""L9[?9.2E$]=;T]:*-NC6X1R_4E7T8
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MZW9'PV8:[333)-7C\8K%Y<DC8S;@MZRZ]EL+(SPUX%H!E]!1CJ[""^I&X)"
M[!/?F2=K)Q .+D[TH^6@Z00(D^3KF&TZX1S>DQ]1ULM-.L8C(;H^K[I)#"&0
MX@C&3D9R7VA%TL^C6.SWN<^#Z(]E^WR_RSAA6BSO2@[;EM.?ZR+N<!HH]X4"
M"!K_:+<3D:D)D-;&Q@E-TLF5@T5:W7]G#K74V!A0%$FBD7]C@&]$:9$O[375
MKU2IBG?F7*H:Y?N;.Q;U;"YV_Y8Y>0 R+W3<&39W*C.MH+TU_/U,*%4Z3VU:
MF-69EL1'7EJ"#%MOM^[-YL61' EF,P!P)$F>=:_&&=]4?S04DYS[G:N=_ 6L
M)'2=VX$0\&![P.(;R(:](5ZF4'\!+Q$7\_CDS9/.EOU4H=J+X4!-QBON\YZX
M;D*S5!%;:I;!8!GJ*(;+W;'S*3'/,IQ['$F,X7A6,:G6#92V231I=1(WC'H7
M"J0H&\H4"[:#Z'M0AI%&T_&-(K@2X46E-P  ($*!8*2<)+XB-VK;1-)2N5[M
MUAJPRJ_ZZI]6 ALV"[O2P- ;:V^ZRJND,*<8AM_)R4B8\SF-5R20^!$0J)TU
MF^8U^M*/:[T)FT"OMY?0E'R^Z* 7>[NM!*HI BW\<_E+K.7K:>6175MWVXB-
MCP@! 628+['*H'UM+4$R%^LK10*KG?<(]^%?F^,D_KZ)4U9: ZRGQXC2S1XL
MZ<GM^'UPDW*T)!E8<U87MAFQ!P-^9L4H?&?BWPN[(UG7?2$"C)$K--_G@-%H
MO9+U&;2;5DO)*W'32]%*%<WV^"X>D@Y>12O.BTR-T+;.NJ'3OZ?7Q99. K>_
MFIZ%?9CX#!R1Z!_FC/MR;=X)'B,P5ZH"*_T*A8J^Q\#;]TU9];-U8PAO5C1?
MTZ>GY]_$-6R\5'\$0(G%U( YRG$4UN'O4[K7G1 $I9?225VLK$=^(O39_/3K
M",FWYM-%_93)BR"2HQ(A+QI(7<0RP4M\>1Q\#X")1L(G,(N:0)7FDL]DR5W;
MC4D>U;L$&JHH' 4IU<#A79;/1U87"FXA#'[>)^ S(GAI085G=^VD)%UKJ9.8
M-PK@YE@(%+:A[^&INCPOXX(SR#\V-=\\C'+U+@/G(5W[QOC600,RG5NB+RP[
MFWB[W)Q 9KTK9>D]V[EL_FF_F-KORT!]\'C\GJ$J,1'/D*&WJUTX7H6)036[
M>7"[Z$P!/5EELD@'83E,(1B7M2"=-G&_23.P5_QR3*\+ZNR./E0F:<YH0<,L
MH]S;I#.GQV/1._F<<T^WF(2WV TU\WQ"LO@.#\&MG2T@(9,)$O^HKT\?KU@G
M)ZO[U82#+ JJ.7@R1\H!<&+(B Q^ "78&<G013<IXCU=0B.J\)AG<F<9 MYZ
MY 72B]Y77A*D>P[9V=J]:,GM(C_\-? N8!_UB<8EF_>(H^V.=3IZE.SO-Z*K
MUR6\8^0MW;6I/V1U=<6/.6/$WFJYOTR<1$"-0C]F7Y?;Y"N1+=7! \-]!N@+
MG?'E]4RO^T7P! 1*?*(X<T-L8CL<')V283P!PWT8[)X,*S]W1$X%L0]T&GOV
M^)ZT[K_;DCLY4#>2DQ@TE,"G:XZ;\8-HGB]%]!*\/Q;92QSP_S3F@ADW++&Y
M02,Z=S"98]LSFH,:AB/9ZX]V UU*S*:(SZ4YHMLRZV^-C <?&/ESE\A=R$](
M<;VR/8[SO,@]3RV5UB8><U/+&7#=UK<AJJ+D_OWTJ8_64G3>748..UO['\)C
MG(5?/$WN6^5IV8,E#C29^<X*S[?3TFH0K6L&7?6AK'C2[UG5K)(HW!H67_;Z
M3/DQ.1D8&/>+VI+:[4P5(S(3K(Q&O%U__?'.418.)GDR6.APG]$F?UC.&C<Z
M"?1"[+-Q'>S;V4B9<=KV^-;,(CX^ E;M+]!R8/1(Q+U !>QK5C9]2%@7ZG^Z
M#@2OR-Q<P,_%7EV1;#;[Y_(@OM?]8G-B&3U&HQ-"&(($)U.KJ]*EW /ZDB6X
M0]H7_]Q!(U9^U_WX_7K5 LF4&IOG7^OWJG^Z36WU#52JP>;I]EY=#825([%E
M80E:?:9OK7Z!O2BZX60FQZO=MNK-V'Z7$'*Y(PUW%%0'W 46-&V8Z'0*B<6=
M8;?/Y[+\U($ 6>,UT2RMO6G68S-6U!$F\F^]*^VSKZW\'P2U1L,Q*BBDU"2X
M&<9)>#"B:;ZX!1JR9:[=-PW1U8=.\DK?IRX07]]I^K._CU=K>%V!!R 4N,]I
M><>MDZLS;:H!0/N5+W!^R"_S\\+CM/);6F-^2YH#&I;L Y!BJ+<VL>YYEYXR
M]397S6CQ#P>?P'ZQ?%\"+^6HFG[:LX*L[^+J+"_-]\49**,_6OW90HT9M[\3
MB!PA22A65H%%EMRTTJ#(Y,<=*DUQ$J$C=H_M7PUUJ1DR+_0VI8_B8^M-1';.
MI@BA>#K<R\T71QW#[8VLK <C[L2NHNID:T,EWXJ@T<Y"],I*;5\-NS&*4Q[$
MV!-VWI'8UIIY4VO4_["F7*)(&-?"2[CD_>I8I,:%JC8LKO).[DC!(#,&$FQ=
MP);J(-?<^C!? GLYCO 7(_E6VD3(,%BA<OI3<"<")N+=P?GV?'5L4^QLXA$
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M>_AJ\0@8U_J5?^5OO.^L?N3#/KY0IHS[""B> AW2H"%"]-W_[7\#NY4N*^X
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M)1N01P#,Q_C!6T9G9L.<:WX:./C#+,6H<*A1?B=WH&P/[\/$@#<*S5.B-_M
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M%[J:1-T!#BC1BQAXDD&&$AK.V7LIVRW6:S>.=,TKD:5%1S0OG@@MKEHS%!I
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MGV&3BSS3FX#3E/&%9YVAA;M[.5<<O;5Q-*L-'I*]_C3L&R>E.9/\4JC0?"P
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MCKS])MHZ+VZQ*OS:VL""N[W$%_YFPP6C]IX0?]\;W7A#,;E^\VCW(2@N3&Q
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M+8%*!G8$EAWJ)"O2?YDPQN?]^/R^^]UD@69C"X)=CJ*EM6.CT$XZ-%& /G2
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M4O @Y*NC%EEA[[(08.Y1R3[83X=93_F9.N1Z&+*7@54]XZ.:DE^Y:30O =D
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M4[W:6[8*N\M( E/4?M<R@2CDQZXS!_=N6ABQ"U"GZ1@;F7ZS(9!A^_P;4/7
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M@N_5H>VHRM1+M9[OB9CZ&Q+UGF;,LJ^RC7!?18&XO\MP_V)(/ZXI ;)8NG[
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MP?._ES9+!7,A#7-:OKIK)?^@QYQ'A\XGIA9"]/U#7$FWH[HEK]VMEHECZZ#
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M6R&>#S<P$W3S^MKT[%C-2\,?XAWMZ_,EBS<*\@T@ ZQ"B]J('O(Q0UDXR<"
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MLT9![HU",B%])+'M,6#U"P5FH:LH\> W\)A<"7A<WVA1V320E$U5<M:P)Z(
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MK#CO(96-.P?U"?)7V61T^099UR(Q\\!O/(_O?_ 7;OQ8^!M02P,$%     @
M"#I75O5_VZK4-@$ [ET! !,   !I;6<R-30Q.3,T-C-?-3@N:G!GW+ME6%S-
MMB[:6-#@[FX-!'=/<'>'$)S&70,)[A8DN#?6N&L([@[!W=T=+FN=N\Y9^]MK
MG;/OW<]S?]SJY_W1->?LKG?4K%'O&%7U^N=U#8 N*RDC"8""!@"@WCZ UT7
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M(#[')EKTR$IA2I(^:EVGE,B*;X^OPQ_:L@&($MQ/9$?A)0>VA/NY!L+IA:;
M' *!8NV]#[3<Y]6O "P'($7TM*"S/N?#*)AKP+0]4PB\350M@NXU"WDIW7AW
MUK**3+_ASU[<'(6JJ,@K!.<^\8,T[,!I%-F5YO,Y=X%#Z$W2,"Z7J 7YY9CU
M^H+!R;"2KN]5Y9BI6U[9LL%00LNABN596J6)PYH)A?^(NYR$J>=U"8-WU3PV
MB[M>1VK47)V22?'3/3XJO)=]*.4C\Z\@L<5H@A#::HI7@&&!%VJ';(8\ZB2P
MZ"1W^")(;5[*:_>:88%.(8"\2C"ZSHY7E\A#<4T^HA7JCSE8^IBZ+F4IKDWJ
MY'Y71$E6,!:GC*LE'G>)3Y0?KKB^=2IHJX:P]+U_0V/X!I]LHX"_V48M7>;:
M*&2G<'N+\S.23QGT3<\QM4J3 ;Z;8'B6].1F1T=M^,&.@)Y%+%!?YE;9*UV#
MK]PT57ERH%E>_6:O6H*<1U@-8SPR0"9;N':<TT!$="*[<DH9V94 !54^\!6
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MU&9;YB2((^PR*[\7O!,-)AEQHJ0TG7_'#(<?)^B#N6G3"R1EW(1,UJDM7C"
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M%0T-5<[%9K=)S:%S$EU[1D@Q]FA1&[L0]E'D,;R:B8Z-.N7;:URNEX#TEA#
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MZ;E'Y&HV<1T+GT^FG?%_())*60=9<F(/RV^.^>TR%//JB09XA-+YP%AF*O+
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MYA8D:8(&KRZ AN=J!W,S]K?:)OJT)<F1OG^'H2;LI*T:%R:JGENXQFGCK<Z
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M\6LY87KXI)RF4-TRH5&K[?E%?"V::)-H-EZTC(SD<H_M;86#=@$7L6-?'18
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M\''C\.(>!$=?%_DQ?B3R_$V"J)Z",,^LLJ5BZ5>=^'J.0+[QREU1%+NYS\^
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M?.PLW^CP=E^Z-2@0))8:\W6N"96\OD)>UK;3GO;S6@,6[$'(K>,9C>\IXI\
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M+ TB[3F1LV;D%*4E+,H*1X'?5UA:S $_9F;N:HZK[SEFPPP3""\QM)-MVOC
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MF9!D>W0NO>>Q,B%/':H]_HVJ OG*7G/.?^+^>].9>\BF>5GH/T#61\U*>9X
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M(A0D=>.74=D1H/Q8,1IC[#LX#FQM+;IEQ\*[P#-2@!M MN&-@13;@<4GP[T
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M#%@5: #4B'+SGR/\.1BVAT]_G>Q1%^*Z]97W ,.6QJCP3\:F5Y===I>%;$^
M/]7X4Z.0YE;CA8&)"WY6#7AV?-%:>'CY@9\ UQ/XX75%\SF=\!AH87VKMT&)
M-O(#"^N$O860_QPC(-<VO[*&L]]=7\F^'.=#4QMZ=,O'<Z7QA^$K]+/,@2>
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M,1'-"*6U6:_^J02/(K9H3\:K8FEVU,LV6\W#_*[LZKPOO4\[TV]63W;1ZFO
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MLEG^"ICOV5G155#XJ$N/<'"GA7.L,DRYE69>RYJQD.\8L8ECOIJ7IL*3%@+
MMH%G(L3@_I1)L"1%\'V?D0),3^<ELN^X=OV*,=7V!"(!%M#2FM-4+* \'0AD
M55(MB=%3TAZ?[DJ:9[*S..;)>2&2WYUW?]*\6Z1H@_OA74L]G%I;B64CRXV7
M_?F0Z6DQ Q.AZ>:M]W?_-2''A>:"24X4AIE9CB#D1U 5W=*I;VU*!G?]R Q9
M=!RS3O.NZ#@@=>1B-['X7DUWO$-9(.9-XCN(K/=/RR:I8IH>O0J$.+O>FIS2
MD7ABJA91R,. [;I(? (C=VQ;SS1WB 4G?(ZV' \#@?MLBT Q./>3%M[9>0V\
MA9>OL6TQANWMW1I_28QZ11^5?K!C"O(:>0V>7#^VFY[N*9Q\X;,45L40DIGM
MY*%2,\99Y.&H?TP;$PAJZ9'S99DW(?<G6T3HG>Y,OP6K-E=QC0Y/0ARC5;A:
M/C:^:P]VE*101*47B121@ASV4_2G@LP<-<]<M=PR7U7&]9EK\\QAK<:S]J,/
M!9JBZ_%Q12:;%9MK<.@2A3'%+KQ"4,5WXB6D](^\ERQCJ ^THBL?B!WK+9LU
M8V>*+"(7$[E=/\=868\Q5ESBK5!47EP&+@2U%4D($4C<!M@ELNVENS]"A$%A
MZ?7U4C7'/K9X3TN"]WGT$P$;\F]Q16(P+25XGEJXB=N)X'908A_UO:";<A=A
M'Y>T>(GP0Z.<+A#;>KJ&5JHL_MCSGRUK=?QCJ-< F-5)L+G<2HN%[Z X04Z/
M^DA!A-RP)8MAB+0&_O1R2W5,OQYZ#E<P874>R(SD'7];Y.U2D@^):BRW&\/2
M(M!\K%]LH"PYYB=(JI0-/:>MJW:0=2JJ'96%HBW2DU<NC7/!LA%["O[93ZX!
MDSZC [Z,SXC86V!9[*TA7U##[1HW7RJ+;R:8:\?N''$&4S^;*WX3+FW']K%K
MSO!C&[;-,'W0&#PB1PP&(:P*PN@F:-%O*E<_0E\S9U&)'6\!0K=KR\J%$Z&T
M3G!B*=%T;#'?5:MW029CF;O!@[6[43%\92%31-8T'_4!:)YJ+@\X3H?NE#[?
M! :NESW=E2B>5F1_:45*=L>!=W4",^(P_V$#'PUJ#HSE^[W3YK%9J<!='CR<
MR\@?G&,FG9V+2:"FQA[+\5M$6B!=F7-J=03C*E0O/?<:X$B?LQDP-';T\1 J
MTL_&>8)7$8#\*GPX1!$@$B/D8]2C>44(36(,W?)'USTS8TAH2Z(H7SR?^/;-
MD@IT7^NJ'?^ALYR8=VWCYHA!@+BVSF9^SS84M_*5=)<WM<17=<LYBJ,[.1X4
MT1E@W2Z>Y[C12/ZBK;2IF^6]^!V-HXV-5<Y+KLF91A.77=!T9;>,)VHGI=-[
MJ5[IO&M 2SMXV-ZK1SFI?!I[4FF!2T1S]0I5+L[, EBZ;7(?3/VD62)37;$J
M/^3%F0:]_X52(D7 DX#9;4T%,2)O/4G"N8R)8V(J'%70CA8-._P$\"E]D;ZP
MUSFS@ )A/N^FX:8H3G>\+X5<V )+J+\(<Z N4$KS.J(=X,VK59@$C>P<?G_.
M!&-Z4UE=&]]*(OM8'/#LC33@S!UA(A^A%LXG@H!"H4N8W$PU;2\DWX7?8? Y
MCC. 7W[86#N.+LJK<5AW1HP+\C!(S ?9'^4F$D8.JXT=KEDNUPS#EH.ARU&*
MK&D$W>WUIYZ\9\:>97Z*XOA*4II"V1[M%[/?/&36S!-'1!:OK$[J,\PE[>((
M=E,1^,I@]+L_C@*)L,N9$<Y@\HV!X ^]"!B6%LS =;17]I3F78%!@*''D7D=
M U^, R1\3?W[VE^G";4:FX=Y&'5S%T#=F&I;YO59:<WID636GJB#M9<,Q]Z9
MG9F0]P+^F-&VE;'SG7V&EO71BDTI/*ZDTI+AFV<[P!&6AXK#J]4V87B$DY>+
M$^[TMS+*.;A*Y:US2_#OB+_V*NH@B,N^!F1N'/-;K_#V(U?/GC6A'EEZS''!
M^6BX9.VX\_&-9S:LL-.@64A1^JKHU4\/?7R9MV8[L(_2=%XG&4>3&&? =,S*
MN<>WGV=*2)?=#< CD#DA0O7>! N'V@BM!!O9V,:91!&8$+73NJ@$5KZE2BU=
M_^XSO=GL9F2"P=AIW0,2:20)*G%W0MW4-*>1NP;(CWQ#<'3=.6>JO ;HX_1(
MCI9\5U[P7RG?79YL6.%YK-;!GQJ%$K>+-NA&^HAI*=D?QL4]4F#YZH&W <I^
M:Z/()BVY:.C+S4UUDU$$WY,J?O<XLK)CF/J,LQR4$27\@<&1D%E05$ZR?%IF
MC(=@'F<W2KFS(RPLK!MEDMR6X3@G6VB[)U;H0T=H$%@GBLA+47]CR6%[+'(:
MP1+Y>MT4 CDIVN!WJ]VB^KCZ8HY'><NL5PQB=3LCGONXX2[UBX\H_:@SF7D2
MS.,#-PLT&L%_/2QIT/28Z_]^J_[20>0,8YR9Y=0D+?(:4/,N9E!9G& Y2>I_
M_GM8!?>3I."9FJX)Y<&0[OG6 "H4QF2Q7!$U,\.;7AG1$_-9K]J 6/CT5N#F
M?7F%+EF!3:<=IO0&IW1BC<:.CC,OA;\>7X=? V:-?SSR7F>Y/#:]!<]/@0"7
M[F'GZ-]&2CA21=JJG5.D[6:&XJS?3R,GMY\T&@[AL*!!P>%;/R+.2_I[Y'\]
M\+^)HG6] D7:F!7#V\Q99;&N3DM1H]T-/>P&;]C"UEM?7OIDD+-#.2= <<^^
MQFIA8(5H+84+V?4"?X<!T7D>=*G83$)7@H^[P6]4V^$)_=A1:4CA>=2J,78A
M;/GNB;!W:B!4^%E$AX!!4_M#RB13\JY5BE6NDG\#H?P;VW#U?:I2A&];WWU9
M^WMHN#";OW:0N:N!@9,SD]+0MVAVC53-[=2^&A1S@[]+#Q%'9IR*-%<Q?:T>
MMC>7-0_"74GW8.U/V3[5B$SPR4PB"_LZV7Y+FD9F_@Z/ %D)I2WD&O"[4K@G
M\:0MC*=,<7L7 J&6?$&64?WF-H13_HOT##B98YT7\EHD%%&<FVZ\6B^/!1PT
M?<GK&=CCWZ,7K>3_H#*D/;Z5_"!/#J.OSCG!/F&DD#&K;+?:_#0>=VGO/L8#
M9\,EN!M'[QN6YMF[-'D%?C#49QW4CQOSKP'_6/7?&@XLA+ SB<@CAFEBF P8
M5WL.NF3QP!-+X8K?&_"+ULN4IL!3DE"27N?R;>Q',=:L/"YS-BJ_88 +$'@4
M'A9E34ZX^>(4@_AK6+>_&QCQJ: 7I<>]'(+3U(5 A=%E][$&##N^!!DXPED9
M9O\1_:<OA2T-,6;.<X$<IO3$&3Z*T8L.8E\Y:)"A"QF)95PF<)U0%F)"+.7-
M$5_TIJ='VY\^7)IVI/YWQ3Z>\.%,$.:L$2_Y\&3S4278^R$>JRSV=S)-EIQ3
M_GDN+;A]-Y1ZHY=)8_0Y%ZT!&0#/CABPR <(<B ;!__!5>13>#-MD([->Y@/
M,D9;<-O>LN4H0B#8'?<9YG$EG)1>&&RX,9:]G0FJI*$A1D?[.?'^ Q!6>05M
M5(N+98)Y^OJ EK;X,NA%-:ZM OK(D?"16<H?/!TS@(F]#4MB43E@B+:F0ET[
M2[V9EQQ%>!2DL;L2#"]ER864G5CAG)5%LFN.F PC"WXSQDZKH4G_O!O&2I\L
MGWV<1'FXKE#:OB>%,6"*;6 .)4Q>F&! (9PS+1WIYJ/;\^"[ <HUH':S>C8?
M\B?7PH[+T#(]?C^L4!J !,A:!-N$NT1LN/4RK$?EY=7E+$<X[0:Z+?LWW0(!
M[,GBDW1P9*)_<'X_MGW%_F#(TNM/OF;83,3F@2!C#HZ/> C'!ENYAOT21O0Z
M&O0>;K:*_-8Z^0YX JC[7<2\/$0?+=6T.<C'9M"O(O<,[I-A[H^WX< Z?=?_
MV0JSS"H<)V5'8+3^#QX=T!+6%B91U!80EHR1FX;R8@V0]1>5]XME4/^A+7\)
M>/\B*'_IU//_8>/< <AQU+BCIC6HG;QU4%4P@-60@;7RJ&$AZ7>/'$ E52B!
M2G,]A.+62O4P"L_&/^9C3)(;H[D0V?U<4CKDY-*8;OR\9Q UW,W<]3?E9CG0
M19"C/9A\\>DEGC@>5@Z9&8&:"X!?+1+GU^GX#_WYB\Y^LIW_#0KMSXVEZ<_*
MSDAZ/8Z"C[B<)F]2Z;_ 0$H^QB]? [[E9G>UV?FQ2034'O/6ZO[8E6KC4G]Y
MI-XG66RLOAT)3X,\R=BZ)U3CC4,:Y+LJ./;6ST=0)&.*-!"+8@CY!N:SJ(.'
M@_;V&YAG8N'(XWPCM*AUXZ8@&R6;W])NOP8TH<S?8KL&W)U)N :XUY\=Y7.'
M9>F(0_#'E#H)XA@G:9A?R:5AO#A"S8"ZA;!HWL#-/B=[7?!CNV(?1>=GL\+A
M;=_LLZ@F2R3NG7WI)M1J@,-JQ&:K^>4?&IO3*.W"O?+ <;5B4J55%52HM'D1
M7D-5NG\#HC0('/UQNWS-7SGN'0HQR#^VC^'<=!P>T8?&L'O'[^(H0.Q[2>4&
M]4SMNXF8:.PJ6V2#VT<2L_;R^W_K8:*$PDT8N7(U=&S())1Y#: -M_;QO=<.
MY^VOS%-W_9<")?^ECQ#K8[G5(T4<4^1DVUEFC)738(X:![-#2$7.X39#LV09
M-Q*:KE%(R&SP4<]2Z!KP$B3R]RC"[8_R?NSOM?,K,B)A./E-NS&O?OZ[<]/]
M7VW5'QVKI_#M7P. %>K*['F^=HB8KD&PYK%ZTL7^I>E55\F-L^OFZY:#@^HR
MF%?IUL(E!CL"UAKR&#'?X[QA%&YN1G)'6@]/0*+&#G"#][*H7'!>'L(/SAGZ
MKYS=2SV,M*\!_2QCH9;5Z"-94W,%[P12-S3?;)S((BJ2 ,XA,;38,4<7YM)J
MU#[J&+FL "* BZ;F9:3)-4"P'BA2#+L&K$9O2I:#O3=4=VS*HI2T[WVXJ];+
M*/^8_DE"5;@'2Q?,G@^>]Z?!,J8.FN=9L$O;5-. Q/<M9PM7^?KS02/V8 [-
MKY=I^K<[0W>('T6>42"F?HIMY8E\7SX;W![7OU3PZ+$E/-X%@C)J2]F:,0WN
M_9AMKAB&&AJ[,U.OJ2F%YYZ&=?:)!CVE\([X/F[T!\0^1\\<^8"^&V,SQ]/Y
M.RG2*>\L@]M>-G9<OH W_QGO_!$YJ=SHZ"/EHO>K)E/LS#*7.,JJ2&WD!.@)
M(J%&8Y=^.N0)1FHUY=\P_QE3J&J+4B7)+C*UJN!/5Z+M(N&N2M> T._U,U>1
MZQY?-3P.NH^RXUX.@P.Y<@F%I/-\&=@<BX(MJMX2? Y;P=?,\F@2R;C!%>\1
M2;D;NNYQL$JY#'1S$ KQV I(Z@EE2ZT5N,*]9+EZMWAQ4U%\\+B)"TDW 9%!
MN)JB\3),]7O8LBURLE>0HQM#L##\C0/Q4T45!K/#;Z>2A_7?#T+WTWX*GVVY
MXIQ39QW0="TB?!ECX.H>;MP#6PJV^'HX^JI_A"$Y;C A4LP@4AI*G20^M&-9
M-RKD4Q.Q1+X5'\YO,KZ7UWY;JH^=K=7%XX+F3/?B>_MWY9L@<A5]#1"VN5)S
MLR7W6N9Z?:#KO^Q0-O 5V0Z]M17 A<R+WU,IU%2Y2;.(J(+>,PY? ^8IAVZ,
MV"?2%?H3\V;1%N57 IX5R;"O:V>626RQ0VUWC6A(!YW;DP^S#7=G_)\'T\:"
M\P3P>EKY:(^XMG1_(OX'B<K9DLCG@JVJ\7J1%6<C1"FAP[H5%$\<PSK;&Z"&
M6)_]34#U1CT/+\.4+].=@PG^<%WY:.+XT;&XXHKDE_&_*@Z1ORJ.FRCP#^J\
MJ+)/VJ_>E =)?%A%';\(Z*I[HA;*(*F!PY* 4;.=>5/+:A)O^/SR1I;___GS
MA_+ZZ_\!4$L#!!0    (  @Z5U9**KW)E;X  %+/   3    :6UG,C4T,3DS
M-#8S7S4Y+FIP9]R[951<3;<NV@D$@@=W)X&@P9U& @0(3FB<$-P=&@L)!'<(
MD*!!&R>XN[O3N#0.01IMH('+^WY[?_L[X^Y[SM[[WSW5XUFC1M=<J]:LFK/F
M?-9:]3#WL 9XH2BG( =X\A0 >/+X SPL F0 S]'0T-&>/4='1\? >(Z)382#
MC86%34Y B$=$34%+0TU!147'Q,E,Q\#.2$7%(OB:_0TW'Q\?+;.PN!"/&"<O
M'\]?%WF"@8&!C85-AH-#QD-/1<_SWRX/[0#\YT_L4051GC  GN(_0<%_\M -
MH'V\SV=/_BZ ?RM/GJ*@/D-#?XZ!B?4H4/,"\/0)"LI35)1GSU!1'UO]'ML!
MJ/C/".BYI= (U4W0&9R)>+[&93UGE*[H(-:8.&'B_>02@(%)0DI&3O'R%3/+
M:U8^?@%!(6$1F;>R<O+O%!0UM3YH@W1T]4S-S"TLK:QM7-W</3S!7MZ!WX*"
M0T+#PN,3OB<F)?_XF9*=DYN7#RDH+*JLJJZIK:MO:.SLZN[I[>L?&)R<FIZ9
MA<[-+ZS#-C:WMG=V]_;AIV?G%Y=7B.N;O_1Z D!Y\N_E/]4+_U&OIZBH**CH
M?^GUY*GG7P+XJ,_HN=$(I-3139P)&7B^/B>2CLNJZ,!@Y-4X(?[D,H%)PL2W
M_A+^EVI_:_9?4RS@?Z39/Q7[#[T6 -@H3QXG#P4?  1<W;!D?\%D*;ESU8Z0
M&C_FU]WP8J@)[>__L21Y/@*P4M?)((++AD2<"UTH [U[A]4W$BAS3.8V3H R
M6F+Z&X=<G:2-?NE+KJJNWG/OUGL_N*!M#U"9W0=GLK4$#9>Z%F6'O\9FR6Y8
M10=7<I'NU0E6Z(E7=KA=]AAV$6BA9$A4'TZ#0!43ZK)$P43J!G=]X3EU\-+R
MX.A,\*2!I 6I8F:C@66 /VYKKJ8BS*%/2I98VL^B<U6W9I(IDQ2JWAPG6YU6
M="&\^QJ[3=;U!%PDC+1U7<^"K+#'2KX2E 6ZS?<![L7]I,H"4K4)/#'91(UF
MZ<?YV$;T8(+Q;#K(WG?P^A@[*#YZKS)[!_',44CI_-Q05%V\O@4[30C=^8U%
M2H0/Q@#'V+OLABC+/@J'&.=??95*!1<-;STFVZ74XW]Q#^R=12=RA?N:0Q!:
M>K)BFLM&*PI;B_.+@,EW?D[O-B [2HDA/"*LK(1.%;J4J7&;K/+;[\@"?S])
MB!=GBVY")%J:K*4Z$BWM)=O:N@,3L24+7=H$J$X!Z-8;>]+*?P29ZD2]V0*J
M$.6Y+1<M^<5Y^PNB!@)SN6UU\Y2TRO,/@ .M>V9$@O5Z^8O\4+<HN?O#=4*6
M:LEK=/&JC-Y,1E(Q>Y_T&N*>W4S":F5CK1BE^H!;Q;;D.RV1;Q+&/_R>C!F7
M\1H:98%3/%+=?1BJ7C9S\;)>T$LQX0TF*#OP,UW(IK"EGWA&5A]3[&D86Q\P
M6;P6:S!)IAR_H,98BSE00TSU>5M^/>3(;U/(CU\?[,,66I+<7XIKWSC+25SI
MW-9NDRG(_DD48*6A]APWZXO$^8WL,^+T<IN!+"O!A9(XOD)K+$53S8!VCQ'F
MD LWZ#D6AYZ0'E%CZ#M&T_B&PQ2/25AC2Q0KJVA84$MU%7Z]7-")Z)I%O8X$
MRZ+RNJ&HH2'%]>3ER4*H25?E"^\$9!"&X&_AEPVK_S D6<#_&T;NS#U#W(6K
M\QWKRP['?WCY>)7L 7%: 7)@,4OT4GZ22\)X_8P(65.P;8\(*()ORB_O_6CX
M(E,4U+9W)1+87YJBK$/86L"2'8Y&!!(M 5=RT/:(< 9?QC"E9#E5A@#DZZ8]
M(0C''FY$]([65[[;(4W($AF6P:L)9B/YK:DE[ZFJFI[A<M//X6Q/Q#0I$0O&
M./Z6RV$$2ZJ7V9F-XD)C&U HP[<RG+G5OQVFS*=7@C6BD^*]X.F"^."02](Z
M?D"L#F'&Y\0&5U><])(Z$ ^[VMM@!>KHIP7D3%._RVI?9C<? 2,IQ.)+,N<I
MQJ<,+U]E74I_,DWSWKFY!66CQ.*5XG(X8"K\>1P,^B B;?3P9DW:H-*2[035
MIF9202R OMD22'P,X9F?V+U<8W%'I/[.1)9X&#S4>^,?\+$R4RT IG.4QQWX
M'-T!34&8(45Y]]N"XI^]W8*U#+9B<!E=G%FP%FXTA/Y[9 #;SPKX97(! K;3
M.5LQ\G*DDE=!J"\YL5?+-2UR Z)FI?#;GO$?RT*9JQ'<3H\TU(V#_I#&<B;/
M:E+6"17,-D!]?[5G2"V*N1=$/(IHZXD#*T[VPO3E&T@]K6V>"AGF?17>V3,D
M)MDG!?U6EW5I-(ZVKVDC&,O=:[2_Z&FICB*Z^2)))Z^F8+##G ^D5?F7#A_'
MR#C"P[IH=:YC_=#F;R-0L/V'$8B?>$\IM'S;3-K)5C<HK>O&(7D =()6&"JM
M+0(&%#)PFLRE@=\"5^$]!C5PAU3!P!RXV)_96AR\--\E!Q2A/FH%,8"XU9;)
M<-0^&VGG/;TQD=5!D:R)J[4C&RWS(0 MSK\9P RX+$CH45.&48,4@Q<42)5J
M=<LL4>VQNQC>B*:935A0]:]F-X]"-^327:T<_=>IH;*A3/R3^B%1SE F*F?]
MF[%N<4K%DZ"VL*PSQQ+F.%-5.IQYX7U*LM[G#)E,WR"DTP=6Y2(1&VC)Y'+3
MY^*NRG6? /7UU7=S8X7HP%C^U07#Q54]67=;'F5'GI#HM\+:Z%EH"1'Z ?$^
MA(]>$X[Y=QCX=Q1=0:U-($LK[TH&4)79GNU+!X"1!4][B$?!@KTICE'5 XY\
M%TF,V!D&OX>B!KT#.\1H=VV %."#]R?BB<U7>^R3!L(ZZR&4H=2J3$Y"R!X)
MD _A<.GG$%59'G+4<7G6 )2"CWCUD$D6EB**[8+&5T%^16+*K O24V33:[_5
MTRQR3HXJ,^A/[I)*J3@P#>6WG\]ME@L=(#1KDXEG_EA/O$]1?87QDI&>J%;<
MB0VO8X4EHI>&)@84/',8MVEVNAR(7[U1D+U@P/F7OZW5&(<+-#J&<;D)57,8
MW</&:&QUNYD +W"=TS;B]#-(X/D)L-V=6Q1EZIZ&[LLZC$J=L7JDJ*:SM8&B
M0A,U#I&ZAMJCD9'<BP?XQ!!V\RW&NU$=X\>. %=N<^J6[ZQSYU*57,NSJ\3$
M2\I#^2B5/W#DU^H'+3&D.PT-T$X%+FG_I'NJT$X4G-X9GI5S($!QGY(2G K,
MM/DS6&G/^%(!O;R^^!R@;G <X6MLO8ZE__KH<.>GP]&SQM"*V'?,S,P0XM*B
M??P]"MGM'![>/ENLX<'T=VH***OA'I\:.=5U)2B@O^# D$/W"*O<<,HO/1KO
M'<@^-6_LZ4UG!*K<!!&I2S[[S^!*B^^_F7ZP>K%[,36K&E8= FWF+;!6'ZP0
MGWY%SX@=-.:KJ1^NE^\E^(U3<_UP)<Q/+!B(APA4C<KW +*3LOX<&W\ &-MT
MPE$)#RZ=$?O7AA0/ )W@E<Y7#X DCZ&FS.Z8\8R+/YDGWW2,P21=72+MM^^U
M)^2"WPW(-* )<D'\VU,">UHQ*"X#\ZQ%?"=T92!+/:QHTEV?GCZ-]).UR2]W
M)55>Z./8X")>4=T8$!-*"89 K"^3#M@GK9.V=;<\.E#HJ(M0</V[/WV7 $+=
M5)^#HQ7NY]WL\L+X%A=O-0G[F9A\V[_&US.O- %?( 3N=[HKP,E=C=E["P4A
M_3^4:'\2P2^QQ;T_RTS&-5,6VAI13%>W$=M*WQTK5I)]Q"^M,$H5S7">C7>N
MI(PLZT6X=M'05R=UJ3?#_2X614*::I+XK3+9KD"W]>)]$)NS<K0]D9G5 %^I
M AUP_(%R].@13&>M3A*EOX@LV2$7_VOXN2%Z5ROW[_J*"'7X6\*]65.K:#8U
MIG3)=MP^R/H(5[ 8OO,OL+SNA%E+N#779OKL!^FG7J%$9I9IGZ)M#80=[;%E
MH0X7;2$BN*4%X HQB9?8G-MOC7G\<LO[?6B3F5%:S,#^/=!#O,CJ)C_O#:V:
MRJF,_=[[#VRLZ6FGDLRHT7XM!SJ^;Z8/V<7X9D5*?T[SJ;/&5$L:D:-4V!V.
M2I'?&W*#2N]I]DW5H,?'[@5'9351_*74R*@ 049R &TC (7:>H6A^ER8_*A9
M'Z^+4I72OU/7 \K]C0$ZI$[XZNZ'X[&@B[([&PQ'\0#6%G(8-%TQMV+U +".
MG]'?Y)2AVCA%%AWV?2FS0(!H WO.I=UEC:OM1,$)_BHM0H5K)\K=$KP3-5,^
M^#&J4[();U]LS;'AM.] ^-(2D'(Y+QWC.O<R&-L:X.+#-(QP"\@OF\Z3$I(H
MP"V;?-S7_HXQ1N:YS9E2SW>MS8@M:ZN4"R0.1\005<7A\M/X!P #/*K9<R=E
M90:) 5,E8/?V:"J?-]BS=GJUDB3%28:2WC!*.L50ADCMT,M[ $2PB\G_VO\]
M9[2XF&I!V+7]6C-#OFW87]%W$+;EP7O(WR+=!2NK,''U=W:&S.T6 [\?=ICC
M;U7L>R'W8[X=^JIO1-'>$UB+Z7KF#XB-7=KJ@V>RHH@K@C6O&M!+W2X_XV9P
MT:P@PH^.R&%-4[,CZ_B)3,B?XLZ!U?!CG1O_+\VJZXC\R7,\(EG;'(77<21*
MZDSC3UVD$SJ0UH9NU)F:KC AMA.H/O;B#[U8?;*!_NUF6%\W16_52>UBYPWH
M6XUHV*MJ??^:P:\?.X!@[H/#R1;+[D;VQJL@KFKW>@R.80E0VD%<AC"=W^M[
MLDE:R9/1S#P%UN'+WZ'#X6\HJ>$*"BR)+'5<<9N?^2<=D<*F)ZOO0P8;ICDX
M!;*;3&@,)V)S'P">S.3GI5Q/WSNVLMB<@FL%8GKPRSCH[;S4>Z)]R[R$Q/TP
M)&KFP5T=9XA4W9/#<Y!S>^,'Z *U(08/3K^3N,0><J^5_T0>R52ELZ_GMWKY
MN<:$SHJS<X<M[=!DR?_B3EG";.:G6)1H-E=8<H)$B/WZ[:N>HP:G6NN8]<@S
M1K^G)Y]K1I$V52$J"$O(_.*K.8ZC]7!^ZD13)V"BN\ *[0PGT@NWJ3C5%2<H
M-&#F$S,.[P.@- ']*&8=1?SUZHMF1F"4F#C)3T=/ZJJ\P6&CM^S/,;NH_%L4
M.5Z%,"U8XL&*2SUA1JGF63H(D/KO+TM,\2O[&+_E (R,T'+H0OD8;<*M])[Z
M$4>5PF+]A9 NVPR^1W:A<'N/$\W+$X&& C",EM J9:;E&UP?RYV@8]O?ASE#
MA!]3R3Y S=9PT)CJ8\T#X!N#:-]"<M*5\UV*5-=3UUB\<<L3XME]#67!KJ$!
M!]Z=UN^'K_R;/PG?V::&K(_F%=O,0N]YX%@V>S:WZU71^$3T+3JX;<D;T6SU
M,R6+ZA/E)>J=_"/-L<&,]$JOR>^L!4IB)^UKP?Z!9 @*/!SP#X)&B2K\ZNFV
M)JJOBV8A)[0YWC-XE,?PSS'EX$G[59, \!^WO+%G*,ACQ - <\^H+0_!, L,
M^0U6!9DW!3&R''TI4SEMCY'F ;)&=-^CAGPX(0#K*\:Q_PKMVZH*:'\FO-/
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MRSB.D T.6951I'_67V1^C[[&]+K*/Z#A@:.56ZZ)MM"<Z"SM'[)KOB8/;?V
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M@3"3DK#R'>:"%=R.<ZR8T4*%M1@"8* =DMFU4,K+_+*:T. TNC;<TZY/6!B
MY\ V7L;QMM&M-LX^2H^1 -ZY^5%K-S$"Y/#G9#7D,_NTG=B35W$0,$AC>CMN
M"XM'_C:RCHSC<$G35W6]> P3B57S>_HYJ6HA^R1#[5N?0-^&FR>(!*/"-5K,
MD;5C;,X$\4F#QN%3K] \.4JJCU.?Z1 J_N0(>[=ZSIQ:9Z<$K^B\8  CE9_-
M-50P+K/*-^78]-/VPNQ5EXO^*H-X25*3.=Z4PXKM-P2Y>'?KLQ1A\I3GCF9*
M+JM+G0DQW9FCN0TG@E'\$<9_#HU[(^[2ABIU#MEGR*&W#62PIG1"N8J3^SC'
MO+T)+^UQ3B)+IHS<A*6$@0+[EY\F'4 5CTFL%L7_\NS- AQQ+QNE?]^\_0 8
MQ[&>,529*#]/'>)WBG)&Z2:+_*+[;NQ V8&Y8MT(TW0MPA@'G*=3EE!<K&OC
M=5M1'U?[SD_H+S:G2D4*_YQ8CABT7_U8DR**\UI5.JOW&DB[[\<&=?-'690Z
MN:3%V/^3'!MD[BD)$G;Y!YF+Z6Y%"=$Z>8H _47F(O]!YNS2;A(.]FV-W$=<
M:?^F<[W0"S]C#;A%R-HAL[J?@'!)T,S,M")VJJ30AS'5)NCJ8I)UXW;Y.A?5
M$L)6:SI_YH]>1WGI3AJ>L$" 8KS(W>P=FV.W$4;#M.-YB^6[Z:#@&HCL9NX(
M#6+KT0!;TS+'3BV"UGP*:@Y:_+M3PFWTTKO1YM^J7SO+XN\#KG8R70\TP7/%
MBCN8A-U&K C[$G#E57>R6LGXJ*9JV".=2Z8K1(>B6A9 %&#%AZ3KJP'5Z1)>
MI6;3L6$.O[X-,3D7[GRZ,LV<K+-O)3^XU!._"K'W5:NP(KP.8KA]PXNSVJGS
MZ)?>&^7BO'H@6EP:?_1=;QL;BT7M"95;_=T$.@&OP8R^F*&3HNTPL<HW2,'2
M_3AP8G5].7^+JGQ#56**O<9(CH_7!X7;3>P -"#%+(+Y <"TLGK?^O)Q,HM-
M%29\];A>IAK"B5NZ7Y&$_47@Z)G\MIG3;C%3VS^3IG;2D,:\R]CB-'SI>8:O
M&/-C)ZLP09N5V_/]6:BO%%=(*S^B"%SM<Z><%\YW^B=G9>BTU\7OF=%4]:$?
MIYCU1L00\T3&CFH<A_W09[ABP?6C\Z,;;4)-<Q 2?KPPDAH8J"D*-OU)2T?Z
MQ4!4<\(#X,F=K8_!U*KV.#^.B#")8&,=^,.<V6MS1J;/?$M0234_59Z3PP=
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M\,YZU1*83782I''*KTS=/*0_-_7E>FQ9O/&S<9"MM0AM6(92%4S<F[+^59W
M@;VM Z-41IG"CN>>C.VO23\5]/6+_#H(DB55;Y(?:R@U#O7 $4*L'48[?#O(
M'3^'NM' #SG9T(W1F/Y% ![2K)_VS7;D*T8$;,%'AZ,!8B?>WMJ9P6+$L$R<
M7:B>;%N8?=(X8X2 _ILQRBJ')1>O(^XQ8YN*? 0;J![NEQF*E"_4-3"8ZQUX
MJKMX[1.&ZN"BHHJ>AP-QEN/0Z49L&UAYDT?)"$U#;1*^J,SVJ,+\0'V5"!!(
M:0S'>GRA)BU;E^36^>V<B^21Y*$A>DPS+3#2KGJ7KBEZ;L&PM(,SJ [PO(]6
M;P5:O3.#!!;L5?17M"Q7QQ;_[M<8E'N'M'[-1E]?NRCF  5-\V4&93P3\=N<
M[?53'4P>LG.48=RDM3GT!17OD_@3-M.;.'JQ:R<;>69BUI*\Q^41G=;TY4WR
M#_&V#(G.K5C=J_++7CED%)4Y^L0C_F;U!Z1GS?B%(0(B"[UH>R'E*9$V]N-3
M[>GX:[)KYZ4,!8GIQ0CHM(("FS=5_D_!<#$I$]A!!:SI0&N2<\<6G(,2W_"1
MO/&P\VN,JYK1P6<V&D -_ & 9'+EZ$B7O_1U_NI8]7D8?RG-+-/[F(\6Q<#J
MQC*<@^;R-:5NDC5^P N&%3+7@\@9I9@004TD6TC'AMHW5<I@01K=!7^P,<0(
M 1FAC(C7QB-?H4\:]%FEDOAJSE'O;&N7,^HI=M0_1'P8Z5'V!KQAD+DN4.>2
M4EUI9+T0KM_U.=!TB-PD0'Y*W,>];/:JO7'8B-/XA55C:9IF2XK>(.=A9)/
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M$.ML'$RR\]ND.A+0:>.2P<>UWWU2'8>&;6&6,QS-O#[.^5CJ/D2/,7$2RPZ
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MC^H6:<I"#AWV(7)A:1=@%K+X)YPVNG1J71\1WU\IOOE4U!SH9>Y;)E'D28O
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M'O%Y1N0:PB#6NZH(5_V*5"X=R]X-*]E+J5ZUDJQC(^RB'Z [.HSW![".7(;
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M%-V_?0"<7:Y>=3X @FC^I0[0R2Z^)GP C"WZKV+=$WG]1_7)_^T=:;EBA;X
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M_[V@,*^J(6"%,LQ^*QJCXTW_KG0_N@:D;5UM_*\+TOU;QH"RB_<U*N;9R@,
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M@TZ2>5:.GMOYZ.B&\J]M$4&VO&,BFT6XK\IZP=X_=4+7#,=<]GI*6^<K_%'
M=-I')G>=GQ:'^[CI#D8MWYQN5YI9*W$'KIO[ZTA0#9'^^AHMKF$2>LK[^==V
M<Q'MMF%_)*'<Z4PM3GWRL9I5 5:&Q(,,D+[RPGW7,>>9YZRI!PP Q]6G[##
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M&TR-@9>!Y.A9V<?3*XYJ:R"(T/P*!LC5PNQX>QMZ1M1W$O+(N5$N[WGT4]$
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M[<(A;@_=BA+\FO'[=8'"0*YNYCM,=QIHUS@<^S4R-):]7">$!/,_AP$,=V&
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M#?_34X7^UK%+W_.W5MZ_,L(!;1.FC:)"CEYO"@5!HMUS& !_7?/[?;7T)@S
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MKTG:/5V4]+WB&YVT$FM"OH_23A:4APO]=.QGD6-ACJ!IP9#%<K.$&2<6_F<
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M=__%$EUWSTC;E2A+&$&+@D85A3=\$H#K,6D!QWX9[;DYO.L-/DX#?]?6FC-
M"\+CT@W@W",C $.#R?KN[[BF&#J2H6E=N?D]O*RPC[6*)\P2&/>:WB=^_4"_
M0_<;RC#"N*G?EG=&#OC5>TE41$S0Z,Z4)5_J3AAI"=&.NI&;L(F!R=AM!R&
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MQJ1N5(4!YFL7,?ZS'R%^_O5_ 5!+ P04    "  (.E=6,"X=H&ET  ! @0
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M=]@')EG;MJ-8LV^?O S6_<W:@L.V8(Z4&3H4$P^Z<=T@6/[L1H:FRSG(+,2
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M[MKGQ:AAWS$4E)EJFY&J;V+Z35WA>],U!",D ME)MJN-FI/6SAHD8"3 X/+
MQ"1- 6<!DITOAVI*M@V+LB"2WL\E''GDHZ3R/?YPNA&VY;>VR!E[GYUTI41
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M2W9?R&[P:JETS:-?$<R%E?F@P)3-^$'"-+C+C<R^.56M6E!73RQS24-GP*J
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MV*P&BV5__##H&$,L7]-=FHY(ZI/YR7R'TUG2_:8'HTX#98<<(GI;:B# [I]
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MSD^W99\DJTYS]VI:"PN4+/1'X3K4!D>"5S]$8A4\LIA;V;97.^=8U1LM1=[
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M>2+:REQX0U^V9WM#_8>NI;Z^J:XA*C=<'<765MQAH7Y-=S:@A3K[1MXZ039
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MMVX97&71=IA419_ZI#-(N/[]C-[;3+:Y %W&J&P7)70=SKH^BF034D'+ZB%
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MEP8Z]/HRK:+H-)I#GO'COS''3^47=ZQRA/H=L1<[EP-D =H=@)M:YIEA*X2
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MU!_RWG9$W20W/3FV'&5.9A2:Q<1I/FW,OOU$Z8B=<B#EC*U%=)".,(?G-%<
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MW?*)$'IT#C2]L,1N1784MK"+ CSOGEF4$#,O]KEI>:1=G/=UX4(^'*P?WE#
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MVD8:7>PX=>5/,#ZE:ISHOP#!'&7),[H+]NM@(@CW?G\G_TP3555Y<+WGSXW
MQ HNQHQ)K8^?NI*NH7$>_X2!IH*-0RC0E0QAX]0?0X!!'D]U(2JHI,I(%%N\
M*FH5===T;PD1!F/K^#MTM$B;5VK.4C-CX\5*NX3_Z&2"L*)\NL$2QW=-#W%^
M86']?^)BO)B"BAB.+=X^""_2J5] 2R8KG$\++"A$PEPWE%O5RF\!A'^,#'9J
M7^61HRS!;-P8[26+*K]L$BFTW X7PQ@S?XBV,B,D?VYKAF32]4T(O^0YKWE_
M%\OOFY[B6QTQQH"=&XJHAL0/Z5RP1 8(E2-0$?H=*=IMQMRS9Q8C]$P>80?B
MN1)N9GY#7R0UMGFP$(>9S0VV7.L=V^_K&9GTE2J5-L2SL_=)&G:L,-=0A6"L
MT[/"KT#8AZV';LV+EYNVAQJJ3EFO8Q9*EG>:8@*M+%!C%:B@5;.V'W69@\)Y
M([8Y!?I;$FR,UU<3&B0=$Q&#N )]5956'85.@V\'/5KCEZ@>1?SOC4Q<M["_
M![&L0ZK7Y<&EC:3; +P+69WLJR=*YHO \2YBK@=#[D)2I"F5QPN\RT]]8H<;
MZ?P/F*.WOT5E(J3)H_<'.QE]%H2T$2Z%;=[KA/M;68^NMW=!I5F%SM(,67U_
M 01FJBVM>=KA]^"6#8LDG^;3SU<2'I^E.*!S#Z]K#W*%NQ8$H0Z+4CPZK29G
MX-U0CT0L)KG3^=]Y:H)6:" _FMK(IY[JU=7U(Y^0/:PTFFV^EIQJ_'+1TE]=
M;UB;2MJ^R^"Z"JK'6:[8(/'@F=V1CU6:\_9,#@'NL@PP1NN]#K\67)$>\86?
M,2?MRMM@^4'@"8-=B 3KJQ<L#!XI(\>S;7=1C1OAW^;4M0NCV;'_PPAO0;6S
M@NKL;CM?QBMK#&J[E.@NC636O;BB5)*9< IC.T(='=6>\C;I,+D!53&.(HX^
MQ-+-;HRFS64.G2W.+UJ!H7W3:Y*.1M+$2.BV2A$-R0L,=;581TJ@OD^@\9%H
M*PS#CEC'6%H@2R^BU^>X"#'F4:Y!E_)J*+;"1<3C $LFS#EU)<O;2/)R7RE]
MZ!.JMO_'<X>P15R*(9T;CY;ZOX#V%;JHFOKCH2"KWBND/;0EUS ,*P%E*-]#
MY2WQ8C(H%2_UHJPOS=0 VG[SN_V0*,K"I5A[*N'[)B\:BY"6W)R7#&9PKV+1
MZH'>D:ELJLM'!KP6SP LAC$OANGKO4:P &-QI\->&$\TMPTH2NB??ZHY[?F,
M.IBJ7-7M,IX\W,HRO+4V/.\B><*C:OR6TJ9>?&$*,:_T9*L"0"^8?/ZXYIB9
MUR?.@$\]5'F P+B-N&J">;:'[Q-"QR/.3F/YT&@\!HPO/AP]T2UZ@2GWY=LA
M+DVJ9[./K_Z\%>FA8-R7]$3K8&F@7#<?O.!%VFW0S1O)!_(CR*^IDFD/394R
M8(%K.!BT#XO9/PF:V!YP"T!IPMJ!];<ZZFS@7Q^(DTU4<%>9E/!%H0D1XN"S
M]'Q+N4 P4WMM^9I:Y4YR]0HFLD9ZJ,]T/AB_7>3#W<=C+]=M]-;,MR]TWS D
M#ZVBZ\UT*%:J#>Z>1[;;%J%"IA3A&NQ'^T:&]\1U'(5F</?['C'[5^Y\(5HE
M3JA@R\4B)/@\7&BO(7=/PJ =UMJL0)Z$A5!@8T&GU"("^BP%$TK2!6)4)YLB
MJ&H;U8IV$SRMN8-*JS8.3=L"M#OGJT]7&, 8^2&[$<,L&VJA=Y2F@H85B:#,
MGW'M4J7JV]A_ 2<VCFBAW#D$WL&</ZA55#!:I]X;!>-421*.9ZR^#:>X8A#:
M3N^D[E@(H/ "L7QM4D]X3>[A$1S,2M\BQLQO?#;)2_QLL2.SAU)*?(%&#=[[
MY<O))S95#G2JU@_1K.6"_^,Q]M*1MPJO51DPWF%D),AB4 &.V,-SJHV/-AR7
M]S9L1:WU0V3$N_2P!MWV0N'LVM_H.%._ZRB2O(NLKN&O?GG84U(K@U(9:*2Q
M8LQ#9:UY26_#8_X""!&'3XRS5V)O4VN$2)(*O="<3RC$*MT:ZMB-C(19JV/R
M"%9-485#LI 2$;+$]N$=*EG-_-L):Y[^++/OS($"[Q::R&"IVZWJ3G*7WLEB
MC)LIL9_YW0[54T.3E<&*[K?24K-O+KY:,D=,MM0G*R8XL^)5F[F\9 G!-YU&
MDD5"VT7*%/R]B.N5.9'=Z)!A[D_X4N4-=/S"K#6.>LAL0[]QA$%\:KDSS'NX
MUKW9J5B>W%Z!E"%9#&!X'8?XN=SG^6/B9:J"KT>!LI4#9D'AQ'-@VG^V//6O
MX]];$<73SQ3?UL/#E7#*"C#I9_\Y(K&\N_FI\:.E$YZH[.I*I<Y ._I" V!<
MV+[S7EH0V5%Y3 A2WSH5_MA4TFXX)EB3DS'F.67^:AW6M2C)L36A=C]@U RK
M,^%&U7#ML%[6B/-?X6@"!O2BV(WFC\IK)>KJD3^C/^XLE"#1_=#URI,W1C<6
M[-G+DCJR6FFZ'@V"^W+?+IRVJ[.$!6C\DOJ')>PC+&5+=(\D?U_>V!R>!+_^
M1AR_&'WYB(ZJ':!,CV0,'4A>+HDOX6KD?8P7(W/ZY2@JA30\>3"!BD0\6-B6
M2Z*93!<&6)C5$,EJUTO/32.'#[42U1P+9RR!6Z<L@_"A",]'&TG/0Z9Y;-X0
M#7%A695)K$D-%Y1>_^UM9L=MA!#J381)G6)B._H?'T+:^/Q+"3O_63<,B1PO
M8AU=X_]39/C?A;X/@;(7^!^F,/0VU>;$68U-,+.!TMM'Z3_*-0JCH_4+U-@)
M#!7U*]B3][+:_GE-C?27KN%/G!=/427.B_#<6B!(;,&%6IEC\Y31^BF\%I)E
M-)<0)TFVK=@1UOAQK=L5+>C4)!V-:]K]Y0.N3UP!$&\@2ZW.@84QRY,Q;[04
M+#U2_32XZ+VW] 3YGN[X^#O6H)5C;4(1,92G#@4BI@8U,*Y66\X*HP>W*(WC
M#\9L17&GDW[2"&C_0PTM0XL.X.V4:54@H*!?SGBX6/&K\9(6=OR-PU6A0QT3
M4[E=7\,?0[]"&%;(J9X=)[Q?DMA*P.PK!LZM'NF8; POS5DH[=&OHF5_%L'#
MI1Y=Q#/,F1+/TFB7P1!2GVI0JUMS=M2))VJQ#YW0RPY\)J.&0$5MY^ ;7>QE
MN98>:5NJ+=W,IGZ!G5BL6]'YU(@-"1W9ZU?H/M/EE:/^4#E0 IQ^AU2P 5&[
M]&00D3R+%$./=?=0EH;9C)0D]:#2:$CQ"9Q-<].W45=<WJQ+IVYM%?'@JF\_
MJ0+/>/EE<KR"\!9<F[I>'L+32@ A9]M<L_2ZSWY]EI7B!\C$ <T/,P-/*K@6
MXAHO6=:!'PPYKA@-\GEYV42\/GS[>$:LHZ@J]U\5^I@@=K_"<Y.DBOG_N$OS
M:BF$9M/9F@KJZX=4D&%]'/V:S5@,4^()]XR)H]-PXK;'.[EOKABV%'^%*(S6
MKU#Z1B)Z$J%;7*DQ:?:C&I_J\/=1Y\O%C]#43%^PN5+5PG><+Z@=DBY%YYR<
M<02\;CQ >J'Z.ACMD,?I^#M748CQD/$Z,1NZ]^$? _RHFWWCBQ=-]K;L8UXN
M49R)@]TMKWHBZ=U%T>^WR^:E*5%!]SII3X2^96OC'AS&YHUO%8YDMYL%Z7"!
MEE1-$,%5<"YPG;-FX->WNP9:#8-9GW<K3:,#%XM01RC*>_!NT""9XHT5/.@0
M+57Z*RV?>5#!6U >I2?DA%I%$&1B>?-.[*6YC7:>9;;_8LEM'QV>Q<:8UZL-
MX#G?>)7MI^FB/"_J((.. HB'VL5"4N,LE C=MG6U:CC0)('QT0ENFM^8&_O;
M"M,8DGRNA[29\6JSD":L'J>Q;_C]'48=FK1*;:3@L^74+K2)_[K!8B(PV!\D
MN.3C82T(_;'SI1OM1TV1TL5C>,CMN5T]6J#[DIYKX(KW<8*<D1#52R$-X;W>
M7WPA>\S1&F68(!QJVGFQ(R9L!K)NZ@#I:8&_ &F^X(.WK1/\^DO2PE;.PCCU
M)H<(IX9,NUU3W?OF_8(AF53SA"V9B*(H&S+QUB]*,V2K:\Q2O!)&)L4'=]X1
MUFGB]L6&S2,S#.0CURP5TGOAB\WH6?6!V/,ZBG+Y_TI@^><ZR%S)M]./!64O
MWSO[-XL6KZ<.IJY''=2 >GTR!Y8078V+6EPJR[/,<[F;GSA*JG]<I_HY%VI8
MM98X:WY;H^IHPR#6,:.@=LG;:0C<?'2U%*:2:6#*E6$9G\K8C=T7W1&27QH*
M8DY12C!)Z7&Y\TR,ZENU*NI*4_)H .1*&$GD!X^\0=8^!EK^!;PQ$O1!7G7A
M-:(\VZ083B:L8ZBBLB?U7+5?KK;1EE% ?742!*8/KZ?HS(PAE#\'*+WJ.D*V
M9FSCLL9D^ ;QS0F4V*M0?0/-?%1Q"MWI=(XZZ2#UY3TOFLF>D1IUJRRU]$WO
MS$SQR;3$#05"U;^ 18XHO,WE';&1G7C02OH9?@ESLAEQ5LK:U/3U&#XAD/?(
M].,&N+T#BYQ=V8"ACJ3(TO?BU\L'C1TGKL^D6!6A!%9PZM!V_-D.O$*U\?*V
MJK#_.0O=_PP%U4?_3[Z>,<D;D]VLJ,3MKA-_TJ5H!_$W?5K[ 430L<W<\$[*
M[4@&>=7JJ54[]VCB*XE_V]74)%K'(#8DB[V6B*/JR>PL @[TDX[/9#N"/#$O
M)H-?+7 <.*RGCF9.]<O@.!E-V/M6H'EV!;$R $UD-A!X[+NUL8)4IR_V39OF
M;3,'5[#'#["<NBG$+//O/Y0'2$Y77[EB J?0G5Q<-M5CLN)K.5IP5%W*:C!8
MXDXX3R4QMX%@J$VXZLDOH*G@*[LW*N@[4(,B_]>^IK\,?Q(_T'F\9;DI^*H:
MER!)I 3-NXG>AH-.=8?>S^5I=\"CJ00M)@1$QD+GCC,OVZPH#I9^XIY(\KDZ
M>E0XSQU&N=)\;[*FZ+=V6>O&09O<]#?LA&W1.#T(37O>>\;_UIZU#]E6-PI.
MWK$62V )$7MPTQ@@*CU=._ ,CI2F6'*='1S3^0M037DT]WB'I)!97WL1_.KP
M.&8FP*T89#K0G%4!3*<T;,S@-?O9$YKML=L5))U1,AM@(^F=RT;Y,QE&27Q)
M>CDX?7&Z3M%SIDS"S<3FX^AH D_K*'6Z31.&W:JCPV;)H;=HX3;Q M->-*"D
MZ0=??Y8O0G%&IK!H7"UUW+W>_'(Q[9E/6I]&.<@&[@*>F&F?UR]%JL?LL+5<
MOEB/_X##=R7Z4%%^7)Y]-7T=Q6A<Z$N]I:/^^H0#SY7\(!%B*D.DZMFG'@!.
M'_N8W3QSN2,%PNPS?3QHFF_GV,:D6_4+; -_N^#>ZEEEO\O[-_\8-SCL(4LQ
M?9;GD4X^'!Z:FZY<L!R@>E%:X$-3Z1ST_I*F',;;+I%09XWAY;6;*XITC9!4
MWV)KM& W6+A6SZ\ 8[0KKE@Q[$U*F_LM%0,_38&+5^3<[_?CT56IQ,8P 'F3
MWU(3=SC:2 \*HY/_U3TD\*@T+H36TT.\'K'.Z8%-8F5)3*^\\Q,! E>5=\$1
MDOXVA:L'%\<(J8Y&@D@BIU.:$@,TBE\[HK6R#OH6XSW*%:(%)A8^'"]H\_>J
M,E*&X_'U4>YT6R?2Y+,U"[1BBQYN[EB_J87W6&A+2]-546'^="M[2-(4Q]>?
M9E=6ZA+Q4&N?\#N\KW3&^Y(H:*DO=B/"KK[.5:-]P[%4901/<>16#[4*U2J2
M<*T55_\O;_VW\C;>"2&F8T%NDQHN1WS$ZKRIZ K&K7[+ 4EF'5*4^Z([H\B8
M;*@ AGF3&.G-;2XTMD&E#UYCC&L0?Z:FYNVITM<CW(-S%VQW89@P1P1OK4(=
M%E=_-7;\L&<J>B(8]2/@E9D$J>NF].>^O1")U/VM:,;<T@0Y@:)G[7^LH),6
M1<^VQA]LBV9OA2_'6Z:+4@30N%4%B$U#!X^Y_-\WAITR2PH*L.-_NZ>V3KBH
MZK-"&CTP>(L<;M7?#M\+8;,D,G[%PW[G1Z E^<CQHS#>96?WQ'=^I!JRVI])
MT[]!USK+Z9F5UR2Y5/(NF9?Z;;F4P/R\--]%:5DY9!'_A^Q$R3'A %[E3B&G
M+B;Z/_5]%Y>?!;''JHT[<Y/DU, &\0+/ \B5)K453&4D_!> ^"C.DK@:'KQA
MCM\+"S HM=R =/62"2].,764S$])E&\+L7W6VK$()/;@NV1(1BZ%.2Q5VW;.
M_B*]._WLV/C=K8UA+ZYKQ6;HC]"(LR75HCT*"U@X5*:)R/3UAWZF&F0>>12K
M-2T,$_ZZF8%#BI2/UB560CQ#Y.O/_PN$6\\NZ4U4<5)(X?/QH?SG.3IK<C0+
MC8EJ M31!A%UQ>=@$<JF:W8@?"(>NA<8#]X3",=08?A==9U4B/);>B<@B,_0
MWF&"[+[:;CKFE*@\+#-AXF%0&\W,NC'S#>,'ZKZT2U/XJL@YM(PS=R2V91;C
M:QW<]I98](J!I"YICY9ZN@B5CK[!A&2$"9A,"$##<QOX%8G5/F%AQ];U[#_$
M-RA>,*=N35B=(M[!FNN(V6\^;&62L121?,Q.@+H_82^=2N*"6;X&:(C6I4T:
M"<,$[#^T?FV6PYVF]0N^/JK6/9A[,)RAZQ//&;@<7B(ZDC:8FR"RUUR[U,=)
MZ;Z!6IS=DY<F:U4L6D(NT>==3JXFZ/07)K(^PI-'Z769SUH976P.V$&U-(<$
M$&&MUWW[YB9*\O5OMQ7!/6J)_WPV;UMKGX/@1F&-CWJ*2[70JT=YQ!W0SBS]
MI;VAF)'YXZ9R68G';^"M7T3O%*6S\,TE5W-1><=IL;T*%X$74_?Q)-8#ZZX1
MG43=D>4;)%=MA"!AU=H 9V):G/?@B_/LS^*/H!0D?BS/QR!&8)HV,'/\!FFF
M:8D-Z2%C#.MC71/!V$^9SAQ#A6UW8!NB_#&:\RKDO"23S632L5U9T6K4=\[\
M/.(AT&#"(U(_Y0$MO(TC$3Y31([TMHRXPZNL%M&1[>0XN ^6VKWT4"!(K+4Q
MW ,G,8. +UXG_'W\5[_HM")8+D<5Y(P^R2[< "^^[,VWV!!VM?'Y_XI'U/]7
M"#F:7+SC83]#4$7^!;2QOZ!+*EP<G1V4X9Y=I/*4Z2.VP3PTI\W8^4D$PO;Q
M*$7)N9R<UC#"..$A# UL^Z_Z#BV4PR6U@-MQXNI93KLAQDR\:V;O>2^&Q2LJ
MW9Q2&6\$:SR/J9:4X0VPG)2SQCH.DCL[@[A\[C7<ED$)W1E='4TI#LUP,8;H
MW@4BO0P2&VWJZU^VF<E'@[-_2+A/K5L4Q0S2>#?I=#+K3&@9YIMH.-3N-=.+
M.RL\]M@?<ZC9$%I<*8=:;A*,(/8P[4H P/H9(BU)E1V+G-%=B@V(PUK\03[Y
MA0HUONGHQ5Y)^1'<".&EP70UEL>7?G*V%3\-^9A@BN%A^D^RL?G?,3WQ7X&V
MI>"AO809*[#W-67N:3R['YN0ETV9HT?F1<Y>G==-[:E0RIBNL&!4XWX+]:M#
MI\+ZOEG/BG(Q,;,J0:B.?E:RX>4_-:#AH'(\!*U?O#FC[)]2/3CLW(O72SW\
MM2([HW^]M*XQ<NX:*E  J56^L.PHEQ4^1D WX9E4#&GA_$J& NLW^WFC\"X,
MB',P]B&L&49&.+E$5K]6$4L "'";"N(P,P[5R].RG^5YT]2.0V'IU-Y/3ZL?
M&QIZ) :E;IH>D;L\<J,E69"4<LD,VTBO A&9(Q"2*8>9WR;-P13K38,>@_QE
MU/.6=!>[Y]'M OB1K@\*58J5&P6YK\'NMM$_&4\-Y'K08O>AX&6(F6X[DN?F
M/'+_1[)=(T@%>E)H+P^]C1&@3EFE>>&<6OOUP:3P\+S0"7X:#:3C[V.::) :
M@(M(Z(<CED=Z!"T\;1P7J&\*MJ&.ABC0UJD21Q&XLKF6I#JY;-T;9RP9TT 4
M/3ZU:/N1UA4+]?8(9.&HWP)OZ6@&.K:T,#6TH\'($7A^KY8[+M!M>Q',8:7F
MG#J'L!_K@BDX&=[)$W.MC)D+R+R(4J1,1'P6.K)W#U+RDY[1AEQ8]$YGO*::
MNF;R/J-3P()^K>>Q:=MLE<I!GFAP5C>.P_'<YIGWG6>-F<K"]?T4!JIR2+8=
MWMDR=_;5^_7XR^S>9<: ;J(>'UL&H84C::K% N2WC3<SW)Z7M\(CKIP^R#9?
M?]4>^;+?U'J"75C'F?*@!K/C3T)/)9_2L=R8FO4)7NS:32D,DXNA;7Q=^%*Z
MHMR]9$F7I<=6!J*<_5FM/#7GI9K=*AFP:^Y%6^DV\0$(ZWS;AI*?.YRS7+/X
M"W!2:6CD@>\,$^7T\@?'T$A5U?RXV*CUVFZS(@#="K_P9Z6E@E3;VF,&;S@Z
MB$EZTC2\GY'D@:+\>[%*@8B<0BNFN:D]U6>0=9.H924Y&K\$->Z0\=#N='&,
M@8FI&^&&RC'V0?2[H"*!M,C]<W"0W&FBVX0/R<C!!N5\1'0)DKG5S>ZVR_Z>
M4<=$:30Z"T8TT&J;-VQDHL<U%G?RO[2X\?]38/Y=^3\ 4$L#!!0    (  @Z
M5U:4D7_2<<$! .53 @ 3    :6UG,C4T,3DS-#8S7S8P+FIP9^R\=US3WY;W
M^T6:(E($1!"("$H34021&A4A("I20T=$I/=>@R @-0(*B$*HTGNO$6DJ($@+
MO23T'FH(*4]^Y\[<9^Z=9\YSYIESYIP[=[Z\%O]DOY+OVOGNM=Z?M=<.>8P\
M![ \4E57!:A. 0 5Y0\@3P+*P&DZ.GHZVM/T]/1GSIQF8&0_QWCV+"/7>39F
M=EYN$!\O-P_/9<$;0I>O7!?@X1&6$;E^\Y:4E!1(2%;QKJ3"C=M2DG^\"=69
M,V<8SS)>/'?NHB0_#[_DO_LB?P583]/HT%=14UT!3K%24;-2D3L $.4^::G^
M= '_=%&=HJ:AI:,_?8;A+&5 #0MPBHJ:^A0--2TM#0WEU4#*ZP -*^UY_EOW
MZ=BT+.BON+)+OH[//"WPH**-0_OWCN#M%VXA9Q@N<%[DXKYZ34A81%1*^H[,
M75DYY8<JJA U]4<ZNGKZ4 -#(\N75J^L;6SMW#T\O;Q]?/U"WX2%1[R-C$I(
M?/\A*3GE8VI6=D[NE[S\@L+*JNJ:VKKZAL9O[1V=7=W??_P<'!H>&46-C4_,
MHS$+BTO+*ZMKV-V]_8/#(]PQ_@^_J !JJG^^_I=^L5+\.D5#0TU#_X=?5*>\
M_QC 2D/+?XON_'TM>@M7MBN2KT^S/XC/K&@[(W!;>X?CA=MOA@N"4O-7L7^X
M]B?/_C+'0OZ///N_'?N??DT C-14E"^/FA4  T=XX:Q@AO^V_[;_MO_2)DL&
MV'"3[3/,82#CX>PZ6SK+MZ=VP?5Z/[J1CW;(0(0YQW4'@C?Z["S+NG=!WNS/
MKM_7)-5Y?-^5'ZMZS;'(N9KTQVV5E+;*39.!;T\'TR3%5M ?[X/%Z[MNQ=WK
M%N+9=>WSSR.(2823A'Z/[!/O=&Z.O9 O47)@)0.G=$)@,WV ]VV["UYX=[O;
MIBJ\"=U+U1MSEQ];>_E9<BSYP3?IYXHN?0GG&-Y^#^LQMO<\#=NNU<%#78M\
MC(;T=EZV7KS]A"-[4KP\7NU&8080V'^J@:OU#(YAJ!W%HI0^GW!!//!J^T?V
MUT?X, Q7UZW->[R@-TJ7??R[L(\\_+_<[KA]M;JG\B%7E^N4?XC?:&U3F6TZ
M]V#N\(%_=6T-/&3SAU!EL*P@GN$8.N?;"+H@A:ARFM!WEN>]X_L$A9W$H1N=
M)X3T&UJP<9\RLT%79L9?GDEGK+S%!0XI6PJTH6XRGQ!J"U]XZ.@9]F1L+[;1
ML;ML=AK>+KV*UR^R++5]9V?D^--DXFE3=CPS#>R!'(LOQS+?%9S*?#0LO"[)
MJ]'D;+Z1H53%3"'I8%'EEX8G_]LN.?>OI1*''JBKM? .N8!2HU'A)*PNHE%5
MV7+M#DF7:BWH%BYW'D%C(EZ:ZRJ%RJ&[4_N63X4^T^$=/=K=<.8B#C4/8K>K
M6"UO6?S0VU?+[\^=$=]"+7:S'\55=A$'S6['<J+#-H_>"G!J%;N9]5U")$&N
MGRHXO-0(JZ2U(P3LF"7.]Y0(Z?XNSJJ,6P_043FU>:\GI!B8.W]F=468>M5/
M[/,.4]&=NCE>9JT&Q[T^FW1+!/KYG43<NR<>'H"6"OM_VW\]HVKS.9E7BL!T
M<[HK),FEEK9YGZ9WX:4N.!G#AVY'[4BP^AAWSM)+^]NOFZKEZ-QBF9YH.,O/
ML^D!3F>Z?[345';>!X5.#I9N,?/_Q.J?)3T%=Y;NI3/(CD4L4 V$-+, ECBH
M;,$/+ BC82!@L^K\)9LS2B\RLVXY9'$L86RURW_N&?V $@U6P*>IS>A5G: ]
M#XHU7E3BWEKG);Z. H$Q5!+!'I=:Q#C#.&#2YPW>*LN-3@LF SU7N_45F3,P
M!7<W#EK$M'9DVFSWD>=\C[C#TBJ[V=JY;+G2[R_)Y2^ /H[Y!7'LU84E=@:Q
MH^@JZ$.76YL?ITS@OWFSUAT%:R-E&OH _[HV1'C9W*;X@:G^9>E/PT#FNC.G
M*6+[/!7XGCPT*<"A \1UWE!SB]!DO9RAA3KF7J_6C :=WZ[95!K<^\8*L5?L
M=>U=SS,IT'U%%:?Q[N:9A1C]B&[-"#GX6U(?FO<"74-C3<2/^MH8JX68\WKO
MO2\G?5^[?W'U'E\)6N2"!*/=8,.WJY][-<N5S64(9VL3; .,5M2ZXK ABL9Y
MI%"5[0XDW_H,AQ(+-WN)^_4'$[;9M>_ZKEC2<*R<X6&+>[-?9HB3W2%AVH*X
MZQ-U8Z$ZPX9&/KL75:.8AA4C%R/QF!K -WEC\@KS1;O?GYWM&>$9\>Z$3@]D
M=7&4E"*=9-"KA@_!APRW"9VNJ?!P@MZ.>W=LL<WA>3/;COIP+38%1S98C^RM
MG^68H;O?<Y#17<A+S4]>#*X^L;1PNG,FH-;@N?;]5U.SOG'TU .NPP/T#81K
M81DXP_E]IR]3R+G>7G":ER?TR=#F?LF-H:<UVK6'Y3FWJ(=%@^E71$< =BT5
MP#U($7M]AF5'/[-T<K+;5;PLN5;D#,-DCNX"_*C*$'F6X.J.V6:<6JO3=S5J
MAL8ZG+]V_?3IV'38+%&TK&OV6%!NF]A$!E8?>O:3?H%W-:693QA^D(&LK SF
MYUE1PL#_OZVK&<M;@WA;(N4=I6J+6OYL^?+Z^.Y(RZPE9MIUZAE='[O6/=K_
M(L;3#V\6$8I5$'#/[ ZXWOLK=BGE"/XA]'D,_-' 3M=;!9GY6!E5PV8R4/&U
M@LMK<P:B$_/YY<EHS;\=%Y?)P"78PKMUY.$V&<AE18%/[I*!'PK#X TQ(5)4
M5"-S+')7S7/VQ)L,#+Y=1Q _PQ;2[4"''(ED0$7E'E^;"OLSJK^IZ0W7G'44
M>MPX+"'(.FG\</#G<F7^CS).G 4V6@LK$>=47>*(T; G]N<)JY@+QL3SW3NN
M;%A86/"GK-)_@+SS;YB 9%:2%T/&RP076D YT)<NS<+5W^/D<EUL3GP+.V/J
MUZJ!E\,*,C[2O -VW-F!A?H\-<V?+P8?Q8A238IJ^G5BH;'-8&*1U1>-?(AT
M\?4;6YW(;9GWX*;H.%G7^H5]./VVGA[N1Z[T;I?'9&Z-$-V+GGIFTVR"/=<+
M$97Q[_LV5G<GL$MYZC5'0?Z$.,S]883N8':2A\&VP*OP-?[?UY0CJ"<%+A_1
M\!WDF@Q.*5NA+SFJ3J@$RICHJ7J"A>OUB)-DX.L A] (BW=I4JW"8:J7!>6K
MNOSWCP1_4Z/N)]VA+ U^%&QSE@P\$BB%';J2@03??-B8OB:1@\,#].<64K!B
M2)1PQJF_F8F6YN8;V\I9C6;Z7HZ;F+B6!%7\H/H$\ 5U*_JM'5<CJ6SI TE%
MHE)K>5E.WT3V:<,U,S3]LK'*\VB<>QOWA;+Y'>VC=@OJGZ&,JTVN[TXBF;9Q
M;'Y0\+SB*\.#-'MT4 &0L.:;BGH4HOSUQ4W-D_P4\\#N%D]N:.?9GJ:\2BR/
M_I&<WMC-7Q<4<UG#F9]FT\>/EA=$YCTU2?!+KV6[VHE>45 17FD]6O&#A39K
MT$<WBUB4W']]^)8,^%$XI^B=RSJ.!<;(/5U&CS/V%PHF":RU4K=\"HS%^.(]
M<G:6N;29-3_>0GAT^G<Z^?+_S6/.7VK\_+I5+ "7X&&IMPYV-GS_W;= ;2Y!
MT.XOZJ4[@4IF])BHCT]O01,K:G@4C787<SF%%DH]/*#OUV!<V5RF8AJO]A-6
ML60@K@R'NE1 >(B]4_#!4:4$ VZS4R@'L^X%U?0H> IO%FS-UYN#C US:9<H
M,1?6U=TRNX;W>O]I>[MD,UQ28?Q4XC[O$U<\HK.,>7S+6+J^U74@RT&SKX%X
MSL<A05TJ5K#TUX:;89PZP6XD_$.^78)#>65]@\/<L592-XI7+,D GS#(,!NY
M_6S^\56._LA/R:1'R'ZLO*D.>JO)B\OA>5V%\N_@/9X@(?A@?0O4?+B&P[=&
M414]KWOABOH9K7U>^GG3H(\[GSIDFHPV)L<RUP0#MX]O0)94'"8)8H.P^2O5
M0T(-Z<?/-6O,83U2DPD"CYGNOV+TVX^)0^=J=>@'$3<<%=JO]62-\@K=2((2
M8'/IZM:,GV0D$Z7Z&MZ[W5>DG[LINMB7-I)8:&K\A+HR0N\#0T)>?;\=WOGI
M0'4)_[VA_1-[]Q@GM2[,@=.7"H+SO'"S7@[[O0(8(.[,?["5-T9*LUL.3A;[
M<"#K0H!")KH2PS)'ZLJ*S-/S4GP$.EP5<V8NC.39;#CA:NO[[U19BWX]/ Y^
M[G^3?K0E\=ZPU7!UKO\'W9:PU+/UJ*S>SW<4X3-\A5^/RCXZB2_6U"?,^$S(
M9K^(B[FI&Y>!RB4H8#^2IL-_X373#RY,3\-GXR%;4V2@&BJL&0#9U@OI@/44
M!""_=T=6>EK'952?F!.2CXG$_A=946)#2I>%LZ* _\JV1P;^'$N8TO\=0;?L
M(FZY;&J&]_97/_7IP,)'\+OT_Q0F,2ML,RW>VL/BU6F2Z\^:WT$<'=DTQ-)_
M9E]K-2D?<?),,S;$EJR(^>:K'8Z*:N+SL1$"*Y\LZ5N7MD1%G^A$)ZYXS.U4
M=:)B3SO-$N2/.6M\2Q(W&O73QX<\QEK[G5SAM^DE^(^\>H($!JOLC(UMRVYD
MU=0I"P[=?7A_F ('?JC(5JY.SM#-IY\N!C[J4OBIZ^XB5X=F4CM$-TL_S0VR
M1>0/=\Y+=D(8IA-_^_HB$4L^1V^=MFYX1)_%O7PYXB'#['CSI(MELI:2L"\M
M\76VT :*SVV?;T-O,QC8/WL>F 6>R0"O+?#(D6A [72M=E:,N0:G3K?1UY=^
MFK..-&XGB37OQ"ZDU+1>,W[0_5J8%SSW""Q-W>)WD9N 74A:.>83_CG*5]BI
M8[9QM O;@<DC5+54.&8"4OY3:4IKRD39UE&\KR.:YV9F L0RN)!.'1P6,)E)
M>#YZ">VW+G/$J3X??9)4K?92Z$<DW<VO'HQ-\2EQ+MW#S^@'ARGJC%WK_N53
MZE\I;V5"*L# F6QIDY9UPW(H<9SMCSAN@L%29".BRX;3;=7(^+N_NML\A+C;
MT+\DQH464?;R,W! \$:.ILDX;:O@TO/T)&J>@#7@O<B6NEJS+L-3RZOI-7.I
M>1W.;&NOWZ_1C=XF7"A:Q)!HCY!&BXM)Z@NV5^,7O-9^C0MA2]676,U/*46<
M:SNP*KV29:9AWJTY?*2HB>Z.<*BL30_<#\U[_PD*UN]>.4>YG4ZBTTKEZN'A
MH;#?+3Y[> <6#SUG^6763OM8_X[[%#+G_PKO94-*[#YQ)^?<R@VZ8,M56PZ!
MG. "COY-K'0KZ.N!OEZB%1YEB]R6)X%VF,RU436.)HGY=C(RP%[-@CSDMQ]#
M/Y  < EE<&SZF;<1N2?/Y4^;F-6O%9WD@(-_$.VKA@(4LU?FSH&?U@;#,;J7
MR, %!<2OPKO<5=Z?ZM!6QE$N=WUV+3(65QJ@QR3ZX-5T>BQ?2?7DJKN@-<GH
MJ4)-=UE?#(FKM/\Q[O9M1T>H[D->3.V3;A+>P7)7>KT:JGM3*KLU+S027>QI
M*C)Q]H<I<9L0!WV,<Y^/E6"4PKI?)LEG+UGOG"!S/; J/*S%KJKQ7<VT*E]!
M84I1ZS$"S&$&._;H(C3O^I.>D2FQ=T-LG=SN,]_Q5\,Z.Z=[^@1G)U3<E-:$
M^;2^ZC* 3_FCS%6T7O>3 1M<'BEL$D3@!I&D(8?P*-B*:049:,LD QB] :U[
M?/+8L^W<I.*RDLX,HW8%D4^OSQVE6&G-\ADL, ^MFCVV0EZ\];7B>XZD6N)\
M_.OO%KL']'2M364LN.0YY(9]>]$JUE*SWGGF2AR_.QFH3)^)@#_:J_#PA?G3
MKI.LQW<.K3>APZYL7GX09P*]+LG<VW)0X1PZ!_OT-?L0^Q-5#MVF2$TJ[%'$
MB5 "^,;($*HWG0>U19 I5LDW^KQY_#(F75!Y1/-X#MT:.RAM_\19(_1996*
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MU:IEL[KHNL[EY^M=@3Z;_79U9J"=GB[0V$3PH$1.9]@0:3,%RQZ!YXN8I6B
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M>RXSKD?E+^,OT? QQ!/MITF\N%Z?:,V3<QNA)T_'@UYHXA=(1RC4WK8!F#V
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M/ES1_E^.<J=_EN8:T&G?O,]% PTA*.]8["QE'_9(@<>3KWM9D@QE3",FA\A
MB=F1GK3B'11T**^\.4;=67+3BI0]$%<3?B6DY)*GHDFV5+JY>9H]9^,N&9 *
MV)Z78#/!&1MJU%?N*)U'\^RLD@3RP6C[E::SZXY/NRY-JC^LW1-^:3$%BPV8
M1\.93'TL#1.Z,/]4\O$"FVNMFS*WP[EY3Y&!$SF\)BYI2H91DZ6!))&Y34DU
MB+#258WQ?N?O^(T3L7"+^Y8NC3^GE0;)@#09 ([LA&E8X[]GM;CO??T'R !_
M]0C[CUCH;(#Q^;SS<6YWZV%#[V)N&<?-P_4)]& 3Z%,U(,&%7MM^&<:'>X=+
M[$CH85OZ-4L9T,%4@DL/2BDU,76VTGPROO62RQGEJO'1/WZ$%+U\;+($V(*H
MK_<&Y:3BQ;ZV7N+CWIFZJ99AIGDR&4KZO8(,QJPCC/9 8:W<)!3J:9[+Q^IR
M_G (L\0.O+UL<=ULU03'<,?L-P%N&7V;$I-Y9;)&S5HXUX\HC[M9/-;B7W1[
MT+-B+[61@9UWJS#'*KC<A\*$#":KI[E!+=V+,\U\,CY6A@*OU%E#Q:A#<KS+
MBM8[6X5QX!.YG?7:6^C!>>0@*X3U.RQZ9;9_3:RO:YX,+&X$64_LM#I:'XCV
M0W;(0/)Q8#=L3O."4)24Q;)D[(,IFOJGGUIX_$'+J6M%2V"F=909SZC%L./3
M1SSJ?#[QS'K@Y5*Q55X)G9I1J3&)C859FIX&3=<UYGH%?=QC2$UL^LHN+E0$
M'^ML^R1HBX)2LXN4![Y.A1UJN/?7[=FS6@_B'U)0M#V,?;3Z@G[K\N(47O2(
MI(<)$L%]+%C_M%DL8V"0?EJ5N!!*_,*K%'I0ZC>6HCT;U%V2M#!6[-_,D3V]
MN;OE)Q05)&AK!IIU=% YP&%Z8EL?@C=E]GF(8EV>VVQVK8*->S67$M:8M#G0
M4GCF]='*[-BE>,M(K@7W,#TN03R56?*\\YLC&?\;!X?V-LQ71IBW+Q$Q!/!3
MY*,]*^U:D7&'P)KKUXSCAPX_@%JFMXB<FFL;\U*FU#I8VN7QZDGHQX@9IZC0
M$?A]L^YYYW YI^C*=>UQ6(#LI8BM;*6??@CW8X:-:J)<_Z,J#8VS-IMS3]^&
M@B(/E)9*H)Z,/"+KXH:[QWGG7]SRSH-,1:")YBM("G2+E1^7_T<6+W7G#&<=
M]FG,8:6CQOL>XU[(E#/,<H ,'!0M&Z^+Q<H=VLO7IXK,OXB+J"@KM'^-BY]#
M;DX*%!I R #;)<_C#Y#;ES=).YO'?E"FV^=^-6 :E?(B;B,*^]=&$ WBS8AC
M,$ZQ=S:,)'WR6'V>J&H^JWK+5@#4FHUCKM_<[+8[8#A6E14,>9DD9+,8&RHF
MTJ8MQVI^#\?<Q8K+?C0N+[JF/W=FZ MVO+MB>P7&\/F"T$=_6>>!R4@W9TNA
MZ(P65./&"1[</[QNDQ6US_SN[WUVZ*]M"F0 XTQ(X/4F4<37?I;<,AFP!AT+
MI480PUZ2@=]:T/O8.I(Z$X6HG<@ 7HO7G0Q4P0F)?<JD;Y6PE?Q\ZK&_?H--
M=GU]U. $A9HAC&JF4_MZU((#4I^\(*Q_D//8!#.%G-&[./:YW7@RP$KP"Q(:
M;):;F+#OR2\I&:!P-BN+I^!G*J,@850NE@_IGO_C78S7MPB< ,@#9EX@/440
MV$$AW&\@W1""@IT.I]?(0,=L, :K] '=U_S$7QRIO-\L??>EK^5GDOCLY_2>
M19+#?MDY&Q><]_W:H:PV&Y1D/4D&[$."?1$SBA(;C]'5BS]N,:HLDM%VVFRB
MK!*1CV'_$C7N^]K2$C^/)FM%7O[((,<W-[RO53_DZFV,D,;5M>O@S(T3?CZN
M/K<W^1,RJXGE/><<((V-.&3*(Z;Y7Y-:_W+2ZQ/U]'5K1":!V>[ ^2+N!8A]
MQ=EN4G]-H:4Z#V<^<,(7L;=I+CLU^<3:4[RFPY'G]RV(ZEJ.)P=&/^^ZM)[P
M)M$F*#'YQ:JU =>S,JPX:/4JT7DAT%#%=[:=^2+,;BR6&_]X9E)HRQ NV07.
M)YG'^EWUJRX4C=>&?+5T\;SIN?C@RSK6]%N4< G3O?]X%E\D:&):!-I%?ZL+
M33A7=%9#XDE8$BO^1/>7:TAS6FPYSJ\^LM#CQ<*L96Z2P5QD;JI*G!27M7LP
M?<&UYOY.\(7GM;.V\P>&BRM.GP.B22LDB0+,NID_6I/+CB3TGECJ?&.,)[?:
MY#(>CW#'Z^M_RIVUYXRVS9M4=Y6',3"%#J<'^Z?NB5E:"?6HG<0TA0L/P&N[
MI3:'L@X"81):=:@CO[3):;,IRFCB<GQE4'K[1%W K3E'\XZM2F50O!4B=4TK
MC P$P]%@S5YHI@]T_DEN>$^+9]+6G)LXBJ@="&N&:9;XR5WIBGJ;J:5Z*O_K
MJ:B[G!)^!;+)[#HY+7&T9M-^$BJHW0-9,G#.1T)MI\.BQ&+/Z7N[R4_)Y57B
M[PTP#TI%A6.UZU94M1:68WVD3$:[^)-S$66-YG__:RPK;'\DB>&$I[^,HAVS
MOX\WQD+PM> NQ<CU[0-,\&_/Z!9ZO8AGE8&5'7Y\<?(%A]+[A(%N5\9WO=&"
MVB)052Y&9AKNX[UN,Y;$;Q.U+Q@G/-NNT2ML'CP(A*R!N7<K/'BN;CX/) -,
M2[\[M?%Q0E![L0/3%NCBBG]RQ,&D)JO-SMH%QUTDTYN]2W&%L/Y<.^BO]#-8
MAQF.D8X8PXU7_$Y7^-)2_.&H>'-EXREE;T?>SN9H0<E\#T]91F9ETQ2[M6+/
M:9!TVJ)DS_JX_1D',J"IJT$A '5TV%^KMON?9.R>IO8: R5*(X5K%T:?65,M
MO[LL-&!=<,B!03*11%KS,$@62"DN;D91/,?B2[>+MG3;NTV&,5#[ZQ_;)O0=
M9SNQ$MUGI(A!QYL>WYW/]_M>/LW__0?7G+7@ GZYQJ_OZ"LSK=D83>6)8TZN
M6S+KE.^G^KEWXS2!M^[Q%9^^S.+&_$",N2/H%@72WF3&F7KKAO>JN40IR]?5
MJ]"^/>H2M:YL'FH6'.4V2;<ZJ(D,'U6_M:=6,7^FG_=>64K0%8(22D$^T]@G
MNF.BH65D>^N-YL47\W2C3B8'"I; <Z\^(% CVUX.]M8C1=I4=,%DW.24Y7L1
MT[&KFC2G9&G<Y/7,67!5#W:*GVF4VMTRS%DH-FX_O^#Y%4B7!,LM*9V!_> ?
M0&YB*'0O6,IV^)$,P&'G8$AW0E8&LS)%(K;-@? 7Y\@ 4AN&E1ZV:5SZB!:_
M)<U[;?-&"6]4\=O3"SRL(51EXD-* $YN3[VJ(<E4IS>5)KYVZH:D+AL\J86S
M/8AG2(%MONW+ZI*6-96OQJ/)E.4$]:\9-%C.6 79>>F8]=3B"[&7?ZK>][98
M8[WOX(_.7P&=)X#0_IU5@P?Y+QN=FQCSL;=!*DQTF/V^@).Y:>$ ,UP9S+-$
MH:NW.-DMJ_;TO3;MF_Y4#1#>U_@11 SIU% S?<$J-SSB36WMD7QYB+XE>[YN
MN+Z0PC(JI)KJ0)PC;*[EA2:+CP1DQ)H,F+O;P46ZH5T72<]'-_]TTLJ7#/RY
M>E9IZ)]-W,_HR__:[8G0E !CK,1X,69 ''%4]?KJ#_HLZS""6O^ /RIS;2*M
M%9YKLL;YY.WS!\NS \QN+F#NXT_ZPUO2L?K+SQH=^N23E=K+^;X^#^)HCROY
MP:32I)0=MCM;_$*I0GJK'1NHM$F:GU!*=BVQ.YSPS.^MJG_F^BUNX80J$0<=
MXC9+<\ZQ3<('%FZ&TYQN)>6<)/9CS )WDMO-7Y8GFC4\?N+&8!RBM.&[B#P/
MYM\V^ZC* !>4G=FXBY#$=PFL[01M@#E16Y/;E&#:!$_^7Z+0GD14$/.)59/]
MX2TRD/, N:J6O9U! N=O;^Z7/<FY?/-R\/VYT)FJ(G7=T&CYFQ<G4D2Q99I?
M2/:%2M"*UOHAY\R6ZG?="C=X+WI)[\/"FB'.Z,#S8BLNE8$_T/WX.E[(4/UA
MV25<Q#SU?(OQYIU\6)532DK%X)TMQ+!_H&A$"$%'(JRFYG.2O6QY\JVX=>+\
MEAS)LL575U2#6>N;/\P(X9\ZMVI]41CM0@;.0\T"T62@I#_;)G\N7:S(9^MR
M_,MP/::X//[7"ZS:T,H@IZ&GO9283\/^IX[0?X^9^7\A& ]*2T3*\#''T9G&
M_%;Q>TEK]0'2^\FU^P%5OZ#'PC/Z3"T5?O[[@L'T@JF 46[!VBBW]"?3-4ZM
MR6_R#0N(>W*)&V)16,U.^7-B@:7OSN,W7%[V;[TC0F8(=X_*0",U:<HFS3)&
ML4/](JOU.]D#3,&!8E&M=U@&Y:I6*UNY.UZ4:",;F#L)C7[(^DV"#E;_2&O6
M/HN^JE:!JQ^/XIN=)L@><2P_K(XSC+2V3- 43)W8.7ISX,QFXE!>I_3LKG_D
MW5BEO(9#+NE-O@LX_QR<@^!&UB[!??EGLP@9L/ /]#M!L=OJ=[3:.A(= J4#
MO$P3= YU/RR..^_!4 D*V]]FS];PFEN-%IIU]>ZRP&>^*[X^0>H<0RMLN:^E
M98Q'F\J-7(;CWBY^QE>L/;'1,DOC41 1EU$2N/7KUMWC(.R$8M+L3A!%;.LO
MO__WS_Z_;1R(DI715%+BG32_CU'WVYGRIU/\HP:R$M6+)%=_Z2[DT;^J57J.
MJM9 ,MOMV:*B][K<2N746E+\N3=;N7Q0)W<6/11530Q[9U=V;Z&%%.$G0OM@
M';-0#/QT)[KD<B&M!H[*WI?9?5JS@BBV7#"7-(I6$XK-3KHCO-).J[9VSF>$
M_[JXF<T?.!D?VC'0[W+C@W.D\P)>'68&&:F&I@=(8<L..[-6\&\:D*]A'AN^
M'^E)O6"M_A(_7K_A-=4<W:P@6&S;2!O*PZX$BF[*H$A*Y7=_[R;^?X_M(B/-
MZ<05;/TFNCYYU<I5"9]W-NE4HJ-R<,N[R,4UYU'&E[".%FHK>7KQ:KK:)F]D
MW!V8W*"+W)R74OW$R Q%8W 'Z,SUL]FE!K7,CS14&Q>H?$H87<R:\K*HK2R?
MC+O77U JTTF2PC)W&6Y(E0BUPWF>J9E V#ZJN]U*>E<8!OAARJX%*\%W(MYF
M8:W?[&^Z7>Q]L*90[?NKFZ:(\>2F]))Y-9P0V:A)? ,^_(3RGR\1(K$PAP\8
MMMX0''(43-4"\5D2!F^"(B]S'\^B-3N1. ,CZ2\(8L0A<]64+\EZ@C#]1V_#
M"TP)X(]HDZ#D'$YB,VSUX7L$>] E#>QYWEM7A@<[QJ7>)+WY@0R:=8UQ)-KW
MMK('F'/K(2*:V2<N/>);WB ##L;%EGTIGS?&)V%'3=! K  ZEPRT;Y\?FZR-
MJFNTZJS=NW88^^93"LLEVJ< _<5^11OJ7@7C'42G&?7OERB' -4CEHE-R13>
M^81;[ZBHA2[S>)<>S</BI,$7"7)8VM)<"43^ZH#<V=#80;'LC2EZ%]V8(TRK
M>SMN%N/8'^O!I2"?8^,V^6FP0(!+89SG)6]AAK< +V[3+'$'^C4YZ,+.A\EU
MEF-OOVRZA.F(/I[G+(4SR^X\7OVE-M2_D*\&D3O)=G/$[7+&0(7._OW2Y,,/
M5MQ,;QHNQ0Z_87;,)JCX'A39@ZE;!9M1%ZZA1T;0#XSMIB833HM.S;_6$_02
MX-W3QI5U-/9WS;*O-@;!<YIO3H94=)D']74X):A2 R[@&PL#],T$P5@,#CI_
M$/1EJF[.]"WQ=.E@ODVJKMR%,(M<XX07575J'&\7:X,E _N-D'_"13[8GY7?
M11FXR3]:44S)0!V,*!S70 ;&NTGJ2YF44&<(WM?5I=KX:T8A=BT#DC J:V?I
M-456AZS=H<CJ!3!%5F=(Y5[E\+)]]'ZM3R>DR>G[GGETT-63)PM^M%6DM5."
M#9</ ER0P;)XA!VZ62Q# ZW)8KRZ&L\EO^1*8(W+PS.[B5U#HXV;/CH)N0L.
M-GB[CZ1\3C1;W^EN-Q]K!7&BSD3WS/$LN%'D/@,9T#G@^X#1T60SVW8>( IP
M:'-=,R@8PM6:N?DCDX\%JD-.EY1@0MC/L-NQLGCH40.Z[[7,?A]G._ZAS859
M_JVCPX@2F\/&PT2E-)^&*+VO%B.7JIA=[)<VG2&- YZ^^^N='?$RC')RAQ8;
M]FO<F"!^GWL^B6HG*H7,FV)ZUZY[QOOG'?!1[LS$IQ=<#9?RA@RZ;#D?R,UT
M%1&GD/2S!#(PQP/_AKP8F*ZW<T! -+Y;^CU&'%746?&#!\FCRJ$_@6;M4V<%
M,O$L*H%4%#;O[$$[@GKJ78FY#J=ZY9QY/P?ZGQ!5K$(Z3/UE ^*VA'[*7CV8
M$(-@_8Z.#_8.Y/#"62ULF ?_WO[<V^B(Z.[0 %;O0+:PUL^!Z0/>>Q=!GTBG
M)&>##\J8FW'6L'D*=Z>:QXJG&AST^';N3WW.N:[:#M?C-R #K>.KIO11$B5!
M @$OHS4;ZV,5;L]/U?3&C4%$5;%;AB%?Y(/52D.[S-G9GE4W#'K8L$\\CF6O
MZD4$GFYCR,L0:#A8$1.MF5<W>[Q_D^N5$.\-HUM#12NML"&Y3Z H(T;2N7*4
M4%K 24JE UH^YSP3E^L8'7UB3-2>)KL/&=#'BOAX$Q.^[M=%ME)FRX8,<.X>
MEDG\GJYN,0N\H>TE.\VJV$\&3&"B!\YG V1' I0KT2X.Q<Q*#M%[=\F E3]1
M$V2TA^40TT4(WK$>7<"9(&DC?(HAW1>&D*J-5W$'UD+VMJZ!;DFC[]2E?KE4
M=.50&+009SPO6MJ#9&G%#!MV33$?C<'XCU&!&3Z6CW:FZS[D3=*ZW=P#2X*'
MR<#]3@?]X9NWXFJDK=-2756,CO+"CBQGB\B 1&_4S,19#8^0"?9P]HL&F&>%
MV6,,25%BS<>JD]Y_LW/'9=(XQ!QR\ZP7RF,%.9AIOI\R#"N^3U">"LI>-?N@
M8JW_W@Z2!'E%?PE*:ZJ?VTB 6BYJ:!1L.*$;:S]DI5]CBFNYS[$/"0V TD=5
M>WYVU/A>7G>+>=Y9:\,_2*#&-[FCC!;V8H;76#.:.[ ]",ON>A9!?'^XK^ '
M%9GO9S'%V1M$/ZN1[>ZY_G).+8TR.^GG?*4*-<[J)!E3J!8&__:[_^:C%N9(
M1WPG&3#S!SWYK5N=IC]D/'1Y^'K.+&-/_%I>O1*Z%%69:K="F'!Y+XBY^BHD
M2OB+VM__Y/M?9%0_".H[OS(IO$YC9I/Z<G1GRD3!VK-=\@M'.\\'FL/]$F:Z
M%3><?=N$?JS\PSTCXV(W*<,)\R+6=TR2FA;&[Y]1#3\?@94;DH'^'-#1AEZ4
M\"GVJIK8]MQJT?9,72 J8*#3E4U%2EW0L0WR[#[AG%(44.*89S!>86\LYG/Q
MX-;#0MA]?9NLX"OU-75-T3\;0D2R?WFIO0X/"D^8^#71QV TV7Z*+:'B\C/-
M>9W_6:3XQ\HZ'/-@=@4-8D49S'JRU6%#_2DSLQ 6U)XW%V@_U.R+OC^//-=S
M73.Z)Z;323Y<T7B'A^AJ+A\\J$1GF$)4EU["K!OZ2^\IH=[L3O[ V(E?B">:
MKQZE:08K2).!,Z"W&,-$SP^U5^O['\A+H&&/40.XKU]+K?^M[;?5HKRSD'$=
ME)=/ \GJ8,IX,6C!P[SHF*1/$9&-FBS_^R+<'RKS:KM/R#?PU..Q1A60:S\$
MST<B T9S^[Q.Z^WX#N[8[  LXN.9>50CPM+\B<FDLJ^]>$V'O:!D 41UY>L!
MQUY>3("$3%A-=ZU\ZNCC/PK!R0,G<1%[VV9/)4/S).R95Q$9+EO6/*:<KSOL
M!@>)EI.+QWZ@^S;XFM*&W/OYAJTKKTPPC>EK@6WH,FA(@"SV]<Y6T:%\PZTO
MTS>9--40&; \R^/#,O\_]I-+"8J>^ISKP\<FF.M)YF]=3B1T"<@^RB-BG/X7
M+D#W=$%L+7S^O9B[S"?OF))JB 2.#'@$PHP^/KWYQW%R!@[[/IW<"Y,;'@^#
MSP@!GM>:F]#@SC[Y]@GIZ5JX<.-PC@Z[6Q?,FXTU=IQT10[;W>*J= U[6('6
M_JV L*I0%,^\2P.K]JNC9( [%^KXA+"Z1H$YDB:"0GPF=@85VU^/,#NETM'+
M'S(KIQ$J2B ?(P:#B),?3:IB+V?U"4DMS3U!H"I[4_F -\=U]+T!B)YC4LVP
M32MHF'#?^S#PSLBBP#;XH::74TC+V7;0Z>E#4Y_P)]'#1@^GR,#7% \\\Z\6
M[9]=0T]J-"C+;>ZUG*#]:S*P7LS_)LU6=GAPN>@MFO&.Z7T+%XVT3B.B8@#)
MR!<!)CS 05WGD0S&N-2?FWDC4JM)ZH<2WRN60S)VO6J9%2/G7K24M<U<K<,Z
MAUV7SK\#KX:<C'43JO[Y=P50C34A^%_V&BFC!A2)%G\I6^3B91)=,W@^C!)<
MF5NOVE'^'YRYM)&LS57,B[]M*0J;4T<1<SK]7$+>^%I68"_&J#Q6@>H7-5DW
M::EPJ/Y'?X& 'A'@F*06Q&9_3>CE=0MM7<SEG\'P#BCUO'EP*A-R7E%,OW[$
M4WBIN58]34"D1H-QSLH/ZHVE1(MK920"""\KYCZ/)"2:,\'&E$!$&LK;412#
MC(\S*52N;!E$!M@@A-O>X61@Y78AR94,8*4W*1\9_?\:8X+L (>D2H02V )+
M#=>,W@Q-5EM8?GHUU*BB\UE8\5P@O]F__$1A:MC\0N63G?7VRD<;6Q,!LJ]D
MA19YUW-+S?_EG4#_=>F6Q<QP<G:\S];S? _-3ZW?C2SVR\X7<4:8;XT]QK7+
MU<GBSB*DJ_M*&.3R3.N[8OAYG!^J8T*JEE/ %BRE_3KQTJ$ _@1Z1XRIL/O)
M[ZV7OM65^-'D-G'4^BY!"ST#8*-QECJ[-PS2)!>#WWON3E:])A A U"D0$Y%
M<7SYR^=<AD_OTV=R["X5Y4[;3'S&!V[X"X650RQ7(/D"J?N(L!GIW0DPLYTD
M(<;56H O@N2+6#WV@_(QL\P1W_=GHA6^W(V"F;7;;7H[%2$/!@Y^4J!19^YO
MTA?QGWWN /SGLY'>0,#_IJ$<./RK[:@^N$>3&"R7J&$BU,E\G@Q8VH#'#[<I
M\D4G]">$ ,&NXA"/HA)UT0MXWKL*U[&>F >7ZL@ $PF2@COJB.A(%TPR0-SQ
M.HZ:\KKLZ=RQM]]I1Q#?01VV-GK*O^G+?<TH>=<7]B:(%R9A-+]9\J6Y,6IB
MFC'QT3PKO;;Z5X[]NO#JNP'R&9.VOY]7VW\T@5U"-,/ 0QR+%L_7]3RO#IQL
M['$P5E'QB)_C^9"<!]TC.ME3(L &Z/-?M'=AX5/5_LPG^V'"S\>"ZWMM(B#7
MDR#ZS)()42N.JS_[;$;3N*-R95[50'[6)7ES!RZ,)FNE+(=%R?%U0,L)XMB(
MP[",@;*<ON&SI+@-WX1;!+ >R?R1>902,VFP2FXQQK>ISGPV*^YEC#>^;!?/
M@.W1:-B0X&^J_5--E<>3!@K?MK#W#;(A"AS)DLPG-':2C\$]O?C2J+8=>.1S
MK&H$+]K1^,WQC2N@KQ2UY0<GU3A#*[A$KEZM.&ZQNYVI-9A?/!I#R<#9?P:Q
MXVS1M6%+Z;I1@ES67@R%BNI2YZY-QU]]-E)3(J]<+2/W8<H%,NFZ",^*RR&*
M!6/!G47^CH>--"_09N%K]T]J*&G-T_F/+4G-_#7OB9I)4_-I=5=Y3VO9[G)>
MX)"CW9CWHNTY\[E 5<-O!]@+Z4)3<*<R0BO,=1J'0->0LELG5?0K:Q6XX/A1
MONGDG>69YLWI!2_O5]Z6";UNZB7]3#@P%"N5O:%_XMC6/M6SVX6$NV^(C2O<
MVMF&[&S]F%::#&@^WBUC@(V;A:[_."J].U@2&3 XB1_#BXYMU%W-VR@0ZZF<
M72(#98(^?:B0 #6%J_XE*GF]-%JAC/QG4DW*30J97&Y_3F]OT<>YH@/-YP_3
MW,\'R(U(E#F]G+XZ?E[U4=Q;^O<N]$)E@JBA86B!ZAN;HH>X@'[ILA1=G8(L
MXZL#6!C.=$:0#&19%I*!V54PKA.TT]2L3@8>=NN1 >0@#!MU&"5FV:M@3N+T
MC@2OI*PAC_":I%LF('B .AK$M9:J7V([9VK^:$1JZ:=)X0^1YTR+%W>3LU_"
M"\H*A#,8N'DWNW(S5H]07F7V[J[./)5?,71W1,]H,RMP(_^/ 5T/H5U9VY_F
M>9YUK+Q_<33UR<:YL1H5"TUTG]SUMX1Q^(G8:SRZ2@C[?C/>V9[;O^D"R:#$
M\D'VRJNU3D]Y!OOO\3=6>;4@7G<YEH=P$;KUWV4>AP[>Y#S@&?5(^'';*4G5
MZ\ RT1A"AZ_D]?Q]GN X<OT5SKAPLM.=)Z&J+4PY/2%S[6Y!,S.ZWH$$LKF
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MNLZC[/T72]E:@A+^&;YT52=4UQ[S1IR'\55]PPP4@*^\?P+T906.E'C/7P8
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ML&IXB<LZIE=V1 'X4FB5C*H@-[ @@)%:]T)]F;1Z!Q_2,4FW5H$[)L\!.ZB
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M/M.-(QH;-9!7YZ'TG_7.P=_;?!^OQ.QDV=QR"\EB0I:/9JE(5C0ZU>H_%<B
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MIA+%\?8U]MP<1<)7J<'?%G/J1XI=S<PW!V;?:K^S^6@8C(NL5 ;8DKGQ.@F
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M4/2:"@D3)@YQ_:\M,M4YP:X%5R^<Z#X$6?Q]Y]W+B0$3(NN.Y+Y1#>E-:55
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M-%@<[E-$&[ER!*9V3]9T/GN]=@K"X+<J;WSI-;*1*Y#>8F#=8^^P0-6K$0T
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M :?Q7,0IFU/KBMLCQ:6B*Z9/6H]GSN&+:I@W-%'Q,I\7CZT*[V8A_EKNN!+
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M$B)_RD]D>&?M%S5?M^BM(DB_\EZT?LX=1!Y8?4+EK!>Z9D:/[B8^,0:?+),
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M\R3%NLR^O'&FR,UKNOS>-J2KLR3R+D4S$F6$5T*S[4L%(C#>^4DS J4L.B3
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MSE]D&/NYU7 +K3'CD]:>P.V18Y(?9\'M=/FHA>4+'37[%=NR"6_9>P&TN7K
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M #=FGK\Q;_YW"WT>#&];%<=EM&E?F0T;PVQ1!YNJ@AI#S[E.2L9V3:/Z)?\
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M2W#XA3GYJ-^*D_%BNJ(\<2VPQIE]@.#K2Y0\V.)OX><JX@Y_]^@&GY+7*)>
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M!9:5-;CD=8(6BXP#I&D?A%U+C^65*+ J_>P#;<*2D_@VK0>>8J]#D$69+9<
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M^T8S2&N17T'E@;*WUK3<QGV)?<[:BL-JO6+*8T05*B^^WX1,V*:^N 8^^+[
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MR+MJGWB_3-;.?JUAV8,-5K3L<:?O96LJ5U"'&?W823Z<N#9,+%UF:B7$O"6
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M^LX"XGW/CS3<G#B;I0>[T5(B)YW@8KL+K<[>1<VQO0)'2^K9V2<E[4'8ERH
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M#,\VLCOSKFCXHFL^_RNK?5MXE'A0[&#(+"=&R4P %0/ NOX>?EU81;WM!7'
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M@MF;!+4WLHR=I+B&[2^_DKP&/&I%\4346!V2PG]9+<DTLU]AM3Q/>6 PSO/
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M'IV(IE(\XI02O/-*FB2%)!C[2Y.!+%W2O58RT#H"KF@].IW!L4!/P&$US62
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MX^#KJXYPKFDF@C3:3MS[H-,P9/ZCYYMSJ0JS3.G,26=[NU3MC[XO5D7'@]U
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M7]/ -*.'#F^Z?")H?S63*&I0%B8W\37-,^,(QKU"*Y%?XT^CB\G U_OYA60
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MRFN7_>1;$7F5&^Q7V^JD'JA/%.^I%S"U!#> ^ UXGXGN5D1[T%](%EYC!C,
MA;21]9?A%GC)H<HPZ1G]'P%.+6X\QB)BC'4C$K_\:#\U4&;5XT$MR'=6E\J"
MS89 C\J3O*X;JD X.EA^<:8Q?5?::]-]:$F[,>C]I@#+>'E-:K3YJI'W"_Y
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MF(/>=>H?*RZ\=8OVKVS)0'L$VH>P3@9$LHW.%,0/Q$HK^NII-F;ATRH9.&!
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M'$VB7&4+[/Z%6P5"!<,D+[-V(&<V4?M$-O"SX<.A_*&#:F>VDXWO@=66@ZJ
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MODNNW*?NS!1R6A;)_N?'W[#-,S:7&LN+K E4.SB;@B_W!L5=-RPZ":6/:CC
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M,"B7QNU)?:*3)/QF?K FYV$Z-Q)=@(G4"90SK-$N5>>L<4\4HU0>6#<,IR/
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M>&D$N \ >!PX!!RXUSX Y=]Y(L']LP'^2X.#1T!$0D9!14/'^#L \A8 #X>
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ML]VPK!T\$2K?\]#%)MOK<@KVYNDOT5.,]=,L4;:?V&B9M]\L>52V_&'2SDB
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M#(<OS5?0RM6>,]:)8%X!$K,0P^7/,;<ZVV1I8V&]A% G/*P E:_DR@ANNX?
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M_MW4#WQ'3A&U :W/I .Q,PPM_:(4/X >WGD4W\G<K"Q ^%J:Y$:K310;^"E
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MT<@(E+5B\YM<6;SMI>[C*R KB3^4+?M12F-Z;O\$;)?IFVK8B)-5GO7,Y$!
M*F%-Y"?*[F!PU"B97NVG M$_NXE,8TNKSB!>.DT-<[^BZ"WTBBT6!^_=M#H8
MIDV)MKW(YC(.'L"N)]F5%I(V%ALC'E4:LG9 AD+J*ZXU9KBR$G&P^GI29A_S
M9""K,JC5FA-"H;2.[6_-VZZ-08R+L<P'^BGXCI5I@%SS <?@^GN82H+N; 4K
M?6.-E:0$'B/2ED WPO23#;W =%^SJ/\C6&RG4UOS/=,O-X+B9<NJU8#?]N
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MB&-@FP)JV?I58$_[@U,M+CTY:D@;>DJ^P+JRLU@[HZ:;R8],!9L'6@?@X45
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M(/3Z3Y/).GLXT-#MSG7UX8K&4/91?""MF</ @%N62"Y'<C!G8JK1KDW"Q*4
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M,W=\'=XUQ7;]QQXAO_%**BYY!])!&N>Z^@A-\HE8CL'?EH>&K'05 YFS?Y5
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M'KB_^ZXNO22?P3WT/4ZTP3>O 5%D);'#[EM^"J+Y^ER/MPGJ'?'[-$R.@9E
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MXKXY>A(+](ORT:\L 1T(=:U:? \=0$ZT8^-@-T15 R/LS,EP]Y5=U S7XUA
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MBPHDR;V6;4 H-3$U@0S^L%/]19JBZ# <$ D$@5+Q9_OW:"]E?E5RARTM>C%
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M[RU611Y)=O>5PUYNK1>,:9!X)@[3_KVNZ9>.V6@90[+HM;=<*HT-KB!-O3\
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M+G.-:(9=:RH3D/0RVAF'K<:$,?[WR2*J?#KB]^ITRV(#M"2,]@:$^.=CK2^
MQ6)C/WPJR:VG\L4X3+Y./JC(U[PDE-0,BV=(P;Y3/_5SGJU=P@N@C&/HC<>T
ML$W4PU;XQ@JO;#B%CVV+K#UJ]M:V7&#,@F!91$US<\.DKW"1O@X2\N0$4<G5
M36-\>DZ@]%DFC&#S#"%-:IEP41@YIKZD:S/\%LR6Q _U3\5B2F;/N/?*+K53
M%6X9'#<7>H(&$G.V7W\\J0P1I,P':I6-/+%:V3(UPY=_/Z@Q G73+.QOL*/
M,:QOH0QE^F0L:Q6JRVH7MV3G1M#CXJH  ?]O"5Z/YW3_]SO+&^C8N'SR@70R
M=::5:G5/I:.(_9'73V\M!T.G<\LGD72K0DF0G_#02J>K;Z16O 0C\5.'F<B*
M37;E-06X>,_!,ZP'&E+89I5MK<EF<."!Q=V=GBH'1)5S2B;'2?#$L^KRIW+
MTE[^E3M_E'*CA6;K@7#<:6XDN4R:V^0G\?@HVD\8$#77]PRFN52TE973XT]
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MC\FE\&5I3'[3(S_ H*CN3!777>KZ"L>26+"JGN-MC0+(+E$06Y.=_"=ZL/#
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M80_4$-)91XGV7NJ&O@\\!1]7?IKWF$?]8=F+2!EE_L.IH\BS>CN!]XG6J^1
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MQ0+N#:^+6W4^LL5C2;QV$_IY?JCLZ=)]RY-":*>U2A3*SZ1%9O_H%>\!#R7
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M4[-FK=-/0.J^T)2=Y_WCWM'\^O3C2C%H0>N(;[J6T&[QOF$P4,34"X/V<LJ
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M<<G_AK//R3 LWT:$I"%FJENNJ5[[1->H%H@UU&1HY&"'84\OQT-LX>PV3^F
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M^H;&SJ[NGMZ^_H'!R:GI&>CLW/S"^L;FUO;.[M[^ ?ST[/SB\NKZYO9/=B$
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MM,VT.;;MWF5DC(C]FU=*__6<H5.@>E&^Q;L.AK*O=1>O&D^@\9Z<R;J\*PI
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M'G7:#>YJ2SHLA$5SN#P"PA88"N)Z'$L/.E=(\"HKON?I;6W^W-K(FW2%>2O
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M2<BD]]?:IQHPKO._NC3CP]%ERS90$:')$8"AD\L&^PTV*M'W*X(TF",4<8,
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M(A=')QF8$V:?1L.P\[SI&V;%'FK+J]@_SY5&%TY@2Q=3%(%F;AJ 6LQ3,GA
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M(!D%(!@AK.$[JMD^$(-J+R]KLQ8:2^>U]=EF\DL_MNJQ4KO+M_$Y20L>."K
MZYU&>XW@4I698FF*,S7.N1*7$X1)X$:_/?M7HP@O+,+L^_V2,MPW_5\<"(56
M\25>=LN+P6 0\-ID=*>":OEWIFW@.4D?X?S2-14&3)O]N,97Y0 JG.U)&36%
MB"^++26P7&T1,OHZ)1.A)DVMJ:5RYL*6U5#L=[V-W3.ZD>4&I&+1?IJD#6PN
M(5W2K<8I6!E#X(]DK:05QD/2E_B%2RZE!'.;>!_B@[J90Y!C@'W%1Z"9[T7_
ME3WN3A_#:+,3I(EZ>JJ#92W$N7Z65+*'_/46AJMV/.X!"/@0E"_K'[.B!XO+
MNB1V$/M&E;0O1G=R7Q=>'5RP/,3J2(HO/X%+SMP1IN3+O-2H_GD!3):>'"]Z
M_MPTPJE-Z/4!PMTC@/M0(R^ABMO1=IE*,,>*ZT[LI"T<<M[#K4A56_M&)$(7
M4PUK6]H@+%9/4_.']0.M_OM+Z(-NL8UDXFAJ<GY^&F^0DM\A9L!0C%=PK^BA
MZQUJGKP%1$?O>T&D1B._TW8 YT O.JY K^B!@ \&6E5KS71-BZEJQ-'2(M>R
MWA:-ZV  8+EO19!G*:<[E\Y9C!(>D_/ 4S&Y:ABK6]U6ES0<:60+)99</N6'
M%^^O5,)$C#<N3A0R-GY'&RQHR<_5)71KE]R$[Q#0M3J1Q[2C'_&, 1;V;Y/3
MBN1*K=SKR'SL,5$V))DK*FT7JYD0$=M45WDF3HX_4F$&=ST[./X5-[8+_JZ_
M=<P1\ZU7,5_,,C+YDS\AO<<#M6%O[$]%NC?"7BPRV6T?8WNK+N1@OG=/Z>EY
M05C)NP+MGES((+<..!^]X2/F9E&?WHE 67F/%\UU;.=M3((6B]Z'#S;^(7W,
M_L<_F&/BUPO):@J_7 A26#/*R9%_F0B,+#*1)AWU/5#5>%VPY5!KP W_E$H5
MON%Y@:%1W3B-WVDKRA: ]*G8]V9T0RW=A93@WKJGL2Q&Q-'5Q-8DM?=V4D!+
MMT#&#_L413=F-WZA<:^5"A3O8=[W7K>TRM["BT-Y0'^[BZACDV1KHNA.>(I7
MX*([^0 F52'"/59=WF^Z1QR3V3"BR6.GR/I+=<I5$7??']?VG-)0-4PEZ';@
M*"EA3F)+*-V6A)'E8J>I:O)G^1VWK><&B>LJGZ,[<GIR,9F ^JNJ4<<XST,5
M#TW9Q@D?3M/"E:66D6$9GP'*H?0$!7XJ&=)>WQ+*S(+XQO$S<G\2CWX/144X
MBQ74"7Q5T/4KUARP_?U#2.#H.\3 P,"+LA3Y65Z8N#Z<**3DD,\=972 '7:!
M!NN6HUH?O5!!&??]K9'J(SSUHO,R%=#8])NW9JU9>O"8E:06AZ1/+,E4[83]
M.]CP8%;3:8D:)ORA)HDP +WD';+'89S0EKK@AQ!2VN23U8@+X3:BOIPL/"R=
ME=M!H K,Y1%0=8//X=+?5;X+_'']%$[[PK-/TNLT)@Q!4X,+20?,>([XN(2F
M!MV[.^=]Z_J$60'&3WR<)M>=L>. P?)J(SSS5"M(C(S=UO"FO3(;"B5.SH#5
M=1/04=UO["X-41/++(BL^:W7<?%G*,>WRAY!41$K:-3F<.FH7Z8;*Z*2C,IS
M//&A]M.:MGJSP=5R(\R+RHW3EUC2*BT)!V;1=<S/'")P' AP1AMUOMOI_>GC
M2=Z/?_3;0YGJAN%=8K3[0TOL&>$,U*TEMV,#"_L,V) @L]X8.^062QYP.2+0
M)!PANY\[>#Z&IW<G-E%V)UHK%VX1)!R-A)?X*@W0]PA <%*L'ZM1'K?(6F^'
M;\W_-MO^RB<Y/_!J)XZR^[>=\S7Z)?4O2M[1U+.%/I$%IY":9,DAZ792U-E
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MSB*[[1ZN)%IM*B?%D'FWF/2IGJ2$5+.])\>PAK#5R4(W5)IP<=OQ!3=G*:[
M_/#8*..3UNP-U!E;4A[=1\#/(9O: (R1,L*,-$$5=VS4?+=6JI.,3AP<*YWA
M$%=]FAG8L\[U7%=!I;ZH74O4 ]#D4R"@/UDIS:Z9F:N;/B8[U<1L2AIB,?;H
MY<HI3:793IS;N7@$/&5)OY9--)LH/-',)*03X*4+.\GF,1]75V+'1IG682O#
MU!UPW67Z0MAZ4=Z/D0W)+>>57>>;3>M/R8<QUL[*)T09Q7H'9T/.+I 2'6D0
MDTJ]^D>C<DJ/8TV&DXRO5XW(4_("OGC:1H H,27&D;X?L B]B9].@X^ 66>_
M9KO-7C'V2(E9GP^ID.+:B0MM-LE$'9S5'PYO1K&E$#&-W'9:J#N]1%<B\X#V
MGJZLIT!GUJ$=63/.4CYU?JIZDCL@>-Z/<C_AVEUK0GYDKF[&GNS4XE]M%%.&
M?M515,G+@X;:)4&N@Q7@J7N-O:6VWE@KR?:3IG:OB'YAHY]X*C0GI@Y.^E@4
M<T3Q1!+!*<AFRO).)3D2C8QC4#"2. <F^NP*FH0? 2B@A4PP+\9W1M/[]%OK
M#R3(EFF"HMR9OM9B7>LS&4F]2<('M_E3^Q_]>JL&\VGTF]Q@Z*B%HAX4&QD;
M\GG.\.NZ;HL>U/9C7]3+'\U+KJ+AP=9U?GPN9XZ]G ^\+=D<\WZOKW-66&]4
M%W66&B_QC;]F%0/4"M='O[I4UQ+SFUQP^*W>YS;XC5N,L2IP1CE&F4"N[25:
MJF9Y[TU5YB\SWF]KT$OU:]&2F]XITL5ZD6N,XR==".DPY53Q_N<^MN:9H^=_
M"P ,,-8 G/P8X277WKH_*XA:7=B)=/?KC'2Z1RM*L_2J_-Y.K[R!>UW+["<,
M69XMZBN89N0.6,:]-EG#_H&0^ O+*9G,KFEC2-Y;(XB2$^P*&^^[['H9;SO%
M] W]#??0O0((2A9UFW;-3'XB?Q&3[6CL!>;^3ALD27=[1")^PCR51.K,70WU
M><MS[0*"J A_JV'9LPT.6Z,+R%B+:4'=U?$*N:A-*5PR7.ZGK:N+&J#-'$21
M]\PL+UBY=M8?=]'*]71Y[5ID9Y-5/O]\N?7%P]A(TIVT%:S9-D_/>@5SQF5(
M16Q"!'4(:=/Y&0E.'\D=B*?Z-?# 7.?PX4U;;:S*4UN2,R>#V&<O>C14(#&^
M:=<CL(OTP#NE;U5+1*6R:K"HT]SF:/%=J>*<5.2!<$3;1_KDZM)'SMWILC&H
M",BS&]XZ7FF*_ PAP7F*,,&NFH6#Z#I&D8CNN=UGJ8ERDWYO>U:S%R]/R=W4
MG!,EFT-&[ JS:[I?\SA43X2;(?6&A.XBEJ'ZF.?R0R-&(:Z 3X[DB"\'&_8*
MEW;S/=T2Z5(I#!#;9C$6%B6Q?C'HIL?2&Z(0.GE1!F#[<JKSDK*Y.I;)1.[J
MZ%VG*")ZX=*]KPCN^.6Y6Y\;)SBF3K:2?.E.[&A%5"5A@Y,*'P;CWN+CH!XJ
M>_CK5\.)8FV+=(3\;NGB<_!1+",Q838NO/U67F9@ ]'6RIK*D%?U)TLA:S$O
MB:2UWWXL(J&SB)BZ!HDE<02=[YV?V=B]J@GA0&)&1'M_2DW=,PO!8M&S4K@4
M?J+4CY]_,&4ABNO/;(R[L"QKN(!H:\+SF3)T*4.<&@VC><MAOD2S>I.V;&O0
M38NJ!.A:OU((5NW;M[^\8E@L^E2L\*YI-6VYEO3T[]-#H@KNVT]6.?Q31#2_
M78-XK.T)KC4?\%@6(;*[0YQ6>$O/-E;P<QUOPHYBWJWYBC5*,D3M,N2;SO@H
MERZ!R%1X$^A2KC3Q%A; WQ=WA$W98MK-8B>+#E)7&GT^W$J%F1H[C.OT.3K2
M+QV3J/QJ9UJ W'>"1$Q_EZYBZHO??G/UZ/Z^Q]^[E_<(:/_N+S0$5_5 OA!>
MA=5&NZJ'JZWU)[[IU1SJ6Q&!UXE,RCC9P, C0]J=]BITC4PB,R&1+^W6\!%H
M3TIT+JMYY B36(\XV,WLV5<6D(=DKAF1SI4[Z&,!Z,,GM<5L9>$_0*FPKK(Z
M=RLM:2;A5<N!)2\[="GG46==G;)\L_PYT9[[);[QK#@@RU-!%)B:9B6\3.*6
MR2EQLB^B[6ZC[C=L84DCN"L >'$< V+S>0?N ,_MI\Y$I^-;.<I *W5&)S^[
MZ/?HX0I3Y<:P?)VH,7D$('X0DI!P][4U+Q9!#]*(UO[97>A$[-AQ&.'W)96W
M/(H';UU?P5>+1T72<_?C[+,5K.]8#6TSE!U2$U'G?80^I2J"F6'.Z[X&MA:2
MVF6;,L<_DN6LJQ4;*WM[=*GZ2*FZ-4:<5M!HU&>/$N_E>ZL<)O F@F#OI>_0
MR!I3PQKRW/[0'OM_6B!%[QQ="\>0(8LZ>D*$,>M*@E&W:R?^9.U45'#J2\[J
M1\#GWDU8EN69V/PE2565G4A+"V>F,S3UO7W_ 5/)@FM+3UD6$K%[M*=#9#@[
MZ3-2G#+49^!)DC]TK&'::$(2\!+A+0" ^O8U'[MSM87@J/!L[/[QNG"&I@$5
M[;1]\HVK]Y=-M<8&)=HEO@!<&.4AI&&F>@SKL'$8AG7H;P'"'=Q2&(60L!(@
MB?><GG9?W<[4QQ6X?4:<1EQ)KL^P[V[<\"#7G$X$RH'PIYM?O/-)*$//2L=%
M9>GH\^N>6:3&7_FP@)697\##3Y8F8K5JJ?T&G^WW**J?E+#*MNF.M.)VX?<=
M&_U[?M.LT:1X7?*O%!11,:'-CX ^G=U%'G]<4/B+[EO;T4S,[$< U#.A=PE[
M;E^W\1$0[DJ) ].D?9N\*5_UCN[*T/*#L&,R4WIR^V%&B\ (!5@P?J*RM%A3
M:= ;+_Z=I*@:E?-DJ;PO@8Y>:L!09]SW7N$B_=7!^E@<#Y"(=O;BX>W%938O
M[/8&#B9.D* LX6>N*,$5(-G:2@2R@\GW8M\N\-NUCW*F$A(BH&<[.3EPCCAK
MZ@S?2BX7AE4OZD:;JNC:"RYXA\3:O(7AT&XF* (01K$DJ:/7$T8G)8QYW+FL
M2O/U=)NBH:?I6PD"QE&XTDJ2?U)Q9D)OM&:3Y-QZ6649G&GXZY['"OES@#WR
M=[<8 7$.G1@<8@-*A=[)L_?)$[PDRV#],KRHJ-(VT\ K-(H+'J>?.]+JDHXK
MSZ UT2:3I_)2 PFOW!WPW>HU>^E?2E=C1PB,U;CQ\%H8%[HZ_)&3TZ]+OH1$
ME 0M):!PJ[OJJTQ)3A[QDM]\UH#NZ<_=>N&H>"$8V/]0A"S?*4S5B.IH&Y,E
M9XF,[V_%L>5@9B-0S@4!;V>8EE)8A*GB2_9K4UN_BT:?VM4F^?FG@4@$D:BZ
M<9^+S5@/O5=+PM0\2N"2=*;B9SB8E9VH_.!5D$W9?"W \)),FOK+1U\T<),H
MKX@%^/#,BE@SW+YPA1Q#P+;,  _M@\JD3YY9N%VA $ I.6"E5MJ:_BO^2I?'
M?J,E83*7(D83J<#%)FEQ!F$OI03.>VZ]J\ :X1;5SO&6NTS;)?PA:];ZOF^F
M3FFM>0"_&O=N(J^DAZQ+7W$E(H3%J[,2NZ_2P?'41GV!B>G.*TDU/X_S1SY$
MTXYVJX_I8:I^5/[L4/+"SYUP[=Y93S/4SG[KFM?>T7Y7[P"KH-^D@_68@=R>
ML7B4.>LSVSF+J,KDJ#>;U916PO2:E=.@RB8Z4L@[M_?>FT$(^XHI3IZUPA .
MA>I)ER9K#()YZV?(418B7HE+F7E7([IEANW@<9#F@BKGI\GRG:HO%0.G@9C!
M)YJ()V4YB4OY_[1S6__^WW)I:FI<:E3J+<M3O/G0E DD82ZZH#L'MUW+^0A?
MXM0] NQ JY_.?++$81A5?MQU@KV.HZ_G(_;F<[)KFNI::V(.)CUV@Y0;Z**#
M67"4I'52_W# Q:3&L*P38O6J7&JVL><5/-H\'1"0I@5LN6[\R/HPK=F]4 NQ
MO>0G%O+1&.]ST 6Y6C!Z(![%=17X)6&VX59K631ITTQ_('(6(2:6,Z.5("_N
M,FNG180V>C!$[#S?#9),>$T@)$01JL+U7"Q)X5!#MFJ"@K(ML)QNZD[R><00
M,%:MZK>(FT8"=V>"S_S7+0!:/XGRN#NOTZXDG'*F(,S/9$I58]+<I';#@E..
M7/IGT&\G\O28YV69^BK/:[[QU *'SSY,ECX/CT(6$+0+.)LLFQCNSHD5:SEQ
M:RC6O0X\*OBIFZ%B3:IL8CY/$O*U,D%*$:/CR!M=$?>:6P-J5U,=S\H^>8&^
M\.0%!EN"'_J1N.3.38P.HC>CG 9!O_!(QR1)>;.R#QO]OYP7U;!Q^0LM? QP
M#,IS17+C<1;MZ+!1M !M@_@NG4-\XUA5L'^L._BC;_WB\2>Z-E_]S2)ER_Q;
M[KW?X&PED.+G:\&YQ7<K*!Y[U@K^Y/NXEM#& O;\H*-MR"N9'Q;Q6\A? W(S
MBV:LI>%2WR&*HM58(OP.3)ZV93\L/ZF+DELCQ!\QS:#$%B?QA6]@R)NLZE5E
M]IXI6;\">1,L9L=\Y#1S><FI@D:+*HA2/+#6\G$?1Z"QQM>VQF6F_]5GY%F
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MAKC#KWK>;2\A)$JO2'$99T1Q8TNRH!%1[PQK%MM@9; P2LSUXV%VS'U1]:<
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M+&3T45-WS+8RVA4Y-&?WDF#B)KLS)I<2Q$"VOT,+H-Q#,#!2$62$=9]]'_[
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M00_26NN!/D'F+>0#T4[%-;,[W*O&A5X C"2>#YI2%(@0J'N6549\GP2+_Q\
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M/Q?U@\YJ(JIK/_;]3KDQ76ZZ%%O],5 LNL!FM]&!=W OD&(]/ZT!IDR#>(/
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MB"(0?R$MO$Z!YSLM"D,2#@;1T-VOW?A>"3P?=KFK_ L(HF\N8&*EP6O=[_+
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M\++M#,U92_W4TJUB90O9BHZX?VD/JUA5LT+KU3$JR+<EBKT-'R1SA/* ]?X
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M5?VD8O7L)'D<'+:U.8NKQ]C:;QK4V]4=GE7WN%&J40Q^FVS_J02-46[ #ZI
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M[%<$RL+6P7H>:\5N16M=B,^S(MU7/Y45S'%'[?H+BGY4W$:%#\ESP8V<*<6
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MO3C[+O0/./[BPL6#;BPY,U_BA]D5)W\ N+/\.D;C]"E\GL"H&X0A$.@)T.]
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MN* KWVT1)!W,0L/SJ40'"_\+KK+#I:N!+N5F<ILM.I6ZZMOL1%?XXP5AC_X
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M.^YU])UN2."/QB:K87>CU;#;UBE@X%9^['^#U7#_K^HY0IZP%259+0KLLG&
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ML"N-*+W6>\I&Y\[KVYVPY[^<]T]_/O1%B=W>DQML\(UM[X:M;>^VW;9W.]^
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M/E;A8V9=<;'V7*GX/,<'OT#WBF3B&RNJCUO@"^R3B7P)@W.6B(<D:[NQ6-Y
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M%#RA, !@),:36!%!RBD*34YHD\ZCGE36Y!8-,AED,L+)H6P3LWH8?X\,&LJ
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M9G@UQ8GF#&9 X>D'/_(K&+SNLN25D64;F#^K 1?30XE?H]9<24$ "GWW[#X
MOV?W#,;4M(H E :K+[M=ZOR3S.G:3+K8OO%#9YB^8*MT<;ZCQ/DF57L4RB#^
MG]']O'L1?R8I0KY9E?%<GZ&+?J-9\>3MV=N:+<L;8F-//OT*W_(-?.Q<41/<
MB-5#B]@(&A<9=K]=G+T[BY'"F>WGPB!4Y9]MLB(<*/X$3*0T*]1Y_05^ 3_
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M>/>+^AZ#7EAW@GTD_/M5^%?,\JS]&OUGLEJ_@N.)H>V;9)GT=L-6=M;6#&]
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M"K0E<0.$URZJ8:)Z(^GO_+&XM/#5AB@+QSNY0^=CO)/?XTZN345]$"7NF<S
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M0&,@C"3\;XQX(-H9O'E)DZ#[6[=KA$KIST=+>+?V>KQ?W^5^)1NMJ6MKI%9
M_J8Y03Q/-<SK71A43ELNS5B9_&]6)A^,E<EW49D\"N]1>/]%A+<GHXF7SZLK
M$8$==) '?RK3OH?Z'?PQ\RH5&S:Q9E=9+0X;Y^UB+HLDEZC8^ 4T%KNN>/,
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M?(_="S]PA_H)G&H2]"N3+I,BJU=*U)](Q)7C-U@_AF*PXO*QA'*C/')+9*,
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MR^*RYJ-KL#Q4RI/I0E2]1Q:(X#94@45_*PTK'3,1RXN,Y2Q8G35NW(N86_E
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MO8 --+VCG'+6=Z6'0;)7&[NYD6,K=2;4KPK/!AE [D)< N(" 7(.ZR+ $7B
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M0P[7]HD'SX$WK@C%1SX+0"Q$9"JBJ65ZMPTOW1&&M^'C<GP0A8%#%T:S+,"
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M=1-."I^*24H-NX=+R#I)[4!*9\AJK!WGWT.ESC*VXJ1Q2C^FDP[TO5(.JKS
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M=_*[26+AJ^U[.)WZ'B:)A0-8B$"X_.R)[*^U_D5$>/6AH\#D;8)J$HM#=FW
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MO'^4S+I%WAZB&)]<_)("H(%M??QW,%FR6:JD%0!'2C&_X']A?C98%KQZ<L8
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MX2.^.YF[=WE?[G^/#6)4^K&]L G"(",*E#ACE=U0HW8P9%LJLOO[:L=>*/-
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M,YC> 9N?-IIUYH.YN&8B%-GX"=9Q9$O/F#12V1]>N_.B[5NTO7;,F5RVM*O
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MBN28@&J%9JO9(&=KY.@7YQ%R+]PEGTH!YI>VKXZ2ZY0%BPT:RHZCNWOJ03Y
MF1FQ#Y]8QCM7R7VVE8 /U!-PNX?3K?=7H'W 4,A7 .7>AFM%#-43.1VAT#K,
M3LNI//=#)D!/5/W -#L>J<F&QFK,&2>HZC$4]R$3S0S;_2=F.>+/V#Z\;VZC
M][7PY:AE=WVRMW3-ZX*.-Q0C]!8[_$X/W3OHYD9[H[0.=]@EC#$2]3W(1%VL
M7@J3'\=53*3)KH_V>"50B:2<9-YKU@O;WE.5ZV'&>+-I)>#1JK=]RXN^H!,
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M###+JS(O.3=FL"&KCGX$LV'=G>#7$?1/'!4C];N=B2495%0G( ?G(\D9W/0
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MY$FXQ4)-^Q[7Q/?73,2$]I4;[D]QK;T1JG['&S<C_]#>3GZ_NW CC=&0AC=
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M: \^7:W]]8]Z??*4N,*-'O0^][SZE9$ZT!ZJ]<;"GK6N=$A2$/=C$F)-J4:
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M9+K+Z[*JA7/$(K*Q9.!1*.E]\ES$NA1_PP"BCLY@_H/EOV.U(*)=;F4#W(K
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MG?1\Q::N6<-O!XK3,TDQNY.=KO8E.@H%?M8;.GL3G*J!_;'0,F+,?S.%F0
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MGVGGIFFH;MO-L>TP)61'>S3)'!B,=.SDIT/+C$?X04[]JXIY:$I\349SY)S
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MG-Z(&!7[2 2!H9Y>[CKT'GK(E]AI0VT9&A'/*7QZ>F)Q+\ <"2XF%,KX !*
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M-:OFNDVH2?LG,]1YVIQ#A. P8=3^:^E')/&&*'X\51"EYB%M.TSC#?0Z8E)
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MS5C"\LS =F-VAI@^1#-75[+8][,#JH3+T%41KE>W,3,)U5L'/=(M(F=,>,"
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MGT5=T;"B/^MA85$IA8(+P?.@6YY-E>>OV0AJB8#6$L=%(2Q)QB)UG]0^!M*
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MM=6J 6=^=TQ30#4>F&R)BIB1EE1(>DP[[9+>^K33[J7+@EU?*F#V<0!5CTX
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M)!I>2:Z1_6E?>*TYG8?HFM:6:0GJ4FH[DRMD'(H!5@AYWA Z=S]@[@XW%?Y
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M"O8'VUQPBJ'9$/;?35<@%DHYP,C5]UQN?-N;O.XHB 6G7&3#,>NQ8#F[$>@
M^K[PJ68#-D+4O(>5"^;J!7^UIFA?"AG(IK?."^?#5=(Q]1TB6:"[X\G0[R4^
M(B ;V+-6_&C$C2<2QX@.HUB+Z-<PS,#<!L\0A1G6@_<0P5[L?Y;I\Q8LSB>U
MIE<L0]^"YAX6J6]$:=HNDP"KWYRB >49=,!AM"$7R/'.L'<) I.J%@AA+&(5
M@>889\BX5R;IQ<OQ"'C-XX,1G)<35<1SZFG([50-WYS&.RR*)1.%BEN\4@5Q
M2C.' 9SA)=;*\MC?N- N+3R1?"_%@:>![2CTM/&](?DE)4)#<5W1 H#/L>),
M7A+ZSW<KJ_30@M"SG%U6F"YC[B+-DG.!F '/*$)E4X@XA8B3'WX'XB-1 ^8(
MY$V Y;K9_1'.)VR$@QEWI]OU1]N5@$3@,@.)?+5IHK:3S3Z<\?)Y,O.1>HG-
MX,<%JL*M.+]+PYJ\\HNP@Y-7?BY[C;*$V"UJ7 '=K9K8%W<K(ID'5REG'5])
M5!.!KV@]@^M=-AOI5<%LO!.?MRH1S&?N*FZ8Z=:)BG5$9%**C+#G:]&3'@T$
M5TO$9?,--S#O>#^Z/[JUZ>PF16-!M"H]LZ %MC+=D,IURFH6:9;5U"B# $!,
M"IA?;-<H[,?-74V/EH;\8/.(U[,GD:IA,'ZC1@_^?]FRMBH7 <67'F5;3KR7
MQS[?4!MQB;41)_K5H:Z'00Z8XMR[LB?95@5 CS5_SIX:JTXA5@0"%1J59<T
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M3-+\M5WO&Y@C BRJ.^4;;/&)2JJ;F1J,[[ICQ27P9QCJIX47KMMXE+@"+9,
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MA&-6V/Y?4[J$4:491HACI72Q8NF:>RMG@H#4VJ[ 3BW%O;,MT@.RI1Z0H?2
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M7S_^8BTNXFRV&\[[%FQ@23" I=-0^HTJ.X"7[[7H8?\'*CS9N+VZ\W/='G=
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MBCO%\LOHDBLK6^V.LUV*N+'PV,9\>*BBTM-DJ@#H/G4MEW@**AI>#5=1<-O
MN("I$-JX'-HPRT6,"19Q=:PRIW/,EOC 6_B[;,A;%PW12%:RWI)B7E/?'C@G
MB(%S791_$-@,0;=@I)$OM'2@C C9A#'9+@\@@_T T*9SHFXZ0Z.I'9FD":]X
MBBVB#H.E0ICI0'D:<]A.^-7I!S+S6LNSI&F>M,%D&%1VY3I%A_50&O#<+ B3
M#5W#2Z^++C.'85(\8,]QVFXU3_5188O4CFXB"Y*Z'K6-FE(\]AI3ON7#S8\5
MB'=$Z24$)9VUT6:DB9>CN3PIHYF..C_H+%.?IG5;HZHU\MJP+3*6;NU<DU$Q
M]7"@"V(7BK!]&;>NP<;Q48\X'\N@OA/$78AM?^F2'<U#BU<-Y)4$ZS*\08N,
M6&TF2J6!WJU'1!%X=F>ZPTT?Z]AP);5N]71[5!GA^P],H'+V#W'@TQBIJCMD
M,;5M]B5;F/8_RJ @*J.#1FZF%=P]2Y0;0PEXR51T%N5B%0W<RPB2CTI)(F]/
M5EV'N-P@-YI2;0Q+F$2I.R="U9B00H06599ZCD"DRW9!9C8'$#'SGDG$&OX6
MH$9+"5=3\MEJ]M))_)C@ST\WNNP!44*#>_(5OLF-B]EXV(+C8<J,W<1. Q.P
M:4-%8V5>PE9%H\$?>6(GAM01XY$GP6"!18MJZJZ6C"P[5R.Q([Z;G.SFA&/R
M)OB$16,8/],]"62#$LSA#(X(;$?B3 U%([FUJVCH!Y? 5$YQC+%/J#&,ND$*
M')5N8FH_O24\A3&8+^BAZ+F=B_M0=XT5NGQ-B%-!>;I',,6$O^*B @VA2+D"
M3@XDH0G$4N2RR E[PX0O0X:9&U=%UJ -OC1HE 8$T8%*KY3]-F-!5@LP6F=T
M&&:J-H5V:3[E\35N^8\#^(EOYZ(X?H>!GZ S@*@3"*5QI*<I&##+".R@A6EF
M@YLHSH#S2"NZA!N^#(0(5C:1#\ 2GOLU*AS_L(RI8:FKWQ.G)9RG*W8E=(L=
MB"/$ FMHX(-&K2AF=IQ/B->!0,@: P%27Q>V7FRNBCD?Y?&"<3>BIIX6?.#0
M B]UE9)#UVJIX,?Y+%[/6OJZ=4YZ9T+\;-<:Q7-5-6A6IOB ]BA:2]P2C#0A
MZ4\-/ Z4UR5'K$&WF5GR0=V(%2M6["Y*-, 9K'6R^,\+;-#RR_I\1CPE%1F^
M<M3]7: W>9T>V4%/#A1_"[T=:XXS04,VK=X!6UY31WET?>=HU7;Z5+=3E<N!
M[X5(;0:Z.9[II&QX:)V9$U695&6G3IO,;4ZV4R?HK+CB$*29W-?:O/OOR8J#
MN#4)A-IF4F#-MVD7,7!T-2DD=!>I +EF'+_<;1XQQ4>5PM+O]0\8+W3GNZV"
M,LRG _CW92J'80A]L"B7.P#&150FW2&C-J;;'4N'E*642(K\;U'K5F9SMHO5
MKLJK;VC=KI[*+6IB\%;,<O79QA0H<LOP_+O7*XH&G  0)HM7DTS=N*QS2FO4
MQ]^\CJX"%@8)^IKXXPB^?5:]&D>50E#(M=S4+APY]NR[0V2O#EDM3=,<B7)$
MI+WUO<M"Z1:RN]0\.QD.SLY/CR^&H[/CL^')=Y1NOL&V/&MI.,>ANZR]I_F+
M_X[6"0)&[L;X# WJ*95B_%/LTD!P')S 4T>7EY1NH]\?81,DXUB&W#+%2;N"
MP\0S:GBTT0]^I4G(T<1CE(0U]8EAK.AURY&P%OU?X4SAS&?%F:!1I^E8X];D
MKE8V0,0FS7]=XOPL&H1:4:"636H=,#;-1%FVYAG8N4QS7:G5$B>_*L:369W&
M+5SITPD1KMP-5SH9(.8K#<AM.&>U+1BCXEC!E'#J0 ?%U^A=Y$BL.W9JC0E7
M!#,+Y$)034$;5\>A490<ND* ;G8ZL'OUGT6I:ST(_\ Q\!55DA08OQ8EZ]71
M$G;>"3LG5Y2J T,UC54WNTLC+!U]B75V117I1&)>S/2X<[Z2K%C2R<4&_UKX
MS:>]%W[S1'UB%EZ9Z<D;(E,:&(,CM0DC8+ 26QO?53=8ITALR7E?0NE*V^I&
MTJP8%J.24E*=;HEF%EV'[7A=4\F'2T*'-J.B9P06J:^+HWJ::L0=FECE#-SM
M#JF&E[#?C*%K4L18?5QGG,>B)>AR""M)1'CX>I!%>.Q>>/!DZ*US9L&1>1(/
M.AP/$F&-[\UC>/EB7=(4+TVNI@C\+3D!QB 1QO;GD EC[X*Q2<MR45?KMJY+
M4!7<@(J9KXEB,"$&LLHY]DR%526\IO61USS&3';J,+41)<B1'#U;?@D:(:8(
MC\=\!U5#18VE&6BO?ZR_P,%L[^*U;^!X2=%^_5'JM+",VVG D<859-G+M:>F
M8,'V8E]BR8-S=KK2W#3N#/L69LF6//R%&\F#M^8%P2]H0\+)>/>7M[^8>"Q7
M*W!0U]86.Z@3L[%U*:D'KPL[=TV]6@/$P=.ED5K%N*K-56:FG!01M-85=%!&
MFBS@3NZ6&X2^)LU]>VX;<]BWM.DL8^VU4-Q13-J?!4$Q)NHMY;O7<#N5;,*!
MH*J0V.E>(I"[^=Q44%.=,MCE1Z8(9%V CNJCX0.D;O.Y=F\?2_?V[F $1-,Y
MWA!B7MI:H'0V5PEA5ZKR$L=5X#AMBJE,&,001/S-@@=P5+6>D4-YOK9*R.@+
M1QOHF33TJK3":8\$H>H^J[JK[W*!,QFLJEDNQ*-HARNN)SRK(9X61:4'6[ 6
M;_1\'7@1/\IJ<RO7\5785%,JGJ:Y7"JEHRKK"J;J,LJKUK6[NUJ*2<-+NU>]
M(C6DT^!7*?N7LG\I4O[JT1"W6)G<64=HU"8T@\*K)L@$"K+>Q-AN=$70L,V,
M8\5VP(,=[VP[O!%<6%N1R;J8\[HJYHU3=5S\.39CHZ S3#BEA'*[,O3X:6H%
MN05-M?]5R=[SL91/;YVF+H9:<3L#(Z8_17.OE2EJHN%2.!(=X4PXW%*YJ1)$
MS<BHY;.V;!UJ,.2FI'@QCND#)K<AIL^U=F&M'Y^R=*B*C.$DUHD)C Q;9'$L
MC$QGG +^?O #]Z<"%:YX%:U!T4ZLMD/BS>PR-8VRR>O@^R'?KN_!>DN-M<(O
M(:.B1! ,JB2!'Z.S 3*'+)I)FC0@->#CD@:#:-<LI[A?EFV64.?,RG:>-@YC
M*Q;*&"QD8;4C,;O%7]^/[EA?IVXE7[1VI V74"QDX];?&E?02[KES+S&:[X_
MOF.1RS$>VR8<32916A(23EV"D68G0=C#\3,=@=_,5Y&YO/&W&I4("V#G<YZO
M2$,9T5[DI(1>H4;U;QNT/ZNX*;F[EP $5]NVN<G\-OTW86!ZV[.L)U=LC:7^
MEM.@%&*@*GB75D R6"MSF@%=MS^&1WV G8"S"A]?8]P4$9VH\/ N9J/JIRM&
M'%HP2!5BQ'8WUO3VWI.D=F=_ULCM*QO;B2+><>RZ-*9S3VW-^!)*\2Z0,6#S
MC#=#G'>=8F". EKFX^@DLG.VE*&*&5-?^Q$IFC=JQHEC@N72U2NT8XG97/[]
M;0?8HF=NH,-K\VE)B!WRX$&A7TDE;ZX3IZ<F4N#<G'GJ<>ZL\3JBMGKC;KI0
M8P1LI)=0M3M%Q#5+;#$"W*F)A!1%V[P_+I58%M\$N0.A*2YS'*U@81<>>^Z-
MTW\;TU,R:(;!8RLIX$&.YX#X==52V3:#_**6-#Q/K1)L0H0!SA/&L$E4@KY(
M665V[M;S*6 M*&]HL&:04^/%6F/&3C+"(,2U E$^71'%H<:0P^F7U-3517?0
MLS. .JUB@.62#KLGE>[O"XU+5U&35[3D"YFM72!66.+X3.N<)&,RV)"-M7_H
M5\;TJ=SLC!/D8KBU3-?"X^<T-*_I$O1/16.934??NA>0/FO?@-&G +..EU/2
MJK'&6*/Y0@BD,FFR4+?:C56N)FM(MJ268-&9ZI[SS\T<BR.T&D:1J:?LFM ;
MGA#M!Y-0;N93E3$O$'0@IU^UD#<B>7G_G? @38LJC?U@9\.R2;S1H@'E8$S@
MM)T71^MRP/^:7/OC./^&#%,[DD5'_^@[2.4H1,G1TV,V*_7)[4R/1GR3&W2=
M)M</98P7/3*(!\TX',]L#AQ5Q!P;H,/76BW$X(PR4['!N.G]=H[1(\0*#LMB
MBZB5?G/WRU!L.-_#23':<E[4 UPD.PW]ZTQ ^[GLPV#(F#%96C ;9U8S%?5<
M4VS%W7T7W=J<!SH_42>Y;YI7#0@VGV,S]*^(S61EYP5DGU$,6K6BB>H4-.L2
M:"!N;KM>_4!.S99<C=2**/:LZ$-6.'L[R9'SK1D$09K\Z066!/T^&/_>Y'R<
M5?([2)#)Y'>,:N,'[TM8<6.M $(O#?[<@Z.LOW"=$;EWGT4\.9F0WB=<3[^"
MA=\ZXG8J9K$AZ:^%DVOR3[8,?^<Q+V@8'(0L&?90GQ^$$-';(K+CN<H.<*EU
M(92>]CK7F,8W*8['A!^.CL.3X3# 2\C J?[5$+"X4F3NZ?X,FO$9C3&,B[#(
M]$%H]O\=9VS6Q3684EW#D-V&B*:^:F>>1PB3Q_F!!B$/^Z,^84/R\!VPJ.:F
MK0/V0FD+53]!E1Q*G%! OK6J:6[SLL-+98%Z/O.P/QR@X:]!.J.\8Y/3P_&Y
M@WX_/!T>;^G[C3>J/7=";X'O5XB;2)X)CFCF_=##LW]%#':]WM$J8B95"-ZV
M%BQCM8"&"/A)'^"@(?%X( L<B7XPS^UIJ<&/LA#K=K9S5.F"6G!_\3$.Y*%_
M^FCT>Z8NH^SW-E5S&&H)#L4O^&%KDZ][]TF_M;LCVNFY:J>?L0.04(4QQP%_
MV@C-6-'072YPXSIO)WQB$Y_$Z4Y2MB+!B?(;0R6MYHLH*FO3=]U'K3R$!&1H
M&OF*>9H[TZ-=(&6"R4O_4)P89"W6CITVTQ]X5H'-$^M"\5[PB6:?4'R!GEWC
M)X>=,!'LKM&-YFDX''OU::$S=L'.I YMX 6?SW,43<4X?&[%ZLA!U4W41.7<
M:!F@&M/#0RA:%2*>$*Q D\(99F:GL3A!R@F/H_9831S_C@TFOU?11-6+WQT$
MX(-0%L>]X -\7O YFAR$NH ]PBBDV:-[G2N1Q0^+,M1N!LF/TL<#ZC@XD8X#
M&5RX:S'ZVYM/7X+W[WWKXFBU\LGO7(#_.[CDO_,TL!('N/W.-?B_JW\U^[X'
MI)]/>A@#P4X#C#U\LA]J$NJ5SO<'/_T+_/1%:-'2/]=%?! :W63U/G!6E6S'
M]]@67.*47BRTXLHI)H"3?#XD=_%.)MLG ^6;DO.MKNI_[TS2^=29,_VEC!)=
MYD'S!)A_D%_^$&OQ6V!H=]NB@/K*K1:I%C,X$ $+M/CU7__QX1/_/7D=:$B>
M7Z,JB?X5_"4KQN"V?N8>L@_M-#^0 >"=JES/@D0O&]\"OFF*58=OFDN@9S <
MA!@S[6/6QC;Q8P4XQ1.X$.4ZPN(),U-RUDK>Y?:N[=B]^W10OBG7$O<%OZF2
MF!8W[2_P_JGPX]9' %.%7Y85UR@"+Y'(034ML/26^T++%(N9"7)KB6]T>6!:
MPL_TU%E,#W1+EUU6OT:.6F+)T(+8VKS+B)\_#.U4)QY0AOF;NJAITFK=E 2*
M&U&-?S.C2!\.+#780"\'?:!3'V-Q<51-V_%.[7IX_;^^^?SNS?]'N9:BPEFT
M[^$8W=@R)_WK/Z=%K>)I#CMXN="7F"*G*K+3S7K!YX: =W%]/.3-]FN :*F+
M$KSDS$;7""Q!QQRQ_)L**4$,5<WE)5:"F]&C+1OT@G=1'=E7/W[Q3#5829=L
M#/V=)VMGZ#S-\=XJM+\G8OE O,"WK4" LS*\"#[ KZ;!VY8_OQ!_?J+S__^>
MFP>^<I97P\]?0?PW(+@N@[\N9JJ,L&@3WJZ:.HVK$%@Z[GVE-/-YK^X('FV5
MRG[&CM+995"5\9]>P%^&)\>#B]'QZ>CWTW[OG_/+%]BDM>$WAH#TH:=GP_G-
MZRF?U='9&?P#(X7FBSWY5-EX_ZGA A(.1KW3-7B$3QYAWC^!_O_01M5F*YN(
M2P8V=0+:66<X1356G9KWC=;;1K-'=FXKY0=I%>L*LD Q\)KCO7B2 A/4%/'M
M.[ZC]NZI.B6M DXGF.Z@MEUWK&SLK2K 5>?^<%.<TH;BRJ6+<>)X8G]M.WN=
MYB^48K:/'<.L:455(>C-4BN9CMP;I,7!N6U#VO"0-]Q:A%8/=S)R,V+8[;-V
M)KI376C*38>I$W:,:O-6W=I#'>K=5N8.?N089X!3RQ+5<QI <8YZ<-_@+2UP
MO.:1:=%T?KO^TS2BN?X JG&MJ315H]M@\:J[/H3B6ETA]2M%>G7>5=CLN6_\
M/RW:JV01OK5D>T-T_EF-RP8A3P9G9#"-;-2>>@"[U>IG+AXO=HLSH-OF<"5V
M1J)P;$BM)X6J=)R.(8 [#9@HP:ZGQ<P\#H-ZU%H+PM;(1YH8HI0K0*V<K4NE
M:ON;',28)T;$ =71G$H=S0Z1.T5/F,R68PDPYOF_<:0)2 ,L8B [[6]D-NCZ
M!0SEJ;SBQ/5O6917HDZ^A:&<.O4![C 8;2:CNH'?!X/^T5\1@T;7#RC>I-C=
MI#EN$MK5'8,1%1/"?;M6&=ADW(0\Q.?_%I5U\/[]>S9ZX?XW>=Y0-!U!%L1>
MV^Z>?U*HVX+/4<;J'YO L9B*AMJV3"K,]LRZDD]_K_1$XM]M9\3O251'^W[@
M2=*<]H)/!U$%>!A8#3A.V^F)/(#"1)&%#^V=>.-;[\0A^1WB +<.\)DXP'M\
M$)D8K9UR]GO;25E1&V)#T?3?X:?9HDJKWR<'8;&<8<.#^="VR^&=_6"*U[_1
M'PV6_$$8!L'/MBOWK>G*I0_]U#;F?K2-N8=D0)SV3D_/Q(!X-,1^MZ WZ;))
MU+*)3E2M]'X;(,\U[=_5E #R:!)O1+%MN.N?3<[9.LKX$2)HDQ T8/MP0IYD
MD#Q^.K<DY05"!T;SN8H(7T]EE6+\/I.C[$1 L$+"QF!ZP6?L\]?Y03=X@Z2(
M: 2@><HF(NAN=0R^P=(?\G:W",-]MT%_G.MT(Y*#PT'TKAI#09<+VT#0-N'K
MK )E$JZC,CG*BN(/GN1F24=92@UL$)1I]0<_M07*Q!ZGX!]%8S:J5%<I'"?&
M]=;3R7GDL$D\?(*G!#]SR[U-/\#G<R@JU-&I-^LC4AV*,#2^2VJ$<)_A=0@)
MK]OZ^1O<T3GP\\:IB,8A.00%:1/.V8*+SPD%6E\%A(K+=,Q;S-./LK3%=+^%
MADN'XQZLXEVH8L\UV\<K\'GA6!Z0RA*T[H="BQ&0;#!.B_DT@G?%5,A,6H@1
MKR8%L"+7Q!$D\Y4!;TV ]Z]4AM JEZ _X*]!-<-2C5F1J;AA1&1;&:T[4ABZ
M^ K3P(FZQ+83?"H">!VA$,)'S4O016E.PYYA22B437O@N$@6K=U97.=!'M5-
MR<@O>)-^*&N :E&!K.$)#0AO6*:JQA0U_.=2H=);<Q.5JWSY[5V(NJ)&;6)0
MP*X59PL(?Z8*?E.74=6 I!Z<C(#,$8JN2@]&,W0*IK"'\*7VJY<)U%V T@-Q
M"=CV"G,9!N%Z(XETPPZ.T#7T60\[=N>+&80Z3__5()K8%2B*"(>NT6>HF[2J
M]1[ AIK2'_IF_<E1DI0(@A,%&5(W("SJ=MS(M($C&5RJ' T%6A1V\^$HN+1H
M*BJ8 84<,Y@9URMA)ZB&-)L52<1%0O1Q="+Q/,*AS8I+.JWSJ)ZBG\P/IX^A
MKD,<\J9K<@ACF0N&@%QL7ORA%NY3\@+4V8^6NF:B S\J*;$5*&' 9B#:OQHN
M9] _[P5?"NJ](OPC)F>=9I12Q!WH'!A[NG@4'<+::19:W1G#@%I+ K]&%6OT
M6<-M R#\)EDTF[5C7XL\IM]P!16/&8$=;"C/Q5-0M#U$JVAY*H[F;446[ZO9
M!8>;>1$.[%]@ZL?P<X >-.>=^0PQR"L-4L_'(%99AJR")PI8C1G4(-R9#4-+
M@><; AUF7,;Q_M.;OQZ'],?[#^D[_KC/7]Y\&1DF)0!K<Q:1^PS4$J^%^4L3
MDH9\9*H!N^1H@&4H:@YVT8\U6"%'" AE?T0RX?TO1X-//W[YY1._]9]1#F<0
M;@6V_)$&G.FYA4EC0>>)C2,S2I%^"Z;2W(J9_WWSUQ]Q]:$]O:$>\V'D'<[$
M+6O@2H:]JH'J-0T;*L#F+\W<1#H(JCT$""BH)08\<:KP1W3"P9!#_86> /Z&
M[. "F"*HFQD"/05&5#+)U0W"YH.BTV.(-==I\N(:UU%XB0&5GB,#RX<SJ"<_
M=GBZA3-,2KH22R6!( 6("Z4=I!G8FND<D2VQMZ^I[/?IZ<SP551[E^-HG1D<
MNIE*F*,1,+$]J#3OA&0_L20"% 0#H"MZ1O":OWXY.CX[-H=).P()0IC#UQ*&
M8JQKC).BXK%$G]^@KF!I%R(CF)6NN?:#<RV?$/-@OF12%,F11AJ+BRG:]0BC
M6:%83"NNX<0K;<\AD"EE<"^\F-Y![L); C[3O]4T^I_/')UY1\,+7&3-81A\
MCO)BDM+TF@E:[PU+F+KB7DB>(X5:(5::2%S&R!0<MEQ+I 2";_A%2V1&J.1!
M?EPQB=7S")JFZ+WMK&GX$KOVL"UF[3[9DH1[8*E G\6AGA6H$3HU,.<:W]"(
M3'O^[2QR!9JCX2? VD>C$>XSB1TKI4.>D6$.U-+:5O8"O>XYR/0?P:(HR1U#
M/+M_-6FRPI2N>QM=7A+GP4'.%K/Y%.P\)+4^!"HO0711_P$99SRSE::/Y)>%
M_GXDD5YEM*RD:;%68S#2*5+'3%5R9RV8#\1LK$-7;4[B,($NU8X'(Q[?9(3W
M-DGW9U(I+4U<FGWXQ[OS<^!*<GW1GT5/EVV4Y=N"[]_]\N>WO_S@%4G7,.LU
MJR8:XO3SNS=PIXI*8DT3S&B9B9^=@U> :IDUV:^H.3G39:%Z>;-X;,>'=Q^&
MSO; [@U/1K=N4T]?U*(]:-= ]U#79%/\FV4[G>N@:N9S/,Q8;PXWDC2T-N0U
MTN8J0H.="KGQ"I 7\+#%W#P _TI&!7AITP[+,.[$!K5'AQ3C0+@P.XW>U09+
M)Y E%GX<O$O10"#:&?%&MU^/1Y @?(#1]-(#H, T/6F-:CA9!2KPJAE7R-2L
M/M#>U(%44*!%R?&KHKR,\O3?QE^EF1E+D[8)7U,1E+7CTC++LQM&MI()#]+1
MR>$9<%_$L^WT2#B\!HZH>3SJS0S=OH:]4T1Q7Y!XF,!1+0Q^IS;VT-1!-Y;9
M .A#4%+L,C9D!!H%AR"?;;)AU>>PD@'VOJH,(FK%. R]_@C<G2Q+#8Q$94JN
MF"(@-D!\C<E!1%\7ZZ\<? :\F@=U.T@2K:C%9YBV.6Z9(^5N$%MH_CE1#H70
M;Q]#,R+/F/YSFM5)W!EK<%9\Y/\VS'(#'2 \(O$Z:<,0=S^B7=707N*TZZ4&
MG4;7$+(A]?ZWGYPULY'*\!A,K$SC=U,\GG33_P'UU T*$B>04F%+N*T]I$?S
M==I](<M+I,DWB6T11Z1\.I*.EZ!Y"$Y05I!WRG!$5N[HN9[M1#3FT)H\4O#Q
M$#$7G)E&+2&V@_])@1>X:I+6YGZR=1,U5Z28HJL4_6^V'-JA8UW9@T/+T%MJ
M.!0W4R6F;])_1\:\*'(:;<0CCB8=E'BS1/C2A$(>-,")@GD:Q63E O[>'#PG
M30_JVW@Y.#GN@?7$(B-D))>A^3<M\N7Q2>_4_L18X03H'S"(RAHP&>)FO)NQ
M:[0E3F'!I=%J'.I8>82Y><!RCR<"Q!J<1J$8QSUA])G1^:C]!E[S<'C1Z[>?
MU7W_WUM#S43/\-\&4]E, -6%R3-MFI(S$Y<TBJ"KFC@WEZNEU)RQ(%TMLSQV
MD-0![L6KO9FIN23(DO1J7;\SB++A^9J&9QP<F$6+5Y-,W:RFF;5L,J^CJXZ
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ML]1_R_Q@UH&)-81%SPQB%2OCM3:&<9&+2OL]'#(LJQ862.-$?%_]0)4V"*[
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MV8P!G?']53M4OE99!K]KN.ADKE"QXHS/29&EA?"23_LJO.0!+ZU3;JY1:L>
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M$V6:-YEGURF_3>7'AB>)2<^?J/3[#EFQ:B%N4U2LW>"GV9?=[<,CRL"?<A>
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M^%"'XZF>]&F;9&MD:T22B203=I&M.8RM$4DFDDS81;9&:LHDNG#/FC*#"H]
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MI6A,M*IH5=&JHE6?I*YZ^.BQ;Z)5]XCC1:N*5A6M*EI5M.HWUZK@JIY</'8
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M 32X2F.@SB._K'>?DW<GMQ^@S;M#8K0FSIZSX& X6J+HU.:7Y]&E8HOA*)K
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M\Q2<PB[V3_:"S44E>L"NGI%<5**H1%&)HA*W>0K.CL.+1]<XB4KT))H.?T9
M)_KK6HH<]TY&H^]N)<GP:TGRSZ:JT\G"+ZWU-10Y%8H\$47V4'!^NBO3$5RK
M4@4O!Z.S7C^ MV5ID0>3H@SJJ0H6<&^@@.Y)\$[%:C9693 :A,&P/X3_QL5L
M'I7PN[H(7IX.>X.'W-_O!5_@BC2/00A7*B@FP<NSX]Z%?<9U5 7S,H6= A($
M2:/P-5.@&3PC24L5.]]0JBRJ>2'O?WUWI'(0,VE^"?O6)"G\'C\^AI^@. ^B
MN$ZOTAI_CNLLFC+ F7['86!&^X5T X%-PQ**RS*:5;3 X:!W8A8(%R'QLBS
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M.U0_J(6VJPM=;:R5(FI/Y3C"M>72^=+4"B/#@S'KH5[-L57F.<=Z3)4$V7<
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M%USEA>R6V/HX%B![VA9SR-?$K+Q1M +@$"8);OVLA]=VQ"AN7D"72**T!AQ
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MEBF/4R\NTBE\)@^BAK-P%H8^J6'[)!(EN3QJ]\F+VLQ(U?GH>E)!^+Q823W
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MG >#SO8X0M(]P0F2;3VO"JO'YQX#6;YK^NUNPA#:LT[L[D@.]ER9%)ED,LD
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M7X7$,/FY!C2% \3H_G4!VUJV/VV[:_;MR['CEMBI#I5MM"U\SE?+NK,Z<8$
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MR91W">C<A_KWTID?!*3^CT*Z407-D<: /M9+/G?JC2X==N0B6$;?P\& DT;
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MMM!Q/6 */'.?J]^R.;^J5TMXVE<)YKYZLN>J(S-?$)AX?MG*9ZT$0P&DN$D
M'N4'?Z[:*J_F()V?=9_>DB5L'AZ?^'[P9SRL;;X*\R%\_XV?"$Z",/[AI]SF
M$\F]O"<X21,X]^'_PGMXJ7_B)QYM[C!NXI$3*\DF.<3LVZOUW"G$3^C&V>C_
M[D<61?[:2Y-[H4SF9O?]4CA>[S[>$YY$678O[W'C<'R(T7<^\H:JG/C[BG(>
MHI=J;(/G)K['^"T<./[FKT^B)P]97WRK\=G=43X0)1_,DIOT/GR W\*W/DAI
M2J9&'@[]@VMN#AO+T6\Q:=GV>T,R@&3  \N 4Q( ) !( #Q> ? S"0 2 "0
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MR WB@_@?37Q1;-!!4J*B#D2.*YU#8HH(*1-ES@DM[Y+X/_OCTWPU\#]YA32
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MF^ST>'A>'ZVO>IYS^BJL9U_\Y=R<_>PO+DS<6[R;X]+A<OGJ=.O'38L,4&#
M(3'@$0      APN OP(     <,  ( P(  * @,-%P&,   ! 6^_.3MONU76H
M C(3F7EVZ]O)R6J)1#R,1'QO;[YG>[=>H]YL^RBEQ;C2TA^_'=OZZH_%L@T'
MMUYL&++]&G5GR!A/3TZ/QSO(84*8<!HUZMF$VUA\NGF9U^].!YW4S_,R+X?%
MKQD6A46G4:/>+/I?/ZXV[P:MY]=._1<LV8\E<4=LGR?U]@U/G-2[IPMAV]W3
MVB J3N=-Y)K)3<T,# /#P/"HWL_^^+21J28H#%\W6\O>?(WA%8P-8T_0V AL
M^!J^GIZO$=@P-HP]06,CL.%K^'IZOD9@P]@P]@2-C<"&K^'KZ?D:@0UCP]@3
M-#8"^R!\C:7R'=U(A*7R+50!47A@48@Q[F%D(8Q]8,;&&!>^AJ^GY^O'_M5B
M7&P(9\/9</:4G/U-+HNXV,#9<#:</2EG_\TOEE]\]H_5\+L-).%NN!ON[M_=
MES9&AK&G9NSSO4%PR:*9LC331>FW8_>>:K2];MEPD5 8% 8, \-@%10&[CG$
M(J$PC18&[NF@2"A,HX6!>SHH$@K3:&'@G@Z*A,(T6ABXIX,BH3"-%@;NZ:!(
M*$RCA8%[.B@2"M-H8>">#HJ$PDR@,%C7W5&Q4 4$#KB&PK16&+BG@R*A,(T6
M!N[IH$@H3*.%@7LZ*!(*TVAAX)X.BH3"-%H8N*>#(J$P[15F=WO)4S/GDM;Z
M\0F>(+V+E=[+U?K$']]5R?_JC_TRYIG?S+[),9^$O)X)-I]QRNDG.O1C*[Q<
M=5/?%H&X8T,U#\3^//:?__&:4R;W56#XJ24_M25X&Z.)PS[H/P%@^V/5G]IP
M#5((*804@MRMR@U\ 5_PTT'*C>$;^ ?^-61(\ ]R U_ %_P$?&'X!OZ!?UT9
M$OR#W, 7\ 4_ 5\8OH%_X%]7A@3_(#?P!7S!3\ 7AF_@'_C7E2';YQ\:7DWJ
M1FU4H84J@% M'?2?GOB,[B?R;UF$_D8,7RU>U]^P_&[MXV:Q6LX6Z>NC[_YI
MF/!,YTBL])Y(+15Q204B0K:L>)Y%<$>S[;N\WOR0R]='C_])E>:!*4&*29Q(
MQQSQ1M07TJ+KRX0IV1S-EOZDRGPZD!?>OWKX_*5?Y^'IZ6;8^&5:+%\<S4Z7
MB[-W_.F?P_;1HUG*<5$E&+X^HD>S,LJQ^?IH\;I*<WJ25INW#Q_]1<JYM/5(
MM?JK+W[_M?X"W$P1-QW)C0DAXF$R\6"M*+SRG,3B(I'<9!)R2D1(2;D6AL7L
M=Q(/FU7\Y>7JN,Z+AK/-VG^7#S\]_^9H-M3#J+Y$G(\)(J[/"<0#XJ$MN1$/
MB(<)Q4-4--I ?*A_2)D4"2IXHK6S7E!:HN07XT%)R;B4D13M&9'1V?IJ5M,B
M45<?TF8;*?N)!\;GQAB$!$*B+;D1$E,(B?XH_]F[TB+KKCA3YDHT3)(21"8R
MRT)\9'4J)"+GF4;&_*6L<\X$&STG-%-+9#"%A, IR=H$QQDS.8A=9MU0C\7Z
MT[6AQ[B=&ZT0>GU3^'/4JZMZ(361F@>8FHX:J3*5)'/):VJ.":BI(8*'F#PO
MS/!T,36C8(QK70@K01*I0B:VC&<1F7-.L:R#V>D,\8:IB<3LF\!(S+[JA<3$
MR<B/B1KN9/T?L\1G46.CR%0G:%01H:T5BEO/Y:5K54$S2P471 5EB+0V$"OK
M'S'FXED-KB3=GDY&<BOFUB)E&CP9N;M>\9/>3+,_D'S[.J_C8LBS5:E?HMIZ
MMGHUFF[8TU8.,!UVSICTU/B6RQ3@IY[]U);@W=SYCH.^:;D1(@@1^ ER=RHW
M\ 5\P4^0NU.Y@2_@"WZ"W)W*#7P!7_ 3Y.Y4;N +^(*?('>G<@-?P!?\!+D[
ME1OX K[@)\C=J=S %_ %/T'N3N4&OH O^.FF<J/'^:3N,4856J@""-7208^%
MP<V-&*Y>&*RY9%2,39L"HT3J*(D361#C:,@I9T99OM3$EFN7N:?$B"2)--J0
MX(HB@IH@=7TC*>B5"X.?#,-I3M^<KA?+%\_JAUVEL];GVP>?GJTN?+?L,-VJ
M"3J;2\'FW+!=+1D&CIK&$>0&_4'_CZ:_5)J[3#UA?&P+89,GP7-'E'0QI9H(
MQ5SJ0+1#^O_LCT_S'\/_4[M& /Z'02/(#?@#_A\-?Q4+"ZXRW%EAB12!$6^C
M(852396.S 5Z$?Z>1N.M5.,>2&;L(Z2)E:X0+8JMLPB6N$QMP-_,M> (@(,@
M$N2>1@#@:@^N]AR@GR W\ 5\P4^=^@ER3P-?F'[O=?H=$J4E<44X%YY(3CFQ
ML61B?#)%\A(MEY?V!W-)9Y<IH9DY(@UG)&AOB-4E&6-",$*W,_T6F'ZW1Z3=
M]>O=<2_QMNK2'V5^SL.FNGNVKO]>+^(FC_6K]D:/['OW7$^-^3&)N9M)#/S4
MLY_:$KR;FSAQT#<M-T($(0(_0>Y.Y0:^@"_X"7)W*C?P!7S!3Y"[4[F!+^ +
M?H+<G<H-? %?\!/D[E1NX OX@I\@=Z=R U_ %_P$N3N5&_@"ON GR-VIW, 7
M\ 4_W51NM.N=U#W&J$(+50"A6CKHL6BXN1'#U8N&H\K),LN(D(R-BX8-<5ZF
M^I/U.60>7;:W:=CXRYN3]?6]>G]XO[QP^[1QU>$M>_4:/A?*[6JM,$#4-(@@
M]S2XCYD>9GH'Z"?(#7P!7_!3IWZ"W, 7\ 4_=>HGR U\ 5_P4Z=^@MS %_ %
M/^W#3[MK\SGI[7#[\]AX7<XO8YZMRNSL2MNL?OJ\GN635\>K-SG/O@KKV1=O
M#XVS/[=]0&>O3M?QI1_R[-6Q7Z(3[[U;M*?>X(B\NXD\^*EG/[4E>#?WBN&@
M;UINA A"!'Z"W)W*#7P!7_ 3Y.Y4;N +^(*?('>G<@-?P!?\!+D[E1OX K[@
M)\C=J=S %_ %/T'N3N4&OH O^ ER=RHW\ 5\P4^0NU.Y@2_@"WZZJ=SH"CJI
M>XQ1A1:J $*U=-"C*VAS(X:KNX+J8%0R49*D!"/294$<TX*(F&)2*1O+;]45
M]'0@+[Q_=7UCT&_?KC_</NG9V[6&SX[]<KA5=U#FYMJ:774'!9":!A+DG@;_
M,>/#C.\ _02YIX$O#%_W.GRE05+MK"21YT1DI)Q8GE7]3QNUSEG8I"\.7SV-
MQEM9QZLA&R*+U,1*5X@6Q0J16>(RW7#X^K,_/LT?'+W^;O#ZT_-OCF9#/=+J
MNXKS8U@BKF]Q;RU&L ?!),@]C0C "!8CV /T$^0&OH O^*E3/T'N:> +$_"]
M3L!YE)Q1X8@)X_4CGU2=@-<9->?<:9J5,)Q>G( KEW1VF1*:F2/2<$:"]H98
M79(Q)@0C-";@8-*U3-I=E]I)[P+;'V?.=ZG]=;M%Y&S]?N/(V5D_VLUJ1,IP
M>KSQR\WP03?6;S<^\O41/]KO,=#\Z+N;VX!0F,,H3%O4;*@*8!BL@L+ /1,N
M$@K3:&'@G@Z*A,(T6ABXIX,BH3"-%@;NZ:!(*$RCA8%[.B@2"M-H8>">#HJ$
MPC1:&+BG@R*A,(T6!N[IH$@HS 0*@S8\'14+5>BC"KAEL:6#'K=1-W=[X]6W
M45M9O*-:D92](9)Y23Q+ABBIM ]911-NU8;GES<GZX?O[JQ\6G[>WE?YP_O;
M*K=W3O^X>OS;/96W:[S#YXK27=TU#00UC2#(/0WB8]W?W:S[@Y^:]A/D!KZ
M+_BI4S]!;N +^(*?.O43Y :^@"_X"9?7[]U;D[TDA<*TU6]CTONK])=0VVL_
M)/@ACW0\>967@Q\OUWP5UK,OWAX0Y__,K\>G9+3 :2/0]NJUYEG9G_W05?"
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M-R\-9J^MS5[WZ]'6\QAF;9:CW=S@C-1K?6#[I]Z<B-A$;"(V6ZY0HQB>0F%
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M2\Q+>HQDC6S[?NU**"=K?-4NBU_F,Y0::2Y]X_727K99&_Z]G\[3VL_-+$;
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MP^XX8)<84YE2"&3*N!OB,45:,($JSZRJ,+6B.H@)^)(FLT\#N]6D9#3#;M9
M0Q-XAMWG'X,QB#O#[CA@ESK!*&85HL%PL%P%P*YU8,AZ$3!U8.X>YCM^21_2
MIX%=4F;0':#^R<D57X7/P5\MIO-K[SOGPV*]M)>Z2;TW9L/PC0]KO$^&BV7_
MZZ#%G;G8J>G-.P)"C+66:(&$(P1QARE2A%:(RRI^#NS*LT?Q/+P%!7VD_A@3
M(HZ6WYK5SBFKG6$)/&/M\X_!&,2=L78<6(LU4U4I&-(L%HSP)"#-I40F2&=+
MC1TWXE'<#<?#VDK*C+19Z0Q-X!EIGW\,QB#NC+3C0%HOB0RED\AI4R).RQ(I
M)6/JH+3!ZE I43Z*A^$!2)L3"D]!Z>14AK&Z%?1U[#73Q I-\Q#@V-E%6UVI
MJ&=15<Q\JV$^U*M+^*A>U7I:+-9F6MO-"<-PA ]K*IP,-\O>UT&+^VOG9C>N
MAAIO4?TGNJP=O-7WK_ZN/<'&V I5Q 3@+PXC79(2>5LZ5DK'+8S5R:OI+3?J
M)MW^C[SBOYX5/RR!9YA[_C$8@[A/'N9.#U.^[8<V[Z0<^BQDI:75 3%,#>(5
M_&9\$$A[[X/%%%O/C^*SZ,RO5_/EK[Z/XGH37K=VUMMD9KWIK*SC)"FJ*H=M
M/H8=_W0S]KMAJ.1AC5CF(<\_!F,0]\GSD$<VMP.MI#-<H,H)C+@%PUNYP)#G
M6)7$*5H9>_K4*)O; UWQ.;UA]'Z(61'JF9[9Z(B8>OWEI91&/<(GPW>R%W;0
MXCYYOG-ZJB[ON]R][V*M=2YPA;AR G$)[%-Y7").L-6ZU-*1<)2\C YNWH17
M/=B\B$[O8V5FL)R9\97NLF36<8HP>$*K9@SBSJPCLXX!L0X3G"PY5<@138%Z
MZ HI:@DB#K-28F$,.\@&?8BWYU%8A^0J<X[,.3+G.!40/*%5,P9Q9\Z1.<>
M. <K%2?6E\ Y6.0<-B;$D@I5005N2RJ4.MCI^*)<G<?D'.)X!:]'K#U/CW/D
M=)^QNMGVJHB%^70Z_X! )]U(Z.G[L(..<'[Y85FOHC?.U8V%EUTUA9ZYNUJT
M[R<1#2-J8UBSYF0(;0Y<&+2X3Y[09B;8EF.W)2;8221,]'1Y6R)5.8I\D,IA
MIRI>'?2'_1R?UQ_75\N]E.U72>V_F?6!Q;_XU9OP^XZF?]DK^O.9ZP]Z &E\
MO!3OK*%.64,-2^ 9EI]_#,8@[@S+XX#E(*3G6E6(N.@4PDPB78D*4:$U=5Y:
M*Q[D%'IV6+ZQEQ-W7ZKR:'$K64N=LI8:EL S-#__&(Q!W!F:QP'-I0D.JZ"1
MD+A"W&(/UJ\$VQE[F O:<*(/VKE_CN_DV:$Y6\RGH*%R,M)7X26YH^C9<_M(
M1CUG3H;QC=AM/09Q9\9W:KKW#A^)LIC&0)E260*,SU$DM3"H)"40/D*]E=6Q
M^[6\;IJUGEE_Q&(LN=AMUD/#%W@&W^<?@S&(.X/O.,"W<H9[0%/D:9"(:^Z0
M%BING91E$*2R@,'';N"2P3?KH0R^&7SSI,_@^U6#K^2&N%)IQ&1) 7P-12H
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MB,?LH^!=J1A&SBD,@!RQF,:ZJM@(J9FG$A_%VW.*($XF_'A!)UF?G;(^&Y;
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M]<0P1(CSL3QPB4S%./*L\I6V5);$W.003BFB&#,(&V,1]UPA[4(9XW4JK(+
M6!PW0.<Y.$1532J9:\*,04WF7*SL^=*KPL/'#_5YC7H"G S7S 6IAQU_\*5Y
M_[FB=2:K]]8?Q"7%9160X3'OWV(@GM80Q,M2ET&XLN3X)EG%'!M/286$BS4+
M.<-(>U,B73+E65E1R]WIDU4^$50,,FPKD]5GA[],0H8P"IF$9!*22<CIDQ!G
M*RR"P<AJPA%WVB-#B$=.!V,%<ZX2!R0D1^X,6KUF$O+L:G)8 L\D)).03$(R
M"1DL"3%4E0ISCWBI&>(8$R0)\TC3P+B(>R'Z(*\^A_X,6KUF$I(3UH;BMC/S
MJ7LLA?9NO5A,4U= /2T<:(+IO%DO?73-)4]=F,X_Y$9AIT)/0>;QFW__AG[S
MM"/RY53E^&-T*U,9T"#E@<D#DW58UF%YJ>2!.>V!R3HLZ["\5/+ #'&78=0>
MD=/;.'V1VI#KVL7MPJ*.*\ WJV'LQP]K;(>Q$',]L>S%.O6"D=D[E;Q34GL%
M_Y,H"!40=Y0A4W&&L*H"=T9P8L0Q6C>\[I3Z6]#RO_CCE&4F5:[)/$!G4,;H
MC-'//089HS-&CP:CRZ!$PF@8>8&XY!)I'@PR''-CL)",'J4SPZ-@M) 9HS-&
M#TW@&:.??PPR1F>,'@U&:VM<&0!@#1$<;&)# :-+@2@8PY53I6#X(-7D2SH6
M/ I&DV'FHPY+79VPNV/4GMT1!57" DQQE?7L/2SQ6/@_UD<)?0_['&IY*IPN
MN_B'[4G.+OX\,%F'91V6ETH>F!$,3-9A68?EI9('9HA[#Z-V(YS>[N7;]=)>
MZ@9.C/55E_,%2/DZ;3/$LJR+N"U1K"[AE2XNNXT'G[Z=QMZFQ;36IIX^9 =B
MU--A&&OWZ]ZFS5ZE[%4:CU>)>X^YX8BS4B"NB4/*>(DTL=Y)S+1S!R7_/R<Z
M\X_KJ^7W&TAX$]YV@' ^<S_U</!;BP:O6C" ;_X6H>!O6R0XC@]J(G!N9CU
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MTV7#UU$9_S/^#VO-9/P?'?Z[RBFML$$2>X8XY23B/T"[IMY;4II V#%<.H^
M_V0BI,KX/PI=EC-MQNOK^6V^TM//J18YC+B$@0W\Z;#!HWK!]U4I/:-1E[KY
M.I; '#0?S+$_GTTH[QO=3"D'J-GOZ.'H;# <!V0-5H@+$9 2Q",:A%%:8NG*
M\EA9/3="A/99YOG,[7^P<^3KF9VN73V[>%DWBWFCIW\%T2_@#/@[/EH]6WOW
M9N&7J>1Q<Q3"6O&)H,-,#OKH0LR<=0#J<OA*,+.4S%(R2QGP LTLI6,I'*#8
M5EPCK A'/!B+)),.!:NJ2LA24*R/E:-T4BQ%\ E6-+.4S%(R2SFYH<DL);.4
MS%+&PU*TQB$0("@EY1+QTE3(2**05-2PP)B1[F@95R?%4AB=",4R2QD)2QE0
M<\_A.5\&UP+M!-7K:)I&$GQC9N2ND7E!?4+EV^.*]+_^OY]_^O6\^.T_X=^W
M/_W^V^L7[R;%ZU]>#$O(B42E'KY_7\W_OMNH]^^;1KU_[QOUGOJ0_))Z%:_F
MQ8N=]WPJI?>H;U:\VG15?K?IJGQCIKGZ_;'8RX:+_[*^@@]L1\5)<$;(0!'V
MT@.MY@PI4@I$I%4<,TQ4.(B4\Y6JM!0E*HUQB'-%D&*6(5DR3+T0N,('5/S'
M=5//?-.\](U=UHM(:X%*GUL+(P94^N(MC*VM??,;W.;'Z=S^\4T!1^I%7&7+
MM;^'2MZ_Z@A]Z+)[PGZXC[Z2"G)6[(Q ;%;;#TP*67JWO@)I7,?/W\&[UP'L
M@-FJV Y3T8_3+MW-K8H?CCS7L"AU\=LE_+OP:["_&D">F3V;@.Z[\"OXO/A0
MKRZ+>M44S=HTM:OC0'7GO?-VO:Q7,"Z@)Y>+>6N33HJZ*98^^.72NZA#8<3U
M?F=WHYLZM2^./8O_[__K3XJ)_>%%VRJ^_=/]<!8?J^@^C)?4A:GGBTL-$K'I
M66,@7/=UF-MU Q>&6[EH)X,Q&:=-G%S.O_?3^2+^V8 LI\75? K/#?;C:N>U
MX0^] FG!5ZL:3KB&\RZ6VOEX/:\;CZR.4_8BMG)>^7K6%.:Z@(>)DSCU>8:'
M-7/7/;[ZH2EB!^:97JUCEWOKI]/U5"_CV1;.F,#;7(%\YZ[X8Y9:-<,3P*SS
M43K=';HG2#+=%\8E' VO-8\'QY'Q 8Q[^+F E[;U E[R.LI]Z>')E_9R5PQ1
MW1?PP-9W&P*W7AQ@OKCVJR3>:?],;FU7NY>9%*&>PE=PG2+^WZPT+.D8@'@!
MK[J:PSS1B]CX6D^;=%"\>G<=$ !,[2(.4ZCC+($'@%7W!]Q36^L7J]C@NGON
MJ_@CGM^LX5WZ"YP5YVTW[68]A4=9[<\5F*O_"R,9I:"+V3JUC03MLJR;/YKX
M5E<P4> [0+^XTB^Z>10G,L@]#64-TH7;@5J!U;Z\/BO>]L(M-)R=!KSQW17U
M,LVF8@U/O8QB2&NB[\G=BZZ;F-<'X[&9%,XO?-1C\.[P@'_XZWC_^GWMUB##
MR=XYW<4;@+LH_:8&70#S*S[T##3-15H>]6P&XD\;17&Z[@AI.TWCJ_M5#>,%
M=TA3S_9*&OZ"*>57<<EO+GP]::=%G88H:8>+^%JS]%C=X*<[QM?L9P!\\8]U
MO6SIQN3V)]%M^^LT:#8*I  DKF.\:[S25K8)* YG2_O [>2XC:H-40$7QP"T
MDR(;CQT??4.37=8CV:IH8(&F-3V#63^=-XWO%ACHFJB6DKT2,:Q>P:*<3HM^
MLS@N)]!<ZV5_5E2E<?W!3]!@/FX1%F$-.-4JW$L=+QH7UOHJ+F4?=14PLCKI
MG'^Y39S9P]"9-53S*F!?(JE<K-6J)5+*<E0):IPT@1I;':< 2(NU/P'_ /AJ
MSK>#];(=JSO] N6>7T# YZ  X+?['022G<D[_0,GOK(*N, TCB&HB_E(WBD4
MN]VRB]@6])#E!7BCEGL!D>F4PQZ%O(27O@ .U#3K+<+VQ!X4DOTC<H%9\MQ$
M+9)VAR8]O^H.J'N'5J*J-<S*N/>P6!NPZ."*8<O4X5*@II8M(ZJ!MP!WFH($
M$['84E%@:.?K"T"L^%JX^+:W'UZ_?=/;#M\!-YU/I_,/*!&9+[K'_UF#"&++
MOW@'QG]XM;G@F^Z"Z6.XU?9I:&2)Z:*O02K-*ET5KO6V?=OHY@/VTE[O[>NW
M/[57V#QAF\ 3EO.K-K<G\4+OHC5E/5@EZ;G@#68=14ODZPY2-YUJTQEDA;Y8
M^I9YM:?\-PR8_[-XNV=+-='PZZPXN--&K.W!&\FF1_RKG_T33,!=JV][PCL]
MFX=Z>\*W #)%V@80W^U/0O_G MXD[;,=HM6\]7'"N.V@W<Q?Z&B?M?(),"!-
M$;<(IJUQL(*U$I<Q8-6%G\7SXWG%-/+FQ/_AEW23!)313 A16\91@OLVZP6\
MS2K-4SN'$07B#VP2@/$LT[3CZJ?S9!T=Z*A].RXRD=LSW=)<:"V 1%^:=B-B
M),J[LQTSU;J/:GEL=&650R4Q&'&)%9)>*X0EBW$>,HAP%*JU5>1-5T7WTZG5
M?8&A0IW=G;URXA.X&,E[=,1P'[2,G]8 (TW'FSY+0<65G8PSXV]@3^1B"7CF
MF]">KJ%>NP,2H7+FZF2E[6ZE;$@: -K4:P"MU0<_!8 $!K:Z;%HR$97J+HGK
MGGQW1W;CPBN:C5<HH]XC;D[L<)]6]NT.8F>(W[EU&WE)0H<Z[?>V.XN1M0#?
MK>?;S7K_9]TD\O2Y\W-2I.V!=E(! 8+)< '4M9L?<,%Y(DE1!=;]EH.=KZ>N
M(_I^4ICU*NV(QEWD:7U5KUHW0/=J/=G=O(5/K'AR)V?MGLBWO'#INTGLO%F=
M%?\Y_P#262;BL(RS'.Y:7*SU4H/0.Z(7Q;V9]=M7@JO>]5;]&O5_@ESBX\.Q
M2P_3\9^MCR'H]_"<47 KO[R")ZQ#7(!@-;44OIE?^4XJ)GH0INM$6N..<S\N
MR3JZG$^=7S9GQ>NPQWR"KJ=I:K2;ZH5VL/1!*K \.REV>F$2J>Z5CEH)4*E]
MHOG&CFDGR53/9FD'W]LIF%\VK7&PR#I*O?EPM83E?^I;IYTNB6$RO7;Z/,?M
M83?<X:JKHSANV_/C0WX?9U1M[ZDS#BL-EM"[.'6+=XOIEG$/T1_[2*$+/)1!
M8NI14$0@KIE%2E*':$5H4,(Z;0Z(IU"N],ICA#U1B%>4(%/J"LDRN*JJC*E8
M>9-XOMM1$.W&02?_]$62_NDCXIN=O9QD N+6!/QQKI>]\PATERX( C)]:]AA
MMHBZB8FY8L148-T0+!%GPB+C;(6P@1_PELX2>6 1E31(0QQ2E%.PH@1!.@B!
M7.FPXI1B8>G')V;<W-G.RA=I1["!!_LU0CG9LY<6 %X;@PGO&DS\_OI49T+Q
MNPM4G?@R2!M3R\1.HFIMHAA[#^_!WEYD\G%- ';/URN@Z[.TN]I< N=*I&IW
M_[7U$25/+O";ED)H%S7F56=YQ'MLV>)F[(K$PUIOD=? 1.]ZG+UG@+=LG^'&
M/O%949P#I4K/F!X)K)S^KZL8Y+-QO&O;Q71TCW._B=)N"K;!>I$ POM<:F!:
MQGMX []:SG4?S]&^=1>O$.- X!'JN8LL&GCAK".I%Y&G>:"HMA-.BF4Y&)S=
M;>W(JW33  *UF\S=&T5>&UE5*V&0Q+I;K+-BH9?%^]AVYV"THNM[R_46NG8H
M;OFV9&]KC^WATJV+8)"S/%.VIZ9LKSMW2^> Z#T70Z9M)ZB^[V(Q![IR"89G
M,D#KM.([+18MRE?PA,4[1."0:>OUB(Z0>QQFG?&\IST^I+@PT$91[[9*+*JS
M+O)G)UHO:LV?_K27>G:1GO(*,&7?A_/3BXT#!ZS35C6_?OMF4H"L 0SL=-Z%
MV_4O+FYY\5VH CWN;MT7S/RM[Q["G9$5F!.6J-BVG0EDA/1(:1&P$4IX:V[R
MMU([8G7%D;0.(TZE1I+3:&<X3CB<=1=_>YU&YN4ZSJ6W"0C?)?X ;Y*^VD\L
M;+G%+EM[_<NK>_F:FBA9302]NZ?(B:_Y._C6+C$(ZVG<N/5+6S?]OFL1?>[+
M#[ .@5+TBJ&(\7.@%:?SEI7-VS!IT ! EV&5-C[1BBTQR.OHGG446R*#$6.0
MT='8+@5%DH(=%!PQDF-2>2ENKB/N+.;1BB>J CL("XVTU139TM&J(EJ4I7R6
M=40F#--)-?IU-$G[IP<HMP!^Z[,S]&-37GH6S76!E-,5XMJ6,/D5( DE5AC%
MG#_L)>J"T1S3N"X"0SP B!B*%<*5PMJ+RH@*'TQY,-O?A#3QW\:1@1F?ION^
M2W06=_Q3<E'S)IPG&T6_C)O[RZ8[^M/G/P7IC7?N[UC!LS8(7E]<+&.,BR_@
M79IF&P)D?(S7!,DE.Q*6QL$'&V2)?Z1@\W5O(=L-Q>N*!,]3:H<' GZ5;.O-
M@DM^QA0(IJ^3.V$_;!SX7W2SI(VY/].Y8%GGM7DO' 7G&"<54C((@!9GD118
MHHHRAPUAGA/\$%KWQ_75\ONWW31YM9Q?O>X\O9WMUYI^O>7WUSBKCA+!0)0:
M?TSH64P [0,&-^%VR1#*=LZ7+@B-*T\!>)3G/#I# M+,$T2Q%D[I@(4@!_P,
M>)NP7 &L<5A$ @/ ,1QBZ9;*8"DI5[<[4!Z;GY55.6'B[J;7I[X.[MI57F6M
M?[\SQM-2<0%TRE PYF-91,E\B5C%8)IK'(0_T/J^E$Q09I$/D9&50B)5*8<H
M]UHH5G)*>&9D3\7(8MC%+3'B8)1WX=.'E&U#UA))R@ODWL+FVA+J@1:!'H]6
MNO=(<TZ0(:ZL;"FXMP<E0[\$!6YC1F]"%Z;_MA_6XS B-N*0SIX0?=1U\#76
MP(E3W/^9PM^>32JYNM307H20_;HJQ2<7F,HK:UO4[M:EE7W&C^<SWB:Z9:_Q
M(WN-4XYAF3RG9']'89N*J&]+9;S-^QOY:-Z(^)RJ]=9YK(1'5-H2**ASR%!7
M(NF5%2H6?N4'1:B8$[[4+B!J3:QT'TJDC7>(E-XI8S0A_'$<KOC^=*()+^6$
MBO$:9MG=^NQC</LJ(H26I>44T4I'0RXFU>'@$'7>$6IPY<A!/#0LH6 PKY!E
MUB#.E$>*&8U*C9U@W'/)JV=8115A7\$:RJ[6!Y7X"%Z%$ BJI ( <-P@K0E#
MK*H,KQ0-4A_L7L-G+O  0&."A>D.R*$"(TB22A/E0DF<??Z-/5Y]%1M[;3;G
MI_M9G\*MFKVJGYW^+:E2TC/DG(9E*(&'&6L\  JV)14:5M51N-OMVX<O$@5)
MB_,H.X=4P-H;[=*[UY=Z:-QDU^H#-M4)LZ5U,+DU (VO+*R*2B-@9BP !,':
M. 0G)FQIB$!2:#B14H.DPAH)6!\EIQB;6^* 'I^+<351=+SQ!=FO^F4S/&@*
M;(DXY"2CB(/1CHP6!N$@'<%,B*I4!]F7GG&"J4",*ANCXRI@7@$CBQD/F N'
MA<[T*_M53TRF=T77"&T5%P@[%0 "G$**,X^<)O"%],HS?PP(>$*_*CV[NS?1
MJ:^+3W:K?DJIE>S4N%/0GU*7;[\LWX:/9K?'(R7+$7E;U;=D6+>5GF,R\-*[
MNJW(& =NOFR*Y.=.GZ3JWCNEE;;;MWWQF/A1U$T)7]K4M;U[Q>-2WF_CI].M
M!Z6M!IC*?_=WO0.VOJV_2YO%&ZP"1I?QZ;XF?%R#Z6X(DMHPQ&'XD5;&(5I6
MJB2L A9G;^(3<0$L&(T1P0K.$4$B4S&)2D]-)8D#@_]YHC_I!.CFA'X5=LI=
MQ>/WC!>]78-Y/_G34G>8-ER6!I625<"]5%P9Q* *6RD"\Y[RPSJ&,.]5W,-2
M+&Y^:5XB&4+,%E"X,DIQ&3-%G]N@H>578="T.[_?U@ $>:+?6["3EM@*#X:)
M4(@[3T")$XDH%ERZLB(5/;#<OV2BOXC%.-Z$_]'+6 /NS?+7^,IOMD5*'JCR
MV01C'/\;[<Q^"S=]U98&[X38[/G&]_WO6>E_B9%N2RVU$TB8*OK,N06ECS&B
M/'CG1,4M"8^V%G[J0B02#&R^;+IO&_*YB/#YQ9RH.%/PO]&NH(@-\<9=@?T/
MK80GQ;>10XWD)?M*(;=HBTWED)&\:NLQODTMICJAJ> 4O. F]"@KP4],6N=@
M\($N\R[V@&3.($U!H1F."3.*8D[=,2S!<VO]-/4":*V_7WT/5TV?(IL(L:[=
MXY/BF#R%R:@U7[O-?\.SU:ZA33S$8?T@VN\%M1W=4K^066IVM-G]SROJ(RN*
M4EJ53%LD@J:Q-*E'RI:P1)QTO,+&$WH0%/$EM.*OJ;?&]*U>KN"7IH\/?Q%K
M4Q\GDXI_!;GE14K[.(P1.HHO(&\X;^1]WK89O0V_6W^D ^1V?:'&^[>XOMU$
M>7V(2'_E03^UY1UW2_+/8SGNKBADW7;M:8N<?[>_U;WT=K[L6C"E6I>UZXK_
M;SO^W%7 __;W:>XI'QFU[1UON->:=9KNTES"NS5W4Y\HNH[QI("VKLYZ[,#3
MGM15B(V/>]OYL6AY+!"_84WQT3JF',NIKS:7N*T7K0ZAGM8ZM9OZT-59GZ7.
M9ZES5>RH>C5/33EAZF;,N,\4Y9CC$A.D'18Q*"X@H\J G"-2B\K9$.A#6%@J
M3_)S/:NOUE<P#]IIT,^"WA2]NT0PHI]N5O*S\=J4_]HO^VTSVX.M^:BFVMKL
MNS5YZZLK[^HVIK1%G(OZ?<*;397;Y.KJ%^(GK]YZ9I>Q,W)LC@!CT/[>]NB%
M*\%CZPO?MA*.^N_/U- U>\<^$L#'L':2QHZ1T2;2L*ATY4@,' ]$&"VX>_AJ
M?-T-W)OERV[8#A;F<18D4:->D2:ULWY?IV6VZ;_S&//[CE8$5BEAE57(,XX1
MM]XBR9U$+A@GC&3$XP/?T6?/%C".Y\M?YJO69U3/W=Z0H\;;[]UZZ?3UZ3/%
M<INP_?$*VR?X?@6,TC8+;A$'-NKGN%NUSWZS"7)<P;<1"$G"^^VY?(+56_H@
M9I2\K[A2\(X!(J)0QA@24%E(!UVBP$L#NL\&51[$D%C.)9;*(U;&O1$'Y\BR
MK! %&J2DLC$JY2#&45\GB^[5?+G=--QZ3.[<ZF![6QWL4&$"3GX RZ_QLV_^
M8S8?*T+>OF7NMX:C=V?%?9U X<AT>%X,]QEP0 &P4@%YP2L =.U@8N,J=;;T
M DL/\_U@TZ\R"A,#BP$F/N)*2"2#9@@'PX1QA 5_4.XX^]4?NC=^X!'<:YZR
MA[D'_,/5[V,)F7^+/V_E@MCA6.R7(:<<!RY(*%)"*!0JRQ06RF)S4$_+5ZK2
M4I2H-,8ASA5!BED&\X=AZH7 %3[0B>\ F>M06WC\<YMR(6-LW7P:6UDVO\&U
M?YRFK#@/NG 12<-R[;_YTH(V7U]$\UVS)_7/IF?%N_45O''J9[@S$L5V*(I^
M+#*%.^H _/;YO8F6/DS3#LMERNV%86GW=J-KK MP;G;&4&_'<-&-89$:>C1V
M69MV&SGU(XK]CMJH,S]M_(>V\>7#NB?M*1_0,8]LN#KAK=)E0 !9H'@8\V"$
M8HPJ)@23E#C'#@C<ERBK%QL)@-S3PKC^!!65BTL]:AX&S,+%M-VXW!N?K+">
M6V%U'7PWFB05.M@/_6YS)"*/OYQWGI;8XVUMFMK5$9C^"TRFI=YM-O1BOEQT
M77W/4A>X.B9P= ]6K( (-2W3:_51YX!J=AJY^=A%>*;;-)"=][B9.'4K:WH2
M=::4TIX@Z1W8EJ*T2%K@X81QZ[D4&(1Y#'7VHV[J&(*RS[NNLV(;@&)+8].Y
M2V([P:S2!J'2MDH$'GBAEQL5$DW1F/277,J[U&L+4!=MF$OTFUGK%ZN>@OFB
M#0DKVIBP..A=5-BV@=I?S\_?[G10.T_>_N#;[N7M51K?=ZZ<]_0P.M(OUO ^
MZ:BFN/)=ZEHZM]^DU>O5Y1R4JT[=W?:?Y99GOOWE=&SMN9YM7FG'@G@7+5*]
M=%%UN\1.5WO-X<[?;9O#)95]Z[F_+^*P[)[U^_:L#E1>;8;LUDNT78 W5WAU
M_N['K4R'H/B9Y!KCTJ$@B48\> X0P WRQ#*.N8/OCZ+X?X_;CC]U986:K."?
M0\'_WA85W(Q"UNU'U^VMBMX8R7=PU /M_?O9N[,B*MP^#"O&)\STQ::PQ)7^
MPV^J<K4L\W_7[J*+UKJ,H4M=+$0*Y8J=DJ/>O-H08-TTOC.7I[4V]73;1C-6
M!)O.FW4?\IIT&&CY]'U[1=?E!:=R1W>9X7?=>E,YS&U]2.UQ2:$GC^Q9\?/F
M?;=A77>]L$[ES98INJRM8A:?>9U P\>VQ%T<6!>@J]_K>IJ0J9ZU^[<P/)/B
MLHYYT8 -T_2(RSHA6[S>>PW/M&ZZ8F@@NO75HJ7WK:B7$9"GM7_?!MV9^#ZZ
MF<_2/5*UM38>KE[:]57<'05CX*SXT5N][L+$UNU2W+Y@'>=%W =IT_KW!;TC
MK1A)W,1:;7:U3M_$4.,8 !<CR #J(LAV 7?S9F?*I!:H;;1>&H,[;99M\'*Z
MC%DW]2S%O2RZP#ZX^<[<C!-S=Z V0H]O8.#S79GOC$0WL6*P7=N_N[M"X@S:
M^;.]S<'M]9=1[JY8+[H^U&F]=;.JN6-R]D9A[((]6_LD!KCV/^-UTF#-UTN0
MX!2>K+/R=M+OT_I\IV?S4"=!M25>)BFQ/XY [,4=^;)>VLMV.<%=IO-%.KF?
M^I,N>A*UXHG\#SYO;]4=,]FLH78"=QJD/:_S=.^[N/^?.UOK)I^4\:L8*K4K
M?@,O'A7;=AAB(_%V)O4+MEU;<&:T5^&02;=>NSC/G26Y3!)M?6!Q&P0>%=YY
M>CWIYTKJ+-[-3QWOWBFIN#:OVW/;137OWF\[6S].C7*_@MROX+!? <W]"H[;
MK^ )+)#  Y=$(.HP6" 5!D-"!(NHI4[&D%ZK'N3V2R%@[WRB#N<S]U<_OP!Y
M7M;V]58SYOVG 9@GW1@E'-R.4K$S3-E@.6X=HPU,-WZ/60.+BLPZ98X T?*]
M#3%K*Q<!6,<*16:^7G45B9K6ZO')EECZU1[3CI1NRS@B7_);BM-5$;:7M0\[
MO"$&541RD/CE<M(%:*>/$'P4#XG"7L3J^>F;Q&HOYQ_25M04%G%\&F ?0.UL
M9S_$^D=@!35-9W:D!P3.VX:+'^:4W/M(\:42%TM'_?2GM^NTE_4F &7UR[UK
M%N]K_Z%)/H<MBTZ/U!+I]JL-TZYSOL?]6;>".D/+$A$M*\0UH0 8L3Y@:7SL
MH,8K<M =_4NVK'Y)>0IOPF:9= IJ/VJN^_"^0*&#@#E84J.-$9K?5"J#V.8,
MAE*+.4>ED@QQ(C$,O<)(,"TJ+EE55H<M'K[$7:^;2R 9\4<LR0=Z+DZ8WV>@
MB5;P-&#ZW'Y$2T R[W@.WA&'(FGC],O.H&2Z<535D,3KM^)-9.,2[CR]+J8U
M?-Z72-S=U4R;#-K!K>/J?.^7J[K=R .<M_&":7]FOJQ!AGH*@+KJG?9INW+I
M-X'J0"&F$5X_7$976A<*[1)01S;3[H_V6T6[#U+'3,R9OX:++__PJR)&0':/
MUQX6CT@[N+_%;<!UC&TS,'8[.&^[  )?F#F<O,\.KC2\#?S7T0 ]^V,;NJ#C
M#MO_PJ-O-[;@P%6]6J>+#T*W2AF4915'N/*Q;GM9(>6(048X(AUU(2CS8 /N
MUST%^IE1 [D*[=&4Y78<DKK,*O*H*G)'NDFY+?VBC<5HC8WTV:6?=O5>;739
M3-,V;UN'/U6:C:IL;NOD MGTJ#BP;H*VT0=TG5+^/FG#]?$5":&2DJH,"%,J
M$ ==@!0M/<**!:%UD)K*8Y"TGY,>C];H-L8K$[#GTRG;\=@)NLN:Y>C.Z4UG
MSKZN1]-1FB3ZG2K4;401:)](3:(IU]&J%+1_ 21GE3R<CU28X@[M0+W3'%<$
MB3)HQ!G8_LI48/O3BF"N=:D.33CBR]+C$! +KD*\ L6@7"51J86PH"Q*5YK]
M,@^WJ(9?>S'\W$GAGB3BC8E_ZO-EESJ//*5XWR!(%6CZW4H$0XP:,%?V&?O.
M MHU%+:;G #/T4HH^EY1N]M^S>;3SN:(&UN)^.^7K?GY,Y>F:UO!/<_BQ#S
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MN8-=(TM*ADV% B<JEA@F2"OJD'1Q"QW3DI?ZDS?#M_M'X_9^BQ8N/V$+YDE
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M> 43MUKU 5=JL2YNVO2$VD(@"?P5P:\WL!F"*.@NA>@)_C6W X\?9!SVHQ%
MI4&C&-5S>+<&=Z!/@NV=6SLL.# ,@-_;[\&N_[]&$YHUF[##A&TF\O"*;=&^
M[:'7<GK)D:#73;#^Q9YZ$NU6OUO7YB6'ZM5)I!C(Y.#.O7P&=0&2Y)/7@^5J
M ?0;2WUW<Y2%,\O"WU:=RE\$=X\*AO_$QKC6\K67=B'Q:F#SZCMW7]A;O]QM
M"#SK-_-.B[,H?QMOVX5X=6W78>=?F45]6WT7E,")( G_Y,-YL.F5$:AW&^<%
M##9E43<;EZ<</]'O[@.VHS'VK#>+YO;B[@X,G'VID3DQLO-M!>MI;@18>FWR
MF6"X_+=6< -X#+#%U3'-[R8GHVTF9BAS1I&\P/+\GT?$N0I&&Z,JQ[Z:8Y_-
MO^@=UG[:#AFL[; &<*\"7MY-!7_;@M[J5N&>!22M/XP>9'W E5-.WI4"GQ!(
M=EL[IQ)4\WV7%.N=@(/T0+US_IK!OGK9KFQU'TSHLC+>-P1AU<KXN@O'9/WQ
M#C:Z4QE^[QLMT=J@UBMTU0#3"0A;W'ZG,U>P38([\6"%OI9+[\$UQJ<]XN[O
MV2<K6OZ1XWP@J __[5OQT*_>25]W/[MYS4>V) *K66\>_M__YR,-(_Y]8W)_
MVGH&9M0:/*@V2=&F7H)W6=@G6"7E]_.=V%CM=0.OI5?7>W)[=#5[+^E4WPJ>
M4L&#=/L@T:^G$:7>F )/]PY"W0MS[=VZ@DL_K*L-K,9TD8&7[SP&>-2A%/H4
M-V0PE/#JXQOGF^LO-ENM'R4Y<TG_B5Q(%872P19Q<_G^[:8[??1.7&LW))%8
M__>-6'X0#\WWWP3_^L7VT!2']GZ^:*$9[0G<6IXG:/A=,V:^=B3* G]O >K?
M>%3&YW2WZDV4:)KM[5UK4;LHLEH:V$5;;!\%DP<BQ_4XPG2^[L'5[$>(PAK-
MJM@NQ;KS#/T+%S;I8KW(CW?+NMJ<>M%Q*G#H,SOCUT>P=\"&6J$;>/[PLP5Q
MB*Y]W&R?O<1I<R#3>MQIZ[;#G:C4@0AD>U>N81&]*XAPN=/P$"6S+&:1)JF@
MG# S9$^H+"$J2F5(59RHD.Z6@*4NF2QC1E(>%X1%,B>"BY#DFA<T+[,LYW($
M#_G=<>57QY0S]>B$7\.,AV$4XL-A"TT K5G=RNW:INH'@4.?I^R#8*?RVBMV
MTHH#6?-YR'4-?[DU@)$/!D8!_VUA>#N:O<^MF&_;:@;+NAMT05\7HT,<82*.
MP.1*#(;CME7'9O8$+!5B$;>$=FVCH*<5]ET)]^%(3Q +)]E+]6I0L)5/0X!E
MT$8#M2L[G,7T#[#9&I>714UR<L03%T(*%I-0R9 P ?HAIZPD<9QG49;1..)[
MS>5I+K*"\81$<9@0EFA.."]" MJD3'B>)SJ5.T"SCE4_MYSR:N5X*P8?Z97L
MM%ZY8I?;)2X]O+9-'+:#E19FC[L,G$%;.5PM[O:3XY52EH2Y3(G.0FE.'"@)
M3V+3P)=&42D+D:J]IO D3<*$JX*D66$:R9.,Y%%"B4YH(O(RHJ*DY][M^2.[
M_7)M:+O9UWII(P)O/T96;M$G[41Q8^!^K==XP#: ?0)K!1)C#J>JUSYEUAPP
MTF"?3]F;/FHZ9&[0UCRAR0-L#3B9,2G#'#S03'(B9:))489Q0E.ABZC\;%OS
M0\>FIPO?<US8+/P*7-A3M@;W^.DS;40IDIR3F*?@3T$X!E%6G!(:BD*I&/XI
M]QJ9GFUA/G^/IR?W. LO?X>?-C!NJYN8!S2\+80^9G),H=@,+&TL$*0QD_N>
M860@Y#-PNW7]()9=^&<K3FUD5P\?84"I)IB#H.K6+NH&:!<T\!'<5L'M-_;%
M[*<;K0VZJ=G*?_J$W;+^0,;7;N\^B+6"J,WDLIQ!,Q:OM7S5NMC>-AM37L+:
MZPO@,/]1W[O^CBAI^SL^Z!T,YBIX"XQ1!E0 L?-O(/46=3@&^)D__=VC^G9R
MS2T6TP?^[<T.(#?=UO=_MY""->P2@T'<RV+;'7QOJOY[J0R3_W80BE%*NK*]
M:#:% (OJTQA'G^%DZ-AR76:E30P;% FL8@G/M7O =<%4MQ;S9< <MDO)2*W#
M?U$'^S+8J__>5H;6_8+<^CU4992P?F1%4A= O$"7I2YLDQSPI6O@\?R]FF4=
M%J7]#%-".T3O\F&ODM+)Z&#'T%8CM"GT=7U?M9+9FQ:XT;CD;[9N9?7XQB-A
MC1;Q&(%]D+(OM$1]-681_)_WX*2SA5- K<2,$9,[)LZD[$RWZ-(5!EKK=C!>
M:H$A=>,+3@[SLVXVW;/N8&UP];?-=Z;B ^M0\&2[7!=N#4M"O6SWEYGB6%!N
MUQ;9T6L=[]P>D^"9"^?GMJ3,J@GK]7M2BL(T!YHM^[[%H$]MOSS];<ZBWK&G
M9H2CZ^N:8OGP/VTS_"Y&G1P J??%GT$9YV#YU55?3^+D/.3=8CM4WWDK^H:V
MX(-H.F5Y;PV&".Y!)]9K4@!+:H@Q79AD5.E-=6?O^:'>+I7MJ'62X$M9;B5O
MW_T0I&$Z<PV*[LU9!* R!'3&V9KV#L'2@1@-^M<"E_M]/-B?;X)OH^]Z\8 '
MW\/N=Z'QL<:I;^G@&ZVPG/Q"_-T!\3KY#?:L18'G]FWRG$69+Z3/6I3Y1O:=
M1V\[K(WIV_<%UD$\YF"@W^;MM4/MT[W)H(]M6&+=@=R@9'_%D@U1MD6WM8;E
MT*YL()8PNXW:+!K8/_"9(,JQ&2L'I39>N0L?>A/8-'51V<2&#6FZ-JH1,LQ^
MO>VF:$S#EJH@VK9C+IJ-N-9-AR_PLN,[(^$=;ZSY&F[L@=D%J]9L"Q""IMPN
M%W[A[9WW5OZVL1BUA4.QMZIL]Q6&BS4W'$S)&1/EZ!UZ<+J[#6;@7F!KCUH%
MA]MCI.&/ML* NV8V2R\7=MR)Q?R,N3S2R:UF;W?KOLXW?['S4>QA+T5]*^W=
M?5NV3^*":K;)?-LIT'51G%ZP$3PS(<5@;C[41V[1N-?J#?G"9P[\,O:,Q^+P
MNSW'P';$>,FG4*=W#G]C1[T83N[S<.3"6U_[8-/IP9UT"BC93_0QTV=\<<+D
M\>$3F^SP<X)6PO:I^[3)Z)DK"#268.^+FY7K8JY6]Z9CI=.I=DG&QH/*V6A;
M+F_5K(,5Q]\?>,=!= (/:39;U?[LDC9WAUMJ"ZMP#1&E;CO 8"G21$*#EILV
M*0-;<&7##I>015WW KKN<4?1#2#X1!_1*8UV])PR06SG\=N&4)\T+/4Q<^D7
M:,PEZ"@#-I3UO<M:FBJ4$DN32S3SHMPNAC4-S+'%&QH16]I14>YF30=@/*;J
M[$Y^RI)\PX3JE<$&8I;&EX'M:@*3(EH>7LE@W,+._L8^)^QSVN]SBK'/Z17Z
MG-",G"<:-#[+QAK_797HO&%$#YU"#\52AEDD.,E9$1)6JI1(+4I2\I*6BBM:
MF"'?G]G7,?*(.]?S?<^P7PV_L-_CJ5"B%C)A(WO37-'42[ULIU;NMCZ H[(\
MB"#M7:[!9SYA -)DY<O7 W8@2+93KA^TU'[+%*E&'>X^M]$MK/=,CL8L.UZ_
MN;.;>&7*U_5V8U(9/EI;;=;ULKVWUPUM>F?0Y.%:"X<]* YZM=OA8A([!MMA
M)SVY5Q]2XAZ")(O+&C>L>0)U72NEQ?X.'V]Z,XT;Z RE44FWVLXZ, _UC!SB
MG<9U]K;XL3NLQY' O)7#E75=;CNO=17\;K@A-42WAO#;U>"E%OLM,3NOUTTS
M5:I_Q+ZJM:Q:+NNB7<GA4!N#JY<L__7T/]#_U&8QCZ1NNNG;;D,L78'N6.RS
ML# '6UYIW@QY.IA%NXL*R Z@ E35W"W%PYMRJ3_N%W@]F]K7M5<16-)Z\[WE
M(P':WS9OS-+-W.B#7.\)-US#96V#$5D[FE8K0Q1B27ORN;O"<X+L0VIF"4UI
MFF8TBN(\!)DU;O!'@QSJ'.'!;ABO:O8D-YWWAQ3<&W0W3Y_>I,.L %M$M$H8
M82&C)(\S3I*RX%&8,A73/; Z3Z-(%:4F"<_-E/DR!!>U*$@6%O!QRF7,\R_F
M;M*OP-WL%+R9..[_146/BOXK5O04%?TC1[\664QI+(G*2TZ85(+DFJ6$BS35
MK$SS0NW-BZ QXSJGYGPR98X,8!GA-"M)6+(PY:9?+RV_E**/OU(]CT':BZ8N
M?<SF1RF93U"MG%(K:<Y9$2I&0G.R.@N%-LV.E)14Y?!1F<;)WGFXF*[\TIV/
M^_DBJ3<?#+[D!"+CL-T=)RJZLP[W( G#E&*;+O.-C4V'?OJG W@=_6*?-3P.
MP['SN$7[-;WNQZ2YH;X=NL15*>YJVQPS;.E_Y F8,WM!=6P.?+I>P3-,&O5>
MK\SY2X>*\4>R9C[Y^S@ Q_;UMGU4V\:U!P;5ZFYKYQO=U&IAX>UK>QJ G5S<
MV%8J>YB6S47OI'F?DD#O]I7!W,.SMPX![>8V=: G\R#]\:X#.TK=/[<=C+RU
MV!\S(P]>O"D?_&E7@]L>))#+QEOQ+UVK5)>U=[/?38<"W,N,\P96MG .6-O"
MG>*W$@Z9W4O5/[?JV@&7*D=\:0[0NM6B\>@D^X+VC.#:M!@W[9(-84_PTBVU
M/8C+]Y%YM*G%PYD4_H.9/F[T5K=O/&O\UK&(/'A3S[+^9,I@60D_(-&K+K\#
M^Q<S>?=Z:1OA%&BYI5U?<Z.U4R%M(G[P9$\\\]FMJ%8GRRJ>LCU*Y,B.KEIZ
M55I=!;^=J P\4A$XL-X!I=KZD.E;O1,;\(FL,!U#P+?G?&YOMSXS#4Y3<4.V
M=Z[6=+BZ<17LGO2PU_;LNH[;!/EA@-QFI"]ZE)'I=73H(E=).SA->M >T[0M
MSA8Y9#!HSG+9DQC\;6UQ;_Q 84;!-_YYHF\&VQW6/^RS\6TX#C'5]N%T;WHC
M##S.'KY9;%I6' ,IK6P]RW%MP,NJ^Q9L*V/K8..9UIP+<5V<-CA&DTX?6%U0
M;DUILI,:?X3BW@F*5\&//8;M :0T<,V@AXY:/&2A%(8&)T.#J.0B$D5F/'SX
M1Z>"2$T3(DJ3(Y8\342R&QJ$.5RK5$$R%2O"! 060NN8,,5#&1<L$RK=/Z30
MJ71SRLH/OFGM[ZUV_\U)RF\=T\Z3?$B_@B#!CG)P>N847!FG CTM4%8\2\P8
M(%%&L+/#5!)9ICE1452P(BK2,!-[@7)9A F+4I)G)O\6,DUXF<,M<AE&FD:I
MH/$$I"'B5^SBI<%TRNY&(B>"912&4\*099PE.4])%&6E.;6V()*R@B0T3.,P
MUKDL]D%N/&<\3"F)$I&#34DRPID&L:!)#O*1%4PE4Q"&]"I%81ATV?R":=0G
M5&?"+)9)6!*="$U8G!0DYQ%8!T6Y3&6A8'>?PU?R>_ZG=7U[2#;^VIY_^-;'
M.._%1W28GBH5]NR%8X'9Z0 #I>.4=,BHU%3$DF@J8:>K1!&>QHRH5-$XE"4+
MBSW?*10R+4.6D$BHR)B+F @0)?@B#>.<<JYU-@%S$8=7R<4+Q@>;:.HDPF;[
MV\2>.S70M(N9*];*24R7M.N3P(=B^,@G"=L9I?ZN;0'B "QV"(D]F/7;KOK$
MP:D^L=.KW>P+N<GDH9B?$G-5< 962Y*<@G/',IT0'N;@X45,A5S'"=VO):81
ME302*0$[:8;7AXS(M(!?59AD95JF/"^.&,'?VB3MKSV;?^FX?!;I3M@5OW3I
M?FH:+<(TVB=)19+"7J8A)UID( NPJT$^9$*2B(()*R#NH7O',WR*\?M2KB'(
M2'SI,H*YM/-.D1>J4 G$2&$>IX1)71))$TD4;.P\5;DNTSU#H2+P(&.XO(@D
M(XR:[S!M\F])) M6IA"!344D6/*5.(684#L7C%]IQDV$%#$.KE,::B)%E),L
M%;R,65G$:J_6HM,P5@43A,(?"<B"@._D*4EBD>6296&I\JE(1'YUN8?[?$I2
M;2Y13X11S^.BFV=)%!8D5TE)F!(@N@G3)"HS2@N6%XG>$]V(R92+G),$Z WB
M'L>$)UH2FO+_G[UW;6[CN-9&OY]?,>6=[+*KT$S?+U+VKE)B^Y1/)9;+5O9;
M^]-;?141@P"# 20QO_ZLGAG<"("B1) <##M5D4D0&,STZK6>I]?5$"FDTO*8
MZC[!J4>3X6OK?4\]N)QZON[4$SQC*L"17JD %"]19#A)*/) "&?!<KU7KJ =
M0)JC&@GX";3"$*1M:"K4+)$J:K$/:,\1(7H)8%8./"<=T4AY2-AZ!*?]/!X(
M)Z0]5RA&X:4R3D>_-[0NPFO:<C@?":,19]$@BYE!BDL9;;1<\#ZDTA!YH0:O
M#>6L<THW,?9!ZCSYV!&"N :-<$1SI#6<6FQD2J4]AY@PG!,J"8"( 8WPH!%&
MTX2L2LR[H$34I@?*0"](T86M8\XMCE4?"Z"V;88/^9C;I/&B4'>FIJ60F%04
MJ2 -\*:@D;6@55X2YRW65M.XAR[***N%!"7,(5D.7,LPSY"6#-,H!%;8W*KA
MJA<[V>O=N+I?.QF=1']> I84@/C<?HY>6;#S-!-_V,^:462EQ,AX3&322=-L
M[&\#1)#11(QP)/ 910ERTBK8SRDHI9Q33#[]?N;#/RF,5M.O8-$F-TV543-I
MMU[<:H.UF1MU]#RQ.XEJ[:LJVG)GFGXPBFJID!)@O[F&LX4S.(\>-8I[ N<&
MM6?],<<N4J*0",J#FC&,;'02U(R9F*&D25?;I5/_F.;!SC&L:%7=:DKNX'8B
M[C3\F$FQ_9_-+/;!N>@=\M%9./5J!8<#X/W>8&>)C\#T]Q(IO>/,L.01$0Y.
MUUI:9(@10(>2"8QZ[.1>9O%C[V;\ DX"LP0KU2[CJHYN5>C9]'7<*K!=04'W
M^IWEX7=-Q#I<"=9<Z$"^RC8R'1CDNW;F=EW0;X5#;M4''PNKK.OG;8MZMVJ0
M\T#3VL_'+C>'O*O M)WNTXUNS:6N\)?E9!T56DUSM1OG6^ZO65W93^.KY54S
M^NOZ>CZ#W^"N)S?58YB9M=;^O(3#]-BO#B#2Z@"ZBBC-4^%M *XFK46:&V.4
MCX!"^^ZM+SV K ,?OW8K]@X6[&W:.7KNJ"2JHW\5EO-\\CS_(GN6$["[O@4[
M,AB,66D]!,>*/4O3AA-/L04KN%M_OF7OMFP=:NW;5G.- X7H'R]CU^AT7/_>
M]0QPG:T'DU?;2=449=?-$)-1CC2WANYZ-IXN=GP^]66>Q=2.,3\2#M]J^;/J
M1&(W$+%J^C"Y64>\6R._52J_7?F.FLKW/(X6GG3<3*99-1'J7%?M?.QPNR!\
M:^GNAHB+ZL[%;N?!'VDGO1DG?^>R=U?;7"0_*UP"EJ>]?-,>8M6C8A[A-MON
M"MO=!-KUSE>:MX&=6U??OM)LA6.3^,%.CXWDN-7]8*M*/]?>;TKTNT86;9^!
MU;)OMMRN5W!K_-8TF\#9LJX2;)#9O,['STV=?FQ>WBK8W^VY?6?3CWOTXF[Q
M^:&]N!>7</NK-MSK6>4'.W$7$WA:$[@:QPU;<NS'UVT/BB/-1'Z#*\$W_ 7^
M,@6+MFC:AO\R7W'&WQ8SGPT?_+J:5+_'X;)M^=CU0._VKUWK5CM!*=PO)Z%R
MP#"GLVHR@RTYOSV3[O9%Q_G<>=/-G]OK+U'&USS2[AK.^!I>QM<\TOB:%S7H
MW<TFX<$KWG[^/H/1_P>L=/RT<1Z<;.SM$S]'&?!^6MU\.ZW^;F\JDZ&4F.K;
M#+8MSOO7/P" -_ZBZGL T/;5\/J[7?[9 -1F@N=NB\'-063GPK<WX_K2;?R\
M^W.^7OC0]BF[RL>@J]DD^N4D'ACS:-\#5:XS'6W.$.-/77=#.&W\8^U N_VU
MH]4KEWMCZ3<3!5>#--OS7-..:W6^F<_R[,?* []I^JK5ZS:-FZ-8B#5LF/9P
MTXT1OG7<Z^ZA.="LJ.X.2V[FWE]=Y0%[>59FUT[N=N^Q_8?;EA*</&;3R<W>
MF)<PKGUVP[6G0]B ^U,_.W[?W7T[<;O[LO84NWO!S9V/<H.]93YT-#QN=/A)
M5K3^P&HV" IGH_5TP;HY*.W)IG5FPGTWC2]WYSZNSQ#;VW*<>Q?"L>W;I_0*
MYCH>*@UBD@;$A53(2NZ14L9Z::009K_J.S#/K(R(I_Q/S,URA&9(.L,5TY[0
M3<><QBOX4[L&+],GR(?M$?RN=0F.NAFG=J5QMNF5..Y&FV9OQU-N:V=-(-S
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M,KY//6.=A]!VQZ%4Y3B W33NS0Z$>;R$JS4.REE=%P?V2];.6U8S1T%6HT#
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M\3K-4AK[N.6\@H< 9<]_2N.IG6:'Q)_=O/I3MV&V_VW<#&B6T+*.E:WKN'B
M;2B]HOI#J$[:4*5GDAAN#M>)-:AD9O70;!_.S.*).Q\-1Y&+D.>H$F2(YL@D
M[[ ,FCJU%]+407#I+4..)X.X,!$9;AUB&OB2LG"]/$+^GE&F_W<^JT]36B=&
M7(G>-H?JF2T;#( 4,.^/+,Y) 0J8%S ?&I@[Y7!2-B$J4D*<&)"\R7UU%/$4
M)T==B'MIUI10&56>IQHQXBQ09+Q/* DKG#)>6[^79OT$8,Y&1IYT3.J0;=GS
MYTSWK'%C<?2<RM%S,/GM/((LA=*5:='GN>B%D9V?L3PRLRP1P;"/B$HC$*=>
M(!VL1 Y;P:)U6(D]]XHD@1&*!?+4P6>\SOGFU@(CX\Q39G3D^!D8&1\Q?=))
M'L44G;\IZMFR%RSNBR0&L^@%BX>"Q0F04TAO4< A%]18BJQ6">GHJ(R)$<_W
MYH<*S;4/P2!"@T(\Y2)TI04RC%/+O;(R[?4G?@(LIB.-3QKJ**;H#+PC)0VF
M3T;FK[.KZR48_).X2$K4JS\,H7B*SV#1"RT[/XMYF)9%(Q+7SB$2DD4\8H*,
MEAQY*KUT)'&JU6U:EISSCKB$A',4<:D",B9PY)ABWML0 M//$;02JH2LBB'J
M\;(7).Z+) :SZ 6)AX+$ 6 W$$H1EL0@CJ5 5E*'7/ N&J:5\&QO@).10FGE
MD>4,T)MPBJREL&44#9P2YP#9G\-!HOH[=+P8HI(\,GSWR(_+.:CQ<AZK_[17
MUZ^K!%H*OY6!G\.@9L5A? :+7JC9^=G-P]1,84*2#1(YPASBAFCDN!.(!&5H
M5#P2N3?E@9&8/!4.&>55IF:Y#YQ-R'ME K9$!_T<F;UDA&5_1VL64U2PN&!Q
M?R0QF$4O6#P8+'861VH%LB8$Q!V+R'DED0G*::J)-9'<QF(:M+&*$L059H#?
M@2 7#  R)M0ZB;F.\1FPV/"2T=EK0U2R2 ;N)OE;M'6\G$U"-;ZZGL\^Q*S@
M#W&2E/A5?SA"<1N?P:(78G9^5O,P,;-1!,X\0<98AWBP!MF$,<(">^DCP_#;
M7B\3Y5E0(B*93$(\12!S23%$(N/<8"*3LL] S-1(XY.."2^FZ/Q-4<^6O6!Q
M7R0QF$4O6#P4+&9)A2 Q12GF!B2!9G<)M<CY2"5GSG.RETNB%#,2JX1DR--K
MB,7(1$.1I P3ZXP4UC\+%BM."A;WV125;)*!NTG>Y!:Q=36=+:J;N*C&T_S^
M#V,?^^/![YF0SXN=/>(0W./]WGLFL<$(Y_3M^ O;ZXLA/L+VF!1"XX"D811Q
MFA(R7G'$,>;<>Q95W&L\Y_,8<!D](I1$8'L>(YU],-18*4SRU"3Y+.DIA,O>
M!L6^>&Y!L7&%#!0R4,A 7Q6ED('!D0$N*9--?HPU0 :BMTASFY B."EO+;%6
M[G6AQ=%BEVB;U<H]ULAA2I&0!&-FN#1*/0,9D(4)#,O E7R:@3N*WLT6=E)=
M?W9^>XGDG2T]+.[S,UCT$LD[/]MYF,Y1$CT+V"'K,$=<1HX<"<#/$G=$4IX"
MI7MTCF,7*5%(!.41Y[EM7G026<E,9%)1SY^C](C"!J:E14NQ17U>]@+&?9'$
M8!:]@/%0P-B32**R"B5M+.*,1J2-9\A286U*2D>QURS-.\X,2QX1D5-QM+3(
M$".0"LD$1CUV\CEZV!(Q4J: <:]M4<FK&;B[Y&^QKBOK_?)J.;&+&$!]X3;\
MV&9=[$^4H&>"/B^*5L)I/:9R)9QVA/*=H3']=K4/"G4]0%V%EWG$0DX!%P)Q
MDR(R>1J#C$)*[BR35)S"C_1F@V;?;X$9_#R)^0=@LV^N9J \_VY>/\IT3Q-
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MLV'O!'#R[4LN]-"W[ZB:Q_HZPK-]B).;BU,0O /$\\4RO)^F?K+,#&X\/=(
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MGZ8^^SSCVP]Q#J9S*QJYI8+7RWE<ZR"BVTI([XY_#U4#_P@*D)<O.TR;]:L
M6N=;GIQ5 -M>7\]GGV U%G%R\Y2A$:\-5<%K1"20'2XT159RAA270NA@J5-[
MS#H C39<@(U7.L%>@D\[QBT*RF6BC@V)Z@4&K_-TNB$'0E9P,9#'V4J=/(1\
MNR$0,&*SQJ.;83.G(T:_;.(?;;3S8->E/C[TCEL(=FG\U(21GFT2SF;6UYGO
MIA_10-2"JJTMTDY1^O/E>OKWM7T?VY%6J&&-K^SDH[VI7W]3_>G9]E ?IRH^
M7+6*[W6SP' D&(AVM?D!73SQ=K7*8[F!CU _;965RD2D$Y W[G+R+'&@W@)(
M8<1. <=[\#'BY6;%U -G@]'F%-Y%WK]3!*;H][C(+H%8KW)5UKZUACQM):SL
M1])WTTAV#T/%_7:7+X S;#!A<'[3C"/.\S#.2%EV23,A*9,^[96)?TEDY"F3
M2BB^&&YEX[K/P$\Y(V0ZC:T4UYD=N=-'/HRLL]E7ZG,[QZ->'D[9*"D:GZW[
M34I[P012N?T[-Y8B&XU 447C;.**AKVZ7\8DL\+FRDP+J*>20T9@C@@3!H#/
M61?V<I\?(T6#OX"$JW6&AI_8NAZG<6P2I.Z9HW'@P'YMQZ%*XWF]:'T76[[K
M$MNY3^<:2I)(G""'L0+*9S&R G@?Q=JX!!J0V)YS, ;/C.4!*6$EL$J69\/!
MIUE*6!+C-/=[?4Q_L3=-/MV/LWEV.9>XSCT5IBFDC9\:7]2F8]-V5/-6TLHQ
M%6M#-+!4J"EOS82L;2A^1-<&LI 7U9O#SW>[@KI-UE[8WYMTSNEB/INL5KM-
M;8#EFN76F+"<:T3?9L#MF6]5GWSHXNNL--NVW,K7W[3< FQOSXB;OEM;K>"W
M[^.P;2S98*?=.>\.!41OC?#;*;5O2MCK1JJKBH$CXP/;JS0U][ F[R\!]*['
M"SOIY@*>9P;BXW> %<8Y@YU"4>2B'>T M1P.*#K*L(B&4;V7?_LU'?&[SAOU
MXET^]WQAS]>B95^L93F[?C9MLNUWG&5MYX=[S59?9^]6WS9E-K-E#:_4W[TZ
M2U5Z)B_[D5WU.4?[5ZGXO1WM;7RB^G.7B-+>4O<@.2SPRBX7L]<N ^N\N4DP
MSJ_PZ^;M:&)O9LL%?,6G&%ZW7V>:=>S>G^LV['4=7]7QVF;/UFJ)&GQN+_W-
MZA;@'M9!D@_C>MR"]*O5-;;>".\,Z]5KOE7*"ZG%'_/2_FD1[G@CN9"$W>M]
M^#[OHA<&4[SY'SG=I4][H^R":/V5EX-?YH>$=-EJ;MMC^[!T#EM,*L1H]?]L
M&V"SM!&Q5VU<++]PV&)\ +0?PTFFTRA0R]=W- =?J4VC1[H/4;/]?N2G#9H=
MD>TCBZ%=H"*)NR0!ZY[_VIS GU0JG2E>+YVX7E3U;#(.U2Y"'UC.9Y+FTV4T
MW.H<==(]\;_ IP[0J?ZHZV<VQO;7@8C.8(?T1^,+8IZMG2Z(V1=)K!&3%L1\
M$8BY[19_?MTL\%@,;3&TQ= .T]"2_NAF,;3/=0[I?-Q?=!#!:D0Y!FG0ISN(
M/%'&^QF&=]:3%+=#.@]0[5-)]PMA]X64-#RN+*:S\Y'$5ZC:$VK5'_JC00?!
MYKDDV43M;HNRI/JMVCCP*)VQ$2DO-.*<!&2,88BX2*,U49+<[O3AZ1-KF[_.
MHSB:[<=VLOW8W:GC(VR.)\@6^W723=\;T"@ WA]9G),"%  O #XT $^.*6X<
M!L1FN5.PC\@I#T]%%9/<*$W27G=A88*,)N(\^<X@KBA!3EH% )Z"4LHY^&@!
M\/[9K^<!C4?PQSQ'8+B_&//<AN7'6_GKC3_F57]\K3V3<-_XW+-%0OK/$OHF
MJB*>(IYBU8I5*VI3Q'.FU'WW?+6]WMW53L?FMPMZR-;:%X+_A9ODS=4,%OK?
M=E4MWFQ;6"&T+C2N1YLJUC^[>?6G;F-M_]O6H?;'254 M+A)>N0F*5[:XJ4]
M'F95B5/-,*)<:\1#=K9ZGU!@3F"-$\9VKUW7UX196U=.VZ?[U_RX;],_ZO@F
MF_AM$#B)ZY:,B#X^WZ38I!=IDWJV[ 64^R*)P2QZ >6A@+(S7C,9&4I""\0%
M;G*? HJ&18*=E,384X1.GQ*4#3X^TK%8I!Y8I$>/IA:7S#E8I)^:P9'U9DAW
M[FATNY'8JNG;^$%NEQ*WZ _9^%)9%'M:(A"%X7U]YV?-;72!H< LL#4F/7(L
M"20T3=AHY['?8W@/=;NL+'LWK? TKA9E3LGJBA4Z?RO4LV4O,-P720QFT0L,
M#P6&L6,*6V61<(8AKEA$3IJ$!/$\XDB#8?'4CI9'@6%QO+=\L4(]L$*E=<#
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MR#%D@:XL?P6[\^ '1Q4P2T#&R>1F^]960JG7S]6\?9H7*^\U4/O95;.!845
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MS,)?;2C\D)J%O5[[;_,L'625XV%_0SF7]MW[9I?IOQ:3C6VF&^Z0Q@BX:6(
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M3/QU(N^]$HGUP;'I:B/ -T"3[O3>E@/M,SK\7#Q@F]%3S\1EJU/RU+U.[^B
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M)3TF6WFD#XES/NG"[F_:S"5<7X_J[R%X/7GJPE-OY:F%DMZ!<=8*+WC*V_9
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MVMW[5@NP_&PT2 ?/P(A,'EG-X:WQAD6O0MKN??L0G_3O<9QA_C<[FU]\FEG
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M)5/WA.L5'Z]_F4U/-_'COT;SD\U3]A)V>8VPBUL).Q[NK]#9<8"HX +C%3K
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MUCB*#&$)42F5)M$&MYTY=+C0S%NX[FBR&$T^?SB+LX:_O8C2C'>*4N$YK7<
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MLM$&ZQAR5#/$E7'(.NH158K99'B,C_-"%DI1*$7+U%BA% =P(,)K"VOWKXW
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M#>!BU?>M*+)\BT>>N:&^(P-Z,I246]T?=LKM4"+CH.Q?2K*"B$6>#5+B8N#
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M4[5\/#<^LKD:A+YC>*;.=&[N(B+[@T]G><&*^<=_UTDU_] L)N7)XE2G[<V
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M\+\J41?*2,KX<A_GFVOE<HV 57.W$M),([9B7&P]E6CU7B+3\ATYA5KYDN8
MM@GFPI%V+'Y54S8'70M/O.) .<73=4V,6W-#B-;3K.1')9^Q K3O2M;Q2F+R
M15(F09(FU?RHO>.6]&3Y$ML=>X;S$P[<;=RY:0U8)M9VUVUSE3:V+7UWCQMK
MQN$TSC&,'3;.TORUZ^Y)>_<>GO6^XXJ%#9;/5I:7MW/-LW1N/D#Q>)V* ;Q0
M-<GNL7B$$?S<2"RVD-7OW4/VY6LZ.RE:^R"H ?"Y?4V*58+XR#(CTK>D;TG?
M[GG+;E*W@U"W:()W1S8?7 '=]>G0,?$F1=L5)$C1'IZBU;LCFZ1H2=&2HB5%
M.TQ%JW5'-DG1DJ(=O**E;7\&ONW/;]D%+S'P_WV9O'.*D7U*)NQ^,N%S9_!V
M#(G!#'KO3]6CRHLF/<CU[4C78ETU_3!0+<_@*C-XI.J6%VJ>%_+(B&^FT/F6
MS0,W<%4[L"S58J:GLM#Q5,/0;4<+(E\+S9LI=$],G#N9PEA7]VS$J=U=!>OI
M(\_:M#<YZ:H#UE4=&W9:K+N"Q& &G1;KH2S69F@$GNM -\*(J59L:JIG6H8:
M1R'W;4L+7'-#F:01.;$1JY$?.JH515P-(H.IFA98,3<BW[<[N%B;[LBU-I4*
MDJHZ8%75L6&GM;HK2 QFT&FM'LI:[861;3DVK-":'JN6Z5NJ9^BZ&G%FV,R-
MG"A>V^@T"#6N^0'#_:1\U=)8"&NUZZNNI_NN8P::&:W5IKW\6JWK (-FT6)-
MNJK#P]ZAQ7H/,:I=11<I1K4+^+_*VG&L/9W513AAI2ASQ2+4IX:JZ/R8[BA,
M.E>OPZO9RZ=0$4/OBC[>S-!CSGGD.J%J^KZM6LS@<B-<SW6- -BYJP=KH2_/
MM'FD&99J6:&G6C%0>R]RN.HZ=FR%+&2>L[8![,LS=&?DVD#NO$V[P/9"^W5^
MHZU#48,=&W;B"\07NBDHQ!<&QQ<XLV%U#W75]DU-M3#WQ=-MIMIN[!MZ;%F!
MMK9=OAMRSPLM3_6CP%0MWW'5P ECU=#\P&.>'1@^ZR)?,$Q_I&\\L+87VH_X
M0D?48,>&G?@"\85N"@KQA<'Q!9O9@<M#30T--U8MQXY47\<]^&QN^AK30XMI
M:Q% 5W==/6"J&?FA:EFVKGH<F(-K!U8<Q7;$G+A[?$$?V9XV\HV=Q@")+QR@
M&NS8L'>(+U!AV\"#AC_RBJ44ON^^)+[L,13$W#N6YT+,?7#,W621$?B1KAH!
M<U4KB"R5.4#*#=V/':#P41!XN]A7_N69NSO2T--G[M33]YS:CYA[1]1@QX:=
M^ +QA6X*"O&%P?$%+W;=.-8\57><4+5<CZN>8>IJR%S#96:@&WPMU_\Q1TF_
M/%]P1H;KC'S#);Y :I#X0E^P(+[087"(+QP:7PAL(]1,S54=G^-QQZZO,L?1
M5*YKS /Z8+!@)P?^OCQ?T$>.KX\TPR.^0&J0^,+SGM"[>AK@7YLS>C>>W LW
MT_%_UX__>ZGQ>+Z-C_>\\GU2-QT$V\..F/:-F3%9Q-YG[)Q+I::R&& [8NDE
MFY?'KY2W+SF'NJ>ONJ!@!/>"09B>^6?AA&7GO#Q+LK,H*=EYP?D4FE.>72;5
MY(R%X?-O/+Y;!#Y#/Q5_K+R7'5623!QK^V&UL\H_H;/*21CFSR6I>^TR4%6&
MO0*6C7VJ<>T[%[W^E&0L"Q.68O_#-"_K@H^WF9U;'-?N[&D![*&B_))GRV%=
M[4L7&ZOL1#OIZSN;[T ]L3-L9Y&GY=FLR$,>U6AS]5P\I48Z 974]&T02D?H
MEV\+D'8W_??;ZIU,_CZIOKT.YZ\L R*(:^J?_W1E:+I_7"H?+UA:+PZK7ZX[
MB^E_8^;0<K1K5/[)E2E+@!0 ]Y&XA,?1$H=P%8>EFAW)2Z-CA95*Q.,DXQ&R
MI^]U"DW03:;J]FO^1MREVU'S%XP++Y1JPI6EFTWY>"5I)M"1"B>![IO6"!_+
M8*I$/!HIN;QG]<(1?,,JA4$+(UX"(O#Z*E=X)AHM?DLRZ7##N57P?]=)(:\)
MX!;9/]ED?'3!9WD!I$C<>,F5.$DYOK:L@VE2K;3[6F.34GFMOX&;0W2.04/%
M^)0E?BSK*4PA@"L28R!? '\@<VY>6@%<R@S R:-2*6<\3.)DV:33C^^78E*(
M8<4'89_DI]<&#&\8UM,Z957SFC"?3NLL"<47T->\+@#=5NQ&\&ST:2+APU]F
M!?R=S(#P\2O  ]V?#<SM]_&"$N9QG(2\*"4R,^@I7 6OP;>P-,TO17?2N7!Y
MEF);GX*?LT*\;#'\RXDU5KY>:YL8Q?,,!JQ!@67S6R>?DN5P:P6FI#*!-U_R
M-%U. [PVAV'%,1@I(0@GW'F11 !H!NT#,[3,,_3^0$^@)= _CM..A9.$7V!K
M8?230LF#WWF(0R+??GTDE8PCT  P/!%&(\6)G, $^KV.SL4%@")O=)M\)'2F
MK-2 9R LV-M4S,QRDLSP[;.\+!-LTRU=EL-UOURN243;]VV[W3QWI?N[,@%T
M@Y3N8N>K&W*)6D%,DAE#IR[(7KLDXKQ[#Q#%H'I:&?TJ91%NF^3X(C%'RUM%
M.F\O;^>Q?-[2W-OJ>6NJ8*1,X*)FDN-D@^;S.):S)@/I:)N_S:P5%Z\>)*[@
M,;<C^5!L=BR'1VA+>,P%1W42S.%;T,(G659#P[X+)8N6[2> 3]$U]>>Q\HZA
MGJ]G\&U9AY.%5.;92+0N%(.Q-EI2G8K?UGH.';\0?9$!(JFOMNSI)31\.4P*
MW"C7GPW2F?(+GC9#(YH>P3AO)8W/:9#UG)1^1C]R!M@VA%/Y"E-K13;DG +]
M2+; 8X9=WH^-/$HJZ$+X(.M@*= [A8D6JR<L5LAZ09&!/I6$!0BIPDL,IR5
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MYQ3XEY-W Q1CHL $U@ $]!X*_ L+>$KL=^CK-$%%4!%4Q'YI<=TY^_WV_>,
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M'IOO?)875>-OQ?F+A#!3,%H6\ E+8W3@X(.$AU5>,)*TK49/J'@@JZM)7L!
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M81 2Q,[CT$.YHC#(@4\ P8XZ2(XZABRI6,*!<" <" <*AO3'Z44H$ J$ J%
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MCP'_H[8CA='0KM'2H7>&?$;5+[5=*!^YN^FC9'H4_Z:-;+!L<MU1%&HJE&*
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M1?3N/S%FZS;S3TEMC:7\K<6<D^7^9TOR[Y5^$*6WV@"U8:4QAX][FD._2SJ
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MT^FF2/_-(?]RQA%39PFV_.O_ U!+ P04    "  (.E=6>0\FA_\1  !+!@$
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M_(39@Q%*?V8,!L,V<Z-GQ&XX2&\\$#%3H@8;?R:G!C9PM V>*C> ;!K$]D2
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MB5?%>[37JJ@?Y2JVPR*+-/[@TD"8S&_H8W.[V"<".\+'"&8[9)VR/>('=B4
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MZL5J:2<P<%_9ESPL)^IA@8!-V:2-65ZT:=EM'9CT99R4!3>.E-?:PL1_1:1
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M<X__#9V1Z"V<9E0/G<Q$;Z$:RK2EF@?I+9"FC5L]R_P!J\@;DOE:29K>@C7
M2:"=SNDMF(/<"-0R1+W%L >Y=I!NZNTC$69%VV$"J[? #*56Z'"GMV":WH*2
M'&.S. WXZK.!W!E3&<W>8JB8;J7J1O$6!Z,F+UFNN%F4_N++CNN0=.XM4NIZ
MO4*&NK<H]+BK>E0H_^K+AM)*P_<6([6MM)^Y[RVYIK4_3F4 L_C\Z,N6Z5)H
MP%NH>F8E+1'LPJ.'.S_[!>CZP7.V,7F=GC@<QQ.'#3/$=8;OT-?:JDXK(  W
ME&EU&N:"=^_TQK! Y!.,/9U-HFI_,>MA"YO:6)<MA, C:13@*/^R)$^.?GS_
MX8?W/PII4.MKH[S43H:LT(24U7BAC+&3,D\@NLX3_E,8.B/XQVB_@4P/RJ3H
M<DB>JM X62Y%4[ZZB8>"XB3B_!8>:G+-6QP4K1@Z@M!1+)2JJ712+YI(L?G*
M>4AJ.3X<)MNCP[-K!3'B%>N#&@Q4GIYN&:.Y97P%04_85G2+:+5QYM''AG3.
MS]>[-K5+FLYZ-_4T(N%:=\$""=_<[N53%B"[6BR3;(U0(Q%,J/3RV]M8[W".
MHI*$VK&7HYG=5ANWUG0'R2XI!@8^L;_NI]AWIZ$Y:<O@"*_B$'$(3>@TJO03
M%&8O:?P'D$G#CZEW7)W!3'_/D6W87/+F;B'>O8JD/"\7U>\Z;\DC/F(5IB\T
MO!HUPA?I[+^ UI:#=I6 4DEWB1XNW48]&2I&8ZAHJVANTJMR >_Q&&OB)5!]
M_,5.;6L8T)L<A4C-IL&ZS,C+"A[+@LY#)K1YV,!,W2;B;,$3W1UI7/_T-L6T
MNRP[1OGT-CE+%ZZ.2JA?QLE+E(<X7E8[Y;S, 9J<A#(_EHM%@-? -#'L'5(8
M -AE9\3-DC@DP311%%>T-0)_+U$1Q$D'RR;G29GCIL@S<AH=VMCS.<=-B&4A
M-3:LC0LAS1*ENXX<>=/9$YR5>4#+6HBM+_*.QI9L/T. _Q8YIZ4-8,OG/(YB
M6/H&4@+#-;^]J<GGN&A,''[:31I^^.T"#B+@1N)%C:Z .4EX&9,#)(V-K?HO
M",,=_AY.U$40HK* K9.0I,H,+XG/$T5\-E#MZLC+;R1-6_AZEV9GBQS#X'!A
M4[^8VZ9Y^.9^*O2*[/[N#%<WWD728NAF/PO$3%<(D]L-]:XK^*/X[:V\I%<]
M[G 5X!0.P!QTC7)1THH_EZ#WAC%/MBATM,)8;=DF7 A.8RL/SI&+315_D8K>
M-&0T-/A0)(5C]XF;M,KSJL(E[N,EXA^AZIVM!"R :)AG"=QO\VH^#P@V85[9
M41^7"9?+57HZ0=!=5C3F5%4*)1:R!W(!_*!,G6086Z0260]RI20Z>F4RHI:3
M_ Y]I7_BQ\LH=;9[D8*M$R*8&)V5_/K4;M[+,['";,]/F+XIQ1(!6B,XHW9L
MWEK4TCFVG6Q$M%<5@^LI3#'-7-Z40J;LL9M?_=><)P*ZC64G-P$EB-[&*.?O
MJ@WE&R:C&R.((\E>ZC*2!8(_H10FF9"ZB_"/7/0VNU(78Y+B<YS&BW)Q\%;I
MAFM8LD':Q_@3W5.\28@[^"AK@BK=3&I:&8:CMA+D<"!Q-*J]1C8D)KN\ETQD
M2GJY(C.G99&3A !:PT!=/#:[>12+TH?I?IO>;L1,[JBW6<&1I6P6WP+&,U([
MBH':,[8R(W;+K:> F:-@\!E"S7BX90)EF[6;0$@CP4Q[T-K%CKC,YB9:LE+S
M/8AF72^"H\ )A8^*:X%@(=N:SM/."G4R0_P88I:T3F"&D\1-RJU(6#%3N0F4
M<\*UY<SR-Z"MT[82>,2\0Z)O[E%QP/D;X->)?7A./.]@Z)MW6&Y#;RM:=[A#
M:W@LO8.E;]Y1\HEZ5YMY>-1DCE?O2NT. J&"0]>[:JJ] \=U&7M71+-74[2N
M)]N[NI%V+C0[GX_A&^ ([&L=/?*&@1S!7;J3E]\PC".X5(IC!PSCY?%%2C&>
MP3!@'M\>U$,L#&/F\=V!%_)A&*$17 VDT2:&(1O!I4 >U^)7]JM#6:X&LEFM
M9:T>F9UJ(PM5DI+U0&HR<-+%=G\;<C+,9(C]O[HV(>,I:9*)U<H5=VKMOUL(
M#+PKR9>GL^V3"X]5O!TOMI'?WK_2WZ[5F/_SA^\[UYC?]3T]:* 5S1W@W^'@
M!$G^B,(24T?_ R+Z# E*# KRJS4_2EFGNV/<]N.'CYVY;=?7QD)0I0^.911-
M<O+.;?7.RY'+PQG4PJ+=@G:,4/L=L2>$%R2H(FV]@[.W8@H=;21W+I9!C&DH
MQ.PV@VG%*X(Q>=_I*3M'U7//*)K..%2I][= W"6:(6"4_8<VF82PV]I(!I@3
MA6C[F#N5L'$:QLL$<3<]/3G1O@PT,:)/ )!K%OS;- J;83V!X@9N1P6P<)!<
M 2MSQ9&1H7U+,#G64#:&A!%IO/+!9783=MFZQSE/'2\B686\OF*.!TKR8%RX
M-T3N77G=)$\ML/B( .(&#[B)@,QH:\ X*[ M>(>)BLE!]<VEQCW?41S&\\[0
ML)D(1^9T67VX;*CPB:/]U3H6&^\@,BEG&A8>/_,.!F05GDW)SZ![ X>WBA7*
MSZAR$YD'ZC8M/V/(#6#$,8WY&1!N(E3A&*N;G]'@-E';FNK\C ZW!-VA:6^,
M\3/;5E=Y$1."HR\YFI7);3Q#Y'D&FGY(Q7GGH!H3Q=K@[ 7U)"$DI!%)MUFJ
M/)*IT-'J4UK<^0F?TU3M;J>L'GM&.Z;27:I&3Y<(.E_O/R>C2E"CITL$D4D)
MZ_:K]!P;04?$2'%\^[?!\_8[_!JZC%8N07MP5JRX=5?UQK! Y'6)X5"&\Q(F
M=QV_DG_EPF 000<;)<=G<+(C,4N)V]KPM&:+90FZE=JT>:VMQ*/ U9\D_<*M
M%V>KR@(IG+RHAT<.77U5C/UNDTSC<=0)(#=2=@-&25]R$Q/UMS\UU5TE?)KJ
MEYOXJ#F.-/1+)5R:2H_SN(A>;.P/&(_##3KHO%L' $OQ]-8E9%C:LO79\:'#
M9@\53=@[I]F16'#4:N]<8$?"P%74O7-W'0F$4/'WRRY\'<28O"6+/@--\#,E
M9:>D5:Z[^F_1I-@VGZ8/Q'-,_%?G01[G]NS!VRF=!PFI2/(X1ZCXA+-R"7.[
MCE/X71PDVR=E+X+JL5R9M?CH86U8+[9S7K-F+;(C*W6U^@(6V9(7@/8+[*X_
M FE>FT)'"^1\SE*TKJ(O2&$$L;6 T]CZ*@CLW(R&UJ=KE&EL/MW8V*/;?_YW
M#!(?A_/U+5JA1+ RBIUMDM4\@@[G*+3>ZXWQ+1#I"*,VIGJ-T;]*E(9K-2[E
M]G1D];:3TEZS_9YC(\@FZY%BMW7-6Z+,KX*DM4EVBB_/O:#<W^:JW:1P$<NI
MU/X@=D\)>CC"=OGV(J%&B:BK%>]5_2;+>99&NVA:B0]+U,>&6LJ(!V9GCZOT
M<&1GB+/X13TL$/#E\0E3QEXK\I"@@R,,=)>EH38/-3HYPD;BTB.B'E;8Z%.V
M0CBE)HE:RA"S!!QIDQ<XH4F,GRI_Z8]DHY#'*H@3PD+7&2:%D%7EE[R?4\1(
M]Y)25Z=(ND3/Q>XG;;+VNAL+R7I >8'CL$!4!]QN;U9<%J^I#9BIG59=S>6W
M]S ,Q90%N.7^4C*E>NLS5K>0-4'A62\=A4$IYH)OVF2_J,+'RWD41!$6IF!P
M/IY"B2GT+*U,N:%FYW,>)!'/#(22ZRRE'/NFXY[CG$5\<ZJ;V&AO-YF]6,9%
M!T9,YW%1W&&&@7%]4RGH,'VH?1KF8_]QTW%%,=F+988>%2P<EXCT*#LP:7L;
M/=CMHB QBKN)QI#GN%!?<A,>2Q)9Z)KP'RF3,MC?HC;'21N1[\1-*'H7-:SK
MO)M0."16FD9V_\$R*5EZ*LLW8,A[5\G2P9WF+49][#,%_YRWV0/#XM6?=!J@
M=I8=R/9=C-Z5V.H#-K&7T[MZ6KUR%M^KZE>6#TO;V=9ZVM\_[5UC+[&'->F#
MY5((*;JUF9+#FI H#X??WH'@C39G3!89+N(_0(1D>4&3P!2#.*3#V'@Q"P=I
M/D.8/K^(\"H.06Q,9UO!<9."P"RI,DT4R)S])V'DM-%/G$(4M6/[#L$4)2)P
M6I]84_8)F]'_$DD3AN6BI#4,03'(\R\IL&="1,\GF/<YFF48/06OW:28XMBG
MF%!WN> 6?NJ+"]ICV\Q3:,]8+4^!V<>!E1TDFM2/($@E;5EF ?4]K%$;!'T-
MUUML^E C['AA!@_<DE[B6O9SGI[I)@B*$5IBY;GU>(U1/G,>-&'XEAW4^HKM
M&M _;EJ0JVK^W@+6OW2W[@D;T(DZ&/OM73F\!:QO]I/<7KQUN1[-:-V=76YY
M*"ZR!,C:2I4HBJNYWJ2P.1;TM_8\$8W)K= $8_)\"&58X';BEN7\F6Z*(%0J
M-V;T$U:?L3! B=J#%\8^9 .N@%#P6&3A[W?! O[9F)704JO0T<K; /$*A/-]
M$E3O, JM2IS&-BSK:_J6X(XW! X!=EL;-K #3@_8S"U<!-U1OA5"C7LO<EPT
MB(6?=H0RG\2NI]_^VY"38:*Y_]>!)K3W9/;!E-I_MR''R^<\CN( KQN"62!%
M^.UMN 3(TY[U'(2'#J.AL7H+<%L =?7\PT66POVRB.% OL?U"XGT@_QW<52[
M&IOKER5H[VEQ'ZR;MOOFE/9:6%C4!Y0C$N$+LNZ2A.YFM)YQ0PIN7BE]RNX1
M)LHUW"2FQ1SN;H=%C_?XP,S8QI:C=6=X"O +*J8I6W[)VP\DT0"A/$MB\J1@
M=)46U<V-A;FDL3$0?X&=@U[OYP'<LD)4%G$(=]T;T)[K"W?$QU.UJYW'JOZ)
M0ID>VFQC#-";A\G_^X$/6O//YH1HD&:SN,7?C5TID* J_6P<J]LPS<;)(SI6
MN>W]DL#2=P3-C.T7*,,<2T,K_BS9SKD'<)M:J:^ZC(O*=DW?K9[.OJ3T#82H
M?DL!YG;U&B9EA*)KG"UJ%SH5+>?KS7L+4UP+7P&K]_$E'TZBH1GQ<_ JOF.U
M_FY8[Y]L%?8O:<QY/$_:W-B<&M+C<YR@O,A25*OR^UPJ;]^GFOOT-=-2<W?M
M#>N-DQ>,)#H&NZ%!=!8+A(DC26G)1,U-SFF9E6G45JSD4"GUZX>OME]IF,3N
M<1PR"Q\J]K02Y5B=]+_&Q?RBA.6%Q;Z-@^<XB8OU VS7M$0/*,Q>4G*N<'TQ
M6H-8T:;J21#-A;S?7JDU).]I^IS$+W1AN-J22E^#7)87#RA>/)<XIVQ2;S<
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M6=5=:-8-X*=.Z71W\]Q26I.M6U0+KH[<7_^:_,]SD*.__W]02P,$%     @
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M?1_"&[6?';^5F@M#N-"E\@?AD;ZPB[+.WEW;WH7%)!&:!EM+OKRS38;!.QC
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MSJ)]S%X-G9T(DCGN_E:))T[/M^I?&KQL>Q!PYC1I])88] B:>$D+S(!&4]X
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M@LVJ>H<U=3 VKSRA!"2#1DCZRHAG=+*A9@_*6OA&>?1S%3,61G&9D\I"\IG
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MWY4[,8DC^''!@V7WB;K8FXS!R,RR ZPV,UNIBUT3&78X,;>!86TYWYVZN'@
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M:MM8M(>**-RY]Z&8,;[$L?\>A.$T\F_@%$0O6 &7QZ;VL7#D"3KH(- @P>6
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M;!9>^DJ68?P.WQC5/-#CEFIU2ZL>(A8'=X_EGY0BD.GY5OU+C[M>D"&,CG7
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MK"2ZC$T8%THN-*#,GP9N9Z"2N"TOFD%.Q!="#K">SH#6'M.<Z."Z_(/LL,,
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M0%9=<8M\&++FXY"U',C696"'S<+^Q]F[YM5X<_8$?9(/<%3<U?O F[Z@K>!
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MR<:H0;7B$RV^:T1MYE4NEQ0#%V@N?#_ ]# ],D+$+IE6Z5-_LV"!Y\*\4)V
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M $*/E6<]+8USI>!\XH^)SPL9^M;+>W-?^F:U\I+M;/D8P"26P0+]D87M!.]
M4%5N#ZTP5@Y[X*,Q[;,8CWB%X60M1K06!V&77_GJ"3YG2Z*,HYG-Q$A#E(RU
MS+.>VCXFQDNEODN%P.51WWCA5ZS5#@=\MCP]^PJ_?DUGR6T,,DHB2XT59'H>
M 99<G2JETSVM='K*2J<OBJF1E9@;'IK3,[)BTR/P3(=L@A,2Y07*"K*VCL\H
M5E0<LG)MHGPV\"PF!.=#E D1.2."4R)\3F26$#XK6>8--Z[%7.WQ+*)Z:HL2
M=[N;$1ZBTH:MVYPO"?4R64HSWZE#2_-JY<KS;=%&R&<,REO@<\."+VD #*"#
MDYM:2X4&KSYHL@A2VB<%5=6 U(GJ-3:?M]41)RI>.JR],F44$J21>J=HH9RX
MK>368_D&FMV'#V53>@0-,N$%Y_E_;[A-L< Q4()?#X^"8*3)MW*0[W G<)MJ
M,9 :X'N<_#8#F85#L)<7KN9&X]LX[5\"6QC'OT5B%G$/#$Q=#2#%_KR4?&P1
M&I.]CHH!?AY/?3_ P;P0M=Z;Z,);!QF"@H48/#*/2X"\EYC\[E\&;X%/H[VU
MLY*DIDP$-6\OGPI98T@*'+H%GPVH:&PZV"HKX3?#\XE3(KZ8DRW!S-VJ2>.1
MLEKSF!13X $\-Q$1LR!B&MAJ!^693X7(N?QZ%JLR7/>!AVZ"+("BE[Z_3@*X
M[/;?7S:C%=DD[KWDT%KTH>2:<\,H#5)IJN_$=;.-,GN+P7C5NY*'7C##<E],
MW_()#?(3BG5Y6(2'R*D;JDBE+9Y5&-[N7 ]8B](\X^%^W!X3:UK$U<Z=*=]D
M=];_Z1)FR%P P=NA.F,W%X"'(PE'@-6:C599UMRB(.93QI;%8B;Z>W[A)<D6
M$0!9L/\TRY+@><- ^^8QW/&'YQ_MUFV00^7E;M716(%!SVX:IG76RV],1>V*
M@=Z2@5A5GY9=9@=\0F2Y82Q%D@."O5'5$C.-?%3,:_ZL8)*E\QXQ&]KPFJN?
ME6-5_LV5>F8MU#O]PL:W&0?@?+$TGXF8#:]L4[-Z*8N8+T])6T]U4O;7\&8%
M+VZ" \^6[&%XC<-#=<>"%BI".;613U[7"A1-+D'[Y4F\/-FDE"/NL[TO35:@
MLVW8=1\R.]XJ]IF;S&XZEDB^OT_B)4U3)C)=T[Z0 A),0*5*D.P D )F&=+3
MKQ1NEM2&@;$H-' =A#2Y (WR)4X.C;$2U048*2)IC7;2%741;,]\]]Y_$I5=
M"VQ@IHL\14&6/L ->QTGZ*1@EVA?#*3\?H>K08ZK%BKBV0=L:()C$S&XN,,'
M"HT;=FFJ8@9@>7969<I1\"WNB9W4_ *UNX=SM05[H1(9?'C(!1.LAGMR>2SL
MM>(KK KNT@&X4SQIA7NM9T:U!@*D^ Z'R*DVRH\6S#"TEQ#DA06E?GJ=Q"L,
MX&"5!V3@AO';1 S&G7$LR(57:BCB,!Q=+K97(>RW $?,N5Y3(I/Q3L/?0;E3
M62"-]/>&2T(CGK-Z^M@9DBYPF#ZU-GWFI[Q:T>0%QOF2Q._9*T;8>-'V,8,M
M(+(3#I:_2JYN.1!Y82,QF!<8"M.882Q;/FM[[$G%2++%1R!B",+'("+UQ"X:
MJ65.-6VJD5V;"J'0NGEE-9Y@#R/V4V=E9;.<Z-'P4:'A#L<,C_AN2B0O*78_
M,6VO;V _T]8X" #Q>08]MY!+@("D4.TX< #7,JW%^5M? :G=UV('2"S:':66
MCW>TC*O;&RD@QV4>[:$*\$(8-$TIS9]VD+A4%V5JZEGDPRCO/4J:2^&;9=9;
M:V^C+0ZEYL<Y*P0Q]"YH7N=TB'?1%I<[I?TLO1HWBV4BLB:G6493OG&N0^_E
M4$_(Q?4#D7F8"DF"-,?.@P8T,BPC;#?=T2S?2ABPRMRO\YB5B:2'%%4H70=W
ML]N45^;FQ120+*NQ8.L2,,Z0V&5 5SGZ++:7D<:03$[<$BR)':XTZT_=-[*<
M _'<D ,A4B">:U(@1((#:O$W$;RB41HL&#Q%OY+3!54L*'])%PRWAGP^G9"S
M3V=GOX7UD"):APR<K@DXRN00J%!,C\.)6'1VRK2L99Q@4E9A2WJ,0W^:W1]\
M%922Z"9%%AW+ 'MDZ8@X"&XB&.8(.=5\34#2A>6LG.17L*4G Q[JOM9J9C5^
M49Y@*L:Q;A6VS/<^F]A^1(+E;UQ=6;C8O>3;NSBCY/<VLXH80A8K$=8+QDT@
M@/&B?/81W'I/>S<7C5.S# 6(44DP,@\G[&.?$(1^)]-LA@X\[<]-.;)TJ#A2
M4S-7 T6'# OM/?U=]T>J[2B>AF0SQ10-A7$_V$A)9("[IM]\]3ICG)+5&+K-
M:L/RF=BMAL)Q0E]!/LZ!$GLM^W1V<5-SUPSP):QQ5\+\E8.(@&9MF*'2?4OA
M[MSX.MUDKW'2 YMI-Z)=F+0+RD?#DEXS&XY6P@M^[%20\RSRAO:V2V%42G%K
M),@B[)WS[0-.@\)CT->TF],GZ@"HW^9#6#;M6N52JW7<SJI-;^'<^[CQ$3%0
MAF]S')5^;D]$S=6I"FB:(^"DPO$Y(#MZY1'TKS++CBS7UP,05USB.4FEHJ%E
M-%R#O%24,-UER"%23!U0#+_^;Z(T2_AA9\_L_-6+= @9ZDL &7=F0J%>*9-5
MLYS**#X<Z(_/^;>U\)7!M0/@\RAIQ\R.V4^(**H@3,@_?_K^TZ=/IV3M)>0-
M2?^9G/[ATP1^A_\O@R *V:+2)L_\R_ #_/,/?YA\^OSCY/._?&*__,/IY __
M_?/DQ[/?ZP47VLA RS7'/0^W?ZXB^OF/D]-_.95$XTW&*E<P7W=WRN/]8&6S
M@9[BSTA.\N+'0]D4S#"E6A0:V1K0W-#[?"G&AD:>+)NM^_(1MK)@$^XD\X*(
M^E=>@A\]53342PI"6- [JUN.0.00Y%M5#1:C?#?<@;+%LGK$.C,]X'$SS[=Z
M #MS;/DPFN<RW(O!8^*LSC3E<W)'P4JE<#@(,^5:<?-W$'NW>J4XK4B H6*
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M;^_BC)(_6D0<-\J5\@HT<&6/F>L@PBW-GM$'%#1GRZ>4LE07 ^ \@KJ4.]@
M)_'R!(;@V3R3@3!Z++&I!:\H=.3U3Q+*TTZSF"22^0W\GB?WC!$:@?W/',;
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MSES$B?KCXB%+5XRM.>8,HDZA"K78/&2P70KV$(<BMO=4 Y@D+F!F%'F\+.4
M037"N7%HG+.7EXP75,#RNAK#D<;P3C*\\\=PC_Q7H224:9G;4UZ_P!\+X23X
M^.DK-'X==@%5"[.IT0]@,<(6T"WHD$9*]X7$Q<.INO.UT2;T(J8L7#@?/P5;
M/NN?=74KZ\'!1.UZ,NZ\;#FA8"G7[NM/O78V$('S64-UG:D$W\MD?5.;UD=X
M=1YUT'.-="!I>[="C\I9W(^I,^'&K$UD!Z?WG25H5K6TE>T;F #9JM)IK=QW
M?FRV1;NM1-D2!3UWWOR 79PI@(!D2*B^\],M)3J HG].O+4S68,TBUXB?_D@
M_'U\3/=A7.QK!\O ]TW2TY0_7UKZX)FKRUK.N"8TUPD;]W%KG;WE.L%.ST!U
M48[]15GP9(KW=)280T&?*RM5X$(JA@B*]]1?XMG(;.EW$P<=JN,P)&G,4O =
M.S@Z6^:UI#Y5FS>/J>5UC8A:;D;$C>$YFEKU";U<2$W<N_0Y+F]Q3[;.A1\#
M=--6*>0"$5 ^>..J3F:Z9OBJQW?)FOWX*SLY"E_D,$EB :<6 +D9S]R2@C7!
M]-5V4HBW&K(A:#86I-V!SMX*65='W.41X58XW2G<N]Y9=P$-IQK0<*@!#:<'
M@89]6E/UU)"A7[N9[S'-!QV)![/<PM09*54B;0U_-09(NO2?8"1/#7#E,5UQ
M%![D;M)RI36L,K^XY&.QT$@6G)(/#7RC<:,-3.2W7MF^D>$J \ HX!O>$3<&
MXVSX!M<8!U+#H]VD80""I_DV2L)DU3+A?0T+%%;W_!R=?.O;E&:FP_[!0[U1
M$Y 6OEA-(=C*.7A5IJ=;#,,,J$-!PB)4 PN;8&W-#=38 1_<\Z-/L2PF9F0E
MM'U/\$G%*Q%D@]L2,Z_DVBCK,O=H+HR])"8J&_KRS2T9#%+<;7=9^L:]T[5I
M[(YG<F!I0A[P($(,AV:W\N$PM5N-IX>H1')$C+X301 B3L5;@JMGYN4AD4QK
MX^AI06HD!% 082V^@CDGX5D_ :=];5]9499HD+LD0@O:0_D,0LIB \(['+Z3
M8N.;J6WV<)!(C!?L^(!P,X@1@Q<<TEN>FU?&*WU.,GQK!/S(<0(Q4*!&\I7O
M, &_)O0L#THYZEM[E>)K=),='#0!P@3_CIDR76Q34%7_R?\.RP3/3;''Q/,"
M?L.LX=TI 5&6;"8-!::>");ND%,1=AUM,A>!FLX%SX0O+GB3:DY5ZM.5[UP?
MVE5L9$)Y6,<Z;>JG7<H&!*2'1?1=FYUHX6)_:_83+=:_B<5*>'RCNO3NN:G6
MP'>JY^(Q7V+URM9ES,-:'7P-L:LUOJGY2?W;I7QQ9VAI<@SN+I:C2&XO)^;V
MU-P7O9!9N56),#NV@GWX:PK;D2NX",](EV)EEGU3L[P(U#R#>J(<[O)WM<SZ
M?JPI^5L":5G@AH4& ,R-M%,@&Q)#]-1"?[KYPH*FHT;BGWL"P%*_3!NP-Z81
M\")0QI\@\[*S1RB3>H^UL0JV'1Y:_?-6VCUYC>*V@W=()=E[7H4-)S+/DKLG
MKY./LKM>%ZNZ6M3+<+7_RDNE\W?D-F/_4;)DM1\ 3:61"RIZWE&J//!CA!'9
MF)KA@U^5 <1?C;P5#I-&)TS5%07%U+0,%G0C\-G]_.O9JI>*Z:Y838H[4(P5
MV0B7"X?,] FSHM4CT]=&H@Q?IWF1MY9F<."4=:-H>VF:T)J)>3=BXCC>H>5(
M^2I!QW%IKYRPN:=%^9HP Q+[]FJBF"(_+#5K*BJ>.E"?O150],)@W/A878C&
MGJ/._3!HW+$]N/18-9 EH*O%:,U;8Q85QA)A^8D1\A\E:6'3-(A/E@$Y,G=Q
M7\;.AB/#[::Q%1K$/6(^9"]A(DW(L/]S4##6H30OPQG(U2VWV$CM/XQYI1)1
M'VU8-)T^]D5@C,[70!\?A<)J!D$]A4GJY0Q%[UF418[UWT" FWD!0FVFA 4(
M9[K>38>P-@Q6Q&2P93'5C+?ZG2Z.[N=M+,]SY:#UN$A<9/B>/$=QC)7#54Q.
M_A0FZ28:1=I3U+60GSSX$(@1?(EY([,D;XZ*%8VL9,2W6#<R0_HS:N5*?:!I
M[/!P@N"AVH7Q0+SMAJ^A(NL1:=L+.W8O B\OOHG3]SPH<Q$OMY$,QY[K+7=B
M60PZ4X?P.3P>+(_,.>$Z;J: Z_# D&F5H -5X><+C4A#4B90>,Z](E*<.,DV
M4(A('UBAU<SC?D&Q9K'YGC,>Z[MX+L(HP?A?5:[I-LT<J"BGGGH<\4.Z^? ]
M9Q)P48V*UUI5)LJ,AF^D$?P4"V+<%&I52JQ!RX.@@U1;%J8O2YUP8J:8>$G^
MY#(()H_C:R.L]>&*\ROJ[[YDC,O2HTB,QCC!1@XDV0S54+Y$1V]<RJUO<J<&
MD'N[&L*W/.F-2WT_]V/58TA@7;A^F:J2M.P;*T1^)<*X+=-KD*H>LA1+*ZZO
M]G#D,>^ARA/"TK8"KFY@)F0]%82RJB;#<6859"E.Z(_X,\XI4)-"6\0?O@N!
M[X]ZBE4UMTF,.G-83 -:TES1K%I1Q"7F*)'P5_PW%YN5P*REZ56S\5@:^Y&)
MV_MSF*$JGP\4E>53H*A-(AN/P4 #D[A9'-:C\4? D^QO&(<,/=FO(Z@$DLQL
MYVNZ:>2DU[XFS1^22CWEGMV!-0X:@H"F^B)Q7R_^J"P8E@B<.B=:5:7PG^DZ
M*C=V0\2U7W7DBINC%'B?9I4Z%5%&F+<4P=PKO-SH3.B?0'(2MF'=?8%;5'#9
MU^EVFR;<N2NQ;[:[,-ECO%_&;LL$'OS?PHP'UEP636QMD!(6&T6+[YXAJ^!(
MJN1EI'&2LA #=PMJ\\00@P\;/M/@74Y5D&A!<U]PP0$(5L0]:>#S6F1Y7G28
M=C$C&;K06E&8U0<QK4#-"UT7+6SWW^EZ-I%USG==*TRY-&%[ ?^&\QLFSW)B
M@: 6<'(3"+3C<&"$L3;9\#?YSYL-0[6%5:!#F*H@0<IAXTA5Z_22*-4 @09!
MA&-4&JM* ?2>I^&/UY:5U2,3VUV<[AE[8ME;M&(.7W0,HIF,&L%E?DD095[4
M+>+WSOW C(,#D:$7RFPO"LU?A[NH$$CW%YC;B0DKT\3/$Z^6$4LJIQ+(N8AH
MD, 6-5+-!Q,1ZAG)NF%2_I]F ;^ KHZ&F$6"U0L:Z9*CY%'C",I0!1R+8G>1
MBCAJ)$Y.ERGMA_%X",_GQFRKGB2PM]9*+>X4GWA'L+/CTIZM/0,^ZR0;@</P
M],I8\25+RQT\<NT@0KB=^:,W]$VH$W$O% )$P(<.U-@7M@#"0(T_>4K5-*MC
M&#SJ7&7["LUA@>R^?NUU5R:(90H/TB;-MNB[1)BE_&J_A!$&9*4YPP ,X:(J
MLU>D@9R"\.OR2<#3 )/PGLI&LDQ]HD".7RNOA=+LZ HG(20UPS\[021DZ>OI
M\'U\\*I'<_;C=D(4GG$9UF7"?JQZE@#'92_NS]FYL&0 \O'8HJDEG7'Y,2/2
M'JR\!!E&U*!4IT74H%TM:R*TYK+$+2AKP7.81[YLDSIX"$SF'A^"3\N4__?C
M$EZ"? /?26C=PT4["2$9</+!)SB#\I_U4%+#/TM^F^[">?!=UWNX2^#0\3@#
M=A,6X?6@2B*"9*#1#)!H<.V_XL8X?%C*5TS'C)8;^<2X7\Y_@FL. ]'EN'I@
M4YD3!7LX 'VFJP<V+<FNAWCU>?H$6.EMG(8#KPX)OLHIS73"ECO"[ZQK_9!'
M)#V  +_G;P3>2J#%:T4=!D:$R!$"/D2@CV'6>)@"I,$CMZ;.ZV+9'VM+MMVE
M69CM!1K$4#-912X0]":RZHS%A8G"3<+*7;+*4,*^8>*_=\E-R1"36=N$T1%A
M,59#[F4[(B98@QS(PSLRN0UWN W/AU&+IJV&"/Z@!ODC!K7>*$[U \=+LGE6
MNCVQ')_$K4?%5:;QW:;9(]M!PU>8RV*C0C.&Q3*U8I(N B83BSU&$HS,DK*7
MZ%4L:KJH@"O*TS]J R/W.][M*<+N^]:D_@8/]O*=Q6],U)\?LBD__>G3+^?/
MD?Q^QQ47OPC^QL(L6"2^(BJ5A?^WJ'B]+D$/W+*LFLGE>AV=%-+24$ K-X(P
M:LEAM"I$H1K(EP[JATWY22OVD'J@R&OUA:H!SHJ[1CE!P>)]G=9WX9,O(W?U
M-8W76FF886%^%46]\LT4H7XCLM*J9];BQ]-.$X;,;VGQ-TRTDL%(HQBII(DT
M28M@SPH4K')!W=>5,"(K<F=)%H DW-J81E=%:WDV/8W(BI$:9?(35?Q,&BA]
M.!!:H&R.'EW>.\#Y(LCY#'Z*9>D=)#Z#Y7&8)P3C&G[12,:6"X5KJY$^'Z9Z
M5@>^"-)SY*X=\=#^>JWH!O5!SXW-.HBES:09L.*?0QTO&2,C99XGR(>G^N7T
M,DF*^ ?0X#_D0#ZHZ5\H]YS_PD=C\QC;V'MRL'=&?)G8UVE6?, ZNR YO#&9
M&^\UG*-??;VAI00W?4H)GB&?'3F-]IJ!U7//0UC><>? S:.JBHCJ&E4M2<^9
M8+95&<LDZDKO?/=N0QR7J^Z-[-4HBM[8^W0%6_0U39A W#]5?T<R :<C*P[,
M<[IF H/_.7<GJIGY<I?%+5LC6#'&B9=%FNV-QMZS]4!YD!,(JADT.Y'E]'E=
M*L,#"IPR/@5<D+Q:"(_EF/IP#,N^#1-8^)L(+V\&E\-0+;+>&9'XR 6PCFQ6
M.#EB: 26%6/#,U(-[LL"--5B''D\@FK,0!OTS-? >%%M']G?*?^>9%46)/!W
MQ1*VB8Y_/9NJETZ6?TI%>+JD@5$YTW7G#MXF3!$8B;WX $^S9Z"9MY.!-L5=
MVB4L?X: 6/P^55F@/BL)L>>B5A*;ZJ-,AD_+'!D7*=N8TO@@)X:NS^5KF'S\
M)#RHJO"2^OWT"G;/A:$XM_5JD<HD)A?4LPMXQJ4:_R+@Y7(+F&+P\5,@)JF7
MM7KXW:VP 9]8K4/8-LNL\1ODVC=8U>M=UNO-@?"J=&7<P[&^Y%L^ZPG2-X5K
M0U9\6R^21YPYZJE7F&PQ&&U+2V:53A0U%*;W5H,%?#19PC>8)-32]PI8:QC#
MEFDN VH =7Y$>U$\8MI5U9L5B"#((PK;(5IA1F84EP7>V/!5!E=!T]:@PDF$
M 85=]H(SNQ))F&+427?#1&MA;(JZW&J;=W$=J]7Q)/(^ LLK"=AA BL#OU78
MQ$W),"\HS-G7=,UK>6*7@7I0-32RWTX&XVM11\5@Q&B12J#AK38+7PK1E"L3
M*WE&K0BBE? 5@7_4,-Q86+4.I,%82YX\A2NBC_X3+(@IY37WB0'#W7>?S+"*
M#?\_O[*<5^;E>L='NKI)_#^!G(T$R/DYUZQ5E/3#,U^0E;YP;W(A9EL"Z7Y$
MX*F3MLQ$.0K3+U!K?UBAI;15NMH;$%04J\3EQ,6F4>E[/PY@KI#,47"MR%]4
MJ+GROY.(:'ZX-%!<%:MZP;X9;FY9 $V6.4.!=+AC1B.&*LD-6_&HN>"7CQ?!
MIS]]^O03+\-XSVA5?E";TX5W/U<K)PW^(ZI/BH@FM"J/%OBE40]J\N?%7.\
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MV5H+TO;@G):#F 'HD_NCA[,:'\OE>;%G[$3)C,6Y/&G4O?*?+\,?LI*]ED[
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M'"CDSKQQ&E!D7QPW4/OX&":_'MUE21&ML0X&Z#D:^%2X98-0&72R)JA6B&%
MWI$9QF;+\,9T\>8;; *UJ+)X33,4HDY7VK5:@!4Y[_KZ.!Q8<#(,-B;49,?W
M>:$*@O'04I^+X_3=;\[T&#SI_B^+S\'KA;R)BOM3P!H;+CNYD?Z M/YX@?\S
M+KE._)!FXE,4118]ER)GIT@Y8EN:%$ LQF9W"6Q+EOM/K3J=Y7A\;N?(IBU&
MVQ= %BQ'^)QF_+ NP^R%%8ODQ-BP)FJ93AK.$M(.TL1;A-68K,B-9K(@: 9
MU#MLV8BLF/#8%GX^3@;&?Q/E*]C+9<8&6H6:90:"FO*$ 5H*QVR,N+(J$N%\
MYF]L+"/6X'_XF_EU#$,L-K_QA+YBD?'B8D8D<O5C+G_-!P%(@B[Z85,F:Q '
MW@7=8 ?S>T6?UP['.W->U4V'8Z'D)@D&:2:*RETT@];K-GG5:()@!<U2VB@H
M-VJ(B1:[8"D?-T6DR8B,V@1UW>+<KAIX)A_2"E_SV/Y<_L[F%Y:P+(PQ[!W^
MD:M2']=896 0F*4D5 5TG0<+<J=)DH&B^2]5#93@VF_]!3<(N5D7>C#R=:^2
MV;2PZV-QW /M00?-_@.B. =__N,YLVS6V>!UEM]$G>7^M;M1EBKA$&S#HN0V
M*>C[DC&XJ3+OY;I%W$^*-I=%HL[>. %9G.@'7EA5D/46AS7*].5Q%<1 9ZMO
M(M]15Z-,W\0&4$OOKZ)4&UBL9573"O?"7A^]QK<M*#9,C.P'H@K?7E?"5?;]
M*7H127MPLV*(29IP!#7X!2U"C<@G7#-O$<-Z::/FYH:Y@/P&VE'VCE=@\H**
M.);;Q#4:32@RZQUMJN.P$W76U(54%7TJM0D%:S4C$1JO;@%/]: (5RQV+U:@
M7=N_\U5J/&OGL%I5O#B((QQHYBL+T=3%<4ZJ/_XE M$[6[WN!SD]N<C#Z045
M0<[DM\M?)_!Y>F71#&!V\^E-!]9EU*8L>UU+CE^EX+C8( 8-0F-__/25"XPB
MQF^QJ<D,MGTT!-BVD.L6:F.874.BA>-2A2'69/U936:PHG:]L%8+,1@UX(6Y
MM D%:D9H?<$Y!6)2@9B51/+DP*H5R9]Y$>V!K$,T+LOFG/;:NLW8?Y0L60V[
MCS6"0461Z"(>R)%A3K"Q-65R<X7J=1WNHB*,!SIQ'!G<-7:8'&82[XX_;@V7
MSRN&NO,"F6G%9ECK;9HEW:,_Z)'%: )&@^-^F85)#ES!RW8?)>RN8-M3;W-)
MEALR]X%&./@[D@XX;8^?<&RVS))H-+SQU^:1P<Z+5C#^=9B_CF*9JDD&*Z#I
M2]@88^;5[JIFC+1\6Z3&F+FY@8SI^[S(JGJ?H/;A6,.P1"IJ_()">A.@A@QE
M(7;/?L[3-JOEX4KCX0S@J8_>0)!3;&QM?H5IH4,?&4HSZG\M6;8=&S&T&D%F
M^>,8Y\9C.\V?E^3-%&&/7A^!' /:2)@-!F%7,#2*V@0((./,W["'AGL,8^0'
M:"?^_2$3K[H?Y/+K](UE T5D3L.K_,L?N[L\+S'<>+'YE5?]JA\KG@>U3$&C
MS<NXP/B5@8*'&@K535EB+*N?1E%QMDA10U4#GB'/ZOG1>!6#!)H8\*1XO3YK
M7HVP_*,_KBQM-C[?>5:@L7Q=KOAK_,2RMVC%\D%V!4E/))T*@AZM"OS++=_3
MY6M:YC#D\AU.T?[S=A>G>R8J/S_(H#I,3!I%+?CTIT]_"M00\H/5D7LPBB]%
MP3>?\@O",($:)Q #U>R* ZG&XNEGOK4,WVPW\.7AVSX]//A[M3E,U[<TJ6P;
M$L%KB 8BH,=TH@J9S+L>,A8[\2%.9LR"-6I0Y8%HP&G,-R?'%#"XC=X&X8O
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M##88,P]69:/YGJ"W"(T<;/WYQPJ:"O>]C<F3",W,)MSQE/?L0BF<V,!&/SK
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M$N'^M&R;XZB2B];OVC6:I0G\<R4BWWN' 1U+@S98NNE&=6)J/#(.X?(09M9
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M'%UF>KJZ3%&'^I";A_OE(7R#<[]\9_$;:V>J#*4UMSRR:L[')9*UNY%_6_@
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MR?_UKS6/]_"O__V?U%_@_SS#,OWO_Q]02P,$%     @ "#I75FU4BX6M6@
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M?X\*C,E*L$P_DPJ9R<JR5)>6$I4_35:.I7K05*A,5I:E..Q4F$Q6GF5Y"%7
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MF-6FB/YUG![Z!\ZO$N1^AG@[@*^A#RB.ELQFXTZ1A#H47T^I?HC\M@9>[HK
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M)(X!4>*)@T_=S7,!D8:_!I0 ]E$^.2@VQ8D8%QRMW[1 <B'S);G_KG*(EO2
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MJCB"-6+'KQ[V.,I8-"3H9"(!4.2EZ6$*2_B(8U>OWP#TPQ00\CC.K_PU9;&
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MBU<TT)IBV,)>;;AWDL?9HY?--^@8IA[AKK "NY6',7QW]5ZHXB"V[6C]1#T
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M^(FIVG@=?ZMAFX+KJ EE!<=1DC+<U@%C&$D=AZGG \K!-5W-GNLXF$+C;^.
M4HZQX_C(VY?K0'%0=1PO[KM-D]EW+-V.0R,RE]?1$=JGIX65G/>0S%EU'#>^
MH*5JCG<\U*@?;V<H =/"2H5YL9]%AL#,JMA^Z>,H?I1Q/(3M1#F+KC%-"S-U
M@:)Z)W,<)^E3*'ZO<SPHLN>-R*3#:<'%/8#*KZ=#8'>>EZ/$FZWCF1*5"(W[
M(CP$4.=)5>*G:<>3&ZH05:^7[QD_E??P87(8GA=<VM_SG<^Y)XVJ#I^!(3+*
MG1F%RKH=E%!]FJ&2<6VH#$&NFF5/UM0;SA,56LX&+9;:)^)6 3;I@#@M-LN!
MD,6'R(OOO2T_[4JKD3:_L>=OR?,FR5-$2,_?$#Q[<AR7A&(6,;I=??3'\!7@
M[[/],WN,HL^K%(WM(9I_2#+\$2]"!P/1%1U.F1[:9D:2 L/EJOV=94Q/3R/9
MR8#W5BWGTZI^_$HI@2B2A"N]X -:J9N">),3!S41%G?()DOFU>5&-3>4B_VQ
M33GWQ3</!KP -'WC&P#G<Y$+!-O?<UY<:;>=Z<ER&2^MI9$\5Y@)'!XW[I(B
M!0L'9UX/>Q; Q9[?9XZC/I\XZM.1[\T0"ZZ(IH8$$2E1:Y!/F=CG[2Y*]IAU
M'60Q;@ QN_T<]2Q+G!4U'(FE0I6["H4!3*0G.9 UF\LUV]C((%B'MJ-YJ[(#
M\<#G!,=]CLFLE$#%\>_ZOV, +&Y*<N[!E>EI(@2TO'PX![;19'!EG#(1<?OA
MC!R-JZ[R\U<T<8C&&-R,@&:D;D8X=C)SSC(8^IE,%B5ZVW/BI \ 8K.7MT;Z
M?,U86RS'>PNW^58W4Y7YI EM&\0 >A%BDHM@&\8AMN!@<Z ,AY7K.P2KN [7
M&Z3YQTU;)K$'2+,*N3'.B:I;]_:K%T;8XG230+*J@<6$SN?.";HKD/HP)$2@
M&Z;ZT.<$2;6]QW><L>1.SA?/"<""IZ37;XCSARE(;V-T!X1)\(SK1-S&Z J-
MT]#GY5\?Y=-G""GA+X=%_0H()P\6K^@V6@/RXY67@1LOA$.BJSH+DW8F %]#
M']!7?(^?]E,\=;RXE-!(_7?\VG.?9'\#V2/PDW6,#V+MTF1I,>-\VR50"T)"
M]V?Y)]R.E4EBY$F88A(OXN/YPCB>OY"55\?S< Q9@ [VN7/BK\6;PFV,)/F\
M<$O&=82>-UY,Y7FZ&:OJYUTZ_,>1BD[MI8_.947S<8JNFZ>7 #28^'#:9$P\
M,D1DW#I-U)=<JONLUP>YSJ9]_NC/CP=_W#Z^6(X&KRMX=AW@DW"W<A0MO6Y:
MC6A:?1Y/CF//='^JPTEU.W(<& G/I6:-*:Z?D.-@V9SO*[(#H0$=@1K LKUG
M'*?!.5^3')-G Z/B#^0X8E3?(3I6.L^SXZCJ<W92V@IUGR'']T'*J;D.L92G
MT1"@6160KSV.HI'LH.'[Y"@!2CM;'3,<")1I1X'B><31J&9B<,A:HH0.<X[F
MNM-IAZKYZSF*UM@Z&L.?<.KHCBO\2;DY.KXERG*@I$>D\]DP!Y$$)80CQ^E1
M_GJ7=')U/!VD92Q5Z&/K^G8,J1\:2!![)I;S<8F\X0WM>%;000FZ96)U'4J[
MJ%C&@=WQ3*2#$C?W]=AU8.TB=:50@R$2?;JON7"<21S/G&HGK2O'@#B>L'58
MP5P#";B._R"G9*0 'JV)=^>]&28.R/%\O@->,X-$$3F>,]BR6U\Y,LGU),5G
MQM/$X4VCY$EV;L-,A415N^6LG7N0W9*-I*K0'=12:&'.\*=\N_7@OLP\7[YY
M^5GX2LH;S*G#>Z3*6= CUM1RY4@.,J>_GM-?6YC^^E13T_$!X4@8(A(:]IMG
MF(ZAYG_4,M8] LS\T-\ODY@L+_>B9P"W'WG0CCP3?5D8^]+%8KV&I)11TYS/
M(,-AOW6&9[BVZ:.D7F)_[YS ZPBSTT[ V]U;)-9&-PG$/PY/2/6/.9FYUJ:=
M;5T-U=/J PQ]@#=B-=:NRT[$7;C-8GSFP!9>,,-#6'[G#"73<K>Q=B(I#PZ5
M0ZS/3,Q+IG4#_-%@R)6R1OB@C:>6J1K+^#1H88D:9V CP$JK^PR35+M@R_G2
M&0(VYZ[5?\@["S-QSM4F8:2<5^+_7M3GO<K1EJ^+:18>O'7GE6JF3$E<?2!K
MKE2D[*U ..JE*OKD.9ZX<DW8@FKRS*E.PT:HU9<XT/5 ^](9 F:-6?*WG\\<
M/GL-"&</[;@F!(-PZ5'=FP=K!%M!^X-G2&ULR\<8!UGVZ^<-[*#'N/L=TQY<
M\H'VLBXRCB<>FE,4GZ&[H8J+BDZ_^%[N'(YNXBB.'3ICYSA:QQ!;M"LL+ID'
MLS,_;1U_B(%VI>%6X.BI&25P<1(9)\U[/PQT#/BJP,RJ3O95&FC?*DUC$CLT
MIR\];TFVE_N'HTGJ1I-DQ_ X<72/SD:(E98A7-^H,\G,X2S^YR$6ZW0.FW?4
M$J&8ZG'FZ.Z<G1E,*5W:'.@^IA@AT +F/3F'&TO1TW'>5%V75@_?2:W@?RK
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M.)?N<[$+;1^.!C?UNM$D[2N.0J; NJDV&T=A46;<+:G245A4F!'/P.9H"-
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MO?Q+I'OX:&:"4HXRU?2VL:FR5!\\M7WRFG[=R^3"5"64=J/2U[[D_2<DL_
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MS_Q5G7^P)D^.9^9X9HYGWDY[+;;P/CO2F.+#1.>;N;3,UB-6ML< .^H?]0_
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M17F_5E?I?:R??X%^1N;JO:*?\' ):_),Q7D(2'L+MVGJ]T:+O5L. "/I<'\
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M$8K/*XMI+\A[%V<_GS1@^5()Y2/];V =KLNBA_U;D-!T1\8UXG]6,BNG"1+
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M1&SAH(43F_O[C4JJ$BV<#^,QV#@V.@MG>;#(IP[=JDILGM(WR"\BF*,XXH7
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M7G=M3_Q9 ?CGOX38"S,?:70@>F0MO*L]E/8)S<(QH*.Y1L/P6F>9R$V)?DH
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M&6IQ @5NP22FLF5/2#"&DP6&=>+^C?>OE8VB-2?/.D<2/R\=^F%,A>32IQY
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MU8AV&C[='K'C&T)4#&L/0WG(XC:%L37!'9"1-;+.5CBK2LP2-\;$IAA9>I-
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MI1RK<B&&R!W-#C\1ST4O^NSOS5/1O:>B*!U^?)..7L/C)E<W258YC.Y[KR8
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M71<W<%YCP@3,(^'W@_R&A<K!R$_"5FWBH:V4'U6^\:B+-/G[8*Z)AYSIZ9I
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M<M!,U5GRP1TQ:T\H\R%#9D/NYB8A) O<;46G=_ K*U[,EUQ]-?7] H<])9G
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MB^GN ]O=&($(K(X#C@68$F45'-I+11[NRBK/X+I8U+F_$Q)8?817^!/F&<'
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M$^/O J<8/)=R!B-IA5VEEDM\:50<XL1D#QLU(ARG!"'SB+>)YS@5:W7=M4F
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M.A]LH:PO9;G$[D&;J3K5*@SCJ.54#)2YVC9;$) IDYB-4D>?NH@F/7)R;]5
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M31Q*3<XJS&TIFF.0_BLX!#:;3?=95TV&U)@*C(V,O>L*B0:3E*E.NCJ<R;^
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M1(,C&ASW&AP^H=%7&QQCLO'Q=H8:GJKQ\H?ZI#;&V+"M:6$;JM31P(@&1MO
M,!'$'0V,@TF%1LZ6/<4NOP\]=OD1'Y:!_?N1L.,!Q2]CKF=?9V1V=G*-KI*7
MQ41;!0D8E7EK6]BZCRNU[TRB[AY^DBX233:+A4@%_I5QN&&NRX*2)1;:2_I&
MP!5H7A1H(GB99S1'W!53L#?(VU+U$\LF9V 5;$Q:&]O?$?V)\\^HR9M.:",9
M/-Y3J$(EFVW2'0:D,^Z5J4;V#6'^X(^*+Q '2+_$E'>2E06?4HV':J?KYD12
MSG:J!ZD+/E0+NFQTH\=ZB,?50[R,]1"Q'B+60QR7&L-*X\^..@6D*X**<IXM
MM:A']:-C@ZVN<JV8GO5P,:8W=13#)K1H6:LH"@FO:4G:\1F?+J[^]NO%%?Z8
MP4#2/S&D:;SGW7I_*J!%]R93+^IY!A_6I#F_XC&6!N0C1244P*9_U]FAL6=%
MFW%O-N-YSV9<-%4AY(TY6%B4.C4ESZ9)0@LWYC&TFL:,EF(G:=;4K;<LO"]\
M4O1RB9PY]S/@Z7-A4@9]ACPDEK,#F;@PG!O<Y5"_2H];O=N4:EM]-\;@" _E
M6<EM#)3D:T9&Z1;LT\3OJV7Y:R]9SHN,5<E_-S!;O/)S"W#?9K5"LCP=5_/K
MCLED;16KN#G7,TP?/-$4:_ 'OO6M@)UGJ:-,M\S3L7'#+D.D*1(6-7 YOE]3
M5;TA#]2ZT+=;FG=Z-(2&2E@M-\PNJ_545[PNIT/#?_?Y6B8&YN@-A'R5\2=/
MIJ9AJ%(N/<_I*6=]EQTSPW[8K4-M"1OUB?9F4^WCT6)VVE3=H[&#K_AD)QG_
M1)0B7\T59M&^ V8</2));%? I6D<5G'EH0X(G5*"1TD-RQ :61+6$<'#;'S.
M2J_(B_F[K%QCO*8I1*>.'V<I$S)MI#3N)MU,%.NF'NYFVQGFGN;7ERY#R]SO
MG[NEM_!H@=M@7^$8&]J?GG]YTF^NIXU@V"B'5M6YN_L:6N=%PVY8E#4<)X]X
MV%.VOAR:J*7VNENUC3DC4)65ME U".O:,O>VG]?N4-XCZ^5?X 4+WE9.\[+\
MTRAG&VST\*.$8%HL1(YA04D%)[J>9(PD^!:G:-,&Q"H[T\I:954:(A;9S#4;
MCX5E#37B.K:$X_>!'(J?HOAZ9B^XO7$L"18E*Y@V[351DN.8 \,)U#(>^*Y9
MW\#_"U-V!/.3\HR<" 27(6]K=6L)X"U^)X$'P47&:5(B">P5+9$0TE:T1N3*
M7HZSU!(,AE"VG&6/II[!A$M8E157E4Q:+_K\S+D 7:$<.;)_.:9C^: B,_5_
MUO_Z7U!&"5?\T ,/@MLOU"=.X>*_NTK6LC7/N<<=AQI+G1UF$FJ8RQ,%#/A?
MO!N5\90G.CP( 9J:%Q)E1M05WH;7B;NB5!T&5 L!>IB^'DL&>68FS(!]^J/4
M!8(TK&:5%(UQV_1YXJMU7FXXIU8 ;>Y_[2)1VSD):V#E ?BEB-VDZM1:Z"I7
M4V.HC URX4W+('#&2=LCN&E1L16\.8%(811W-^5*OQUU]O13DJKZE>2*OI/O
MZJ!%M*+T8IGSM,E5$I*8/=1XK+<3]=%S>\%MY)?8WF.AJY^C @A0 2#=.;4>
M\6M=,38#[@$8_YM[G)J!/IW^1@&Q<)^*:*D'^03Z0<< F9'-GLHRZD#?8R-[
M@A[<*](ATNJ%KO#OC JLHPZL],!VQM&*-_1PT0\V$<;^]@3AU^U1I-L7$=.5
M_C<Q26'<?/0V\)5Z%S W_B0*!L.5.F3G.VM![^3N&-2]DCGR:>$+W)1-A5;Z
M'^NR,-@???B4R6.?,6WM56-2>.$&&Z!E]EBI, &)A+R4.KI^\,G2B#MZ'.[H
M5<0=1=S18>*.[LF;1"32 V9:^<^GTD$),K%8@ Y$]]#O\F0#W5J-6)B1BS4;
MO=/+JZIP&&BW/%/NZ!SOZE+XYH=>FFWX)RW_6S]U*%.,'K$N DY+J8>RX(I<
MJNL#M6X:O:$P3$)C@\W+JN!N8?\:^')?@#S*CJ#?*W@-S-Z/S1K\(O1DGF'7
M;U,B^>K?YM7__73QV^_OWB<?+CY^?G_Y_L/%Y_>__Y9<_W)]2?_X^/[?_^-S
MK##:B]$W.PN]PDC+;P+6IF*M)/RU[FF;?,2A!2+B0+_]CJ'R(;S?B_GFQ2 .
M<,ZDD%-?9PYS+:$7#$*3NAY)#TG,,'^4YN"P@DK6G7)T=T9*6PG#6."<7&IA
MJ>)0RG-5P:9:% V?*O";/U!*41N#PN_!AT/"6AY_T%,_=#U-?F5% [X\Y<!0
MXU^6JQ6.#<ZQP_4\#+R37%%7'OCD0E,8DKL_#+*DZ#NS5)=[/6KQ0'V]TZ%(
M22<1L+4W=12^0FH?'+]>(9!CX_AH=3:1@NOH9UEPYF?0%$L$EF*KX2FBY!^G
MMEJ(+D=TT[J]Y@Q>@H(J!A\R'6SQ;L.IF@5G?-F&4:W#3Z(Z&R]0B]RU%@0[
M<OM3A=C>^)D8#[8\Y'@?7\=/YU^$<8@FIND>XJDYMCM&@.'=#5=LM*5K@:TP
M/Y6B/*$,VPX:>O<]VZ.]\@_+BOU)L .'EA?%?:?%%A4,'FQVRT1N:FILM1JL
MW?*&;$U\BZHL1*H>697E"D:H!$#2HOSUQZE9K0EA4:F$X2/.N?"1Q./R+#+[
M[LE8. _=5'A?V'K_8[ :'NV]BL6]2O0^(P"IWH6=[A:Y'Z(/%AN/+1"%@+LV
MP0+<1EKD^'8!@KE7E-%>B1AV!:_Y2NKRW@&/V8>!:EV@[DY4^H9W8L% ADW[
M,7)-[&:;UF\9X!QK=#@EM6OWNUIYVD/6EH'-TR7E8H8R6/>C[D'J!Z'T%<PB
MMKC-> YK4W5JE$<L'EWQU K04Q#!K,CV=9AU-(5^]L:.5.QR[IQFJ;7TQQ&K
MR='X%#5'BL$#O]RNF*\XRW+2\K2 "K;I6W+!&W$F\? JF+3#E(X4;:JX,^+.
MZ"6D2&ZJS3#G1I!@,XJB!8;K*P0K6K^AF(Q1KWT9LN%'O:X:GES9\A5G)$2[
M=HM=N[#3Y L#WUS9P=?>'OK"LGV)E,]&0 B+?U#/+97OW2X_HJ!$BN[S7Q"1
M:%N0; $OF;4R4JJVLN)4%D5$"+>\941K>*A.>@V"+EV%J5= SRN)O RYXX\S
MB)8I+,8"K%M8-#W>LA)4U4D-L4P62MG[F6F"5B58[B%;5<DCQ?T57[**YG)+
M[(0R7./)K CM/%)HY^L([8S0S@CM/'9#\VNP#+&V[[F]X ZUYHYQ7!E4V(U2
M?:/M%X_NU7<<!TN"L:W#]I\ART8[@>/A@/==ZZX#>79T,2NS)V?V9>BN[+7Q
M<V"G'0$*ZMO "GT0!*4J"*ZO\(/@@J(#-X03;/F8NWB5"H*G*_+4;Q5B\-@P
M>8G9MH%L2PO.NS^U-[?I)=J,5BUU.*5,]L?N,6_OF-S54>^<Y#>:A> VT$!>
MDPO=]?E18;>=0UF&M- O>A_!R+78"Y-3U6THLYO6SRX=W38U^;'0=B:HWO>6
M0$:[*7)GU=<YMFW>\%T3CKL'9<GZWT:I]Y@Q&Z_AR#9TF\D]L&W] .QA]-GV
MX[.]"MUG^ZT\*N/X*\%T6CC!"N&BR);CA9[9+I*<6%1$+GVL+7N4#AA@+(UX
MEX/;DOTV R-V!"RWZGS,T%5_C-%B$>8[[#9MMR!9XJYV%=DD_,M:Z*+".5D[
M18D=),AK@.>C.UGIEJ,/,:*0D''<6]"(PR0OBZ5"# U/HN9/:+4M4\GR!@.N
M-792P=("C21]B,-RS(?Q[/4LG,[/7B>$86T ,[Q2;&N?S3[)6G5,R-;)5:$7
MUN5RJK2J;XZBX[/9$J]G;X*ADV[C:BIL;*CZ"NJP;"UJRYF'_>6ED@9%=H],
MV])I!F[> :P8:M'IMRO+GA'ZFW"3MZ50@@SC.V4SA]$>6,NHOP8K<[S\):^1
MO^3J^G^N?_G]PZ_7OWU.+MY]OOZ8;&4TB5[L/H["Z_!!M/].!%E@N@6B<9XH
MM3AHM*/1DIPJAN/)CLZ'QF9:@$(7 -KOX'XLAHY,SF>AE%9/PU^U\]GK0!:+
MCF3PZP6.94CKY75R_7U=OWAO8RT=/FU-<: *!10E-R7S53=.BJ58V C>M].6
MX($>PBF6XA5E/:6'V.K/ZR^ZS-7Z'I.'<#SIHMIW@N?9V"/T-?9)=/'$? R:
M"B[#KN^#O9DXQ6FD[?T@E#RF;+$?X>E6M;8=F6A[?EO;,W@N@L^ZBVL@<FJ6
M?&ZUC<$Z;I97G&4;6R"9'6>-+;5'#F29?XPUK/L2@.!^/]J9&Z2$T,HTR9GB
M]3)].2:=NLB'0"EV=02-XSAUW:M=A2%H6<R"9ES"(E)8W/9Q3-C!1 Z?1P52
M.$5V;V*172RRBT5VQZX)TW)-$&%T8JT/^E]%>??B/\H[<N(^\F63,W+XWH'6
M*)92J1NO]WO%<Z8+K[Y9&LR460RVA<>,[FZXS;9^G7:(K;(R;5:J!A^N/35L
M 3?H+,/SUVR-31(KG]=/56Q-\%,I8#48LDRMREO"/:]X)EH]G_F+%:*,IO9)
M\$^Y1CM>WG".?\&""-7G0=8,VY%E2;G&/A/X<Z^V#'."/+TI$!QA6*93%>R=
MQ.K'Y_:"VZL?^UO/F'%(KN,V&\%@3#2*DMG]G>BS,2!QQ+INTU-&FIS]N1CG
M)U</2?M\!;,P L*T5Z*ZINHN:3XO*=U<-S#$7]&VZ\O\%#802.2IZV^#4A))
M1)'HJ0(_@J*:BJ8)_H;;SCD\<^$UC/?:SSA(%VH C%NLL0ULV4B$='G;W WT
M*,,8(8&U-.!J;F/&BH/6YXV!C:/WBB>OYCP7',EO/(:P_@85?D-BT_7)=&3(
MAGLKX/,&NRG@;T=M%OC1UY@LTWM(<EABK"_5+GK;2R^J<J5GS#7ZQ%GV8Q%X
MZ!LIVQ2;O:L&0@0/&0G<O,<T-&23!6I;^317JZ9NX IF19SNJDTR/C:8?GXO
M&,VP8S3#7IY\MK1Q+DMII"!(@[Z0.Z4N0216+G^]G!QE/[W LOQ=4E+^99V7
MPAQT10B]/:7=RV&KO'FWG<>W#?#W^AE04,10_;7$SD!O@OLX!.VI(#N@?R[:
MO(6:,M%].L@!+@IL8T#-J5LOBU->EU%)/K<7W*XDA77R;+T<=BO-%2O2HD'=
M:"E[U=D!2PI>9[GQ=M>15E^$Y.+9#NVJ5 MEH@HQ>$>?T K2N%KP'". %)7X
M(V19B[*_3U2^>V78*0,_J2;7;*X'JIL2F1<#8=M@(_N^:"/W;4 4-VM\IAH0
M*I/6V]#IN2NK/QU?ML>0,3C&KQ'F:,]J!P5_CLNCR,HH[8M"&Y=C!Y'?-86>
M7@7L'>$:5<#7J #? Z8],W+VQBIF58B!S'%G9>UT9FT+"ZSC@SUJ3QKMY8'&
M8AST4+G!OME-D>/9*''+W6&U-IT([UIL'(5RS(W+WN_XVI/Y&BN@BF[EL8-D
M5!N'&-NPOSI),O '4/)%>_2YO> ]PFAWX' ,ISQ)..7529SR/4_YZ\=C%6W*
M9= P,ZF(?4(4?;,9&XJZO P8JA_=V*ZQ50)U[XX@Q2,%*7X?08H1I!A!BL>N
M A<L%3F&ZE5$$106* @A;TQE'7/!#X(B8J+V1JS!V*_OL*6D%Z_ '-_%&BUA
MI(>Y$55&:FX#6JBH*Y;6A"< I:FUU V3"2^6(&UL0TI;XP>7^A #ADI1U#K#
M_)6@@AW"0WZ"'=Q8.TFJ7V>M;DW%=XX[YYY7UQV =M/*Y"LOBU9 :..2X?JQ
MEMQ^IUEG%<;BX*TDV!<$E;#(TMUJ&J-5NC^K],WCK5*QV)V_#$Z@ZS0(&YU9
MKN%K++)%J;"U2;<*53L+UT.WD$<L]1G!Z ^VG!@MPO+WRWD4X _8+:=L<O+>
M)HX$A<41)X'+41;+$O_7E4X[.6K2[NBHY/P68W#VL@\Y*S0=GN=1##H\7.^H
MJ2'*/A43/TF%.,FAQU=\!=(8!W??0 :?J@)*4Y3XIP*>V(ZT>\^Q$G2J$R-T
M@;V<MJ9N;ZSEZ7H-0K@#@QMHF:D&C"^1*:1#]\DHHLNFAO=S]\I YE)Q-^7U
MB%$3[NY? 6.I2,:SW+SEJ-R-A^;1AV9^_Z$9L3_<=KUF%:A1_[+A<T-'HNO*
M7\+J$P8.!"[+"4#7.C.=[^VHF#30R@=%$K:=(0*4BH$Q?H"5L>,8GHYI<GHQ
ML5W7O6E*&6*7O0+J 6K]A[[%M-.PUA\&"H*?QT:">8VG'\SN,F=<W'CW>*S<
M&=^*400]9Q&43DY\$I2*B]6\J:3E2S'\)WZW4NPQJE&4-D<'R]54U=:: 5VF
M;&N3I;'KM=@SQ(=XD<]L15<=6U+N32 YG$CXLB=O+?@V9[^@!=%5+L=T2F)0
MXRF.R>QL;S5[OF(=X@W[MK74C@5L%UXOUWULC3;;:7 -;D(6'ZYU&,585?8^
M22X*6&E!O4BS"OP+8Z</3@7ZGZRN67H#&XP=@[6%;]H@A3(*A4!V0E0D^U,D
MYRW/Z5G11&$)]II51'^!Y9JRR6O32KFVL.SZ!B9]J0I@_O/3)<9@DF:=43YF
M6$:@-PA7)EC@S15["*.L#\N/NA,';H=08)11A.Q/A+ST;5%-3?M!]\Q\I-FY
M4W(K0I1VARC]$"%*$:)TF!"E&!?_FGSVYU%7B0P^O)@Z$BF/>3$.%@)[;<Y5
MRJYF?X*+W6:1@&]JD>LX>GB.]Q^S3[/6S%S8F0G$8K+NM\FTK>TF<5DV^#]M
MY]N<R;S)J.?V(NG-T64I:VF3+WX>L2PP&.0*&<TF4H9^H0U2*KPC&_P(-M3/
M-(^A;2;5C*;$MHJP#[C>,]FHO=AQ1JG!J>Y3B2X;56K?\.(%Y>E@BH9%F_4@
M#>^2><ICV)'4:6@?A*2"2_$5U/ML.*OZVU^M*,P RF!7!'C#;4!KY">V!FP.
M:@^>HG %K3OL^$NPOY&_K$7*[O-;V?;G]/[Z*-L>/3J=+VK"E[J4/YYF/\<-
M%R%,S3C1""&P!8Q>\3,<;OIKU[<O2M#2ZCV03*J92RP#0;G"<HZ\2,G_PKS+
M7:>D?;O/X[]0TTWM4E4@P54 FWOIR$1/?H'SHNJFZ=<$'G4H$8_LBH.)L6(*
M[(61#2%I:4C68>;8$C_9R5TC_E2DA,]0[PN3/:=4]E:%[42M=^@L.FQLSG2M
MK#D^?\"*P1T^(;99@V_MF^H.&JU7H(;UAMY*-S=4A$-XL#RT+ 5R>RD"?W9I
MQR@4[D+GWNV<( !857<O8'T*U=48;ZDVLJ7+DA(6_(\U/5H5$A$^D^XZM;*E
MQ4VF@<U5N:Z(@3S'.:*&AMC!,<>Q&V&@GSDVE68./9CTU@73.(+V@NGU2,M;
M[L_+F,B)IO2W0+E]]@ZZ!:/I(.)X1@*$;<X95>\6BN7@_G4=CUO2CYIJC;@V
MV(UT\, B)SB;MUT9_"I3IT_++K.[X))2NL.'&]^"U@AM-Q#T-1*GI7E;0AAN
M#1NAL.U("<HL*BS9:[ =:>O:;0F<J=/Z]EA28L\._/[8KOZE7TEH [WZ?(,8
MBH?DF^"P+FB7ZU629IMMU<V>#VH6>>QZ.BC6[IJ.$6&AF!>5KN]HL?@<&P8K
MH(B^LMG8@_;7H &C=IWIA69W7[%Q^V],0Q,Y#LC3+D.PM@4HYSSR6VTF[.2]
MM!A)"YBG]V"V&FK/*+B>7G!EDQ-P#TW)C=E5[;UFRS*LW:@2CVB2@L%:<:D(
M.9$96#,G43X2N9OTQFKIY5(Q6X\9#01I1L(8%5A3M1;X-VPQT-%F^X[L-JQ0
M*U/<9^0%5H0^3K7535]H]/VXO=%BQFV/.QL_(>4V"\;;V;U=G23>"DR=V:0E
M?3LP0/[!_9G>UDFRUXX(BTDW,7S,N>"WL[-@>#6CP'QZ@<DG)Y]<2^<C.A9O
M9^?@"Z*[%,CI:#7]]H(4G<!L4;;5(>J4%?J)&,FSZL'&=,8S3DAC:&%!FN^,
MJKE)S3%3?FT8#C]=[G1\(Q9@=RS VX@%B%B B 4X,HV]B!K[N#0VT9PX$HFV
M"W>_DI9NLU"0.")D"XD!M4 V$=E<P2]<4&XL14A<GZJ2, X8I#'9UW1CN:2V
MY*.0!KO3'V)+\P@;<4%F[U@'NR=0]:O0ZV"O!*P9INS#.9R/9IG*=JCD; =
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M^WAU.6UU$/7:=^#![P;,P' "I2+E/1G'(=+%06C3$">F):O[[X95E(KU6&1
MDZU6R'JJL2TPF";7')<P:##)> $CUM3&+6DU&KY7'4B*!+G-B'A&IY3@WF53
MI1CC:_'8^->]^WPMT?P<XLH<?* +T$TP]%^FAHJS%[D;'^\NLP8:P5_X%JL?
MK+J7T2"N6)\@=-J?U2Y2;6CA!QL+#\^WI+5;\=7<]7VE42%4P(,)&?2<54YB
M8$N64JJL"RHK4F]E/O+V.M3?@A65U*RV*02LVJU@;BQH\VLV4IP'<P]1K)NZ
M-R'=43UZ<OS=/C3K:\2.P8W^I<X13-[XHZ(@WI\@?MLA,%,!?-.U.!<K41.3
MM#JTN.5PA5M$B<=E>H/N"L2<VCF)O;L.]LH^J)7V@"K>(F%Z#=I'?,4AFU])
MIZ/:A\&8]2AQ"(!.BJ+$CY$=2A.1MVSX;LD/$;RG-WJ_:1!.M.;WK$3.OKO?
MG/<EA2X-T-+%,YSF/!?\UC"FZ@8"NOR+=L"(3%#7NZ@7@E.T?386XIIV+"VB
MX>Q+,-B$VOI20S)CD4/0=CL<W834 4D):H,9>#3-*DY7*URZUX60)*JQ'='2
MW&+B(N9\R,+=-BKF!\Q6V%8#6;8W1Z; WX;$[/'W_JFB)@IPCL#;(W=3.OF8
MG!KW3B. -8\\'A5-$8N>S)S[9](F$!RY'FU4[/0IB/==\8KH6WH]/Z>^VZ;I
M!S!L,VTY*!X3OAXE^;52EJD@)Q/W>=NW\[M"&"*#?IYCVU%H!\BWA,'?>UZ>
M?8263U__@*GBSM]VH_L@UB&5%ICY">1\]G#N?G*CN[=*+BFNJ57@$^^P;M9Q
M"%:JX5GWU&:WHS@K)NC=VLJVG?IY "+(%FOI<@9/+SM];.>,*6G0;E/DA>Z.
MD+<?;;% 3D^7MXH.1/^\J/H]A!@^F=CWI3)HJG5#/:B5&,;@:HY$L\>,L#7D
MB.'LM&X6DJJ6P4)>EA3]\BK"K!%@37K8$-RSZZ<Z/K&KJS)80?<<IVFTRBEB
M!Q_G.9]%[&#$#@:)'8P4RP^8:<5>EV)_9%'<%[;:&6@E>:Y(-%K>8N>VUD,I
M>OI/Q=^LF:44UF:7R!J"Q[ (F0:@DWVCVI!&U[U3.\Z@_OCX?]AJ_=-5<OUE
M#3,5S:]PS*\I]?FU[!_KII(-*[S,,4\Y;4KT!)'[<^I9X[@%E#6.U\(C&JJH
M=)YUS /L,0]P=M)WV?2R8B3_P#;L[B:$X8@ZL!<<M?1-$@1Y>5+N4?YXB"(?
M=#)12ZW3P.@]=Q(^^D J?-8"SRT7Z]J&I]O/ZZ1FT-VRVPB&PK\PBO.V<$3S
MLOS3Q)-1)D@/]4DAXU;UXW0XU.V:4\-CL&/D8C.H: T!@,;7*&B924'*9K["
MM_&17)'I+IAL]1$PW1W8"VZ'"Y-\42*#Z5+D7J.*%+1P2?!,)4 LR"YK;*@\
M;97?( L#AJ8KC5J IRY4;ICE"3RHJ;B!>BK)!":.%DQD'K=&Y&R?(\6G@^$0
MRI[#'*=B@J%FF814QTR[2XNJJGJS"PEAY_IJHV\#DSZHT!";BQNJW16;*X=M
MX$%P^X7ZQ"E>_'=7V6*UOLTRJAR0LJ@5)Y[A 8$1PEO#</\%OVGG7#P5BK!6
M 4=G:EY'YY?]_:X918I2D</+&W0JZ6'Z>OXEY3QK4=5G0V/4KB$-JUDE16.
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M)Q\@;,EO,09P'62.S9=YQT/=U>CD-)?Y.<-6&JDS1U7;M*&-G_&*YVF:$''
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MF:*N-(E6<QM&&757[*TEWX^UUH=KL0Y -%]VI; X$(-Y*/([HI0PSX;8)J(
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M<-$IVK0+$33W=5J@')'9'YO.<?CQ3#4A0K'7A#=&7+1LKUQDZZN=R "HK0Z
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M[M(H'AAYHB="LA*3GI2*[DNKM256'9N2MVPZ[\,BO=L]HAV!6:X.LSP1F*7
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M_$-W#KF6N8/KZ?.GR.;]IIUZU')R )OEC18_!"R1/QBB8%17P75XHX(LKWB
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MW$CB0:_-@XZ6C$[I4$ZXK[N+[R,8^PT0Z0R>W*=LT;#:'(A_>XY%@50%)[[
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MF6L&Y_OU0@;$KM<&O?I%D Z"=-A/I(.D^M;KC;[V/=7WSCA3;X-WNCG4DXR
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M?9#KL.1YIY6:8H/AN3490S(KH?/OMOUP/\D+G=YH,949ZV6?Z6L:9L/@?5C
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M8MJ<N1AF6=O'D.'QVL+QD.7=W+PGR3%M+\=T^N0=#[.F." IHYJ;OZ;PT]Q
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M5X%D*HOKRZOX\BH;+J]RU-E17U[%EU?QY57VSG%PW[0<%>NAA[8H1<?7.W\
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MUZ?K:5W0T6CZWK65+EN7;]CE&W;YAEV/J*4G#YJ*TJV!9:>BV%+JX5)1.H:
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MOY)I'%+;#;J77 "<1)2,?>.G;5O@ZL9/NCL*M;NS3UWUR(D'^[M;W#;)KH$
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M-7B:8'$V4-;T2+>\KEU(G&4N.^^+M4I NT$*83":F./OEAKH1:\+4<?+TL*
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M8P&2KAHF6>-T$ER>KC8W*(SHRM"VEUJ!HO*YR)]VJ<@8=GI.)B+20A.ESYG
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MKA1HA&/0J4U !^Y,ENT"67+91B>P]US"5$7G\[0TG95-$W086\F,',%.%=M
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MBTA^0SAN)4W3 *UP?Z4>S.F27SK.M-)RBE,?\ZAK/-DCK<$VK7MJQ.1H;<.
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MF>@6[EA#0"]K]POPO 7PS(:74G#%!!!,4,)\U_!EO0[<M-;P;5-1%43;,^O
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M0985]Z98/.B27;5BD.?\V7PB\(/MND-.%.A4VSVGJ+$,T=EWR:V;-^3/%DU
M#($.-U NK61O#T].@6S\()O K0+9!6X5R&8[R"9PJT!V@5L%LMD.LC'<"OX7
M3<<MS*;J?_=1LJE"BL,=MA5C$C;S9%>2SU5T<(#E$IXDH.\"H ^>ER\% [MR
M7@$&>KO.RQ<<Z%TY+U\ LL8[ MR-9^9+SZ2;X,:Z68$FM\]DN)GDO[TMVPM^
M?YV"F$5= 56I"/\W3U*U90M=M:S16[RI6Y,>&/(#'R8_L,E1UG DA."Q6%;
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MY&S(Z+H'6^ZY[QE=Q]^6J4:P!")S(6>++A:K)T8ML+ /#5@HI?>X6U#=M 7
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M0$N6-\*1-RU^VF*@5QJW@9D>9@5A5CA\A[-UT.G6QUVYW4GHE#7L$H'Y XN
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M\EC1DY>^1T\FB*#B5^GMYX)Q83B2N2B2!K**Z@"7!FK1E"29J.1 >:'A Y=
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M[0.VP[N3!<PT%A;[BHHCX)M&Z](U2^F"6\ 2+HS3Y]TF]D1-1Q+^&';Z0V4
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MLA \N?0EF@2@:'AX@@S,A[$<X2\Z$(>>7QG2<)R&\Z:,/1X#)HC"P >[)K;
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M)7.;>V7-1&;*C?,H?H[,5EXC>%.,SE.__:;8@S<&64S*"C?J2G.21G %8NC
M?<:%W+60Y@W,K-?+6:%B7?:13.ALC@H>>?6*51)I+Q8B271[M>6OH&,A9OX*
M&'U>%QC=*?,(=$L /G"E.%-WH%("JDQU(6P7&&J9;TILCNY=R/QOBUPF'WZN
M\+2::Y5BO0M^9+ZTUFEZ--%TV$C1.FC$E>;\""5?V**&3Q6=DR!(6;E(+.<-
M9A+K3*0%QH!!R]+<:Y44=<]QG"GF&;PDW_/LS3]?/#\Z?10<@!;'#0$"G&["
MP1AI+[(IG6QU"8)KLDG[?\9YWA_E#9\>-N2^QWTR7 1"MO"M[;E]@!C>#*#Z
M6!TV5H>-U6%C==C-/5-O:W78@YNQW<;JL-M0'?9Y$S$&FWE*6]%#8_P>,*0-
MO$+T1/-2]]G!^,UDFD1]KB<:R'R/B?G48[+"7\_!+TZ09>KP\BACS\,+S0[S
M9X<]PYZXIQV35ZJ&;CQ8]N<(KPD.'&5H;TM5::=J"1Z0'2Q93.JBY#" ;^VC
MRSR=)FEBV"/L7^C.21%3L\)$$I$@CA]UQ3$30LC#O9B?W+M)^XL^0!9OPB\(
M7UPJ&_C%PK>8[PM7\$LC32P3M])-RWI2)G'B!Q"JG#C555T0"M%\TUS17F&*
M$W__>.-ET1/K_%TE>&(N'D;LI#< 8,H[LW3C;0Z4)&&H@]E!%NR*9C^8:FW2
MJQ'XTS-^.4EP)DT >,)$Q*X*I&>35\+!E_1PLI9"M]I6 \8]!Q&&^26"XZF*
MA/.P"$#]$5T_XI8PT(G%.U>\%ML3P.SAXPCM9,JK#GW0 09:\35V;,I""VF>
MKPUPVGC. N(%5/!90=_'V:Y+:5?5_V9&8UE1I8FK<NH;'2ST8L)ZD1;(1AUE
MA6SJ5][6S@ &@?&/$P4RAEPVNB"V0CZ-B'H'E:&6 IWF8Y RMZZ^Z+QXPH;O
M0>-VP'CS[ER/9=8F%!U9"H4.9M$+?$I! \!MPTN<PJD4H;SW")KI-DIO2YOA
M\?9J(C$;T'=I ++$,GEP?'KWSH@ NYD(,%J<LSN/'CQZ</;P[J-'5&N4W(Q:
MHZ]G U+=/1CV":$^D%*U$+XMFYIKV(9-VO3&%T1#-6PF5$S.%)!#/LM77*37
M:!ODNNHV.KK8840Y')@1;4Z/)I_YL'I?@ PP\ZPGEV,UQ\T[M,T[^-UK+%PR
MFN*$>V41<O'34F7-;A#6N+5FL6]^6SL6/37>Y)1(:_0_(8:Z<2?=QITT^*UD
MBMK1[0+Y3Y8J=07[L(E>P0Z8H2%^"_%.9P_V/RY]"(LV:6*-L+]@)FZY<T E
M[F!I!)#UH0PF8'WDZS;[PWJNN?P3Z5<YW5MGYA?+%.])$4(\I#X9/22"U1"*
M#F,HUOFP/O"!])>@\,HZ*;5Q1+JD2(>'\A':8+PL04I6E WLL*Q019#\97=/
M 3HQ1G5_"]7]:NC:/L;&!U&B>@0^./#8HOILI; 1173=&GRS:4O0RH\C4EMR
M0S%U&TZ1(?"*C=KP]FG#P2M#%:\T'/TE)1!2/:/*\5CR1/"66=8P2I18%FPV
M+22-X*?->J+Y%A&78-@GCQB[Z]^*'X?!("&WL#V 3#,C%WM"<\5\3WC6*;NG
M?+8R^[UIH<7H$KX,%R-2AN-*'L>/'G?Y+=SE@_=PW<[F7=J[-ROJ;VN[47$R
M%+9&9#MJD>LP;I%;N44&OT>\; -UDZ,C<9I\JNB\,I %^M'D%O#G)1X^\JDQ
MJQD+PUMMG1<?30FRS6XNU89/G;PP+$WR.^-OY!A$4(QM.[R4YGGAE7,C^.AQ
ML][*S7I+=BOSG%FL%87HFENHFP/ATE5A2$- 59S@!D(6&MN_M;,3F[=QT3\L
M),HKQQ.+-QRWW.W;<LFGH6^X4J6JH.:@:S7#?R8ZT].D:CI_"[0K)<,O=+[L
MI E>3\/1FF]T"_BXGN<V :E*;%G%%BE\GE(0&SU'6 6#%[A"<3LW:/4PGI?$
MM =>ZC 6,PVNB&><A[&8R=OA8S'3EWWOAS=CNXW%3+>AF&ET#8;K&@S>,YB!
M(U HQ)+,5";H&95V6%_(35CI8HZ%*.R^4Q4' 8ISF\3!7[N,0/H3W$A3^99.
MF/.]I *.8ID;5P ]!%<(9CQX&&-2;?P,DAFO^;+V,U\JBI"0QL]ZC?[\+=RT
MMR2 YH'Z%4A7D>E-:78=5MN4S6!SJ:LJ%6_[]SJ>N?H]BW3#GMF)KDT-UV$C
MQ02/SP020B1V.*$U%@5QSP,.MH6R<_,HJI?R 8:_<RI9155B+W2#\S/._F;G
MG8UO$NX<B9?X(D1><V0V;!%2#KE.*WZ^BSX$\"]]9'+3YO=E741S54KAT4*@
MI(Z<TYC7HY:YC5KFEJ@9N_/\$C_D:9> WBK)4XX:-CNLP5>]K<=;BNH8X/[(
M6)OSKJ+&GA*YGWHM\KH]4@QZA"N%"7;2A(R8V[TDO?%._U$G!6_P6PC^'@+V
M>]2KMU*O#EZQ@JFCTHH2,JB32DZ32'=&JV_)2^*F'/U4JTFF)J[P77I1L3_V
M43M"BZFD385C -ML)E@BAHI7?>)G(XI!V3YL55V REW/=<9TYWA[I%GO#L'K
M@,7]2[--]\$%:^)8$K<+%>O&8>(:_DHO$>3_S_ZHP6?<C"K@-JJ P6-W;3!%
M2$+@K]P/BG9.IYLJ;UNA=*%4+MDZ_50TB$6:Y7EL=[REF$BRP!5N6RJ47'JS
MXM!<^P.F:"Z;=,\$3>J_=X$T*F(FUID=6MPBC$#P+N>:JX3\062J&,,TMW&7
M#WZ3[V!)1WJ4I&(2ZB)8YD@($S$30E4DDYJ<'HZ$3LE&"!!"X8'EFWQ&X_ZY
MC?MG\':R"4!T(G[VU/%BH$1Y7R01V,-(3X?D82Z38 %/&$<(JLU2>Q6 "%VR
M!$ZM\A4ZH)N76J(BCRC+4.!9?CWF/Q)6)[@G4RNY&_FD;"KS 8LT: F?7H9=
M9!J5;5].'-\? 1PMOY>,R3?"1PUR*S7(K5$AS5*94J4",W14 BVLX16Z1(X;
M8H ;8O [(M/D:F*G<^&P:-.8:F9E-3%W+S+5+M"$K3-/D,;5%-R751Y]#(-9
M,H6_(]=H)1A@.'*2BM"]ECB#" QUC/G\,+"7ICD1:N91C:XPMD#F+R2+98Y5
M FH&!G!9]<7]#1.&H:#THVH5=Y(=C[E;N*N'#_ '$0>+6*JAIS42BC7(Q4:Q
MOX5B/WBIE_B*+8E&ST<AJ0%'(3%[K!>9DC-!B/(*'6'PM97/1C;<K/45M5:C
M7W0[=\[@C4"#X;3%EWZVP1&2P0Y KOA-,-=IJ^VR6(I^ X$Q('G;M\TMV3>J
M(-8=Z3T.4@\O4):(0P11TE+"B)SMV-M@D91XK-11U?:T&A"I)Q1I'+?-K=PV
M@]\W;%SYZ!9J1K( 4RP,*N)OI7#<0L>8->;NL.C52).6?ZA_@3&&C2Y>P9_Q
MX;>R@_6=DP&@^F"QPH YBM0$DR8[[ BO;XEI2<)=C;$)4IZ5":9AVIRJQ]O4
M:&_-FNBTSIO^B:JU@3:>&DK?7):DGCZR7>[/_=]NIINN=$29:--Y&SOD4*\C
MRQ,O+:RG25$B!FG6Z>M0!M>8.KP<FTGDF9JDFT#%N =:;C<;4,F"P>3P[]A*
M]Z;5IH_L$X-C71CG862?^ ;'[&UEGWAT,[;;R#YQ&]@GOLU$#-2AF>;((TV$
MV'.5S9A:4.(0JJP+2Y[+'JGA\&S[J\VFN3[UIT,H1!CV<#%#S^0]#H+S3/K"
M=AZL7"_>GKM:DUYX2'N26E$$/Q'N@LNTX=OO#=3QE:[F.8?R7]%C\3$_ISDV
MG86SD+HA,$OW4_MN6)04YTLQY!LS\89:^5(8\Q755L,OYR6U4J7@Q0O$8F2F
MRNC@_/7[%S\]??/J//@_]^\=GQZ!1_'@,,0'1"!;((0%+&RPR.-DFK3=!L2)
MJ F&7O)B@UC*I>;R IF@9VHQ*9)XIG_Z#<-%5;[.I!FOH7.5/IA8@;6C*;!J
M=U>9TNPHG!WSO?,HB6'CU%4!.T/ZS[S?@*NS:$2H)AI$[=!?1:0V)QAI^4>-
M7M0TSROK=#EY"PZ&XG?38K^2!=W_<]YXUHU>LMC[%,O=*G)ZJ:0'7>?K^,VF
MN2M"F/$2F]UFAGZ;M2/9<;RGE.'FWKJDQY20*(9^?V8*LPIZFK_AD-'8,+@A
M>*C:\,/.+FAT438[J?-=^NN*JY5(^0@P.:)ZQ1KC=,%3G)QW-+!K3%%HFS2Q
MZE4+Y'TIL?*P/2EY7YDAWAB$*65*"GA#OZ\S \50#PUEW^'\[O]V.S;[;1]B
M1%<*$HV1YZO.YV]\:CXZ"6)D7R<?G:L6D9@*5*2BOO&I1L.&6LQ3)VRRJ=(<
M+#NB:D]R*JJ6;N=>;-(4*(/Y8;4%VU;3NLB2<NY5>BB&J@JM1#88)7&>9368
M9>_-R^V_PK#G,ZPE6_D@0G;5L<J\4DGZ.(!E/&3BD1PAS&AU$R5X;TR;.B%C
M23Y^?-U37;*:JP03F0UQY1/M8-(:2/L!/E,39L T@PJV/([$'^\.!^T+/KGE
MS:X[<'LG6Q:\=617N$DH!<<1]DBT/@Q2R@@;U8Y#'/8O'F?&CK[3T C(&[#2
MX!&84N6V4+M]3%,2!B 8&K[1M3ZN\SXR*5]D@CL:" ;B3U>SY.SZ,Q &TB:/
M 9%.D7Y:)H:,#Q&5JD@3JBHK8'LU^NU]@(\(O3+U4K*6L8&J!,B<G,#Q(]C+
MG-Z"S;RKOIYY'P3.$"=7Q]H3#B)S0\\*=_.. M5>"S>RT@P-S6U$A;I5+\AQ
MBQ*=16B_XK.68'/7(H^4%5NJ0LU G\WE7<"#7A'%66,^=TZG2UEC2+0KKW9W
M3*E1.K[.!*P'G)!Z"3>1R9)^H_Q;:$2C>5RVIZ'0D4Z6E:F6".59I#_+RGD@
M4CF!^W&6K"@24205Z%C,PR=18PU"*3BD9J5T*-,MY)[27)5]7U3#MA)1=F/,
M(0@2W$<G1S!X.;;-_FPD%#.*<" ; =*0@'\!\E=:$CAY9BF[,JH+%6WZB['=
M@=ZC<G>Z(8X%/T%9YII.?X/BDT6NN\^=Y/E'<Z1@F*9)JMD@RV][7M3HK:8X
MAJ5N0=UH!^1-%)QS)';:]=Q@[,3*JV!UHW*SZ- 9_OS18ST;"/\^%"-(5C9X
MX69U0'80FP';M,$J 9_"K&_/1'C2[K0J6#$9U43/L%D?J222%U+1U]Y.%3(.
MR8U9&\V5Z%.*O)-[CI^HP,01TPT';&?F-]Q*LPPF$+5#K+$&ABA5:M#ZD4\1
M.TV*!::G,0K \46K/O/B(U[A*WR%/)0!P:&%-%+*KN>*&4WHIO@Y7G< 9VO[
MS4OLAT$!'(_O\I C&4MJ4]L,<AY(L3C]#4OK:$)PLB<(>?(V."H: FC3J96J
M#7@RO"_W?3\:O?+"6\ES7D([M_T!@?W:HACWKN.D,JPZLAL'I5O]-7Q'[[?_
MZ^9<3#F?>_2F]?S(50"+Q1RP8O.Q.VD9+DG]=N?*68+&_H,[]RADY^KUWB-?
MEVSYDRMJK%W; LM0L_D6C/$S00GN<&N;P1?O+<4YTET[_$H^4<M+;GD/\")=
MLRI?\G.9:_P@.0RB0N/F\OP,.:#$S,KT)^+2P(%RG #LFS2U#B"^R8+(K'J&
MFN,SX"%_TE$KK^ZA7<FCN*$NVI6$<ZLS?D6![$I.L 9'(R GB4[LSXG<M$2Q
M8:>8.;).XZ81M;BF"%QOGL D*L5[3>*K3-$$TZJ%YIFX]Z/87:U5M[5AYBF4
MEB('L<T*[%W0/^;C_='T_%4<X6,D-$BB*\3X;_Y;;7N'JTI[R1W=' R_+YI"
M%(6TCVS( ,QRZ3 .]_)B?6#28O,&5 BO\PI%EOB7I$<X[I69ATN6NXFR9O[H
M MM"-'UBJ0R ?8$LT57PZ-Z/G')$^ "ZQ[!%,+\>FR;F&U8-7EPKE"K@!3@R
M$@_HF2(_L3E16#U)CH]+;S:C@_:M\;YUQ<RN2!<UFS?&/U>($H"=N&7@^Y#W
MNADPK1$;/6*C;S2>[N;/PXB-'K'17^&]3T]NQGX;P=$C.'K$W.R<43\9)R""
MGRU>FGQ=+M169'F?W06?,@,[7IS;;EC&=W?![]R>FF^YUA+Q]@M^+9;"=1H0
MOM=>>YWKA:<2Z =/8G=F?&H;S:/C\FN%+182\8S:I<@[RY#WT&#WZ =V(M5&
M5HF;PRHAT_>7O]^W$O==622^UI'W7D>@DJI-\%PO\S(9 $(-,P"^JHOYQ3B&
MYS 5%%UHJ4_]"68#U5F4+S>MR&\#D*' RY1Y,[<?5%II>%+ADDKVG./R'E.<
M0G'V;FK=QS4YK'O2R,@WBOVIQ/^L*3RF/J8]K2Z*)3?$ 8DLUIEMU"88I:0H
M]"J/",>7ZJIB,EE)PPQ*_%[:MWM&;S<@\4-D;()L+;S6##F:E,SB6X*@E5-J
MX[=I*AQ*AF4P J\9,$8\N= D2BAT>X"<1YC2 @.J1#"7,2SM-^"><:'6K/P2
M"NM2QRJLG.O4T&$60A2DAYY*RK+6A86IS;UL(=IN&KL+I]H]JK*[!@>X.N0;
M4(H#I/SGYR^>P8&.U7EQ(+3A(.Z8*TPJ:MBQ=5*" S<1T<<L7\-39VQ&PYC>
M@X$)TQ_\$R9!;X*G*ON(PT-<B<&%\)L<"DH81@9CT'IA<++,E%39+"#H?(++
MP%M-+6WSLWP!%OI:JQ1W_S1XI<I21?,:^\*6(=X&<T@9?]$>-M0D %ZI3$"D
M$*8X4NM\%7"$S=3&N7@L!DW82"+BTN(>1(G33'U:8:HM#MJ*B+(-Z<94CII#
M@\&7MC,FGQ0H,B9K<GH23.H2T8(E)RNE)QO1YE>4!/<RT>0#"G*!LHB4%837
M: ^GDU7N(KO,'@RF-:;V+82,DCY;;DL;8@ZZ7;Z(62:\3T9=0U0YMYTYO#S5
MM$,,SN!)*HYMG7M2G4NW@A5A\+L,JC,85T^L^&VD1-;I@2$=?<]P3M[*G SH
MW#/]6;"F>&/7VAG4#OSH27*6BR"+MNW83V+*=63&@Q$V=H.2/HQ;A8W:,X)6
MG/NF/T(!#"1$QY?"W]LA"WX72D*2^M 55D?"?IPF:<J)RW9:]GB,N7W!M,"'
M/M$QH/E>Y=?8A<Y*[Q#V7D,/6H?Q\_V/+B5?</U7XTI^__5L"R889[RB\5 5
MO7.=$:02"(E"/]H_5@LU8ZJ 2)I)M]\DUE-5IZC[?T7KDPH9F,'!\%$^YRMN
M(P?EV1 X*#US!,M!ZU(;(#8[(]25#UONB?;]DX(;VNWG:F:DRE]%IG?Z!]O!
MB\J1Z%R G5<*X ^]%?"<!*GGH?DL.@[1=NV-%]H!$?1<3#7> R&([.\UNF,>
MQ4":F*;"D:I+]GXH7BXB[UX%UNSW.I:W<4,F$M>-:W FZ!V<4/,1W#)5:[.]
MZ.XU/QT7((FDWF#'*;L&QZG,L73//-P$./* 1FWNI?VZL'\OW?G:7/(OL,;^
MU-\&/7!__]5 D[OB*XJ&;%KIS$*>C#F&IHV<VG8XKU^,<AO$Z^ST(#H<@(@1
M[X]1=:BHNIK.VE3--E;7/GK$6FN*WA(EJD)GH'LT^ K65HW>:_G_3D"[MI2I
M!(TU&(?@&Z&0NPB>#3N'GO;W8H(^,4WW;19:5V9;8 1BEA-1%SP1^;]#CIU1
MW27:KR9$T9DMV"Z$=8?=S26T-"*S(!.5?2SJ9<6<-'R Q7H"MSOB:#4/7 H#
M2MM]S&2JOX1R<!7P&H].*=*4TTO8>$T]J&=B6[O5M2/(#<T%+#O\8UM]8R]N
M[G!(9ZWW0BX#A<?T!#M^)"O1A[1@I7D62B8<VB&<P6N<*[R>4_T<((YLZL L
M=#/@BF96E*IDP=';GK24$!#EL#_*>M$@#\XTEAXHCJJ*@2%&NN7\\L  7,9
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MWU?8N2)2J4QE68-:\5[O_O&#+_)VQ0 :+L >SQ"63+%T41"V@0#AFQ&>0TF
MYQA@'Q3:\ITY>.C=]G\Q+=PR=+@0+#?P8KQ^R0EA@BG-Q-;V= I'EA0;N'),
MQ(;!Q0:=!0?M(L]TA?(BZ:)N))D@]52. &>DXT6JUKFY3\E'J"# X%A-LDB[
M$MB6L=)[;'D!<EA&CH^C@\"@%?T'5J+"1W^]$YZ</@P?G)T8X;US=QB2"Z\\
MQ$HM6!ZD57U?3W[W3"@O76T*H\K0M%=M;N30(VF3?5!V(/\[\^1)FW+5/J1G
MSDG:R4-=)Z7>UB&J42!@Q'MT[O9")K>QN;'KA!@"@X3H2-+6X("3S\6R0A-Z
M2XF_H107(;1/VBF_!\1W:K/E4<ZDUXPJ7&@QZ_6GI"1?M?/])BV[O_F<0RG4
MQQX[-DY'V7(E+TN*;G-U17IDYMF/1OB8<QKQ=<@+A.,(J014T9<JY;.#E$K[
MV?3A%J3(SOUN6/M@EN #7;;SQ"^0QEW<-'&67#,ZDADB+@.'J:BU, S3LQ57
MJ,4&:M 0F18YH6M/)]!Q#*)%^8JN8)J%WN+5=LIV9"?88W:"!\-F)_BU'(!1
M+H@?V\7-*AR*^DD Q52%O+7QKU]+OXV\&"035281%14V0WO;ZLZEGP/!.1*G
M87$ J5JC_52 2H!_?Z_C&9DF]!$5XF(L';1^G2JQM:*<>CO&8,50CS?XF<-U
M\$.:1,(W;U50V#1YI,M/5202ZNM@W@2]B9@L.78<=HPB4?RA01([:LA*ZBT/
M_/YSX6"\U)=Z!N?].V\R]W]3&$^5'4\5S9%48[ +-ISU.@P%WP^VH*M:21/0
M E)@PO$&'9POX(81W#G 1G/!\Z3D&A@TU<XQS'#W+/CU^/WQL^, <[D/G@2G
M9Z<GI^$>@1[XJU?A-=;($O+''E$V;PT7'E3Y3%/*P_-L[2%![DR=S@A_Z)P(
MU,]5/AR-?/[\?/^7TMO2$JX[#)0@_\TAW7.&>V9'QSSAEDM!G$>UM-1#8YA[
M3=^22LZ[=_=?,DS'E&2![BU%+GXA'I,%UP6?UZ#V"U;EM[!8]]'^K_ A1M\Q
MG/-[721EG$BLY9*CG4LQN!VV-<?!VZAR/.E3),C)8+-' HUGO>+]'<MR5QA(
MD;B.@1&U*-N$G.T>X?5-(*S=((\B0HY  H%#.;:+HH:74A#6ZODN3>I17J-4
M%8:$:(MP;_JFR-01!:LD3SUJH([%YUZ)JJDPAR(U:NPR-4?&=R5_T-2M2&R)
M:TCHDX7*,BT=P-=YG<8!EB%T$?Y]042B6,)E"5W[=!R!_3R =_Q(H! J?N$(
M&YAL6*9F*0HPB+4LDNQCRM K1F5Q35?9YMTCNAU^5WH?K_"[[[TQ]&7M XIL
MXM5>A['%(H]IQLVY%09-U4-&Y_-S4Y5#Y$JJ &=Y1M'2GJ5I-^5HMQ8Y/6E7
MZS5K\^QBF9HEA?T*X=WJ11#-53'SUE,:"YKI7N;P7AL40.G:V%/,,E5)BJ6M
M4N$D3<FVP7J,=C+K0KF(=G66N[EXT:CFO1;RS?5I";&1"[M\"75I@YTTK5-4
M.U-M+ 18>".O^(G= [B,7%0IHK%6)>9K< .FN1+&H33/2;XP/AI50CK1C >4
M)CG4$B<>H]TA4J36N KO/>%;!X:L P$JGD&+VK?TF2Z<M%<27W7S5I5N>*3.
M/#U*N2H!A,$WI->GJ##94JH6[9LF(*.QZQ?+ 7?B%YFZ^E'8D]JDO=Q\8!%;
M*4]1?O'S+AU39ZE:P]H99=/>&:P*\$K</<N%U+0MP%V'L7#M'662J;.3VX4N
MU)43!53NYR*P5S,%QG,BEH+[K9))(>X#D]#YMZ!/F)"+NTC!W9AU+3C'N[J5
MH8.T!5#M54JD7%BCFA=!@*9]13I]\6'W3DY@HYIA4AJ;21=L3T9?J CIA.D.
MOG@EV0DF4:[FA>U-TAQ^L]]*7K0AMCK5*P4G:&F/9%8 6(IJU!'F$@03UN14
MHN1)3XJE+\UD>W@7=6J[<CO/KC)M9??%>;NZ=WXM_KWAU+J,U6R#J^(:YV&L
M9OL&\:];6\UV=C/VVUC-=ANJV;8@,TZ^"RCCN^(+OMZ.ON#V)&"((Y?*1#O<
MK*NA^2TO/@I$JMM&);RN6=[K1;OP#@>IA(*'8A8!NDM)*GXA4J_H3]$<6Z:'
MP5Q36Y8PF"ETBBNM%B%7UA5)1)$VN*/"Y/I$;_(V["M2,.5)M6D[(8KR.(+<
M4L0"@3YEY(?][/"]9HWM&,.N!K!4]<0-DJ=UD27E7!S3#@KB^#K6^5B:<>4D
M=0/,& KVK+-2P8'MG(P$]0L/0=[35-@4;(J0D-]>L1_<"9$2'[N#?.P,A6'T
M,(EJC.?U178Q"9$O.5F!+)!$R$,>;*HF](V9ALV%TG9X&,)6^\@! / ^M D]
MD-,>4_A:'-Z\QULO['O13C<%$\8<XO;2A47[,NJS@]_P(T02M@RO-&>,<H3)
MH:Y+R%JNF:]2OMS%S@<'5J.UX*O2 RK)+(P?MQ\&'87N/\XQ@),(P5669T<>
MCLA2JA.,7P78RALE$#ED-093N9H@L&H!X:(6D]DC.E3_2WR:7N6OX0VZUHHY
ML:  I8E#&MY_#U1Y>-4%PUOM3(UX,]-).YBP(JPR3$)/;U[#2VJ"NEN;\S8.
MGY[^731#&2-"GR%[5FEYS"2,R/$EN&,FX6(.!W5?N"F-E@T-HW&$+;8YH+[
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M2G<%0%0L.DCJ5LCF4APFO$^,N\B0<SO&CMO6TF (<&LN7SNT>$0\$[?R<U!
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M6XS&TK30PF#E.$_-,C\.@G_\\_R9^3TTR"_. AT@@9-KSHZW.(^2&&SMNBK
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M\OZWC8. 1/>U)(MJ,%2)/)\XA2@?A;?V+Q7BK;=E)J75O'E85-G#+=J%3.X
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M$+@YPVG0PZGIRO,, #V4V./:*>3H'W_"0KN8>=Y?L>3C.F&B?9>HEH_YHG_
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M%*3*REV79*ZK47Y;9DRK S_!BFF"17X>A>1\5E/=?K6121K30V&'J6^R371
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M9W]HQHBT.P.T:SQD$_?WYT[?C^'0PT7ZA![H8UA>'5[&(M:AZT.R8P0?WPV
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M^I% ZE/TD>TMNDI_%8A@3FUW4T@\8"S=S&[T,FSB1E9@395375BD[O:0[#C
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MLV$+[W^HOU41HPUWAO4I!%0\$+%=H50PAJAWB%< YSI.C9!1J"IL3+,\1H+
M3';G-5J/UA!&1 !B9Y+V?S;*/5DS%0(,'Z *^3H2H5OB!C;;S@=FM=\*:9'S
MJ70C;!13=/@G0 C"AH0IFFHP4:_K!!'P,QST H=I*)7!V :IP;V"-2'RPJF"
MWQ5+=UUHT)49-"SG(A>8O$IXJ:(T1YJQ:PJ+PY4+%OQ>9YZ,(E5(1HPQ#[]5
MCJ:\ 49L)I.-Z870&M_..-KB455XPAV]IEZ2,84MAW@Q^A;@-U%4G[#$") _
MFMDE8(Y+7@-V*IKD*J'C$"',!<-\$M)75]2TB1VH99>QY KCPSAM[[B]$2;K
MG$E,:+4-*(11/7V;@G=0:D'%[=@$0XUU$572W/&(#R,WYV U5#YL#76I8WVC
MTWQA[,KWS/PW""W5UX3?.N9X=4R'F"(K"#438 4A!1%('&7YC8NE_,(X-1XT
M025JA&;-BS(Y#)340AVQB$S5!*,M5-+,/"R52E($HQ0!><\S"*P?:11%C5$S
M=L$4Q&>PC$R'@!X!_; ,)E(OPLI)8_:M]!T URW?U;&D 5!#EWE;VG<X[3&L
M\PG<%I#=LJE",W\:_V5_J=(*D\+)',6K#FW18^CF%A\QS].DG.&=:8[P V8!
MT+_(ILEU76A_\A%+QZAWP:K)I]LTHW8&0H$I",Y0AP5;+B@("O$C6S(Q@A4@
M800"Y//]K'9EO,(_92 [%<]6J>::7"G]*>GCWPQH7IIA+7H&J6,A+8@-&98)
M1LK#49W3PR>Z;^*[N^37@"KV.07*XYNI!68PX(R% <TGK:*01<C,B@ZF?V&%
MK7ANE+3U/C[T)Y37"^DW\;F3"<4'4;-CI5>(X=,"/4"*!R9XKS?31-9I?L05
M>4:UP?,\!@D--^ '9=[*PP0Q6JE[?7-<1-T@#[0#VX)5E'BCFN14E$"\HK?!
M-6:4948=FYD]S/A#XT3Q/FAL(3,R9P"W#4S>G'+=' 6,NY@7R")*"1BN"5+C
MGGI&A1+$,"*\([ P>$%*!$V2!/L[IYBS6N!D8,FSP<NP9^,>H4*6(U=1&RBE
M/I1=>MBV&'7ZH]VQ6)!LWDT'-M$$>V'&Y0A2>@*[9 '7N%(L/TH:D:>70D\,
M>X*$_T3"1/[$,L-<YG:YMTE ]"[L]21X4$DP_B.;=^V5NV_J'/@);XEMAB)!
M@JK^U0[MM-GM XZ$-N0J+>X2LQE:&\GW92J352B;41TB%>NC G9BK^^#K'(Q
M4D&.(>_JT#N,\A%4U]'Z#GQK*&@S0A3-:"G?[8CY*LT#^FRJLO;>$V 12KAP
M8$]93SUDDD%A4VLN >E$V/)U(:QE0JP&=XP$*6,]^R#JN,=Y&.O9?X +^FCK
MV4_7X[R-]>R/H9Y])$CY 67OJI3H@'&__%A1R($+[^>O<5V,KU(TG9@I&OU>
MA +M=8K+1Y$A]=77&.T)):%<,'N)&;#DS[O^D7DC_3>%R379;#=8?#M(ZI1M
M>0J0M\U]*BKJ-ZKIUXBDR;E@,J?#1CT1^Q&&#1%'3#> #8ZP^F7'_8DUTZ6
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M#9C->#J0T&'I1-<K/1 (X@NN0- W.A/PU@:G1#G+ZQ3LZH+SB5P#'$D]E]0
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MCG>%/TCIA#.:W5G8J.-)D7I?VJG %M4M%8_F8_VY4=AEQ__U:L^P]0+KE[E
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M/F!LK2G'O^+8@S!,PZ+#?)F$B<X'=#[LQ_G /!8. I_)J?K '58A/1$,B1>
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M5,VYRE82)/1D@E.N.DJ6QO1(LZ90K>]_Z,@9> $^CGII,,W;Y>E/[V0UE7C
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M*):U//(X[7*/QR,BN[Q0?T3>ZHW3^;S9X?;PVB0[U>[K.78W<[1$W,_O*LI
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M(F3!""IMDQ_"^<&#S_#I,!?U*"][L368\J'+U$37Y6E>I7H$>:;0>0KJJ\/
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MO^X!?E_3IQ^[!_9[GOX'4$L#!!0    (  @Z5U:T GS@]00  #DK   /
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M),+,\0A?DB(K&[]AUSSZ>O)DV"T?F?T74$L#!!0    (  @Z5U:P?@;3$ 4
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M93;HZ)]AG#T;=(J?;_P+4$L! A0#%     @ "#I75J&LG) MX@8 YDT( !(
M             ( !     &EM9S(U-#$Y,S0V,U\P+FIP9U!+ 0(4 Q0    (
M  @Z5U;\+T^7V4</ !S4$@ 2              "  5WB!@!I;6<R-30Q.3,T
M-C-?,2YJ<&=02P$"% ,4    "  (.E=6-+WZBC5T  !T?   $P
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M;6<R-30Q.3,T-C-?,30N:G!G4$L! A0#%     @ "#I75E.M##TR0@  !54
M !,              ( !E'X8 &EM9S(U-#$Y,S0V,U\Q-2YJ<&=02P$"% ,4
M    "  (.E=6!*T-(WWM   ?' $ $P              @ 'WP!@ :6UG,C4T
M,3DS-#8S7S$V+FIP9U!+ 0(4 Q0    (  @Z5U:#T&5ORRP  (\X   3
M          "  :6N&0!I;6<R-30Q.3,T-C-?,3<N:G!G4$L! A0#%     @
M"#I75@*%<6L&B   %9<  !,              ( !H=L9 &EM9S(U-#$Y,S0V
M,U\Q."YJ<&=02P$"% ,4    "  (.E=6=S#)MAXN  #T.@  $P
M    @ '88QH :6UG,C4T,3DS-#8S7S$Y+FIP9U!+ 0(4 Q0    (  @Z5U:[
ML7^/58D  $N/   2              "  2>2&@!I;6<R-30Q.3,T-C-?,BYJ
M<&=02P$"% ,4    "  (.E=6MFJKYT(B 0#D40$ $P              @ &L
M&QL :6UG,C4T,3DS-#8S7S(P+FIP9U!+ 0(4 Q0    (  @Z5U9;29_SQ"L
M 'TV   3              "  1\^' !I;6<R-30Q.3,T-C-?,C$N:G!G4$L!
M A0#%     @ "#I75N*+DW+RR0  H-H  !,              ( !%&H< &EM
M9S(U-#$Y,S0V,U\R,BYJ<&=02P$"% ,4    "  (.E=6(N4'$48W  #]/@
M$P              @ $W-!T :6UG,C4T,3DS-#8S7S(S+FIP9U!+ 0(4 Q0
M   (  @Z5U:<J'O'W9T  /*W   3              "  :YK'0!I;6<R-30Q
M.3,T-C-?,C0N:G!G4$L! A0#%     @ "#I75C#8&"X/OP  7LD  !,
M         ( !O D> &EM9S(U-#$Y,S0V,U\R-2YJ<&=02P$"% ,4    "  (
M.E=6'_^1UDEG   N;P  $P              @ '\R!X :6UG,C4T,3DS-#8S
M7S(V+FIP9U!+ 0(4 Q0    (  @Z5U;?9.:>1G<  /]_   3
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M              "  9.O(@!I;6<R-30Q.3,T-C-?,S$N:G!G4$L! A0#%
M  @ "#I75D=0[WO=E0  )Z<  !,              ( !F2@C &EM9S(U-#$Y
M,S0V,U\S,BYJ<&=02P$"% ,4    "  (.E=6N=,7%;]$  "K3@  $P
M        @ &GOB, :6UG,C4T,3DS-#8S7S,S+FIP9U!+ 0(4 Q0    (  @Z
M5U;M!6USE54  +UD   3              "  9<#) !I;6<R-30Q.3,T-C-?
M,S0N:G!G4$L! A0#%     @ "#I75H'7S2%9JP  [+P  !,
M ( !75DD &EM9S(U-#$Y,S0V,U\S-2YJ<&=02P$"% ,4    "  (.E=6OM8F
M82%R   Y@   $P              @ 'G!"4 :6UG,C4T,3DS-#8S7S,V+FIP
M9U!+ 0(4 Q0    (  @Z5U8FZV8 3SP  ))#   3              "  3EW
M)0!I;6<R-30Q.3,T-C-?,S<N:G!G4$L! A0#%     @ "#I75H5TXD]!B
M8*$  !,              ( !N;,E &EM9S(U-#$Y,S0V,U\S."YJ<&=02P$"
M% ,4    "  (.E=68%)PC?Q<  #5:0  $P              @ $K/"8 :6UG
M,C4T,3DS-#8S7S,Y+FIP9U!+ 0(4 Q0    (  @Z5U;-7TE-.:\  .^Z   2
M              "  5B9)@!I;6<R-30Q.3,T-C-?-"YJ<&=02P$"% ,4
M"  (.E=6AWK2#A0B  !8)0  $P              @ '!2"< :6UG,C4T,3DS
M-#8S7S0P+FIP9U!+ 0(4 Q0    (  @Z5U90I+U!R',  #!]   3
M      "  09K)P!I;6<R-30Q.3,T-C-?-#$N:G!G4$L! A0#%     @ "#I7
M5N+>NPBQ;@  3W\  !,              ( !_]XG &EM9S(U-#$Y,S0V,U\T
M,BYJ<&=02P$"% ,4    "  (.E=6)4XL,M"&   WHP  $P
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M-30Q.3,T-C-?-#<N:G!G4$L! A0#%     @ "#I75C;L&D1EF   IJ8  !,
M             ( !]@\J &EM9S(U-#$Y,S0V,U\T."YJ<&=02P$"% ,4
M"  (.E=6QJA.OP0@ 0 71@$ $P              @ &,J"H :6UG,C4T,3DS
M-#8S7S0Y+FIP9U!+ 0(4 Q0    (  @Z5U9K 9LJ7^   +GO   2
M      "  <'(*P!I;6<R-30Q.3,T-C-?-2YJ<&=02P$"% ,4    "  (.E=6
M(Y],LUUM  !-?0  $P              @ %0J2P :6UG,C4T,3DS-#8S7S4P
M+FIP9U!+ 0(4 Q0    (  @Z5U81.H&:H#H  -9    3              "
M =X6+0!I;6<R-30Q.3,T-C-?-3$N:G!G4$L! A0#%     @ "#I75DWWT+A
M @$ -!4! !,              ( !KU$M &EM9S(U-#$Y,S0V,U\U,BYJ<&=0
M2P$"% ,4    "  (.E=6J$NT4TSK   \]P  $P              @ $@5"X
M:6UG,C4T,3DS-#8S7S4S+FIP9U!+ 0(4 Q0    (  @Z5U:LB"_W)&4! *F>
M 0 3              "  9T_+P!I;6<R-30Q.3,T-C-?-30N:G!G4$L! A0#
M%     @ "#I75JC]+\Y.)@  ZBT  !,              ( !\J0P &EM9S(U
M-#$Y,S0V,U\U-2YJ<&=02P$"% ,4    "  (.E=6:@>(4C>?  "]JP  $P
M            @ %QRS  :6UG,C4T,3DS-#8S7S4V+FIP9U!+ 0(4 Q0    (
M  @Z5U;KVF=LZQ<! #$G 0 3              "  =EJ,0!I;6<R-30Q.3,T
M-C-?-3<N:G!G4$L! A0#%     @ "#I75O5_VZK4-@$ [ET! !,
M     ( !]8(R &EM9S(U-#$Y,S0V,U\U."YJ<&=02P$"% ,4    "  (.E=6
M2BJ]R96^  !2SP  $P              @ 'ZN3, :6UG,C4T,3DS-#8S7S4Y
M+FIP9U!+ 0(4 Q0    (  @Z5U8P+AV@:70  $"!   2              "
M <!X- !I;6<R-30Q.3,T-C-?-BYJ<&=02P$"% ,4    "  (.E=6E)%_TG'!
M 0#E4P( $P              @ %9[30 :6UG,C4T,3DS-#8S7S8P+FIP9U!+
M 0(4 Q0    (  @Z5U95GFVYVF,  "!T   2              "  ?NN-@!I
M;6<R-30Q.3,T-C-?-RYJ<&=02P$"% ,4    "  (.E=6B2@P4L-"  #J5
M$@              @ $%$S< :6UG,C4T,3DS-#8S7S@N:G!G4$L! A0#%
M  @ "#I75IRR&&T,JP  PLT  !(              ( !^%4W &EM9S(U-#$Y
M,S0V,U\Y+FIP9U!+ 0(4 Q0    (  @Z5U:'>Y<]07,% "]K3@ 1
M      "  30!. !K>6UR+3(P,C(Q,C,Q+FAT;5!+ 0(4 Q0    (  @Z5U;-
MP41J[A<  .(C 0 1              "  :1T/0!K>6UR+3(P,C(Q,C,Q+GAS
M9%!+ 0(4 Q0    (  @Z5U9Y#R:'_Q$  $L& 0 5              "  <&,
M/0!K>6UR+3(P,C(Q,C,Q7V-A;"YX;6Q02P$"% ,4    "  (.E=6BFGL)U=!
M  !,\ 0 %0              @ 'SGCT :WEM<BTR,#(R,3(S,5]D968N>&UL
M4$L! A0#%     @ "#I75JX3"92YV0  AN<) !4              ( !?> ]
M &MY;7(M,C R,C$R,S%?;&%B+GAM;%!+ 0(4 Q0    (  @Z5U9M5(N%K5H
M +HM!P 5              "  6FZ/@!K>6UR+3(P,C(Q,C,Q7W!R92YX;6Q0
M2P$"% ,4    "  (.E=69@B2*3@; @!+ 2  $               @ %)%3\
M:WEM<BUE>#$P7S$P+FAT;5!+ 0(4 Q0    (  @Z5U;RG3 \,!0  -(W 0 0
M              "  :\P00!K>6UR+65X,3!?,3(N:'1M4$L! A0#%     @
M"#I75F<?:552NP$ =;D5 !               ( !#45! &MY;7(M97@Q,%\Q
M,RYH=&U02P$"% ,4    "  (.E=6SD9AI@,.   #P   #P
M@ &- $, :WEM<BUE>#$P7S,N:'1M4$L! A0#%     @ "#I75CVX]6QG P
MF28   \              ( !O0Y# &MY;7(M97@R,5\Q+FAT;5!+ 0(4 Q0
M   (  @Z5U8*C#<56 0  !(E   /              "  5$20P!K>6UR+65X
M,C-?,2YH=&U02P$"% ,4    "  (.E=6"(%':_8(  "^2@  #P
M    @ '6%D, :WEM<BUE>#,Q7S$N:'1M4$L! A0#%     @ "#I75J0CS>;F
M"   [DD   \              ( !^1]# &MY;7(M97@S,5\R+FAT;5!+ 0(4
M Q0    (  @Z5U:T GS@]00  #DK   /              "  0PI0P!K>6UR
M+65X,S)?,2YH=&U02P$"% ,4    "  (.E=6L'X&TQ %  #%,0  #P
M        @ $N+D, :WEM<BUE>#,R7S(N:'1M4$L%!@    !- $T 8A,  &LS
$0P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
